You are on page 1of 961

Cancer Incidence in Five

Continents
Volume IX

International Agency for Research on Cancer


The International Agency for Research on Cancer (IARC) was established in 1965 by the World Health Assembly, as
an independently financed organization within the framework of the World Health Organization. The headquarters
of the Agency are at Lyon, France.
The Agency conducts a programme of research concentrating particularly on the epidemiology of cancer and
the study of potential carcinogens in the human environment. Its epidemiological studies are supplemented by
studies of the mechanisms of carcinogenesis carried out in the Agencys laboratories in Lyon. The promotion of
collaborative research among scientists worldwide is a strong feature of the Agencys activities. The Agency also
conducts a programme for the education and training of personnel for cancer research.
The publications of the Agency are intended to contribute to the dissemination of authoritative information on
different aspects of cancer research. A complete list is printed at the back of the book. Information about IARC
publications and how to order them is also available via the Internet at: http://www.iarc.fr/

INTERNATIONAL ASSOCIATION OF CANCER REGISTRIES


The International Association of Cancer Registries (IACR) was created following a decision taken during
the Ninth International Cancer Congress held in Tokyo, Japan, in 1966. The Association is a voluntary nongovernmental organization in official relations with WHO, representing the scientific and professional interests
of cancer registries, with members interested in the development and application of cancer registration and
morbidity survey techniques to studies of well-defined populations.
The constitution provides for a Governing Body composed of a President, General Secretary, Deputy Secretary
and nine regional representatives. From 1973 the IARC has provided a secretariat for the Association with the
primary functions of organizing meetings and coordinating scientific studies. Information about the Association,
including membership, activities and publications, can be found on the Internet at: http://www.iacr.com.fr/

International Agency for


Research on Cancer (WHO)

International Association
of Cancer Registries

Cancer Incidence
in Five Continents
Volume IX

Edited by
M.P. Curado, B. Edwards, H.R. Shin,
H. Storm, J. Ferlay, M. Heanue and P. Boyle

IARC Scientific Publications No. 160

International Agency for Research on Cancer


Lyon, France
2007

Published by the International Agency for Research on Cancer,


150 cours Albert Thomas, 69372 Lyon Cedex 08, France
International Agency for Research on Cancer, 2007, printed in 2009.
Distributed by
WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland
(tel: +41 22 791 3264; fax: +41 22 791 4857; email: bookorders@who.int).
Publications of the World Health Organization enjoy copyright protection in accordance with the provisions of Protocol
2 of the Universal Copyright Convention. All rights reserved.
The designations employed and the presentation of the material in this publication do not imply the expression of any
opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any
country, territory, city, or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.
The mention of specific companies or of certain manufacturers products does not imply that they are endorsed or
recommended by the World Health Organization in preference to others of a similar nature that are not mentioned.
Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.
The authors alone are responsible for the views expressed in this publication.
The International Agency for Research on Cancer welcomes requests for permission to reproduce or translate its
publications, in part or in full. Requests for permission to reproduce or translate IARC publications whether for sale
or for noncommercial distribution should be addressed to WHO Press, at the above address
(fax: +41 22 791 4806; email: permissions@who.int).

IARC Library Cataloguing in Publication Data


Cancer Incidence in Five Continents, Volume IX / edited by M.P. Curado [et al.]
(IARC Scientific Publications ; 160)
1. Neoplasms epidemiology 2. Neoplasms prevention & control
I.Curado, M.P. II.Title III.Series
ISBN 978 92832 2160 9
ISSN 0300-5085

(NLM Classification: W1)

Contents
Forewordix
Contributors to Introductory Chapters xi
Contributors xiii
Chapter 1. Introduction1
M.P. Curado, H. R. Shin, J. Ferlay
Chapter 2. Techniques of registration14
M.P. Curado
Chapter 3. Classification and coding40
H. R. Shin
Chapter 4. Histological groups61
L. Egevad, M. Heanue, D. Berney, K. Fleming, J. Ferlay
Chapter 5. Comparability and quality of data67
H. R. Shin, M.P. Curado, J. Ferlay, M. Heanue, B. Edwards, H. Storm
Chapter 6. Processing of data95
J. Ferlay
Chapter 7. Age-standardisation and denominators99
M. Boniol, M. Heanue
THE NARRATIVES AND THE MAPS103
Africa
Map of Africa 104
Algeria 105
Egypt 106
Tunisia 107
Uganda 108
Zimbabwe 110
Central and South America
Map of Central and South America 111
Argentina  112
Brazil  113
Chile  117
Colombia  118
Costa Rica  119
Ecuador 120
France, Martinique 121
Peru 122
North America
Maps of Canada and United States of America123
Canada 124
United States of America 136
Asia
Maps of Asia 209
Bahrain 214
China 216

Contents
Cyprus 223
India 224
Israel 232
Japan 234
Korea 242
Kuwait 253
Malaysia 255
Oman 257
Pakistan 258
Philippines260
Singapore 262
Thailand264
Turkey 267
Europe
Maps of Europe 269
Austria 276
Belarus280
Belgium281
Bulgaria 283
Croatia 285
Czech Republic 286
Denmark 288
Estonia 290
Finland 292
France293
Germany303
Iceland 312
Ireland313
Italy314
Latvia 340
Lithuania 341
Malta342
Norway 343
Poland 344
Portugal348
Russia350
Serbia 351
Slovak Republic 352
Slovenia353
Spain354
Sweden 368
Switzerland 369
The Netherlands 378
United Kingdom 382
Oceania
Map of Oceania 398
Australia 399
French Polynesia  411
New Zealand 413
USA, Hawaii 414

vi

Contents
THE TABLES
Age-standardized and cumulative incidence rates (three-digit rubrics) 417
Age-standardized incidence rates by histological type 679
Indices of data quality801
Cancer Incidence in Five Continents Volume VIII: Errata895

vii

Foreword
It is difficult to estimate the number of people around
the world who work diligently to collect the data that
are presented in Cancer Incidence in Five Continents.
One thing is clear: it is a large number. Surgeons,
oncologists, pathologists, radiologists, radiotherapists,
epidemiologists, statisticians, coding clerks and many
other staff from different specialist backgrounds
engaged in medical practice and medical records
contribute to the accurate diagnosis and coding of
cancer.
Their combined work is summarised in the pages of
this volume. Cancer Incidence in Five Continents (CI5)
has become the recognised reference source on the
incidence of cancer in populations around the world.
The ninth volume has a wider coverage than before
presenting data from around the year 2000 (ideally the
period 19982002) not only for entire populations but
also for sub-populations living in the same geographic
area.
This volume presents incidence data from
populations all over the world for which good quality
data are available. Scanning through the information
gives a clear presentation of the changing cancer patterns
worldwide. The nine volumes of Cancer Incidence in

Five Continents now cover a period of approximately


forty years. These new data are meant to be used and be
useful. Looking ahead, with the rapidly rising cancer
burden in low-income and medium-income countries,
more high-quality incidence data are needed from
regions and countries in such settings. Reliable data are
needed to establish the cancer burden and to monitor
its evolution in all parts of the world, particularly in
response to cancer control activities. Nurturing the
development of cancer registration in such countries is
of major importance and one issue that the International
Agency for Research on Cancer is addressing.
On behalf of the International Agency for Research on
Cancer, and the Editors, I would like to acknowledge the
fruitful collaboration with the International Association
of Cancer Registries, and IARC looks forward to the
continual development of this collaboration. It is also
a pleasure to acknowledge the directors and staff of all
the registries who submitted their data, and responded to
their series of questions and clarifications. Without their
great efforts and dedication, information on the incidence
of cancer, as made available in this volume, would not
be available to all those concerned in the fight against
cancer.
Peter Boyle, PhD
Director, IARC

ix

Contributors to Introductory Chapters


Dan Berney
Department of Cellular Pathology
80 Newark St,
Whitechapel
London E1 2ES
United Kingdom

Jacques Ferlay
International Agency for Research on Cancer
Biostatistics and Epidemiology Cluster
Data Analysis and Interpretation Group
150, cours Albert Thomas
69372 Lyon Cedex 08
France

Mathieu Boniol
International Agency for Research on Cancer
Biostatistics and Epidemiology Cluster
Epidemiology Methods and Support Group
150 cours Albert Thomas
69372 Lyon cedex 08
France

Kenneth Fleming
Head of Medical Sciences Division
University of Oxford
Medical School Office Level 3
John Radcliff Hospital
Headington
Oxford OX3 9du
United Kingdom

Maria-Paula Curado
Registro de Cncer de Base Populacional de Goinia
(Cancer Registry of Goiania)
Associacao de Combate ao Cncer em Gois
Rua 239 No. 209
Sector Oeste Universitrio
74605-070 Goinia - GO
Brazil

Mary Heanue
International Agency for Research on Cancer
Biostatistics and Epidemiology Cluster
Descriptive Epidemiology Production Group
150, cours Albert Thomas
69372 Lyon Cedex 08
France

Brenda Edwards
National Cancer Institute
Suite 504, MSC 8315
6116 Executive Boulevard
Bethesda, MD 20892-8315
USA

Hai Rim Shin


Korea Central Cancer Registry
National Cancer Center
809 Madu-Dong, Ilsan-Gu
Goyang
Gyonggi 411-769
Korea

Lars Egevad
International Agency for Research on Cancer
Pathogenesis and Prevention Cluster
Pathology Group
150 cours Albert Thomas
69372 Lyon cedex 08
France

Hans Storm
Danish Cancer Registry
Dept. of Cancer Prevention & Documentation
Danish Cancer Society
Strandboulevarden 49, Box 839
2100 Copenhagen
Denmark

IARC Secretariat
John Daniel; Office of the Director, Communications Group
Morten J. Ervik; Biostatistics and Epidemiology Cluster, Descriptive Epidemiology Production Group
Eric Masuyer; Biostatistics and Epidemiology Cluster, Data Analysis and Interpretation Group
Mathieu Mazuir; Biostatistics and Epidemiology Cluster, Descriptive Epidemiology Production Group
xi

Contributors
Contributors
Note: The contributors to this volume are listed below. Their names are given as communicated to the
editors, hence the lack of consistency in presentation.
Without the patient cooperation of the contributing registries, the editors of this monograph would
have had no material to edit. The editors hope that scientists will give due recognition to this fact and use
the following style of reference when quoting the data from a given registry:
NORTH, A.B., SOUTH, C.D. Cancer Incidence in Antarctica, 1998-2002. In: Curado. M. P.,
Edwards, B., Shin. H.R., Storm. H., Ferlay. J., Heanue. M. and Boyle. P., eds (2007), Cancer Incidence in
Five Continents, Vol. IX, IARC Scientific Publications No. 160, Lyon, IARC.

Africa
Algeria, Stif
Stif Cancer Registry
Hpital Mre Enfant
19000
CHU de Stif
Algeria
Tel: +(213) 36 91 13 85
Fax: +(213) 36 91 13 85
Email: hamdicherif@wissal.dz
mokhtar@globalink.org

Hamdi Cherif Mokhtar


Guerra Djahid
Abdellouche Djamel
Kadri Loubna
Zaidi Zoubida
Bourenane Cherif Sara
Mahnane abbes
Menaa Nadia
Laouamri slimane
Hamdi Meriem

Egypt, Gharbiah
Gharbiah Population-based Cancer Registry
P.O. Box 295
Tanta
Egypt
Tel.: +(20) 10-603-0480
Fax: +(20) 2-364-4720
E-mail: amalsamyibrahim@yahoo.com
ghb_1@hotmail.com

Amal S. Ibrahim
Hany Hussein
Kadry Ismail
Ahmed Hablas
Ibrahim Abdel Bar
Mohammad Ramadan
Hisham Elhamza

Tunisia, Central Region


Cancer Registry of Sousse
Laboratoire d'Anatomie pathologique
C.H.U. F. Hached
Rue Dr Moro
4002 Sousse
Tunisia
Tel.: +(216) 32-10355
Fax: +(216) 32-10355
E-mail: hmissa_s@yahoo.fr

Korbi Sadok
Hmissa Sihem
Jaidane Lilia
Chatti Danielle
Mokni Moncef

Uganda, Kyadondo County


Kampala Cancer Registry
Department of Pathology
Makerere University Medical School
PO Box 7072
Kampala
Uganda
Tel.: +(256) 41-531730 / 558731 / 17
Fax: +(256) 41-530412 / 543895
E-mail: cancer-reg@infocom.co.ug

Henry Wabinga
Sarah Nambooze
Juma Amero
Max Parkin

xiii

xiii

Contributors

Zimbabwe, Harare
Zimbabwe National Cancer Registry
Parirenyatwa Hospital
P.O. Box A 449, Avondale
Harare
Zimbabwe
Tel.: +(263) 4-791631, ext. 152
Fax: +(263) 4-794445
E-mail: cancer.registry@healthnet.zw

xiv

xiv

E. Chokunonga
M.Z. Borok
B.G. Mauchaza
Z.M. Chirenje
A.M. Nyakabau

Contributors

Central & South America


Argentina, Bahia Blanca
Registro Regional de Tumores del Sur de la Provincia
de Buenos Aires
Lainez 2403
B8001DDU
Baha Blanca
Argentina
Tel: +(54) 291-459-3669
Fax: +(54) 291-459-3669
E-mail: aapec1@criba.edu.ar

Eduardo A. Laura
Mariana S. Gonzalez
Vanina S. Mendiondo
Claudia Grimi
Elena Elverdin
Mario Aggio
Gustavo Salum
Miguel Aimale
Jorge Blasco
Diego Bereilh

Brazil, Brasilia
Registro de Cncer de Base Populacional do Distrito
Federal (Cancer Registry of Brasilia)
SIA Trecho 1
Lote 1730 Bloco E Sala 309
Brasilia, DF, Brazil Zip Code 71200-010
Brazil
Tel.: +(55) 61 340 32 601
Fax: +(55) 61 340 32 393
E-mail: cristinascandiuzzi@gmail.com

Elza Pastor Martinez


Maria Cristina Scandiuzzi
Maria Jos Amparo
Juliana Bernardo da Silva
Katia Silene da Silva Brando
Aline Soares Dantas
Helena de Melo Franco

Brazil, Cuiaba
Registro de Cncer de Base Populacional de Cuiab
Brazil
Tel:+(55) 65-3613-5359.
Fax:+(55) 65 3613-5477
E-mail: copcca@ses.mt.gov.br
m_cris10@hotmail.com

Mrcia Regina Gomes Pereira


Mrcia Cristina Claudiano
Maria Ilma Castilho
Maria Jos Lemes de Oliveira
Lucelleuzy C. Campos Lima
Paulo Csar Fernandes de Souza
Wilson G. Pereira
Rubens Carlos de O Junior
Ney Pereira da Silva
Helen Rosane Meinke Curvo

Brazil, Goinia
Registro de Cncer de Base Populacional de Goinia
(Cancer Registry of Goiania)
Associaao de Combate ao Cncer em Gois
Rua 239 No. 209
Sector Oeste Universitrio
74605-070 Goinia - GO
Brazil
Tel.: +(55) 62-3243-7000
Fax: +(55) 62-3243-7076
E-mail: rcbpgo@gmail.com
Website: www.rcbp-goiania.com

Maria Paula Curado


Carleane Maciel Bandeira e Silva
Edesio Martins
Elcivone Cirineu de Sousa
Matinair Siqueira Mineiro
Jose Carlos de Oliveira

xv

xv

Contributors

xvi

xvi

Brazil, Sao Paulo


Registro de Cncer de So Paulo (Cancer Registry of
Sao Paulo)
Faculdade de Saude Publica
Universidade de Sao Paulo
Av. Dr. Arnaldo, 715 - 1 andar, sala 112
Sao Paulo - SP
CEP 01246-904
Brazil
Tel.: +(55) 11-3061-7799
Fax: +(55) 11-3061-7799
E-mail: apmirra@usp.br

Antonio Pedro Mirra


Maria do Rosrio Dias de Oliveira Latorre
Jos Maria Pacheco de Souza
Sabina La Davidson Gotlieb
Maria Lucia Lebro
Joo Paulo Ach de Freitas
Carlos Marigo

Chile, Valdivia
Registro Poblacional del Cncer Provincia de Valdivia
Chile (Cancer Registry of Validivia)
Servicio de Salud Valdivia
Chacabuco No. 700
Valdivia
Chile
Tel.: +(56) 63-297875 / 297889
Fax: +(56) 63-297912 / 297895
E-mail: mbertran@ssvaldivia.cl

Mara Enriqueta Bertrn Vives


Katy Elena Heise Mora
Ana Mara Jofr Salazar

Colombia, Cali
Cali Cancer Registry
Department of Pathology
Faculty of Health Sciences
Universidad del Valle
P.O. Box 25360
Cali, Colombia
Tel.: +(57) 2-554-2489
Fax: +(57) 2-558-6304
E-mail: regcal@univalle.edu.co

Luis Eduardo Bravo


Edwin Carrascal
Tito Collazos
Luz Stella Garcia
Mariela Palacios
Julio Cesar Guarnizo
Juan Carlos Hernandez

Costa Rica,
Costa Rica National Tumor Registry
Registro Nacional de Tumores
Direccin de Vigilancia de la Salud
Ministerio de Salud
P.O. Box 10123-1000
San Jos
Costa Rica
Tel.: +(506) 221-1662
Fax: +(506) 221-1167
E-mail: aortiz@netsalud.sa.cr

Adolfo Ortz Barboza


Georgina Muoz
Guillermo Torres
Mara Guevara
Rosa Mara Vargas
Ricardo Rojas
Daniel Antich
Rolando Herrero

Ecuador, Quito
Registro Nacional de Tumores (National Cancer
Registry)
Sociedad de Lucha Contra el Cancer
SOLCA, Ncleo de Quito
Av. Eloy Alfaro 53-94 y Los Pinos
Casilla 1711 4965 CCI
Quito
Ecuador
Tel.: +(593) 2-419763
Fax: +(593) 2-403123
E-mail: fbernardcorral@hotmail.com

Fabin Corral Cordero


Patricia Cueva Ayala
Jos Ypez Maldonado
Mara Beln Morejn
Mnica Galarza
Doris Chauca
Paulina Bedn

Contributors

France, Martinique
Registre des Cancers de la Martinique (Cancer
Registry of Martinique)
A.M.R.E.C.
Centre d'Affaires de Californie, Entre Elodie
97232 Lamentin
France
Tel.: +(596)596603248
Fax: +(596)596704239
E-mail: amrec@wanadoo.fr

Moustapha Dieye
Jacqueline Vronique-Baudin
Carole Gentil
Marie Jos Dorival
Pierre Armel Ngasseu
Cyprian Draganescu
Juliette Smith Ravin
Roger Salamon
Herv Azaloux

Peru, Trujillo
Registro de Cncer de Base Poblacional de Trujillo
(Population-Based Cancer Registry of Trujillo)
Calle Guillermo Charn 279
Urb. San Andrs
Trujillo
Peru
Tel.: +(51) 44-244377
Fax: +(51) 44-244261
E-mail: albujarb@ec-red.com

Pedro F. Albjar

xvii

xvii

Contributors

North America
Canada
Canadian Cancer Registry
Health Statistics Division
Statistics Canada
Main Building, Room 2200
Ottawa, Ontario, K1A 0T6
Canada
Tel: +(1) 613-951-1775
Fax:+(1) 613-951-0792
E-mail: michel.cormier@statcan.ca
frieing@statcan.ca

Michel Cormier
Ginette Dussault
Sandra Ladouceur

Canada, Alberta
Alberta Cancer Registry
Alberta Cancer Board
Holy Cross, 5th Floor
Box ACB 2210 2 Street SW
Calgary, AB T2S 3C3
Canada
Tel.: +(1) 403-698-8191
Fax: +(1) 403-698-8159
E-mail: heatherb@cancerboard.ab.ca

Heather Bryant
Carol Russell
Maxine Raphael
Lorette Bowers
Victoria McQuaid

Canada, British Columbia


British Columbia Cancer Registry
British Columbia Cancer Research Centre
Cancer Control Research Program
2nd floor, Room 115 - 675 West 10th Avenue
Vancouver, BC V5Z 1L3
Canada
Tel.: +(1) 604-675-8059
Fax: +(1) 604-675-8180
E-mail: mmcbride@bccancer.bc.ca

Mary McBride
Cathy MacKay

Canada, Manitoba
Epidemiology & Cancer Registry - CancerCare
Manitoba
Room 2114, 675 McDermot Ave.
Winnipeg, MB R3E OV9
Canada
Tel.: +(1) 204-787-2174
Fax: +(1) 204-786-0628
E-mail: Grace.Musto@cancercare.mb.ca
Canada, New Brunswick
New Brunswick Provincial Cancer Registry
P.O. Box 5100
Fredericton
New Brunswick, E3B 5G8
Canada
Tel.: +(1) 506-453-3092
Fax: +(1) 506-453-2780
E-mail: christofer.balram@gnb.ca

xviii

xviii

Christofer Balram
Wilfred Pilgrim
Suzanne Leonfellner

Contributors

Canada, Newfoundland
Newfoundland Cancer Registry
Provincial Cancer Care Program, Eastern Health
Dr H. Bliss Murphy Cancer Centre
300 Prince Philip Drive
St. John's, NL
A1B 3V6
Canada
Tel.: +(1) 709-777-7602
Fax: +(1) 709-753-0927
E-mail: susan.ryan@easternhealth.ca

Susan Ryan
Sharon Smith

Canada, Northwest Territories


Northwest Territories Cancer Registry
Dept. of Health and Social Services
6th floor, Centre Square Tower
P.O. Box 1320
Yellowknife, NT XIA 2L9
Canada
Tel.: +(1) 867-873-3231
Fax: +(1) 867-873-0442
E-mail: andre_corriveau@gov.nt.ca
Canada, Nova Scotia
Nova Scotia Cancer Registry
Surveillance & Epidemiology Unit
1278 Tower Road, Room 569 Bethune Building
Halifax, Nova Scotia, Canada B3H 2Y9
Canada
Tel.: +(1) 902-473-5172
Fax: +(1) 902-473-4425
E-mail: epi.unit@ccns.nshealth.ca

Maureen MacIntyre
Ron Dewar

Canada, Ontario
Cancer Care Ontario
620 University Avenue, 12th Floor
Toronto, Ontario, M5G 2L7
Canada
Tel.: +(1) 416-971-9800,
Fax: +(1) 416-971-6888
E-mail: maryjane.king@cancercare.on.ca

Kamini Milnes
Mary Jane King
Phil Parsons
Karen Hofmann
Jeff Bowler
Susan Sargant
Joshua Mazuryk

Canada, Prince Edward Island


Prince Edward Island Cancer Registry
Queen Elizabeth Hospital
P.O. Box 6000
Charlottetown, PE C1A 8T5
Canada
Tel.: +(1) 902-894-2167
Fax: +(1) 902-894-2187
E-mail: ddryer@isn.net

Dagny Dryer

xix

xix

Contributors

xx

xx

Canada, Saskatchewan
Saskatchewan Cancer Registry
Saskatchewan Cancer Agency
4101 Dewdney Avenue
Regina, Saskatchewan, S4T 7T1
Canada
Tel.: +(1) 306-766-2695
Fax: +(1) 306-766-2179
E-mail: heather.stuart@scf.sk.ca

H. Stuart
K. Robb
T. Goh
D. Popkin

USA, Alabama
Alabama Statewide Cancer Registry
201 Monroe St.
Suite 1480
Montgomery
AL 36130
USA
Tel.: +00-251-438-2809
Fax: +00-251-432-3238
E-mail: vnelson@adph.state.al.us

Janice Cook
Vicki Nelson
Shirley Bowman
XJ Shen
Justin George
Diane Hadley
Regina Dillard
Mark Jackson
Shri Walker
Shirley Williams
Bobbie Bailey
Tracey Taylor

USA, Alaska
Alaska Cancer Registry
3601 C Street Suite 722
P.O Box 240249
Anchorage
AK 99524-0249
USA
Tel.: +00-907-269-8037
Fax: +00-907-561-1896
E-mail: annmarie_bailey@health.state.ak.us

Ann Marie Bailey


David K. O'Brien
Elizabeth J. Blair
Jim G. Whitecavage
Chris J. Geri

USA, Arizona
Arizona Cancer Registry
Arizona Department of Health Services
150 N. 18th Avenue
Suite 550
Phoenix
Arizona 85007-3248
USA
Tel.: +00-602-542-7320
Fax: +00-602-542-7362
E-mail: yeega@azdhs.gov

Georgia Armenta Yee


Richard S. Porter
Timothy J. Flood

USA, California
Cancer Surveillance & Research Branch
California Department of Public Health
California Cancer Registry
1700 Tribute Road, Suite 100
Sacramento, CA 95815-4402
USA
Tel.: +(1) 916-779-0303
Fax: +(1) 916-779-0264
E-mail: ksnipes@ccr.ca.gov

Kurt Snipes
Margaret McCusker
Rosemary Cress
Janet Bates
Dennis Deapen
Dee West

Contributors

USA, California, Los Angeles County


Los Angeles County Cancer Surveillance Program
Keck School of Medicine
University of Southern California,
1540 Alcazar Street, CHP 204
Los Angeles, CA 90033-1042
USA
Tel.: +(1) 323-442-1574
Fax: +(1) 323-442-2301
E-mail: ddeapen@usc.edu

Dennis Deapen
Leslie Bernstein
Lihua Liu
Dianne Kerford
Peg Balcius
Donna Morrell

USA, California, San Francisco Bay Area


Greater Bay Area Cancer Registry
Northern California Cancer Center
2201 Walnut Avenue, Suite 300
Fremont, CA 94538
USA
Tel.: +(1) 510-608-5000
Fax: +(1) 510-608-5085
E-mail: tina@nccc.org

Sally L. Glaser
Dee W. West
Kathleen Davidson-Allen
Christina A. Clarke
Scarlett Lin Gomez

USA, Colorado
Colorado Central Cancer Registry
State Department of Health
4300 Cherry Creek Drive South
Denver, CO 80246-1530
USA
Tel.: +(1) 303-692-2540
Fax: +(1) 303-691-7721
E-mail: rrycroft@smtpgate.dphe.state.co.us

Jack Finch
Randi Rycroft
Kieu Vu

USA, Connecticut
Connecticut Tumor Registry
State of Connecticut, Dept. of Public Health
410 Capitol Avenue, MS# 13TMR
P.O. Box 340308
Hartford, CT 06134-0308
USA
Tel.: +(1) 860-509-7163
Fax: +(1) 860-509-7161
E-mail: cathryn.phillips@po.state.ct.us
USA, District of Columbia
District of Columbia Cancer Registry
825 North Capital Street, NE.
Room 3145
Washingon DC
20002
USA
Tel.: +00-202-442-5910
Fax: +00-202-442-9432
E-mail: aaron.adade@dc.gov

Aaron Adade
Genevieve Matanoski
Xuguang (Grant) Tao
Emmanuel Nwokolo

xxi

xxi

Contributors

xxii

xxii

USA, Florida
Florida Cancer Data System
Sylvester Comprehensive Cancer Center
University of Miami School of Medicine
P.O. Box 016960 (D4-11)
Miami, Fl 33101
USA
Tel.: +(1) 305-243-4600
Fax: +(1) 305-243-4871
E-mail: lfleming@med.miami.edu

Youjie Huang
Lora E. Fleming
Jill A. MacKinnon

USA, Georgia
Georgia Comprehensive Cancer Registry
2 Peachtree Street
NW 14th Floor
Atlanta, Georgia 30303
USA
Tel.: +(1) 404 657 1943
Fax: +(1) 404 463 0780
E-mail: arbayakly@dhr.state.ga.us

A. Rana Bayakly
Carol Crosby
Margaret Padgett
Betty Gentry
Sheree Holloway
Judy Andrews
John Young
Kevin Ward
May Ting Liu
Phyllis Wilson
John Horan

USA, Georgia, Atlanta


Metropolitan Atlanta, Georgia SEER Registry
GA Center for Cancer Statistics
Rollins School of Public Health, Emory University
1518 Clifton Road NE
Atlanta, GA 30322
USA
Tel.: +(1) 404-727-8487
Fax: +(1) 404-727-7261
E-mail: jlyoung@sph.emory.edu

John L. Young, Jr.


Jonathan Liff
Kevin C. Ward
Phyllis Wilson

USA, Idaho
Cancer Data Registry of Idaho
615 N.7th Street
Boise
ID 83702
USA
Tel.: +00-208-338-5100
Fax: +00-208-338-7800
E-mail: scarson@teamiha.org

Stacey L. Carson
Christopher J. Johnson
Denise Jozwik

USA, Illinois
Illinois State Cancer Registry
Division of Epidemiologic Studies
Illinois Department of Public Health
605 W. Jefferson St
Springfield, IL 62761
USA
Tel.: +(1) 217-785-7132
Fax: +(1) 217-524-1770
E-mail: tiefu.shen@illinois.gov

Tiefu Shen
Melinda Lehnherr
Jan Snodgrass

Contributors

USA, Indiana
Indiana State Cancer Registry
Indiana State Department of Health
2 N. Meridian St., Sec. 5-L
Indianapolis IN 46204
USA
Tel.: +00-317-233-7424
Fax: +00-317-233-7722
E-mail: mgraves@isdh.in.gov

Martha Graves

USA, Iowa
State Health Registry of Iowa
Department of Epidemiology
2600 University Capitol Centre
University of Iowa
Iowa City, IA 52242
USA
Tel.: +(1) 319-335-8609
Fax: +(1) 319-335-8610
E-mail: charles-lynch@uiowa.edu

Charles F. Lynch
Charles E. Platz
Kathleen M. McKeen

USA, Kentucky
Kentucky Cancer Registry
2365 Harrodsburg Road, Suite A230
Lexington, KY 40504-3381
USA
Tel.: +(1) 859-219-0773
Fax: +(1) 859-219-0557
E-mail: tct@kcr.uky.edu

Thomas C Tucker
Frances Ross
Eric Durbin

USA, Louisiana
Louisiana Tumor Registry
School of Public Health
Louisiana State University Health Sciences Center
2021 Lakeshore Drive, Ste. 201
New Orleans, LA 70122
USA
Tel.: +(1) 504-280-1564
Fax: +(1) 504-280-1590
E-mail: vchen@lsuhsc.edu

Vivien W. Chen
Xiaocheng Wu
Meichin Hsieh
Patricia A. Andrews
Catherine N. Correa

USA, Louisiana New Orleans


Louisiana Tumor Registry
School of Public Health
Louisiana State University Health Sciences Center
2021 Lakeshore Drive, Ste. 201
New Orleans, LA 70122
USA
Tel.: +(1) 504-280-1564
Fax: +(1) 504-280-1590
E-mail: vchen@lsuhsc.edu

Vivien W. Chen
Xiaocheng Wu
Meichin Hsieh
Patricia A. Andrews
Catherine N. Correa

xxiii

xxiii

Contributors

xxiv

xxiv

USA, Maine
Maine Cancer Registry
Maine Bureau of Health
State House Station 11
Key Bank Plaza, 4th floor
Augusta, ME 04333
USA
Tel.: +(1) 207-287-5296
Fax: +(1) 207-287-4631
E-mail: molly.schwenn@maine.gov

Castine Verrill
Molly Schwenn

USA, Massachusetts
Massachusetts Cancer Registry
Department of Public Health
250 Washington Street 6th floor
Boston, MA 02108-4619
USA
Tel.: +(1) 617-624-5646
Fax: +(1) 617-624-5695
E-mail: susan.gershman@state.ma.us

Susan T. Gershman
Mary Jane King

USA, Michigan
Michigan Cancer Surveillance Program
201 Townsend
P.O. Box 30691
Lansing, MI 48909
USA
Tel.: +(1) 517-335-8677
Fax: +(1) 517-335-9513
E-mail: copelandg@michigan.gov

Glenn Copeland
Won Silva
Georgia Spivak
Michelle Hulbert
Georgetta Alverson

USA, Michigan Detroit


Metropolitan Detroit Cancer Surveillance System
Wayne State University
Karmanos Cancer Institute
110 East Warren Ave.
Detroit, MI 48201
USA
Tel.: +(1) 313-578-4201
Fax: +(1) 313-578-4306
E-mail: schwarta@karmanos.org

Ann G. Schwartz

USA, Missouri
Missouri Cancer Registry
324 Clark Hall
Columbia
Missouri 65211
USA
Tel.: +00-573-882-7775
Fax: +00-573-884-9655
E-mail: jacksonthompsonj@health.missouri.edu

Jeannette Jackson-Thompson
Sue Vest
Nancy Cole
Gentry White

Contributors

USA, Montana
Montana Central Tumor Registry
1400 Broadway
Room C317
PO Box 202952
Helena
MT 59620
USA
Tel.: +00-406-444-6786
Fax: +00-406-444-6557
E-mail: dlemons@mt.gov

Debbi Lemons

USA, New Jersey


New Jersey State Cancer Registry
P.O. Box 369
Trenton, NJ 08525-0369
USA
Tel.: +(1) 609-588-3500
Fax: +(1) 609-588-3638
E-mail: betsy.kohler@doh.state.nj.us

Betsy A. Kohler
Susan Van Loon
Xiaoling Niu
Toshi Abe

USA, New Mexico


New Mexico Tumor Registry
MSC11 6020
1 University of New Mexico
Albuquerque, NM 87131-0001
USA
Tel.: +(1) 505-272-3127
Fax: +(1) 505-272-8572
E-mail: ckey@nmtr.unm.edu

Charles L. Wiggins
Virginia Williams
Charles R. Key.

USA, New York State


New York State Cancer Registry
N.Y. State Dept of Health
Corning Tower - Room 536
Empire State Plaza
Albany, NY 12237-0679
USA
Tel.: +
Fax: +
E-mail: mjs08@health.state.ny.us

Maria J. Schymura
Amy Kahn
Colleen G. Sherman
Colleen C. McLaughlin

USA, NPCR
Cancer Surveillance Branch
Division of Cancer Prevention and Control
Centers for Disease Control and Prevention
4770 Buford Highway NE, Mail Stop K53
Atlanta, GA 30341-3717
Tel.: +(1) 770-488-3005
Fax: +(1) 770-488-4759
E-mail: hbw4@CDC.GOV

Hannah Weir
Cheryll Cardinez

USA, Ohio
Ohio Cancer Incidence Surveillance System
246 N. High Street, PO Box 118
Columbus, OH 43216-0118
USA
Tel.: +00-614-644-7058
Fax: +00-614-644-1909
E-mail: bette.smith@odh.ohio.gov

Robert Campbell
Bette Smith
Holly Engelhardt
William Ruisinger

xxv

xxv

Contributors

USA, Oklahoma
Oklahoma Central Cancer Registry
1000 NE 10th Street
Room 1205
P.O Box 53551
Oklahoma City
OK 74117-1299
USA
Tel.: +00-405-271-4072/57119
Fax: +00-405-271-6315
E-mail: charlotr@health.ok.gov

Adeline Yerkes
Janis Campbell
Charlotte Russell

USA, Oregon
Oregon State Cancer Registry
800 NE Oregon Street
Ste 730
Portland
OR 97232
USA
Tel.: +00-971-673-0986
Fax: +00-971-673-0996
E-mail: donald.k.shipley@state.or.us

Donald Shipley
Claudia Feight

USA, Pennsylvania
Pennsylvania Cancer Registry
Health Statistics and Research
PA Department of Health
555 Walnut Street, 6th Floor
Harrisburg, PA 17101-1914
USA
Tel.: +00-717-783-2548
Fax: +00-717-773-3258
E-mail: ROOTTO@state.pa.us

Raymond K. Powell
Jerry Orris

USA, Rhode Island


Rhode Island Cancer Registry
Rhode Island Department of Health
3 Capitol Hill, Room 403
Providence, RI 02908-5097
USA
Tel.: +(1) 401-277-1172
Fax: +(1) 401-277-3551
E-mail: john.fulton@health.ri.gov

John P. Fulton
Leanne C. Chiaverini
David Rousseau

USA, SEER
Surveillance Research Program
National Cancer Institute
Suite 504, MSC 8315
6116 Executive Blvd
Bethesda, MD 20892-8315
USA
Tel.: +(1) 301-496-8506
Fax: +(1) 301-480-4077
E-mail: edwardsb@mail.nih.gov

xxvi

xxvi

Contributors

USA, South Carolina


South Carolina Central Cancer Registry
SC DHEC
2600 Bull St.
Columbia
SC 29201
USA
Tel.: +00-803-731-1419
Fax: +00-803-898-3599
E-mail: bolicks@dhec.sc.gov

Susan Bolick-Aldrich
Virginia Andrews
Catishia Mosley
Deborah Hurley

USA, Texas
Texas Cancer Registry
1100 West 49th Street
Austin TX 78756
USA
Tel.: +00-512-458-7523
Fax: +00-512-458-7681
E-mail: Melanie.Williams@dshs.state.tx.us

Melanie Williams

USA, Utah
Utah Cancer Registry
650 Komas Drive, Suite 106B
Salt Lake City, UT 84108
USA
Tel.: +(1) 801-581-8407
Fax: +(1) 801-581-4560
E-mail: nan.stroup@hsc.utah.edu

Antoinette M. Stroup
Wallace Akerley
Rosemary Dibble

USA, Vermont
Vermont Cancer Registry
108 Cherry Street
Burlington, VT 05401
USA
Tel.: +00-802-863-7644
Fax: +00-802-652-4157
E-mail: ajohnso@vdh.state.vt.us

Ali Johnson

USA, Washington
Washington State Cancer Registry
PO Box 47855
Olympia, WA, 98597-4855
USA
Tel.: +(1) 360-236-3624
Fax: +(1) 360-586-2714
E-mail: kathryn.golub@doh.wa.gov

Kathryn Golub
Mahesh Keitheri Cheteri

USA, Washington, Seattle


SEER-Puget Sound/Seattle
Fred Hutchinson Cancer Research Center
1100 Fairview Ave. North, MD-B706
P.O. Box 19024
Seattle, WA 98109-1024
USA
Tel.: +(1) 206-667-4716
Fax: +(1) 206-667-4870
E-mail: sschwart@fhcrc.org

Thomas L. Vaughan
Stephen M. Schwartz
Mary S. Potts

xxvii

xxvii

Contributors

xxviii

xxviii

USA, West Virginia


West Virginia Cancer Registry
350 Capitol Street, Room 125
Charleston,WV 25301USA
USA
Tel.: +(1) 304 558 6421
Fax: +(1) 304 558 4463
E-mail: patcolsher@wvdhhr.org

Patricia Colsher

USA, Wisconsin
Wisconsin Cancer Reporting System
Dept. of Health and Family Services
Wisconsin Division of Public Health
P.O. Box 2659
Madison, WI 53701
USA
Tel.: +(1) 608-266-8926
Fax: +(1) 608-264-9881
E-mail: stephla@dhfs.state.wi.us

Laura Stephenson
Mary Foote
Robert Borchers
Kim Ortman
LuAnn Hahn
Diane Austin

Contributors

Asia
Bahrain
Bahrain Cancer Registry
Medical Review Office
P.O. Box 12
Manama
Bahrain
Tel.: +(973) 1727-9843
Fax: +(973) 1727-3540
E-mail: jsayyad@health.gov.bh

Jamal Alsayyad
Adulkareem Ateya
Abdulla Darwish

China, Guangzhou
Guangzhou Cancer Registry
Cancer Center
Sun Yat-sen Unviversity
651 Dongfeng Road
East Guangzhou 510060
China
Tel: +(86) 20-873-43283
Fax: +(86) 20-873-43293
Email: caokajia@mail.sysu.edu.cn

Kajia Cao
Guosheng Ma
Qiaoyang Fan
Chuanzhong Yin
Yilong Liu
Ziqun Liu
Fang Deng

China, Hong Kong


Hong Kong Cancer Registry
C/o Department of Clinical Oncology
Queen Elizabeth Hospital
30 Gascoigne Road
Kowloon, Hong Kong
China
Tel.: +(852) 2958-6021
Fax: +(852) 2958-5559
E-mail: cancereg@ha.org.hk

Stephen Chun Key Law


Oscar W.K. Mang

China, Jiashan
Jiashan County Cancer Registry
142 Garden Road
Weitang Town
Jiashan County
314100 Zheijiang Province
China
Tel.: +(86) 573-402-4016
Fax: +(86) 571-814-7297
E-mail: zgzl@mail.hz.zj.cn

Xinyuan Ma
Kaiyan Yao
Wanli Ma
Qilong Li
Lingling Yu
Ning Zhao
Xiaogang Huang

China, NanGang District, Harbin City


Epidemic Prevention Station of Nan Gang District
Wen Chang Street 227
Nan Gang District
Harbin 150040
China
Tel.: +(86) 451-8621-2954
Fax: +(86) 451-8622-1502
E-mail: ngqfyz@hotmail.com

Shu Ling Wu
Hui He
Li Qiu Yang
Hui Li Han
Xiao Li Shan
Bo Y u

xxix

xxix

Contributors

xxx

xxx

China, Shanghai
Shanghai Municipal Center for Disease Control and
Prevention
Shanghai Municipal Center for Disease Control &
Prevention
1380 Zhong Shan Road (West)
Shanghai 200336
China
Tel.: +(86) 21-6275-8710 / 1314
Fax: +(86) 21-6208-4193
E-mail: ytgao@vip.sina.com

Yu-Tang Gao
Fan Jin
Yongbing Xiang
Wei Zhang
Wei Lu
Ying Zheng
Kai Gu
Pingping Bao
Guixiang Song
Ming Han

China, Zhongshan
Zhongshan Cancer Research Institute
East-Sun-Wen Road
Guangdong 528403
Zhongshan City
China
Tel.: +
Fax: +
E-mail: zszlzl@yahoo.com.cn

Wang De Kun
Yu Yuan Long
Wei Kuang-rong
Liang ZHi-heng
Ren Xiao-qing

Cyprus
Cyprus Cancer Registry
c/o Ministry of Health
10 Markou Drakou Str.
1448 Lefkosia
Cyprus
Tel.: +(357) 22603001
Fax: +(357) 22603154
E-mail: cancer.registry@moh.gov.cy

Charitini Komodiki

India, Chennai (Madras)


Madras Metropolitan Tumour Registry
Cancer Institute (W.I.A.)
38, Sardar Patel Road
Chennai - 600 036
India
Tel.: +(91) 44-2491-0754 / 1526
Fax: +(91) 44-2491-2085
E-mail: rajaraman.swaminathan@yahoo.co.uk

V. Shanta
R. Swaminathan
S. Nalini
M. Kavitha
R. Rama

India, Karunagappally
Rural Cancer Registry, Karunagappally
Natural Background Radiation Cancer Registry
(NBRR)
Puthenthura P.O.
Neendakara, Kollam District
Kerala 691588
India
Tel.: +(91) 476-620609
Fax: +
E-mail: qln_nbrrkply@sancharnet.in

P. Jayalekshmi
B. Rajan

Contributors

India, Mumbai
Mumbai Cancer Registry
c/o Mumbai Cancer Registry
74 Jerbai Wadia Rd
Parel, Mumbai - 400012
India
Tel.: +(91) 22-2412-2351
Fax: +(91) 22-2412-2351
E-mail: bcrics@vsnl.com

Balkrishna B.Yeole
Arun P. Kurku

India, Nagpur
Nagpur Cancer Registry
c/o Mumbai Cancer Registry
74 Jerbai Wadia Rd
Parel, Mumbai - 400012
India
Tel.: +(91) 22-2412-2351
Fax: +(91) 22-2412-2351
E-mail: bcrics@vsnl.com

Balkrishna B.Yeole
Arun P. Kurkure
Varsha Sagdeo

India, New Delhi


Delhi Population Based Cancer Registry
Dr B.R. Ambedkar Institute Rotary Cancer Cancer
Hospital
All India Institute of Medical Sciences
New Delhi, 110 029
India
Tel: (91) 11 25 688 700,
(91) 11 26 588 900 ext 4823
Fax: (91) 11 26 588 408
E-mail: btyagi51@yahoo.co.in

B.B. Tyagi
N. Manoharan
Vinod Raina

India, Poona
Poona Cancer Registry
c/o Mumbai Cancer Registry
74 Jerbai Wadia Rd
Parel, Mumbai - 400012
India
Tel.: +(91) 22-2412-2351
Fax: +(91) 22-2412-2351
E-mail: bcrics@vsnl.com

Balkrishna B.Yeole
Arun P. Kurkure
S.S.Javadekar

India, Trivandrum
Trivandrum Cancer Registry
Regional Cancer Center
P.O. Box 2417
Trivandrum
695 011, Kerala
India
Tel.: +(91) 471-2443128
Fax: +(91) 471-244 7454
E-mail: amathew@rcctvm.org

Aleyamma Mathew
B. Vijayaprasad
P. Jayakumar
B. Rajan

xxxi

xxxi

Contributors

xxxii

xxxii

Israel
Israel National Cancer Registry
4 Shalom Yehuda St.
P.O. Box 1176
Jerusalem 91010
Israel
Tel.: +(972) 2-670-6818
Fax: +(972) 2-670-6884
E-mail: micha.barchana@moh.health.gov.il

Micha Barchana
Irena Liphshitz
Rachel Alon

Japan, Aichi Prefecture


Aichi Cancer Registry
c/o Division of Epidemiology & Prevention
Aichi Cancer Center Research Institute
I-I Kanokoden, Cikusa-ku
Nagoya 464-8681
Japan
Tel.: +(81) 52-762-6111
Fax: +(81) 52-763-5233
E-mail: kmatsuo@aichi-cc.jp

Kazuo Tajima
Hidemi Ito
Keitaro Matsuo
Manami Inoue
Tsuneo Masui
Sachiko Hiraiwa
Mariko Nakano

Japan, Fukui Prefecture


Fukui Prefectural Cancer Registry
Fukui Social Insurance Hospital
2-6-21 Nagayama-cho
Katuyama-shi 911-8558
Japan
Tel.: +
Fax: +
E-mail: fsih-08@crocus.ocn.ne.jp

Manabu Fujita
Masakazu Hattori

Japan, Hiroshima
Hiroshima City Cancer Registry
Department of Epidemiology
Radiation Effects Research Foundation
5-2 Hijiyama Park, Minami-ku
Hiroshima 732-0815
Japan
Tel.: +(81) 82-261-3131
Fax: +(81) 82-262-9768
E-mail: nnishi@rerf.or.jp

Nobuo Nishi
Hiromi Sugiyama
Hiroaki Katayama
Kazunori Kodama
Hirofumi Okuno
Masao Kuwabara
Keiichi Hiramatsu
Kenichi Arita
Wataru Yasui
Shizuteru Usui

Japan, Miyagi Prefecture


Miyagi Prefectural Cancer Registry
Miyagi Cancer Society
5-7-30, Kamisugi, Aoba
Sendai 980-0011
Japan
Tel.: +(81) 22-233-0241
Fax: +(81) 22-262-3775
E-mail: registry@miyagi-taigan.or.jp

Yoshikazu Nishino
Ichiro Tsuji
Kenya Moro

Contributors

Japan, Nagasaki Prefecture


Nagasaki Prefectural Cancer Registry
Department of Epidemiology
Radiation Effects Research Foundation (RERF)
1-8-6 Nakagawa
Nagasaki 850-0013
Japan
Tel.: +(81) 95-823-1125
Fax: +(81) 95-825-7202
E-mail: soda@rerf.or.jp

Midori Soda
Ichiro Sekine
Hisao Morooka
Takeshi Matsuo
Shinichiro Yamazaki
Akihiko Suyama
Takayoshi Ikeda

Japan, Osaka Prefecture


Osaka Cancer Registry
Department of Cancer Control and Statistics
Osaka Medical Center for Cancer and Cardiovascular
Disease
Nakamichi 1-3-3, Higashinari-ku
Osaka 537-8511
Japan
Tel.: +(81) 6-6972-1181, ext. 2301
Fax: +(81) 6-6978-2821
E-mail: ioka-ak@mc.pref.osaka.jp

Akiko Ioka
Hideaki Tsukuma
Kunio Sakai
Yasunori Sasai

Japan, Yamagata Prefecture


Yamagata Prefectural Cancer Registry
Yamagata Prefectural Medical Center for Cancer and
Life-style Related Disease
1800 Aoyagi
Yamagata 990-2292
Japan
Tel.: +(81) 23-685-2752
Fax: +(81) 23-685-2605
E-mail: ashibata@ypch.gr.jp

Toru Matsuda
Akiko Shibata

Korea
Korea Central Cancer Registry
National Cancer Center
809 Madu-Dong, Ilsan-Gu
Goyang
Gyonggi 411-769
Korea
Tel.: +(82) 31-920-1504
Fax: +(82) 31-920-1520
E-mail: hrshin@ncc.re.kr

Hai-Rim Shin
Young-Joo Won
Kyu-Won Jung
Jae-Gahb Park
Eun-Kyung Hong
Chang-In Suh
Sang-Yi Lee
Ki-Young Kim
Sun-Won Seo
Jong-Koo Lee

Korea, Busan
Busan Cancer Registry
Division of Cancer Control & Epidemiology
Research Institute for National Cancer Control &
Evaluation
809 Madu-Dong, Ilsan-Gu
Goyang
Gyonggi 411-764
Korea
Tel.: + (82) 31-920-2003
Fax: +(82) 31-920-1520
E-mail: hrshin@ncc.re.kr

Hai-Rim Shin
Soon-Yong Lee
In-Kyoung Hwang
Seo-Hee Rah
Jong-Tae Lee
Duk-Hee Lee
Hee-Kyoung Jang
Hee-Weon Lee
Hyun-Joo Kong
Ho-Guk Park

xxxiii

xxxiii

Contributors

xxxiv

xxxiv

Korea, Daegu
Daegu Cancer Registry
Department of Preventive Medicine
College of Medicine
Keimyung University
194 Dongsan-dong, Jung-gu
Daegu 700-712
Korea
Tel.: +(82) 53-250-7492
Fax: +(82) 53-250-7494 / 252-6567
E-mail: nukelee@dsmc.or.kr

Choong Won Lee


Sang Pyo Kim
Jong Won Park
In Sung Jung
Hye Young Shim
Eun Hee Kim

Korea, Daejeon
Daejeon Cancer Registry
Department of Preventive Medicine & Public Health
College of Medicine
Chungnam National University
6 Munhwa-Dong, Jung-Ku
Daejeon 301-747
Korea
Tel.: +(82) 42 580 8263
Fax: +(82) 42 586 8875
E-mail: ttylee@cnu.ac.kr

Tae Yong Lee


In Sun Kwon
Dae-Young Kang
Seung-Moo Noh
Samyong Kim
Byung-Yeon Yu
Suk Young Park
Joo Seung Park
Gye-Sung Lee
In-Gyu Hong

Korea, Gwangju
Gwangju Cancer Registry
Department of Preventive Medicine
Chonnam University Medical School
#5 Hak-1-dong Dong-gu
Gwangju 501-746
Korea
Tel.: +(82)-62-220-4162
Fax: +(82) 62-233-0305
E-mail: jschoix@jnu.ac.kr

Jin-su Choi
Tai-ju Hwang
Young-Jin Kim
Sun-Seog Kweon
Min-Ho Shin

Korea, Incheon
Incheon Cancer Registry
Dept. of Medical Information & Record Services
INHA University of Medical Colleges
7-206, 3-Ga, Shinheung-dong, Jung-gu
Incheon 400-103
Korea
Tel: +(82) 32-890-3434
Fax: +(82) 32-890-2012
E-mail: woopark@inha.ac.kr

Ze-Hong Woo
Woo-Chul Kim
Jae-Hwan Oh
Moon-Hee Lee
Jeong-Soo Im
Jong-Han Leem
Sun-Ok Lee

Korea, Jejudo
Jejudo Cancer Registry
Department of Preventive Medicine
Cheju National University College of Medicine
#1-Ara-1-dong, Jeju, 690-756, Jejudo
Korea
Tel.: +(82) 64-755-5567
Fax: +(82) 64-725-2593
E-mail: jrcr@cheju.ac.kr
jmbae@cheju.ac.kr
aquopura@gmail.com

Jong-Myon Bae
Yeong-Ja Yang

Contributors

Korea, Seoul
Seoul Cancer Registry
Department of Preventive Medicine
Sungkyunkwan University & Seoul National
University
28 Yongon-dong, Chongno-gu
Seoul 110-779
Korea (Republic of)
Tel.: +(82) 2-740-8322
Fax: +(82) 2-747-4830
E-mail: mhshin@skku.edu
yoahn@plaza.snu.ac.kr

Myung-Hee Shin
Yoon-Ok Ahn

Korea, Ulsan
Ulsan Cancer Registry
Dept. of Occupational & Environmental Medicine
Ulsan University Hospital
#290-3 Jeonha-Dong, Dong-Gu
Ulsan City 682-714
Korea
Tel.: +(82) 52-250-7283 / 8819
Fax: +(82) 52-250-7289
E-mail: ciyoo62@hanmail.net

Cheol-In Yoo
Yangho Kim
KyoungSook Jeong
Ji Ho Lee
Choong Ryeol Lee

Kuwait
Kuwait Cancer Registry
Kuwait Cancer Control Center Ministry of Health
Al Shwaikh P O Box 42262 70653
Kuwait
Tel.: +(965) 4812931
Fax: +(965) 4810007
E-mail: ohattab@hotmail.com

Omar H. El Hattab
Amany A.El Basmy
Adel Al Asfour

Malaysia, Penang
Penang Cancer Registry
Penang State Health Department
Level 35 & 37
Komtar
10590 Penang
Malaysia
Tel.: +(60) 4-262-5533
Fax: +(60) 4-261-3508
E-mail: binarai@ppg.moh.gov.my

Saraswathi Bina Rai


T. Devaraj
Aishah Knight
Asikin Abdul Kadir
Yasmin Sulaiman

Malaysia, Sarawak
Sarawak Cancer Registry
Sarawak Health Department
Tun Abang Haji Openg Road
93590 Kuching, Sarawak
Malaysia
Tel.: +(60)-82-237466
Fax: +(60)-82-254490
E-mail: ooichoohuck@yahoo.com

Ooi Choo Huck


Andrew Kiyu
Yao Sik King
Mastulu Wahab
Japar Assan

xxxv

xxxv

Contributors

xxxvi

xxxvi

Oman
Oman National Cancer Registry
Non-Communicable Diseases Surveillance & Control
Dept.
DGHA (HQ)
Ministry of Health
P.O. Box 393
AC 113, Muscat
Oman
Tel: +(968) 2469-6187
Fax: +(968) 2469-5480
Email: ncd-oman@moh.gov.om
dir-ncd@moh.gov.om

Jawad A. Al-Lawati, MD
Ali J. Mohammed, MD
Shalini C. Nooyi, MD
Nabil H. Al-Siyabi

Pakistan, South Karachi


Karachi Cancer Registry
Department of Pathology
Sindh Medical College (adjacent JPMC)
Rafiqui Shaheed Road, Cantt
Karachi, 75510
Pakistan
Tel.: +(92) 21-586-8421 / 0913
Fax: +(92) 21-586-0913
E-mail: yasmin.bhurgri@gmail.com

Yasmin Bhurgri
Mishaal Bhurgri
Shahid Pervez
Ahmed Usman
Asif Bhurgri
Naveen Faridi
SMH Zaidi
Imtiaz Bashir
Kauser Nazir
Hadi Bhurgri
GN Kakepoto
Naila Kayani
Sheema H. Hasan
Mohammed Khurshid

Philippines, Manila
Philippine Cancer Society - Manila Cancer Registry
P.O. Box 3066
310 San Rafael St., San Miguel
1005 Manila
Philippines
Tel.: +(63) 2-734-2114/ (63) 2-734-2127
Fax: +(63) 2-735-2707
E-mail: mcr@philcancer.com

Adriano V. Laudico
Ma. Rica Lumague
Divina B. Esteban
Lilia M. Reyes
Cynthia A. Mapua
Ma. Theresa Redaniel

Singapore
Singapore Cancer Registry
Health Promotion Board/NDRO
Level 5, 3 Second Hospital Avenue
Singapore 168937
Singapore
Tel.: +(65) 6435-3068
Fax: +(65) 6536-5307
E-mail: hpb_cancer_registry@hpb.gov.sg

Adeline L.H. Seow


W.P. Koh
K.S. Chia
K.Y. Chow
H.P. Lee
K. Shanmugaratnam

Thailand, Chiang Mai


Chiang Mai Cancer Registry
Department of Otolaryngology
Faculty of Medicine
Chiang Mai University
Chiang Mai 50200
Thailand
Tel.: +(66) 53-945562
Fax: +(66) 53-945564
E-mail: cancer_unit@yahoo.com

Yupa Sumitsawan
Songphol Srisukho
Ampai Sastraruji
Udomluck Chaisaengkhum
Puttachart Maneesai
Narate Waisri
Luckkana Thetpiam
Ubol Chompuphan
Varunee Khamsan

Contributors

Thailand, Lampang
Lampang Cancer Center
199 Moo 12 Lampang-Chiang Rai Road
Pichai, Muang District
Lampang 52000
Thailand
Tel.: +(66) 5433-5262
Fax: +(66) 5433-5273
E-mail: lampangregistry@yahoo.com

Surathat Pongnikorn
Nimit Martin
Wullop Pornruangwong
Nilubol Raunroadroong
Karnchana Daoprasert
Nichapa Yapunya
Panicha Pongnikorn
Arada Pawong

Thailand, Songkhla
Songkhla Cancer Registry
Faculty of Medicine
Prince of Songkla University
Hat Yai
Songkhla 90110
Thailand
Tel.: +(66) 74-451595
Fax: +(66) 74-212900
E-mail: hutcha.s@psu.ac.th

Hutcha Sriplung
Paramee Thongsuksai
Temsak Phungrassami
Paradee Prechavittayakul

Turkey, Antalya
Antalya Cancer Registry
Provincial Health Directorate of Antalya
Toros M. Atatrk Bul. N74
07070 Antalya
Turkey
Tel.: +
Fax: +
E-mail: hulyakarakilinc@yahoo.com

Hulya Karakilinc
Yeliz Tepe
zlem Gunduz
Nuket Ozdemir
Huriye Tekin
Gulcan Yenigelen
Gulsen Buyukgebiz
Hamide Tufekci

Turkey, Izmir
Izmir Cancer Registry
KIDEM, Il Saglik Mudurlugu
35210 Alsancak
Izmir
Turkey
Tel.: +(90) 232-441-0571
Fax: +(90) 232-483-3639
E-mail: eseres@ttnet.net.tr

Sultan Eser
Saniye Ozalan
Cankut Yakut
Tunay Nazli

xxxvii

xxxvii

Contributors

Europe

xxxviii

Austria
Austrian National Cancer Registry
Bundesanstalt Statistik sterreich
Demographie und Arbeitsmarkt
Guglgasse 13
1110 Wien
Austria
Tel.: +(43) 1-71128-7228
Fax: +(43) 1-71128-7445
E-mail: Monika.Hackl@statistik.gv.at

Monika Hackl
Jeannette Klimont
Thomas Pascher
Regina He
Ernst Leser

Austria, Tyrol
Cancer Registry of Tyrol
University Hospital Innsbruck
Anichstrae 35
6020 Innsbruck
Austria
Tel.: +(43) 512-504-22313
Fax: +(43) 512-504-22315
E-mail: willi.oberaigner@tilak.at

Willi Oberaigner
Helmut Mhlbck
Christine Wartha
Alois Harrasser
Hermann Leitner

Austria, Vorarlberg
Krebsregister Vorarlberg (Cancer Registry of
Vorarlberg)
AKS GmbH
Rheinstrasse 61
6900 Bregenz
Austria
Tel.: +
Fax: +
E-mail: elmar.stimpfl@aks.or.at

H. Concin
G. Diem
G. Mathis
K. Parschalk
E. Stimpfl
W. Oberaigner

Belarus
Belarussian Cancer Registry
Belarussian Centre for Medical Technologies
Information Computer Systems, Health Adm. &
Management
7a P. Brovki Street
220600 Minsk
Belarus
Tel.: +375 (17) 231-31-29, 292-30-80
Fax: +375 (17) 231-34-84
E-mail: spolyakov@belcmt.by
belcmt2@mail.belpak.by

Semyon Polyakov
Leonid Levin
Nina Shebeko
Alexander Grakovich

Belgium, Antwerp
Antwerp Cancer Registry
University of Antwerp, Campus Drie Eiken
Dept. of Epidemiology and Community Health
Building R, 2nd floor
Universiteitsplein 1
2610 Antwerp
Belgium
Tel.: +(32) 3-820-2539
Fax: +(32) 3-820-2640
E-mail: jos.droste@ua.ac.be

Eric Van Marck


Joost Weyler
Jos Droste

xxxviii

Contributors

Belgium, Flanders
Belgian Cancer Registry
Rue Royale 215
B-1210 Brussels
Belgium
Tel.: +(32) 2-250-1013
Fax: +(32) 2-250-1011
E-mail: elizabeth.vaneycken@kankerregister.org

Elisabeth Van Eycken


Kris Henau
Nathalie De Wever
Michiel Callens
Hedwig Verhaegen
Karin Haustermans

Bulgaria
Bulgarian National Cancer Registry
National Oncological Hospital
6 Plovdivsko Pole Street
1756 Sofia
Bulgaria
Tel.: +(359) 2-870-6258
Fax: +(359) 2-872-0651
E-mail: BNCR_Zdravka@netbg.com

Shemuel Danon
Zdravka Valerianova
Tsvetelina Ivanova

Croatia
Croatian National Cancer Registry
Croatian National Institute of Public Health
Rockefellerova 7,
10000 Zagreb
Croatia
Tel: (385) 1 4863280
Fax: (385) 1 4863271
E-mail: marija.strnad@hzjz.hr
ariana.znaor@hzjz.hr

Marija Strnad
Ariana Znaor
Ljubica Bubanovic
Petar Novak
Djurdja Selendic
Nedjeljka Vujanic

Czech Republic
National Cancer Registry of the Czech Republic
Institute of Health Information & Statistics of the
Czech Republic
Palackho nm. 4
P.O. Box 60
128 01 Prague 2
Czech Republic
Tel.: +(420) 22-497-2660
Fax: +
E-mail: uzis@uzis.cz

Vlasta Mazankova
Jiri Holub
Lenka Jurickova
Eliska Vankova
Blanka Skorpilova

Denmark
Danish Cancer Registry
Danish National Board of Health
Islands Brygge 67
Postboks 1881
2300 Copenhagen S
Denmark
Tel.: +(45) 7222-7400
Fax: +(45) 7222-7404
E-mail: obl@sst.dk

Hans H. Storm
Morten A. Hjulsager

xxxix

xxxix

Contributors

xl

xl

Estonia
Estonian Cancer Registry
North Estonian Regional Hospital Foundation's Cancer
Centre
Hiiu 44
11619 Tallinn
Estonia
Tel.: +(372) 6-172337
Fax: +(372) 6-172303
E-mail: margit.magi@regionaalhaigla.ee

Tiiu Aareleid
Pille Hrmaorg
Margit Mgi
Kaja Rahu
Mati Rahu

Finland
Finnish Cancer Registry
Institute for Statistical and Epidemiological Cancer
Research
Liisankatu 21 B
00170 Helsinki
Finland
Tel.: +(358) 9-135-331
Fax: +(358) 9-135-5378
E-mail: timo.hakulinen@cancer.fi

T. Hakulinen
I. Ovaska
E. Pukkala
R. Sankila

France, Bas-Rhin
Registre des cancers du Bas-Rhin
Laboratoire dpidmiologie et de Sant Publique
Facult de mdecine
11 rue Humann
F-67085 Strasbourg Cedex
France
Tel: +(33) 3 90 24 31 95
Fax: +(33) 3 90 24 31 89
E-mail: cancer@medecine.u-strasbg.fr
michel.velten@medecine.u-strasbg.fr

Michel Velten
Guy Hdelin
Florence Binder-Foucaud

France, Calvados
Registre Gnral des Tumeurs du Calvados
Centre Franois Baclesse
Av du Gnral Harris
B.P. 5026
14076 CAEN Cedex 05
France
Tel: +(33) 2 31 45 52 45
Fax: +(33) 2 31 45 51 72
E-mail: av.guizard@baclesse.fr

Anne-Valrie Guizard
Vronique Bastard Jaouen
Ccile Chauveau
Michel Henry-Amar
Jean-Franois Heron

Registre des Tumeurs Digestives du Calvados


Facult de Mdecine
CHU Cte de Nacre
14032 Caen Cedex
France
Tel: +(33) 2 31 06 51 20
Fax: +(33) 2 31 53 08 52
E-mail :guy.launoy@unicaen.fr

Vronique Bouvier
Sbastien Boutreux
Sverine Gonfroy-Marlire
Marie Ingouf
Isabelle Salomez
Brice Dubois
Guy Launoy

Contributors

France, Doubs
Registre des tumeurs du Doubs
Centre Hospitalier Universitaire Saint-Jacques
25030 Besanon Cedex
France
Tel: +(33) 3 81 21 83 12
Fax: +(33) 3 81 21 83 11
E-mail: registre-cancers@chu-besancon.fr

A. Danzon
M. Mercier
Y. Kieffer
C. Langlois
V. Queuche
C. Gil
S. Munier

France, Haut-Rhin
Registre des cancers du Haut-Rhin
87 avenue dAltkirch
BP 1070
F 68051 MULHOUSE Cedex
France
Tel: +(33) 3 89 64 62 51
Fax: +(33) 3 89 64 62 52
E-mail: buemia@ch-mulhouse.fr

Antoine Buemi
Jean-Michel Halna
Erik-Andr Sauleau
Mireille Grandadam

France, Hrault
Registre des tumeurs de lHrault
Batiment Recherche
208 rue des Apothicaires
34298 Montpellier Cedex 5
France
Tel: +(33) 4 67 41 34 17
Fax: +(33) 4 67 63 42 26
E-mail: registre-tumeur@wanadoo.fr

Brigitte Trtarre
Jean-Pierre Daurs
Claudine Gras-Aygon
Hlne Mathieu-Daud

France, Isre
Isre Cancer Registry
23 Chemin des Sources
38240 Meylan
France
Tel: +(33) 4 76 90 76 10
Fax: +(33) 4 76 41 87 00
E-mail: registre.cancer.isere@wanadoo.fr

Marc COLONNA
Patricia DELAFOSSE

France, Loire Atlantique


Registre des cancers de Loire-Atlantique et Vende
CHU de Nantes
Plateau des coles
50 Route de St Sbastien
44 093 NANTES CEDEX 1
France
Tel: +(33) 2 40 84 69 81
Fax: +(33) 2 40 84 69 82
E-mail: fmolinie@chu-nantes.fr

Marie-Jose Leroux
Marie-Franoise Le Bodic
Pierre Lombrail
Florence Molini
Solenne Billon-Delacour
Nathalie Auffret
Ana-Maria Chouillet
Christine Cerbelaud
Anne-Delphine Tagri
Magali Mtais
Aurlie Bouron

France, Manche
Registre Gnral des Cancers de la Manche
Centre Hospitalier Public du Cotentin
46 rue du Val de Saire
BP 208
50102 CHERBOURG cedex
France
Tel: +(33) 2 33 20 70 48
Fax: +(33) 2 33 20 76 22
E-mail: s.bara@ch-cherbourg.fr

xli

xli

Contributors

xlii

xlii

France, Somme
Registre du Cancer de la Somme
CHU Nord
Ple Sant Publique
80054 AMIENS Cedex 1
France
Tel: +(33) 3 22 66 82 26
Fax: +(33) 3 22 66 82 25
E-mail: registre.80@chu-amiens.fr

Olivier Ganry
Alain Dubreuil
Nicole Bourdon-Raverdy
Elvira Martin
Agns Thulliez
Christine Cott

France, Tarn
Registre des cancers du Tarn
B.P. 37
81001 Albi Cedex
France
Tel: +(33) 5 63 47 59 51
Fax: +(33) 5 63 38 20 12
E-mail: registre-cancer-du-tarn@wanadoo.fr

Pascale Grosclaude
Martine Sauvage
Laetitia Daubisse-Marliac
Yves Duchne
Corine Ferre-Grevaz
Rgine Litre-Tournier
Chantal Miquel-Herail
Hlne Siguier

France, Vende
Registre des cancers de Loire-Atlantique et Vende
CHU de Nantes
Plateau des coles
50 Route de St Sbastien
44 093 NANTES CEDEX 1
France
Tel: +(33) 2 40 84 69 81
Fax: +(33) 2 40 84 69 82
E-mail: fmolinie@chu-nantes.fr

Anne-Marie Kadi-Hanifi
Paolo Bercelli
Florence Molini
Solenne Billon-Delacour
Marie Proux
Assia Hami
Katia Mnanteau
Thrse Rabaud
Blandine Chauvet
Marie-Louise Rouvier

Germany, Brandenburg
Gemeinsames Krebsregister der Lnder Berlin,
Brandenburg, Mecklenburg-Vorpommern, SachsenAnhalt und der Freistaaten Sachsen und Thringen
(GKR) (Common Cancer Registry)
Brodauer Str. 16-22
12621 Berlin
Germany
Tel.: +(30) 565 81 401
Fax: +(30) 565 81 444
E-mail: Roland.Stabenow@gkr.verwalt-berlin.de

Roland Stabenow
Bettina Eisinger
Brigitte Streller
Mandy Schulz

Germany, Hamburg
Hamburgisches Krebsregister (Hamburg Cancer
Registry)
Billstrasse 80
D - 20539 Hamburg
Germany
Tel.: +(49) 40-428-37-2211
Fax: +(49) 40-428-37-2655
E-mail: HamburgischesKrebsregister@bsg.hamburg.de

Stefan Hentschel
Ulf Haartje
Norbert Burkhardt
Annie Funk
Alice Nennecke

Contributors

Germany, Mecklenburg-Western Pomerania


Gemeinsames Krebsregister der Lnder Berlin,
Brandenburg, Mecklenburg-Vorpommern, SachsenAnhalt und der Freistaaten Sachsen und Thringen
(GKR) (Common Cancer Registry)
Brodauer Str. 16-22
12621 Berlin
Germany
Tel.: +(30) 565 81 401
Fax: +(30) 565 81 444
E-mail: Roland.Stabenow@gkr.verwalt-berlin.de

Roland Stabenow
Bettina Eisinger
Brigitte Streller
Mandy Schulz

Germany, Munich
Tumorregister Mnchen (Munich Cancer Registry)
IBE / Klinikum Grosshadern
Marchioninistr. 15
81377 Mnchen
Germany
Tel.: +(49) 89-7095- 4752
Fax: +(49) 89-7095-4753
E-mail: tumor@ibe.med.uni-muenchen.de

D. Hlzel
G. Schubert-Fritschle
J. Engel
M. Schmidt
W. Tretter
U. Mansmann

Germany, North Rhine-Westphalia: Mnster


Epidemiologisches Krebsregister NRW (Cancer
Registry of Northrhine-Westphalia)
Krebsregister Mnster Domagkstrasse 3
D-48149 Mnster
Germany
Tel.: +(49) 251 8358571
Fax: +(49) 251 8358577
E-mail: volker.krieg@krebsregister.nrw.de
volkmar.mattauch@krebsregister.nrw.de

Volker Krieg
Martin Lehnert
Volkmar Mattauch
Hans-Werner Hense
Birgit Weihrauch

Germany, Saarland
Saarland Cancer Registry
Ministry of Public Health
Virchowstr. 7
66119 Saarbrcken
Germany
Tel.: +(49) 681-501-5969
Fax: +(49) 681-501-5998
E-mail: h.ziegler@gbe-ekr.saarland.de

Hartwig Ziegler
Christa Stegmaier
Rainer Mller

Germany, Free State of Saxony


Gemeinsames Krebsregister der Lnder Berlin,
Brandenburg, Mecklenburg-Vorpommern, SachsenAnhalt und der Freistaaten Sachsen und Thringen
(GKR) (Common Cancer Registry)
Brodauer Str. 16-22
12621 Berlin
Germany
Tel.: +(30) 565 81 401
Fax: +(30) 565 81 444
E-mail: Roland.Stabenow@gkr.verwalt-berlin.de

Roland Stabenow
Bettina Eisinger
Brigitte Streller
Mandy Schulz

xliii

xliii

Contributors

xliv

xliv

Iceland
The Icelandic Cancer Registry
Skgarhld 8
P.O. Box 5420
125 Reykjavik
Iceland
Tel.: +(354) 540-1900
Fax: +(354) 540-1910
E-mail: jongj@krabb.is

Jn Gunnlaugur Jnasson
Laufey Tryggvadttir
Anna Jnsdttir
Kristn Bjarnadttir
Sigrn Stefnsdttir
Elnborg J. lafsdttir
Gudrdur H. lafsdttir
Thorgils Vlundarson

Ireland
National Cancer Registry Ireland
University College
Elm Court
Boreenmanna Road
Cork
Ireland
Tel.: +(353) 21-431-8014
Fax: +(353) 21-431-8016
E-mail: h.comber@ncri.ie

Mary Chambers
Harry Comber
Fiona Dwane
Tracy Kelleher
Paul Walsh

Italy, Biella Province


Piedmont Cancer Registry, Province of Biella
Epidemiology Unit Prevention Department ASL 12
Biella
Via Don Sturzo 20
13900 Biella (BI)
Italy
Tel.: +(39) 015-350-3665 / 3655
Fax: +(39) 015-8495222
E-mail: adriano.giacomin@asl12.piemonte.it

Adriano Giacomin
Simona Andreone
Lucia Preto
Piercarlo Vercellino
Roberto Zanetti

Italy, Brescia Province


Brescia Health Unit Cancer Registry
Registro Tumori dellASL di Brescia
Via Cantore, 20 25128
Brescia
Italy
Tel.: +(39) 030 3838713/714
Fax: +(39) 030 3701404
E-mail: regtumbs@med.unibs.it

Francesco Donato
Rosa Maria Limina
Mario Lazzari
Assunta Omassi
Milena Guarinoni
Giuseppe Zani
Francesco Piovani
Mauro Damiolini
Annamaria Indelicato
Carmelo Scarcella
Giovanna Tagliabue
Paolo Contiero
Paolo Crosignani

Italy, Ferrara Province


Registro Tumori della Provincia di Ferrara (Ferrara
Cancer Registry)
Sez. Anatomia Patologica
Dip. Med. Sperimentale & Diagnostica
Universit di Ferrara
Via Fossato di Mortara, 64
44100 Ferrara
Italy
Tel.: +(39) 0532-291513 / 501
Fax: +(39) 0532-248021
E-mail: frs@unife.it

Stefano Ferretti
Laura Marzola
Elena Migliari
Nada Carletti
Italo Nenci

Contributors

Italy, Florence & Prato


Registro Tumori Toscano (R.T.T) (Tuscany Cancer
Registry)
Unit of Epidemiology
Research Institute of the Tuscany Region
Via di San Salvi 12
50135 Florence
Italy
Tel.: +(39) 055-626-8321
Fax: +(39) 055-679954
E-mail: e.paci@cspo.it

Eugenio Paci
Emanuele Crocetti
Alessandra Benvenuti
Carlotta Buzzoni
Adele Caldarella
Lucia Giovannetti
Francesco Giusti
Teresa Intrieri
Gianfranco Manneschi
Guido Miccinesi
Claudio Sacchettini

Italy, Genoa Province


Liguria Region Cancer Registry
Epidemiologia Descrittiva
Istituto Nazionale per la Ricerca sul Cancro
Largo Rosanna Benzi, n. 10
16132 Genova
Italy
Tel.: +(39) 010-5600-0961
Fax: +(39) 010-5600-0956
E-mail: marina.vercelli@istge.it

Marina Vercelli
Marani Enza
Claudia Casella
Puppo Antonella
Celesia Maria Vittoria
Cogno Roberta
Grondona Anna Maria
Elsa Garrone
Giovanna Giachero
Simone Manenti
Alberto Quaglia
Maria Antonietta Orengo

Italy, Macerata Province


Macerata Province Cancer Registry
Dip. Medicina Sperimentale e Sanit Pubblica
Universit, Via E. Betti 3
62032 Camerino (MC)
Italy
Tel: +(39) 0737-402403
Fax: +(39) 0737-402403
E-mail: susanna.vitarelli@unicam.it

Susanna Vitarelli
Silvia Antonini

Italy, Milan
Cancer Registry of Milan
Epidemiology Unit
Local Health Autority of Milan
Corso Italia, 19
20122 Milano
Italy
Tel.: +(39) 02 85782124
Fax: +(39) 02 85782128
E-mail: arusso@asl.milano.it

Antonio Russo
Mariangela Autelitano
Simona Ghilardi
Annamaria Bonini
Luisa Filipazzi
Cinzia Giubelli
Luigi Bisanti

Italy, Modena Province


Registro Tumori della Provincia di Modena (Modena
Cancer Registry)
Policlinico
Via del Pozzo, 71
41100 Modena
Italy
Tel.: +(39) 059-422-4337 / 2577
Fax: +(39) 059-422-4152 / 4549
E-mail: rtm@unimore.it

Massimo Federico
Maria Elisa Artioli
Claudia Cirilli
Ivan Rashid
Katia Valla

xlv

xlv

Contributors

xlvi

xlvi

Italy, Naples
Registro Tumori di Popolazione Regione Campania
(Campania Cancer Registry)
Azienda Sanitaria Locale Napoli 4
Piazza San Giovanni
80031 Brusciano (NA)
Italy
Tel.: +(39) 081-519-0505
Fax: +(39) 081-519-0505
E-mail: mariofusco2@virgilio.it

Mario Fusco
Raffaele Palombino
Biagio Vassante
Caterina Bellatalla
Maria Fusco
Margherita Panico
Carmela Perrotta

Italy, North East


North East of Italy Cancer Surveillance Network
(NEICSN)
Agenzia Regionale della Sanit
Regione Autonoma Friuli Venezia Giulia
Via Pozzuolo, 330
33100 UDINE
Italy
Tel.: +(39) 434-659-354
Fax: +(39) 434-659-222
E-mail: registro.tumori@sanita.fvg.it

Diego Serraino
Margherita de Dottori
Laura Battisti
Francesco Bell
Eduard Egarter-Vigl
Silva Franchini
Silvano Piffer
Fabio Vittadello
Loris Zanier

Italy, Parma Province


Registro Tumori di Parma (Parma Province Cancer
Registry)
Divisione di Oncologia Medica
Azienda Ospedaliera di Parma
Via dell'Abbeveratoia 4
43100 Parma
Italy
Tel.: +(39) 0521-991660
Fax: +(39) 0521-995448
E-mail: vdelisi@ao.pr.it

Vincenzo De Lisi
Paolo Sgargi
Lidia Serventi
Francesco Bozzani
Francesco Leonardi

Italy, Ragusa Province


Ragusa Cancer Registry
Department of Oncology
Azienda Ospedaliera Civile M.P.Arezzo.
Via Dante, 109
97100 Ragusa
Italy
Tel.: +(39) 0932-600050/600055
Fax: +(39) 0932-682169
E-mail: rtumino@tin.it

Rosario Tumino
Giuseppina Pavone
Maria Guglielmina La Rosa
Giuseppe Cascone
Graziella Frasca
Maria Concetta Giurdanella
Carmela Nicita
Patrizia Concetta Rollo
Aurora Sigona
Eugenia Spata
Giuseppe Cianciolo
Caterina Martorana
Gabriele Morana
Maria Grazia Ruggeri
Stefania Vacirca

Italy, Reggio Emilia Province


Reggio Emilia Cancer Registry
Registro Tumori Reggiano
c/o Dip. Sanita Pubblica AUSL RE
via Amendola 2
42100 Reggio Emilia
Italy
Tel.: +
E-mail: Lucia.Mangone@ausl.re.it

Lucia Mangone
Silvia Candela

Contributors

Italy, Romagna Region


Registro Tumori della Romagna (Romagna Cancer
Registry)
c/o Romagna Cancer Institute (I.R.S.T.)
Department of Medical Oncology
Istituto Oncologico Romagnolo
Hospital Morgagni-Pierantoni
Via Carlo Forlanini, 34
47100 Forl
Italy
Tel.: +(39) 0543-731583
Fax: +(39) 0543-731583
E-mail: rtromagna@ausl.fo.it

Dino Amadori
Fabio Falcini
Chiara Balducci
Lauro Bucchi
Carlo Cordaro
Carla Fabbri
Flavia Foca
Stefania Giorgetti
Alessandra Ravaioli
Mila Ravegnani
Rosa Vattiato
Benedetta Vitali

Italy, Salerno Province


Salerno Cancer Registry
via Loria, 24
84129 Salerno
Italy
Tel.: +(39) 089 522024
Fax: +(39) 089 338514
E-mail: regtum@tiscali.it

Andrea Donato
Anna Maria Apicella
Andrea Ferrentino
Arturo Iannelli
Gennaro Senatore
Arrigo Zevola

Italy, Sassari Province


Registro Tumori della Provincia di Sassari (Cancer
Registry of Sassari)
Via Tempio 5
07100 Sassari
Italy
Tel.: +(39) 079-206-2442
Fax: +(39) 079-206-2445
E-mail: mariobudroni@tiscali.it

Mario Budroni
Rosaria Cesaraccio
Daniela Pirino
Ornelia Sechi
Massimiliano Oggiano
Daniela Piras
Amelia Sechi
Antonio Cossu
Giuseppe Palmieri
Francesco Tanda

Italy, Syracuse Province


Territorial Registry of Pathology (RTP) Siracusa
Local Health Authority of Syracuse
Corso Gelone
17-96100 Syracuse
Italy
Tel.: +(39) 0931-48 4341
Fax: +(39) 0931-484383
E-mail: distretto1.asl8sr@interbusiness.it

Salvatore Sciacca
Anselmo Madeddu
Maria Lia Contrino
Francesco Tisano

Italy, Sondrio
Registro Tumori Della Provincia Di Sondrio (Sondrio
Cancer Registry)
Azienda Sanitaria Locale Sondrio
Via Nazario Sauro, 38
23100 Sondrio
Italy
Tel.: +(39) 342 555845
Fax: +(39) 342 555812
E-mail: r.tessandori@asl.sondrio.it

R. Tessandori
M. Tognela
R. Giardini
A. Buscemi
G. Tagliabue
P. Contiero
M.C. Manca
A. Tittarelli
S. Fabiano
A. Bertolini

xlvii

xlvii

Contributors

xlviii

xlviii

Italy, Torino
Piedmont Cancer Registry, City of Torino
Centro di Prevenzione Oncologica
Via San Francesco da Paola, 31
10123 Torino
Italy
Tel.: +(39) 011-633-3870
Fax: +(39) 011-633-3861
E-mail: roberto.zanetti@cpo.it

Roberto Zanetti
Stefano Rosso
Silvia Patriarca
Piera Vicari
Rossana Prandi
Irene Sobrato
Franca Gilardi
Maria Giusy Miglietta
Cristina Lefevre

Italy, Umbria Region


Registro Tumori Umbro di Popolazione (Umbria
Cancer Registry)
Dipartimento di Specialit Medico-Chirurgiche e
Sanit Pubblica
Universit degli Studi
Via del Giochetto
06100 Perugia
Italy
Tel.: +(39) 075-585-7329
Fax: +(39) 075-585-7317
E-mail: larosaf@unipg.it

La Rosa Francesco
Stracci Fabrizio
Cassetti Tiziana
Petrinelli Annamaria
Costarelli Daniela
Canosa Antonio
Scheibel Massimo
Mastrandrea Vito

Italy, Varese Province


Lombardy Cancer Registry, Varese Province
National Cancer Institute
Via Venezian 1, 20133 Milan
Italy
Tel: (39) 02.23902501
Fax: (39) 0223902762
E-mail: canreg@istitutotumori.mi.it
occam@istitutotumori.mi.it
Paolo.Contiero@istitutotumori.mi.it

Crosignani Paolo
Tagliabue Giovanna
Contiero Paolo
Fabiano Sabrina
Maghini Anna
Tittarelli Andrea
Codazzi Tiziana
Frassoldi Emanuela
Costa Enrica
Gada Daniela
Vigano Clotilde
Berrino Franco

Italy, Veneto Region


Veneto Tumour Registry
Regione del Veneto - Assessorato alle Politiche
Sanitarie
Istituto Oncologico Veneto - IRCCS
Via Gattamelata, 64
35128 Padova
Italy
Tel.: +(39) 049-821-5605
Fax: +(39) 049-821-5983
E-mail: paola.zambon@unipd.it

Paola Zambon
Alessandro Andolfo
Maddalena Baracco
Francesca Barizza
Emanuela Bovo
Antonella Dal Cin
Anna Rita Fiore
Alessandra Greco
Stefano Guzzinati
Daniele Monetti
Alberto Rosano
Carmen Fiorella Stocco
Sandro Tognazzo

Latvia
Latvian Cancer Registry
Latvian Oncological Center
Hipokrata str. 4
1079 Riga
Latvia
Tel.: +(371) 704-2055
Fax: +(371) 753-9160
E-mail: aivars@onkoc.mt.lv

A.Stengrevics
A.Eglite
I.Gajevska
U.Kojalo
K.Rudzitis

Contributors

Lithuania
Lithuanian Cancer Registry
Lithuanian Oncology Center
Polocko 2
Vilnius 2007
Lithuania
Tel.: +(370) 2-614130
Fax: +(370) 2-614130
E-mail: kancerreg@is.lt

Juozas Kurtinaitis
Giedre Smailyte
Birute Aleknaviciene
Kristina Rotkevic
Michailas Aizenas
Arvydas Laurinavicius

Malta
Malta National Cancer Registry (MNCR)
Dept. of Health Information
Guardamangia Hill
Guardamangia PTA 1313
Malta
Tel.: +(356) 25599000
Fax: +(356) 25599385
E-mail: miriam.dalmas@gov.mt

Miriam Dalmas

The Netherlands
Netherlands Cancer Registry
Association of Comprehensive Cancer Centres
Catharijnesingel 53
P.O. Box 19001
3501 DA Utrecht
The Netherlands
Tel.: +(31) 30-234-3780
Fax: +(31) 30-234-3632
E-mail: j.vandijck@iko.nl
s.siesling@ikst.nl

J. van Dijck
S. Siesling
M. Dirx
O. Visser
M. Janssen-Heijnen
M. van der Heiden
M. Schaapveld
A. Reedijk
M. Jansen-Landheer
R. Otter
A. Wit

Netherlands, Eindhoven
Eindhoven Cancer Registry
Comprehensive Cancer Centre South (IKZ)
P.O. Box 231
5600 AE Eindhoven
Netherlands
Tel: +(31) 40 -297-1616
Fax: +(31) 40-297-1610
Email: jw.coebergh@ikz.nl
coebergh@planet.nl

JWW Coebergh
M. Louwman
LH van der Heijden

The Netherlands, Maastricht


Maastricht Cancer Registry
Comprehensive Cancer Centre Limburg (IKL)
Parkweg 20
P.O. Box 2208
6201 HA Maastricht
The Netherlands
Tel.: +(31) 43-325-4059
Fax: +(31) 43-325-2474
E-mail: m.dirx@ikl.nl

Miranda Dirx
Hans Huveneers
Anita Botterweck
Johan Bruijnen

xlix

xlix

Contributors

Norway
Cancer Registry of Norway
Institute for Epidemiological Research
Montebello
0310 Oslo
Norway
Tel.: +(47) 22-451300
Fax: +(47) 22-451370
E-mail: Kreftregisteret@kreftregisteret.no

Frydis Langmark
Bjrn Mller
Freddie I. Bray
Tom B. Johannesen
Aage Johansen
Svein Erling Tysvr
Siri Larnningen
Olaug Talleraas

Poland, Cracow
Cracow Cancer Registry
Unit of Epidemiology
Centre of Oncology
Maria Sklodowska-Curie Memorial Institute
Garncarska 11
31-115 Krakw
Poland
Tel.: +(48) 12-422-9900
Fax: +(48) 12-426-1370
E-mail: z5rachta@cyf-kr.edu.pl

Jadwiga Rachtan
Lucja Molong
Justyna Bajorek
Malgorzata Geleta
Renata Zmurko 6.Anna Widawska

Poland, Kielce
Holycross Cancer Registry
Holycross Cancer Centre
Artwinskiego 3
25-734 Kielce
Poland
Tel.: +(48) 41-367-4901
Fax: +(48) 41-345-4471
E-mail: ryszard.mezyk@onkol.kielce.pl

Stanislaw Gd
Urszula Siudowska
Ryszard Myk
Teresa Karpacz
Sebastian Czarnecki
Anna Giemza
Dorota Stpie
Edyta Pokrzepa
Zbigniew Popioek

Poland, Warsaw City


Warsaw Cancer Registry
The Maria Sklodowska-Curie Memorial
Cancer Center and Institute of Oncology
ul. W.K. Roentgen 5
P.O. Box 106
02-781 Warsaw
Poland
Tel.: +(48) 22-546-28-85
Fax: +(48) 22-546-28-79
E-mail: mzwierko@coi.waw.pl

Zwierko Maria
Wronkowski Zbigniew
Turowicz Agnieszka
Karwowski Andrzej
Charazinska Ewa
Chorchos Ewa
Czerwinska Urszula
Przybysz Elzbieta
Przybysz Zofia
Wasowska Jadwiga

Portugal, Porto
Registo Oncologico Regional do Norte - RORENO
Servico de Epidemiologia
Inst. Portugus de Oncologia do Porto
Rua Antnio Bernardino da Almeida
4250-072 Porto
Portugal
Tel: +(351) 22-550-2011
Fax: +(351) 22-502-6489
Email: diripo@ipoporto.min-saude.pt

Maria Jos Bento


Sofia Silvestre
Beatriz Serro
Teresina Amaro
Rui Henrique
Rosa Morais
Laranja Pontes

Contributors

Portugal, South Regional


Registo Oncolgico Regional Sul (South Regional
Cancer Registry)
Instituto Portugus de Oncologia de Francisco Gentil
Centro Regional de Lisboa
Rua Professor Lima Basto
1093 Lisbon codex
Portugal
Tel.: +(351) 21-722-9852
Fax: +(351) 21-722-9806
E-mail: ana.miranda@ipolisboa.min-saude.pt

Ana Da Costa Miranda


Rute Martins Fonseca
Alexandra Mayer Pereira
Paulo Pinheiro
Luisa Gloria
Pedro Oliveira
Manuel Castro Ribeiro
Edward Limbert

Russia, St Petersburg
Population-Based Cancer Registry of St Petersburg
N.N. Petrov Research Institute of Oncology
Leningradskaya St. 68, Pesochny 2
197758 St Petersburg
Russia
Tel.: +(7) 812-252--5110
Fax: +(7) 812-252-7944
E-mail: cr@miac.zdrav.spb.ru

V.M.Merabishvili
T.L.Tsvetkova
O.F.Chepik
O.T.Dyatchenko
I.V.Apalkova
I.V.Kiselnikova

Serbia
Cancer Registry of Central Serbia
Institute of Public Health of Serbia
5, Dr Subotica St.
11000 Belgrade
Serbia
Tel.: +(381) 11-684566
Fax: +(381) 11-685735
E-mail: nezaraznibatut@yahoo.com

Andjelka Vukicevic
Dragan Miljus
Snezana Zivkovic
Natasa Mickovski
Ivana Rakocevic
Snezana Plavsic
Sanja Savkovic

Slovak Republic
National Cancer Registry of the Slovak Republic
National Health Information Center
Lazaretsk 26
811 09 Bratislava
Slovak Republic
Tel.: +(421) 2-4464-7094
Fax: +(421) 2-4464-7095
E-mail: martina.ondrusova@nczisk.sk
diba@nczisk.sk

Martina Ondruov
Adriana Obsitnikov
Ivan Pleko
Chakameh Safaei Diba
Daniela tefakov
Ivan Kuzma
Juraj Adamk
Boena Hlavat

Slovenia
Cancer Registry of Slovenia
Epidemiology and Cancer Registries
Institute of Oncology
Zaloka 2
1000 Ljubljana
Slovenia
Tel.: +(386) 1-432-2316
Fax: +(386) 1-431-0271
E-mail: mzakelj@onko-i.si

Maja Primic akelj


Vera Pompe Kirn
Vesna Zadnik
Tina agar
Franika krlec

li

li

Contributors

lii

lii

Spain, Albacete
Registro de Cncer de Albacete (Albacete Cancer
Registry)
Junta de Comunidades de Castilla - La Mancha
Seccion de Epidemiologia - Delegacion de Sanidad
Avda. Guardia Civil 5
02005 Albacete
Spain
Tel.: +(34) 967-557956
Fax: +(34) 967- 557964
E-mail: ealmar@jccm.es

Enrique Almar Marqus


Antonio Mateos Ramos
Cristina Ramrez Crcoles
Jos Anglica Gmez Martnez
Isidro de la Cruz de Julian
Carlos Navarro Honrubia
Adelaida Gonzalez Gmez
Manuel Atienzar Tobarra
Pablo Lemberg Lapaco

Spain, Asturias
Registro de Tumores del Principado de Asturias
(Asturias Cancer Registry)
Seccin de Informacin Sanitaria
Consejera de Salud y Servicios Sociales
C/ General Elorza
32,33001 Oviedo
Asturias
Spain
Tel.: +(34) 985-10-63-79
Fax: +(34) 985-10-65-20
E-mail: ramonqg@princast.es

Marcial Argelles
Adamina Losada
J. Ramn Quirs

Spain, Basque Country


Basque Country Cancer Registry
Departamento de Sanidad
Gobierno Vasco
c/ Duque de Wellington, 2
01010 Vitoria-Gasteiz
Spain
Tel.: +(34) 945-019235
Fax: +(34) 945-019280
E-mail: info5-san@ej-gv.es

M Isabel Izarzugaza
Mikel Errasti
Joseba Bidaurrazaga
Nerea Larraaga
M Cres Tobalina
M Jess Michelena
Enrique Peir
Cristina Sarasqueta
Maite Barriola
Isabel Portillo

Spain, Canary Islands


Registro Poblacional de Cncer de la Comunidad
Autnoma de Canarias (Canary Cancer Registry)
Direccin General de Salud Pblica
Rambla General Franco, 53
38006 Santa Cruz de Tenerife
Tenerife
Spain
Tel.: +(34) 928-452626 or (34) 922-474238 / 247
Fax: +(34) 928-452226 or (34) 922-474236
E-mail: mrojmar@gobiernodecanarias.org

Martin Rodriguez
Aleman Herrera
Rojas Martin
Fernandez Nakoura

Spain, Cuenca
Registro de Cncer de Cuenca (Cuenca Cancer
Registry)
Delegacin Provincial de Sanidad
C/ Las Torres, 61
16071 Cuenca
Spain
Tel.: +(34) 969-176544
Fax: +(34) 969-176544
E-mail: epicuenca@jccm.es

Jos Maria Diaz Garcia


Rosario Jimnez Chillaron
Amparo Chumillas Martinez
Ricardo Luengo Higueras
Maria Angeles Higueras Medina
Jesus Razquin Murillo
Jos Luis Guerra Moyano
Maria Otero Lorenzo
Antonio De Lucas Veguillas

Contributors

Spain, Girona
Girona Cancer Registry
Passatge Farinera Teixidor, 1, 1r-2a
17005 Girona
Spain
Tel.: +(34) 972-207406
Fax: +(34) 972-206180
E-mail: aizquierdo@ico.scs.es

Angel Izquierdo
Rafael Marcos-Gragera
Loreto Vilardell
Pau Viladiu
Josep Maria Borrs
Josepa Ribes
Joan Borrs
Jaume Galceran
Francesc-Xavier Bosch
Vctor Moreno

Spain, Granada
Granada Cancer Registry
Escuela Andaluza de Salud Pblica
Campus Universitario de Cartuja, s/n
Ap. Correos 2070
18080 Granada
Spain
Tel.: +(34) 958-027477
Fax: +(34) 958-027503
E-mail: carmen.martinez.easp@juntadeandalucia.es

Carmen Martnez Garca


Maria-Jos Snchez Prez
Victoria Barragn Snchez
Carmen Ruiz Baena
Carmen Estvez Estvez
Yoe Ling Chang Chan
Adriano Calzas Urrutia

Spain, Murcia
Murcia Cancer Registry
Servicio de Epidemiologa
Consejera de Sanidad
Ronsa de Levante, 11
30008 Murcia
Spain
Tel: +(34) 968 362039
Fax: +(34) 968 366656
E-mail: carmen.navarro@carm.es
mdolores.chirlaque@carm.es

Carmen Navarro
Mara-Dolores Chirlaque
Isabel Valera
Jacinta Tortosa
Encarna Prraga
Concepcin Lpez-Rojo
Sandra Garrido
Mirari Mrquez
Mara-Jos Snchez
Diego Salmern

Spain, Navarra
Navarra Cancer Registry
Instituto de Salud Pblica
Servicio de Epidemiologa
C/. Leyre, 15
31003 Pamplona
Spain
Tel.: +(34) 848-423464
Fax: +(34) 848-423474
E-mail: me.ardanaz.aicua@cfnavarra.es

Eva Ardanaz
Aurelio Barricarte
M. Eugenia Prez de Rada
Carmen Ezponda
Nieves Navaridas

Spain, Tarragona
Tarragona Cancer Registry
Fundacio Lliga per a la Investigaci i Prevenci del
Cancer (FUNCA)
C/Sant Joan, s/n
43201 Reus
Catalonia
Spain
Tel.: +(34) 977-326530
Fax: +(34) 977-312353
E-mail: jgalceran@grupsagessa.com

Joan Borrs
Jaume Galceran
Llus Piol
Xavier Card
Alberto Ameijide
ngel Izquierdo
Rafael Marcos
Vctor Moreno
Pau Viladiu
F. Xavier Bosch

liii

liii

Contributors

Spain, Zaragoza
Registro de Cncer de Zaragoza (Cancer Registry of
Zaragoza)
Departamento de Salud y Consumo
Direccin General de Salud Publica
Ramn y Cajal 68
50004 Zaragoza
Spain
Tel.: +(34) 976-715915
Fax: +(34) 976-447148
E-mail: cmartos@aragon.es

M.Carmen Martos
Gloria Garcia-Carpintero
M.Pilar Marco
Salvador Pastor
Jose Luis Arribas
Javier Mateos
Milagros Bernal
Desiderio Buil
Cristina Feja
Mariano Esteba

Sweden
Swedish Cancer Registry
Centre for Epidemiology
National Board of Health and Welfare
SE-106 30 Stockholm
Sweden
Tel.: +(46) 75-247-3000
Fax: +(46) 75-247-3327
E-mail: cancerregistret@socialstyrelsen.se

Lotti Barlow
Mats Talbck
sa Klint

Switzerland, Geneva
Registre Genevois des Tumeurs (Geneva Cancer
Registry)
55 boulevard de la Cluse
1205 Genve
Switzerland
Tel.: +(41) 22-379-4950
Fax: +(41) 22-379-4971
E-mail: christine.bouchardymagnin@imsp.unige.ch

liv

liv

Switzerland, Graubnden & Glarus


Kantonales Krebsregister Graubnden und Glarus
(Cancer Registry of Graubnden und Glarus)
Institut fr Pathologie
Rt. Kantonsspital Chur
Loestrae 170
7000 Chur
Switzerland
Tel.: +(41) 81-256-6543
Fax: +(41) 81-256-6544
E-mail: Harald.Frick@ksgr.ch

Harald Frick

Switzerland, Neuchtel
Registre Neuchtelois des Tumeurs (Neuchtel Cancer
Registry)
7, Avenue des Cadolles
2000 Neuchtel
Switzerland
Tel.: +(41) 32-722-9644
Fax: +(41) 32-722-9643
E-mail: fabio.levi@chuv.ch

F. Levi
G. Erler*
M. Maspoli
R. Choffat
L. Randimbison
* Deceased

Contributors

Switzerland, St Gall-Appenzell
Krebsregister St. Gallen Appenzell (Cancer Registry of
St. Gall-Appenzell)
7 Flurhofstr.
9000 St Gallen
Switzerland
Tel.: +(41) 71-494-2107
Fax: +(41) 71-494-6176
E-mail: silvia.ess@kssg.ch

Silvia Ess
Dyntar Daniela
Egger Hansruedi

Switzerland, Ticino
Registro dei Tumori del Cantone Ticino (Ticino
Cancer Registry)
Istituto Cantonale di Patologia
Via in Selva 24
6601 Locarno 1
Switzerland
Tel.: +(41) 91-816-0823
Fax: +(41) 91-816-0829
E-mail: andrea.bordoni@ti.ch

A.Bordoni
P. Mazzola

Switzerland, Valais
Registre Valaisan des Tumeurs
Institut Central des Hpitaux Valaisans
Avenue Grand-Champsec 86
Case Postale 736
1951 Sion
Switzerland
Tel: +(41) 27-603-4855
Fax: +(41) 27-603-4974
Email: isabelle.konzelmann@ichv.ch
observatoire@ichv.ch

Isabelle Konzelmann
Daniel de Weck
Frdric Favre
Jean-Christophe Lthi

Switzerland, Vaud
Registre Vaudois des Tumeurs (Vaud Cancer Registry)
Institut de mdecine sociale et prventive (IUMSP)
Centre Hospitalier Universitaire Vaudois et Universit
de Lausanne
CHUV- Falaises 1
CH-1011 Lausanne
Switzerland
Tel.: +(41) 21-314-7311
Fax: +(41) 21-323-0303
E-mail: fabio.levi@chuv.ch

F. Levi
V.C. Te
L. Randimbison
R. Choffat

UK, England, East of England Region


Eastern Cancer Registration and Information Centre
(ECRIC)
Unit C, Magog Court
Shelford Bottom
Hinton Way
Cambridge CB22 3AD
UK
Tel.: +(44) 1223-216591
Fax: +(44) 1223-213571
E-mail: david.greenberg@nhs.net

David Greenberg
Karen Wright
Clem Brown
Jem Rashbass

lv

lv

Contributors

lvi

lvi

UK, England, Merseyside and Cheshire


Merseyside & Cheshire Cancer Registry
2nd Floor, Muspratt Building
University of Liverpool
Liverpool L69 3GB
UK
Tel.: +(44) 151-794-5691
Fax: +(44) 151-794-5700
E-mail: tony.moran@nwcr.nhs.uk

A. Moran
L. Shack
J. Kelly

UK, England, North Western


North Western Cancer Registry
Christie Hospital NHS Trust
Kinnaird Road
Withington
Manchester M20 4QL
UK
Tel.: +(44) 161-446-8080
Fax: +(44) 161-446-3590
E-mail: tony.moran@nwcr.nhs.uk

A. Moran
L. Shack

UK, England, Northern and Yorkshire


Northern & Yorkshire Cancer Registry & Information
Service
Arthington House
Hospital Lane
Leeds LS16 6QB
UK
Tel.: +(44) 113-392-4309
Fax: +(44) 113-392-4178
E-mail: d.forman@leeds.ac.uk

David Forman
Caroline Brook
Machael Walkley
Roman Taterek-Gintowt
Gareth Adams

UK, England, Oxford Region


Oxford Cancer Intelligence Unit
4150 Chancellor court
Oxford Business Park South
OX4 2GX
UK
Tel.: +(44)1 865 33 4792
Fax: +(44)1 865 33 4794
E-mail: neil.kennedy@ociu.nhs.uk

Monica Roche
Neil Kennedy
Pat Hall
Sandra Edwards
Ann Watters

UK, England, South and Western Regions


South West Cancer Intelligence Service
South West Public Health Observatory
149 Whiteladies Road
Bristol, BS8 2RA
UK
Tel.: +(44) 1179-706474
Fax: +(44) 1179-706481
E-mail: andy.pring@swpho.nhs.uk

Andy Pring
Tina Ball
Diane Prior
Julia Verne

Contributors

UK, England, Thames


Thames Cancer Registry
King's College London
1st Floor, Capital House
42 Weston Street
London SE1 3QD
UK
Tel.: +(44) 20-7378-7688
Fax: +(44) 20-7378-9510
E-mail: henrik.moller@kcl.ac.uk

Henrik Mller
Neil Hanchett
Heather Bourne
Pat McDade

UK, England, Trent


Trent Cancer Registry
5 Old Fulwood Road
Sheffield S10 3TG
South Yorkshire
UK
Tel.: +(44) 114-226-3560
Fax: +(44) 114-226-3561
E-mail: andy.smith@trentcancer.nhs.uk

Sarah Cuthbertson
Louise Hollingworth
Gillian Percival
Jason Poole
Paul B. Silcocks
Andrew Smith
Alexandra E.A. Thackeray
Sue Wild

UK, England, West Midlands


West Midlands Cancer Intelligence Unit
Public Health Building
The University of Birmingham
Birmingham B15 2TT
UK
Tel.: +(44) 121-414-7711
Fax: +(44) 121-414-7712
E-mail: gill.lawrence@wmciu.nhs.uk

G. M. Lawrence
C. Livings
M. Porter
C. Jones
D. Thomas
C.Thomson

UK, Northern Ireland


Northern Ireland Cancer Registry
Centre for Clinical and Population Sciences
Mulhouse Building
Grosvenor Road
Belfast BT 12 6BJ
UK
Tel.: +(44) 28-9063-2573
Fax: +(44) 28-9024-8017
E-mail: a.gavin@qub.ac.uk
w.hamill@qub.ac.uk

Anna T Gavin
Richard J Middleton
Wendy Hamill
Colin R. Fox

UK, Scotland
Scottish Cancer Registry
Information Services Division (NHS National Services
Scotland)
Area 159A
Gyle Square
1 South Gyle Crescent
Edinburgh EH12 9EB
UK
Tel.: +(44) 131-275-6092
Fax: +(44) 131-275-7511
E-mail: David.Brewster@isd.csa.scot.nhs.uk

David Brewster
Lesley Bhatti
Alison McDonald
Judith Stark
Roger Black

lvii

lvii

Contributors

Oceania

lviii

lviii

Australia, Australian Capital Territory


ACT Cancer Registry
Population Health Research Centre
ACT Health
Level 1, Building 5
The Canberra Hospital
P.O. Box 11
Woden, ACT 2606
Australia
Tel.: +(61) 2-6207-4032
Fax: +(61) 2-6244-4138
E-mail: cancerregistry@act.gov.au

Linda Halliday
Rosalind Sexton
Janet Li
Elizabeth Tracey

Australia, New South Wales


New South Wales Central Cancer Registry
Cancer Institute (NSW)
Level 1 Biomedical Building
Australian Technology Park
Everleigh, NSW 2015
Locked mail bag 1
Kings Cross, NSW 1340
Australia
Tel.: +(61) 2-8374-5747
Fax: +(61) 2-8374-5744
E-mail: elizabeth.tracey@cancerinstitute.org.au

Elizabeth Tracey
Maria Arcorace
Noreen Panos
Shuling Chen
Bruce Armstrong
Freddy Sitas
Paul Jelfs

Australia, Northern Territory


Northern Territory Cancer Registry
Health Gains Planning Branch
NT Department of Health & Community Services
P.O. Box 40596
Casuarina, NT 0811
Australia
Tel.: +(61) 8-8922-7324
Fax: +(61) 8-8922-7144
E-mail: lindy.garling@nt.gov.au

John R Condon
Lindy Garling
Xiaohua Zhang

Australia, Queensland
Queensland Cancer Registry
553 Gregory Terrace
Fortitude Valley Q 4006
Australia
Tel.: +(61) 7-3258-2333
Fax: +(61) 7-3258-2345
E-mail: Kerrie_Dennison@health.qld.gov.au

Kerrie Dennison
Julie Moore

South Australia
South Australian Cancer Registry
Epidemiology Branch
Dept of Health
P.O. Box 6
Rundle Mall, SA 5000
South Australia
Tel.: +(61) 8-8226-6360
Fax: +(61) 8-8226-6291
E-mail: colin.luke@health.sa.gov.au

Colin Luke
Heather Tredrea
Maria Cirillo
Cathy Weisner
Mary Merdo
Teresa Molik
Chris Groeschel
Maxene Rosenberg
Kevin Priest

Contributors

Australia, Tasmania
Tasmanian Cancer Registry
Menzies Research Institute
Private Bag 23
Hobart, TAS 7001
Australia
Tel.: +(61) 3-6226-7706 / 57
Fax: +(61) 3-6226-7755
E-mail: alison.venn@utas.edu.au

A. Venn
L. Newman
M. Dalton

Australia, Victoria
Victorian Cancer Registry
The Cancer Council Victoria
Cancer Epidemiology Centre
1 Rathdowne Street
Carlton, South, Vic. 3053
Australia
Tel.: +(61) 3-9635-5154
Fax: +(61) 3-9635-5330
E-mail: Graham.Giles@cancervic.org.au

Graham Giles
Helen Farrugia
Vicky Thursfield
Debbie Billiet

Western Australia
Western Australian Cancer Registry
Dept of Health (WA)
1st floor C Block
189 Royal St
East Perth
WA 6004
Western Australia
Tel.: +(61) 8-9222-4022 / 4249
Fax: +(61) 8-9222-4236
E-mail: tim.threlfall@health.wa.gov.au

Timothy J. Threlfall
Judith R. Thompson

French Polynesia
Registre des Cancers de Polynsie franaise (French
Polynesia Cancer Registry)
Direction de la Sant
Bureau de la Veille Sanitaire
BP 611
98713 Papeete
Tahiti
French Polynesia
Tel.: +(689) 46.00.52 / 50
Fax: +(689) 46.00.59
E-mail: nicole.cerf@sante.gov.pf

Mareva Tourneux
Nicole Cerf
Laure Yen Kai Sun

New Zealand
New Zealand Cancer Registry
NZ Health Information Service
P.O. Box 5013
Wellington
New Zealand
Tel.: +(64) 4-460-4034
Fax: +(64) 4-922-1897
E-mail: susan_hanna@nzhis.govt.nz

Susan Hanna
Chris Lewis

lix

lix

Contributors

USA, Hawaii
Hawai'i Tumor Registry
Cancer Research Center of Hawai'i
University of Hawai'i
1236 Lauhala St
Honolulu, HI 96813-2424
USA
Tel.: +808-586-9750
Fax: +808-587-0024
E-mail: StevensJ@imsweb.com

lx

lx

Marc T. Goodman
Brenda Y. Hernandez
Laurence N. Kolonel

Chapter 1: Introduction

M.P. Curado, H.R. Shin and J. Ferlay

Table 1.1 Cancer population data submitted to CI5


Volume IX for the period 19982002
Submitted

Accepted

Countries

80

60

Registries

313

225

Populations

406

300

Registries

Populations
Accepted

Africa
South and
Central America
North America
Asia
Europe
Oceania
Total

Countries

Submitted

We received data from 406 cancer registry populations (Table


1.1). Data submitted on 106 populations from cancer registries
were excluded. Volume IX thus presents cancer incidence data
from 300 populations, 225 cancer registries and 60 countries, an
increase of 28.6% over Volume VIII.

Table 1.2 Geographical coverage by country, registry


and population group

Accepted

The publication
The data presented in Volume IX are expanded on by seven
introductory chapters, reduced from nine in the previous volume:
this Introduction, Techniques of registration; Classification and
coding; Histological groups; Comparability and quality of data;
Processing of data; and Age standardization and denominators.
The evaluation criteria used to analyse the data submitted by the
cancer registries were based on Cancer Registration, Principles
and Methods (IARC, 1991).

The share of the world population covered in this volume is


11%, distributed as follows: Africa: 8.8 million (1%), South
and Central America: 23 million (4%), North America: 258.5
million (80%), Asia: 152.3 million (4%), Europe: 238.8 million
(33%) and Oceania: 23 million (73%).

Submitted

The reference time period for Volume IX was defined to be


19982002; in order to allow the Editors to verify some aspects
of quality, comparability and completeness for each submission,
the contributors were asked to also send data for the years prior
to the reference period.

The proportion of cancer registries represented by continent is


as follows: Africa 31% (5/16), South and Central America 38%
(11/29), North America 93% (54/58), Asia 57% (44/77), Europe
83% (100/120) and Oceania 85% (11/13).

Accepted

Background
A detailed questionnaire was requested to be completed by
all cancer registries that were able to contribute to Volume IX
and also by national registry associations and networks. The
registries could delegate data submission to their associations
but had to submit their own questionnaires. All instructions for
preparing the data were explained in the questionnaire and an
email address, CI5-IX@iarc.fr, was expressly created to handle
all correspondence relative to the preparation of this volume.

Geographical coverage in CI5 Volume IX


The geographical coverage of CI5 Volume IX by continent is
shown in Table 1.2 below: Africa has included data from 5 of
the 14 countries that submitted data, South and Central America
8 of 11, North America 2 of 2 countries, Asia 15 of 18, Europe
29 of 30 countries and Oceania 4 of 6 countries.

Submitted

Cancer Incidence in Five Continents (CI5) Volume IX presents


incidence data from populations all over the world for which
good quality data are available.

14

16

16

11

29

11

29

11

2
18
30
6
80

2
15
29
4
60

58
77
120
13
313

54
44
100
11
225

136
84
123
18
406

118
50
100
16
300

Note: The sum of the individual countries is greater than the


total, reflecting the fact that some countries are present in more
than one continent
Geographical coverage in the nine successive volumes of
Cancer Incidence in Five Continents
Tables 1.3 and 1.4 and Figure 1.1 outline the overall geographical
coverage in terms of the number of registries, populations and
countries included in each volume of CI5.

Table 1.3 Coverage in nine volumes of Cancer Incidence in Five Continents


Volume

Year of publication

Registries

Populations

Countries

Period (approx.)

I
II
III
IV
V
VI
VII
VIII
IX

1966
1970
1976
1982
1987
1992
1997
2002
2007

32
47
61
79
105
138
150
186
225

35
58
79
103
137
166
183
214
300

29
24
29
32
36
49
50
57
60

19601962
19631967
19681972
19731977
19781982
19831987
19881992
1993-1997
1998-2002

Introduction

300

traditional tables of incidence rates and registry descriptions


as in previous editions. The website http://www-dep.iarc.
fr/ provides multiple options for analysis of cancer incidence
Countries
across the world, in order to be beneficial to epidemiologists,
Populations
oncologists, researchers and cancer policy makers.

Countries

250

Populations
200

Registries

100
50
0
I

II

III

IV

VI

VII

VIII

IX

Figure 1.1 Coverage in nine volumes of Cancer Incidence in


Five Continents
This publication was developed via an interactive relationship
among the contributors and the editors mainly through the
power of the electronic presentation of data, while retaining the

The Editors would like to thank Vincent


Benoist and Marilyne Goutagny, who abstracted and tabulated
the information from the questionnaires completed by each
contributor, and Krittika Guinot, who created the maps. The
Editors would also like to thank the directors and registrars from
all the cancer registries who submitted their data to this volume
for their efforts to produce cancer incidence data and make it
available to the world. Their work is the cornerstone of cancer
descriptive epidemiology and provides a basis for future cancer
research and health policies.

Registries
Acknowledgments:

150

Reference
Jensen, O.M., Parkin, D.M., Maclennan, R., Muir, C.S., Skeet,
R.G. (1991). Cancer Registration: Principles and Methods.
IARC Scientific Publication No. 95. Lyon: IARCPress.

Introduction

Table 1.4 Geographical coverage in the nine successive volumes of


Cancer Incidence in Five Continents
Vol. I

Vol. II

Vol. III

Vol. IV

Vol. V

Vol. VI

Vol. VII

Vol. VIII

Vol. IX

Algeria, Algiers

1993-97

Egypt, Gharbiah

Africa

Algeria, Stif

France, La Runion
The Gambia

Mali, Bamako

Mozambique, Loureno
Marques

1986-89

1990-93

1998-2002

1988-92

1993-94

1994-96

1987-89
1987-89

1988-92

1997-98

1999-2002
-

1956-60

Nigeria, Ibadan

1960-62

1960-65

1960-69

Senegal, Dakar

1969-74

Rhodesia, Bulawayo: African


South Africa, Cape Province:

1963-67

1968-72

White

1956-59

Bantu

1956-59

Coloured

South Africa, Johannesburg:

Bantu

1953-55

Indian

Natal : African
Tunisia, Central Region

Uganda, Kyadondo County


Zimbabwe:

1956-59

1964-66

European

1998-2002

1993-97

1998-2002

1993-97

1998-2002

1990-92

Bermuda: Black

1983-87

1989-91

1991-95

White and Other

Brazil, Belm

Brazil, Brasilia

Brazil, Campinas
Brazil, Cuiaba

Brazil, Fortaleza
Brazil, Goinia

Brazil, Porto Alegre


Brazil, Recife

Brazil, So Paulo

Chile

1959-61

Colombia, Cali

1962-64

Chile, Valdivia
Costa Rica

1979-82

1969

1973

1978

1962-66

1978-82

1968-71

1967-71
-

1972-76
-

1983-87
-

1998-2002

1990-92

Argentina, Baha Blanca


Argentina, Concordia

1993-97

1968-72
-

1991-93

1963-67
-

Central and South America

1964-66

Bulawayo: African
Harare: African

1954-60

1990-94
-

1993-97
-

1998-2001

2000-2002

1988-89

1990-93

1995-98

1999-2002

1980

1977-81
1980-82

1987
-

1982-86
1984-87

1990-92
-

1987-91
1988-92

1998-2002

1998-2002

1993-97

1998-2002

1992-96

1998-2002

Introduction

Table 1.4 Geographical coverage in the nine successive volumes of


Cancer Incidence in Five Continents
Cuba

Cuba, Villa Clara


Ecuador, Quito

France, Martinique

Jamaica, Kingston and St


Andrews

Vol. II

Vol. III

Vol. IV

Vol. V

Vol. VI

Vol. VII

Vol. VIII

Vol. IX

1995-97

1993-95

1968-72

1973-77

1986

1981-82

1985-87

1988-92

1983-87

1993-97

1998-2002
1998-2002

1958-63

1964-66

1967-72

1973-77

Netherlands Antilles (less Aruba)

1973-78

1978-82

Peru, Lima

1990-91

1990-92

1993-95

Paraguay, Asuncin
Peru, Trujillo

Uruguay, Montevideo
USA, Puerto Rico
North America
Canada

1988-89

1984-87

1988-90

1998-2002

1992-93

1962-63

1964-66

1968-72

1973-77

1978-82

1983-87

1978-82

1983-87

1988-92

1993-97

1998-2002

1973-77

1978-82

1983-87

1988-92

1993-97

1998-2002

1960-62

1963-66

1969-72

1973-77

Canada, Manitoba

1960-62

1963-66

1969-72

1973-77

1969-72

1973-77

1978-82

1983-87

1962-64

1965-66

1978-82

1983-86

1988-92

1993-97

1998-2002

1960-62

1963-66

1969-72

1973-77

1978-82

1983-87

1988-92

1993-97

1998-2002

Canada, Northwest Territories


and Yukon

1973-77

1978-82

1983-87

Canada, Northwest Territories


Canada, Nova Scotia

1983-92

1983-97

1998-2002

Canada, Ontario

1969-71

1983-87

1988-92

1993-97

1998-2002

Canada, Maritime Provinces


(New Brunswick, Nova Scotia,
Prince Edward Island)
Canada, New Brunswick

Canada, Newfoundland and


Labrador

Canada, Prince Edward Island


Canada, Quebec

Canada, Saskatchewan
Canada, Yukon

USA, Alabama:
Black

White

USA, Alaska

USA, Arizona

USA, California:

Asian and Pacific Islander


Black

Hispanic White

Non-Hispanic White

USA, California, Alameda


County:
Black

White

1969-72

1983-87

1978-82

1983-87

1969-72

1973-77

1960-64
1960-64

1969-72
-

1969-73
1969-73

1983-87

1978-82

1963-66
1963-66

1978-82

1983-87

1960-62

1978-82

1988-91

Canada, Alberta

Canada, British Columbia

Vol. I

1973-77
-

1973-77
1973-77

1978-82
1978-81
1978-82
-

1978-82
1978-82

1983-87
1983-87
-

1983-87
1983-87

1988-92
1988-92

1988-92
1988-92
1988-92
1988-92
1983-92
-

1993-97
1993-97

1993-97
1993-97
1993-97

1998-2002
1998-2002

1998-2002
1998-2002
-

1993-97

1998-2002

1998-2002

1998-2002

1983-97
-

1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002

Introduction

Table 1.4 Geographical coverage in the nine successive volumes of


Cancer Incidence in Five Continents
Vol. I

Vol. II

Vol. III

Vol. IV

Vol. V

Vol. VI

Vol. VII

Vol. VIII

Vol. IX

1988-92

1998-2002

Black

1969-73

1973-77

1978-82

1983-87

1988-92

1993-97

1998-2002

Filipino

1978-82

1988-92

1998-2002

USA, California, Central Valley:


Hispanic

Non-Hispanic White

USA, California, Greater San


Francisco Bay Area
Chinese
Hispanic White

Non-Hispanic White
Japanese

1969-73
-

1973-77
-

1978-82
-

1988-92

1988-92

1993-97

1988-92

1988-92

1993-97

1998-2002
1998-2002
1998-2002

1969-73

1978-82
1978-82

1983-87

1998-2002

Black

1972-77

1978-82

1983-87

1988-92

1993-97

1998-2002

Filipino

1978-82

1983-87

1988-92

1993-97

1998-2002

USA, California, Los Angeles


County:
Chinese
Hispanic White

Non-Hispanic White
Japanese
Korean

Spanish-surnamed White
Other White

USA, Colorado

USA, Connecticut:
Black

White

USA, District of Columbia:


Black

White

USA, Florida:
Black

White

USA, Georgia:
Black

White

USA, Georgia, Atlanta:


Black

White

USA, Idaho

USA, Illinois:
Black

White

USA, Indiana
USA, Iowa

1973-77

1972-77
-

1983-87

1972-77

1978-82

1983-87

1972-77
1973-77

1978-82

1968-72

1972-77

1963-65
-

1983-87

1960-62
-

1978-82

1988-92

1973-77

White

1978-82
1978-82
-

1983-87
1983-87
-

1993-97
1993-97
-

1988-92
-

1983-87

1988-92

1993-97

1969-71

1973-77

1978-82

1983-87
-

1983-87

1988-92
-

1988-92

1998-2002
1998-2002
1998-2002
-

1998-2002

1978-82
1978-82

1998-2002

1993-97

1975-77
1975-77

1998-2002

1998-2002

1993-97

1988-92

1993-97

1988-92

1988-92

1983-87

1988-92

1993-97

1993-97

1983-87

1988-92

1993-97

1988-92

1978-82

1988-92

1978-82

1998-2002

1993-97
-

1993-97

1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002

Introduction

Table 1.4 Geographical coverage in the nine successive volumes of


Cancer Incidence in Five Continents
USA, Kentucky

USA, Louisiana:
Black

White

USA, Louisiana, Central Region:


Black

White

USA, Louisiana, New Orleans:


Black

White

USA, Maine

USA, Massachusetts
USA, Michigan:
Black

White

USA, Michigan, Detroit:


Black

White

USA, Missouri:
Black

White

USA, Montana
USA, Nevada

USA, New Jersey:


Black

White

USA, New Mexico:

American Indian
Hispanic

Hispanic White

Non-Hispanic White

Other White (Anglo)

USA, New York City

USA, New York State:


Black

White

USA, New York State (less New


York City):
Black

White

USA, NPCR:
Black

White

Vol. I

Vol. II

Vol. III

Vol. IV

Vol. V

Vol. VI

Vol. VII

Vol. VIII

Vol. IX

1998-2002

1998-2002

1998-2002
1998-2002

1988-92

1993-93

1974-77

1978-82

1983-87

1988-92

1993-97

1998-2002

1998-2002

1983-87
-

1988-92

1988-92
-

1993-97

1993-97
-

1978-82

1983-87

1988-92

1993-97

1978-82

1973-77

1974-77

1969-71

1959-66

1969-71
-

1973-77
-

1978-82
-

1969-72

1973-77

1978-82

1978-82

1978-82

1973-77
1973-77

1983-87

1969-72
1969-72

1983-87

1993-97
-

1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
-

1998-2002

1993-97

1998-2002

1993-97

1993-97

1998-2002

1998-2002

1988-92

1988-92

1993-97

1998-2002

1983-87

1988-92
-

1993-97

1998-2002

1978-82

1988-92

1993-97
-

1998-2002
-

1998-2002
-

1998-2002

1998-2002

1998-2002

1959-61

1969-71

1973-77

1978-82

1983-87

1993-97

1993-97

1998-2002

1998-2002

1993-97
-

1998-2002

Introduction

Table 1.4 Geographical coverage in the nine successive volumes of


Cancer Incidence in Five Continents
USA, Ohio:
Black

White

USA, Oklahoma
USA, Oregon

USA, Pennsylvania:
Black

White

USA, Rhode Island

USA, SEER (9 Registries):


Black

White

USA, SEER (14 Registries):

Asian and Pacific Islander


Black

Hispanic White

Non-Hispanic White

USA, South Carolina:


Black

White

USA, Texas:
Black

White

USA, Texas, El Paso:

Vol. I

Vol. II

Vol. III

Vol. IV

Vol. V

Vol. VI

Vol. VII

Vol. VIII

1998-2002

1998-2002

1983-87

1988-92

1993-97

1983-87
-

1988-92
-

Vol. IX

1993-97
-

1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002

Latin

1960-66

1968-70

USA, Utah

1966-70

1973-77

1978-82

1983-87

1988-92

1993-97

1998-2002

1998-2002

Other than Latin

USA, Vermont

USA, Washington

USA, Washington, Seattle


USA, West Virginia
USA, Wisconsin
Asia

1960-66
-

1968-70
-

1974-77

1978-82

1983-87

1988-92

1993-97

China, Changle

China, Cixian

China, Guangzhou City


China, Hong Kong
China, Jiashan

China, Nangang District,


Harbin City
China, Qidong County

Bahrain: Bahraini
China, Beijing

1993-97

2000-2002

1993-97

1998-2002

1988-92

1993-97

1983-87
-

1998-2002

1978-82
-

1998-2002

1993-97

1974-77
-

1998-2002

1998-2002

1993-97

1998-2002

1998-2002

1998-2002

1983-87

1988-92

1993-97

Introduction

Table 1.4 Geographical coverage in the nine successive volumes of


Cancer Incidence in Five Continents
China, Shanghai
China, Taiwan
China, Tianjin
China, Wuhan

China, Zhongshan
Cyprus

India, Ahmedabad
India, Bangalore

India, Barshi, Paranda and Bhum


India, Chennai (Madras)
India, Karunagappally

India, Mumbai (Bombay)


India, Nagpur

India, New Delhi

India, Poona (Pune)


India, Trivandrum
Israel:

All Jews

Jews born in Israel

Jews born in Africa or Asia

Jews born in Europe or


America
Non-Jews

Japan, Aichi Prefecture

Japan, Fukui Prefecture


Japan, Fukuoka

Japan, Hiroshima

Japan, Miyagi Prefecture

Japan, Nagasaki Prefecture


Japan, Okayama

Japan, Osaka Prefecture


Japan, Saga

Japan, Yamagata Prefecture


Korea

Korea, Busan

Korea, Daegu

Korea, Daejeon

Korea, Gwangju
Korea, Incheon
Korea, Jejudo

Korea, Kangwha County


Korea, Seoul

Korea, Ulsan

Vol. I

Vol. II

Vol. III

Vol. IV

Vol. V

Vol. VI

1981-82

1983-87

1983-87

1982

1993-97

1988-92

1980-82

1973-77

1978-82

1991-92

1960-66

1967-71

1972-76

1977-81

1982-86

1988-92

1960-66

1967-71

1972-76

1977-81

1982-86

1988-92

1960-66

1967-71

1972-76

1977-81

1982-86

1988-92

1993-97

1998-2002

1998-2002

1991-92

1993-97

1998-2002

1988-92

1998-2002

1993-97

1993-97

1988-92

1993-97

1983-87

1960-63

1988-92

1982

1983-87

1998-2002

1988-92

1978-82

Vol. IX

1993-97

1983-87

1973-75

1997

1988-92

1968-72
-

1983-87

1964-66
-

Vol. VIII

1978-82

Vol. VII

1975

1993-97
1993-97
1993-96
1993-97
1993-97
1993-97
1993-97
1993-97
1993-97

1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
-

1960-66

1967-71

1972-76

1977-81

1982-86

1988-92

1993-97

1960-66

1967-71

1972-76

1977-81

1982-86

1988-92

1993-97

1998-2002

1998-2002

1974-75

1996-2000

1973-77

1978-82

1983-87

1988-92

1993-97

1998-2002

1966

1969

1991-95

1998-2002

1986-90

1973-77

1981-85

1968-71
-

1978-80

1962-64
-

1959-60
-

1978-81
-

1983-87
-

1988-92
-

1993-97
-

1998-2002
-

1970-71

1973-77

1979-82

1983-87

1988-92

1993-97

1998-2002

1983-86

1988-92

1993-97

1998-2002

1996-97

1998-2002

1984-86
-

1988-92
-

1993-97
-

1997-98
-

1986-92

1993-97

1993-97

1999-2002
1998-2002
1998-2002
1998-2002
1998-2002
2000-2002
-

1998-2002
1999-2002

Introduction

Table 1.4 Geographical coverage in the nine successive volumes of


Cancer Incidence in Five Continents
Vol. I

Vol. II

Vol. III

Vol. IV

Vol. V

Vol. VI

1979-82

1983-87

1979-82

1983-87

Kyrgyzstan

1986-87

Malaysia, Sarawak

Kuwait: Kuwaitis
Non-Kuwaitis
Malaysia, Penang
Oman: Omani

Pakistan, South Karachi


Philippines, Manila
Philippines, Rizal
Singapore:

Chinese
Indian
Malay

Thailand, Bangkok

Thailand, Chiang Mai


Thailand, Khon Kaen
Thailand, Lampang

Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir

Viet Nam, Hanoi

Viet Nam, Ho Chi Minh City


Europe

1950-61
-

1998-2002

1993-97

1998-2001

1993-97

1983-87

1995-97
1993-97

1968-72

1973-77

1978-82

1983-87

1988-92

1993-97

1988-92

1983-87

1988-89
-

1990-93
-

1995-97

1998-2002

1998-2002

1993-96
-

1998-2002

1993-97

1998-2002

1995-98

1988-92

1993-97

1983-87

1988-92

1993-97

1997-98

Belgium, Limburg

1997-98

Croatia

1988-91

1993-97

Czech Republic
Denmark
Estonia

Finland

France, Bas-Rhin
France, Calvados

France, Cte dOr

1953-57

1958-62

1963-67

1998-2002

1993-97

1998-2002

1998-2002

1993-97

1998-2002

1983-87

1988-92

1993-97

1998-2002

1978-81

1983-87

1988-92

1993-97

1998-2002

1978-82

1998-2001

1988-92

1977-81

1998-2002

1983-87

1971-76

1998-2002

1978-82

1975-77
-

1982-86
1983-87
-

1988-92

1998-2002

1983-87

1966-70
-

1962-65
-

1968-72
1973-76

1959-61
-

1998-2002

1993-97

1998-2002

1991-93

1993-97

1993-97

1998-2002
1998-2002

Bulgaria

1998-2002

1993-97

1998-2002

1993-97

1988-92

1998-2002

1993-97

1988-92

1983-87

1998-2002

1998-2002

1983-87

1978-82

1998-2002

1978-82

1973-77

1973-77

1968-72

Belgium, Flanders (less


Limburg)

1968-72

Austria, Vorarlberg

Belgium, Flanders

1998-2002

1994-98

Belgium, Antwerp

1988-89
1992-93

1998-2002

Belarus

1994-98

1988-92

Vol. IX

1983-87

1978-82

Austria

Austria, Tyrol

Vol. VIII

Vol. VII

1988-89
1992-93

1987-92
1988-92
-

1993-97
1993-97
1993-97

1998-2002
1998-2002
-

Introduction

Table 1.4 Geographical coverage in the nine successive volumes of


Cancer Incidence in Five Continents
France, Doubs

France, Haut-Rhin
France, Hrault
France, Isre

France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn

France, Vende

Germany, Federal States of


Berlin etc. :

Vol. II

Vol. III

Vol. IV

1977
-

Vol. V

1978-82
-

1979-82

Vol. VI

Vol. VII

Vol. VIII

1988-92

1993-97

1983-87

1988-92

1988-92

1983-87
-

1988-92
-

1998-2002

1993-97
-

1988-92

1993-97

1988-92

1983-87

1993-97

1994-97

1983-84

1998-2002

Vol. IX

1993-97

1993-97
-

1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002

Germany, Brandenburg

1998-2002

Germany, Mecklenburg-Western
Pomerania

1998-2002

1964-66

1968-72

1973-77

1978-82

1983-87

1988-89

1960-62

1963-66

1969-72

1973-77

1978-79

1998-2002

1998-2002

1968-72

1973-77

1978-82

1983-87

1988-92

1993-97

1998-2002

1962-66

1969-71

1973-77

1978-82

1983-87

1962-66

1968-72

1973-77

1978-82

1983-87

1955-63

1964-72

1973-82

1983-87

1988-92

1993-97

1998-2002

1995-97

1998-2002

Germany, Free State of Saxony

Germany, Eastern States


(ex-GDR)
Germany, Hamburg
Germany, Munich

Germany, North RhineWestphalia: Mnster


Germany, Saarland

Hungary, County SzabolcsSzatmar


Hungary, County Vas
Hungary, Miskolc
Iceland
Ireland

Italy, Biella Province

Italy, Brescia Province


Italy, Ferrara Province

Italy, Florence and Prato


Italy, Genoa
Italy, Latina

Italy, Liguria

Italy, Liguria, Genoa Province


Italy, Macerata Province
Italy, Milan

Italy, Modena Province


Italy, Naples

Italy, North East

Italy, Parma Province

Italy, Ragusa Province

Italy, Reggio Emilia Province


Italy, Romagna Region

10

Vol. I

1962-66
-

1980-82
-

1983-86
-

1988-91

1991-92

1993-97

1988-92

1993-97

1995-97

1988-92

1993-97

1988-92

1996-97

1983-87

1993-97

1978-82
-

1988-92

1988-91

1994-97

1986-87
1983-85

1988-92

1993-97

1991-92

1985-87

1986-87
1985-87

1989-92

1998-2002

1998-2002

1998-2002
1999-2001
1998-2002
1998-2002
-

1993-96

1998-2000

1999-2002

1993-97
-

1993-97

1998-2000
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002
1998-2002

Introduction

Table 1.4 Geographical coverage in the nine successive volumes of


Cancer Incidence in Five Continents
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio

Italy, Syracuse Province


Italy, Torino

Italy, Trieste

Italy, Umbria Region

Italy, Varese Province


Italy, Veneto Region
Latvia

Vol. I

Vol. II

Vol. III

Vol. IV

Vol. V

Vol. VI

Vol. VII

Vol. VIII

1993-97

1994-96

1998-2002

1988-92

1993-96

1998-2001

1983-87

1989-92

1978-81

1983-87

1988-92

1983-87

1988-92

Malta

1969-72

1992-93

1960-62

The Netherlands, Three Provinces


The Netherlands, Eindhoven
The Netherlands, Maastricht
Norway

Poland, Cieszyn Area


Poland, Cracow

Poland, Katowice District


Poland, Kielce

Poland, Lower Silesia


Poland, Nowy Sacz
Poland, Opole

Poland, Warsaw City

Poland, Warsaw Rural Areas


Portugal, Porto

Portugal, South Regional

Portugal, Vila Nova de Gaia


Romania, Banat Region
Romania, County Cluj

Romania, County Timis


Russia, St Petersburg
Serbia

Slovak Republic

Slovakia, Western
Slovenia

Spain, Albacete
Spain, Asturias

Spain, Basque Country


Spain, Canary Islands
Spain, Cuenca
Spain, Girona

1973-77
1973-74
-

1965-66

1968-72

1973-77

1980-82

1965-66
-

1968-72
-

1967

1970-72

1983-86

1998-2002

1993-97

1978-82

1973-76
-

1973-77

1983-87

1998-2002

1983-87

1993-97

1993-97

1988-92

1989-92

1983-87

1983-87

1998-2002

1993-96

1983-87

1988-92

1979-82

1968-72

1974-78

1961-65
-

1973-77

1998-2002

1956-60
-

1998-2002

1993-97

1985-87

1978-81

1993-97

1988-92

1973-77

1988-92

1983-86

1984-87

1968-72

1986-88

1998-2002

1978-81

1998-2002

1993-97

1973-77

1998-2002

1993-97

1988-92

1968-72

1993-97

1983-87

1965-66

1998-2002

1998-2002

1970-72

1998-2002

1993-97

1978-82

1965-66

1988-92
1993-97

1988-92

1973-77

1993-97

1998-2000

1983-87

1968-72
1968-72

1989-92

1993-97

1978-82

1964-66
-

1998-2002

1959-61
-

1999-2002

1993-97

1998-2002

1988-91

Lithuania
The Netherlands

1998-2002

1984-85

1976-77
-

1998-2001

Vol. IX

1999-2001
-

1994-97

1998-2002

1983-87

1988-92

1993-97

1998-2002

1978-81

1982-87

1988-92

1993-97

1998-2002

1988-91

1992-95

1996-2000

1986-87

1991-92
1988-91

1993-97
-

1993-95

1994-97

1993-97

1999-2002
-

1998-2001
1998-2001
1997-2001
1998-2002
1998-2002

11

Introduction

Table 1.4 Geographical coverage in the nine successive volumes of


Cancer Incidence in Five Continents
Spain, Granada

Spain, Mallorca
Spain, Murcia

Spain, Navarra

Spain, Tarragona
Spain, Zaragoza
Sweden

Vol. II

Vol. III

Vol. IV

Vol. V

1988-92

1980-83

1984-87

1968-72

1973-77

1978-82

1983-86
1983-85

1970-72

1973-77

Switzerland, Neuchtel

1974-76

1978-82

Switzerland, Ticino

Switzerland, Geneva

Switzerland, Graubnden

Switzerland, Graubnden and


Glarus
Switzerland, St Gall-Appenzell
Switzerland, Valais
Switzerland, Vaud

Switzerland, Zrich
UK, England

UK, England and Wales

UK, England, East of England


Region
UK, England, Merseyside and
Cheshire
UK, England, North Western
UK, England, Northern and
Yorkshire

UK, England, Oxford Region


UK, England, South Thames
(South Metropolitan)

1975-77

1978-82

1962-65

1971-75

1993-96

1984-87

1966-70

1988-92

1978-82

Vol. VIII

1988-92

1973-77

Vol. VII

1985-87

Vol. VI

1959-61

Switzerland, Basel

1981-82
1979-82
-

1978-82
1980-82
-

1983-87
1983-87
1983-87

1987-91
1988-92
1986-90
1988-92
1988-92

1998-2002

1993-96

1997-2001

1993-97

1998-2001

1993-97
1991-95
1993-97
1993-97

1998-2002
1996-2000
1998-2002
-

1993-97

1998-2002

1993-97

1998-2002

1983-87

1988-92

1993-96

1998-2002

1996-97

1998-2002

1983-87

1988-92

Vol. IX

1993-97

1989-92

1988-92

1989-92

1983-87

1988-92

1983-87
-

1988-92
-

1979-82

1983-86

1988-90

1993-97
1993-97
1993-96
1993-96
1993-97
-

1998-2002
1998-2002
1998-2002
-

1988-92

1993-97

1998-2002

1959-63

1963-66

1968-72

1975-77

1978-82

1983-87

1988-92

1993-97

1998-2002

1973-77

1979-82

1983-87

1988-92

1993-97

1998-2002

1998-2002

1963-66

1968-72

1974-77

1979-82

1983-87

1988-92

1993-97

1998-2002

1960-62

1963-66
1967-71

1973-77

1978-82

1983-87

1988-92

1993-97

UK, England, South and Western


1960-62
Regions

1962-65

1966-70

1979-82

1983-87

1988-92

1993-97

1998-2002

UK, England, Trent

1963-66

1967-70

1974-76

1979-82

1983-87

1998-2002

1960-62

1963-66

1968-72

1973-76

1979-82

1983-86

1988-92

1983-87
-

1988-92

UK, England, Thames


UK, England, Wessex

UK, England, West Midlands


UK, England, Yorkshire
UK, Northern Ireland
UK, Scotland

UK, Scotland, Ayrshire


UK, Scotland, East

UK, Scotland, North

UK, Scotland, North-East

UK, Scotland, South-East


UK, Scotland, West

Yugoslavia, Vojvodina

12

Vol. I

1963-66

1998-2002

1993-97

1998-2002

1988-92

1973-77

1978-82

1983-87

1973-77

1978-82

1983-87

1993-97

1983-87

1988-92

1978-82

1970-72

1993-97

1973-77
1973-77
1975-77
-

1978-82
1978-82
1978-82
-

1983-87
1983-87
1983-87
-

1988-92
1988-92

1993-97
1993-97
-

1993-97

1998-2002
-

1998-2002
-

Introduction

Table 1.4 Geographical coverage in the nine successive volumes of


Cancer Incidence in Five Continents
Vol. I

Vol. II

Vol. III

Australian Capital Territory

Australia, Northern Territory

Oceania

Australia, New South Wales


Australia, Queensland
South Australia

Australia, Tasmania
Australia, Victoria
Western Australia
French Polynesia
New Zealand:
Maori

Non-Maori

Pacific Polynesian Islanders

USA, Hawaii:
Chinese

1960-62

Vol. IV

Vol. V

Vol. VI

Vol. VII

Vol. VIII

Vol. IX

1978-82

1983-87

1988-92

1993-97

1998-2002

1993-97

1998-2002

1973-77
-

1978-82
1982

1983-87
-

1977

1978-82

1983-87

1988-92

1982

1983-87

1988-92

1978-82
1982
-

1983-87
1983-87
-

1962-66

1968-71

1972-76

1978-82

1983-87

1978-82

1960-63

1962-66
-

1988-92

1968-71
-

1972-76
-

1978-82
-

1983-87
-

1988-92
1988-92
1988-92

1968-72

1973-77

1978-82

1983-87

1988-92

White

1960-63

1960-64

1968-72
1968-72

1973-77
1973-77

1978-82
1978-82

1983-87
1983-87

1998-2002
1998-2002
1998-2002
-

1998-2002

1960-64
1960-64

1998-2002

1993-97

1960-63
1960-63

1998-2002

1988-92

Hawaiian
Japanese

1998-2002

1998-2002

1988-92

1983-87

1998-2002

1993-97

1983-87

1978-82

1993-97

1998-2002

1978-82

1973-77

1993-97

1973-77

1968-72

1993-97

1968-72

1960-64

1993-97

1993-97

1960-64

1993-97

1988-92

Filipino

1993-97

1988-92
1988-92

1993-97
1993-97
1993-97
1993-97

1998-2002
1998-2002
1998-2002
1998-2002

13

Chapter 2: Techniques of registration


M.P. Curado

The quality of the cancer database in a cancer registry rests not


only upon the quality of its sources of information but also upon
the registration techniques adopted by the cancer registration
team. If these techniques follow the international rules of cancer
registration, populations may be compared with confidence.
This chapter describes the variation between registries in the
methods used to collect data on new cancer cases and on the
population at risk in the geographical area covered by the cancer
registry.
Registry background
The background of each cancer registry is relevant to the
information it delivers. These definitions could affect the data,
potentially resulting in an under- or over-reporting of cases.
Each point of this issue is discussed briefly below.
Table 2.1 presents a definition of the area covered by the cancer
registry. This includes its population, surface area, latitude, the
year the registry started, the year population-based data became
available, and whether cancer is reportable by L (Legislation), A
(Administrative), N (Not reportable) or M (Mixed, a combination
of the above). Other variables presented include the percentage
of cases treated outside the registration area and the percentage
of non-residents treated in the registration area. These topics are
discussed in greater detail below.
Populations. The denominator used to calculate rates generally
comes from official census data. Rates based on interpolations
between censuses tend to be better than projections since the
last census. The absolute size of the populations on which the
rates are based affects the accuracy of the estimated rates. Rates
based on small numbers are more subject to random variation
than are rates based on large populations.
Surface area. The population density is calculated by each
registry based on the population estimates from the surface
area.
Latitude. This localises the position of the cancer registry and
enables comparison within the same region.
Year registry started and Year population based data available.
To get good-quality data in cancer incidence takes time. For
instance, data from new cancer registries should be viewed with
some caution, because in the first years of data collection the
rates can be underestimated (due to over selectivity causing
under collection) or overestimated (due to conflation with
already-existing cases).
Cancer reportable. This is a tool used to get a better picture
of completeness in cancer registration. The presence of laws
and rules that make cancer diagnosis a reportable disease can
ensure completeness of the registry data collection, especially
in countries where the cancer registry is part of an integrated
cancer control programme.
Percentage of cases treated outside the area. If the area covered
by the population cancer registry has limited facilities for cancer
diagnosis and care, such as surgery, radiotherapy, chemotherapy
and pathology laboratories, it will be quite difficult for the cancer
registry to get completeness in the area, as the residents with a

14

suspicion of cancer will seek treatment outside the catchment


area. Patients may also die outside the catchment area, or even
return to die at home after having being diagnosed elsewhere,
thus causing underestimation of the local incidence rates.
Percentage of non-residents treated inside the area. If the
catchment area has a cancer care centre with a good reputation
and treatment and diagnosis facilities available to the population,
there may be an increased number of non-residents being treated
in the same area as the resident cases. If these non-resident
cancer cases are included in the cancer registry database, the
local rates may be overestimated.
Case finding
If the geographical area covered by the cancer registry includes
cancer centres and radiotherapy services, or any type of oncology
or onco- haematological treatment and diagnosis centres such
as pathology laboratories where cases can be microscopically
verified, this can improve data quality in cancer diagnosis, and is
also an important source of quality data on local health services.
The main sources of cases are described in Table 2.2.
Data Sources. These sources include hospital in-patient records,
radiotherapy departments, public and private hospitals and their
in- and out-patient facilities, pathology laboratories, autopsies,
haematology laboratories, death certificates and screening
programmes.
Abstraction and coding. This details the proportion of manual
abstraction and coding of cancer information done by trained
cancer registry personnel. Nowadays some cancer registries
have automatic registration for which cancer registry personnel
must verify the data quality and comparability.
Information recorded
Table 2.3 presents the information recorded by the populationbased cancer registry. This is the most relevant information that
should be collected by the cancer registries: Basic information
includes name, sex, date of birth or age, and usual resident
address (permanent) of each patient, which enables personal
identification. Further information collected includes ID number;
ethnic group/race/colour; incidence date, stage of disease; nature
of the first treatment; brain and nervous system; followup for
vital status (all/selected/none); death certificates used to update
vital status; and active follow-up of the alive cases.
Basic information includes name, sex, date of birth or age, and
permanent address of the patient. These items are essential for
establishing the patients background in the cancer registry database,
precluding double entry of the same case in the registry.
Incidence date includes the date of diagnosis or hospitalisation
for first treatment, as well as if possible the primary site and
histological type of the cancer diagnosed. It must be coded
according to ICD-O-3 (see Chapter 3).
Date of birth is important to assist identification, particularly
where there is limited variation in names, or when other
specific identifying information is lacking. For comparability,
it is necessary to convert any local dating system to a standard
system used internationally.

Techniques of registration

ID number. Some countries have a number unique to the individual,


and others have more than one. The use of these identification
numbers varies, but whenever such a number exists, the cancer
registry should promote its inclusion in the notification form of the
cancer registry, as it can be used to eliminate double notification
stemming from using multiple sources of information.
Ethnic group/race/colour. For some cancer registries this is an
essential item, because social and cultural differences between
groups may be related to the utilisation of medical facilities.
It can be an indicator of differences in culture and habits that
may determine exposure to carcinogenic factors. The definitions
of the ethnic groups used by the cancer registries should be
compatible with official definitions used for census reports.
Stage of disease can be identified when the diagnosis is made
by the physician, and is a standard data point used to analyse
References
Jensen, O.M., Parkin, D.M., Maclennan, R., Muir, C.S., Skeet,
R.G. (1991). Cancer Registration: Principles and Methods.
IARC Scientific Publication No. 95. Lyon: IARCPress.

post-diagnosis survival and disease stage. The final evaluation


of survival depends upon the topography of the tumour at time
of the diagnosis.
Nature of the first treatment. The type of treatment modality
reflects the general access to basic treatment modalities (but it
cannot be used to assess the efficacy of specific treatment).
Brain and nervous system identifies whether cancer registries
include benign cancers of the brain and nervous system or not.
Follow-up for vital status, Death certificates used to update vital
status, and Active follow-up of the living cases. The follow-up
for vital status is important to evaluate survival after treatment
and diagnosis, and it can be done actively through a phone
call or visit, or passively by matching death certificates with
incidence cases.

International Agency for Research on Cancer (2002). Cancer


Incidence in Five Continents Volume VIII. eds: Parkin,
D.M., Whelan, S.L., Ferlay, J., Teppo, L., and Thomas, D.B.
Lyon: IARCPress. Pgs. 1143.

15

16

1 839 932

1 420 578

Ecuador, Quito

938 857

Canada, Prince Edward Island

Canada, Saskatchewan

1 016 987

137 693

11 717 355

41 123

Canada, Nova Scotia

Canada, Ontario

Canada, Northwest Territories

535 263

753 833

1 152 523

4 060 110

3 009 814

23 363 550

592 568

381 639

3 921 558

Canada, Newfoundland and Labrador

Canada, New Brunswick

Canada, Manitoba

Canada, British Columbia

Canada, Alberta

Canada

North America

Peru, Trujillo

France, Martinique

Costa Rica

362 394

Colombia, Cali

Chile, Valdivia

10 408 477

1 097 218

713 391

2 009 106

284 776

1 736 809

1 526 966

494 800

3 665 524

1 365 488

Brazil, So Paulo

Brazil, Goinia

Brazil, Cuiaba

Brazil, Brasilia

Argentina, Bahia Blanca

South and Central America

Zimbabwe, Harare

Uganda, Kyadondo County

Tunisia, Central Region

Egypt, Gharbiah

Algeria, Setif

Africa

Population

1 943

651 903

5 660

1 070 000

55 491

1 346 106

371 364

73 437

NS

892 677

661 848

9 970 610

112

1 080

360

51 100

121

18 472

1 509

739

4 476

5 789

2 300

872

1 914

2 669

6 504

Surface area (km2)

51 N

46 - 48 N

44 N

NS

NS

NS

45 - 48 N

NS

50 N

52 N

42 - 83 N

8 S

14 N

NS

NS

39 S

23 S

16 S

NS

15 - 16 S

38 - 42 S

18

0 N

NS

31 N

35 N

Latitude

1998

1932

1969

1964

1964

1986

1955

1955

1937

1966

1942

1992

1990

1983

1984

1977

1962

1992

1969

1986

1999

1997

1989

1986

1951

1987

1986

Year registry
started

Table 2.1 Registry background

1999

1944

1969

1964

1964

1950

1955

1989

1956

1969

1951

1969

1984

1981

1985

1980

1962

1993

1969

1988

2000

1996

1989

1990

1960

1989

1986

Year
population-based
data available

Cancer reportable
by: L/A/N/M*

NS

NS

<1

NS

NS

NS

NS

NS

12,1

NS

NS

NS

NS

NS

NS

NS

NS

~5

60

% cases treated
outside
registration area

1.7

NS

~2

NS

NS

NS

39.1

52

6.2

35.1

3.04

30

50

NS

30

70

70

10

20

% non-residents
treated inside
registration area

Techniques of registration

8 215 680

12 434 662

USA, Illinois

USA, Indiana

6 083 754

4 048 728

USA, Michigan, Detroit

USA, Oklahoma

USA, Ohio

USA, NPCR

USA, New York State

USA, New Mexico

USA, New Jersey

USA, Montana

USA, Missouri

USA, Michigan

3 450 643

11 360 971

223 467 872

18 974 870

1 822 108

8 432 830

901 930

5 599 094

9 949 858

1 276 563

6 354 587

USA, Massachusetts

USA, Maine

971 090

4 462 873

4 042 038

2 923 062

USA, Louisiana, New Orleans

USA, Louisiana

USA, Kentucky

USA, Iowa

1 298 409

2 915 231

USA, Idaho

USA, Georgia, Atlanta

16 068 139

USA, Georgia

USA, Florida

569 765

3 411 252

4 319 872

9 543 402

116 105

177 850

123 234

314 926

20 300

381 160

180 550

5 094

264 180

27 340

91 660

7 217

134 382

102 900

145 800

94 330

146 080

NS

4 500

150 000

NS

170

12 973

269 620

404 000

6 427

4 136 868

295 274

404 000

5 162 349

1 481 350

34 001 960

629 290

133 550

Surface area (km2)

4 446 355

USA, District of Columbia

USA, Connecticut

USA, Colorado

USA, California, Los Angeles County

USA, California, Greater San Francisco


Bay Area

USA, California

USA, Arizona

USA, Alaska

USA, Alabama

Population

40 N

35 N

38 - 42 N

43 N

35 N

40 N

44 - 49 N

38

42 - 43 N

41 - 47 N

42 N

44 N

30 N

30 N

38 N

44 N

40 N

37 - 42 N

44 N

33 N

30 - 35 N

27

39

41 - 42 N

34 N

38 - 39 N

34 N

33 N

61 N

30 - 35 N

Latitude

1968

1992
1995

1940

1967

1979

1979

1972

1949

1981

1980

1981

1974

1974

1991

1973

1987

1985

1969

1975

1995

1981

1985

1941

1970

1973

1988

1980

1996

1996

Year registry
started

Table 2.1 Registry background

1988

1996
1997

1976

1969

1979

1979

1985

1973

1985

1982

1981

1974

1988

1995

1973

1987

1986

1971

1975

1999

1981

1996

1935

1972

1973

1988

1995

1996

1996

Year
population-based
data available

L
L

Cancer reportable
by: L/A/N/M*

NS

NS

1,7

10

NS

NS

NS

1,42

NS

0,2

1,9

3,1

NS

NS

3-5

15

NS

NS

NS

NS

1,6

18,9

4,5

% cases treated
outside
registration area

NS

NS

<5

NS

NS

13.53

7.1

4.7

4.8

NS

3.7

NS

2-3

12

30

NS

14.6

15.8

0.03

12.8

% non-residents
treated inside
registration area

Techniques of registration

17

18
NS

5 369 826

843 937

1 325 722

4 308 843

11 815 502

12 527 357

1 157 702

1 060 078

China, Zhongshan

India, Chennai (Madras)

India, Mumbai (Bombay)

India, New Delhi

India, Trivandrum

Japan, Aichi Prefecture

Japan, Fukui Prefecture

Israel

India, Poona

India, Nagpur

India, Karunagappally

Cyprus

China, Shanghai

829 265

6 128 406

3 550 945

2 020 995

413 094

NS

698 320

4 189

646

22 145

336

344

891

438

438

192

170

1 683

289

188

507

1 098

1 335

118

145 440

62 360

45830

184 675

23 960

219 888

678 055

80 650

6 284 314

381 289

China, Nangang District, Harbin City

China, Jiashan

6 665 420

3 608 260

398 455

China, Hong Kong

China, Guangzhou

Bahrain

Asia

1 808 253

USA, Wisconsin

USA, West Virginia

4 060 760

5 916 597

608 882

2 242 702

20 948 520

4 016 127

3 145

74 331 088

1 049 908

117 330

251 180

3 434 016

12 284 430

USA, Washington, Seattle

USA, Washington

USA, Vermont

USA, Utah

USA, Texas

USA, South Carolina

USA, SEER

USA, Rhode Island

USA, Oregon

USA, Pennsylvania

Surface area (km2)

Population

36 N

35 N

NS

8 N

17 - 19 N

28 N

21 N

18 - 19 N

9 N

13 N

NS

NS

31 N

44 - 44 N

30 50 N

22 N

22 N

NS

44 N

39 N

47 N

45 - 49 N

44 N

41 N

31 N

NS

NS

41 - 42 N

45 N

40 N

Latitude

1984

1962

1960

1994

1972

1986

1980

1963

1990

1981

1998

1970

1963

1997

1987

1963

1999

1994

1976

1993

1974

1991

1994

1966

1979

1993

1973

1986

1996

1982

Year registry
started

Table 2.1 Registry background

1996

1984

1962

1960

1991

1972

1986

1980

1964

1990

1982

1998

1970

1963

1980

1987

1965

1999

1998

1978

1993

1974

1992

1996

1966

1995

1996

1973

1986

1985

Year
population-based
data available

Cancer reportable
by: L/A/N/M*

NS

NS

NS

NS

0,5

100

<2

NS

30

< 0,1

NS

45

NS

< 0,5

NS

12

<5

NS

25

NS

1,1

5,7

NS

NS

3,2

% cases treated
outside
registration area
7.9

NS

NS

NI

90

50

40

50

60

40-45

20

60

NI

> 50

NS

13.6

10

~5

10

15

NS

3.5

NS

10

7.7

% non-residents
treated inside
registration area

Techniques of registration

1 893

546 696

17 818

2 071 506

1 723 615

3 263 209

Pakistan, South Karachi

Singapore

1 255 662

3 353 446

Turkey, Izmir

Belarus

Austria, Vorarlberg

Austria, Tyrol

Austria

Europe

Turkey, Antalya

670 595

10 038 230

349 737

8 021 504

1 392 172

782 152

Thailand, Songkhla

Thailand, Lampang

1 500 127

5 287 426

Thailand, Chiang Mai

Philippines, Manila

1 777 685

Malaysia, Sarawak

Oman

207 600

2 601

12 648

83 871

11 973

20 723

7 394

12 543

20 107

683

274

100

309 500

124 450

1 031

1 057

2 172 958

1 007 173

Malaysia, Penang

Kuwait

1 040 089

Korea, Ulsan

605

1 848

986

501

540

886

764

99 500

9 853 972

2 536 528

Korea, Jejudo

Korea, Seoul

Korea, Incheon

1 369 836

1 372 533

2 524 362

3 800 836

47 675 096

Korea, Gwangju

Korea, Daejeon

Korea, Daegu

Korea, Busan

Korea

9 323

4 092

8 789 355

1 244 260

Japan, Yamagata Prefecture

Japan, Osaka Prefecture

1 517 713

7 291

742

Surface area (km2)

2 364 498

1 117 564

Japan, Nagasaki Prefecture

Japan, Miyagi Prefecture

Japan, Hiroshima

Population

38 N

46 N
54 N

47 N

NS

38 N

36 N

7 N

17 - 18 N

18 N

1 N

14 N

24 N

23 N

3 N

5 N

NS

35 N

37 N

33 - 34 N

37 N

36 N

NS

35 N

35 N

36 - 37 N

39 N

34 N

33 N

NS

Latitude

1951

1987

1972

1978

1958

1992

1995

1988

1993

1978

1950

1959

1995

1985

1996

1994

1974

2001

1991

2000

1996

1997

1998

1997

1995

1980

1974

1962

1958

1957

Year registry
started

Table 2.1 Registry background

1988

1972

1981

1970

1993

1995

1989

1995

1983

1968

1980

1995

1996

1996

1994

1974

2001

1991

2000

1997

1996

1998

1997

1996

1999

1974

1963

1958

1959

1957

Year
population-based
data available
N

L;M

Cancer reportable
by: L/A/N/M*

NS

<1

NS

<1

< 10

10

15

NS

NS

14,78

~ 85

25

NS

0,05

55

< 0,1

29,3

30

30

< 30

8,7

10,6

NS

NS

NS

1,6

NS

NS

% cases treated
outside
registration area

NS

NI

55

15

NS

20

40

NI

80.6

~ 85

20-30

20.7

76

<1

NS

50

< 40

NS

36

NS

NS

NS

NS

NS

NS

% non-residents
treated inside
registration area

Techniques of registration

19

20
45 227

502 897

France, Doubs

France, Haut-Rhin

714 738

556 929

Germany, Saarland

Italy, Brescia Province

Italy, Biella Province

Ireland

Iceland

1 001 930

3 460

914

70 280

3 799 840

188 791

2 567

103 000

6 906

2 613 486

280 949

310

2 340 075

Germany, Munich

Germany, North Rhine-Westphalia:


Mnster

1 070 388

23 180

755

1 703 189

1 780 055

Germany, Hamburg

Germany, MecklenburgWestern Pomerania

18 416

4 439 006

29 479

6 720

5 758

6 170

5 938

6 815

7 431

6 101

3 522

5 234

2 591 809

550 743

NS

5 548

Germany, Free State of Saxony

Germany, Brandenburg

France, Vende

348 036

483 644

France, Somme

France, Tarn

France, Manche

1 151 896

1 109 587

915 645

France, Loire-Atlantique

France, Isre

France, Hrault

652 274

1 036 738

France, Calvados

304 112

43 080

1 370 505

5 182 506

5 337 420

78 866

56 542

110 912

2 867

13 522

Surface area (km2)

10 255 038

France, Bas-Rhin

Finland

Estonia

Denmark

Czech Republic

4 418 155

8 080 354

Bulgaria

Croatia

1 644 169

5 940 556

Belgium, Antwerp

Belgium, Flanders

Population

45 N

45 N

53 N

49 N
64 N

51 N

49 N

54 N

53 N

51 N

52 N

47 N

44 N

49 N

49 N

47 N

45 N

43 N

48 N

47 N

49 N

48 N

62 N

58 N

55 N

50 N

45

41 - 44 N

51 N

51 N

Latitude

1994

1997

1994

1967
1954

1986

1978

1953

1926

1953

1953

1997

1981

1982

1994

1997

1978

1983

1989

1976

1978

1974

1952

1978

1942

1976

1959

1952

1990

1983

Year registry
started

Table 2.1 Registry background

1990

1993

1995

1994

1967
1955

1986

1998

1953

1900

1953

1953

1998

1982

1982

1994

1998

1979

1986

1988

1977

1978

1975

1953

1968

1943

1976

1962

1952

1996

Year
population-based
data available

NS

Cancer reportable
by: L/A/N/M*
NS

9,8

40,4

NS

0-1

~ 10

NS

<2

NS

<5

NS

NS

NS

35

10

<5

NS

20

NS

<5

2,4

NS

0,1

NS

NS

NS

NS

% cases treated
outside
registration area
NI

NS

NS

10-15

NS

> 40

15-25

NS

NS

NS

NS

10

30

NS

NS

NS

15

NI

NS

<1

NS

NS

% non-residents
treated inside
registration area

Techniques of registration

300 362

632 493

2 108 544

Italy, Modena Province

Italy, North East

3 212

176 878

15 927 902

The Netherlands

The Netherlands, Eindhoven

987 198

1 648 296

4 450 012

Portugal, South Regional

3 165 766

1 290 791

Poland, Warsaw City

Portugal, Porto

Poland, Kielce

743 722

4 500 716

867 248

Poland, Cracow

Norway

The Netherlands, Maastricht

388 414

3 514 664

Malta

Lithuania

2 003 027

2 381 395

Latvia

Italy, Veneto Region

806 107

Italy, Varese Province

903 568

824 525

Italy, Umbria Region

Italy, Torino

396 175

470 153

Italy, Syracuse Province

Italy, Sondrio

Italy, Sassari Province

39 700

21 278

495

11 691

327

324 000

1 355

2 500

NS

316

64 000

64 589

9 081

1 199

8 456

130

2 109

7 520

5 303

4 922

984 424

1 087 279

Italy, Romagna Region

Italy, Salerno Province

2 293

1 614

3 449

21 451

456 026

295 754

400 056

499

536 106

Italy, Reggio Emilia Province

Italy, Ragusa Province

Italy, Parma Province

Italy, Naples

2 690

182

2 774

1 834

3 879

2 632

Surface area (km2)

1 302 388

905 261

Italy, Macerata Province

Italy, Milan

Italy, Genoa Province

1 162 009

348 068

Italy, Florence and Prato

Italy, Ferrara Province

Population

38 N

41,5 N

NS

51 N

51 N

57 - 71 N

51 N

52 N

53 N

36 N

NS

55 - 58 N

45 N

45 N

43 N

45 N

37 N

46 N

41 N

40 N

44 N

44 N

37 N

45 N

46 N

40 N

44 N

45 N

43 N

44 N

44 N

45 N

Latitude

1989

1988

1963

1962

1965

1952

1984

1955

1955

1985

1975

1993

1990

1974

1991

1985

1997

2001

1991

1997

1985

2001

1979

1976

1998

1996

1988

2002

1989

1984

1984

1987

Year registry
started

Table 2.1 Registry background

1994

1988

1963

1988

1978

1952

1986

1958

1989

1991

1978

1965

1987

1976

1994

1985

1999

1998

1992

1996

1986

1996

1981

1978

1995

1997

1988

1999

1991

1986

1985

1991

Year
population-based
data available
A

Cancer reportable
by: L/A/N/M*

NS

NS

0,9

<1

NS

NS

~ 0,1

NS

13

10

12

47

15

NS

25

3-5

20

80

2,57

65

~2

14,6

% cases treated
outside
registration area

10

NS

3.5

NI

NS

NS

~ 0.05

NS

16

20

46

10

NS

NS

10-15

NS

10

5-10

10

5-10

50

20

~ 19

NS

% non-residents
treated inside
registration area

Techniques of registration

21

22

362 543

2 087 227

201 008

Spain, Albacete

Spain, Basque Country

Spain, Cuenca

555 735

8 880 323

Sweden

275 600

Switzerland, Valais

8 200

28 500

6 560 118

6 684 815

UK, England, South and Western


Regions

UK, England, Trent

UK, England, Thames

4 785 950

13 883 842
14 763

16 000

30 000

NS

2 716 680

4 130 253

UK, England, Northern and Yorkshire

UK, England, Oxford Region

UK, England, North Western

NS

13 800

3 211

5 225

2 357 153

2 732 948

614 829

2 812

2 430

796

7 790

282

449 964

17 252

6 283

10 491

11 317

12 531

5 569

17 061

7 500

7 261

10 565

14 862

20 273

49 035

570

55 968

Surface area (km2)

UK, England, Merseyside and Cheshire

UK, England, East of England Region

Switzerland, Vaud

309 578

166 459

517 318

Switzerland, Ticino

Switzerland, Neuchtel

Switzerland, St Gall-Appenzell

411 794

224 541

Switzerland, Graubnden and Glarus

Switzerland, Geneva

844 261

593 176

Spain, Zaragoza

Spain, Tarragona

1 149 595

Spain, Navarra

Spain, Murcia

810 967

547 305

1 447 771

1 081 836

Spain, Granada

Spain, Girona

Spain, Canary Islands

Spain, Asturias

1 987 309

5 400 679

Slovak Republic

Slovenia

4 669 043

5 482 807

Russia, St Petersburg

Serbia

Population

53 N

51 - 52 N

50 N

52 N

54 N

NS

NS

52 N

47 N

NS

NS

47 N

47 N

46 N

46 N

58 N

41 N

41 N

42 - 43 N

37 N

37 N

41 - 42 N

40 N

28 N

43 N

43 N

39 N

46 N

47 - 49 N

NS

60 N

Latitude

1955

1958

1945

1952

1965

1962

1944

1960

1972

1988

1995

1960

1972

1989

1970

1958

1960

1979

1970

1981

1985

1995

1993

1992

1986

1978

1990

1950

1976

1953

1996

Year registry
started

Table 2.1 Registry background

1980

1971

1960

1971

NS

1976

1962

1944

1960

1974

1989

1996

1980

1974

1989

1970

1958

1960

1980

1973

1982

1985

1994

1993

1993

1986

1982

1991

1950

1968

1999

Year
population-based
data available

Cancer reportable
by: L/A/N/M*
0,5

10-15

1,6

2,4

<1

NS

NS

NS

< 10

NS

<5

NS

9,6

<5

4,2

10

NS

1,7

NS

NS

NS

~5

% cases treated
outside
registration area
5

10-15

0.2

1.2

9.1

40

NS

NS

10

20

NS

17

NI

NS

NS

20

10

3.5

NS

< 0.5

~ 30

% non-residents
treated inside
registration area

Techniques of registration

3 853 350

232 782

1 218 833

*
L = legislation (a law exists)
A = administrative order (without a specic law)
N = not reportable
M = mixed (a combination of above)
NS, not stated
NI, not included

USA, Hawaii

New Zealand

French Polynesia

4 763 103

1 877 923

Western Australia

Australia, Victoria

472 195

Australia, Tasmania

3 575 470

1 504 567

South Australia

Australia, Queensland

194 922

6 489 196

315 652

Australia, Northern Territory

Australia, New South Wales

Australian Capital Territory

Oceania

1 685 136

5 066 191

UK, Scotland

UK, Northern Ireland

5 279 560

UK, England, West Midlands

Population

14 139

801 400

16 635

270 534

4 000

NS

227 420

68 114

984 375

1 600 000

1 346 200

2 400

77 925

13 014

Surface area (km2)

54 N

21 N

39 S

7 - 29 S

NS

37 S

42 S

26 - 38 S

26 S

13 S

28 - 38 S

35 S

56 N

52 N

Latitude

1994

1971

1960

1948

1981

1981

1940

1978

1977

1982

1981

1971

1936

1936

Year registry
started

Table 2.1 Registry background

1972

1960

1972

1985

1982

1982

1978

1977

1982

1991

1972

1958

1993

1957

Year
population-based
data available
N

Cancer reportable
by: L/A/N/M*

NS

NS

NS

<1

0,8

NS

NS

NS

NS

< 0,5

<5

% cases treated
outside
registration area

8-12

<1

NS

NI

0.4

NS

NS

1-4

<5

4.9

% non-residents
treated inside
registration area

Techniques of registration

23

24

Ecuador, Quito

Canada, Prince Edward Island

Canada, Ontario

Canada, Nova Scotia

Canada, Northwest Territories

Canada, Newfoundland and Labrador

Canada, New Brunswick

Canada, Manitoba

Canada, British Columbia

Canada, Alberta

Canada

North America

Peru, Trujillo

France, Martinique

Costa Rica

Colombia, Cali

Chile, Valdivia

Brazil, So Paulo

Brazil, Goinia

Brazil, Cuiaba

Brazil, Brasilia

Argentina, Bahia Blanca

South and Central America

Zimbabwe, Harare

Uganda, Kyadondo County

Tunisia, Central Region

Egypt, Gharbiah

Algeria, Setif

Africa

Hospital
in-patient
records

Radiotherapy
depts.

Public
hospital
in-patient
facilities

Private
hospital/
clinic
in-patient
facilities

Y
Y

Private
Public
hospital/
hospital
clinic
out-patient out-patient
facilities
facilities

Pathology
labs

Table 2.2 Case nding, abstracting and coding

Autopsy

Haematology
labs

Death
certicates

Screening
programmes

10

100

50

100

100

NS

100

50

100

95

100

100

90

75

100

NS

100

99

100

NS

100

100

% cases
abstracted
by registry
personnel

90

100

50

100

100

NS

100

100

100

100

100

100

100

25

100

100

100

100

100

100

100

100

100

% cases
coded by
registry
personnel

Techniques of registration

USA, California

USA, Michigan, Detroit

USA, Montana

USA, NPCR

USA, New York State

USA, New Mexico

USA, New Jersey

USA, Missouri

NS

NS

USA, Massachusetts

USA, Michigan

USA, Maine

NS

Radiotherapy
depts.

USA, Louisiana, New Orleans

USA, Louisiana

USA, Kentucky

USA, Iowa

NS

USA, Indiana

USA, Illinois

USA, Idaho

USA, Georgia, Atlanta

USA, Georgia

USA, Florida

USA, District of Columbia

USA, Connecticut

USA, Colorado

USA, California, Los Angeles County

USA, California, Greater San Francisco


Bay Area

USA, Arizona

USA, Alaska

USA, Alabama

Canada, Saskatchewan

Hospital
in-patient
records

NS

Public
hospital
in-patient
facilities

NS

Private
hospital/
clinic
in-patient
facilities

NS

NS

NS

Private
Public
hospital/
hospital
clinic
out-patient out-patient
facilities
facilities

NS

Pathology
labs

Table 2.2 Case nding, abstracting and coding

NS

NS

NS

Autopsy

NS

NS

Haematology
labs

NS

Death
certicates

NS

Screening
programmes

<3

90

100

6.3

65

95-98

100

100

85

100

NS

1-2

80

100

95

99

15

NS

100

NS

100

50

97

% cases
abstracted
by registry
personnel

<3

100

100

15

0.5

100

15

95-98

100

100

15

100

NS

1-2

100

100

10

100

NS

100

NS

100

50

100

% cases
coded by
registry
personnel

Techniques of registration

25

26

USA, Vermont

China, Zhongshan

India, Chennai (Madras)

India, Mumbai (Bombay)

India, New Delhi

India, Trivandrum

India, Poona

India, Nagpur

India, Karunagappally

Cyprus

China, Shanghai

China, Jiashan

China, Nangang District, Harbin City

China, Hong Kong

China, Guangzhou

Bahrain

Asia

USA, Wisconsin

USA, West Virginia

USA, Washington, Seattle

USA, Washington

USA, Utah

USA, Texas

USA, South Carolina

USA, Rhode Island

USA, SEER

USA, Pennsylvania

USA, Oregon

Radiotherapy
depts.

USA, Oklahoma

USA, Ohio

Hospital
in-patient
records

NS

Public
hospital
in-patient
facilities

NS

Private
hospital/
clinic
in-patient
facilities

NS

NS

Private
Public
hospital/
hospital
clinic
out-patient out-patient
facilities
facilities

Pathology
labs

Table 2.2 Case nding, abstracting and coding

Autopsy

Haematology
labs

Death
certicates

Screening
programmes

100

100

100

100

100

100

90-92

100

90

15

100

20

95

NS

90

23.4

100

85

NS

~100

% cases
abstracted
by registry
personnel

100

100

100

100

100

100

100

100

100

100

100

NS

85

100

100

10

20

100

NS

10

100

100

15

NS

~100

20

% cases
coded by
registry
personnel

Techniques of registration

N
Y

Korea, Busan

Singapore

Turkey, Izmir

Turkey, Antalya

Thailand, Songkhla

Thailand, Lampang

Thailand, Chiang Mai

Philippines, Manila

Pakistan, South Karachi

Oman

Malaysia, Sarawak

Kuwait

Malaysia, Penang

Korea, Ulsan

Korea, Seoul

Korea, Jejudo

Korea, Incheon

Korea, Gwangju

Korea, Daejeon

Korea, Daegu

Korea

Japan, Yamagata Prefecture

Japan, Osaka Prefecture

Radiotherapy
depts.

Japan, Nagasaki Prefecture

Japan, Miyagi Prefecture

Japan, Hiroshima

Japan, Fukui Prefecture

Japan, Aichi Prefecture

Israel

Hospital
in-patient
records

Public
hospital
in-patient
facilities

Private
hospital/
clinic
in-patient
facilities

NS

Private
Public
hospital/
hospital
clinic
out-patient out-patient
facilities
facilities

Pathology
labs

Table 2.2 Case nding, abstracting and coding

Autopsy

Haematology
labs

Death
certicates

NS

NS

Screening
programmes

100

95

100

60

100

100

~30

80

50

100

100

100

100

56.1

35

100

6.2

100

100

25

NS

50

70

75.7

100

% cases
abstracted
by registry
personnel

100

80

100

100

95

100

100

100

100

100

100

100

100

100

43.9

35

100

8.3

100

100

100

NS

100

100

100

100

18

100

% cases
coded by
registry
personnel

Techniques of registration

27

28

Bulgaria

Finland

France, Tarn

Germany, Munich

Germany, MecklenburgWestern Pomerania

Germany, Hamburg

Germany, Free State of Saxony

Germany, Brandenburg

France, Vende

Radiotherapy
depts.

France, Somme

France, Manche

France, Loire-Atlantique

France, Isre

France, Hrault

France, Haut-Rhin

France, Doubs

France, Calvados

France, Bas-Rhin

Estonia

Denmark

Czech Republic

Croatia

Belgium, Flanders

Belarus

Belgium, Antwerp

Austria, Vorarlberg

Austria, Tyrol

Austria

Europe

Hospital
in-patient
records

Public
hospital
in-patient
facilities

Private
hospital/
clinic
in-patient
facilities

Y
Y

Private
Public
hospital/
hospital
clinic
out-patient out-patient
facilities
facilities

Pathology
labs

Table 2.2 Case nding, abstracting and coding

Autopsy

NS

Haematology
labs

Death
certicates

NS

Screening
programmes

40

<5

NS

NS

100

32

100

NS

100

NS

100

80

100

NS

100

NS

36

100

100

% cases
abstracted
by registry
personnel

100

100

100

NS

100

100

100

100

100

100

100

100

NS

100

100

100

100

100

100

100

90

80

100

64

100

100

92

% cases
coded by
registry
personnel

Techniques of registration

Italy, Macerata Province

Italy, Modena Province

Italy, North East

Italy, Sassari Province

Latvia

The Netherlands

Malta

Lithuania

Italy, Veneto Region

Italy, Varese Province

Italy, Umbria Region

Italy, Torino

Italy, Syracuse Province

Italy, Sondrio

Italy, Salerno Province

Italy, Romagna Region

Italy, Reggio Emilia Province

Italy, Ragusa Province

Italy, Parma Province

Italy, Naples

Italy, Milan

Italy, Genoa Province

NS

Italy, Florence and Prato

Italy, Ferrara Province

NS

Radiotherapy
depts.

Italy, Brescia Province

Italy, Biella Province

Ireland

Iceland

Germany, Saarland

Germany, North Rhine-Westphalia:


Mnster

Hospital
in-patient
records

NS

Public
hospital
in-patient
facilities

NS

Private
hospital/
clinic
in-patient
facilities

NS

NS

Private
Public
hospital/
hospital
clinic
out-patient out-patient
facilities
facilities

Pathology
labs

Table 2.2 Case nding, abstracting and coding

NS

Autopsy

Haematology
labs

Death
certicates

NS

Screening
programmes

100

NS

80

NS

98.8

100

63

90

100

10-30

NS

100

100

NS

NS

51

100

85

10

100

100

100

0
100

75

% cases
abstracted
by registry
personnel

100

NS

95

100

30

30

98.8

100

100

37

100

100

NS

100

100

30

100

NS

51

100

100

100

100

79.7

100

100

100
100

100

% cases
coded by
registry
personnel

Techniques of registration

29

30
Y

Spain, Basque Country

Spain, Cuenca

Switzerland, Valais

Switzerland, Vaud

Switzerland, St Gall-Appenzell

Switzerland, Ticino

Switzerland, Neuchtel

Switzerland, Graubnden and Glarus

Switzerland, Geneva

Sweden

Spain, Zaragoza

Spain, Tarragona

Spain, Navarra

Spain, Murcia

Spain, Granada

Spain, Girona

Spain, Canary Islands

Spain, Albacete

Spain, Asturias

Slovenia

Serbia

Slovak Republic

Russia, St Petersburg

Portugal, Porto

Portugal, South Regional

Poland, Kielce

Poland, Warsaw City

Radiotherapy
depts.

Poland, Cracow

Norway

The Netherlands, Maastricht

The Netherlands, Eindhoven

Hospital
in-patient
records

Public
hospital
in-patient
facilities

NS

Private
hospital/
clinic
in-patient
facilities

Private
Public
hospital/
hospital
clinic
out-patient out-patient
facilities
facilities

Pathology
labs

Table 2.2 Case nding, abstracting and coding

Autopsy

Haematology
labs

Death
certicates

Screening
programmes

100

100

100

100

100

100

100

50

50

85

99

20

35

5-10

100

78

100

40

100

NA

~ 75

40

44

NS

30

10

NS

100

% cases
abstracted
by registry
personnel

100

100

100

100

100

100

100

100

50

100

100

80

65

100

100

100

100

100

100

100

100

~ 25

100

100

61

100

70

100

100

100

NS

% cases
coded by
registry
personnel

Techniques of registration

New Zealand

NS, not stated

USA, Hawaii

French Polynesia

South Australia

Western Australia

Australian Capital Territory

Australia, Victoria

Australia, Tasmania

Australia, Queensland

Australia, Northern Territory

Australia, New South Wales

Oceania

UK, Northern Ireland

UK, Scotland

UK, England, West Midlands

UK, England, Trent

UK, England, Thames

UK, England, Oxford Region

UK, England, South and Western Regions

UK, England, Northern and Yorkshire

UK, England, North Western

Radiotherapy
depts.

UK, England, Merseyside and Cheshire

UK, England, East of England Region

Hospital
in-patient
records

Public
hospital
in-patient
facilities

Private
hospital/
clinic
in-patient
facilities

Private
Public
hospital/
hospital
clinic
out-patient out-patient
facilities
facilities

Pathology
labs

Table 2.2 Case nding, abstracting and coding

Autopsy

Haematology
labs

Death
certicates

Screening
programmes

100

100

60

100

20

35

20

100

20

~ 90

>1

91

50

1-2

100

95

100

% cases
abstracted
by registry
personnel

100

100

100

99.5

100

75

80

100

65

100

75

100

~ 90

90

91

50

100

100

100

100

100

% cases
coded by
registry
personnel

Techniques of registration

31

32

Colombia, Cali

Ecuador, Quito

Canada, Prince Edward Island

Canada, Ontario

Canada, Nova Scotia

Canada, Northwest Territories

Canada, Newfoundland and Labrador

Canada, New Brunswick

Canada, Manitoba

Canada, British Columbia

Canada, Alberta

Canada

North America

Peru, Trujillo

France, Martinique

Costa Rica

Chile, Valdivia

Brazil, So Paulo

Brazil, Goinia

Brazil, Cuiaba

Brazil, Brasilia

Argentina, Bahia Blanca

South America

Zimbabwe, Harare

Uganda, Kyadondo County

Tunisia, Central Region

Egypt, Gharbiah

Algeria, Setif

Africa

Basic
information

Date of birth

ID number

Ethnic
group/
race/
colour

Incidence
date

Stage of the
disease

Table 2.3 Information recorded

Nature of 1st
treatment

Brain and
nervous
system

Sel

None

All

All

All

All

All

None

All

All

All

All

Sel

All

All

All

None

All

None

Sel

None

All

Sel

Sel

Sel

Sel

Follow-up
for vital
status: all/
selected/
none

Death
certicates
used to
update vital
status

Active
follow-up of
alive cases

Techniques of registration

USA, Michigan, Detroit

USA, Montana

USA, NPCR

USA, New York State

USA, New Mexico

USA, New Jersey

USA, Missouri

USA, Massachusetts

USA, Michigan

USA, Maine

USA, Louisiana, New Orleans

USA, Louisiana

USA, Kentucky

USA, Iowa

NS

Date of birth

USA, Indiana

USA, Illinois

USA, Idaho

USA, Georgia, Atlanta

USA, Georgia

USA, Florida

USA, District of Columbia

USA, Connecticut

USA, Colorado

USA, California, Los Angeles County

USA, California, Greater San Francisco


Bay Area

USA, California

USA, Arizona

USA, Alaska

USA, Alabama

Canada, Saskatchewan

Basic
information

ID number

NS

Ethnic
group/
race/
colour

NS

Incidence
date

NS

Stage of the
disease

Table 2.3 Information recorded

NS

Nature of 1st
treatment

NS

Brain and
nervous
system

All

All

All

All

Sel

All

Sel

Sel

All

All

All

All

All

All

None

All

All

All

All

All

All

All
All

NS

All

All

All

Sel

All

Follow-up
for vital
status: all/
selected/
none

Y
Y

NS

Death
certicates
used to
update vital
status

Y
N

NS

Active
follow-up of
alive cases

Techniques of registration

33

34

USA, Vermont

China, Zhongshan

India, Chennai (Madras)

India, Mumbai (Bombay)

India, New Delhi

India, Trivandrum

India, Poona

India, Nagpur

India, Karunagappally

Cyprus

China, Shanghai

China, Jiashan

China, Nangang District, Harbin City

China, Hong Kong

China, Guangzhou

Bahrain

Asia

USA, Wisconsin

USA, West Virginia

USA, Washington, Seattle

USA, Washington

USA, Utah

USA, Texas

USA, South Carolina

USA, Rhode Island

USA, SEER

USA, Pennsylvania

USA, Oregon

Date of birth

USA, Oklahoma

USA, Ohio

Basic
information

ID number

Ethnic
group/
race/
colour

Incidence
date

Stage of the
disease

Table 2.3 Information recorded

Nature of 1st
treatment

Brain and
nervous
system

Sel

Sel

None

All

None

Sel

All

Sel

None

All

All

All

All

All

Sel

All

All

All

Sel

All

All

Sel

All

All

All

All

All

None

All

Follow-up
for vital
status: all/
selected/
none

Death
certicates
used to
update vital
status

NS

Active
follow-up of
alive cases

Techniques of registration

Korea, Busan

Singapore

Turkey, Izmir

Turkey, Antalya

Thailand, Songkhla

Thailand, Lampang

Thailand, Chiang Mai

Philippines, Manila

Pakistan, South Karachi

Oman

Malaysia, Sarawak

Kuwait

Malaysia, Penang

Korea, Ulsan

Korea, Seoul

Korea, Jejudo

Korea, Incheon

Korea, Gwangju

Korea, Daejeon

Korea, Daegu

Japan, Yamagata Prefecture

Korea

Japan, Osaka Prefecture

Japan, Nagasaki Prefecture

Japan, Miyagi Prefecture

Japan, Hiroshima

Japan, Fukui Prefecture

Japan, Aichi Prefecture

Israel

Basic
information

Date of birth

ID number

Ethnic
group/
race/
colour

Incidence
date

Stage of the
disease

Table 2.3 Information recorded

Nature of 1st
treatment

Brain and
nervous
system

All

All

All

All

All

All

Sel

Sel

None

Sel

Sel

All

All

All

All

All

All

All

All

All

All

All

All

All

All

None

All

None

All

Follow-up
for vital
status: all/
selected/
none

Death
certicates
used to
update vital
status

Active
follow-up of
alive cases

Techniques of registration

35

36

Bulgaria

Finland

France, Tarn

Germany, Munich

Germany, MecklenburgWestern Pomerania

Germany, Hamburg

Germany, Free State of Saxony

Germany, Brandenburg

France, Vende

France, Somme

France, Manche

France, Loire-Atlantique

France, Isre

France, Hrault

France, Haut-Rhin

France, Doubs

France, Calvados

France, Bas-Rhin

Estonia

Denmark

Czech Republic

Croatia

Belgium, Flanders

Belarus

Belgium, Antwerp

Austria, Vorarlberg

Austria, Tyrol

Austria

Europe

Basic
information

Date of birth

ID number

Ethnic
group/
race/
colour

Incidence
date

Stage of the
disease

Table 2.3 Information recorded

Nature of 1st
treatment

NS

Brain and
nervous
system

All

All

All

All

All

All

All

Sel

Sel

All

Sel

All

Sel

All

All

All

All

All

All

None

All

All

All

All

None

All

Follow-up
for vital
status: all/
selected/
none

Death
certicates
used to
update vital
status

Active
follow-up of
alive cases

Techniques of registration

Italy, Macerata Province

Italy, Modena Province

Italy, North East

Italy, Sassari Province

Latvia

The Netherlands

Malta

Lithuania

Italy, Veneto Region

Italy, Varese Province

Italy, Umbria Region

Italy, Torino

Italy, Syracuse Province

Italy, Sondrio

Italy, Salerno Province

Italy, Romagna Region

Italy, Reggio Emilia Province

Italy, Ragusa Province

Italy, Parma Province

Italy, Naples

Italy, Milan

Italy, Genoa Province

Italy, Florence and Prato

Italy, Ferrara Province

Date of birth

Italy, Brescia Province

Italy, Biella Province

Ireland

Iceland

Germany, Saarland

Germany, Northrhine-Westphalia:
Mnster

Basic
information

ID number

Ethnic
group/
race/
colour

Incidence
date

Stage of the
disease

Table 2.3 Information recorded

Nature of 1st
treatment

NS

Brain and
nervous
system

All

All

All

All

All

All

All

All

All

All

All

All

All

All

All

All

All

All

All

All

All

All

Sel

All

All

All

All

Sel

None

All

Follow-up
for vital
status: all/
selected/
none

NS

Y
Y

Death
certicates
used to
update vital
status

Active
follow-up of
alive cases

Techniques of registration

37

38

Portugal, South Regional

Spain, Basque Country

Spain, Cuenca

Switzerland, Valais

Switzerland, Vaud

Switzerland, St Gall-Appenzell

Switzerland, Ticino

Switzerland, Neuchtel

Switzerland, Graubnden and Glarus

Switzerland, Geneva

Sweden

Spain, Zaragoza

Spain, Tarragona

Spain, Navarra

Spain, Murcia

Spain, Granada

Spain, Girona

Spain, Canary Islands

Spain, Albacete

Spain, Asturias

Slovenia

Slovak Republic

Serbia

Russia, St Petersburg

Portugal, Porto

Poland, Kielce

Poland, Warsaw City

Date of birth

Poland, Cracow

Norway

The Netherlands, Maastricht

The Netherlands, Eindhoven

Basic
information

ID number

Ethnic
group/
race/
colour

Incidence
date

Stage of the
disease

Table 2.3 Information recorded

Nature of 1st
treatment

Brain and
nervous
system

All

All

All

All

All

All

All

All

All

All

All

All

All

All

Sel

None

All

All

Sel

All

All

Sel

All

All

Sel

All

Sel

All

All

All

All

Follow-up
for vital
status: all/
selected/
none

Death
certicates
used to
update vital
status

Active
follow-up of
alive cases

Techniques of registration

New Zealand

USA, Hawaii

Western Australia

French Polynesia

Australia, Victoria

Australia, Tasmania

South Australia

Australia, Queensland

Australia, Northern Territory

Australia, New South Wales

Australian Capital Territory

Oceania

UK, Scotland

UK, Northern Ireland

UK, England, West Midlands

UK, England, Trent

UK, England, Thames

UK, England, Oxford Region

UK, England, South and Western Regions

UK, England, Northern and Yorkshire

UK, England, North Western

Date of birth

UK, England, Merseyside and Cheshire

UK, England, East of England Region

Basic
information

ID number

Ethnic
group/
race/
colour

Incidence
date

Stage of the
disease

Table 2.3 Information recorded

Nature of 1st
treatment

Brain and
nervous
system

All

Sel

All

All

None

All

All

All

All

All

All

All

All

All

None

All

All

All

None

All

All

All

Follow-up
for vital
status: all/
selected/
none

Death
certicates
used to
update vital
status

Active
follow-up of
alive cases

Techniques of registration

39

Chapter 3: Classification and coding


H.R. Shin

The Cancer Incidence in Five Continents series has followed the


evolution of the International Classification of Diseases through
four revisions and the creation of a coding scheme for oncology,
the International Classification of Diseases for Oncology
(ICDO), now in its third edition (ICDO3). Volumes I and II
(Doll et al., 1966; 1970) presented the data on cancer incidence
coded to the 7th Revision (ICD7; WHO, 1957). Volume III
(Waterhouse et al., 1976) published data using both the 7th and
the 8th (ICD8; WHO, 1967) revisions. ICD8, which came
into effect in 1968, was used in Volume IV (Waterhouse et al.,
1982), presenting data for the years 197377. The 9th Revision
of the ICD (ICD9; WHO, 1977) was used for Volumes V (Muir
et al., 1987), VI (Parkin et al., 1992), VII (Parkin et al., 1997),
The 10th revision of the ICD (ICD10, WHO, 1992) was used
for Volume VIII (Parkin et al., 2002) and the present volume.
The data are published at the level of the 3-character ICD
10 codes in the individual registry tables and, as in previous

Table 3.1 Classification used in incidence tables

Site
C00

Full title
Malignant neoplasm of lip

C02

Malignant neoplasm of other and unspecified parts of tongue

C01
C03
C04
C05
C06
C07
C08
C09
C10
C11

C12
C13
C14
C15
C16
C17
C18
C19
C20
C21
C22
C23
C24
C25
C26

40

volumes, some grouping of ICD codes has been used. Malignant


neoplasm of gum, floor of mouth and other and unspecified parts
of mouth have been put together (ICD10 C03-C06). Follicular
(nodular) non-Hodgkin lymphoma, diffuse non-Hodgkin
lymphoma, peripheral and cutaneous T-cell lymphomas and
other and unspecified types of non-Hodgkin lymphoma have
been combined as Non-Hodgkin lymphoma. Other categories
have been combined to correspond to a single three-digit rubric
in ICD10; for example base of tongue + other and unspecified
parts of tongue (ICD10 C01C02), and rectosigmoid junction
and rectum (C19C20). Myeloproliferative disorders (MPD)
including morphology behavior M9950/3, 996_/3, 9975/3 and
Myelodysplastic syndromes (MDS) including M998_/3 were
separately presented according to the ICDO3. Table 3.1
presents the ICD10 individual site codes, the full ICD10
titles, the Volume IX groupings and short titles used in the tables
of incidence.

Malignant neoplasm of base of tongue


Malignant neoplasm of gum

Malignant neoplasm of floor of mouth

Groupings used in tables


-

Short title used in tables


Lip

C03-C06 are grouped

Mouth

C01-C02 are grouped

Tongue

Malignant neoplasm of palate

Malignant neoplasm of other and unspecified parts of mouth


Malignant neoplasm of parotid gland

Malignant neoplasm of other and unspecified major salivary


glands
Malignant neoplasm of tonsil

Malignant neoplasm of oropharynx

Malignant neoplasm of nasopharynx

Malignant neoplasm of pyriform sinus


Malignant neoplasm of hypopharynx

C07-C08 are grouped

Salivary gland

Tonsil

Nasopharynx

C12-C13 are grouped

Other oropharynx
Hypopharynx

Malignant neoplasm of other and ill-defined sites in the lip, oral


cavity and pharynx

Pharynx unspecified

Malignant neoplasm of oesphagus


Malignant neoplasm of stomach

Malignant neoplasm of small intestine

Oesophagus

Small intestine

Malignant neoplasm of colon

Malignant neoplasm of rectosigmoid junction


Malignant neoplasm of rectum

Malignant neoplasm of anus and anal canal

Malignant neoplasm of liver and intrahepatic bile ducts


Malignant neoplasm of gallbladder

Malignant neoplasm of other and unspecified parts of biliary


tract
Malignant neoplasm of pancreas

Malignant neoplasm of other and ill defined digestive organs

C19-C20 are grouped


-

C23-C24 are grouped

C26 is included in other


and unspecified

Stomach
Colon

Rectum
Anus

Liver

Gallbladder etc.

Pancreas

Classification and coding

Table 3.1 Classification used in incidence tables

Site

Full title

C31

Malignant neoplasm of accessory sinuses

C30
C32

Malignant neoplasm of nasal cavity and middle ear


Malignant neoplasm of larynx

C37-C38 are grouped

Other thoracic organs

Malignant neoplasm of other and ill-defined sites in the


respiratory system and introthoracic organs

C39 is included in other


and unspecified

Malignant neoplasm of bronchus and lung

C38

Malignant neoplasm of heart, mediastinum and pleura

C41
C43
C44
C45
C46

Malignant neoplasm of bone and articular cartilage of limbs

Malignant neoplasm of bone and articular cartilage of other and


unspecified sites

Melanoma of skin

Mesothelioma

Mesothelioma

Other malignant neoplasms of skin


Kaposi sarcoma

C48

Malignant neoplasm of retroperitoneum and peritoneum

C49

Malignant neoplasm of other connective and soft tissue

C51

Malignant neoplasm of vulva

C53
C54
C55
C56
C57
C58
C60
C61
C62
C63
C64
C65
C66
C67
C68
C69

Malignant neoplasm of breast

Malignant neoplasm of vagina

Malignant neoplasm of cervix uteri

Malignant neoplasm of corpus uteri

Malignant neoplasm of uterus, part unspecified


Malignant neoplasm of ovary

Malignant neoplasm of other and unspecified female genital


organs

C47+C49 are grouped


C48 is included in other
and unspecified

C49 is grouped with C47

Malignant neoplasm of other and unspecified male genital


organs

Vagina

Malignant neoplasm of ureter

Malignant neoplasm of bladder

Malignant neoplasm of other and unspecified urinary organs


Malignant neoplasm of eye and adnexa

Malignant neoplasm of brain

Malignant neoplasm of spinal cord, cranial nerves and other


parts of central nervous system
Malignant neoplasm of thyroid gland

Malignant neoplasm of adrenal gland

Connective and soft


tissue

Malignant neoplasm of kidney, except renal pelvis


Malignant neoplasm of renal pelvis

Kaposi sarcoma

Breast

Malignant neoplasm of testis

Other skin

Malignant neoplasm of prostate

Malignant neoplasm of penis

C71

C74

Malignant neoplasm of meninges

C73

Malignant neoplasm of placenta

C70

C72

Bone

C47

C52

C40-C41 are grouped

Malignant melanoma of skin

Malignant neoplasm of peripheral nerves and autonomic


nervous system

C50

Larynx

Malignant neoplasm of thymus

C34

C40

Nose, sinuses, etc.

Trachea, bronchus and


lung

Malignant neoplasm of trachea

C39

C30-C31 are grouped

Short title used in tables

C33-C34 are grouped

C33
C37

Groupings used in tables

C70-72 are grouped


together

Vulva

Cervix uteri

Corpus uteri

Uterus unspecified
Ovary

Other female genital


organs
Placenta
Penis

Prostate
Testis

Other male genital


organs
Kidney

Renal pelvis
Ureter

Bladder

Other urinary organs


Eye

Brain, nervous system

Thyroid

Adrenal gland

41

Classification and coding

Site

Full title

Table 3.1 Classification used in incidence tables

C75

Malignant neoplasm of other endocrine glands and related


structures

C76

Malignant neoplasm of other and ill-defined sites

C80

Malignant neoplasm without specification of site

C81

Hodgkin disease

C82

Follicular (nodular) non-Hodgkin lymphoma

C83

Diffuse non-Hodgkin lymphoma

C85

Other and unspecified types of non-Hodgkin lymphoma

C84

C80 is included in other


and unspecified
-

C82-C85, C96 are grouped

C90

Multiple myeloma and malignant plasma cell neoplasms

Lymphoid leukaemia

C92

Myeloid leukaemia

C93

Monocytic leukaemia

C95

Leukaemia of unspecified cell type

C96

Other endocrine

Hodgkin disease
Non-Hodgkin
lymphoma

Peripheral and cutaneous T-cell lymphomas


Malignant immunoproliferative diseases

C94

Short title used in tables

C76 is included in other


and unspecified

C88
C91

Other and unspecified malignant neoplasms of lymphoid,


haematopoietic and related tissue

MPD

Myeloproliferative disorders

MDS

Myelodysplastic syndromes

ALL
ALLb

Classifications used in the cancer registry


Since the publication in 1976 of the first edition of the ICDO (WHO,
1976) with clearly defined axes of anatomical location, histology
and behaviour, international conformity to standard classification
systems and coding rules has increased steadily. For data published
in Volume IV (197377), 90% of registries recorded histological
diagnosis; for coding just over one third of the registries used
MOTNAC (ACS, 1951; 1968), one third had started to use ICDO
and 12% used SNOP (CAP, 1965). About 75% of contributors to
Volume V used ICDO to code histology, and this figure rose to
over 90% for Volumes VI and VII. Four of the 186 contributors to
the Volume VIII and only one of the 225 contributors to the present
volume did not code their histological data to ICDO.
Data submitted for the first four volumes of Cancer Incidence
in Five Continents were sent in tabular format, by sex, site and
five-year age group, on tape, diskette or, most frequently, the forms
designed for the purpose. The only verification possible was to tally
the columns and rows. For the fifth volume, registries were given
the opportunity of sending data in the form of a case-listing coded

C92-C94 are grouped


(following ICD-O-3)

Other leukaemias of specified cell type

O&U

42

Groupings used in tables

C96 is grouped with


C82-C85

Immunoproliferative
diseases
Multiple myeloma

Lymphoid leukaemia
Myeloid leukaemia

Leukaemia unspecified

Includes C26, C39, C48,


C76 and C80

Other and unspecified

Includes ICD-O-3 M
998_/3

Myelodysplastic
syndromes

Includes ICD-O-3 M
9950/3, 996_/3, 9975/3

Myeloproliferative
disorders

All sites

All sites but C44

to ICD9 topography only, or to ICD9 or ICDO topography plus


ICDO morphology. A very small minority of registries sent data
coded to ICDO. Contributors to Volume VI were encouraged to send
data as a listing of cases, but 24% sent tabulated data. For Volumes
VII, VIII and IX, data had to be sent as a case listing. In practice, it
was still necessary to ask registries some questions, notably in relation
to non-melanoma skin, breast, ovary and bladder cancer.
While the majority of the data submitted for this volume had
been coded or converted to ICDO, registries were asked what
classification systems were used for coding data in the registry
during the period. Of the 225 registries contributing data to this
volume, 202 (89.8%) coded to ICDO3 or ICDO2 topography
and morphology, 29 (12.9%) to ICD9 or ICD10 topography
and ICDO morphology, and 4 (1.8%) did not register histology
and coded topography to ICD9 or ICD10. Seven registries
used ICDO1 topography and morphology, and one registry
coded morphology to MOTNAC with ICDO7 topography
(Table 3.2).

Classification and coding

Table 3.2 Coding practices

ICD-9 + ICD-9 + ICD-10 + ICD-10 +


Continents
ICD-O-3 ICD-O-2 ICD-O-1 ICD-O-1
ICD-O-2 ICD-O-2 ICD-O-3
(No. of Registries) (T+M)
(T+M)
(T+M)
(M)
(M)
(M)
(M)
Africa (5)
4
1
0
0
0
0
0
South and Central
7
4
0
0
0
0
0
America (11)
North America (54)
53
1
0
0
0
0
0
Asia (44)
31
5
2
1
1
6
0
Europe (100)
75
12
5
3
1
12
3
Oceania (11)
8
1
0
1
0
1
0
Total (225)

178

24

*Total greater than 44 (registries using two systems).

Table 3.3 presents the summary table of coding practices for the
selected sites, carcinoma of bladder, benign tumors of brain and
nervous system, borderline tumours of brain, endometrium of uterus,
ovary and carcinoma of breast with ductal carcinoma in situ, intraductal
and lobular carcinoma in situ. Borderline ovary cancer is no longer

19

ICD-9

ICD-7+ Total
ICD-10 MOTNAC

11

0
0
2
0

0
0
2
0

0
0
1
0

54
56*
116**
11

253

**Total greater than 100 (registries using two or three systems).


behavior /3 according to the ICDO3. However, some registries are
still coding it as /3. For the comparison of cancer incidence from these
selected sites, the coding practices of each registry should be reviewed.
Table 3.4a and Table 3.4b present the coding practices recorded in the
questionnaires by registry

Table 3.3 Summary table of coding practices for the selected sites
Continents
(No. of Registries)
Africa (5)

South and Central


America (11)

North America (54)


Asia (44)
Europe (100)
Oceania (11)
Total (225)
% of coded
(% of behavior/3)

Carcinoma of Bladder

Borderline Tumours

Carcinoma of Breast

In situ

NOS

Benign Tumours of
Brain and Nervous
system

3 (0)

4 (4)

1 (0)

2 (0)

2 (0)

2 (0)

Ductal, Intraductal Lobular,


in situ
NOS
in situ
3 (0)
4 (1)
3 (0)

8 (1)

11 (9)

5 (3)

4 (2)

2 (0)

5 (1)

11 (1)

43 (1)
19 (3)
70 (3)
4 (0)
142 (10)
63.1
(4.4)

38 (0)
23 (5)
79 (4)
4 (0)
150 (11)
66.7
(4.9)

10 (0)
21 (6)
58 (3)
5 (0)
98 (9)
43.6
(4)

51 (6)
49 (31)
25 (2)
36 (33)
86 (8)
89 (55)
8 (0)
8 (7)
181 (17) 197 (139)
80.4
87.6
(7.6)
(61.8)

( ) Recoded to behaviour /3

Brain

Endometrium

Ovary

28 (3)
50 (0)
23 (7)
27 (1)
77 (14) 83 (3)
6 (1)
10 (0)
141 (26) 184 (5)
62.7
81.8
(11.6)
(2.2)

11 (4)

11(2)

50 (4)
30 (9)
82 (10)
10 (0)
187 (28)
83.1
(12.4)

50 (0)
28 (2)
82 (2)
9 (0)
183 (6)
81.3
(2.7)

References
ACS (1951). Manual of Tumor Nomenclature and Coding. New
York, NY, American Cancer Society.
ACS (1968). Manual of Tumor Nomenclature and Coding, 1968
Edition. New York, American Cancer Society.

Muir, C., Waterhouse, J., Mack, T., Powell, J. & Whelan, S.


(eds) (1987). Cancer Incidence in Five Continents, Volume
V (IARC Scientific Publications No. 88), Lyon, IARC.

CAP (1965). Systematized nomenclature of pathology. Chicago,


IL, College of American Pathologists.

Parkin, D.M., Muir, C.S., Whelan, S.L., Gao, Y.-T., Ferlay, J.


& Powell, J. (1992). Cancer Incidence in Five Continents,
Volume VI. (IARC Scientific Publications No. 120), Lyon,
IARC.

Doll, R., Payne, P. & Waterhouse, J. (eds) (1966). Cancer


Incidence in Five Continents: A Technical Report. Berlin,
Springer-Verlag (for UICC).

Parkin, D.M.,Whelan, S.L., Ferlay, J., Raymond, L. & Young, J.


(1997). Cancer Incidence in Five Continents, Volume VII.
(IARC Scientific Publications No. 143), Lyon, IARC.

Doll, R., Muir, C. & Waterhouse, J. (eds) (1970). Cancer


Incidence in Five Continents, Volume II. Berlin, SpringerVerlag (for UICC).

Parkin, D.M., Whelan, S.L., Ferlay J., Teppo L., Thomas


D.B. (2002). Cancer Incidence in Five Continents,
Volume VII1. (IARC Scientific Publications No. 155),
Lyon, IARC.

Fritz, A., Percy, C., Jack, A., Shanmugaratnam, K., Sobin, L.,
Parkin, D.M. & Whelan, S.L. (eds) (2000). International
Classification of Diseases for Oncology, 3rd edition. World
Health Organization, Geneva.

Waterhouse, J., Muir, C., Correa, P. & Powell, J. (eds) (1976).


Cancer Incidence in Five Continents, Volume III (IARC
Scientific Publications No. 15), Lyon, IARC.

43

Classification and coding

Waterhouse, J., Muir, C., Shanmugaratnam, K. & Powell, J.


(eds) (1982). Cancer Incidence in Five Continents, Volume
IV (IARC Scientific Publications No. 42), Lyon, IARC.

WHO (1992). International Statistical Classification of Diseases


and Related Health Problems, tenth revision, Geneva, World
Health Organization.

WHO (1957). International Classification of Diseases, 1955


Revision, Geneva, World Health Organization.

WHO (1976). International Classification of Diseases


for Oncology, first edition, Geneva, World Health
Organization.

WHO (1967). International Classification of Diseases, 1965


Revision, Geneva, World Health Organization.
WHO (1977). International Classification of Diseases, 1975
Revision, Geneva, World Health Organization.

44

WHO (1990). International Classification of Diseases


for Oncology, second edition, Geneva, World Health
Organization.

N
Y

Ecuador, Quito

Canada, Nova Scotia

Canada, Prince Edward Island

Canada, Ontario
Y

Canada, Northwest Territories

Canada, Newfoundland and Labrador

Canada, New Brunswick

Canada, Manitoba

Canada, British Columbia

Canada, Alberta

Canada

North America

Peru, Trujillo

France, Martinique

Costa Rica

Colombia, Cali

Chile, Valdivia

Brazil, So Paulo

Brazil, Goinia

Brazil, Cuiaba

Brazil, Brasilia

Argentina, Bahia Blanca

South and Central America

Zimbabwe, Harare

Uganda, Kyadondo County

Tunisia, Central Region

Egypt, Gharbiah

Algeria, Setif

Africa

Carcinoma of
bladder,
in situ

Carcinoma of
bladder NOS

Benign tumours
of brain and
nervous system

NS

NS

NS

NS

Borderline
Borderline
Borderline
tumour, uns. and tumour, uns. and tumour, uns. and
unk. behaviour
unk. behaviour
unk. behaviour
of ovary
of endometrium
of brain

Table 3.4a Coding practices: Recorded

Ductal
carcinoma in
situ of breast

Intraduct
carcinoma NOS
of breast

Lobular
carcinoma
in situ of breast

Classification and coding

45

46
Y

USA, Illinois

USA, Kentucky

Y
Y
Y

USA, Michigan, Detroit

USA, Montana

USA, Ohio

USA, NPCR

USA, New York State

USA, New Mexico

USA, New Jersey

USA, Missouri

USA, Michigan

USA, Massachusetts

USA, Maine

USA, Louisiana, New Orleans

USA, Louisiana

USA, Iowa

USA, Indiana

USA, Idaho

USA, Georgia, Atlanta

USA, Georgia

USA, Florida

NS

USA, District of Columbia

USA, Connecticut

USA, Colorado

USA, California, Los Angeles County

USA, California, Greater San Francisco


Bay Area

USA, California

USA, Arizona

USA, Alaska

USA, Alabama

Canada, Saskatchewan

Carcinoma of
bladder,
in situ

NS

Carcinoma of
bladder NOS

NS

Benign tumours
of brain and
nervous system

NS

NS

NS

NS

Borderline
Borderline
Borderline
tumour, uns. and tumour, uns. and tumour, uns. and
unk. behaviour
unk. behaviour
unk. behaviour
of ovary
of endometrium
of brain

Table 3.4a Coding practices: Recorded

NS

Ductal
carcinoma in
situ of breast

NS

Intraduct
carcinoma NOS
of breast

NS

Lobular
carcinoma
in situ of breast

Classification and coding

USA, SEER

N
Y

N
N
N
N

China, Zhongshan

India, Chennai (Madras)

India, Mumbai (Bombay)

India, New Delhi

India, Trivandrum

Israel

India, Poona

India, Nagpur

India, Karunagappally

Cyprus

China, Shanghai

NS

China, Nangang District, Harbin City

China, Jiashan

China, Hong Kong

China, Guangzhou

Bahrain

Asia

USA, Wisconsin

USA, West Virginia

USA, Washington, Seattle

USA, Washington

USA, Vermont

USA, Utah

USA, Texas

USA, South Carolina

USA, Rhode Island

USA, Pennsylvania

USA, Oregon

USA, Oklahoma

Carcinoma of
bladder,
in situ

NS

Carcinoma of
bladder NOS

NS

Benign tumours
of brain and
nervous system

NS

NS

NS

Borderline
Borderline
Borderline
tumour, uns. and tumour, uns. and tumour, uns. and
unk. behaviour
unk. behaviour
unk. behaviour
of ovary
of endometrium
of brain

Table 3.4a Coding practices: Recorded

NS

NS

Ductal
carcinoma in
situ of breast

NS

NS

Intraduct
carcinoma NOS
of breast

NS

NS

Lobular
carcinoma
in situ of breast

Classification and coding

47

48
Y

Y
Y

Japan, Yamagata Prefecture

Korea, Busan

Singapore

N
Y

Turkey, Izmir

Austria

Europe

Turkey, Antalya

Thailand, Songkhla

Thailand, Lampang

Thailand, Chiang Mai

Philippines, Manila

Pakistan, South Karachi

Oman

Malaysia, Sarawak

Kuwait

Malaysia, Penang

Korea, Ulsan

Korea, Seoul

Korea, Jejudo

Korea, Incheon

Korea, Gwangju

Korea, Daejeon

Korea, Daegu

Korea

Japan, Osaka Prefecture

Japan, Nagasaki Prefecture

Japan, Miyagi Prefecture

Japan, Hiroshima

Japan, Fukui Prefecture

Japan, Aichi Prefecture

Carcinoma of
bladder,
in situ

Carcinoma of
bladder NOS

Benign tumours
of brain and
nervous system

NS

Borderline
Borderline
Borderline
tumour, uns. and tumour, uns. and tumour, uns. and
unk. behaviour
unk. behaviour
unk. behaviour
of ovary
of endometrium
of brain

Table 3.4a Coding practices: Recorded

Ductal
carcinoma in
situ of breast

Intraduct
carcinoma NOS
of breast

Lobular
carcinoma
in situ of breast

Classification and coding

Y
Y

Bulgaria

France, Isre

France, Somme

Y
Y

Germany, North Rhine-Westphalia: Mnster

Iceland

Ireland

Germany, Saarland

Germany, Munich

Germany, Mecklenburg-Western Pomerania

Germany, Hamburg

Germany, Free State of Saxony

Germany, Brandenburg

France, Vende

France, Tarn

France, Manche

France, Loire-Atlantique

France, Hrault

France, Haut-Rhin

France, Doubs

France, Calvados

France, Bas-Rhin

Finland

Estonia

Denmark

Czech Republic

Croatia

Belgium, Flanders

Belgium, Antwerp

Belarus

Austria, Vorarlberg

Austria, Tyrol

Carcinoma of
bladder,
in situ

Carcinoma of
bladder NOS

Benign tumours
of brain and
nervous system

NS

Borderline
Borderline
Borderline
tumour, uns. and tumour, uns. and tumour, uns. and
unk. behaviour
unk. behaviour
unk. behaviour
of ovary
of endometrium
of brain

Table 3.4a Coding practices: Recorded

NS

Ductal
carcinoma in
situ of breast

NS

Intraduct
carcinoma NOS
of breast

NS

Lobular
carcinoma
in situ of breast

Classification and coding

49

50
Y

N
N
N

Italy, Macerata Province

Italy, Modena Province

Italy, North East

Poland, Kielce

Poland, Cracow
Y

Norway

The Netherlands, Maastricht

The Netherlands, Eindhoven

The Netherlands

Malta

Lithuania

Latvia

Italy, Veneto Region

Italy, Varese Province

Italy, Umbria Region

Italy, Torino

Italy, Syracuse Province

Italy, Sondrio

Italy, Sassari Province

Italy, Salerno Province

Italy, Romagna Region

Italy, Reggio Emilia Province

Italy, Ragusa Province

Italy, Parma Province

Italy, Naples

Italy, Milan

Italy, Genoa Province

Italy, Florence and Prato

Italy, Ferrara Province

Italy, Brescia Province

Italy, Biella Province

Carcinoma of
bladder,
in situ
Y

NS

Carcinoma of
bladder NOS

Benign tumours
of brain and
nervous system

NS

NS

NS

NS

NS

NS

NS

NS

Borderline
Borderline
Borderline
tumour, uns. and tumour, uns. and tumour, uns. and
unk. behaviour
unk. behaviour
unk. behaviour
of ovary
of endometrium
of brain

Table 3.4a Coding practices: Recorded

Ductal
carcinoma in
situ of breast
N

NS

Intraduct
carcinoma NOS
of breast
N

NS

Lobular
carcinoma
in situ of breast

Classification and coding

Serbia

Y
Y
Y

Spain, Basque Country

Spain, Cuenca

Y
Y

Switzerland, Valais

UK, England, Oxford Region

UK, England, Northern and Yorkshire

UK, England, North Western

UK, England, Merseyside and Cheshire

UK, England, East of England Region

Switzerland, Vaud

Switzerland, Ticino

Switzerland, St Gall-Appenzell

Switzerland, Neuchtel

Switzerland, Graubnden and Glarus

Switzerland, Geneva

Sweden

Spain, Zaragoza

Spain, Tarragona

Spain, Navarra

Spain, Murcia

Spain, Granada

Spain, Girona

Spain, Canary Islands

Spain, Asturias

Spain, Albacete

Slovenia

Slovak Republic

Russia, St Petersburg

Portugal, South Regional

Portugal, Porto

Poland, Warsaw City

Carcinoma of
bladder,
in situ

Carcinoma of
bladder NOS

NS

Benign tumours
of brain and
nervous system

NS

NS

NS

NS

Borderline
Borderline
Borderline
tumour, uns. and tumour, uns. and tumour, uns. and
unk. behaviour
unk. behaviour
unk. behaviour
of ovary
of endometrium
of brain

Table 3.4a Coding practices: Recorded

NS

Ductal
carcinoma in
situ of breast
Y

NS

Intraduct
carcinoma NOS
of breast
Y

NS

Lobular
carcinoma
in situ of breast

Classification and coding

51

52
Y

NS, not stated

USA, Hawaii

New Zealand

French Polynesia
Y

Western Australia

Australia, Victoria

Australia, Tasmania

South Australia

Australia, Queensland

Australia, Northern Territory

Australia, New South Wales

Australian Capital Territory

Oceania

UK, Scotland

UK, Northern Ireland

UK, England, West Midlands

UK, England, Trent

UK, England, Thames

UK, England, South and Western Regions

Carcinoma of
bladder,
in situ

Carcinoma of
bladder NOS

Benign tumours
of brain and
nervous system

NS

Borderline
Borderline
Borderline
tumour, uns. and tumour, uns. and tumour, uns. and
unk. behaviour
unk. behaviour
unk. behaviour
of ovary
of endometrium
of brain

Table 3.4a Coding practices: Recorded

Ductal
carcinoma in
situ of breast

Intraduct
carcinoma NOS
of breast

Lobular
carcinoma
in situ of breast

Classification and coding

NS

Canada, Nova Scotia

Canada, Ontario

NA

Canada, Northwest Territories

Canada, Newfoundland and Labrador

Canada, New Brunswick

Canada, Manitoba

NS

Canada, British Columbia

Canada, Alberta

Canada

North America

Peru, Trujillo

France, Martinique

Ecuador, Quito

Costa Rica

NA

Colombia, Cali

Chile, Valdivia

Brazil, So Paulo

Brazil, Goinia

Brazil, Cuiaba

Brazil, Brasilia

N
N

NS

NS

NA

NA

Carcinoma of
bladder NOS

Argentina, Bahia Blanca

South America

Zimbabwe, Harare

Uganda, Kyadondo County

Tunisia, Central Region

Egypt, Gharbiah

Algeria, Setif

Africa

Carcinoma of
bladder,
in situ

NA

NS

NS

NS

NS

NA

NA

NA

NA

NA

NA

Benign tumours
of brain and
nervous system

NS

NS

NS

NS

NS

NA

NA

NA

NA

NA

NS

NS

NS

NS

NA

NA

NA

NA

NA

NA

NA

NA

NS

NS

NS

NA

NA

NA

NA

NA

NA

NA

Borderline
Borderline
Borderline
tumour, uns. and tumour, uns. and tumour, uns. and
unk. behaviour
unk. behaviour
unk. behaviour
of ovary
of endometrium
of brain

Table 3.4b Coding practices: Recoded to behaviour /3

NA

NS

NS

NS

NA

Ductal
carcinoma in
situ of breast

NA

NS

NS

NS

Intraduct
carcinoma NOS
of breast

NA

NS

NS

NS

NA

Lobular
carcinoma
in situ of breast

Classification and coding

53

54
Y

N
N

USA, Michigan, Detroit

USA, Montana

USA, NPCR

USA, New York State

USA, New Mexico

USA, New Jersey

USA, Missouri

USA, Michigan

N
N

NS

USA, Massachusetts

USA, Maine

USA, Louisiana, New Orleans

USA, Louisiana

USA, Kentucky

USA, Iowa

USA, Indiana

NS

USA, Illinois

USA, Idaho

NA

NS

NS

Carcinoma of
bladder NOS

USA, Georgia, Atlanta

USA, Georgia

USA, Florida

USA, District of Columbia

USA, Connecticut

USA, Colorado

USA, California, Los Angeles County

USA, California, Greater San Francisco


Bay Area

USA, California

USA, Arizona

USA, Alaska

USA, Alabama

Canada, Saskatchewan

Canada, Prince Edward Island

Carcinoma of
bladder,
in situ
N

NA

NA

NA

NA

NS

Benign tumours
of brain and
nervous system

NA

NA

NA

NA

NA

NS

NA

NA

NA

NS

NS

NA

NS

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NS

NA

NS

NA

NA

NA

NA

NS

NA

NS

NA

NS

NA

NS

NA

NA

NA

NS

NS

NA

NS

NS

Borderline
Borderline
Borderline
tumour, uns. and tumour, uns. and tumour, uns. and
unk. behaviour
unk. behaviour
unk. behaviour
of ovary
of endometrium
of brain

Table 3.4b Coding practices: Recoded to behaviour /3

NS

NS

Ductal
carcinoma in
situ of breast
N

N
N

NS

NS

Intraduct
carcinoma NOS
of breast
N

N
N

NS

NS

Lobular
carcinoma
in situ of breast

Classification and coding

N
Y

USA, SEER

USA, Vermont

N
N

N
NA
N

India, Chennai (Madras)

India, Mumbai (Bombay)

India, New Delhi

India, Trivandrum

India, Poona

India, Nagpur

India, Karunagappally

Cyprus

China, Shanghai

China, Zhongshan

China, Nangang District, Harbin City

NS

China, Jiashan

NS

Carcinoma of
bladder NOS

NA

China, Hong Kong

China, Guangzhou

Bahrain

Asia

USA, Wisconsin

USA, West Virginia

USA, Washington, Seattle

USA, Washington

USA, Utah

USA, Texas

NS

USA, South Carolina

USA, Rhode Island

USA, Pennsylvania

USA, Oregon

USA, Oklahoma

USA, Ohio

Carcinoma of
bladder,
in situ
N

NA

NA

NA

Benign tumours
of brain and
nervous system

NA

NA

NA

NA

NA

NA

NA

NS

NS

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NS

NA

NA

NA

NA

NS

NA

NA

NA

NA

NA

NS

NA

Borderline
Borderline
Borderline
tumour, uns. and tumour, uns. and tumour, uns. and
unk. behaviour
unk. behaviour
unk. behaviour
of ovary
of endometrium
of brain

Table 3.4b Coding practices: Recoded to behaviour /3

NA

NS

Ductal
carcinoma in
situ of breast

NS

NS

Intraduct
carcinoma NOS
of breast

NA

NS

Lobular
carcinoma
in situ of breast

Classification and coding

55

56

Japan, Aichi Prefecture

Korea, Busan

Pakistan, South Karachi

Singapore

N
N

Turkey, Izmir

Turkey, Antalya

Thailand, Songkhla

Thailand, Lampang

Thailand, Chiang Mai

Philippines, Manila

NA

Oman

Malaysia, Sarawak

Malaysia, Penang

Kuwait

Korea, Ulsan

Korea, Seoul

Korea, Jejudo

Korea, Incheon

NA

Korea, Gwangju

Korea, Daejeon

Korea, Daegu

Korea

Japan, Yamagata Prefecture

Japan, Osaka Prefecture

NA

NS

Carcinoma of
bladder NOS

NS

Japan, Nagasaki Prefecture

Japan, Miyagi Prefecture

Japan, Hiroshima

Japan, Fukui Prefecture

Israel

Carcinoma of
bladder,
in situ

NA

NA

NA

NA

NA

NS

NA

NA

NS

Benign tumours
of brain and
nervous system

NA

NS

NA

NA

NA

NS

NA

NS

NA

NA

NA

NA

NS

NA

NS

NA

NA

NS

NA

NA

NS

Borderline
Borderline
Borderline
tumour, uns. and tumour, uns. and tumour, uns. and
unk. behaviour
unk. behaviour
unk. behaviour
of ovary
of endometrium
of brain

Table 3.4b Coding practices: Recoded to behaviour /3

NA

NA

NS

Ductal
carcinoma in
situ of breast

NA

NA

NS

Intraduct
carcinoma NOS
of breast

NA

NA

NS

Lobular
carcinoma
in situ of breast

Classification and coding

N
N

Bulgaria

France, Somme

France, Tarn

Germany, North Rhine-Westphalia:


Mnster

Germany, Munich
N

Germany, Mecklenburg-Western
Pomerania

Germany, Hamburg

NA

Germany, Free State of Saxony

Germany, Brandenburg

France, Vende

NA

France, Manche

France, Loire-Atlantique

France, Isre

France, Hrault

France, Haut-Rhin

France, Doubs

France, Calvados

France, Bas-Rhin

Finland

Estonia

Denmark

NA

Czech Republic

Croatia

Belgium, Flanders

Belgium, Antwerp

Belarus

Austria, Vorarlberg

Austria, Tyrol

Austria

Europe

Carcinoma of
bladder,
in situ

Carcinoma of
bladder NOS

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

Benign tumours
of brain and
nervous system

NA

NA

NS

NS

NA

NA

NA

NA

NA

NA

NA

NA

NA

NS

NA

NA

NA

NA

NA

NA

NA

NA

NA

NS

NA

NS

NA

Borderline
Borderline
Borderline
tumour, uns. and tumour, uns. and tumour, uns. and
unk. behaviour
unk. behaviour
unk. behaviour
of ovary
of endometrium
of brain

Table 3.4b Coding practices: Recoded to behaviour /3

NA

NA

NS

NS

Ductal
carcinoma in
situ of breast

NA

NA

NS

NS

Intraduct
carcinoma NOS
of breast

NA

NA

NS

NS

Lobular
carcinoma
in situ of breast

Classification and coding

57

58
N

NA
N
N

Italy, Macerata Province

Italy, Modena Province

Italy, North East

The Netherlands, Maastricht

The Netherlands, Eindhoven


N

The Netherlands

Malta

NS

Lithuania

Latvia

NA

NS

NS

NA

Italy, Veneto Region

Carcinoma of
bladder NOS

NA

Italy, Varese Province

Italy, Umbria Region

Italy, Torino

Italy, Syracuse Province

Italy, Sondrio

Italy, Sassari Province

Italy, Salerno Province

Italy, Romagna Region

Italy, Reggio Emilia Province

Italy, Ragusa Province

Italy, Parma Province

Italy, Naples

Italy, Milan

Italy, Florence and Prato

Italy, Genoa Province

Italy, Ferrara Province

Italy, Brescia Province

Italy, Biella Province

Ireland

Iceland

Germany, Saarland

Carcinoma of
bladder,
in situ
N

NS

NS

NA

NA

NA

NA

NA

NA

NA

NA

Benign tumours
of brain and
nervous system

NS

NS

NS

NA

NA

NA

NA

NA

NS

NS

NS

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NS

NS

NA

NA

NA

NS

NA

NA

NA

Borderline
Borderline
Borderline
tumour, uns. and tumour, uns. and tumour, uns. and
unk. behaviour
unk. behaviour
unk. behaviour
of ovary
of endometrium
of brain

Table 3.4b Coding practices: Recoded to behaviour /3

NS

NS

NA

NA

NS

Ductal
carcinoma in
situ of breast
N

NS

NS

NA

NA

NS

Intraduct
carcinoma NOS
of breast
N

NS

NS

NA

NA

NS

Lobular
carcinoma
in situ of breast

Classification and coding

Portugal, South Regional

Serbia

N
N
Y

Spain, Basque Country

Spain, Cuenca

Switzerland, Valais

UK, England, Merseyside and Cheshire

UK, England, East of England Region

Switzerland, Vaud

Switzerland, Ticino

N
N

Switzerland, Neuchtel

Switzerland, St Gall-Appenzell

Switzerland, Geneva

Switzerland, Graubnden and Glarus

NS

NA

Sweden

Carcinoma of
bladder NOS

NA

Spain, Zaragoza

Spain, Tarragona

Spain, Navarra

Spain, Murcia

Spain, Granada

Spain, Girona

Spain, Canary Islands

Spain, Asturias

Spain, Albacete

Slovenia

NS

Slovak Republic

Russia, St Petersburg

Portugal, Porto

Poland, Warsaw City

Poland, Kielce

Poland, Cracow

Norway

Carcinoma of
bladder,
in situ
N

NS

NS

NA

NA

NS

Benign tumours
of brain and
nervous system

NS

NA

NA

NA

NA

NA

NS

NS

NS

NS

NA

NS

NS

NA

NA

NA

NA

NA

NA

NA

NS

NS

NS

NS

NS

NS

NA

NS

NS

NS

Borderline
Borderline
Borderline
tumour, uns. and tumour, uns. and tumour, uns. and
unk. behaviour
unk. behaviour
unk. behaviour
of ovary
of endometrium
of brain

Table 3.4b Coding practices: Recoded to behaviour /3

NS

NA

NA

NS

NS

Ductal
carcinoma in
situ of breast
N

NS

NA

NA

NS

NS

Intraduct
carcinoma NOS
of breast
N

NS

NA

NA

NS

NS

NS

NS

Lobular
carcinoma
in situ of breast

Classification and coding

59

60
N

New Zealand

NA, not applicable (not recorded)

NS, not stated

USA, Hawaii

NA

Western Australia

French Polynesia

Australia, Victoria

NA

NA

Australia, Tasmania

South Australia

Australia, Queensland

Australia, Northern Territory

Australia, New South Wales

Australian Capital Territory

Oceania

NS

UK, Scotland

UK, Northern Ireland

UK, England, West Midlands

UK, England, Thames

UK, England, Trent

NS

NA

NA

NS

UK, England, Oxford Region

UK, England, South and Western Regions

Carcinoma of
bladder NOS

UK, England, Northern and Yorkshire

UK, England, North Western

Carcinoma of
bladder,
in situ

NA

NA

NA

NA

NA

NA

NA

NS

Benign tumours
of brain and
nervous system

NS

NA

NA

NA

NA

NA

NS

NS

NS

NS

NA

NA

NA

NA

NA

NA

NS

NA

NA

NA

NA

NA

NA

NA

NS

Borderline
Borderline
Borderline
tumour, uns. and tumour, uns. and tumour, uns. and
unk. behaviour
unk. behaviour
unk. behaviour
of ovary
of endometrium
of brain

Table 3.4b Coding practices: Recoded to behaviour /3

NA

NS

NS

Ductal
carcinoma in
situ of breast

NA

NS

NS

Intraduct
carcinoma NOS
of breast

NA

NA

NS

NS

N
N

Lobular
carcinoma
in situ of breast

Classification and coding

Chapter 4: Histological groups

L. Egevad, M. Heanue, D. Berney, K. Fleming, J. Ferlay


Background
The data presented in this edition of Cancer Incidence in Five
Continents (CI5) are mainly organised according to anatomical
site. However, for some sites, the histological type of cancer
is particularly relevant clinically and epidemiologically. For
practical reasons, detailed data on every available morphological
entity cannot be presented or used for longitudinal and geographic
comparisons. In the latest editions of CI5, edition VII (Parkin et
al., 1997) and VIII (Parkin et al., 2002), these data were grouped
according to histological types as defined in Histological
Groups for Comparative Studies (Parkin et al., 1998), based on
the second edition of International Classification of Diseases
for Oncology (ICD-O-2) (Percy et al., 1990). Since then, the
second edition has been followed by the third edition (ICD-O-3)
(Fritz et al., 2000). Furthermore, some cancer classifications
have been revised, e.g. through the third edition of the WHO
Classification of Tumours. Consequently, there was a need to
update the Histological Groups for Comparative Studies, and
the revised version is presented in this chapter.

Types of neoplasms that are included


The CI5 data include all invasive malignant neoplasms and
some non-invasive malignant neoplasms. For most morphology
codes, a fifth digit /1 or /2 automatically excludes the data entry.
Carcinoma in situ is reported to many cancer registries, but
is generally not dealt with in this volume, with the exception
of urothelial carcinoma in situ. A few lesions of borderline
malignancy are included, such as low-grade non-invasive
papillary transitional cell tumours, which are now designated
as Papillary urothelial neoplasia of low malignant potential,
PUNLMP (8130/1). Flat carcinoma in situ of urothelium
(8120/2) and PUNLMP (8130/1, 8130/2) have been grouped
with Transitional cell carcinoma in this edition. As the skin
has been added to the sites, Basal cell carcinoma is reported
as a separate group although many cancer registries do not
have statistics on them. Within the 15 tumour sites presented,
there are no cases of mesothelioma (ICD-O M905_), Kaposi
sarcoma (9140), lymphoma or leukaemia (9590-9989), as these
cancers have their own specific ICD-10 codes and are presented
separately in the volume.

General structure
The main structure of the histological grouping is that Morphology codes
specific types of malignant neoplasms are listed as well as Grouping of morphological codes presents several difficulties.
Unspecified malignant neoplasms (Unspecified cancer in the The ICD-O system is based on separate site (topography) and
previous edition), i.e. malignant tumours that are so poorly morphology (histology) codes that can be combined. Inevitably,
differentiated that we are unable to classify them in major in registry data morphology codes may mistakenly have been
groups such as carcinoma or sarcoma. Neoplasms that have combined with codes for sites where these entities do not
a specific morphology but are too unusual to be listed among occur or have not been reported yet. Some morphology codes
the specific types of malignant neoplasms are lumped under are redundant, i.e. multiple codes can be applied for the same
Other specified malignant neoplasm (Other specified cancer tumour. Other codes are obsolete, i.e. the entities have been
in the previous edition). Similarly, under Carcinoma, specific renamed or deleted in later revisions of tumour classifications.
cancer subtypes such as Squamous cell carcinoma and A major difficulty is the variation in coding precision (specific
Adenocarcinoma are listed as well as Unspecified carcinoma, codes for tumour subtypes vs. comprehensive codes for broad
i.e. carcinomas that are so poorly differentiated that we are categories such as adenocarcinoma), which limits the utility of
unable to classify them according to histogenetic subtype, detailed codes. An example of this is the kidney tumours where
while it is still possible to distinguish them from non-epithelial renal cell carcinomas are often coded as renal cell carcinoma,
malignant neoplasms such as sarcoma. Morphological codes NOS (8312) or adenocarcinoma, NOS (8140), while others are
are listed under the specific types of neoplasms (or carcinoma) subtyped. Therefore, all of these carcinomas of the kidney are
and under Unspecified malignant neoplasms (or carcinoma). grouped together in this chapter.
The remaining codes of neoplasia (or carcinoma) will then
automatically be assigned to the Other specified malignant Some specified cancer types occur in several organs, but may have
neoplasm (or carcinoma) group.
different clinical behaviour depending on site of origin. For most
sites adenosquamous carcinoma (8560) and mucoepidermoid
Sites
carcinoma (8430) are included in Other specified carcinoma.
For inclusion as a histological group, a cancer type has An exception is corpus uteri (C54) where these are included
to be sufficiently common at the site and clinically and in Adenocarcinoma because they are supposed to have
epidemiologically relevant. The following 15 sites are similar biology (Zaino et al., 1988). Furthermore, squamous
included: oesophagus, anus, liver, lung, bone, skin, cervix, differentiation is very common in Endometrioid carcinoma,
corpus uteri, ovary, testis, kidney/renal pelvis, urinary bladder, which makes it difficult to separate between these tumours.
eye, central nervous system and thyroid, together with the Another example is metaplastic carcinoma (8575), which is
haematological system. Some major cancer sites such as breast generally included under Other specified carcinoma. However,
and prostate were not included because the vast majority of for the corpus uteri, it is grouped with Other specified neoplasm
malignant neoplasms at these sites are adenocarcinomas, and because metaplastic carcinoma is considered equivalent with
the coding of subtypes of these is not consistent. Compared to carcinosarcoma on this site (Silverberg et al., 1990).
the previous edition of Histological Groups for Comparative
Studies, the anus and skin have been added. The kidney was Unspecified carcinoma includes tumours that are coded as
combined with the renal pelvis because some urothelial Carcinoma NOS, but also some descriptive diagnoses of poorly
carcinomas originating from the renal pelvis are site coded as differentiated cancers. These tumours can be recognised as
kidney cancers while others are coded as renal pelvis cancers. carcinomas but are too undifferentiated to be further classified
Hodgkin disease and leukaemias were lumped together in the according to their histogenetic origin. This group generally includes
haematological system.
the morphology codes 8010-8035. An exception is lung tumours,

61

Histological groups

where Large cell carcinoma is a separate entity in the WHO


classification and includes 8010-8012, 8014-8031 and 8035 (Travis
et al., 2004). The thyroid is another exception where Anaplastic
carcinoma also is a specific entity in the WHO classification and
includes the morphology codes 8020-8035 (Delellis et al., 2004).

1.4
2
3

Unspecified carcinoma
Melanoma
Other specified malignant
neoplasm

8010-8011
8720-8790
8800-8811, 8830, 88408920, 8990-8991, 90409044, 9120-9133, 9150,
9540-9581
8000-8005

Unspecified malignant
Some tumours are evidently miscoded in cancer registry data, 4
neoplasm
because their incidence is far higher than expected. Papillary
carcinomas NOS (8050) are listed under Squamous cell
neoplasm in ICD-O-3. When used for bladder tumours, most of Liver (C22)
them are probably miscoded urothelial carcinomas rather than Hepatocellular carcinoma includes hepatoid carcinoma (8576),
papillary squamous cell carcinomas, and therefore included in assuming that these are miscoded Hepatocellular carcinomas.
the Transitional cell carcinoma group. In the thyroid, it can be The category Cholangiocarcinoma applies to all primary
assumed that carcinomas that have been assigned the morphology carcinomas of the liver of biliary epithelial type, i.e. excluding
code 8050 are actually papillary carcinomas of the thyroid, and hepatocellular carcinoma and combined hepatocellular and
they are therefore included in that category. In the kidney it can cholangiocarcinoma. Klatskin tumours (8162) are excluded
be assumed that a majority of tumours with the morphology code because they are by definition extrahepatic. Combined
8050 are miscoded papillary renal cell carcinomas, and they are hepatocellular and cholangiocarcinomas (8180), with less than
1% of cancers of known histology in the Cancer Incidence in
consequently grouped with the Renal cell carcinoma group.
Five Continents Vol. IX database, appear in the Other specified
carcinoma category. Carcinoid is included in the same group.
Oesophagus (C15)
Adenocarcinoma excludes Linitis plastica (8142), which occurs in
1
Carcinoma
8010-8576
gastric epithelium. Squamous cell carcinomas includes basaloid
1.1
Hepatocellular carcinoma
8170-8176
squamous cell carcinoma (8083). The principal cancers in the Other
Cholangiocarcinoma
8050, 8140-8141, 8160specified carcinoma group are Small cell carcinomas (8041-8045). 1.2
(all intrahepatic biliary
8161, 8260, 8440, 8480Melanoma and Carcinosarcoma are included among Other specified
carcinomas, i.e. all primary
8500, 8570-8572
malignant neoplasms.
adenocarcinomas)
1.3
Other specified carcinoma
1.4
Unspecified carcinoma
8010-8035
1
Carcinoma
8010-8576
2
Hepatoblastoma
8970
1.1
Squamous cell carcinoma
8050-8078, 8083-8084
Sarcoma
1.2
Adenocarcinoma
8140-8141, 8143-8145, 3
9120-9133, 9161
8190-8231, 8260-8263, 3.1 Haemangiosarcoma
8800-8811, 8830, 88408310, 8401, 8480-8490, 3.2 Other sarcomas
8921, 8990-8991, 90408550-8551, 8570-8574,
9044, 9150, 9170, 95408576
9581
1.3
Other specified carcinoma
4
Other specified malignant
1.4
Unspecified carcinoma
8010-8035
neoplasm
2
Sarcoma
8800-8811, 8830, 8800Unspecified malignant
8000-8005
8811, 8830, 8840-8921, 5
neoplasm
8990-8991, 9040-9044,
9120-9133, 9150, 9540Lung (C34)
9581
Squamous cell carcinoma includes papillary carcinoma NOS (8050)
3
Other specified malignant
because these are listed under Squamous cell neoplasms in ICD-O-3.
neoplasm
Adenocarcinoma includes bronchiolo-alveolar adenocarcinoma
4
Unspecified malignant
8000-8005
(8250-8254) but excludes adenoid cystic (8200), mucoepidermoid
neoplasm
(8430) and adenosquamous carcinoma (8560), which appear
in Other specified carcinoma. Small cell carcinoma includes
Anus (C21)
The category Squamous cell carcinoma includes basaloid and neuroendocrine carcinoma NOS (8246). These may include some
cloacogenic carcinomas (8123-8124) and basaloid squamous cell large cell neuroendocrine carcinomas, but it is assumed that the vast
carcinomas (8083). Cloacogenic carcinoma is a controversial entity, majority of cancers that are coded 8246 are small cell carcinomas.
sometimes defined as carcinoma arising from the anal transition zone, Large cell carcinoma includes cancers so described (8012), as well as
sometimes as a morphological variant of squamous cell carcinoma. other morphological variants of undifferentiated carcinomas (except
The term basaloid carcinoma has also been used to designate this those with neuroendocrine or spindle cell differentiation) and clear
group of tumours. Their reported incidence is highly variable, possibly cell adenocarcinoma (8310). Other specified carcinoma includes
because of the confusing nomenclature. Hence, these tumour types non-small cell carcinoma (8046), carcinoid tumours (8240-8245),
adenoid cystic (8200), mucoepidermoid (8430), adenosquamous
are lumped together with Squamous cell carcinoma.
(8560) and large cell neuroendocrine carcinomas (8013).
1
Carcinoma
8010-8576
1
Carcinoma
8010-8576
1.1
Squamous cell carcinoma
8050-8076, 8083-8084,
1.1
Squamous cell carcinoma
8050-8078, 8083-8084
8123-8124
1.2 Adenocarcinoma
8140, 8211, 8230-8231,
1.2 Adenocarcinoma
8140-8145, 8190-8231,
8250-8260, 8323, 84808260-8263, 8310, 8401,
8490, 8550-8551, 85708480-8490, 8550-8551,
8574, 8576
8570-8574, 8576
1.3
Small cell carcinoma
8041-8045, 8246
1.3
Other specified carcinoma

62

Histological groups

1.4

1.5
2

3
4

Large cell carcinoma (include 8010-8012, 8014-8031,


giant cell, clear cell and
8035, 8310
large cell undifferentiated
carcinoma)
Other specified carcinoma
Sarcoma
8800-8811, 8830, 88408921, 8990-8991, 90409044, 9120-9133, 9150,
9540-9581
Other specified malignant
neoplasm
Unspecified malignant
8000-8005
neoplasm

1.2

Adenocarcinoma

1.3
1.4
2

Other specified carcinoma


Unspecified carcinoma
Sarcoma

Other specified malignant


neoplasm
Unspecified malignant
neoplasm

8140-8141, 8190-8211,
8230-8231, 8260-8263,
8310, 8380, 8382-8384,
8440-8490, 8570-8574,
8576
8010-8035
8800-8811,8830, 88408921, 8990-8991, 90409044, 9120-9133, 9150,
9540-9581

4
8000-8005
Bone (C40-41)
The main categories are Osteosarcoma, Chondrosarcoma
and Ewing sarcoma. These three groups contain the same Corpus uteri (C54)
ICD-O entities as groups VIII A-C in the International Squamous cell carcinomas are grouped with Other specified
Classification of Childhood Cancer, Third Edition carcinoma because of their rarity at this site. Contrary to
(Steliarova-Foucher et al., 2005). The Other specified other sites, mucoepidermoid (8430) and adenosquamous
sarcomas category includes epithelioid sarcoma (8804), carcinoma (8560) are included in Adenocarcinoma because
fibrosarcoma (8810-8812), malignant fibrous histiocytoma squamous differentiation is very common in adenocarcinoma
(8830), liposarcomas (8850-8858), angiosarcomas (9120- of the corpus uteri, and it is assumed that partial squamous
9133) and malignant giant cell tumours (9250). The Other differentiation does not change the behaviour of these
specified malignant neoplasm category includes desmoplastic neoplasms. As opposed to other sites, metaplastic carcinoma
small round cell tumour (8806), mesenchymoma (8990), (8575) is grouped with Other specified malignant neoplasm
chordoma (9370-9372), adamantinomas (9261, 9310) and in the corpus uteri because metaplastic carcinoma of the
PNET (9473).
endometrium has been equated with carcinosarcoma.
Endometrioid adenofibroma, malignant (8381) is classified as
1
Sarcoma
8800-8921, 9040-9044, Other specified malignant neoplasm.
9120-9133, 9150, 91809250, 9260, 9540-9581
1.1
Osteosarcoma
9180-9200
1
Carcinoma
8010-8574, 8576
1.2
Chondrosarcoma
9210-9243
1.1 Adenocarcinoma (include
8140-8141, 8190-8211,
1.3
Ewing sarcoma
9260
mucoepidermoid and
8230-8231, 8260-8263,
1.4
Other specified sarcomas
adenosquamous carcinoma)
8310, 8380, 8382-8384,
1.5
Unspecified sarcoma
8800-8803, 8805
8430, 8440-8490, 8510,
2
Other specified malignant
8560, 8570-8574, 8576
neoplasm
1.2
Other specified carcinoma
3
Unspecified malignant
8000-8005
1.3
Unspecified carcinoma
8010-8035
neoplasm
2
Sarcoma
8800-8811, 8830, 88408921, 8990-8991, 9040Skin (C43-44)
9044, 9120-9133, 9150,
The skin has been added since the last edition of Histological Groups
9540-9581
for Comparative Studies. Basal cell carcinoma is registered and
3
Other specified malignant
reported by several cancer registries and has thus been included.
neoplasm
4
Unspecified malignant
8000-8005
1
Carcinoma
8010-8576
neoplasm
1.1
Squamous cell carcinoma
8050-8078, 8083-8084
1.2
Basal cell carcinoma
8090-8098
Ovary (C56)
1.3
Other specified carcinoma
The first four carcinomas correspond to malignant serous,
1.4
Unspecified carcinoma
8010-8035
mucinous, endometrioid and clear cell tumours. Among the
2
Melanoma
8720-8790
carcinomas not encompassed within these four groups, there
3
Other specified malignant
are various adenocarcinomas that cannot with certainty be
neoplasm
allocated to any of the above groups, and are hence included in
4
Unspecified malignant
8000-8005
Adenocarcinoma, NOS. In this category are grouped papillary
neoplasm
adenocarcinoma (8260), cystadenocarcinoma (8440) and
other variants of adenocarcinoma. Within adenocarcinoma,
Cervix uteri (C53)
NOS, there are most likely a substantial number of tumours
Mucoepidermoid carcinoma (8430) and adenosquamous that actually belong to categories 1.1-1.4. Truly unclassified
carcinomas (8560) are included with Other specified carcinoma. adenocarcinomas of the ovary are uncommon. Sex cord/
The Other specified malignant neoplasm category includes stromal tumours have their own group. Germ cell tumours
mullerian mixed tumour (8950), carcinosarcoma (8980) and include dysgerminomas, embryonal carcinomas and teratomas,
melanoma (8720-8790).
as well as the rare carcinoid tumours of the ovary, and the very
rare gonadoblastomas. Lipid cell tumours, malignant Brenner
1
Carcinoma
8010-8380, 8382-8576
tumours and sarcomas are very rare and are consigned to Other
1.1
Squamous cell carcinoma
8050-8078, 8083-8084
specified malignant neoplasm.

63

Histological groups

Carcinoma

1.1
1.2
1.3
1.4
1.5

Serous carcinoma
Mucinous carcinoma
Endometrioid carcinoma
Clear cell carcinoma
Adenocarcinoma NOS

1.6
1.7
2
3
4

Other specified carcinoma


Unspecified carcinoma
Sex cord-stromal tumours
Germ cell tumours
Other specified malignant
neoplasm (include
Mullerian mixed tumour,
carcinosarcoma)
Unspecified malignant
neoplasm

8010-8231, 8246-8576,
9014-9015, 9110
8441, 8460-8463, 9014
8470-8490, 9015
8380-8383, 8560, 8570
8310-8313, 9110
8140-8147, 8170-8190,
8211-8231, 8260, 8384,
8440, 8576
8010-8035
8590-8671
8240-8245, 9060-9102

8000-8005

Testis (C62)
The grouping of the testicular tumours has been completely
revised. Spermatocytic seminoma has a more favourable
prognosis than seminoma, and these tumours should not be
grouped. Embryonal carcinoma, malignant teratoma, Yolk sac
tumour, choriocarcinoma and mixed germ cell tumours are
included in non-seminomatous germ cell tumours. Sex cordstromal tumours are included in Other specified malignant
neoplasm.
1
1.1
1.2
1.3
2
3

Germ cell tumours


Seminoma
Spermatocytic seminoma
Non-seminomatous germ cell
tumours
Other specified malignant
neoplasm
Unspecified malignant
neoplasm

9060-9102
9060-9062, 9064
9063
9065-9102

8000-8005

1.3
1.4
2
3

Other specified carcinoma


Unspecified carcinoma
Other specified malignant
neoplasm
Unspecified malignant
neoplasm

8010-8035
8000-8005

Urinary bladder (C67)


The classification of urinary bladder tumours has undergone
several revisions in recent years. Some low-grade papillary
transitional cell tumours are now designated as papillary
urothelial neoplasia of low malignant potential, PUNLMP
(8130/1). In order to enable longitudinal comparisons, flat
carcinoma in situ (8120/2) and PUNLMP (8130/1, 8130/2) have
been grouped with Transitional cell carcinoma.
Papillary carcinomas (NOS 8050) are listed under squamous cell
neoplasm in ICD-O-3. When used for bladder tumours, most of
these are probably miscoded transitional cell carcinomas, and
are therefore included in the Transitional cell carcinoma group.
Pheochromocytoma, malignant paraganglioma, melanoma
and carcinosarcoma are included in Other specified malignant
neoplasm.
1
1.1
1.2

1.3

Carcinoma
Squamous cell carcinoma
Transitional cell carcinoma
(include transitional cell
carcinoma with squamous and/
or glandular differentiation)
Adenocarcinoma

1.4
1.5
2

Other specified carcinoma


Unspecified carcinoma
Sarcoma

8010-8576
8051-8078, 8083-8084
8050, 8120-8122, 81308131
8140-8145, 8190-8231,
8260-8263, 8310, 8401,
8480-8490, 8550-8551,
8570-8574, 8576
8010-8035
8800-8811, 8830, 88408921, 8990-8991, 90409044, 9120-9133, 9150,
9540-9581

3
Other specified malignant
neoplasm
Kidney (C64) and Renal Pelvis (C65)
There are several major difficulties with the histological grouping
4
Unspecified malignant
8000-8005
neoplasm
of kidney tumours. Transitional cell and squamous carcinomas in
the kidney usually originate from the renal pelvis, although it may
be difficult to trace the origin of the tumour. It can be assumed Eye (C69)
that some of these are site coded kidney (C64) and others renal The principal eye cancersretinoblastoma and malignant
pelvis (C65). Hence, these two sites are now grouped.
melanomaform two groups. The carcinomas (11.4% of eye
Renal cell carcinomas have recently undergone a reclassification cancers in the IARC database) are divided into three subgroups:
based on molecular, cytogenetic, morphological and clinical Squamous cell carcinomas (70% of the carcinomas, principally
data. However, a substantial portion of these tumours are tumours of the conjunctiva and cornea), Other specified
coded as renal cell carcinoma, NOS (8312) or adenocarcinoma, carcinomas (comprising almost entirely adenocarcinomas,
NOS (8140), while others are subtyped. Therefore, the renal 14.6%, and mainly originating in the lacrimal gland and
cell carcinomas are grouped together with adenocarcinoma, duct), and Unspecified carcinoma. Squamous cell carcinomas
NOS (8140), specific subtypes of renal cell carcinoma and that are site coded for the eye (C69) probably include some
also obsolete entities such as granular cell carcinoma (8320). cancers that originate in the skin (C44) of the eyelids.
Papillary carcinoma, NOS (8050) is listed under squamous cell
1
Retinoblastoma
9510-9513
neoplasm in ICD-O-3. When used for renal tumours most of
2
Malignant melanoma
8720-8790
these are probably miscoded papillary renal carcinomas, and
3
Carcinoma
8010-8576
are therefore included in 1.2.
3.1 Squamous cell carcinoma
8050-8078, 8083-8084
3.2 Other specified carcinoma
1
Carcinoma
8010-8576
3.3 Unspecified carcinoma
8010-8035
1.1
Squamous, transitional cell
8051-8084, 8120-8122,
4
Sarcoma
8800-8811, 8830, 8840carcinoma
8130-8131
8921, 8990-8991, 90401.2
Renal cell carcinoma
8050, 8140, 8260, 8270,
9044, 9120-9133, 9150,
8280-8312,8316-8320,
9540-9581
8340-8344

64

Histological groups

5
6

Other specified malignant


neoplasm
Unspecified malignant
neoplasm

8000-8005

Brain and central nervous system (C71-C72)


The categories are based upon those of the WHO Pathology &
Genetics classification (Kleihues & Webster, 1997). Atypical
teratoid/rhabdoid tumour (9508) is included in Embryonal
tumours. Olfactory, pineal and some pituitary tumours are
lumped together under Other neuroepihelial tumours. These
are craniopharyngioma (9350-9352), pinealoma, pineocytoma,
pineoblastoma (9360-9362) and olfactory neuroepitheliomatous
neoplasms (9520-9523). Pinealoma (9360) encompasses
pineocytoma (9361) and pineoblastoma (9362). The lymphomas
and haemopoietic neoplasms are not included.
1
1.1
1.1.1
1.1.2
1.1.3
1.1.4
1.2
1.2.1
1.2.2
1.3
2
3

Tumours of neuroepithelial
tissue
Gliomas
Astrocytic tumours

8680, 9350-9362, 93809508, 9520-9523


9380-9384, 9391-9460
9384, 9400-9421, 9424,
9440-9442
Oligodendroglial tumours and 9382, 9450-9451
mixed gliomas
Ependymal tumours
9383, 9391-9394
Gliomas, others
9380-9381, 9423, 9430,
9444, 9460
Embryonal tumours
9470-9474, 9490, 95009504, 9508
Medulloblastoma
9470-9472, 9474
Other
9473, 9490, 9500-9504,
9508
Other neuroepithelial tumours
Other specified malignant
neoplasm
Unspecified malignant
8000-8005
neoplasm

Carcinoma

8010-8576

1.1

Follicular carcinoma

8290, 8330-8335

1.2

Papillary carcinoma

8050, 8260, 8340-8344,


8350, 8450-8460

1.3

Medullary carcinoma

8345, 8510-8513

1.4

Anaplastic carcinoma

8020-8035

1.5

Other specified carcinoma

1.6

Unspecified carcinoma

8010-8015

Sarcoma

8800-8811, 8830, 88408921, 8990-8991, 90409044, 9120-9133, 9150,


9540-9581

Other specified malignant


neoplasm

Unspecified malignant
neoplasm

8000-8005

Haematopoietic and lymphoid tissues (9590-9989)


In the previous edition of Histological Groups for Comparative
Studies, haematologic tumours were listed separately as
Hodgkin disease and Leukaemias, but are now included in the
same grouping based on cellular origin. Hodgkin lymphoma has
been reclassified and lymphocytic predominance (9657-9659,
9660) is replaced by the new categories nodular lymphocytic
predominance (9659) and classical lymphocyte-rich (9651).
The category Non-Hodgkin lymphoma NOS is used because
some cancer registries lack sufficiently specific data for lineagebased classification.

Thyroid (C73)
Follicular and Papillary carcinomas make up the majority of
thyroid cancers; the latter includes follicular carcinomas with a
papillary component (8340). It is assumed that the vast majority
of cases of Papillary squamous carcinoma (8050) are actually
papillary carcinomas, and they are therefore included in this
category. Minimally invasive follicular carcinoma (8335) is a new
code in ICD-O-3 and is included among Follicular carcinomas.
Squamous carcinomas are no longer recognised as a major
histological type in the WHO Classification of Tumours and are
included in Other specified carcinomas.
Anaplastic carcinomas (undifferentiated, giant cell, spindle cell
carcinomas) are separated from Unspecified carcinomas. The
entity Poorly differentiated carcinoma is controversial and has
been lumped with Anaplastic carcinoma. Small cell carcinoma
(8040-8045) is specifically excluded, since the great majority of
tumours previously so diagnosed are in fact lymphomas.

1
1.1

Insular thyroid carcinoma (8337) is a distinctive clinicopathologic


entity that has been included in Other specified carcinoma.
Mixed medullary-follicular carcinoma (8346) and mixed
medullary-papillary carcinoma (8347) are also included in
Other specified carcinoma.

1.2
1.3
1.4
1.5
1.6
2
3
4
5

Hodgkin lymphoma
Nodular lymphocytic
predominance
Classical lymphocyte-rich
Nodular sclerosis
Mixed cellularity
Lymphocytic depletion
Unspecified
B-cell neoplasms

9650-9667
9659
9651
9663-9667
9652
9653-9655

9670-9699, 9728, 97319734, 9761-9764, 98239826, 9833, 9836, 9940


T-cell and NK-cell neoplasms 9700-9719, 9729, 98279831, 9834, 9837, 9948
Myeloid neoplasms
9840, 9860-9931, 99459946, 9950, 9960-9964,
9975, 9980-9989
Non-Hodgkin lymphoma
9591
NOS
Other specified malignant
neoplasms
Unspecified malignant
9590, 9596, 9727, 9760,
neoplasms
9800-9801, 9805, 9820,
9832, 9835

65

Histological groups

References
Delellis, R. A., Lloyd, R. V., et al. (2004). Pathology and
Genetics of Tumours of Endocrine Organs, Volume 8 (World
Health Organization Classification of Tumours). Lyon:
IARC Press.
Fritz, A., Percy, C., et al. (2000). International Classification
of Diseases for Oncology (ICD-O). Geneva: World Health
Organization.
Parkin, D. M., Shanmugaratnam, K. et al. (1998). Histological
Groups for Comparative Studies (IARC Technical Report
No. 31). Lyon: IARC Press. p. 184-187.
Parkin, D. M., Whelan, S. L., et al. (1997). Cancer Incidence
in Five Continents Vol. VII (IARC Scientific Publications
No.143). Lyon: IARC Press. p. 34.
Parkin, D. M., Whelan, S. L. et al. (2002). Cancer Incidence
in Five Continents Vol. VIII (IARC Scientific Publications
No.155). Lyon: IARC Press. p. 45-55.

66

Percy, C., Van Holten, V., et al. (1990). International


Classification of Diseases for Oncology (ICD-O). Geneva:
World Health Organization.
Silverberg, S. G., Major, F. J. et al. (1990). Carcinosarcoma
(malignant mixed mesodermal tumor) of the uterus. A
Gynecologic Oncology Group pathologic study of 203
cases. Int J Gynecol Pathol, 9, n.1, p.1-19.
Steliarova-Foucher, E., Stiller, C. A., et al. (2005). International
Classification of Childhood Cancer. Cancer, 103, n.7,
p.1457-1467.
Travis, W. D., Brambilla, E., et al. (2004). Pathology and
Genetics of Tumours of the Lung, Pleura, Thymus and Heart,
Volume 10 (World Health Organization Classification of
Tumours). Lyon: IARC Press. p. 179-184.
Zaino, R. J., Kurman R. J. (1988). Squamous differentiation
in carcinoma of the endometrium: a critical appraisal of
adenoacanthoma and adenosquamous carcinoma. Semin
Diagn Pathol, 5, n.2, May, p.154-71.

Chapter 5: Comparability and quality of data

H.R. Shin, M.P. Curado, J. Ferlay, M. Heanue, B. Edwards and H. Storm


The purpose of Cancer Incidence in Five Continents is to present
comparable incidence rates of cancer from different populations
world-wide. The process of selecting the data to be included
and the review and evaluation of the datasets by the Editors
therefore require careful attention to several aspects related to
comparability. As far as the cases registered (numerators of the
rates) are concerned, these include:
(a) The definition of an incident case of cancer,
(b) The completeness of enumeration of cases in the
population covered, and
(c) The accuracy of abstraction and coding of
information.
In addition to these, the denominatorperson-years at risk
for the period under considerationshould be estimated as
accurately as possible.
In this chapter we explain the evaluation of data
comparability and quality undertaken by the Editors for this
volume, and introduce the traditional tables of Indices of Data
Quality with which the users themselves can make judgements
on the completeness and validity of the different datasets.
Details of the standard definitions used by cancer registries
to define an incident cancer, and the indices of comparability
or validity that are found in the publication Comparability
and Quality Control in Cancer Registration (Parkin 1994) and
Chapter 5, Comparability and quality of data in the previous
volumes (Parkin and Plummer 2002, in Volume VIII), were
adopted to evaluate submissions for this volume.
In contrast to Volume VIII of Cancer Incidence in Five
Continents, a comparison with standard values for several
quantitative indices in the same region (see Chapter 5 in Volume
VIII, pp. 6667) was not executed for this volume. However,
the editors tried to achieve standardization for this volume with
more thorough efforts.
For Volume IX, the Editors considered these items:
(a) The number of cases in each year within the reference
years 19982002, for the abrupt changes of number of
cases by year in terms of completeness;
(b) The rates for each year, to check the tendency and
stability of cancer incidence rates within the reference
year;
(c) Other indices of data quality traditionally used by
cancer registries, which are described later in detail;
(d) The existence and usage of official mortality data;
and
(e) The coverage of the defined population.
The following Chapter 6, on Processing of Data, makes it
clear that an extensive process of verifying coding, identifying
possible duplicate registrations, querying unlikely or impossible
combinations of codes, and converting data to a standard format
has been carried out before any tabulations are prepared for
editorial evaluation. These steps in validation of the data are
part of the routine to which all datasets are subjected, and the
successful completion of these steps forms part of the editorial
evaluation.
A systematic and standard analysis according to the internal
protocol at IARC produced the editorial tables and figures
(listed below) that were provided to each contributor to allow
an opportunity for feedback. These editorial sheets, along with
the responses to the questionnaire filled by the registry and data
process summary sheet were transferred to the secure FTP site.
The site was subdivided into directories for each continent,

country and registry. The external Editors, each assigned a


continent, downloaded them for an initial review of the editorial
sheets, and filled in a review summary form that was uploaded
to the FTP site before the editorial meetings.
The systematic analysis produced the following:
(a) A set of editorial tables and figures including Editorial
Sheets 1a (number of cancer cases) and 1b (agestandardized rates in major diagnosis groups in single
calendar years of observation by sex)(Tables 5.1, 5.2),
and Editorial Sheets 2a and 2b, age-specific graphs for
major diagnosis groups, linear and logarithmic (Figures
5.1 and 5.2 respectively);
(b) The tables of age- and site-specific rates and summary
rates (crude, age-standardized, percentage of
Microscopically Verified cases (MV), and the change
from the rates reported in Volume VIII (CH V8) (when
available: see subsection Comparison of rates with
those in Volume VIII in the section Stability of incidence
over time) (Table 5.3);
(c) Other indices of data quality traditionally used for
cancer registration, which are described later in detail
(Table 5.4);
(d) The estimated population at risk, with the source of
information as a form of population pyramid by sex
and age, and the method of estimation used (population
pyramids: Figure 5.3);
(e) The questionnaire responses provided by the registry;
and
(f) Summary sheet to check the coding system, with
applied rules for multiple primaries in the questionnaire
(Figure 5.4).
At their formal meetings, the editors had access to all of the
above, and each external editor reported the review result. All
Editors agreed upon the final decision, and the responsible
Editor filled in an evaluation form with the final decision and
some queries, if necessary.
Comparability
Definition of incidence
In defining incidence rates, particular attention is required
in three broad areas:
(a) The distinction between recurrence or extension of an
existing cancer and the development of a new primary;
(b) The detection of cancers incidentally, in asymptomatic
individuals; and
(c) The detection of cancers at autopsy.

Multiple primaries
Contributing registries were invited to submit all malignant
and non-malignant diagnoses collected so that a common set of
multiple primaries rules could be applied to each dataset. In this
volume, the data were recoded (when necessary) into ICDO3
(Fritz et al., 2000), and the international rules used to distinguish
new primary cancers from existing extensions/recurrences were
those set out in the IARC/IACR definitions (IARC, 2004). This
also requires that all cancers in the same individual could be
identified. Of the registries included in this volume, 46 did not
provide a patient identification number, making it impossible
for the Editors to distinguish multiple primary tumours from
duplicate registrations. For those registries, the rules used prior
to submission are indicated below the population pyramid of the
corresponding registry.

67

Comparability and quality of data

As a result of recoding the datasets to the international standard,


for those contributors who sent data already recoded according
to a different set of rules, the results published in the volume
do not exactly correspond to those published by the registries
themselves. Table 5.5 shows the registration practices for the
multiple primary rules by continent.
The second multiple primary check procedure performed at
IARC may have removed some cases considered as duplicate
registrations and, conversely, some records that are considered
multiple primaries following the IARC/IACR rules (2004)
may have been considered duplicates following the registry
rules and excluded from the submission. For example, the
Korea Central Cancer Registry submitted data for the period
19992002 according to the IARC/IACR rules (IARC, 2000).
According to these rules, at least 261 cancer cases (of a total
of approximately 430 000) that should have been considered
multiple primaries following the IARC/IACR rules (2004) were
considered duplicates by the registry and were not sent to IARC.
In addition, 433 records that were considered multiple primaries
by the registry were considered duplicates following the IARC/
IACR (2004) rules and excluded from the final tables.
The number of cases to be removed due to duplicate cases
on the basis of the 2004 rule is in fact very small, mostly
affecting the number of cases from groups of tumours of the
bladder, kidney and renal pelvis. Groups of haematopoietic and
lymphoid tissues were changed to a more detailed classification.
To compare the effect on incidence rates and time trends of
certain sites, therefore, we should pay special attention to the
changes in application of the multiple primary rules.
Incidental diagnosis
Almost all registries include malignant tumours diagnosed during
screening programmes, or histological specimens taken from
individuals in whom there were no symptoms, or no clinical
suspicion of cancer. These cases will increase incidence rates if
the malignant cells so identified would never have resulted in a
clinical cancer had they remained undetected. The incidence of
breast cancer appears to have been increased by the introduction
of systematic mammographic screening for cancer. More striking,
however, are the effects of such incidental diagnoses on the reported
incidence of prostate cancer following the introduction of screening
with prostate-specific antigen. Similarly, the increase in diagnostic
activity may have influenced the incidence of thyroid cancer. Table
5.6 and 5.7 show the registration practices for using a screening
program as a data source by continents.
Autopsy diagnosis
Most registries include cancers identified in necropsy
examinations of subjects in whom cancer was not diagnosed
(or perhaps even suspected) during life. The possible influence
on incidence rates will depend upon the extent of necropsy
examinations in different populations; in general this has been
declining in most countries in recent decades. The registries
own appraisal of the percentage of cancer deaths autopsied is
reproduced in Table 5.7.
Coding practice
For five cancer sitesskin, non-melanoma (ICD10 C44), ovary
(ICD10 C56), urinary bladder (ICD10 C67), brain and central
nervous system (ICD10 C7072), and myeloproliferative
disorders and myelodysplastic syndromes (MPD/MDS)
comparability is particularly affected by differences in
classification and coding practices. These sites are printed in
italics in the cancer registry tables, and care should be taken
when comparing data from different registries for these sites.
Non-melanoma skin cancer. The incidence of non-melanoma
skin cancer (NMSC) is difficult to assess. These cancers are very

68

common but rarely fatal, and completeness of registration varies


widely depending on access to outpatient records and general
practitioners. Most NMSCs are basal cell (BCC) or squamous cell
(SCC) carcinomas; other skin cancers are rare. While some registries
record the first occurrence of all NMSC, others register BCC only,
several registries collect information for lip and/or genital sites only,
and many do not collect data on either SCC or BCC.
Ovarian cancer. Registries contributing to this volume
were asked how they coded ovarian cystadenoma of borderline
malignancy and borderline tumour of the ovary (see Chapter
3). Clearly, for these diagnoses, registration practice varies
considerably. The borderline ovarian diagnoses were considered
as non-malignant tumours in ICDO1/ICD9. They were
considered malignant in ICDO2/ICD10, and have been
changed back to the /1 borderline category in ICDO3; as
a result, they have been excluded from the final tables in the
present volume. Studies of trends in incidence should take into
account the practice in previous volumes.
Bladder cancer. The problem of the coding of non-invasive
tumours, taking into account recorded level of invasion and
grade, and which to include in the tables as cancer of the
bladder has long been the subject of debate. In principle, the
availability of data on histological type and behaviour has
made it possible to publish only data on malignant cancer by
excluding diagnoses with any behaviour code other than /3.
However, many registries assign the behaviour code /3 to both
non-invasive and unspecified diagnoses, making it impossible
to distinguish such cases. The Editors decided to follow the
policy adopted in the last two volumes and to accept that noninvasive diagnoses of bladder cancer (/1 and /2) are considered
malignant, and the bladder cancer category includes the in situ
and unspecified categories. A few registries preferred not to
include such cases in their dataset, even when available in the
registry, for the sake of continuity over time.
Brain and central nervous system. Benign and unspecified
tumours of the brain and central nervous system are excluded
from the tabulation. Some registries choose to include benign
and unspecified tumours of the brain and central nervous
system in their data because of the potentially serious clinical
consequences of these tumours, and assign the behaviour code
/3 to both benign and unspecified diagnoses, so making it
impossible to distinguish such cases.
Myeloproliferative disorders and myelodysplastic syndromes.
Unlike ovarian borderline tumours, these diagnoses that were
considered as non-malignant disease (/1) in ICDO2 and in
ICD10 (D45D47) have changed behaviour code to malignant
(/3) in ICDO3. Only registries that collect information
according to ICDO3, or those registries which have collected
and submitted such cases although they were considered as nonmalignant, can present data. Because no ICD10 codes in the
C (malignant) category have been allocated to them, they are
presented under the category MPD/MDS.
Completeness
Completeness of registration is the proportion of all incident
cases in the registry population that have been included in the
registry database. Completeness should be as close to 100%
as possible, so that comparison of incidence rates between
registries reflects true differences in cancer risk.
The Editors main concern is with the possibility of
incompleteness in the data submitted. Duplicate registration of
the same case should be avoided by careful attention to record
linkage during the registration process. Because the case lists
submitted do not contain personal identifying information, it
is impossible for the Editors to check for possible duplicates.
However, sometimes the existence of duplicate registration was
suspected, e.g. by indices of completeness (see below) being

Comparability and quality of data

higher than expected, and listings of possible duplicates (based


on birthdate, sex, diagnosis and date of incidence) were returned
to the registry for checking.
The following indices of completeness are routinely used
during the editorial process:
(1) Historic data methods:

(a) Stability of incidence rates over time

(b) Age-specific incidence curves

(c) Childhood cancer
(2) Proportion of cases microscopically verified
(3) Proportion of unknown basis of diagnosis
(4) Mortality:incidence (M:I) ratio
(5) Death certificate methods
Stability of incidence over time
Constancy of registrations during the period under review
Editorial Tables 1a and 1b (Tables 5.1 and 5.2) simply present
the distribution of cases registered and age-standardized rates,
by site and year. Those permit a rapid visual check on the
stability of numbers of cases being recorded each year and
signal potential problems in the registration process and/or in
the population during the period under review.
Comparison of rates with those in Volume VIII
The change in incidence rates (as average percentage annual
change) since Volume VIII is presented in the column headed
CH V8 in Editorial Table 3 (Table 5.3). Those changes that
are statistically significant, based on a comparison of the agestandardized rate in Volume VIII, are marked in bold. Changes
in incidence rates over time that are greater than expected, and
which cannot be ascribed to discrepancies in the estimation
of person-years at risk, suggest the possibility of changes in
the completeness of case ascertainment. When there was no
corresponding rate published for that site in Volume VIII, the
current rate was compared with an average value from other
regions in the same country, or from neighbouring countries.
Age-specific incidence curves
Age-specific incidence curves for 12 sites in each sex comprised
Editorial Sheet 2a, 2b (Figures 5.1 linear, 5.2 logarithmic). The
curves were examined during the editorial process in order
to detect abnormal fluctuations in the anticipated patterns,
including any fall-off in the rate of increase in incidence in
older subjects (suggestive of under-ascertainment in the oldest
age groups). The curves also reveal problems with estimates of
population at risk for specific age groups.
Childhood cancer
The possibility of under-enumeration (or duplicate registrations)
in this age range was investigated by comparing the observed
age-specific rates in the childhood age range (groups: 04,
59, 1014 for all cancer sites) with the corresponding rates in
Volume VIII, when available.
Proportion of cases microscopically verified
Editorial Sheet 4 (Table 5.4) tabulates, for each site by sex (19 for
men, 21 for women), the percentage of cases for which the diagnosis
was based upon microscopic verification of a tissue specimen
(MV%). This includes, in addition to histological confirmation of
diagnosis, those based upon exfoliative cytology specimens, and
diagnoses of leukaemia based on haematological examination
(without examination of bone marrow). The MV% figures are also
presented in the tables of Indices of Data Quality on the website.
The main value of the MV% is as an indicator of the validity
of the diagnostic information (Parkin et al., 1994). However,
a very high proportion of cases diagnosed by histology or

cytology/haematologyhigher than might reasonably be


expectedsuggests over-reliance on the pathology laboratory
as a source of information, and failure to find cases diagnosed
by other means.
In Editorial Sheet 4 (Table 5.4), the column MV% values
in bold, accompanied by a flag (</>) signifies that the number
of cases so diagnosed is significantly greater than (>) or less
than (<) the value observed by sex and site in Volume VIII when
available. When there was no MV% published for that site in
Volume VIII, the current MV% was compared with an average
MV% value from the other regions in the same country, or from
neighbouring countries.
Proportion of cases of unknown basis of diagnosis
When each new cancer case is registered, the diagnostic modality
is described as being by histology, cytology/haematology,
clinical investigation with X-ray, ultrasound, MRI, autopsy or
clinical diagnosis only. Cases not distinguished by the above
modalities are listed as unknown basis of diagnosis. If the
proportion of cases denoted as unknown basis of diagnosis is
higher than 20%, completeness of the registry is not sufficient
to be included in this volume.
Mortality:Incidence ratio
This ratio is an important indicator of completeness, an example of
the independent case ascertainment method (Parkin et al., 1994).
Registries are asked to provide the mortality data on cancer by
sex, age group and site, for the same period as the registered cases,
from the local vital statistics office (municipal, provincial, national,
etc.). Registry-generated mortality statistics (based on cases in
the registry database who die during the period, or incorporating
corrections to the certified cause of death) are not acceptable, since
they do not constitute an independent data source.
When the quality of the mortality data is good, the M:I ratio
is related to case fatality (1-survival). However, when mortality
statistics are of poorer quality (incomplete certification,
inaccurate cause of death statements) the relationship will be
less close. Evaluation of the M:I ratio should take this into
account. Since both survival and quality of mortality statistics
are somewhat related to geographical region the regional
location of the registry is important in evaluation of the statistic.
As it is typical to use M:I ratio as a criteria for inclusion or
exclusion, in the process of evaluation the editors compared the
M/I ratio by site with a reasonable threshold level.
In Editorial Sheet 4 (Table 5.4), the M:I ratios for a given
site are marked as being significantly greater (>) or less (<) than
observed on the Cancer Incidence in Five Continents, Volume
VIII, when available. When there was no corresponding ratio
published for that site in Volume VIII, the current ratio was
compared with an average value from the other regions in the
same country, or from neighbouring countries. The tables of
Indices of Data Quality show the values of the M:I ratio for
registries where official mortality statistics are available.
Death certificate methods
Death certificates provide an important supplementary source of
information for cancer registries. As far as incidence statistics
are concerned, they function as a means of capturing information
on cases that escaped the registration process during life.
Completeness of registration may be evaluated on the basis of
the proportion of incident cancers that first come to the registrys
attention via a death certificate notification of cancer (DCN cases).
This proportion was provided by the registry to the editors of Cancer
Incidence in Five Continents, whose data include only the numbers
of death certificate only (DCO cases)that is, the residuum of cases
remaining after various follow-back procedures have been carried
out on DCN cases. By itself, therefore, the DCO% is not an indicator

69

Comparability and quality of data

of completeness of registration; a low DCO% may indicate efficient


case-finding, but it could equally well result from the efficient
traceback of DCN cases (for example, there are actually no DCO
cases with complete traceback in the Australia South and Canada
Northwest Territories datasets). Nevertheless, the DCN% will always
be equal to or greater than the DCO%, so an elevated DCO% is
suggestive of incompleteness. Even this must be interpreted in the
light of local circumstances; in some developing countries, the
quality of death certificates may be very poor, with a fair number
of erroneous cancer deaths, which the registry may have difficulty
tracing back to a hospital capable of confirming (or not) the death
certificate statement. Table 5.8 shows the registration practice used
to distinguish the DCN cases and DCN (%) by each registry.
Failure to use death certificates, when these are available
and can be linked to the registry database, is generally taken to
mean that some lack of completeness is likely to be present.
Validity
Validity is defined as the proportion of cases in a data-set with a
given characteristic (e.g., site, age) that truly have the attribute.
Cancer Incidence in Five Continents uses five of the common
indices of validity (Parkin et al., 1994):
(a) Internal consistency
(b) Histological verification
(c) Death certificate only
(d) Other and unspecified cases (ill-defined cases)
(e) Age unknown
The use of the IARC-CHECK program to perform consistency
checks on the submitted data-sets is described in the chapter
on data processing (Chapter 6). In practice, all datasets were
submitted to this process, and the cases queried checked by the
registry before incorporation into the database.
Microscopical verification
For most cases, the accuracy of the stated diagnosis is likely
to be higher if it is based on histological examination by a
pathologist. Previous surveys have shown that many cancer
registries code diagnoses based on exfoliative cytology or on
haematological examination of peripheral blood in the same
category as histological examinations, so that it is impossible
to distinguish between them. Partly for this reason, the index of
validity used in the Editorial Sheet (Table 5.4) and the tables of
Indices of Data Quality in this volume concern the percentage
of cases microscopically verified.
For example, the MV% of liver cancer gradually decreased
in the data from some Asian registries. In the practice guidelines,
the diagnostic criteria of hepatocellular carcinoma included the
non-invasive methods defined by the European Association for
the Study of the Liver (Bruix et al., 2001) and by the American
Association for the Study of Liver Disease (Bruix & Sherman
2005). In the regions with a high proportion of liver cancer
among the total number of incidence cases, the overall MV%
will be highly affected by the MV% of liver cancer. The practice
guidelines should be considered in the evaluation of cancer
cases from registries. Therefore, MV% without liver cancer was
considered as one of the criteria for acceptance.
Also, MV% without leukaemia was considered when the MV%
of each registry was less than the threshold of inclusion criteria.
Death certificate only
In this volume, considerable effort has been made to ensure that
what is reported as DCO cases in the Editorial Tables and Indices of
Data Quality Tables does, indeed, refer to such cases. That is, they
represent the residuum of casesafter all trace-back manoeuvres
have been completedfor which no other information than a death
certificate mentioning cancer could be obtained. Inasmuch as the

70

diagnostic information on death certificates is well known to suffer


from lack of accuracy, or lack of precision, a high proportion of
DCO cases implies a lack of validity of the data. It would usually
imply a lack of completeness also, as noted earlier (see section
on Death certificate methods).
There are many considerations involved in interpretation, and
the sensitivity of the DCO% to local circumstances (availability of
death certificates, quality of cause-of-death statements, facility to
trace back cases). In this volume, the datasets with less than 20%
of DCO cases were considered for the evaluation.
Other and unspecified (ill-defined) cases
The content of this category is defined in Chapter 3 (see Table 3.1). A
high proportion of cases assigned to these rubrics generally implies
poor diagnostic precision (as evidenced by the low MV% observed
for this rubric), or failure to specify the site of the primary cancer in
cases diagnosed on the basis of tissue obtained from a metastasis.
The percentage of ill-defined cases is given in Editorial
Sheet 4 (Table 5.4). In this volume, only data with less than 20%
of ill-defined cases were considered for the evaluation.
Age unknown
The proportion of cases for which age was unknown is reported
in Table 5.3. In this volume, only data with less than 20% of
age-unknown cases were taken into account for the evaluation.
Population
It is obvious that a 10% error in the estimation of population
at risk produces just as much inaccuracy in the calculated
incidence rate as a 10% error in enumeration of cases. However,
cancer registries are generally not responsible for population
estimates, and must rely upon various departments of central and
local government to supply the required information. Registries
should, however, inform themselves about the source of the
population-at-risk figures that they use, and the methods used to
produce estimates and projections. The Editors of this volume
asked all contributing registries to provide this information, and
it is summarised, along with the average annual population at
risk for the period covered by the registrations, for each entry.
The population data provided by a registry could rarely be
subjected to verification by the Editors. The shape of the population
pyramids and irregularities in the age-specific incidence curves
sometimes suggested errors in the estimates, and occasionally
the appropriateness of the source of the information provided
was queried. For Volume IX, which mainly concerns periods of
time around 2000, census data were usually available, so that part
of population at risk was based on post-censal and the other on
intercensal estimates.
Grouping of datasets according to the inclusion criteria
Inclusion criteria
The Editors applied standard definitions for the inclusion criteria
using the indices described above.
Up until Volume VIII, there were no rigidly defined criteria with
ranges of acceptability for some quality indices; however, the
Editors considered the guidelines for scrutinising the data when
comparing them to previous volumes. The comparability groups A,
B and C were created to facilitate high throughput of evaluation,
did not require strict criteria for inclusion, and aided the Editors in
the evaluation process. Table 5.7 shows the summarised inclusion
criteria used for the review and evaluation of submissions and
resubmissions. For some datasets, the intrinsic interest in providing
information on little-known geographical and ethnic patterns, or
continuity with earlier data from the same registry, were taken
into consideration. The specialised cancer registriese.g. sitespecific cancer registries and childhood cancer registrieswere
not considered for inclusion.

Comparability and quality of data

Categorisation (Grouping)
Submissions with more than three-year data were taken into
account for evaluation. Data with less than 20% of DCO cases,
ill-defined cases, age-unknown cases were considered, except
for some registries of special interest due to their geographical
location.
An overall MV% of more than 75% was considered
acceptable (data with higher than 99% of MV% were not
considered for evaluation; see section on Proportion of cases
microscopically verified). However, some registries reported a
MV% without liver cancer or ill-defined cases that was higher
than 75% (higher than 70% for some special-interest registries,
for example China Jiashan) and were included as described in
subsection Microscopical verification in the Validity section.
Even though there was no strictly applied threshold of
Mortality:Incidence ratio, a practically reasonable value by site
was considered. Those with implausibly low or high incidence
rates were not included in this volume.
The Editors received 313 submissions from cancer
registries. For the editorial process, the submissions were
categorized into three groups (group A, B, and C) according
to the quality indicators. Of these, 225 (71.8% of submissions)
were included.
Group A
The registries that included death reporting in the registry region
that was in compliance with WHO recommendations were
grouped as Group A. Data in this group also had more than 80%
MV% and less than 10% ill-defined site, DCO% and unknown
basis of diagnosis. Ideally, the registries with almost 100%
completeness were considered for this group. The registries
should have well-defined denominators and not show abrupt
changes in trends. (For an example of Group A, see Editorial
Sheet 4; Table 5.4a).

Group B
If a cancer registry had no access to death certificate data, even the
existence of official mortality with causes of death, it was classified
as comparability Group B. The registries were those with MV%
between 75% and 80%. As described above, registries with a MV%
due to a high proportion of liver cancer were calculated without liver
cancer. MV% without leukaemia was also considered for this group.
(For an example of Group B, see Editorial Sheet 4; Table 5.4b).
Group C
Regions or countries without official mortality were grouped as
C for comparability. In terms of completeness, the registries in
which ad hoc study is not available and death clearance is not a
source of case finding were grouped into Group C. (For examples
1 and 2 of Group C, see Editorial Sheet 4; Table 5.4c).
The asterisk (*) for Group C and datasets of special interest
The presence of an asterisk on a registry table denotes that care
should be taken in interpreting the rates for some or all of the
cancer sites listed. The principal reason for use of an asterisk is to
indicate those datasets, a total of 26, that the Editors considered
to have some limitations in determining the number of cases or
the population at risk that could affect the ability to make direct
comparisons with other registry datasets. The criteria used to
assign an asterisk were not strictly defined, being based instead
on a number of quantitative indices discussed in this chapter as
well as knowledge of the circumstances under which the registry
operates. Certain registries were considered to be of special
interest due to their providing important data on geographic or
population groups little represented in the literature, and this
was taken into consideration as well.
The submitting registries were notified of the assigned
comparability group, but this information does not appear in the
published volume.

References
Bruix J., Sherman M., Llovet J.M., et al. (2001). Clinical
management of hepatocellular carcinoma. Conclusions of
the Barcelona-2000 EASL conference. European Association
for the Study of the Liver. J Hepatol 35(3):421-30.
Bruix J., Sherman M. (2005). Management of hepatocellular
carcinoma. Hepatology 42(5):1208-36.
Chirpaz E., Colonna M., Mngoz F., Grosclaude P., Schaffer P.,
Arveux P., Mace-Lesech J., Exbrayat C., Schaerer R. (2002).
Incidence and mortality trends for prostate cancer in 5 French
areas from 1982 to 1996. Int J Cancer, 97:372-6.
Fritz A., Percy C., Jack A., Shanmugaratnam K., Sobin L., Parkin
D.M., Whelan S. (eds) (2000). International Classification
of Diseases for Oncology, 3rd edition. Geneva: World Health
Organization, Geneva.

IARC (2000). Multiple Primaries. Internal Report No. 94/003,


distributed in 1995 and revised in 2000. Lyon: IARC.
IARC (2004). International Rules for Multiple Primary Cancers ICD-O
Third Edition. Internal Report No. 2004/02. Lyon: IARC.
Parkin D.M., Chen V.W., Ferlay J., Galceran J., Storm H.H., Whelan
S.L. (1994). Comparability and Quality Control in Cancer
Registration (IARC Technical Reports No. 19). Lyon: IARC.
Parkin DM, Plummer M (2002). Comparability and quality of
data. In: Parkin D.M., Whelan S.L., Ferlay J., Teppo L.,
Thomas D.B. Cancer Incidence in Five Continents, Volume
VIII. (IARC Scientific Publications No. 155). Lyon: IARC.

71

Comparability and quality of data


Table 5.1 Number of cases
major
groups
in single
years of observation
Tablein
5.1
CI5diagnosis
Volume IX
(Editorial
Tablecalendar
1a)

ELSEWHERE (1998-2002)
Number of cases in major diagnosis groups in single calendar years of observation

72

SITE
Oral cavity & pharynx
Digestive organs
Respirathory organs
Bone & cartilage
Breast
Male genital
Urinary organs
Eye, brain & NS
Thyroid & endocrine
Ill-defined & unknown
Haematopoietic
All sites but skin

1998
88 (23)
2375 (614)
694 (179)
26 (07)
1 (00)
69 (18)
237 (61)
57 (15)
45 (12)
84 (22)
157 (41)
3867 (1000)

1999
79 (18)
2641 (616)
745 (174)
12 (03)
2 (00)
110 (26)
230 (54)
56 (13)
50 (12)
96 (22)
215 (50)
4285 (1000)

MALE
2000
99 (23)
2655 (613)
807 (186)
13 (03)
4 (01)
97 (22)
236 (54)
72 (17)
51 (12)
65 (15)
198 (46)
4334 (1000)

2001
110 (24)
2919 (624)
812 (174)
23 (05)
5 (01)
117 (25)
287 (61)
47 (10)
54 (12)
81 (17)
180 (38)
4679 (1000)

2002
114 (24)
2968 (614)
850 (176)
18 (04)
3 (01)
139 (29)
314 (65)
45 (09)
56 (12)
73 (15)
204 (42)
4834 (1000)

Total
490 (22)
13558 (616)
3908 (178)
92 (04)
15 (01)
532 (24)
1304 (59)
277 (13)
256 (12)
399 (18)
954 (43)
21999 (1000)

S
O
D
R
B
B
M
U
E
T
Il
H
A

SITE
Oral cavity & pharynx
Digestive organs
Respirathory organs
Bone & cartilage
Breast
Female genital
Urinary organs
Eye, brain & NS
Thyroid & endocrine
Ill-defined & unknown
Haematopoietic
All sites but skin

1998
29 (10)
1266 (431)
217 (74)
12 (04)
408 (139)
520 (177)
67 (23)
40 (14)
144 (49)
73 (25)
114 (39)
2934 (1000)

1999
40 (12)
1427 (424)
309 (92)
12 (04)
465 (138)
562 (167)
74 (22)
44 (13)
184 (55)
81 (24)
118 (35)
3362 (1000)

FEMALE
2000
50 (15)
1425 (413)
277 (80)
19 (06)
496 (144)
540 (157)
92 (27)
55 (16)
202 (59)
90 (26)
158 (46)
3448 (1000)

2001
38 (10)
1465 (402)
329 (90)
22 (06)
550 (151)
567 (156)
106 (29)
53 (15)
250 (69)
71 (19)
154 (42)
3646 (1000)

2002
40 (10)
1624 (421)
308 (80)
16 (04)
621 (161)
608 (158)
101 (26)
39 (10)
230 (60)
60 (16)
170 (44)
3858 (1000)

Total
197 (11)
7207 (418)
1440 (83)
81 (05)
2540 (147)
2797 (162)
440 (26)
231 (13)
1010 (59)
375 (22)
714 (41)
17248 (1000)

S
O
D
R
B
B
F
U
E
T
Il
H
A

SITE
Oral cavity & pharynx
Digestive organs
Respirathory organs
Bone & cartilage
Breast
Female genital
Male genital
Urinary organs
Eye, brain & NS
Thyroid & endocrine
Ill-defined & unknown
Haematopoietic
All sites but skin

1998
117 (17)
3641 (535)
911 (134)
38 (06)
409 (60)
520 (76)
69 (10)
304 (45)
97 (14)
189 (28)
157 (23)
271 (40)
6801 (1000)

1999
119 (16)
4068 (532)
1054 (138)
24 (03)
467 (61)
562 (73)
110 (14)
304 (40)
100 (13)
234 (31)
177 (23)
333 (44)
7647 (1000)

BOTH SEXES
2000
149 (19)
4080 (524)
1084 (139)
32 (04)
500 (64)
540 (69)
97 (12)
328 (42)
127 (16)
253 (33)
155 (20)
356 (46)
7782 (1000)

2001
148 (18)
4384 (527)
1141 (137)
45 (05)
555 (67)
567 (68)
117 (14)
393 (47)
100 (12)
304 (37)
152 (18)
334 (40)
8325 (1000)

2002
154 (18)
4592 (528)
1158 (133)
34 (04)
624 (72)
608 (70)
139 (16)
415 (48)
84 (10)
286 (33)
133 (15)
374 (43)
8692 (1000)

Total
687 (18)
20765 (529)
5348 (136)
173 (04)
2555 (65)
2797 (71)
532 (14)
1744 (44)
508 (13)
1266 (32)
774 (20)
1668 (43)
39247 (1000)

S
O
D
R
B
B
F
M
U
E
T
Il
H
A

1998

ALL SITES NUMBER OF CASES BOTH SEXES


1999
2000
2001

782%

880%

895%

Population data provided for 5 year(s)


Mon Nov 26 2007

958%

2002

1000%

Comparability and quality of data


Table 5.2 ASR inTable
major
groups
single calendar
years of observation
5.2diagnosis
CI5 Volume
IXin
(Editorial
Table 1b)

ELSEWHERE (1998-2002)
ASR in major diagnosis groups in single calendar years of observation
SITE
Oral cavity & pharynx
Digestive organs
Respirathory organs
Bone & cartilage
Breast
Male genital
Urinary organs
Eye, brain & NS
Thyroid & endocrine
Ill-defined & unknown
Haematopoietic
All sites but skin

1998
57 (22)
1565 (602)
511 (197)
15 (06)
00 (00)
63 (24)
154 (59)
35 (14)
24 (09)
59 (23)
95 (36)
2598 (1000)

1999
48 (17)
1660 (598)
538 (194)
06 (02)
01 (00)
92 (33)
151 (54)
34 (12)
28 (10)
67 (24)
125 (45)
2776 (1000)

MALE
2000
60 (23)
1567 (594)
533 (202)
07 (03)
05 (02)
74 (28)
150 (57)
41 (16)
25 (10)
43 (16)
111 (42)
2637 (1000)

2001
62 (22)
1679 (603)
537 (193)
14 (05)
03 (01)
87 (31)
172 (62)
25 (09)
28 (10)
53 (19)
99 (35)
2784 (1000)

2002
61 (22)
1635 (594)
521 (189)
12 (04)
02 (01)
95 (34)
183 (67)
24 (09)
31 (11)
47 (17)
113 (41)
2752 (1000)

Total
58 (21)
1622 (598)
529 (195)
11 (04)
02 (01)
83 (31)
163 (60)
32 (12)
27 (10)
53 (20)
109 (40)
2713 (1000)

SITE
Oral cavity & pharynx
Digestive organs
Respirathory organs
Bone & cartilage
Breast
Female genital
Urinary organs
Eye, brain & NS
Thyroid & endocrine
Ill-defined & unknown
Haematopoietic
All sites but skin

1998
14 (10)
629 (448)
108 (77)
06 (04)
176 (126)
234 (167)
35 (25)
22 (16)
64 (46)
35 (25)
56 (40)
1404 (1000)

1999
19 (12)
685 (437)
148 (94)
06 (04)
200 (128)
247 (157)
37 (24)
21 (13)
83 (53)
40 (26)
61 (39)
1569 (1000)

FEMALE
2000
23 (15)
658 (421)
129 (83)
09 (05)
208 (133)
231 (148)
46 (30)
28 (18)
87 (56)
42 (27)
82 (52)
1563 (1000)

2001
17 (11)
658 (409)
151 (94)
13 (08)
224 (139)
238 (148)
49 (30)
27 (17)
108 (67)
32 (20)
76 (47)
1611 (1000)

2002
17 (10)
710 (428)
134 (81)
09 (05)
250 (150)
254 (153)
45 (27)
18 (11)
96 (58)
26 (15)
84 (50)
1660 (1000)

Total
18 (11)
669 (428)
134 (86)
08 (05)
212 (136)
241 (154)
43 (27)
23 (15)
88 (56)
35 (22)
72 (46)
1564 (1000)

SITE
Oral cavity & pharynx
Digestive organs
Respirathory organs
Bone & cartilage
Breast
Female genital
Male genital
Urinary organs
Eye, brain & NS
Thyroid & endocrine
Ill-defined & unknown
Haematopoietic
All sites but skin

1998
32 (17)
1017 (545)
270 (145)
11 (06)
92 (49)
124 (66)
23 (12)
85 (46)
28 (15)
45 (24)
45 (24)
73 (39)
1868 (1000)

1999
31 (15)
1099 (539)
302 (148)
06 (03)
104 (51)
131 (64)
34 (16)
83 (41)
27 (13)
56 (27)
50 (25)
90 (44)
2038 (1000)

BOTH SEXES
2000
39 (19)
1052 (527)
296 (148)
08 (04)
109 (55)
123 (61)
28 (14)
90 (45)
34 (17)
57 (29)
42 (21)
96 (48)
1995 (1000)

2001
36 (18)
1100 (531)
307 (148)
13 (06)
116 (56)
125 (60)
33 (16)
100 (48)
25 (12)
68 (33)
40 (19)
87 (42)
2071 (1000)

2002
37 (18)
1110 (531)
294 (141)
10 (05)
129 (62)
133 (64)
36 (17)
104 (50)
21 (10)
63 (30)
34 (16)
95 (46)
2090 (1000)

Total
35 (17)
1077 (534)
294 (146)
09 (05)
110 (55)
127 (63)
31 (15)
93 (46)
27 (13)
58 (29)
42 (21)
89 (44)
2016 (1000)

ALL SITES ASR BOTH SEXES


2000

1998

1999

894%

975%

955%

Population data provided for 5 year(s)


Mon Nov 26 2007

2001

2002

991%

1000%

73

Comparability and quality of data


Figure 5.1
Age-specific
rates forIXmajor
diagnosis
- linear
Figure
5.1 CI5 Volume
(Editorial
Table groups
2a)

ELSEWHERE (1998-2002)

Age-specific rates for major diagnosis groups - linear


Oesophagus

Stomach

Colon, rectum and anal canal

1000 -

6000 -

3000 -

800 -

5000 -

2500 -

4000 -

2000 -

3000 -

1500 -

2000 -

1000 -

1000 -

500 -

600 400 200 00

5-

15- 25- 35- 45- 55- 65- 75- 85+


Liver

00

5-

15- 25- 35- 45- 55- 65- 75- 85+


Pancreas

1000 -

4000 -

5-

15- 25- 35- 45- 55- 65- 75- 85+


Lung

33

5-

15- 25- 35- 45- 55- 65- 75- 85+


Prostate

5-

15- 25- 35- 45- 55- 65- 75- 85+


Leukaemia

5-

15- 25- 35- 45- 55- 65- 75- 85+

8000 -

800 -

3000 -

00

6000 -

600 2000 -

4000 400 -

1000 -

00

2000 -

200 -

5-

15- 25- 35- 45- 55- 65- 75- 85+


Breast

00

5-

15- 25- 35- 45- 55- 65- 75- 85+


Cervix uteri

500 -

800 -

2000 -

400 -

600 -

00

1500 -

300 400 -

1000 200 -

200 -

00

500 -

100 -

5-

15- 25- 35- 45- 55- 65- 75- 85+


Hodgkins disease

00

20 -

400 -

15 -

300 -

5- 15- 25- 35- 45- 55- 65- 75- 85+


Non-Hodgkin lymphoma

00
250 200 150 -

10 -

200 100 -

05 -

00

74

100 -

5-

15- 25- 35- 45- 55- 65- 75- 85+

00

50 -

5-

15- 25- 35- 45- 55- 65- 75- 85+


Mon Nov 26 2007

00

Comparability and quality of data


Figure 5.2 Age-specific
for major
- logarithmic scale
Figure 5.2rates
CI5 Volume
IXdiagnosis
(Editorial groups
Table 2b)

ELSEWHERE (1998-2002)

Age-specific rates for major diagnosis groups - logarithmic scale


Oesophagus

860

01
3300

01
690

01
20

01

5-

15- 25- 35- 45- 55- 65- 75- 85+


Liver

5-

15- 25- 35- 45- 55- 65- 75- 85+


Breast

5-

15- 25- 35- 45- 55- 65- 75- 85+


Hodgkins disease

5-

15- 25- 35- 45- 55- 65- 75- 85+

Stomach

5200

01
970

01
490

5-

15- 25- 35- 45- 55- 65- 75- 85+


Pancreas

5-

15- 25- 35- 45- 55- 65- 75- 85+


Cervix uteri

02

5- 15- 25- 35- 45- 55- 65- 75- 85+


340 Non-Hodgkin lymphoma

01

5-

15- 25- 35- 45- 55- 65- 75- 85+


Mon Nov 26 2007

Colon, rectum and anal canal


2800

01
6200

02
1700

01
210

10

5-

15- 25- 35- 45- 55- 65- 75- 85+


Lung

5-

15- 25- 35- 45- 55- 65- 75- 85+


Prostate

5-

15- 25- 35- 45- 55- 65- 75- 85+


Leukaemia

5-

15- 25- 35- 45- 55- 65- 75- 85+

75

76

02
02
02
02
07
14
23
14
07
18
11
07
40
16
04
05
172
172

0-

01
03
06
04
01
01
21
01
06
01
40
07
96
96

502
02
02
02
02
24
08
02
02
20
02
03
09
27
15
02
119
118

1001
02
01
05
01
07
01
02
07
15
02
05
01
08
07
05
02
15
12
16
03
01
120
120

1502
01
03
13
03
07
07
01
02
02
04
07
04
01
02
01
09
01
03
02
17
10
03
01
10
10
13
04
147
144

2001
05
01
03
01
29
01
13
11
16
02
02
01
09
08
06
05
01
06
01
08
03
05
21
10
01
11
01
08
11
02
07
211
206

2505
01
02
105
21
16
63
04
09
22
04
05
07
01
02
10
02
05
10
11
15
15
04
27
05
05
21
07
406
396

3009
06
13
13
11
09
01
47
697
13
120
158
783
74
51
06
10
33
211
17
06
16
01
03
21
01
06
01
04
61
87
36
44
04
07
60
16
06
14
07
43
2723
2702

4502
20
04
15
18
20
22
143
1091
15
197
234
1294
119
115
05
16
79
516
09
05
20
04
09
33
02
16
02
02
135
106
02
44
40
05
07
86
22
07
31
05
73
4592
4559

50-

55-

60-

65-

70-

80-

85+

41
201
41
165
201
41
247
535
603
5146 4118
288
1688 1306
1112
603
2841 2210
1029 1406
618
904
247
301
6134 3515
41
100
82
100
41
41
100
165
402
124
100
1647 1306
82
1482
904
247
201
165
402
165
82
41
100
82
100
741
904
25400 20088
25236 19687

75-

05
09
44
60
35
27
50
18
18
10
45
33
22
60
110
90
100
42
36
80
54
17
29
27
50
18
17
24
57
65
81
50
09
10
18
17
216
420
623
587
853
1782 2601 3509 4338 4365
22
48
70
90
100
299
530
723
831 1405
370
554
798
922 1154
1696 2101 2383 3163 3261
218
337
578
904 1037
198
337
518
560
970
09
03
05
18
17
33
12
40
72
17
150
241
374
380
435
1060 1907 3295 4672 5468
29
24
40
72
84
11
27
25
18
33
26
51
40
36
84
11
03
05
27
15
24
25
27
17
55
89
140
181
234
04
10
09
17
95
212
449
840 1421
02
06
05
09
11
06
10
18
17
09
15
33
242
355
643
994 1154
172
313
304
425
318
03
10
27
57
66
70
172
100
64
66
65
54
84
04
03
15
27
17
11
06
10
17
119
185
160
262
334
29
69
65
99
84
07
12
25
09
68
60
75
99 100
03
05
09
17
03
11
15
35
72
84
117
203
354
587 552
7397 11157 15876 20958 24164
7342 11067 15736 20777 23930

Mon Nov 26 2007

40-

04
07
07
05
02
01
08
08
09
02
02
10
214 372
01
03
43
74
42
75
163 432
05
30
08
30
03
05
06
10
29
84
04
08
05
08
10
12
01
01
01
05
08
07
02
01
03
02
02
01
02
14
47
26
63
22
20
18
36
02
02
01
06
30
43
05
04
05
24
28
01
05
03
11
18
721 1492
713 1485

35-

* Average percentage annual change since volume VIII (1993-1997)


Significant changes (95% confidence level, Miettinen method, page 869 of Volume VI) are marked in bold
Rate 5- is significally different (96 vs 102)
Rate 10- is significally different (118 vs 136)

ALL AGE
AGES UNK
0
3
Lip
0
83
Tongue
0
51
Salivary gland
0
98
Mouth
0
82
Oropharynx
0
80
Nasopharynx
0
81
Hypopharynx
0
12
Pharynx unspecified
0
620
Oesophagus
0
5009
Stomach
0
85
Small intestine
0
1014
Colon
0
1087
Rectum
0
4438
Liver
0
682
Gallbladder etc
0
592
Pancreas
0
23
Peritoneum
0
59
Nose, sinuses etc
0
382
Larynx
0
3368
Bronchus, lung
0
96
Other thoracic organs
0
92
Bone
0
119
Connective tissue
0
15
Mesothelioma
0
2
Kaposis sarcoma
0
42
Melanoma of skin
0
187
Other skin
0
15
Breast
0
455
Prostate
0
47
Testis
0
21
Penis
0
9
Other male genital
0
766
Bladder
0
538
Kidney etc
0
13
Eye
0
264
Brain, nervous system
0
215
Thyroid
0
41
Other endocrine
0
31
Hodgkins disease
0
Non-Hodgkin lymphoma 417
0
97
Multiple myeloma
0
128
Lymphoid leukaemia
233
Myeloid leukaemia
0
5
Monocytic leukaemia
0
1
Other leukaemia
0
55
Leukaemia unspecified
0
433
Other and unspecified
0
22186
All sites
0
21999
All sites but skin
0

SITE

Table
Volume
(editorial
table3a)
3a)
Table
5.35.3
CI5CI5
Volume
IX IX
(Editorial
Table
ELSEWHERE (1998-2002)
ANNUAL INCIDENCE PER 100 000 BY AGE GROUP (YEARS) - MALE
CRUDE
RATE
00
09
05
10
09
08
09
01
65
527
09
107
114
467
72
62
02
06
40
355
10
10
13
02
00
04
20
02
48
05
02
01
81
57
01
28
23
04
03
44
10
13
25
01
00
06
46
2336
2317
00
04
02
04
04
04
04
01
28
228
04
46
49
202
31
27
01
03
17
153
04
04
05
01
00
02
09
01
21
02
01
00
35
24
01
12
10
02
01
19
04
06
11
00
00
03
20
1009
1000

(%)

MV ASR
(%) (W)
1000
0.0
928
1.0
922
0.5
898
1.3
890
0.9
962
0.8
877
1.0
583
0.1
824
8.1
888 59.9
871
1.1
844 12.7
913 13.0
199 49.8
462
9.3
341
7.7
739
0.3
915
0.7
838
4.9
706 46.2
792
1.1
772
1.1
899
1.3
1000
0.2
1000
0.0
976
0.5
947
2.4
800
0.2
796
7.3
936
0.6
1000
0.2
1000
0.1
883 10.2
812
6.1
769
0.2
598
3.0
930
2.2
439
0.5
1000
0.3
930
4.5
938
1.1
984
1.7
979
2.5
1000
0.1
1000
0.0
564
0.7
00
5.9
677 273.7
675 271.3
*CH
V8
-47.5
-72
13.6
-26
50
20
6.5
-10.0
-59
-53
16.5
31
65
-49
-13
-06
-16.0
-10.9
-50
-30
03
-55
-14
-14.9
-50.5
7.1
-77
-3.1
10
1.3
-9.4
-9.0
02
-33
-13.3
-20
100
12.4
1.5
27
52
111
46
15.4
-31.1
92
-12.0
-2.9
-2.9

ICD
(10th)
C00
C01-02
C07-08
C03-06
C09-10
C11
C12-13
C14
C15
C16
C17
C18
C19-21
C22
C23-24
C25
C48
C30-31
C32
C33-34
C37-38
C40-41
C47,49
C45
C46
C43
C44
C50
C61
C62
C60
C63
C67
C64-66,68
C69
C70-72
C73
C74-75
C81
C82-85,96
C88,90
C91
C92
C93
C94
C95
O&U
ALL
ALLb

Comparability and quality of data

Table
5.4 Volume
CI5 Volume
IX (editorial
table
Table
5.4 CI5
IX (Editorial
Table
4) 4)
ELSEWHERE (1998-2002)
Quality indicators
MALE
SITE

Mouth & pharynx


Oesophagus
Stomach
Colon, rectum, anus
Liver
Pancreas
Larynx
Lung, trachea, bronchus
Pleura & other thoracic
Melanoma of skin
Prostate
Testis
Kidney & urinaryNOS
Bladder
Brain & nervous sytem
Thyroid
Lymphoma
Leukaemia
Ill-defined (18%)
All sites but skin

Cases

490
620
5009
2101
4438
592
382
3368
96
42
455
47
538
766
264
215
545
422
399
21999

ASR (l-u)

58
(48 - 69)
8.1
(6.9 - 9.5) <
599
(463 - 775)
258
(186 - 356)
498
(364 - 682)
77
(68 - 88)
4.9
(4.1 - 5.8) <
462
(385 - 553)
11
(09 - 15)
05
(04 - 07)
73
(58 - 92)
06
(05 - 08)
61
(48 - 78)
102
(88 - 117)
30
(25 - 34)
2.2
(1.8 - 2.8) >
59
(46 - 77)
5.1
(4.6 - 5.6) >
5.3
(3.8 - 7.4) <
271.3 (258.7 - 284.6) <

ASR v8 MV(%) MV v8(%) DCO(%) M/I(%) UB(%) ICD-10

60
100
725
219
594
79
58
513
11
04
71
06
69
101
32
16
53
40
86
3008

90.4 >
82.4 >
88.8 >
88.0 >
19.9 <
341
83.8 >
70.6 >
792
97.6 <
796
936
812
883
598
93.0 >
936
927
471
67.5 >

829
763
835
816
279
410
696
653
719
1000
831
955
776
869
559
784
976
920
531
649

24
48
33
27
55
91
47
61
73
24
24
13
30
129
05
35
64
80
46

41.2 <
824
535
374
788
1019
675
874
39.6 <
59.5 <
424
213
355
316
88.3 >
167
54.5 >
70.9 <
514
648

C00-14
C15
C16
C18-21
C22
C25
C32
C33-34
C37-38
C43
C61
C62
C64-66,68
C67
C70-72
C73
C81-85,90,88,96
C91-95
C76-80
ALLb

FEMALE
SITE

Mouth & pharynx


Oesophagus
Stomach
Colon, rectum, anus
Liver
Pancreas
Larynx
Lung, trachea, bronchus
Pleura & other thoracic
Melanoma of skin
Breast
Cervix
Corpus & uterus NOS
Ovary
Kidney & urinaryNOS
Bladder
Brain & nervous sytem
Thyroid
Lymphoma
Leukaemia
Ill-defined (22%)
All sites but skin

Cases

197
75
2617
1665
1582
411
58
1303
50
38
2540
1812
335
565
264
176
218
989
424
316
375
17248

ASR (l-u)

18
(14 - 23)
0.7
(0.6 - 0.9) <
23.9 (19.8 - 28.8) <
154
(134 - 177)
149
(120 - 186)
38
(30 - 49)
06
(04 - 07)
122
(105 - 141)
0.5
(0.3 - 0.6) >
03
(03 - 04)
21.2 (20.1 - 22.4) >
15.3 (13.0 - 17.9) <
30
(26 - 33)
51
(44 - 59)
26
(20 - 34)
17
(14 - 21)
2.1
(1.8 - 2.6) <
8.5
(7.0 - 10.4) >
41
(34 - 50)
3.3
(2.9 - 3.8) >
35
(24 - 51)
156.4 (148.1 - 165.2) <

ASR v8 MV(%) MV v8(%) DCO(%) M/I(%) UB(%) ICD-10

19
12
304
144
171
45
07
124
03
03
186
211
30
48
21
20
30
61
39
23
45
1668

848
640
85.5 >
84.4 >
19.7 <
294
72.4 >
59.2 >
820
100.0 <
95.6 >
93.4 >
85.4 >
876
754
744
523
95.0 >
943
949
477
75.7 >

827
644
796
800
237
300
333
497
692
1000
892
890
538
826
731
763
509
852
973
945
517
704

66
160
55
39
76
78
172
90
20
13
13
116
16
27
62
151
08
33
38
107
47

365
813
587
431
742
981
862
881
38.0 <
42.1 <
210
225
657
460
394
449
83.0 >
74
46.5 >
64.6 <
515
499

C00-14
C15
C16
C18-21
C22
C25
C32
C33-34
C37-38
C43
C50
C53
C54-55
C56
C64-66,68
C67
C70-72
C73
C81-85,90,88,96
C91-95
C76-80
ALLb

Data compared to: ELSEWHERE (1993-1997) (Published in CI5 Volume VIII)

77
Mon Nov 26 2007

Comparability and quality of data

Table 5.4a CI5 Volume IX (editorial table 4)


Group A (1998-2002)
CI5 volume 9 (Editorial sheet 4)
Quality indicators
MALE
SITE

Mouth & pharynx


Oesophagus
Stomach
Colon, rectum, anus
Liver
Pancreas
Larynx
Lung, trachea, bronchus
Pleura & other thoracic
Melanoma of skin
Prostate
Testis
Kidney & urinaryNOS
Bladder
Brain & nervous sytem
Thyroid
Lymphoma
Leukaemia
Ill-defined (26%)
All sites but skin

Cases

1252
600
1825
7808
388
1403
534
6516
93
2305
14669
1171
1652
3889
955
247
2964
1817
1412
53499

ASR (l-u)

76
(58 - 99)
33
(30 - 36)
9.1
(8.0 - 10.4) <
407
(379 - 438)
21
(16 - 26)
73
(60 - 90)
30
(25 - 36)
355
(252 - 499)
06
(04 - 08)
142
(111 - 181)
76.0 (61.2 - 94.3) >
9.6
(8.5 - 10.8) >
95
(74 - 121)
196
(159 - 241)
6.7
(5.9 - 7.5) <
16
(13 - 20)
178
(157 - 202)
11.0 (10.0 - 12.1) >
6.8
(5.3 - 8.6) <
2938 (2821 - 3059)

ASR v8 MV(%) MV v8(%) DCO(%) M/I(%) UB(%) ICD-10

82
33
116
396
17
75
33
364
05
143
609
82
103
213
78
15
163
81
91
2825

991
963
965
961
83.5 <
609
99.4 >
87.4 <
763
99.7 <
92.1 <
996
86.1 <
979
85.0 >
984
97.5 >
93.3 >
60.7 <
91.7 >

989
940
963
964
890
642
975
903
758
1000
952
995
890
984
752
987
841
601
661
913

07
03
04
21
17
10
32
00
10
10
02
04
04
05
49
35
09

407
887
814
50.1 <
781
963
324
886
92.5 >
281
36.8 <
43
513
320
77.7 >
263
54.9 <
43.0 <
1002
52.3 <

00
01
00
00
00
01
01
00

C00-14
C15
C16
C18-21
C22
C25
C32
C33-34
C37-38
C43
C61
C62
C64-66,68
C67
C70-72
C73
C81-85,90,88,96
C91-95
C76-80
ALLb

FEMALE
SITE

Mouth & pharynx


Oesophagus
Stomach
Colon, rectum, anus
Liver
Pancreas
Larynx
Lung, trachea, bronchus
Pleura & other thoracic
Melanoma of skin
Breast
Cervix
Corpus & Uterus NOS
Ovary
Kidney & urinaryNOS
Bladder
Brain & nervous sytem
Thyroid
Lymphoma
Leukaemia
Ill-defined (36%)
All sites but skin

Cases

655
252
1192
8066
250
1633
96
3761
41
2472
12521
1524
2813
2343
1078
1341
736
649
2670
1278
1757
49387

ASR (l-u)

32
(26 - 40)
1.0
(0.9 - 1.2) >
4.4
(3.7 - 5.3) <
327
(267 - 401)
11
(08 - 15)
58
(48 - 71)
0.5
(0.4 - 0.6) <
192
(151 - 244)
02
(01 - 02)
146
(111 - 191)
71.0 (65.2 - 77.3) >
10.0
(8.3 - 12.1) <
144
(130 - 159)
128
(101 - 162)
48
(37 - 63)
54
(39 - 75)
4.8
(4.2 - 5.4) <
42
(39 - 46)
129
(110 - 153)
6.7
(5.9 - 7.5) >
58
(40 - 84)
2464 (2356 - 2576)

Data compared to: Group A (1993-1997) (Published in CI5 Vol8)

78

ASR v8 MV(%) MV v8(%) DCO(%) M/I(%) UB(%) ICD-10

32
08
55
327
09
58
06
166
02
161
632
122
138
132
55
55
65
43
110
54
77
2413

989
956
941
945
772
50.0 <
958
87.1 <
610
99.8 <
984
996
985
940
79.0 <
956
77.3 >
985
96.1 >
95.5 >
57.1 <
92.0 >

987
930
937
942
750
589
990
896
759
1000
985
993
980
950
861
960
691
980
831
543
646
910

04
07
05
24
27
09
73
03
02
07
12
06
10
02
07
25
65
08

411
841
852
49.7 <
892
976
417
830
976
163
29.4 <
356
23.1 <
678
564
417
76.1 >
193
54.7 <
52.0 <
1007
49.1 <

00
02
01
02
00

C00-14
C15
C16
C18-21
C22
C25
C32
C33-34
C37-38
C43
C50
C53
C54-55
C56
C64-66,68
C67
C70-72
C73
C81-85,90,88,96
C91-95
C76-80
ALLb

88,96

88,96

Comparability and quality of data

Table 5.4b CI5 Volume IX (editorial table 4)


Group B (1998-2002)
CI5 volume 9 (Editorial sheet 4)
Quality indicators
MALE
SITE

Mouth & pharynx


Oesophagus
Stomach
Colon, rectum, anus
Liver
Pancreas
Larynx
Lung, trachea, bronchus
Pleura & other thoracic
Melanoma of skin
Prostate
Testis
Kidney & urinaryNOS
Bladder
Brain & nervous sytem
Thyroid
Lymphoma
Leukaemia
Ill-defined (50%)
All sites but skin

Cases

5006
2406
5895
6570
585
1315
2542
6525
148
1392
16155
740
1469
3309
1796
861
3887
2029
3541
70229

ASR (l-u)

23.9 (21.0 - 27.2) <


12.0 (10.4 - 13.8) <
29.4 (26.7 - 32.4) <
328
(273 - 393)
2.9
(2.2 - 3.8) >
66
(57 - 75)
12.8 (11.4 - 14.4) <
33.5 (31.0 - 36.2) <
07
(05 - 09)
6.5
(5.8 - 7.3) >
84.8 (71.4 - 100.7) >
2.7
(2.3 - 3.0) >
72
(62 - 83)
168
(130 - 218)
80
(76 - 85)
3.6
(3.4 - 3.9) >
178
(169 - 188)
9.1
(8.7 - 9.6) <
17.3 (15.3 - 19.5) <
346.6 (339.6 - 353.8) <

ASR v8 MV(%) MV v8(%) DCO(%) M/I(%) UB(%) ICD-10

283
150
398
342
19
68
176
440
05
53
666
23
66
206
80
31
181
102
225
3733

85.5 >
78.1 >
79.5 >
81.8 >
94.7 <
360
81.5 >
66.9 >
547
996
83.8 >
76.5 <
74.1 >
858
584
85.9 <
994
991
442
79.0 >

811
685
711
768
1000
352
730
597
400
998
776
852
654
840
612
911
998
997
436
735

49
93
84
62
12
270
68
138
216
53
20
91
47
149
12
222
76

35.3 >
65.1 >
55.1 >
37.9 >
209.9 <
927
473
72.8 >
743
200
20.4 <
134
337
26.6 >
61.5 >
78
358
51.0 >
401
416

C00-14
C15
C16
C18-21
C22
C25
C32
C33-34
C37-38
C43
C61
C62
C64-66,68
C67
C70-72
C73
C81-85,90,88,96
C91-95
C76-80
ALLb

FEMALE
SITE

Mouth & pharynx


Oesophagus
Stomach
Colon, rectum, anus
Liver
Pancreas
Larynx
Lung, trachea, bronchus
Pleura & other thoracic
Melanoma of skin
Breast
Cervix
Corpus & Uterus NOS
Ovary
Kidney & urinaryNOS
Bladder
Brain & nervous sytem
Thyroid
Lymphoma
Leukaemia
Ill-defined (47%)
All sites but skin

Cases

1682
621
3600
7518
300
1449
486
3247
154
1687
22598
6028
2940
3197
925
1299
1716
4399
3656
1739
3662
77358

ASR (l-u)

5.9
(4.8 - 7.3) <
2.2
(1.9 - 2.6) <
12.4 (11.0 - 13.9) <
263
(219 - 315)
11
(08 - 16)
50
(44 - 57)
18
(14 - 23)
11.7 (10.8 - 12.6) <
0.6
(0.4 - 0.8) >
57
(44 - 75)
808
(741 - 881)
21.1 (20.2 - 22.0) <
10.7
(8.6 - 13.3) <
116
(99 - 135)
34
(30 - 40)
45
(31 - 64)
63
(59 - 67)
14.9 (12.4 - 17.8) >
130
(121 - 139)
6.4
(6.0 - 6.8) <
12.7 (11.2 - 14.4) <
273.8 (267.9 - 279.8) <

ASR v8 MV(%) MV v8(%) DCO(%) M/I(%) UB(%) ICD-10

74
30
156
270
09
55
20
131
03
46
876
263
154
120
34
46
67
107
130
74
166
3022

795
75.0 >
77.9 >
81.0 >
91.3 <
382
745
66.6 >
63.0 >
100.0 <
82.2 >
856
762
74.4 >
74.3 >
791
53.6 <
86.3 <
996
99.4 <
448
78.5 >

793
684
691
739
1000
335
717
598
387
1000
788
842
765
690
662
747
612
919
996
1000
457
752

55
106
96
70
40
289
49
142
136
46
41
83
91
86
62
161
07
214
71

221
548
502
368
2800
927
286
65.5 >
591
172
228
24.9 >
40.1 >
383
330
273
59.3 >
33
366
529
404
345

C00-14
C15
C16
C18-21
C22
C25
C32
C33-34
C37-38
C43
C50
C53
C54-55
C56
C64-66,68
C67
C70-72
C73
C81-85,90,88,96
C91-95
C76-80
ALLb

Data compared to: Group B (1993,1997) (Submitted for CI5 Vol8 - Not published)

79
Mon Nov 26 16:51:38 CET 2007

Comparability and quality of data

Table 5.4c CI5 Volume IX (editorial table 4)


Group C, Example 1 (1998-2002)
CI5 volume 9 (Editorial sheet 4)
Quality indicators
MALE
SITE

Mouth & pharynx


Oesophagus
Stomach
Colon, rectum, anus
Liver
Pancreas
Larynx
Lung, trachea, bronchus
Pleura & other thoracic
Melanoma of skin
Prostate
Testis
Kidney & urinaryNOS
Bladder
Brain & nervous sytem
Thyroid
Lymphoma
Leukaemia
Ill-defined (41%)
All sites but skin

Cases
93
125
59
75
100
12
14
46
1
9
262
7
23
29
10
11
198
33
90
2173

ASR (l-u)

64
(49 - 83)
141
(116 - 171)
62
(41 - 94)
75
(59 - 96)
87
(57 - 133)
12
(09 - 16)
14
(11 - 18)
48
(39 - 61)
0.0
(0.0 - 0.0) <
0.9
(0.7 - 1.1) <
376
(302 - 468)
06
(05 - 08)
08
(06 - 12)
30
(22 - 41)
06
(04 - 10)
05
(04 - 07)
8.4
(7.1 - 9.9) >
1.3
(0.9 - 1.9) >
69
(50 - 96)
1536 (1453 - 1624)

ASR v8 MV(%) MV v8(%) DCO(%) M/I(%) UB(%) ICD-10

60
132
70
77
65
10
13
39
03
13
371
05
12
29
08
06
71
09
91
1581

65.6 <
56.0 >
424
587
400
167
571
652
100.0 <
100.0 >
57.6 <
714
783
517
500
54.5 <
818
100.0 >
556
67.1 <

805
396
509
588
365
250
900
606
1000
909
772
500
727
529
636
1000
814
783
688
742

C00-14
C15
C16
C18-21
C22
C25
C32
C33-34
C37-38
C43
C61
C62
C64-66,68
C67
C70-72
C73
C81-85,90,88,96
C91-95
C76-80
ALLb

FEMALE
SITE

Mouth & pharynx


Oesophagus
Stomach
Colon, rectum, anus
Liver
Pancreas
Larynx
Lung, trachea, bronchus
Pleura & other thoracic
Melanoma of skin
Breast
Cervix
Corpus & Uterus NOS
Ovary
Kidney & urinaryNOS
Bladder
Brain & nervous sytem
Thyroid
Lymphoma
Leukaemia
Ill-defined (33%)
All sites but skin

Cases
61
78
64
89
73
6
6
40
3
16
332
649
57
114
17
17
14
26
156
29
92
2777

ASR (l-u)

33
(22 - 49)
8.4
(6.4 - 11.1) <
69
(51 - 93)
81
(63 - 105)
58
(47 - 72)
0.4
(0.3 - 0.5) <
0.3
(0.2 - 0.5) <
3.8
(2.9 - 5.0) >
0.2
(0.2 - 0.3) <
1.4
(1.1 - 1.8) <
23.4 (20.8 - 26.4) >
45.8 (42.8 - 49.1) >
54
(45 - 66)
81
(58 - 114)
0.4
(0.3 - 0.5) <
1.8
(1.4 - 2.3) >
0.7
(0.5 - 1.0) >
1.5
(1.2 - 1.9) <
64
(53 - 78)
14
(09 - 21)
79
(54 - 115)
1714 (1618 - 1815)

ASR v8 MV(%) MV v8(%) DCO(%) M/I(%) UB(%) ICD-10

47
122
55
73
60
11
11
23
05
20
207
417
54
63
15
12
04
46
61
16
68
1699

689
474
453
640
288
167
667
700
667
938
684
592
719
491
706
647
35.7 <
923
788
100.0 >
50.0 <
65.9 <

Data compared to: Group C, Example 1 (1993-1997) (Published in CI5 Vol8)


No mortality data to compare to

80
Mon May 14 11:04:27 CEST 2007

721
418
447
672
390
222
875
652
600
615
634
639
833
547
727
250
1000
809
799
625
675
690

03
00

C00-14
C15
C16
C18-21
C22
C25
C32
C33-34
C37-38
C43
C50
C53
C54-55
C56
C64-66,68
C67
C70-72
C73
C81-85,90,88,96
C91-95
C76-80
ALLb

88,96

88,96

Comparability and quality of data

Table 5.4c (contd). CI5 Volume IX (editorial table 4)


Group C, Example 2 (1998-2002)
CI5 volume 9 (Editorial sheet 4)
Quality indicators
MALE
SITE

Mouth & pharynx


Oesophagus
Stomach
Colon, rectum, anus
Liver
Pancreas
Larynx
Lung, trachea, bronchus
Pleura & other thoracic
Melanoma of skin
Prostate
Testis
Kidney & urinaryNOS
Bladder
Brain & nervous sytem
Thyroid
Lymphoma
Leukaemia
Ill-defined (07%)
All sites but skin

Cases
83
254
431
272
440
91
14
600
7
2
16
8
24
73
46
11
48
52
17
2586

ASR (l-u)

64
(56 - 73)
202
(169 - 242)
32.1 (29.2 - 35.2) <
209
(169 - 257)
338
(261 - 437)
71
(56 - 90)
11
(09 - 13)
467
(422 - 517)
0.6
(0.5 - 0.7) <
0.1
(0.1 - 0.2) <
1.4
(1.3 - 1.5) <
0.7
(0.6 - 0.8) >
1.8
(1.5 - 2.2) >
59
(48 - 72)
40
(29 - 56)
1.0
(0.7 - 1.4) >
43
(29 - 64)
58
(39 - 86)
1.3
(1.1 - 1.6) >
2027 (1567 - 2621)

ASR v8 MV(%) MV v8(%) DCO(%) M/I(%) UB(%) ICD-10

56
207
389
218
367
60
10
441
07
04
19
04
10
61
47
06
43
54
03
2097

964
77.2 <
90.7 <
967
20.0 >
308
100.0 <
32.5 >
286
100.0 <
562
100.0 <
625
973
543
72.7 <
100.0 <
100.0 <
88.2 >
613

984
898
970
988
103
190
1000
256
250
1000
688
1000
700
923
458
1000
1000
1000
613

12
05
04
05
05
118
05

C00-14
C15
C16
C18-21
C22
C25
C32
C33-34
C37-38
C43
C61
C62
C64-66,68
C67
C70-72
C73
C81-85,90,88,96
C91-95
C76-80
ALLb

FEMALE
SITE

Mouth & pharynx


Oesophagus
Stomach
Colon, rectum, anus
Liver
Pancreas
Larynx
Lung, trachea, bronchus
Pleura & other thoracic
Melanoma of skin
Breast
Cervix
Corpus & Uterus NOS
Ovary
Kidney & urinaryNOS
Bladder
Brain & nervous sytem
Thyroid
Lymphoma
Leukaemia
Ill-defined (07%)
All sites but skin

Cases
33
70
156
242
174
82
2
182
5
4
199
33
17
47
11
15
45
20
23
41
11
1507

23
48
10.6
178
126
5.4
0.2
13.0
0.4
0.3
14.7
2.4
1.2
3.7
0.8
1.0
3.6
15
25
4.5
0.8
1109

ASR (l-u)

(18 - 29)
(37 - 62)
(9.0 - 12.5) <
(138 - 230)
(103 - 155)
(4.5 - 6.5) >
(0.1 - 0.2) >
(11.7 - 14.4) >
(0.3 - 0.4) >
(0.2 - 0.3) <
(13.3 - 16.3) >
(2.0 - 2.9) >
(1.1 - 1.4) <
(2.9 - 4.8) >
(0.7 - 1.0) >
(0.8 - 1.3) >
(2.6 - 5.1) >
(11 - 19)
(18 - 33)
(3.2 - 6.4) >
(0.7 - 0.9) >
(907 - 1356)

ASR v8 MV(%) MV v8(%) DCO(%) M/I(%) UB(%) ICD-10

22
53
157
179
145
34
01
110
01
03
91
12
29
23
06
07
24
12
19
30
01
1037

93.9 <
843
81.4 <
971
16.7 >
256
100.0 <
32.4 >
60.0 >
100.0 <
995
100.0 <
882
100.0 >
727
867
511
95.0 <
100.0 <
100.0 <
81.8 >
711

1000
909
947
990
48
220
1000
212
1000
981
1000
812
889
500
875
615
1000
1000
1000
704

29
06
06
05
22
91
05

C00-14
C15
C16
C18-21
C22
C25
C32
C33-34
C37-38
C43
C50
C53
C54-55
C56
C64-66,68
C67
C70-72
C73
C81-85,90,88,96
C91-95
C76-80
ALLb

Data compared to: Group C, Example 2 (1993-1997) (Published in CI5 Vol8)

81
Wed Oct 17 14:27:31 CEST 2007

Comparability and quality of data


Figure
Population
pyramids
Figure 5.3
CI55.3
Volume
IX (Editorial
Table 5)

ELSEWHERE (1998-2002)
Population Pyramids

1991
4858
11960
22130
40124
67116
90928
109406
140564
173728
166700
161440
174945
180112
173127
132279
134001
113899
1899314
Vol 8: 1928923
(V9/V8: 98%)

50%

85+
80757065605550454035302520151050MALE

FEMALE

Population data provided for 5 year(s)

82
Mon Nov 26 2007

50%

8331
13150
25783
40346
54648
74145
91724
108644
140952
179626
170615
160355
168065
170870
161110
118404
114291
100458
1901520
Vol 8: 1930295
(V9/V8: 98%)

95

Comparability and quality of data

Figure
5.45.4
CI5
Volume
ProcessSummary
Figure
CI5
VolumeIXIX Data
Data Process-Summary
Registry number: 441099
Registry name: Elsewhere Cancer Registry
Date: 20/03/2007
Files submitted:
Case listing

Population

Mortality

Data originally re-coded/coded according to ICDO-3. yes

No

Data originally coded according to:


Topography:.ICD9

ICD10

Morphology: M-ICDO-1
Re-code performed by:registry

or

Validity of single records checked (IARCcrgTools)

T-ICDO-2

Other

M-ICDO-2

Other

IARC
by registry & confirmed
by IARC
Data-check list

Date:

Multiple Primaries
ICDO-3 (2004) by IARC-DEP (IARCcrgTools) on historical data ..
ICDO-3 (2004) by IARC-DEP (IARCcrgTools) only on the CI5 IX period ..
Years ..

1998-2002

Remarks

DATA VALIDATED

yes

No

83

Comparability and quality of data

Table 5.5 Multiple primary rules for the years 19982002


ICD-O-1

ICD-O-2

ICD-O-3
2000

ICD-O-2 +
ICD-O-3
2000

ICD-O-3
2004

Others

N/A

Africa (5)

South and Central America (11)

North America (54)

29

13

Europe (100)

28

12

25

22

55
(24.4%)

26
(11.6%)

46
(20.4%)

39
(17.3%)

42
(18.7%)

Continents
(No. of registries)

Asia (44)

Oceania (11)

14

6
(2.7%)

Total (225)

5
0
11
(4.9%)

Table 5.6 Screening program as data source


Cases with Distinguish
Necropsy
DCN

Continents
(No. of registries)
Cervix

Breast Prostate

Colorectal

Melanoma

Lung

Mouth

Others

Yes

Yes

Africa (5)

South and Central America (11)

10

North America (54)

35

36

51

20

Asia (44)

18

16

13

12

21

31

Europe (100)

45

59

14

86

53

Oceania (11)

8
(3.6%)

6
(2.7%)

14
(6.2%)

175
(77.8%)

116
(51.6%)

Total (225)

118
124
13
33
10
(52.4%) (55.1%) (5.8%) (14.7%) (4.4%)

Table 5.8 Summary of applied inclusion criteria for comparability and quality of data in Volume IX
Group A

Group B

Group C

Excluded

Complete coverage

No access to death certificates

No ad hoc study of
completeness

Data with <2 years

Death reporting meets WHO


recommendations

Official mortality data not


available by cause, or poor
quality by cause

No death clearance as source of


case finding

10% < %Unk <20%


10% < DCO <20%
10% < ill defined <20%
10% < age unk <20%
75% < MV% <80%

DCO >20%
%Unk >20%
ill-defined site >20%;
overall MV% <75%

No official mortality data

MV% too high (99100%)


MV% low for selected sites;
M/I threshold by site

%Unk <10%
DCO <10%
Ill-defined site <10%
MV% >80%
DCO 0.0% (no DCOs)*
No abrupt trends, cases;
Denominators OK

MV% but C22**


MV% but C91-95***

Implausible incidence rates;


Specialized registries, e.g.
childhood, mesothelioma

*No DCO cases due to complete trace back for the DCN cases; **C22: liver cancer; ***C91-95: leukaemia.

84

Other

ICDO-3 (2004)

ICDO-2

Ecuador, Quito

Canada, Northwest Territories

Canada, Newfoundland and Labrador

Canada, New Brunswick

Canada, Manitoba

Canada, British Columbia

Canada, Alberta

Canada

North America

Peru, Trujillo

France, Martinique

Costa Rica

ICDO-2 and ICDO-3


(2004)

ICDO-2 and ICDO-3


(2000)

SEER rules

ICDO-2 and ICDO-3


(2000)

Other

ICDO-3 (2004)

ICDO-2 and ICDO-3


(2000)

ICDO-3 (2000)

ICDO-2

ICDO-3 (2000)

ICDO-3 (2004)

Colombia, Cali

Chile, Valdivia

ICDO-2

ICDO-2 and ICDO-3


(2000)

ICDO-2

ICDO-2

ICDO-3 (2004)

ICDO-3 (2000)

ICDO-3 (2000)

ICDO-2

ICDO-1

1998-2002

Brazil, So Paulo

Brazil, Goinia

Brazil, Cuiaba

Brazil, Brasilia

Argentina, Bahia Blanca

South and Central America

Zimbabwe, Harare

Uganda, Kyadondo County

Tunisia, Central Region

Egypt, Gharbiah

Algeria, Setif

Africa

Registry

MP rules

No

Yes

Yes

No

Yes

Yes

No

No

Yes

Yes

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

No

Yes

Yes

Cervix

No

Yes

Yes

Yes

Yes

Yes

No

No

Yes

No

Yes

No

Yes

No

Yes

No

No

Yes

Yes

No

No

No

No

Breast

No

No

No

Yes

No

No

No

No

No

No

Yes

No

No

No

No

No

No

Yes

No

No

No

No

No

Prostate

No

No

No

No

No

No

No

No

No

No

Yes

No

No

No

No

No

No

No

No

No

No

No

No

Colorectal

No

No

No

No

No

No

No

No

No

No

Yes

No

No

No

No

No

No

No

No

No

No

No

No

Melanoma

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

Lung

Screening programme as data source

Table 5.7 Registration practices

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

Mouth

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

NA

No

No

No

No

Others

No

Yes

No

Yes

Yes

No

Yes

Yes

No

No

No

Yes

No

Yes

Yes

No

No

Yes

Yes

Yes

Yes

Yes

No

Necropsy

NK

0.69

0.3

NK

0.42

NK

NK

0.6

12

NK

NK

<1

Necropsy
(%)

Cases with

Yes

No

No

NA

No

Yes

No

Yes

NA

Yes

Yes

No

No

Yes

Yes

No

Yes

No

Yes

No

No

Yes

No

DCN

NK

NA

0.3

86.3

NA

8.2

1.75

9.6

4.23

60

10

5.5

DCN%

Distinguish

Comparability and quality of data

85

86
Other

SEER rules

USA, Louisiana

ICDO-2 and ICDO-3


(2000)

SEER rules

USA, Kentucky

SEER rules

ICDO-2 and ICDO-3


(2000)

ICDO-3 (2004)

ICDO-2 and ICDO-3


(2000)

ICDO-3 (2000)

NA

ICDO-2, ICDO-3
(2000) and SEER rules

ICDO-2 and ICDO3(2000)

No

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

No

ICDO-2, ICDO-3
(2000) and SEER rules

Yes

No

Yes

Yes

NA

USA, Indiana

USA, Iowa

No

Yes

NA

ICDO-2 and ICDO-3


(2000)

SEER rules

ICDO-2 and ICDO-3


(2000)

ICDO-2 and ICDO-3


(2000)

ICDO-3 (2004)

No

Yes

ICDO-2 and ICDO-3


(2000)

ICDO-3 (2004)

Cervix

1998-2002

ICDO-2 and ICDO-3


(2000)

USA, Illinois

USA, Idaho

USA, Georgia, Atlanta

USA, Georgia

USA, Florida

USA, District of Columbia

USA, Connecticut

USA, Colorado

USA, California, Los Angeles County

USA, California, Greater San Francisco


Bay Area

USA, California

USA, Arizona

USA, Alaska

USA, Alabama

Canada, Saskatchewan

Canada, Prince Edward Island

Canada, Ontario

Canada, Nova Scotia

Registry

MP rules

No

No

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

No

NA

Yes

No

Yes

Yes

Yes

No

Yes

Breast

No

No

No

No

No

No

No

No

No

No

Yes

No

No

No

NA

No

No

No

No

NA

No

Yes

Prostate

No

No

No

No

No

No

No

No

No

No

No

No

No

No

NA

No

No

No

No

NA

No

No

Colorectal

No

No

No

Yes

No

No

No

No

No

No

No

No

No

No

NA

No

No

No

No

NA

No

No

Melanoma

No

No

No

No

No

No

No

No

No

No

No

No

No

No

NA

No

No

No

No

NA

No

No

Lung

Screening programme as data source

Table 5.7 Registration practices

No

No

No

No

No

No

No

No

No

No

NA

No

No

No

NA

No

No

No

No

NA

No

No

Mouth

No

No

No

No

No

No

No

No

No

No

No

No

No

No

NA

No

No

No

No

NA

No

No

Others

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Necropsy

0.2

0.1

NK

NK

NK

NK

NK

NK

<0.5

<3

NK

<1

NK

NK

0.21

0.1

2.6

NK

2.4

NK

<5

<1

Necropsy
(%)

Cases with

No

No

No

Yes

No

No

Yes

No

No

Yes

No

Yes

No

No

NA

No

NA

Yes

No

Yes

No

No

DCN

1.2

5.22

2.7

<1

NA

NA

2.06
(2002)

2.78

DCN%

Distinguish

Comparability and quality of data

ICDO-2 and ICDO-3


(2000)

SEER rules

USA, Vermont

USA, Utah

ICDO-2, ICDO-3
(2000) and SEER rules

ICDO-2, ICDO-3
(2000) and SEER rules

ICDO-2, ICDO-3
(2000) and SEER rules

ICDO-2 and ICDO-3


(2000)

SEER rules

ICDO-2 and ICDO-3


(2000)

ICDO-2 and ICDO-3


(2000)

NA

SEER rules

NA

ICDO-2 and ICDO-3


(2000)

ICDO-2 and ICDO-3


(2000)

ICDO-2 and ICDO-3


(2000)

ICDO-2 and ICDO-3


(2000)

SEER rules

SEER rules

Yes

No

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

No

Yes

Yes

Yes

Yes

No

Yes

Yes

No

No

ICDO-2 and ICDO-3


(2000)

ICDO-2 and ICDO-3


(2000)

Cervix

1998-2002

USA, Texas

USA, South Carolina

USA, SEER

USA, Rhode Island

USA, Pennsylvania

USA, Oregon

USA, Oklahoma

USA, Ohio

USA, NPCR

USA, New York State

USA, New Mexico

USA, New Jersey

USA, Montana

USA, Missouri

USA, Michigan, Detroit

USA, Michigan

USA, Massachusetts

USA, Maine

USA, Louisiana, New Orleans

Registry

MP rules

Yes

No

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

No

Yes

Yes

Yes

Yes

No

Yes

Yes

No

No

Breast

NA

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

Yes

No

No

Prostate

NA

No

No

No

Yes

No

No

No

Yes

Yes

No

No

No

No

No

No

No

No

No

No

Colorectal

NA

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

Melanoma

NA

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

Lung

Screening programme as data source

Table 5.7 Registration practices

NA

No

No

No

No

No

No

No

Yes

No

No

No

No

No

No

No

No

No

No

No

Mouth

NA

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

Others

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Necropsy

0.2

NK

NK

NK

NK

0.1

NK

0.1

1.3

0.001

34

0.1

<1

NK

<5

0.15

0.04

0.2

Necropsy
(%)

Cases with

Yes

No

No

No

No

Yes

No

No

Yes

No

No

No

Yes

Yes

Yes

Yes

Yes

Yes

No

No

DCN

1-2

1.7

1.3

NK

NA

DCN%

Distinguish

Comparability and quality of data

87

88
No
Yes

ICDO-2

ICDO-2 and ICDO-3


(2000)

China, Zhongshan

ICDO-2 and ICDO-3


(2000)

ICDO-2

Japan, Hiroshima

Japan, Fukui Prefecture


Other

NA

ICDO-3 (2000)

Japan, Aichi Prefecture

Israel

ICDO-2

ICDO-2 and ICDO-3


(2000)

ICDO-1

ICDO-2 and ICDO-3


(2000)

India, Trivandrum

India, Poona

India, New Delhi

India, Nagpur

NA

India, Mumbai (Bombay)

India, Karunagappally

ICMR National Cancer


Registry

ICDO-2

India, Chennai (Madras)

Cyprus

China, Shanghai

No

No

No

NA

NA

No

No

No

No

Yes

No

No

No

No

Other

ICDO-3 (2000)

China, Nangang District, Harbin City

China, Jiashan

No

No

Yes

No

Yes

NA

ICDO-2

ICDO-3 (2004)

ICDO-3 (2000)

ICDO-2

No

Yes

ICDO-2 and ICDO-3


(2000)

ICDO-2 and ICDO-3


(2000)

Cervix

1998-2002

China, Hong Kong

China, Guangzhou

Bahrain

Asia

USA, Wisconsin

USA, West Virginia

USA, Washington, Seattle

USA, Washington

Registry

MP rules

No

No

No

NA

NA

No

No

No

No

Yes

No

Yes

No

No

No

No

No

No

Yes

No

Yes

No

Yes

Breast

No

No

No

NA

NA

No

No

No

No

NA

No

No

No

No

No

No

No

No

No

No

NA

No

No

Prostate

No

Yes

No

NA

NA

No

No

No

No

NA

No

No

No

No

No

Yes

No

No

No

No

NA

No

Yes

Colorectal

No

No

No

NA

NA

No

No

No

No

NA

No

No

No

No

No

No

No

No

No

No

NA

No

No

Melanoma

No

No

No

NA

NA

No

No

No

No

NA

No

No

No

No

No

No

No

No

No

No

NA

No

No

Lung

Screening programme as data source

Table 5.7 Registration practices

No

No

No

NA

Yes

No

No

No

No

Yes

No

No

No

No

No

No

No

No

No

No

NA

No

No

Mouth

No

Stomach

No

NA

No

No

No

No

No

Other

No

No

Nasopharynx

No

No

No

No

No

No

No

NA

No

No

Others

Yes

Yes

No

Yes

No

No

No

No

No

No

No

No

Yes

No

No

Yes

Yes

No

No

Yes

Yes

Yes

Yes

Necropsy

NK

<1

<0.01

NK

<0.01

NK

NK

NK

NK

<0.5

Necropsy
(%)

Cases with

No

Yes

NA

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

NA

Yes

Yes

Yes

Yes

No

Yes

Yes

Yes

No

Yes

Yes

DCN

1.7

NA

2.9

42

NA

30

52

NA

5.1

NA

0.08

10

1.94

0.5

9.3

15-25

<1

1-2

DCN%

Distinguish

Comparability and quality of data

ICDO-3 (2004)

Korea, Gwangju

Turkey, Izmir

Turkey, Antalya

Thailand, Songkhla

Thailand, Lampang

Thailand, Chiang Mai

Singapore

Philippines, Manila

Yes

ICDO-2

ICDO-2

ICDO-2 and ICDO-3


(2000)
No

No

Yes

Yes

ICDO-2 and ICDO-3


(2000)

ICDO-2

No

No

No

No

Yes

NA

Yes

Yes

Yes

Yes

No

No

Yes

No

No

No

No

No

Yes

NA

Yes

Yes

Yes

Yes

No

Yes
Yes

No

Yes

Yes

Yes

Yes

No

No

Yes

Yes

Breast

No

Yes

Yes

Yes

ICDO-2

NA

ICDO-2

ICDO-3 (2004)

Pakistan, South Karachi

Oman, Omani

ICDO-3 (2004)

Malaysia, Sarawak

Malaysia, Penang

NA

ICDO-3 (2000)

Korea, Ulsan

ICDO-2

ICDO-3 (2004)

Korea, Seoul

Kuwait

ICDO-3 (2004)

Korea, Jejudo

Korea, Incheon

ICDO-3 (2000)

Korea, Daejeon

ICDO-2 and ICDO-3


(2000)

ICDO-2

ICDO-3 (2000)

Yes

No

Other and ICDO-3


(2004)

ICDO-3 (2000)

No

Yes

Yes

Cervix

ICDO-2

ICDO-2

ICDO-3 (2004)

1998-2002

Korea, Daegu

Korea, Busan

Korea

Japan, Yamagata Prefecture

Japan, Osaka Prefecture

Japan, Nagasaki Prefecture

Japan, Miyagi Prefecture

Registry

MP rules

No

No

No

No

No

No

No

No

No

No

NA

Yes

No

No

No

No

No

No

No

No

No

No

No

No

No

Prostate

No

No

No

No

No

No

No

No

No

No

NA

Yes

Yes

Yes

Yes

No

No

Yes

Yes

Yes

Yes

Yes

No

Yes

Yes

Colorectal

No

No

No

No

No

No

No

No

No

No

No

NA

No

No

No

No

No

No

No

No

No

No

No

No

No

Melanoma

No

No

No

No

No

No

No

No

No

No

No

NA

No

Yes

No

Yes

No

Yes

No

No

No

No

No

Yes

Yes

Lung

Screening programme as data source

Table 5.7 Registration practices

No

No

No

No

No

No

No

No

No

No

NA
Yes

No

No

No

No

No

No

No

No

No

No

No

No

No

Mouth

No

No

No

No

No

No

No

No

No

No

No

NA

Stomach,
liver

No

No

Yes

No

Yes

Yes

Yes

No

No

Yes

Yes

Yes

Yes

No

No

Stomach,
liver
No

No

No

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Necropsy

No

No

Stomach,
liver

No

No

No

Stomach

No

Stomach

Stomach

Others

NK

0.01

10

<1

0.028

NK

NK

NK

NK

<1

5.5 in
2000

NK

NK

Necropsy
(%)

Cases with

NA

Yes

No

Yes

No

Yes

No

Yes

No

Yes

Yes

Yes

Yes

No

Yes

Yes

No

Yes

Yes

No

Yes

Yes

Yes

No

Yes

DCN

NA

NA

0.9

0.1

NA

10

10.4

6.4

5.1

4.6

33.1

12.9

7.9

22

35.1 in
2000

14

DCN%

Distinguish

Comparability and quality of data

89

90

ICDO-2

ICDO-2

Belgium, Antwerp

Belgium, Flanders

Bulgaria

Other

Finland

France, Loire-Atlantique

France, Isere

France, Herault

France, Haut-Rhin

France, Doubs

France, Calvados

France, Bas-Rhin

ICDO-2 and ICDO-3


(2000)

ICDO-2, ICDO-3
(2000) and ICDO-3
(2004)

ICDO-2 and ICDO-3


(2000)

ICDO-2

ICDO-2

ICDO-2, ICDO-3
(2000) and ICDO-3
(2004)

ICDO-3 (2000)

ICDO-2

ICDO-3 (2004)

Denmark

Estonia

ICDO-3 (2000)

Czech Republic

Croatia

ICDO-2, ICDO-3
(2000) and ICDO-3
(2004)

Other

ICDO-2 and ICDO-3


(2000)

Belarus

ICDO-2

ICDO-1 and ICDO-3


(2000)

ICDO-2

1998-2002

Austria, Vorarlberg

Austria, Tyrol

Austria

Europe

Registry

MP rules

No

Yes

No

No

Yes

No

Yes

Yes

No

No

Yes

No

No

Yes

Yes

Yes

No

No

No

Yes

Yes

No

No

Yes

No

No

Yes

No

No
Yes

NA

Yes

Yes

No

Breast

NA

Yes

Yes

No

Cervix

No

No

Yes

No

No

No

NA

No

No

No

No

No

No

No

No

NA

Yes

Yes

No

Prostate

No

Yes

Yes

No

No

No

NA

Yes

No

No

Yes

No

No

No

No

NA

Yes

Yes

No

Colorectal

No

No

No

No

No

No

NA

No

No

No

No

No

No

Yes

No

NA

No

Yes

No

Melanoma

No

No

No

No

No

No

NA

No

No

No

No

No

No

No

No

NA

No

No

No

Lung

Screening programme as data source

Table 5.7 Registration practices

No

No

No

No

No

No

NA

No

No

No

No

No

No

No

No

NA

No

No

No

Mouth

No

No

No

No

No

No

NA

No

No

No

No

No

No

Yes

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Regional
practices
No

No

Yes

Yes

Yes

Yes

Necropsy

No

NA

No

No

No

Others

<1

NA

NA

NK

<1

NA

NK

No

No

No

No

No

No

NA

No

No

No

No

21 in
2002
< 12

NA

Yes

NA

No

No

Yes

Yes

No

DCN

NA

6-8

NA

13

NA

DCN%

Distinguish

<1

0.05

0.2-0.5

<1

15

NK

Necropsy
(%)

Cases with

Comparability and quality of data

ICDO-2 and ICDO-3


(2000)

Other

No
No

ICDO-3 (2004)

ICDO-2 and ICDO-3


(2004)

ICDO-3 (2000)

Italy, Genoa Province

Italy, Macerata Province

Italy, Modena Province

Italy, Ragusa Province

Italy, Parma Province

Italy, North East

Italy, Naples

Italy, Milan

ICDO-3 (2004)

ICDO-3 (2004)

ICDO-1 and ICDO-2


and ICDO-3 (2004)

ICDO-3 (2000)

ICDO-3 (2004)

No

Yes

Yes

Yes

Yes

No

Yes

Yes

ICDO-3 (2004)

ICDO-3 (2004)

Italy, Florence and Prato

Italy, Ferrara Province

No

Yes

No

Yes

ICDO-2

ICDO-3 (2004)

ICDO-2

No

No

ICDO-3 (2004)

ICDO-2

Yes

Italy, Brescia Province

Italy, Biella Province

Ireland

Iceland

Germany, Saarland

Germany, North Rhine-Westphalia:


Mnster

Germany, Munich

ICDO-3 (2004)

No

ICDO-3 (2004)

Germany, Mecklenburg-Western
Pomerania

No

No

Germany, Hamburg

ICDO-3 (2004)

No

ICDO-3 (2004)

ICDO-3 (2004)

No

No

Germany, Free State of Saxony

Germany, Brandenburg

ICDO-3 (2004)

France, Vendee

France, Tarn

No

No

ICDO-2, ICDO-3
(2000) and ICDO-3
(2004)

ICDO-3 (2004)

Cervix

1998-2002

France, Somme

France, Manche

Registry

MP rules

Yes

Yes

Yes

Yes

Yes

Yes

No

Yes since
2000

Yes

Yes

Yes

Yes

No

Yes

No

No

No

No

No

No

No

Yes

No

Yes

No

Breast

No

NA

No

No

NA

No

No

No

Yes

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

Prostate

No

NA

No

No

Yes

No

No

No

Yes

Yes

No

Yes

No

No

No

No

No

No

No

No

No

No

No

No

No

Colorectal

No

NA

No

No

NA

No

No

No

Yes

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

Melanoma

No

NA

No

No

NA

No

No

No

Yes

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

Lung

Screening programme as data source

Table 5.7 Registration practices

No

NA

No

No

NA

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

Mouth

No

NA

No

No

NA

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

Others

No

Yes

Yes

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

No

Yes

Yes

Yes

Yes

No

Yes

Yes

Yes

Necropsy

NK

0.25

0.1

0.07

0.1

<1

0.06

<1

0.02

0.06

NK

NK

<1

<1

NK

0.02

NK

Necropsy
(%)

Cases with

Yes

Yes

Yes

No

Yes

Yes

Yes

No

No

Yes

Yes

No

No

Yes

Yes

Yes

Yes

Yes

No

Yes

Yes

No

No

Yes

Yes

DCN

1.6

1.2

1.3

2.2

1.3

0.1

2.38

10

18

10

NA

NA

NA

29

NK

DCN%

Distinguish

Comparability and quality of data

91

92

ICDO-2

Yes

No

No

ICDO-3 (2000)

ICDO-2 and ICDO-3


(2000)

Spain, Asturias

Spain, Albacete

Slovenia

Slovak Republic

Serbia

Russia, St Petersburg

ICDO-3 (2004)

ICDO-2

ICDO-2 and ICDO-3


(2000)

ICDO-1

ICDO-2

ICDO-3 (2000)

No

No

Yes

No

Yes

Yes

No

Yes

Portugal, South Regional

Portugal, Porto

Other

ICDO-3 (2004)

Poland, Kielce

Poland, Warsaw City

No

Yes

ICDO-3 (2000)

ICDO-2

Yes

ICDO-2 and ICDO-3


(2000)

NA

Yes

No

Yes

ICDO-3 (2004)

ICDO-2

ICDO-2

No

Yes

Poland, Cracow

Norway

The Netherlands, Maastricht

The Netherlands, Eindhoven

The Netherlands

Malta

Lithuania

ICDO-3 (2004)

Latvia

Italy, Veneto Region

ICDO-2

Italy, Varese Province

No

Yes

No

No

No

Yes

Yes

Yes

No

Yes

No

Yes

Yes

Yes

Yes

No

Yes

No

Yes

No

Yes

Yes

ICDO-1 and ICDO-3


(2004)

Italy, Umbria Region


No

Yes

Yes

Yes

ICDO-1

Yes

Italy, Torino

ICDO-3 (2004)

Yes since
2000

Yes

Yes

Yes

Yes

Breast

Italy, Syracuse Province

No

Yes

Yes

Yes

Yes

Cervix

ICDO-3 (2004)

ICDO-2

ICDO-3 (2004)

ICDO-2

ICDO-3 (2004)

1998-2002

Italy, Sondrio

Italy, Sassari Province

Italy, Salerno Province

Italy, Romagna Region

Italy, Reggio Emilia Province

Registry

MP rules

No

No

No

No

No

Yes

No

NA

No

NA

No

No

No

No

No

No

No

No

NA

No

No

No

No

No

No

No

NA

NA

Prostate

No

No

No

No

No

No

No

NA

No

Yes

No

No

No

No

No

No

No

No

No

No

No

No

Yes

No

No

No

Yes

Yes

Colorectal

No

No

No

No

No

Yes

No

NA

No

NA

No

No

No

No

No

No

No

No

Yes

No

No

No

No

Yes

No

No

NA

Yes

Melanoma

No

No

No

No

No

No

No

Yes

No

NA

No

NA

No

No

No

No

No

No

No

No

NA

No

No

No

No

No

No

No

NA

NA

Mouth

No

No

No

Yes

No

NA

No

NA

No

No

No

No

No

No

No

No

NA

No

No

No

No

No

No

No

NA

NA

Lung

Screening programme as data source

Table 5.7 Registration practices

No

No

No

No

No

No

No

NA

No

NA

No

No

No

No

No

No

No

No

NA

No

No

No

No

No

No

No

NA

NA

Others

Yes

Yes

Yes

Yes

No

Yes

Yes

No

Yes

Yes

Yes

Yes

Yes

NA

Yes

Yes

Yes

Yes

Yes

Yes

No

No

No

Yes

Yes

Yes

Yes

Yes

Necropsy

0.8

<0.1

NK

4-6

<1

NK

0.1

0.2

0.45

NK

NA

0.4

0.2

12

1.5

<1

0.01

<1

0.3

NK

1.7

NK

Necropsy
(%)

Cases with

No

No

Yes

No

No

NA

Yes

Yes

No

No

Yes

No

Yes

No

No

No

No

Yes

NA

No

Yes

No

Yes

Yes

Yes

No

Yes

Yes

DCN

NA

4-6

12.4

7.2

5 - 10

NA

1.5

1.5

0.6

0.3

DCN%

Distinguish

Comparability and quality of data

ICDO-3 (2000)

Other

Other

ICDO-2

ICDO-2

Switzerland, Valais

Other

Other
Other

UK, England, Oxford Region

UK, England, South and Western Regions

Other

Other

UK, Scotland

UK, Northern Ireland

Other

Other

Other

UK, England, West Midlands

UK, England, Trent

UK, England, Thames

ICDO-2

UK, England, Northern and Yorkshire

UK, England, North Western

ICDO-2

Other

ICDO-1

ICDO-2

UK, England, Merseyside and Cheshire

UK, England, East of England Region

Switzerland, Vaud

Switzerland, Ticino

ICDO-1

Switzerland, St Gall-Appenzell

Switzerland, Neuchtel

ICDO-2

ICDO-2

ICDO-3 (2000)

ICDO-2

Switzerland, Graubnden and Glarus

Switzerland, Geneva

Sweden

Spain, Zaragoza

Spain, Tarragona

ICDO-2

Spain, Navarra

Spain, Murcia

ICDO-3 (2000)

Spain, Granada

ICDO-3 (2000)

Spain, Girona

Spain, Cuenca

No

Yes

Yes

No

Yes

No

Yes

Yes

Yes

Yes

Yes

No

No

No

No

No

No

No

No

No

NA

Yes

Yes

No

No

Yes

No

No

ICDO-2 and ICDO-3


(2000)

ICDO-3 (2000)

Cervix

1998-2002

Spain, Canary Islands

Spain, Basque Country

Registry

MP rules

Yes

Yes

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

No

No

No

No

No

No

Yes

Yes

Yes

Yes

No

Yes

Yes

No

Yes

Breast

No

No

No

NA

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

NA

No

No

No

No

No

No

No

No

Prostate

No

No

No

NA

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

NA

No

No

No

No

No

No

No

No

Colorectal

No

No

No

NA

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

NA

No

No

No

No

No

No

No

No

Melanoma

No

No

No

NA

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

NA

No

No

No

No

No

No

No

No

Lung

Screening programme as data source

Table 5.7 Registration practices

No

No

No

NA

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

NA

No

No

No

No

No

No

No

No

Mouth

No

No

No

NA

No

No

No

No

No

No

No

No

No

No

No

No

No

No

No

NA

No

No

No

No

No

No

No

No

Others

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Necropsy

0.1

NK

<1

0.8

NK

NK

NK

2-3

1.6

NK

NK

1.4

1-2

10

2.5

10

10

1.15

NK

0.1

<1

NK

NK

NK

Necropsy
(%)

Cases with

No

Yes

Yes

Yes

Yes

No

Yes

Yes

Yes

Yes

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

No

No

Yes

Yes

Yes

No

Yes

Yes

No

Yes

DCN

3.2

NA

2.4

30

NK

13 in
2002

17

NK

19

NK

NA

NA

NA

NK

0.7

9.2

3.4

4.1

5.7

12.5

4.8

DCN%

Distinguish

Comparability and quality of data

93

94

NK = not known

NA = not applicable

USA, Hawaii

New Zealand

French Polynesia

Australia, Victoria

Australia, Tasmania

Western Australia

Australia, Queensland

Australia, Northern Territory

Australia, New South Wales

Australian Capital Territory

Oceania

Registry

Yes

ICDO-2 and ICDO-3


(2000)

ICDO-2
Yes

Yes

Yes

ICDO-3 (2000) and


ICDO-3 (2004)

ICDO-2

Yes

Yes

No

No

No

No

Cervix

ICDO-3 (2000)

ICDO-2

ICDO-3 (2000)

ICDO-2

ICDO-2

ICDO-2

1998-2002

MP rules

Yes

Yes

Yes

Yes

Yes

Yes

No

No

No

No

Breast

Yes

No

No

No

No

No

No

No

No

No

Prostate

Yes

No

No

No

No

No

No

No

No

No

Colorectal

Yes

No

No

No

No

No

No

No

No

No

Melanoma

Yes

No

No

No

No

No

No

No

No

No

Lung

Screening programme as data source

Table 5.7 Registration practices

Yes

No

No

No

No

No

No

No

No

No

Mouth

Yes

No

No

No

No

No

No

No

No

No

Others

Yes

Yes

No

Yes

No

Yes

Yes

Yes

Yes

Yes

Necropsy

NK

NK

NK

0.08

NK

NK

NK

Necropsy
(%)

Cases with

No

NA

Yes

No

Yes

Yes

Yes

No

No

No

DCN

NA

NA

15

1.31
(based on
2003 dx
patients)

DCN%

Distinguish

Comparability and quality of data

Chapter 6: Processing of data


J. Ferlay

There were 313 cancer registries that replied to the invitation


to participate by submitting data for Volume IX of Cancer
Incidence in Five Continents (CI5) Each cancer registry sent
its own data, except the registry members of the Surveillance
Epidemiology and End Results (SEER) and of the National
Program of Cancer Registries (NPCR) of the United States,
and six Canadian registries that provided their data in a single
data submission
The data were generally sent to the IARC secretariat
through electronic mail or on CD-ROM for large files, and
as usual, were accepted in any electronic format (text files,
Excel spreadsheet, database files, etc.) and with any file
layout Contributing registries were also invited to send
all their data containing all malignant and non-malignant
diagnoses collected. In addition, official cancer mortality
data for the reference period, and population data, ideally
for each calendar year of the reference period, should also be
provided and checked by the IARC secretariat This resulted
in the manipulation of more than thirty million individual
records, and in the production of 389 preliminary datasets
(including different ethnic groups) to be examined carefully
by the editors A procedure for data validation and storage,
summarised in Figure 61, was established to handle the large
amount of data submitted for the project

and ICD-10 codes (for coding of the DCO cases) depending


on the year of incidence of the case, so that they had to be
split into two or more files, each piece of the puzzle being
converted using the appropriate program (Figure 62) These
preliminary conversions proved to be particularly valuable in
detecting incompatibilities between ICD-9 or ICD-10 codes
and ICD-O morphology and behaviour (Table 61), which
were transmitted back to the cancer registry for review and
correction
Figure 6.1. Processing of cancer registry data to generate
Cancer Incidence in Five Continents Volume IX

Incidence data
The incidence data were submitted as listings of individual
anonymous cases with at least the following variables:
1
2
3
4
5
6
7
8
9

A registration number that identifies the patient or the


case
Sex
Ethnic group or race (optional)
Age and/or birth date
Date of incidence
Site of the tumour (topography)
Morphology of the tumour
Behaviour of the tumour
Most valid basis of diagnosis

A description of all the codes used for the variables had


to be provided with the data However, it was not unusual for
the code values to not match the description provided or for
the coding information to be missing In that case, the registry
was asked for clarification and to provide the correct codes
if necessary This is particularly important when computing
the percentage of microscopically verified (MV) or death
certificate only (DCO) cases used for the editorial process: a
misinterpretation of the basis of diagnosis code could lead to
a false picture of the data quality
Conversion into ICD-O-3
The first stage of the editorial process is to examine the
incidence data using the standard IARC-CHECK program
This requires the data to be coded into a full (Topography
and Morphology) ICD-O-3 coding schema A large majority
(230) of the registries submitted data according to this
classification, but the others (72) had to be converted before
they could be handled by the program Several datasets
included both ICD-O-1 and ICD-O-2, not to mention ICD-9

95

Processing of data

ICD-10
C22.0
C45.0
C46.0
C91.0
C81.9
C43.9
C34.9
C53.9

Table 6.1 Examples of unlikely ICD-10 site/ICD-O-2 morphology combinations


ICD-O second edition (correct code if incorrect)
Hepatocellular carcinoma
8010/3 Carcinoma, NOS (8170/3)
Mesothelioma of pleura
8050/3 Papillary carcinoma, NOS (9050/3)
Kaposi sarcoma of skin
8140/3 Adenocarcinoma, NOS (9140/3)
Acute Lymphoid Leukaemia
9823/3 Chronic Lymphocytic Leukaemia (9821/3)
Hodgkin disease, NOS
9670/3 Malignant lymphoma, small lymphocytic (9650/3)
Melanoma of skin, NOS
8090/3 Basal cell carcinoma (8720/3)
Lung (primary cancer)
8140/6 Adenocarcinoma, metastatic (8140/3)
Uterine cervix, malignant
8070/2 Squamous cell carcinoma in situ (8070/3)
For Finland, the site was coded to ICD-7 (1955) and the
morphology using a modified version of the Manual of
Tumor Nomenclature and Coding by the American Cancer
Society (1951). A specific conversion program had been
developed within the framework of the NORDCAN project,
a collaboration between the IARC and the Nordic Association
of Cancer Registries.
Although the ICD-O-3 gives clear instructions that behaviour
codes /6 and /9 should not be used by cancer registries (page
27 of ICD-O-3), these codes appeared in few datasets,
giving rise to problems with respect to the corresponding
topography code. Usually, this was assumed to represent
the site of the primary tumour. Where this was evidently
not the case (carcinomas in lymph nodes, in bone, etc.), a
listing of such cases was sent back to the registries with a
request for clarification. As a last resort, they were recoded
to topography C80.9 (primary site unknown).
Checking
Once a dataset had been converted into ICD-O-3, or if
it had been originally coded using ICD-O-3 codes, it was
submitted to the IARC-CHECK program, which performed
the following edits:
1. Code verification

Figure 6.2 Preliminary conversions of cancer registry data


(1) ICD-9 (1975), chapter II neoplasms, to the second
edition of ICD-O (1990) conversion program.
(2) ICD-10 (1990), chapter II neoplasms, to the second
edition of ICD-O (1990) conversion program.
(3) ICD-9 (1975), chapter II neoplasms for topography
and the first edition of ICD-O (1976) for morphology
to the second edition of ICD-O (1990) conversion
program.
(4) ICD-10 (1992), chapter II neoplasms for topography
and the second edition of ICD-O (1990) for morphology
to the second edition of ICD-O (1990) conversion
program.
(5) First edition of ICD-O (1976) to the second edition of
ICD-O (1990) conversion program.
(6) Second edition of ICD-O (1990) to the third edition of
ICD-O (2000) conversion program.

96

Sex
Incidence date and, if provided, birth date
ICD-O-3 topography and morphology
2. Consistency between items

Age versus birth/incidence dates


Sex versus site
Sex versus histology
Age versus site
Age versus histology
Site versus histology
Basis of diagnosis versus histology

Registries submitting data for Vol. IX were invited to run their own
data through the IARC-CHECK program prior to submission,
and a number of contributors did so (143), particularly the users
of the CanReg-4 software (30), which includes the same edits.
However, these datasets were automatically re-checked by the
IARC secretariat. All errors or unlikely or rare combinations
of items were sent back to the cancer registry for verification.
The corrections or new submissions were then incorporated,
converted again (if necessary) and always re-checked to ensure
no more errors were found.

Processing of data

Multiple primaries
For the datasets that included a unique patient identification
number, it was possible to check for multiple primary tumours
following the IARC/IACR rules (IARC, 2004) especially
defined for ICD-O-3 (see Chapter 5). The multiple primary
check program can detect all the duplicate records that appeared
during the reference period if the cancer registry submitted a
complete dataset of the malignant cancer cases collected since
the starting of registration; otherwise, some of the multiple
tumours (generally those occurring at the beginning to the
reference period) may not have been detected because of a
lack of information on the earlier diagnoses.
Conversion into ICD-10
When no more errors remained, the incidence data were
converted from ICD-O-3 to ICD-10. This ensured that the
final ICD-10 codes used in the publication followed a standard
ICD-O-3 to ICD-10 conversion program. When a dataset
included an ICD-10 code, this was ignored in the tabulations.
The ICD-O-3 to ICD-10 conversion program was written at
IARC using the rules of the ICD-O-2 to ICD-10 conversion
program, which was used for processing data for Volume VIII
of CI5. The ICD-O-2 to ICD-10 conversion program was also
developed at IARC, based on the Conversion of neoplasms
by topography and morphology from ICD-O-2 to ICD-9. The
terms deleted from ICD-O-3 (as indicated in Appendix 5) were
first removed from the list of ICD-O-2. The conversion rules
for the new ICD-O (M) codes (listed in Appendix 1) were
defined by looking first at the most appropriate ICD-O-2 (M)
code using the ICD-O-3 to ICD-O-2 conversion program, and
then by applying the corresponding conversion rule to the
ICD-O-3 (M) code. For example, the ICD-O-3 code M8174/3
Hepatocellular carcinoma, clear cell type is converted into
ICD-10 following the rule that applies to the ICD-O-2 code
M8170/3 Hepatocellular carcinoma, NOS. The ICD-O-3 codes
M995_, M996_ (myeloproliferative disorders) and M998_
(myelodysplastic syndromes) that changed behaviour code from
borderline (/1) to malignant (/3), and for which no ICD-10 code
in the malignant C category can be found, have been converted
to the ICD-10 codes D45, D46_ and D47_ (i.e. non-malignant
tumours). They are included and presented in the tables under
the categories MPD and MDS respectively.
When a dataset was submitted with cases coded to ICD-9 or ICD10 for topography and ICD-O-1 or ICD-O-2 for morphology, the
series of conversion processes (Figure 6.2) and the final conversion
from ICD-O-3 to ICD-10 produced some unexpected results and,
for example, created new ICD-10 codes which were not originally
recorded in the input file. For example, suppose the following
combination of ICD-10 (T) and ICD-O-2 (M) was present:

ICD-10
ICD-O-2 (M)
C80
8640/3
Unknown primary

The first conversion into ICD-O-2 (T+M) will produce the


following output:


ICD-O-2 (T+M)
C80.9
Unknown primary

8640/3

The second conversion into ICD-O-3 (T+M) will produce


the following output:

ICD-O-3 (T+M)
C80.9

8640/3

Finally, the ICD-O-3 to ICD-10 conversion program used for


the data processing will create the following ICD-10 code:

C62.9

Testis, NOS

Thus the final ICD-10 site becomes sex-specific and does


not correspond to that provided in the original record.
Generally, such change in ICD-10 codes will occur when the
registry has not followed the rules in the ICD-O manuals;
in the example above, a Sertoli cell carcinoma (M8640/3)
should have been coded to testis (C62.9) if the site of the
tumour was not specified (rule 8 of ICD-O-2 or rule H of
ICD-O-3). It would also have occurred with other specific
morphological diagnoses such as malignant melanoma,
regressing (M8723/3) or osteosarcoma (M9180/3), which
are automatically converted to an ICD-10 code for skin
(C43._) or bone (C40._) cancer.
This example illustrates the importance of the
primary conversion into ICD-O-3 and explains why the
ICD-10 code provided by the cancer registry (if any) has not
been used in the final tabulations. For certain morphological
codes, the conversion is independent of topography.
Hepatocellular carcinoma (M8170/3), for instance, is
automatically converted to ICD-10 C22.0 irrespective of the
ICD-O topography code (whether specific or unknown). The
combination C34.9 (lung) plus M8170/3 will be converted
to C22.0. This combination of topography and morphology
is certainly incorrect. These types of potential errors are at
the origin of the creation of the first version of the IARCCHECK program. The validation of ICD-O-3 topography
and histology combinations is an essential part of the data
processing.
Miscellaneous conversions
In addition to the topography and the morphology codes, certain
variablessex, basis of diagnosis, ethnic group or race and
datesmust be re-coded into a common schema following the
instructions supplied by the cancer registry. When necessary,
the basis of diagnosis variable was recoded following the
IARC proposal (ICD-O-3, pg. 38). After the conversions into
a common dictionary, the data corresponding to a registry are
stored in the CI5 Vol. IX database, irrespective of whether
they will be published in Cancer Incidence in Five Continents
Vol. IX. All malignant neoplasms and non-malignant (except
benign) neoplasms of the bladder are recorded in the database.
These are stored as individual records containing the nine
compulsory variables having topography and morphology
coded to ICD-O-3 together with the corresponding ICD-10
code used for tabulation.
Mortality data
The mortality data are used for editorial purposes as an
indicator of the completeness of registration, and are
generally provided as a tabulation of ICD-9 or ICD-10 threedigit categories by sex and five-year age group, so that no
validity check (except the basic combination of sex and site)
can be performed. For some data sources, the original data
were grouped by cancer sites or by wider age groups than
the traditional five-year age groups, and had to be formatted
before being handled by the series of editorial programs and
stored in the CI5 Vol. IX database.
Population data
Cancer registries generally submitted population denominators
for each individual year of the reference period, or for one year
corresponding to the mid-year of the reference period. These
are based on a census, which was carried out around the year

97

Processing of data

2000 in most of the countries. File editing and misinterpretation


of the codes were the only source of errors discovered in the
last three volumes. Whenever possible, the population data
have been checked by comparing the age distribution with
that from the previous volume. Unexpected change in the
age structure or in the total population by year and sex were
identified and sent to the registry for clarification. After this
careful examination, the population files were formatted and
stored in the CI5 Vol. IX database.
Conclusion
This protracted process for both cancer registry staff and the
IARC secretariat took several months. However, it ensured a
maximum level of data comparability and validity, but it is not
in itself sufficient to ensure inclusion in the present volume.
This depended upon other considerations of comparability
and quality, as described in Chapter 5. The seven conversion
programs, together with the latest version of the IARCCHECK and the multiple primary check programs used in
References
Cooke, A.P., Parkin, D.M., Ferlay, J. CanReg4: Computer Software
for Cancer Registries. Available at http://www.iacr.com.fr.
Ferlay, J., Burkhard, C., Whelan, S., Parkin, D.M. (2005).
Check and Conversion Programs for Cancer Registries
(IARC/IACR Tools for Cancer Registries). IARC
Technical Report No. 42. Lyon, IARCPress.
Fritz, A., Ries, L. Conversion of Neoplasms by Topography and
Morphology from the International Classification of Diseases
for Oncology, Third Edition (ICD-O-3), to International
Classification of Diseases for Oncology, Second Edition
(ICD-O-2). National Cancer Institute, DCCPS, Surveillance
Research Program, Cancer Statistics Branch.
Fritz, A., Percy, C.L., Jack, A., Shanmugaratnam, K., Sobin,
L., Parkin, D.M., Whelan, S. eds (2000). International
Classification of Diseases for Oncology, third edition,
Geneva, World Health Organization.
Parkin, D.M., Whelan, S.L., Ferlay, J., Teppo, L., and Thomas, D.B.,
eds (2002). Cancer Incidence in Five Continents, Vol. VIII.
IARC Scientific Publications No. 155, Lyon, IARCPress.
Parkin, D.M., Chen, V.W., Ferlay, J., Galceran, J., Storm,
H.H and Whelan, S.L. (1994). Comparability and Quality
Control in Cancer Registration. (IARC Technical Report
No. 19), Lyon, IARCPress.

98

the incidence data process, have been published as a PC


Windows-based package, IARCcrgTools. This is available
for free at the International Association of Cancer Registries
(IACR) web site http://www.iacr.com.fr/. IARCcrgTools
also includes the detailed definition of the edits and controls
performed on each variable or within variables. All of the
necessary programs to convert and check the data, then to
create the tables were written in C++ and Java. The thousands
of tables produced were generated in PostScript format and
later converted into PDF files for publication.
The Editors would like to particularly thank Mr Mathieu
Mazuir who performed most of the data entry and the data
cleaning, Mr Eric Masuyer for his help in the data cleaning,
and Mr Morten Ervik for his help in the data processing and
his work in creating and managing the necessary tables.
Finally, the Editors would like to acknowledge the
contributors who converted and checked their data prior to
submission. This was very helpful and much appreciated.
Percy, C.L. ed. (1992). Conversion of Neoplasms by
Topography and Morphology from the ICD-0-2 to ICD9 and the ICD-9-CM. Washington, National Cancer
Institute.
Percy, C.L, Van Holten, V. & Muir, C.S., eds (1990).
International Classification of Diseases for Oncology, 2nd
edition (ICD-O-2). Geneva, World Health Organization.
WHO (World Health Organization) (1957). Manual
of the International Statistical Classification of
Diseases, Injuries and Causes of Death (Based on the
Recommendations of Seventh Revision Conference,
1955), Geneva, World Health Organization.
WHO (World Health Organization) (1976). International
Classification of Diseases for Oncology (ICD-O),
Geneva, World Health Organization.
WHO (World Health Organization) (1977). Manual
of the International Statistical Classification of
Diseases, Injuries and Causes of Death (Based on the
Recommendations of Ninth Revision Conference, 1975),
Geneva, World Health Organization.
WHO (World Health Organization) (1992). Manual
of the International Statistical Classification of
Diseases, Injuries and Causes of Death (Based on the
Recommendations of Seventh Revision Conference,
1990), Geneva, World Health Organization.

M. Boniol, M. Heanue
Objective
The key determinant of cancer incidence is age, as the risk of cancer increases exponentially with increasing age. The
crude rate of incidence is therefore influenced by the population structure, and cannot be used alone to evaluate whether
the burden of cancer differs between populations.
To compare the incidence of cancer, the summary rates should be independent of age. A common way to take into
account the age structure of a population is to standardise incidence rates for age using an external (standard) population.
Crude incidence rate
The crude incidence is the rate at which new cases occur in a population during a specific period. This rate is classically
expressed as the average number of cases occurring per 100 000 persons each year or 100 000 person-years. In Cancer
Incidence in Five Continents (CI-5), Volume IX, numbers of cancer cases are reported for the period 19982002. Hence the
crude incidence rate is computed with the following formula:

Chapter 7: Age-standardisation and denominators

M. Boniol and M. Heanue Number of new cancer cases observed in the period 1998 - 2002
Crude incidence rate =

Total population in the period 1998 - 2002

Objective
Age-standardised
incidence
The total population
in the period 19982002
corresponds rate
to the sum of population size for each year between 1998 and
The key determinant of cancer incidence is age, as the2002.
riskThis
of rateThe
age-standardised
ratetoiseach
a summary
individual
age-specific
is called
crude because it relates
population of
as athe
whole
and is influenced
by the age structure of
population.rates
It cannot
be used
comparison
purposes. called a standard population. This
cancer increases exponentially with increasing age. Theeachcrude
using
an for
external
population
rate of incidence is therefore influenced by the population is the incidence that would be observed if the population had the age
Age-standardised
incidenceof
rate
structure, and cannot be used alone to evaluate whether
the structure
the standard population, and corresponds to the crude
The age-standardised rate is a summary of the individual age-specific rates using an external population called a standard
burden of cancer differs between populations.
incidence
rate
thebestandard
population.
age-standardised
population. This is the incidence
thatin
would
observed if the
population hadThe
the age
structure of the standard population,
and
correspondsincidence
to the crude incidence
rate
in the standard
population.
The age-standardised
incidence
To
compare
the
incidence
of
cancer,
the
summary
rates
should
rate
is
expressed,
as
is
the
crude
incidence
rate,
asrate
theis expressed, as
Chapter 7 Age-standardisation and Denominators
is the crude incidence rate, as the number of new cases per 100 000 person-years.
beHeanue
independent of age. A common way to take into account
the number of new cases per 100000 person-years.
M. Boniol, M.
age structure of a population is to standardise incidence rates
for The
calculation
a weighted
The calculation
is a weighted
average ofisage-specific
rates. average of age-specific rates.
Objective
age
using
an
external
(standard)
population.
The key determinant of cancer incidence is age, as the risk of cancer increases exponentially with increasing age. The

dw

i i
crude rate of incidence is therefore influenced by the population structure, and cannot be used alone to evaluate whether
Age - standardised rate =
the burden of cancer
differs
between populations.
yi
Crude
incidence
rate
i
To compare the incidence of cancer, the summary rates should be independent of age. A common way to take into
crude
incidence
is the rate
at rates
which
new
occur
in population.
Such that i represents each age group,
account the ageThe
structure
of a population
is to standardise
incidence
for age
usingcases
an external
(standard)
Such that i represents each age group,
a population during a specific period. This rate is classically
di theinnumber
of cases in the ith age group,
the ith age group,
di the number of cases
expressed
as
the
average
number
of
cases
occurring
per
100
the
populationyisize
in population
the ith age groupsize in the ith age group,
yi the 000
Crude incidence rate
applied
for the
ith age group,
with for the ith age group, with
and wi the weight
persons
In Cancer
Incidence
wi the
weight
applied
The crude incidence
is theeach
rate atyear
which or
new100
cases000
occurperson-years.
in a population during
a specific period.
This rate isand
classically
rates for each ith category
di/yi being the age-specific
expressed as the
number of cases(CI5),
occurring
per 100 IX,
000 persons
each of
yearcancer
or 100 000
person-years.
Cancer
inaverage
Five Continents
Volume
numbers
cases
aresum ofdInwi/y
being
the
age-specific
rates
for eachrate
ithpercategory
being
equal
to
100
000
to
express
the
age-standardised
100 000 person-years.
With the
i i
Incidence in Five Continents (CI-5), Volume IX, numbers of cancer cases are reported for the period 19982002. Hence
the
for with
the the
period
19982002.
Hence the crude incidence and the
sum of wi being equal to 100 000 to express the agecrude incidencereported
rate is computed
following
formula:
It should be stressed that the objective of age standardisation is essentially to establish rates for comparison purposes. Any
rate is computed with the following formula:
standardised rate per 100 000 person-years.
population standard would enable comparison, even considering equal weights for each age group.
The most commonly used standard worldwide is the Segi standard population (Segi 1960). Modified by Doll et al.
Number of new cancer cases observed in the period 1998
- 2002
(1966),
it was It
based
on the be
age structure
of the
of populationsof
from
46 countries.
The use of this standard
Crude incidence rate =
should
stressed
thatpooling
the objective
age
standardisation
Total population in the period 1998 - 2002 population allows international comparison and evaluation of changes in incidence by comparing them to rates published
is essentially
to establish rates for comparison purposes. Any
in previous volumes
of CI-5.

The total population in the period 19982002 corresponds to the

population standard would enable comparison, even considering

whole and is influenced by the age structure of each population.


It cannot
used for comparison purposes.
Age-standardised
incidencebe
rate

worldwide is the Segi


standard population (Segi, 1960). Modified by Doll et al. (1966),
it was based on the age structure of the pooling of populations

example
of this
ageand
standardisation appears in table 1.
The total population in the period 19982002 corresponds to the sum of population size for each
between
1998
sum of population size for each year between 1998 andAnyear
2002.
equal
weights for each age group.
2002. This rate is called crude because it relates to each population as a whole and is influenced by the age structure of
This
ratebeisused
called
crude because
The most commonly used standard
each population.
It cannot
for comparison
purposes. it relates to each population as a

The age-standardised rate is a summary of the individual age-specific rates using an external population called a standard
population. This is the incidence that would be observed if the population had the age structure of the standard population,
and corresponds to the crude incidence rate in the standard population. The age-standardised incidence rate is expressed, as
is the crude incidence rate, as the number of new cases per 100 000 person-years.

Table 7.1 Computation of age-standardised incidence rates (Melanoma cancer, Denmark, males, 19982002)

The calculation is a weighted average of age-specific rates.

d i wi
Age group Age - standardis
No. of
at risk
edcases
rate = Person-years
yi
i

di
yi
Such that i represents each agei group,
di the number of cases in the ith age group,
0
869 668
ith age group
yi the population size in the 04
and wi the weight applied for the ith age group, with
59for each ith category
0
878 535
di/yi being the age-specific rates
With the sum of wi being equal to 100 000 to express the age-standardised rate per 100 000 person-years.
1014

779 915

Age-specific
incidence
(per 105 years)

Standard world
population

Expected cases in
standard population

105(di /yi)

wi

di wi /yi

0.00

12000

0.00

0.00

9 000

0.00

0.00

It should be stressed that the objective of age standardisation is essentially to establish rates for comparison purposes. Any
7 equal weights for each age
723
313
0.97
population standard would1519
enable comparison, even considering
group.
The most commonly used standard worldwide is the Segi standard population (Segi 1960). Modified by Doll et al.
2024
23
840
592
(1966), it was based on the age structure of the pooling of populations from 46 countries. The use of this standard2.74
population allows international comparison and evaluation of changes in incidence by comparing them to rates published
2529
59
961 907
6.13
in previous volumes of CI-5.

3034

83

1 042 749

4044

153

953 731

16.04

5054

262

990 187

26.46

An example of this age standardisation appears in table 1.

3539
4549
5559
6064

117

188
303
272

1 041 800
930 210
871 969
649 423

7.96

11.23

20.21
34.75
111
41.88

10 000
9 000
8 000
8 000
6 000
6 000
6 000
6 000
5 000
4 000
4 000

0.00
0.09
0.22
0.49
0.48
0.67
0.96
1.21
1.32
1.39
1.68

6569

223

523 486

42.60

3 000

1.28

7579

162

342 435

47.31

1 000

0.47

7074

8084
85+

Total

217
119
115

2 303

439 676
210 084

140 073

13 189 753

49.35

56.64

82.10
17.46

2 000
500
500

100 000

111

0.99
0.28

0.41

11.94

99

Age-standardisation and denominators

from 46 countries. The use of this standard population allows The sum of the age specific rates between ages 074 is: (0.97
international comparison and evaluation of changes in incidence +2.74+6.13+7.96+11.23+16.04+20.21+26.46+34.75+41.88+4
by comparing them to rates published in previous volumes of CI5. 2.60+49.35)/100 000 = 260.33/100 000. Hence the cumulative
Table 1. Computation of age-standardised incidence rates (Melanoma cancer, Denmark, males, 19982002)
An example of this age standardisation appears in Table 7.1.
rate is (260.33/100 000) 5, or 1.3%.
In thisPerson-years
example, the
rate is 2303 / 13Standard
189 753world
= 17.46Expected cases in
Age group
No. of
at crudeAge-specific
cases per 100
and the age-standardised
age-specific incidence rates calculated in a registry are
population rate is The
standard
cases
risk000 person-years,
incidence
cumulative incidence rate ranges
between
0 and 75,birth
and cohorts;
by its construction
overestimates
11.94 per 100 000 person-years.
derived
from different
i.e. populations
born at the probability of
years)
population
(per 105The
ai /ycancer
during
life
when
incidence
rates
are
high.
However
when
incidence
rates
are
sufficiently small, apart fro
yi
105(dis
)
w
d
w
/y
I
di
The age-standardised
rate
lower
than
the
crude
rate
different
periods
who
experienced
different
levels
of
exposure
i
i i i between 0 and 75, and by its construction overestimates the probability of devel
The cumulativei incidence rate ranges
04
0
869standard
668
0.00
12
000
0.00
cancer
sites
combined,
the
cumulative
rate
is
not
significantly
affected
by
this
bias.
because
the
population
is on average
younger
than
the
to
carcinogens.
The
cohort
effect
is
an
important
determinant
a cancer during life when incidence rates are high. However when incidence rates are sufficiently small, apart from all
59
0
878 535
0.00rateInofthe
10be
000
0.00 observed
Danish
population.
However, the
11.94
can
compared
of the
incidence
for most
sites.
For can
example,
previous
example
forcumulative
melanoma
inismen
in Denmark,
the cancer
cumulative
rate
be estimated from the age
cancer
sites
combined,
the
rate
not
significantly
affected
by this
bias.
1014
0
779
915
0.00
9 000
0.00
with other rates standardised on the
world
population.
mesothelioma
incidence
is driventhe
by asbestos
exposure
that
took
rates:
In
the
previous
example
for
melanoma
in
men
in
Denmark,
cumulative
rate
can
be
estimated
from the age-spec
1519
7
723 313
0.97
9 000
0.09
place
in
the
past
(until
the
1990s
in
most
developed
countries),
The
sum
of
the
age
specific
rates
between
ages
074
is:
rates:
2024
23
840 592
2.74
8 000
0.22
Reference
and0.49
the
cumulative
ratesis:calculated in CI5 Volume IX would
The sum of 8the
between
ages 074
2529
59
961population
907
6.13
000age specific rates
(0.97+2.74+6.13+7.96+11.23+16.04+20.21+26.46+34.75+41.88+42.60+49.35)/100
000 =not260.33/100 000. Henc
A
new
standard
population
was
proposed
by
WHO
in
2000
reflect
the
lifetime
risk
of
mesothelioma
of
a
population
3034
83
1 042 749
7.96
6 000
0.48or 1.3%.
(0.97+2.74+6.13+7.96+11.23+16.04+20.21+26.46+34.75+41.88+42.60+49.35)/100
000 = born
260.33/100 000. Hence the
cumulative
rate
is
260.33/100
000*5,
The
cumulative
incidence
rate2000.
ranges between 0 and 75, and by its construction overestimates the probability of developing
(Ahmad1 et
standard
allows
the
estimation
3539
117
041al.,
8002000). This new
11.23
6rate
000
0.67
cumulative
is 260.33/100in000*5,
or 1.3%.
a
cancer
during
life
when
incidence
rates
are
high.
However
when
incidence
rates
are
sufficiently
4044
153
953 731
16.04world population.
6 000This new
0.96
of incidence
for the theoretical
Nevertheless, the cumulative rate reflects the burden of cancersmall, apart from all
cancer
sites
combined,
the
cumulative
rateinhas
is anot
significantly
affectedover
by
this bias.
The
age-specific
incidence
rates
calculated
registry
derived
from
different
birth cohorts; i.e. populatio
4549
188
930
210
20.21
6
000
1.21
population is, however, not of great utility
cancer incidence
in a place,
and
addedare
advantage
age-standardised
The for
age-specific
incidence
rates
calculated
inmen
athe
registry
are
derived
fromthe
different
birth
cohorts;
i.e.the
populations
bo
In the
previous
example
for
melanoma
in
in Denmark,
the cumulative
rate can be
estimated
from
age-specific
5054
262
990 187for two main reasons:
26.46
5 000
1.32
different periods
who experienced
different
levels
of exposure
to carcinogens.
The cohort
effect
is an
standardisation
rate
of
not
imposing
an
external
population
structure.
different
periods
who
experienced
different
levels
of
exposure
to
carcinogens.
The
cohort
effect
is
an
imp
rates:
5559
303
871 969
34.75
4 000
1.39 for most cancer sites. For example, mesothelioma incidence is driven b
determinant
ofbetter
the
observed
incidence
This new
standard population
is supposed
represent
determinant
observed
for most
cancer
Thetosum
of the
the
age
specificincidence
rates
ages 074
is: sites. For example, mesothelioma incidence is driven by asb
6064
272
649 423
41.88
4 of
000
1.68between
exposure
that
took
placeplace
in
past
(until
the
developedcountries),
countries),
cumulative
the theoretical
world population42.60
compared
to Segis
population,
butthe
Statistical
tests
exposure
that
took
in the
past
(until
the1990s
1990sin
in most
most developed
and
thethe
cumulative
ratesrates
calcula
(0.97+2.74+6.13+7.96+11.23+16.04+20.21+26.46+34.75+41.88+42.60+49.35)/100
000
=and
260.33/100
000. Hence
the ca
6569
223
523 486
3 000
1.28
still does 439
so insufficiently,
as population
data
is
lacking
for
the
results of which
are not born
published
here,
volume
IXcumulative
would
not
reflect
theStatistical
lifetime
risk
ofofmesothelioma
of aa population
population
born
2000.
rate
ismany
260.33/100
000*5,
ortests,
1.3%.
volume
IX
would
not
reflect
the
lifetime
risk
mesothelioma
of
in in
2000.
7074
217
676
49.35
2 000
0.99
regions in342
the435
world. Secondly,
thereNevertheless,
is noNevertheless,
additional
were
used
to flag
certain
registries
as
orhashas
possibly
7579
162
47.31
1 000
0.47
thestatistical
cumulative
rate
reflects
the
inaaunusual
place,and
and
added
advantage
the cumulative
rate
reflects
theburden
burden of
of cancer
cancer in
place,
thethe
added
advantage
over ov
the
property from
this standard to the
Segi population
forof
comparison
inconsistent
with
published
8084
119
210 084
56.64
500
0.28
Therate
age-specific
incidence
rates
calculated
inprevious
a registrystructure.
are deriveddata.
from different birth cohorts; i.e. populations born a
standardised
rate
of imposing
not
imposing
an
external
population
structure.
standardised
not
an
external
population
85+
115
073 2002). For data
82.10in the present
500
0.41
purposes 140
(Bray,
volume,
forwho
all experienced
different
periods
different levels of exposure to carcinogens. The cohort effect is an importan
The cumulative incidence
rate ranges between 0 and 75, and by its construction overestimates the probability of developing
Total
2 303
189 753
100 000
11.94
determinant
of
the during
observed
incidence
for
most
cancer
For example,
mesothelioma incidence is driven by asbesto
cancer13incidences
excluding 17.46
non-melanoma
skin
cancer,
we life
Calculation
of variance
of sites.
ASRswhen
Statistical
tests
a
cancer
when
incidence
are high. However
incidence rates are sufficiently small, apart from all
Statisticalexposure
tests that took place in the past (untilrates
the
1990s
in here,
mostrates
developed
countries),
andassess
theregistries
cumulative
calculated
estimated the Spearman correlation (r)Statistical
between the
rates
using
Variances
ofnot
age-standardised
(ASR)
are
usedcertain
to
the as rates
cancer
sites combined,
the cumulative
rate
is not significantly
affected
by this
bias.
tests,
the
results
of
which
are
published
were
used
to
flag
unusual
or poin
Statistical
tests,
the
results
of
which
are
not
published
here,
were
used
torate
flag
registries
as unusual
o
In this example, the crude rate is 2303 / 13 189 753 = 17.46 cases
per 100 000
person-years,
the
age-standardised
rate
volume
IX would
notprevious
reflect
the lifetime
risk
ofinmesothelioma
ofthea cumulative
population
born
in
2000.
In and
the
example
forsignificance
melanoma
men
inthe
Denmark,
can
becertain
estimated
from the age-specific
Segis standard compared to the new
standard.
The
percentage
of
statistical
of
difference
between
rates
in
Volume
inconsistent with
previous published data.
is 11.94 per 100 000 person-years.
rates:
inconsistent
with
previous
published
data.
Nevertheless,
the
cumulative
rate
reflects
the
burden
of
cancer
in
a
place,
and
has
the
added
advantage
over
the
age
notthan
explained
thebecause
new standard
compared
to isthe
old
VIII
andrates
Volume
IX 074
andis:to compute confidence intervals of
The
theimposing
age
specific
between
ages
The age-standardised variation
rate is lower
the crudeby
rate
the standard
population
on
average
younger
than
the population
standardised
ratesum
of ofnot
external
structure.
2
standard
(1-r
) wascan
0.14%
for menwith
andother
0.11%
women.
When
rates
inanVolume
IX. We based
the estimation of
(0.97+2.74+6.13+7.96+11.23+16.04+20.21+26.46+34.75+41.88+42.60+49.35)/100
000 variance
= 260.33/100of
000. Hence the
Calculation
of variance
ofworld
ASRs
Danish population. However,
the rate
of 11.94
be compared
ratesfor
standardised
on the
population.
cumulative
rate
is
260.33/100
000*5,
or
1.3%.
Calculation
of
variance
of
ASRs
looking at ranking of registries by level
of incidence,
the new ASR
on(ASR)
Breslow
and
Days
method
modified significance
to use a binomial
Variances
of
age-standardized
rates
are
used
to
assess
the
statistical
of
the
difference between ra
Statistical tests
Variances
oflevels
age-standardized
rates
(ASR)
are
to assess
the statistical
of We
the
difference
betwe
Reference population standard produces an average change
of 2.9
rank
men
assumption
(Keyfitz,
1966)
for
variance
ofsignificance
the
crude
ageVolume
VIII for
and
IX
torates
compute
confidence
intervals
of torates
in
Volume
IX.
based
theor
The Volume
age-specific
incidence
calculated
in a registry
are
derivedused
from
different
birth
cohorts;
i.e. populations
born
at estimati
Statistical
tests,
theand
results
ofand
which
are
not used
published
here,
were
flag
certain
registries
as unusual
possibly
A new standard population
WHOincluding
in 2000 (Ahmad
etvariance
al, VIII
2000).
This
new
standard
allows
the
estimation
1.9was
forproposed
women by
in data
all
registries;
this
corresponds
to
specific
rates.
Volume
and
Volume
IX
and
to
compute
confidence
intervals
of
rates
in
Volume
IX.
We
based
the
est
different
periods
who
experienced
different
levels
of
exposure
to
carcinogens.
The
cohort
effect
is
an
important
of ASRwith
on Breslow
and Days
method modified to use a binomial assumption (Keyfitz 1966) for the varian
inconsistent
previous published
data.
of incidence for the theoretical
world population.
This new
is,
however,
notfor
ofdeterminant
great
utility
forobserved
cancer incidence
ofand
the
incidence
formodified
most cancer to
sites.
For aexample,
mesothelioma
incidence(Keyfitz
is driven by1966)
asbestosfor the v
an average
of 0.7% change
forpopulation
men
and the
0.5%
change
women.
variance
of
ASR
on
Breslow
Days
method
use
binomial
assumption
crude
age-specific
rates.
exposure that took place in the past (until the 1990s in most developed countries), and the cumulative rates calculated in
standardisation for two main
Thereasons:
lack of clear difference between
incidence
rates computed
Calculation
of population
variance
ofcompared
ASRs
the crude
age-specific
rates.
18
volume
IX would
not reflect the
born in 22000.
This new standard population is supposed to better represent
the theoretical
world
to lifetime
Segis risk of mesothelioma
the added
- d i )significance
*of (astatistical
*andwhas
d the
ypopulation
with Segis population compared to the new world
standard
does
i
i
of age-standardized
rates (ASR)
are used
assess
of the
difference
between
Nevertheless,
cumulative
rate is
reflects
the to
burden
in
a place,
advantage
over the
age- rates in
of icancer
2
population, but still does so insufficiently, as population data is lacking for Variances
many regions
in
the world.the
Secondly,
there
18
3rates
IX. We based the estimation o
standardised
rate ofIX
not and
imposing
an externalconfidence
populationstructure.

Volume
VIII
and
Volume
to
compute
intervals
of
in
Volume
*
(
)
*
d
y
d
w

not
justify
the
use
of
the
new
population.
i
i
i
i
no additional statistical property from this standard to the Segi population for comparison purposes (Bray, 2002). For data
y
i =1
i
(Keyfitz 1966) for the variance o
variance
of ASRwe
on Breslow and
Forcancer
these incidences
reasons, and
to allow
international
in the present volume, for all
excluding
non-melanoma
skin comparisons
cancer,
theDays
Spearman
3 assumption
( ASRmodified
) = to use a binomial
Varmethod

Statistical estimated
tests
2
y
the
crude
age-specific
rates.
18
i
=
1
with
continuity
from
the previous
use here
correlation (r) between the
rates
using Segis
standard
compared volumes,
to the newwe
standard.
The only
percentage
of variation
as unusual or possibly
Statistical
tests, the results
of whichnot
are not published here, were
registries
used toi flag certain
2
(
)
Var
ASR
=
2
18
inconsistent
with previous
published
data.
and 0.11%
for women.
When
explained by the new standard
to the old standard (1-r ) was 0.14% for men
wdi ) *2 w
Segis compared
world standard.
d *( y18

i i =1i 3 i i
looking at ranking of registries by level of incidence, the new standard produces an average change of 2.9 rank levels for

Calculation
of
variance
of
ASRs

yw
men and 1.9 for women in
data including
all registries; this corresponds to an average of 0.7% change for men and 0.5%
i =1
i i significance
of the difference between rates in
Cumulative
rate
Variances of age-standardized rates
(ASR)
are)used
to assess the statistical
(
Var
ASR
=
change for women. The lack of clear difference between incidence rates computed with Segis
population
compared
to
the
i
=
1

2 in of
Volume
VIII and Volume
IX and
to of
compute
confidence
intervals
of rates
Volume
IX. We based
the estimation
of rates.
The cumulative rate is an approximation
of the 95%
probability
18
We
estimated
confidence
intervals
(CI)
rates
based
on
an
assumption
the
normal
distribution
of the
new world standard does not justify the use of the new population.
a binomial
assumption (Keyfitz
variance of aASR We
on Breslow
and Days
method
modified to
use
1966)
for the variance of
to
develop
a
cancer
during
a
certain
periodfor
example,
estimated
95%
confidence
intervals
(CI)
of
rates
based
on
an
w

For these reasons, and to allow international comparisons with continuity from the previous
werates.
use here only
i
the crudevolumes,
age-specific
rates for the
lifeconfidence
spans of intervals
assumption
normal distribution
=1 of the rates.
i assumption
We estimated
95%
(CI)ofoftherates
an
of the normal distribution of the rat
Segis world standard. lifetime. We present the cumulative
18on
* Var ( ASR )2
CI = based
1.96

d i * ( yi d i ) * wi

064 and 074 years. This has the advantage of summarising

CI = 1.96 * Var ( ASR )

yi
Cumulative rate
the age-specific rates independently of the We
ageestimated
structure95%
of the
confidence intervals (CI) of rates basedi =1on
an assumption
of the normal distribution of the rates.
Var ( ASR) =
2
The cumulative rate is anpopulation,
approximation
the probability
to develop
cancer during
a certain periodfor example, a
18
andofgives
the probability
of ana individual
developing

lifetime. We present the cumulative


the life spansisoftheoretical
064 and 074
years.
This hasthat
the advantage
of summarising
wi
a cancer. rates
Thisforcalculation
and
assumes
no
CI = 1.96 * Var
( ASR
)
i =1

the age-specific rates independently


of
the
age
structure
of
the
population,
and
gives
the
probability
of
an
individual
Comparison
of ASRs
from Volume
IX with the
values from
from Volume
death occurs in the period, and that the
age-specific
incidence
Comparison
of ASRs
Volume VIII
IX with the values from
developing a cancer. This calculation is theoretical and assumes that no death occurs in the period, and that the age-specific
changes
in VIII
incidence
between
Volume
VIII and
Volume
IX we ofestimated
the Compa
rates will be stable for an individual. To identify significant
Volume
We estimated
95%
confidence
intervals (CI)
of rates based
on an assumption
of the
normal distribution
the rates.
incidence rates will be stable for an individual.
3

Incidence Figure (CIF), which


to the ratio
of theinage
standardised
incidence
Tocorresponds
identify significant
changes
incidence
between
Volumerate
VIIIin Volume IX divided b

d i inVolume
Comparison
of ASRs15from
IX
with the
values
from
Volume
VIII
age-standardised
Volume
VIII.
Volume
IXthe
wevalues
estimated
the
CI =from
1.96
* Comparative
Var
( ASR ) Incidence Figure
Cumulative rate between 0 -To
74 identify
years
oldsignificant
= 5 ofrate
Comparison
ASRs
from and
Volume
IX with
Volume
VIII
changes
in
incidence
between
Volume
VIII the
and
Volume
IX we estimated the C
(CIF), in
which
corresponds
the ratio
age
standardised
To identify i significant
changes
incidence
between to
Volume
VIIIofand
Volume
IX we estimated the Comparativ
=1 yi
ASR
from
Volume rate
Incidence
Figure
(CIF),
which
corresponds
to
the
ratio
of
the
age
standardised
incidence
in Volume
IXbydivi
incidence
rate
in
Volume
IX
divided
by
the
age-standardised
Incidence Figure (CIF), Comparativ
which correspondsetoIncidence
the ratio of theFigure
age standardised
IX divided
the
= incidence rate inIXVolume
Such that i = 5-year age groups,
rateComparison
in Volume
VIII.
i = and
5-year age groups, age-standardised
rate
in
Volume
VIII.
age-standardised
rate inofVolume
VIII.
ith agethat
group,
di=number of cases in theSuch
ASR
ASRs from Volume IX with the values from Volume VIII

di=number
ofgroup.
cases in the ith age group, and
in the ith age
yi=number of person-years

yi=number of person-years in the ith age group.


The upper

from Volume VIII

ASR
ASR
Comparativ
e Incidence Figure
Figure ==
Comparativ
e Incidence
ASR
ASR

To identify significant changes in incidence between Volume VIII and Volume IX we estimated the Comparative
fromfrom
Volume
IX
Incidence Figure (CIF), which corresponds to the ratio of the age standardised incidence
rate inVolume
Volume
IX
IXdivided by the
and lower (CI
confidence
interval limits of CIF were computed using the following formula:
(CIu)age-standardised
rate
in Volume
VIII.
l) 95%
from Volume VIII

ASRfrom Volume
fromIXVolume VIII
The cumulative incidence rate ranges between ages 0 and
Comparative Incidence Figure =
75, and by its construction overestimates the
probability
of
The
upper
(CI
)
and
lower
(CI
)
95%
confidence
interval
limits
(
)
(VIII
)
Var
ASR
Var
ASR
ASR
interval limits
CIF were IX
computed
the
followingVIII
formula:
The upper (CIu) and lower (CIl) 95% confidence
l of
fromVolume
fromVolume
from Volume
(CIF computed
)u 1.96
* using
+ using
Ln
developing a cancer during life when
incidence
high.(CIl) of
CIF
were
the following
formula:
2 computed using the following
2
) andare
lower
95%
confidence
interval
limits
of
CIF
were
formu
The upper
(CIurates
ASR
ASR
fromVolume
IXcomputed using
VIII
limits
of CIF were
the fromVolume
following formula:
The upper
However when incidence rates are sufficiently small, apart
u / (CI
l u) and lower (CIl) 95% confidence interval
Var ( ASRfromVolume IX ) Var ( ASRfromVolume VIII )
from all cancer sites combined, the cumulative rate is not
+
Ln (CIF )1.96*
2 Var ( ASR
( ASR
) 2
Var
(
) ASR
( ASR
Var
ASR
Var
significantly affected by this bias.
fromVolume
IX ) IX
fromVolume
VIII VIII
ASR
fromVolume
VIII ) if the
fromVolume
IX
fromVolume
(
)

1
.
96
*
+
Ln
CIF
We considered the difference
between
rates
in96Volume
XI compared to2rates in +Volume
VIII2fromVolume
to be significant
u / l Ln
(
)

1
.
*
CIF
In the previous example for melanoma in men in Denmark CI u / l =
ASRfromVolume IX
ASR
2
fromVolume VIII
1.0 was not included in the 95% confidence interval of the
CIF.
ASR
ASRfromVolume VIII 2
(Table 7.1), the cumulative rate can be estimated from uthe/ lagefromVolume IX
We
considered
the
difference
between
rates
in
Volume
XI
compared
to
rates
in
Volume
VIII to be significant if the value
specific rates:
We considered the difference between rates in Volume XI compared to rates in Volume VIII to be significant if the value

CI

CI

CI

=e

=e

=e

1.0 was not 1.0


included
in the 95% confidence interval of the CIF.
was not included in the 95% confidence interval of the CIF.

We considered the difference between rates in Volume XI compared to rates in Volume VIII to be significant i
1.0 was not included in the 95% confidence interval of the CIF.
100
113

Age-standardisation and denominators

We considered the difference between rates in Volume XI compared


to rates in Volume VIII to be significant if the value 1.0 was not
included within the 95% confidence interval of the CIF.

population estimate. Moreover, population estimates are often


revised once a new census is available but not all cancer registries
collect these updated figures. Hence the drift and even a significant
change in incidence rate between the year of the census and the
Comparison of percentage of microscopically verified cases preceding year could occur simply because of the imprecision of
Comparison
percentage
microscopical
verification
volume
IX with the
values from
volume
VIII
(MV%) from
volumeof IX
with theofvalues
from volume
VIII(MV%) from the
population
estimate.
This
is especially
true when population
We estimated
the Z statistic
We estimated
the Z statistic
as: as:
sizes are small and susceptible to more variability, for example,
when there is migration within a country.
Despite these considerations, for most countries contributing
V
V
to CI5 a census occurred during the period 19982002. Hence,
Ln VIII - Ln IX
we can expect that the biases described earlier could be largely
nVIX
nVVIII
alleviated. However, in some registries the population figures
Z=
1
1
1
1
were estimated from a census performed more than 10 years
+
+
+
before the period used in Cancer Incidence in Five Continents,
VVIII nVVIII VIX nVIX
Volume IX.
With VVIII and VIX being the number of cases microscopically
Another limitation in the population figure is the choice of
VIX being
number
of cases microscopically
verifiedthe
in volumes
respectively,
andestimate.
nVVIII and The best estimate
VVIII and VIII
verified With
in Volumes
andthe
IX,
respectively,
and nVVIII and
date in VIII
the and
yearIX,for
population
nV being the number of cases not microscopically verified in Volumes VIII and IX, respectively.
nVIX being IXthe number
of
cases
not
microscopically
verified
in
of
the
population
at
risk
for
a
specific
year in which cancer
We considered the difference in the proportion of cases microscopically verified to be significant if Z was greater
Volumesthan
VIII1.96.
and IX, respectively.
incidence was observed is considered to be at mid-year, and
We considered the difference in the proportion of some registries provided yearly population estimates for the 1st
microscopically
verified
Population
at risk cases to be significant if Z was greater of July. However, this is not a systematic practice and many
Population at risk figures are used as denominators in the formulas forregistries
the calculation
of incidence
rates, crude statistics
or adjusted. estimated at the
than 1.96.
provided
populations
These denominators are often disregarded, and readers tend to onlybeginning
focus on the
incidence
rates
the In a population
of final
the year,
using
theand
1st discuss
of January.
variability
notion isthe
driven
st age standardisation
Population
at riskin incidence data gathering (completeness, classification).
thatThis
increases,
use by
of 1the
of January for population size could
process, which tends to eliminate the effect of population age structure and gives the reassuring but false impression that
Population
at riskstructure
figures
arelonger
usedinfluencing
as denominators
theIt must
induce
a systematic
overestimation
of incidence
rates. It is
population
is no
the incidencein
rates.
be stressed
that denominators
are an essential
part
formulasofforthethecalculation
calculation
of incidence
crudetheir
or adjusted.
expected
to have
only be
a minor
Cancer Incidence in
of incidence
rates,rates,
and have
own biases and
limitations
that must
kept ininfluence
mind. Theinage
These denominators
often
disregarded,
and imprecise
readers tend
to size
Fiveestimation.
Continents, which uses a period of 5 years combined.
standardisationare
process
is not
intended to solve
population
Numbers
of incidence
population at
riskand
are discuss
routinelythe
collected
by registries from official statistical offices for example and
only focus on
the final
rates
variability
registries
these(completeness,
figures to Cancer classification).
Incidence in Five This
Continents
along with their incidence figures.
in incidence
dataprovided
gathering
Migration
notion is driven by the age standardisation process, which tends Population size could also be overestimated or underestimated
Comparability
to eliminate
the effect of population age structure and gives the if migration flux patterns are not considered. Some registries
Population size estimates are frequently calculated by the official statistical office using the results from a census and a
reassuring
but
false
impression
that population
structure
is no
population
data
projection
for the
years following
the most recent
census. The
closer collected
the year a population
estimate
is tocorrected
a census date,for
the immigration and
longer influencing
It mustwhen
be stressed
emigration.
Between-country
is often
better handled
more accuratethe
theincidence
estimate willrates.
be. Therefore
countries that
do not have
the same census
year, there willmigration
be differences
in
denominators
are anofessential
part of estimate.
the calculation
ofpopulation
incidenceestimates
than are
within
countryonce
migration,
which
is of major concern to
the precision
their population
Moreover,
often revised
a new census
is available
buthave
not alltheir
cancer
registries
updated that
figures.
Hence
drift and even
a significant
in incidence rate
rates, and
own
biasescollect
and these
limitations
must
be theregional
registries
taskedchange
with maintaining
optimal coverage of
between
theage
yearstandardisation
of the census andprocess
the preceding
could occur
simplypopulation.
because of the
imprecision
of the population
kept in mind.
The
is notyear
intended
to their
Indeed,
populations
of a highly nomadic nature
estimate. population
This is especially
true when population sizes are small and
susceptible
to more variability,
example,
when estimates a real
solve imprecise
size estimation.
make
the production
of inter for
censal
population
there is migration within a country.
Numbers
of population at risk are routinely collected challenge. Hence incidence figures for these populations must be
Despite these considerations, for most countries contributing to CI5 a census occurred during the period 1998-2002.
by registries
official
offices
for example
and be evaluated
with care,
and their
comparability
Hence,from
we can
expectstatistical
that the biases
described
earlier could
largely alleviated.
However,
in some
registries theis to be questioned.
registriespopulation
providedfigures
thesewere
figures
to Cancer
Incidence
in more
Five than 10 years before the period used in Cancer Incidence
estimated
from a census
performed
Continents
along
with their
incidence
figures.
A few words of caution
in Five
Continents,
Volume
IX.
Another limitation in the population figure is the choice of theCancer
date in isthe
year for that
population
best ages, and standard
a disease
mainlyestimate.
occurs The
at older
estimate of the population at risk for a specific year in which cancerpopulations
incidence wassuch
observed
is considered
be at midComparability
as Segi
have the to
tendency
to give more weight
st
of July. However,
this age
is notgroups
a systematic
practice
year,
andestimates
some registries
provided yearly
population
estimates
for theto1 incidence
Population
size
are frequently
calculated
by the
official
in young
and hide
differences observed
st
and many registries provided populations statistics estimated at the beginning of the year, using the 1 of January. In a
statisticalpopulation
office using
the results from a census and a projection in older populations. Therefore it cannot be stressed enough
that increases, the use of 1st of January for population size could induce a systematic overestimation of
for the years
following
the
most recent
census.
Theinfluence
closer the
thatIncidence
neitherinthe
ratea nor
the cumulative rate
incidence
rates. It is
expected
to have only
a minor
in Cancer
Fiveage-standardised
Continents, which uses
period
year a population
estimate is to a census date, the more accurate are alternatives to the age-specific incidence rates, which should
of 5 years combined.
the estimate will be. Therefore when countries do not have the always be the starting point and foundation of any thorough
Migration
same census
year, there will be differences in the precision of their analysis of the incidence data.
Population size could also be overestimated or underestimated if migration flux patterns are not considered. Some
registries collected population data corrected for immigration and emigration. Between-country migration is often better
handled than within country migration, which is of major concern to regional registries tasked with maintaining optimal
References
coverage of their population. Indeed, populations of a highly nomadic nature, make the production of inter censal
population estimates a real challenge. Hence incidence figures for these populations have to be evaluated with care, and
Ahmad their
O., comparability
Boschi-Pintois toC.,be Lopez
A., Murray C., Lozano Doll R., Payne P., Waterhouse J. (1966). Cancer
questioned.

Incidence
R., Inoue M. (2000). Age standardization of rates: a new
in Five Continents: A Technical Report. Berlin: SpringerWHOA few
standard.
GPE Discussion Paper Series: no31.
Verlag (for UICC).
words ofIncaution
Cancer is a disease
mainly occurs at older ages, and standard populations such as Segi have the tendency to give more
Geneva:World
Healththat
Organization.
weight to incidence in young age groups and hide differences observed in older populations. Therefore it cannot be

Bray F., Guilloux A., Sankila R., Parkin D.M. (2002). Practical
implications of imposing a new world standard population.
Cancer Causes Control 13:175-182.

Keyfitz N. (1966). Sampling variance of age standardised


mortality rates. Human Biology 38; 309-317.

114
Breslow
N.E., Day N.E. (1987). Statistical Methods in Cancer
Research, Volume II: The Design and Analysis of Cohort
Studies. Lyon: IARCPress:59.

Segi M. (1960). Cancer Mortality for Selected Sites in 24


Countries (1950-57). Sendai, Tohoku University School of
Public Health.

101

The Narratives and The Maps

117

Africa

Africa

Algeria, Stif
Registration area
The Stif Cancer registry covers the population of 10 dairates,
which include a total of 60 communes. The population at the last
census (1998) was 1 299 117, representing 4.33% of the overall
Algerian population making it the second-largest population
centre after Algiers. The population growth rate for this area
in 2001 was 1.8%. About 48% of the population live in rural
areas, and 99% are Sunni Muslims. The Wilaya (province) of
Stif covers an area of 6504 km2, corresponding to 0.27% of
the country. The Wilaya of Stif is the capital of the highlands,
having an altitude of 1300m and a semi-arid continental climate.
It represents 4.7% of the national population at a density of 213
inhabitants per km2.

hospitals and ofces, insurance ofces, other cancer registries


in Algeria and death registration ofces. The death registration
system is incomplete; the certicates of death are examined
and a record completed for each certicate mentioning cancer
or malignant tumour. Collection is primarily active. For each
patient we collect data from four or ve different sources, which
permits the information to be completed and checked before
coding. For each cancer case a limited number of variables
(18) have been put into a sample record. The variables include
the sources of information. For the tumour, only four variables
are collected, including the date of diagnosis, the site, and the
morphology. The data are coded according to ICD-O. Impossible
or improbable combinations (site, sex, age and morphology)
are identied by computer.
Duplicate registrations have
been reduced to a minimum
ALGERIA, SETIF (1998-2002)
thanks to a careful control of
ALGERIA, SETIF (1998-2002)
name, sex, date of birth and
diagnosis. The registry staff visit
these sources once a month.

Cancer care facilities


General health care in the region
is provided predominantly by
the CHU (University Hospital
Centre) and 6 other hospitals,
16 health centres and 55
primary care centres. These
Interpreting the results
are supplemented by private
Arrangements have been made
practitioners and hospitals for








 





with the hospitals outside the


a total of 2115 beds, or 1 bed







registration area to notify the


per 690 inhabitants. The total














registry of any area-resident


number of health workers is







cancer cases that they may


5772: 215 public specialists,














diagnose and treat. These


198 private specialists, 387





 

outside hospitals are visited


public generalists, 278 private














regularly to collect records, but


generalists, 2944 public nurses

 





some small underestimation due


and 50 private nurses.





 


 





to cancer cases treated outside


The CHU, located in







the area is possible.


Stif, provides cancer surgery
and chemotherapy services.







(#%


(#%
Uses of the data
Radiotherapy is provided by the
 


')$('"'(((

The registry has prepared a
cancer centres of Constantine
report of cancer incidence from
(120 km distant) and Algiers
  

1986 to 2005, with 20 years of
(300 km distant), and as a result 
(  ( ( ***,!,! ,!!(
(

((
(( ( **)((
(
      
( 
(#!%(
many patients are treated in Algiers
and Constantine. All breast registration highlighting trends and changes. A study of survival
  
cancers are treated at the breast health
centre in Algiers. A large of registered cancer cases of breast, colon, rectum, large bowel,

(  (

((
(
(
(
((
(

( (

(+(

( 
(&(#
 %(
new Cancer Centre is now being implemented in Stif, and is and prostate during 19901994 has been carried out within the
expected to provide care for all cancer patients from the area of CONCORD Survival study.
about 5 million inhabitants in 2008.
Registry structure and methods
The registry, founded in 1989, is located in the epidemiology and
preventive Medicine service of the Hospital Mere Enfant of the
CHU in Stif under the auspices of the Ministry of Health and
Ministry of Research and Education. The registry is staffed by two
epidemiology assistants, one pathology assistant, one technician
in epidemiology, and 3 postgraduate students in epidemiology.
The Stif Cancer Registry uses active case nding from 16
sources of data consisting of University Hospital Centres, cancer
hospitals, public health hospitals, pathology laboratories, private

Source of population
The populations of 1999 2000 2001 2002 are estimated on
the basis of the1998 National Census.
Multiple primary rules used
IACR rules (2000)
Notes on the data
The Editors recommend that some care be taken in the interpretation of these data; see Chapter 5 (Categorisation).

105

Africa

Egypt, Gharbiah
Registration area
The Gharbiah Population-based Cancer Registry (GPCR) covers
the population of eight districts (Tanta, Elmahalla Elkobra, Kafr
Elzayat, Zefta, Kotour, Elsanta, Basyoun & Samannoud) within
the state of Gharbiah, in the west and central Delta region in
lower Egypt. The population at the most recent census (1996)
was 3.406 million (5.7% of the total population of Egypt).
About 40% of the population lives in urban areas. The majority
are Moslems and the remainder are Christians.

The death registration system is adequate; the cause of


death from cancer is often mentioned. The registry staff visit
these sources, where they scrutinise the records kept in medical
records departments and the registers of individual departments
concerned with diagnosis and treatment of cancers in order to
identify and abstract information on cases of cancer, diagnosed
by all methods, among residents of the registry region.
Although cancer is a notiable disease by administrative
order (without a specic law), few registration forms are received
from private practitioners. Arrangements have been made with
the hospitals outside the registration area to be visited every
13 months according to workload in order to abstract resident
cancer cases which are diagnosed and treated in them.

Cancer care facilities


General health care in the region is provided predominantly by
the Gharbiah Health Services Department (Ministry of Health
and Population), through the
Interpreting the results
district hospitals and a network
of primary health centres.
It is not possible to estimate
EGYPT, GHARBIAH (1999-2002)
These are supplemented by
how many cancer cases remain
EGYPT, GHARBIAH (1999-2002)
Tanta University Hospitals,
undiagnosed, but underdiagnosis
insurance hospitals and clinics,
probably occurs for elderly
private practitioners and private
subjects in rural areas. TCC has a
hospitals. The Tanta Cancer
full range of diagnostic facilities,
Center (TCC) is located in Tanta,
so that it is unlikely that cases
the principal town and capital of
referred will be missed.














Gharbiah, and provides cancer


There is a breast cancer







surgery and chemotherapy


early detection program in Tanta














services. Gharbiah Cancer


Cancer Centre. PSA testing is







Society (GCS), NGO, and the


not common in this population.














radiotherapy department at
Bladder cancer, which is the







Tanta University Hospital in the


most common cancer in Egypt, is







 



 
 

vicinity of Tanta Cancer Centre


related to Schistosomiasis, which







provide radiotherapy services.


is currently being eradicated.








 


 


In the registry area, patients


Smoking is becoming the most







at the primary and secondary


important risk factor for bladder
care facilities suspected to have
cancer. Liver cancer incidence







'"$


'"$
cancer are generally referred
is high compared to almost all




')%('& )'''

to TCC or to one of the two
countries in the world except some
hospitals with comprehensive 
  
in Asia and Africa; this could be
**&'
' '
'  ' ''
''''' 
''

'
cancer services within a 60-km 
'

' '
'  ,, ''
''
'
attributed to high prevalence of
 '''' '
'
 '
+'
radius (Mansoura Urology Center 


  
& Mansoura Gastroenterology the hepatitis virus, mainly HCV. Aatoxin contamination might be
' 
'"!#$''%''
'
Center) or to the National Liver Institute, Menoufeya University another risk factor. High incidence of NHL is another characteristic
(40 km distant), or occasionally to National Cancer Institute, feature in Egypt, but no specic culprit risk factor for this has been
Cairo University (100 km distant).
identied.
Registry structure and methods
The registry is located within TCC, and is sponsored by MECC,
the US National Cancer Institute in Bethesda, USA, and the
Ministry of Health and Population, Cairo, Egypt. A principal
investigator, executive director, two co-investigators and eld
supervisors, two data managers, four part-time registrars and
four full-time secretaries staff the registry.
The Gharbiah Population-based Cancer Registry (GPCR)
uses active case nding from 57 sources of data consisting
of cancer hospitals, general hospitals, university hospitals,
insurance hospitals, private hospitals and clinics, specialized
hospitals and centres, pathology and haematology labs and the
district death registration ofces.

106

Use of the data


The registry prepares an annual report of cancer incidence, highlighting
trends and changes. Some specic studies of survival of registered
cancer cases (breast and liver cancer) have been carried out.
Source of population
The estimate of the populationatrisk is based on the 1996
census, making allowance for births and deaths, but it was not
possible to estimate migration into and out of the registration
area.
Multiple primary rules used
IACR rules (2004) on CI5 IX period.

Africa

Tunisia, Central Region


Registration area
Tunisia, an Arab-Islamic North African country, is usually divided
into three regions: the northern, the central and the southern region.
The Central Region registry includes six provinces: Sousse,
Monastir, Mahdia, Kairouan, Kasserine and Sidi Bouzid.
Sousse province, with an area of 2669 km2 and the capital
of the central region, had a 2000 population of 495 000, 18.3%
of the overall population of the central region (2 697 200). The
population is relatively young, with 48.1% being under 20 years
of age, and 8% being over 60 years.
The main economic sectors of the region are agriculture,
industry (textile) and tourism.

suggest therefore studying the epidemiological particularities of


that province and not of the whole region. Moreover, we have
encountered other practical difculties related to the systematic
declaration of cancerous diseases, changes in patient names,
and the lack of information on the evolution of patients (treated
outside the hospitals of Sousse or lost).
These difculties are also due to the lack of precision in
issued death certicates, which can be a source of information
on the evolution of the diseases.
We have two national screening programs concerning
cervix and breast cancer. PSA testing is done only in university
institutions; to date there is no large screening program for
prostate cancer.

Registry
structure
and
Use of the data
methods
The registry develops an annual
The registry of the central
TUNISIA, TUNISIA,
CENTRAL
REGION
(1998-2002)
report on the incidence of
region, staffed by four full-time
CENTRAL REGION (1998-2002)
cancer in order to define the
physicians, is located in the
epidemiological profile of the
Department of Pathology of the
region and compare it with those
University Hospital of Sousse.
of the north and south regions
The search for new cases
of Tunisia and those of other
is proactive, which means that
countries. Certain special studies
the registry does not wait to be














of five-year survival of cervical


informed, but actively looks for







cancer, breast cancer and lung


information from certain specic














cancer have been performed.


sources. Primary sources include







Our registry is involved in


the Departments of Pathology of














some epidemiological research,


the public and private medical







especially in cancer genetics.


centres (ve, three of which are














Our registry is used as a base for


in Sousse). The other primary







planning and providing some


sources are the Departments














health services, for example


of Radiotherapy (in Sousse),







providing instruments for new


Oncology (in Sousse) and
cancer diagnosis and treatment
Haematology, in addition to







'# %


'# %
(radiation, new-generation CT
the other 24 departments of the



"&'&'''

scans, and mammographs).
University Hospital of Sousse.
In
addition
to
the   

Source of population
histologically conrmed cases, !))(+""'

'#'''
' 
%'
''!))$'
'
      
'
'#"$%''&''
'
more and more cases have been
discovered in recent years 19982002 estimates (Institut National de Statistique) based on
  
without microscopic conrmation
and are related to the gall the 1994 census.

' '

''
'
'
'
''
'
 
' '

'*'

' 
'&'#
%'
bladder, the pancreas, the prostate, the lungs and the ovaries.
Multiple primary rules used
IACR rules (2004) on CI5 IX period.
Interpreting the results
The registry counts all of the new declared cases of cancer in
the entire central region of Tunisia. Nevertheless, apart from Notes on the data
the province of Sousse where the completeness reaches 97%, a The Editors recommend that some care be taken in the
lack of completeness is observed in the other 5 provinces. We interpretation of these data; see Chapter 5 (Categorisation).

107

Africa

Uganda, Kyadondo County


The registry is computerised, and data management is
Registration area
The Kampala Cancer Registry collects data on the population carried out using the IARC/IACR CanReg software, which
of Kyadondo County, which includes the city of Kampala (the includes checks for consistency and validity and permits a
capital of Uganda), with its peri-urban areas and an area extending search for potential duplicate registrations.
Patient condentiality is ensured by using only registration
30km to the north. This population, which is mainly urban (80%),
is composed of the Ganda ethnic group (50%) and other ethnic numbers during analysis of data. The registry is off-limits for
groups (30%). There are also immigrants from neighbouring unauthorised persons.
Completeness of registration was evaluated at 90% for the
countries, particularly from Kenya and Rwanda. Europeans, Asians
period 19941996 (Wabinga et al, Cancer Causes & Control
and other nationalities make up 1% of the population.
The major activities of the residents of the capital include 2001; 12:147-52)
administration, trade, professional and para-professional activities,
personal services, and plant and machine operation. There are no Interpreting the results
major industries in the county; subsistence farming is carried out Since its inception in 1951, the county covered by the registry
has not changed its boundaries.
on the outskirts of the capital.
However
the
population
Fifty percent of the population
is
becoming
increasingly
are Catholic, 30% Anglican, 15%
UGANDA, KYADONDO COUNTY (1998-2002)
urbanised as the city expands.
Muslim and 5% other.
UGANDA, KYADONDO COUNTY (1998-2002)
Immigration is also increasing
Staple foods consumed by the
as part of the worldwide trend
population of Kyadondo County
of rural to urban migration.
include matoke (steamed green
Another factor that may
banana), posho (maize bread),
inuence incidence rates is the
beans and groundnuts. About
improvement in availability of
50% of the city dwellers receive
,.&1'...
/#1.1''...
&.00&...
,+!
'.&1#...
diagnostic services, particularly
chlorine-treated piped water from
+.#',...
,#!
,.&/0...
in the national referral hospital
the freshwater Lake Victoria.
+./1%...
++!
+.))&...
%#.1/0...
+#!
%#.+,'...
Screening
programmes
%+.'+'...
)+!
%'.&+&...
for cancer are not organised,
Cancer care facilities
&+.)''...
)#!
&&.#0%...
'/.10&...
'+!
'&.,&#...
but with the health-oriented
Kyadondo County is served
,&.%''...
'#!
+%.##)...
population of the county, many
by a 900-bed national referral
0+./,'...
&+!
0+.###...
1,.,)/...
&#!
%%+.%%#...
patients seek screening services.
hospital, Mulago Hospital,
0,.##0...
%+!
%%0.)'%...
PSA testing, mammography
which is well equipped with
0+.0/#...
%#!
%#).''1...
1'.,1,...
+!
11.1++...
and Pap smears are done on an
modern diagnostic facilities.
%%).%+%...
#!
%%+.,+%...
individual basis.
Mulago, which is also a teaching
Uganda was one of the rst
hospital for Makerere University
%#
+
#
#
+
%#
countries to be severely affected
Faculty of Medicine, is well
 .($*
  .($*
by the HIV/AIDS epidemic, and
supplied with consultants and
/1&.1+%...
/').#%+...

this has profoundly inuenced the
teaching staff in all disciplines
  

..  . .  . . .  . . ..
pattern of cancer in Kyadondo
of medicine. An oncology unit  .

.... .. . . . .%11&..&##&. .
.+. . .
".
involved in chemotherapy for various
types of cancer and a County (Wabinga et al, Int J Cancer. 1993; 54:26-36). However,
      
 . .(&##)*.. +..
.
radiotherapy unit are attached.  
The county has three other as a result of vigorous national campaigns, prevalence of HIV
 . .  .. . . . .. . 
 . .  .2. . 
 .+.(  *".
. .. . ..  . .. .
".
missionary hospitals with 100 beds
each. The Uganda Hospice infection is now fallingaccording to UNAIDS, prevalence in
provides services for the care of terminal cases of cancer in pregnant women in Kampala fell from 18.5% in 1995 to 13.8% in
addition to other terminal diseases. Two private histopathology 1998 and 8.3% in 2002. This, together with the slowly increasing
laboratories provide additional histological data to the registry. availability of anti-retroviral therapy, will result in changes in the
incidence of AIDS-related cancers.
Registry structure and methods
The Kampala Cancer Registry is situated in the Department of Use of the data
Pathology, Faculty of Medicine, Makerere University. Personnel The registry provides the longest continuous time series of
include a pathologist director, a cancer registrar and an assistant cancer incidence in Africa. This makes the data of special value
in cancer surveillance and research, particularly to monitor the
cancer registrar. All are employees of Makerere University.
However, in various hospitals and units the registry has effects of the HIV/AIDS epidemic and to serve as the baseline
recruited personnel to assist in coordinating collection of data. for analytical studies and intervention studies. The registry has
Submission of data to the registry is voluntary, as cancer is not also published the rst population-based estimates of cancer
a notiable disease, and registration is almost entirely active. survival in sub-Saharan Africa.
Doctors report a few cases to the registry directly. For hospitals,
hospices and histopathology laboratories, the registrars visit Source of population
at least once a month and consult the hospital records, which The population at risk is based on the results of the 1992 and
include admissions and discharge registers, clinical notes and 2002 census data, with intercensal years estimated from the
pathology reports. For each case both demographic and cancer observed rate of growth within 5 year age groups.
diagnostic data are sought. Certication of death is only carried
out for legal reasons, and is very incomplete, so death certicates Multiple primary rules used
IACR rules (2004) on CI5 IX period.
are not used as a source of information.

108

Africa

Notes on the data


The Editors recommend that some care be taken in the
interpretation of these data; see Chapter 5 (Categorisation).

This registry has the lowest histological verication rate in the


monograph.

109

Africa

Zimbabwe, Harare
Registration area
Harare is located in north-eastern Zimbabwe and is the capital city.
The population of the city according to the 2002 national census
was 1.9 million. The national population was 11.6 million.

Histology reports from the public and private sectors,


medical records of the radiotherapy department, death
certicates of patients dying of cancer in greater Harare,
and records of specic clinical research studies.
Hospital inpatients are interviewed to verify the accuracy
of reported age, residential status and other demographic data.
Cancer care facilities
The current difcult economic situation currently in Zimbabwe Information recorded on each case includes sex, date of birth or
is negatively affecting healthcare delivery, particularly in the age, residence, racial group, basis of diagnosis, tumour site and
public sector. In spite of this, the system in Harare, based on histology. Residence status is dened as the patients place of
a network of primary health care facilities provided by the residence during the previous six months.
All notications coming into the registry are thoroughly
municipality, government-funded referral facilities and a private
sector that caters mainly to middle- and higher-income groups, vetted to ensure that only incident cases are recorded.
Incident cases are veried by the treating doctors to conrm
continues to perform reasonably.
the diagnosis, and completed
forms are coded. The data are
Registry
structure
and
stored electronically using the
methods
ZIMBABWE, HARARE: AFRICAN (1998-2002)
IARC/IACR CanReg system.
The Zimbabwe National Cancer
ZIMBABWE, HARARE: AFRICAN (1998-2002)
Patient name lists are generated
Registry (NCR) was established
periodically
to
physically
in 1985 in Harare as a result of
eliminate duplicates.
an agreement between IARC
When several lesions of the
and the Zimbabwean Ministry
same histological type occur in
of Health. The target population
a patient, only the rst lesion is
of the registry is that of Harare














recorded. Subsequent lesions


city, and adequate population

 





are ignored. For example, the


coverage was achieved in 1990.












 

incidence of non-melanoma
Although the registry records all





 

skin cancer is very high in the


cancer patients identied from

 






 





white community of Zimbabwe,


its diverse sources irrespective





 

and many patients develop


of residence, the present data












 

several lesions of the same


for 19982002 are conned to





 

histological type during their


the Harare city population.














lifetime. However, if basal cell


The activities of the registry

 





carcinoma and squamous cell


are overseen by a constituted
carcinoma of the skin occur in
advisory committee, and the






the same patient affecting the
day-to-day administration is the
 +&#(
  +&#(



-*,+-%,+++

same or different sites, they are
responsibility of the registrar
recorded separately.
under the guidance of the
  

medical director. The registry + +%""% +++ +$..-0%""%+
 + ++ 
+
      
has four full-time staff comprising
the registrar, secretary Use of the data
 + +&%""'(++ )++
+
and two data collection clerks.  
It is strategically located at Data from the registry are extensively utilised by both indigenous
 + +  ++ + + + ++ + 
 + +  +/+ + 
 +)+&  (!+
+ ++ + ++  + ++ +
!+
Parirenyatwa Hospital, a large government
referral centre and and foreign researchers, lecturers, students, conference participants,
also the location of the University of Zimbabwe College of health educators, and the Ministry of Health and Child Welfare for
Health Sciences. The registry is supported by the Ministry of management planning and cancer control programmes.
Health and Child Welfare, the IARC and other organisations.
Case-nding is mainly active, with the registry staff visiting Source of population
institutions within the healthcare delivery system which are Claimed to derive from the 2002 census, but the data do not
correspond to the period 1998-2002.
involved in the management of cancer patients.
The registry information sources include:

Routine weekly visits to the inpatient wards of the


two government central referral hospitals (Harare and
Parirenyatwa);

Medical records of discharged and deceased cancer patients


from the two central hospitals and visits to oncology
outpatient clinics;

110

Multiple primary rules used


IACR rules (2004) on CI5 IX period.
Notes on the data
The Editors recommend that some care be taken in the
interpretation of these data; see Chapter 5 (Categorisation).
This registry has the lowest histological verication rate in the
monograph.

Central and South America

Central and South America

Argentina, Bahia Blanca


has been received from IARC. The foundation Alberto J.
Registration area
The Regional Tumor Registry of the South of the Province Roemmers provided funds for epidemiological research in
of Buenos Aires covers an area corresponding to 15 political 20002001, and the National Ministry of Health in 2004.
Data collection is mainly active. The sources of cancer cases
areas, with a population of 627 505 inhabitants in 2001. The
data presented are for the political area of Bahia Blanca are public, private and military hospitals, as well as pathology
laboratories and a flux cytometry laboratory. We also visit
(population 284 776) only.
Bahia Blanca is mainly an urban area, with a large Radiotherapy Institutes and haematology doctors ofces.
Data management is carried out using the IARC/IACR
petrochemical industry. The remainder of the population
CanReg software.
lives in small rural villages.
Practically 100% of the population is white, most of
them descended from European immigrants who arrived Interpreting the results
during the late 19th and early 20th centuries. In some political There have been few changes in the population since the
areas, such as Coronel Suarez, there are settlements of establishment of the Registry. The Registry has more
information sources for this
German descendants. In the
period compared to in 1989
south of the province, there
92 and 19931997, so the data
is a varying population of
ARGENTINA, BAHIA BLANCA (1998-2002)
are now more complete.
workers who come from Chile
ARGENTINA, BAHIA BLANCA (1998-2002)
There are no organised
for the onion harvest, but the
screening programmes within
permanent Chilean population
the region. PSA is used more
amounts to less than 5%.
frequently, but it is not possible
The predominant religion is













to determine the proportion


Catholic, but there are also







of the male adult population


other Christian minorities.





 








screened.







Cancer care facilities



 







 

Use of the data


The two public hospitals of the







Reporting of incidence is
area have oncology services.











considered the most important


Surgery is performed in the







activity of the registry, as


general surgical services.

 



 







population-based
cancer
There are two private







registration is so limited in the


radiotherapy institutes, which





 


 





country.
also treat patients from public





 

In combination with the


hospitals; one has a linear
registry, the Epidemiological
accelerator.
Computerised






Investigation Unit on Cancer
tomography is available in
 % "
 % "
performs
some
tobacco
almost all of the larger public


$%&''%%%

control activities.
and private institutions, and

  
During the last three
one of them has a nuclear  %  %
% %(%)  % % %% %%   %%
 


  
years we have been consulted at the national and provincial
magnetic resonance imaging facility.
%  % !"%%#%% %
levels to develop new cancer registries, and we have trained
professionals and technicians in the provinces of La Pampa
Registry structure and methods
Although the registry was recognised by Provincial law and and Jujuy, where new cancer registries have recently been
a municipal resolution in 1993, it still does not have a specic established.
The registry is currently involved in epidemiological
budget. It is based in the Dr. Jose Penna General Hospital
and its Director has been appointed Chief of the Biomedical research, and policymakers use our data for planning and
Investigation Unit, but no specic personnel or funds have evaluation of health services.
been assigned. The Argentinean Association for Education
and Prevention of Cancer, a non-prot organization founded Source of population
in 1986 to improve cancer control, maintains the registry The estimate of the populationatrisk is based on the 2001
and other high-priority activities of the Association, such Census.
as the Tobacco Control Programme. Although its resources
are limited, it is able to pay for a registrar, and has provided Multiple primary rules used
small fellowships for training young students. Some support IACR rules (2004) on CI5 IX period.

112

Central and South America

Brazil, Brasilia
Cancer care facilities
Registration area
The PBCR Federal District (DF) covers the capital city, in the In 2002 the DF had 60 hospitals: 14 state-provided, 5 federal
Mid-West region of Brazil. It is located between 1530 and and 41 private. Early Detection programs are available in basic
1603 South latitude and 4725 and 4812 West longitude, care units (68 Health Centres and Units with Family Health
covers an area of 5 789.16 km, with 255.25 km being urban Program - PSF), and in the regional referral units (10 Regional
and 5533.91 km being rural. The climate includes tropical Hospitals). The Federal District has High Complexity Centres
savannas and temperate rainy areas with dry winters; of Cancer Treatment (CACON) at 3 hospitals.
annual average temperature is 20.5C (69F) with average air
humidity varying between 39 to 83%, being lowest in August Registry structure and methods
and September and highest in December. The altitude is The Epidemiology and Regulation Management coordinates
the Population-Based Cancer Registry in the DF and
between 1000 and 1152 meters above sea level.
The last demographic census carried out in 2000 by supervises, assesses and monitors the hospital-based cancer
the Brazilian Institute of Geography and Statistics (IBGE) registries in this district. In the DF there is a Skin Cancer
Registry that assesses skin
disclosed that in the DF,
cancer cases diagnosed in the
the resident population was
public health system.
2 139 580 inhabitants (1
BRAZIL, BRASILIA (1998-2001)
The PBCR of the Federal
069 790 women and 981
BRAZIL, BRASILIA (1998-2001)
District registers all the cases
356 men), distributed in 28
of cancer (invasive and in situ)
Administrative Regions, with
and benign CNS tumours
4.2% (89 647) in the rural
(in children and adolescents
area. The vast majority of the














under 19 years old) diagnosed


population is Catholic.







in the DF resident population.
















Cancer is not a notiable


Interpreting the data







disease. The main sources


The life expectancy for those

 










 

of data collection are located


born in 2000 was of 69.24







in pathology labs, health


years. Currently, the Federal

 










 

information systems, hospitals


District as well as the whole

 





and private oncology clinics.


country is experiencing rapid














and expansive demographic


The PBCR initiated its







change, with an aging


activities on 27 November














population and consequent


1997 and follows the rules







increase in the chronic


of the National Institute of
degenerative illnesses reected
Cancer/Brazil (INCA). It uses






in mortality statistics. In 2002,
SISBASEPOP/INCA software
  0+' !  0+'/),000
$
1*2000
cardiovascular illness was the
and it has published data referring




3/*0&12000
 
most frequent cause of death
to the years 19962001.

  
in the DF, representing 27.7%
0)&&&$0(332#0(333#0)&&(#0)&&)0 !  0"0  0 00  0  0 040% 0
 


  
of all deaths, followed by cancer
(16.6%). In 1979 cancer Use of the data

0 0+)&&,-00
.00  0
was responsible for 9.4% of the deaths in the DF; therefore, The Cancer Registry works in cooperation with Cancer Care
from 1979 to 2002 cancer mortality increased by 76%. The Coordination, which is responsible for planning, evaluating and
Ministry of Health (MS) has been publishing data on causes executing the Oncological Plan for the DF. The structure of the
of mortality in Brazilian capitals since 1944. In 1975, the coordination includes Care Delivery Management, Primary
MS implemented the Subsystem of Information of Mortality Prevention Management, Early Detection Management,
(SIM), dening the national model of death certication Epidemiology and Regulation Management, Financial and
and centralising the processing and annual publication of Human Resources Management, Palliative Care Management,
these data. The quality of information in the DF is partially and Evaluation, Teaching and Research Management. It is
attributed to low levels of unclear causes of mortality (0.8 responsible for planning and coordinating health promotion,
5%) in the last ve years, the lowest rate among states of prevention and care activities in the district.
the federation. A study carried out in 130 480 deaths in the
DF from 19791988 disclosed that 16 098 deaths had cancer Source of population
as the primary cause; 41.3% of the deaths had been veried Census 2000. 1998, 1999, 2001, 2002 estimated by Brasilian
through autopsies. However, in the deaths caused by cancer, Institute of Geography and Statistics (IBGE/DATASUS).
only 12.2% were submitted to necropsy; the younger the
patient the higher the number of autopsies. Thus, the fewest Multiple primary rules used
autopsies were performed in patients over 74 years old.
IACR rules (2004) on CI5 IX period.

113

Central and South America

Brazil, Cuiaba
Registration area
The PBCR of Cuiab covers the cities of Cuiab and Vrzea
Grande, in the Midwest region of Brazil. Cuiab and Vrzea
Grande have a total area of 4482 Km2. About 98.44% of the
population (some 686,481 inhabitants) lives in urban areas,
and the annual growth rate is 2.72% for Cuiab and 2.66%
for Vrzea Grande.
The city of Cuiab is 177 meters above sea level, and
Vrzea Grande, 191 meters. The climate is continental
tropical, with a mean annual temperature of 33C.

Registry structure and methods


The PBCR was established in 1999, and data collection
started in the year 2000. It is located in the Health Care
Department of the State Health Secretariat of Mato Grosso,
and has xed funding.
The registry staff includes a coordinator, a supervisor
and 3 registrars. The advisory committee includes an
epidemiologist, a pathologist and an oncologist.
Data are actively collected from 25 sources: one specialised
hospital, two university hospitals, one general hospital, 10
pathology labs, one hematology clinic, two oncology clinics,
two radiation therapy clinics, and 6 chemotherapy clinics.
Information on deaths is retrieved from the Mortality
Information System (SIM).

Cancer care facilities


The State Cancer Control and Prevention Coordination
of
the
State
Health
Secretariat of Mato Grosso
has been working to
meet the needs for those
BRAZIL,
CUIABA
(2000-2002)
BRAZIL,
CUIABA (2000-2002)
who work in the eld
of oncology, supporting
prevention and delivery of
care actions, research and











 

epidemiological studies.







Health progra ms and







 


 





services are provided by









4 public hospitals and 1
















private hospital, with 162









public beds (2.3 per 1000
















i n habit a nt s). T her e a r e









also healthcare units with















cancer prevention and early









detection facilities. Other
















cancer diagnostic and









treatment facilities include:


two radiation therapy clinics,






5 chemotherapy clinics, and
 -)%+
  -)%+
10 pathology labs. There are



(,$-*.'--
22 universities, 3 of which

  
'$$&--'$$'"-   #-'$$$0- #-  -!-- - - 

---1--1- - have medical schools.
)#! ##!+ 


  
 - -)&//$+--

114

Use of the data


In addition to determining
cancer incidence and
geographic distribution in the
city of Cuiab, the information
has been used to study temporal
trends, to provide access to
screening programs, to collect
dat a for epidem iologica l
studies, to provide resources
for teaching and delivery of
lectures, and to support cancer
prevention and care actions.
Source of population
2001 and 2002, estimates. 2000:
census. Estimated by Brasilian
Institute of Geopgraphy and
Statistics (IBGE) Official
Bureau (www.ibge.gov.br).
Multiple primary rules used
IACR rules (1990).

Central and South America

Brazil, Goinia
also an Advisory Council comprising seven specialists in
Registration area
The Cancer Registry of Goinia is a population-based cancer oncology.
Data collection is active and no precoded data are received.
registry that covers an area of 739 Km2. The city is a part
of the central plateau in Brazil. The local altitude is 800 The main sources of information are the Cancer Hospital,
meters, at latitude 16 40 and longitude 49 15. The climate outpatient cancer clinics, histopathology laboratories and
is tropical and the city is hot and sunny almost all year. the University Hospital. The registry has access to death
The average annual temperature is 1030C.The humidity certicates, which include identifying information. Cancer
averages 43% during the winter and 74% during the summer. is not a notiable disease.
Quality control procedures include verication of date
Two rivers, Joo Leite and Meia Ponte, cross the city and
provide its water. Goinia, the second planned city in Brasil, of birth versus topography, sex versus topography and
morphology, etc. Analyses of incidence and mortality
is now 72 years old.
The majority of the population comes from rural areas. In the being evaluated include: cervix cancer, breast cancer, and
last ten years, the population migrating to the city is decreasing, prostate cancer. We also carry out studies on survival of
cervix cancer, breast cancer,
because agricultural industries
colon cancer, larynx, mouth,
are increasing in the rural
oesophagus and cutaneous
areas. The ethnic composition
BRAZIL, GOIANIA (1999-2002)
melanoma.
is primarily mulattos and
BRAZIL, GOIANIA (1999-2002)
whites, with a few blacks. The
Interpreting the results
main religion is Catholic but
There
are
screening
the number of evangelicals is
programmes for detection
increasing.
of breast, skin and prostate













cancer. PSA testing is not


Cancer care facilities







common.
We have one Cancer Hospital








 





founded 50 years ago, which







 








Use of the data


provides 180 beds, chemotherapy,







Data on incidence are reported


4 radiotherapy machines, surgery,








 





to the providers of information


and chemotherapy, as well as





 

to the registry, and the registry


bone marrow transplantation














collaborates with postgraduate


since 2000. There are 5 private







students
doing
theses.
clinics also doing chemotherapy.





 


 



 

Research is being carried out


The cancer centre also provides







on cancer of the oral cavity,


cancer training courses in
larynx and oesophagus in a
surgery, radiotherapy and






collaborative study.
chemotherapy.
"! /+' #"! /+'(,0///
.)*/.(&///

%
"!

(1,///
 


Source of population
Registry structure and

  
#" /$/"!"/ // " /" /"/2//2/ "!/ "/+
%$ %%$-/
Estimated by the Brasilian
methods
The registry is located in the 


  
Cancer Hospital. Financial Institute of Geography and Statistics (IBGE) Ofcial Bureau

/! /+)&&,-//
.//  /
support comes from the Associao de Combate ao Cancer (www.ibge.gov.br).
em Gois (ACCG).
The registry is coordinated by an oncologist. Four Multiple primary rules used
people collect data and there is one to code. There is IACR rules (2004) on CI5 IX period.

115

Central and South America

Brazil, So Paulo
Registration Area
The So Paulo Cancer Registry covers the resident population
of the city of So Paulo, capital of the State of So Paulo,
located in the Brazilian Southeast Administrative Region.
The population data is based in the most recent Census (2000),
and it includes more than 10 million people, mostly urban
(almost 99%) and formed by migrants of many nationalities
(Italians, Portuguese, Spanish, Japanese, Germans, etc.). A
high percentage of the population is Catholic.

Although cancer is not considered a notiable disease,


the methods of data collection are mixed; some hospitals
have active notications (spontaneously) of newly diagnosed
cases, and others have passive notications. The main data
sources (380 units) are hospitals (some are cancer hospitals)
and pathology laboratories.
A special study of survival of cervix cancer and
breast cancer in young women illustrated the very good
completeness and accuracy of the information recorded in
the registry.

Cancer care facilities


General health care is provided by the local and state Interpreting the results
health services departments through the district health There are breast and cervix
centres
and
hospitals,
supplemented by private
practitioners and covered
BRAZIL, SAO PAULO (1998-2002)
by insurance. Regarding
BRAZIL, SAO PAULO (1998-2002)
cancer, So Paulo has many
hospitals, radiotherapy and
chemotherapy services and
pathology laboratories.

cancer screening programmes


in the area covered, and PSA
testing is also common.
Use of the data
Annual reports on cancer
incidence and mortality are
prepared highlighting trends
and changes. Some special
survival studies (cancer in
childhood and cervix cancer)
have been carried out.
Many graduate students
use the registry data bank for
their PhD theses or Masters
Degree dissertations; the local
health authorities use it as
well.

.',!%.,,,
-)+
#)%,))),,,
Registry structure and
-*,#/#,,,
-!
##%,--*,,,
#!#,!.-,,,
*)
#%.,'#.,,,
methods
#%$,*-',,,
*!
#-!,-*),,,
The Registry belongs to the
#**,$-),,,
))
$!$,.)$,,,
$$-,.-/,,,
)!
$*/,$--,,,
Department of Epidemiology
$.','#!,,,
')
%%#,.*/,,,
of the School of Public Health
%'$,!/*,,,
'!
%/!,%!$,,,
%.-,/).,,,
%)
'%#,-#-,,,
of the University of So Paulo,
'$%,#./,,,
%!
')),$'),,,
one of the ve preeminent
').,'.#,,,
$)
'./,$)#,,,
'..,%!$,,,
$!
)#-,.)',,,
Brazilian universities.
'-%,/*',,,
#)
'/#,'%/,,,
The nancial support is
''!,/'$,,,
#!
'%-,%!.,,,
'$),*!%,,,
)
'#',%'#,,,
Source of population
provided at all three government
')#,!%-,,,
!
'%*,%.*,,,
Census 2000. 1998, 1999, 2001,
levels (local, state and federal
2002 estimated by Foundation
resources). A coordinator (a
#!
)
!
!
)
#!
Seade (Ofcial Institucion For
cancer surgeon physician),
 ,&"(
  ,&"(
Population Statistics In The
8 data collectors, and three
),''',%)',,,
',/*',#$-,,,

State Of Sao Paulo).
informatics
processors

  
compose the administrative ,$!!! ,#//.,#///,$!!#,$!!$,  ,,,  ,& ,,,
,,, , , ,,( ,
 


  
framework. There is also a Scientic
Commission that provides Multiple primary rules used
 , ,&$!!'(,, ),,
,
IACR rules (2004) on CI5 IX period.
epidemiological, statistical and pathology assistance.

116

Central and South America

Chile, Valdivia
Registration area
Valdivias registry area corresponds to Valdivia province,
which is divided into 12 districts, located in the 10th region
in the south of Chile. The total population of the province,
based on the last 2002 census, is 356 396 inhabitants, with
a male:female ratio of 1:1; the rural population reaches 38%.
Some 70% of the population is in the public health system.
According to the 2002 national census, among the
population over 15 years old in Valdivia province 62.5%
are Catholic, with 24.5% evangelicals, 7.8% atheists and
5.2% other religions. Ethnic groups comprise 11.4%; the
indigenous Mapuche represent 99.1% of these.

We use the CanReg program to register the basic variables


dened for the population cancer registries of Chile. The quality
standards used are: Percentage of cases with microscopic
conrmation; Percentage of cases with death certicate only;
Percentage of cases registered without age; and Ratio mortality/
Incidence. Cases are maintained condentially, preserving the
patients individual information.

Interpreting the results


It is not possible to estimate the proportion of cases of Valdivia
residents who choose to continue study or seek treatment in
another province, but it is considered to be low as Valdivia
Regional Clinical Hospital is the referral centre for the southern
area of the country.
Cancer care facilities
Data are evaluated by
The health care network of
checking different data sources
Valdivia province is mainly
CHILE, VALDIVIA (1998-2002)
and their validity, as well as
public. It comprises 16
CHILE, VALDIVIA (1998-2002)
the coding system and correct
primary care centers and
computational support and
8 public general hospitals,
quality standards. We apply the
which refer their patients
IARC Check program once a
with presumed oncological
'/'(*///
1$.
(/$1$///
year in order to nd and correct
diseases to Valdivia Regional
'/*$0///
0,"
(/$02///
any errors.
Clinical Hospital. This is
(/*$0///
0$"
*/&-(///
*/-'-///
-,"
,/(2&///
There
are
national
the only oncology centre of
,/,$*///
-$"
-/&11///
programs of early detection
the registry area, and it also
-/2$(///
,,"
0/'$$///
1/'((///
,$"
1/*('///
for cancer of the cervix (Pap
provides teaching and health
&$/&-0///
*,"
2/00&///
smear) and breast (physical
services in coalition with the
&'/-&$///
*$"
&'/$1-///
&*/1((///
(,"
&*/&-0///
exam and breast x-ray in
Universidad Austral de Chile.
&(/2*&///
($"
&(/0*0///
high risk group). There
This core hospital has
&(/(10///
',"
&(/&''///
&(/2-&///
'$"
&(/*,-///
is no national program of
a pathology laboratory and
&-/1*$///
&,"
&-/$*,///
PSA testing; it is usually
provides surgical, radiotherapy
&1/-*(///
&$"
&0/-&1///
&1/(,2///
,"
&0/,0,///
requested in patients with
and chemotherapy treatments.
&,/1,,///
$"
&,/(-(///
benign prostate hyperplasia,
The
child
radiotherapy
and sometimes requested in
treatment facility is the only
&$
,
$
$
,
&$
preventive medicine.
one in our region.
 /)%+
  /)%+
No environmental changes
&1$/*1*///
&1&/2&$///

Registry structure and
that would affect cancer incidence

  
 / // /  ///  / /  /&$/ #/ // ///'$$'/ #/ / / /  / /
methods
have been registered during the
 /  / / / !/  //
 /
The population cancer registry 


  
is in the Epidemiology Unit study period, but in 2004 a cellulose factory began operating.

/ /)'$$*+//
,// /
Ofce of Valdivia Province, which is part of the Regional
Health Authority of the 10th region, a dependent unit of the Use of the data
Undersecretary of Public Health of the Health Ministry.
The registry has prepared incidence reports for publication in
It receives technical support from the oncology committee the epidemiology bulletin El Vigia from the Health Ministry,
of Valdivia Regional Clinical Hospital and it has one nutrition and which are available on the Ministrys web site. Last year
professional with 33-hour week and two physicians part- we completed specic survival studies in gastric and gall
time, all with masters degrees in public health.
bladder cancer; these were provided to the groups in charge
The registry uses six information sources, passively of the protocols for both diseases in the Health Ministry.
receiving weekly notifications from the pathology
Registry information was also used in planning
laboratory of the Valdivia Regional Clinical Hospital and modernisation and enlargement projects for the oncology
actively reviewing all of the clinical records of previous service at Valdivia Regional Hospital.
weeks patients discharged with cancer diagnosis,
both from the Regional Hospital of Valdivia and from Source of population
the private centres. Also, all cases that enter through The National Statistics Institute makes a national population
particular units and programs are reviewed: Hematology, census every 10 years. the last of which was in 2002. This
National Program for Cancer Medication (drugs) and provides a projection of the population for each region,
Pain Control Program. The registry also has access to province and commune.
review all of the provinces death certicates and the
data kept by the Statistical Departments of the Chilean Multiple primary rules used
Health Ministry.
IACR rules (2004) on CI5 IX period.

117

Central and South America

Colombia, Cali
Registration area
clerks and a secretary. Once a year, a group of specially
The Registry, in operation since 1962, is limited to the urban area trained medical students is selected to carry out a eld survey
of the city of Cali. Cali is the capital of the Department of Valle, of les of all private physicians who diagnose or treat cancer
one of Colombias 32 departments. The department is located in patients. The registry staff and part of the operating cost are
the south-west of Colombia on the Pacic Ocean. Cali is situated covered by de Universidad del Valle. Most of the operating
1000m above sea level between the Cauca river to the east and the costs are obtained from foundations and specic grants for
chain of the Andes to the west, at latitude 327 N and longitude each activity.
The CCR registry uses active case nding from 57 sources
731 W. The average temperature is 24C. The urban registration
area of the registry is 120.9 km2. The population at the most of data, including cancer hospitals, general hospitals, teaching
recent census (2005) was 2 030 000. The great majority of the hospitals and 32 pathology laboratories. The information
population are Mestizos (a mixture of Spanish and Indian) with a from death certicates is obtained from the Municipal Ofce
minority of blacks and whites. More than half of the population of Vital Statistics to check against cancer registration. The
are migrants from other areas of Colombia, and in lesser part death registration system is very adequate and complete, and
the cause of death is always
from other countries. The
noted. The registry staff visit
major part of the population is
these sources, where they
Catholic. The ofcial language
COLOMBIA, CALI (1998-2002)
scrutinise the records kept in
is Spanish.
COLOMBIA, CALI (1998-2002)
medical records departments,
and registers of individual
Cancer care facilities
departments concerned with
The
Colombian
Social
diagnosis
and
treatment
Security System reformed in
$+ -,+++
-(*
(+&)#+++
&+("&+++
- 
)+.(&+++
of cancers, to identify and
1993, creating two healthcare
-+&).+++
,(
""+(,,+++
abstract information on cases
systems, one for those who
"#+",,+++
, 
")+&),+++
")+..$+++
)(
#"+,( +++
of cancer, diagnosed by all
can afford to pay for health
##+& #+++
) 
#,+,)-+++
methods, among residents
care and one for those
#,+(",+++
((
$$+."-+++
$(+.&,+++
( 
&$+"$"+++
of the registry region. The
who cannot. Because the
&$+-()+++
&(
("+-,(+++
data concerning each case
subsidised healthcare system
()+# -+++
& 
)&+ ."+++
)$+$)&+++
$(
,&+&--+++
are registered on a special
does not have the capacity to
,"+.((+++
$ 
-"+..(+++
form at the source site. They
meet demand, a third system
,-+( "+++
#(
. +-&$+++
-#+.-&+++
# 
.,+ $.+++
are classied and revised
has developed for those who
- +-"#+++
"(
."+( +++
at the registry ofce, and
are linked to the subsidised
-.+()(+++
" 
-.+)""+++
-,+ & +++
(
-&+-,#+++
the information is entered
health care system but are
-"+-.)+++

,.+$ (+++
into a computer database
not part of it. Those who are
for checking for duplicates,
linked receive a document
"
(
(
"
errors and inconsistencies.
attesting to their status, and

+%!'


+%!'
Difcult cases are discussed
they can receive emergency
.,#+)&(+++
-),+#--+++

by the staff and resolved
care.
Health services

  
+# "++# #+++
+

+

+

+
either by the registry director
management and delivery 

+

+ +
+

+  ++
+
+  +
+
 +"..,+"..-+"...+#

++
 
+
+ +
+
++ +"..$++# (+
are decentralised to strengthen 


  
the role of departments and or by revisiting the source and sometimes reviewing the
+ 
+%# '+
municipalities, the private sector is incorporated within the microscopic slides. No active follow-up is carried out.
insurance and health services delivery functions, and basic
Use of the data
health services are free and compulsory.
A basic network of health centres has been planned The population-based cancer registry of Cali has been
for the entire urban territory, and programmes of primary studying incidence and mortality trends in the city for the
care and prevention have been promoted. About 60% of period 19622001 using the age-period-cohort model. A
the cancer patients diagnosed in Cali are treated at Valle long-term analysis of survival of uterine cervix cancer is
University Hospital, a public general hospital with a total of underway.
A brochure that contains information on CCR activities
630 beds. A hospital-based cancer registry was established in
1986, a team for the management of childhood cancer began and incidence and trends in Cali was issued by CCR and
activities in 1989, and a formal oncology department was distributed to physicians and Health Services. The Cali
initiated at the end of the 1990s. The hospital also maintains Cancer Registry is pleased to provide cancer statistics
radio- and chemotherapy facilities. Other facilities for cancer through this Web page: http://rpcc.univalle.edu.co.
diagnosis and treatment include four major non-university
hospitals, cytopathology and haematology laboratories, and Source of population
Intercensal estimates of the resident population by age and
radiotherapy and chemotherapy centres.
sex for each year 1997, 1998, 1999, 2000, 2001 and 2002.
The intercensal estimates were obtained by exponential
Registry structure and methods
The registry is located in the Department of Pathology of interpolation from the census counts of 1993 and 2005.
the Medical School in the Universidad del Valle. The staff
includes a Director, who is the Professor of Pathology, three Multiple primary rules used
assessing pathologists, a statistician coordinator, three record IACR rules (2000)

118

Central and South America

Costa Rica
Registration area
Costa Rica covers an area of 51 100 km2. At the 2000 census
the population was 3 810 179 (1 902 614 males and 1 907 565
females), of whom 59% lived in cities and 41% in rural areas.
The ofcial religion is Roman Catholic. The main ethnic
group is Caucasian-Native, and there are smaller proportions
of Blacks, Natives, Chinese and Caucasian-Black.

of the healthcare system, after which they are classied as


DCN or DCO cases or are discarded.
The registry is fully computerised, and each report sheet
is checked against the Civil Registry database to determine if
the report concerns a Costa Rican. For nationals the personal
identication number, name and date of birth or death are
veried. Foreigners are included and coded as such in the
ID variable; there is a special code for cases of uncertain
origin. Reports are then linked to the registry database, using
Cancer care facilities
The country has a national health care system and good- software specially designed to nd duplicates, to classify the
quality vital statistics. The National Social Security system case as incident or not. Each primary tumour case is given a
covers more than 90% of the population. The remaining 10% unique identifying registry number, which is included in the
are attended by private health services. Social Security is registry database. Several consistency check edits are carried
out during data entry, including
organized in 3 levels: patients
date of birth/incidence date/
with suspected cancer are
date of death, sex/site, age/
referred to the 2nd and 3rd
COSTA RICA (1998-2002)
site, age/histology, and site/
levels (specialised). The Social
COSTA RICA (1998-2002)
histology. Multiple primaries
Security system is made up of
are registered according to the
29 hospitals; 5 of them have an
IARC rules.
Oncology Department. Only
Follow-up of cases is
2 hospitals have radiotherapy
mostly passive, although every
departments, and there are 2
!&()%)(((
)%'
#!(+*(((
four years an update of death
private radiotherapy centres.
)( %(((
)
+(#!(((
!#(!#*(((
&%
!&(*(((
dates is conducted with the
#!())(((
&
#%( %+(((
Civil Registry.
Registry structure and
%#()&&(((
%%
%%(+!*(((
)!(& *(((
%
)!(%!)(((
methods
(*%(((
#%
+)(&&+(((
Interpreting the results
The Costa Rica National
!(#++(((
#
 #(*(((
%!(%)(((
!%
#&(
#(((
Although no study has
Tumour
Registry
was
%+(!%&(((
!
%(+& (((
been made to evaluate the
founded in December 1976
%)()%(((
%
%(#!*(((
*(#)(((

) ( )(((
registrys completeness of
by Executive Decree and
!(*%(((
%
+!(+%)(((
coverage, under-registration is
started functioning in 1977,
+() !(((

)(+ )(((
%(&# (((
%
!(#&#(((
estimated to be low given the
but nationwide coverage was
!()*(((

+!( !*(((
characteristics of the health
achieved only in 1980. The
system and the vital statistics.
aims were to collect data

%


%

Cases with a cytological
about cancer incidence and

("$


("$
(+ )(#(((
(++#(%)(((

diagnosis are accepted when
prevalence regarding age, sex,
localized in specic sites such
cancer site and geographical 
  
as lung and cervix.
distribution
within
the 
(

((  (

(
((
(

( (+*#(( (
 


  
The country has made important efforts to establish early
country.
( 
(" $((%((
(
The registry occupies a section of the Statistics cancer detection programmes, especially for cervix, breast,
Department of the Ministry of Health, which provides stomach, colon, prostate and skin cancers.
all nancial support. One physician, a medical registry
technician and two statistical assistants are dedicated full Use of the data
time to the registry. Several medical registry technicians The registry information is used in cancer control decision-making
of the Statistics Department collaborate with the registry at several levels, and also has been used in various studies regarding
obtaining information on incomplete cases at the hospitals occupational exposure cohorts and the risk of cancer during recent
and clinics and during the death clearance process.
years, as well as in descriptive and survival studies.
The sources of information for the registry are the
The country will soon reinforce the Cancer National
compulsory notication sheets on patients leaving hospital, Health Care Network as part of the recently-dened National
biopsy and autopsy reports with a diagnosis of cancer Cancer Plan. As cancer is the second cause of mortality in the
from all pathology services (public and private), and death country, it is considered a principal public health problem.
certicates mentioning cancer from the National Institute of
Statistics and Census.
Source of population
Except for death certicates, which must be retrieved by The estimated annual populations were based on the censuses
the staff, data collection and case follow-up are passive. Death of 1984 and 2000.
registration is complete, as it is compulsory to show a death
certicate before burial. All death certicates mentioning Multiple primary rules used
cancer undergo a clearance process within the hospitals IACR rules (2000) on CI5 IX period

119

Central and South America

Ecuador, Quito
Registration area
The National Cancer Registry covers the population living
in the city of Quito, the capital of the Republic of Ecuador,
situated at 2810m above sea level, in the Andes Cordillera.
The city is surrounded by mountains and the average
temperature is 17C.
The average annual growth rate of the population is 2%,
which includes a large number of immigrants from rural
areas and migrants to migrants to other countries. Most of the
population are mestizos (mixed race), and the main religion
is Catholic. The literacy rate is 97% of the population; 39%
have received primary school education and 23% higher
studies.
Cancer care facilities
The healthcare facilities in
the city comprise nine general
hospitals, relying on the
Social Security system and
the Ministry of Health, two
private hospitals and 30 private
clinics. The largest hospital
belongs to the Social Security
system and has 700 beds used
by afliated workers. The
private clinics have between
20 and 80 beds. There is a
new modern oncological
hospital with 160 beds, which
belongs to the Fight Against
Cancer Association (Lucha
contra el Cncer, or SOLCA).
A full range of diagnostic
facilities and treatment by
surgery, chemotherapy and
radiotherapy are available.
According to registry data
34% of patients are diagnosed
in the private sector.




and the private sectors, and clinical records of public and


private hospitals. Registrars also contact many physicians
who treat cancer patients in the private sector.
The 53 pathologists in the city collaborate voluntarily
and enthusiastically in the work of the registry, allowing the
registrars to consult their records and in many cases lling
out a part of the notication form themselves.
Other sources of information are the death certicates and
hospital discharge lists collected by the Institute of Statistics
and Census of Ecuador (Instituto de Estadsticas y Censos
del Ecuador, or INEC). Follow-up is passive and consists of
matching death certicates with the cases registered.
The registry has promoted the creation of cancer
registries in other cities in the
country, and is monitoring
their activities; there are
ECUADOR, QUITO (1998-2002)
now registries in the cities
ECUADOR, QUITO (1998-2002)
of
Guayaquil,
Cuenca,
Portoviejo, Loja, and Machala,
and a gastric cancer registry in
the province of Tungurahua.



































Interpreting the results


The National Cancer Registry





 

publishes data in an annual
















report that is distributed









within the country and abroad.
















The 19992002 report shows



 





a signicant improvement





 








in the quality of the data.









Data on 73 651 cases, 48% of
















whom were residents of Quito,









were received in the registry


between 1985-2003.






 -(%*
  -(%*
In the last three years



,.,-&$&--
a
screening
programme
for
cervical
cancer
has

  
'$$&-
"-  - -2   - -- - #-- - -0--
- 
#-  - -!/- been undertaken with great
"-"-1 "- -- - - #-  -$&- -'$,#-#--'$$)- 


  
enthusiasm. It is supported by WHO, and the registry

- -('$$)*--
+-- provides the baseline data to monitor results.
Registry structure and methods
The National Cancer Registry of Ecuador was created in Use of the data
1984, with the initial collaboration of PAHO/WHO, by a The registry has carried out a number of studies on the
ministerial degree in which SOLCA was declared responsible epidemiology of selected cancer sites and on quality control,
for the funding and administration of the registry. The and results have been published locally or internationally.
registry has a Steering Committee directed by the President The majority of the scientic research on cancer carried out
in the city and in much of the country uses the data from the
of the Association.
The personnel of the registry comprises a Director, registry.
two epidemiologists and four full-time registrars including
on responsible for the computer system. The Director Source of population
is a medical pathologist and establishes the registry 2001 Census, corrected for nonresponse rate and for
procedures, coordinates the general activities of the registry migration. Instituto Nacional de Estadstica y Censos INEC.
and is responsible for inter-institute relationships. The Proyecciones de Poblacin por provincias, cantons, reas,
epidemiologists coordinate personnel activities, control data sexo y grupos de edad. Serie 01 Nro 206. Quito. Agosto
quality and set up and facilitate studies, particularly between 2004.
physicians in SOLCA.
Data collection is active, and the main data sources are Multiple primary rules used
pathology and haematology records, from both the public IACR rules (2004) on CI5 IX period.

120

Central and South America

France, Martinique
Registration area
Martinique, a French overseas department, is a 1100 km2
island located between the Caribbean sea and the Atlantic
ocean. The department is divided into 34 administrative
areas called communes (municipalities).
In the 1999 census, 381 500 inhabitants were living on
the island; 57% of people aged >65 years were women. The
ethnic distribution was: African or African/white/Indian
mixture 90%, white 5%, and East Indian, Lebanese, and
Chinese less than 5% each. Immigrants made up about 1%
of Martinique inhabitants.

of the national public medical insurance system. Cases


are also declared spontaneously by doctors or by active
collection. Letters are sent regularly to all private and public
cancer treatment structures. Cancer diagnoses are veried
using private and public laboratories of pathology. Cancer
cases are only kept for people living in Martinique at the time
of diagnosis. The registry is staffed by a full-time medical
ofcer, a full-time registrar and one full-time health worker.

Interpreting the results


In the last decade cancer has become a high public health
concern in Martinique. It is the second leading cause of death
Cancer care facilities
in men and in women. Several tumoursprostate, breast, colon
The population is served by
and rectum, non-Hodgkins
9 public hospitals, including
lymphomaare increasing in
the University Hospital of
the general population. The way
FRANCE, MARTINIQUE (1998-2002)
Fort-de-France. The medical
of life in Martinique has been
FRANCE, MARTINIQUE (1998-2002)
infrastructure in Martinique
changing considerably over
is almost entirely located in
the past 20 years. The socioFort de France: the University
economic status is now among
Hospital, which comprises
the highest the Caribbean
" """
$!
"$"""
"$"""
$
"$"""
the
radiotherapy-oncology
area, and Martiniques way of
"#"""
#
"##"""
service, the nuclear medicine
life tends to be westernised
"$"""
#
"%"""
"%"""

#" """
service, the haematological
because of constant exchange
#"$"""

$""""
and pathological laboratories,
with metropolitan France. Other
#"#%"""

$"#$"""
%" """

"$#"""
the clinical haematology
characteristics include a highly
"$%"""

"$"""
service
and
department
mixed population, low tobacco
""""

"#%"""
" """

#""""
of
medical
information,
consumption and, in most areas,
"$"""

 "%"""
two private clinics and
replacement of traditional diet
"%#%"""

"#"""
" """

" $"""
one laboratory. Eight other
by imported food. Changes
"#"""

""""
municipal hospitals contribute
in a common set of exposures
 """"

" #"""
"%#"""

"$%"""
to diagnosis and treatment of
(lifestyle modification, life
" """

"%"""
cancer. Medical care is free of
expectancy) and improved
diagnostic procedures, earlier
charge, allowing unrestricted






detection (use of the PSA test,
access to high-quality medical
 "

 "
services for all cancer patients
mammography, the Hemoccult
" %$"""
$"%"""

registered in regional health
test and an organised cervical

   


insurance les.
cancer screening programme
 "  """   ""
in Martinique since 1991) have been suggested to explain these
Registry structure and methods
trends.
Cancer registration has been mandatory in Martinique since
1981, with the Association Martiniquaise pour la Recherche Use of the data
Epidemiologique en Cancrologie (AMREC) being ofcially The registry provides a ve-year report of cancer incidence,
created in 1986. The Registry has been integrated into the highlighting trends and changes. Data are also use for
CHU de Fort de France since 2003. In France, the Registry evaluation of cancer screening, medical practices and
is integrated into the National Cancer Registry Association environmental risk assessment. Survival studies for prostate
(France Cancer Incidence Monitoring, or FRANCIM).
and colorectal cancer patients have also been carried out.
Cancer cases are identied using common sources of
information: medical evacuation les, data from private and Multiple primary rules used
public hospitals, laboratory les, regional insurance records IACR rules (2004) on historical data.

121

Central and South America

Peru, Trujillo
Registration area
The Trujillo Cancer Registry covers the population of ve
districts (Trujillo, La Esperanza, El Porvenir, Florencia
de Mora and Vctor Larco). They represent Metropolitan
Trujillo, on the north coast of Per. The population at the
most recent census (1993) was 513 223. About 96% of the
population live in urban areas; 90% are Roman Catholics

A formal evaluation of the completeness or accuracy has


not been accomplished for the 19982002 period, but quality
data are available.

Interpreting the results


The high incidence of cervical cancer is probably results from
the cervical screening programmes implemented by MINSA,
EsSALUD and the Trujillo Cancer Prevention League.
Breast cancer detection is limited, and PSA screening has
Cancer care facilities
Diagnostic and treatment facilities are provided by the not been established.
Transformative industries (agro-industrial, leather,
Ministry of Health (MINSA) and the Social Security
(EsSALUD) hospitals, supplemented by private clinics. metalmechanic) are located in the suburban areas of the
Radiotherapy is supplied by one telecobalt unit and radium region. Trujillo has a high proportion of motor vehicles, but
results of ofcial CO testing
devices at Beln Hospital.
are within acceptable limits.
The relatively high cost of
Registry structure and
PERU, TRUJILLO (1998-2002)
cigarettes probably explains
methods
PERU, TRUJILLO (1998-2002)
the low lung cancer incidence.
Financial
and
technical
assistance are received from
Use of the data
IARC under a Collaborative
Every ve years a cancer
Agreement with the National
%.#+,...
0+%.,/)...
%.&,#...
0#!
%.01#...
incidence and mortality report
University
of
Trujillo.
%.110...
/+!
&.,+'...
is published and delivered to the
The Central Ofce of the
'.##&...
/#!
'.//0...
).#&%...
,+!
+.%#1...
health authorities, universities
Registry is at Belen Hospital.
+./%'...
,#!
,./0/...
and medical institutions. The
The Registry is staffed by
/.%#+...
++!
0.#%'...
1.+%1...
+#!
%#.+/%...
Registry has also carried out
a pathologist (head of the
%%./,,...
)+!
%'.&&'...
cervical cancer survival and
Registry), one statistician
%'.0%'...
)#!
%,.)&/...
%,.++'...
'+!
&#.&&'...
childhood cancer research.
pathologist, one computer
&#.&0/...
'#!
&).','...
Registry data have also been
analyst and one part-time
&'.,1&...
&+!
&0.&0%...
&1.+1'...
&#!
''.1/%...
used for university theses and
statistical technician.
''.&+#...
%+!
'0.#))...
in planning for the Northern
Data
are
collected
'&.1#'...
%#!
''./)%...
'%.,,+...
+!
'%.+'#...
Cancer Hospital.
actively from three general
'&.1,#...
#!
'&.%')...
hospitals, the radiotherapy
Source of population
service, and private clinics,
%#
+
#
#
+
%#
The population data were
pathology laboratories and
 .($*
  .($*
estimated by linear interpolation
oncologists. Mortality data
'%&.)%&...
&0#.%+,...

on the basis of the 1981 National
are obtained from the original
  

. . 
.. . . . .%10%.. .. .%11'.. ". .
 .
Census and the 1993 National
death certicates furnished by  .

..  .  .
. . . .
. . . ".
the Regional Health Authority.       
The Registry staff scrutinise Census. The projection was made by age group for each sex.
 . .(&###*...
the death certicates to complete
the database records or to
  
 . .  .. . . . .. . 
 . .  .2. . 
 .+.(  *".
follow up. The Registry members
visit the sources to screen Multiple primary rules used
the hospital discharge notes and scrutinise the cancer medical IACR rules (2000).
records to abstract the required information onto special
forms. Data from patients referred to the National Cancer Notes on the data
Hospital (Instituto Nacional de Enfermedades Neoplsicas) The Editors recommend that some care be taken in the
interpretation of these data; see Chapter 5 (Categorisation).
in Lima are also recorded.

122

North America
Canada

North America

Canada (Excluding Quebec, Yukon and Nunavut)


Canadian incidence and survival information required for
cancer control. The Canadian Cancer Registry forms a personal
information bank that is listed in the annual publication Info
Source: Sources of Federal Government Information.
The Canadian Cancer Registry is a collaborative effort
between the thirteen Canadian provincial and territorial
cancer registries and the Health Statistics Division of
Statistics Canada.
The Canadian Cancer Registry is a dynamic database of
all Canadian residents alive or dead who have been diagnosed
with cancer. The function of the Canadian Cancer Registry
is to produce standardised and comparable cancer incidence
data for each newly diagnosed primary site of cancer. The
Canadian Cancer Registry
Registration area
system records the kind and
Canada is the second-largest
number (incidence) of primary
country in the world, with
CANADA (Excluding Quebec, Yukon and Nunavut)
cancers diagnosed for each
an area of 9 984 670 km2
CANADA (Excluding(1998-2002)
Quebec, Yukon and Nunavut) (1998-2002)
person over a number of years
extending from longitude 53
until death. The advantage of
to 141 W and from latitude
this system is that longitudinal
42 to 83 N. It is bounded to
data are available for each
the west by the Pacic Ocean












cancer patient. New primary


and Alaska, to the north by the







cancers occurring for previous


Arctic Ocean, to the east by












 

cancer patients are identied.


the Atlantic Ocean and to the







The patient data are linked


south by the United States.
 



 









annually to the Canadian


In 2001, the population of







Mortality Database so that the


Canada numbered 31 110 565,














 

date, place and cause of death


of whom 25.5% were under 20







of every cancer patient are


years of age and 12.6% aged














eventually known.
65 or over. Most Canadians







In addition to information
live in a corridor about 300














on
cancer incidence, data
km wide along the southern




 


are available about the


border. Almost one third of
characteristics of patients as
the population is concentrated






well as about the nature and
in the metropolitan areas

)%!'


)%!'
frequency of their tumour(s).
of Toronto, Montreal and


 

"")(*+)&**)))

Since patients records remain
Vancouver.

   
active on the Canadian Cancer
Between 1991 and 2001, 
) )  ))
))
) ))
) 
))
)

)%",,+-# $'))
Canada attracted 1 830 680 new immigrants (almost 6% of its Registry until conrmation of their death, survival rates for
population). Ontario attracted 55.8% of the new arrivals, followed the various forms of cancer can be calculated.
The Canadian Cancer Registry also employs specialised
by British Columbia (20.2%), Quebec (13.4%) and Alberta (7.1%).
internal record linkage software for detecting duplicate
Almost one fth of all Canadians are foreign-born.
Canada is an ethnocultural society. In 2001, visible records and for clearing death records. These procedures are
minorities constituted 13.4% of the population. Of these, done annually. Conicting information and other problems
the largest three groups are: Chinese (25.8%), South Asian with the cancer data are resolved through consultation with
(23.0%), Black (16.6%), and Filipino (7.7%). English is the the reporting provinces and territories.
mother tongue of 58.5% of the population and French is
the mother tongue of 22.6% of the population. The major Use of the data
religious denominations are: Catholic (42.9%), United Church The annual publication Canadian Cancer Statistics is
(9.6%), and Anglican (6.8%). The aboriginal population of produced by the Canadian Cancer Society, the National
Canada (accounting for 3.4% of the population) is primarily Cancer Institute of Canada, the Public Health Agency of
Canada, Statistics Canada, the Provincial/Territorial Cancer
comprised of North American Indians, Mtis, and Inuits.
Registries and Health Canada. The estimates are calculated
through extrapolation of cancer incidence data from the
Registry structure and methods
The patient-oriented Canadian Cancer Registry evolved from National Cancer Incidence Reporting System (NCIRS, 1969
the event-oriented National Cancer Incidence Reporting 1991) and the Canadian Cancer Registry. Also, non-nominal
System1 established in 1969. The Canadian Cancer Registry data for all Canadian registries are published annually by
is an administrative survey. Beginning with cases diagnosed NAACCR in Cancer Incidence in North America.
in 1992, cancer incidence gures collected by provincial and
territorial cancer registries have been reported to the Canadian Source of population
Cancer Registry, which is maintained by Statistics Canada. Estimates of Population by Age and Sex for Canada, the
The Canadian Cancer Registry has been developed to provide Provinces and the Territories (19982003).
Since 1969, Statistics Canada, Canadas central statistical
agency, has collected population-based cancer incidence
data. Starting with the 1992 data year, these data have been
compiled by the Canadian Cancer Registry (CCR), replacing
the event-oriented National Cancer Incidence Reporting
System that existed from 1969 to 1991. The CCR provides
national incidence and survival information required for
cancer control. Reporting of cancer data by the ten Canadian
provinces and two territories is coordinated by the Canadian
Council of Cancer Registries, which includes representatives
from each of the provincial and territorial cancer registries,
Statistics Canada, and the Public Health Agency of Canada.

124

North America

Canada, Alberta
Registration area
Alberta is one of the Prairie Provinces of Canada. Its area
of 661 688 km2 lies between latitudes 49 and 60 W. The
Alberta Cancer Registry covers the population of the 9
Regional Health Authorities within the province of Alberta.
The population estimated for Alberta in 1999 consisted of 1
466 696 females and 1 497 933 males.
Alberta has a multi-ethnic population; half of the population
are of British extraction, the remainder including people of
other European, Asian and Native American origins.

enables the Registry to identify patients who have died from


cancer or cancer patients dying from other causes.
The Alberta Cancer Registry maintains routine
computerised and manual quality assurance data reviews of
specic variables on a monthly, quarterly, and yearly basis as
required. Mechanisms have also been established to measure
the quality of registry-collected variables with respect to
completeness, accuracy, and timeliness. The Alberta Cancer
Registry received the Gold Standard awarded by the North
American Association of Central Cancer Registries (NAACCR)
for 1998, 1999, 2000, 2002, 2003, and 2004 incidence data.
For 2001 data, silver certication was awarded.

Cancer care facilities


Cancer care is provided and administered by the Alberta Cancer
Board in two major treatment
centres, four associate and eleven
community cancer treatment
CANADA, ALBERTA (1998-2002)
centres throughout the province.
CANADA, ALBERTA (1998-2002)
The two major tertiary centres,
the Cross Cancer Institute, in
Edmonton and the Tom Baker
Cancer Centre, in Calgary

 






provide radiotherapy, systemic




therapy, and limited surgical







procedures. The associate and




community cancer centres

 






provide chemotherapy services.

Use of the data


The Alberta Cancer Registry
publishes or is involved in
the development of several
documents on cancer incidence
and mortality in Alberta.
Publications include the annual
report, A Regional Picture of






Cancer in Alberta (for the



 

Regional Health Authorities), A








Snapshot of Cancer in Alberta,



 

and various monographs.








The registry is the key source







 

of information for service provision
















Registry structure and


planning by the Alberta Cancer







methods
Board, its host agency. Information








 





The Alberta Cancer Boards


on cancer within each regional





 

Division of Population Health


health authority in Alberta is also

 












and Information operates a


released to them for planning







number of cancer prevention,


services. The registry provides
screening and surveillance
data to the screening programs







/*&,

!
/*&,
initiatives on behalf of
to allow for quality assurance and

 
 

'/-'1/+)'///

the organisation. Several
follow-up of mammography and
organisation-wide
services 
  
cervical screening.
#/
// !/'1102(%%)/
/"

/
!
//
/
/

// 
/
!
/"
//
/
are also coordinated by this 
/  22/"/

The Cancer Registry also has


'11./
#// 
/"/
/  /!
/
#/
! / #//$/
 


  
Division, which maintains the Alberta
Cancer Registry under a close relationship with the Alberta Cancer Boards clinical
/
/*(%%+,////
the directorship of Dr. Heather Bryant. The Alberta Cancer database, which enhances data analysis opportunities.
Registry operates out of the two tertiary cancer centres.
We also respond to over 100 requests for information from
Calgary is responsible for the southern half of the province the Registry each year. Many of these requests involve the use
while Edmonton maintains data for the northern half. The of Registry data for population or clinical research questions.
Registry staff is involved in coding and abstracting, entering Examples of this include the use of registry data to invite
data into the collaborative stage program, research projects, participants into intervention trials, or studies of the use of
and quality assurance activities. Completeness of cancer cases complementary therapies for cancer treatment. All research
is very high in the Registry; however, passive follow-up to nd projects must be approved by the Research Ethics Board prior
additional cases includes record linkage with Alberta Vital to initiation, and the registry, rather than the investigator, is
Statistics and an ongoing case ascertainment project with the the usual originator of contact with the individual. Registry
Alberta Health Registration le.
data has also been included in several multi-centre studies, and
Provincial legislation mandates the registration of all the Alberta Cancer Registry has combined registry data with
reportable cancers from diagnostic facilities and medical other research data to examine the projected impact of the use
practitioners within Alberta. The Alberta Cancer Registry of Hormone Replacement Therapy in the population.
primarily uses a passive case-nding approach. Pathology,
cytology, and operative cytology reports as well as reports Source of population
from scans, x-rays, etc. with the mention of cancer are sent to The populationatrisks by sex and age from 19982003 have
the registry. The province is in the process of implementing been estimated using the adjusted intercensal or postcensal
a provincial electronic health record, which will improve estimates based on the 1996 Census, as provided by the Population
the accuracy of patient demographic information as well as Estimates Section, Demography Division, Statistics Canada.
provide timelier access to the reports previously outlined. In
addition, Alberta Vital Statistics provides an electronic le Multiple primary rules used
each month of all individuals dying in the province, which IACR rules (2004) on historical data

125

North America

Canada, British Columbia


about 61% of cancer cases are treated or seen at some
Registration area
The registry covers all of British Columbia (BC) (926 492 point. The registry receives listings of all deaths in the
km2), the most westerly province of Canada, bordered by province from the BC Vital Statistics Agency. Follow-up is
Alberta to the east and by the Pacic Ocean to the west. Most performed to obtain complete registration information and
of the population is concentrated in the southwest corner of documentation on all cases.
The personnel consists of a director and a scientic
the province, where the climate is the mildest.
The proportion of immigrants in the population has director, one senior, one supervisor and eight health record
increased by 1.3% from 17.7% for the 19911995 period to technicians.
19.0% for 19962001. Currently, most immigrants to BC come
from Asia, in particular China, Taiwan, India, Hong Kong, the Interpreting the results
Philippines and South Korea. Based on the 2001 census, 56% The Screening Mammography Program of BC (SMPBC) was
of British Columbians belong to a single ethnic origin and established in 1988 through the BC Cancer Agency to reduce
44% to more than one. The largest group of visible minorities breast cancer mortality through early detection. From 20002004
within British Columbia is
(inclusive), 1 134 806 examinations
the Chinese, followed by
were performed for 512 372
South Asians. Aboriginal
women, and 4627 breast cancers
CANADA, BRITISH COLUMBIA (1998-2002)
people comprised 4.4% of the
were diagnosed (overall cancer
CANADA, BRITISH COLUMBIA (1998-2002)
population in 2001.
detection rate of 4.1 per 1,000).
The top three industries
The BCCAs Cervical
within British Columbia are
Cancer Screening Program
retail trade, health care and
was the rst organised

 






 





manufacturing, with the largest


programme in the world to







component of the working


screen for cervical cancer.








 





population employed in clerical


In BC, approximately 71%







and sales occupations.


of women age 20 to 69 were

 










 

screened in a recent 30-month









Cancer care facilities


period. The cervical screening
 



 

 



 


programme is credited with an


Cancer diagnostic services







85% reduction in the number


are provided through general

 



 






 

of BC women getting cancer


hospitals and specialty clinics.







of the cervix and for reducing


Cancer therapy is provided





 








cervical cancer deaths by 75%


through a mix of dedicated







since the 1950s.


cancer facilities and general
The Hereditary Cancer
hospitals. The BC Cancer






  0+' "  0+'Program (HCP) is a result
Agency (BCCA), a provincial




)0&(/0),(000
 
of the BCCA and the BC
government agency responsible
Provincial Medical Genetics
for cancer care, control and 
  
3 30#0 !$0  00 "0(2213)&&*0  0# 0 "  00 0  0   00
  0 "  0#  00 0
Program working together to
research in British Columbia,  0


(22/0 $0 0
 0#0 0
 0"  0 $0 "
0 $0 0   %0
 


  
operates four regional cancer centres
that have close links provide information and genetic counselling for individuals
 0 0+)&&,-00 .00
0
with local hospitals. Radiation therapy is provided exclusively and families with a strong history of cancer.
PSA screening for prostate cancer became common in the
through the four regional cancer centres. The regional cancer
centres also provide approximately 50% of cancer chemotherapy early 1990s although it is not a publicly funded service. Rates of
services, with the remainder provided through the Communities prostate cancer peaked in 1993 and have declined since then.
Oncology Network, a collaborative voluntary partnership with 19
Community Cancer Centres, 6 Community Cancer Services and 12 Use of the data
Consultative Clinics across BC, in conjunction with the Regional The registry was originally set up to monitor cancer incidence
Cancer Centres and the Systemic and Radiation Programs. The and mortality in the province, but is now extensively used for
Network also supports appropriate delivery of cancer patient care health services planning and epidemiological research. Registry
data are used as a source of cases for surveys and case-control
and support in 33 other Community Hospitals.
studies, and as outcome data for cohort studies of occupational
groups. Registry statistics and estimates of future incidence
Registry structure and methods
The registry is part of a combined population-based registry trends have also been used in conjunction with clinic referral
and clinical database maintained by the BCCA. The registry data for cancer services, budgeting and facilities planning.
has monitored the impact of cancer on the BC population
since 1969. For many years it was mandatory to report cancer Source of population
cases; however, legislation passed in 1987 authorised the The populationatrisks by sex and age from 19982003 have
registry to obtain relevant information without the provision been estimated using the adjusted intercensal or postcensal
of mandatory reporting.
estimates based on the 1996 Census, as provided by the Population
The registry received notication of 95% or more of Estimates Section, Demography Division, Statistics Canada.
the cancer cases diagnosed in the province by submission
of pathology reports from hospital laboratories or following Multiple primary rules used
attendance at one of the four BCCA Cancer Centres, where IACR rules (2004) on CI5 IX period.

126

North America

Canada, Manitoba
eight cancer registrars, a quality assurance technician, a
Registration area
Manitoba is a province located in central Canada, bordered senior cancer registrar, three clerks and an administrative
to the east by Ontario and Hudson Bay, to the west by assistant. Three of the staff are Certied Tumor Registrars.
Saskatchewan, to the north by Nunavut and the Northwest Staff from the epidemiology section of the department also
Territories and to the south by the American states of North provide support for the registry (four epidemiologists and six
Dakota and Minnesota. It lies between latitude 49 and 60 analysts); the epidemiology staff are also extensively involved
N and longitude 90 and 102 W. The altitude varies from in research, much of which revolves around the cancer
sea level to 823m, and the province covers an area of 649 registry and linkage to other population-based datasets.
950 km2.
Reporting of cancer has been mandated by law since 1956.
At the time of the 2001 census, 72% of the population Case nding is passive, and multiple sources of ascertainment
was urban, with 60% living in the capital city of Winnipeg. are used. These include physician notications, pathology and
Manitoba is ethnically diverse. Approximately 13.6% of all cytology reports, and hospitalisation, mortality and autopsy
residents were Aboriginal (Native Americans 60.2%; Mtis records. Cancer registrars collect, classify and maintain
37.9%; Inuits 2.3%). A similar
comprehensive information on
number had immigrated from
cancer patients. Quality control
other countries. Of the 133 660
is an important part of cancer
CANADA, MANITOBA (1998-2002)
immigrants, 47.5% where born
registration in Manitoba, and the
CANADA, MANITOBA (1998-2002)
in Europe and 30.3% were
registry has been consistently
born in Asia. The majority of
certied by NAACCR for the
Manitobans reported British
past eight years.
(36.7%), French (12.6%) and/














or other European (48.0%)


Interpreting the results







heritage.
The cancer statistics presented in














this volume may be inuenced








Cancer care facilities


by diagnostic and early detection














CancerCare Manitoba is a
tech nologies. T he most







provincial cancer agency


significant effect is expected





 






 

with a mandate to coordinate


to be increased breast cancer







all aspects of cancer control


incidence resulting from the














in Manitoba. Direct patient


establishment of the provincial







care involves the provision of


breast screening programme








 





treatment services, including


in 1995. An organised cervical





 

outpatient-based
radiation
cancer screening programme
therapy at one centre in
wa s i n it iat e d i n 19 9 9.






the major urban centre
Opportunistic screening for
  0+' "  0+' 


./10/.)000
 
(Winnipeg),
chemotherapy
prostate and colorectal cancer
and
breast
screening 
  
occurs, but the magnitude of
3 30#0 !$0  00 "0(2213)&&*0  0# 0 "  00 0  0   00
  0 "  0#  00 0
mammography. The cancer  0


these practicesand therefore
(22/0 $0 0
 0#0 0
 0"  0 $0 "
0 $0 0   %0
agency partners with other community
the effect on cancer incidence ratesremains unknown.
 


   care facilities to
 0 0+)&&,-00 .00
0
provide cancer services through the Community Cancer
Programs Network, an innovative program for delivering Use of the data
cancer careprimarily chemotherapyin local communities The data are used to answer questions relating to the whole
throughout the province. Supportive activities include cancer- spectrum of cancer control in Manitoba. They are also used
related consultation services for other healthcare providers for surveillance, research, evaluation, planning and teaching
and the development of standards for the delivery of cancer purposes and to provide diagnostic conrmation and
care in Manitoba, as well as the facilitation of cancer-related treatment-related information to healthcare providers.
education, surveillance and research activities.
Source of population
Registry structure and methods
The populationatrisks by sex and age from 19982003
Manitoba has one of the longest standing cancer registries have been estimated using the adjusted intercensal or
in the world. It was started in 1937, although it did not postcensal estimates based on the 1996 Census, as provided
become fully population-based until 1956. The registry by the Population Estimates Section, Demography Division,
is located within the Department of Epidemiology and Statistics Canada.
Cancer Registry at CancerCare Manitoba. It is funded via
CancerCare Manitoba by Manitoba Health, the provincial Multiple primary rules used
health department. The registry staff include the manager, IACR rules (2004) on CI5 IX period.

127

North America

Canada, New Brunswick


Epidemiology Services and the Provincial Epidemiologist
Registration area
The New Brunswick (NB) registry covers the population of for NB.
The NB registry uses passive case-nding predominantly
seven regions and eight Regional Health Authorities within
the province. The provinces of Quebec, Nova Scotia and from pathology laboratories, radiation and haematology
the state of Maine, USA border NB. The population at the centres, death registrations, autopsies and data from other
most recent census (2001) was 729 498. About 50.4% of the provincial registries. An electronic linkage is conducted
population lives in urban areas (>1000 and no fewer than 400 annually between Vital Statistics and the registry database
persons per km2). There are seven cities, none of which has a to reconcile missing death information and to identify cases
where there is a mention of cancer on the death certicate
population greater than 100 000.
In New Brunswick, religious makeup as reported by the but no abstract is found in the registry database.
The cancer registry is a patient- and disease-oriented
Statistics Canada 2001 census is reported as 54% Catholic,
37% Protestant and 8% with no religious afliation. Men database. Persons may have more than one type of tumour in
account for 49.4%, of whom 6% are over 65 years of age, the database, and the rules governing multiple primary tumours
are those of the CCR and SEER.
compared to women, 50.6%
NB also registers basal and
and 8% respectively. Ethnicity
squamous cell carcinoma of
is reported predominantly as
CANADA, NEW BRUNSWICK (1998-2002)
the skin, one of each, per person
Canadian and then French,
CANADA, NEW BRUNSWICK (1998-2002)
per lifetime since 1989.
English and Irish.
The
AJCC
TNM
classication
method
is
Cancer care facilities
currently used to assign stage
Medical treatment of cancer














to breast cancer cases.


focuses on four modalities:







Authorization to submit
surgery, medical oncology,














patient-specic information
radiation and supportive







is derived from Section


services. Paediatric oncology














21(1), regulation 92-84 of the


cases are generally referred

 





Hospital Services Act of NB.


to Nova Scotia or Quebec for

 



 






 

initial consultations with a









Interpreting the results


paediatric oncologist. There








 





NAACCR has awarded silver


are two major radiation-based





 

certication to the NB Cancer


cancer centres located in the












 

Registry for years 1997, 1998,


southern part of the province





 

1999, 2000, 2002, and 2003,


in the cities of Moncton and
and gold in 2001. Incidence
Saint John. In 1993, the second






is grouped according to the
radiation facility was added in
  0+' "  0+' 


Surveillance, Epidemiology and


*1*0&))000
 
Moncton.
End Results (SEER) Groups for
Chemotherapy
is 
  
4 40#0 !$0  00 "0(3324)&&*0  0# 0 "  00 0  0   00
  0 "  0#  00 0
Primary site of ICD-0-3.
administered in the major  0


(33/0 $0 0
 0#0 0
 0"  0 $0 "
0 $0 0   %0
centres and in 12 outreach centres.
There is a provincial
 


  
 0 0+)&&,-00 .00
0
Breast Cancer Screening Program that was rolled out in 16 Use of the data
facilities in NB in 1995 to service asymptomatic women The registry prepares a ve-year report of cancer incidence
between the ages of 50 and 69. There is decentralised cervical and mortality, highlighting trends and changes by region and
community. Some special studies of survival of registered
screening in NB.
There is no organized prostate screening. PSA testing is cancer cases (breast), as well as epidemiological research,
ordered at the discretion of the urologist or family physicians have been carried out. Policymakers use our data to assess
the need for specialized oncology services in the regions
in the regions.
and to assess costs on insurance reimbursements for various
drugs and equipment related to cancer.
Registry structure and methods
The registry is a population-based central cancer registry
located in Saint John, NB. The registry is funded by Source of population
the Department of Health and overseen by Provincial The populationatrisks by sex and age from 19982003
Epidemiology Services (PES), which is located in the city have been estimated using the adjusted intercensal or
postcensal estimates based on the 1996 Census, as provided
of Fredericton.
The registry is staffed by 4 permanent employees, one by the Population Estimates Section, Demography Division,
PES person who serves as liaison between the coding staff Statistics Canada.
and several internal and external parties, such as Statistics
Canada, NAACCR, and the Public Health Agency of Canada. Multiple primary rules used
The Director of the registry is Director of the Provincial IACR rules (2004) on CI5 IX period.

128

North America

Canada, Newfoundland and Labrador


Registration area
The Registry covers the whole of the province of
Newfoundland and Labrador, which lies on the east coast of
Canada. The island of Newfoundland is surrounded by the
Atlantic Ocean. Labrador is bounded by the Atlantic to the
east and the province of Quebec to the west and south. The
landmass of the province extends between 47 and 61 N and
longitudes 52 and 76 W. The altitude varies from sea level
to 1600m in the interior of Labrador. The total area is 371
634 km.
The population according to the 2000 census was 554
076 and in 1991 the population was 568 475. The decrease in
population is the result of the net outow due to migration to
other provinces.

Happy Valley-Goose Bay. The Registry is staffed by a fulltime director, a manager, a part-time programmer analyst
and three full-time health record professionals.
The process for cancer registration is through an
Electronic Pathology reporting system (E-Path). The Cancer
Registry receives pathology reports electronically from
six pathology laboratories through a HL7 interface. Each
report is ltered using the ICD-0-3 auto-coding engine.
The automated ltering logic examines the topography and
morphology codes, and then based on registry reporting
requirements selects reports for submission to the registry.
E-path has improved the timeliness, completeness and
consistency of pathology information.
Cancer is not a reportable
disease in our province; the
CANADA, NEWFOUNDLAND AND LABRADOR Cancer Act provides a legal
mandate for the Provincial
(1998-2002)
CANADA, NEWFOUNDLAND
AND LABRADOR (1998-2002)
Cancer Care Program to
establish and maintain a
cancer registry.

Registry structure and


methods
The
Provincial
Cancer
Registry was started by the
Department of Radiotherapy
of St. Johns General Hospital














Interpreting the results


in 1954. In 1974, the registry







The Cancer Registry is in


came under the jurisdiction

 



 


 





the process of reactivating a


of the Newfoundland Cancer







provincial death clearance


Treatment and Research

 












process. We have purchased


Foundation
(NCTRF).







a software package (Linkage


NCTRF was dissolved in








 





Wiz) to assist with this


2005 and is know under one







process.
of four Regional Integrated

 











Health
Authorities.
The







Use of the data


Newfoundland
Cancer














The data are used to answer


Registry is a part of the

 





questions relating to the


Provincial
Cancer
Care
whole spectrum of cancer
Program, Eastern Health,






control in Newfoundland
formed on 1 April 2005.
  0+' "  0+'and Labrador. The data are
Eastern Health is the largest
 


)/,03&1000
 
also used for surveillance,
integrated health network in

  
4 40#0 !$0  00 "0(3324)&&*0  0# 0 "  00 0  0   00
  0 "  0#  00 0
research, evaluation, planning
Newfoundland and Labrador,  0


(33/0 $0 0
 0#0 0
 0"  0 $0 "
0 $0 0   %0
serving a regional population  


  
of more than 290 000 and and to provide diagnostic conrmation and treatment-related
 0 0+)&&,-00 .00
0
offering unique provincial programs and services. The new information to healthcare providers.
health region extends west to Port Blandford and includes all
communities on the Avalon, Burin and Bonavista Peninsulas. Source of population
There are more than 80 hospital, health care centres, long- The populationatrisks by sex and age from 19982003
have been estimated using the adjusted intercensal or
term care facilities and community care sites.
The Provincial Cancer Registry is located within the postcensal estimates based on the 1996 Census, as provided
Dr. H. Bliss Murphy Cancer Centre, in St. Johns. There are by the Population Estimates Section, Demography Division,
regional programs in Corner Brook, Grand Falls-Windsor, Statistics Canada.
St. Anthony and Gander, and regional clinics at the Burin
Peninsula Health Centre, Burin; Captain William Jackman Multiple primary rules used
Memorial Hospital, Labrador City; and Melville Hospital, IACR rules (2004) on CI5 IX period.

129

North America

Canada, Northwest Territories


and visited by itinerant physicians. Three hospitals provide
Registration area
The area covered by the registry is the one of the largest in second-line specialist services. However, most tertiary-level
Canada, yet is sparsely populated. The Northwest Territories services are offered outside the jurisdiction.
All cancers are registered using a form that must be
(NWT) comprises the area north of the 60th parallel, lying
between the Yukon Territory and the Beaufort Sea to the completed by the treating physician at the time of diagnosis.
west and Nunavut to the east. The Arctic Ocean forms the Also, the contract with out-of-territory laboratories requires
that a copy of pathology reports indicative of cancer be
northern border, which reaches as far as the 83rd parallel.
All forms of malignancy have been reportable in the forwarded to the Registrar. Other sources of information
Northwest Territories since late 1980. However, the very result from an active search of vital statistics, discharge
extensive circumpolar geographical area, which constitutes summaries and physicians notes. The principal sources
this jurisdiction, results in an additional reliance on diagnostic of information on cancer cases are laboratory reports and
service and reporting and may also affect completeness. It discharge summaries. Death certicates are retrieved from
should be noted that collection of cancer data was initiated the Northwest Territories Vital Statistics ofce in Inuvik.
Informal evaluations are
in the late 1950s.
performed to ensure validity
In 2003 the population
and completeness.
of NWT was about 42 406
CANADA, NORTHWEST TERRITORIES
persons living in some 32
(1998-2002)
CANADA, NORTHWEST
TERRITORIES (1998-2002)
Interpreting the data
communities, half of which
In 1999, Nunavut separated
had populations of fewer than
from the Northwest Territories.
500 residents. One-quarter of
Over time we have gained
the population is under 15 years





services for mammography


of age. Health programmes





and are now able to provide


and services were provided










chemotherapy and hormone


by eight health and social
 




therapy treatment. Since


services authorities and/or












last year, we now have an


boards, reecting ten ofcial







oncologist that comes to the


language groups in four ethnic














territories on a monthly basis.


categories (Dene, Inuit, Metis,






There is an organized
and non-Aboriginal). Half of













screening
programme
the population are Aboriginal







for breast cancer in the


people.














Yellowknife region, and PSA









testing is common in our


Cancer care facilities
population.
In NWT it is possible to






  0+' "  0+'perform biopsies, but all



)(0)1,000
 
Use of the data
diagnostic laboratories are
The registry is not currently
based in Alberta, Canada. 
  
4 40#0 !$0  00 "0(3324)&&*0  0# 0 "  00 0  0   00
  0 "  0#  00 0
involved in epidemiological
It is possible to perform  0


(33/0 $0 0
 0#0 0
 0"  0 $0 "
0 $0 0   %0
chemotherapy and hormone therapy
in the Territories, but research beyond the production of routine statistics, but
 


  
 0 0+)&&,-00 .00
0
policymakers use our cancer registry data for planning and
there are no radiotherapy departments in the area.
evaluation of health services.
Registry structure and methods
The NWT Cancer Registry is maintained by two registry Source of population
staff within the Population Health Division, Department of The populationatrisks by sex and age from 19982003
Health and Social Services, Government of the Northwest have been estimated using the adjusted intercensal or
Territories. These consist of one coder and one analyst. postcensal estimates based on the 1996 Census, as provided
Two are in the process of training to code and we are in the by the Population Estimates Section, Demography Division,
process of having the Alberta Cancer Registry administer Statistics Canada.
the database.
Most formal health services and programmes are Multiple primary rules used
provided through community health centres staffed by nurses IACR rules (2004) on CI5 IX period.

130

North America

Canada, Nova Scotia


The Nova Scotia Cancer Registry (NSCR) is operated
Registration area
The registry covers the whole of the province of Nova Scotia, as part of the provincial cancer program and funded by
one of the three Maritime Provinces of Canada, lying to the government. It is physically located in Halifax, at a site
south of the St. Lawrence River, east of the Gulf of Maine within the largest district health authority. A total of 12
and south of the provinces of New Brunswick and Prince FTEs are in place (registrars, analytic, administrative staff).
Edward Island. Although joined to New Brunswick by a Two cancer centres that operate as part of DHAs also have
central peninsula to the north, it is separated from Prince on-site abstracting staff who submit cases to the registry.
Edward Island by the Northumberland Strait; to the south, Cancer has been a reportable disease by law since 1964.
west and east lies the Atlantic Ocean. Most of the province The main reporting sources include hospital health record
is less than 200m above sea level, the highest point being at departments (since 1964), pathology/cytology laboratories
529m in Cape Breton. The province covers and area of 55 (since 1964), cancer centres since 1981 (includes all
radiotherapy delivery), death record linkage (since 1969) and
491km2.
At the 2001 census, the total population of Nova Scotia more recently, screening of visits at targeted clinical areas
(e.g. haematology clinics).
was 932 389, of which 45%
report to be of United Kingdom
Interpreting the results
origin, and 16% French while
CANADA, NOVA SCOTIA (1998-2002)
The NSCR is active in the
just over 3% indicate North
CANADA, NOVA SCOTIA (1998-2002)
Canadian Council of Cancer
American Indian. Some
Registries and is a full member
40% of census respondents
of t h e No r t h A m e r i c a n
indicate
multiple
ethnic
Association of Cent ra l
origins. The active labour








 





Cancer Registries, including


force (443 000) was employed

 





participation in the annual


in the following categories













certification program. In the


of industry: manufacturing,







ve-year period covered by this


9.3%; construction 6.1%;














data submission, several studies


primary industry (agriculture,







were carried out to review case


shing, forestry, mining),













completeness and demonstrated


4.2%. Almost 80% report







excellent results. New processes


being involved in service













have been put in place to target


related
industries
(e.g.







out patient haematological


trade; nance, healthcare,














diagnoses. During and at the


government, education). In







end of each calendar year, a


2001, 56% of the population
series of edit checks ensure the
described itself as urban and






quality of data, which are then
44% as rural dwellers. Over
  0+' "  0+'submitted to Statistics Canada
95% of the population who



,/&0(&&000
 
to become part of the Canadian
report religion on the census

  
3 30#0 !$0  00 "0(2213)&&*0  0# 0 "  00 0  0   00
  0 "  0#  00 0
Cancer Registry.
indicate Christian, while 11%  0


(22/0 $0 0
 0#0 0
 0"  0 $0 "
0 $0 0   %0
did not respond.
 


  
 0 0+)&&,-00 .00
0
Use of the data
The registry prepares an annual report of cancer incidence
Cancer care facilities
All residents of Nova Scotia are covered by a publicly funded and provides this data to users, highlighting trends and
comprehensive health insurance scheme. This includes access changes. A major monograph is produced every ve years,
to family physician and hospital-based care. Many residents and includes incidence, mortality, survival, projections and
have supplemental insurance programs for costs not covered prevalence analyses. Ad-hoc queries are frequently received
by the public system (e.g. prescription drugs). Since 1993, and responses provided. Data are also made available for
all residents are assigned a unique health card number that research purposes to ethically-approved studies.
remains with them for life and aids in the maintenance of an
unduplicated patient index. Health care is administratively Source of population
managed and delivered by district health authorities (DHAs). The populationatrisks by sex and age from 19982003 have
Cancer care is highly centralised, with coordination been estimated using the adjusted intercensal or postcensal
occurring under a provincial cancer program. There are estimates based on the 1996 Census, as provided by the Population
two main provincial cancer centres that operate satellite Estimates Section, Demography Division, Statistics Canada.
facilities across the province for oncology specialist referral
and follow-up. Approximately 60% of all patients have some Multiple primary rules used
contact with a centre or satellite clinic at diagnosis.
IACR rules (2004) on CI5 IX period.

131

North America

Canada, Ontario
Registration area
The Ontario Cancer Registry is the largest patient-specic
population-based cancer registry in Canada. Operated by
Cancer Care Ontario (CCO) since 1964, it covers the entire
province of Ontario. The population at most recent census
(2001) is approximately 11.4 million people, with over 80%
of the population living in urban centres. The major racial/
ethnic groups in Ontario are: European 80.9%, South Asian
4.9%, Chinese 3.7%, Black 3.6%, Aboriginal 1.7%, Filipino
1.3%, Latin-American 0.9% and other 3.0%

for compiling statistics or carrying out medical or


epidemiological research. Under the 2004 Personal Health
Information and Privacy Act, CCO is also mandated to
use this information for planning and management of the
cancer system in Ontario.

Interpreting the results


Because of changes in diagnostic practices or rules
of coding and registration, interpretation of temporal
trends must be done with caution. For example, with the
introduction of ICD0-2 in Ontario in 1993, borderline
ovarian tumours were now registered as invasive
Cancer care facilities
Cancer Care Ontario is the principal adviser on cancer issues neoplasms; this increased incidence by about 30%. But with
the introduction of ICD0-3
for the Provincial Government.
in 2002, the classication of
CCO is responsible for longborderline tumours reverted
term planning of the cancer
CANADA, ONTARIO (1998-2002)
from malignant to uncertain
care system and coordination
CANADA, ONTARIO (1998-2002)
behaviour. Thus, incidence
of cancer prevention and
seemingly fell by 30%.
control
activities
and
Limitations in the range
programmes
(cancer
of registered tumours may
surveillance,
prevention,














limit
comparability.
For
screening, diagnostic services,

 


 


example, the Ontario Cancer


treatment, supportive care and
 













Registry does not register


research) in Ontario.







non-malignant brain tumours,


CCO does much of its




 


 



 


non-melanoma skin cancers,


work through 14 Regional







or in-situ cancers, nor is there


Cancer Programs, which are
 



 









registration of other cancer


geographically aligned with







precursors (e.g. adenomatous


Ontarios health planning







 






polyps of the colorectum).


regions (called Local Health




 


Limitations in the accuracy


Integration Networks, or




 









and
timeliness of registering
LHINs). The 12 Integrated

 





and reporting actual incident


Cancer Programs are located
cases may also be critical
in major urban centres,






factors. For example, annual
and serve as the hub of the
  0+' "  0+'incidence data are generally not
Regional Cancer Programs.




.012)0(*1000
 
considered nal and reported
CCO continues to directly

  
4 40#0 !$0  00 "0(3324)&&*0  0# 0 "  00 0  0   00
  0 "  0#  00 0
publicly until approximately
manage the Ontario Breast  0


(33/0 $0 0
 0#0 0
 0"  0 $0 "
0 $0 0   %0
1824 months following initial diagnosis. This may be a
Screening Program and the New
Drug Funding Program.
 


  
 0 0+)&&,-00 .00
0
limitation for researchers who desire more rapid reporting.
Problems in coding consistency and classication constancy
Registry structure and methods
The registry operates under CCOs Informatics Unit. CCOs may also occur.
Further, new methods of screening and diagnosis can
operating expenses were approximately $460 million in FY
2005/06, and it currently has approximately 330 employees, also change patterns of incidence. With rapid diffusion of
including planners, scientists, analysts, statisticians, new methods (e.g. PSA screening introduced in Ontario in
clinical and non-clinical managers, technicians and other 1989) incidence may increase dramatically, often within
months, and may distort assessment of the underlying risk
professionals.
Cancer registration in Ontario is passive, relying of cancer, or present a sudden increase in demand for the
almost completely on electronic records collected for other cancer system.
purposes. Close to one million source records are submitted
to the OCR each year. Since 1979, the OCR has relied on Use of the data
four major data sources: hospital discharge (including day The OCR is an invaluable resource for conducting
surgery) summaries that include a diagnosis of cancer; epidemiological studies, and is also used to follow up patients
pathology reports with any mention of cancer; records of or individuals who may have been exposed to risk factors.
The OCR can also be used to help evaluate the
patients referred to the Integrated Cancer Programs; and
effectiveness of screening programmes. The Ontario Breast
death certicates for all underlying causes of death.
While cancer is not a legally reportable disease in Screening Program links its database to the OCR in order
Ontario, the Cancer Act provides a legal mandate for to conrm diagnoses of cancer in the screened population,
Cancer Care Ontario to establish and maintain a cancer identify interval cancers and verify vital status.
Over the 1990s, use of the OCR expanded to include
registry. Further, under the Cancer Act, any information
about a registered case must be kept confidential and health care utilisation studies. The availability of data
not be used or disclosed for any purpose other than regarding utilisation of hospitals and cancer clinics by

132

North America

cancer patients as well as details regarding treatment (e.g.


surgical procedures) provides researchers with a useful tool
in performing these studies.
Finally, with the evolution of CCO into Ontarios planning
agency for cancer services, there has been a substantial
investment in modern statistical methods of forecasting, as
applied to predicting future incidence, survival, prevalence
and mortality, over the short (35 yrs) and medium (1015
yrs) terms.

Source of population
The populationatrisks by sex and age from 19982003
have been estimated using the adjusted intercensal or
postcensal estimates based on the 1996 Census, as provided
by the Population Estimates Section, Demography Division,
Statistics Canada.
Multiple primary rules used
IACR rules (2004) on CI5 IX period.

133

North America

Canada, Prince Edward Island


to the registry from the provincial pathology laboratory. The
Registration area
The registry covers all of Prince Edward Island, the smallest registry has 98% completeness using the Canadian I/M ratio.
province of Canada, which is situated to the southwest of the Gulf The percentage of microscopically conrmed cases for PEI
of St. Lawrence, lying between longitudes 62 and 65 W and was 93% for the 2003 data submission year. Additional data
latitudes 46 and 48 N. The island covers an area of 5684 km.
necessary for cancer registration are obtained from the outpatient
The population according to the 2001 census was 135 294, cancer treatment centre charts and hospital charts. Physicians
with 60 675 being urban and 74 619 being rural. A preliminary and nursing homes are also contacted as needed to obtain
population count on 1 July 2005 showed a population of 138 information. Electronic sources of data available to the cancer
113 on PEI. The male to female breakdown from the 2005 registry staff include the radiology information system, and the
population estimates that 67 198 are men and 70 915 are laboratory case management system. Death lists are sent from
women. Of these, 11 993 of the females and 12 459 of the Vital Statistics to the registry monthly. All deaths with mention
males were under age 15. A large majority of the population of cancer are researched and followed back to ensure all cases are
of PEI is of British Isles origins, followed by French origins. registered. Death certicates as the only source of information
A smaller number are of other
comprise a very small number of
European origins.
registrations due to the rigorous
The primary employment
follow-up procedures; in fact
EDWARD ISLAND (1998-2002) for the 2003 data submission
by industry are service sector CANADA, PRINCE
CANADA, PRINCE EDWARD ISLAND (1998-2002)
jobs followed by agriculture
year there were no cancer
and shing.
registrations in which death
certicates were the only source
Cancer care facilities
of the cancer registration data.












The PEI Cancer Registry was


The registry staff follows up







formerly part of the Provincial


on any cases that require further





 






 

Health Services Authority


information for registration. The







and is now a division of the


small size of the province and

 












Department of Health under the


the accessibility of information




 

Queen Elizabeth Hospital (QEH)


enable staff to complete cases





 








and the PEI Cancer Treatment


with a very high degree of







Centre (PEICTC). Hospital


quality. The implementation














organisation and practice are


of an electronic health record







based on a comprehensive
in the spring of 2007 will











government-organised health
further enhance the ability of







insurance scheme. There are


the registry to follow up cases
no private hospital facilities.
for further information.







/*&,

!
/*&,
Treatment services are provided
The registry started to

 

.0/-')///

at the Queen Elizabeth Hospital
collect staging information on
in the PEI Cancer Treatment 
  
all breast and colorectal cancers
#/
// !/'2213(%%)/
/"

/
!
//
/
/

// 
/
!
/"
//
/
Centre. Satellite clinics are held 
/  33/"/

starting with cases diagnosed in


'22./
#// 
/"/
/  /!
/
#/
! / #//$/
at the Prince County and Kings 


  
County Memorial Hospitals, 2003. Staging information on all lung and prostate cancers was
/
/*(%%+,////
providing medical oncology services. Diagnostic services added for diagnosis year 2005 with the expectation of stage
include CAT scan and MRI, both of which are located in the collection on the whole incidence le in future years. The time
Diagnostic Imaging Department of the QEH adjacent to the frame for this is nancial/human resource dependant. The
PEICTC. Radiation treatment on a Linear Accelerator became registry staff has received formalised training on the staging
available on Prince Edward Island in October 2003. Previously of breast, colorectal and lung cancer using the Collaborative
all radiation treatments delivered on PEI were via a Cobalt Stage method of data collection, with prostate and head and
60 machine. All radiation treatment necessitating a Linear neck sites completed in September 2006 and 2007 respectively.
Accelerator required travel to another province prior to this The manager of the registry has been very involved in the
time. There is an organised Breast Screening program in PEI. national implementation of stage collection and is currently
There is no formalised colorectal screening program. PSA one of six Canadian staging specialists providing training to
testing and colorectal screenings are done at the discretion other cancer registrars. The manager of the cancer registry
of the physicians.
keeps the statistics for cancer incidence as well as all workload
statistics for the PEICTC, which are used by policymakers for
Registry structure and methods
future planning of required health services.
The PEI Cancer Registry commenced with cancer collection in
1969 and has been submitting cancer data nationally to Statistics Source of population
Canada since then. The registry personnel consist of the director The populationatrisks by sex and age from 19982003 have
(medical oncologist), the manager (1FTE) and a health records been estimated using the adjusted intercensal or postcensal
technician (.5 FTE). The PEI Cancer Registry is not currently estimates based on the 1996 Census, as provided by the Population
involved in any epidemiological research projects but did participate Estimates Section, Demography Division, Statistics Canada.
in the National Enhanced Cancer Surveillance study.
The main source of data for the registry is pathology Multiple primary rules used
reports with a diagnosis of cancer, copies of which are sent IACR rules (2004) on historical data.

134

North America

Canada, Saskatchewan
each year. All cancer cases in the database are coded according
Registration area
The registry includes all of Saskatchewan, a province of to ICD-O-3. Causes of death from cancer are coded using ICD651 903 km2 located between Alberta to the west, Manitoba 10, and non-cancer causes of death up to 1999 remain as ICD-9.
to the east, the Northwest Territories to the north and the In 2005 the Registry started using Collaborative Staging for
USA to the south. Saskatchewan is between latitudes 49 and breast and colon cancers. In 2006 additional cancer sites will
60 N and longitudes 102 and 110 W. Most of the province is have collaborative staging applied to them. The Saskatchewan
at or above 300m altitude, and the majority of the population Cancer Registry is a member of the Canadian Council of Cancer
Registries and the North American Association of Central
live in the southern half of the province.
Among provinces, Saskatchewan ranks sixth in population Cancer Registries (NAACCR). Our data are submitted annually
with 990 930 people according to the 2006 census estimate. to the Canadian Cancer Registry and the NAACCR.
The population of Saskatchewan is of mixed ethnic origin.
The quality of the registry data is maintained through internal
More than 40% of inhabitants trace their ancestry to the British edit processes at the point of data entry as well as yearly processing
Isles. The next largest ethnic groups claim German, French, of edit checks. Edits are also conducted by Statistics Canada/
Ukrainian, American Indian,
Canadian Cancer Registry and
Metis and Scandinavian
NAACCR on the data we submit
ancestry. Indigenous peoples,
to them for quality, accuracy,
CANADA, SASKATCHEWAN (1998-2002)
mainly Cree, Assiniboine, and
timeliness and completeness.
CANADA, SASKATCHEWAN (1998-2002)
Chipewyan account for 17.3%
Statistics Canada now produces
of the population.
a report card each year; both
Approximately 64% of the
the Statistics Canada report and
population resides in cities of
the NAACCR report outline our











more than 5000 inhabitants,


results and subsequent areas for







including Saskatoon (237 017)


improvement.














and the provincial capital,


Patient follow-up has been







Regina (200 854).


active since 1932. Every case












 

diagnosed (excluding non








Cancer care facilities


melanoma skin cancer) is














The Saskatchewan Cancer


reviewed
at least annually either







Commission Act of 1930 authorised


through an examination at one














of the clinics or through our


a commission to establish a cancer





 

control program in Saskatchewan.


follow-by-mail program, which

 












In 1979, the Saskatchewan Cancer


sends letters to family/referring







Foundation Act established a new


physicians at regular intervals for
organisation to replace the Cancer
10 years minimum. Although this






  0+' "  0+'Commission. The Saskatchewan
program is still used as a method


.&.0(22000
 
of survival/recurrence analysis, it
Cancer Agency is now responsible
for treatment, prevention and early 
  
now also helps ensure continuity
3 30#0 !$0  00 "0(2213)&&*0  0# 0 "  00 0  0   00
  0 "  0#  00 0
detection programs, research, and  0


of patient care once the patient
(22/0 $0 0
 0#0 0
 0"  0 $0 "
0 $0 0   %0
 


  
education services. The Agency maintains
two clinics, the Allan is discharged from the Clinic. The response rate to these letters
 0 0+)&&,-00 .00
0
Blair Memorial Clinic in Regina and the Saskatoon Cancer Centre in is approximately 98%. The Registry began performing an active
Saskatoon, which provide radiotherapy, chemotherapy and follow-up follow-back process on all registered DCO cases in 2002.
services. The Agency also has two Cancer Patient Lodges associated
with the clinics, a Health Research Division, a Screening Program Interpreting the results
for Breast Cancer, a Prevention Program for Cervical Cancer, as well The vast majority of the population is involved in farming, which
as an Education Division. The Screening Program for Breast Cancer may result in higher exposure to pesticides, herbicides, fungicides
was established in 1990 and the Prevention Program for Cervical etc. Recent literature also suggests a link between cancer and
diabetes; if substantiated this could have a huge impact on our
Cancer began in 2003.
First Nations population that have a higher rate of diabetes.
Registry structure and methods
The province is covered by a universal comprehensive health Use of the data
insurance plan. The Cancer Foundation Act mandates that all The Cancer Agency will be producing its third annual Cancer
cancers be reported to the Agency. This reporting structure Control Report this year. The information in the registry also
captures approximately 95% of our case ascertainment. The other supports Agency planning for cancer control services and is also
5% is captured through death certicate notication received used as an information source for various research studies.
monthly from the Vital Statistics branch of Saskatchewan
Health. The Saskatchewan Cancer Agency is funded by the Source of population
Saskatchewan Government. The Registry is staffed by 10 FTE The populationatrisks by sex and age from 19982003 have
cancer registrars, 2 supervisors, 1 coordinator and the director. been estimated using the adjusted intercensal or postcensal
Complete computerised information is available on all estimates based on the 1996 Census, as provided by the Population
cancers diagnosed since 1967. There are currently about 212 200 Estimates Section, Demography Division, Statistics Canada.
patients and about 281 000 case records on the database. The
registry also records follow-up information on approximately 36 Multiple primary rules used
000 clinic examinations per year and 25 000 physician reports IACR rules (2004) on CI5 IX period.

135

North America

USA, Alabama
Registration area
Public Health. The ASCR staff comprises 12 permanent
Alabama is located on the southern coast of the United States. employees, including an Administrative Director, a Program
The state is divided into 67 counties, and the states largest Manager, an Epidemiologist, an Operations Analyst, and
city is Birmingham, located in the central region of the state. four Regional Coordinators (RC), three of which also have
Among the 50 states, Alabama ranks 30th in size, covering additional functions within the registry such as Completeness
52 423 square miles. According to the 2000 U.S. Census, it Coordinator, Quality Assurance Coordinator, and Education
the 23rd most populous state, with 4 447 100 residents, and Coordinator. In addition, the ASCR has a Death Clearance
the states population is projected to increase to 4.8 million and Research Coordinator, two case nding auditors and an
by 2010 (Alabama Dept. of Industrial Relations). According Administrative Assistant.
to the Census Bureau, Alabama is considered an urban
The ASCR is supported through Federal funds under the
state with 55 percent of its population living in an urban US Centers for Disease Control and Preventions National
setting and 45 percent in rural areas. Nearly every county in Program of Cancer Registries (NPCR). The ASCR does not
Alabama has some rural population, even the most densely currently receive any state funds except through support
settled counties, but some
from ve county health
sparsely settled counties have
departments, which provide
no urban population at all.
ofce space for regionallyUSA, ALABAMA (1998-2002)
Residents of Alabama are
based staff.
USA, ALABAMA (1998-2002)
predominantly white (71.1%),
Electronic reporting is
with a signicant Africancurrently being phased in with
American population (26.0%).
pathology labs and physician
Hispanics make up 1.7% of
groups. All other reporting








 





the states population, though


sources report via the ASCRs

 





Birmingham has been ranked


secure website. Thirty-eight














6th among US cities with


of these healthcare facilities

 





the fastest growing Hispanic


are certied by the American

 



 






 

population
(http://apha.
College of Surgeons and







c on fex.com /apha /133a m /


report approximately 80% of




 






 


techprogram/paper_112388.
Alabamas incidence.

 





htm). Asians make up 0.7%



 












of the states population,


Interpreting the results







and Native Americans 0.5%.


Alabama has captured at least

 












Alabama has a large number


95% of its expected caseload







of
prime
workforce-age
over the past several years,
residents, with 29% of the
and is proud to provide a high






states population between
quality, statistically useful
 /*',
 ! /*',
ages 25 and 44.
database.


 

)/(+./0.+///

Screening programs are

  
/(//

/ ! /"/ #/ #/  #//
/ 2/
 / ! /" //)&&&/ / / $/ /
Cancer care facilities
offered through hospitals,


// / /"  / 3  / ! /  / !/ / /!
 3  /   // /)&&&/ / / $/
Cancer is a reportable disease 
1%%$ $ $%

$/
under Alabama Act 95-275. physicians and community organisations such as the American
 


  
 /  /*)&&+,// -//
/
There are 55 healthcare facilities
in the state that have fully Cancer Society for sites such as breast, skin, colorectal, and
staffed and functioning cancer registries, along with 54 non- prostate. The Alabama Breast and Cervical Cancer Early
registry facilities who utilise independent CTR contractors Detection Program (ABCCEDP) offers screenings for
to capture and report cancer data. In addition, there are 22 breast and cervical cancers. Prostate Specic Antigen (PSA)
free-standing treatment centres, 36 physicians or physician testing is a common practice used by healthcare providers
groups and 13 pathology laboratories that currently report in Alabama.
to the ASCR.
Full-service cancer health care is provided by many Use of the data
hospitals in Alabama including two academic teaching The ASCR, in conjunction with the American Cancer
facilities. Physicians also deliver limited diagnostic and Societys Alabama Afliate Ofce, prepares an annual
treatment services in ofce settings. There are 25 free- report of cancer incidence, highlighting trends and changes,
standing cancer centres (including radiation centres) and as well as the efforts of Alabamas Comprehensive Cancer
clinics that also provide a full scope of therapeutic options Control Program. In addition, the ASCR collaborates with
for their patients.
researchers and Principal Investigators across Alabama and
around the US on special data linkages and research projects
Registry structure and methods
addressing issues from cancer prevalence to disparities in
The ASCR is housed in the Bureau of Health Promotion care. The ASCR limits participation in such activities to
and Chronic Disease of the Alabama Department of twelve open research projects at any given time.

136

North America

USA, ALABAMA: BLACK (1998-2002)


USA, ALABAMA:
BLACK (1998-2002)

USA, ALABAMA: WHITE (1998-2002)


USA, ALABAMA:
WHITE (1998-2002)


 





 





























 















 























 

































 




















 










 




















 





















































































































 0+'.,*0/&1000





 ! 0+'

 0+'


(0.1*012/000



 ! 0+'






  
0(00

0 ! 0"0 #0 #0  #00
0 30
 0 ! 0" 00)&&&0 0 0 $0 0


00 0 0"  0 4  0 ! 0  0 !0 0 0!
 4  0   00 0)&&&0 0 0 $0

2%%$ $ $%

$0


  
0(00

0 ! 0"0 #0 #0  #00
0 40
 0 ! 0" 00)&&&0 0 0 $0 0


00 0 0"  0 5  0 ! 0  0 !0 0 0!
 5  0   00 0)&&&0 0 0 $0

3%%$ $ $%

$0

 


  
 0  0+)&&,-00 .00
0

categories in the 2000 United States Census. http://www.


seer.cancer.gov/popdata.

Source of population
July 1 county population estimates by age, sex, race, and
Hispanic origin; postcensal estimates based on 2000 United
States Census. The population data include the bridged
singlerace estimates derived from the original multiplerace

 


  
 0  0+)&&,-00 .00
0

Multiple primary rules used


IACR rules (2004) on CI5 IX period.

137

North America

USA, Alaska
Manual case reports are also generated as a result of
Registration area
The Alaska Cancer Registry (ACR) covers the population of casending audits of hospitals and death clearance. Casending
the State of Alaska, the northernmost state in the United States. audits are conducted by reviewing the medical disease index
Alaska represents 16% of the total land area of the country, but from the hospital for a given time period for cancer cases and
only 0.2% of the countrys population. The population at the most removing cases that have already been reported by the hospital.
recent census (2000) was 626 932. The state is divided into 27 The remaining cases are researched by the registrars, and new
county-equivalent areas of municipalities, boroughs, and census cases are added to the registry. Death clearance is performed
areas. Most of the state is rural and sparsely populated. About by comparing a list of all Alaska resident cancer deaths for a
42% of the population lives in the Municipality of Anchorage given time period against the registry database and removing
(260 283), although Anchorage represents only 0.3% of the land death cases that have already been reported by other sources.
area of the state. The top ve county-equivalent areas in the state The remaining cases are researched by the registrars, and new
(Municipality of Anchorage, Fairbanks North Star Borough, cases are added to the registry.
Quality control is performed on the data on a regular
Matanuska-Susitna Borough, Kenai Peninsula Borough, and
basis. All new cases need
Juneau Borough) make up 77%
to pass at minimum the
of the states population and
NPCR Required, NPCR
represent only 9.2% of the land
USA, ALASKA (1998-2002)
Supplemental, and Site/Typearea. The statewide population
USA, ALASKA (1998-2002)
-Over-rides - Missue Edit
is 73.5% White, 17.2% Native
Sets of the current NAACCR
Alaskans or American Indians,
Edits Metale. In addition,
5.1% Asian or Pacic Islanders,
during the annual NAACCR
and 4.3% Black.










 

and CDC Calls for Data, the



 





data submission le must pass


Cancer care facilities














specic Edits Sets specied


General healthcare in the state







by NAACCR and CDC at the


is provided by 24 hospitals,








 





time of data submission. Also


numerous health clinics, and many







during the Calls for Data, ACR


private practitioners. Because





 






 

runs specic database queries


the Anchorage Municipality







to check for data quality.


has the highest population, it














also has the highest number of







 

Interpreting the results


healthcare facilities, including














There are no unusual


four hospitals. In rural areas,







geographical, clinical, or
many boroughs/census areas only
coding factors that inuence
have one hospital, and some have






 0+' ! 0+'incidence rates. However, the
no hospitals. Alaska Natives are



*).0/.*000

Alaska Department of Labor
provided healthcare at no cost at a
publishes annual population
central hospital in Anchorage. 
  
0(00

0 ! 0"0 #0 #0  #00
0 20
 0 ! 0" 00)&&&0 0 0 $0 0
estimates for Alaska that are


00 0 0"  0 3  0 ! 0  0 !0 0 0!
 3  0   00 0)&&&0 0 0 $0

1%%$ $ $%

$0
different from those published by the federal government
Registry structure and methods
 


  
 0  0+)&&,-00 .00
0
ACR is located in the city of Anchorage,
and is part of the Alaska (CDCs National Center for Health Statistics). The incidence
Department of Health and Social Services, Division of Public and mortality rates ACR generates are based on federal
Health, Section of Chronic Disease Prevention. It is funded governments population data.
mostly by the US Centers for Disease Control and Prevention
(CDC) through the National Program of Central Cancer Use of the data
Registries (NPCR), and partly by the state health department. ACR prepares an annual report of cancer incidence and
ACR is staffed by a full-time manager, three full-time registrars, mortality. Data are submitted annually to NAACCR and
and a full-time data analyst. Several full-time administrative CDC for use in multi-registry databases and data reports. In
addition, registry data are regularly requested by members
clerks provide part-time support for the program.
Cancer is a reportable disease by state law; a hospital, of the US Congress, the Alaska state legislature, researchers,
physician, surgeon, or other healthcare facility or provider physicians, researchers, and the general public.
diagnosing, screening, or providing treatment for a cancer
patient is required to report to the registry. The annual
caseload for ACR is approximately 2000 consolidated Source of population
cases per year. ACR receives about 50% of its case reports July 1 county population estimates by age, sex, race, and
(source records) electronically from hospitals in the standard Hispanic origin; postcensal estimates based on 2000 United
NAACCR Record Layout. Electronic cases are also received States Census. The population data include the bridged
from other state central cancer registries in the United States singlerace estimates derived from the original multiplerace
with which ACR has data exchange agreements (currently categories in the 2000 United States Census.
ACR has 30 of these agreements). The rest are manually http://www.seer.cancer.gov/popdata.
abstracted in-house by the registrars. The manual case reports
consist of hardcopy medical records sent to the registry by Multiple primary rules used
IACR rules (2004) on CI5 IX period.
hospitals, private physicians, and pathology laboratories.

138

North America

USA, Arizona
Registration area
The Arizona Cancer Registry covers the population of the State
of Arizona in the United States of America. Arizona is located
in the west in the Rocky Mountain region. The population at
the most recent population census projection (2005) was 5.8
million. About 89% of the population lives in urban areas (>5000
population). Arizona has the second largest state concentration
of Native Americans in the United States, comprising 5% of the
population. The racial breakdown of the population in Arizona
is: White Non-Hispanic 60%, Hispanic 29%, and all other races,
Non-Hispanic 11%.
Cancer care facilities
General health care in the region is
provided by private practitioners,
clinics, and hospitals. Health
insurance is used by 82% of the
population to pay for health care.
Most health insurance is private,
non-governmental insurance
(75%) of healthcare coverage.
The amount the insurance plan
pays varies greatly between
health plans. The remainder of
health insurance is provided
by the government. There are
both hospital and freestanding
radiotherapy departments in
Arizona.













completeness and accuracy, visual editing and immediate and


batch editing. The staff also collects cases from facilities that
do not report directly to the registry, including hospitals with
fewer than 50 beds and pathology laboratories.
The Data section analyses the incidence, mortality and
survival of people diagnosed with cancer in Arizona. It provides
this data to cancer support organizations and government
agencies as well as to researchers, members of the medical
community and the public. The section also audits reporting
hospitals, to identify areas for improvement when abstracting
and reporting cases.
The training section plans and administers a statewide
training program for registry staff, reporting facilities including
hospital and clinic personnel,
and physicians and their staff.
In addition, the training section
USA, ARIZONA (1998-2002)
develops written materials such
USA, ARIZONA (1998-2002)
as brochures and newsletters.
Finally, it is also responsible
for keeping cancer registry and
reporting facility staff updated








of coding and regulatory






changes.





 




 



















Interpreting the results


The rate of cancer in Arizona






is stable, with rates of increase













 


and decline following United


 



 


States trends. Arizona age 








 



 


adjusted incidence rates of






 


cancer are generally lower than


Registry structure and
 



 






 


the overall United States cancer


methods




 


rates. Completeness of data


The registry is located in
coverage is between 90 and
Phoenix, Arizona, the state






95%. Arizona has organised
capital. The registry receives
 /*',
 ! /*',
screening programs for breast,

 


its funding from state


)/-0./1+2///

cervical, and colorectal cancer.
legislature appropriations to 
  
#/  #//
/ 4/
 / ! /" //)&&&/ / / $/ /
Over half of all men over age 40
the Arizona Department of /(//

/ ! /"/ #/


// / /"  / 5  / ! /  / !/ / /!
 5  /   // /)&&&/ / / $/
Health Services. Enhancement
3%%$ $ $%

$/
funds are provided through yrs are screened for prostate cancer using the PSA test.
 


  
 /  /*)&&+,// -//
/
the National Program of Cancer
Registries (NPCR) from a
US Centers for Disease Control and Prevention cooperative Use of the data
Agreement. The registry is staffed with 13 FTEs and The registry prepares an annual report of cancer incidence,
highlighting trends and changes. The registry also is involved in
comprises three sections, Operations, Data, and Training.
The ACR is considered a population-based surveillance research studies that have been approved by our Human Subjects
system that collects, manages, and analyses information on Review Committee. Data are used for comprehensive cancer
the incidence, survival, and mortality of persons having been control planning; to respond to concerns in the community
diagnosed with cancer. Arizona Revised Statute 36-133 about cancer; to assist in the identication of geographic regions
mandates the reporting of cancer cases in the state of Arizona. of the state that need intervention programs or epidemiologic
Reporting rules (Arizona Administrative Code Title 9, Chapter research, detection, and prevention; to perform epidemiologic
4) require hospitals, clinics, and physicians to report cases to studies; and to provide biostatics and epidemiologic information
the ACR. The registry also collects information from pathology to the medical community.
laboratories. All hospitals are required to perform follow-up
on cases. All data reported from hospitals is electronic. The Source of population
registry also performs a linkage with vital records on the death July 1 county population estimates by age, sex, race, and
certicate le. The registry also performs case ascertainment Hispanic origin; postcensal estimates based on 2000 United
reviews and reabstracting studies at hospitals. The registry has States Census. The population data include the bridged
17 data exchange agreements with other US states, including singlerace estimates derived from the original multiplerace
categories in the 2000 United States Census.
all bordering states.
The sections of the registry are as follows: The Operations http://www.seer.cancer.gov/popdata.
section processes incoming case information from hospitals,
clinics, and physicians. The quality assurance program is a Multiple primary rules used
comprehensive program that includes reviewing data to ensure IACR rules (2004) on CI5 IX period.



139

North America

USA, California
approximately 2.5 million records for cases diagnosed 1988
Registration area
The California Cancer Registry (CCR) is a collaborative forward, and adds approximately 150 000 new cases to the
effort between the California Department of Public Health database each year.
The Central Registry in Sacramento houses numerous
Cancer Surveillance and Research Branch, the Public
Health Institute, and ten Regional Cancer Registries. These research scientists, quality control staff, IT programmers,
Registries encompass all of Californias approximately and scal and administrative support staff. Additionally,
156 000 square miles (404 000 km2). All cancers, with the each Regional Registry maintains their own ofce of
exception of basal and squamous cell skin cancers and in epidemiologists, research scientists, certied tumour
situ cervical cancers, diagnosed among Californias 34 043 registrars and support staff.
The CCR combines elements of an active and a passive
198 residents are considered reportable cancers. California
is not only the most populous state in the United States, but surveillance system at both the Regional and Central Registry
also the most ethnically diverse, with substantial Hispanic, levels. Active follow-up includes letters to physicians and
African-American, and Asian-American populations in telephone calls to patients. Passive follow-up involves
computer linkages to vital
addition to a large nonstatistics, voter registration,
Hispanic White population.
credit records and medical
There are also a wide variety
USA, CALIFORNIA (1998-2002)
resources. These various
of
religious
afliations,
USA, CALIFORNIA (1998-2002)
surveillance systems have
socioeconomic levels, and
allowed CCR to follow up
sociocultural characteristics
over 95% of patients.
within California.
Over 90 percent of




 
 








cancer reports are received


Cancer care facilities

 





electronically from hospitals,


Health care in California is














using hospital-based computer


provided by a variety of health







software supported by the


care facilities, including















CCR. Regional Registry


approximately 422 acute care






 


staff also routinely review


hospitals, 42 radiation therapy







 



 






the records of outpatient


centres, 308 free-standing









radiation and surgery centres,


surgery centres, and numerous


 















as well as all non-hospital


healthcare clinics. This care






 


based pathology laboratories


is supplemented by more











 






to identify unreported cases.


than 80 000 physicians, both








Physicians complete cancer


general practice and those
reports of patients diagnosed
specialising in oncology.






or treated in non-hospital
 0+' ! 0+'facilities. All CCR data are
Registry structure and




(/02.)0/*1000

edited for completeness and
methods

  
#0  #00
0 40
 0 ! 0" 00)&&&0 0 0 $0 0
accuracy and then are checked
Legislation declaring cancer 0(00

0 ! 0"0 #0


00 0 0"  0 5  0 ! 0  0 !0 0 0!
 5  0   00 0)&&&0 0 0 $0
to be a reportable disease in 
3%%$ $ $%

$0
California became effective by computer for allowable codes and compatibility between
 


  
in 1985. Statewide collection of 0  0+)&&,-00 .00
0
cancer cases began in 1988 different data elds. Regular audits are conducted at selected
under the Statewide Cancer Reporting Law. Additionally, hospitals to check for completeness and accuracy.
state law mandates that hospitals and physicians report all
cancer diagnoses to their Regional Registry. While recent Interpreting the results
legislation has made all CCR data variables condential, CCR The CCR makes efforts to identify persons who resided in
has always considered personally identifying information to California at the time of diagnosis, but were diagnosed or
treated in another state. California has case-sharing agreements
be condential.
The Central Registry of the CCR is located in Sacramento, not only with neighbouring states, but also with many states
California; there are eight Regional ofces throughout throughout the nation. While there have been no changes in
California, housing the ten Regional Registries. All of the area covered by the CCR, the population in California has
California participates in the Surveillance, Epidemiology, steadily increased since its 1988 inception. Efforts to improve
and End Results (SEER) Program, although there are screening rates among immigrant and low-income populations
three separate SEER Registries within California. The San through community outreach programs have increased over
Francisco Bay Area Registry became a SEER Registry the years. Cancer incidence in California is similar to that in
in 1973, with four adjacent counties added in 1992. The other parts of the United States; however an aggressive antiregistry in Los Angeles County became a SEER Registry smoking campaign has resulted in the dramatic reduction in
in 1992. The remaining areas of California, known as the smoking-related cancers in recent years.
Cancer Registry of Greater California, became a SEER
Registry in 2000. The CCR also participates in the National Use of the data
Program of Cancer Registries (NPCR) at the US Centers The CCR produces an annual report of cancer incidence and
for Disease Control and Prevention (CDC) and annually mortality in California for all of the major cancer sites. This
submits statewide data for inclusion in the NPCR Cancer report lists rates by year of diagnosis, sex, race/ethnicity,
Surveillance System. The CCR database currently contains and age. Additionally, each Regional Registry produces an

140

North America

annual report that lists rates by county. CCR data is used by


researchers throughout the United States to investigate causes
of cancer, survival, quality of care, tumour characteristics
and treatment. Since 1988, researchers in California have
used CCR data in 450 funded studies and have published

nearly 1700 articles using CCR data. CCR data also are
used by policymakers and currently are being utilised by
Californias cancer control planning organisation to measure
the burden of cancer in California and evaluate interventions
to reduce incidence and mortality.

USA, CALIFORNIA: BLACK (1998-2002)

USA, CALIFORNIA: NON-HISPANIC WHITE


USA, CALIFORNIA: NON-HISPANIC WHITE (1998-2002)
(1998-2002)

USA, CALIFORNIA: BLACK (1998-2002)








 


































 




 















 





















 



























 






























 







 

 




















 












 
























 

 





 










 



 















 











 




 



 /+'-





 ! /+'-

(/)*0/(,(///


 




 /*',


  
/(//

/ ! /"/ #/ #/  #//
/ 2/
 / ! /" //)&&&/ / / $/ /


// / /"  / 3  / ! /  / !/ / /!
 3  /   // /)&&&/ / / $/

1%%$ $ $%

$/

USA, CALIFORNIA: HISPANIC WHITE (1998-2002)

 


  
 /  /+)&&,-// .//
/

USA, CALIFORNIA: HISPANIC WHITE (1998-2002)



 ! /*',

0/(&(/.0.///




  
/(//

/ ! /"/ #/ #/  #//
/ 2/
 / ! /" //)&&&/ / / $/ /


// / /"  / 3  / ! /  / !/ / /!
 3  /   // /)&&&/ / / $/

1%%$ $ $%

$/

USA, CALIFORNIA: ASIAN AND PACIFIC


ISLANDER (1998-2002)
USA, CALIFORNIA: ASIAN AND PACIFIC ISLANDER (1998-2002)

 


  
 /  /*)&&+,// -//
/














































 




































 












 






 




 
 







 















 













 








 

 
 




 









 













 

 
 



 


















 




















 
 








 





 


























 0+'.0*/)0,/1000





 ! 0+'




 /+'
 



  
0(00

0 ! 0"0 #0 #0  #00
0 30
 0 ! 0" 00)&&&0 0 0 $0 0


00 0 0"  0 4  0 ! 0  0 !0 0 0!
 4  0   00 0)&&&0 0 0 $0

2%%$ $ $%

$0

 


  
Source
of population
 0  0+)&&,-00 .00
0
July 1 county population estimates by age, sex, race, and
Hispanic origin; postcensal estimates based on 2000 United
States Census. The population data include the bridged
singlerace estimates derived from the original multiplerace
categories in the 2000 United States Census.
http://www.seer.cancer.gov/popdata.

)/&(0/*(0///



 ! /+'






  
/(//

/ ! /"/ #/ #/  #//
/ 2/
 / ! /" //)&&&/ / / $/ /


// / /"  / 3  / ! /  / !/ / /!
 3  /   // /)&&&/ / / $/

1%%$ $ $%

$/

 


  
Multiple
primary rules used
 /  /+)&&,-// .//
/
IACR rules (2004) on CI5 IX period.

141

North America

USA, California, Greater San Francisco Bay Area


Registration area
The registration area includes nine counties (Alameda, Contra
Costa, Marin, Monterey, San Benito, San Francisco, Santa
Clara, San Mateo, Santa Cruz) in northern California, USA.
The US Census counted 6 516 923 persons living in the region
in the year 2000. Compared to other parts of the USA, this area
is noteworthy for its racial/ethnic diversity, with substantial
Hispanic, Chinese, Filipino, and other Asian populations. The
majority of the population lives in the urban San Francisco Bay
Area, which includes a major financial centre as well as the
Silicon Valley centre for technology innovation and industry.
Overall levels of education and income are higher than USA
averages and accordingly, cost of living tends to be higher in the
Greater San Francisco Bay Area than in other parts of the USA.
Cancer care facilities
Healthcare services in this region, including cancer
screening, diagnosis and treatment, are provided mostly by
private hospitals and physicians, but also by publicly funded
hospitals, clinics and public health agencies. At least 61
hospitals and over 21 000 physicians treat cancer patients
in the region and two major academic cancer centres are
located in the region. In addition, there are a number of freestanding radiation centres, surgery centres, and pathology
laboratories involved in cancer diagnosis and treatment. A
signicant proportion of residents receive managed health
care services through health maintenance organizations.
Registry structure and methods
The Greater Bay Area Cancer Registry, with a staff of about 50,
is operated by the Northern California Cancer Center (NCCC),
founded in 1974 as an independent consortium centre for cancer
research in Northern California. The registry has been part
of the Surveillance, Epidemiology and End Results (SEER)
Program of the National Cancer Institute since 1973 and has
contributed data to the statewide California Cancer Registry
since 1988. Cancer registry efforts at NCCC also include a
population-based registry covering four counties south of the
Bay Area (Santa Clara, Santa Cruz, San Benito, Monterey)
that have been included in the SEER program since 1992 and
the California Cancer Registry since 1988. Data from these
two registries have been combined to create the Greater San
Francisco Bay Area region shown in this volume. In total, this
registry contains well over 700 000 incident cases and processes
about 30 000 incident cases annually. The registry collects
data not only on incident cancer diagnoses but on diagnostic
procedures, tumour characteristics (including stage, grade and
tumour markers), treatment and survival time. Each patient
is given a unique identifying number and multiple primaries
designated by sequence number. All patients reported to the
registry are followed both actively and passively for vital status
to monitor survival time. Active follow-up consists of letters
to physicians. Passive follow-up involves computer linkages to
vital statistics, voter registration, credit records and medical
resources. Through these methods, the registry maintains
current follow-up information for over 95% of cancer patients.
Cancer has been a reportable disease by California state
mandate since 1987. This law requires that hospitals report to
regional registries such as NCCC all cancer diagnoses occurring
in their facilities and that physicians report cancers not diagnosed
in a hospital. Well over 90% of cancer registry reports are received
electronically from hospitals. The registry supports a hospital-based

142

computerised reporting system allowing each hospital to collect,


maintain, and easily transmit registry-reportable information and
facilitating editing by cancer registry staff. Quality assurance
procedures implement SEER and NAACCR standards for visual
and computerized editing, reabstractions and audits.
Interpreting the results
The registry identies cases residing in the Bay Area but who
are diagnosed or treated elsewhere through well-established
data sharing programs with neighbouring cancer registries.
The registry is also linked semi-annually to California vital
statistics records in order to identify persons for whom
cancer is mentioned on the death certicate but not already
reported to the registry. It is estimated that over 98% of cancer
diagnoses in region residents are captured by the registry.
Use of the data
Registry data are used primarily for investigating trends
in cancer incidence, survival, tumour characteristics and
treatment, thus providing a critical resource for monitoring the
burden of cancer in the region. Data are routinely combined
with California Cancer Registry and SEER program data for
larger surveillance efforts. A number of investigators apply each
year to access cancer registry information needed to carry out
analytic epidemiologic studies of many different cancer types
and outcomes. The large and diverse population has made this
registry a valuable resource for epidemiologic research into
the genetic and environmental causes of cancer, as well as for
cancer control interventions and healthcare planning efforts.

USA, CALIFORNIA,
GREATER
SAN FRANCISCO
BAY BAY
AREA
(1998-2002)
USA, CALIFORNIA,
GREATER SAN FRANCISCO
AREA (1998-2002)

%.-.0&---

/*,

+%-"/"---

&0-+.(---

/"

+&-"*%---

+%-*0&---

.*

//-+(&---

..-((&---

."

0.-0"$---

0"-"$(---

+*

$"(-%/%---

$$&-"0+---

+"

$%%-/+"---

$*&-/&%---

**

$+"-..+---

%$$-""&---

*"

%$.-*/.---

%($-/*&---

(*

%(%-+(*---

%..-0"$---

("

%++-.%*---

%0/-*%&---

&*

%.0-*0+---

%0/-/+0---

&"

%.+-"(&---

%+/-%%(---

%*

%(0-.++---

%$(-&/+---

%"

$0+-%%$---

%".-+%.---

$*

$0&-&++---

%$.-+(%---

$"

%"+-%$+---

%%.-+/&---

%$+-+(/---

%%%-((/---

"

%$$-0//---

$"

"

"

 -'#)
&-%*"-+"+---

$"

  -'#)


&-%*+-&0+---

  

-$--

-  -- -- 1-
 -  - --%"""- - - !-

      
 -  -'%""()-- *--
Source
of population
  
July
1 county population estimates by age and sex; postcensal
--- - -- -- - - - 
-
  !estimates based on 2000 United States Census.

Multiple primary rules used


IACR rules (2004) on CI5 IX period.
Notes on the data
This is not the same as the sum of the other groups presented.

North America

USA, CALIFORNIA, GREATER SAN FRANCISCO


BAY AREA: BLACK (1998-2002)
USA, CALIFORNIA, GREATER SAN FRANCISCO BAY AREA: BLACK (1998-2002)

USA, CALIFORNIA, GREATER SAN FRANCISCO


BAY AREA: FILIPINO (1998-2002)
USA, CALIFORNIA, GREATER SAN FRANCISCO BAY AREA: FILIPINO (1998-2002)

#,''-,,,

.)+

%,)'/,,,

#,$/),,,

.)+

#,''/,,,

$,$%',,,

.!

',!%),,,

#,%!.,,,

.!

#,//%,,,

%,)/.,,,

-)

),--#,,,

$,*$*,,,

-)

%,-*#,,,

',*.',,,

-!

*,%)*,,,

%,*'*,,,

-!

),%'%,,,

*,!$.,,,

*)

-,%//,,,

%,.-!,,,

*)

*,!.$,,,

-,/*!,,,

*!

.,//',,,

),%/*,,,

*!

#!,#/*,,,

))

##,)#-,,,

*,''',,,

))

.,'*),,,

)!

##,/.#,,,

-,$/*,,,

#',*#',,,

)!

#),/*/,,,

/,*/*,,,

#-,-#',,,

')

#.,*#!,,,

#!,-%!,,,

')

#$,/-!,,,

$!,./%,,,

'!

$#,#$/,,,

##,.*),,,

'!

#',%/*,,,

$#,-'/,,,

%)

$#,/$!,,,

#$,$%#,,,

%)

#',)*',,,

$!,'-!,,,

%!

$!,)-*,,,

#$,%$.,,,

%!

#',#%-,,,

#-,)#-,,,

$)

#.,)-#,,,

#$,-!*,,,

$)

#%,$%/,,,

#*,-#*,,,

$!

#*,///,,,

#$,%$',,,

$!

#$,$$#,,,

#)

##,%)-,,,

#/,#*/,,,

#)

#.,).#,,,

#$,!$$,,,

$#,)!!,,,

#!

$!,---,,,

##,-'-,,,

#!

#!,/'!,,,

$$,$#$,,,

)

$#,*)#,,,

##,)/%,,,

)

#!,-)*,,,

#/,#!',,,

!

#.,%/$,,,

#!,*'-,,,

!

/,/#),,,

#!

 ,&"(

#!

#!

$'-,.!),,,

$*!,-/*,,,



 ,&"(

  ,&"(

#!

  ,&"(

#)$,'-',,,

#-!,.*),,,



,#,,

,  ,, , ,,  0,
 ,  , ,,$!!!, , ,  ,
Source
of population
 


  
 ,  ,&$!!'(,, ),,
,
July
1 county population estimates by age, sex and race;
postcensal estimates based on 2000 United States Census.

,#,,

,  ,, , ,,  0,
 ,  , ,,$!!!, , ,  ,
Source
of population
 


  
 ,  ,&$!!'(,, ),,
,
July
1 county population estimates by age, sex and race;
postcensal estimates based on 2000 United States Census.

Multiple primary rules used


IACR rules (2004) on CI5 IX period.

Multiple primary rules used


IACR rules (2004) on CI5 IX period.


  

USA, CALIFORNIA, GREATER SAN FRANCISCO


BAY AREA: CHINESE (1998-2002)
USA, CALIFORNIA, GREATER SAN FRANCISCO BAY AREA: CHINESE (1998-2002)


  

USA, CALIFORNIA, GREATER SAN FRANCISCO


BAY AREA: HISPANIC WHITE (1998-2002)

USA, CALIFORNIA, GREATER SAN FRANCISCO BAY AREA: HISPANIC WHITE (1998-2002)

#,./%,,,

.)+

%,'%),,,

$-/.0---

/*,

(-$./---

%,!.),,,

.!

',#!),,,

%-*.0---

/"

(-**0---

),-%$,,,

-)

*,*#),,,

*-"$0---

.*

.-%*$---

-,#.-,,,

-!

/,##-,,,

.-(/(---

."

$"-"&$---

.,.%#,,,

*)

/,.-*,,,

0-+"+---

+*

$%-"*$---

.,/$%,,,

*!

#!,'.',,,

$%-+.0---

+"

$(-.%.---

/,!$',,,

))

#!,#.%,,,

$+-/((---

**

$/-%0/---

#),'//,,,

)!

#-,%!/,,,

%(-(**---

*"

%*-"$$---

#/,!!*,,,

')

$#,$*%,,,

&&-*.$---

(*

&%-&$$---

$!,-..,,,

'!

$$,.'$,,,

(+-$(+---

("

($-+&.---

$$,--),,,

%)

$',/%!,,,

*0-"./---

&*

*"-%&*---

#/,*!%,,,

%!

$$,').,,,

.$-*0*---

&"

*.-+%+---

#.,-)#,,,

$)

#/,-*/,,,

..-.""---

%*

+"-(%+---

#),-##,,,

$!

#),%*-,,,

.$-/./---

%"

*+-"0&---

#',.!$,,,

#)

#',!)#,,,

*/-+(*---

$*

*$-+.*---

#),$%*,,,

#!

#',!-.,,,

*+-.%$---

$"

*(-""%---

#),)$',,,

)

#),!*%,,,

++-$%*---

+&-"0/---

#','%',,,

!

#%,.-',,,

+/-($"---

"

+*-*0&---

#!

 ,&"(
$%*,.!',,,

#!

$"

  ,&"(


"

"

 -'#)
$)',.#/,,,


  
,#,,

,  ,, , ,,  0,
 ,  , ,,$!!!, , ,  ,

+0"-($&---

$"

  -'#)


+%/-/""---


  
-$--

-  -- - -  --
-  1-
 -  - --%"""- - - !-

Source of population
July 1 county population estimates by age, sex and race;
postcensal estimates based on 2000 United States Census.

 -  -'%""()-- *--
Source
of population
July 1 county population estimates by age, sex, race, and Hispanic
origin; postcensal estimates based on 2000 United States Census.

Multiple primary rules used


IACR rules (2004) on CI5 IX period.

Multiple primary rules used


IACR rules (2004) on CI5 IX period.

 


  
 ,  ,&$!!'(,, ),,
,

 


  

143

North America

USA, CALIFORNIA, GREATER SAN FRANCISCO


BAY AREA: JAPANESE (1998-2002)
USA, CALIFORNIA, GREATER SAN FRANCISCO BAY AREA: JAPANESE (1998-2002)

USA, CALIFORNIA, GREATER SAN FRANCISCO BAY AREA: NON-HISPANIC WHITE (1998-2002)

%//,,,

.)+

-%/,,,

%"-"."---

/*,

(.-&**---

.*',,,

.!

#,#)#,,,

%/-%++---

/"

(*-&""---

#,%)%,,,

-)

$,!'#,,,

(%-"".---

.*

+"-"".---

#,'#.,,,

-!

$,/$#,,,

(0-%**---

."

*0-00+---

#,%-/,,,

*)

$,-/%,,,

**-"$&---

+*

*0-/&+---

#,%.!,,,

*!

$,!)',,,

+0-*.(---

+"

.$-.$*---

#,/--,,,

))

$,'-.,,,

00-&$%---

**

00-++/---

$,-$.,,,

)!

%,$!#,,,

$&"-(0+---

*"

$&"-%.0---

%,'*#,,,

')

%,-#/,,,

$("-*0&---

(*

$&+-&%*---

',$!-,,,

'!

','!%,,,

$*$-/0/---

("

$($-+$(---

',$!.,,,

%)

),!#.,,,

$*$-(%*---

&*

$&0-$..---

%,-%-,,,

%!

',)*',,,

$&.-/.0---

&"

$%+-*+"---

%,!!),,,

$)

%,-##,,,

$"+-.*(---

%*

$"%-"(&---

$,$##,,,

$!

$,*-),,,

.*-(.+---

%"

.&-"%*---

#,/-!,,,

#)

#,/.),,,

/%-(*%---

$*

./-&%%---

$,$)-,,,

#!

$,#'.,,,

0"-((+---

$"

/*-($+---

$,)!),,,

)

$,''!,,,

/0-%*/---

/(-&$/---

$,%)',,,

!

$,$/!,,,

/(-++*---

"

/"-*+/---

#!

 ,&"(
'#,'#%,,,

#!

$"

  ,&"(



  
,#,,

,  ,, , ,,  0,
 ,  , ,,$!!!, , ,  ,

"

"

 -'#)
)!,%%#,,,

$-+"(-/&0---

$"

  -'#)


$-+%$-*%*---


  
-$--

-  -- - -  --
-  1-
 -  - --%"""- - - !-

Source of population
July 1 county population estimates by age, sex and race;
postcensal estimates based on 2000 United States Census.

 


  
Source
of population
 -  -'%""()-- *--
July 1 county population estimates by age, sex, race, and Hispanic origin;
postcensal estimates based on 2000 United States Census.

Multiple primary rules used


IACR rules (2004) on CI5 IX period.

Multiple primary rules used


IACR rules (2004) on CI5 IX period.

 


  
 ,  ,&$!!'(,, ),,
,

144

USA, CALIFORNIA, GREATER SAN FRANCISCO


BAY AREA: NON-HISPANIC WHITE (1998-2002)

North America

USA, California, Los Angeles County


Registration area
Los Angeles County is an urban area covering more than
10 000 km2 and has the largest population of any county in
the United States, with nearly 9.5 million residents in the 2000
census. Among these residents are more than four million selfdeclared Latinos including more than three million Mexicans,
38 000 Puerto Ricans, 38 000 Cubans and sizeable populations
representing various Central and South American countries. There
are nearly one million blacks in the county and between 100 000
and 400 000 each of Japanese, Chinese, Koreans and Filipinos.
Other major south-east Asian groups include Vietnamese, Asian
Indians, Cambodians and Thais. There is wide variation in socioeconomic as well as socio-cultural characteristics in the county.
Registry structure and methods
The Cancer Surveillance Program (CSP) of Los Angeles
County was started at the University of Southern California
in 1970 as part of an epidemiology and biostatistics program.
In June 1987, the CSP became one of the ten regional registries
of the population-based California Cancer Registry. This
registry, established by California law in 1985, places the
obligation for identifying and abstracting cancer cases on
those facilities where cancer is diagnosed or treated.
The CSP combines elements of an active and a passive
surveillance system. Under the active surveillance component,
CSP personnel systematically screen pathology reports and
other relevant les at all hospitals and free-standing pathology
laboratories, as well as some treatment facilities, to obtain
pathology reports for each cancer patient diagnosed or treated.
For passive surveillance, each hospital or other reporting
facility completes a full abstract, including stage and treatment
information on every cancer patient diagnosed and/or treated
at that facility. For each cancer patient, over 200 data items
including disease or medical variables, demographics and
administrative descriptors are coded and computerised.
The responsibility for completing reporting at some hospitals
is contracted back to the CSP; currently about 9% of all hospital
reports in Los Angeles County are so reported. All of the completed
abstracts are record-linked by the CSP to the pathology reports
obtained under active surveillance to assure that an abstract is
completed on every histologically veried cancer case.
Before 1992, linkage with the State of California death
tapes was the only means of passive follow-up. However,
beginning with 1992 diagnoses, the CSP instituted complete
follow-up as a function of its new afliation with the National
Cancer Institutes Surveillance, Epidemiology and End
Results (SEER) Program. Follow-up data are collected by
record linkages with multiple sources as well as incorporating
active follow-up information provided by hospitals.
Manual and computerised record linkages are performed
separately with a variety of external data sources, using a
sophisticated probabilistic methodology. Multiple primaries are
noted by a tumour sequence number. Each data item is checked as
an allowable code, and selected intereld checks are performed.
Interpreting the results
Los Angeles County has more than 100 hospitals and clinics,
many of them providing screening programs. The availability
of cancer screening programs can, in some instances such as
PSA for prostate cancer, result in increasing incidence rates.
Cancer mortality rates may not be directly related to cancer
incidence rates due to several factors including migration.

Differences in classifying cancers by primary site between


incidence and mortality data sources may also differentially
affect incidence and mortality rates. Furthermore, a cancer
may be reported as a cause of death when in fact it is a site of
metastasis from other cancer(s).
Race/ethnicity information for cancer incidence is based
primarily on information contained in the patients medical
record. Race/ethnicity for cancer deaths, on the other hand, is
based on information on the death certicate, which may not
always be based on information provided by next-of-kin. The
reporting of race/ethnicity in either system may be inuenced
by the racial/ethnic distribution of the local population, by local
interpretation of data collection guidelines, and other factors.
Some differences in race/ethnicity-specic rates likely reect
biases of classication rather than true differences in risk.
Use of the data
The CSP is one of the most productive cancer registries in the
world, in terms of scientic contributions toward understanding
the demographic patterns and the etiology of specic cancers.
More than 850 publications using CSP data have been
contributed to scientific journals. The registry supports a
large ongoing body of research funded mainly by the National
Cancer Institute. The CSP also prepares an annual report of
cancer incidence and mortality in Los Angeles County and
other monographs monitoring the trends and patterns of cancer
among the Countys populations. As a service to the community,
the CSP provides community-wide or hospital-specic data
on cancer occurrence. The CSP responds to requests from
concerned residents, community physicians, or from the County
and State health departments seeking assistance in investigating
perceived cancer risks from environmental exposures.

USA, CALIFORNIA, LOS ANGELES COUNTY (1998-2002)


USA, CALIFORNIA, LOS ANGELES COUNTY (1998-2002)

%',/%!,,,

.)+

)!,#!',,,

.!

-),.'%,,,
.!,#/.,,,

.!,)/!,,,

-)

##),$'.,,,

#!#,*$/,,,

-!

#%#,**$,,,

##.,'*/,,,

*)

#'$,*'$,,,

#'*,)!',,,

*!

#*',*-#,,,

#./,*!/,,,

))

$!.,#.#,,,

$)%,).$,,,

)!

$-','.-,,,

%!.,)$$,,,

')

%$$,#-#,,,

%*',*/$,,,

'!

%**,-%),,,

'!#,%$-,,,

%)

%/#,%.),,,

'#*,)#!,,,

%!

%//,$)$,,,

%/%,.%%,,,

$)

%-/,/!/,,,

%)%,./!,,,

$!

%%*,.$*,,,

%'/,!**,,,

#)

%$.,.'#,,,

%-$,%$-,,,

#!

%)*,!/),,,

'!',.*-,,,

%.-,-!$,,,

%-/,)#-,,,

%*#,).$,,,

#!

 ,&"(
',-#/,/**,,,

#!

  ,&"(


',.$%,'%#,,,


  
,#,,

,  ,, , ,  ,,
,  0,
 ,  , ,,$!!!, , , ,

 


  
Source
of population
 ,  ,&$!!'(,, ),,
,
July 1 county population estimates by age, sex, race, and Hispanic
origin; postcensal estimates based on 2000 United States Census.

Multiple primary rules used


IACR rules (2004) on CI5 IX.

145

North America

USA, CALIFORNIA, LOS ANGELES COUNTY:


BLACK (1998-2002)
USA, CALIFORNIA, LOS ANGELES COUNTY: BLACK (1998-2002)

USA, CALIFORNIA, LOS ANGELES COUNTY:


FILIPINO (1998-2002)
USA, CALIFORNIA, LOS ANGELES COUNTY: FILIPINO (1998-2002)

%-+*+---

/*,

.-$.0---




&-//.---

/"

.-*&*---


 






+-/*"---

.*

$"-000---









0-%0"---

."

$&-$.+---









$&-$.%---

+*

$+-**.---









$+-*%"---

+"

%"-"//---






$0-%"/---

**

%(-%"$---






%(-/%0---

*"

&$-"*"---









&"-%+"---

(*

&+-&$/---


 






&.-&"%---

("

(&-%&"---









&0-&(+---

&*

(+-%((---






&.-&""---

&"

(&-0+$---









&$-%*+---

%*

&.-."%---


 




 

&"-+/"---

%"

&(-.(/---









&/-0"%---

$*

&/-"0/---









(*-0*/---

$"

((-*+"---






(+-/(&---

(*-+*0---






&0-($*---

"

&/-%%0---






$"

"

"

 -'#)



$"

*&0-*&*---



 -)%+

  -'#)

(.&-+.(---




Source of population
 


  
 -  -'%""()-- *--
July
1 county population estimates by age, sex, race, and Hispanic
origin; postcensal estimates based on 2000 United States Census.

  
-$--

-  -- - -  --
-  1-
 -  - --%"""- - - !-

Multiple primary rules used


IACR rules (2004) on CI5 IX period.

USA, CALIFORNIA, LOS ANGELES COUNTY:


CHINESE
(1998-2002)
USA, CALIFORNIA,
LOS ANGELES
COUNTY: CHINESE (1998-2002)



  -)%+

&'.-('*---






Source of population
Census 2000. Because the US 2000 Census allowed multiple selection
of
race categories, there are two ways of counting the population for
 


  

- -)'$$*+--
,--  a given race group: one is the minimum count, which consists of
individuals who reported that particular race as their only race, the
other is the maximum count that includes individuals who reported
that race alone as their only race, as well as individuals who reported
that race in combination with other race(s). The population counts
included in this le are the simple averages of the minimum and
maximum counts for each of the agesexracespecic groups.

  

-'$$$#-  - --'$$$-


- -   -  - - -  "-  - --- -- -  - - - - /- -- -   ---- -  --  -- - -- -- "- - --   --- -  --  -- - -- -- -- --  --  -- - !-- - )+#- -  -- ---  - - -  -  - - -   - -   -- -  - - 0 0 0  - #-

Multiple primary rules used


IACR rules (2004) on CI5 IX period.

 













































































 












 


 




































 











 -(%*
&,.-/.'---



  -(%*


 



  

-'$$$#-  - --'$$$-


- -   -  - - -  "-  - --- -- -  - - - - 0- -- -   ---- -  --  -- - -- -- "- - --   --- -  --  -- - -- -- -- --  --  -- - !-- - (*#- -  -- ---  - - -  -  - - -   - -   -- -  - - 1 1 1  - #-

Source of population
Census
2000. Because the US 2000 Census allowed multiple selection
 


  

- -('$$)*--
+--  of
race categories, there are two ways of counting the population for
a given race group: one is the minimum count, which consists of
individuals who reported that particular race as their only race, the
other is the maximum count that includes individuals who reported
that race alone as their only race, as well as individuals who reported
that race in combination with other race(s). The population counts
included in this le are the simple averages of the minimum and
maximum counts for each of the agesexracespecic groups.
Multiple primary rules used
IACR rules (2004) on CI5 IX period.

146

USA, CALIFORNIA, LOS ANGELES COUNTY:


HISPANIC WHITE (1998-2002)
USA, CALIFORNIA, LOS ANGELES COUNTY: HISPANIC WHITE (1998-2002)

*-%"$---

/*,

$$-%+%---

.-$+.---

/"

$%-+$%---

$&-/%(---

.*

%$-%(&---

%"-*0%---

."

%0-*/.---

%+-++%---

+*

&*-+0%---

&*-/"&---

+"

(&-0".---

(0-+&.---

**

.%-%+$---

*"

/$-"&"---

00-...---

(*

$"*-/%"---

$&&-*$"---

("

$&&-*./---

$+/-/."---

&*

$*.-+*&---

%"$-"/.---

&"

$.0-0*/---

%".-$+$---

%*

$/+-(%0---

$0%-%+*---

%"

$.%-."0---

$.0-""0---

$*

$+*-0/*---

$0%-(.*---

$"

$/(-*%/---

%%+-&..---

%$.-&&"---

%%"-/%"---

"

%$$-%*.---

$"

"

"

 -'#)
%-"*%-(0/---

*.-/&(---

$"

  -'#)


%-""/-($*---


  
-$--

-  -- - -  --
-  1-
 -  - --%"""- - - !-

Source
of population
 


  
 -  -'%""()-- *--
-

July 1 county population estimates by age, sex, race, and Hispanic


origin; postcensal estimates based on 2000 United States Census.
Multiple primary rules used
IACR rules (2004) on CI5 IX.

North America

USA, CALIFORNIA, LOS ANGELES COUNTY:


JAPANESE (1998-2002)
USA, CALIFORNIA, LOS ANGELES COUNTY: JAPANESE (1998-2002)















 




























 















 




































 


 








































 ,(%*



  ,(%*

+.,'-),,,







  

,&$$$#,  , ,,&$$$,


, ,   ,  , , ,  ",  , ,,, ,, ,  , ,,
 , , /, ,, ,   ,,,, ,  ,,  ,, , ,, ,, ", , ,, ,
  ,,, ,  ,,  ,, , ,, ,, ,, ,,  ,,  ,, ,,
 !,, , (*#, ,  ,, ,,,  , , ,  ,  , , ,   , ,   ,, , ,
 , , 0 0 0  , #,

Source of population
 


  
Census
2000. Because the US 2000 Census allowed multiple selection

, ,(&$$)*,,
+,,  ,
of race categories, there are two ways of counting the population for
a given race group: one is the minimum count, which consists of
individuals who reported that particular race as their only race, the
other is the maximum count that includes individuals who reported
that race alone as their only race, as well as individuals who reported
that race in combination with other race(s). The population counts
included in this le are the simple averages of the minimum and
maximum counts for each of the agesexracespecic groups.

individuals who reported that particular race as their only race, the
other is the maximum count that includes individuals who reported
that race alone as their only race, as well as individuals who reported
that race in combination with other race(s). The population counts
included in this le are the simple averages of the minimum and
maximum counts for each of the agesexracespecic groups.
Multiple primary rules used
IACR rules (2004) on CI5 IX period.

USA, CALIFORNIA, LOS ANGELES COUNTY:


NON-HISPANIC WHITE (1998-2002)
USA, CALIFORNIA, LOS ANGELES COUNTY: NON-HISPANIC WHITE (1998-2002)

%%-+0.---

/*,

*"-(0*---

&%-$%%---

/"

*"-&(/---

(/-%"*---

.*

+.-%(*---

*+-%%"---

."

+/-+0*---

+"-$.+---

+*

++-.&(---

."-/""---

+"

0$-"/+---

**

0%-&0(---

$$*-$/.---

*"

$$(-.%$---

$%0-%"$---

(*

$%%-*/%---

$("-$+0---

("

$%/-%//---

$&/-(*.---

&*

$%+-0$%---

$%&-"*+---

&"

$$*-&*+---

$""-*"0---

%*

0+-(+*---

.0-%(/---

%"

..-0%&---

/$-$+$---

$*

..-(%/---

/*-+.+---

$"

/$-/&0---

/*-".%---

/"-(/.---

..-(//---

"

.%-.$"---

$"

"

.&-+("---

"

 -'#)
$-*&+-*&&---

$"

  -'#)


$-*+(-%+"---


  
-$--

-  -- - -  --
-  1-
 -  - --%"""- - - !-

Multiple primary rules used


IACR rules (2004) on CI5 IX period.

 


  
Source
of population
 -  -'%""()-- *--
July 1 county population estimates by age, sex, race, and Hispanic
origin; postcensal estimates based on 2000 United States Census.

USA, CALIFORNIA, LOS ANGELES COUNTY:


KOREAN (1998-2002)

Multiple primary rules used


IACR rules (2004) on CI5 IX period.

USA, CALIFORNIA, LOS ANGELES COUNTY: KOREAN (1998-2002)
































 




























 














 










 




















 



















 +'%)
,$+&(*+++



  +'%)






  

+&$$$#+  + ++&$$$+


+ +   +  + + +  "+  + +++ ++ +  + ++

 + + -+ ++ +   ++++ +  ++  ++ + ++ ++ "+ + ++ +
  +++ +  ++  ++ + ++ ++ ++ ++  ++  ++ ++
Source
of population
 !++ + ')#+ +  ++ +++  + + +  +  + + +   + +   ++ + +
 + + . . .  + #+
Census
2000. Because the US 2000 Census allowed multiple selection
 


  

+ +'&$$()++
*++  +
of
race categories, there are two ways of counting the population for
a given race group: one is the minimum count which consists of

147

North America

USA, Colorado
Registration area
The Colorado Central Cancer Registry (CCCR) covers the
population of the entire state of Colorado (United States).
The state is composed of 64 counties with a total population
of approximately 4.3 million.
Cancer care facilities
Colorado has 75 inpatient facilities around the state that provide
most cancer care; most are privately operated, 2 are public
institutions, and 3 are military facilities. Colorado also has
many free-standing surgery and radiation therapy facilities,
as well as a large network of cancer care specialty clinics that
provide radiation and chemotherapy services. Private oncology
practitioners also provide care
in their ofces.

pathology labs and some of the free-standing radiation and


surgery centres. Annually, the CCCR links its database with the
ofcial death le for Colorado to obtain follow-up information,
and to identify potential missed cases.
Interpreting the results
Colorado has no special characteristics that inuence
incidence rates.

Use of the data


The CCCR produces an annual report of incidence and
mortality. In alternate years, the report includes survival
statistics and county-level data. The data are published on
the internet and can be queried
interactively. The CCCR
data are also used for many
USA, COLORADO (1998-2002)
special studies, including
USA, COLORADO (1998-2002)
epidemiologic studies, clinical
studies, environmental risk
analyses,
cancer
control
program evaluation, cancer








care facility market analyses,






and citizen inquiries.






Registry structure and


methods
The registry is located in
Denver, the capital of Colorado.
The registry is funded mostly






by federal funds through the





US Centers for Disease Control



 








and Preventions National









Source of population
Program of Cancer Registries














July 1 county population


(NPCR) and receives some







estimates by age, sex, race, and


support from state funding.
 



 
 

 






Hispanic origin; postcensal


The registry is staffed by







estimates based on 2000


11.5 FTEs: a Director, 2
 













United States Census. The


statisticians, 1 administrative

 





population data include the


assistant, 1 data quality and








 





bridged singlerace estimates


training coordinator, and 6.5







derived from the original


registrars.
multiplerace categories in the
Hospitals in Colorado with






2000 United States Census.
50 beds or more must actively
 0+' ! 0+'http://www.seer.cancer.gov/
report their cancer cases to




)0(1,0(*/000

popdata.
the Colorado Central Cancer

  
#0  #00
0 30
 0 ! 0" 00)&&&0 0 0 $0 0
Registry. Staff from the Central 0(00

0 ! 0"0 #0


00 0 0"  0 4  0 ! 0  0 !0 0 0!
 4  0   00 0)&&&0 0 0 $0

2%%$ $ $%

$0
Registry travel to smaller facilities
once per year to collect Multiple primary rules used
 


  
data. The CCCR also receives  0  0+)&&,-00 .00
0
data reports from numerous IACR rules (2004) on CI5 IX period.

148

North America

USA, Connecticut
Registration area
The Connecticut Tumor Registry (CTR) covers the entire
State of Connecticut, which is bounded by Massachusetts to
the north, Rhode Island to the east, Long Island to the south
and New York to the west. It lies between latitudes 41 and
42 N and longitudes 71 and 73 W. The total registration
area is 12 973 km. At the 2000 census, the population of
Connecticut was 3.4 million, composed of 82% white,
and 9.1% black. Approximately 9.4% of the Connecticut
population is Hispanic, the majority of Puerto Rican origin.

In an effort to increase the accuracy, timeliness and


completeness of reporting to the CTR, the registry has
implemented a quality control plan. This calls for biannual
audits and annual re-abstracting audits of hospitals, regular
detailed analysis of reporting errors received by the CTR,
regular quality and quantity reports of CTR staff productivity,
and training workshops for in-house and hospital registrars.
All death certicates that mention cancer are reviewed
and checked against the CTR for prior registration. Followback is initiated on all death certicates that do not match to
a patient in the registry database.
From its inception in 1941, the CTR has maintained
Cancer care facilities
Health care related to cancer is provided predominantly by lifetime follow-up on all tumours. Follow-up information
is primarily obtained from
hospitals in Connecticut, but
the hospitals. Follow-up
reciprocal reporting agreements
information is also obtained
with surrounding states also
USA, CONNECTICUT (1998-2002)
from periodic linkages with
identify some cases. Most
USA, CONNECTICUT (1998-2002)
the Connecticut mortality
patients suspected to have cancer
les, State of Connecticut
who are rst seen in facilities
motor vehicle license les, the
outside of a hospital are likely
Medicare les of the Centers
to be referred to a hospital for
$/-///--/*,
(.-(&*--%.-"/(--/"
(+-...--for Medicare and Medicaid
testing and/or treatment.
("-.$&--.*
*0-&&"--Services, and the Social
There are 32 acute care
(0-.%%--."
+&-+*0--*&-$&$--+*
+&-$(/--Security
Administration.
hospitals in the state of
+&-.+*--+"
."-*"*--Although not legislatively
Connecticut. All hospitals
/.-"(0--**
0&-"&+--$$"-(0&--*"
$$.-0$"--mandated to report cancer
have diagnostic radiology
$%*-($(--(*
$&"-+(&--cases to the CTR, physicians
services; in addition there are
$(&-"."--("
$(.-0&+--$($-.0(--&*
$(.-%0"--have also been contacted as
many free-standing radiology
$%%-(.$--&"
$%+-0+0--part of follow-up activities.
facilities located throughout
00-*(0--%*
$""-&%*--0.-+.%--%"
0(-(.(--To ascertain completeness,
the state, operated by hospitals
$$%-((+--$*
$"+-(+.--we
monitor
hospitals
or by private companies.
$%&-$$.--$"
$$.-&"(--$%&-+0*--*
$$/-"/$--submissions
on
a
monthly
Approximately one third
$$%-&.+--"
$".-*$%--basis; we also send eld staff
of Connecticuts hospitals
to the pathology departments
have therapeutic radiology
$"
*
"
"
*
$"
 -'#)
  -'#)
of all hospitals to perform
facilities. In addition, there
$-.*/-/"%--$-+*%-(*"--
case-nding audits. All case
are a number of free-standing
submissions received from
radiation therapy centres, three 
  
each hospital and private
of which are privately operated; -$--

-  -- - -  --
-  1-
 -  - --%"""- - - ! 


  
 -  -'%""()-- *--
laboratory are visually edited by the CTRs coding and
the remainder are associated with
a parent hospital.
abstracting staff.
Registry structure and methods
The CTR is located in the Connecticut Department of Public Interpreting the results
Health in Hartford, Connecticut. The CTR is funded by Lack of reporting of cancer diagnoses from physicians
the State of Connecticut and the federal government. Since may result in under-ascertainment, mainly for certain
1973, the registry has participated in the Surveillance, cancers treated and diagnosed solely in physicians or
Epidemiology and End Results (SEER) Program sponsored dermatopathologists ofces. The possibility of use of
by the National Cancer Institute (NCI). The registry is staffed out-of-state pathology laboratories also requires periodic
by over 20 full-time employees including an epidemiologist, examination.
research analyst, supervisor, coders, quality control staff and
Use of the data
ofce support personnel.
The CTR is primarily a hospital-based reporting system. CTRs database contains statistical information on cancers
All hospitals in Connecticut are required by public health diagnosed since 1935, the earliest year among registries in
legislation to report incident cases, along with follow- the USA.
Data from the registry are included with those from
up and treatment information, to the registry. Reports
containing pre-coded data are prepared by hospital-based other SEER registries in the NCIs annual publication
tumour registrars and submitted, either on paper, diskette or entitled Cancer Statistics Review. This document is used
electronically, to the registry. In 1981, this reporting mandate by the NCI as part of the process of setting priorities for
was extended to include private pathology laboratories. The research on the prevention and treatment of cancer in the
CTR also has reciprocal cancer-reporting agreements with US population. The data the CTR collects are also used to
all the adjacent states and several other states. This allows identify priorities and target prevention and control activities
for the identication of Connecticut residents whose cancers in Connecticut, educate the public and health professionals
about specic cancer risks, trends and treatments, monitor
are diagnosed or treated in other states.

149

North America

cancer incidence and trends and aid research studies. Data


from the CTR have been used in hundreds of scientic
publications by researchers worldwide, including the Pratt
and Whitney Brain Cancer Study. http://www.dph.state.
ct.us/. Incidence rates in Connecticut are routinely reported
in various monographs produced by the CTR.

USA, CONNECTICUT: BLACK (1998-2002)


USA, CONNECTICUT: BLACK (1998-2002)

*&*---

/*,

$-+.0---

/%/---

/"

$-+*/---

$-.&*---

.*

%-..%---

%-(.&---

."

&-*+*---

&-&&0---

+*

(-**"---

(-*(.---

+"

*-0&/---

*-//$---

**

.-*"+---

.-/."---

*"

0-.+(---

0-&.$---

(*

$$-"(0---

$%-""0---

("

$&-.%*---

$&-&/.---

&*

$*-.&*---

$&-&(+---

&"

$*-%"%---

$%-%+(---

%*

$&-&//---

$&-(+%---

%"

$&-+.&---

$*-""/---

$*

$(-$0.---

$+-&.&---

$"

$+-"%&---

$.-$&*---

$+-*(%---

$*-.."---

"

$(-/0.---

$"

"

"

 -'#)
$+*-&&(---

$"

  -'#)


$/$-/+(---


  
-$--

-  -- - -  --
-  1-
 -  - --%"""- - - ! 


  
 -  -'%""()-- *--
-

150

USA, CONNECTICUT: WHITE (1998-2002)


USA, CONNECTICUT: WHITE (1998-2002)

$/-%&+---

/*,

(*-*(*---

%+-"*/---

/"

((-/($---

&/-+".---

.*

*+-"+0---

(+-+(/---

."

*0-&+%---

(/-//0---

+*

*.-+$(---

*.-/*&---

+"

+&-%$&---

.0-%0%---

**

/&-***---

00-0+*---

*"

$"*-%0&---

$$%-+.%---

(*

$$+-""/---

$%+-/+*---

("

$%0-0"%---

$%&-$*.---

&*

$%+-*%(---

$"&-*..---

&"

$"+-$*%---

/%-%"*---

%*

/$-(($---

.0-.+&---

%"

.+-&%(---

0&-*+/---

$*

//-*+0---

$"%-0.$---

$"

0.-+".---

$"%-**.---

0.-*%%---

0%-%(/---

"

//-".$---

$"

"

"

 -'#)
$-(&*-$&"---

$"

  -'#)


$-*%&-+$(---


  
-$--

-  -- - -  --
-  1-
 -  - --%"""- - - ! -  -'%""()-- *--
Source
of population
July 1 county population estimates by age, sex, race, and Hispanic
origin; postcensal estimates based on 2000 United States Census.
 


  

Multiple primary rules used


IACR rules (2004) on CI5 IX period.

North America

USA, District of Columbia


Registration area
The District of Columbia Cancer Registry (DCCR) operates
within the DC Department of Health (DOH) and serves a
total population of 572 059 (2000 census) District residents.
The District population consists of about 60% AfricanAmericans, 31% Caucasians and the remainder from other
racial/ethnic backgrounds. The gender distribution is 47%
males and 53% females. In addition, the Districts area
hospitals provide cancer diagnosis and treatment to residents
from the surrounding jurisdictions (Maryland and Virginia).

pathology laboratories. Death registration is performed


by the State Center for Health Statistics where the DCCR
obtains a death tape to match the registry database. Death
certicates received at the registry are manually entered
into the registrys database. For verication, registry staff
performs a follow-up by contacting the physician signing the
certicate or the institution listed on the certicate where the
patient might have died.
Interpreting the results
The number of cases for the District of Columbia has been on
a steady decline since the 2000 diagnosis year. Almost all of
the decline can be attributed to a decrease in the population.
PSA testing is common.

Cancer care facilities


The District of Columbia has 3 teaching hospitals, 1 specialty
hospital for children, 2 federal
hospitals, and 3 other hospitals.
All of the hospitals provide
USA, DISTRICT OF COLUMBIA (1998-2002)
diagnostic and treatment services
USA, DISTRICT OF COLUMBIA (1998-2002)
for cancer patients. Almost all
of the radiotherapy departments
are located in a hospital facility.
Almost all of the Districts private





 








practitioners are associated with



 



 

at least one of the hospitals where







 








cancer patients receive diagnostic



 





and/or treatment services.























 

Use of the data


The DCCR prepares and
publishes an annual report of
cancer incidence and mortality.
The DCCR collaborates
with the George Washington
University on a number of
cancer research studies. Some
recent titles include:
1. The Association of SES
with Breast Cancer Incidence,
Grade & Stage at Diagnosis
Among
Caucasian
&
African American Women in
Washington, D.C.
2. The Role of Race and
Poverty in Determining Breast
Cancer Patterns in the District
of Columbia.
3. Using Demographic Data
to Improve Breast Cancer
Screening and Education
in
Underserved
DC

Registry structure and
















methods







The District of Columbia Cancer
















Registry (DCCR) is located within









the DC Department of Health










 





(DOH) and is funded partly by the



 





US Centers for Disease Control


and Preventions National Program






 0+' ! 0+'of Cancer Registries (NPCR),



)/20*1/000

which pays the salaries of 3 staff
members and a contractor. The 
  
#0  #00
0 40
 0 ! 0" 00)&&&0 0 0 $0 0
DOH pays the salaries of 2 staff 0(00

0 ! 0"0 #0


00 0 0"  0 5  0 ! 0  0 !0 0 0!
 5  0   00 0)&&&0 0 0 $0

3%%$ $ $%

$0
Communities.
members, one of whom is the Program
Director.
 


  
 0  0+)&&,-00 .00
0
In addition, the DCCR also collaborates with other
Data collection is passive notication
of pre-coded data
from the hospitals through electronic means (e.g. diskette, independent researchers by providing data, or performing
data linkage of its data with other databases. The DCCR also
CD-ROM, etc.).
The principal sources of information on cancer cases are performs statistical reviews for the Comprehensive Cancer
the hospitals. The District does not have any freestanding and Breast Cancer Programs.

151

North America

USA, DISTRICT OF COLUMBIA:


BLACK (1998-2002)

USA, DISTRICT OF COLUMBIA:


WHITE (1998-2002)
USA, DISTRICT OF COLUMBIA: WHITE (1998-2002)

USA, DISTRICT OF COLUMBIA: BLACK (1998-2002)





 




























 















 


 









































 


 







 























 









 


 















 















































 


















 

















 




















 










 



 .*',
(-0./+-...



 0+' 


110/*/000



 ! 0+'


  
.(..

. ! .". #. #.  #..
. 2.
 . ! ." ..)&&&. . . $. .


.. . ."  . 3  . ! .  . !. . .!
 3  .   .. .)&&&. . . $.

1%%$ $ $%

$.


  
0(00

0 ! 0"0 #0 #0  #00
0 30
 0 ! 0" 00)&&&0 0 0 $0 0


00 0 0"  0 4  0 ! 0  0 !0 0 0!
 4  0   00 0)&&&0 0 0 $0

2%%$ $ $%

$0

 


  
 .  .*)&&+,.. -..
.

 


  
 0  0+)&&,-00 .00
0

Source of population
July 1 county population estimates by age, sex, race, and
Hispanic origin; postcensal estimates based on 2000 United
States Census. The population data include the bridged
singlerace estimates derived from the original multiplerace

152





 ! .*',

categories in the 2000 United States Census. http://www.


seer.cancer.gov/popdata.
Multiple primary rules used
IACR rules (2004) on CI5 IX period.

North America

USA, Florida
Registration area
The Florida Cancer Data System (FCDS) is a legislatively
mandated, statewide population-based registry covering
a population of approximately 16 million. The State is
comprised of 67 counties. Approximately 95% of the
population (~15 million) live in 38 counties designated as
Urban by the 2003 Beale codes. The remaining 29 counties
are classied as Rural.

registries that meet or exceed all standards for completeness,


timeliness, and quality.
Data collected and coded by the FCDS are in accordance
with national standards as put forth by the NAACCR. To
code primary site (typography and morphology), the FCDS
uses the International Classication of Diseases Oncology,
3rd edition (ICD-O-3). During the study time period, the
national staging criteria were revised. Tumours diagnosed
between 1998 and 2000 were staged using the SEER General
Cancer care facilities
Summary Stage 1977. Tumours diagnosed between 2001
There are over 230 primary care facilities reporting data and 2002 were staged under the SEER General Summary
to FCDS. Additionally, data are collected from over 350 Stage 2000 schema. Both schemas as presented in Table
ambulatory care facilities, 800 pathology laboratories, the 2 categorise stage of disease as in-situ, local, regional or
State of Florida Vital Statistics,
distant, but the site-specic
the State of Florida discharge
conversion was not necessarily
database and inter-state data
a one-to-one conversion within
USA, FLORIDA (1998-2002)
exchange agreements.
and between the regional and
USA, FLORIDA (1998-2002)
distant categories. However
Registry structure and
because regional and distant
methods
staged breast cancer were
The FCDS is a joint project
combined into late stage, the














of the Florida Department


revised coding schema had







of Health and the University


no effect on this analysis, and




 



 


 
 

of Miami Miller School of


the year-specic stages could




 


Medicine (UMMSM). The


be combined into a common
 






 






UMMSM has operated the


stage variable.







FCDS since its inception in







 


 





1981 under contract with the


Interpreting the results







DOH.
The FCDS collects in excess




 


 






FCDS is part of the


of 95% of cancer cases among




 


US Centers for Disease


Florida residents.














Control and Preventions



 


 


National Program of Cancer


Use of the data
Registries (NPCR) and is
The FCDS prepares an annual






 /*',
 ! /*',
nationally certied by the
report of cancer incidence,




0/1++/.1-///

North American Association
highlighting
trends
and
of Central Cancer Registries 
  
changes, and maintains a
#/  #//
/ 3/
 / ! /" //)&&&/ / / $/ /
(NAACCR) at its highest level, /(//

/ ! /"/ #/
web site for dissemination of


// / /"  / 4  / ! /  / !/ / /!
 4  /   // /)&&&/ / / $/

2%%$ $ $%

$/
gold certication. Gold certication
is
conferred
on central tabular data. Additionally, data are provided for researchers.
 


  
 /  /*)&&+,// -//
/

153

North America

USA, FLORIDA: BLACK (1998-2002)

USA, FLORIDA: WHITE (1998-2002)

USA, FLORIDA: BLACK (1998-2002)

USA, FLORIDA: WHITE (1998-2002)








 


















































 







































































 







































 


 







 







 






 




 










 





 







 

 
 




 






























 










 









 /+'(/)&(/0,*///





 0+'
 


/0,.20*1.000



 ! 0+'






  
/(//

/ ! /"/ #/ #/  #//
/ 2/
 / ! /" //)&&&/ / / $/ /


// / /"  / 3  / ! /  / !/ / /!
 3  /   // /)&&&/ / / $/

1%%$ $ $%

$/


  
0(00

0 ! 0"0 #0 #0  #00
0 40
 0 ! 0" 00)&&&0 0 0 $0 0


00 0 0"  0 5  0 ! 0  0 !0 0 0!
 5  0   00 0)&&&0 0 0 $0

3%%$ $ $%

$0

 


  
 /  /+)&&,-// .//
/

 


  
 0  0+)&&,-00 .00
0

Source of population
July 1 county population estimates by age, sex, race, and
Hispanic origin; postcensal estimates based on 2000 United
States Census. The population data include the bridged
singlerace estimates derived from the original multiplerace

154



 ! /+'-

categories in the 2000 United States Census. http://www.


seer.cancer.gov/popdata.
Multiple primary rules used
IACR rules (2004) on CI5 IX period.

North America

USA, Georgia
Registration area
The Georgia Comprehensive Cancer Registry is a
population-based cancer registry covering the population of
the entire state of Georgia. The population as of the most
recent census projection (2000) is 8 186 453. Based on the
2000 census 65.1% of Georgia population is white, 28.7%
black or African American, 2.1% Asian, 0.3% American
Indian and Alaska Native, 0.1% Native Hawaiian and Other
Pacic Islander, and 2.4% other race. Additionally 5.3% of
the Georgia population is of Hispanic or Latino origin. The
majority (80%) of Georgians live in urban areas, while 20%
live in areas classied as rural.

pathology laboratories submit their pathology reports


electronically, and small pathology laboratories whether
in-state or out-of-state may submit a photocopy of their
pathology reports. Since 2001, the GCCR has conducted a
yearly electronic match with the Georgia Hospital Discharge
database to identify potential missed cases. Cases identied
are researched by the GCCR regional cancer coordinators for
reportability; identied missed cases are the responsibility of
the facility to report. Additionally, the GCCR conducts death
linkage with the State of Georgia death le, and follow-up of
missed cases is done via hospitals, nursing homes, hospice
and next-of-kin. Additionally the GCCR regional cancer
coordinators conduct yearly casending audits on a sample
of hospitals. During these
Cancer care facilities
audits cancer registrars check
For each cancer case, facilities
on missed cases in hospital
are required to report
USA, GEORGIA (1998-2002)
departments
of
medical
information such as sex, race
USA, GEORGIA (1998-2002)
records, pathology, radiology,
and date of birth; cancer
outpatient department, and
diagnostic information such
other hospital sources.
as primary site, histology,
Since 1995 all healthcare
grade, and date of diagnosis;












 

providers in the state of


diagnostic conrmation and







Georgia have been required


stage information such as





 






 

to report specic information


SEER summary stage 2000

 



 

on all cancers in their patient


and Extent of Disease (EOD);
 
 


 
 








population to the Georgia


and treatment information
 



 


Comprehensive
Cancer
related to rst course of








 





Registry. This includes all


treatment such as surgery,





 

facilities providing diagnostic


radiation,
chemotherapy,

 



 


 



 

evaluations and/or treatment


hormone and other treatment.




 


for cancer patients, including


Additionally information is














hospitals, outpatient surgical


collected on the patients vital




 


facilities,
laboratories,
status.
radiation therapy and medical






oncology
facilities,
and
Registry structure and
 .*',
 ! .*',
physicians ofces. In addition,
methods

 


+.&+&.+&(...

reporting agreements are
The Georgia Comprehensive

  
#.  #..
. 0.
 . ! ." ..)&&&. . . $. .
maintained with neighbouring
Cancer Registry (GCCR) is .(..

. ! .". #.


.. . ."  . 1  . ! .  . !. . .!
 1  .   .. .)&&&. . . $.

/%%$ $ $%

$.
located in the Georgia Department
of Human Resources, states so that Georgia residents who are diagnosed or treated
 


  
 .  .*)&&+,.. -..
.
Division of Public Health in Atlanta,
Georgia. The registry in out-of-state facilities can be identied.
is funded by the state of Georgia and the federal government.
Since 1995, the GCCR has participated in the National Use of the data
Program for Cancer Registries (NPCR) that was established The registry prepares an annual report of cancer incidence
by the US Centers for Disease Control and Prevention and mortality, highlighting trends and changes. Special
reports on breast, cervical, colorectal, lung, prostate, and
(CDC).
The GCCR registry covers the entire State of Georgia, childhood cancers are prepared on an annual basis. GCCR
which is bounded by Tennessee and North Carolina to the annual reports, cancer incidence and mortality analysis are
north, Alabama to the east, Florida to the south, and South available at http://health.state.ga.us/programs/gccr. Cancer
Carolina to the west. Reports are prepared by cancer registrars data are analysed regularly to meet the needs of the statelocated in hospitals with more than 100 licensed beds and wide Georgia Comprehensive Cancer Control Program. The
submitted to the central registry. The GCCRs ve regional GCCR provides qualied researchers with cancer data to
coordinators are responsible for abstracting cancer reports assist in investigating their proposed studies, and responds
for facilities with less than 100 licensed beds. Independent to various data requests and cancer cluster for the public.

155

North America

USA, GEORGIA: BLACK (1998-2002)

USA, GEORGIA: WHITE (1998-2002)


USA, GEORGIA: WHITE (1998-2002)

USA, GEORGIA: BLACK (1998-2002)











































 







 































 















 












 

 





















 























 


























































 




 

 




 










 




 










 




 



 






 
 



 




 /+'(/(*&/,0)///



 .*',




 /  /+)&&,-// .//
/
Source
of population
July 1 county population estimates by age, sex, race, and
Hispanic origin; postcensal estimates based on 2000 United
States Census. The population data include the bridged
singlerace estimates derived from the original multiplerace
 


  





 ! /+'-


  
/(//

/ ! /"/ #/ #/  #//
/ 2/
 / ! /" //)&&&/ / / $/ /


// / /"  / 3  / ! /  / !/ / /!
 3  /   // /)&&&/ / / $/

1%%$ $ $%

$/

156




)./&).(&0...



 ! .*',







  
.(..

. ! .". #. #.  #..
. 2.
 . ! ." ..)&&&. . . $. .


.. . ."  . 3  . ! .  . !. . .!
 3  .   .. .)&&&. . . $.

1%%$ $ $%

$.
 .  .*)&&+,.. -..
.
categories
in the 2000 United States Census. http://www.
seer.cancer.gov/popdata.
 


  

Multiple primary rules used


IACR rules (2004) on CI5 IX period.

North America

USA, Georgia, Atlanta


Registration area
the area identify and electronically transmit their cases to
The Metropolitan Atlanta Registry records cancer diagnosed in the registry on a monthly basis. Registry eld staff actively
residents of ve contiguous counties (Clayton, Cobb, DeKalb, identify and collect cases from radiation therapy facilities,
Fulton and Gwinnett) surrounding the state capital of Atlanta, large physician practices and other selected facilities without
Georgia. Covering an area of 4500 km2, the metropolitan Atlanta the ability to report data electronically.
Patient follow-up is primarily conducted through
area is situated in the southeastern United States at latitude 33
N and longitude 84 W. The population in 2000 was estimated hospital cancer registries, treating physicians and record
to be 2 914 587, of which 54% were white, 36% were black, 4% linkage against a variety of available data sources. Death
were Asian and 6% were other races. Approximately 6% of the certicates are obtained electronically on a monthly basis
population were Hispanic. The combined population of these and are used to supplement case-nding and update patient
5 metropolitan Atlanta counties comprised 36% of the entire follow-up. Data are processed at the registry using software
population of Georgia (159 counties). The area has one of the developed by in-house staff. Extensive automated and visual
fastest-growing populations in the USA, with an increase of editing is performed on the data to enhance and ensure
quality. Both case-nding and
737 546 (33.8%) between 1990
re-abstraction audits are
and 2000. Atlanta lies at an
periodically performed at
altitude of over 320m and enjoys
USA, GEORGIA, ATLANTA (1998-2002)
facilities reporting data.
a temperate climate with 4
USA, GEORGIA, ATLANTA (1998-2002)
distinct seasons. Air pollution is
Interpreting the results
a growing problem, particularly
The Metropolitan Atlanta
during summer months.
Registry
actively
shares
+-$&*--/*,
$.-/(&--0-&"0--/"
$/-(&*--data with the Georgia
Registry structure and
$*-0*0--.*
%+-"0*--Comprehensive
Cancer
methods
%%-$"&--."
&"-/*(--%0-%"*--+*
&*-(.*--Registry to help ensure
The Georgia Center for
&0-0(0--+"
((-(*.--complete case ascertainment
Cancer Statistics (GCCS), a
*0-+0*--**
+&-*.&--/*-/%*--*"
0&-0/0--and treatment information
division of the Department of
$"$-0".--(*
$"0-0&.--on residents of the 5-county
Epidemiology in the Rollins
$%$-*$.--("
$%+-&+"--$&*-&%*--&*
$&+-&%%--catchment area diagnosed
School of Public Health
$&0-(*0--&"
$&+-$/(--and/or treated elsewhere
at Emory University, was
$&&-"0&--%*
$%0-*0.--$".-&+"--%"
$""-"0&--in Georgia. Case sharing
founded in 1976 to provide
$"$-00$--$*
0(-$*%--agreements with Georgias
population-based incidence
$"+-%&*--$"
$"$-+&&--$"0-0&.--*
$"+-"&.--bordering states also exist. For
data for a 5-county region in
$$%-"0&--"
$".-"0+--selected cancers that may be
the southeastern USA as part of
solely diagnosed and treated in
the National Cancer Institutes
$"
*
"
"
*
$"
the physicians ofce setting,
Surveillance, Epidemiology
 -'#)
  -'#)
incidence records may be
and End Results (SEER)
$-(./-$&%--$-(&.-"00--
missing from the registry due
Program.
Metropolitan

  
to a general lack of reporting
Atlanta was a logical choice, -$--

-  -- - -  --
-  1-
 -  - --%"""- - - !since it had been included in  


  
the First, Second and Third by physicians throughout the state.
 -  -'%""()-- *--
National Cancer Surveys. Since its inception the population
covered by the registry has increased dramatically, but the Use of the data
The Metropolitan Atlanta Registry submits data on an annual
geographical boundaries have not changed.
The GCCS also operates the Rural Georgia SEER basis to the National Cancer Institutes SEER Program and
Registry and carries out the day-to-day operations of the the Center for Disease Control and Preventions National
Georgia Comprehensive Cancer Registry. It collaborates Program of Cancer Registries, in collaboration with the
with the SEER Program of the National Cancer Institute, Georgia Comprehensive Cancer Registry. A number of
the Cancer Control Program of the State of Georgia and population-based descriptive and analytical epidemiological
the National Program of Cancer Registries at the Centers investigations have been conducted through the registry.
for Disease Control and Prevention on these cancer registry Several of these have focused on factors, which may relate
projects. The registry is staffed by over 25 full-time employees to the observed high incidence and low survival rates for
including epidemiologists, data abstractors, quality control cancer among blacks. These studies have included cancers
of the prostate, breast, pancreas, esophagus, ovary, colon,
editors, data analysts and other support staff.
Cancer is a reportable disease in the state of Georgia. rectum and multiple myeloma. Registry data extensively
The Metropolitan Atlanta Registry combines both active support the research of faculty within the Rollins School of
and passive case-nding and reporting systems. Most of Public Health at Emory University as well as many other
the hospitals and free-standing pathology laboratories in researchers throughout the state.

157

North America

USA, GEORGIA, ATLANTA: BLACK (1998-2002)

USA, GEORGIA, ATLANTA: WHITE (1998-2002)


USA, GEORGIA, ATLANTA: WHITE (1998-2002)

USA, GEORGIA, ATLANTA: BLACK (1998-2002)

$-%.$---

/*,

(-"+0---

(-.+&---

/*,

$&-+"%---

$-.((---

/"

(-"/+---

.-&.*---

/"

$(-"+(---

%-0.%---

.*

*-.*0---

$%-+$+---

.*

$0-.0.---

(-*"0---

."

.-+0.---

$+-/+&---

."

%%-&%"---

+-0.$---

+*

0-0&&---

%$-"*+---

+*

%(-%&.---

0-0((---

+"

$%-/.*---

%/-$*0---

+"

%0-./&---

$(-+./---

**

$/-$(%---

(%-&*+---

**

(%-//&---

%&-*"0---

*"

%0-$*/---

*/-*%/---

*"

+"-/$/---

&$-*0.---

(*

&/-//*---

+*-*%&---

(*

++-"*&---

&0-.(0---

("

(.-*"%---

.*-.&0---

("

.%-/%(---

(+-*&(---

&*

*(-$((---

/$-+(%---

&*

.*-(""---

(.-+&0---

&"

*(-/&/---

/&-*0/---

&"

.&-((*---

((-*+(---

%*

*$-/$/---

/"-$./---

%*

+0-&$"---

&0-$&%---

%"

(&-+$0---

+%-"0.---

%"

*"-.((---

($-&%(---

$*

($-&+(---

**-&"&---

$*

(.-0*%---

(+-.0"---

$"

(*-./"---

*(-*%.---

$"

*$-$(0---

(0-"//---

(/-"(*---

**-*0/---

*&-"%0---

(.-(%*---

"

(*-+0%---

*/-0(.---

"

**-.%+---

$"

"

"

 -'#)
(00-(&0---



"

"

 -'#)
*+&-("(---

/+(-/+0---

$"

  -'#)


/(&-$&0---


  
-$--

-  -- - -  --
-  1-
 -  - --%"""- - - !-


  
-$--

-  -- - -  --
-  1-
 -  - --%"""- - - !-

 


  
 -  -'%""()-- *--
-

 


  
 -  -'%""()-- *--
-

Source of population
July 1 county population estimates by age, sex, race, and
Hispanic origin; postcensal estimates based on 2000 United
States Census.

158

$"

$"

  -'#)

Multiple primary rules used


IACR rules (2004) on CI5 IX period.

North America

USA, Idaho
Both hospital-based registrars and central registry
Registration area
According to the US Census Bureau (internet release 22 personnel conduct active and passive follow-up of cancer
December 2006), Idahos total resident population for 1 July patients. CDRI conducts an annual linkage with vital records
2006 was 1 466 465. Idaho is the 4th fastest growing state to obtain survival data as well as determine cancer cases that
since the 2000 Census. Idaho ranks 3rd among the 50 states were not identied through other sources.
CDRI has worked since 1999 with the Northwest Portland
plus the District of Columbia in terms of the proportion
of the population aged 18 and under, and 41st in terms of Area Indian Health Board (NPAIHB) on probabilistic
the proportion of the population aged 65 and older (2000 linkages between cancer registry, tribal registry and Indian
Census). The majority of Idahoans are non-Hispanic whites; Health Service administrative data to improve the accuracy
Hispanics and Native Americans are the two largest minority of cancer statistics among Native Americans in Idaho.
groups, comprising 8.9% and 1.6% of Idahos population,
Interpreting the results
respectively (2004).
Idaho ranks near the bottom of states on several CDRI has achieved NPCR and North American Association
of Central Cancer Registries
demographic measures that
(NAACCR) standards for
have been shown to be related
data completeness, timeliness
to lower rates of cancer
USA, IDAHO (1998-2002)
and quality since 1993; for
screening and later stage at
USA, IDAHO (1998-2002)
the last ten years of submitted
diagnosis. Idaho is a large
data (19952004) CDRI has
geographical state of 82 413
achieved the NAACCR Gold
square miles, and over one
Standard. Idaho data are
third of Idaho counties are











included in USCS and CINA.


classied as frontier with less

 





In 2004, Idaho was


than 6.0 persons per square














twelfth-worst in the nation


mile. The rural character of





 

for men aged 40 and older


Idaho combined with severe

 



 








who have not had a prostate


winters in much of the state







specic antigen (PSA) test


pose difculties with access














within the past two years,


to cancer care.







according to the Behavioral
















Risk Factor Surveillance


Cancer care facilities







System (BRFSS).
Thirty-seven
hospitals








 





routinely provide cancer









Use of the data


diagnosis and/or treatment.
CDRI data are used for
There are seven hospitals






 /*',
 ! /*',
many purposes, including
in Idaho that have approved



.-&/+0+///

surveillance
of
cancer
cancer programs from the
incidence rates, program
American College of Surgeons 
  
#/  #//
/ 2/
 / ! /" //)&&&/ / / $/ /
planning and evaluation,
Commission on Cancer. Seven /(//

/ ! /"/ #/


// / /"  / 3  / ! /  / !/ / /!
 3  /   // /)&&&/ / / $/

1%%$ $ $%

$/
quality assurance, measurement against clinical guidelines
hospitals offer radiotherapy, and
there
is
one
free-standing
 


  
 /  /*)&&+,// -//
/
and benchmarks, central registry systems development,
radiation facility in Idaho.
responding to requests for information from hospitals, media
and the public, and public health practice.
Registry structure and methods
CDRI data are used in approved projects for use in
The Cancer Data Registry of Idaho (CDRI) is a populationbased, statewide cancer registry that collects incidence and epidemiologic and translational studies. In 2006 CDRI was
survival data on all cancer patients who reside in the state of funded to participate in the CDC/ORC Macro study Accuracy
Idaho or who are diagnosed and/or treated for cancer in the state of Cancer Mortality Measured by Death Certicates. CDRI
of Idaho. Idaho has one of the oldest cancer registries in the worked with NPAIHB to link tribal registries to CDRI data
United States. Established before the National Cancer Institutes to improve quality of race-specic incidence rates and used
Surveillance, Epidemiology, and End Results (SEER) Program, linked data in studies.
Published reports of cancer incidence and mortality are
the Cancer Data Registry of Idaho (CDRI) has functioned since
available on the CDRI web site at: www.idcancer.org.
1969 and has been population-based since 1971.
Since 1969, CDRI has been supported with state funding
by a dedicated fund from a portion of Idahos tobacco tax. Source of population
Since 1994, CDRI has enhanced cancer registry operations July 1 county population estimates by age, sex, race, and
and increased utilisation of cancer registry data with National Hispanic origin; postcensal estimates based on 2000 United
Program of Cancer Registries (NPCR) funding administered States Census. The population data include the bridged
by the US Centers for Disease Control and Prevention (Public singlerace estimates derived from the original multiplerace
categories in the 2000 United States Census.
Law 102-515).
CDRI is staffed by six employees, including a vice http://www.seer.cancer.gov/popdata.
president of operations and registry services, a director, an
epidemiologist, a database coordinator and two cancer data Multiple primary rules used
IACR rules (2004) on CI5 IX period.
controllers.

159

North America

USA, Illinois
Registration area
The Illinois State Cancer Registry covers the population of
the State of Illinois, USA. The population at the most recent
census was 12 439 738, with an urban population of 12 378
679 and a rural population of 61 059. Eighty percent of the
population is white, 16% African American, and 4% of the
Illinois residents reported themselves as some other race;
12% of the population is Hispanic or Latino.

All hospitals are visited at least once every ve years for


casending. Re-abstracting studies will be performed online
within the next year, and online abstracting will also be
available. Death clearance is performed as a casending tool,
and data exchange is performed with 12 other US states.
There are 23 staff supporting the registry and include a
PhD, MD Medical Director, along with 11 certied tumour
registrars (including registry manager, trainer and QC
manager), 3 database support staff, 1 data use coordinator,
2 registry operations staff, 1.75 clerical support staff, 2.5
epidemiologists and 1.75 research support staff. The registry
performs all activities required by the National Program of
Cancer Registries and has been certied as a gold standard
registry by the North American
Association of Central Cancer
Registries for the past 9 years.

Cancer care facilities


Throughout Illinois cancer patients are treated at hospitals,
ambulatory surgery centres, out-patient non-hospital facilities
that house radiation therapy equipment, physicians ofces
and chemotherapy centres.
The size of the hospitals
varies from large teaching
USA, ILLINOIS (1998-2002)
and university-based hospitals
USA, ILLINOIS (1998-2002)
to small rural community
hospitals. There are two NCIdesignated
Comprehensive
Cancer Centers in Illinois.








About 6% of the Illinois




residents visit hospitals in

 


 



other states for diagnosis and



treatment.
 









 














 







Interpreting the results


The completeness of reporting
for the Illinois State Cancer
Registry is at estimated
to be 100%. However,
melanomatous cancers of
the skin and prostate cancer
are estimated to be under
reported.


 





Registry structure and







 

 



 


Use of the data


methods
 




 

The registry provides yearly


The Illinois State Cancer














annual reports at the state and


Registry is housed in the Illinois







county levels; a public dataset


Department of Public Health,







 






le with data at state, county


Division of Epidemiologic

 





and postal code levels; an


Studies and state law provides
interactive query system of all
the authority for collection of






public data on the Departments
cancer incidence cases.
 /*',
 ! /*',
web site; access to condential
The state accounts for




./&11/.0(///

data by researchers through
one third of the Registry
/(//

/ ! /"/ #/ #/  #//
/ 3/
 / ! /" //)&&&/ / / $/ /
application and IRB review;
funding, and the other two 
  


// / /"  / 4  / ! /  / !/ / /!
 4  /   // /)&&&/ / / $/

2%%$ $ $%

$/
thirds is funded by the US Centers
for Disease Control and cluster investigations; quality control reports to reporting
 


  
 /  /*)&&+,// -//
/
Preventions National Program of
Cancer Registries (NPCR). facilities; linkage with the Departments Breast and Cervical
The registry receives reports from over 400 facilities, cancer program and the States death certicates and various
and 97% of the reports are received in electronic format. non-condential data requests from reporting facilities.

160

North America

USA, ILLINOIS: BLACK (1998-2002)

USA, ILLINOIS: WHITE (1998-2002)


USA, ILLINOIS: WHITE (1998-2002)

USA, ILLINOIS: BLACK (1998-2002)











 







 




































 















 
 









 








 























 




 


 




































 



 









 





















 










 




 


 












 












 







 










 




 











 /*',
1&./0&0///







 /+'-

 ! /*',




,/0*)/,,)///



 ! /+'



 


  
/(//

/ ! /"/ #/ #/  #//
/ 3/
 / ! /" //)&&&/ / / $/ /


// / /"  / 4  / ! /  / !/ / /!
 4  /   // /)&&&/ / / $/

2%%$ $ $%

$/


  
/(//

/ ! /"/ #/ #/  #//
/ 2/
 / ! /" //)&&&/ / / $/ /


// / /"  / 3  / ! /  / !/ / /!
 3  /   // /)&&&/ / / $/

1%%$ $ $%

$/

 


  
 /  /*)&&+,// -//
/

 


  
 /  /+)&&,-// .//
/

Source of population
July 1 county population estimates by age, sex, race, and
Hispanic origin; postcensal estimates based on 2000 United
States Census. The population data include the bridged
singlerace estimates derived from the original multiplerace

categories in the 2000 United States Census. http://www.


seer.cancer.gov/popdata.
Multiple primary rules used
IACR rules (2004) on CI5 IX period.

161

North America

USA, Indiana
Interpreting the results
Registration area
The Indiana State Cancer Registry covers the population in Estimates of completeness of case ascertainment are made
the state of Indiana, USA. The population at the most recent using the NAACCR method, which compares the ratio of
census (2000) was 6 080 485. The majority of the population incidence rates to mortality rates for over a dozen cancers,
(85.8%) is white, non-Hispanic. Non-Hispanic Black or and compares this ratio with the ratio calculated for areas
African Americans comprise 8.3% of the population, covered by SEER.
The Indiana State Department of Health (ISDH) has a
Hispanics of any race 3.5%, and all other non-Hispanics 2.3%.
The majority of the population (70.8%) resides in urban areas Breast and Cervical Cancer Program through the Centers
with 56.1% of the total population living in areas with more for Disease Control and Prevention (CDC), which provides
than 50 000 residents. Although 29.2% of the population lives funding and guidelines for the program. This program
in rural areas, only 2.1% of the total population live on farms. provides mammograms and Papanicolau testing for lowSurveys from 1990 suggest that about 87.5% of the population income women ages 4065. The ISDH organizes the annual
is Christian (Catholic 16%), about 7.4% is nonreligious, Black & Minority Health Fair, which occurs in conjunction
with the Indiana Black Expo
about 0.30.4% is Jewish,
Summer Celebration. Free
about 0.1% is Muslim, and
PSA testing is offered as one
the others belong to a variety
USA, INDIANA (1998-2002)
of a number of screening
of religions. Approximately
USA, INDIANA (1998-2002)
tests for chronic diseases.
14% of the population has
There is information available
no health insurance, 24%
about screening for other
has
government-sponsored
cancers, including breast
health insurance, and 63% has














cancer, cervical cancer, and


private health insurance (59%

 



 

colon cancer, though these


through their employers).





 






 

screenings are not generally









offered at the fair. Outside of


Cancer care facilities







 
 


 


ISDH, there are many public


Approximately 44 of the







and private organisations


approximately 120 acute care

 



 







offering free or low-cost


hospitals in Indiana have a







screenings for breast, cervical,


cancer program approved by














prostate, and colon cancers.


the Commission on Cancer/







Self-reported information
American College of Surgeons.














from
the 2004 Indiana Survey
Patients also receive cancer







of the Behavioral Risk Factors


care in a variety of outpatient
Surveillance System indicates
settings, such as ambulatory






that an estimated 48.9% of
surgery centres, radiation
 /+' ! /+'Indiana men age 40 or above
therapy centres, cancer clinics,




)/10*/.,)///

have had a PSA test within the
home care, private physician

  
/(//

/ ! /"/ #/ #/  #//
/ 3/
 / ! /" //)&&&/ / / $/ /
past 2 years. This is lower than
ofces, and other locales.


// / /"  / 4  / ! /  / !/ / /!
 4  /   // /)&&&/ / / $/

2%%$ $ $%

$/
the nationwide (USA) average of 51.8%. In Indiana, only an
 


  
 /  /+)&&,-// .//
/
estimated 55% of men age 40 or over report ever having had
Registry structure and methods
The registry is located within the Indiana State Department a PSA test.
Indiana is second highest in the USA in the percentage
of Health, and is funded through state and federal funds from
the US Centers for Disease Control and Preventions National of current smokers (27.3% of the population age 18 or older).
Program of Cancer Registries (NPCR). The registry is staffed by Both tobacco growing and coal mining are fairly common
a director, three full-time cancer registrars, one full-time software occupations in southern Indiana.
programmer/analyst, one grant coordinator, and one secretary.
The registry collects data from approximately 120 Use of the data
hospitals throughout the state plus additional surgery centres, The Cancer Registry supports the Comprehensive Cancer
radiation centres, pathology laboratories, and physician Control program with data used both in educational
ofces. Cancer registry records are matched electronically publications and to provide an evidence base for the planning
with death certicates every year. Unreported cancer cases and implementation of strategies. The registry prepares an
identied through this death clearance process are followed annual report of cancer incidence. Cancer registry data are
back and added to the registry as either a new case or a Death also matched with data from the Breast and Cervical Cancer
Early Detection Program annually. Cancer registry data are
Certicate Only (DCO) case.
Cancer is a reportable disease by state statute. Most cases provided to the Shared Information Pathology Network project
are reported electronically by hospitals using various cancer at Regenstrief Clinic in Indianapolis quarterly. Data are also
registry software programs. Case-sharing agreements are in used to respond to numerous unscheduled requests for data
place with the four surrounding states (MI, OH, KY, & IL) from other sources. Neither the registry nor any other programs
or divisions in the ISDH does epidemiological cancer research
and approximately 14 other states.
Numerous quality control procedures are performed on beyond producing routine statistics. However, the Indiana
all incoming data using electronic and manual edit checking State Cancer Registry makes its data available to bona fide
researchers in both public and private organisations.
procedures.

162

North America

Source of population
July 1 county population estimates by age, sex, race, and
Hispanic origin; postcensal estimates based on 2000 United
States Census. The population data include the bridged
singlerace estimates derived from the original multiplerace

categories in the 2000 United States Census. http://www.seer.


cancer.gov/popdata.
Multiple primary rules used
IACR rules (2004) on CI5 IX period.

163

North America

USA, Iowa
residents are obtained from 154 hospitals, clinics, and pathology
Registration area
The state of Iowa is located near the geographical middle of the laboratories located both within the state and bordering the
United States and is part of its agricultural heartland. Iowa state. Cancer data are exchanged with other states.
Data are collected by Hospital Cancer Registrars and by
is bordered on the north by Minnesota, the south by Missouri,
the east by Illinois, and the west by Nebraska. The total area 20 eld staff employed by the Registry to cover specied
is about 145 800 km2 with elevation ranging between 146 and geographic areas. The eld personnel visit hospitals and
other facilities in their areas and abstract data using laptop
505m above sea level.
Ninety-two percent of the land area in the state is devoted computers. The Registrys remaining 30 full-time employees
to agriculture, ranking the highest in the USA among its 50 work in the central ofce where they edit the data, consolidate
states. Agricultural exposures include pesticides, fertilizers, multiple reports for the same cancer, perform follow-up,
fuels and oils, animal viruses, organic solvents, engine respond to data requests, and conduct research.
Since 1969, there have been changes in case denition
exhausts and paints. These may inuence cancer incidence in
this population, but likely not as strongly as lifestyle factors and coding. These are documented in revisions to coding
manuals and extent of disease
like tobacco use, alcohol
classications, provided at
consumption and overweight/
http://www.seer.cancer.gov/
physical inactivity.
USA, IOWA (1998-2002)
tools/codingmanuals.
Iowa had a 2000 population
USA, IOWA (1998-2002)
The
International
of 2 926 324, a 3.6% increase
Classication of Disease for
over its 1970 population. The
Oncology is used to assign codes
population aged 65 years
for topology, morphology, and
and older increased from
%0.)%+...
0+)/.0+0...
&).00/...
0#!
)&.,01...
tumour behaviour. The Registry
12.4% in 1970 to 14.9% in
'/.11/...
/+!
+'.'))...
is currently using the 3rd edition
2000. The principal ethnic
)+.//0...
/#!
+/.)&/...
)1.0&/...
,+!
+/./1)...
group is Northern European,
of ICD-O.
+/.+%0...
,#!
,&.%,&...
with Germans, Danes and
The Registry uses active
,1.+#)...
++!
/%.1#)...
1%.',#...
+#!
1%.##%...
Swedes accounting for a large
and passive follow-up activities
%#/.+&%...
)+!
%#,.%&/...
segment of the population.
to obtain survival data. Passive
%%).#,/...
)#!
%%'.100...
%#/.,1'...
'+!
%#/.&'#...
The 2000 population is 93.9%
follow-up activities include
1'.1)0...
'#!
1#.00'...
white with 2.1% blacks, 1.3%
computerized
linkage
of
1%.%'1...
&+!
0/.0#0...
%#,./0,...
&#!
%#&.0&&...
Asian/Pacic Islander, 0.3%
data
with
death
certicate
%%).&11...
%+!
%#0.01#...
American
Indian/Alaskan
information, drivers license
%#,.0#'...
%#!
%#%.&&/...
%#%.%0#...
+!
1,.%11...
Native, and 2.4% other or more
les from the Iowa Department
1).0)+...
#!
1#.%)'...
than one race. Over 80% of
of Transportation, the Social
Iowa residents are native-born.
Security
Administration
%#
+
#
#
+
%#
The population is primarily
Epidemiological Vital Status
 .($*
  .($*
%.)01.)1+...
Christian, the most prevalent
%.)''.+,/...

data, and Medicare information
religions being Roman Catholic,   

provided by the Centers for
. .  . .. .&###.
 .   .. .. .. .
".
Lutheran, and Methodist.
Medicare & Medicaid Services.
      
Cancer diagnostic and treatment
services are widely Active patient follow-up is conducted annually.

. .(&##)*..
+..  .
  
available to the entire Iowa population
through both in-state
Quality control activities, including computer edits,

)).  .. .. .. . .".


and out-of-state facilities. These include surgery, radiation statistical comparisons, and visual review of data, occur
therapy, chemotherapy, and other treatment modalities such daily. Site-specic re-casending and re-abstracting are also
as immunotherapy. Radiation oncology services are provided performed on a regular basis.
as in-hospital facilities as well as stand-alone facilities. These
types of diagnostic and treatment services have increased Interpreting the results
over time and have been accompanied by increasing numbers Although some Iowans who leave the state for care are not
of medical, surgical, and radiation oncologists.
identied and missed, ascertainment is thought to be about
99%. The Iowa Cancer Registry successfully follows over 98%
Registry structure and methods
of all patients into the current year.
Cancer data collection for the entire state of Iowa began in
1969 with the Third National Cancer Survey sponsored by the Use of the data
National Cancer Institute (NCI). With the completion of the The Registry functions as a collaborative program with the
survey in 1971, no further funding for cancer registration was Iowa Department of Public Health. Many University of Iowa
available and 1972 data are incomplete. In 1973 the State Health researchers have used Registry data. Registry data have also
Registry of Iowa, frequently referred to as the Iowa Cancer been used extensively in a number of local, national and
Registry, became part of the NCI Surveillance, Epidemiology international epidemiological studies.
and End Results (SEER) Program. The area covered by the
Policymakers look to the cancer registry to provide
Registry has not changed since 1969, and includes all 99 information regarding the burden of cancer and time trends
counties in the state of Iowa.
in cancer incidence, stage of disease at diagnosis, survival,
Cancer became a reportable disease in Iowa in 1982. The and mortality. To this extent, they are currently used to
Iowa Department of Public Health has designated responsibility address and assess cancer prevention and control issues.
for cancer data collection to the Registry. Cancer data for Iowa Occasionally, the data are also used to determine certicate

164

North America

of need requests for new medical facilities and equipment in


selected geographic areas of the state.

Multiple primary rules used


IACR rules (2004) on CI5 IX period.

Source of population
Annual census projection based on the 2000 Census, prepared
by the US Bureau of the Census.

Notes on the data


C44 does not include basal cell or squamous cell
carcinoma.

165

North America

USA, Kentucky
Registration area
The Kentucky Cancer Registry (KCR) is a population-based
central cancer registry for the entire state of Kentucky.
According to the 2000 U.S. Census, the population of
Kentucky was approximately 4 042 000. Of that, 75.1%
are White, 12.3% are Black and the remaining 12.6% are
American Indians, Alaska Natives, Asian, Hawaiian Natives,
Pacic Islanders or other races.

into four regions and assigned to one of four Regional


Abstractors employed by KCR. The Regional Abstractors
record and report information on all cases of cancer seen in
these smaller institutions. The KCR Regional Coordinators
and Regional Abstractors are required to be Certied Tumor
Registrars (CTRs) or become CTRs within two years of their
date of employment.

Interpreting the results


Data from KCR have been submitted to the North American
Cancer care facilities
All health care facilities in Kentucky that diagnose or Association of Central Cancer Registries (NAACCR) for
treat cancer patients are required to report cancer cases to an objective evaluation of completeness, accuracy and
KCR. Facilities that are also required to report cancer cases timeliness each year since a formal certication program
was established in 1997. In
include freestanding treatment
each year (19992001), KCR
centres, non-hospital (private)
received the highest level
pathology laboratories, and
USA, KENTUCKY (1998-2002)
of NAACCR certication
physician ofces.
USA, KENTUCKY (1998-2002)
available (Gold). KCR has also
submitted its data for inclusion
Registry structure and
in the Cancer in North
methods
America (CINA) publication.
KCR has been collecting
$*-++*--/*,
(%-&($--%(-%&+--/"
((-*&"--A registry must have complete
data on incident cases of
($-*+0--.*
+$-/*.--data for the most current vecancer since 1991, when
**-0*"--."
.&-"0*--+.-$+/--+*
./-+"(--year period before their data
the State General Assembly
/"-+&$--+"
//-0("--can be evaluated for inclusion
approved legislation requiring
$""-&$.--**
$"+-("0--$%/-//"--*"
$&&-0/"--in the CINA combined rates.
mandatory
reporting
of
$(*-$("--(*
$(0-+(/--KCR data have been included
all cases of cancer to the
$*.-/."--("
$+%-+%0--$*.-*$%--&*
$+"-&00--in the CINA combined rates
registry.
The
legislation
$((-&*/--&"
$((-*$+--each year since ve years of
provided recurring funding
$&0-0/%--%*
$&.-0"(--$(*-+%%--%"
$($-"&$--KCR data became available.
for staff, travel and computer
$(/-&.*--$*
$("-(..--equipment. KCR also receives
$((-&((--$"
$&+-$$*--$($-/%0--*
$&(-%&$--Use of the data
funding from the US Centers
$&+-$&"--"
$%0-.**--KCR data are used to initiate
for Disease Control and
cancer control programs,
Prevention (CDC) through the
$"
*
"
"
*
$"
evaluate intervention activities,
National Program of Cancer
 -'#)
  -'#)
or conduct epidemiological
Registries (NPCR) and the
%-"++-(+$--$-0.*-*/"--
research. KCR data have been
National Cancer Institutes
-$--

-  -- - -  --
-  1-
 -  - --%"""- - - !used in preparing hundreds
Surveillance Epidemiology 
  
 


  
and End Results (SEER) program.
KCR employs three of research projects and proposals. Also, data from KCR
 -  -'%""()-- *--
Regional Coordinators to work with larger institutions and are presented each year to cancer councils in 15 Area
four Regional Abstractors that work with smaller hospitals in Development Districts (groups of counties) covering the
order to ensure the quality, accuracy, timeliness of the data entire state. These District Cancer Councils use the data
from KCR to identify specic types of cancer that occur in
reported.
The larger hospitals (those diagnosing or treating more their area at substantially different rates compared to state
than 100 new primary cancer cases annually) are required to and US rates.
have their own tumour registrar(s). These larger hospitals are
divided into three geographic regions. The three Regional Source of population
Coordinators employed by KCR spend one day each month July 1 county population estimates by age, sex, race, and
in each of these larger facilities providing additional Hispanic origin; postcensal estimates based on 2000 United
training, re-abstracting cases for quality control and helping States Census.
the hospital-based registrars prepare reports from the data.
The smaller hospitals (those diagnosing or treating fewer Multiple primary rules used
than 100 new primary cancer cases annually) are divided IACR rules (2004) on CI5 IX period.

166

North America

USA, Louisiana
Registration area
Louisiana law requires all licensed healthcare providers to
Louisiana belongs to what is historically known as the Deep report cancer cases who receive medical services for cancer.
South of the US, a warm and at section of the country. The Because the LTR is considered a public health authority, it is
2000 Louisiana population of 4 468 976 is 63.9% white and exempt from the patient consent requirement of the HIPAA
32.5% African-American. Louisiana has less racial diversity legislation.
than the nation, with 1.2% Asians, 2.4% Latin Americans,
Most incident cases are identied in hospitals. One fourth
and 2.6% foreign-born. One population group unique to the of the hospitals in Louisiana operate cancer registries, and
state is the Cajuns, descendants of French-Canadians who these report about two thirds of new cases. Registrars from
live in central and southwest Louisiana.
the LTR regional ofces screen and abstract at the remaining
Per-capita income and graduation rates for high school hospitals. The LTR follows the reportability guidelines of the
and college well below the national levels reect Louisianas SEER Program and the CDC National Program of Cancer
low socioeconomic ranking in the US. The percentage Registries andthe coding guidelines of the SEER Program.
living below the poverty level is 50% higher in Louisiana
Non-hospital sources of reportable cancer cases include
than nationally. Louisiana
pathology
laboratories,
is unusual, however, in its
radiation and dermatology
dedication
to
providing
clinics, and one-day surgery
USA, LOUISIANA (1998-2002)
free medical care through a
facilities. Pathology reports
USA, LOUISIANA (1998-2002)
statewide system of ten public
from both hospital and
hospitals.
freestanding
laboratories,
including out-of-state labs,
Cancer care facilities
are screened, and all positive
$+-%0&--/*,
($-*0/--%(-.&"--/"
((-/0%--During the years 19982002
reports are followed back to
(&-"*(--.*
+&-/"/--cancer diagnostic care and
the diagnosing healthcare
*.-+**--."
.+-./.--++-/+.--+*
/"-/*/--treatment were available at
provider to obtain the
/"-%/0--+"
0$-$%"--approximately 125 inpatient
required information. Death
$""-(/"--**
$$"-"%/--$&$-+0&--*"
$&0-*0/--hospitals in Louisiana. The
certicates also identify a
$*&-+(+--(*
$+%-"%.--cancer programs at 29 hospitals
small number of cases, and
$+0-*(&--("
$..-*(/--$+(-(/&--&*
$.&-...--and one cancer treatment
these too are followed back
$(0-&(0--&"
$**-((*--centre were accredited by
to the diagnosing physician or
$(*-*&(--%*
$*"-/*%--$+(-+.(--%"
$+.-(&0--the Commission on Cancer.
hospital if possible.
$/&-/*(--$*
$.0-*(*--Radiotherapy services were
$.+-/&.--$"
$+0-("&--$+0-/$*--*
$+$-+&*--available at most of these
Industry in Louisiana
$+$-00%--"
$**-.%+--facilities, located in the
Although the states economy
larger cities throughout the
traditionally
relied
on
$"
*
"
"
*
$"
 -'#)
  -'#)
state. One notable change in
agriculture, Louisiana is now
%-&"%-"/(--%-$+"-./0--
medical practice has been the
the second-largest rener
rise of freestanding outpatient 
  
of petroleum in the US,
surgery facilities. Only a -$--

-  -- - -  --
-  1-
 -  - --%"""- - - !and manufactures a quarter
 -  -'%""()-- *--
handful existed in Louisiana in 


  
19982002, but two dozen of the nations petrochemicals. Over 25 000 people are
are open now.
employed in chemical manufacturing and another 14 000
in shipbuilding. The presence of 100 large petrochemical
Registry structure and methods
facilities has given rise to concerns about excess cancer
The Louisiana Tumor Registry (LTR) was established in incidence among workers and residents there. The LTR
1974 to monitor cancer incidence in the three-county area of publishes comparisons of cancer incidence rates in the
Greater New Orleans. Its catchment area gradually expanded industrial corridor from Baton Rouge to New Orleans with
to include the entire state by 1988. The LTR participates in those for the state and the nation in its annual Cancer in
both the US Centers for Disease Control and Preventions Louisiana series. Although monitoring environmental
National Program of Cancer Registries and the National indicators remains the responsibility of the federal
Cancer Institutes Surveillance, Epidemiology, and End Environmental Protection Agency and the state Department
Results (SEER) Program.
of Environmental Quality, the LTR collaborates with the
The LTR comprises a central ofce and eight regional Louisiana Ofce of Public Health in investigating reports
ofces. The LSU Health Sciences Center operates the LTR of excess cancer incidence in specic areas.
central ofce and three of the regional ofces while local
academic and medical organisations with cancer research Use of the data
and treatment interests coordinate the activities of the Louisiana incidence and mortality data are published annually
remaining ve regions.
in Cancer in Louisiana and are available on the registry
The registry staff in early 2005 numbered 54, with 18 website: http://publichealth.lsuhsc.edu/tumorregistry. In
of those in the central ofce. The LTR staff included 23 addition, they are incorporated into several databases on
Certied Tumor Registrars, and the central ofce, housed the Web: the CDC/NCIs State Cancer Proles, the CDCs
in the Louisiana State University in New Orleans, had a WONDER, and the North American Association of Central
research/technical team that included 4 doctorate degrees Cancer Registries CINA+. The LTR cooperates with
and 6 Masters degrees.
outside researchers investigating the correlations between

167

North America

cancer incidence and workplace exposures or lifestyle risk


factors and with the Louisiana Ofce of Public Health in
investigations of potential cancer clusters. LTR staff
members also participate in patterns-of-care studies for the
CDC and the SEER Program, as well as publishing numerous
descriptive epidemiology articles.

USA, LOUISIANA: BLACK (1998-2002)


USA, LOUISIANA: BLACK (1998-2002)

USA, LOUISIANA: WHITE (1998-2002)

$$-/(/---

/*,

&$-(*%---

$0-&("---

/"

&(-.*"---

&&-/.0---

.*

(/-00/---

((-0/$---

."

*.-."*---

*"-.(+---

+*

*/-0&0---

+"-$0$---

+"

+*-&*+---

.(-..$---

**

0(-0&/---

*"

0+-(%+---

$".-&.*---

(*

$".-$//---

$$.-%./---

./-*&&---

("

$$+-%.&---

$$%-&.&---

&*

$$%-(0&---

(-&$.---

/*,

0-0$0---

$""-."%---

&"

00-"."---

*-$00---

/"

0-0"%---

0*-(0$---

%*

0(-%+(---

/-/&*---

.*

$(-&+(---

$"%-"%"---

%"

00-.$(---

$%-"/&---

."

$/-&&.---

$"/-**.---

$*

$"(-&+.---

$*-%*&---

+*

%"-0+"---

$"%-&$(---

$"

0.-$"$---

$/-//"---

+"

%(-(.*---

0+-*%/---

0$-%$/---

0%-.%0---

"

//-.$+---

%(-""$---

**

%0-."+---

&(-&*0---

*"

("-*+/---

(&-&*.---

(*

*$-+((---

(/-0&.---

("

*.-.&*---

(/-(&/---

&*

*.-.%&---

(*-".$---

&"

*%-..0---

(+-$"&---

%*

*%-."/---

*/-("(---

%"

+&-//*---

.$-%((---

$*

.$-&*(---

."-.$/---

$"

+/-/$$---

+0-/"$---

+.-$+(---

+*-0+/---

"

+&-//0---

$"

"

"

 -'#)
+0"-0+/---

$"

  -'#)


..*-0%&---


  
-$--

-  -- - -  --
-  1-
 -  - --%"""- - - ! 


  
 -  -'%""()-- *--
-

168

USA, LOUISIANA: WHITE (1998-2002)

$"

"

"

 -'#)
$-(%+-"+$---

$"

  -'#)


$-(/%-*++---

-$--

-  -- - -  --
-  1-
 -  - --%"""- - - !Source
of population
 


  
 -  -'%""()-- *--
July
1 county population estimates by age, sex, race, and
Hispanic origin; postcensal estimates based on 2000 United
States Census.

  

Multiple primary rules used


IACR rules (2004) on CI5 IX period.

North America

USA, Louisiana, New Orleans


Registration area
The New Orleans region, comprising three counties in
southeast Louisiana in the American Deep South, had
a population of 1 007 369 in 2000. Of these, 99% were
considered urban dwellers. The average per capita income of
metropolitan New Orleans was slightly higher than the state
average, but the state per capita income is 22% lower than
the national level. The areas population is approximately
44% African American and 53% white, with only a small
presence of Asians or American Indians. About 5% of the
population is of Hispanic origin.
Cancer care facilities
Cancer registration in the three-county area of Greater
New Orleans began in 1974. The New Orleans Regional
Registry, which also documents cancer incidence in eight
surrounding counties, has a staff of six full-time employees
and a supervisor. Of these, ve are Certied Tumor
Registrars.
Diagnosis and treatment for cancer during the period
1998-2002 was available at 18 hospitals in Greater New
Orleans. Eight offered cancer programs approved by the
Commission on Cancer, and a few others had extensive
cancer services as well. Radiotherapy was available only at
these large facilities.
Registry structure and methods
Although the Louisiana Tumor Registry (LTR) encompassed
only the New Orleans area in 1974, its catchment area
expanded incrementally, covering the entire state in 1988.
The LTR participates in both the U.S. Centers for Disease
Control and Preventions National Program of Cancer
Registries and the National Cancer Institutes Surveillance,
Epidemiology, and End Results (SEER) Program.
The LTR comprises a central ofce and eight regional
ofces. The LSU Health Sciences Center operates the LTR
central ofce and three of the regional ofces, while local
academic and medical organizations with cancer research
and treatment interests coordinate the activities of the
remaining ve regions.
Louisiana law requires all licensed healthcare providers
to report cases that receive medical services for cancer,
whether a resident of the state or not. Because the LTR is
considered a public health authority, it is exempt from the
patient consent requirement of the HIPAA legislation.
Most incident cases are identied in hospitals. One
fourth of the hospitals in Louisiana operate cancer
registries, and these report about two thirds of the new
cases. Registrars from the LTR regional ofces screen
and abstract at the remaining hospitals. The LTR follows
the reportability guidelines of the SEER Program and the
CDC National Program of Cancer Registries, abstracting

all data items required by these programs as well as other


data items.
Non-hospital sources of reportable cancer cases include
pathology laboratories, radiation and dermatology clinics,
and one-day surgery facilities. Pathology reports from both
hospital and freestanding laboratories, including out-of-state
labs, are screened, and all positive reports are followed back
to the diagnosing healthcare provider to obtain the required
information. Death certicates also identify a small number
of cases, and these too are followed back to the diagnosing
physician or hospital.
For cancer cases diagnosed in its area, each regional
ofce abstracts, consolidates, and edits data and documents
survival through active follow-up. The central ofce
consolidates and edits data from the regional registries,
monitors completeness of case ascertainment, exchanges
case reports with other states, obtains survival information
through data linkages, and analyzes and interprets the
statistical information derived from the data.
Both regional registries and the central ofce evaluate
case completeness on an ongoing basis by comparing each
facilitys case counts with those for previous years. The LTR
conducts case-nding audits throughout the state, as do the
major funding agencies (the CDC and the SEER Program).
Abstractors from the central and regional ofces participate in
national reliability studies at least biennially to evaluate their
coding expertise, and samples of cases prepared by hospital
registrars are re-abstracted to appraise their accuracy.
The LTR follows the coding guidelines of the SEER
Program. Over time, some changes have been adopted
nationwide to reect changes in the understanding of cancer
and in treatment modalities. These include the transition from
the First Edition to the Third Edition of the ICD-O manuals
and from the SEER 1977 staging manual to the SEER 2000
staging manual, as well as updates to the treatment codes.
Use of the data
Louisiana incidence and mortality data are published
annually in the LTRs Cancer in Louisiana series and are
available on the registry website: http://publichealth.lsuhsc.
edu/tumorregistry. In addition they are incorporated into
several databases on the Web: the CDC/NCIs State Cancer
Proles, the CDCs WONDER, and the North American
Association of Central Cancer Registries CINA+.
The LTR cooperates with outside researchers studying
correlations between cancer incidence and workplace
exposures or lifestyle risk factors, and with the Louisiana
Ofce of Public Health in investigations of areas with
possible high rates of cancer incidence. In addition, LTR
staff participates actively in patterns-of-care studies for the
CDC and the SEER Program, as well as publishing numerous
descriptive epidemiology articles.

169

North America

USA, LOUISIANA, NEW ORLEANS: BLACK


(1998-2002)
USA, LOUISIANA, NEW ORLEANS: BLACK (1998-2002)

USA, LOUISIANA, NEW ORLEANS: WHITE (1998-2002)

$-"$/---

/*,

%-*&%---

%-(/*---

/*,

$-($*---

/"

%-.".---

(-$/%---

/"

.-.%&---

%-.$"---

.*

(-&$*---

.-+(0---

.*

$$-(/%---

&-*%/---

."

*-($%---

0-%/*---

."

$%-.*/---

(-*%%---

+*

+-&"/---

0-%+*---

+*

$$-(++---

*-+++---

+"

.-*.&---

$$-$(&---

+"

$%-(+&---

.-&$&---

**

0-*$&---

$(-.(0---

**

$*-++*---

$"-+$.---

*"

$&-%/"---

$/-/&*---

*"

$0-*/%---

$&-"*0---

(*

$+-&00---

%"-.%0---

(*

%"-+/.---

$(-&.*---

("

$/-"$/---

%$-/+"---

("

%$-&*"---

$&-0((---

&*

$.-0"/---

%$-$//---

&*

%"-(%*---

$%-/*0---

&"

$+-(*.---

%"-$$$---

&"

$/-0%.---

$&-+/%---

%*

$.-(("---

$0-"""---

%*

$/-+&(---

$+-$%"---

%"

$0-%/(---

$.-"%%---

%"

$.-%.*---

$0-/+%---

$*

%"-0$.---

$+-%+(---

$*

$*-.*&---

%"-.+(---

$"

%"-&$(---

$*-*"*---

$"

$(-/%"---

$&-0&/---

"

$&-0&$---

%"-/%0---

%"-".*---

$(-.%+---

$0-%."---

"

$/-*"&---

$(-(/"---

$"

"

"

 -'#)
%"$-**(---

$"

$"



"

.-%%(---

"

 -'#)

  -'#)
%&+-0**---

%*/-(./---

$"

  -'#)


%.(-$"(---


  
-$--

-  -- - -  --
-  1-
 -  - --%"""- - - !-


  
-$--

-  -- - -  --
-  1-
 -  - --%"""- - - !-

 


  
 -  -'%""()-- *--
-

 


  
 -  -'%""()-- *--
-

Source of population
July 1 county population estimates by age, sex, race, and
Hispanic origin; postcensal estimates based on 2000 United
States Census.

170

USA, LOUISIANA, NEW ORLEANS: WHITE


(1998-2002)

Multiple primary rules used


IACR rules (2004) on CI5 IX period.

North America

USA, Maine
Registration area
The Maine Cancer Registry covers the entire population of the
state of Maine in the United States of America. According to
the 2000 US Census, 58% of the population lives in a rural area.
About 82% are Christian, while 17 % classify themselves as
non-religious. About 97% of the population is Caucasian.
Cancer care facilities
Health care in Maine is provided by 37 hospitals and many private
physician ofces. Of the 37 hospitals, 11 have approved cancer care
programs. The availability of care is more prominent in the more
populous southern regions of Maine. Citizens in northern Maine
may have to drive further to obtain appropriate cancer care.

Interpreting the results


Maines cancer incidence database meets the highest standards
for quality, completeness, and timeliness. The registry database
is 100% complete for the data years of interest. Screening for
prostate, colon, breast, and cervical cancer have increased but
remain largely opportunistic. Environmental concerns in Maine
include high levels of arsenic in private well water, and high
radon air concentrations in Maine homes, as these chemicals
occur naturally in Maines geography. Maine is also home to
a shipbuilding company that used asbestos in the past.

Use of the data


The registry prepares an annual report of cancer incidence
and includes mortality from
the states vital statistics
ofce. Annual reports may
USA, MAINE (1998-2002)
also include information on
USA, MAINE (1998-2002)
trends and stage at diagnosis.
Maine does not operate a
follow-up registry, so survival
studies are not produced. Data








are used for program planning






and
evaluation.
Maines








database has also been used






in special studies of bladder




 





cancer, cervical cancer, colon




 

cancer treatment, and quality









of-life surveys.




Registry structure and


methods
The registry is located in
Augusta, the state capital. The
registry is staffed by 6.5 fulltime employees, two of whom
are certied tumour registrars.



Funding for the central registry





is a 3:1 match between federal






 

dollars from the US Centers




for Disease Control and



 




Preventions National Program





of Cancer Registries (NPCR)








and state dollars. Cancer is a





reportable disease according



 










 

to state law. The majority



 





Source of population
of our cases are reported by














July 1 county population


hospitals on a routine basis.







estimates by age, sex, race, and


These data are supplemented
Hispanic origin; postcensal
by required physician reporting,






 0+' ! 0+'estimates based on 2000
active case-nding at Maines



/)(0).*000

United States Census. The
one independent pathology
population data include the
laboratory, and review of death 
  
#0  #00
0 20
 0 ! 0" 00)&&&0 0 0 $0 0
bridged singlerace estimates
certicates with a mention of 0(00

0 ! 0"0 #0


00 0 0"  0 3  0 ! 0  0 !0 0 0!
 3  0   00 0)&&&0 0 0 $0

1%%$ $ $%

$0
cancer. Death registry information
in Maine is very complete derived from the original multiplerace categories in the
 


  
 0  0+)&&,-00 .00
0
and accessible. Maine also has data
exchange agreements with 2000 United States Census.
all bordering states and other states where Maine residents http://www.seer.cancer.gov/popdata.
tend to vacation during the winter. The Maine Cancer Registry
has a quality control program, and the resulting data meet the Multiple primary rules used
IACR rules (2004) on CI5 IX period.
highest standards for data quality.

171

North America

USA, Massachusetts
Registration area
The Massachusetts Cancer Registry (MCR) covers the
population of the Commonwealth of Massachusetts. The
population at the most recent US Census (2000) was 6 349
097. The population is represented as follows: 84% White
non-Hispanic; 5% Black non-Hispanic; 7% Hispanic; 4%
Asian non-Hispanic; .02% Native American non-Hispanic.

ofces when this information is available. Not all hospitals


report this type of case, however, and some hospitals report
such cases as if the patients had been diagnosed and treated
by the hospital directly. Collecting this type of data makes
the MCRs overall case ascertainment more complete. The
cancer types most often reported to the MCR in this manner
are prostate cancer and melanoma.
In addition, the MCR identies previously unreported
cancer cases through death certicate clearance to further
Cancer care facilities
The MCR collects reports of newly diagnosed cancer cases improve case completeness. When possible, the MCR obtains
from multiple sources. In 2003, 70 Massachusetts acute care additional information on these cases through follow-up
hospitals, 3 medical practice associations, 5 laboratories, activities with hospitals, nursing homes and physicians
1 radiation/oncology facility, dermatologists and urologists ofces. Otherwise, a cancer-related cause of death recorded
on a Massachusetts death
reported to the MCR.
certicate is the only source
of information for a cancer
Registry structure and
USA, MASSACHUSETTS (1998-2002)
case. As a result, these cancer
methods
USA, MASSACHUSETTS (1998-2002)
cases
identied
through
The MCR is located within the
death certicates are poorly
Center for Health Information,
documented and have not
Statistics,
Research
and
been conrmed by review of
Evaluation
(CHISRE),














complete clinical information.


Massachusetts
Department





 

These
cases,
however,
of Public Health (DPH).

 






 





comprise less than 3% of all


The MCR is 75% funded by







cancer cases in this report.


the US Centers for Disease












 

Control and Preventions


There are organised screening





 

National Program of Cancer


programs at the state level for











 


Registries (NPCR), and 25%


breast, cervical and prostate







by the Commonwealth of
cancer. According to data from





 


 





Massachusetts. The Registrys


the behavioural risk factor





 

staff include a director,


survey (BRFS), a questionnaire

 












assistant director of registry


administered randomly to the




 


operations, an administrative
state, 57.9% of men over 50 had
assistant, 9 operations staff
a prostate specic antigen PSA in






(quality assurance and data
the past year. Additionally, 65.4%
 0+' ! 0+'acquisition), 3 epidemiology

 
 

of men over 50 had a digital rectal


*0&/*0(((000

staff, and 3 geographic
exam (DRE).

  
#0  #00
0 20
 0 ! 0" 00)&&&0 0 0 $0 0
information systems/special 0(00

0 ! 0"0 #0


00 0 0"  0 3  0 ! 0  0 !0 0 0!
 3  0   00 0)&&&0 0 0 $0

1%%$ $ $%

$0
project staff.
Use of the data
 


  
 0  0+)&&,-00 .00
0
The MCR follows all CDC/NPCR
program requirements The MCR produces two annual reports: Cancer Incidence
for data collection and reporting. We are certied by the and Mortality in Massachusetts (providing information on
North American Association for Central Cancer Registries cancer incidence and mortality for the state as a whole),
(NAACCR) and have received their gold standard for and Cancer Incidence in Massachusetts: City and Town
completeness, quality and timeliness for the past several Supplement (providing information on cancer incidence
years.
for Massachusetts 351 cities and towns). We also produce
special reports on a periodic basis, such as Data Report on
Interpreting the results
In Situ Breast Cancer in Massachusetts, Data Report on
As noted above, the MCR collects reports of newly diagnosed Colorectal Cancer in Massachusetts, Childhood Cancer
cancer cases from multiple sources, including acute care in Massachusetts, 19901999, Cancer in Massachusetts
hospitals, medical practice associations, laboratories, Women, 19891998: Data Report, and Selected Cancers in
radiation/oncology facilities, dermatologists and urologists Massachusetts Men, 19821996.
reported to the MCR. Reports from dermatologists ofces
Data are available to the public via MassCHIP,
and dermatopathology laboratories, particularly on cases the MDPHs online information service that provides
of melanoma, have only been collected by the MCR since community-level data (http://masschip.state.ma.us), and at
2001. Reports from urologists ofces have only been Massachusetts Cancer Information Online, a website that
collected by the MCR since 2002. Currently, the MCR allows users to access a variety of local, state and national
collects information on in situ and invasive cancers and cancer information in three waysby age, by geography and
benign tumors of the brain and associated tissues. The MCR by type of cancer (http://www.mass.gov/dph/cancer). MCR
does not collect information on basal and squamous cell reports are also posted on the program website (http://www.
carcinomas of the skin.
mass.gov/dph/bhsre/mcr).
The MCR also collects information from reporting
The MCR receives approximately 1015 requests for
hospitals on cases diagnosed and treated in staff physician data each month. Data are used by other DPH programs for

172

North America

program planning and evaluation, and by external researchers


for epidemiologic studies. MCR staff provide support and
consultation to other DPH programs and outside agencies.
Source of population
July 1 county population estimates by age, sex, race, and
Hispanic origin; postcensal estimates based on 2000 United

States Census. The population data include the bridged


singlerace estimates derived from the original multiplerace
categories in the 2000 United States Census.
http://www.seer.cancer.gov/popdata.
Multiple primary rules used
IACR rules (2004) on CI5 IX period.

173

North America

USA, Michigan
Registration area
This Registry covers the State of Michigan within the United
States of America. The state of Michigan is approximately 82%
white, 12% black, 4% Asian and
2% Native American. The state
is roughly 3% Hispanic.
Cancer care facilities
Diagnostic and treatment
services for cancer are widely
available throughout the state.
Radiotherapy services are
widespread and generally
readily available in population
centres, with some access
issues in rural areas.

pathology laboratories, clinics, physicians and dentists. Resident


case exchange agreements are in place with 19 other states.
The registry is located within the vital records ofce
with ready access to death
information.
Reporting is required
USA, MICHIGAN (1998-2002)
by law. Case information is
USA, MICHIGAN (1998-2002)
condential and protected by
law. Improper use or release
of the information is a crime.
R e g i s t r y q u a l i t y,


 





completeness,
accuracy and




timeliness a re mon itored



 






t h roug h ongoi ng rout i ne






auditing of reporting facilities,










with independent assessments



 


of quality conducted annually







 
 

by NAACCR and by CDC.





















 









 


 

Registry structure and





methods

 












Interpreting the results


The registry is located within







 
 



 

Breast and cervical cancer


the Department of Community
 
 





screening
programs
for
Health for the State of







the uninsured are in place


Michigan. It is staffed using 12






throughout the state. Screening
full time equivalent positions.
 0+' ! 0+'prevalence for breast and
The registry is funded in part

 


,02120/*/000

cervical cancer is reasonably
by the US Centers for Disease
high by US standards, and
Control and Preventions 
  
#0  #00
0 40
 0 ! 0" 00)&&&0 0 0 $0 0
PSA testing is common in the
National Program of Cancer 0(00

0 ! 0"0 #0


00 0 0"  0 5  0 ! 0  0 !0 0 0!
 5  0   00 0)&&&0 0 0 $0

3%%$ $ $%

$0
population.
Registries (NPCR).
 


  
 0  0+)&&,-00 .00
0
Data collection is passive,
with routine auditing of
Use of the data
reporting by health facilities using CTRs.
Eighty-five percent of case reports are submitted Registry data are used for reporting incidence, extent of
electronically. Reports are received largely from hospitals disease, and survival. Data are also used in research, and for
and regional cancer registries. Reporting is supplemented by planning and evaluation of heath services.



USA, MICHIGAN:
WHITE
(1998-2002)
USA, MICHIGAN:
WHITE (1998-2002)

USA, MICHIGAN:
BLACK
(1998-2002)
USA, MICHIGAN:
BLACK (1998-2002)



















 











































 







 











 
















 









 
 



 



 






















































 




 

























 




 














 















 















 
 










 








 0+'/2*02*1000



 .*',



Source of population
 


  
July
1 county population estimates by age, sex, race, and
 0  0+)&&,-00 .00
0
Hispanic origin; postcensal estimates based on 2000 United
States Census. The population data include the bridged
singlerace estimates derived from the original multiplerace

  
0(00

0 ! 0"0 #0 #0  #00
0 40
 0 ! 0" 00)&&&0 0 0 $0 0


00 0 0"  0 5  0 ! 0  0 !0 0 0!
 5  0   00 0)&&&0 0 0 $0

3%%$ $ $%

$0

174





 ! 0+'+.&-(.&&/...



 ! .*',






categories in the 2000 United States Census. http://www.


 


  
seer.cancer.gov/popdata.
 .  .*)&&+,.. -..
.

  
.(..

. ! .". #. #.  #..
. 1.
 . ! ." ..)&&&. . . $. .


.. . ."  . 2  . ! .  . !. . .!
 2  .   .. .)&&&. . . $.

0%%$ $ $%

$.

Multiple primary rules used


IACR rules (2004) on CI5 IX period.

North America

USA, Michigan, Detroit


We have a staff of 35 in abstracting, 14 in editing, 5 in followRegistration area
The Metropolitan Detroit Cancer Surveillance System (MDCSS) up and 4 in IT who handle case nding, abstracting, editing,
covers three adjacent counties in southeastern Michigan in the follow-up and computer issues. In addition, there are over 40
United States (US) of America. Metropolitan Detroit is between individuals working in research.
The MDCSS provides both incidence and survival
longitudes 82 and 83 W and latitudes 42 and 43 N. These three
counties, Wayne, Oakland and Macomb, comprise 42% of the reporting for the Metropolitan Detroit area. Data are
overall population of the state of Michigan. The total population of collected by the MDCSS abstracting staff from area hospitals,
the Metropolitan Detroit area, according to the 2000 US Census was private pathology laboratories, radiation therapy facilities
4 043 467. Of this total, 2 784 071 (68.8%) persons were Caucasian and selected clinics and physician ofces. These facilities
and 1 011 038 (25.0%) persons were African American. Of the total include those located within Metropolitan Detroit, as well
population, 118 641 (2.9%) persons were of Hispanic origin. The as facilities outside the area, which routinely provide care
City of Detroit is the major urban centre of this area. In the City for cancer patients who reside in the MDCSS registration
of Detroit, 12.3% of the population was Caucasian and 81.6% was area. Both passive and active follow-up are maintained for
all cases. Re-admissions to
African-American, with 5.0%
hospitals are also abstracted
of the total being of Hispanic
for follow-up data. Death
descent. The Metropolitan
USA, MICHIGAN, DETROIT (1998-2002)
certicates for the State of
Detroit area is culturally diverse,
USA, MICHIGAN, DETROIT (1998-2002)
Michigan, and for other states
with representation from Arabic,
that are primary retirement
Polish, Greek, Italian, German,
areas for local residents, are
English, Irish and Scottish
linked by computer tape each
ancestry. The area is heavily
$+-"0(--/*,
($-"&"--%*-/0(--/"
(+-&/0--quarter to provide up-to-date
industrialised, being the centre
(&-(0(--.*
+*-$&*--information on new deaths
of the United States automobile
*&-+.0--."
.%-$*+--*+-&%+--+*
.$-&(*--and causes of death.
manufacturing industry. The total
+0-&"0--+"
./-(%.--registration area is 5094 km2.
The completeness and
0*-(&"--**
$"$-0/(--$%+-($&--*"
$&(-($"--accuracy of our data are
$(.-$"%--(*
$*(-.&%--Cancer care facilities
evaluated both by the SEER
$+&-/%*--("
$.$-"*&--$+%-%(%--&*
$+*-/*%--The MDCSS began in 1949
program and internally on a
$*&-*0%--&"
$*.-$+(--as a pathology registry for 25
routine basis. The Metropolitan
$&.-%/$--%*
$(%-./"--$$.-*/&--%"
$$0-"$(--collaborating hospitals. In 1960,
Detroit Cancer Surveillance
$&*-+"(--$*
$%/-%&*--System routinely scores in the
the MDCSS became a central
$*(-//&--$"
$(/-$/&--$*/-0(.--*
$*$-(&0--top 5 of all SEER registries
statistical resource for these
$((-%"/--"
$&.-(0+--25 hospitals, providing reports
nationally.
comparing the experience of
$"
*
"
"
*
$"
 -'#)
  -'#)
each hospital with the entire
Interpreting the results
%-"/+-/%(--$-0+$-0"(--
Besides the metropolitan Detroit
group of collaborating hospitals.
area being highly industrialised,
In 1969 the MDCSS became the 
  
the area is also home to a plant
designated arm of the Michigan -$--

-  -- - -  --
-  1-
 -  - --%"""- - - ! 


  
 -  -'%""()-- *--
Department of Community Health
(MDCH) for collection of that was involved in the processing of vermiculite contaminated
cancer information in the Metropolitan Detroit area. In this same with asbestos.
year, the MDCSS was organised in its current form to participate
in the Third National Cancer Survey for the years 19691971. In Use of the data
1973 the MDCSS became one of the founding participants in the From 1973 through 1978, the MDCSS and the Metropolitan
National Cancer Institutes (NCI) Surveillance, Epidemiology Detroit SEER Program were essentially data collection
operations, with minimal reporting of descriptive data.
and End Results (SEER) Program.
Development of a research program in cancer epidemiology
began in 1979. Cancer epidemiology evolved into a major
Registry structure and methods
In 1976, the MCF became a member of the NCI-funded research program with a current focus on racial disparities in
Comprehensive Cancer Center in Detroit along with Wayne State risk and survival. The Metropolitan Detroit SEER data are
University (WSU) and the Detroit Medical Center. In 1995, all utilised extensively for descriptive and analytic epidemiology.
programs of the Comprehensive Cancer Center were consolidated The data are also utilised by local health departments,
under the name of the Barbara Ann Karmanos Cancer Institute the Michigan Department of Community Health and area
(KCI). The Director of KCI reports to the Dean of the WSU health professionals for planning, evaluation and educational
School of Medicine and the Comprehensive Cancer Centers purposes. Community concerns regarding cancer risk are
also addressed through use of MDCSS data.
Programs are administered by the School of Medicine.

175

North America

USA, MICHIGAN, DETROIT: BLACK (1998-2002)


USA, MICHIGAN, DETROIT: BLACK (1998-2002)

USA, MICHIGAN, DETROIT: WHITE (1998-2002)

%-0$$---

/*,

.-"$+---

$&-"$(---

/*,

&&-.%$---

(-&..---

/"

.-.+$---

%$-%++---

/"

&/-$0/---

.-0$0---

.*

$%-"&&---

&*-"*.---

.*

*%-&*"---

0-/&%---

."

$(-(($---

(&-$$(---

."

*+-+.$---

$$-&/0---

+*

$+-".&---

(&-/$&---

+*

*&-0+0---

$&-%+.---

+"

$.-*$.---

*(-$%"---

+"

*0-"&&---

$/-.$0---

**

%%-/0&---

.(-"0"---

**

.+-("$---

%+-**0---

*"

&%-//%---

0+-&*"---

*"

0.-+%%---

&$-%+%---

(*

&0-("$---

$$$-.*.---

(*

$$$-""%---

&(-(0*---

("

(%-/%"---

$%(-%"&---

("

$%&-&(/---

&&-("(---

&*

($-0"%---

$%%-($&---

&*

$$.-0**---

&(-+0+---

&"

(&-"//---

$$$-0($---

&"

$".-""0---

&*-"."---

%*

(&-&%/---

0*-(%.---

%*

0%-&*%---

&%-/**---

%"

&.-%&/---

/"-+/&---

%"

..-&("---

&/-((+---

$*

&/-&+*---

0%-.$.---

$*

/*-+0+---

(/-(%*---

$"

(.-$/0---

$"$-&$.---

$"

0+-"0&---

*%-"*%---

*"-.%$---

$"$-(($---

0*-*+.---

(%-0((---

"

($-.&$---

0*-%+(---

"

0"-$/&---

$"

"

"

 -'#)
(./-+%$---

$"

$"

  -'#)


"

"

 -'#)
**+-&0/---


  
-$--

-  -- - -  --
-  1-
 -  - --%"""- - - !-

176

USA, MICHIGAN, DETROIT: WHITE (1998-2002)

$-($.-0/*---

$"

  -'#)


$-(+(-*"0---


  
-$--

-  -- - -  --
-  1-
 -  - --%"""- - - !-

 


  
 -  -'%""()-- *--
-

Source of population

 -  -'%""()-- *--
Multiple
primary rules used

July 1 county population estimates by age, sex, race, and


Hispanic origin; postcensal estimates based on 2000 United
States Census.

IACR rules (2004) on CI5 IX period.

 


  

North America

USA, Missouri
Registration area
The Missouri Cancer Registry (MCR) covers the population
of the state of Missouri, located in the middle of the United
States and having as its eastern border the Mississippi River.
The majority of Missouris 5.5 million people live in two
major metropolitan areas (Kansas City and St. Louis) and
ve minor metropolitan areas. The remainder of the state
consists of small towns and rural areas.

melanoma skin cancer by physician ofces. Another source


is death certicates. Death information for Missouri residents
who died in Missouri is available both in an electronic le and
as a paper record through a Memorandum of Understanding
with DHSSs vital records unit. Death information for
Missouri residents that die elsewhere is available from some
but not all states. MCR staff conduct death clearance and
follow-back on in-state cancer deaths not matched in the
registry database; the number of new cases identied only
through death certicates is <3% for data from 19982003.
Cancer care facilities
Over 85% of annual cancer incidence cases are reported by MCR staff process over 45 000 records annually. After case
hospitals, of which there are 126 in Missouri, including four consolidation, this yields approximately 28 000 Missouri
Veterans Affairs (VA) hospitals and two military hospitals. incident cases.
Quality control is an
Most of the remaining cases
ongoing process at MCR. All
are reported by long-term care
records receive an initial review
facilities, ambulatory surgery
USA, MISSOURI (1998-2002)
and an additional in-depth
centres, freestanding cancer
USA, MISSOURI (1998-2002)
review. Before each call for
clinics and treatment centres,
data, all cases are run against
pathology laboratories and
GenEdits and Interrecord
physician
ofces/groups
Edits and corrections made
that diagnose or treat cancer

 












prior to submission. Quality


or
through
case-sharing







control is also part of each


agreements with 18 other








 



 

data request. Prior to nalising


states. The states of Kansas,







the data request, the data are


Illinois and Texas contribute

 



 








reviewed for accuracy. In


the largest number of data
 
 





addition, reports are produced


exchange cases.

 












whenever necessary to look at


 



 


possible errors that have been


Registry structure and




 







 

identied through the review


methods







process.
MCR is a joint endeavour of the











 

University of Missouri and the









Interpreting the results


Missouri Department of Health
MCR data meet NPCR
and Senior Services (DHSS).






standards and North American
It is located on the campus of
 /+' ! /+'



)/0))/10*///

Association of Central Cancer
the University of MissouriRegistry (NAACCR) criteria
Columbia and is housed 
  
#/  #//
/ 3/
 / ! /" //)&&&/ / / $/ /
for timeliness completeness
in the School of Medicine, /(//

/ ! /"/ #/


// / /"  / 4  / ! /  / !/ / /!
 4  /   // /)&&&/ / / $/

2%%$ $ $%

$/
Department of Health Management
and Informatics (HMI). and quality. While MCR data are more than 95% complete
 


  
The primary funding source for /  /+)&&,-// .//
/
operating the registry is the (i.e., >95% of expected cases are available within 24 months
US Centers for Disease Control and Preventions National of the close of a diagnosis year), some sites are less complete.
Program of Cancer Registries (NPCR) through a contract Less than 60% of expected melanoma skin cancer cases were
between the University and DHSS. The registrys operations reported annually through 2003. In 2004, MCR initiated
director is also a member of the HMI faculty. Registry staff reporting of melanoma skin cancers by physicians; this has
include 9.25 Certied Tumor Registrars (CTRs), 3 health resulted in increased reporting of these cases. Prostate cancer
program specialists or assistants, 2.25 technical staff (data cases were also underreported. In 2005, Missouri became
base manager and IT support), a half-time statistician, 1 one of eight states funded by CDC-NPCR to pilot web-based
support staff and 2 part-time graduate research assistants. reporting of prostate cancers by physicians. We hope to see
The registry also receives support from four DHSS staff an increase in reporting of these cases in 2006.
members who are partly funded by CDC-NPCR.
Data collection from hospitals is 8085% automated. Use of the data
Approximately 5% of the cases are received as copies of Missouri incidence data are used for program planning
medical records, which are then abstracted by MCR staff. and evaluation, epidemiological studies, cancer cluster
Another 5% are submitted by non-hospital facilities (surgery investigations, annual reports and a variety of other purposes.
centres, radiation centres, physician ofces and nursing Missouri incidence data are available online at http://www.
homes); most of these cases are submitted on paper but dhss.mo.gov/cancerMICA/ by site, race, age group and
MCR is piloting web-based reporting of prostate cancer and geographic unit.

177

North America

USA, MISSOURI: BLACK (1998-2002)

USA, MISSOURI: WHITE (1998-2002)

USA, MISSOURI: BLACK (1998-2002)

USA, MISSOURI: WHITE (1998-2002)








 













 




 























































































 












 

 















 




 



 












 















 


























 




















 









 
 




































 



 /+'*&./.0*///








Source of population
July 1 county population estimates by age, sex, race, and
Hispanic origin; postcensal estimates based on 2000 United
States Census. The population data include the bridged
singlerace estimates derived from the original multiplerace

178

 0+'-


  
/(//

/ ! /"/ #/ #/  #//
/ 2/
 / ! /" //)&&&/ / / $/ /


// / /"  / 3  / ! /  / !/ / /!
 3  /   // /)&&&/ / / $/

1%%$ $ $%

$/
 


  
 /  /+)&&,-// .//
/



 ! /+'-




)0*/10)2)000



 ! 0+'






  
0(00

0 ! 0"0 #0 #0  #00
0 40
 0 ! 0" 00)&&&0 0 0 $0 0


00 0 0"  0 5  0 ! 0  0 !0 0 0!
 5  0   00 0)&&&0 0 0 $0

3%%$ $ $%

$0
 


  
 0  0+)&&,-00 .00
0

categories in the 2000 United States Census. http://www.


seer.cancer.gov/popdata.
Multiple primary rules used
IACR rules (2004) on CI5 IX period.

North America

USA, Montana
Registration area
The Montana Central Tumor Registry (MCTR) is a
population-based registry covering the entire State of
Montana. The MCTR was started in 1979 by the Montana
Tumor Registry Act. About 60% of the state is actually
prairie in the Great Plains. Montana is primarily rural. The
state ranks fourth among US states in size but has a relatively
low population and consequently a very low population
density. The race of Montanans is about 92% Caucasian and
6% American Indian.

laboratories. MCTR has access to all death certicates from


the Ofce of Vital Statistics on a quarterly basis. Quality
control procedures are being developed. Presently, the MCTR
undergoes a casending, data quality, and timeliness audit by
the CDC once every 5 years.
Interpreting the results
The population in Montana is growing and grew almost 10%
in 2005. Prior to that, the population increased about 3%
since the year 2000. Diagnostic and treatment facilities for
cancer patients are increasing, and several cancer treatment
facilities are seeking ACoS approval. Montana has breast
and cervical cancer screening and a health assistance
programme, and PSA testing
is common in the population.

Cancer care facilities


Montana has 4 American College of Surgeons cancer
approved
programmes;
Benes Healthcare in Great
Falls, St. Patrick Hospital in
USA, MONTANA (1998-2002)
Missoula, St. Peters Hospital
USA, MONTANA (1998-2002)
in Helena, and Billings Clinic
in Billings. Other cancerrelated facilities include:
St. Vincents Hospital in








Billings, Bozeman Deaconess




Hospital in Bozeman, St.








James Community Hospital in




Butte, and Kalispell Regional








Hospital in Kalispell.
































Use of the data


The MCTR publishes an
annual report that presents
topics on incidence rates,
mortality rates, incidence by
sites, stage at diagnosis, rates
by counties, risk and associated
factors, age-specic incidence
rates, and ten-year trends.
Data are used for individual
requests for information and
are used for cancer cluster
investigations. The registry
is not currently involved in
epidemiological
research
beyond the production of
routine statistics, but the
Montana
Comprehensive
Cancer Program routinely
uses our cancer registry data.




Registry structure and







 

methods





 








The MCTR is housed in the









Montana State Department






 








of Public Health and Human









Services, Division of Public


Health and Safety, Bureau of






 .*',
 ! .*',
Chronic Disease Prevention



++0.)/+...

and Health Promotion, Cancer
Control Section. Financial 
  
#.  #..
. 2.
 . ! ." ..)&&&. . . $. .
Source of population
support includes about 20% of .(..

. ! .". #.


.. . ."  . 3  . ! .  . !. . .!
 3  .   .. .)&&&. . . $.

1%%$ $ $%

$.
the budget covered by State funds
and
about
80%
of
the budget July 1 county population estimates by age, sex, race, and
 


  
 .  .*)&&+,.. -..
.
covered by Federal support through
the US Centers for Disease Hispanic origin; postcensal estimates based on 2000 United
Control and Preventions National Program of Cancer Registries States Census. The
(NPCR). MCTR staff include: 1 Cancer Epidemiologist, 1 population data include the bridged singlerace estimates
Program Manager, 1 Administrative Support/Follow-up, and derived from the original multiplerace categories in the
2 Quality Assurance Technicians. Data collection is passive, 2000 United States Census.
with each facility responsible for abstracting and reporting http://www.seer.cancer.gov/popdata.
its own cancer cases. MCTR staff do not abstract for any
facility. The principal sources of information on cancer cases Multiple primary rules used
are hospitals, radiation centres and independent pathology IACR rules (2004) on CI5 IX period.






 




 

179

North America

USA, New Jersey


Registration area
New Jersey is located on the east coast of the United States,
bordered by the states of New York, Pennsylvania, and
Delaware. In 2000, the population of the state of New Jersey
comprised over 8.4 million inhabitants. Of these, 13.6% were
African American, 13.3% were Hispanic and 5.7% were Asian.
The median household income, according to the 2000 census,
was US$55 146 (in 1999 dollars). Of the population over 16
years of age, 64.2% are in the labour force.

psychiatric facilities and rehabilitation facilities. Physicians


and dentists are required to report non-hospitalised cases.
Matching of the registry database with the Departments AIDS
registry and the Breast and Cervical Cancer Early Detection
Program have resulted in the identication of cases.
Quarterly record linkages are performed between the registry
database and the state death le. A built-in death certicate match
system links and updates cancer registry records with death
information. Linkages are also performed with individual state
tax return les, hospital discharge les, motor vehicle drivers
license files, the federal Centers for Medicare and Medicaid
Services, Social Security Administration, and National Death
Index to obtain follow-up information.

Cancer care facilities


A total of 76 in-state hospitals report to the registry on
a monthly basis via e-mail to a secure, encrypted e-mail
server. The proximity of New
Jersey to prestigious cancer
centres in neighbouring states
USA, NEW JERSEY (1998-2002)
attracts many residents to seek
USA, NEW JERSEY (1998-2002)
diagnosis and treatment outside
the state. Over 10 000 case
reports are received annually
from out-of-state sources
$.+)#.+++
-(*
(.+-&,+++
- 
through reciprocal reporting
.(+$-(+++
,(
agreements with other states.
"# +&-)+++
, 
"$#+ &#+++

)(

.-+&-,+++
" (+$&$+++
"&$+$,$+++
"(-+.$,+++
"(.+,,.+++

Interpreting the results


New Jersey has Gold Certication
Status from NAACCR. The data
quality assurance programme
is a continuous multi-faceted
programme of checks and
balances, performed by highly
skilled CTRs with years of
quality control experience. Other
components include consistent
application of computerised
edits, systematic review of
problem cases, re-abstracting
and re-coding studies centred in
hospitals, feedback and training
programmes for hospital staff,
documentation of policies and
procedures, and case-nding
audits.
Denite and possible
duplicates are electronically
generated and resolved by
staff. Computerised programs
are used to identify multiple

"(,+-()+++
) 
",)+,-$+++
Registry
structure
and
# (+), +++
((
##&+"#(+++
#)$+)$#+++
( 
#-&+ -(+++
methods
$ "+&,#+++
&(
$")+)- +++
Cancer
Epidemiology
$&.+$&-+++
& 
$) +"(#+++
$(.+"#(+++
$(
$))+, ,+++
Services (CES) is located in
$#"+##-+++
$ 
$#)+($ +++
the Division of Epidemiology,
#),+-.)+++
#(
#))+ ,-+++
#&(+. +++
# 
#$(+#) +++
Environmental
and
#,)+&-&+++
"(
#) + .-+++
Occupational Health Services.
$ #+)")+++
" 
#-,+.#-+++
$ ,+&. +++
(
#.$+"&$+++
CES is nanced by both state
#-,+),$+++

#,(+()"+++
and federal sources, including
the US Centers for Disease
"
(
(
"
Control and Preventions
 +%!'
  +%!'
&+$$.+ &.+++
&+ .$+,,.+++

National Program of Cancer
Registries (NPCR). There are 
  
42 full-time equivalent staff # + + + + + +

 ++ ++ + + + +
 


  
working in the unit on cancer registry
cancer surveillance primary cancers for review.
 +  +%# and
&'++ (++
+
activities. Certied Tumor Registrars (CTRs) are employed in
all aspects of the registry operations including data collection, Use of the data
The Cancer Surveillance Program, staffed by epidemiologists
quality assurance, reporting and analysis.
The majority of cases are reported by hospitals throughout and a statistician, monitors cancer incidence trends,
the state. Abstracting, coding and data entry are conducted at disseminates data, and responds to citizens concerns about
the hospital level by CTRs directly from source records and cancer. The staff have published a variety of registry reports,
reported electronically to the central ofce. All health care including a report on trends in cancer incidence and mortality,
facilities are required by law to report cancer cases electronically cancer survival, cancer prevalence, an in-depth analysis of
within three months of discharge or six months of diagnosis prostate cancer, breast cancer, colon and rectum cancer, and
or face a penalty. Hospitals are required to report all cases of childhood cancer.
The data are employed in a wide range of activities including
cancer, regardless of in- or out-patient status. Reporting from
non-hospital facilities accounts for a small but growing number applications in cancer control and prevention, aetiological
of cases. The majority of non-hospitalised cases are reported by studies, policymaking, and epidemiological research. Registry
16 independent pathology laboratories. Other sources include data were also used to dene baseline measures for the general
117 surgery centres and 9 free-standing radiation treatment and special populations in the state to establish public health
centres. Reports are also received from nursing homes, objectives for the next decade.

180

North America

USA, NEW JERSEY: WHITE (1998-2002)

USA, NEW JERSEY: BLACK (1998-2002)

USA, NEW JERSEY: WHITE (1998-2002)

USA, NEW JERSEY: BLACK (1998-2002)

#+&-#+++

-(*

,+ $$+++

$)+&&"+++

-(*

$+).&+++

- 

,+&-$+++

(&+..(+++

- 

.)+ ) +++

,+ ("+++

,(

""+-" +++

-)+"$ +++

,(

"#-+$,)+++

" +($"+++

, 

"(+#-"+++

" )+(#(+++

, 

"$-+.$ +++

"&+# .+++

)(

".+&),+++

""#+$.#+++

)(

"$$+.$.+++

"-+) (+++

) 

#&+",-+++

"$ +()(+++

) 

"&&+ &&+++

#$+ $&+++

((

#.+$))+++

", +.-,+++

((

"-#+."&+++

#.+("$+++

( 

$,+(#"+++

#",+-))+++

( 

##.+)$#+++

$(+)& +++

&(

&$+##"+++

#&(+.)$+++

&(

#(#+)-#+++

&&+)-"+++

& 

("+&(.+++

#- +& $+++

& 

#-$+&$-+++

( +$--+++

$(

()+,,.+++

#-#+ --+++

$(

#-#+--#+++

&-+#.$+++

$ 

(&+# &+++

#&)+)",+++

$ 

#&$+,$$+++

&$+&&"+++

#(

&,+"&$+++

"..+)-$+++

#(

".$+#$.+++

&&+&,"+++

# 

&(+$,$+++

"-$+$,(+++

# 

","+-(-+++

( + ))+++

"(

&-+,$(+++

# ,+,

+++

"(

".$+-#"+++

(&+, $+++

" 

(#+.-&+++

##,+-,.+++

" 

#")+#$-+++

()+#) +++

(

(&+ $.+++

##.+.,#+++

(

#"-+-#.+++

("+)("+++

&.+,- +++

#"&+& $+++

# &+,$.+++

"

 +%!'
(--+,"$+++

"

"



 +%!'

  +%!'
)((+-((+++

$+#$$+.-&+++

"

  +%!'



  
# + + + + + +

 ++ ++ + + + +


  
#
+ + + + + +

 ++ ++ + + + +

 


  
 +  +%# &'++ (++
+

 


  
 +  +%# &'++ (++
+

Source of population
2000 Census of the United States, prepared by the US Bureau
of the Census.

. +##$+++

$+& (+(,)+++

Multiple primary rules used


IACR rules (2004) on CI5 IX period.

181

North America

USA, New Mexico


cases are registered from hospital admission and outpatient
Registration area
With an area of 314 926 km2, New Mexico is the fth largest records. Other methods of casending are used to obtain
state in the USA. Located in the southwest of the country information on cancer cases not seen in reporting hospitals.
(latitude 30 to 37 N), it has extensive high desert and Radiation therapy records and death certicates are reviewed
mountain terrain, the altitude ranging from 859 to 4010m regularly.
Medical chart data are entered directly onto diskettes
above sea level. Rainfall and humidity are low.
Its population is about 1.9 million, of whom approximately using a software package assembled locally, allowing
one third live in the Albuquerque metropolitan area; the collection of supplemental data items of special interest
remainder live in small cities or in villages. The population to individual hospitals and physicians. It also allows each
come from diverse ethnic backgrounds: 42% have Spanish hospital to analyse its own 30+ year complete dataset and
and/or Mexican-American heritage (Hispanics); 9.5% are to compare it with a statewide analytical dataset. Data from
American Indians (Navajo, Pueblo, Apache); 1.9% are Black; the abstractors diskettes are edited, linked and merged into
about 1% are Asian; the remaining 45% are non-Hispanic white the master le.
Abstracted cases are
of European descent. A sizeable
reviewed for thoroughness
subgroup of New Mexicos
and accuracy. The le is
Hispanic population traces its
USA, NEW MEXICO (1998-2002)
ordered by the computerancestry to Spanish soldiers and
USA, NEW MEXICO (1998-2002)
generated accession numbers,
colonists who settled in New
but can be sorted by any item
Mexico during the 17th and
of data. Numerous routine
18th centuries. Median levels of
crosschecks are made to
education and per capita income
.-.+%--/*,
$*-.%/--$$-(0(--/"
$+-+*%--eliminate duplicate cases.
are in the lowest decile of the
$/-.+(--.*
%(-%"(--50 states.
%*-&"(--."
%0-/&%--&"-"*+--+*
&%-/+"--Interpreting the results
&(-+%(--+"
&.-0""--Cancer
surveillance
in
Cancer care facilities
(%-+0"--**
(*-0"(--*+-($&--*"
*/-0$(--New Mexico is conducted
An overwhelming majority
+&-..0--(*
+.-&0/--according
to
prevailing
of cancer patients in New
+0-*+"--("
.%-$"(--+/-%(%--&*
+0-+%$--standards
promulgated
by
Mexico are diagnosed and
*0-+00--&"
+"-"($--the SEER Program and the
treated at one or more of
*+-0"/--%*
*+-.."--+&-$/%--%"
+$-&&*--North American Association
seven medical facilities that
.*-&%.--$*
.$-(*0--of Central Cancer Registries
support cancer programmes
.(-/.*--$"
.$-//+--."-/.+--*
+/-*$0--(NAACCR). As such, the data
accredited by the American
++-+%0--"
+(-.0*--have been subject to the same
College of Surgeons. Cancerchanges in denitions and
related care is also provided by
$"
*
"
"
*
$"
 -'#)
  -'#)
coding as other registries that
several private oncology and
0%*-0%*--/0+-$/&--
abide by SEER and NAACCR
radiation-oncology practices
standards. The Registrys
afliated with the latter 
  
geographic area of coverage
medical facilities. Some New -$--

-  -- - -  --
-  1-
 -  - --%"""- - - ! 


  
 -  -'%""()-- *--
Mexico residents receive cancer-related
care in neighbouring has remained constant since it initiated statewide coverage
states; the registry has longstanding agreements with central in 1969.
Because incidence rates vary by cancer primary site
cancer registries in all bordering states to routinely receive
among the States three largest racial/ethnic groups, New
reports on diagnosis or treatment of New Mexico residents.
Mexico data must not be considered in aggregate, that
is, without stratication by race/ethnicity. Descriptive
Registry structure and methods
Cancer reporting has been required (but not enforced) epidemiological analyses have shown that Hispanics and
by a State Health Agency regulation since 1922. The American Indians have lower rates than the non-Hispanic
New Mexico Tumor Registry, located at the University white population for skin, breast, endometrium, lung and
of New Mexico Cancer Research and Treatment Center colorectal cancers, and higher rates for stomach, uterine
in Albuquerque, began operation in 1966 and became the cervix, kidney and gallbladder cancers.
ofcial cancer data repository for the State Health Agency in
1975. Registry funding initially came from the New Mexico Use of the data
Regional Medical Program and since 1973 primarily from Periodic reports are sent to participating hospitals and
the National Cancer Institutes Surveillance, Epidemiology, individual physicians. The registry also handles over 100
special requests for cancer data annually. The registry has
and End Results (SEER) Program.
The registry abstracts and follows all cases of known been a casending source for a variety of population-based
malignancy. Multiple primaries are counted separately by assigning casecontrol studies relating to cancer etiology. It has also
sequence numbers within the records of individual patients. Patients been used to monitor patterns of cancer care and survival in
relation to factors such as ethnicity, age and marital status.
entered into the registry system are followed for life.
The development of new techniques for investigating
Some of the larger hospitals employ tumour registrars,
and abstractors from the central registry travel to other molecular and cellular changes in preserved tissue specimens
hospitals and clinics throughout the state to review and has created requests for the registry to help select cases that have
abstract cancer patient records. The majority of the registrys documentation of different clinical courses and outcomes.

182

North America

USA, NEW MEXICO: AMERICAN INDIAN


(1998-2002)
USA, NEW MEXICO: AMERICAN INDIAN (1998-2002)

USA, NEW MEXICO: NON-HISPANIC WHITE


(1998-2002)
USA, NEW MEXICO: NON-HISPANIC WHITE (1998-2002)

(&(---

/*,

.*(---

*-"**---

/*,

$"-./0---

*"(---

/"

.%$---

.-00*---

/"

$$-*%0---

.0(---

.*

$-"."---

$%-(0&---

.*

$+-%%+---

$-$0%---

."

$-*&$---

$+-%+%---

."

$/-++$---

$-*.(---

+*

%-"."---

$/-*0.---

+*

$0-*++---

%-$"+---

+"

%-."(---

%"-+&(---

+"

%%-"&"---

%-.*(---

**

&-%./---

%*-*$(---

**

%.-"&$---

&-/%*---

*"

(-&+%---

&%-(/.---

*"

&&-+$.---

(-..&---

(*

*-*+%---

&(-+"$---

(*

&+-*+(---

*-0.&---

("

+-.&&---

&(-*++---

("

&*-.&&---

+-+%&---

&*

.-$.$---

&"-%+&---

&*

&$-"%0---

+-%.+---

&"

+-+"0---

%(-*.(---

&"

%(-+%0---

+-(+0---

%*

+-."+---

%$-.*%---

%*

%$-+%"---

.-("*---

%"

.-*/$---

%%-0(%---

%"

%$-00%---

0-&0%---

$*

0-%*0---

%.-/*$---

$*

%*-0"&---

$"-&(&---

$"

$"-$0.---

%+-."*---

$"

%*-"0/---

0-0"*---

0-0%&---

%&-.(.---

%%-(".---

/-../---

"

/-+."---

%$-"%0---

"

%"-%/%---

$"

"

"

 -'#)

$"

$"

  -'#)

/0-$$0---

"

"

 -'#)
0(-0"$---



(".-"+/---

$"

  -'#)


(%(-."+---


  
-$--

-  -- - -  --
-  1-
 -  - --%"""- - - !-


  
-$--

-  -- - -  --
-  1-
 -  - --%"""- - - !-

 


  
 -  -'%""()-- *--
-

 


  
 -  -'%""()-- *--
-

USA, NEW MEXICO: HISPANIC WHITE (1998-2002)


USA, NEW MEXICO: HISPANIC WHITE (1998-2002)

%-$(/---

/*,

&-0%&---

%-/%"---

/"

(-$&.---

*-$(/---

.*

+-(+*---

.-&+0---

."

/-0%(---

0-$&(---

+*

$"-&/(---

$$-"*&---

+"

$%-%*.---

$&-&""---

**

$(-&+0---

$/-(/(---

*"

$0-$+.---

%%-%"*---

(*

%&-"&$---

%+-(..---

("

%.-"+$---

%/-(.*---

&*

%/-+((---

%+-%$(---

&"

%+-%"+---

%*-0%"---

%*

%*-.*%---

%0-+%&---

%"

%/-0+(---

&(-///---

$*

&&-(*%---

&(-.(+---

$"

&&-+*(---

&(-$+*---

&&-"0*---

&&-+%/---

"

&%-.0.---

$"

"

"

 -'#)
&+*-.0/---

Source of population
July 1 county population estimates by age, sex, race, and
Hispanic origin; postcensal estimates based on 2000 United
States Census.
Multiple primary rules used
IACR rules (2004) on CI5 IX period.

$"

  -'#)


&.%-%/%---


  
-$--

-  -- - -  --
-  1-
 -  - --%"""- - - ! 


  
 -  -'%""()-- *--
-

183

North America

USA, New York State


complete diagnostic information. To further assure complete
Registration area
The New York State Cancer Registry (NYSCR) contains reporting, cases diagnosed and/or treated in 16 other states
reports on all malignant tumours (except basal cell and are identied through reciprocal reporting agreements.
In order to provide detailed geographic information for
squamous cell skin cancers), most in situ lesions, and certain
benign tumours. The Registry, the second oldest state tumour cancer surveillance and cancer mapping, attempts are made
registry in the United States, has had mandated cancer to geo-code the addresses of all cancer cases to the county,
reporting since 1940, when the registration area covered the postal code and census block level.
In order to evaluate the quality and completeness of
entire state except New York City. Beginning in 1973, the
reporting mandate was extended to include New York City. cancer reporting, the Registry conducts routine audits at
hospitals throughout the state. Staff from the Field Services
The Registry has been population-based since 1976.
The population of New York State was 18 976 457 in the year Unit also compare the number of cases reported to the number
2000, according to the U.S. census; the estimated population of cancer-related hospital discharges for consistency. Results
for 2004 is 19 227 088. In 2000, about 90% of the population are used to target the location and content of statewide
educational and training
lived in metropolitan areas; 62%
programs.
were Non-Hispanic Caucasians,
16% were African-Americans,
USA, NEW YORK STATE (1998-2002)
Interpreting the results
15% were Hispanics (of any
USA, NEW YORK STATE (1998-2002)
The registration area for the
race), 0.4% were American
Registry has been constant since
Indians and 5.5% were Asians
1973. Although no new class of
(including Pacic Islanders).
sources of cancer case reports
..,'.),,,
.)+
$$),)%/,,,
#$*,$/!,,,
.!
$$',*-!,,,
was added during 19982002,
Cancer care facilities
$!),/%),,,
-)
%!-,-)-,,,
ambulatory surgery centres
Residents of New York State
$*$,%/!,,,
-!
%'.,#-!,,,
$/*,''!,,,
*)
%*!,*#$,,,
have been added as sources
have access to more than 250
%)',!!',,,
*!
'#!,.#),,,
more recently.
acute-care hospitals, including
''),$$$,,,
))
)!',''%,,,
)-.,.'/,,,
)!
*%',/).,,,
Changes in cancer screening
22 Community Hospital
*)%,-)$,,,
')
*/*,!'),,,
patterns have had a large impact
Comprehensive Cancer Care
-'!,!%$,,,
'!
--!,-**,,,
-*-,)*$,,,
%)
-/#,/*-,,,
on the number of cancer cases
facilities located throughout
-#.,##),,,
%!
-'!,-#.,,,
diagnosed in New York State.
the State and three National
*'$,-#!,,,
$)
**',)!/,,,
*%$,#*-,,,
$!
*$%,$$#,,,
According to the Behavioral
Cancer Institute-designated
*)),)%%,,,
#)
*$!,''$,,,
Risk Factor Surveillance System
Comprehensive Cancer Centers.
*-',/)-,,,
#!
*'$,*#),,,
*-.,/'),,,
)
*'/,!/*,,,
telephone survey, the percentage
In addition, many freestanding
*%$,-#*,,,
!
*!','##,,,
of persons aged 50 years or older
healthcare facilities and private
who ever had colorectal cancer
physicians diagnose and treat
#!
)
!
!
)
#!
screening grew from 56.6% in
cancer. There are 54 Ambulatory
 ,&"(
  ,&"(
1996 to 67.8% in 2002. By 1997
/,.$!,-)),,,
/,#)',#!),,,

Surgery Centers and 12 Veterans
(the most recent available data),
Administration Hospitals that 
  
  , ,, ,  0, , , , , ,

,  ,, ,
0   

 ,
74.6% of New York women aged
also provide cancer services.
 


  
fty or older had had a mammogram and clinical breast exam
 ,  ,&$!!'(,, ,,
within the previous two years; 77% of men aged fty or older
Registry structure and methods
The Registry is located within the New York State Department had ever had a prostate specic antigen (PSA) test.
of Health (NYSDOH), and is funded partly by the NYSDOH
and partly by the National Program of Cancer Registries. Use of the data
The Registry has a director, eld staff, coding staff, quality The Registry prepares an extensive annual report of cancer
assurance staff, research scientists, computer programmer incidence and mortality. The most frequently requested tables
analysts, and geo-coding and secretarial support staff; 22 are produced in a printed volume, whereas the entire report is
available on our Web site: http://www.health.state.ny.us.
staff members are Certied Tumor Registrars.
Within the New York State Department of Health,
Law mandates cancer reporting with full personal
identiers. The NYSCR uses passive notication of reports Registry data are used extensively for cancer surveillance and
from more than 300 sources including hospitals, pathology for program planning. The Cancer Surveillance Program has
and cytology laboratories, radiation treatment centres, access to the database for use in investigating possible cancer
ambulatory surgery centres, and state vital records. Data are clusters and addressing community concerns. The Cancer
received electronically in the NAACCR (North American Screening Research and Evaluation unit uses Registry data
Association of Central Cancer Registries) format and are for programme evaluation, targeting and prioritisation. The
mostly pre-coded. Many quality checks, including single Health Department provides cancer education and awareness
eld range and validity edits as well as intereld edits, are programs and funds screening for breast, cervical and
routinely applied to the data and much time and effort are colorectal cancer for under- or uninsured individuals.
Cancer Registry data are routinely provided to other
devoted to elimination of duplicate case reports.
New York State law mandates reporting of mortality, organisations within the state for planning and evaluation of
and death certicates are electronically matched against health services, grass-roots advocacy, and generating etiologic
Registry les. Cancer deaths not previously reported to the hypotheses. In addition, the Registry is utilised by researchers
Registry are followed back to hospitals and physicians for nationwide for a variety of epidemiological studies.

184

North America

USA, NEW YORK STATE: BLACK (1998-2002)


USA, NEW YORK STATE: BLACK (1998-2002)

USA, NEW YORK STATE: WHITE (1998-2002)


USA, NEW YORK STATE: WHITE (1998-2002)

*,'-),,,

.)+

#/,-)-,,,

-/,*)*,,,

.)+

$!#,)/%,,,

/,%%.,,,

.!

$#,!'/,,,

##%,'%.,,,

.!

#/.,)/-,,,

#-,-'-,,,

-)

%$,.)%,,,

#.#,)*#,,,

-)

$**,''),,,

-!

$/',./),,,

$',-'#,,,

-!

'#,!*/,,,

$$-,/%),,,

%%,*##,,,

*)

'/,*)*,,,

$'.,''),,,

*)

$/),!!.,,,

'',%)),,,

*!

*$,/!*,,,

$./,)%%,,,

*!

%$-,!'%,,,

)',/.),,,

))

-*,/)),,,

%*),'-$,,,

))

'!#,%'%,,,

-!,-'%,,,

)!

/%,#'*,,,

'-#,.#),,,

)!

)!%,/$/,,,

.',%%#,,,

')

#!),'$%,,,

)$',.*.,,,

')

)'*,###,,,

#!$,.--,,,

'!

#$',)%$,,,

).%,/-),,,

'!

)/),#!$,,,

##$,)/#,,,

%)

#%',*!%,,,

)//,/##,,,

%)

*!#,$/#,,,

#!',.%.,,,

%!

#$),*%/,,,

))*,*/#,,,

%!

))),-!),,,

/),/*-,,,

$)

##$,/.),,,

'/!,*-%,,,

$)

'/#,'%$,,,

#!%,-*$,,,

$!

###,)*$,,,

'-/,!)!,,,

$!

'*#,.#*,,,

##-,#%!,,,

#)

##),%)/,,,

'/-,#)!,,,

#)

'**,%!*,,,

#$*,))/,,,

#!

#$%,$'*,,,

)!.,/*#,,,

#!

'.$,-%%,,,

#$/,#-!,,,

)

#$),!#/,,,

)!/,$%%,,,

)

'.),*)$,,,

##',---,,,

!

##$,!'/,,,

'--,'#%,,,

!

')%,#'-,,,

#!

 ,&"(
#,%)%,//-,,,



 ,&"(
#,).-,.!.,,,


  
  , ,, ,  0, , , , , ,

,  ,, ,
0   

 ,

Source of population
Modied Census and census estimates: NCI modication of
U.S.Census Bureau population estimates. See http://seer.cancer.
gov/popdata/
 


  
 ,  ,&$!!'(,, ,,

#!

#!

  ,&"(
-,$!),--/,,,

#!

  ,&"(


-,*$.,#'-,,,


  
  , ,, ,  0, , , , , ,

,  ,, ,
0   

 ,

Multiple primary rules used


 


  
 ,  ,&$!!'(,, ,,

IACR rules (2004) on historical data.

185

North America

USA, National Program of Cancer Registries


(NPCR)
Registry structure and methods
Registration area
The United States Centers for Disease Control and Prevention Participating cancer registries transmit data to CDC using a
(CDC) provides nancial and technical support to Public standardised record layout and coding system documented by
Health Departments (or their designees) for the operation the North American Association of Central Cancer Registries.
and maintenance of population-based cancer registries The data les are updated annually beginning with the diagnosis
in 45 states, the District of Columbia and 3 US territories year for which the cancer registry rst received federal support
(Palau, Puerto Rico, and Virgin Islands): 27 to collect data (e.g. 1995 or later). Reportable cases include all malignant and
for cases diagnosed beginning in 1995; 13 to collect data in situ neoplasm as dened in ICD-0, excepting most nonfor cases diagnosed beginning in 1996; 4 to collect data for melanoma skin cancers and in situ cervical cancer. Neither
cases diagnosed beginning in 1997; and the remaining 5 to the patients name nor the name of the reporting facility is
collect data for cases diagnosed either beginning in 1999 provided to CDC. Upon arrival at CDC, the data undergo
evaluation prior to publication
or 2000. The remaining 5
and use.
statesConnecticut, Hawaii,
Data included in this
Iowa, New Mexico, and
USA, NPCR (1998-2002)
report
are from statewide
Utahreceive federal support
USA, NPCR (1998-2002)
or metropolitan area cancer
from the National Cancer
registries that have high quality
Institutes (NCI) Surveillance
cancer incidence data for
Epidemiology and End Results
19982002 as demonstrated
(SEER) Program. In addition,










 







by meeting the following data


SEER supports metropolitan









quality criteria for all cancer


area cancer registries in the

 








 




 


sites combined:
states of California, Georgia,

 







Case ascertainment is
Michigan and Washington.


















90% or more complete. The


These metropolitan area









registry data include at least


registries
report
their


















90% of the expected cases


incidence data both to the


 



 


where the expected cases are


National Cancer Institute and






 











estimated by using methods


to the statewide NPCR-funded

 







developed by the North


cancer registries and, thus,


















American Association of
these data are included in the






 
 

Central Cancer Registries.


NPCR statewide database.

No more than 5% of
The NPCR programme covers






cases are ascertained solely
96% of the US population. In
 0+' ! 0+'on the basis of a death
2000, SEER began to provide (&10/.&0*,,000


 


certicate.
support for the operations of

  
#0  #00
0 30
 0 ! 0" 00)&&&0 0 0 $0 0

No more than 3% of
cancer registries in California, 0(00

0 ! 0"0 #0


00 0 0"  0 4  0 ! 0  0 !0 0 0!
 4  0   00 0)&&&0 0 0 $0
cases are missing information on sex.
Kentucky, Louisiana and New 
2%%$ $ $%

$0
Jersey. These four registries
 


  
 0  0+)&&,-00 .00
0
No more than 3% of cases are missing information on
report their incidence data to both
CDC and NCI.
age.
To be eligible for inclusion in this volume of Cancer in Five
Continents, NPCR-funded cancer registries had to consent No more than 5% of cases are missing information on
race.
and had to report data that met stringent criteria for incidence
reporting as established by CDC (see below). Incidence data At least 97% of the registrys records passed a set of
single-eld and inter-eld computerised edits.
from 31 cancer registries reported to CDC as of January 2005
(Alabama, Alaska, Arizona, California, Colorado, District of
Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kentucky, Use of the data
Louisiana, Maine, Massachusetts, Michigan, Missouri, CDC and NCI annually publish the United States Cancer
Montana, New Jersey, New York, Ohio, Oklahoma, Oregon, Statistics report, beginning with cases diagnosed in 1999
Pennsylvania, Rhode Island, South Carolina, Texas, Vermont, forward. These federal cancer statistics are also made available
Washington, West Virginia, Wisconsin), covering 83% of the to the public and cancer control planners through public use
U.S. population, met these criteria and are included. Each and restricted access data sets. In addition, several monographs
and reports on special topics have been published.
registry is featured separately in this report.

186

North America

USA, NPCR: BLACK (1998-2002)

USA, NPCR: WHITE (1998-2002)

USA, NPCR: BLACK (1998-2002)

USA, NPCR: WHITE (1998-2002)


 

 






 







 









 






 



 






 





























 







 
 
















 




 







































 




 




 

























 





























 







 



















 


 













 
 










































 















 
 













 0+'(*0,))0/,&000





 ! 0+'

 /+'




  
0(00

0 ! 0"0 #0 #0  #00
0 20
 0 ! 0" 00)&&&0 0 0 $0 0


00 0 0"  0 3  0 ! 0  0 !0 0 0!
 3  0   00 0)&&&0 0 0 $0

1%%$ $ $%

$0

 


  
Source
of population
 0  0+)&&,-00 .00
0
July 1 county population estimates by age, sex, race, and
Hispanic origin; postcensal estimates based on 2000 United
States Census. The population data include the bridged
singlerace estimates derived from the original multiplerace

1&/,)*/110///



 ! /+'






  
/(//

/ ! /"/ #/ #/  #//
/ 3/
 / ! /" //)&&&/ / / $/ /


// / /"  / 4  / ! /  / !/ / /!
 4  /   // /)&&&/ / / $/

2%%$ $ $%

$/

 


  
categories
in the 2000 United States Census. http://www.
 /  /+)&&,-// .//
/
seer.cancer.gov/popdata.

Multiple primary rules used


IACR rules (2004) on CI5 IX period.

187

North America

USA, Ohio
Registration area
Ohios cancer registry covers a population of over 11 000
000 residents. The state has large metropolitan areas of over
1 000 000 as well as rural areas. Manufacturing, agriculture,
and business are all important factors in Ohios economy and
play roles in the lifestyles of Ohioans.
Cancer care facilities
Ohio has two National Cancer Institute designated
Comprehensive Cancer Centers: Case Western Reserve
University in Cleveland and The Arthur G. James Cancer
Hospital in Columbus. The state has over 160 other hospitals,
most of which offer cancer treatment services.

surgery centres. Physicians ofces and pathology


laboratories also report data. The pathology laboratories are
seen as increasingly good sources of initial cancer data as
electronic means for them to report are developed.
Death certicates are available for the death clearance
procedures that are performed annually. The Bureau of Vital
Statistics, where the death certicates are housed, is a part of
the Department of Health, where the Registry is housed.
Automated editing processes are part of the database
software used by the Registry and of the Web-based
reporting system recently put into operation. Quality control
procedures are attended to on a daily basis by OCISS
registrars. Evaluation of data by two national organisations
each year also comprises part
of quality control.

Registry structure and


methods
USA, OHIO (1998-2002)
Use of the data
The registry, established by
USA, OHIO (1998-2002)
Reporting
of
incidence,
Ohio law in 1991, is in the
extent of disease, survival:
Ohio Department of Health
The registry produces an
and is funded by the US
annual report and posts data
Centers for Disease Control








 





in the Data Warehouse at the


and Preventions National




 


Ohio Department of Healths


Program of Cancer Registries







 




 

website. In addition, several


(NPCR) and by the State of







fact sheets are published


Ohio.
 
 


 






 


each year for different


Staff include 13 cancer







types of cancers. These are


registrars, four administrative














available on the registrys


staff, and two IT staff
 



 


website or in paper form.


members.







 



 


Data are also submitted to


Cancer
data
are







the National Program for


reportable by law for all





 





 


Cancer Registries and to the


who diagnose and/or treat
 






North American Association


cancer patients, including
for Central Cancer Registries,
pathology
laboratories.






both of which publish annual
Some data are submitted on
 0+' ! 0+'reports and post data to web
paper, but increasingly data




.0.(/01/*000

sites.
are submitted in electronic

  
#0  #00
0 30
 0 ! 0" 00)&&&0 0 0 $0 0
Research use: Registry
formats, either on diskettes or 0(00

0 ! 0"0 #0


00 0 0"  0 4  0 ! 0  0 !0 0 0!
 4  0   00 0)&&&0 0 0 $0

2%%$ $ $%

$0
via email in encrypted les. The
OCISS recently opened a data are accessed by researchers several times each year,
 


  
 0  0+)&&,-00 .00
0
Web-based system for reporting
and is enrolling the larger often including Institutional Review Board approvals for
reporting sources to use it at this time. This is the mode of condential data.
Planning and evaluation of heath services: Local health
reporting that the registry is promoting, as it automates much
departments use registry data to perform surveillance studies
of the processing of data as they are submitted.
Principal sources of information on cancer cases are the and to support funding efforts to provide screening and other
hospitals, free-standing radiation centres, and ambulatory cancer-related services.

188

North America

USA, OHIO:
BLACK (1998-2002)
USA, OHIO:
BLACK
(1998-2002)

USA, OHIO:
WHITE (1998-2002)
USA, OHIO:
WHITE
(1998-2002)
























 




 






















 













 










 


















































 


























 




 








 


























 




























 
































 


 














 0+'/,*0,*(000



 .*',





  
0(00

0 ! 0"0 #0 #0  #00
0 20
 0 ! 0" 00)&&&0 0 0 $0 0


00 0 0"  0 3  0 ! 0  0 !0 0 0!
 3  0   00 0)&&&0 0 0 $0

1%%$ $ $%

$0
 


  
 0  0+)&&,-00 .00
0





 ! 0+'-

Source of population
July 1 county population estimates by age, sex, race, and
Hispanic origin; postcensal estimates based on 2000 United
States Census. The population data include the bridged
singlerace estimates derived from the original multiplerace
categories in the 2000 United States Census.
http://www.seer.cancer.gov/popdata.

+./0+.&/+...



 ! .*',







  
.(..

. ! .". #. #.  #..
. 2.
 . ! ." ..)&&&. . . $. .


.. . ."  . 3  . ! .  . !. . .!
 3  .   .. .)&&&. . . $.

1%%$ $ $%

$.
 


  
 .  .*)&&+,.. -..
.

Multiple primary rules used


IACR rules (2004) on CI5 IX period.

189

North America

USA, Oklahoma
Registration area
The Oklahoma Central Cancer Registry covers the population
of 77 counties within the state of Oklahoma, in the central
United States. The population at the most recent census
(2000) was 3 450 654. About 65% of the population lives in
urban areas (>2 250 000 inhabitants).
Cancer care facilities
General health care in the state is provided predominantly by
private practitioners and hospitals. This includes 17 facilities
that have been designated as Approved Cancer Programs by
the American College of Surgeons Commission on Cancer.

Registrars within individual facilities involved in diagnosis and


treatment of cancers identify and abstract information on cases of
cancer, diagnosed by all methods, among residents of the state.
Interpreting the results
OCCR is obtaining 96% of the incident cancer cases in
Oklahoma each year, of which 2% are Death Certicate Only
cases. An additional 4% is believed to be diagnosed and/or
treated but not reported to OCCR, or may be attributable to
error in the method of estimating completeness.

Use of the data


OCCR publishes a quarterly report of Chronic Disease
Service Data Analysis, or an
article focussing on a specic
topic around cancer important
USA, OKLAHOMA (1998-2002)
for Oklahoma. Data are
USA, OKLAHOMA (1998-2002)
presented to interested groups,
including but not limited to
Comprehensive Cancer, Indian
Health Services, College








of Public Health, and the






Oklahoma State Legislature,










and OCCR has instituted and






maintains a queryable cancer










data website (http://www.






health.ok.gov/stats/cancer/).




Registry structure and


methods
The registry is located within
the Oklahoma State Department
of Health, and is funded partly
by the US Centers for Disease
Control and Preventions
National Program of Cancer

 




Registries (NPCR), and partly





by the state health department.








The registry is staffed by





a surveillance coordinator,






nine full-time registrars, an



 

administrative assistant and a












part-time epidemiologist.





 

Source of population
The
OCCR
utilizes














July 1 county population


automated data collection via







estimates by age, sex, race, and


electronic media to receive an














Hispanic origin; postcensal


average of 31 000 cancer reports







estimates based on 2000


per year from approximately
United States Census. The
230 active sources of data such






 /*',
 ! /*',
as cancer hospitals, general
population data include the




(/.0./+++///

hospitals, teaching hospitals,
bridged singlerace estimates
pathology
laboratories, 
  
derived from the original
#/  #//
/ 2/
 / ! /" //)&&&/ / / $/ /
freestanding oncology centres, /(//

/ ! /"/ #/
multiplerace categories in the


// / /"  / 3  / ! /  / !/ / /!
 3  /   // /)&&&/ / / $/

1%%$ $ $%

$/
mammography centres, ambulatory
surgery centres, Indian 2000 United States Census. http://www.seer.cancer.gov/popdata.
 


  
 /  /*)&&+,// -//
/
Health facilities, some dermatologists
and urologists ofces,
and the vital statistics ofce of the Oklahoma State Department Multiple primary rules used
of Health, along with data sharing with surrounding states. IACR rules (2004) on CI5 IX period.

190

North America

USA, Oregon
Registration area
The Oregon State Cancer Registry (OSCaR) is a populationbased registry covering the state of Oregon. Oregon, located
in the northwestern United States, is about 360 miles long and
261 miles wide. The population in the 2000 census was 3 421
399 and is estimated to have increased to 3 594 586 by 2004.
About 70% of the population lives in urban areas. The racial
make-up is approximately 87% White, 3% Asian, 1.6% Black
and 1.3% American Indian/Alaska Native (approximately
7% are some other race or two or more races).

of Oregons cancer cases are collected by certied tumour


registrars (CTR) in established hospital cancer registries
and are reported to OSCaR. The statewide populationbased cancer registry collects the remaining 25% from nonregistry hospitals, outpatient clinics, physician ofces, and
neighbouring state registries diagnosing or treating Oregon
residents. The annual process of death clearance identies
missed cases by comparing the Registry database with
Oregon death certicates. The majority of cases identied
through death clearance are subsequently reported by one of
the above-mentioned sources. Remaining cases are recorded
as death certicate only cases.

Cancer care facilities


Cancer care in the state is provided predominantly by
56 hospitals. Of these, 18
have American College of
Surgeons Commission on
USA, OREGON (1998-2002)
Cancer-approved
cancer
USA, OREGON (1998-2002)
programs. Additional services
are provided at ambulatory
surgery centres, freestanding
cancer treatment facilities,








physicians ofces and clinics




around the state.

 






















Interpreting the results


OSCaR consistently exceeds
the NPCR standard of
ascertaining 95% of expected
cases based on the North
American Association of
Central Cancer Registries case
completeness calculation.
Use of the data
The registry prepares an
annual report of cancer
incidence
and
mortality
highlighting cancer risks,
screening and trends. Other
cancer control programmes
use registry data for planning
and evaluation. The registry
also collaborates with local
and national researchers on
a variety of special studies
designed to reduce the burden
of cancer in Oregonians.








Registry structure and















methods







The registry is located within



 











the Health Promotion and









Chronic Disease Prevention
















section of the Oregon









Department of Human Services,
















along with the Oregon Breast








and Cervical Cancer Early


Detection Program and the






Oregon Comprehensive Cancer
 /+' ! /+'

 

(/0&)/1*(///

Control Program. Funding for
the registry comes through a 
  
#/  #//
/ 3/
 / ! /" //)&&&/ / / $/ /
Source of population
cooperative agreement with /(//

/ ! /"/ #/


// / /"  / 4  / ! /  / !/ / /!
 4  /   // /)&&&/ / / $/

2%%$ $ $%

$/
the US Centers for Disease Control
and
Preventions
National July 1 county population estimates by age, sex, race, and
 


  
 /  /+)&&,-// .//
/
Program of Cancer Registries (NPCR).
The program manager, Hispanic origin; postcensal estimates based on 2000 United
one ofce-support staff, ve certied cancer registrars and States Census. The population data include the bridged
singlerace estimates derived from the original multiplerace
three research analysts staff the registry.
Information processed by OSCaR comes from a variety of categories in the 2000 United States Census.
sources including: hospital cancer registries, state cancer http://www.seer.cancer.gov/popdata.
registries, ambulatory surgery centres, physician ofces, vital
statistics, pathology laboratories, hospital medical record Multiple primary rules used
departments and the US Census Bureau. Approximately 75% IACR rules (2004) on CI5 IX period.

191

North America

USA, Pennsylvania
Registration area
Principal sources of information on cancer cases include
The Pennsylvania Cancer Registry covers the population of the acute care hospitals, freestanding pathology laboratories,
entire state and has been collecting statewide cancer data since radiation therapy and cancer centres, physicians ofces, and
1985. In Pennsylvania, racial categories other than White made death certicates.
up 13.5% of the total population in 2004, compared to 11.5% in
Death certicate les (with personal identiers) are
1990, 9.6% in 1980, and 9.0% in 1970. Of the 1 674 223 residents used annually to conduct death clearance by linking to
other than White in 2004, 77.7% identied themselves as Black. update existing cancer cases with death information, and by
The number of Asian/Pacic Islanders in the state increased identifying cancer deaths not included in the registry.
Cancer is a reportable disease in Pennsylvania as
by 9.2% between 2000 and 2004, and by 77% between 1990
and 2004. The number of black residents increased by 6.3% mandated by the Pennsylvania Cancer Control, Prevention,
between 2000 and 2004, and by 19.4% between 1990 and and Research Act (Act 224) and Department of Health
2004. The number of Hispanics in Pennsylvania increased by Regulations regarding communicable and non-communicable
81 464 (20.7%) between 2000 and 2004. Between 1990 and diseases. According to Act 224, information collected by the
Cancer Registry is condential
2000, the number of Hispanic
but can be used for medical
residents increased by almost
research as approved by the
70%. Pennsylvania Hispanics
USA, PENNSYLVANIA (1998-2002)
PA Department of Health
tend to be much younger than
USA, PENNSYLVANIA (1998-2002)
Policy.
white, black or even Asian/
The PA Cancer Registry
Pacic Islander residents. The
uses national and local edits
2004 median age for Hispanics
metales to edit data to meet
was 24.9, compared to 31.7 for




 









national and local standards;


Asian/Pacic Islanders, 31.1 for







conducts casending and reBlacks, and 39.9 for Whites.






 









abstracting audits at reporting






 


hospitals; performs special


Cancer care facilities

 





 




 

studies to check data and


Cancer cases are reported







identify potential quality


by all acute care hospitals
 




 








issues used to improve data


in Pennsylvania. Interstate







and train staff; and requests


data exchange is conducted







 



 


feedback from data users to


regularly with all contiguous







improve data and increase


states as well as Florida and














usability of data.
Michigan. Other non-hospital
 
 





sources where patients are


Interpreting the results
diagnosed or treated for






There has been a shift in
cancer also report to the PA
 /+' ! /+'



./0*)/)&)///

diagnosis and treatment of
Cancer Registry, including
certain types of cancer from
freestanding
pathology 
  
#/  #//
/ 2/
 / ! /" //)&&&/ / / $/ /
inpatient to outpatient facilities.
laboratories, radiation therapy /(//

/ ! /"/ #/


// / /"  / 3  / ! /  / !/ / /!
 3  /   // /)&&&/ / / $/
The only recent change in case denition and coding is the
centres and physicians ofces. 
1%%$ $ $%

$/
 


  
 /  /+)&&,-// .//
/
addition of benign brain and CNS tumours to reportable
diagnoses effective in 2004. Pennsylvania participates in the
Registry structure and methods
The PA Cancer Registry operates in the Pennsylvania CDC Breast and Cervical cancer screening program.
In the 2004 Behavioral Risk Factor Surveillance System
Department of Health, and is funded by the state and the
US Centers for Disease Control and Preventions National (BRFSS) survey, 78% of Pennsylvania men aged 50 and
older said that they had ever had a prostate-specic antigen
Program of Cancer Registries (NPCR).
Fifteen staff work directly on PA Cancer Registry operations blood test to detect the presence of prostate cancer.
(8/15 are CTRs); two additional statistical support staff generate
cancer reports and statistics; 1 IT staff provides computer Use of the data
Incidence, extent of disease, and survival data are produced
support; 1.5 epidemiologists perform analysis of cancer data.
The PA Cancer Registry uses the CDC Registry Plus and made available on PA Department of Health website
cancer data system; uses active casending from all reporting at www.health.state.pa.us/stats. Cancer data are used for
sources and passive follow-up through death clearance. PA medical research studies as approved by the PA Department
Cancer Registry has received NAACCR Gold Certication of Health, and we receive numerous requests for hospitalspecic data, which is used to evaluate their services.
for approximately six years.

192

North America

USA, PENNSYLVANIA: BLACK (1998-2002)


USA, PENNSYLVANIA: BLACK (1998-2002)

USA, PENNSYLVANIA: WHITE (1998-2002)


USA, PENNSYLVANIA: WHITE (1998-2002)


 





 


 








 











 




 









 





































 


 






 




 











 































 







 







 


































































 









 
 



































 
 



 /*',
.&1/&(0///







 /*',

 ! /*',
 



  
/(//

/ ! /"/ #/ #/  #//
/ 3/
 / ! /" //)&&&/ / / $/ /


// / /"  / 4  / ! /  / !/ / /!
 4  /   // /)&&&/ / / $/

2%%$ $ $%

$/

Source
of population
 


  
 /  /*)&&+,// -//
/
July 1 county population estimates by age, sex, race, and
Hispanic origin; postcensal estimates based on 2000 United
States Census. The population data include the bridged
singlerace estimates derived from the original multiplerace

-/(1)/.+0///



 ! /*',







  
/(//

/ ! /"/ #/ #/  #//
/ 3/
 / ! /" //)&&&/ / / $/ /


// / /"  / 4  / ! /  / !/ / /!
 4  /   // /)&&&/ / / $/

2%%$ $ $%

$/

categories
in the 2000 United States Census. http://www.
 


  
 /  /*)&&+,// -//
/
seer.cancer.gov/popdata.
Multiple primary rules used
IACR rules (2004) on CI5 IX period.

193

North America

USA, Rhode Island


Registration area
The Rhode Island Cancer Registry, an administrative unit
of the Rhode Island Department of Health (RIDOH), covers
the population of the State of Rhode Island and Providence
Plantations in the Northeastern region of the United States.
The population at the most recent census (2000) was 1 048
000. About 85% of the population lives in urban areas;
roughly 10% are of recent immigrant status.

Registry is a member of the North American Association


of Central Cancer Registries (NAACCR), and conforms to
NAACCR standards for central registry operations, including
data reporting, editing and transmission.

Interpreting the results


Data from the Rhode Island Cancer Registry have consistently
met NAACCR quality control standards for inclusion in
national and international aggregates of cancer incidence.
Reporting completeness exceeds 95 %, with less than 3% of
Cancer care facilities
General health care in the region is provided by 10 privately cases being reported on the basis of death certicates only
funded acute care hospitals, one federally funded acute care (DCO). During the 1990s, Rhode Island experienced surges
(veterans) hospital, 25 community health centres (for primary in screening for cancers of the breast (clinical breast exam
and mammogram), cervix
care), and several hundred
(pelvic exam and Pap test),
private physician ofces (for
colon-rectum (faecal occult
primary and specialty care).
USA, RHODE ISLAND (1998-2002)
blood and endoscopy), and
All eleven hospitals provide
USA, RHODE ISLAND (1998-2002)
prostate (PSA), resulting in
cancer care; all have Cancer
increases in the incidence of
Care Committees. Nine of
cancers of the breast, cervix
the eleven acute care hospitals
and prostate, and a decrease
have American College of











in the incidence of cancer of


Surgeons-approved
cancer







the colon-rectum (because of


programs. In addition, the state













the removal of pre-cancerous


is served by two freestanding







lesions).
radiotherapy centres.














Rhode Island is a highly







 

urbanised state, best compared


Registry structure and

 












with highly urbanised areas


methods







such as cities. Historically,


The Rhode Island Cancer












 

Rhode Island has had an


Registry
(RICR)
is
a







urban cancer prole, with


population-based
cancer

 












higher incidence of cancers


registry established in 1985.







related to tobacco and alcohol


It began collecting reports
use, cancers related to diet,
of newly diagnosed cancers






and cancers of the female
on 1 October 1986. Under
 /*',
 ! /*',
breast and of the prostate.
Rhode Island law, all newly

 

-&+/.)0///

diagnosed cases of cancer

  
#/  #//
/ 2/
 / ! /" //)&&&/ / / $/ /
Use of the data
and of benign tumours of the /(//

/ ! /"/ #/


// / /"  / 3  / ! /  / !/ / /!
 3  /   // /)&&&/ / / $/

1%%$ $ $%

$/
brain and central nervous system
are
reportable
to
the Rhode The Registry produces ofcial cancer statistics for Rhode
 


  
 /  /*)&&+,// -//
/
Island Cancer Registry. The Registry
is funded by the State Island, including an annual report posted on the RIDOH
and by the US Centers for Disease Control and Preventions website, and also supplies cancer data to researchers (strict
National Program of Cancer Registries (NPCR). It is run guidelines are used to protect patient condentiality so
collaboratively by the Rhode Island Department of Health that individuals cannot be identied). Special studies are
(HEALTH) and the Hospital Association of Rhode Island performed regularly to support the planning and management
(HARI). There are 5 persons employed: a Registry Manager, of cancer control efforts in the state, and also to assist with
2 Registrars (CTR), a Data Manager and an epidemiologist. environmental health risk assessments.
The prole of the principal sources of information are as
follows: 8590% of case reports are received from 11 acute Source of population
care hospitals; ~10% of case reports are developed from July 1 county population estimates by age, sex, race, and
pathology reports; ~5% of case reports are developed from Hispanic origin; postcensal estimates based on 2000 United
States Census. The population data include the bridged
death certicates (12% death certicate only cases).
In Rhode Island, all cancer registries (including 11 hospital- singlerace estimates derived from the original multiplerace
based tumour registries and the central registry) conform to categories in the 2000 United States Census.
data collection standards adopted by the American College http://www.seer.cancer.gov/popdata.
of Surgeons (FORDS). Data are transmitted electronically
from hospital registries and other reporting sources to the Multiple primary rules used
central registry and vice versa. The Rhode Island Cancer IACR rules (2004) on CI5 IX period.

194

North America

USA, SEER
reporting system and for their epidemiologically signicant
Registration area
Participants in the Surveillance, Epidemiology, and End population subgroups.
The Program aims to determine the incidence and
Results (SEER) Program were selected on the basis of their
ability to operate and maintain a population-based cancer survival of cancer in selected geographical areas in relation
reporting system and for their population sub-groups, to demographic and social characteristics of the population
which were of special epidemiological interest. The SEER and to estimate annual cancer incidence for the US. Trends
Program now covers over one fourth of the United States in incidence by site and histology are monitored, as are
(US) population. Data are available back to at least 1975 survival and trends in survival. Studies are conducted to
from the SEER 9 areas (States of Connecticut, Iowa, New identify etiological factors that can possibly reveal groups
Mexico, and Utah and metropolitan areas San Francisco- of the population at high or low cancer risk, which may be
Oakland (California), Detroit (Michigan), Seattle-Puget dened by social, occupational, environmental, dietary or
Sound (Washington), and Atlanta (Georgia)), which represent other characteristics. Geographical information systems are
about 10% of the total US population. The SEER 14 areas developed for use with SEER and other population-based
central cancer registries in
(States of Connecticut, Iowa,
the USA through linkage with
New Mexico, Utah, Kentucky,
small area demographic census
New Jersey, and Louisiana
USA, SEER (9 registries) (1998-2002)
data and national surveys on
and
metropolitan
areas
USA, SEER (9 registries) (1998-2002)
health behaviours, risk factors
Greater
California
(San
and environmental exposures
Francisco-Oakland and San
for use in cancer control and
Jose-Monterey) (California),
surveillance research.
Los Angeles (California),
$$0-"*$--/*,
%./-$(0--$.%-0.&--/"
%/(-&"&--Greater California (California
Data for publication are
%.%-%./--.*
&/+-""$--excluding
SF/SJM/LA),
transmitted by the participants
&&.-$0+--."
(%.-++%--&/"-%$&--+*
((&-*+%--Detroit (Michigan), Seattleto NCI 22 months after the end of
(+(-"$$--+"
*"(-0$"--Puget Sound (Washington),
each calendar year. All malignant
+%*-""(--**
+**-%0"--/&0-*%0--*"
/.&-.*.--and Atlanta plus Rural
and in situ neoplasms as dened
0.$-%$"--(*
000-+/*--Georgia (Georgia)) cover
in ICD-O are collected except
$-"/*-*&&--("
$-"0/-.&(--$-$"$-%$.--&*
$-"0*-...--26.1% of the US population.
for basal and squamous skin
$-"((-0**--&"
$-"%%-(/+--The data are considered
cancers since 1973, in situ and
0+/-$*"--%*
0(%-0"$--0$(-*+"--%"
/.0-+(0--fairly representative of the
CIN III of the cervix uteri since
0*/-+0.--$*
0"+-+&*--US population with respect
1996, and PIN III since 2001.
0/.-*.$--$"
0("-.$%--0/0-".*--*
0(%-$&+--to selected demographic
SEER registries must collect
0(.-.%.--"
0"&-/(/--variables. With regard to
information about extent of
race, rural blacks are underdisease, rst course of therapy,
$"
*
"
"
*
$"
represented, whereas other
and follow-up. Neither the
 -'#)
  -'#)
minority populations such as
patients name nor the name of
$&-*/+-$0.--$&-$./-0(0--
Chinese, Japanese, Hawaiians
the hospital is provided to NCI.

  
and American Indians are -$--

-  -- - -  --
-  1-
 -  - --%"""- - - !The
SEER
Program
 


  
over-represented. Over 350 000
new cases of in situ and conducts studies to evaluate quality and completeness of
 -  -'%""()-- *--
invasive cancers are added each year to the SEER database. data, and provides specialist training for personnel.
In addition to contributing to SEER, many of the SEER areas
report data separately for their own registry in this volume.
Use of the data
Updated annually and provided as a public service in print
Registry structure and methods
and electronic formats, SEER data are used by thousands
The SEER Program is a continuing project of the Surveillance of researchers, clinicians, public health ofcials, legislators,
Research Program of the US National Cancer Institute policymakers, community groups, and the public. Each year
(NCI). The Program was initiated in 1973 as an outgrowth since 1985, the NCI has published a SEER Annual Cancer
of the End Results Program and the three National Cancer Statistics Review (www.seer.cancer.gov/publications), which
Surveys and The National Cancer Act of 1971, which comprises principally SEER cancer incidence and survival
mandated the collection, analysis and dissemination of data data, and cancer mortality data from the National Center for
useful in the prevention, diagnosis and treatment of cancer. Health Statistics. In addition, data are made available on the
The participating regions were selected principally for their SEER home page (www.seer.cancer.gov) and via SEER*Stat
ability to operate and maintain a population-based cancer software on a client-server and CD-ROM.

195

North America

USA, SEER (9 registries): BLACK (1998-2002)


USA, SEER (9 registries): BLACK (1998-2002)

USA, SEER (9 registries): WHITE (1998-2002)

+-+$0---

/*,

$.-%&"---

$"$-+.0---

/*,

%((-%00---

0-/&/---

/"

$/-*+/---

$(/-*&"---

/"

%(*-%"%---

$.-(.*---

.*

%/-"*$---

%%0-*+*---

.*

&%(-.*0---

."

&(-$"*---

%/$-0&0---

."

&(0-+*(---

+*

&*(-0$.---

%&-$%(--%0-00%---

+*

("-$..---

&$%-*&0---

&/-(**---

+"

(.-..+---

&.0-*(&---

+"

("&-$&(---

*&-($%---

**

+&-&("---

*$&-*((---

**

*%+-$*(---

./-/"(---

*"

0%-0(%---

+./-*/0---

*"

+//-.%/---

0/-.*(---

(*

$$*-"0.---

..*-/""---

(*

..+-$*/---

$$/-$"$---

("

$&(-%%0---

/*+-&/$---

("

/((-$+&---

$%.-*0&---

&*

$((-$*&---

/*&-*$0---

&*

/%(-&*&---

$%0-$"(---

&"

$((-%+&---

.0&-/*/---

&"

.(0-&+0---

$%%-&/$---

%*

$&/-"+(---

.%(-*"/---

%*

+./-.$.---

$$+-00"---

%"

$%&-*""---

+/+-/.(---

%"

+(+-.*"---

$%.-0/(---

$*

$%*-".0---

.$0-.".---

$*

+.*-+0/---

$(/-$&"---

$"

$(&-0(/---

.%+-.$+---

$"

+/0-""*---

$*.-(&%---

$*%-0(*---

.$/-.%/---

+/$-*%"---

$(%-$%*---

"

$&+-*..---

+0*-0$(---

"

++%-$$(---

$"

"

"

 -'#)

$"

$"

"

"

 -'#)

  -'#)

$-*(+-&$&---

$-.""-"(&---



$"

  -'#)

$"-$0.-0&(---

$"-&+(-+0%---




  
-$--

-  -- - -  --
-  1-
 -  - --%"""- - - !-


  
-$--

-  -- - -  --
-  1-
 -  - --%"""- - - !-

 


  
 -  -'%""()-- *--
-

 


  
 -  -'%""()-- *--
-

USA, SEER (14 registries) (1998-2002)

USA, SEER (14 registries): BLACK (1998-2002)


USA, SEER (14 registries): BLACK (1998-2002)

USA, SEER (14 registries) (1998-2002)

&$"-+0"---

/*,

.$(-(00---

$/-.0&---

/*,

(/-$/$---

(+"-/(+---

/"

.*%-0*&---

%+-(0%---

/"

*"-&%0---

.&*-(."---

.*

$-"(+-0+"---

(.-%$.---

.*

.*-&&0---

0%+-&&.---

."

$-$..-+%%---

+(-0+.---

."

0(-""+---

$-"*+-(*"---

+*

$-%&+-$$$---

/+-/("---

+*

$$&-+$&---

$-%.&-("*---

+"

$-&00-"(%---

$$"-$+*---

+"

$&+-%0*---

$-+.*-%/+---

**

$-...-&"+---

$(%-%$&---

**

$."-+//---

%-%&*-/+0---

*"

%-&&%-0".---

%"$-$"&---

*"

%&+-$.0---

%-+"/-.(%---

(*

%-+/(-"+*---

%*&-.0%---

(*

%0$-$+&---

%-0+0-%"%---

("

%-00$-.*/---

&"/-"0$---

("

&(%-&/%---

&-"*.-$*&---

&*

&-"%*-("*---

&&"-$.+---

&*

&+(-"/&---

%-0".-&%"---

&"

%-/%*-/0.---

&%"-&+&---

&"

&(0-%/"---

%-+0+-(+&---

%*

%-*0$-(*$---

&"$-"*$---

%*

&%+-%**---

%-+$%-".%---

%"

%-(*%-&$+---

&$&-*%&---

%"

&%$-""&---

%-.&.-*0"---

$*

%-*.%-**&---

&**-*&&---

$*

&((-%+$---

%-/&*-/0%---

$"

%-.""-$./---

&0$-./+---

$"

&.0-/$&---

%-//0-&.+---

%-.*"-00&---

(".-$$*---

&0&-$&(---

%-.$.-$0/---

"

%-*0&-.%$---

&+.-"$$---

"

&*(-"."---

$"

"

"

 -'#)

$"

$"

&.-+%*-.&/---



"

"

 -'#)

  -'#)

&+-."*-&+"---

$"

  -'#)

(-"(+-%&$---

(-&0"-".(---




  
-$--

-  -- - -  --
-  1-
 -  - --%"""- - - !-


  
-$--

-  -- - -  --
-  1-
 -  - --%"""- - - !-

 


  
 -  -'%""()-- *--
-

 


  
 -  -'%""()-- *--
-

USA, SEER (14 registries): ASIAN AND


PACIFIC ISLANDER (1998-2002)

USA, SEER (14 registries): ASIAN AND PACIFIC ISLANDER (1998-2002)

USA, SEER (14 registries): HISPANIC WHITE


(1998-2002)
USA, SEER (14 registries): HISPANIC WHITE (1998-2002)

%"-$.*---

/*,

&"-$&"---

$.-0(&---

/*,

&*-0((---

%0-&%&---

/"

("-*&%---

%*-&/.---

/"

("-0("---

*$-"$.---

.*

+.-+"%---

(0-&*/---

.*

+.-(&&---

."

0$-(/(---

.&-//.---

."

0+-0($---

/$-+//---

+*

$"*-/+$---

0+-%"&---

+*

$$/-(/(---

$"%-/&(---

+"

$$0-&"*---

$%+-"+$---

+"

$(*-$/$---

$&"-*$.---

**

$(+-0+&---

$+0-*"%---

**

$/.-$.%---

$/(-(//---

*"

%"/-.(0---

%(+-*..---

*"

%*/-.&*---

%%$-0/*---

(*

%*$-+/(---

&&.-$+(---

(*

&&/-(%&---

%*%-((/---

("

%./-*&.---

(**-%."---

("

(&*-"$+---

%."-/%&---

&*

%/0-%0"---

*."-0"0---

&*

*$/-%00---

%.(-&(*---

&"

%0*-$&0---

++"-&"+---

&"

*.$-00+---

%."-/((---

%*

%/+-+$%---

+0*-+($---

%*

*0"-"(/---

%(&-+&"---

%"

%($-(.*---

+/(-*&(---

%"

*+/-++.---

%((-*$*---

$*

%&$-/$&---

+$0-*&"---

$*

**/-$&+---

%(%-.&"---

$"

%%/-(/0---

+&&-..(---

$"

+"*-+++---

%($-$."---

%%/-(0(---

.%*-&("---

+0(-"*&---

%&$-/&"---

"

%%"-+%(---

.%.-/&*---

"

+0.-"++---

$"

"

"

 -'#)
&-$+$-.0*---

196

USA, SEER (9 registries): WHITE (1998-2002)

$"

$"

  -'#)


"

"

 -'#)
&-&+%-./&---

+-0$*-%$0---

+/-*"/---

$"

  -'#)


+-*%0-%.(---


  
-$--

-  -- - -  --
-  1-
 -  - --%"""- - - !-


  
-$--

-  -- - -  --
-  1-
 -  - --%"""- - - !-

 


  
 -  -'%""()-- *--
-

 


  
 -  -'%""()-- *--
-

North America

USA, SEER (14 registries): NON-HISPANIC WHITE


(1998-2002)
USA, SEER (14 registries): NON-HISPANIC WHITE (1998-2002)

%*%-$0+---

/*,

*0.-$./---

&..-(($---

/"

+$.-../---

*/&-0&0---

.*

/&"-"$(---

.$&-/.(---

."

//.-+%*---

./&-%00---

+*
+"

0/*-%&&---

**

$-%*(-**.---

$-*/"-"0$---

*"

$-+"(-"0%---

$-.+*-///---

(*

$-..$-$".---

$-0$.-%&(---

("

$-/0/-$**---

$-/(*-.%+---

&*

$-/$(-%"+---

$-+$&-..*---

&"

$-*.%-(*$---

$-&0"-("%---

%*

$-&*%-/$&---

$-&%/-.%&---

%"

$-%/%-00+---

$-(."-.(.---

$*

$-&0&-$$0---

$-*$.-*"+---

$"

$-(++-"(/---

$-&/.-"%(---

$-&(/-&$.---

"

$-%/$-+&&---

"

%%-"0(-$&$---

$-(&.-$&%---

"

 -'#)

Multiple primary rules used


IACR rules (2004) on CI5 IX period.

///-%&0---

0%%-(*(--$-%$+-(.%---

$"

Source of population
July 1 county population estimates by age, sex, race, and
Hispanic origin; postcensal estimates based on 2000 United
States Census.

$"

  -'#)


%%-/**-&*%---


  
-$--

-  -- - -  --
-  1-
 -  - --%"""- - - ! 


  
 -  -'%""()-- *--
-

197

North America

USA, South Carolina


Registration area
The South Carolina Central Cancer Registry covers the entire
state. The state is 60.5% urban and 39.5% rural, comprised
racially of 31% African
American, 68% Caucasian,
and 1% Other Races.
Cancer care facilities
Health care is provided in SC
by 65 acute care hospitals,
~35 freestanding surgical and
oncology treatment centres, and
private oncology practices.








 





 

and physician identiers are reported via state statute and


protected by this law.
Quality control procedures include visual review of
patient abstracted data along
with computerised interrecord, intra-record edits.
USA, SOUTH CAROLINA (1998-2002)
Routine casending and
USA, SOUTH CAROLINA (1998-2002)
quality audits are performed
at reporting facilities. Once
every ve years, the SCCCR
undergoes a national data




completeness and quality




 





audit. Results of most




 

recent national audit: 97%










completeness, 98% accuracy.










The SCCCR has attained






Gold
Certication for 6 years, and








Silver for 2 from the NAACCR





certication process since 1997.







 

Registry structure and








methods


The SCCCR is located at the








SC Department of Health and





Environmental Control, funded



 






 

by the US Centers for Disease









Use of the data


Control and Preventions National

 












The data are used to report


Program of Cancer Registries







ofcial
annual
cancer
(NPCR) and state funds.
incidence, extent of disease
The SCCCR is comprised






and survival for the state.
of 17 staff, including the
 .*',
 ! .*',
An annual Cancer Report
Director, 10 CTRs who




(./-&.()-...

Card is produced as well as
perform data coordination and
.(..

. ! .". #. #.  #..
. 1.
 . ! ." ..)&&&. . . $. .
County Cancer Fact Sheets.
quality control, 4 Masters- 
  


.. . ."  . 2  . ! .  . !. . .!
 2  .   .. .)&&&. . . $.

0%%$ $ $%

$.
level research analysts, database
manager and statistician, Assessments of community cancer concerns (potential
 


  
cancer clusters) are carried out with the data.
and administrative coordinator. .  .*)&&+,.. -..
.
The data are available through the on-line query system,
The majority of data collection (85%) comes from
pre-coded data from hospital registries. The remainder is called SC Community Assessment Network (SCAN).
actively sought by staff from small hospitals, pathology labs, Researchers and the public can create their own query by
accessing the cancer module on SCAN. Maps, trend graphs,
freestanding treatment centres and physicians.
The hospital medical record is the principal source of bar charts and tables are provided.
The data are used for research as prescribed by the
information on cancer cases. Secondly, pathology reports
from reference labs are a contributing source of information. protocol for data release and approval by the advisory
Access to death certicates (with personal identiers) is committee. Data are used by multiple university researchers
as well as SC medical schools, by state cancer control
provided by the SC Div of Vital Registry.
Cancer reporting is mandated in SC by the state statute planners and evaluators, the statewide Cancer Alliance, and
SC Code Section 44-35-10-60. Condential patient, hospital the American Cancer Society.

USA,
SOUTH CAROLINA: BLACK
(1998-2002)
USA, SOUTH
CAROLINA:
BLACK
(1998-2002)





 





 









































 




















 


 







 

























 







 















 


















 




















 























 







 






















 







 











































 /*',
-.-/-0&///

198

SOUTH CAROLINA: WHITE


(1998-2002)
USA, SOUTHUSA,CAROLINA:
WHITE
(1998-2002)





 ! /*',


 0+'


(0*./01,*000



 ! 0+'


 



  
/(//

/ ! /"/ #/ #/  #//
/ 2/
 / ! /" //)&&&/ / / $/ /


// / /"  / 3  / ! /  / !/ / /!
 3  /   // /)&&&/ / / $/

1%%$ $ $%

$/


  
0(00

0 ! 0"0 #0 #0  #00
0 30
 0 ! 0" 00)&&&0 0 0 $0 0


00 0 0"  0 4  0 ! 0  0 !0 0 0!
 4  0   00 0)&&&0 0 0 $0

2%%$ $ $%

$0

 


  
 /  /*)&&+,// -//
/

 


  
 0  0+)&&,-00 .00
0

North America

Source of population
July 1 county population estimates by age, sex, race, and
Hispanic origin; postcensal estimates based on 2000 United
States Census. The population data include the bridged
singlerace estimates derived from the original multiplerace

categories in the 2000 United States Census. http://www.


seer.cancer.gov/popdata.
Multiple primary rules used
IACR rules (2004) on CI5 IX period.

199

North America

USA, Texas
Registration area
The Texas Cancer Registry (TCR) covers the statewide
population of Texas, in the south central United States of
America. The estimated mid-year 2000 population census
was 20 851 820. Although 86% of the population lives in
urban counties, these represent only 30.3% of all Texas
counties. The 2000 Texas population also shows considerable
race/ethnic diversity with 53.1% being non-Hispanic White,
32.0% Hispanic (of any race), 11.6% Black and 3.3% Other
Races.

agreements with other states to obtain data on Texas residents


diagnosed and/or treated out-of-state.

Interpreting the results


We estimate the completeness of our cancer data by
predicting the number of cases to be expected each year,
based on standard age-, sex-, and race/ethnic-specic rates
from another state registry with a similar population to
the Texas population. Based on these estimates, we do not
produce a nal dataset for any given year until the estimated
completeness of the data is at least 95%. The average
completeness of the entire 19982002 dataset is 96.3%.
Cancer care facilities
Cancer care in Texas may be provided by a wide variety of
The population of Texas is unusual in that there is a large
facilities, from large medical
proportion of the total statewide
centres specialising in cancer
population made up of Hispanics.
treatment to community
For most major cancer types,
USA, TEXAS (1998-2002)
hospitals. The M.D. Anderson
incidence rates in Hispanics are
USA, TEXAS (1998-2002)
Cancer Center in Houston,
lower than for many other race/
Texas is a leader with a
ethnic groups, leading to generally
worldwide reputation in cancer
lower (overall) incidence rates in
care, as well as research,
Texas than in surrounding states.




 






 


education and prevention.


For this reason, Texas rates are
 
 





Numerous other researchalso reported by race/ethnicity.









 






based University medical


The goal of the DSHS




 


centres and American College


Breast and Cervical Cancer












 

of
Surgeons
Accredited
Control Program is to reduce







Cancer Programs are found in


mortality from breast and














the state, and provide state-ofcervical cancer in Texas. This









the-art cancer diagnosis and


program provides free breast














treatment.
and cervical cancer screening







and diagnostic services to



 












Registry structure and


low-income women with no





 

methods
health insurance at over 200
The TCR is part of the Texas
sites throughout Texas. Since






 /+' ! /+'Department of State Health
1991, more than 190 000




(&/,&(/0*.///

Services (DSHS), and also
women in Texas have received
receives federal funding from 
  
early cancer detection services
#/  #//
/ 2/
 / ! /" //)&&&/ / / $/ /
the US Centers for Disease /(//

/ ! /"/ #/
through this program.


// / /"  / 3  / ! /  / !/ / /!
 3  /   // /)&&&/ / / $/

1%%$ $ $%

$/
Control and Prevention, National
Program of Central Cancer
According to the DSHS Texas Behavioral Risk Factor
 


  
Registries (NPCR). The TCR is /  /+)&&,-// .//
/
staffed by 46 full-time state Surveillance System, in 2002, 70% of Texas men 50 years
staff and 10 contract staff.
and older had a PSA test within the past ve years. NonOur cancer data are reported to the TCR primarily by Hispanic white men and men 65 and older had higher PSA
hospitals, but also by cancer treatment centres, pathology prevalence rates, while Hispanic males and those with less
labs and medical practitioners.
than a high school education have lower PSA rates.
Cancer case reporting in Texas is required by state law
(Chapter 82, Health and Safety Code), and the TCR has Use of the data
specic cancer reporting rules. Cancer death reporting The registry produces an annual report of cancer incidence
is through the Texas DSHS, Vital Statistics Unit. Cancer and mortality, examining race/ethnic differences, trends,
case reporting is done electronically for approximately and other patterns in statewide cancer data, and maintains
98% of cases, and 0% of deaths. All personal identifying tables of average annual rates, published on our website.
data are considered condential, and are used internally These data are provided statewide, by sex and race/ethnicity,
by TCR staff for registry operations and approved research and by various geographical areas including counties. Also
purposes. Condential data may only be released with DSHS provided are childhood cancer incidence and mortality rates,
Institutional Review Board approval.
as well as estimated cases and deaths for future years at the
Texas Cancer Registry staff work with the cancer statewide, regional and county levels. Data are also provided
reporters to provide training in case reporting as needed, to external customers upon request, and have resulted
and technical assistance to identify and abstract information in numerous specialised studies of cancer incidence and
on cancer cases. In addition, the TCR has data exchange mortality, as well as health services studies.

200

North America

USA, TEXAS: BLACK (1998-2002)

USA, TEXAS: WHITE (1998-2002)

USA, TEXAS: BLACK (1998-2002)

USA, TEXAS: WHITE (1998-2002)








 










































 


 







































 







 




































 






 




















 


























 















 































 









































 .*',
(.)&-.&)+...





 /*',




  
.(..

. ! .". #. #.  #..
. 0.
 . ! ." ..)&&&. . . $. .


.. . ."  . 1  . ! .  . !. . .!
 1  .   .. .)&&&. . . $.

/%%$ $ $%

$.
 


  
 .  .*)&&+,.. -..
.



 ! .*',

Source of population
July 1 county population estimates by age, sex, race, and
Hispanic origin; postcensal estimates based on 2000 United
States Census. The population data include the bridged
singlerace estimates derived from the original multiplerace

1/1&./002///



 ! /*',







  
/(//

/ ! /"/ #/ #/  #//
/ 4/
 / ! /" //)&&&/ / / $/ /


// / /"  / 5  / ! /  / !/ / /!
 5  /   // /)&&&/ / / $/

3%%$ $ $%

$/
 


  
 /  /*)&&+,// -//
/

categories in the 2000 United States Census. http://www.


seer.cancer.gov/popdata.
Multiple primary rules used
IACR rules (2004) on CI5 IX period.

201

North America

USA, Utah
pathology reporting and plans to receive some 90% of
Registration area
The State of Utah covers 299 888 km2 and is geographically pathology reports electronically within the next 5 years.
Both hospital-based registrars and central registry
the 11th largest US state. There were 2 233 169 residents in
Utah at the time of the decennial census conducted in 2000. personnel conduct active and passive follow-up of cancer
Approximately 89% of Utah residents are white, and 9% patients. For example, registry records are routinely linked
are of Hispanic origin (any race). The remaining population with administrative databases, including those maintained
comprises American Indians (1.3%), Asians (1.7%), Pacic by the Centers for Medicare/Medicaid Services and the Utah
Islanders (0.7%), blacks (0.8%), and individuals of other Department of Public Safetys Driver License Division, and
local voter registration les. UCR routinely queries vital
racial/ethnic backgrounds (4.2%).
Utahs 2000 birth rate of 21.1/1000 was approximately records from the Utah Department of Health for information
47% higher than the national average of 14.4/1000. As a about cancer patients who may have died. In rare instances,
result, the median age of Utah residents was 27.1 years, fully death certicates may provide information about cancer
cases that were not identied through other sources.
8 years younger than the national gure of 35.3 years.
Cancer data are abstracted
Approximately 70% of
and coded by both hospitalUtah residents are members of
based registrars and central
the Church of Jesus Christ of
USA, UTAH (1998-2002)
registry personnel. HospitalLatter-day Saints (LDS), whose
USA, UTAH (1998-2002)
based
registrars
submit
doctrine places a high value
abstracts
and
pathology
on marriage and encourages
reports to UCR, allowing
large families (hence, high
central registry staff to
fertility rates). The church also














monitor the quality of data


discourages consumption of







and process difcult-to-code


tobacco, alcohol and caffeine,














items such as extent of disease


and proscribes premarital sex,





 

and site-specic treatment. All


profoundly inuencing cancer

 






 





electronic records are subjected


incidence and mortality rates







to various automated edits


in Utah.














developed by SEER and other



 





professional
organizations.
Cancer care facilities













UCR
also
participates
in
Forty-ve health care facilities







SEER-sponsored
quality
in Utah routinely provide









 

control projects.
cancer-related services to







state residents. Seven of


Interpreting the results
Utahs largest facilities have






With respect to the 1998
ACoS accredited cancer
&%71-3
(&%71-3




2002 data, the UCR has


.7./07808777
 &%
care programmes. Fourteen
had consistent coverage,
hospitals in Utah support one   

%%&*7 
( % *7&
7
7%7137 &(71$$$++&+ 375&7&&)&:7 %& 7;7 &%7"++7
geographically
and
or more cancer registrars on 
1.969;/,,037;7!
7 7 7)7;7 &%7"++*7.969;/,,07 *7 & &%7 &7*7 *7 %%&7&7
 &(*7 &7&7&*7%&
7#&&7/,,6+7
their staff, including each of the
AcoS-accredited facilities. demographically. UCR, along with other registries in the
      
 7%71/,,237 7 477 
7
Six Utah hospitals have radiation
therapy units; there are 2 SEER Program, changed topograhy and morphology coding
  
227
7 7%
7)&&%7%%7 7&( 7%%7& (&7' 7 7!7 7&+7
rules from ICD-O-1 to ICD-O-2 for cases diagnosed from
freestanding radiation therapy units
in the state.
19982000 and 20012002, respectively. However, these
changes in coding rules will not have an effect on the 1998
Registry structure and methods
The Utah Cancer Registry (UCR) has operated since 1966 2002 statistics, as 19982000 cases were retrospectively
on a population-based, statewide level. In 1973, UCR coded using ICD-O-2.
According to data from the Utah Behavioral Risk Factor
became one of the original members of the National Cancer
Institutes Surveillance, Epidemiology, and End Results Surveillance System (BRFSS), as many as 64% (95%CI
(SEER) Program. UCR has continuously participated in the 6168%) of men aged 40+ surveyed in 2002 reported a PSA
test within the last ve years. Therefore, PSA is relatively
SEER program since that time.
UCR is staffed by 20 employees, including 5 administrative common in the Utah population.
personnel, 1 research coordinator, 2 supervisors, 3 coders, 4
eld pathology and hospital abstractors, 1 follow-up coordinator, Use of the data
UCR data are combined with those from other SEER Program
3 IT and data support staff, and 1 data entry/le clerk.
Cancer cases are identied and followed using participants to monitor cancer trends in the USA. UCR data
information from hospitals, pathology laboratories, radiation are also well utilised by independent investigators and the
treatment centres, physician ofces, nursing homes, vital Utah Department of Health for studies of cancer etiology,
records, other central cancer registries, and by direct patient prevention and control. By combining UCR records with
contact. Cancer reporting in Utah is mandated by legislation genealogy les and other sources, researchers have made
notable contributions in the eld of cancer genetics. The
and regulatory rule.
Central registry personnel annually travel to outlying registry maintains a web page (http://ucr.utah.edu), publishes
areas to identify and abstract cases in the smaller rural trends in incidence and mortality annually, and responds to
hospitals. The UCR is now advancing toward electronic ad hoc requests for cancer-related data.

202

North America

Source of population
Surveillance, Epidemiology, and End Results (SEER) Program
(www.seer.cancer.gov) SEER*Stat Database: Populations Total U.S.
(19692003) Linked To County Attributes Total U.S., 19692003
Counties, National Cancer Institute, DCCPS, Surveillance Research
Program, Cancer Statistics Branch, released January 2006.

Multiple primary rules used


IACR rules (2004) on CI5 IX period .
Notes on the data
C44 does not include basal cell or squamous cell carcinoma
except for skin of anus.

203

North America

USA, Vermont
Registration area
The Vermont Cancer Registry (VCR) covers the population
of the State of Vermont. The population at the most recent
census (2000) was 608 827. About 38% of the population
lives in urban areas (areas designated by the U.S. Census
Bureau as Urbanized Areas and/or Urban Clusters); 97% are
white, the remainder other races.

Interpreting the results


VCR data are estimated to be at least 95% complete, 24
months after the close of the diagnosis year.
Ladies First is a health screening program for Vermont
women. Ladies First removes nancial barriers, which
prevents many women from being screened for breast and
cervical cancer.

Use of the data


Cancer care facilities
General health care in the region is provided predominantly VCR prepares an annual report of cancer incidence,
by 15 hospitals, including a Veterans Affairs Medical Center. highlighting trends and changes. Site-specic reports are
This is supplemented by private practitioners and one outpatient also published. Because active follow-up is not conducted,
radiation therapy facility. The Vermont Cancer Center (VCC) is survival analyses have not been possible.
The registry is currently
an NCI-designated facility for
involved in the NCI-sponsored
Phase I, II and III therapeutic
New England Study of
clinical trials. VCC and Fletcher
USA, VERMONT (1998-2002)
Environment and Health,
Allen Health Care (FAHC) are
USA, VERMONT (1998-2002)
which is investigating the
located in Burlington, the largest
possible causes of elevated
city in Vermont, and provide
bladder cancer incidence
radiotherapy, cancer surgery and
and mortality in the states of
chemotherapy services. Patients














Maine, New Hampshire and


suspected to have cancer in the







Vermont.
primary and secondary care














VCR data are used for


facilities in the registry area







planning and evaluation of


are mostly referred to VCC,








 





cancer control objectives e.g.


FAHC, Dartmouth Hitchcock







comprehensive cancer control,


Medical Center in neighbouring














detailed incidence/mortality
New Hampshire, one of the





 

statistics,
health
event
hospitals with comprehensive














investigations
and
program
cancer services in the state,







evaluation.
or occasionally to one of the













For Needs Assessment/


hospitals in Boston, MA or







Program Planning: VCR


Albany, NY.
completed a project using






 .*',
 ! .*',
GIS to identify opportunities
Registry structure and

 

)10.-&/...

for breast cancer screening of
methods
income-eligible women. The
The registry is located within 
  
#.  #..
. 3.
 . ! ." ..)&&&. . . $. .
purpose of the project was
the Vermont Department of .(..

. ! .". #.


.. . ."  . 4  . ! .  . !. . .!
 4  .   .. .)&&&. . . $.
Health and is funded by the US
2%%$ $ $%

$.
Centers for Disease Control to identify areas where the Ladies First breast and cervical
 


  
 .  .*)&&+,.. -..
.
and Preventions National Program
of Cancer Registries program services are less utilised and enrolment could be
(NPCR) and in-kind support from reporting hospitals. The increased, particularly for women ages 4064 who meet
registry is staffed by a full-time director, a cancer data eligibility requirements, by examining the current enrolment
specialist, a certied cancer registrar and an epidemiologist. of Ladies First clients, the distribution of providers and
The VCR uses active case nding from 13 non-federal facilities providing services, screening patterns and stage
hospital cancer registries, one out-of-state reference distribution of breast cancers to determine if there were any
pathology laboratory, one radiation therapy centre, 5 parallels with areas of lower membership.
The VCR has started routinely evaluating late stage
dermatologists, 8 urologists, 1 VA hospital, and a small
number of other physicians. The cancer registry is linked diagnosis of certain cancers (colon, breast, cervical) as a
with the VT death le annually. Non-matches are followed measure of the effectiveness of cancer screening efforts.
back to identify cases potentially unreported to VCR. These
cases identied by death certicates are followed back with Source of population
hospitals and physicians to either rule out reportability or July 1 county population estimates by age, sex, race, and
be reported to VCR. Records that cannot be followed back Hispanic origin; postcensal estimates based on 2000 United
to source records are accessioned as death-certicate-only States Census. The population data include the bridged
cases. Cancer is required to be reported by Vermont health singlerace estimates derived from the original multiplerace
care facilities and healthcare providers. Interstate data categories in the 2000 United States Census.
exchange agreements exist with all bordering states and http://www.seer.cancer.gov/popdata.
Florida.
Electronic editing, visual editing, and hospital auditing Multiple primary rules used
IACR rules (2004) on CI5 IX period.
are all used as quality assurance strategies.

204

North America

USA, Washington State


Registration area
The Washington State Cancer Registry is responsible for
cancer case surveillance throughout the State of Washington
(USA). The mid-2000 population for Washington State is
reported at 5 894 121 of which approximately 49.8% are
males, 50.2% females.
Registry structure and methods
Case information is provided to the State Cancer Registry
by healthcare facilities (hospitals, laboratories, physician
ofces) throughout the state.
The registry is located within the Washington State
Department of Health and is funded by the US Centers
for Disease Control and Preventions National Program of
Cancer Registries (NPCR) and partly by state funds. The
registry is staffed by experienced certied tumour registrars
(CTRs) and an epidemiologist.
Use of the data
The registry prepares an annual report of cancer incidence,
highlighting trends and changes.

USA, WASHINGTON STATE (1998-2002)


USA, WASHINGTON (1998-2002)


 













 



































 
 







 






 



























 







 































 




 /*',
)/0+./&.0///



 ! /*',







  
/(//

/ ! /"/ #/ #/  #//
/ 2/
 / ! /" //)&&&/ / / $/ /


// / /"  / 3  / ! /  / !/ / /!
 3  /   // /)&&&/ / / $/

1%%$ $ $%

$/

Source of population
July 1 county population estimates by age, sex, race, and
Hispanic origin; postcensal estimates based on 2000 United
States Census. The
population data include the bridged singlerace estimates
derived from the original multiplerace categories in the
2000 United States Census.
http://www.seer.cancer.gov/popdata.

 


  
 /  /*)&&+,// -//
/

Multiple primary rules used


IACR rules (2004) on CI5 IX period.

205

North America

USA, Washington, Seattle


in the central ofce by registry staff. Both active and passive
Registration area
The Cancer Surveillance System (CSS) operates under follow-up methods are used. Passive follow-up is performed
the Surveillance, Epidemiology, and End Results (SEER) via data linkage with both medical and non-medical source
program to provide incidence, treatment, and follow-up data records. Active follow-up consists of annual letters sent to
on all newly-diagnosed malignancies (except non-melanotic the physicians. Death clearance and unduplication activities
skin cancers and in situ cancers of the cervix) occurring in are performed annually. The data are submitted annually
to the SEER Program and North American Association of
residents of 13 counties of northwest Washington State.
While the geographic area has not changed, the population Central Cancer Registries (NAACCR), and monthly to the
has grown substantially in size. The CSS reporting area has a State registry.
population of over 4.2 million (based on 2000 census), which
As a member of SEER, we annually evaluate the
is approximately 70% of the state population. Counties in
the reporting area include Clallum, Grays Harbor, Island, completeness and accuracy of the information recorded.
Jefferson, King, Kitsap, Mason, Pierce, San Juan, Skagit,
Interpreting the results
Snohomish, Thurston and
This
registry
has
no
Whatcom. The CSS reporting
circumstances
that
are
area includes four Primary
USA, WASHINGTON, SEATTLE (1998-2002)
particularly different from
Metropolitan Statistical Areas
USA, WASHINGTON, SEATTLE (1998-2002)
any other region with a highly(PMSAs).
Approximately
medicalised society.
86% of the people in the CSS
reporting area reside in these
Use of the data
PMSAs:
Seattle-Bellevue$.-.%/--/*,
&0-$""--%+-%&0--/"
("-(+%--CSS provides reports to
Everett (57.7%), Tacoma
&0-**&--.*
**-""&--reporting hospitals on a
(17.5%), Bremerton (5.6%) and
(/-%(/--."
*/-+(0--*+-0%&--+*
+%-&*&--monthly basis. Identiable
Olympia (5.1%). The racial
.$-(""--+"
.&-(+"--information is reported only
distribution of the population
00-/**--**
$""-0/%--$&+-%((--*"
$&/-/"%--to the reporting physician
base is as follows (2000 data):
$*/-(.*--(*
$+$-$0.--or institution, to FHCRC
80.4% White, 5.3% Hispanic,
$.*-$+%--("
$.(-"%(--$.(-0$&--&*
$+0-0*&--investigators conducting IRB4.2% Black, 7.2% Asian, 1.4%
$+*-&"/--&"
$*.-%.*--approved research, and to the
Native American, and 1.5%
$(+-+&"--%*
$&0-$.+--$&/-$*/--%"
$%0-("0--state Department of Health
Other.
$((-&/*--$*
$&+-$/$--as required by law. Statistical
$(+-..&--$"
$&0-*$(--$(&-&*0--*
$&*-+$.--reports for publication contain
Cancer care facilities
$&&-&0+--"
$%+-/**--no data identifying patients,
Cancer patients have extensive
physicians or institutions. Nonaccess to diagnostic and
$"
*
"
"
*
$"
identiable data are released
treatment facilities throughout
 -'#)
  -'#)
%-"&/-"$%--%-"%%-.(/--
to scientists working at the
the CSS catchment area.
local, regional, national and
The increasing provision of 
  
international level. Aggregate
services in outpatient settings -$--

-  -- - -  --
-  1-
 -  - --%"""- - - !has necessitated expansion of  


  
activities to make sure that reports of non-identiable data, such as incidence rates by
 -  -'%""()-- *--
county or 5-year survival rates, are provided to the public
cancers and details about them are not missed.
upon request. The CSS responds to many requests from the
local medical and scientic community, registrars, health
Registry structure and methods
The registry is located within Fred Hutchinson Cancer care administrators, news media, public, Cancer Information
Research Center (FHCRC), and is funded primarily by Service, and students receiving graduate training in public
the SEER Program, and partly by the FHCRC and the health sciences.
CSS also contributes to collaborative studies involving
Washington State Department of Health. The registry is
staffed by 28 full-time technical staff members and 9 hourly multiple SEER areas. Data released to SEER are stripped
technical/data processing staff, and 3.5 programming staff, of information which would identify the patient, physician,
2 part-time epidemiologists, 1 part-time staff scientist, and 1 or reporting institution and is identied only by a unique
number assigned by the CSS.
part-time administrator.
The CSS registry uses active case nding from over
100 sources of data consisting of cancer hospitals, general
hospitals, teaching hospitals, pathology laboratories and the Source of population
Washington State Bureau of Vital Statistics. All the case July 1 county population estimates by age, sex, race, and
nding is performed at the central registry ofce. Abstraction Hispanic origin; postcensal estimates based on 2000 United
of medical records is performed by a mix of hospital staff States Census.
and registry staff. The latter perform abstracting either at
the healthcare facilities or via remote access at the central Multiple primary rules used
ofce. All the coding and case consolidation is performed IACR rules (2004) on CI5 IX period.

206

North America

USA, West Virginia


Registration area
The West Virginia Cancer Registry (WVCR) covers the state
of West Virginia, which is the only state that is classied as
entirely Appalachian. West Virginia is racially and ethnically
homogeneous, with 95% of its population identifying as white
and 0.7% identifying as Hispanic. West Virginians have an
overall lower educational attainment than the US as a whole,
with 75.2% of persons 25 and older having a high school
education or higher (80.4% for the US), lower per capita
income ($16 477 compared to $21 587) and a higher median
age (38.9 years compared to 35.3 years). West Virginia is one
of the least urban states in the United States, with 46.1% of
the states population living in urban areas.
Cancer care facilities
As of January 2006, 51 of West
Virginias 55 counties were
classied by the US Department
of Health and Human Services
as medically underserved or
had medically underserved
populations. West Virginia
has 57 hospitals, 11 of which
have cancer programs approved
by the Commission on Cancer.
In addition, there are 18 freestanding cancer diagnostic and
treatment centres and 7 day
surgery centres.



















WVCR performs computerised edits on all data and visual


editing on a minimum of 10% of cases from each reporter.
Additional data quality studies are performed as indicated
by the results of the computerised and visual edits. Hospitals
undergo case-nding and re-abstracting audits every ve years
but may be audited more frequently if systematic problems are
found. To maintain quality control, formal studies/evaluations
are carried out. West Virginia Cancer Registry data are
submitted to NAACCR for evaluation of completeness and
quality, and also undergo regular audit by NPCR.

Interpreting the results


West Virginia is known to have relatively high levels of cancer
risk factors including tobacco
use and obesity in comparison
to the US, screening rates
USA, WEST VIRGINIA (1998-2002)
for breast and cervical
USA, WEST VIRGINIA (1998-2002)
cancer similar to those of
the US and colonoscopy and
sigmoidoscopy rates lower
than those of the US. BRFSS








data indicate that PSA testing






levels in West Virginia are










similar to those in the US as






a whole.





 
























 

Use of the data


The West Virginia Cancer







Registry publishes an annual










 



 

report on cancer incidence and








mortality in West Virginia,


Registry structure and














conducts investigations of
methods






possible cancer clusters,


The West Virginia Cancer
performs analyses as needed
Registry is part of the West






for special projects, promotes
Virginia Department of Health
 .*',
 ! .*',
the use of WVCR data in
and Human Resources, Bureau



0/1.(0/...

planning and evaluation of
for Public Health, Ofce of

  
#.  #..
. 3.
 . ! ." ..)&&&. . . $. .
cancer control activities and
Epidemiology and Health .(..

. ! .". #.


.. . ."  . 4  . ! .  . !. . .!
 4  .   .. .)&&&. . . $.

2%%$ $ $%

$.
Promotion, Division of Surveillance
and Disease Control and makes de-identied data available to approved researchers.
 


  
is funded by the State of West  .  .*)&&+,.. -..
.
Virginia and the US Centers
for Disease Control and Preventions National Program of Source of population
Cancer Registries (NPCR). WVCR has 10 full-time staff July 1 county population estimates by age, sex, race, and
including 4 cancer surveillance staff, 3 data quality staff, a Hispanic origin; postcensal estimates based on 2000 United
programmer analyst, an epidemiologist/program director and States Census. The
an administrative professional. WVCR receives electronic population data include the bridged singlerace estimates
reports from hospitals with cancer registries and provides derived from the original multiplerace categories in the
abstracting services to other hospitals as well as free-standing 2000 United States Census.
diagnostic and treatment facilities, day surgery centres and http://www.seer.cancer.gov/popdata.
large urology and dermatology practices. WVCR also receives
pathology reports and conducts annual linkages with death Multiple primary rules used
IACR rules (2004) on CI5 IX period.
certicates. Cancer is reportable by law in West Virginia.

207

North America

USA, Wisconsin
Registration area
The Wisconsin Cancer Reporting System (WCRS) covers the
statewide population of Wisconsin, USA. The population at
the most recent census (2000) was 5 363 675. About 89% of
the population is white, 6% African American, 1% American
Indian or Native Alaskan, 2% Asian/Pacic Islander and 1%
multiple race. Almost 4% are of Hispanic origin.

reported and identify cases not previously reported by the


above mentioned sources. Follow up is conducted on the
death certicate only cases annually. Cancer is a reportable
disease in Wisconsin per Chapter 255.04, Wisconsin
statutes. Data submitted to WCRS is processed through a
combination of NPCR-required and recommended edits and
Wisconsin-specic edits. All cases are edited electronically,
and the incoming paper reports are also reviewed manually.
WCRS participates annually in the NAACCR Certication
Process and has received the Silver or Gold standard for its
data every year since 1995.

Cancer care facilities


Wisconsin has approximately 150 hospitals and over
1700 clinics (including radiation therapy centres, health
maintenance organisation outpatient clinics and private
physician ofces) serving its population. Residents living near Interpreting the results
state borders may cross into
other states for their cancer
diagnoses and care depending
USA, WISCONSIN (1998-2002)
on proximity to the out-ofUSA, WISCONSIN (1998-2002)
state facilities and restrictions
based on insurance coverage.

Wisconsin incidence rates


overall remain stable but can
be inuenced by periodic
reporting anomalies (e.g. a
facility loses cancer reporter
and cannot submit for extended
period)
or
inconsistent
reporting on residents seen
outside of Wisconsin for
diagnosis and/or care.

Registry structure and






 








methods







WCRS is located within the
















Bureau of Health Information









Use of the data


and
Policy,
Wisconsin













WCRS data are published in


Department of Health and







an annual report (incidence


Family Services. It is funded














and mortality rates by site,


partly by general purpose




 
 

diagnosis year, race and


revenue funds (25%) and by
 
 



 








county, stage at diagnosis).


the US Centers for Disease







Special site-specic reports are


Control
and
Prevention




 
 

 



 


periodically produced. Data


through the National Program
 






are used by researchers for


of Cancer Registries (NPCR)
case control studies, linkage
(75%). The registry has six






studies, and extensively by
full-time staff: a program
 /*',
 ! /*',
comprehensive cancer control
director, epidemiologist, CTR




)/.-(/0&&///

organisations for planning and
data editor and state trainer,

  
#/  #//
/ 2/
 / ! /" //)&&&/ / / $/ /
prevention strategies.
quality control data and GIS /(//

/ ! /"/ #/


// / /"  / 3  / ! /  / !/ / /!
 3  /   // /)&&&/ / / $/

1%%$ $ $%

$/
analyst, data processor, ofce operations
assistant and a part
 


  
 /  /*)&&+,// -//
/
time data entry staff person. WCRS
collects data (passive Source of population
data collection) from Wisconsin hospitals, clinics, physician July 1 county population estimates by age, sex, race, and
ofces and out-of-state hospitals along state borders. These Hispanic origin; postcensal estimates based on 2000 United
facilities are required to submit data electronically using States Census. The population data include the bridged
the NAACCR standard layout or on paper using the WCRS singlerace estimates derived from the original multiplerace
reporting form. Wisconsin also has data exchange agreements categories in the 2000 United States Census.
with 19 other state central cancer registries, and receives http://www.seer.cancer.gov/popdata.
data on Wisconsin residents from those registries annually.
WCRS conducts an annual link with the Wisconsin Resident Multiple primary rules used
Death File to update death information on cases previously IACR rules (2004) on CI5 IX period.

208

Asia

China

India

Japan and Republic of Korea

South-East Asia

Asia

Bahrain
a specially designed registration form, and entered and
Registration area
The Kingdom of Bahrain is located centrally on the southern checked for duplication and consistency using CANREG
shores of the Arabian Gulf, and comprises an archipelago IV. Coding anatomical sites and morphology of tumours is
with a total area of 717.5 km2. Bahrain Island is the largest according to the ICD-O-3.
In addition to passive notication, case nding is enhanced
of these islands, accounting for nearly 83% of the total area
by several approaches. Clinical records of cancer patients
of the kingdom and the capital, Manama.
According to the 2001 census, the total population of admitted to SMC, the main source of cases, are sorted out
Bahrain was 650 604 persons of whom 405 667 (62.4%) at the Medical Record Department (MRD) upon discharge
and checked for their registration status. The registrar visits
were Bahraini, and 244 937 non-Bahraini.
The growth rate between the 1991 and 2001 censuses was the BDF Hospital periodically to review and identify lists of
2.7% for the total population, 2.5% for the Bahraini and 3.1% newly diagnosed cases.
The registry also receives regular cancer death notications
for non-Bahraini. The ve-year average estimated mid-year
population for 19982002 was 638 033 of whom 398 455 from the Birth and Death Registration Ofce at the Ministry of
Health. Death cases are cross(62.5%) were Bahraini and 239
matched with the registered
578 (37.5%) non-Bahraini. The
cases to sort out the unmatched
majority of the non-Bahraini
BAHRAIN: BAHRAINI (1998-2002)
cases, which are then followed
population (69.2%) are males,
BAHRAIN: BAHRAINI (1998-2002)
back for any information on
who form the major part of the
their malignancy and date
workforce. This population is
of diagnosis. Those with
characterised by a very rapid
insufcient clinical information
turnover during the year, and
or information not indicative of
their transitional nature could
"*#+***
+')
"*"!,***
cancer are registered as Death
affect the interpretation of
"*!((***
+
"*!+"***
"*(,'***
('
"*-%(***
Certicate Only (DCO) cases.
cancer occurrence.
#*+-%***
(
%*!***
Using the check program,
%*!+#***
''
%*#"!***
(*##,***
'
'*%!#***
data are examined for
Cancer care facilities
,*-%,***
%'
,*'!#***
duplicate registration as well
The government provides
!!*#+,***
%
!"*!,%***
!#*((***
#'
!%*+***
as for illogical errors in the
high-standard comprehensive
!#*+,%***
#
!%*'!(***
combinations of variables such
health care to residents,
!'*",+***
"'
!'*"!***
!-*"%#***
"
!,*#"+***
as site-sex, site-morphology
including
public
health,
""*!%'***
!'
"!*'***
and age-morphology. Data are
primary,
secondary
and
"%*,'(***
!
"#*'%"***
"'*%#%***
'
"%*+++***
also examined for illogical
tertiary care services. Primary
"%*+-"***

"#*(%+***
combinations that cannot be
healthcare
is
delivered
captured by CANREG, such
through 22 well-equipped
!
'


'
!
as morphology versus basis
health centres distributed
 *$ &
  *$ &
of diagnosis (e.g. leukaemia),
in all geographic regions.
!-+*%"***
"!*'#***

behaviour versus stage codes
Secondary care is provided

  
(for in-situ), basis of diagnosis
through the main government  *
 * **"!* * * * *
hospital, Salmaniya Medical  


  
Complex (SMC), recently versus status codes (for DCO) and morphology versus
 * *$"%&** '**
*
expanded to house the new Oncology Services Centre stage. Cases in which diagnosis was based on histology of
equipped with the latest diagnostic and treatment technology metastasis (secondary site) are reviewed to ensure that the
including chemotherapy, radiotherapy, immunotherapy and depicted site is for the suggested primary tumour.
Missing data on date of birth are replaced by the rst
bone marrow transplant.
The Royal Medical Services Hospital of the Bahrain two digits of the Central Population Register (CPR) number,
Defense Force (BDF) is the second general secondary which represents the year of birth. In this case the rst day
hospital, primarily serving Ministry of Defense employees of January is designated to complete the full date of birth.
and their families. Secondary care is also provided by six Missing data for unknown primary site (PSU) and other
other private hospitals. Together, the government and private variables are sought and recorded when found.
hospitals have a capacity of around 2000 beds and ratios of
Interpreting the results
22 doctors and 50 nurses per 10 000 population.
Underreporting is expected especially for patients who
might have sought treatment in private hospitals or abroad.
Registry structure and methods
The Bahrain Cancer Registry (BCR) is a population-based However, Bahrain is a small country, and free cancer
registry covering all residents in the country. Per ministerial treatment facilities, especially radiotherapy, are located in
decree 5/1994 cancer became notiable to the Cancer one public hospital (SMC) providing good opportunity for
Registry Ofce, part of the Medical Review Ofce of the capturing cases not known to the registry. Those seeking
Ministry of Health. The registry is operated by a part-time treatment abroad may eventually come to the SMC for
epidemiologist and a part-time medical records technician further treatment or follow-up, or will be captured by the
national and well established death register. The CANREG
working as a tumour registrar.
Cases are registered as having a malignant disease in software has limitations in morphology descriptions of nonthe BCR whether microscopically or clinically diagnosed. invasive cancer (e.g. in situ or non-inltrating intraductal
Personal, clinical and tumour details are collected using carcinoma); however, these can be identied by behaviour

214

Asia

and stage codes. The problems of duplication and unknown


age in Bahrain is minimal because of the unique identication
number (the CPR number) that is assigned for each resident.
Use of the data
The registry produces regular statistical reports that show
the distribution of different types of cancer according to age,
gender and nationality. These reports are being utilised by
health planners and policymakers to address the importance

of cancer problem, allocate resources and to evaluate cancer


prevention and control activities.
Source of population
Medium projections based on the 2001 census. Central
Informatics Organization.
Multiple primary rules used
IACR rules (2004) on CI5 IX period.

215

Asia

China, Guangzhou City


Registration area
Guangzhou is the largest city in southern part of China, with
a population of about 7.25 million and an area of 7434.4
km2. It is the capital of Guangdong province and is situated
at latitude 22N and longitude 112E.
The Guangzhou Cancer Registry covers the population
of seven districts (central urban area) within Guangzhou city
with an area of 1335.3 km2. The population was 3 560 810
in 2000, with people of the Han race making up more than
99%.

by the Guangzhou Health Bureau as a part of the medical


quality control service in each hospital. The registry staff
also periodically goes to review the patient records in all
hospitals that are located in registry area in order to control
report quality.
The registry staff check, code and le the cards according
to year, sex, usual residence, ICD code, etc. Then the registry
staff determines whether a patient has already been reported
to the registry, so as to avoid duplication.

Interpreting the results


Guangzhou has a full range of diagnostic facilities, so that it
Cancer care facilities
The Cancer Centre in Sun Yat-sen University is one of is unlikely that cases referred will be missed.
Screening service for cancer
the largest cancer centres
was not operated in Guangzhou
in China. It has more than
in the period 20002002. PSA
1000 beds and employs 1300
CHINA, GUANGZHOU (2000-2002)
testing is not common in our
people. More than 40% of the
CHINA, GUANGZHOU (2000-2002)
population, being only carried
cancer patients in Guangzhou
out in urology departments of
are diagnosed and treated in
some hospitals.
the centre. There are national,
provincial,
municipal
$+."-+++
-(*
"#+$"$+++
.+ ,+++
- 
",+)((+++
Use of the data
and district hospitals in
# +-(,+++
,(
$ +$&-+++
Cancer
incidence
and
Guangzhou, which provide
$&+.,-+++
, 
&#+,)$+++
("+,.)+++
)(
(,+).(+++
mortality data are provided to
radiotherapy, cancer surgery
,"+&##+++
) 
, +).)+++
the Guangzhou government
and chemotherapy services
-$+#-"+++
((
-)+"-#+++
.,+#,)+++
( 
.#+,")+++
as a reference for planning
for cancer patients.
" #+& (+++
&(
..+)#,+++
projects in cancer prevention
"$#+,-)+++
& 
"#$+- &+++
",$+(((+++
$(
")"+&,$+++
and control. The registry
Registry structure and
"-#+&-(+++
$ 
", +##.+++
has also carried out some
methods
".-+)- +++
#(
",$+,,"+++
",.+$#-+++
# 
"&$+)#$+++
epidemiological studies based
The registry is located within
")&+.)"+++
"(
"&"+&,,+++
on the data from Guangzhou.
the Cancer Center, Sun Yat"".+#&$+++
" 
" .+&(#+++
"#,+ #&+++
(
""(+((,+++
sen University and is funded
"" +".)+++

.(+)-"+++
Source of population
partly by the cancer centre
Projections based on 2000
and partly by the Guangzhou
"
(
(
"
census.
Health Bureau. There are 7
 +%!'
  +%!'
"+,&(+ )$+++
"+-)$+".-+++

registrars in the registry.
Multiple primary rules used
Physicians and medical   

IACR rules (1990).
clerks in the hospitals of the  + ++# + +
registry area are responsible for      
lling'+ out a report card for
+  +%"..
each newly diagnosed cancer   
patient. Each hospital has a Notes on the data
 +  +  ++ + + + ++ +  +
+  +/+ + +(+%  '+
special department to collect, check and send the cards to The Editors recommend that some care be taken in the
the registry on time. The quality of this work is checked interpretation of these data; see Chapter 5 (Categorisation).

216

Asia

China, Hong Kong


Registration area
Situated in the south-eastern part of China, Hong Kong is
one of the most densely populated places in the world with
an average population density of 6,140 persons per km2.
The population was about 6.78 million in mid-2004. About
93% are Chinese, mostly descendents from people of the
Guangdong Province in southern China. Hong Kong Cancer
Registry covers the entire population of the area.

years. Death certicate only percentage (DCO%) is the other


indicator. Our completeness in data collection is illustrated
by the very low DCO% of 1.5% in 2003 against 7.6% in
1990.
The only organised mass screening programme (by
Health authorities) is cervical cancer screening; PSA testing
is not common in the population covered.

Expanding the scope of data collection


Information Technology in Hospital Authority (HA) has
Cancer care facilities
The Hospital Authority (HA) is a statutory body to manage contributed signicantly to the Registry in recent years. The
all public hospitals in Hong Kong. Clinical Oncology is a Registry was linked up with the Electronic Patient Record
discipline of medicine that manages cancer patients by (ePR) System of HA in 2004. Since then, the registry has been
able to collect histological data
non-surgical means such as
and staging information more
radiotherapy, chemotherapy,
comprehensively and easily.
biological
therapy
and
CHINA, HONG KONG (1998-2002)
On the other hand, death
palliative care. There are
CHINA, HONG KONG (1998-2002)
data are collected from
currently
six
Clinical
the Death Registry of the
Oncology centres in the
Government. Previously death
Hospital Authority. A few
records other than cancer
private hospitals also provide














were not available to the


similar services.







registry because of legislative
















restrictions. The individual


Registry structure and







case record obtained was


methods












 

anonymous
and
without
The Registry is an ofcial







the unique identity number.


and
professional
body





 








Therefore survival analysis


for
population-based







has not been part of the output


data collection in cancer




 
 








of the registry. Since 2000 the


epidemiology. It is currently







death data has been linked


run by one statistical











 


with the Registry data, which


analyst and four clerks in







helps minimise loss of patients


the Department of Clinical
to follow-up. The Registry can
Oncology of Queen Elizabeth






thus target compilation of a
Hospital, Hospital Authority.
 *&!(
  *&!(
population-based
survival
The director is a specialist in

 
 

%*$+ *)' ***



analysis in the near future.
Clinical Oncology who, apart
  

*$ $.*0  *  *  ** *  /* *#**
  *$ "* * **  **
from overseeing operations, "--,0$
 *  /* *#**
  *
Use of the data
provides regular input on the validity
of clinical data.
      
 **  * *  *
The Registry obtains data  
through electronic means The Registry updates annual reports of cancer incidence and
 **  **
0-*%* *   * * *
directly from clinical oncology
centres, pathology mortality in electronic format on its website. Basic descriptive
laboratories and hospital discharge summaries of all public epidemiological analyses are included. Registry data are
hospitals. For the private sector, the Registry has had a good routinely used by ofcials, health professionals, cancer control
working relationship with most cancer centres and pathology groups and the public. The data are also extensively used by
laboratories over the years. Near-complete coverage can be local researchers for various epidemiological studies.
achieved within the territory. Voluntary notication nowadays
contributes very little to the data pool. Death certicates are Source of population
19982000, 2002: Midyear estimate produced by the
obtained from the Department of Health.
Cancer notication is by administrative order without a specic Governments Census & Statistics Department.
law in Hong Kong. The privacy of the cancer patient and the use of 2001: Population Census data produced by the Governments
the related information are protected by the Governments Personal Census & Statistics Department.
Data (Privacy) Ordinance. There is no personal contact with cases
Multiple primary rules used
or patient follow-up by the registry staff.
The Registry evaluates the quality of incoming and output Impossible to detect multiple primaries.
data using both automatic and manual review processes.
Histological verication percentage (HV%) is one of the two Notes on the data
internationally accepted indicators of data quality in cancer For this registry, only ICD9 3 digit categories were
registries, and we achieved over 85% conrmation in recent available.

217

Asia

China, Jiashan
Registration area
Jiashan County is located in the north of Zhejiang province,
near Shanghai City. It is at latitude 30 N and longitude 120 E.
The area of Jiashan County is about 506.6 km2; 14.3% of the
county is covered by rivers and lakes. The average annual
temperature is around 16 C.
Jiashan County is covered by atlands with a network
of waterways. About 80% of the population lives in rural
areas. Population density in the county is 751 persons per
km2. Agriculture is a major industry, and the main crops are
rice, wheat and broad beans. The county once had a serious
schistosomiasis epidemic, but the disease was eradicated in
1985.
Cancer accounted for
23.8% of all deaths in 1997.
Cancer care facilities
There were 24 medical
establishments, 1296 medical
workers and 1135 hospital
beds in the county at the end
of 1997.

in the rural area hospitals collect cancer cases in each village


and lling in report cards. All the cards are sent to the cancer
registry. After receiving the report cards, the doctors in the
cancer registry check details by phone or by going to the source.
Multiple cards on the same patient are merged, and cards for
non-resident patients are removed. Physicians working in the
cancer registry visit the medical establishments several times a
year and inspect the reporting of cancer cases to assess quality
and completeness. A meeting is held at the end of every year,
with ofcers of the county health bureau, to discuss problems
encountered in order to improve quality.
In 1991, two computers were purchased. Software for
vital statistics and cancer reporting, produced by the Sanitary
and Anti-Epidemic Station
of Liaoning Province and
recommended by the National
CHINA, JIASHAN (1998-2002)
Cancer Research and Control
CHINA, JIASHAN (1998-2002)
Ofce, was adopted.

 


 

















Use of the data


Data on cancer incidence,
prevalence and mortality by
sex, age and site are used
in cancer prevention and
treatment and for research
into etiology.








Registry structure and









methods








 



 

A population-based cancer







registry was established



 






 





Source of population
in Jiashan County in 1987,





 

The sex and age distribution


according to documents of the














of the population 19981999


Jiashan County Government







was estimated by interpolation


and Health Bureau on














based
the sex and age
reporting cancer incidence







distributions of the 1990 and


and mortality, and mortality
2000 census populations. The
from all causes. It is attached







($!%


($!%
sex and age distribution of the
to the Jiashan Institute of



"*"('#'(((

population 20012002 was
Cancer Research.
estimated by extrapolation
In
accordance
with   

((
based on the sex and age
Jiashan County Health Bureau 
(
((
( ( (
(  ("**),"***((

((
(
((
(
((
( ( (
("**
# (
(  (
(
((
( ( (
(  (# ",# #((

((
  (
(((
(
((
(
 ( (# (
(  (
regulations, all medical establishments,
whether hospital or distribution of the 2000 census population.
      
clinic, must report new cases of( 
($#
cancer%(((diagnosed, including
  

(  (

((
(
(
(
((
(

( (

(+(

( 
(&($
 %(
benign tumours of the central nervous
system, and cause of Multiple primary rules used
IACR rules (2000).
death for all diseases.
Physicians in healthcare departments of medical
establishments in the county towns are charged with collecting Notes on the data
report cards on cancer, which are completed by doctors in each The Editors recommend that some care be taken in the
ward and diagnostic service. Doctors of preventive medicine interpretation of these data; see Chapter 5 (Categorisation).



218






Asia

China, Nangang District, Harbin City


Registration area
Nangang district, located in the centre of Harbin, is the
largest canton in Harbin and borders on the Daoli, Daowai,
Xiangfang, Dongli and Pingfang districts. It lies within
longitude 12542 and 13010W, and latitude 4404 and
4640N. It has a temperate zone continent/trade wind
climate, with an average monthly rainfall of 3868mm and
average annual humidity of 65%. The total area of the district
is 182.87 km2, including an urban area of 60 km2, which is
one third of the total area of Harbin.
The population of Nangang is 1 001 377 persons, of
which 90% are Han. The rural/urban breakdown is 61 146
and 940 231 persons respectively.

area, pinyin and kinds of diseases and after coordination and


elimination; they are coded according to the international
disease classication ICD-10 and reserved in the tumour
cards tank. Computers manage and analyse the data, and all
tasks of the registry ofce are now computerised.

Use of the data


Data accumulated through the years have been used in
epidemiological research, cancer trend prediction and
research on cancer control policies and counter-measures.
Since the tumour reporting system was established in
1997, we have accumulated malignant tumour occurrence
and death data from 1990 to 2001 in Nangang district.
These data play a vital role
in tumour prevention and
Cancer care facilities
treatment as well as scientic
The following diagnostic
CHINA, NANGANG DISTRICT, HARBIN CITY
research, and have been used
facilities are available in
(1998-2002)
CHINA, NANGANG
DISTRICT, HARBIN CITY (1998-2002)
in 10 articles published in
the area: clinical, surgical,
China Fundamental Medical
pathology, radioactive x-ray,
Care, Public Hygiene and
supravital, CT scan, bone
Management of China Public
marrow aspiration and autopsy.
##"
"
 !
 #
"
 !
Hygiene. In the framework of
Chemotherapy, radiotherapy,
 !
!
 !"
the Ninety-Five National
surgery, Chinese medical
# #""
!
# #
 

 
Science and Technology
science and immunization are
! !

 
Innovation Programme, we
the treatments available to the
 #

" !#
 "

 ##
have submitted basic and
community.
 "

 !
statistical data of tumour
 

 
 #

 
registration reports to some
Registry structure and
 

! !
relevant faculties. Malignant
methods
 

 
 #

 #
tumour
occurrence
and
The Harbin cancer registry
 #"

 !
death data from 1990 and
ofce was established in
 "#

 "
# 

! !!
1992 were published in the
1997, comprising the people
 !!

 #
book The Occurrence and
of Nangang district, which
Death of Malignant Tumor in
includes 18 community ofces






Experimental Cities in China.
in 3 counties and 1 town. It is




Data on tumour occurrence
located in the chronic faculty
" ""
 
 
and death during 1993 and
of the Nangang disease
1997 in Nangang district have
prevention and control centre, 
   




        


with the supervision of the Nangang board of health. The been constantly used by Malignant Tumor Occurrence and
ofce is in charge of the registration and reporting of newly Death (93-97 volume) of 11 experimental cities around the
acquired malignant tumours and carcinoids of the central country; occurrence and death data during 1998 and 2002
nervous system among permanent residents in the district. have been used in the compiled book of volume. The data
The administrative obligatory report system is used in the are an important component of the project The Research
of Common Malignant Tumor Occurrence, Death and
ofce. The ofce now has 2 full-time and part-time clerks.
All personnel providing health care at all levels in Harbin Dangerous Factors Monitoring Method, which is the product
are required to complete a report card and submit it to the of many years of hard work; it will be of vital importance
supervising epidemic prevention station if they diagnose a in future cancer control projects, hygiene projects, hygiene
malignant tumour. Malignant tumour death reports are to be cause planning, and investigations of cancer prevalence.
It is believed that with time, these data can play more
submitted with data on the cause of death.
All healthcare personnel are also required to complete important roles. With support from health policy leaders at
the death report card as well as the medical certicate of various levels, and with continued effort from the staff, the
death. At present, follow-up visits are limited to tumour death Nangang tumour registry ofce can be expected to achieve
cases, and family doctors in the community health service greater coverage and completeness, and will contribute richer
centre complete the tumour follow-up table. This measure has and more accurate data for cancer prevention and control in
been in place for three years. The Nangang district includes the future.
1 tumour professional hospital, 6 large polyclinics, and 109
medical units in 23 medium-sized polyclinics. The tumour Multiple primary rules used
report cards are catalogued according to administrative Impossible to detect multiple primaries.

219

Asia

China, Shanghai
Registration area
Shanghai is situated on the east coast of China at 3114 N
latitude and 12129 E longitude. The total area of Shanghai
Municipality is 6340.5 km2. There are about 13.52 million
inhabitants in the municipality. The registration area during
19982002 covered nine urban districts with an area of about
289.4 km2 and 6.19 million inhabitants, 99.1% of whom are
Han Chinese. Ninety-ve percent of the population are nonreligious; the other 5% are Buddhists, Taoists, Islamites and
Christians. Most of the population is immigrants from all
over China, mainly from neighbouring Zhe Jiang and Jiang
Su Provinces.
Cancer care facilities
Shanghai has a 3-level general
health care network, including
more than 400 hospitals and
community health service
centres. The rst-level facilities
are all the community health
service centres providing
predominantly
primary
health care. The secondlevel facilities are the district
hospitals, most of which have
a Cancer Department. The
third-level facilities are all the
municipal hospitals and the
Shanghai Cancer Hospital.
Most of the second- and
third-level facilities provide
radiotherapy, cancer surgery
and chemotherapy services.

%,.#%'...
'+./&+...
/&.)0'...
%%%.&'%...
%'1./&&...
%%/./,,...
%&).&&#...
&%'.'1%...
''+.%0&...
'0+.'%,...
&1,.'&,...
&&/./&1...

notication card, which includes demographic information,


cancer site, date and basis of cancer diagnosis, is used for
reporting cancer cases. The notications are sent to the
cancer registry and led according to the name of the patient
and administrative district of residence. Home visits are
carried out for every case to conrm if the cancer patient
is a permanent resident. All patients residing outside the
registration area are deleted from the cancer registry.
Data on cancer notication cards are computerised
using specially-designed computer software that directly
reads Chinese characters. Cards with similar contents are
examined by registry staff and duplicates are deleted.
Death certicates for all cancer patients are obtained
monthly from the Vital
Statistics Section of the
Shanghai Municipal Center
CHINA, SHANGHAI (1998-2002)
for Disease Control and
CHINA, SHANGHAI (1998-2002)
Prevention and collated with
the le of new cases kept in
the registry. If the deceased
was not registered prior
0+&1.)1,...
0#!
+%.,1/...
to death, the registry staff
/+!
1'.01%...
interviews the relatives of the
/#!
%'+.+1,...
,+!
%,+.,10...
case to obtain information on
,#!
%&1.,1#...
the hospital where the case
++!
%&#.'',...
+#!
%1'.1,,...
was diagnosed and treated,
)+!
'%#.#,1...
date and basis of cancer
)#!
',+.+1,...
'+!
&,1.+10...
diagnosis.
'#!
%1,./,#...

Interpreting the results


For a long time the Registry
%#,.&,1...
+!
%#&./%,...
collected information on
/+.1%+...
#!
/#.0'%...
new cancer cases only in the
urban area, and in suburban
%#
+
#
#
+
%#

.($*


.($*
and rural areas of Shanghai
Registry structure and
'.%#%.)'1...
'.%0&.0/)...

collected information only on
methods
cancer deaths. The urban area
Organisation of the Shanghai   

.%1112.

..
.
..
. . .
.  . .
.%11,..&###.
.".&###2.
".&##% .&##&2.
expanded from 159 km2 to
Cancer Registry is now based %110
  
..
.
..
. . .
.  ..&###.
".
2
      
upon a 3-level network of disease
prevention
and
control.
289
km
over
the
past
30
years,
and the population increased
. 
.(%11#*.
The rst level is the Registry of  
Shanghai CDC. The staff of from about 5.7 million to 6.3 million.

.  .

..
.
.
.
..
.

. .

.3.

. 
.+.(
 *".
.
 ..
.
..
 . 
..
.  ".
this level consists of 2 senior and
3 junior epidemiologists,
In the past 30 years the number of hospitals responsible
2 statisticians and 1 assistant statistician. The second level for cancer cases increased from 117 to 175 in Shanghai.
consists of CDCs in 19 districts. In each district CDC, 12 Shanghai is one of the areas with the highest level of cancer
epidemiologists and 1 assistant are responsible for cancer diagnosis and treatment in China. Almost all of the cancer
registration. The third level consists of 207 community patients in urban area covered by our Registry are diagnosed
health service centres. There are 12 workers responsible for and treated in those hospitals.
home visit and data checking; most of them are community
A mass screening programme on cervical cancer with
GPs.
Pap smear examination began in urban Shanghai in the late
Shanghai Cancer Registry is a population-based cancer 1950s. All employed women have a Pap smear every 2 years,
registry that collects, analyses and disseminates information provided by local maternal hospitals and paid for by both the
on cancer incidence, mortality and survival in the Shanghai government and the employer. Almost all of the hospitals in
urban area. The registry was established and started operating Shanghai can provide PSA testing when necessary, but there
in 1963. The registry became essentially population-based is no mass PSA testing programme screening for prostate
by 1972, and complete incidence and mortality data for the cancer.
urban area in Shanghai Municipality are available from 1973
The anatomic sites of cancer cases were coded using both
onward. The registry was operated by the Shanghai Cancer ICD-9 and ICD-10 from 1998 to 2001 and using only ICD-10
Institute before 2002, when it moved to Shanghai Municipal since 2002. The histology and behaviour have been coded
Centre for Disease Control and Prevention.
using ICD-O-2 since 2002.
All second- and third-level medical facilities (about 170
units) in Shanghai are responsible for notifying all newly Use of the data
diagnosed cancer cases and cases of benign tumours of The registry provides a Shanghai Cancer Report annually
the central nervous system to the registry. A standardised to the government, institutes and hospitals. The report

220

&&%.&#)...

&+!

%1).0#&...

&)).,)1...

&#!

&%1.1)+...

&,&./)#...

%+!

&+1.'++...

%1,.11&...

%#!

%1%.'1,...

Asia

helps to establish cancer prevention plan and policy. The


report also provides basic cancer information to support
community cancer control and prevention activities,
such as community-based cancer patient care services.
More than 20 casecontrol and cohort studies have been
conducted in the past 30 years using Shanghai Cancer
Registry data.
Source of population
1998, 1999: Interpolated by the sex and age distribution of the
population of the 1996 and 2000 census data. 2000: census.

2001, 2002: Extrapolated by the sex and age distribution of


the population in the 2000 census.
Multiple primary rules used
IACR rules (1990).
Notes on the data
The Editors recommend that some care be taken in the
interpretation of these data; see Chapter 5 (Categorisation).
This registry has the lowest histological verication rate in
the monograph.

221

Asia

China, Zhongshan
Interpreting the results
Theoretically all cancer data should be reported to
Zhongshan cancer registry if all cancer patients go to
hospitals for diagnosis and treatment. But some patients do
not want it known they are ill with cancer, and use a false
address or name; these patients are very often missed. Some
foreign cancer patients use the local address when asked
to provide their place of residence, which results in the
cancer patient being mistakenly identied as a native cancer
Cancer care facilities
The city hygiene bureau, through all kinds of hospitals, clinics patient.
As Zhongshan is one of the areas with high incidence
and the CDC, provides health care in Zhongshan. Private
practitioners are relatively few in the region. Although there are of and mortality from nasopharyngeal cancer in China, in
not any independent cancer centres or hospitals in Zhonghsan, 1986 we screened more than 42 000 natives aged 2565 in
16 of 34 towns in Zhongshan
several large comprehensive
using EBV VCA/IGA and
hospit a ls have ca nc er
EA/IGA immuno-enzyme
departments that provide surgery
CHINA, ZHONGSHAN (1998-2002)
serological tests; most of
and chemotherapy service
CHINA, ZHONGSHAN (1998-2002)
them were followed up until
for cancer patients. Only the
2000.
Municipal Peoples Hospital has
PSA testing is part of
radiotherapy facilities, to which
routine hospital checkups,
all cancer patients in Zhongshan
$,#!/,,,
.)+
),#-',,,
',#.),,,
.!
-,#.),,,
and almost every hospital in
are referred when radiotherapy is
.,'%#,,,
-)
#$,$*#,,,
Zhongshan provides it.
necessary. For differing reasons,
#%,/$!,,,
-!
#),--%,,,
#-,*)',,,
*)
#.,%/.,,,
Before
1990,
liver
some cancer patients will go to
$!,!.#,,,
*!
#/,%$#,,,
trematode disease, cirrhosis
hospitals of neighbouring cities
$!,''*,,,
))
$!,%#%,,,
%',/-*,,,
)!
%',).!,,,
and bile duct cancer were very
such as Guangzhou for diagnosis
'-,)#%,,,
')
'*,%$!,,,
common in Zhongshan due to
or treatment.
'),-#-,,,
'!
'%,-).,,,
)-,#-),,,
%)
)*,.)*,,,
special sh breeding methods
*$,!!!,,,
%!
*),*)),,,
and the local diet that includes
Registry structure and
)-,..*,,,
$)
*#,*%.,,,
'),#.-,,,
$!
'),'-),,,
uncooked sh meat. Since then
methods
)$,-$%,,,
#)
'/,#*.,,,
sh breeding methods and the
The Zhongshan cancer registry
*-,*//,,,
#!
*$,$$-,,,
).,)$/,,,
)
)#,./%,,,
habit of eating uncooked sh
is afliated with Zhongshan
)!,.#.,,,
!
'$,*.!,,,
meat have changed, and the
Peoples Hospital, and is
incidence of those diseases
funded by the hospital and
#!
)
!
!
)
#!

,&"(


,&"(
decreased greatly. In recent
the municipal and provincial
*).,*-$,,,
**-,!)#,,,

years, with the progression of
health departments. One fullindustrialisation, urbanisation
time medical ofcer and two   

and heavy transportation,
full-time registrars staff the 
,
,1 ,  , ,$!!!,,
,,
 , 
,  ,,,

, ,
      
,
,&#//!(,
registry. Each hospital in Zhongshan
has a part-time registrar environmental pollution has worsened, which may inuence
cancer incidence
and mortality in Zhongshan.
to help collect cancer data and   
to follow up cancer patients.

, ,

,,
,
,
,
,,
,
 
, ,

,0,

, 
,),&
(
,
Passive and active registration methods are used in
Zhongshan cancer registry. The active case nding method is Use of the data
the major means of nding new cancer cases, as more and more The registry prepares an annual report of cancer incidence,
highlighting trends and changes. Some special studies of
doctors do not notify cancer cases on their own initiative.
The registrars identify cancer cases from all possible survival of registered cancer cases (nasopharyngeal and lung
sources, such as medical record departments, pathology cancer) have been carried out, and we are now collaborating
departments, bone marrow test laboratories, radiotherapy with Queen Mary Hospital of Hong Kong to explore new
departments, the death registry, etc. All cancer data are serological screening tests of nasopharyngeal carcinoma.
collected and sent to Zhongshan cancer registry, where an Zhongshan policymakers are paying increased attention to
experienced registrar rst checks the data to see if it is a health problems, and refer to our cancer registry data when
duplicate case, is missing any important items or has any making health policy.
logic mistakes. If everything is acceptable, the cancer data
are coded and entered on computer for storage and analysis, Source of population
and the notifying card is stored in the data room. If not, the The age group proportion of 2000 was obtained through
data are traced back to correct or complete the faulty or census. Other population data were estimated accordingly.
missed information.
Arrangements are also made with the hospitals outside Multiple primary rules used
the registration area to notify the registry of any resident IACR rules (1990).
cancer cases that they diagnosed or treat; they are visited
once a year to review these procedures. Data are evaluated Notes on the data
according to the IARC and the Cancer Prevention and The Editors recommend that some care be taken in the
interpretation of these data; see Chapter 5 (Categorisation).
Treatment Ofce of China rules.
Registration area
Located at the mid-southern part of Canton in the hinterland
of the Pearl River delta, the Zhongshan cancer registry
covers 1683 km2 and includes the population of 24 towns and
districts. In 2000, the population of Zhongshan was 1 360 302,
about 45% of whom lived in urban areas. Most Zhongshan
residents practice Buddhism, Daoism, or Christianity.

222

Asia

Cyprus
Registration area
The Cyprus Cancer Registry covers the population of
ve districts (Nicosia, Limassol, Larnaka, Paphos and
Famagusta). The population in the government-controlled
areas was 715 100 in 2002.
Cancer care facilities
General health care in Cyprus is provided by both the Ministry
of Health through the district hospitals and the primary
health care centres and through the private sector. The Bank
of Cyprus Oncology Center, a non-prot organisation funded
by the Government provides healthcare services to cancer
patients. The services provided at the oncology centre include
radiotherapy, chemotherapy
and hormonotherapy.

death registration system is inadequate and incomplete for


the time being. A restructuring of the death registration
system is currently underway.
The registry staff visits all sources and scrutinises
the records kept in the medical records departments and
registers of individual departments concerned with diagnosis
and treatment of cancers, in order to identify and abstract
information on cases of cancer diagnosed by all methods
among residents of the registry coverage area. Cancer is not
currently a notiable disease in Cyprus.

Interpreting the results


Estimation of the completeness and accuracy of data is
performed by external quality
control group. A breast
cancer screening program has
CYPRUS (1998-2002)
been operating since 2003;
CYPRUS (1998-2002)
screening is provided by the
Ministry of Health free of
charge to all women between
the ages of 5069.
+(
)&')))
The data provided in
*&
+)'!)))
Volume IX includes all
*
)&')))
'&
")&!)))
foreigners registered in the
'
&)"')))
CyCR, which is not the case
&&
*),$)))
&
! ) !)))
in our cancer report.

Registry structure and


methods
The Registry is co-funded
by the Ministry of Health
and the Middle East Cancer
*)')))
Consortium (MECC). Its main
')+')))
ofces are located within the
,)"$)))
)'')))
Ministry of Health. It comes
$)$$)))
under the supervision of the
*)$)))
!)'')))
Chief Health Ofcer and it
!!)'!)))
$&
!")$)))
is staffed by three full-time
!&)$+)))
$
!&),$)))
!&)'')))
"&
!*)$)))
Use of the data
registrars.
!")+')))
"
!&),)))
The Registry prepares a
The
Cyprus
Cancer
!")&)))
!&
!&)&!)))
!&)+$)))
!
!')")))
triennial report of cancer
Registry (CyCR) uses active
!+)*!)))
&
!*)')))
incidence, highlighting trends
case nding from various
!+)$)))

!')*$)))
!*)'!)))
&
!') !)))
and changes.
sources, mainly (a) general
!")$$)))

!!)"$)))
hospitals in-patient records,
Multiple primary rules used
and inpatient and outpatient

&


&

IACR rules (2000)
facilities in each district, (b)
 )#%
  )#%
"&&)!!)))
"$") )))

the bank of Cyprus Oncology
Notes on the data
Center, (c) the private
The Editors recommend that
sector hospitals inpatient     


)  )#!%)
and outpatient facilities, (d)  
  
pathology laboratories, (e) some care be taken in the interpretation of these data; see
 )  )  )) ) ) ) )) )  )
)  )-) ) )&)#  %)
haematology laboratories and (f) cytology department. The Chapter 5 (Categorisation).

223

Asia

India, Chennai (Madras)


from various departments within a hospital for completeness
Registration area
The Madras Metropolitan Tumour Registry (MMTR), a of details.
Mortality information on all deaths occurring in the
population-based cancer registry, was established at the
Cancer Institute (WIA) in 1981 in the network of the National city, irrespective of the cause of death stated on the death
Cancer Registry Programme (NCRP) of Indian Council of certicate, is collected from the Vital Statistics Division
Medical Research, New Delhi, to study patterns and trends (VSD) of the Corporation of Chennai.
Management of data has been progressively computerised
in cancer incidence and mortality in Chennai City (formerly
to minimize the manual work, resulting in the enhancement
Madras). Data collection commenced 1st January 1982.
The city of Chennai is situated at sea level on the of data quality. Reliability of data and quality of registration
Coromandel coast of peninsular India at latitude 13.04 N and are constantly monitored, with emphasis on re-abstraction
longitude 80.17oE. The MMTR caters to an area of 170 km2 and coding on a random sample of cases and case nding.
and a population (entirely urban) of 4.3 million (957 females Validity checks are done using IARC, NCRP and other into 1000 males) as on 1st March 2001, constituting 0.4% and house developed computer programs.
7.0% of the total population
Interpreting the results &
of India and the state of
use of the data
Tamil Nadu respectively. The
INDIA, CHENNAI (MADRAS) (1998-2002)
The
completeness
of
decadal population growth
INDIA, CHENNAI (MADRAS) (1998-2002)
registration of cancer cases
rate during 19912001 was
in MMTR is estimated to be
13.07%, and the population
96%. Cancer information is
density was estimated to be 24
disseminated by publishing
964 persons/km2. The literacy
periodic
reports
and
rate is 85% (M: 90%; F: 80%)

 





descriptive epidemiological
and the predominantly spoken












 

studies on cancer incidence


language is Tamil. The





 

and mortality highlighting the


majority are Hindus (82%)

 












trends and patterns.


followed by Muslims (9%) and







MMTR has been the


Christians (8%), with the rest











 


pioneer
in many registrybelonging to other religious
 
 





related activities in India:


groups (1%).














systematic trace-back of death









certicate notications, active


Cancer care facilities




 


 



 


follow-up of registered cases,


General
health
care,







collection of mortality data


including cancer diagnostic
and survival analysis of top
and treatment facilities, is






"! 3/*1
 %"! 3/*1
ten cancers.
provided by the government




-3-).300)333
"!
A new registry known
health service, the Cancer
as the Dindigul Ambilikkai
Institute (WIA), which is 
  
Cancer Registry, covering
a Regional Cancer Centre %" 33+6657-)))3,3   33-))+3,3-))-(3 !"3 %" 3&3 3 "3" 3 3"33 $3&3   3&3
% 33 $  "!3 3" 3&  3+66+3,3-))+3 3  !"33
 "3(3
33"3+66+(3373
!"!3"&! 3
#!(33  3-.383"%!3 "'3"3#3373
3  (3 " 33
3 "'3"%!3 "3+664(3
33"3-))+(3 3"3
"&! 33 (3"%!3 "'3
7+03  (3 " 33
3 "'3"%!3 "3-))2(3
in Ministry of Health and Family
Welfare, Government a population of 2 million, was started in 2004 to provide
 


  
of India and supplemented by
private practitioners and reliable data on cancer incidence in rural area and to evaluate

3! 3/-))0133
233 3
hospitals. The Radiation Oncology division at the Cancer the randomised eld intervention trial on cervix cancer
Institute (WIA) is one of the best equipped centres in India. under the auspices of the International Agency for Research
Radiation facilities are also available in four Government on Cancer, France.
MMTR provides data to the ICMR project on
and ve private hospitals. Surgical and Chemotherapeutic
services are offered in government and private hospitals and Development of an Atlas of Cancer in India. It is also
involved in a population-screening program on cancers of
nursing homes.
the cervix, breast and oral cavity that is conducted by the
Cancer Institute (WIA) in the neighbourhood.
Registry structure and methods
The MMTR, besides a Principal Investigator, comprises a
medical ofcer, two statisticians, a computer programmer, Source of population
ten social workers and a data entry operator. Cancer is not a Estimated for 19982000 & projected for 2001 & 2002.
notiable disease in India; therefore registration of cases is Population estimates by ve-year age groups according to sex
by difference distribution method using exponential growth
done actively.
The registry continues to enjoy good cooperation from all rate between 1991 & 2001 census populations of Chennai
healthcare facilities in and around Chennai, with more than city. Census of India 1991. Socio Cultural Tables Vol. I
225 sources of registration to date: government and private Series 23, Tamil Nadu, Part IV A C Series. Directorate
hospitals, nursing homes, clinics, consultants, pathology of Census Operations, Tamil Nadu 1997. Census of India
2001. Report and Tables on Age. Tamil Nadu, C14 Series.
laboratories, imaging centres and hospices.
The Social Scientists of the registry visit the collaborating Directorate of Census Operations, Tamil Nadu 2005.
hospitals regularly and collect data on cancer by interviewing
the cases wherever possible and/or medical records. Decient Multiple primary rules used
medical records are updated via linkage of data collected IACR rules (2004) on CI5 IX period.

224

Asia

India, Karunagapally
continued with funding from Health Research Foundation,
Registration area
The Cancer Registry Karunagapally, India is located in the Japan & Local Area Development fund, Government of
Kollam District of Kerala, situated around 9 N latitude Kerala. Registry staff includes one Research Ofcer from
and 77 E longitude. The area is rural as per census RCC, 6 Field Investigators, 3 Data Processing Assistants and
denition; geographically, it is lowlands with backwaters one Statistician.
We adopted active cancer case finding method for
and coastlines. The Registry area covers 212 km 2 (land
area 193 km 2) covering the total taluk of Karunagapally Cancer Registration, as cancer is not a notiable disease
with a population density of over 2000/km 2. The coastal here. The eld investigators scrutinise medical records
belt of this taluk is known worldwide for its rich deposits of of several hospitals to locate cancer cases. More than
rare earth mineral sands containing radioactive materials, 60 sources including Regional Cancer Centre, Medical
mainly thorium. About 100 000 people are constantly College Hospital Thiruvananthapuram, District Hospital
exposed to this radiation. Population is more or less stable, Kollam and Taluk Hospital and other Government
and the majority are agricultural labourers, fishermen, hospitals in Karunagappally are visited regularly. Major
pr ivate hospitals in the
coir labourers, etc. 99% of
registry area and nearby
the people live in rural areas
Kollam town are also visited
and 1% in semi-urban area.
INDIA, KARUNAGAPPALLY (1998-2002)
regularly for case finding.
Births & deaths occurring in
INDIA, KARUNAGAPPALLY (1998-2002)
Further, records maintained
the Panchayats are registered
by Pathological laboratories
in the respective Panchayat
i n Kol la m Dist r ict a nd
ofces.
Thir uvananthapuram and
The three major religions
also of the Vital Statistics
are Hindus, Christians and







d ivision of t he loca l
Muslims. The population at













pa nchayat s a nd Kol la m
the 1991 census was 383 514







Muncipal Cor poration


(189 647 males and 193 867











are scrutinised to locate


females). There has been no

 





cases from the panchayat.


change in area or population














Investigators abstract cancer


covered by the registry since





 

cases d iag nose d by a l l


its initiation in 1990.














methods among residents of









the registry area. Medical


Cancer care facilities














Practitioners give details


Health Care Services in







about t he ca ncer cases


Karunagapally
taluk
is
seen in outpatient clinics.
provided mainly by State






Systematised eld visits are
Health & Family Welfare
 +'$)
  +'$)



&#(+-.#+++

done in the registry area to
Department through a Taluk
locate these cases. Death
Headquarters Hospital, 12 
  
 "+ + +  +  +
registers are available in Vital
Primary Health Centres and +  ++++
"+ +  + +++
+%.-%!+%..%++&##%+ +
%..%++&##%++  +++,"..$!+++ ++ + +  +  +%.-%/%..%+'%#"*-$)"+ + 
+ ++
+&##%+
++  +
 +  +"+ +%..%/&##%+ +  ++ ++ + +
+%..%+  +  ++
Division of the panchayats but the information is
few sub-centres. There are several
Private Hospitals
and Statistics
+ +  + +  !+ ++
+ ++ ++++&###++
 "+
 


  
not adequate for scientic purposes. We trace back all the
Medical Practitioners in the area.
  ++  + +  +
Regional Cancer Centre in Thiruvananthapuram located deaths in the community through house visits and obtain
100 km away and Alappuzha Medical College Hospital relevant information about cause of death etc. Autopsies
65 km away are the two nearest cancer treatment centres are extremely rare, restricted to medico-legal cases. The
collected data are processed and computerised after
offering cancer care and treatment facilities.
There are no cancer detection facilities or dedicated duplicate elimination and checked for consistency using a
cancer treatment facilities in the area except cytology computer programme. Regular evaluatory procedures are
detection facilities, pain clinics and supportive clinics done to ensure accuracy of the registry data.
The radiation effects study has progressed from 1999
offered by the registry with the technical help of Regional
Cancer Center, Thiruvananthapuram. There are no added onwards based on a cohort approach. A radiation cohort
diagnostic facilities like PSA testing in this area, and the with high radiation and a control cohort with low radiation
only regular screening procedure available was Pap smear exposure were selected, and the study was pursued with
individual dose estimation and special surveys like
screening programs.
migration, occupancy, and mortality for in-depth analysis
and estimation.
Registry structure and methods
Regional Cancer Centre, the comprehensive cancer treatment
centre of Kerala, started Cancer Registry, Karunagappally Interpreting the results
as a special purpose registry in 1990. The Registrys main The Registry ofce has a well-equipped cytology laboratory,
objective is to study cancer occurrence and its relation to the and weekly detection clinics are run by the registry in
natural radiation present in the sea coast of Karunagappally Government Taluk Headquarters Hospital. This increased the
taluk. The registry ofce is located in Neendakara. The study microscopically veried percentage of cases. Cancer followand the Registry were initiated in 1990 with the support up clinics, pain & palliative care services, eld detection
of Department of Atomic Energy, and since 1999 it has clinics and Pap screening programmes were organised by

225

Asia

the Registry in which doctors from RCC participated. Thus


cancer cases diagnosed in this area will not be missed due
to intensive casending methods including house-to-house
visits in the registry area.
Use of the data
The main objective of the data is research on the effects of
chronic exposure to the natural radiation. Cancer control
measures and cancer patient services are developed in the
registry area using the registry data. Studies are ongoing
for population-based survival and mortality data analysis.
The registry annually prepares reports on cancer incidence
highlighting trends and changes.

226

Source of population
The Governmental census population data of 1981, 1991 and
2001 were available. The growth rate between 1991 and 2001
in rural Kollam was 7.99%, which was lower than the growth
rate between 19811991 (10.68%). Age-specic census data
of 2001 was not available for Karunagappally Taluk. The
19912001 growth rate was applied to each group of 1991
estimated Karunagappally population and using exponential
growth rate, the population by age and sex as on July 2000
was obtained.
Multiple primary rules used
Impossible to detect multiple primaries.

Asia

India, Mumbai (Bombay)


The registry staff consists of a Deputy Director who looks
Registration area
The Mumbai (Bombay) registry covers the resident population after the day-to-day administration, prepares research articles
of Greater Mumbai, a densely-populated metropolis on the and annual reports, attends National & International conferences
west coast of India, occupying an area of 437.7 km2 between etc.; social investigators (12 involved in data collection); research
latitudes 18190 N and longitudes 70710 E. Greater Mumbai assistants (6 Editing and Coding); two data entry operators; a
is in fact an island joined to the mainland by bridges, and has programmer; an ofce superintendent and two attendants.
Information is obtained on all cancer patients registered in
a warm, humid climate.
The population of Greater Mumbai as per 2001 census (1st 160 Government hospitals/institutions and private hospitals/
March) was 11.9 million with a sex ratio of 811 females per 1000 nursing homes in Mumbai who are under the care of a specialist.
males. It has a density of 2220 inhabitants per km2, making General Medical Practitioners are not contacted individually
it the most populated district in the country. The decennial as according to local practice. Only specialists assume charge
growth rates of the population between 1991 and 2001 were in of cancer patients in private hospitals and nursing homes, and
even the few patients not admitted for hospital care are at some
the order of 20.2. The literacy rate was found to be 87%.
stage referred to a specialist.
The city is the industrial
Staff members of the registry
heart of India. As a result
visit the wards of all co-operating
of continuing immigration
INDIA, MUMBAI (BOMBAY) (1998-2002)
hospitals at least weekly to
it has multi religious and
INDIA, MUMBAI (BOMBAY) (1998-2002)
personally interview each
multilingual
population
cancer patient as well as those
representing every state in the
suspected of having cancer. All
Union, approximately 67.4%
les maintained by the various
being Hindus, 18.6% Muslims,







departments of these hospitals are


3.7% Christians, 5.2% Neo






crosschecked individually. Care


Buddhists and 3.7% Jains,














is taken to prevent duplication


0.5% Parsis and 0.6% Sikhs.






of an entry relating to a patient


 






 






already registered.
Cancer care facilities




 


With the exception of Tata


Municipal Corporation and













Memorial Hospital for cancer,


State Government maintain
 






hospital outpatient records are


the majority of hospitals in












 

not included in the registry les,


Mumbai and the major source







because of the paucity of clinical


of the data is the Tata Memorial














details and the lack of specic


Center, which is a postgraduate
 
 



 

information on the residential


university teaching centre for
status of patients attending
cancer research. The City has






these clinics. Supplementary
five medical colleges. The

*%!'


*%!'
+*&,(***

(*(&#***
information is gleaned from the
diagnosis and treatment of

 


)*($(*+")***

death records maintained by the
cancer is centralised in certain

  
Municipal Corporation.
hospitals. Major cancer surgery 
**

 * 
* * *


*
*
* *"--".# "*
 


  
The registry records follow-up information for almost all
is undertaken in all the major hospitals
and
well-equipped private
* 
*%#
&'**(**
*
nursing homes. Facilities for cobalt60 are available in 9 hospitals, major sites.
Already we have carried out two special studies on the
while ulto-voltage deep x-ray therapy is available in 15 hospitals.
A total of about 30 000 hospital beds are available in evolution of the completeness and accuracy of the data.
the registration area. There have been improvements in
diagnostic facilities, as new hospitals have immerged with Interpreting the results
histopathology and imaging facilities in registration areas. There are no screening programmes underway in the area covered.
Radiotherapy departments have also increased from 2 to 9 Tobacco chewing is very prevalent in both sexes. Smoking,
hospitals. Chemotherapy is available in many new hospitals. particularly bidi, is prevalent in males but almost nil in females.
Registry structure and methods
The Mumbai cancer registry was established in June 1963 as
a unit of the Indian Cancer Society with the aim of obtaining
reliable incidence and mortality on cancer from a precisely
dened urban population. Compilation of data began in
1964. Until then, no continuing activity on registration of
cancer cases in a population had been undertaken in India.
The registry started in collaboration with and up to 1975
received nancial support from the Biometry branch of the
US National Cancer Institute. During 197680 the registry
received Financial support from the Department of Science
& Technology, of the Government of India and the Indian
Cancer Society. Since 198182, the registry has been funded
in part by the Indian Council of Medical Research.

Use of the data


The registry publishes annual reports, and has published
numerous journal articles and monographs. The data are
also used by public health workers for etiological and cancer
control studies. As the oldest registry in the country, the
registry is a rich source of data for studying time trends in
cancer incidence and mortality.
Source of population
Estimated using geometric rate of growth between census
periods of 19912001.
Multiple primary rules used
IACR rules (2004) on CI5 IX period.

227

Asia

India, Nagpur
of these hospitals histopathology and imaging methods are
Registration area
Western Maharashtra, Vidarbha, and Marathwada are three available. In Nagpur there are two radiotherapy centres, and
geographical divisions of Maharashtra state. Nagpur city is chemotherapy treatment is available in 5 hospitals.
the headquarters of the Vidarbha region. The city of Nagpur
is located in the centre of the Indian sub-continent and is Registry structure and methods
linked by air with all parts of the world and by rail and road The Nagpur Cancer Registry division of the Indian cancer
with all parts of the country. Its conguration presents a Society became operative on 1st January 1980, with the
unique combination of plateau, plain, hill and dale along the collaborative effort with Nagpur Medical College, with the
Nag Stream following West-East.
aim of obtaining reliable incidence and mortality data on
Nagpur city has extremely hot summers and moderately cancer from a precisely dened urban population.
cold winters. The lowest temperature reaches to 3.90C in
Since its inception this registry has been nancially
January and the maximum reaches 47.80C in May. The main supported by Indian Cancer Society, Mumbai. The staff of
precipitation occurs during the Monsoon, which begins around the registry consists of 4 Social Investigators (registrars are
involved in data collection)
mid-June and lasts until midand one supervisor (who
October. The average annual
looks after administration
rainfall is about 1130mm.
INDIA, NAGPUR (1998-2002)
and completeness of data
Nagpur city receives its water
INDIA, NAGPUR (1998-2002)
collection). Editing, coding
supply from the Ambazari and
and analysis are carried out at
Gorewara tanks.
the Mumbai Registry Ofce
Nagpur lies on latitude
where 1 coder and 1 DEO are
21N and longitude 79E.







involved.
Nagpur city covers 236.93







Data are maintained on


km2 with a population of 2.05








 





registry proformas and on


million (2001 Census). The







computer les. Duplication


density of population is 8660

 






 





of cases is checked via a


per km2, and the population





 

comprehensive alphabetical
is multi-religious, with 71.4%












 

index card system and by


Hindus, 10.3% Muslims, 1.1%







computer programmes. Data


Christians, and 15.4% Neo
 












analysis is carried out at the


Buddhists.







Mumbai Cancer Registry.


Nagpur city is of historical














The registry does not record


importance. In mythology the







follow-up information.
god Ram traversed this region
in route to the hermitage of






Interpreting the results
Saint Shrutikrishna. He is
 &"$
  &"$
There are no screening
supposed to have proposed on



&##&#('&&&

programmes underway in the
the Ramtek Hill, which has
  

area covered. Tobacco chewing
the name of Ramgiri, where  & &   &  &
& &  & & &
& )) +! &
a very beautiful Meghdoot       
was ))$&
composed and written is very prevalent in both sexes. Smoking, particularly bidi, is
&  &"
  
by the famous Sanskrit poet Kalidas.
Buddhist ruins and prevalent in males but almost nil in females.
 &  &  && & & & && &  &
&  &*& & &%&"  $&
archaeological remains show that this region was underdeveloped until the 18th century. Although it was ruled by Use of the data
the dynasties such as the Vakataka Rajputs, Rashtrakuts, The registry publishes reports every ve years. The State
the Parmars, and the Shails, the semi-aboriginal nomadic Government also uses the data for district cancer control
programs. The data are also used by public health workers
Gaolies also occupied it from the 6th to 16th centuries.
for etiological and cancer control studies.
Cancer care facilities
Information is obtained on all cancer patients registered at Source of population
the 10 major hospitals and 25 nursing homes in Nagpur, and Estimated using geometric rate of growth between census
from the Tata Memorial Hospital and other leading hospitals periods of 19912001.
in Mumbai, as patients from Nagpur go there for treatment
because of their excellent facilities. General medical Multiple primary rules used
practitioners are not contacted individually. Missed cases IACR rules (1990).
are checked via the death records maintained by Nagpur
Notes on the data
Municipal Corporation.
The 10 major hospitals in Nagpur City and 6 major The Editors recommend that some care be taken in the
hospitals in Mumbai contribute data to this registry. In all interpretation of these data; see Chapter 5 (Categorisation).

228

Asia

India, New Delhi


Registration area
Medical social workers visit various collaborating hospitals and
Delhi is a densely populated urban metropolis situated between nursing homes and interviews the patients who are either undergoing
the Himalayas and the Aravalli range in the heart of Indian sub- cancer treatment or being investigated for cancer at radiotherapy
continent. It lies between 28 25 and 28 53 N latitude and 76 department. They also examine the case records maintained
50 and 73 20 E longitude. It is surrounded on the north, west by various departments of these hospitals, viz. Pathology,
and south by Haryana and the east by the Uttar Pradesh.
Haematology, Radiology etc. Many patients present at advanced
The population census is taken every ten years in India, the last stages of disease, and treatment may commence without waiting
one being in 2001. According to the 2001 census the population in for the results of investigations. Therefore even cases diagnosed
Delhi was 13 850 507 (Males: 7 607 234; Females: 6 243 273). The on the basis of clinical ndings alone are also registered. All the
sex ratio in Delhi is 821 females per 1000 males. The density of information collected is cross-checked for completeness of the data.
population is 9 294 persons per km2, versus 6352 persons in 1991. Sometimes the same patient may register in more than one hospital
The total population of Delhi UT as per 2001 census for treatment, so care has been taken to exclude duplicates.
(as on 1 March 2001) was 12 819 761 (Males: 7 030 671;
The death registration system is very inadequate and incomplete;
Females: 5 782 090). The sex
the cause of death often not
ratio in Delhi UT Urban was
mentioned or given as cardio822 females per 1 000 males.
respiratory arrest. The registry
INDIA, NEW DELHI (1998-2002)
staff visits these sources, where
The total area of NCT of
INDIA, NEW DELHI (1998-2002)
they scrutinise the records kept
Delhi is 1483 km2. Per the
in medical records departments,
1991 census, its rural and urban
and registers of individual
composition are 797.66 km2 and
departments concerned with
685.34 km2 respectively. During
the diagnosis and treatment of
Population Census 2001, the area





 

cancers, to identify and abstract


of the NCT of Delhi remained





 








the same at 1483 km2. However,


information on cancer, diagnosed

 





its rural-urban composition has


by all methods, among residents





 





 


undergone change. According


of registry area. These death







records are then matched with


to provisional results released by




 



 





the morbidity records. Cases not


Directorate of Census Operations,







matching with the records are


Delhi, the rural-urban distribution
 


 









registered as Death Certicate


of the NCT of Delhi is 591.91 km2







Only cases (DCOs) in that


and 891.09 km2 respectively.





 


 


 


corresponding year.
Since the population by







All the data collected were


age is available for Delhi
coded using ICD-O-1 and ICDUT urban areas only, it was






 )%"&
  )%"&
9. Inconsistencies in coding are
therefore suggested that Delhi




()+*()*$$)))

corrected using quality check
Registry may be dened for
Delhi UT Urban areas only.   

programmes. Validity checks are
 ) ) )) ) ))) ) ) )#,,+))$!!$)) ) ))  ) ))) ) ) )
also carried out on all variables,
#,+##,,#))$!!#) )   )
      
Registry structure and methods
and records with missing values and impossible codes were checked
 .
.#))%#,+!&)
The population-based cancer registry
at Institute Rotary Cancer against the original les and corrected. Finally, a series of checks
  
 ) )  )) ) ) ) )) )  ) )  )-) ) )')% & )
Hospital (IRCH), All India Institute
of Medical Sciences such as site versus sex and histology, sex versus histology, age,
(AIIMS), New Delhi was established in January 1986 with the etc., were carried out to detect coding or keying errors.
aim of obtaining reliable morbidity and mortality cancer data
among the Delhi residents.
Use of the data
The registry collects morbidity and mortality data on The registry regularly prepares annual/biennial reports on
cancer patients from 159 major government hospital centres and cancer morbidity and mortality along with the cancer incidence,
institutions, more than 250 private hospitals and nursing homes, highlighting trends and changes. Casecontrol studies on gall
and the Dept. of Vital Statistics of the Delhi Municipal Corporation, bladder cancer and prostate cancer among the Delhi resident
New Delhi Municipal Committee and the Cantonment Board.
population have also been carried out. Some special studies
Staff working in Population Based Cancer Registry, Delhi, on patterns of care and survival in breast, cervix and head and
Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute neck cancers are ongoing.
of Medical Sciences, Ansari Nagar, New Delhi-110 029 are 3
scientists in statistics and medicine, 9 medical social workers, Source of population
one data entry operator and one lower division clerk.
The estimation of population for Delhi UT urban for the
Although cancer is not a notiable disease, arrangements years 1998 to 2002 has been done exponential method by
have been made with the hospitals outside the registration area taking as a basis a 1981, 1991 and 2001 census gures.
to notify the registry of resident cases which are diagnosed and
treated in them; they are visited once a month or year to review Multiple primary rules used
these procedures. General medical practitioners are not contacted ICDO1 (1980)
individually, as at one stage or the other almost all cancer patients
are referred to specialists. The smaller nursing homes/clinics are Notes on the data
contacted by letters and registration about cancer patients being The Editors recommend that some care be taken in the
interpretation of these data; see Chapter 5 (Categorisation).
treated by them are recovered on a per forma.

229

Asia

India, Poona (Pune)


and completeness of data collected. Editing, coding, analysis
Registration area
The Poona (Pune) is a district of Maharashtra lying between is carried out in the Mumbai Registrys ofce by 1 coder and
170 & 190 N and 170 & 750 E. It has a dry and invigorating 1 DEO.
Information is obtained on all cancer patients attending
climate due to its attitude (487m) above sea level and the
prevalence of westerly breezes. Its soil is free from alluvial the 35 hospitals in Poona, and from the Tata Memorial
deposits. The lowest temperature is 90C in January and Hospital and other leading hospitals in Mumbai where
maximum reaches 400C in May. Precipitation occurs patients from Poona go for treatment because of the excellent
primarily during the south-west monsoon, which begins medical facilities there. General medical practitioners are
around the middle of June and lasts until mid-October. The not contacted individually, according to local practice only.
average rainfall is about 900mm. Poona city receives its Specialists are in charge of cancer patients in private hospitals
and nursing homes in Poona City. Even those patients not
water supply from Khadakwasala dam nearby.
The Poona city agglomeration covers 344.18 km2 with admitted for hospital care are referred to a specialist by the
a population of 3.55 million (2001 Census). The population general practitioners at some stage.
The
death
records
density in 2001 was 10 330/
maintained by the Poona
km2, and the area supports
Municipal
Corporation
a
multi-religious
group.
INDIA, POONA (1998-2002)
provide
a
means
for
checking
According to 2001 Census,
INDIA, POONA (1998-2002)
on missed cases.
79.7% are Hindus, 8.9%
St a f f memb er s of t he
Muslims, 2.6% are Christians,
registry visit the wards of all co5.8% Neo-Buddhisst, and
operating hospitals at least once
2.2% Jains.







a week to personally interview


Poona city is of great







each cancer patient, including


historical importance. It was














those only suspected of having


once the capital of the old







cancer. All les maintained by


Maratha Kingdom of Shivaji














the various departments of these


and Peshwas. It has been







hospitals are also crosschecked


renowned for its educational














individually. Editing, coding


facilities since the early part







a nd a na lysis of d at a a re
of the century. Being the
 



 






 


carried out at Mumbai Cancer


district headquarters, medical
 






Registry. Data are maintained


and educational facilities are




 



 





on computer files. Duplicates


available in abundance, and







are sought using computer


many industries have been
programs and a comprehensive
established in the city and its






alphabetical card index. No
surroundings.

)$ &


)$ &
patient is followed-up directly

 


!)+(+)#+*)))

by the registry staff.
Cancer care facilities
  

About 10 000 hospital beds 
))

 ) 
) ) )


)
)
) )!,,!."!)
      
are available in the registry area.
The Tata Memorial Center Interpreting the results
) 
)$"%&))'))
)
  
in Mumbai is the only specialised
cancer institute in the There are no screening programmes underway in the area covered.

)  )

))
)
)
)
))
)

) )

)-)

) 
)')$
 &)
India, and patients from Poona often seek treatment there. Tobacco chewing is very prevalent in both sexes. Smoking,
There are 35 major hospitals offering cancer diagnosis and particularly bidi, is prevalent in males but almost nil in females.
treatment facilities in Poona.
There are 16 major hospitals in Poona City and 6 major Use of the data
hospitals in Mumbai that contribute data to this registry. In A ve-year report on cancer incidence and mortality is
Poona and Mumbai hospitals, histopathology and imaging published regularly, and the seventh in this series is ready for
method are available. In Poona city there are 2 radiotherapy publication. The data have also been used for special studies
centres, and chemotherapy treatment is also available in of cancer epidemiology. We report on extent of disease for
9 hospitals. In 1999, a specialised cancer hospital (Inlak all sites, and survival only for breast and cervix. District and
Badharani) was established in Poona City.
state cancer control programmes also use this registry data.
Registry structure and methods
The Poona Cancer Registry, a satellite registry of the
Mumbai Cancer Registry of Poona, commenced operations
on 1 March 1972 as a collaborative effort with the B.J.
Medical College and the Sasson hospital at Poona with the
aim of obtaining reliable incidence and mortality data on a
cancer in a precisely dened urban population. Since then,
the Indian Cancer Society has provided nancial support.
Registry staff includes 3 social investigators for data
collection, and a supervisor who looks after administration

230

Source of population
Estimated using geometric rate of growth between census
periods of 19912001.
Multiple primary rules used
IACR rules (2004) on CI5 IX period.
Notes on the data
The Editors recommend that some care be taken in the
interpretation of these data; see Chapter 5 (Categorisation).

Asia

India, Trivandrum
Registration area
Trivandrum registry is situated in Kerala, the most South
Western state of India. The health status of Kerala is
very advanced, higher than the national average, and is
comparable with developed countries. The registry covers
both urban and rural population. The estimated urban and
rural populations are 568 421 and 589 280 respectively as
on 1st July 2000 using data from the census of India. The
major religion in this part of the population is Hindus (68%),
followed by Christians (18%) and Muslims (13%).

certication by a medical practitioner is not. Hence it is


assumed that cancer deaths are underestimated.
Quality control (QC) procedures: Annually a 10%
random sample is selected from all cases, and re-abstraction
is made by a senior staff member with the help of medical
ofcers at RCC. Re-abstraction is done using the same
procedure adopted for data abstraction, without reference to
the original data. QC data is then checked with the original
data; the error percentage is less than 5%.

Interpreting the results


Registry structure and methods
The population at risk was obtained from the decennial census
The physical location of the registry is at the Regional Cancer gures. The census data for the year 1991 and 2001 are available
Centre (RCC), Trivandrum.
by sex and ve-year age groups.
The registry is partially
The populations for urban and
supported by the Finnish
rural areas are estimated by
INDIA, TRIVANDRUM (1998-2002)
Cancer Society, Finland. Four
using an exponential growth
INDIA, TRIVANDRUM (1998-2002)
eld staff and a data manager
rate method based on 1991 and
work in the registry. The active
2001 census gures (Census of
registration method is used for
India report 1991 & 2001, Final
casending by periodic visits
Population Total, Kerala, India).
to major hospitals, pathology
Further, an organised oral
!!*#,***
+')
!'*',***
laboratories, and vital statistic
cancer-screening programme
-*'((***
+
!!*'(***
!%*(%(***
('
!+*'%%***
ofces in the registry area.
is conducted during the
!,*(+***
(
"*'++***
The major sources of data
reporting period in some rural
""*%((***
''
"#*-***
",*%#+***
'
"+*+!-***
for the registry are the Hospital
populations in the registry
#,*%'***
%'
#+*-(+***
Based Cancer Registry of the
area. PSA testing is not
#,*(#+***
%
#,*+!%***
%'*-("***
#'
%-*#""***
RCC, Trivandrum Medical
common in the population.
%'*-(#***
#
%-*(%,***
College hospitals (two), and
As the registry data (more
%,*'+***
"'
'%*%%#***
'*'!***
"
'%*+,#***
Sree Chitra Thirunal hospital,
than 80%) are obtained from
'*,(***
!'
%-*(%,***
Trivandrum. All four of
the hospital-based registry of
'"*#,#***
!
%-*'#-***
%'*,((***
'
%#*("***
these hospitals are located in
the RCC, information such as
%,*"'-***

%'*%,#***
the same campus. Regional
extent of disease, treatment and
Cancer Centre has excellent
disease status are available for
!
'


'
!
diagnostic and treatment
most patients. Thus the registry

*$ &


*$ &
facilities. Patients come from
data are largely utilised for
',,*(-+***
'(-*'***

all parts of the state of Kerala
cancer control evaluation
and from adjoining states.     


programmes in the state of
* 
*$"%&**'**
*
Annually around 10 000 cancer
patients are reported in Kerala. The data have also been widely used for a variety of
 
  

*  *

**
*
*
*
**
*

* *

*.*

* 
*'*$
 &*
this hospital. In the medical college hospitals, around 2000 analyses resulting in several scientic publications.
cancer patients are reported annually. Other data sources
include a few government and private hospitals, pathology Multiple primary rules used
laboratories and radiological diagnostic centres.
IACR rules (2004) on CI5 IX period.
Information on cancer death is collected from the vital
statistics ofces. For personal identication, name, age Notes on the data
and address of the deceased are obtained from the above The Editors recommend that some care be taken in the
ofces. Death certication is mandatory, but cause of death interpretation of these data; see Chapter 5 (Categorisation).

231

Asia

Israel
Registration area
Israel is home to a widely diverse population. Of its 7 million
people, 76.2% are Jews, 19.5% are Arabs (mostly Muslim) and
the remaining 4.3% comprise Druze, Circassians and others
not classied by religion. In the Jewish population there are
marked differences in incidence based on birthplace: (Europe
and America, Asia, Africa, of Israel). The Israeli population
is growing rapidly, both by internal and external means. In
the late 80s approximately one million (a fth of the existing
population at that time) immigrated to Israel, mostly from
the former Soviet Union. The Israeli population is relatively
young; 9.9% are 65 years old and above.

a le containing all deaths in the country, which it uses to


update vital statuses.
Accuracy and completeness of registration at the Israel
National Cancer Registry (INCR) is checked regularly,
and a systematic review is done every few years. Ongoing
monitoring includes monitoring all reporting sources (more
than 90) for volume of reporting, continuous colloquium
and monitoring changes and by record linkage with specic
cancer databases. A 2003 report based on registration in the
early 1990s, estimated completeness of solid tumours to be
>95% (90% for non-solid tumours). As a result the INCR,
together with the Israeli Center for Disease Control and the
4 HMOs operating in Israel, developed a continuous medical
education
and
training
Cancer care facilities
program. In addition, the
There are 33 public general
Israeli Cancer Organization
hospitals and numerous private
nances 10 clerical positions at
facilities that diagnose and
ISRAEL
ISRAEL(1998-2002)
(1998-2002)
various oncology departments
treat cancer patients, including
for secretaries devoted to
18 public oncology institutes
registration and notication
and several private facilities.
to the INCR. More than 150
There are 7 radiotherapy
clerks, nurses and physicians
institutes with more than
,)*)))
*&(
&*)$$)))
have attended these courses
18 linear accelerators and
',)'')))
*
, )+!)))
+)*!)))
'&
,,)+$)))
to date, and several hundred
other facilities for treating
,")*)))
'
+)")))
attended the seminars.
cancer patients. Radiotherapy
 ),$)))
&&
) )))
&"),')))
&
'$)')))
In 2001, the entire database
institutes
distributed
*"),!)))
$&
+$)&!)))
was converted to ICD-O-3.
throughout the country are
**) )))
$
+')')))
+!)$+)))
"&
++)!)))
Prior to this change, sites
accessible to all patients. There
! ),)))
"
,&)+$)))
were coded by the ICD-9 and
are however only 14 active
!$")')))
!&
!"*)$+)))
!'")++)))
!
!&&)!')))
morphology by ICD-O-2. All
radiotherapists (physicians).
!*")"')))
&
!&,)'+)))
copies of medical documents
!+!)"!!)))

!'+)*)))
!,*)*')))
&
!+!)+')))
are archived (electronically
Registry structure and
"!&)')))

"*),$)))
since 1997), and in cases
methods
where simple code conversion
The Israel National Cancer

&


&

 )#%
  )#%
was not possible, we revised
Registry, established in 1960,
"),*)++$)))
")")&!!)))

the original documentation
is part of the Center for Disease
and assigned the new code.
Control at the Ministry of 
  
The database still contains
Health of Israel. Reporting )  )  ) )  )) )
) ) ))

) )#!$%))
&))  )
has been mandatory since 1982, 


  
and all Israeli hospitals (and backups of the former coding.
since the late 1980s, also the private pathology laboratories)
report, usually by submitting a copy of the medical Interpreting of the results
documentation. Thus data collection is mostly passive, but The Ministry of Health together with the Israeli Cancer
when needed, registry staff visit reporting sources to collect Association and the 4 HMOs operates screening programs
for breast and colorectal cancers. Active mammography
data actively.
Reporting sources include pathology, cytology, and screening began in late 1996, and all women aged 5074
haematology laboratories; hospital discharge forms; receive biennially a personal invitation for screening.
oncology institutes; death notication from district health Screening for colorectal cancer, which began in 2005, is made
ofces; and the le of deaths from the Central Bureau of by Faecal Occult Blood Tests. The recruitment technique is
Statistics. Since 2000, through collaboration with the Israeli the same as for mammography and involves active recruiting.
Hematology Society, all haematologists have been reporting Compliance for the mammography screening is about 60%.
There is no organised cervical cancer screening due to its
the haematological malignancies that they see.
Beginning in the 1970s, several studies have assessed the low incidence. The INCR collects data on CIN-III that can
registrys completeness, with the latest one based on 1994 also serve as an estimation of ad-hoc screening. There is
data. These studies actively searched for cancer patients no ofcial recommendation or screening programme for
in a dened period in major hospitals, and compared the prostate cancer and PSA testing. Survey data show that
resulting data with the registry le. These studies resulted awareness of PSA screening is relatively high and use of this
in estimated completeness rates of >94% (usually >95%) for test is widespread.
There is an elevated risk of radiation-induced malignant
solid tumours.
All Israeli citizens are given unique identication number brain tumours and benign meningiomas after childhood
(at birth or immigration). This number, used in all contacts exposure to ionizing radiation used in the 1950s to treat
with the health system and government departments, tinea capitis, almost exclusively affecting the sub-group
prevents duplication of data. The registry annually receives originating from North African countries. Thyroidal cancer

232

Asia

Use of the data


The registry is involved in active cancer research and
health planning. Numerous record linkage studies have

been performed locally and internationally. The registry


participates in the national council for oncology, the
countrys policymaking body in the eld, collaborates with
HMOs helping them build capacity and monitoring abilities,
participates in new technologies for screening and treatment
implementation, as well as conducting cluster investigations
and disseminating information.

ISRAEL: JEWS (1998-2002)

ISRAEL: NON-JEWS (1998-2002)

morbidity may be increased in that population as well as in


those emigrating from regions in the former Soviet Union
affected by the 1986 Chernobyl accident.

ISRAEL: JEWS (1998-2002)

ISRAEL: NON-JEWS (1998-2002)

"),)))

*&(

&)*')))

&)+)))

*&(

')'+)))

'&)!+)))

*

+') !)))

$)"+)))

*

&)*)))

*$)$)))

'&

, )+$)))

')'+)))

'&

+))))

+")*+)))

'

,*),')))

,),!)))

'

)"$)))

++)$+)))

&&

,')+!)))

")$')))

&&

"+)+)))

&

$*),+)))

&)++)))

&

')+)))

&!)$+)))

$&

'") )))

! )$$)))

$&

! )$!)))

$+)$!)))

$

&+)&+)))

!+)'+)))

$

!+)!)))

$$)$!)))

"&

& )')))

"+)')))

"&

"')')))

&*)"+)))

"

&,),*)))

$$)&!)))

"

"&)

,)*)))

!&

+')+!)))

&!)"')))

!&

&)'')))

!*) +)))

")!+)))

$)))

!

!))))

&')*)))

!

&&)!')))

! ")*!)))

&

!!)*!)))

&,)'$)))

&

&'),')))

! $) !!)))



!")"')))

'+)!)))



'&)"$)))

! $)!)))

&

!")&')))

+")*$)))

&

*,)")))

!!+)!$)))



! ')')))

,')+!)))



, )++)))

&

 )#%
!)$!$)!$!)))

&

  )#%


&

 )#%
!)& *)!&)))

'')!+)))




  
)  )  ) )  )) )
) ) ))


  
)  )  ) )  )) )
) ) ))

 


  

) )#!$%))
&))  )

 


  

) )#!$%))
&))  )

Source of population
Annual population estimates are published by the Central
Bureau of Statistics.

&

  )#%
&+)'"$)))

Multiple primary rules used


IACR rules (2004) on CI5 IX period.

233

Asia

Japan, Aichi Prefecture


The registry staff consists of 2 doctors and 3 registrars,
Registration area
Aichi Prefecture is located in the approximate centre of and a local government ofcer for Registry who is also a
Japan, between latitudes 34.5and 35.2N and longitudes doctor.
A dramatic overhaul of the registration system has
136.5and 137.5E, and is anked on the south by the Pacic
Ocean. The prefecture spans an area of 5,146 km2 and has been undertaken with a view to rationalising Aichi Cancer
a population of 7.4 million. The altitude ranges from sea Registry and strengthening its effectiveness. This has been
level to 1415m. Nagoya, the capital city of Aichi Prefecture, supported by a grant from the Ministry of Health, Labour
is situated about 350 km west of Tokyo. The annual mean and Welfare (awarded 1998). The aims of the Revised Cancer
temperature in Nagoya is 15.6 (5.919.9 degrees) and annual Registry System are: 1) to establish a more comprehensive
organization, with Aichi Cancer Center as a core institution
rainfall is about 1500mm.
The quality of the Aichi Cancer Registry remains for cancer research and treatment, and the prefectural
modest, mainly due to dependence on voluntary-based public health centres as core facilities for community health
operations without legal obligations. During the last 20 years services; 2) to promote the installation of a hospital cancer
registration system in every
we established a model area,
relevant medical institution; 3)
located in the central part of
to provide cancer information
Aichi Prefecture, with goodJAPAN, AICHI PREFECTURE (1998-2002)
and expedite cancer control
quality registry data, covering
JAPAN, AICHI PREFECTURE (1998-2002)
measures in the community.
a reasonable population,
The new system has been in
including both urban and rural
operation since 1999.
areas. The Central Area of
The
research
group
Aichi Prefecture consists of 8














supported by a Grant-in-Aid
cities and one town. The total







from the Ministry of Health,


registration area is 646 km2,














Labour and Welfare from


and the population as of 2000






2004 monitors the quality


was 1 060 529. Only 2.1% of





 






 

in the registry every year. In


the economy is engaged in

 




2006, a national standardised


primary industry; 46.7% is in












 

database system for regional


secondary industry and the




 

cancer registry developed


remaining 50.5% in tertiary














by the research group was


industry.







introduced.
All of the registered














subjects
are
Japanese.

 





Interpreting the results


Buddism is traditionally the
As in other areas in Japan, local
dominant religion (more than






 *&"(
  *&"(
governments support stomach,
90%); however, precise data
%'#***

##!***

 

)')*!)+***

colon, breast, lung and cervix
on religion are not available.
screening. In practice, PSA is

  
***$!!! * **  *#--,**#---* *  **  *
* *#--).$!!!* *** *  *$!!#**
commonly available; however,
Cancer care facilities
$!!$* **  *  
 *
As in large cities in Japan,  


  
every kind of diagnostic/ PSA is not dened as ofcial tool for prostate cancer
 *  *&$!!'(** )**
*
treatment service for cancer is easily available. The costs screening.
required are covered by public health insurance in general;
there is no limitation for access to each service. Radiotherapy Use of the data
In addition to providing descriptive data on cancer incidence,
departments are available in large institutions in the area.
the data have been used for various epidemiological
investigations including cohort studies, case-control studies
Registry structure and methods
Aichi Cancer Registry was established in 1962 as a population- and evaluation of screening programmes for important
based cancer registry, the purpose of which was to form an cancer sites.
accurate picture of cancer in Aichi Prefecture, in order to
control its impact. Initially under the direction of the Aichi Source of population
Prefecture Department of Health and Public Welfare, all Census data in 2000. The data for 1998 and 1999 were
medical institutions in Aichi Prefecture are requested to report estimated by linear interpolation from 19952000
incident cancer cases on the basis of the cancer registry outline. census data, and those for 2001 and 2002 were by linear
The registry has received technical support from the Division of extrapolation.
Epidemiology and Prevention, Aichi Cancer Center Research
Institute, since 1983, and has been subject to periodic evaluation Multiple primary rules used
IACR rules (2004) on CI5 IX period.
by the Administration and Guidance Council since 1984.

234

Asia

Japan, Fukui Prefecture


Registration area
Fukui Prefecture is located in the centre of Japan, and has a
population of about 820 000 people and an area of 4189 km2.
About 90% of the population lives in urban areas (>10 000
inhabitants); 99% are Buddhist.
Cancer care facilities
The six main district hospitals provide radiotherapy, cancer
surgery and chemotherapy services. Patients suspected to
have cancer in the primary and secondary care facilities in
the registry area are mostly referred to these six hospitals.

cancer reports and the copies of death certicates mentioning


cancer are also stored, living cases being led by date of
birth, dead cases grouped by year of death and led by date
of birth. Multiple primary cancers in the same patient are
counted separately.
The research group, supported by a Grant-in-Aid from
the Ministry of Health, Labour and Welfare from 2004,
monitors quality in the registry.
Interpreting the results
Organised screening services for stomach, colorectal and
cervix are operated. PSA testing is not common.

Registry structure and methods


Use of the data
In 1984, the Fukui Prefectural
The data are used for
Government (FPG) decided
geographical analysis in the
to start cancer registration on
JAPAN, FUKUI PREFECTURE(1998-2002)
prefecture and comparison of
a voluntary basis in order to
JAPAN, FUKUI PREFECTURE(1998-2002)
cancer morbidity with existing
obtain information about the
cancer registries in Japan. The
nature and extent of the cancer
registry prepares an annual
problem in Fukui and assist
report of cancer incidence,
in planning cancer control
'*%%***
,')
!#*(++***
+*%%#***
,
!%*!(#***
highlighting
trends
and
programs, and entrusted the
!"*-!***
+'
"*##'***
changes. Some special studies
survey to the Fukui Medical
"*,",***
+
"%*-#"***
"#*##+***
('
"(*++!***
Association (FMA). The
of survival of registered cancer
"#*'!***
(
"'*'"-***
registry is located within FPG
cases (stomach, colorectal
"'*+,***
''
"(*%+***
#"*-',***
'
#"*"%%***
and is staffed by a part-time
and cervix cancer) have been
"-*+#,***
%'
"-*!-%***
registrar and a full-time health
carried out. Policymakers use
"'*-+(***
%
"'*,##***
"%*,#(***
#'
"'*!!(***
worker.
the cancer registry data for
"'*("+***
#
"'*'-#***
The central registry
evaluation of screening for
"+*-#+***
"'
"+*"!(***
"#*-'***
"
"!*-%'***
receives monthly a batch of
gastric cancer and colorectal
"'*+!%***
!'
"%*#%!***
cancer reports transferred
cancer.
"%*+-***
!
""*,,#***
"!*-'!***
'
"*'-,***
from the FMA and death
"*-#"***

"*",***
certicates
from
the
Source of population
Department. Each data card
1998, 1999, 2001, 2002
!
'


'
!
is checked for consistency,
Estimates based on the 1995
 *$ &
 *$ &
!'"***

'-***
coded and stored on computer
and 2000 census data. 2000
%"(*-"+***
%"*'%,***

les. Questionnaires are sent
census (Vital statistics of

  
to physicians who signed !--,*!---"!*""*
 * ***!--'**"*  **"*  **$*   * *&*
Japan).
 


  
death certicates that are unmatched
with cancer reports.
 ****  *
The data in the questionnaire replies are also stored in the Multiple primary rules used
computer le after being checked for logicality. The original Impossible to detect multiple primaries.

235

Asia

Japan, Hiroshima
eld personnel visit the medical record rooms of various
Registration area
Hiroshima City, the capital of Hiroshima Prefecture, is departments and services of most large hospitals in the area,
located in the western part of Japan facing an inland sea. It and review all hospital records, including clinical records,
covers an area of 742 km2, from 13218 to 13241E and from surgical reports, radiology reports, and cytology, pathology
3417 to 3436 N, and the altitude ranges from sea level and autopsy reports. Causes of death are also ascertained at
to 890m. The annual mean temperature of the city is 16.1 that time.
The Hiroshima Prefecture Tissue Registry was started in
and the annual rainfall is about 1320mm. Hiroshima City
is an administratively dened area that does not completely 1973 under the auspices of the Hiroshima Prefectural Medical
correspond to the Hiroshima metropolitan area. The latter Association and has been integrated with the Hiroshima
Prefecture Cancer Registry since April 2005, serving as
includes the city itself and its surrounding areas.
As is widely known, Hiroshima City was destroyed by an an additional source of information. The Tissue Registry is
atomic bombing in 1945. After the war, it developed into the designed to collect and examine surgically removed tumour
administrative centre of the Chugoku and Shikoku regions. tissues; tumours are then classied and tissue slides of
malignant tumours are stored.
The major industries include
Malignant cases residing in
shipbuilding,
automobile,
the city and identied through
metalworking,
machinery
JAPAN, HIROSHIMA (1996-2000)
the Tissue Registry are added
and other manufacturing/
JAPAN, HIROSHIMA (1996-2000)
to the Cancer Registry le.
production.
Cases identied from
The population in 2000 was
various hospitals and sources
1.13 million, comprising mostly
are collated, and data are
Japanese (99%) and very few














stored in computerised les.


non-Japanese nationals (1%).







Checking for duplicate entries


The population density was














is performed manually with


1518/km2 in 2000, slightly






the assistance of a computer.


higher than the 1467 calculated














All cases with possible


in 1990. The proportion of





 

multiple primary tumours are


residents 65 years and over was














reviewed; pathology slides


14.2% in 2000, compared with







from the Tissue Registry are


9.8% in 1990. The population














also reviewed, if necessary.


is primarily urban; 73% of







RERF are involved in all


employees are in the sales trade





 



 

of
the registries mentioned
and service industries, 24% in







above, and 16 staff including


construction and manufacturing
one medical doctor are
industries and only 1% are






employed in the Tumor and
engaged in agriculture and

&!#


&!#
& &&&

$ &&&
Tissue Registry Ofce.
related work.
 


$"$&$ $&&&

''%('''& 
&
&&
&''$&& &
&& &
&
Cancer care facilities
 


  
The number of hospital beds per
100
000 population was
& 
&!
"#&&$&&
&
1351 in 2000, and the number of physicians per 100 000
population was 246. Diagnostic and treatment services for
cancer are abundant in the area, and cancer patients are
treated with radiotherapy in most of the major hospitals.
Cancer screenings for stomach, colon, lung, female breast,
and cervix uteri are provided in local governments and
workplaces as well as private sectors. PSA testing is also
widely available.

  

Cancer registry and structure


The Hiroshima City Medical Associations Tumor Statistics
registry was established in 1957 with technical support
from the Atomic Bomb Casualty Commission (ABCC),
predecessor of the Radiation Effects Research Foundation
(RERF). As of April 2005, the registry has been placed
under the auspices of the Hiroshima City government and
renamed the Hiroshima City Cancer Registry.
The case-nding and data-collection procedures
combine both active and passive approaches. All physicians
and hospitals in the city are requested to report tumour cases
to the registry. However, the great majority (about 90%)
of cases are accessed by means of hospital visits. RERF

236

Interpreting the results


Since a majority of cases are ascertained by visits to large
hospitals, cases missed by not including all area hospitals
present a source of concern. However, a previous survey of
three medium-sized hospitals not included in the regular
data abstraction schedule showed the number of missed
cases from medium-sized hospitals to represent less than 1%
of the total cancers.
Use of the data
The objectives are to maintain a source of information on
tumours diagnosed in the community and to provide cancer
incidence data for studies on the effects of exposure to
radiation from the atomic bombing in 1945. This has resulted
in a number of large-scale cancer studies in the area.
The incidence data are used for health promotion
planning for Hiroshima City.
Source of population
19961999 Estimates based on the 1995 and 2000 census
data; 2000 census.
Multiple primary rules used
IACR rules (2004) on CI5 IX period.

Asia

Japan, Miyagi Prefecture


Registration area
Miyagi prefecture is situated in the northern part of Japan,
between latitudes 37 and 39N and longitudes 140 and
141E, and is anked on the east by the Pacic Ocean.
Sendai, the capital city of the prefecture, is situated about
350 km north of Tokyo. The annual mean temperature in
Sendai is 12.3C, and the annual rainfall is about 1200mm.
The altitude ranges from sea level to 1841m. The total
registration area is 7291 km2, and the population as of 2000
was 2 365 320, including 10401 foreigners (4515 male and
5886 female). Of the economically active population, 26%
is engaged in personal services, 25% in commerce, 15% in
industry and 5% in agriculture.

each area. Radiation therapy is available at the university


hospital, one cancer centre (Miyagi Cancer Center), and
several general hospitals.
Cancer cases are registered from clinics and hospitals
(inpatients and outpatients), radiology and pathology
departments, autopsy records, mass screening records and
death certicates. Reporting by clinics and hospitals is
voluntary. About 30% of cases are reported from hospitals
and clinics, and 70% abstracted by the registrars at the cancer
registry. Multiple primary cancers are counted separately in
computing incidence.
All the death certicates of Miyagi Prefecture are
collated with the registered cases. Follow-up is passive,
with only perusal of all
death certicates. Active
follow-up of the cases is not
JAPAN, MIYAGI PREFECTURE (1998-2002)
currently conducted. Quality
JAPAN, MIYAGI PREFECTURE (1998-2002)
of the information recorded
is evaluated by the research
group supported by a Grantin-Aid from the Ministry of

 










 

Health, Labor and Welfare.

Registry structure and


methods
The
Miyagi
Prefectural
Cancer Registry (formerly
Miyagi Cancer Registry,
initiated in 1951 by the late
Professor Mitsuo Segi at the
Department of Public Health,







Tohoku University School
















Use of the data


of Medicine) marked its







In addition to providing
47th year since registration














descriptive data on cancer


was restarted in 1959. The







incidence, the data have


registry has covered the














been used for various


entire prefecture from the







epidemiological investigations
beginning. The ofce has been

 



 








including
evaluation
of
located in the Miyagi Cancer







screening
programs
for
Society since 1976. Miyagi













cancers of the stomach,


Prefecture provides grants for







colon, prostate, cervix and


cancer registration, and the
breast, and population-based
Miyagi Cancer Society also






prospective cohort studies of
supports it nancially. All

,(%*


,(%*
&$.,,,
#
++,,,
cancer and lifestyle factors
the work of the registry is the




&,&+-,&-+,,,

(such as smoking, drinking,
responsibility of the Registry

  

,!
,,
,&..+,,'$$$,
,#,'$$$,
#,,&..+,  ,
, , ,#,'/'/$)",
and diet).
Committee,
comprising &..-",&..."'$$&",'$$', 
/
#,,'$$$,  ,
, , ,#'/'/$)",/
,
representatives of the Miyagi Medical
Association, Tohoku
 


  
,
,('$$)*,,,,
University Graduate School of Medicine, Miyagi Prefecture, Source of population
and the Miyagi Cancer Society. The registry is staffed by a 1998, 1999, 2001, 2002 estimates based on the 1995 and
part-time medical doctor, three full-time registrars and three 2000 census data. 2000 census. 1995 Population census of
Japan vol. 2204.
personnel.
In Sendai, cancer diagnostic and treatment services MiyagiKen. 2000 Population census of Japan vol. 2204,
are mainly provided at Tohoku University Hospital and MiyagiKen.
several general hospitals. Provincial areas outside Sendai
are divided into nine secondary medical care areas; a few Multiple primary rules used
general hospitals provide cancer diagnosis and treatment in IACR rules (2004) on historical data.

237

Asia

Japan, Nagasaki Prefecture


sets. With respect to cases recorded as cancer, if there are
Registration area
The Nagasaki Prefectural Cancer Registry is a community- no matched cases among the registered cases, the cases are
based cancer registry covering the entire prefecture. Nagasaki registered as DCO (death certicate only).
Medical organisations in Japan are not legally required to
prefecture is located on the western end of the Japanese
archipelago, comprising 4092 km2 and 1.52 million people le notices of cancer cases. As a result, obtaining notication
(based on a 2000 National Census). The proportion of non- of cancer cases remains difcult, particularly in Nagasaki,
since data collection has traditionally depended on medical
Japanese citizens is only 0.3% of the total population.
One third of the prefectures population resides in Nagasaki record abstraction. A Personal Information Protection Law
City, where shipbuilding is one of the primary industries. For became effective in April 2005. However, the Ministry of
the overall prefecture, the combined proportion of service Health, Labour and Welfare informed medical organisations
and retail/restaurant industries is over 60% of the total, that providing cancer registries with incident data would
while the manufacturing industry including shipbuilding be exempt from application of this law, thus avoiding any
comprises 12%. The combined proportion of agriculture, decrease in registration rate caused by the laws effects.
For the pur pose of
forestry and shery makes up
preventing errors in coding and
only 1% of all industries.
entry, varied logical checking
Nagasaki Prefecture also
JAPAN, NAGASAKI PREFECTURE (1998-2002)
functions are utilised at the time
contains 55 inhabited islands
JAPAN, NAGASAKI PREFECTURE(1998-2002)
of data entry. Also, comparison
whose residents comprise 10%
among the registry cases is
of the prefectures population.
conducted once a year to prevent
This is a primary reason for
overlapping, with error in such
the difculty of providing
/,'#!,,,
.)+
$',.!%,,,
#%,$%',,,
.!
$*,!'-,,,
comparison work detected at a
medical care uniformly within
$%,/-!,,,
-)
%/,%!-,,,
rate of about 0.2%.
the prefecture.
%*,')',,,
-!
'-,//',,,
'$,*#%,,,

*)

)#,/*-,,,

'$,)-%,,,
*!
)!,.-%,,,
Interpreting the results
Cancer care facilities
'$,%..,,,
))
'/,#%!,,,
)-,**.,,,
)!
)/,)/),,,
In 1958 a cancer registry
Nagasaki Prefecture does
)-,-/-,,,
')
).,.$-,,,
covering Nagasaki city was
not have a cancer centre but
'.,-$!,,,
'!
)!,/'#,,,
'$,--/,,,
%)
'*,%#',,,
started, and in 1985 the
does have 13 hospitals where
'!,/%#,,,
%!
'),%/.,,,
Nagasaki Prefectural Cancer
more than 100 cancer cases
'$,-*!,,,
$)
'*,!-/,,,
%-,$/$,,,
$!
'#,!.),,,
Registry was initiated, thus
are treated annually. These
'/,%#$,,,
#)
'-,./-,,,
covering the entire prefecture.
hospitals are concentrated in
'*,/)!,,,
#!
'',*$',,,
'!,.!*,,,
)
%.,/$/,,,
Concerning the effect of the
Nagasaki city and in the city
%-,!!!,,,
!
%),$'),,,
changes of coding rules on
of Sasebo, and 70% of cancer
incidence, it is conceivable
patients in the prefecture are
#!
)
!
!
)
#!
that the incidence of MDS and
 ,&"(
 ,&"(
treated at hospitals in these
)$%,,,

$)-,,,
.!),%#%,,,
-#%,#.!,,,

uterine cervical severe dysplasia
cities.
have contributed to an increase
Nagasaki
Prefecture 
  
in incidence because these two
also has cancer screening #//.,#///$!!#,$!!$,  , ,, ,#//),,$!!!, , ,$!!!,  ,,&,,
,(,
facilities, where examinations  


  
are conducted for cancers of diagnoses are coded as malignancy using ICD-O-3.
,  ,&$!!'(,, ,,
Although screening has been conducted for stomach
the stomach, colon, lung, breast and uterus.
cancer (12.4% participation), colon cancer (16.5%), lung
cancer (27.5%), breast cancer (16.9%) and uterus cancer
Registry structure and methods
The Department of Epidemiology of the Radiation Effects (18.7%), such screening is not obligatory and the participation
Research Foundation houses the central registry ofce of rates are not very high. Recent changes of note are increased
the Nagasaki Prefectural Cancer Registry, which consists of use of mammography in breast cancer screening and change
one physician, nine full-time employees, and a few part-time in the eligible age for undergoing uterus cancer screening
from 30 years and over to 20 and over. Although PSA testing
employees.
The Nagasaki Prefectural Cancer Registry collects cancer is commonly utilised, it is still being debated whether the test
incidence data mainly by abstraction from clinical records, should be used in cancer screening, and as a result testing
and three of the full-time staff members are exclusively remains unorganised.
Many A-bomb survivors still reside in Nagasaki, on
engaged in visiting hospitals for such abstraction work.
Every year these staff members visit 2030 hospitals (most which an atomic bomb was dropped in 1945. The effects
are hospitals with 200 beds or more) within the prefecture of A-bomb radiation on cancer incidence remain, but there
to collect the necessary information. We also make an effort have been no other reports on environmental or occupational
to collect data on pathological diagnoses with support from exposure that could affect cancer incidence.
pathologists. Cases with histological diagnoses comprise
more than 80% of the registered cases. Data on cancer Use of the data
cases detected in such screening programs have also been Every year we compile and announce the incidence, mortality,
and survival on cancer in Nagasaki prefecture, and we also
obtained.
The Nagasaki Prefecture government provides data on participate in a project to estimate nationwide cancer incidence
all deaths within the prefecture, enabling verication of the in Japan, providing the project with our data. Our data are
deaths in the registered cases through matching both data often used for research purposes, thus greatly contributing

238

Asia

to the elucidation of association between radiation exposure


and cancer incidence. Additionally, the data are frequently
utilised in descriptive epidemiology involving ATL/ATLL,
which are unique to Nagasaki Prefecture. For governmentrelated purposes, our data is also utilised in the design of
medical projects and assessments of cancer screening.

Source of population
1998, 1999, 2001, 2002 estimates based on the 1995 and
2000 census data; 2000 census. (Vital statistics of Japan).
Multiple primary rules used
IACR rules (2004) on historical data.

239

Asia

Japan, Osaka Prefecture


Registration area
Osaka Prefecture is located in the central part of the main
island of Japan. The surface area is the second-smallest (1893
km2), but its population density is the second highest (4652/
km2) among all 47 prefectures in Japan. Osaka City is the
capital of the Prefecture. The population of Osaka Prefecture
was 8.8 million in the 2000 census; 98% were Japanese, 1.5%
Koreans, and 0.2% Chinese. Of all workers, 30% are engaged
in industry, 68% in commerce, and 0.5% in agriculture.

hospital-based cancer registries, and assist in notication of


cases to the OCR.
In order to assess accuracy and completeness we have
incorporated a data check program compatible with the
IARC-CHECK, and routinely used several validity indexes
such as DCN/I, DCO/I, I/D and HV/I.
The Osaka Prefecture Privacy Protection Law has been
effective since October 1996, while the Prefecture Privacy
Protection Council has approved the schemes of OCR as
legitimate under the Law. On April 2005 a Privacy Protection Law
came into effect in Japan, but informed consent is waived when
personal information is needed to improve public health, including
submission of cancer data from medical institutions for populationbased cancer registries.

Registry structure and methods


The Osaka Cancer Registry (OCR), covering Osaka Prefecture,
has been operating in cooperation with the Osaka Prefectural
Department of Health and
Welfare (OPDHW), the Osaka
Medical Association (OMA)
Interpreting the results
JAPAN, OSAKA PREFECTURE (1998-2002)
and the Osaka Medical Center
According to recommendation
JAPAN, OSAKA PREFECTURE (1998-2002)
for Cancer and Cardiovascular
of the Japanese Ministry of
Diseases (OMCCD) since 1962.
Health, Labor and Welfare,
women over age 30 have been
The central registry, located in the
screened for cervical cancer
Department of Cancer Control














since 1982 (proportion of cases


and Statistics of the OMCCD, is





 

receiving screening was 16.5 %


staffed by 9 regular employees (2

 












medical doctors, 2 public health


in 2001, in Osaka), and for breast
 



 


nurses, 2 system engineers, 1


cancer since l987 (11.2%). The











 
 

operator and 2 clerks) and 7 partpopulation over age 40 has been


 






time workers.
screened for stomach cancer since














The OMA requests that


1982 (15.7% in male and 11.8%







all medical institutions in


in female), lung cancer since
 



 









the Prefecture cooperate


1987 (9.2% in male and 6.5% in





 

with cancer registration, and


female) and large bowel cancer














prepare cancer reports when


since 1992 (11.2% in male and





 

cancer diagnoses are made. The


9.0% in female). The screenings
cancer reports are sent to the
are all opportunistic and the






OMA, and they are transferred
proportions screened remain
"! 3.*0
 %"! 3.*0
+)3,62333
(
13/-+333
monthly from the OMA to the
low in Osaka. PSA testing is not




/3-)/3)16333
"!
central registry. Information on
common yet in the population.

  
 3 %" 3&3! "3 
!"3 %3 3+6613"3,)))3 3""'3"3 3 3,))+3"3,)),3
death certicates mentioning ,)))3 (3 3""3 3+6653"3+6663
 3&3! "3 $"
!"(3 73,)))(3"3 "'3"" % 3"3 "3 '3 % 3 3"
"'3,)))3
!"3
cancer is also obtained through 3 3"
"'3#!(3,8,8,43)""8  (3'3,))+(3+661(3"3 "'3"" % 3"3 "3 '3 % 3 3
the OPDHW.
Use of the data
"
"'3+6613
!"3 3 3"
"'3#!(3,8,8,43 ""8  (3'3+662(3
The data are processed in an 


  
annual batch via mainframe, The major objectives of the OCR are (1) to estimate incidence
 3! 3.+66)03
although the data processing has changed to an online network rates, (2) to compute statistics on medical treatment given
with client-server system. Computerised record linkage is to cancer patients and (3) to estimate survival for cancer
used to avoid duplicate registration, distinguish multiple patients. Annual reports including these statistics have
primaries, and identify registered cases who died of cancer been published. Summary statistics of these can be seen
and cancer deaths that had not been registered. Computer- on the OMCCD website (http://www.mc.pref.osaka.jp/
produced possible matches are shown and resolved manually ocr_e/index.html). The OCR takes the initiative to conduct
through referring to the original reports.
epidemiological research, and policymakers use our cancer
In order to evaluate survival of cancer patients, active follow- registry data for planning and evaluation of health services.
up to ascertain vital status has been undertaken progressively.
High-quality survival data have been available for patients Source of population
diagnosed from 1975 except for Osaka City, and all patients 2000 census. The data for 1998 and 1999 were estimated by
diagnosed after 1993 in Osaka Prefecture. Proportion of the linear interpolation from the 1995 and 2000 census data, and
lost-follow-ups has been 1-2% at ve years after diagnosis.
those for 2001 and 2002 were by linear extrapolation. Refs:
The OCR has implemented cancer information service 2000. Statistics Bureau, Management and Coordination
programs since 1975. The prognoses of reported patients, as Agency, Government of Japan, 2000 Population Census of
well as cancer statistics of each hospital, are provided at the Japan, Vol. 2227 0sakaPrefecture. Tokyo, 2001. 1995.
request of participating hospitals or hospital doctors. The Statistics Bureau, Management and Coordination Agency,
central registry holds an annual conference to report and Government of Japan, 1995 Population Census of Japan, Vol.
discuss cancer registration activities, inviting representatives 2227 OsakaPrefecture. Tokyo, 1996.
from all large and medium-sized general hospitals and
clinical departments of medical university hospitals. Since Multiple primary rules used
1999 software has been developed and distributed to support IACR rules (1990).

240

Asia

Japan, Yamagata Prefecture


Registration area
The Yamagata prefectural cancer registry covers the entire
Prefecture of Yamagata, which is located in northeastern
Japan. It lies between latitudes 37 and 39N and longitudes
139 and 140E. The total registered area is 9323 km2,
and over two thirds of the area consists of forests and
mountains.
The 2000 census determined the total population of the
Yamagata prefecture was 1 244 147 and composed of 99.6%
Japanese nationals. Of working adults, 54% are engaged in
the sales and service industry, 35% work in construction and
manufacturing, and 11% work in agriculture. The population
of people who are 65 years and over was 23% in 2000 and
16% in 1990.
Cancer care facilities
In 2000, Yamagata had 2307
physicians (1.9 per 1000
inhabitants) and 11 336 hospital
beds (excluding psychiatric
hospitals). The prefecture
is divided into 4 healthcare
districts. Each district has
several core general hospitals,
where two thirds of the
cancer patients in Yamagata
prefecture are diagnosed and
treated. Eight of the hospitals
have a radiotherapy unit.

about these cases. The registry staff has access to all death
certicates with their personal information. A research group
supported by the Grant-in-Aid from the Ministry of Health,
Labour and Welfare since 2004 monitors quality standards
in the registry every year.
In 2005, we performed data cleaning for all registered
data in 2005, including converting site and histological codes
from ICD-10 and ICD-O-3 to ICD-O-3.

Interpreting the results


The establishment of three major general hospitals in 1976,
1993 and 2000 likely altered the availability of diagnostic
and/or treatment services. Since our establishment in 1974,
there has been no serious
environmental or occupational
exposure that may inuence
JAPAN, YAMAGATA PREFECTURE (1998-2002)
cancer incidence in the
JAPAN, YAMAGATA PREFECTURE (1998-2002)
population.
Organised
screening
programs are conducted in
Japan (for gastric and cervical
,*%"-***
,')
"*%***
!"*(-+***
,
""*,%,***
cancer since 1961 and for colon,
""*(!%***
+'
#'*,",***
lung and breast cancer since
#%*%+'***
+
%%*-#***
#,*!(,***
('
%'*%+%***
1987). Screening for breast
#(*-#***
(
%!*(#(***
cancer by mammography
#(*-***
''
#+*+,***
%,*+('***
'
%'*#+'***
was introduced in 2002.
%,*!-+***
%'
%(*++***
The prostate cancer cases
%*,+,***
%
%*"-***
#'*-",***
#'
#'*-%,***
diagnosed by opportunistic
#%*#"#***
#
##*-'(***
PSA testing have been
#(*"+!***
"'
#%*,+!***
##*(%***
"
#!*!(!***
increasing in several hospitals
#+*'''***
!'
#'*+,#***
recently.
#'*(!"***
!
#%*!'!***

Registry structure and


#!*',***
'
"-*-("***
methods
",*'(%***

"+*"(#***
The Yamagata prefectural
Use of the data
cancer registry was established
The registry provides periodic
!
'


'
!
in 1974. The prefectural
reports on cancer incidence
 *$ &
 *$ &
!,#***

!***
government nances the
and
ve-year
survival
(%#*#'(***
(!*!,(***

registry. A full-time medical
statistics. The regional health

  
doctor as the medical !--,*!---"!*""*
 * ***!--'**"*  **"*  **$*   * *&*
authority for planning and
supervisor and researcher staffs 


  
the registry, and also a full- evaluating health services uses the data. The data are also
 ****  *
time and a part-time registered staff member since 2004. used to estimate cancer incidence in Japan.
Before 2004, it was staffed by a part-time medical doctor
and a part-time registered staff member.
Source of population
Although cancer is not a notiable disease, the main 1998, 1999, 2001, 2002 estimates based on the 1995 and
method of data collection is passive notication. To increase 2000 census data; 2000 census. (Vital statistics of Japan).
the number of notications, the registry staff supplements
their casending with pathology reports from several major Multiple primary rules used
general hospitals and request physicians to be notied Impossible to detect multiple primary.

241

Asia

Korea
cancer registrar training, (3) analyses and summary of data
Registration area
The Republic of Korea (South Korea) occupies the southern from the central and regional cancer registries, (4) carrying
portion of the Korean Peninsula. It lies between longitudes out administrative tasks related to the registry.
The KCCR established the Korea National Cancer
124 and 131E and latitudes 33 and 38N, and has an area
of 99 500 km2 including about 3000 islands. South Korea is Incidence Data Bases (KNCIDB) by merging the KCCR
highly mountainous, and lowlands constitute only 30% of mother DB and all 8 population-based Regional Cancer
the total area. There are seven cities with provincial status Registry databases, the site-specic cancer registry
databases (breast, uterus, ovary, oral cavity, liver cancer),
and nine provinces.
The population of the Republic of Korea is 48 million the medical record review survey and the cancer mortality
(2005 estimates), which the Central Cancer Registry is database from National Statistics Ofce. For the medical
supposed to cover. Its population density of 493/km2 is one review survey, a 1999-2003 cancer claims DB from the
of the highest in the world. Annual population growth has National Health Insurance Corporation was also used. The
dropped steadily from more than 3% in the late 1950s to dataset was rened further by conrming multiple primaries
and removing duplicates with
0.38% in 2005. Due to rapid
expert help from various
urbanisation, 80% of the
elds-clinicians, pathologists
population is now classied
KOREA (1999-2002)
and medical recorders.
as urban. The population is
KOREA (1999-2002)
In an effort to improve
ageing very quickly: The 2003
the KCCR data quality,
population estimate revealed
data completeness has been
that 8.3% were 65 years old
evaluated, with a preliminary
or over; 71% were aged 1564














result as high as 90.3%. We


years. South Korea is one of the




 


are in the process of evaluating


most ethnically homogeneous





 






 

the accuracy of stomach


countries in the world. Most







cancer data through abstractpeople are ethnically Korean.












 
 






reabstract method, and plan


Buddhism and Christianity are






 


to perform the evaluation on


the largest religions in South











 






a regular basis for additional


Korea, but Confucianism,









types of cancers.
rather a philosophy than a


















religion, is in many ways more











Interpreting the results


prominent in Korean culture

 
















To cover cases diagnosed


than any organised religion.

 
 






outside
KCCR-afliated
In 2004, the economically
hospitals, we perform an
active population was 23.3






 .)%+
  .)%+
additional medical record
million. Of this gure, 8%




'(./(&.,(-...

review survey and supplement
were engaged in agriculture,
our data with cases from
forestry and shing; 27% in 
  
0 .  .) .  .. .&..+".!... ". .  .
regional registries. Thus
industry; and 65% in services.  .  . .. . .  ...
  . .  ....   .. . . .  .. #.
 


  
data completeness in areas with regional registries may be

. .)'$$*+..
,.. .
different from those without.
Cancer care facilities
In 2000, most teaching hospitals in Korea could not
In 2005, there were approximately 1500 hospitals in Korea,
1000 of them, including 29 multidisciplinary cancer provide medical service properly at least for 3 months due
treatment units, providing specialised cancer diagnostic to a doctors strike. Delayed diagnosis and reporting of new
and therapeutic services. There were 60 radiology units and cases resulted, which could decrease the number of 2000
123 specialists nationwide in 2006. In addition, 2500 out of cases and increase the 2001 cases.
The National Cancer Screening Program (NCSP) was
26 000 private clinics provide general cancer care services.
implemented in 1999 and has since expanded its target
population and cancers. NCSP provides screening for
Registry structure and methods
The Korea Central Cancer Registry (KCCR) was one stomach, liver (high-risk groups only), cervical, breast and
of the ambitious projects of the Ministry of Health and colorectal cancer. Opportunistic screening is also common.
Welfare in 1980. Beginning in 1982, 47 general hospitals Annual PSA testing is actively recommended by urologists
voluntarily participated in this program. Participating for men aged over 50. Though there are no ofcial data, most
hospitals and registered malignancies increase annually, men over 50 have received a PSA test.
Even though the 2003 Cancer Act clearly stated that
and 154 of 242 teaching hospitals participated in 2005. The
KCCR is composed of a chief, an executive secretary (head cancer registration should be performed to know the burden
of cancer registration), a medical ofcer, 6 cancer registrars, of cancer, privacy protection laws prohibit access to personal
6 statisticians, and 11 advisors. In a 2004 workshop for information. An amendment to the Cancer Act to allow
the new cancer registry manual, approximately 300 cancer access is underway.
registrars attended from the hospitals.
The KCCR is responsible for (1) collection, analysis Use of the data
and management of national cancer statistics, (2) technical The KCCR has released its annual reports since 1983, and
and nancial support of regional cancer registries including published Cancer Incidence in Korea 19992001 in August

242

Asia

2005 as the rst cancer incidence report based on the entire


population using KNCIDB. Annual data are published in
the ofcial journal of Korean Cancer Association (Cancer
Research and Treatment). The KCCR provides data
without personal information to researchers as well as other
government departments for statistical analysis. Registry
data are essential to evaluate cancer control programmes in
Korea, including the National Cancer Screening Program.

Source of population
The population used to calculate cancer incidences is a
midyear population (the population at the 1st of July), but in
this report, the modied resident registration population data
that is released annually from the Korea NSO was used.
Multiple primary rules used
IACR rules (2004) on CI5 IX period.

243

Asia

Korea, Busan
Registration area
In 1995, the Busan Cancer Registry (BSCR) was established
in cooperation with the Cancer Centres of four University
hospitals, and has administratively been supported by the
Department of Public Health and Sanitation of Busan City
and the Medical Association of Busan. The Korean National
Cancer Control Program is responsible for the nancial
support of the registry, with technical support from the
Korea Central Cancer Registry.
The city of Busan is located on the southeastern tip of
the Korean Peninsula, between latitudes 3452 and 3523
N, and longitudes 12852 and 1298 E. The city has an
area of 531.17 km2. At the 1995 census, the total population
of Busan was 3 806 888, of
whom 99.6% were Korean.

Statistical Ofce (NSO), and are compared with Registry


les. If a deceased person were not registered, the Registry
staff would obtain the appropriate medical records from the
hospital where the case was diagnosed and treated.
We are in the process of evaluating the accuracy of
stomach cancer data through abstract-reabstract method,
and plan to perform the evaluation regularly for additional
types of cancers.

Interpreting the results


We collected data according to ICD-O-2, but reported in
ICD-O-3 format.
In 2000, most teaching hospitals in Korea could not
provide
medical
service
properly for at least for 3
months due to a doctors
KOREA, BUSAN (1998-2002)
strike. As a result, diagnosis
Cancer care facilities
KOREA, BUSAN (1998-2002)
and reporting of new cases
In
2005,
there
were
were delayed, which could
approximately 110 hospitals
decrease the number of 2000
including
teaching
and
cases and increase the cases
general hospitals (4 university














reported in 2001.
hospitals and 22 general







Even though the Cancer


hospitals) in Busan. Because














Act launched in 2003 clearly


Korea is a one-day life zone







stated that cancer registration


for the whole country, every














should be performed to know


cancer patient can go to other







the burden of cancer; the


regional hospital if he/she
 










 


regulations prohibit accessing


wants.







personal information based on


 






 



 


the personal privacy protection


Registry structure and
 






law. The amendment of the


methods












 

Cancer Act to allow access for


The nation-wide, hospital-based







personal information based


Korea Central Cancer Registry
on the National Statistics Law
(KCCR) was established in






is underway. Registration of
1980 and has been managed
 -)%+
  -)%+
2003 cancer cases is ongoing.
by the Ministry of Health and




&-.//-(&*--
The Korean Government
Welfare (MOHW) since then.

  
0 -  -) -  -- -&--+"-!--- "- -  began implementing the
All inpatient cancer cases are  -  - -- - -  --  - -  ----   -- - - -  -- #voluntarily notied to the KCCR
by the Medical Record National Cancer Screening Program (NCSP) in 1999 and
 


  

- -)'$$*+--
,-- has since expanded its target population and target cancers.
Department of about 80% of teaching hospitals.
In 1995, a pilot study was conducted to expand the into In 2006, NCSP provides cancer screening for 5 major
a population-based registry of Busan. We found that 72% cancers including stomach, liver (only for high-risk groups),
(67% from hospitals in Busan; 5% from other places) of the cervical, breast and colorectal cancer. Urologists actively
total incidental cancer cases could be registered using the recommend annual PSA testing for men aged over 50. There
is no available information on the prevalence of the test;
KCCR data and the remaining 28% by active registration.
In Busan, there are 26 large hospitals including four however, most men over 50 receive a PSA test.
university hospitals and additional 80 medium- and smallsized hospitals. Among these, 22 teaching hospitals notify all Use of the data
inpatient cases as well as some of outpatient cases to KCCR. The Registry holds an annual conference to report and discuss
The KCCR annually gives data to the BSCR on the cancer cancer registration activities in Busan, and invites oncologists
patients living in Busan at the time of their initial cancer from the four University hospitals, representatives of the
diagnosis. Cases from hospitals in other places are treated Association of Anatomical Pathologists and Diagnostic
similarly. Additional cancer cases from outpatient clinics are Radiologists, radiation therapists and medical recorders of
identied from the records of the Departments of Anatomical the Busan hospitals. The President of the Medical Association
of Busan and the Chief of the Department of Public Health
Pathology, Diagnostic Radiology, and Radiation Oncology.
Three part-time medical ofcers visit 110 hospitals and Hygiene of Busan City are also invited.
The data are published in an annual report that provides
that are currently not notifying cancer patients to the
KCCR, and collect the medical records of newly diagnosed the basic statistics on cancer incidence that may be helpful for
cancer patients. They register the cancer cases, which are evaluating survival of cancer patients. BSCR data, included
then scrutinised by Registry faculty members under the in the KCCR data, is provided without personal information
supervision of the Registry Director. Death certicates of to researchers as well as other government departments for
all cancer patients are obtained annually from the National statistical analysis. The cancer registry data are essential to

244

Asia

evaluate various cancer control programs in Korea, including


the National Cancer Screening Program.
Source of population
The population used to calculate cancer incidences is a
midyear population (the population at the 1st of July), but

in this report, the modied resident registration population


data that is released annually from the Korea NSO was
used.
Multiple primary rules used
IACR rules (2004) on CI5 IX period.

245

Asia

Korea, Daegu
Registration area
Daegu is an extended metropolitan city in southeastern Korea with
a well-dened geographical border surrounded by mountains.
It covers an area of 885.56 km2. The climate is temperate; it is
situated at 128 E and 35 N. The 2000 population was 2 473
990 by 2000 census report. About 6% of the population lives in
rural areas. Korea has virtually no ethnic group except Korean,
only about 151 000 persons being registered as foreigners
nationwide. However, international marriages are increasing
rapidly, especially in rural areas. The proportion who had more
than junior college education is 18.7%. More than half (52.4%)
of Daegu citizens reported practicing a religion in 1995; 33.1%
Buddhist, 11.6% Protestant, 6.7% Catholic.
Cancer care facilities
Medical care for the whole
population is covered and
provided by the National Health
Insurance Plan. Daegu has 16
223 hospital beds in 2002, in 74
hospitals (12 general hospitals,
51 hospitals, 9 dental hospitals,
and 2 mental hospitals), of which
four are university hospitals and
1274 private clinics. There are
4722 doctors including dentists.

records. Mortality les containing data on all cancer deaths are


obtained annually from the Korea National Statistical Ofce.
Cancer cases on insurance claims not matched to DCR data
are followed back to the hospitals to conrm the diagnosis. The
data are processed using the IARC/IACR CanReg software.
The registry uctuations in reporting of new cancer cases by
institution and source of case-nding are analysed monthly and
annually. The registry carries out reabstracting and recoding
periodically and uses CanReg to ascertain multiple primaries and
DEPedits to see unusual combinations of various kinds. Conventional
medical records are being replaced by EMRs (electronic medical
records) including inpatient records in some university hospitals. We
are establishing a new system to more efciently collect computerised
incident cases.

Interpreting the results


There was no change in area
KOREA, DAEGU (1998-2002)
or population covered during
19982002. The DCR has been
using ICD-O-2 for coding since
its inception. However, several







doctors strikes happened during









2000, substantially lowering



 












cancer cases diagnosed that









year. DCO% is 4.4 (males 4.5,



 












females 4.4).







Organised stomach, breast,










 





Registry structure and


cervical,
liver and colorectal







methods
cancer screening programmes













Daegu
Cancer
Registry,
for persons aged more than 40







nancially supported by the


began in 1999. However, these














Ministry of Health & Welfare,


programmes
are not the same







has been collecting new cancer


as those in developed countries.
cases in Daegu since 1 January
Some of their costs are just







($ &


($ &
1997. Located in the Dongsan
covered by Gover n ment




!(")#(%"#(((

Medical Centre, Keimyung
subsidies. During 19992002,
University, the staff consists 
  
the uptake rate of the screening
of two doctors, one medical 
(

( (
(  ** (
(
((
("(
( (
(  ( (
(( (
tests was very low. We do not
 


  
( 
($"%&(('((
(
records administrator and one medical
records technician.
collect information on whether a cancer case is diagnosed by the
Cancer reporting is voluntary in Korea. DCR receives screening or diagnostic tests, so the number of these included in
inpatient cases from the medical record technicians responsible for our databases is unknown. PSA testing in Korea is opportunistic; it
reporting cases to the Central Hospital Cancer Registry (CHCR), is usually done as part of Comprehensive Health Checkups but
and inpatient cases with an address in Daegu treated outside it there are no statistics to cite.
direct from the CHCR. CHCR has been collecting cancer cases
from major member hospitals in Korea since 1980. The staff of Use of the data
the DCR visits every major hospital dealing with diagnosis and DCR is an incidence registry and is not actively collecting survival
treatment of cancer to nd and abstract cancer cases from sources data on registered cases. It collects vital status when the information
other than inpatients, such as pathology, haematology, CT/MRI, is available, for example from medical records, death certicates
nuclear medicine and radiotherapy medical records. The cases or the ofcial cancer mortality data. It does not collect stage of
from the other sources in hospitals are followed back to the disease. Currently, the registry is being used in Effects of doctors
original medical records to check the addresses, unique Resident walkouts on cancer cases diagnosed in 2000 in Daegu, Estimation
Registration Number (RRN) and diagnosis date. The staff also of lifetime and age conditional probabilities of developing cancer,
visits private pathology laboratories to review pathology reports Survival of gastric cancer patients in the young, and Changes of
and sends query letters to physicians who sent their samples to cancer stages for major cancers in 19972003. We are planning
the laboratory to obtain further information.
to establish an occupational cancer registry as well as a birth
After checking for duplicates, the database is matched defect registry as ramications of the DCR.
against two external data sources, the ofcial cancer mortality
data and insurance claims. Cases not already in the database Source of population
become Death Certicate Notication (DCN) cases because The estimates of the populationatrisk are based on the 2000
death certicates do not contain information that makes follow- census, making allowance for births, deaths and migration.
back possible. Instead, the RRN is used to clear the DCNs. The
DCNs were matched with the databases of the seven major Multiple primary rules used
hospitals using the RRN to find out and abstract medical IACR rules (2004) on CI5 IX period.

246

KOREA, DAEGU (1998-2002)

Asia

Korea, Daejeon
medical record review surveys, site-specic cancer registry
Registration area
Daejeon is located in the centre of South Korea: 167.3 km databases and cancer mortality data for identifying Death
from Seoul, 294 km from Busan, and 169 km from Gwangju. Certicate Only (DCO) from the Korea National Statistical
The city is located between 1273321 and 1271454 E Ofce (KNSO).
In an effort to improve the quality of the KCCR data,
longitude, and 361050 through 362947 N latitude.
Daejeon is surrounded by four mountains and located along an evaluation of data completeness has been conducted, in
three major rivers; the city originally developed from farms particular cases diagnosed during 19992001 and cases
and houses that were on the hillsides and the valleys between deceased until 2003. We used the ow method developed
them. The three rivers divide the citys ve boroughs: Dong- by Bullard et. al (Br. J Cancer 2000). The ow method is
gu and Daedeok-gu are located east of Daejeoncheon; Jung- based on the concept that registration is a time-dependent
gu is between Daejeoncheon and Yudeungcheon; Seo-gu is event observed after diagnosis, following a probabilistic
between Yudeungcheon and Gapcheon; and Yuseong-gu is approach. The overall 3-year completeness of all cancer was
west of Gapcheon.
90.5%, 90.7% in males and 90.3% in females. There were
Daejeon is the fth among
no differences in gender and
South Koreas largest six
among different age groups.
cities, including Seoul, Busan,
We are in the process
KOREA, DAEJEON (1998-2002)
Daegu, Incheon, and Gwangju.
of
evaluating the accuracy
KOREA, DAEJEON (1998-2002)
Its population is 1 390 510 and
of stomach cancer data
it covers an area of 539.83 km
through
abstract-reabstract
at the end of 2000.
method, and plan to perform
The population is mainly
the evaluation on a regular
" """
$!
"$"""
""""
$
""""
of the Asian race (mostly
basis for additional types of
" """
#
$" #"""
Korean);
religions
are
cancers.
#"%"""
#
"$$"""
""""

 "%$"""
Buddhism 26.0%, Christianity
$"%$"""

" """
Interpreting the results
20.6%, Catholicism 5.4% the
"$"""

" """
""""

%" %"""
We collected data according
others 1.6% and no religion
"#%"""

" #"""
to ICD-O-2, but reported in
46.5%.
""""

"#"""
"#%"""

" """
the ICD-O-3 format.
"%"""

" #%"""
To cover cases diagnosed
Cancer care facilities
"%"""

" """
%"#$$"""

%"%#"""
outside
Daejeon hospitals, we
Both public and private sectors
"%"""

 " $"""
performed additional medical
provide cancer-related services
" """

#"$ """
$" """

"%%#"""
record review surveys and
in this region. General health
"$ """

#" """
also supplemented our data
care in the region is provided
with cases from KCCR.
by the 9 general hospitals and






In 2000, most teaching
20 hospitals (2003). Daejeon
 "
 "
hospitals in Korea could
cancer registry cooperates
$"$#%"""
$%" """

not provide medical service
with 6 registry hospitals and

  
properly at least for 3 months
many non-registry hospitals.    ""  "
 


  
due to doctors strikes regarding separation of prescribing
There were 4 therapeutic radiology
units in 2006.
 "
 """""
"
Also, the Korean government provides the National Cancer from drug dispensing. As a result, diagnosis as well as
Control Programme, mainly related to cancer prevention, reporting of new cases were delayed, which could increase
screening and supportive-palliative care including National the reported cases in 2001 as the incidence date is the rst
Cancer Screening Program, Terminal Cancer Patient date of diagnosis on cancer.
Urologists actively recommend PSA testing for men
Management, Home-based Cancer Patient Management through
National Cancer Center of Korea. Private hospitals provide aged over 50 annually. There is no available information on
mainly diagnostic and therapeutic services.
the prevalence of the test; however, most men aged over 50
receive a PSA test once in their lifetime.
Registry structure and methods
Cancer is not a notiable disease in Korea; however the Use of the data
Cancer Act (2003) clearly states that cancer registration must The registry prepares an annual report of cancer incidence,
be performed to know the burden of cancer. The Daejeon highlighting trends and changes. Some special studies of
Cancer Registry (DJCR) is a population-based registration survival of registered cancer cases will be carried out.
that has been in operation since 1998. The registry is located
The cancer registry data is essential to evaluate various
in Medical School of Chungnam National University. A cancer control programs in Daejeon, Korea including the
medical doctor, a full-time registrar and one part-time National Cancer Screening Program.
registar staff the registry.
The DJCR is responsible for (1) collection, analysis and Source of population
management of Daejeon cancer statistics; and (2) analyses Census and estimate.
and summary of data from Daejeon cancer registries. The
data sources for the Daejeon cancer incidence database are Multiple primary rules used
the DJCR, the KCCR database, the data from additional IACR rules (2004) on CI5 IX period.

247

Asia

Korea, Gwangju
registered. Data obtained from outside sources are reviewed
Registration area
Gwangju (formerly transliterated into English as Kwangju) with the collaboration of Korean National Cancer Institute
has 1.36 million inhabitants and is situated on the and other regional cancer registries.
Death certicate data are obtained from the Korea
southwestern tip of the Korean Peninsula. The city is the
economic, educational and cultural centre of essentially rural National Statistical Ofce. The death certicate data are
surrounding provinces. The rapid transition of the Korean then merged and veried with the GCR database, teaching
economy from agriculture to manufacturing industries hospital records and cancer claims data. Subsequently, the
during the authoritarian governments during the past 30 years death certicates, which have no linked information, would
leaves the area to suffer from low income and emigration of be treated as death certicate only (DCO).
Our registry has regularly evaluated the completeness and
working-age population to the more industrialised parts of
accuracy of information recorded through record linkages
the country.
The 1980 uprising proclaiming the democratic with other registries, routine checks using the IARC tool,
governmentthe Gwangju democratization movement and reabstracting of medical records.
The Ministry of Health
allegedly made the city
and Welfare of the Korean
politically well known.
government provides nancial
There
are
some
KOREA, GWANGJU (1998-2002)
support.
manufacturing
industries
KOREA, GWANGJU (1998-2002)
including an automobile
Interpreting the results
assembly plant, though the
In Korea, there are ve
service industries occupy
national screening programs
the majority of the citys
.$$+++
-(*
&+#"#+++
#+ &&+++
- 
(+)) +++
for stomach, colorectum,
workforce.
&+&()+++
,(
.+$# +++
breast, uterine cervix, liver
,+," +++
, 
"$+ ,,+++
"#+&$-+++
)(
",+$,-+++
cancer. PSA testing has
Cancer care facilities
".+,.&+++
) 
##+--$+++
increased during this period
According to 2002 statistics,
#(+&$,+++
((
#)+- (+++
$"+$(&+++
( 
$#+)".+++
even though it is not involved
the city has 10 general
$-+.- +++
&(
& + #.+++
in routine screening for
hospitals, 24 hospitals with
((+# )+++
& 
()+&,&+++
)"+" $+++
$(
) +"))+++
cancer, and its inuence on
7674 hospital beds. Two
)&+. #+++
$ 
)$+&.&+++
the prostate cancer incidence
traditional medicine hospitals
)(+,&-+++
#(
)(+ ($+++
)$+&$(+++
# 
)#+.&&+++
is not clear. ICD-O-2 was
also provide palliative services
)"+#$-+++
"(
(,+)& +++
used for years 19982002;
to cancer patients.
(#+("(+++
" 
&-+),.+++
(.+"$-+++
(
($+&$#+++
for incident cases from 2003,
($+.#.+++

&.+)"$+++
ICD-O-3 has been used.
Registry structure and
methods
"
(
(
"

+%!'


+%!'
Use of the data
The Gwangju Cancer Registry
)-.+&,,+++
)- +$(.+++

The cancer incidence and
was established in 1997 after
other statistics contained in the
a yearlong feasibility study. 
  
annual report are recognised
The registry is operated "..-+"...+# +# "+# #/+


+  +
++ +


+  +% ++"...+# +# "+# #+# $'+
+ 
+%#
by director, part-time medical 


  
staff &'++ ++
and one or two full- as ofcial public data of Gwangju metropolitan city.
Each year the Registry submits the annual report to the
time registrars. The registry has a management committee
composed of directors and oncologists of major hospitals City Hall. The City Hall then makes a public announcement
and the chief of the Gwangju metropolitan city health of the statistics and distributes copies to the relevant
department. The committee determines the major direction agencies. Local health departments and public health centres
of the registry activities and cooperates in data collection use Registry data for planning or evaluation of their health
as well as advocates the registry. There is also a practicum services. We permitted access to our registry database for
committee composed of hospital medical record keepers to public health and clinical study, if not conicting with our
condentiality guidelines.
handle the practical details of cancer registration.
The Registry has participated in some epidemiological study
The majority of the case information is linked to
the Korean Central Cancer Registry (KCCC), which is for regional difference of cancer, such as thyroid cancer.
Follow-up for survival of cancer patients and publication
provided by teaching hospitals throughout the country. The
corresponding hospitals in the city provide the data directly of an English version of the annual report are under
to our registry. Data on Gwangju residents registered from consideration.
hospitals outside of Gwangju city are obtained from KCCC
database. The cancer claims data for medical insurance Source of population
are also used, especially for the non-teaching hospitals. 1998, 1999, 2000, 2001, 2002: Registered population; the
The pathology reports without signicant hospital records, statistics of registered population (Gwangju city, 1999, 2000,
outpatient department (OPD) reports and radiation oncology 2001, 2002, 2003).
records are also examined for adjuvant information.
The registrar reviews the original information by hospital Multiple primary rules used
visit and medical record check. The justied cases are nally IACR rules (2004) on historical data.

248

Asia

Korea, Incheon
Registration area
Incheon is the third largest city in South Korea and is located
on the western part of the Korean peninsula with the sea
to the west and metropolitan Seoul to the east. It is an
industrialized city with a well-established medical delivery
infrastructure. The population of the city according to socialID registration by Statistics of Incheon city was about 2.63
million in December 2005. Most of the population is Korean
(98.6%).

ofcials, and has performed mail research to identify cancer


patients from the hospitals which had identied the patient as
having died of cancer.
ICR primarily classies cancer patients by ICD-O-3 and
multiple cancer and other specic classications in accordance
with the KCCR guidelines based on IARC manual. ICR uses
its own registration format, which has more mandatory and
optional items than KCCRs, and removes duplications and
errors from the data by an ICR computer programme.
Follow up information is obtained predominantly by
passive methods. These include obtaining cancer mortality
Cancer care facilities
More than 100 medical institutions are in Incheon, and three information from death certicates in the Vital Statistics
university hospitals are available in diagnostic and treatment section. The mortality data are periodically matched with
the incident cancer database
service for cancer. Patients
using the National Identity
suspected to have cancer in the
number. The vital status of the
primary and secondary care
KOREA, INCHEON (1998-2002)
unmatched incident cases is
facilities are mostly referred
KOREA, INCHEON (1998-2002)
also ascertained by review of
to one of the three University
medical records. However, all
hospitals. Two hospitals have
incident cases for which death
all cancer treatment facilites,
information is not forthcoming
10 have chemotherapy, 3 have
#,/'*,,,
.)+
),'#-,,,
',%)',,,
.!
.,.%.,,,
are presumed to be alive on
radiotherapy and 46 have
.,.%.,,,
-)
#*,%/.,,,
the last day of the year for
surgery.
#%,)!#,,,
-!
$',!/!,,,
$$,'#',,,
*)
%$,%*',,,
which the mortality data are
%',-/),,,
*!
'!,'*-,,,
fully utilised for matching.
Registry structure and
'',/*#,,,
))
'),-'.,,,
)-,.%-,,,
)!
)%,%-%,,,
methods
.#,//!,,,
')
-',#/!,,,
Interpreting the results
The Incheon Cancer Registry
#$*,.-),,,
'!
##),!%',,,
#%.,*/',,,
%)
#%!,#/!,,,
National cancer screening
was organized in 1997 by
#$/,.%',,,
%!
#%!,-//,,,
programs have been applied
Inha University Hospital in
##%,%'!,,,
$)
##$,*.-,,,
/-,)%!,,,
$!
/','%/,,,
for cervix and lung cancer.
collaboration with the Korean
//,-.-,,,
#)
/',$#%,,,
The incidences of prostate
Central Cancer Registry
/-,#'.,,,
#!
/!,').,,,
###,)/*,,,
)
#!#,$%),,,
cancer have been very low as
(KCCR) and is incorporated in
/',*!!,,,
!
.*,)'*,,,
compared to other developed
the International Association
countries, so the national
of Cancer Registries.
#!
)
!
!
)
#!
cancer screening program
Financial
support
is
 ,&"(
  ,&"(
#,$)*,'.*,,,
#,$.!,!'$,,,

did not cover PSA test for
provided primarily by KCCR
detection of prostate cancer.
and partly by Inha University 
  
,$!!!, ,
 ,$!!#,$!!$, ,
Many individual hospitals
Hospital. ICR was composed #//.,#///, ,,, , ,,, , ,,  
,, , ,,, , ,,   ,
of 7 members, 5 from Inha University
Hospital and 2 from employ PSA testing on a case-by-case basis.
 


  

, ,&$!!'(,,
),, ,
GachunGil hospital.
There are four main sources of cancer registry in Use of the data
ICR. The primary source of the ICR data is the registry We report the incidence of cancer annually by site, sex and
les from the KCCR (Korean Central Cancer Registry) at age excluding extent of disease or survival to the government.
National Medical Center, which are transferred from each Policymakers in government use regional cancer registry
regional cancer registries including ICR, allowing ICR to data, including Incheon Cancer Registry, for developing
collect cancer cases diagnosed in Incheon as well as outside health services or laws.
Incheon. The secondary source was cancer cases registered
at non-KCCR hospitals in Incheon. Others come from health Source of population
insurance documents (medical insurance claims) and death 1998, 1999 estimated, Annual statistics of Incheon city on
Registration of Social Identication. 2000 National Census.
records from the National Statistic Ofce.
Trained medical record administrators (MRA) review 2001, 2002 estimated, Annual statistics of Incheon city on
the inpatient and outpatient medical record including Registration of Social Identication.
pathologic, radiologic and endoscopic reports. To collect the
death certicate cases from death records, ICR has applied Multiple primary rules used
the public-health personnel with the support of Incheon city IACR rules (2004) on CI5 IX period.

249

Asia

Korea, Jejudo
epidemiology. The other staff member is a medical recorder
Registration area
The Jejudo registry covers the population of Jejudo Island, who visits the regional hospitals that are able to diagnose
which is situated in the southern part of Korea peninsula, cancer; reviews medical charts, and gathers information
between latitudes 33 and 34 N and longitudes 126 and about cancer incidence.
126 E, and is the largest island in South Korea with a total
Among the six hospitals in Jejudo, two teaching hospitals
area of 1848 Km. The island came into existence 700 to report all inpatient cancer cases as well as some outpatient cases
1200 thousand years ago when lava spewed from a sub-sea to KCCR. The KCCR annually offers information to the JCR on
volcano and surfaced above the waters. The annual mean the cancer patients with an address in Jejudo at the time the initial
temperature reaches 17C and the annual rainfall is about diagnosis of cancer is made. Another source of registration is an
1676 mm. It is famous as the clean island in Korea because active search by the registrars for cancer patients diagnosed in
there are no industrial factories giving rise to air and/or the non-KCCR registered hospitals in Jejudo. The registrar visits
environmental pollution.
these hospitals to review and abstract medical records of potential
The population as of 2001 was 546 696. Of the economically cancer patients who appear in the list of cancer claims submitted
active population, 71% is
to the NHI. This list also serves
engaged in the service industry,
as a good source for tracking the
25% in agriculture including
identity of cases notified by a
KOREA, JEJUDO (2000-2002)
shing, and 4% in industry.
death certicate alone.
KOREA, JEJUDO (2000-2002)
The religious distribution
Death certificates for all
in residents is as follows:
cancer patients are obtained
Buddhist 36%, Christian 17%,
annually from the National
Confucian 3%, and atheist
Statistical Office, and are
"""
$!
""""
"#"""
$
"$"""
44%. Almost all of residents
compared with the le entries
"$$#"""
#
"#"""
are Korean; the proportion
of cases in the registry using the
"#"""
#
#"##"""
#" """

""""
of foreigners is 0.1%. Thus,
unique Resident Registration
""""

"#"""
we exclude events of cancer
Number (RRN). The cases not
"#$"""

"%"""
""""

"#$"""
incidence in foreigners.
already registered in the databases
 " %"""

 """"
become Death Certificate
"#%"""

"%"""
"%"""

"#$"""
Cancer care facilities
Notication (DCN) cases. For
 "%"""

"#"""
the DCNs, the registrar searches
Medical care for the whole
""""

"$$"""
"$%"""

" $ """
population is covered and
and reviews medical records from
""""

%" """
the six hospitals using RRN.
provided by the National Health
$"$ """

#"%"""
""""

""""
The JCR evaluates the
Insurance (NHI) Plan. All
"%# """

%""""
validity of the registry data
six hospitals (two general and
with the IARC CHECK
four private) on the island can






 "
 "
program and re-abstracts the
diagnose cancer. However, one
#""""
#" """
 
medical records to check for
general and one private hospital
errors in the data.
among them can treat cancer 
  
patients because only these two    "
 


  
  " "  "  "

"
hospitals have oncologists and cancer
treatment facilities including Interpreting the results
radiotherapy departments. Hospital beds in these hospitals total There was no change in area or population covered during
the period of 20002002. The JCR has been using ICD-O-3
1528, approximately 2.8 beds per 1000 residents.
for coding since its inception, and there has been no change
in case denition and coding.
Registry structure and methods
The NHI in Korea supports a biennial cancer screening
Jejudo Cancer Registry (JCR) has been collecting new
cancer cases occurring in Jejudo since 1 January 1999. It is program for all Korean people aged above 40 years, including
located in the Cheju National University College of Medicine Jejudo residents. The sites covered by the programme are
(CNUMC). It receives nancial support from the Korean stomach by endoscopy, colon by colonoscopy, breast by
National Cancer Control Program, and is administratively mammography, uterine cervix by Pap smear test, and liver by
supported by the Department of Public Health and Sanitation ultrasonography. PSA testing is not common but is feasible
as it is not expensive.
of Jejudo Provincial Government.
The Ministry of Health and Welfare (MOHW) established
the nationwide, hospital-based Korea Central Cancer Use of the data
Registry (KCCR) in 1980. According to the KCCR program, The registry prepares an annual report of cancer incidence,
the medical records department of nationwide teaching highlighting trends and changes in Jejudo, Korea. Some
hospitals noties all in-patient cancer cases voluntarily. In special studies of the utilisation pattern of medical services
2000, a pilot study was conducted to expand the pre-existing in the registered cancer cases have been carried out.
hospital-based registry into a population-based registry for
Jejudo. It was found that 78% of the total incidental cancer Source of population
cases could be registered using the KCCR data and that the Census.
remaining 22% could be collected by active registration.
There are two staff in the registry. The chief, taking total Multiple primary rules used
responsibility for the operation the registry, has majored in Impossible to detect multiple primaries.

250

Asia

Korea, Seoul
Registration area
The Seoul Cancer Registry (SCR) covers the population
of Seoul Metropolitan city, the capital of the Republic of
Korea. The population at the most recent census (2001) was
10 263 336, about 21% of the total population of the country.
The Korean population is very homogeneous, with a
very small Chinese minority of around 20 000. Traditional
culture is mostly based on Confucianism, while Buddhism
(25%) and Christianity (19%) are two of the most vigorous
religions.

mid-sized hospitals to review and abstract medical records


of potential cancer patients who made insurance claims for
cancer to the Association of Korean Medical Insurance. The
insurance claim data also serves as a good source for tracking
the identity of cases notied by a death certicate alone.
The third source is the death certicates to nd the
vital status of the registered cases and to register the
Death Certicate Only cases (DCO). Death certicates
from the National Statistics Ofce (NSO) cover all deaths
occurring in Korea and include the full National Identity
Number issued by the Korean Government to every
Korean citizen at birth. The quality of death certicates
Cancer care facilities
Cancer care in the region is provided predominantly by large in Seoul is good, about 98% being certied by medical
doctors.
teaching hospitals and midsized hospitals, numbering 63
Using both the health insurance
and 117, respectively, in 2003.
data and mortality data further
KOREA, SEOUL (1998-2002)
There are also 5948
enhances the completeness of
KOREA, SEOUL (1998-2002)
clinics and 25 community
the registration.
health centres, but cancers
The SCR evaluates the
are rarely conrmed in these
validity of the registry data
facilities. Patients suspected
with the IARC CHECK
"$$$$
&!#
$$$$
$"!$$$
&
$"$$$
to have cancer in primary
program and re-abstracts the
$!"$$$
%!
"$%!$$$
clinics and community health
medical records to correct the
!$%!$$$
%
&%$$$$
$%&$$$
"!
$%$$$
centres are referred to one of
errors in the data.
%$$$$
"
%$&&!$$$
the teaching hospitals, except
$'"$$$
!!
$!!%$$$
&$&"$$$
!
&'$!$$$
for some elderly patients
Interpreting the results
&$'&$$$
!
!%$$$$
who decline further medical
The size of the population and
!$&$$$

"$"%%$$$
&$&&&$$$
!
$%'&$$$
work-ups. This might cause
the number of medical facilities
%$&"$$$

'$!$$$
incomplete registration among
to be covered make it necessary
!$&%$$$
!
!%$!!'$$$
&'$$$$

"'$"!$$$
the elderly, unless the elderly
to accept the data from KCCR
'$%$$$
!
%"$!"$$$
cases are captured through the
pre-coded by many medical
$'!&$$$

&$$$$
!$&"$$$
!
'%$&'$$$
death certicates. Ninety-nine
recorders from each hospital.
"$!"%$$$

&$'"%$$$
percent of cancers occurring
Although the Association of
in Seoul are treated in Seoul,
Medical Recorders continuously

!


!

and about 76% of patients
instructs its members on
 $
 $
treated in Seoul are from
cancer registry methods, the
$'$$$$
$'$!!$$$

outside the city.
process still calls for a constant

  
Apart
from
these  $
$   $($$
evaluation of the validity of the
 


  
facilities, there are 2545 clinics
and$$!$$ $
hospitals practicing registry data.
$  $
traditional oriental medicine. Although most cancer patients
Around 1998, opportunistic screening for breast and
resort to western medicine eventually, some patients would thyroid cancer started to become popular among women.
only go to these traditional oriental clinics. These patients The rapid increase in thyroid cancer among women could be
are not registered to SCR unless they are captured through accounted for by this change in screening rate.
the death certicates.
Uses of the data
Registry structure and methods
The registry produces reports on cancer incidence by sub
The SCR is located in the Department of Preventive district in Seoul, Korea. A special study of survival for all
Medicine, Seoul National University College of Medicine, cancers has been carried out.
and in the Department of Social and Preventive Medicine,
Sungkyunkwan University School of Medicine. It is funded Source of population
by the Ministry of Health and Welfare. There are two part- Seoul Population Census : 2000
time medical ofcers, one data manager, and four full-time
registrars.
Multiple primary rules used
The SCR uses several sources of data nding. About 87% IACR rules (2004) on CI5 IX period
of the SCR data are registered through the Korean Central
Cancer Registry (KCCR). KCCR is operated by voluntary Acknowledgement
registration from teaching hospitals throughout the country. We thank Dr. Jae-Gab Park and Dr. Keun-Young Yoo, the
The second source of registration is active case nding former and current President of National Cancer Center in
by the registrars. The registrars make visits to about 81 Korea, for their support to SCR.

251

Asia

Korea, Ulsan
Registration area
The Ulsan Cancer Registry (UCR) covers the population of
Ulsan metropolitan city in Korea. Ulsan is a representative
port city located in southeastern region of Korea. It covers
an area of 1056.7 km2. The population at the most recent
census (2000) was 1 012 110. About 84% of the population
(>850,000 inhabitants) lives in urban areas. In general, Korea
has virtually no other ethnic group except Korean and only
2318 persons are registered as foreigners in Ulsan.
The annual mean temperature in Ulsan is 14.3 C, and
annual rainfall is about 1272 mm.
Ulsan has become a rapidly industrialised city, accounting
for 12.2% of the manufacturing industry in Korea. The
main industries are the
petrochemical, shipbuilding,
and automobile industries.
Cancer care facilities
Medical care for the whole
population is covered and
provided by the National
Health Insurance Plan. In
2004, Ulsan had 7279 hospital
beds and 39 hospitals (2
teaching hospitals, 1 general
hospital, 23 hospitals, 2
dental hospitals, 3 psychiatric
hospitals,
4
sanatorium
hospitals, and 4 traditional
medicine hospitals), of which
one is a university hospital,
and 912 private clinics. The
university hospital provides
cancer surgery, chemotherapy
and radiotherapy services.

The third source is the death certicates. The cases


not already registered in the UCR database become Death
Certicate Notication (DCN) cases. Death certicates from
the National Statistics Ofce (NSO) cover all deaths occurring
in Korea and include the unique Resident Registration Number
(RRN) issued by the Korean Government to every Korean
citizen at birth. The RRN also serves as a good indicator for
tracking cases notied by death certicate alone.
In addition to these three major sources, several secondary data
sources, such as log les from pathology laboratories and radiotherapy
departments, help to identify unregistered cancer patients.
The UCR evaluates the validity of the registry data with the IARC
CHECK program and re-abstracts the medical records to check
for errors in data. A formal
evaluation of the data is done in
collaboration with the Korean
KOREA, ULSAN (1999-2002)
National Cancer Centre.
KOREA, ULSAN (1999-2002)

 













































 












































 















 







 























 





Interpreting the results


There has been no change in
area or population covered by
the UCR during the period
19992002. The UCR has
been using ICD-O-2 for
coding since its inception, and
there has been no change in
case denition and coding.
There are 5 cancer screening
programs in Korea, namely
cervix, breast, prostate, stomach
and liver. If prostate cancer is
suspected or if symptomatic
of BPH, then PSA testing is
regularly performed.

Use of the data





&""'&)('''

Registry structure and
The registry produces annual

  

'

' '
'  ** ''
''
'!'
' '
'  ' ''
''''' 
''

'
methods
reports on cancer incidence
 '''' '
'
 '
'
The registry is located in the department
of occupational and and mortality in Ulsan. The data have been used for several
 


  
' 
'#!$%''&''
'
environmental medicine, Ulsan university hospital, and is epidemiological studies on primary, secondary and tertiary
funded partly by Ministry of Health and Welfare, and partly prevention of cancer. The registry is especially interested in
by the citys health department. Two part-time medical monitoring occupational cancer.
doctors and one full-time registrar staff the registry.
Approximately 79% of the cases are registered from the Source of population
data les of the Korean Central Cancer Registry (KCCR). The The estimate of the populationatrisk is based on the
KCCR identies incidence from cancer cases in Korea through 2000 census, making allowance for births and deaths, but
the nationwide hospital-based discharge system. This hospital- it was not possible to estimate migration into and out of the
based database covers all general hospitals in Korea.
registration area.
The second source of registration is the list of cancer cases
from claims made through the National Health Insurance Multiple primary rules used
Corporation.
IACR rules (2004) on CI5 IX period

252


'# %



'# %

Asia

Kuwait
Registration area
Kuwait is one of the major oil-producing countries in the
Middle East, with a surface area of 17 818 km2, and is
situated in the northwestern corner of the Arabian Gulf.
The mainland is at sandy desert with a scattering of oases.
There are a few rocky hills ranging from 180 to 300m above
sea level. Kuwait experiences wide variation in temperature,
ranging from an average of 45C in July to an average of 8C
in January. There is also wide variation in annual rainfall,
ranging from as little as 22 mm to 350 mm. This falls almost
entirely between November and April.
Kuwait has experienced rapid social and economic
development over the past four decades. It is a society undergoing
demographic and epidemiological transition. For Kuwaiti
nationals, these changes have included important declines in
infant mortality (11.4/1000 live births) and improvements in life
expectancy (75 years). Kuwait also has one of the highest annual
population growth rates in the world (4.5%) and has greatly
increased the literacy rate to about 85%.
The total population in 1995 was about 1.88
million: 37% are Kuwaiti nationals and 63% are nonKuwaitis (expatriates). Expatriates living in Kuwait are a
heterogeneous and transitory group representing over 50
countries. However, it is noteworthy that the vast majority
(95%) are from Southeast Asian and Arab countries. In
1994, Southeast Asians (from Afghanistan, Bangladesh,
India, Iran, Pakistan, Philippines, and Sri Lanka)
represented 58% and Arabs (from Egypt, Jordan, Lebanon,
and Syria) 37% of the expatriate population. Compared
with countries in Europe and North America, Kuwait has
a relatively young population structure: about 44% of
Kuwaitis and 17% of non-Kuwaitis are aged <15 years.
Cancer care facilities
For administrative purposes, the country is divided into ve health
regions: Capital, Hawali, Al-Farwania, Al-Ahmadi, and Al-Jahra.
The medical services in each health region comprise a number
of primary/family healthcare clinics, which provide general,
maternal, child and dental healthcare services, and a general public
hospital. Besides these facilities, there are a number of centralised
specialist hospitals including Kuwait Cancer Control Centre. The
centre was established in 1982 and is the only specialised cancer

treatment hospital in the country. It offers modern facilities for


cancer diagnosis, treatment and follow-up.
Registry structure and methods
The Kuwait Cancer Registry was established in 1971 in the
Radiotherapy Department at the Al-Sabah hospital. The
initial purpose of the registry was to study the incidence and
morphology of cancers in the Kuwaiti population and to use
this information as the basis for establishing a comprehensive
cancer centre for diagnosis, treatment, follow-up and care of
cancer patients. Subsequently, the Kuwait Cancer Control
Centre was established in 1982 and the registry became a
separate department of the hospital.
Notication of cancer is compulsory through a Ministerial
Decree. Cancer registrations are fairly comprehensive as
almost all cases not initially diagnosed or treated at the
Kuwait Cancer Control Centre (including those who receive
initial treatment at other hospitals or abroad) are ultimately
referred to the centre for further treatment or follow-up. The
registry maintains a separate alphabetical and numerical
index, which includes information such as case note number,
name, age, sex, nationality, year of diagnosis, and site.
Pathology reports and death certicates are led numerically
by year. All new registrations are checked against these data
items to avoid duplication.
The sources of information are: case notes from the
Cancer Control Centre and other hospitals; reports from
the pathology departments of the Cancer Control Centre
and of other hospitals; and mortality data from the Vital
and Health Statistics Division of the Ministry of Health. All
coding (topography, morphology, TNM classication, etc.)
and computerisation of data is done by the registry staff.
The registry is staffed by a director, a medical ofcer and
an administrator, two cancer registrars, and one medical
records clerk and two computer technicians.
Use of the data
The data are used for monitoring trends in incidence and in
research. They are also used for planning and evaluation of
cancer care facilities. The registry is especially interested in
monitoring any change in the incidence of cancer that may
have occurred following the Gulf War in 1991.

253

Asia

KUWAIT: KUWAITIS (1998-2002)

KUWAIT: NON-KUWAITIS (1998-2002)

KUWAIT: KUWAITIS (1998-2002)

 #

!

 !

 

!

 !

 

!

 

 !

!

 

 !



 

 "!



 

! !



! #

 



 #

! "



 #

 "



 #

" #



 ""

 "



 "#

 



! #

!" ""



 !#

! "#



 "

 #!



 

 !



 !!

! #



 !

# 



 "

! #



! 

 #



 

 



 !

" 



" 

 



 #

 



 !

 "#



# 

 !



 "

 #



 #

 #



 #

 !



 !

 "



 #

 "



 !





 #!


  
 
 

Source of population
2001 estimates.
 


  


        

254

KUWAIT: NON-KUWAITIS (1998-2002)







 





 

"# 

 


  
 
 



        


Multiple
primary rules used
Impossible to detect multiple primaries.
 


  







 #

Asia

Malaysia, Penang
well as pathology record listings from the public and private
Registration area
The Penang Cancer Registry covers the population of 5 laboratories, to ensure completeness of data. Registry staff
districts (Timur Laut, Barat Daya, Seberang Perai Utara, visit the sources of data to extract required information. The
Seberang Perai Tengah and Seberang Peri Selatan) within registry also relies on other healthcare workers to complete
the state of Penang, in the northwestern part of the Malaysian notication forms and forward them to the registry. This is
peninsula. The population at the most recent census (2000) supplemented by case detection from death records supplied
was 1 313 449, with 79.6% of the population living in urban by the National Registration Department. All possible
areas. Penang has a higher population density than the rest sources of data in the State are identied. Arrangements
are also made with other hospitals outside the registration
of the country.
The ethnic composition and socio-economic prole of area to notify the registry of resident cancer cases that are
the Penang population differs from the other states within diagnosed and treated there.
The Cancer Registry Committee and the State Technical
Malaysia in that Penang has a better economic attainment
and higher per-capita income than most other states. It also Committee evaluate the completeness and accuracy of the
information.
has a higher proportion of
Chinese residents than the rest
Interpreting the results
of the country, with an overall
MALAYSIA, PENANG (1998-2002)
It is not possible to estimate
ethnic composition of 53.4%
MALAYSIA, PENANG (1998-2002)
how many cancer cases remain
Malays, 26.0% Chinese, 7.6%
undiagnosed.
However,
Indians and 12.9% others
Penangs health coverage is
(Department of Statistics,
very extensive even in the
2001). The ofcial religion is
remotest areas, and a full range
Islam.
#%'%%%
&"$
(%&&%%%
of diagnostic and treatment
#% &%%%
&
'% "%%%
'%"'%%%
#"
%&'#%%%
facilities are available here,
Cancer care facilities
 % %%%
#
"%"&%%%
so it is very unlikely that any
Both the private and the
#%"&%%%
""
#%"%%%
"%&%%%
"
 %## %%%
referred cases will be missed.
public sector, through a
%'"%%%
"
%"'%%%
Screening services for
network of regional hospitals,
#%"'%%%

#%& %%%
'%'"%%%
"
(%''%%%
cervical cancer and a breast
provide general health care in
%&'%%%

%( %%%
self examination programme
the regions district hospitals
%((#%%%
"
"% "&%%%
'%
%%%

"
%%%%
are routinely carried out by the
with and without specialists
&%"(%%%
"
%&(%%%
primary healthcare facilities.
and a network of primary
%&(%%%

%(#%%%
#%# &%%%
"
%&%%%
Extensive screening services
health centres. In addition
#%(''%%%

%' %%%
are also provided by the private
there are 11 private hospitals
sector. PSA testing is offered
in the state and 426 General

"


"

by all the private hospitals for
practitioners. All modalities
 %!
 %!
a fee, and in general hospitals
of treatment for cancer are
"#%&(%%%
"%&( %%%

only when indicated.
available in Penang. However,

  
radiotherapy services are only (((%)
%
%((%  %)%  %%)%
%
%%  %
 


  
available at Mount Miriam Hospital
and at Pantai Mutiara Use of the data
 %
 %((!%
Hospital. Mount Miriam Hospital is the regional cancer The registry has prepared annual statistical reports for the
years 1994, 1995, 1996 and 1997 as well as two 5-year reports
centre for Northern Peninsula Malaysia.
(19941998 and 19992003). The reports highlight trends
and changes. The data are used for planning and evaluation
Registry structure and methods
The registry is located within and funded by the State of cancer control programme in the state, and are also used
Health Department. An epidemiologist, nurse, 2 clerical by universities for specic research.
staff and part-time clerical staff (when the need arises) staff
the registry. In addition, nurses from each of the districts Source of population
also assist in active case detection. Strict condentiality is 1999: projection from 1991 census. 2000: census. 2001,
2002: projection from 2000 census.
maintained at all times at the registry.
The Penang Cancer Registry uses both active and passive
nding methods. Active case nding and routine checks are Multiple primary rules used
done using public and private hospital discharge records, as IACR rules (1990).

255

Asia

Malaysia, Sarawak
Registration area
The Sarawak Cancer Registry is a population-based cancer
registry that commenced data collection on 1 January 1996.
The registry covers the population of 11 divisions (Kuching,
Sri Aman, Sibu, Kapit, Miri, Limbang, Sarikei, Bintulu
and Samarahan, Mukah and Betong Divisions) in the state
of Sarawak in Malaysia. The population at the most recent
census (2000) was 2 071 506. About 48% of the population
lives in urban areas; ethnic composition is 30.0% Iban,
26.7% Chinese, 23.0% Malays, 8.3% Bidayuh, 5.9% other
Indigenous, 5.6% Melanau and 0.4% other ethnic Groups
Cancer care facilities
General health care in
Sarawak
is
provided
predominantly by the Sarawak
Health Department, through
the district hospitals and a
network of primary health
centres. Private practitioners
and hospitals supplement
this. Radiotherapy service
in Sarawak is only available
at the Sarawak General
Hospital in Kuching. Patients
who require radiotherapy
treatment are referred to the
Sarawak General Hospital for
treatment. Furthermore, as this
is the only hospital providing
radiotherapy services in the
State, the likelihood of cancer
patients seeking radiotherapy
treatment
beyond
the
catchment area of the registry
is minimal.

 '*()'''
'%'''

In order to ascertain high coverage and accuracy of data,


the Sarawak Cancer Registry team performs several quality
control checks. These include sourcing out missed cases,
identifying multiple notications and inaccurate information
and inspecting case notes of discharged cancer patients in
all government hospitals in Sarawak. Although cancer is not
a notiable disease, a fair number of registration forms are
received from private practitioners.

Interpreting the results


It is not possible to estimate how many cancer cases remain
undiagnosed, but underestimation could occur for elderly
subjects in rural areas. Health services in Sarawak have
a full range of diagnostic
facilities, so that it is unlikely
that cases referred will be
MALAYSIA, SARAWAK (1998-2002)
missed. Screening service
MALAYSIA, SARAWAK (1998-2002)
for cervical cancer is ongoing
and provided by the primary
health centres. While there
is increasing interest in PSA
testing, it is not routinely done
($&
"')* '''
in our population.
(
'( '''

%' $'''

%$

)' '''

')"'''

%

'% ('''

') '''

$$

)'()'''

"'( *'''

$

*'$'''

Use of the data


The registry had published
$"''''
"$
")'%($'''
the 19962000 cancer report
%$''''
"
%'* '''
($' "'''
$
('$ '''
highlighting incidence of
) '("'''

)'"%*'''
cancer in Sarawak by gender,
)%'%)%'''
$
)%' %'''
)('%( '''

)*'"'''
age and ethnic group. The data
**' %)'''
$
*('$ '''
from the cancer registry are
*' '''

 '%)"'''
*'%'''
$
'*'''
being used for planning and
 $'$$"'''

 ''''
evaluation of health services.
The registry is currently

$


$

developing a cancer atlas for

'!#


'!#
Sarawak and analysing cancer
')'" '''
'$ '(%'''

survival in Sarawak.

  
Our registry is currently
Registry structure and **)'***'+ 
' '**'
'+'
''+' 
' ''
'
 


  
doing research on the geographical distribution of common
methods
' 
'!"#''$''
'
The registry is located in the Non-Communicable Diseases cancers in our population, such as nasopharyngeal
Control Section of the Sarawak Health Department, and carcinoma, colorectal cancer, breast cancer and cervical
fully managed and fully funded by the Sarawak Health cancer. Preliminary results of the research on the
Department. A full-time medical ofcer, two full-time geographical distribution of nasopharyngeal carcinoma in
Sarawak were presented as part of the paper Epidemiology
registrars and a part-time registrar staff the registry.
Cancer registration is based primarily on voluntary of Nasopharyngeal Cancer in Sarawak, presented at the
notications. The registry seeks basic epidemiological Beijing IACR Meeting. Our registry is currently working on
and clinical data for all cancers diagnosed in Sarawak a proposal for research into screening for nasopharyngeal
since 1 January 1996. The registry receives notications cancer in Sarawak.
in a standardised format from all sections of the medical
profession in Sarawak. Active case nding and routine checks Source of population
are made of government and private hospital discharge 1998, 1999: projection from 1990 census. 2000: census.
records as well as pathology record listings from the public 2001, 2002: projection from 2000 census.
and private laboratories to ensure completeness of the data.
This is supplemented by case detection from death Multiple primary rules used
IACR rules (2004) on CI5 IX period.
records supplied by the National Registration Department.

256

Asia

Oman
two full-time cancer registrars. Cancer notication forms
Registration Area
The Sultanate of Oman is located in the southeastern corner were modied and distributed to all regional hospitals and
of the Arabian Peninsula. It has a costal line extending sister institutions for reporting.
Sources of cancer information for the Registry include
almost 1700 km from the Strait of Hormuz in the north
to the borders of the Republic of Yemen in the south and passive reporting by the diagnosing physicians from different
overlooks three seas; the Arabian Gulf the Gulf of Oman hospitals including University, Police and Armed Forces
and the Arabian Sea. The Sultanate of Oman borders the Hospitals, histopathology and cytology reports from the ve
Kingdom of the Saudi Arabia and United Arab Emirates in main laboratories in the country and the outpatient logbooks
the west, the Republic of Yemen in the south, the Strait of and radiotherapy and chemotherapy appointment lists of the
Hormuz in the north and the Arabian Sea in the east. There Oncology Department at the main tertiary facility, the Royal
are a number of scattered Omani islands in the Arabian Sea; Hospital. In addition, discharge diagnosis and monthly
hospital mortality lists of patients with diagnosis of cancer
the most important are Masirah and Al Halaniyat.
The total area of the Sultanate of Oman is approximately are obtained from different hospitals in the country.
In
December
2004
309 500 km2, making it the
radiotherapy services became
second largest country in
available in Oman in addition
the Arabian Peninsula. The
OMAN: OMANI (1998-2001)
to the other modalities of
Sultanate is composed of
OMAN: OMANI (1998-2001)
treatment, which already
varying topographic areas
existed. This minimised the
consisting of plains, wadis (dry
number of patients sent abroad
river beds) and mountains. The
for treatment and provided the
most densely populated and
registry with an extra source
agriculturally fertile area is







of cancer notication. Details


plain overlooking the Gulf of











 

of the patients sent abroad


Oman and the Arabian Sea (3%







for treatment (mainly for


of the total area). The mountain





 








radiotherapy) were obtained


ranges occupy almost 15% of







from the Department of


the total land of Oman and are














Treatment Abroad and from


inhabited by about 5% of the







Tuwam Hospital (main referral


population. The remaining














hospital for radiotherapy in


area is mainly sand, wadis







the neighbouring United Arab


and desert (about 82% of the














Emirates).
total area). The climate differs

 





Between 1985 and 1997,


from one area to another: it is
the registry used Dbase
hot and humid in the coastal






software for data entry. In
areas in summer, hot and dry

-)%*


-)%*



1998 the whole database


/0&-0.,--
in the interior with exception of
converted to the IARC/IACR
higher mountains and southern   


--
-- 
-
 
"--!
--
- 
-
-- 
--
-&00(CanReg software programme.
regions of Dhofar, which enjoy - -&00/2'$$&-
-- 

a moderate climate throughout       
the year.
-
-)&00$*Based on the 1993 census the  
estimated Omani population Interpreting the results

--

--
-
-
-
--
-
 
- -

-1-

- 
-+-)
*#in 1998 was 1 684 850. Based on
a second census conducted Opportunistic screening activities are ongoing for cervical
in 2003, the estimated Omani population in 2004 was 1 802 cancer. However there are no organised screening programmes
931. In 2004 about 12% of the population was under 5 years yet. PSA testing is not common in the population.
of age and 40% were under 15 years. Only 3.1% of the total
Smoking is on the increase in Omanis, and many
Omani population was above the age of 60 years. There were industries are promoted now, both of which could result in
102 males for every 100 females.
an increase in the incidence of cancer.
Patients are classied as nationals and non-nationals.
However, no data is collected on ethnic background of Source of population
patients.
Data for 19982001 are annual projections based on the
Cohort Component Technique, using the West UN life table
Registry Structure and Methods
model and based on the 1993 census.
The cancer registry in Oman was established in 1985 in Al
Nahdha Hospital as a hospital-based registry. In 1996 it was Multiple primary rules used
moved to the Department of Non-Communicable Diseases IACR rules (1990).
Control at the Ministry of Health Headquarters. Since then
the Oman National Cancer Registry has functioned as a Notes on the data
population-based registry covering the entire Sultanate of The Editors recommend that some care be taken in the
Oman and is staffed by two part-time epidemiologists and interpretation of these data; see Chapter 5 (Categorisation).

257

Asia

Pakistan, South Karachi


volunteer workers in 2 ofces at the Sindh Medical College
Registration area
Karachi is the largest city of Pakistan, an Islamic Republic in and Aga Khan University (pathology department).
Data collection is a combination of active search, passive
south central Asia and the capital of Sindh province. Located on
coast of the Arabian Sea, at latitude 24 51 N, longitude 67 02 notication, and automated notication. The principal source
S, it is the nations major commercial and industrial centre as of information on cancer cases is the diagnostic centres of
well as the largest seaport. The city covers 591 km2 while the the Aga Khan University.
The registry has access to death certicates with personal
metropolitan area covers 1450 km. The city of Karachi is
divided into 5 districts. The Karachi Cancer Registry (KCR) identiers. This source has limited value as the cause of
registers incident cases of the southernmost district of the city. death registered is non-specic. Cancer is not a notiable
Karachi South has a year-2000 population of 1 723 617; males disease and problems of condentiality are high with major
centres, e.g. the Aga Khan University.
928 695 and females 794 922. The population is urban.
Karachi is a multi-ethnic city. The dominant ethnic group in
Karachi is the Urdu-speaking Muhajirs; the other large groups Quality control
include the Sindhis, Balochis,
The data are classified using
Punjabis, Pashtuns, Kashmiris
ICD-O3 and computerised
using a customised version of
and Seraikis. There is a refugee
PAKISTAN, SOUTH KARACHI (1998-2002)
population that includes Afghan,
CanReg-4, with internal checks
PAKISTAN, SOUTH KARACHI (1998-2002)
Pakhtuns, Tajiks, Hazaras,
on the validity of entered data.
Uzbeks, and Turkmens. There
Manual and computerised
validity checks for the cancer
are also Bengali, Arab, Iranian
and African immigrants,
data were performed as per IARC
and a large community of
and IACR recommendations.







Zoroastrian-Persian Parsis
This involved factors inuencing














and Goan Catholic Christians.


comparability, i.e. classication







The linguistic distribution of


and coding. Demographic














variables recorded were the


population was: Urdu-speaking







hospital patient-number, date


48.52%; Punjabi 13.94%; Sindhi













of incidence, name, age, sex,


7.22%; Pushto 11.42%; Balochi







address, ethnicity, topography,


4.34%; Seraiki 2.11%; others














morphology, grading and


12.4%. Most inhabitants are







Muslim (96.49%), with some


staging.














Christians (2.35%), Hindus



 





(0.83%) and Qadiani (0.17%).


Interpreting the results
Private sector input has
Karachi South is a sample






 '"$
  '"$
signicantly increased and
population of Pakistan, having



)!('&)%'''

altered the contribution from
an equal distribution of the
data sources. Whereas the
major ethnic groups and all the   

public health sector contribution
minority groups of the country.  ' ))(' )))+!!'  ' ' )#' '  '
' ' ))('
      
'  '"!#$'' ''
The population distribution of KS
and Pakistan are similar as was more in 19951997, the private health sector contribution
  
regards age, gender and religion. The
male preponderance reects far outweighs the former in the present reference period.
 '  '  '' ' ' ' '' '  '
'  '*' ' '%'"  $'
There are no screening programs for any region in
the in-migration for work from other regions of Pakistan i.e. Sindh,
Baluchistan, NWFP and Punjab. These men are residents of the Pakistan; however, there are facilities for PSA testing, PAP
district, as they spend an entire life in Karachi, going back to their smears and mammography.
It is not possible to precisely estimate how many cancer
village only during their annual or bi-annual leave.
cases remain undiagnosed, as there are no autopsies and the
death registration system is very inadequate and incomplete.
Cancer care facilities
Karachi South has 2 provincially administered tertiary care The registry however annually conducts a formal evaluation
public health hospitals and 1 armed force administered hospital, of the completeness or accuracy by utilizing the wellone with a radiotherapy facility, that provide free to subsidized maintained and documented cancer data at Zainab Punjwani
surgery and diagnosis. The Aga Khan University had 6 diagnostic Medical Centre and the Baqai Institute of Oncology.
The district has a preponderance of self-inicted
centres in the district during the reference period. Other private
medical facilities provide surgical and diagnostic facilities but (tobacco, arecanut, paan misuse) malignancies in men and
provide less-than-optimal quantitative medical oncology or breast cancer in women. These outweigh any occupational
radiotherapy treatment cover, as the tertiary care facilities are exposures if present, there being oil reneries and tanneries
also shared by numerous referral cases from across the Province in this district. Karachi South is a belt fringing the Arabian
of Sindh. Thus the majority of the cancer patients utilise services Sea. Potential environmental hazards could be oil spillage
and un-detoxied chemical products discharged into the sea
outside the district, city or even the country.
by tanneries and other factories.
Registry structure and methods
The Karachi Cancer Registry (KCR), the rst population- Use of the data
based registry in Pakistan, has been philanthropically funded The incidence data are reported regularly to the Federal
for 12 years. It has 6 permanent staff members and many Government and various agencies in Pakistan requiring the same

258

Asia

for health sector planning and monitoring. The data are used
for casecontrol studies, for research theses and dissertations
of post-graduate students and fellows. The NCCP Pakistan
planning, implementation and monitoring is based on this data.

Multiple primary rules used


IACR rules (2004) on historical data

Source of population
Census 1998. 19992002 estimated using 1.94% growth rate
from Census 1998.

Notes on the data


The Editors recommend that some care be taken in the
interpretation of these data; see Chapter 5 (Categorisation).

259

Asia

Philippines, Manila
logs, radiology, ultrasound, nuclear medicine, CT/MRI
Registration area
The registry covers the four major cities (Manila, Quezon, reports and logs, and hospital tumour registries. Death
Pasay, Caloocan) of the National Capital Region (NCR), the certicates from the ofce of the Local Civil Registries are
major urban centre of the country. It encompasses a land also reviewed. The registry staff also visits selected private
area of 274.2 km2 located in the southwest portion of Luzon surgeons, oncologists and hematologists.
Data received are checked manually and electronically
between latitudes 144823 and 143115 N and longitudes
143953 and 1210520 W. Manila is the capital and main for completeness and consistency as well as for duplication.
port of the Philippines, the hub of commerce and trade and Coding consistency and validity is checked with the IARC/
IACR CanReg-4 software. Followup was done previously
the seat of cultural and intellectual activities.
The population covered by the registry, based on the through death certicate review. In 1997, however, PCS2000 census of Population and Housing, is 5 287 425, a 4.1% MCR conducted its rst population-based survival study
increase over 1995. As a whole, the population is young, on the 1987 incident cancer cases, using both active and
with 31.87% under 15 years of age and only 2.10% over 65. passive follow-up. Although regular formal evaluation of
data completeness or accuracy
It comprises 140 different
is ideal, limitation in funding
ethnic groups, the largest of
still restricts this activity.
which are Tagalog (69.85%),
PHILIPPINES, MANILA (1998-2002)
Bicol
(4.27%),
Ilocano
PHILIPPINES, MANILA (1998-2002)
Interpreting the results
(4.16%), Bisaya (3.87%) and
Some challenges faced by the
Waray (2.81%). Among the
registry include inadequate
foreign ethnic groups the
manpower for data collection
largest are Chinese (0.59%),





and other registry procedures;


Other Foreign (0.04%) and







poor record-keeping in some


American/English (0.02%).














hospitals; non-inclusion of
Most (88.8%) are Roman







private pathologists reports in


Catholic, 3.2% Iglesia ni














some hospital records; use of


Kristo and 0.6 % Muslim.





 

different names (particularly







 


 





among Chinese); and delayed


Cancer care facilities







data collection due to


Health services in the







 






condentiality concerns in
National Capital Region and







some hospitals.
the adjacent province of Rizal






 



 
 

The increase in availability


include four cancer institutes,

 





of diagnostic and treatment


168 secondary and tertiary
facilities has not necessarily
care hospitals, 43 primary care






increased their utilisation
hospitals and 32 Department

*&$(


*&$(
because of economic and
of Health clinics for out-patient




%*),+*%#%***

educational factors; PSA
consultations. Ten hospitals
  

*
*

**
..
***

* **
testing is not common, and
have radiotherapy facilities. 
*%###"*
* *  *****
 
*

  
*

* *
*
"*
*
**
*

*"*

!** 

** * !****

!***
*
there are no organised screening programmes for any cancer
      
*
*&%##'(****
site. There were no unusual environmental or occupational
Registry structure and methods
  

* *

**
*
*

*
**
*
 
* *

*-*

* 
*)*&
("*
The Philippine Cancer Society
(PCS) began
cancer exposures which could have inuenced cancer incidence in
registration in 1959 in an attempt to organise a national cancer the population.
Those changes in case denition and coding initiated
registry. Although this was not successful, it served as a pilot
study. In 1968, the Central Tumor Registry of the Philippines by IARC are the only ones used by the registry. High
(CTRP) was launched, covering 25 hospitals in Manila and percentages of DCO registrations in 19931997 led to
one in Cebu, completely relying on notications from these more thorough trace-back of DCN cases in the hospitals
hospitals. In 1983, it was converted to a population-based and patient residences, particularly for liver cases (50% at
cancer registry and renamed the Philippine Cancer Society- the time). In spite of these problems, the staff continues its
Manila Cancer Registry. Cancer registry clerks were trained efforts at improving completeness as well as data accuracy.
to abstract pertinent information from hospital records and
death certicates and they actively collected data on cancer Use of the data
cases in its catchment area for the period 198082 onwards. The registry prepares reports on cancer incidence as
The registry is located in the PCS building, and is fully well as trends. Data generated from the Manila and Rizal
funded by the PCS. The registry staff comprises six part-time registries have served as a basis for planning of most of the
consultants, one full-time supervisor, and six cancer registry cancer control activities of the Philippine Cancer Control
research assistants. In 1984, the registry started a cooperative Program of the Department of Health. They have been
effort with the Department of Health-Rizal Cancer Registry used for epidemiological research, as well as for public
in covering 134 hospitals within the National Capital Region information activities of the media and NGOs. There is an
and Rizal Province. Both registries use the same active data ongoing collaboration with the German Cancer Research
Center regarding recent trends, up-to-date estimates and
collection methods.
Hospital data sources include medical records, determinants of cancer survival on 10 leading sites among
radiotherapy records, pathology/haematology records and 19932002 incident cases.

260

Asia

Source of population
Census 2000. Gathering of population and housing
data was performed by census enumerators through
househouse visits and interview of a responsible member
of each household. The household was the enumeration
unit.

Multiple primary rules used


IACR rules (2004) on historical data
Notes on the data
The Editors recommend that some care be taken in the
interpretation of these data; see Chapter 5 (Categorisation).

261

Asia

Singapore
Registration area
that notications are as complete as possible by checking
The registry covers the whole of the Republic of Singapore, all pathology reports from public and private laboratories,
situated in Southeast Asia, and comprises the main island of and death certicates issued in Singapore as well as records
Singapore and several offshore islands which jointly cover of all public hospitals. Cancer cases identied from these
an area of 682.7 km2. The main island measures 42 km from sources are checked against registered cases, and reminders
east to west and 23 km from north to south, and is situated are sent to doctors in charge of cases that have not been
on latitude 117N and longitude 10315E, at the southern notied to the Registry. Cancer cases not notied by doctors
tip of the Malayan Peninsula. The island is rather at, the (approximately 10%) are registered by the Registry staff on
highest point being a central granite hill 166 metres high. the basis of information derived from the sources mentioned
The maximum temperature is around 31C and the minimum above. Cancer registration is generally comprehensive since
24C. The mean relative humidity is around 84%. The island all cases diagnosed histologically and all cases with mention
generally has rainfall throughout the year (total annual of cancer in hospital discharge forms and death certicates
rainfall approximately 2344mm), but is particularly wet are included.
There is no personal
during the monsoon season
contact with cases or patient
from November to January.
follow-up by the Registry.
The resident population (3
SINGAPORE (1998-2002)
Information on diagnosis and
263 209 in 2000) comprises
SINGAPORE (1998-2002)
survival is obtained through
several ethnic groups, the
hospital, pathology and death
largest of which are Chinese
records.
(76.8%), Malays (13.9%) and
The cancer notication
Indians (7.9%). Overall, the
 %&%%%
'$
"%"#%%%
forms and a register of cases
population density (2000
&%"'%%%
&"
%''%%%
are maintained on a current
Census) is 4780 persons per
%((%%%
&
"%#"%%%
2
% %%%
#"
"%'(%%%
chronological
basis.
All
km .
"%'%%%
#
""%(#%%%
relevant information is coded,
#% &%%%
""
#%" #%%%
%'(%%%
"
%%%%
and the Registry maintains a
Cancer care facilities
%&"%%%
"
'%('%%%
computerised le of all cases.
In
2000,
there
were
"#%%%%

"%((%%%
#%&%%%
"
"'%%%%
Duplication of cases is avoided
5395
registered
medical
 %"'%%%

 #%%%%
by checking all new cases
practitioners (one medical
'%(%%%
"
#%%%%
"%""%%%

 %''%%%
against the master index.
practitioner to 745 people), of
&%#'%%%
"
%''%%%
Certication of death
whom 2779 were in private
(%("%%%

%(%%%
&%'##%%%
"
% %%%
is
virtually complete in
practice and 2616 in the
'%&#%%%

%("#%%%
Singapore. In 2000, 97.6% of
public sector. A total of 11
all deaths were certied by
798 hospital beds (2.9 hospital

"


"

qualied medical practitioners
beds per 1000 population)
 %!
 %!
or the Coroner and 2.4% by
were available: 9556 in 13
%#%&&%%%
%#%" &%%%

Inspecting Ofcers. The latter
public hospitals and 2242 in

  
would certify a case as cancer
13 private hospitals. There  % %% %((%%%  %%
were also 16 public outpatient 


  
Polyclinics, which together only on the basis of a previous hospital diagnosis.
%
 %((!%
Evaluation of completeness or accuracy of information
with private clinics offer primary health care. Diagnostic
and treatment services including radiotherapy are available recorded will be carried out at the end of a 5-year period before
publishing the Singapore Cancer Registry 5-year monograph.
in the public and private hospitals.
Registry structure and methods
Comprehensive population-based cancer registration began in
January 1968. The Registry was founded primarily to obtain
information on cancer patterns and trends in Singapore. Until
March 2001, the Registry was staffed by one pathologist and
three epidemiologists (part- time), and three secretaries and
one record searcher (full-time). In April 2001, the Registry
came under the auspices of the National Disease Registries
Ofce and is currently situated at the Health Promotion
Board with two additional full-time staff. There is a Steering
Committee comprising representatives of the Ministry of
Health and various hospitals.
Sources of data are: (a) cancer notications from all
sections of the medical profession, (b) pathology records, (c)
hospital records and (d) death certicates. Cancer notication
is voluntary. All doctors in Singapore are provided with
notication forms with prepaid postage. The Registry ensures

262

Interpreting the results


Although the population covered by the registry has
increased (the growth rate for resident population was 1.8%
in 2000), it is unlikely that cancer cases will be missed as the
public and private hospitals in Singapore have the full range
of diagnostic and treatment facilities and the populationto-doctor ratio continued to improve. Opportunistic cancer
screening services were offered by hospitals and clinics in
the public and private sectors.
Use of the data
The data have been used mainly to determine incidence
levels and relative risks of cancers in Singapore by sex, ethnic
groups and migrant status. Such information has formed
the basis of epidemiological and clinical studies on specic
cancers. The Ministry of Health Singapore and hospitals
administrators use the data for planning and evaluation.

Asia

SINGAPORE: CHINESE (1998-2002)

SINGAPORE: MALAY (1998-2002)


SINGAPORE: MALAY (1998-2002)

SINGAPORE: CHINESE (1998-2002)

%"(%%%

'$

% %%%

% &'%%%

'$

%"%%%

%"((%%%

&"

'%&(%%%

% "'%%%

&"

%%%%

% "%%%

&

(%#"%%%

%('%%%

&

%#%%%

%(&'%%%

#"

&% "%%%

%#&%%%

#"

"%&&%%%

%&%%%

#

#%"%%%

"%#%%%

#

"%(((%%%

"%"'%%%

""

"% %%%

"%""%%%

""

#%(%%%

'"%&# %%%

"

' %"&%%%

%&%%%

"

%"%%%

"

 %'&%%%

 %# %%%

"

"%'%%%

%'#%%%



%("&%%%

(%(# %%%



(%&%%%

% '(%%%

"

%&%%%

%(( %%%

"

%'('%%%

'% %%%



 %"%%%

'%' %%%



(% "%%%

%"#%%%

"

(%'&%%%

#%#%%%

"

#%#'%%%

' %%%%



'%"'%%%

 %(%%%



%#& %%%

'%(%%%

"

& %&%%%

'%('#%%%

"

&%(&%%%

&%(%%%

'#%#(%%%



'%(#%%%

%'(%%%



%'%%%

(%# %%%

"

'"%('%%%

 %'(%%%

"

%"%%%

&#%'%%%



&%

%#'%%%



(%'"%%%



"

 %!

"

'%%%





% &%'%%%

%#%'(%%%



"

 %!

 %!
'%#%%%


  
 % %% %((%%%  %%


  
 % %% %((%%%  %%

 


  
%
 %((!%

 


  
%
 %((!%

SINGAPORE: INDIAN (1998-2002)

"



 %!


"%'&%%%

Source of population
Estimates based on the 1990 and 2000 census data.

SINGAPORE: INDIAN (1998-2002)

Multiple primary rules used


IACR rules (1990)
%#%%%

'$

%" %%%

&"

(" %%%

"%%%%

&

%%%%

"#"%%%

%"#"%%%

#"

%((%%%

%((%%%

#

%'"&%%%

%" %%%

""

%(%%%

&%"'%%%

"

#%((%%%

(%(%%%

"

(%(%%%

% ( %%%



%&%%%

%''&%%%

"

%'&"%%%

%'%%%



%#(%%%

(% ''%%%

"

%## %%%

&% (%%%



&%#&%%%

'%# %%%

"

'%%%%

%"%%%



(%'#"%%%

%&%%%

"

%(#%%%

%(#%%%



(%#"#%%%



"

 %!
 %''%%%

"



 %!


%""%%%


  
 % %% %((%%%  %%
 


  
%
 %((!%

263

Asia

Thailand, Chiang Mai


Registration area
Chiang Mai Cancer Registry covers the population of Chiang
Mai province. The population of the province at the 2000
census was 1 500 127 persons. There were approximately
430 154 families, and the population density averaged 79.1
people per km2. In the municipal area, this gure increased
to 4789.9 per km2. Only 26.5% of the total population was
living in the municipal area.
Eighty-two percent of the population was local by birth,
and the remainder was made up of Thai nationals, Chinese,
Laos, and hill tribe people. Buddhism was the professed
religion of 91.7% of the people in the province. For the
remainder, most were either Christians or Muslims.

against the registered cases. Every cancer death not traceable to


an existing entry is labelled as death certicate only.
The registry staff visits all sources and registers of
individual departments concerned with diagnosis and
treatment of cancers, to identify and abstract information
on cases of cancer into the tumour registration forms.
Although cancer is not a notiable disease, the hospitals in
the registration area cooperate with the registry.

Interpreting the results


It is not possible to estimate how many cancer cases remain
undiagnosed, but this probably occurs for subjects in rural areas.
Maharaj Nakorn Chiang Mai Hospital is the only university
hospital in the area and has a
full range of diagnostic facilities,
so that it is unlikely that cases
THAILAND, CHIANG MAI (1998-2002)
referred will be missed. The
THAILAND, CHIANG MAI (1998-2002)
diagnostic facilities are increased
by image studies (CT scan and
MRI) and especially by cytology
(ne needle aspiration biopsy)
and histology.
'.0--'000
1-/
'30%(3000
There is only one screening
'10'..000
1%#
'20)''000
()03'1000
.-#
(-0-'3000
program for cancer of cervix,
(+03)%000
.%#
(.0++'000
and there are sporadic health
(-0-%-000
--#
(-0'.2000
)+02+%000
-%#
)+0-+)000
education campaigns about
-(022'000
+-#
-+0%3%000
common cancers in the region.
1%0.+(000
+%#
1+0%1)000
1%0%1%000
)-#
1+02.(000
PSA testing is commonly used
-302(3000
)%#
..0'3.000
in the Maharaj Nakorn Chiang
--0(.-000
(-#
-20'%%000
.(0+''000
(%#
.(0-'.000
Mai Hospital.
.)02'3000
'-#
.)0(%)000
Coding was changed from
-201-2000
'%#
--0.+1000
-102'+000
-#
--0+--000
ICD-0-2
to ICD-0-3 as of the
+10)(2000
%#
+-0(+2000
cases registered in 2000. Plans
are underway to use the IT
'%
%
%
'%
system of the hospitals in Chiang

0*&,


0*&,
1-20+%'000
1+'01(.000

Mai to evaluate the completeness
and accuracy of data.
  


Cancer care facilities


The Chiang Mai Provincial
Public Health Office, through
the provincial hospitals and
district hospitals, predominantly
provides general health care in
Chiang Mai province. Cancer
diagnostic services (clinical
consultations, radiological and
pathological investigations) are
available at most public and
private hospitals in the province.
However, diagnostic and cancerrelated therapeutic facilities
are available within the same
institution only at the University
Hospital (Maharaj Nakorn
Chiang Mai Hospital). Cancer
surgery services are provided at
several locations; the university
hospital, five government
hospitals, two community
hospitals and eight private
hospitals. Cancer chemotherapy 
0(%%%"0
0(%%%0  000
"000 
"000 
"0 
0 0
0 
0
$0
      
services are provided at the university
hospital, two government Use of the data
0
0*'33%,0
  
and six private hospitals. Radiotherapy
equipment
is available at The registry has reported annually on cancer occurrence

00


00
0
0!
0
00
0
 
0 0

040

0 
0-0*
,$0
the university hospital. Most patients at primary and secondary since the rst volume in 1978, when it was a hospital-based
care facilities suspected of having cancer are referred to Maharaj registry. Population-based registration was started in 1986 to
Nakorn Chiang Mai Hospital.
report the incidence and mortality of cancer in Chiang Mai
province since 1983.
Registry structure and methods
The registry has also joined with the other registries in
The registry is located within The Maharaj Nakorn Chiang Thailand to report on national cancer incidence every 35 years.
Mai Hospital, and is fully supported by the Faculty of
The registry is involved in epidemiological research of
Medicine of Chiang Mai University. The registry is staffed common cancer in Chiang Mai.
by 3 part-time physicians, 4 full-time registrar nurses, and
Chiang Mai Cancer Registry data are used together with other
3 practical nurses, and is supervised by members of the Cancer Registries to inform the Ministry of Public Health.
Hospital Cancer Committee.
Data on patients diagnosed with cancer are collected Source of population
actively from the university hospital (Maharaj Nakorn Chiang Census 2000, the 2000 Population and Housing Census,
Mai Hospital, 1800 beds), 11 government hospitals (2200 beds), Chiang Mai province, National Statistical Ofce, Ofce of
17 community hospitals (620 beds), 13 private hospitals (1500 the Prime Minister.
beds) and medical clinics, under the care of 900 physicians,
with the total of about 6185 beds in Chiang Mai province.
Multiple primary rules used
The principal sources of information on cancer cases are IACR rules (1990).
hospital and pathology laboratory records.
Death certificates were taken from the Unit of Data Notes on the data
Processing, 5th Region of Ministry of Interior. All death The Editors recommend that some care be taken in the
certicates that mention cancer as the cause of death are matched interpretation of these data; see Chapter 5 (Categorisation).

264

Asia

Thailand, Lampang
New cancer cases from all hospitals are collected from
Registration data
Lampang is one of the 17 provinces located in the northern out- and inpatient departments, wards, radiotherapy units,
part in Thailand, between 17-19N and 98-100E, 269 m surgery units and pathology services. Data collection consists
above sea level, 602 km by car from Bangkok (625 km of: registry number, name, residential address, date of birth, age,
by train) with a land area of 12 534 km2. It has common sex, date of diagnosis, site of cancer, histology of cancer, staging,
boundary with Chiang Mai in the north and the west. This extension of disease, method of diagnosis, treatment, date of
last contact and status of cancer patients (alive or dead).
registry covers the population of 13 districts.
We carried out follow-up of registered cases by matching
The total population in 2000 (housing census by National
Statistical Ofce, ofce of the Prime Minister) was 782 152, of cases with all death certicates. Death certicates
with 390 256 males and 391 896 females at a population density mentioning cancer death without other information about
of 62 people per km2. About 30% of the population live in urban the individual traceable from other sources are registered as
Death Certicate Only (DCO).
areas; 97% are Buddhists, the remainder mainly Christians.
We have used histologically veried percentage (%HV),
The climate is generally cooler than the rest of the country
Mortality Incidence ratio (MI
in winter from November
Ratio) and percent of DCO
to February, and hot and
(%DCO) for evaluation of our
dry during March to May in
THAILAND, LAMPANG (1998-2002)
completeness since our rst
summer. The average total
THAILAND, LAMPANG (1998-2002)
report on 2002.
rainfall is 974.5 mm per year.
Most people are farmers,
Interpreting the results
working in rice and tobacco.
There are many porcelain
Cancer cases are collected
&/*'2///
1,.
'/(01///
'/,1(///
1$"
(/(00///
production and very large open
from all hospitals in Lampang.
*/12-///
0,"
-/$20///
cast-mines (with national coalHowever, there were some
1/-'0///
0$"
&$/(('///
&(/*,2///
-,"
&*/-,'///
red
electricity-generating
patients referred to Chiang Mai
&,/(-2///
-$"
&,/02,///
plants close by).
University Hospital and the
&-/$'2///
,,"
&-/&-$///
&2/12*///
,$"
&2/,'$///
National Cancer Institute in
'2/*22///
*,"
'1/20-///
Cancer care facilities
Bangkok. We therefore collected
(0/2,,///
*$"
(0/-&1///
(1/,2*///
(,"
(2/(-$///
General health care in the region
these cases in our registry as
('/20'///
($"
(,/$2*///
is provided in all 13 districts. In
well. We also have back up data
'0/,'(///
',"
'1/*11///
',/20'///
'$"
'*/,1$///
the urban area (Muang district),
since 1983. Due to these reasons,
'2/('1///
&,"
'1/$$$///
there is one cancer centre
we believe that cases might not
($/2-$///
&$"
'2/*$(///
($/-$*///
,"
'1/0(,///
(Lampang Cancer Center),
be missed or repeated. Data are
'*/,-(///
$"
'(/((&///
two private hospitals and one
entered using the IARC/IACR
milita r y hospital. Cancer
CanReg software.
&$
,
$
$
,
&$
diagnostic services including
A cervical cancer screening

/)%+


/)%+
CT scan (clinical consultations
programme (Pap smear every
(2&/12-///
(2$/',-///

and radiological/pathological
5 years) has been supported by
  

investigations), cancer surgery 
/'$$$!/ / // 
#/
Ministry of Public Health since
services and chemotherapy are       
available in Lampang Cancer 1999. The target population is women aged 3564 years old. Pap
/
/)&22$+/
  
Center and Lampang provincial
hospital. Radiation therapy smear is available in all hospitals in Lampang and easily accessible.

//

//
/
/
/
//
/
 
/ /

/3/

/ 
/,/)
+#/
equipment (one simulator, two cobalt-60 machines, one linear
PSA testing is available only at provincial hospitals,
accelerator and two remotes after-loading for brachytherapy) university hospitals, cancer centres and some private hospitals,
is provided at Lampang Cancer Center. All hospitals in the and is not routinely included in yearly checkup programmes,
province provide palliative care.
except in cancer centres.
Patients suspected to have cancer in the primary and secondary
health care centres in the registry area are mostly referred to Use of the data
The registry provides periodic reports on cancer incidence,
Lampang Cancer Center and Lampang provincial hospital.
mortality and survival in Lampang. The data are also sent
to the National Cancer Institute to help compile the report
Registry structure and methods
The registry is located within Lampang Cancer Center, Cancer in Thailand. The data are also used by the local
which also provides equipment, and is funded by cancer health authority for the evaluation of public health measures
research foundation for National Cancer Institute. A part- in the prevention, screening and treatment of cancer.
time expert consultant, a part-time doctor, a part-time nurse
Source of population
and two full-time health workers staff the registry.
The Lampang registry was established in 1995 with Census 2000, Lampang Provincial Statistical Ofce.
the backup data of a population-based cancer registry in
Lampang dating from 1983 which was collected by Dr.Nimit Multiple primary rules used
Martin, our expert consultant. The registration uses passive IACR rules (1990).
methods by notication from 21 sources of data consisting
of cancer centres, general hospitals, community hospitals, Notes on the data
private hospitals, university hospital, the provincial public The Editors recommend that some care be taken in the
interpretation of these data; see Chapter 5 (Categorisation).
health service of Lampang and pathological laboratories.

265

Asia

Thailand, Songkhla
Registration area
The Songkhla Registry covers the population of 16 districts
in the south of Thailand. The population at the 2000 census
was 1 255 662. About 80% of the population is Buddhist,
and nearly 20% are Moslems. Christians and others account
for less than 1% of the population. People with Chinese
ancestry live in Songkhla town and Hat Yai city, which is the
economic centre of the south of Thailand.

registry. The registry staff visits Hat Yai, Songkhla, and private
hospitals to consult medical records and pathology records.
Assigned staff in community hospitals send the record
forms of cancer cases to the registry once a year. Registry
staff regularly visit them to reviews procedures. Some cases
are sent to the registry by the network of cancer registries in
Thailand, especially the registry of Bangkok.

Interpreting the results


The number of undiagnosed and unregistered cancer cases is
Cancer care facilities
The government of Thailand predominantly provides general difcult to estimate. Some Moslems in a remote area in the south
health care in the region. There are three hospitals with over of Songkhla visit large hospitals in the two nearby provinces,
500 beds, 13 community hospitals and an extensive network and some residents, especially the elderly, use traditional herbal
medicines and never enter the
of healthcare facilities at
countrys healthcare system.
the household level. Private
Because of the linkage between
practitioners, a few private
THAILAND, SONGKHLA (1998-2002)
the referral system and the
hospitals, and a few small special
THAILAND, SONGKHLA (1998-2002)
new national health assurance
hospitals, all in the urban area,
system, it is expected that only a
supplement this. The university
small number of cancer patients
hospital of Prince of Songkla
in that remote area seek medical
University is the larger of the two
facilities outside the province. A
places in the south of Thailand
&'(#&&&
'#%
#&(&&&
few other cases look for special
providing radiotherapy services.
&)&&&
'
&$&&&
!&'&&&
$#
$&#&&&
medical care in Bangkok, the
A few other large hospitals
)&'&&&
$
&'#&&&
capital of Thailand.
also have facilities for cancer
&)'&&&
##
&(!#&&&
#&!)(&&&
#
'&!&&&
There were no screening
surgery and chemotherapy.
!&!#'&&&
!#
$&#&&&
programmes over the period
Patients suspected to have
!&##&&&
!
!#&#&&&
!(&!!#&&&
#
#&')&&&
in question, and PSA testing is
cancer in the health care system
#&!#&&&

##&'&&&
not common.
and community hospitals are
#&((&&&
#
#(&'&&&
#$&'!&&&

#)&)&&&
referred to Songkhla, Hat Yai or
A very recent study of ours
$&!!!&&&
#
#)&'$&&&
Songklanagarind hospitals.
demonstrates a relationship
#'&'!&&&

##&$&&&
#$&)#&&&
#
#&!$&&&
between radium-contaminated
#&'!&&&

!)&(&&&
Registry structure and
shallow well water and oral
methods
pharynx and oesophageal cancer.

#


#

 & "
 & "
The registry is located within
$!&!$&&&
$#&$&&&

the Faculty of Medicine,
Use of the data
Prince of Songkla University. 
  
The registry is preparing a fteenThree part-time medical   &&& &

&
year report providing information
&  &
))"&
doctors, a full-time nurse as a 


  
registrar
and four full-time on cancer incidence and trends in Songkhla. It provides data for
workers staff the registry.
causation studies, especially in the eld of oral and esophageal
The Songkhla registry undertakes active casending from cancer, which is the main burden in this area. Extent of disease and
23 sources of data, consisting of Songklanagarind hospital, survival are reported in Cancer in Thailand vol. IV.
Hat Yai hospital, Songkhla hospital, community hospitals,
The Thai Network of Cancer Registries (TNCR) was
private hospitals, special hospitals, provincial health ofce, recently founded. The Thai NCI and TNCR work together
and the population registration ofce of the province.
to supply policymakers, academic bodies and public
The completeness of death registration is acceptable organisations recent accurate cancer statistics, projections,
but the cause of death is not so accurate, being mostly and ideas for cancer control for Thailand. We plan to
cardiopulmonary arrest and senility. After the national undertake this collaboration as a non-governmental academic
heath care reform started in 2000, the validity of the death body to have more power and a louder voice.
certicates has been improving.
The registry staff also runs the hospital-based registry of Source of population
the Songklanagarind hospital, and the data are shared with the Census 2000, National Statistical Ofce.
registry of Songkhla. Hat Yai hospital has its own system of
cancer case reporting but not a full-scale hospital-based cancer Multiple primary rules used
registry, and provides the cases residing in Songkhla to the IACR rules (1990).

266

Asia

Turkey, Antalya
Registration area
Antalya is a city located in the southern part of Turkeys
Mediterranean region. The province of Antalya is located
between the 3607N latitude and 2920E longitude.
The population of Antalya according to health statistics is
1 392 172 (2000); 74% of the population lives in urban areas.
The region of the most of people is Islam. Antalya has had the
fastest population growth in Turkey in recent years because
of internal immigration. Regional income comes from trade,
agriculture (especially commercial growing of hothouse
owers, vegetables, or fruits), tourism and construction.
Cancer care facilities
Genera l hea lt h ca re is
predominantly provided by
primary health centres and
government hospitals, but in
the last few years the number
of private health centres has
increased. Patients suspected to
have cancer in the primary and
secondary care facilities in the
registry area are mostly referred
to Mediterranean University
hospital and government hospitals
in the centre of Antalya.

areas, and the cause of death is often not mentioned or given as


cardio-respiratory arrest. The registry staffs work government
and university hospitals, where they scrutinise the records kept
in medical records departments, and the registers of individual
departments concerned with diagnosis of cancers, to identify
and abstract information on cases of cancer, diagnosed by
all methods. Additionally, private hospitals and other sources
are visited monthly by registry personnel who take note of
medical records of cancer patients.

Interpreting the results


It is not possible to estimate how many cancer cases remain
undiagnosed, but underdiagnosis probably occurs for elderly
subjects in rural areas. An
opportunistic
screening
service for cervical cancer has
TURKEY, ANTALYA (1998-2002)
been operated by the cancer
TURKEY, ANTALYA (1998-2002)
society since 2006.

%.1/&...

0+-

&.%1)...

0#!

&.+##...
&.0,&...

).+0%...

/+!

+.#/0...

%%.'&1...

/#!

%%.0/+...

%,.1/,...

,+!

%,.)&#...

&#.+//...

,#!

&#.+/+...

&).+#%...

++!

&'.)#0...

'%.&0%...

+#!

'#.'10...

'1.#1&...

)+!

'/.#+1...

Use of the data


The registry prepares an annual
report of cancer incidence,
highlighting trends and
changes. In 2006, the pathology
laboratories of three hospitals in
Antalya with access to county
government hospital records
were scrutinised and our data
were examined for completeness
and accuracy for 19982002.
The statistical analysis of the
information recorded is not yet
complete.

+,.%+/...
Registry structure and
,'.'0+...
'#!
,%.1##...
methods
,,.%'0...
&+!
,0.'+#...
,).+',...
&#!
,0.00%...
The registry centre is staffed
,'.0%0...
%+!
,&.')+...
by a full-time public health
,%./''...
%#!
+1.)&%...
,#.''0...
+!
+/.,0/...
specialist (MD), and full-time
,%.0%+...
#!
+0./%)...
health workers. Additionally
there are 17 cancer registry
%#
+
#
#
+
%#
staff in the hospital; the six
Source of population

.($*


.($*
,01.,%%...
/#&.+,%...

staff members who work in
Annual
registrations
by
the government and university   

primary health center of the
hospital in the centre of .
. . .
.

. .
. .
. 

. ...&###.
Provincial Health Directorate
      
Antalya are full-time, other registry
staff are part-time.
of Antalya in 2000.
.
.(%11#*..
The Antalya Cancer Registry  
collects data on
.
..
.
 
. .

.2.

. 
.+.(
*".
all new cases

..

..
.
.
of cancer from all hospitals and some clinics that provide all Multiple primary rules used
diagnostic and treatment services for cancer in the province. IACR rules (1990)
In 19982002, Antalya registry used active case nding from
14 government hospitals, 2 university hospitals, 2 private Notes on the data
radiotherapy clinics and 7 private pathology laboratories. The The Editors recommend that some care be taken in the
death registration system is incomplete, particularly in the rural interpretation of these data; see Chapter 5 (Categorisation).
)0.1/)...

)#!

+1.'&%...

'+!

)+.10%...

267

Asia

Turkey, Izmir
Registration area
The Izmir Cancer Registry covers the population of the
province of Izmir, which is divided into 28 administrative
districts. zmir province is in the extreme west of the country,
on the Aegean Sea coast. The population is 3.37 million (mid
2000), making it the third-largest province in Turkey; 81% of
the population lives in urban areas, with the remaining 19%
in rural areas. Most of the people are Islamic. Izmir is one of
the most developed and westernised parts of the country.

are continuously done for all cases and for whole database, in
addition to this, re-coding of selected cases (10% by random
selection) for each series are performed systematically.
Similar to Turkey in general, mortality data in Izmir are
incomplete, and notied only for urban areas, with a problem
of accuracy in regard to underlying cause of death. Although
ICR collects data of death certicates referred to cancer
obtained from Provincial Health Directorate records, these
certicates are poor in quality and lack information even
for socio-demographic data and addresses. Matching these
data with ICR database is quite difcult. Despite all these
realities, ICR began in 2005 to routinely match the death
certicates with the records of incident cases and process
them.

Cancer care facilities


The registry is a subdivision of the Provincial Health
Directorate of Izmir and is mainly funded by the state. ICR
is also nancially supported
by the MECC (Middle East
Interpreting the results
Cancer Consortium).
TURKEY, IZMIR (1998-2002)
It is not possible to estimate
General healthcare in the
TURKEY, IZMIR (1998-2002)
how many cancer cases
region is provided predominantly
remain undiagnosed, but
by the Turkish state health services
underdiagnosis
probably
department, through the two
occurs for older adults in rural
university hospitals, state hospitals
(/0$,///
1,.
,/1$1///
-/($1///
1$"
1/,--///
areas. While awareness of the
and a network of primary health
&,/012///
0,"
&2/$1*///
public has been increasing in
centres. This is supplemented by
(&/0&$///
0$"
(-/22$///
*,/(1'///
-,"
,$/$11///
the last 510 years, cancer
private physicians and private
,*/2&(///
-$"
,1/,$&///
diagnosis at health facilities
hospitals. While major hospitals
-0/($&///
,,"
--/*(2///
11/*20///
,$"
10/$$0///
in the region has improved
provide radiotherapy and
&$-/'&0///
*,"
&$$/2',///
consistently.
Opportunistic
chemotherapy services, cancer
&''/*2&///
*$"
&&0/(1*///
&(,/*-(///
(,"
&('/*&$///
screenings for breast, prostate,
diagnosis and cancer surgery
&*'/',-///
($"
&(2/-(*///
cervical and colorectal cancers
procedures are available in most
&,,/$''///
',"
&,*/0$*///
&-$/,&1///
'$"
&-(/02'///
are quite widely performed.
health facilities. Also, there are
&,*/$*$///
&,"
&*2/'&2///
Systematic screening for
five private oncology centres
&*$/$22///
&$"
&(,/$((///
&($/*&'///
,"
&',/*$-///
breast cancer has been applied
that provide radiotherapy and
&'(/202///
$"
&&1/(,*///
for a small population, which
chemotherapy facilities. With its
covers approximately 2000
developed health services, Izmir
&$
,
$
$
,
&$
women aged 5069. ICR
is a referral centre for patients
 /)%+
  /)%+
collects data from all of these
from other provinces, especially
&/--2/(*(///
&/-1*/&$'///

screenings.
the provinces of the Aegean
  

Region. It is possible that some / /!/
 / /  / / // /   / / #/
      
Izmir residents with cancer choose
to be treated elsewhere, such Use of the data
 / /)&22$+//
  
as Istanbul or Europe. However, this
is unlikely
to be more than The registry has published the results occasionally in
 // 
// / /! / // / 
 / /  /3/ / 
 /,/)  +#/
1% of the cancer patients, bearing in mind the social composition scientic meetings and journals and at the website: http://
www.ism.gov.tr/kidem.
of the population.
Some special studies such as survival of registered cancer
cases and some casecontrol (colorectal cancer) studies have
Registry structure and methods
The Izmir Cancer Registry (ICR) collects data on all new been carried out.
cases of cancer from all of the facilities in the province,
including university hospitals, state hospitals, teaching Source of population
hospitals, municipality hospitals, other governmental Annual registrations by primary health center of the
hospitals, private hospitals, private cancer centres (n=25) and Provincial Health Directorate of Izmir.
pathology laboratories (n=23). Nine hospitals have hospitalbased cancer registries, from which the ICR receives the Multiple primary rules used
data directly. The staffs of these hospital registries apply the IACR rules (1990).
same rules with ICR while collecting, abstracting and coding
the data and are supervised by ICR. For all other sources, Notes on the data
data collection is active at the time of visits by full-time, The Editors recommend that some care be taken in the
medically qualied registrars. Internal consistency checks interpretation of these data; see Chapter 5 (Categorisation).

268

Europe

Central and Western Europe

France

Italy

Portugal and Spain

Switzerland

United Kingdom and Ireland

Europe

Austria
Four Austrian provinces run their own regional cancer
Registration area
The Austrian National Cancer Registry covers the whole registries. Information on every cancer case is collected in
population of Austria, approximately 8.3 million (2007) close cooperation with the main hospital of the respective
inhabitants. About 90% of the Austrian population are Austrian area and is electronically processed. The information is
citizens; other nationalities and/or ethnic groups include Turks, forwarded to Statistics Austria on a regular basis.
Serbs, Germans and Croatians. Approximately 15% of the
All invasive and in-situ tumours are registered, and topography,
population are foreign-born. More than 80% of the population morphology and behaviour are coded to ICD-O-3. The coding is
are Catholic, and about 5% are Protestant. Another 5% are part done centrally in Vienna apart from the codes assigned by the
of Islamic, Israelite and other Non-Catholic denominations.
Tyrolean Cancer Registry are accepted separately.
Austria is divided into 9 provinces. The population is
All incoming data are stored in a database that performs
distributed as follows. Most of them reside in the provinces data checks at the point of data entry. These data checks
of Vienna (19.5%) and Lower Austria (19.2%), followed by are based on the IARC CHECK program, broadened at the
Upper Austria (17.1%), Styria (14.7%), and Tyrol (8.4%). The national level. IARC/IACR rules for classifying multiple
lowest population can be found
primaries are implemented as
in Salzburg (6.4%), Carinthia
well. Multiple notications for
(6.9%), Vorarlberg (4.4%) and
the same person are identied
AUSTRIA (1998-2002)
Burgenland (3.4%).
using the full name, date of
AUSTRIA (1998-2002)
The Austrian territory
birth, sex and address as well
covers 83 871 km of which
as social security number.
2/5 is permanently habitable.
For the quality control and
The country is characterised
assessment of completeness,
#'*''***
,')
!'*+(***
%#*+'!***
,
!!*%,***
by a diversied geographical
electronic data of pathology
-%*+%***
+'
!,+*'#***
situation.
laboratories and of various
!#(*'-'***
+
!-"*%((***
!'(*#"***
('
!,%*#("***
study groups are used.
!--*(-(***
(
"!(*#!"***
Cancer care facilities
The causes of death statistics
"#+*,(***
''
"%,*+--***
"%%*+!***
'
"%+*#'***
A nationwide social security
are available electronically and
"(*'***
%'
"(*+#(***
system covers 98% of the
are used for passive follow up
#+*!"***
%
#!*%+-***
#'"*-(!***
#'
#%*,%***
Austrian population. For
and generating DCN cases. All
#%#*+'+***
#
##'*+(#***
inpatient treatment about 275
death certificates mentioning
",*#"***
"'
",!*#-'***
"%!*,",***
"
"#(*#!+***
hospitals are available. More
cancer are available for the
"%(*#!%***
!'
"#'*#-+***
than two thirds of Austrian
registry as paper forms as well,
"%"*#-(***
!
"#*%#!***
"%!*-(***
'
"#*#(%***
hospital beds are maintained
and are traced back when the
"!'*","***

"%*,'"***
by 133 public hospitals. Four of
patient died in a hospital.
these hospitals are university
!
'


'
!
hospitals, located in Vienna,
Interpreting the results

*$ &


*$ &
Graz, Salzburg and Innsbruck.
For the whole of Austria
%*!%!*(,***
#*,,*%#(***

More than thirty hospitals run
opportunistic screening is

  
departments specialising in 
**
*

*** *
**
**"!*** 
**
*
 *  *
 *
carried out for cervix, breast
cancer treatment; many include 


  
a radiotherapy department.
and prostate. For some regions organised screening is carried
* 
*$"%&** **
out for prostate and large bowel. A regional comparability
Registry structure and methods
study of the data is currently underway.
The Austrian National Cancer Registry is located in Vienna and
is operated by Statistics Austria, the former sterreichisches Use of the data
Statistisches Zentralamt. According to the Federal Statistics The registry publishes data annually since 1970 in the
Act 2000 (Bundesstatistikgesetz 2000) the Austrian government yearbook on health statistics. Tables printed in this annual
appointed Statistics Austria as the national provider of various report show incidence rates broken down by primary site,
statistics. The government nances all statistics prescribed stage, sex, age and region. In 2005 a publication contrasting
by this law (including cancer statistics). Altogether 13 people incidence and mortality data was released. In 2006 the scope
are directly involved in the cancer registry workow. Some of was further enlarged when it was published on the Internet.
them work part-time or are involved in other projects as well, A special analysis of survival for colorectal cancer was
which results in 9.4 FTE.
published in 2006 as well.
Preparatory work for the cancer statistics was done by the
Highly aggregated data are available for all interests.
Austrian Cancer Society, which led to a legal basis for cancer Medical Universities, the Gesundheit sterreich GmbH
registration in 1957 (Krankenanstaltengesetz). Since 1969 a (GG), and cancer study groups are provided with data,
more detailed law (Krebsstatistikgesetz) obliges hospitals to which are at a lower aggregation level but still anonymous.
report every cancer case to Statistics Austria. Populationbased data collection started only one year later. Hospitals Source of population
ll in a form providing personal data, topography, histology The data are estimated by Statistics Austria, based on census data
and behaviour of the tumour as well as the incidence date. 2001 and data provided by the Central Population Registry.
The stage of the tumour at diagnosis and the rst treatment
are also reported. Files are increasingly now transmitted Multiple primary rules used
electronically (via disk or secure FTP).
IACR rules (2004) on historical data.

276

Europe

Austria, Tyrol
Registration area
Tyrol is one of nine provinces in Austria, and is situated in
the west. The area covers 12 648 km; only some 12.5% is
habitable. The average altitude of the habitable regions is about
740m. Nearly 20% of the population lives in one town with
more than 100 000 inhabitants (the capital Innsbruck), the rest
in smaller towns (less than 15 000) and in some 260 villages.
Nine percent of the people are from foreign countries, mainly
from the former Yugoslavia and Turkey. About 90% are Roman
Catholics. The main occupational groups are personal services
(32%), commerce and trafc (22%), industry and trade (22%)
and tourism (10%), with some 6% unemployed.

Multiple cancers are recorded separately at the request of


the physicians, but the IARC rules are used for reporting.
Follow up information is based on probabilistic record
linkage between the incidence data and all-cause mortality
data for the province of Tyrol. Coding is done by one trained
person in cooperation with a pathologist.
Programs for checking personal data were developed within the
registry. Lists generated are checked manually, and if there are queries
the local communities are contacted. The cancer data are checked
using IARC Tools. For formal evaluation of completeness, since 2003
we have applied the Bullard method using a program developed by
the Thames Cancer Registry. Besides extensive plausibility checks, no
formal evaluation of accuracy has been done to date.

Cancer care facilities


Medical facilities are provided
Interpreting the results
The population in the province
by Innsbruck Medical University
AUSTRIA, TYROL (1998-2002)
is stable, and there have not
(offering both basic facilities for
AUSTRIA, TYROL (1998-2002)
been changes in the structure
Innsbruck and special facilities
of the medical services. The
for the whole province), nine local
organisation of the registry has
hospitals in the rural districts
not changed in the last ten years.
and two semi-private hospitals
'/2&-///
1,.
0/*,1///
(/(&$///
1$"
0/&12///
PSA tests were introduced in
in Innsbruck. All diagnostic
-/0$*///
0,"
&'/,(-///
1988/89 and since 1993 have
and therapeutic services for
&$/&,&///
0$"
&(/*,2///
&'/',*///
-,"
&(/002///
been offered to all men aged
oncological patients are provided
&,/-(*///
-$"
&-/02*///
4574 free of charge; more
in the country. Most pathology
&1/--(///
,,"
&2/,*0///
&2/0,$///
,$"
&2/2*-///
than 3/4 of all men in this age
diagnoses are done by one main
'$/,&$///
*,"
'&/$1,///
group had at least one PSA test
institute in Innsbruck and ve
'*/1(,///
*$"
'*/-$-///
'2/201///
(,"
'2/($-///
in the last decade. There is also
smaller pathology laboratories.
($/,$(///
($"
($/$(,///
a spontaneous mammography
Radiotherapy is offered by one
',/'0'///
',"
',/,$&///
'&/-&$///
'$"
'&/&*$///
programme which has had some
Department of Radiotherapy at
'&/11$///
&,"
'$/1&*///
inuence on breast cancer rates.
Innsbruck Medical University
'&/,,2///
&$"
'$/,&2///
'&/1($///
,"
'$/12$///
In addition, Pap smear tests and
and by a radiotherapy unit within
&2/0-'///
$"
&1/10&///
haemoccult tests are offered free
the Department of Gynaecology
of charge, and dermatologists
of Innsbruck Medical University.
&$
,
$
$
,
&$
orga n ise e a rly d et e ct ion
Chemotherapy is provided by all
 /)%+
  /)%+
activities for melanomas every
(*(/*0*///
('0/&''///

hospitals. For some cancer sites
spring. We have no knowledge
(leukaemias and lymphomas, 
  
//#// /'$$&!/ /

///  / / / /  !// / / / /
of unusual environmental or
head and neck cancer, ovarian /

//  /


/  / / /  ///#/
cancers, and advanced melanomas)
most patients are treated at occupational exposures in Tyrol that could influence cancer
 


  
 / /)'$$*+// ,//
/
Innsbruck Medical University. Treatment outside the country is incidence figures on the population level besides high radon
rather rare. Tumour boards have been installed in the last years, exposure in a small village with a population of 2800.
but until now did not cover all cancer patients.
Use of the data
Annual reports have been produced since 1988. Besides usual
Registry structure and methods
The Cancer Registry of Tyrol commenced operations at gures, the report also includes staging information, regional
the end of 1986, and has been population-based since distribution and relative survival rates. Reports are distributed to
1988. Since 1969 there has been a law obliging hospitals key decision makers and are accessible online from our website.
to report every cancer case to the Austrian Federal Bureau The data are widely used by physicians (especially from Innsbruck
of Statistics. In addition, local registries are responsible for Medical University). Quality improvement programmes at the
cancer registration in some provinces.
department level make use of survival rates. Survival data have
The Cancer Registry of Tyrol is a department within been published within the EUROCARE study group.
and funded by the TILAK, an organisation managing
Besides routine reports, the registry has been involved in a study of
the university hospital of Innsbruck and some smaller radon exposure and lung cancer. Main scientic work is concentrating on
hospitals in the Tyrol. The registry is staffed by a part- analysing time trends, mainly for prostate cancer and breast cancer.
time epidemiologist, a full time registrar and one part-time
registrar, and data entry clerks as needed.
Source of population
All hospitals are obliged to report cancer cases. Most Ofcial population data collected by Statistics Austria. In 2001, the
departments ll in a form consisting of personal data, population data were extracted from the census le; in the other years
incidence date, most valid basis of diagnosis, topography, the population gures have been estimated in usual way.
histology, behaviour, staging and summary of rst treatment.
All pathology diagnoses concerning cancer and all death Multiple primary rules used
certicates are sent to the registry.
IACR rules (2004) on CI5 IX period.

277

Europe

Austria, Vorarlberg
medicine. Per Vorarlberg government decree, hospitals are
Registration area
Vorarlberg is the westernmost of the nine federal states of required to send their records to the local cancer registry,
Austria. It borders Switzerland, Germany, Liechtenstein and from where they are forwarded to the Federal Bureau of
the Austrian federal state of Tyrol (19% of the border). Lake Statistics. The main source of the data is the Institute of
Constance comprises 8% of the border between Austria and Pathology (histological, cytological and necropsy diagnoses).
Germany and Austria and Switzerland. Vorarlberg covers The data are transferred to the cancer registry and compared
2601 km, of which only 21% are habitable. 90% of the area to data already registered. From there a registration sheet
is mountainous. Vorarlberg lies between 9 and 10E and (including the pathology diagnosis) is sent to the hospital for
further information. In cases with no pathology diagnosis
46 and 47N.
The total population of 351 570 (177 971 females, the hospitals report the cases directly. The radiooncology
173 599 males per census 2001) lives in 96 communities, ve department, which tracks each patient, also sends data to
of which are cities; 51% live in communities with more than the registry. In general, multiple notications are received
10 000 inhabitants, 43% in communities with 1000 to 10 000 for one cancer phase. Persons are identied by name, date of
birth, sex, address and (since
inhabitants and the others in
1995) social security number.
smaller communities. The
A sophisticated program
Rheintal (Rhine River valley)
AUSTRIA, VORARLBERG (1998-2002)
developed by the Cancer
and Walgau are home to
AUSTRIA, VORARLBERG (1998-2002)
Registry of Tyrol establishes
81% of the population. The
links between various records.
population density in the
Multiple cancers for a person
Rheintal (permanently settled
are
recorded
separately.
area) is 1125/km, whereas
%.&'0...
0+'.+/0...
%.'&/...
0#!
'.%%'...
Follow-up is conned to date
the population density for
'.#1/...
/+!
+.0+1...
of death.
the whole federal state
).0/'...
/#!
,.+&0...
,.%+%...
,+!
/.#'%...
Topography and histology
(permanently settled area) is
0.#,+...
,#!
0.+,,...
are classied according to
620/km. Life expectancy at
1./,)...
++!
1.,%'...
%#./)'...
+#!
%#.&,%...
ICD-O-DA (German edition).
birth is 75.8 for males and 82.6
%%.#/0...
)+!
%%.%',...
Coding is done by a trained
for females (2001). Inhabitants
%&.1'/...
)#!
%&.+,,...
%+.))+...
'+!
%).+/&...
person in cooperation with
from foreign countries make
%+.+,0...
'#!
%).1#+...
a pathologist and medical
up 14.5% of the population:
%'.%,&...
&+!
%'.%%/...
%%./,+...
&#!
%%.+'&...
doctor. The rst quality
5.2% from Turkey, 4.6%
%&.%%/...
%+!
%%.+'%...
inspection is performed by
former Yugoslavia, 2.8% from
%%.0,#...
%#!
%%.#1+...
%&.&&,...
+!
%%.+&/...
the medical manager before
Germany, and 0.4% from
%%.%&&...
#!
%#.,/#...
data is entered. In addition,
Switzerland. 87.2% are Roman
IARC check programs and
Catholics, 2.8% Protestants,
%#
+
#
#
+
%#
 .($*
  .($*
plausibility checks established
4.7% Muslims, 3.3% other
%//.&##...
%/&.+'/...

by the Cancer Registry are
denominations. The main
applied periodically.
occupational groups are: 
  
The
only
pathology
services (55.4%) and industry  .. .  .. . . ... .  . .    . .. .. .&##%".
 


  
 .  .(&##)*.. +..
.rate was 4.3%.
institute in our region provides the rst information on
and trade (42.7%). The 2001 unemployment
cancer at primary histological diagnosis and on autopsy
See http://www.vorarlberg.at for further information.
reports. Clinicians from the clinical departments supplement
the remaining data. Aks staff merge the data into the cancer
Cancer care facilities
5 public hospitals and 2 private hospitals cover most medical registry. Completeness is examined by comparison with all
needs. In special cases patients are sent to hospitals in other hospitals discharge diagnoses. We organise team sessions on
areas, mostly the university hospital in Innsbruck, Tyrol. a regular basis with participation from responsible persons
Cancer treatment is provided by every hospital. There is from the aks.
only one Radio-Oncology department in the province,
in Feldkirch. Hohenems hospital has recently opened a Interpreting the results
The population in the province is stable and there have
palliative care department.
been no changes in the medical services structure or in
availability of diagnostic or treatment services. Case
Registry structure and methods
The Cancer Registry of Vorarlberg was founded in 1978 by denitions and coding did not change in 19982002. Wellthe Pathology Department at Feldkirch hospital. Electronic organised preventive care and early detection programs have
been available in Vorarlberg for many years. In 19982000,
data processing was introduced in 1981.
In 1968 a cancer registration law was passed in Austria, 37% of women and 32% of men took part in health checks
obliging hospitals to report every cancer case to the Federal (including hemocult tests) and 45% in gynaecological exams
Bureau of Statistics. In addition to this federal registry, local (including Pap smear). Mammography screening has been
cancer registries exist in some federal states. In Vorarlberg active since 1989.
the cancer registry is part of the Arbeitskreis fr Vorsorge
und Sozialmedizin (aks), a non-prot organisation founded Use of the data
in 1964, working on behalf of the local government in the Annual reports are made to the government health
eld of health promotion, preventive medicine and social department. The data are used for evaluating local cancer

278

Europe

screening programs, such as early breast cancer detection,


cervical cytology and colon adenoma. In Vorarlberg, health
checks (Gesundenuntersuchungen) are very common, so
the cancer registry also documents dysplasia and adenoma
of the colon as cancer risks. Incidence data for the Cancer
Registry of Vorarlberg between diagnosis years 19962000
have appeared in a publication entitled Cancer Mapping
in Alpine Regions 1996-2000: Trentino, South Tyrol,
Carinthia, Tyrol, Vorarlberg. Data are linked and used for
publications and scientic reports known as the Vorarlberg

Health Monitoring and Promotion Programm (VHM&PP).


For further information see: http://www.aks.or.at and search
Health Monitoring & Promotion.
Source of population
The data are estimated by the Institute of Statistics in the
Government of Vorarlberg, based on census data from 2001.
Multiple primary rules used
IACR rules (2004) on CI5 IX period.

279

Europe

Belarus
Registration area
The Belarussian Cancer Registry covers the population of
Belarus, which occupies 207 600 km2. The population in
1999 was 10 179 121 (males 46.6%, females 53.4%, urban
70.3%).

from the Institute for Oncology and Medical Radiology, the


Childrens Oncological and Haematological Centre, Centre
for Thyroid Tumours Pathology, Institute for Neurology,
haematological hospitals, hospitals with cancer beds, and
out-patient clinics, where cancer is diagnosed and treated.
Pathologists must also complete and send a notication if
they incidentally diagnose cancer as a result of an autopsy.
Cancer care facilities
Death certicates are checked monthly by the personnel
The main treatment facilities are the 12 oncological
dispensaries, which combine outpatient and inpatient clinics, of the oncological dispensaries and the Institute for Oncology
and Medical Radiology in regional state statistics departments
and an Institute for Oncology and Medical Radiology.
for any mention of cancer. Information found is checked
against the database in the dispensary. For each cancer case
Registry structure and methods
Cancer registration is mandatory and has been carried out not found in the database additional information is requested
from the institution, which
according to the directive of
issued the certicate.
the Ministry of Public Health
In-situ
cancers
are
of the USSR since 1953.
BELARUS (1998-2002)
registered
but
are
not
included
However, until the beginning
BELARUS (1998-2002)
in the cancer statistics.
of the 1970s, it was performed
Primary multiple tumours
on the basis of obligatory
are registered as separate
ofcial statistical reports,
cancer cases if they appear
and there was no computer
'20((2000
2-/
1(02))000
(-0+'-000
2%#
2%0.3%000
(simultaneously or at a later
database with individual
.20+-2000
1-#
'2'032'000
time) in different organs or
information on cancer cases.
'+-0312000
1%#
(120.)1000
'2-0-2%000
.-#
(3)0%%2000
different parts of the same
The Belarussian Cancer
((20.)1000
.%#
)(%0'.3000
organ (including skin); each
Registry includes complete
'3%0.+2000
--#
()10)3.000
(-303(1000
-%#
(3-0'-2000
tumour is entered into the
individual information on
))20)%2000
+-#
).30(.(000
database separately according
cancer cases since 1978, but
+%-0%32000
+%#
+(-0.(2000
)310%1'000
)-#
+%10)%+000
to the 4-digit ICD-9 code. The
for the period 19781985 there
)+)03%+000
)%#
)-'02%)000
records have the same unique
are no personal identiers
)+10+((000
(-#
)+10+-(000
)1)0()3000
(%#
).(0...000
key and may be analysed
such as name and address. In
+'+03-+000
'-#
+%%0.%.000
together if desired.
19851988 a computer system
+%.0(%+000
'%#
)230.+(000
)'%0+)2000
-#
(3-0)3'000
was gradually set up in the
(+'0(-'000
%#
((102+)000
Interpreting the results
oncological
dispensaries,
In 1986 the Chernobyl
which allowed long-term
'%
%
%
'%
accident resulted in radiation
continuous data collection for
 0*&,
  0*&,
-0))10+.3000
exposure to about 20% of
+01%%01.%000

each patient and easier followthe Belarussian population.
up. Since 1991 this system   

 "0 0!0 0 00
 00 0!0 0 0'3330 "0 0 0 0!00
After 1991, a high increase
has functioned on personal 0

0 0 
 "00 0000 0 0 0 $000 00
 0!0 00 0 0 00 0 0
0
 $0
computers in all the Belarussian
oncological dispensaries in the number of thyroid cancers in children, related to I131
      
 0 0*(%%+,00 -00
0
and the Institute for Oncology and
Medical Radiology. Since irradiation of the thyroid gland, was observed.
 00 
00based
0 0! 0 00 0 
 0 0  040 0 
 0-0*  ,$0
1999 new computer system was  
introduced
on ICD-10
and ICD-O-2 morphological classication.
Use of the data
The Belarussian cancer registry has been located in the The Belarussian Cancer Registry submits ofcial statistical
Belarussian Centre for Medical Technologies, Computer reports to the Ministry of Health annually, including data on
Systems, Administration, and Economics of Public Health cancer incidence, mortality and treatment in Belarus, as well
in Minsk since 1992.
as the statistical collection Malignant Neoplasms in Belarus
In Belarus, the majority (about 8085%) of cancer patients for a Decade, highlighting trends and changes.
are diagnosed and treated in the oncological dispensaries and
the Institute for Oncology and Medical Radiology, which is Source of population
responsible for the registration of cancer cases for Minsk oblast Annual populations are estimates, calculated by the State
(region). This makes data collection signicantly easier. The Statistical Department on the basis of the 1999 census,
12 oncological dispensaries and the Institute for Oncology making allowance for births and deaths, and migration into
and Medical Radiology are responsible for registration of and out of the registration area. Migration data are annually
all cancer patients permanently residing in their service provided by the Ministry of Internal Affairs to the State
area, and regional sub-registries of the Belarussian Cancer Statistical Department.
Registry are maintained in the oncological dispensaries and
the Institute for Oncology and Medical Radiology.
Multiple primary rules used
Most information is entered onto computers directly IACR rules (2004) on CI5 IX period.
from patients medical records (outpatient medical card and
history of disease) stored in the dispensaries and the Institute Notes on the data
for Oncology and Medical Radiology. Extracts of medical The Editors recommend that some care be taken in the
documents and special notication forms are also obtained interpretation of these data; see Chapter 5 (Categorisation).

280

Europe

Belgium, Antwerp
Interpreting the results
Coverage of the entire province was not complete until the
incidence year 2000, when all hospitals in the registration
area participated in registration; under-registration in 1998
and 1999 may be estimated around 5%. Some organised
screening programmes exist for cervical, breast and prostate
cancer; however, these data are not being used directly for
case nding.

Registration area
The Antwerp Cancer Registry covers the province of
Antwerp in the north-west of Belgium. Almost half of its
population of 1.6 million inhabitants is concentrated in and
around the city of Antwerp. The western half of the province
has a high urbanisation grade, whereas the eastern half of the
province is mainly rural.
Cancer care facilities
The province of Antwerp has 36 hospitals, of which 6 have
an oncology centre. Five hospitals in the registration area
have radiotherapy departments
Registry structure and
methods
The ACR is located at the
Department of Epidemiology
and Community Medicine
of the University of Antwerp
and is funded by the Flemish
government.
The staff of the registry
consists of a head medical
ofcer, an epidemiologist
and 7 registration workers.
The registration process is
based upon the Dutch cancer
registry, characterised by
active case nding, data
collection and coding by
the registration workers in
all hospitals and the major
private pathology laboratories
of the province. There is no
access to death certicates;
therefore these are not used
for case nding.

Use of the data


The ACR reports crude, age-specic and age-adjusted (ESR)
incidences annually; moreover, each participating hospital
obtains an annual report on all of its own diagnosed and/
or treated cancer patients.
Registration data are provided
for research purposes to internal
BELGIUM, ANTWERP (1998-2002)
as well as external institutions.
BELGIUM, ANTWERP (1998-2002)
Our data are used directly
by local health authorities, for
evaluation of screening programs
and indirectly: hospitals report
/",
($-%""--to the federal health department
.*
&(-$""--using cancer registration data.
."
("-.(/---

$/-0$0--%(-$+"--&&-**&--("-*.%---

+*

((-+($---

(&-"$$---

+"

((-&(&---

((-/%0---

**

((-$/"---

*(-("/---

*"

*%-.("---

*/-*".---

(*

*+-%.&---

+(-&*$---

("

+%-$+"---

+.-*0*---

&*

+*-&%0---

+%-0%+---

&"

+"-.%&---

*(-"*0---

%*

*%-0/.---

(0-%%$---

%"

(.-//%---

(0-0.*---

$*

(.-/+/---

(/-0%&---

$"

(+-/"*---

(0-(+/---

(.-*""---

(+-""%---

"

((-%$"---

$"

"

"


-'#)
/$"-(.0---

$"



-'#)


  

-- -  -

- 
--
--

/&&-+0"---

Source of population
Ofcial data from population
register, provided by the
administration.
Multiple primary rules used
IACR rules (1990).
Notes on the data
The Editors recommend that
some care be taken in the
interpretation of these data; see
Chapter 5 (Categorisation).

      
-
-'$00")  

- -

--
-
-
-
--
-
 
- -

-1-

- 
-*-'
)!-

281

Europe

Belgium, Flanders
Registration area
Flanders is situated in the north of Belgium and comprises 5
provinces. The estimated mid-year population for 2000 was
5 946 402, of whom approximately 5% are foreigners. The
mean population density is 439 inhabitants per km.
In 2000 people over age 60 made up 22.2% of the total
population, with 11.7% older than 70 years of age. The life
expectancy at birth was 76.0 years for men and 81.9 years
for women.

consisted of 2 data managers, a part-time pathologist and a


physician coordinator.
Both active and passive data collection methods are used
in this network, but all data are provided electronically to
the Belgian Cancer Registry in a predened structure. Due
to privacy regulations only encrypted data are allowed to be
transmitted. The personal identiers are encrypted by the
same procedure at the hospitals, the National Health Services
and the pathology laboratories.
All invasive and in situ tumours are registered.
Topography, morphology, behaviour and differentiation
Cancer care facilities
In 2000 there were 3.1 physicians per 1000 inhabitants and are coded to ICD-O-2. In Flanders the majority of the
5.1 general hospital beds per 1000 inhabitants. The medical pathologists work with CODAP codes which are translated
automatically to ICD-O-2 by
care institutions are easily
means of a computer program.
accessible and medical care
For staging of tumours the
is provided by 116 general
BELGIUM, FLANDERS (1998-2001)
TNM classication is used.
hospitals.
BELGIUM, FLANDERS (1998-2001)
The IARC rules for classifying
There are no specic cancer
multiple
primaries
were
hospitals or regional cancer
adapted slightly.
centres. Oncological care and
radiotherapy are provided
All incoming data are checked














within general and university


at the Belgian Cancer Registry







hospitals. For the whole country


with a control programme based

 












in 2000, 163 radiotherapists and


on the rules of the IARC-check







almost 287 pathologists were


program and supplemented with











 


registered at the Ministry of


other controls developed at the






Health and Social Affairs. In


registry. Multiple notifications














2000 there were 25 radiotherapy


for the same tumour are linked







services in Belgium, of which


according to the encrypted




 


 
 





14 were located in the Region


personal identier at the Cancer
 



 


of Flanders.
Registry and summarised by
 









 


More than 99% of the


automated decision rules. A







population living in Flanders


signicant number of cases are
are afliated with one of the
resolved manually.






National Health Services for
Death certicates are
 )%"'
  )%"'




$)+$+)*#&)))

mandatory medical insurance.
also transmitted to the
All of these National Health 
  
cancer registry, but they are
Services are grouped in a #++*-$!!#)) )

)  ) ,) ) )-)   )   ) ) ) ) )
anonymous and do not permit
 


  
National Health Insurance System.
any trace-back procedure. They can only be used as an
 ) )%$!!&')) ())
)
Although there were no regional or national organised additional check for date of death and the cause of death. The
screening programs for cervical nor breast cancer until June independent data set method was used in 2005 to evaluate
2001, many women did have a Pap smear and mammography the completeness of the cancer registry (year of incidence
taken regularly at that time. In June 2001 a national breast 20002001). The completeness was estimated to be 98.2%.
cancer screening program was launched for women aged
5069 years. There are also local initiatives for screening Use of the data
of cervical cancer and malignant melanoma. Opportunistic Annual incidence data by sex, age, site and geographical
PSA testing has been used increasingly.
units are routinely produced. Detailed data for the major
cancer sites are analysed in separate chapters that are
Registry structure and methods
published and distributed. Survival data were published
The Belgian Cancer Registry is subsidised by the National for the rst time in March 2006. Data are also displayed
Ministry of Public Health and by the Ministries of Public on the website of The Belgian Cancer Registry and www.
Health of both communities (French and Flemish). Since tegenkanker.be/kankerregistratie. Numerous requests for
1983 the National Health Services have been collecting data are provided to research workers, clinicians, health care
data on newly diagnosed malignant tumours among their planners, paramedics and the general public.
contributing members and families. In Flanders, from 1996
onwards, different cancer registration systems, essentially Source of population
the provincial cancer registry in Antwerp (AKR), the 19972001: Mid-year population estimate. Source: FOD
provincial pathology cancer registry in Limburg (LIKAR), Economie Algemene Directie Statistiek en Economische
the bronchus carcinoma registry for Flanders (VRGT), Informatie.
some hospital cancer registries and almost all pathology
laboratories, have been integrated in a cancer registration Multiple primary rules used
network. In 2003 the Flemish staff of the cancer registry IACR rules (2004) on CI5 IX period.

282

Europe

Bulgaria
Registration area
The Bulgarian National Cancer Registry (BNCR) covers the
whole population of Bulgaria. The population at the most
recent census (1 March 2001) was 7 932 984. About 70%
of the population (<6 000 000) lives in urban areas. The
predominant religion is Eastern Orthodox Christians (85%);
13% are Moslems and nearly 1% Catholics.

Dispensary clerks frequently visit all hospitals with wards


diagnosing or treating cancer patients, pathological laboratories,
etc. to add to the rapid notication data.
In January 2006 the ICD-10 was introduced in Bulgaria;
all cancer cases since 1993 have been recoded. To improve
the registration system a check of the Central Population
Register was made for all cases who died after 1998.
For registration of malignant neoplasms a new software
product has been developed. In each regional register trained
Cancer care facilities
Until 1989, medical care in Bulgaria was free. Private medical clerks, under the supervision of physicians, code the data.
practice has been permitted since 1991. National Health Processing includes verification of completeness, checking
Insurance was introduced in 2000. Health care is mostly public, for duplicates by name, identication number (PIN), address
including regional hospitals, university clinics, specialised and diagnosis, consistency and compliance between clinical
and morphological diagnosis,
hospitals and primary health
computerised checking and
establishments, supplemented
correction of coding and typing
by private practitioners and
BULGARIA (1998-2002)
errors. Histology is coded
hospitals.
BULGARIA (1998-2002)
according to ICD-0-2. Benign
A sp e cia l ise d ca ncer
lesions and those of uncertain
network was founded in
behaviour are not registered. The
Bulgaria in 1952. It includes
BNCR uses IARC Tools Version
13 Regional Oncological
).13()111
3.0
,,1,22111
,.1**/111
3&#
2&1.4*111
2.03 (2006) and DEPedits
C e n t e r s (d i s p e n s a r i e s),
((.1()2111
2.#
(/312)(111
Version 1.00 (2006). Legislation
covering populations between
(/41*42111
2&#
)))1/)*111
)&21,2,111
/.#
).)1.((111
for data condentiality is not yet
370 000 and 1.2 million
)&412&3111
/&#
),*134,111
available in Bulgaria; thus each
inhabitants. Another part,
))41),2111
..#
).*13/)111
)241&2.111
.&#
)421233111
patient is assigned a unique ID
National Oncological Hospital
)3.1344111
,.#
)421&32111
number.
(NOH) is located in Sofia.
)241)2.111
,&#
)3*1/./111
)2&13/4111
*.#
)/313.4111
The specialised cancer system
In the registry we currently
)2/1/&3111
*&#
)/41*4.111
provides prevention, diagnostic,
compare (for completeness and
)4/1())111
).#
)33122*111
*&4134/111
)&#
)4.1/22111
t reat ment (r ad iot her apy,
accuracy) and evaluate the data
)3.1///111
(.#
)2&1*)(111
surgery, chemotherapy) and
between: incidence and mortality
)/*13&)111
(&#
).(1(/&111
)()1,((111
.#
)&(1.32111
follow-up services for cancer
data; incidence data between 28
(2*1,24111
&#
(/,1(2(111
patients. In 2000 a total of 27
districts in Bulgaria and over
526 physicians were engaged
time; incidence data between
(&
.
&
&
.
(&
  1+' !  1+'in healthcare activities, 471
Balkan countries, etc. Every three
,1(,.1(.*111
*14*.1)&,111
 
of whom were physicians in
months we receive information
oncological centres. Natioanlly   

for all deaths from the Central
there were 60 552 hospital  1 !  $1 51 1  1  1 1+ 5%%$$"-1
Population Register in Bulgaria.
      

1 1+)&&,-11
.11 1
beds, of which 2005 were in oncological
centres.
This comparison is published in Lung Cancer: Current Status
  
September 2005; Balkan Union of Oncology,
 11 !! 1 1! 1  1" 1  11 1    11  1 and
 61 1
 Perspectives,
 1.1+
  -$1
1 1 1 1 1 1  1  11 1! $1
Registry structure and methods
Proceedings/ Educational Book, 5th Congress, etc.
The Bulgarian National Cancer Registry, funded by the
Ministry of Health, is part of the National Oncological Interpreting the results
Hospital. One physician, one statistician, one specialist in Despite active and passive methods of cancer registration
computing and six full-time clerks staff it. In each of the there is possible nonregistration of cancer cases mainly
13 dispensaries, there is a Regional Cancer Registry, usually among elderly people and among inhabitants of the rural
staffed by one full-time physician and 2-3 clerks.
areas. There are some omissions in coding cause of death
The BNCR uses active and passive methods of data collection. (metastasis instead of primary site) as well, leading to a
Compulsory registration of malignant diseases in Bulgaria was discrepancy between incidence and mortality data, especially
introduced in 1952. Every physician is required to send a rapid in liver cancer, esophageal cancer, etc.
notication to the Regional Oncological Centre for each newly
Bulgaria now has opportunistic screening for breast cancer and
diagnosed or suspected cancer case, death from a malignant cervix uteri cancer funds from the National Health Insurance Fund.
neoplasm, and since 1975 for cancer in situ as well. The rapid A Strategy for Prophylactic Oncological Screening in Bulgaria was
notication system was updated in 1992. From 1993 cancer patients created for 20012006. It includes breast cancer, cervical cancer
have been followed up by type of treatment and date of death as and prostate cancer. The Strategy was accepted by the Council
well. In 2000 new items and codes were introduced according to of Ministers on 23rd of April 2001 but it was not undertaken for
European Network of Cancer Registries recommendations.
various reasons (faults in program organisation, screening tests,
Other sources of information on cancer patients are medical interpretation of the results, etc.). PSA testing is not common.
records from oncological centres and other specialized hospitals,
university clinics, primary health establishments (outpatient Use of the data
and inpatient), pathology and haematology laboratories, The BNCR annually publishes cancer incidence data in
death certicates, Central Population Register, hospices, etc. Bulgaria. The data available in the BNCR are used for

283

Europe

epidemiological studies, reports, communications and the


like. Bulgarian policymakers use cancer registry data for
planning or evaluation of health services.
Source of population
Ofcial estimate. Source: The National Statistical Institute
(http://www.nsi.bg).

284

Multiple primary rules used


IACR rules (2004) on CI5 IX period.
Notes on the data
The Editors recommend that some care be taken in the
interpretation of these data; see Chapter 5 (Categorisation).
This registry has the lowest histological verication rate in
the monograph.

Europe

Croatia
Registration area
The Croatian National Cancer Registry covers the whole
country of Croatia. The Republic of Croatia is situated along the
eastern coast of the Adriatic Sea and covers an area stretching
up to the last slopes of the Alps and deep into the Pannonian
Valley to the banks of the Drava and Danube Rivers. Croatia
is divided into three geographical regions: the Mediterranean,
the Mountainous, and the Pannonian. Roman Catholics account
for 87.8% of the population. Administratively, the country is
divided into 20 counties and the City of Zagreb.

are used as a supplementary data source. Topography is coded


in ICD-10, and morphology in ICD-0-2 classication.
Interpreting the results
There have been no organised population-based screening
programmes in Croatia in the period 19982002. National
population-based screening programmes were introduced
in 2006 for breast cancer and in 2007 for colorectal cancer.
However, opportunistic screening for cervical cancer has
been going on since the 1960s, and the number of Pap
smears taken yearly is increasing, as well as the number of
mammographies. Opportunistic screening by faecal occult
blood test has been going on in some regions, while PSA
testing is becoming more
common, but only in patients
with urological symptoms.

Cancer care facilities


In 2003, the health service entry points are 2372 primary
care physicians, i.e. general
practitioners, gynaecologists and
paediatricians. There were 23
CROATIA (1998-2002)
general hospitals. In addition, there
CROATIA (1998-2002)
were 12 clinical and two clinical
teaching hospitals, and some
specialised hospitals, of which
one was dedicated to oncology.
$$-*.+--/*,
$.-"("--/"
Most health institutions admitted
((-$(0--.*
oncology cases, but the main
/$-//(--."
$$"-(*0--+*
regional oncology centres with a
$%"-++.--+"
full range of services are located
$"/-+.&--**
$(/-%%(--*"
in the clinical hospitals in Zagreb,
$+/-%0"--(*
Split, Osijek and Rijeka.
$++-(00--("

Use of the data


Cancer incidence data have
appeared each year in an annual
report (bulletin in Croatian and
&"-0..--&0-0$(--English) and in the Institutes
0&-"*%--joint annual report since 1976.
$%%-""$--$(%-(//--Analyses and observed trends
$($-&(0--are published in medical
$%$-$"%--$*$-*(0--journals, masters and doctoral
$+*-%/+--theses, and presented in
$++-0"(--$*/-*"+--&*
$*/-.+.--congresses and other scientic
$(.-0%"--&"
$(.-*$$--gatherings. Survival analyses of
Registry structure and
$(/-+++--%*
$(*-/&$--$**-.&0--%"
$(0-/0%--registered cancer cases in the
methods
$*%-+.+--$*
$(*-0&"--periods 19881993 and 1994
The registry is part of the
$&.-$.*--$"
$&$-("0--$%.-%.(--*
$%$-%*(--1998 have been carried out.
Chronic Disease Epidemiology
$%$-.$/--"
$$*-/"(--The registry was created
Service at the Croatian
in response to the growing
National Institute of Public
$"
*
"
"
*
$"
public health problem posed

-'#)


-'#)
Health in Zagreb, the capital
/-.+*--!
$"-*("--%-&"$-*+"--%-$&*-0""--
by cancer. Data on cancer
of Croatia, and is funded by
incidence
and
mortality
the Ministry of Health and 
  
are used for planning and
Social Welfare. A medical 
-%""$!-
- -  -
--
 -&$- -%""$-


-%-$.-


-%""&-
- - -1-
 
- -! 


  
doctor specialist of epidemiology,
a senior statistician, a evaluation of preventive measures and healthcare services.
- 
-'%""()-- -technician and two data entry clerks staffs the registry fullSource of population
time. Software support is provided by an external IT rm.
The basic notications are from hospital discharge, Census 2001. Census of population, households and dwellings
pathology reports and primary care. Additional information 31st March 2001, Release 2, 17th September 2003, Republic
is derived from every ofcial death certicate that mentions of Croatia Central Bureau of Statistics.
cancer. Notications include the name of the health providers
(hospital or physician) so that they can be contacted for further Multiple primary rules used
information. Hospital discharge records in electronic format IACR rules (2004) on historical data

285

Europe

Czech Republic
nurses) and about 80 physicians look after data entry and
Registration area
The National Cancer Registry of the Czech Republic is proper classication.
In the Czech Republic reporting of malignant neoplasms,
a territorial registry covering all residents of the Czech
Republic, which lies in Central Europe. Mild climatic in situ neoplasms and neoplasms of uncertain or unspecied
conditions do not vary markedly with geographical latitude behaviour is obligatory. The report is returned by the
physician who diagnoses the neoplasm. Data collection is
over the territory.
The population of the Czech Republic is 10.2 million performed with the aid of Regional Units of the NCR, which
(2002). According to the 2001 Census more than 70% of collect the mandatory reports, histopathological reports,
the population is urban. A signicant ageing trend in the discharge reports, protocols on surgery, etc. These data are
population is accompanied by low fertility rates (during collated by the workers of the NCR Regional Units.
Collated data are transferred electronically to the
1998-2002 total fertility rate was below 1.2). Life expectancy
at birth was 72.1 years for males and 78.5 years for females Registry. All data are collected, processed and transferred
to the central database using unied software with built-in
(2002).
online controls. Data are kept
The population of the
condential in the recording
Czech Republic is ethnically
and data transfer process.
homogenous. The majority
CZECH REPUBLIC (1998-2002)
The central unit updates the
of population (90.2 %)
CZECH REPUBLIC (1998-2002)
Registry after checking and
declared
Czech nationality
eliminating duplicates. This
(Census 2001). The biggest
process is supplemented by
ethnic
minorities
are
annual comparison with the
Slovak (1.9 % of the whole














database of deaths run by the


population) and Polish (0.5 %





 

Czech Statistical Ofce; NCR


of the whole population).







 






also has access to the death


Regarding religion, many







certicate database, which


are
nondenominational








 





is used for additional case(59.0%); the


majority
of
 






nding.
believers (26.8% of the total





 








Apart from this statistical


population) were afliated







activity, patients are followed


with the Roman Catholic

 










 

continuously (except nonChurch.







 

melanoma
skin
cancer











 


patients).
Specialised
followCancer care facilities







up
(dispensary)
health
There is an extended network
establishments
return
a
of health services in the






mandatory check-up report
Czech Republic. Oncological
 $ "
 $ "




for each case after 1, 2, 3, 4,


!$&&$##$$$

diseases are treated in
5, 7 and 10 years, then every
specialised establishments in 
  
ve years and on the patients
accordance with the kind of  $  $$ $$  $
 $&&%'$ $ $$ $$ $&&$$
 $'$$ $$ $$ $
 


  
cancer. There are 83 outpatient
establishments
for clinical death. The Regional Units employ physician cancer specialists
$  $
!"$$ $$
oncology, employing 112 physicians and 226 paramedical and nurses on part-time contracts, mostly in addition to their
personnel. There are 39 outpatient radiotherapy departments practice in the eld. The centre in IHIS has three specialists
with 117 physicians and 362 paramedical personnel. In the working directly in NCR activities.
hospitals there are 11 departments of clinical oncology with
286 beds and 48 physicians, and 24 radiotherapy departments Interpreting the results
with 1185 beds, staffed by 113 physicians (as of the end of The rst organised screening programme in the Czech
Republic was introduced in August 2001 for colorectal
2002).
cancer. Women and men older than 50 years are involved in
the colorectal screening programme. Nationwide organised
Registry structure and methods
The National Cancer Registry of the Czech Republic (NCR) breast cancer screening of women aged 4569 was
was founded in 1976 and connected with data collection introduced in September 2002. Opportunistic screening for
on mortality from oncological diseases. However, cancer cervical cancer could inuence incidence rates. In the Czech
incidence has been registered since 1956. The NCR receives Republic PSA testing was introduced in 1990 and has been
nancial support from the Ministry of Health. Administrator done routinely since 1992.
of the NCR is the Institute of Health Information and
Use of the data
Statistics (IHIS).
The National Cancer Registry of the CR itself has no IHIS publishes a yearbook entitled Cancer Incidence in
regular staff. Programming is outsourced; data managing the Czech Republic, containing detailed data on incidence
and analysis are done by three full-time employees of IHIS of neoplasms and mortality from cancer. Additional details
CR and two full-time employees of the Coordination Centre (stage of disease, therapy) are analysed for 10 selected
for Departmental Medical Information Systems (CCDMIS diagnoses. The Central Unit in IHIS processes additional
has an executive role in managing NCR). About 120 data responding to about 50 special requests a year, from
professionals are responsible for data entry (mostly hospital specialists as well as the lay public (media), and compiles

286

Europe

additional special publications. Other publications


using registry data are prepared by other specialists or
organisations.
Although IHIS of CR is not involved in epidemiological
research, data of NCR of CR are submitted to scientists
(e.g. researchers in Masaryk Memorial Cancer Institute).
One of the tasks of the National Oncological Programme
(NOP) is to support continuity, stabilisation, modernisation
and practical utilisation of the database for controlled
preventive and diagnosis-treatment care in oncology. NOP
was ofcially supported by President Vaclav Klaus and

by Ministry of Health of CR. The politicians devote great


interest in oncological data. Practical cancer incidence data
are used to evaluate the quality of hospitals services.
Source of population
Postcensal estimates.
The population estimates for
19982000 are based on the 3 March 1991 Census and for
20012002 on the 1 March 2001 Census.
Multiple primary rules used
IACR rules (2004) on historical data.

287

Europe

Denmark
Registration area
The Kingdom of Denmark, excluding Greenland and the
Faroe Islands, covers 43 080 km2 between latitudes 55 and
58 N, and longitudes 8 and 1230E. The mean population
of Denmark was 5 340 000; it is of Caucasian stock and fairly
homogeneous. Approximately one third of the population
live in the greater Copenhagen area, 40% live in provincial
towns of 10 000 to about 200 000 inhabitants, and the rest
live in rural areas. Since 1968 all inhabitants have been
given a unique personal identifying number, used in most
registration systems, including the cancer registry. A central
computerised population register keeps a continuously
updated le of personal information on all inhabitants.

copy of the Danish Cancer Registry operates under the law


on private registries also supervised by the National Data
Protection Agency. Data extraction and requests for data for
research projects external to the Danish Cancer Society must
be forwarded to the Cancer Registry at the National Board
of Health.
Upon receipt at the cancer registry, notications are checked
and coded. Medical coding is carried out by physicians (1 fulltime equivalent) and trained medical coding staff (10 full-time
persons), supported by an academic staff and IT coordinator
(1 full-time equivalent). Duplicate registrations are readily
picked up with the help of the personal ID number. The entire
coding process is supported by computer checks of consistency
between variables (sex, codes,
Cancer care facilities
procedures, etc.), warning
The medical care system is
programmes and manual check
DENMARK (1998-2002)
organised into a private sector
procedures. New tumour cases
DENMARK (1998-2002)
of general practitioners and
are then included in the registrys
specialists under contract
computerised database and
with the National Health
additions or corrections are made
insurance, and a public sector
to previously notified cases.














operating hospitals under the


If the information received is







authority of the counties and


incomplete or contradictory, an





 







municipalities or the Danish


inquiry is made to the notifying





 

State. Health care is provided


clinician. All data up to 1977
 
 


 






 


free to all inhabitants. Cancer


were classified according to
 



 


surgery is carried out both


a modified version of ICD-7
 



 









at general hospitals and at


expanded to include information







oncological centres. The


on histology and tumour
 
 












hospital departments are


behaviour. All cases diagnosed







serviced by 23 institutes
since 1978 have been classied






 






of pathology. Non-surgical
according to the ICD-O as well
 






cancer treatment is partially


as the modied ICD-7.
centralised at ve university
Reported cases of cancer






hospitals with radiotherapy
are linked to the Central
 '"$
  '"$
and oncology expertise and
Population Registry using




'&!(')%'''

one regional oncological centre
the personal identication

  
(Vejle Hospital). Almost the ''' ' '

'' ' '*  '
'' ' '  ' '  '
number, the identity is checked
 


  
entire population is capable of reaching
a specialised cancer and information corresponding to the date of diagnosis is
 '  '" #$'' %''
'
centre within a few hours by ground transport.
transferred to the registry le.
The entire registry database is cross-checked annually by
Registry structure and methods
computerised record linkage with all deaths that occur in the
The Danish Cancer Registry was founded in May 1942 as country. Medical certication of death by medical doctors
a nationwide programme to register all cancer cases in the is compulsory. Follow-back on death certied cancer cases
population. Incidence gures are available from 1 January unreported to the cancer registry is accomplished by mailed
1943. Registration is compulsory by administrative order as enquiries to the certifying physician or hospital. Less than
of 1 March 1987, today incorporated in the National Health 2% remain as death-certicate-only cases.
Law. This order also covers Greenland, and a similar order
Computerised medical information systems on hospital
was issued for the Faroe Islands by the Faroe authorities. discharges have been operating nationally since 1977.
Data from Greenland are not included in the Danish Since 1987, cases are also captured from this registry but
incidence gures, but published separately. Data from the only included if conrmed. In preparation for extensive
Faroe Islands are not included in the Danish Cancer Registry. computerised data capture from 2004, the reporting of
The registry was, until January 1997 administratively part cancer to the discharge registry was expanded and improved
of the Danish Cancer Society, but has since then been the to full the requirements of the cancer registry.
responsibility of the National Board of Health. A close
collaboration between the Cancer Registry and the Danish Interpretation and use of data
Cancer Society that holds the full and regularly updated Assessments by linkage to patient discharge registers,
copy of the cancer registry for research purposes has been pathology registers, and patient series have shown that the
established. The Cancer Registry operates under the law on completeness of the registry is 9597%.
public authorities registries with instructions established
The registry produces morbidity statistics in relation to
by the Ministry of Health and supervised by the National variation over time, age and geographical location, and is
Data Protection Agency, whereas the Danish Cancer Society used extensively for research. Since 1978, incidence data

288

Europe

have been published for each year separately. From 1999


onwards the annual incidence publication can be obtained
electronically from http://www.sst.dk (search term: cancer)
at the level of ICD-7, and tabulated electronically from 1977,
or from the NORDCAN database http://www.ancr.nu where
annual data are available from 1972.

Source of population
A continuous count of the population is maintained. The
midyear point has been taken for each year.
Multiple primary rules used
IACR rules (2004) on CI5 IX period.

289

Europe

Estonia
Registration area
The Estonian Cancer Registry (ECR) covers the whole
Republic of Estonia, population 1.4 million according to
the 2000 census. Of the total population at the 2000 census,
68% were Estonians, 26% Russians, 2% Ukrainians, 1%
Byelorussians and 3% other ethnic minorities; 69% of the
population was living in urban areas. The life expectancy at
birth was 65.1 years for men and 76.0 years for women.

the Statistical Ofce of Estonia, and the Registry performed


a trace-back procedure for cancer cases rst notied by a
death certicate. But due to the lack of legislative basis,
the Registry has no access to death certicates issued in
Estonia since 2001; therefore the incidence data may also be
incomplete.
For updating the migration data and other personal
data, in 2000 the Registry started regular linkage with the
Population Registry (founded in 1992 when the national
identication code was introduced in Estonia). In 1998, the
Cancer care facilities
After Estonia regained independence in 1991, the national data condentiality issue was drastically emphasised in the
healthcare system was reorganised from a state-controlled public media. To solve the conict between the Ministries
system to a decentralised health-insurance-based system. and specify the legal aspects of personal data protection, the
forwarding of notications to
Patients suspected of having
the Registry was suspended
cancer by the primary
for a month by administrative
and secondary healthcare
ESTONIA (1998-2002)
order. In February 2001, the
facilities are mostly referred
ESTONIA (1998-2002)
Minister of Social Affairs
to two specialised cancer
issued a revised Decree (No.
hospitals, which provide
21) on Cancer Registration
radiotherapy, cancer surgery
and Running the Estonian
and chemotherapy. Some












 

Cancer Registry, providing


cancer treatment is performed







access to the Registrys data in


in general hospitals (surgery)














accordance with the Personal


or other specialised hospitals/

 





Data Protection Act. Recently,


departments (neurosurgery,








 





the Ministry of Social Affairs


haematology,
paediatric







of Estonia has started to


oncology).





 








modify the existing laws









in order to create the legal


Registry structure and








 





basis for all health registries,


methods







including the ECR.


Cancer registration in Estonia













dates to 1953 when compulsory


The quality of the ECRs data

 





registration of incident cancer


has not been formally evaluated;
cases started in the former
the rst study that partially covered






USSR. The Estonian Cancer
this subject was carried out within
*%!'
*%!'
"+(***

"#$***
Registry was founded in



the framework of a doctoral


)$#*",+***

1978, while reliable incidence
thesis by a young researcher and

  
**#
-**
data are available since 1968. ",,+.",,,-*
***",+,** **  * *** ** *  *#
published in 2005.
# ".# #-****#
** **  * *****  * *
Until 1991, the Registry consisted
of two subdivisions:
 


  
* *%# &'** **
(a) The Department of Statistics of the Estonian Cancer Interpreting the results
Centre (ECC), and (b) Department of Epidemiology and No nationwide organised mass screening programmes for the
Biostatistics of the Institute of Experimental and Clinical early detection of cancer have been introduced in Estonia.
Medicine. In 1991, the former of these subunits, responsible However, the wide use of PSA testing since 1993 may have
for the data collection, was renamed the Estonian Cancer caused the rapid increase in detection of prostate cancer.
Registry; the scientic analyses based on the Registrys data
Opportunistic mammographic screening was introduced
continued to be a responsibility of the latter subunit (since in some regions of the country in the 1990s and in the whole
2003, the Department of Epidemiology and Biostatistics country in 2002. Also, an early detection project for cervical
of the National Institute for Health Development). The cancer in Estonia was introduced in 2003, and all regions
year 1994 was a landmark of major reorganisations in the were included by 2004.
Registry, particularly in the data collection procedures and
the structure of the database. The Registry is funded from Use of the data
the state budget and employs a staff of ve (Director, Data The Registry publishes annual reports of cancer incidence,
analyst, Physician-Data Manager, two Coding Clerks). Since highlighting also time trends in incidence (the rst report
the end of 2001, the ECR has operated as a subunit of the available for 1996, the last for 2000). Registry data have been
North-Estonian Regional Hospital Foundations Cancer used for a number of descriptive and analytical epidemiological
Centre.
studies, including international comparisons. In 1996, a
Reporting of cancer cases in Estonia is compulsory. statistical compendium, Cancer in Estonia 19681992:
The Registry receives notications from treating physicians Incidence, Mortality, Prevalence, Survival, was published.
and pathology and haematology laboratories. Coding and
For the rst time, the National Cancer Strategy was
input are carried out in the Registry. The cancer patients developed by the Working Group and presented to the
are followed up to death or emigration. The data le for all Government in Spring 2000, but was not approved and
death certicates issued in Estonia was provided annually by nanced. The present version of the Strategy covering the

290

Europe

years 20072015, was submitted to the Government in 2006,


and state funding will start in 2007.
Source of population
19981999: Estimate, based on 1989 census, making
allowance for births, deaths and migration and revised after

2000 census. 2000: census. 20012002: estimate, based on


2000 census, making allowance for births and deaths but not
for migration.
Multiple primary rules used
IACR rules (2004) on historical data.

291

Europe

Finland
The principal sources of information on cancer cases are
Registration area
The Registry covers the whole of Finland (area 338 145 km2), physicians and hospitals, pathological laboratories and death
which is bordered to the north by Norway, to the east by Russia, certicates from Statistics Finland.
Reporting of cancer cases has been compulsory since
to the west by Sweden and the Gulf of Bothnia, and to the south
by the Gulf of Finland. The average altitude is 150m. Finland 1961. If needed, requests are sent to notiers in order to
has 33 615 km2 of inland water and belongs to the coniferous ensure accurate information of the identity of the individual
forest zone. The population of Finland is 5 181 000 (2000). in question, and primary site and date of diagnosis of the
Ethnically, the Finns are Caucasian, and of mixed origin, tumour. Coding of information at the Cancer Registry
including Baltic, Scandinavian and probably eastern elements; has always been done or supervised by a physician. Case
85% are Lutherans. The ofcial languages of the country are identication is based on the personal identication number
Finnish and Swedish; 5.6% of the population speak Swedish as used in Finland since 1967. This also enables accurate followtheir mother tongue. The main occupational groups are: industry up of cancer patients for death through ofcial sources.
(26.8%), services (65.5%) and agriculture and forestry (6.1%). Besides continuous quality control procedures, formal
evaluations also take place.
Some 60% of the population
Nationwide
screening
lives in urban municipalities.
programmes
for
breast,
The population of Helsinki with
FINLAND (1998-2002)
cervical
and
colorectal
cancer
its suburbs accounts for 18% of
FINLAND (1998-2002)
are coordinated, monitored
the total. The life expectancy at
and evaluated by the Mass
birth is 73.7 years for males and
Screening Registry that is a
81.0 years for females.
part of the Cancer Registry.














Opportunistic PSA testing is


Cancer care facilities







very common.
In 1999 Finland had 15








 





800 physicians (3 per 1000







 

Use of the data


inhabitants) and 39 700

 



 








Apart from producing routine


hospital beds (excluding





 

statistics (annual incidence


psychiatric hospitals). The
 






 



 


rates by sex, age, primary


country is divided into 22
 






site and healthcare district)


healthcare districts, of which














and data for planning and


ve (Helsinki, Turku, Oulu,







health education purposes,


Kuopio and Tampere) have a














the Registry is actively


university teaching hospital.

 





engaged in research on cancer


Diagnosis and treatment
epidemiology,
biometrics
of cancer is only partly






and cancer patient survival,
centralised; cancer surgery

)%!'


)%!'
and provides material for
is practiced in all major




#)($ )"* )))



clinical and pathological
hospitals and also in many
  

studies, and follow-up data
smaller clinics. Nine hospitals )
)) )
)  ))
 
))))))
)  )

)

)
)

))  )  )
",,+-# #)) 
))  ))))
have a radiotherapy unit. Specialised
paediatric oncological on cancer patients. The Registry also acts as a consultant
      
) 
)) 
))
)
)
 )
body in Finland on issues related to cancer epidemiology
services are available in ve university
hospitals.
  
&&)
))
))
) )
and research.
Registry structure and methods
The Finnish Cancer Registry (Institute for Statistical and Source of population
Epidemiological Cancer Research) was established in 1952 A census count of the population is performed on a
on the initiative of the Cancer Society of Finland. Data on continuous basis by the Population Register Centre. The
newly diagnosed cancer cases have been collected since average annual population for 19982002 is published by
1953. Finland has been included in all the previous eight Population Statistics, Statistics Finland.
volumes of Cancer Incidence in Five Continents.
The total number of employees in the registry is 36, of Multiple primary rules used
whom 22 are at the cancer registry and 14 at the Mass Screening IACR rules, modied by the cancer registry.
Registry (part of the Finnish Cancer Registry). There are 7
senior ofcials; IT personnel, secretaries and clerks account Notes on the data
C44 does not include basal cell carcinoma.
for 20 more, and researchers an additional nine.

292

Europe

France, Bas-Rhin
Cancer registration is active, the doctors from the
Registration area
The dpartement (French administrative district) of Bas-Rhin registry visiting each of many sources regularly to establish
constitutes the northern half of the Alsace region, occupying the lists of new cases and to complete an epidemiological
west side of the plain drained by the Rhine, which represents a questionnaire. The lists from each of these sources are
natural border with Germany. On the opposite side the Bas-Rhin compared to ensure complete registration and to eliminate
reaches the massif of the Vosges on the west, with a total area of errors, particularly duplicate registrations. Cancers
4 58 km2. The town of Strasbourg is its regional centre. Forest discovered by autopsy are registered. Death certicates
covers 30% of the land area. The maximum altitude (1100m) is are not used as a source, but serve only to verify the
reached in the Vosges, and the minimum (32m) on the Rhine completeness of registration.
For each case of cancer registered, the identity and
plain. The climate is temperate to semi-continental.
The population consisted of 1 026 120 inhabitants in 1999 address of the patient are noted as well as the date
(density: 216 inhabitants/km2). Of these, 54.4% live in an urban of diagnosis, the method of diagnosis, the pathology
environment in agglomerations with over 5000 inhabitants, and 27.6% department, the identication number of the pathological
examination, the topography
in villages with fewer than 2000;
and morphology coded to
40.8% live in the urban district
ICD-O, and the behaviour.
of Strasbourg. The population is
FRANCE, BAS-RHIN (1998-2002)
The two sources where the
slightly younger than the general
FRANCE, BAS-RHIN (1998-2002)
most complete information
French population.
was found are also noted,
The economically active
as well as the identication
population amounts to 53.1%
number of the medical le,
of the total population: 67.0%
'.0/#...
0+%&.%''...
).,/,...
0#
%#.#&1...
the date of death or the
of these work in the services
%#.''1...
/+
%1.%0/...
date of last infor mation
sector, 30.8% in industry, and
%+.0%%...
/#
&%.01&...
&#.##1...
,+
&'.'#%...
concerning vital status of the
2.2% in agriculture.
&&.)/'...
,#
&'.&+/...
patient.
The dpartement is without
&).,10...
++
&'.1&'...
'&.0#1...
+#
'%.+01...
T h e id ent it y of t h e
mineral resources and does
'0.#++...
)+
'/.)#0...
patients is used only to avoid
not produce any raw materials,
'1.'1+...
)#
'1.+/'...
)%.&'&...
'+
)#.0'+...
registering more than once
but has a major energy)%.,//...
'#
)#.)1#...
the same patient with the
production industry (petrol
'1.+%%...
&+
'1.))%...
',.#1)...
&#
'/.&,,...
same cancer. The data are
reneries and hydroelectric
')./#0...
%+
').%0%...
coded by the doctors who
stations). The mechanical
''.1&'...
%#
'&.1%#...
''.+'0...
+
'%./%%...
have visited the information
and electrical construction
''.'#0...
#
'%.)0+...
sources.
industry and the food industry
Lesions
or
cancers
(including breweries and
%#
+
#
#
+
%#

.($*


.($*
diagnosed or discovered in
wine production) are the most
+'#.,%&...
+#,.%&,...

situ and with histological
important. Agriculture plays
verication are registered, but
an important role in spite   

are not included in calculations
of the low percentage of the  3.
.

.
.  ..%
.
.2
.4.   .
.



.
.%11#.
.
.%111!. 3""!

! .
      
. 
.(&##)*.. ..
of incidence.
population employed in this sector.
Bas-Rhin is a relatively wealthy  
dpartement: incomes are high,
))..
!.
and the level of consumption is also high, notably for food. Life Interpreting the data
Organised breast cancer screening of the population aged
expectancy in 1999 was 75 years for males and 82 years for females.
5065 has been carried out since 1989 (20 000 examinations
annually). Organised screening for cervical cancer was
Cancer care facilities
Bas-Rhin has a high level of medico-social equipment, with introduced in 1994 for women aged 2565. Screening for
8457 hospital beds in 1999 (1 bed per 121 inhabitants), 1636 cancer of other sites is opportunistic.
general practitioners and 1802 specialists. Hospitals employ
37.2% of all doctors. Many scattered small rural hospitals Source of population
allow for hospital care close to the place of residence. More INSEE: http://www.insee.fr
than 70% of cancer patients die in hospitals.
Multiple primary rules used
IACR rules (2004) on historical data.
Registry structure and methods
The activity of the Cancer Registry of Bas-Rhin began in
1974. The registration of cases covers the resident population Notes on the data
C44 not available.
of the dpartement of the Bas-Rhin.

293

Europe

France, Calvados
Registration area
The dpartement (French administrative district) of Calvados
covers an area of 5548 km2. Situated in Normandy, it includes
parts of the Armorican Massif (Bocage) and the Paris Basin
(Pays dAuge, Plaine de Caen, Bessin). To the North is the
coastline of the English Channel. The highest elevation is
365m above sea level. The dpartement of Calvados includes
621 rural communes (37.7% of the population) and 84 urban
communes. There are 652 273 inhabitants, of whom 6.9%
are aged 75 years and older. Among those employed (250 725
individuals), 5.2% are in agriculture, 19% in industry, 5.6%
in building, 13.6% in commerce, and 56.6% in the service
industries. In 1999, unemployment was 7.4%.

doctors including 1137 specialists, and ve pathology


laboratories.
Registration is active, and information is directly taken
from the medical and pathology records. Death certicates
are also referred to; however, cases for which information
only originates in death certicates are not registered.
Completeness is ensured by linking the information collected
from all sources. The index date is the date of rst pathological
diagnosis or, if not available, the date of rst diagnosis (radiological
or biological). TNM stage and treatment are routinely coded for
digestive tumours. Follow-up information is collected at regular
intervals from treating doctors as well as from public registry
ofces for all cases. Data from the different registries are linked
periodically in order to exclude
cases registered twice. Paper
documentation is kept for each
FRANCE, CALVADOS (1998-2002)
case.
FRANCE, CALVADOS (1998-2002)

Registry structure and


methods
Two cancer registries, both
located in Caen, the departmental
Use of the data
capital, cover the dpartement of
In addition to analysis of
Calvados. The general registry
incidence and trends, many
is located at the Comprehensive
&.101...
0+0.000...
'./,0...
0#
/.&0+...
studies are conducted: change
Cancer Centre Franois
0.,#&...
/+
%'.&&+...
of disease stage at diagnosis,
Baclesse, and the specialised
%%.&+0...
/#
%+.%##...
%&.1&%...
,+
%,.#10...
evaluation of mass screening,
digestive tumour registry at the
%'.%00...
,#
%+.%&'...
evaluation of treatment impact
University Hospital. These two
%).%+,...
++
%).1/+...
&%.))&...
+#
&%.,1#...
on survival, and survival
registries are supported by the
&'.0'1...
)+
&).#'1...
trends. Relationships between
National Institute for Heath and
&'.%++...
)#
&'.0&+...
&&.,,0...
'+
&'.#%'...
environmental factors and
Medical Research (INSERM)
&&.&11...
'#
&&.&0#...
oesophageal cancer, colorectal
and by the Health Watch
&&.1++...
&+
&&.,&#...
&'.//0...
&#
&).#'&...
cancer, peritoneal and pleural
Institute (InVS) of the Ministry
&'.0,1...
%+
&'./10...
mesotheliomas are also studied,
of Health. They also receive
&&.&1+...
%#
&%.,%,...
&#.//%...
+
%1.10&...
as well as occupational exposure
contributions from the Conseil
&#./,+...
#
%1.1/#...
to pesticides and cancer.
Rgional de Basse-Normandie.
They are affiliated with the
%#
+
#
#
+
%#
Source of population
French Association of Cancer

.($*


.($*
INSEE: http://www.insee.fr.
Registries (FRANCIM), and to
''/.++0...
'%)./%,...

the EUROCARE network.
  

Multiple primary rules used
Registration has been  3.
.

.
.  ..%
.
.2
.4.   .
.



.
.%11#.
.
.%111!. 3""!

! .
carried out without interruption      
since 1978, using data from IACR rules (2004) on historical data.
. 
.(&##)*.. ..
  
private as well as public medical
facilities. They include a
))..
!.
University Hospital, one regional comprehensive cancer Notes on the data
centre and one cancer hospital, 22 general hospitals, 2160 C44 not available.

294

Europe

France, Doubs
registration area are found using discharge recording systems
Registration area
The registration area is the Doubs departement (French of hospitals and clinics outside the registration area. Death
administrative district), which covers 5234 km2. According registration is based on death notication in the patients
to the 1999 census, the total population comprises 499 062 birthplace. The registry staff visits the sources and consults
inhabitants, of whom 346 720 live in urban areas and 152 computerised medical records to collect data.
Data collection follows rules and recommendations of the
342 in rural areas. The economically active sector includes
204 219 residents, and the unemployment rate is 10.4%. A ENCR. All types of invasive tumours are included (basal and
notable proportion of residents living by the border cross it to squamous cell skin cancer are included) as well as uncertainwork in Switzerland. There are 26 262 foreigners who work behaviour tumours and in situ tumours of the urinary bladder,
in the department, mostly from North Africa. The main and in situ tumours of the cervix and breast. Benign tumours
of the brain and in situ tumours of colon and rectum and
religion is Roman Catholic.
There are two industrial areas: one in Sochaux- melanoma were not included for the study period but have
Montbeliard, with a large automobile factory, and the been registered since 2003. French registries must maintain
data security, condentiality
other in Besanon, the main
and information to patient
city, which has several small
following recommendations
industries that produce little
FRANCE, DOUBS (1998-2002)
of the CNIL (Commission
or no pollution.
FRANCE, DOUBS (1998-2002)
Nationale Informatique et
Libert), and the Doubs
Cancer care facilities
registry has developed internal
There was one physician per
checking and rules to follow
523 inhabitants in 1999. The
&.'0&...
0+,.&'0...
&.0&'...
0#
+.#,/...
these
recommendations.
entire population is covered
+.1'&...
/+
0.1')...
Checking for duplicates is done
by health insurance. Nearly
0.)%0...
/#
%#./#+...
%#.&&0...
,+
%%.,/,...
at data entry, and regularly
all Doubs residents are treated
%#.1&&...
,#
%%.+0'...
veried on the database using
in the departement. There are
%&.'/#...
++
%&.%1&...
%/.'##...
+#
%,.0%'...
computer programmes.
two
oncology-radiotherapy
%/.',+...
)+
%/.0#)...
wards, one in the teaching
%/.)'1...
)#
%0.#%)...
%0.#0%...
'+
%0.##1...
Uses of the data
hospital of Besanon and
%0.)'#...
'#
%0.%%)...
The registry prepares an
one in the general hospital of
%0.%1+...
&+
%/.0/1...
%0.')'...
&#
%0.&,0...
annual report of cancer
Montbliard. During the study
%0./&,...
%+
%0.%%%...
incidence, highlighting trends
period there was no cancer
%/.%')...
%#
%,.'0/...
%,.%%'...
+
%+.)&+...
and changes. It collaborates
screening programme (the
%,.%%/...
#
%+.',%...
with the French Cancer
breast screening programme
Network
FRANCIM
to
began in 2003).
%#
+
#
#
+
%#
publish studies on national

.($*


.($*
&+,.+/1...
&),.'%1...

and
regional
incidence
Registry structure and
estimates
as
well
as
survival
methods
  

and evaluation of care studies.
The Doubs Cancer registry  3.
.

.
.  ..%
.
.2
.4.   .
.



.
.%11#.
.
.%111!. 3""!

! .
began its activities in 1976. The      
registry is mainly supported The registry also conducts specic studies in collaboration
. 
.(&##)*.. ..
by the InVS (Institut de Veille  
Sanitaire, a national agency with local clinicians and epidemiologists.
))..
!.
funded by the Health Ministry, and by the teaching hospital
Source of population
of Besanon.
The registry uses active and passive casending from 38 INSEE: http://www.insee.fr.
sources of data consisting of public and private pathology
laboratories, computerised hospital and clinic discharge Multiple primary rules used
recording systems, and medical records. The law allows IACR rules (2004) on historical data.
physicians to transmit data to registries. In the registration
area, there are only a few physicians who do not collaborate Notes on the data
with the registry. The few residents treated outside of C44 not available.

295

Europe

France, Haut-Rhin
The hospital infrastructure, public and private, comprises 1582
Registration area
The dpartement (French administrative district) of Haut- beds in medical wards, 1141 in surgery, and 325 in gynaecology
Rhin, an area of 3522 km, is situated in the northeast of and obstetrics. There are two radiotherapy wards, one in the
France. It is adjacent to the dpartement of Bas-Rhin in south (Mulhouse), and the other in the north (Colmar). There is
the north (with which it constitutes the Alsace region), the no specialised cancer centre in the dpartement.
dpartement of the Vosges to the west, and the Franche-Comt
region and Switzerland to the south. To the east, the Rhine Registry structure and methods
separates Haut-Rhin from Germany. The altitude varies The Haut-Rhin Cancer Registry is a general populationfrom 195m on the Rhine to 1424 m in the Vosges mountains. based registry. Created in 1989, it is administered by an
The climate is semi-continental, with fairly cold winters and association under a specially constituted law for the purpose.
hot, dry summers. The conditions favour the vineyards of the It is entirely nanced by local funds (local and regional
lower slopes of the Vosges. The area has four geographical groups, health insurance funds, the Anti-Cancer League).
The registry collects information on all new cases of
regions: the Vosges mountains (crystalline massif), the lower
cancer occurring among the
hills of the Vosges (wine and
inhabitants of Haut-Rhin,
fruit cultivation), the plain of
including those diagnosed and
the Rhine (land of loess and
FRANCE, HAUT-RHIN (1998-2002)
treated elsewhere. Registration
former marshland), and the
FRANCE, HAUT-RHIN (1998-2002)
is active. The main sources
Alsacian Jura (limestone).
of information are pathology
The population of Hautand cytology laboratories,
Rhin is divided into 377
and radiotherapy, oncology,
communes, of which 269 are
&.,)%...
0+0.'/)...
'.%'&...
0#
,.,0,...
paediatrics and haematology
rural with fewer than 1000
/.0##...
/+
%'.)+#...
services. The medical
inhabitants. Haut-Rhin has
%&.#'+...
/#
%,.&+1...
%).00&...
,+
%/.&1)...
information departments and
a higher proportion (47%) of
%,.%%%...
,#
%,.)/+...
medical records departments of
economically active (aged
%/.1/'...
++
%/.#,#...
&).#11...
+#
&&.+#,...
the hospitals are also excellent
1564) persons and a lower
&/.#1)...
)+
&,.,+&...
sources of first notifications.
proportion aged over 65
&/.+'&...
)#
&/.+1%...
&0.,'0...
'+
&0.%+1...
Cases discovered at autopsy
years than France as a whole.
&0.%,0...
'#
&/.+'%...
are registered, and identified
Foreigners make up 8.1% of
&).//#...
&+
&).,'&...
&#.1,'...
&#
&#.%++...
as such. The data collected
residents, of whom 69% were
&'.001...
%+
&&.+10...
are systematically verified,
born outside metropolitan
&).,)+...
%#
&'.,,1...
&'.+/+...
+
&&.+%,...
c o m pl e t e d o r m o d i f i e d ,
France. The population is
&'.%#%...
#
&&.#0&...
usi ng se cond a r y sou rces
21% rural; 52% live in the 23
(hospitalisation ser vices,
communes with more than
%#
+
#
#
+
%#
t reating physicia ns). T he
5000 inhabitants. The urban

.($*


.($*
average number of sources per
area of Mulhouse has 228 115
','.,1%...
'+%.#)/...

registered case is over three.
inhabitants. The average
  

Death certicates are not used.
population density is 201  3.
.

.
.  ..%
.
.2
.4.   .
.



.
.%11#.
.
.%111!. 3""!

! .
      
Data are entered using the IARC CanReg software.
inhabitants per km, varying from
81 in the rural communes
. 
.(&##)*.. ..
  
to 4975 in the commune of Mulhouse.
))..
!.
The unemployment rate is 9% among men and women. Use of the data
The industrial sector employs 25% of the active population The registry was established in order to obtain data on the
(automobile, arms, chemicals, textiles, wood and paper, nuclear burden of cancers in the area, so as to maintain an updated
power); the agricultural sector 2% (market gardening, wine database for evaluation of public health measures in the
production, forestry), the building sector 6%, and the tertiary prevention, screening and treatment of cancer.
sector 67% (commerce, administration, education, health,
transport). A special feature related to the geographical situation Source of population
of Haut-Rhin is that 12% of the employed population resident INSEE: http://www.insee.fr.
in the dpartement works in Switzerland or Germany.
Multiple primary rules used
IACR rules (2004) on historical data.
Cancer care facilities
With 98 general practitioners and 63 specialists per 100 000
inhabitants, the medical coverage of the Haut-Rhin population Notes on the data
is below the national French average (respectively 113 and 88). C44 not available.

296

Europe

France, Hrault
3 radiotherapy units, 2 general hospitals, 10 private clinics,
Registration area
The registry is located in Montpellier, the capital of the general and specialist practitioners, and the medical les
Hrault dpartement (French administrative district), which of 2 health insurance companies. For data collection, 20%
is part of the Languedoc-Roussillon region and covers 6101 are collected via active search, 65% by passive notication,
and 15% as pre-coded data from the hospital specialising in
km2 in the south of France, near the Mediterranean.
In 2000 the population of Hrault comprised 920 000 cancer. Registration is active: medical and pathology records
inhabitants (48% males, 52% females) with a population are consulted directly by medical doctors and registry
density of 151 inhabitants per km2. The departement is investigators.
The administrative information is coded by the registrars
highly urbanised (the urban population is 4.25 times the
and all medical information is coded by the medical director
rural population).
Of the active population, 81.1% work in the services of the registry. Death certicates are not used as a source.
All invasive and in situ cancers are registered, with the
sector, 15% in industry and 3.9% in the agricultural sector.
exception of basal cell carcinomas of the skin. Stages are
The unemployment rate is 14.5%.
registered for all localisations
The population is slightly
and coded according to the
older than the general French
TNM 5th edition.
population (23.1% older than
FRANCE,
HERAULT
(1998-2002)
60, vs. 19.8% in France).
There is active follow-up
FRANCE, HERAULT (1998-2002)
Life expectancy is 76.3 years
of the registered cancer cases
for males and 83.2 years for
since 1997.
females (vs. 75.9 and 82.9
years in France, respectively).
Interpreting the results
+.11%...
0+%'.1/+...
/.'%+...
0#
%%.,,,...
The birth rate is 12.0 per
Since 1990, we have had
%).,&&...
/+
&#.,+0...
1000 and the mortality rate 9.5
two organised breast cancer
%0.'#%...
/#
&&.1,)...
&#.0++...
,+
&'.1)/...
per 1000 (vs. 12.7 and 9.0 per
screening programmes for
&#.'',...
,#
&&.&0)...
1000 respectively in France).
women aged 4049 years
&&.0&+...
++
&).'1)...
&1.+01...
+#
'%.,#)...
and 5069 years. Hrault is
&1.0/,...
)+
'&.&),...
Cancer care facilities
the only French area covered
&1.,/1...
)#
'&.'1)...
'#.,%1...
'+
''.&)'...
Hrault has a high level of
by a cancer registry in which
'#.&0'...
'#
'&.%+/...
medico-social
equipment,
there is an organised breast
'%.%#+...
&+
'&.)+%...
'&.1)+...
&#
'+.,+,...
with 2.5 beds per 1000
screening programme for
'#.'1&...
%+
'#.%'+...
inhabitants in medicine and
women aged 4049 years.
&0./'#...
%#
&/.)#+...
&/.'/+...
+
&+.001...
2.2 beds per 1000 inhabitants
&,.+,)...
#
&+.%/)...
in surgery (vs. 2.2 and 1.8 per
Use of the data
1000 inhabitants in France
A report of all data is
%#
+
#
#
+
%#
respectively)
distributed
published biannually. The last

.($*


.($*
among
one
hospital
report was published in April
)/0.&)%...
)'/.)#)...

specialising in cancer, 10
2005 for cancers diagnosed
  

public hospitals (including one  3.
.

.
.  ..%
.
.2
.4.   .
.



.
.%11#.
.
.%111!. 3""!

! .
in 20012002. All incidence
      
academic hospital in Montpellier
and 6 small rural hospitals) data, chronological tendencies and relative survival by
. 
.(&##)*.. ..
  
and 16 private clinics. The medical
coverage of the Hrault sex, age and stages for each organ are detailed. Screening
))..
!.
population is greater than the national average of 200 general programmes for breast cancer are evaluated.
practitioners and 246 specialists per 100 000 inhabitants.
The Hrault Cancer Registry performs many studies
(casecontrol studies, medical economic studies, evaluation
Registry structure and methods
of therapeutic practices), alone and in collaboration with
The majority of the registrys budget comes from the other French or European registries.
National Health Department through InVS (Institut de Veille
Sanitaire) but also from INSERM (Institut National de la Source of population
Sant et de la Recherche Mdicale) and Hrault Committees INSEE: http://www.insee.fr.
League against Cancer.
The registry staff consists of ve persons: one medical Multiple primary rules used
epidemiologist, one secretary, two registrars and one IACR rules (2004) on historical data.
investigator.
Our principal sources of information on cancer cases are 11 Notes on the data
pathological laboratories, one hospital specialising in cancer, C44 not available.

297

Europe

France, Isre
Registration area
The Isre Cancer Registry covers the population of the
dpartement (administrative region) of Isre in southeastern
France. Besides some recreational activities (e.g. ski
resorts, lakes), industrial activities are important (chemical
production), and research and teaching (universities). Less
than 20% of the population resides in rural areas. In 2002
the population was estimated to be 1 126 000, with 301 000
people under age 20, 622 000 aged 2059 years and 203 000
over age 60.

in the medical records departments. As death certicates are


anonymous, they are of no use for case-nding. There is no
active follow-up of the registered cases, except for specic
survival studies.

Interpreting the results


An active screening programme (breast, colon and cervix)
and well-implemented habits of PSA testing for prostate
cancer may explain rather high incidence rates for these
tumours, as compared with French standards. In operation
since 1985 (PSA) and 1990 (screening), these activities
probably no longer have an effect on trends, but some
Cancer care facilities
In 2001, the density of specialised and general practitioners research has shown an increase in the proportion of localised
compared to distant tumours,
was 206 per 100 000
which supports a benecial
inhabitants. In December 1999,
effect of those programmes
there were 3586 physicians
FRANCE, ISERE (1998-2002)
for the populations health.
in charge of the populations
FRANCE, ISERE (1998-2002)
Systematic sending of
health in Isre. There are two
medical record abstracts
specialist cancer hospitals,
by hospitals may improve
and diagnosis and treatment
coverage in coming years.
are also undertaken in general
).0%)...
0+%'.%0'...
+.0/+...
0#
%#.'0%...
hospitals and private clinics.
%'.%'0...
/+
%1.%&,...
Use of the data
%/./&+...
/#
&&.,#+...
&%.%'%...
,+
&'.0++...
A report for researchers and
Registry structure and
&'.&//...
,#
&'.10%...
people in charge of cancer in
methods
&0.#,0...
++
&/./0/...
'/.#1,...
+#
',.0,+...
Isre is published annually.
Of the registrys budget, 70%
'0.'0,...
)+
'1.'&'...
The prevalence of cancer has
comes from the Isre General
'1.)+1...
)#
)#.#/&...
)%./++...
'+
)%./,%...
been estimated. Mapping
Council (Conseil Gnral)
)%.,+%...
'#
)%.&&)...
of disease is carried out by
and from InVS (Institut de la
)#.),%...
&+
'1.##&...
)#.+1&...
&#
'0.,/#...
the registry. The screening
Veille Sanitaire) and INSERM
'1./%,...
%+
'/.0&'...
programmes
for
breast,
(Institut National de la Sant
'0.//%...
%#
',.0))...
'/.'+&...
+
'+.''0...
colon
and
cervix
cancers
are
et de la Recherche Mdicale).
'/.&+)...
#
'+.&&/...
evaluated.
The bulk of the research
The
registry
also
work is funded by the French
%#
+
#
#
+
%#
undertakes
surveillance
League against Cancer and by

.($*


.($*
of occupational cohorts.
foundations or by contracts
+,'.#,/...
+),.+&#...

In co-operation with other
with industrial companies.
  

French Cancer Registries
The registry staff, both for  3.
.

.
.  ..%
.
.2
.4.   .
.



.
.%11#.
.
.%111!. 3""!

! .
registration and research work,      
consists of two clerks (part- (FRANCIM) and the Institut de la Veille Sanitaire, the
. 
.(&##)*.. ..
time), two registrars (part-time),  
1.6 medical epidemiologists, registry contributes to the detection of new cancer risks in
))..
!.
one statistician and one secretary. For some studies, extra the French population.
Analyses of different methods of diagnosis and
medical interviewers are hired.
Among the sources of information, in Isre and in treatment for some cancer sites, including breast, prostate,
three contiguous areas, there are 34 laboratories providing bladder, kidney and colon cancer, have been carried out as
pathological reports. The registry also obtains information well.
from two hospitals specialising in cancer, 13 general
hospitals, the network of hospitals in the city of Lyon, six Source of population
private clinics and the medical les of two Health Insurance INSEE: http://www.insee.fr.
Companies. Since 1997, abstracts of the medical les from
the hospital patient-disease information systems are received Multiple primary rules used
for most patients treated for cancer, at least for hospitals IACR rules (2004) on historical data.
in the public domain. All of the information received is
carefully checked and when judged insufcient, registry Notes on the data
staff visit the sources where they scrutinise the records kept C44 not available.

298

Europe

France, Loire-Atlantique and Vende


Registration area
The registration area is composed of the two dpartements
(French administrative districts) of Loire-Atlantique and
Vende, situated in western France, which cover 13 535 km
and have a total population of 1 134 493 for Loire-Atlantique
and 539 806 for Vende according to the 1999 census. The
population density gures were 172 and 84 inhabitants per
km in Loire-Altantique and in Vende respectively. About
54% of the Loire-Atlantique population and 25% of the
Vende population live in urban areas (10 000 inhabitants).
Cancer care facilities
There are 23 public and 37 private hospitals in the two
dpartements, including one university hospital and two
anticancer centres. Most radiotherapy and chemotherapy
structures are present in the 3 main towns (Nantes, Saint
Nazaire, La Roche-sur-Yon). The two dpartements have
2613 general practitioners and 2520 specialists (respectively,
108 and 62 per 100 000 inhabitants).
Registry structure and methods
The Loire-Atlantique and Vende Cancer Registry is a general
population-based registry. Created in 1998, it is one of the
biggest French Registry, affiliated with the association of
French Cancer Registries (FRANCIM) and recognized by the
National Committee of Registries (CNR). It is administered by an
association according to the French association law of 1901. It is
entirely nanced by the General Council, the Regional Council,
the Departmental League Against Cancer, the Loire-Atlantique
private anticancer centre, the National Institute for Medical
Research (INSERM) and the Health Watch Institute (InVS).
The registry is located within the university hospital
of Loire-Atlantique (CHU Nantes) and the departmental
public hospital of Vende (CHD La Roche-sur-Yon). The

registry is staffed by a medical epidemiologist, a part-time


anatomopathologist and 10.5 full-time equivalent persons.
Cancer cases are found by an active search in the medical
records from several sources of data. The three main sources
are pathologists, medical information systems in the hospitals
and clinics, and health insurance notications. The registry
staff visits these sources, where they scrutinise the records
kept in medical records departments, to identify and abstract
information on cases of cancer (diagnosis and treatment of
cancers) among residents of the registry dpartements. Until
now, death certicates have been forbidden by law to be used
as data sources for registries in France.
Although cancer is not a notiable disease, a few
registration forms are received from private practitioners.
Arrangements have been made with the hospitals outside the
registration area to notify the registry of any resident cancer
cases that they diagnose and treat.
Quality in the registry is monitored every four years by
the National Committee of Registries (CNR). The Registry is
monitored by the National Commission of Data Processing
and Freedom (CNIL) for condentiality.
Interpreting the results
Organised breast cancer screening of the population aged
50-74 has been carried out since 1996 in Loire-Atlantique
and since 2002 in Vende.
Uses of the data
The Loire-Atlantique and Vende Cancer Registry has produced
basic descriptive data and participated in collaborative studies at
a national level. It prepares an annual report of cancer incidence,
highlighting trends and changes. Some special studies have been
carried out (including evaluation of clinical care for breast cancer
or colon cancer, and survival).

FRANCE,
VENDEE (1998-2002)
FRANCE, VENDEE (1998-2002)

FRANCE, LOIRE-ATLANTIQUE
(1998-2002)
FRANCE, LOIRE-ATLANTIQUE (1998-2002)

+.&++...

0+-

%+.)+/...

'.+0)...

0+-

,.')0...

0#

%&.%,/...

).%0%...

0#

,./1'...

%).+'/...

/+

&&.0&%...

1.+/+...

/+

%'.&'1...

1.%/+...

%0.010...

/#

&,.&),...

%&.)&/...

/#

%+.''0...

&&.%0&...

,+

&/.&'#...

%).++'...

,+

%+.11#...

&'.'#1...

,#

&,.&%&...

%'.1'1...

,#

%).1&%...

&+.++&...

++

&/.%)1...

%&.//,...

++

%'.)+/...

'0.,1,...

+#

'1.+/'...

%0.)#%...

+#

%0.%&#...

)%.%#+...

)+

)&.#/0...

%1.1'+...

)+

%1.%1+...

)%.#+&...

)#

)%./0/...

%1.1)1...

)#

%1.)+&...

)%.,'&...

'+

)%.1'1...

%1.///...

'+

%1.'1%...

)#.,##...

'#

)#.,)#...

%0.+//...

'#

%/.0))...

)#.+&+...

&+

)#.##+...

%/.','...

&+

%,.')#...

)%.,,,...

&#

)#.)#'...

%,.+/,...

&#

%).'%0...

)&.#'0...

%+

)#.&1#...

%0./%&...

%+

%/.),1...

'1.&+,...

%#

'/./0,...

%0.##0...

%#

%/.%)/...

'/.'##...

'+.0+'...

%,.)%)...

%+./,%...

'0.#&)...

',.&0+...

%,.)##...

%+.,)1...

%#


.($*
++/.1/+...

%#

%#



+1'.1&%...

  

 3.
.

.
.  ..%
.
.2
.4.   .
.



.
.%11#.
.
.%111!. 3""!

! .

Source
of population
      
. 
.(&##)*.. ..
INSEE:
   http://www.insee.fr.
))..
!.

Multiple primary rules used


IACR rules (2004) on historical data.


.($*



.($*
&/%.%)/...

%#



.($*


&/1.+1/...

  

 3.
.

.
.  ..%
.
.2
.4.   .
.



.
.%11#.
.
.%111!. 3""!

! .
      
. 
.(&##)*.. ..

Notes
on the data
  
))..
!.
C44
not available.

299

Europe

France, Manche
and was created by an association of practitioners of the
Registration area
Situates in the area of Basse Normandie, the dpartement department. It is supported by the Ministry of Health, the
(French administrative region) of the Manche covers 5938 Regional Council of Basse Normandie, the General Council
km and has 330km of coastline. It is a part of the Armorican of Manche, the local League against Cancer, communes,
massif and consists of three different zones: in the north the local associations, and industries. It is afliated with the
Cotentin peninsula; in the centre a formerly swampy zone, association of French Cancer Registries (FRANCIM).
Data collection is active in Manche and the surrounding
now meadows; in the south the hills of the Norman bocage,
which reach 368m. The climate is of the oceanic type. The departments. The registration of cases covers the resident
department contains 602 communes, 86% of which have population of the department of the Manche. The sources of
fewer than 1000 inhabitants. The population is slightly older information are regional, including 12 pathology and cytology
than the national average. It is mainly rural, with only 48% laboratories, services of oncology, radiotherapy, paediatrics
living in the ve urban areas (of which half are in the only and haematology, and medical records departments of
urban zone, Cherbourg, in the North) and density is low (81 hospitals. After rst notication of cases, every medical le
is checked in regional, private
habitants per km).
and public, medical facilities,
The working population
and then coded to ICD-O by
represents 43.2% of the total
FRANCE, MANCHE (1998-2002)
the physician. All invasive and
population. Among those
FRANCE, MANCHE (1998-2002)
in situ cancers are registered
employed, 47.5% are in the
except basal cell skin cancers.
service sector, 19.9% in industry
Death certicates are not
(predominantly farm produce),
used as a source of data. The
14.4% in agriculture, 10.4% in
&.,)/...
0+/.,/,...
'.+,,...
0#
,.+''...
registry carries out active
commerce and 7.8% in building
0.&#'...
/+
%&.#&'...
follow-up of all cases from the
and public works. In 1999
%#./1#...
/#
%'.1&+...
%&.'%+...
,+
%).')0...
municipal registry ofce.
the unemployment rate was
%%.,%+...
,#
%&.1&+...
The industrial characteristics
11.5%. The dpartement has
%#./##...
++
%%.&#+...
%+.,''...
+#
%+.',&...
of the north of the department
a low proportion of foreigners
%/.&0#...
)+
%,.&&#...
led to the implementation of a
(0.8%). The economy is
%0.#/0...
)#
%,.0,)...
%0.##&...
'+
%/.%,&...
specialised collection system
mainly agricultural, breeding
%,.)0)...
'#
%,.#0,...
for haematopoietic cancers.
representing 90% of this
%).,0'...
&+
%).&%&...
%'.)/,...
&#
%&.#%+...
It consists of collection of
production. Fishing and tourism
%,.+++...
%+
%+.&&)...
reports from the medical
are developed in the coastal
%,./)#...
%#
%+.1%0...
%+.)0'...
+
%)./%+...
biology laboratories of the
zones. There is an industrial
%).,1'...
#
%).&0+...
department, validation by a
area in the north, mainly the
haematologist, and records
nuclear industry (nuclear waste
%#
+
#
#
+
%#
of
immunophenotypic,
reprocessing plant, surface

.($*


.($*
conventional cytogenetic and
storage facility for nuclear waste,
&),./##...
&',.1))...

molecular data, and the tumour
power station) and shipyards.
  

 3.
.

.
.  ..%
.
.2
.4.   .
.



.
.%11#.
.
.%111!. 3""!

! .
cells are cryopreserved.
      
Cancer care facilities
. 
.(&##)*.. ..
With 611 general practitioners   
and 511 specialists in 2002, Use of the data
))..
!.
the department has a low medical coverage. There are seven The Manche Cancer Registry produces basic descriptive
beds per 1000 inhabitants. The department possesses 11 data and participates in collaborative studies at a national
public hospitals, general and local, and seven private care and international level.
structures. There is no specialised cancer centre, but there
are two radiotherapy units, one private in the south of the Source of population
department, one public in the north which is a delocalised INSEE: http://www.insee.fr.
structure associated with the regional cancer care centre of
Multiple primary rules used
the neighbouring department (Calvados).
IACR rules (2004) on historical data.
Registry structure and methods
The Cancer Registry of Manche began its activities in 1994. Notes on the data
The registry is based in Cherbourg, in the general hospital, C44 not available.

300

Europe

France, Somme
Cancer cases are collected by active search from listings and
Registration area
Situated 140km from Paris, the Somme registry covers in medical records of about 90 sources of data. The two main
6170 km2, includes 60km of coastline and is composed of sources are pathologists and medical information ofces of public
three main types of landscapes: Bocage in the West, Picardy and private hospitals, but also registers of chemotherapy and
plateau at the centre, and Santerre in the East, occupied by radiotherapy in two clinics, The Regional Factory Inspectorate,
extensive cultures. The river Somme passes through and Parisian hospitals administration, and regional cancer centres
is bordered by ponds and marshes attracting many anglers contribute to collection. Every year the registrars contact the
and hunters. Tourism is developed. The Bay of Somme is a outside sources and consult their records.
Cancer is not a notiable disease in France. Identifying
natural reserve and a landing zone for migratory birds.
The population is 41.5% rural. The West of the county data are known only by registry staff. The Registry refers its
is traditionally both rural and industrial, with factories work to Commission Nationale Informatique et Liberts.
producing taps and locks. There is also a large industrial Every four years the registry undergoes a quality audit by
Registries National Committee.
area around Amiens.
The Somme Registry is the
Interpreting the results
only general registry north of
Paris. The population census
A written agreement was signed
FRANCE, SOMME (1998-2002)
in 2000 counted 557 121
with private pathologists and
FRANCE, SOMME (1998-2002)
inhabitants. Amiens is the
a public one in 1998, so the
principal town with 136 000
incidence has increased since
inhabitants; the other towns count
then. There have been no changes
less than 30 000 inhabitants.
in case denition and coding.
&.1)#...
0+/.))+...
'.)#,...
0#
,.#0'...
The natural population
A screening programme
/./)&...
/+
%%.&%/...
increase by birthrate is +2.6%
for breast cancer has existed
1.1,,...
/#
%'.%'+...
%%.%++...
,+
%'.)0%...
(INSEE 2003).
since 1990. In 1996 PSA testing
%%.)%%...
,#
%&.+0+...
was introduced, and we have
%&.)&&...
++
%&.,++...
%0.)'&...
+#
%0.&+/...
Cancer care facilities
likewise improved monitoring
%1./)/...
)+
%1.+/1...
Theres no specialised cancer
of prostate cancers.
%1.',,...
)#
%1./+0...
%1./1/...
'+
%1.,#)...
care centre in the dpartement.
There are no known
%1.11%...
'#
%1.+1+...
Cancer care is shared by the
unusual
environmental,
&#.%0+...
&+
%1.1/'...
%1.1%#...
&#
&#.#%'...
University Regional Hospital
occupational
exposures
that
&#.&0)...
%+
%1./1&...
and the general hospitals and
may inuence incidence.
%1.&,)...
%#
%0.)0/...
%/.,'&...
+
%/.##+...
clinics located in six towns
Melanomas and squamous cell
%/./%/...
#
%,.011...
of Somme. Ten percent of
carcinomas of skin are not likely
patients are treated outside the
to be exhaustive, for many are
%#
+
#
#
+
%#

.($*


.($*
registration area in cancer care
diagnosed by non-corresponding
&0+.+,'...
&/%.',,...

centres in Paris or Lille (to the
pathologists in Paris.
north), or in a general hospital   

or clinic in Saint-Quentin and  3.
.

.
.  ..%
.
.2
.4.   .
.



.
.%11#.
.
.%111!. 3""!

! .
Use of the data
      
. 
.(&##)*.. ..
Chauny (Aisne dpartement). Chemotherapy
and radiotherapy Tables of incidence are carried out every year, and trends are
  
are dispensed privately or publicly.
Since about 1998 physicians produced for physicians on request. Area oncologists also
))..
!.
groups have organised multidisciplinary examinations of patient receive the results of any specic studies.
records to improve quality of treatment and more consistently
Somme is a participating registry in the Eurocare project,
apply national consensus standards of care.
Europreval and European Rare Cancers studies, Epilymph,
Since 1997 the regional health authority has recognised cancer and Eurodeucatam.
The Somme registry has been part of the Regional
as one of the priorities of the county. The registry is acknowledged
Schedule of Care organization since 1994, and a member of
to be the best tool to monitor cancer in the community.
the Oncopic network.
Registry structure and methods
Somme cancer registry is managed by the 1901 law and Source of population
funded by Institut de Veille Sanitaire, Inserm, County INSEE: http://www.insee.fr
committee of National League against Cancer and General
Multiple primary rules used
Council. It forms part of FRANCIM network.
The registry is presided over by a Public Health Professor IACR rules (2004) on historical data
and counselled by another Public Health Professor; there
are also an epidemiologist doctor (DM, PhD), a technical Notes on the data
C44 not available.
director (MSc), two inquirers/registrars and a secretary.

301

Europe

France, Tarn
load in the different sources. The staff also visit Toulouse
Registration area
The department of Tarn is part of the Midi-Pyrenean region, University Hospital and the Regional Cancer Control Centre.
situated in the southwest of France. It covers an area of 5758 km2, In recent years, the search for cases in public hospitals has
mostly situated south of latitude 44N and on longitude 2E. been simplied by the existence of Medical Information
In 1999, the population was composed of 343 402 inhabitants, Departments, which provide computerised lists of the cancer
with an urban/rural ratio of 1.65, and a ratio of French citizens cases treated in those establishments. Name-specic death
to foreigners of 22.8. The population overall is slowly increasing certicates are not used as a source of information, according
(344 620 at mid-year 2000), but certain areas are undergoing to French law.
For each case, a notication form is completed with the
quite a rapid increase while others are in recession.
The Tarn Cancer Registry was created in 1981. The medical and administrative information from the medical
arguments favouring the creation of a Registry in this le. The names of the doctors involved in the diagnosis and
department included the insufcient development of population- the treatment of the patient, including primary physician, are
based cancer registries in France at this time and their systematically noted in order to contact them if necessary.
absence in the Southwest, and
When the forms arrive in
certain characteristics of the
the registry, the secretaries rst
department of Tarn such as the
check the computing database
FRANCE, TARN (1998-2002)
age-structure of its population
to avoid duplicate registrations.
FRANCE, TARN (1998-2002)
and its relative stability with
The cases are then systematically
little migration, the large size
checked in a second source by
of its rural population and some
the investigators. If information
longstanding industries such as
is not sufcient, a questionnaire
'.%0/...
0+/.'##...
'.&,+...
0#
+.##'...
tanning, textiles and minerals.
is sent to the regular doctor.
/.'+)...
/+
1./&+...
These procedures allow missing
1.#&0...
/#
%#.11)...
1./0/...
,+
%#.0%0...
Cancer care facilities
information to be completed and
0.0'+...
,#
1.+)1...
The department of Tarn is fairly
patients with metastasis from or
0.0+1...
++
1.'#&...
%%.10/...
+#
%&.%)0...
autonomous in its provision of
recurrence of a cancer diagnosed
%&.))%...
)+
%&.,/%...
cancer care facilities. These
prior to 1982, or not resident in
%&.%%%...
)#
%&.+&%...
%%.1))...
'+
%&.%&#...
are complemented by a cancer
the area, to be excluded.
%#.010...
'#
%%.#1&...
care network. Medical coverage
The medical information
1.+)1...
&+
1.)&/...
1.''#...
&#
0.'/)...
is high, with 118 general
on
the remaining cases is
%#.1#0...
%+
%#.#/#...
practitioners and 118 specialists
coded by the Medical Director
%#.+0%...
%#
1.1&'...
1./)&...
+
1.&#%...
per 100 000 inhabitants,
of the registry, assisted by
1.&&1...
#
0./,)...
including four pathologists, two
specially trained coders. The
medical oncologists and two
administrative data are coded
%#
+
#
#
+
%#
radiotherapists. There are four
by two secretaries. The data are

.($*


.($*
public hospitals and four private
then entered onto the computer
%/1.##%...
%,1.#'+...

of the registry, creating a
clinics in the department of Tarn.
  

computing le which can be
However, a few types of cancer  3.
.

.
.  ..%
.
.2
.4.   .
.



.
.%11#.
.
.%111!. 3""!

! .
      
(haematological, paediatric) are sent
to the specialised services of updated when additional information from other sources
. 
.(&##)*.. ..
  
reaches the registry. This le has been declared to the National
the University Hospital or to the Regional
))..
!. Cancer Control Centre,
Commission on Information and Liberty (CNIL).
both situated in Toulouse, the capital of the region.
Active follow-up by writing to the town halls where the
In the department of Tarn, a programme of organised
breast cancer screening has existed since 2003, and a patients were born and writing to the regular doctor is only
colorectal cancer screening programme is underway. carried out for cases that are the object of special studies.
However these elements do not affect the data published
Use of the data
here, given that the period of study is 1998-2002.
In addition to basic descriptive epidemiology, the Tarn Cancer
Registry carries out several studies, alone or in collaboration
Registry structure and methods
The Tarn Cancer Registry operates as a French Law 1901 with other registries (the Association of French Cancer Registries
Association and is constituted by representatives of the medical FRANCIM and the European Network). These include estimates
and university sectors, and of the elected ofcials of the department of the incidence and prevalence of cancer in France, the study of
and the Midi-Pyrenean region. Funding for registration activities time trends, casecontrol studies and evaluation of diagnostic
comes from the General Council of Tarn, the departmental and therapeutic regimes for selected sites.
committee of the National League Against Cancer and the
Source of population
Ministry of Health. Research is funded through grants.
The staff, composed of 11 people (8.8 full-time equivalents) INSEE: http://www.insee.fr.
carries out both registration activities and research.
The search for the cases is active, and four investigators Multiple primary rules used
of the registry staff visit the data sources. The different IACR rules (2004) on historical data.
laboratory, private and public hospital departments,
administrative services and medical specialists in Tarn are Notes on the data
regularly visited, with a frequency varying according to case- C44 not available.

302

Europe

Germany, Federal States of Berlin,


Brandenburg, Mecklenburg-Western
Pomerania, Saxony-Anhalt and the Free States
of Saxony and Thuringia
Registration area
The Common Cancer Registry (CCR) covers the population of
the federal states Berlin, Brandenburg, Mecklenburg-Western
Pomerania, Saxony-Anhalt and of the Free States of Saxony
and Thuringia, all located in the east part of Germany and
constituting the territory of the former German Democratic
Republic (GDR), except for West Berlin. Thus, the CCR is the
only cancer registry in Germany that covers several states.
The population in the catchment area of the CCR is about 17.1
million inhabitants, 48.9% males and 51.1% females (2002),
almost all of them being of Caucasian origin. About 59% live
in urban areas (dened as population >5000 and population
density >400 inhabitants per km).
Cancer care facilities
The territory covered by the CCR has 339 hospitals (Berlin
71, Brandenburg 47, Mecklenburg-Western Pomerania 34,
Saxony-Anhalt 51, Saxony 86, Thuringia 50), most of them
afliated with a regional tumour centre. Although there are
some hospitals specialising in oncology services, most of the
other hospitals are involved in cancer care as well (e.g. offering
special diagnostic or treatment methods). The tumour centres,
however, are the focal point in cancer care. Tumour centres
are specic hospitals and university hospitals specialising in
diagnostics, treatment, and aftercare of cancer patients and
the documentation of pertinent information. Also, general
practitioners, radiotherapy departments and other specialists
are involved in cancer care on an outpatient basis.
Registry structure and methods
The CCR is located in Berlin and is associated with the Senate
Department for Health, the Environment and Consumer
Protection (Senatsverwaltung fr Gesundheit, Umwelt und
Verbraucherschutz) in Berlin. The registry is funded by the
contributing states according to their population size and
is staffed with 1 physician, 3 mathematicians/statisticians/
computer experts, 2 epidemiologists, 15 documentation or
coding employees and 2 administration secretaries.
In Germany, cancer is a reportable disease. Cancer
notication became mandatory in all states of the CCR
(Saxony 1993, Mecklenburg-Western Pomerania 1998,
Saxony-Anhalt 2000, Thuringia 2003, Berlin 2004,
Brandenburg 2006). Patients are informed about the
notication to the registry by the diagnosing physician.
The major sources of notication in the CCR are the
regionally organised tumour centres (Tumorzentren).
Tumour centres cooperate with the population-based registry
in that they abstract all pertinent information from medical
records of cancer cases seen in a hospital or special clinic
afliated with a tumour centre and report them to the CCR.
There are about 30 tumour centres reporting to the CCR,
providing >90% of all notications per year. The remaining
10% the registry receives directly from the physician via

the traditional reporting by means of notication forms.


Additionally, all death certicates have been made available
to the registry by local health authorities. Data of German
non-residents of the CCR are exchanged with neighbouring
cancer registries.
The cancer registration law from 1995 requires, for reasons
of condentiality, that all population-based registries have
two independent units (in terms of space, organisation and
personnel): one unit handling incoming (person identifying)
notication (Vertrauensstelle) and one unit holding the
epidemiological data set and conducting the statistical
analysis with the anonymised data (Registerstelle).
Registration and quality control are performed according
to the ENCR and IACR guidelines. Accuracy of the
information is checked in an automated manner, in that
implausible or questionable information will be identied
and corrected if necessary. Annually, our data are formally
evaluated on completeness by the Robert-Koch-Institute, the
National Cancer Reporting Unit.
Interpreting the results
After 1989 the notication rate declined sharply due to
political changes in the former GDR and the resulting
lack of a legal framework for cancer registration. With
the cancer registration law taking effect in 1995, the legal
basis was re-established for the CCR and cancer cases were
again reported to the registry. The availability of death
certicates as a principal source of information on cancer
cases was regulated by the cancer registration law. Since
1995, the number of reported cancer cases has steadily
increased, while the percentage of DCO cases is decreasing.
Note that although cancer is a reportable disease, it became
mandatory only recently for some of the states of the CCR
(see above).
There are opportunistic screening programmes for
colorectal, prostate, cervical and female breast cancer and
for skin melanoma. Data on testing for PSA are not available,
but it is increasing in this population.
In the past there were some unusual occupational
exposures of radon for employees in the Wismut mining
area (West Saxony and East Thuringia), as well as unusual
environmental exposures of radon in houses which might
still be a problem in parts of this area today.
Use of the data
CCR data have been used for health services planning and for
epidemiological research. Linkage with the CCR was performed
for casecontrol and cohort studies. Annual reports on cancer
incidence and mortality are published for the entire population
of the CCR. In addition, state-specic reports are prepared on
request. In cooperation with the association of population based
cancer registries in Germany (GEKID) and the Robert-KochInstitute, the data are pooled for nation-wide analyses.

303

Europe

Germany, Brandenburg
Registration area
The state of Brandenburg is one of the six states covered
by the Common Cancer Registry (CCR) and is located in
the North-East of Germany. The population of Brandenburg
is about 2.6 million inhabitants, 49.4% males and 50.6%
females (2002), almost all of them being of Caucasian origin.
About 48% live in urban areas (dened as population >5000
and population density >400 inhabitants per km).

available to the registry by local health authorities. Data


on German non-residents of the CCR are exchanged with
neighbouring cancer registries.

Interpreting the results


After 1989 the notication rate in Brandenburg declined
sharply due to political changes in the former GDR and the
resulting lack of a legal framework for cancer registration.
With the cancer registration law taking effect in 1995, the legal
basis for cancer registration was re-established and cancer
Cancer care facilities
In Brandenburg there are 47 hospitals, most of them afliated cases were again reported to the registry. The availability
with one of the regional tumour centres (see below). The state of death certicates as a principal source of information on
of Brandenburg has ve tumour centres, located in the cities cancer cases was regulated by the cancer registration law.
Since 1995, reported cancer
of Cottbus, Frankfurt/Oder,
cases from Brandenburg have
Neu r uppi n, Potsda m a nd
been steadily increasing,
Schwedt. Although there are
GERMANY, BRANDENBURG (1998-2002)
while the percentage of DCO
some hospitals specialising in
GERMANY, BRANDENBURG (1998-2002)
cases is decreasing. Note that
oncology services, most of the
although cancer is a reportable
other hospitals are involved
disease, it became mandatory
in cancer care as well (e.g. by
only recently for the state of
offering special diagnostic or














Brandenburg (see above).


treatment methods). The tumour







There are opportunistic


centres, however, are the focal





 








screening programmes for


point in cancer care. Tumour







colorectal, prostate, cervical


centres are specic hospitals and







 





and female breast cancer


university hospitals specialising







and for skin melanoma. Data


in diagnostics, treatment, and





 








on testing for PSA are not


aftercare of cancer patients







available, but it is increasing


and the documentation














in this population.
of per tinent infor mation.







We are aware of no
Also, general practitioners,

 












unusual
environmental and/
radiotherapy departments and







or occupational exposures in
other specialists are involved in
Brandenburg.
cancer care as they see cancer






patients in an outpatient setting.
 ,($*
  ,($*
Use of the data




%,&-.,').,,,

Brandenburg cancer data have
Registry structure and

  
 ,  , , ,  22,,  ,,, , , , ,  1, ,  ,,', ,%//#,,,,
been used for health services
methods
  ,, , , , ,, , !, , ,", 0, ,, ,3 ",
For a description of the structure
of the registry, please refer planning and for epidemiological research. Linkage with
 


  

, ,(&##)*,,
+,,  ,
the CCR was performed for case-control and cohort studies.
to the general narrative for the CCR.
In Brandenburg, cancer is a reportable disease. However, Annual reports on cancer incidence and mortality are
cancer notication became mandatory only recently (2006). prepared. In cooperation with the association of population
Patients are informed about the notication to the registry by based cancer registries in Germany (GEKID) and the RobertKoch-Institute, the data are pooled for nation-wide analyses.
the diagnosing physician.
The major sources of notication in Brandenburg are the
regionally organised tumour centres (Tumorzentren). The Source of population
tumour centres abstract all pertinent information from The estimate of the population at risk is based on an extract
medical records of cancer cases residing in the state of from the central residents registration ofce on 3 October
Brandenburg seen in a hospital or special clinic afliated 1990, which is annually updated with the results of the
with a tumour centre and report them to the CCR. The tumour statistics of births, deaths and migration. Source: Statistisches
centres provide 99% of all notications per year. Thus, the Amt der Lnder.
registry receives only 1% of the notications directly from the
physician via traditional reporting by means of notication Multiple primary rules used
forms. Additionally, all death certicates have been made IACR rules (2004) on CI5 IX period

304

Europe

Germany, Mecklenburg-Western Pomerania


Registration area
The state of Mecklenburg-Western Pomerania is one of the
six states covered by the Common Cancer Registry (CCR)
and is located in the North-East of Germany. The population
of Mecklenburg-Western Pomerania is about 1.8 million
inhabitants, 49.5% males and 50.5% females (2002), almost
all of them being of Caucasian origin. About 36% live in
urban areas (dened as population >5000 and population
density >400 inhabitants per km).

of reporting by means of notication forms. Additionally, all


death certicates have been made available to the registry by
local health authorities. Data of non-residents of the CCR are
exchanged with German neighbour cancer registries.

Interpreting the results


After 1989 the notication rate in Mecklenburg-Western
Pomerania declined sharply due to political changes in the
former GDR and the resulting lack of a legal framework for
cancer registration. With the cancer registration law taking
effect in 1995, the legal basis for cancer registration was
Cancer care facilities
In Mecklenburg-Western Pomerania there are 34 hospitals, re-established and cancer cases were again reported to the
most of them afliated with one of the regional tumour registry. The availability of death certicates as a principal
source of information on
centres (see below). The state
cancer cases was regulated
of
Mecklenburg-Western
by the cancer registration
Pomerania has four tumour
GERMANY, MECKLENBURG-WESTERN
law. Since 1995, the number
centres, located in the cities of
GERMANY, MECKLENBURG-WESTERN POMERANIA (1998-2002)
POMERANIA (1998-2002)
of reported cancer cases
Greifswald, Neubrandenburg,
from Mecklenburg-Western
Rostock
and
Schwerin.
Pomerania has been steadily
Although there are some
increasing,
while
the
hospitals specialising in














percentage of DCO cases is


oncology services, most of the







decreasing.
other hospitals are involved












There are opportunistic


in cancer care as well (e.g. by





 

screening programmes for


offering special diagnostic or





 








colorectal, prostate, cervical


treatment methods). The tumour







and female breast cancer


centres, however, provide a focal














and skin melanoma. Data


point in cancer care. Tumour





 

on testing for PSA are not


centres are specic hospitals and








 





available but it is increasing in


university hospitals specialising







this population.
in diagnostics, treatment, and














We are not aware of any


aftercare of cancer patients







unusual environmental and/


and
the
documentation
or occupational exposures
of pertinent information.






in
Mecklenburg-Western
 ,($*
  ,($*
Also, general practitioners,



.-/,)##,,,

Pomerania.
radiotherapy departments and
other specialists are involved in 
  
 ,,, , , , ,  1, ,  ,,', ,%//#,,,,
Use of the data
cancer care, as they see cancer  ,  , , ,  22,,
  ,, , , , ,, , !, , ,", 0, ,, ,3 ",
Mecklenburg-Western Pomerania cancer data have been
patients in an outpatient setting. 


  

, ,(&##)*,,
+,,  ,
used for health services planning and for epidemiological
research. Linkage with the CCR was performed for caseRegistry structure and methods
For a description of the structure of the registry, please refer control and cohort studies. Annual reports on cancer
incidence and mortality are prepared. In cooperation with
to the general narrative for the CCR.
In Mecklenburg-Western Pomerania, cancer is a the association of population based cancer registries in
reportable disease. In 1998, cancer notication became Germany (GEKID) and the Robert-Koch-Institute, the data
mandatory in this state. Patients are informed about the are pooled for nation-wide analyses.
notication to the registry by the diagnosing physician.
The major sources of notication in Mecklenburg-Western Source of population
Pomerania are the regionally organised tumour centres The estimate of the population at risk is based on an extract
(Tumorzentren). The tumour centres abstract all pertinent from the central residents registration ofce on 3 October
information from medical records of cancer cases residing 1990, which is annually updated with the results of the
in the state of Mecklenburg-Western Pomerania seen in a statistics of births, deaths and migration. Source: Statistisches
hospital or special clinic being afliated with a tumour centre, Amt der Lnder.
and report them to the CCR. The tumour centres provide 95%
of all notications per year. The remaining 5% the registry Multiple primary rules used
receives directly from the physician via the traditional way IACR rules (2004) on CI5 IX period.

305

Europe

Germany, Free State of Saxony


Registration area
The state of Saxony is one of the six states covered by the
Common Cancer Registry (CCR) and is located in the East
of Germany. The population of Saxony is about 4.4 million
inhabitants, 48.5% males and 51.5% females (2002), almost
all of them being of Caucasian origin. About 57% live in
urban areas (dened as population >5000 and population
density >400 inhabitants per km).

to the registry by local health authorities. Data of German


non-residents of the CCR are exchanged with neighbouring
cancer registries.

Interpreting the results


After 1989 the notication rate in Saxony declined sharply
due to political changes in the former GDR and the resulting
lack of a legal framework for cancer registration. With the
cancer registration law taking effect in 1995, the legal basis
for cancer registration was re-established and cancer cases
Cancer care facilities
In Saxony there are 86 hospitals, most of them afliated were again reported to the registry. The availability of death
with one of the regional tumour centres. The state of Saxony certicates as a principal source of information on cancer
has ve tumour centres, located in the cities of Chemnitz, cases was regulated by the cancer registration law. Since
1995, the number of reported
Dresden, Grlitz, Leipzig, and
cancer cases from Saxony
Zwickau. Although there are
has been steadily increasing,
some hospitals specialising in
GERMANY, FREE STATE OF SAXONY
while the percentage of DCO
oncology services, most of the
(1998-2002)
GERMANY, FREE
STATE OF SAXONY (1998-2002)
cases is decreasing.
other hospitals are involved
There are opportunistic
in cancer care as well (e.g. by
screening programmes for
offering special diagnostic or
colorectal, prostate, cervical
treatment methods). The tumour











 

and female breast cancer


centres, however, are the focal







and for skin melanoma. Data


point in cancer care. Tumour








 





on testing for PSA are not


centres are specic hospitals and




 
 

available, but it is increasing


university hospitals specialising

 






 





in this population.
in diagnostics, treatment and
 
 





aftercare of cancer patients


In the past there were some
 






 



 


and the documentation


unusual
occupational exposures of







of pertinent information.
radon for employees in the Wismut














Also, general practitioners,


mining area (West Saxony), as







radiotherapy departments and


well as unusual environmental














other specialists are involved


exposures of radon in houses





 

in cancer care, as they see


which might be still a problem in
cancer patients in an outpatient
parts of this area today.






setting.
 -($*
  -($*


 

&-%)/-.%,--
Use of the data
Registry structure and 
  
Saxony cancer data have
 -  - - -  22--  --- - - - -  1- -  --'- -%//#---methods
been used for health services
  -- - - - -- - !- - -"- 0- -- -3 "For a description of the structure
of the registry, please refer planning and for epidemiological research. Linkage with the
 


  

- -(&##)*--
+--  to the general narrative for the CCR.
CCR was performed for casecontrol and cohort studies.
In Saxony, cancer is a reportable disease. In 1993, Annual reports on cancer incidence and mortality are
cancer notication became mandatory in this state. Patients prepared. In cooperation with the association of population
are informed about the notication to the registry by the based cancer registries in Germany (GEKID) and the Robertdiagnosing physician.
Koch-Institute, the data are pooled for nation-wide analyses.
The major sources of notication in Saxony are the
regionally organised tumour centres (Tumorzentren). The Source of population
tumour centres abstract all pertinent information from The estimate of the populationatrisk is based on an
medical records of cancer cases residing in the state of Saxony extract from the central residents registration ofce on 3
seen in a hospital or special clinic afliated with a tumour october 1990 which is annually updated with the results
centre and report them to the CCR. The tumour centres of the statistics of births, deaths and migration. Source:
provide 93% of all notications per year. The remaining Statistisches Amt der Lnder.
7% the registry receives directly from the physician via
the traditional reporting by means of notication forms. Multiple primary rules used
Additionally, all death certicates have been made available IACR rules (2004) on CI5 IX period

306

Europe

Germany, Hamburg
Registration area
With 1.7 million inhabitants, the Free and Hanseatic City of
Hamburg is the second-largest city in Germany and one of
the 16 federal states. The city area comprises 755 km2, 14%
of which are covered by green spaces, water and recreational
areas. Hamburg is one of the worlds major trade centres. Its
port is the central hub for trade with Eastern and Northern
Europe, supplemented by important rail and motorway
connections. The predominantly urban area shows highly
specialised industries, particularly medical devices, biotechnology and aircraft industry. With 11 universities, higher
education is a main focus.
Cancer care facilities
Being a metropolitan area,
the medical infrastructure
in the city of Hamburg is
above-average. Medical care
is provided by a complex
healthcare system including
3600 general practitioners and
specialists, and 53 hospitals
including
a
university
hospital. The main institutions
of specialised cancer care are
about 10 hospital departments
and 8 oncological practices,
the latter including in- and
outpatient settings. These are
supplemented by numerous
diagnostic, therapeutic and
supporting facilities, such as
laboratories, pathology units,
radiology and radiotherapy
institutions
and
psychosocial services. Up to 25%
of oncological patients reside
outside of Hamburg.


 











 











 

In addition, all death-certicates are made available to


the cancer registry staff for evaluation and trace back. The
procedure of matching the HCR-data with information
kept in residential registry ofces was started in 2004. The
step was a one-time check of 75 000 cases without date
of death. Since then the update has been done monthly.
Many plausibility tests are done, and a Best-of tumour
information is generated in case of multiple notications of
a single malignancy.

Interpreting the results


Since 1995 the number of notications to the HCR has doubled
while the DCO rate has declined signicantly. Completeness is
independently reviewed by the
Robert Koch Institute based
on the M/I index, having been
GERMANY, HAMBURG (1998-2002)
estimated in 2005 as sufciently
GERMANY, HAMBURG (1998-2002)
complete. Nevertheless quality
differs considerably concerning
site and year of diagnosis.
Although methods of






 

early detection are used






widely (e.g. Pap smear, PSA,










mammography) it is impossible




to quantify their numbers and










to estimate their inuence on






incidence rates.





 






























Use of the data


Comprehensive
reports






on cancer incidence and
















mortality in Hamburg are



 





published every third year.


In addition, in 2004 the HCR






started publishing data online

,(%*


,(%*
(www.krebsregister.hamburg.

 

.'$,-&/,,,

de). Routine reports cover data

  

,(, 
,  ,  ,,
1
!, 0##"1 "
*,
on incidence and mortality. In
 


  
2005 we began including survival analysis for clinical use.
, 
,('$$)*,,+,,
,
In cooperation with the Association of population-based
Registry structure and methods
Having started between 1926 and 1929, the Hamburg Cancer cancer registries in Germany (GEKID) and the Robert-KochRegistry (HCR) is one of the oldest population-based cancer Institute (RKI) the data are pooled and documented in Krebs
registries of the world. During the Second World War the in Deutschland.
The HCR both initiates and participates in various
reporting process stopped, and again paused in the 1980s
because of a general controversy on data protection in research projects, for instance risk factors for breast
Germany. Since 1985 the HCR has been based on a specic carcinoma, regional analysis of incidence concerning
law with two essential elements: the principle of informed leukaemia and lymphoma, feedback on long-term survival
consent from the patient and voluntary cooperation on the to notifying institutions, acute and post-traumatic stress
disorder in breast cancer patients.
physicians side. Since 1991 notications are remunerated.
One current project is the multi-centre MARIE- Study
The state health authority, staffed with four scientists,
two computer experts and six documentation and coding (Postmenopausal Hormone Replacement Therapy and breast
employees, runs the HCR. Additional project equipment is cancer risk). The HCR also collaborates with the hospital
planning unit of the Ministry of Health in Hamburg in the
provided by the Hamburg cancer society.
Traditionally the physicians in hospitals report by means assessment of numbers of cancer cases given from the hospitals,
of notication forms. Pathologists provide a partly lled and is involved in the evaluation of mammography screening.
notication form to be completed by the attending physician.
Electronic data transmission is now realised by providing Source of population
purpose-developed software to the cooperating practitioners. Projection (Statistical ofce for Hamburg and
This software transfers data from the surgerys software into SchleswigHolstein, http://www.statistiknord.de).
an electronic notication form completed on screen by the
physician. A rising number of hospitals are supplied with Multiple primary rules used
IACR rules (2004) on CI5 IX period.
facilities to enable electronic notications as well.

307

Europe

Germany, Munich
send cancer-specic forms with pre-coded data on an
Registration area
Munich is the capital of the federal state of Bavaria, one of individual level, including identifying items for each primary
sixteen states of the Federal Republic of Germany (Munich malignancy. Additionally, collaborating hospitals report on
City: latitude 488 N, longitude 1134 E, 519m above sea local and regional progressions and on the occurrence of
level, area 310km2). With its 1.3 million inhabitants, Munich metastases. These data are important outcome criteria for
is Germanys third-largest city, located in the southeast of clinicians and are used for evaluating therapeutic strategies
and for quality control.
the country about 50km north of the Alps.
Since 1994, the 12 pathological services have been
The Munich Cancer Registry (MCR) covers the population
of the City of Munich and 7 surrounding districts, in total sending copies of the reports for malignant diagnoses to
2.3m inhabitants, 56% living in Munich City. About 23% of the MCR. The histological verication rate for almost all
the inhabitants are foreigners, 8.6% from the EU. Most of prognostic favourable types of cancer is 95%.
The Bavarian Cancer Registration Law allows the
them come from Turkey (3.4%), and from Croatia, Serbia,
Greece, Austria and Italy each with about 1.7%. Most work MCR to process all death certicates in the catchment
area.
Information
from
in the service and trade sector
death certicates has been
and in growth industries such
compared with registry data
as media, information and
GERMANY, MUNICH (1998-2002)
on an individual level since
communication technology,
GERMANY, MUNICH (1998-2002)
1998. This has revealed a
the nancial industry and
noteworthy underreporting for
biotechnology. Munich is
prognostically unfavourable
Germanys
second-largest
cancer sites like pancreas,
university city.
%"#'%%%
'"$
% (%%%
%& %%%
'
(%'&%%%
liver, gallbladder, CNS and
In 1998, legislation was
"%"%%%
&"
'%( %%%
lung. Remarkably, the agepassed authorising population'%%%%
&
'%(&#%%%
(%#%%%
#"
""%%%%
standardised mortality rate for
based cancer registration in
&(% "'%%%
#
'%# (%%%
lung cancer in Munich is about
Bavaria. The registration
'%('&%%%
""
'%'& %%%
&#%'&%%%
"
'%#(%%%
30% lower than the overall rate
system in Bavaria for a total
&%& %%%
"
&&%& %%%
for Germany, corresponding
of 12.4m people, based at
''%(' %%%

'#% &%%%
% %%%
"
 %'%%%
to a high social status and low
the Munich Cancer Centre
#%%%%

&%#%%%
rate of smoking.
and ve other comprehensive
'%#%%%
"
'% %%%
#"% %%%

#&%'(%%%
Haematological diseases
cancer centres, has been
"%"#%%%
"
"%''&%%%
are
underreported.
For
centralised to further improve
""%# #%%%

"% #%%%
"&% #%%%
"
" % %%%
the
other
cancer
sites,
a
the collection and processing
#% %%%

"'%&&%%%
remarkable incidence rate
of cancer data. Since 2007 the
could be obtained without
MCR has covered the entirety

"


"

involvement of DCO-cases

%!


%!
of Southern Bavaria, with
%%"%%%
%'%'&%%%

and without including follow4.4m inhabitants.
back results. The impact on

  
% 
%

%
success of motivation to join
Cancer care facilities
 


  
the MCR can be assessed by analysing the stable incidence
Hospitals and private practitioners
provide
% 
%
!%%"%%
%health care in
the region. There are two university hospitals in the city of rate from 342.5/266.4 in 1998 to 361.7/ 271.0 in 2002 (male/
Munich. All necessary diagnostic and treatment services female, world standard, without 174/C44).
In 2002 we handled about 29 000 pathological reports,
are available to deliver healthcare according to international
standards. The population-based stage distributions and 36 000 death certicates and 50 000 other forms and reports.
treatment results show international comparability. All Additionally, life status was veried by more than 100 000
hospitals cooperate in the comprehensive Munich Cancer requests at Residents Registration Ofces. This paperwork
is done by 13 documentation ofcers. In addition three
Centre.
The MCR supports networking in oncology by compiling scientists are responsible for organisation, statistics and
cancer data from all sources. Presentation of individual computer technology.
In Germany, cancer screening is offered but the
and aggregated data is offered to the closed community of
participation rate varies widely between men and women,
cooperating doctors.
according to their age. Medical examination includes
palpation of breast, cervical smear, haemoccult test and
Registry structure and methods
As part of the comprehensive Munich Cancer Centre, the palpation of prostate, with a high rate of self-initiated PSA
MCR started registering patients in 1978. In the rst years tests at the patients own expense.
a few departments of the Ludwig-Maximilians-University
and the Technical University Munich collaborated. There Use of the data
are now 39 hospitals in Munich, and 11 hospitals from the The MCR analyses cancer incidence and mortality
surrounding districts taking part in the MCR. The number of concerning secular and regional aspects. Survival rates are
cooperating institutions and the catchment rate has reached a calculated for the different cancer sites. Results are used
to answer important questions, e.g. concerning quality
steady state and guarantees a high coverage rate.
Notication is on a voluntary basis, and no legal duty assurance in health care. Additionally, the MCR releases
is imposed upon doctors to report cancer cases. Hospitals periodical reports via Internet for all cooperating hospitals

308

Europe

to keep them permanently informed about the medical data


they have provided.
Many of the most frequent cancer diagnoses are analysed
in detail. Routine statistics show comparisons to the
recommendations of guidelines with hints to those patients
for whom the standards are not realised. The larger hospitals
are informed about their own results, main outcome criteria
are compared anonymously with the other hospitals. Some

of the data are available for the scientic community on the


internet (www.tumorregister-muenchen.de).
Source of population
2000. Postcensal estimate.
Multiple primary rules used
IACR rules (2004) on CI5 IX period.

309

Europe

Germany, North Rhine-Westphalia: Mnster


registry include hospitals, outpatient departments and
private practitioners. Since 1998 the registry has included
Registration area
The Muenster District (Regierungsbezirk) is a region of reports from pathologists with anonymised personal
the Federal State of North Rhine-Westphalia (NRW). It identiers. Follow-up of patients is largely passive.
is located in the north-west of Germany bordering the Annually, the register database is linked with death
Netherlands. The population of Regierungsbezirk Muenster certicates from the district. Follow-back is pursued if
was 2 625 637 in 2002, with 48.8% males and 51.2% females patients were initially identied in the register by death
and a population density of 379 inhabitants per km2. The certicate.
District encompasses rural areas as well as large industrial
areas and cities. The great majority of the population are Interpreting the results
Caucasians. The Muenster Registry was the only cancer The catchment area has remained unchanged over the
registry in NRW until 2005, when it was transferred into reporting period. Likewise, the diagnostic and therapeutic
the Epidemiologisches Krebsregister Nordrhein-Westfalen, facilities developed in line with the general medical progress
in Germany. Coding has been
a new epidemiological cancer
performed according to ICDregistry now covering the
10 and the ICD-O-3 guidelines
entire state of North RhineGERMANY, NORTHRHINE-WESTPHALIA:
throughout the period. No
Westphalia.
(1998-2002)
GERMANY,MUNSTER
NORTHRHINE-WESTPHALIA:
MUNSTER (1998-2002)
organised
population-wide
cancer screening programmes
Cancer care facilities
have been established, although
Cancer
diagnosis
and
opportunistic mammography,
treatment in Regierungsbezirk
%"$%"""
$!
"%"""
"$"""
$
"##"""
colonoscopy, skin inspection
Muenster are carried out by
"%"""
#
#""""
and PSA testing are rather
hospitals and specialists.
"#"""
#
""""
"$$"""

%" %"""
common.
There are 63 hospitals with
#%"%"""

$"$%"""
more than 20 000 beds
#"##"""

#" """
#"$"""

#"$ """
Use of the data
in the registration area.
$%"%"""

$$"%"""
The registry prepares regular
Morphological examinations
"#% """

"%"""
""""

"#"""
annual reports of cancer
and diagnoses are performed in
%" """

"%$"""
incidence and mortality. More
14 pathological institutes, one
$"#"""

$" #"""
#""""

#"%"""
detailed reports of trends
specialising in neuropathology
##" """

#"%%$"""
and survival are prepared
and ve in dermatohistology.
$"%"""

##" #"""
#%" """

#"%#"""
infrequently for specic
Radiology
services
are
#""""

$"#"""
entities (e.g. breast, leukaemia,
provided by departments in
malignant melanoma and
numerous hospitals.






prostate cancer). Data are also
 "
 "
provided by an interactive
"%"$ """
"#"%%"""

Registry structure and
database via Internet. The
methods

  
registry contributes frequently
The registry was established    "
 


  
in 1985 and was completely funded
by the State Ministry of to the ofcial Health Report System in North Rhine "
 """""
"
Health. Full-time personnel comprise two senior scientists Westphalia.
for data management and analysis, one epidemiologist, and
four medical records clerks. A consultant from the Institute Source of population
of Epidemiology and Social Medicine of the University of Census.
Muenster accompanies the registry.
Cancer notication requires the signed consent of Multiple primary rules used
patients. The sources of notication for the Muenster IACR rules (2004) on CI5 IX period.

310

Europe

Germany, Saarland
force in April 2002. Since April 2000 the registry has been an
Registration area
The Saarland Cancer Registry covers the population of the Federal integrated unit of the Ministry of Public Health. Until 1999, it was
State of Saarland. Located in the south-west of Germany between nanced by the Government of Saarland and by regular subsidies
latitudes 49038 and 49007 and longitudes 6021 and 7024, bordering from the Federal Ministry of Health. Since 2000, it has been
France and Luxembourg, Saarland is the second-smallest state in completely funded by Saarland State. Two full-time ofcers of
Germany. The area amounts to 2569 km2 of hilly country with health holding a university degree, two full-time registrars and
altitudes ranging from 150 to 695m above sea level. Saarland lies three half-time clerks are afliated with the registry.
in the cooler part of the temperate zone, occupying an intermediate
The basic system of registration is centralised collecting of
position between the oceanic climate in the west and the continental individual records including personal identiers, which do not
climate of the east. The average annual temperature is about 100 require the written formal consent of the registered patients.
Notication is compulsory since 2002. Hospitals, physicians
C. Average annual rainfall is about 1050 L/m2.
The administrative structure consists of ve counties and one and persons acting on their behalf are obliged to report all newly
metropolitan area, comprising 52 communities altogether.
diagnosed and treated cancer cases. In principle physicians must
The population of the Saarland
inform patients on the reporting
is 1 070 102 (in 2000); 48.5% are
to the registry, but there are some
males and 51.5% females, at a
derogations. Patients have a right
GERMANY, SAARLAND (1998-2002)
density of 417 inhabitants/km2.
to withdraw from registration,
GERMANY, SAARLAND (1998-2002)
but in practice withdrawal
Some 52.9% live in 13 conurbations
is extremely rare. Sources
of more than 20 000 inhabitants.
of information are hospitals,
Life expectancy for males is 75.0
outpatient depa r tments,
years and 80.5 years for females.
',%*.,,,
.)+
#),#-*,,,
*,!!),,,
.!
#',''#,,,
pathology and radiotherapy
The overwhelming majority
#',#-!,,,
-)
$-,'!.,,,
departments and private
(72.7%) are Roman Catholic,
$$,#-),,,
-!
%!,#.',,,
$.,'%*,,,
*)
%#,/%$,,,
practitioners. Death certicates
with 21.7% Protestants and 5.6%
%*,-)-,,,
*!
%/,'**,,,
are also used, and traced back
with other/no religious afliation.
%#,'/-,,,
))
%$,$%#,,,
%$,.%!,,,
)!
%#,-%.,,,
Of the total population, 92.5% are
when necessary.
'!,)#),,,
')
%.,/.*,,,
German and 7.5% possess foreign
Due to restrictive legal
'','$!,,,
'!
'$,')$,,,
'*,'%',,,
%)
'),!$#,,,
regulations, follow-up of patients
nationality. About 47.8% of Saarland
'#,/*/,,,
%!
'!,$./,,,
is largely passive. Though all
residents are married, 36.8%
%#,!$%,,,
$)
$/,/'*,,,
$-,/-.,,,
$!
$-,%#-,,,
physicians treating cancer
unmarried and 15.4% widowed
$.,.$.,,,
#)
$-,$!/,,,
patients are generally requested
or divorced. The economically
$/,-./,,,
#!
$.,!$#,,,
$-,/.-,,,
)
$*,)$-,,,
to report any serious change
active population, 46.1% of the
$%,.**,,,
!
$$,//.,,,
in a patients health status,
total, is employed in production
the registry is not allowed to
industries (32.7%), distribution,
#!
)
!
!
)
#!
conduct further enquiries. The
transport and communications

,&"(


,&"(
les of the registered cases are
(23.6%), agriculture, forestry and
))#,%'#,,,
)#/,!'*,,,

linked annually with all death
sheries (1.0%) and other sectors/

  

,
,,
,#/.-,
,,
,  , ,,
,,
,,  , ,,,, ,
,
 ,
 ,
certicates.
services (42.7%).
 


  
, 
,&$!!'(,,),,
,

Cancer care facilities


Cancer treatment is carried out by both hospitals and private
physicians. Treatment at the hospital level in Germany
has been coordinated under a governmental programme
structured on several levels. The Tumorzentren (tumour
centres involved in both research and treatment) cover large
regions and are connected with big university hospitals. In
the Saarland area there is one Tumorzentrum and one big
university clinic. A series of regional hospitals dedicate
considerable personnel and funds to cancer treatment.
A small number of private oncological practices provide
diagnostic and aftercare structures.
There are 27 hospitals with 8060 beds in the registration
area. Hospitals comprise 144 special medical departments
including four radiotherapeutic units. Morphological
examinations and diagnoses are performed in eight
pathological institutes, one specialising in neuropathology.

Interpreting the results


Early detection and population screening activities in Germany
started in 1971. Since programme restructuring in 1982, the
population has been screened for cervix, breast, rectal and skin
cancer. All tests are offered annually to eligible population
groups, but there was no individually organised invitation by
letter with location and time of testing. To date (September 2006)
there is no regular PSA testing for men in Germany. Organised
mammography screening for women from 50 to 69 years of age
is currently to be established in all federal states of Germany.

Registry structure and methods


The registry was established in 1967 in the State Statistical Ofce
and is based on the Saarland Law on Cancer Registration, whose
rst edition came into force in 1979. A new, completely revised
Saarland Law on Cancer Registration regulating and improving
the use of personal data for epidemiological research, came into

Source of population
Estimate based on the 1987 census, making allowance for births and
deaths, as well as for migration into and out of the registration area.

Use of the data


The registry prepares annual reports of cancer incidence
and mortality, and provides an interactive database (www.
krebsregister.saarland.de) on the Internet. The registry carries out
descriptive and analytical epidemiological studies, independently
and in national and international collaborations.

Multiple primary rules used


IACR rules (2004) on CI5 IX period.

311

Europe

Iceland
Registration area
The Icelandic Cancer Registry is a population-based
nationwide cancer registry covering the whole of the
Icelandic population. Iceland is located in the middle of the
North Atlantic Ocean between 6468N and 1424W.
The geographical size of the country is 103 000 km2. The
Icelandic population is around 300 000 inhabitants.
Around 80% of the population is urban, and the urban
population is mostly located in the southwest part of Iceland.
The population ethnicity is northern European, and the
religion is Christian Protestantism for the vast majority of
the population.

the registry from the Icelandic government. A new law was


enacted in 2007 which makes cancer registration in Iceland
compulsory.
The core staff consists of a medical director, a managing
director, two registrars, a computer technician, a data
manager and a statistician. In addition there are part-time
positions for 12 researchers.
The sources of data for the cancer registration are
the pathology and haematology laboratories, all hospital
departments and healthcare facilities. Registrations are also
received from private-practicing consultants. Incomplete
information is followed up by contact with the aforementioned
institutions and individuals. The majority of the data is
received in electronic form.
The rst information on
cancer cases in most instances
ICELAND (1998-2002)
(>95%) comes from pathology
ICELAND (1998-2002)
laboratories.
Further
information is then requested
from all those who are likely
to give additional details if


 





needed.


 

The Icelandic Cancer










Registry receives information






from all death certicates from








Statistics Iceland, where there






is a mention of a malignant








disease. The registry further






checks this information and










additional information called






for if needed.








Periodically,
all


 

registration for each site is


checked and discrepancies





are further investigated. The
 )$!&
  )$!&
IARC check program is used.





Cancer care facilities


Patients in Iceland have easy
access to physicians, whether
in primary health care or
consulting in a specic eld
of medicine. The healthcare
system is a socialised system
and the proportion of the cost






of the healthcare burden laid





on the individual or his private



 




insurance is minimal.



Imaging
facilities




 

are available with highly





sophisticated techniques both








in the major hospitals and in





private practice. There are








four pathology laboratories in





the country, one of which is








purely for dermatopathology,





and all of those provide the


Cancer Registry with their

valuable information. There
are
also
well-equipped
"% )(%#)))
haematology and biochemical
  

laboratories as well as a  )

++ )  ) ) ) )) ))
) )"*'#))  )
 )  ) ) )) ) Use of the data
      
cytogenetic laboratory available
for %&)) ))
various investigations Figures on incidence, prevalence and survival are published
 )  )$#
of patients. Cancer surgery in   
Iceland is for the most part every year in the yearbook of the Icelandic Cancer Society
%%) )) )) ) )
limited to two hospitals, although minor surgical operations as well as on the home page of the Icelandic Cancer Registry
are performed both in private ofces and in smaller hospitals. (www.cancerregistry.is). The registry staff is actively engaged
Specialised work on cancer treatment like neurosurgery and in epidemiological research on cancer, and the registry
radiation treatment of cancer is centralised at Landspitalinn is also the source of data for such research conducted by
others. The Icelandic Cancer Registry in addition provides
University Hospital in Reykjavik.
A nationwide screening programme for cervical cancer information to assist public health ofcials in planning for
has been operating since 1964 and for breast cancer both the prevention and treatment of cancer.
since 1987. It has been decided that Iceland shall take up
nationwide colorectal cancer screening in the near future. It Source of population
is quite common for men above the age of 50 to have their The populationatrisk derives from the Icelandic National
Roster, in operation since 1952 and regularly updated for
PSA levels measured.
births, deaths and migration.
Registry structure and methods
At the request of the Director General of Health the Multiple primary rules used
Icelandic Cancer Society undertook in 1954 to establish IACR rules (2004) on historical data.
and run a cancer registry. It has ever since been located at
and run by the Icelandic Cancer Society. In recent years the Notes on the data
Society has received a subsidy towards the cost of running C44 does not include basal cell carcinoma.

312

Europe

Ireland
The Registry is administered by the National Cancer
Registration area
The catchment area of the National Cancer Registry is the Registry Board, whose members are mainly medical
Republic of Ireland. A separate registry covers Northern practitioners, and is fully funded by the Department of
Health and Children. The Registry has a staff of 42, 22 of
Ireland.
The Republic of Ireland is situated between 5130 and whom are engaged in active data collection.
Reporting of cancer cases is not obligatory, and the
5530 N and between 60 and 1040 W. The total land
area is 70 282 km2, comprising 83% of the island of Ireland, Registry collects most of its information through active
with a long indented coastline of 3169km. The highlands casending and data abstraction. Most notications come
are mainly coastal, with a central limestone plain, and the from pathology departments, with a smaller number from
country does not rise above 1040m at any point. The climate other hospital sources, death certicates and GPs.
The Registry has full access to all death certicates
is temperate and oceanic, with average winter temperatures
between 4C and 7C, and summer temperatures between issued in Ireland since 1994, and uses these for case14C and 16C. Yearly rainfall is highest on the mountains of nding and follow-up. Death certicates are followed up
with the hospital of death
the west and lowest in the east
or the certifying doctor if
midlands.
the cancer is not already
The population at the
IRELAND (1998-2002)
registered. Unconrmed death
2002 census was 3 917 203 (1
IRELAND (1998-2002)
certicates are registered as
946 164 males and 1 971 039
death certicate only (DCO).
females). The population is
At present the Registry does
predominantly native-born and
not carry out active follow-up.
Caucasian, but information on













All data is extracted directly


ethnicity is not collected either







onto laptop computers and no


at census or by the Registry.














paper forms are generated.


Most of the population (88%







The ICD-O-2 coding system is


at the 2002 census) are Roman












 

used for both topography and


Catholic. In 2002, 40% of the

 





morphology. All malignant, in


population lived in rural areas








 



 

situ and uncertain cancers are


(centres with fewer than 1500







registered, as well as benign


inhabitants).

 












intracranial and intraspinal









cancers. CIN III of cervix is


Cancer care facilities














not registered on the basis of


Cancer patients in Ireland






cytology, but only if conrmed


can avail of either private or
by biopsy.
public health care. All public







)&"(


)&"(
We have recently carried
and private hospitals allow the




#)++*),*%)))

out a formal evaluation of
Registry full access to case
completeness, using statistical
information. The majority of 
  
methodology, in collaboration
cancer patients (about 84% of )#,,*.$!!#-)  )))

)&)
)
)
)) 
)& () 
))

) )
)  ))
 ) ))
 ))))
))
))

)))

) )
)))) ()))))))))))))))))))))$!!$-)
)$!!$)
 


  
incident cases) attend public hospitals.
There are two main with Dr David Robinson of Thames Cancer Registry.
)
)&$!!'())))
publicly-funded radiotherapy centres in Ireland, located in Periodic checks for completeness are carried out against
Dublin and Cork, and two smaller private centres both in other cancer databases. We plan to carry out a reabstraction
Dublin. Almost all cancer treatment is provided within the of a 2% sample of records next year.
country.
No co-ordinated screening programmes existed in Use of the data
Ireland in the period 19942000, but breast screening began Annual reports, with information on incidence, mortality,
in 2000 and by the end of 2002 covered approximately 50% treatment and survival are produced. The Registry has also
of the population. It is hoped to have full population cover published a number of scientic papers and special reports
by the end of 2007. Opportunistic but unorganised cervical on a number of different topics, a list of which is available on
screening has existed for many years, but it is not possible the website (www.ncri.ie/pubs/pubs.shtml). The data are also
to estimate the proportion of the population covered. In widely used in the Irish health services for service planning
October 2000 the rst phase of a national cervical screening and needs assessment.
program was established in one region of the country. PSA
Source of population
testing is common in the population.
For 19972001: Population and migration estimates (Each
year the Central Statistics Ofce (CSO) publishes an
Registry structure and methods
The National Cancer Registry was founded in 1991 and estimate of the population at April of that year. This is based
began collecting population-based cancer incidence data for on the natural increase and on estimates of the gross annual
the entire country in 1994. In 1991 it took over the functions migration ows). For 2002: Census 2002.
of the Southern Tumour Registry, which had provided
population-based registration for about one sixth of the Multiple primary rules used
IACR rules (2004) on historical data.
country since 1975.

313

Europe

Italy, Biella Province


staff looks up other specic les of hospital departments
Registration Area
The Cancer Registry covers an area with 82 municipalities: (radiology, radiotherapy, oncology), laboratories, the
22 have fewer than 500 inhabitants and 15 have a population palliative care unit (active since 2000) or the hospital cancer
between 500 and 1000 inhabitants. Most of the population registry (active 19591997). Finally, the registry regularly
(187 041 inhabitants in the 2001 census) resides in urban receives records from the local ofcial mortality registry
areas (24.3%). The textile industry had always been the main and has access to original documents for further checks.
activity in the area; however, during the last 20 years other Completeness and accuracy of the information are formally
electronic and metal-mechanical industries have arisen. Due evaluated in several ways. After data verication with the
to its industrial background dating back to the 19th century, IARC-Check tools, we analyse short-term trends in number
this area has always been a place of immigration. In the of cases, percentage contributions of each information
1950s people arrived from the Northeast of Italy (about 20% sources, cases with poor site or histological specication,
of population now aged 6080) while in the 1970s people microscopic verication, prevalence of multiple primary
migrated from the south of Italy. Migrations from other cases, mortality incidence ratio, and proportion of DCI and
DCO.
countries are only recent and
limited to young people (<5%
Interpreting the results
of population). The birth rate
ITALY, BIELLA PROVINCE (1998-2002)
Cancer incidence in the
is rather low (7.36 in 2001) and
ITALY, BIELLA PROVINCE (1998-2002)
Province
of
Biella
is
the elderly index high (198.95
inuenced by its social and
in 2004). Nowadays, there is
industrial history, with a high
relative demographic stability,
incidence of larynx, lung,
especially in the valleys where
&/(*'///
1,.
*/'*1///
&/,'-///
1$"
(/'(-///
oesophagus and stomach
the communities are more
(/'2,///
0,"
,/-((///
cancers in men. Recently,
isolated.
*/-'&///
0$"
-/,,1///
,/*0&///
-,"
-/-*&///
screening programmes have
-/&10///
-$"
-/1(,///
made an important impact,
Cancer care facilities
-/$$*///
,,"
-/(',///
-/,2*///
,$"
-/-,'///
with increasing incidence
The registry area is served by
-/*,0///
*,"
-/*-$///
rates for breast, prostate, and
one public hospital of about
-/,-(///
*$"
-/($(///
0/(,(///
(,"
-/2'0///
rectum cancers. Clusters of
500 beds with the main surgical
0/*11///
($"
0/&('///
cases in a particular area
and medical specialities,
-/02*///
',"
-/(00///
,/'-1///
'$"
,/$$*///
(mainly thyroid cancer) are
radiotherapy, oncology and a
*/$($///
&,"
(/1(0///
presently under study.
palliative care unit, and two
(/0((///
&$"
(/(1'///
(/0-(///
,"
(/-$'///
private clinics. Population(/-*2///
$"
(/,$'///
Use of the data
based screening programmes
The Registry reports on
have been active since 1997
&$
,
$
$
,
&$
incidence, mortality, survival
for cervical cancer, and since
 /)%+
  /)%+
and their trends to the local
1995 for breast cancer, while
21/-,(///
2$/&(1///

and regional authorities. In
in the previous years screening

  
//  / / /
addition, it reports on hospital
practice was rather diffuse /'$$&//  /  3/  /  //

//(&#&'/ /  / !/ /
 /
 / /) +#/ / /
 / // / /

/
although opportunistic. A multi-centre
evaluation trial has cancer patient migration and quality of hospital records. The
 


  
 / /)'$$*+////
been carried out for colorectal cancer screening using FOBT Registry collaborates to the evaluation of cancer care quality
and endoscopy since 1997. Opportunistic screenings with and to the preparation of cancer treatment guidelines. It also
PSA for prostate and with clinical skin examination for provides a follow-up service for clinical and epidemiological
melanoma were carried out with the support of the local researches, and is actively involved in the following studies:
the Colon-rectal screening evaluation trial (SCORE),
cancer foundations for the past few years.
the evaluation of prostate screening, the evaluation of
implementation of colon-rectal cancer treatment (TRIPPs)
Registry structure and methods
The registry is part of the Centre for Cancer Prevention in collaboration with CPO, and the prevalence of anaemia
(CPO) of the Piedmont Region, located in the Epidemiology in the elderly (ANGEM) in collaboration with the Mario
Unit of the Local Health Authority (ASL 12), staffed by a Negri Institute. The Registry contributes its own data to
director, a part-time public health doctor and a registrar the National Database of the Italian Association of Cancer
nurse. The registry actively searches for cases in all clinical Registry (AIRTum).
records of local hospitals and pathology laboratories. It also
actively searches for patients who migrated towards other Source of population
centres, mainly in Piedmont and Lombardy, as indicated by Census 2001 and Intercensual estimates: Intercensual
the reports originating from the regional hospital discharge estimates with population as of 31.12 of every year are provided
records. The registry also double-checks data with other by the statistical ofce of the Piedmont region (BBDE). The
repositories of cancer data: the Piedmont Childhood Cancer registry provides the annual median population.
Registry, the National Malignant Bone Tumour Registry
and the Mesothelioma Piedmont Cancer Registry. If case Multiple primary rules used
conrmation or prevalence checks are needed, the registrys IACR rules (2004) on historical data.

314

Europe

Italy, Brescia Province


Ofce collects all hospital discharge data from Lombardy
Registration area
Brescia is one of the most densely populated provinces in the and bordering regions, the proportion of cases missed is likely
Lombardy region of northern Italy. The Brescia Health Unit to be very small. Most pathological records are uncoded, and
Cancer Registry covers about 91% of the population of the Registry staff code about 80% of them to ICD-O-2.
Computerised records containing all the collected data
province. Registry data are available for 19931995 and for
19992001. The Brescia Health Unit Cancer Registry started (hospital discharge records, pathological records and death
in 1994 using manual methods, and covered a smaller area with certicates) are automatically linked to the Social Security
about 390 000 inhabitants, consisting of the town of Brescia System to assign a patient code to each record, and all records
and 23 surrounding municipalities. The Registry currently uses with that code are linked with prevalence les. Concordant
an automated population-based cancer registration system. It incident malignant cases are assigned to the Registry. For
covers an area of 3460 km2 at 45N latitude. It covers Brescia discordant and incomplete cases, the Registry staff review
(population 195 000) and 163 other smaller towns, 55 with the computerised information, and if any remain unresolved,
more than 5000 inhabitants (33.7%) and 108 with fewer than they scrutinise hospital records and abstract information
on cancer cases directly. For
5000 inhabitants (66.3%). The
cases with death certicate
population was 1 004 980
notication, they trace-back
inhabitants, 51% females, at
ITALY, BRESCIA PROVINCE (1999-2001)
and ultimately reister those
the October 2001 census. The
ITALY, BRESCIA PROVINCE (1999-2001)
that do not link with another
population density is 290/
source as death certicate
km2.
only (DCO).
In 2001 about 8% of the
Completeness
and
population were foreigners:














accuracy of ascertainment of
30% came from East Europe







cases are provided through


and 70% from non-European














comprehensive computerised
countries (25% from Asia,







data sources and also through


20% from North Africa, 20%








 





checking and comparison of


from Sub-Saharan Africa, and







incidence rates in previous


5% from South America).














years and with other registries









in northern Italy.
Cancer care facilities














In the Registry area there









Interpreting the results


are 12 public and 9 private














Two ndings from the Brescia


hospitals; the largest, located







data are high frequencies of


in Brescia, has medical and
liver cancer among men and
surgical specialists and a






breast cancer among women.
Radiotherapy
Department.
 ($!&
  ($!&
A comparison with 1993
The Oncology Department



%*'(#)*(((

1995 data conrms these
covers the Brescia province.

  
"(  ((((( (((( (
ndings. In the last decade,
In 2001 there were 3822 beds  (  (  ((  ((( (( ( ("**"((#
( ( (($(  (((+(&(
in public hospitals and 2365 in
private hospitals (6.1/1000 epidemiological studies have been carried out to investigate
 


  

( ($"** &(
inhabitants), and is 846 general practitioners (84.2/100 000 the causes of liver cancer, mainly hepatocellular carcinoma,
inhabitants). Brescia has had mammographic screening for in the area; the role of hepatitis B and C viruses and of heavy
alcohol intake have been elucidated. The breast cancer
women aged 5069 years since the late 1980s.
rate among women may be partially due to populationbased mammographic screening in the area in recent years.
Registry structure and methods
The Brescia Cancer Registry is located in the Brescia Non-organized PSA testing concerns 12.56% of the male
Local Health Unit (Azienda Sanitaria Locale, ASL), which population (38.7% aged 50 years).
The Brescia province is a highly industrialised area, with
provides nancial support. The Registry is also funded by
the non-prot Lega Italiana per la Lotta Contro i Tumori, one of the highest concentrations of steel and metalworking
Sezione di Brescia (Italian League Against Cancer, Brescia industries in Europe. Working in these factories has been
Division), and ASM S.p.A. (Public Utility Company). The associated with possible exposure to IARC class 1 and 2A
ASL provides all the equipment and some of the human carcinogens. Air pollution has been observed in the area,
resources (4 nurses and a secretary); the two other founders especially on the plain: the mean annual PM10 concentration
support the activity of 1 medical doctor and 1 computer ranged from 3042 /m3 and most daily values in the winter
programmer. A medical doctor and university researcher of 2004-2005 exceeded 75 /m3.
also provide scientic support.
The Registry uses three computerised data sources: Use of the data
hospital discharge records provided by the Lombardy Region, The aim of the Registry is to produce and analyse incidence,
pathology reports from 9 public and private laboratories, and mortality, prevalence and survival data according to
death certicates provided by the Local Health Unit death demographic, topographic, morphological and behavioural
registration ofce. All Italian hospitals must report each characteristics. The Registry works alongside Regional and
admission using a standardised form in order to receive other Italian Cancer Registries in research projects and on
payment. As the Regional Hospital Discharge Diagnosis publications of incidence, prevalence and survival data. A

315

Europe

multi-centre national study coordinated by the Director of the


Brescia Health Unit Cancer Registry and funded by the Italian
Ministry of Research is being conducted on the prevention of
liver cancer through improved control of hepatitis B and C.
A programme for the prevention and control of liver disease
by general practitioners is also underway. Registry data
are used routinely for monitoring population-based cancer
screening programmes in the Brescia Local Health Unit.

316

Source of population
The resident population is estimated annually on the basis
of the 1991 and 2001 censuses, taking into account births,
deaths and migrations, by the National Institute of Statistics
(Istituto Nazionale di Statistica ISTAT).
Multiple primary rules used
IACR rules (1990).

Europe

Italy, Ferrara Province


The main sources of information are discharge diagnoses
Registration area
The province of Ferrara is located in the northwest of Emilia- from all national hospitals and the database of the Pathology
Romagna Region and is mainly agricultural. It lies close to Department (covering all pathological diagnostic activity in the
sea level (maximum altitude 22m) and is bordered to the province). Additional information is provided by direct contact
north by the Po River, to the east by the Adriatic Sea, to the with care services (medical records) and general practitioners.
south by the provinces of Bologna and Ravenna and to the Mortality data for all causes are provided by public health services
west by those of Modena and Mantova.
to identify DCN and DCO cases and for follow-up purposes.
The population (348 651 in 2000) is fairly stable,
Data collection is performed both actively and passively.
characterised by elevated aging (24% over 65 years) with a Personal identifying data are protected in compliance with
crude annual birth rate at the lowest levels in Italy (6.1/1000 current Italian law. Regular maintenance is carried out on
inhabitants in 2000). Among the 26 municipalities of the the computerised database. Checks for duplicates, errors and
province, the only one with a population >100 000 is Ferrara consistency are performed using the IARCcrg and DEPedits
(132 085 inhabitants in 2000).
tools. Completeness and accuracy evaluations are performed
The prevalence of nonusing death certicates, recordCaucasians is low, and the
linkage with pathological
most widespread religion
archives and checking of siteITALY, FERRARA PROVINCE (1998-2002)
is Christian Catholic. The
specic changes in incidence
ITALY, FERRARA PROVINCE (1998-2002)
number of immigrants is
over time.
lower than in other regional
provinces, but the proportion
Interpreting the results
increased in size from the late
The high prevalence of old-aged














1990s (from 0.52% in 1995 to


population has a great effect on







2.43% in 2004). A majority


crude incidence rates of many

 












(54.5%) of them come from


sites. In the area covered by







ve countries (Morocco,
the Registry, lung cancer is














Ukraine, Albania, Romania


traditionally the most common







and Pakistan), and the female/


male malignant tumour. The





 








male ratio is 1.23.


rate of cigarette smoking in the







The level of employment


Province (32.6% over 14 years








 





was 47.8% (35.6% industry,


old in 1996) is the highest in the







9.4% agriculture, 55.0% trade


Region (average 26.3%) and one








 





and services). Mechanical and


of the highest in Italy. About







chemical industries are present


42% of children have at least
in the province, and they
one smoker parent. Air pollution






represent the main sources
from the aforementioned sources

*&#(


*&#(
of water and air pollution,
 


and fog also add further risk for


$))*'')***

together with animal breeding,
lung cancer. Dietary risks are

  
* *
*

*  *&
** 
.* 
 *
-**
trafc, heating plants and $,,+*/*%""%-*
** 
.*

* 

also remarkable, due to high


*

*/*0** -!!
 


/ !

!  $ (*
agriculture chemical treatments.
In 2000 the average meat, cold cuts and saturated fats intake, compared with low
 


  
*
*&%""'(****
temperature was 13.3C (monthly average from 0.5C in vegetable consumption. The province shows also high incidence
January to 23.8C in August) and the overall rainfall was rates for colorectal, gallbladder, soft tissue and endometrial
443mm. In the period 19982002 the population showed a cancers, brain tumours and multiple myeloma.
progressive decrease due to a fall in births and low migration
The very high incidence of breast and cervix cancer is
rates from other areas.
explained by the population-based screenings started in
199697. Prostate and thyroid cancers also increased in the
Cancer care facilities
period, the former as a result of PSA diffusion, the latter of
In 2000 the province had a network of three care districts diagnostic echography improvement. DCN and nal DCO
with 5 general hospitals (1851 beds). These provided cancer were 1.1% and 1% respectively. The proportion of cancer
surgery units, haematology, radiotherapy and chemotherapy deaths necropsied in 19982002 was low (<1%).
services. Cervix uteri and breast cancer organised screening
programmes started in 1996 and 1997 respectively as a part Use of the data
of a regional project. Colorectal cancer screening started The Registry is involved in local and regional cancer
in 2005. PSA testing is widespread among the adult male care networks and it publishes periodic reports on cancer
population, especially in recent years. In 2003, 14.6% of incidence, prevalence and survival. Determining the impact
patients were treated outside the Registry area.
of screening on incidence, mortality and therapy and cancer
care needs in the covered population are its main purposes.
Registry structure and methods
It is also involved in several studies on multiple tumours, the
The Registry is supported by the Emilia-Romagna regional prognostic and predictive power of biological assessment in
Health Care Service since 1994, and it has also been funded breast cancer, social inequalities and cancer care access.
by the Health Care Units of Ferrara province. Its staff of three
The Registry is part of the Italian Association of Tumor
clerks and a director is located in the Pathology Department Registries (AIRTum). Several studies on cancer descriptive
of Ferrara University.
epidemiology and breast cancer screening in Italy are now

317

Europe

in progress. Further activities on registration and coding


techniques are also being carried out.
Source of population
1998 2002: Census and municipalities residents les. Ofcial
regional resident population based on municipalities les.

318

Source: Statistics Department Regione EmiliaRomagna,


Italy (http://rersas.regione.emiliaromagna.it/statexe/popol1.
htm).
Multiple primary rules used
IACR rules (2004) on historical data.

Europe

Italy, Florence and Prato


concerning each tumour, including personal identication and
Registration area
The territory of the Tuscany Cancer Registry (RTT) corresponds full clinic details, is coded and registered into the computer.
to two of the ten provinces of the Tuscany region, the provinces Specic procedures and key words protect the access to the RTT
of Florence and Prato. It is situated at 44N and 11E. The les; names and other personal data and clinical information
registry covers an area of 3879 km2, with a population of 1 are stored on different les and, when necessary, are linked
162 273 inhabitants according to the 2001 census (density 300 each other by an identication number.
Death certicates with personal identiers are received from
inhabitants/km2). The territory is divided into 52 municipalities
(the municipality of Fucecchio, 21 105 inhabitants at the 2001 the Regional Mortality Registry, which collects and analyses
census, is included since 1997) collected in 3 local health units. for all inhabitants in the region a copy of the National Institute
The only two municipalities with a population larger of Statistics mortality form. Mortality data are periodically
than 100 000 in 2001 were Prato (population 172 499) and checked against the cancer registry records to identify cases
not otherwise notied.
Florence (population 356 118).
Catholicism is the prevalent religion in the area. About 4.1%
The current staff of the registry comprises clinical
of the residents (at 2001) in the
e p id em iolog i st s, nu r s e s
area are foreign, mainly coming
s p e c i a l i si ng i n t u m o u r
from Europe and Asia.
registration, biologist, statisticians
ITALY, FLORENCE AND PRATO (1998-2002)
I n 20 01, 74.1% of t he
and data managers.
ITALY, FLORENCE AND PRATO (1998-2002)
residents aged 1564 years
were employed. Industry in
Interpreting the results
the provinces is concentrated
The completeness in case
mainly in the surroundings of
collection was estimated at 97.4%












the cities of Florence and Prato.


during a formal evaluation carried







Since 2006 the RTT has been


out in 2001. Data are periodically














embedded within the regional


veried according to IARC tools







oncological network, and the


and specific software developed














coverage of all the resident


by the Italian Network of Cancer







population of Tuscany (about 3


Registries (AIRTum).





 








500 000 inhabitants) is ongoing.


Since the late 1990s screening







for female breast, cervix and
















Cancer care facilities


colorectal cancer has been active in







The registry is part of the


all areas covered by the RTT. From














Tuscany Cancer Institute, a


the regional report on screening







network of all health services


activity, the average compliance
active in the Tuscany region
was 67% for mammographic






aimed at cancer research,
breast cancer, 45% for cervix uteri
 !
 !

 

prevention and care.


 ! "!!!

screening and 51% for colorectal
In 2002, in the whole 
  
cancer screening.
Tuscany region there were ##"%$!  !!! !
 !  !!
In the district of Florence a
 


  
14 956 beds in public hospitals
and 2353 beds in private cohort of more than 6800 males aged 6074 years were included
!
 !!!  
!!
hospitals. There were 4.9 beds for every 1,000 inhabitants.
during 19911994 in the European Randomized Study of
Screening for Prostate Cancer (ERSPC). Moreover, widespread
Registry structure and methods
spontaneous PSA testing is worth noting; the regional archive
The Tuscany Cancer Registry is associated with the Unit of Clinical of diagnostic examinations in 2004 estimated that about 25% of
and Descriptive Epidemiology of the Centre for the Study and resident men over 50 had undergone a PSA test.
In the RTT area a pilot study of lung cancer screening with
Prevention of Cancer (CSPO) in Florence. The registry, which is
commissioned and funded by the Tuscany Region Department of low-dose computed tomography has been performed, and a
Health, collects, registers and analyses information related to cases of randomised clinical trial named Italung-CT is ongoing.
cancer in residents of the provinces of Florence and Prato. The Registry
started its activity on 1 January 1985 after a one-year experimental Use of the data
The registry routinely publishes incidence and survival data
phase to evaluate feasibility and to collect prevalent cases.
While instituted by regional law, notication is and participates in clinical and analytical epidemiological
studies. RTT is improving the collection of relevant clinical
compulsory by an administrative order.
The registry receives from the Regional Health Authority data for the evaluation of the diagnostic and clinical pattern. It
copies of the ofcial les of hospital admissions in Italian public is participating in national and international projects on cancer
or private hospitals (provided the latter are funded by the Public incidence, prevalence and survival (e.g. the Eurocare project).
Health system), which have been abstracted from pre-coded
electronic media since 1995. Copies of the autopsies and cyto- Source of population
histology referrals are received from the pathology departments 19982002: Census 2001 and ofcial intercensal estimates
of the whole Tuscany region. Since 1998 pathological data have (ISTAT).
been received on computerised les.
The RTT used ICD-O-1 and ICD-O-2; all case series have Multiple primary rules used
now been automatically recoded into ICD-O-3. The information IACR rules (2004) on historical data.

319

Europe

Italy, Genoa Province


Registration area
The Liguria Region Cancer Registry (LRCR) covers the
population of Genoa Province (1834.3 km2) within the
Liguria Region in northwestern Italy. The population (67
municipalities) at 30 June 2000 was 900 736 inhabitants
(Statistical Ofce of the Region of Liguria). About 70% of
the population lives in the urban area of Genova (632 366
inhabitants). In 2002 the Liguria Region age-adjusted death
rate per 100 000 inhabitants was 1370.1, among the highest
in Italy, due to the ageing of the population, the oldest in
Italy; the birth rate is among the lowest, 7.3.
Cancer care facilities
Healthcare
services
are
provided by hospitals and
centres located predominantly
in the city of Genoa. They
consist of 17 public and 4
private hospitals providing
radiotherapy, cancer surgery
and chemotherapy services,
and microscopic verications
supplied by ve pathology
services. Among the public
hospitals there is also a
comprehensive cancer centre,
the National Cancer Research
Institute (NCRI)

Interpreting the results


The LRCR collects and records data on all malignant
tumours and on in situ carcinomas and other tumours of
benign and uncertain nature of the urinary tract, brain and
central nervous system; multiple primary cancers (multiple
skin cancers excluded) are included as independent primary
tumours. The Registry uses the IARC/IACR CHECK
Program to test the validation of dataset. To conform to the
Italian law regarding the care
of personal data, the Registry
follows an Ethical Code of
ITALY, GENOA PROVINCE (1998-2000)
Behaviour (published in
ITALY, GENOA PROVINCE (1998-2000)
their Web site and sent to all
collaborating institutions and
to the National Authority for
Individual Data Protection),














created to describe the data







 

collection and managing







 








procedures and the physical



 





and electronic measures







 








adopted to protect the Cancer



 





Registry data bank.
















A screening programme







for breast cancer has been






 







operating
since
1998,







organised by the NCRI on
















the behalf of the Region









Health Councillorship and


collaborating with all hospitals,






pathology departments and
 #!
 #!
territorial health services of



$#"%"###

the region.

Registry structure and


methods
The LRCR is property of
the Health Councillorship
of the Liguria Region and
is located at the Descriptive
Epidemiology Service of
NCRI, which is also houses 
  
the Liguria Region Registry of #%%'&#  ##
#
Cause of Death (LRDCR). The  


  
LRCR is
staffed by eight full#  #
!##  ##
time researchers and one clerk: two are coders; two manage
the electronic records provided by the Ligurian Health
Informative System (hospital discharge records, registers of
population) and the pathological records, and perform the
quality control and statistical analyses; four are registrars;
the clerk is mostly engaged in following the cancer cases for
vital status. They are also supported by a full-time researcher
and two clerks from the LRDCR, who select the certicates
of causes of death of each registered case.
The LRCR registry uses active case nding from various
sources of data consisting of cancer hospitals (NCRI), general
hospitals (13), teaching hospitals (St. Martino and University
Clinics) and pathology laboratories. The registry staff visit
these sources, where they scrutinise the records kept in
medical records departments, and registers of individual
departments concerned with diagnosis and treatment of
cancers, to identify and abstract information on cases of
cancer, diagnosed by all methods, among residents of the
registry region. Arrangements have been made with the
hospitals outside the registration area to collect the resident
cancer cases they diagnose and treat; they are consulted once
a year to ask for the clinical records of these cases. As regards

320

as the mortality data, in addition to the LRDCR source, the


registry also uses ofcial mortality data obtained through
the regional organs ofcially connected with the National
Statistics Service (ISTAT).

Use of the data


The LRCR is involved in the planning and evaluation of health
programmes in the Ligurian Region. It also collaborates with
the Italian Association of Cancer Registries on joint research
efforts and publication programmes devoted to describe cancer
incidence, mortality, and prevalence and survival data. With
the same purposes, it actively contributes to many European
projects (e.g. EUROCARE, EUROPREVAL, etc) aimed at
analysing data on incidence, mortality, survival and prevalence
(or their determinants) in Italy and in Europe. In these latter
projects, the LRCR is interested in some specic research
elds: the socio-economic determinants of cancer survival,
cancer in the elderly, and the equity in care resources allocation.
Recently, LRCR work has aimed at producing regional and
national estimates of survival in the European population by
using the demographic, socio-economic and clinical (Health
System organisation) characteristics of each area.
Source of population
19932000: ISTAT for the Province
Multiple primary rules used
IACR rules (2004) on historical data

Europe

Italy, Macerata Province


laboratories, radiotherapy centres, the Italian cancer registry
Registration area
The Macerata province registry covers the population of and the death certicates from Mortality Registry of
the whole province (57 municipalities) ranging from a Macerata Province. This mortality registry receives copies
mountainous zone in the west to the Adriatic Sea on the east of death certicates for all inhabitants from LHUs and a list
of all deaths from the municipalities. The registry staff visit
within the Marches Region, in central Italy.
The population at the recent cancer registry census (2000) these sources and record diagnosis and treatments for every
was 304 443. Around 32% of the municipalities are located resident patient in the province. Cancer is not a notiable
in the mountainous areas and have a low population density disease; registration forms are not received from private
with a high proportion of people engaged in services. The practitioners. The information concerning each tumour,
5% of municipalities situated in the coastal areas bordering including personal identication and full clinical details, is
the Adriatic Sea have a high number of people engaged coded and entered using the CanReg 4 computer program.
The accuracy of age, residential status and other
in the industrial sector, and few in agriculture. Some 63%
are located in the hill zone and can be characterised as demographic data are veried before records are included. The
registry collects data not only
intermediate between the
on cancer incidence but also on
other two zones.
diagnostic procedures, cancer
Practically 100% of the
ITALY, MACERATA PROVINCE (1998-2000)
characteristics
(including
population covered by the
ITALY, MACERATA PROVINCE (1998-2000)
stage and grade), treatment
registry is white, with a small
and survival. Follow-up is
percentage of immigrants
performed to obtain complete
from China, India, Pakistan
registration information and
and Africa. The predominant
"*+#(***
,')
'*,#"***
"*-(%***
,
%*,-+***
documentation on all cases.
religion is Catholic, but
(*%"***
+'
,*'(%***
there are now also Muslim
+*,++***
+
-*(##***
,*''+***
('
-*+'***
Interpreting the results
minorities.
-*'%#***
(
!*#!"***
Screening for breast and
,*#"-***
''
,*,("***
-*%!"***
'
-*'(+***
cervical cancer has been
Cancer care facilities
!*!""***
%'
-*,!(***
implemented in the province
General health care in
!*'-***
%
!*"'+***
!!*(+!***
#'
!!*+!***
by the Sanitary Service,
the province is provided
!!*-#(***
#
!!*!(***
but the magnitude of these
predominantly by the three
!*-%***
"'
!*'+(***
-*"+***
"
,*,'"***
practices is as yet unknown.
Local
Health
Districts
+*%'-***
!'
+*#%"***
PSA is used frequently, but it
(LHUs), through the district
(*-"%***
!
(*+"(***
(*+"+***
'
(*#,!***
is not possible to determine
hospitals, a network of
(*"-+***

'*-##***
the proportion of the male
primary health centres and
adult population screened.
two pathology laboratories.
!
'


'
!

*$ &


*$ &
This is supplemented by
!''*%,%***
!%+*#!(***

Use of the data
private practitioners and
Information on incidence,
regional oncology hospitals. 
  
prevalence, survival and
Each province in the region !--!**"*

*
*
 *

*
*
*  **#!*


* *

*
 * *
* 
*
 


  
* 
*$"%&** **
provides one radiotherapy centre.
Many patients suspected mortality are produced and used in the LHUs and in the
to have cancer in the primary and secondary care facilities Regional Health Agency for service planning and needs
in the registry area are referred to Ancona regional hospital assessment. The data are also sent to the Italian Cancer
(4090km distant), to Perugia regional hospital (80130km, Registries databank. The registry collaborates with some
Umbria Region) or, occasionally to one of the cancer hospitals other registries in research projects and publications. Registry
data are used to monitor cancer incidence and mortality
in northern Italy (e.g. Milano, Aviano).
in the province, as well as for health service planning and
epidemiological research.
Registry structure and methods
The registry (cancer and mortality) is located within the
Department of Experimental Medicine and Public Health of Source of population
Camerino University, and is funded partly by the Regional 1991 and 2000 censuses. Cancer registry personnel census
Health Agency. The registry is staffed by two epidemiologists the population as of 31 December of every year through the
and a registrar full-time; a doctor, a medical oncologist and Municipalities.
a pathologist as consultants. The Macerata Cancer registry
uses active case nding from different sources of data Multiple primary rules used
consisting of public and private general hospitals, pathology IACR rules (2004) on historical data.

321

Europe

Italy, Milan
Registration area
The Milano Cancer Registry refers to the resident population
of Milano, the largest metropolitan town in northern Italy (Lat.
45 27 N; Long. 9 10 E), covering a total area of 182 km2. The
population at the last 2001 census was 1 263 158 inhabitants
with a population density of 6940/Km2. At the last census 87
590 subjects (6.7%; 42 146 males and 45 444 females) were
immigrants originating from Asia (30 116), Africa (19 481),
South America (17 873) and Europe (19 950).

Overall the automated procedure identied 165 614


prevalent cancer cases, 66 485 in situ/benign neoplasm;
accepted 24 841 invasive cancer cases and temporarily
rejected 24 695 cases. After manually resolving rejected cases,
39 404 incident cases were identied. Manually resolved
cases, as well as all automatically detected genitourinary,
haematological and soft tissue neoplasms, were coded with
ICD-10 for topography and with ICD-O-3 for morphology.
For selected cancers (including breast cancer) stage was
systematically recorded.

Cancer care facilities


A single Local Health Authority serves the population Interpreting the results
area. In the registration area there are 29 hospitals, which Population-based breast cancer screening was initiated in
Milano in November 1999.
allow full access to case
Furthermore, opportunistic
information. Among them,
PSA screening for prostate
two
research
hospitals
ITALY, MILAN (1999-2002)
cancer
was
extensively
(National Cancer Institute of
ITALY, MILAN (1999-2002)
adopted in the same period:
Milan and European Institute
26.9% of male population aged
for Oncology) admit only
40 or older with no history of
oncological cases. A very
prostate cancer have received
small proportion of cancer








 





at least one PSA test in 2 years;


cases are treated outside the







the same rate rises to 34% for


Lombardy region.














subjects older than 50 (J Med









Screen. 2002;9(4):179-80).
Registry structure and














methods






Use of the data


The cancer registry is located














The Milano Cancer Registry


in the Epidemiology Unit of







will be used to evaluate breast


the Local Health Authority












 

and colorectal cancer screening


of Milano; it was established







programmes. Furthermore,
in May 2002 in adherence to








 



 

policymakers use registry data


the Regional Health Plan and







to evaluate healthcare and


funded by the Lombardy Region
cancer treatment policies and
Department of Health. The






to plan prevention activities.
registry employs three medical
 -($*
  -($*
Considering
the
high
epidemiologists and four nurses
 
 

,%&-'#,--
proportion of immigrants,
as cancer registrars.

  
 -! -- -&##%- "----!"- -- -  -  -!- -- -- registry data will be also
The registry is based on - 

  ---( -  -- - - ---.-*the automated cancer registration


procedure (ACR) rst used to study differential cancer risks within the resident
 


  

- -(&##)*--
+-- adopted in Italy by the Venetian Tumour Registry and by the population and to plan differential preventive actions.
The registry supports etiological research. Cases are
North East Cancer Surveillance Network. Accordingly, the
resident population roster, death certicates, hospital/day- followed annually to determine survival, taking advantage of
hospital discharges and pathology records archives are fed a consolidated record linkage between the registry database
and the Municipal Census Ofce.
into the information system of the cancer registry.
The underlying cause of death and hospital admission
diagnoses are coded in ICD-9. Pathology records are coded Source of population
in SNOMED, and ad hoc transcoding algorithms from Annual estimates based on the 2001 census, taking into
SNOMED to ICD-9 were developed and implemented. A account births, deaths and migration, were produced by the
total of 524 722 hospital/day-hospital discharges (1990 Ufcio Sistemi Statistici del Comune di Milano (Municipal
2003), 289 980 pathology records (19762003) and 18 295 Ofce of the National Institute of Statistics ISTAT).
death certicates (19992002), corresponding to 281 635
subjects, were considered in estimating the population Multiple primary rules used
IACR rules (2004) on CI5 IX period.
incidence of cancer in the period 19992002.

322

Europe

Italy, Modena Province


Registration area
The Modena Cancer Registry (MCR) covers the population of
the province of Modena, which is one of the nine provinces of the
Emilia-Romagna region in northern Italy. Modena borders the
provinces of Bologna to the east, Lucca and Pistoia to the south,
Reggio Emilia to the west and Mantua and Ferrara to the north.
The population according to the 2001 census was about 634
000 (growing by about 1% every year). Approximately 7% of
all residents had emigrated from other countries (34% from
northern Africa, 19% from Asia, 18% from Eastern Europe,
14% from the European Union and 11% from West Africa).
The province is divided into 47 municipalities. The
only municipality with a population greater than 100 000
is Modena (about 175 000
inhabitants in 2001).
Cancer care facilities
With respect to health services,
the province of Modena shows
the features typical of most
western countries. The area
is served by 9 public general
hospitals,
including
one
university teaching hospital,
and by 5 private clinics.
The university hospital
also includes a Comprehensive
Cancer
Centre
(Centro
Oncologico Modenese).

The registry mostly carries out follow-up by matching


registrations with notications of death and with public
health databases. Only non-matched patients (less than 1%)
are actively followed-up by obtaining information directly
from the registry ofces.
All data are evaluated for completeness using IARC
software and a tool developed by Modena Cancer Registry
and distributed among Italian Cancer Registries that consists
of more than one thousand internal checks.

Interpreting the results


Since 1994, two organised screening programmes have been
offered to all women aged 2464 and 5069 respectively
for early detection of cervical
and breast cancer. The impact
of cervical screening seems to
ITALY, MODENA PROVINCE (1998-2002)
be less marked because it was
ITALY, MODENA PROVINCE (1998-2002)
carried out many years earlier,
but not on population basis.
It should be underlined
that the increasing use of














PSA testing has resulted









in an increase in prostate














cancer incidence rates, while









the advances in diagnostic










 





medical practices and new









histological criteria seems to







 








be related to an increasing







incidence of thyroid cancer in










 




the province of Modena.







 

Registry structure and







 








Use of the data


methods







The MCR produces annual


The MCR, established in
reports on cancer incidence,
1988, is located in the Cancer






mortality
and
survival,
Centre of the University of
 !
 !
including
trends
and
Modena and Reggio Emilia.



"!#""!!!

predictions of cancer incidence
It is recognised and supported

  
and survival for the coming
by the Emilia-Romagna    !!!!  !
 !##"$!!!!
 


  
region, the Azienda USL of Modena
and the
Angela Serra years. The MCR is involved in many collaborative studies,
!  !!!
!! !
such as EUROCARE studies. The registry also participates
Association for Research on Cancer.
Registry staff comprises a medical director and in the evaluation of breast, cervix and the recently organised
coordinator, a research manager, a statistician, a system colorectal screening programmes. Other areas of interest are:
the investigation of local clustering of disease, estimations of
manager, two registrars and a secretary.
The principal data sources are the reports from the three future cancer incidence and survival, high-resolution studies
pathology laboratories located in Modena (including one on lymphoma and myeloma, and quality control techniques.
haematological laboratory), hospital discharge les and death
certicates. These les are periodically sent to the registry Source of population
and processed by specic software. All cases are identied Census 2001 and population estimates for 19982000 and
and pre-coded by the computer system, and then the trained 2002 (ISTAT).
registry staff manually reviews them. Several validation
checks are performed by the computer system at the time of Multiple primary rules used
IACR rules (2004) on CI5 IX period.
data entry, and periodically over the whole archive.

323

Europe

Italy, Naples
Registration area
Registry structure and methods
The Population Cancer Registry of Campania Region c/o The Registry is a structure of Campania Region and A.S.L.
Local Health Unit Napoli 4 (R.T.P.-A.S.L. NA4) covers an NA4; The Registry personnel is composed of a physician,
area of 499 km2 in the northeast part of the province of specialising in oncology and epidemiology, one informatics
Naples, in the Campania region of southern Italy (latitude technician and four social workers. Data collection method
40 47 N; longitude 14 23). According to the national is active, and the sources of information are:
census of 31 October 2001, the population covered by the Case sheets, clinical records and pathology laboratories data,
Registry is 537 860 inhabitants (264 472 males and 273 388 supplied by: a) National Cancer Institute of Naples, b) the two
females) distributed in 35 towns. In the last ten years the area University General Hospitals, c) the Campania Region hospitals;
covered by the Registry has been characterised by signicant d) the biggest private hospitals in the region;
migration from Naples, which is the largest and most important Regional Centre of Hospital Discharging Forms (SDO),
city in the region. In fact, between the national census years which also provides data referring to patients who are admitted
of 1991 and 2001 the population of the area covered by the in other Italian regions;
A.S.L . NA4 regist r ies
Registry increased by 45 000
referring to patients who are
inhabitants. In the area, which
exempted from bearing health
is economically depressed
ITALY, NAPLES (1998-2002)
participation expenses because
and characterised by high
ITALY, NAPLES (1998-2002)
of oncological diseases;
unemployment, there are a
A.S.L. NA4 records referring
vast rural zone, an industrial
to admissions abroad;
pole with large and middle General practitioners of the
sized factories, and also small




 








area covered by the Registry


sized disorderly distributed







(about 480) consulted for DCN


factories.









 

cases; and







Mortality data coded by the


Cancer care facilities














ASL NA4 epidemiology ofce.


In the area covered by the

 





Registry there are two public
















Registry personnel have


general hospitals with two







access to both the ofcial


chemotherapy services, one














mortality statistics and to


pathology laboratory and one







individual death certicates


private radiotherapy service














mentioning cancer. Incidence


having an agreement with







cases are coded by Registry


the Public Health Service.
personnel. Malignant tumours
The majority of resident






included in incidence gures
patients who are affected by
 !
 !
 


 ! !!!

are dened as those for which
oncological diseases (about
the ICD-O-3 behaviour code is
80%) seek care in Naples, 
  
3, and according to the IARCabout 10km away, at the    !  !!
 !##"$!!!   !
 !!!   !  !
 !!!
 


  
National Cancer Institute, at the
two University Faculties of IACR rules. Mortality data are coded and provided by the
!  !!
Medicine and at the oncology departments of other hospitals A.S.L. NA4 epidemiology service; they are dened as those
in the city. Though it is decreasing, there is still migration coded in sections 140208 of ICD-9. The software used for
from the area to health services located in Northern Italy for the registration of incidence data is CANREG-4, which is
the treatment of oncological diseases. In the same area, and provided by IARC.
The Registry prepares periodical reports of cancer
over the whole Campania Region, there are also many private
hospitals having an agreement with Public Health Service, in incidence, mortality and survival; moreover, it collaborates
which patients affected by cancer are admitted. All patients with public health services in the planning and evaluation of
affected by oncological diseases are exempted from bearing cancer services.
health participation expenses, and all patients who are
admitted to hospitals abroad are previously authorised and Source of population
Intercensal estimate for 19972000 (ISTAT), national
registered by the A.S.L. NA4 ofces.
Since April 1996, screening for uterine cervix carcinoma census for 2001 and postcensal estimates for 2002 (ISTAT).
has been active over the entire Registry area, while breast
cancer screening has been active since November 1998 over Multiple primary rules used
IACR rules (2000).
a limited part of the area covered by the Registry.

324

Europe

Italy, North East Cancer Surveillance Network


registration (ACR) methodology, which implies availability of
Registration area
The area covered by the North East Cancer Surveillance Network computerised and coded (ICD and SNOMED) diagnoses of
(NEICSAN) is located in northeast Italy, and is made up of three cancer from the pathology departments, hospital archives and
parts: the provinces of Bolzano (4603N, 1314E; 7400 km2; population ofces (for population les and death certicates).
485 042 inhabitants; 65.5 inhabitants/km2) and Trento (4604N, The process is carried out through record linkage procedures
1108E; 6202 km2; 499 321 inhabitants; 80.5 inhabitants/km2), and that include analyses of computerised records, ascertainment
the whole of the Friuli Venezia Giulia region (4603N, 1314E; of prevalent cases, case consolidation and quality control.
Traditional cancer registration techniques based on collection
6845 km2; 1 184 000 inhabitants; 173.0 inhabitants/km2).
The provinces of Trento and Bolzano are mostly mountainous of cancer forms prepared by pathologists, medical personnel
areas, while the Friuli Venezia Giulia is a largely industrialised in the hospitals and general practitioners are still used in the
region bordered by the Adriatic Sea and the Padanian Valley Province of Bolzano, where the ACR process has been carried
(South), Slovenia (East) and Austria (East, North-East). out in parallel to the existing system.
Approximately 50% of the population of Trento and Bolzano
For the period 19982002, a total of 9 461 762 records
were treated by the automated
and 80% of population of Friuli
Venezia Giulia lives in urban
process. Approximately 20% of
areas (largest cities are Trento
these records concerned cancer
ITALY, NORTH EAST CANCER
with 112 142 inhabitants, Bolzano
cases, and the automated process
ITALY, NORTH EAST CANCER SURVEILLANCE NETWORK (1998-2002)
SURVEILLANCE
NETWORK (1998-2002)
with 98 657 and Trieste with
registered nearly two thirds of
incident cases. Quality controls
242 235). In addition to industry
are based on the IARC Check
in the Friuli Venezia Giulia
software: quality indicators
region, agriculture and tourism
#',#)-,,,
.)+
'!,$$/,,,
#',.)#,,,
.!
%!,#*$,,,
such as the percentage of
represent the main economical
%%,!-.,,,
-)
)*,$-#,,,
microscopically veried cases
activities of the whole area,
'%,-#',,,
-!
*!,$/-,,,
)!,-'*,,,
*)
*!,'-',,,
(histology and cytology), the
with low unemployment rates
*#,$*',,,
*!
*),.#.,,,
by Italian standards (between
percentage of cases known from
*.,'%!,,,
))
-!,$$',,,
-#,/.#,,,
)!
-#,//),,,
2.7% and 6%). In the Bolzano
the death certicate only (DCO)
-!,!%-,,,
')
*/,$/.,,,
province, 68% of the population
and the mortality/incidence ratio
-',*-*,,,
'!
-#,/'/,,,
.*,**%,,,
%)
.$,))),,,
is German-speaking.
are also veried.
/!,#*#,,,

%!

.*,!#*,,,

*!,$..,,,
Cancer care facilities
Interpreting the results
)!,-!),,,
#)
'-,.).,,,
The territory is divided into 11
Several analytical studies
'*,*.!,,,
#!
'',*!#,,,
'-,./',,,
)
'),-/-,,,
local health units of variable
conducted in the Friuli Venezia
'/,#-/,,,
!
'*,*'!,,,
size, being smaller in the
Giulia region have shown cancer
mountainous area. Hospital
excesses associated with personal
#!
)
!
!
)
#!
services are provided by 35
habits and occupational exposures
 ,&"(
  ,&"(
public hospitals (including one
(namely exposure to asbestos
#,!..,.*!,,,
#,!#/,*.%,,,

National Cancer Institute in
in the shipbuilding industry).

  
Aviano, Friuli Venezia Giulia) ,  , ,,, ,#//#,,$!!#,  ,,,, , ,, ,
 ,, , , ,
Incidence rates for the period
,&, , ,,0,(,
and 16 private clinics. Cancer patients
are generally treated 19982002 well reect these previous ndings. Changes in smoking
 


  
 ,  ,&$!!'(,, ,,
at the National Cancer Institute, and in the oncology and habits in recent decades are a likely explanation for diverging trends
radiotherapy departments uniformly distributed throughout in lung cancer rates seen in the two sexes, with a decline observed
the territory. A small proportion of cancer patients are also in men (from 56.3 in 19951997 to 49.1 in the most recent period)
treated outside the region, including Innsbruck (Austria) for and a slight increase in women (from 11.3 to 12.0). PSA testing has
some patients from the province of Bolzano.
been widely used in men for voluntary testing. Accordingly, prostate
cancer turned out to be by far the most frequently diagnosed cancer
Registry structure and methods
in men (69.3/100.000; it was 51.6 in 19951997).
The NEICSAN is a collaborative network of cancer
registration in three administrative units: Azienda Sanitaria Use of the data
di Bolzano, Registro tumori dellAlto Adige-Tumorregister The main task of the NEICSAN is to help plan careful
Sud Tirol (1 director, 1 pathologist, 1 statistician/IT manager, surveillance and preventive programmes. In addition,
1 data collection ofcer and 5 collaborators); Agenzia the registry data are used to implement population-based
Regionale della Sanit, Udine, Friuli Venezia Giulia (1 intervention studies (e.g. Pap smear and cervical cancer)
director, 1 pathologist, 1 data manager, 2 statisticians, 2 data and investigations on the causes of cancer (e.g. alcohol
collection ofcers and 5 collaborators); Azienda Provinciale consumption and risk of liver cancer).
per i Servizi Sanitari, Osservatorio Epidemiologico, Trento
(1 director, 1 pathologist, 2 statistician/it manager, 1 data Source of population
collection ofcer). In the Friuli Venezia Giulia region, cancer Annual estimates based on the 1991 and 2001 censuses, taking
registration began in 1984 in the province of Trieste, and it into account births, deaths and migration, produced by the Ufcio
has been expanded to the whole region since 1995.
Sistemi Statistici (National Institute of Statistics, ISTAT).
The objective was to produce comparable cancer incidence
estimates in a large population (about 2 150 000 inhabitants). Multiple primary rules used
Incidence data have been collected using the automated cancer IACR rules (2004) on historical data.
.$,##.,,,

$)

*%,%)!,,,

$!

-.,%.-,,,

325

Europe

Italy, Parma Province


director, or consulting the patients family doctor by written
Registration area
On 1 January 1998 the population of the registry area was request. Patient vital status is easily updatable, since PCR
393 963; ve years later it was 404 722. This increasing trend has access to the computerised registry database of the Local
is mainly related to foreign immigration; overall foreigners, Health Service.
Data are regularly submitted to IARC Check program.
most from North Africa, currently represent 5% of Parma
residents. About 80% of the population lives in urban Complementary evaluations have been made to compare
areas, 43% in the principal town. Local migration from the our data (incidence trends and crude rates, percentage of
mountainous municipalities towards the city has been steady MV/Dco, relative and observed survival rates) with those of
since the 1970s. In 2001 the employment rate was 74% for men neighbouring registries, and to examine the main features
and 55% for women, while unemployment was respectively of special sub-areas of Parma Province (urban/rural area,
2% and 4%. The main occupational group is tertiary (59.4% altimetric zone, health service districts, etc.).
of the total employed population), followed by industry
(37.4) and agriculture (3.2%). The industrial sector employs Interpreting the results
Two screening services began
workers primarily in the agroto operate in the area of
alimentary branch (45%),
registration: the population
followed by manufacturing
ITALY, PARMA PROVINCE (1998-2002)
aged 5069 has been screened
(15%) and building (15%).
ITALY, PARMA PROVINCE (1998-2002)
for breast cancer since 1997
and the population aged 24
Cancer care facilities
67 for cervical cancer since
The area is served by one main
1998. Some recent, increasing
general university hospital, two
!(&%+(((
*%'
+(! #(((
#(! (((
*
)(%%#(((
trends of incidencebreast
small public hospitals and three
)(+* (((
)%
 (!%!(((
and prostate cancerreect
private ones; the hospital of Parma
+(+#(((
)
 (**&(((
(**(((
&%
 ())&(((
the diffusion of early diagnosis
houses a division of Medical
 (&+&(((
&
!(&! (((
due to voluntary screening
Oncology, including a section for
 (# &(((
%%
 ()+(((
!( ))(((
%
!(# *(((
and asymptomatic forms
cytopathological diagnosis, and a
 ()+(((
#%
 (& *(((
through PSA testing. Trends in
radiotherapy Service.
#(##!(((
#
!(&!(((
&(+)+(((
!%
%(%&!(((
melanoma can be interpreted
)( +(((
!
&(&+(((
as being related to previous
Registry structure and
#(*+(((
%
#(!!!(((
(%*+(((

(*(((
underestimation. M/I ratio
methods
*(!(((
%
)(%!#(((
offers an encouraging sign
The PCR is located at the
)(%+)(((

)(  (((
)(&)(((
%
)( &(((
of the level of completeness
Medical Oncology Division
)(+))(((

)(#%(((
obtained for each site. PCR
of
the
local
hospital;
continues to integrate and
the staff is made up of a

%


%

correct
data
previously
medical doctor as Director, a
 ("$
 ("$
collected.
statistician as data manager,
&( !)(((
+!(*+(((

and a full-time biologist

 ("(, $(


Use of the data
for collecting and decoding 
  
 


  
data. Information regarding new
cases
is obtained through Study data are aimed on one hand to promote the comparison
(  ("
#$((  ((
examination of discharge forms from public and private of data and collaborative studies with other Cancer Registries,
hospitals (representing the rst level of information for each and on the other to support Health Services programming by
case, independent from the hospital where each patient was estimating and quantifying the cancer burden.
treated), oncological outpatient clinics, day hospitals, death
certicates, and from the two archives of pathology services. Source of population
The staff has direct access to the public pathology archive; the Estimates (ISTAT http://www.istat.it).
private hospitals annually provide the registry with electronic
data. For extra-provincial hospital discharges, diagnoses Multiple primary rules used
are detected through an ofcial inquiry to the departments IACR rules (2004) on historical data.

326

Europe

Italy, Ragusa Province


Registration area
The Ragusa Cancer Registry (RCR) covers the population
of the province of Ragusa in southeast Sicily (Italy). At the
2001 census the population was 295 264 (5650 of whom
were migrants, mainly from North Africa) living in small
to medium-sized municipalities: the largest is Ragusa city,
with 68 000 inhabitants; 9 cities consist of 8000 to 50 000
inhabitants, and in two villages the population accounts for
3000 people. Almost all people are white and Catholic; about
20% of the working population is involved in agricultural
occupations (mainly farming and cattle).

with the Sicilian computerised hospital discharge recording


system; the latter is an independent source of data that
includes all hospital discharges of all of the patients resident
in Ragusa province who were admitted in any Italian
hospital.

Interpreting the results


Cancer occurrence in Ragusa province has been slightly
increasing in the last ten years, but this area is still at a lower
cancer risk in comparison to other registries from western
countries. This is mainly attributable to Mediterranean dietary
habits and to a lesser extent to the un-polluted environment.
Despite this low risk, the 5-year relative survival ranks among
Cancer care facilities
the lowest in comparison
The local health system is
to North European cancer
arranged in one Main Hospital
registries; this low survival
(Azienda Ospedaliera Civile
ITALY, RAGUSA PROVINCE (1998-2002)
seems to be related to an
M.P.Arezzo, Ragusa), one
ITALY, RAGUSA PROVINCE (1998-2002)
advanced stage of the tumour
Local Health Authority (AUSL
at diagnosis.
7) that includes one private and
The main change in
4 small public hospitals, and
the period 19982002 that
350 general practitioners. There














may have affected cancer


are two histopathological units,







registration was the settlement


one oncological department and





 








of the radiotherapy unit and


one radiotherapy unit; all of the

 





public CT facilities: this has


public radiological departments

 



 








made it possible to retrieve


have CT facilities, and the main







core cancer data like anatomic


public hospital provides MRI














site, histological reports and


exams. All of the 7 surgical







stage at a more detailed level.


units of the local hospitals














PSA testing has become


provide cancer surgery. A

 





more common since 2000, and


district-based breast cancer











prostate needle-biopsies have


screening programme was







been increasing from year


established in 1995, covering
2001 according to the data of
half of the provinces female






the local surgical pathological
population aged 5069 years.
 # "
 # "
laboratories; these practices

 

!!#$###

may have slightly affected
Registry structure and

  
    #  ###  #
#   # "#
 #%%&#   #
 ##    #  ###  #
#   #
the local prostate cancer
methods

 ##
RCR is part of the Oncological
department of the main occurrence in the period 19982002.
 


  
#  # !"##  ##
hospital (Azienda Ospedaliera Civile M.P.Arezzo,
Ragusa). It is funded by the hospital itself and the Sicilian Use of the data
Government. The staff consists of a half-time medical doctor Data are sent to the Italian Association of Cancer Registry,
pathologist (director), two full-time social workers, and 12 which publishes periodical national reports including specic
part-time collaborators. Cancer registration is essentially an tables of RCR. RCR is a collaborating centre for the European
active process by means of eld workers who abstract the Prospective Investigation into Cancer and Nutrition (the
required information from hospital admission/discharge les EPIC study), and a partner and member of the EUROCARE
and clinical notes; case nding is also performed at pathology and EUROCHIP studies and the EU-funded research EPIClaboratories, radiotherapy units, oncological outpatient ELDERLY, the EU integrated project INTERACT and EUclinics and the local private TC centre (CITC srl Ragusa); coordinated action HECTOR. RCR data have been used for
a notable source of cases are the administrative ofces evaluation of the local breast cancer screening programme
that deal with cancer patients needs (i.e. exemption from (the Italian IMPACT study).
cancer care and diagnostic charges). The local vital statistics
and death registration ofces provide RCR with all death Source of population
certicates where cancer is mentioned. Municipal registers Intercensus estimate by Italian Institute of statistics (ISTAT)
are involved for validation of the identity and residential data for 19922000, census for 2001, intercensus estimate by
Italian Institute of Statistics for 2002.
of each registered case, and checking vital status.
Ragusa Cancer Registry is carrying on a linkage study
in order to evaluate the completeness of registration by Multiple primary rules used
comparing the records already detected from clinical notes IACR rules (2004) on historical data.

327

Europe

Italy, Reggio Emilia Province


The staff is composed of an oncologist as director,
Registration area
The Reggio Emilia Cancer Registry (RECR) covers the three biologists as data collectors, one statistician and one
population of Reggio Emilia Province in the centre of the healthcare planning administrator.
The purpose of the registry, since its founding in
Emilia-Romagna Region, in north Italy. Reggio Emilia is
characterised by an interesting and varied landscape that 2001, has been to collect cancer incidence and survival
ranges from the vast plain in the North, where the main for the target population, to promote ad hoc studies and
Italian river (Po) ows, to the Apennine Mountains in the to collaborate with studies organised by other institutions.
These activities contribute both to producing scientic
South, which reach a height of 2150 meters.
The territory is divided into 45 municipalities, the reports and publication and to improving cancer prevention
principal one being Reggio Emilia, which accounts for more and control in the province of Reggio Emilia.
than 142 000 inhabitants.
The main sources of information are: the files of the two
The total population at the end of 2003 was 477 534; pathology services, hospital discharge records and death certicates.
foreign residents represented 6.4%. The most common Site-specific cancer registry information (i.e. mesothelioma,
foreign groups came from
melanoma, breast and cervix) is
North Africa, Eastern Europe
also used to improve the accuracy
and Central-South Asia.
of RECR data.
EMILIA PROVINCE (1998-2002)
Reggio Emilia is a ITALY, REGGIO
At the end of each incidence
ITALY, REGGIO EMILIA PROVINCE (1998-2002)
highly industrialised area:
year, data are checked using
the principal industries are
IARCcrgTools. Other checks
mechanical and ceramics
are also performed to evaluate
production,
although
data completeness and validity












 

agriculture is also present.


(mortality incidence ratio, the





 

Until the late 1980s, some


proportions of DCO, cases with





 








of the most important Italian


morphological conrmation,







asbestos cement factories were


and unknown cases). When data














in this province, although the


have been processed, incidence







number of workers employed


trends are analysed.














there was limited.









Interpreting the results
















Cancer care facilities


Population-based breast and







Public healthcare is provided


cervical cancer screening














by
the
territorial-based
programmes might inuence the







Azienda USL and the


incidence rates. It should also be
Arcispedale Santa Maria
underlined that increasing use of






 #!
  #!
Nuova (ASMN) hospital. The
PSA testing most likely caused



#$###

Azienda USL is divided into
an articial rise in the incidence
6 healthcare districts, each 
  
of prostate cancer.
with its own hospital. The ###

#  #  #%%$&#### # ##'#!#
 


  
 #  #
!## "##
# oncology and
ASMN includes several healthcare
facilities:
Use of the data
radiotherapy departments (both since the 1970s), digestive The registry publishes data periodically on incidence,
endoscopy, dermatology and pathology departments. In each mortality and survival. The RECR is involved in several inhealthcare district there is a medical oncology unit.
house and collaborative studies. These cover many elds:
At present, there are three working screening programmes from epidemiological studies to clinical research, public
in the province of Reggio Emilia: for breast and cervix health surveillance and social inequality studies.
cancers (since 1994) and for colorectal cancer (since 2005).
Source of population
Registry structure and methods
Census 2001 and population estimates for 19982000 and
The RECR is recognised and nanced by the Emilia- 2002 (National Institute of Statistics, ISTAT).
Romagna Region.
The registry is physically located at the Unit of Multiple primary rules used
Epidemiology of the Department of Public Health.
IACR rules (2004) on CI5 IX period.

328

Europe

Italy, Romagna Region


Registry structure and methods
Registration area
The area covered by the Romagna Cancer Registry is part of The Romagna Cancer Registry was funded by the Istituto
the Emilia-Romagna region situated in the northeast of Italy. Oncologico Romagnolo until 1995, and has been supported
The Romagna region extends from the Adriatic Sea in the by the Government of the Emilia-Romagna Region since
east to the borders of the provinces of Bologna in the west, 1995. The major information sources for the Romagna
Ferrara in the north, Florence and Pesaro in the south. The Cancer Registry are the archives of histology and cytology
population is fairly stable. Among residents, the prevalence of reports, hospital discharge forms, outpatient records of
non-Caucasians as well as of foreigners is low. The Romagna the medical oncology departments, the archives of private
region amounts to 4769 km. The south of the region (48% clinics, and death certicates obtained from the departments
of the total surface) is hilly and sparsely populated. The area of public health of local health care districts. The registry is
is subdivided into three provinces (Ravenna, Forl-Cesena staffed by an epidemiologist, two statisticians, and 12 data
and Rimini) with a total of 68 municipalities. The population managers.
density is 158/km in the Province of Forl-Cesena, 199/
Interpreting the results
km in the Province of
Between 1996 and 1997,
Ravenna and 544/km in
population-based screening
the Province of Rimini. The
ITALY, ROMAGNA REGION (1998-2002)
programmes for breast cancer
area is socioeconomically
ITALY, ROMAGNA REGION (1998-2002)
and cervical cancer were
homogeneous. The proportion
progressively implemented in
of adults employed is 59.9
each of the four health care
60.5% for men and 40.542.9%
districts of Romagna. In 2005,
for women. The industrial and
$" """
$!
%" """
%" %"""
$
"% """
a screening programme for
agricultural sectors employ
%"$"""
#
 "%"""
colorectal cancer was also
29.6% and 7.5% of the active
"$"""
#
%""""
#" $ """

"#"""
launched.
population, respectively.
"$#"""



"##"""

"%"""

" """
Use of the data
Cancer care facilities
"%$"""

"%"""
Incidence data from the
The Romagna region has
"$%"""

"%#"""
"%%"""

$"%"""
Romagna Cancer Registry are
13 public (National Health
"%"""

%"%"""
published through the IARC,
Service) hospitals and 15
#""""

 """"
#"$"""

 """"
the Health Department of
certied private hospitals.
"%%"""

%"%%"""
the Emilia-Romagna Region,
The total number of hospital
%"$"""

$"#"""
%""""

$"##"""
and the Italian Association of
beds is 5163 (or 5.2 per 1000
""""

$"$#"""
Cancer Registry (AIRTum).
residents) with 221 821 annual
The registry participates
discharges. The number of






in many research projects
general practitioners is 836
 "
 "
 "$"""
#$" """

coordinated by the AIRTum.
(0.84 per 1000 adult residents).
The active contribution of the
Cancer care facilities in the
registry to local cancer control
area include medical oncology 
   


 "
 """""
"
departments and centres for early detection of cancer at the strategies includes situation analyses (studies of the patterns
hospitals of Ravenna, Forl, Faenza, Lugo, Cesena, Rimini of stage, diagnosis and treatment of major malignancies) as
and Riccione. The hospital-based oncology departments in well as cervical and breast cancer screening monitoring.
the three provinces of Romagna (Forl-Cesena, Ravenna The registry database has been used for several cohort and
and Rimini), offering a total of 168 beds (87 inpatient and casecontrol studies. Most of these have addressed the
81 outpatient), have long been working towards a greater relationship between diet and digestive tumours, diet and
understanding of all aspects of the cancer problem, with the breast cancer, pesticides and haematopoietic malignancies.
nal aim of improving the quality of health care and patient Others have evaluated the risk of breast cancer for women
management. The Cancer Institute of Romagna (Istituto bearing breast cysts and the risk of colorectal cancer for
Scientico Romagnolo per lo Studio e la Cura dei Tumori subjects undergoing polypectomy. The registry participates
[IRST]) has recently been established to further enhance in the planning, conduct and analysis of numerous studies
the already high-quality health care for cancer patients of aimed at validation of diagnostic techniques and evaluation
the region and to become a cancer centre of excellence for of health services.
central Italy. Part of the institutes mission is to take in hand
the fundamental research programmes and activities that the Multiple primary rules used
IACR rules (2004) on CI5 IX period.
public health sector cannot cope with.
%"%%"""



"  """

329

Europe

Italy, Salerno Province


Registration area
The Salerno Cancer Registry (SCR) covers the population of
the whole Province of Salerno. It is the largest province in
the Campania Region, consisting of 158 municipalities. The
province of Salerno extends from the Tyrrhenian Sea in the
west, to the borders of the provinces of Napoli and Avellino
in the north and Potenza in the southeast. The vast area of
Salerno has a varied territory, divided into inland hills (that
cover 45% of its total area), mountains (29%) and coastal
hills (15%), while only 11% is covered by plains.
Salerno is characterised by a densely populated urban
area with a number of industrial activities in the north and
by a wide rural area in the south. Coastal settlements and
mountain villages are found
in the west and in the east
respectively.

completeness of the data, the staff of SCR actively collects


hospital discharges and pathology les from these hospitals.
A huge population data le allows us to prevent double
registrations. Follow-up status is periodically updated, and
this procedure consists of annual linkage with the mortality
registry and by active research for vital status in the registry
ofces.

Interpreting the results


Incidence rates are inuenced by a probable risk gradient
between the urban north and the rural south. In the north
some areas are also potentially affected by water pollution
due to past industrial contaminations. A population-based
screening programme for
breast cancer was implemented
only few years ago; we expect
ITALY, SALERNO PROVINCE (1998-2001)
that it will affect breast cancer
ITALY, SALERNO PROVINCE (1998-2001)
incidence and mortality rates
only in the future.

Registry structure and


methods
The registry is supported
Use of the data
by the local administration














Reports
on
incidence,
(Provincia di Salerno) and is







mortality and survival are


staffed by a Director, a data

 












periodically provided by the


collection coordinator, an







Salerno Cancer Registry to


IT manager, two full-time








 



 

general practitioners, public


registrars and ve part-time







health professionals and


workers.














epidemiologists.
Specic
Almost all sources of







and collaborative studies on


information
(pathology








 





survival, dietary and other


reports, hospital discharge







risk factors are in progress.


forms and death certicates)














come from electronic media,









Source of population
but they are processed by
Census 2001 and population
registry personnel without






estimates for 19982000
any
automated
coding.
 $ "
  $ "
(Istituto Nazionale di Statistica
Compared with the cancer



#$#!%$$$

ISTAT).
registries of northern Italy, a

  
higher proportion of patients $$$

$  $  $&&%'$$ $ $$$'$"$
are likely to be diagnosed and 


  
treated
in hospitals located Multiple primary rules used
 $  $
!"$$ $$
outside the province of Salerno. In order to assure the IACR rules (2004) on historical data.

330

Europe

Italy, Sassari Province


are considered just when evidence is clear or when a tumour
Registration area
The Sassari cancer registry covers the population of Sassari diagnosis is found on the death certicate.
The variables collected are: health unit to which patients
province in the Mediterranean island of Sardinia (Italy). The
population at the most recent census (2001) was 453 628. belong, name, place and date of birth, sex, marital status,
Between 1991 and 2001 there was a small population decrease of address, occupation or social class, attending physician,
about 0.3% (1276 persons); nevertheless in the previous decade hospital and department of admission, site of tumour,
presence of tumour in other family member, basis of
there was an increase of about 4.5% (20 286 persons).
The province covers 7520 km2 and has a population density diagnosis, grading, extension (or TNM) of neoplasm, leading
of 60 persons/km2, nearly 1/3 of the national population density. treatment, causes of death, and place and date of death.
The registry receives the list of all persons admitted to
The population is not evenly distributed across the land; the
provincial chief town has 128 000 inhabitants; three towns have Sassari Hospital and the list of biopsies. In addition, we use
30 00040 000 inhabitants, three towns have 10 000 inhabitants active casending in two regional hospitals (Sassari and
Nuoro), in ve district hospitals, in all medical ofces for
and all the other people live in 83 small villages.
oncology and in the death
With few exceptions, the
registration ofces.
population is of the same race and
the same culture. The economic
Registry staff visit these
ITALY, SASSARI PROVINCE (1998-2002)
sources
per iodically, and
activities are mostly agriculture
ITALY, SASSARI PROVINCE (1998-2002)
scrutinise the medical records
and tourism. In the north of the
of departments concerned with
area there are also two harbours
diagnosis and treatment of
for trade and one cracking plant.
cancer, to identify and abstract














Cancer care facilities


information on cases of cancer,







The National Health Service


diagnosed by all methods,














provides general health care


among residents of the registry

 





through 1 regional and 4


area. Cancer is not a reportable








 





district hospitals and primary


disease, and the registry does not

 





health
centres.
Private
receive information about cancer

 












practitioners supplement this.


cases from private practitioners.







The oncology department is


Arrangements have been made





 








located in the regional hospital


with the hospitals outside the





 

in Sassari, and provides facilities


region to notify the cancer cases














for diagnosis, PSA testing as a


in Sassari residents that are







routine procedure for elderly


diagnosed or treated in their area.
people, cancer surgery, and
In order to verify the






chemotherapy services.
completeness of the registry, the
 '#%
 '#%

 

!" '(&)'''

Patients suspected to have
mortality/incidence ratio and
cancer in the primary and 
  
DCO percentage are calculated
))!+!!*'  '  '# '' ' )) ''! ' '' ' '
 ' ' '' ''''
' '
secondary care facilities are   %'
annually, and the list is linked
mostly referred to district or  


  
regional hospitals. Usually with that of the hospitals inpatient records and biopsies.
'  '#!$%'' ''
patients are referred to district hospitals, but can also use
hospitals in other provinces or outside of the island.
Interpreting the results
In the registry area, hospitals and diagnostic facilities are
Registry structure and methods
adequate in number and well distributed in the territory, so that it
The registry is a result of the work in partnership between is unlikely that cases referred will be missed. Also, ASL operates
the Epidemiology Service of Azienda Sanitaria of Sassari a screening service for breast cancer and cervical cancer.
and the Anatomy and Histopathology Institute of Sassari
University. It is funded by Azienda Sanitaria and is located Use of the data
in the Epidemiology Service. Four epidemiologists and two The registry prepares an annual report of cancer incidence
health workers staff the registry.
highlighting changes and peculiar tumours (e.g. Kaposi
The registry collaborates in research with the institute of sarcoma, chronic myeloid leukaemia, chronic lymphatic
Anatomy and Histopathology Institute of Sassari University leukaemia), and points out the registered cancer cases
and the genetics OU of the CNR in order to dene the survival after ve years from registration.
prevalence of some genetic markers (BRCA, BRAF) and
The data of the registry have been used from the regional
their inuence on the prognosis of tumours.
government to dene cancer-control plans.
The Sassari Cancer Registry (SCR) has collected,
starting from 1 January 1992, all cases of malignant tumours Source of population
occurring in the Sassari province. Particularly, all tumours 19922002: Intercensal estimates (based on the 1991 and
listed in sections 140-208 of the ICD-9 and in sections 2001 census data, making allowance for births, deaths and
C00C97 of the ICD-10; intracranial and spinal neoplasms, migration into and out of the province).
malignant and benign; in situ carcinomas are normally
collected but not utilised to calculate incidence, except Multiple primary rules used
urinary bladder carcinoma. The cases with insufcient detail IACR rules (2004) on historical data.

331

Europe

Italy, Sondrio
Registration area
The Sondrio Registry covers the population of the district of
Sondrio in Northern Italy. It is a predominantly mountainous
district, but about 68% of the population lives under 600m
above sea level, 18% from 6001000m and the remainder over
1000m. The main city is Sondrio, with 23 000 inhabitants.
The greater part of the population lives in rural areas or small
towns with <5000 inhabitants. The population is Caucasian
(99.8%), and predominantly Christian. Women (51.1%) have
longer life expectancy (median age of death for males is
74 years; for females, 84 years). In the district of Sondrio a
small proportion of immigrants (1.4%) were registered in the
national census of 2001.
Cancer care facilities
The public health services
department, through 4 public
hospitals and a network
of primary health centres,
provides general health care in
the region. Hospitals provide
cancer
surgery,
thoracic
surgery,
neurosurgery,
haematology,
radiotherapy
and chemotherapy services
and imaging services (4 CAT
scan, 2 NMR). About 15%
of patients with cancer are
referred to secondary care in
hospitals in Milano (120km
distant).

and recodes all cancer cases. The staff scrutinises registers


of radiotherapy and chemotherapy services and of hospitals
when cases are uncertain.
If DCO (Death Certicate Only) cases are detected,
the registry interviews the practitioner. Quality control,
i.e. evaluation of DCO, of percentage of microscopically
veried cases, of mortality/incidence ratio, of time trends,
external comparison with Italian Registries, and capturerecapture analysis with independent databases (the Registry
of Mesotheliomas, Italian Association of Paediatric
Oncologists), are carried out with INT. The registry began
the registration of incident cases in 1998 and has collected
6600 prevalent cases (with incidence date before 1998).

ITALY, SONDRIO (1998-2002)


ITALY, SONDRIO (1998-2002)














 































 




























 




















































 

Interpreting the results


The population within the area
is stable, and there have been
no changes in the availability
of diagnostic and treatment
services or in denition and
coding.
Screening for breast cancer
by mammography has been
active since 2000; screening
for melanoma has been offered
since 1999. The number of
PSA tests is increasing; in
2004 there were 16 000. In the
past many workers have been
exposed to siliceous powder,
and in 2004, the prevalence of
silicosis was 800 cases.

Registry structure and


Use of the data
methods






 #
  #
The registry prepares an
The registry is located within



$"#!###

annual report of cancer
the Public Health Department,
incidence and survival. The
which provides physical and 
  
data are used for evaluation of
nancial support. The registry ###

#  #  #%%$&### # ##'# #
 


  
 #  #
## !##
#
is staffed by a full-time medical
doctor
(epidemiological health services (for example migration of patients, terminal
specialist), a full-time nurse (registrar), and a part-time care). Some special studies on therapy for breast cancer have
informatics specialist. The Istituto Nazionale per la cura been carried out.
dei Tumori of Milano (INT) provides technical and
Source of population
epidemiological support.
The registry receives all Italian Hospital Discharge Census 2001 and population estimates for 19982000
Data of inhabitants in the area of the registry, databases (National Institute of Statistics, ISTAT).
of pathology laboratories in Sondrio and Milano area
and mortality databases (pre-coded data). The registry Multiple primary rules used
scrutinises the records with cancer diagnosis or treatment IACR rules (2004) on CI5 IX period.



332




 

Europe

Italy, Syracuse Province


the archives of private clinics, clinical and administrative
Registration area
The Syracuse Cancer Registry inhabits the Territorial records of local healthcare districts, and death certicates
Registry of Pathology (RTP) of the Local Health Authority obtained from the department of public health. The registry
of Syracuse. The Registry covers 21 municipalities within the checks municipality rosters for vital status.
Since 1996 the Registry has received from the Regional
province of Syracuse in southeast Sicily. The area consists of
a western highland with altitudes ranging from 450865m, Department of Epidemiological Observatory the records
and an eastern coastal plan facing the Mediterranean Sea. of all residents admitted to any regional or extra-regional
The province borders the province of Catania in the north and hospital. Active casending is undertaken in hospitals,
the province of Ragusa in the south. The population density pathology laboratories, and local healthcare districts.
is 193 inhabitants/km2. The province has about 400 000 The department of public health provides copies of death
inhabitants; the principal town, Syracuse, has about 123 000. certicates for all causes. Arrangements have been made
People over age 65 comprise 15.5% of the population; those with hospitals outside the region to notify the Syracuse
under age 14 comprise 17%. The area is socioeconomically residents diagnosed and treated in their area. A traceback
is performed for undened
heterogeneous,
with
an
malignity, unknown primary
industrial economy in the
site, with outpatient record
cities of Augusta, Priolo and
ITALY, SYRACUSE PROVINCE (1999-2002)
as the only source or other
Melilli, and an agricultural
ITALY, SYRACUSE PROVINCE (1999-2002)
missing information as well as
economy in the north (District
death certicate notications.
of Lentini) and south (District
Traceback includes contacting
of Noto). The great majority
the general practitioner and
of Syracuses population is
%-%*"--/*,
(-"$&--%-0."--/"
(-+%%--rescreening the sources.
employed in tertiary activities,
*-/(/--.*
.-0($--Data
collection
and
especially tourism. With a few
.-/$.--."
0-&&*--0-"/.--+*
$"-$**--registration is done in three
exceptions, the population is
$"-&*"--+"
$$-%&$--steps: a) checking data quality
of the same race and the same
$"-0+.--**
$$-*$"--$%-/+&--*"
$&-%./--and linkage with the other
culture.
$%-%""--(*
$%-+0*--information; b) evaluating
$&-*&.--("
$(-"$"--$*-"$$--&*
$*-$"*--and coding all cases by
Cancer care facilities
$*-%0&--&"
$*-&.$--two
epidemiologists;
c)
In the area covered by RTP
$*-++%--%*
$*-&""--$(-"(+--%"
$&-.*.--computer
entry
with
IARC
there is a main hospital (A.O.
$%-00&--$*
$%-&0(--CanReg software. Follow-up
Umberto I) in Syracuse and
$%-&+$--$"
$$-*+/--$$-""(--*
$"-*&"--procedures include periodic
four other public municipal
0-.+%--"
0-&&0--record linkage with mortality
hospitals (in Lentini, Augusta,
data. Specic procedures and
Avola and Noto), ve certied
$"
*
"
"
*
$"
keywords restrict le access.
private hospitals and 396
 -'#)
  -'#)
general practitioners. The
%"%-$*(--$0(-"%$--
Interpreting the results
Syracuse and Avola hospitals

  
have medical oncology units  - -  -- -%""$- ----- ---  -- - - - --1-!- The insufcient cancer care
with chemotherapy services.  


  
There are no radiotherapy facilities and the number of cancer patients hospitalised

- -'%""()--
*-- services. The province has few cancer care facilities; many outside the province create many problems for casending.
patients are admitted to hospitals and specialised institutes Differential distribution of environmental and occupational
outside the RTP area at the University of Catania. Many exposure can lead to different incidence rates. In the
cases are diagnosed and treated in extra-regional hospitals registry area some suspected etiological factors have been
with comprehensive cancer services (esp. in northern Italy). investigated. Chemical industries in Augusta, for example,
represent the main source of water and air pollution that
inuence the high incidence rates of several tumours,
Registry structure and methods
The registry is sited within and supported by the Healthcare especially of lung cancer.
Since 2001 there have been population-based screening
District of Syracuse. RTP was established in 1997 by the
Sicilian Government with the partnership of Department programmes for breast cancer and cervical cancer in Syracuse
of Hygiene of the University of Catania and the Syracuse city (although breast cancer screening was interrupted
Local Health Authority. In 2005 it joined the new Integrated in 2004). PSA testing is commonly used as a diagnostic
Cancer Registry (RTI) of the Province of Catania, Messina technique, but not in organised screening programmes.
and Syracuse. Two full-time epidemiologists, one part-time
epidemiologist, two full-time health nurses and one full-time Use of the data
registrar staff the registry, with MDs and undergraduates The Registry aims to identify cancer incidence in an area
(epidemiologist and pathologist) of the University of Catania. (southern Italy) formerly covered only by the Ragusa Cancer
RTP started on 1 January 1999, after a one-year experimental Registry, that has low incidence rates, probably related to
phase to evaluate feasibility and to collect prevalent cases. Mediterranean dietary habits and lifestyle. The registry
seeks to establish these incidence rates to evaluate future
Registration is voluntary and based on active casending.
The major information sources for the Syracuse Cancer needs and to target prevention activities appropriately. The
Registry are histology and cytology reports, the regional registry contributes to local cancer control strategies via
archive of hospital discharge forms, hospital clinical records, monitoring cervical cancer screening and evaluating health

333

Europe

services. The registry prepares an annual report of cancer


mortality and, more recently, of incidence as well. The
Registry is not currently involved in national or international
epidemiological research, but data are provided to the Local
Health Unit and the Regional Government for planning
health services. Survival studies will be possible after ve
years of recording.

334

Source of population
Source of population is the 2001 census, taking into account
birth, deaths and migration, produced by the National
institute of Statistics (ISTAT).
Multiple primary rules used
IACR rules (2004) on CI5 IX period.

Europe

Italy, Torino
Registration area
The area covered by the Piedmont Cancer Registry
corresponds to the city of Torino, which is the main city of
the Piedmont Region, in the northwest of Italy. At the year
2001 census the population was 902 235 inhabitants. The
present population structure is still inuenced by signicant
internal migration: 4.4% of the population was born in the
northeast of Italy, 4.5% in the centre and 26.6 in the south.
This composition may inuence incidence gures, as people
born in southern Italy have lower risk proles than people
born in northern regions.
Cancer care facilities
In Turin and its surroundings
there are 14 public hospitals
and 12 private clinics: all
these hospitals and clinics
offer cancer treatments in
varying proportions. Recently
the Piedmont Region has
developed a regional network
for cancer services with four
sub-areas serving the city
of Turin. Since 1992, two
screening programmes have
been set up in the Turin area:
mammographic
screening
for women aged 5069 years
and cytological screening for
women 2564 years of age. In
1998 a screening program for
colon cancer was implemented,
based on sigmoidoscopy for
men and women aged 58 years
or faecal occult blood test for
men and women between
59 and 69 who refused the
sigmoidoscopy.

input, after checks for data quality and linkage with other
information. Follow-up procedures include periodical record
linkage with the mortality Registry and the active follow-up
in the municipality rosters.

Interpreting the results


During recent years, the incidence trend slowed its increase.
Tobacco- and alcohol-related cancers are clearly decreasing
in both sexes, with the only exception being lung cancer in
women.
Breast, colorectal and prostate cancers are increasing,
mainly due to the screening programs (for breast and colon)
or the increasing use of opportunistic PSA testing.
For more than a century,
Torino has been the Italian
capital of automotive industry
ITALY, TORINO (1998-2002)
(cars, trains, trucks, planes).
ITALY, TORINO (1998-2002)
In recent decades, automation
of the production processes
had importantly cut the
proportion of manpower, as
#&$)&&&
(#%
$&'&&&
'&(&&&
(
!&(&&&
well as had improved the
#&!!&&&
'#
!&$$&&&
working conditions and put
&)#&&&
'
)&!(&&&
$&$#&&&
$#
&!!!&&&
occupational hazards under
&)(&&&
$
!&!(&&&
strict control. However, due to
)&$!&&&
##
&($#&&&
&($&&&
#
&$&&&
the latency of cancer induction,
)&$&&&
!#
&!)&&&
a consistent occupational
&#&&&
!
&!!&&&
$&'!(&&&
#
!&!(&&&
etiological fraction is still
)&#$&&&

$&!&&&
present in the Turin cancer
#&)&&&
#
&(&&&
!&!&&&

&('&&&
incidence of mesothelioma,
'&($!&&&
#
$&(#(&&&
lung and bladder cancers.
$&$!&&&

#&##'&&&
$&#!&&&
#
#&$#(&&&
Furthermore, this heavy
'&#'&&&

$&$&&&
industrial
environment,
together with road trafc, has

#


#

also induced signicant air

& "


& "
pollution, responsible for a
!$)&#$(&&&
!&$'&&&

further fraction of respiratory

  
 & 
& 
& &

&  &
 
&&
& & 
&&
&
& &
&
 "&
cancers.
 


  
& 
& !"&& &&

Registry structure and methods


The Registry is a part of Centre for Cancer Prevention (CPO).
The registry is staffed by a director, two epidemiologists, two
full time registrars and six part-time registrars. Sources of
information and methods of registration remained unchanged
in recent years.
The principal sources of information for the Registry
are: a) the hospital archive of clinical records; b) the regional
archive of hospital discharge forms; c) pathology reports; d)
the archives of Day Hospitals and Radiotherapy Services;
e) health insurance les for those cases treated outside the
region; and f) death certicates. The Registry has access
to the municipality roster in order to check personal data
for vital status. Registration is carried out in an almost
completely active manner. The collection of data comes
about in two steps: a) a provisional input into a portable
computer, carried out at hospital archives after reading
clinical records and histological reports; b) a denitive

Use of the data


The registry provides periodical reports on cancer incidence,
prevalence, mortality and survival, published and updated
on the web (www.cpo.it). The data are used by local heath
authorities for planning for the regional network of cancer
services. The data are also sent to the Italian Cancer
Registries Association database. The Torino branch of the
EPIC cohort study is annually linked with the Piedmont
Cancer Registry in order to check the occurrence of cancers.
A follow-up facility is also provided on demand for clinical
epidemiological studies.
Source of population
Municipality rosters (balance of resident population recorded
by the municipality roster at the end of each year).
Multiple primary rules used
IACR rules (2004) on historical data.

335

Europe

Italy, Umbria Region


hospitals. Other sources of data are cytology centres for
Registration area
The Umbrian population-based Cancer Registry covers the cervical cancer screening, personal case histories and
population of the Umbria Region. Umbria is a small Region independent studies, reimbursement requests for patient
in central Italy, divided into two Provinces. The regional treated outside the region, and other cancer registries.
A traceback is performed for cases of undened
population was 825 826 inhabitants (426 664 females) at the
last census (2001). The regions area is 8456 km2, and population malignity, of unknown primary site, with outpatient record
density is about 96 inhabitants per km2. The population is older as the only source or with other missing information besides
than the Italian average: the ratio of people >65 years old to death certicate incident cases. The traceback procedure
all residents is over 23%. The population is stable, growing includes contacting the family doctor and re-abstracting or
slowly due to migration while natural balance is negative. re-screening of acquired sources.
Foreigners, most of them coming from Eastern Europe and
North Africa, form about 2% of the resident population. Nearly Interpreting the results
70% of people live in centres of >5000 inhabitants. The great Opportunistic screening for cervical cancer was introduced
long ago. More recently, the
majority of Umbrias population
opportunistic screening was
is employed in services and
supplanted by an organised
industry (agriculture 6% both
ITALY, UMBRIA REGION (1998-2002)
programme, and an organised
sexes). The unemployment rate
ITALY, UMBRIA REGION (1998-2002)
screening programme for beast
is at 8.9%.
cancer was also introduced
(1999).
Opportunistic
Cancer care facilities
screening
activities
for
Health care is provided








 





prostate cancer and melanoma


mostly in public hospitals and







do exist, but are perhaps less


districts of the 4 Local Health














widespread than in most


Services. There are 2 main







other northern Italian regions.


teaching hospitals and 18












 

Invitation letters for the rst


public hospitals in the region







round of the large bowel


with 3949 beds overall, as














screening program are now


well as 5 private clinics.







being distributed. Historically,


The main specialised













there has been an area of high


oncology centres (including







risk for gastric cancer in the


clinical oncology, surgical












 

north of the region.


oncology, paediatric oncology,







radiotherapy and haematology


Use of the data
specialties) are located in the






Annual incidence and survival
two larger cities, Perugia and
!
!
reports are produced and
Terni (maximum distance



#"!"!!!

distributed. A survival study
within the region 55km). As an

  
by prognostic factor for breast
overall technology investment !!!!!  !##"$!!! !
 


  
indicator 18 TC, 7 RMN, and 2 PET
are available in the regional and large bowel cancer is ongoing. The registry participates
! !!!
$ $!!
in various multicenter researches (e.g. the EUROCARE
centres (data from Osservatorio Regionale Tecnologie).
study on patient survival, the OCCAM study on occupational
cancer monitoring, and the IMPACT study on breast cancer
Registry structure and methods
The Cancer Registry is managed at the Department of screening effectiveness). Policymakers also use registry data
Hygiene of the University of Perugia. The registry is funded for planning and evaluation of health services.
by the Regional Health Authority while staff and equipment
are supplied by the University. All the staff is yet part-time. Source of population
Sources used for casending include public and private Census 2001 and population estimates for 19982000 and
clinics/hospitals outpatient records, pathology reports, 2002 (ISTAT).
radiotherapy outpatient records, and death certicates.
Relevant information for eligible cases (i.e. residents) is Multiple primary rules used
abstracted from medical records of 20 public and 5 private IACR rules based on ICDO1.

336

Europe

Italy, Varese Province


Cancer Institute. The professional registry staff consists of
Registration area
The Province of Varese is in northern Italy. It is bordered three epidemiologists, two data managers/statisticians, three
to the north by Switzerland, to the west by Lake Verbano case ascertainers and three clerks concerned with record
and the river Ticino, which mark the border with the Region linkage and the checking of data.
The Varese Cancer Registry uses an automated cancer
of Piedmont, and to south and east by two other Provinces
of the Region of Lombardy, to which Varese Province also registration system, called Open Registry (Methods of
belongs. The northern part of the Province is mountainous; Information in Medicine 2005;44:66-71) developed inthe southern part encompasses part of the Lombardy plain house and based on the Linux operating system and Oracle
database. The main electronic information sources are
and is at. The Province has an area of 1198 km2.
The population has increased considerably since the hospital discharges, routinely generated by all hospitals in
1960s (581 526 in 1961; 807 579 in 2000). In these years Italy; surgical pathology reports from pathology units in the
considerable numbers of people have moved into the Province and, since 1998, from major pathology units outside
Province from eastern and southern Italy. Those who settled the Province, which often examine specimens from persons
resident in the Province;
tended to retain the distinctive
and mortality data from
dietary and cultural habits
Local Health Units. Using
of their origins, which differ
ITALY, VARESE PROVINCE (1998-2000)
the Open Registry software
considerably from those of the
ITALY, VARESE PROVINCE (1998-2000)
and translation tables to cope
indigenous population. These
with the different information
differences have made it
coding systems in use, 60%
possible to conduct descriptive
of cases are identied and
studies on differences in
#(!(((
*%'
 (&))(((
#()+%(((
*
( #(((
accepted
automatically.
cancer risk by place of birth
+(+%+(((
)%
&(+)(((
For the remaining cases,
and also to perform analytical
%( +(((
)
( +#(((
+()*%(((
&%
!(%(((
the clinical records are
studies on diet and cancer.
!(*!*(((
&
&()#(((
scrutinised manually. The
The population density is
&(!&(((
%%
)(& &(((
)(!+(((
%
*(!! (((
accuracy of the automated
695.6 inhabitants per km2. The
)(&+(((
#%
*(# (((
system has been tested by
ratio of elderly to children (over
)()#(((
#
*( !(((
!(!&!(((
!%
!(+*)(((
comparison with manual
64 years/less than 15 years)
!%(!* (((
!
!#(#%(((
registration and showed a site
was 132.8 in 2000. Currently
! ()#!(((
%
!(! &(((
)( &(((

&(&+(((
code concordance between
about 43% of the working
(%%(((
%
+(& )(((
the two systems (automated
population are employed in
*(#%&(((

)(#!!(((
*(! %(((
%
)(%*!(((
and manual) of 98.4%. In
industrya
considerable
)(++%(((

)(&(((
collaboration with Local
decline compared to 1971
Health Units of the Lombardy
and about 2% are employed in

%


%

Provinces of Brescia, Mantova
agriculture; it is not possible
 ("$
 ("$
and Sondrio of the Lombardy
#)(!*)(((
to partition the Province into
!**() (((

Region, Open Registry has
urban and rural areas.

  

 ("(, $(


been exported to the Cancer
 


  
Registries of these Provinces. The completeness of registration
Cancer care facilities
(  (" #$((%(( (
The Province of Varese is served by 11 general hospitals, is monitored yearly using capture-recapture methods. Clinical
including one university teaching hospital with modern consistency is also checked routinely by re-abstraction and
facilities for the diagnosis and treatment of cancer. There are manual recoding of a random sample of cases.
The Varese Cancer Registry participates in major
also ve private clinics. There are 3950 hospital beds; the
epidemiological studies, including those of EUROCARE,
hospitalization rate is 161/1000 per year.
ORDET, EPIC and ACCIS.
Registry structure and methods
The Lombardy Cancer Registry, which serves the Province Source of population
of Varese, was established in 1974; is it now called the Varese Estimates (ISTAT http://www.istat.it).
Cancer Registry. The Registry is supported by the Lombardy
Regional Health Authority and is run by the Cancer Registry Multiple primary rules used
and Environmental Epidemiology Unit of the Milan National IACR rules (2004) on CI5 IX period.

337

Europe

Italy, Veneto Region


2. Death certicates relating to all deaths among residents
Registration area
in the region, transmitted by the same Department; and
The Veneto Region is the largest region in Northeast Italy,
with 4 527 694 inhabitants at the 2001 Census, 44% of 3. Pathology records transmitted by the fteen pathology
laboratories covering the registered areas.
whom (2 002 705 inhabitants) reside in the area covered by
the Veneto Tumour Registry, which includes six of the seven Furthermore, all the LHUs of the region transmit a copy of
major urban centres and almost all the mountainous part of the population les, which are merged into a single archive,
used as a reference for linking source records: the latter are
the Region.
Immigrants make up 6% of the population covered by the evaluated using a case resolution programme that accepts:
Veneto Tumour Registry (source: Ministry of the Interior). cancer cases where data from two or more sources are
Most of these come from Eastern Europe (47.8%) and from identical; histologically conrmed cases in the presence
Africa (16.7% from Maghreb and 11% from other Countries); of other compatible hospital diagnoses (e.g. metastases or
ill-dened sites); and histologically conrmed skin cancer
15% are from Asia (including China).
Most Venetians are Christian Catholics, whereas half of unless combined with skin melanoma.
The programme rejects
immigrants embrace Christian
diagnoses based on only
religions (25% Orthodox
one source (unless based on
Church, 17% Catholic, and
ITALY, VENETO REGION (1998-2001)
histology), multiple primary
4% Protestant); a third of the
ITALY, VENETO REGION (1998-2001)
tumours and discordant or
foreign population is Muslim.
incompatible
diagnoses:
The Region encompasses
in these situations manual
many of the leading economic
checking is carried out by the
districts
in
Italy:
the













registry operators, who where


unemployment rate in 2001







necessary gather further


was only 4.1%, compared to














information from the local


the national average of 11.6%.







information systems of the


At the 2001 Census,














LHUs and clinical records


employment was distributed







from the hospitals.


as follows: 4% in agriculture,











 

A quality assessment of
42% in industry and 54%







in other activities (national


automatically accepted cases was














averages are 5%, 34% and


carried out by a re-abstraction





 

61%, respectively): industrial


study in the year 2002, with

 











activities are distributed


positive results, and a few







throughout the territory rather


corrections were consequently
than being geographically
made to the programme.






concentrated.

($ &


($ &




+'+(%*(((

Interpreting the results
Cancer care facilities
The proportion of aged

  
Twenty-one Local Health !++)-",( (
 
(

( (  ((#!(


($ 
,((
( ((&("!(
(
population has markedly
(
( ((("",( (
 
(

( (  ((#!(


($ 
,((
( (
Units (LHU) are responsible (&(
for all public health-related increased: ageing index for the whole region, which was 107
 


  
( 
($"%&(( ((
matters, including the management
of all the hospitals in the in 1991, had become 136 in 2001; in the area covered by the
Region (98 in the year 2000). Only the two major hospitals registry it rose from 119 to 145.
are managed autonomously. Most of the LHUs provide
A prevention programme for early detection of skin
comprehensive services for cancer diagnosis, surgery and melanoma has existed since 1990. Organised screening for
chemotherapy: radiotherapy and a few expensive diagnostic breast and cervix cancer detection started in 1998 in three
tools are available at least at county level (the Region includes and ve LHUs, respectively, and progressively included
seven counties), while patients with rare cancers or particular further LHUs. PSA testing became a routine practice in the
sites involved (i.e. brain tumours) are mostly referred to a late 1990s.
restricted number of departments. Paediatric patients are
treated in the two major hospitals.
Use of the data
Incidence gures with LHU details are reported on the
Registry structure and methods
Registry website, as well as prevalence and survival gures
The Registry is nancially supported by the Regional for the entire Registry area: a report has also been prepared
administration. The staff is composed of a physician (director and some small area analyses of incidence and mortality
of the registry), three registry operators, three statisticians, a have been carried out.
data manager, two computer programmers and two clerks
The Registry collaborates with all other Italian Registries
with secretarial and data-entry duties.
in research projects and publications of incidence, prevalence
The registration system uses medical information, and survival data.
received annually from the following computerised and
The Veneto Tumour Registry is currently involved in
codied sources:
epidemiological researche (EUROCARE IV, Concord,
1. Hospital discharge records from all the hospitals in Haematocare, ACCIS, Eurocim, and others).
the region, transmitted by the Regional Department of
Veneto Tumour Registrys data are used for drafting the
Social Security and Health;
Oncological Regional Health Plan of the Veneto Region.

338

Europe

Source of population
19972000: Municipal registries estimates of population
at 31st December (source: National Institute of Statistics,
ISTAT). 2001: census, National Institute of Statistics,
ISTAT. 2002: Municipal registries estimates of population

at 31st December (source: National Institute of Statistics,


ISTAT).
Multiple primary rules used
IACR rules (2004) on historical data

339

Europe

Latvia
Cancer care facilities
The Latvian Oncology Centre, 2 regional oncology
hospitals and the oncology department at the Republics
Clinical Hospital provide complete specialized diagnostic
and treatment services for the population of Latvia. All of
these hospitals have well-equipped radiology departments.
Specialised aid for children is provided by the oncology
department of the Central Childrens Hospital.

29 000 of the population were lost because of emigration;


but mainlyabout 71 000because of the natural decrease
in the population (about 14 000 persons per year).

Interpreting the results


The availability of medical services is nearly the same over
time, with some difculties for the less-secure population, but
cancer diagnosis and treatment possibilities have increased.
From the beginning of the registry the ICD-7,8,9
revisions were used for coding of malignancies. Now all
Registry structure and methods
The staff of Latvian Cancer Registry (LCR) includes 5 data are transformed to ICD-10 (topography) and ICD-0
ofcials: an MD medical statistician, an epidemiologist (morphology) codes.
No organised screening programmes have been organised
(biologist), a programmer, a PC operator and the principal of
in Latvia, but opportunistic
CR (director).
programmes for breast cancer
All
physicians
and
(mammography) and cervical
practitioners
(GP,
outLATVIA (1998-2002)
carcinoma (Pap smears) as
patient department, hospital,
LATVIA (1998-2002)
well as PSA tests are ongoing.
pathology
and
forensic
medicine laboratory) have
Use of the data
to report new cancer cases
The LCR publishes regular
to LCR. At least quarterly














statistical issues. During the


the persons responsible for

 



 

19982002 period: Cancer


oncology at every district








 





Incidence in Latvia 19971998


central hospital in the republic

 





(the 4th issue) and 19992000


provide information on cancer














(5th issue); Cancer Mortality


in their districts (new cases,







in Latvia, 19802000 (2002)


deaths, changes of therapy,














and Cancer Incidence and


progress of the disease, etc.).







Mortality in Latvia, 2001


Additionally, the LCR














2002 in 2004.
receives regular information







The LCR is not currently


from the Latvian Agency for

 



 



 

involved
in epidemiological
Medical Statistics concerning

 





research, but some projects have


the cases identied from death
been completed recently. The
certicates.






CR data are widely requested
 .)%+
  .)%+
The completeness of

 
 

&.$00.$00...

and used by policy makers,
the data is evaluated by
insurance companies, etc.
comparison of the CR data 
  
# .  . .".
.'$$$.).(&!'$$$++1.
with the data of big hospitals. &00/2&000.
.. . ..) . . .
. . . .'$$$.  . 2..  !!'$$&!-'. ".'$$&2'$$'1. . 2. . .
..
 . .".
Source of population
A specic evaluation study is not
performed.
 


  

. .)'$$*+..
,..  .
19981999 Central Statistical Bureau of Latvia (estimation
allowing for the birth/death levels and migration. Census
Registration area
Since 1965, the cancer registry has covered all the population 2000 (March 31, 2000): Provisional results of the 2000
of the republic, but a separate cancer registry unit (LCR) population census Statistical bulletin, Riga, 2001, 62p.
was organised in 1993, after state independence was re- 20012002: Estimated data from the Central Statistical
established. The area covered has not changed, but the bureau of Latvia.
population has changed considerably: in 19661967 mainly
because of the departure of Soviet Army troops and their Multiple primary rules used
families; during the reporting period (19982002) about IACR rules (2004) on CI5 IX period.

340

Europe

Lithuania
Registration area
Lithuania is the southernmost of the Baltic States, which
were part of the USSR from 1940 through 1990. In 1990,
Lithuania gained independence. Lithuania has total land
area of 653000 km2 giving a population density of 53.68
persons per km2. The resident population in Lithuania in
2001 was 3 483 972 1 629 148 males and 1 854 824 females
(census data) where 83.45% of inhabitants are Lithuanians,
6.74% Polish, 6.31% Russians, and 3.5% others. Birth rate
in Lithuania has been decreasing for the last decade, and it
continues to fall. In 2000, the crude birth rate was 8.52 per
1000 population. Average annual rate of natural increase was
1.3%. The infant mortality was 8.52 per 1000 live births.

edition since 1993 and ICD-O-3 since 2003. Before 1993, a local
one-digit morphology code was used. The cancer registry le
is updated monthly with information on death certicates that
are completed according to the international standards. The last
update for the analyses presented here was done on 31 March
2005. On average, two notications from different sources per
skin melanoma case were registered since 2000.
There are obstacles to continuing the full-scale activity of the
cancer registry due to legislative issues. The rst regulations of the
registry were signed by the Ministry of Heath in 1984. Discussion
continued on cancer registry regulations despite the law on the
registries adopted by the Lithuanian Parliament in 1996. The
importance of the registry data was recognised by researchers, health
care organisers and policymakers.
The cancer registry data was used
as a basis for the National Cancer
LITHUANIA (1998-2002)
Control programme adopted
LITHUANIA (1998-2002)
by the government in 2003,
establishing cervical and breast
cancer screening programmes
and numerous local investment

 


projects funded by EU and local


sources.



Cancer care facilities


There were 97.9 hospital beds
and 40.3 medical doctors per
100 000 population in 2000. The
availability of diagnostic and
treatment services is increasing.
Modern complex treatment


of oncology patients (surgery,

radiotherapy, chemotherapy) is
 


 
provided at Institute of Oncology



Vilnius University, Kaunas
Interpreting the results



 

 
Medical University Clinics,
During 19982002 there



Klaipeda City Hospital and
were no nation-wide cancer


 



screening programmes. Some
Siauliai City Hospital. Surgery and


 
small-scale
opportunistic
chemotherapy are also available






activities
were
established
at other university hospitals and


 
for cervical, breast or colon
major treatment centres.





 
cancer. PSA testing became
The highly centralised
 


widely available around 2000.
healthcare system has been
The cervical cancer screening
finally changed to a state






programme with a 3-year
insurance-based system in 1997.


invitation interval started in
The changes required the registry
 



June 2004. The mammography
to establish new connections
screening programme started in
with primary healthcare centres 
   


   
(360 in 2006) that became to play a major role in primary cancer May 2006 though it is still lacking coverage due to limited
mammography services. Despite the opposition of the experts,
assessment and referral of patients to diagnostic services.
lobbying activities forced the introduction of nationwide free
PSA testing in 2006. The registry is responsible for evaluating
Registry structure and methods
The cancer registry operates as a separate department of the effectiveness of these cancer screening programmes.
Institute of Oncology, Vilnius University. The registry staff
includes 10 employees: epidemiologist, medical doctor, medical Use of the data
coders, programmer and registry clerks. Support to the registry Annual registry reports on cancer incidence, extent of
is provided by the Institute of oncology. The principal sources disease, microscopic verication of cases, mortality, and
of information on cancer cases are primary, secondary and prevalence by site and municipality have been published
tertiary healthcare institutions that are required to complete since 1994. Registry publications covering incidence and
mortality trends and survival data have been published on
a notication when cancer is diagnosed.
Lithuania has a compulsory nationwide cancer registration some individual sites. The registry is also involved in cancer
since 1957. Administratively Lithuania was divided to 44 districts epidemiology research, and has participated in several
(municipalities) up to the year 2000. The new administrative descriptive and occupational epidemiology projects including
division is built upon 60 municipalities established within the Chernobyl clean-up workers, nuclear workers, radiologists,
borders of previous territory units. Some of districts were split in and asbestos-, cement- and wood dust-exposed workers.
two or three municipalities; some small territories were joined The occupational exposure pattern in Lithuania follows that
across borders. The cancer registry successfully adopted the in industrial countries; study of environmental radiation
new territorial division without loss of information on long-term exposure due to Chernobyl is needed in order to evaluate the
consequences for the general population. A study of clean-up
trends within major units.
The compulsory case notication includes surname, name, workers from Lithuania shows no elevated cancer risk.
sex, date of birth, place of residence, nationality, date of diagnosis,
site according to ICD-9 from 1978 through 1997 and according Multiple primary rules used
to ICD-10 since 1997, morphology according to ICD-O-2 IACR rules (1990).

341

Europe

Malta
active and passive). Passive methods include the receipt of
Registration area
The Malta National Cancer Registry covers the population notications of cancer from the clinicians, a monthly report
of the Maltese Islands, a small archipelago in the middle of from the Oncology department on the new cases referred to
the Mediterranean Sea. The total resident population at the their department and an annual report on the cases of cancer
sent abroad for treatment by the state.
most recent census (2005) was 404 039.
The National Mortality Registry is also housed within
There is no clear distinction on the islands between urban
and rural areas. However the harbour area (centred around the Department of Health Information, and linkage between
the capital Valletta) can be considered as the most urban, the cancer and mortality databases is routinely performed.
with much of the rest of Malta being suburban, and most of The mortality registry is the recognised national source on
death statistics.
the northwest part and the whole of Gozo being rural.
The majority of the local population are Roman Catholic.
The number of foreigners resident on the Islands is increasing, Interpreting the results
leading to growing changes in the ethnic compositions of It is estimated that only a small proportion of the cancers
diagnosed
in
Maltese
the resident population. The
residents remain unregistered.
Maltese people are descendents
These mainly include cases
of ancient Carthaginians and
MALTA (1998-2002)
diagnosed,
treated
and
Phoenicians, with strong GrecoMALTA (1998-2002)
followed-up abroad. The
Roman and Arab influences.
registry staff actively tries to
European elements, namely
reduce the proportion of cases
Italian, Spanish and French with
that remain registered on the
traces of Anglo-Saxon origins,

 












basis of a death certicate


were assimilated later.







only by reviewing all possible
















medical information on the


Cancer care facilities





 

cases. The staff is permitted


In Malta, there is a comprehensive





 








access to the hospital les of


national health service that is





 

cases diagnosed and treated at


available to all Maltese residents





 








all public and private hospitals


and entirely free at the point







and clinics.
of delivery. All residents have





 


 





To date, no organised
access to preventive, diagnostic,







cancer screening programme


therapeutic and rehabilitative














has been implemented in


services in the Government Health







Malta. However, facilities


Centres and Hospitals. The public
for opportunistic screening
health services are funded from






$!#
$!#
for breast, cervical, prostate
general taxation. There is one
 


&$" $$$

and colorectal cancers are
major general acute hospital in
available locally.
Malta, a smaller one in Gozo and 
  
a number of public health centres &&%('$
($$$$$$ $ $$ $$$ $$$ $
 


  
$ $!&&#$
scattered all over the islands. Since
1996, three private hospitals Use of the data
have also been operating in Malta. Cancer surgery is carried out in The registry has published cancer incidence and mortality
any of the above-mentioned hospitals, whilst radiotherapy and most information since 1992. On the registrys web site (http://
of the chemotherapy are given at the oncology department in Sir www.sahha.gov.mt/pages.aspx?page=91) there are les with
cancer incidence and mortality data for Maltese residents
Paul Boffa Hospital, which is the only cancer centre in Malta.
from 19942005/6 as well as other cancer statistics including
survival and temporal trends. The registry is the recognised
Registry structure and methods
The registry is located near to the major general acute (St. national source of information on cancer incidence. Its staff
Lukes) hospital in Malta. It is part of the Department of annually answers several requests for information originating
Health Information within the Health Division and is wholly from various sources, including both local and foreign
funded by the Government of Malta. A full-time principal clinicians and other professionals, students, journalists and
medical ofcer, one full-time and one part-time registrar interested organisations.
staff the registry.
The Malta National Cancer Registry uses both active Source of population
and passive methods from multiple sources for data 19982002: Postcensal estimates. Census data with
collection. Active data collection includes review of and addition of births and immigrants and deletion of deaths and
extraction from the pathology laboratories reports databases emigrants.
(histology, cytology and autopsy reports) of cases of cancer,
review of the hospital les of known cases and collection Multiple primary rules used
of information from the National Mortality Registry (both IACR rules (1990).

342

Europe

Norway
Registration area
Norway covers 324 000 km2 between latitudes 57 and 71 N
and longitudes 4 and 31 E. The total population is 4 640 219
(1 January 2006), most of whom are Caucasians, but 0.5%
are Lapps and 8% are foreign-born (2% western and 6%
non-western). At the 2005 census the main occupations for
men were: industry 32%, agriculture 5%, community 22%
and other services 41%; the corresponding gures for women
were: industry 1.5%, agriculture 8%, community 57% and
other services 33%.

tonsils or the stomach are coded both to the lymphoma site


and to the specic organ site.
The registry is based on compulsory reporting of all new cases
of cancer in the Norwegian population since 1953. Each year the
registry receives more than 100 000 reports which include clinical
forms, copies of cytology, biopsy and autopsy reports, and copies of
death certicates from Statistics Norway. In recent years the Patient
Administrative System has been linked to the Cancer Registry
of Norway to ensure completeness and quality. The registry is
organised as a multi-user online database. All reports are interpreted
and, after coding, updated and processed. At regular intervals, the
Cancer care facilities
registry material is matched against all deaths in the country and
In 2004 there were approximately 4 hospital beds and 3.5 physicians date and cause of death are recorded. Since the 1960 census, all
per 1000 inhabitants. Surgical
inhabitants in Norway have had
treatment of cancer is carried out
a unique personal identication
both in general hospitals and at
number, and this number is used
NORWAY (1998-2002)
oncological centres. There are
to link records from the different
NORWAY (1998-2002)
about 90 hospitals (both private
data sources.
and public) and a number of
private clinics offering diagnostics
Interpreting the results
The
Norwegian
Cancer
and treatment of cancer in
"$ """
$!
"#"""
" %"""
$
#""""
Registry has both a cervical
Norway. Most cancer diagnosis
"%#"""
#
$%"# """
screening programme and a
and treatment is, however, carried
#"$#"""
#
$%""""
#%""""

$#"$"""
breast screening programme.
out at the public hospitals. These
%""""

%""""
PSA testing has become
hospitals are organised in regions
 "% %"""

""""
"%"""

$" """
increasingly more common
covering different parts of Norway
 " """

" """
since the rst commercial PSA
(Eastern Norway Regional Health
 "  """

 "%"""
#"$#"""

 "$"""
test became available in 1989,
Authority, Southern Norway
#$"% """

#"#$"""
and is now very common in
Regional Health Authority,
 "$$"""

%"#"""
"#"""

 "%"""
the Norwegian population.
Western Norway Regional Health
#"$ """

"$"""
Authority, Central Norway
%"%"""

"$ """
$""""

%"# """
Use of the data
Regional Health Authority and
"#"""

"#%"""
The purpose of the Cancer
Northern Norway Regional
Registry is to:
Health Authority). There are







collect and, within the


10 radiotherapy departments in
 "

 "
scope of the Regulations,
Norway, situated at different parts
"#"$"""
"%"$"""

process data relating to cases
of the country.

   


of cancer and cancer studies
 "  """   ""
in Norway in order to document the distribution of cancer
Registry structure and methods
in the country and describe changes over time;
The Cancer Registry of Norway was initiated by the
conduct, promote and provide a basis for research to
Norwegian Cancer Society and established in 1951. Since
develop new knowledge of the causes, diagnosis, natural
1979 the Ministry of Health and Social Affairs has been
course and effects of treatment of cancer in order to
administratively and nancially responsible for the registry.
improve and enhance the quality of preventive measures
There are 130 employees in the Norwegian Cancer Registry. The
and medical assistance that are offered or provided to
Cancer Registry is organised in 4 departments: an administration
combat cancer, including the follow-up of individual
(29 employees, including 9 information and 13 IT-staff) and three
patients and groups of patients;
research departments (environmental and occupational research,
provide advice and counselling on medical assistance to
screening research and clinical research). The staff consists of,
combat cancer; and
among others, doctors, scientists, statisticians, research assistants,
provide advice and information to other public
IT staff, economy, personnel and PR.
administrative bodies and the population at large on
Site and morphology have been coded according to
measures that may prevent the development of cancer.
ICD-O-2 since 1993. Before 1993, site was coded according
to ICD-7, while the morphology was coded according to a In addition to such purposes data in the Cancer Registry
modied version of SNOMED. Primary tumours in different may be processed for the following purposes: management,
organs in one individual are classied as independent planning and quality assurance of public health services
tumours. If multiple tumours occur within paired organs or and the public health administration, for the preparation of
other sites within the same ICD code (e.g. kidney, colon), the statistics and for research.
case is classied in such a way that it can be counted either as
Main research areas are etiological screening-based and
one primary cancer only or as the number of primaries that clinical, based on population data and epidemiological methods.
actually exists. For the female breast, two primary cancers
may be registered in one individual. A double coding system Multiple primary rules used
is also used for lymphomas. Lymphomas in, for instance, the IACR rules (2004) on historical data.

343

Europe

Poland, Cracow
Registration area
The Cracow Cancer Registry covers the population of
the Maopolska Province in southern Poland, an area of
15 144 km2, with 3 233 799 inhabitants.
In 2000 the City of Cracow, the data for which are
presented here, an area 327 km2, had 741 500 inhabitants
(46.8% male, 53.2% female). The population is little
differentiated ethnically, and the large majority is Roman
Catholic. The city of Cracow is one of the biggest industrial
(with metallurgical, electromechanical, chemical and food
industries), cultural and educational centres of Poland.
Cancer care facilities
In Cracow, diagnostic and
treatment services for cancer
are provided by the Centre of
Oncology Maria SkodowskaCurie Memorial Institute (220bed hospital and an out-patient
department for 300 patients daily)
as well as 22 clinics of Collegium
Medicum Jagiellonian University.
Types of treatment include
chemotherapy, immunotherapy,
surgery and radiotherapy.
Patients are also treated at ten
hospitals in Cracow.





























 

The registry also conducts active registration by checking hospital records, pathology records and death certicates. Patient follow-up is carried out by the registry every
year through the checking of medical records and death certicates. If no data about cancer patients are available, information is collected via the Address Ofce in Cracow.
Quality control of the data is done using the IARCCHECK programme and other programs developed in the
registry.

Use of the data


The registry publishes an annual report of cancer incidence
and mortality by sex, age, primary site and place of residence.
In addition, the registry
prepares survival analyses of
cancer patients.
POLAND, CRACOW (1998-2002)
The
Cracow
Cancer
POLAND, CRACOW (1998-2002)
Registry is participating in the
EUROCARE international,
multicentre
studies
on
survival and care of patients.



The registry also participates






in studies on childhood cancer










incidence and survival.




 

The registry data serve










as a basis for planning of






cancer control programmes










and epidemiological research






as well as for education of









clinicians and postgraduate






students in the eld of cancer










prevention.




Registry structure and








methods



The registry is a part of the








Epidemiology Unit of the Centre





of Oncology Maria SkodowskaSource of population


Curie Memorial Institute, and






19982001:
population
receives nancial support

)%!'


)%!'
estimates. 2002: Census.
from the Ministry of Health
 

$&*)*$$)))

and Social Welfare. The staff
  

Multiple primary rules used
consists of an epidemiologist, "++*.# ",)  )

)
)# #)
IACR rules (2004) on historical data.
four registrars, a statistician and      
one computer
) 
)%#
&')) )) programmer.
  
Notication of cancer cases
or suspected malignant

)  )

))
)
)
)
))
)

) )

)-)

) 
)()%
 ')
)
 ))
)
))
 ) 
))
)  ))
neoplasms has been compulsory
in Poland since 1952. All Notes on the data
hospitals and outpatient clinics must report all cancer cases The Editors recommend that some care be taken in the
on special cards, which are submitted to the registry. In the interpretation of these data; see Chapter 5 (Categorisation).
registry, each new notication is compared and checked with This registry has the lowest histological verication rate in
the monograph.
the main database of cases already registered.

 

344

Europe

Poland, Kielce
completed and checked by the registry staff against data
Registration area
The registry covers the Holycross Province (area 11 691 obtained from local civil departments and hospitals.
The National Cancer Registry of Poland evaluates our
km), one of 16 provinces in Poland. It is located in the
south-eastern part of the country between latitudes 50 and incidence data every year. In 2002 the completeness was
100%.
51 N and longitudes 19 and 21 E.
The Holycross Mountains (with mountains about 600m
above sea level) are situated in the northern part of the Interpreting the results
province. In the south there is a fertile agricultural region. In 1999, administration reform took place and the area of our
The Vistula (Wisa) river forms the provinces southeastern registry was enlarged, and the population increased. In 1999
border. The annual average temperature is 6.9 C (max. we changed from ICD-9 to ICD-10, and in 2002 we changed
32.9 C and min.-33.9 C). Annual rainfall amounts to about morphology from MOTNAC to ICD-O-3.
There are some organised and opportunistic screening
565mm.
The population as of the ofcial statistical ofce estimate programs for breast cancer, prostate cancer, colon cancer
and cervix uteri cancer, and
(30 June 2000) was 1 325
PSA testing is common.
000 (about 3% of the Polish
population), with 49% males
POLAND, KIELCE (1998-2002)
Use of the data
and 51% females. Of these,
POLAND, KIELCE (1998-2002)
The registry maintains two
47% lived in towns and 53%
basic les: a computerised
in the country. The population
le containing the patients
of Holycross province is
serial number, sex, name and
predominantly white race
'(('''
)$&
*'*'''
%'('''
)
'%'''
surname, date of birth, date
belonging to the Slavonic
 ''''
($
 '('''
of the rst cancer diagnosis,
group; 95% are Roman
'%)'''
(
')))'''
"'))'''
%$
'%""'''
ICD code and year of death
Catholic.
%'"'''
%
'**'''
(if applicable), and a le
$')%'''
$$
)'*$'''
"'" )'''
$
"'"()'''
containing cards of rst and
Cancer care facilities
$'%%'''
"$
"*'()('''
follow-up registration arranged
The Holycross Cancer Centre
$')'''
"
"*'"%*'''
" '%('''
$
"'*()'''
according to information
is located in Kielce, the capital
"'%%*'''

('))'''
mentioned above.
of the Holycross province, and
"('$ '''
$
" ')"'''
$"'%('''

$'"(%'''
The registry prepares an
provides various services in the
$%'**'''
$
$"')*'''
annual report on cancer
eld of treatment (oncological
"*'$ ('''

"('"(('''
"'  '''
$
"'$"'''
incidence and mortality for
surgery,
chemotherapy,
"'%%'''

'"$('''
local government as well as
radiotherapy, brachytherapy,
sending the incidence data to
hematology, endocrynology,

$


$

the National Cancer Registry
palliative care) and diagnostics

'!#


'!#
of Poland. The Registry
(e.g.
radiology,
nuclear
%$)'")*'''
% ' '''

cooperates with the European
medicine, microbiology).

  

'' 
'' '
Network, IARC and IACR,
 


  
and is a member of ENCR.
Registry structure and methods
'
'!"#''$''
'
We report regularly on extent of diseases. The Registry is
The Holycross Cancer Registry is a department of the
Holycross Cancer Centre; its full name is Department not involved in epidemiology research. Policymakers use our
of Epidemiology and Cancer Control, Regional Cancer cancer registry data but (in our opinion) not in a sufcient
Registry. It is managed by a physician oncologist, one full- way.
Every two years incidence data are sent to the National
time biologist and four full-time registrars. The Registry
closely cooperates with the IT department in data processing Cancer Registry of Poland, which publishes bulletins of
cancer incidence in Poland.
and statistical analysis.
All medical centres are obliged to report all cases of cancer
on a special notication form that includes basic demographic Source of population
and diagnostic information. These notication forms are the Central Statistical Ofce in Poland.
main sources of information on cancer incidence.
Although cancer reporting is obligatory, it is often Multiple primary rules used
neglected, and therefore all the received records are IACR rules (2004) on CI5 IX period.

345

Europe

Poland, Warsaw
cancers, and registration now embraces all sites. The registry
Registration area
In the years 19631988 the Warsaw Cancer Registry collected is located at the Maria Sklodowska-Curie Memorial Cancer
data on the population living in Warsaw city and selected rural Center and Institute of Oncology in Warsaw, the institution
populations in the provinces of Warsaw, Ciechanow, Plock responsible for organising nationwide epidemiological studies,
and Siedlce. In 19891998 the Registry collected data on the scientic research, and therapeutic services related to cancer.
population in Warsaw city and six voivodships (the Province It is supported by the Ministry of Health and Social Welfare.
of Warsaw, Ciechanow, Ostroleka, Plock, Radom, and Siedlce). The total database now contains over 70 000 records from the
After 1999 this area became one voivodship (Mazovian). The old database (Warsaw and Selected Rural Areas: 196388),
Mazovian Province covers an area of 38 000 km2, 12.5% of and over 260 000 from the new database (19892005). The
the total Polish territory. The area is inhabited by 5 112 000 Registry now contains over 50 000 records from the old database
(19631986) and over 100 000 from the new (19872005).
people (13.5% of the total Polish population).
The recording and reporting on a special reporting card
Warsaw, the capital of Poland and the largest centre of
the Mazovian Province, is a major industrial centre in Poland of every case or suspected case of malignant neoplasm by
all health service institutions
lying on the river Vistula, in the
and individual physicians has
Mazovian Lowland in eastern
been compulsory in Poland
central Poland, at 52 16 N
POLAND, WARSAW CITY (1998-2002)
since
1952.
Information
and 20 59 E. The registration
POLAND, WARSAW CITY (1998-2002)
about cancer-related deaths
area amounts to 495 km2,
in Warsaw in 19982002 was
populated by 1 673 000 pertaken from death certicates
sons. The average altitude is
issued by the Central
100m above sea level.
'*%#%***
,')
!(*,-%***
(*---***
,
!(*,#***
Statistical Ofce of Poland.
The population structure
!,*-'"***
+'
#"*+!,***
Since 1989 the database
by sex and age groups was
#"*#'!***
+
%(*,%!***
#,*##+***
('
'%*!"-***
has been maintained in a
analysed on the basis of
#+*!--***
(
'"*-(***
computerised le arranged
data released by the Central
#,*!-,***
''
%-*#%+***
'(*-,***
'
(,*+%***
by patients names, date of
Statistical Ofce of Poland,
+*+%%***
%'
,"*#'-***
birth and cancer site, and a
valid by June 30 every year.
('*!#,***
%
+#*'%+***
%-*!("***
#'
'"*('***
card le containing the rst
The population-at-risk is the
%,*!%(***
#
%-*#((***
registration and follow-up
average of the population at
',*#%,***
"'
(*(%#***
('*!'#***
"
('*''(***
cards arranged by sex and
30 June of each the years 1998
'-*!+-***
!'
'+*(!%***
registration number.
through 2002, estimated on
%'*+#%***
!
%#*+"%***
#'*'!'***
'
##*,%!***
The
epidemiological
the basis of the 1988 Census
#*-,%***

"-*(#,***
data on cancer incidence in
population. The population is
19982002 in Warsaw were
ethnically little differentiated,
!
'


'
!

*$ &


*$ &
collected from the Cancer
and mostly Roman Catholic.
,,'*+%%***
+("*''#***

Reporting Cards (MzN-1)
routinely submitted to the
Cancer care facilities

  
Warsaw Cancer Registry. The
Poland is divided into 16 
*
* *
*  ** **
**
*!-,,*
* *
*  * **
*
 


  
* 
*$"%&**'**
*
regions with regional oncological
centres localised in data collected are recorded on reporting cards and include
each of them. Nationwide supervision is performed by personal identication data (name and surname, sex, date of
the Maria Sklodowska-Curie Memorial Cancer Center birth, address, occupation); medical institution; date of rst
and Institute of Oncology in Warsaw and two branches in diagnosis/rst hospital admission; primary site, pathology,
Cracow and Gliwice. Provincial Oncological Clinics provide clinical stage, method of diagnosis, methods of treatment,
oncological diagnostic and therapeutic health services, and (if applicable) date of death.
The reporting cards are sent from hospitals and outpatient
including radiotherapy, in each of Polands 16 provinces. The
oncologists are usually concentrated where the oncological clinics from Warsaw city, the region and other areas of
Poland; for all from oncological outpatient clinics, medical
centres are located.
In Warsaw, specialised cancer care is provided by the records departments, and other cancer registries. New
Maria Sklodowska-Curie Memorial Cancer Center and notications are immediately checked for consistency of the
Institute of Oncology, clinics of the Medical Academy, the identifying data. When more than one neoplasm is observed,
Institute of Mother and Child and Center of Child Health. with other histopathology, in the same person, a new card
Patients are also treated at other hospital wards in Warsaw, is prepared for each different site. All entries are checked
district outpatient clinics and specialist private and public for duplicates. Site is coded to ICD-9 (to 1998), to ICD-10
centres, as well as cooperatives and foundations. Warsaw has (from 1999) and histology to MOTNAC. Active and passive
follow-up continue until the patients death. If current data
over 400 oncologists and 1000 oncological beds.
about the patients vital status are unavailable, information is
requested from the Address Register.
Registry structure and methods
The Warsaw Cancer Registry was one of the rst Registries
in Poland, established in 1963 in collaboration with the USA Interpreting the results
National Cancer Institute to conduct comparative studies The percentage of underregistration was estimated in
on gastric cancer incidence in Poland and among Polish- Poland in 19982002 at about 12%; however, in Warsaw
Americans. These studies were subsequently extended to other underregistration is lower. In Warsaw there are organised

346

Europe

screening programs for the cancers of the cervix uteri, breast


in women and for the cancers of colon and prostate.
Use of the data
The data are analysed to describe the patterns and trends
of incidence and mortality by sex, age groups and cancer
site in Warsaw. Clinical stage is also analysed for selected
cancers. Survival studies are conducted, as well as analysis
of treatment regimes for some sites. The data are published
in annual reports, monographs, and other publications and

papers. They are also used in many research projects and


international collaborative projects. Policymakers use
registry data for health services planning and evaluation.
Source of population
The estimation of the population at risk is based on the 1988
census, making allowance for births and deaths.
Multiple primary rules used
IACR rules (2004) on CI5 IX period.

347

Europe

Portugal, Porto
The main method of data collection is passive notication
Registration area
The Registo Oncolgico Regional do Norte (RORENO) of the cases. The majority of the information on classication
registers all new cancer cases of the North Region of Portugal. of cancer arrives already coded (ICD-O-1). In 2000, 81.4%
According with the last census, in 2001, the population was 3 of the registrations (32 sources of data) were coming from
236 089 inhabitants distributed in ve districts (Porto, Braga, public health institutions and 18.6% from eight private
Viana do Castelo, Vila Real and Bragana). The population pathology laboratories and hospitals.
Since mid-June 2005 every hospital has had the ability to
reveals a relatively young age structure, and is fairly unevenly
distributed, its density in Porto being 53 times greater than in send the data via a common website: www.roreno.ipoporto.
min-saude.pt.
the easternmost parts of the region.
Although the registry was built on a legal framework,
The Portuguese population is remarkably homogenous
and has been so for all of its history. Legal immigrants access to a unique personal identication number is denied.
represent around 1.5% of the north population, and the largest Our main problems concern the promotion of the follow-up
communities are from Brazil, Cape Verde and Angola and of all the cancer cases, access to digital death certicates
and the completeness of some
lately from Eastern European
items as address and age.
countries. Around 96% of
the population is Roman
PORTUGAL, PORTO (1998-2002)
Interpreting the results
Catholic.
PORTUGAL, PORTO (1998-2002)
There has been an improvement
Some specific areas such
on completeness of data
as Ave and Minho-Lima are
and for most cancer sites;
highly industrialised, mainly
incidence rates must be close
in textiles, clothing, footwear
to reality. Some undiagnosed
and furniture. The mountains

 





cancers concern mainly those


on Northwest and the eastern

 



 








with clinical and radiological


region are predominantly rural







diagnosis only.
areas with little socio-economic














dynamism. The worlds first









Uses of the data


demarcated wine region is













Every year since 1988 an


located in the Douro Valley

 





annual report of cancer


where Porto wine grapes grow.














incidence in the North Region









has been published. Childhood


Cancer care facilities














cancer data were used for a


Porto is home to the main cancer







few masters theses and for


treatment centre of the north
epidemiological studies. The
region, the Instituto Portugus






registry receives weekly data
de Oncologia do Porto, which
 ,($*
  ,($*
requests for epidemiological




%,+'.,.-.,,,

provides radiotherapy, surgery
studies on risk factors and
and chemotherapy for all   

, ,

,, ,, !, , ,  , ",, , ,&###!,, ,
, ,%#, ,  ,
survival. A study on quality
patients. In Porto there are also %//.2&###0, ,

  ,,  ,  ",  ,  ,, , ,, ,,,,  ",&##%, , ",
two general hospitals capable of      
providing cancer treatment. (accuracy) of the data was published in 1995. Registry data
 , ,(&##)*,, +,,
,
Some kinds of cancer may be treated
in the other districts. The have been used to support some projects of the Regional
  
 ,,  ,, , , , ,, , 
 , ,  ,1, , 
 ,+,(  *",
health system is based on a network
of primary health centres Health Administration, namely in planning of screening
services.
and is supplemented by private clinics and laboratories.
Screening programmes are mostly opportunistic and
include cancers of the breast, cervix, prostate and colorectum. Source of population
In 2001 population-based screening for breast cancer began 19982000: Ofcial numbers for population in the north
region, for years between census. For the year 2000, only
in Bragana, involving 22 541 women.
age groups of 10 years were published and freely available.
These estimates allow for births and deaths and to migration
Registry structure and methods
The registry is located in Porto at the Instituto Portugus movements. 2001: ofcial census.
de Oncologia, which is responsible for the co-ordination and
organisation of the program and for the quality of its data. Multiple primary rules used
In 2000 a medical epidemiologist, two full-time registrars IACR rules (2004) on CI5 IX period.
and a part-time statistician staffed the registry. Two medical
pathologists were also included as consultants. The staff is Notes on the data
responsible for treating the incoming information from the The Editors recommend that some care be taken in the
interpretation of these data; see Chapter 5 (Categorisation).
health institutions and also for quality evaluation.

348

Europe

Portugal, South Regional


pathology report from all hospital and private pathology
Registration area
The South Regional Cancer Registry (ROR-Sul) is the labs. Necessary information is abstracted from the medical
population-based cancer registry responsible for cancer records in each hospital or health centre by trained tumour
registration in the south of Portugal. Its area of activity registrars or local physicians and entered into the central
includes the Lisbon area, Alentejo and Algarve regions, server via the network. In addition, hospital discharge les
and Madeira Autonomous Region, covering approximately of cancer patients, and hospital pharmacy and radiotherapy
half of the country (39 700 km2) both in terms of area and service records are compared with registry database, and all
the cases not in the registry are reviewed.
population.
Site and morphology codes have been coded according
According to the end-of-year 2001 estimates, RORSul has 4 490 491 inhabitants, 17.5% of them aged 65 or to ICD-O-3 since 2000. The rules used for coding multiple
more. Of these, 45% live in the Lisbon region (capital of the tumours are those proposed by IARC/IACR. For the staging
country and suburbs). Birth rate in 2001 was 10.9%, and life of tumours, the TNM classication is used.
Completeness of records, data consistency and
expectancy was 73.5 for men and 80.3 for women.
duplicate
records
are
The occupational distribution
continuously and extensively
by economic sector in the 2001
checked using the IARCcensus was distributed as
PORTUGAL, SOUTH REGIONAL (1999-2001)
Check program, other specic
follows: 5% agricultural, 35.1%
PORTUGAL, SOUTH REGIONAL (1999-2001)
computer program developed
industry and construction, and
in the registry, and by
59.9% services.
reviewing a sample of cases.
Arrangements
have
Cancer care facilities
been made with the other two
General health care in the




 
 

Regional Cancer Registries


region is provided by 40





 








in
order
to
exchange
public general hospitals, one







information on those resident


university hospital, a network














cases diagnosed and treated


of 147 primary health care





 

in hospitals outside the


centres and Lisbons Cancer





 








registration area.
Institute. There is one







Patient follow up is
general practitioner per 2000




 


 






carried
out every year by
inhabitants. Almost all cancer







checking death certicates.


patients are diagnosed and







 





treated by medical specialists









Use of the data


working at the hospitals.
The main purpose of the







'# %


'# %
registry is to estimate cancer
Registry structure and


 

"'!$$')"('''

incidence in the region, and
methods
annually the registry prepares
South
Regional
Cancer 
  
a report on incidence. In
Registry began operation 
'

' '  ** '
'
''
'!))!''"!'
' '
' ' ''
'''' 
''


' '''' '
'
 '
'
 


  
in 1989 as part of a programme
for nationwide cancer addition some casecontrol studies have been carried out.
' 
'#"%''&''
'
The registry also participates in several national and
registration, and is nanced by public health funds.
Since 2000 there has been a registry network; data are international research projects, including EUROCARE.
The registry is the recognised regional source of
collected by laptop computer from all hospitals and health
centres, and by means of standardised paper forms for information on cancer incidence. There are often requests
private hospitals and pathology labs and for annual follow for information from physicians, politicians, journalists and
up. The laptop is under the control of one clinician at each interested organisations.
site. The Registry network server is located in Lisbons
Source of population
Cancer Institute.
The permanent staff of the Registry network includes The estimates of populationatrisk are based on the 1991
two physician specialising in epidemiology, one of them and 2001 Censuses, making allowance of births and deaths.
as head of the registry, three statisticians and ten tumour It was not possible to estimate migration into and out of the
registrars. In addition, two consultantsone pathologist and registration area.
one oncologistare available.
The Registry is based on compulsory reporting of all Multiple primary rules used
new cases since 1988. The rst tumour identier is the IACR rules (2000) on CI5 IX period.

349

Europe

Russia, St. Petersburg


detects a cancer patient must send a notication card to the
Registration area
St. Petersburg is the second largest city in Russia and one oncological dispensary or the cancer registry for the region
its biggest industrial, scientic and cultural centres. It was of residence of the patient. On the basis of this card and other
founded in May 1703, and in 1914 its name was changed to supporting documents a control card is compiled and entered
Petrograd and in 1924 to Leningrad. It was the capital of the into the computer. The data of the oncological dispensary are
state from 1712 to 1728 and from 1732 to 1918. St. Petersburg checked regularly against those of the statistics department,
is situated at the point where the Neva River ows into the which is responsible for registering cancer deaths.
Gulf of Finland and includes 42 islands of the Neva delta.
The climate is of a maritime type with mild winters, rather Interpreting the results
cool summers, and very changeable weather. The average There are screening programs, but since 1991 they have been
temperature in January is -7 -9 C, in July +17.7 C. The performed less actively. PSA testing is used but not widely
annual precipitation is 585mm and the total area is 570 km. because of nancial difculties.
The main occupations are heavy industry, especially
Use of the data
heavy engineering (energy
Information about all cancer
engineering
industry,
patients and about deaths is
machine-tool
construction,
RUSSIA, ST PETERSBURG (1998-2002)
included in special tables,
shipbuilding). In 2000 the total
RUSSIA, ST PETERSBURG (1998-2002)
which are sent to the Russian
population was 4 660 792.
Ministry of Health annually.
The mortality rate for all
N. Toichkin made the rst
causes in St. Petersburg in 2000
evaluation of cancer rates in
was 16.3 per 1000 inhabitants,
!*-+"***
,')
%!*("+***
!%*%,#***
,
'"*'%***
St. Petersburg in 1912. His
and the average life expectancy
"-*'"***
+'
--*'***
research was based on the
in 2000 was 66.0 years.
('*'%(***
+
!#,*(,,***
,"*'++***
('
!%"*%((***
cancer mortality rate of 93
The national structure of
!!#*+"%***
(
!+*!,%***
99 per 100 000 inhabitants
the population in St. Petersburg
-"*('"***
''
!"#*('+***
!%*,#,***
'
!,"*!,"***
in St. Petersburg from 1901
according to the census of
!(#*+"-***
%'
"!*#'#***
to 1910, which he obtained
2002 was 3949.6 thousand
!+-*-#(***
%
""*#"***
!+%*-"+***
#'
!--*-+***
from the municipal statistics
Russians (84.7%), 87.1 thousand
!+"*%(#***
#
!("*""(***
department.
U k r a i n ia n s (1.9%), 5 4. 5
!+,*!%'***
"'
!("*#!!***
!('*-'-***
"
!(%*,(%***
In 1926 N. N. Petrov
thousand Belorussians (1.2%),
!+%*!++***
!'
!(,*!,***
initiated an institute of
36.6 thousand Jews (0.8%) and
!',*#'+***
!
!'!*!%(***
!'*,(%***
'
!*(#+***
oncology in St. Petersburg,
35.6 thousand Tatars (0.8%).
,*%"#***

+'*++-***
which was later named after
him. Obligatory registration
Cancer care facilities
!
'


'
!
was
attempted
in
St.
There are three medical
*$ &
*$ &
Petersburg in the 1930s and
institutes and two advanced
"*'(%*+%-***
"*!%*"-#***

was permanently adopted
training institutes for doctors,

  
after the Second World
as well as a large number

*  *****""**$***


**   &*
of clinics and hospitals. Some 


  
of the patients come from War. Epidemiological research is carried out in the Petrov
* *$"&** **
other parts of the country. Treatment of cancer patients is Institute of Oncology, including a study of cancer incidence
carried out mostly in the City oncological dispensary at the in different areas of the ex-USSR.
Annually we publish 12 editions on morbidity and
Professor N. N. Petrov Research Institute of Oncology, or in
a number of oncology departments in large general hospitals. survival. Additionally we systematically take part in different
The total number of oncological beds is 1252, including 428 conferences and have TV and radio presentations. Data of
radiological and 75 paediatric. Ordinary hospitals and clinics the Cancer Registry are systematically presented to the local
government, and they are taken into account in developing
treat 40% of oncological patients.
Since 1953 in Russia there has been an established the organisation of oncological services to the population.
state system of oncological services (cancer control). Each Our suggestions to develop establishment of further cancer
administrative territory has its own centre (an oncological registries are accepted in a draft of the Order of the Ministry
dispensary) with 200 to 1000 beds depending on population. of Health concerning improvement of oncological services
This oncological centre provides all three components of curative in Russia.
treatment (surgery, radiotherapy and chemo-hormonotherapy).
In general this therapy is free of charge using federal funds as Source of population
well as funds of obligatory medical insurance.
Ofcial governmental estimates based on the 2002 census.
(Committee on Statistics of St. Petersburg).
Registry structure and methods
The General process of registration is the same as that used Multiple primary rules used
across the whole territory of the ex-USSR. A doctor who IACR rules (2000) on historical data.

350

Europe

Serbia
Registration area
The Population Register for Cancer was formed in Serbia
in 1970, originating from the Plan of Statistical Research
of Interest for the Republic of Serbia. In the 1990s the data
quality and the functioning of the registry greatly improved.
The Central Serbia Cancer Registry covers an area of
55 968 km2, and had a population of 5 484 920 (June 2000
estimate). About half live in urban areas (48.7% male, 51.3%
female); 90% are Serbs and 60% are Orthodox Christians.
Central Serbia includes 18 districts, in the central part, within
the Republic of Serbia, divided into 115 municipalities.
Cancer care facilities
Notication of neoplasms is
mandatory by law for every
physician who diagnoses or
treats a malignant tumour.
Information
sources
concerning new cancer cases/
deceased cases are data
from the oncology institutes,
oncology
dispensaries,
oncology clinics, hospitals and
outpatient health institutions,
pat hoh ist olog y/cy t olog y,
haematology
and
other
laboratories, death reports,
health insurance funds and
targeted researches. The
notication is sent to a regional
Cancer Registry located in the
Institute of Public Health of
Serbia.

)%.%&&...
/#.&+/...
%&&.0/,...
%,%.&+,...
%,#.&,'...
%)#.)),...
%01.'++...
&&/.#00...

The Central Serbia Cancer Registry includes the


following data: personal characteristics of new cases/
deceased, possible appearance of multiple primary tumours,
date of determination of current illness, diagnostic methods,
tumour characteristics (primary and secondary anatomy
localisation, histology type, stage), outcome of the disease, as
well as data on the health institution reporting the tumour.

Interpreting the results


Since 1994 the diagnosis, cause of death and morphology
have been coded using ICD-10, and according to the ICD-10
and ICD-O-2 (1998) and ICD-O-3 (2001). The Register does
not include in situ tumours (codes D00-D09), but includes
clinical stage in situ.
The Register is supported
by the CanReg3 (1998) and
SERBIA (1999-2002)
CanReg4 (2001) programme
SERBIA (1999-2002)
packages.
With the aim of providing
quality in collection, entry,
keeping, processing and
0#,).&,1...
analysis of data in the
/+!
%#/.,+#...
Registry, the methodology of
/#!
%,#.,&0...
,+!
%01.',)...
international associations was
,#!
%/0.1%'...
applied (IARC I ENCR) for
++!
%+%.'%,...
+#!
%1,./',...
cancer registers.
)+!

&&1.&),...

Use of the data


Following the aforementioned
%01./,)...
&#!
%0).#&1...
activities and the several
%0,.%#)...
%+!
%/0.'00...
years necessary for achieving
%,0.+/+...
%#!
%,#.+'&...
%+&./#+...
+!
%)+.#%&...
stability of the data, conditions
%',.#%%...
#!
%&1.&)/...
were created for issuing the
rst Report in December
%#
+
#
#
+
%#
2001.

.($*


.($*
Registry structure and
&.0%&.&%)...
&.,/#.+1)...

Unpublished data of the
methods
Republic Statistics Institute
In 1986, with the aim of 
  
.&###..&##%.
.

. 
..
.. 
. .
. .
".
.

.  .

.
were used for the analysis of
applying a unied Registry 
.  .  .%111
.
  . .
.&##&.
..
 . ..

.
..
.  ".
methodology in all territorial units
of
the
Former
Yugoslavia, death due to malignant tumours in Central Serbia.
 


  
. 
.(%11#..&###*..
Apart from crude rates, the Report includes standardised
the Guidelines On Ways And Procedures Of Reporting
Persons With Malign Neoplasms, the Regulation Book For incidence and mortality rates on World population. These rates
The Register Form And The Method Of Updating, The were standardised by the method of direct standardisation, with
Report Forms And Reporting And Cancelation Procedures the World, European or truncated population as the standard
population. Registry data calculated and analysed at the Center
For Certain Diseases were adopted.
Imprecise guidelines, insufcient education of medical of Prevention and Control of Noncommunicable Diseases have
personnel, and a lack of informatics support resulted in the been used for the purposes of descriptive epidemiology.
The percentage of new malign tumour cases registered
under-registration of newly found cases of cancer, as well as
relatively poor data quality on the report forms themselves. on a death report only basis, as well as the percentage of
Starting from legal obligations and role of the Registry, the histologically and cytologically-veried malignant tumours
reorganisation of the Register began in 1996, in accordance of the total number of reported cancer cases, were the
with the recommendations of the International Agency for foundation for the evaluation of Registry data quality.
Research on Cancer (IARC), and European Network of
Cancer Registries (ENCR). The reorganisation encompassed: Source of population
decentralisation (registers are formed on a regional level, The populations for 1999, 2000 and 2001 are estimates
while the main database for Central Serbia is located in the provided by The Statistical Ofce of Republic of Serbia. The
Institute of Public Health of Serbia), active data collection, estimated populations were an extrapolation from the 2002
new sources of information, education of medical personnel, census assuming linear growth in every age and sex group.
informatics support and a feedback system. In 1998, due to
this successful reorganisation, the Central Serbia Cancer Multiple primary rules used
IACR rules (1990 and 2000).
Registry was admitted into the IACR.
%1+.)')...

)#!

%11.0+/...

%/,.,%#...

'+!

%0%.'%&...

%/%.&/,...

'#!

%/).+#1...

%0%.)+'...

&+!

%0%.&#,...

351

Europe

Slovak Republic
Registration area
clinics is provided about change of name, address, diagnosis
The National Cancer Registry of the Slovak Republic covers the and about the death of any cancer patient. In the registry
whole population of the Slovak Republic, with 5 400 679 inhabitants each newly notied patient is compared and checked with
(2 625 691 males and 2 774 988 females) in 2000. The Slovak the main le of patients already registered to ensure proper
Republic is divided into 8 regional units and 79 districts and covers registration of new primaries and elimination of duplicates.
an area of 49 035 km2, with a perimeter of 1672 km and a population All death certicates (all causes of death) are regularly
density of 110.1/km2. In 2000 nearly 13% of the inhabitants lived reviewed to ensure the inclusion of previously unregistered
in the two bigger cities, Bratislava and Koice. Twelve percent lived cases and consequently to include DCO cases.
The National Cancer Registry database is annually
in another nine towns with 50 000100 000 inhabitants, 30.4% in
communities and smaller towns of 500049 999 inhabitants, and reconciled with the database of hospitalised patients
the remainder in villages with fewer than 5000 inhabitants. In 2000 (established by the Ministry of Health). If any cancer report
the majority of the working population was employed in industry is missing, it is searched for and requested of the provider.
and agriculture (37.8%), the remainder being employed in building
The completion of dates of death is now also assessed using
and service industries, research
data from the Office for the
and trade. In 2000, employees
Evidence of Population of the
in the Slovak Republic could be
Slovak Republic. Since 1990, the
SLOVAK REPUBLIC (1998-2002)
divided by education into four
registry has received considerable
SLOVAK REPUBLIC (1998-2002)
categories: basic (9.1%), trained
information about cancer
(29.2%), secondary (48.8%)
patients from other documents
and university (12.9%). The
accompanying the notication
majority of the population is of
form (discharge summary,





 








Slovak nationality, the second


hospital record, operation report,







most numerous group being


results of histology or cytology

 












Hungarian. Unemployment was


and autopsy report).







18.3% in 2000, but 9.6% at the



 












end of 2006.
Interpreting the results

 





There was no national screening













 


programme in 19982002,
Cancer care facilities
 
 


 


although screening for colorectal


In 2000 there were 95 hospitals














cancer was introduced in 2002


in the Slovak Republic. There







and PSA testing is widely


were 92 public (state) hospitals







 



 


available. An increase of in situ


and hospitals with polyclinics (7






cervical cancer and a decrease


university hospitals, 79 hospitals
in breast cancer mortality
and 6 psychiatric hospitals) and






despite increasing incidence
3 private hospitals. Cancer care

(# %


(# %
would suggest the existence of
at the highest level is provided



"('"&('*!(((

some screening programmes
by the St Elisabeth Cancer

  
or at least an improvement
Institute and the National Cancer !**),"+(

("!(
(""(

(#( 
( (
(
%(
 


  
Institute, both in the capital of Slovakia.
There are oncology in diagnosis and health education. The national screening
( 
(#"$%((&((
(
and radiology departments at the university and most of the programme for cervical cancer became available in 2007.
county hospitals. The peripheral network of oncology outpatient
clinics is oriented to registration and notication of diagnosis, Use of the data
active lifelong follow-up and providing treatment for cancer Annual reports have been published regularly since 1983. The
patients. The creation in 2000 of the Eastern Slovak Cancer annual report contains detailed data on cancer incidence in
Institute has also contributed to improving high-level cancer Slovakia, including sub-regions, and is distributed to all the
care and, in general, the quality of diagnostic and treatment health institutions of the country (Ministry of Health, central
institutes, hospitals, centres of clinical oncology, public
services for cancer patients is gradually improving.
health institutes). The data are used for policy preparation
for cancer care and prevention, as well as for planning
Registry structure and methods
The National Cancer Registry of the Slovak Republic is facilities for the diagnosis and treatment of cancer patients.
a population-based cancer registry established in 1976. Recently these data have been increasingly used by the
It covers the entire population of the country and collects National Centre of Health Promotion and by the Slovakian
League Against Cancer, mainly for health education of the
cancer data from the year 1968 onwards.
Cancer reports and death notication forms are used for data population in the eld of cancer prevention.
The data are also used for many other international
collection. The registry has had its own computer centre since 1990.
In 2005 it moved from the National Cancer Institute to the National collaborative projects.
Centre for Health Information, Bratislava. The staff of the registry
now consists of one epidemiologist, one full-time and four part-time Source of population
physicians (oncologists and pathologists), seven registrars and one 19982000: estimates. 2001: Census. 2002: estimates
computer specialist. Notication of cancer is compulsory, and all (Statistical Ofce of the Slovak Republic).
physicians have three months to complete the notication forms.
The registry notication form is completed in the district Multiple primary rules used
oncology outpatient clinics. Further information from the IACR rules (2004) on CI5 IX period.

352

Europe

Slovenia
Registration area
The Cancer Registry of Slovenia covers the entire population
of the Republic. The population at the most recent census
(2002) was 1 964 036. About 50.8% of the population lives
in urban areas (>3000 inhabitants); 83.1% are Slovenians,
2.0% Serbs, 1.8% Croats, the remainder other nationalities,
mainly from neighbouring countries and countries of former
Yugoslavia. The prevailing religion is Roman Catholic, and
84.7% of population is aged 15 years or over.

information as well as to the hospitals or doctors who signed


the death certicates in case the patient had not yet been
registered. Trained registrars, supervised by a physician,
perform coding of the information. Case identication is
based on a personal identication number that also enables
accurate follow-up of patients for death by regular linkage of
our data to the Central Population Register. Data protection
regulations are strictly respected.

Interpreting the results


The small and stable proportion of cases registered after
Cancer care facilities
Health care centres and private practitioners provide the publication of annual reports (about 4%) shows that the
primary and outpatient secondary health care; most of them majority of cases are reported to the Registry by the time of
publication. The registration
are included in the public
of patients treated in the
health care network. There
outpatient department only
are 12 general hospitals and
SLOVENIA (1998-2002)
(e.g. non-melanoma skin
Clinical Center in Ljubljana as
SLOVENIA (1998-2002)
cancer, multiple myeloma,
a tertiary healthcare facility.
chronic lymphatic leukaemia,
The Institute of Oncology,
as well as prostate cancer) is
founded in Ljubljana in 1938,
incomplete.
is the only Slovenian national
#$,.$',,,
.!+
%',!!),,,
There are no ofcial
comprehensive cancer centre.
#-,$-',,,
-)
%.,#)#,,,
data on PSA testing, but it is
Besides patient care, it is
%!,'#*,,,
-!
'/,)#),,,
'$,#)/,,,
*)
)',..),,,
becoming very popular among
involved in research and
'/,%'!,,,
*!
)',/!.,,,
urologists. It is not paid to
education in the framework
)',$-.,,,
))
)*,%/',,,
*),*!.,,,
)!
*%,-#$,,,
general practitioners by health
of the University of Ljubljana
.#,%.*,,,
')
--,!.#,,,
insurance.
Medical Faculty. Common
-/,$'%,,,
'!
--,!-!,,,
--,!'.,,,
%)
-*,)'#,,,
cancers are treated in general
-%,*//,,,
%!
-%,%-$,,,
Use of the data
hospitals, though the Institute
-%,'/',,,
$)
-!,)*),,,
-*,/-.,,,
$!
-$,-*),,,
Annual reports on cancer
of Oncology is the referral
-!,..%,,,
#)
*-,**/,,,
incidence have been published
centre for rare cancers. Except
*$,*/*,,,
#!
)/,-!%,,,
)$,)#),,,
)
'/,-*-,,,
since 1951, since 1965 in
for skin cancer, radiotherapy
'-,!--,,,
!
'',$.*,,,
Slovenian
and
English.
is administered only there.
The data collected serve as
About half of cancer patients
#!
)
!
!
)
#!
the basis for assessing the
are admitted to the Institute

,&"(


,&"(
national cancer burden, for
at some time during their
#,!$!,%/!,,,
/**,/#/,,,

programming and evaluation
illness.

  
,
, ,
,  ,,,%!,
, 
,,
,, 
, ,
,
, ,
,
,,
,
,  ,
of
primary
prevention,


, ,
,
, ,
,
diagnosis, treatment and rehabilitation, for programming
Registry structure and methods
 


  
,
,&$!!'(,,,,
The registry was founded in 1950 and is located at the and evaluating primary prevention, diagnosis, treatment and
Institute of Oncology Ljubljana. Notication of cancer has rehabilitation, planning facilities and funding needed for
been compulsory since the beginning and is prescribed by cancer control (personnel, equipment and hospital capacities)
law. In 2003, the Registry was merged with Epidemiology as well as for clinical and epidemiological research in
Unit in a single service, Epidemiology and Cancer Slovenia and in international multicentric studies. The results
Registries, which also comprises, the hospital-based Cancer of our studies are published in national and foreign medical
Registry of the Institute of Oncology, Epidemiology Unit literature and as publications for lay readers.
Our data have been published in all eight volumes
for epidemiological studies and Cervical Cancer Screening
Registry, which coordinates, monitors and evaluates the of the Cancer Incidence in Five Continents. The data on
nationwide organised cervical cancer screening program, cancer incidence and mortality for the years 198399 were
introduced in 2002. The Registry is staffed by two full- also included in the international databases EUROCIM,
time medical doctors, specialising in epidemiology and GLOBOCAN, ACCIS. The survival of Slovenian cancer
public health, a junior researcher in statistics, 4 registrars, a patients is included into and analysed by the international
computer operator and part-time system analyst. Other staff studies EUROCARE II and EUROCARE III.
are involved in screening and other work.
The main sources of data are notications gathered Source of population
from all hospitals and diagnostic centres in Slovenia, and Ofcial number of the population as at 30 June provided by
exceptionally from primary health care centres in cases in the Statistical Ofce of the Republic of Slovenia based on the
which the patient was not referred for further diagnostic Central Population Register of the Republic of Slovenia.
investigations. Death certicates and autopsy protocols
stating cancer diagnosis supplement this information. When Multiple primary rules used
needed, requests are sent to notiers to ensure accurate IACR rules (2004) on historical data.

353

Europe

Spain, Albacete
the Comunidad Autonoma. Our Registry currently employs
Registration area
Albacete is situated in the Central Meseta in the southeast of 2 doctors and a nurse.
Data collection is active, carried out by the personnel
Spain. The province consists of 87 municipalities, 67.5% of
which have fewer than 2000 inhabitants and only 5.9% have of the registry from lists provided by the sources, and by
more than 10 000. The climate is Mediterranean temperate consulting the les and clinical records concerned. The
with some continental features. The average total annual registry records cases voluntarily notied by physicians in
the primary care services.
rainfall is approximately 275mm.
No active follow-up of cases is carried out. The registry
The size of population covered by the registry at midyear 2000 was 363 263 inhabitants. The population density has access to death certicates mentioning cancer for local
(24 inhabitants per km2) is very low compared to that of residents who die in the Autonomous Community. Death
the country as a whole. Of this population, 15.5 % live in certicates are traced back to nd further information if the
rural areas of fewer than 2000 inhabitants, 24.5% in semi- case is not already registered, and if no further information
rural areas of 2000-10 000 inhabitants, and 60.0% in urban is found the case is registered as death certicate only. There
is no personal contact with
areas.
patients or their families.
The
ethnic/racial
All data are automatically
composition that our Registry
SPAIN, ALBACETE (1998-2001)
processed
using a system,
covers is practically all white.
SPAIN, ALBACETE (1998-2001)
which includes checking
Only in recent years have
for duplicate registrations
immigrants accounted for
by name, social security
35% of the population, and
number or clinical record.
these are generally young
(# (((
*%'
!(++*(((
(+%!(((
*
#(&)*(((
Cases are coded by ICD-O
people with low risk of
%(&+%(((
)%
)(! *(((
topography and morphology.
cancer.
*( +(((
)
+(! (((
+(! #(((
&%
( *(((
Multiple tumours are coded
*(&+&(((
&
+( +%(((
following the IARC/IACR
Cancer care facilities
*( #)(((
%%
*(%%*(((
*(+#*(((
%
+(&&(((
recommendations.
The
Six hospital centres are
+(* (((
#%
+(% (((
CHECK program is used to
located in the province, three
(**(((
#
(#)(((
#(% (((
!%
!(* *(((
detect errors and discrepancies
of which are private surgical
%(*(((
!
#(&+%(((
in the data.
hospitals and three public
#(+#(((
%
#( )#(((
#(+)+(((

#(#%(((
general hospitals. There is one
!(&#(((
%
 ( &+(((
Interpreting the results
private pathology laboratory.
(% (((

(+%)(((
()&&(((
%
()(((
It is not possible to estimate
There are 34 public primary
+(#*(((

*(*(((
how many cancer cases remain
care centres. Almost all of
undiagnosed, but it probably
the population is covered

%


%

does occur for elderly subjects
by the public health system

("$


("$
in rural areas. SESCAM has
(SESCAM).
* (#!)(((
*(&(((

a full range of diagnostic
Data for the registry

  
facilities, so it is unlikely that
are obtained from the 
,(((
( (" ,

$(
General Hospital of Albacete  


  
(pathology and haematology cases referred will be missed. A screening service for breast
( 
("++$((
laboratories, oncological and medical records departments); cancer is operated by the Asociacin Espaola contra el
the Local Hospital of Hellin (pathology and haematology Cncer since 1991. Use of PSA tests is opportunistic and of
laboratories and medical records); the hospitals N S de los an unknown extent, but in general it is not uncommon.
Llanos; Santa Cristina, Virgen del Rosario and Clinica de
Recoletas; the Dr liguez de Onzoo pathology laboratory, Use of the data
the Provincial Ofce of SESCAM, the regional mortality The registry prepares an annual report of cancer incidence by
site, sex and age. The registry also participates in analytical
register and the National Institute of Statistics.
In general our area has a good availability of diagnostic epidemiological investigations. Policymakers use our cancer
and treatment services, but the radiotherapy department did registry data for planning or evaluation of health services,
especially in breast cancer screening programme and the
not begin operation until the year 2002.
regional cancer programme.
Registry structure and methods
The Cancer Registry of Albacete was created in February Source of population
1990 by the Consejera de Salud de la Comunidad Autonoma Census: Instituto Nacional de Estadistica (http://www.ine.es).
de Castilla-La Mancha, and it belongs to the Regional
Service of epidemiology with the principal objective of Multiple primary rules used
analysing cancer incidence in the province. It is nanced by IACR rules (1990).

354

Europe

Spain, Asturias
funded by a Public Health Directorate from Asturias Health
Registration area
The Asturias cancer registry covers the whole Principality of and Health Services Council, a government body in charge
Asturias, a Spanish Autonomous Community of 10 565 km2 of planning and providing health care and public health
located on the northern coast of the Iberian Peninsula. This services to the whole Asturian population. The registry staff
well-dened region lies between latitudes 42 and 43 N and comprises one part-time epidemiologist and two full time
registrars.
longitudes 4 and 7 W.
The registry uses active casending from different
In 2000 the total population was 1 076 567 inhabitants.
Of these, 21.4% were aged 65 or more, and 60.4% lived in sources including public and private hospitals, pathology and
the central urban area of Asturias but only 43.4% in cities of haematology laboratories and death certicates to identify
more than 100 000 inhabitants. The population density that cancer cases diagnosed among the residents of Asturias.
There is also a hospital-based registry in Central Hospital,
year was 101.53 inhabitants per km2.
In 2000 the unemployment rate was 16.4% in Asturias, and which provides computer les to the registry. Cancer is not a
the distribution of occupation by sector was 10.2% in agriculture notiable disease in Asturias.
and shing, 16.9% in industry,
Interpreting the results
11.8% in the building sector and
From 1998 to 2000 an
61.1% in services.
SPAIN, ASTURIAS (1996-2000)
organised
breast
cancer
The prevailing religion in
SPAIN, ASTURIAS (1996-2000)
screening programme was
Asturias is Roman Catholic.
implemented in Asturias
covering women aged 5064,
Cancer care facilities
reaching a 60.5% participation
General health care in
"$"$$$
&!#
"$!!$$$
'$%!$$$
&
&$$$$
in the rst round.
Asturias is provided mostly
%$!$$$
%!
"$$$$
Trends in prostate cancer
by public services through a
!$&$$$
%
$!$$$
$""$$$
"!
%$&$$$
incidence should be evaluated
well-developed network that
$$$$
"
$!$$$
with caution because the
comprises 8 district hospitals,
$!&$$$
!!
!$'%'$$$
$!""$$$
!
!$!!$$$
impact of opportunistic PSA
220 urban and local primary
%$%$$$
!
%$"'$$$
screening.
health care centres, and Central
'$"$$$

$&$$$
$%!$$$
!
$%"$$$
Hospital in the capital (Oviedo),
'$&$$$

'$!$$$
Use of the data
home to a comprehensive
$"$$$
!
'$$$$
$&$$$

$"$$$
The registry publishes regular
oncology centre that offers
"$&$$$
!
!$%$$$
reports on cancer incidence.
cancer surgery, radiotherapy
%$""$$$

!$"$$$
'$&%'$$$
!
'$%$$$
Data from the registry have
and chemotherapy services.
!$"!$$$

$&&$$$
been used for etiological
Patients suspected to have
research in the EPIC cohort,
cancer are diagnosed and

!


!

evaluation of breast cancer
given treatment in the 8 health
 $
 $
programmes, and to plan
districts and referred to Central
!"$$$$
!'$!$$$

radiotherapy facilities and
Hospital when required. These

  
other cancer services.
facilities are supplemented by    $$
$" $
 


  
one private hospital that offers some
cancer
treatments. Very few
$  $
$$  $$
Source of population
cancer cases require additional treatment outside Asturias.
Census data (INE 2006).
Registry structure and methods
The registry was initiated in 1978 and become population- Multiple primary rules used
based in 1982. It is located in Oviedo and since 1981 has been IACR rules (2004) on historical data.

355

Europe

Spain, Basque Country


an epidemiologist partially assigned to the registry, and
Registration area
The area covered by the Basque Country Cancer Registry several administrative registrars have the hospital registries
(BCCR) is the Autonomous Community of the Basque Country, as the main sources of information. Notication is voluntary.
an area of 7261 km2 situated in northern Spain between latitude An active system of data collection from other sources has
4027 and 4228N and longitudes 144 and 326W. It been established, and cases are abstracted from clinical
consists of three provinces: Alava, Bizkaia and Gipuzkoa. records and entered in the computer. Data from incident
At the 2001 census, the total population was 2 082 587, of cases are complemented by death certicates mentioning
whom 17% were over 65 years old. The population density cancer (pre-1996) and all death certicates since then. A
is 286.8 persons/km2. About 28% of the population live in case is registered as Death Certicate Only when no further
rural municipalities. The employment of the active population information has been obtained after looking for information
by sector is: services sector 62%, industry 27.5%, building in the sources. Checking for duplicates is routine, and the
activity 8.7% and agriculture 1.8%. The prevalence of smoking IARC-Check program is used periodically. Arrangements
in men and women is decreasing: 31% and 21% respectively. have been made with cancer registries outside the registration
area to notify the BCCR of
The proportion of immigrants
any resident cancer cases they
was low but increasing. Most
diagnose or treat.
of the population is Roman
SPAIN, BASQUE COUNTRY (1998-2001)
Catholic.
SPAIN, BASQUE COUNTRY (1998-2001)
Interpreting the results
Rates from 1986 to 1994 were
Cancer care facilities
converted from ICD-O-1 to
General health care in the
ICD-O-2. Since November
region is provided by the
-*##***
,')
"'*-!'***
!%*(%#***
,
",*##'***
1995 there has been an
Osakidetza, the public Basque
"+*,(+***
+'
%!*-!"***
organised
breast
cancer
Health Service, to 95% of
%"*-,(***
+
'#*!,%***
'#*'"#***
('
(*",,***
screening programme in the
the population. There are 40
'"*'+***
(
''*%"(***
Basque Country covering
hospitals (public and private,
(*''***
''
("*!",***
(,*+#***
'
(-*"+***
women aged 5064 years.
one of them devoted to
+"*-,,***
%'
+#*'%***
There is no populationcancer treatment) excluding
+-*#'%***
%
,*#"(***
,'*%%***
#'
,'*(***
based cervical screening
the psychiatric ones, and
,(*-%'***
#
,#*-("***
programme, but there is
approximately 4 beds per
,-*-#-***
"'
,'*###***
,!*-!***
"
+,*'%***
opportunistic
screening
1000 inhabitants. Most cancer
(#*!#***
!'
'-*+%***
mainly in women at higher
patients attending the network
%+*''***
!
%'*#+(***
%!*"'#***
'
#-*'"***
risk. The large increase in
of primary healthcare centres
%"*#%!***

%*#***
prostate cancer in recent years
are referred to medical
can be related to the use of
specialists at the general
!
'


'
!
PSA by general practitioners
hospitals
with
oncology
 *$ &
  *$ &
!*((*+!'***
!*"*'!"***

and specialists since 1998.
facilities. Over the last 10
years the number of radiology 
  
Use of the data
facilities for cancer diagnosis  *
* *** ** ** *!--(**"!* ** *** *
* * ***
 


  
and treatment as well as the number
of oncology specialists A report with descriptive results of the registry is published
*  *$"%&** **
in an annual report by the Basque Health Department.
has increased in both the private and the public system.
Information provided by the registry is used for planning
and evaluation of health services. Survival has been studied
Registry structure and methods
The Basque Country Cancer Registry was created in in the framework of the EUROCARE study.
Data have been used for the evaluation of the breast
1986 by the Department of Health. The main aim was to
determine cancer incidence and its characteristics in the screening programme and in several collaborative studies
Basque Country, to provide information for the planning of such as EUROCARE, Europreval, ACCIS and EPIC among
cancer services and preventive activities, and to facilitate others. In-house studies include several cancer sites and
their relation to health services, and evaluation of coding to
epidemiological research.
A major reorganisation of the Cancer Registry has taken implement a semi-automated programme.
place since 1995. In each province a team was dened
and ve hospital cancer registries were established. The Source of population
coordination of the BCCR remained in the Health Department Estimate of the population at risk is based on the 1996 and
(Vitoria-Gasteiz), where a computer technician and one 2001 censuses without taking into account immigration into
epidemiologist were assigned part-time to the registry. or out of the area.
Previously registered cases were converted from ICD-O-1
to ICD-O-2 with IARCtools, and a new data management Multiple primary rules used
application was developed. The head of the provincial team, IACR rules (2004) on historical data.

356

Europe

Spain, Canary Islands


method or tumour site. Since 2006 we have had internetRegistration area
The archipelago of the Canary Islands is one of the based access to the records of the 4 major hospitals, which
autonomous regions of Spain. It is located 100km east has been an excellent tool.
Some patients go to hospitals in mainland Spain for
from the African coast and 1500km from mainland Spain,
treatment, but most diagnoses are made in the islands, and in
between latitude 27 and 30 N.
The Registry covers the population of the two major any case many of these are collected via death certicates, so
islands (Gran Canaria and Tenerife), which are the we believe the registry completeness level is acceptable.
administrative capitals of the two provinces. Those two
islands had a population at mid-year 2000 of 1 474 802 Interpreting the results
There is an organised screening programme for breast
inhabitants (population covered by the registry).
The population is almost 100% Catholic although there cancer in women aged 5064 years from, and opportunistic
are some people from India who have lived in the islands for screening for cervix and prostate cancer. PSA testing is
generations. In recent years, especially in 2001 and 2002, common in the population.
the islands have undergone
Use of the data
a
strong
immigration
The registry publicises an
phenomenon, mostly from
SPAIN, CANARY ISLANDS (1997-2001)
annual report of incidence
South America.
SPAIN, CANARY ISLANDS (1997-2001)
with the cases of one given
The economic activities
year, available online at: http://
are agriculture (7%), industry
www.gobier nodecanarias.
(3.4%) and services, mainly
org/sanidad/scs/3/3_5/cancer/
tourism (77.9%).

 












ppal.jsp.







The data are used


Cancer care facilities

 












continuously
by
health
There is a network of







managers in health planning


primary health care centres














for
the
hospitals
and
and two reference hospitals





 

government. The Registry has


in each island with services












 

also conducted some other


of oncology, radiotherapy,







studies in cancer mortality,


haematology and cancer














and collaborates with several


surgery and chemotherapy.







investigations of colorectal,














breast, cervix and thyroid


Registry structure and







cancer and melanoma.


methods
The registry belongs to the






Source of population
Public Health headquarters

*&"(


*&"(
1998 Census. Geometrical
and is part of the Epidemiology



+#+*#%#***

interpolation
between
Service. Each island has a
  

*

 *
*


*#--).#--- *#---.$!!#*
 *

 *
*


*
*  **
*  *
19961999.
19992001
team of 2 medical doctors, 2 #--,*

* * * *
*
 **
*  **
*  ** * * *
*
*
 *
Census. Geometrical interpolation between the population
nurses and 1 clerk.
      
* 
*&$!!'(** **
The Registry actively collects
data from public and private on the rst day of January of the year, and the population on
  
)+*
**
*  *
sources. Registrars search for cases
at pathology, oncology, the rst day of January of the next year.
radiotherapy, and haematology services, in inpatient records
and hospital cancer registries, as well as in private pathology Multiple primary rules used
laboratories and among death certicates with cancer as IACR rules (2004) on historical data.
primary cause of death.
If necessary, patient medical records are veried by the Notes on the data
originating hospitals, either to conrm the incidence date, C67 includes only invasive tumours.

357

Europe

Spain, Cuenca
3. To know the temporal evolution of cancer incidence in our
Registration area
The population-based Cancer Registry of Cuenca was created in province.
1993, within the Epidemiology Service of the Health Department 4. To know survival rates in cancer patients and their
temporal evolution.
of the Autonomous Community of Castilla-La Mancha.
The area covered by the Registry is the Cuenca province, 5. To contribute to improving and encouraging epidemiological
located between 4033 and 3935 N latitude, corresponding investigation, preventive measures and sanitary care in
oncology patients.
to the Spanish Central Plateau.
The population (according to the 2000 census) was
201 060 inhabitants (100 127 males and 100 933 females), Material and methods
including 1289 immigrants; 44% live in rural areas (<2000 All malignant tumours diagnosed from 1 January 1993
inhabitants). Some 25% are older than 65 years, and 14% are in persons residing in Cuenca at the moment of diagnosis
under the age of 15. The province covers 17 140 km2 (238 are eligible for the RCCU. Furthermore, following WHO
municipalities), at a population density of 11.7 inhabitants/ recommendations, we register all bladder tumours,
independent of their behaviour.
km2. The economic activity
Basal and squamous cell skin
rate for the population aged
cancers are not registered.
1665 is about 50%. Economic
SPAIN, CUENCA (1998-2002)
The data are automatically
activity is developed in the
SPAIN, CUENCA (1998-2002)
processed using a system
services sector (45.1%), in
that includes checking to
agriculture (25.2%) and in
avoid duplication, such as
industry and construction
surnames, Social Security
(29.7%).
'/&*-///
1,.
(/-31///
'/,30///
1$!
(/111///
number and Clinical History
*/-0&///
0,!
,/0(0///
code. We use the CHECK
Cancer care facilities
-/'03///
0$!
-/03'///
-/1'$///
-,!
0/$1*///
program to detect errors and
In the registry area there are
,/,-&///
-$!
-/&&0///
inconsistencies between the
a public hospital (with 90% of
*/0-,///
,,!
,/&0*///
,/$$(///
,$!
*/1&*///
different variables.
the beds) and a private hospital.
,/(-0///
*,!
*/110///
Cases are codied according
In the public hospital, there is
-/0-'///
*$!
,/3&$///
0/3-,///
(,!
0/&-$///
to the ICD-O-2, following the
an oncology service where
0/00(///
($!
-/333///
recommendations of the IARC
chemotherapy is provided,
0/'$&///
',!
-/,3,///
-/30-///
'$!
-/'00///
to classify multiple primary
and a surgery service that
-/$&&///
&,!
,/-,-///
tumours as well as to register the
serves cancer patients. Patients
,/(-,///
&$!
,/''1///
,/$('///
,!
*/11&///
different variables (incidence
are sent to referral centres for
(/3-,///
$!
(/1,&///
date, diagnosis basis). Access
radiotherapy. There are 37 public
to patient data is restricted to
Primary Health Care Centres
&$
,
$
$
,
&$
Registry personnel.
covering the province.
 /)%+
  /)%+
&$$/',1///



&$$/0,$///

Use of the data


Registry structure and

  
2/ /
2/
/ / / //5/
/
/ /// / /) +"/
4##" "  /
The registry publishes a report
methods

//
2/ / /&/5/ /&331 /  / /// / //  /  /"/
The personnel devoted to the Cancer
Registry of Cuenca are of cancer incidence from 1993 to 2002, highlighting trends,
 


  
 / /)'$$$+/
evaluating survival and making geographical comparisons.
two physicians, three nurses and a clerk (all part-time).
Data collection is carried out actively by the personnel Our registry is also taking part in the Regional Plan Oncology
of the Registry through the review of clinical histories in the in CastillaLa Mancha. The registry also participates in a
hospital or in the Primary Health Care Centres. The registry national research project about rare tumours.
The information obtained was used to produce three
receives the automated discharge les and the computerised
pathology reports from the public hospital. Furthermore, we incidence posters at the National and Regional Epidemiology
receive individualised information from the cases treated by Annual Conference.
The data will also be used to measure the effect of the
general practitioners, and from the hospital physicians who
attend patients with cancer, as well as information from death breast cancer screening programme.
certicates. There is an organised screening programme for
breast cancer that also informs us of newly diagnosed cases. Source of population
The principal objectives of the Population Cancer Updated information from the municipal registers of
inhabitants for each year published by the Instituto
Registry of Cuenca are:
Nacional de Estadistica (INE http://www.ine.es), except for
1. To know the real incidence of the Cancer in our province, the population aged less than 1 year in 1998, which was
as well as its distribution by age, sex, morphology and calculated based on annual growth.
topographic site of the different tumours.
2. To compare our incidence with that in other registries in Multiple primary rules used
IACR rules (2000).
Spain and other countries.

358

Europe

Spain, Girona
year the registry analyses all death certicates. The registry
Registration area
The Girona Cancer Registry covers the population of Girona staff visit the sources, where they check medical records
Health Region, located in the north of Catalonia in the and database of individual departments related to both the
northeast of Spain. The population at the most recent census diagnosis and treatment of cancers. Their main objective is
(2000) was 538 139. The area covered by the registry is to identify and abstract information on cases of cancer that
divided into 209 municipalities, with Girona city the largest have been diagnosed by all methods. Arrangements have
(approximately 86 672 inhabitants). Within this region, also been made with the hospitals located outside the Girona
about 57% of the population live in urban areas (>5000 registration area in order to obtain information from patients
whose cancers have been diagnosed and treated outside the
inhabitants).
The population in Girona province is ethnically very Girona area. Accordingly, these sources are visited once a
homogeneous, with the majority of the population being year to review these procedures. All records are interpreted
Caucasian. However in recent years there has been a huge increase and after coding, updated and processed. The registry is
in immigration from Africa. According to the 2001 census in organised as a multi-user online database.
Morphology has been coded
the province of Girona, 7.7% of
according to ICD-O-3 since
the population are immigrants,
1998 and site has been coded
originating from other European
SPAIN, GIRONA (1998-2002)
according to ICD-O-3 since
countries (1.8%), Africa (4.0%),
SPAIN, GIRONA (1998-2002)
2000. Before 2000, site was
South America (0.85%) and Asia
coded according to ICD-O-1
(0.26%).
and morphology according
to ICD-O-2 since 1993. The
Cancer care facilities





 








rules used for coding multiple


He a lt h c a r e i s p r ov id e d







tumours are those proposed by


predominantly by the National








 





IARC/IACR. Quality control


Health Service through the





 

of data is ensured through the


district hospitals and a network












 

DEPedit programme.
of primary health care centres.







Condentiality is ensured
There are nine public hospitals














by
the
application of the rules
with 1087 beds and three private







proposed by the European


hospitals with 233 beds (2.45

 



 


 





Network of Cancer Registries


beds per 1000 inhabitants).







(ENCR).
Medical specialties concerning














The estimated completeness


ca ncer t reat ment i nclude






for the period 19982002, taking


radiotherapy, cancer surgery
into account the proportion of
and chemotherapy and are







)$!&


)$!&
DCN cases, was around 95.7%.
carried out at different general
 


#*")''()))

hospitals but coordinated by the
Interpreting the results
reference cancer centre in the 
  
)  )
)

)

)
))
)",,())# ")

)

)
)  ) )
))
A screening program for
city of Girona (Catalan Institute 
)",,+)",,,)#
 )
)

)
)
)# "))# #)  )
) 
)

)

)
)
)
 )
))
)",,+-#
))
of Oncology-Hospital Universitari

) 
)) ))
)
)))
)
))
de Girona Dr. Josep Trueta) breast cancer was started in the area covered by the registry
 


  
which has radiotherapy facilities) 
)$#
at its %&)) ))
disposal. Some cancer in 1999, and there are opportunistic screening services for
patients may be diagnosed in hospitals located in Barcelona cervical cancer in the area. Use of the PSA test in the medical
(100km from Girona), and the cancer registry also covers such practices has also increased during this period.
sources of information.
Use of the data
The information obtained is used to produce annual incidence
Registry structure and methods
The Girona Cancer Registry began its activities in 1995. reports. Data on cancer incidence serve as a basis for health
It is funded by the Department of Health of the Catalan planning. Our registry has carried out and participated in
Government and is carried out by the Catalan Institute of epidemiological studies. Studies on both survival and care of
patients with some specic tumours are also being carried out.
Oncology.
The staff is composed of a director, an oncologist as a
coordinator, an epidemiologist, a technical registrar and Source of population
a clerk. Several oncologists, hematologists, pathologists, The 1998, 1999, 2000 populations are intercensal estimates
computer scientists and statisticians are external based on the 1996 and 2001 censuses, where allowance for
births, deaths and migration have been made. The 2001 and
collaborators.
Notication of cancer is voluntary. Data collection is 2002 populations are postcensal estimates, where the same
active, from 21 sources consisting of general hospitals and methodology used in 19982000 has been applied, without
pathology laboratories. Data are obtained mainly from making any correction based on a later census.
admission services and medical records, as well as from
pathology, oncology and haematology departments. The Multiple primary rules used
death registration system is adequate and complete; every IACR rules (2004) on historical data.

359

Europe

Spain, Granada
les for the hospitals and the computerised pathological
Registration area
The population covered is the province of Granada within reports from the public hospitals. Data collection is mixed:
the Andalusian Region in the south of Spain. It lies between incorporation of the automated hospital systems and active
latitudes 38 and 36 N, and has an area of 12 635.3 km2. The complementary search in hospital records by the registry
province has 71km of coast along the Mediterranean; a large staff. Information based on primary health care is limited.
part of its territory is mountainous, and one of the highest Due to condentiality requirements, access to death
certicates at the National Statistics Institute is not possible,
summits of Spain is found there (Mulhacn, 3481 m).
The population in 2000 was 809 006 inhabitants (395 and registry personnel have to collect this information in
659 men and 413 347 women), 16% of them aged 65 years each of the municipalities. Coverage of this source was about
or more. The province is divided into 168 municipalities: 90% until the year 2000. From this year the access to this
there is only one urban centre (Granada) with approximately source is forbidden.
Data processing is carried out on a personal computer,
240 000 inhabitants, and 6 other municipalities have more
than 20 000 inhabitants, the rest of the population (56%) living and quality control of the data is ensured through the IARCCHECK programme and
in smaller municipalities. The
other specic programmes
population is ethnically very
developed in the registry.
homogeneous.
SPAIN, GRANADA (1998-2002)
Granada has been one of
SPAIN, GRANADA (1998-2002)
Interpreting the results
the Spanish provinces with the
lowest income per inhabitant,
Undiagnosed cancer cases are
an important factor inuencing
unlikely because diagnosis
migratory movements from
and treatment (radiotherapy
&+ , +++
-(*
-+"- +++
(+)"$+++
- 
/+&$-+++
1950 to 1970, which have since
and chemotherapy) of cancer
" +/ (+++
,(
"(+""-+++
stabilised. Of the economically
are available in the province
")+"()+++
, 
"/+,($+++
# +","+++
)(
##+()#+++
active population, 10% are
of Granada. From the year
"-+#-(+++
) 
# +&- +++
employed in agriculture, 22%
2000 it is not possible to use
"-+$$&+++
((
"/+)/,+++
# +("#+++
( 
#"+(/&+++
in industry and building, and
death certificates as a source
##+&$)+++
&(
##+, "+++
62% in services. Industrial
for case-nding, and this could
#,+(#(+++
& 
#,+($(+++
$"+(#(+++
$(
$"+,,$+++
activity is limited to light
slightly decrease the degree
$$+$"#+++
$ 
$$+"/"+++
industry, particularly food and
of completeness, although
$$+-(/+++
#(
$$+ ((+++
$&+/, +++
# 
$$+/#)+++
wood processing. The rate of
the percentage of DCO in the
$ +-("+++
"(
#/+))&+++
unemployment is 7% of the
previous period was quite low
#)+/& +++
" 
#(+," +++
#&+(,#+++
(
#$+&#-+++
active population.
(4%).
",+ /,+++

")+ #,+++
An organised populationCancer care facilities
based breast cancer screening
"
(
(
"
The entire population (100%)
programme
has
been
 +%!'
  +%!'
has free access to public
established gradually in the
&"$+-$&+++
$/,+"$&+++

hospitalisation. The area is
province of Granada since the

  
served by four public (2137  .+ +
 .+
+ + ++"+ +  ++ + 0+ +0+% '+   0+ + 0+++
year 1997. Opportunistic PSA
 


  
beds) and three private (356 beds)
hospitals.
Private hospitals screening for prostate cancer could be responsible for the
 +  +%#
&'++ (++
+
serve a small part of the population. Diagnosis and treatment increase of prostate cancer incidence rates in the area.
of cancer are available within the province, so few cancer
cases are diagnosed or treated outside.
Use of the data
In addition to incidence gures and descriptive studies, some
Registry structure and methods
casecontrol studies on lip, skin and oral cavity cancer have
The Cancer Registry of Granada was established in 1985. It is been carried out. The registry is also involved in studies on
supported by the Regional Health Department of Andaluca care and survival of cancer patients within the framework
and run by the Andalusian School of Public Health in of the EUROCARE study, and in a cohort study on diet and
Granada.
cancer (EPIC Project).
The main registry staff consists of an oncologist as
director, one physician, and three clerks for case-nding Source of population
and data processing. In addition, one epidemiologist, one Updated using municipal registers of residents as of 1 January.
statistician and one computer expert (part-time) collaborate Instituto de Estadstica de Andaluca (IEA). Consejera de
with the activities of the registry and research projects.
Economa y Salud.
Cancer notication in Granada is voluntary. The basic
information sources include all public and private hospitals of Multiple primary rules used
the province. The registry receives the automated discharge IACR rules (2004) on CI5 IX period.

360

Europe

Spain, Murcia
pathology, hematology, oncology, radiotherapy, outpatient
Registration area
The Murcia Cancer Registry (Registro de Cncer de clinics and clinical departments of public hospitals. Registry
Murcia) covers the whole region of Murcia, one of the 17 staff abstracts medical records to complete cancer data.
autonomous communities of Spain. This region is situated In private hospitals the main sources of information are
in the southeast, a Mediterranean area. The average pathology laboratories and medical record departments. In
density is 118.1 inhabitants. The region is divided into 45 order to ascertain cancer patients who are treated out of the
municipalities. Approximately 53% of the population lives region, the RCM receives notications from the National
in three municipalities with more than 50 000 inhabitants, Registry for Childhood Cancer (RNTI) as well as from
while 7% lives in rural areas (<10 000 inhabitants). The the social security reimbursement service, which refunds
main cities are Murcia, the capital, with 409 818 inhabitants, expenses for being treated in hospitals out of the Region of
Murcia.
Cartagena with 203 945 and Lorca 87 153.
In 1996, a new semi-automated program was developed.
The population (2000) was 1 149 328, of whom 17.7% are
children. Nearly 11% of the working population is employed All previously registered cases were converted from
ICD-O-1 to ICD-O-2 with
in agriculture, although the
IARCtools and, in addition, a
proportion has been decreasing
considerable number of cases
during the last decades; 62%
SPAIN, MURCIA (1997-2001)
were manually reviewed.
work in services and 27% in
SPAIN, MURCIA (1997-2001)
When cancer is mentioned
industry and construction. The
on a death certicate (DC),
region has an important foodand the Registry has no
processing industry. Adequate
information on that case, the
food consumption frequencies
%*%!+***
,')
.*.***
(*++,***
,
!!*(!.***
main les of the principal
are observed in most of the
!#*%'+***
+'
!,*('***
hospitals are searched. If the
population for fruit, dairy
"*%.***
+
"%*...***
"%*..!***
('
",*",%***
case is not found, the certifying
products, olive oil and protein
"'*((***
(
"+*%'.***
physician is questioned. If
foods such as poultry, eggs
"%*(#***
''
"(*!.+***
",*.+(***
'
#*!"***
the information gathered is
and sh. Consumption of
#"*!"***
%'
#"*!(.***
sufcient to register the case,
red meat is higher than
#,*!(***
%
#+*(!.***
%'*!#***
#'
%#*+!,***
that case is registered as a
recommended. Two in three
'*.'!***
#
%,*'!***
Death Certicate Notication
people are overweight. The
'"*%%#***
"'
%,*,(#***
'"*.!"***
"
%.*.!***
(DCN). If no other information
prevalence of smoking in
%'*#+'***
!'
%"*'.!***
is available apart from that on
2002 was 41% in males and
#+*,(#***
!
#'*'(***
#'*#'%***
'
##*"+%***
the DC, the case is accepted
34% in females, showing an
#"*"'"***

#*%.***
as a Death Certicate Only
increasing trend for women
(DCO). Both DCO and DCN,
and a decreasing one for men.
!
'


'
!
among other indicators, are
During the last decades the

*$ &


*$ &
used for monitoring quality
city of Cartagena had severe
'+,*%%+***
'+!*!%,***

control.
air pollution problems, mostly

  
due to industrial emissions. *

/*
-*
*  -*
*
**!*
**
*!..(*!..+*!..,*!...*"*"!* * *
 


  
Interpreting the results
 * 
*$!..&*
Opportunistic screening for cervical cancer is carried out
Cancer care facilities
Primary health care and hospital treatment are provided by public and private healthcare, increasing the number of
free of charge to every member of the population through a Pap tests from the eighties to the nineties, but there is a
National Health Service. The region is divided into 6 health low number of total cervical cytology compared with the
districts, each with at least one public hospital. There are 25 rest of Spain. The PSA testing is an irregular practise in
Hospitals, 12 public and 13 private hospitals for a total of the region of Murcia operating by the cancer society and
4317 beds, 73% of which belong to public hospitals, although clinicians. A population-based screening programme for
practically all private beds may be used by the public health breast cancer started at the end of 1995 with a current
participation rate near 70% of the total female population
service by agreement.
Patients suspected to have cancer in the primary and in the region.
secondary care facilities in the registry area are referred rstly
to local public hospitals, and secondarily to the reference Use of the data
hospital located in Murcia, which has a comprehensive The main purpose of the Registry is to estimate cancer
incidence in the region, trends and survival. In addition,
cancer Radiotherapy Unit.
the RCM is used for planning and evaluation of cancer
control programmes as well as for epidemiological studies.
Registry structure and methods
The Murcia Cancer Registry (Registro de Cncer de Murcia, The RCM has participated in two multicentre casecontrol
RCM) was established in 1981 as a project of the Consejera studies, one on HPV and cervical cancer carried out in
de Sanidad of the Region of Murcia, developed by the Colombia and Spain, and another on non-melanoma skin
Department of Epidemiology. The database is registered at cancer in four Mediterranean countries (initially Helios
I Project and afterwards Helios II Project). Currently it
the Spanish Data Protection Authority as stipulated by law.
Information is principally collected by registry personnel. is involved in the European Prospective Investigation on
The identication of new cases is done mainly through the Nutrition and Cancer (EPIC study), coordinated by IARC.

361

Europe

The registry participates in EUROCARE, following up


cases diagnosed between 1990 and 1998 to provide data
and contribute to calculating survival throughout Europe.
The Registry is also involved in two multicentre Spanish
studies, the first in rare tumours and the second in
validating the cancer diagnoses in the minimum dataset
from hospitals.

362

Source of population
Annual estimates: Updated using municipal registers of
residents as of 1 May of 1996, 1997, 1998, 1999, 2000, 2001.
Madrid, INE.
Multiple primary rules used
IACR rules (1990).

Europe

Spain, Navarra
Association Against Cancer and the Public Health Institute
Registration area
The area covered is the Community of Navarra, one of the of Navarra. The main objective is to study the incidence and
17 Autonomous Communities of Spain. Situated in the north principal characteristics of cancers occurring in Navarra, to
of the peninsula, Navarra borders on France to the north (the promote and facilitate epidemiological investigations, and to
Pyrenees), the Autonomous Community of Aragn to the east, provide data for planning of health services and preventive
the Autonomous Community of La Rioja to the south and the activities.
The registry staff includes one part-time epidemiologist,
Autonomous Community of the Basque Country to the west.
The total area of Navarra is 10 491 km2. Navarra is and a full-time nurse and a social assistant who are
scantily populated, with a density of 49.6 inhabitants per responsible for casending and coding. An administrator
records and processes the data. The Advisory Committee of
km2, and is the fth least inhabited Community in Spain.
According to the 2001 census, Navarra had 555 829 the Navarra Cancer Registry collaborates with the staff. The
inhabitants, of whom 33.5% lived in Pamplona, capital of data are processed in the Registry itself.
Active casending involves systematic collection of
the provincerising to 50% if the surrounding area is
information on all cancer
included with the city. Of this
cases diagnosed in hospital
population 49.8% are men,
departments in Navarra.
13.7% are aged 014, and
SPAIN, NAVARRA (1998-2002)
Notication of cancer is
18.1% are 65 or over.
SPAIN, NAVARRA (1998-2002)
voluntary. The principal
In the last decade Navarra
sources of information are the
has had a small positive
pathology and haematology
migratory balance, as well as
laboratories,
radiotherapy
a signicant re-distribution
(/0&$///
1,.
1/'01///
*/2'-///
1$!
1/,&0///
and oncology departments,
of the population toward
1/1'0///
0,!
&&/22'///
as well as the medical records
Pamplona and its surrounding
&&/-$&///
0$!
&(/1$,///
&(/($(///
-,!
&*/*&(///
departments of all public and
area. There are more
&'/,0'///
-$!
&'/20,///
private hospitals. Data on
births than deaths, and the
&,/&*2///
,,!
&*/0'2///
&0/-*$///
,$!
&0/',&///
incident cases are completed
population has grown older
&1/,21///
*,!
&0/00*///
by data on deaths obtained
over the last years due to the
'$/1(0///
*$!
&2/1$'///
'(/&&2///
(,!
'&/,(*///
from the Mortality Registry
large decrease in mortality.
'*/(*'///
($!
''/*'1///
through a systematic search,
During the last 25 years, the
'*/*'$///
',!
''/*2'///
''/'&(///
'$!
'$/0&(///
mainly for completing the
birth rate fell from 17.72 in
&-/-&*///
&,!
&,/,&0///
cause and date of death.
197576 to 10.04 in 2001.
&(/*2*///
&$!
&'/*02///
&'/-*$///
,!
&&/1&,///
Follow-up
is
carried
The mortality rate adjusted
&'/220///
$!
&'/'&-///
out through examination
for the European population
of medical records and
in the period 199599 was
&$
,
$
$
,
&$
death certicates. There is
774.8/100 000 inhabitants for
 /)%+
  /)%+
no personal contact with
men, and 410.9 for women;
'01/0((///
'00/$$'///

patients. Data are recorded on
in 200004 it was 691.6 and

  
 / /"/
individual notication forms
368.1, respectively. During  /   "// / 5/ /"/

4##" " # # #
 # 3 # 3 32-$'"/
200004, life expectancy for those
born in Navarra was 77.9 and later entered onto computer with a system of individual
 


  
 / /)'$$*+// ,//
/
access for each registry staff member. Duplicate and quality
for men and 85.0 for women.
control checks are run periodically. The IARC rules are used
for multiple primaries.
Cancer care facilities
The Navarra Health Service covers 95% of the population.
Health care in Navarra is composed of basic health districts, Interpreting the results
which are grouped into three health areas. All inhabitants During this period, no changes occurred in the area covered,
have access to the health system through the primary level although the number of inhabitants increased by 6.7%
(Health and Consultation Centres), or through the emergency between 1996 and 2001. The aging of the population is to
departments at the primary or secondary (specialised) level. be taken into consideration: at the time of the 1996 Census
Cancer control activities in the region are based on there were 14.3% population under 15 years and 17.4% over
promotion of healthy lifestyle, health checks for people 65 years. There have been no changes in the availability of
occupationally exposed to carcinogenic substances, and diagnostic services and/or treatment.
In 1993, topography and morphology were coded using
hepatitis B vaccination in childhood. There is breast cancer
screening in women aged 4569, cytology screening for CIE-0-2 for Oncology. During 19932002, the European
cervical cancer among groups considered to be at risk, and Network of Cancer Registries recommendations on incidence
ad hoc advice to the population. Any patient suspected of date and behavioural classication in bladder cancer were
having cancer has access to any diagnostic and treatment applied. Since 1995, all tumours of the Central Nervous
facilities considered necessary, and is followed by public System have been collected.
Since 1990, there has been a breast cancer screening
assistance services and/or by private services.
programme for women aged 45-64, raised to age 69 for the
years 19982002. The increase of prostate cancer incidence
Registry structure and methods
The population-based Cancer Registry of Navarra was created rates could be due to increased use of the PSA test during
in 1970, as a result of the collaboration between the Spanish this period.

363

Europe

Use of the data


The registry produces local reports on cancer incidence
in Navarra for biennial and quinquennial periods. It has
collaborated in evaluation of the breast cancer screening
programme in Navarra. The registry has participated in
two casecontrol studies on cancer of the cervix and of the
larynx, and in a study on brain cancer. It is collaborating
in the EPIC study as well as in studies of trends and of
childhood cancer. The registry participates in EUROCARE
and the EUROPREVAL group. It has been providing data

364

to Cancer Incidence in Five Continents since Volume III, as


well as to the ACCIS and EUROCIM databases of IARC.
Source of population
Intercensal estimates. Instituto de Estadstica de Navarra.
Gobierno de Navarra. http://www.cfnavarra.es/estadistica/
agregados/poblacion/estim_censo/estim_censo_9602.xls.
Multiple primary rules used
IACR rules (2004) on CI5 IX period.

Europe

Spain, Tarragona
by active search in the rest. The main sources of information
Registration area
The Tarragona Cancer Registry covers the province of are inpatient records, pathology laboratories, hospital-based
Tarragona, located in the south of Catalonia in the northeast cancer registries and haematology laboratories. The Registry
of Spain next to the Mediterranean Sea. In July 2000 the receives copies of all death certicates of people who were
population was 595 652. The two largest towns have 114 000 living in the province. Cases notied from a death certicate
and 89 000 inhabitants respectively. Five other towns have are systematically traced, and if no further information is
more than 20 000 inhabitants, 26 other towns have 3000 obtained, are registered as death-certicate only cases.
The Registry records malignant tumours whether in situ
20 000 inhabitants and 147 villages fewer than 3000.
Approximately a third of the population was born in other or invasive, and includes tumours of the nervous system of
parts of Spain and migrated between the 1950s and 1970s. undetermined nature. Bladder papillomas, if histologically
About 20 000 foreigners are ofcially residents in the province veried, are not registered. Although the Registry employs a set
(among them, more than 8000 from Morocco and 7000 from of rules for the inclusion of multiple primaries, which are more
Europe). Since the establishment of the Registry in 1980, liberal than those of IARC/IACR, the results presented here
strictly follow these rules.
there have been no changes in
The control of duplicates
the area covered by it, although
is based on name, birthdate,
the population increased from
SPAIN, TARRAGONA (1998-2001)
sex, places of birth and
513 000 in 1980 to 607 000 in
SPAIN, TARRAGONA (1998-2001)
residence, personal identity
2001. Most of the people belong
number and social security
to the white Mediterranean race.
number. Online checks are
Roman Catholicism is the major
made when entering the data
religion.














in the computer to detect


The prevalence of smoking





 

errors and inconsistencies.


in people aged 1564 was 55%













The IARC-Check program


in males and 20% in females





 

is used periodically to detect


in 1982, and 43% in males











errors and unlikely situations.


and 25% in females in 1998.







From 1998, the Registry


Of the working population,














adopted
the criteria and
7% belong to the agricultural







the codes of ICD-O-3 for


sector, 21% to the industrial








 





recording morphology.
sector, 14% to the building





 

sector and 58% to the service










 



 

Interpreting the results


sector. In the province there

 





Some assessments indicate


is a petrochemical complex
that the completeness of the
active since the 1970s. Three







*%!'


*%!'
Registry exceeds 9697%.
nuclear power stations have



#.(* #+***

Since the beginning of the
been running from the 1980s;
Registry in 1980, availability
another has been stripped down 
  
"..,0# "
*

*

*
*
**
*"..)**# "*

**
*  * *
** ****
of diagnostic and treatment
after running since 1975.
 *
*
 *
*
*
* -*
*# "**$ /*
**
 


  
services increased, although it is difcult to estimate the
* 
*%# &'** **
inuence of these changes in the cancer incidence trends.
Cancer care facilities
There was no population-based cervical cancer screening
Practically all the population is covered by the National Health
Service. In 2000 the number of physicians was around 2000. programme in the area during the period, but an annual
In the period 19982001 there were seven public hospitals average of approximately 36 000 cytological examinations
and six private ones in the area, with a total of 1250 beds. for cervical cancer were carried out.
A population-based breast cancer screening programme
One of the public hospitals has a 32-bed oncology department
that includes medical oncology, radiotherapy oncology and started in 1998 for women aged 5064, raised to age 66 in
palliative care units. Some cancer patients are transferred the second round. The participation rate in the rst round
to specic hospitals in Barcelona (100km from Tarragona), was 58%. About 36% of participants of this programme had
a previous mammogram within the two years before the
which are also sources of information for the Registry.
mammogram of the programme.
The use of the PSA test was quite high during this period,
Registry structure and methods
Since 2001, the Registry has belonged to the Foundation but the degree of inuence of this diagnostic procedure on the
League for the Cancer Research and Prevention, which prostate cancer incidence rates in Tarragona is not known.
receives nancial support from the Department of Health of
the Catalan Government. The Registry also receives funds Use of the data
The Registry produces cancer incidence and survival
from the provincial administration.
The staff includes a director, two epidemiologists, a statistics for the area, and describes their major
computer scientist, a nurse, a medical ofcer and one clerk. epidemiological characteristics and their evolution. It
Several specialists (in oncology, pathology, epidemiology also promotes epidemiological research and advises
policymakers on current and future needs for cancer care
and others) act as external collaborators.
Notication of cancer is voluntary. Data collection is services. It collaborates directly in the evaluation of the
through passive notication in the majority of sources and Breast Cancer Screening Programme of the province,

365

Europe

supports the evaluation of cervical cancer prevention and


other cancer control activities and evaluates its effects.
Source of population
19982001. The intercensal estimates are based on the
1996 and 2001 censuses, making allowance for births,

366

deaths and migrations into and out of the registration


area. Population census of 2001. Institut dEstadstica de
Catalunya.
Multiple primary rules used
IACR rules (2004) on historical data.

Europe

Spain, Zaragoza
Registration area
The Zaragoza Cancer Registry covers the population of one
province (Zaragoza) within the region of Aragn, in the
northeast of Spain. The population at the most recent census
(2000) was 848 006. About 81% of the population lives in
urban areas; most are Christians.

death certificates when cause of death is identified as


cancer.
For some cancers, such as haematological tumours and
childhood tumours, complementary information sources
(such as the Haematological Registry and the paediatric
hospital cancer registry) are used to evaluate the completeness
and accuracy of the information recorded.

Cancer care facilities


General health care in the region is provided predominantly Interpreting the results
by the Health Services Department of Aragn through a It is not possible to estimate how many cancer cases remain
network of primary health centres and public hospitals. undiagnosed, but it probably occurs only for elderly subjects
This is supplemented by private practitioners and hospitals. who have had a pathology diagnosis. PSA testing is common
The Zaragoza Cancer Registry is located in Zaragoza, the in the population.
In interpreting these results,
capital of the province, and
note that since year 2000 data
provides radiotherapy, cancer
have been received electronically,
surgery and chemotherapy
SPAIN, ZARAGOZA (1996-2000)
as a new met hod of d at a
services. Patients suspected
SPAIN, ZARAGOZA (1996-2000)
collection. Automatic registration
to have cancer in the primary
began in 2000 as well.
and secondary care facilities
in the registry area are mostly
Use of the data
diagnosed and treated in the
#&)&&&
(#%
&###&&&
'&#&&&
(
&$)&&&
The registry prepares an annual
public hospitals of Zaragoza.
&)&&&
'#
)&)&&&
report of cancer incidence,
We estimate that very few
)&)&&&
'
&)&&&
&&&&
$#
$&!&&&
highlighting
trends
and
patients are followed outside
&'&&&
$
!&'$&&&
changes. Some special studies
the registry area.
&!&&&
##
&$)&&&
$&'&&&
#
$&(&&&
have been carried out. The
'&)&&&
!#
'&#''&&&
Registry is participating in
Registry structure and
)&!&&&
!
)&(&&&
&(&&&
#
&!##&&&
several epidemiological studies
methods
&)'$&&&

&'(!&&&
such as risk of second primary
The registry was funded
&$!&&&
#
&#)&&&
&!'&&&

&('!&&&
cancers, rare tumours in Spain,
in 1960 by the state Health
'&($&&&
#
#&)'&&&
childhood cancer trends,
Department. The registry
&'(&&&

&&&&
(&(&&&
#
'&#&&&
incidence and mortality cancer
is staffed by two part-time
$&(&&&

$&!&&&
inequalities, the HAEMACARE
medical ofcers, one part-time
project and validity of hospital
administrative worker and one

#


#

discharge records for estimating
full-time health worker.

& "


& "
cancer incidence. Policymakers
The Zaragoza Cancer
!&!(&&&
!&&&&

mainly use our cancer registry
R e g i s t r y u s e s s e ve r a l

& & &
&
data for planning purposes.
different sources of data: 
  
 


  
primarily pathology and haematology
laboratories,
& 
& ))"&&
radiotherapy and chemotherapy services and hospital Source of population
discharge records. The registry staff visits these sources Obtained from municipal census.
and records all cases with diagnosis and treatment of
cancers diagnosed by all methods, among residents of Multiple primary rules used
the registry region. We supplement this information with IACR rules (1990).

367

Europe

Sweden
Registration area
The Swedish Cancer Registry covers the whole population
of Sweden. The mean population in 2002 was 8 924 958.
About 24% of the population lives in urban areas (>100 000
inhabitants). The main part of the population is Protestant;
approximately 15% are not members of the Church in
Sweden.

The registration of newly detected tumour cases is based


on compulsory reporting by all physicians responsible for
in-patient and out-patient departments in all public and
private establishments for medical treatment. The data in
the Registry are supplemented with information on cause
and date of death by computerised linking with the Cause of
Death Registry. The Swedish Cancer Registry does not use
information on cancers based on death certicates only.

Cancer care facilities


Cancer care facilities in Sweden are incorporated with Interpreting the results
the general healthcare system. There are oncological The overall reporting to the registry is estimated to be 96%
centres in each one of the six medical regions of Sweden. of all diagnosed cases.
There are two main screening programmes in Sweden:
Nearly every cancer case will sooner or later be seen at a
breast and cervix cancer. PSA
hospital. Hospital and forensic
testing for men is also quite
pathologists make independent
common in recent years.
compulsory reports on every
SWEDEN (1998-2002)
cancer diagnosis made from
SWEDEN (1998-2002)
surgical biopsies, cytological
Use of the data
specimens and autopsies.
The registry prepares an
annual report of cancer
Registry structure and
%'" '''
)$&
"' )'''
*"'( '''
)
"*' "'''
incidence, highlighting trends
methods
"$'$%'''
($
* ')$"'''
and changes. The publication
The Swedish Cancer Registry,
%%'%%'''
(
**' ")'''
)'*$'''
%$
' )"'''
is, since year 2000, only
which was established in 1958,
%'($('''
%
' '''
published on the Internet.
is managed by the Centre for
)*' '''
$$
)'%%'''
"'%"'''
$
(')"'''
Many researchers in
Epidemiology (EpC) at the
**'))%'''
"$
*'*('''
Sweden and in other parts of
National Board of Health and
*('*)$'''
"
)(' * '''
)'*$'''
$
 '%*'''
the world use the registry.
Welfare. The Government
$' $'''

')"'''
nances the registry. Six
**'% "'''
$
)*'%'''
%%')))'''

$%'*%"'''
regional cancer registries
%' '''
$
")'"" '''
Source of population
covering the whole country
*$'*'''

(*' "'''
'))'''
$
)%''''
Ofcial population statistics
perform the registration of new
"'$)'''

 '$)'''
from Statistics Sweden.
cancer reports and the major
check-up and correction work.

$


$

These registries are associated
 '!#
 '!#
Multiple primary rules used
with the oncological centres
"'")*'%'''
"' *'% '''

IACR rules (2004) on
in each medical region of

  

''' ''  '


historical data.
Sweden.
 


  
'  '!"#'' ''

368

Europe

Switzerland, Geneva
is located in an apartment opposite the Geneva University
Registration Area
The Canton of Geneva is situated at the extreme west of Hospital in the centre of the city.
Diagnostic and treatment services are easily accessible:
Switzerland. It has a total surface of 282 km2, of which Lake
Geneva occupies 36 km2. The climate is temperate: mean Biopsies are mainly carried out at the central laboratory or
temperature is 11.5C, with temperatures varying from -8.8C in other specialised services of the public hospital. Since two
to 35.3C in 2002. The annual rainfall amounts to 1166mm years ago, a large part of the biopsies have been transmitted
(2002). Air quality is fairly good: the annual average pollutant in electronic form, allowing a linkage with the registrys
concentrations observed in the centre of Geneva are 6 g/m3 database each month. There are three private pathology
for S02, 32 g/m3 for NO, 42 g/m3 for NO2, 34 g/m3 for 03 laboratories that provide records to the registry or permit
systematic consultation of them. Autopsies are performed at
and 0.6 mg/m3 for CO (2002, from ROPAG-SCPA).
On 31 December 2002, the population of the canton was the university hospitals, and the necropsy rate is estimated at
427 705, of whom 14.5% were aged 65 and more and only 21.9% 7% of deceased residents (2002). Every case has a personal
younger than 20. This structure is due not only to the joint number for condentiality.
Data collection for the
effects of a low fertility rate and
registry is undertaken by
an increase in life expectancy,
examining the university
but also reects fairly heavy
SWITZERLAND, GENEVA (1998-2002)
hospitals records of the
immigration (often temporary)
SWITZERLAND, GENEVA (1998-2002)
various services concerned, as
at the ages of economic
well as by a questionnaire sent
activity. This immigration
out to private practitioners.
comes traditionally from Latin
The response rate of the latter
countries. Due to a restrictive








 





is more than 90%.


policy in granting Swiss







We have access to
nationality, the proportion














all reports from the only


of the resident population







department of radiation
considered as foreign remains














oncology in the canton. This


high, at 38.4%, of which 18%







department provides us with


were Portuguese, 14% were














a control listing each year.


Italian, 12% French and 10%






The registry also has access


Spanish.










 

to all death certicates in


The economically active







the canton, which in addition


population is concentrated in














to clinical records, permit


the administrative and service







a continuous follow-up.
sectors (82%), with production
In addition to this passive
workers comprising most






follow-up, the registry also
of the remaining population
 *%!'
  *%!'
undertakes active follow-up



",)*(++***

(16%); agricultural workers
of all cases each year. This
are few (<2%), due to the small 
  
follow-up is facilitated by
amount of cultivated land and   *- **  * ** * * ** *** **   *$"*
 *
* *  *
the high degree of agricultural mechanisation
(1995 gures). direct access to the Cantonal Ofce of Population. In
 


  
* *%# &'****
the case of death, the primary cause is recorded and reThese gures remain unchanged to date.
examined, as well as the possible presence of a tumour,
clinical or conrmed, at the time of death.
Cancer care facilities
The hospital facilities for acute illnesses comprise one
general public university hospital with 1267 beds (1997) Interpreting the results
and some smaller private hospitals and clinics. Cancer As an indicator of reliability of the data, a very low
patients are also treated at two other university hospitals, percentage of cases (<1% 19982002) are recorded from
namely a geriatric institution (300 beds) and a hospital death certicates only. In addition, the low rate of cases
for chronic affections (300 beds). No hospital, either found at autopsy (0.7% 19982002) compared with the total
public or private, has beds reserved specifically for number of cases conrmed histologically suggests that most
cancer patients. Between 1997 and 2002 there were no cases are identied during the lifetime of the patient.
During this period 19982002, there was not yet a screening
major changes.
program in the canton for any localisation of cancer, but
since 1 January 1999 there has been a screening programme
Registry structure and methods
The Geneva Cancer Registry was founded in 1969 and for breast cancer. Nonetheless, spontaneous screening is
started recording cases in 1970. In 1991, the Registry was well accepted in the population, with mean annual screening
attached directly to the Public Health Service of the Canton rates of about 40% for Pap tests (women aged 15) and about
of Geneva. Since 1999, it has been attached to the University 20% for mammographic screening (19911995). PSA testing
of Geneva, which provides most of the budget. Additional is generalised in the population of the canton.
funds are obtained from the Federal Ministry of Health,
Use of the data
through the Swiss Association of Cancer Registries.
The staff is composed of 12 persons, most of whom are Policymakers do not use our cancer data to evaluate health
part-time, with 3 doctors and 2 statisticians. The registry services. For planning, the cancer registry has received an

369

Europe

ofcial mandate to evaluate the breast cancer screening


program and the campaign against melanoma.
In addition to the processing and publication of routine,
incidence and survival data, the registry initiates or
participates in analytical epidemiological investigations.
Several casecontrol and cohort studies have been undertaken
for etiological or evaluative purposes.

370

Source of population
Average midyear annual estimates, based on ofcial
numbers of births, deaths, immigrations and emigrations, on
December 31st. Ofce cantonal de statistique.
Multiple primary rules used
IACR rules (2004) on historical data.

Europe

Switzerland, Graubnden and Glarus


Switzerland and the central ofce help to complete the data
Registration area
The cancer registry of Graubnden Glarus covers the les in the registry of Graubnden and Glarus, which in fact
population of the two corresponding cantons in the needs more personnel. As an active member of the Swiss
eastern part of Switzerland. The Canton of Glarus has 29 Association of Cancer Registries, the registry has permission
communities and Graubnden 213. The population at the from the Central Data Commission for Data Protection in
ofcial census 2000 was 36 600 for Glarus and 187 058 for Medical Research of the Swiss Government to receive nonGraubnden. About 15% of the population of Glarus live anonymised data on cancer patients.
Periodically quality control and plausibility procedures
in the capital of Glarus, while 20% of the population of
Graubnden live in the capital Chur. In both cantons about are performed partly by the registry itself, partly by the
40% are Catholics and 50% Protestants. Glarus has about Swiss Association of Cancer Registries.
During the reported period there have not been any
25% foreigners, while in Graubnden there are about 15%.
Most are Christians, whereas only a very small minority are changes in the covered area or the population registered.
Muslims. Only very few people immigrated from African Case denition and coding have been kept stable, except
for adaptation to TNMor South American countries.
Classication
or
the
Among the population of
recommendations of the
Graubnden, 27 038 were rtoSWITZERLAND, GRAUBUNDEN
AJCC. Reporting includes
roman, who keep their native
AND GLARUS
SWITZERLAND,
GRAUBUNDEN(1998-2002)
AND GLARUS (1998-2002)
incidence and follow-up for
language, the Rumantsch.
periods of 5 and 10 years.
Cancer care facilities
Interpreting the results
General healthcare in Glarus














Because neither of the two


is provided by the district





 

cantons has university service


hospital in the capital Glarus














and because a large population


and a network of about 40





 

live in rural areas, some cancers


practitioners. In the main











might
go
unrecognised.
hospital, cancer surgery and







However, the cooperation


chemotherapy are available.











of the neighbouring cantons


In Graubnden cancer







ensures that cancers treated


care is provided mostly in the





 








outside the registration area


main hospital in Chur, which







are captured.
includes all cancer services.












 

Still, screening for some


Radiotherapy is available only







cancers (e.g. cervix) is not


at the centre in Chur; some
thoroughly established, and
of the patients are treated in






needs further distribution
Zurich or St. Gall. A network
 )'#(
  )'#(
among the rural population
of some 10 hospitals and about



$$")*"&)))

at the cantons periphery.
300 practitioners supplement

  
) )) )%""") ))))) ) ))!)
For other cancers, i.e. breast
this care. Altogether 5% of the )  ) )
 )  )

)), 
 +)  )  ) ) ) !)
patients are treated in the cantons
of St. Gall, Zurich, Ticino cancer, a screening program is widely accepted. PSA
 


  
 ) )'%"""())
or even at hospitals over the Italian frontier (patients from screening for cancer of the prostate is widely accepted and
performed. Discussion is ongoing on the possibility of lung
the Posciavo).
cancer associated with exposure to free radicals (i.e. radon)
and also to dust-mediated pneumopathies.
Registry structure and methods
The registry is located within the Department of Pathology at
the main hospital at Chur, and is funded partly by the cantons Use of the data
of Graubnden and Glarus, and by the Federal Government The main objective of the registry is to make the data on
of Switzerland. A part-time pathologist (less than 10%) and a cancer incidence available to the Swiss Association of Cancer
part-time registrar (80%) are responsible for the registration Registries for publication and dissemination. In the future,
of new cases. The method of registration is strongly related more active participation in analytical epidemiological
to guidelines of the cancer registry network of Switzerland. investigations is planned. Providing data to policymakers
About 85% of new cases are directly notied through the for planning and evaluation of health services has to be
pathology network, the reminder being found by case study established in the future.
(scrutinising medical documents) in about 30 departments
of 12 hospitals of the two cantons. Notication is based on a Source of population
voluntary agreement between the medical institutions and the Annual estimate of permanently resident population at
registry. Death certicates are provided by the Federal Ofce midyear, based on the 2000 census and taking into account
of Statistics by special contract. In fact, there are more and births, deaths and migration. Source: Federal Ofce of
more pre-coded data available, facilitating the registry work. Statistics, Switzerland.
Cancer registries of Zurich, St. Gall and the Ticino complete
the datasets with information about patients hospitalised Multiple primary rules used
outside the registration area. The network of the registries in IACR rules (2000).

371

Europe

Switzerland, Neuchtel
Registration area
The Registry, which covers the whole of the French-speaking
canton of Neuchtel (800 km2 with about 168 000 inhabitants),
is located in the western part of Switzerland, sharing half of
its frontier with France. The canton is a mainly rural region
with only two cities of approximately 35 000 inhabitants. In
the absence of heavy industry, watchmaking and the microtechnical industry are the main activities.
Almost all the population is of Caucasian origin; 38% are
Protestant, 31% are Catholic, and foreigners, predominantly
of Mediterranean origin, currently account for about 23%
of residents. In 2000, the main occupational sectors in the
canton of Neuchtel were: industry 34%, agriculture 4% and
services 62%.
Cancer care facilities
In 2000, the region covered
by the Registry had around
900 hospital beds available
for diagnosis and treatment
(i.e. about ve beds per
1000 population). In the
same year there were about
520 practicing physicians
(one per 320 population).
Radiotherapy and oncology
services are integrated in a
unique coordinated multi-site
public organisation covering
the whole area.

an abstract of the medical record in the registry datale


and periodic computer linkage between the latter and the
centralised cantonal administrative population database
(active follow-up).
All death certicates are checked annually against the
Registry les. This constitutes a process of passive follow-up,
each subsequent item of information being used to complete
the record of an already-registered case.
All relevant information is manually scrutinised before
being interactively introduced into the computer of the
Computer Center of Neuchatel. Additional, more sophisticated
automated verications and analyses are also performed on
stored data in batch mode using ad hoc programs by the
Vaud Cancer Registry on the
computer of the University of
Lausanne (UNIL).

SWITZERLAND, NEUCHATEL (1998-2002)


SWITZERLAND, NEUCHATEL (1998-2002)


























































 























 
























Interpreting the results


There has been no organised
screening during the incidence
period for CI5-IX, but
prescription of the PSA test
is increasing, although not as
dramatically as in most western
European countries (preventive
prostate
examinationvia
biological test or clinical
examinationreported
on
average by 15% of men aged
4069 and resident in Frenchspeaking Swiss cantons).

Registry structure and









Use of the data


methods
The registry provides routine
The bulk of information






statistical annual incidence
is provided by the local
! 1,(.
 #! 1,(.
and mortality data by sex, age
Institute of Pathology (INAP)



2'1033111
!
and primary site, and data for
through biopsy, cytology and

  
1 11!61  1   !1$1 "1! 1/8 !1! 1 11  #$ 1+)&1 51 1
local planning purposes. It is
autopsy reports. Notication #! 51 #! 1#1 1 !!
4 4! 1 1 !1! 1,.%1  61  1 !! 1 1! &1! 1! 1 1!1 1
7 %1
7 %1)3328*''*&1
is based on voluntary agreement
between the recording also engaged in (mostly) descriptive epidemiological studies
 


  
 1 1,*''-.11 /11  1
medical institutions of the canton and the Registry. Other in collaboration with the Vaud Cancer Registry and the six
sources of information are the departments of oncology and other Swiss population-based registries belonging to the
haematology, which also centralise diagnostic and therapeutic Swiss Institute for Applied Cancer Research (SIAK).
Among the research opportunities offered by the
procedures for malignant haematological disorders.
The Registry is nancially supported by the local League operating structure within the collaboration agreement with
against Cancer (60% of the budget) and by the cantonal public the Registry of the Canton of Vaud is the denition of risk
health department for the remainder. Marginal support is of second neoplasms for patients registered with a dened
also provided by the Swiss government through the Swiss primary.
Association of Cancer Registries.
Moreover, information on residents diagnosed or treated Source of population
outside hospital, elsewhere in Switzerland, or in other Estimate: estimates from the Cantonal Ofce of Statistics;
countries, is provided by the neighbouring cantonal tumour resident populations by sex and 5year age group on
registries of Vaud and Geneva (mostly upper aero-digestive December 31st. Sources: Ofce rne; Service Cantonal de
tract, skin and childhood cancer cases) and the general Statistiques. Annuaires statistiques du canton de Neuchtel,
Neuchtel, 19982002.
practitioners.
Further information is also abstracted and systematically
checked by the registry staff from hospital charts. A specicity Multiple primary rules used
and strength of the registry is the routine integration of IACR rules (2004) on CI5 IX period.

372










 






Europe

Switzerland, St Gall-Appenzell
Registration area
The registry covers the three cantons of St Gall, Appenzell AR
and Appenzell IR in the northeastern part of Switzerland, a total
area of 2430km2. It extends between latitudes 46 and 47 N; the
lowest point is 396m and the highest 3247m above sea level.
The registry covers the entire resident population, amounting
to 521 971 in mid-2002. Of this total, 87% belong to the canton
of St Gall. Major parts of the area are rural. There is one city with
73 000 inhabitants. Important industries are metal machines and
vehicles, and construction, which are relatively broadly distributed
over much of the region. In 2000 the per capita income was 86%
of the Swiss average in St Gall, 81% in Appenzell AR and 87%
in Appenzell IR. Five sixths of the population are Swiss, the
others mainly of other European
origin.

follow-up for survival is carried out systematically at 5 and


10 years after diagnosis.
Reports are usually checked within a few days after
receipt. Names and dates of birth are checked in order to
nd duplicates. In case of doubt, a physician is asked for
advice. Six months after receipt of the rst report, additional
information is sought if necessary by mailed questionnaire
or in the case notes of hospitals. Addresses are checked with
ofcial population control ofces. Cases are nally coded
and closed by a physician only about two years after onset.
Several logical checks are automatically made by the
computer system. The coding is visually checked on the screen
and, after completion of a case, on the case printout. Additional
systematic checks on duplicate
registrations are done after
SWITZERLAND, ST GALL-APPENZELL
completion of a registration
year. Checks on consistency of
(1998-2002)
SWITZERLAND,
ST GALL-APPENZELL (1998-2002)
site, morphology and age are
done through the Association of
Swiss Cancer Registries.
Completeness of registration














has been traditionally evaluated







 

by the incidence/mortality














method (death cer tificate









method) and more recently via















the so-called flow method









(Boullard et al.). By this method
















it was ascertained that over









90% of the incident cases are
















registered within 12 months.









Cancer care facilities


In 2002 there were 882 active
physicians (1 per 592 inhabitants).
About 1720 hospital beds were
available in acute hospitals. The
central hospital in the city of
St Gall has a special clinic for
oncology as well as for radiooncology, and a public outpatient
clinic for cancer patients that
takes care of patients referred by
general practitioners and other
clinics. In addition, there are
ten consultant oncologists. For
inpatient care patients are usually








 





Interpreting the results


referred to a hospital within their





 

region. Most cancer patients are


There are no population-based
treated at the central hospital or
cancer screening programmes






in one of the peripheral acute
in this region. Screening is
 *%#'
  *%#'



$((*&)$***

hospitals within the region at
performed as an individual
least once during their disease. 
  
initiative and seems to be
* ** *$"""* ***** * **!*
Some people in areas adjacent to *  * *
 *  *

**, 
popular and effective for cervical
 +*  *  * * * !*
the urbanised canton of Zurich seek
care there.
cancer. More than 85% of cervical cancers registered were in situ
 


  
 * *%$""&'****
carcinomas. Early detection of breast cancer, on the other hand,
Registry structure and methods
could be much improved. Only 7% of breast cancers registered in
The cancer registry was founded by the Regional Cancer women aged 5069 years during 20002004 were non-invasive.
League in 1960 at the department of pathology in the central
hospital of St Gall. It was hospital-based until 1980, when Use of the data
it became population-based. The sponsoring bodies are the The registry prepares yearly routine reports on cancer incidence
Regional Cancer League and the three cantons covered by the including ve-year periods. Analyses such as time trends of cancer
registry, and it is also subsidised by the Federal Government. incidence and mortality, survival and stage distribution in selected
At present the registry has 3.6 full-time positions.
cancer sites are also carried out. Ad hoc analyses are done on request.
Reporting of cancer cases is voluntary. The most
The registrys data have been included in joint studies of
important data source is active and passive collection of the Association of Swiss Cancer Registries, e.g. on time trends
reports from the central pathology laboratory. In addition, of incidence of lung cancer, incidence of cancer in childhood,
the registry staff actively collects data in the other pathology and the risk of cancer by occupation. The registry takes part
laboratories in the region and in all regional acute hospitals. in international studies (ACCIS, EUROCARE, CONCORD,
In the central hospital, the departments of oncology, EUROPREVAL, EUROCHIP) as well.
haematology, radiotherapy, neurosurgery, paediatrics and
the geriatric clinic are actively scrutinised. There is a routine Source of population
exchange of information with the other cancer registries of Annual estimate of permanently resident population at midyear,
Switzerland, especially with those covering two neighbouring based on the 2000 census and taking into account births, deaths
cantons (Zurich and Grisons). Active case ascertainment and migration. Source: Federal Ofce of Statistics, Switzerland.
has also been organised with consultant oncologists in the
region. Finally, all death certicates with a cancer diagnosis Multiple primary rules used
are scrutinised, and further information is sought out. Active IACR rules (2004) on historical data.

373

Europe

Switzerland, Ticino
radiotherapy and oncology centres, haematology laboratory,
Registration area
The Canton of Ticino is situated at the extreme south of oncologists, general practitioners and from cancer registries
Switzerland. It has a total area of 2812 km2 and is bordered of Geneva, Vaud, Basel, Zrich and St Gallen (mostly skin
on the north by the Canton of Uri, on the east by the Canton cancer). Autopsy is performed on 3% of all deaths. Finally,
of Graubnden and Italy, and on the south and west by Italy. death certicates with cancer diagnosis are scrutinised and
The highest point is 3402m and the lowest 194m above see additional information is found by mailing a questionnaire
level. The climate is temperate, with average temperatures to the physician or by examining case notes in hospitals.
varying from 4.0 in January to 21.8 in August, and the annual Online control of inhabitants of the canton is performed at
rainfall amounts to 1564mm (1997). Air quality has been the Cantonal Ofce of Population Registry.
The Registry collects all malignant invasive and in
measured in Ticino from 1990: the annual average pollutant
concentrations observed are 13 g/m3 for SO2, 44 g/m3 for situ tumours. The registration of basal-cell carcinoma is
incomplete for the years 19962003. The following data are
NO2 and 218 g/m3 for O3 (City of Lugano, 1996).
The population of the canton at 31 December 2000 was coded: personal identication number, tumour occurring
before the registry was
309 357. The structure also
started personal data, date
reects immigration in the
of rst symptoms, date of
age of economic activity:
SWITZERLAND, TICINO (1998-2002)
morphology
conrmation,
73% of the population have
SWITZERLAND, TICINO (1998-2002)
topography,
morphology,
Swiss nationality and 27% is
stage, diameter in mm and
foreign, mainly from Italy and
axillary node for breast cancer,
the former Yugoslavia. The
basis of diagnosis, method of
majority of the population














diagnosis, rst treatment and


is Christian, with 84%







date of death.
Roman
Catholics.
The














All
information
are
ofcial language is Italian.







manually checked and coded


Employment
distribution












(according to ICD-O-2) by the


is: 1.7% in agriculture and





 

registry staff before entry in


forestry, 24.8% in industry





 








the computer. The computers


and 71.8% in the service sector







themselves do preliminary
(census 2000).








 





plausibility tests at data









entry, and a second check is


Cancer care facilities











performed by the staff daily.


In 2000, there were ve public





Several plausibility checks,


regional hospitals and four
like logical sequence of dates,
zone hospitals, for a total of






validity of codes, morphology
1042 beds and 695 hospital
 +'#)
  +'#)
by topography, by sex and age



$(,+,*(+++

and private practitioners in
(over 200 crosschecks) are
the canton. There are no 
  
+ +++ ++ +  +++  ++   +&$!+  +
performed monthly in addition
population-based screening   +- ++  
+ + !+
programmes in Canton Ticino.
Spontaneous screening is to the IARC Check programme.
 


  
 + +'%""()++ *++
+
Active follow-up of all patients with tumours is performed
well accepted in the population, for either breast or cervical
cancer. There is one radiotherapy department for the entire yearly. We have published a study of completeness: http://
region covered by the Cancer Registry. Opportunistic PSA www.ti.ch/DSS/DSP/IstCP/RCT/pdf_ppt/Relazioni_e_
Poster/2005/GRELL05_completeness.pdf.
testing is common in the population.
Registry structure and methods
The Cancer Registry of Canton Ticino was founded in 1995
by the local government. Collection of population-based
data began in 1996. The Cantone Ticino provides most of the
budget and additional funds are obtained from the Federal
Ministry of Health, through the Swiss Association of Cancer
Registries.
The Registry was founded on a cantonal law, based on
a popular initiative. It is located at the Cantonal Institut
of Pathology. One medical doctor and a data manager are
responsible for active data collection and coding. A statistician
is responsible for quality control and data elaboration.
Reporting of cancer cases is done on a voluntary basis. A web
page is updated regularly (www.ti.ch/cancer). About 80%
of cases are notied by the Cantonal Institute of Pathology
and Cytology. Additional cases come from main hospitals,

374

Use of the data


The Registry is currently involved in epidemiological
research such as biomolecular epidemiology, survival
analysis (EUROCARE), and others:
http://www.ti.ch/DSS/DSP/IstCP/RCT/temi/studies.htm .
Policymakers use our Cancer Registry data for planning
and evaluation of health services. Please see the website for
further information: www.ti.ch/tumori.
Source of population
Average midyear annual estimates, based on ofcial
numbers of births, deaths, immigrations and emigrations, on
December 31st. Ofce cantonal de statistique.
Multiple primary rules used
IACR rules (2004) on CI5 IX period.

Europe

Switzerland, Valais
(CIVH). The registry is largely nanced by the Canton of
Registration area
The canton of Valais covers an area of 5225 km2, with a Valais; the Swiss Confederation contributes 1015% of the
population of 281 500 at the end of 2002. The population budget.
The staff consists of a physician responsible for
is 35% urban, the majority living in a rural area or in the
mountainous region of the Alpine range. The Valais Alps, registration (80% of one post), an assistant physician (40%
a non-productive area, account for 54% of the land surface. of one post) and two secretaries (one post full-time, one halfThe climate is relatively drier and sunnier than in the rest of time).
The principal source is the pathology department of the
northern Switzerland. The German-speaking High Valais,
28% of the canton, is distinguished from French-speaking CIVH, whose histological or cytological reports concerning
Central Valais and Low Valais not only by language, but cancer are available to the registry via specic software.
This source represents about 75% of the cases registered.
also by culture.
The population is largely of Caucasian origin; the Other sources comprise registries situated in the university
majority are Roman Catholics (81%). The population is 17.6% centres of other cantons, the medical records of the hospitals
(notications are made on the
of foreign origin, principally
basis of computerised lists of
Italian Portuguese and people
hospitalisation with diagnoses
from the former Yugoslavia.
SWITZERLAND, VALAIS (1998-2002)
coded to the ICD), oncological
The structure is that of an
SWITZERLAND, VALAIS (1998-2002)
specialists who send a copy
ageing population, with 15.6%
of their consultation reports,
of people older than 65 years.
and a computerised listing of
One of the features of this
deaths.
population is its great stability,











 

Notication is essentially
the genetic structure being






passive, but a questionnaire is


more homogeneous than is














sent to the treating physician


general in the countrya fact







for the majority of registered


demonstrated by the studies








 





cases,
and
demographic
on genetic predisposition to







data are veried through


colorectal cancer.





 








the municipalities, again by


The economically active







questionnaire.
population works 58.5% in












Access to death certicates


the services and tourism





 

is authorised for DCN cases


sector, 22.5% in industry





 





through a contract with the


(construction,
chemical,







Federal Ofce of Statistics,


metallurgical, wood) and
Neuchtel, thus guaranteeing
3.5% in agriculture. Valais is






condentiality.
an important producer of wine
 +'#)
  +'#)
Notication of cancer
(40% of the national total),



$&*+,,$+++

is voluntary. Physicians are
fruit and vegetables. From

  
+ ++ +%"""+ +++++ + ++!+
authorised to transmit data if
the viewpoint of potential +  + +
 +  +

++. 
 -+  +  + + + !+
their patient has not specically refused such communication,
occupational risk factors, there 


  
are
three
industrial
centres,
 + +'%""()++++
each with more than 1000 employees, producing plastics, which had never happened by the end of 2002. In 1995 an
colorants, agrochemical products, aluminium (exposure to expert commission on professional secrecy and medical
uorine and asbestos), solvents and products derived from research authorised regulations for medical condentiality
throughout the process of data collection, storage and
cyanide.
processing of data.
The data are validated by different programs, including
Cancer care facilities
There are 19 physicians per 10 000 inhabitants. The health IARC Check. Quality control of data notied electronically
system centres around six public hospitals, a specialist is carried out by the suppliers.
respiratory centre and one private clinic, a total of 840 beds
for acute care, excluding several geriatric, psychiatric and Interpreting the results
chronic care institutions. The Department of Oncology of Most demographic factors have remained stable. The
Valais is a network of cancer care facilities which gather increasing percentage of foreigners since 2000 is due partly
specialists consulting in the public hospitals and in private, or to a renewal of immigration and a more constant birth rate in
working in a centralised radiotherapy service in Sion. A few the native population.
cases requiring additional facilities are treated in university
Use of the data
centres such as Lausanne, Geneva, Berne, Zurich or Basel.
The incidence data are used to inform the public health
planners and the medical profession about cancer in the
Registry structure and methods
Since 2002, the registry has been attached administratively population. The results of the most recent reports have
to a newly created Health Observatory of Valais, supervised conrmed discrepancies between the incidence of some
by the Public Health Service of the canton and situated in tumours in two different regions, i.e. High Valais and
the capital Sion. The registry is located there and shares the Low Valais. In particular, lung cancer is more frequent
computer network of the Central Institute of Valais Hospitals in the western (lower) part than in the eastern, German-

375

Europe

speaking (higher) part of canton Valais. The intensication


of cancer screening (an ofcial breast cancer screening
programme for women aged 5070 started in autumn
1999) has contributed to an increase in the incidence of
breast cancer mainly and prostate cancer secondarily. The
registry also participates in survival studies at the national
(Association of Swiss Cancer Registries) and international
levels (CONCORD study).

376

Source of population
Annual estimate of permanently resident population at
midyear, based on the 2000 census and taking into account
births, deaths and migration.
Source: Federal Ofce of Statistics, Switzerland.
Multiple primary rules used
IACR rules (2004) on historical data.

Europe

Switzerland, Vaud
private pathology laboratories, which perform the majority of
Registration area
The registry covers the French-speaking Canton of Vaud, the histological examinations for the population. Most cases
the fourth-largest of the 26 cantons in the Swiss Confederation are registered repeatedly and from different institutions.
(surface area 3212 km2) and third in number of inhabitants Cancer cases are listed alphabetically and according to a
chronological registration numerical index.
(about 640 000 in 2000).
The 385 communes that compose the canton are grouped
All relevant information is checked manually by the registry
into 19 administrative and political districts. The density of staff and subsequently coded before being entered into the computer
population (193/km2) slightly exceeds the mean for the whole of the University Hospital of Lausanne (CHUV). A rst series of
country. In 2000, foreigners, predominantly of Mediterranean automatic checks on data is run whenever new information or
origin, accounted for about 25% of residents. Since the early modications are added. Data are transferred to the computer of the
1970s the number of resident workers has remained stable. In University of Lausanne (UNIL), where more specialised checks and
2000, the main occupations were industry (19%), agriculture and analyses are performed. Passive and active follow-up information
shing (5%) and services (76%). In December 2000, only 23% of is recorded. Identication data on all deaths in the Canton of Vaud
the Vaud population were 019
as well as on cancer deaths are
years old, while 15% were aged
available.
65 years and older. Although
SWITZERLAND, VAUD (1998-2002)
Lausanne, the capital and its
Interpreting the results
SWITZERLAND, VAUD (1998-2002)
suburbs represent only 4% (115
A mammography screening
km2) of the cantons area, about
programme
for
breast
cancer was activated in 1999
45% of the total population
targeting all resident (about
reside there.

 



 








70 000) women aged 5069



 





(participation rate around 50%


Cancer care facilities














in 2003). Spontaneous screening


In 2000, about 3000 public and







for cervical cancer is common


private hospital beds (about








 





(over two thirds of women aged


five hospital beds per 1000







20 or older report at least one


population) were available for














examination). According to the


diagnosis and treatment. In the







most recent National Health


same year there were about














Survey, on average 15% of men


2800 hospital medical doctors







aged 4069 and residing in the


and private practitioners (one














French-speaking cantons (Suisse


per 230 population). The health







Romande) reported a biological


care system is insurance-based,
test or clinical examination of
but practically the whole of the






 -($*
  -($*
the prostate within the year
population enjoys access to



&0,-.#.--
preceding the survey.
medical care. A major public
university multi-disciplinary 
  
 -Use of the data
oncology and radiotherapy (1142   -2 --%00/2&##&"- 1- -  ---( *-- - - -- 2 - -
!- -- !- !--- !--   -'%" 


  
Annual
incidence
data
by sex, age, site and morphology
treatments in 2003) centre is available
to
the
whole
population,
 - -(&##)*-- +--
as well as a few peripheralmostly hospital-basedmedical and are routinely provided. The registry is also engaged in both
surgical oncological facilities. Two additional radiotherapy private descriptive and analytical research in the eld of epidemiology.
Features of the registry include good registration of nonunits are in operation (overall, 948 treatments in 2003).
melanoma skin, since traditionally the large majority of
cutaneous lesions are surgically resected and examined by
Registry structure and methods
The Registre Vaudois des Tumeurs (RVT) began in January a pathologist, linkage of selected pre-neoplastic conditions
1972, and population-based data have been available since to the cancer registry datale in order to study subsequent
1974. The registry is a constituent part of the Cancer cancer risk, risk of second neoplasms for patients registered
Epidemiology Unit at the Social and Preventive Medicine with a dened primary, and systematic analyses of trends in
Institute (IUMSP), University of Lausanne. The majority survival. The registry cooperates with clinicians, and is used
of the nancial support comes from the Public Health for population-based casecontrol studies on ENT, colorectal,
Department of the Canton of Vaud. Additional ad hoc funds breast, endometrial and thyroid cancers. It also serves to
are supplied by the Swiss Federal Government and the Swiss evaluate the three breast cancer screening programmes run
League against Cancer, which support several studies in the in the Cantons of Vaud, Wallis and Jura.
elds of descriptive and analytical epidemiology.
In addition to the director, the staff comprises one part-time Source of population
medical associate, one part-time computer programmer, and 3.5 Average midyear annual 19982002. Estimate: Cantonal
clerks. The director is also in charge of the administrative and Ofce of Statistics (SCRIS) for each calendar year and
veyear age group, based on ofcial numbers of births,
scientic supervision of the cantonal Registry of Neuchatel.
Notication is based on a voluntary agreement between deaths, immigrations and emigrations, on December 31st.
the recording medical institutions of the canton and the
registry. The main sources are the cantonal University Multiple primary rules used
Pathology Department of Lausanne and three other major IACR rules (2004) on CI5 IX period.

377

Europe

The Netherlands
Registration area
The Netherlands Cancer Registry (NCR) comprises nine
regional cancer registries and covers the whole population of
the Netherlands. The population in 2007 was 16.3 million.

registration is funded according to the policy regulations


of the National Health Tariffs Authority on the basis of the
National Health Tariffs Act.
The main source of data is the pathological automated
archive (PALGA). Notication also comes from radiotherapy
centres and haematology labs, and once a year the cancer
registry is linked with the Hospital Discharge Register,
which accounts for about 8% of the registered cases. Death
certicates are not available because of privacy regulations.
Specially trained registration clerks register direct from the
medical records in the hospitals.

Comprehensive Cancer Centres


General health care in the Netherlands is provided by general
practitioners and specialists in academic (7), oncological (2)
and general hospitals (520 hospitals per region). At least one
radiotherapy institution is situated in every region. The nine
Comprehensive Cancer Centres (CCC), which are partnerships
between healthcare professionals and cancer and palliative care
institutions, together form the Association of Comprehensive Interpreting the results
The Netherlands Cancer
Cancer Centres). The purpose is to
Registry has been populationprovide access to comprehensive
based since 1989 and is more
and high-quality care as close
THE NETHERLANDS (1998-2002)
than 95% complete. Patients
to home as possible. The CCCs
THE NETHERLANDS (1998-2002)
with cancer only on their
support networks of specialists
death certicate will be
and tumour-specific working
missed, as will cases that have
groups with the development,
no pathology, cytology or
implementation and evaluation of














hospital intake.
national and regional guidelines.




 


Consultants are supported for
















Use of the data


several specialties. Patients in





 

The registry prepares an


need of specialist care can be














annual report of cancer


referred out of their CCC region.
 






incidence, highlighting trends


More than 300 employees work














and changes on both national


in these CCCs, and about 400







and regional level. Data are


consultants are actively involved.
 












linked with the breast cancer


CCC,s are independent, private







screening programme for


institutions and all hospitals,
 
 


 






 


evaluation purposes. Several


radiological cent res and



 


projects
(e.g.
guideline
pathology labs are afliated with
evaluation and evaluation of
one of the nine centres.






the National Cancer Control
The CCCs receive a xed
 $!
 $!
Plan) with hospitals and




%$&%'$%'#$$$

annual sum for stafng,
universities are supported by
materials and location costs, and   

cancer registry data. More
a variable amount to cover the $  $
      
costs of consultants funded according
to!$$ "$$
$
the policy regulations than 25 data requests are answered every year, both at the
 $  $
  
of the National Health Tariffs Authority
on the basis of the national and regional levels.
#%$ $$ $( $ $
National Health Tariffs Act. In addition, grants are obtained
from various bodies including the Dutch Cancer Society (used Source of population
for activities such as the support of clinical trials), the Ministry Statistics Netherlands.
of Health, Welfare and Sport (for developing guidelines) and
Multiple primary rules used
from other organisations (for projects).
IACR rules (2004) on CI5 IX period.
Registry structure and methods
The nine regional Cancer Registries, located within the Notes on the data
CCCs, pool their data once a year in the NCR. Cancer C67 does not include noninvasive tumours.

378

Europe

The Netherlands, Eindhoven


the number of hospital beds decreased from 5 to 2.0 per 1000
Registration Area
Since 1972 the registry has served an area of about 2500 km2, persons in the past 25 years, while the number of nursing home
lying 2050m above sea level and including almost one beds has increased, as has, more recently, home care provision.
million inhabitants (6% of the 1990 Dutch population). In the late 1990s, hospitals halved in number by mergers to only
Since 1988 another million have been added bringing the middle- and large-sized hospitals from 400 to 800 beds.
total 2000 population to 2.3m and being part of the national
registry. This dataset only includes incidence and mortality Registry structure and methods
data from the original population that grew from almost 300 This regional registry began operation in 1955 as part of
000 since 1958. The population density was about 400 per a programme for nationwide cancer registration. The 13
km2, roughly the national average; 47% of the population- participating hospitals of the 1970s have now been merged
at-risk live in urban, 43% in suburban and 10% in rural into 6. The registry has always cooperated systematically
municipalities. The traditionally Catholic population has with up to three regional pathology laboratories, which
secularised rapidly since the mid-1960s, with concurrent have parafn-embedded blocks of biopsy specimens from
all patients since the 1970s.
large-scale introduction of
These laboratories also serve
oral contraceptives leading to
GPs. Moreover, through
a lower fertility rate (from 3
THE NETHERLANDS, EINDHOVEN (1998-2002)
the various medical records
to 1.5) and higher age at rst
THE NETHERLANDS, EINDHOVEN (1998-2002)
departments the registry
birth (from 22 to 29 years).
has access to the medical
The proportion of immigrants
records of most hospitals, in
has been rapidly rising since
particular in the department of
the 1970s, to >10% at younger
%-++.--/*,
.-0"%--(-/""--/"
0-*&&--Radiotherapy in Eindhoven,
and middle age.
$"-$/*--.*
$*-$(*--which has gradually extended
With regard to the
$*-&(*--."
$0-%&*--%$-$*$--+*
%&-"($--service to all of these hospitals.
environment, an intensive
%(-0&"--+"
%*-$/%--Since 1988 the registry has
pig and poultry breeding
%0-+0*--**
%/-"+0--&.-"&(--*"
&(-/.$--functioned within the scope
industry has developed since
&/-%*"--(*
&*-."/--of a national scheme for
the
1970s,
contributing
("-/0.--("
&/-%*%--(&-/*&--&*
($-&"$--cancer registration, developed
considerably to acid rain
(&-"*"--&"
&0-.(+--since 1984. Assessment of
and rising nitrate levels in
&.-%"0--%*
&(-%$%--&"-/0%--%"
%/-"*$--completeness and accuracy
groundwater,
decreasing
&"-"/"--$*
%/-(*+--was carried out in the period
again since the 90s. The main
&$-**%--$"
&"-$("--&%-./$--*
&$-(".--198083 with continuing
industries produce electronic
&$-0"0--"
&"-((/--support from the Department
goods, trucks, photocopiers,
of Epidemiology, now Public
textiles and milk products,
$"
*
"
"
*
$"
Health, of Erasmus University,
 -'#)
  -'#)
but increasingly replaced
*""-+0/--*"+-%/%--
Rotterdam. Extensive analyses
by employment in services
of incidence since 1958 thus
and transport. The declining 
  
became possible, e.g. for lung
tobacco-processing and cigar 
-- - -- -$-1- - -  ---  - - -
-

-  ! 


  
and breast cancer, both of which exhibited major changes.
 - -'%""()---- area until the
industry, important in the south-of-Eindhoven
1980s, had a marked effect on the incidence of lung cancer Such data have now been submitted to Cancer Incidence in
among males, whose prevalence of smoking was 95% in Five Continents since 1958 and EUROCIM since the early 80s.
the 1950s. By contrast, smoking prevalence and incidence They includein a large part of the areanon-melanoma skin
of smoking-related cancers among females have only risen cancer, based on early involvement of also dermatologists.
Using the municipal population registers, active followrapidly since the mid-60s. Among those born after 1965
up with respect to vital status was performed in 1987,
incidence appears to have begun decreasing again.
1991, 1994, 1999, 2002 and 2006. Patients lost to follow-up
declined from 5% to less than 1%, with regular aid from the
Cancer care facilities
In 2004 we began a national obligatory insurance system. Central Bureau of Genealogy.
Some 98% of the inhabitants are covered by Sickness Benet
Funds, a compulsory social insurance policy for people Interpreting the results
with low income; less than 1% of the population may be Screening for cervical cancer, started during the 1970s but
declining in the 1980s, started again in 1988, being adapted
uninsured.
The growing interest in oncology during the 1970s in 1996 among women 3060 years of age at 5-year intervals.
led in 1979 to a regional organisation, the Cooperating Biannual mass mammography screening for breast cancer
Association of Hospitals in Oncology (SOOZ). In 1982 the gradually started among women between 50 and 70 years
Comprehensive Cancer Centre South (IKZ) was founded during 199296, rising to age 75 in 1998.
as a collaborative effort of the radiotherapy institutes in
Eindhoven and Tilburg and 18 community hospitals, one of Use of the data
Regular overviews of trends in incidence, stage and survival
its main tasks being cancer registration.
Access to clinical specialists was good but deteriorated of patients registered since 1958 are published every ve
a bit until 2000, generally through general practitioners, one years, including detailed information on uncommon tumours
for every 2200 persons. Despite a markedly ageing population and prevalence since 1970 and co-morbidity at diagnosis

379

Europe

since 1993. Cancer survival has also been studied since 1978
within the framework of the EUROCARE study.
In recent years the data have been used increasingly for
quality-of-care purposes and studies of cancer in the elderly;
for that purpose, serious co-morbidity at diagnosis was also
registered and a research department developed with a strong
regional, national and European orientation.

380

Source of population
Population data are calculated annually for 1 January; they
are derived by Statistics Netherlands from the municipal
population registries.
Multiple primary rules used
IACR rules (2004) on historical data.

Europe

The Netherlands, Maastricht


computer programmer and six tumour registrars. In addition,
Registration area
The Maastricht Cancer Registry is situated in the southeastern one consultant on cancer registration is available.
Notication is voluntary. The cancer registry receives
part of The Netherlands, and comprises the southern and
middle parts of the province of Limburg, an area of some lists of newly diagnosed cases on a regular basis from the
1355 km2. A large area to the west, south and east is bordered four pathology departments in the region. In addition, the
by Belgium and Germany. The Eindhoven Cancer Registry medical records departments of the ve hospitals provide
lists of hospitalised cancer patients. Following notication,
is on the northern boundary.
In the southern part of Limburg, the population density the medical records of newly diagnosed patients are collected
is very high, with about 30% of the population living in rural and trained tumour registrars for the cancer registry abstract
municipalities, 57% in sparsely and moderately urbanised the necessary information from them.
Death certicates cannot be used because of the privacy
municipalities and 14% in densely urbanised municipalities.
Current industrial activities in the region include chemical, regulations of the Dutch Central Bureau of Statistics. Tumour
automobile, ceramic and cement industries. Until 1975, coal data are copied onto registration forms at the hospitals and
entered into the computer at the
mining was a very important
registration ofce. Completeness
source of employment.
of records, data consistency
The vast majority of
MAASTRICHT (1998-2002) and the possibility of duplicate
the Limburg population is THE NETHERLANDS,
THE NETHERLANDS, MAASTRICHT (1998-2002)
records are continuously and
Catholic.
extensively checked by the
computer program.
Cancer care facilities
There is easy access to medical
$%$$$
&!#
&$'$$$
!$"$$$
&
$"%$$$
Interpreting the results
care in the Netherlands. In the
$&"!$$$
%!
"$"&$$$
Research into the completeness
province of Limburg there is
!$%!$$$
%
'$'"$$$
'$&&!$$$
"!
$'$$$
of ascertainment and into
about one general practitioner
$'$$$
"
$"!$$$
the validity and accuracy of
(GP) per 2300 inhabitants.
%$'!$$$
!!
"$"!"$$$
$'&$$$
!
$&!$$$
data show that the quality of
Medical specialists usually
$!$$$
!
$!$$$
the data is high (Int J Epid
work at the hospitals: they
!$'$$$

$&'&$$$
"$"&'$$$
!
!$!&$$$
1993;22:369-76, Br J Cancer
can be consulted after referral
$$$$

$!$$$
1993; 68:947-77, Int J Epid
by the GP. Due to the ageing
"$$$$
!
!$!%&$$$
$&%'$$$

$"&$$$
1994 23;1111-6).
population,
cancer
care
$"'$$$
!
$%$$$
In 1990 a breast cancer
facilities will be consulted
!$""$$$

$!%$$$
!$%$$$
!
$%%$$$
screening
programme started,
more frequently in the future.
$'$$$

$&$$$
resulting in a large increase in
Almost all cancer patients
the incidence of breast cancer.
are diagnosed and treated by

!


!

A cervical cancer screening
medical specialists. In the
 $
 $
&$$$$
&$&"$$$

program started in 1992 and
area of the Maastricht Cancer
expanded to the whole region
Registry, there are four general 
  
in 1996 for women aged 30
hospitals and one university   $ 
 $
60. Trends in prostate cancer incidence also show a large
hospital. The area also has one  


  
radiotherapy
institute.
$
 $
$$  
$$
increase, associated with opportunistic PSA screening.
Registry structure and methods
The Maastricht Cancer Registry was established in 1984 as Use of the data
part of the Comprehensive Cancer Centre (CCC) Limburg. The registry regularly publishes a report on cancer incidence.
Within CCC, there is collaboration between the hospitals, Data for the Maastricht Cancer Registry have been used for
Maastricht University and the Maastro Clinic (radiotherapy etiological research, evaluation of guidelines, evaluation of
institute). The aim of the CCC is to improve care for screening programmes and the treatment of cancer in the
cancer patients through research, treatment, guidelines and elderly. The data are also used to plan healthcare facilities.
coordination of regional activities (e.g. cancer screening).
The Maastricht Cancer Registry (MCR) is part of the Source of population
nine regional cancer registries in the Netherlands. Together Statistics Netherlands.
these registries make up the Netherlands Cancer Registry.
The staff of the registry includes one epidemiologist as Multiple primary rules used
head of the registry, two epidemiological researchers, one IACR rules (2004) on historical data.

381

Europe

UK, England, East of England Region


Registry structure and methods
The registry is funded by the government Department of Health
under the Public Health budget. There are 24 staff as follows:
Director, operations manager, consultant oncologist, two senior
registration ofcers, 11 registration ofcers, two clerical ofcers
and three workers each in analysis/quality assurance and IT.
Registry staff extract data from patients notes and
hospital PAS systems at all the hospitals in the region.
Data are recorded on paper forms and later transferred to a
computer database when complete.
A monthly updated snapshot of the database is produced using
Microsoft Access for the analysis team to interrogate to produce
reports and answer specic queries from external sources.
A
detailed
formal
evaluation
of
Annual
UK, ENGLAND, EAST OF
Performance Indicators is
already carried out according
ENGLAND
REGION
(1998-2002)
UK, ENGLAND, EAST
OF ENGLAND REGION
(1998-2002)
to the guidelines established
by the UKACR.

Registration area
ECRIC registers cancers occurring in the resident population
of Norfolk, Suffolk, Cambridgeshire and, since 1996,
Bedfordshire. It is situated in eastern England UK with a
population (at the most recent census) of 2.75 million; 90%
of the population describe themselves as white British.
In 1995 the registry assumed responsibility for the resident
population of Bedfordshire, and in 2006 responsibility for
Hertfordshire and Essex was added. As a result of this,
the population covered increased from approximately 2.2
million to 2.6 million in 1995, and from 2.8 million to 5.3
million in 2006.
Cancer care facilities
The registry is situated in
Addenbrookes NHS Trust
Hospital
in
Cambridge,
with 2 satellite ofces in
The Norfolk and Norwich
University
Hospital
in
Norwich and the Ipswich
Hospital. Each of them has
radiotherapy, oncology and
surgical facilities. There
are 6 other hospitals in the
region providing oncology
services. Some patients are
sent out of the area to receive
radiotherapy treatment at
Mount Vernon Hospital,
Northwood, Middlesex.

 "#"""

$!

%"#"""

" """

$

$"$"""

"%%"""

#

" %#"""

"##"""

#

"$#"""

"##"""




%"#$"""



$""""

%" %"""



% "%"""

$#"#"""



$%"#"""

%" %"""



%" """

""""



""""

"%$"""



"$$$"""

%""""



$%""""

#$" """



#"%#"""

$"$"""



$%"$%"""



$""""

$%"$%"""



$"# """

$"#"""



#%"$ """



""% """


   


 "  """   ""

$"%"""

 "

382

"%#"""

$"$"""
#%"%# """



 "


"$#""""

Interpreting the results


PSA testing is quite common,
and parts of the registry
population are included in a
large-scale study evaluating
screening for prostate cancer.
Multiple primary rules used
IACR rules (2004) on
historical data.

Europe

UK, England, Merseyside and Cheshire


Registration area
Since 1974, the registry has collected data on all cancers
occurring in residents of Merseyside and Cheshire, wherever
treated, and on residents of other areas treated in Merseyside
and Cheshire hospitals. The registry also collects data on
Isle of Man residents.
Population centres in the area include the city of
Liverpool; industrial towns such as Birkenhead (previously
shipbuilding), Runcorn (chemicals), St Helens (glass); the
retirement coastal town of Southport; and the rural towns
of Cheshire.

Validation checks within the system were extended in 1994


to improve the quality of data inputting. The registry has
a rolling programme of quality assurance focussing on the
ascertainment, completeness, timeliness and housekeeping,
and several projects have explored different aspects of data
quality. Data are coded in ICD-0-2, kept securely and
released in a controlled manner, in accordance with ethical
and data protection conventions. Regular backups are taken
of the data and kept both locally and off-site.

Interpreting the results


There have been no coding or registration practice changes
that affect the interpretation of the data in this report compared
Cancer care facilities
with earlier volumes.
Local
Cancer
Services
Organised
screening
have been reorganised into
networks with a specialist
UK, ENGLAND, MERSEYSIDE AND CHESHIRE programmes are in place for
breast and cervical tumours.
cancer centre (containing full
(1998-2002)
UK, ENGLAND, MERSEYSIDE
AND CHESHIRE (1998-2002)
In 1988 a national breast
radiotherapy and oncology
screening programme was
facilities) and cancer units in a
introduced, through women
hub and spoke arrangement
aged 5064 years are routinely
to achieve the most effective
#!,.*-,,,
.)+
%#,$-#,,,
#-,'*/,,,
.!
%$,%.*,,,
invited to be screened for
concentration of expertise
%$,!/%,,,
-)
'-,)#),,,
breast cancer every three
and also obtain the closer
'',!./,,,
-!
)',-%$,,,
)$,.*#,,,
*)
).,)/#,,,
years; women above 64 years
involvement of primary care.
)/,$/*,,,
*!
*%,!*!,,,
are screened if they, or their
**,$%',,,
))
*.,#*.,,,
-/,.%#,,,
)!
.#,')/,,,
general practitioners, request
Registry structure and
-*,!*#,,,
')
-.,-)#,,,
a test. A similar screening
methods
.!,/!$,,,
'!
.),##!,,,
.-,)$$,,,
%)
/%,)$),,,
programme for cervical cancer
The registry was founded
.%,'--,,,
%!
./,!)',,,
was introduced in 1964,
in 1944 as the Liverpool
-#,*%$,,,
$)
-',./$,,,
*','#/,,,
$!
**,/)),,,
whereby all women aged 20Clinical Cancer Registry,
-*,''-,,,
#)
-),$).,,,
64 are screened, currently
with the primary objective
.$,//.,,,
#!
-/,).#,,,
-/,$*#,,,
)
-),#)*,,,
every three to ve years,
of registering all cases of
*/,-**,,,
!
**,'*',,,
depending on their primary
malignancy occurring in the
care trust and their age.
area served by the Liverpool
#!
)
!
!
)
#!
The increasing use of
Radium Institute. It extended
 ,&"(
  ,&"(
opportunistic PSA testing
its coverage to the surrounding
#,$$#,/$.,,,
#,#%),$$),,,

within
Merseyside
and
area in 1974. The registry is
  

Cheshire coincides with an
part of the National Health ,
,,, , ,,$!!#, , ,
 , ,, ,, ,,,,
, ,,
      
increase in the number of prostate cancer cases registered
Service.
,  ,&$!!'(,, ,,
Registry staff comprise: a   
medical
director, a general locally.
'',,
,
manager, two deputy managers, an epidemiologist, a
secretary, a quality assurance ofcer, an IM&T ofcer, an Use of the data
intelligence ofcer, 6 registration ofcers and a database Publications include specialist reports on breast cancer
specialist. In addition, project work is undertaken by students (2003), colon cancer (2003) and oesophageal cancer (2003).
Other output includes responding to over 80 ad hoc
studying for higher degrees and professional examinations.
The most important source of notication is pathology queries annually; presentations concerned with place of
reports, copies of which are routinely sent to the registry. All death and also cervical screening age; audits with specialist
cases are followed up by trained registration ofcers, who researchers; responding to genetic counselling service
abstract relevant clinical information from hospital records. enquiries; contributions to the regional public health report;
Notications are also received from the Ofce for National analyses to support the planning of local cancer services;
Statistics about death certicates for people who have died and regular presentations to specialist groups.
of cancer. Full registration for these cases is then sought by
Merseyside and Cheshire Cancer Registry from the hospital Source of population
or certifying doctor. The local specialist centres for oncology Estimation of population at risk based on 2001 census,
also supply notications. Details of Merseyside and Cheshire allowing for births and deaths and migration into and out
residents whose cancers are diagnosed elsewhere are supplied of the area.
by the local registry. Cases registered during life are agged
at the National Health Service Central Register so that the Multiple primary rules used
IACR rules (2004) on historical data.
cancer registry is informed when these cases die.
Registry data are held on a dedicated relational personbased system. Each tumour is allocated a unique tumour Notes on the data
number in addition to the patients unique identier. C44 not available.

383

Europe

UK, England, North Western


Registration area
The North Western Cancer Registry (NWCR) collects data
on all residents of Greater Manchester, Lancashire, South
Cumbria and a small part of Derbyshire who develop cancer.
The Registry covers an area of 4500km2 and has a population
of four million. Sixty-ve percent of the population resides
in the conurbation of Greater Manchester, which is almost
entirely urban. The remainder of the region is of mixed
urban-industrial and rural character. Eleven percent of the
population lives in areas adjoining the coast, which are
characterised by a high proportion of elderly retired residents.
Ethnic minority groups comprise almost 8% of the North
West population, concentrated mainly in large cities.
Cancer care facilities
Local cancer care services are
being reorganised into networks
with a specialist cancer centre
(containing full radiotherapy
and oncology facilities) and
cancer units in a hub and
spoke arrangement to achieve
the most effective concentration
of expertise and obtain closer
involvement of primary care.

Cases are followed up through the statutory registration


of deaths. All patients are agged at the National Health
Service Central Register and the Ofce for National Statistics
informs the Registry of patients who have been previously
agged as having developed cancer.
All addresses are assigned post-codes, and all information
is computerised and submitted to validation and consistency
checks. Diagnostic details are entered on the computer,
which then automatically codes them to ICD-O. Validation
checks within the system were extended in 1994 to improve
the quality of data input.
Interpreting the results

UK, ENGLAND, NORTH WESTERN (1998-2002)


UK, ENGLAND, NORTH WESTERN (1998-2002)

There have been no coding or


registration practice changes
that affect the interpretation
of the data in this report
compared with earlier
volumes.

Use of the data


A number of reports have
'(*("#***
+'
,"*+'#***
been published examining
+!*--'***
+
,-*(""***
,(*!+%***
('
-'*!%***
variations in cancer incidence
!*,"+***
(
!#*"'#***
and survival in the population
!!'*,,***
''
!!(*,""***
!#-*%',***
'
!#,*+"#***
covered by the Registry. A joint
!#*#,-***
%'
!"-*++(***
report with the Merseyside
Registry structure and
!#,*##,***
%
!#-*-+'***
!''*--'***
#'
!'+*,((***
and Cheshire Cancer Registry
methods
!'(*-+%***
#
!',*-"#***
(MCCR) covering the whole
The NWCR was founded in
!#,*%+-***
"'
!#-*',***
!""*+"***
"
!"#*(,+***
of the North West Region has
1962. It is situated at the Christie
!#%*"%***
!'
!#!*!('***
been published. Registry data
Hospital, the principal cancer
!%'*'(+***
!
!#-*!,'***
!%"*'#***
'
!#%*,+***
are used to plan and evaluate
centre serving the Region.
!"-****

!""*(!,***
cancer services, including the
Registry staff comprise a
breast and cervical screening
medical director, ofce manager,
!
'


'
!
programmes. A number of
systems manager, epidemiologist,
 *$ &
 *$ &
audits using Registry data
information manager, systems
"*!!(*!"%***
"*!%*!"-***

have been undertaken. Several
analyst, deputy manager, quality
  

research studies, both national
assurance ofcer, one secretary,   .*"!* *
 *  ***
      
and international have used Registry data. In addition,
and eight cancer registration ofcers.
*  *$"%&** **
The vast majority of patients  
receive their hospital care in Registry staff have collaborated on several studies on a
%%** *
the National Health Service hospitals. All NHS and private range of topics, including the genetics of breast cancer and
hospitals use special form to notify the Registry of all cases the reasons why women with bladder cancer have a worse
of cancer diagnosed in patients admitted to their hospital. The prognosis than men.
registries of other regions notify the Registry of residents of
the region who are treated in hospitals outside the region. The Source of population
Registry also receives data from hospital information systems. Source: 2001 Census, Ofce for National Statistics.
The Registry has links with all pathology laboratories in the
region so that copies of pathology reports can be sent directly to Multiple primary rules used
the Registry. The Registry receives copies of death certicates IACR rules (2004) on historical data.
of all regional residents whose certicate mentions cancer. The
Registry collects further information on patients identied Notes on the data
C44 not available.
only by a death certicate.

384

!-*"(,***

,')

'(*#'+***

#*"%***

,

'(*%''***

Europe

UK, England, Northern & Yorkshire


regional cancer registries of Northern and Yorkshire. Due to
the quality of pre-1998 Northern data, only Yorkshire cases
Registration area
The area covered by NYCRIS (Northern and Yorkshire have been included in earlier volumes of CI-5.
NYCRIS is based in Leeds, adjacent to Cookridge
Cancer Registry and Information Service) is a little under
30 000 km2, and includes much of the North of England: Hospital, which is part of Leeds Cancer Centre. It currently
from North Cumbria to Northumberland (Scottish border), employs around 50 staff, of whom approximately 60% are
down to West Yorkshire (east of the Pennines) and across to involved in data collection and validation (for the whole of
the Northern and Yorkshire area), 15% in data management/
Humberside and the North Lincolnshire Coast.
The region comprises the large rural expanses of the quality assurance and 15% in information and research.
Northern Lake District, Northumberland, County Durham,
Cancer registration in the UK is mandatory, and cases
West, East and North Yorkshire. Within these are several diagnosed in hospitals (inpatient and outpatient) are notied
densely populated urban clusters, including Tyne & Wear/ directly to NYCRIS. All pathology laboratories throughout the
Teesside, Leeds/Bradford, Hudderseld/Calderdale and region routinely send copies of pathology reports, and these act as
Humberside, along with
a cross-reference to information
some
smaller
(formerly
received directly. Northern
fortied) cities, such as York,
UK, ENGLAND, NORTHERN AND YORKSHIRE & Yorkshire residents treated
Durham and Carlisle. Health
outside the region are notied
(1998-2002)
UK, ENGLAND, NORTHERN
AND YORKSHIRE (1998-2002)
geography, for 19982002,
by other cancer registries.
maps the area directly to
Notication also comes from
four Cancer Networks or 44
Breast Screening Units and
Primary Care Trusts (PCTs).
hospices. Cases are registered
'$*'''
)$&
)(')"'''
"*'* )'''
)
*'$'''
by registry staff who visit the
Total population is around
* ') "'''
($
 '*(*'''
6.7 million (at 2001 census),
hospitals and abstract treatment
'")'''
(
$'$)'''
"$'%"'''
%$
%'(()'''
which constitutes 12.4% of the
details from hospital case notes
%'(%$'''
%
('("'''
following primary notication.
population of England & Wales.
)'(* '''
$$
)"'%*$'''
"'"'''
$
$'"('''
Copies of death certificates
There is marked variation in
 '** '''
"$
"'( '''
are routinely received from
population density across the
('))'''
"
 '%%%'''
"$'"'''
$
$'"()'''
National Statistics for all cases
region, varying from 0 to over
 %'"%'''

"$'$"'''
2500 people/km 2 in Hull &
where cancer is a cause of death.
"'%"%'''
$
'"'''
*%'$ '''

*$'$(('''
When this information is the rst
Stockton-on-Tees (www.statistics.
 '*("'''
$
(') "'''
notication of cancer, the registry
gov.uk/regionalsnapshot/). Ethnic
"'%$'''

$'$%'''
(' '''
$
('%%'''
traces the death to search for
groups include Black 0.4%, Asian
*$'")'''

)%'(*'''
further information. When the
3.4%, and Other 0.4% (% of total
population, 2001 census).
cause of death is non-malignant,

$


$

 '!#
 '!#
the registry is notied by the
The age structure is not
' (')%'''
'))'$('''

signicantly different from
National Health Service Central
that of England and Wales 
  
Register, where all registered
as a whole, although the ' '
 ' ' '
cancer patients are agged.
'  '!"#''$'' '
percentage aged 2535 years is 


  
slightly higher.
A new registration system (PRAXIS) was implemented
Traditional industries include shipping, shing, textile in 2006 to enable NYCRIS to move from the current, largely
& clothing manufacture, steel production, shipbuilding and manual, cancer registration process to one making greater
coal mining.
use of electronic data feeds. The cancer registry database is
patient-based. Records of existing registrations are updated
Cancer care facilities
with new information, new cases being assigned an accession
The vast majority of patients receive their hospital care in number by the computer. All data items are encoded by the
National Health Service (NHS) hospitals. A major national computer. The system also automatically generates a general
reorganisation of cancer services has taken place since 1995, practitioners enquiry letter, a cancer registration document
following the report of an Expert Advisory Group on Cancer and a follow-up enquiry letter where necessary. At the point
to the Chief Medical Ofcers of England and Wales. The of entry, data are validated using the National Statistics edit
subsequent National Cancer Plan (2000) established a system procedures. Data are regularly exchanged with local specialist
of Cancer Networks each serving populations of 13 million tumour registers to ensure complete ascertainment.
and organising specialist cancer care through multidisciplinary
teams. There are four such networks in the NYCRIS region, Use of the data
based around hospitals in Newcastle, Middlesbrough, Leeds In addition to providing a responsive information service,
and Hull, which, together with their associated local units in NYCRIS regularly produces data and reports in a variety of media
smaller district hospitals, provide integrated cancer services and actively promotes the use of its data. Summary statistical
for their populations. The hospitals within these 4 cities are the information (incidence, mortality and survival) is contained in
cancer treatment centres; there are radiotherapy departments CIS (Cancer Information Service), a web-based analytical tool
located proximate to the treatment centres.
available over NHSnet (protected health service WAN).
Details of CIS and all of its published reports are
Registry structure and methods
available on its web site (www.nycris.org.uk). In addition
NYCRIS was set up in 1997 to integrate the two separate NYCRIS has conducted a series of regional audit reports,

385

Europe

on important issues related to cancer service delivery; for


example, analysis of variation in the patterns of cancer care
and the effect of such variation on survival, an examination
of methods to improve the registration of skin cancer and
analyses of patient waiting times before receiving treatment.

386

Source of population
UKACR Populations Dataset Version 3.
Multiple primary rules used
IACR rules (2004) on CI5 IX periods.

Europe

UK, England, Oxford Region


for National Statistics (ONS). In addition, all registered
Registration area
The Oxford region consists of the counties of Berkshire, cancer patients are agged on the NHS Cancer Register to
Buckinghamshire, Northamptonshire and Oxfordshire, and ensure that the local registry is informed of deaths among
covers a population of about 2.7 million people. There are the registered population, including those from causes other
slightly more females than males (51%/49%). During the last than cancer and those occurring outside the region. There is
20 years higher population growth has been experienced collaboration with specialist registers (e.g. Childhood Cancer
Research Group, Oxford Regional Leukaemia Register) and
within major urban areas.
Berkshire has the highest population with 800 100 directly with clinicians to collect certain types of data.
The registry collects data on all malignant tumours, in situ
residents, Buckinghamshire has 686 100, Oxfordshire has
605 500 and Northamptonshire 629 700. Oxfordshire has neoplasms and certain benign tumours. An abstract of each
the highest proportion of elderly residents, with 14.5% tumour record is passed to ONS for inclusion in the National
being 65 or over. Northamptonshire has 14.2% of over-65s, Cancer Registration Scheme. Information on non-residents
Buckinghamshire has 13.3% and Berkshire 12.7%. Around treated within the Oxford Region is passed to the appropriate
regional registry and is part of
13% of the population are
a reciprocal arrangement.
aged under 10, about 13% are
Until 1992, the process
aged between 20 and 30 and
UK, ENGLAND, OXFORD REGION (1998-2002)
of
registration was entirely
6% are aged 75 or over.
UK, ENGLAND, OXFORD REGION (1998-2002)
manual. In September 1992,
Berkshire
has
more
a Hewlett Packard 9000
residents from Black (African,
RISC minicomputer system
Caribbean or other), Indian,
was installed running Unix,
Pakistani,
Bangladeshi,
!)&)))
+&(
" )&')))
+)$+)))
+
")+')))
Informix, SQL and the C-Cris
Chinese, or other minority
"!)$!)))
*&
$$)&$)))
1 Cancer Registration System.
ethnic groups (including other
$!)"+)))
*
$+)+$)))
& )"$)))
'&
&")'')))
Currently electronic versions of
White ethnic groups) than the
'),)))
'
') ')))
pathology reports (abstracted by
other counties, accounting
*&)")))
&&
*$)*)))
,$)!$)))
&
,$) !)))
identifying all cancer SNOMED
for 15% of its population.
, )$)))
$&
, )$)))
codes) with demographic
Buckinghamshire has 11.4%
) +)))
$
,,) ')))
!) +)))
"&
) $)))
details separately identied are
Black and minority ethnic
)&)))
"
)")))
received from all laboratories.
citizens, Oxfordshire 8.8%
,+)')))
!&
,')+)))
+") ')))
!
+ )!$)))
Electronic downloads from
and Northamptonshire 6.7%.
+,)'$)))
&
+")&!)))
Casemix/Patient Administration
In general, the regional
,!),!)))

+')&!)))
,!)'+)))
&
+*) ')))
Systems and from Oncology
population is healthier and
+*)+$)))

+")')))
systems are received from all
less deprived than those
provider sites. Ox-link record
living in many other parts of

&


&

matching software is used to
England. There are, however,
 )#%
  )#%
distinguish new registrations
pockets of deprivation in
)"',),!)))
)"$')*')))

from amendments or nonsome parts of the Region

  
registrable cases. Demographic
and there are higher rates of ) )  ) ))  )) ,, ))! )#  )) )%)
 


  
diseases (e.g. breast cancer) associated
with a higher social details of new registrations are added automatically to the le.

) )#!$%))
&)) )
Clerks then add the diagnosis and treatment details.
class distribution.
Cancer care facilities
Cancer services are organised by the Thames Valley Cancer
Network for Berkshire, Buckinghamshire and Oxfordshire,
and by the Leicestershire, Northamptonshire and Rutland
Cancer Network for Northamptonshire. Within the area
there are eight hospitals providing cancer care; three of these
have radiotherapy facilities.
PSA (prostate specic antigen) testing has been common
within the area since the early 1990s, but there are currently
no routine data on levels of testing.
Registry structure and methods
The registry is centrally funded by the Department of Health.
There are 15 full-time-equivalent staff members, with 5.5 in
the registration section, 4.5 information analysts, 4.0 IT and
business support, and a part-time Medical Director.
Cancer registration data have been collected on a
regional basis since 1952. The registry is notied of cases by
histopathology and cytopathology laboratories and medical
records departments. Death certicates where cancer is
mentioned are also passed to the registry from the Ofce

Interpreting the results


All borderline malignant tumours were included in downloads
from anniversary year 1993. Prior to this, apart from one or
two tumour types (i.e. polycythaemia vera) with a fth digit
of 1 (borderline malignant), they were not collected.
There were signicant changes to the UK practice of
bladder coding from anniversary year 2000. This meant that
bladder cases diagnosed as papillary non-invasive transitional
cell carcinomagrades I and IIwhich had previously been
coded as malignant (pathology reports also reported them
as 81303 - malignant) were now to be coded to a borderline
code. This had quite an impact in the number of malignant
cases reported; the malignant cases reduced in number and
the borderline cases rose signicantly. It was also agreed at
the same time that papillary non-invasive transitional cell
carcinoma grade III was to be coded to in situ.
Use of the data
The Oxford Cancer Registry is now part of the Oxford
Cancer Intelligence Unit (OCIU). OCIU is responsible
for cancer registration, for providing a cancer information

387

Europe

service, managing quality assurance and evaluation of the


breast and cervical screening programmes in the Region
and undertaking and contributing to programmes of clinical
audit and research. The registry contributes to the annual UK
Association of Cancer Registries review of the completeness
and accuracy of registry data.

388

Source of population
Mid-year estimates based on censuses in 1991 and 2001
(Ofce for National Statistics).
Multiple primary rules used
IACR rules (2004) on CI5 IX period.

Europe

UK, England, South and Western Regions


Interpreting the results
The coverage provided by the above range of sources, and
veried by checks made through audit, is over 99%. Death
Certicate Only registrations are less than 3%.
The UK runs screening services of more than ten years
standing for cervical and breast cancer.
The registry has only recently started registering skin
cancers of basal cell carcinoma (BCC, C44) due to the large
numbers and limited interest in this type of cancer in the past.
C44 were not collected systematically until 1998. For BCC
and Squamous Cell Carcinoma (SCC) only the rst primary
diagnosis is registered. Cervix in situ D06 is incomplete for all
Cancer care facilities
The SWCIS area is served by 12 main hospitals, within which areas. Registration of D45 is incomplete until 2001/2002. Bladder
C67/D41 coding was changed
there are seven designated
in 2000. Some 80% of cancer
cancer centres. There are a
registrations are supported by
further eight regional hospitals
UK, ENGLAND, SOUTH
pathological conrmation. The
with Accident and Emergency
AND
WESTERN
REGIONS
(1998-2002)
UK, ENGLAND,
SOUTH AND
WESTERN REGIONS
(1998-2002)
incidence of prostate cancer
(A&E) departments and
has risen dramatically in parts
signicant treatment facilities,
of the registry area since 2001.
as well as numerous small
This has largely been attributed
hospitals for minor injuries
##(+))(((
*%'
 (#!(((
&!(+&&(((
*
*( )&(((
to increased PSA testing.
and recuperation.
Registration area
The South West Cancer Intelligence Service (SWCIS)
collects data on all cancers and suspected cancers for the
South West region of England, including Hampshire and
the Isle of Wight. In all, it covers an area some 300km by
100km, with a coastline of over 1400km. The population of
6.8 million is nearly all white Caucasian and predominantly
Christian, with an approximate 60/40% split between urban/
suburban and rural. A large proportion of the population
(approximately 20%) are retired.

*(+!+(((

)%

% (*)!(((

% ()+#(((
&%
&&(!%(((
Use of the data
Registry structure and
&*(&))(((
&
)#(&#+(((
There are ve principal ways
methods
++(&))(((
%%
 (&+(((
!#(!(((
%
!+( )#(((
in which our data are made
The SWCIS is one of nine
!()&%(((
#%
+(%*(((
available:
regional registries in England.
&(##(((
#
+()&!(((
#)(&#%(((
!%
%()*(((
It is split between two sites,
T h e S W PH O we b s i t e
!*(+(((
!
# (&(((
one in Bristol (mainly data
(www.swpho.nhs.uk). This
&(#!)(((
%
!(++(((
+(&!(((

)+(&) (((
users) and one in Winchester
site is accessible to all for
*(%+#(((
%
+#(%+ (((
(mainly registration and
epidemiological statistics of the
)(!%(((

%(%!(((
+(+%&(((
%
++(#%%(((
IT). The SWCIS is funded
important cancers and information
+ (**(((

* (!*!(((
by government, through the
on cancer epidemiology.
Department of Health.
An ad-hoc information request

%


%

In 2005 the SWCIS
service. Each year the SWCIS

("$


("$
merged with the South West
deals with over 200 information
!(# %(!*)(((
!( %+(#!(((

Public Health Observatory
requests by phone, email, fax or

  
(SWPHO). The aim of the (
 (

(
((

((++(( (" 
(  (($(
letter from a wide range of health
 


  
SWPHO is to provide a seamless
public health intelligence professionals and others. Regular users of the service are strategic
 ( 
("++*$(
service for the region. The SWCIS employs 17 registry staff, health authorities, consultants, medical students, clinical audit,
4 information analysts, 5 clinical audit team members, and research bodies and the media.
5 Network Liaison Ofcers who provide an important link
To government via data exchange. A regular download
between the registry and cancer networks. Their work is of new and updated registrations is sent to the National
supported by Business Management, IT and Publications Registry (ONS) for Government publication.
and Communications teams who work across the whole
Publications. Cancers of special interest, patterns of treatment,
organisation.
and health service facility usage are regular topics of reports.
The SWCIS collects its data from three principal
Collaborative research. The SWCIS works with a variety
sources: Hospital Patient Administration Systems (Clearnet); of partners including Cancer Networks on a range of topics
pathology laboratory reporting systems, and the national to produce varied outputs including audit, new databases,
deaths database. These are accessed via electronic capture and follow-up studies and treatment effectiveness have all been
processing with manual intervention to resolve complexity or covered in recent years.
data conict. Over 75% of records are initially electronically
captured with more than two independent sources usually Source of population
involved. Eight subsidiary data sources include: private Mid-year estimates based on censuses in 1991 and 2001
hospitals, military hospitals, cancer screening centres, (Ofce for National Statistics).
follow-up with consultants, audit databases, other cancer
registries, cancer/treatment centre databases and national Multiple primary rules used
research centres.
UKACR rules (1998).
!#(*#(((

)

&(+&(((

389

Europe

UK, England, Thames


The Registry collects patient identifying information.
Registration area
The Registry was founded in 1958 as the South Metropolitan Special provision within the Health and Social Care Act 2001
Cancer Registry, became population-based in 1960, and enables the Registry to continue this practice without the direct
was renamed the South Thames Cancer Registry in 1974. consent of patients. Cancer is not a notiable disease in the UK.
A wide range of data validation checks are applied by the
Until 1984 it covered the South East and South West Thames
Regional Health Authority areas (the South Thames Health Registrys computerised registration system at the time of
Regions), with a population of approximately 6.8 million. In data entry/import. Automated retrospective validation checks
1985 the Registry expanded to include the North Thames are made daily. Patient deduplication is done annually. The
Health Regions, becoming the Thames Cancer Registry Registry regularly reports and monitors the stability of its
(TCR) and covering, in 2000, a population of approximately case ascertainment and data and process quality indicators.
14 million across the counties of Hertfordshire, Essex, The Registry participates in the quality assurance activities
London, Surrey, Sussex and Kent. Data in this volume cover of the United Kingdom Association of Cancer Registries,
this population, and have been submitted for diagnosis years which formally evaluate the Registrys stability, data quality
and completeness.
19852002. Previous volumes
have covered the South
Interpreting the results
Thames Health Regions only.
UK, ENGLAND, THAMES (1998-2002)
Previous
volumes
have
The
Registry
region
UK, ENGLAND, THAMES (1998-2002)
reported incidence in the
includes some of the most
South
Thames
Health
afuent areas in England,
Regions only. The data in the
and also some of the most
present submission cover the
deprived. London has an




 
 





 
 

residential population of South


ethnically diverse population.







East England (the counties of


In the 2001 census, 17% of




 






 


Hertfordshire, Essex, London,


the TCR population were not





 

Surrey, Sussex and Kent) in


classed as white, compared

 



 


 





the period 19852002. This


with 9% in England.







is the territory of the (now


 




 





 


historic) North and South


Cancer care facilities
 






Thames Health Regions.


The majority of cancer patients








 





are treated within the National


There
are
organised







Health Service (NHS). The


national screening programmes





 








Registry region is covered by


for breast and cervical cancer.







13 NHS Cancer Networks and


The Registry exchanges data
more than 50 NHS secondary
with the breast-screening






and tertiary care trusts. The
programme. Prostate-specic
 ,'#)
  ,'#)
Cancer Networks co-ordinate
antigen testing is common in




+,-%&,/.",,,

cancer care.
the Registrys population, and

  
Most
patients
are  ,

, ,, ,  , ,,

,  ,
 ,, ,  , ,,,' )!,, , ,
this has led to increased rates


, , , ,  , ,, ,$/.*,1,%""%, , , , , , ,$/.*,1,%""%!,,  ,  ,
 ,,$/.$ ,$//$,,%""$!, ,$//$,,%""$,

,,, , , , ,  ,, , !, ,

, , , ,
diagnosed and treated in a secondary
care trust. Patients of prostate cancer, particularly in men under 70 years of age.
 ,, ,  , ,0 ,  , ,, ,!,
 


  
with rare cancers and those requiring
specialised care are
 , ,'%""(),,,,
referred to a tertiary care trust. There are 22 radiotherapy Use of the data
centres in the area, 19 NHS and 3 private.
A range of reports are provided for health organisations in the
Registrys region. Research activity and output in the Registry
Registry structure and methods
have increased in recent years. The Registry contributes data to
The Registry is located on the Guys Hospital campus at a regional Cancer Information Service available online to NHS
London Bridge, and is a department in Kings College users. The Registry recently prepared national long-term cancer
London School of Medicine. It is funded through a contract incidence predictions for the Department of Heath. For further
with the Regional Director of Public Health in London.
information, see http://www.tcr.org.uk/.
The Registry has approximately 70 staff. Thirty mobile
staff actively abstract registration information from hospital Source of population
medical records. The other 40 staff, at the London Bridge The population table has been extracted from national
ofce, perform data entry, computing, quality assurance, population les produced by the Ofce for National Statistics
analysis, reporting, research and management functions.
(ONS). It details the population of the Thames Cancer
Principal sources of information on cancer cases are Registry diagnosis years 1985-2002 catchment area for the
pathology reports and information systems, paper medical calendar years 1985-2002. National censuses were held in
records, hospital patient information systems and death 1981, 1991 and 2001. The 1991 and 2001 populations in this
certicates.
table are from the censuses in those years. The populations
for the other years in the le are midyear estimates based
Death certicates are provided electronically to the Registry on census data.
by the Ofce for National Statistics. Certicates are provided
for registered patients, and for all people dying in the Multiple primary rules used
Registrys catchment area from or with cancer.
IACR rules (2004) on historical data.

390

Europe

UK, England, Trent


from a merger with the East Midlands Public Health
Registration area
The Trent region covers the counties of Derbyshire (except Observatory giving greater opportunities for joint working
its north-west tip), Leicestershire, Rutland, Lincolnshire, and signicantly expanding the type of work/projects the
Nottinghamshire and South Yorkshire, an area of 14 763 km2 registry is able to undertake.
Trent Cancer Registry collects a common minimum
with a resident population of 4.8 million. The area is served
by 11 Acute Trusts, 12 Primary Care Trusts and three medical dataset on cancer. Cases diagnosed in hospitals (inpatient
schools (Leicester, Nottingham and Shefeld). It spans two and outpatient) are notied to the registry electronically,
Government Ofce Regions (Yorkshire and the Humber, and including details taken from pathology reports. Other
East Midlands) and is the lead Cancer Registry for providing cancer registries notify the registry of Trent residents treated
information to four Cancer Networks (North Trent, Mid outside the region. Copies of Death Certicates are routinely
Trent, Derby/Burton, Leicestershire, Northamptonshire and received from the Ofce for National Statistics (ONS) for
Rutland). Cancer Centres are located in Derby, Leicester, all cases where cancer is a cause of death. When the cause
Nottingham and Shefeld, where radiotherapy and of death is not cancer related, the registry is notied by
the National Health Service
chemotherapy services are
Central Register, where all
available. United Lincolnshire
registered cancer patients are
Hospitals NHS Trust is a
UK, ENGLAND, TRENT (1998-2002)
agged.
cancer unit with radiotherapy
UK, ENGLAND, TRENT (1998-2002)
On receipt, data are
services.
validated using extensive edit
Despite variations within
procedures
(incorporating
the region, the overall
those of the ONS), and checked
Trent population prole is
$'"$$$
&!#
"$&""$$$
'$"$$$
&
""$&$$$
for duplicate registrations and
comparable with that of
%$&''$$$
%!
'%$!$$$
identication of patients with
England. Forty percent of
'$$$$
%
%$&$$$
!$!$$$
"!
$!$$$
multiple primaries. Formal
Trent local authorities are
&$%%$$$
"
$%$$$
evaluation of the completeness
in the two most deprived
'$'$$$
!!
'$%%"$$$
"!$&%$$$
!
"$&'$$$
and accuracy of information
quintile groups for the whole
!$&!$$$
!
!$%$$$
recorded by Trent Cancer
of England, compared with
"$'""$$$

"$&$$$
&$!$$$
!
&$'"$$$
Registry is ongoing as part of
35% in the two least deprived
%'$&%$$$

&$!"'$$$
the UKACR National Cancer
quintile groups. Just less than
!$"$$$
!
!!$%$$$
"$$$$

$'!$$$
Peer Review Programme.
75% of the resident population
!$"%!$$$
!
!$&!$$$
This aims to improve the
live in urban areas. The ethnic
!'$&$$$

!$$$$
!%$&"&$$$
!
'$$$$
processes, timeliness, quality
prole of the population is
$!&$$$

$'$$$
and provision of cancer
predominantly White (93.7%),
information.
with sizeable numbers from

!


!

The current database holds
Asian ethnic groups (3.9%),
 $
 $
$%$'"$$$
$&$$$$

records from 1966 comprising
most notably Indian (2.5%).
more than 900 000 individual
The area covers a variety 
  
registrations from across the
of industry. The decline of the  $  $ $
$$
 


  
coal and steel industries over the
last thirty
years has led to Trent Region, with approximately 35 000 new registrations
 $
 $''&
$
considerable economic re-development with heavy industry (malignant and non-malignant) each year. At intervals, new
being replaced with light engineering and service industries. registrations are abstracted and sent to ONS to update the
Textiles and the pharmaceutical industry also have a strong national system.
hold in the region. Many of the rural areas support farming,
Use of the data
food production and tourism.
Routine breast and cervical screening programmes Data are used for a variety of purposes, in particular,
operate in the Trent Region. Roll-out of the regional bowel responding to local health requests for information to support
cancer screening programme commenced in March 2007 at the effective provision of cancer services, use in studies both
the Derbyshire Screening Centre, and completion is planned locally and nationally, providing information to support
for 2009. The NHS Prostate Cancer Programme was launched genetic counselling service enquiries, and responding to ad
in 2000 and testing for prostate cancer is now available on hoc requests as appropriate.
Some statistics, further details and also information
request to men aged over 50 years on an informed choice
about reports and other publications, can be found on the
basis.
Trent Cancer Registry Website: www.trentcancer.nhs.uk
Registry structure and methods
Cancer registration in the Trent region began in 1955. Since Source of population
then there have been a number of signicant changes and UKACR Populations Dataset Version 3.
recongurations that have resulted in the organisation we
see today: Most recently, in 2003, the Registry moved to the Multiple primary rules used
current premises in Fulwood, Shefeld and in 2005 beneted UKACR rules (1998).

391

Europe

UK, England, West Midlands


5 staff. A further 6 staff provide business, administrative
Registration area
The West Midlands registration area covers a population and secretarial support. The WMCIU is funded, as are all
of 5 300 000 people in 2002, just over 10% of the total English cancer registries, via top-sliced, earmarked funding
population of England. There are marked differences in from the Department of Health.
Cancer registration is not a legal requirement in the UK
population density across the region, with very densely
populated urban areas and more sparsely populated rural at present. However, regulations passed under section 60 of
areas. Non-white residents make up 11% of the total West the Health and Social Care Act 2002 permit cancer registries
Midlands population, with the largest ethnic groups being to collect identiable patient data assuming the implicit
Indian (3.4%), Pakistani (2.9%) and Black Caribbean (1.6%) consent of the data subjects. Cases are mainly registered
(2001 census). The percentage of non-white residents is following receipt of information from clerical staff at
considerably higher in some areas of the West Midlands such individual hospitals in the form of relevant histopathology
as Birmingham (30%), Wolverhampton (22%), Sandwell reports and clinical case notes, such as radiotherapy reports.
Some hospitals send this information in electronic format
(20%) and Coventry (16%).
as a single patient record.
In April 2002, the West
The information collected
Midlands region was divided
includes demographic details,
into three Strategic Health
UK, ENGLAND, WEST MIDLANDS (1998-2002)
tumour characteristics, details
Authorities, but in October
UK, ENGLAND, WEST MIDLANDS (1998-2002)
of the involved clinicians and
2006 these were amalgamated
hospitals, and the nature of
into single Strategic Health
treatment. Copies of death
Authority covering the whole
certicates are routinely
region. There are ve cancer





 








received from the Ofce for


networks covering the West







National Statistics (ONS) for


Midlands population. Three














all cases mentioning cancer.


(Arden, Pan Birmingham







If no further information is
and the Greater Midlands








 



 

received after six months,


Cancer Networks) are entirely





 

additional details are sought


contained within the West
 






 




 

from Primary Care Trust


Midlands; the Derby/Burton

 





medical records departments


and 3 Counties Cancer
 



 









(to
whom
all
general
Networks
also
include
 






practitioner
records
are
residents of other registration
 



 






 


returned
after
a
patients
death)
areas.







and hospitals are contacted to


obtain relevant details. NonCancer care facilities






cancer deaths are provided
There are 18 acute hospital

+'#)


+'#)
routinely by the National
NHS Trusts within the

 

%+*--+,,&+++

Health
Service
Central
West Midlands, all of

  
!++ +

+
+

+
++

+
Register where all registered
which diagnose and treat  +

+
+
++
+%""$+
+++ + +
+
++

+  + ++++
+
+
+$..-/%""%!+
cancer patients. Five of these  


  
are cancer centres providing cancer patients are agged. Active follow-up of patients is
+
+'%""()++++
radiotherapy. A relatively small number of cancers are carried out for specic research studies (particularly survival
diagnosed in private hospitals, nursing homes and hospices. studies that include extra-regional cases) but not routinely.
In 1994, the WMCIUs existing tumour-based records
The WMCIU receives diagnostic and treatment information
were converted to a patient-based system in which all patients
from all of these organisations.
Whilst there are no routine data available on the rates have a unique identier and individual patients can have
of PSA testing in the West Midlands, there has been a large several tumours each with a unique tumour number. This
increase in prostate cancer since the late 1980s, when the increased the ease and speed of registration and facilitated
PSA test was made widely available. Furthermore, this more complex validation and data-quality checks in line
with IARC and ONS recommendations.
increase is much greater in the most afuent men.
Registry structure and methods
Cancer registration in Birmingham dates to 1936. Originally
based on a single hospital, its scope was gradually extended
until by 1957 it included the whole region.
The WMCIU employs 23 staff in the cancer registration
and data quality section. Four teams of tumour registrars
and cancer registration clerks are responsible for processing
the data received from NHS and private hospitals, nursing
homes and hospices in a particular geographical area. Each
team leader also has a specic area of responsibility; cancer
registration, data quality, training and records management.
The research and information team consists of 7 staff and
the computing and automated cancer registration teams of

392

Use of the data


The WMCIUs database is used for routine data provision
and for clinical audit and research purposes. Since 1995, data
collected by the WMCIU have been used to assist in planning
and monitoring the efcacy and cost-effectiveness of cancer
services. The WMCIU is also involved in the EUROCARE
study and contributes data to EUROCIM. The April 1996
incorporation of the NHS Breast and Cervical Screening
Quality Assurance Services into the existing structure
facilitated the synergistic combination of cancer registration
and screening databases. The rst major outcome of this
has been the establishment of routine systems for obtaining
breast and cervical cancer screening histories for all women

Europe

in the screening age band, including the determination of


interval cancer and non-attender rates.
In 2001, the WMCIU launched the electronic Cancer
Information Service (CIS), providing a powerful tool to
enable health workers connected to the NHS Net to access
cancer data from their own PC. Modules available include
cancer incidence, mortality and survival data, analyses
of cancer registration data quality and outcome measures
relevant to the quality assurance of the NHS Breast and
Cervical Screening Programmes. The WMCIU has a web
site (www.wmpho.org.uk/wmciu/) from which general

information on cancer incidence, mortality and survival can


be obtained.
Source of population
Population estimates are based on the 2001 Census and built
up from Census Area Statistical Wards. ONS estimates
have been used to estimate the populations forwards and
backwards to cover the period 19982002.
Multiple primary rules used
IACR rules (2004) on historical data.

393

Europe

UK, Northern Ireland


Registration Area
The registry collects information on all neoplasms
Northern Ireland consists of the six counties in the north diagnosed in Northern Ireland. Some cancer-related
of the island of Ireland and is part of the United Kingdom. conditions such as Barretts oesophagus, hydatiform moles
The population of Northern Ireland was 1 689 319 at the and CIN-I and CIN-II of the cervix are also recorded.
last census year of 2001. Whereas most of the population
A major focus of the registrys operation work is on the
is rural, there are two major urban areas situated around verication of information from a single death certicate
the cities of Belfast and Londonderry. Most of the heavy (death initiated cases), a single hospital admission or a single
industry is located in the two urban areas. The population histopathology report. Registry staff examine practitioners
is relatively racially homogeneous with only a few small notes for patients who have died from cancer. The staff
ethnic minorities, although there has been a recent inux of also examines hospital records for cases identied without
immigrants mainly from Eastern Europe.
conrmatory histopathology or cytology. Histopathology
The Northern Ireland Cancer Registry is a population-based reports are also checked for conicting information or other
registry that covers the entire population of Northern Ireland. possible errors.
Historically we have had high
The registry does not
death rates from mesothelioma
routinely receive tumour staging
due to the shipbuilding industry
information but extracts some
UK, NORTHERN IRELAND (1998-2002)
in Belfast. In April 2007, a
staging information from the
UK, NORTHERN IRELAND (1998-2002)
smoking ban was introduced
written histopathology reports.
into all work and public places.
Pathological staging is carried
out by Registry staff on selected
Cancer care facilities
sites onlybreast, colon, rectum,

 












Most cancer patients are treated


cervix, melanoma, bladder, testis






within the National Health


and ovary. An electronic tool














Service system and even most


to facilitate clinicians staging







private patients receive some


cancer has been developed














of their treatment in National


by the registry. Pilot studies





 

Health Service hospitals.


indicate enhanced recording of














Until 1 April 2007 there were


stage. The Registry has piloted





 

13 separate Hospital Trusts,


the capture of staging and other

 






 




which treat cancer patients


information at Multidisciplinary

 





amongst the four regional


Team meetings, which discuss







 





Health Boards. There is one


individual patient treatment






radiotherapy department in
plans and care.
the region, serving all cancer
The Registry has rigorous






"!1,(.
#"!1,(.
patients in the area. The vast
Quality Control and Quality



2**1)20111
"!
majority of patients receive all
Assurance programmes to
their care within the region. 
  
ensure high levels of data
A major re-organisation of *'')1&1 1!" 1 !"11  11*31 !1*'')&1)332%1)333%1*'''%1*''*&1 1
"1  !"1$" 111
completeness and accuracy.
!111)33)1" 1*'')11"  11"1"11%1"1" 1"1$ 1 1"1" 11 4
"1 "11
+'11
cancer services in 1997 introduced
the concept of a cancer The Registry contributes annually to the UAKACR Quality
 


  
centre and four cancer units for 1!1,*''-.11 /11  1
the population.
Assurance Group to help monitor data quality issues. Additionally
we routinely use the Flow Method for case ascertainment and
Registry structure and methods
yearly data re-abstraction to monitor data quality.
The current N. Ireland Cancer Registry was established
in 1994 to provide information on cancers in the Northern Interpreting the results
Ireland population for the purposes of research, education Population-based breast screening has been offered to all
and the planning of services. The new registry, located in women aged 5064 since 1993. The programme operates
Queens University Belfast, replaced an existing Department a three yearly recall system and was recently extended to
of Health and Social Services (DHSS) Registry that began in include women up to the age of 70. Cervical screening has
1959. It is funded by an annual grant from the Department been available population-wide to all women over 20 since
of Health with ve yearly reviews to ensure quality and to the late 1980s. PSA testing for prostate cancer has steadily
advise on direction.
risen since the early 1990s; however there are no formal
The registry uses an automated computer system with guidelines at present to use this for population screening.
multiple sources of notication of patients with cancer. The
Registry uses three main sources for registration, the Patient Use of the data
Administration System (PAS) used by all the Hospital Trusts, The registry not only registers all cancers in the region, but
histopathology reports and death notifications. From PAS also provides a cancer information service and has a close
the registry obtains demographic information on individual connection with the breast and cervical screening services
patients along with data on their length of hospital stay and basic and the local cancer network. Registry data are routinely
tumour site and behaviour information as an ICD-10 code. PAS used by policymakers to evaluate and plan cancer services
information includes limited surgical treatment information. The throughout the region. Registry reports on cancer survival,
tumour information is supplemented by electronic downloads trends, cluster investigation and disease-specic audits
are available at www.qub.ac.uk/nicr. The registry data on
from histopathology and cytopathology laboratories

394

Europe

Barretts oesophagus and prostate cancer screening have


formed the basis of research projects.
Source of population
2001 census. Northern Ireland Population census conducted
on 29th April 2001. 1998, 1999, 2000, 2002: Mid Year

population based on the results of the 1991 and 2001 censuses


adjusted to take account of births, deaths and migration
between Census Day and the MidYear date of 30th June.
Multiple primary rules used
IACR rules (2004) on CI5 IX period.

395

Europe

UK, Scotland
Registration area
The Scottish Cancer Registry covers the whole of Scotland,
which has a population of just over ve million. The majority
of the population live in an industrialised belt across the
centre of the country. The majority (87.15%) of the population
were born in Scotland but 9.07% were born elsewhere in the
United Kingdom (England, Wales, or Northern Ireland). A
relatively small percentage (1.53%) were born elsewhere in
Europe, and 2.25% in the rest of the world.

Interpreting the results


The registry introduced ICD-10 and the second edition of
ICD-O for diagnostic coding of patients diagnosed on or
after 1 January 1997. Previously records were coded to
ICD-9 and morphology to the rst edition of ICD-O. The
registry dataset was also expanded in 1997 to include most
valid basis of diagnosis, method of rst detection, grade
of differentiation, stage of disease (for colorectal, female
breast and cervix cancers), treatment details and entry to any
clinical trial.
Cancer care facilities
Cervical screening began in parts of Scotland in the
The National Health Service in Scotland is funded mainly early 1960s, but coverage was uneven until a computerised
through taxation and is mostly free at the point of use. Access call-recall system was introduced in the late 1980s, offering
to hospital care is controlled
cervical smears to eligible
by a well-developed system
women in the age group
of primary care. Radiotherapy
2060 every three years. A
UK, SCOTLAND (1998-2002)
facilities are provided at ve
national breast screening
UK, SCOTLAND (1998-2002)
main centres (Inverness,
programme was phased in to
Aberdeen,
Dundee,
Scotland in the late 1980s for
Edinburgh, and Glasgow), but
all women aged 5064 years
many patients with cancer are
every three years, and older














diagnosed and receive their


women on demand. However,





 

primary therapy at district


beginning in 2003/04, the








 





general hospitals. The private


age range for invitation was







healthcare sector in Scotland


extended to include women up











 


is relatively small.
to the age of 70. In April 2000,




 


in three (out of 15) Scottish


 






 






Registry structure and


health boards, a colorectal







methods
cancer screening pilot project














The Scottish Cancer Registry


was established to assess the







forms part of the Information


feasibility of introducing a














Services Division (ISD) of


national screening programme

 





the National Health Service


based on offering faecal occult
National Services Scotland
blood testing to individuals







-)&+

!
-)&+
(NHS NSS). The core
aged 5069 every two years.


 

'-*(*-,/.--
registration function is funded
The prostate specic
by the Scottish Executive 
  
antigen (PSA) test was
-
!
0-1
 -)(%-
+-  -
!
#-

-

- 
--) +0-)!1
 -'%%'+Health Department.
introduced to Scotland in
 0$$# 1##$$"  $  
$%'1!1
 1"
$
#! 


  
Until 1997, ve regional cancer
registries carried out 1989, and use of the test has increased strikingly since then.
- 
-)'%%*+-- -registration, and the role of the national registry was limited Although screening for prostate cancer is not currently
to coordination, data collation, analysis and publication. recommended in Scotland, there is some evidence of
In 1997, the national registry assumed responsibility for differing thresholds for application of the PSA test since
all aspects of registration and established a network of there is now considerable variation in incidence across the
outposted, peripatetic cancer registration ofcers based in 15 Scottish health board areas despite much less variation
the main hospitals. Currently the registry is staffed by a in mortality.
medical director, a national coordinator, six central registry
In adults, the prevalence of smoking is estimated to have
staff (two of whom work part-time), and 24 outposted staff fallen from 46% in 1976 to 28% in 2002, although serious
(three of whom work part-time).
concerns remain about the prevalence of smoking among
Cancer is not a notiable disease in Scotland. Until 1997, teenagers in Scotland. Alcohol consumption has increased
the regional registries relied mainly on hospital inpatient greatly in Scotland since the 1950s. The diet in Scotland
sources, pathology records and death records to identify is widely regarded as unhealthy, and there is no evidence
registrations. Since reorganisation, potential registrations of any substantial change overall in fresh fruit or vegetable
are identied from four main computerised sources: hospital consumption since the early 1950s.
discharge records, oncology records, pathology records
and death records. Information from these and other, Use of the data
non-computerised sources is linked to create provisional The Scottish Cancer Registry publishes data regularly
registrations that are made available to the outposted cancer on incidence, and periodically on survival. Increasingly,
information ofcers. By referring to medical records, information is being made available on the internet (http://www.
the outposted staff validate the provisional registration isdscotland.org/cancer). Ad hoc analyses of the data are carried
and abstract additional information that cannot currently out in response to many requests for information from a wide
be collected electronically. The registry has an active variety of data users. The Scottish Cancer Registry is involved
programme of quality assurance.
in several major studies, both in-house and collaborative. The

396

Europe

registry data are used for a wide range of purposes including


public health surveillance, needs assessment, planning and
commissioning of cancer services, evaluating the impact of
interventions on incidence and survival, clinical audit and
health services research, epidemiological studies aimed at
determining the causes of cancer, and providing information
to support a range of functions including genetic counselling
and health education.

Source of population
Ofcial estimates: Midyear (30 June) population estimates.
General Register Ofce Scotland (GROS): (midyear 2002)
ht t p://www.g ro scotla nd.gov.u k /st atistics/ l ibra r y/
poptest/02midyeartables/index.html.
Multiple primary rules used
IACR rules (2004) on historical data.

397

Oceania

Oceania

Australian Capital Territory


Registration area
The Australian Capital Territory (ACT) covers an area of
approximately 2400 km2 and is surrounded on all sides by the state
of New South Wales (NSW). Almost all the ACT residents live in
metropolitan Canberra, although 85% of the Territorys land mass
is devoted to national park, nature reserves, pine plantations and
properties. The population at the most recent census in 2001 was
311 947, which represents 1.6% of the Australians population.
The estimated median age in 2001 was 32 years.

paper notications, with the exception of the Department of


Radiation Oncology at the Canberra Hospital and one private
hospital in the ACT. The forms are collated and forwarded
onto the NSW Cancer Registry, which processes all new
cases of cancer for the ACT. Data on deaths from cancer
is obtained from the ACT Registrar of Births, Deaths and
Marriages.

Interpreting the results


Under the current arrangements, it is unlikely that any referred
Cancer care facilities
cases will be missed. Before 1994, voluntary reporting led to a
The ACT Health oversees general health care in the region dramatic under-reporting of cancer cases. Since 1994, the reporting
in partnership with the service providers. The ACT has a of cancer cases has improved steadily to a level at or near 100%. For
comprehensive range of cancer
example, the age-standardised
prevention, early detection,
rate for malignant melanoma of
treatment, community care and
the skin for males was 30.6 in the
CAPITAL TERRITORY (1998-2002) 1998-92 statistics, and 40.7 in the
palliative services available to AUSTRALIAN
AUSTRALIAN CAPITAL TERRITORY (1998-2002)
the local community, in both
199496 statistics.
the public and private sectors.
The Canberra Hospital is the
Use of the data
principal cancer care provider in
The registry monitors the













the ACT and surrounding NSW


incidence and trends in cancer





 

region, and offers expertise in


for ACT residents. With

 












surgery, medical and radiation


regard to the small numbers







oncology and haematology


involved in the ACT cancer












 

services. The Canberra Hospital


statistics, data on incidence







is active in cancer research and


and mortality are analysed in





 








clinical trials.
ve-year blocks and reported







There is a strong network


every two years.

 












of consumer and carer support


Record information is







groups and the Cancer Council


made available to approved














ACT is well supported by


medical researchers engaged







service providers and the ACT


in studies that are considered
community.
by the ACT Health Ethics






  0+' "  0+'Committee to be of importance



(./0((.000
 
Registry structure and
to the community.
methods

  
 0)&&(0  0 0   $0  0 0 4 "  0  0  0  0 "  0  %0 0   0
The cancer registry is (22($0(22/0
Source of population
"  0  0#  0 "0 0  0 0#0  0  0  0 0 0#$0 0  0"" %0 0  0  00 00
 0 0 0 %0  0#0  0  0 !30  0  0  0  0 0(22)00 0
the agency established under 0 0 0 %0 30
the Public
Health
(Cancer
(221%00

  0%0*)&(%&+(221-0

#  $0
 0 0 0 %0
1991, 1996 and 2001 are census populations, adjusted for
 


  
Reporting) Regulations gazetted
in 1994, to receive underenumeration and Australian residents temporarily

0 0+)&&,-00
.00  0
notication of cancer in the ACT. Previously, the NSW overseas. The intercensal estimates are obtained from the
Cancer Registry had been collecting data for the ACT since previous census by advancing age and allowing for births,
1972, although notication was voluntary.
deaths and immigration. They are adjusted in the light of
The ACT Health funds the registry, which is located the succeeding census. Ref: Australian Bureau of Statistics.
at the Canberra Hospital in Woden in ACT. Since the Population by age and sex: Australian States and Territories
regulations came into effect in July 1994, notication of June 1992 to June 1997. ABS Catalogue no. 3201.0(1997)
malignant neoplasms has been mandatory for all ACT Canberra, Australian Bureau of Statistics.
hospitals (public, private and day), radiotherapy departments,
pathology laboratories, hospice facilities and nursing homes. Multiple primary rules used
Currently, data are received from 18 sources. These are all IACR rules (2004) on CI5 IX period.

399

Oceania

Australia, New South Wales


manager, biostatistician, analyst programmer, medical
Registration area
The NSW Central Cancer Registry covers the population of adviser, medical coders and data entry clerks. The Registry
New South Wales. There were 6 686 644 residents in 2003; maintains a register of cases of cancer diagnoses since 1972.
of these, two thirds live in the capital city, Sydney. NSW is The information collected includes name, address, date of
the most populated of the six federated states, with 34% of birth, country of birth, clinical details about the cancer,
the population of Australia. The area of NSW is 801 400 Km2 the notifying institution and doctor. All information sent
(309 433 square miles), comprising 10.4% of the total area of to the Registry is kept condential, held under security and
Australia. Geographically, the Western Slopes of the Tablelands protected by the Public Health Act. Presently there is an
and the Western Plains occupy two thirds of the State, but initiative to develop clinical cancer registries to collect TNM
most of the population lives in the east, with 74% living in the staging and treatment information. These are being piloted
in 5 of the 9 Area Health Services.
adjacent coastal cities of Sydney, Newcastle and Wollongong.
Forty percent of all notications are received electronically;
At 30 June 2003, 20% of the population was aged under
15 years of age, 67% between 15 and 65 and 13% 65 years and the remaining notications and pathology reports are paper
based. Death registrations are
older. By comparison, in 1972,
provided by the Registrar of
the rst year of registration of
Births, Deaths and Marriages
cancer in New South Wales,
AUSTRALIA, NEW SOUTH WALES (1998-2002)
and received regularly. Coded
9% of the population was aged
AUSTRALIA, NEW SOUTH WALES (1998-2002)
death registrations are also
over 65 years.
received from the Australia
In the 2001 Census, 4 450
Bureau of Statistics. The
772 people (70.5%) stated that
Registry routinely matches
they were Australian-born. This














cancer cases against deaths in


compares with 4 394 326 people

 



 

Australia from all causes.


(73.3%) in the 1996 Census and





 


 





4 284 568 (75.1%) in the 1991









Interpreting the results


Census.1 The number of people














As notification is mandatory
born overseas in the 2001 Census

 





and provided through a number


was 1 474 987 (23.4%) compared





 








of different sources (on average,


with 1 388 849 (23.2%) in the







four notications per case), the


1996 Census and 1 286 847

 












level of enumeration is likely to


(22.5%) in the 1991 Census. Of







those born overseas, the three


be high. Indicators of data quality














main countries of birth in the


support this assertion, with only







2001 Census were the United


1.4% of cases registered as death
Kingdom 275 130 (4.4%), New
certicate only and 88% of all






 !
 !
cases histologically veried.
Zealand 105 708 (1.7%) and China




!!#!!!

(excludes Special Administrative
Use of the data
Region and Taiwan Province) 85 
  

 !  !!!!$! !##"$!


An annual statistical report
363 (1.4%).
 


  
!  !!! !! !
is published that provides information on the number of new
cases and deaths by counts, rates and trends over time. The
Cancer care facilities
There are 9 metropolitan and rural Area Health Services Registry contributes to the prevention, planning, control and
responsible for providing cancer services. These Area Health treatment of cancer in the population of NSW by providing
Services provide hospital inpatient, outpatient and community timely accurate data and the evaluation of both breast and
health care and specialist Cancer Care Centres for their residents. cervical screening programs. It contributes to national and
Radiotherapy and chemotherapy services are predominantly international publications and a variety of specialist reports by
outpatient and provided in specialist Cancer Care Facilities. cancer site. In addition, there are a number of other reports on
specic cancer sites, risk factors and cancer survival in NSW
Cancer services are also provided by private facilities.
Notication of malignant neoplasms is a statutory in progress. Tabulated data is made available through a web
requirement and currently operates under the authority of the based reporting module that can be accessed at www.statistics.
Public Health Act of 1991. All public and private hospitals, cancerinstitute.org.au.
Unit record information is made available to approved
departments of radiation oncology, nursing homes and pathology
laboratories, outpatient departments and day procedure centres medical researchers engaged in studies that are considered
are required by law to notify the NSW Central Cancer Registry by the NSW Cancer Institute Ethics Committee and the
Department of Health Ethics Committee to be of benet to
when cancer is diagnosed or treated by them.
the wider community.
Registry structure and methods
The NSW Central Cancer Registry is managed and funded Source of population
by the NSW Cancer Institute on behalf of the NSW Estimated resident population data June 19982002.
Health Department. There are 19 full-time-equivalent
staff employed at the Registry. These include a manager, Multiple primary rules used
operations coordinator, coding supervisor, data quality IACR rules (2004) on CI5 IX period.

400

Oceania

Australia, Northern Territory


Registration area
The Registry was established in 1981 to cover the entire
population of the Northern Territory, a sparsely settled area
of 1.4 million square kilometres in central and northern
Australia. The population of the Northern Territory increased
from 122 000 in 1981 to 203 000 in 2005. Seventy-ve
percent live in ve urban areas.
The population has a very young age distribution, with
only 5% of the population aged over 65 years, although the
over-65 population is increasing at a faster rate than are
younger age-groups. Twenty-nine percent of the population
are Indigenous Australians, most of whom live in small,
remote communities.

cancer registries for cases notied in one state but resident in


another at the time of diagnosis. There have been no substantial
changes to case denitions or coding practices since 1991.

Interpreting the results


Prior to 1991, case ascertainment is estimated to have been
only about 60% complete. A data quality audit of the register
estimated that since 1991, case ascertainment has been less than
3% incomplete, in comparison with registration rates of other
Australian registries. Incidence rates for Indigenous people
under-estimate actual cancer incidence by approximately 18%
because of mis-classication of indigenous status (Indigenous
people incorrectly identied as non-Indigenous).
Indigenous Australians
Cancer care facilities
(Aborigines and Torres Strait
There are six hospitals,
AUSTRALIA, NORTHERN TERRITORY
Islanders) have a very different
including
two
referral
pattern of cancer incidence and
(1998-2002)
AUSTRALIA, NORTHERN
TERRITORY (1998-2002)
hospitals, and a well-developed
survival at specic cancer sites
private health care system in
than other Australians, with
the larger towns.
much higher incidence of some
There has been some
cancers but lower incidence
improvement
in
cancer
of others, and lower cancer







diagnostic and treatment


survival. Cancer incidence and

 





 





services since the establishment


mortality statistics are published







of the Registry. A breast


separately for Indigenous and














cancer screening service


non-Indigenous people. Among







commenced operation in
Indigenous Australians, smoking














1994 and a cervical screening


prevalence is very high (over 50%







register in 1996. The extent of


of adults are current smokers),












 

PSA testing is not known. A


as is consumption of alcohol at







specialist medical oncologist


dangerous levels; the prevalence

 









commenced practice in the NT


of chronic infection with Hepatitis

 





in 1991 and a haematologist


B virus is also high, but Pap test
in 2006, but other specialist
participation rates are relatively






oncology services are provided
low. The prevalence of smoking
"! 2-)/
 #"! 2-)/
by visiting specialists from
and consumption of alcohol at

 

*(+2,0(222
"!
interstate; there is no specialist
dangerous levels is also higher

  
cancer treatment centre or #" 2  2 !"%2$" 22 7 "2 &2"!"2 "22"&2,++4&(272 #" 2#" 2"2 62
among non-Indigenous people in

 %2 2"2 %2*550&2


""! 2 2,++4&(&2-""!"$! 2"2
 6''
&"$&&"''"$8&' $
!! '
3. 
5.(,3
+01 (((+3.51./22
radiotherapy facility.
the NT than for the total Australian population.
 


  

2! 2-*55(2"2+(((/22
Patients requiring treatment
not available locally are
transferred to specialist treatment centres in an interstate Use of the data
capital city. There is an extensive network of primary health Because of the small number of cases registered each year,
care centres in remote communities.
the registry produces statistical reports only every few
years. The Registry participates in a small epidemiological
Registry structure and methods
research program focussing predominantly on issues relating
The Registry is located within and fully funded by the Health to cancer in Indigenous Australians and performance of
Gains Planning Branch of the state health department and local cancer diagnosis and treatment services. In recent
staffed by one full-time research assistant. Data processing, years Registry data have been increasingly used for health
coding and database maintenance are performed under service planning purposes, particularly in consideration of
contract by the South Australian Cancer Registry. Data the feasibility of establishing a radiation oncology service
analysis and publication are performed by Health Gains within the Northern Territory.
Planning Branch staff.
Notication of cases from the three pathology laboratories Source of population
in the NT and the Registry of Births, Deaths and Marriages Estimated Resident Population, based on veyears census.
has been mandatory under the Cancer (Registration) Act Australian Bureau of Statistics. 3228.0 Demographic
since 1991. The Registry also performs active case detection Estimates and Projections: Concepts, Sources and Methods,
from hospital inpatient morbidity data and follow-up from 1995. Catalogue No 3228.0. (available at http://www.
hospital medical records and medical practitioners for abs.gov.au/AUSSTATS/abs@.nsf/DSSbyCollectionid/
incomplete notications.
FCEF74DBECB94037CA256BD000274964).
Death registration in the NT is complete. The Hospital
Morbidity Dataset is complete for the ve public hospitals. There Multiple primary rules used
is a well-established system to exchange data with interstate IACR rules (1990 and 2000).

401

Oceania

Australia, Queensland
Registration area
The Queensland Cancer Registry collects data relevant to the
State of Queensland, which occupies the northeastern portion
of the Australian continent. Queensland is the second-largest
of the six Australian states and has the largest habitable area.
Queensland boasts a subtropical to tropical climate.
The Queensland population of 3 522 044 (2001) is 19% of
the total population of Australia. Queenslands population is
the least centralised of all the mainland states of Australia.
Aboriginal and Torres Strait Islander people represent
approximately 3.1% of the total population. Approximately
70% of the population are of Christian denomination.
Cancer care facilities
Specialist cancer treatment
is primarily provided by the
major Brisbane hospitals
(Princess Alexandra Hospital,
Mater Misericordiae Hospital,
Royal Brisbane and Womens
Hospitals and the Greenslopes
and Wesley Private Hospitals)
with large regional hospitals
(e.g.
Townsville
and
Rockhampton
hospitals)
also providing specialised
treatment. In addition, some
oncology specialists visit
patients at regional centres.
Radium treatment is available
at Townsville and Brisbane.

Arrangements for completion of forms vary according


to the type of hospital. Resident medical staff and medical
records staff are involved in the larger hospitals, medical
superintendents and nursing staff at smaller hospitals.

Interpreting the results


A number of new initiatives have been undertaken in recent
years. Quality assurance reviews have been conducted on
cause of death coding from the Australian Bureau of Statistics.
A review comparing cancer notications against the hospital
morbidity collection has been conducted and indicated underreporting. The registry is able to obtain access to electronic
pathology reports for all public hospitals, and is currently
working on accessing other
pathology laboratory results
electronically. Access to the
AUSTRALIA, QUEENSLAND (1998-2002)
electoral roll with date of
AUSTRALIA, QUEENSLAND (1998-2002)
birth has been gained, which
assists in identifying patients
still alive, and the registrar of
births, death and marriages
%'.0+)...
0+&0.1'#...
&%.,)1...
0#!
'&.++#...
ahs introduced date of birth
'0.)&0...
/+!
)/./)1...
and indigenous identier to
+%.0+1...
/#!
+,.'%#...
+1.1'1...
,+!
,#.&,%...
the death certicates.
/'.)/,...
,#!
/#.))'...
There is population-based,
1'.+&1...
++!
01.%)%...
%%1.#/&...
+#!
%%+.&#,...
coordinated screening for
%&+.+)1...
)+!
%&).1+%...
breast and cervix, and about
%''.'+1...
)#!
%'+.&&/...
%'+.1'/...
'+!
%'1.)),...
30% of men older than 50
%'#.1,0...
'#!
%''.%0/...
yrs have a PSA test in any
%').'/+...
&+!
%').,%)...
%&0.+%&...
&#!
%&+.+0+...
specied year.
%''.00%...

%+!

%&/.%1%...

Use of the data


Registry structure and
While the QCR doesnt undertake
methods
an epidemiological research
%#
+
#
#
+
%#
The registry is located at the
itself, it does provide data for
 .($*
  .($*
Queensland Cancer Fund and
researchers wishing to undertake
%./1#./0'...
%./0).,00...

is funded and managed by
epidemiological research. Policy
. . ."..&##%. . .
.. .   ....  . ... .
the Queensland Department   

makers also use our cancer
&#%+"'"...
of Health. The registry has a core
of eight clinical coding registry data for planning and evaluation of health services.
      
 . .(&##)*.. +..
.
staff as well as a number of temporary
staff to undertake
  
)). .. .. .. . .".
supplementary projects.
Source of population
Data collection for the Queensland cancer Registry Australian Bureau of Statistics. 2001 Census of Population
commenced on 1 January 1982. The registry operates under and Housing, Selected Social and Housing Characteristics
an Act of Parliament that requires compulsory notication for Statistical local Areas 2015.3.
of all cancer patients in Queensland to the registry from all
hospitals (public, private, psychiatric) and nursing homes. In Multiple primary rules used
addition, it is compulsory for all pathology laboratories to IACR rules (2004) on CI5 IX period.
provide pathology reports mentioning cancer to the registry.
Death certicates are accessed where the cause of death is Notes on the data
cancer and also for cancer patients dying of causes other C44 does not include basal cell or squamous cell
than cancer.
carcinoma.

402

%'&.%%'...

%#!

%&+.%%0...

%'&.//'...

+!

%&+.0/+...

%&+.)%,...

#!

%%0.110...

Oceania

South Australia
Registration area
South Australia is a state in the Australian federation of six
states and two territories. It is situated between 26 and 38S
and 129 and 141E, and covers a total area of 984 375 km2.
Over one third of this area is desert, and over half of the state
is devoted to extensive pastoral pursuits.
Approximately 99% of the population lives south of the
32nd parallel, and a high proportion of the population lives in
or around the coastal state capital city, Adelaide.
South Australia has a multicultural population with
increasing immigration from many overseas countries.
The Cancer Registry records Country of Birth and Race
(whether Caucasian, Indigenous, Asian or Other).

searching the current le of death certicates obtained


from the Registrar of Births, Deaths and Marriages.
Hospitals or treating medical advisers are consulted when
a cancer death certificate is received for someone not
already known to the registry. All Australian registries
communicate regularly with each other about cases who
have moved interstate.
Ascertainment checks to nd unreported cases are
performed at least every six months by comparing
hospitals inpatient separation data with the registrys
les. An annual data validation check is performed in
addition to the routine editing and validation procedures
incorporated into the data entry software.
Since 1987, a system
of hospital-based (clinical)
registries has been established
SOUTH AUSTRALIA (1998-2002)
in major teaching hospitals
SOUTH AUSTRALIA (1998-2002)
in South Australia. Special
liaisons have been established
with the hospitals departments
to facilitate the follow-up of




patients by clinicians and






to enable them to evaluate








 

clinical aspects such as






treatment outcomes in relation










to disease stage and important






prognostic
factors.
The








relevant
clinical
areas
own




these hospital-based registries,










but signicant interaction




 

with the population-based










registry is required for case






ascertainment
and
data
provision.






Registry structure and


methods
The South Australian Cancer
Registry started in 1976, on a
voluntary basis, but since 1977
notication of cancer has been
a statutory obligation (without



penalty) for all hospitals and





pathology laboratories in




 

South Australia. Hospitals are





required to report all cases of






 

cancer (expect non-melanotic





skin cancers) within one








calendar month of the patients





commencing
radiotherapy,

 




the patients discharge from




the hospital and/or death of








the patient in the hospital.





Pathology laboratories are


required to send copies of

 ,'#)
  ,'#)
reports of all cases of cancer



-(&,-*.,,,

Use of the data
within one calendar month
The primary objective of the
of the nalisation of the 
  
 , 0 ,%""",  ,,  ,, ,, , , , ,, ,$//+,  , , , , ,,
registry is to describe the
pathology report.
, ,, , !,
Registry staff consists of  


  
a Manager and ve cancer nature and extent of cancer in South Australia, to monitor

, ,'%""(),,
*,,  ,
cancer incidence, mortality and survival, and to evaluate
registry project ofcers.
The system of notication varies among hospitals spatial and sub-population differences. Registry publications
depending on hospital size, stafng and types of record on cancer in South Australia are current, timely and wellsystems. In general, the responsibility lies with medical received locally, interstate and overseas.
The data are used extensively for monitoring the burden
records ofcers in public hospitals and managers in private
institutions. The multiple notications received are linked of cancer in the community and evaluating the effectiveness
and a le is created for each patient. Checks are available to of cancer control and prevention programmes, for example
the registry from death certications and pathology reports. breast and cervical cancer screening, and of clinical
Cases from such sources that are not reported by hospitals services. PSA testing is also common within the population.
Other international, national and local bodies also use the
are followed up.
Information collected includes country of birth, race, data extensively for their cancer prevention, cancer control,
occupation, Breslow thickness and Clark level for melanoma clinical services and/or research activities. The Cancer
Council South Australia is one local organisation that uses
and tumour diameter and nodal status for breast cancer.
The registry staff regularly telephone, visit or write registry data heavily in its activities.
An analysis of survival has provided valuable information
all hospitals to obtain information on inadequately
reported cases and cases identified from pathology for the entire South Australian community, and has served as
laboratory reports. Patients medical advisers may be a standard comparison for intra-hospital survival studies. The
consulted by letter or telephone if case discrepancies are data are now sufcient for ten-year relative survival rates to
not resolved by other means. An annual cross-linkage be calculated based on the proportion of survivors from 1977
checks cancer registry live cases with the Registrar in the patient group, as related to the proportion of survivors
of Deaths main deaths le to see whether any cancer in a similar group of people without the disease.
Cancer registry data also are used in investigating
cases have died of a condition other than cancer. Cancer
deaths are detected on a monthly basis by electronically perceived cancer clusters in various geographical areas.

403

Oceania

These perceptions usually arise from a citizen or group of


citizens concerned about their local environment.
Other cancer epidemiology and statistics endeavours are
supported, such as the National Malignant Mesothelioma
Project, National Paediatric Cancer Registry, the National
Cancer Statistics Clearing House and various ad hoc
international, national and local projects.

404

Source of population
The midyear 2000 population was estimated by the Australian
Bureau of Statistics, based on the 1996 census, and advancing
age and allowing for migration, births and deaths.
Multiple primary rules used
IACR rules (2004) on CI5 IX period.

Oceania

Australia, Tasmania
Registration area
transfer. Death certicates of Tasmanian people are reviewed for
Tasmania, the smallest state of Australia, is a group of islands mention of cancer as a cause of death. Since 1994 breast and cervix
of 68 114 km2, about 0.9% of the total area of Australia, lying cancer screening programs have been undertaken in Tasmania, and
between 40 and 43S, and having a temperate climate. The listings from these sources are available to check against registry
principal industries are aquaculture, viticulture, mining and records. In the 1990s, the increase in the incidence of prostate
forestry. Secondary industries include textile, confectionery, cancer coincided with a greater use of PSA testing. Incidence
beer and beverages, zinc and aluminium smelters, and peaked in 1995 before declining. Interstate registries supply data
vegetable and milk processing. Tourism is also a major to the Tasmanian Cancer Registry on Tasmania residents who
industry in Tasmania. Waterpower stations provide nearly seek treatment interstate or who move interstate at some time
all the electricity generated in the state. Wood res used for after cancer diagnosis.
home heating produce smoke in populated areas during the
The Tasmanian Cancer Registry collects and registers
winter. A degree of heavy metal pollution of river waters non-melanoma skin cancers (NMSC) on a register established
occurs in some areas.
in 2001 for this purpose. Currently NMSC registrations are
complete from 1978 to 2004.
Only 2.5% of Australias
To help achieve high data
population reside in Tasmania.
quality and case ascertainment,
Ta sm a n ia i s t h e mo st
AUSTRALIA, TASMANIA (1998-2002)
data are obtained from multiple
decentralised state in Australia,
AUSTRALIA, TASMANIA (1998-2002)
sources including pathology
with almost 60% of people living
laboratories, hospitals and the
outside the capital city statistical
Registrar of Births, Deaths and
division. Like the national
Marriages. Most registered
population, that of Tasmania














cases include data from both


is ageing with an increasing





 

a pathology laboratory and


proportion of the population














a hospital service (inpatient


aged 65 years and over.







or radiation oncology clinic).


Tasmania is the least diverse













Where information received


population in multicultural terms







is insufcient to enable
of all the states in Australia with














complete registration, active


95.5% of the population born in





 

follow-up is undertaken by
Australia, the USA, the UK,














contacting treating doctors,


New Zealand and South Africa.







pathology laboratories and


Three percent of the population














medical records departments.


are of indigenous origin.





 

In addition, the National


Cancer Statistics Clearing
Cancer care facilities






House (NCSCH) in the
Tasmania is well served by
! /+' "! /+'national capital, Canberra,
oncology services. The three



)*)/1(0///
!
collates all State and Territory
main population regions all
  

!$/! // 3 " !/!/! !/  / " ! /  !%/ /  ! / "! /
data and checks for duplicate
have a public hospital system as (11./!/)&&(/! / /  
! /#! /"/ /  / /#/!!/! /!/! //#$/ !/!/"!%/ /! /! // / // /
 / %/ %2/! !/ "! /!$/! !/ !//!$/ !%/
%/*(&(%&$/ %/(11.3)&&(%/ /
$/
well as a number of private hospitals.
There are!/ !//!$/ !%/
%/*(&(%.$/(11.%/
two radiation registrations across two or more States.
!"!!/ !//(11.$/!
      
Prior to the year 2000 cases were not accepted by the
oncology units in the state.
 / /+)&&,-//! /!!/
  
registry on the basis of death certicate only. Each death
,,//!! !# %/
certicate is actively followed up to ascertain the time
Registry structure and methods
The Tasmanian Cancer Registry was established in 1977 as and place of diagnosis and to verify the diagnosis, and the
a population-based registry covering the state. The registry percentage of death certicate only cases registered since
was set up for the purpose of providing the state government 2000 is 1% per annum.
with accurate cancer incidence and mortality statistics and to
provide the capacity to monitor cancer trends. In July 1988 Use of the data
the responsibility for the operation of the cancer registry The registry publishes a report each year showing the
was transferred from the Department of Health and Human number of new cases of cancer in Tasmania, and each cancer
Services to the Menzies Research Institute, University of registry in Australia sends information to the NCSCH which
publishes a national report. More detailed information
Tasmania, Hobart.
Cancers were proclaimed as notiable diseases in is made available to the State Government healthcare
December 1992, and since then cancer has had a legislative institutions, healthcare professionals and health researchers
basis. The registry is assisted by an Advisory Committee. to plan cancer education, treatment and research. In ethically
The registry staff currently comprises a director, manager, approved research projects, identied data from the cancer
registry may be released to researchers.
two medical coders and a clerical assistant.
All the pathology laboratories in the State send the registry
copies of histopathology, cytology and cell marker reports of cancer. Source of population
Notication of cancer forms are supplied by the two radiation 1996 and 2001 are Census populations, adjusted for
oncology clinics. Private and public hospitals notify diagnoses underenumeration and Australian residents temporarily
of cancer to the registry upon discharge of patients or provide a overseas. The intercensal estimates are obtained from the
computerised listing of cancer cases periodically by electronic previous census by advancing age and allowing for births,

405

Oceania

deaths and migration. They are adjusted in the light of the


succeeding census. Ref.: Australian Demographic
Statistics, Australian Bureau of Statistics, Cat. No. 3101.0,
Dec. 19962001. Allen DN, Tasmanian Year Book 1996,
Australian Bureau of Statistics, Cat. No. 3101.6, 1996.

406

Multiple primary rules used


IACR rules (2004) on historical data.
Notes on the data
C44 not available.

Oceania

Australia, Victoria
Registry structure and methods
Registration area
The Victorian Cancer Registry covers the State of The Victorian Cancer Registry was established in 1940 by
Victoria, the second most populous State in the Australian the Anti-Cancer Council of Victoria (as it was then known).
Commonwealth, situated in the southeastern corner of the Since legislation was passed in December 1982, cancer
continent and bounded to the north by New South Wales and notication has been compulsory for all hospitals and
to the west by South Australia. The estimated population pathology laboratories in Victoria, and fully populationin 2004 comprised 4 962 970 persons, of whom 19% were based coverage was achieved in 1982. The registry is central
under 15 years and 13% were aged 65 years or more. One in to Cancer Council Victorias cancer control programme,
four Australians lives in Victoria, and almost three quarters and is housed in its Cancer Control Research Institute in
of these live in the Melbourne Metropolitan Area with most Melbourne. The registry is also funded by the Department
of the remainder in small provincial cities. The average of Human Services, Victoria. The Registry has a staff of 20:
population density is 22 persons/km2, ranging from <2 in medical coders and clerical staff, a consultant pathologist,
registrar and deputy registrar, director, information manager
the Wimmera to over 400 in Melbourne.
and administrative support
Since the registrys inception
from the Cancer Epidemiology
in 1982, the population has
Centre.
both grown and aged, and
AUSTRALIA, VICTORIA (1998-2002)
The registry is largely a
the mix of immigrants has
AUSTRALIA, VICTORIA (1998-2002)
passive notication system,
altered from predominantly
receiving
reports
from
European to growing numbers
around 250 hospitals and 50
from Asia, South America and
pathology labs in Victoria
Africa. The newest migrant

 












and exchanging non-resident


groups tend to be younger







data with neighbouring states.


and, therefore, contribute

 












Hospital data are received on


little to cancer incidence. At







handwritten forms, computer


the 2001 census, 24% of the













printouts or increasingly
population was described as







in
electronic
format.
being overseas born. Of these

 


 
 

 



 


Notications from pathologists


1 080 344 persons, 15% were
 



 

are usually full copies of


from the United Kingdom, 4%
 



 


 






pathology reports in computer


from New Zealand, 7% from







readable format. Over 70 000


Italy, 4% from Greece, and 4%














notications are processed for


from Vietnam. The remainder







each year of incidence data.


originated in China, India, Sri
Other data sources include
Lanka, Malaysia, Germany,






details of all death certicates
former Yugoslavia and other
 .*&,
 ! .*&,
supplied on magnetic tape by
European countries, and small


 

(.)-+./))...

the Registrar of Births, Deaths
numbers from Asia, South

  
0.#. . .  $.. ... $.
$.
and Marriages. Some active
America, Africa and Oceania.  1 . ! .  .  .*,.". . . .
)(%'$%.*$"$$,.
Almost 70% of Victorians were Christians
(28% Catholic) with follow-up is pursued for cases in specialist sub-registers e.g.
 


  
 . .*(%%+,.. -..  .
less than 1% each of Muslim, Jewish, Buddhist, Hindu and other for in-situ and small invasive breast cancers, CNS neoplasms,
childhood cancers, and prostate cancers.
religious denominations; one third stated no religion.
The Victorian Cancer Registry adheres to IACR
Because of its low latitude and highly susceptible
population Victoria has a high incidence of skin cancers. No denition and coding recommendations; all data from
other cancer risk factors are particularly prominent; smoking 1982 have been recoded according to IACR rules. Data are
rigorously computer-checked for validity and consistency,
has long been in decline but obesity is increasing.
and routine checks are regularly conducted on the entire le.
Data quality is assured by matching pathology reports with
Cancer care facilities
Victorias medical care system is a mix of private and hospital registrations for cases where diagnosis was based
public sectors. In 20034 it had a well-established system on histological conrmation. There are no plans for a formal
of 144 public hospitals with several specialist oncology units review of completeness or accuracy. Periodic record linkage
including Radiation Oncology centres, and one large hospital with other administrative databases has conrmed virtually
dedicated to cancer treatment, for a total of 11 950 public complete casending. For death certicate only registrations,
hospital beds. In addition there were 135 private hospitals correspondence is sent to the signatory doctor to conrm
containing 6674 beds. A mix of public hospital departments diagnosis. The registry only contacts patients directly within
and private laboratories provided pathology services. In the the context of research study recruitment.
last two decades there has been some de-centralisation of
Use of the data
treatment services, especially radiotherapy.
Victoria has organised screening programmes for breast The registry produces regular statistical reports and overviews
and cervical cancer and bowel cancer screening is being of its accumulated data. It also produces a regular pamphlet,
introduced. Since the early 1990s the use of the PSA test has CANSTAT, a topical epidemiological digest of cancer facts
become widespread, though this is not supported by cancer and gures. Registry data are used to assess the extent of
the cancer epidemic and to monitor trends, particularly in
agencies or the government.

407

Oceania

cancers targeted by prevention programs (skin, lung, breast


and cervix). The registry also facilitates cancer management
surveys by identifying random samples of patients and
sending their treating doctors questionnaires regarding care
patterns. Cancers surveyed in this way have included breast,
bowel, prostate, lung, and testis, rectum, ovary and bladder.
One of the registrys most important functions is to facilitate
epidemiological research. In addition to epidemiological
analysis of registry data, the registry is used to follow up
cancer events in cohort studies, to identify cases for case-

408

control studies, and to conrm cancer occurrence in


population-based studies.
Source of population
Midyear estimated resident population (ERP) by age group
and sex; Australia, States and Territories. Australian Bureau
of Statistics Cat. No. 3201.0 (www.abs.gov.au).
Multiple primary rules used
IACR rules (2004) on CI5 IX period.

Oceania

Western Australia
additional data when necessary; enquiries are also made of
Registration area
The Western Australian population of is approximately 10% private pathology laboratories and medical practitioners in
of the total population of Australia. Western Australia now case of need. Mortality information is routinely searched
has a high proportion of migrant inhabitants; 69% of the for outcomes of known cases, and additional cases are
population were born in Australia, 22% in New Zealand, recordedthen subjected to the routine enquiry process
and 18% in Europe (including the UK). Approximately 3% when a death certicate indicates a cancer in an individual
of the population are Aboriginals, for whom life expectancy previously unknown to the Registry. Search and matching
is on average between 15 and 20 years less than for non- routines are now fully computerised.
For selected cancers, additional data (such as level and
Aboriginal persons.
The Registry covers the entire State of Western Australia, depth for melanomas) are stored in linked data les. The
an area of 2 525 500 km2, almost one third of the total area database is a relational structure consisting of individual
of Australia. The State lies between latitude 13 and 35S and linked Dbase3+ les controlled by a locally-developed
longitude 113 and 129E and extends approximately 2400 program using the Clipper5 compiler.
There are 4 hospital-based
km from north to south. The
cancer registries in Western
northern third of the State lies
Australia that collect additional
within the tropics where desert
WESTERN AUSTRALIA (1998-2002)
data concerning cancer stage
or near-desert conditions prevail
WESTERN AUSTRALIA (1998-2002)
and treatment, and regularly
over some 900 000 km 2 and
exchange information with the
population density is sparse.
central Registry and hospital
Population distribution overall
registries. This enhances
is extremely uneven; 73% of the

 









the completeness of WACR


population live in the capital city







data, and provides hospital


Perth, in the south of the State














teams with outcome (survival)


The States economy has







information.
diversied, and it is now a














leading producer of several key









Interpreting the results


minerals. Heavy manufacturing












 

In
Western
Australian
is relatively insignicant,






women, around 54% of the


but light manufacturing is














target population (5069


widespread. Air pollution has







years) are screened for breast


not been a major problem in





 








cancer and 61% of the target


Western Australia; however,






population (2069) undergo


there has been increasing
routine Pap smears to detect
public concern over the possible






cervical cancer. Screening for
effects of industry, to which

($!&


($!&
other specic diseases is at
the Cancer Registry has had to



)%"("')(((

present reserved for high-risk
devote signicant time in recent

  

(

( (
(  ** ((
(( (

(( (
( ((
*
(

( (
families.
years.

(  ( ((
(( (((( (
(
 (
(
Within WACR, data quality is assessed in various ways.
 


  
( 
($# %&(( ((
For completeness of data, the mortality to incidence ratio is
Cancer care facilities
Cancer therapy is concentrated in the Perth metropolitan a reasonable indicator and for the 2004 data were 0.33 for
area, the major (government-operated) teaching hospitals males and 0.30 for females. The IARC rules for agging of
and several private clinics acting as referral centres for non-reportable multiple primary tumours are incorporated
in the Registry software (recently updated to the current
country areas.
ICDO-3 rules).
Processing of death information has a special statusat
Registry structure and methods
Reporting of cancer in Western Australia became a statutory the time of death data linkage, each case is reviewed for
obligation in August 1981 with the establishment of the compatibility of incidence and mortality data, cause of death
population-based Western Australian Cancer Registry. is coded by registry staff, and letters are sent to doctors or
Notications are received from pathologists and radiation hospitals to resolve outstanding questions. The Registry
oncologists. Scope includes all malignancies and in situ records cause and date of death when notied of events
neoplasms other than primary cutaneous BCC and SCC, and outside our jurisdiction, so as to facilitate accurate survival
analysis and prevalence studies.
includes benign CNS tumours.
The WACR has the equivalent of 6 full-time staff who
handle preparation, linkage, coding and entry of data, as Use of the data
well as administrative and statistical reporting functions. The WACR maintains a comprehensive statistical analysis
A detailed statistical report is produced each year and tool for response to queries, based on a statistical extract
includes incidence and mortality rates and most common which can be updated periodically. Population les are
cancer types data, while other analyses such as survival and maintained to serve the Department of health administrative
boundaries, and a choice of standard population weightings
geographic-area analysis are periodically included.
Registry staff have access to medical records is available to meet the needs of both local and International
departments of major public hospitals to allow collection of communities.

409

Oceania

Data from the WA Cancer Registry are used in


a wide variety of research projects, many of which
include the contacting of individual persons on behalf
of researchers. Use of named data for such purposes is
strictly controlled, and the increasing use of Registry
data for research purposes is encouraged. The staff
support the view that the value of the Registry lies
mainly in its being used.

410

Source of population
The estimate of the populationatrisk is based on
Australian censuses and Australian Bureau of Statistics
intercensal estimates, making allowance for births and
deaths, and migration into and out of the registration area.
Multiple primary rules used
IACR rules (2004) on historical data.

Oceania

French Polynesia
recommended the establishment of a cancer registry in each
Registration area
The registry covers all of the islands of French Polynesia, country of the region. To date, only two island countries
i.e. 118 main islands distributed over 5 archipelagos, have such a registry: Papua New Guinea (since 1958) and
corresponding to a total of 4000 km2 land area, but spread Fiji (since 1965). French Polynesia, as well as American
Samoa and New Caledonia, immediately showed interest in
over an area of ocean the size of Europe.
Seventy-ve per cent of the 244 830 inhabitants (Nov. having a common notication system for cancer cases. Other
2002 population census) live on the island of Tahiti, where countries of the region have since adhered to this proposal.
Data collection started in French Polynesia in 1981, with the
Papeete is the only real town of the area. The population is
young: 40% are aged less than 20 years. In 2002, the birth technical assistance of the South Pacic Commission, UCLA
rate was 19.6%; during the same period, the crude mortality and the University of Hawaii Cancer Research Institute.
rate was 4.6%, and 6.7% for child mortality.
The cancer registry of French Polynesia is not an administrative
Census data for 1988 show the following ethnic independent body: it is managed by the Health Directorate, under
distribution (information on ethnic groups has no longer the administrative responsibility of the Director.
been collected after that date):
Sources of cancer data
Polynesian and related groups
include: Physicians voluntary
83%, European and related
notications,
pathology
FRENCH POLYNESIA (1998-2002)
groups 12%, and Asian and
reports
from
the
three
existing
FRENCH POLYNESIA (1998-2002)
related groups 4%.
laboratories, cytology reports
The majority of the population
from the biology laboratories,
is of Christian denominations,
the computerised medical
mostly Protestant. In 2002, the
systems (PMSI) of the French
(&*--0",
.(+--economically active rate was
Polynesia University Hospital
."*--.*
000--58%.
Centre and private clinics,
$-&*"--."
$-(%&--%-%$(--+*
%-$"1--death certicates and the
&-"(&--+"
%-.(0--Cancer care facilities
registry of repatriation towards
(-"1*--**
&-*.0--(-11+--*"
(-($&--Health care in French Polynesia
France or New Zealand and
+-&1&--(*
*-.(0--is characterised by the cothe long-diseases registry of
.-1%+--("
.-".1--1-%0"--&*
0-*+1--existence of an important public
the Social Security system.
$"-%(.--&"
1-*$"--sector and a free enterprise
Some physicians are often
$"-"".--%*
1-&&+--$"-$+*--%"
1-*++--sector that has greatly increased
reluctant
to reveal the names of
$$-0&"--$*
$$-&+0--over the past 10 years.
their cancer patients. However,
$&-%&(--$"
$%-*%0--$%-.*.--*
$$-1""--Healthca re expenses
follow-up of identied cases
$%-"%.--"
$$-$0&--have been evaluated to 420
has improved thanks to the
million euros. Since 1995, all
above PMSI.
$"
*
"
"
*
$"
Polynesians have had social
Data is coded according

-'#)


-'#)
healthcare coverage. Moreover,
$$%-+1%--to Version 3 of the WHO
$%"-."*--
an interaction between
International Classication of

  
preventive and medical care, the -
--  -

-

!--
-- 
-
- 2
-/
-'!! !!)!-%""%3-



-22-
-Diseases for Oncology. A patient
 -
- 2
- /
-

-%""%!improvement of lifestyle and education,
and the development of with two distinct tumours will be entered twice. The crude registry
 


  
-
-'$11")-public structures such as drinking-water networks and wastewater data are analysed on a yearly basis (number of cases declared and
treatment have improved the level of health indicators, despite the distribution). A 5-year synthesis is performed regularly.
important rise of diseases linked to lifestyle (diabetes, obesity).
The Polynesian health system on Tahiti Island has one Interpreting the data
well-equipped university hospital centre with 436 beds, Cancer currently is the second-leading cause of death in
2 private clinics, one secondary hospital, administered by Polynesia (23% of certied deaths), following cardiovascular
the Health Directorate, with 44 beds for medico-obstetrics, diseases. In the majority of cases, cancer treatment leads to
public community clinics also administered by the Health medical repatriation towards France or New Zealand, once the
Directorate and one growing free-enterprise sector with diagnosis has been conrmed by one of the of the countrys
193 physicians (as at 1 Jan 2007), corresponding to 114 per three pathology laboratories. Only basic chemotherapy protocols
100 000 inhabitants in Tahiti.
and surgery of some tumours take place locally.
The global healthcare distribution currently (2007) is of
282 physicians per 100 000 inhabitants in Tahiti, and of 234 Use of the data
per 100 000 over the whole country, the actual distribution The registrys current task is limited to basic descriptive
being very uneven (84% work on the island of Tahiti).
analysis of the distribution by sex and age of the main cancer
In addition to the above there are 7 specialised medical clinic incidence in French Polynesia.
departments combining care and prevention: Hygiene and Public
Health, Mothers Care, Child Care, School Health, Dental care, Sources:
Child and Youth Psychiatry, and Alcohol and Drug Addiction.
- French Polynesian Institute of Statistics
- Department of Health Care Planning, Health Directorate,
Registry structure and methods
French Polynesia
The 8th Regional Conference of South Pacic Commission - Cancer Registry of French Polynesia, Health Directorate,
Health Directors organised in 1979 in Apia (Western Samoa) French Polynesia

411

Oceania

Source of population
Estimated annual median population. Institut de la Statistique
de Polynsie Franaise (I.S.P.F.). 2002: General census of the
population in French Polynesia, November 2002.

412

Multiple primary rules used


IACR rules (1990).

Oceania

New Zealand
Registration area
New Zealand is situated in the South Pacic Ocean, 1600
km southeast of Australia. It is a long mountainous country
surrounded by a large expanse of ocean, and consists of two
main land masses: the North Island and the South Island.
The total land area (including offshore islands) is 270 534
km. In 2001, 75% of the population lived in the North Island,
and more than 30% of the population lived in the Auckland
region. New Zealand is one of the most urbanised countries
in the worldapproximately 85% of New Zealands 2001
Census usual population count lived in an urban area.
In 2001, 80% of New Zealanders identied as European
and 14.7% identied as Maori. The other main ethnic groups
were Asian (6.6%) and Pacic
Peoples (6.5%).
Cancer care facilities
Cancer care in New Zealand
is
predominantly
statefunded, supplemented by
private hospitals and private
practitioners. Cancer surgery
and chemotherapy services are
provided in the main centres
of population; there are six
radiotherapy centres.

cell skin cancers. Additional data sources include Medical


Certicates of Causes of Death, Coroners Findings, and
public and private hospital discharge data received in
electronic form.
All cancer registrations are coded by registry staff.
Quality control procedures include computerised validation
checks at data input, and rigorous edit checks on prepublication incidence data.
The New Zealand Cancer Registry carries out internal
and external audits from time to time. We last had a review
by an external auditor in 2005.
Use of the data

NEW ZEALAND (1998-2002)


NEW ZEALAND (1998-2002)


















































 


 




 










 

Cancer registry data are used to


monitor the burden of disease
and to assess the impact of
screening programmes, and as
a resource for cancer research.
The New Zealand Health
Information Service produces
an annual cancer publication
containing information about
cancer incidence and trends.
The registry provides data
for epidemiological research
and identies cases for ethicsapproved case-control studies.
Cancer registry data is also
used by Genetics Services
centres to assist in identifying
familial cancers. Policymakers
use our cancer registry
data for planning and
evaluation of health services.




Registry structure and









methods








 





The New Zealand Cancer







 

Registry is located in the New










 





Zealand Health Information







 

Service (NZHIS), which is a unit


of the New Zealand Ministry






of Health in Wellington. The
 -)%+
  -)%+
Source of population
registry has operated since




&-./,-(&$--
Annual estimates of the
1948. The New Zealand Cancer

  
 -- -0-  -  1-  -!-- - "-! --- 2 - ----usually resident population
Registry is staffed by seven - 
!"- -- #clinical coders and two support 


  
staff. Honorary consultants supplied by Statistics New Zealand, based on a veyearly

- -)'$$*+--
,-- census and taking into account births, deaths and
include pathologists, epidemiologists and oncologists.
Since 1994, laboratories have been the primary source migration.
of cancer notications to the New Zealand Cancer Registry.
Laboratories are required by law to report any new diagnosis Multiple primary rules used
of cancer in New Zealand, excluding squamous and basal IACR rules (2004) on CI5 IX period.






 






413

Oceania

USA, Hawaii
Registration area
The Hawaii Tumor Registry (HTR) is an active cancer
surveillance monitoring system for the entire US state
of Hawaii, consisting of 8 major and 124 minor islands,
covering 1367 miles from tip to tip. The resident population
in 2005 was approximately 1 275 000, with the majority of
residents living on the island of Oahu.
Cancer care facilities
As the central statewide collection point for cancer data, the
HTR receives data from collaborating hospitals maintaining
their own hospital-based Tumor Registries. HTR staff also
gathers data from other facilities, in addition to cases from
oncology clinics, pathology labs, private physicians and
radiation oncology facilities. The HTR database currently
contains 137 591 reportable resident cases.
Registry structure and methods
The Hawaii Tumor Registry (HTR) maintains a database of
information on all cases of cancer diagnosed in the State of
Hawaii. It provides complete cancer reporting for the entire
state and serves as a resource for nearly all epidemiologic
cancer research and cancer control activities in Hawaii. HTR
collects the required SEER demographic and diagnostic items
for all malignancies diagnosed in the state. Patients are followed
annually during their lifetime. To ensure accuracy, strict quality
control and assurance procedures have been established.
The HTR was established in 1960 by the Hawaii
Medical Association (HMA), the Hawaii State Department

of Health (DOH) and the Hawaii Pacic Division of the


American Cancer Society (ACS). Presently, HTR is jointly
operated by the Cancer Research Center of Hawaii and
DOH, and became a member of the National Cancer Institute,
Surveillance, Epidemiology and End Results (NCI/SEER)
program in 1973. HTR has received its primary nancial
support from the National Cancer Institute through its
Surveillance, Epidemiology and End Results (NCI/SEER)
Program, with additional funding from a DOH fee-forservice contract.
Interpreting the results
In its years of operation, HTR has been a major source
of cancer data and information, locally, nationally and
internationally. HTR data collected for diagnosis years 1973
2003 are complete. There is some difference in incidence
rates between males and females and among several ethnic
groups. Hawaii is unique in that its population is racially
diverse, with no one ethnicity in the majority.
Use of the data
Hawaii statistics on a wide variety of malignancies are
available to the research community world wide. The most
recently available statistical publication, Hawaii Cancer
Facts & Figures 2003-2004, is available for download
at http://www.crch.org/Cancer0304.pdf. The publication
provides an overview of cancer, a discussion of the impact of
gender and age and racial/ethnic disparities in cancer, and an
analysis of six major cancer sites by race/ethnicity.

USA, HAWAII
USA, HAWAII (1998-2002)
(1998-2002)

USA, HAWAII:
CHINESE
(1998-2002)
USA, HAWAII:
CHINESE (1998-2002)







4((333

502

*3*(*333






6,,333

5(%

*3,(*333









*3.54333

40%

*3465333









*3410333

4(%

+3(46333









*315+333

10%

*3610333









*315*333

1(%

*36,*333


 






+3(6,333

00%

+3+*5333









,3((*333

0(%

,3,(1333









,3+4(333

.0%

,31.+333









,3.(*333

.(%

,315,333


 






,3,(1333

,0%

,3001333









+34.4333

,(%

,3*0,333









+310*333

+0%

+3404333








+31+,333

+(%

+3064333









+364.333

*0%

+351,333









,3**+333

*(%

+3605333


 






,3(*5333

0%

+351.333


 






+304+333

(%

+31,+333



 /*',
.((/0()///



  3-)/




  
/(//

/ ! /"/ #/ #/  #//
/ 2/
 / ! /" //)&&&/ / / $/ /


// / /"  / 3  / ! /  / !/ / /!
 3  /   // /)&&&/ / / $/

1%%$ $ $%

$/

414

*(



 ! /*',
.,3(*1333

*(

 !  3-)/
 

.13.(.333


  
  3  3
3   3  3!  373*66(33+(((&3 733  3 $3&&3
3 $3# $3
33+(+,,3
- 7''&  &' " '/3

Source of population
 


  
July
1 county population estimates by age, sex, race, and
 /  /*)&&+,// -//
/
Hispanic origin; postcensal estimates based on 2000 United
States Census. The population data include the bridged
singlerace estimates derived from the original multiplerace
categories in the 2000 United States Census.
http://www.seer.cancer.gov/popdata.

Source
of population
 


  

3 3-+((./33
033  3
State
and County Intercensal Population Estimates : 1990
to 2000. Source: Population Division, U.S. Census Bureau,
Washington, DC 20233 (http://www.hawaii.gov/dbedt/).

Multiple primary rules used


IACR rules (2004) on CI5 IX period

Multiple primary rules used


IACR rules (2004) on CI5 IX period

Oceania

USA, HAWAII: FILIPINO (1998-2002)

USA, HAWAII: JAPANESE (1998-2002)

USA, HAWAII: FILIPINO (1998-2002)

USA, HAWAII: JAPANESE (1998-2002)

*346.333

502

*3((6333

+34(5333

502

.3.1*333

*3*6,333

5(%

*3++6333

.3(,+333

5(%

03104333

+3.50333

40%

+3,.6333

13*,+333

40%

53+(0333

+36(*333

4(%

,3.+5333

13405333

4(%

63.1+333

,3(1+333

10%

.3(.5333

031.5333

10%

53(*,333

,35*5333

1(%

.340(333

03,+(333

1(%

13*.(333

.3,15333

00%

03+46333

13540333

00%

43+(,333

03*06333

0(%

13(5(333

63*+(333

0(%

5360+333

13+(4333

.0%

135((333

63461333

.0%

63051333

43,+0333

.(%

435,0333

63,04333

.(%

63,5.333

434+,333

,0%

53.,6333

43554333

,0%

53++(333

430(4333

,(%

53(.,333

13+6+333

,(%

1350+333

43,05333

+0%

431(5333

03*.*333

+0%

030,*333

43*45333

+(%

135.*333

.31*,333

+(%

.3.4.333

434(.333

*0%

43,*+333

03++1333

*0%

.360,333

4310.333

*(%

43.+1333

03(55333

*(%

.356.333

43606333

0%

43,*0333

.3454333

0%

.3,4*333

135*5333

(%

13,10333

,3560333

(%

,315,333

*(

  3-)/

*(

*(

 !  3-)/

653+*,333

*(+3*01333

 

  3-)/


  
  3  3
3   3  3!  373*66(33+(((&3 733  3 $3&&3
3 $3# $3
33+(+,,3

*(

 !  3-)/

*(53140333

*+(3(.*333

 


  
  3  3
3   3  3!  373*66(33+(((&3 733  3 $3&&3
3 $3# $3
33+(+,,3

- 7''&  &' " '/3


Source
of population
 


  

3 3-+((./33
033  3
State
and County Intercensal Population Estimates : 1990
to 2000. Source: Population Division, U.S. Census Bureau,
Washington, DC 20233 (http://www.hawaii.gov/dbedt/).

- 7''&  &' " '/3


Source
of population
 


  

3 3-+((./33
033  3
State
and County Intercensal Population Estimates : 1990
to 2000. Source: Population Division, U.S. Census Bureau,
Washington, DC 20233 (http://www.hawaii.gov/dbedt/).

Multiple primary rules used


IACR rules (2004) on CI5 IX period.

Multiple primary rules used


IACR rules (2004) on CI5 IX period.

USA, HAWAII: WHITE (1998-2002)

USA, HAWAII: HAWAIIAN (1998-2002)


USA, HAWAII: HAWAIIAN (1998-2002)

USA, HAWAII: WHITE (1998-2002)

,01333

502

4.1333







1(0333

5(%

644333









*3*0.333

40%

*3011333









*340,333

4(%

+3,+0333


 






+3,6(333

10%

+3406333









,3(.*333

1(%

,3,++333






.3,*(333

00%

.30(.333


 






030,1333

0(%

03.46333









135++333

.0%

1364,333









43600333

.(%

436**333









5304.333

,0%

536*.333


 






53*6*333

,(%

53+,1333









53.+,333

+0%

53**1333












63*,5333

+(%

5354,333









*+3+(6333

*0%

**3.50333


 






*,3+.0333

*(%

*+3.*0333









*,34++333

0%

*+360,333


 




 

*+3160333

(%

**365+333









*(

  3-)/
*+(3**6333

*(



 !  3-)/
 

 /+'**630,1333


  
  3  3
3   3  3!  373*66(33+(((&3 733  3 $3&&3
3 $3# $3
33+(+,,3

(.0/,1*///



 ! /+'


 


  
/(//

/ ! /"/ #/ #/  #//
/ 3/
 / ! /" //)&&&/ / / $/ /

- 7''&  &' " '/3


Source
of population
 


  

3 3-+((./33
033  3
State
and County Intercensal Population Estimates : 1990
to 2000. Source: Population Division, U.S. Census Bureau,
Washington, DC 20233 (http://www.hawaii.gov/dbedt/).


// / /"  / 4  / ! /  / !/ / /!
 4  /   // /)&&&/ / / $/
Source
of population

2%%$ $ $%

$/
 


  
July
1
county
population estimates by age, sex, race, and
 /  /+)&&,-// .//
/
Hispanic origin; postcensal estimates based on 2000 United
States Census. The population data include the bridged
singlerace estimates derived from the original multiplerace
categories in the 2000 United States Census.
http://www.seer.cancer.gov/popdata.

Multiple primary rules used


IACR rules (2004) on CI5 IX period.

Multiple primary rules used


IACR rules (2004) on CI5 IX period.

415

The Tables
Age-standardized and cumulative
incidence rates (three-digit rubrics)

359

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Lip (C00)
Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

17
21
12
0
1

0.9
0.4
1.2
0.1

0.23
0.10
0.36
0.13

12
29
10
23
356
2
14
6
3
2
6

1.5
1.5
1.4
1.5
1.7
0.2
0.4
0.1
0.1
0.2
0.8

0.45
0.29
0.46
0.32
0.09
0.17
0.11
0.03
0.08
0.15
0.32

0.15
0.16
0.17
0.15
0.18
0.02
0.04
0.01
0.01
0.02
0.15

1423
167
122
195
60
137
1
80
521
9
131
263
3
259
12
128
1219
16
7
84
1073
196
0
1
0
0
10
174
221
4
2
1
0
0
36
171
133
43
0
41
2
1
1
504
2
497
171
5
165
19
0
19
140
309
2
294
241
263
231
171
4
166
1
17

1.7
1.8
0.8
4.4
2.2
7.0
1.8
2.3
1.3
1.6
2.9
1.8
0.1
2.2
0.8
0.7
1.2
0.1
0.1
0.5
1.6
0.9
0.0
0.4
1.3
0.8
0.2
0.2
0.1
0.6
1.3
1.0
0.3
0.4
0.2
0.1
0.2
0.8
0.0
0.9
0.8
0.1
0.9
0.2
0.3
3.2
0.7
0.0
0.8
1.2
2.2
1.7
1.3
0.1
1.7
0.1
0.9

0.05
0.14
0.07
0.34
0.29
0.62
1.77
0.27
0.06
0.57
0.28
0.11
0.07
0.14
0.23
0.06
0.03
0.04
0.05
0.06
0.05
0.07
0.03
0.14
0.10
0.06
0.08
0.16
0.08
0.10
0.11
0.09
0.06
0.06
0.11
0.13
0.24
0.04
0.02
0.04
0.06
0.04
0.07
0.06
0.08
0.28
0.04
0.03
0.05
0.08
0.15
0.12
0.10
0.07
0.13
0.13
0.22

0.19
0.20
0.10
0.49
0.27
0.81
0.44
0.24
0.14
0.19
0.34
0.22
0.02
0.26
0.09
0.07
0.14
0.02
0.01
0.05
0.19
0.10
0.06
0.14
0.09
0.02
0.03
0.07
0.15
0.11
0.04
0.04
0.02
0.02
0.04
0.08
0.00
0.09
0.08
0.01
0.10
0.02
0.03
0.37
0.08
0.01
0.09
0.15
0.25
0.19
0.17
0.02
0.21
0.02
0.11

360

Female
ASR(W)
CUM 0-74

1
6
2
2
1

0.0
0.1
0.2
0.2
0.1

0.05
0.04
0.14
0.16
0.15

0.05
0.04
0.07
0.04
0.01
0.02
0.01
0.00
0.01
0.02
0.07

1
13
1
12
117
0
5
4
0
2
3

0.1
0.5
0.2
0.7
0.4
0.1
0.1
0.1
0.3

0.11
0.15
0.19
0.20
0.04
0.06
0.03
0.10
0.16

0.01
0.05
0.03
0.07
0.05
0.02
0.01
0.01
0.05

0.01
0.02
0.03
0.03
0.01
0.01
0.00
0.01
0.04 *

0.01
0.02
0.01
0.05
0.04
0.09
0.44
0.03
0.01
0.08
0.04
0.02
0.01
0.02
0.04
0.01
0.00
0.00
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.04
0.00
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.04
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.01
0.02
0.02
0.03

410
42
39
50
7
27
0
26
187
4
28
56
3
51
3
33
385
2
6
27
329
73
0
1
0
0
4
64
76
6
0
0
0
0
12
56
38
17
0
15
1
0
1
200
1
196
45
5
40
6
2
4
25
85
3
75
52
54
51
32
3
29
1
5

0.4
0.4
0.2
0.9
0.2
1.0
0.6
0.3
0.7
0.5
0.3
0.1
0.3
0.1
0.1
0.3
0.0
0.1
0.1
0.4
0.3
0.1
0.1
0.4
0.2
0.2
0.1
0.3
0.2
0.1
0.1
0.0
0.1
0.2
0.0
0.3
0.1
0.1
0.2
0.1
0.1
0.0
0.5
0.2
0.1
0.2
0.2
0.3
0.3
0.2
0.1
0.2
0.0
0.1

0.02
0.07
0.03
0.15
0.08
0.21
0.12
0.03
0.40
0.11
0.04
0.05
0.05
0.08
0.02
0.02
0.01
0.04
0.03
0.02
0.03
0.06
0.07
0.05
0.02
0.08
0.04
0.04
0.04
0.03
0.03
0.02
0.09
0.02
0.01
0.02
0.02
0.03
0.03
0.03
0.07
0.03
0.11
0.02
0.03
0.02
0.03
0.06
0.04
0.03
0.04
0.04
0.04
0.04

0.04
0.06
0.02
0.10
0.02
0.10
0.08
0.03
0.10
0.05
0.04
0.01
0.04
0.01
0.01
0.03
0.00
0.01
0.01
0.04
0.03
0.01
0.01
0.04
0.02
0.02
0.02
0.03
0.02
0.01
0.01
0.02
0.03
0.02
0.01
0.02
0.01
0.01
0.01
0.05
0.02
0.01
0.02
0.02
0.04
0.03
0.02
0.00
0.02
0.01

0.00
0.01
0.01
0.02
0.01
0.03
0.02
0.00
0.06
0.01
0.01
0.01
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.01
0.00
0.00
0.01
0.01

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

418

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Lip (C00) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

77
149
292
5
270
95
4
88
271
0
268
74
7085
63
6786
140
2
135
177
5
23
149
284
9
274
166
2
155
296
206
258
2
251
28
945
5
909
2559
20
21
119
2325
135
2
131
724
7
705
76
22
200
105
61
172

1.5
0.7
0.9
0.1
0.9
0.7
0.1
0.8
1.4
1.5
2.1
0.9
0.1
1.0
0.5
0.1
0.5
3.0
1.6
1.1
4.2
0.4
0.1
0.5
0.4
0.1
0.4
2.4
1.6
0.5
0.1
0.6
0.6
1.1
0.1
1.2
1.1
0.1
0.1
0.5
1.3
1.0
0.1
1.3
1.2
0.2
1.3
1.4
1.0
1.0
0.8
0.8
0.9

0.18
0.06
0.05
0.06
0.06
0.08
0.07
0.09
0.09
0.09
0.25
0.01
0.01
0.01
0.04
0.05
0.05
0.23
0.75
0.24
0.37
0.03
0.04
0.03
0.03
0.04
0.04
0.15
0.12
0.03
0.05
0.04
0.13
0.04
0.03
0.04
0.02
0.03
0.02
0.05
0.03
0.09
0.05
0.11
0.05
0.06
0.05
0.17
0.22
0.07
0.08
0.11
0.07

0.20
0.08
0.11
0.01
0.11
0.08
0.01
0.10
0.16
0.18
0.22
0.11
0.01
0.12
0.04
0.01
0.05
0.36
0.24
0.11
0.52
0.04
0.01
0.05
0.05
0.01
0.05
0.29
0.18
0.06
0.01
0.07
0.05
0.12
0.01
0.14
0.12
0.01
0.01
0.06
0.16
0.12
0.00
0.15
0.14
0.02
0.16
0.18
0.12
0.12
0.09
0.09
0.11

0.03
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.03
0.00
0.00
0.00
0.01
0.01
0.01
0.03
0.12
0.03
0.05
0.00
0.00
0.00
0.00
0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.02
0.01
0.00
0.01
0.00
0.00
0.00
0.01
0.00
0.01
0.00
0.02
0.01
0.01
0.01
0.02
0.03
0.01
0.01
0.02
0.01

33
63
113
7
102
42
5
37
54
0
54
13
2112
40
1974
68
3
64
36
0
5
31
137
4
130
73
0
71
49
52
101
1
98
16
270
10
251
754
8
23
35
663
27
1
25
158
2
149
12
4
69
41
13
60

0.5
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.0
0.2
0.2
0.1
0.2
0.5
0.2
0.7
0.1
0.0
0.2
0.1
0.1
0.3
0.3
0.1
0.0
0.1
0.3
0.2
0.1
0.3
0.2
0.0
0.1
0.1
0.3
0.1
0.0
0.2
0.2
0.0
0.2
0.2
0.1
0.3
0.2
0.1
0.2

0.09
0.03
0.03
0.06
0.03
0.04
0.07
0.04
0.03
0.03
0.08
0.00
0.01
0.01
0.02
0.05
0.02
0.09
0.09
0.14
0.01
0.02
0.02
0.02
0.02
0.05
0.05
0.02
0.03
0.02
0.08
0.02
0.04
0.02
0.01
0.01
0.02
0.02
0.01
0.03
0.03
0.03
0.02
0.02
0.02
0.06
0.07
0.04
0.04
0.04
0.04

0.06
0.02
0.03
0.02
0.03
0.02
0.02
0.02
0.02
0.03
0.03
0.02
0.00
0.02
0.02
0.01
0.02
0.05
0.01
0.08
0.01
0.00
0.02
0.01
0.02
0.03
0.04
0.01
0.00
0.02
0.02
0.02
0.01
0.03
0.02
0.00
0.01
0.01
0.03
0.01
0.00
0.01
0.02
0.00
0.02
0.02
0.02
0.03
0.02
0.01
0.03

0.01
0.00
0.00
0.01
0.00
0.01
0.01
0.01
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.01
0.02
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.00
0.00
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.01
0.00
0.01

3
4
27
2
2
22
3
7
21
49
8
82
16
39
12
260
245
14
3
4
1
8
7
13
7

0.6
0.1
0.1
0.1
0.1
0.1
0.1
0.3
0.2
0.2
0.9
0.4
0.5
0.6
0.4
1.6
1.6
0.9
0.1
0.1
0.0
0.1
0.1
0.0
0.1

0.34
0.03
0.03
0.10
0.07
0.02
0.05
0.11
0.05
0.04
0.32
0.04
0.12
0.10
0.13
0.10
0.11
0.25
0.04
0.05
0.03
0.02
0.03
0.01
0.05

0.05
0.01
0.01
0.01
0.01
0.01
0.01
0.03
0.04
0.02
0.08
0.04
0.06
0.07
0.04
0.18
0.19
0.12
0.01
0.02
0.00
0.01
0.01
0.00
0.01

0.04
0.00
0.00
0.01
0.01
0.00
0.01
0.01
0.01
0.00
0.04
0.01
0.02
0.01
0.01
0.01
0.01
0.04
0.01
0.01
0.00
0.00
0.01
0.00
0.00

0
1
14
0
3
14
3
2
19
23
1
41
9
22
7
99
94
5
0
2
1
7
5
13
3

0.0
0.1
0.1
0.0
0.1
0.1
0.2
0.1
0.1
0.2
0.2
0.4
0.3
0.5
0.5
0.3
0.0
0.0
0.0
0.0
0.0
0.0

0.02
0.02
0.08
0.01
0.03
0.06
0.05
0.03
0.10
0.03
0.08
0.08
0.10
0.05
0.06
0.13
0.02
0.02
0.01
0.01
0.01
0.01

0.00
0.01
0.01
0.01
0.01
0.01
0.03
0.02
0.01
0.03
0.03
0.04
0.04
0.05
0.05
0.03
0.00
0.00
0.00
0.00
-

0.00 *
0.00
- *
0.01
0.00 *
0.01 *
0.01 *
0.01
0.00 *
0.01
0.00
0.01 *
0.01 *
0.01 *
0.01
0.01
0.02
0.00
0.00
0.00
0.00
-

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

361

419

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Lip (C00) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

362

Female
ASR(W)
CUM 0-74

91
3
4
0
0
5
1
25
0
3
3
3
2
8
25
0
0
0
0
0
10
6
5
84
97

0.1
0.0
0.1
0.1
0.1
0.1
0.2
0.0
0.2
0.1
0.5
0.9
0.2
0.3
0.2
2.9
1.3

0.01
0.03
0.05
0.05
0.11
0.02
0.14
0.02
0.10
0.04
0.19
0.19
0.08
0.11
0.08
0.32
0.13

0.01
0.01
0.00
0.02
0.01
0.02
0.04
0.00
0.01
0.00
0.09
0.11
0.03
0.03
0.02
0.37
0.16

0.00
0.01
0.00
0.01
0.01
0.00
0.03
0.00
0.01
0.00
0.04
0.03
0.01
0.01
0.01
0.05
0.02

49
3
1
0
1
3
0
10
0
2
0
1
3
1
7
3
1
0
0
1
17
13
15
16
12

0.0
0.0
0.0
0.0
0.1
0.0
0.2
0.0
0.1
0.1
0.4
0.0
0.0
0.1
0.4
0.6
0.4
0.6
0.2

0.01
0.02
0.02
0.02
0.03
0.01
0.16
0.05
0.05
0.08
0.16
0.02
0.01
0.15
0.10
0.16
0.11
0.14
0.04

0.00
0.00
0.00
0.00
0.00
0.01
0.02
0.01
0.04
0.00
0.04
0.05
0.03
0.05
0.01

0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.01 *
0.02 *
0.00 *
0.01 *
0.02 *
0.01
0.02 *
0.01 *

224
23
12
1190
23
164
1013
386
297
318
60
418
9
24
0
0
57
28
58
56
12
21
35
79
54
13
61
43
6
33
11
118
6
12
56
77
17
3
24
3
16
171
14
30
11
8
24
40
10
0
27
52
26
132

0.7
1.0
1.1
4.0
0.4
0.8
3.0
2.3
0.8
1.4
1.3
2.0
0.3
1.0
1.4
0.6
1.3
2.7
0.5
1.0
1.3
0.8
0.3
0.2
0.9
0.5
0.0
0.7
1.1
1.0
0.7
0.4
2.7
1.2
0.8
0.2
0.4
0.1
1.0
1.6
0.6
2.6
0.4
0.1
0.7
1.9
0.8
0.6
0.9
1.2
1.7

0.05
0.20
0.31
0.12
0.08
0.06
0.10
0.12
0.05
0.08
0.17
0.10
0.09
0.21
0.20
0.12
0.18
0.40
0.16
0.24
0.23
0.09
0.04
0.05
0.13
0.07
0.02
0.12
0.36
0.09
0.29
0.12
0.39
0.14
0.23
0.10
0.09
0.05
0.26
0.13
0.16
0.50
0.13
0.05
0.15
0.31
0.27
0.12
0.14
0.25
0.15

0.09
0.11
0.12
0.51
0.04
0.08
0.37
0.27
0.09
0.16
0.18
0.23
0.05
0.12
0.17
0.07
0.16
0.30
0.07
0.10
0.15
0.10
0.03
0.03
0.12
0.05
0.01
0.08
0.13
0.12
0.05
0.04
0.38
0.15
0.08
0.04
0.00
0.14
0.19
0.07
0.27
0.06
0.02
0.09
0.21
0.09
0.08
0.11
0.14
0.21

0.01
0.03
0.04
0.02
0.01
0.01
0.01
0.02
0.01
0.01
0.03
0.02
0.02
0.03
0.03
0.02
0.03
0.05
0.03
0.03
0.03
0.01
0.01
0.01
0.02
0.01
0.00
0.02
0.05
0.01
0.03
0.02
0.06
0.02
0.02
0.01
0.00
0.04
0.02
0.03
0.06
0.02
0.01
0.02
0.05
0.03
0.02
0.02
0.03
0.02

85
8
2
374
6
49
282
156
131
105
36
228
10
11
0
0
14
5
24
16
4
5
7
9
22
5
19
19
6
6
4
13
0
5
12
8
4
0
7
1
1
53
6
3
1
1
4
5
0
1
6
15
3
40

0.2
0.2
0.1
0.6
0.0
0.2
0.5
0.6
0.2
0.4
0.4
0.6
0.2
0.3
0.2
0.1
0.3
0.4
0.1
0.2
0.2
0.1
0.1
0.0
0.2
0.1
0.0
0.1
0.2
0.1
0.1
0.3
0.1
0.1
0.1
0.0
0.1
0.3
0.3
0.1
0.1
0.0
0.1
0.2
0.0
0.1
0.1
0.1
0.3

0.02
0.07
0.07
0.03
0.02
0.03
0.03
0.05
0.02
0.04
0.07
0.05
0.06
0.10
0.06
0.03
0.07
0.11
0.06
0.13
0.07
0.03
0.01
0.02
0.04
0.03
0.02
0.03
0.12
0.03
0.04
0.12
0.03
0.04
0.04
0.02
0.07
0.07
0.13
0.05
0.07
0.01
0.05
0.08
0.03
0.04
0.04
0.04
0.05

0.02
0.03
0.02
0.07
0.00
0.02
0.07
0.06
0.02
0.05
0.05
0.06
0.03
0.03
0.02
0.01
0.03
0.03
0.01
0.02
0.01
0.01
0.00
0.00
0.02
0.01
0.01
0.01
0.02
0.01
0.01
0.03
0.01
0.02
0.01
0.01
0.01
0.03
0.03
0.01
0.02
0.03
0.00
0.01
0.01
0.02

0.00
0.01
0.02
0.00 *
0.00 *
0.00
0.01 *
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.02
0.00
0.01
0.02
0.00
0.01
0.00
0.01
0.01
0.01
0.02
0.01
0.01
0.02
0.00
0.01
0.01
0.01

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp

*Important. See note on population page.

420

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Lip (C00) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

111
277
38
255
24
202
48
204
196
112
455
335
97
109
68
194
219
102
92
307
291
133
74
99
508
12
25
0
28
2
2
17
743
64
22
110
24
29
210
88
127
79
53
65
74
238

1.4
2.5
2.8
1.4
1.0
4.6
0.7
1.9
1.7
0.8
2.4
2.1
1.4
8.8
1.2
2.6
4.7
9.0
3.8
9.8
7.4
5.2
3.3
2.6
1.1
0.8
2.4
1.5
0.2
0.2
0.6
1.3
1.7
0.6
0.9
0.2
0.2
0.7
0.9
0.4
0.2
0.3
0.3
1.3
1.1

0.14
0.15
0.47
0.09
0.20
0.34
0.10
0.14
0.13
0.07
0.12
0.12
0.14
0.92
0.15
0.19
0.33
1.04
0.42
0.59
0.45
0.48
0.42
0.28
0.06
0.24
0.52
0.30
0.12
0.14
0.15
0.05
0.21
0.13
0.09
0.05
0.03
0.05
0.09
0.04
0.02
0.04
0.04
0.15
0.08

0.16
0.29
0.36
0.15
0.14
0.55
0.09
0.22
0.19
0.10
0.31
0.26
0.16
1.05
0.12
0.32
0.56
1.11
0.44
1.28
0.90
0.65
0.41
0.33
0.12
0.10
0.21
0.19
0.01
0.04
0.07
0.16
0.21
0.07
0.11
0.03
0.02
0.08
0.10
0.05
0.02
0.03
0.03
0.14
0.13

0.02
0.02
0.07
0.01
0.03
0.05
0.02
0.02
0.02
0.01
0.02
0.02
0.02
0.12
0.02
0.03
0.05
0.14
0.06
0.08
0.06
0.07
0.06
0.04
0.01
0.03
0.06
0.04
0.01
0.03
0.02
0.01
0.03
0.02
0.01
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.01
0.02
0.01

48
76
5
82
7
42
23
109
50
36
147
106
32
9
23
29
39
18
18
44
27
19
10
8
265
4
4
0
5
0
0
5
237
18
7
34
11
23
114
37
65
59
16
23
16
90

0.3
0.3
0.2
0.4
0.2
0.6
0.2
0.7
0.3
0.1
0.6
0.4
0.3
0.5
0.2
0.2
0.6
0.8
0.5
1.0
0.4
0.4
0.2
0.1
0.5
0.2
0.4
0.1
0.1
0.3
0.4
0.2
0.2
0.1
0.1
0.3
0.3
0.1
0.1
0.1
0.1
0.1
0.3

0.05
0.04
0.12
0.05
0.06
0.11
0.05
0.07
0.05
0.03
0.05
0.04
0.06
0.20
0.06
0.04
0.11
0.24
0.13
0.17
0.09
0.10
0.09
0.05
0.04
0.12
0.22
0.06
0.06
0.02
0.10
0.10
0.04
0.03
0.03
0.03
0.05
0.02
0.01
0.02
0.02
0.04
0.04

0.03
0.04
0.02
0.05
0.02
0.07
0.02
0.08
0.03
0.01
0.07
0.05
0.03
0.04
0.02
0.02
0.07
0.06
0.05
0.13
0.05
0.04
0.01
0.01
0.05
0.03
0.05
0.02
0.02
0.03
0.04
0.01
0.02
0.01
0.01
0.03
0.04
0.01
0.01
0.01
0.01
0.02
0.03

0.01
0.01
0.02
0.01
0.01 *
0.01
0.01
0.01 *
0.01
0.00
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.03
0.02
0.02
0.01
0.02
0.01
0.01
0.00
0.02
0.03
0.01
0.01
0.00
0.01
0.01
0.01
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00

884
29
862
475
158
878
325
16
1
144
16
1
0
1
0
12

4.0
5.5
7.4
8.8
9.5
5.4
5.4
1.6
0.3
1.1
0.4
0.1
0.3
0.9

0.14
1.08
0.26
0.42
0.79
0.19
0.31
0.42
0.26
0.10
0.10
0.13
0.26
0.28

0.41
0.58
0.78
0.94
1.02
0.59
0.58
0.19
0.03
0.12
0.04
0.03
0.08

0.02
0.15
0.03
0.05
0.10
0.02
0.04
0.06
0.03
0.01
0.01
0.03
0.03

351
9
322
155
55
371
127
6
0
74
9
1
0
0
3
5

1.2
2.6
2.3
2.0
2.4
1.7
1.8
0.5
0.4
0.2
0.3
0.1
0.4

0.07
0.96
0.14
0.19
0.37
0.10
0.17
0.20
0.06
0.06
0.33
0.05
0.21

0.13
0.39
0.27
0.20
0.26
0.19
0.18
0.03
0.05
0.02
0.03
0.01
0.06

0.01
0.18
0.02
0.02
0.05
0.01
0.02
0.02
0.01
0.01
0.03
0.01
0.03

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

363

421

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Tongue (C01-02)
Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

364

Female
ASR(W)
CUM 0-74

3
42
3
8
9

0.2
0.9
0.4
0.7
0.6

0.10
0.15
0.21
0.30
0.23

2
24
4
2
5

0.1
0.5
0.4
0.2
0.5

0.08
0.10
0.22
0.13
0.25

13
100
33
70
1338
3
33
55
10
33
9

1.5
4.2
4.7
4.9
6.4
0.4
1.0
0.8
0.3
3.1
1.1

0.44
0.45
0.86
0.61
0.18
0.21
0.17
0.11
0.10
0.55
0.37

0.18
0.48
0.52
0.49
0.77
0.04
0.13
0.10
0.03
0.44
0.16

0.06
0.06
0.11
0.07
0.02
0.03
0.03
0.02
0.01
0.08
0.06

7
35
5
10
370
1
41
34
21
8
12

0.7
1.4
0.7
0.6
1.3
0.1
0.9
0.4
0.6
0.5
1.1

0.29
0.25
0.31
0.19
0.07
0.11
0.15
0.07
0.15
0.18
0.32

0.10
0.17
0.08
0.09
0.15
0.01
0.12
0.05
0.09
0.05
0.16

0.04
0.04
0.04
0.03
0.01
0.01
0.02
0.01
0.03
0.02
0.06 *

1594
183
259
88
47
34
0
74
851
9
49
361
66
291
52
409
2674
146
174
237
2083
538
39
29
9
4
40
394
647
88
10
6
8
7
90
414
273
307
22
280
57
39
17
2010
134
1858
683
136
541
186
42
143
91
1019
166
827
523
235
363
390
82
305
19
81

2.1
2.0
1.9
2.3
1.8
1.9
2.4
2.2
1.9
1.5
2.6
2.6
2.7
3.2
2.6
2.8
1.2
3.1
1.5
3.4
2.7
2.9
1.8
0.9
1.3
1.9
3.2
2.6
3.6
0.7
0.8
1.4
1.2
1.4
3.4
2.1
2.7
3.2
2.7
3.7
4.1
3.2
3.5
2.6
3.6
3.1
3.0
3.1
2.6
2.1
2.9
2.3
2.8
4.0
2.7
2.9
2.5
2.9
3.0
2.6
3.2
2.0
4.3

0.05
0.15
0.12
0.25
0.27
0.32
0.28
0.08
0.63
0.22
0.14
0.33
0.16
0.46
0.13
0.06
0.10
0.24
0.10
0.08
0.12
0.48
0.35
0.31
0.67
0.31
0.17
0.10
0.38
0.25
0.32
0.56
0.47
0.16
0.17
0.13
0.16
0.69
0.17
0.49
0.67
0.79
0.08
0.23
0.09
0.12
0.26
0.14
0.20
0.35
0.25
0.25
0.09
0.31
0.09
0.13
0.17
0.16
0.16
0.29
0.18
0.46
0.50

0.25
0.24
0.23
0.27
0.22
0.23
0.29
0.26
0.19
0.19
0.32
0.34
0.32
0.34
0.31
0.34
0.12
0.37
0.19
0.42
0.33
0.34
0.19
0.09
0.13
0.22
0.41
0.31
0.44
0.06
0.07
0.15
0.13
0.18
0.42
0.24
0.34
0.42
0.33
0.47
0.51
0.41
0.42
0.32
0.44
0.36
0.36
0.37
0.31
0.24
0.35
0.27
0.34
0.50
0.32
0.36
0.30
0.36
0.36
0.28
0.38
0.21
0.55

0.01
0.02
0.02
0.03
0.04
0.05
0.04
0.01
0.08
0.03
0.02
0.05
0.02
0.06
0.02
0.01
0.01
0.03
0.01
0.01
0.02
0.06
0.04
0.04
0.08
0.04
0.02
0.01
0.05
0.03
0.04
0.07
0.07
0.02
0.02
0.02
0.02
0.10
0.02
0.07
0.09
0.12
0.01
0.03
0.01
0.02
0.04
0.02
0.03
0.04
0.03
0.03
0.01
0.04
0.01
0.02
0.02
0.02
0.02
0.04
0.02
0.06
0.07

894
111
179
46
20
6
0
28
453
8
43
172
28
143
14
188
1328
115
71
145
971
267
15
17
3
0
25
190
365
38
15
13
8
4
56
213
139
138
9
122
23
14
8
931
57
858
321
54
264
94
25
68
49
515
51
444
216
139
145
177
29
147
6
38

1.0
1.1
1.1
1.0
0.7
0.3
0.7
1.0
1.7
1.1
0.9
0.7
1.0
0.9
1.0
1.1
0.8
1.0
0.7
1.3
1.1
1.0
0.8
0.2
0.9
1.3
1.1
1.2
1.2
1.2
1.2
0.6
0.7
1.4
1.0
0.9
0.9
0.9
1.1
1.0
1.2
1.3
0.8
1.3
1.1
0.9
1.2
1.1
1.0
1.1
1.1
1.1
0.9
1.1
0.9
1.1
0.9
1.0
0.7
1.2
0.5
1.5

0.04
0.11
0.09
0.17
0.16
0.14
0.14
0.05
0.60
0.18
0.08
0.14
0.09
0.26
0.08
0.03
0.08
0.13
0.06
0.05
0.07
0.25
0.21
0.14
0.19
0.10
0.06
0.19
0.31
0.34
0.47
0.29
0.10
0.11
0.09
0.09
0.32
0.09
0.24
0.29
0.46
0.05
0.11
0.05
0.07
0.13
0.08
0.12
0.22
0.15
0.17
0.05
0.13
0.06
0.07
0.11
0.08
0.08
0.13
0.11
0.20
0.28

0.11
0.13
0.13
0.12
0.09
0.04
0.09
0.11
0.18
0.15
0.11
0.08
0.12
0.10
0.12
0.13
0.09
0.13
0.08
0.15
0.13
0.14
0.09
0.04
0.12
0.15
0.13
0.15
0.12
0.15
0.12
0.05
0.07
0.16
0.12
0.10
0.09
0.09
0.14
0.12
0.18
0.15
0.10
0.15
0.13
0.12
0.13
0.13
0.13
0.13
0.14
0.13
0.12
0.13
0.10
0.12
0.11
0.13
0.09
0.15
0.08
0.18

0.00
0.02
0.01
0.02
0.02
0.02
0.02
0.01
0.07
0.03
0.01
0.02
0.01
0.04
0.01
0.00
0.01
0.02
0.01
0.01
0.01
0.04
0.03
0.02
0.03
0.01
0.01
0.03
0.04
0.05
0.05
0.03
0.01
0.01
0.01
0.01
0.04
0.01
0.03
0.04
0.08
0.01
0.02
0.01
0.01
0.02
0.01
0.02
0.03
0.02
0.02
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.03
0.04

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

422

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Tongue (C01-02) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

122
622
914
133
768
410
112
293
484
46
434
81
19700
1871
17237
841
110
692
98
1
25
71
1589
202
1341
937
82
813
303
347
1221
89
1096
103
2208
216
1856
6133
260
573
351
4885
414
111
301
1521
127
1364
120
46
531
368
180
454

2.7
3.1
3.0
4.0
2.9
3.4
4.6
3.1
2.8
3.3
2.7
2.7
2.9
3.1
2.9
3.2
4.0
3.1
1.7
0.3
1.4
2.1
2.7
3.0
2.8
2.6
2.6
2.5
2.8
3.1
3.0
3.0
2.9
3.0
2.8
3.2
2.8
2.8
1.4
3.2
1.6
3.1
3.4
4.1
3.2
2.7
2.5
2.7
2.2
2.3
2.9
3.0
2.8
2.7

0.25
0.13
0.10
0.36
0.11
0.17
0.45
0.19
0.13
0.50
0.13
0.31
0.02
0.07
0.02
0.11
0.39
0.12
0.18
0.25
0.28
0.25
0.07
0.22
0.08
0.09
0.29
0.09
0.16
0.17
0.09
0.32
0.09
0.31
0.06
0.22
0.07
0.04
0.09
0.14
0.09
0.05
0.17
0.39
0.19
0.07
0.23
0.08
0.21
0.34
0.13
0.16
0.21
0.13

0.35
0.37
0.36
0.49
0.34
0.41
0.57
0.38
0.33
0.42
0.32
0.31
0.35
0.38
0.35
0.38
0.49
0.37
0.22
0.02
0.15
0.27
0.33
0.36
0.34
0.31
0.30
0.30
0.33
0.36
0.36
0.38
0.35
0.38
0.34
0.39
0.35
0.34
0.15
0.39
0.20
0.38
0.41
0.49
0.38
0.33
0.32
0.33
0.27
0.28
0.36
0.37
0.34
0.32

0.04
0.02
0.01
0.05
0.01
0.02
0.06
0.03
0.02
0.07
0.02
0.04
0.00
0.01
0.00
0.01
0.05
0.02
0.02
0.02
0.04
0.04
0.01
0.03
0.01
0.01
0.04
0.01
0.02
0.02
0.01
0.04
0.01
0.04
0.01
0.03
0.01
0.01
0.01
0.02
0.01
0.01
0.02
0.05
0.02
0.01
0.03
0.01
0.03
0.05
0.02
0.02
0.03
0.02

60
337
428
39
378
180
33
145
235
10
222
38
9410
699
8311
387
41
328
57
2
11
41
808
93
690
434
25
392
123
183
584
44
519
55
1125
88
927
2976
205
228
201
2301
185
34
150
693
48
629
63
30
259
185
90
239

1.0
1.3
1.1
0.9
1.1
1.2
1.0
1.2
1.0
0.6
1.1
1.0
1.1
0.9
1.1
1.1
1.1
1.1
0.9
0.5
0.5
1.0
1.0
1.0
1.0
0.9
0.6
1.0
0.9
1.3
1.1
1.1
1.0
1.3
1.1
1.0
1.1
1.1
0.9
1.0
0.8
1.2
1.2
0.9
1.3
1.0
0.7
1.0
1.0
1.3
1.2
1.2
1.2
1.2

0.15
0.08
0.06
0.14
0.06
0.09
0.18
0.11
0.07
0.18
0.08
0.19
0.01
0.03
0.01
0.06
0.17
0.07
0.12
0.38
0.16
0.17
0.04
0.10
0.04
0.05
0.12
0.05
0.09
0.11
0.05
0.17
0.05
0.20
0.04
0.11
0.04
0.02
0.07
0.07
0.06
0.03
0.09
0.16
0.11
0.04
0.11
0.04
0.14
0.25
0.08
0.10
0.14
0.08

0.12
0.16
0.13
0.10
0.13
0.13
0.11
0.13
0.12
0.06
0.12
0.13
0.13
0.10
0.13
0.12
0.12
0.12
0.10
0.07
0.04
0.12
0.12
0.12
0.12
0.11
0.07
0.11
0.10
0.16
0.12
0.13
0.12
0.16
0.13
0.11
0.13
0.13
0.10
0.12
0.08
0.14
0.13
0.10
0.14
0.12
0.08
0.12
0.12
0.19
0.13
0.14
0.14
0.14

0.02
0.01
0.01
0.02
0.01
0.01
0.02
0.01
0.01
0.02
0.01
0.03
0.00
0.00
0.00
0.01
0.02
0.01
0.02
0.05
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.02
0.01
0.02
0.01
0.03
0.00
0.01
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.04
0.01
0.01
0.02
0.01

8
79
361
8
11
146
62
21
473
1250
52
1048
222
207
165
132
118
10
59
33
74
142
120
560
88

1.4
1.4
1.7
0.6
0.5
0.6
1.9
1.0
5.1
6.1
5.8
4.6
5.5
3.2
6.0
0.8
0.8
0.6
1.5
1.0
1.8
1.5
1.9
1.6
1.5

0.51
0.16
0.09
0.20
0.14
0.05
0.25
0.22
0.24
0.18
0.82
0.15
0.38
0.23
0.47
0.08
0.08
0.19
0.20
0.18
0.22
0.13
0.18
0.07
0.18

0.10
0.15
0.20
0.03
0.05
0.08
0.22
0.11
0.61
0.73
0.60
0.55
0.67
0.38
0.71
0.10
0.10
0.07
0.17
0.10
0.20
0.17
0.22
0.18
0.16

0.05
0.02
0.01
0.02
0.02
0.01
0.03
0.03
0.03
0.03
0.10
0.02
0.05
0.03
0.06
0.01
0.01
0.03
0.03
0.02
0.03
0.02
0.02
0.01
0.02

7
67
221
4
4
141
23
17
144
317
22
399
68
126
81
109
100
4
28
33
42
96
76
288
51

1.1
1.1
1.0
0.2
0.2
0.5
0.6
0.7
1.6
1.8
2.4
1.9
1.7
2.0
2.6
0.5
0.5
0.2
0.7
0.7
1.0
0.8
0.9
0.7
0.7

0.43
0.14
0.07
0.12
0.08
0.05
0.13
0.17
0.14
0.11
0.51
0.10
0.21
0.18
0.30
0.05
0.05
0.11
0.13
0.15
0.16
0.09
0.13
0.04
0.12

0.10
0.14
0.12
0.03
0.01
0.06
0.07
0.08
0.19
0.22
0.29
0.24
0.20
0.22
0.32
0.05
0.05
0.02
0.08
0.09
0.10
0.09
0.09
0.07
0.08

0.04
0.02 *
0.01
0.02 *
0.01
0.01 *
0.02 *
0.02 *
0.02
0.02 *
0.07
0.01
0.03 *
0.02 *
0.04 *
0.01
0.01
0.01
0.02
0.02
0.02
0.01
0.01
0.01
0.01

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

365

423

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Tongue (C01-02) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

366

Female
ASR(W)
CUM 0-74

919
83
66
27
20
41
8
233
20
5
19
25
42
16
151
122
140
114
11
15
81
21
118
20
63

1.0
1.0
1.1
1.0
0.7
0.8
1.0
1.0
1.5
0.6
0.8
1.4
1.1
0.9
5.3
1.8
1.7
1.7
1.7
1.4
2.1
0.9
4.4
0.7
0.8

0.03
0.12
0.15
0.22
0.17
0.14
0.37
0.07
0.40
0.25
0.31
0.28
0.18
0.24
0.46
0.18
0.14
0.16
0.52
0.39
0.24
0.20
0.41
0.16
0.10

0.12
0.10
0.14
0.12
0.10
0.09
0.14
0.12
0.16
0.07
0.13
0.18
0.13
0.10
0.64
0.24
0.19
0.20
0.17
0.13
0.24
0.13
0.51
0.07
0.11

0.01
0.01
0.02
0.03
0.03
0.02
0.06
0.01
0.05
0.03
0.07
0.04
0.03
0.03
0.07
0.03
0.02
0.02
0.06
0.04
0.03
0.03
0.06
0.02
0.02

418
48
29
11
16
23
1
123
3
10
6
17
33
6
128
90
70
56
9
5
37
19
22
17
42

0.4
0.4
0.4
0.3
0.5
0.4
0.1
0.5
0.1
0.9
0.3
0.8
0.9
0.4
6.6
1.1
0.7
0.7
1.4
0.4
0.9
0.8
0.7
0.5
0.5

0.02
0.07
0.08
0.10
0.12
0.08
0.11
0.04
0.08
0.29
0.17
0.19
0.16
0.15
0.63
0.12
0.09
0.09
0.50
0.17
0.15
0.18
0.15
0.13
0.08

0.04
0.05
0.05
0.05
0.05
0.04
0.01
0.05
0.01
0.10
0.03
0.11
0.10
0.04
0.80
0.14
0.07
0.07
0.15
0.03
0.10
0.09
0.10
0.08
0.06

0.00
0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.04
0.02
0.03
0.02
0.02 *
0.09 *
0.02 *
0.01
0.01
0.06
0.01
0.02 *
0.03 *
0.02
0.02 *
0.01 *

640
50
23
692
129
433
554
576
874
358
118
279
165
124
58
118
142
110
215
91
128
51
83
240
391
133
184
280
179
137
8
188
27
64
28
71
57
8
106
36
21
279
45
6
22
63
39
57
12
24
86
79
48
202

2.4
2.3
2.1
2.4
2.1
2.5
1.9
3.7
2.5
1.8
2.8
1.5
5.0
5.9
3.5
4.9
4.5
3.1
5.9
5.2
7.0
3.8
4.1
2.5
2.3
2.1
2.9
3.3
1.9
3.4
0.9
1.6
3.2
2.7
1.8
1.4
2.3
1.2
2.3
1.4
1.3
3.3
2.6
0.6
1.1
1.4
1.4
3.4
1.1
3.4
2.2
1.9
2.5
3.2

0.09
0.33
0.45
0.09
0.19
0.12
0.08
0.16
0.09
0.10
0.26
0.09
0.39
0.55
0.47
0.45
0.39
0.30
0.41
0.57
0.64
0.58
0.46
0.16
0.12
0.18
0.21
0.20
0.14
0.29
0.32
0.12
0.63
0.35
0.37
0.17
0.33
0.58
0.24
0.24
0.29
0.20
0.40
0.25
0.25
0.19
0.23
0.46
0.34
0.71
0.25
0.23
0.37
0.23

0.28
0.26
0.24
0.30
0.24
0.29
0.22
0.44
0.28
0.23
0.34
0.18
0.63
0.69
0.43
0.56
0.52
0.36
0.68
0.61
0.84
0.41
0.47
0.29
0.27
0.25
0.34
0.38
0.23
0.39
0.09
0.19
0.40
0.30
0.19
0.16
0.26
0.12
0.28
0.16
0.17
0.41
0.32
0.06
0.15
0.16
0.15
0.42
0.09
0.47
0.24
0.26
0.30
0.37

0.01
0.04
0.05
0.01
0.02
0.02
0.01
0.02
0.01
0.01
0.03
0.01
0.05
0.07
0.06
0.06
0.05
0.04
0.05
0.07
0.08
0.06
0.06
0.02
0.01
0.02
0.03
0.02
0.02
0.04
0.04
0.02
0.08
0.04
0.04
0.02
0.04
0.05
0.03
0.03
0.04
0.03
0.05
0.03
0.03
0.02
0.03
0.06
0.03
0.11
0.03
0.03
0.05
0.03

233
9
16
96
40
141
91
101
173
173
42
191
34
28
21
40
38
23
44
20
25
12
18
58
120
67
50
116
76
54
7
76
13
22
13
52
28
5
61
22
8
101
19
6
13
32
11
17
8
8
37
38
17
68

0.6
0.3
1.3
0.2
0.6
0.7
0.2
0.5
0.4
0.7
0.6
0.8
0.9
0.9
1.1
1.4
1.0
0.6
1.0
0.8
1.1
0.6
0.8
0.5
0.5
0.8
0.7
1.1
0.6
1.0
0.6
0.6
0.9
0.8
0.6
0.8
0.7
0.3
0.9
0.6
0.4
0.9
0.8
0.5
0.5
0.6
0.3
0.8
0.5
0.9
0.7
0.9
0.6
0.8

0.05
0.10
0.34
0.02
0.10
0.06
0.03
0.05
0.03
0.06
0.10
0.06
0.16
0.19
0.24
0.24
0.18
0.13
0.16
0.21
0.23
0.20
0.20
0.07
0.05
0.11
0.10
0.11
0.08
0.15
0.25
0.07
0.33
0.18
0.21
0.13
0.19
0.17
0.13
0.13
0.14
0.10
0.23
0.22
0.16
0.12
0.11
0.20
0.20
0.35
0.12
0.17
0.16
0.12

0.07
0.03
0.14
0.03
0.06
0.07
0.03
0.06
0.04
0.08
0.06
0.09
0.10
0.08
0.14
0.16
0.11
0.06
0.10
0.11
0.12
0.07
0.08
0.05
0.06
0.09
0.07
0.13
0.07
0.11
0.06
0.07
0.09
0.09
0.06
0.09
0.08
0.05
0.10
0.08
0.02
0.11
0.10
0.04
0.05
0.07
0.03
0.09
0.06
0.12
0.07
0.11
0.08
0.09

0.01
0.01
0.04
0.00 *
0.01 *
0.01
0.00 *
0.01
0.00
0.01
0.01
0.01
0.02
0.02
0.03
0.03
0.02
0.02
0.02
0.03
0.03
0.03
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.03
0.01
0.04
0.02
0.02
0.02
0.02
0.03
0.02
0.02
0.01
0.01
0.03
0.02
0.02
0.02
0.01
0.03
0.03
0.05
0.01
0.02
0.02
0.01

*Important. See note on population page.

424

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Tongue (C01-02) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

162
255
15
240
46
41
83
263
334
395
288
745
216
30
159
243
189
13
55
77
106
44
57
84
398
40
17
19
46
25
29
71
878
42
61
162
146
300
461
140
455
781
277
282
90
467

2.2
2.6
1.2
1.5
2.0
1.0
1.5
2.7
3.4
2.8
1.8
4.9
3.2
2.9
3.8
3.9
4.3
1.5
2.7
2.8
2.9
2.2
3.3
2.7
1.1
2.8
2.2
3.4
2.6
2.0
3.1
3.4
1.6
1.2
1.8
1.6
1.7
2.0
2.0
1.5
1.8
1.7
1.5
1.5
1.7
2.6

0.17
0.17
0.32
0.10
0.29
0.16
0.16
0.17
0.19
0.14
0.11
0.18
0.22
0.56
0.31
0.25
0.32
0.47
0.38
0.33
0.29
0.35
0.45
0.31
0.06
0.45
0.53
0.78
0.39
0.42
0.59
0.42
0.05
0.18
0.24
0.13
0.14
0.12
0.09
0.13
0.09
0.06
0.10
0.09
0.18
0.12

0.27
0.30
0.15
0.18
0.25
0.12
0.16
0.31
0.40
0.34
0.21
0.55
0.39
0.37
0.46
0.48
0.53
0.19
0.32
0.33
0.37
0.27
0.39
0.33
0.13
0.35
0.27
0.43
0.31
0.25
0.39
0.41
0.19
0.12
0.20
0.17
0.18
0.24
0.23
0.17
0.21
0.19
0.17
0.18
0.20
0.31

0.02
0.02
0.04
0.01
0.04
0.02
0.02
0.02
0.02
0.02
0.01
0.02
0.03
0.07
0.04
0.03
0.04
0.06
0.05
0.04
0.04
0.04
0.06
0.04
0.01
0.06
0.07
0.10
0.05
0.06
0.08
0.05
0.01
0.02
0.03
0.02
0.02
0.02
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.02

40
52
8
142
14
12
39
76
97
118
94
82
43
7
38
75
44
0
18
30
45
15
15
19
295
25
7
15
16
6
7
31
660
39
30
100
88
150
229
102
301
492
181
183
42
253

0.3
0.3
0.5
0.7
0.4
0.2
0.5
0.6
0.7
0.5
0.5
0.4
0.5
0.5
0.7
1.0
0.8
0.8
0.9
1.0
0.7
0.6
0.5
0.7
1.4
0.8
2.2
0.8
0.4
0.6
1.2
1.0
1.1
0.9
0.8
0.8
0.9
0.8
0.9
0.9
0.8
0.9
0.8
0.6
1.1

0.05
0.05
0.18
0.07
0.10
0.07
0.08
0.07
0.08
0.05
0.06
0.05
0.08
0.22
0.13
0.13
0.13
0.20
0.17
0.16
0.18
0.17
0.11
0.05
0.31
0.31
0.60
0.20
0.18
0.25
0.23
0.04
0.18
0.17
0.09
0.09
0.08
0.06
0.10
0.06
0.04
0.07
0.07
0.11
0.08

0.04
0.04
0.05
0.08
0.04
0.03
0.06
0.06
0.07
0.06
0.06
0.05
0.06
0.07
0.08
0.12
0.09
0.10
0.09
0.12
0.08
0.05
0.06
0.08
0.19
0.10
0.23
0.08
0.03
0.06
0.13
0.12
0.12
0.11
0.09
0.09
0.09
0.08
0.11
0.10
0.10
0.10
0.09
0.08
0.13

0.01
0.01
0.02
0.01
0.01 *
0.01
0.01
0.01 *
0.01
0.01
0.01
0.01
0.01
0.03
0.01
0.02
0.02
0.03
0.02
0.02
0.02
0.02
0.02
0.01
0.04
0.04
0.07
0.03
0.02
0.03
0.03
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01

525
28
321
97
45
325
137
17
10
172
120
8
5
12
38
53

2.4
6.1
2.7
1.9
2.9
2.1
2.3
1.8
2.2
1.4
2.9
2.2
0.7
2.4
3.0
4.7

0.11
1.21
0.16
0.20
0.44
0.12
0.20
0.45
0.71
0.11
0.27
0.87
0.32
0.70
0.56
0.66

0.29
0.70
0.33
0.24
0.37
0.25
0.25
0.22
0.27
0.16
0.34
0.24
0.05
0.25
0.39
0.56

0.01
0.15
0.02
0.03
0.06
0.02
0.02
0.06
0.09
0.01
0.04
0.11
0.03
0.08
0.08
0.09

277
5
150
59
14
179
52
8
4
100
73
5
7
11
24
23

1.1
1.6
1.2
0.9
0.8
1.0
0.7
0.7
0.8
0.7
1.4
1.2
1.0
2.2
1.2
2.0

0.07
0.79
0.10
0.12
0.22
0.08
0.11
0.27
0.40
0.08
0.18
0.56
0.37
0.67
0.32
0.44

0.13
0.23
0.13
0.10
0.09
0.11
0.09
0.07
0.02
0.08
0.17
0.11
0.09
0.27
0.13
0.28

0.01
0.14
0.01
0.02
0.03
0.01
0.02
0.03
0.01
0.01
0.02
0.07
0.04
0.09
0.04
0.07

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

367

425

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Mouth (C03-06)
Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

368

Female
ASR(W)
CUM 0-74

7
57
9
16
8

0.3
1.3
1.0
1.6
0.4

0.11
0.18
0.33
0.46
0.17

2
55
1
14
7

0.1
1.0
0.1
1.0
0.4

0.05
0.14
0.12
0.32
0.20

16
117
35
58
1414
2
29
78
11
39
12

2.2
5.5
4.9
3.8
6.7
0.2
0.8
1.1
0.4
3.7
1.3

0.55
0.54
0.89
0.52
0.19
0.17
0.16
0.13
0.12
0.61
0.39

0.27
0.66
0.62
0.44
0.78
0.04
0.11
0.13
0.03
0.48
0.13

0.07
0.08
0.13
0.07
0.03
0.03
0.03
0.02
0.02
0.08
0.06

13
45
13
23
559
0
49
39
10
9
8

1.1
1.8
1.9
1.2
1.9
1.1
0.5
0.3
0.7
0.7

0.33
0.28
0.55
0.26
0.09
0.16
0.08
0.10
0.24
0.25

0.12
0.23
0.25
0.11
0.20
0.12
0.04
0.04
0.07
0.08

0.04
0.05
0.09
0.03
0.01
0.02
0.01
0.02
0.03
0.04 *

1458
163
245
64
40
29
1
63
799
13
41
362
74
283
27
292
1758
99
153
184
1294
352
30
15
7
1
31
249
467
82
6
1
4
5
70
286
193
261
20
236
65
53
11
1553
141
1388
565
148
413
156
49
104
69
908
146
731
419
249
363
446
136
309
32
59

1.9
1.8
1.7
1.6
1.5
1.6
1.0
1.9
2.1
2.6
1.1
2.5
2.8
2.4
1.7
1.8
1.8
0.9
2.6
1.1
2.0
1.7
2.2
0.9
0.8
0.6
1.2
2.0
1.9
3.3
0.5
0.2
0.8
1.0
1.2
2.3
1.5
2.3
3.0
2.2
3.9
5.2
2.1
2.6
2.7
2.6
2.6
3.3
2.4
2.3
2.8
2.2
1.8
2.5
3.4
2.3
2.2
2.6
2.8
3.4
4.3
3.1
3.4
2.9

0.05
0.15
0.11
0.21
0.25
0.30
0.98
0.25
0.07
0.75
0.18
0.14
0.34
0.15
0.34
0.11
0.04
0.09
0.21
0.09
0.06
0.10
0.41
0.23
0.32
0.58
0.23
0.13
0.09
0.37
0.23
0.18
0.40
0.45
0.15
0.15
0.11
0.15
0.68
0.15
0.50
0.73
0.65
0.07
0.23
0.08
0.11
0.28
0.12
0.19
0.43
0.22
0.22
0.08
0.29
0.09
0.11
0.17
0.15
0.16
0.38
0.18
0.61
0.40

0.23
0.23
0.21
0.20
0.18
0.18
0.12
0.23
0.25
0.25
0.14
0.30
0.34
0.29
0.25
0.21
0.22
0.11
0.29
0.13
0.26
0.21
0.24
0.10
0.09
0.07
0.10
0.25
0.24
0.38
0.10
0.03
0.11
0.10
0.17
0.29
0.17
0.28
0.31
0.28
0.46
0.60
0.26
0.31
0.33
0.31
0.32
0.42
0.30
0.30
0.37
0.29
0.24
0.31
0.43
0.29
0.27
0.30
0.35
0.42
0.53
0.39
0.39
0.36

0.01
0.02
0.02
0.03
0.03
0.04
0.12
0.04
0.01
0.09
0.03
0.02
0.04
0.02
0.06
0.01
0.01
0.01
0.03
0.01
0.01
0.01
0.06
0.03
0.04
0.07
0.02
0.02
0.01
0.05
0.04
0.03
0.06
0.06
0.02
0.02
0.02
0.02
0.08
0.02
0.07
0.09
0.09
0.01
0.03
0.01
0.02
0.04
0.02
0.03
0.07
0.03
0.03
0.01
0.04
0.01
0.02
0.02
0.02
0.02
0.05
0.03
0.08
0.06

1000
113
198
65
25
11
2
48
486
8
44
248
34
211
14
178
1394
97
92
127
1036
273
29
10
8
5
10
187
332
37
9
11
4
1
54
206
151
205
14
188
29
22
7
1076
91
971
378
87
288
110
35
73
53
597
75
503
276
171
218
212
50
160
16
33

1.0
1.1
1.1
1.3
0.8
0.6
2.0
1.2
1.0
1.3
0.9
1.1
0.8
1.2
1.0
0.9
1.1
0.7
1.3
0.6
1.2
1.1
1.9
0.4
0.6
1.3
0.4
1.2
1.0
1.1
0.6
1.0
0.6
0.2
0.6
1.2
1.0
1.2
1.5
1.2
1.3
1.5
1.0
1.3
1.3
1.3
1.2
1.4
1.2
1.2
1.3
1.2
1.0
1.2
1.2
1.2
1.1
1.2
1.3
1.2
1.1
1.2
1.2
1.2

0.04
0.11
0.09
0.18
0.18
0.17
1.50
0.19
0.05
0.52
0.16
0.08
0.15
0.09
0.27
0.07
0.03
0.07
0.14
0.06
0.04
0.07
0.36
0.14
0.23
0.63
0.13
0.10
0.06
0.19
0.22
0.31
0.36
0.15
0.09
0.10
0.09
0.10
0.40
0.10
0.26
0.35
0.42
0.05
0.14
0.05
0.07
0.15
0.08
0.13
0.24
0.15
0.15
0.05
0.15
0.06
0.07
0.11
0.09
0.09
0.16
0.10
0.32
0.24

0.12
0.13
0.14
0.17
0.09
0.08
0.22
0.13
0.12
0.16
0.09
0.13
0.11
0.13
0.16
0.10
0.13
0.07
0.14
0.07
0.15
0.13
0.20
0.05
0.10
0.12
0.07
0.14
0.11
0.12
0.09
0.09
0.08
0.02
0.07
0.14
0.11
0.15
0.17
0.15
0.16
0.18
0.14
0.15
0.14
0.16
0.14
0.17
0.13
0.15
0.17
0.14
0.10
0.14
0.14
0.14
0.13
0.13
0.15
0.13
0.11
0.14
0.14
0.15

0.01
0.02
0.01
0.03
0.02
0.03
0.17
0.02
0.01
0.07
0.02
0.01
0.02
0.01
0.05
0.01
0.00
0.01
0.02
0.01
0.01
0.01
0.04
0.02
0.04
0.07
0.02
0.01
0.01
0.02
0.04
0.04
0.05
0.02
0.01
0.01
0.01
0.01
0.06
0.02
0.04
0.05
0.07
0.01
0.02
0.01
0.01
0.02
0.01
0.02
0.04
0.02
0.02
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.04
0.03

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

426

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Mouth (C03-06) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

136
523
773
133
614
370
119
247
375
46
324
51
15646
1967
13136
548
80
447
85
2
16
65
1288
218
1024
738
103
618
196
212
984
112
838
74
1762
233
1429
4669
180
606
265
3560
361
134
221
1226
136
1061
70
44
389
261
169
436

3.0
2.6
2.5
4.1
2.2
3.1
5.0
2.6
2.1
3.2
2.0
1.6
2.2
3.2
2.1
2.1
2.9
2.0
1.5
0.6
1.0
1.9
2.2
3.2
2.1
2.0
3.4
1.8
1.7
1.9
2.3
3.8
2.1
2.1
2.2
3.5
2.1
2.1
1.0
3.3
1.2
2.2
2.9
4.9
2.2
2.1
2.6
2.1
1.3
2.1
2.1
2.1
2.6
2.5

0.27
0.12
0.09
0.36
0.09
0.16
0.47
0.17
0.11
0.49
0.11
0.23
0.02
0.07
0.02
0.09
0.33
0.10
0.17
0.43
0.24
0.25
0.06
0.22
0.07
0.08
0.34
0.08
0.13
0.14
0.08
0.37
0.08
0.26
0.05
0.24
0.06
0.03
0.08
0.14
0.08
0.04
0.15
0.44
0.15
0.06
0.23
0.07
0.16
0.33
0.11
0.13
0.21
0.12

0.37
0.31
0.30
0.48
0.28
0.37
0.58
0.32
0.26
0.36
0.25
0.18
0.27
0.39
0.26
0.25
0.33
0.24
0.18
0.05
0.13
0.22
0.25
0.36
0.25
0.25
0.43
0.23
0.22
0.26
0.28
0.45
0.26
0.28
0.26
0.41
0.26
0.26
0.12
0.40
0.15
0.27
0.33
0.61
0.25
0.27
0.33
0.26
0.16
0.27
0.26
0.24
0.32
0.29

0.04
0.02
0.01
0.05
0.01
0.02
0.06
0.02
0.02
0.06
0.02
0.03
0.00
0.01
0.00
0.01
0.04
0.01
0.02
0.05
0.04
0.03
0.01
0.03
0.01
0.01
0.05
0.01
0.02
0.02
0.01
0.05
0.01
0.04
0.01
0.03
0.01
0.00
0.01
0.02
0.01
0.01
0.02
0.06
0.02
0.01
0.03
0.01
0.02
0.05
0.02
0.02
0.03
0.02

77
335
558
46
484
240
38
198
272
16
254
33
10804
1005
9372
421
46
358
69
0
12
56
929
115
788
507
54
436
164
179
640
66
563
44
1309
118
1114
3368
144
304
178
2681
215
53
159
771
76
672
62
20
317
210
106
305

1.3
1.2
1.4
1.0
1.3
1.4
1.1
1.5
1.1
0.8
1.1
0.8
1.1
1.2
1.1
1.1
1.1
1.1
0.9
0.6
1.2
1.1
1.1
1.1
1.0
1.3
1.0
1.0
1.1
1.1
1.5
1.0
0.9
1.2
1.3
1.2
1.1
0.6
1.2
0.7
1.2
1.3
1.4
1.2
1.1
1.1
1.1
0.9
0.7
1.3
1.2
1.2
1.3

0.16
0.07
0.06
0.16
0.07
0.10
0.19
0.12
0.07
0.21
0.08
0.15
0.01
0.04
0.01
0.06
0.17
0.07
0.12
0.18
0.18
0.04
0.11
0.04
0.05
0.18
0.05
0.08
0.10
0.05
0.20
0.05
0.16
0.04
0.13
0.04
0.02
0.05
0.07
0.05
0.03
0.09
0.20
0.11
0.04
0.13
0.04
0.13
0.17
0.08
0.10
0.13
0.08

0.15
0.15
0.15
0.11
0.15
0.16
0.13
0.17
0.13
0.10
0.13
0.08
0.13
0.14
0.13
0.12
0.12
0.12
0.10
0.07
0.13
0.13
0.13
0.13
0.12
0.16
0.11
0.10
0.14
0.12
0.17
0.12
0.11
0.14
0.15
0.14
0.13
0.07
0.13
0.08
0.14
0.14
0.17
0.13
0.13
0.13
0.13
0.11
0.10
0.14
0.13
0.13
0.16

0.02
0.01
0.01
0.02
0.01
0.01
0.03
0.02
0.01
0.03
0.01
0.02
0.00
0.01
0.00
0.01
0.02
0.01
0.02
0.02
0.02
0.01
0.01
0.01
0.01
0.03
0.01
0.01
0.01
0.01
0.03
0.01
0.02
0.01
0.02
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.03
0.01
0.01
0.02
0.01
0.02
0.03
0.01
0.01
0.02
0.01

7
89
334
8
11
176
44
17
548
821
60
1460
224
449
247
161
140
18
33
39
81
137
131
510
72

1.3
1.7
1.6
0.6
0.4
0.8
1.3
0.8
6.0
3.9
7.1
6.1
5.5
6.7
9.2
1.0
1.0
1.2
0.8
0.9
1.9
1.3
1.9
1.4
1.2

0.49
0.18
0.09
0.21
0.13
0.06
0.21
0.20
0.26
0.15
0.92
0.17
0.38
0.33
0.59
0.08
0.09
0.29
0.15
0.15
0.22
0.11
0.18
0.06
0.16

0.18
0.17
0.19
0.07
0.06
0.09
0.16
0.09
0.73
0.46
0.86
0.72
0.63
0.82
1.15
0.12
0.12
0.15
0.10
0.12
0.24
0.17
0.25
0.17
0.13

0.08
0.02
0.01
0.03
0.02
0.01
0.03
0.03
0.04
0.02
0.13
0.02
0.05
0.05
0.09
0.01
0.01
0.04
0.02
0.02
0.03
0.02
0.02
0.01
0.02

3
48
165
2
9
176
12
9
441
323
50
735
130
315
124
127
116
4
41
20
29
91
75
341
39

0.5
0.8
0.7
0.1
0.4
0.6
0.4
0.3
5.2
1.8
5.4
3.7
3.4
5.0
4.1
0.6
0.6
0.2
0.9
0.3
0.5
0.6
0.8
0.7
0.4

0.28
0.11
0.06
0.06
0.12
0.05
0.11
0.11
0.25
0.10
0.77
0.14
0.30
0.29
0.37
0.06
0.06
0.12
0.15
0.09
0.10
0.07
0.10
0.04
0.08

0.10
0.09
0.08
0.04
0.07
0.05
0.03
0.68
0.22
0.69
0.44
0.41
0.60
0.52
0.07
0.07
0.03
0.12
0.03
0.04
0.06
0.09
0.08
0.04

0.07
0.02 *
0.01
- *
0.02
0.01 *
0.01 *
0.01 *
0.04
0.02 *
0.11
0.02
0.04 *
0.04 *
0.06 *
0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

369

427

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Mouth (C03-06) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

370

Female
ASR(W)
CUM 0-74

1264
98
74
29
38
66
17
274
14
10
21
35
34
16
440
125
119
93
21
5
79
29
124
17
64

1.5
1.3
1.4
1.2
1.6
1.4
2.5
1.4
1.3
1.0
0.7
1.7
1.0
0.9
15.3
1.8
1.5
1.5
2.8
0.5
2.0
1.3
4.6
0.6
0.8

0.04
0.15
0.18
0.24
0.27
0.19
0.65
0.09
0.40
0.33
0.28
0.30
0.17
0.24
0.78
0.18
0.14
0.16
0.63
0.24
0.23
0.25
0.42
0.15
0.10

0.18
0.16
0.17
0.15
0.20
0.17
0.34
0.17
0.11
0.08
0.11
0.27
0.14
0.10
1.73
0.22
0.18
0.19
0.26
0.08
0.21
0.10
0.53
0.06
0.10

0.01
0.02
0.03
0.03
0.04
0.03
0.10
0.01
0.04
0.03
0.06
0.05
0.03
0.03
0.11
0.03
0.02
0.02
0.07
0.04
0.03
0.03
0.06
0.02
0.01

634
54
31
17
26
21
5
151
10
4
7
25
48
9
249
129
64
45
13
6
67
43
47
12
55

0.5
0.5
0.4
0.5
0.6
0.3
0.4
0.6
0.6
0.4
0.8
1.2
1.4
0.5
12.3
1.7
0.7
0.6
2.8
0.6
1.6
1.7
1.5
0.4
0.7

0.02
0.07
0.08
0.11
0.13
0.07
0.17
0.05
0.20
0.19
0.42
0.24
0.20
0.18
0.83
0.15
0.09
0.09
0.81
0.26
0.20
0.27
0.22
0.11
0.09

0.05
0.06
0.05
0.05
0.05
0.03
0.03
0.06
0.07
0.06
0.07
0.17
0.18
0.06
1.42
0.21
0.07
0.05
0.31
0.05
0.18
0.16
0.19
0.05
0.09

0.00
0.01
0.01
0.01
0.02
0.01
0.02
0.01
0.03
0.04
0.05
0.04
0.03
0.02 *
0.11 *
0.02 *
0.01
0.01
0.10
0.03
0.03 *
0.03 *
0.03
0.02 *
0.01 *

727
78
26
1050
158
597
578
513
849
604
132
256
224
143
100
123
148
165
279
120
143
48
107
272
508
215
285
289
276
230
14
214
25
62
41
98
58
7
75
43
21
355
46
16
40
70
35
31
14
24
108
56
53
283

2.7
3.6
2.4
3.7
2.6
3.5
2.0
3.3
2.5
3.1
3.1
1.3
6.8
6.9
6.0
5.0
4.6
4.5
7.4
7.5
7.9
3.3
5.4
2.8
3.0
3.4
4.4
3.3
2.9
5.7
1.6
1.9
3.1
2.6
2.4
1.8
2.2
1.0
1.7
1.6
1.4
4.1
2.8
1.5
1.8
1.5
1.1
1.8
1.0
3.6
2.7
1.5
2.8
4.5

0.10
0.41
0.48
0.12
0.21
0.15
0.08
0.15
0.09
0.13
0.27
0.09
0.46
0.59
0.61
0.45
0.39
0.36
0.45
0.70
0.68
0.51
0.54
0.17
0.14
0.24
0.26
0.20
0.18
0.39
0.44
0.13
0.64
0.34
0.40
0.20
0.31
0.38
0.20
0.26
0.30
0.22
0.43
0.39
0.31
0.19
0.19
0.33
0.29
0.74
0.28
0.21
0.39
0.27

0.31
0.40
0.29
0.45
0.31
0.40
0.23
0.40
0.28
0.36
0.39
0.15
0.81
0.84
0.75
0.60
0.52
0.51
0.82
0.85
0.90
0.36
0.59
0.31
0.34
0.40
0.50
0.37
0.35
0.65
0.23
0.23
0.34
0.31
0.33
0.22
0.26
0.11
0.21
0.19
0.15
0.50
0.33
0.18
0.24
0.18
0.13
0.21
0.11
0.48
0.33
0.19
0.31
0.55

0.01
0.05
0.06
0.01
0.03
0.02
0.01
0.02
0.01
0.02
0.04
0.01
0.06
0.08
0.08
0.06
0.05
0.04
0.06
0.08
0.08
0.06
0.06
0.02
0.02
0.03
0.03
0.02
0.02
0.05
0.07
0.02
0.08
0.04
0.05
0.03
0.04
0.05
0.03
0.03
0.04
0.03
0.05
0.05
0.04
0.02
0.02
0.04
0.04
0.10
0.04
0.03
0.05
0.04

252
26
13
131
65
194
124
129
249
362
40
204
51
39
29
38
59
55
53
16
30
25
13
81
154
109
54
120
110
64
17
108
4
32
19
61
39
1
56
19
15
151
21
8
28
37
17
16
5
11
67
32
21
108

0.7
1.1
1.1
0.3
0.8
0.9
0.3
0.7
0.6
1.4
0.5
0.8
1.3
1.6
1.3
1.4
1.4
1.3
0.9
0.6
1.4
1.3
0.5
0.7
0.6
1.3
0.7
1.1
0.9
1.3
1.2
0.7
0.2
1.1
0.9
0.9
1.0
0.2
0.7
0.7
0.8
1.4
0.8
0.6
0.9
0.5
0.4
0.8
0.3
1.4
1.2
0.5
0.7
1.1

0.05
0.24
0.30
0.03
0.11
0.07
0.04
0.06
0.04
0.08
0.09
0.06
0.20
0.27
0.27
0.24
0.20
0.20
0.15
0.18
0.28
0.32
0.19
0.09
0.06
0.14
0.10
0.11
0.10
0.17
0.33
0.08
0.13
0.23
0.23
0.14
0.19
0.17
0.11
0.21
0.22
0.13
0.21
0.21
0.20
0.09
0.11
0.24
0.17
0.47
0.18
0.11
0.18
0.13

0.08
0.11
0.12
0.03
0.10
0.11
0.03
0.07
0.06
0.17
0.06
0.08
0.15
0.18
0.12
0.16
0.15
0.13
0.09
0.04
0.15
0.13
0.06
0.08
0.07
0.15
0.08
0.13
0.11
0.16
0.11
0.08
0.05
0.13
0.12
0.10
0.11
0.02
0.07
0.07
0.08
0.16
0.09
0.07
0.10
0.04
0.04
0.07
0.03
0.18
0.13
0.07
0.09
0.13

0.01
0.02
0.04
0.00 *
0.02 *
0.01
0.00 *
0.01
0.00
0.01
0.01
0.01
0.02
0.03
0.03
0.03
0.02
0.02
0.02
0.02
0.03
0.03
0.02
0.01
0.01
0.02
0.01
0.01
0.01
0.02
0.05
0.01
0.03
0.03
0.03
0.02
0.02
0.02
0.01
0.02
0.03
0.02
0.03
0.03
0.03
0.01
0.01
0.02
0.02
0.06
0.02
0.02
0.02
0.02

*Important. See note on population page.

428

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Mouth (C03-06) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

188
297
18
241
42
76
110
256
297
506
281
761
300
27
109
335
216
16
60
76
152
53
71
78
486
70
17
22
33
30
39
113
1265
79
81
151
214
378
504
121
403
774
326
290
100
625

2.5
3.0
1.4
1.5
1.8
1.9
2.0
2.7
3.1
3.7
1.7
4.9
4.4
2.6
2.6
5.5
5.0
2.0
2.8
2.8
4.3
2.5
3.9
2.4
1.3
4.9
2.0
3.7
1.9
2.6
4.2
5.3
2.3
2.2
2.4
1.4
2.4
2.6
2.1
1.2
1.4
1.6
1.8
1.5
1.9
3.4

0.19
0.18
0.34
0.10
0.27
0.22
0.19
0.17
0.18
0.16
0.11
0.18
0.26
0.53
0.26
0.31
0.34
0.56
0.38
0.34
0.36
0.36
0.50
0.29
0.06
0.59
0.50
0.81
0.33
0.49
0.67
0.51
0.07
0.25
0.27
0.12
0.17
0.14
0.10
0.12
0.08
0.06
0.10
0.09
0.19
0.14

0.32
0.35
0.14
0.18
0.21
0.25
0.23
0.31
0.35
0.45
0.20
0.57
0.51
0.29
0.31
0.64
0.63
0.21
0.32
0.35
0.54
0.29
0.46
0.27
0.15
0.59
0.22
0.46
0.26
0.27
0.47
0.63
0.28
0.27
0.28
0.15
0.29
0.30
0.25
0.14
0.17
0.18
0.21
0.17
0.22
0.42

0.02
0.02
0.04
0.01
0.04
0.03
0.02
0.02
0.02
0.02
0.01
0.02
0.03
0.06
0.03
0.04
0.05
0.06
0.05
0.04
0.05
0.05
0.06
0.03
0.01
0.08
0.06
0.10
0.05
0.06
0.08
0.06
0.01
0.03
0.03
0.01
0.02
0.02
0.01
0.02
0.01
0.01
0.01
0.01
0.03
0.02

39
59
21
191
17
18
46
68
76
108
219
106
68
8
50
86
38
5
21
24
46
25
10
32
395
32
17
14
20
20
10
46
923
46
36
115
123
234
305
104
314
555
212
244
82
362

0.3
0.4
1.1
0.8
0.5
0.3
0.6
0.5
0.5
0.5
1.4
0.5
0.8
0.7
0.9
1.0
0.8
0.4
0.7
0.7
1.0
0.9
0.4
0.7
0.8
1.7
1.5
2.1
1.0
1.3
0.9
1.6
1.4
1.1
1.0
0.9
1.1
1.3
1.0
0.9
0.9
0.8
0.9
1.0
1.1
1.5

0.06
0.05
0.26
0.07
0.13
0.09
0.09
0.07
0.06
0.05
0.10
0.05
0.11
0.29
0.16
0.12
0.13
0.24
0.18
0.16
0.16
0.21
0.14
0.15
0.05
0.33
0.42
0.62
0.23
0.33
0.31
0.26
0.05
0.17
0.19
0.09
0.11
0.09
0.06
0.09
0.06
0.04
0.07
0.07
0.13
0.09

0.03
0.04
0.13
0.10
0.05
0.05
0.07
0.05
0.06
0.05
0.13
0.06
0.10
0.06
0.10
0.11
0.08
0.05
0.08
0.07
0.11
0.10
0.05
0.08
0.09
0.22
0.18
0.21
0.12
0.15
0.11
0.20
0.16
0.12
0.12
0.10
0.12
0.15
0.11
0.10
0.10
0.09
0.11
0.12
0.12
0.18

0.01
0.01
0.04
0.01
0.01 *
0.01
0.01
0.01 *
0.01
0.01
0.01
0.01
0.01
0.03
0.02
0.02
0.02
0.03
0.02
0.02
0.02
0.03
0.02
0.02
0.01
0.05
0.05
0.07
0.03
0.04
0.04
0.03
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01

470
14
276
101
44
333
137
20
11
186
82
5
8
8
21
33

2.1
3.0
2.4
1.8
2.7
2.1
2.3
2.1
2.5
1.5
1.8
1.5
1.2
1.7
1.2
2.7

0.10
0.86
0.15
0.18
0.41
0.12
0.20
0.49
0.76
0.11
0.21
0.78
0.47
0.61
0.31
0.50

0.26
0.36
0.29
0.21
0.36
0.28
0.28
0.23
0.37
0.19
0.20
0.09
0.16
0.22
0.12
0.30

0.01
0.11
0.02
0.03
0.06
0.02
0.03
0.06
0.13
0.02
0.03
0.05
0.07
0.09
0.04
0.07

308
6
158
69
28
233
65
12
5
142
45
1
9
3
9
20

1.1
2.3
1.2
1.0
1.3
1.2
0.9
1.2
1.1
0.9
0.9
0.3
1.2
0.5
0.5
1.7

0.07
0.97
0.10
0.14
0.28
0.09
0.12
0.36
0.50
0.08
0.15
0.33
0.42
0.29
0.19
0.41

0.13
0.34
0.14
0.11
0.14
0.13
0.11
0.17
0.15
0.11
0.11
0.03
0.14
0.04
0.06
0.22

0.01
0.15
0.01
0.02
0.03
0.01
0.02
0.06
0.08
0.01
0.02
0.03
0.06
0.03
0.03
0.06

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

371

429

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Salivary glands (C07-08)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

372

Female
ASR(W)
CUM 0-74

5
33
8
12
16

0.3
0.7
0.9
0.6
0.4

0.12
0.14
0.32
0.21
0.16

4
27
4
6
20

0.2
0.6
0.4
0.4
0.7

0.09
0.11
0.21
0.23
0.22

8
28
6
14
231
5
31
39
8
10
2

0.9
1.1
0.8
0.9
1.1
0.5
0.9
0.5
0.3
1.0
0.2

0.34
0.24
0.37
0.26
0.07
0.24
0.16
0.08
0.11
0.31
0.13

0.10
0.09
0.09
0.07
0.11
0.04
0.09
0.05
0.03
0.14
-

0.04
0.02
0.05
0.02
0.01
0.03
0.02
0.01
0.01
0.05
-

9
34
5
12
257
7
33
56
8
10
2

1.0
1.1
0.7
0.6
0.9
0.7
0.7
0.6
0.2
0.7
0.1

0.36
0.20
0.31
0.19
0.06
0.27
0.13
0.09
0.09
0.24
0.10

0.09
0.13
0.07
0.10
0.09
0.08
0.08
0.07
0.03
0.06
0.01

0.03
0.03
0.04
0.03
0.01
0.04
0.02
0.01
0.01
0.02
0.01 *

722
48
96
35
28
17
0
22
436
3
37
142
19
120
13
160
998
64
41
89
789
216
15
13
8
2
13
159
244
11
3
7
3
4
38
171
116
126
6
118
19
9
9
806
42
755
209
37
169
72
24
46
38
407
35
358
185
113
132
157
28
128
8
21

0.9
0.5
0.6
0.8
1.0
0.9
0.6
1.1
0.6
0.9
0.9
0.7
1.0
0.7
0.9
1.0
0.6
0.7
0.5
1.2
1.0
1.1
0.8
0.9
0.6
0.5
1.2
0.9
0.4
0.4
1.0
0.5
0.7
0.5
1.3
0.9
1.0
0.8
1.0
1.1
0.9
1.4
1.1
0.7
1.2
0.9
0.8
1.0
1.0
1.3
0.9
0.9
1.0
0.8
1.0
0.9
1.0
1.0
1.1
0.8
1.2
0.8
1.0

0.03
0.07
0.07
0.14
0.19
0.21
0.14
0.05
0.35
0.15
0.08
0.17
0.09
0.20
0.07
0.03
0.07
0.11
0.06
0.05
0.07
0.28
0.23
0.32
0.45
0.16
0.10
0.06
0.14
0.20
0.38
0.33
0.33
0.09
0.11
0.08
0.09
0.35
0.10
0.26
0.30
0.50
0.04
0.11
0.05
0.06
0.13
0.08
0.12
0.28
0.14
0.14
0.05
0.13
0.06
0.07
0.10
0.09
0.09
0.16
0.12
0.29
0.22

0.09
0.05
0.08
0.09
0.07
0.06
0.08
0.11
0.12
0.10
0.10
0.09
0.11
0.08
0.09
0.11
0.07
0.07
0.05
0.13
0.11
0.09
0.10
0.13
0.07
0.04
0.13
0.10
0.05
0.05
0.10
0.07
0.07
0.06
0.15
0.09
0.11
0.07
0.11
0.11
0.10
0.14
0.12
0.07
0.13
0.10
0.09
0.11
0.11
0.16
0.09
0.10
0.11
0.09
0.11
0.10
0.09
0.11
0.12
0.09
0.13
0.12
0.12

0.00
0.01
0.01
0.02
0.02
0.02
0.02
0.01
0.07
0.02
0.01
0.02
0.01
0.03
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.03
0.03
0.05
0.07
0.01
0.01
0.01
0.02
0.03
0.05
0.05
0.04
0.01
0.01
0.01
0.01
0.05
0.01
0.03
0.04
0.06
0.01
0.01
0.01
0.01
0.02
0.01
0.02
0.04
0.02
0.02
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.05
0.03

552
49
82
21
15
11
1
16
322
8
27
107
21
80
13
110
690
76
44
91
459
169
12
12
9
0
16
101
168
17
6
4
4
3
37
89
98
95
4
89
13
8
4
491
45
437
196
44
148
67
15
48
33
300
29
257
147
86
89
94
28
64
7
11

0.6
0.5
0.6
0.5
0.5
0.5
1.3
0.4
0.8
1.3
0.7
0.6
0.6
0.6
0.8
0.6
0.6
0.6
0.6
0.4
0.7
0.7
0.8
0.6
0.8
0.6
0.8
0.5
0.5
0.6
0.4
0.7
0.4
0.4
0.6
0.6
0.7
0.4
0.7
0.5
0.6
0.4
0.7
0.7
0.7
0.7
0.6
0.7
0.8
0.5
0.9
0.7
0.7
0.5
0.7
0.6
0.7
0.6
0.6
0.6
0.5
0.5
0.4

0.03
0.07
0.07
0.13
0.14
0.15
1.31
0.11
0.05
0.51
0.14
0.06
0.13
0.07
0.24
0.06
0.02
0.07
0.10
0.05
0.04
0.06
0.23
0.19
0.26
0.16
0.09
0.04
0.13
0.27
0.19
0.37
0.26
0.07
0.08
0.07
0.08
0.21
0.09
0.17
0.21
0.22
0.04
0.10
0.04
0.05
0.10
0.07
0.10
0.13
0.14
0.14
0.04
0.10
0.05
0.06
0.09
0.07
0.06
0.12
0.07
0.21
0.12

0.06
0.04
0.05
0.05
0.05
0.05
0.16
0.03
0.08
0.12
0.08
0.06
0.06
0.06
0.09
0.07
0.06
0.07
0.07
0.04
0.07
0.08
0.10
0.07
0.09
0.07
0.09
0.05
0.06
0.08
0.04
0.06
0.07
0.03
0.06
0.07
0.08
0.05
0.08
0.06
0.07
0.02
0.07
0.08
0.07
0.07
0.06
0.07
0.08
0.05
0.10
0.07
0.07
0.05
0.07
0.06
0.07
0.06
0.06
0.06
0.06
0.06
0.04

0.00
0.01
0.01
0.01
0.02
0.02
0.16
0.01
0.01
0.05
0.02
0.01
0.01
0.01
0.03
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.03
0.02
0.03
0.02
0.01
0.01
0.02
0.03
0.02
0.04
0.04
0.01
0.01
0.01
0.01
0.03
0.01
0.02
0.03
0.02
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.03
0.02

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

430

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Salivary glands (C07-08) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

47
201
371
31
332
150
16
132
196
11
183
26
7507
506
6735
313
35
269
53
3
13
37
669
58
589
351
26
313
131
128
475
31
430
28
884
63
761
2345
106
158
130
1925
138
23
112
615
44
558
63
20
178
126
72
167

0.9
0.9
1.1
0.9
1.1
1.1
0.6
1.2
1.0
0.8
1.0
0.7
1.0
0.8
1.0
1.0
1.0
1.1
0.9
0.6
0.7
1.0
1.1
0.9
1.1
0.9
0.8
0.9
1.1
1.0
1.0
1.0
1.0
0.7
1.0
0.9
1.1
1.0
0.6
0.8
0.5
1.1
1.1
0.8
1.1
1.0
0.8
1.0
1.1
0.9
1.0
1.0
0.9
0.9

0.14
0.07
0.06
0.16
0.06
0.09
0.15
0.11
0.08
0.25
0.08
0.15
0.01
0.04
0.01
0.06
0.18
0.07
0.13
0.36
0.19
0.17
0.04
0.11
0.05
0.05
0.16
0.05
0.10
0.10
0.05
0.18
0.05
0.15
0.04
0.11
0.04
0.02
0.06
0.06
0.05
0.03
0.09
0.17
0.11
0.04
0.12
0.05
0.15
0.21
0.07
0.09
0.12
0.07

0.10
0.10
0.11
0.09
0.11
0.11
0.05
0.12
0.11
0.09
0.11
0.07
0.11
0.08
0.11
0.11
0.08
0.12
0.10
0.05
0.06
0.13
0.12
0.09
0.12
0.10
0.09
0.09
0.12
0.11
0.12
0.10
0.11
0.08
0.11
0.09
0.11
0.11
0.07
0.08
0.05
0.12
0.12
0.10
0.12
0.11
0.09
0.12
0.13
0.08
0.10
0.11
0.10
0.09

0.02
0.01
0.01
0.02
0.01
0.01
0.02
0.01
0.01
0.03
0.01
0.02
0.00
0.00
0.00
0.01
0.02
0.01
0.02
0.03
0.02
0.03
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.01
0.02
0.00
0.01
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.03
0.01
0.01
0.02
0.01
0.02
0.03
0.01
0.01
0.02
0.01

34
154
271
29
237
126
21
101
125
5
117
22
5454
512
4650
253
28
203
33
3
11
19
523
56
443
288
27
247
78
90
348
27
310
33
707
57
576
1724
136
149
127
1270
86
14
71
436
68
360
54
11
140
95
37
141

0.7
0.6
0.7
0.6
0.8
0.9
0.6
0.9
0.5
0.3
0.6
0.5
0.6
0.6
0.6
0.8
0.7
0.7
0.6
0.6
0.5
0.6
0.7
0.6
0.7
0.6
0.6
0.6
0.5
0.7
0.7
0.6
0.7
0.6
0.7
0.6
0.8
0.7
0.7
0.6
0.4
0.7
0.6
0.4
0.6
0.6
1.0
0.6
0.8
0.4
0.7
0.7
0.4
0.7

0.13
0.06
0.05
0.12
0.05
0.08
0.14
0.10
0.05
0.13
0.06
0.14
0.01
0.03
0.01
0.05
0.14
0.06
0.10
0.38
0.16
0.16
0.03
0.08
0.04
0.04
0.11
0.04
0.07
0.09
0.04
0.12
0.04
0.12
0.03
0.08
0.04
0.02
0.06
0.05
0.04
0.02
0.07
0.10
0.08
0.03
0.12
0.03
0.12
0.14
0.06
0.07
0.08
0.06

0.07
0.06
0.07
0.06
0.08
0.09
0.06
0.10
0.06
0.04
0.06
0.05
0.07
0.06
0.07
0.08
0.08
0.08
0.06
0.06
0.06
0.06
0.07
0.06
0.08
0.07
0.05
0.07
0.06
0.08
0.07
0.07
0.07
0.05
0.08
0.07
0.08
0.07
0.07
0.07
0.04
0.07
0.07
0.04
0.07
0.07
0.10
0.06
0.08
0.05
0.07
0.07
0.04
0.08

0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.02
0.01
0.01
0.00
0.00
0.00
0.01
0.02
0.01
0.01
0.04
0.02
0.02
0.00
0.01
0.00
0.00
0.01
0.01
0.01
0.01
0.00
0.02
0.00
0.01
0.00
0.01
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.01
0.02
0.01
0.01
0.01
0.01

3
38
146
2
5
143
21
10
48
180
5
129
18
29
8
158
138
12
22
12
35
49
44
120
25

0.4
0.6
0.7
0.2
0.2
0.6
0.6
0.4
0.5
0.8
0.6
0.5
0.4
0.4
0.3
0.9
0.9
0.6
0.7
0.3
0.9
0.5
0.7
0.3
0.4

0.26
0.11
0.06
0.11
0.09
0.06
0.13
0.12
0.08
0.06
0.26
0.05
0.10
0.08
0.11
0.08
0.08
0.18
0.16
0.09
0.16
0.07
0.11
0.03
0.08

0.01
0.08
0.07
0.02
0.02
0.06
0.07
0.03
0.06
0.10
0.09
0.06
0.06
0.04
0.03
0.10
0.10
0.05
0.06
0.04
0.10
0.05
0.09
0.04
0.04

0.01
0.02
0.01
0.02
0.01
0.01
0.02
0.02
0.01
0.01
0.04
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.02
0.01
0.01
0.00
0.01

2
32
116
5
2
130
10
12
28
107
5
85
11
25
9
119
107
8
15
8
13
34
35
69
19

0.2
0.5
0.5
0.3
0.1
0.6
0.3
0.6
0.3
0.5
0.5
0.4
0.3
0.4
0.3
0.6
0.5
0.4
0.4
0.2
0.3
0.3
0.5
0.2
0.3

0.13
0.09
0.05
0.14
0.07
0.06
0.09
0.16
0.06
0.05
0.25
0.04
0.08
0.07
0.09
0.06
0.06
0.15
0.11
0.07
0.08
0.06
0.10
0.02
0.08

0.01
0.05
0.05
0.05
0.00
0.06
0.02
0.06
0.03
0.06
0.07
0.04
0.03
0.04
0.03
0.05
0.05
0.03
0.04
0.02
0.04
0.04
0.05
0.01
0.03

0.01
0.01 *
0.01
0.03 *
0.00
0.01 *
0.01 *
0.02 *
0.01
0.01 *
0.04
0.01
0.01 *
0.01 *
0.01 *
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

373

431

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Salivary glands (C07-08) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

374

Female
ASR(W)
CUM 0-74

553
51
36
10
18
29
5
156
10
6
12
21
15
8
35
70
60
52
4
4
26
10
5
21
39

0.6
0.5
0.6
0.3
0.7
0.6
0.7
0.7
0.7
0.5
0.5
1.0
0.3
0.4
1.0
0.8
0.7
0.8
0.6
0.4
0.7
0.4
0.2
0.7
0.5

0.03
0.08
0.10
0.11
0.18
0.12
0.32
0.06
0.22
0.22
0.27
0.23
0.09
0.16
0.18
0.11
0.09
0.11
0.31
0.18
0.13
0.14
0.08
0.16
0.08

0.07
0.06
0.05
0.04
0.07
0.06
0.08
0.08
0.08
0.05
0.09
0.12
0.03
0.04
0.09
0.10
0.08
0.09
0.05
0.04
0.08
0.04
0.01
0.07
0.05

0.00
0.01
0.01
0.01
0.02
0.02
0.05
0.01
0.03
0.03
0.06
0.03
0.01
0.02
0.02
0.02
0.01
0.02
0.03
0.02
0.02
0.02
0.01
0.02
0.01

427
31
27
17
18
26
3
136
11
9
9
19
21
7
25
64
48
44
2
2
22
10
10
15
27

0.4
0.3
0.4
0.5
0.5
0.4
0.4
0.5
0.6
0.6
0.7
0.7
0.6
0.3
1.1
0.7
0.5
0.6
0.2
0.2
0.5
0.4
0.3
0.5
0.3

0.02
0.05
0.08
0.12
0.11
0.08
0.23
0.04
0.19
0.20
0.37
0.17
0.12
0.13
0.24
0.10
0.08
0.09
0.17
0.16
0.11
0.13
0.10
0.13
0.06

0.04
0.03
0.03
0.04
0.05
0.03
0.03
0.05
0.09
0.07
0.04
0.07
0.07
0.03
0.12
0.08
0.06
0.07
0.02
0.03
0.04
0.05
0.03
0.05
0.04

0.00
0.01
0.01
0.01
0.02
0.01
0.02
0.01
0.03
0.04
0.03
0.02
0.02
0.01 *
0.03 *
0.01 *
0.01
0.01
0.01
0.02
0.01 *
0.02 *
0.01
0.02 *
0.01 *

216
17
5
224
34
157
201
253
301
141
35
125
27
8
12
20
30
23
30
10
13
11
12
58
112
49
47
62
42
32
9
87
5
15
14
38
29
4
46
17
14
72
10
13
11
44
31
12
7
8
36
39
14
67

0.7
0.8
0.5
0.8
0.5
0.9
0.6
1.6
0.8
0.7
0.8
0.7
0.8
0.4
0.7
0.7
0.8
0.6
0.8
0.6
0.7
0.7
0.5
0.6
0.6
0.8
0.7
0.7
0.4
0.7
0.9
0.7
0.3
0.6
0.8
0.8
1.0
0.4
0.9
0.5
0.9
0.8
0.5
0.9
0.6
1.0
0.9
0.6
0.5
1.0
0.9
1.0
0.8
1.0

0.05
0.19
0.20
0.05
0.09
0.07
0.05
0.10
0.05
0.06
0.14
0.06
0.16
0.14
0.20
0.17
0.16
0.12
0.15
0.19
0.20
0.21
0.14
0.08
0.06
0.12
0.11
0.09
0.07
0.13
0.32
0.08
0.16
0.16
0.23
0.14
0.22
0.22
0.15
0.14
0.25
0.10
0.16
0.26
0.20
0.18
0.18
0.19
0.21
0.34
0.16
0.19
0.25
0.12

0.08
0.09
0.05
0.09
0.05
0.10
0.08
0.19
0.09
0.08
0.09
0.07
0.08
0.02
0.09
0.08
0.11
0.05
0.07
0.06
0.07
0.07
0.06
0.06
0.06
0.08
0.09
0.07
0.04
0.07
0.09
0.07
0.02
0.06
0.09
0.09
0.10
0.08
0.09
0.04
0.10
0.07
0.06
0.07
0.06
0.10
0.11
0.07
0.07
0.13
0.10
0.12
0.07
0.09

0.01
0.03
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.02
0.01
0.03
0.02
0.02
0.02
0.02
0.02
0.02
0.03
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.04
0.01
0.02
0.02
0.03
0.02
0.02
0.04
0.02
0.01
0.03
0.01
0.02
0.03
0.02
0.02
0.02
0.03
0.03
0.06
0.02
0.02
0.02
0.01

163
13
10
184
24
92
127
115
266
126
44
127
25
10
6
18
24
15
28
6
7
4
8
49
87
43
34
53
47
17
8
63
6
14
10
33
29
3
32
19
10
53
6
6
10
33
16
13
4
6
32
25
20
41

0.4
0.4
0.6
0.4
0.3
0.4
0.4
0.6
0.6
0.5
0.7
0.5
0.6
0.4
0.4
0.6
0.7
0.4
0.5
0.2
0.2
0.3
0.3
0.4
0.3
0.5
0.4
0.4
0.4
0.3
1.0
0.4
0.6
0.4
0.5
0.5
0.8
0.2
0.5
0.6
0.6
0.5
0.3
0.3
0.3
0.6
0.5
0.5
0.4
1.1
0.7
0.6
0.9
0.5

0.04
0.14
0.21
0.04
0.07
0.05
0.03
0.06
0.04
0.06
0.11
0.05
0.13
0.13
0.17
0.17
0.15
0.10
0.12
0.11
0.10
0.15
0.15
0.06
0.05
0.09
0.08
0.07
0.07
0.08
0.37
0.06
0.30
0.13
0.18
0.10
0.26
0.19
0.11
0.17
0.20
0.10
0.13
0.15
0.12
0.13
0.14
0.15
0.19
0.57
0.17
0.15
0.25
0.09

0.04
0.04
0.09
0.04
0.03
0.05
0.04
0.06
0.06
0.05
0.07
0.05
0.06
0.04
0.03
0.07
0.06
0.03
0.05
0.03
0.02
0.04
0.03
0.04
0.03
0.05
0.04
0.04
0.04
0.03
0.13
0.04
0.07
0.05
0.05
0.05
0.07
0.01
0.06
0.07
0.05
0.05
0.03
0.05
0.05
0.07
0.05
0.05
0.04
0.10
0.08
0.06
0.10
0.05

0.00
0.01
0.04
0.00 *
0.01 *
0.01
0.00 *
0.01
0.00
0.01
0.01
0.01
0.02
0.02
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.05
0.01
0.03
0.02
0.02
0.01
0.02
0.01
0.01
0.02
0.02
0.01
0.02
0.03
0.02
0.01
0.01
0.02
0.02
0.05
0.02
0.02
0.03
0.01

*Important. See note on population page.

432

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Salivary glands (C07-08) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

53
100
8
117
36
40
45
58
83
109
121
147
26
7
33
43
25
10
13
18
27
15
10
16
246
8
9
5
9
15
7
21
344
21
20
62
55
99
161
66
192
325
123
110
34
102

0.7
1.0
0.6
0.7
1.5
1.0
0.8
0.6
0.8
0.8
0.7
0.9
0.4
0.6
0.7
0.7
0.5
1.1
0.5
0.6
0.6
0.6
0.5
0.4
0.7
0.6
1.2
0.8
0.4
1.2
0.7
0.9
0.6
0.6
0.6
0.6
0.6
0.6
0.6
0.7
0.6
0.6
0.6
0.5
0.6
0.5

0.10
0.10
0.22
0.07
0.25
0.15
0.11
0.08
0.09
0.08
0.07
0.08
0.08
0.23
0.14
0.11
0.11
0.49
0.15
0.16
0.13
0.18
0.16
0.12
0.05
0.23
0.43
0.38
0.15
0.33
0.27
0.20
0.03
0.13
0.14
0.08
0.09
0.07
0.05
0.08
0.05
0.04
0.06
0.05
0.11
0.05

0.08
0.10
0.06
0.09
0.17
0.11
0.08
0.06
0.09
0.10
0.09
0.11
0.05
0.06
0.08
0.06
0.06
0.07
0.05
0.05
0.07
0.08
0.05
0.05
0.08
0.08
0.12
0.12
0.06
0.13
0.10
0.12
0.07
0.07
0.07
0.05
0.07
0.06
0.07
0.07
0.06
0.07
0.07
0.06
0.08
0.07

0.01
0.01
0.03
0.01
0.03
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.03
0.02
0.01
0.01
0.04
0.02
0.02
0.02
0.02
0.02
0.02
0.01
0.03
0.05
0.06
0.02
0.04
0.04
0.03
0.00
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.02
0.01

45
91
8
107
22
19
40
41
49
100
94
91
36
7
25
31
16
11
9
9
21
12
11
16
229
16
3
1
9
3
6
8
279
16
20
58
41
88
120
49
160
248
110
89
30
103

0.4
0.6
0.4
0.6
0.6
0.4
0.5
0.3
0.4
0.4
0.5
0.4
0.4
0.5
0.5
0.4
0.3
1.1
0.4
0.3
0.5
0.5
0.4
0.3
0.6
0.9
0.5
0.1
0.5
0.3
0.5
0.3
0.5
0.4
0.6
0.5
0.4
0.5
0.5
0.5
0.6
0.4
0.6
0.4
0.5
0.4

0.07
0.07
0.16
0.07
0.14
0.09
0.08
0.05
0.06
0.05
0.06
0.05
0.08
0.21
0.14
0.08
0.08
0.41
0.15
0.10
0.11
0.16
0.16
0.09
0.05
0.25
0.31
0.10
0.16
0.18
0.24
0.13
0.03
0.11
0.17
0.08
0.07
0.06
0.05
0.07
0.05
0.03
0.06
0.05
0.09
0.05

0.04
0.06
0.04
0.06
0.07
0.05
0.06
0.03
0.04
0.05
0.06
0.05
0.05
0.07
0.06
0.04
0.03
0.12
0.04
0.02
0.05
0.06
0.04
0.03
0.06
0.08
0.04
0.03
0.05
0.03
0.05
0.03
0.05
0.05
0.05
0.05
0.04
0.05
0.05
0.05
0.06
0.05
0.06
0.04
0.06
0.04

0.01
0.01
0.02
0.01
0.02 *
0.01
0.01
0.01 *
0.01
0.01
0.01
0.01
0.01
0.03
0.01
0.01
0.01
0.04
0.02
0.01
0.01
0.02
0.02
0.01
0.01
0.02
0.02
0.03
0.02
0.02
0.03
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01

264
6
153
57
9
118
57
10
4
104
37
1
8
5
8
10

1.1
1.7
1.2
1.0
0.5
0.7
0.9
1.0
1.1
0.8
0.9
0.4
1.3
0.8
0.5
0.9

0.07
0.74
0.10
0.14
0.19
0.07
0.12
0.33
0.58
0.09
0.15
0.37
0.48
0.38
0.19
0.29

0.12
0.11
0.13
0.12
0.06
0.07
0.09
0.09
0.07
0.09
0.10
0.03
0.14
0.08
0.07
0.09

0.01
0.07
0.01
0.02
0.02
0.01
0.02
0.04
0.04
0.01
0.02
0.03
0.06
0.04
0.03
0.04

152
1
79
47
14
100
40
9
4
75
37
1
6
7
11
6

0.6
0.2
0.6
0.6
0.8
0.6
0.6
1.1
0.9
0.6
0.9
0.4
0.8
1.3
1.2
0.6

0.05
0.21
0.07
0.10
0.23
0.06
0.11
0.36
0.45
0.07
0.15
0.36
0.35
0.48
0.44
0.31

0.06
0.01
0.05
0.06
0.09
0.06
0.06
0.13
0.12
0.06
0.08
0.05
0.09
0.14
0.10
0.04

0.01
0.01
0.01
0.01
0.03
0.01
0.01
0.05
0.06
0.01
0.02
0.05
0.04
0.06
0.04
0.02

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

375

433

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Tonsil (C09)
Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

376

Female
ASR(W)
CUM 0-74

7
8
4
5
3

0.4
0.2
0.4
0.4
0.1

0.14
0.06
0.21
0.20
0.09

0
8
1
4
1

0.2
0.1
0.1
0.0

0.06
0.11
0.09
0.02

12
24
10
25
339
0
24
43
8
27
3

1.6
1.0
1.6
1.7
1.6
0.7
0.6
0.3
2.6
0.4

0.47
0.23
0.51
0.35
0.09
0.14
0.10
0.11
0.50
0.23

0.18
0.12
0.23
0.17
0.20
0.07
0.08
0.03
0.35
0.07

0.06
0.03
0.09
0.04
0.01
0.02
0.01
0.02
0.07
0.04

2
4
3
3
78
0
12
9
0
3
1

0.3
0.2
0.3
0.1
0.3
0.3
0.1
0.2
0.1

0.19
0.08
0.20
0.06
0.03
0.08
0.05
0.13
0.08

0.03
0.01
0.03
0.01
0.03
0.04
0.02
0.03
-

0.02
0.01
0.02
0.00
0.00
0.01
0.01
0.02
- *

927
101
179
47
50
18
1
64
434
5
28
247
47
199
29
232
1663
72
118
170
1279
325
25
10
8
3
28
244
387
57
8
1
5
5
53
251
172
175
21
152
44
35
7
1305
118
1174
447
95
348
129
34
91
55
653
116
524
356
142
286
253
65
187
18
32

1.2
1.1
1.3
1.3
2.0
1.0
0.8
2.1
1.2
1.2
0.9
1.8
1.8
1.8
1.5
1.5
1.8
0.6
2.1
1.0
2.2
1.7
1.9
0.6
0.9
0.7
1.3
2.1
1.6
2.4
0.7
0.2
1.3
1.0
0.8
2.1
1.3
1.6
3.0
1.5
2.7
3.7
1.1
2.5
2.3
2.5
2.0
2.1
2.0
1.8
1.8
1.8
1.4
1.8
2.7
1.7
2.0
1.6
2.3
2.0
2.0
2.0
2.0
1.8

0.04
0.11
0.10
0.19
0.29
0.23
0.80
0.26
0.06
0.53
0.18
0.12
0.27
0.13
0.30
0.10
0.04
0.08
0.20
0.08
0.06
0.10
0.39
0.19
0.33
0.43
0.26
0.14
0.08
0.32
0.25
0.17
0.58
0.44
0.12
0.14
0.10
0.12
0.66
0.13
0.42
0.63
0.43
0.07
0.21
0.08
0.09
0.22
0.11
0.16
0.34
0.19
0.19
0.07
0.26
0.08
0.11
0.13
0.14
0.13
0.26
0.15
0.48
0.32

0.15
0.12
0.15
0.16
0.26
0.10
0.07
0.25
0.15
0.14
0.11
0.21
0.21
0.21
0.19
0.17
0.21
0.08
0.27
0.12
0.25
0.21
0.20
0.05
0.12
0.14
0.16
0.26
0.20
0.34
0.09
0.02
0.17
0.15
0.11
0.25
0.15
0.18
0.37
0.17
0.31
0.44
0.09
0.29
0.28
0.29
0.23
0.25
0.23
0.21
0.22
0.21
0.17
0.22
0.34
0.20
0.23
0.19
0.28
0.23
0.25
0.23
0.24
0.20

0.01
0.01
0.01
0.03
0.04
0.03
0.07
0.03
0.01
0.07
0.02
0.01
0.04
0.02
0.04
0.01
0.01
0.01
0.03
0.01
0.01
0.01
0.05
0.02
0.05
0.10
0.03
0.02
0.01
0.05
0.04
0.02
0.08
0.08
0.02
0.02
0.01
0.02
0.09
0.02
0.05
0.08
0.04
0.01
0.03
0.01
0.01
0.03
0.01
0.02
0.05
0.02
0.03
0.01
0.04
0.01
0.01
0.02
0.02
0.02
0.03
0.02
0.06
0.04

335
30
54
24
14
9
0
17
172
1
14
89
17
71
4
50
462
23
37
33
365
80
3
3
0
0
6
65
113
25
1
1
2
1
14
66
50
60
6
54
8
5
3
422
44
373
143
37
105
35
16
19
20
177
27
148
88
41
69
77
18
59
6
14

0.4
0.3
0.3
0.6
0.4
0.5
0.5
0.4
0.2
0.4
0.5
0.5
0.6
0.3
0.3
0.4
0.2
0.5
0.2
0.5
0.3
0.2
0.2
0.2
0.5
0.4
0.8
0.1
0.1
0.5
0.2
0.2
0.5
0.4
0.5
0.7
0.5
0.4
0.4
0.6
0.6
0.7
0.6
0.5
0.6
0.5
0.4
0.6
0.4
0.4
0.4
0.5
0.4
0.4
0.4
0.5
0.5
0.5
0.6
0.5
0.7

0.02
0.06
0.05
0.12
0.12
0.17
0.13
0.03
0.22
0.11
0.06
0.12
0.07
0.15
0.04
0.02
0.04
0.09
0.03
0.03
0.04
0.11
0.10
0.09
0.06
0.04
0.16
0.12
0.10
0.36
0.15
0.05
0.07
0.06
0.06
0.28
0.07
0.16
0.18
0.35
0.03
0.11
0.04
0.05
0.10
0.05
0.07
0.16
0.09
0.11
0.03
0.09
0.04
0.05
0.06
0.06
0.06
0.11
0.08
0.20
0.20

0.05
0.05
0.04
0.08
0.05
0.06
0.07
0.05
0.02
0.04
0.07
0.06
0.07
0.03
0.04
0.05
0.02
0.07
0.02
0.07
0.04
0.04
0.02
0.02
0.06
0.05
0.09
0.01
0.01
0.05
0.01
0.02
0.07
0.05
0.06
0.10
0.06
0.06
0.05
0.09
0.08
0.09
0.08
0.07
0.07
0.06
0.05
0.07
0.04
0.05
0.05
0.05
0.05
0.05
0.04
0.05
0.07
0.06
0.07
0.07
0.08

0.00
0.01
0.01
0.02
0.02
0.02
0.02
0.00
0.02
0.01
0.01
0.02
0.01
0.02
0.01
0.00
0.00
0.01
0.00
0.00
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.04
0.02
0.01
0.01
0.01
0.01
0.05
0.01
0.02
0.02
0.05
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.02
0.01
0.03
0.02

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

434

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Tonsil (C09) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

104
284
518
90
421
243
79
163
334
29
301
64
11940
1348
10283
376
72
295
79
3
16
59
791
108
669
566
73
480
215
194
687
88
582
39
1337
169
1099
3719
120
430
236
2895
257
67
190
969
101
849
48
36
338
255
120
270

2.5
1.5
1.7
2.7
1.6
2.0
3.2
1.7
2.0
2.2
1.9
2.1
1.8
2.2
1.8
1.5
2.5
1.4
1.5
0.9
0.9
1.9
1.4
1.6
1.4
1.6
2.3
1.5
2.0
1.8
1.7
3.1
1.6
1.2
1.7
2.5
1.7
1.7
0.7
2.4
1.1
1.9
2.1
2.4
2.1
1.7
2.0
1.7
0.9
1.7
1.9
2.0
1.9
1.6

0.25
0.09
0.08
0.29
0.08
0.13
0.37
0.14
0.11
0.41
0.11
0.27
0.02
0.06
0.02
0.08
0.30
0.08
0.17
0.52
0.23
0.25
0.05
0.15
0.06
0.07
0.28
0.07
0.14
0.13
0.07
0.33
0.07
0.20
0.05
0.19
0.05
0.03
0.06
0.12
0.07
0.04
0.13
0.30
0.15
0.06
0.21
0.06
0.14
0.29
0.10
0.13
0.18
0.10

0.29
0.18
0.20
0.34
0.18
0.23
0.40
0.20
0.22
0.29
0.22
0.23
0.21
0.27
0.21
0.17
0.30
0.16
0.18
0.10
0.12
0.22
0.16
0.20
0.17
0.18
0.28
0.17
0.23
0.20
0.20
0.36
0.18
0.14
0.20
0.30
0.20
0.20
0.08
0.29
0.13
0.22
0.24
0.29
0.23
0.20
0.25
0.20
0.10
0.20
0.22
0.24
0.20
0.19

0.03
0.01
0.01
0.04
0.01
0.02
0.05
0.02
0.01
0.06
0.01
0.03
0.00
0.01
0.00
0.01
0.04
0.01
0.02
0.06
0.03
0.03
0.01
0.02
0.01
0.01
0.04
0.01
0.02
0.02
0.01
0.04
0.01
0.03
0.01
0.03
0.01
0.00
0.01
0.02
0.01
0.00
0.02
0.04
0.02
0.01
0.03
0.01
0.02
0.04
0.01
0.02
0.02
0.01

28
118
160
19
139
74
16
58
97
2
94
19
3515
377
3061
117
17
100
20
0
2
16
256
39
214
186
20
161
49
66
202
32
167
10
357
42
297
1043
34
114
49
838
65
15
50
245
19
225
8
13
91
55
38
85

0.6
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.1
0.5
0.6
0.4
0.5
0.4
0.4
0.5
0.4
0.3
0.1
0.5
0.4
0.4
0.4
0.4
0.5
0.4
0.4
0.5
0.4
0.8
0.4
0.3
0.4
0.5
0.4
0.4
0.2
0.5
0.2
0.5
0.5
0.4
0.5
0.4
0.3
0.4
0.1
0.5
0.4
0.4
0.5
0.5

0.11
0.05
0.04
0.11
0.04
0.06
0.13
0.08
0.05
0.08
0.05
0.13
0.01
0.03
0.01
0.03
0.11
0.04
0.08
0.08
0.13
0.02
0.07
0.03
0.03
0.11
0.04
0.06
0.07
0.03
0.15
0.03
0.09
0.02
0.07
0.02
0.01
0.03
0.05
0.03
0.02
0.06
0.11
0.07
0.02
0.06
0.03
0.05
0.15
0.05
0.05
0.08
0.05

0.07
0.07
0.06
0.05
0.06
0.06
0.06
0.07
0.06
0.01
0.06
0.06
0.05
0.06
0.06
0.04
0.05
0.04
0.03
0.01
0.05
0.05
0.05
0.05
0.05
0.06
0.05
0.04
0.06
0.05
0.09
0.05
0.03
0.05
0.06
0.05
0.05
0.02
0.06
0.02
0.06
0.06
0.05
0.06
0.04
0.03
0.05
0.02
0.05
0.05
0.04
0.06
0.06

0.02
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.01
0.00
0.02
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.01
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.01
0.02
0.01
0.01
0.01
0.01

0
15
52
1
5
29
16
3
124
402
10
251
71
47
24
32
30
1
2
2
15
17
18
79
4

0.3
0.2
0.2
0.2
0.1
0.5
0.1
1.4
1.9
1.2
1.1
1.9
0.8
0.9
0.2
0.2
0.1
0.0
0.1
0.4
0.2
0.3
0.2
0.0

0.08
0.03
0.21
0.09
0.03
0.13
0.08
0.12
0.10
0.38
0.07
0.23
0.12
0.18
0.04
0.04
0.08
0.03
0.05
0.09
0.04
0.08
0.03
0.02

0.02
0.03
0.03
0.01
0.07
0.02
0.17
0.23
0.16
0.14
0.23
0.09
0.09
0.02
0.02
0.01
0.00
0.01
0.05
0.02
0.03
0.03
0.01

0.01
0.00
0.02
0.00
0.02
0.01
0.02
0.01
0.06
0.01
0.03
0.02
0.02
0.00
0.00
0.01
0.00
0.01
0.02
0.01
0.01
0.00
0.00

1
3
13
1
1
20
2
1
21
69
0
54
10
23
2
10
10
0
2
1
5
1
3
20
1

0.2
0.0
0.1
0.1
0.0
0.1
0.1
0.0
0.2
0.4
0.3
0.2
0.4
0.1
0.1
0.1
0.0
0.0
0.1
0.0
0.0
0.1
0.0

0.18
0.03
0.02
0.09
0.04
0.02
0.04
0.04
0.05
0.05
0.04
0.08
0.08
0.04
0.02
0.02
0.03
0.01
0.05
0.01
0.01
0.01
0.00

0.02
0.00
0.01
0.01
0.01
0.01
0.01
0.03
0.05
0.03
0.03
0.04
0.00
0.01
0.01
0.00
0.02
0.00
0.00
0.00
-

0.02
0.00 *
0.00
0.01 *
0.00 *
0.00 *
0.01 *
0.01
0.01 *
0.01
0.01 *
0.01 *
0.00 *
0.00
0.00
0.00
0.01
0.00
0.00
0.00
-

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

377

435

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Tonsil (C09) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

378

Female
ASR(W)
CUM 0-74

496
58
29
15
10
25
2
169
3
1
0
4
16
2
26
45
54
42
7
5
49
12
34
5
28

0.6
0.6
0.5
0.7
0.4
0.5
0.3
0.8
0.2
0.1
0.2
0.4
0.1
1.0
0.6
0.7
0.7
0.9
0.6
1.3
0.5
1.3
0.2
0.3

0.03
0.09
0.10
0.19
0.13
0.10
0.23
0.07
0.14
0.11
0.12
0.11
0.08
0.21
0.09
0.09
0.11
0.36
0.27
0.19
0.16
0.22
0.08
0.06

0.07
0.08
0.08
0.09
0.05
0.05
0.06
0.10
0.03
0.01
0.02
0.05
0.01
0.15
0.06
0.09
0.09
0.13
0.05
0.15
0.05
0.12
0.01
0.04

0.00
0.01
0.02
0.03
0.02
0.01
0.05
0.01
0.02
0.01
0.01
0.02
0.01
0.04
0.01
0.01
0.02
0.05
0.03
0.02
0.02
0.03
0.01
0.01

90
7
4
1
3
8
1
35
0
0
1
5
10
0
9
30
16
14
1
1
15
4
6
1
5

0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.2
0.3
0.5
0.4
0.2
0.2
0.2
0.1
0.3
0.2
0.2
0.0
0.1

0.01
0.02
0.03
0.03
0.05
0.04
0.11
0.02
0.03
0.08
0.08
0.18
0.07
0.04
0.05
0.20
0.08
0.09
0.08
0.06
0.04
0.03

0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.00
0.02
0.03
0.06
0.04
0.02
0.02
0.03
0.01
0.03
0.03
0.02
0.00
0.01

0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.00
0.00
0.01
0.01
- *
0.02 *
0.01 *
0.01
0.01
0.03
0.01
0.01 *
0.01 *
0.01
0.00 *
0.00 *

467
31
16
331
99
288
406
304
760
382
25
139
93
84
60
64
100
121
195
53
86
27
65
194
257
91
121
196
66
88
4
73
10
44
31
36
39
2
44
14
12
156
26
3
13
53
14
25
5
7
62
25
31
113

1.7
1.5
1.4
1.2
1.6
1.7
1.4
2.0
2.2
2.0
0.6
0.8
2.8
4.1
3.7
2.6
3.1
3.4
5.3
3.0
4.9
1.9
2.8
2.0
1.5
1.4
1.8
2.3
0.7
2.2
0.4
0.7
1.2
1.9
2.0
0.7
1.7
0.3
0.9
0.5
0.8
1.8
1.6
0.3
0.8
1.3
0.5
1.5
0.4
1.1
1.4
0.7
1.6
1.8

0.08
0.27
0.36
0.06
0.16
0.10
0.07
0.11
0.08
0.10
0.12
0.06
0.29
0.45
0.48
0.33
0.33
0.31
0.39
0.43
0.54
0.39
0.37
0.15
0.10
0.15
0.17
0.17
0.09
0.24
0.23
0.08
0.40
0.30
0.38
0.13
0.28
0.23
0.15
0.15
0.24
0.15
0.33
0.16
0.21
0.19
0.13
0.30
0.19
0.42
0.19
0.15
0.30
0.17

0.20
0.18
0.13
0.14
0.19
0.19
0.17
0.24
0.25
0.23
0.06
0.09
0.36
0.50
0.44
0.35
0.35
0.39
0.66
0.31
0.60
0.17
0.33
0.24
0.17
0.16
0.22
0.26
0.09
0.26
0.05
0.08
0.16
0.23
0.24
0.09
0.20
0.04
0.10
0.07
0.09
0.22
0.18
0.04
0.10
0.15
0.06
0.18
0.05
0.14
0.18
0.09
0.20
0.22

0.01
0.03
0.04
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.04
0.06
0.06
0.05
0.04
0.04
0.05
0.05
0.07
0.04
0.05
0.02
0.01
0.02
0.02
0.02
0.01
0.03
0.03
0.01
0.05
0.04
0.05
0.02
0.03
0.02
0.02
0.02
0.03
0.02
0.04
0.02
0.03
0.02
0.02
0.04
0.02
0.05
0.03
0.02
0.04
0.02

151
16
10
43
33
80
53
36
160
142
7
46
19
14
10
17
26
21
23
11
19
8
10
46
79
36
21
53
23
18
2
28
4
9
8
15
11
1
22
4
0
28
5
2
7
12
5
1
4
3
14
6
1
20

0.5
0.7
0.7
0.1
0.5
0.4
0.1
0.2
0.4
0.7
0.1
0.2
0.5
0.5
0.6
0.6
0.9
0.5
0.5
0.6
1.0
0.7
0.5
0.4
0.4
0.5
0.3
0.5
0.2
0.4
0.2
0.3
0.5
0.4
0.4
0.2
0.4
0.0
0.4
0.1
0.3
0.2
0.2
0.4
0.2
0.2
0.1
0.3
0.4
0.3
0.2
0.1
0.2

0.04
0.18
0.25
0.02
0.09
0.05
0.02
0.03
0.03
0.06
0.03
0.03
0.13
0.15
0.19
0.16
0.17
0.12
0.11
0.20
0.23
0.24
0.17
0.06
0.04
0.08
0.07
0.07
0.05
0.11
0.17
0.05
0.28
0.13
0.17
0.07
0.14
0.03
0.09
0.07
0.06
0.10
0.15
0.15
0.07
0.07
0.07
0.16
0.24
0.09
0.07
0.06
0.06

0.05
0.09
0.06
0.01
0.05
0.05
0.02
0.02
0.04
0.08
0.01
0.02
0.06
0.06
0.07
0.06
0.09
0.06
0.05
0.08
0.09
0.07
0.05
0.04
0.05
0.06
0.04
0.06
0.02
0.05
0.02
0.03
0.05
0.04
0.06
0.03
0.05
0.05
0.02
0.03
0.02
0.02
0.05
0.03
0.01
0.01
0.03
0.04
0.04
0.02
0.01
0.03

0.00
0.02
0.02
0.00 *
0.01 *
0.01
0.00 *
0.00
0.00
0.01
0.00
0.00
0.02
0.02
0.02
0.02
0.02
0.01
0.01
0.03
0.02
0.03
0.02
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.02
0.01
0.03
0.02
0.02
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.02
0.03
0.01
0.01
0.01
0.01

*Important. See note on population page.

436

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Tonsil (C09) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

76
69
8
169
18
17
22
130
128
107
120
507
166
5
47
100
85
1
32
22
44
15
18
21
365
50
9
15
21
19
23
54
504
31
44
74
101
198
244
77
221
434
123
185
18
214

1.0
0.7
0.6
1.1
0.8
0.4
0.3
1.4
1.3
0.8
0.7
3.3
2.4
0.6
1.2
1.7
2.0
0.2
1.6
0.8
1.3
0.8
1.0
0.6
1.1
3.4
1.1
2.8
1.3
1.6
2.6
2.6
0.9
0.8
1.3
0.8
1.2
1.4
1.1
0.8
0.9
1.0
0.7
1.0
0.3
1.2

0.12
0.08
0.23
0.09
0.19
0.10
0.08
0.12
0.12
0.07
0.07
0.15
0.19
0.29
0.18
0.17
0.22
0.22
0.29
0.19
0.20
0.21
0.25
0.14
0.06
0.49
0.39
0.74
0.28
0.36
0.54
0.35
0.04
0.15
0.20
0.09
0.13
0.10
0.07
0.10
0.07
0.05
0.07
0.08
0.08
0.08

0.13
0.08
0.07
0.14
0.09
0.05
0.04
0.15
0.16
0.10
0.08
0.37
0.30
0.05
0.14
0.20
0.23
0.02
0.18
0.12
0.14
0.09
0.10
0.08
0.13
0.44
0.14
0.31
0.16
0.21
0.30
0.30
0.11
0.10
0.16
0.09
0.15
0.16
0.12
0.10
0.10
0.11
0.08
0.12
0.04
0.14

0.02
0.01
0.03
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.03
0.03
0.02
0.02
0.03
0.02
0.04
0.03
0.02
0.03
0.03
0.02
0.01
0.07
0.05
0.08
0.04
0.05
0.07
0.05
0.01
0.02
0.03
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01

23
20
1
58
5
10
19
11
12
31
19
40
39
0
5
9
10
0
1
3
2
0
3
5
166
17
2
6
4
5
8
22
272
9
18
35
42
49
99
30
79
144
36
74
6
83

0.2
0.1
0.1
0.3
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.2
0.5
0.1
0.2
0.2
0.0
0.1
0.0
0.1
0.1
0.5
1.0
0.2
0.7
0.2
0.4
0.9
0.8
0.5
0.2
0.5
0.3
0.5
0.3
0.4
0.3
0.3
0.3
0.2
0.4
0.1
0.4

0.04
0.03
0.09
0.05
0.09
0.07
0.05
0.03
0.03
0.02
0.02
0.03
0.08
0.05
0.05
0.07
0.04
0.08
0.04
0.08
0.07
0.04
0.25
0.16
0.32
0.11
0.18
0.32
0.19
0.03
0.08
0.12
0.06
0.08
0.05
0.04
0.06
0.03
0.02
0.03
0.04
0.05
0.05

0.02
0.01
0.01
0.04
0.02
0.02
0.03
0.01
0.01
0.01
0.01
0.02
0.06
0.01
0.01
0.02
0.01
0.01
0.00
0.01
0.01
0.06
0.12
0.03
0.11
0.03
0.04
0.10
0.09
0.05
0.03
0.06
0.04
0.05
0.04
0.05
0.03
0.03
0.03
0.02
0.04
0.01
0.05

0.01
0.00
0.01
0.01
0.01 *
0.01
0.01
0.00 *
0.00
0.00
0.00
0.00
0.01
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.01
0.00
0.03
0.02
0.05
0.02
0.02
0.04
0.02
0.00
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.00
0.00
0.00
0.01
0.01
0.01

253
28
163
78
19
189
87
8
9
112
57
1
5
13
9
24

1.2
5.5
1.4
1.5
1.2
1.2
1.5
0.9
1.9
1.0
1.4
0.3
0.6
2.5
1.0
2.0

0.08
1.11
0.11
0.18
0.27
0.09
0.16
0.32
0.64
0.09
0.19
0.33
0.30
0.70
0.36
0.42

0.14
0.60
0.17
0.18
0.13
0.15
0.17
0.10
0.21
0.11
0.16
0.03
0.08
0.32
0.11
0.21

0.01
0.13
0.02
0.02
0.03
0.01
0.02
0.04
0.08
0.01
0.02
0.03
0.05
0.10
0.04
0.05

84
6
47
21
4
62
19
3
2
28
21
2
2
0
2
13

0.4
1.6
0.4
0.3
0.3
0.4
0.3
0.3
0.4
0.2
0.4
0.6
0.2
0.0
1.1

0.04
0.72
0.06
0.08
0.13
0.05
0.08
0.19
0.32
0.04
0.10
0.43
0.18
0.03
0.34

0.04
0.24
0.05
0.04
0.03
0.05
0.04
0.04
0.06
0.02
0.05
0.08
0.02
0.16

0.01
0.13
0.01
0.01
0.02
0.01
0.01
0.03
0.04
0.01
0.01
0.06
0.02
0.05

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

379

437

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other oropharynx (C10)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

380

Female
ASR(W)
CUM 0-74

0
3
1
7
6

0.1
0.1
0.6
0.4

0.04
0.11
0.28
0.20

0
2
1
1
1

0.0
0.1
0.0
0.0

0.03
0.12
0.02
0.02

7
24
14
22
464
2
6
8
0
23
0

0.9
1.1
1.8
1.5
2.2
0.2
0.2
0.1
2.2
-

0.35
0.23
0.49
0.32
0.11
0.15
0.09
0.04
0.47
-

0.10
0.16
0.20
0.17
0.27
0.02
0.04
0.01
0.26
-

0.04
0.04
0.06
0.04
0.01
0.02
0.02
0.01
0.06
-

1
7
4
2
88
0
3
1
1
5
2

0.1
0.2
0.7
0.1
0.3
0.1
0.0
0.0
0.3
0.2

0.13
0.10
0.35
0.06
0.04
0.04
0.01
0.04
0.16
0.15

0.02
0.03
0.09
0.01
0.04
0.01
0.00
0.00
0.04
0.03

0.02
0.02
0.05
0.01
0.00
0.01
0.00
0.00
0.02
0.02 *

288
24
53
19
5
5
0
21
149
0
12
103
29
74
7
53
271
8
31
37
194
50
6
1
0
0
8
35
84
17
1
0
0
2
16
47
33
55
6
49
23
21
2
356
57
296
144
52
92
45
25
20
12
231
50
179
76
20
60
84
33
51
5
8

0.4
0.3
0.4
0.5
0.2
0.3
0.6
0.4
0.3
0.8
1.1
0.7
0.3
0.3
0.3
0.1
0.6
0.3
0.3
0.3
0.5
0.1
0.4
0.3
0.4
0.7
0.1
0.4
0.3
0.4
0.3
0.5
1.0
0.5
1.4
2.1
0.4
0.6
1.1
0.6
0.7
1.2
0.6
0.7
1.5
0.5
0.3
0.6
1.2
0.6
0.4
0.2
0.5
0.6
0.9
0.5
0.4
0.5

0.02
0.06
0.05
0.12
0.09
0.14
0.14
0.03
0.10
0.08
0.21
0.08
0.13
0.05
0.02
0.03
0.10
0.04
0.02
0.04
0.20
0.06
0.13
0.05
0.04
0.17
0.10
0.27
0.08
0.06
0.05
0.07
0.42
0.07
0.31
0.48
0.25
0.03
0.15
0.03
0.06
0.17
0.06
0.11
0.31
0.11
0.09
0.04
0.17
0.04
0.05
0.04
0.06
0.07
0.17
0.08
0.20
0.17

0.05
0.04
0.04
0.06
0.02
0.05
0.07
0.05
0.05
0.09
0.13
0.09
0.03
0.04
0.04
0.01
0.08
0.03
0.04
0.04
0.07
0.01
0.05
0.04
0.05
0.10
0.01
0.07
0.05
0.05
0.03
0.06
0.14
0.06
0.19
0.27
0.06
0.08
0.14
0.07
0.09
0.15
0.07
0.09
0.20
0.06
0.04
0.08
0.14
0.07
0.05
0.02
0.06
0.07
0.09
0.07
0.02
0.06

0.00
0.01
0.01
0.02
0.01
0.02
0.02
0.00
0.02
0.01
0.03
0.01
0.01
0.01
0.00
0.00
0.02
0.01
0.00
0.01
0.03
0.01
0.02
0.01
0.01
0.03
0.01
0.06
0.01
0.01
0.01
0.01
0.06
0.01
0.04
0.06
0.05
0.00
0.02
0.00
0.01
0.02
0.01
0.02
0.05
0.02
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.02
0.02

88
11
19
3
0
0
0
5
46
1
3
29
5
24
2
29
123
4
13
10
94
27
4
1
0
0
1
21
35
6
0
1
0
0
4
24
17
24
1
23
5
5
0
134
14
118
47
16
31
18
8
10
9
65
12
51
43
11
17
20
5
15
3
1

0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.1
0.2
0.1
0.0
0.2
0.0
0.1
0.1
0.3
0.1
0.0
0.1
0.1
0.2
0.1
0.0
0.2
0.1
0.2
0.1
0.2
0.2
0.3
0.2
0.2
0.2
0.2
0.2
0.1
0.2
0.3
0.2
0.2
0.1
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.3
0.1

0.01
0.04
0.03
0.03
0.05
0.02
0.06
0.06
0.03
0.06
0.04
0.10
0.03
0.01
0.01
0.05
0.01
0.01
0.02
0.13
0.06
0.04
0.03
0.02
0.07
0.06
0.02
0.04
0.03
0.04
0.13
0.04
0.09
0.14
0.02
0.06
0.02
0.03
0.06
0.03
0.05
0.11
0.06
0.07
0.02
0.06
0.02
0.03
0.03
0.02
0.03
0.06
0.03
0.15
0.06

0.01
0.01
0.01
0.00
0.02
0.01
0.01
0.02
0.02
0.02
0.03
0.02
0.01
0.00
0.02
0.00
0.02
0.01
0.03
0.00
0.01
0.02
0.01
0.02
0.01
0.02
0.02
0.03
0.02
0.03
0.02
0.03
0.02
0.03
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.01
0.01
0.01
0.02
0.01
0.03
0.01

0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.02
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.02
0.00
0.01
0.01
0.00
0.01
0.00
0.00
0.01
0.01
0.02
0.01
0.01
0.02
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.02
0.01

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

438

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other oropharynx (C10) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

18
100
145
26
116
43
20
23
71
13
58
11
3321
628
2638
107
21
84
7
0
1
6
347
79
264
168
25
143
46
52
208
41
161
22
269
59
200
754
19
145
56
532
121
59
61
227
31
192
7
5
59
40
26
94

0.4
0.5
0.5
0.8
0.4
0.4
0.8
0.2
0.4
1.1
0.4
0.3
0.5
1.0
0.4
0.4
0.8
0.4
0.1
0.0
0.2
0.6
1.2
0.5
0.5
0.8
0.4
0.4
0.4
0.5
1.4
0.4
0.7
0.3
0.9
0.3
0.3
0.1
0.8
0.3
0.3
1.0
2.2
0.6
0.4
0.6
0.4
0.1
0.3
0.3
0.3
0.4
0.5

0.10
0.05
0.04
0.16
0.04
0.06
0.19
0.05
0.05
0.30
0.05
0.10
0.01
0.04
0.01
0.04
0.17
0.04
0.05
0.04
0.07
0.03
0.14
0.03
0.04
0.16
0.04
0.07
0.06
0.04
0.22
0.03
0.14
0.02
0.13
0.02
0.01
0.03
0.07
0.04
0.01
0.09
0.29
0.08
0.03
0.12
0.03
0.05
0.11
0.04
0.05
0.08
0.06

0.06
0.06
0.06
0.09
0.05
0.05
0.09
0.04
0.05
0.15
0.05
0.05
0.06
0.13
0.06
0.05
0.10
0.04
0.02
0.00
0.02
0.08
0.16
0.07
0.06
0.11
0.05
0.06
0.06
0.06
0.17
0.05
0.10
0.04
0.12
0.04
0.04
0.01
0.10
0.04
0.04
0.11
0.25
0.07
0.05
0.08
0.05
0.01
0.04
0.04
0.03
0.04
0.06

0.02
0.01
0.01
0.02
0.01
0.01
0.02
0.01
0.01
0.04
0.01
0.02
0.00
0.01
0.00
0.01
0.03
0.01
0.01
0.00
0.01
0.00
0.02
0.00
0.01
0.02
0.01
0.01
0.01
0.00
0.03
0.00
0.02
0.00
0.02
0.00
0.00
0.00
0.01
0.01
0.00
0.01
0.04
0.01
0.00
0.02
0.00
0.01
0.02
0.01
0.01
0.01
0.01

9
48
40
6
34
17
3
13
16
0
16
2
1247
182
1040
58
13
45
5
0
0
5
140
29
109
65
10
53
17
17
75
11
63
10
109
16
89
311
6
46
16
240
29
14
15
76
10
64
3
3
23
11
14
42

0.2
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.3
0.1
0.1
0.1
0.2
0.3
0.2
0.1
0.3
0.1
0.1
0.1
0.1
0.3
0.1
0.3
0.1
0.2
0.1
0.1
0.0
0.2
0.1
0.1
0.2
0.3
0.1
0.1
0.2
0.1
0.0
0.1
0.1
0.1
0.2
0.2

0.06
0.03
0.02
0.06
0.02
0.03
0.06
0.03
0.02
0.02
0.04
0.00
0.02
0.00
0.02
0.10
0.02
0.03
0.06
0.02
0.05
0.02
0.02
0.09
0.02
0.03
0.03
0.02
0.10
0.02
0.10
0.01
0.05
0.01
0.01
0.01
0.03
0.01
0.01
0.04
0.09
0.04
0.01
0.06
0.01
0.02
0.05
0.02
0.03
0.05
0.04

0.03
0.02
0.01
0.02
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.02
0.03
0.02
0.02
0.04
0.02
0.01
0.02
0.02
0.04
0.02
0.02
0.03
0.02
0.02
0.02
0.02
0.04
0.02
0.04
0.01
0.02
0.01
0.01
0.00
0.02
0.01
0.01
0.03
0.03
0.02
0.02
0.02
0.01
0.01
0.00
0.02
0.01
0.03
0.03

1
16

0.2
0.3

0.21
0.09

0.03
0.04

0.03
0.01

0
0

3
1
28
4
7
99
140
12
172
40
29
49
28
25
2
28
12
29
102
34
242
40

0.2
0.0
0.1
0.1
0.3
1.1
0.7
1.5
0.8
1.1
0.5
1.8
0.2
0.2
0.1
0.7
0.3
0.7
1.0
0.5
0.7
0.6

0.14
0.04
0.03
0.06
0.12
0.11
0.06
0.43
0.06
0.18
0.09
0.26
0.04
0.04
0.09
0.14
0.09
0.13
0.11
0.09
0.04
0.11

0.03
0.01
0.01
0.01
0.04
0.14
0.09
0.20
0.10
0.14
0.06
0.25
0.02
0.02
0.00
0.09
0.04
0.11
0.13
0.06
0.09
0.08

0.02
0.01
0.00
0.01
0.02
0.02
0.01
0.06
0.01
0.02
0.01
0.04
0.00
0.00
0.00
0.02
0.01
0.02
0.01
0.01
0.01
0.01

0
0
11
0
0
11
20
0
29
6
5
1
13
11
2
6
2
3
12
5
34
10

0.0
0.1
0.1
0.2
0.2
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1

0.01
0.04
0.03
0.03
0.07
0.04
0.03
0.02
0.02
0.08
0.06
0.03
0.04
0.03
0.03
0.01
0.04

0.00
0.01
0.01
0.02
0.02
0.02
0.01
0.01
0.01
0.01
0.02
0.00
0.01
0.01
0.01
0.01
0.02

0.01
0.00
0.00
0.01
0.00
0.00
0.01
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.01
0.00
0.01
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.01
0.01
- *
- *
0.00 *
- *
- *
0.00
0.00 *
0.00
0.01 *
0.01 *
0.01 *
0.00
0.00
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.01

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

381

439

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other oropharynx (C10) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

382

Female
ASR(W)
CUM 0-74

229
24
13
7
20
10
1
44
4
0
0
12
8
2
14
6
26
25
1
0
7
5
17
1
9

0.3
0.3
0.3
0.3
0.7
0.2
0.1
0.2
0.5
0.6
0.2
0.1
0.5
0.1
0.3
0.4
0.1
0.2
0.3
0.6
0.0
0.1

0.02
0.06
0.08
0.12
0.17
0.07
0.09
0.04
0.23
0.19
0.09
0.08
0.16
0.04
0.06
0.08
0.14
0.07
0.12
0.16
0.03
0.03

0.04
0.04
0.04
0.04
0.11
0.03
0.01
0.03
0.09
0.09
0.03
0.01
0.07
0.01
0.04
0.06
0.01
0.02
0.04
0.07
0.00
0.01

0.00
0.01
0.01
0.02
0.03
0.01
0.01
0.01
0.05
0.03
0.01
0.01
0.02
0.00
0.01
0.01
0.01
0.01
0.02
0.02
0.00
0.01

22
3
1
1
2
1
0
5
2
0
0
4
5
0
5
3
3
3
0
0
3
3
0
1
2

0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.2
0.1
0.3
0.0
0.0
0.0
0.1
0.1
0.0
0.0

0.00
0.02
0.01
0.03
0.04
0.02
0.01
0.08
0.10
0.05
0.12
0.03
0.02
0.02
0.04
0.07
0.03
0.02

0.00
0.00
0.00
0.00
0.00
0.00
0.02
0.03
0.00
0.05
0.01
0.00
0.00
0.01
0.00
0.00
0.00

0.00
0.00
0.00
0.00
0.00
0.00
0.02
0.01
0.00
- *
0.02 *
0.01 *
0.00
0.00
0.01 *
0.00 *
0.00 *
0.00 *

287
23
15
596
27
131
88
220
277
129
97
17
119
93
52
71
67
82
122
73
59
23
62
142
271
157
159
63
223
91
1
37
7
21
16
23
8
0
33
26
3
75
6
4
13
8
9
4
1
5
47
14
22
30

1.1
1.1
1.4
2.1
0.4
0.8
0.3
1.4
0.8
0.7
2.3
0.1
3.5
4.4
3.1
2.9
2.3
2.2
3.3
4.3
3.4
1.8
3.2
1.5
1.7
2.5
2.5
0.7
2.4
2.2
0.1
0.3
0.7
0.9
0.9
0.5
0.4
0.7
1.0
0.2
0.9
0.3
0.3
0.7
0.2
0.3
0.2
0.0
0.7
1.2
0.4
1.3
0.5

0.06
0.22
0.36
0.09
0.08
0.07
0.04
0.10
0.05
0.06
0.24
0.02
0.33
0.47
0.43
0.35
0.28
0.25
0.31
0.52
0.44
0.40
0.41
0.12
0.10
0.20
0.20
0.09
0.16
0.24
0.11
0.06
0.29
0.20
0.24
0.11
0.14
0.13
0.20
0.13
0.11
0.15
0.17
0.20
0.07
0.11
0.12
0.04
0.32
0.19
0.11
0.27
0.09

0.13
0.13
0.17
0.25
0.05
0.09
0.04
0.17
0.09
0.08
0.29
0.01
0.41
0.54
0.37
0.35
0.25
0.26
0.41
0.47
0.39
0.18
0.36
0.17
0.18
0.30
0.28
0.09
0.29
0.26
0.01
0.04
0.11
0.10
0.13
0.06
0.04
0.10
0.10
0.03
0.11
0.04
0.04
0.09
0.02
0.04
0.03
0.11
0.15
0.04
0.14
0.06

0.01
0.03
0.05
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.03
0.00
0.04
0.06
0.06
0.05
0.03
0.03
0.04
0.06
0.05
0.04
0.05
0.02
0.01
0.03
0.02
0.01
0.02
0.03
0.01
0.01
0.05
0.02
0.03
0.01
0.02
0.02
0.02
0.02
0.01
0.02
0.02
0.03
0.01
0.01
0.02
0.05
0.02
0.01
0.03
0.01

60
4
7
27
6
23
10
38
51
62
12
5
23
14
5
8
9
7
15
4
12
3
5
31
41
70
26
22
68
19
0
6
0
3
1
5
5
0
10
7
0
15
2
1
3
1
2
3
0
2
9
2
5
6

0.2
0.2
0.6
0.1
0.1
0.1
0.0
0.2
0.1
0.3
0.2
0.0
0.7
0.6
0.3
0.3
0.3
0.2
0.3
0.3
0.6
0.3
0.3
0.3
0.2
1.0
0.3
0.2
0.7
0.4
0.0
0.1
0.1
0.1
0.1
0.2
0.3
0.2
0.1
0.1
0.1
0.0
0.1
0.1
0.3
0.2
0.0
0.3
0.1

0.03
0.10
0.24
0.01
0.03
0.03
0.01
0.03
0.02
0.04
0.06
0.01
0.14
0.17
0.14
0.11
0.09
0.07
0.09
0.14
0.18
0.16
0.12
0.05
0.03
0.12
0.06
0.05
0.09
0.10
0.02
0.05
0.08
0.04
0.06
0.07
0.10
0.05
0.06
0.11
0.09
0.02
0.04
0.08
0.22
0.06
0.01
0.12
0.03

0.02
0.02
0.08
0.01
0.01
0.01
0.00
0.02
0.01
0.04
0.02
0.00
0.08
0.07
0.03
0.04
0.03
0.02
0.04
0.03
0.07
0.02
0.02
0.03
0.02
0.11
0.04
0.02
0.08
0.04
0.01
0.01
0.01
0.01
0.02
0.02
0.04
0.02
0.01
0.01
0.02
0.00
0.01
0.01
0.04
0.02
0.03
0.01

0.00
0.01
0.03
0.00 *
0.00 *
0.00
0.00 *
0.00
0.00
0.01
0.01
0.00
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.03
0.01
0.01
0.00

*Important. See note on population page.

440

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other oropharynx (C10) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

89
225
4
47
27
59
120
95
87
220
94
420
217
1
118
111
52
3
14
22
13
26
17
14
51
34
10
4
24
15
6
35
350
24
27
17
38
61
71
18
54
111
43
51
13
85

1.2
2.3
0.3
0.3
1.0
1.5
2.1
1.0
0.9
1.6
0.6
2.7
3.2
0.1
3.0
1.8
1.2
0.4
0.8
0.9
0.4
1.3
1.0
0.5
0.1
2.4
1.3
0.7
1.4
1.2
0.6
1.7
0.6
0.7
0.8
0.2
0.4
0.4
0.3
0.2
0.2
0.2
0.2
0.3
0.3
0.5

0.13
0.15
0.15
0.05
0.20
0.20
0.20
0.11
0.10
0.11
0.06
0.13
0.22
0.12
0.29
0.18
0.17
0.25
0.21
0.20
0.11
0.27
0.26
0.13
0.02
0.41
0.42
0.37
0.29
0.31
0.25
0.28
0.03
0.14
0.15
0.04
0.07
0.05
0.03
0.05
0.03
0.02
0.04
0.04
0.07
0.05

0.16
0.26
0.03
0.04
0.14
0.17
0.26
0.12
0.11
0.20
0.07
0.30
0.39
0.01
0.35
0.21
0.14
0.06
0.09
0.11
0.04
0.16
0.13
0.05
0.02
0.30
0.16
0.08
0.17
0.14
0.05
0.21
0.08
0.09
0.09
0.02
0.05
0.05
0.04
0.02
0.02
0.03
0.03
0.03
0.03
0.05

0.02
0.02
0.02
0.01
0.03
0.02
0.03
0.01
0.01
0.01
0.01
0.02
0.03
0.01
0.03
0.02
0.02
0.03
0.03
0.02
0.01
0.03
0.03
0.01
0.00
0.06
0.05
0.04
0.04
0.04
0.03
0.04
0.00
0.02
0.02
0.00
0.01
0.01
0.00
0.01
0.00
0.00
0.00
0.01
0.01
0.01

11
20
0
25
4
7
46
7
3
33
14
14
16
0
6
6
0
0
0
1
2
1
1
1
25
13
2
2
5
6
2
10
125
8
3
9
12
20
20
4
18
46
11
16
8
35

0.1
0.1
0.1
0.1
0.1
0.6
0.1
0.0
0.1
0.1
0.1
0.2
0.2
0.1
0.0
0.1
0.1
0.0
0.0
0.1
0.8
0.3
0.3
0.3
0.4
0.2
0.4
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.1
0.1

0.04
0.03
0.03
0.06
0.05
0.09
0.02
0.01
0.03
0.02
0.02
0.05
0.06
0.04
0.02
0.04
0.05
0.03
0.04
0.01
0.23
0.20
0.22
0.14
0.18
0.12
0.14
0.02
0.08
0.05
0.03
0.04
0.03
0.02
0.02
0.01
0.01
0.02
0.02
0.05
0.02

0.01
0.02
0.02
0.01
0.01
0.07
0.01
0.02
0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.11
0.03
0.05
0.03
0.04
0.01
0.05
0.03
0.03
0.01
0.01
0.01
0.02
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.02

0.00
0.00
0.00
0.01 *
0.01
0.01
0.00 *
0.00
0.00
0.00
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.00
0.00
0.03
0.02
0.03
0.02
0.02
0.01
0.02
0.00
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

106
10
63
19
9
60
24
3
4
25
13
0
3
1
3
4

0.5
2.1
0.6
0.4
0.6
0.4
0.4
0.4
0.8
0.2
0.3
0.2
0.2
0.3
0.4

0.05
0.68
0.07
0.09
0.20
0.05
0.08
0.21
0.41
0.04
0.09
0.13
0.19
0.19
0.18

0.06
0.24
0.07
0.04
0.06
0.06
0.04
0.04
0.08
0.03
0.03
0.02
0.03
0.04

0.01
0.08
0.01
0.01
0.02
0.01
0.01
0.02
0.04
0.01
0.01
0.02
0.02
0.02

24
2
15
8
2
20
5
1
0
6
3
0
0
1
0
2

0.1
0.4
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.2
0.2

0.02
0.32
0.04
0.05
0.06
0.03
0.04
0.11
0.02
0.04
0.18
0.13

0.01
0.05
0.02
0.01
0.02
0.02
0.01
0.03
0.00
0.01
0.02
0.02

0.00
0.04
0.00
0.01
0.02
0.00
0.00
0.03
0.00
0.01
0.02
0.02

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

383

441

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Nasopharynx (C11)
Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

384

Female
ASR(W)
CUM 0-74

140
57
44
42
20

5.4
1.2
4.6
2.3
0.6

0.50
0.17
0.71
0.48
0.16

47
23
21
31
9

1.7
0.4
1.9
1.3
0.3

0.27
0.08
0.43
0.34
0.12

3
17
2
25
216
3
17
68
6
9
2

0.4
0.5
0.3
1.4
1.0
0.3
0.5
0.8
0.2
0.9
0.2

0.22
0.13
0.22
0.31
0.07
0.17
0.12
0.10
0.09
0.29
0.16

0.03
0.03
0.03
0.14
0.11
0.02
0.05
0.08
0.02
0.11
0.03

0.02
0.01
0.03
0.04
0.01
0.01
0.01
0.01
0.01
0.04
0.02

1
7
2
4
97
2
13
27
1
5
1

0.1
0.3
0.3
0.2
0.3
0.2
0.3
0.3
0.0
0.3
0.1

0.14
0.11
0.21
0.09
0.04
0.14
0.08
0.06
0.02
0.16
0.12

0.01
0.03
0.04
0.01
0.03
0.02
0.03
0.02
0.02
0.01

0.01
0.02
0.03
0.01
0.00
0.02
0.01
0.01
0.01
0.01 *

623
64
152
20
8
16
4
16
326
1
16
85
20
65
24
71
809
431
43
79
247
236
6
120
28
2
10
43
229
23
64
29
1
5
28
41
55
67
5
58
13
12
0
388
45
326
133
33
93
40
14
20
13
216
50
137
91
35
78
107
44
53
11
13

0.8
0.7
1.1
0.5
0.4
0.9
4.3
0.5
0.9
0.2
0.5
0.6
0.7
0.6
1.5
0.4
0.9
3.8
0.7
0.4
0.4
1.2
0.4
8.1
3.1
0.9
0.4
0.4
0.9
0.9
6.0
3.8
0.3
1.1
0.3
0.4
0.4
0.6
0.7
0.6
0.8
1.2
0.7
0.8
0.7
0.6
0.7
0.6
0.6
0.7
0.4
0.3
0.6
1.1
0.5
0.5
0.4
0.6
0.8
1.4
0.6
1.2
0.7

0.03
0.09
0.09
0.13
0.13
0.23
2.31
0.13
0.05
0.20
0.13
0.07
0.16
0.07
0.31
0.06
0.03
0.19
0.11
0.05
0.03
0.08
0.19
0.75
0.60
0.65
0.13
0.06
0.06
0.19
0.77
0.72
0.33
0.49
0.07
0.06
0.06
0.08
0.31
0.08
0.22
0.36
0.04
0.12
0.04
0.05
0.12
0.06
0.09
0.20
0.09
0.10
0.04
0.16
0.04
0.06
0.07
0.07
0.08
0.21
0.08
0.35
0.20

0.09
0.08
0.11
0.07
0.04
0.12
0.55
0.06
0.09
0.05
0.05
0.07
0.06
0.07
0.17
0.05
0.09
0.41
0.07
0.05
0.05
0.14
0.06
0.94
0.31
0.10
0.04
0.05
0.09
0.10
0.63
0.40
0.04
0.13
0.04
0.04
0.05
0.07
0.09
0.06
0.09
0.14
0.08
0.08
0.08
0.07
0.07
0.07
0.07
0.07
0.05
0.03
0.07
0.11
0.05
0.06
0.04
0.07
0.09
0.16
0.06
0.14
0.08

0.00
0.01
0.01
0.02
0.01
0.03
0.34
0.02
0.01
0.05
0.02
0.01
0.01
0.01
0.05
0.01
0.00
0.02
0.01
0.01
0.00
0.01
0.03
0.09
0.07
0.08
0.02
0.01
0.01
0.02
0.09
0.08
0.04
0.06
0.01
0.01
0.01
0.01
0.05
0.01
0.03
0.04
0.00
0.01
0.00
0.01
0.02
0.01
0.01
0.03
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.03
0.01
0.05
0.03

270
21
76
15
4
2
1
6
140
0
5
42
9
32
14
28
373
205
25
31
109
127
5
66
12
0
4
24
99
10
24
9
1
1
16
24
22
26
2
22
5
5
0
206
29
166
81
24
50
23
12
6
8
128
29
79
41
22
33
40
14
26
6
8

0.3
0.2
0.5
0.4
0.2
0.1
1.3
0.2
0.4
0.2
0.3
0.3
0.3
0.9
0.1
0.4
1.5
0.3
0.1
0.2
0.6
0.3
4.0
1.0
0.1
0.2
0.3
0.3
1.9
0.8
0.1
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.3
0.4
0.3
0.4
0.3
0.3
0.3
0.3
0.3
0.4
0.1
0.2
0.3
0.5
0.2
0.2
0.2
0.2
0.3
0.3
0.2
0.4
0.4

0.02
0.05
0.06
0.10
0.10
0.06
1.31
0.09
0.03
0.07
0.04
0.09
0.05
0.26
0.03
0.02
0.11
0.07
0.03
0.02
0.06
0.16
0.50
0.30
0.07
0.06
0.03
0.09
0.39
0.28
0.06
0.27
0.04
0.04
0.04
0.04
0.12
0.05
0.16
0.21
0.03
0.08
0.03
0.04
0.07
0.04
0.06
0.13
0.05
0.07
0.03
0.10
0.03
0.04
0.05
0.04
0.04
0.09
0.05
0.18
0.14

0.03
0.02
0.05
0.04
0.01
0.00
0.16
0.03
0.04
0.01
0.03
0.02
0.03
0.13
0.02
0.04
0.16
0.04
0.01
0.02
0.07
0.02
0.44
0.12
0.02
0.02
0.03
0.03
0.18
0.09
0.01
0.01
0.02
0.02
0.02
0.01
0.02
0.03
0.04
0.04
0.04
0.03
0.03
0.03
0.03
0.02
0.04
0.01
0.02
0.03
0.05
0.03
0.02
0.03
0.03
0.03
0.03
0.03
0.03
0.05

0.00
0.01
0.01
0.01
0.01
0.00
0.16
0.01
0.00
0.01
0.01
0.01
0.01
0.04
0.00
0.00
0.01
0.01
0.00
0.00
0.01
0.01
0.06
0.04
0.01
0.01
0.00
0.01
0.04
0.04
0.02
0.00
0.01
0.00
0.01
0.01
0.01
0.02
0.02
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.02
0.00
0.01
0.00
0.01
0.00
0.00
0.01
0.01
0.01
0.01
0.01
0.02
0.02

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

442

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Nasopharynx (C11) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

22
131
146
28
111
73
21
48
78
9
62
11
4294
565
2791
189
26
126
14
3
3
5
499
59
255
155
18
127
57
43
192
31
137
18
577
50
276
1610
592
166
105
714
87
29
58
332
62
242
23
8
111
82
31
84

0.5
0.7
0.5
0.8
0.4
0.6
0.9
0.5
0.5
0.7
0.4
0.4
0.6
0.9
0.5
0.7
0.8
0.6
0.3
0.6
0.1
0.2
0.9
0.9
0.6
0.5
0.6
0.4
0.6
0.4
0.5
1.0
0.4
0.6
0.7
0.7
0.4
0.8
3.4
0.9
0.4
0.5
0.8
1.0
0.7
0.6
1.0
0.5
0.4
0.4
0.6
0.7
0.5
0.5

0.12
0.06
0.04
0.16
0.04
0.08
0.20
0.08
0.05
0.22
0.05
0.12
0.01
0.04
0.01
0.05
0.17
0.05
0.07
0.36
0.08
0.10
0.04
0.11
0.04
0.04
0.13
0.04
0.08
0.06
0.04
0.18
0.03
0.14
0.03
0.11
0.03
0.02
0.14
0.07
0.04
0.02
0.08
0.19
0.09
0.03
0.13
0.03
0.09
0.15
0.06
0.08
0.09
0.05

0.05
0.07
0.05
0.08
0.05
0.07
0.09
0.06
0.05
0.07
0.05
0.05
0.07
0.09
0.06
0.08
0.08
0.07
0.02
0.05
0.01
0.01
0.10
0.09
0.06
0.05
0.06
0.05
0.06
0.05
0.06
0.10
0.05
0.07
0.08
0.08
0.05
0.08
0.37
0.09
0.05
0.05
0.08
0.12
0.07
0.06
0.10
0.06
0.05
0.05
0.07
0.08
0.07
0.05

0.01
0.01
0.01
0.02
0.01
0.01
0.02
0.01
0.01
0.03
0.01
0.02
0.00
0.00
0.00
0.01
0.02
0.01
0.01
0.03
0.01
0.01
0.00
0.01
0.00
0.00
0.02
0.00
0.01
0.01
0.00
0.02
0.00
0.02
0.00
0.01
0.00
0.00
0.02
0.01
0.01
0.00
0.01
0.02
0.01
0.00
0.02
0.00
0.01
0.02
0.01
0.01
0.01
0.01

9
79
83
10
68
40
6
31
33
6
24
3
2116
295
1383
81
10
48
9
2
1
6
242
42
137
84
6
69
37
24
97
21
73
5
286
26
131
721
269
74
43
315
38
16
20
160
26
116
13
6
46
35
17
44

0.2
0.4
0.2
0.2
0.2
0.3
0.2
0.3
0.2
0.3
0.1
0.1
0.3
0.4
0.2
0.3
0.3
0.2
0.2
0.4
0.1
0.2
0.3
0.4
0.2
0.2
0.2
0.2
0.3
0.2
0.2
0.5
0.2
0.1
0.3
0.3
0.2
0.3
1.3
0.3
0.2
0.2
0.3
0.4
0.2
0.3
0.4
0.2
0.2
0.3
0.2
0.3
0.2
0.2

0.10
0.04
0.03
0.08
0.03
0.05
0.07
0.06
0.03
0.13
0.03
0.04
0.01
0.02
0.01
0.03
0.09
0.03
0.06
0.30
0.06
0.12
0.02
0.07
0.02
0.02
0.07
0.02
0.05
0.04
0.02
0.12
0.02
0.05
0.02
0.05
0.02
0.01
0.08
0.04
0.02
0.01
0.05
0.11
0.05
0.02
0.08
0.02
0.07
0.14
0.04
0.05
0.05
0.04

0.02
0.04
0.03
0.03
0.02
0.04
0.02
0.04
0.02
0.03
0.02
0.01
0.03
0.03
0.02
0.03
0.03
0.02
0.02
0.02
0.01
0.02
0.04
0.04
0.03
0.02
0.02
0.02
0.04
0.02
0.02
0.05
0.02
0.01
0.03
0.02
0.02
0.03
0.14
0.03
0.01
0.02
0.03
0.04
0.02
0.03
0.04
0.02
0.03
0.04
0.02
0.02
0.03
0.03

0.01
0.00
0.00
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.02
0.01
0.01
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.01
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.01
0.00
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.01
0.02
0.00
0.00
0.01
0.00

14
1343
3884
53
28
918
946
10
82
132
5
117
20
35
18
144
119
20
16
9
17
43
30
149
20

2.0
22.2
17.8
4.0
1.1
4.1
26.9
0.5
0.8
0.6
0.6
0.5
0.4
0.4
0.6
1.0
0.9
1.1
0.4
0.3
0.5
0.5
0.6
0.5
0.4

0.56
0.62
0.29
0.57
0.21
0.14
0.90
0.16
0.09
0.05
0.26
0.05
0.10
0.08
0.15
0.08
0.09
0.27
0.11
0.10
0.12
0.08
0.12
0.04
0.09

0.19
2.23
1.88
0.47
0.12
0.45
2.82
0.05
0.09
0.07
0.07
0.05
0.04
0.04
0.07
0.11
0.10
0.15
0.04
0.03
0.05
0.06
0.06
0.05
0.04

0.07
0.07
0.03
0.07
0.03
0.02
0.10
0.02
0.01
0.01
0.03
0.01
0.01
0.01
0.02
0.01
0.01
0.05
0.01
0.01
0.01
0.01
0.01
0.00
0.01

2
613
1503
17
14
351
367
7
27
44
0
47
12
15
9
69
63
6
2
3
12
13
11
53
9

0.3
9.8
6.7
1.3
0.5
1.5
10.1
0.3
0.3
0.2
0.2
0.3
0.2
0.3
0.4
0.4
0.4
0.1
0.0
0.3
0.1
0.2
0.1
0.1

0.23
0.40
0.18
0.32
0.14
0.08
0.54
0.12
0.05
0.04
0.03
0.08
0.06
0.09
0.05
0.05
0.15
0.05
0.03
0.08
0.04
0.05
0.02
0.05

0.04
0.99
0.69
0.12
0.06
0.16
1.03
0.04
0.03
0.03
0.02
0.03
0.02
0.03
0.04
0.04
0.05
0.01
0.00
0.03
0.01
0.02
0.02
0.02

0.03
0.04 *
0.02
0.03 *
0.02
0.01 *
0.06 *
0.01 *
0.01
0.01 *
0.00
0.01 *
0.01 *
0.01 *
0.01
0.01
0.03
0.00
0.00
0.01
0.00
0.01
0.00
0.01

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

385

443

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Nasopharynx (C11) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

386

Female
ASR(W)
CUM 0-74

902
80
52
30
34
55
16
262
14
17
23
225
633
20
48
518
1089
1012
14
63
154
58
78
44
112

0.9
0.8
0.8
1.0
1.0
0.9
2.0
1.1
0.9
1.7
0.6
9.3
15.0
1.0
1.4
5.8
11.0
12.8
1.8
5.5
3.9
2.5
2.7
1.3
1.3

0.03
0.09
0.12
0.20
0.18
0.13
0.51
0.07
0.26
0.42
0.25
0.64
0.62
0.24
0.21
0.29
0.34
0.41
0.50
0.74
0.32
0.34
0.31
0.21
0.12

0.11
0.09
0.10
0.09
0.10
0.09
0.28
0.12
0.07
0.21
0.09
1.01
1.63
0.11
0.13
0.66
1.17
1.37
0.15
0.57
0.42
0.26
0.28
0.15
0.13

0.00
0.01
0.02
0.02
0.02
0.01
0.09
0.01
0.02
0.06
0.06
0.08
0.08
0.03
0.02
0.04
0.04
0.05
0.05
0.09
0.04
0.04
0.04
0.02
0.01

346
39
15
13
10
22
3
84
6
10
9
81
280
7
15
238
373
348
1
24
63
33
31
16
46

0.3
0.3
0.2
0.3
0.3
0.3
0.3
0.3
0.3
0.8
0.8
3.3
6.5
0.3
0.6
2.4
3.6
4.1
0.1
2.0
1.5
1.5
0.9
0.5
0.5

0.02
0.05
0.05
0.10
0.10
0.07
0.20
0.03
0.15
0.26
0.43
0.37
0.41
0.11
0.19
0.17
0.19
0.22
0.11
0.43
0.20
0.27
0.17
0.12
0.08

0.03
0.04
0.03
0.04
0.04
0.03
0.02
0.04
0.04
0.10
0.06
0.34
0.72
0.03
0.06
0.26
0.36
0.41
0.01
0.18
0.17
0.19
0.10
0.05
0.06

0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.02
0.04
0.03
0.04
0.05
0.01 *
0.02 *
0.02 *
0.02
0.03
0.01
0.04
0.02 *
0.04 *
0.02
0.01 *
0.01 *

108
13
6
140
23
60
229
101
213
60
11
53
16
9
8
23
22
18
20
5
8
11
9
41
65
40
36
37
31
14
4
51
13
11
12
36
19
3
35
11
17
62
9
7
15
35
22
3
9
7
25
16
21
33

0.4
0.7
0.5
0.5
0.4
0.4
0.9
0.7
0.6
0.4
0.2
0.3
0.5
0.4
0.6
1.0
0.7
0.5
0.6
0.3
0.5
0.9
0.5
0.5
0.4
0.7
0.6
0.4
0.3
0.3
0.5
0.5
1.7
0.5
0.8
0.9
0.7
0.3
1.0
0.5
1.1
0.8
0.5
0.9
0.9
0.8
0.8
0.2
0.8
1.1
0.7
0.4
1.2
0.5

0.04
0.19
0.22
0.04
0.08
0.06
0.06
0.07
0.04
0.05
0.08
0.04
0.12
0.15
0.20
0.21
0.15
0.12
0.13
0.14
0.16
0.29
0.16
0.07
0.05
0.13
0.10
0.07
0.06
0.09
0.27
0.07
0.51
0.15
0.24
0.15
0.18
0.20
0.19
0.14
0.26
0.10
0.19
0.33
0.25
0.15
0.17
0.10
0.26
0.43
0.15
0.11
0.28
0.10

0.04
0.08
0.06
0.06
0.05
0.04
0.09
0.07
0.07
0.04
0.04
0.03
0.06
0.06
0.06
0.10
0.07
0.05
0.06
0.02
0.05
0.10
0.05
0.05
0.04
0.07
0.06
0.05
0.04
0.03
0.06
0.05
0.18
0.07
0.10
0.09
0.08
0.06
0.10
0.05
0.11
0.08
0.05
0.08
0.11
0.09
0.09
0.01
0.10
0.14
0.08
0.05
0.14
0.06

0.00
0.02
0.03
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.02
0.02
0.01
0.01
0.01
0.02
0.03
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.03
0.01
0.05
0.02
0.03
0.02
0.02
0.03
0.02
0.02
0.03
0.01
0.02
0.03
0.03
0.02
0.02
0.01
0.04
0.06
0.02
0.01
0.03
0.01

61
2
2
58
9
18
109
35
61
33
8
26
6
5
6
4
7
9
8
1
1
5
0
13
29
20
13
9
17
7
6
13
3
9
3
16
4
0
16
5
1
20
2
4
7
10
6
6
2
5
3
12
8
13

0.2
0.1
0.2
0.2
0.2
0.1
0.4
0.2
0.2
0.2
0.2
0.1
0.2
0.2
0.4
0.1
0.1
0.2
0.2
0.0
0.1
0.3
0.1
0.1
0.2
0.2
0.1
0.2
0.2
0.7
0.1
0.4
0.4
0.1
0.3
0.1
0.3
0.2
0.1
0.2
0.1
0.4
0.3
0.3
0.2
0.3
0.2
0.7
0.1
0.3
0.4
0.3

0.02
0.04
0.13
0.02
0.07
0.03
0.04
0.04
0.02
0.03
0.09
0.03
0.08
0.10
0.16
0.07
0.06
0.08
0.08
0.04
0.06
0.17
0.03
0.03
0.06
0.06
0.03
0.05
0.08
0.33
0.03
0.25
0.13
0.07
0.08
0.06
0.10
0.11
0.06
0.05
0.08
0.18
0.14
0.09
0.09
0.13
0.17
0.33
0.06
0.10
0.16
0.11

0.02
0.01
0.02
0.02
0.01
0.01
0.04
0.02
0.02
0.02
0.01
0.01
0.02
0.03
0.03
0.02
0.02
0.03
0.01
0.01
0.01
0.03
0.01
0.02
0.03
0.02
0.01
0.02
0.02
0.08
0.00
0.03
0.05
0.01
0.03
0.01
0.04
0.02
0.01
0.02
0.01
0.05
0.04
0.03
0.02
0.03
0.02
0.10
0.01
0.03
0.04
0.02

0.00
0.01
0.02
0.00 *
0.01 *
0.00
0.00 *
0.00
0.00
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.00
0.00
0.01
0.01
0.00
0.00
0.01
0.04
0.00
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.04
0.00
0.01
0.02
0.01

*Important. See note on population page.

444

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Nasopharynx (C11) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

31
46
27
54
9
18
32
84
100
55
132
94
29
12
53
77
34
8
20
27
31
11
17
23
128
5
1
1
15
6
10
8
240
15
10
36
23
45
65
26
96
202
62
69
20
52

0.4
0.5
2.2
0.4
0.4
0.5
0.6
0.9
1.2
0.4
0.8
0.6
0.4
1.3
1.5
1.3
0.8
0.7
1.2
1.0
0.9
0.5
1.0
0.8
0.4
0.4
0.1
0.2
0.9
0.5
1.2
0.3
0.5
0.4
0.3
0.4
0.3
0.3
0.3
0.3
0.4
0.5
0.4
0.4
0.4
0.3

0.08
0.07
0.42
0.05
0.13
0.11
0.11
0.10
0.12
0.05
0.08
0.07
0.08
0.39
0.22
0.15
0.13
0.30
0.27
0.20
0.16
0.16
0.25
0.18
0.04
0.16
0.12
0.18
0.24
0.21
0.38
0.12
0.03
0.12
0.11
0.07
0.06
0.05
0.04
0.07
0.05
0.03
0.05
0.05
0.09
0.05

0.05
0.05
0.25
0.04
0.05
0.06
0.07
0.09
0.13
0.05
0.09
0.07
0.05
0.12
0.15
0.15
0.08
0.07
0.12
0.11
0.09
0.05
0.12
0.08
0.04
0.04
0.01
0.03
0.07
0.07
0.10
0.03
0.05
0.04
0.03
0.04
0.03
0.03
0.03
0.04
0.04
0.05
0.04
0.04
0.04
0.03

0.01
0.01
0.05
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.04
0.02
0.02
0.02
0.04
0.03
0.02
0.02
0.02
0.03
0.02
0.00
0.02
0.01
0.03
0.02
0.03
0.03
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.00
0.00
0.01
0.01
0.01
0.00

21
25
14
17
4
9
12
28
40
34
53
43
20
1
12
22
12
1
3
6
8
4
6
4
48
1
1
0
2
3
2
6
104
2
1
13
20
31
30
18
58
84
23
30
7
33

0.2
0.2
1.1
0.1
0.1
0.2
0.2
0.2
0.4
0.1
0.3
0.2
0.3
0.1
0.3
0.3
0.3
0.2
0.1
0.3
0.2
0.1
0.3
0.1
0.2
0.1
0.2
0.1
0.3
0.3
0.3
0.2
0.1
0.0
0.1
0.3
0.2
0.1
0.2
0.2
0.2
0.1
0.2
0.1
0.2

0.05
0.04
0.30
0.03
0.05
0.07
0.06
0.05
0.07
0.03
0.04
0.04
0.07
0.14
0.10
0.07
0.08
0.25
0.08
0.16
0.08
0.07
0.15
0.05
0.03
0.07
0.16
0.08
0.16
0.25
0.12
0.02
0.04
0.03
0.03
0.06
0.04
0.03
0.05
0.03
0.02
0.03
0.03
0.04
0.03

0.02
0.02
0.13
0.01
0.01
0.02
0.02
0.02
0.04
0.02
0.03
0.03
0.03
0.01
0.03
0.03
0.03
0.02
0.02
0.02
0.02
0.01
0.04
0.01
0.01
0.01
0.01
0.01
0.03
0.02
0.03
0.02
0.01
0.00
0.01
0.02
0.02
0.01
0.02
0.02
0.02
0.02
0.02
0.02
0.02

0.00
0.00
0.03
0.00
0.01 *
0.01
0.01
0.01 *
0.01
0.00
0.00
0.00
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.01
0.00
0.01
0.01
0.01
0.02
0.02
0.01
0.00
0.01
0.00
0.00
0.01
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00

178
5
49
19
6
128
31
2
14
73
76
26
20
10
7
9

0.9
1.6
0.5
0.4
0.4
0.9
0.6
0.3
2.6
0.6
2.0
9.9
3.3
2.0
0.6
0.8

0.07
0.75
0.07
0.09
0.17
0.08
0.10
0.21
0.72
0.07
0.24
1.98
0.77
0.65
0.26
0.28

0.09
0.12
0.05
0.04
0.05
0.10
0.06
0.02
0.29
0.07
0.23
1.08
0.42
0.21
0.06
0.08

0.01
0.08
0.01
0.01
0.02
0.01
0.01
0.01
0.09
0.01
0.03
0.22
0.11
0.08
0.03
0.03

75
1
16
7
4
47
8
1
4
32
18
4
8
1
3
0

0.4
0.2
0.1
0.1
0.2
0.3
0.1
0.1
0.9
0.3
0.4
1.1
1.3
0.2
0.2
-

0.04
0.25
0.03
0.04
0.09
0.05
0.05
0.10
0.48
0.05
0.11
0.60
0.45
0.24
0.15
-

0.04
0.03
0.02
0.02
0.01
0.03
0.01
0.01
0.12
0.02
0.05
0.09
0.12
0.03
0.02
-

0.00
0.03
0.00
0.01
0.01
0.01
0.01
0.01
0.06
0.00
0.01
0.05
0.05
0.03
0.02
-

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

387

445

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Hypopharynx (C12-13)
Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

388

Female
ASR(W)
CUM 0-74

82
56
1
2
2

4.4
1.3
0.1
0.3
0.1

0.49
0.18
0.10
0.21
0.13

9
56
1
0
1

0.5
1.0
0.1
0.1

0.16
0.14
0.11
0.15

6
36
8
45
420
2
10
42
1
30
0

0.6
1.5
1.4
3.1
2.1
0.3
0.3
0.5
0.0
2.7
-

0.27
0.27
0.52
0.47
0.11
0.18
0.09
0.09
0.02
0.51
-

0.09
0.19
0.25
0.38
0.27
0.03
0.03
0.06
0.33
-

0.05
0.04
0.10
0.07
0.02
0.02
0.01
0.01
0.07
-

0
1
0
5
54
0
1
6
1
4
0

0.0
0.3
0.2
0.0
0.1
0.0
0.2
-

0.03
0.13
0.03
0.03
0.03
0.03
0.12
-

0.00
0.03
0.02
0.00
0.01
0.00
0.02
-

0.00
0.01
0.00
0.00
0.00
0.00
0.01
- *

643
76
104
32
33
11
0
30
328
6
23
185
47
138
11
141
827
52
74
116
578
162
17
8
3
0
12
115
213
34
5
2
3
5
48
111
77
142
15
126
52
43
9
738
103
631
287
101
184
66
27
37
27
421
97
315
193
90
138
156
47
108
15
24

0.8
0.9
0.7
0.8
1.2
0.7
0.9
0.9
1.3
0.6
1.3
1.9
1.2
0.8
0.8
0.8
0.5
1.3
0.8
0.9
0.8
1.3
0.4
0.4
0.7
0.9
0.8
1.4
0.5
0.2
0.6
0.9
0.8
0.8
0.6
1.2
2.2
1.2
3.3
4.3
1.7
1.2
2.1
1.1
1.3
2.3
1.1
1.0
1.5
0.8
0.7
1.1
2.3
1.0
1.0
0.9
1.1
1.2
1.6
1.1
1.7
1.1

0.03
0.10
0.07
0.15
0.22
0.20
0.17
0.05
0.55
0.13
0.10
0.28
0.10
0.25
0.07
0.03
0.07
0.16
0.07
0.04
0.07
0.33
0.16
0.23
0.19
0.09
0.06
0.24
0.24
0.16
0.38
0.41
0.12
0.08
0.07
0.11
0.58
0.11
0.46
0.67
0.59
0.05
0.20
0.05
0.08
0.24
0.08
0.12
0.30
0.14
0.14
0.06
0.24
0.06
0.07
0.10
0.09
0.10
0.23
0.11
0.44
0.24

0.11
0.12
0.08
0.13
0.15
0.09
0.12
0.12
0.18
0.10
0.17
0.25
0.15
0.13
0.11
0.11
0.06
0.16
0.09
0.12
0.11
0.16
0.06
0.07
0.09
0.13
0.11
0.16
0.08
0.02
0.11
0.09
0.10
0.11
0.08
0.16
0.33
0.16
0.47
0.58
0.31
0.16
0.29
0.15
0.17
0.31
0.14
0.13
0.16
0.11
0.09
0.15
0.29
0.13
0.12
0.12
0.13
0.15
0.21
0.14
0.22
0.14

0.01
0.02
0.01
0.03
0.03
0.03
0.03
0.01
0.08
0.02
0.01
0.04
0.01
0.04
0.01
0.00
0.01
0.02
0.01
0.01
0.01
0.05
0.03
0.04
0.03
0.01
0.01
0.03
0.04
0.02
0.06
0.05
0.02
0.01
0.01
0.02
0.10
0.02
0.07
0.10
0.11
0.01
0.03
0.01
0.01
0.04
0.01
0.02
0.05
0.02
0.02
0.01
0.03
0.01
0.01
0.01
0.01
0.01
0.04
0.02
0.07
0.04

126
11
25
8
3
0
0
7
67
1
4
30
8
22
1
35
274
12
19
14
229
64
6
0
1
2
5
48
64
9
1
0
4
0
2
48
13
41
3
38
14
9
4
212
17
193
69
14
55
17
2
15
13
100
19
79
49
27
35
43
13
30
6
7

0.2
0.1
0.2
0.2
0.1
0.2
0.2
0.2
0.1
0.2
0.2
0.2
0.1
0.2
0.2
0.1
0.3
0.1
0.3
0.3
0.4
0.1
0.4
0.2
0.3
0.2
0.3
0.1
0.8
0.0
0.3
0.1
0.3
0.3
0.3
0.6
0.6
0.5
0.3
0.3
0.3
0.3
0.2
0.3
0.2
0.1
0.3
0.3
0.2
0.3
0.2
0.2
0.2
0.2
0.3
0.3
0.3
0.5
0.3

0.01
0.04
0.03
0.08
0.08
0.07
0.02
0.22
0.07
0.03
0.09
0.04
0.06
0.03
0.02
0.03
0.07
0.02
0.02
0.04
0.18
0.10
0.30
0.10
0.05
0.03
0.10
0.05
0.43
0.01
0.05
0.03
0.05
0.16
0.05
0.18
0.22
0.25
0.02
0.06
0.02
0.03
0.06
0.04
0.05
0.05
0.08
0.09
0.02
0.08
0.03
0.03
0.05
0.04
0.04
0.10
0.05
0.22
0.12

0.02
0.02
0.02
0.02
0.01
0.02
0.02
0.04
0.02
0.02
0.03
0.02
0.01
0.02
0.03
0.01
0.03
0.01
0.04
0.04
0.06
0.02
0.02
0.02
0.05
0.02
0.03
0.08
0.04
0.01
0.04
0.02
0.04
0.09
0.09
0.06
0.04
0.03
0.04
0.03
0.03
0.03
0.03
0.01
0.04
0.03
0.03
0.04
0.03
0.02
0.03
0.03
0.03
0.04
0.03
0.07
0.04

0.00
0.01
0.00
0.01
0.01
0.01
0.00
0.04
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.01
0.00
0.00
0.01
0.03
0.02
0.02
0.01
0.01
0.00
0.01
0.05
0.01
0.00
0.01
0.02
0.01
0.03
0.03
0.05
0.00
0.01
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.01
0.00
0.01
0.00
0.00
0.01
0.01
0.01
0.01
0.01
0.03
0.02

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

446

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Hypopharynx (C12-13) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

45
270
355
88
260
167
68
97
157
31
125
20
7101
1170
5763
270
58
202
31
1
14
15
532
91
429
339
46
284
94
84
433
80
345
46
788
130
583
2080
118
317
162
1467
179
81
97
553
73
474
29
22
136
96
64
210

1.0
1.3
1.1
2.8
0.9
1.4
3.0
1.0
0.9
2.3
0.8
0.6
1.0
2.0
0.9
1.0
2.1
0.9
0.5
0.4
0.7
0.4
0.9
1.4
0.9
0.9
1.5
0.9
0.8
0.8
1.0
2.8
0.8
1.3
1.0
1.9
0.9
0.9
0.7
1.8
0.8
0.9
1.4
3.1
1.0
1.0
1.5
1.0
0.6
1.0
0.7
0.8
0.9
1.3

0.15
0.08
0.06
0.31
0.06
0.11
0.37
0.10
0.07
0.42
0.07
0.15
0.01
0.06
0.01
0.06
0.27
0.06
0.09
0.38
0.19
0.11
0.04
0.15
0.04
0.05
0.23
0.05
0.09
0.09
0.05
0.32
0.05
0.21
0.04
0.18
0.04
0.02
0.06
0.10
0.06
0.02
0.11
0.35
0.10
0.04
0.18
0.04
0.12
0.22
0.07
0.08
0.12
0.09

0.13
0.17
0.15
0.34
0.12
0.18
0.37
0.13
0.11
0.29
0.09
0.08
0.13
0.26
0.12
0.14
0.27
0.13
0.06
0.06
0.07
0.05
0.11
0.17
0.11
0.12
0.19
0.11
0.11
0.11
0.12
0.37
0.10
0.18
0.13
0.25
0.12
0.12
0.08
0.23
0.10
0.12
0.19
0.41
0.12
0.13
0.18
0.12
0.07
0.12
0.10
0.11
0.12
0.17

0.02
0.01
0.01
0.04
0.01
0.02
0.05
0.02
0.01
0.06
0.01
0.02
0.00
0.01
0.00
0.01
0.04
0.01
0.01
0.06
0.03
0.01
0.01
0.02
0.01
0.01
0.03
0.01
0.01
0.01
0.01
0.05
0.01
0.03
0.01
0.03
0.01
0.00
0.01
0.02
0.01
0.00
0.02
0.05
0.01
0.01
0.03
0.01
0.02
0.03
0.01
0.01
0.02
0.01

14
86
75
19
55
33
15
18
45
5
40
8
2002
260
1702
74
9
63
9
1
3
5
171
33
137
92
9
82
14
34
124
12
111
11
232
28
195
618
16
68
23
506
47
16
31
161
25
134
9
3
55
43
13
62

0.3
0.3
0.2
0.5
0.2
0.2
0.5
0.1
0.2
0.3
0.2
0.2
0.2
0.3
0.2
0.2
0.2
0.2
0.1
0.2
0.1
0.1
0.2
0.3
0.2
0.2
0.2
0.2
0.1
0.2
0.2
0.3
0.2
0.3
0.2
0.3
0.2
0.2
0.1
0.3
0.1
0.3
0.3
0.5
0.3
0.2
0.4
0.2
0.1
0.1
0.3
0.3
0.1
0.3

0.08
0.04
0.02
0.11
0.02
0.04
0.13
0.04
0.03
0.13
0.03
0.09
0.01
0.02
0.01
0.03
0.08
0.03
0.05
0.23
0.08
0.06
0.02
0.06
0.02
0.02
0.07
0.03
0.03
0.05
0.02
0.09
0.02
0.09
0.02
0.06
0.02
0.01
0.02
0.04
0.02
0.01
0.05
0.12
0.05
0.02
0.08
0.02
0.05
0.08
0.04
0.05
0.04
0.05

0.04
0.05
0.02
0.05
0.02
0.03
0.06
0.02
0.02
0.03
0.02
0.03
0.03
0.04
0.03
0.02
0.03
0.02
0.02
0.02
0.02
0.01
0.03
0.04
0.03
0.03
0.02
0.03
0.02
0.04
0.03
0.03
0.03
0.04
0.03
0.04
0.03
0.03
0.01
0.04
0.01
0.03
0.04
0.06
0.03
0.03
0.05
0.03
0.02
0.02
0.03
0.04
0.02
0.05

0.01
0.01
0.00
0.01
0.00
0.01
0.02
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.02
0.01
0.01
0.00
0.01
0.00
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.02
0.01
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01

3
77
310
6
6
42
28
2
460
430
23
840
119
151
52
33
27
4
36
23
67
142
127
560
71

0.6
1.3
1.4
0.5
0.2
0.2
0.8
0.1
5.1
2.3
2.6
4.1
3.1
2.4
2.0
0.2
0.2
0.3
0.9
0.6
1.6
1.4
1.9
1.5
1.1

0.33
0.15
0.08
0.19
0.10
0.03
0.16
0.07
0.24
0.12
0.55
0.14
0.29
0.20
0.28
0.04
0.04
0.16
0.15
0.12
0.20
0.12
0.18
0.06
0.14

0.04
0.16
0.17
0.05
0.04
0.02
0.11
0.01
0.63
0.30
0.28
0.54
0.38
0.30
0.27
0.03
0.03
0.04
0.12
0.07
0.23
0.18
0.24
0.19
0.14

0.04
0.02
0.01
0.03
0.02
0.00
0.02
0.01
0.03
0.02
0.07
0.02
0.04
0.03
0.04
0.01
0.01
0.02
0.02
0.02
0.03
0.02
0.02
0.01
0.02

2
6
30
4
1
7
0
2
166
95
3
183
41
65
6
20
15
4
4
5
14
25
11
51
23

0.4
0.1
0.1
0.2
0.0
0.0
0.1
1.8
0.5
0.3
0.9
1.0
1.0
0.2
0.1
0.1
0.2
0.1
0.1
0.3
0.2
0.2
0.1
0.3

0.27
0.04
0.03
0.13
0.03
0.01
0.07
0.14
0.06
0.20
0.07
0.16
0.12
0.08
0.03
0.03
0.11
0.06
0.03
0.08
0.04
0.05
0.02
0.08

0.04
0.01
0.01
0.02
0.00
0.00
0.01
0.21
0.06
0.04
0.10
0.12
0.12
0.02
0.01
0.01
0.01
0.01
0.00
0.04
0.03
0.02
0.01
0.04

0.03
0.01 *
0.00
0.01 *
0.00
0.00 *
- *
0.01 *
0.02
0.01 *
0.03
0.01
0.02 *
0.02 *
0.01 *
0.00
0.00
0.01
0.01
0.00
0.01
0.01
0.01
0.00
0.01

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

389

447

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Hypopharynx (C12-13) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

390

Female
ASR(W)
CUM 0-74

1061
81
61
24
36
52
7
238
9
3
13
22
23
5
108
27
78
62
10
6
55
12
73
1
48

1.3
1.0
1.2
1.0
1.5
1.2
1.1
1.2
0.7
0.3
1.0
1.3
0.6
0.2
4.6
0.4
1.0
1.0
1.4
0.7
1.4
0.5
2.7
0.0
0.6

0.04
0.12
0.16
0.20
0.26
0.17
0.42
0.09
0.26
0.19
0.55
0.28
0.14
0.11
0.46
0.09
0.12
0.13
0.47
0.30
0.19
0.16
0.32
0.04
0.09

0.16
0.13
0.15
0.12
0.19
0.15
0.17
0.15
0.07
0.06
0.03
0.14
0.07
0.02
0.58
0.05
0.12
0.13
0.17
0.10
0.15
0.07
0.35
0.07

0.01
0.02
0.02
0.03
0.04
0.03
0.08
0.01
0.03
0.04
0.02
0.04
0.02
0.01
0.07
0.01
0.02
0.02
0.06
0.04
0.03
0.02
0.05
0.01

77
9
2
0
3
1
0
17
0
2
2
8
10
6
34
11
12
7
3
2
16
4
14
2
22

0.1
0.1
0.0
0.1
0.0
0.1
0.2
0.3
0.4
0.3
0.3
1.8
0.1
0.1
0.1
0.6
0.2
0.4
0.2
0.5
0.1
0.3

0.01
0.03
0.02
0.04
0.02
0.02
0.18
0.30
0.13
0.09
0.14
0.33
0.04
0.04
0.04
0.35
0.14
0.10
0.09
0.12
0.04
0.05

0.01
0.01
0.00
0.00
0.01
0.03
0.08
0.05
0.03
0.04
0.20
0.01
0.02
0.01
0.12
0.04
0.04
0.02
0.05
0.01
0.03

0.00
0.00
0.00
0.00
0.00
0.03
0.08
0.02
0.01
0.02 *
0.04 *
0.00 *
0.01
0.01
0.07
0.03
0.01 *
0.01 *
0.02
0.00 *
0.01 *

603
42
17
798
88
296
307
752
567
244
78
96
263
198
125
111
132
174
229
177
182
52
101
298
385
156
217
279
235
129
5
95
20
73
16
35
33
1
48
20
10
303
24
0
9
15
15
34
5
13
60
28
42
108

2.3
2.0
1.6
2.8
1.5
1.7
1.1
4.8
1.6
1.3
1.9
0.5
8.0
9.6
7.3
4.5
4.3
4.7
6.1
9.8
10.2
3.9
5.0
3.1
2.3
2.4
3.3
3.2
2.6
3.2
0.6
0.8
2.5
3.1
0.9
0.7
1.3
0.1
1.2
0.7
0.7
3.5
1.4
0.5
0.4
0.5
2.0
0.3
2.0
1.6
0.7
2.2
1.8

0.09
0.31
0.38
0.10
0.16
0.10
0.06
0.18
0.07
0.08
0.21
0.05
0.50
0.70
0.66
0.43
0.38
0.36
0.41
0.77
0.77
0.57
0.51
0.18
0.12
0.20
0.23
0.20
0.17
0.28
0.29
0.09
0.59
0.37
0.25
0.12
0.23
0.12
0.18
0.17
0.21
0.21
0.30
0.16
0.10
0.14
0.35
0.16
0.56
0.22
0.14
0.35
0.17

0.27
0.24
0.20
0.34
0.19
0.21
0.12
0.59
0.19
0.15
0.22
0.06
1.01
1.19
0.87
0.56
0.49
0.56
0.75
1.20
1.24
0.43
0.55
0.36
0.26
0.29
0.39
0.38
0.30
0.37
0.10
0.11
0.30
0.41
0.12
0.08
0.17
0.02
0.15
0.11
0.09
0.44
0.19
0.06
0.05
0.06
0.23
0.04
0.26
0.18
0.08
0.30
0.21

0.01
0.04
0.05
0.01
0.02
0.01
0.01
0.02
0.01
0.01
0.03
0.01
0.07
0.09
0.09
0.06
0.05
0.05
0.05
0.10
0.10
0.07
0.06
0.02
0.01
0.02
0.03
0.02
0.02
0.03
0.05
0.01
0.07
0.05
0.03
0.02
0.03
0.02
0.02
0.03
0.03
0.03
0.04
0.02
0.01
0.02
0.04
0.02
0.08
0.03
0.02
0.05
0.02

83
4
2
9
17
41
39
68
60
68
1
21
14
10
8
5
15
16
10
6
7
2
5
29
44
19
17
31
33
24
1
37
3
12
2
7
7
0
11
9
1
22
1
0
2
3
2
3
0
1
6
1
3
18

0.3
0.2
0.1
0.0
0.3
0.2
0.1
0.3
0.1
0.3
0.0
0.1
0.4
0.4
0.4
0.2
0.4
0.4
0.3
0.3
0.3
0.1
0.3
0.3
0.2
0.3
0.2
0.3
0.3
0.6
0.2
0.3
0.2
0.4
0.1
0.1
0.3
0.2
0.4
0.1
0.2
0.1
0.1
0.0
0.1
0.2
0.2
0.1
0.0
0.1
0.2

0.03
0.08
0.10
0.01
0.07
0.04
0.02
0.04
0.02
0.04
0.01
0.02
0.12
0.14
0.14
0.09
0.12
0.10
0.09
0.15
0.13
0.10
0.12
0.05
0.03
0.06
0.06
0.06
0.06
0.13
0.15
0.05
0.10
0.13
0.10
0.04
0.11
0.07
0.13
0.07
0.05
0.06
0.07
0.01
0.05
0.10
0.15
0.06
0.04
0.08
0.06

0.03
0.02
0.03
0.00
0.04
0.03
0.01
0.04
0.01
0.04
0.00
0.01
0.06
0.05
0.04
0.03
0.05
0.04
0.03
0.03
0.03
0.02
0.03
0.03
0.03
0.03
0.03
0.03
0.04
0.07
0.01
0.04
0.02
0.06
0.02
0.01
0.03
0.02
0.04
0.01
0.02
0.01
0.01
0.01
0.02
0.02
0.02
0.00
0.01
0.03

0.00
0.01
0.02
0.00 *
0.01 *
0.00
0.00 *
0.01
0.00
0.01
0.00
0.00
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.02
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.00
0.01
0.01

*Important. See note on population page.

448

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Hypopharynx (C12-13) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

183
304
7
116
16
22
72
139
197
429
295
746
233
16
195
269
190
8
57
51
62
55
52
45
247
50
13
23
29
28
31
92
662
38
62
62
78
134
223
47
133
333
117
166
41
247

2.5
3.1
0.6
0.7
0.7
0.6
1.2
1.5
2.1
3.1
1.8
4.8
3.4
1.6
4.7
4.4
4.4
1.1
3.0
2.0
1.8
2.7
3.1
1.4
0.6
3.6
1.8
4.0
1.7
2.5
3.1
4.2
1.2
1.1
1.8
0.5
0.8
0.9
0.9
0.5
0.5
0.7
0.6
0.8
0.7
1.3

0.19
0.18
0.22
0.07
0.18
0.12
0.15
0.13
0.15
0.15
0.11
0.18
0.23
0.43
0.35
0.28
0.33
0.43
0.41
0.29
0.23
0.37
0.45
0.22
0.04
0.52
0.49
0.85
0.31
0.47
0.58
0.45
0.05
0.17
0.23
0.07
0.10
0.08
0.06
0.07
0.04
0.04
0.06
0.06
0.11
0.08

0.30
0.37
0.08
0.09
0.08
0.07
0.15
0.17
0.25
0.39
0.21
0.54
0.43
0.19
0.57
0.51
0.53
0.13
0.38
0.24
0.22
0.34
0.38
0.16
0.09
0.47
0.22
0.44
0.21
0.32
0.37
0.57
0.15
0.11
0.24
0.07
0.10
0.12
0.11
0.06
0.05
0.09
0.08
0.10
0.08
0.17

0.02
0.02
0.03
0.01
0.02
0.02
0.02
0.02
0.02
0.02
0.01
0.02
0.03
0.05
0.04
0.03
0.04
0.05
0.05
0.04
0.03
0.05
0.05
0.03
0.01
0.07
0.06
0.10
0.04
0.06
0.07
0.07
0.01
0.02
0.03
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01

9
13
3
30
3
1
15
4
11
22
65
22
17
0
2
8
5
0
0
1
6
2
1
0
54
7
4
6
2
5
7
20
188
10
12
29
37
54
77
17
52
128
43
78
12
98

0.1
0.1
0.2
0.2
0.1
0.0
0.2
0.0
0.1
0.1
0.4
0.1
0.2
0.0
0.1
0.1
0.0
0.2
0.1
0.0
0.1
0.5
0.4
0.9
0.1
0.4
0.8
0.9
0.3
0.3
0.3
0.2
0.3
0.3
0.2
0.1
0.1
0.2
0.2
0.3
0.2
0.4

0.03
0.03
0.12
0.04
0.05
0.03
0.05
0.02
0.03
0.02
0.05
0.03
0.06
0.03
0.05
0.05
0.02
0.07
0.08
0.02
0.02
0.18
0.22
0.37
0.06
0.17
0.29
0.20
0.02
0.09
0.10
0.04
0.06
0.04
0.03
0.04
0.02
0.02
0.03
0.04
0.05
0.05

0.01
0.01
0.03
0.02
0.02
0.00
0.02
0.00
0.01
0.01
0.04
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.05
0.03
0.10
0.01
0.05
0.09
0.10
0.03
0.03
0.03
0.03
0.04
0.04
0.03
0.02
0.02
0.03
0.02
0.04
0.02
0.05

0.00
0.00
0.02
0.00
0.01 *
0.00
0.01
0.00 *
0.00
0.00
0.01
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.00
0.02
0.02
0.04
0.01
0.02
0.04
0.02
0.00
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.00
0.00
0.00
0.01
0.01
0.01

216
16
149
40
10
161
62
8
6
80
59
8
6
11
19
13

0.9
3.7
1.2
0.7
0.5
1.0
1.0
0.9
1.5
0.6
1.4
2.1
0.9
2.2
1.7
1.3

0.07
1.00
0.10
0.12
0.18
0.08
0.13
0.32
0.62
0.07
0.20
0.80
0.39
0.68
0.43
0.36

0.12
0.57
0.17
0.08
0.08
0.13
0.13
0.13
0.26
0.09
0.19
0.22
0.11
0.28
0.25
0.19

0.01
0.19
0.02
0.02
0.03
0.01
0.02
0.05
0.11
0.01
0.03
0.10
0.06
0.10
0.06
0.06

50
1
25
5
3
37
7
1
0
15
9
0
0
1
1
7

0.2
0.2
0.2
0.1
0.2
0.2
0.1
0.1
0.1
0.2
0.2
0.0
0.5

0.03
0.20
0.04
0.04
0.09
0.03
0.05
0.10
0.03
0.06
0.18
0.04
0.20

0.03
0.02
0.03
0.01
0.01
0.03
0.02
0.01
0.01
0.02
0.02
0.01
0.04

0.00
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.02
0.01
0.03

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

391

449

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Pharynx unspecified (C14)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

392

Female
ASR(W)
CUM 0-74

2
8
1
1
1

0.1
0.2
0.1
0.0
0.1

0.08
0.06
0.10
0.03
0.07

1
8
0
1
0

0.1
0.1
0.1
-

0.06
0.05
0.09
-

6
23
21
4
228
2
16
16
2
15
0

0.7
0.9
3.5
0.3
1.1
0.2
0.5
0.2
0.1
1.3
-

0.30
0.20
0.79
0.15
0.08
0.15
0.13
0.06
0.06
0.35
-

0.10
0.11
0.39
0.05
0.13
0.01
0.06
0.02
0.01
0.18
-

0.05
0.03
0.10
0.03
0.01
0.01
0.02
0.01
0.01
0.05
-

2
7
8
0
62
0
6
5
1
1
0

0.2
0.2
1.1
0.2
0.1
0.0
0.0
0.1
-

0.12
0.08
0.38
0.03
0.05
0.02
0.02
0.14
-

0.01
0.02
0.09
0.02
0.01
0.00
0.01
-

0.01
0.01
0.04
0.00
0.01
0.00
0.01
- *

282
27
29
12
6
9
0
16
171
0
12
63
16
46
5
59
253
8
23
20
196
27
4
0
1
0
2
20
59
7
1
1
1
0
7
39
72
31
2
29
13
10
2
468
44
419
98
34
64
28
14
14
8
169
43
120
72
17
50
78
29
49
10
10

0.4
0.3
0.2
0.3
0.2
0.5
0.4
0.4
0.4
0.4
0.7
0.4
0.3
0.4
0.3
0.1
0.4
0.1
0.3
0.1
0.3
0.1
0.1
0.2
0.2
0.3
0.1
0.1
0.1
0.1
0.3
0.6
0.2
0.3
0.2
0.8
0.9
0.4
0.8
0.8
0.8
0.4
0.7
0.4
0.4
0.8
0.3
0.2
0.5
1.0
0.4
0.4
0.1
0.4
0.6
1.0
0.5
1.1
0.5

0.02
0.06
0.04
0.09
0.09
0.17
0.12
0.03
0.11
0.06
0.17
0.06
0.13
0.05
0.02
0.03
0.09
0.03
0.02
0.03
0.17
0.10
0.08
0.04
0.03
0.12
0.07
0.13
0.14
0.05
0.05
0.07
0.05
0.21
0.05
0.23
0.31
0.27
0.04
0.13
0.04
0.05
0.13
0.05
0.08
0.22
0.09
0.07
0.04
0.16
0.04
0.05
0.04
0.05
0.07
0.19
0.07
0.36
0.16

0.04
0.04
0.03
0.04
0.03
0.08
0.05
0.05
0.05
0.06
0.10
0.05
0.03
0.05
0.03
0.01
0.05
0.02
0.04
0.02
0.04
0.01
0.02
0.02
0.03
0.04
0.03
0.04
0.02
0.04
0.07
0.02
0.04
0.02
0.09
0.11
0.05
0.10
0.11
0.10
0.05
0.08
0.05
0.05
0.07
0.05
0.02
0.06
0.13
0.05
0.05
0.02
0.04
0.08
0.14
0.06
0.14
0.05

0.00
0.01
0.01
0.01
0.01
0.03
0.02
0.00
0.02
0.01
0.03
0.01
0.02
0.01
0.00
0.00
0.01
0.00
0.00
0.00
0.02
0.01
0.02
0.01
0.01
0.02
0.03
0.04
0.01
0.01
0.01
0.01
0.03
0.01
0.03
0.04
0.03
0.01
0.02
0.01
0.01
0.02
0.01
0.01
0.02
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.03
0.01
0.05
0.02

128
10
13
2
1
1
0
5
92
0
4
22
5
17
2
27
142
2
11
7
119
23
1
0
0
0
1
20
28
6
2
0
0
0
1
19
21
13
4
9
2
1
1
199
16
182
35
8
26
9
2
7
4
62
11
50
29
6
17
23
8
15
2
6

0.1
0.1
0.1
0.0
0.0
0.1
0.2
0.2
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.0
0.1
0.0
0.2
0.1
0.1
0.0
0.1
0.1
0.2
0.1
0.0
0.1
0.1
0.1
0.5
0.1
0.1
0.1
0.2
0.2
0.2
0.3
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.0
0.1
0.1
0.2
0.1
0.1
0.2

0.01
0.03
0.02
0.03
0.01
0.05
0.07
0.02
0.06
0.03
0.06
0.03
0.13
0.03
0.01
0.01
0.04
0.01
0.02
0.02
0.06
0.03
0.03
0.02
0.07
0.11
0.01
0.03
0.03
0.03
0.25
0.03
0.08
0.08
0.20
0.02
0.06
0.02
0.02
0.06
0.02
0.05
0.08
0.05
0.05
0.02
0.06
0.02
0.02
0.02
0.02
0.03
0.06
0.03
0.08
0.09

0.02
0.01
0.01
0.00
0.00
0.02
0.02
0.01
0.01
0.01
0.01
0.02
0.02
0.02
0.00
0.01
0.00
0.02
0.01
0.01
0.00
0.02
0.01
0.02
0.02
0.00
0.01
0.02
0.02
0.09
0.01
0.01
0.01
0.02
0.03
0.03
0.03
0.01
0.02
0.01
0.02
0.01
0.02
0.01
0.01
0.02
0.01
0.01
0.00
0.01
0.02
0.02
0.01
0.02
0.02

0.00
0.01
0.00
0.00
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.02
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.01
0.00
0.01
0.00
0.01
0.02
0.00
0.00
0.01
0.00
0.05
0.00
0.01
0.01
0.02
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.02
0.01

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

450

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Pharynx unspecified (C14) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

22
63
137
23
113
73
20
51
70
8
62
10
2892
448
2382
91
22
67
15
0
4
11
235
47
181
135
21
112
56
26
146
27
117
6
238
41
191
689
13
118
32
518
67
22
45
264
44
216
14
7
49
33
22
52

0.5
0.3
0.5
0.7
0.4
0.6
0.8
0.6
0.4
0.6
0.4
0.3
0.4
0.7
0.4
0.3
0.8
0.3
0.3
0.2
0.3
0.4
0.7
0.3
0.4
0.7
0.3
0.5
0.2
0.3
1.0
0.3
0.2
0.3
0.6
0.3
0.3
0.1
0.7
0.2
0.3
0.5
0.8
0.5
0.5
0.9
0.4
0.3
0.4
0.2
0.2
0.4
0.3

0.11
0.04
0.04
0.14
0.04
0.08
0.19
0.08
0.05
0.20
0.05
0.10
0.01
0.04
0.01
0.04
0.18
0.04
0.07
0.12
0.10
0.03
0.10
0.03
0.03
0.16
0.03
0.07
0.05
0.03
0.19
0.03
0.08
0.02
0.10
0.02
0.01
0.02
0.06
0.03
0.01
0.07
0.18
0.07
0.03
0.14
0.03
0.07
0.15
0.04
0.05
0.08
0.04

0.06
0.04
0.06
0.08
0.06
0.08
0.10
0.08
0.05
0.06
0.05
0.03
0.05
0.09
0.05
0.04
0.11
0.04
0.04
0.03
0.05
0.05
0.08
0.04
0.05
0.08
0.04
0.06
0.03
0.04
0.12
0.03
0.04
0.04
0.07
0.04
0.04
0.01
0.08
0.02
0.04
0.06
0.11
0.05
0.06
0.11
0.05
0.03
0.04
0.03
0.03
0.04
0.04

0.01
0.01
0.01
0.02
0.01
0.01
0.03
0.01
0.01
0.03
0.01
0.01
0.00
0.01
0.00
0.01
0.03
0.01
0.01
0.02
0.02
0.00
0.01
0.00
0.00
0.02
0.00
0.01
0.01
0.00
0.03
0.00
0.02
0.00
0.01
0.00
0.00
0.00
0.01
0.00
0.00
0.01
0.03
0.01
0.00
0.02
0.00
0.01
0.02
0.01
0.01
0.01
0.01

4
33
44
8
36
16
4
12
28
3
25
2
1168
156
990
52
9
42
5
0
1
4
89
23
65
61
11
48
17
10
53
12
39
4
98
11
87
318
3
41
13
258
27
10
17
87
7
77
7
3
30
23
9
24

0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.2
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.3
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.2
0.0
0.1
0.2
0.3
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1

0.05
0.02
0.02
0.06
0.02
0.03
0.06
0.03
0.02
0.09
0.02
0.04
0.00
0.02
0.00
0.02
0.07
0.02
0.05
0.07
0.05
0.01
0.05
0.01
0.02
0.08
0.02
0.03
0.03
0.01
0.07
0.01
0.05
0.01
0.04
0.01
0.01
0.01
0.03
0.01
0.01
0.03
0.08
0.03
0.01
0.04
0.02
0.04
0.07
0.03
0.04
0.04
0.03

0.01
0.02
0.02
0.03
0.01
0.02
0.02
0.02
0.01
0.02
0.01
0.01
0.02
0.02
0.02
0.02
0.02
0.02
0.01
0.00
0.01
0.01
0.02
0.01
0.02
0.03
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.02
0.02
0.01
0.00
0.02
0.00
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.01
0.02
0.02
0.02
0.01

0.01
0.00
0.00
0.01
0.00
0.00
0.01
0.01
0.00
0.02
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.00
0.01
0.00
0.01
0.01
0.00
0.01
0.01
0.00

0
10
9
0
5
8
9
2
60
86
1
198
24
28
9
14
12
2
14
3
12
10
37
66
14

0.2
0.0
0.3
0.0
0.3
0.1
0.6
0.4
0.1
1.0
0.6
0.4
0.3
0.1
0.1
0.1
0.4
0.1
0.3
0.1
0.5
0.2
0.2

0.06
0.01
0.15
0.01
0.10
0.04
0.09
0.05
0.12
0.07
0.12
0.09
0.11
0.02
0.02
0.09
0.11
0.05
0.10
0.03
0.09
0.02
0.06

0.02
0.01
0.02
0.00
0.04
0.08
0.06
0.02
0.12
0.07
0.06
0.05
0.01
0.01
0.01
0.06
0.01
0.04
0.01
0.07
0.02
0.02

0.01
0.00
0.01
0.00
0.01
0.01
0.01
0.02
0.01
0.02
0.01
0.02
0.00
0.00
0.01
0.02
0.01
0.01
0.00
0.01
0.00
0.01

0
1
1
0
3
3
1
3
29
15
1
55
9
11
2
10
9
1
0
1
2
2
5
15
1

0.0
0.0
0.1
0.0
0.0
0.1
0.3
0.1
0.1
0.3
0.2
0.2
0.1
0.0
0.0
0.1
0.0
0.1
0.0
0.1
0.0
0.0

0.02
0.00
0.08
0.01
0.03
0.10
0.06
0.02
0.12
0.04
0.07
0.05
0.05
0.01
0.01
0.06
0.01
0.04
0.01
0.03
0.01
0.01

0.00
0.00
0.01
0.00
0.00
0.01
0.03
0.01
0.01
0.03
0.02
0.02
0.01
0.00
0.00
0.00
0.01
0.00
0.01
0.00
-

0.00 *
0.00
- *
0.01
0.00 *
0.00 *
0.01 *
0.01
0.00 *
0.01
0.01
0.01 *
0.01 *
0.01 *
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

393

451

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Pharynx unspecified (C14) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

394

Female
ASR(W)
CUM 0-74

126
12
14
4
11
8
2
16
3
0
1
3
2
0
15
60
9
9
0
0
5
2
8
1
1

0.2
0.1
0.3
0.1
0.4
0.2
0.3
0.1
0.3
0.0
0.2
0.1
0.6
0.9
0.1
0.1
0.1
0.1
0.3
0.0
0.0

0.01
0.04
0.08
0.06
0.14
0.07
0.22
0.03
0.17
0.02
0.09
0.05
0.17
0.12
0.04
0.05
0.05
0.05
0.10
0.03
0.01

0.02
0.02
0.05
0.01
0.06
0.03
0.02
0.01
0.02
0.00
0.01
0.01
0.08
0.12
0.01
0.02
0.01
0.00
0.02
0.00
0.00

0.00
0.01
0.01
0.01
0.02
0.01
0.02
0.00
0.02
0.00
0.01
0.01
0.03
0.02
0.01
0.01
0.01
0.00
0.01
0.00
0.00

22
3
1
0
0
2
0
4
0
0
0
2
2
1
6
32
4
2
1
1
3
2
0
2
2

0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.2
0.4
0.1
0.0
0.2
0.1
0.1
0.1
0.1
0.0

0.00
0.02
0.02
0.03
0.01
0.06
0.04
0.08
0.09
0.07
0.03
0.04
0.21
0.08
0.04
0.05
0.04
0.02

0.00
0.01
0.00
0.00
0.00
0.01
0.01
0.01
0.02
0.05
0.00
0.00
0.03
0.01
0.01
0.00
0.00
0.00

0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.01 *
0.01 *
0.01 *
0.00
0.00
0.03
0.01
0.01 *
0.00 *
0.00 *
0.00 *

80
7
10
27
11
82
62
70
46
25
10
10
59
14
5
48
17
21
42
23
53
3
19
32
37
55
66
0
26
13
0
52
3
7
5
8
10
3
12
5
3
148
1
1
3
11
8
27
4
2
10
3
2
99

0.3
0.3
1.0
0.1
0.2
0.4
0.2
0.4
0.1
0.1
0.2
0.0
1.8
0.6
0.3
2.0
0.5
0.6
1.1
1.4
3.0
0.1
1.0
0.3
0.2
0.8
1.0
0.3
0.3
0.4
0.4
0.3
0.3
0.2
0.4
0.4
0.3
0.2
0.2
1.8
0.1
0.1
0.1
0.3
0.2
1.6
0.4
0.3
0.3
0.1
0.1
1.5

0.04
0.12
0.31
0.02
0.05
0.05
0.03
0.05
0.02
0.03
0.08
0.02
0.23
0.17
0.15
0.29
0.13
0.13
0.17
0.30
0.42
0.10
0.23
0.06
0.04
0.12
0.13
0.05
0.10
0.06
0.22
0.11
0.12
0.06
0.12
0.26
0.09
0.08
0.11
0.15
0.09
0.09
0.09
0.08
0.09
0.31
0.18
0.19
0.08
0.04
0.06
0.16

0.04
0.04
0.12
0.01
0.02
0.05
0.02
0.05
0.01
0.02
0.03
0.01
0.23
0.09
0.04
0.24
0.07
0.08
0.12
0.17
0.36
0.01
0.11
0.04
0.02
0.10
0.11
0.03
0.04
0.05
0.05
0.03
0.04
0.02
0.05
0.06
0.04
0.02
0.03
0.23
0.01
0.01
0.01
0.03
0.03
0.19
0.03
0.05
0.03
0.01
0.01
0.20

0.00
0.02
0.04
0.00
0.01
0.01
0.00
0.01
0.00
0.00
0.01
0.00
0.03
0.03
0.02
0.04
0.02
0.02
0.02
0.04
0.05
0.01
0.03
0.01
0.00
0.02
0.01
0.01
0.01
0.01
0.03
0.01
0.02
0.01
0.02
0.03
0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.04
0.02
0.04
0.01
0.01
0.01
0.02

17
1
0
4
1
12
13
10
14
9
4
6
5
4
0
6
0
5
1
0
1
2
4
2
10
19
7
0
10
3
0
17
0
2
1
3
1
2
1
0
0
42
0
0
1
2
2
3
0
0
6
2
0
21

0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.2
0.2
0.2
0.1
0.0
0.1
0.1
0.2
0.0
0.0
0.2
0.1
0.1
0.0
0.1
0.0
0.0
0.1
0.0
0.3
0.0
0.4
0.0
0.0
0.1
0.1
0.1
0.0
0.3

0.01
0.04
0.01
0.02
0.02
0.01
0.02
0.01
0.01
0.02
0.01
0.07
0.10
0.09
0.06
0.03
0.06
0.10
0.10
0.01
0.01
0.06
0.03
0.03
0.01
0.03
0.02
0.02
0.03
0.04
0.22
0.02
0.07
0.01
0.02
0.05
0.05
0.03
0.02
0.07

0.01
0.01
0.00
0.00
0.01
0.00
0.00
0.00
0.01
0.00
0.00
0.02
0.02
0.02
0.01
0.00
0.01
0.02
0.02
0.00
0.01
0.03
0.01
0.01
0.02
0.00
0.01
0.03
0.00
0.05
0.01
0.00
0.01
0.01
0.00
0.03

0.00
0.01
0.00 *
0.00 *
0.00
0.00 *
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.02
0.00
0.01
0.00
0.00
0.01
0.00
0.00
0.01

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp

*Important. See note on population page.

452

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Pharynx unspecified (C14) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

15
36
0
13
8
9
13
40
62
89
45
40
2
2
34
93
85
2
8
4
30
12
7
9
10
5
0
4
1
4
1
11
37
3
2
14
42
78
84
30
109
173
71
37
33
89

0.2
0.4
0.1
0.3
0.2
0.2
0.4
0.6
0.6
0.3
0.3
0.0
0.2
0.8
1.6
2.0
0.1
0.4
0.1
0.9
0.6
0.5
0.3
0.0
0.4
0.7
0.1
0.4
0.1
0.5
0.1
0.1
0.1
0.1
0.4
0.5
0.4
0.3
0.4
0.4
0.4
0.2
0.6
0.5

0.05
0.06
0.02
0.12
0.08
0.07
0.07
0.08
0.07
0.04
0.04
0.02
0.15
0.14
0.16
0.22
0.08
0.16
0.08
0.17
0.19
0.20
0.09
0.01
0.17
0.38
0.06
0.19
0.13
0.15
0.01
0.05
0.04
0.04
0.07
0.06
0.04
0.06
0.04
0.03
0.05
0.03
0.11
0.05

0.03
0.05
0.01
0.05
0.03
0.03
0.05
0.07
0.08
0.03
0.03
0.00
0.03
0.10
0.17
0.24
0.02
0.05
0.02
0.10
0.06
0.05
0.03
0.00
0.05
0.10
0.01
0.05
0.02
0.06
0.01
0.01
0.01
0.02
0.06
0.06
0.04
0.04
0.05
0.04
0.04
0.02
0.07
0.06

0.01
0.01
0.00
0.02
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.00
0.02
0.02
0.02
0.03
0.02
0.02
0.01
0.02
0.02
0.02
0.01
0.00
0.03
0.05
0.01
0.03
0.02
0.02
0.00
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.01
0.00
0.01
0.00
0.01
0.01

1
5
2
3
5
3
3
4
11
16
14
8
1
0
1
15
2
0
0
1
2
1
1
1
5
1
0
2
0
2
0
6
8
0
0
6
16
30
30
21
50
77
31
24
16
48

0.0
0.0
0.1
0.0
0.2
0.1
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.2
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.2
0.1
0.2
0.0
0.0
0.1
0.1
0.1
0.2
0.2
0.1
0.1
0.1
0.2
0.2

0.01
0.02
0.10
0.01
0.08
0.04
0.02
0.02
0.04
0.02
0.02
0.01
0.01
0.01
0.06
0.03
0.05
0.03
0.06
0.05
0.02
0.01
0.02
0.11
0.11
0.09
0.00
0.02
0.03
0.03
0.02
0.04
0.03
0.02
0.03
0.02
0.06
0.03

0.00
0.00
0.02
0.00
0.02
0.01
0.00
0.00
0.01
0.01
0.01
0.00
0.00
0.02
0.01
0.00
0.00
0.00
0.01
0.00
0.00
0.03
0.01
0.02
0.00
0.00
0.01
0.02
0.01
0.02
0.02
0.01
0.02
0.01
0.03
0.03

0.00
0.00
0.01
0.00
0.01 *
0.00
0.00
0.00 *
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.00
0.00
0.01
0.01
0.00
0.00
0.03
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00

105
5
71
11
7
57
24
2
7
25
5
0
1
0
1
3

0.5
1.2
0.6
0.2
0.4
0.4
0.4
0.2
1.8
0.2
0.1
0.2
0.0
0.2

0.05
0.57
0.07
0.06
0.16
0.05
0.08
0.15
0.68
0.04
0.05
0.20
0.03
0.15

0.06
0.09
0.08
0.03
0.05
0.04
0.04
0.03
0.22
0.02
0.01
0.03
0.03

0.01
0.05
0.01
0.01
0.02
0.01
0.01
0.03
0.10
0.01
0.01
0.03
0.02

21
1
24
6
6
19
5
0
1
12
2
0
0
0
0
2

0.1
0.3
0.2
0.1
0.3
0.1
0.1
0.3
0.1
0.1
0.3

0.02
0.33
0.04
0.03
0.14
0.02
0.04
0.28
0.02
0.05
0.19

0.01
0.02
0.01
0.04
0.01
0.01
0.05
0.01
0.01
0.03

0.00
0.01
0.00
0.02
0.00
0.00
0.05
0.00
0.01
0.02

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

395

453

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Oesophagus (C15)
Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

396

Female
ASR(W)
CUM 0-74

4
70
5
125
219

0.2
1.7
0.5
14.1
15.1

0.10
0.22
0.22
1.39
1.15

4
41
2
78
67

0.2
0.9
0.2
8.4
5.3

0.09
0.14
0.16
1.03
0.74

58
262
72
115
2406
81
112
159
55
82
26

6.7
13.1
11.7
8.1
12.0
9.2
3.3
2.1
2.0
7.1
3.1

0.92
0.85
1.43
0.78
0.25
1.04
0.32
0.17
0.28
0.81
0.62

0.79
1.43
1.51
1.01
1.48
1.06
0.36
0.25
0.26
0.95
0.33

0.13
0.11
0.22
0.11
0.04
0.15
0.05
0.03
0.05
0.12
0.09

36
95
19
43
621
51
78
55
24
17
5

3.1
3.9
2.7
2.6
2.2
4.9
1.7
0.6
0.7
1.0
0.4

0.57
0.42
0.66
0.39
0.09
0.70
0.20
0.09
0.15
0.27
0.18

0.38
0.50
0.28
0.29
0.26
0.65
0.23
0.06
0.10
0.15
0.04

0.08
0.07
0.08
0.05
0.01
0.11
0.03
0.01
0.03
0.04
0.03 *

3568
349
673
171
112
62
5
174
1836
30
156
816
243
569
91
799
4569
282
325
492
3436
912
73
55
14
13
72
661
1036
133
28
13
23
17
189
605
625
714
53
655
179
149
26
3734
433
3276
1292
470
809
359
132
219
210
2562
421
2098
1179
600
763
823
259
557
57
105

4.3
3.9
4.3
4.2
4.2
3.3
6.5
5.1
4.5
6.1
4.0
5.7
9.6
4.8
6.3
4.4
4.5
2.5
5.9
3.3
5.0
4.5
5.9
3.4
1.8
3.5
3.6
5.1
4.0
5.4
2.4
1.7
4.5
3.0
3.3
4.4
5.0
6.0
7.9
5.9
10.8
14.8
4.1
5.6
8.4
5.4
5.9
11.1
4.6
5.4
8.2
4.6
5.1
6.6
10.1
6.2
6.0
5.5
5.8
6.1
8.2
5.4
5.9
5.1

0.08
0.21
0.17
0.34
0.41
0.43
3.05
0.40
0.11
1.14
0.35
0.20
0.63
0.21
0.69
0.16
0.07
0.16
0.33
0.15
0.09
0.16
0.71
0.48
0.48
1.09
0.43
0.21
0.13
0.47
0.48
0.48
0.98
0.74
0.25
0.19
0.20
0.24
1.11
0.25
0.83
1.24
0.84
0.10
0.41
0.10
0.17
0.53
0.17
0.29
0.75
0.32
0.37
0.14
0.50
0.14
0.18
0.24
0.21
0.22
0.52
0.24
0.81
0.53

0.54
0.49
0.55
0.53
0.55
0.35
0.93
0.61
0.55
0.78
0.48
0.71
1.22
0.61
0.86
0.55
0.56
0.32
0.77
0.42
0.63
0.58
0.85
0.46
0.27
0.32
0.42
0.66
0.50
0.67
0.30
0.21
0.62
0.28
0.43
0.55
0.63
0.74
1.03
0.73
1.36
1.81
0.56
0.71
1.04
0.68
0.74
1.44
0.57
0.68
1.04
0.58
0.64
0.83
1.27
0.78
0.77
0.67
0.74
0.74
1.00
0.66
0.67
0.62

0.01
0.03
0.03
0.05
0.06
0.06
0.55
0.06
0.02
0.17
0.05
0.03
0.09
0.03
0.11
0.02
0.01
0.02
0.05
0.02
0.01
0.02
0.12
0.07
0.08
0.14
0.06
0.03
0.02
0.07
0.07
0.07
0.15
0.10
0.04
0.03
0.03
0.03
0.17
0.04
0.12
0.17
0.15
0.01
0.06
0.01
0.02
0.08
0.02
0.05
0.11
0.05
0.05
0.02
0.07
0.02
0.03
0.03
0.03
0.03
0.07
0.03
0.11
0.08

1424
123
293
68
43
12
0
58
759
6
62
238
72
164
24
243
1677
112
141
140
1273
345
34
10
10
10
19
245
418
72
15
8
6
1
54
258
198
288
36
250
65
58
7
1288
171
1105
419
198
215
129
62
62
62
800
168
616
350
180
205
254
82
171
19
38

1.3
1.1
1.5
1.2
1.2
0.4
1.2
1.3
0.8
1.2
1.2
1.9
1.0
1.5
1.0
1.2
0.8
2.0
0.7
1.4
1.3
2.0
0.5
0.7
1.8
0.6
1.4
1.1
2.1
1.1
0.7
0.8
0.1
0.6
1.3
1.3
1.7
3.9
1.6
2.6
3.5
0.8
1.4
2.4
1.3
1.4
3.1
0.9
1.4
2.5
0.9
1.2
1.5
2.8
1.2
1.3
1.2
1.0
1.4
1.9
1.2
1.5
1.3

0.04
0.11
0.10
0.16
0.20
0.13
0.18
0.05
0.40
0.18
0.08
0.24
0.08
0.32
0.07
0.03
0.08
0.17
0.06
0.05
0.08
0.37
0.18
0.24
0.67
0.15
0.10
0.06
0.26
0.32
0.25
0.35
0.10
0.09
0.10
0.10
0.12
0.66
0.12
0.36
0.50
0.34
0.05
0.19
0.05
0.07
0.24
0.06
0.13
0.34
0.12
0.16
0.06
0.22
0.06
0.08
0.10
0.08
0.10
0.22
0.10
0.35
0.24

0.15
0.12
0.16
0.14
0.14
0.03
0.13
0.16
0.08
0.14
0.15
0.25
0.12
0.16
0.12
0.15
0.10
0.27
0.08
0.18
0.16
0.28
0.07
0.08
0.21
0.06
0.18
0.14
0.29
0.16
0.09
0.13
0.07
0.16
0.16
0.22
0.50
0.20
0.36
0.47
0.08
0.17
0.28
0.16
0.17
0.40
0.10
0.16
0.30
0.09
0.16
0.18
0.35
0.15
0.17
0.14
0.13
0.18
0.28
0.15
0.24
0.16

0.01
0.02
0.01
0.03
0.03
0.02
0.02
0.01
0.05
0.03
0.01
0.04
0.01
0.05
0.01
0.01
0.01
0.03
0.01
0.01
0.01
0.06
0.03
0.04
0.09
0.02
0.02
0.01
0.04
0.05
0.04
0.06
0.01
0.01
0.02
0.02
0.10
0.02
0.06
0.08
0.06
0.01
0.03
0.01
0.01
0.04
0.01
0.02
0.05
0.02
0.03
0.01
0.03
0.01
0.01
0.01
0.01
0.01
0.04
0.02
0.06
0.03

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

454

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Oesophagus (C15) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

312
1495
2086
280
1791
814
217
591
1088
130
955
173
41538
5264
35284
1646
259
1355
278
11
61
201
3517
556
2861
2412
252
2089
611
703
2875
287
2534
239
4513
503
3715
11756
496
1380
721
9070
898
377
516
2800
352
2410
202
124
1114
748
415
1278

6.5
7.1
6.4
8.8
6.2
6.5
9.3
5.9
5.7
9.5
5.4
5.1
5.7
8.9
5.5
5.8
9.6
5.5
4.6
3.4
3.4
5.5
5.7
8.4
5.4
6.2
8.2
5.9
5.2
5.8
6.2
9.6
5.9
6.7
5.4
8.0
5.3
5.1
2.9
7.9
3.6
5.3
7.1
14.4
5.2
4.9
7.2
4.7
3.7
6.1
5.8
5.8
5.8
6.9

0.38
0.19
0.15
0.54
0.15
0.24
0.65
0.25
0.18
0.85
0.18
0.40
0.03
0.12
0.03
0.15
0.60
0.16
0.29
1.06
0.44
0.41
0.10
0.36
0.11
0.13
0.53
0.13
0.22
0.23
0.12
0.58
0.13
0.46
0.08
0.36
0.09
0.05
0.14
0.22
0.14
0.06
0.24
0.75
0.23
0.09
0.39
0.10
0.27
0.56
0.18
0.22
0.30
0.20

0.77
0.90
0.82
1.17
0.79
0.84
1.24
0.75
0.73
1.21
0.70
0.67
0.72
1.14
0.69
0.73
1.34
0.68
0.57
0.44
0.39
0.69
0.72
1.06
0.69
0.78
1.05
0.74
0.64
0.73
0.79
1.24
0.75
0.84
0.68
1.06
0.66
0.64
0.37
1.04
0.44
0.66
0.90
1.91
0.64
0.62
0.94
0.60
0.48
0.77
0.74
0.73
0.69
0.87

0.05
0.03
0.02
0.08
0.02
0.04
0.10
0.04
0.03
0.13
0.03
0.06
0.00
0.02
0.00
0.02
0.10
0.02
0.04
0.16
0.06
0.06
0.01
0.05
0.02
0.02
0.08
0.02
0.03
0.03
0.02
0.09
0.02
0.07
0.01
0.06
0.01
0.01
0.02
0.03
0.02
0.01
0.03
0.11
0.03
0.01
0.06
0.01
0.04
0.08
0.03
0.03
0.04
0.03

93
501
600
110
487
264
90
174
312
54
255
46
13450
2101
10997
613
100
499
51
1
9
39
1382
309
1043
771
110
631
150
224
870
134
723
82
1470
229
1158
3998
169
544
202
3061
244
97
145
854
133
704
45
46
338
230
117
352

1.2
1.5
1.3
2.4
1.2
1.4
2.6
1.1
1.2
2.7
1.0
1.0
1.3
2.5
1.2
1.5
2.6
1.4
0.6
0.1
0.3
0.8
1.5
3.0
1.3
1.4
2.4
1.3
1.0
1.4
1.3
3.1
1.1
1.4
1.3
2.6
1.2
1.3
0.8
2.3
0.8
1.3
1.4
2.5
1.1
1.1
2.0
1.0
0.6
1.6
1.4
1.3
1.2
1.4

0.15
0.08
0.06
0.25
0.06
0.10
0.29
0.10
0.07
0.39
0.07
0.16
0.01
0.06
0.01
0.07
0.27
0.07
0.09
0.14
0.11
0.13
0.05
0.18
0.05
0.06
0.24
0.06
0.09
0.10
0.05
0.28
0.05
0.19
0.04
0.18
0.04
0.02
0.06
0.10
0.06
0.03
0.10
0.27
0.10
0.04
0.18
0.04
0.10
0.27
0.08
0.10
0.13
0.08

0.16
0.17
0.16
0.28
0.14
0.17
0.31
0.13
0.14
0.33
0.12
0.15
0.16
0.32
0.15
0.20
0.35
0.18
0.07
0.03
0.10
0.18
0.38
0.15
0.17
0.32
0.15
0.12
0.16
0.16
0.40
0.13
0.15
0.15
0.31
0.14
0.16
0.10
0.30
0.09
0.16
0.17
0.29
0.13
0.13
0.25
0.12
0.08
0.17
0.17
0.16
0.14
0.17

0.02
0.01
0.01
0.03
0.01
0.01
0.04
0.01
0.01
0.05
0.01
0.03
0.00
0.01
0.00
0.01
0.04
0.01
0.01
0.02
0.02
0.01
0.03
0.01
0.01
0.04
0.01
0.01
0.01
0.01
0.04
0.01
0.03
0.01
0.03
0.01
0.00
0.01
0.02
0.01
0.00
0.01
0.04
0.01
0.01
0.03
0.01
0.02
0.04
0.01
0.02
0.02
0.01

23
514
2030
254
230
2291
532
25
808
1070
69
1369
333
380
91
358
332
15
252
246
503
1656
773
4084
892

4.2
9.3
9.4
20.2
10.3
9.2
16.5
1.1
9.1
5.5
8.3
6.7
8.7
6.1
3.5
2.1
2.1
1.1
6.4
6.0
12.1
15.4
10.7
10.8
13.0

0.88
0.42
0.21
1.31
0.71
0.20
0.73
0.23
0.32
0.18
1.01
0.19
0.49
0.33
0.37
0.11
0.12
0.29
0.41
0.40
0.54
0.39
0.40
0.17
0.46

0.44
1.03
1.19
2.60
1.08
1.01
2.04
0.12
1.14
0.68
1.12
0.83
1.02
0.75
0.47
0.24
0.24
0.17
0.80
0.78
1.59
1.96
1.39
1.37
1.70

0.12
0.06
0.03
0.19
0.09
0.03
0.10
0.03
0.05
0.03
0.16
0.03
0.07
0.05
0.06
0.02
0.02
0.05
0.06
0.06
0.08
0.06
0.06
0.02
0.07

10
120
455
70
43
965
60
7
479
598
19
905
214
295
28
228
221
7
37
61
106
327
123
823
150

1.8
1.8
1.7
4.8
1.7
3.0
1.9
0.3
5.4
3.6
2.0
4.6
5.7
5.0
0.9
0.9
0.9
0.4
0.8
1.1
2.0
2.2
1.2
1.7
1.6

0.58
0.17
0.09
0.60
0.27
0.10
0.25
0.11
0.25
0.15
0.47
0.16
0.40
0.29
0.18
0.06
0.07
0.14
0.14
0.16
0.20
0.14
0.12
0.06
0.16

0.36
0.23
0.19
0.64
0.22
0.34
0.27
0.03
0.66
0.45
0.21
0.55
0.66
0.62
0.13
0.10
0.10
0.03
0.10
0.11
0.25
0.26
0.14
0.19
0.19

0.12
0.03 *
0.01
0.09 *
0.04
0.02 *
0.04 *
0.02 *
0.03
0.02 *
0.06
0.02
0.05 *
0.04 *
0.03 *
0.01
0.01
0.02
0.02
0.02
0.03
0.02
0.02
0.01
0.02

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

397

455

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Oesophagus (C15) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

398

Female
ASR(W)
CUM 0-74

6856
620
397
142
253
280
51
1334
83
20
14
45
72
41
174
195
390
352
25
13
84
34
204
47
182

8.3
8.1
8.1
6.0
10.6
6.3
7.2
7.1
7.9
2.2
1.4
2.5
2.2
2.6
6.7
3.1
5.0
5.8
3.3
1.7
2.2
1.6
7.8
1.6
2.3

0.10
0.35
0.42
0.52
0.68
0.39
1.04
0.21
0.95
0.50
0.63
0.37
0.26
0.40
0.54
0.23
0.26
0.31
0.69
0.46
0.24
0.27
0.55
0.24
0.17

1.09
1.02
1.08
0.79
1.26
0.83
0.84
0.91
1.07
0.23
0.13
0.32
0.29
0.28
0.85
0.38
0.61
0.69
0.44
0.24
0.26
0.17
1.05
0.21
0.29

0.02
0.05
0.07
0.08
0.10
0.06
0.14
0.03
0.15
0.07
0.08
0.06
0.04
0.06
0.08
0.04
0.04
0.05
0.10
0.07
0.03
0.04
0.08
0.03
0.02

662
75
49
16
29
41
7
154
12
16
3
39
55
41
166
61
110
94
11
5
31
16
49
18
95

0.6
0.7
0.7
0.5
0.8
0.7
0.5
0.6
0.7
1.6
0.5
1.7
1.7
2.7
8.6
0.8
1.1
1.2
2.5
0.6
0.7
0.6
1.7
0.6
1.1

0.02
0.08
0.10
0.12
0.15
0.10
0.19
0.05
0.20
0.41
0.43
0.28
0.23
0.44
0.73
0.10
0.11
0.12
0.78
0.26
0.13
0.16
0.24
0.14
0.12

0.06
0.08
0.07
0.06
0.08
0.08
0.03
0.08
0.08
0.20
0.08
0.20
0.22
0.35
1.04
0.08
0.12
0.13
0.12
0.02
0.09
0.09
0.28
0.05
0.14

0.00
0.01
0.01
0.02
0.02
0.02
0.02
0.01
0.03
0.06
0.07
0.04
0.03
0.07 *
0.10 *
0.01 *
0.02
0.02
0.06
0.02
0.02 *
0.03 *
0.04
0.01 *
0.02 *

1297
97
58
1742
362
1274
702
943
1780
1329
224
700
370
327
161
253
211
261
503
268
271
97
237
679
1036
456
513
553
680
302
49
941
42
170
71
134
92
12
181
62
36
748
87
13
53
94
63
79
19
49
133
95
100
452

4.5
4.1
5.1
6.1
5.2
6.7
2.2
5.8
5.0
6.1
5.1
3.4
10.9
14.6
9.0
10.1
5.9
6.7
12.7
13.1
14.1
5.4
10.3
6.7
5.7
6.6
7.7
6.0
6.8
6.8
5.2
7.6
4.8
7.1
4.1
2.2
3.0
1.3
3.7
2.1
2.4
8.0
4.2
0.9
2.5
1.8
1.8
4.3
1.3
6.7
3.0
2.1
4.8
6.6

0.13
0.43
0.68
0.15
0.28
0.19
0.09
0.19
0.12
0.17
0.34
0.13
0.58
0.84
0.73
0.64
0.43
0.43
0.59
0.85
0.89
0.61
0.70
0.26
0.18
0.31
0.35
0.26
0.27
0.40
0.77
0.25
0.78
0.55
0.51
0.20
0.34
0.40
0.29
0.28
0.40
0.30
0.48
0.28
0.36
0.20
0.24
0.50
0.33
0.97
0.27
0.23
0.49
0.32

0.56
0.47
0.67
0.76
0.64
0.82
0.27
0.71
0.60
0.75
0.66
0.41
1.43
1.83
1.10
1.25
0.75
0.81
1.54
1.58
1.70
0.64
1.29
0.81
0.70
0.84
0.92
0.73
0.85
0.85
0.59
0.91
0.60
0.98
0.54
0.24
0.39
0.19
0.44
0.27
0.28
1.02
0.54
0.10
0.32
0.22
0.23
0.53
0.13
0.85
0.39
0.27
0.65
0.85

0.02
0.06
0.10
0.02
0.04
0.03
0.01
0.03
0.02
0.03
0.05
0.02
0.08
0.12
0.10
0.09
0.06
0.06
0.08
0.11
0.12
0.08
0.10
0.03
0.02
0.04
0.04
0.04
0.04
0.05
0.11
0.04
0.10
0.08
0.07
0.03
0.05
0.06
0.04
0.04
0.05
0.04
0.07
0.04
0.05
0.03
0.03
0.07
0.04
0.14
0.04
0.03
0.07
0.05

340
27
11
209
108
373
205
213
319
518
48
399
38
78
18
53
58
51
93
43
42
20
33
144
271
172
117
147
206
85
16
597
19
40
20
54
37
5
81
27
13
198
37
4
19
35
16
12
6
14
54
29
27
144

0.8
1.0
0.6
0.4
1.1
1.5
0.5
0.9
0.6
1.8
0.5
1.1
0.9
2.1
0.7
1.4
1.2
1.0
1.6
1.6
1.5
0.7
1.0
1.0
0.9
1.8
1.1
1.2
1.6
1.5
1.3
3.5
1.3
1.2
0.6
0.5
0.8
0.2
0.9
0.6
0.7
1.3
1.3
0.2
0.6
0.4
0.3
0.5
0.5
1.4
0.8
0.5
0.7
1.3

0.05
0.20
0.21
0.03
0.13
0.08
0.04
0.06
0.04
0.09
0.08
0.06
0.16
0.27
0.19
0.21
0.18
0.15
0.19
0.30
0.26
0.21
0.19
0.10
0.06
0.15
0.12
0.10
0.12
0.17
0.35
0.16
0.33
0.21
0.16
0.09
0.15
0.10
0.12
0.13
0.20
0.11
0.26
0.09
0.16
0.09
0.08
0.16
0.20
0.41
0.13
0.10
0.16
0.13

0.10
0.12
0.07
0.04
0.14
0.17
0.05
0.10
0.06
0.23
0.07
0.12
0.11
0.26
0.09
0.17
0.13
0.10
0.18
0.18
0.20
0.07
0.11
0.12
0.10
0.21
0.13
0.14
0.19
0.19
0.18
0.38
0.15
0.16
0.06
0.06
0.08
0.02
0.09
0.05
0.09
0.15
0.18
0.01
0.06
0.05
0.03
0.06
0.06
0.21
0.10
0.04
0.09
0.15

0.01
0.03
0.03
0.00 *
0.02 *
0.01
0.00 *
0.01
0.00
0.01
0.01
0.01
0.02
0.04
0.03
0.03
0.02
0.02
0.03
0.04
0.04
0.03
0.03
0.01
0.01
0.02
0.02
0.01
0.02
0.02
0.06
0.02
0.05
0.03
0.02
0.01
0.02
0.02
0.02
0.02
0.03
0.02
0.04
0.01
0.02
0.01
0.01
0.02
0.03
0.07
0.02
0.01
0.02
0.02

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp

*Important. See note on population page.

456

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Oesophagus (C15) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

435
707
39
600
115
166
210
740
578
1077
549
1253
371
43
311
576
355
36
143
103
148
101
109
156
1345
125
57
44
96
87
76
221
4306
237
204
995
1046
1708
2367
861
2824
4622
2032
1918
455
2391

5.8
6.8
2.8
3.3
4.7
4.0
3.6
7.4
5.5
7.7
3.1
8.2
5.4
3.8
7.0
8.6
8.1
3.4
6.7
3.6
4.0
4.9
5.6
4.6
3.4
8.3
6.6
6.9
5.3
6.5
7.1
9.3
7.3
6.5
5.7
7.8
10.3
10.0
8.5
8.2
8.8
8.4
9.7
8.4
7.9
11.7

0.28
0.26
0.46
0.14
0.44
0.32
0.26
0.29
0.24
0.24
0.13
0.23
0.28
0.62
0.42
0.37
0.43
0.67
0.58
0.37
0.34
0.50
0.57
0.38
0.10
0.76
0.91
1.07
0.56
0.71
0.84
0.65
0.11
0.43
0.41
0.26
0.33
0.25
0.18
0.29
0.18
0.13
0.23
0.20
0.38
0.25

0.73
0.83
0.35
0.41
0.58
0.50
0.46
0.86
0.64
0.96
0.40
1.01
0.68
0.44
0.84
1.04
1.02
0.40
0.81
0.43
0.47
0.58
0.67
0.53
0.43
1.08
0.80
0.85
0.67
0.82
0.81
1.18
0.90
0.78
0.67
0.90
1.20
1.19
1.03
0.99
1.03
0.99
1.13
1.00
0.91
1.43

0.04
0.03
0.07
0.02
0.06
0.04
0.03
0.04
0.03
0.03
0.02
0.03
0.04
0.08
0.05
0.05
0.06
0.08
0.08
0.05
0.04
0.06
0.08
0.05
0.01
0.11
0.12
0.15
0.08
0.11
0.11
0.10
0.02
0.06
0.06
0.04
0.05
0.04
0.03
0.04
0.03
0.02
0.03
0.03
0.05
0.04

76
103
11
252
30
42
63
203
106
446
165
128
93
5
40
75
55
4
25
20
24
20
12
20
596
55
13
15
17
27
20
69
1796
85
61
602
692
992
1525
483
1791
2878
1176
1347
304
1524

0.5
0.6
0.6
1.0
0.7
0.7
0.7
1.3
0.6
1.4
0.8
0.6
0.9
0.2
0.5
0.8
0.9
0.4
0.9
0.4
0.4
0.6
0.5
0.4
1.1
2.4
1.2
1.6
0.6
1.5
1.4
2.2
2.3
1.9
1.5
3.3
4.6
3.8
3.6
3.3
3.6
3.3
3.8
4.1
3.4
4.7

0.07
0.06
0.18
0.08
0.14
0.11
0.09
0.10
0.06
0.07
0.07
0.05
0.10
0.08
0.10
0.11
0.13
0.26
0.20
0.09
0.09
0.17
0.16
0.10
0.05
0.36
0.38
0.48
0.16
0.33
0.35
0.29
0.06
0.22
0.21
0.16
0.20
0.14
0.11
0.17
0.10
0.07
0.13
0.13
0.22
0.14

0.05
0.07
0.05
0.12
0.08
0.07
0.08
0.15
0.05
0.13
0.09
0.06
0.10
0.01
0.05
0.08
0.10
0.04
0.12
0.03
0.03
0.07
0.06
0.04
0.13
0.27
0.15
0.17
0.06
0.17
0.17
0.26
0.27
0.22
0.16
0.36
0.52
0.43
0.40
0.37
0.39
0.37
0.41
0.46
0.40
0.53

0.01
0.01
0.02
0.01
0.02 *
0.01
0.01
0.01 *
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.03
0.03
0.01
0.01
0.02
0.02
0.01
0.01
0.05
0.05
0.06
0.02
0.04
0.05
0.04
0.01
0.03
0.03
0.02
0.03
0.02
0.02
0.03
0.02
0.01
0.02
0.02
0.03
0.02

1123
29
682
308
135
856
326
45
39
694
190
18
12
33
68
45

4.7
7.7
5.4
5.2
7.6
4.8
5.1
5.2
9.3
5.2
4.6
5.4
1.7
7.1
6.0
3.8

0.14
1.54
0.22
0.31
0.68
0.17
0.29
0.79
1.53
0.20
0.35
1.37
0.51
1.26
0.81
0.60

0.56
0.78
0.68
0.60
0.97
0.56
0.62
0.51
1.10
0.61
0.58
0.70
0.23
0.84
0.79
0.48

0.02
0.19
0.03
0.04
0.10
0.02
0.04
0.11
0.21
0.03
0.05
0.19
0.09
0.17
0.11
0.09

664
10
293
161
59
484
158
25
4
370
43
0
7
9
9
17

2.0
3.1
1.8
2.1
2.2
1.9
2.0
2.3
1.1
1.9
0.8
0.9
1.8
0.7
1.0

0.09
1.02
0.12
0.18
0.33
0.10
0.18
0.50
0.55
0.11
0.13
0.33
0.61
0.35
0.27

0.22
0.27
0.21
0.24
0.26
0.20
0.25
0.27
0.13
0.21
0.10
0.13
0.22
0.06
0.14

0.01
0.12
0.02
0.03
0.05
0.01
0.03
0.08
0.08
0.02
0.02
0.06
0.08
0.03
0.05

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

399

457

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Stomach (C16)
Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

400

Female
ASR(W)
CUM 0-74

147
147
51
59
129

7.1
3.3
5.1
6.2
9.0

0.62
0.29
0.73
0.92
0.92

71
111
25
64
102

3.1
2.0
2.5
6.9
9.2

0.37
0.20
0.50
0.94
1.02

120
575
119
259
5895
381
935
2444
599
236
222

13.4
29.0
19.2
19.0
29.4
43.1
27.4
33.2
21.8
18.7
25.2

1.29
1.30
1.84
1.21
0.40
2.24
0.93
0.69
0.93
1.26
1.73

1.48
3.32
2.31
2.21
3.43
5.24
3.36
3.77
2.56
2.23
2.94

0.18
0.19
0.28
0.18
0.06
0.34
0.14
0.10
0.14
0.19
0.27

83
343
70
167
3600
182
736
1438
484
157
187

7.0
13.2
9.4
9.0
12.4
16.0
15.9
17.3
13.8
8.7
16.5

0.85
0.76
1.16
0.72
0.22
1.22
0.62
0.47
0.67
0.76
1.25

0.76
1.53
0.86
0.90
1.37
1.62
1.81
1.84
1.48
1.00
2.03

0.11
0.11
0.15
0.10
0.03
0.17
0.09
0.07
0.10
0.11
0.20 *

6653
702
1144
363
247
257
8
296
3300
30
306
896
320
563
116
955
7725
1312
595
1638
4112
1610
153
204
38
57
222
785
2393
261
121
45
107
177
672
940
634
1033
96
916
154
116
30
4540
624
3851
1314
477
792
377
163
179
199
2842
498
2194
1052
573
792
1016
410
592
117
136

7.9
7.5
7.1
8.1
8.7
13.4
10.9
8.2
7.9
5.5
7.3
5.8
11.6
4.4
8.3
5.1
7.3
11.1
10.2
10.3
5.8
7.6
11.5
11.4
4.2
14.3
10.3
5.8
8.8
10.1
9.8
5.2
17.1
33.0
10.9
6.5
5.0
8.0
13.4
7.6
8.6
10.4
4.9
6.2
11.6
5.7
5.7
10.5
4.4
5.6
10.3
3.7
4.6
7.0
11.6
6.1
5.1
5.1
5.8
7.1
12.2
5.5
12.0
6.4

0.10
0.29
0.22
0.45
0.58
0.86
4.04
0.50
0.14
1.06
0.45
0.20
0.67
0.19
0.80
0.18
0.09
0.32
0.43
0.27
0.10
0.20
0.96
0.84
0.70
2.14
0.72
0.22
0.19
0.64
0.94
0.80
1.86
2.52
0.44
0.23
0.20
0.26
1.39
0.27
0.73
1.01
0.97
0.10
0.47
0.10
0.16
0.50
0.16
0.30
0.85
0.28
0.34
0.14
0.53
0.14
0.16
0.23
0.21
0.23
0.62
0.23
1.14
0.58

0.91
0.83
0.82
0.92
1.01
1.65
1.71
0.96
0.92
0.71
0.85
0.68
1.40
0.51
0.95
0.62
0.86
1.26
1.19
1.19
0.68
0.91
1.40
1.25
0.48
1.41
1.19
0.72
1.03
1.16
1.06
0.62
1.88
4.16
1.25
0.77
0.60
0.92
1.43
0.88
1.04
1.25
0.53
0.71
1.31
0.66
0.68
1.22
0.53
0.68
1.24
0.44
0.54
0.82
1.40
0.72
0.59
0.60
0.70
0.81
1.39
0.62
1.36
0.77

0.01
0.04
0.03
0.07
0.09
0.13
0.75
0.07
0.02
0.17
0.07
0.03
0.10
0.03
0.12
0.03
0.01
0.05
0.06
0.04
0.01
0.03
0.15
0.12
0.10
0.30
0.11
0.03
0.03
0.09
0.14
0.13
0.26
0.40
0.07
0.03
0.03
0.04
0.20
0.04
0.11
0.14
0.14
0.01
0.07
0.01
0.02
0.07
0.02
0.05
0.14
0.04
0.05
0.02
0.08
0.02
0.02
0.03
0.03
0.03
0.09
0.03
0.16
0.08

3736
431
650
200
131
110
5
172
1832
18
187
640
197
435
64
525
5064
970
439
1241
2379
1071
105
142
39
61
165
467
1748
217
105
27
70
137
557
591
427
647
49
592
149
117
23
2685
429
2205
954
386
541
297
136
144
131
1904
377
1430
631
329
460
719
331
378
84
92

3.5
3.7
3.2
3.3
3.3
4.8
7.3
3.5
3.4
2.1
3.4
2.8
4.1
2.4
4.4
2.3
3.7
6.3
5.3
6.0
2.5
3.8
5.7
6.4
3.0
10.8
5.7
2.4
4.9
5.5
7.2
2.3
9.4
18.3
6.6
3.1
2.5
3.3
4.8
3.2
5.1
5.8
2.6
2.7
5.4
2.5
2.9
5.2
2.2
3.1
5.1
2.1
2.4
3.1
5.3
2.7
2.1
2.0
2.4
3.5
6.4
2.5
5.3
2.8

0.06
0.20
0.14
0.27
0.33
0.52
3.49
0.31
0.09
0.57
0.29
0.13
0.32
0.13
0.58
0.11
0.06
0.21
0.27
0.18
0.06
0.13
0.60
0.58
0.50
1.56
0.47
0.13
0.13
0.40
0.75
0.46
1.27
1.63
0.29
0.15
0.13
0.15
0.72
0.16
0.48
0.61
0.62
0.06
0.27
0.06
0.10
0.29
0.10
0.19
0.47
0.19
0.24
0.08
0.29
0.08
0.10
0.13
0.12
0.15
0.38
0.15
0.61
0.34

0.39
0.43
0.35
0.35
0.35
0.53
0.99
0.42
0.39
0.19
0.40
0.31
0.43
0.27
0.56
0.26
0.42
0.68
0.59
0.66
0.28
0.43
0.67
0.65
0.34
1.38
0.59
0.27
0.56
0.61
0.71
0.20
1.10
1.92
0.73
0.37
0.28
0.37
0.56
0.35
0.55
0.59
0.29
0.30
0.57
0.26
0.33
0.57
0.25
0.35
0.57
0.24
0.27
0.33
0.55
0.28
0.23
0.22
0.27
0.40
0.71
0.29
0.58
0.32

0.01
0.03
0.02
0.04
0.05
0.07
0.52
0.05
0.01
0.08
0.04
0.02
0.05
0.02
0.09
0.02
0.01
0.03
0.04
0.03
0.01
0.02
0.09
0.08
0.07
0.23
0.07
0.02
0.02
0.06
0.10
0.06
0.17
0.22
0.04
0.02
0.02
0.02
0.11
0.02
0.07
0.08
0.09
0.01
0.04
0.01
0.01
0.04
0.01
0.03
0.07
0.03
0.03
0.01
0.04
0.01
0.01
0.02
0.02
0.02
0.06
0.02
0.09
0.05

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

458

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Stomach (C16) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

334
1654
2091
373
1681
1072
283
768
1056
148
881
203
50995
6864
40907
2581
343
2090
397
41
180
168
5747
796
4514
2267
326
1866
603
686
3454
365
2987
320
6215
738
4457
17304
2093
2025
2196
10779
895
365
517
3861
556
3189
265
119
1194
855
379
1213

6.6
7.2
6.1
11.0
5.5
7.9
11.2
7.1
5.3
10.4
4.8
5.7
6.6
10.9
6.0
8.7
12.3
8.0
6.4
11.8
9.5
4.4
8.7
11.7
8.0
5.5
9.8
4.9
4.9
5.3
7.0
11.2
6.6
7.6
7.0
11.0
6.0
7.2
11.5
11.0
10.3
5.9
6.7
12.8
4.9
6.4
10.6
5.9
4.5
5.3
6.0
6.4
5.1
6.3

0.38
0.19
0.14
0.59
0.14
0.26
0.70
0.27
0.17
0.87
0.17
0.42
0.03
0.13
0.03
0.18
0.67
0.19
0.33
1.90
0.72
0.36
0.12
0.42
0.13
0.12
0.56
0.12
0.21
0.22
0.13
0.60
0.13
0.46
0.09
0.42
0.10
0.06
0.26
0.25
0.23
0.06
0.23
0.69
0.22
0.11
0.46
0.11
0.29
0.51
0.18
0.23
0.27
0.19

0.82
0.83
0.71
1.26
0.64
0.93
1.29
0.84
0.63
1.27
0.57
0.66
0.77
1.27
0.70
1.03
1.49
0.95
0.74
1.42
1.08
0.51
1.00
1.36
0.92
0.63
1.15
0.56
0.59
0.61
0.83
1.26
0.78
0.84
0.82
1.28
0.70
0.85
1.32
1.28
1.20
0.70
0.79
1.51
0.59
0.74
1.17
0.70
0.49
0.63
0.69
0.74
0.56
0.75

0.06
0.03
0.02
0.09
0.02
0.04
0.10
0.04
0.02
0.13
0.02
0.06
0.00
0.02
0.00
0.03
0.10
0.03
0.05
0.29
0.11
0.05
0.02
0.06
0.02
0.02
0.08
0.02
0.03
0.03
0.02
0.09
0.02
0.07
0.01
0.06
0.01
0.01
0.04
0.04
0.03
0.01
0.03
0.10
0.03
0.02
0.07
0.02
0.04
0.08
0.03
0.03
0.04
0.03

181
1087
1359
313
1017
751
254
490
615
102
493
115
32695
5303
25097
1653
254
1295
248
36
130
74
4025
763
2988
1469
253
1164
364
353
2193
297
1845
242
4040
580
2718
11269
1532
1564
1623
6413
544
230
307
2519
423
2009
175
65
688
489
227
650

2.4
3.0
2.8
5.7
2.3
3.6
6.0
2.9
2.2
4.4
1.9
2.6
3.0
5.3
2.6
3.7
5.9
3.3
3.4
7.8
5.7
1.7
4.1
6.5
3.6
2.4
4.6
2.1
2.0
2.1
2.9
5.5
2.6
3.8
3.2
5.6
2.6
3.4
6.4
5.6
5.9
2.5
2.8
4.9
2.1
3.2
5.4
2.9
2.4
2.1
2.7
2.9
2.1
2.4

0.21
0.11
0.09
0.35
0.08
0.15
0.41
0.16
0.10
0.47
0.10
0.28
0.02
0.08
0.02
0.11
0.38
0.11
0.23
1.34
0.53
0.22
0.07
0.25
0.08
0.07
0.31
0.07
0.12
0.13
0.07
0.35
0.07
0.30
0.06
0.25
0.06
0.04
0.17
0.15
0.15
0.04
0.13
0.35
0.13
0.07
0.28
0.07
0.19
0.31
0.12
0.15
0.16
0.11

0.27
0.34
0.29
0.57
0.25
0.37
0.62
0.30
0.24
0.46
0.21
0.29
0.34
0.58
0.29
0.42
0.66
0.36
0.39
0.87
0.64
0.20
0.46
0.71
0.40
0.28
0.49
0.24
0.22
0.24
0.32
0.61
0.28
0.42
0.36
0.60
0.29
0.39
0.69
0.62
0.66
0.28
0.29
0.53
0.22
0.36
0.60
0.33
0.29
0.22
0.32
0.34
0.24
0.28

0.03
0.02
0.01
0.05
0.01
0.02
0.06
0.02
0.01
0.06
0.01
0.04
0.00
0.01
0.00
0.02
0.06
0.02
0.03
0.20
0.07
0.03
0.01
0.04
0.01
0.01
0.05
0.01
0.02
0.02
0.01
0.05
0.01
0.04
0.01
0.04
0.01
0.01
0.02
0.02
0.02
0.01
0.02
0.05
0.02
0.01
0.04
0.01
0.03
0.04
0.02
0.02
0.02
0.02

47
917
3291
431
585
8367
302
164
1119
704
51
961
158
265
122
2025
1907
101
1967
2673
3377
7073
4446
19306
5290

8.5
17.0
14.7
32.1
24.8
34.1
9.4
7.0
12.2
3.4
6.1
4.6
4.1
4.3
4.6
11.6
12.0
6.7
50.2
64.8
80.3
65.8
59.5
51.3
79.4

1.26
0.58
0.26
1.56
1.05
0.39
0.55
0.56
0.37
0.14
0.86
0.15
0.33
0.27
0.42
0.27
0.29
0.70
1.14
1.33
1.40
0.81
0.95
0.38
1.17

0.97
1.92
1.66
4.26
3.08
3.96
1.24
0.87
1.53
0.41
0.77
0.56
0.49
0.49
0.59
1.36
1.41
0.77
6.05
7.83
9.94
7.90
7.21
6.04
9.72

0.18
0.08
0.04
0.24
0.15
0.06
0.08
0.09
0.05
0.02
0.13
0.02
0.05
0.04
0.06
0.04
0.04
0.10
0.16
0.18
0.21
0.11
0.13
0.05
0.16

31
487
1926
156
295
4839
149
110
544
327
24
477
76
149
31
1371
1279
60
945
1492
1637
3249
2317
9372
2799

5.4
7.6
7.3
10.6
11.6
17.2
4.2
4.3
6.0
1.7
2.6
2.3
1.9
2.4
1.0
6.3
6.3
3.5
21.6
27.9
30.2
24.2
22.3
19.8
31.3

0.99
0.35
0.18
0.88
0.69
0.27
0.36
0.43
0.26
0.10
0.54
0.11
0.23
0.20
0.18
0.18
0.19
0.47
0.75
0.86
0.80
0.48
0.55
0.22
0.72

0.88
0.91
0.76
1.41
1.45
1.92
0.50
0.47
0.74
0.19
0.32
0.27
0.22
0.26
0.15
0.69
0.71
0.37
2.52
3.07
3.37
2.67
2.45
2.18
3.49

0.18
0.05 *
0.02
0.14 *
0.10
0.04 *
0.05 *
0.06 *
0.04
0.01 *
0.07
0.02
0.03 *
0.03 *
0.03 *
0.03
0.03
0.06
0.10
0.11
0.11
0.06
0.07
0.03
0.09

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

401

459

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Stomach (C16) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

402

Female
ASR(W)
CUM 0-74

57198
5009
3645
1924
1701
3039
413
13090
944
31
44
225
420
219
156
497
1439
1316
60
63
227
120
73
310
881

65.9
59.9
69.2
73.8
66.6
62.4
54.3
63.7
67.4
3.4
2.8
12.5
12.3
13.4
6.0
7.9
18.3
21.5
7.8
6.5
5.9
5.3
2.7
10.6
11.0

0.28
0.92
1.21
1.78
1.69
1.20
2.75
0.60
2.48
0.63
0.77
0.85
0.61
0.91
0.51
0.38
0.49
0.60
1.06
0.85
0.40
0.49
0.32
0.61
0.38

8.20
7.38
8.42
9.15
8.28
7.86
6.77
7.71
7.93
0.38
0.25
1.50
1.57
1.68
0.73
0.93
2.05
2.44
0.88
0.71
0.70
0.65
0.30
1.28
1.34

0.04
0.13
0.18
0.27
0.25
0.18
0.42
0.09
0.37
0.09
0.08
0.13
0.09
0.14
0.07
0.06
0.07
0.09
0.13
0.12
0.05
0.07
0.04
0.09
0.05

29856
2617
2009
1019
989
1474
228
7165
490
30
42
181
220
99
83
427
958
884
33
41
195
81
36
162
443

25.9
23.9
28.8
29.1
27.5
22.5
19.8
27.1
26.8
2.6
4.2
8.1
6.2
6.2
3.6
5.4
9.9
10.8
5.9
3.8
4.6
3.3
1.2
5.5
5.1

0.15
0.47
0.65
0.94
0.89
0.60
1.37
0.33
1.28
0.50
0.92
0.61
0.42
0.64
0.43
0.27
0.33
0.37
1.05
0.62
0.34
0.38
0.19
0.43
0.25

3.05
2.81
3.43
3.42
3.32
2.65
2.13
3.20
3.15
0.29
0.38
0.88
0.76
0.80
0.37
0.61
1.07
1.19
0.83
0.33
0.56
0.39
0.16
0.63
0.61

0.02
0.07
0.09
0.13
0.13
0.09
0.18
0.05
0.18
0.08
0.10
0.08
0.06
0.10 *
0.05 *
0.04 *
0.05
0.06
0.16
0.07
0.05 *
0.05 *
0.03
0.06 *
0.03 *

4213
420
145
10596
574
1940
5898
3697
5209
1574
1233
2106
380
245
183
312
293
405
370
316
187
151
270
1662
3261
844
1339
1282
1600
657
116
1426
151
667
330
1488
457
311
750
654
218
2052
571
153
538
1550
383
180
141
196
624
1135
489
1176

13.1
17.1
12.4
35.7
7.5
9.0
17.2
21.8
14.1
7.1
27.6
10.2
10.5
9.4
9.3
11.5
7.0
9.6
8.5
13.3
8.3
7.3
9.8
16.2
16.4
11.4
19.9
13.0
15.0
13.6
11.4
11.4
14.5
26.3
15.3
21.7
13.6
29.8
13.7
18.7
13.9
20.0
24.1
10.8
20.7
27.0
10.8
9.0
10.3
25.7
13.1
23.5
22.3
15.7

0.21
0.86
1.05
0.35
0.33
0.21
0.23
0.37
0.20
0.19
0.79
0.23
0.55
0.64
0.71
0.66
0.44
0.49
0.46
0.80
0.65
0.66
0.64
0.40
0.29
0.40
0.55
0.37
0.38
0.54
1.12
0.31
1.24
1.04
0.92
0.61
0.69
1.85
0.52
0.78
0.95
0.46
1.10
0.94
0.96
0.74
0.58
0.69
0.91
1.89
0.55
0.77
1.03
0.48

1.44
1.93
1.38
4.52
0.84
0.98
2.13
2.65
1.58
0.84
3.46
1.11
1.24
0.99
1.04
1.34
0.78
1.06
0.96
1.43
0.86
0.78
1.12
1.80
1.87
1.29
2.31
1.38
1.66
1.56
1.29
1.35
1.69
3.06
1.75
2.47
1.61
3.41
1.52
2.17
1.63
2.33
2.73
1.30
2.31
3.10
1.20
1.12
1.24
2.89
1.53
2.74
2.49
1.85

0.03
0.12
0.15
0.05
0.05
0.03
0.03
0.05
0.03
0.03
0.11
0.03
0.08
0.09
0.10
0.10
0.06
0.07
0.07
0.11
0.09
0.09
0.09
0.05
0.04
0.06
0.08
0.05
0.05
0.08
0.17
0.05
0.18
0.15
0.13
0.09
0.10
0.26
0.07
0.11
0.13
0.07
0.16
0.14
0.14
0.11
0.08
0.10
0.13
0.26
0.08
0.11
0.15
0.07

3733
366
124
7638
369
1323
3682
2395
3873
933
999
1741
210
160
97
172
172
259
215
205
108
68
107
1346
2842
697
1011
1175
1241
521
70
910
112
497
223
1099
356
196
698
430
145
1529
400
86
338
1202
273
121
76
120
431
823
368
873

7.1
9.5
6.7
15.3
3.6
4.3
8.3
9.5
6.9
3.2
13.1
5.6
3.7
3.8
3.4
4.3
3.1
4.4
3.2
5.0
3.2
2.5
2.5
8.4
8.4
5.8
9.1
7.5
7.6
6.9
5.8
5.6
7.1
12.9
7.2
10.8
7.0
13.9
7.9
8.8
7.9
9.3
10.8
5.1
9.4
14.7
5.8
4.9
4.2
9.6
6.1
12.4
10.8
7.3

0.14
0.56
0.67
0.19
0.21
0.14
0.15
0.21
0.12
0.12
0.46
0.15
0.29
0.36
0.39
0.38
0.28
0.31
0.25
0.43
0.36
0.37
0.29
0.26
0.19
0.26
0.32
0.26
0.25
0.35
0.78
0.20
0.84
0.67
0.66
0.40
0.48
1.22
0.36
0.52
0.68
0.29
0.68
0.64
0.64
0.52
0.39
0.49
0.54
1.02
0.36
0.53
0.66
0.29

0.74
1.01
0.68
1.85
0.39
0.44
0.96
1.06
0.74
0.36
1.56
0.60
0.35
0.36
0.35
0.47
0.35
0.48
0.34
0.49
0.35
0.27
0.28
0.90
0.89
0.64
0.91
0.78
0.80
0.78
0.64
0.63
0.74
1.39
0.75
1.09
0.72
1.48
0.86
0.90
0.86
1.02
1.15
0.48
1.01
1.59
0.67
0.57
0.50
1.03
0.64
1.28
1.05
0.80

0.02
0.08
0.09
0.03 *
0.03 *
0.02
0.02 *
0.03
0.02
0.02
0.06
0.02
0.04
0.05
0.05
0.05
0.04
0.04
0.03
0.06
0.05
0.05
0.04
0.03
0.03
0.04
0.04
0.04
0.03
0.05
0.11
0.03
0.11
0.09
0.08
0.05
0.06
0.16
0.05
0.07
0.09
0.04
0.09
0.08
0.09
0.07
0.05
0.07
0.08
0.14
0.05
0.07
0.08
0.04

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp

*Important. See note on population page.

460

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Stomach (C16) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

1842
3018
148
1825
447
793
646
3584
2352
4592
2581
3088
1460
159
850
1401
489
168
314
360
506
407
275
509
3182
118
115
58
186
193
140
188
6687
436
383
1341
1434
2412
4017
955
3386
5543
2833
3084
780
2740

24.0
27.7
10.9
9.1
17.7
18.1
10.2
33.3
19.9
32.7
13.9
19.2
20.9
12.7
15.8
19.0
10.3
12.3
12.4
10.9
11.9
15.8
12.6
12.3
7.2
7.9
11.8
7.9
9.0
13.9
12.4
7.6
11.0
11.5
10.6
10.1
13.8
13.7
13.6
8.7
10.0
9.5
12.6
13.1
12.9
12.8

0.56
0.51
0.91
0.23
0.85
0.66
0.41
0.60
0.43
0.48
0.28
0.35
0.55
1.10
0.58
0.53
0.48
1.12
0.75
0.61
0.55
0.84
0.82
0.58
0.14
0.75
1.16
1.09
0.69
1.04
1.09
0.58
0.14
0.56
0.55
0.29
0.38
0.29
0.23
0.29
0.18
0.13
0.25
0.25
0.48
0.25

2.98
3.40
1.42
1.04
2.18
2.24
1.23
3.88
2.30
3.99
1.71
2.26
2.46
1.52
1.82
2.23
1.21
1.35
1.53
1.29
1.43
1.80
1.44
1.46
0.82
1.02
1.31
0.86
0.99
1.56
1.38
0.88
1.30
1.40
1.29
1.16
1.60
1.59
1.60
0.96
1.15
1.07
1.48
1.55
1.58
1.53

0.08
0.07
0.14
0.03
0.12
0.10
0.06
0.08
0.06
0.07
0.04
0.05
0.08
0.15
0.08
0.07
0.07
0.15
0.11
0.08
0.08
0.12
0.11
0.08
0.02
0.11
0.17
0.16
0.10
0.15
0.16
0.08
0.02
0.08
0.08
0.04
0.06
0.04
0.03
0.04
0.03
0.02
0.04
0.04
0.07
0.04

1567
2245
85
1192
241
435
394
2428
1563
4582
1346
1913
936
88
524
722
298
79
214
225
338
244
161
333
2084
89
59
33
120
140
68
105
3935
272
270
658
829
1402
2405
505
1745
3168
1534
1554
507
1860

11.6
12.4
4.6
4.4
6.0
6.6
4.2
17.1
9.8
15.9
6.0
7.8
8.8
6.0
6.5
7.1
4.9
5.1
6.5
5.6
6.0
6.7
5.4
5.6
3.7
3.7
4.5
3.0
4.4
5.9
4.4
3.2
4.7
5.7
5.4
3.6
5.1
5.1
5.6
3.3
3.6
3.6
4.9
4.6
5.7
5.8

0.32
0.28
0.53
0.15
0.41
0.35
0.23
0.39
0.28
0.26
0.18
0.19
0.31
0.77
0.34
0.30
0.30
0.73
0.52
0.42
0.37
0.52
0.51
0.36
0.10
0.44
0.70
0.63
0.46
0.60
0.60
0.37
0.08
0.37
0.36
0.17
0.21
0.16
0.13
0.17
0.10
0.08
0.15
0.14
0.28
0.15

1.38
1.41
0.56
0.51
0.70
0.73
0.49
1.97
1.06
1.80
0.71
0.87
1.02
0.60
0.71
0.76
0.48
0.53
0.72
0.66
0.67
0.73
0.56
0.58
0.41
0.43
0.45
0.36
0.49
0.62
0.42
0.33
0.54
0.62
0.60
0.38
0.56
0.54
0.62
0.34
0.39
0.39
0.55
0.49
0.65
0.64

0.04
0.04
0.08
0.02
0.06 *
0.05
0.03
0.05 *
0.04
0.03
0.02
0.03
0.04
0.09
0.05
0.04
0.04
0.09
0.07
0.06
0.05
0.07
0.07
0.05
0.01
0.07
0.09
0.09
0.06
0.08
0.08
0.05
0.01
0.05
0.05
0.02
0.03
0.02
0.02
0.02
0.01
0.01
0.02
0.02
0.04
0.02

2083
22
1078
567
155
1751
512
71
29
1212
546
21
63
59
285
77

8.5
6.4
8.3
9.2
7.9
9.9
8.0
8.1
6.8
9.1
11.1
4.6
8.7
12.8
17.2
5.7

0.19
1.42
0.26
0.41
0.66
0.25
0.36
0.99
1.30
0.27
0.51
1.15
1.18
1.69
1.22
0.70

0.97
0.76
0.93
1.12
0.93
1.17
0.92
1.01
0.79
1.01
1.34
0.39
1.14
1.74
2.12
0.56

0.03
0.21
0.04
0.06
0.10
0.04
0.05
0.15
0.18
0.04
0.08
0.14
0.18
0.27
0.18
0.10

1171
13
530
305
87
1014
276
46
20
743
381
24
34
51
191
45

3.8
3.1
3.5
3.7
3.8
4.4
3.5
4.8
5.0
4.5
5.9
4.1
4.3
8.3
7.2
3.0

0.12
0.94
0.17
0.24
0.46
0.16
0.23
0.74
1.13
0.18
0.34
0.97
0.76
1.19
0.68
0.52

0.43
0.37
0.37
0.39
0.37
0.48
0.41
0.60
0.74
0.53
0.61
0.38
0.46
0.93
0.71
0.32

0.02
0.15
0.02
0.03
0.06
0.02
0.03
0.11
0.20
0.03
0.05
0.13
0.10
0.18
0.09
0.08

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

403

461

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Small intestine (C17)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

404

Female
ASR(W)
CUM 0-74

5
20
8
0
2

0.3
0.6
0.9
0.1

0.13
0.13
0.33
0.07

3
27
2
0
4

0.1
0.5
0.2
0.2

0.08
0.10
0.16
0.08

4
56
3
12
240
9
25
37
15
11
6

0.4
2.3
0.4
0.9
1.2
1.1
0.7
0.5
0.6
0.9
0.8

0.21
0.35
0.21
0.27
0.08
0.36
0.15
0.08
0.15
0.28
0.31

0.05
0.26
0.04
0.14
0.14
0.13
0.09
0.06
0.06
0.10
0.10

0.03
0.05
0.02
0.05
0.01
0.05
0.02
0.01
0.02
0.04
0.05

3
46
7
10
220
12
32
32
32
12
4

0.3
1.7
0.8
0.5
0.8
1.1
0.7
0.4
1.0
0.8
0.4

0.18
0.28
0.31
0.15
0.06
0.33
0.14
0.07
0.19
0.25
0.20

0.03
0.19
0.08
0.03
0.10
0.13
0.08
0.05
0.12
0.10
0.07

0.02
0.04
0.04
0.01
0.01
0.05
0.02
0.01
0.03
0.03
0.04 *

893
121
122
45
20
18
2
57
451
18
39
173
47
124
12
202
1179
84
131
139
815
223
28
9
4
2
16
146
317
64
5
5
5
2
51
178
173
166
13
150
35
28
7
836
83
745
282
81
199
90
35
54
44
591
105
463
303
176
218
231
75
154
24
39

1.1
1.3
0.8
1.1
0.7
1.0
1.6
1.6
1.1
3.7
0.9
1.2
1.7
1.0
0.8
1.1
1.2
0.7
2.3
0.8
1.2
1.1
2.2
0.6
0.5
0.7
0.8
1.1
1.2
2.5
0.4
0.6
0.9
0.4
0.8
1.3
1.4
1.4
1.9
1.4
1.8
2.3
1.1
1.2
1.5
1.2
1.2
1.7
1.1
1.3
2.1
1.1
1.1
1.5
2.5
1.4
1.5
1.6
1.7
1.7
2.3
1.5
2.4
1.9

0.04
0.12
0.07
0.18
0.17
0.24
1.15
0.22
0.06
0.91
0.15
0.09
0.25
0.10
0.25
0.08
0.04
0.08
0.20
0.08
0.05
0.08
0.42
0.20
0.27
0.50
0.20
0.10
0.07
0.32
0.17
0.28
0.45
0.29
0.12
0.11
0.11
0.11
0.55
0.12
0.33
0.46
0.43
0.05
0.17
0.05
0.07
0.20
0.08
0.14
0.37
0.15
0.17
0.07
0.25
0.07
0.09
0.13
0.12
0.11
0.27
0.12
0.51
0.31

0.13
0.16
0.08
0.14
0.08
0.13
0.15
0.17
0.14
0.41
0.11
0.14
0.23
0.12
0.09
0.13
0.14
0.08
0.26
0.11
0.15
0.13
0.22
0.08
0.06
0.07
0.09
0.14
0.14
0.30
0.03
0.04
0.11
0.01
0.11
0.15
0.17
0.17
0.26
0.17
0.19
0.25
0.08
0.14
0.16
0.14
0.15
0.20
0.13
0.17
0.26
0.14
0.13
0.18
0.29
0.16
0.18
0.19
0.20
0.20
0.28
0.17
0.24
0.25

0.01
0.02
0.01
0.02
0.02
0.04
0.11
0.03
0.01
0.12
0.02
0.01
0.04
0.01
0.03
0.01
0.01
0.01
0.03
0.01
0.01
0.01
0.05
0.03
0.03
0.07
0.03
0.01
0.01
0.05
0.01
0.03
0.06
0.01
0.02
0.01
0.02
0.02
0.09
0.02
0.05
0.06
0.05
0.01
0.02
0.01
0.01
0.03
0.01
0.02
0.06
0.02
0.02
0.01
0.03
0.01
0.01
0.02
0.02
0.02
0.04
0.02
0.07
0.05

746
95
91
50
26
22
0
39
378
6
39
178
58
119
13
182
1051
79
112
143
708
193
24
13
8
3
16
120
320
63
8
12
5
3
61
163
138
167
8
154
42
36
6
706
88
603
318
94
222
111
43
66
54
540
87
440
257
150
172
181
65
113
23
28

0.8
0.9
0.5
0.8
0.8
1.0
1.0
0.8
1.1
0.9
0.9
1.4
0.8
0.9
0.9
0.8
0.5
1.5
0.7
0.9
0.8
1.3
0.7
0.6
0.6
0.6
0.8
0.9
1.8
0.5
1.0
0.6
0.4
0.8
1.0
0.9
1.1
0.7
1.1
1.8
2.2
0.9
0.8
1.2
0.8
1.1
1.3
1.0
1.2
1.6
1.1
1.1
1.1
1.4
1.0
1.0
1.1
1.0
1.0
1.4
0.9
1.8
1.1

0.03
0.10
0.06
0.14
0.17
0.23
0.17
0.04
0.49
0.16
0.08
0.20
0.08
0.26
0.07
0.03
0.06
0.15
0.06
0.04
0.06
0.29
0.21
0.23
0.38
0.17
0.08
0.06
0.24
0.19
0.30
0.32
0.24
0.10
0.09
0.08
0.10
0.27
0.10
0.30
0.41
0.39
0.04
0.13
0.04
0.06
0.14
0.07
0.12
0.26
0.15
0.16
0.05
0.16
0.05
0.07
0.10
0.09
0.08
0.19
0.09
0.39
0.23

0.09
0.11
0.05
0.08
0.10
0.13
0.13
0.09
0.14
0.10
0.11
0.16
0.09
0.10
0.10
0.10
0.04
0.18
0.09
0.10
0.09
0.13
0.06
0.05
0.04
0.07
0.09
0.11
0.23
0.04
0.09
0.05
0.06
0.09
0.11
0.10
0.13
0.09
0.13
0.22
0.27
0.11
0.10
0.15
0.09
0.12
0.13
0.12
0.13
0.15
0.12
0.13
0.13
0.15
0.12
0.12
0.13
0.12
0.13
0.17
0.12
0.24
0.16

0.00
0.01
0.01
0.02
0.03
0.03
0.03
0.01
0.06
0.02
0.01
0.03
0.01
0.04
0.01
0.00
0.01
0.02
0.01
0.01
0.01
0.04
0.02
0.02
0.04
0.02
0.01
0.01
0.04
0.02
0.04
0.03
0.05
0.01
0.01
0.01
0.01
0.05
0.01
0.04
0.05
0.06
0.00
0.02
0.00
0.01
0.02
0.01
0.02
0.03
0.02
0.02
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.03
0.01
0.06
0.04

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

462

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Small intestine (C17) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

65
268
455
95
355
221
78
141
230
26
203
51
9691
1303
8097
422
63
341
72
3
24
42
855
126
710
514
54
447
130
153
654
79
561
53
1211
168
968
3122
138
438
212
2307
175
64
110
751
108
626
95
28
283
190
65
237

1.4
1.2
1.4
2.7
1.2
1.7
3.0
1.4
1.2
1.8
1.2
1.5
1.3
2.1
1.3
1.5
2.2
1.4
1.2
1.1
1.4
1.1
1.4
1.8
1.3
1.3
1.7
1.3
1.1
1.3
1.4
2.5
1.3
1.4
1.4
2.4
1.4
1.4
0.8
2.4
1.0
1.4
1.3
2.2
1.1
1.3
2.1
1.2
1.8
1.3
1.5
1.5
0.9
1.2

0.18
0.08
0.07
0.28
0.07
0.12
0.35
0.12
0.09
0.37
0.09
0.21
0.01
0.06
0.01
0.08
0.28
0.08
0.15
0.61
0.29
0.17
0.05
0.17
0.05
0.06
0.23
0.06
0.10
0.11
0.06
0.29
0.06
0.20
0.04
0.19
0.05
0.03
0.07
0.12
0.07
0.03
0.10
0.28
0.11
0.05
0.21
0.05
0.19
0.25
0.09
0.11
0.12
0.08

0.17
0.14
0.16
0.32
0.14
0.20
0.35
0.17
0.14
0.21
0.14
0.19
0.16
0.24
0.15
0.17
0.26
0.16
0.14
0.15
0.18
0.12
0.16
0.21
0.16
0.16
0.21
0.16
0.13
0.17
0.16
0.30
0.15
0.17
0.17
0.28
0.17
0.16
0.09
0.28
0.13
0.16
0.16
0.24
0.14
0.15
0.25
0.14
0.21
0.17
0.18
0.17
0.11
0.15

0.03
0.01
0.01
0.04
0.01
0.02
0.05
0.02
0.01
0.05
0.01
0.03
0.00
0.01
0.00
0.01
0.04
0.01
0.02
0.09
0.04
0.02
0.01
0.02
0.01
0.01
0.03
0.01
0.01
0.02
0.01
0.04
0.01
0.03
0.01
0.03
0.01
0.00
0.01
0.02
0.01
0.00
0.01
0.04
0.02
0.01
0.03
0.01
0.03
0.04
0.01
0.02
0.02
0.01

62
256
403
107
293
216
81
133
228
39
188
32
8829
1309
7267
370
61
296
66
2
15
46
822
148
661
506
68
428
111
119
604
78
515
60
1104
175
867
2744
117
400
207
1988
146
45
100
696
110
568
70
27
232
157
75
231

1.0
0.9
1.0
2.3
0.8
1.3
2.3
1.1
0.9
1.9
0.9
0.9
1.0
1.5
0.9
1.0
1.6
0.9
1.0
0.4
0.7
1.1
1.0
1.4
1.0
1.0
1.5
1.0
0.8
0.8
1.0
1.8
0.9
1.3
1.0
1.8
1.0
1.0
0.5
1.6
0.8
0.9
0.9
1.2
0.8
1.0
1.6
0.9
1.1
0.8
1.0
1.0
0.9
1.0

0.15
0.06
0.05
0.23
0.05
0.10
0.27
0.10
0.07
0.33
0.07
0.16
0.01
0.04
0.01
0.06
0.21
0.06
0.13
0.26
0.20
0.19
0.04
0.12
0.04
0.05
0.20
0.05
0.08
0.08
0.05
0.21
0.05
0.19
0.03
0.15
0.04
0.02
0.05
0.08
0.06
0.02
0.08
0.18
0.09
0.04
0.16
0.04
0.14
0.18
0.07
0.09
0.11
0.07

0.11
0.10
0.12
0.29
0.10
0.16
0.27
0.13
0.11
0.23
0.10
0.11
0.11
0.18
0.11
0.12
0.20
0.11
0.11
0.02
0.09
0.13
0.12
0.17
0.11
0.13
0.19
0.12
0.09
0.11
0.12
0.22
0.11
0.15
0.12
0.21
0.12
0.11
0.05
0.19
0.10
0.11
0.09
0.13
0.08
0.11
0.20
0.11
0.15
0.09
0.13
0.13
0.10
0.12

0.02
0.01
0.01
0.03
0.01
0.01
0.04
0.01
0.01
0.05
0.01
0.02
0.00
0.01
0.00
0.01
0.03
0.01
0.02
0.02
0.03
0.02
0.01
0.02
0.01
0.01
0.03
0.01
0.01
0.01
0.01
0.03
0.01
0.03
0.00
0.02
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.02
0.01
0.01
0.02
0.01
0.02
0.03
0.01
0.01
0.01
0.01

2
75
125
8
17
231
22
17
21
44
3
51
2
12
6
151
142
9
30
21
53
82
57
264
39

0.3
1.3
0.6
0.6
0.7
1.0
0.7
0.7
0.2
0.2
0.4
0.2
0.1
0.2
0.2
0.9
0.9
0.6
0.8
0.6
1.3
0.8
0.8
0.7
0.6

0.24
0.15
0.05
0.21
0.17
0.07
0.16
0.18
0.05
0.03
0.22
0.04
0.04
0.06
0.10
0.08
0.08
0.22
0.14
0.14
0.18
0.09
0.11
0.05
0.11

0.15
0.06
0.07
0.09
0.12
0.09
0.10
0.02
0.02
0.04
0.03
0.01
0.02
0.03
0.11
0.11
0.06
0.07
0.08
0.16
0.09
0.10
0.09
0.07

0.02
0.01
0.03
0.03
0.01
0.02
0.03
0.01
0.00
0.03
0.01
0.00
0.01
0.01
0.01
0.01
0.03
0.02
0.02
0.03
0.01
0.02
0.01
0.01

3
55
121
3
17
210
20
3
7
30
1
38
2
12
3
117
107
9
24
36
25
45
48
168
32

0.5
0.9
0.5
0.2
0.7
0.8
0.6
0.1
0.1
0.2
0.1
0.2
0.1
0.2
0.1
0.5
0.5
0.5
0.5
0.6
0.5
0.3
0.5
0.4
0.4

0.30
0.12
0.05
0.14
0.17
0.06
0.13
0.08
0.03
0.03
0.13
0.03
0.04
0.06
0.06
0.05
0.06
0.16
0.11
0.12
0.10
0.05
0.08
0.03
0.10

0.06
0.10
0.05
0.03
0.10
0.10
0.08
0.02
0.01
0.02
0.01
0.02
0.01
0.02
0.01
0.06
0.06
0.04
0.08
0.09
0.05
0.03
0.06
0.04
0.05

0.04
0.02 *
0.01
0.02 *
0.03
0.01 *
0.02 *
0.01 *
0.00
0.00 *
0.01
0.00
0.01 *
0.01 *
0.01 *
0.01
0.01
0.02
0.02
0.02
0.01
0.01
0.01
0.00
0.01

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

405

463

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Small intestine (C17) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

406

Female
ASR(W)
CUM 0-74

879
85
71
23
36
55
5
224
24
4
12
17
19
5
8
45
67
60
4
3
11
5
10
14
31

1.0
1.1
1.3
0.8
1.4
1.2
0.7
1.1
1.6
0.4
0.3
0.9
0.4
0.3
0.2
0.7
0.8
1.0
0.6
0.3
0.3
0.2
0.4
0.5
0.4

0.03
0.13
0.16
0.17
0.24
0.17
0.32
0.08
0.37
0.21
0.09
0.22
0.11
0.14
0.09
0.11
0.10
0.12
0.31
0.18
0.09
0.10
0.12
0.13
0.07

0.12
0.13
0.14
0.11
0.20
0.15
0.11
0.12
0.20
0.05
0.03
0.10
0.06
0.05
0.02
0.07
0.10
0.12
0.06
0.03
0.03
0.03
0.04
0.06
0.05

0.01
0.02
0.02
0.03
0.04
0.03
0.06
0.01
0.06
0.03
0.01
0.03
0.02
0.03
0.01
0.01
0.01
0.02
0.03
0.02
0.01
0.02
0.02
0.02
0.01

650
54
53
12
25
36
8
172
10
8
4
13
12
4
7
35
58
48
4
6
13
3
3
10
11

0.6
0.5
0.8
0.4
0.7
0.6
0.7
0.7
0.5
0.6
0.6
0.6
0.3
0.3
0.4
0.4
0.6
0.6
0.8
0.5
0.3
0.1
0.1
0.3
0.1

0.02
0.07
0.11
0.11
0.14
0.09
0.25
0.05
0.18
0.25
0.40
0.16
0.10
0.13
0.14
0.08
0.08
0.09
0.38
0.22
0.08
0.07
0.06
0.11
0.04

0.06
0.06
0.09
0.05
0.08
0.06
0.06
0.08
0.06
0.04
0.05
0.07
0.05
0.04
0.03
0.06
0.07
0.07
0.12
0.03
0.04
0.01
0.02
0.03
0.02

0.00
0.01
0.01
0.02
0.02
0.01
0.03
0.01
0.03
0.02
0.05
0.02
0.02
0.02 *
0.01 *
0.01 *
0.01
0.01
0.07
0.02
0.01 *
0.01 *
0.01
0.01 *
0.01 *

240
10
10
93
55
167
109
91
282
166
28
204
36
33
17
28
42
39
53
20
22
13
25
78
154
43
49
103
88
27
12
126
8
26
20
54
26
4
56
48
14
114
20
12
33
65
26
11
6
7
35
27
19
68

0.8
0.4
0.9
0.3
0.8
0.8
0.3
0.5
0.8
0.8
0.6
1.0
1.0
1.3
0.9
1.0
1.1
1.0
1.3
1.0
1.2
0.8
1.0
0.8
0.8
0.7
0.8
1.1
0.9
0.6
1.3
1.1
0.8
1.1
0.9
1.0
0.9
0.4
1.2
1.6
0.9
1.2
1.0
1.0
1.4
1.3
0.7
0.6
0.5
1.0
0.7
0.5
0.9
1.0

0.05
0.14
0.27
0.03
0.11
0.07
0.03
0.06
0.05
0.06
0.12
0.07
0.17
0.23
0.22
0.19
0.19
0.16
0.18
0.23
0.26
0.24
0.22
0.09
0.07
0.11
0.11
0.11
0.09
0.12
0.40
0.10
0.29
0.21
0.22
0.14
0.19
0.22
0.17
0.25
0.24
0.12
0.24
0.29
0.26
0.18
0.14
0.20
0.21
0.37
0.13
0.11
0.22
0.12

0.09
0.05
0.11
0.04
0.09
0.10
0.04
0.07
0.09
0.09
0.09
0.11
0.13
0.15
0.09
0.11
0.13
0.12
0.13
0.10
0.15
0.11
0.15
0.10
0.09
0.08
0.09
0.14
0.10
0.08
0.11
0.14
0.13
0.11
0.10
0.11
0.10
0.06
0.15
0.21
0.10
0.14
0.13
0.13
0.18
0.16
0.08
0.08
0.04
0.10
0.09
0.06
0.10
0.11

0.01
0.02
0.04
0.00
0.01
0.01
0.00
0.01
0.01
0.01
0.02
0.01
0.03
0.03
0.03
0.03
0.02
0.02
0.02
0.03
0.04
0.03
0.03
0.01
0.01
0.01
0.01
0.02
0.01
0.02
0.04
0.01
0.05
0.03
0.03
0.02
0.02
0.03
0.02
0.03
0.03
0.02
0.03
0.04
0.04
0.02
0.02
0.03
0.02
0.05
0.02
0.02
0.03
0.02

239
20
9
114
47
148
85
63
233
142
31
183
29
27
10
28
39
27
35
14
13
9
18
76
154
45
46
77
72
31
12
78
10
13
25
41
32
3
40
34
7
101
25
8
30
49
22
6
6
3
30
24
16
43

0.5
0.5
0.7
0.3
0.5
0.6
0.2
0.3
0.5
0.5
0.5
0.7
0.6
0.8
0.5
0.8
0.9
0.5
0.7
0.7
0.5
0.4
0.7
0.6
0.5
0.4
0.5
0.7
0.5
0.5
1.2
0.5
0.6
0.4
0.7
0.6
0.9
0.3
0.5
0.9
0.4
0.7
1.1
0.6
1.1
0.8
0.5
0.2
0.4
0.4
0.5
0.5
0.5
0.5

0.04
0.13
0.25
0.03
0.08
0.06
0.02
0.04
0.03
0.05
0.09
0.06
0.12
0.17
0.16
0.17
0.16
0.11
0.13
0.21
0.16
0.15
0.18
0.07
0.05
0.07
0.08
0.09
0.07
0.11
0.39
0.06
0.21
0.12
0.18
0.11
0.18
0.23
0.09
0.18
0.14
0.09
0.24
0.22
0.23
0.14
0.12
0.12
0.19
0.25
0.10
0.13
0.14
0.09

0.06
0.06
0.07
0.03
0.06
0.07
0.02
0.03
0.05
0.06
0.05
0.08
0.07
0.09
0.05
0.09
0.12
0.06
0.08
0.08
0.07
0.06
0.09
0.06
0.06
0.05
0.06
0.08
0.06
0.06
0.12
0.05
0.06
0.05
0.09
0.07
0.11
0.03
0.05
0.11
0.04
0.08
0.14
0.07
0.13
0.09
0.07
0.02
0.06
0.03
0.05
0.06
0.05
0.05

0.01
0.02
0.03
0.00 *
0.01 *
0.01
0.00 *
0.00
0.00
0.01
0.01
0.01
0.02
0.02
0.02
0.02
0.02
0.01
0.02
0.02
0.02
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.05
0.01
0.03
0.02
0.03
0.01
0.02
0.02
0.01
0.02
0.02
0.01
0.03
0.03
0.03
0.02
0.02
0.01
0.03
0.02
0.01
0.01
0.02
0.01

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp

*Important. See note on population page.

464

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Small intestine (C17) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

37
55
9
242
11
7
16
94
143
33
104
111
46
4
37
54
29
4
25
23
39
20
12
17
541
19
8
6
29
20
15
28
485
20
32
76
85
150
247
85
294
363
170
181
73
163

0.5
0.5
0.7
1.4
0.5
0.2
0.3
0.9
1.2
0.2
0.6
0.7
0.7
0.3
0.7
0.8
0.6
0.3
1.1
0.7
1.0
0.8
0.6
0.5
1.4
1.2
0.8
0.9
1.5
1.6
1.4
1.0
0.8
0.5
0.9
0.6
0.9
0.9
0.9
0.8
0.9
0.7
0.9
0.9
1.3
0.8

0.08
0.07
0.23
0.09
0.14
0.06
0.07
0.09
0.11
0.04
0.06
0.07
0.10
0.15
0.13
0.11
0.12
0.19
0.24
0.16
0.16
0.18
0.18
0.12
0.06
0.28
0.31
0.39
0.29
0.37
0.35
0.21
0.04
0.12
0.16
0.08
0.10
0.08
0.06
0.09
0.06
0.04
0.07
0.07
0.16
0.07

0.07
0.06
0.12
0.16
0.06
0.02
0.03
0.10
0.14
0.02
0.07
0.07
0.08
0.06
0.09
0.09
0.08
0.05
0.11
0.09
0.13
0.11
0.10
0.05
0.17
0.13
0.10
0.08
0.19
0.24
0.22
0.12
0.10
0.05
0.10
0.07
0.09
0.10
0.11
0.10
0.11
0.09
0.10
0.10
0.17
0.11

0.01
0.01
0.04
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.03
0.02
0.01
0.02
0.03
0.03
0.02
0.02
0.03
0.03
0.02
0.01
0.04
0.05
0.04
0.04
0.06
0.07
0.03
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01

43
65
10
247
7
12
13
81
117
75
77
97
32
7
38
40
23
6
9
12
20
11
11
19
475
17
11
10
17
15
5
33
422
18
20
87
86
135
222
61
241
300
134
144
67
162

0.3
0.3
0.6
1.2
0.2
0.2
0.1
0.6
0.7
0.3
0.4
0.4
0.3
0.3
0.5
0.5
0.4
0.7
0.4
0.4
0.3
0.4
0.4
0.4
1.0
0.9
1.3
1.1
0.7
0.8
0.4
1.2
0.6
0.4
0.5
0.6
0.7
0.6
0.6
0.4
0.6
0.5
0.6
0.5
0.8
0.6

0.06
0.05
0.21
0.09
0.06
0.06
0.04
0.07
0.07
0.04
0.05
0.05
0.07
0.13
0.09
0.09
0.10
0.31
0.14
0.13
0.08
0.13
0.14
0.10
0.05
0.23
0.40
0.41
0.20
0.24
0.17
0.23
0.03
0.10
0.12
0.07
0.08
0.06
0.05
0.06
0.05
0.03
0.06
0.05
0.12
0.06

0.04
0.05
0.07
0.16
0.01
0.03
0.02
0.07
0.07
0.03
0.04
0.05
0.04
0.05
0.06
0.05
0.06
0.09
0.04
0.05
0.04
0.04
0.07
0.05
0.13
0.12
0.17
0.12
0.09
0.10
0.06
0.15
0.07
0.04
0.05
0.07
0.08
0.07
0.07
0.04
0.07
0.06
0.07
0.06
0.09
0.08

0.01
0.01
0.03
0.01
0.01 *
0.01
0.01
0.01 *
0.01
0.00
0.01
0.01
0.01
0.03
0.01
0.01
0.01
0.04
0.02
0.01
0.01
0.02
0.02
0.01
0.01
0.03
0.05
0.05
0.03
0.03
0.03
0.03
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.02
0.01

282
2
157
65
19
166
61
7
4
146
54
1
5
11
9
25

1.2
0.3
1.3
1.1
1.0
1.0
1.0
0.8
0.9
1.1
1.3
0.2
0.6
2.2
0.6
2.1

0.08
0.25
0.11
0.15
0.25
0.08
0.13
0.32
0.44
0.10
0.18
0.23
0.29
0.68
0.22
0.44

0.14
0.04
0.14
0.13
0.11
0.11
0.12
0.10
0.11
0.13
0.14
0.06
0.06
0.26
0.07
0.26

0.01
0.03
0.01
0.02
0.03
0.01
0.02
0.05
0.06
0.01
0.02
0.06
0.04
0.09
0.03
0.07

221
2
119
47
14
160
43
5
5
115
24
1
5
6
6
4

0.9
0.4
0.9
0.7
0.8
0.8
0.6
0.6
1.2
0.8
0.5
0.2
0.7
1.1
0.2
0.3

0.06
0.25
0.09
0.12
0.23
0.07
0.10
0.29
0.61
0.08
0.11
0.19
0.34
0.45
0.09
0.17

0.10
0.03
0.10
0.10
0.10
0.09
0.06
0.08
0.14
0.09
0.05
0.05
0.08
0.10
0.02
0.03

0.01
0.02
0.01
0.02
0.03
0.01
0.01
0.04
0.07
0.01
0.01
0.05
0.04
0.05
0.02
0.02

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

407

465

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Large bowel (C18-21)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

408

Female
ASR(W)
CUM 0-74

152
339
113
75
125

6.6
6.9
12.0
7.5
7.4

0.58
0.40
1.15
1.03
0.80

154
271
95
89
94

6.8
4.8
9.2
8.1
6.3

0.57
0.30
0.96
0.98
0.79

260
494
103
246
6570
119
472
975
234
189
84

28.5
24.4
15.8
17.7
32.8
13.5
13.6
13.0
8.4
16.2
9.4

1.85
1.18
1.65
1.17
0.42
1.26
0.65
0.43
0.57
1.21
1.05

3.37
2.81
1.90
2.20
3.86
1.62
1.51
1.49
0.98
1.93
1.13

0.27
0.17
0.24
0.18
0.06
0.19
0.09
0.06
0.08
0.17
0.16

210
590
106
330
7518
144
648
1020
290
275
106

15.9
23.0
15.4
18.2
26.3
13.5
14.3
12.1
8.9
18.0
9.0

1.24
1.02
1.55
1.03
0.32
1.16
0.59
0.39
0.55
1.17
0.91

1.84
2.69
1.97
2.06
2.98
1.58
1.67
1.29
1.04
1.96
0.94

0.17
0.15
0.25
0.15
0.04
0.17
0.09
0.06
0.08
0.15
0.13 *

42.6 0.23
40.1 0.68
37.2 0.51
46.7 1.11
42.9 1.28
53.5 1.72
71.7 10.25
51.0 1.24
43.6 0.34
43.5 2.94
40.4 1.08
38.2 0.52
39.8 1.25
37.7 0.57
38.3 1.69
33.1 0.44
35.1 0.19
30.0 0.52
40.9 0.86
29.1 0.45
36.6 0.24
35.3 0.43
38.7 1.74
32.7 1.46
29.2 1.89
38.5 3.74
32.4 1.28
36.2 0.55
35.6 0.38
43.9 1.34
33.0 1.76
32.7 2.10
47.5 3.13
35.9 2.63
27.1 0.70
38.4 0.56
33.7 0.53
42.0 0.61
40.1 2.45
41.9 0.64
42.6 1.60
50.7 2.22
27.6 2.20
39.5 0.26
41.2 0.90
39.2 0.27
38.4 0.42
44.4 1.03
37.1 0.47
36.9 0.77
46.3 1.77
34.5 0.87
32.1 0.90
43.6 0.34
49.9 1.10
42.7 0.37
41.7 0.47
43.7 0.66
44.7 0.59
46.3 0.59
49.8 1.27
45.4 0.68
51.6 2.38
45.1 1.54

5.14
4.82
4.32
5.59
5.30
6.58
8.51
5.84
5.34
4.90
4.83
4.59
4.80
4.53
4.77
3.88
4.15
3.53
4.89
3.49
4.32
4.13
4.28
3.82
3.77
4.40
3.69
4.26
4.23
5.33
3.81
3.94
5.30
4.56
3.30
4.55
4.06
5.02
4.75
5.01
4.88
5.68
3.36
4.69
4.97
4.66
4.54
5.22
4.40
4.34
5.34
4.10
3.85
5.20
6.06
5.08
4.92
5.19
5.30
5.55
5.93
5.46
6.22
5.65

0.03
0.10
0.07
0.16
0.20
0.26
1.49
0.18
0.05
0.44
0.16
0.07
0.18
0.08
0.26
0.06
0.03
0.08
0.13
0.07
0.04
0.06
0.25
0.21
0.29
0.53
0.19
0.08
0.06
0.20
0.25
0.31
0.43
0.41
0.11
0.08
0.08
0.09
0.36
0.10
0.23
0.31
0.34
0.04
0.13
0.04
0.06
0.15
0.07
0.11
0.27
0.13
0.13
0.05
0.16
0.05
0.07
0.10
0.09
0.09
0.19
0.10
0.36
0.23

31165
2914
5048
1746
1137
774
33
1690
16167
253
1403
5630
1330
4231
506
5592
35620
3312
2506
3981
25444
7219
524
529
251
145
552
4878
9675
1268
333
217
276
180
1562
5592
4216
5659
382
5210
930
690
211
27711
2363
24982
8668
2299
6285
2623
861
1714
1342
18153
2456
15259
8780
5302
6335
6035
1737
4262
521
912

29.4
26.1
25.9
30.5
31.7
35.3
45.6
35.3
30.4
36.8
27.0
27.3
31.9
26.0
33.4
23.8
25.7
22.6
32.4
19.9
26.9
25.6
28.9
25.2
20.5
26.9
19.7
26.5
26.3
34.3
23.1
19.9
35.3
24.8
19.1
28.6
25.6
31.2
38.9
30.5
33.2
37.1
23.9
29.4
32.3
29.0
28.1
34.0
26.6
28.5
35.3
26.3
24.5
31.2
38.1
30.0
30.7
32.2
34.1
31.5
36.3
29.9
35.9
28.7

0.18
0.52
0.41
0.84
1.05
1.35
8.34
0.97
0.26
2.63
0.85
0.40
0.95
0.44
1.55
0.35
0.15
0.41
0.68
0.33
0.20
0.34
1.36
1.17
1.33
2.53
0.88
0.44
0.30
1.02
1.35
1.39
2.47
1.91
0.50
0.46
0.43
0.48
2.05
0.50
1.24
1.60
1.96
0.21
0.69
0.22
0.33
0.75
0.37
0.60
1.27
0.69
0.75
0.26
0.80
0.28
0.37
0.53
0.47
0.45
0.93
0.51
1.66
1.11

3.41
2.99
2.97
3.56
3.74
4.23
5.40
4.01
3.55
4.29
3.09
3.19
3.82
3.00
3.96
2.72
2.93
2.59
3.79
2.26
3.08
2.89
3.30
2.91
2.30
3.29
2.12
2.99
2.95
3.96
2.48
2.26
3.93
2.72
2.15
3.25
3.02
3.60
4.80
3.51
3.63
4.12
2.38
3.35
3.73
3.30
3.28
4.03
3.08
3.35
4.14
3.09
2.81
3.59
4.48
3.44
3.57
3.73
4.01
3.63
4.14
3.45
4.03
3.30

0.03
0.08
0.06
0.12
0.15
0.20
1.31
0.14
0.04
0.39
0.12
0.06
0.14
0.06
0.24
0.05
0.02
0.06
0.10
0.05
0.03
0.05
0.20
0.17
0.18
0.35
0.12
0.07
0.04
0.15
0.19
0.19
0.32
0.26
0.07
0.07
0.07
0.07
0.31
0.07
0.17
0.22
0.28
0.03
0.10
0.03
0.05
0.11
0.05
0.09
0.19
0.10
0.11
0.04
0.12
0.04
0.05
0.08
0.07
0.06
0.13
0.07
0.24
0.16

35704
3709
5920
1999
1211
1017
54
1839
18074
241
1640
5782
1090
4634
554
6296
36828
3456
2344
4536
26000
7417
522
556
254
130
686
4889
9612
1109
390
259
293
192
1616
5523
4308
5373
280
5004
767
570
173
28655
2171
26101
8695
1991
6609
2479
760
1660
1402
17898
2146
15271
8658
5039
6168
6449
1620
4777
492
953

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

466

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Large bowel (C18-21) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

2171
9712
13112
1629
11279
5555
1254
4224
8625
715
7832
1340
307163
27683
268954
13569
1396
11779
2009
73
633
1260
28258
2766
24605
16548
1421
14702
4945
4489
22290
1524
20421
1789
33857
3020
27826
92106
5622
8328
6364
70792
5557
1321
4180
22324
2474
19326
1688
865
7301
4765
3249
7687

42.5
42.8
38.5
48.2
37.3
41.7
50.1
40.0
42.8
49.2
42.4
37.8
40.1
44.7
39.6
44.9
49.6
44.7
32.5
21.4
34.3
32.4
43.1
41.3
43.9
41.1
43.4
40.0
39.8
35.4
45.3
48.9
44.7
45.2
38.4
45.3
37.9
38.6
31.5
45.8
30.4
39.3
42.3
47.7
40.6
37.3
47.9
36.3
29.5
38.6
36.7
35.5
44.4
39.8

0.96
0.46
0.35
1.24
0.37
0.59
1.47
0.65
0.48
1.88
0.50
1.09
0.08
0.27
0.08
0.41
1.35
0.44
0.75
2.57
1.39
0.97
0.27
0.80
0.30
0.33
1.18
0.35
0.59
0.56
0.32
1.29
0.34
1.15
0.22
0.85
0.24
0.13
0.43
0.51
0.39
0.16
0.58
1.35
0.65
0.26
0.99
0.27
0.75
1.37
0.45
0.54
0.82
0.48

5.00
5.19
4.58
5.74
4.43
4.98
6.00
4.77
5.07
5.77
5.02
4.47
4.77
5.35
4.72
5.32
5.81
5.30
3.94
2.59
4.10
3.96
5.14
5.07
5.23
4.93
5.19
4.81
4.68
4.24
5.43
6.09
5.36
5.30
4.55
5.26
4.51
4.57
3.73
5.42
3.65
4.66
5.09
5.80
4.88
4.44
5.73
4.32
3.42
4.65
4.37
4.20
5.30
4.83

0.14
0.07
0.05
0.18
0.05
0.09
0.22
0.10
0.07
0.28
0.07
0.16
0.01
0.04
0.01
0.06
0.19
0.07
0.11
0.37
0.20
0.14
0.04
0.12
0.04
0.05
0.17
0.05
0.09
0.08
0.05
0.19
0.05
0.17
0.03
0.13
0.04
0.02
0.06
0.08
0.06
0.02
0.08
0.20
0.09
0.04
0.15
0.04
0.11
0.21
0.07
0.08
0.12
0.07

2240
10291
13331
1813
11320
5814
1412
4348
8496
840
7594
1186
305145
31173
263920
13925
1499
12088
1710
58
477
1138
29994
3664
25520
17131
1611
15061
4719
4518
22679
1724
20624
1864
33868
3361
27853
91132
5089
9161
5649
70342
5153
1389
3715
20818
2653
17644
1657
888
6881
4644
3310
7392

32.6
30.8
28.6
37.3
27.3
30.8
38.4
28.8
29.9
37.9
29.2
26.7
29.2
34.1
28.5
32.2
36.2
31.9
22.2
13.3
20.9
23.8
31.7
33.8
31.6
30.4
33.4
29.5
28.3
27.5
31.7
34.6
31.2
31.6
28.4
35.5
27.9
28.3
22.5
35.5
21.2
28.7
28.9
32.8
27.5
26.4
36.0
25.2
23.8
29.8
27.0
27.0
33.9
27.6

0.79
0.35
0.28
0.94
0.29
0.46
1.09
0.51
0.37
1.40
0.39
0.88
0.06
0.20
0.06
0.31
0.97
0.34
0.58
1.79
1.00
0.79
0.21
0.59
0.23
0.26
0.89
0.27
0.46
0.47
0.25
0.90
0.26
0.87
0.17
0.65
0.19
0.10
0.33
0.39
0.29
0.13
0.44
0.94
0.50
0.20
0.74
0.21
0.64
1.13
0.37
0.44
0.67
0.37

3.78
3.51
3.30
4.32
3.14
3.59
4.49
3.36
3.43
4.35
3.35
3.17
3.36
3.99
3.28
3.73
4.34
3.67
2.55
1.56
2.35
2.76
3.66
4.01
3.64
3.57
3.94
3.46
3.28
3.19
3.68
4.02
3.62
3.66
3.27
4.17
3.22
3.26
2.57
4.16
2.42
3.31
3.33
3.79
3.16
3.02
4.20
2.88
2.73
3.41
3.16
3.14
3.91
3.19

0.11
0.05
0.04
0.13
0.04
0.07
0.16
0.07
0.05
0.20
0.06
0.13
0.01
0.03
0.01
0.05
0.14
0.05
0.08
0.25
0.14
0.11
0.03
0.09
0.03
0.04
0.13
0.04
0.07
0.07
0.04
0.13
0.04
0.13
0.03
0.10
0.03
0.02
0.05
0.06
0.04
0.02
0.06
0.13
0.07
0.03
0.11
0.03
0.09
0.16
0.05
0.07
0.09
0.05

80
1374
8775
272
427
6533
575
510
543
1155
36
1334
249
335
151
7337
6966
272
1630
1812
2304
6166
3464
14062
3652

13.2
25.4
39.2
20.9
18.3
27.2
17.4
21.6
5.7
5.4
4.1
5.9
6.0
5.3
5.6
41.7
43.0
19.2
41.5
44.3
54.8
58.7
46.8
37.4
55.8

1.52
0.70
0.43
1.30
0.90
0.35
0.74
1.00
0.25
0.17
0.69
0.17
0.39
0.30
0.46
0.51
0.55
1.20
1.04
1.10
1.16
0.77
0.84
0.32
0.99

1.67
3.00
4.63
2.59
2.26
3.25
2.06
2.74
0.64
0.63
0.48
0.67
0.70
0.60
0.74
4.97
5.15
2.40
5.10
5.44
6.74
7.21
5.68
4.44
6.79

0.23
0.10
0.06
0.18
0.13
0.05
0.10
0.15
0.03
0.02
0.10
0.02
0.05
0.04
0.07
0.08
0.08
0.19
0.15
0.15
0.17
0.11
0.12
0.04
0.13

47
1135
7234
242
366
6339
448
457
395
675
34
914
160
302
115
7371
6982
257
1220
1454
1749
4331
2842
10353
2807

7.3
17.8
28.4
17.8
14.9
23.2
12.7
16.9
4.3
3.7
3.6
4.4
3.9
4.9
3.9
33.8
34.7
15.8
26.8
28.0
32.7
32.6
27.3
21.7
31.4

1.11
0.54
0.36
1.19
0.79
0.31
0.62
0.85
0.22
0.15
0.63
0.15
0.32
0.29
0.37
0.43
0.45
1.01
0.81
0.86
0.83
0.55
0.60
0.23
0.71

0.78
2.20
3.28
2.21
1.81
2.78
1.56
2.01
0.49
0.43
0.46
0.51
0.42
0.59
0.52
3.95
4.08
1.90
3.11
3.28
3.86
3.81
3.18
2.50
3.70

0.15
0.08 *
0.05
0.16 *
0.11
0.04 *
0.09 *
0.12 *
0.03
0.02 *
0.09
0.02
0.04 *
0.04 *
0.06 *
0.06
0.06
0.15
0.11
0.11
0.12
0.07
0.08
0.03
0.09

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

409

467

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Large bowel (C18-21) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

410

Female
ASR(W)
CUM 0-74

25365
2101
1490
899
695
1497
165
7332
369
131
152
443
490
94
210
1560
3228
2907
117
204
389
265
265
385
1139

29.5
25.8
29.0
34.8
27.5
31.4
21.9
36.6
27.2
13.7
8.3
24.4
13.8
5.3
7.1
24.3
40.1
46.0
15.8
22.5
9.9
12.1
9.7
12.9
14.4

0.19
0.61
0.79
1.22
1.10
0.86
1.76
0.46
1.59
1.24
1.26
1.19
0.64
0.56
0.53
0.66
0.72
0.87
1.54
1.62
0.51
0.75
0.60
0.67
0.43

3.61
3.02
3.47
4.29
3.39
3.84
2.80
4.35
3.56
1.56
0.87
3.02
1.66
0.65
0.83
2.89
4.63
5.36
1.81
2.60
1.14
1.39
1.11
1.61
1.77

0.03
0.09
0.11
0.18
0.16
0.13
0.27
0.07
0.26
0.18
0.16
0.18
0.09
0.08
0.08
0.10
0.10
0.13
0.19
0.23
0.07
0.10
0.09
0.10
0.06

19979
1665
1245
642
623
1167
156
5539
327
152
83
373
438
62
112
1483
2782
2537
72
173
384
235
217
272
842

17.7
15.4
18.4
18.8
17.6
18.6
14.1
21.6
18.7
12.5
9.5
16.8
12.2
3.7
5.2
18.5
29.3
31.7
13.7
18.2
9.2
9.7
7.1
9.2
9.9

0.13
0.38
0.52
0.76
0.72
0.56
1.18
0.30
1.07
1.07
1.41
0.88
0.59
0.48
0.53
0.50
0.57
0.65
1.69
1.42
0.48
0.64
0.49
0.56
0.34

2.12
1.84
2.22
2.22
2.14
2.27
1.54
2.62
2.29
1.46
1.03
1.98
1.42
0.41
0.59
2.24
3.30
3.58
1.66
2.12
1.09
1.09
0.93
1.10
1.20

0.02
0.05
0.08
0.11
0.11
0.08
0.15
0.04
0.16
0.15
0.20
0.13
0.08
0.07 *
0.07 *
0.08 *
0.08
0.09
0.24
0.20
0.06 *
0.08 *
0.07
0.08 *
0.05 *

12767
908
452
7875
2819
8578
10419
7224
21727
8994
1454
5234
1780
858
744
1224
1570
1675
1671
754
813
709
1076
4491
8616
2277
2975
4465
4778
2473
308
5362
401
1013
1036
3008
1364
416
2257
1433
452
4781
944
425
1019
2470
1009
638
398
286
2052
2175
920
3307

40.9
37.6
39.2
26.4
37.4
40.6
30.6
42.5
59.1
39.3
31.6
25.6
48.7
33.6
38.6
45.7
38.0
40.3
39.0
32.4
37.5
37.2
40.2
43.2
43.8
30.7
43.9
45.7
44.4
51.1
31.2
43.2
39.4
39.6
50.4
47.1
42.4
41.6
41.7
44.5
29.0
47.4
42.6
30.9
43.3
45.5
28.2
32.0
28.8
37.4
42.4
47.0
43.4
44.9

0.37
1.27
1.86
0.30
0.73
0.46
0.31
0.51
0.41
0.43
0.84
0.36
1.18
1.21
1.46
1.33
1.03
1.02
0.99
1.27
1.39
1.54
1.31
0.65
0.48
0.66
0.81
0.70
0.66
1.05
1.86
0.61
2.05
1.27
1.68
0.93
1.24
2.22
0.93
1.25
1.38
0.72
1.50
1.61
1.45
0.99
0.93
1.31
1.52
2.26
0.98
1.10
1.47
0.81

4.98
4.53
4.93
3.31
4.44
4.82
3.84
5.22
7.32
4.64
4.06
2.96
5.93
3.78
4.73
5.36
4.54
4.80
4.75
3.82
4.62
4.60
5.03
5.32
5.36
3.54
5.30
5.47
5.18
6.17
3.76
5.27
5.03
4.62
6.18
5.61
5.09
5.12
4.84
5.48
3.25
5.68
5.29
3.63
5.37
5.54
3.45
4.07
3.59
4.48
5.07
5.73
5.09
5.45

0.05
0.19
0.28
0.04
0.11
0.06
0.04
0.07
0.06
0.07
0.12
0.05
0.17
0.17
0.22
0.19
0.15
0.15
0.15
0.18
0.20
0.22
0.19
0.09
0.07
0.10
0.12
0.10
0.09
0.15
0.28
0.09
0.31
0.18
0.24
0.13
0.18
0.32
0.13
0.18
0.19
0.10
0.22
0.23
0.21
0.14
0.13
0.20
0.22
0.33
0.14
0.16
0.21
0.12

11780
858
435
8868
2287
7301
8271
5693
16111
8821
1803
5780
1367
747
576
1012
1348
1362
1372
641
703
571
718
4166
8443
2851
2773
4239
4923
2438
269
4075
367
983
861
2490
1344
371
2302
1104
431
3974
814
365
779
2112
840
469
396
265
1839
1798
811
2751

24.3
23.9
26.4
18.2
23.1
26.7
19.6
23.7
30.6
29.8
22.3
19.5
26.1
20.2
21.9
27.2
25.4
24.6
21.9
19.3
22.8
22.9
21.0
26.4
25.7
23.4
26.0
29.3
29.2
32.8
23.8
26.6
25.7
27.8
31.8
29.5
29.8
28.7
27.8
25.6
22.3
28.4
27.1
22.8
26.0
31.6
18.9
19.7
23.6
25.3
27.7
30.5
27.5
26.6

0.26
0.92
1.39
0.21
0.55
0.35
0.23
0.34
0.26
0.36
0.57
0.29
0.80
0.86
1.03
0.96
0.80
0.75
0.68
0.92
1.00
1.17
0.92
0.45
0.33
0.52
0.54
0.51
0.48
0.77
1.60
0.46
1.73
1.01
1.30
0.70
1.01
1.78
0.68
0.91
1.12
0.53
1.17
1.34
1.12
0.81
0.73
1.00
1.31
1.79
0.75
0.85
1.08
0.59

2.75
2.58
3.00
2.25
2.60
3.03
2.38
2.77
3.60
3.52
2.71
2.16
3.04
2.25
2.38
3.07
2.98
2.75
2.45
2.15
2.56
2.53
2.50
3.03
2.93
2.63
2.88
3.30
3.27
3.72
2.71
3.10
2.92
3.12
3.66
3.33
3.43
3.39
3.10
2.97
2.69
3.26
3.08
2.66
3.03
3.71
2.19
2.35
2.83
2.85
3.12
3.61
3.25
3.09

0.04
0.13
0.20
0.03 *
0.08 *
0.05
0.03 *
0.05
0.04
0.05
0.08
0.04
0.11
0.12
0.14
0.13
0.11
0.10
0.09
0.12
0.14
0.15
0.13
0.06
0.05
0.07
0.07
0.07
0.07
0.11
0.23
0.07
0.21
0.13
0.17
0.09
0.13
0.24
0.09
0.12
0.16
0.07
0.15
0.18
0.15
0.11
0.10
0.14
0.18
0.24
0.10
0.12
0.15
0.08

*Important. See note on population page.

468

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Large bowel (C18-21) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

2116
3384
375
7808
801
1245
1860
4368
4871
5299
5616
8311
3093
358
2043
3328
1453
343
1126
995
1681
1022
934
1236
13048
527
335
272
648
503
372
935
23987
1627
1541
4507
4206
6644
11592
3604
11560
18022
7801
8807
2382
9035

26.9
30.4
27.6
40.7
31.6
28.6
28.8
40.4
40.9
37.4
30.0
52.5
44.5
26.0
37.5
44.8
30.6
28.5
44.1
29.9
38.5
39.4
41.3
29.7
30.0
32.8
35.5
37.9
32.2
36.0
35.1
36.9
39.8
43.9
42.0
35.0
40.9
38.6
40.5
33.8
35.5
32.0
36.1
38.3
40.1
43.1

0.59
0.53
1.46
0.50
1.14
0.83
0.69
0.65
0.61
0.52
0.41
0.59
0.80
1.51
0.89
0.81
0.82
1.80
1.42
1.01
0.98
1.32
1.46
0.91
0.29
1.47
2.03
2.45
1.32
1.67
1.89
1.27
0.26
1.10
1.10
0.55
0.66
0.50
0.39
0.58
0.36
0.25
0.43
0.43
0.85
0.47

3.44
3.74
3.40
4.75
3.82
3.53
3.72
5.04
4.92
4.67
3.72
6.59
5.45
2.91
4.39
5.32
3.62
3.39
5.20
3.63
4.47
4.89
4.89
3.39
3.56
3.87
4.29
4.76
3.74
4.37
4.26
4.36
4.80
5.37
5.11
4.11
4.92
4.63
4.88
4.06
4.20
3.77
4.23
4.60
4.87
5.19

0.09
0.08
0.22
0.07
0.16
0.12
0.10
0.09
0.09
0.07
0.06
0.09
0.12
0.20
0.12
0.11
0.12
0.24
0.20
0.14
0.14
0.19
0.21
0.12
0.04
0.22
0.30
0.37
0.19
0.25
0.27
0.19
0.04
0.16
0.16
0.08
0.10
0.07
0.06
0.09
0.05
0.04
0.06
0.06
0.13
0.07

2598
3472
390
8066
779
1093
1752
3528
3749
7610
3859
6086
2450
268
1381
2129
1224
252
789
774
1299
717
687
962
12548
569
262
209
561
454
257
856
22425
1493
1382
3983
3309
5751
9400
3204
10896
17201
6420
7116
2181
8111

18.5
19.1
22.6
32.7
20.3
17.9
18.5
25.2
24.2
27.3
17.7
26.7
23.9
16.6
18.9
22.0
21.2
19.2
26.4
19.6
24.3
22.1
25.8
18.8
23.4
24.9
21.1
21.3
20.9
23.3
19.4
24.7
28.7
32.3
29.4
24.5
23.0
24.5
24.2
23.7
24.8
22.3
22.9
23.9
27.7
27.5

0.39
0.35
1.21
0.43
0.77
0.59
0.47
0.47
0.44
0.34
0.30
0.36
0.52
1.19
0.60
0.54
0.64
1.55
1.09
0.79
0.75
0.97
1.14
0.71
0.25
1.18
1.49
1.71
1.00
1.28
1.33
0.97
0.21
0.89
0.87
0.45
0.46
0.37
0.29
0.47
0.28
0.20
0.33
0.32
0.66
0.35

2.30
2.25
2.64
3.80
2.31
2.12
2.26
3.00
2.71
3.28
2.14
3.15
2.80
1.79
2.23
2.47
2.38
2.22
3.02
2.27
2.85
2.59
2.89
2.15
2.82
2.77
2.52
2.41
2.47
2.67
2.30
2.96
3.40
3.89
3.58
2.87
2.62
2.86
2.80
2.78
2.83
2.57
2.65
2.76
3.23
3.21

0.06
0.05
0.17
0.06
0.11 *
0.08
0.07
0.06 *
0.06
0.05
0.04
0.05
0.07
0.15
0.08
0.07
0.09
0.19
0.15
0.10
0.10
0.13
0.15
0.09
0.04
0.16
0.22
0.23
0.14
0.17
0.18
0.14
0.03
0.13
0.13
0.06
0.07
0.05
0.04
0.07
0.04
0.03
0.05
0.05
0.09
0.05

11289
144
6249
2928
885
8543
2894
438
69
6436
1890
134
270
200
739
458

47.2
36.8
50.1
48.5
48.4
48.3
46.3
50.9
17.3
49.3
41.1
33.1
38.5
41.7
53.8
37.0

0.46
3.29
0.65
0.94
1.69
0.54
0.88
2.50
2.18
0.64
1.01
3.22
2.52
3.01
2.29
1.81

5.81
4.80
6.17
5.94
6.06
5.83
5.51
6.33
2.07
6.13
4.99
3.57
4.67
4.96
6.68
4.37

0.07
0.53
0.10
0.14
0.25
0.08
0.13
0.38
0.31
0.09
0.15
0.43
0.36
0.45
0.32
0.27

9461
82
5143
2605
830
7252
2282
340
40
6296
1470
116
143
162
613
334

33.2
24.9
35.3
34.1
36.3
33.1
30.7
32.7
9.8
39.5
26.4
22.5
18.6
28.8
32.0
24.8

0.38
2.94
0.54
0.76
1.40
0.43
0.70
1.88
1.57
0.55
0.76
2.44
1.61
2.33
1.62
1.50

3.96
2.67
4.15
3.91
4.25
3.89
3.50
3.68
1.01
4.77
3.01
2.38
2.14
3.24
3.74
2.80

0.05
0.40
0.08
0.11
0.20
0.06
0.10
0.27
0.21
0.08
0.11
0.33
0.22
0.31
0.21
0.22

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

411

469

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Colon (C18)
Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

412

Female
ASR(W)
CUM 0-74

66
212
62
29
67

3.0
4.2
6.5
2.9
3.8

0.40
0.31
0.85
0.63
0.55

65
152
62
43
44

2.8
2.7
6.1
4.1
3.2

0.37
0.22
0.79
0.68
0.56

186
311
53
146
3866
68
270
616
150
125
55

20.3
15.3
7.9
10.5
19.3
7.8
7.8
8.3
5.5
10.9
6.0

1.56
0.94
1.14
0.90
0.32
0.96
0.49
0.34
0.47
1.00
0.83

2.34
1.74
0.94
1.32
2.23
0.97
0.86
0.94
0.65
1.33
0.68

0.22
0.14
0.17
0.14
0.05
0.15
0.07
0.05
0.07
0.14
0.12

145
378
56
189
4593
101
409
673
181
177
51

11.2
14.9
8.0
10.5
15.9
9.4
9.0
7.9
5.5
11.3
4.3

1.05
0.82
1.12
0.78
0.25
0.96
0.46
0.31
0.42
0.92
0.63

1.31
1.66
0.92
1.16
1.78
1.07
1.05
0.81
0.65
1.19
0.47

0.15
0.12
0.17
0.11
0.04
0.14
0.07
0.04
0.06
0.12
0.10 *

22226
2205
3437
1195
742
638
30
1163
11659
150
1007
4096
819
3239
366
4278
24224
2130
1663
2803
17350
4881
364
370
135
87
434
3269
6405
784
269
151
178
108
1016
3763
2821
3649
195
3394
549
418
117
20057
1574
18229
5951
1436
4457
1669
522
1111
902
12175
1594
10275
5820
3443
4144
4365
1183
3153
357
632

26.1
23.6
21.2
27.2
25.7
33.2
40.2
31.7
27.7
25.5
24.2
26.7
29.7
25.9
25.9
21.9
22.6
18.3
29.1
18.2
23.7
22.8
26.8
21.1
15.3
26.6
20.5
23.6
23.3
30.8
22.3
18.8
27.0
20.3
17.4
25.2
21.8
28.0
28.1
27.8
29.7
36.0
18.0
26.6
30.0
26.2
26.2
32.4
24.7
25.1
33.0
23.0
20.3
29.1
36.9
28.0
27.5
29.0
29.6
30.7
36.1
29.2
37.2
29.0

0.18
0.52
0.38
0.84
0.98
1.35
7.70
0.97
0.27
2.20
0.83
0.43
1.08
0.47
1.40
0.36
0.15
0.41
0.73
0.36
0.19
0.34
1.45
1.16
1.36
3.15
1.02
0.44
0.30
1.12
1.43
1.58
2.30
1.98
0.57
0.45
0.43
0.50
2.05
0.51
1.33
1.86
1.76
0.21
0.77
0.22
0.35
0.88
0.38
0.63
1.51
0.71
0.71
0.28
0.94
0.29
0.38
0.53
0.47
0.48
1.08
0.54
2.02
1.22

3.08
2.77
2.41
3.15
3.19
3.98
4.79
3.61
3.33
2.47
2.80
3.19
3.58
3.09
3.17
2.50
2.64
2.14
3.45
2.16
2.76
2.64
2.94
2.45
1.96
3.14
2.26
2.74
2.74
3.73
2.50
2.26
2.90
2.56
2.14
2.94
2.57
3.29
3.29
3.27
3.34
4.00
2.10
3.11
3.62
3.06
3.06
3.77
2.90
2.88
3.77
2.65
2.37
3.41
4.41
3.28
3.21
3.34
3.45
3.65
4.25
3.48
4.45
3.71

0.03
0.08
0.06
0.12
0.15
0.20
1.12
0.14
0.04
0.31
0.12
0.06
0.16
0.07
0.22
0.05
0.02
0.06
0.11
0.05
0.03
0.05
0.21
0.17
0.21
0.45
0.15
0.07
0.05
0.17
0.21
0.24
0.32
0.32
0.09
0.07
0.06
0.07
0.30
0.08
0.19
0.26
0.28
0.03
0.11
0.03
0.05
0.13
0.06
0.09
0.23
0.11
0.11
0.04
0.14
0.04
0.06
0.08
0.07
0.07
0.16
0.08
0.30
0.19

22087
1979
3389
1218
804
553
16
1190
11744
185
1009
4170
1056
3064
341
4033
25391
2270
1928
2702
18248
5262
405
382
175
99
376
3588
6826
981
239
147
193
107
1041
3965
3041
4142
286
3812
717
541
153
20498
1768
18470
6326
1756
4515
1913
641
1239
968
13615
1933
11369
6573
4004
4596
4388
1308
3055
391
652

20.3
17.3
16.7
20.5
21.7
24.9
22.3
24.2
21.6
26.1
18.7
19.6
25.0
18.0
23.2
16.5
17.7
15.3
24.7
13.5
18.3
18.0
22.1
17.9
14.1
17.3
13.3
18.5
17.9
26.2
16.3
13.4
23.1
14.3
12.6
19.2
18.0
21.9
29.2
21.2
25.3
28.4
17.5
20.7
24.0
20.2
20.1
25.7
18.5
20.5
26.3
18.5
16.7
22.6
29.7
21.4
22.1
23.3
23.9
22.1
27.0
20.4
26.4
19.1

0.15
0.42
0.32
0.68
0.86
1.13
5.78
0.80
0.22
2.18
0.70
0.34
0.84
0.36
1.31
0.29
0.12
0.33
0.60
0.27
0.16
0.28
1.19
0.98
1.10
1.97
0.72
0.37
0.24
0.89
1.12
1.14
1.95
1.44
0.41
0.37
0.36
0.40
1.78
0.41
1.08
1.38
1.69
0.17
0.60
0.18
0.27
0.65
0.30
0.50
1.10
0.58
0.61
0.22
0.71
0.24
0.31
0.44
0.39
0.37
0.80
0.42
1.41
0.88

2.34
1.97
1.89
2.40
2.53
2.99
2.38
2.72
2.51
3.13
2.14
2.29
3.02
2.08
2.83
1.87
1.99
1.73
2.90
1.51
2.07
2.02
2.53
2.11
1.58
2.12
1.39
2.07
2.00
3.01
1.75
1.52
2.46
1.54
1.39
2.17
2.10
2.49
3.74
2.39
2.82
3.21
1.80
2.34
2.77
2.29
2.34
3.03
2.15
2.41
3.07
2.18
1.90
2.58
3.46
2.43
2.54
2.70
2.79
2.50
3.04
2.32
2.87
2.14

0.02
0.06
0.05
0.10
0.13
0.17
0.96
0.12
0.03
0.34
0.10
0.05
0.12
0.05
0.21
0.04
0.02
0.05
0.09
0.04
0.02
0.04
0.17
0.14
0.15
0.28
0.10
0.05
0.04
0.13
0.16
0.16
0.26
0.19
0.06
0.05
0.05
0.06
0.28
0.06
0.15
0.19
0.24
0.02
0.09
0.02
0.04
0.10
0.04
0.08
0.17
0.09
0.09
0.03
0.10
0.03
0.05
0.07
0.06
0.05
0.11
0.06
0.20
0.13

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

470

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Colon (C18) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

1409
6516
8957
1194
7635
3694
915
2732
6017
529
5439
882
208706
20141
181971
9177
985
7955
1313
40
391
853
19243
1971
16695
11405
1069
10071
3494
3009
15234
1124
13884
1207
22515
2129
18527
61287
3435
5945
3951
47351
3907
984
2891
15039
1794
12914
1100
598
4771
3105
2149
5270

27.1
28.1
25.9
35.2
24.8
27.3
36.3
25.3
29.4
36.6
28.9
24.2
26.7
32.5
26.2
29.8
35.1
29.4
20.8
12.1
21.0
21.5
28.7
29.5
29.0
27.8
32.7
26.8
27.5
23.0
30.2
36.0
29.6
29.8
25.1
32.2
24.7
25.2
19.1
32.8
19.1
25.6
29.3
35.3
27.6
24.8
34.8
23.8
18.8
26.0
23.6
22.8
29.0
26.7

0.76
0.37
0.29
1.06
0.30
0.47
1.25
0.51
0.40
1.63
0.41
0.86
0.06
0.23
0.06
0.33
1.14
0.35
0.60
1.96
1.09
0.78
0.22
0.67
0.24
0.27
1.03
0.28
0.49
0.45
0.26
1.11
0.27
0.93
0.18
0.72
0.19
0.11
0.34
0.44
0.31
0.13
0.48
1.16
0.53
0.21
0.84
0.22
0.59
1.11
0.36
0.43
0.66
0.39

3.17
3.39
3.04
4.17
2.90
3.23
4.34
2.98
3.45
4.34
3.39
2.80
3.14
3.88
3.07
3.48
4.08
3.44
2.55
1.68
2.61
2.60
3.38
3.63
3.40
3.29
3.85
3.18
3.19
2.70
3.59
4.48
3.50
3.49
2.93
3.72
2.89
2.95
2.24
3.85
2.28
2.99
3.51
4.31
3.29
2.90
4.13
2.79
2.18
3.03
2.79
2.68
3.44
3.21

0.11
0.06
0.04
0.16
0.04
0.07
0.19
0.08
0.06
0.24
0.06
0.13
0.01
0.03
0.01
0.05
0.16
0.05
0.09
0.32
0.17
0.12
0.03
0.10
0.04
0.04
0.15
0.04
0.07
0.07
0.04
0.17
0.04
0.14
0.03
0.11
0.03
0.02
0.05
0.06
0.05
0.02
0.07
0.17
0.08
0.03
0.12
0.03
0.09
0.17
0.06
0.07
0.10
0.06

1655
7521
9822
1380
8309
4194
1055
3108
6382
685
5653
883
223919
24011
193048
10170
1141
8811
1224
42
347
809
22028
2776
18687
12656
1248
11106
3533
3241
16792
1335
15260
1370
24700
2530
20284
65837
3504
6945
3845
50950
3917
1105
2780
15045
2040
12661
1140
647
5017
3370
2358
5610

22.7
21.4
20.3
27.6
19.2
21.3
27.7
19.7
21.6
31.0
20.7
19.1
20.6
26.0
20.0
22.8
27.4
22.4
15.5
9.7
15.0
16.5
22.5
25.3
22.2
21.7
25.5
20.8
20.5
18.7
22.5
26.5
22.1
22.7
19.9
26.4
19.4
19.7
15.2
26.6
14.4
19.8
21.4
25.9
19.8
18.5
27.3
17.4
15.6
20.7
18.9
18.8
23.3
20.2

0.65
0.29
0.23
0.80
0.24
0.38
0.92
0.41
0.31
1.27
0.32
0.73
0.05
0.18
0.05
0.26
0.84
0.28
0.48
1.53
0.85
0.65
0.17
0.50
0.19
0.22
0.77
0.23
0.39
0.38
0.21
0.79
0.21
0.74
0.14
0.56
0.16
0.09
0.27
0.34
0.24
0.10
0.37
0.83
0.42
0.16
0.64
0.17
0.51
0.93
0.30
0.37
0.55
0.31

2.58
2.42
2.32
3.14
2.20
2.47
3.20
2.29
2.45
3.56
2.35
2.29
2.36
3.03
2.28
2.61
3.24
2.55
1.79
1.20
1.67
1.92
2.58
2.99
2.54
2.53
2.98
2.43
2.35
2.15
2.60
3.08
2.55
2.62
2.28
3.09
2.23
2.25
1.71
3.11
1.62
2.27
2.46
3.03
2.28
2.09
3.15
1.97
1.77
2.34
2.21
2.18
2.72
2.33

0.10
0.04
0.03
0.12
0.04
0.06
0.13
0.06
0.05
0.18
0.05
0.11
0.01
0.03
0.01
0.04
0.12
0.04
0.07
0.23
0.12
0.09
0.03
0.07
0.03
0.03
0.11
0.03
0.06
0.06
0.03
0.11
0.03
0.11
0.02
0.08
0.02
0.01
0.04
0.05
0.04
0.02
0.05
0.12
0.06
0.02
0.09
0.02
0.07
0.14
0.05
0.06
0.08
0.05

48
756
5366
127
219
3788
280
335
181
548
18
672
113
147
62
5047
4823
149
983
1133
1368
3850
2063
8907
2263

7.9
14.0
23.8
9.8
9.4
15.8
8.5
14.1
1.9
2.6
2.0
3.0
2.7
2.3
2.2
28.2
29.2
10.6
24.9
27.2
32.1
36.0
27.2
23.6
33.9

1.17
0.53
0.33
0.89
0.65
0.27
0.52
0.81
0.14
0.12
0.47
0.12
0.27
0.20
0.29
0.42
0.45
0.89
0.80
0.85
0.88
0.60
0.64
0.25
0.76

0.96
1.66
2.78
1.24
1.14
1.88
1.00
1.78
0.21
0.30
0.23
0.34
0.32
0.25
0.30
3.32
3.46
1.35
2.99
3.30
3.89
4.42
3.30
2.78
4.05

0.17
0.08
0.05
0.13
0.09
0.04
0.07
0.12
0.02
0.02
0.07
0.02
0.04
0.03
0.04
0.06
0.07
0.14
0.11
0.12
0.13
0.09
0.09
0.04
0.10

32
698
4875
119
192
4051
225
325
148
339
19
479
73
141
46
5341
5060
175
835
1040
1198
2932
1869
7354
1954

5.1
10.9
18.9
8.7
7.8
14.6
6.5
12.1
1.6
1.9
2.1
2.4
1.8
2.3
1.6
24.0
24.6
10.8
18.1
19.6
21.9
21.5
17.1
15.0
21.1

0.94
0.42
0.29
0.83
0.57
0.25
0.45
0.72
0.13
0.11
0.48
0.11
0.22
0.20
0.24
0.36
0.38
0.84
0.66
0.71
0.68
0.44
0.46
0.19
0.57

0.59
1.37
2.16
1.10
0.94
1.78
0.81
1.45
0.18
0.24
0.26
0.27
0.18
0.28
0.21
2.80
2.89
1.35
2.11
2.30
2.59
2.54
2.00
1.72
2.51

0.13
0.06 *
0.04
0.11 *
0.08
0.03 *
0.06 *
0.10 *
0.02
0.02 *
0.07
0.02
0.02 *
0.03 *
0.03 *
0.05
0.05
0.13
0.09
0.09
0.10
0.06
0.06
0.03
0.08

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

413

471

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Colon (C18) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

414

Female
ASR(W)
CUM 0-74

12181
1014
684
422
362
727
85
3682
194
80
83
253
261
46
101
909
1818
1663
58
97
197
174
143
230
619

14.2
12.7
13.5
16.7
14.6
15.5
11.2
18.7
14.8
8.4
5.5
13.9
7.3
2.5
3.6
14.5
22.6
26.5
7.4
10.5
5.0
7.9
5.3
7.6
7.8

0.13
0.44
0.55
0.86
0.82
0.61
1.25
0.33
1.21
0.97
1.06
0.89
0.47
0.38
0.38
0.52
0.54
0.66
1.04
1.11
0.36
0.61
0.44
0.51
0.32

1.72
1.43
1.64
2.07
1.76
1.85
1.52
2.23
1.91
0.91
0.58
1.64
0.85
0.29
0.42
1.70
2.57
3.03
0.90
1.18
0.58
0.87
0.59
0.93
0.93

0.02
0.06
0.08
0.13
0.12
0.09
0.21
0.05
0.19
0.14
0.13
0.13
0.07
0.05
0.05
0.08
0.08
0.10
0.14
0.15
0.05
0.08
0.06
0.07
0.04

10043
838
613
303
319
611
75
2938
169
94
55
231
254
37
73
906
1810
1673
41
96
208
172
117
167
452

8.8
7.8
9.1
8.8
8.9
9.8
6.9
11.5
9.9
7.6
6.7
10.4
7.1
2.2
3.5
11.4
19.0
20.8
8.2
9.9
5.0
7.2
3.8
5.6
5.3

0.09
0.27
0.37
0.52
0.51
0.40
0.82
0.22
0.79
0.83
1.20
0.70
0.45
0.38
0.44
0.39
0.46
0.52
1.32
1.04
0.36
0.56
0.35
0.44
0.25

1.04
0.91
1.10
1.02
1.06
1.19
0.77
1.38
1.17
0.93
0.69
1.22
0.83
0.23
0.42
1.34
2.09
2.31
1.02
1.11
0.60
0.78
0.48
0.72
0.63

0.01
0.04
0.05
0.07
0.07
0.06
0.10
0.03
0.11
0.12
0.15
0.10
0.07
0.05 *
0.06 *
0.06 *
0.07
0.08
0.19
0.14
0.05 *
0.07 *
0.05
0.06 *
0.03 *

7660
529
273
3598
1542
4908
5360
3660
11758
5161
844
2972
1072
496
437
765
973
957
992
440
473
347
676
2576
4836
1427
1700
2724
2911
1454
230
3060
269
681
746
1950
885
301
1615
1086
308
3270
643
260
729
1684
697
417
256
190
1421
1344
641
2250

24.1
21.3
23.4
12.1
20.1
22.8
15.8
21.4
31.6
22.1
18.3
14.4
28.9
19.0
22.4
28.2
23.2
22.8
22.9
18.7
21.8
17.0
24.8
24.7
24.2
18.8
25.1
27.6
26.6
29.6
23.4
24.3
26.2
26.4
36.0
30.3
27.0
29.9
29.2
33.5
19.7
32.1
28.5
18.5
30.3
30.5
19.4
20.6
18.1
24.6
29.0
28.8
30.2
30.1

0.28
0.95
1.43
0.20
0.53
0.34
0.22
0.36
0.30
0.32
0.63
0.27
0.90
0.90
1.11
1.04
0.80
0.76
0.76
0.96
1.05
1.01
1.03
0.49
0.35
0.51
0.62
0.54
0.50
0.80
1.62
0.45
1.67
1.03
1.42
0.74
0.98
1.87
0.76
1.09
1.13
0.59
1.22
1.24
1.20
0.80
0.77
1.05
1.18
1.83
0.81
0.86
1.22
0.66

2.85
2.48
3.03
1.49
2.32
2.66
1.96
2.59
3.88
2.56
2.32
1.62
3.45
2.16
2.67
3.25
2.76
2.67
2.76
2.13
2.73
2.13
3.07
3.06
2.94
2.09
2.98
3.24
3.02
3.52
2.91
2.94
3.24
3.08
4.47
3.61
3.20
3.63
3.34
4.11
2.18
3.84
3.56
2.18
3.77
3.69
2.40
2.62
2.31
2.78
3.42
3.50
3.49
3.67

0.04
0.14
0.22
0.03
0.08
0.05
0.03
0.05
0.04
0.05
0.09
0.04
0.13
0.13
0.16
0.15
0.12
0.11
0.11
0.13
0.16
0.15
0.15
0.07
0.05
0.07
0.09
0.08
0.07
0.11
0.25
0.07
0.25
0.15
0.21
0.11
0.14
0.27
0.11
0.16
0.15
0.09
0.18
0.18
0.18
0.12
0.11
0.16
0.18
0.26
0.12
0.12
0.17
0.10

7688
523
294
4608
1475
4783
4762
3021
9660
5730
1138
3739
885
473
367
665
882
883
880
415
433
330
494
2659
5401
1953
1797
2874
3419
1587
187
2772
264
676
639
1675
954
279
1698
851
298
2857
586
242
567
1504
597
326
288
188
1341
1219
575
2023

15.5
14.3
17.3
9.4
14.2
16.9
11.2
12.6
18.0
18.7
13.9
12.5
16.1
12.5
13.4
17.2
16.3
15.6
13.6
11.5
13.5
12.7
13.9
16.5
15.9
15.1
16.4
19.3
19.4
20.2
15.6
17.8
18.6
18.9
23.2
19.5
21.0
21.9
20.1
19.5
15.6
20.2
19.8
15.1
19.0
21.9
13.3
13.7
16.6
18.4
20.0
19.9
19.0
19.4

0.21
0.71
1.12
0.15
0.42
0.28
0.17
0.25
0.20
0.28
0.45
0.24
0.62
0.67
0.80
0.75
0.64
0.59
0.53
0.68
0.76
0.87
0.74
0.35
0.25
0.40
0.43
0.41
0.38
0.59
1.26
0.37
1.53
0.83
1.09
0.57
0.85
1.56
0.58
0.79
0.94
0.45
1.01
1.09
0.96
0.66
0.60
0.83
1.08
1.55
0.64
0.68
0.89
0.50

1.74
1.57
1.92
1.17
1.55
1.88
1.36
1.46
2.11
2.18
1.69
1.35
1.81
1.41
1.39
1.91
1.93
1.73
1.52
1.22
1.46
1.38
1.63
1.86
1.77
1.65
1.78
2.11
2.14
2.23
1.75
2.05
1.98
2.12
2.70
2.22
2.40
2.60
2.26
2.26
1.79
2.32
2.27
1.76
2.21
2.56
1.54
1.64
2.02
2.09
2.25
2.31
2.26
2.26

0.03
0.10
0.16
0.02 *
0.06 *
0.04
0.02 *
0.03
0.03
0.04
0.06
0.03
0.09
0.09
0.11
0.10
0.09
0.08
0.07
0.09
0.10
0.11
0.10
0.05
0.04
0.06
0.06
0.06
0.05
0.08
0.18
0.05
0.17
0.11
0.15
0.08
0.11
0.21
0.08
0.11
0.13
0.06
0.13
0.15
0.13
0.09
0.08
0.11
0.16
0.20
0.08
0.09
0.12
0.07

*Important. See note on population page.

472

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Colon (C18) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

1076
1582
206
4719
481
629
1105
2564
2947
2941
2702
4401
1648
203
1299
2026
913
205
747
608
1007
589
607
745
7768
339
228
168
348
336
233
551
14436
938
858
2547
2457
3738
6158
2032
7285
10533
4271
4988
1472
5425

13.6
14.3
15.1
24.1
18.8
14.3
17.0
23.6
24.6
20.7
14.6
27.5
23.6
14.5
23.3
27.0
19.2
17.4
28.6
18.2
23.0
22.6
26.6
17.9
17.5
20.5
23.6
22.8
16.8
23.3
21.3
21.3
23.6
25.1
23.3
19.3
23.5
21.1
21.0
18.8
21.9
18.3
19.4
21.3
24.6
25.4

0.42
0.36
1.08
0.38
0.87
0.59
0.53
0.49
0.47
0.38
0.29
0.42
0.59
1.12
0.69
0.62
0.64
1.43
1.13
0.78
0.76
1.00
1.17
0.71
0.22
1.15
1.64
1.89
0.94
1.32
1.46
0.96
0.20
0.83
0.82
0.41
0.49
0.36
0.28
0.43
0.28
0.19
0.31
0.32
0.67
0.36

1.73
1.72
1.93
2.80
2.20
1.81
2.19
2.91
2.98
2.55
1.78
3.41
2.92
1.67
2.69
3.14
2.24
2.03
3.33
2.22
2.66
2.77
3.09
2.03
2.02
2.33
2.81
2.74
1.91
2.82
2.57
2.56
2.82
3.08
2.77
2.20
2.77
2.48
2.47
2.26
2.56
2.11
2.21
2.50
2.93
3.00

0.06
0.05
0.16
0.06
0.12
0.09
0.08
0.07
0.07
0.06
0.04
0.06
0.08
0.15
0.10
0.09
0.09
0.19
0.16
0.11
0.11
0.15
0.16
0.10
0.03
0.17
0.25
0.28
0.14
0.20
0.21
0.14
0.03
0.12
0.12
0.06
0.07
0.05
0.04
0.07
0.04
0.03
0.05
0.05
0.10
0.05

1488
1943
252
5538
477
622
1089
2202
2485
4872
1932
3628
1376
193
944
1386
828
170
558
521
886
469
478
590
8313
380
191
131
357
307
163
531
15383
1013
881
2588
2173
3704
5926
2044
7595
11270
4203
4727
1502
5550

10.4
10.8
14.1
21.8
12.4
10.0
11.4
15.5
15.8
17.2
8.9
15.8
13.3
11.9
12.9
14.0
14.2
12.8
18.6
13.0
16.3
14.3
17.6
11.5
15.2
16.0
14.8
12.4
12.5
15.0
11.9
14.8
19.2
21.5
18.2
15.4
14.8
15.5
14.8
14.7
16.9
14.2
14.7
15.4
18.5
18.4

0.29
0.26
0.94
0.35
0.60
0.44
0.37
0.37
0.35
0.27
0.22
0.28
0.39
1.00
0.50
0.43
0.52
1.27
0.92
0.64
0.61
0.78
0.94
0.55
0.20
0.93
1.23
1.28
0.75
1.00
1.02
0.74
0.17
0.72
0.67
0.35
0.37
0.29
0.22
0.37
0.23
0.16
0.26
0.26
0.54
0.28

1.30
1.25
1.65
2.52
1.41
1.17
1.37
1.83
1.74
2.06
1.06
1.86
1.54
1.31
1.54
1.56
1.57
1.42
2.13
1.53
1.92
1.69
1.95
1.35
1.81
1.73
1.82
1.38
1.45
1.69
1.44
1.75
2.26
2.55
2.21
1.79
1.69
1.81
1.71
1.73
1.92
1.63
1.68
1.76
2.15
2.13

0.04
0.04
0.14
0.05
0.08 *
0.06
0.05
0.05 *
0.05
0.04
0.03
0.04
0.05
0.13
0.07
0.06
0.07
0.15
0.12
0.09
0.08
0.11
0.12
0.07
0.03
0.13
0.18
0.18
0.11
0.14
0.15
0.11
0.03
0.10
0.10
0.05
0.05
0.04
0.03
0.06
0.03
0.02
0.04
0.04
0.08
0.04

6716
86
3900
1789
527
5136
1705
268
36
3941
1198
89
149
115
466
320

27.8
22.3
30.8
29.2
28.1
28.5
27.0
31.2
9.6
29.8
25.6
21.6
20.6
24.5
31.9
25.9

0.35
2.58
0.51
0.73
1.27
0.41
0.67
1.96
1.66
0.49
0.79
2.61
1.82
2.33
1.72
1.52

3.38
2.86
3.74
3.52
3.44
3.40
3.14
3.90
1.22
3.65
3.08
2.32
2.53
2.74
3.98
3.07

0.05
0.41
0.08
0.11
0.19
0.06
0.10
0.30
0.25
0.07
0.12
0.35
0.27
0.33
0.25
0.23

6511
56
3697
1750
572
4992
1542
239
23
4505
1051
90
96
108
452
235

22.3
18.2
24.8
22.3
24.8
22.3
20.4
23.6
5.8
27.6
18.1
17.3
12.3
18.9
22.0
16.6

0.31
2.59
0.45
0.61
1.15
0.35
0.57
1.62
1.22
0.45
0.62
2.14
1.30
1.87
1.30
1.21

2.67
2.00
2.92
2.56
2.96
2.59
2.33
2.77
0.61
3.30
2.05
1.82
1.41
2.05
2.56
1.89

0.04
0.36
0.07
0.09
0.17
0.05
0.08
0.24
0.16
0.07
0.09
0.28
0.18
0.25
0.18
0.18

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

415

473

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Rectum (C19-20)
Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

84
104
48
44
54

3.6
2.1
5.1
4.4
3.4

0.42
0.22
0.75
0.80
0.57

72
164
46
98
2535
47
183
335
77
59
25

8.1
8.1
7.3
7.1
12.7
5.3
5.2
4.4
2.6
4.9
2.9

0.99
0.68
1.15
0.74
0.26
0.78
0.41
0.25
0.32
0.66
0.59

1.01
0.95
0.88
0.86
1.54
0.59
0.57
0.51
0.32
0.55
0.39

12700
1457
2380
779
441
374
24
649
5889
89
618
1595
249
1329
182
1891
11596
1297
601
1616
7891
2289
129
181
114
42
228
1448
2946
286
118
106
114
83
558
1591
1392
1645
74
1544
175
123
43
7981
524
7338
2534
506
1992
712
208
481
476
5420
497
4755
2685
1545
1930
1966
416
1529
125
283

15.6
16.0
15.4
18.8
16.2
20.1
31.6
18.5
14.6
17.6
15.8
10.9
9.3
11.2
12.0
10.5
11.5
11.4
10.6
10.3
11.8
11.3
9.8
11.3
13.4
11.7
10.9
11.2
11.3
11.5
10.4
13.8
20.2
15.4
9.1
11.8
11.2
13.4
10.6
13.5
10.3
11.8
7.3
11.8
9.9
12.0
11.3
11.1
11.4
10.5
12.0
10.1
11.2
13.7
11.8
13.9
13.4
14.3
14.4
14.6
13.1
15.1
13.4
14.0

0.14
0.43
0.33
0.71
0.80
1.06
6.77
0.75
0.20
1.93
0.69
0.28
0.61
0.32
0.93
0.26
0.11
0.32
0.44
0.27
0.14
0.25
0.89
0.88
1.29
2.01
0.75
0.31
0.22
0.69
1.00
1.38
2.10
1.71
0.40
0.32
0.31
0.35
1.26
0.37
0.80
1.10
1.15
0.14
0.44
0.15
0.23
0.51
0.26
0.41
0.89
0.48
0.54
0.19
0.54
0.21
0.27
0.39
0.34
0.34
0.66
0.40
1.23
0.87

1.94
1.99
1.84
2.35
1.99
2.58
3.72
2.14
1.86
2.40
1.98
1.34
1.13
1.38
1.56
1.29
1.39
1.36
1.29
1.26
1.43
1.36
1.11
1.33
1.75
1.26
1.33
1.36
1.38
1.43
1.25
1.67
2.38
1.95
1.11
1.46
1.41
1.65
1.30
1.67
1.27
1.42
0.97
1.46
1.20
1.48
1.39
1.34
1.40
1.32
1.43
1.29
1.40
1.69
1.51
1.72
1.62
1.79
1.76
1.81
1.63
1.87
1.67
1.71

416

Female
ASR(W)
CUM 0-74

88
97
31
43
48

3.8
1.7
2.9
4.0
3.0

0.43
0.17
0.54
0.70
0.56

0.15
0.10
0.17
0.11
0.04
0.11
0.06
0.04
0.05
0.09
0.09

55
175
45
128
2606
42
180
303
88
83
42

3.9
6.7
6.5
7.1
9.2
4.0
3.9
3.6
2.8
5.8
3.5

0.60
0.55
1.01
0.64
0.19
0.64
0.31
0.22
0.31
0.68
0.56

0.46
0.85
0.95
0.86
1.07
0.50
0.46
0.41
0.31
0.69
0.32

0.09
0.09
0.18
0.10
0.03
0.10
0.05
0.03
0.04
0.09
0.07 *

0.02
0.06
0.05
0.11
0.12
0.16
0.99
0.11
0.03
0.31
0.10
0.04
0.09
0.04
0.14
0.04
0.02
0.05
0.06
0.04
0.02
0.04
0.12
0.12
0.19
0.27
0.11
0.05
0.03
0.10
0.14
0.20
0.28
0.25
0.06
0.05
0.05
0.05
0.18
0.05
0.12
0.15
0.18
0.02
0.06
0.02
0.03
0.08
0.04
0.06
0.14
0.07
0.08
0.03
0.08
0.03
0.04
0.06
0.05
0.05
0.10
0.06
0.18
0.12

8067
858
1490
489
289
209
16
448
3837
63
368
1285
246
1021
144
1368
8860
983
511
1129
6114
1714
105
142
71
46
154
1101
2517
257
89
67
83
65
450
1418
1022
1390
84
1284
182
130
46
6214
525
5593
2024
482
1515
600
190
396
323
4069
456
3495
1931
1174
1545
1466
393
1062
115
225

8.1
8.0
8.2
9.2
8.5
9.9
21.3
9.8
7.6
10.1
7.8
6.7
6.2
6.8
8.9
6.3
6.9
6.9
6.8
5.7
7.2
6.5
5.9
7.1
5.9
9.6
5.6
6.6
7.4
7.3
6.5
6.2
12.2
9.4
5.7
8.1
6.6
8.5
8.4
8.5
6.6
7.3
5.0
7.3
7.3
7.3
6.9
7.5
6.8
6.8
8.0
6.5
6.6
7.6
7.4
7.6
7.3
7.9
9.0
8.3
8.6
8.3
8.5
8.1

0.10
0.29
0.23
0.47
0.55
0.72
5.68
0.52
0.13
1.43
0.47
0.20
0.42
0.23
0.77
0.19
0.08
0.23
0.31
0.18
0.10
0.17
0.62
0.63
0.72
1.59
0.47
0.23
0.16
0.48
0.73
0.78
1.51
1.19
0.28
0.25
0.22
0.26
0.95
0.27
0.55
0.72
0.87
0.11
0.33
0.11
0.16
0.36
0.19
0.30
0.61
0.35
0.40
0.13
0.36
0.15
0.19
0.27
0.25
0.23
0.46
0.28
0.83
0.61

0.95
0.94
0.97
1.08
1.02
1.21
2.69
1.15
0.90
1.06
0.88
0.78
0.73
0.79
0.96
0.73
0.81
0.81
0.79
0.66
0.85
0.75
0.65
0.79
0.65
1.17
0.64
0.77
0.84
0.85
0.70
0.70
1.47
1.04
0.67
0.93
0.80
1.01
0.92
1.01
0.69
0.79
0.44
0.85
0.85
0.85
0.81
0.91
0.79
0.81
0.97
0.76
0.78
0.90
0.90
0.90
0.90
0.92
1.07
0.99
1.02
0.98
1.07
0.98

0.01
0.04
0.03
0.07
0.08
0.10
0.84
0.08
0.02
0.19
0.06
0.03
0.06
0.03
0.11
0.03
0.01
0.03
0.05
0.03
0.01
0.02
0.09
0.08
0.09
0.21
0.07
0.03
0.02
0.07
0.10
0.10
0.20
0.16
0.04
0.03
0.03
0.04
0.13
0.04
0.07
0.09
0.11
0.01
0.05
0.02
0.02
0.05
0.03
0.04
0.09
0.05
0.06
0.02
0.05
0.02
0.03
0.04
0.03
0.03
0.06
0.04
0.12
0.09

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

474

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Rectum (C19-20) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

712
3003
3938
403
3462
1760
313
1418
2478
171
2279
436
92462
6836
81871
4194
368
3670
643
30
230
369
8436
703
7431
4887
322
4411
1373
1363
6756
369
6275
553
10604
788
8701
28865
2142
2156
2260
21944
1542
320
1198
6819
622
6014
561
253
2368
1551
1042
2313

14.3
13.8
11.9
12.2
11.9
13.6
12.8
13.9
12.7
11.7
12.8
13.0
12.6
11.1
12.6
14.4
13.1
14.6
10.8
8.5
12.6
9.8
13.4
10.5
13.9
12.6
9.8
12.5
11.6
11.3
14.4
12.0
14.5
14.6
12.5
11.8
12.4
12.5
12.2
11.9
10.7
12.8
12.1
11.8
12.1
11.7
12.1
11.7
10.2
12.0
12.3
11.9
14.6
12.5

0.56
0.27
0.20
0.63
0.21
0.34
0.75
0.39
0.27
0.91
0.28
0.65
0.04
0.14
0.05
0.23
0.69
0.26
0.44
1.58
0.85
0.54
0.15
0.40
0.17
0.19
0.56
0.20
0.33
0.32
0.19
0.64
0.20
0.66
0.13
0.43
0.14
0.08
0.27
0.26
0.23
0.09
0.32
0.67
0.36
0.15
0.50
0.16
0.45
0.78
0.26
0.32
0.47
0.27

1.69
1.69
1.46
1.49
1.45
1.66
1.58
1.70
1.54
1.37
1.56
1.58
1.54
1.36
1.55
1.76
1.60
1.78
1.29
0.84
1.43
1.23
1.65
1.29
1.73
1.56
1.23
1.55
1.41
1.41
1.76
1.50
1.78
1.73
1.52
1.40
1.51
1.53
1.46
1.45
1.30
1.56
1.47
1.43
1.47
1.45
1.49
1.45
1.18
1.54
1.48
1.44
1.77
1.56

0.08
0.04
0.03
0.09
0.03
0.05
0.11
0.06
0.04
0.13
0.04
0.09
0.01
0.02
0.01
0.03
0.10
0.04
0.06
0.19
0.12
0.08
0.02
0.06
0.02
0.03
0.08
0.03
0.05
0.05
0.03
0.09
0.03
0.10
0.02
0.06
0.02
0.01
0.04
0.04
0.03
0.01
0.04
0.10
0.05
0.02
0.07
0.02
0.06
0.12
0.04
0.05
0.07
0.04

523
2519
3164
383
2720
1463
315
1125
1888
142
1730
267
71954
6378
62612
3407
331
2969
419
16
121
271
7177
773
6171
4025
320
3559
1044
1076
5377
352
4903
444
8137
733
6667
22327
1502
1989
1591
16974
1089
268
806
5065
548
4349
448
223
1600
1087
830
1627

8.7
8.4
7.4
8.6
7.2
8.5
9.3
8.2
7.4
6.3
7.5
6.6
7.5
7.2
7.4
8.4
8.1
8.5
5.7
3.6
5.5
5.9
8.2
7.3
8.3
7.8
6.8
7.6
6.7
7.3
8.3
7.3
8.2
7.7
7.4
8.1
7.4
7.5
6.9
8.0
6.0
7.7
6.6
6.6
6.5
6.9
7.7
6.7
7.0
8.3
6.9
7.0
9.0
6.7

0.42
0.19
0.15
0.46
0.15
0.25
0.55
0.28
0.19
0.57
0.20
0.45
0.03
0.09
0.03
0.16
0.46
0.18
0.30
0.92
0.52
0.40
0.11
0.28
0.12
0.14
0.40
0.14
0.23
0.25
0.13
0.42
0.14
0.43
0.09
0.31
0.10
0.06
0.18
0.19
0.16
0.07
0.22
0.43
0.25
0.10
0.35
0.11
0.36
0.62
0.19
0.23
0.35
0.19

1.07
0.98
0.87
1.04
0.84
1.00
1.13
0.96
0.87
0.70
0.89
0.75
0.88
0.86
0.88
1.00
1.01
1.00
0.65
0.36
0.63
0.68
0.96
0.89
0.98
0.93
0.82
0.92
0.80
0.87
0.98
0.82
0.98
0.91
0.87
0.95
0.86
0.88
0.81
0.95
0.71
0.90
0.76
0.72
0.77
0.81
0.93
0.79
0.81
0.99
0.81
0.83
1.01
0.77

0.06
0.03
0.02
0.06
0.02
0.03
0.08
0.04
0.03
0.08
0.03
0.06
0.00
0.01
0.00
0.02
0.07
0.03
0.04
0.11
0.07
0.06
0.02
0.04
0.02
0.02
0.06
0.02
0.03
0.04
0.02
0.06
0.02
0.06
0.01
0.04
0.01
0.01
0.03
0.03
0.02
0.01
0.03
0.06
0.03
0.01
0.05
0.02
0.05
0.09
0.03
0.03
0.05
0.03

26
605
1558
140
201
2688
287
170
311
447
18
581
109
157
85
2202
2060
118
623
669
919
2289
1391
5043
1374

4.4
11.1
7.0
10.7
8.6
11.2
8.7
7.3
3.3
2.0
2.1
2.6
2.6
2.4
3.2
13.0
13.3
8.3
16.0
16.9
22.3
22.4
19.5
13.5
21.7

0.90
0.46
0.18
0.93
0.62
0.23
0.52
0.59
0.19
0.10
0.51
0.11
0.26
0.20
0.35
0.29
0.31
0.79
0.65
0.69
0.74
0.48
0.55
0.19
0.63

0.56
1.31
0.85
1.29
1.08
1.35
1.03
0.93
0.37
0.23
0.25
0.29
0.31
0.28
0.42
1.59
1.61
1.02
2.04
2.12
2.79
2.76
2.36
1.63
2.70

0.13
0.07
0.03
0.13
0.09
0.03
0.07
0.09
0.03
0.01
0.07
0.02
0.04
0.03
0.06
0.04
0.05
0.12
0.09
0.10
0.11
0.07
0.07
0.03
0.08

15
429
1055
122
168
2223
215
127
206
265
13
368
73
147
67
1930
1826
78
368
403
539
1374
955
2892
840

2.2
6.8
4.2
9.0
6.8
8.3
6.0
4.6
2.2
1.4
1.4
1.8
1.8
2.4
2.2
9.3
9.6
4.7
8.4
8.2
10.6
10.9
10.0
6.5
10.2

0.60
0.33
0.14
0.85
0.53
0.19
0.42
0.44
0.16
0.09
0.38
0.09
0.21
0.20
0.28
0.23
0.24
0.55
0.46
0.47
0.48
0.32
0.37
0.13
0.42

0.20
0.82
0.49
1.10
0.82
0.97
0.71
0.56
0.25
0.15
0.17
0.20
0.20
0.29
0.30
1.10
1.13
0.54
0.95
0.96
1.25
1.25
1.16
0.76
1.17

0.07
0.05 *
0.02
0.12 *
0.07
0.03 *
0.06 *
0.06 *
0.02
0.01 *
0.06
0.01
0.03 *
0.03 *
0.04 *
0.03
0.03
0.08
0.06
0.06
0.07
0.04
0.05
0.02
0.05

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

417

475

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Rectum (C19-20) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

418

Female
ASR(W)
CUM 0-74

12875
1054
795
468
326
750
80
3555
173
50
65
179
223
37
90
631
1377
1218
55
104
182
85
119
149
496

14.9
12.6
15.2
17.7
12.6
15.4
10.7
17.4
12.1
5.2
2.8
9.9
6.3
2.1
2.9
9.5
17.1
19.1
7.9
11.6
4.6
3.9
4.4
5.1
6.3

0.13
0.42
0.57
0.86
0.73
0.59
1.24
0.32
1.03
0.76
0.68
0.76
0.43
0.36
0.33
0.41
0.47
0.56
1.11
1.17
0.35
0.43
0.40
0.42
0.29

1.85
1.55
1.82
2.17
1.62
1.95
1.28
2.08
1.62
0.63
0.28
1.33
0.79
0.28
0.30
1.16
2.01
2.27
0.86
1.36
0.52
0.49
0.51
0.63
0.81

0.02
0.06
0.08
0.13
0.11
0.09
0.17
0.05
0.17
0.11
0.08
0.12
0.06
0.06
0.04
0.06
0.07
0.08
0.13
0.16
0.05
0.06
0.06
0.06
0.04

9613
796
605
332
298
543
78
2505
154
51
25
133
180
24
31
563
927
825
29
73
158
60
96
104
363

8.6
7.4
8.9
9.8
8.5
8.7
7.0
9.7
8.6
4.2
2.4
6.0
5.0
1.4
1.3
7.0
9.9
10.5
5.1
7.8
3.7
2.4
3.2
3.5
4.2

0.09
0.26
0.37
0.55
0.50
0.38
0.82
0.20
0.73
0.62
0.69
0.53
0.38
0.29
0.26
0.31
0.33
0.38
1.01
0.94
0.30
0.31
0.33
0.35
0.22

1.05
0.90
1.07
1.17
1.07
1.05
0.75
1.19
1.12
0.43
0.33
0.71
0.59
0.17
0.14
0.88
1.16
1.23
0.55
0.96
0.43
0.30
0.43
0.39
0.53

0.01
0.04
0.05
0.08
0.07
0.05
0.10
0.03
0.11
0.08
0.12
0.07
0.05
0.04 *
0.03 *
0.05 *
0.05
0.06
0.13
0.13
0.04 *
0.05 *
0.05
0.05 *
0.03 *

4954
367
178
4135
1253
3587
4846
3529
9827
3696
594
2221
686
345
300
448
577
697
653
310
336
355
384
1866
3660
785
1240
1698
1815
991
75
2234
126
318
271
1025
457
114
622
332
138
1428
286
162
275
759
287
214
134
94
590
804
270
1010

16.3
15.8
15.7
13.8
17.0
17.3
14.2
20.9
27.0
16.6
13.0
11.0
19.2
13.9
15.8
17.0
14.2
17.0
15.4
13.6
15.5
19.7
14.6
18.0
19.0
10.9
18.3
17.7
17.2
20.9
7.6
18.3
12.6
12.7
13.3
16.2
14.7
11.6
12.1
10.6
8.9
14.4
13.4
12.0
12.2
14.4
8.1
11.1
10.2
12.5
12.5
17.6
12.8
14.1

0.24
0.84
1.18
0.22
0.50
0.30
0.21
0.36
0.28
0.28
0.54
0.24
0.74
0.79
0.94
0.82
0.63
0.67
0.63
0.83
0.89
1.15
0.80
0.42
0.32
0.40
0.52
0.44
0.41
0.68
0.92
0.40
1.17
0.72
0.87
0.54
0.74
1.18
0.51
0.62
0.76
0.40
0.86
1.01
0.79
0.56
0.50
0.78
0.92
1.31
0.54
0.67
0.79
0.46

2.06
1.97
1.89
1.76
2.09
2.12
1.80
2.60
3.39
2.02
1.72
1.32
2.41
1.54
2.01
2.05
1.72
2.06
1.92
1.66
1.85
2.39
1.88
2.21
2.35
1.35
2.26
2.18
2.11
2.58
0.84
2.27
1.74
1.49
1.59
1.93
1.80
1.49
1.45
1.33
1.04
1.77
1.66
1.41
1.51
1.79
0.96
1.43
1.20
1.66
1.53
2.15
1.55
1.70

0.03
0.12
0.17
0.03
0.07
0.04
0.03
0.05
0.04
0.04
0.08
0.03
0.11
0.11
0.14
0.12
0.09
0.10
0.09
0.12
0.13
0.16
0.12
0.06
0.05
0.06
0.07
0.06
0.06
0.10
0.13
0.06
0.18
0.10
0.12
0.08
0.10
0.17
0.07
0.09
0.11
0.06
0.12
0.14
0.11
0.08
0.07
0.12
0.12
0.20
0.08
0.09
0.12
0.06

3724
302
122
4093
775
2424
3356
2612
6213
2786
620
1919
436
235
182
318
385
420
453
200
244
224
195
1378
2836
769
907
1278
1420
782
71
1227
89
281
200
743
342
90
540
233
123
967
200
114
187
562
218
137
100
72
428
539
217
662

7.9
8.6
7.6
8.4
8.4
9.5
8.1
10.9
12.1
9.8
7.8
6.6
8.9
6.5
7.4
9.1
7.3
7.8
7.6
6.8
8.4
9.4
6.1
9.0
9.2
6.9
8.9
9.3
9.2
11.5
7.0
8.3
5.9
8.2
7.8
8.9
7.6
6.7
6.8
5.6
6.3
7.1
6.2
7.2
6.3
8.9
5.1
5.8
6.4
6.5
6.5
9.8
7.8
6.6

0.15
0.56
0.75
0.14
0.34
0.21
0.15
0.23
0.17
0.21
0.34
0.17
0.48
0.49
0.61
0.57
0.43
0.43
0.41
0.57
0.62
0.76
0.51
0.27
0.20
0.29
0.32
0.29
0.28
0.47
0.90
0.26
0.72
0.56
0.68
0.39
0.50
0.85
0.35
0.43
0.59
0.27
0.55
0.76
0.55
0.44
0.38
0.54
0.71
0.88
0.37
0.49
0.59
0.30

0.90
0.91
0.91
1.04
0.99
1.11
0.98
1.28
1.43
1.20
0.95
0.77
1.10
0.70
0.86
1.07
0.85
0.90
0.85
0.82
1.00
1.07
0.73
1.05
1.08
0.80
1.02
1.09
1.07
1.37
0.81
0.98
0.80
0.90
0.90
1.00
0.88
0.79
0.73
0.63
0.83
0.82
0.70
0.84
0.72
1.07
0.58
0.68
0.74
0.71
0.73
1.20
0.93
0.76

0.02
0.08
0.11
0.02 *
0.05 *
0.03
0.02 *
0.03
0.02
0.03
0.05
0.02
0.07
0.07
0.08
0.08
0.06
0.06
0.05
0.08
0.09
0.10
0.07
0.04
0.03
0.04
0.04
0.04
0.04
0.06
0.12
0.04
0.11
0.07
0.08
0.05
0.07
0.12
0.04
0.06
0.09
0.04
0.07
0.10
0.07
0.06
0.05
0.07
0.09
0.12
0.05
0.07
0.08
0.04

*Important. See note on population page.

476

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Rectum (C19-20) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

1011
1767
160
3012
310
611
734
1712
1866
2328
2856
3817
1423
152
695
1268
525
131
363
368
660
419
318
471
5100
177
101
96
289
164
131
365
9330
678
677
1897
1672
2808
5229
1504
4063
7132
3410
3722
876
3492

12.9
15.8
11.9
16.2
12.4
14.1
11.5
16.0
15.7
16.4
15.1
24.4
20.5
11.1
13.1
17.3
11.1
10.4
14.8
11.1
15.2
16.3
14.4
11.3
12.1
11.6
11.2
13.7
14.9
12.4
13.0
14.9
15.8
18.4
18.5
15.1
16.6
16.9
18.8
14.3
12.9
13.0
16.2
16.5
14.9
17.1

0.41
0.38
0.96
0.32
0.72
0.59
0.44
0.41
0.38
0.34
0.29
0.40
0.55
0.99
0.53
0.50
0.49
1.05
0.83
0.62
0.62
0.85
0.87
0.56
0.18
0.90
1.16
1.47
0.92
1.00
1.17
0.82
0.17
0.72
0.73
0.37
0.42
0.33
0.27
0.38
0.22
0.16
0.29
0.28
0.52
0.30

1.67
1.98
1.39
1.92
1.57
1.70
1.50
2.02
1.88
2.09
1.90
3.11
2.51
1.22
1.56
2.14
1.34
1.29
1.79
1.37
1.77
2.04
1.74
1.30
1.49
1.43
1.41
1.83
1.79
1.53
1.60
1.74
1.93
2.26
2.32
1.85
2.05
2.07
2.32
1.72
1.56
1.59
1.96
2.04
1.87
2.11

0.06
0.06
0.14
0.05
0.10
0.08
0.06
0.06
0.05
0.05
0.04
0.06
0.08
0.13
0.07
0.07
0.07
0.15
0.12
0.09
0.09
0.12
0.12
0.08
0.03
0.13
0.17
0.23
0.13
0.15
0.16
0.12
0.02
0.10
0.11
0.05
0.06
0.05
0.04
0.06
0.03
0.02
0.04
0.04
0.08
0.04

1049
1481
131
2356
285
466
605
1223
1153
2660
1872
2372
1030
73
414
704
378
73
221
240
398
233
196
352
3823
143
69
59
175
132
79
263
6736
464
481
1298
1043
1870
3203
1071
2943
5403
2054
2207
637
2373

7.7
8.1
8.2
10.1
7.5
7.7
6.6
8.9
7.7
9.7
8.5
10.5
10.1
4.6
5.7
7.5
6.8
5.7
7.3
6.4
7.6
7.3
7.8
7.0
7.3
6.7
6.0
6.8
7.1
7.2
6.3
7.9
9.0
10.4
10.8
8.4
7.4
8.1
8.6
8.3
6.9
7.2
7.6
7.8
8.5
8.4

0.26
0.23
0.75
0.24
0.47
0.39
0.28
0.28
0.25
0.20
0.21
0.23
0.34
0.63
0.33
0.32
0.37
0.84
0.57
0.46
0.42
0.56
0.64
0.44
0.14
0.62
0.81
1.00
0.60
0.72
0.77
0.55
0.12
0.51
0.54
0.27
0.26
0.22
0.17
0.28
0.15
0.11
0.19
0.19
0.37
0.19

0.95
0.96
0.93
1.18
0.86
0.95
0.82
1.09
0.88
1.19
1.04
1.25
1.21
0.47
0.65
0.86
0.78
0.71
0.84
0.71
0.90
0.84
0.90
0.77
0.90
0.75
0.68
0.80
0.84
0.88
0.74
0.97
1.09
1.29
1.32
1.00
0.84
0.94
1.00
0.96
0.79
0.84
0.91
0.92
1.02
0.99

0.04
0.03
0.10
0.03
0.06 *
0.05
0.04
0.04 *
0.03
0.03
0.03
0.03
0.05
0.08
0.04
0.04
0.05
0.11
0.08
0.06
0.06
0.08
0.09
0.06
0.02
0.08
0.11
0.13
0.08
0.10
0.10
0.08
0.02
0.07
0.08
0.04
0.04
0.03
0.02
0.04
0.02
0.02
0.03
0.03
0.05
0.03

4341
55
2250
1119
337
3307
1148
164
30
2422
676
44
119
82
271
130

18.4
13.6
18.5
19.0
19.1
19.2
18.6
18.9
7.2
18.9
15.2
11.4
17.6
16.5
21.8
10.5

0.29
1.97
0.40
0.59
1.08
0.35
0.56
1.51
1.39
0.40
0.62
1.88
1.72
1.86
1.49
0.96

2.31
1.74
2.32
2.38
2.43
2.36
2.29
2.32
0.81
2.41
1.87
1.25
2.13
2.07
2.68
1.24

0.04
0.31
0.06
0.09
0.16
0.05
0.08
0.23
0.18
0.06
0.09
0.25
0.24
0.29
0.20
0.14

2671
24
1330
799
239
2146
685
92
15
1664
393
24
47
52
158
80

9.8
6.2
9.7
10.9
10.6
10.3
9.5
8.3
3.5
11.0
7.7
4.8
6.3
9.5
9.8
6.6

0.21
1.36
0.28
0.43
0.76
0.24
0.39
0.93
0.92
0.29
0.42
1.13
0.95
1.35
0.95
0.80

1.17
0.63
1.14
1.25
1.19
1.23
1.09
0.86
0.33
1.36
0.91
0.51
0.73
1.13
1.15
0.76

0.03
0.17
0.04
0.06
0.11
0.04
0.06
0.13
0.11
0.04
0.06
0.15
0.13
0.18
0.12
0.11

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

419

477

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Anus (C21)
Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

420

Female
ASR(W)
CUM 0-74

2
23
3
2
4

0.1
0.6
0.3
0.2
0.2

0.06
0.13
0.20
0.16
0.09

1
22
2
3
2

0.1
0.4
0.2
0.0
0.0

0.07
0.10
0.11
0.03
0.03

2
19
4
2
169
4
19
24
7
5
4

0.2
0.9
0.6
0.1
0.8
0.5
0.6
0.3
0.2
0.4
0.5

0.14
0.22
0.32
0.09
0.06
0.24
0.14
0.07
0.08
0.19
0.23

0.02
0.12
0.08
0.01
0.09
0.06
0.08
0.03
0.01
0.06
0.07

0.02
0.03
0.04
0.01
0.01
0.04
0.02
0.01
0.01
0.03
0.05

10
37
5
13
319
1
59
44
21
15
13

0.8
1.4
0.8
0.6
1.1
0.1
1.4
0.6
0.7
0.9
1.2

0.29
0.24
0.37
0.18
0.07
0.12
0.18
0.09
0.15
0.25
0.34

0.07
0.18
0.10
0.05
0.13
0.01
0.17
0.08
0.08
0.08
0.15

0.03
0.04
0.05
0.02
0.01
0.01
0.03
0.01
0.02
0.03
0.05 *

778
47
103
25
28
5
0
27
526
2
15
91
22
66
6
127
1008
29
80
117
759
247
29
5
5
1
24
172
261
39
3
2
1
1
42
169
95
79
11
66
43
29
13
617
73
534
210
49
160
98
30
68
24
303
55
241
153
51
94
118
21
95
10
38

1.0
0.5
0.7
0.7
1.1
0.2
0.8
1.3
0.4
0.4
0.6
0.8
0.6
0.3
0.8
1.0
0.3
1.3
0.6
1.2
1.2
2.0
0.3
0.6
0.3
1.0
1.4
1.0
1.5
0.3
0.2
0.3
0.2
0.5
1.3
0.7
0.7
1.4
0.6
2.6
2.8
2.3
1.1
1.3
1.0
0.9
0.9
0.9
1.3
1.2
1.3
0.6
0.8
1.2
0.7
0.8
0.5
0.7
0.9
0.6
1.0
1.0
2.1

0.04
0.08
0.07
0.14
0.21
0.11
0.15
0.06
0.25
0.11
0.07
0.18
0.07
0.15
0.07
0.03
0.05
0.15
0.06
0.05
0.08
0.38
0.14
0.25
0.25
0.21
0.11
0.06
0.24
0.20
0.15
0.27
0.22
0.09
0.11
0.08
0.08
0.44
0.08
0.40
0.54
0.66
0.04
0.15
0.05
0.06
0.14
0.07
0.13
0.25
0.17
0.13
0.05
0.16
0.05
0.07
0.07
0.08
0.08
0.13
0.10
0.32
0.34

0.11
0.06
0.07
0.08
0.13
0.02
0.09
0.16
0.02
0.04
0.07
0.09
0.07
0.04
0.09
0.12
0.03
0.15
0.07
0.14
0.13
0.23
0.04
0.06
0.10
0.16
0.11
0.17
0.05
0.01
0.02
0.05
0.04
0.15
0.08
0.08
0.16
0.08
0.27
0.27
0.30
0.12
0.15
0.11
0.10
0.10
0.10
0.14
0.13
0.15
0.08
0.09
0.13
0.09
0.09
0.06
0.08
0.10
0.05
0.11
0.10
0.22

0.00
0.01
0.01
0.02
0.03
0.01
0.02
0.01
0.02
0.01
0.01
0.02
0.01
0.02
0.01
0.00
0.01
0.02
0.01
0.01
0.01
0.05
0.02
0.03
0.03
0.01
0.01
0.03
0.03
0.01
0.02
0.05
0.01
0.01
0.01
0.01
0.06
0.01
0.05
0.06
0.09
0.01
0.02
0.01
0.01
0.02
0.01
0.02
0.03
0.02
0.02
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.04
0.04

1011
77
169
39
44
12
1
52
586
5
26
175
28
146
21
191
1369
59
67
150
1082
243
14
5
5
0
22
189
332
30
5
3
0
8
71
209
153
127
12
114
31
19
12
999
70
919
318
61
255
110
30
79
51
469
67
395
276
124
194
181
36
145
15
35

1.1
0.7
1.0
0.8
1.5
0.5
2.0
1.3
1.2
0.7
0.6
1.0
0.7
1.1
1.3
1.0
1.1
0.4
0.9
0.8
1.4
1.0
0.9
0.2
0.4
0.8
1.3
1.0
0.9
0.3
0.3
1.1
0.9
1.3
1.1
0.9
1.2
0.8
1.3
1.4
1.4
1.4
1.0
1.4
1.2
0.9
1.3
1.2
1.0
1.3
1.1
1.0
1.1
1.0
1.2
1.1
1.2
1.1
0.8
1.2
1.0
1.5

0.04
0.09
0.08
0.14
0.24
0.15
1.96
0.19
0.05
0.34
0.13
0.08
0.14
0.10
0.29
0.08
0.03
0.06
0.12
0.06
0.05
0.07
0.25
0.10
0.20
0.18
0.10
0.06
0.16
0.15
0.19
0.40
0.11
0.10
0.09
0.08
0.36
0.09
0.26
0.33
0.46
0.05
0.12
0.05
0.07
0.12
0.08
0.12
0.20
0.16
0.17
0.05
0.14
0.05
0.08
0.11
0.09
0.09
0.14
0.11
0.28
0.27

0.12
0.08
0.12
0.08
0.19
0.04
0.33
0.14
0.14
0.10
0.07
0.12
0.07
0.13
0.17
0.12
0.13
0.05
0.10
0.08
0.16
0.11
0.12
0.01
0.07
0.09
0.15
0.11
0.09
0.03
0.04
0.14
0.09
0.15
0.12
0.11
0.14
0.11
0.12
0.13
0.13
0.15
0.11
0.16
0.13
0.09
0.14
0.13
0.09
0.15
0.12
0.11
0.11
0.11
0.13
0.11
0.14
0.13
0.08
0.16
0.09
0.18

0.00
0.01
0.01
0.02
0.03
0.02
0.33
0.02
0.01
0.06
0.02
0.01
0.02
0.01
0.05
0.01
0.00
0.01
0.02
0.01
0.01
0.01
0.04
0.01
0.03
0.03
0.01
0.01
0.02
0.02
0.03
0.06
0.02
0.01
0.01
0.01
0.05
0.01
0.03
0.03
0.07
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.02
0.02
0.02
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.03
0.03

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

478

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Anus (C21) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

50
193
217
32
182
101
26
74
130
15
114
22
5995
706
5112
198
43
154
53
3
12
38
579
92
479
256
30
220
78
117
300
31
262
29
738
103
598
1954
45
227
153
1497
108
17
91
466
58
398
27
14
162
109
58
104

1.1
0.9
0.7
0.8
0.6
0.8
0.9
0.7
0.7
0.9
0.7
0.7
0.8
1.0
0.8
0.7
1.3
0.7
0.9
0.9
0.6
1.1
1.0
1.3
1.0
0.7
0.9
0.7
0.7
1.0
0.7
1.0
0.7
0.8
0.9
1.3
0.9
0.9
0.3
1.1
0.6
0.9
0.9
0.6
1.0
0.8
1.0
0.8
0.5
0.7
0.8
0.8
0.8
0.5

0.16
0.07
0.05
0.15
0.05
0.08
0.19
0.09
0.06
0.23
0.07
0.15
0.01
0.04
0.01
0.05
0.21
0.06
0.13
0.52
0.19
0.19
0.04
0.13
0.05
0.05
0.17
0.05
0.08
0.10
0.04
0.18
0.04
0.16
0.03
0.13
0.04
0.02
0.04
0.08
0.05
0.02
0.08
0.14
0.10
0.04
0.13
0.04
0.10
0.18
0.07
0.08
0.11
0.06

0.14
0.10
0.08
0.08
0.07
0.09
0.08
0.09
0.08
0.07
0.08
0.09
0.10
0.12
0.09
0.08
0.12
0.08
0.10
0.07
0.06
0.13
0.11
0.15
0.11
0.08
0.11
0.07
0.08
0.13
0.08
0.11
0.07
0.08
0.10
0.14
0.10
0.10
0.03
0.12
0.07
0.11
0.10
0.06
0.12
0.09
0.11
0.09
0.07
0.08
0.10
0.09
0.09
0.07

0.02
0.01
0.01
0.02
0.01
0.01
0.02
0.01
0.01
0.02
0.01
0.02
0.00
0.01
0.00
0.01
0.02
0.01
0.02
0.05
0.02
0.02
0.01
0.02
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.01
0.02
0.00
0.02
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.02
0.01
0.00
0.02
0.01
0.02
0.03
0.01
0.01
0.02
0.01

62
251
345
50
291
157
42
115
226
13
211
36
9272
784
8260
348
27
308
67
0
9
58
789
115
662
450
43
396
142
201
510
37
461
50
1031
98
902
2968
83
227
213
2418
147
16
129
708
65
634
69
18
264
187
122
155

1.2
1.0
0.9
1.1
0.9
1.0
1.3
0.9
0.9
0.6
1.0
1.0
1.1
0.9
1.1
1.0
0.7
1.0
1.0
0.4
1.4
1.0
1.1
1.1
1.0
1.0
1.0
1.1
1.5
0.9
0.9
0.9
1.1
1.0
1.1
1.1
1.1
0.4
0.9
0.8
1.2
0.9
0.4
1.1
1.0
0.9
1.1
1.1
0.7
1.2
1.2
1.6
0.7

0.16
0.07
0.05
0.16
0.05
0.08
0.21
0.09
0.07
0.17
0.07
0.18
0.01
0.03
0.01
0.06
0.14
0.07
0.12
0.14
0.21
0.04
0.11
0.04
0.05
0.16
0.05
0.10
0.11
0.04
0.15
0.05
0.17
0.03
0.11
0.04
0.02
0.04
0.06
0.06
0.03
0.08
0.10
0.11
0.04
0.12
0.04
0.14
0.19
0.08
0.09
0.15
0.06

0.13
0.11
0.11
0.14
0.10
0.12
0.17
0.11
0.11
0.10
0.11
0.13
0.12
0.10
0.13
0.12
0.10
0.12
0.11
0.05
0.16
0.12
0.13
0.12
0.11
0.14
0.11
0.13
0.17
0.10
0.12
0.10
0.14
0.12
0.13
0.13
0.13
0.05
0.10
0.09
0.14
0.10
0.05
0.12
0.12
0.11
0.12
0.15
0.08
0.13
0.13
0.18
0.09

0.02
0.01
0.01
0.02
0.01
0.01
0.03
0.01
0.01
0.03
0.01
0.03
0.00
0.00
0.00
0.01
0.02
0.01
0.02
0.02
0.03
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.02
0.01
0.02
0.01
0.02
0.00
0.02
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.02
0.01
0.02
0.02
0.01
0.01
0.02
0.01

6
13

1.0
0.3

0.39
0.08

0.15
0.04

0.07
0.01

0
8

0.1

0.05

0.02

0.01 *

5
7
57
8
5
51
160
0
81
27
31
4
88
83
5
24
10
17
27
10
112
15

0.4
0.3
0.2
0.2
0.2
0.5
0.8
0.3
0.6
0.5
0.1
0.5
0.5
0.3
0.6
0.2
0.4
0.3
0.1
0.3
0.2

0.17
0.12
0.03
0.09
0.09
0.08
0.06
0.04
0.12
0.09
0.07
0.06
0.06
0.13
0.13
0.06
0.09
0.05
0.04
0.03
0.07

0.06
0.04
0.02
0.03
0.02
0.06
0.10
0.04
0.07
0.07
0.02
0.06
0.07
0.03
0.07
0.02
0.06
0.03
0.02
0.04
0.03

0.03
0.02
0.00
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.02
0.01
0.01
0.00
0.01

1
6
65
8
5
41
71
2
67
14
14
2
100
96
4
17
11
12
25
18
107
13

0.1
0.2
0.2
0.2
0.1
0.5
0.4
0.2
0.3
0.4
0.2
0.1
0.5
0.5
0.2
0.4
0.2
0.2
0.2
0.2
0.2
0.1

0.06
0.10
0.03
0.08
0.07
0.08
0.05
0.16
0.04
0.10
0.06
0.05
0.05
0.06
0.11
0.09
0.07
0.07
0.04
0.05
0.02
0.04

0.00
0.04
0.03
0.03
0.01
0.07
0.05
0.03
0.04
0.04
0.02
0.01
0.05
0.06
0.00
0.04
0.02
0.03
0.02
0.02
0.03
0.01

0.00 *
0.02
0.00 *
0.01 *
0.01 *
0.01
0.01 *
0.02
0.01
0.01 *
0.01 *
0.01 *
0.01
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.01

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

421

479

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Anus (C21) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

422

Female
ASR(W)
CUM 0-74

309
33
11
9
7
20
0
95
2
1
4
11
6
11
19
20
33
26
4
3
10
6
3
6
24

0.4
0.4
0.2
0.4
0.3
0.5
0.5
0.2
0.1
0.1
0.5
0.2
0.7
0.7
0.3
0.4
0.4
0.5
0.3
0.3
0.3
0.1
0.2
0.3

0.02
0.08
0.07
0.13
0.11
0.12
0.06
0.14
0.11
0.05
0.17
0.07
0.21
0.17
0.06
0.07
0.08
0.25
0.19
0.08
0.12
0.06
0.09
0.06

0.04
0.04
0.02
0.05
0.02
0.05
0.05
0.04
0.01
0.01
0.04
0.02
0.08
0.10
0.04
0.06
0.06
0.06
0.05
0.03
0.03
0.01
0.04
0.03

0.00
0.01
0.01
0.02
0.01
0.02
0.01
0.03
0.01
0.01
0.02
0.01
0.03
0.03
0.01
0.01
0.01
0.03
0.03
0.01
0.01
0.01
0.02
0.01

323
31
27
7
6
13
3
96
4
7
3
9
4
1
8
14
45
39
2
4
18
3
4
1
27

0.3
0.3
0.4
0.2
0.2
0.2
0.3
0.4
0.2
0.6
0.4
0.4
0.1
0.1
0.4
0.2
0.5
0.5
0.4
0.5
0.5
0.1
0.1
0.0
0.3

0.02
0.05
0.08
0.08
0.07
0.06
0.17
0.04
0.09
0.25
0.28
0.13
0.05
0.06
0.13
0.04
0.07
0.08
0.29
0.26
0.11
0.07
0.07
0.03
0.06

0.03
0.03
0.04
0.02
0.01
0.03
0.03
0.05
0.00
0.10
0.01
0.05
0.01
0.01
0.03
0.02
0.04
0.04
0.08
0.05
0.06
0.01
0.02
0.00
0.04

0.00
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.00
0.05
0.00
0.02
0.01
0.01 *
0.01 *
0.01 *
0.01
0.01
0.06
0.03
0.02 *
0.01 *
0.01
0.00 *
0.01 *

153
12
1
142
24
83
213
35
142
137
16
41
22
17
7
11
20
21
26
4
4
7
16
49
120
65
35
43
52
28
3
68
6
14
19
33
22
1
20
15
6
83
15
3
15
27
25
7
8
2
41
27
9
47

0.5
0.5
0.1
0.5
0.3
0.4
0.6
0.2
0.4
0.6
0.3
0.2
0.6
0.7
0.4
0.4
0.6
0.5
0.7
0.2
0.2
0.5
0.7
0.5
0.6
1.0
0.5
0.4
0.5
0.6
0.2
0.6
0.6
0.5
1.0
0.6
0.7
0.1
0.5
0.4
0.4
0.8
0.8
0.3
0.7
0.5
0.7
0.3
0.6
0.3
1.0
0.7
0.5
0.7

0.04
0.15
0.09
0.04
0.07
0.05
0.05
0.04
0.03
0.06
0.09
0.03
0.13
0.18
0.16
0.14
0.14
0.12
0.14
0.11
0.11
0.19
0.20
0.07
0.06
0.13
0.09
0.07
0.07
0.13
0.14
0.07
0.24
0.15
0.25
0.11
0.16
0.06
0.11
0.12
0.15
0.10
0.21
0.19
0.20
0.12
0.14
0.13
0.21
0.20
0.16
0.15
0.16
0.10

0.06
0.07
0.01
0.06
0.03
0.04
0.08
0.02
0.04
0.07
0.02
0.03
0.07
0.08
0.04
0.06
0.06
0.08
0.07
0.02
0.04
0.07
0.08
0.05
0.07
0.11
0.06
0.06
0.05
0.07
0.01
0.06
0.05
0.05
0.12
0.07
0.09
0.04
0.05
0.03
0.08
0.07
0.03
0.09
0.06
0.09
0.02
0.08
0.05
0.12
0.08
0.05
0.08

0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.00
0.00
0.01
0.01
0.00
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.01
0.02
0.03
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.03
0.02
0.03
0.01
0.02
0.01
0.02
0.02
0.01
0.02
0.02
0.03
0.01
0.02
0.01
0.03
0.03
0.02
0.02
0.02
0.01

368
33
19
167
37
94
153
60
238
305
45
122
46
39
27
29
81
59
39
26
26
17
29
129
206
129
69
87
84
69
11
76
14
26
22
72
48
2
64
20
10
150
28
9
25
46
25
6
8
5
70
40
19
66

0.9
1.0
1.5
0.3
0.5
0.4
0.4
0.3
0.5
1.3
0.7
0.4
1.0
1.2
1.2
0.9
1.7
1.2
0.7
1.0
1.0
0.8
1.1
0.9
0.7
1.4
0.7
0.8
0.6
1.1
1.2
0.5
1.1
0.8
0.8
1.0
1.2
0.1
0.8
0.6
0.5
1.1
1.0
0.5
0.7
0.8
0.6
0.3
0.6
0.4
1.2
0.8
0.6
0.7

0.05
0.20
0.35
0.03
0.09
0.05
0.03
0.04
0.04
0.08
0.11
0.04
0.16
0.22
0.24
0.18
0.22
0.17
0.13
0.22
0.21
0.23
0.22
0.09
0.06
0.14
0.09
0.09
0.07
0.15
0.38
0.07
0.35
0.17
0.21
0.15
0.21
0.05
0.12
0.14
0.15
0.10
0.23
0.19
0.17
0.13
0.14
0.12
0.23
0.19
0.16
0.15
0.16
0.10

0.10
0.11
0.17
0.04
0.06
0.04
0.04
0.03
0.06
0.15
0.08
0.05
0.13
0.14
0.13
0.09
0.21
0.12
0.08
0.11
0.11
0.08
0.14
0.11
0.08
0.18
0.08
0.09
0.06
0.12
0.15
0.07
0.14
0.10
0.06
0.11
0.15
0.10
0.08
0.07
0.11
0.11
0.06
0.10
0.08
0.07
0.03
0.07
0.04
0.14
0.10
0.06
0.07

0.01
0.02
0.04
0.00 *
0.01 *
0.01
0.00 *
0.00
0.00
0.01
0.01
0.01
0.02
0.03
0.03
0.02
0.03
0.02
0.02
0.03
0.03
0.03
0.03
0.01
0.01
0.02
0.01
0.01
0.01
0.02
0.05
0.01
0.05
0.02
0.02
0.02
0.03
0.02
0.02
0.03
0.01
0.03
0.03
0.03
0.02
0.02
0.01
0.03
0.03
0.02
0.02
0.02
0.01

*Important. See note on population page.

480

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Anus (C21) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

29
35
9
77
10
5
21
92
58
30
58
93
22
3
49
34
15
7
16
19
14
14
9
20
180
11
6
8
11
3
8
19
221
11
6
63
77
98
205
68
212
357
120
97
34
118

0.4
0.3
0.6
0.4
0.4
0.1
0.3
0.9
0.5
0.2
0.3
0.6
0.3
0.3
1.0
0.5
0.3
0.7
0.8
0.6
0.3
0.6
0.4
0.5
0.5
0.7
0.7
1.4
0.5
0.2
0.7
0.6
0.4
0.3
0.2
0.5
0.8
0.6
0.8
0.6
0.7
0.7
0.6
0.5
0.6
0.6

0.07
0.06
0.20
0.05
0.13
0.05
0.07
0.10
0.07
0.04
0.04
0.06
0.07
0.18
0.16
0.09
0.08
0.32
0.21
0.14
0.09
0.16
0.13
0.13
0.04
0.23
0.29
0.52
0.15
0.15
0.26
0.16
0.03
0.10
0.08
0.07
0.10
0.07
0.06
0.08
0.05
0.04
0.06
0.05
0.11
0.06

0.04
0.04
0.08
0.04
0.05
0.01
0.03
0.11
0.06
0.02
0.04
0.07
0.03
0.02
0.14
0.04
0.04
0.07
0.08
0.05
0.04
0.07
0.06
0.05
0.05
0.11
0.07
0.19
0.04
0.02
0.10
0.06
0.04
0.03
0.02
0.06
0.10
0.08
0.09
0.08
0.09
0.08
0.07
0.06
0.07
0.07

0.01
0.01
0.03
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.01
0.03
0.02
0.02
0.01
0.02
0.02
0.01
0.00
0.04
0.03
0.07
0.02
0.01
0.04
0.02
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01

61
48
7
172
17
5
58
103
111
78
55
86
44
2
23
39
18
9
10
13
15
15
13
20
412
46
2
19
29
15
15
62
306
16
20
97
93
177
271
89
358
528
163
182
42
188

0.4
0.3
0.4
0.9
0.4
0.1
0.6
0.7
0.7
0.3
0.3
0.4
0.5
0.1
0.3
0.4
0.3
0.7
0.4
0.3
0.3
0.5
0.4
0.3
0.9
2.2
0.3
2.0
1.4
1.0
1.2
2.0
0.4
0.4
0.4
0.7
0.8
0.9
0.8
0.8
1.0
0.9
0.6
0.7
0.6
0.8

0.06
0.05
0.14
0.07
0.11
0.04
0.09
0.07
0.08
0.04
0.04
0.04
0.08
0.12
0.08
0.08
0.08
0.28
0.15
0.08
0.09
0.16
0.13
0.09
0.05
0.35
0.19
0.53
0.27
0.35
0.36
0.28
0.03
0.10
0.10
0.08
0.09
0.08
0.06
0.09
0.06
0.04
0.06
0.06
0.10
0.06

0.05
0.04
0.06
0.10
0.05
0.01
0.07
0.08
0.09
0.04
0.03
0.04
0.05
0.01
0.03
0.05
0.02
0.10
0.05
0.02
0.03
0.06
0.04
0.03
0.11
0.29
0.02
0.23
0.18
0.10
0.11
0.25
0.05
0.04
0.05
0.08
0.09
0.11
0.10
0.09
0.12
0.10
0.06
0.08
0.06
0.08

0.01
0.01
0.03
0.01
0.02 *
0.00
0.01
0.01 *
0.01
0.00
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.04
0.02
0.01
0.01
0.02
0.02
0.01
0.01
0.05
0.02
0.07
0.04
0.03
0.04
0.04
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01

232
3
99
20
21
100
41
6
3
73
16
1
2
3
2
8

1.0
0.9
0.8
0.4
1.2
0.6
0.7
0.8
0.5
0.6
0.4
0.1
0.3
0.7
0.2
0.6

0.07
0.53
0.09
0.08
0.26
0.06
0.11
0.32
0.28
0.07
0.09
0.14
0.21
0.42
0.15
0.23

0.12
0.19
0.11
0.04
0.18
0.07
0.09
0.11
0.04
0.07
0.04
0.02
0.15
0.02
0.06

0.01
0.13
0.01
0.01
0.04
0.01
0.02
0.05
0.03
0.01
0.01
0.02
0.09
0.02
0.03

279
2
116
56
19
114
55
9
2
127
26
2
0
2
3
19

1.1
0.4
0.8
0.9
0.9
0.6
0.8
0.7
0.5
0.9
0.5
0.4
0.4
0.1
1.5

0.07
0.31
0.08
0.13
0.23
0.06
0.11
0.24
0.36
0.09
0.11
0.32
0.30
0.09
0.38

0.12
0.05
0.10
0.10
0.10
0.07
0.08
0.04
0.07
0.10
0.06
0.05
0.05
0.02
0.15

0.01
0.03
0.01
0.02
0.03
0.01
0.01
0.02
0.07
0.01
0.01
0.05
0.04
0.02
0.05

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

423

481

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Liver (C22)
Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

424

Female
ASR(W)
CUM 0-74

22
912
20
100
265

1.1
21.9
2.2
8.7
14.4

0.23
0.76
0.51
1.05
1.09

16
227
7
73
159

0.8
4.4
0.7
5.8
12.7

0.20
0.30
0.25
0.79
1.17

41
135
41
49
585
46
105
444
94
44
22

4.5
6.3
6.4
3.4
2.9
5.4
3.1
5.8
3.4
3.6
2.4

0.74
0.58
1.05
0.50
0.12
0.81
0.31
0.28
0.37
0.57
0.52

0.51
0.67
0.84
0.40
0.35
0.61
0.36
0.65
0.42
0.39
0.29

0.11
0.08
0.17
0.07
0.02
0.11
0.05
0.04
0.06
0.08
0.08

16
148
26
22
300
41
124
321
129
25
13

1.3
5.8
3.9
1.2
1.1
3.8
2.7
3.8
3.9
1.5
1.2

0.37
0.50
0.80
0.25
0.07
0.61
0.25
0.22
0.37
0.33
0.33

0.18
0.67
0.55
0.07
0.13
0.42
0.31
0.41
0.49
0.17
0.12

0.05
0.07
0.12
0.02
0.01
0.09
0.04
0.03
0.06
0.05
0.04 *

3301
417
736
168
59
32
1
87
1696
16
89
638
123
506
100
798
7052
1858
525
1594
2987
1651
139
294
93
21
240
616
2083
224
190
99
36
144
591
642
537
602
57
527
135
98
30
3370
358
2914
872
216
603
326
108
170
130
2031
343
1553
766
379
516
853
228
591
86
162

4.2
4.6
5.0
4.2
2.3
1.9
1.8
2.4
4.4
3.2
2.3
4.2
4.4
4.1
6.2
4.6
7.2
16.8
9.2
10.3
4.6
8.5
10.9
18.9
10.4
7.0
11.1
5.0
8.3
9.0
17.2
12.5
7.9
27.5
10.2
5.0
4.2
4.9
7.8
4.6
8.2
9.7
5.5
5.2
6.5
4.9
3.9
4.5
3.5
4.8
5.5
3.7
3.2
5.2
8.0
4.6
4.0
3.5
3.8
6.3
7.1
5.8
9.2
7.6

0.08
0.23
0.19
0.34
0.31
0.37
1.77
0.27
0.11
0.92
0.27
0.17
0.40
0.19
0.65
0.17
0.09
0.40
0.41
0.27
0.09
0.22
0.94
1.15
1.10
1.64
0.74
0.22
0.19
0.61
1.32
1.29
1.55
2.33
0.43
0.21
0.19
0.21
1.06
0.22
0.73
1.01
1.15
0.10
0.35
0.10
0.14
0.32
0.15
0.27
0.57
0.29
0.29
0.12
0.44
0.12
0.15
0.19
0.17
0.22
0.48
0.25
1.02
0.62

0.51
0.54
0.59
0.53
0.29
0.25
0.44
0.28
0.54
0.32
0.28
0.49
0.52
0.47
0.75
0.54
0.88
2.05
1.10
1.28
0.54
1.03
1.34
2.36
1.21
0.98
1.27
0.60
1.02
1.04
1.97
1.59
0.84
3.40
1.33
0.59
0.47
0.58
0.89
0.55
0.95
1.12
0.61
0.61
0.71
0.58
0.46
0.52
0.42
0.58
0.59
0.47
0.40
0.63
1.02
0.55
0.46
0.43
0.44
0.73
0.83
0.66
1.12
0.89

0.01
0.03
0.03
0.05
0.05
0.05
0.44
0.04
0.02
0.12
0.04
0.02
0.06
0.03
0.10
0.02
0.01
0.06
0.06
0.04
0.01
0.03
0.13
0.16
0.16
0.25
0.10
0.03
0.03
0.08
0.18
0.20
0.17
0.33
0.07
0.03
0.03
0.03
0.15
0.03
0.10
0.13
0.14
0.01
0.05
0.01
0.02
0.04
0.02
0.04
0.08
0.05
0.04
0.02
0.07
0.02
0.02
0.03
0.02
0.03
0.07
0.03
0.14
0.09

1393
164
309
79
25
18
0
45
708
5
40
359
81
271
47
345
3296
804
207
768
1475
713
56
92
47
22
114
276
1072
92
84
33
46
73
340
348
257
276
18
249
56
49
7
1550
153
1356
457
108
323
143
53
73
74
1074
185
834
392
203
291
349
89
255
36
67

1.4
1.5
1.7
1.4
0.7
1.1
0.9
1.5
0.7
0.8
1.7
1.9
1.7
3.3
1.6
2.6
5.7
2.8
4.0
1.7
2.9
3.3
4.8
3.7
3.7
4.5
1.7
3.2
2.7
6.1
2.6
7.3
10.2
4.3
2.1
1.7
1.7
1.9
1.6
2.1
2.6
1.0
1.8
2.1
1.7
1.5
1.6
1.4
1.6
2.2
1.1
1.4
1.9
2.9
1.7
1.5
1.3
1.6
1.9
2.0
1.8
2.6
2.1

0.04
0.13
0.11
0.20
0.15
0.30
0.17
0.06
0.37
0.16
0.10
0.23
0.11
0.50
0.10
0.05
0.21
0.20
0.15
0.05
0.12
0.48
0.54
0.55
0.88
0.44
0.13
0.11
0.29
0.74
0.47
1.39
1.24
0.24
0.14
0.11
0.12
0.47
0.13
0.31
0.42
0.44
0.05
0.18
0.06
0.08
0.17
0.08
0.15
0.32
0.14
0.18
0.07
0.22
0.07
0.09
0.11
0.11
0.11
0.22
0.13
0.45
0.30

0.17
0.16
0.19
0.15
0.08
0.10
0.08
0.19
0.09
0.09
0.21
0.21
0.20
0.39
0.18
0.32
0.70
0.34
0.48
0.20
0.36
0.37
0.60
0.46
0.58
0.59
0.19
0.39
0.33
0.64
0.28
0.87
1.15
0.51
0.24
0.19
0.19
0.20
0.18
0.24
0.29
0.13
0.20
0.26
0.19
0.17
0.19
0.15
0.20
0.30
0.13
0.16
0.23
0.33
0.20
0.18
0.16
0.18
0.22
0.23
0.21
0.29
0.26

0.01
0.02
0.01
0.02
0.02
0.03
0.02
0.01
0.05
0.02
0.01
0.03
0.02
0.07
0.01
0.01
0.03
0.03
0.02
0.01
0.02
0.06
0.08
0.09
0.15
0.07
0.02
0.02
0.04
0.10
0.07
0.16
0.17
0.04
0.02
0.02
0.02
0.06
0.02
0.04
0.06
0.07
0.01
0.03
0.01
0.01
0.02
0.01
0.02
0.05
0.02
0.03
0.01
0.03
0.01
0.01
0.02
0.01
0.02
0.03
0.02
0.06
0.04

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

482

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Liver (C22) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

196
1162
1613
295
1257
791
233
529
813
146
646
99
39416
4843
30392
1621
229
1247
368
37
175
145
4206
616
3072
1576
265
1247
495
462
2366
354
1865
201
4885
584
3210
13843
2592
1483
2082
7485
583
141
427
4014
463
3301
163
73
991
748
259
893

4.1
5.6
5.0
8.9
4.3
6.2
9.8
5.2
4.4
10.6
3.8
3.0
5.5
7.8
4.8
5.8
8.1
5.1
6.3
10.6
9.8
4.0
6.9
9.2
5.9
4.1
8.4
3.5
4.1
3.9
5.3
11.6
4.4
5.4
5.9
8.7
4.6
6.2
15.1
8.1
9.9
4.4
4.5
4.9
4.2
6.9
8.8
6.4
2.9
3.4
5.2
5.8
3.7
4.8

0.31
0.17
0.13
0.53
0.13
0.23
0.65
0.24
0.16
0.89
0.16
0.31
0.03
0.11
0.03
0.15
0.54
0.15
0.34
1.77
0.75
0.35
0.11
0.37
0.11
0.11
0.52
0.10
0.19
0.19
0.11
0.63
0.11
0.40
0.09
0.37
0.09
0.05
0.30
0.21
0.22
0.05
0.19
0.42
0.21
0.11
0.42
0.11
0.24
0.41
0.17
0.22
0.24
0.17

0.48
0.67
0.59
1.09
0.52
0.76
1.23
0.62
0.52
1.36
0.44
0.35
0.65
0.92
0.56
0.67
0.94
0.60
0.73
1.26
1.14
0.46
0.83
1.10
0.71
0.46
0.96
0.39
0.48
0.43
0.62
1.35
0.53
0.65
0.69
1.04
0.55
0.73
1.82
0.96
1.21
0.52
0.51
0.55
0.48
0.80
1.04
0.74
0.35
0.45
0.59
0.67
0.42
0.60

0.04
0.02
0.02
0.07
0.02
0.03
0.09
0.03
0.02
0.13
0.02
0.04
0.00
0.02
0.00
0.02
0.07
0.02
0.05
0.27
0.10
0.05
0.02
0.05
0.02
0.01
0.07
0.01
0.03
0.03
0.02
0.08
0.02
0.06
0.01
0.05
0.01
0.01
0.04
0.03
0.03
0.01
0.03
0.06
0.03
0.02
0.06
0.02
0.03
0.06
0.02
0.03
0.03
0.02

72
488
799
113
664
373
90
271
375
59
309
66
18834
2074
15047
752
83
619
178
15
68
88
1981
291
1520
854
102
729
291
238
1074
140
895
97
2297
232
1574
6525
1129
582
970
3746
250
71
164
1854
179
1588
96
27
506
382
143
430

1.1
1.6
1.9
2.6
1.8
2.2
2.7
2.0
1.5
2.8
1.4
1.5
1.9
2.3
1.7
1.8
1.9
1.7
2.4
3.2
2.8
2.2
2.2
2.7
2.0
1.6
2.1
1.5
1.8
1.6
1.6
2.9
1.4
1.9
2.1
2.6
1.7
2.2
5.3
2.4
3.8
1.6
1.5
1.7
1.2
2.4
2.4
2.3
1.4
1.1
2.1
2.4
1.4
1.7

0.15
0.09
0.08
0.25
0.08
0.13
0.30
0.14
0.09
0.38
0.10
0.22
0.02
0.05
0.02
0.08
0.22
0.08
0.20
0.87
0.35
0.28
0.06
0.17
0.06
0.06
0.22
0.07
0.12
0.12
0.06
0.27
0.06
0.24
0.05
0.18
0.05
0.03
0.17
0.10
0.12
0.03
0.10
0.22
0.10
0.06
0.19
0.06
0.16
0.26
0.11
0.14
0.14
0.10

0.12
0.18
0.23
0.32
0.21
0.25
0.35
0.22
0.17
0.34
0.16
0.14
0.22
0.27
0.20
0.21
0.21
0.20
0.29
0.38
0.30
0.27
0.26
0.33
0.23
0.17
0.23
0.15
0.20
0.20
0.18
0.33
0.16
0.19
0.25
0.32
0.19
0.26
0.65
0.28
0.44
0.19
0.17
0.21
0.14
0.27
0.26
0.26
0.16
0.09
0.22
0.25
0.15
0.21

0.02
0.01
0.01
0.04
0.01
0.02
0.04
0.02
0.01
0.06
0.01
0.03
0.00
0.01
0.00
0.01
0.03
0.01
0.03
0.14
0.05
0.04
0.01
0.02
0.01
0.01
0.03
0.01
0.02
0.02
0.01
0.04
0.01
0.03
0.01
0.03
0.01
0.00
0.02
0.01
0.02
0.00
0.01
0.03
0.01
0.01
0.03
0.01
0.02
0.03
0.01
0.02
0.02
0.01

30
2425
6289
440
713
6001
857
74
269
491
34
895
65
209
78
556
463
42
862
815
1632
1709
1923
13494
969

5.3
42.5
29.5
33.8
30.3
25.9
25.7
3.2
3.0
2.4
3.9
4.5
1.6
3.4
2.8
3.3
3.1
2.7
22.0
20.4
39.8
16.4
26.8
35.6
14.3

0.98
0.88
0.38
1.66
1.16
0.35
0.90
0.39
0.18
0.12
0.67
0.15
0.21
0.24
0.32
0.15
0.15
0.43
0.75
0.76
1.00
0.42
0.65
0.31
0.50

0.58
4.79
3.51
4.10
3.59
2.94
3.00
0.36
0.37
0.28
0.43
0.56
0.19
0.41
0.32
0.41
0.38
0.29
2.89
2.59
5.27
2.05
3.52
4.75
1.76

0.13
0.12
0.05
0.23
0.15
0.05
0.12
0.05
0.03
0.02
0.09
0.02
0.03
0.04
0.04
0.02
0.02
0.06
0.11
0.11
0.15
0.06
0.09
0.05
0.07

17
729
1771
174
252
2300
177
29
83
232
8
433
35
88
30
333
293
15
388
446
659
880
906
5654
607

3.1
11.3
7.3
12.6
10.3
8.3
5.0
1.1
0.9
1.3
0.8
2.2
0.9
1.4
1.0
1.5
1.4
0.7
8.0
7.5
11.9
5.6
8.2
11.2
5.9

0.76
0.43
0.19
1.00
0.66
0.20
0.39
0.22
0.10
0.09
0.30
0.11
0.15
0.15
0.18
0.09
0.09
0.19
0.43
0.41
0.50
0.21
0.32
0.16
0.31

0.41
1.26
0.87
1.59
1.15
0.95
0.60
0.13
0.10
0.16
0.10
0.25
0.10
0.15
0.12
0.17
0.16
0.05
0.99
0.95
1.62
0.66
1.04
1.43
0.74

0.12
0.06 *
0.03
0.14 *
0.09
0.03 *
0.05 *
0.03 *
0.01
0.01 *
0.05
0.02
0.02 *
0.02 *
0.03 *
0.01
0.01
0.02
0.07
0.06
0.08
0.03
0.05
0.03
0.04

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

425

483

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Liver (C22) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

426

Female
ASR(W)
CUM 0-74

40709
4438
2582
990
1349
1961
352
9909
659
74
77
209
325
124
138
1570
1522
1352
59
111
730
723
233
109
253

44.9
49.8
46.1
35.4
50.2
36.7
44.4
44.1
42.7
8.1
6.0
10.6
9.1
7.4
5.4
21.7
18.8
21.3
8.1
12.3
18.4
32.3
8.6
3.8
3.2

0.23
0.81
0.95
1.18
1.42
0.88
2.42
0.47
1.84
0.97
1.16
0.76
0.52
0.68
0.48
0.60
0.49
0.59
1.10
1.20
0.69
1.21
0.57
0.37
0.20

5.40
6.06
5.32
4.25
6.13
4.37
5.29
5.23
5.19
0.86
0.66
1.34
1.16
0.99
0.69
2.55
2.21
2.56
0.78
1.33
2.18
3.97
1.05
0.43
0.41

0.03
0.12
0.13
0.17
0.21
0.13
0.34
0.07
0.27
0.13
0.16
0.12
0.08
0.10
0.07
0.09
0.07
0.09
0.13
0.15
0.09
0.17
0.08
0.05
0.03

13339
1582
869
339
374
712
131
3269
185
37
27
82
114
53
70
568
459
409
14
36
278
347
60
36
111

12.0
14.9
12.9
10.3
10.8
11.7
12.0
13.0
11.0
3.6
6.6
3.8
3.1
3.2
3.7
7.0
4.8
5.0
3.2
3.6
6.7
14.8
1.9
1.2
1.3

0.11
0.38
0.44
0.57
0.57
0.45
1.10
0.23
0.84
0.62
1.40
0.42
0.30
0.46
0.46
0.30
0.23
0.26
0.90
0.61
0.41
0.81
0.25
0.20
0.12

1.46
1.85
1.53
1.26
1.34
1.41
1.30
1.59
1.33
0.41
0.79
0.47
0.36
0.39
0.45
0.80
0.50
0.53
0.22
0.39
0.81
1.79
0.20
0.14
0.14

0.01
0.06
0.06
0.08
0.08
0.06
0.14
0.03
0.12
0.09
0.22
0.06
0.04
0.07 *
0.06 *
0.05 *
0.03
0.04
0.09
0.08
0.06 *
0.11 *
0.03
0.03 *
0.02 *

2604
174
79
998
88
496
1949
1162
2569
878
182
972
485
372
150
301
339
475
588
128
162
93
197
619
1255
355
459
407
615
323
20
291
149
732
243
558
351
75
794
333
535
1709
450
188
224
354
510
316
145
192
608
456
308
1325

8.6
7.3
6.9
3.4
1.2
2.5
5.9
6.9
7.1
4.0
4.2
4.8
13.6
15.2
7.9
11.6
9.0
11.7
14.6
6.4
7.8
4.9
7.9
6.0
6.5
5.0
6.7
4.3
5.8
6.9
1.8
2.4
14.4
29.5
11.6
9.0
11.5
7.3
15.2
10.4
34.8
17.4
20.0
14.5
10.1
6.9
14.6
16.0
11.3
26.0
13.0
9.3
14.9
18.2

0.17
0.56
0.79
0.11
0.13
0.12
0.14
0.21
0.14
0.14
0.33
0.16
0.63
0.83
0.67
0.68
0.52
0.55
0.63
0.61
0.64
0.55
0.60
0.25
0.19
0.27
0.32
0.22
0.24
0.40
0.42
0.15
1.24
1.12
0.80
0.41
0.70
0.90
0.57
0.61
1.51
0.44
1.02
1.13
0.71
0.41
0.67
0.93
1.00
1.91
0.55
0.47
0.86
0.52

1.10
0.92
0.88
0.43
0.16
0.30
0.72
0.85
0.86
0.49
0.47
0.55
1.89
1.96
1.06
1.55
1.13
1.50
1.98
0.85
1.13
0.65
1.14
0.73
0.82
0.57
0.84
0.57
0.71
0.85
0.19
0.28
1.82
3.88
1.41
1.11
1.34
1.05
1.90
1.37
4.67
2.23
2.58
1.84
1.34
0.87
1.93
2.08
1.39
3.53
1.63
1.15
1.98
2.40

0.03
0.08
0.12
0.02
0.02
0.02
0.02
0.03
0.02
0.02
0.04
0.02
0.10
0.12
0.10
0.10
0.07
0.08
0.09
0.08
0.10
0.08
0.09
0.03
0.03
0.04
0.04
0.03
0.03
0.06
0.06
0.02
0.19
0.17
0.12
0.06
0.09
0.14
0.08
0.09
0.23
0.07
0.15
0.16
0.11
0.06
0.10
0.14
0.14
0.29
0.08
0.07
0.13
0.08

1319
78
31
705
50
366
1100
784
1449
540
150
744
104
77
48
96
110
123
75
21
52
31
39
386
666
280
231
129
324
156
7
164
59
284
129
294
185
29
383
192
199
635
296
86
104
193
295
184
90
52
249
277
122
525

2.7
2.3
1.9
1.4
0.6
1.3
2.5
3.0
2.6
1.9
2.0
2.1
2.2
2.4
1.6
2.6
2.3
2.1
1.4
1.2
1.9
1.1
1.4
2.5
2.1
2.2
2.1
1.0
2.1
2.1
0.6
1.1
3.7
7.4
3.9
3.0
3.5
2.3
4.0
4.0
10.2
3.8
9.0
5.0
3.5
2.4
6.2
6.4
4.8
4.1
3.3
3.6
3.4
4.2

0.09
0.29
0.37
0.06
0.10
0.09
0.09
0.12
0.08
0.09
0.20
0.09
0.23
0.32
0.26
0.32
0.25
0.22
0.18
0.30
0.30
0.27
0.25
0.15
0.10
0.16
0.15
0.10
0.13
0.20
0.26
0.09
0.56
0.49
0.44
0.20
0.32
0.62
0.26
0.37
0.75
0.18
0.69
0.61
0.44
0.21
0.41
0.51
0.55
0.65
0.24
0.25
0.35
0.21

0.32
0.30
0.23
0.16
0.07
0.15
0.30
0.34
0.30
0.22
0.22
0.20
0.28
0.28
0.17
0.28
0.29
0.23
0.18
0.13
0.20
0.11
0.18
0.28
0.26
0.27
0.24
0.11
0.25
0.22
0.10
0.13
0.45
0.95
0.44
0.37
0.41
0.25
0.47
0.46
1.44
0.45
1.07
0.57
0.44
0.28
0.71
0.84
0.60
0.48
0.37
0.42
0.41
0.49

0.01
0.05
0.06
0.01 *
0.01 *
0.01
0.01 *
0.02
0.01
0.01
0.02
0.01
0.03
0.04
0.04
0.04
0.03
0.03
0.03
0.03
0.04
0.03
0.03
0.02
0.01
0.02
0.02
0.01
0.02
0.03
0.04
0.01
0.08
0.07
0.06
0.03
0.05
0.07
0.04
0.05
0.12
0.03
0.09
0.08
0.06
0.03
0.06
0.09
0.09
0.10
0.03
0.04
0.05
0.03

*Important. See note on population page.

484

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Liver (C22) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

313
420
35
388
92
122
182
330
623
651
1070
1041
415
66
491
778
395
61
219
264
285
202
177
194
1250
176
57
58
88
216
125
214
1029
40
58
223
506
634
825
239
907
1736
595
616
136
794

4.0
3.9
2.5
2.1
3.5
2.9
2.9
3.2
5.4
4.8
5.6
6.7
6.0
4.9
9.8
10.7
8.4
4.5
9.2
7.8
6.9
7.7
8.3
5.3
3.0
11.7
6.3
8.5
4.3
16.3
12.0
9.3
1.8
1.1
1.7
1.8
5.1
3.7
3.0
2.3
3.0
3.4
2.8
2.8
2.4
3.9

0.23
0.19
0.44
0.12
0.37
0.28
0.22
0.18
0.23
0.19
0.18
0.21
0.30
0.66
0.50
0.40
0.43
0.67
0.68
0.51
0.43
0.59
0.66
0.41
0.09
0.91
0.87
1.17
0.48
1.14
1.11
0.67
0.06
0.17
0.24
0.13
0.24
0.16
0.11
0.16
0.11
0.09
0.12
0.12
0.21
0.15

0.48
0.45
0.33
0.22
0.40
0.37
0.36
0.41
0.66
0.56
0.72
0.82
0.79
0.56
1.27
1.37
1.03
0.57
1.10
0.98
0.86
0.91
1.13
0.70
0.34
1.43
0.79
1.11
0.53
2.00
1.57
1.20
0.22
0.13
0.21
0.22
0.61
0.43
0.35
0.26
0.35
0.40
0.32
0.33
0.25
0.46

0.03
0.03
0.07
0.02
0.05
0.04
0.03
0.03
0.03
0.03
0.02
0.03
0.04
0.09
0.07
0.06
0.06
0.10
0.09
0.07
0.06
0.08
0.10
0.06
0.01
0.13
0.13
0.18
0.07
0.17
0.17
0.10
0.01
0.02
0.03
0.02
0.03
0.02
0.02
0.02
0.01
0.01
0.02
0.02
0.03
0.02

251
299
17
250
61
117
152
159
269
565
793
667
168
37
146
332
187
31
99
112
135
76
78
98
705
50
22
20
37
64
31
72
484
28
23
163
673
425
540
155
607
912
401
366
114
512

1.9
1.7
1.1
1.1
1.4
1.7
1.7
1.2
1.7
2.1
3.5
2.8
1.6
1.9
1.8
3.1
3.2
2.0
2.8
2.5
2.1
1.9
2.7
1.7
1.4
2.1
1.8
2.1
1.4
3.2
2.3
2.3
0.7
0.6
0.6
1.0
4.4
1.7
1.4
1.1
1.5
1.2
1.4
1.2
1.5
1.7

0.13
0.11
0.28
0.08
0.19
0.17
0.15
0.11
0.13
0.10
0.14
0.12
0.14
0.37
0.17
0.20
0.25
0.50
0.34
0.26
0.20
0.27
0.36
0.20
0.07
0.33
0.42
0.54
0.27
0.53
0.44
0.32
0.04
0.14
0.16
0.09
0.20
0.10
0.07
0.11
0.08
0.05
0.08
0.08
0.15
0.09

0.22
0.19
0.15
0.12
0.16
0.15
0.21
0.14
0.18
0.23
0.42
0.32
0.20
0.15
0.20
0.35
0.39
0.19
0.29
0.29
0.25
0.22
0.31
0.20
0.17
0.27
0.25
0.24
0.16
0.38
0.35
0.28
0.08
0.07
0.05
0.10
0.51
0.19
0.15
0.12
0.17
0.14
0.16
0.14
0.19
0.20

0.02
0.01
0.04
0.01
0.03 *
0.02
0.02
0.01 *
0.02
0.01
0.02
0.02
0.02
0.05
0.02
0.03
0.04
0.06
0.05
0.04
0.03
0.04
0.05
0.03
0.01
0.05
0.07
0.07
0.04
0.07
0.07
0.04
0.00
0.02
0.01
0.01
0.03
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01

997
28
439
196
55
836
229
34
59
506
395
46
68
54
107
69

4.3
7.8
3.6
3.2
3.5
4.9
3.7
4.1
13.4
4.2
9.1
13.9
10.2
11.0
8.5
5.5

0.14
1.56
0.18
0.24
0.49
0.18
0.25
0.73
1.83
0.19
0.49
2.20
1.31
1.52
1.09
0.69

0.52
0.89
0.44
0.39
0.41
0.58
0.45
0.51
1.54
0.49
1.02
1.57
1.27
1.13
0.87
0.61

0.02
0.23
0.03
0.04
0.06
0.03
0.04
0.11
0.25
0.03
0.07
0.28
0.19
0.20
0.12
0.10

378
6
189
72
19
292
85
18
18
247
171
17
21
27
65
18

1.4
2.0
1.4
0.9
1.1
1.3
1.2
1.8
4.4
1.6
3.3
3.9
2.7
4.4
3.5
1.5

0.08
0.87
0.11
0.12
0.28
0.09
0.15
0.44
1.06
0.11
0.28
1.06
0.61
0.87
0.54
0.38

0.16
0.28
0.16
0.12
0.12
0.14
0.14
0.23
0.66
0.19
0.41
0.52
0.29
0.48
0.45
0.17

0.01
0.13
0.02
0.02
0.03
0.01
0.02
0.07
0.18
0.02
0.04
0.16
0.08
0.12
0.08
0.05

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

427

485

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Gallbladder etc. (C23-24)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

428

Female
ASR(W)
CUM 0-74

38
49
16
3
9

2.1
1.2
1.8
0.5
0.7

0.35
0.19
0.45
0.28
0.25

199
47
31
4
9

10.0
1.0
3.1
0.4
0.7

0.72
0.14
0.56
0.24
0.26

24
53
7
41
488
110
87
152
126
13
26

2.9
3.0
1.1
3.1
2.4
12.3
2.5
2.0
4.5
1.1
3.0

0.60
0.43
0.43
0.49
0.11
1.20
0.28
0.17
0.42
0.32
0.60

0.38
0.33
0.12
0.44
0.28
1.45
0.27
0.21
0.51
0.14
0.37

0.09
0.06
0.07
0.08
0.02
0.18
0.04
0.02
0.06
0.05
0.09

33
107
13
60
839
274
234
258
245
33
78

2.7
4.6
2.0
3.5
2.9
27.3
5.3
3.2
7.4
2.2
7.5

0.52
0.47
0.59
0.46
0.10
1.69
0.36
0.20
0.50
0.41
0.87

0.32
0.60
0.24
0.40
0.32
3.23
0.67
0.37
0.85
0.25
0.96

0.07
0.08
0.09
0.07
0.01
0.24
0.06
0.03
0.07
0.05
0.14 *

1402
152
258
82
31
23
1
42
740
4
69
183
28
152
23
284
1663
236
81
351
985
292
19
34
7
5
45
156
506
36
19
19
17
32
148
218
168
226
16
207
15
10
5
1197
91
1090
268
41
216
80
11
59
66
669
60
586
318
186
220
194
39
152
5
33

1.6
1.6
1.6
1.9
1.0
1.2
1.4
1.0
1.7
0.6
1.6
1.1
1.0
1.2
1.5
1.4
1.5
2.0
1.4
2.2
1.3
1.4
1.4
1.8
0.8
1.4
2.2
1.1
1.9
1.4
1.6
2.3
2.6
5.9
2.4
1.5
1.3
1.6
2.5
1.6
0.9
1.1
0.8
1.5
1.7
1.5
1.2
0.9
1.2
1.1
0.7
1.2
1.4
1.5
1.5
1.5
1.5
1.6
1.5
1.3
1.1
1.4
0.5
1.5

0.05
0.13
0.11
0.22
0.19
0.26
1.41
0.17
0.07
0.30
0.21
0.09
0.19
0.10
0.34
0.09
0.04
0.13
0.16
0.12
0.05
0.08
0.33
0.33
0.30
0.65
0.33
0.10
0.09
0.24
0.38
0.55
0.71
1.06
0.20
0.11
0.11
0.12
0.64
0.12
0.24
0.34
0.37
0.05
0.18
0.05
0.07
0.15
0.08
0.13
0.21
0.16
0.18
0.06
0.19
0.07
0.09
0.12
0.11
0.10
0.18
0.12
0.22
0.27

0.19
0.17
0.19
0.24
0.11
0.16
0.10
0.20
0.05
0.19
0.13
0.11
0.13
0.18
0.16
0.18
0.23
0.15
0.25
0.15
0.15
0.14
0.20
0.09
0.18
0.20
0.14
0.22
0.15
0.23
0.26
0.25
0.74
0.28
0.17
0.16
0.18
0.42
0.17
0.13
0.16
0.09
0.18
0.19
0.18
0.13
0.10
0.13
0.11
0.05
0.11
0.15
0.18
0.19
0.18
0.17
0.17
0.18
0.14
0.10
0.15
0.04
0.15

0.01
0.02
0.02
0.03
0.03
0.04
0.02
0.01
0.05
0.03
0.01
0.03
0.01
0.05
0.01
0.01
0.02
0.02
0.02
0.01
0.01
0.04
0.05
0.04
0.11
0.04
0.02
0.01
0.03
0.07
0.08
0.09
0.17
0.03
0.02
0.02
0.02
0.12
0.02
0.04
0.05
0.06
0.01
0.03
0.01
0.01
0.02
0.01
0.02
0.03
0.02
0.03
0.01
0.03
0.01
0.01
0.02
0.02
0.01
0.02
0.02
0.03
0.04

1872
219
294
111
52
30
4
87
957
15
103
250
63
185
33
338
2347
318
115
672
1230
438
24
36
15
7
87
236
780
62
30
24
17
30
300
295
228
291
18
269
33
25
7
1386
140
1224
403
81
307
118
25
79
73
1053
107
907
427
279
304
313
96
209
32
33

1.7
1.9
1.4
1.9
1.1
1.4
5.0
1.8
1.7
2.3
1.6
1.1
1.4
1.0
2.3
1.5
1.7
2.1
1.4
3.5
1.3
1.6
1.3
1.6
1.2
1.3
3.3
1.3
2.2
1.6
2.2
2.0
1.4
3.6
3.9
1.5
1.3
1.6
1.8
1.5
1.2
1.4
0.9
1.4
1.9
1.4
1.2
1.1
1.2
1.2
0.9
1.1
1.4
1.8
1.7
1.8
1.5
1.6
1.5
1.5
1.9
1.4
2.2
1.1

0.04
0.14
0.09
0.21
0.17
0.26
2.64
0.22
0.06
0.66
0.19
0.08
0.19
0.08
0.42
0.09
0.04
0.12
0.14
0.14
0.04
0.09
0.28
0.30
0.32
0.55
0.36
0.10
0.09
0.21
0.43
0.42
0.39
0.68
0.23
0.10
0.09
0.11
0.43
0.11
0.24
0.31
0.36
0.05
0.17
0.05
0.06
0.13
0.07
0.12
0.20
0.14
0.18
0.06
0.17
0.07
0.08
0.12
0.09
0.10
0.20
0.11
0.40
0.23

0.20
0.21
0.16
0.22
0.12
0.20
0.61
0.23
0.20
0.31
0.16
0.13
0.16
0.11
0.30
0.17
0.21
0.23
0.16
0.43
0.15
0.19
0.14
0.17
0.10
0.18
0.41
0.16
0.27
0.18
0.24
0.20
0.07
0.43
0.47
0.19
0.14
0.19
0.16
0.19
0.14
0.14
0.14
0.17
0.21
0.16
0.13
0.11
0.13
0.14
0.11
0.13
0.19
0.21
0.20
0.21
0.18
0.19
0.16
0.17
0.19
0.16
0.23
0.14

0.01
0.02
0.01
0.03
0.03
0.04
0.48
0.03
0.01
0.11
0.03
0.01
0.03
0.01
0.07
0.01
0.01
0.02
0.02
0.02
0.01
0.01
0.04
0.04
0.04
0.08
0.06
0.02
0.01
0.03
0.06
0.06
0.04
0.11
0.03
0.02
0.01
0.02
0.05
0.02
0.03
0.04
0.07
0.01
0.02
0.01
0.01
0.02
0.01
0.02
0.04
0.02
0.03
0.01
0.02
0.01
0.01
0.02
0.01
0.01
0.03
0.02
0.06
0.03

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

486

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Gallbladder etc. (C23-24) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

72
351
537
62
463
251
46
199
278
16
261
56
11835
863
10369
514
44
441
110
13
41
54
1163
100
993
576
39
525
156
158
876
49
804
63
1417
101
1122
3811
389
267
467
2649
185
40
144
855
81
740
76
33
266
173
93
300

1.4
1.4
1.5
1.8
1.4
1.8
1.8
1.8
1.3
1.0
1.3
1.5
1.5
1.4
1.5
1.6
1.6
1.5
1.7
3.8
2.1
1.4
1.7
1.5
1.7
1.4
1.1
1.4
1.2
1.2
1.7
1.5
1.6
1.4
1.5
1.5
1.5
1.5
2.1
1.5
2.2
1.4
1.3
1.3
1.3
1.4
1.6
1.4
1.3
1.4
1.3
1.2
1.3
1.5

0.17
0.08
0.07
0.24
0.07
0.12
0.27
0.13
0.08
0.25
0.09
0.21
0.01
0.05
0.02
0.07
0.25
0.08
0.17
1.09
0.34
0.20
0.05
0.15
0.06
0.06
0.18
0.06
0.10
0.10
0.06
0.22
0.06
0.20
0.04
0.16
0.05
0.03
0.11
0.09
0.11
0.03
0.10
0.22
0.12
0.05
0.18
0.05
0.15
0.26
0.08
0.10
0.14
0.09

0.16
0.16
0.17
0.22
0.17
0.21
0.23
0.21
0.14
0.09
0.15
0.17
0.17
0.16
0.17
0.18
0.18
0.18
0.21
0.37
0.24
0.19
0.19
0.17
0.19
0.17
0.12
0.17
0.15
0.13
0.19
0.19
0.19
0.16
0.17
0.20
0.16
0.17
0.24
0.17
0.25
0.16
0.15
0.14
0.15
0.16
0.19
0.15
0.15
0.17
0.15
0.14
0.15
0.17

0.03
0.01
0.01
0.04
0.01
0.02
0.04
0.02
0.01
0.03
0.01
0.03
0.00
0.01
0.00
0.01
0.03
0.01
0.03
0.14
0.05
0.03
0.01
0.02
0.01
0.01
0.03
0.01
0.02
0.01
0.01
0.03
0.01
0.03
0.01
0.03
0.01
0.00
0.02
0.01
0.02
0.00
0.01
0.03
0.02
0.01
0.03
0.01
0.02
0.04
0.01
0.02
0.02
0.01

107
513
733
96
627
338
75
259
484
49
430
70
16980
1597
14558
774
83
659
157
34
64
58
1879
228
1568
833
81
739
229
231
1236
92
1120
117
1909
149
1540
5370
465
452
864
3513
233
63
166
1286
132
1117
88
37
374
250
121
496

1.6
1.4
1.6
2.0
1.5
1.8
2.0
1.7
1.7
2.2
1.7
1.4
1.6
1.7
1.5
1.7
2.0
1.6
2.0
7.1
3.0
1.1
1.9
2.0
1.9
1.4
1.5
1.3
1.4
1.3
1.7
1.9
1.6
2.1
1.6
1.5
1.5
1.6
2.0
1.7
3.4
1.4
1.2
1.5
1.1
1.6
1.7
1.6
1.2
1.1
1.4
1.4
1.1
1.8

0.17
0.07
0.07
0.22
0.07
0.11
0.25
0.12
0.09
0.34
0.09
0.20
0.01
0.05
0.01
0.07
0.23
0.07
0.18
1.28
0.39
0.16
0.05
0.14
0.06
0.05
0.19
0.06
0.10
0.10
0.06
0.21
0.06
0.23
0.04
0.13
0.04
0.03
0.10
0.08
0.12
0.03
0.09
0.20
0.10
0.05
0.16
0.05
0.14
0.20
0.08
0.10
0.11
0.09

0.20
0.15
0.18
0.25
0.17
0.20
0.26
0.18
0.20
0.29
0.19
0.18
0.18
0.20
0.18
0.21
0.25
0.19
0.25
0.85
0.40
0.12
0.22
0.24
0.22
0.15
0.16
0.15
0.16
0.15
0.19
0.21
0.19
0.24
0.18
0.18
0.18
0.19
0.22
0.20
0.41
0.16
0.14
0.20
0.12
0.19
0.18
0.19
0.14
0.11
0.17
0.17
0.12
0.20

0.03
0.01
0.01
0.03
0.01
0.02
0.04
0.02
0.01
0.05
0.01
0.03
0.00
0.01
0.00
0.01
0.04
0.01
0.03
0.21
0.06
0.02
0.01
0.02
0.01
0.01
0.03
0.01
0.01
0.01
0.01
0.03
0.01
0.03
0.01
0.02
0.01
0.00
0.01
0.01
0.02
0.00
0.01
0.03
0.01
0.01
0.02
0.01
0.02
0.03
0.01
0.02
0.02
0.01

4
147
681
28
51
858
140
46
88
764
3
333
31
56
16
255
215
27
236
381
263
817
570
2172
638

0.8
2.8
2.9
2.2
2.1
3.5
4.4
1.7
1.0
3.9
0.3
1.6
0.8
0.9
0.6
1.5
1.3
2.0
5.9
8.0
6.1
6.9
7.0
5.7
8.4

0.40
0.24
0.12
0.45
0.30
0.13
0.39
0.27
0.10
0.15
0.20
0.09
0.14
0.13
0.14
0.10
0.10
0.39
0.39
0.44
0.38
0.25
0.31
0.12
0.36

0.09
0.30
0.32
0.29
0.26
0.37
0.54
0.20
0.12
0.49
0.03
0.19
0.10
0.11
0.07
0.17
0.16
0.29
0.66
0.80
0.69
0.71
0.76
0.59
0.90

0.05
0.03
0.02
0.06
0.04
0.02
0.06
0.04
0.01
0.02
0.02
0.01
0.02
0.02
0.02
0.01
0.01
0.07
0.06
0.06
0.06
0.04
0.04
0.02
0.05

5
165
783
50
50
1538
90
69
72
1476
8
457
29
71
12
455
401
40
259
484
296
911
834
2632
749

0.9
2.6
2.8
3.4
2.0
5.1
2.4
2.3
0.8
8.6
0.9
2.3
0.8
1.2
0.4
2.0
1.8
2.8
5.0
6.5
4.5
5.2
6.4
4.7
6.0

0.40
0.20
0.11
0.50
0.29
0.14
0.26
0.30
0.10
0.23
0.31
0.11
0.14
0.14
0.12
0.10
0.10
0.44
0.33
0.35
0.29
0.19
0.26
0.10
0.26

0.10
0.30
0.29
0.46
0.22
0.60
0.24
0.29
0.10
1.05
0.13
0.27
0.08
0.14
0.06
0.24
0.22
0.38
0.51
0.67
0.43
0.53
0.67
0.47
0.60

0.05
0.03 *
0.02
0.08 *
0.04
0.02 *
0.03 *
0.05 *
0.01
0.03 *
0.05
0.02
0.02 *
0.02 *
0.02 *
0.02
0.02
0.07
0.05
0.05
0.04
0.03
0.04
0.01
0.04

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

429

487

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Gallbladder etc. (C23-24) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

430

Female
ASR(W)
CUM 0-74

6557
682
477
163
233
308
58
1468
111
16
16
18
21
12
32
74
162
129
17
16
68
62
20
39
120

8.1
9.3
10.4
7.0
10.0
7.1
8.5
8.0
10.1
1.8
1.2
1.0
0.6
0.8
1.3
1.2
2.0
2.1
2.3
1.4
1.7
2.9
0.8
1.4
1.5

0.10
0.40
0.50
0.58
0.69
0.43
1.16
0.23
1.03
0.46
0.51
0.24
0.14
0.22
0.24
0.15
0.16
0.19
0.59
0.36
0.22
0.37
0.17
0.23
0.14

0.98
1.14
1.23
0.80
1.17
0.89
0.86
0.89
1.38
0.17
0.17
0.05
0.09
0.10
0.16
0.14
0.24
0.24
0.29
0.15
0.23
0.35
0.08
0.16
0.21

0.02
0.06
0.07
0.08
0.10
0.07
0.15
0.03
0.17
0.06
0.08
0.02
0.02
0.03
0.04
0.02
0.02
0.03
0.08
0.05
0.03
0.05
0.02
0.03
0.02

6518
782
504
159
210
312
101
1609
120
19
10
29
32
17
94
101
225
191
10
24
101
92
38
50
167

5.6
7.4
7.5
4.8
5.8
5.0
8.0
6.3
7.0
1.7
2.5
1.3
0.9
1.1
4.9
1.3
2.4
2.4
2.3
2.5
2.4
3.7
1.2
1.8
2.0

0.07
0.27
0.34
0.39
0.41
0.29
0.84
0.16
0.67
0.42
0.81
0.25
0.15
0.28
0.53
0.13
0.16
0.18
0.75
0.53
0.25
0.39
0.20
0.25
0.16

0.67
0.94
0.93
0.63
0.64
0.58
0.76
0.73
0.84
0.24
0.25
0.16
0.08
0.15
0.57
0.15
0.26
0.25
0.30
0.33
0.30
0.50
0.14
0.20
0.23

0.01
0.04
0.05
0.06
0.06
0.04
0.11
0.02
0.10
0.07
0.12
0.04
0.02
0.04 *
0.07 *
0.02 *
0.02
0.03
0.11
0.08
0.04 *
0.06 *
0.03
0.04 *
0.02 *

698
52
22
340
43
216
459
471
1652
338
72
435
65
55
31
49
66
96
51
16
20
35
16
271
644
104
239
229
265
127
15
256
25
73
90
191
111
23
172
74
56
341
67
58
39
163
134
83
47
23
200
140
91
243

2.1
2.0
1.9
1.2
0.6
1.0
1.3
2.8
4.4
1.4
1.6
2.1
1.8
2.0
1.5
1.9
1.5
2.2
1.2
0.7
0.8
1.7
0.6
2.6
3.2
1.4
3.7
2.3
2.4
2.5
1.6
2.0
2.2
2.9
4.1
2.8
3.2
2.2
3.1
1.8
3.5
3.2
2.5
3.7
1.4
2.6
3.8
3.9
3.3
3.0
3.9
2.7
4.1
3.0

0.08
0.28
0.41
0.06
0.09
0.07
0.06
0.13
0.11
0.08
0.19
0.10
0.23
0.28
0.28
0.27
0.20
0.24
0.17
0.18
0.18
0.31
0.15
0.16
0.13
0.14
0.24
0.15
0.15
0.23
0.45
0.13
0.47
0.34
0.47
0.22
0.33
0.49
0.25
0.23
0.48
0.18
0.33
0.52
0.24
0.22
0.34
0.45
0.51
0.64
0.29
0.25
0.44
0.20

0.23
0.18
0.27
0.14
0.06
0.11
0.15
0.31
0.51
0.16
0.20
0.21
0.21
0.20
0.17
0.24
0.13
0.27
0.13
0.10
0.07
0.20
0.06
0.30
0.37
0.16
0.40
0.24
0.27
0.30
0.21
0.22
0.20
0.35
0.44
0.32
0.34
0.23
0.36
0.16
0.49
0.36
0.24
0.44
0.19
0.27
0.42
0.46
0.42
0.38
0.44
0.34
0.49
0.34

0.01
0.04
0.07
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.03
0.01
0.03
0.04
0.04
0.04
0.02
0.04
0.02
0.03
0.02
0.05
0.02
0.02
0.02
0.02
0.03
0.02
0.02
0.03
0.07
0.02
0.06
0.05
0.06
0.03
0.05
0.07
0.04
0.03
0.08
0.03
0.05
0.08
0.04
0.03
0.05
0.07
0.08
0.10
0.04
0.04
0.07
0.03

1433
88
50
623
81
314
837
933
3436
486
150
887
87
75
43
85
81
109
69
51
41
39
29
726
1699
187
559
338
554
258
18
360
66
131
111
256
175
37
268
97
107
578
107
60
91
212
236
109
71
28
291
214
110
361

2.6
2.3
2.7
1.2
0.8
1.1
1.9
3.5
6.0
1.5
1.8
2.5
1.4
1.6
1.5
2.3
1.2
1.8
1.0
1.6
1.1
1.4
0.7
4.4
4.8
1.4
4.9
2.1
3.0
3.1
1.4
2.2
3.5
3.3
3.4
2.7
3.3
2.7
2.8
1.9
5.3
3.3
2.9
3.3
2.8
2.4
5.0
3.7
4.0
2.3
3.6
3.0
3.1
3.0

0.08
0.28
0.43
0.05
0.10
0.07
0.07
0.12
0.11
0.08
0.16
0.10
0.17
0.22
0.26
0.27
0.16
0.19
0.13
0.27
0.20
0.28
0.15
0.18
0.13
0.12
0.22
0.13
0.15
0.22
0.38
0.13
0.49
0.32
0.40
0.20
0.31
0.55
0.20
0.24
0.53
0.16
0.35
0.48
0.35
0.20
0.36
0.39
0.51
0.50
0.25
0.25
0.34
0.18

0.30
0.25
0.28
0.16
0.10
0.13
0.23
0.39
0.67
0.18
0.22
0.27
0.17
0.14
0.17
0.28
0.15
0.19
0.10
0.16
0.12
0.16
0.08
0.49
0.55
0.16
0.54
0.22
0.34
0.34
0.16
0.25
0.41
0.39
0.35
0.30
0.42
0.31
0.31
0.23
0.64
0.36
0.28
0.35
0.34
0.25
0.61
0.41
0.49
0.24
0.38
0.33
0.34
0.36

0.01
0.04
0.06
0.01 *
0.01 *
0.01
0.01 *
0.02
0.02
0.01
0.02
0.01
0.03
0.03
0.04
0.04
0.03
0.03
0.02
0.03
0.03
0.04
0.02
0.03
0.02
0.02
0.03
0.02
0.02
0.03
0.06
0.02
0.08
0.05
0.05
0.03
0.05
0.07
0.03
0.03
0.08
0.02
0.05
0.07
0.05
0.03
0.05
0.06
0.08
0.07
0.03
0.04
0.05
0.03

*Important. See note on population page.

488

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Gallbladder etc. (C23-24) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

109
183
19
285
83
109
182
154
300
252
247
587
245
18
57
180
95
28
73
83
83
89
45
54
771
32
10
15
33
33
16
42
1152
70
62
112
105
163
285
83
327
596
224
244
108
321

1.4
1.6
1.3
1.5
3.4
2.3
2.8
1.4
2.4
1.8
1.3
3.6
3.5
1.2
1.1
2.3
2.0
1.7
2.8
2.3
1.9
3.1
1.9
1.2
1.8
2.0
1.1
2.4
1.6
2.4
1.5
1.6
1.9
1.9
1.6
0.8
1.1
0.9
1.0
0.8
1.0
1.0
1.0
1.0
1.9
1.5

0.13
0.12
0.31
0.09
0.37
0.23
0.22
0.12
0.14
0.11
0.08
0.15
0.22
0.30
0.15
0.18
0.21
0.37
0.38
0.26
0.22
0.36
0.31
0.18
0.07
0.36
0.35
0.64
0.30
0.44
0.37
0.26
0.06
0.23
0.22
0.08
0.11
0.08
0.06
0.09
0.06
0.05
0.07
0.07
0.19
0.09

0.18
0.19
0.14
0.17
0.36
0.25
0.35
0.17
0.26
0.22
0.16
0.42
0.40
0.16
0.13
0.26
0.22
0.18
0.32
0.25
0.21
0.35
0.25
0.14
0.22
0.21
0.14
0.27
0.20
0.31
0.20
0.18
0.22
0.21
0.19
0.08
0.13
0.11
0.11
0.09
0.11
0.12
0.11
0.12
0.23
0.18

0.02
0.02
0.04
0.01
0.05
0.03
0.03
0.02
0.02
0.02
0.01
0.02
0.03
0.05
0.02
0.03
0.03
0.05
0.05
0.04
0.03
0.05
0.05
0.03
0.01
0.05
0.06
0.08
0.04
0.07
0.06
0.04
0.01
0.03
0.03
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.03
0.01

182
460
30
385
190
345
388
176
330
651
444
1455
414
49
101
317
179
37
91
201
151
131
83
115
1337
41
31
18
76
40
29
82
1617
109
99
169
158
216
393
102
484
834
350
386
158
420

1.2
2.3
1.7
1.5
4.5
5.2
3.7
1.1
1.8
2.1
1.9
5.9
3.5
3.0
1.2
2.8
2.9
1.8
2.3
4.3
2.5
3.0
2.7
1.8
2.5
1.8
2.6
1.7
2.3
2.1
1.8
2.2
1.9
2.2
1.9
0.9
1.1
0.9
1.0
0.7
1.1
1.1
1.3
1.3
1.9
1.3

0.10
0.12
0.33
0.09
0.35
0.31
0.20
0.09
0.11
0.09
0.10
0.17
0.19
0.51
0.14
0.18
0.23
0.39
0.28
0.34
0.22
0.32
0.34
0.20
0.08
0.31
0.54
0.50
0.30
0.38
0.38
0.28
0.05
0.22
0.21
0.09
0.10
0.07
0.06
0.08
0.06
0.04
0.08
0.07
0.17
0.08

0.14
0.29
0.20
0.17
0.51
0.61
0.42
0.13
0.21
0.23
0.24
0.70
0.38
0.32
0.12
0.29
0.34
0.21
0.25
0.52
0.26
0.29
0.29
0.21
0.31
0.23
0.29
0.16
0.26
0.24
0.18
0.29
0.23
0.23
0.21
0.10
0.11
0.11
0.12
0.06
0.12
0.12
0.15
0.15
0.22
0.15

0.01
0.02
0.05
0.01
0.05 *
0.04
0.03
0.01 *
0.02
0.01
0.01
0.02
0.03
0.07
0.02
0.03
0.03
0.06
0.04
0.05
0.03
0.05
0.05
0.03
0.01
0.05
0.07
0.06
0.05
0.05
0.05
0.04
0.01
0.03
0.03
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01

403
11
236
120
40
318
128
11
6
175
103
7
16
15
43
14

1.6
2.7
1.8
1.9
2.0
1.8
2.0
1.1
1.5
1.3
2.0
1.2
2.1
3.2
2.4
1.0

0.08
0.90
0.12
0.18
0.33
0.10
0.18
0.35
0.60
0.10
0.22
0.51
0.56
0.84
0.45
0.29

0.20
0.28
0.22
0.21
0.21
0.21
0.24
0.08
0.15
0.16
0.22
0.12
0.23
0.40
0.25
0.08

0.01
0.12
0.02
0.03
0.05
0.02
0.03
0.04
0.07
0.02
0.03
0.08
0.08
0.12
0.06
0.04

636
7
275
185
61
429
138
18
9
235
85
8
11
7
35
17

2.0
2.6
1.6
2.2
2.4
1.9
1.7
1.8
2.2
1.4
1.4
1.3
1.4
1.2
1.5
1.0

0.09
1.01
0.11
0.18
0.35
0.10
0.15
0.43
0.75
0.10
0.17
0.55
0.43
0.47
0.33
0.28

0.24
0.31
0.18
0.26
0.27
0.22
0.18
0.21
0.32
0.16
0.15
0.14
0.22
0.13
0.17
0.10

0.01
0.16
0.02
0.03
0.05
0.02
0.02
0.06
0.12
0.01
0.02
0.08
0.08
0.06
0.05
0.04

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

431

489

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Pancreas (C25)
Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

432

Female
ASR(W)
CUM 0-74

9
164
22
12
66

0.5
4.0
2.5
1.2
4.6

0.17
0.33
0.54
0.40
0.63

8
109
18
6
56

0.3
2.3
1.9
0.4
4.8

0.12
0.23
0.46
0.17
0.71

90
112
28
47
1315
39
141
341
81
56
18

9.9
5.7
4.2
3.6
6.6
4.2
4.2
4.6
3.0
4.7
2.0

1.09
0.57
0.83
0.54
0.18
0.68
0.36
0.25
0.35
0.66
0.48

1.23
0.66
0.50
0.42
0.79
0.49
0.54
0.48
0.38
0.51
0.19

0.16
0.08
0.12
0.08
0.03
0.11
0.06
0.04
0.06
0.08
0.06

89
113
14
65
1449
41
182
337
102
49
28

6.4
4.8
2.1
3.8
5.0
3.8
4.0
4.0
2.9
3.3
2.6

0.76
0.47
0.57
0.48
0.13
0.61
0.30
0.22
0.30
0.52
0.51

0.75
0.59
0.25
0.41
0.57
0.49
0.45
0.41
0.33
0.39
0.32

0.11
0.07
0.09
0.07
0.02
0.10
0.05
0.03
0.05
0.07
0.08 *

5651
667
1058
302
223
50
5
285
2750
38
273
1178
283
892
115
1237
7730
627
552
1015
5484
1470
119
94
45
21
129
1006
1966
252
55
30
36
38
341
1182
940
1079
76
995
188
139
40
5626
464
5100
1741
467
1256
520
164
343
294
3509
482
2955
1549
893
1023
1360
402
949
116
196

6.7
7.1
6.7
7.1
7.7
2.8
5.8
7.9
6.6
6.7
6.5
7.7
10.0
7.2
8.0
6.7
7.4
5.4
9.9
6.6
7.7
7.0
9.1
5.7
5.0
5.2
6.3
7.5
7.3
10.3
4.5
3.6
5.5
6.9
5.8
8.1
7.3
8.4
10.9
8.2
10.5
12.5
6.4
7.8
8.8
7.7
7.7
10.6
7.0
7.8
10.1
7.1
6.6
8.6
11.2
8.3
7.6
8.0
7.5
9.7
12.5
8.9
12.6
8.8

0.09
0.28
0.22
0.43
0.54
0.40
2.75
0.49
0.13
1.15
0.43
0.23
0.62
0.25
0.78
0.20
0.09
0.22
0.43
0.21
0.11
0.19
0.86
0.61
0.77
1.27
0.57
0.25
0.17
0.66
0.64
0.68
1.03
1.14
0.32
0.25
0.25
0.27
1.27
0.28
0.80
1.10
1.06
0.11
0.42
0.12
0.19
0.51
0.20
0.35
0.83
0.40
0.41
0.15
0.52
0.16
0.20
0.29
0.24
0.27
0.64
0.30
1.19
0.67

0.79
0.82
0.78
0.90
0.90
0.39
0.57
0.96
0.79
0.67
0.73
0.94
1.19
0.88
1.03
0.80
0.89
0.63
1.27
0.81
0.92
0.84
1.15
0.67
0.62
0.57
0.85
0.88
0.88
1.36
0.48
0.43
0.71
0.75
0.72
0.96
0.84
0.99
1.32
0.98
1.22
1.46
0.67
0.93
1.05
0.92
0.90
1.28
0.82
0.90
1.25
0.81
0.74
1.04
1.40
1.00
0.93
0.97
0.88
1.17
1.66
1.04
1.80
0.98

0.01
0.04
0.03
0.07
0.08
0.06
0.34
0.07
0.02
0.16
0.06
0.03
0.09
0.04
0.12
0.03
0.01
0.03
0.07
0.03
0.02
0.03
0.14
0.09
0.12
0.20
0.09
0.04
0.03
0.10
0.09
0.10
0.16
0.16
0.05
0.04
0.04
0.04
0.19
0.04
0.12
0.16
0.15
0.02
0.06
0.02
0.03
0.08
0.03
0.05
0.13
0.06
0.06
0.02
0.08
0.02
0.03
0.04
0.03
0.04
0.10
0.04
0.20
0.09

5909
657
1156
332
230
38
5
287
2897
40
267
1265
325
930
105
1190
8080
650
646
1139
5594
1647
156
84
51
33
150
1100
2102
295
56
53
56
25
449
1132
908
1128
78
1033
210
159
42
5598
524
5010
1710
495
1198
504
183
314
320
3752
571
3103
1593
906
1062
1317
420
891
119
188

5.3
5.6
5.5
5.4
6.2
1.8
7.2
5.7
5.2
5.0
4.8
5.5
6.9
5.2
7.2
4.9
5.7
4.3
8.1
5.8
5.7
5.6
8.3
3.6
4.0
6.0
5.5
5.7
5.6
7.7
3.7
4.5
6.4
3.2
5.5
5.8
5.4
6.2
7.7
6.0
7.2
8.2
4.6
5.7
7.0
5.6
5.3
7.0
4.8
5.4
7.2
4.8
5.6
6.3
8.7
6.0
5.5
5.4
5.4
6.4
8.4
5.8
8.1
6.0

0.08
0.24
0.18
0.35
0.47
0.30
3.36
0.38
0.11
0.91
0.35
0.17
0.42
0.19
0.73
0.16
0.07
0.18
0.34
0.18
0.09
0.16
0.73
0.42
0.58
1.21
0.47
0.20
0.14
0.48
0.52
0.65
0.98
0.67
0.27
0.20
0.20
0.22
0.90
0.22
0.57
0.74
0.84
0.09
0.32
0.09
0.14
0.34
0.15
0.26
0.56
0.29
0.35
0.12
0.38
0.13
0.16
0.21
0.18
0.20
0.44
0.22
0.79
0.50

0.60
0.64
0.59
0.63
0.74
0.23
0.97
0.65
0.59
0.48
0.55
0.63
0.84
0.58
0.90
0.57
0.66
0.51
0.97
0.66
0.67
0.64
0.98
0.39
0.39
0.61
0.64
0.66
0.66
0.95
0.40
0.55
0.80
0.30
0.63
0.68
0.64
0.75
0.84
0.73
0.85
0.96
0.50
0.67
0.80
0.66
0.63
0.84
0.57
0.64
0.80
0.59
0.65
0.76
1.05
0.72
0.67
0.64
0.62
0.77
0.97
0.70
0.90
0.71

0.01
0.04
0.03
0.05
0.07
0.05
0.59
0.06
0.02
0.13
0.05
0.03
0.07
0.03
0.11
0.02
0.01
0.03
0.05
0.03
0.01
0.02
0.11
0.06
0.07
0.15
0.07
0.03
0.02
0.08
0.08
0.10
0.15
0.09
0.04
0.03
0.03
0.03
0.13
0.03
0.09
0.11
0.13
0.01
0.05
0.01
0.02
0.05
0.02
0.04
0.09
0.05
0.05
0.02
0.06
0.02
0.02
0.03
0.03
0.03
0.07
0.03
0.11
0.07

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

490

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Pancreas (C25) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

419
1813
2760
395
2334
1241
305
921
1614
150
1455
244
60120
6260
52183
2532
273
2188
458
20
149
278
5743
634
4925
2992
322
2633
952
906
3988
346
3587
304
7026
717
5767
18724
1048
1937
1390
14219
1047
277
765
4459
539
3845
381
182
1607
1080
517
1543

8.3
8.1
8.2
11.8
7.8
9.5
12.4
8.8
8.1
10.5
8.0
6.6
7.9
10.2
7.7
8.5
9.9
8.4
7.4
6.3
7.9
7.2
8.8
9.5
8.8
7.5
9.8
7.3
7.7
7.1
8.2
11.4
7.9
8.0
8.0
10.9
7.9
7.9
5.8
10.9
6.7
7.9
7.8
9.9
7.2
7.4
10.4
7.2
6.8
8.4
8.2
8.2
7.2
8.0

0.43
0.20
0.16
0.61
0.17
0.28
0.74
0.31
0.21
0.88
0.22
0.45
0.03
0.13
0.04
0.18
0.61
0.19
0.36
1.42
0.66
0.46
0.12
0.38
0.13
0.14
0.56
0.15
0.26
0.25
0.14
0.63
0.14
0.49
0.10
0.42
0.11
0.06
0.19
0.25
0.19
0.07
0.25
0.61
0.27
0.11
0.46
0.12
0.36
0.65
0.21
0.26
0.33
0.22

1.01
0.97
0.97
1.44
0.92
1.13
1.57
1.04
1.00
1.24
0.98
0.75
0.94
1.25
0.92
1.02
1.24
1.01
0.93
0.91
0.96
0.90
1.05
1.18
1.05
0.90
1.19
0.87
0.92
0.85
0.99
1.46
0.95
1.00
0.97
1.37
0.95
0.95
0.67
1.39
0.82
0.94
0.89
1.15
0.82
0.90
1.29
0.87
0.81
1.05
1.00
1.01
0.84
0.96

0.06
0.03
0.02
0.09
0.02
0.04
0.11
0.04
0.03
0.13
0.03
0.07
0.00
0.02
0.01
0.03
0.09
0.03
0.05
0.23
0.10
0.07
0.02
0.06
0.02
0.02
0.08
0.02
0.04
0.04
0.02
0.09
0.02
0.07
0.02
0.06
0.02
0.01
0.03
0.04
0.03
0.01
0.04
0.09
0.04
0.02
0.07
0.02
0.05
0.10
0.03
0.04
0.05
0.03

417
2124
2860
467
2358
1360
357
993
1620
210
1399
233
63114
7539
53793
2885
363
2456
422
22
150
240
6762
972
5643
3192
404
2748
923
980
4149
434
3646
386
7256
832
5787
19530
1119
2209
1542
14516
1138
378
757
4479
564
3832
325
156
1617
1111
463
1660

6.1
6.3
6.1
9.6
5.6
7.2
9.6
6.6
5.5
8.9
5.2
5.3
5.9
8.0
5.6
6.5
8.2
6.4
5.2
4.7
6.3
4.7
6.9
8.5
6.8
5.5
8.1
5.2
5.3
5.9
5.9
8.6
5.5
6.3
6.0
8.6
5.7
5.9
4.8
8.3
5.8
5.7
6.0
8.5
5.3
5.5
7.5
5.3
4.5
5.5
6.2
6.3
4.4
6.1

0.34
0.16
0.13
0.47
0.13
0.22
0.55
0.24
0.16
0.67
0.16
0.40
0.03
0.10
0.03
0.14
0.45
0.15
0.28
1.04
0.54
0.34
0.09
0.29
0.10
0.11
0.43
0.11
0.20
0.22
0.11
0.45
0.11
0.39
0.08
0.32
0.09
0.05
0.15
0.19
0.15
0.06
0.20
0.47
0.21
0.09
0.34
0.09
0.27
0.49
0.17
0.22
0.23
0.17

0.75
0.75
0.73
1.16
0.67
0.87
1.19
0.79
0.65
1.06
0.61
0.65
0.69
0.95
0.67
0.75
0.92
0.74
0.64
0.48
0.75
0.58
0.80
1.01
0.79
0.65
0.98
0.61
0.60
0.71
0.69
1.03
0.66
0.74
0.71
1.03
0.68
0.69
0.55
0.97
0.67
0.67
0.71
1.03
0.61
0.65
0.90
0.62
0.51
0.68
0.72
0.75
0.55
0.72

0.05
0.02
0.02
0.07
0.02
0.03
0.08
0.04
0.02
0.10
0.02
0.06
0.00
0.01
0.00
0.02
0.07
0.02
0.04
0.13
0.08
0.05
0.01
0.04
0.02
0.02
0.07
0.02
0.03
0.03
0.02
0.07
0.02
0.06
0.01
0.05
0.01
0.01
0.02
0.03
0.02
0.01
0.03
0.07
0.03
0.01
0.05
0.01
0.04
0.07
0.03
0.03
0.04
0.03

28
180
1006
91
172
1812
84
94
134
412
21
436
50
116
47
1446
1300
71
349
381
369
1119
733
3524
718

4.9
3.4
4.5
7.1
7.5
7.5
2.6
4.0
1.4
2.1
2.5
2.2
1.3
1.9
1.7
8.4
8.3
5.0
8.8
8.8
8.6
10.1
9.3
9.3
9.9

0.94
0.26
0.15
0.76
0.58
0.19
0.29
0.43
0.13
0.11
0.54
0.11
0.19
0.18
0.25
0.23
0.24
0.61
0.48
0.48
0.46
0.31
0.36
0.16
0.40

0.63
0.41
0.53
0.88
0.96
0.90
0.36
0.48
0.16
0.26
0.32
0.27
0.15
0.23
0.22
1.00
0.99
0.64
1.04
1.03
0.99
1.17
1.10
1.07
1.15

0.15
0.04
0.02
0.11
0.08
0.03
0.04
0.06
0.02
0.02
0.08
0.02
0.02
0.03
0.04
0.03
0.04
0.09
0.07
0.07
0.07
0.04
0.05
0.02
0.06

17
134
797
82
122
1587
48
58
60
234
11
299
21
72
31
1373
1260
37
242
353
285
987
661
2874
546

2.8
2.1
3.1
5.4
5.1
5.3
1.4
1.8
0.7
1.4
1.2
1.6
0.5
1.2
1.0
5.9
5.8
2.4
5.0
5.3
4.9
6.3
5.2
5.4
5.1

0.70
0.18
0.12
0.63
0.46
0.14
0.22
0.25
0.09
0.10
0.36
0.09
0.12
0.14
0.19
0.17
0.18
0.40
0.34
0.34
0.31
0.22
0.24
0.11
0.26

0.33
0.25
0.37
0.62
0.60
0.63
0.19
0.20
0.08
0.18
0.15
0.19
0.06
0.15
0.13
0.67
0.67
0.29
0.58
0.57
0.54
0.66
0.56
0.60
0.55

0.10
0.03 *
0.02
0.09 *
0.07
0.02 *
0.03 *
0.04 *
0.01
0.01 *
0.05
0.01
0.01 *
0.02 *
0.03 *
0.03
0.03
0.06
0.05
0.05
0.04
0.03
0.03
0.02
0.04

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

433

491

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Pancreas (C25) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

434

Female
ASR(W)
CUM 0-74

6464
592
359
194
193
361
36
1664
113
34
32
61
82
34
25
261
399
342
21
36
54
45
48
122
320

7.8
7.7
7.3
7.9
8.3
7.8
5.0
8.7
8.7
3.7
3.2
3.4
2.3
2.1
0.9
4.3
5.0
5.4
3.1
3.9
1.4
2.0
1.8
4.2
4.1

0.10
0.35
0.41
0.60
0.63
0.43
0.86
0.23
0.89
0.64
0.91
0.44
0.26
0.36
0.19
0.28
0.25
0.30
0.70
0.68
0.19
0.30
0.26
0.39
0.23

0.95
0.91
0.89
0.97
1.01
0.97
0.83
1.02
1.10
0.44
0.30
0.42
0.25
0.21
0.10
0.50
0.56
0.62
0.26
0.47
0.17
0.21
0.24
0.59
0.49

0.01
0.05
0.06
0.09
0.09
0.06
0.16
0.03
0.14
0.09
0.11
0.06
0.04
0.04
0.02
0.04
0.04
0.04
0.07
0.10
0.03
0.04
0.04
0.06
0.03

4709
411
294
149
154
244
43
1253
80
31
16
53
64
25
9
305
336
294
11
31
51
44
21
78
225

4.1
3.8
4.4
4.5
4.4
3.8
3.6
5.0
4.6
3.0
2.6
2.5
1.8
1.6
0.5
4.0
3.5
3.6
2.3
3.1
1.2
1.9
0.7
2.6
2.7

0.06
0.19
0.26
0.37
0.36
0.25
0.58
0.14
0.54
0.55
0.78
0.34
0.23
0.34
0.18
0.23
0.20
0.22
0.72
0.58
0.17
0.29
0.16
0.30
0.18

0.49
0.47
0.53
0.56
0.56
0.45
0.43
0.60
0.61
0.33
0.35
0.32
0.22
0.22
0.06
0.48
0.39
0.41
0.28
0.34
0.17
0.22
0.09
0.36
0.34

0.01
0.03
0.04
0.06
0.06
0.04
0.08
0.02
0.09
0.07
0.12
0.05
0.03
0.05 *
0.02 *
0.04 *
0.03
0.03
0.10
0.08
0.03 *
0.04 *
0.02
0.05 *
0.03 *

2732
214
99
2229
280
1026
2816
1555
4030
1746
466
1811
267
192
109
194
244
248
170
92
110
112
94
985
1686
638
655
818
1051
386
78
939
84
300
184
501
253
71
468
262
92
985
213
125
153
527
181
195
99
90
345
335
185
747

8.8
8.9
8.6
7.6
4.0
5.0
8.6
9.4
11.0
7.8
10.6
8.8
7.4
7.6
5.8
7.5
6.6
6.2
4.4
4.5
5.1
6.2
4.0
9.6
8.7
8.8
9.7
8.3
9.9
8.2
8.0
7.4
8.6
11.9
9.3
7.8
8.0
7.2
8.9
8.0
6.0
10.1
9.6
9.1
6.5
9.4
5.1
9.7
7.3
12.2
7.0
7.2
8.7
9.9

0.17
0.62
0.87
0.16
0.25
0.16
0.17
0.24
0.18
0.20
0.49
0.21
0.46
0.57
0.58
0.55
0.45
0.41
0.34
0.49
0.51
0.65
0.43
0.31
0.22
0.36
0.38
0.30
0.31
0.43
0.95
0.25
0.98
0.70
0.73
0.37
0.54
0.92
0.44
0.52
0.63
0.34
0.71
0.87
0.56
0.44
0.40
0.72
0.78
1.31
0.39
0.43
0.65
0.38

1.06
1.10
1.09
0.94
0.52
0.63
1.03
1.10
1.34
0.92
1.32
1.04
0.96
0.87
0.70
0.91
0.81
0.80
0.62
0.59
0.61
0.76
0.59
1.11
1.03
1.08
1.21
0.96
1.13
0.98
0.97
0.84
1.02
1.47
1.15
0.91
0.93
0.90
1.06
0.99
0.71
1.22
1.19
1.09
0.81
1.13
0.60
1.07
0.79
1.61
0.81
0.85
1.07
1.14

0.03
0.09
0.13
0.02
0.04
0.02
0.02
0.03
0.03
0.03
0.07
0.03
0.07
0.08
0.08
0.08
0.06
0.06
0.05
0.07
0.07
0.09
0.07
0.04
0.03
0.05
0.05
0.04
0.04
0.06
0.14
0.04
0.14
0.10
0.10
0.05
0.08
0.13
0.06
0.08
0.09
0.05
0.10
0.13
0.08
0.06
0.05
0.10
0.10
0.20
0.06
0.06
0.10
0.05

3397
232
90
1872
272
1050
1895
1368
3958
1958
438
2098
263
196
100
172
219
279
118
62
116
103
69
1028
1957
751
687
893
1021
476
66
916
103
275
171
510
303
86
609
255
77
1115
274
103
204
485
165
175
94
96
408
291
173
857

6.5
6.0
5.0
3.6
3.0
3.9
4.3
5.2
7.2
6.6
5.3
6.4
5.0
5.2
3.5
4.3
4.2
4.8
2.1
2.4
3.8
3.5
2.5
6.6
6.0
6.1
6.4
5.7
6.1
6.3
5.3
5.5
6.5
6.9
5.8
5.2
5.9
5.7
6.3
5.4
3.7
7.1
7.6
5.6
5.5
5.8
3.6
6.0
5.0
7.0
5.5
4.3
4.9
7.0

0.13
0.45
0.58
0.09
0.20
0.13
0.11
0.15
0.12
0.17
0.28
0.16
0.34
0.43
0.39
0.37
0.33
0.32
0.21
0.35
0.40
0.43
0.34
0.23
0.16
0.26
0.27
0.22
0.22
0.34
0.72
0.20
0.76
0.47
0.53
0.28
0.42
0.76
0.30
0.40
0.44
0.25
0.60
0.62
0.47
0.32
0.32
0.51
0.57
0.82
0.33
0.31
0.43
0.28

0.72
0.63
0.58
0.45
0.36
0.45
0.52
0.61
0.83
0.80
0.63
0.70
0.64
0.60
0.37
0.48
0.52
0.53
0.25
0.30
0.46
0.39
0.31
0.78
0.69
0.72
0.72
0.62
0.69
0.70
0.61
0.63
0.77
0.83
0.67
0.54
0.67
0.60
0.70
0.62
0.44
0.82
0.85
0.58
0.60
0.63
0.39
0.65
0.58
0.75
0.60
0.45
0.58
0.82

0.02
0.06
0.09
0.01 *
0.03 *
0.02
0.01 *
0.02
0.02
0.03
0.04
0.02
0.05
0.06
0.06
0.05
0.05
0.05
0.03
0.05
0.06
0.06
0.04
0.03
0.02
0.04
0.04
0.03
0.03
0.05
0.11
0.03
0.11
0.07
0.07
0.04
0.06
0.10
0.04
0.06
0.06
0.04
0.08
0.08
0.07
0.04
0.04
0.07
0.08
0.12
0.04
0.04
0.06
0.04

*Important. See note on population page.

492

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Pancreas (C25) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

853
1175
97
1403
243
383
386
265
702
1338
1143
1650
561
66
281
530
378
64
160
149
244
208
129
170
2162
148
79
59
183
134
92
175
3716
240
193
799
737
1114
1886
702
2200
4002
1537
1525
380
1418

11.2
10.9
7.3
7.3
9.6
8.9
6.3
2.6
6.0
9.6
6.2
10.4
8.1
5.3
5.5
7.4
8.0
5.5
6.6
4.8
6.0
8.3
5.9
4.3
5.3
9.0
8.4
8.3
8.9
9.6
8.4
7.0
6.2
6.4
5.3
6.3
7.2
6.4
6.7
6.4
6.7
7.1
7.2
6.6
6.3
6.8

0.39
0.32
0.76
0.21
0.62
0.47
0.33
0.16
0.24
0.26
0.19
0.26
0.34
0.71
0.35
0.33
0.42
0.82
0.56
0.42
0.40
0.62
0.56
0.36
0.12
0.76
0.99
1.15
0.68
0.86
0.91
0.56
0.10
0.42
0.39
0.24
0.28
0.20
0.16
0.25
0.15
0.12
0.19
0.18
0.34
0.19

1.37
1.32
0.96
0.84
1.15
1.04
0.78
0.32
0.72
1.14
0.77
1.30
0.96
0.68
0.62
0.87
0.93
0.60
0.76
0.58
0.72
1.05
0.68
0.48
0.67
1.07
0.99
0.99
1.08
1.08
0.99
0.87
0.76
0.76
0.64
0.74
0.84
0.78
0.79
0.71
0.77
0.81
0.86
0.77
0.72
0.80

0.05
0.04
0.12
0.03
0.09
0.06
0.04
0.02
0.03
0.04
0.03
0.04
0.05
0.10
0.05
0.05
0.06
0.10
0.08
0.06
0.05
0.09
0.08
0.05
0.02
0.12
0.15
0.17
0.11
0.12
0.13
0.08
0.02
0.06
0.06
0.03
0.04
0.03
0.02
0.04
0.02
0.02
0.03
0.03
0.05
0.03

807
1033
125
1633
247
363
365
213
620
1668
840
1317
594
52
269
484
281
50
136
141
176
166
138
165
2336
144
84
50
163
141
81
191
3781
202
186
803
761
1188
2093
718
2258
4283
1587
1572
369
1630

5.6
5.3
6.9
5.8
6.0
5.3
3.7
1.5
3.7
5.7
3.7
5.5
5.5
2.6
3.1
4.6
4.5
2.7
4.2
3.3
3.2
4.3
4.6
2.7
4.6
5.9
5.8
5.5
5.2
6.0
5.2
5.1
4.7
4.1
4.0
4.6
4.9
4.7
5.2
4.9
4.7
5.2
5.5
5.0
4.2
5.3

0.22
0.18
0.65
0.17
0.41
0.30
0.21
0.11
0.17
0.15
0.14
0.16
0.24
0.42
0.23
0.24
0.28
0.49
0.42
0.31
0.27
0.40
0.46
0.25
0.11
0.56
0.74
0.88
0.47
0.60
0.66
0.42
0.09
0.31
0.32
0.19
0.21
0.16
0.13
0.21
0.12
0.09
0.16
0.14
0.25
0.15

0.66
0.62
0.85
0.65
0.70
0.59
0.44
0.18
0.38
0.65
0.46
0.66
0.64
0.25
0.33
0.49
0.46
0.31
0.49
0.38
0.39
0.50
0.50
0.30
0.58
0.63
0.70
0.68
0.56
0.64
0.54
0.58
0.56
0.47
0.49
0.55
0.55
0.52
0.59
0.56
0.54
0.58
0.65
0.58
0.48
0.62

0.03
0.02
0.10
0.03
0.06 *
0.04
0.03
0.01 *
0.02
0.02
0.02
0.02
0.03
0.06
0.03
0.03
0.04
0.07
0.06
0.04
0.04
0.06
0.06
0.03
0.02
0.08
0.12
0.12
0.07
0.09
0.09
0.06
0.01
0.05
0.05
0.03
0.03
0.02
0.02
0.03
0.02
0.01
0.02
0.02
0.04
0.02

1586
28
862
403
118
1253
397
43
17
815
365
35
45
48
123
92

6.3
7.0
6.7
6.4
6.1
7.1
6.3
5.0
4.0
6.1
7.6
8.2
5.9
10.1
7.8
7.1

0.17
1.41
0.23
0.34
0.59
0.21
0.33
0.79
1.00
0.22
0.43
1.62
0.95
1.49
0.84
0.79

0.72
0.91
0.77
0.75
0.73
0.83
0.76
0.58
0.46
0.73
0.89
0.87
0.72
1.24
0.93
0.79

0.02
0.22
0.03
0.05
0.09
0.03
0.05
0.12
0.14
0.03
0.06
0.22
0.15
0.22
0.12
0.12

1594
17
788
389
138
1200
417
45
19
780
384
27
37
68
159
73

5.0
5.7
4.9
4.6
5.3
4.8
5.2
4.5
4.5
4.5
6.7
5.0
4.5
11.5
8.3
5.6

0.14
1.43
0.19
0.27
0.52
0.16
0.28
0.70
1.06
0.18
0.38
1.11
0.76
1.44
0.83
0.73

0.59
0.61
0.53
0.51
0.58
0.52
0.56
0.61
0.59
0.51
0.77
0.49
0.51
1.20
0.97
0.69

0.02
0.22
0.03
0.04
0.08
0.02
0.04
0.12
0.18
0.03
0.05
0.15
0.11
0.19
0.11
0.11

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

435

493

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Nose, sinuses etc. (C30-31)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

436

Female
ASR(W)
CUM 0-74

8
22
2
2
16

0.4
0.5
0.2
0.2
0.8

0.13
0.11
0.12
0.11
0.25

3
17
4
2
13

0.1
0.3
0.4
0.1
0.6

0.08
0.09
0.19
0.10
0.20

3
22
3
9
157
10
19
18
15
7
8

0.3
1.2
0.5
0.6
0.7
1.2
0.5
0.2
0.5
0.6
1.0

0.17
0.26
0.31
0.20
0.06
0.39
0.12
0.05
0.14
0.21
0.34

0.01
0.17
0.04
0.05
0.07
0.15
0.06
0.02
0.06
0.07
0.10

0.01
0.04
0.03
0.03
0.01
0.05
0.02
0.01
0.02
0.03
0.05

1
18
0
9
124
2
31
26
24
2
6

0.1
0.6
0.5
0.4
0.2
0.7
0.3
0.8
0.2
0.6

0.13
0.15
0.16
0.04
0.13
0.13
0.06
0.17
0.11
0.25

0.02
0.07
0.05
0.04
0.02
0.09
0.03
0.09
0.03
0.11

0.02
0.02
0.02
0.00
0.02
0.02
0.01
0.02
0.02
0.05 *

394
57
62
24
11
10
0
17
197
2
14
100
21
75
11
89
554
55
35
105
349
102
5
10
2
5
15
57
157
21
4
2
0
4
45
74
74
63
6
57
8
6
2
411
33
370
163
36
124
55
11
42
23
258
32
216
120
42
107
100
25
75
10
14

0.5
0.6
0.4
0.6
0.4
0.5
0.4
0.5
0.5
0.4
0.7
0.7
0.7
0.8
0.6
0.6
0.5
0.6
0.6
0.6
0.5
0.4
0.7
0.3
1.5
0.6
0.5
0.6
0.8
0.4
0.2
0.7
0.6
0.6
0.6
0.5
0.8
0.5
0.5
0.7
0.3
0.7
0.6
0.7
0.7
0.8
0.7
0.8
0.6
0.9
0.6
0.7
0.8
0.7
0.6
0.4
0.8
0.8
0.8
0.7
1.0
0.7

0.03
0.08
0.06
0.12
0.12
0.17
0.11
0.04
0.34
0.13
0.07
0.17
0.08
0.23
0.06
0.02
0.07
0.10
0.06
0.03
0.06
0.20
0.23
0.19
0.78
0.17
0.06
0.05
0.18
0.19
0.15
0.36
0.10
0.08
0.07
0.07
0.34
0.07
0.18
0.27
0.19
0.04
0.11
0.04
0.06
0.13
0.07
0.11
0.19
0.14
0.13
0.04
0.14
0.05
0.06
0.07
0.08
0.08
0.16
0.09
0.33
0.19

0.05
0.06
0.04
0.06
0.05
0.07
0.04
0.05
0.08
0.04
0.09
0.10
0.09
0.07
0.07
0.07
0.07
0.07
0.06
0.06
0.07
0.04
0.10
0.05
0.19
0.07
0.06
0.07
0.08
0.05
0.02
0.11
0.06
0.07
0.08
0.05
0.11
0.05
0.05
0.08
0.01
0.07
0.07
0.07
0.09
0.08
0.09
0.10
0.07
0.11
0.06
0.08
0.09
0.08
0.07
0.05
0.09
0.09
0.09
0.09
0.10
0.09

0.00
0.01
0.01
0.02
0.02
0.03
0.01
0.00
0.06
0.01
0.01
0.02
0.01
0.03
0.01
0.00
0.01
0.02
0.01
0.00
0.01
0.03
0.03
0.04
0.11
0.03
0.01
0.01
0.02
0.03
0.02
0.06
0.01
0.01
0.01
0.01
0.06
0.01
0.02
0.03
0.01
0.00
0.01
0.00
0.01
0.02
0.01
0.02
0.03
0.02
0.02
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.04
0.03

287
21
70
10
14
3
0
12
138
2
17
68
10
58
8
69
420
42
21
66
286
79
6
4
3
2
6
53
121
11
3
5
3
4
35
56
53
51
1
49
7
4
3
315
27
284
88
23
65
37
16
21
15
166
19
139
77
51
62
56
13
43
5
9

0.3
0.2
0.4
0.2
0.5
0.2
0.4
0.3
0.3
0.4
0.4
0.2
0.4
0.6
0.3
0.3
0.3
0.3
0.3
0.4
0.3
0.4
0.3
0.3
0.2
0.2
0.3
0.4
0.3
0.1
0.5
0.2
0.6
0.4
0.4
0.4
0.3
0.1
0.4
0.3
0.3
0.5
0.4
0.4
0.4
0.3
0.3
0.3
0.4
0.6
0.4
0.4
0.3
0.3
0.3
0.3
0.4
0.4
0.3
0.3
0.4
0.4
0.4

0.02
0.05
0.06
0.07
0.14
0.11
0.12
0.03
0.24
0.11
0.05
0.08
0.06
0.21
0.04
0.02
0.05
0.07
0.04
0.03
0.04
0.16
0.17
0.16
0.17
0.09
0.05
0.04
0.10
0.09
0.24
0.10
0.29
0.07
0.07
0.06
0.05
0.08
0.06
0.14
0.15
0.34
0.03
0.07
0.03
0.04
0.07
0.04
0.07
0.14
0.08
0.10
0.03
0.07
0.03
0.04
0.06
0.06
0.05
0.08
0.06
0.19
0.14

0.03
0.02
0.05
0.03
0.07
0.02
0.04
0.03
0.02
0.04
0.05
0.02
0.05
0.06
0.04
0.04
0.03
0.04
0.04
0.04
0.04
0.06
0.03
0.03
0.03
0.02
0.04
0.04
0.03
0.01
0.07
0.08
0.04
0.04
0.04
0.04
0.01
0.04
0.04
0.03
0.07
0.04
0.03
0.05
0.03
0.03
0.03
0.04
0.04
0.04
0.04
0.04
0.02
0.04
0.04
0.04
0.04
0.04
0.02
0.04
0.03
0.04

0.00
0.01
0.01
0.01
0.02
0.01
0.01
0.00
0.02
0.01
0.01
0.01
0.01
0.03
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.03
0.02
0.02
0.03
0.01
0.01
0.00
0.01
0.01
0.04
0.05
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.05
0.00
0.01
0.00
0.00
0.01
0.01
0.01
0.02
0.01
0.01
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.02

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

494

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Nose, sinuses etc. (C30-31) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

43
112
183
16
163
80
11
66
115
7
108
23
4421
447
3787
183
22
157
28
1
9
17
359
55
287
231
26
198
62
56
271
20
240
19
464
39
383
1346
79
126
136
987
81
16
63
383
41
335
35
14
100
73
35
98

1.0
0.6
0.6
0.5
0.6
0.6
0.5
0.7
0.6
0.5
0.6
0.6
0.6
0.7
0.6
0.7
0.8
0.7
0.5
0.3
0.5
0.5
0.6
0.8
0.6
0.6
0.9
0.6
0.6
0.5
0.6
0.6
0.6
0.6
0.6
0.6
0.6
0.6
0.5
0.7
0.6
0.6
0.7
0.6
0.7
0.7
0.8
0.7
0.6
0.7
0.5
0.5
0.5
0.6

0.16
0.05
0.04
0.13
0.05
0.08
0.16
0.09
0.06
0.20
0.06
0.14
0.01
0.03
0.01
0.05
0.17
0.06
0.09
0.25
0.15
0.12
0.03
0.11
0.04
0.04
0.17
0.04
0.08
0.07
0.04
0.14
0.04
0.14
0.03
0.10
0.03
0.02
0.05
0.06
0.05
0.02
0.08
0.15
0.09
0.03
0.12
0.04
0.11
0.22
0.05
0.06
0.09
0.06

0.11
0.06
0.07
0.06
0.07
0.07
0.07
0.07
0.08
0.06
0.08
0.06
0.07
0.08
0.07
0.08
0.10
0.08
0.05
0.02
0.05
0.06
0.07
0.09
0.07
0.07
0.10
0.06
0.07
0.05
0.07
0.06
0.07
0.06
0.06
0.07
0.06
0.07
0.06
0.08
0.06
0.07
0.07
0.06
0.07
0.08
0.08
0.08
0.07
0.07
0.05
0.05
0.06
0.06

0.02
0.01
0.01
0.02
0.01
0.01
0.02
0.01
0.01
0.03
0.01
0.02
0.00
0.00
0.00
0.01
0.02
0.01
0.01
0.02
0.02
0.02
0.00
0.01
0.00
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.01
0.02
0.00
0.01
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.02
0.01
0.00
0.02
0.00
0.01
0.03
0.01
0.01
0.01
0.01

22
96
137
16
117
58
12
45
75
5
69
13
3161
251
2766
126
10
112
28
1
12
13
305
38
250
165
9
150
39
49
203
11
188
11
365
35
300
975
62
77
90
732
52
12
40
249
21
220
14
7
83
51
38
75

0.4
0.4
0.4
0.3
0.4
0.4
0.3
0.4
0.3
0.3
0.4
0.3
0.4
0.3
0.4
0.4
0.2
0.4
0.4
0.1
0.6
0.4
0.4
0.4
0.4
0.3
0.2
0.3
0.2
0.3
0.4
0.2
0.4
0.2
0.4
0.3
0.4
0.4
0.3
0.3
0.3
0.4
0.3
0.3
0.3
0.3
0.3
0.3
0.2
0.2
0.4
0.4
0.5
0.3

0.10
0.04
0.04
0.09
0.04
0.05
0.09
0.07
0.04
0.14
0.05
0.09
0.01
0.02
0.01
0.04
0.08
0.04
0.09
0.13
0.17
0.11
0.02
0.06
0.03
0.03
0.07
0.03
0.04
0.05
0.03
0.07
0.03
0.08
0.02
0.06
0.02
0.01
0.04
0.04
0.04
0.02
0.05
0.09
0.06
0.02
0.07
0.02
0.06
0.10
0.05
0.06
0.08
0.05

0.04
0.04
0.04
0.03
0.04
0.04
0.02
0.05
0.04
0.04
0.04
0.03
0.04
0.03
0.04
0.04
0.03
0.05
0.04
0.06
0.03
0.04
0.05
0.04
0.03
0.02
0.03
0.02
0.03
0.04
0.02
0.04
0.03
0.04
0.03
0.04
0.04
0.03
0.03
0.04
0.04
0.04
0.03
0.04
0.04
0.04
0.03
0.02
0.03
0.04
0.04
0.05
0.04

0.01
0.01
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.02
0.01
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.01
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.01
0.02
0.01
0.01
0.01
0.01

3
44
140
4
10
128
23
6
67
58
1
142
44
66
24
81
72
5
21
24
35
98
58
254
79

0.4
0.7
0.7
0.3
0.4
0.6
0.7
0.3
0.7
0.2
0.1
0.6
1.1
1.0
0.9
0.5
0.5
0.3
0.5
0.7
0.9
1.0
0.8
0.7
1.3

0.24
0.11
0.06
0.14
0.13
0.06
0.15
0.11
0.09
0.03
0.12
0.05
0.17
0.13
0.18
0.06
0.06
0.15
0.12
0.15
0.15
0.11
0.11
0.05
0.16

0.04
0.08
0.08
0.03
0.03
0.06
0.10
0.02
0.09
0.03
0.02
0.07
0.12
0.12
0.10
0.06
0.06
0.03
0.06
0.07
0.10
0.12
0.10
0.08
0.16

0.02
0.01
0.01
0.02
0.01
0.01
0.02
0.01
0.01
0.00
0.02
0.01
0.02
0.02
0.03
0.01
0.01
0.02
0.01
0.02
0.02
0.01
0.02
0.01
0.02

1
42
90
4
6
100
11
6
39
37
3
93
21
38
12
49
45
1
14
18
21
60
40
153
38

0.2
0.7
0.4
0.2
0.2
0.4
0.3
0.2
0.4
0.2
0.3
0.5
0.5
0.6
0.4
0.2
0.2
0.1
0.4
0.4
0.5
0.4
0.4
0.3
0.4

0.20
0.12
0.04
0.12
0.10
0.05
0.10
0.11
0.07
0.03
0.18
0.05
0.11
0.10
0.11
0.03
0.04
0.06
0.10
0.10
0.11
0.07
0.08
0.03
0.09

0.03
0.07
0.04
0.03
0.04
0.05
0.04
0.03
0.05
0.03
0.05
0.06
0.05
0.07
0.04
0.02
0.02
0.01
0.05
0.05
0.06
0.05
0.05
0.03
0.05

0.03
0.01 *
0.01
0.02 *
0.02
0.01 *
0.01 *
0.02 *
0.01
0.01 *
0.04
0.01
0.01 *
0.01 *
0.01 *
0.00
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

437

495

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Nose, sinuses etc. (C30-31) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

438

Female
ASR(W)
CUM 0-74

612
59
36
22
20
39
4
146
8
3
11
9
15
6
17
87
69
60
2
7
28
9
25
19
41

0.7
0.7
0.7
0.7
0.8
0.7
0.5
0.6
0.4
0.3
0.6
0.4
0.4
0.4
0.7
1.0
0.9
0.9
0.3
0.7
0.7
0.4
0.9
0.6
0.5

0.03
0.09
0.13
0.18
0.18
0.12
0.24
0.06
0.15
0.17
0.39
0.15
0.10
0.14
0.17
0.12
0.11
0.12
0.19
0.29
0.14
0.13
0.18
0.14
0.08

0.08
0.10
0.10
0.07
0.10
0.08
0.06
0.07
0.04
0.03
0.02
0.04
0.04
0.04
0.07
0.12
0.09
0.11
0.02
0.06
0.08
0.04
0.10
0.08
0.06

0.00
0.02
0.02
0.02
0.03
0.02
0.03
0.01
0.02
0.02
0.01
0.02
0.01
0.02
0.02
0.02
0.01
0.02
0.02
0.03
0.02
0.02
0.02
0.02
0.01

363
29
32
14
22
15
2
103
3
3
2
11
13
3
7
70
21
21
0
0
17
10
7
4
20

0.3
0.3
0.5
0.4
0.6
0.2
0.2
0.4
0.2
0.2
0.0
0.5
0.3
0.1
0.4
0.8
0.2
0.3
0.4
0.4
0.2
0.1
0.2

0.02
0.05
0.09
0.10
0.14
0.06
0.15
0.04
0.11
0.13
0.02
0.15
0.09
0.08
0.15
0.10
0.05
0.06
0.10
0.13
0.08
0.07
0.05

0.04
0.03
0.06
0.04
0.07
0.03
0.02
0.04
0.02
0.02
0.00
0.07
0.02
0.01
0.05
0.10
0.02
0.03
0.05
0.04
0.02
0.02
0.03

0.00
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.00
0.02
0.01
0.01 *
0.02 *
0.02 *
0.01
0.01
0.01 *
0.02 *
0.01
0.01 *
0.01 *

140
21
10
201
48
205
137
141
192
184
38
91
42
20
16
25
29
42
61
23
24
13
36
51
90
42
30
48
50
27
10
55
13
16
11
44
20
7
23
17
6
71
18
8
5
30
17
6
4
7
27
32
20
54

0.5
0.9
0.9
0.7
0.7
1.1
0.5
0.9
0.5
0.9
0.9
0.5
1.2
0.9
0.9
1.0
0.8
1.1
1.6
1.2
1.1
0.9
1.6
0.5
0.5
0.6
0.5
0.5
0.5
0.6
1.0
0.5
1.4
0.6
0.5
0.8
0.6
0.8
0.5
0.5
0.4
0.9
1.1
0.6
0.2
0.6
0.5
0.4
0.3
1.0
0.7
0.9
1.0
0.9

0.04
0.20
0.29
0.05
0.11
0.08
0.04
0.08
0.04
0.07
0.15
0.05
0.20
0.21
0.24
0.19
0.15
0.17
0.21
0.26
0.25
0.30
0.27
0.07
0.05
0.09
0.08
0.08
0.07
0.11
0.35
0.07
0.39
0.16
0.17
0.13
0.15
0.34
0.10
0.14
0.16
0.11
0.27
0.22
0.11
0.12
0.12
0.20
0.17
0.39
0.16
0.20
0.23
0.14

0.06
0.09
0.10
0.08
0.07
0.14
0.05
0.10
0.06
0.11
0.10
0.05
0.14
0.13
0.11
0.16
0.08
0.14
0.21
0.14
0.13
0.12
0.22
0.07
0.06
0.07
0.05
0.06
0.06
0.07
0.08
0.05
0.20
0.07
0.05
0.09
0.07
0.12
0.06
0.05
0.05
0.10
0.12
0.07
0.02
0.06
0.05
0.05
0.05
0.13
0.07
0.11
0.13
0.10

0.01
0.02
0.04
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.02
0.01
0.03
0.03
0.03
0.03
0.02
0.03
0.03
0.03
0.03
0.04
0.04
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.04
0.01
0.06
0.02
0.02
0.02
0.02
0.05
0.01
0.02
0.02
0.01
0.03
0.03
0.01
0.01
0.02
0.02
0.03
0.05
0.02
0.02
0.03
0.02

80
11
6
124
13
59
84
96
115
134
28
81
14
10
3
5
14
18
12
8
5
5
5
37
61
21
28
32
40
13
5
55
1
6
6
6
12
3
11
4
8
31
7
4
5
16
8
4
2
1
11
15
8
32

0.2
0.4
0.4
0.3
0.1
0.3
0.2
0.4
0.2
0.5
0.4
0.3
0.3
0.3
0.1
0.2
0.4
0.3
0.2
0.4
0.2
0.4
0.1
0.2
0.2
0.2
0.3
0.2
0.3
0.3
0.6
0.4
0.2
0.2
0.3
0.1
0.2
0.2
0.1
0.1
0.5
0.2
0.1
0.4
0.2
0.3
0.2
0.1
0.2
0.1
0.2
0.3
0.3
0.3

0.03
0.13
0.19
0.03
0.04
0.04
0.03
0.05
0.03
0.05
0.07
0.04
0.09
0.11
0.07
0.08
0.11
0.09
0.07
0.14
0.09
0.18
0.06
0.04
0.03
0.05
0.06
0.05
0.06
0.09
0.28
0.05
0.19
0.08
0.14
0.03
0.09
0.15
0.04
0.06
0.17
0.05
0.06
0.20
0.11
0.08
0.09
0.08
0.12
0.12
0.07
0.09
0.13
0.07

0.03
0.04
0.07
0.03
0.01
0.03
0.02
0.05
0.02
0.06
0.04
0.03
0.03
0.04
0.03
0.02
0.05
0.04
0.02
0.04
0.02
0.05
0.02
0.03
0.02
0.03
0.03
0.03
0.04
0.03
0.05
0.04
0.02
0.02
0.03
0.01
0.03
0.03
0.01
0.02
0.06
0.02
0.02
0.05
0.03
0.03
0.02
0.02
0.02
0.02
0.02
0.03
0.03
0.04

0.00
0.01
0.03
0.00 *
0.00 *
0.00
0.00 *
0.01
0.00
0.01
0.01
0.00
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.02
0.01
0.02
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.03
0.01
0.02
0.01
0.02
0.00
0.01
0.02
0.01
0.01
0.02
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.01

*Important. See note on population page.

496

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Nose, sinuses etc. (C30-31) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

74
90
6
128
12
22
35
63
60
70
115
98
60
2
70
58
35
4
10
15
13
17
11
31
162
14
8
2
13
12
9
26
463
27
25
59
31
87
141
60
155
255
89
81
42
102

1.0
0.9
0.4
0.8
0.5
0.6
0.6
0.6
0.6
0.5
0.6
0.6
0.9
0.2
1.7
0.9
0.8
0.3
0.4
0.6
0.3
0.7
0.5
1.0
0.4
0.8
1.5
0.2
0.7
0.9
0.9
1.2
0.8
0.7
0.8
0.5
0.3
0.6
0.6
0.6
0.5
0.5
0.4
0.4
0.7
0.5

0.12
0.09
0.18
0.07
0.15
0.13
0.11
0.08
0.07
0.06
0.06
0.06
0.12
0.13
0.22
0.12
0.14
0.18
0.14
0.15
0.09
0.19
0.17
0.22
0.04
0.23
0.58
0.12
0.21
0.26
0.31
0.24
0.04
0.13
0.16
0.08
0.07
0.07
0.05
0.08
0.05
0.03
0.05
0.05
0.11
0.06

0.12
0.10
0.02
0.09
0.06
0.07
0.08
0.07
0.06
0.06
0.07
0.07
0.11
0.02
0.21
0.11
0.08
0.05
0.03
0.07
0.04
0.09
0.08
0.10
0.05
0.08
0.14
0.07
0.10
0.10
0.18
0.10
0.07
0.09
0.05
0.04
0.07
0.06
0.05
0.06
0.06
0.05
0.04
0.07
0.06

0.02
0.01
0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.03
0.02
0.02
0.03
0.01
0.02
0.01
0.03
0.03
0.02
0.00
0.03
0.05
0.02
0.04
0.04
0.04
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01

40
65
0
73
8
14
20
28
38
68
80
56
32
2
21
21
15
3
4
5
6
5
6
10
128
9
3
3
3
3
4
15
223
13
13
42
42
64
102
39
123
191
55
67
27
88

0.3
0.4
0.4
0.2
0.3
0.2
0.2
0.3
0.3
0.4
0.3
0.3
0.1
0.4
0.3
0.3
0.3
0.1
0.2
0.1
0.3
0.3
0.2
0.3
0.5
0.1
0.4
0.1
0.1
0.4
0.5
0.3
0.3
0.3
0.3
0.4
0.3
0.3
0.3
0.4
0.3
0.2
0.3
0.3
0.3

0.06
0.06
0.05
0.08
0.08
0.05
0.04
0.05
0.05
0.04
0.04
0.06
0.11
0.13
0.09
0.07
0.25
0.08
0.09
0.06
0.19
0.13
0.09
0.03
0.17
0.06
0.24
0.08
0.11
0.18
0.15
0.02
0.09
0.10
0.06
0.07
0.05
0.04
0.06
0.04
0.02
0.03
0.04
0.07
0.04

0.04
0.05
0.04
0.03
0.04
0.03
0.02
0.03
0.03
0.04
0.03
0.04
0.01
0.05
0.03
0.03
0.02
0.01
0.02
0.01
0.02
0.03
0.02
0.03
0.06
0.04
0.03
0.01
0.06
0.07
0.03
0.03
0.03
0.04
0.03
0.03
0.04
0.03
0.04
0.03
0.02
0.03
0.04
0.04

0.01
0.01
0.01
0.01 *
0.01
0.01
0.01 *
0.01
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.01
0.00
0.02
0.03
0.02
0.01
0.03
0.02
0.00
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.01

159
2
59
35
21
106
41
7
2
47
22
1
5
2
5
8

0.7
0.6
0.5
0.7
1.2
0.7
0.7
0.9
0.3
0.4
0.5
0.1
0.8
0.4
0.4
0.7

0.06
0.41
0.07
0.12
0.28
0.07
0.10
0.33
0.19
0.06
0.11
0.13
0.39
0.31
0.22
0.26

0.09
0.11
0.06
0.07
0.15
0.08
0.06
0.13
0.02
0.04
0.05
0.08
0.06
0.04
0.07

0.01
0.09
0.01
0.01
0.04
0.01
0.01
0.06
0.02
0.01
0.01
0.04
0.05
0.03
0.03

81
0
32
12
5
67
17
2
0
48
18
1
1
2
5
7

0.3
0.2
0.2
0.3
0.3
0.2
0.2
0.4
0.4
0.3
0.1
0.4
0.5
0.5

0.04
0.05
0.06
0.15
0.05
0.06
0.16
0.05
0.10
0.31
0.15
0.25
0.37
0.19

0.04
0.02
0.02
0.03
0.03
0.02
0.02
0.04
0.04
0.05
0.01
0.06
0.03
0.05

0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.05
0.01
0.05
0.02
0.03

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

439

497

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Larynx (C32)
Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

440

Female
ASR(W)
CUM 0-74

53
162
51
14
55

2.8
4.2
5.7
1.4
4.2

0.40
0.34
0.81
0.43
0.63

3
14
2
6
8

0.1
0.3
0.2
0.3
0.9

0.09
0.07
0.16
0.18
0.33

70
184
57
108
2542
10
181
233
40
59
17

8.8
9.2
8.9
7.8
12.8
1.2
5.4
3.3
1.5
5.0
2.0

1.10
0.72
1.22
0.76
0.26
0.38
0.41
0.22
0.25
0.67
0.48

1.14
1.19
1.01
0.91
1.64
0.16
0.64
0.41
0.18
0.62
0.21

0.15
0.11
0.17
0.11
0.04
0.06
0.06
0.03
0.04
0.10
0.07

5
56
9
16
486
1
47
14
7
11
6

0.6
2.1
1.4
0.9
1.8
0.1
1.1
0.2
0.2
0.9
0.6

0.26
0.29
0.48
0.23
0.09
0.06
0.17
0.05
0.08
0.28
0.23

0.07
0.25
0.22
0.09
0.22
0.15
0.02
0.02
0.11
0.07

0.03
0.04
0.08
0.03
0.01
0.03
0.01
0.01
0.04
0.03 *

3092
291
497
140
134
106
4
164
1577
38
141
947
240
696
51
719
3868
192
392
513
2724
722
88
36
11
5
75
476
1041
196
19
15
6
13
200
575
470
631
70
550
151
128
20
4264
417
3786
1483
396
1076
336
120
212
172
2323
421
1861
1107
530
995
1022
339
680
113
147

3.9
3.3
3.4
3.6
5.1
5.8
5.5
4.7
4.0
7.9
3.8
6.7
9.3
6.0
3.3
4.3
4.0
1.7
7.1
3.5
4.2
3.7
6.9
2.1
1.5
1.6
3.8
3.8
4.2
8.0
1.4
1.9
1.0
2.3
3.6
4.5
3.9
5.4
10.1
5.1
9.3
12.7
3.7
6.8
8.2
6.6
6.8
9.1
6.3
5.1
6.9
4.6
4.1
6.2
10.0
5.7
5.9
5.4
7.9
7.8
11.0
6.9
12.2
7.6

0.07
0.20
0.16
0.32
0.45
0.57
2.83
0.38
0.10
1.32
0.34
0.22
0.62
0.23
0.49
0.17
0.07
0.12
0.37
0.16
0.09
0.14
0.76
0.36
0.46
0.78
0.45
0.18
0.13
0.58
0.33
0.51
0.48
0.66
0.26
0.20
0.18
0.23
1.23
0.23
0.78
1.15
0.84
0.11
0.41
0.12
0.18
0.47
0.20
0.29
0.67
0.33
0.32
0.13
0.50
0.14
0.18
0.24
0.25
0.25
0.61
0.27
1.18
0.65

0.50
0.42
0.43
0.47
0.63
0.76
0.55
0.57
0.52
1.03
0.50
0.86
1.18
0.78
0.46
0.57
0.51
0.21
0.93
0.44
0.54
0.48
0.90
0.27
0.25
0.24
0.50
0.49
0.54
1.05
0.14
0.27
0.13
0.27
0.50
0.58
0.53
0.69
1.28
0.64
1.19
1.54
0.59
0.85
1.06
0.83
0.88
1.09
0.83
0.65
0.81
0.61
0.53
0.79
1.26
0.73
0.76
0.69
1.01
1.00
1.40
0.88
1.58
0.98

0.01
0.03
0.02
0.05
0.07
0.09
0.32
0.06
0.02
0.20
0.05
0.03
0.09
0.03
0.08
0.02
0.01
0.02
0.06
0.02
0.01
0.02
0.12
0.06
0.08
0.12
0.07
0.03
0.02
0.09
0.05
0.09
0.06
0.09
0.04
0.03
0.03
0.03
0.18
0.03
0.11
0.15
0.15
0.02
0.06
0.02
0.03
0.07
0.03
0.04
0.09
0.05
0.05
0.02
0.07
0.02
0.03
0.03
0.04
0.04
0.09
0.04
0.18
0.09

615
76
88
27
36
17
1
31
300
6
33
225
46
176
18
170
967
27
101
78
750
167
23
7
4
0
14
118
245
44
1
1
2
1
29
164
136
180
16
162
32
23
9
1052
96
943
346
91
253
86
37
49
37
538
118
406
328
137
288
267
74
191
25
41

0.7
0.8
0.5
0.7
1.3
0.9
1.9
1.0
0.7
1.1
0.8
1.4
1.4
1.4
1.2
0.9
0.9
0.2
1.5
0.4
1.1
0.7
1.5
0.4
0.4
0.5
0.8
0.8
1.4
0.1
0.1
0.2
0.1
0.4
1.1
1.0
1.3
1.7
1.3
1.5
1.7
1.3
1.5
1.5
1.5
1.4
1.6
1.3
1.1
1.8
0.9
0.9
1.2
2.1
1.1
1.5
1.2
2.0
1.7
1.8
1.7
1.9
1.7

0.03
0.09
0.06
0.14
0.23
0.22
1.88
0.18
0.04
0.52
0.15
0.10
0.21
0.11
0.29
0.07
0.03
0.04
0.15
0.05
0.04
0.06
0.33
0.16
0.18
0.15
0.08
0.06
0.22
0.07
0.09
0.17
0.10
0.07
0.10
0.09
0.11
0.45
0.11
0.28
0.37
0.48
0.05
0.15
0.05
0.08
0.17
0.09
0.13
0.30
0.14
0.16
0.06
0.20
0.06
0.09
0.11
0.12
0.11
0.21
0.13
0.39
0.29

0.09
0.11
0.07
0.09
0.18
0.11
0.47
0.13
0.09
0.12
0.10
0.17
0.18
0.17
0.15
0.11
0.12
0.03
0.20
0.06
0.14
0.10
0.20
0.07
0.05
0.08
0.11
0.11
0.19
0.01
0.02
0.03
0.05
0.16
0.14
0.17
0.20
0.17
0.19
0.22
0.18
0.19
0.19
0.19
0.18
0.22
0.18
0.15
0.24
0.12
0.11
0.16
0.26
0.15
0.20
0.16
0.26
0.21
0.23
0.21
0.24
0.22

0.00
0.01
0.01
0.02
0.03
0.03
0.47
0.02
0.01
0.06
0.02
0.01
0.03
0.01
0.04
0.01
0.00
0.01
0.02
0.01
0.01
0.01
0.05
0.03
0.03
0.03
0.01
0.01
0.03
0.01
0.02
0.03
0.01
0.01
0.01
0.02
0.06
0.02
0.04
0.05
0.08
0.01
0.02
0.01
0.01
0.03
0.01
0.02
0.05
0.02
0.02
0.01
0.03
0.01
0.01
0.02
0.02
0.01
0.03
0.02
0.05
0.04

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

498

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Larynx (C32) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

244
1122
1744
312
1411
787
243
535
1163
130
1027
145
39169
5208
33037
1522
242
1246
228
4
70
148
3308
459
2778
2089
260
1778
664
451
2577
283
2254
202
3811
544
3062
10735
328
1512
742
8052
911
281
624
3200
486
2669
126
103
729
472
488
874

5.3
5.4
5.6
9.7
5.1
6.5
10.2
5.6
6.3
9.5
6.1
4.5
5.6
8.7
5.4
5.5
8.9
5.3
3.9
1.3
3.8
4.2
5.5
7.0
5.5
5.7
8.3
5.4
5.8
3.9
5.8
9.4
5.6
5.8
4.7
8.4
4.6
4.9
1.9
8.6
3.7
4.9
7.2
10.4
6.3
5.7
9.9
5.3
2.4
5.1
4.0
3.8
7.3
5.0

0.35
0.17
0.14
0.56
0.14
0.24
0.67
0.25
0.19
0.85
0.20
0.39
0.03
0.12
0.03
0.15
0.58
0.16
0.27
0.67
0.47
0.36
0.10
0.33
0.11
0.13
0.52
0.13
0.23
0.19
0.12
0.57
0.12
0.43
0.08
0.37
0.09
0.05
0.11
0.23
0.14
0.06
0.24
0.63
0.26
0.10
0.46
0.11
0.22
0.52
0.15
0.18
0.34
0.18

0.67
0.69
0.71
1.23
0.65
0.83
1.31
0.72
0.79
1.25
0.76
0.58
0.72
1.11
0.69
0.71
1.13
0.67
0.53
0.21
0.54
0.56
0.70
0.90
0.70
0.74
1.04
0.70
0.75
0.51
0.76
1.24
0.73
0.71
0.61
1.07
0.60
0.63
0.24
1.11
0.48
0.64
0.90
1.33
0.78
0.72
1.25
0.68
0.31
0.63
0.54
0.51
0.93
0.66

0.05
0.02
0.02
0.08
0.02
0.03
0.10
0.04
0.03
0.13
0.03
0.06
0.00
0.02
0.00
0.02
0.08
0.02
0.04
0.12
0.08
0.05
0.01
0.05
0.02
0.02
0.08
0.02
0.03
0.03
0.02
0.09
0.02
0.06
0.01
0.06
0.01
0.01
0.02
0.03
0.02
0.01
0.03
0.09
0.04
0.02
0.07
0.02
0.03
0.07
0.02
0.03
0.05
0.03

76
315
508
95
408
247
75
171
272
41
228
37
10149
1407
8548
414
65
345
68
1
9
56
996
172
817
559
85
462
184
117
665
107
549
57
1013
165
813
2848
53
403
129
2243
204
50
152
739
107
623
37
36
191
121
129
235

1.5
1.3
1.4
2.2
1.3
1.7
2.3
1.6
1.3
2.2
1.2
1.1
1.3
1.8
1.2
1.3
1.7
1.3
1.0
0.2
0.4
1.4
1.4
1.8
1.3
1.3
2.1
1.2
1.4
1.0
1.3
2.7
1.2
1.1
1.1
2.0
1.1
1.1
0.3
1.8
0.5
1.2
1.4
1.4
1.4
1.1
1.7
1.1
0.7
1.5
0.9
0.8
1.7
1.2

0.19
0.08
0.07
0.23
0.07
0.12
0.28
0.13
0.08
0.35
0.09
0.18
0.01
0.05
0.01
0.07
0.22
0.07
0.13
0.22
0.15
0.20
0.05
0.14
0.05
0.06
0.23
0.06
0.11
0.09
0.05
0.27
0.05
0.17
0.04
0.16
0.04
0.02
0.04
0.09
0.05
0.03
0.10
0.20
0.12
0.04
0.17
0.05
0.11
0.28
0.07
0.08
0.16
0.08

0.21
0.17
0.18
0.28
0.17
0.21
0.30
0.20
0.17
0.27
0.16
0.17
0.16
0.23
0.16
0.17
0.21
0.17
0.14
0.02
0.05
0.19
0.17
0.21
0.17
0.17
0.27
0.15
0.18
0.13
0.16
0.37
0.15
0.14
0.14
0.25
0.14
0.15
0.04
0.23
0.07
0.16
0.18
0.17
0.18
0.14
0.22
0.14
0.09
0.18
0.13
0.11
0.22
0.16

0.03
0.01
0.01
0.03
0.01
0.02
0.04
0.02
0.01
0.05
0.01
0.03
0.00
0.01
0.00
0.01
0.03
0.01
0.02
0.02
0.02
0.03
0.01
0.02
0.01
0.01
0.03
0.01
0.02
0.01
0.01
0.04
0.01
0.02
0.01
0.02
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.03
0.02
0.01
0.02
0.01
0.02
0.04
0.01
0.01
0.02
0.01

25
273
958
14
90
679
156
71
419
1546
44
1341
313
370
133
766
656
89
113
96
194
354
258
926
191

4.7
4.9
4.4
1.1
3.8
2.8
5.1
3.2
4.7
8.0
5.3
6.5
8.5
6.2
5.1
4.9
4.6
6.1
2.8
2.2
4.6
3.3
3.6
2.4
2.9

0.94
0.30
0.15
0.29
0.41
0.11
0.41
0.39
0.23
0.21
0.82
0.18
0.49
0.33
0.44
0.18
0.19
0.66
0.27
0.23
0.33
0.18
0.23
0.08
0.22

0.77
0.63
0.56
0.17
0.47
0.36
0.70
0.44
0.56
1.01
0.76
0.81
1.08
0.82
0.65
0.63
0.59
0.73
0.35
0.26
0.57
0.43
0.48
0.29
0.37

0.18
0.05
0.02
0.05
0.06
0.02
0.06
0.06
0.03
0.03
0.13
0.03
0.07
0.05
0.07
0.03
0.03
0.10
0.04
0.03
0.05
0.03
0.03
0.01
0.03

4
22
78
2
17
80
9
8
47
185
1
170
54
65
7
127
115
9
14
10
14
25
14
75
10

0.7
0.3
0.3
0.2
0.7
0.2
0.3
0.3
0.5
1.1
0.1
0.8
1.4
1.1
0.2
0.7
0.7
0.6
0.3
0.2
0.3
0.2
0.1
0.2
0.1

0.36
0.07
0.04
0.11
0.17
0.03
0.10
0.11
0.08
0.08
0.12
0.06
0.19
0.13
0.09
0.06
0.07
0.21
0.08
0.07
0.08
0.04
0.03
0.02
0.04

0.11
0.04
0.03
0.03
0.11
0.03
0.04
0.03
0.06
0.14
0.01
0.10
0.17
0.12
0.03
0.08
0.08
0.09
0.04
0.03
0.04
0.03
0.01
0.02
0.01

0.06
0.01 *
0.00
0.02 *
0.03
0.00 *
0.01 *
0.01 *
0.01
0.01 *
0.01
0.01
0.03 *
0.02 *
0.02 *
0.01
0.01
0.03
0.01
0.01
0.01
0.01
0.00
0.00
0.01

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

441

499

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Larynx (C32) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

442

Female
ASR(W)
CUM 0-74

3999
382
256
111
122
203
48
916
67
24
45
84
70
22
267
334
340
294
19
27
116
41
100
211
875

4.8
4.8
5.1
4.6
5.0
4.4
6.3
4.7
5.4
2.7
2.5
4.7
2.1
1.4
10.7
5.5
4.4
4.9
2.4
3.0
3.0
1.9
3.8
7.2
10.9

0.08
0.27
0.33
0.45
0.46
0.32
0.93
0.16
0.71
0.55
0.62
0.52
0.25
0.29
0.69
0.31
0.24
0.29
0.57
0.59
0.28
0.30
0.38
0.50
0.37

0.64
0.64
0.74
0.55
0.73
0.57
0.81
0.59
0.57
0.27
0.35
0.62
0.23
0.15
1.38
0.70
0.56
0.64
0.26
0.36
0.37
0.21
0.43
0.89
1.40

0.01
0.04
0.06
0.06
0.08
0.05
0.14
0.02
0.09
0.07
0.11
0.08
0.04
0.04
0.10
0.05
0.04
0.04
0.07
0.08
0.04
0.04
0.05
0.07
0.05

408
58
27
12
12
31
7
85
5
4
3
11
16
6
38
65
27
23
2
2
23
20
10
18
41

0.3
0.6
0.4
0.4
0.3
0.5
0.8
0.4
0.3
0.5
0.4
0.5
0.5
0.3
1.8
0.8
0.3
0.3
0.4
0.2
0.6
0.8
0.3
0.6
0.5

0.02
0.07
0.08
0.11
0.10
0.09
0.31
0.04
0.13
0.23
0.31
0.15
0.12
0.14
0.31
0.11
0.06
0.06
0.29
0.14
0.12
0.18
0.11
0.14
0.07

0.04
0.08
0.05
0.07
0.03
0.07
0.07
0.04
0.04
0.04
0.09
0.03
0.06
0.04
0.21
0.10
0.03
0.03
0.08
0.02
0.08
0.11
0.05
0.07
0.06

0.00
0.01
0.01
0.02
0.01
0.01
0.03
0.01
0.02
0.03
0.08
0.01
0.02
0.02 *
0.04 *
0.02 *
0.01
0.01
0.06
0.02
0.02 *
0.03 *
0.02
0.02 *
0.01 *

1376
128
65
2908
369
1322
2647
2001
2289
975
359
515
220
202
124
183
285
276
434
169
169
85
182
523
745
351
381
402
474
262
29
502
92
325
168
473
317
71
448
241
178
924
179
55
206
404
271
151
74
94
343
312
166
761

4.9
5.8
5.9
10.1
5.5
7.0
9.0
12.5
6.5
4.7
8.4
2.6
6.4
9.1
7.2
7.4
8.3
7.3
11.5
9.1
9.2
5.5
8.8
5.2
4.1
5.3
5.7
4.4
4.8
5.9
3.2
4.3
10.1
13.7
9.3
8.4
11.5
8.4
9.2
8.3
11.7
10.3
8.9
4.7
9.8
8.3
8.3
8.5
5.8
13.3
7.8
7.7
8.2
11.2

0.13
0.52
0.73
0.19
0.30
0.20
0.18
0.28
0.14
0.16
0.44
0.12
0.44
0.66
0.66
0.55
0.52
0.45
0.56
0.74
0.72
0.64
0.68
0.23
0.15
0.29
0.29
0.22
0.23
0.37
0.62
0.19
1.10
0.77
0.76
0.41
0.69
1.06
0.46
0.56
0.89
0.35
0.72
0.66
0.72
0.44
0.52
0.70
0.70
1.41
0.44
0.46
0.65
0.42

0.60
0.74
0.73
1.27
0.68
0.89
1.06
1.55
0.79
0.60
1.04
0.31
0.85
1.20
0.91
0.93
0.99
0.88
1.38
1.09
1.13
0.62
1.07
0.66
0.51
0.64
0.72
0.56
0.59
0.73
0.38
0.53
1.30
1.78
1.25
1.08
1.49
1.11
1.11
1.05
1.56
1.32
1.11
0.67
1.23
1.08
1.02
1.11
0.76
1.60
0.97
1.01
1.10
1.45

0.02
0.07
0.10
0.03
0.04
0.03
0.02
0.04
0.02
0.02
0.06
0.02
0.06
0.09
0.09
0.08
0.07
0.06
0.07
0.09
0.10
0.08
0.09
0.03
0.02
0.04
0.04
0.03
0.03
0.05
0.09
0.03
0.15
0.11
0.11
0.06
0.09
0.15
0.06
0.08
0.13
0.05
0.10
0.10
0.10
0.06
0.07
0.10
0.10
0.19
0.06
0.06
0.10
0.06

167
12
3
80
47
133
151
166
259
228
27
67
24
18
15
16
44
32
32
11
10
11
13
48
53
81
36
66
78
31
10
103
8
20
20
49
28
3
59
29
18
114
12
3
12
48
21
13
4
11
37
23
7
88

0.5
0.4
0.2
0.2
0.7
0.7
0.4
0.8
0.6
1.0
0.5
0.2
0.6
0.8
0.8
0.4
1.2
0.8
0.7
0.6
0.5
0.6
0.7
0.4
0.2
1.1
0.4
0.6
0.7
0.6
1.4
0.7
0.8
0.7
0.9
0.7
0.8
0.5
0.8
0.8
1.1
1.0
0.5
0.2
0.5
1.0
0.7
0.7
0.3
1.5
0.6
0.5
0.2
1.0

0.04
0.14
0.13
0.02
0.11
0.06
0.04
0.07
0.04
0.07
0.09
0.03
0.13
0.20
0.22
0.12
0.19
0.14
0.13
0.21
0.16
0.21
0.19
0.06
0.04
0.13
0.08
0.08
0.08
0.13
0.44
0.08
0.32
0.16
0.21
0.12
0.18
0.31
0.12
0.16
0.26
0.11
0.17
0.12
0.17
0.16
0.15
0.20
0.14
0.48
0.11
0.11
0.10
0.12

0.06
0.05
0.03
0.02
0.08
0.08
0.04
0.10
0.07
0.13
0.06
0.03
0.06
0.09
0.11
0.05
0.13
0.09
0.08
0.06
0.07
0.08
0.08
0.05
0.03
0.13
0.05
0.08
0.08
0.08
0.18
0.09
0.09
0.07
0.12
0.09
0.11
0.05
0.12
0.10
0.10
0.12
0.08
0.01
0.06
0.12
0.07
0.07
0.04
0.16
0.07
0.05
0.03
0.13

0.01
0.02
0.02
0.00 *
0.01 *
0.01
0.00 *
0.01
0.00
0.01
0.01
0.00
0.02
0.02
0.03
0.02
0.02
0.02
0.02
0.02
0.02
0.03
0.02
0.01
0.00
0.02
0.01
0.01
0.01
0.02
0.06
0.01
0.04
0.02
0.03
0.01
0.02
0.03
0.02
0.02
0.03
0.01
0.02
0.01
0.02
0.02
0.02
0.02
0.02
0.05
0.02
0.01
0.01
0.02

*Important. See note on population page.

500

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Larynx (C32) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

589
940
70
534
223
544
450
702
813
818
2122
1391
516
107
648
1042
475
92
208
323
535
282
228
508
775
78
33
48
74
94
71
108
2868
204
180
328
429
783
1271
295
970
1745
720
864
270
1237

7.8
9.2
5.2
3.0
9.2
13.2
7.6
7.2
7.9
5.9
12.3
9.2
7.6
10.1
14.6
16.1
10.8
10.5
9.7
11.2
14.3
13.2
12.0
15.4
2.0
5.6
4.2
8.0
4.1
7.6
7.3
4.9
5.0
5.6
5.1
2.7
4.6
5.0
4.9
2.9
3.4
3.4
3.7
4.1
4.9
6.4

0.32
0.30
0.64
0.14
0.62
0.58
0.37
0.28
0.29
0.21
0.27
0.25
0.34
1.05
0.61
0.51
0.50
1.24
0.71
0.65
0.64
0.82
0.84
0.72
0.08
0.64
0.75
1.20
0.49
0.80
0.89
0.49
0.10
0.40
0.39
0.16
0.23
0.19
0.14
0.18
0.11
0.09
0.14
0.14
0.31
0.19

1.03
1.16
0.61
0.37
1.10
1.64
0.97
0.88
0.96
0.76
1.53
1.13
0.95
1.21
1.78
1.96
1.35
1.26
1.18
1.44
1.78
1.63
1.54
1.89
0.26
0.68
0.53
0.91
0.55
1.03
0.87
0.60
0.64
0.69
0.64
0.33
0.57
0.62
0.62
0.37
0.43
0.43
0.46
0.51
0.61
0.81

0.05
0.04
0.09
0.02
0.08
0.08
0.05
0.04
0.04
0.03
0.03
0.03
0.05
0.13
0.08
0.07
0.07
0.15
0.09
0.09
0.08
0.11
0.11
0.09
0.01
0.08
0.10
0.15
0.07
0.12
0.11
0.07
0.01
0.06
0.06
0.02
0.03
0.03
0.02
0.03
0.02
0.01
0.02
0.02
0.04
0.03

40
54
9
96
43
57
88
31
44
64
212
87
56
4
21
57
22
0
3
5
20
8
5
15
162
13
5
7
16
13
8
23
526
31
29
72
107
184
315
59
188
357
153
158
66
301

0.3
0.4
0.6
0.5
1.4
1.2
1.2
0.2
0.3
0.3
1.1
0.5
0.7
0.2
0.5
0.8
0.5
0.2
0.2
0.5
0.4
0.3
0.4
0.4
0.7
0.5
1.1
0.7
1.0
0.7
0.9
0.9
0.8
0.8
0.5
0.9
1.0
1.0
0.5
0.5
0.6
0.6
0.6
1.1
1.3

0.06
0.05
0.22
0.05
0.22
0.16
0.13
0.05
0.05
0.04
0.08
0.05
0.09
0.09
0.12
0.12
0.11
0.10
0.08
0.11
0.16
0.16
0.11
0.03
0.21
0.25
0.42
0.20
0.30
0.26
0.20
0.04
0.15
0.15
0.07
0.09
0.08
0.06
0.07
0.04
0.03
0.06
0.06
0.14
0.08

0.04
0.04
0.07
0.07
0.17
0.13
0.14
0.03
0.03
0.03
0.13
0.05
0.08
0.03
0.05
0.10
0.06
0.02
0.02
0.06
0.04
0.04
0.04
0.05
0.07
0.07
0.13
0.09
0.11
0.09
0.11
0.11
0.10
0.10
0.07
0.12
0.13
0.13
0.06
0.06
0.07
0.09
0.08
0.14
0.18

0.01
0.01
0.03
0.01
0.03 *
0.02
0.02
0.01 *
0.01
0.00
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.02
0.01
0.00
0.02
0.04
0.05
0.03
0.03
0.04
0.03
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.02
0.01

931
34
492
172
69
596
226
23
19
330
183
10
15
22
39
88

4.1
8.6
4.1
2.8
3.8
3.6
3.8
2.2
4.7
2.6
4.5
3.1
1.9
4.2
3.2
8.0

0.14
1.56
0.19
0.22
0.47
0.15
0.26
0.48
1.09
0.15
0.35
1.04
0.54
0.91
0.58
0.89

0.53
1.21
0.53
0.35
0.49
0.47
0.48
0.18
0.65
0.34
0.60
0.43
0.18
0.57
0.47
1.07

0.02
0.26
0.03
0.03
0.07
0.02
0.04
0.06
0.18
0.02
0.05
0.15
0.07
0.15
0.09
0.13

114
5
42
27
12
89
35
3
1
48
27
1
0
8
7
10

0.4
1.7
0.3
0.4
0.7
0.5
0.5
0.3
0.3
0.4
0.5
0.1
1.4
0.4
0.6

0.04
0.79
0.05
0.09
0.22
0.05
0.09
0.15
0.28
0.06
0.10
0.11
0.52
0.18
0.22

0.05
0.26
0.04
0.06
0.11
0.07
0.06
0.04
0.05
0.05
0.06
0.18
0.05
0.07

0.01
0.14
0.01
0.01
0.03
0.01
0.01
0.03
0.05
0.01
0.01
0.07
0.02
0.04

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

443

501

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Trachea, bronchus and lung (C33-34)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

444

Female
ASR(W)
CUM 0-74

374
541
335
46
146

19.9
14.0
37.1
4.8
9.5

1.05
0.63
2.05
0.84
0.90

37
174
17
40
59

1.7
3.6
1.7
3.8
4.8

0.29
0.28
0.43
0.69
0.69

379
500
154
266
6525
100
711
810
214
156
52

45.5
26.8
26.3
21.0
33.5
11.2
21.5
11.1
7.9
13.7
5.9

2.42
1.25
2.18
1.30
0.42
1.14
0.82
0.40
0.56
1.12
0.83

5.72
3.31
3.17
2.71
4.23
1.37
2.62
1.29
0.99
1.87
0.70

0.34
0.19
0.34
0.21
0.06
0.18
0.13
0.06
0.09
0.17
0.13

106
307
71
173
3247
51
412
364
136
74
52

11.0
12.5
10.4
10.0
11.7
4.6
9.4
4.5
4.1
4.9
4.8

1.13
0.75
1.27
0.78
0.21
0.67
0.48
0.24
0.37
0.61
0.68

1.32
1.52
1.28
1.18
1.41
0.51
1.19
0.53
0.49
0.61
0.58

0.14
0.11
0.20
0.12
0.03
0.10
0.07
0.04
0.06
0.09
0.10 *

40042
3948
6580
2196
1850
837
34
2329
20105
307
1856
10879
1969
8849
744
8606
46192
3838
3728
3847
34497
8531
890
565
394
97
565
5650
10878
1697
357
367
184
195
1327
6474
5102
6670
443
6176
1141
886
221
43150
3357
39440
15518
3314
12103
3682
1105
2519
1913
24478
3560
20524
13811
6363
12143
10320
2882
7389
895
1478

47.9
42.8
41.5
51.2
66.6
45.6
49.2
65.8
48.6
60.2
44.8
72.1
73.5
71.7
53.2
45.6
44.7
33.1
66.6
25.7
49.4
41.2
69.3
31.1
44.7
26.2
27.8
42.6
41.2
68.0
29.3
45.5
29.3
36.0
23.2
46.4
40.6
53.9
66.1
53.4
66.2
82.6
36.2
61.2
64.9
61.0
70.2
77.8
68.8
57.2
70.7
54.0
43.8
61.1
83.8
58.8
68.7
56.7
90.1
75.0
91.7
70.3
96.6
69.6

0.25
0.70
0.53
1.16
1.61
1.62
8.78
1.42
0.35
3.55
1.13
0.71
1.71
0.79
2.01
0.52
0.22
0.55
1.11
0.43
0.28
0.47
2.39
1.38
2.33
2.95
1.20
0.60
0.41
1.68
1.64
2.47
2.41
2.62
0.66
0.62
0.59
0.70
3.19
0.73
2.03
2.87
2.58
0.32
1.14
0.34
0.58
1.39
0.64
0.97
2.23
1.11
1.05
0.41
1.43
0.43
0.61
0.76
0.84
0.76
1.75
0.85
3.30
1.92

6.09
5.40
5.16
6.42
8.70
6.23
7.08
8.33
6.21
7.92
5.60
9.33
9.28
9.32
6.92
5.80
5.67
4.04
8.49
3.07
6.34
5.16
8.94
3.47
5.69
3.40
3.22
5.44
5.20
8.67
3.48
5.80
3.88
4.28
2.85
5.92
5.22
6.89
8.31
6.84
8.21
10.25
4.38
7.78
8.11
7.78
9.10
9.92
8.99
7.25
8.73
6.96
5.72
7.84
10.54
7.57
8.97
7.32
11.69
9.59
11.61
9.04
12.16
8.97

0.04
0.11
0.08
0.18
0.26
0.25
1.49
0.22
0.05
0.56
0.17
0.11
0.26
0.12
0.32
0.08
0.03
0.09
0.17
0.07
0.04
0.07
0.37
0.20
0.36
0.48
0.18
0.10
0.06
0.26
0.25
0.40
0.37
0.41
0.10
0.10
0.09
0.11
0.48
0.11
0.30
0.41
0.40
0.05
0.17
0.05
0.09
0.22
0.10
0.15
0.35
0.18
0.17
0.06
0.21
0.07
0.09
0.12
0.13
0.12
0.26
0.13
0.49
0.29

30202
3097
5444
1777
1133
404
23
1597
15202
219
1306
6475
997
5430
586
6977
40142
2420
2582
2941
31947
7758
684
377
170
89
479
5687
9142
1174
263
187
112
116
982
6156
4288
5844
324
5489
831
611
203
33649
1840
31524
9874
1722
8086
2847
723
2089
1408
18851
2509
16117
9897
4518
8305
6723
1501
5186
487
1180

31.6
30.4
30.8
36.6
36.2
21.6
36.9
38.3
31.4
38.5
30.3
34.1
25.6
36.2
40.9
32.1
31.4
16.5
36.0
15.3
37.9
29.8
41.7
16.9
13.7
15.5
18.3
34.8
26.7
34.1
18.9
16.5
14.2
15.2
12.3
35.8
28.4
37.4
33.4
38.2
34.1
36.8
28.5
39.3
26.9
40.8
34.9
27.5
37.4
33.7
30.9
35.5
29.1
37.1
41.2
37.2
40.1
33.5
50.3
37.8
33.5
39.7
34.9
41.7

0.20
0.58
0.46
0.97
1.16
1.11
7.88
1.05
0.27
2.81
0.94
0.45
0.86
0.53
1.76
0.42
0.17
0.35
0.74
0.29
0.24
0.37
1.69
0.94
1.09
1.82
0.87
0.52
0.30
1.04
1.24
1.25
1.51
1.47
0.41
0.52
0.47
0.55
1.91
0.58
1.30
1.63
2.25
0.24
0.65
0.26
0.37
0.70
0.44
0.67
1.21
0.83
0.84
0.30
0.85
0.33
0.44
0.56
0.59
0.50
0.91
0.60
1.65
1.37

4.07
3.90
3.86
4.74
4.80
2.96
5.46
4.97
4.02
4.98
4.02
4.49
3.29
4.79
5.43
4.19
4.04
1.95
4.64
1.88
4.96
3.79
5.26
1.88
1.67
2.19
2.34
4.53
3.39
4.38
2.17
1.96
1.89
1.76
1.53
4.66
3.71
4.87
4.18
4.98
4.30
4.54
3.87
5.01
3.43
5.20
4.63
3.54
4.98
4.42
4.01
4.70
3.90
4.84
5.20
4.87
5.30
4.40
6.68
4.86
4.19
5.14
4.35
5.33

0.03
0.09
0.07
0.14
0.17
0.16
1.38
0.16
0.04
0.41
0.14
0.07
0.13
0.08
0.28
0.06
0.03
0.05
0.11
0.04
0.04
0.06
0.25
0.14
0.16
0.28
0.14
0.08
0.05
0.16
0.18
0.19
0.23
0.22
0.06
0.08
0.07
0.08
0.29
0.09
0.19
0.23
0.37
0.03
0.10
0.04
0.06
0.11
0.07
0.11
0.19
0.13
0.13
0.04
0.13
0.05
0.07
0.08
0.09
0.07
0.13
0.09
0.25
0.20

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

502

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Trachea, bronchus and lung (C33-34) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

3155
12065
19922
2761
16959
8615
2062
6473
13338
1232
12012
1818
437751
45345
382072
16153
1982
13847
2377
43
545
1723
34267
4036
29314
25578
2624
22547
8706
6547
28694
2648
25678
2444
44153
4900
36166
123409
5996
13468
5597
97660
9181
2074
7059
34371
4249
29652
1483
1190
10394
6966
5602
10021

64.0
54.4
60.0
83.7
57.5
66.6
85.0
62.8
68.1
88.4
66.5
51.2
58.3
75.0
57.4
54.7
72.3
53.8
37.8
12.2
28.7
44.2
53.3
60.8
53.4
64.8
81.1
62.7
71.5
52.5
59.7
85.9
57.6
64.6
51.2
76.5
50.3
52.8
33.6
76.5
27.8
55.4
70.0
75.7
68.2
58.1
85.3
56.1
26.3
54.5
53.4
53.1
77.9
53.0

1.19
0.52
0.44
1.65
0.46
0.75
1.94
0.83
0.62
2.58
0.64
1.26
0.09
0.36
0.10
0.45
1.64
0.49
0.81
1.91
1.26
1.12
0.30
0.97
0.33
0.42
1.63
0.44
0.80
0.69
0.38
1.72
0.39
1.40
0.26
1.12
0.28
0.16
0.45
0.67
0.38
0.19
0.75
1.70
0.84
0.32
1.34
0.34
0.71
1.64
0.55
0.67
1.08
0.56

8.32
7.04
7.81
10.75
7.50
8.65
11.06
8.16
8.83
10.92
8.67
6.55
7.50
9.54
7.40
6.97
9.39
6.84
4.76
1.16
3.42
5.69
6.74
7.71
6.76
8.38
10.51
8.11
9.06
6.83
7.72
10.93
7.46
8.51
6.56
9.79
6.47
6.75
4.13
9.77
3.34
7.14
9.05
9.68
8.87
7.44
11.03
7.19
3.37
7.03
6.84
6.74
9.95
6.83

0.18
0.08
0.07
0.25
0.07
0.12
0.30
0.13
0.09
0.38
0.10
0.20
0.01
0.05
0.02
0.07
0.25
0.07
0.13
0.27
0.19
0.17
0.05
0.15
0.05
0.07
0.25
0.07
0.12
0.11
0.06
0.26
0.06
0.22
0.04
0.17
0.04
0.02
0.07
0.10
0.06
0.03
0.11
0.26
0.13
0.05
0.21
0.05
0.11
0.26
0.09
0.11
0.16
0.09

2458
11381
15710
1980
13569
7167
1527
5592
9559
858
8626
1485
339134
29126
302680
13910
1389
12332
1747
18
327
1378
29887
3048
26285
19374
1850
17242
6075
5846
21873
2074
19547
2008
35923
3445
30559
99833
3766
8824
4128
82579
5538
963
4531
24136
2400
21393
920
853
9039
6168
4148
7694

41.5
40.3
39.1
44.1
38.6
43.3
44.4
43.6
39.9
42.7
39.8
38.1
36.4
34.3
37.2
36.5
35.0
37.9
23.7
3.9
14.6
30.7
35.5
29.5
37.5
38.9
41.2
38.4
41.1
40.5
35.8
46.8
34.7
42.0
33.8
38.7
35.1
34.3
16.8
36.5
16.0
38.5
33.6
24.2
36.5
32.9
35.6
33.0
14.3
33.3
39.8
40.0
46.3
34.7

0.92
0.42
0.34
1.04
0.36
0.56
1.20
0.65
0.45
1.53
0.47
1.08
0.07
0.21
0.07
0.34
0.97
0.38
0.61
0.96
0.85
0.90
0.23
0.55
0.26
0.31
1.01
0.32
0.57
0.58
0.27
1.09
0.28
1.06
0.20
0.69
0.22
0.12
0.29
0.41
0.26
0.15
0.48
0.82
0.58
0.23
0.76
0.24
0.51
1.23
0.46
0.56
0.79
0.44

5.38
5.24
5.15
5.74
5.09
5.70
5.77
5.77
5.25
5.40
5.25
5.12
4.73
4.40
4.86
4.65
4.44
4.84
3.12
0.50
1.79
4.13
4.55
3.70
4.83
5.14
5.45
5.08
5.41
5.39
4.63
5.98
4.50
5.37
4.40
5.00
4.61
4.45
2.04
4.68
1.97
5.04
4.39
3.05
4.80
4.27
4.62
4.29
1.87
4.42
5.22
5.21
6.08
4.58

0.14
0.06
0.05
0.16
0.05
0.08
0.18
0.10
0.07
0.22
0.07
0.17
0.01
0.03
0.01
0.05
0.15
0.06
0.09
0.16
0.13
0.14
0.03
0.08
0.04
0.05
0.15
0.05
0.09
0.09
0.04
0.16
0.04
0.15
0.03
0.11
0.03
0.02
0.04
0.06
0.04
0.02
0.07
0.12
0.09
0.03
0.12
0.04
0.08
0.19
0.07
0.09
0.12
0.07

186
3847
12941
600
1282
12766
1088
569
962
2525
175
1933
284
363
264
5201
4506
553
1511
1627
1806
4635
3806
16759
2877

34.2
71.9
57.9
46.7
55.5
51.5
34.0
24.8
10.8
13.5
21.3
9.7
7.5
6.1
9.9
32.2
30.5
40.4
37.5
34.9
42.0
40.6
46.2
43.3
38.2

2.53
1.19
0.52
1.95
1.59
0.48
1.05
1.07
0.35
0.28
1.62
0.23
0.45
0.33
0.62
0.46
0.47
1.76
0.97
0.91
1.00
0.62
0.79
0.34
0.76

4.05
8.61
7.00
6.11
6.49
6.29
4.41
3.19
1.37
1.76
3.03
1.21
0.96
0.78
1.28
4.20
3.99
5.28
4.20
3.95
5.14
4.78
5.50
4.85
4.55

0.38
0.17
0.08
0.29
0.21
0.07
0.16
0.16
0.05
0.04
0.26
0.03
0.07
0.05
0.09
0.07
0.07
0.28
0.14
0.13
0.15
0.09
0.12
0.05
0.11

64
1765
6136
182
845
5720
521
128
228
540
20
600
96
182
51
2496
2334
82
589
618
720
1801
1608
7144
1042

11.8
26.7
23.4
13.0
34.6
19.9
14.8
5.0
2.6
3.2
2.3
3.1
2.4
3.0
1.7
12.1
12.4
5.1
12.1
10.4
12.9
12.5
14.6
13.9
11.7

1.49
0.65
0.32
0.99
1.20
0.28
0.68
0.46
0.17
0.14
0.51
0.13
0.26
0.22
0.24
0.26
0.28
0.58
0.53
0.49
0.52
0.33
0.42
0.18
0.43

1.41
3.13
2.62
1.69
4.28
2.37
1.90
0.65
0.32
0.40
0.28
0.37
0.29
0.37
0.19
1.49
1.53
0.63
1.36
1.21
1.52
1.43
1.70
1.53
1.33

0.22
0.10 *
0.05
0.14 *
0.18
0.04 *
0.10 *
0.07 *
0.02
0.02 *
0.07
0.02
0.03 *
0.03 *
0.03 *
0.04
0.04
0.09
0.08
0.07
0.07
0.05
0.06
0.03
0.06

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

445

503

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Trachea, bronchus and lung (C33-34) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

446

Female
ASR(W)
CUM 0-74

41176
3368
2480
1083
1201
2170
309
9057
628
143
156
698
711
160
596
3165
3547
3145
89
313
1236
1117
409
1090
5886

51.1
46.2
52.8
46.3
51.4
50.2
45.0
49.7
57.6
15.6
15.3
39.0
21.0
9.8
25.2
51.7
45.3
51.8
12.1
34.8
32.6
51.7
15.4
37.5
74.5

0.26
0.85
1.10
1.46
1.54
1.12
2.64
0.56
2.45
1.33
1.92
1.51
0.81
0.79
1.08
0.97
0.77
0.93
1.35
2.02
0.94
1.56
0.77
1.15
0.98

6.59
5.90
6.86
6.03
6.92
6.41
5.55
5.89
7.46
1.91
1.62
5.04
2.70
1.27
3.31
6.69
5.37
6.26
1.27
4.03
4.18
6.71
2.06
4.79
9.89

0.04
0.13
0.17
0.23
0.25
0.18
0.41
0.08
0.39
0.20
0.25
0.24
0.12
0.12
0.17
0.15
0.11
0.14
0.16
0.29
0.13
0.23
0.12
0.16
0.15

14691
1303
933
399
479
822
120
3667
227
46
22
220
395
36
62
1139
1584
1436
33
115
934
634
168
142
505

12.5
12.2
13.6
11.7
13.3
13.0
10.7
14.4
13.9
4.6
3.1
9.9
11.2
2.3
3.6
14.8
16.4
17.5
6.8
11.8
23.6
27.0
5.4
4.8
5.9

0.11
0.34
0.45
0.60
0.62
0.46
1.01
0.24
0.95
0.72
0.81
0.68
0.57
0.39
0.47
0.45
0.42
0.48
1.25
1.13
0.78
1.09
0.43
0.40
0.26

1.47
1.40
1.56
1.34
1.58
1.52
1.35
1.65
1.73
0.54
0.24
1.25
1.44
0.25
0.47
1.85
1.72
1.86
0.48
1.33
3.07
3.47
0.66
0.60
0.74

0.02
0.05
0.07
0.09
0.09
0.07
0.15
0.04
0.15
0.11
0.08
0.10
0.09
0.05 *
0.07 *
0.07 *
0.06
0.07
0.13
0.15
0.11 *
0.16 *
0.06
0.06 *
0.04 *

12849
1071
547
19017
3997
11993
15536
12086
23276
10243
2971
7809
2091
1257
978
1316
1740
1958
1579
941
1212
727
776
5810
9140
3833
4175
3525
6019
2873
296
5184
632
1607
1346
3306
1994
432
3125
1812
1035
4931
1212
565
1236
3179
1795
961
609
501
2790
2091
1308
4797

42.4
45.5
47.3
64.4
54.6
58.0
49.6
72.1
64.4
46.2
65.8
37.3
59.2
55.6
53.3
51.6
47.5
49.5
40.8
48.6
61.4
41.1
34.5
55.6
46.4
53.9
60.9
36.8
56.7
59.6
32.3
41.4
63.2
62.7
64.4
52.9
63.3
44.0
57.8
55.6
66.2
49.1
53.9
45.1
50.7
58.5
50.0
49.4
45.0
67.1
57.8
44.6
61.2
64.0

0.38
1.42
2.04
0.47
0.90
0.55
0.41
0.67
0.43
0.48
1.21
0.43
1.31
1.62
1.75
1.45
1.21
1.15
1.06
1.68
1.84
1.67
1.31
0.74
0.49
0.89
0.95
0.63
0.75
1.14
1.96
0.59
2.63
1.60
1.89
0.99
1.52
2.27
1.09
1.39
2.07
0.73
1.67
2.01
1.54
1.11
1.23
1.65
1.90
3.06
1.14
1.06
1.73
0.96

5.34
5.73
6.06
8.53
6.85
7.44
6.28
9.34
8.33
6.05
8.91
4.64
7.55
7.09
6.70
6.63
6.06
6.28
5.18
5.93
7.79
5.02
4.16
7.21
6.04
6.83
7.87
4.58
7.17
7.56
4.23
5.17
8.26
8.14
8.38
6.75
8.03
5.77
7.23
7.39
8.93
6.30
6.89
5.92
6.38
7.48
6.54
6.30
6.07
8.65
7.39
5.78
7.79
8.24

0.06
0.21
0.31
0.07
0.13
0.08
0.05
0.09
0.06
0.07
0.18
0.07
0.19
0.23
0.25
0.21
0.17
0.17
0.15
0.22
0.26
0.23
0.17
0.11
0.07
0.13
0.14
0.09
0.11
0.17
0.30
0.09
0.39
0.24
0.28
0.14
0.22
0.34
0.16
0.21
0.32
0.11
0.25
0.29
0.23
0.17
0.18
0.24
0.29
0.46
0.17
0.16
0.26
0.15

5532
447
186
2337
1021
2330
2789
2830
6851
7803
678
2745
479
218
202
306
403
400
362
128
196
139
167
1597
2188
1901
1104
1648
1875
990
303
3066
166
391
327
900
496
101
1295
470
189
1625
398
92
343
856
260
187
88
112
815
510
309
1459

13.9
15.2
13.2
4.6
13.4
10.7
7.0
12.5
14.0
31.6
8.7
9.6
11.1
7.7
9.8
9.9
10.5
8.7
7.7
6.0
8.4
6.7
6.9
11.5
7.7
20.8
11.6
13.6
14.2
17.3
31.3
20.3
10.8
11.3
12.7
12.1
11.5
9.0
16.7
12.9
10.2
12.0
13.5
5.4
13.4
14.1
6.1
8.2
6.4
11.4
12.6
9.8
10.9
14.3

0.21
0.79
1.03
0.10
0.46
0.24
0.14
0.25
0.18
0.39
0.36
0.20
0.55
0.57
0.74
0.61
0.57
0.47
0.43
0.59
0.66
0.68
0.58
0.31
0.19
0.54
0.38
0.37
0.37
0.61
1.92
0.40
1.00
0.64
0.82
0.47
0.62
1.05
0.54
0.67
0.77
0.35
0.82
0.62
0.84
0.57
0.42
0.65
0.74
1.20
0.51
0.51
0.70
0.43

1.67
1.82
1.72
0.56
1.70
1.29
0.84
1.51
1.73
4.23
1.07
1.16
1.34
0.90
1.16
1.21
1.23
1.02
0.93
0.69
0.93
0.69
0.83
1.43
0.95
2.57
1.48
1.68
1.71
2.12
4.09
2.60
1.32
1.35
1.61
1.45
1.41
1.09
2.00
1.56
1.20
1.48
1.63
0.69
1.64
1.69
0.70
1.00
0.77
1.39
1.51
1.21
1.31
1.74

0.03
0.11
0.15
0.01 *
0.06 *
0.03
0.02 *
0.03
0.03
0.06
0.05
0.03
0.07
0.07
0.10
0.08
0.07
0.06
0.06
0.07
0.08
0.08
0.07
0.04
0.03
0.07
0.05
0.05
0.05
0.08
0.28
0.06
0.14
0.09
0.11
0.06
0.08
0.14
0.07
0.09
0.10
0.05
0.11
0.09
0.11
0.07
0.05
0.09
0.09
0.17
0.07
0.07
0.09
0.06

*Important. See note on population page.

504

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Trachea, bronchus and lung (C33-34) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

4793
6950
533
6516
1506
3229
2955
3133
3718
7745
10672
9481
4033
491
2833
3857
2287
443
1300
1402
2074
1254
1037
1839
8437
705
403
343
779
648
514
1126
32797
2272
2138
4688
5873
9094
15639
3630
11995
23713
10193
10435
2693
12969

61.8
64.5
38.8
35.5
60.2
76.9
48.2
30.5
32.5
55.0
59.3
61.2
57.8
38.1
56.4
54.3
49.4
38.2
54.7
43.0
50.4
51.6
49.3
49.1
20.9
45.4
44.7
49.3
39.9
48.8
48.7
46.8
54.6
60.4
57.4
35.4
55.9
51.9
53.4
33.0
35.8
41.2
46.0
44.3
44.8
60.9

0.90
0.78
1.72
0.47
1.57
1.39
0.91
0.56
0.55
0.63
0.59
0.64
0.91
1.87
1.13
0.91
1.05
2.12
1.62
1.22
1.16
1.55
1.64
1.21
0.24
1.76
2.33
2.80
1.48
1.97
2.22
1.46
0.31
1.28
1.27
0.55
0.76
0.57
0.45
0.57
0.35
0.28
0.48
0.45
0.89
0.55

8.23
8.48
5.01
4.53
7.90
10.24
6.46
3.89
4.05
7.27
7.58
8.06
7.54
4.78
6.89
6.51
6.05
4.67
6.80
5.63
6.27
6.59
6.04
6.28
2.79
5.72
5.57
6.61
5.14
6.47
6.28
5.94
7.10
7.74
7.43
4.32
6.73
6.46
6.62
3.90
4.31
4.92
5.60
5.50
5.79
7.64

0.13
0.11
0.27
0.07
0.23
0.20
0.13
0.08
0.08
0.09
0.08
0.10
0.14
0.26
0.15
0.12
0.15
0.28
0.23
0.18
0.16
0.22
0.23
0.17
0.04
0.27
0.35
0.44
0.23
0.31
0.33
0.22
0.05
0.20
0.19
0.08
0.11
0.09
0.07
0.09
0.05
0.04
0.07
0.07
0.14
0.08

929
1230
98
3761
613
611
1520
685
867
1894
3076
1777
1188
49
354
558
398
39
134
122
231
166
99
172
6073
391
106
140
274
250
197
528
12386
740
729
2606
4320
6169
10864
2130
7253
15168
6107
5650
1735
9764

7.0
6.6
6.1
19.2
17.0
10.4
17.4
5.3
6.2
6.6
15.3
8.1
13.0
3.3
5.8
7.0
7.5
3.4
5.4
3.3
4.8
6.9
4.1
4.2
14.5
18.9
10.9
17.3
12.9
15.5
16.8
19.0
19.7
18.7
19.1
17.3
31.9
28.3
30.0
16.4
17.8
21.1
23.1
19.9
22.9
34.9

0.25
0.21
0.65
0.35
0.73
0.45
0.47
0.22
0.23
0.17
0.29
0.20
0.40
0.53
0.36
0.33
0.40
0.71
0.52
0.33
0.34
0.59
0.47
0.38
0.20
1.04
1.15
1.61
0.84
1.09
1.27
0.90
0.19
0.71
0.74
0.38
0.54
0.40
0.32
0.39
0.24
0.19
0.33
0.30
0.60
0.39

0.85
0.76
0.77
2.54
2.00
1.25
2.22
0.64
0.70
0.77
1.83
0.95
1.63
0.43
0.64
0.76
0.85
0.31
0.66
0.38
0.54
0.79
0.42
0.45
1.90
2.38
1.33
2.11
1.58
1.88
2.13
2.35
2.54
2.37
2.40
2.15
4.07
3.67
3.89
2.08
2.21
2.65
2.97
2.56
2.98
4.52

0.03
0.03
0.09
0.05
0.10 *
0.06
0.06
0.03 *
0.03
0.02
0.04
0.03
0.05
0.08
0.04
0.04
0.05
0.07
0.07
0.04
0.04
0.07
0.06
0.04
0.03
0.15
0.15
0.22
0.11
0.14
0.18
0.12
0.03
0.10
0.10
0.06
0.08
0.06
0.05
0.06
0.04
0.03
0.05
0.04
0.09
0.06

9278
175
5270
2323
816
6619
2524
223
250
4733
1983
121
332
324
504
566

37.7
51.4
41.2
36.3
42.9
36.6
39.8
25.6
62.3
35.3
43.8
28.6
48.7
68.4
31.0
48.1

0.41
4.07
0.59
0.79
1.56
0.47
0.81
1.77
4.06
0.53
1.05
2.92
2.86
3.86
1.64
2.11

4.77
6.44
5.14
4.51
5.51
4.49
5.02
3.07
7.86
4.42
5.63
3.60
6.17
8.88
3.80
6.45

0.06
0.62
0.09
0.12
0.24
0.07
0.13
0.27
0.60
0.08
0.16
0.45
0.42
0.61
0.25
0.34

4685
70
2487
1202
447
3685
1339
138
95
3159
1275
85
143
257
278
423

17.1
22.7
18.1
16.7
21.4
17.5
18.5
13.7
23.6
21.3
24.2
16.7
19.1
45.9
13.7
33.3

0.27
2.87
0.39
0.54
1.10
0.32
0.54
1.24
2.45
0.41
0.74
2.06
1.64
2.93
1.03
1.77

2.18
2.92
2.34
2.11
2.61
2.19
2.36
1.68
2.93
2.74
3.10
2.20
2.42
5.88
1.68
4.34

0.04
0.49
0.06
0.08
0.16
0.05
0.08
0.19
0.36
0.06
0.11
0.32
0.24
0.44
0.15
0.28

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

447

505

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other thoracic organs (C37-38)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

448

Female
ASR(W)
CUM 0-74

38
21
5
1
12

1.8
0.4
0.5
0.0
0.7

0.30
0.08
0.24
0.02
0.24

17
6
2
3
11

0.8
0.1
0.1
0.2
0.6

0.20
0.05
0.10
0.18
0.27

15
58
12
11
148
2
36
46
11
3
1

1.6
2.9
2.1
0.7
0.7
0.2
1.0
0.6
0.3
0.3
0.1

0.45
0.40
0.61
0.21
0.06
0.14
0.17
0.09
0.10
0.17
0.06

0.16
0.32
0.28
0.05
0.08
0.04
0.12
0.06
0.03
0.03
0.00

0.06
0.06
0.10
0.02
0.01
0.03
0.03
0.01
0.02
0.02
0.00

4
69
3
9
154
1
19
28
1
12
1

0.4
2.7
0.4
0.5
0.6
0.1
0.4
0.4
0.0
0.9
0.1

0.22
0.35
0.22
0.16
0.05
0.09
0.10
0.07
0.04
0.26
0.12

0.04
0.31
0.04
0.04
0.06
0.01
0.05
0.04
0.00
0.08
0.02

0.02
0.05
0.03
0.02
0.01
0.01
0.02
0.01
0.00
0.03
0.02 *

355
43
40
12
7
3
0
12
219
3
16
49
14
35
5
53
431
57
27
99
241
92
6
6
6
4
15
47
116
10
5
3
4
1
34
54
44
36
4
32
8
4
3
225
28
194
85
25
56
40
15
24
16
141
23
111
58
29
35
63
15
45
6
10

0.5
0.5
0.4
0.3
0.3
0.2
0.5
0.6
0.6
0.5
0.4
0.6
0.4
0.3
0.3
0.5
0.5
0.5
0.4
0.4
0.5
0.5
0.3
0.7
1.5
0.5
0.5
0.5
0.4
0.6
0.3
0.9
0.2
0.4
0.5
0.4
0.4
0.5
0.4
0.5
0.4
0.4
0.4
0.5
0.4
0.4
0.5
0.3
0.6
0.7
0.5
0.5
0.4
0.5
0.4
0.3
0.3
0.3
0.5
0.5
0.6
0.6
0.5

0.03
0.07
0.07
0.09
0.12
0.11
0.17
0.04
0.36
0.14
0.06
0.15
0.07
0.16
0.05
0.02
0.07
0.09
0.04
0.03
0.06
0.21
0.14
0.29
0.81
0.13
0.08
0.04
0.13
0.28
0.20
0.46
0.19
0.07
0.07
0.06
0.07
0.25
0.07
0.17
0.22
0.25
0.03
0.10
0.04
0.04
0.10
0.05
0.09
0.20
0.10
0.12
0.03
0.11
0.04
0.05
0.07
0.06
0.07
0.12
0.09
0.24
0.18

0.05
0.04
0.04
0.03
0.03
0.02
0.04
0.06
0.08
0.06
0.04
0.06
0.04
0.03
0.03
0.05
0.05
0.05
0.03
0.05
0.05
0.07
0.05
0.06
0.14
0.04
0.05
0.05
0.05
0.07
0.04
0.09
0.02
0.03
0.05
0.03
0.03
0.05
0.03
0.04
0.04
0.04
0.04
0.06
0.04
0.04
0.06
0.03
0.06
0.08
0.06
0.05
0.04
0.05
0.04
0.03
0.03
0.03
0.05
0.05
0.06
0.05
0.06

0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.06
0.02
0.01
0.02
0.01
0.02
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.03
0.02
0.03
0.09
0.01
0.01
0.01
0.02
0.03
0.03
0.05
0.02
0.01
0.01
0.01
0.01
0.03
0.01
0.02
0.02
0.02
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.03
0.02
0.01
0.00
0.01
0.00
0.00
0.01
0.01
0.01
0.01
0.01
0.03
0.02

255
28
34
6
5
0
0
6
166
1
9
42
11
30
3
32
199
39
20
34
105
56
4
5
3
2
7
26
51
8
1
2
1
1
11
24
28
40
4
36
7
5
1
151
21
126
65
21
42
24
10
13
5
108
13
93
40
13
25
39
12
26
4
11

0.3
0.3
0.3
0.1
0.2
0.2
0.4
0.3
0.4
0.3
0.3
0.2
0.2
0.2
0.2
0.3
0.3
0.2
0.2
0.3
0.2
0.3
0.2
0.4
0.2
0.2
0.2
0.2
0.1
0.2
0.1
0.2
0.1
0.2
0.2
0.4
0.4
0.4
0.4
0.3
0.2
0.2
0.3
0.2
0.3
0.3
0.2
0.3
0.4
0.2
0.2
0.3
0.2
0.3
0.2
0.1
0.2
0.3
0.3
0.3
0.3
0.7

0.02
0.06
0.06
0.06
0.08
0.08
0.03
0.27
0.13
0.04
0.09
0.05
0.09
0.03
0.01
0.05
0.06
0.03
0.02
0.04
0.15
0.14
0.15
0.33
0.10
0.04
0.03
0.08
0.10
0.13
0.08
0.16
0.04
0.05
0.04
0.07
0.22
0.08
0.18
0.15
0.17
0.02
0.07
0.03
0.03
0.08
0.04
0.06
0.14
0.06
0.07
0.03
0.06
0.03
0.03
0.03
0.04
0.05
0.08
0.07
0.14
0.26

0.03
0.03
0.03
0.02
0.02
0.03
0.04
0.03
0.03
0.03
0.03
0.03
0.01
0.02
0.02
0.03
0.03
0.02
0.02
0.03
0.01
0.02
0.02
0.03
0.02
0.02
0.02
0.03
0.01
0.02
0.01
0.02
0.02
0.02
0.04
0.04
0.04
0.04
0.03
0.04
0.02
0.03
0.02
0.03
0.03
0.02
0.03
0.05
0.02
0.02
0.03
0.03
0.03
0.02
0.01
0.02
0.03
0.03
0.03
0.04
0.07

0.00
0.01
0.01
0.01
0.01
0.01
0.00
0.03
0.01
0.00
0.01
0.01
0.01
0.00
0.00
0.01
0.01
0.00
0.00
0.00
0.01
0.01
0.02
0.03
0.01
0.00
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.03
0.01
0.02
0.02
0.04
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.02
0.01
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.02
0.02

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

506

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other thoracic organs (C37-38) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

20
95
149
22
125
68
15
53
77
11
66
11
2800
328
2298
146
15
120
17
0
9
8
269
38
209
123
16
103
34
39
178
18
154
11
366
46
275
978
99
101
140
628
44
11
31
220
29
176
22
5
84
66
24
51

0.5
0.5
0.5
0.6
0.5
0.6
0.6
0.7
0.4
0.8
0.4
0.4
0.4
0.5
0.4
0.6
0.5
0.6
0.3
0.5
0.3
0.5
0.5
0.5
0.4
0.5
0.4
0.3
0.4
0.5
0.6
0.5
0.4
0.5
0.6
0.5
0.5
0.6
0.5
0.4
0.5
0.4
0.4
0.4
0.4
0.5
0.4
0.4
0.2
0.5
0.6
0.4
0.3

0.12
0.06
0.05
0.13
0.05
0.08
0.15
0.10
0.05
0.25
0.06
0.12
0.01
0.03
0.01
0.05
0.14
0.06
0.09
0.17
0.17
0.03
0.09
0.04
0.04
0.12
0.04
0.06
0.07
0.04
0.14
0.04
0.13
0.03
0.10
0.03
0.02
0.06
0.05
0.04
0.02
0.07
0.11
0.09
0.03
0.10
0.03
0.09
0.10
0.06
0.07
0.09
0.05

0.04
0.05
0.05
0.05
0.05
0.06
0.05
0.07
0.04
0.10
0.04
0.04
0.04
0.05
0.04
0.06
0.05
0.06
0.02
0.05
0.02
0.05
0.05
0.05
0.03
0.04
0.03
0.03
0.04
0.05
0.06
0.05
0.04
0.05
0.07
0.05
0.05
0.05
0.05
0.04
0.05
0.03
0.04
0.03
0.04
0.05
0.03
0.04
0.02
0.05
0.06
0.05
0.03

0.01
0.01
0.00
0.01
0.01
0.01
0.02
0.01
0.01
0.04
0.01
0.01
0.00
0.00
0.00
0.01
0.02
0.01
0.01
0.02
0.01
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.01
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.01
0.01
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01

10
67
83
10
73
38
6
31
52
6
46
10
1812
255
1455
100
13
83
16
0
4
12
194
26
158
83
15
67
31
25
132
15
110
8
218
25
160
548
65
67
50
364
30
12
15
145
27
116
8
5
41
28
7
52

0.2
0.3
0.3
0.2
0.3
0.3
0.2
0.4
0.3
0.2
0.3
0.3
0.2
0.3
0.2
0.4
0.4
0.3
0.3
0.2
0.5
0.3
0.3
0.3
0.2
0.4
0.2
0.3
0.2
0.3
0.4
0.3
0.4
0.3
0.3
0.3
0.2
0.3
0.3
0.2
0.2
0.2
0.3
0.2
0.2
0.3
0.2
0.1
0.2
0.2
0.2
0.1
0.3

0.06
0.05
0.03
0.07
0.04
0.06
0.09
0.07
0.04
0.11
0.05
0.13
0.01
0.02
0.01
0.04
0.12
0.04
0.08
0.09
0.18
0.02
0.05
0.03
0.03
0.10
0.03
0.06
0.05
0.03
0.11
0.03
0.14
0.02
0.06
0.02
0.01
0.04
0.04
0.03
0.01
0.05
0.10
0.06
0.02
0.07
0.02
0.04
0.08
0.04
0.05
0.04
0.05

0.02
0.03
0.03
0.01
0.03
0.03
0.01
0.03
0.03
0.02
0.03
0.03
0.02
0.03
0.02
0.03
0.03
0.03
0.02
0.01
0.04
0.03
0.02
0.03
0.02
0.02
0.02
0.02
0.02
0.03
0.04
0.03
0.03
0.03
0.03
0.02
0.02
0.03
0.03
0.02
0.02
0.02
0.04
0.01
0.02
0.04
0.02
0.01
0.03
0.02
0.02
0.01
0.02

0.01
0.00
0.00
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.01
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.01
0.00
0.00
0.02
0.00
0.00
0.00
0.00

5
50
134
7
42
288
22
8
29
111
3
80
11
27
8
116
100
9
27
26
40
62
51
162
24

0.8
0.9
0.6
0.6
1.8
1.2
0.7
0.5
0.3
0.5
0.3
0.3
0.3
0.4
0.3
0.7
0.7
0.4
0.9
0.8
1.1
0.7
0.8
0.5
0.4

0.36
0.13
0.06
0.24
0.28
0.08
0.15
0.18
0.06
0.05
0.19
0.04
0.08
0.09
0.10
0.07
0.08
0.17
0.18
0.17
0.20
0.09
0.13
0.05
0.09

0.11
0.10
0.07
0.05
0.21
0.13
0.07
0.05
0.03
0.07
0.03
0.03
0.03
0.05
0.02
0.08
0.08
0.06
0.09
0.10
0.11
0.07
0.09
0.05
0.05

0.06
0.02
0.01
0.03
0.04
0.01
0.02
0.02
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.03
0.02
0.02
0.02
0.01
0.01
0.00
0.01

1
25
102
5
28
178
13
10
14
93
0
61
8
9
6
104
93
7
12
6
13
38
38
87
21

0.2
0.4
0.5
0.4
1.1
0.8
0.4
0.4
0.2
0.5
0.3
0.2
0.2
0.2
0.6
0.6
0.2
0.3
0.1
0.4
0.4
0.6
0.2
0.2

0.20
0.08
0.05
0.17
0.22
0.08
0.11
0.13
0.04
0.06
0.04
0.07
0.05
0.08
0.06
0.07
0.09
0.09
0.06
0.14
0.09
0.13
0.03
0.05

0.03
0.04
0.05
0.05
0.12
0.08
0.04
0.06
0.01
0.06
0.03
0.02
0.02
0.02
0.05
0.05
0.02
0.05
0.01
0.03
0.04
0.07
0.02
0.03

0.03
0.01 *
0.01
0.02 *
0.03
0.01 *
0.01 *
0.02 *
0.00
0.01 *
0.00
0.01 *
0.01 *
0.01 *
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

449

507

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other thoracic organs (C37-38) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

450

Female
ASR(W)
CUM 0-74

707
96
53
23
26
35
6
176
18
6
10
11
17
8
8
54
41
36
1
4
14
0
8
14
51

0.8
1.1
0.9
0.9
0.9
0.6
0.8
0.8
1.5
0.4
0.8
0.4
0.4
0.4
0.3
0.8
0.5
0.6
0.2
0.5
0.4
0.3
0.5
0.6

0.03
0.13
0.14
0.19
0.19
0.12
0.32
0.07
0.41
0.19
0.45
0.13
0.11
0.15
0.13
0.12
0.08
0.09
0.21
0.23
0.10
0.09
0.13
0.09

0.08
0.12
0.10
0.13
0.09
0.06
0.10
0.09
0.12
0.03
0.09
0.04
0.05
0.03
0.05
0.10
0.05
0.05
0.01
0.04
0.03
0.02
0.04
0.08

0.00
0.02
0.02
0.03
0.02
0.01
0.06
0.01
0.04
0.02
0.06
0.01
0.02
0.01
0.02
0.02
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01

424
50
31
13
17
37
2
121
5
3
3
2
20
1
5
56
32
27
2
3
4
2
4
8
12

0.4
0.5
0.5
0.3
0.5
0.6
0.2
0.5
0.3
0.2
0.8
0.1
0.5
0.0
0.2
0.7
0.3
0.3
0.4
0.2
0.1
0.1
0.1
0.3
0.1

0.02
0.07
0.09
0.09
0.12
0.10
0.12
0.05
0.14
0.13
0.51
0.06
0.12
0.02
0.11
0.09
0.06
0.07
0.29
0.15
0.06
0.05
0.07
0.09
0.04

0.04
0.05
0.06
0.02
0.06
0.06
0.01
0.05
0.03
0.02
0.11
0.01
0.06
0.00
0.02
0.06
0.04
0.04
0.05
0.03
0.01
0.01
0.02
0.04
0.02

0.00
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.02
0.02
0.08
0.01
0.02
0.00 *
0.02 *
0.01 *
0.01
0.01
0.04
0.02
0.00 *
0.00 *
0.01
0.01 *
0.00 *

159
8
9
169
23
141
237
99
284
97
13
53
31
15
5
12
17
27
33
16
8
12
18
60
119
11
43
52
56
36
3
61
6
18
19
41
44
12
35
18
30
48
14
14
15
37
21
16
8
8
37
17
14
67

0.6
0.4
0.8
0.6
0.4
0.7
0.8
0.7
0.8
0.5
0.3
0.3
1.0
0.7
0.3
0.5
0.5
0.7
0.9
0.9
0.4
0.8
0.8
0.6
0.7
0.3
0.8
0.6
0.6
0.8
0.4
0.5
0.5
0.7
0.9
0.9
1.3
1.5
0.6
0.7
2.1
0.6
0.8
1.3
0.8
0.8
0.7
0.9
0.7
0.9
0.9
0.5
0.8
1.1

0.05
0.14
0.27
0.05
0.09
0.06
0.06
0.07
0.05
0.06
0.09
0.04
0.18
0.19
0.15
0.15
0.12
0.14
0.16
0.25
0.14
0.25
0.20
0.07
0.07
0.09
0.13
0.09
0.08
0.17
0.24
0.07
0.20
0.17
0.23
0.17
0.23
0.54
0.14
0.18
0.38
0.09
0.25
0.36
0.22
0.15
0.16
0.23
0.27
0.33
0.16
0.12
0.22
0.16

0.07
0.04
0.08
0.07
0.05
0.08
0.09
0.07
0.09
0.05
0.03
0.03
0.12
0.09
0.03
0.05
0.05
0.06
0.08
0.10
0.04
0.12
0.09
0.07
0.08
0.02
0.08
0.06
0.06
0.09
0.03
0.05
0.04
0.08
0.08
0.07
0.14
0.18
0.04
0.08
0.22
0.06
0.08
0.17
0.09
0.09
0.06
0.11
0.08
0.07
0.08
0.06
0.08
0.11

0.01
0.02
0.03
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.02
0.03
0.02
0.03
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.03
0.02
0.03
0.01
0.03
0.06
0.01
0.02
0.05
0.01
0.03
0.05
0.03
0.02
0.02
0.03
0.03
0.04
0.02
0.02
0.02
0.02

122
7
3
107
21
111
112
84
191
74
11
54
13
8
6
5
11
9
8
9
8
2
16
52
56
22
27
34
33
12
1
39
3
14
15
29
31
4
33
13
21
28
17
10
16
20
14
5
5
7
18
16
8
29

0.4
0.3
0.3
0.3
0.3
0.5
0.4
0.4
0.4
0.3
0.3
0.2
0.3
0.4
0.3
0.2
0.3
0.2
0.1
0.6
0.4
0.1
0.6
0.4
0.2
0.2
0.3
0.3
0.3
0.2
0.1
0.3
0.2
0.6
0.7
0.3
0.6
0.3
0.4
0.5
1.2
0.3
0.6
0.8
0.8
0.4
0.3
0.3
0.4
1.1
0.4
0.3
0.6
0.5

0.04
0.11
0.15
0.04
0.08
0.06
0.04
0.05
0.04
0.04
0.10
0.04
0.09
0.16
0.12
0.13
0.09
0.08
0.06
0.24
0.14
0.10
0.17
0.06
0.05
0.06
0.07
0.06
0.05
0.06
0.12
0.05
0.11
0.21
0.22
0.07
0.15
0.22
0.09
0.15
0.27
0.07
0.19
0.28
0.29
0.09
0.09
0.13
0.19
0.42
0.10
0.10
0.28
0.12

0.04
0.04
0.03
0.03
0.04
0.05
0.04
0.05
0.04
0.03
0.02
0.02
0.03
0.03
0.03
0.03
0.03
0.02
0.02
0.06
0.05
0.02
0.07
0.05
0.02
0.02
0.03
0.03
0.03
0.02
0.01
0.03
0.03
0.05
0.06
0.03
0.08
0.03
0.05
0.05
0.13
0.02
0.07
0.11
0.07
0.05
0.03
0.04
0.06
0.13
0.04
0.05
0.05
0.04

0.00
0.02
0.02
0.00 *
0.01 *
0.01
0.00 *
0.01
0.00
0.01
0.01
0.00
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.02
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.02
0.01
0.02
0.02
0.01
0.02
0.03
0.01
0.02
0.04
0.02
0.01
0.01
0.02
0.03
0.05
0.01
0.01
0.02
0.01

*Important. See note on population page.

508

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other thoracic organs (C37-38) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

55
87
4
93
28
57
38
63
74
53
156
136
22
6
18
51
24
3
13
10
26
14
16
16
71
7
6
6
14
2
2
11
225
13
16
41
77
92
79
25
282
175
107
82
12
90

0.8
0.8
0.3
0.6
1.2
1.4
0.6
0.7
0.7
0.4
1.0
0.9
0.4
0.6
0.4
0.8
0.6
0.3
0.7
0.5
0.7
0.8
0.9
0.5
0.2
0.5
0.6
0.9
0.8
0.2
0.3
0.5
0.4
0.4
0.5
0.4
0.7
0.6
0.3
0.3
1.0
0.4
0.6
0.4
0.3
0.5

0.12
0.09
0.14
0.06
0.24
0.19
0.11
0.09
0.09
0.06
0.09
0.08
0.08
0.24
0.10
0.14
0.13
0.16
0.23
0.19
0.15
0.21
0.24
0.13
0.03
0.20
0.27
0.37
0.22
0.12
0.24
0.15
0.03
0.12
0.14
0.07
0.09
0.07
0.04
0.05
0.06
0.03
0.06
0.05
0.07
0.05

0.09
0.10
0.02
0.06
0.12
0.17
0.08
0.07
0.09
0.05
0.11
0.10
0.04
0.08
0.05
0.09
0.06
0.03
0.08
0.04
0.09
0.08
0.10
0.06
0.02
0.06
0.05
0.10
0.09
0.03
0.03
0.05
0.04
0.04
0.05
0.03
0.07
0.07
0.04
0.02
0.12
0.04
0.07
0.05
0.03
0.05

0.01
0.01
0.02
0.01
0.03
0.03
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.03
0.01
0.01
0.01
0.02
0.02
0.01
0.02
0.02
0.03
0.02
0.00
0.03
0.03
0.05
0.03
0.02
0.02
0.02
0.00
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.00
0.01
0.01
0.01
0.01

43
45
4
41
18
26
42
43
54
57
85
84
19
4
15
23
8
5
7
3
11
6
8
8
51
8
2
2
1
3
2
10
120
7
4
24
73
61
49
18
187
125
73
34
7
64

0.5
0.3
0.3
0.2
0.6
0.5
0.5
0.4
0.5
0.3
0.5
0.4
0.2
0.7
0.4
0.4
0.2
0.4
0.4
0.2
0.3
0.3
0.4
0.4
0.1
0.5
0.3
0.2
0.1
0.1
0.2
0.5
0.2
0.3
0.1
0.3
0.5
0.3
0.2
0.2
0.5
0.2
0.3
0.2
0.2
0.2

0.09
0.06
0.14
0.03
0.15
0.11
0.11
0.08
0.09
0.05
0.05
0.05
0.06
0.41
0.18
0.11
0.09
0.20
0.21
0.16
0.09
0.18
0.15
0.15
0.02
0.19
0.19
0.11
0.06
0.09
0.15
0.18
0.02
0.11
0.05
0.06
0.06
0.04
0.03
0.04
0.04
0.02
0.05
0.03
0.08
0.04

0.05
0.03
0.04
0.02
0.07
0.05
0.05
0.05
0.05
0.03
0.05
0.04
0.03
0.05
0.04
0.03
0.02
0.04
0.03
0.01
0.03
0.03
0.04
0.03
0.02
0.07
0.03
0.03
0.01
0.02
0.03
0.04
0.02
0.02
0.01
0.02
0.06
0.04
0.02
0.02
0.06
0.02
0.04
0.02
0.01
0.03

0.01
0.01
0.02
0.00
0.02 *
0.01
0.01
0.01 *
0.01
0.00
0.01
0.01
0.01
0.03
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.01
0.00
0.02
0.02
0.03
0.01
0.02
0.02
0.02
0.00
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.00
0.01
0.00
0.00
0.00

90
7
54
15
4
53
15
4
3
69
25
1
5
4
7
6

0.5
2.0
0.5
0.3
0.2
0.4
0.3
0.4
0.7
0.6
0.7
0.1
0.9
0.7
0.6
0.5

0.05
0.78
0.07
0.09
0.10
0.06
0.07
0.19
0.38
0.08
0.14
0.11
0.41
0.33
0.28
0.22

0.04
0.25
0.05
0.03
0.02
0.03
0.03
0.03
0.08
0.07
0.06
0.09
0.05
0.05
0.05

0.01
0.12
0.01
0.01
0.01
0.01
0.01
0.02
0.05
0.01
0.01
0.04
0.02
0.03
0.02

46
2
24
7
2
40
14
1
0
38
17
1
4
4
5
1

0.2
0.7
0.2
0.1
0.1
0.3
0.2
0.1
0.3
0.4
0.3
0.5
0.7
0.6
0.1

0.03
0.54
0.04
0.04
0.05
0.05
0.06
0.09
0.06
0.11
0.31
0.27
0.38
0.28
0.09

0.02
0.11
0.03
0.01
0.01
0.03
0.02
0.01
0.03
0.04
0.05
0.06
0.06
0.05
0.01

0.00
0.09
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.05
0.04
0.04
0.02
0.01

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

451

509

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Bone (C40-41)
Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

452

Female
ASR(W)
CUM 0-74

45
106
5
29
44

1.4
1.5
0.4
1.2
1.4

0.23
0.16
0.16
0.34
0.27

35
71
6
29
49

1.2
1.0
0.5
0.7
1.5

0.23
0.13
0.22
0.17
0.25

12
97
25
24
558
13
67
78
48
13
11

1.6
3.3
3.2
1.1
2.2
1.3
1.6
0.8
1.4
1.4
0.9

0.48
0.37
0.71
0.23
0.10
0.38
0.20
0.10
0.21
0.41
0.29

0.14
0.31
0.37
0.07
0.18
0.12
0.14
0.07
0.11
0.12
0.07

0.04
0.05
0.11
0.02
0.01
0.04
0.02
0.01
0.02
0.04
0.03

11
67
27
21
482
9
41
63
37
5
7

1.4
1.9
3.1
0.9
1.7
0.8
0.8
0.7
1.0
0.3
0.4

0.43
0.25
0.65
0.22
0.08
0.29
0.13
0.09
0.16
0.17
0.17

0.11
0.18
0.33
0.09
0.14
0.07
0.06
0.06
0.07
0.02
0.04

0.03
0.03
0.10
0.03
0.01
0.03
0.01
0.01
0.02
0.01
0.03 *

688
72
116
24
22
18
0
28
381
1
26
137
21
112
19
138
942
67
51
264
547
157
7
7
6
0
36
92
250
27
8
5
3
2
84
113
142
93
7
81
12
7
3
513
49
459
195
41
148
67
16
48
31
303
37
253
182
86
115
114
41
72
14
24

1.1
0.9
1.1
0.8
1.0
1.5
1.2
1.3
0.1
1.0
1.1
0.7
1.2
1.1
1.0
1.1
0.7
0.8
1.0
1.3
1.0
0.6
0.5
0.9
1.2
1.1
1.0
1.1
0.9
0.8
1.6
0.5
0.8
1.4
1.3
1.0
0.8
1.1
0.9
0.8
0.5
1.2
0.8
1.2
1.0
0.8
1.0
0.9
0.7
1.1
0.9
0.9
0.8
1.0
1.2
1.1
1.0
1.0
1.2
1.0
1.4
1.9

0.05
0.11
0.11
0.18
0.23
0.38
0.25
0.07
0.14
0.19
0.10
0.16
0.12
0.26
0.09
0.04
0.08
0.12
0.07
0.06
0.08
0.23
0.22
0.38
0.21
0.13
0.07
0.22
0.33
0.35
0.99
0.38
0.10
0.15
0.11
0.11
0.30
0.13
0.28
0.33
0.30
0.06
0.12
0.07
0.07
0.13
0.09
0.12
0.18
0.17
0.17
0.06
0.13
0.06
0.09
0.13
0.10
0.10
0.19
0.12
0.39
0.42

0.09
0.08
0.08
0.05
0.09
0.10
0.09
0.10
0.09
0.09
0.05
0.10
0.07
0.09
0.08
0.05
0.06
0.08
0.10
0.08
0.04
0.04
0.05
0.10
0.09
0.08
0.08
0.07
0.05
0.11
0.03
0.07
0.10
0.11
0.09
0.06
0.09
0.07
0.07
0.05
0.10
0.08
0.10
0.09
0.08
0.09
0.08
0.06
0.09
0.07
0.08
0.06
0.08
0.08
0.09
0.08
0.08
0.11
0.08
0.14
0.13

0.00
0.01
0.01
0.01
0.02
0.02
0.02
0.01
0.02
0.01
0.01
0.01
0.02
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.02
0.03
0.01
0.01
0.02
0.03
0.02
0.07
0.02
0.01
0.01
0.01
0.01
0.02
0.01
0.02
0.03
0.03
0.00
0.01
0.01
0.01
0.02
0.01
0.01
0.02
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.04
0.03

516
52
76
18
16
7
1
11
314
1
20
98
21
76
12
129
680
57
49
197
366
114
10
7
7
2
18
61
194
20
5
7
3
3
72
80
106
74
5
69
13
6
5
386
50
333
145
36
106
43
15
26
27
278
33
235
133
73
100
116
25
88
10
16

0.8
0.7
0.7
0.6
0.7
0.6
1.8
0.4
0.9
0.2
0.7
0.7
0.6
0.7
0.8
0.9
0.8
0.5
0.8
0.8
0.8
0.7
0.7
0.6
0.7
0.3
0.6
0.8
0.8
0.7
0.4
0.8
1.1
1.0
0.7
0.9
1.0
0.7
0.4
0.8
0.7
0.4
0.8
0.8
0.7
0.8
0.7
0.6
0.7
0.6
0.5
0.6
0.8
0.8
0.6
0.8
0.8
0.8
0.8
0.9
0.6
1.0
0.8
0.8

0.04
0.10
0.08
0.15
0.20
0.24
1.77
0.12
0.06
0.21
0.17
0.07
0.13
0.09
0.24
0.08
0.03
0.07
0.11
0.06
0.05
0.07
0.24
0.27
0.28
0.25
0.15
0.12
0.06
0.17
0.22
0.30
0.77
0.63
0.09
0.12
0.10
0.09
0.17
0.11
0.20
0.23
0.38
0.05
0.10
0.05
0.06
0.10
0.08
0.09
0.15
0.13
0.15
0.05
0.11
0.06
0.07
0.10
0.09
0.08
0.12
0.11
0.26
0.21

0.06
0.05
0.05
0.04
0.06
0.04
0.22
0.02
0.08
0.02
0.05
0.06
0.04
0.06
0.05
0.07
0.06
0.04
0.07
0.07
0.06
0.05
0.06
0.04
0.05
0.04
0.06
0.06
0.06
0.07
0.03
0.08
0.09
0.05
0.05
0.07
0.07
0.06
0.02
0.07
0.06
0.03
0.10
0.06
0.06
0.07
0.05
0.04
0.06
0.04
0.04
0.05
0.07
0.07
0.04
0.07
0.06
0.07
0.07
0.07
0.05
0.08
0.06
0.08

0.00
0.01
0.01
0.01
0.02
0.02
0.22
0.01
0.00
0.02
0.01
0.01
0.01
0.01
0.02
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.02
0.02
0.02
0.04
0.02
0.01
0.00
0.02
0.01
0.03
0.05
0.03
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.05
0.00
0.01
0.00
0.00
0.01
0.01
0.01
0.01
0.01
0.02
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.02

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

510

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Bone (C40-41) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

38
173
294
31
257
108
22
85
146
10
134
29
6323
581
5433
268
22
225
45
4
13
26
567
76
454
289
27
256
95
101
365
28
321
23
707
61
586
2047
113
179
336
1382
95
21
72
583
48
512
82
20
144
89
46
155

1.1
1.1
1.1
0.9
1.2
1.0
0.9
1.1
1.0
0.7
1.0
1.2
1.1
0.9
1.1
1.2
0.7
1.3
1.0
0.8
0.7
1.2
1.1
1.1
1.1
1.0
0.8
1.0
1.0
1.1
1.1
0.9
1.1
0.8
1.0
0.8
1.1
1.1
0.7
0.9
1.0
1.2
0.9
0.7
1.0
1.1
0.8
1.1
1.4
1.2
0.9
0.8
0.9
1.1

0.19
0.09
0.07
0.16
0.08
0.10
0.19
0.13
0.08
0.21
0.09
0.22
0.01
0.04
0.02
0.08
0.16
0.09
0.14
0.42
0.19
0.25
0.05
0.13
0.06
0.06
0.16
0.07
0.11
0.12
0.06
0.17
0.07
0.18
0.04
0.10
0.05
0.02
0.07
0.07
0.06
0.03
0.09
0.16
0.12
0.05
0.12
0.05
0.16
0.27
0.08
0.09
0.14
0.09

0.07
0.08
0.09
0.07
0.09
0.09
0.07
0.09
0.09
0.07
0.09
0.09
0.09
0.07
0.09
0.10
0.07
0.11
0.07
0.06
0.05
0.10
0.09
0.07
0.10
0.08
0.08
0.08
0.09
0.09
0.09
0.08
0.09
0.07
0.09
0.06
0.09
0.09
0.06
0.07
0.08
0.09
0.07
0.05
0.08
0.09
0.08
0.09
0.13
0.11
0.07
0.07
0.08
0.08

0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.03
0.01
0.02
0.00
0.00
0.00
0.01
0.02
0.01
0.01
0.03
0.01
0.02
0.00
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.01
0.02
0.00
0.01
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.02
0.03
0.01
0.01
0.01
0.01

28
136
241
27
207
86
19
65
141
11
121
22
5246
519
4457
232
18
193
45
3
19
23
594
90
479
247
26
211
95
77
274
16
244
19
587
54
484
1638
91
145
269
1099
87
21
66
509
50
438
61
13
145
104
39
118

0.8
0.7
0.8
0.7
0.9
0.7
0.6
0.8
0.8
0.6
0.8
1.0
0.8
0.7
0.9
0.9
0.5
0.9
0.9
0.6
1.0
0.9
1.1
1.1
1.1
0.8
0.7
0.8
0.9
0.8
0.8
0.4
0.8
0.6
0.8
0.6
0.8
0.8
0.5
0.6
0.8
0.8
0.8
0.6
0.9
0.9
0.7
0.9
1.1
0.7
0.8
0.9
0.9
0.7

0.17
0.07
0.06
0.13
0.07
0.09
0.15
0.11
0.07
0.18
0.08
0.22
0.01
0.03
0.01
0.07
0.12
0.08
0.14
0.35
0.23
0.22
0.05
0.12
0.06
0.05
0.14
0.06
0.11
0.10
0.05
0.10
0.06
0.15
0.03
0.08
0.04
0.02
0.06
0.05
0.05
0.03
0.09
0.14
0.12
0.04
0.10
0.05
0.14
0.22
0.07
0.09
0.15
0.08

0.06
0.06
0.07
0.05
0.07
0.06
0.04
0.07
0.07
0.05
0.07
0.07
0.07
0.05
0.07
0.08
0.04
0.08
0.07
0.04
0.07
0.07
0.09
0.09
0.10
0.06
0.05
0.06
0.07
0.07
0.06
0.03
0.06
0.05
0.06
0.04
0.07
0.06
0.04
0.05
0.07
0.07
0.06
0.05
0.07
0.07
0.06
0.08
0.09
0.05
0.07
0.08
0.06
0.07

0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.02
0.00
0.00
0.00
0.01
0.01
0.01
0.01
0.03
0.02
0.02
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.01
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.01
0.02
0.01
0.01
0.01
0.01

12
63
146
21
73
283
36
29
118
502
9
295
67
75
17
225
194
24
12
15
13
56
27
118
33

1.5
1.1
0.9
1.5
3.1
1.3
1.0
1.6
1.1
1.7
0.9
1.0
1.3
0.9
0.6
1.5
1.5
0.9
0.4
0.4
0.5
0.9
0.8
0.5
0.8

0.47
0.14
0.08
0.34
0.38
0.08
0.18
0.30
0.10
0.08
0.30
0.06
0.16
0.11
0.16
0.10
0.11
0.21
0.13
0.12
0.14
0.13
0.17
0.05
0.17

0.22
0.09
0.07
0.22
0.34
0.12
0.10
0.13
0.10
0.16
0.08
0.09
0.09
0.09
0.05
0.12
0.13
0.08
0.04
0.04
0.04
0.07
0.06
0.04
0.07

0.09
0.01
0.01
0.06
0.05
0.01
0.02
0.03
0.01
0.01
0.03
0.01
0.01
0.01
0.02
0.01
0.01
0.03
0.01
0.01
0.01
0.01
0.01
0.00
0.01

5
34
107
9
48
251
23
22
92
283
2
178
27
54
13
183
158
18
13
13
10
30
17
93
21

0.6
0.6
0.6
0.6
1.9
1.1
0.6
1.2
0.9
1.2
0.2
0.7
0.6
0.7
0.4
1.1
1.2
0.6
0.5
0.3
0.4
0.5
0.3
0.4
0.5

0.30
0.10
0.06
0.22
0.28
0.08
0.12
0.26
0.09
0.08
0.12
0.05
0.11
0.10
0.13
0.09
0.10
0.16
0.14
0.10
0.16
0.09
0.08
0.05
0.15

0.08
0.05
0.05
0.09
0.22
0.11
0.05
0.10
0.07
0.12
0.01
0.06
0.05
0.06
0.04
0.09
0.09
0.05
0.04
0.03
0.03
0.04
0.02
0.03
0.04

0.05
0.01 *
0.01
0.03 *
0.04
0.01 *
0.02 *
0.02 *
0.01
0.01 *
0.01
0.01
0.01 *
0.01 *
0.01 *
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

453

511

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Bone (C40-41) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

454

Female
ASR(W)
CUM 0-74

900
92
57
29
49
60
8
250
18
15
25
23
47
18
61
244
46
39
3
4
30
12
20
34
95

1.0
1.1
1.0
0.9
1.5
1.0
1.1
1.1
1.0
0.6
1.9
1.0
0.9
0.7
1.3
2.7
0.6
0.6
0.3
0.4
0.8
0.6
0.6
1.0
1.1

0.03
0.12
0.14
0.18
0.22
0.13
0.39
0.08
0.27
0.18
0.68
0.23
0.14
0.18
0.17
0.20
0.08
0.10
0.21
0.22
0.16
0.18
0.14
0.17
0.11

0.08
0.08
0.08
0.10
0.13
0.07
0.14
0.09
0.08
0.03
0.09
0.11
0.08
0.07
0.10
0.28
0.05
0.06
0.04
0.05
0.06
0.05
0.04
0.09
0.09

0.00
0.01
0.01
0.03
0.02
0.01
0.06
0.01
0.03
0.01
0.03
0.03
0.02
0.03
0.02
0.03
0.01
0.01
0.02
0.03
0.01
0.02
0.01
0.02
0.01

722
81
52
30
22
57
7
187
21
15
11
20
36
16
57
203
49
41
4
4
19
17
14
24
57

0.7
0.8
0.9
0.9
0.7
0.9
0.8
0.8
1.2
0.9
1.0
0.8
0.7
0.4
1.5
2.0
0.6
0.6
0.9
0.4
0.6
0.8
0.4
0.7
0.7

0.03
0.10
0.13
0.16
0.14
0.13
0.33
0.06
0.26
0.26
0.40
0.18
0.12
0.11
0.22
0.15
0.08
0.10
0.49
0.22
0.14
0.20
0.12
0.15
0.09

0.06
0.07
0.07
0.07
0.05
0.08
0.08
0.06
0.10
0.09
0.11
0.07
0.05
0.03
0.12
0.21
0.04
0.04
0.04
0.02
0.03
0.08
0.04
0.07
0.05

0.00
0.01
0.01
0.02
0.01
0.01
0.03
0.01
0.03
0.03
0.06
0.02
0.01
0.01 *
0.02 *
0.02 *
0.01
0.01
0.03
0.01
0.01 *
0.02 *
0.01
0.02 *
0.01 *

199
17
9
345
37
178
270
388
309
132
48
131
18
17
15
16
25
38
18
16
16
14
15
95
128
32
45
45
53
29
13
107
6
21
15
41
14
6
30
20
26
52
17
7
17
23
35
7
8
10
36
28
15
39

1.0
0.9
1.0
1.3
0.8
1.3
1.1
3.2
1.1
1.0
1.4
0.9
0.7
1.0
1.2
0.9
1.1
1.3
0.5
1.3
1.2
1.2
1.0
1.3
0.9
0.7
0.8
0.7
0.8
1.3
1.8
1.1
1.3
1.4
1.1
1.5
1.2
1.3
1.2
0.9
1.9
1.0
1.4
0.8
1.4
0.9
1.3
0.5
0.9
2.0
1.2
1.3
1.0
0.9

0.08
0.22
0.35
0.07
0.14
0.11
0.07
0.18
0.06
0.09
0.20
0.08
0.17
0.26
0.32
0.23
0.24
0.23
0.13
0.33
0.30
0.38
0.27
0.14
0.09
0.15
0.14
0.12
0.11
0.26
0.50
0.11
0.65
0.34
0.38
0.28
0.38
0.59
0.26
0.24
0.39
0.16
0.46
0.34
0.37
0.22
0.25
0.19
0.36
0.71
0.23
0.30
0.27
0.16

0.08
0.10
0.07
0.12
0.07
0.11
0.10
0.28
0.09
0.07
0.12
0.07
0.06
0.08
0.09
0.07
0.08
0.11
0.05
0.11
0.09
0.09
0.08
0.11
0.08
0.06
0.08
0.06
0.06
0.09
0.17
0.08
0.09
0.11
0.10
0.10
0.08
0.11
0.10
0.11
0.12
0.08
0.12
0.06
0.12
0.07
0.09
0.04
0.07
0.14
0.12
0.11
0.11
0.07

0.01
0.03
0.03
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.02
0.01
0.01
0.02
0.02
0.02
0.02
0.02
0.01
0.03
0.02
0.03
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.05
0.01
0.04
0.03
0.03
0.02
0.02
0.05
0.02
0.02
0.03
0.01
0.04
0.03
0.03
0.02
0.02
0.02
0.03
0.05
0.02
0.02
0.03
0.01

159
18
1
282
28
135
205
311
234
102
33
103
14
22
15
19
17
38
24
9
13
8
16
85
132
34
46
60
62
21
1
78
5
13
5
37
14
4
29
13
19
50
18
9
13
28
28
5
3
6
23
34
9
32

0.7
1.1
0.2
0.9
0.6
1.0
0.8
2.3
0.7
0.7
0.8
0.6
0.6
1.3
1.1
0.8
0.7
1.2
0.6
0.5
0.8
0.6
0.9
1.0
1.0
0.8
0.9
1.0
1.0
0.8
0.2
0.7
0.6
0.7
1.3
1.0
0.9
0.4
0.7
0.7
1.3
0.9
1.1
1.0
1.1
1.1
1.0
0.3
0.5
1.8
0.9
1.3
0.3
0.6

0.07
0.29
0.16
0.06
0.12
0.09
0.07
0.15
0.05
0.08
0.16
0.07
0.17
0.30
0.29
0.21
0.18
0.21
0.13
0.19
0.26
0.28
0.25
0.14
0.12
0.16
0.14
0.15
0.14
0.20
0.15
0.09
0.31
0.23
0.63
0.22
0.37
0.22
0.19
0.24
0.32
0.15
0.30
0.36
0.39
0.29
0.24
0.15
0.32
0.79
0.26
0.29
0.13
0.15

0.06
0.09
0.01
0.07
0.05
0.08
0.07
0.18
0.06
0.06
0.06
0.05
0.04
0.09
0.08
0.07
0.05
0.10
0.04
0.06
0.08
0.04
0.07
0.09
0.08
0.06
0.07
0.07
0.07
0.06
0.01
0.06
0.04
0.07
0.08
0.09
0.07
0.05
0.06
0.06
0.10
0.07
0.11
0.07
0.07
0.07
0.07
0.03
0.04
0.12
0.07
0.11
0.03
0.05

0.00
0.02
0.01
0.00 *
0.01 *
0.01
0.01 *
0.01
0.00
0.01
0.01
0.01
0.01
0.02
0.02
0.02
0.01
0.02
0.01
0.02
0.02
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.03
0.02
0.03
0.02
0.02
0.03
0.01
0.02
0.02
0.01
0.03
0.03
0.02
0.02
0.02
0.01
0.02
0.05
0.02
0.02
0.01
0.01

*Important. See note on population page.

512

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Bone (C40-41) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

85
126
9
127
21
42
39
92
108
106
370
207
50
8
41
59
36
3
25
22
30
16
10
31
234
10
6
2
18
10
7
14
423
34
19
65
128
91
138
58
226
366
107
132
26
129

1.3
1.3
1.0
1.1
1.0
1.1
0.9
1.1
1.3
1.0
2.7
1.5
0.9
1.2
1.4
1.4
0.9
0.4
2.0
1.0
1.0
1.1
0.9
1.4
1.0
0.9
0.8
0.8
1.2
1.3
1.0
1.1
1.0
1.1
0.7
0.8
1.7
0.9
0.8
0.7
1.2
1.1
0.9
1.0
0.6
1.1

0.14
0.12
0.37
0.10
0.22
0.17
0.15
0.12
0.14
0.11
0.16
0.11
0.13
0.46
0.24
0.21
0.16
0.34
0.45
0.24
0.20
0.30
0.30
0.30
0.07
0.31
0.35
0.54
0.29
0.44
0.38
0.32
0.05
0.21
0.17
0.11
0.16
0.10
0.08
0.10
0.09
0.06
0.10
0.09
0.12
0.10

0.13
0.13
0.07
0.08
0.09
0.11
0.07
0.10
0.11
0.08
0.26
0.14
0.08
0.11
0.11
0.11
0.07
0.03
0.14
0.09
0.08
0.09
0.06
0.11
0.08
0.06
0.10
0.04
0.10
0.10
0.09
0.08
0.08
0.10
0.07
0.07
0.15
0.07
0.06
0.06
0.10
0.08
0.06
0.07
0.05
0.08

0.02
0.01
0.02
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.04
0.02
0.02
0.01
0.02
0.03
0.02
0.01
0.02
0.02
0.02
0.01
0.02
0.05
0.03
0.03
0.03
0.04
0.02
0.00
0.02
0.02
0.01
0.02
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01

64
104
7
111
15
38
28
85
88
85
260
146
47
7
26
33
22
4
17
11
29
8
15
32
164
13
1
3
17
10
5
14
389
27
14
45
138
59
114
56
225
286
98
114
23
93

0.8
0.8
0.8
0.9
0.7
1.0
0.4
1.0
0.9
0.5
1.7
0.9
0.7
0.7
0.7
0.6
0.6
0.5
1.0
0.4
1.0
0.5
1.4
1.3
0.7
1.3
0.1
0.9
1.1
1.1
0.7
1.0
0.9
1.1
0.5
0.5
1.4
0.5
0.6
0.8
1.0
0.8
0.7
0.8
0.4
0.6

0.12
0.09
0.31
0.10
0.19
0.17
0.09
0.12
0.12
0.07
0.12
0.08
0.12
0.29
0.17
0.12
0.13
0.30
0.27
0.14
0.21
0.20
0.40
0.27
0.06
0.39
0.14
0.55
0.31
0.43
0.31
0.29
0.05
0.24
0.16
0.09
0.14
0.08
0.06
0.12
0.08
0.05
0.09
0.08
0.10
0.08

0.07
0.07
0.05
0.07
0.05
0.08
0.04
0.08
0.07
0.05
0.16
0.08
0.06
0.07
0.06
0.05
0.04
0.03
0.08
0.03
0.07
0.03
0.10
0.10
0.05
0.10
0.01
0.06
0.07
0.09
0.06
0.07
0.07
0.09
0.05
0.04
0.13
0.04
0.05
0.06
0.08
0.06
0.05
0.06
0.03
0.05

0.01
0.01
0.02
0.01
0.01 *
0.01
0.01
0.01 *
0.01
0.01
0.01
0.01
0.01
0.03
0.01
0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.03
0.02
0.00
0.03
0.01
0.03
0.02
0.03
0.03
0.02
0.00
0.02
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.00
0.01
0.01
0.01
0.01

178
2
100
49
8
128
43
8
17
133
33
0
5
6
6
11

1.0
0.4
1.1
1.3
0.7
1.0
0.8
0.9
3.0
1.3
1.0
0.9
1.1
1.3
1.0

0.08
0.29
0.11
0.19
0.25
0.09
0.13
0.34
0.77
0.12
0.19
0.40
0.44
0.62
0.31

0.08
0.02
0.09
0.10
0.06
0.08
0.08
0.08
0.35
0.10
0.09
0.10
0.10
0.10
0.09

0.01
0.02
0.01
0.02
0.02
0.01
0.01
0.03
0.12
0.01
0.02
0.05
0.06
0.04
0.03

144
4
87
34
7
99
47
5
12
87
19
2
2
3
4
5

0.8
0.8
0.9
0.7
0.5
0.8
0.9
0.6
1.9
0.9
0.6
0.8
0.4
0.5
1.0
0.8

0.07
0.40
0.11
0.14
0.21
0.08
0.14
0.28
0.57
0.10
0.16
0.53
0.28
0.27
0.54
0.41

0.06
0.07
0.07
0.06
0.04
0.06
0.08
0.05
0.14
0.07
0.04
0.08
0.03
0.03
0.07
0.05

0.01
0.04
0.01
0.01
0.02
0.01
0.01
0.02
0.04
0.01
0.01
0.06
0.02
0.02
0.04
0.02

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

455

513

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Melanoma of skin (C43)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

5
15
5
9
15

0.2
0.3
0.6
0.9
0.9

0.11
0.10
0.25
0.37
0.28

27
102
16
69
1392
16
124
188
73
18
16

3.3
4.2
2.7
4.4
6.5
1.8
3.5
2.4
2.5
1.4
1.8

0.66
0.46
0.70
0.55
0.20
0.46
0.33
0.18
0.30
0.35
0.47

0.34
0.57
0.35
0.46
0.70
0.19
0.35
0.25
0.24
0.15
0.25

8496
945
1550
352
283
116
6
458
4438
62
286
1557
17
1420
149
2636
15400
100
57
536
13688
2657
9
15
4
1
67
2391
3197
24
12
6
6
2
185
2737
2176
2053
7
1971
123
8
108
8811
41
8590
3205
46
3080
1229
15
1181
671
4084
28
3832
2336
1357
2145
1179
30
1129
9
183

10.9
10.3
10.8
9.1
11.3
6.4
5.9
14.0
11.4
12.6
8.0
10.8
0.6
12.4
8.8
15.4
15.2
0.9
1.0
2.9
22.0
12.9
0.6
0.9
0.4
0.1
2.6
19.3
11.9
1.0
1.2
0.8
1.1
0.3
2.8
21.7
16.9
18.0
0.9
19.0
7.1
0.8
17.3
13.7
0.8
15.1
14.1
1.0
17.7
17.3
0.9
23.8
16.8
10.6
0.6
11.7
12.2
13.7
16.7
8.6
0.9
11.3
1.0
9.0

0.12
0.34
0.28
0.51
0.69
0.61
2.59
0.68
0.18
1.65
0.50
0.28
0.15
0.34
0.76
0.31
0.13
0.09
0.13
0.13
0.20
0.26
0.21
0.24
0.19
0.15
0.34
0.41
0.22
0.21
0.37
0.34
0.51
0.25
0.22
0.44
0.37
0.42
0.37
0.45
0.66
0.28
1.72
0.16
0.12
0.18
0.25
0.15
0.32
0.51
0.25
0.71
0.67
0.17
0.12
0.20
0.26
0.39
0.37
0.26
0.16
0.35
0.33
0.70

1.21
1.11
1.17
1.00
1.24
0.66
0.68
1.62
1.28
1.29
0.89
1.22
0.07
1.39
0.94
1.72
1.70
0.10
0.10
0.32
2.44
1.46
0.05
0.12
0.03
0.31
2.18
1.35
0.12
0.15
0.10
0.12
0.01
0.30
2.43
1.85
2.06
0.11
2.17
0.80
0.11
1.98
1.53
0.09
1.69
1.63
0.11
2.02
1.99
0.08
2.72
1.83
1.21
0.08
1.34
1.37
1.49
1.83
0.94
0.09
1.22
0.13
1.02

456

Female
ASR(W)
CUM 0-74

11
14
5
16
28

0.4
0.3
0.5
1.4
2.3

0.14
0.07
0.22
0.40
0.50

0.08
0.08
0.10
0.07
0.03
0.06
0.04
0.02
0.04
0.05
0.08

29
122
15
93
1687
32
135
173
96
19
23

2.9
4.2
2.0
4.5
5.7
3.5
2.9
2.1
2.8
1.1
2.1

0.60
0.43
0.53
0.49
0.16
0.62
0.27
0.17
0.31
0.27
0.45

0.32
0.46
0.23
0.47
0.61
0.39
0.34
0.23
0.31
0.14
0.27

0.07
0.06
0.08
0.06
0.02
0.08
0.04
0.02
0.04
0.04
0.07 *

0.02
0.04
0.04
0.06
0.09
0.07
0.35
0.09
0.02
0.21
0.06
0.04
0.02
0.04
0.10
0.04
0.02
0.01
0.02
0.02
0.03
0.04
0.03
0.04
0.02
0.05
0.06
0.03
0.03
0.05
0.05
0.06
0.01
0.03
0.06
0.05
0.06
0.05
0.06
0.09
0.04
0.24
0.02
0.02
0.02
0.04
0.02
0.04
0.07
0.03
0.10
0.08
0.02
0.02
0.03
0.03
0.05
0.05
0.03
0.02
0.04
0.05
0.09

7658
948
1329
285
298
129
4
441
3834
78
312
1180
17
1045
115
1697
11330
111
44
689
9605
1995
6
13
4
4
114
1711
2389
20
7
7
5
6
236
1947
1727
1665
5
1595
92
4
79
5923
68
5726
2478
44
2351
946
17
907
488
3133
34
2916
1862
1262
1796
890
35
834
10
135

9.3
10.0
8.9
7.0
11.1
6.7
5.3
12.5
9.2
15.7
8.5
7.4
0.5
8.8
6.7
9.7
10.3
0.8
0.6
3.1
15.7
8.9
0.3
0.6
0.3
0.8
4.0
13.8
7.9
0.6
0.4
0.7
0.9
1.2
2.6
16.2
12.6
13.3
0.5
14.3
4.3
0.1
11.6
8.9
0.9
10.2
9.3
0.6
12.6
10.7
0.6
16.6
11.6
7.3
0.5
8.4
9.0
12.6
13.0
5.7
0.7
7.9
0.6
6.6

0.11
0.34
0.26
0.44
0.68
0.62
2.88
0.63
0.16
1.89
0.52
0.23
0.12
0.29
0.66
0.25
0.10
0.08
0.10
0.12
0.18
0.21
0.14
0.17
0.16
0.41
0.39
0.37
0.17
0.14
0.17
0.28
0.44
0.61
0.18
0.41
0.32
0.35
0.25
0.39
0.47
0.08
1.40
0.13
0.12
0.15
0.19
0.10
0.27
0.36
0.15
0.57
0.56
0.14
0.09
0.17
0.22
0.39
0.32
0.20
0.12
0.30
0.19
0.62

0.96
1.00
0.92
0.74
1.20
0.76
0.68
1.33
0.95
1.69
0.86
0.74
0.06
0.87
0.69
0.98
1.06
0.07
0.07
0.33
1.58
0.92
0.02
0.05
0.03
0.08
0.41
1.42
0.82
0.08
0.03
0.08
0.10
0.10
0.27
1.64
1.23
1.40
0.05
1.50
0.43
0.03
1.24
0.93
0.11
1.05
0.97
0.06
1.28
1.13
0.08
1.70
1.18
0.75
0.04
0.86
0.89
1.23
1.29
0.57
0.07
0.78
0.06
0.64

0.01
0.04
0.03
0.05
0.08
0.08
0.41
0.07
0.02
0.22
0.06
0.02
0.02
0.03
0.08
0.03
0.01
0.01
0.01
0.02
0.02
0.02
0.01
0.02
0.02
0.05
0.05
0.04
0.02
0.02
0.01
0.03
0.05
0.05
0.02
0.04
0.03
0.04
0.03
0.04
0.05
0.02
0.18
0.01
0.02
0.02
0.02
0.01
0.03
0.04
0.03
0.07
0.06
0.02
0.01
0.02
0.02
0.04
0.03
0.02
0.02
0.03
0.03
0.06

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

514

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Melanoma of skin (C43) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

706
3140
4579
36
4343
1721
21
1679
1781
8
1751
395
93718
462
89053
3941
16
3863
824
8
44
771
5706
53
5589
4566
25
4153
1192
2108
5533
20
5175
640
12579
58
12120
33579
174
162
734
31093
1823
17
1763
6036
25
5664
968
428
3235
2168
855
2002

15.7
15.0
14.5
1.0
15.8
13.7
0.8
17.4
9.8
0.5
10.6
12.7
13.1
0.7
14.4
14.2
0.5
16.6
14.2
2.1
2.4
23.7
9.3
0.8
10.9
12.4
0.8
12.6
10.3
18.5
12.7
0.6
13.1
18.2
15.1
0.8
17.9
14.8
1.0
0.9
3.0
19.4
14.4
0.6
18.4
10.2
0.5
10.9
16.7
20.6
17.2
16.9
13.2
11.3

0.62
0.28
0.22
0.18
0.25
0.34
0.19
0.44
0.24
0.19
0.27
0.67
0.04
0.03
0.05
0.24
0.14
0.28
0.51
0.77
0.36
0.91
0.13
0.11
0.15
0.19
0.16
0.20
0.31
0.42
0.18
0.15
0.19
0.76
0.14
0.11
0.17
0.08
0.08
0.07
0.12
0.12
0.35
0.15
0.45
0.13
0.09
0.15
0.56
1.03
0.31
0.38
0.47
0.26

1.69
1.69
1.61
0.10
1.75
1.52
0.09
1.91
1.08
0.04
1.18
1.40
1.46
0.08
1.61
1.63
0.05
1.90
1.59
0.20
0.28
2.58
1.05
0.09
1.24
1.37
0.08
1.39
1.15
2.08
1.42
0.07
1.45
2.11
1.69
0.09
2.00
1.65
0.11
0.09
0.33
2.15
1.62
0.07
2.03
1.13
0.04
1.20
1.79
2.20
1.93
1.89
1.45
1.26

0.08
0.04
0.03
0.02
0.03
0.04
0.03
0.06
0.03
0.02
0.03
0.08
0.01
0.00
0.01
0.03
0.01
0.04
0.07
0.09
0.05
0.11
0.02
0.02
0.02
0.02
0.02
0.03
0.04
0.05
0.02
0.02
0.02
0.10
0.02
0.02
0.02
0.01
0.01
0.01
0.02
0.01
0.04
0.02
0.06
0.02
0.01
0.02
0.07
0.13
0.04
0.05
0.06
0.03

576
2716
3804
29
3590
1428
18
1392
1271
10
1232
307
71525
545
67236
3099
24
3023
583
3
72
504
4554
73
4434
3779
23
3426
831
1764
4297
17
3997
453
10207
55
9791
26085
190
160
942
23543
1392
35
1306
4277
49
3921
781
361
2810
1922
668
1591

11.8
11.5
11.4
0.7
12.9
10.5
0.6
14.2
6.2
0.4
6.8
9.7
9.2
0.6
10.3
9.7
0.6
11.8
9.7
0.8
3.5
16.5
6.4
0.7
7.8
9.6
0.5
9.9
6.5
15.5
9.4
0.4
9.9
11.1
11.4
0.6
14.1
10.5
0.9
0.6
3.2
14.4
10.0
0.8
13.4
6.4
0.6
6.8
13.0
17.4
14.5
14.3
9.9
8.7

0.54
0.24
0.20
0.13
0.23
0.29
0.14
0.41
0.19
0.15
0.21
0.60
0.04
0.03
0.04
0.19
0.12
0.24
0.42
0.45
0.42
0.81
0.10
0.08
0.13
0.17
0.11
0.18
0.24
0.39
0.16
0.10
0.17
0.57
0.12
0.08
0.15
0.07
0.06
0.05
0.11
0.10
0.28
0.15
0.39
0.10
0.09
0.12
0.48
0.96
0.29
0.34
0.42
0.23

1.16
1.20
1.13
0.08
1.26
1.03
0.06
1.38
0.61
0.04
0.67
0.97
0.94
0.07
1.05
1.03
0.07
1.23
0.98
0.10
0.37
1.60
0.67
0.07
0.82
0.96
0.06
0.99
0.68
1.53
0.96
0.07
1.00
1.17
1.16
0.06
1.42
1.08
0.08
0.07
0.34
1.45
1.03
0.11
1.35
0.64
0.07
0.69
1.34
1.75
1.45
1.43
0.98
0.89

0.06
0.03
0.02
0.02
0.02
0.03
0.02
0.04
0.02
0.02
0.02
0.06
0.00
0.00
0.00
0.02
0.02
0.03
0.05
0.06
0.05
0.08
0.01
0.01
0.01
0.02
0.02
0.02
0.03
0.04
0.02
0.02
0.02
0.07
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.03
0.02
0.04
0.01
0.01
0.01
0.06
0.10
0.03
0.04
0.04
0.03

2
45
150
2
2
107
7
59
24
58
4
61
13
0
5
1774
1701
23
18
17
17
48
36
129
23

0.4
0.8
0.7
0.1
0.1
0.4
0.2
2.9
0.3
0.3
0.5
0.3
0.4
0.2
11.2
12.2
1.4
0.5
0.4
0.5
0.5
0.7
0.4
0.4

0.25
0.12
0.06
0.10
0.05
0.05
0.08
0.39
0.05
0.04
0.23
0.04
0.10
0.09
0.27
0.30
0.32
0.12
0.11
0.13
0.09
0.13
0.04
0.09

0.05
0.10
0.07
0.01
0.01
0.05
0.03
0.36
0.03
0.03
0.06
0.03
0.04
0.02
1.24
1.33
0.17
0.05
0.03
0.05
0.05
0.06
0.04
0.04

0.05
0.02
0.01
0.01
0.01
0.01
0.01
0.05
0.01
0.01
0.03
0.00
0.01
0.01
0.04
0.04
0.04
0.01
0.01
0.01
0.01
0.01
0.00
0.01

1
28
129
4
5
91
7
82
28
44
1
48
3
0
9
1726
1681
16
22
14
28
45
41
87
32

0.2
0.5
0.6
0.3
0.2
0.3
0.2
3.3
0.3
0.2
0.1
0.2
0.1
0.3
9.5
10.5
0.8
0.6
0.3
0.7
0.5
0.5
0.2
0.5

0.18
0.09
0.05
0.14
0.09
0.04
0.06
0.39
0.06
0.04
0.09
0.04
0.05
0.09
0.24
0.27
0.22
0.12
0.11
0.13
0.08
0.09
0.03
0.12

0.05
0.05
0.06
0.05
0.03
0.04
0.02
0.36
0.04
0.03
0.03
0.01
0.03
0.99
1.09
0.08
0.05
0.03
0.06
0.04
0.04
0.02
0.05

0.05
0.01 *
0.01
0.03 *
0.02
0.00 *
0.01 *
0.05 *
0.01
0.01 *
0.01
0.00 *
- *
0.01 *
0.03
0.03
0.03
0.01
0.01
0.01
0.01
0.01
0.00
0.01

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

457

515

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Melanoma of skin (C43) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

458

Female
ASR(W)
CUM 0-74

465
42
37
9
18
23
3
123
11
2
10
9
39
6
16
55
34
26
2
6
27
18
13
32
107

0.5
0.5
0.7
0.3
0.7
0.5
0.4
0.6
0.5
0.2
0.6
0.5
1.2
0.4
0.5
0.8
0.4
0.4
0.4
0.7
0.6
0.8
0.5
1.0
1.3

0.02
0.09
0.11
0.11
0.16
0.10
0.21
0.06
0.14
0.17
0.27
0.17
0.19
0.16
0.13
0.12
0.07
0.08
0.25
0.29
0.13
0.20
0.13
0.18
0.12

0.06
0.06
0.08
0.04
0.10
0.07
0.05
0.06
0.04
0.02
0.10
0.02
0.16
0.05
0.05
0.10
0.04
0.04
0.04
0.05
0.06
0.10
0.04
0.12
0.14

0.00
0.01
0.02
0.02
0.03
0.02
0.03
0.01
0.01
0.02
0.06
0.01
0.03
0.02
0.02
0.02
0.01
0.01
0.03
0.03
0.01
0.03
0.02
0.03
0.02

490
38
22
26
19
27
3
124
13
4
3
9
16
6
6
47
35
32
0
3
16
7
13
47
86

0.4
0.3
0.3
0.8
0.5
0.4
0.2
0.5
0.5
0.3
0.3
0.4
0.5
0.3
0.3
0.6
0.4
0.4
0.2
0.4
0.3
0.4
1.5
1.0

0.02
0.06
0.07
0.16
0.12
0.08
0.15
0.04
0.16
0.18
0.23
0.14
0.12
0.15
0.12
0.08
0.06
0.07
0.13
0.10
0.10
0.12
0.22
0.11

0.05
0.04
0.03
0.08
0.05
0.04
0.03
0.06
0.05
0.03
0.03
0.05
0.06
0.03
0.03
0.06
0.04
0.04
0.04
0.06
0.02
0.06
0.17
0.11

0.00
0.01
0.01
0.02
0.01
0.01
0.02
0.01
0.02
0.02
0.03
0.02
0.02
0.02 *
0.01 *
0.01 *
0.01
0.01
0.03
0.02 *
0.01 *
0.02
0.03 *
0.01 *

2407
278
135
782
289
958
822
1044
3457
2303
222
1664
375
104
120
258
236
261
373
124
110
89
159
721
1497
629
406
1113
726
336
78
860
76
186
99
441
177
63
449
178
59
772
136
39
104
395
148
56
56
36
399
196
141
568

8.6
13.0
12.4
2.7
4.6
5.5
2.7
6.9
9.9
11.9
5.3
8.8
11.3
4.7
7.4
10.7
7.1
7.2
9.8
6.7
6.2
6.2
7.3
7.4
8.6
9.7
6.4
12.7
8.0
8.1
9.3
7.4
9.8
8.4
6.4
9.8
7.9
9.6
10.4
7.0
3.9
9.5
7.8
3.8
6.1
10.0
5.0
3.4
4.6
5.4
10.7
5.6
7.8
9.4

0.18
0.80
1.08
0.10
0.28
0.18
0.10
0.22
0.17
0.26
0.36
0.22
0.59
0.48
0.70
0.69
0.49
0.45
0.52
0.65
0.62
0.74
0.62
0.28
0.23
0.40
0.32
0.40
0.31
0.46
1.08
0.26
1.21
0.64
0.70
0.51
0.66
1.32
0.53
0.57
0.51
0.36
0.75
0.64
0.67
0.55
0.42
0.47
0.64
0.92
0.57
0.44
0.67
0.41

0.93
1.38
1.35
0.30
0.49
0.58
0.30
0.74
1.13
1.30
0.59
0.97
1.24
0.50
0.79
1.15
0.75
0.78
1.03
0.69
0.65
0.67
0.78
0.85
0.95
1.08
0.73
1.40
0.83
0.89
0.97
0.77
0.96
0.92
0.66
1.02
0.84
0.97
1.08
0.76
0.43
1.02
0.84
0.37
0.60
1.05
0.52
0.36
0.53
0.61
1.19
0.60
0.85
1.05

0.02
0.09
0.13
0.01
0.03
0.02
0.01
0.03
0.02
0.03
0.04
0.03
0.07
0.06
0.08
0.08
0.06
0.06
0.06
0.07
0.07
0.08
0.07
0.04
0.03
0.05
0.04
0.05
0.03
0.05
0.13
0.03
0.13
0.08
0.08
0.05
0.07
0.13
0.06
0.06
0.06
0.04
0.08
0.07
0.07
0.06
0.05
0.05
0.08
0.12
0.07
0.05
0.08
0.05

2570
284
159
1422
371
1543
790
1034
3586
2811
400
1626
432
165
180
304
252
323
505
205
124
114
227
759
1564
739
506
1078
930
334
153
1397
83
183
129
500
189
79
441
166
57
947
126
53
127
353
154
56
56
72
425
209
158
638

7.8
11.4
12.9
3.5
5.9
8.8
2.4
5.8
8.8
14.1
6.6
7.5
12.1
6.3
9.5
11.5
7.3
8.4
11.8
9.8
5.7
7.5
10.4
7.0
8.0
10.5
7.0
11.5
10.1
7.8
19.0
11.0
10.1
8.2
7.9
10.6
7.4
11.4
9.7
6.3
3.4
10.6
7.1
4.4
6.7
9.3
5.1
3.3
4.7
9.5
11.4
6.2
7.6
10.0

0.17
0.74
1.09
0.10
0.34
0.25
0.09
0.19
0.16
0.29
0.36
0.20
0.61
0.55
0.77
0.72
0.50
0.49
0.57
0.79
0.56
0.81
0.80
0.28
0.23
0.43
0.34
0.38
0.37
0.49
1.57
0.31
1.28
0.69
0.82
0.54
0.68
1.41
0.52
0.54
0.46
0.39
0.73
0.67
0.69
0.57
0.44
0.46
0.69
1.22
0.63
0.51
0.66
0.44

0.79
1.09
1.28
0.38
0.60
0.87
0.24
0.58
0.93
1.43
0.71
0.80
1.21
0.68
0.96
1.16
0.77
0.83
1.19
0.98
0.59
0.77
1.01
0.75
0.83
1.08
0.73
1.17
0.94
0.78
1.71
1.14
1.03
0.79
0.80
1.01
0.71
1.10
0.97
0.64
0.34
1.07
0.71
0.45
0.69
0.87
0.48
0.33
0.45
1.03
1.11
0.60
0.79
1.00

0.02
0.08
0.12
0.01 *
0.03 *
0.02
0.01 *
0.02
0.02
0.03
0.04
0.02
0.06
0.06
0.08
0.08
0.05
0.05
0.06
0.08
0.06
0.08
0.08
0.03
0.02
0.04
0.04
0.04
0.03
0.05
0.15
0.04
0.13
0.07
0.08
0.05
0.06
0.14
0.05
0.06
0.05
0.04
0.07
0.07
0.07
0.05
0.04
0.05
0.07
0.14
0.06
0.05
0.07
0.04

*Important. See note on population page.

516

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Melanoma of skin (C43) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

238
385
72
2305
137
151
259
259
367
523
642
1006
595
55
152
308
181
31
114
112
239
143
113
129
4232
269
97
104
230
148
110
371
5348
327
285
882
580
988
1570
892
2772
2977
1064
1303
395
1471

3.2
3.7
5.5
14.2
5.7
3.7
4.4
2.6
3.7
3.8
4.0
6.4
9.0
5.0
3.4
4.9
3.9
3.3
5.2
4.3
6.5
6.6
6.4
4.0
11.9
18.5
11.5
18.6
12.8
12.4
11.8
16.6
10.0
9.4
8.9
8.8
6.9
6.8
6.9
9.8
10.7
6.2
6.1
6.9
7.5
8.4

0.21
0.19
0.67
0.31
0.50
0.31
0.28
0.17
0.20
0.17
0.16
0.20
0.37
0.73
0.30
0.29
0.30
0.72
0.53
0.43
0.43
0.58
0.66
0.39
0.20
1.17
1.22
1.93
0.88
1.07
1.17
0.90
0.14
0.53
0.55
0.31
0.30
0.23
0.18
0.34
0.22
0.12
0.20
0.20
0.39
0.23

0.35
0.43
0.64
1.58
0.71
0.41
0.51
0.27
0.41
0.42
0.43
0.74
0.98
0.52
0.37
0.52
0.39
0.35
0.51
0.42
0.69
0.72
0.68
0.40
1.34
1.95
1.10
1.95
1.41
1.39
1.13
1.77
1.06
0.98
0.93
0.94
0.72
0.71
0.74
1.08
1.16
0.66
0.64
0.73
0.78
0.88

0.03
0.02
0.09
0.04
0.07
0.04
0.04
0.02
0.02
0.02
0.02
0.03
0.05
0.08
0.04
0.03
0.03
0.08
0.06
0.04
0.05
0.07
0.07
0.04
0.02
0.14
0.13
0.21
0.11
0.13
0.13
0.11
0.02
0.06
0.06
0.04
0.03
0.03
0.02
0.04
0.03
0.01
0.02
0.02
0.05
0.03

464
728
70
2472
166
190
341
412
550
1055
663
1191
686
57
272
447
242
28
142
147
276
149
146
148
4267
293
109
97
247
176
157
448
7164
430
386
1020
831
1364
2153
1212
3267
3802
1345
1608
607
1954

4.2
5.2
5.1
14.6
5.6
4.0
4.6
3.5
4.8
4.8
3.8
6.3
8.7
4.8
5.8
6.6
4.8
2.0
6.6
4.8
7.0
7.5
8.7
4.2
12.1
19.0
13.2
15.4
12.7
14.3
16.5
19.6
12.9
12.9
12.6
9.8
9.4
9.1
8.9
12.6
11.9
7.1
7.5
8.2
10.2
10.1

0.21
0.21
0.64
0.32
0.46
0.30
0.27
0.19
0.22
0.16
0.16
0.19
0.36
0.72
0.39
0.34
0.32
0.47
0.61
0.43
0.45
0.68
0.83
0.40
0.21
1.20
1.38
1.71
0.88
1.20
1.41
1.01
0.16
0.66
0.69
0.33
0.36
0.27
0.21
0.39
0.24
0.13
0.22
0.22
0.45
0.25

0.45
0.57
0.53
1.53
0.55
0.44
0.50
0.35
0.51
0.52
0.39
0.66
0.92
0.52
0.61
0.65
0.52
0.25
0.72
0.49
0.69
0.70
0.77
0.41
1.26
1.83
1.29
1.52
1.33
1.33
1.66
1.99
1.27
1.26
1.21
1.03
0.91
0.89
0.87
1.26
1.23
0.73
0.74
0.82
1.02
0.99

0.02
0.02
0.07
0.04
0.05 *
0.04
0.03
0.02 *
0.02
0.02
0.02
0.02
0.04
0.08
0.04
0.03
0.04
0.06
0.07
0.05
0.05
0.06
0.07
0.04
0.02
0.12
0.14
0.17
0.10
0.11
0.15
0.11
0.02
0.07
0.07
0.04
0.04
0.03
0.02
0.04
0.03
0.01
0.02
0.02
0.05
0.03

8624
127
6504
1658
498
4434
2658
294
15
4284
564
1
7
13
22
483

38.5
25.4
55.8
31.0
30.8
27.3
44.5
32.4
3.1
34.8
13.6
0.3
1.0
2.4
2.2
41.1

0.43
2.44
0.71
0.79
1.44
0.42
0.88
1.93
0.83
0.55
0.60
0.33
0.41
0.68
0.55
1.95

4.31
2.88
6.14
3.31
3.42
2.98
4.88
3.69
0.36
3.86
1.53
0.03
0.16
0.29
0.24
4.66

0.06
0.35
0.09
0.10
0.18
0.05
0.11
0.26
0.11
0.07
0.08
0.03
0.07
0.10
0.06
0.26

6068
100
4821
1427
518
3977
1927
254
20
4140
356
4
6
10
19
278

26.5
21.7
41.1
25.7
32.4
23.4
31.5
26.0
4.7
31.4
8.3
0.9
1.0
1.6
1.4
26.3

0.36
2.34
0.62
0.74
1.51
0.39
0.75
1.69
1.08
0.51
0.47
0.49
0.41
0.50
0.45
1.68

2.79
2.16
4.18
2.58
3.33
2.42
3.21
2.76
0.67
3.30
0.87
0.11
0.11
0.15
0.15
2.86

0.04
0.30
0.07
0.08
0.16
0.05
0.09
0.21
0.18
0.06
0.05
0.06
0.05
0.06
0.04
0.20

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

459

517

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other skin (C44)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

154
262
133
50
64

7.7
6.8
13.4
3.9
2.9

0.64
0.44
1.19
0.72
0.48

164
2474
431
2703
19192
145
26
3175
796
192
196

18.9
120.1
69.9
198.1
94.8
15.6
0.7
42.5
29.1
16.8
21.9

1.54
2.72
3.55
3.91
0.82
1.32
0.15
0.78
1.08
1.26
1.61

2.30
13.71
8.73
22.24
10.75
1.65
0.07
4.73
3.32
1.79
2.41

5590
98
96
5168
24
29

6.5
1.0
0.6
119.2
1.0
1.5

0.09
0.10
0.06
1.75
0.21
0.28

44
82
5
44
146
20
120
15
140
1461
69
78
134
1090
261
8
10
9
1
16
199
438
39
4
5
7
0
50
294
177
125
4
117
20
15
5
643
28
603
235
66
163
92
30
58
31
348
36
291
172
129
142
155
23
129
7
22

1.2
0.2
0.9
1.1
0.9
0.7
0.9
0.9
0.8
1.4
0.6
1.2
0.7
1.6
1.2
0.6
0.6
1.0
0.4
0.6
1.5
1.6
1.5
0.4
0.7
1.3
0.6
2.1
1.4
1.0
0.5
1.0
1.1
1.3
0.9
0.9
0.5
0.9
1.0
1.1
0.9
1.2
1.2
1.2
0.7
0.9
0.8
0.8
0.9
1.1
1.0
1.1
0.7
1.2
0.7
0.9

0.20
0.02
0.42
0.19
0.08
0.16
0.09
0.24
0.07
0.04
0.07
0.14
0.06
0.05
0.08
0.21
0.21
0.33
0.44
0.16
0.11
0.08
0.24
0.19
0.30
0.58
0.09
0.14
0.11
0.10
0.28
0.10
0.26
0.36
0.41
0.04
0.09
0.04
0.07
0.14
0.07
0.13
0.24
0.16
0.13
0.05
0.13
0.05
0.07
0.11
0.09
0.09
0.15
0.11
0.27
0.20

460

Female
ASR(W)
CUM 0-74

97
128
107
33
86

4.5
2.5
10.5
2.1
4.5

0.46
0.23
1.03
0.49
0.68

0.22
0.40
0.55
0.57
0.12
0.19
0.02
0.11
0.16
0.16
0.24

141
2531
372
3177
21205
169
27
3079
934
253
226

12.4
97.0
51.7
177.1
72.9
15.8
0.6
37.5
27.6
18.4
19.2

1.17
2.13
2.86
3.21
0.60
1.26
0.12
0.70
0.96
1.22
1.33

1.36
11.09
6.07
19.41
8.08
1.64
0.06
4.05
3.19
2.02
2.05

0.71
0.09
0.06
13.65
0.10
0.13

0.01
0.01
0.01
0.25
0.03
0.03

5026
105
117
4594
35
24

4.9
1.0
0.7
88.7
0.9
1.1

0.08
0.10
0.07
1.48
0.17
0.24

0.53
0.09
0.06
9.96
0.07
0.11

0.01
0.01
0.01
0.20
0.02
0.03

0.11
0.02
0.07
0.13
0.09
0.06
0.10
0.11
0.07
0.14
0.07
0.13
0.06
0.16
0.14
0.05
0.08
0.12
0.07
0.07
0.17
0.15
0.16
0.06
0.06
0.10
0.05
0.21
0.15
0.09
0.04
0.09
0.12
0.14
0.09
0.09
0.04
0.09
0.10
0.09
0.09
0.10
0.11
0.10
0.06
0.09
0.07
0.08
0.09
0.12
0.11
0.11
0.06
0.13
0.05
0.10

0.02
0.00
0.05
0.03
0.01
0.01
0.01
0.04
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.02
0.03
0.05
0.07
0.03
0.02
0.01
0.03
0.03
0.03
0.06
0.01
0.02
0.01
0.01
0.03
0.01
0.03
0.05
0.05
0.00
0.01
0.01
0.01
0.01
0.01
0.02
0.03
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.03

34
73
3
41
104
27
76
12
124
1212
67
68
143
849
237
14
13
2
2
20
165
358
32
9
3
4
1
57
221
119
109
8
98
17
10
4
485
59
417
182
53
127
66
28
37
31
359
43
302
155
114
102
127
25
100
6
18

0.8
0.2
0.8
0.9
0.6
0.8
0.6
0.7
0.6
1.0
0.5
0.9
0.6
1.1
0.9
1.0
0.6
0.2
0.5
0.6
1.1
1.1
1.0
0.7
0.3
0.4
0.2
0.6
1.4
0.8
0.7
0.9
0.7
0.8
0.7
0.8
0.7
0.8
0.6
0.6
0.8
0.6
0.7
0.9
0.6
0.6
0.7
0.7
0.7
0.6
0.9
0.6
0.7
0.6
0.8
0.5
0.6

0.16
0.02
0.46
0.16
0.07
0.16
0.07
0.21
0.06
0.03
0.06
0.12
0.06
0.05
0.07
0.27
0.17
0.16
0.37
0.15
0.10
0.06
0.18
0.25
0.17
0.27
0.19
0.09
0.12
0.08
0.08
0.33
0.08
0.20
0.26
0.38
0.04
0.11
0.04
0.05
0.11
0.06
0.09
0.18
0.11
0.13
0.04
0.11
0.05
0.06
0.10
0.07
0.07
0.12
0.09
0.19
0.16

0.08
0.02
0.10
0.09
0.06
0.06
0.06
0.07
0.06
0.10
0.04
0.09
0.06
0.11
0.09
0.09
0.04
0.02
0.04
0.05
0.11
0.11
0.10
0.06
0.03
0.02
0.02
0.07
0.14
0.08
0.07
0.08
0.07
0.08
0.06
0.10
0.06
0.08
0.06
0.06
0.07
0.05
0.08
0.09
0.07
0.06
0.07
0.06
0.07
0.06
0.09
0.06
0.08
0.05
0.09
0.04
0.07

0.02
0.00
0.06
0.02
0.01
0.01
0.01
0.03
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.03
0.02
0.01
0.03
0.01
0.01
0.01
0.02
0.02
0.02
0.02
0.02
0.01
0.01
0.01
0.01
0.03
0.01
0.02
0.02
0.05
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.02
0.01
0.02
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.02

*Important. See note on population page.

Care should be taken when comparing populations. See Chapter 5 Comparability and quality of data
518

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

*
*
*
*

0.15
0.32
0.43
0.47
0.09
0.17
0.02
0.10
0.14
0.15
0.20 *

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp
Care

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other skin (C44) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

33
252
349
45
289
168
30
132
179
17
158
25
7591
600
6578
343
37
292
67
0
17
49
676
65
597
303
28
254
95
113
497
24
454
57
1072
84
909
3014
121
220
178
2382
123
18
101
506
48
435
93
15
219
168
57
146

0.8
1.1
1.1
1.3
1.0
1.3
1.2
1.3
0.9
1.2
0.8
0.7
1.0
0.9
1.0
1.2
1.2
1.2
1.1
0.9
1.3
1.1
0.9
1.1
0.8
0.8
0.7
0.8
0.9
1.1
0.8
1.1
1.6
1.2
1.1
1.3
1.3
0.7
1.1
0.6
1.4
0.9
0.6
1.0
0.8
0.8
0.8
1.6
0.7
1.1
1.2
0.9
0.8

0.14
0.08
0.06
0.20
0.06
0.11
0.23
0.12
0.07
0.30
0.07
0.15
0.01
0.04
0.01
0.07
0.20
0.08
0.14
0.23
0.21
0.04
0.11
0.05
0.05
0.15
0.05
0.08
0.09
0.05
0.16
0.06
0.23
0.04
0.12
0.04
0.02
0.06
0.08
0.05
0.03
0.09
0.14
0.10
0.04
0.12
0.04
0.18
0.20
0.08
0.10
0.12
0.07

0.08
0.11
0.11
0.14
0.10
0.13
0.15
0.13
0.09
0.14
0.08
0.06
0.10
0.08
0.10
0.13
0.12
0.13
0.10
0.10
0.11
0.11
0.08
0.11
0.08
0.08
0.07
0.08
0.10
0.11
0.08
0.11
0.16
0.12
0.12
0.13
0.13
0.07
0.11
0.06
0.14
0.08
0.05
0.09
0.09
0.08
0.08
0.18
0.10
0.12
0.13
0.09
0.09

0.02
0.01
0.01
0.02
0.01
0.01
0.03
0.01
0.01
0.04
0.01
0.02
0.00
0.00
0.00
0.01
0.02
0.01
0.02
0.03
0.02
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.01
0.03
0.01
0.02
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.03
0.01
0.01
0.01
0.01

36
249
345
42
284
168
32
126
142
11
128
22
6513
647
5465
272
24
238
61
4
13
44
699
85
600
281
35
234
67
102
402
40
348
55
968
93
791
2537
110
204
179
1926
107
26
80
351
46
291
75
26
235
186
51
142

0.6
1.0
0.9
0.9
0.9
1.1
0.9
1.1
0.6
0.5
0.6
0.6
0.7
0.8
0.7
0.8
0.6
0.8
1.0
1.0
0.6
1.2
0.9
0.9
0.9
0.6
0.8
0.6
0.5
0.7
0.8
1.0
0.7
1.3
1.0
1.0
1.0
0.9
0.5
0.8
0.6
1.0
0.7
0.7
0.7
0.5
0.6
0.4
1.2
1.1
1.1
1.2
0.7
0.7

0.11
0.07
0.05
0.14
0.06
0.09
0.17
0.11
0.06
0.16
0.06
0.14
0.01
0.03
0.01
0.05
0.12
0.06
0.13
0.49
0.18
0.21
0.04
0.10
0.04
0.04
0.15
0.04
0.07
0.08
0.04
0.16
0.04
0.21
0.03
0.11
0.04
0.02
0.05
0.06
0.05
0.03
0.07
0.14
0.09
0.03
0.10
0.03
0.15
0.23
0.08
0.10
0.11
0.06

0.08
0.10
0.09
0.08
0.08
0.11
0.09
0.11
0.06
0.04
0.06
0.06
0.07
0.07
0.07
0.08
0.05
0.08
0.10
0.10
0.06
0.13
0.09
0.08
0.09
0.06
0.07
0.06
0.05
0.08
0.08
0.09
0.07
0.13
0.10
0.10
0.10
0.09
0.04
0.08
0.06
0.10
0.06
0.06
0.06
0.05
0.06
0.04
0.13
0.10
0.10
0.12
0.07
0.06

0.02
0.01
0.01
0.02
0.01
0.01
0.02
0.01
0.01
0.02
0.01
0.02
0.00
0.00
0.00
0.01
0.01
0.01
0.02
0.06
0.02
0.02
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.01
0.00
0.02
0.00
0.02
0.00
0.01
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.02
0.03
0.01
0.01
0.01
0.01

23
122
1267
25
15
420
74
543
117
267
20
317
45
100
45
599
551
35
99
93
264
315
473
416
143

4.1
2.2
5.7
1.9
0.7
1.8
2.3
21.9
1.3
1.3
2.3
1.4
1.1
1.6
1.7
3.4
3.5
2.1
2.6
2.2
6.2
3.0
5.9
1.1
2.1

0.88
0.21
0.17
0.38
0.19
0.09
0.28
1.02
0.12
0.08
0.53
0.08
0.17
0.16
0.25
0.15
0.16
0.38
0.27
0.25
0.39
0.17
0.29
0.06
0.20

0.55
0.22
0.61
0.28
0.06
0.20
0.24
2.42
0.17
0.14
0.31
0.15
0.13
0.16
0.17
0.35
0.35
0.25
0.25
0.23
0.69
0.29
0.60
0.11
0.20

0.14
0.03
0.02
0.06
0.02
0.01
0.04
0.15
0.02
0.01
0.08
0.01
0.02
0.02
0.03
0.02
0.02
0.06
0.03
0.03
0.06
0.02
0.04
0.01
0.02

13
104
1499
13
8
372
62
502
96
162
7
172
31
67
28
634
604
25
123
61
247
327
573
408
140

2.2
1.6
5.4
0.8
0.3
1.3
1.7
17.1
1.0
1.0
0.8
0.8
0.8
1.1
0.9
3.0
3.2
1.3
2.2
1.1
3.9
2.2
4.3
0.8
1.3

0.64
0.16
0.15
0.24
0.11
0.07
0.22
0.85
0.11
0.08
0.29
0.07
0.14
0.13
0.17
0.13
0.14
0.28
0.22
0.20
0.28
0.14
0.23
0.04
0.15

0.32
0.16
0.53
0.11
0.04
0.13
0.20
1.88
0.11
0.11
0.10
0.09
0.08
0.13
0.11
0.31
0.33
0.13
0.18
0.13
0.36
0.19
0.37
0.08
0.13

0.10
0.02 *
0.02
0.04 *
0.02
0.01 *
0.03 *
0.12 *
0.01
0.01 *
0.04
0.01
0.02 *
0.02 *
0.03 *
0.02
0.02
0.04
0.03
0.02
0.04
0.02
0.03
0.01
0.02

*Important. See note on population page.


Care should be taken when comparing populations. See Chapter 5 Comparability and quality of data
Cancer Incidence in Five Continents Vol. IX, IARC 2007

461

519

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other skin (C44) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

Female
ASR(W)
CUM 0-74

2191
187
193
59
76
137
16
456
28
15
49
102
161
69
116
224
714
658
16
40
146
79
133
563
955

2.6
2.4
3.8
2.3
3.1
2.7
2.1
2.4
2.2
1.4
2.8
5.6
4.6
4.2
4.3
3.5
8.8
10.3
1.8
4.4
3.7
3.7
4.9
19.8
12.7

0.06
0.20
0.29
0.32
0.38
0.26
0.53
0.13
0.45
0.39
0.66
0.56
0.37
0.51
0.42
0.26
0.33
0.41
0.49
0.73
0.31
0.42
0.43
0.85
0.42

0.30
0.28
0.44
0.30
0.35
0.26
0.26
0.24
0.28
0.15
0.40
0.56
0.56
0.56
0.50
0.35
0.92
1.09
0.15
0.53
0.39
0.41
0.58
2.41
1.45

0.01
0.03
0.04
0.05
0.05
0.03
0.08
0.02
0.07
0.05
0.11
0.07
0.06
0.08
0.06
0.03
0.05
0.06
0.05
0.10
0.04
0.06
0.06
0.12
0.06

2282
189
230
68
112
155
17
459
47
14
14
92
137
70
84
234
754
706
14
34
145
84
114
450
831

1.9
1.8
3.4
2.0
3.0
2.5
1.5
1.8
2.6
1.3
1.6
4.1
3.8
4.2
4.1
2.9
7.6
8.3
2.7
3.7
3.4
3.6
3.5
15.4
9.8

0.04
0.13
0.22
0.24
0.29
0.20
0.38
0.09
0.40
0.37
0.58
0.43
0.33
0.52
0.48
0.20
0.28
0.32
0.78
0.65
0.29
0.40
0.33
0.74
0.34

0.21
0.19
0.34
0.21
0.35
0.26
0.18
0.19
0.31
0.12
0.18
0.43
0.43
0.52
0.49
0.33
0.73
0.81
0.18
0.47
0.36
0.38
0.36
1.83
1.16

0.01
0.02
0.03
0.03
0.05
0.03
0.06
0.01
0.06
0.05
0.08
0.06
0.05
0.08 *
0.06 *
0.03 *
0.04
0.05
0.07
0.09
0.04 *
0.05 *
0.04
0.11 *
0.05 *

7813
420
161
6844
855
7012
7323

24.2
17.1
13.4
23.3
10.5
33.1
21.0

0.28
0.85
1.07
0.29
0.37
0.41
0.25

2.62
1.90
1.32
2.62
1.02
3.63
2.47

0.04
0.12
0.15
0.04
0.05
0.06
0.04

8005
425
165
10604
538
6600
6478

16.3
11.7
7.8
20.7
4.6
25.9
14.5

0.21
0.65
0.68
0.22
0.23
0.36
0.20

1.73
1.20
0.74
2.43
0.44
2.78
1.70

0.03
0.09
0.10
0.03 *
0.03 *
0.05
0.03 *

23175
14331
1299
1883

62.4
64.2
29.0
8.6

0.42
0.56
0.81
0.20

7.16
7.14
3.25
0.79

0.06
0.08
0.11
0.03

23883
14960
2074
2144

46.3
57.6
27.1
5.3

0.33
0.53
0.65
0.13

5.19
6.36
3.23
0.44

0.04
0.07
0.09
0.02

766
1807
3721
491
688
4696
2536
101
13904
631
1838
1725
3882
1908
686
2524
1996
344
6187
986
924
1550
3499
1214
1255
915
469
2073
2235
1240
5264

7.5
8.6
49.8
7.4
6.7
43.7
52.2
9.4
111.8
63.5
72.5
82.7
61.6
60.5
69.0
47.4
62.0
22.0
62.7
43.1
69.9
66.7
65.0
34.3
62.9
64.8
61.2
44.7
44.9
58.7
71.7

0.28
0.21
0.84
0.34
0.26
0.65
1.07
0.99
0.98
2.68
1.73
2.16
1.08
1.52
2.94
1.00
1.49
1.20
0.84
1.51
2.46
1.83
1.20
1.03
1.84
2.25
2.90
1.04
1.04
1.71
1.03

0.75
0.80
5.58
0.71
0.64
4.87
5.89
0.86
12.99
7.45
8.32
9.47
7.06
6.82
7.71
5.48
7.13
2.36
7.12
4.76
8.16
7.75
7.38
4.05
7.48
7.84
7.26
5.13
5.11
6.65
8.18

0.04
0.03
0.12
0.04
0.04
0.09
0.15
0.13
0.14
0.37
0.24
0.30
0.15
0.20
0.39
0.14
0.20
0.16
0.12
0.20
0.34
0.25
0.16
0.14
0.26
0.33
0.42
0.14
0.15
0.24
0.14

705
1365
3574
437
462
4202
2310
104
12196
598
1538
1249
2990
1524
567
2217
1540
252
5979
697
465
1142
2559
895
869
408
499
1902
1549
991
4524

3.6
3.1
35.0
3.3
3.0
29.1
34.2
9.1
80.9
45.1
45.2
45.1
40.6
39.0
44.1
31.6
39.4
12.7
45.3
26.2
30.8
41.0
41.0
19.6
37.8
26.3
46.0
32.1
24.6
35.0
46.3

0.16
0.10
0.68
0.18
0.16
0.51
0.82
0.99
0.80
2.30
1.33
1.56
0.89
1.24
2.28
0.80
1.19
0.84
0.70
1.26
1.60
1.48
0.97
0.74
1.41
1.44
2.41
0.87
0.78
1.26
0.81

0.30
0.28
3.98
0.29
0.29
3.27
3.74
1.07
9.22
4.96
4.84
5.02
4.42
4.36
4.72
3.61
4.40
1.38
4.99
2.83
3.53
4.47
4.59
2.15
4.11
3.04
5.04
3.61
2.60
3.91
5.13

0.02
0.01
0.09
0.02
0.02
0.07
0.11
0.14
0.11
0.28
0.16
0.20
0.11
0.15
0.28
0.10
0.15
0.11
0.09
0.15
0.21
0.18
0.12
0.10
0.18
0.19
0.32
0.11
0.10
0.16
0.10

*Important. See note on population page.

Care should be taken when comparing populations. See Chapter 5 Comparability and quality of data
520
462

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Care

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other skin (C44) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

1417
3226
1009
2602
535
778
840
42
1257
1715
4520
7495
2852
21

18.1
29.4
72.2
12.5
21.2
17.7
13.0
0.4
9.9
12.1
24.1
46.3
41.0
1.8

0.49
0.52
2.34
0.27
0.93
0.65
0.46
0.07
0.30
0.29
0.37
0.55
0.77
0.43

2.09
3.37
8.12
1.25
2.37
2.07
1.45
0.05
1.05
1.42
2.88
5.40
4.75
0.17

0.07
0.07
0.33
0.04
0.13
0.09
0.06
0.01
0.04
0.04
0.05
0.08
0.11
0.05

2193
5494
653
2128
653
837
918
74
1177
3397
3951
8083
3144
14

15.5
31.3
39.4
7.1
16.8
12.7
9.5
0.6
6.0
12.2
17.6
35.2
29.8
1.6

0.36
0.46
1.63
0.19
0.70
0.48
0.34
0.07
0.20
0.23
0.30
0.42
0.58
0.46

1.86
3.67
4.51
0.69
1.93
1.37
1.10
0.06
0.53
1.43
2.04
4.07
3.31
0.17

59
33
3
1687
2594
2159
2253
1790
1997
6517
2123
264
738
1611

1.0
0.7
0.6
64.5
79.7
51.0
88.1
79.4
48.6
12.8
133.3
24.1
102.2
78.3

0.14
0.12
0.41
1.71
1.66
1.15
1.99
2.12
1.17
0.17
2.98
1.58
3.99
2.04

0.08
0.07
0.04
7.23
9.56
5.80
9.95
8.79
5.44
1.20
15.17
2.42
11.98
8.87

0.01
0.02
0.03
0.24
0.23
0.15
0.27
0.29
0.16
0.03
0.43
0.24
0.58
0.29

62
45
7
1376
2008
1705
1930
1529
1441
4870
2292
260
767
1471

0.9
0.8
0.7
45.2
52.1
31.5
67.5
61.8
30.2
7.0
113.0
14.6
80.3
56.2

0.13
0.13
0.36
1.43
1.31
0.85
1.79
1.90
0.93
0.13
2.60
1.10
3.39
1.67

0.08
0.09
0.05
4.87
5.84
3.47
7.34
7.08
3.26
0.69
12.89
1.24
8.80
6.38

0.01
0.02
0.03
0.18
0.17
0.11
0.22
0.25
0.11
0.02
0.35
0.15
0.44
0.23

970
3180
10368
645
531
9624

90.9
126.3
16.3
17.0
14.0
75.9

3.02
2.36
0.17
0.69
0.63
0.83

10.87
14.58
1.66
1.63
1.43
8.49

0.43
0.34
0.02
0.09
0.09
0.11

978
3329
7079
394
357
7911

73.8
105.2
7.8
7.7
7.1
52.1

2.61
2.07
0.11
0.42
0.42
0.68

8.31
11.70
0.78
0.75
0.75
5.80

0.35
0.27
0.01
0.06
0.06
0.09

20783
2
33917
6412
14644
9
5886
16153

73.4
0.0
105.3
10.1
68.3
0.1
97.3
77.0

0.54
0.01
0.62
0.13
0.60
0.02
1.32
0.63

8.22
0.00
11.87
0.98
7.66
0.00
11.01
8.65

0.07
0.00
0.09
0.02
0.08
0.00
0.19
0.09

19689
1
28668
4323
12311
5
5297
15547

53.7
0.0
72.9
4.4
46.6
0.0
64.7
54.2

0.44
0.01
0.51
0.08
0.48
0.02
1.00
0.50

5.94
0.00
8.08
0.41
5.16
0.00
7.16
5.91

0.06
0.00
0.07
0.01
0.06
0.00
0.14
0.07

22

0.1

0.02

0.01

0.00

13

0.0

0.01

0.01

0.00

199
309
41
34
1263
71
0
167
67
4
8
7
10
32

1.5
5.6
2.1
0.2
19.7
7.5
1.2
1.4
1.0
1.3
1.3
0.6
2.5

0.11
0.33
0.34
0.03
0.57
0.91
0.10
0.19
0.55
0.47
0.50
0.22
0.47

0.13
0.58
0.25
0.02
2.09
0.74
0.12
0.15
0.08
0.16
0.10
0.06
0.26

0.01
0.04
0.05
0.00
0.08
0.12
0.01
0.02
0.06
0.06
0.06
0.03
0.07

140
207
45
19
672
38
1
148
43
4
3
4
9
15

1.0
2.8
1.9
0.1
8.9
3.8
0.2
0.8
1.0
0.9
0.5
0.6
0.4
1.5

0.09
0.23
0.31
0.02
0.37
0.65
0.23
0.08
0.16
0.50
0.30
0.32
0.18
0.42

0.10
0.29
0.19
0.01
0.91
0.47
0.08
0.09
0.11
0.06
0.06
0.04
0.14

0.01
0.03
0.04
0.00
0.05
0.10
0.01
0.02
0.06
0.03
0.03
0.02
0.05

*Important. See note on population page.


Care should be taken when comparing populations. See Chapter 5 Comparability and quality of data
Cancer Incidence in Five Continents Vol. IX, IARC 2007

0.05
0.06
0.22
0.03
0.10 *
0.06
0.05
0.01 *
0.03
0.03
0.04
0.06
0.08
0.05

463

521

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Mesothelioma (C45)
Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

464

Female
ASR(W)
CUM 0-74

2
18
1
0
4

0.1
0.4
0.1
0.2

0.07
0.09
0.11
0.11

0
13
0
0
0

0.3
-

0.07
-

10
5
0
0
38
2
10
3
4
2
6

1.2
0.2
0.2
0.2
0.3
0.0
0.1
0.2
0.6

0.40
0.09
0.03
0.12
0.09
0.03
0.08
0.13
0.25

0.12
0.02
0.02
0.01
0.03
0.01
0.02
0.03
0.03

0.05
0.01
0.00
0.01
0.01
0.00
0.01
0.02
0.02

7
3
0
2
39
2
6
5
1
1
9

0.7
0.1
0.1
0.1
0.2
0.1
0.1
0.0
0.1
0.8

0.28
0.08
0.08
0.02
0.13
0.06
0.03
0.02
0.06
0.28

0.07
0.02
0.01
0.02
0.02
0.02
0.01
0.02
0.11

0.03
0.02
0.01
0.00
0.02
0.01
0.00
0.02
0.05 *

1045
149
263
53
31
9
0
51
438
4
47
158
17
141
22
194
1228
32
50
181
960
253
16
3
8
2
25
195
275
21
2
2
1
2
70
176
129
173
2
170
15
8
7
880
22
853
148
8
140
34
2
32
50
584
21
561
242
86
134
210
30
179
12
60

1.3
1.6
1.6
1.3
1.1
0.5
1.5
1.1
0.8
1.2
1.0
0.6
1.1
1.7
1.0
1.1
0.3
0.8
1.2
1.2
1.1
1.1
0.2
0.9
0.5
1.1
1.3
1.0
0.8
0.1
0.2
0.1
0.4
1.2
1.1
1.0
1.3
0.3
1.3
0.9
0.9
1.0
1.1
0.4
1.1
0.6
0.2
0.8
0.5
0.1
0.7
1.0
1.4
0.5
1.5
1.1
0.8
0.9
1.4
0.9
1.6
1.3
2.7

0.04
0.14
0.11
0.19
0.21
0.17
0.21
0.05
0.43
0.19
0.08
0.14
0.10
0.37
0.07
0.03
0.05
0.12
0.09
0.04
0.07
0.28
0.10
0.34
0.38
0.23
0.10
0.06
0.17
0.06
0.15
0.08
0.27
0.14
0.09
0.09
0.10
0.22
0.11
0.24
0.31
0.40
0.04
0.09
0.04
0.05
0.07
0.07
0.09
0.10
0.12
0.15
0.06
0.11
0.07
0.08
0.09
0.08
0.10
0.17
0.12
0.38
0.37

0.17
0.22
0.20
0.16
0.16
0.06
0.22
0.15
0.12
0.16
0.12
0.05
0.14
0.21
0.11
0.13
0.03
0.07
0.14
0.15
0.13
0.10
0.01
0.12
0.04
0.10
0.16
0.11
0.08
0.03
0.05
0.14
0.13
0.11
0.15
0.03
0.16
0.11
0.11
0.12
0.13
0.06
0.14
0.08
0.02
0.09
0.07
0.01
0.09
0.09
0.17
0.05
0.19
0.13
0.10
0.12
0.17
0.14
0.18
0.23
0.30

0.01
0.02
0.02
0.03
0.03
0.03
0.04
0.01
0.07
0.03
0.01
0.02
0.01
0.06
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.04
0.01
0.05
0.04
0.03
0.02
0.01
0.02
0.03
0.03
0.02
0.01
0.01
0.02
0.03
0.02
0.03
0.04
0.06
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.03
0.02
0.08
0.05

235
31
47
18
6
4
2
8
105
1
13
31
1
30
3
46
348
15
14
53
260
80
5
1
4
0
10
57
86
7
1
0
3
1
21
53
34
47
2
45
2
2
0
242
12
228
57
10
47
16
2
14
15
181
10
170
57
33
49
58
12
46
8
26

0.3
0.3
0.3
0.4
0.2
0.2
2.9
0.2
0.2
0.2
0.3
0.1
0.0
0.2
0.1
0.2
0.3
0.1
0.2
0.3
0.3
0.3
0.3
0.1
0.4
0.3
0.3
0.3
0.2
0.1
0.4
0.2
0.3
0.3
0.2
0.3
0.3
0.3
0.2
0.2
0.3
0.2
0.3
0.2
0.1
0.2
0.2
0.1
0.2
0.3
0.3
0.1
0.4
0.2
0.2
0.3
0.3
0.3
0.4
0.6
1.0

0.02
0.06
0.04
0.11
0.09
0.10
2.12
0.08
0.02
0.22
0.10
0.03
0.01
0.04
0.08
0.03
0.02
0.03
0.05
0.04
0.02
0.04
0.14
0.08
0.20
0.11
0.05
0.03
0.09
0.07
0.27
0.18
0.06
0.05
0.04
0.05
0.19
0.05
0.13
0.18
0.02
0.05
0.02
0.03
0.05
0.03
0.04
0.07
0.06
0.09
0.03
0.05
0.03
0.03
0.05
0.04
0.05
0.08
0.06
0.20
0.22

0.03
0.03
0.03
0.05
0.02
0.02
0.57
0.02
0.03
0.02
0.03
0.02
0.02
0.01
0.03
0.03
0.01
0.02
0.03
0.04
0.04
0.02
0.01
0.04
0.05
0.05
0.03
0.04
0.01
0.03
0.03
0.03
0.03
0.03
0.04
0.04
0.04
0.01
0.02
0.03
0.03
0.03
0.02
0.02
0.02
0.02
0.01
0.02
0.05
0.04
0.02
0.04
0.02
0.02
0.03
0.04
0.03
0.05
0.05
0.13

0.00
0.01
0.01
0.01
0.01
0.02
0.48
0.01
0.00
0.02
0.01
0.00
0.00
0.01
0.00
0.00
0.00
0.01
0.01
0.00
0.01
0.02
0.01
0.02
0.02
0.01
0.00
0.01
0.01
0.03
0.03
0.01
0.01
0.01
0.01
0.03
0.01
0.01
0.01
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.00
0.01
0.00
0.00
0.01
0.01
0.01
0.01
0.01
0.02
0.03

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

522

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Mesothelioma (C45) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

96
392
429
18
406
155
15
138
186
6
180
51
9676
385
9164
558
25
527
73
3
26
43
805
44
754
502
19
476
109
194
783
38
734
62
1068
37
979
3001
65
129
242
2547
129
15
114
607
27
577
66
21
350
245
119
292

1.8
1.6
1.2
0.5
1.3
1.1
0.6
1.3
0.9
0.4
0.9
1.4
1.2
0.6
1.3
1.7
0.9
1.8
1.1
0.9
1.4
1.0
1.2
0.6
1.3
1.2
0.5
1.2
0.9
1.5
1.5
1.1
1.5
1.5
1.1
0.6
1.3
1.2
0.4
0.7
1.2
1.3
0.9
0.5
1.0
1.0
0.5
1.0
1.1
0.9
1.6
1.7
1.6
1.5

0.20
0.09
0.06
0.13
0.07
0.10
0.16
0.12
0.07
0.18
0.07
0.21
0.01
0.03
0.01
0.08
0.18
0.09
0.14
0.51
0.28
0.16
0.04
0.10
0.05
0.06
0.13
0.06
0.09
0.11
0.06
0.19
0.06
0.21
0.04
0.09
0.04
0.02
0.05
0.06
0.08
0.03
0.08
0.15
0.10
0.04
0.10
0.04
0.14
0.21
0.09
0.12
0.15
0.09

0.21
0.19
0.15
0.08
0.16
0.14
0.10
0.15
0.11
0.05
0.12
0.17
0.14
0.07
0.15
0.20
0.13
0.21
0.13
0.06
0.18
0.11
0.13
0.07
0.15
0.14
0.06
0.15
0.10
0.17
0.17
0.12
0.17
0.19
0.13
0.07
0.15
0.14
0.04
0.09
0.14
0.15
0.13
0.07
0.14
0.12
0.06
0.13
0.14
0.08
0.19
0.19
0.20
0.19

0.03
0.01
0.01
0.02
0.01
0.02
0.03
0.02
0.01
0.03
0.01
0.03
0.00
0.00
0.00
0.01
0.03
0.01
0.02
0.06
0.05
0.02
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.02
0.01
0.03
0.01
0.03
0.01
0.02
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.02
0.02
0.01
0.01
0.01
0.02
0.02
0.01
0.02
0.02
0.01

30
81
134
8
123
52
4
47
58
1
56
17
2618
138
2425
148
4
139
13
0
5
8
218
14
201
130
4
123
31
38
191
12
175
18
272
12
250
826
23
40
74
679
35
6
29
157
14
142
14
11
70
42
30
87

0.4
0.3
0.3
0.2
0.3
0.3
0.1
0.3
0.2
0.0
0.2
0.3
0.3
0.2
0.3
0.3
0.1
0.4
0.2
0.2
0.2
0.3
0.1
0.3
0.2
0.1
0.2
0.2
0.3
0.3
0.2
0.3
0.3
0.2
0.1
0.3
0.3
0.1
0.2
0.3
0.3
0.2
0.1
0.2
0.2
0.2
0.2
0.2
0.5
0.2
0.2
0.2
0.3

0.09
0.03
0.03
0.06
0.03
0.04
0.05
0.05
0.03
0.02
0.03
0.09
0.01
0.01
0.01
0.03
0.05
0.04
0.06
0.10
0.08
0.02
0.04
0.02
0.02
0.04
0.02
0.04
0.05
0.02
0.07
0.02
0.08
0.02
0.04
0.02
0.01
0.02
0.03
0.03
0.01
0.04
0.05
0.04
0.02
0.05
0.02
0.07
0.16
0.03
0.04
0.05
0.04

0.04
0.03
0.04
0.02
0.04
0.03
0.01
0.03
0.02
0.03
0.03
0.03
0.02
0.03
0.04
0.02
0.04
0.02
0.02
0.03
0.03
0.02
0.04
0.03
0.01
0.03
0.02
0.03
0.03
0.03
0.03
0.04
0.03
0.01
0.03
0.03
0.01
0.02
0.03
0.03
0.03
0.01
0.03
0.03
0.02
0.03
0.03
0.05
0.02
0.02
0.02
0.04

0.01
0.01
0.00
0.01
0.00
0.01
0.01
0.01
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.01
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.01
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.01
0.02
0.00
0.01
0.01
0.01

2
10
38
1
0
13
11
11
10
3
0
11
0
0
3
128
116
9
5
12
35
40
39
340
15

0.4
0.2
0.2
0.1
0.1
0.4
0.4
0.1
0.0
0.0
0.1
0.8
0.8
0.6
0.1
0.3
0.8
0.4
0.6
0.9
0.2

0.28
0.07
0.03
0.08
0.02
0.11
0.14
0.04
0.01
0.01
0.06
0.07
0.08
0.22
0.05
0.09
0.14
0.06
0.09
0.05
0.06

0.07
0.02
0.02
0.01
0.01
0.04
0.05
0.01
0.00
0.01
0.01
0.10
0.11
0.08
0.02
0.02
0.10
0.05
0.08
0.11
0.03

0.05
0.01
0.00
0.01
0.00
0.01
0.02
0.01
0.00
0.00
0.01
0.01
0.01
0.04
0.01
0.01
0.02
0.01
0.01
0.01
0.01

0
24
20
0
0
5
7
7
1
2
0
5
0
0
3
49
43
4
1
6
5
14
16
102
2

0.4
0.1
0.0
0.2
0.3
0.0
0.0
0.0
0.1
0.3
0.3
0.2
0.0
0.1
0.1
0.1
0.2
0.2
0.0

0.09
0.02
0.01
0.08
0.10
0.01
0.01
0.01
0.06
0.04
0.04
0.12
0.02
0.04
0.06
0.03
0.04
0.02
0.03

0.05
0.01
0.00
0.03
0.03
0.00
0.00
0.00
0.01
0.03
0.03
0.03
0.01
0.01
0.01
0.02
0.02
0.00

0.01 *
0.00
- *
0.00 *
0.01 *
0.02 *
0.00
0.00 *
0.00
- *
- *
0.01 *
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.00
0.00

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

465

523

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Mesothelioma (C45) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

466

Female
ASR(W)
CUM 0-74

129
15
6
9
2
11
1
34
3
4
10
1
0
5
4
5
28
23
1
4
0
0
0
35
57

0.1
0.2
0.1
0.4
0.1
0.2
0.1
0.2
0.3
0.4
0.7
0.1
0.3
0.1
0.1
0.3
0.4
0.1
0.4
1.1
0.7

0.01
0.05
0.05
0.15
0.07
0.07
0.13
0.03
0.17
0.23
0.41
0.06
0.13
0.07
0.04
0.07
0.08
0.08
0.22
0.19
0.10

0.02
0.03
0.02
0.04
0.01
0.02
0.02
0.02
0.02
0.02
0.05
0.01
0.04
0.01
0.01
0.05
0.05
0.06
0.15
0.09

0.00
0.01
0.01
0.02
0.01
0.01
0.02
0.00
0.02
0.02
0.03
0.01
0.02
0.01
0.01
0.01
0.01
0.03
0.03
0.01

71
12
3
2
0
3
0
16
0
2
4
0
0
1
0
3
9
9
0
0
0
0
0
26
29

0.1
0.1
0.0
0.1
0.0
0.1
0.2
0.4
0.1
0.0
0.1
0.1
0.8
0.3

0.01
0.03
0.02
0.04
0.03
0.02
0.15
0.31
0.06
0.02
0.03
0.03
0.17
0.06

0.01
0.01
0.00
0.01
0.01
0.01
0.04
0.09
0.00
0.00
0.01
0.01
0.11
0.04

0.00
0.00
0.00
0.00
0.00
0.00
0.03
0.08
0.01 *
- *
0.00 *
0.00
0.00
- *
- *
0.02 *
0.01 *

225
14
17
165
164
403
54
225
176
368
18
257
37
33
10
16
39
84
107
41
25
15
24
74
132
263
42
128
241
77
9
72
8
44
41
58
169
7
87
27
29
291
25
8
44
63
26
15
33
19
78
36
44
125

0.8
0.6
1.5
0.6
2.3
2.0
0.2
1.4
0.5
1.7
0.4
1.3
1.0
1.3
0.5
0.6
1.0
2.0
2.5
2.1
1.3
0.8
0.8
0.7
0.7
3.6
0.6
1.3
2.3
1.6
1.0
0.6
1.0
1.8
2.3
1.1
5.8
0.6
1.6
0.9
1.9
3.0
1.3
0.7
2.1
1.3
0.7
0.8
2.7
2.8
1.7
0.8
2.2
1.8

0.05
0.17
0.37
0.04
0.18
0.10
0.03
0.09
0.04
0.09
0.10
0.08
0.17
0.23
0.17
0.16
0.17
0.23
0.25
0.35
0.26
0.23
0.19
0.09
0.06
0.23
0.10
0.12
0.15
0.18
0.34
0.08
0.37
0.28
0.38
0.15
0.47
0.25
0.18
0.19
0.36
0.18
0.27
0.27
0.34
0.19
0.15
0.21
0.48
0.64
0.20
0.15
0.33
0.16

0.09
0.08
0.23
0.07
0.29
0.25
0.02
0.17
0.06
0.22
0.05
0.16
0.12
0.18
0.07
0.07
0.12
0.27
0.33
0.24
0.19
0.09
0.10
0.08
0.07
0.44
0.08
0.16
0.31
0.20
0.15
0.08
0.14
0.22
0.26
0.13
0.74
0.08
0.20
0.10
0.19
0.38
0.18
0.06
0.26
0.15
0.08
0.10
0.36
0.41
0.21
0.10
0.27
0.23

0.01
0.02
0.06
0.01
0.03
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.02
0.04
0.03
0.02
0.02
0.04
0.04
0.04
0.04
0.03
0.03
0.01
0.01
0.03
0.01
0.02
0.02
0.03
0.06
0.01
0.05
0.04
0.05
0.02
0.07
0.04
0.03
0.02
0.04
0.03
0.04
0.03
0.05
0.02
0.02
0.03
0.07
0.10
0.03
0.02
0.05
0.02

128
6
7
97
23
88
56
56
136
76
11
79
5
19
6
1
8
22
15
4
12
7
6
59
100
83
29
47
51
7
2
17
7
38
13
21
44
1
69
13
20
71
13
4
11
25
4
5
5
12
62
14
15
44

0.3
0.2
0.6
0.2
0.3
0.4
0.2
0.3
0.3
0.3
0.2
0.3
0.1
0.6
0.2
0.0
0.2
0.4
0.3
0.2
0.6
0.4
0.1
0.4
0.4
0.7
0.3
0.4
0.3
0.1
0.2
0.2
0.6
1.2
0.6
0.3
1.0
0.0
0.9
0.3
1.0
0.5
0.7
0.4
0.5
0.5
0.1
0.3
0.4
1.0
1.0
0.4
0.6
0.4

0.03
0.08
0.23
0.02
0.07
0.05
0.03
0.04
0.03
0.04
0.06
0.03
0.06
0.16
0.10
0.02
0.07
0.09
0.07
0.12
0.17
0.16
0.06
0.08
0.05
0.08
0.06
0.06
0.05
0.06
0.15
0.04
0.25
0.22
0.20
0.07
0.18
0.03
0.13
0.10
0.23
0.07
0.19
0.21
0.16
0.11
0.05
0.13
0.18
0.31
0.15
0.11
0.17
0.07

0.04
0.03
0.05
0.03
0.03
0.05
0.02
0.03
0.04
0.04
0.02
0.04
0.02
0.08
0.03
0.01
0.02
0.05
0.04
0.03
0.08
0.04
0.02
0.04
0.04
0.08
0.03
0.05
0.04
0.01
0.04
0.02
0.07
0.12
0.05
0.04
0.15
0.10
0.04
0.11
0.07
0.09
0.05
0.06
0.06
0.01
0.04
0.04
0.12
0.13
0.04
0.07
0.05

0.00
0.01
0.02
0.00 *
0.01 *
0.01
0.00 *
0.00
0.00
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.02
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.03
0.01
0.03
0.03
0.02
0.01
0.03
0.02
0.01
0.03
0.01
0.03
0.02
0.02
0.01
0.01
0.02
0.02
0.05
0.02
0.01
0.02
0.01

*Important. See note on population page.

524

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Mesothelioma (C45) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

57
34
24
286
11
21
22
24
37
69
44
77
81
4
41
57
8
2
13
21
26
27
10
22
530
23
16
13
47
16
20
26
1654
78
139
382
396
530
1188
292
1185
1813
585
528
239
766

0.8
0.3
1.7
1.5
0.5
0.5
0.4
0.2
0.3
0.5
0.3
0.5
1.2
0.3
0.9
0.8
0.2
0.2
0.5
0.7
0.7
1.1
0.5
0.7
1.3
1.7
1.7
2.0
2.6
1.2
1.8
1.3
2.8
2.1
3.8
3.1
3.8
3.1
4.2
2.8
3.8
3.4
2.8
2.4
4.0
3.6

0.10
0.06
0.36
0.10
0.14
0.11
0.08
0.05
0.06
0.06
0.04
0.06
0.13
0.19
0.16
0.11
0.06
0.18
0.15
0.17
0.14
0.22
0.17
0.15
0.06
0.37
0.46
0.58
0.39
0.31
0.42
0.25
0.07
0.24
0.33
0.17
0.20
0.14
0.13
0.17
0.12
0.08
0.12
0.11
0.27
0.14

0.10
0.04
0.21
0.19
0.05
0.06
0.05
0.03
0.04
0.06
0.03
0.06
0.14
0.03
0.09
0.09
0.02
0.04
0.07
0.10
0.10
0.14
0.07
0.07
0.16
0.18
0.20
0.22
0.38
0.14
0.22
0.17
0.36
0.26
0.53
0.40
0.47
0.41
0.54
0.35
0.47
0.43
0.36
0.31
0.52
0.44

0.01
0.01
0.05
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.02
0.01
0.01
0.03
0.02
0.02
0.02
0.03
0.02
0.02
0.01
0.04
0.07
0.07
0.06
0.04
0.06
0.03
0.01
0.04
0.05
0.03
0.03
0.02
0.02
0.03
0.02
0.01
0.02
0.02
0.04
0.02

42
39
4
52
13
8
22
14
18
60
20
42
46
1
18
15
7
0
7
5
6
23
6
11
127
2
5
2
6
6
4
5
259
16
10
81
68
120
229
64
192
402
104
99
27
116

0.4
0.3
0.3
0.3
0.4
0.1
0.2
0.1
0.2
0.2
0.1
0.2
0.5
0.1
0.4
0.2
0.2
0.3
0.1
0.1
1.0
0.2
0.2
0.3
0.1
0.4
0.3
0.2
0.3
0.3
0.1
0.4
0.4
0.3
0.6
0.5
0.5
0.6
0.6
0.5
0.6
0.4
0.4
0.4
0.4

0.07
0.04
0.14
0.04
0.13
0.05
0.05
0.03
0.04
0.03
0.03
0.03
0.08
0.13
0.10
0.06
0.06
0.12
0.06
0.06
0.22
0.07
0.07
0.03
0.09
0.21
0.23
0.10
0.15
0.17
0.05
0.02
0.10
0.09
0.07
0.07
0.05
0.05
0.08
0.04
0.03
0.05
0.04
0.08
0.04

0.04
0.03
0.02
0.04
0.04
0.01
0.04
0.02
0.02
0.03
0.01
0.02
0.06
0.01
0.04
0.03
0.02
0.02
0.01
0.01
0.11
0.02
0.03
0.03
0.02
0.08
0.04
0.02
0.06
0.06
0.01
0.05
0.05
0.03
0.06
0.07
0.06
0.08
0.08
0.06
0.07
0.06
0.05
0.05
0.05

0.01
0.01
0.01
0.01
0.01 *
0.01
0.01
0.00 *
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.03
0.01
0.01
0.00
0.01
0.04
0.03
0.01
0.03
0.03
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01

712
0
414
212
34
450
295
21
3
285
37
5
1
4
11
15

2.9
3.3
3.6
1.9
2.5
4.7
2.5
0.6
2.1
0.7
0.7
0.1
0.9
0.6
1.2

0.11
0.17
0.26
0.33
0.12
0.28
0.56
0.39
0.13
0.13
0.32
0.08
0.44
0.21
0.32

0.36
0.38
0.46
0.28
0.30
0.57
0.39
0.11
0.27
0.08
0.06
0.16
0.08
0.11

0.02
0.02
0.04
0.05
0.02
0.04
0.10
0.08
0.02
0.02
0.06
0.09
0.04
0.04

157
0
84
40
7
97
45
1
1
52
5
0
1
0
3
0

0.5
0.6
0.6
0.4
0.5
0.6
0.1
0.3
0.3
0.1
0.1
0.1
-

0.05
0.07
0.11
0.15
0.05
0.10
0.11
0.28
0.05
0.04
0.12
0.08
-

0.06
0.07
0.07
0.05
0.06
0.08
0.01
0.07
0.03
0.01
0.03
0.01
-

0.01
0.01
0.01
0.02
0.01
0.02
0.01
0.07
0.01
0.01
0.03
0.01
-

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

467

525

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Kaposi sarcoma (C46)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

468

Female
ASR(W)
CUM 0-74

3
9
5
802
1822

0.1
0.2
0.5
33.0
52.2

0.08
0.08
0.24
1.56
1.46

1
1
5
641
909

0.1
0.0
0.5
21.5
25.2

0.06
0.02
0.22
1.14
1.04

4
24
4
19
452
2
113
60
7
13
7

0.5
0.8
0.3
1.0
1.6
0.2
2.5
0.6
0.2
1.2
0.7

0.27
0.18
0.16
0.25
0.09
0.12
0.24
0.08
0.07
0.33
0.28

0.07
0.09
0.03
0.09
0.14
0.21
0.04
0.01
0.12
0.10

0.04
0.03
0.01
0.03
0.01
0.02
0.01
0.00
0.04
0.05

1
7
2
3
74
1
9
10
4
2
4

0.0
0.2
0.3
0.1
0.2
0.1
0.2
0.1
0.1
0.1
0.2

0.03
0.08
0.20
0.09
0.03
0.12
0.05
0.04
0.05
0.04
0.12

0.02
0.04
0.02
0.02
0.01
0.01
0.01
0.01
0.01

0.01
0.03
0.01
0.00
0.01
0.00
0.00
0.01
0.01 *

214
24
76
10
8
4
0
6
80
1
5
36
8
27
5
72
1477
48
209
412
717
382
64
3
8
0
54
229
610
102
5
8
2
0
225
228
93
67
14
50
85
60
16
587
135
447
288
154
125
237
137
91
4
212
93
108
61
18
36
118
46
70
21
24

0.3
0.2
0.5
0.3
0.3
0.2
0.1
0.2
0.2
0.1
0.2
0.3
0.2
0.2
0.5
1.4
0.4
2.9
1.5
1.2
1.7
4.1
0.2
0.8
1.4
1.9
2.1
3.7
0.5
1.0
0.5
2.0
2.0
0.6
0.6
1.5
0.5
4.6
6.2
2.3
1.2
2.0
1.0
1.1
2.3
0.7
2.4
4.3
1.5
0.1
0.5
1.9
0.3
0.3
0.2
0.3
0.9
1.3
0.7
2.0
1.5

0.02
0.05
0.06
0.10
0.09
0.11
0.06
0.02
0.22
0.06
0.04
0.10
0.05
0.10
0.06
0.04
0.05
0.20
0.08
0.05
0.09
0.52
0.12
0.27
0.21
0.13
0.09
0.37
0.23
0.36
0.37
0.14
0.14
0.07
0.07
0.39
0.07
0.51
0.80
0.58
0.05
0.18
0.05
0.07
0.19
0.06
0.16
0.39
0.16
0.05
0.04
0.19
0.03
0.04
0.05
0.05
0.08
0.19
0.09
0.44
0.30

0.03
0.03
0.05
0.03
0.02
0.04
0.01
0.02
0.02
0.01
0.02
0.02
0.02
0.02
0.04
0.12
0.03
0.25
0.15
0.11
0.16
0.36
0.02
0.06
0.16
0.17
0.19
0.32
0.07
0.08
0.04
0.18
0.18
0.06
0.05
0.13
0.05
0.40
0.51
0.22
0.10
0.18
0.09
0.09
0.19
0.06
0.20
0.36
0.13
0.01
0.05
0.16
0.03
0.03
0.02
0.02
0.07
0.09
0.06
0.17
0.12

0.00
0.01
0.01
0.01
0.01
0.02
0.01
0.00
0.02
0.01
0.00
0.01
0.00
0.01
0.01
0.00
0.01
0.02
0.01
0.00
0.01
0.05
0.01
0.02
0.03
0.01
0.01
0.03
0.03
0.03
0.03
0.02
0.01
0.01
0.01
0.03
0.01
0.05
0.07
0.07
0.00
0.02
0.00
0.01
0.02
0.01
0.02
0.04
0.02
0.01
0.00
0.02
0.00
0.00
0.00
0.00
0.01
0.02
0.01
0.04
0.03

32
6
12
2
1
3
0
2
6
0
0
8
3
3
2
7
111
4
10
25
62
27
4
0
0
0
5
14
38
4
0
1
0
0
11
17
4
24
2
22
6
6
0
103
43
60
14
9
4
8
6
2
1
33
9
23
13
2
9
32
8
24
1
8

0.0
0.1
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.3
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.2
0.1
0.3
0.5
0.1
0.6
0.1
0.0
0.1
0.0
0.1
0.2
0.0
0.0
0.1
0.2
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.2

0.01
0.03
0.03
0.02
0.01
0.04
0.01
0.00
0.01
0.04
0.01
0.06
0.01
0.01
0.01
0.04
0.02
0.01
0.02
0.14
0.08
0.02
0.02
0.07
0.10
0.03
0.02
0.01
0.03
0.13
0.03
0.12
0.19
0.02
0.09
0.01
0.01
0.04
0.01
0.03
0.07
0.03
0.03
0.01
0.06
0.01
0.02
0.01
0.02
0.02
0.05
0.03
0.04
0.07

0.00
0.01
0.01
0.00
0.00
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.01
0.01
0.00
0.01
0.03
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.02
0.01
0.03
0.04
0.01
0.06
0.01
0.00
0.01
0.00
0.01
0.02
0.00
0.00
0.01
0.02
0.01
0.00
0.00
0.01
0.01
0.00
0.00

0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.00
0.00
0.01
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.02
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.00

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

526

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Kaposi sarcoma (C46) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

5
146
145
56
83
105
47
56
63
13
48
7
5568
1446
3787
258
86
161
37
3
19
13
831
300
515
99
20
71
30
44
215
85
122
27
946
275
597
2509
68
561
505
1243
31
24
6
435
68
361
10
4
137
114
18
34

0.1
0.7
0.5
1.5
0.3
0.8
1.8
0.5
0.3
0.7
0.3
0.3
0.8
1.9
0.6
0.9
2.4
0.6
0.7
0.7
0.9
0.5
1.4
3.8
1.0
0.3
0.6
0.2
0.3
0.4
0.5
2.5
0.3
0.7
1.1
3.0
0.9
1.1
0.3
2.4
1.4
0.8
0.3
0.8
0.1
0.7
0.9
0.7
0.2
0.2
0.7
0.8
0.3
0.2

0.06
0.06
0.04
0.20
0.03
0.08
0.26
0.07
0.04
0.21
0.04
0.11
0.01
0.05
0.01
0.06
0.27
0.05
0.11
0.43
0.22
0.14
0.05
0.22
0.05
0.03
0.13
0.03
0.05
0.06
0.04
0.27
0.03
0.15
0.04
0.18
0.04
0.02
0.04
0.10
0.07
0.02
0.05
0.16
0.03
0.03
0.11
0.04
0.05
0.09
0.06
0.08
0.06
0.03

0.01
0.06
0.04
0.12
0.02
0.07
0.14
0.04
0.03
0.06
0.02
0.02
0.07
0.16
0.05
0.08
0.22
0.06
0.06
0.05
0.10
0.04
0.12
0.33
0.09
0.02
0.05
0.02
0.03
0.04
0.04
0.20
0.03
0.06
0.10
0.25
0.08
0.09
0.03
0.20
0.14
0.07
0.02
0.06
0.00
0.06
0.07
0.06
0.01
0.01
0.06
0.07
0.02
0.02

0.01
0.01
0.00
0.02
0.00
0.01
0.02
0.01
0.00
0.02
0.00
0.01
0.00
0.00
0.00
0.01
0.03
0.01
0.01
0.04
0.03
0.01
0.00
0.02
0.00
0.00
0.01
0.00
0.01
0.01
0.00
0.02
0.00
0.01
0.00
0.02
0.00
0.00
0.00
0.01
0.01
0.00
0.00
0.02
0.00
0.00
0.01
0.00
0.00
0.01
0.01
0.01
0.01
0.00

1
24
27
4
20
17
4
12
11
1
10
1
767
187
537
49
9
39
7
0
5
2
164
57
105
14
0
13
7
4
30
4
25
7
94
19
69
270
6
43
42
168
1
0
1
71
9
60
3
1
7
5
3
8

0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.1
0.2
0.1
0.1
0.2
0.1
0.1
0.2
0.0
0.2
0.6
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.1
0.2
0.1
0.1
0.0
0.2
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0

0.01
0.02
0.01
0.04
0.01
0.02
0.04
0.02
0.01
0.02
0.01
0.04
0.00
0.02
0.00
0.02
0.08
0.02
0.03
0.09
0.01
0.02
0.08
0.01
0.01
0.01
0.01
0.02
0.01
0.06
0.01
0.05
0.01
0.04
0.01
0.01
0.01
0.02
0.02
0.01
0.00
0.00
0.01
0.04
0.01
0.02
0.01
0.01
0.02
0.02
0.01

0.01
0.00
0.00
0.00
0.01
0.01
0.00
0.00
0.00
0.00
0.01
0.02
0.00
0.01
0.02
0.01
0.01
0.02
0.01
0.05
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.01
0.02
0.00
0.01
0.00
0.01
0.01
0.00
0.01
0.01
0.01
0.00
0.00
0.00
0.00
0.00

0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

1
0
7
0
0
0
0
11
0
1
0
3
0
0
0
517
487
17
2
0
0
1
0
0
0

0.2
0.0
0.5
0.0
0.0
2.8
2.9
1.2
0.1
0.0
-

0.22
0.01
0.14
0.00
0.00
0.13
0.14
0.30
0.04
0.01
-

0.04
0.00
0.04
0.00
0.00
0.31
0.32
0.17
0.01
0.00
-

0.04
0.00
0.02
0.00
0.00
0.02
0.02
0.05
0.01
0.00
-

1
0
1
0
0
0
0
7
0
2
0
0
0
0
0
229
212
6
2
0
0
0
2
0
0

0.2
0.0
0.2
0.0
0.9
0.9
0.4
0.1
0.0
-

0.18
0.00
0.09
0.02
0.06
0.07
0.16
0.04
0.01
-

0.02
0.00
0.02
0.00
0.08
0.09
0.04
0.01
0.00
-

0.02
- *
0.00
- *
- *
- *
0.01 *
0.00 *
- *
- *
- *
0.01
0.01
0.02
0.01
0.00
-

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

469

527

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Kaposi sarcoma (C46) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

470

Female
ASR(W)
CUM 0-74

34
2
1
1
2
6
1
26
1
2
2
0
1
8
0
2
10
9
0
1
3
1
0
14
11

0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.0
0.2
0.1
0.0
0.5
0.0
0.1
0.1
0.1
0.1
0.1
0.5
0.1

0.01
0.01
0.02
0.02
0.07
0.06
0.14
0.03
0.03
0.15
0.04
0.02
0.19
0.02
0.03
0.04
0.06
0.04
0.06
0.14
0.04

0.00
0.00
0.00
0.02
0.02
0.02
0.01
0.00
0.03
0.01
0.00
0.09
0.00
0.01
0.01
0.00
0.00
0.00
0.05
0.02

0.00
0.00
0.00
0.01
0.01
0.02
0.00
0.00
0.02
0.00
0.00
0.04
0.00
0.00
0.01
0.01
0.00
0.00
0.02
0.01

24
0
1
1
2
2
0
10
1
0
0
1
0
7
1
1
0
0
0
0
0
0
0
7
3

0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.4
0.0
0.0
0.2
0.0

0.00
0.01
0.02
0.04
0.02
0.01
0.03
0.06
0.15
0.02
0.01
0.09
0.02

0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.04
0.00
0.03
0.01

0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.02 *
0.00 *
- *
- *
- *
0.01 *
0.00 *

13
1
1
27
6
20
32
17
29
45
7
44
0
1
2
1
11
3
3
2
1
1
1
6
1
9
2
13
4
3
8
19
8
55
22
52
43
8
75
34
13
53
20
13
35
41
17
44
7
6
85
6
27
67

0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.2
0.1
0.1
0.0
0.4
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.0
0.1
0.0
0.1
0.7
0.2
1.0
2.2
1.3
1.0
1.7
0.9
1.9
1.4
0.8
0.6
1.1
0.8
1.7
1.0
0.5
2.1
0.5
0.8
2.1
0.2
1.5
1.1

0.02
0.04
0.08
0.02
0.05
0.03
0.02
0.02
0.01
0.04
0.06
0.03
0.05
0.07
0.04
0.11
0.05
0.05
0.10
0.06
0.03
0.06
0.02
0.01
0.04
0.02
0.04
0.02
0.04
0.25
0.04
0.38
0.30
0.30
0.16
0.28
0.37
0.23
0.24
0.24
0.08
0.27
0.24
0.31
0.17
0.12
0.33
0.21
0.31
0.24
0.07
0.30
0.14

0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.00
0.01
0.00
0.03
0.01
0.01
0.02
0.00
0.01
0.01
0.00
0.02
0.00
0.01
0.00
0.01
0.05
0.01
0.10
0.25
0.13
0.10
0.18
0.09
0.17
0.16
0.07
0.06
0.10
0.09
0.18
0.07
0.06
0.21
0.05
0.09
0.23
0.02
0.17
0.11

0.00
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.01
0.00
0.01
0.01
0.01
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.03
0.00
0.04
0.04
0.03
0.02
0.03
0.04
0.02
0.03
0.03
0.01
0.03
0.04
0.04
0.01
0.02
0.05
0.02
0.05
0.03
0.01
0.04
0.02

5
0
0
18
2
12
11
9
23
7
2
48
0
0
0
0
4
1
0
1
0
0
0
1
1
2
2
3
0
0
8
3
9
20
12
16
13
1
26
19
7
23
4
6
17
6
15
24
5
1
28
6
9
15

0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.4
0.0
0.7
0.4
0.4
0.2
0.4
0.0
0.3
0.4
0.3
0.1
0.2
0.3
0.5
0.1
0.2
1.1
0.2
0.2
0.5
0.1
0.2
0.1

0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.02
0.08
0.03
0.01
0.01
0.00
0.02
0.01
0.01
0.17
0.02
0.27
0.12
0.12
0.05
0.12
0.04
0.07
0.12
0.13
0.04
0.11
0.11
0.16
0.06
0.07
0.25
0.09
0.20
0.12
0.04
0.08
0.04

0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.02
0.00
0.06
0.03
0.04
0.02
0.05
0.03
0.04
0.03
0.02
0.01
0.03
0.05
0.01
0.03
0.10
0.03
0.02
0.05
0.01
0.01
0.02

0.00
0.00 *
0.00 *
0.00
0.00 *
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.02
0.00
0.03
0.01
0.02
0.01
0.02
0.01
0.02
0.02
0.00
0.01
0.02
0.02
0.01
0.01
0.03
0.02
0.02
0.01
0.01
0.01
0.01

*Important. See note on population page.

528

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Kaposi sarcoma (C46) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

6
13
9
25
3
2
1
66
169
16
1
14
4
10
25
43
58
0
16
9
24
9
17
10
92
19
1
3
4
10
5
18
171
6
9
8
6
28
12
9
17
210
11
20
3
22

0.1
0.1
0.6
0.1
0.1
0.1
0.0
0.7
2.1
0.1
0.0
0.1
0.1
0.9
0.7
0.7
1.3
0.9
0.3
0.7
0.3
1.0
0.3
0.2
1.4
0.1
0.5
0.2
0.7
0.5
0.9
0.3
0.2
0.3
0.1
0.1
0.2
0.1
0.1
0.1
0.5
0.1
0.1
0.1
0.2

0.03
0.03
0.22
0.03
0.06
0.04
0.01
0.08
0.17
0.03
0.01
0.02
0.03
0.31
0.15
0.11
0.17
0.22
0.10
0.15
0.10
0.27
0.10
0.03
0.31
0.07
0.29
0.12
0.24
0.23
0.21
0.03
0.08
0.09
0.03
0.04
0.04
0.02
0.03
0.02
0.03
0.02
0.03
0.03
0.03

0.01
0.01
0.06
0.01
0.02
0.00
0.06
0.18
0.01
0.00
0.01
0.00
0.13
0.06
0.06
0.13
0.08
0.03
0.06
0.03
0.09
0.02
0.03
0.14
0.03
0.02
0.06
0.06
0.09
0.03
0.02
0.03
0.01
0.01
0.02
0.00
0.01
0.01
0.04
0.01
0.01
0.01
0.01

0.00
0.00
0.03
0.00
0.01
0.00
0.01
0.01
0.00
0.00
0.00
0.00
0.04
0.01
0.01
0.02
0.02
0.01
0.01
0.02
0.02
0.01
0.00
0.04
0.02
0.01
0.03
0.03
0.02
0.00
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

3
5
4
16
0
2
1
19
35
6
2
7
2
6
11
13
3
0
4
5
5
1
2
4
43
3
0
1
0
3
1
1
28
0
0
3
2
7
5
2
6
49
5
3
1
4

0.0
0.0
0.2
0.1
0.0
0.0
0.2
0.4
0.0
0.0
0.0
0.0
0.4
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0

0.02
0.01
0.13
0.02
0.02
0.01
0.04
0.07
0.01
0.01
0.01
0.02
0.20
0.05
0.04
0.03
0.07
0.05
0.05
0.05
0.09
0.07
0.01
0.12
0.10
0.12
0.03
0.04
0.01
0.01
0.01
0.02
0.01
0.02
0.01
0.02
0.01
0.01
0.01
0.01

0.00
0.00
0.03
0.00
0.01
0.00
0.01
0.03
0.00
0.00
0.00
0.00
0.05
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.03
0.02
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.00

0.00
0.00
0.02
0.00
- *
0.00
0.00
0.00 *
0.01
0.00
0.00
0.00
0.00
0.02
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.03
0.02
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

138
0
31
26
0
74
19
3
0
13
28
1
2
3
1
14

0.6
0.3
0.4
0.4
0.3
0.4
0.1
0.7
0.4
0.4
0.6
0.1
1.2

0.06
0.05
0.09
0.05
0.07
0.21
0.03
0.14
0.37
0.29
0.34
0.12
0.33

0.06
0.03
0.05
0.05
0.03
0.04
0.01
0.07
0.03
0.03
0.09
0.01
0.13

0.01
0.01
0.01
0.01
0.01
0.02
0.00
0.01
0.03
0.02
0.06
0.01
0.04

20
0
2
6
0
23
4
2
0
4
3
0
0
0
1
2

0.1
0.0
0.1
0.1
0.0
0.2
0.0
0.0
0.0
0.1

0.01
0.01
0.02
0.03
0.02
0.14
0.02
0.01
0.02
0.05

0.01
0.00
0.00
0.01
0.00
0.02
0.00
-

0.00
0.00
0.00
0.00
0.00
0.02
0.00
-

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

471

529

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Connective and soft tissue (C47+C49)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

472

Female
ASR(W)
CUM 0-74

22
169
15
42
46

0.8
3.3
1.4
1.5
1.5

0.18
0.28
0.37
0.32
0.28

14
173
15
46
43

0.5
2.7
1.3
2.7
1.8

0.14
0.21
0.35
0.51
0.38

19
102
13
46
767
20
87
150
81
25
35

2.5
3.8
1.6
2.6
3.4
2.2
2.2
1.8
2.7
2.4
3.6

0.59
0.42
0.48
0.40
0.13
0.50
0.24
0.15
0.32
0.50
0.63

0.22
0.32
0.14
0.26
0.33
0.26
0.23
0.17
0.28
0.27
0.44

0.06
0.05
0.05
0.06
0.02
0.07
0.03
0.02
0.04
0.06
0.10

21
72
22
47
892
11
106
143
87
15
24

2.2
2.3
2.7
2.3
3.2
1.0
2.3
1.6
2.6
1.1
2.2

0.56
0.30
0.62
0.35
0.11
0.32
0.23
0.14
0.29
0.32
0.46

0.22
0.24
0.28
0.22
0.31
0.12
0.24
0.16
0.26
0.10
0.24

0.06
0.04
0.08
0.04
0.01
0.05
0.03
0.02
0.04
0.03
0.06 *

1808
193
272
95
61
39
1
81
963
10
93
356
69
276
36
428
2749
189
158
505
1801
537
37
26
16
9
83
332
694
64
13
18
4
6
194
365
353
304
26
268
31
19
10
1691
163
1513
570
132
434
198
61
135
99
957
121
797
492
265
346
357
88
261
21
48

2.4
2.2
2.0
2.3
2.6
2.2
1.8
2.5
2.7
2.0
2.7
2.5
2.4
2.4
2.3
2.6
2.8
1.7
2.6
2.4
3.0
2.8
2.7
1.8
2.0
2.6
2.9
2.9
2.6
2.6
1.2
2.2
1.4
1.3
2.2
3.0
2.8
2.8
3.2
2.6
1.9
1.9
1.6
2.8
2.8
2.8
2.6
2.5
2.7
2.9
2.7
3.0
2.7
2.6
2.7
2.6
2.8
2.7
2.9
2.7
2.6
2.7
2.0
2.4

0.06
0.16
0.13
0.25
0.36
0.35
1.81
0.30
0.09
0.66
0.31
0.14
0.30
0.16
0.40
0.13
0.06
0.13
0.21
0.11
0.08
0.13
0.46
0.36
0.51
0.89
0.35
0.18
0.10
0.33
0.35
0.53
0.93
0.54
0.17
0.18
0.15
0.17
0.64
0.18
0.36
0.45
0.54
0.08
0.22
0.08
0.11
0.22
0.14
0.21
0.37
0.27
0.28
0.09
0.25
0.10
0.13
0.18
0.16
0.15
0.28
0.18
0.43
0.37

0.23
0.20
0.19
0.22
0.24
0.20
0.30
0.24
0.26
0.11
0.24
0.24
0.21
0.24
0.21
0.24
0.27
0.18
0.25
0.23
0.29
0.28
0.27
0.20
0.20
0.27
0.32
0.29
0.25
0.25
0.14
0.20
0.09
0.10
0.20
0.28
0.28
0.27
0.32
0.26
0.14
0.16
0.09
0.28
0.28
0.28
0.24
0.23
0.25
0.26
0.26
0.27
0.24
0.26
0.26
0.25
0.27
0.28
0.28
0.26
0.24
0.26
0.13
0.24

0.01
0.02
0.01
0.03
0.04
0.04
0.30
0.03
0.01
0.05
0.03
0.02
0.03
0.02
0.05
0.01
0.01
0.02
0.03
0.02
0.01
0.02
0.06
0.04
0.06
0.11
0.05
0.02
0.01
0.04
0.05
0.06
0.05
0.05
0.02
0.02
0.02
0.02
0.08
0.02
0.03
0.04
0.03
0.01
0.03
0.01
0.01
0.03
0.01
0.02
0.05
0.03
0.03
0.01
0.03
0.01
0.02
0.02
0.02
0.02
0.03
0.02
0.03
0.04

1481
147
205
70
44
37
2
56
837
15
68
311
86
216
34
338
2074
151
126
465
1288
357
29
15
10
1
59
219
559
59
12
16
7
5
180
262
290
244
20
220
44
31
12
1284
160
1103
490
153
330
168
66
98
82
807
121
660
438
203
288
330
112
216
36
48

1.9
1.7
1.5
1.6
1.8
2.0
2.6
1.5
2.2
2.8
2.2
2.0
2.5
1.8
2.3
1.9
2.0
1.2
1.8
2.0
2.1
1.7
1.9
0.8
1.3
0.4
2.0
1.8
1.9
1.8
0.9
1.8
1.5
0.6
2.0
2.2
2.2
1.9
2.1
1.9
2.0
2.3
1.8
2.1
2.3
2.0
2.0
2.3
1.8
2.2
2.6
2.1
2.0
1.9
2.0
1.9
2.2
1.9
2.1
2.2
2.5
2.0
2.8
2.2

0.06
0.15
0.12
0.22
0.30
0.35
2.05
0.23
0.08
0.85
0.29
0.13
0.28
0.14
0.41
0.11
0.05
0.11
0.16
0.10
0.07
0.10
0.37
0.25
0.43
0.43
0.27
0.15
0.09
0.24
0.26
0.50
0.76
0.27
0.15
0.17
0.14
0.14
0.48
0.15
0.34
0.44
0.75
0.07
0.19
0.08
0.09
0.20
0.11
0.18
0.34
0.23
0.24
0.08
0.19
0.09
0.12
0.16
0.14
0.13
0.25
0.15
0.47
0.38

0.18
0.15
0.15
0.16
0.16
0.20
0.38
0.14
0.20
0.26
0.22
0.19
0.25
0.16
0.19
0.19
0.19
0.12
0.17
0.19
0.20
0.16
0.19
0.07
0.10
0.03
0.20
0.18
0.18
0.18
0.12
0.18
0.11
0.05
0.18
0.20
0.21
0.19
0.25
0.18
0.20
0.23
0.13
0.20
0.23
0.20
0.19
0.23
0.18
0.23
0.30
0.21
0.19
0.18
0.19
0.18
0.20
0.18
0.19
0.21
0.22
0.20
0.22
0.23

0.01
0.01
0.01
0.02
0.03
0.04
0.33
0.02
0.01
0.09
0.03
0.01
0.03
0.01
0.04
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.04
0.02
0.03
0.03
0.03
0.02
0.01
0.03
0.04
0.05
0.06
0.04
0.02
0.02
0.02
0.02
0.07
0.02
0.04
0.05
0.05
0.01
0.02
0.01
0.01
0.02
0.01
0.02
0.05
0.02
0.03
0.01
0.02
0.01
0.01
0.02
0.01
0.01
0.03
0.02
0.04
0.04

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

530

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Connective and soft tissue (C47+C49) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

109
523
816
78
706
359
55
294
442
48
389
65
18132
1599
15738
749
61
663
186
11
45
128
1496
171
1268
889
74
772
218
294
1033
74
932
105
2293
188
1909
6152
317
479
664
4546
271
61
207
1406
137
1216
175
65
531
337
163
402

2.4
2.6
2.7
2.2
2.7
3.0
2.2
3.2
2.5
3.3
2.5
2.4
2.7
2.4
2.7
2.9
2.1
3.0
3.4
2.9
2.5
4.0
2.6
2.5
2.7
2.6
2.3
2.5
2.0
2.5
2.5
2.4
2.5
2.9
2.9
2.5
3.0
2.8
1.9
2.4
2.4
2.9
2.3
2.1
2.3
2.5
2.3
2.4
3.0
3.5
3.0
2.8
2.7
2.4

0.25
0.12
0.10
0.26
0.11
0.17
0.30
0.20
0.13
0.48
0.13
0.34
0.02
0.06
0.02
0.11
0.28
0.13
0.26
0.89
0.37
0.39
0.07
0.19
0.08
0.09
0.27
0.10
0.15
0.16
0.09
0.29
0.09
0.32
0.06
0.18
0.07
0.04
0.11
0.11
0.10
0.05
0.14
0.27
0.17
0.07
0.21
0.07
0.23
0.47
0.14
0.16
0.23
0.13

0.22
0.27
0.25
0.19
0.26
0.28
0.20
0.30
0.25
0.31
0.24
0.21
0.26
0.24
0.26
0.28
0.22
0.30
0.36
0.36
0.25
0.43
0.26
0.25
0.26
0.25
0.23
0.24
0.21
0.26
0.25
0.25
0.25
0.29
0.28
0.24
0.29
0.27
0.18
0.24
0.24
0.28
0.21
0.17
0.22
0.24
0.24
0.23
0.30
0.33
0.28
0.26
0.28
0.24

0.03
0.01
0.01
0.03
0.01
0.02
0.03
0.02
0.01
0.05
0.01
0.03
0.00
0.01
0.00
0.01
0.04
0.01
0.03
0.14
0.05
0.05
0.01
0.02
0.01
0.01
0.03
0.01
0.02
0.02
0.01
0.04
0.01
0.04
0.01
0.02
0.01
0.00
0.01
0.01
0.01
0.01
0.02
0.03
0.02
0.01
0.03
0.01
0.03
0.05
0.02
0.02
0.03
0.01

95
483
672
82
571
270
52
213
342
29
305
64
15124
1756
12703
662
95
548
105
7
35
61
1403
199
1149
730
85
617
225
245
919
88
801
76
1703
182
1402
4827
231
505
604
3408
274
84
186
1100
136
924
127
41
411
272
135
342

2.1
2.0
2.0
2.1
2.0
2.0
1.8
2.0
1.7
1.5
1.7
1.9
2.0
2.1
2.0
2.2
2.6
2.2
1.7
1.6
1.6
1.7
2.1
2.2
2.1
1.8
2.1
1.7
1.9
2.1
1.9
2.2
1.8
1.9
1.9
2.1
2.0
2.0
1.2
2.1
2.0
2.1
2.0
2.2
2.0
1.7
1.9
1.7
2.2
2.0
2.2
2.1
1.9
1.8

0.26
0.11
0.09
0.24
0.10
0.13
0.26
0.16
0.11
0.29
0.11
0.29
0.02
0.05
0.02
0.10
0.28
0.11
0.18
0.60
0.28
0.28
0.06
0.16
0.07
0.08
0.24
0.08
0.14
0.16
0.08
0.25
0.08
0.26
0.05
0.16
0.06
0.03
0.08
0.10
0.09
0.04
0.13
0.25
0.17
0.05
0.17
0.06
0.20
0.35
0.12
0.15
0.19
0.11

0.19
0.20
0.19
0.19
0.19
0.18
0.16
0.19
0.16
0.16
0.15
0.21
0.19
0.21
0.19
0.20
0.26
0.20
0.16
0.14
0.14
0.17
0.20
0.22
0.20
0.17
0.24
0.16
0.18
0.18
0.18
0.22
0.17
0.20
0.18
0.21
0.19
0.19
0.11
0.21
0.19
0.20
0.19
0.21
0.18
0.16
0.19
0.16
0.20
0.18
0.20
0.19
0.18
0.16

0.02
0.01
0.01
0.03
0.01
0.01
0.03
0.02
0.01
0.04
0.01
0.03
0.00
0.01
0.00
0.01
0.03
0.01
0.02
0.06
0.03
0.03
0.01
0.02
0.01
0.01
0.03
0.01
0.01
0.01
0.01
0.03
0.01
0.03
0.01
0.02
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.03
0.02
0.01
0.02
0.01
0.02
0.03
0.01
0.01
0.02
0.01

10
85
352
5
13
343
37
38
113
468
12
337
56
123
35
521
457
43
31
21
45
97
69
264
45

1.4
1.5
1.9
0.4
0.5
1.6
1.1
1.9
1.1
1.8
1.3
1.3
1.3
1.6
1.3
3.3
3.3
2.0
1.0
0.7
1.3
1.1
1.3
1.0
1.2

0.46
0.17
0.11
0.20
0.14
0.11
0.19
0.32
0.11
0.09
0.38
0.07
0.17
0.16
0.22
0.15
0.16
0.35
0.19
0.21
0.22
0.12
0.19
0.07
0.25

0.11
0.14
0.18
0.04
0.05
0.16
0.11
0.22
0.11
0.18
0.13
0.13
0.12
0.18
0.13
0.35
0.35
0.25
0.09
0.06
0.10
0.12
0.12
0.08
0.10

0.05
0.02
0.01
0.02
0.02
0.01
0.02
0.04
0.01
0.01
0.05
0.01
0.02
0.02
0.03
0.02
0.02
0.06
0.02
0.02
0.02
0.01
0.02
0.01
0.02

4
91
340
8
5
302
23
36
86
373
13
241
54
79
26
400
350
31
24
19
30
94
66
206
35

0.5
1.5
1.8
0.7
0.2
1.3
0.7
1.9
0.9
1.7
1.1
1.0
1.2
1.1
0.8
2.3
2.3
1.2
0.8
0.4
0.9
1.1
1.1
0.7
0.7

0.24
0.16
0.11
0.27
0.09
0.09
0.14
0.34
0.10
0.10
0.31
0.07
0.17
0.13
0.16
0.12
0.13
0.24
0.18
0.10
0.21
0.13
0.17
0.06
0.17

0.04
0.15
0.16
0.08
0.03
0.14
0.05
0.16
0.08
0.18
0.08
0.11
0.11
0.10
0.09
0.23
0.23
0.12
0.07
0.04
0.08
0.10
0.11
0.06
0.05

0.02
0.02 *
0.01
0.03 *
0.01
0.01 *
0.01 *
0.03 *
0.01
0.01 *
0.02
0.01
0.02 *
0.01 *
0.02 *
0.01
0.01
0.03
0.02
0.01
0.02
0.01
0.01
0.00
0.01

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

473

531

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Connective and soft tissue (C47+C49) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

474

Female
ASR(W)
CUM 0-74

1224
119
75
30
39
95
8
320
24
19
30
27
64
38
84
200
122
96
8
18
43
25
40
69
140

1.3
1.3
1.3
1.1
1.2
1.6
0.9
1.4
1.4
1.3
1.0
1.3
1.4
1.4
2.4
2.3
1.4
1.5
1.1
1.7
1.1
1.2
1.3
2.3
1.7

0.04
0.13
0.15
0.22
0.21
0.18
0.34
0.09
0.31
0.33
0.42
0.26
0.18
0.25
0.29
0.19
0.14
0.16
0.41
0.42
0.18
0.25
0.21
0.28
0.15

0.14
0.13
0.14
0.08
0.13
0.17
0.11
0.15
0.11
0.14
0.07
0.14
0.12
0.12
0.23
0.26
0.15
0.15
0.11
0.17
0.11
0.10
0.13
0.23
0.17

0.01
0.01
0.02
0.02
0.03
0.02
0.04
0.01
0.04
0.04
0.03
0.03
0.02
0.03
0.04
0.03
0.02
0.02
0.04
0.05
0.02
0.02
0.03
0.03
0.02

1071
96
83
24
36
67
8
299
26
19
15
31
51
22
59
203
96
79
5
12
28
19
28
52
134

1.0
0.9
1.2
0.7
1.1
1.1
1.0
1.2
1.3
1.3
0.7
1.2
1.1
0.8
2.3
2.0
1.0
1.0
0.8
1.1
0.7
1.0
0.9
1.6
1.7

0.03
0.10
0.14
0.15
0.19
0.14
0.35
0.07
0.26
0.34
0.24
0.23
0.16
0.19
0.34
0.15
0.11
0.13
0.38
0.34
0.14
0.24
0.17
0.23
0.15

0.10
0.10
0.13
0.06
0.11
0.09
0.09
0.12
0.11
0.13
0.07
0.12
0.10
0.07
0.24
0.20
0.09
0.09
0.05
0.11
0.06
0.08
0.06
0.14
0.14

0.00
0.01
0.02
0.01
0.02
0.01
0.03
0.01
0.03
0.05
0.03
0.03
0.02
0.03 *
0.04 *
0.02 *
0.01
0.01
0.02
0.04
0.01 *
0.02 *
0.01
0.02 *
0.01 *

585
56
25
556
121
399
461
285
703
426
81
468
62
45
38
46
87
53
65
33
28
26
29
184
358
130
120
198
220
80
17
265
15
35
39
114
53
13
132
39
26
191
35
20
37
59
51
28
16
5
90
58
45
140

2.2
2.7
2.2
2.1
1.9
2.5
1.9
2.1
2.3
2.4
2.1
2.9
2.1
2.3
3.1
2.1
3.1
1.5
1.9
2.0
1.5
1.8
1.3
2.1
2.3
2.4
2.1
2.7
2.7
1.9
2.0
2.4
1.7
1.9
2.4
2.4
1.9
2.1
3.4
1.8
1.8
2.5
2.0
1.7
2.2
1.8
1.8
1.9
1.4
0.7
2.8
1.7
2.5
2.5

0.10
0.39
0.45
0.09
0.19
0.14
0.10
0.13
0.09
0.13
0.24
0.15
0.28
0.36
0.56
0.33
0.37
0.22
0.25
0.41
0.30
0.45
0.29
0.18
0.14
0.25
0.21
0.22
0.20
0.23
0.50
0.15
0.47
0.37
0.56
0.25
0.31
0.67
0.35
0.37
0.36
0.21
0.42
0.41
0.44
0.33
0.28
0.42
0.38
0.32
0.37
0.27
0.42
0.24

0.22
0.24
0.23
0.20
0.18
0.24
0.18
0.20
0.22
0.22
0.22
0.26
0.20
0.23
0.21
0.21
0.27
0.15
0.18
0.18
0.15
0.20
0.13
0.21
0.24
0.24
0.21
0.24
0.26
0.20
0.20
0.24
0.19
0.16
0.26
0.23
0.17
0.22
0.34
0.17
0.18
0.23
0.16
0.19
0.21
0.15
0.19
0.18
0.13
0.06
0.26
0.17
0.22
0.23

0.01
0.04
0.06
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.03
0.01
0.03
0.04
0.04
0.03
0.03
0.02
0.03
0.04
0.04
0.05
0.03
0.02
0.01
0.02
0.02
0.02
0.02
0.03
0.06
0.02
0.06
0.03
0.05
0.03
0.03
0.07
0.03
0.03
0.04
0.02
0.04
0.05
0.04
0.02
0.03
0.04
0.04
0.04
0.03
0.03
0.04
0.02

533
47
24
642
88
347
363
272
601
360
98
437
65
42
25
36
70
58
63
35
26
27
16
176
310
156
105
174
207
66
8
165
11
40
36
87
61
11
98
46
18
163
27
12
23
69
54
26
15
5
70
49
29
108

1.7
2.1
1.9
1.8
1.4
2.0
1.3
1.5
1.6
1.8
1.8
2.3
1.6
1.9
1.3
1.7
2.1
1.5
1.5
1.6
1.6
1.7
0.8
1.7
1.5
2.2
1.4
1.9
2.0
1.4
0.9
1.4
1.1
2.0
1.8
2.0
2.3
1.7
2.2
2.1
1.1
1.8
1.3
1.1
1.8
1.5
1.9
2.0
1.3
0.6
2.2
1.3
1.2
1.5

0.09
0.36
0.44
0.08
0.17
0.13
0.08
0.11
0.08
0.11
0.23
0.14
0.23
0.34
0.33
0.31
0.31
0.23
0.23
0.32
0.37
0.41
0.26
0.16
0.12
0.23
0.17
0.18
0.18
0.23
0.36
0.12
0.38
0.36
0.36
0.29
0.42
0.63
0.32
0.42
0.28
0.18
0.35
0.33
0.50
0.22
0.30
0.50
0.40
0.33
0.39
0.27
0.27
0.17

0.16
0.20
0.13
0.17
0.13
0.19
0.12
0.15
0.16
0.17
0.17
0.21
0.16
0.17
0.08
0.15
0.16
0.15
0.15
0.15
0.12
0.16
0.07
0.17
0.15
0.22
0.14
0.18
0.19
0.14
0.07
0.14
0.14
0.18
0.18
0.16
0.21
0.14
0.22
0.18
0.10
0.17
0.13
0.11
0.13
0.17
0.16
0.16
0.11
0.06
0.19
0.13
0.12
0.14

0.01
0.03
0.03
0.01 *
0.02 *
0.01
0.01 *
0.01
0.01
0.01
0.02
0.01
0.02
0.03
0.02
0.03
0.02
0.02
0.02
0.03
0.03
0.04
0.02
0.01
0.01
0.02
0.02
0.02
0.02
0.02
0.03
0.01
0.05
0.03
0.04
0.02
0.03
0.05
0.03
0.03
0.03
0.02
0.03
0.04
0.03
0.02
0.03
0.04
0.03
0.03
0.03
0.02
0.03
0.02

*Important. See note on population page.

532

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Connective and soft tissue (C47+C49) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

113
158
31
329
27
62
65
178
208
196
291
267
113
13
72
139
91
11
56
67
75
40
34
53
846
35
19
15
42
20
26
67
1245
94
79
187
181
281
512
195
672
834
369
331
109
324

1.6
1.6
2.5
2.1
1.3
1.6
1.2
1.8
2.3
1.5
2.0
1.8
2.2
1.4
1.6
2.3
2.2
2.5
2.9
2.6
2.1
1.6
2.5
2.1
2.5
2.4
2.1
2.5
2.4
2.0
2.9
3.5
2.5
2.9
2.8
1.7
2.1
2.0
2.3
2.2
2.6
1.8
2.1
1.9
2.1
1.9

0.16
0.14
0.46
0.13
0.28
0.20
0.15
0.14
0.19
0.12
0.13
0.12
0.24
0.47
0.21
0.22
0.24
1.00
0.45
0.34
0.27
0.28
0.53
0.36
0.10
0.43
0.50
0.75
0.41
0.48
0.60
0.47
0.08
0.32
0.36
0.14
0.17
0.13
0.11
0.17
0.11
0.07
0.12
0.12
0.21
0.11

0.16
0.15
0.27
0.21
0.13
0.17
0.12
0.17
0.22
0.17
0.20
0.18
0.17
0.11
0.18
0.22
0.22
0.14
0.24
0.25
0.21
0.22
0.22
0.15
0.24
0.28
0.19
0.26
0.23
0.20
0.23
0.33
0.24
0.31
0.28
0.18
0.23
0.19
0.23
0.21
0.25
0.18
0.20
0.17
0.20
0.19

0.02
0.01
0.06
0.01
0.03
0.02
0.02
0.02
0.02
0.01
0.01
0.01
0.02
0.04
0.02
0.02
0.03
0.06
0.04
0.03
0.03
0.04
0.04
0.03
0.01
0.06
0.06
0.09
0.05
0.05
0.06
0.05
0.01
0.04
0.04
0.02
0.02
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.01

136
210
21
285
29
61
77
188
177
292
196
255
109
9
75
103
62
19
32
58
55
38
37
49
668
18
9
9
26
17
23
51
1038
79
70
155
129
199
366
154
604
669
292
269
91
260

1.7
1.6
1.4
1.5
1.1
1.4
1.2
1.8
1.5
1.4
1.2
1.5
1.4
1.0
1.4
1.6
1.3
3.1
1.4
2.2
1.4
2.0
2.2
1.5
2.0
1.2
1.2
1.0
1.1
1.2
1.4
2.0
1.8
2.1
2.2
1.5
1.3
1.3
1.4
1.6
2.2
1.3
1.6
1.4
1.4
1.3

0.20
0.13
0.36
0.11
0.21
0.21
0.16
0.15
0.14
0.11
0.10
0.10
0.14
0.35
0.18
0.20
0.19
0.92
0.31
0.35
0.22
0.42
0.50
0.26
0.10
0.33
0.52
0.39
0.26
0.41
0.33
0.33
0.07
0.27
0.31
0.15
0.13
0.11
0.09
0.15
0.11
0.06
0.11
0.10
0.16
0.09

0.15
0.16
0.13
0.14
0.10
0.13
0.12
0.16
0.13
0.15
0.12
0.13
0.14
0.10
0.15
0.15
0.11
0.26
0.13
0.20
0.13
0.19
0.18
0.17
0.18
0.10
0.10
0.11
0.08
0.11
0.16
0.20
0.17
0.21
0.20
0.14
0.13
0.12
0.13
0.16
0.22
0.13
0.16
0.14
0.13
0.13

0.01
0.01
0.04
0.01
0.02 *
0.02
0.01
0.01 *
0.01
0.01
0.01
0.01
0.02
0.04
0.02
0.02
0.02
0.07
0.03
0.03
0.02
0.04
0.04
0.03
0.01
0.03
0.04
0.05
0.02
0.03
0.05
0.03
0.01
0.03
0.03
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.01

429
15
357
138
48
407
162
12
11
378
119
5
22
19
30
32

2.1
3.5
3.1
2.8
3.1
2.6
2.9
1.3
2.3
3.0
2.9
1.5
3.9
3.5
2.6
2.9

0.11
0.98
0.17
0.26
0.47
0.14
0.24
0.37
0.75
0.16
0.29
0.79
0.91
0.83
0.54
0.60

0.20
0.30
0.33
0.27
0.36
0.26
0.27
0.11
0.19
0.31
0.27
0.10
0.38
0.20
0.28
0.29

0.01
0.11
0.02
0.03
0.06
0.02
0.03
0.04
0.07
0.02
0.03
0.06
0.10
0.06
0.06
0.07

362
8
228
102
37
329
83
13
9
269
70
6
8
14
13
25

1.7
2.5
1.8
2.0
2.0
1.9
1.4
1.1
2.3
2.1
1.5
1.9
1.2
2.2
0.7
2.2

0.10
0.94
0.13
0.22
0.39
0.12
0.16
0.33
0.77
0.14
0.21
0.89
0.46
0.60
0.26
0.53

0.16
0.39
0.19
0.17
0.18
0.20
0.14
0.13
0.30
0.20
0.12
0.14
0.11
0.20
0.06
0.17

0.01
0.19
0.02
0.02
0.04
0.01
0.02
0.05
0.12
0.02
0.02
0.07
0.04
0.07
0.03
0.05

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

475

533

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Breast (C50)
Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

476

Female
ASR(W)
CUM 0-74

12
31
8
15
9

0.6
0.8
0.9
1.4
0.6

0.19
0.14
0.32
0.42
0.22

414
2426
308
332
330

18.8
42.5
29.8
23.4
19.0

0.96
0.88
1.74
1.53
1.24

16
13
1
10
211
1
11
28
9
10
1

1.9
0.6
0.1
0.8
1.0
0.1
0.3
0.4
0.3
0.8
0.1

0.48
0.18
0.12
0.26
0.07
0.08
0.11
0.08
0.12
0.25
0.11

0.19
0.10
0.01
0.10
0.11
0.04
0.05
0.04
0.09
0.01

0.06
0.03
0.01
0.04
0.01
0.01
0.01
0.02
0.04
0.01

844
2023
423
1046
22598
300
2139
2971
966
730
332

85.7
68.7
51.7
53.8
80.8
30.9
47.5
37.4
30.7
55.2
29.4

3.16
1.67
2.65
1.71
0.56
1.82
1.06
0.71
1.02
2.12
1.65

9.73
7.69
5.47
5.80
9.15
3.30
5.40
4.25
3.41
5.92
3.15

0.38
0.23
0.35
0.22
0.07
0.22
0.14
0.09
0.13
0.25
0.20 *

541
50
93
31
16
15
0
27
279
5
25
206
41
161
9
237
710
42
67
64
526
150
16
4
5
2
8
107
196
31
2
4
0
3
21
132
75
134
8
124
41
18
22
598
56
534
166
50
115
60
27
32
49
367
58
298
157
65
92
158
56
100
23
23

0.7
0.5
0.6
0.7
0.6
0.8
0.8
0.7
1.1
0.6
1.4
1.4
1.4
0.6
1.3
0.7
0.4
1.1
0.4
0.8
0.7
1.3
0.3
0.5
0.9
0.4
0.8
0.7
1.2
0.3
0.5
0.6
0.3
1.0
0.6
1.1
1.1
1.2
2.5
1.8
3.7
0.9
1.0
0.9
0.7
1.1
0.6
0.9
1.7
0.7
1.2
0.9
1.3
0.9
0.8
0.6
0.7
1.1
1.7
1.0
2.2
1.2

0.03
0.08
0.06
0.13
0.15
0.21
0.16
0.04
0.50
0.12
0.10
0.23
0.11
0.21
0.09
0.03
0.06
0.14
0.05
0.04
0.06
0.32
0.14
0.25
0.66
0.15
0.08
0.06
0.23
0.19
0.28
0.33
0.08
0.09
0.07
0.10
0.40
0.11
0.39
0.43
0.80
0.04
0.14
0.04
0.06
0.17
0.06
0.12
0.34
0.13
0.17
0.05
0.18
0.05
0.07
0.08
0.08
0.09
0.23
0.10
0.48
0.26

0.08
0.06
0.08
0.09
0.05
0.09
0.09
0.08
0.14
0.06
0.17
0.16
0.17
0.09
0.15
0.08
0.04
0.14
0.04
0.09
0.09
0.13
0.03
0.06
0.10
0.04
0.10
0.09
0.16
0.03
0.06
0.07
0.03
0.12
0.06
0.14
0.08
0.14
0.35
0.28
0.51
0.10
0.12
0.10
0.09
0.15
0.08
0.13
0.22
0.11
0.14
0.11
0.14
0.11
0.09
0.08
0.09
0.13
0.17
0.11
0.22
0.15

0.00
0.01
0.01
0.02
0.02
0.03
0.02
0.01
0.07
0.02
0.01
0.03
0.02
0.04
0.01
0.00
0.01
0.02
0.01
0.01
0.01
0.04
0.01
0.04
0.08
0.02
0.01
0.01
0.03
0.02
0.04
0.04
0.01
0.01
0.01
0.01
0.04
0.02
0.06
0.07
0.14
0.01
0.02
0.01
0.01
0.03
0.01
0.02
0.06
0.02
0.02
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.03
0.01
0.06
0.04

69765
7942
12036
3532
2309
1418
69
3165
35883
438
2973
14411
2772
11396
1578
15932
103024
8465
5850
12858
74632
21604
1265
1061
727
317
1869
15257
26058
2796
654
958
509
289
4837
15293
13519
13411
791
12386
2156
1299
754
62279
4975
56396
24156
5235
18594
8107
2159
5757
4044
42991
5240
36402
20631
10645
13794
14040
3757
10202
1199
2240

80.7
81.9
77.1
80.8
78.3
72.2
75.6
83.1
82.3
81.9
76.2
83.8
74.5
85.3
96.7
84.7
91.0
62.6
81.4
63.9
105.2
94.5
77.7
59.0
63.8
79.3
70.7
110.9
86.1
84.4
52.1
92.1
87.7
43.7
58.6
110.0
95.6
97.1
80.8
98.6
98.5
88.4
115.2
88.0
71.5
90.2
89.0
78.4
92.5
94.1
80.0
102.0
91.0
93.5
87.5
94.4
90.2
89.3
89.4
86.4
85.4
87.0
87.9
93.0

0.32
0.96
0.74
1.47
1.73
1.99
9.77
1.58
0.46
4.17
1.54
0.74
1.48
0.85
2.55
0.71
0.30
0.69
1.10
0.58
0.42
0.68
2.27
1.88
2.40
4.81
1.69
0.97
0.56
1.64
2.10
3.02
4.24
2.60
0.87
0.97
0.86
0.91
2.94
0.96
2.26
2.63
4.53
0.39
1.04
0.43
0.60
1.13
0.71
1.09
1.83
1.41
1.52
0.48
1.24
0.53
0.67
0.95
0.80
0.77
1.44
0.92
2.61
2.15

9.32
9.47
8.89
9.29
9.08
8.30
8.71
9.66
9.52
9.61
8.81
9.70
8.33
9.96
11.16
9.95
10.64
7.05
9.28
7.37
12.43
10.94
8.82
6.52
7.33
9.11
8.20
13.05
10.02
9.74
5.67
10.29
10.00
4.73
6.73
12.96
11.16
11.29
9.22
11.48
11.10
9.87
13.37
10.17
8.07
10.43
10.34
8.81
10.85
10.97
9.08
12.00
10.74
10.86
9.99
11.00
10.54
10.37
10.33
9.99
9.58
10.20
9.84
10.96

0.04
0.13
0.10
0.19
0.23
0.26
1.42
0.21
0.06
0.55
0.20
0.09
0.19
0.11
0.36
0.09
0.04
0.09
0.15
0.08
0.05
0.09
0.30
0.23
0.30
0.58
0.23
0.13
0.07
0.22
0.26
0.37
0.51
0.30
0.12
0.13
0.12
0.12
0.39
0.13
0.29
0.32
0.61
0.05
0.14
0.05
0.08
0.15
0.09
0.15
0.25
0.19
0.20
0.06
0.16
0.07
0.09
0.12
0.10
0.10
0.19
0.12
0.34
0.28

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

534

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Breast (C50) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

63
184
310
42
262
120
29
90
134
21
111
20
6798
760
5823
266
30
228
33
0
5
28
728
79
622
317
35
269
76
82
477
45
421
26
653
83
539
1787
67
229
85
1390
147
42
103
692
65
617
34
25
125
88
46
197

1.3
0.8
0.9
1.3
0.9
0.9
1.2
0.9
0.7
1.6
0.6
0.6
0.9
1.2
0.9
0.9
1.0
0.9
0.5
0.3
0.6
1.1
1.2
1.1
0.8
1.1
0.8
0.6
0.7
1.0
1.4
1.0
0.7
0.8
1.2
0.8
0.8
0.4
1.2
0.4
0.8
1.1
1.5
1.0
1.2
1.2
1.2
0.6
1.1
0.6
0.7
0.6
1.1

0.17
0.07
0.05
0.20
0.06
0.09
0.22
0.10
0.06
0.34
0.06
0.14
0.01
0.05
0.01
0.06
0.19
0.06
0.09
0.12
0.13
0.04
0.14
0.05
0.05
0.19
0.05
0.08
0.08
0.05
0.21
0.05
0.14
0.03
0.14
0.03
0.02
0.05
0.08
0.04
0.02
0.10
0.24
0.10
0.05
0.16
0.05
0.10
0.22
0.06
0.08
0.09
0.08

0.15
0.10
0.11
0.13
0.11
0.11
0.12
0.10
0.08
0.21
0.07
0.07
0.11
0.14
0.11
0.11
0.12
0.11
0.05
0.02
0.07
0.14
0.16
0.14
0.10
0.13
0.09
0.09
0.08
0.12
0.16
0.11
0.08
0.09
0.14
0.09
0.09
0.04
0.14
0.04
0.10
0.13
0.18
0.12
0.14
0.14
0.14
0.06
0.12
0.07
0.08
0.07
0.12

0.02
0.01
0.01
0.03
0.01
0.01
0.03
0.01
0.01
0.05
0.01
0.02
0.00
0.01
0.00
0.01
0.03
0.01
0.01
0.01
0.02
0.01
0.02
0.01
0.01
0.03
0.01
0.01
0.01
0.01
0.03
0.01
0.02
0.00
0.02
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.03
0.01
0.01
0.02
0.01
0.01
0.03
0.01
0.01
0.01
0.01

5015
25386
34337
3770
29961
13845
2801
10870
19564
1685
17697
3222
764169
66900
668489
31011
3104
26794
5242
160
1327
3650
67708
7618
58020
40806
3548
36041
12184
13397
49083
3566
44441
4034
89413
7442
75089
237378
13427
19968
17512
184010
13371
2974
10251
56843
5499
49755
4884
2325
22098
14728
6593
19401

93.3
101.5
92.4
84.9
93.2
91.2
83.7
94.5
89.7
86.1
90.3
91.0
91.6
79.3
93.4
93.3
78.9
96.8
81.0
36.3
65.5
95.8
91.4
76.1
96.0
90.9
83.0
89.7
91.3
102.2
92.8
83.8
92.6
92.7
93.2
81.2
97.1
90.9
64.7
81.7
65.4
98.5
88.4
77.5
91.6
84.5
78.9
85.2
81.4
97.6
105.1
103.1
83.8
94.5

1.41
0.69
0.53
1.44
0.58
0.83
1.65
0.98
0.69
2.17
0.73
1.71
0.11
0.32
0.12
0.57
1.45
0.64
1.17
2.92
1.84
1.70
0.37
0.89
0.43
0.48
1.45
0.51
0.88
0.95
0.46
1.47
0.49
1.61
0.33
0.98
0.38
0.20
0.57
0.60
0.51
0.25
0.80
1.47
0.96
0.37
1.10
0.40
1.22
2.15
0.75
0.90
1.11
0.73

10.90
11.76
10.76
9.69
10.90
10.56
9.56
10.98
10.50
9.77
10.60
10.73
10.67
9.00
10.91
10.75
9.00
11.16
9.41
4.15
7.52
11.19
10.58
8.67
11.15
10.64
9.62
10.51
10.75
12.13
10.79
9.64
10.78
10.69
10.86
9.25
11.37
10.58
7.36
9.29
7.52
11.55
10.29
8.73
10.74
9.85
9.00
9.96
9.49
11.37
12.44
12.20
9.72
11.01

0.18
0.09
0.07
0.19
0.08
0.11
0.22
0.13
0.09
0.28
0.09
0.23
0.01
0.04
0.02
0.07
0.19
0.08
0.15
0.38
0.24
0.22
0.05
0.12
0.06
0.06
0.19
0.07
0.12
0.13
0.06
0.19
0.06
0.21
0.04
0.13
0.05
0.03
0.07
0.08
0.07
0.03
0.10
0.19
0.12
0.05
0.15
0.05
0.16
0.28
0.10
0.12
0.14
0.10

1
9
69
1
3
106
13
16
43
133
2
93
64
62
8
191
181
6
13
8
5
22
18
72
15

0.2
0.2
0.3
0.1
0.2
0.4
0.4
0.7
0.5
0.7
0.2
0.4
1.5
1.0
0.3
1.1
1.2
0.4
0.3
0.2
0.1
0.2
0.2
0.2
0.2

0.16
0.05
0.04
0.07
0.11
0.04
0.10
0.18
0.07
0.06
0.17
0.05
0.19
0.13
0.11
0.09
0.09
0.16
0.09
0.06
0.06
0.05
0.06
0.02
0.06

0.02
0.02
0.03
0.01
0.01
0.05
0.05
0.09
0.06
0.08
0.03
0.05
0.16
0.12
0.04
0.14
0.14
0.03
0.05
0.01
0.02
0.03
0.02
0.02
0.03

0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.03
0.01
0.01
0.03
0.01
0.02
0.02
0.02
0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.00
0.01

340
1903
9411
199
703
8508
561
1444
2487
5839
149
5792
1133
1598
746
16409
15456
686
1309
1102
1774
3966
2481
11103
1882

46.8
31.4
41.3
14.7
25.7
35.3
15.4
62.2
26.5
30.7
16.0
26.9
27.4
24.4
24.2
92.2
96.8
38.5
35.8
32.2
41.7
42.5
38.1
32.0
35.3

2.68
0.73
0.45
1.07
0.98
0.40
0.67
1.69
0.54
0.42
1.33
0.36
0.84
0.63
0.89
0.75
0.82
1.52
1.03
1.06
1.03
0.71
0.83
0.32
0.90

5.03
3.21
4.31
1.51
2.80
3.81
1.54
6.89
2.96
3.44
1.76
3.03
2.95
2.73
2.63
10.59
11.12
4.29
3.85
3.39
4.50
4.54
4.05
3.40
3.73

0.33
0.08 *
0.05
0.12 *
0.12
0.05 *
0.07 *
0.20 *
0.07
0.06 *
0.16
0.05
0.10 *
0.08 *
0.11 *
0.09
0.10
0.20
0.12
0.11
0.12
0.08
0.09
0.04
0.09

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

477

535

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Breast (C50) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

478

Female
ASR(W)
CUM 0-74

201
15
11
4
4
13
0
76
4
6
12
8
6
15
24
83
22
18
2
2
13
3
6
16
68

0.2
0.2
0.2
0.2
0.2
0.3
0.4
0.2
0.7
0.7
0.4
0.2
0.9
1.0
1.2
0.3
0.3
0.3
0.2
0.3
0.1
0.2
0.5
0.8

0.02
0.07
0.06
0.08
0.08
0.09
0.05
0.12
0.27
0.40
0.14
0.06
0.23
0.20
0.15
0.06
0.07
0.22
0.17
0.09
0.08
0.09
0.13
0.10

0.02
0.02
0.02
0.02
0.03
0.04
0.05
0.03
0.08
0.04
0.03
0.02
0.09
0.12
0.14
0.03
0.02
0.05
0.02
0.03
0.01
0.03
0.07
0.10

0.00
0.01
0.01
0.01
0.02
0.01
0.01
0.02
0.03
0.02
0.01
0.01
0.03
0.03
0.02
0.01
0.01
0.03
0.02
0.01
0.01
0.01
0.02
0.01

26441
2540
1857
968
803
1756
163
8501
491
551
519
1055
845
265
1497
5148
5335
4553
270
512
959
538
593
940
3071

23.3
21.2
24.9
25.2
21.2
25.0
16.6
28.8
21.3
41.3
39.2
43.9
20.5
14.6
69.0
55.2
54.1
56.4
45.0
43.5
21.6
22.0
18.2
29.1
34.8

0.15
0.43
0.58
0.83
0.77
0.62
1.32
0.32
1.02
1.85
2.46
1.38
0.73
0.93
1.92
0.81
0.76
0.85
2.86
2.02
0.72
0.97
0.76
0.97
0.63

2.33
2.19
2.49
2.53
2.16
2.55
1.58
2.97
2.08
4.41
4.66
4.74
2.13
1.56
7.65
6.22
5.84
6.12
5.15
4.27
2.23
2.28
1.87
3.14
3.83

0.02
0.05
0.06
0.09
0.09
0.07
0.13
0.04
0.11
0.23
0.38
0.17
0.09
0.12 *
0.25 *
0.11 *
0.09
0.11
0.38
0.22
0.08 *
0.11 *
0.09
0.12 *
0.08 *

218
16
9
108
63
207
163
163
213
131
23
73
20
25
12
13
30
35
31
13
20
9
27
48
120
59
33
54
77
29
7
63
8
26
13
49
28
7
65
25
4
71
15
6
18
36
23
10
8
5
37
25
28
48

0.7
0.6
0.8
0.4
0.9
1.0
0.5
1.0
0.6
0.6
0.5
0.4
0.5
1.2
0.7
0.5
0.9
0.9
0.7
0.5
0.9
0.6
1.1
0.5
0.6
0.8
0.5
0.6
0.8
0.6
0.8
0.5
0.7
1.1
0.7
0.9
0.9
0.8
1.3
0.9
0.2
0.7
0.8
0.4
0.7
0.6
0.7
0.6
0.6
0.6
0.8
0.6
1.4
0.7

0.05
0.15
0.28
0.04
0.12
0.07
0.04
0.08
0.04
0.05
0.11
0.04
0.12
0.24
0.20
0.15
0.17
0.15
0.13
0.16
0.22
0.23
0.22
0.07
0.06
0.11
0.08
0.08
0.09
0.12
0.31
0.07
0.27
0.22
0.20
0.14
0.18
0.34
0.17
0.18
0.12
0.09
0.23
0.20
0.18
0.11
0.14
0.19
0.20
0.30
0.14
0.13
0.27
0.11

0.08
0.06
0.13
0.04
0.10
0.13
0.06
0.11
0.07
0.07
0.05
0.04
0.06
0.12
0.08
0.06
0.09
0.10
0.08
0.07
0.12
0.06
0.15
0.05
0.07
0.09
0.07
0.06
0.09
0.07
0.11
0.06
0.03
0.13
0.07
0.09
0.11
0.07
0.15
0.11
0.03
0.07
0.10
0.06
0.09
0.07
0.08
0.06
0.10
0.06
0.09
0.07
0.17
0.07

0.01
0.02
0.04
0.00
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.03
0.03
0.02
0.02
0.02
0.02
0.02
0.03
0.03
0.03
0.01
0.01
0.02
0.01
0.01
0.01
0.02
0.05
0.01
0.02
0.03
0.03
0.02
0.03
0.04
0.02
0.02
0.02
0.01
0.03
0.03
0.03
0.02
0.02
0.02
0.04
0.04
0.02
0.02
0.04
0.01

23551
1905
998
14046
6288
19351
16212
10984
24587
18687
2828
17864
3610
2268
1513
2547
3514
3675
4278
1599
1825
1212
1929
7317
13711
6113
5075
8997
8671
3965
756
9637
800
2622
1833
4932
2598
575
5368
2808
1058
8570
1840
748
1995
4313
1971
1415
831
667
4074
3155
2088
6894

67.2
72.3
75.1
35.6
93.2
101.3
47.9
57.4
55.9
83.7
47.2
80.6
93.9
91.0
79.1
91.8
95.1
90.2
98.1
78.8
86.1
74.5
85.7
62.4
60.9
77.7
64.5
84.9
76.1
76.6
84.6
78.1
81.6
97.4
100.7
87.0
84.1
65.4
94.4
98.2
62.9
84.4
96.3
61.6
95.7
91.0
59.1
73.9
63.7
89.3
86.7
79.3
91.9
91.6

0.48
1.77
2.52
0.32
1.26
0.78
0.40
0.58
0.38
0.66
0.94
0.64
1.65
2.03
2.15
1.93
1.73
1.57
1.59
2.17
2.16
2.40
2.11
0.79
0.58
1.09
0.97
0.96
0.89
1.34
3.23
0.83
3.28
2.06
2.64
1.38
1.93
3.11
1.45
2.02
1.98
1.02
2.51
2.43
2.39
1.54
1.42
2.07
2.37
3.72
1.52
1.58
2.19
1.22

7.59
8.22
8.39
3.95
10.54
11.32
5.38
6.41
6.38
9.64
5.31
9.06
10.80
10.50
9.15
10.49
10.68
10.29
11.28
8.89
9.77
8.40
9.80
7.01
6.88
9.00
7.18
9.72
8.59
8.70
9.60
8.79
9.03
11.03
11.45
9.53
9.41
7.15
10.82
11.03
6.99
9.48
10.94
6.94
10.72
10.28
6.54
8.45
7.04
10.22
9.87
9.05
10.20
10.25

0.06
0.22
0.31
0.04 *
0.15 *
0.09
0.05 *
0.07
0.05
0.08
0.11
0.08
0.20
0.25
0.27
0.24
0.20
0.19
0.19
0.25
0.26
0.28
0.25
0.09
0.07
0.13
0.11
0.12
0.11
0.16
0.40
0.10
0.37
0.24
0.30
0.16
0.22
0.35
0.17
0.23
0.24
0.12
0.29
0.29
0.28
0.18
0.16
0.25
0.28
0.44
0.18
0.18
0.26
0.14

*Important. See note on population page.

536

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Breast (C50) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

32
60
11
79
16
17
24
78
67
72
230
88
42
4
29
49
27
4
9
16
24
15
11
18
163
11
5
6
10
9
6
19
358
19
21
58
61
81
156
60
245
320
107
154
37
77

0.4
0.5
0.8
0.4
0.6
0.4
0.4
0.7
0.6
0.5
1.3
0.5
0.6
0.3
0.5
0.7
0.6
0.5
0.3
0.5
0.6
0.7
0.6
0.5
0.4
0.7
0.4
0.9
0.5
0.7
0.6
0.8
0.6
0.5
0.6
0.4
0.6
0.5
0.5
0.6
0.8
0.6
0.5
0.7
0.6
0.4

0.08
0.07
0.25
0.05
0.15
0.10
0.08
0.09
0.08
0.06
0.09
0.06
0.10
0.15
0.11
0.10
0.11
0.28
0.12
0.14
0.13
0.19
0.19
0.13
0.03
0.23
0.20
0.39
0.16
0.23
0.24
0.18
0.03
0.12
0.13
0.06
0.08
0.05
0.05
0.07
0.05
0.03
0.05
0.06
0.10
0.04

0.06
0.07
0.09
0.04
0.06
0.04
0.05
0.09
0.08
0.05
0.16
0.06
0.07
0.03
0.07
0.08
0.06
0.05
0.04
0.05
0.07
0.06
0.08
0.07
0.04
0.09
0.02
0.09
0.05
0.08
0.05
0.09
0.07
0.05
0.07
0.04
0.06
0.06
0.06
0.06
0.09
0.07
0.05
0.08
0.07
0.04

0.01
0.01
0.03
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.01
0.03
0.02
0.02
0.02
0.02
0.03
0.02
0.00
0.03
0.02
0.05
0.02
0.03
0.03
0.03
0.00
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01

4645
6192
1027
12521
1840
2083
4068
5924
7428
10556
10774
9223
4910
517
2675
4454
2998
389
1460
1651
2282
1447
1232
1998
29643
1759
675
653
1395
1130
975
2547
56440
3486
3193
9817
8126
13745
21597
8802
27384
44467
16611
17740
4688
17137

44.1
43.7
67.7
71.0
57.0
43.0
53.5
52.0
63.5
47.7
59.1
46.9
58.8
47.7
54.1
64.3
60.2
45.2
66.5
55.9
57.3
66.2
64.1
54.6
78.9
103.0
71.4
90.3
68.0
78.0
90.7
99.1
90.3
90.4
85.9
84.4
79.9
81.3
79.1
85.2
89.1
80.4
82.0
80.9
76.5
79.2

0.69
0.59
2.20
0.69
1.39
0.99
0.88
0.72
0.79
0.49
0.60
0.51
0.88
2.32
1.17
1.03
1.14
2.70
1.90
1.48
1.28
1.89
2.00
1.34
0.50
2.59
3.00
3.84
1.96
2.53
3.06
2.10
0.40
1.59
1.61
0.93
0.96
0.75
0.58
0.96
0.60
0.41
0.69
0.66
1.19
0.65

5.00
4.88
7.62
8.05
6.57
4.86
6.09
5.65
7.05
5.33
6.58
5.34
6.66
5.09
5.96
6.98
6.73
4.93
7.34
6.20
6.27
7.09
7.10
6.04
9.07
11.81
7.85
10.44
7.66
8.88
10.35
11.49
10.23
10.37
9.57
9.46
8.90
9.01
8.73
9.46
9.90
8.99
9.08
8.97
8.48
8.79

0.08
0.07
0.27
0.09
0.17 *
0.12
0.10
0.08 *
0.09
0.06
0.07
0.06
0.11
0.25
0.13
0.12
0.14
0.29
0.22
0.17
0.15
0.21
0.23
0.15
0.06
0.32
0.36
0.47
0.24
0.31
0.37
0.26
0.05
0.20
0.19
0.11
0.12
0.09
0.07
0.12
0.07
0.05
0.08
0.08
0.14
0.08

160
3
75
37
6
15
33
7
3
74
25
3
0
5
4
12

0.7
0.9
0.6
0.6
0.3
0.1
0.5
0.9
0.8
0.5
0.6
1.0
1.1
0.2
1.0

0.06
0.55
0.07
0.10
0.13
0.02
0.09
0.33
0.48
0.07
0.13
0.62
0.48
0.13
0.32

0.08
0.20
0.08
0.08
0.03
0.01
0.07
0.10
0.09
0.06
0.07
0.09
0.11
0.01
0.15

0.01
0.13
0.01
0.02
0.02
0.00
0.01
0.04
0.06
0.01
0.02
0.07
0.06
0.01
0.05

19216
277
10449
4952
1405
14383
5228
906
339
11339
4078
241
433
667
1311
1184

83.1
70.0
86.6
87.5
80.4
83.9
84.4
93.1
75.1
86.5
92.1
59.5
64.3
118.9
107.5
105.6

0.63
4.55
0.88
1.31
2.25
0.74
1.21
3.19
4.19
0.85
1.52
4.19
3.14
4.69
3.38
3.24

9.52
7.98
10.06
9.86
9.35
9.63
9.55
10.69
8.36
9.67
10.77
6.84
7.18
14.05
12.66
12.34

0.08
0.66
0.11
0.16
0.28
0.09
0.15
0.42
0.54
0.11
0.19
0.54
0.38
0.62
0.40
0.43

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

479

537

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Vulva (C51)
Cases

Male
ASR(W)
CUM 0-74

Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

480

Female
ASR(W)
CUM 0-74

1
31
4
7
16

0.0
0.7
0.3
0.3
0.7

0.04
0.13
0.17
0.13
0.21

6
35
5
29
474
5
43
59
11
10
21

0.5
1.4
0.8
1.5
1.6
0.5
0.9
0.7
0.3
0.6
2.0

0.22
0.24
0.39
0.29
0.08
0.23
0.15
0.09
0.11
0.20
0.44

0.06
0.14
0.16
0.18
0.17
0.05
0.08
0.07
0.04
0.05
0.23

0.03
0.04
0.08
0.04
0.01
0.03
0.02
0.01
0.02
0.03
0.07 *

1402
153
228
60
69
34
2
65
724
10
57
327
45
274
28
251
1594
59
85
211
1203
337
20
9
8
2
27
260
402
42
2
3
4
1
91
250
197
272
16
253
39
26
11
1182
64
1102
458
69
383
145
27
117
49
837
79
728
403
266
305
321
73
246
26
51

1.4
1.3
1.2
1.1
2.3
1.5
1.9
1.5
1.5
1.9
1.2
1.7
1.2
1.9
1.8
1.2
1.2
0.4
1.1
1.0
1.4
1.3
1.2
0.5
0.7
0.2
0.9
1.7
1.1
1.2
0.1
0.3
0.3
0.1
1.0
1.5
1.3
1.5
1.5
1.5
1.6
1.8
0.9
1.5
0.9
1.6
1.5
1.0
1.7
1.5
0.9
1.8
0.9
1.5
1.3
1.6
1.6
1.9
1.8
1.9
1.6
2.0
2.0
2.1

0.04
0.11
0.09
0.16
0.30
0.28
1.32
0.21
0.06
0.67
0.19
0.11
0.18
0.13
0.35
0.08
0.03
0.05
0.13
0.07
0.05
0.08
0.28
0.16
0.26
0.14
0.19
0.12
0.06
0.19
0.10
0.18
0.15
0.10
0.11
0.11
0.10
0.11
0.38
0.11
0.29
0.38
0.34
0.05
0.11
0.06
0.08
0.12
0.09
0.13
0.19
0.18
0.14
0.06
0.15
0.07
0.09
0.14
0.11
0.11
0.20
0.14
0.40
0.33

0.15
0.14
0.12
0.11
0.25
0.17
0.14
0.17
0.15
0.19
0.13
0.18
0.12
0.19
0.19
0.12
0.13
0.04
0.12
0.10
0.16
0.14
0.11
0.07
0.09
0.10
0.18
0.13
0.13
0.02
0.04
0.03
0.12
0.17
0.15
0.16
0.14
0.16
0.16
0.19
0.06
0.15
0.09
0.16
0.16
0.11
0.18
0.16
0.10
0.20
0.09
0.17
0.14
0.17
0.17
0.21
0.20
0.20
0.18
0.22
0.25
0.22

0.01
0.02
0.01
0.02
0.04
0.04
0.10
0.03
0.01
0.08
0.02
0.01
0.02
0.01
0.05
0.01
0.00
0.01
0.02
0.01
0.01
0.01
0.03
0.02
0.04
0.03
0.02
0.01
0.03
0.02
0.02
0.03
0.02
0.01
0.01
0.01
0.05
0.02
0.03
0.04
0.04
0.01
0.01
0.01
0.01
0.02
0.01
0.02
0.03
0.03
0.02
0.01
0.02
0.01
0.01
0.02
0.01
0.01
0.03
0.02
0.06
0.04

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

538

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Vulva (C51) (contd)


Cases

Male
ASR(W)
CUM 0-74

America, North (contd)


USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Cases

Female
ASR(W)
CUM 0-74

134
470
736
55
669
318
37
277
396
24
372
50
14291
985
12897
633
62
560
91
4
20
67
1307
107
1182
820
42
753
221
238
1081
62
999
114
1684
114
1497
4323
106
326
300
3530
264
51
210
941
65
848
81
46
344
235
157
335

2.1
1.4
1.7
1.2
1.8
1.8
1.1
2.0
1.6
1.2
1.7
1.3
1.5
1.1
1.5
1.5
1.5
1.6
1.2
0.8
0.8
1.6
1.4
1.0
1.6
1.5
0.9
1.6
1.5
1.6
1.7
1.5
1.7
2.2
1.5
1.2
1.6
1.4
0.5
1.3
1.1
1.6
1.5
1.3
1.6
1.3
0.9
1.3
1.2
1.6
1.5
1.5
1.7
1.3

0.20
0.08
0.07
0.17
0.08
0.11
0.18
0.14
0.09
0.26
0.10
0.20
0.01
0.04
0.02
0.07
0.19
0.08
0.14
0.41
0.19
0.23
0.05
0.10
0.05
0.06
0.14
0.07
0.11
0.12
0.06
0.20
0.06
0.24
0.04
0.11
0.05
0.02
0.05
0.07
0.06
0.03
0.10
0.19
0.12
0.04
0.11
0.05
0.14
0.26
0.09
0.10
0.15
0.08

0.24
0.15
0.18
0.11
0.19
0.18
0.10
0.21
0.17
0.14
0.18
0.13
0.16
0.12
0.16
0.17
0.17
0.18
0.12
0.07
0.07
0.16
0.16
0.12
0.17
0.16
0.09
0.17
0.16
0.18
0.18
0.16
0.17
0.25
0.16
0.11
0.17
0.15
0.05
0.14
0.11
0.18
0.16
0.14
0.17
0.14
0.10
0.14
0.12
0.18
0.16
0.15
0.18
0.14

0.03
0.01
0.01
0.02
0.01
0.01
0.02
0.02
0.01
0.03
0.01
0.02
0.00
0.00
0.00
0.01
0.03
0.01
0.02
0.04
0.02
0.03
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.02
0.01
0.02
0.01
0.03
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.02
0.02
0.01
0.02
0.01
0.02
0.04
0.01
0.01
0.02
0.01

1
18

0.2
0.3

0.19
0.06

0.02
0.03

0.02
0.01 *

2
0
99
7
37
53
82
1
65
28
8
10
240
233
3
8
15
33
39
35
111
21

0.1
0.3
0.2
1.3
0.6
0.5
0.1
0.3
0.7
0.1
0.3
1.0
1.1
0.2
0.2
0.2
0.5
0.2
0.3
0.2
0.2

0.10
0.04
0.08
0.22
0.09
0.06
0.09
0.04
0.14
0.05
0.11
0.07
0.08
0.11
0.07
0.07
0.10
0.04
0.05
0.02
0.05

0.01
0.04
0.02
0.15
0.09
0.06
0.04
0.09
0.02
0.05
0.11
0.12
0.03
0.02
0.02
0.05
0.03
0.03
0.02
0.02

0.01 *
0.01 *
0.01 *
0.03 *
0.01
0.01 *
0.01
0.02 *
0.01 *
0.02 *
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.00
0.01

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

481

539

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Vulva (C51) (contd)


Cases

Male
ASR(W)
CUM 0-74

Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

482

Female
ASR(W)
CUM 0-74

261
25
21
4
9
18
1
69
1
3
2
12
7
3
3
30
53
50
0
3
50
18
14
17
42

0.2
0.2
0.3
0.1
0.3
0.3
0.1
0.3
0.0
0.3
0.1
0.5
0.2
0.2
0.1
0.4
0.6
0.7
0.3
1.2
0.7
0.5
0.6
0.5

0.01
0.05
0.07
0.06
0.09
0.07
0.06
0.03
0.04
0.19
0.13
0.16
0.07
0.14
0.07
0.08
0.08
0.10
0.20
0.17
0.18
0.12
0.14
0.08

0.03
0.03
0.04
0.01
0.04
0.03
0.04
0.04
0.02
0.07
0.02
0.06
0.01
0.05
0.07
0.08
0.03
0.12
0.08
0.05
0.07
0.06

0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.03
0.02
0.02
0.01
0.03 *
0.01 *
0.01 *
0.01
0.01
0.03
0.02 *
0.02 *
0.02
0.02 *
0.01 *

674
60
20
691
109
303
502
313
961
429
163
365
63
28
34
41
42
60
45
23
31
12
19
254
487
108
163
194
215
101
12
185
19
47
49
122
61
26
94
49
32
208
39
17
58
105
78
16
29
9
79
106
40
165

1.4
1.6
1.0
1.2
1.1
1.2
1.2
1.2
1.8
1.5
1.9
1.2
1.2
0.8
1.3
1.0
0.8
1.2
0.6
0.5
0.9
0.3
0.6
1.7
1.6
0.8
1.6
1.4
1.4
1.4
1.0
1.2
1.0
1.2
1.4
1.3
1.2
2.0
1.0
0.9
1.7
1.4
1.2
0.9
1.8
1.4
1.5
0.5
1.4
0.7
1.1
1.6
1.2
1.3

0.06
0.24
0.26
0.05
0.12
0.08
0.06
0.08
0.06
0.08
0.16
0.07
0.17
0.17
0.25
0.18
0.14
0.17
0.11
0.13
0.20
0.12
0.17
0.12
0.09
0.10
0.14
0.11
0.11
0.16
0.32
0.10
0.29
0.20
0.25
0.14
0.19
0.47
0.14
0.15
0.31
0.12
0.25
0.24
0.29
0.16
0.19
0.13
0.29
0.29
0.15
0.19
0.21
0.12

0.15
0.19
0.08
0.15
0.10
0.12
0.14
0.14
0.19
0.15
0.22
0.13
0.13
0.08
0.14
0.14
0.08
0.12
0.06
0.05
0.10
0.01
0.06
0.19
0.17
0.09
0.20
0.14
0.14
0.15
0.09
0.12
0.09
0.13
0.14
0.16
0.14
0.22
0.09
0.09
0.22
0.16
0.12
0.11
0.21
0.16
0.18
0.04
0.18
0.06
0.13
0.17
0.15
0.14

0.01
0.04
0.03
0.01 *
0.01 *
0.01
0.01 *
0.01
0.01
0.01
0.02
0.01
0.02
0.02
0.03
0.03
0.02
0.02
0.01
0.02
0.03
0.01
0.02
0.02
0.01
0.01
0.02
0.02
0.01
0.02
0.04
0.01
0.04
0.03
0.03
0.02
0.03
0.06
0.02
0.02
0.05
0.02
0.03
0.04
0.04
0.02
0.03
0.02
0.05
0.03
0.02
0.03
0.03
0.02

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp

*Important. See note on population page.

540

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Vulva (C51) (contd)


Cases

Male
ASR(W)
CUM 0-74

Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Cases

Female
ASR(W)
CUM 0-74

206
259
57
373
40
98
82
222
162
436
335
343
172
15
83
115
57
19
36
51
75
56
29
65
766
25
20
10
27
32
9
44
1220
87
60
254
212
372
637
179
690
906
462
531
124
445

1.4
1.3
3.5
1.5
1.0
1.4
0.9
1.4
1.0
1.4
1.5
1.4
1.7
0.7
1.1
1.0
0.9
1.2
1.1
1.1
1.3
1.7
1.1
1.0
1.5
0.9
1.6
0.9
1.1
1.4
0.5
1.2
1.4
1.6
1.2
1.5
1.5
1.7
1.8
1.3
1.6
1.2
1.6
1.8
1.6
1.6

0.11
0.09
0.49
0.09
0.17
0.16
0.11
0.10
0.08
0.07
0.09
0.08
0.14
0.21
0.14
0.11
0.12
0.33
0.21
0.17
0.16
0.27
0.23
0.15
0.06
0.21
0.42
0.35
0.23
0.28
0.18
0.21
0.05
0.19
0.18
0.11
0.12
0.10
0.08
0.11
0.07
0.05
0.09
0.09
0.16
0.09

0.16
0.16
0.40
0.14
0.11
0.15
0.10
0.16
0.10
0.15
0.19
0.15
0.18
0.05
0.11
0.11
0.11
0.17
0.12
0.12
0.13
0.21
0.12
0.11
0.16
0.08
0.15
0.12
0.11
0.16
0.07
0.13
0.16
0.17
0.15
0.16
0.14
0.19
0.18
0.14
0.18
0.12
0.17
0.20
0.17
0.16

0.01
0.01
0.07
0.01
0.02 *
0.02
0.01
0.01 *
0.01
0.01
0.01
0.01
0.02
0.03
0.02
0.02
0.02
0.05
0.03
0.02
0.02
0.04
0.03
0.02
0.01
0.03
0.05
0.05
0.03
0.04
0.03
0.03
0.01
0.03
0.03
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01

394
16
175
96
45
253
90
10
2
231
51
4
5
5
13
20

1.3
3.3
1.3
1.1
1.9
1.1
1.2
0.9
0.4
1.4
0.9
0.8
0.6
0.9
0.5
1.6

0.07
0.87
0.10
0.13
0.31
0.08
0.13
0.28
0.31
0.10
0.15
0.43
0.30
0.43
0.18
0.41

0.14
0.23
0.14
0.11
0.21
0.12
0.13
0.09
0.08
0.14
0.10
0.12
0.05
0.13
0.05
0.17

0.01
0.07
0.01
0.02
0.04
0.01
0.02
0.04
0.07
0.01
0.02
0.07
0.03
0.07
0.03
0.05

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

483

541

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Vagina (C52)
Cases

Male
ASR(W)
CUM 0-74

Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

484

Female
ASR(W)
CUM 0-74

4
12
4
6
6

0.2
0.2
0.4
0.6
0.3

0.11
0.07
0.20
0.29
0.11

9
37
6
12
255
4
38
25
11
13
2

1.0
1.5
0.8
0.6
0.9
0.4
0.7
0.3
0.3
0.9
0.2

0.33
0.26
0.35
0.17
0.06
0.19
0.13
0.06
0.11
0.26
0.11

0.10
0.18
0.13
0.01
0.11
0.02
0.06
0.03
0.03
0.11
0.01

0.04
0.04
0.07
0.01
0.01
0.01
0.02
0.01
0.01
0.04
0.01 *

440
60
70
19
12
11
0
24
226
4
14
102
22
78
8
70
580
58
48
109
356
112
9
2
7
2
15
67
164
24
6
0
1
4
59
62
73
61
7
51
23
15
7
375
49
320
188
58
128
46
18
28
17
239
61
170
127
60
100
118
44
74
13
13

0.4
0.6
0.4
0.3
0.4
0.4
0.5
0.5
0.9
0.3
0.5
0.5
0.5
0.6
0.3
0.5
0.4
0.7
0.6
0.4
0.4
0.6
0.1
0.5
0.4
0.6
0.4
0.5
0.8
0.4
0.3
0.5
0.8
0.4
0.5
0.4
0.7
0.3
0.9
0.8
1.0
0.5
0.7
0.5
0.6
0.8
0.6
0.5
0.7
0.4
0.3
0.5
0.9
0.4
0.5
0.4
0.6
0.7
1.0
0.6
1.1
0.7

0.02
0.08
0.05
0.09
0.12
0.13
0.12
0.03
0.44
0.10
0.06
0.11
0.06
0.21
0.04
0.02
0.06
0.11
0.06
0.03
0.05
0.21
0.10
0.21
0.33
0.16
0.05
0.04
0.16
0.18
0.25
0.25
0.10
0.06
0.06
0.05
0.29
0.05
0.20
0.23
0.40
0.03
0.10
0.03
0.05
0.11
0.06
0.08
0.17
0.09
0.09
0.03
0.12
0.03
0.05
0.06
0.06
0.07
0.16
0.08
0.32
0.25

0.05
0.06
0.04
0.04
0.04
0.03
0.06
0.05
0.09
0.03
0.05
0.05
0.06
0.07
0.04
0.05
0.04
0.10
0.07
0.05
0.05
0.08
0.02
0.05
0.03
0.08
0.04
0.06
0.12
0.04
0.03
0.03
0.08
0.05
0.05
0.04
0.07
0.04
0.10
0.08
0.14
0.06
0.08
0.05
0.06
0.09
0.06
0.04
0.08
0.03
0.04
0.05
0.08
0.04
0.06
0.04
0.07
0.07
0.10
0.06
0.15
0.07

0.00
0.01
0.01
0.01
0.02
0.01
0.02
0.00
0.04
0.01
0.01
0.01
0.01
0.03
0.01
0.00
0.01
0.02
0.01
0.00
0.01
0.03
0.01
0.02
0.03
0.03
0.01
0.01
0.03
0.02
0.03
0.02
0.01
0.01
0.01
0.01
0.03
0.01
0.03
0.03
0.07
0.00
0.01
0.00
0.01
0.02
0.01
0.01
0.02
0.01
0.01
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.02
0.01
0.04
0.02

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

542

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Vagina (C52) (contd)


Cases

Male
ASR(W)
CUM 0-74

America, North (contd)


USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Cases

Female
ASR(W)
CUM 0-74

34
127
242
43
194
102
30
70
96
20
75
16
4543
672
3689
163
28
127
35
4
12
18
371
68
294
232
35
189
67
64
276
29
240
23
486
71
379
1376
81
196
150
929
87
22
59
422
59
351
18
15
102
71
49
97

0.5
0.4
0.6
1.0
0.6
0.6
0.8
0.6
0.4
0.9
0.4
0.6
0.5
0.7
0.5
0.5
0.7
0.4
0.5
1.0
0.6
0.4
0.5
0.7
0.4
0.5
0.8
0.4
0.5
0.4
0.4
0.5
0.4
0.5
0.5
0.8
0.4
0.5
0.4
0.8
0.6
0.4
0.5
0.5
0.5
0.6
0.7
0.5
0.3
0.5
0.4
0.5
0.6
0.4

0.10
0.04
0.04
0.16
0.04
0.07
0.16
0.08
0.05
0.21
0.05
0.17
0.01
0.03
0.01
0.04
0.14
0.04
0.09
0.49
0.18
0.10
0.03
0.09
0.03
0.03
0.14
0.03
0.06
0.06
0.03
0.11
0.03
0.13
0.02
0.10
0.02
0.01
0.04
0.06
0.05
0.02
0.06
0.11
0.07
0.03
0.10
0.03
0.07
0.14
0.05
0.06
0.10
0.05

0.05
0.04
0.07
0.11
0.06
0.07
0.09
0.07
0.05
0.08
0.04
0.06
0.05
0.08
0.05
0.05
0.08
0.05
0.06
0.17
0.09
0.04
0.05
0.08
0.05
0.05
0.08
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.09
0.05
0.05
0.04
0.09
0.07
0.05
0.06
0.06
0.05
0.06
0.07
0.06
0.03
0.06
0.05
0.05
0.06
0.04

0.01
0.01
0.01
0.02
0.01
0.01
0.02
0.01
0.01
0.02
0.01
0.02
0.00
0.00
0.00
0.01
0.02
0.01
0.01
0.10
0.03
0.01
0.00
0.01
0.00
0.00
0.02
0.00
0.01
0.01
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.02
0.01
0.00
0.01
0.00
0.01
0.02
0.01
0.01
0.01
0.01

2
13

0.4
0.2

0.26
0.06

0.09
0.02

0.07
0.01 *

1
3
48
6
5
71
85
6
127
0
45
7
62
59
3
0
9
10
23
20
69
14

0.1
0.1
0.2
0.2
0.2
0.8
0.5
0.7
0.6
0.7
0.2
0.3
0.3
0.2
0.1
0.3
0.2
0.2
0.1
0.3

0.06
0.06
0.03
0.08
0.10
0.10
0.06
0.28
0.06
0.11
0.09
0.04
0.04
0.10
0.06
0.11
0.04
0.06
0.02
0.08

0.02
0.01
0.02
0.02
0.03
0.10
0.06
0.09
0.08
0.08
0.03
0.03
0.03
0.02
0.01
0.03
0.02
0.02
0.01
0.02

0.02 *
0.01
0.00 *
0.01 *
0.01 *
0.01
0.01 *
0.04
0.01
- *
0.01 *
0.01 *
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

485

543

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Vagina (C52) (contd)


Cases

Male
ASR(W)
CUM 0-74

Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

486

Female
ASR(W)
CUM 0-74

207
12
32
6
9
15
1
63
4
3
2
9
3
6
6
27
40
37
0
3
15
3
12
3
16

0.2
0.1
0.5
0.2
0.3
0.2
0.1
0.2
0.2
0.3
0.0
0.4
0.1
0.3
0.3
0.3
0.4
0.5
0.3
0.4
0.1
0.4
0.1
0.2

0.01
0.04
0.08
0.08
0.09
0.06
0.06
0.03
0.12
0.18
0.03
0.14
0.04
0.15
0.14
0.07
0.07
0.08
0.17
0.09
0.07
0.11
0.06
0.05

0.02
0.01
0.06
0.02
0.04
0.04
0.03
0.02
0.05
0.00
0.06
0.01
0.04
0.03
0.04
0.05
0.06
0.05
0.04
0.03
0.02
0.02

0.00
0.00
0.01
0.01
0.01
0.01
0.00
0.01
0.03
0.00
0.02
0.00
0.02 *
0.02 *
0.01 *
0.01
0.01
0.03
0.01 *
- *
0.01
0.01 *
0.01 *

171
6
8
131
31
102
150
73
239
125
45
91
23
9
8
22
15
9
21
4
11
3
6
72
155
50
53
43
72
19
3
43
2
19
14
25
10
3
27
9
9
61
9
4
16
23
15
8
4
3
20
9
5
43

0.4
0.2
0.7
0.3
0.4
0.5
0.4
0.4
0.5
0.4
0.6
0.3
0.4
0.3
0.3
0.5
0.4
0.2
0.5
0.1
0.4
0.2
0.1
0.5
0.5
0.5
0.5
0.4
0.5
0.2
0.2
0.3
0.1
0.6
0.6
0.2
0.3
0.3
0.3
0.2
0.4
0.4
0.1
0.3
0.3
0.3
0.4
0.3
0.2
0.1
0.2
0.2
0.1
0.4

0.03
0.10
0.25
0.03
0.08
0.05
0.04
0.05
0.03
0.04
0.10
0.04
0.10
0.11
0.12
0.12
0.13
0.07
0.12
0.03
0.14
0.11
0.07
0.06
0.05
0.08
0.08
0.07
0.08
0.06
0.15
0.05
0.04
0.15
0.19
0.06
0.09
0.21
0.08
0.08
0.14
0.07
0.04
0.16
0.10
0.08
0.10
0.12
0.12
0.06
0.05
0.08
0.04
0.07

0.04
0.02
0.08
0.03
0.06
0.05
0.05
0.04
0.06
0.05
0.07
0.03
0.04
0.03
0.02
0.05
0.03
0.02
0.05
0.04
0.03
0.02
0.05
0.06
0.06
0.05
0.04
0.05
0.02
0.01
0.03
0.08
0.07
0.03
0.03
0.03
0.03
0.02
0.06
0.04
0.05
0.02
0.03
0.04
0.04
0.02
0.02
0.01
0.01
0.04

0.00
0.01
0.03
0.00 *
0.01 *
0.01
0.00 *
0.01
0.00
0.01
0.01
0.00
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.01
0.02
0.01
0.01
0.02
0.01
0.02
0.01
0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.01

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp

*Important. See note on population page.

544

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Vagina (C52) (contd)


Cases

Male
ASR(W)
CUM 0-74

Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Cases

Female
ASR(W)
CUM 0-74

39
48
3
78
14
13
20
54
37
95
114
83
59
2
16
18
16
2
10
8
10
5
8
16
194
2
10
5
8
7
3
18
224
11
8
42
41
108
137
33
116
222
106
100
32
104

0.3
0.3
0.2
0.4
0.3
0.2
0.2
0.4
0.3
0.3
0.5
0.4
0.6
0.1
0.2
0.2
0.3
0.1
0.3
0.2
0.2
0.1
0.4
0.3
0.4
0.1
0.8
0.4
0.3
0.3
0.2
0.6
0.3
0.3
0.2
0.3
0.3
0.5
0.5
0.3
0.3
0.3
0.5
0.4
0.5
0.5

0.07
0.04
0.11
0.05
0.09
0.06
0.06
0.06
0.05
0.04
0.06
0.04
0.08
0.09
0.06
0.06
0.07
0.04
0.10
0.09
0.09
0.06
0.15
0.10
0.03
0.09
0.27
0.22
0.14
0.15
0.14
0.17
0.02
0.08
0.08
0.05
0.06
0.06
0.04
0.05
0.03
0.03
0.05
0.05
0.09
0.06

0.03
0.03
0.02
0.04
0.02
0.02
0.03
0.04
0.03
0.04
0.07
0.04
0.06
0.03
0.02
0.02
0.03
0.04
0.03
0.01
0.00
0.03
0.03
0.04
0.01
0.09
0.05
0.04
0.03
0.03
0.07
0.03
0.03
0.02
0.03
0.03
0.06
0.05
0.03
0.04
0.04
0.05
0.04
0.06
0.05

0.01
0.01
0.01
0.01
0.01 *
0.01
0.01
0.01 *
0.01
0.00
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.02
0.01
0.01
0.00
0.02
0.01
0.00
0.01
0.04
0.03
0.02
0.02
0.02
0.02
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.00
0.01
0.01
0.01
0.01

126
0
62
28
8
52
33
4
0
54
16
3
0
2
3
6

0.5
0.4
0.4
0.4
0.2
0.5
0.3
0.4
0.3
0.9
0.3
0.3
0.5

0.05
0.06
0.08
0.14
0.04
0.09
0.18
0.06
0.08
0.53
0.20
0.19
0.21

0.05
0.05
0.04
0.05
0.02
0.05
0.02
0.04
0.05
0.12
0.04
0.04
0.10

0.01
0.01
0.01
0.02
0.00
0.01
0.02
0.01
0.01
0.07
0.04
0.02
0.05

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

487

545

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Cervix uteri (C53)


Cases

Male
ASR(W)
CUM 0-74

Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

488

Female
ASR(W)
CUM 0-74

229
109
72
649
818

11.6
2.1
7.1
45.8
47.3

0.78
0.21
0.86
2.11
1.99

139
1154
302
711
6028
216
1314
1655
637
220
498

16.0
37.7
37.7
33.9
21.1
22.2
27.9
18.9
20.0
16.5
43.9

1.42
1.20
2.30
1.32
0.28
1.54
0.82
0.48
0.83
1.16
2.03

1.54
4.16
4.35
3.80
2.29
2.17
3.02
1.96
2.27
1.86
5.05

0.14
0.16
0.32
0.18
0.04
0.17
0.10
0.06
0.11
0.14
0.27 *

5389
797
828
267
191
138
6
295
2623
30
214
1157
391
723
119
965
8109
909
532
2990
3524
1263
112
59
61
13
295
581
2769
262
64
91
23
69
1404
740
799
700
82
600
194
151
23
4771
854
3794
2098
662
1371
647
247
353
216
3401
775
2492
1410
651
1245
1244
513
711
151
126

6.9
8.6
5.8
7.0
7.4
7.7
7.0
9.1
6.6
6.3
7.0
7.5
10.3
6.6
6.5
6.0
7.7
6.6
7.1
13.0
6.2
5.8
6.5
3.1
5.2
3.6
10.0
5.0
9.5
7.8
4.9
8.8
4.6
9.8
15.1
6.6
5.9
5.7
8.2
5.5
9.8
12.0
3.8
8.6
12.1
8.3
7.9
9.5
7.4
7.0
8.7
6.1
5.5
8.4
13.1
7.5
7.2
7.0
9.3
8.8
12.0
7.6
11.4
6.7

0.10
0.31
0.21
0.45
0.57
0.68
3.15
0.55
0.13
1.19
0.50
0.23
0.54
0.26
0.62
0.20
0.09
0.22
0.32
0.25
0.11
0.17
0.64
0.42
0.68
1.04
0.61
0.22
0.19
0.50
0.63
0.94
1.01
1.20
0.42
0.26
0.22
0.23
0.93
0.24
0.73
1.01
0.83
0.13
0.42
0.14
0.18
0.39
0.21
0.29
0.59
0.34
0.39
0.15
0.48
0.16
0.20
0.29
0.27
0.26
0.54
0.30
0.94
0.62

0.67
0.82
0.56
0.68
0.71
0.78
1.02
0.86
0.64
0.65
0.67
0.74
1.09
0.63
0.63
0.59
0.77
0.72
0.70
1.37
0.59
0.59
0.58
0.33
0.53
0.33
1.06
0.49
0.98
0.80
0.54
0.98
0.41
1.19
1.62
0.66
0.57
0.58
0.89
0.55
1.05
1.26
0.44
0.85
1.31
0.80
0.79
1.01
0.72
0.74
0.96
0.61
0.55
0.84
1.34
0.75
0.70
0.65
0.91
0.88
1.24
0.73
1.14
0.64

0.01
0.03
0.02
0.05
0.06
0.07
0.58
0.06
0.01
0.13
0.05
0.02
0.07
0.03
0.07
0.02
0.01
0.03
0.04
0.03
0.01
0.02
0.07
0.05
0.08
0.10
0.07
0.02
0.02
0.06
0.08
0.12
0.10
0.17
0.05
0.03
0.02
0.02
0.12
0.03
0.08
0.11
0.11
0.01
0.05
0.01
0.02
0.05
0.02
0.04
0.08
0.04
0.04
0.02
0.05
0.02
0.02
0.03
0.03
0.03
0.06
0.03
0.11
0.06

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

546

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Cervix uteri (C53) (contd)


Cases

Male
ASR(W)
CUM 0-74

America, North (contd)


USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Cases

Female
ASR(W)
CUM 0-74

278
1224
2193
425
1690
1013
337
645
1390
216
1146
206
55469
8693
43436
2339
466
1759
394
27
150
201
4976
1199
3533
2569
302
2191
919
719
3020
415
2487
215
5553
826
4075
17731
1395
2360
3732
9923
1113
399
688
5333
712
4439
311
153
1102
734
591
1247

6.1
5.4
6.7
9.5
6.3
7.4
10.0
6.7
7.4
10.6
7.0
6.9
7.6
10.2
7.2
7.9
11.9
7.5
6.9
5.5
7.5
6.8
7.5
12.2
6.8
6.8
7.0
6.7
8.3
6.5
7.1
10.3
6.6
6.2
6.3
8.5
6.0
7.4
6.6
9.4
12.3
6.4
8.3
10.5
7.6
8.3
9.8
8.2
5.3
7.3
5.8
5.5
9.1
7.6

0.39
0.16
0.15
0.48
0.16
0.24
0.56
0.28
0.21
0.75
0.22
0.51
0.03
0.11
0.04
0.17
0.56
0.19
0.36
1.08
0.62
0.52
0.11
0.36
0.12
0.14
0.42
0.15
0.29
0.25
0.14
0.52
0.14
0.44
0.09
0.31
0.10
0.06
0.18
0.20
0.21
0.07
0.26
0.55
0.30
0.12
0.38
0.13
0.31
0.62
0.18
0.21
0.40
0.23

0.62
0.55
0.65
0.96
0.60
0.72
1.00
0.64
0.73
1.04
0.69
0.66
0.75
1.06
0.70
0.80
1.22
0.74
0.69
0.52
0.74
0.67
0.77
1.31
0.68
0.67
0.71
0.65
0.81
0.62
0.70
1.07
0.65
0.59
0.62
0.88
0.58
0.74
0.71
0.97
1.29
0.62
0.81
1.10
0.71
0.81
1.02
0.79
0.49
0.76
0.56
0.53
0.89
0.70

0.04
0.02
0.02
0.06
0.02
0.03
0.07
0.03
0.02
0.08
0.02
0.05
0.00
0.01
0.00
0.02
0.07
0.02
0.04
0.12
0.07
0.05
0.01
0.04
0.01
0.01
0.05
0.02
0.03
0.03
0.01
0.06
0.01
0.04
0.01
0.04
0.01
0.01
0.02
0.02
0.03
0.01
0.03
0.06
0.03
0.01
0.05
0.01
0.03
0.07
0.02
0.02
0.04
0.02

38
298
2251
33
86
722
133
101
2550
3653
93
3121
741
1138
284
911
853
44
229
204
500
512
651
1963
313

6.0
4.6
9.8
2.4
3.0
2.8
3.5
4.3
28.0
19.5
10.6
14.5
18.4
17.3
9.4
5.4
5.8
2.4
6.2
6.3
12.2
6.0
10.9
5.6
6.8

1.01
0.27
0.22
0.43
0.33
0.11
0.31
0.45
0.56
0.34
1.11
0.27
0.69
0.53
0.56
0.18
0.20
0.37
0.42
0.49
0.57
0.28
0.48
0.14
0.43

0.67
0.43
1.07
0.28
0.34
0.29
0.36
0.48
3.22
2.25
1.42
1.66
2.10
1.99
1.15
0.55
0.58
0.23
0.66
0.60
1.22
0.56
1.04
0.56
0.64

0.13
0.03 *
0.03
0.06 *
0.04
0.01 *
0.03 *
0.05 *
0.07
0.05 *
0.17
0.04
0.09 *
0.07 *
0.08 *
0.02
0.02
0.04
0.05
0.05
0.06
0.03
0.05
0.01
0.04

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

489

547

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Cervix uteri (C53) (contd)


Cases

Male
ASR(W)
CUM 0-74

Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

490

Female
ASR(W)
CUM 0-74

17576
1812
1169
696
540
1375
141
5033
283
58
90
416
671
108
159
1966
1023
910
35
78
1297
546
573
136
467

15.4
15.3
16.0
18.6
14.5
19.8
13.8
17.8
14.2
4.5
5.3
17.9
15.9
6.5
7.5
19.8
10.6
11.5
6.3
7.3
28.9
22.4
17.8
4.4
5.4

0.12
0.36
0.47
0.73
0.64
0.55
1.18
0.26
0.90
0.63
0.83
0.89
0.63
0.64
0.63
0.47
0.34
0.39
1.11
0.86
0.83
0.98
0.76
0.38
0.25

1.67
1.61
1.78
2.02
1.57
2.19
1.51
1.99
1.65
0.50
0.63
2.08
1.67
0.86
0.83
2.14
1.18
1.27
0.69
0.80
3.08
2.35
1.95
0.51
0.61

0.01
0.04
0.06
0.09
0.08
0.07
0.14
0.03
0.12
0.08
0.14
0.12
0.08
0.10 *
0.08 *
0.06 *
0.04
0.05
0.14
0.11
0.10 *
0.11 *
0.09
0.05 *
0.03 *

2644
285
82
4015
419
1503
5148
1920
5414
2019
771
788
312
165
135
200
328
237
240
149
161
100
110
1102
1937
539
761
714
747
426
74
930
64
171
105
276
195
33
283
172
83
585
106
65
113
312
183
79
63
46
247
179
112
355

8.7
12.0
6.8
10.9
6.6
8.7
18.0
11.5
14.9
10.7
14.7
4.0
8.3
6.9
7.9
7.8
9.8
6.2
5.6
7.6
8.0
7.6
5.8
11.2
11.1
7.7
11.4
7.8
7.0
9.8
9.2
8.1
7.9
7.0
7.2
5.4
7.5
4.4
5.8
6.4
5.0
6.9
6.5
5.7
6.1
7.3
5.7
4.6
5.1
6.5
5.5
4.9
5.6
5.4

0.18
0.74
0.79
0.18
0.35
0.24
0.26
0.28
0.21
0.25
0.56
0.16
0.49
0.57
0.70
0.57
0.57
0.43
0.39
0.71
0.67
0.83
0.60
0.36
0.28
0.36
0.44
0.31
0.28
0.51
1.09
0.27
1.10
0.58
0.75
0.37
0.62
0.84
0.38
0.53
0.56
0.31
0.69
0.76
0.63
0.46
0.45
0.54
0.67
1.04
0.40
0.41
0.58
0.31

0.86
1.12
0.69
1.11
0.66
0.86
1.78
1.16
1.48
1.03
1.50
0.40
0.84
0.71
0.77
0.78
0.99
0.60
0.54
0.72
0.82
0.73
0.53
1.07
1.08
0.77
1.09
0.75
0.72
0.96
0.89
0.78
0.81
0.71
0.72
0.57
0.80
0.48
0.61
0.65
0.56
0.68
0.68
0.64
0.61
0.72
0.59
0.46
0.57
0.60
0.57
0.49
0.56
0.54

0.02
0.07
0.08
0.02 *
0.04 *
0.02
0.03 *
0.03
0.02
0.03
0.06
0.02
0.05
0.06
0.07
0.06
0.06
0.04
0.04
0.07
0.07
0.08
0.06
0.04
0.03
0.04
0.04
0.03
0.03
0.05
0.11
0.03
0.11
0.06
0.08
0.04
0.06
0.09
0.04
0.06
0.07
0.03
0.07
0.09
0.06
0.05
0.05
0.06
0.08
0.10
0.04
0.04
0.06
0.03

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp

*Important. See note on population page.

548

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Cervix uteri (C53) (contd)


Cases

Male
ASR(W)
CUM 0-74

Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Cases

Female
ASR(W)
CUM 0-74

980
2400
54
1524
502
702
871
1356
1033
1874
4149
2664
1007
52
323
324
415
36
132
167
244
86
129
141
2235
66
58
22
119
86
46
109
3380
177
191
536
728
1289
2081
407
1809
2842
1257
1448
405
1591

10.4
18.9
3.9
10.0
17.5
15.5
12.5
12.5
10.1
9.3
25.7
15.0
14.5
5.3
7.1
5.0
8.8
5.3
6.6
6.0
6.7
4.3
7.4
4.1
7.0
4.0
6.5
3.5
6.6
6.5
4.4
4.5
5.9
4.9
5.7
5.4
8.3
8.8
9.2
4.2
7.5
5.6
7.5
8.1
7.6
8.9

0.35
0.40
0.56
0.27
0.80
0.61
0.44
0.35
0.33
0.23
0.42
0.30
0.47
0.79
0.43
0.29
0.44
0.97
0.61
0.49
0.44
0.50
0.70
0.37
0.16
0.54
0.91
0.78
0.63
0.77
0.70
0.47
0.11
0.38
0.43
0.26
0.33
0.26
0.22
0.22
0.19
0.11
0.23
0.23
0.39
0.24

1.08
1.89
0.39
0.97
1.77
1.62
1.33
1.25
1.01
0.92
2.59
1.47
1.38
0.49
0.75
0.51
0.89
0.54
0.67
0.61
0.69
0.42
0.78
0.44
0.67
0.38
0.66
0.37
0.67
0.65
0.43
0.44
0.58
0.50
0.58
0.48
0.80
0.85
0.85
0.40
0.69
0.54
0.71
0.76
0.72
0.83

0.04
0.04
0.06
0.03
0.09 *
0.07
0.05
0.04 *
0.03
0.02
0.04
0.03
0.05
0.08
0.05
0.03
0.05
0.10
0.06
0.05
0.05
0.05
0.08
0.04
0.02
0.06
0.10
0.09
0.07
0.08
0.07
0.05
0.01
0.04
0.05
0.02
0.03
0.03
0.02
0.02
0.02
0.01
0.02
0.02
0.04
0.02

1338
48
805
261
108
837
412
49
73
993
298
16
56
56
47
75

6.1
10.0
7.0
5.1
7.1
5.1
6.7
5.0
15.6
8.0
7.4
4.7
8.4
9.3
5.2
7.5

0.17
1.57
0.25
0.33
0.71
0.18
0.34
0.73
1.89
0.26
0.44
1.33
1.15
1.26
0.85
0.91

0.61
0.97
0.68
0.48
0.70
0.51
0.67
0.51
1.70
0.78
0.70
0.41
0.84
0.86
0.48
0.70

0.02
0.19
0.03
0.03
0.07
0.02
0.04
0.09
0.24
0.03
0.04
0.12
0.12
0.13
0.08
0.09

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

491

549

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Corpus uteri (C54)


Cases

Male
ASR(W)
CUM 0-74

Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

492

Female
ASR(W)
CUM 0-74

22
127
32
38
53

1.1
2.6
3.4
3.7
4.1

0.24
0.23
0.60
0.64
0.64

87
185
14
110
2025
48
247
548
125
91
47

8.2
7.5
2.0
6.1
7.4
4.9
5.9
7.2
4.0
6.2
4.7

0.96
0.59
0.56
0.60
0.17
0.73
0.39
0.32
0.37
0.69
0.70

0.99
0.94
0.31
0.72
0.93
0.57
0.71
0.85
0.51
0.81
0.65

0.13
0.09
0.11
0.09
0.03
0.10
0.05
0.04
0.06
0.10
0.11 *

13240
1569
2129
808
410
260
2
561
6857
84
560
2047
429
1574
235
2436
17933
1495
879
2403
12921
3857
215
171
141
60
330
2719
4814
440
106
165
84
50
995
2827
1992
2793
124
2628
345
215
110
10691
951
9590
3500
739
2715
1159
276
855
686
8021
756
6999
4140
2326
2441
2012
521
1471
145
286

15.4
16.8
13.7
18.9
13.9
13.1
2.0
14.8
15.7
14.8
14.9
11.4
11.3
11.4
15.4
12.8
15.8
11.1
12.7
12.3
17.7
16.7
13.6
9.4
12.1
13.2
12.8
19.2
16.1
13.6
8.8
16.0
14.7
7.4
12.3
20.0
14.3
20.4
13.7
21.0
15.1
13.4
16.8
14.6
14.1
14.9
13.0
12.1
13.5
14.1
11.8
15.4
15.5
17.8
12.7
18.6
18.6
20.1
16.1
12.3
11.9
12.8
11.0
12.4

0.14
0.44
0.32
0.72
0.73
0.85
1.40
0.67
0.20
1.74
0.69
0.27
0.58
0.31
1.05
0.28
0.13
0.29
0.44
0.26
0.17
0.29
0.98
0.74
1.04
1.89
0.73
0.40
0.24
0.67
0.88
1.26
1.74
1.06
0.41
0.41
0.34
0.42
1.26
0.45
0.87
0.99
1.74
0.16
0.47
0.17
0.23
0.47
0.27
0.43
0.75
0.55
0.63
0.21
0.48
0.24
0.31
0.46
0.34
0.29
0.55
0.36
0.94
0.80

1.91
2.10
1.70
2.35
1.80
1.57
0.20
1.83
1.94
1.78
1.81
1.39
1.47
1.36
1.90
1.54
1.92
1.28
1.58
1.46
2.19
2.05
1.73
1.11
1.36
1.50
1.58
2.40
1.96
1.69
1.03
1.85
1.66
0.75
1.48
2.49
1.75
2.51
1.81
2.58
1.88
1.68
2.13
1.79
1.86
1.80
1.61
1.58
1.65
1.77
1.58
1.91
1.89
2.19
1.56
2.29
2.27
2.49
1.95
1.48
1.55
1.49
1.38
1.36

0.02
0.06
0.04
0.10
0.10
0.11
0.14
0.09
0.03
0.24
0.09
0.04
0.08
0.04
0.15
0.04
0.02
0.04
0.06
0.04
0.02
0.04
0.14
0.10
0.13
0.23
0.10
0.06
0.03
0.09
0.11
0.16
0.20
0.12
0.06
0.06
0.05
0.06
0.19
0.06
0.12
0.14
0.26
0.02
0.07
0.02
0.03
0.07
0.04
0.06
0.12
0.08
0.09
0.03
0.07
0.03
0.04
0.06
0.05
0.04
0.08
0.05
0.14
0.10

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

550

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Corpus uteri (C54) (contd)


Cases

Male
ASR(W)
CUM 0-74

America, North (contd)


USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Cases

Female
ASR(W)
CUM 0-74

1115
4929
6898
611
6164
2846
485
2330
3828
268
3521
560
139510
10674
123708
6790
575
6039
864
50
215
582
14221
1549
12287
8369
523
7592
1706
2233
11360
578
10565
823
17062
1156
14502
43641
2417
3047
3196
34472
2045
519
1484
8506
775
7526
990
511
3778
2608
1516
3771

21.9
20.4
18.9
14.4
19.6
19.0
14.9
20.5
17.5
13.9
18.0
15.7
16.9
13.0
17.4
20.7
14.8
22.1
13.5
10.6
10.6
15.3
19.5
15.8
20.6
19.1
12.3
19.5
12.4
17.0
22.3
13.7
23.1
19.4
17.9
13.5
18.8
16.8
11.8
13.0
12.3
18.4
13.2
13.7
13.0
12.7
11.7
12.9
16.6
21.5
18.0
18.3
19.8
18.9

0.70
0.31
0.24
0.61
0.27
0.38
0.71
0.46
0.30
0.89
0.33
0.71
0.05
0.13
0.05
0.27
0.63
0.31
0.48
1.52
0.74
0.68
0.17
0.41
0.20
0.22
0.56
0.24
0.32
0.39
0.23
0.60
0.24
0.74
0.15
0.41
0.17
0.09
0.24
0.24
0.23
0.11
0.31
0.63
0.36
0.14
0.44
0.16
0.56
1.01
0.31
0.38
0.54
0.33

2.67
2.54
2.33
1.84
2.40
2.34
1.87
2.52
2.15
1.85
2.19
1.93
2.07
1.67
2.13
2.59
1.89
2.76
1.62
1.10
1.27
1.87
2.42
2.05
2.55
2.36
1.55
2.39
1.55
2.07
2.72
1.75
2.80
2.40
2.21
1.72
2.33
2.06
1.36
1.65
1.48
2.27
1.61
1.76
1.55
1.55
1.51
1.57
2.06
2.54
2.20
2.27
2.38
2.33

0.09
0.04
0.03
0.09
0.04
0.05
0.10
0.06
0.04
0.13
0.04
0.10
0.01
0.02
0.01
0.04
0.09
0.04
0.06
0.19
0.10
0.09
0.02
0.06
0.03
0.03
0.08
0.03
0.04
0.05
0.03
0.08
0.03
0.10
0.02
0.06
0.02
0.01
0.03
0.04
0.03
0.01
0.04
0.09
0.05
0.02
0.07
0.02
0.08
0.14
0.04
0.05
0.07
0.04

33
370
1848
14
70
1358
359
282
171
623
10
547
90
117
82
2363
2187
139
202
145
312
588
463
1263
316

5.2
6.2
8.8
1.0
2.8
6.0
10.8
11.8
2.0
3.7
1.1
2.8
2.3
1.9
2.8
13.0
13.2
9.0
5.2
3.9
7.2
5.9
6.9
3.3
5.5

0.94
0.32
0.21
0.28
0.34
0.17
0.58
0.72
0.15
0.15
0.35
0.12
0.25
0.18
0.31
0.28
0.30
0.78
0.38
0.35
0.42
0.26
0.34
0.10
0.35

0.55
0.70
0.98
0.12
0.31
0.69
1.16
1.49
0.24
0.47
0.10
0.36
0.26
0.25
0.32
1.63
1.65
1.12
0.61
0.46
0.81
0.69
0.77
0.38
0.64

0.11
0.04 *
0.03
0.04 *
0.04
0.02 *
0.07 *
0.10 *
0.02
0.02 *
0.03
0.02
0.03 *
0.03 *
0.04 *
0.04
0.04
0.11
0.05
0.04
0.05
0.03
0.04
0.01
0.04

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

493

551

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Corpus uteri (C54) (contd)


Cases

Male
ASR(W)
CUM 0-74

Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

494

Female
ASR(W)
CUM 0-74

3157
274
190
116
77
188
24
972
49
42
29
129
118
14
130
876
867
734
46
87
140
73
90
215
548

2.9
2.4
2.7
3.3
2.1
2.9
2.5
3.5
2.4
3.6
4.3
5.7
3.1
0.9
6.7
9.9
9.2
9.4
7.8
8.6
3.5
3.1
3.0
7.2
6.5

0.05
0.15
0.20
0.32
0.25
0.22
0.53
0.11
0.36
0.59
0.95
0.51
0.29
0.24
0.62
0.35
0.32
0.36
1.18
0.96
0.30
0.37
0.32
0.50
0.28

0.31
0.27
0.29
0.38
0.22
0.34
0.25
0.39
0.24
0.48
0.49
0.72
0.36
0.13
0.76
1.19
1.07
1.10
1.09
0.93
0.42
0.37
0.33
0.88
0.79

0.01
0.02
0.02
0.04
0.03
0.03
0.06
0.01
0.04
0.09
0.12
0.07
0.04
0.04 *
0.08 *
0.05 *
0.04
0.05
0.19
0.11
0.04 *
0.05 *
0.04
0.07 *
0.04 *

4778
371
202
5719
917
2892
5420
2582
8224
3079
939
3535
563
276
232
393
442
446
401
205
295
200
235
1611
3754
620
1159
1544
1407
809
122
1219
144
361
276
820
349
105
701
492
155
1182
350
164
307
650
353
256
187
115
614
571
315
919

12.5
12.6
14.5
14.2
11.6
12.9
15.3
12.2
18.1
12.5
14.5
14.4
13.2
9.2
10.8
13.2
10.2
10.0
8.0
8.7
11.5
10.4
8.7
12.1
14.5
6.6
12.9
12.7
11.0
13.3
12.6
9.6
13.1
12.1
13.3
13.7
10.0
11.1
11.0
15.9
8.8
10.9
15.0
12.3
13.4
12.3
9.9
12.3
13.9
14.5
11.4
13.0
12.4
11.6

0.20
0.71
1.09
0.20
0.42
0.26
0.22
0.26
0.21
0.24
0.50
0.26
0.60
0.61
0.77
0.71
0.54
0.51
0.44
0.68
0.74
0.84
0.63
0.32
0.26
0.30
0.41
0.35
0.32
0.51
1.22
0.29
1.21
0.69
0.90
0.53
0.62
1.24
0.46
0.78
0.73
0.35
0.92
1.04
0.85
0.53
0.56
0.82
1.08
1.46
0.51
0.61
0.76
0.42

1.59
1.60
1.86
1.73
1.51
1.67
1.90
1.52
2.28
1.60
1.77
1.86
1.70
1.25
1.31
1.67
1.24
1.29
1.01
1.10
1.53
1.31
1.14
1.57
1.82
0.85
1.63
1.64
1.38
1.69
1.49
1.20
1.75
1.46
1.67
1.58
1.20
1.32
1.38
1.99
1.09
1.35
1.84
1.55
1.68
1.49
1.23
1.55
1.72
1.74
1.41
1.56
1.55
1.42

0.03
0.10
0.15
0.02 *
0.06 *
0.04
0.03 *
0.03
0.03
0.04
0.06
0.04
0.08
0.09
0.10
0.10
0.07
0.07
0.06
0.09
0.11
0.11
0.09
0.05
0.04
0.04
0.06
0.05
0.04
0.07
0.16
0.04
0.16
0.09
0.12
0.06
0.08
0.15
0.06
0.10
0.10
0.05
0.12
0.14
0.11
0.07
0.07
0.11
0.14
0.18
0.07
0.08
0.10
0.05

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp

*Important. See note on population page.

552

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Corpus uteri (C54) (contd)


Cases

Male
ASR(W)
CUM 0-74

Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Cases

Female
ASR(W)
CUM 0-74

1856
2424
252
2760
485
662
1012
874
1246
3184
2349
3409
1402
141
575
901
597
115
314
448
522
347
269
442
6404
228
108
142
262
160
150
346
7601
487
507
1522
1087
1843
2785
1114
3646
5776
2381
2635
618
2291

16.4
16.4
16.5
14.2
14.9
13.5
12.4
7.0
9.4
14.0
12.2
17.0
16.2
10.5
10.4
11.4
11.5
11.9
13.0
13.6
12.3
14.6
12.7
10.8
14.6
11.2
10.8
16.9
11.8
9.6
13.0
12.6
11.3
11.9
12.6
12.2
10.1
10.1
9.4
10.3
11.1
9.7
10.8
11.2
9.8
10.0

0.40
0.35
1.08
0.30
0.70
0.55
0.41
0.25
0.29
0.26
0.26
0.30
0.46
0.99
0.48
0.41
0.49
1.30
0.81
0.70
0.57
0.86
0.86
0.57
0.20
0.81
1.14
1.57
0.79
0.83
1.13
0.74
0.14
0.56
0.59
0.34
0.33
0.26
0.19
0.33
0.20
0.14
0.24
0.24
0.42
0.22

2.06
1.99
2.08
1.76
1.87
1.71
1.59
0.88
1.18
1.73
1.46
2.16
2.05
1.34
1.33
1.41
1.48
1.45
1.64
1.71
1.51
1.73
1.52
1.35
1.89
1.36
1.38
2.30
1.54
1.23
1.58
1.65
1.40
1.47
1.59
1.57
1.26
1.27
1.19
1.32
1.39
1.24
1.36
1.43
1.21
1.24

0.05
0.04
0.15
0.04
0.09 *
0.07
0.05
0.03 *
0.04
0.03
0.03
0.04
0.06
0.13
0.06
0.05
0.07
0.16
0.11
0.09
0.07
0.11
0.11
0.07
0.03
0.11
0.16
0.23
0.11
0.12
0.15
0.10
0.02
0.08
0.08
0.05
0.04
0.03
0.03
0.05
0.03
0.02
0.03
0.03
0.06
0.03

2237
36
1418
751
164
2052
593
81
58
1473
806
46
111
158
216
208

9.2
10.3
11.3
12.3
8.6
11.5
9.0
8.7
12.9
11.0
19.0
13.1
16.9
28.0
19.6
19.5

0.21
1.84
0.32
0.48
0.72
0.27
0.39
1.01
1.74
0.30
0.70
2.04
1.63
2.27
1.49
1.43

1.12
1.26
1.40
1.53
1.00
1.42
1.09
1.17
1.57
1.38
2.20
1.58
1.85
3.29
2.14
2.39

0.03
0.28
0.04
0.07
0.10
0.04
0.05
0.15
0.24
0.04
0.09
0.26
0.19
0.30
0.16
0.20

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

495

553

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Uterus unspecified (C55)


Cases

Male
ASR(W)
CUM 0-74

Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

496

Female
ASR(W)
CUM 0-74

6
17
5
19
24

0.3
0.3
0.5
1.7
1.9

0.14
0.09
0.22
0.47
0.43

8
176
54
19
915
6
41
57
50
16
0

0.8
5.6
7.3
1.0
3.3
0.7
0.9
0.7
1.2
1.3
-

0.30
0.46
1.04
0.24
0.11
0.27
0.14
0.09
0.19
0.34
-

0.09
0.61
0.84
0.09
0.36
0.07
0.08
0.07
0.11
0.14
-

0.04
0.06
0.15
0.03
0.02
0.03
0.02
0.01
0.03
0.04
- *

290
24
33
14
5
5
0
16
174
2
17
65
25
39
5
98
375
28
41
67
232
61
10
2
0
0
5
36
80
17
3
5
1
0
25
26
15
74
5
68
30
20
10
435
68
365
127
46
80
32
9
22
34
343
80
254
79
49
66
71
29
42
6
11

0.3
0.2
0.1
0.2
0.1
0.2
0.3
0.3
0.3
0.4
0.4
0.7
0.3
0.2
0.5
0.3
0.2
0.5
0.3
0.3
0.2
0.6
0.1
0.2
0.2
0.2
0.4
0.2
0.4
0.2
0.3
0.1
0.1
0.5
0.4
0.5
1.3
1.3
1.5
0.5
1.0
0.5
0.4
0.6
0.4
0.3
0.3
0.3
0.7
0.7
1.3
0.6
0.3
0.4
0.4
0.4
0.6
0.4
0.4
0.4

0.02
0.04
0.03
0.07
0.05
0.10
0.09
0.03
0.28
0.12
0.05
0.15
0.05
0.11
0.06
0.02
0.04
0.09
0.04
0.02
0.04
0.21
0.08
0.08
0.04
0.03
0.12
0.10
0.20
0.22
0.06
0.03
0.03
0.06
0.17
0.07
0.26
0.32
0.52
0.03
0.12
0.03
0.04
0.10
0.04
0.06
0.12
0.08
0.13
0.04
0.15
0.04
0.04
0.06
0.05
0.05
0.11
0.06
0.16
0.14

0.02
0.02
0.01
0.01
0.00
0.02
0.03
0.03
0.03
0.04
0.04
0.10
0.03
0.01
0.05
0.03
0.03
0.05
0.03
0.03
0.03
0.04
0.01
0.01
0.03
0.02
0.05
0.02
0.07
0.02
0.03
0.01
0.01
0.05
0.02
0.05
0.15
0.15
0.14
0.06
0.12
0.05
0.04
0.07
0.04
0.03
0.04
0.03
0.08
0.08
0.15
0.06
0.03
0.05
0.04
0.05
0.07
0.04
0.03
0.04

0.00
0.01
0.00
0.01
0.00
0.01
0.01
0.00
0.03
0.01
0.01
0.02
0.01
0.01
0.01
0.00
0.01
0.01
0.00
0.00
0.00
0.02
0.01
0.01
0.01
0.00
0.02
0.02
0.04
0.02
0.01
0.00
0.00
0.01
0.01
0.01
0.03
0.04
0.06
0.00
0.02
0.00
0.01
0.01
0.01
0.01
0.02
0.01
0.02
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.02
0.02

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

554

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Uterus unspecified (C55) (contd)


Cases

Male
ASR(W)
CUM 0-74

America, North (contd)


USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Cases

Female
ASR(W)
CUM 0-74

26
147
233
40
191
70
24
45
147
13
133
0
4929
866
3906
267
59
206
36
5
9
20
579
147
414
285
45
238
190
27
143
17
123
15
351
53
265
1092
43
177
100
753
87
34
53
642
130
488
9
8
74
26
36
212

0.5
0.5
0.5
0.9
0.5
0.4
0.7
0.3
0.5
0.6
0.5
0.5
1.0
0.5
0.7
1.4
0.7
0.4
0.8
0.4
0.3
0.7
1.4
0.6
0.6
1.0
0.5
1.3
0.2
0.2
0.3
0.2
0.3
0.3
0.6
0.3
0.4
0.2
0.7
0.4
0.3
0.5
0.9
0.4
0.9
1.8
0.8
0.1
0.3
0.3
0.1
0.4
0.9

0.11
0.05
0.04
0.15
0.04
0.06
0.16
0.05
0.05
0.17
0.05
0.01
0.03
0.01
0.05
0.19
0.05
0.08
0.35
0.14
0.08
0.03
0.12
0.03
0.04
0.15
0.04
0.10
0.04
0.02
0.09
0.02
0.08
0.02
0.08
0.02
0.01
0.03
0.05
0.04
0.01
0.06
0.16
0.07
0.04
0.16
0.04
0.04
0.11
0.04
0.03
0.08
0.07

0.05
0.05
0.06
0.10
0.05
0.04
0.08
0.03
0.06
0.07
0.06
0.06
0.12
0.05
0.09
0.17
0.08
0.03
0.04
0.04
0.02
0.08
0.16
0.07
0.06
0.13
0.05
0.14
0.02
0.02
0.03
0.02
0.03
0.03
0.06
0.03
0.04
0.02
0.08
0.03
0.04
0.06
0.12
0.04
0.10
0.19
0.09
0.01
0.03
0.03
0.01
0.04
0.10

0.01
0.01
0.01
0.02
0.01
0.01
0.02
0.01
0.01
0.03
0.01
0.00
0.00
0.00
0.01
0.03
0.01
0.01
0.02
0.02
0.01
0.00
0.02
0.00
0.00
0.02
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.01
0.00
0.00
0.01
0.02
0.01
0.00
0.02
0.00
0.00
0.01
0.00
0.00
0.01
0.01

9
13
30
3
0
190
27
11
47
125
1
189
14
31
14
292
262
18
26
38
10
99
75
532
42

1.5
0.2
0.2
0.2
0.7
0.8
0.4
0.5
0.7
0.1
1.0
0.3
0.5
0.4
1.6
1.5
1.1
0.6
0.6
0.2
0.7
0.8
1.1
0.4

0.53
0.06
0.03
0.13
0.06
0.16
0.15
0.08
0.07
0.12
0.07
0.09
0.09
0.12
0.10
0.10
0.25
0.13
0.13
0.06
0.08
0.11
0.05
0.08

0.18
0.02
0.02
0.04
0.07
0.09
0.04
0.06
0.09
0.01
0.11
0.03
0.06
0.05
0.18
0.19
0.11
0.06
0.05
0.02
0.07
0.07
0.10
0.03

0.06
0.01 *
0.00
0.02 *
0.01 *
0.02 *
0.01 *
0.01
0.01 *
0.01
0.01
0.01 *
0.01 *
0.02 *
0.01
0.01
0.03
0.02
0.01
0.01
0.01
0.01
0.01
0.01

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

497

555

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Uterus unspecified (C55) (contd)


Cases

Male
ASR(W)
CUM 0-74

Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

498

Female
ASR(W)
CUM 0-74

626
61
35
16
20
39
2
157
19
9
15
20
31
22
5
196
0
0
0
0
2
0
3
22
21

0.5
0.5
0.5
0.4
0.5
0.6
0.2
0.6
0.7
0.7
1.4
0.8
0.7
1.2
0.2
2.1
0.1
0.1
0.7
0.2

0.02
0.07
0.08
0.10
0.12
0.09
0.11
0.05
0.16
0.25
0.51
0.19
0.13
0.28
0.12
0.16
0.04
0.06
0.14
0.05

0.05
0.07
0.04
0.02
0.06
0.07
0.02
0.05
0.05
0.07
0.20
0.09
0.07
0.16
0.03
0.23
0.00
0.01
0.06
0.02

0.00
0.01
0.01
0.01
0.02
0.01
0.02
0.01
0.01
0.03
0.09
0.02
0.01
0.05 *
0.01 *
0.02 *
0.00 *
- *
0.01
0.02 *
0.01 *

245
1
6
194
5
181
238
129
265
136
9
74
36
6
5
2
3
14
47
6
33
9
19
83
148
183
65
72
154
38
0
89
0
8
10
47
20
11
18
1
42
174
5
14
16
30
58
14
22
6
18
22
6
142

0.4
0.0
0.3
0.5
0.1
0.8
0.7
0.5
0.5
0.5
0.1
0.2
0.8
0.2
0.3
0.1
0.1
0.3
1.0
0.2
1.2
0.2
0.6
0.5
0.4
1.6
0.5
0.5
0.9
0.5
0.7
0.2
0.4
0.4
0.3
1.0
0.2
0.0
2.1
1.5
0.1
0.6
0.4
0.4
1.4
0.4
1.1
0.6
0.1
0.4
0.2
1.8

0.03
0.01
0.12
0.04
0.04
0.07
0.05
0.05
0.03
0.05
0.04
0.03
0.14
0.07
0.13
0.05
0.06
0.08
0.16
0.11
0.25
0.11
0.16
0.06
0.04
0.14
0.07
0.07
0.09
0.09
0.07
0.09
0.13
0.08
0.10
0.37
0.06
0.05
0.35
0.13
0.05
0.19
0.14
0.09
0.21
0.12
0.27
0.30
0.03
0.11
0.08
0.17

0.04
0.03
0.06
0.01
0.09
0.07
0.04
0.05
0.06
0.01
0.02
0.08
0.02
0.03
0.00
0.01
0.02
0.11
0.02
0.11
0.02
0.07
0.05
0.03
0.16
0.04
0.05
0.08
0.05
0.08
0.02
0.04
0.03
0.03
0.11
0.02
0.00
0.20
0.17
0.01
0.05
0.04
0.04
0.17
0.03
0.12
0.06
0.00
0.05
0.01
0.19

0.00
0.02
0.00 *
0.00 *
0.01
0.01 *
0.01
0.00
0.01
0.00
0.00
0.02
0.01
0.02
0.00
0.01
0.01
0.02
0.01
0.03
0.01
0.02
0.01
0.00
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.04
0.01
0.00
0.04
0.02
0.01
0.03
0.02
0.01
0.03
0.02
0.04
0.03
0.00
0.01
0.01
0.02

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp

*Important. See note on population page.

556

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Uterus unspecified (C55) (contd)


Cases

Male
ASR(W)
CUM 0-74

Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Cases

Female
ASR(W)
CUM 0-74

22
131
6
53
16
49
22
132
127
61
313
83
53
11
48
52
19
9
14
4
8
10
17
13
664
6
3
1
4
26
6
3
36
0
0
44
92
122
246
72
224
335
187
207
25
214

0.1
0.8
0.3
0.2
0.5
1.0
0.2
1.1
0.7
0.2
1.6
0.3
0.5
0.9
0.8
0.6
0.3
1.1
0.5
0.1
0.1
0.3
0.7
0.2
1.7
0.2
0.3
0.0
0.1
1.5
0.3
0.0
0.1
0.3
0.8
0.6
0.7
0.7
0.5
0.4
0.8
0.8
0.3
0.9

0.03
0.08
0.14
0.03
0.12
0.15
0.06
0.10
0.07
0.03
0.10
0.04
0.08
0.33
0.14
0.10
0.07
0.43
0.16
0.03
0.05
0.12
0.19
0.08
0.07
0.09
0.19
0.04
0.03
0.32
0.15
0.02
0.01
0.05
0.09
0.06
0.05
0.08
0.04
0.03
0.06
0.06
0.06
0.06

0.01
0.09
0.03
0.02
0.05
0.10
0.03
0.12
0.07
0.03
0.18
0.03
0.06
0.07
0.09
0.06
0.03
0.10
0.06
0.01
0.01
0.04
0.08
0.03
0.19
0.04
0.03
0.20
0.03
0.01
0.03
0.09
0.07
0.08
0.07
0.06
0.05
0.08
0.08
0.02
0.11

0.00
0.01
0.02
0.00
0.01 *
0.02
0.01
0.01 *
0.01
0.00
0.01
0.00
0.01
0.03
0.02
0.01
0.01
0.04
0.02
0.01
0.01
0.02
0.02
0.01
0.01
0.02
0.02
0.05
0.02
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01

138
0
43
0
4
109
10
7
15
30
15
0
3
3
5
3

0.5
0.3
0.2
0.5
0.1
0.6
3.3
0.2
0.3
0.3
0.6
0.3
0.3

0.05
0.05
0.09
0.06
0.05
0.25
0.86
0.03
0.08
0.20
0.37
0.16
0.18

0.06
0.03
0.02
0.05
0.01
0.07
0.34
0.02
0.04
0.02
0.08
0.03
0.04

0.01
0.01
0.01
0.01
0.00
0.04
0.10
0.00
0.01
0.02
0.05
0.02
0.03

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

499

557

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Ovary (C56)
Cases

Male
ASR(W)
CUM 0-74

Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
*Important. See note on population page.

Care should be taken when comparing populations. See Chapter 5 Comparability and quality of data
558
500

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Cases

Female
ASR(W)
CUM 0-74

53
290
34
114
122

2.1
5.1
3.3
8.1
6.8

0.31
0.31
0.57
0.92
0.79

97
331
52
126
3197
81
426
483
207
70
68

9.1
11.0
6.2
6.6
11.6
8.6
9.5
5.9
6.4
5.2
6.0

1.00
0.66
0.90
0.61
0.21
0.98
0.47
0.28
0.46
0.66
0.75

1.05
1.25
0.66
0.72
1.34
0.87
1.10
0.67
0.72
0.52
0.64

0.13
0.09
0.12
0.08
0.03
0.11
0.06
0.04
0.06
0.07
0.09 *

8326
815
1365
428
283
137
4
342
4580
46
326
1721
270
1431
129
1702
11298
996
478
1758
7981
2275
121
130
83
31
226
1562
2961
216
104
86
52
40
739
1633
1467
1412
45
1340
193
123
59
7411
510
6817
2573
477
2061
843
206
612
440
4556
417
3987
2204
1275
1516
1438
322
1111
106
234

9.4
8.3
8.3
9.5
9.4
7.3
3.9
8.8
10.3
8.1
8.0
9.5
6.9
10.2
8.3
8.8
9.9
7.5
6.6
8.7
11.0
9.9
7.2
7.7
7.2
7.7
8.5
11.1
9.7
6.4
8.2
8.6
9.8
6.0
8.9
11.7
10.2
10.0
4.8
10.4
9.0
8.4
9.4
10.1
7.1
10.6
9.3
7.2
10.0
9.9
8.2
10.7
9.4
9.8
7.0
10.2
9.5
10.3
9.7
8.7
7.2
9.5
7.9
10.0

0.11
0.31
0.24
0.51
0.61
0.65
2.07
0.52
0.16
1.33
0.50
0.25
0.45
0.29
0.76
0.23
0.10
0.24
0.31
0.22
0.14
0.22
0.68
0.73
0.81
1.47
0.58
0.31
0.19
0.46
0.84
0.94
1.44
0.98
0.34
0.33
0.28
0.29
0.73
0.32
0.71
0.82
1.42
0.13
0.33
0.15
0.19
0.35
0.23
0.36
0.61
0.46
0.49
0.16
0.35
0.18
0.22
0.33
0.27
0.25
0.42
0.31
0.80
0.73

1.07
0.95
0.93
1.08
1.09
0.85
0.11
1.02
1.17
0.79
0.90
1.12
0.82
1.20
0.94
0.99
1.13
0.81
0.76
0.99
1.28
1.12
0.81
0.79
0.78
0.82
0.98
1.29
1.11
0.74
0.86
0.96
1.12
0.68
0.99
1.36
1.17
1.16
0.58
1.21
1.02
0.96
0.99
1.16
0.80
1.21
1.09
0.82
1.18
1.18
0.94
1.29
1.04
1.12
0.78
1.17
1.10
1.16
1.09
1.01
0.84
1.10
0.91
1.14

0.01
0.04
0.03
0.06
0.08
0.08
0.07
0.07
0.02
0.15
0.06
0.03
0.06
0.04
0.10
0.03
0.01
0.03
0.04
0.03
0.02
0.03
0.09
0.08
0.10
0.16
0.08
0.04
0.02
0.06
0.10
0.11
0.17
0.13
0.05
0.04
0.04
0.04
0.10
0.04
0.09
0.10
0.17
0.02
0.05
0.02
0.03
0.05
0.03
0.05
0.09
0.06
0.06
0.02
0.05
0.02
0.03
0.04
0.03
0.03
0.06
0.04
0.11
0.09

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp
Care

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Ovary (C56) (contd)


Cases

Male
ASR(W)
CUM 0-74

America, North (contd)


USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

*Important. See note on population page.


Care should be taken when comparing populations. See Chapter 5 Comparability and quality of data
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Cases

Female
ASR(W)
CUM 0-74

538
2656
3771
336
3385
1586
258
1313
2101
131
1950
394
84293
5946
75272
3942
320
3473
602
47
166
382
8177
818
7068
4229
255
3886
1302
1325
5647
301
5213
426
9907
657
8477
26634
1518
1762
2344
20761
1361
273
1069
5991
478
5358
601
223
2414
1670
831
2179

9.6
10.4
9.9
7.4
10.4
10.0
7.4
11.0
9.2
6.4
9.6
10.9
9.9
6.9
10.3
11.7
8.1
12.3
9.2
10.9
7.9
10.1
11.0
8.1
11.6
9.3
5.9
9.6
9.5
9.8
10.6
6.7
10.8
10.1
10.1
7.2
10.6
10.0
7.4
7.2
8.7
10.9
8.6
6.8
9.1
8.7
6.8
9.0
9.6
9.4
11.3
11.4
10.3
10.6

0.46
0.22
0.18
0.43
0.19
0.27
0.49
0.34
0.22
0.59
0.24
0.60
0.04
0.09
0.04
0.20
0.47
0.23
0.40
1.62
0.64
0.57
0.13
0.29
0.15
0.16
0.39
0.17
0.29
0.29
0.16
0.41
0.17
0.55
0.11
0.29
0.13
0.07
0.19
0.18
0.19
0.08
0.25
0.44
0.30
0.12
0.32
0.13
0.41
0.67
0.25
0.30
0.39
0.25

1.10
1.18
1.14
0.85
1.18
1.14
0.85
1.25
1.05
0.72
1.08
1.25
1.14
0.79
1.19
1.32
0.90
1.40
1.07
1.27
0.90
1.17
1.25
0.92
1.33
1.07
0.68
1.11
1.08
1.13
1.21
0.76
1.23
1.13
1.15
0.83
1.23
1.15
0.79
0.82
0.98
1.26
1.00
0.75
1.07
0.98
0.78
1.01
1.06
1.09
1.33
1.34
1.18
1.23

0.06
0.03
0.02
0.06
0.02
0.04
0.07
0.04
0.03
0.08
0.03
0.08
0.00
0.01
0.01
0.03
0.06
0.03
0.05
0.22
0.08
0.07
0.02
0.04
0.02
0.02
0.05
0.02
0.04
0.04
0.02
0.05
0.02
0.07
0.01
0.04
0.02
0.01
0.02
0.02
0.03
0.01
0.03
0.06
0.04
0.02
0.05
0.02
0.05
0.09
0.03
0.04
0.05
0.03

49
322

7.4
5.5

1.10
0.31

0.67
0.60

0.14
0.04 *

47
133
1634
139
190
559
1802
45
1541
282
443
148
1741
1617
64
232
239
313
668
448
1994
352

3.7
5.2
7.1
4.1
8.1
6.0
9.4
4.8
7.1
6.4
6.8
4.8
9.5
9.9
3.7
6.3
6.7
7.8
7.0
6.6
5.3
6.2

0.56
0.46
0.19
0.35
0.61
0.26
0.23
0.73
0.19
0.39
0.33
0.40
0.24
0.26
0.48
0.44
0.49
0.46
0.29
0.36
0.13
0.38

0.38
0.58
0.75
0.41
0.98
0.67
1.03
0.53
0.80
0.65
0.81
0.52
1.10
1.14
0.47
0.65
0.72
0.81
0.72
0.68
0.56
0.64

0.06 *
0.06
0.02 *
0.04 *
0.08 *
0.03
0.03 *
0.09
0.03
0.04 *
0.05 *
0.05 *
0.03
0.03
0.07
0.05
0.05
0.05
0.03
0.04
0.01
0.04

501

559

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Ovary (C56) (contd)


Cases

Male
ASR(W)
CUM 0-74

Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
*Important. See note on population page.

Care should be taken when comparing populations. See Chapter 5 Comparability and quality of data
560
502

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Cases

Female
ASR(W)
CUM 0-74

5334
565
340
167
186
354
43
1618
116
64
60
230
289
111
201
1133
771
619
44
108
235
124
178
195
425

4.9
5.1
4.9
4.7
5.2
5.4
4.5
5.9
5.8
5.4
5.8
9.7
6.7
6.2
8.8
11.8
8.2
8.0
7.1
10.1
5.6
5.4
5.6
6.1
4.9

0.07
0.22
0.27
0.38
0.39
0.30
0.70
0.15
0.57
0.72
1.03
0.65
0.41
0.62
0.67
0.37
0.30
0.33
1.12
1.01
0.38
0.50
0.43
0.45
0.24

0.50
0.53
0.52
0.47
0.55
0.56
0.45
0.63
0.59
0.61
0.75
1.07
0.69
0.71
0.97
1.32
0.88
0.86
0.72
1.07
0.60
0.54
0.58
0.74
0.56

0.01
0.03
0.03
0.04
0.05
0.04
0.08
0.02
0.07
0.10
0.18
0.08
0.05
0.09 *
0.09 *
0.05 *
0.04
0.04
0.13
0.12
0.04 *
0.05 *
0.05
0.06 *
0.03 *

4153
338
128
4081
622
2208
3729
2529
5834
2984
784
2217
398
246
191
336
371
378
311
232
199
129
165
1175
2561
861
842
1267
1402
560
105
1531
96
243
163
593
308
82
574
310
127
881
268
107
209
482
297
161
110
95
483
420
252
680

11.3
12.1
9.3
10.4
8.2
10.5
11.3
13.3
13.6
13.2
12.3
9.6
9.8
8.7
9.2
11.8
9.2
8.6
6.9
10.1
8.9
7.0
6.5
9.3
10.4
9.7
10.0
10.9
11.3
10.1
10.6
11.8
9.1
9.3
7.7
10.0
10.2
8.4
9.1
9.4
7.6
8.8
11.9
9.5
9.1
9.3
8.3
7.8
8.3
11.0
9.6
9.9
10.5
8.0

0.20
0.72
0.88
0.17
0.36
0.24
0.20
0.28
0.19
0.26
0.48
0.22
0.53
0.61
0.73
0.70
0.52
0.48
0.42
0.75
0.68
0.72
0.57
0.30
0.24
0.38
0.38
0.34
0.34
0.49
1.11
0.32
1.07
0.69
0.70
0.46
0.72
1.07
0.45
0.63
0.69
0.34
0.86
1.02
0.72
0.51
0.53
0.67
0.85
1.25
0.50
0.58
0.73
0.35

1.25
1.31
1.03
1.17
0.99
1.20
1.26
1.51
1.54
1.60
1.41
1.11
1.12
1.04
1.03
1.34
1.13
0.97
0.80
1.21
1.10
0.82
0.83
1.06
1.22
1.13
1.14
1.25
1.29
1.10
1.19
1.37
1.07
1.05
0.86
1.16
1.11
0.93
0.98
1.05
0.88
0.97
1.35
1.02
1.04
1.00
0.88
0.87
0.98
1.24
1.09
1.07
1.19
0.90

0.02
0.09
0.11
0.02 *
0.05 *
0.03
0.02 *
0.03
0.02
0.03
0.06
0.03
0.07
0.08
0.09
0.08
0.07
0.06
0.05
0.09
0.09
0.09
0.07
0.04
0.03
0.05
0.05
0.04
0.04
0.06
0.14
0.04
0.13
0.08
0.08
0.05
0.08
0.13
0.05
0.07
0.09
0.04
0.10
0.11
0.09
0.06
0.06
0.08
0.10
0.16
0.06
0.06
0.09
0.04

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Care

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Ovary (C56) (contd)


Cases

Male
ASR(W)
CUM 0-74

Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

*Important. See note on population page.


Care should be taken when comparing populations. See Chapter 5 Comparability and quality of data
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Cases

Female
ASR(W)
CUM 0-74

1405
2120
159
2343
473
563
797
477
902
2547
1720
2140
818
77
600
581
388
81
195
256
338
214
167
264
3989
185
111
82
224
128
128
256
5946
392
345
1543
1294
1963
3399
1246
4131
6896
2494
2789
905
2656

13.2
14.5
10.8
12.8
14.9
11.7
10.4
4.3
7.3
11.6
9.6
11.0
9.7
6.4
11.4
8.1
7.8
8.4
7.9
8.3
8.2
9.1
8.3
7.1
10.5
9.2
11.9
10.5
9.7
9.1
10.7
9.2
9.2
10.0
9.4
12.2
11.9
11.0
11.4
11.6
12.7
11.8
11.6
12.1
14.8
11.1

0.38
0.34
0.89
0.29
0.72
0.52
0.39
0.21
0.27
0.25
0.25
0.25
0.36
0.84
0.56
0.37
0.42
1.18
0.65
0.56
0.48
0.69
0.71
0.49
0.18
0.74
1.23
1.37
0.72
0.89
1.02
0.64
0.13
0.54
0.55
0.35
0.37
0.27
0.22
0.36
0.22
0.16
0.26
0.25
0.53
0.24

1.48
1.64
1.25
1.48
1.66
1.30
1.21
0.47
0.81
1.28
1.06
1.24
1.12
0.70
1.25
0.91
0.89
0.86
0.86
0.90
0.93
1.04
0.92
0.80
1.23
1.05
1.35
1.17
1.16
1.09
1.23
1.13
1.08
1.20
1.09
1.44
1.39
1.30
1.34
1.39
1.51
1.39
1.38
1.42
1.65
1.30

0.04
0.04
0.11
0.04
0.09 *
0.06
0.05
0.02 *
0.03
0.03
0.03
0.03
0.04
0.10
0.06
0.04
0.05
0.12
0.08
0.06
0.06
0.08
0.08
0.06
0.02
0.10
0.15
0.16
0.10
0.11
0.13
0.08
0.02
0.07
0.07
0.04
0.05
0.03
0.03
0.05
0.03
0.02
0.03
0.03
0.06
0.03

1967
24
1035
494
148
1515
500
84
36
1262
381
24
59
50
111
110

7.9
6.1
8.2
7.9
7.8
8.1
7.6
8.4
8.2
9.3
8.6
5.6
8.5
8.8
10.3
9.3

0.19
1.38
0.27
0.40
0.69
0.23
0.36
0.96
1.40
0.28
0.48
1.27
1.14
1.28
1.20
0.96

0.89
0.72
0.93
0.86
0.94
0.91
0.85
0.95
1.07
1.04
0.92
0.63
0.77
0.92
1.12
0.99

0.02
0.20
0.04
0.05
0.09
0.03
0.05
0.13
0.21
0.04
0.06
0.16
0.12
0.16
0.12
0.12

503

561

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other female genital organs (C57)


Cases

Male
ASR(W)
CUM 0-74

Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

504

Female
ASR(W)
CUM 0-74

1
7
4
1
1

0.0
0.1
0.4
0.1
0.1

0.04
0.05
0.18
0.05
0.05

54
101
3
0
144
2
20
17
4
6
1

7.3
2.2
0.4
0.5
0.2
0.4
0.2
0.1
0.4
0.1

0.99
0.24
0.26
0.04
0.15
0.10
0.05
0.05
0.16
0.10

0.59
0.21
0.05
0.05
0.02
0.05
0.02
0.01
0.05
0.01

0.08
0.03
0.03
0.01
0.02
0.01
0.01
0.00
0.02
0.01 *

577
44
41
15
4
9
0
11
434
4
15
37
5
32
9
69
500
36
28
59
373
104
10
5
3
0
7
72
141
13
2
3
0
0
24
95
63
62
2
59
10
4
5
313
25
285
105
23
80
40
14
26
23
178
18
153
80
70
51
31
10
21
3
7

0.7
0.5
0.3
0.3
0.1
0.4
0.3
1.0
0.8
0.4
0.2
0.1
0.2
0.7
0.4
0.4
0.3
0.4
0.3
0.5
0.5
0.6
0.2
0.3
0.3
0.5
0.5
0.4
0.2
0.3
0.3
0.6
0.4
0.4
0.2
0.5
0.3
0.2
0.6
0.4
0.3
0.4
0.4
0.4
0.4
0.5
0.6
0.5
0.5
0.4
0.3
0.4
0.4
0.5
0.3
0.1
0.2
0.1
0.2
0.2

0.03
0.07
0.05
0.09
0.07
0.14
0.10
0.05
0.42
0.11
0.03
0.06
0.04
0.24
0.05
0.02
0.04
0.07
0.04
0.03
0.05
0.19
0.10
0.17
0.12
0.07
0.04
0.12
0.12
0.16
0.06
0.07
0.06
0.06
0.15
0.07
0.12
0.13
0.30
0.03
0.07
0.03
0.04
0.08
0.04
0.09
0.17
0.10
0.11
0.03
0.07
0.04
0.04
0.07
0.05
0.03
0.06
0.03
0.11
0.09

0.08
0.05
0.03
0.04
0.02
0.04
0.04
0.12
0.13
0.05
0.02
0.01
0.02
0.08
0.05
0.05
0.03
0.04
0.03
0.06
0.06
0.05
0.03
0.04
0.04
0.07
0.06
0.05
0.02
0.04
0.04
0.08
0.05
0.05
0.02
0.05
0.03
0.02
0.04
0.05
0.03
0.05
0.05
0.05
0.05
0.07
0.08
0.06
0.05
0.05
0.04
0.05
0.04
0.06
0.05
0.02
0.02
0.01
0.03
0.03

0.00
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.07
0.02
0.00
0.01
0.01
0.03
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.02
0.02
0.02
0.02
0.01
0.01
0.02
0.02
0.03
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.04
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.03
0.02
0.01
0.00
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.02
0.02

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

562

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other female genital organs (C57) (contd)


Cases

Male
ASR(W)
CUM 0-74

America, North (contd)


USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Cases

Female
ASR(W)
CUM 0-74

38
121
127
14
108
52
9
40
94
7
87
11
3315
274
2913
137
13
115
27
1
10
15
319
36
273
134
13
119
44
76
189
13
172
21
452
37
379
1097
60
84
83
857
61
7
54
218
31
179
25
13
124
85
23
73

0.7
0.5
0.3
0.3
0.3
0.3
0.2
0.3
0.4
0.3
0.4
0.3
0.4
0.3
0.4
0.4
0.4
0.4
0.4
0.2
0.5
0.4
0.4
0.3
0.5
0.3
0.3
0.3
0.3
0.6
0.3
0.2
0.3
0.5
0.5
0.4
0.5
0.4
0.3
0.3
0.3
0.4
0.4
0.1
0.5
0.3
0.4
0.3
0.4
0.5
0.6
0.6
0.2
0.3

0.13
0.05
0.03
0.08
0.03
0.05
0.08
0.06
0.05
0.11
0.05
0.09
0.01
0.02
0.01
0.04
0.10
0.04
0.08
0.23
0.15
0.11
0.03
0.06
0.03
0.03
0.09
0.03
0.05
0.07
0.03
0.07
0.03
0.12
0.02
0.07
0.03
0.01
0.04
0.04
0.04
0.02
0.05
0.06
0.07
0.02
0.09
0.02
0.09
0.16
0.06
0.07
0.06
0.04

0.09
0.06
0.04
0.03
0.04
0.04
0.03
0.04
0.05
0.02
0.05
0.03
0.05
0.04
0.05
0.06
0.05
0.06
0.06
0.02
0.05
0.06
0.05
0.04
0.05
0.04
0.04
0.04
0.04
0.07
0.04
0.03
0.04
0.06
0.06
0.05
0.06
0.05
0.04
0.04
0.04
0.06
0.04
0.02
0.05
0.04
0.05
0.04
0.05
0.05
0.08
0.07
0.02
0.04

0.02
0.01
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.00
0.00
0.01
0.02
0.01
0.01
0.02
0.02
0.02
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.01
0.00
0.01
0.00
0.02
0.00
0.01
0.00
0.00
0.01
0.01
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.01
0.02
0.01
0.01
0.01
0.01

2
14

0.4
0.2

0.26
0.06

0.09
0.03

0.07
0.01 *

5
1
81
5
1
8
36
0
35
1
6
4
111
105
2
3
6
5
14
17
39
5

0.4
0.0
0.3
0.1
0.0
0.1
0.2
0.2
0.0
0.1
0.1
0.6
0.6
0.1
0.1
0.2
0.1
0.1
0.2
0.1
0.1

0.17
0.04
0.04
0.07
0.04
0.03
0.03
0.03
0.03
0.04
0.07
0.06
0.06
0.09
0.05
0.08
0.06
0.03
0.06
0.02
0.04

0.04
0.04
0.02
0.01
0.01
0.02
0.02
0.00
0.01
0.01
0.07
0.07
0.03
0.01
0.02
0.01
0.01
0.03
0.01
0.01

0.02 *
0.01 *
0.01 *
0.01 *
0.00
0.00 *
0.00
0.00 *
0.00 *
0.01 *
0.01
0.01
0.02
0.01
0.01
0.01
0.00
0.01
0.00
0.01

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

505

563

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other female genital organs (C57) (contd)


Cases

Male
ASR(W)
CUM 0-74

Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

506

Female
ASR(W)
CUM 0-74

152
14
13
3
6
14
2
34
3
1
0
3
2
0
0
13
26
20
5
1
15
1
3
2
15

0.1
0.1
0.2
0.1
0.2
0.2
0.2
0.1
0.2
0.1
0.1
0.1
0.2
0.3
0.3
0.6
0.1
0.4
0.0
0.1
0.1
0.2

0.01
0.03
0.05
0.05
0.07
0.06
0.14
0.02
0.11
0.08
0.08
0.04
0.04
0.06
0.06
0.27
0.13
0.10
0.03
0.05
0.05
0.05

0.02
0.01
0.02
0.01
0.01
0.03
0.02
0.02
0.02
0.01
0.01
0.01
0.02
0.03
0.03
0.05
0.02
0.04
0.00
0.01
0.01
0.02

0.00
0.00
0.01
0.01
0.01
0.01
0.02
0.00
0.01
0.01
0.01
0.01
- *
- *
0.01 *
0.01
0.01
0.02
0.02
0.01 *
0.00 *
0.00
0.01 *
0.01 *

275
23
9
211
26
54
105
101
355
163
30
293
23
13
7
8
7
20
17
14
21
1
6
122
180
56
61
54
66
26
6
33
7
36
14
27
26
2
18
15
2
231
8
8
11
26
17
4
5
0
32
10
12
118

0.8
0.9
0.6
0.4
0.3
0.3
0.3
0.5
0.7
0.7
0.4
1.1
0.6
0.4
0.4
0.3
0.2
0.5
0.3
0.4
0.9
0.0
0.3
0.8
0.6
0.5
0.7
0.5
0.5
0.5
0.8
0.3
0.9
1.2
0.5
0.4
0.8
0.3
0.2
0.5
0.1
1.8
0.4
0.5
0.5
0.5
0.4
0.2
0.3
0.6
0.2
0.5
1.5

0.05
0.20
0.22
0.03
0.08
0.04
0.03
0.05
0.04
0.06
0.08
0.07
0.14
0.12
0.16
0.10
0.08
0.12
0.09
0.14
0.21
0.02
0.11
0.08
0.05
0.08
0.10
0.07
0.07
0.10
0.33
0.05
0.37
0.22
0.17
0.09
0.19
0.18
0.06
0.14
0.09
0.15
0.15
0.19
0.18
0.10
0.10
0.11
0.16
0.11
0.08
0.15
0.15

0.09
0.10
0.07
0.05
0.04
0.03
0.03
0.06
0.07
0.08
0.05
0.13
0.07
0.04
0.06
0.04
0.02
0.07
0.04
0.05
0.12
0.03
0.10
0.07
0.06
0.09
0.06
0.06
0.05
0.10
0.03
0.08
0.12
0.06
0.05
0.08
0.04
0.03
0.04
0.01
0.19
0.05
0.04
0.05
0.05
0.04
0.02
0.05
0.07
0.03
0.07
0.17

0.01
0.02
0.03
0.00 *
0.01 *
0.00
0.00 *
0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.02
0.02
0.01
0.02
0.01
0.02
0.03
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.04
0.01
0.03
0.03
0.02
0.01
0.02
0.03
0.01
0.01
0.01
0.02
0.02
0.02
0.02
0.01
0.01
0.01
0.02
0.01
0.01
0.02
0.02

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp

*Important. See note on population page.

564

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other female genital organs (C57) (contd)


Cases

Male
ASR(W)
CUM 0-74

Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Cases

Female
ASR(W)
CUM 0-74

39
41
6
160
10
22
30
128
56
67
101
75
52
13
31
34
27
4
9
3
17
9
11
10
296
11
2
8
19
17
3
19
206
13
22
23
20
48
45
26
189
123
46
86
20
79

0.4
0.3
0.4
0.8
0.3
0.4
0.4
1.0
0.3
0.3
0.6
0.3
0.6
0.9
0.6
0.4
0.4
0.4
0.3
0.1
0.4
0.2
0.3
0.2
0.7
0.6
0.1
0.9
0.7
0.7
0.2
0.5
0.3
0.3
0.5
0.2
0.2
0.3
0.2
0.3
0.6
0.2
0.2
0.3
0.3
0.3

0.08
0.05
0.19
0.07
0.09
0.09
0.07
0.10
0.05
0.04
0.06
0.04
0.08
0.29
0.11
0.07
0.09
0.22
0.12
0.06
0.10
0.07
0.12
0.07
0.05
0.19
0.09
0.35
0.17
0.20
0.12
0.14
0.02
0.08
0.12
0.05
0.05
0.05
0.03
0.06
0.05
0.02
0.03
0.04
0.07
0.04

0.05
0.03
0.04
0.10
0.03
0.04
0.04
0.12
0.03
0.03
0.06
0.04
0.07
0.11
0.06
0.04
0.05
0.03
0.05
0.01
0.05
0.01
0.03
0.01
0.09
0.07
0.02
0.11
0.09
0.10
0.01
0.07
0.04
0.03
0.07
0.03
0.02
0.03
0.02
0.03
0.07
0.03
0.02
0.04
0.04
0.03

0.01
0.01
0.02
0.01
0.01 *
0.01
0.01
0.01 *
0.01
0.00
0.01
0.01
0.01
0.04
0.01
0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.02
0.01
0.01
0.03
0.02
0.05
0.03
0.03
0.01
0.02
0.00
0.01
0.02
0.01
0.01
0.01
0.00
0.01
0.01
0.00
0.00
0.01
0.01
0.00

92
1
41
29
10
80
28
4
2
62
15
1
2
1
1
5

0.4
0.2
0.3
0.5
0.6
0.4
0.4
0.4
0.5
0.4
0.3
0.2
0.3
0.2
0.1
0.4

0.04
0.17
0.05
0.10
0.20
0.05
0.09
0.19
0.36
0.06
0.09
0.19
0.24
0.17
0.13
0.17

0.05
0.01
0.04
0.07
0.09
0.05
0.06
0.06
0.07
0.06
0.03
0.05
0.03
0.04
0.01
0.02

0.01
0.01
0.01
0.01
0.03
0.01
0.01
0.04
0.05
0.01
0.01
0.05
0.02
0.04
0.01
0.01

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

507

565

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Placenta (C58)
Cases

Male
ASR(W)
CUM 0-74

Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

508

Female
ASR(W)
CUM 0-74

0
15
3
39
23

0.2
0.3
0.9
0.5

0.05
0.15
0.20
0.12

1
10
1
3
42
0
7
2
17
1
1

0.2
0.2
0.1
0.1
0.1
0.1
0.0
0.4
0.1
0.0

0.15
0.07
0.07
0.07
0.02
0.04
0.01
0.10
0.09
0.05

0.01
0.02
0.00
0.01
0.01
0.01
0.00
0.03
0.01
0.00

0.01
0.01
0.00
0.01
0.00
0.00
0.00
0.01
0.01
0.00 *

25
2
1
2
4
0
0
1
14
0
1
11
8
3
2
11
83
16
7
38
21
15
2
3
0
0
3
5
31
2
1
2
0
0
17
7
9
6
2
4
1
1
0
53
16
35
26
16
8
7
5
1
2
28
9
15
13
7
4
10
4
6
0
3

0.0
0.0
0.0
0.1
0.2
0.1
0.0
0.0
0.1
0.3
0.0
0.2
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.3
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.2
0.1
0.1
0.1
0.0
0.1
0.1
0.2
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.2

0.01
0.02
0.01
0.06
0.10
0.06
0.01
0.05
0.03
0.09
0.03
0.12
0.03
0.01
0.03
0.04
0.02
0.01
0.02
0.11
0.13
0.05
0.02
0.02
0.05
0.07
0.18
0.04
0.03
0.03
0.03
0.17
0.03
0.06
0.11
0.02
0.06
0.02
0.03
0.06
0.02
0.03
0.06
0.02
0.04
0.02
0.06
0.02
0.03
0.04
0.02
0.03
0.05
0.03
0.14

0.00
0.00
0.00
0.01
0.01
0.00
0.00
0.00
0.01
0.02
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.02
0.01
0.00
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.00
0.00
0.01
0.01
0.02
0.01
0.01
0.02
0.00
0.01
0.01
0.00
0.00
0.01
0.01
0.00
0.01
0.01
0.00
0.01
0.01
0.01
0.02

0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.00
0.00
0.00
0.00
0.01
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

566

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Placenta (C58) (contd)


Cases

Male
ASR(W)
CUM 0-74

America, North (contd)


USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Cases

Female
ASR(W)
CUM 0-74

0
14
33
17
15
15
11
4
7
2
5
0
506
139
311
36
14
19
5
1
4
0
54
19
30
21
5
14
4
0
24
3
21
1
72
20
36
195
28
43
53
65
12
4
7
27
6
19
6
0
7
6
3
13

0.1
0.1
0.5
0.1
0.2
0.5
0.1
0.0
0.1
0.0
0.1
0.2
0.1
0.2
0.4
0.1
0.1
0.2
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.2
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.1
0.1

0.02
0.03
0.12
0.02
0.05
0.14
0.03
0.02
0.09
0.02
0.00
0.02
0.00
0.03
0.12
0.03
0.05
0.17
0.12
0.02
0.05
0.02
0.02
0.06
0.02
0.03
0.02
0.06
0.02
0.04
0.01
0.05
0.01
0.01
0.03
0.03
0.02
0.01
0.03
0.06
0.04
0.01
0.04
0.01
0.04
0.02
0.02
0.04
0.03

0.01
0.01
0.03
0.01
0.01
0.03
0.00
0.00
0.01
0.00
0.01
0.01
0.00
0.01
0.03
0.01
0.01
0.01
0.02
0.01
0.02
0.01
0.01
0.01
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.02
0.00
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.01
0.01

0.00
0.00
0.01
0.00
0.00
0.01
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

2
18
9
0
0
14
7
0
4
46
0
26
5
3
0
10
7
3
2
1
1
3
2
7
3

0.2
0.3
0.0
0.1
0.2
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.0
0.1

0.12
0.06
0.01
0.04
0.06
0.02
0.02
0.02
0.04
0.02
0.02
0.02
0.06
0.05
0.03
0.02
0.02
0.04
0.01
0.06

0.01
0.02
0.00
0.01
0.01
0.00
0.01
0.01
0.01
0.00
0.00
0.00
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.01

0.01
0.00 *
0.00
- *
0.00 *
0.00 *
- *
0.00
0.00 *
0.00
0.01 *
0.00 *
- *
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

509

567

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Placenta (C58) (contd)


Cases

Male
ASR(W)
CUM 0-74

Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

510

Female
ASR(W)
CUM 0-74

287
34
8
9
7
22
5
68
4
3
4
4
9
4
11
64
4
3
0
1
23
1
15
0
4

0.2
0.3
0.1
0.2
0.2
0.3
0.5
0.2
0.2
0.2
0.1
0.1
0.2
0.2
0.3
0.5
0.0
0.0
0.1
0.5
0.1
0.4
0.0

0.01
0.05
0.04
0.07
0.06
0.06
0.23
0.02
0.09
0.09
0.05
0.06
0.06
0.11
0.09
0.06
0.02
0.02
0.12
0.11
0.07
0.11
0.02

0.02
0.02
0.01
0.02
0.01
0.02
0.04
0.02
0.01
0.01
0.01
0.01
0.02
0.02
0.02
0.04
0.00
0.00
0.01
0.04
0.00
0.03
0.00

0.00
0.00
0.00
0.01
0.00
0.00
0.02
0.00
0.01
0.01
0.00
0.01
0.01
0.01 *
0.01 *
0.01 *
0.00
0.00
0.01
0.01 *
0.00 *
0.01
- *
0.00 *

4
1
0
20
3
4
17
6
17
7
5
10
2
0
0
1
1
5
3
1
0
0
2
2
9
0
11
2
1
0
0
4
0
0
1
5
1
0
1
0
0
1
0
0
0
2
1
0
0
0
0
4
1
0

0.0
0.0
0.1
0.1
0.0
0.1
0.0
0.1
0.1
0.2
0.1
0.1
0.0
0.0
0.2
0.1
0.1
0.2
0.0
0.1
0.3
0.0
0.0
0.0
0.2
0.2
0.1
0.0
0.0
0.1
0.0
0.1
0.1
-

0.01
0.04
0.02
0.05
0.02
0.02
0.02
0.02
0.02
0.07
0.03
0.06
0.05
0.04
0.08
0.06
0.07
0.14
0.03
0.03
0.09
0.02
0.01
0.02
0.18
0.09
0.09
0.03
0.02
0.07
0.01
0.07
0.06
-

0.00
0.00
0.01
0.01
0.00
0.01
0.00
0.00
0.00
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.00
0.01
0.02
0.00
0.00
0.00
0.01
0.01
0.01
0.00
0.00
0.01
0.01
0.00
-

0.00
0.00
0.00 *
0.00 *
0.00
0.00 *
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.00
0.01
0.01
0.00
0.00
0.01
0.00
0.00
0.00
0.01
0.01
0.01
0.00
0.00
0.00
0.01
0.00
-

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp

*Important. See note on population page.

568

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Placenta (C58) (contd)


Cases

Male
ASR(W)
CUM 0-74

Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Cases

Female
ASR(W)
CUM 0-74

19
9
1
13
1
0
3
9
6
7
5
7
3
0
0
2
0
0
1
1
0
1
3
0
12
1
0
0
1
1
0
1
25
2
2
4
1
5
9
4
9
12
6
5
0
8

0.3
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.1

0.07
0.03
0.11
0.03
0.04
0.04
0.03
0.03
0.02
0.02
0.02
0.03
0.03
0.07
0.05
0.05
0.14
0.02
0.07
0.09
0.09
0.09
0.01
0.06
0.05
0.03
0.02
0.02
0.02
0.03
0.02
0.01
0.02
0.02
0.02

0.02
0.01
0.01
0.01
0.00
0.00
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.02
0.00
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

0.01
0.00
0.01
0.00
0.00 *
0.00
0.00 *
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

11
1
3
5
0
6
2
3
0
16
8
1
2
0
0
1

0.1
0.3
0.0
0.1
0.0
0.0
0.3
0.2
0.2
0.4
0.4
0.2

0.02
0.25
0.02
0.07
0.02
0.03
0.18
0.04
0.08
0.38
0.25
0.19

0.00
0.01
0.00
0.01
0.00
0.00
0.02
0.01
0.02
0.03
0.03
0.01

0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.03
0.02
0.01

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

511

569

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Penis (C60)
Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

0
1
0
25
19

0.0
2.8
0.9

0.03
0.65
0.26

10
80
15
38
330
6
64
100
21
9
15

1.1
3.7
2.3
2.6
1.5
0.7
1.8
1.3
0.8
0.7
1.8

0.37
0.44
0.66
0.45
0.09
0.27
0.24
0.13
0.18
0.24
0.49

0.15
0.43
0.19
0.34
0.17
0.08
0.19
0.15
0.10
0.07
0.23

0.06
0.06
0.08
0.07
0.01
0.04
0.03
0.02
0.03
0.03
0.07

507
58
88
34
25
11
0
32
233
1
25
72
16
55
9
79
461
30
25
106
292
80
5
3
4
2
17
43
109
7
5
0
0
0
45
49
58
83
5
77
12
9
2
376
41
329
138
29
107
28
8
19
26
231
25
193
116
66
127
88
26
61
3
11

0.6
0.7
0.6
0.9
0.9
0.6
0.9
0.6
0.2
0.6
0.5
0.5
0.5
0.7
0.5
0.4
0.3
0.4
0.6
0.4
0.4
0.3
0.2
0.4
0.6
0.7
0.3
0.4
0.3
0.4
0.6
0.3
0.4
0.6
0.6
0.6
0.7
0.9
0.4
0.6
0.7
0.5
0.6
0.6
0.6
0.4
0.5
0.4
0.6
0.6
0.6
0.5
0.6
0.6
1.0
0.6
0.8
0.6
0.3
0.5

0.03
0.09
0.06
0.16
0.19
0.18
0.17
0.04
0.24
0.13
0.06
0.14
0.07
0.24
0.05
0.02
0.05
0.09
0.06
0.03
0.04
0.16
0.09
0.23
0.45
0.18
0.05
0.04
0.11
0.18
0.11
0.05
0.06
0.07
0.29
0.08
0.22
0.31
0.25
0.03
0.12
0.03
0.05
0.12
0.06
0.08
0.20
0.09
0.13
0.04
0.11
0.04
0.06
0.08
0.09
0.07
0.16
0.08
0.20
0.16

0.07
0.08
0.07
0.09
0.10
0.08
0.09
0.07
0.04
0.08
0.06
0.05
0.06
0.05
0.05
0.05
0.03
0.04
0.06
0.05
0.04
0.01
0.03
0.06
0.07
0.07
0.03
0.04
0.02
0.07
0.08
0.03
0.05
0.07
0.04
0.07
0.10
0.13
0.06
0.06
0.07
0.06
0.07
0.09
0.07
0.04
0.08
0.03
0.08
0.06
0.07
0.06
0.06
0.07
0.11
0.07
0.08
0.07
0.05
0.04

0.00
0.01
0.01
0.02
0.02
0.03
0.02
0.01
0.04
0.02
0.01
0.02
0.01
0.03
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.01
0.02
0.04
0.07
0.02
0.01
0.01
0.01
0.04
0.01
0.01
0.01
0.01
0.03
0.01
0.03
0.05
0.05
0.00
0.01
0.00
0.01
0.02
0.01
0.01
0.04
0.01
0.02
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.03
0.02

512

Female
ASR(W)
CUM 0-74
*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

570

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Penis (C60) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

37
139
190
18
170
81
16
65
106
2
103
24
4146
356
3636
172
16
146
33
7
14
10
363
33
318
193
8
178
72
48
243
18
218
24
448
37
381
1237
47
108
171
887
84
21
62
412
32
373
23
16
83
59
58
89

0.7
0.6
0.6
0.6
0.6
0.6
0.6
0.6
0.5
0.1
0.6
0.7
0.6
0.6
0.6
0.6
0.5
0.6
0.5
1.8
0.7
0.2
0.6
0.5
0.6
0.5
0.2
0.5
0.6
0.4
0.5
0.6
0.5
0.6
0.5
0.5
0.5
0.5
0.3
0.6
0.7
0.5
0.6
0.7
0.6
0.7
0.6
0.7
0.4
0.8
0.4
0.4
0.8
0.5

0.12
0.06
0.04
0.14
0.05
0.07
0.17
0.08
0.06
0.10
0.06
0.14
0.01
0.03
0.01
0.05
0.13
0.05
0.09
0.70
0.19
0.08
0.03
0.08
0.03
0.04
0.09
0.04
0.07
0.06
0.03
0.14
0.04
0.13
0.02
0.09
0.03
0.02
0.04
0.06
0.06
0.02
0.07
0.17
0.08
0.04
0.11
0.04
0.09
0.20
0.05
0.06
0.11
0.05

0.09
0.07
0.07
0.06
0.07
0.07
0.06
0.07
0.06
0.01
0.07
0.08
0.06
0.06
0.06
0.07
0.05
0.07
0.05
0.20
0.07
0.03
0.06
0.05
0.07
0.06
0.03
0.06
0.06
0.05
0.06
0.06
0.06
0.08
0.05
0.05
0.06
0.06
0.03
0.06
0.08
0.06
0.07
0.08
0.07
0.08
0.08
0.08
0.05
0.09
0.05
0.05
0.10
0.06

0.02
0.01
0.01
0.02
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.00
0.00
0.00
0.01
0.02
0.01
0.01
0.10
0.03
0.01
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.02
0.00
0.01
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.02
0.01
0.00
0.02
0.01
0.01
0.03
0.01
0.01
0.02
0.01

1
17

0.2
0.3

0.17
0.07

0.03

0.01

11
5
71
20
17
162
211
9
196
68
87
22
19
15
4
5
8
10
28
20
55
12

0.9
0.3
0.3
0.6
0.7
1.7
0.9
1.0
0.8
1.6
1.3
0.8
0.1
0.1
0.2
0.1
0.2
0.2
0.3
0.3
0.2
0.2

0.27
0.13
0.04
0.14
0.17
0.14
0.07
0.34
0.06
0.21
0.14
0.18
0.02
0.02
0.13
0.06
0.06
0.07
0.05
0.07
0.02
0.05

0.08
0.03
0.03
0.08
0.07
0.20
0.10
0.12
0.09
0.21
0.13
0.09
0.01
0.01
0.01
0.02
0.02
0.02
0.03
0.04
0.01
0.02

0.03
0.01
0.00
0.02
0.02
0.02
0.01
0.05
0.01
0.03
0.02
0.02
0.00
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01

Cases

Female
ASR(W)
CUM 0-74

*
*
*
*
*
*
*
*
*

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

513

571

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Penis (C60) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

215
21
16
6
3
12
1
43
0
0
3
8
42
0
1
47
40
37
3
0
69
36
58
1
2

0.3
0.2
0.4
0.2
0.2
0.2
0.1
0.2
0.0
0.4
0.9
0.0
0.6
0.5
0.5
0.4
1.7
1.6
2.2
0.0
0.0

0.02
0.06
0.10
0.11
0.13
0.07
0.09
0.04
0.03
0.16
0.15
0.05
0.10
0.07
0.09
0.23
0.21
0.27
0.29
0.03
0.02

0.03
0.03
0.03
0.05
0.03
0.02
0.01
0.02
0.00
0.04
0.10
0.05
0.04
0.05
0.05
0.21
0.17
0.29
0.00
0.00

0.00
0.01
0.01
0.02
0.02
0.01
0.01
0.00
0.00
0.02
0.02
0.01
0.01
0.01
0.03
0.03
0.03
0.04
0.00
0.00

225
13
4
197
41
132
226
96
338
240
39
99
23
21
10
19
25
26
22
16
18
16
7
95
151
58
67
60
59
30
10
106
6
4
9
39
20
6
39
15
6
60
15
11
8
40
41
12
13
7
32
35
9
50

0.8
0.6
0.4
0.7
0.6
0.6
0.7
0.6
0.9
1.1
0.9
0.5
0.6
0.7
0.6
0.7
0.6
0.6
0.5
0.8
0.8
0.7
0.3
0.9
0.8
0.8
1.0
0.6
0.6
0.6
1.1
0.9
0.6
0.2
0.5
0.7
0.7
0.7
0.8
0.5
0.4
0.6
0.8
0.7
0.4
0.8
1.2
0.6
1.1
0.9
0.7
0.9
0.4
0.7

0.05
0.16
0.20
0.05
0.09
0.06
0.05
0.06
0.05
0.07
0.15
0.05
0.13
0.17
0.19
0.17
0.13
0.13
0.11
0.20
0.20
0.19
0.11
0.10
0.07
0.11
0.12
0.08
0.08
0.12
0.36
0.09
0.24
0.09
0.16
0.12
0.16
0.29
0.13
0.14
0.15
0.08
0.21
0.24
0.16
0.14
0.20
0.18
0.32
0.36
0.12
0.16
0.14
0.10

0.09
0.08
0.04
0.07
0.06
0.07
0.08
0.07
0.10
0.12
0.10
0.06
0.05
0.08
0.07
0.07
0.06
0.06
0.04
0.09
0.09
0.07
0.04
0.11
0.09
0.10
0.11
0.06
0.06
0.06
0.13
0.10
0.05
0.03
0.05
0.09
0.06
0.07
0.09
0.05
0.02
0.06
0.09
0.07
0.05
0.08
0.12
0.06
0.12
0.08
0.08
0.09
0.06
0.07

0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.02
0.02
0.02
0.02
0.02
0.01
0.03
0.03
0.03
0.02
0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.05
0.01
0.03
0.01
0.02
0.02
0.02
0.04
0.02
0.02
0.02
0.01
0.03
0.03
0.02
0.02
0.02
0.02
0.04
0.04
0.02
0.02
0.02
0.01

514

Female
ASR(W)
CUM 0-74

*
*
*

*
*
*
*

*
*
*

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp

*Important. See note on population page.

572

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Penis (C60) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

67
104
11
127
12
28
56
113
123
80
132
111
40
14
42
50
48
14
21
26
57
20
27
29
379
13
8
8
18
6
7
22
466
26
19
94
90
154
256
101
264
354
190
170
67
176

0.9
1.0
0.8
0.7
0.5
0.7
0.9
1.1
1.1
0.6
0.7
0.7
0.6
1.2
0.9
0.7
1.0
1.0
0.9
0.9
1.4
0.7
1.3
0.7
1.0
0.9
0.9
1.2
1.0
0.5
0.6
0.9
0.8
0.7
0.5
0.8
1.0
0.9
1.0
1.0
0.9
0.7
1.0
0.8
1.2
0.9

0.11
0.10
0.24
0.06
0.14
0.13
0.13
0.10
0.11
0.07
0.07
0.07
0.09
0.35
0.15
0.10
0.15
0.30
0.22
0.19
0.19
0.16
0.27
0.14
0.05
0.24
0.32
0.44
0.23
0.20
0.25
0.19
0.04
0.14
0.12
0.09
0.11
0.08
0.06
0.10
0.06
0.04
0.08
0.07
0.15
0.07

0.10
0.11
0.08
0.08
0.03
0.06
0.11
0.12
0.13
0.07
0.08
0.09
0.06
0.11
0.10
0.08
0.11
0.13
0.11
0.10
0.16
0.09
0.17
0.06
0.11
0.08
0.09
0.09
0.12
0.05
0.06
0.11
0.09
0.07
0.07
0.09
0.11
0.11
0.10
0.11
0.10
0.07
0.11
0.09
0.13
0.10

0.01
0.01
0.04
0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.04
0.02
0.01
0.02
0.04
0.03
0.02
0.03
0.03
0.04
0.02
0.01
0.03
0.04
0.05
0.04
0.02
0.03
0.03
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01

115
4
75
28
7
84
27
7
3
62
13
0
3
0
3
7

0.5
1.1
0.6
0.4
0.4
0.5
0.4
0.8
0.7
0.5
0.3
0.3
0.2
0.6

0.05
0.58
0.07
0.09
0.14
0.05
0.08
0.32
0.38
0.06
0.08
0.18
0.12
0.23

0.06
0.12
0.07
0.05
0.04
0.05
0.04
0.09
0.07
0.05
0.03
0.03
0.02
0.07

0.01
0.09
0.01
0.01
0.02
0.01
0.01
0.04
0.04
0.01
0.01
0.03
0.02
0.03

Cases

Female
ASR(W)
CUM 0-74

*
*

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

515

573

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Prostate (C61)
Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

142
273
134
262
418

7.5
8.5
14.1
37.6
38.1

0.64
0.53
1.22
2.45
2.02

341
1727
415
1029
16155
529
2070
3406
1075
1932
229

36.4
101.5
79.3
83.4
84.8
57.6
63.2
47.0
39.7
153.0
27.3

2.08
2.62
3.94
2.62
0.69
2.55
1.47
0.83
1.27
3.61
1.84

4.68
12.14
10.27
10.21
10.57
6.83
7.80
5.47
4.74
20.08
3.56

0.33
0.40
0.65
0.42
0.11
0.41
0.23
0.13
0.20
0.58
0.31

76342
9362
14085
3649
2562
1515
29
3315
37402
542
3881
13398
3460
9447
1496
14987
103927
6246
9190
12278
70762
21432
1903
920
605
229
1740
14539
27673
4491
587
670
466
160
4991
14329
12995
14162
1156
12665
2665
1934
603
72917
7976
63829
23930
7023
16649
7971
2714
5119
4628
41322
6238
33285
17485
11050
13571
15914
4777
11003
1343
2008

93.3
105.1
92.1
87.0
94.3
81.3
43.7
95.1
91.8
112.1
93.6
90.5
133.2
78.1
109.1
84.5
106.4
55.7
170.9
87.4
108.2
110.4
155.8
52.0
68.5
66.6
91.6
118.0
110.2
186.4
48.7
88.5
74.7
30.9
92.8
109.3
109.4
121.5
177.5
116.3
158.6
178.6
109.4
105.8
160.6
100.4
111.2
172.9
97.2
129.4
185.7
114.9
110.3
107.2
149.3
99.8
89.3
100.9
100.9
116.7
153.6
106.1
148.2
97.7

0.35
1.12
0.81
1.52
1.94
2.15
8.35
1.71
0.49
4.97
1.63
0.80
2.34
0.83
2.91
0.72
0.34
0.73
1.81
0.80
0.43
0.79
3.65
1.80
2.88
4.87
2.23
1.03
0.69
2.82
2.12
3.56
3.89
2.48
1.34
0.97
0.99
1.08
5.28
1.10
3.18
4.22
4.61
0.42
1.82
0.43
0.73
2.11
0.77
1.49
3.69
1.65
1.69
0.55
1.92
0.57
0.70
1.02
0.89
0.96
2.28
1.05
4.13
2.30

12.39
14.07
12.12
11.67
12.55
11.05
5.95
12.38
12.25
14.96
12.08
12.21
17.85
10.65
14.40
11.58
14.41
7.54
22.95
11.87
14.74
15.02
21.24
7.16
9.39
9.59
12.58
16.13
14.83
25.00
6.26
12.20
10.24
4.31
12.40
14.84
14.96
16.57
24.28
15.88
21.48
23.85
15.33
14.56
21.78
13.85
15.06
22.90
13.33
17.78
24.62
16.08
14.87
14.56
19.69
13.61
12.14
13.60
13.34
15.45
20.10
14.15
19.67
13.29

0.05
0.18
0.13
0.24
0.31
0.34
1.38
0.27
0.08
0.76
0.26
0.12
0.36
0.13
0.46
0.11
0.05
0.12
0.28
0.13
0.07
0.13
0.57
0.30
0.47
0.81
0.36
0.16
0.11
0.44
0.34
0.58
0.61
0.43
0.21
0.15
0.16
0.17
0.83
0.17
0.50
0.65
0.75
0.06
0.29
0.07
0.12
0.33
0.12
0.24
0.59
0.27
0.27
0.09
0.30
0.09
0.11
0.16
0.14
0.15
0.36
0.16
0.65
0.36

516

Female
ASR(W)
CUM 0-74
*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

574

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Prostate (C61) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

5417
25644
42512
6463
34438
19137
5154
13626
17661
1980
15519
3980
784436
95223
653240
38030
5225
31523
5891
143
1533
4074
70437
12099
56746
38748
4595
31442
11245
13098
53915
5325
46933
4342
97659
11739
79315
255181
10110
30470
17271
189664
15161
4735
10135
55354
6685
47288
6477
2302
21790
14760
7073
20032

111.1
125.3
131.2
200.9
120.0
151.2
216.0
135.6
94.6
147.3
90.5
118.8
108.5
163.0
102.2
134.7
195.0
128.7
98.8
43.8
85.2
110.3
114.8
187.9
108.3
100.4
146.5
89.4
93.3
111.5
117.3
180.6
110.0
118.8
118.4
190.1
116.0
113.7
58.0
178.8
90.8
112.3
117.6
178.5
99.8
97.4
139.1
93.2
120.1
110.5
117.7
118.7
96.5
110.6

1.58
0.82
0.66
2.58
0.68
1.15
3.13
1.23
0.74
3.38
0.75
1.96
0.13
0.54
0.13
0.72
2.73
0.77
1.33
3.75
2.22
1.81
0.45
1.73
0.48
0.53
2.21
0.53
0.92
1.03
0.54
2.54
0.54
1.93
0.40
1.80
0.43
0.23
0.60
1.04
0.70
0.27
0.98
2.66
1.02
0.43
1.74
0.44
1.56
2.38
0.83
1.02
1.20
0.82

15.04
17.26
17.64
26.62
16.24
20.18
28.79
18.11
13.04
19.76
12.52
16.23
14.74
21.79
13.93
18.29
26.34
17.48
13.34
5.24
11.46
14.96
15.55
24.98
14.72
13.53
19.88
12.06
12.47
15.31
16.04
24.53
15.07
15.93
16.00
25.45
15.73
15.34
7.74
23.85
12.28
15.23
15.79
23.87
13.54
13.23
18.39
12.70
16.40
14.99
15.98
16.05
12.85
15.04

0.25
0.13
0.10
0.40
0.11
0.18
0.49
0.19
0.11
0.52
0.12
0.31
0.02
0.08
0.02
0.11
0.43
0.12
0.21
0.56
0.36
0.28
0.07
0.27
0.07
0.08
0.34
0.08
0.14
0.16
0.08
0.39
0.08
0.30
0.06
0.28
0.07
0.04
0.10
0.16
0.11
0.04
0.15
0.42
0.16
0.07
0.27
0.07
0.25
0.37
0.13
0.16
0.19
0.13

78
335
3553
16
47
1838
73
1030
326
1346
36
1219
108
346
143
8689
7779
253
573
690
981
2688
1787
4452
1106

14.3
6.7
15.0
1.4
2.1
6.9
2.3
40.8
3.9
8.4
4.4
6.9
3.0
6.4
5.6
50.2
49.2
20.0
14.2
13.6
21.5
22.0
20.0
11.3
13.4

1.63
0.39
0.26
0.37
0.31
0.17
0.27
1.35
0.22
0.23
0.73
0.20
0.30
0.35
0.47
0.57
0.59
1.27
0.60
0.54
0.70
0.44
0.49
0.17
0.43

1.38
0.65
1.67
0.12
0.22
0.71
0.32
5.08
0.48
1.04
0.62
0.76
0.38
0.67
0.66
6.55
6.45
2.76
1.69
1.51
2.43
2.46
2.34
1.20
1.53

0.23
0.05
0.04
0.04
0.04
0.02
0.04
0.22
0.03
0.04
0.13
0.03
0.04
0.05
0.07
0.09
0.09
0.22
0.09
0.08
0.11
0.07
0.08
0.02
0.07

Cases

Female
ASR(W)
CUM 0-74

*
*
*
*
*
*
*
*
*

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

517

575

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Prostate (C61) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

6354
455
309
123
187
308
74
1947
75
88
58
186
187
166
206
1239
1314
1093
84
137
211
106
127
508
1014

8.5
7.3
7.7
5.8
9.0
7.8
11.8
12.7
8.6
10.5
9.4
11.3
5.8
10.5
10.1
25.3
17.3
18.6
11.1
16.1
5.3
4.9
4.6
19.1
13.7

0.11
0.37
0.45
0.54
0.69
0.46
1.41
0.31
1.07
1.12
1.63
0.84
0.43
0.82
0.72
0.74
0.48
0.56
1.29
1.40
0.36
0.49
0.41
0.86
0.44

0.95
0.81
0.85
0.72
0.91
0.93
1.27
1.30
0.97
1.31
0.88
1.16
0.69
1.37
1.34
2.75
1.96
2.14
1.07
1.90
0.51
0.51
0.48
2.42
1.78

0.02
0.05
0.07
0.09
0.09
0.07
0.20
0.04
0.16
0.18
0.20
0.12
0.07
0.13
0.12
0.11
0.07
0.09
0.15
0.21
0.05
0.07
0.06
0.13
0.07

24603
2691
1204
6114
5407
18254
6551
4879
15172
9906
1857
17314
3267
1789
1535
2185
3574
3157
4325
1512
1710
1576
2244
5902
9864
4245
3814
7814
6291
3313
823
8490
626
1752
957
3268
1827
611
3207
2004
298
7321
1225
446
1100
3480
948
776
448
534
2935
2251
1423
4572

79.5
117.3
103.7
19.9
70.0
84.8
17.1
27.7
39.5
40.4
39.4
82.7
87.7
70.0
76.7
78.4
82.7
75.1
99.2
59.6
73.2
79.0
80.8
55.6
47.8
56.6
55.6
78.9
56.3
65.3
82.7
66.6
57.7
65.4
41.5
46.1
51.5
52.4
56.2
58.9
18.6
69.3
49.1
28.1
42.7
57.1
23.8
34.5
28.3
67.6
56.1
41.7
63.0
57.9

0.52
2.30
3.02
0.26
0.99
0.65
0.22
0.41
0.33
0.43
0.92
0.64
1.56
1.74
2.02
1.71
1.48
1.38
1.58
1.63
1.87
2.18
1.82
0.73
0.49
0.88
0.91
0.90
0.72
1.15
3.04
0.75
2.40
1.59
1.43
0.86
1.28
2.27
1.03
1.39
1.09
0.84
1.50
1.41
1.37
1.03
0.80
1.29
1.40
2.98
1.07
0.94
1.70
0.89

10.39
15.59
13.72
2.49
8.85
10.86
2.11
2.99
4.74
4.71
4.77
10.11
11.62
9.56
10.01
9.82
10.91
9.68
13.22
7.85
9.20
10.31
10.75
6.80
5.88
7.13
6.84
10.19
7.00
8.38
10.64
8.17
7.44
8.32
5.04
5.76
6.36
6.71
7.05
8.07
2.23
8.94
6.14
3.29
5.57
7.08
2.90
4.19
3.37
9.20
7.14
5.31
7.69
7.38

0.08
0.35
0.47
0.04
0.15
0.10
0.03
0.06
0.05
0.07
0.14
0.10
0.25
0.28
0.32
0.27
0.23
0.22
0.25
0.26
0.29
0.33
0.28
0.11
0.07
0.14
0.13
0.14
0.11
0.18
0.48
0.12
0.38
0.25
0.22
0.14
0.20
0.37
0.16
0.22
0.16
0.13
0.24
0.22
0.22
0.16
0.12
0.21
0.22
0.49
0.17
0.15
0.26
0.14

518

Female
ASR(W)
CUM 0-74

*
*
*

*
*
*
*

*
*
*

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp

*Important. See note on population page.

576

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Prostate (C61) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

2548
5009
509
14669
633
1468
2002
5755
7139
2654
3385
4821
2875
622
2768
4282
2692
457
1578
1062
1822
1558
1111
1787
37300
1327
686
558
1640
724
826
2234
34831
2108
2029
7547
5424
9897
15705
7073
20113
31674
10334
13588
2759
10668

31.4
43.0
35.1
76.0
24.7
31.2
30.0
50.9
55.4
18.5
16.0
28.8
40.6
39.2
45.6
54.1
55.3
29.9
57.5
29.0
38.5
56.4
43.6
42.2
84.6
85.4
67.6
77.7
76.9
49.6
75.1
88.7
56.5
55.9
54.3
54.8
49.1
53.1
51.4
64.2
56.9
54.1
44.4
54.6
43.6
47.6

0.63
0.61
1.61
0.68
1.00
0.84
0.69
0.73
0.68
0.36
0.28
0.42
0.76
1.68
0.92
0.85
1.08
1.58
1.55
0.94
0.94
1.52
1.41
1.06
0.47
2.40
2.74
3.48
1.99
1.91
2.70
1.97
0.31
1.24
1.23
0.67
0.69
0.56
0.43
0.80
0.43
0.32
0.46
0.49
0.86
0.48

3.86
5.13
4.13
9.49
2.84
3.63
4.07
6.72
6.82
2.34
1.89
3.32
4.97
4.61
5.47
6.75
7.01
3.47
7.60
3.79
4.48
7.40
5.24
5.80
10.85
11.43
8.20
10.02
9.95
6.15
9.70
11.90
7.31
7.23
6.97
6.62
5.64
6.32
6.16
7.86
6.78
6.66
5.11
6.51
5.18
5.74

0.09
0.09
0.25
0.11
0.14
0.13
0.11
0.11
0.10
0.05
0.04
0.06
0.11
0.26
0.14
0.13
0.17
0.24
0.25
0.15
0.14
0.24
0.22
0.17
0.08
0.38
0.44
0.54
0.33
0.31
0.42
0.32
0.05
0.19
0.19
0.10
0.11
0.09
0.07
0.13
0.07
0.05
0.07
0.08
0.13
0.07

19271
199
9436
5171
1439
13958
4668
753
233
13827
3762
283
604
328
1184
1140

78.4
61.7
73.1
82.0
74.0
77.3
75.3
89.0
67.9
104.4
79.8
69.1
78.0
71.3
74.2
95.3

0.59
4.55
0.78
1.20
2.03
0.68
1.13
3.33
4.57
0.92
1.40
4.61
3.46
4.00
2.54
2.96

10.01
7.55
8.96
10.30
8.96
9.33
9.47
10.87
7.48
13.29
10.30
8.96
9.82
9.50
9.55
12.40

0.09
0.68
0.12
0.19
0.31
0.10
0.17
0.50
0.64
0.14
0.22
0.71
0.55
0.65
0.39
0.47

Cases

Female
ASR(W)
CUM 0-74

*
*

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

519

577

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Testis (C62)
Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

6
33
5
7
16

0.2
0.5
0.4
0.6
0.6

0.09
0.10
0.19
0.26
0.18

40
49
10
34
740
86
115
276
147
13
38

5.5
1.6
1.0
1.4
2.7
8.8
2.3
2.6
3.9
1.3
2.7

0.89
0.26
0.37
0.24
0.10
0.96
0.23
0.16
0.33
0.36
0.45

0.41
0.15
0.12
0.10
0.20
0.68
0.19
0.20
0.30
0.10
0.21

0.07
0.03
0.06
0.02
0.01
0.08
0.02
0.01
0.03
0.03
0.04

3034
451
520
153
76
39
4
115
1508
19
149
443
34
401
98
665
4585
180
96
1171
3063
926
31
25
8
13
164
640
1126
29
14
11
10
3
444
597
698
493
14
467
50
7
40
1840
70
1735
858
66
779
340
37
294
185
1554
60
1426
817
467
511
454
45
405
14
75

4.7
5.2
4.5
5.0
3.6
2.5
2.9
4.6
4.6
5.1
5.5
3.8
1.2
4.7
5.3
4.7
4.7
1.5
1.4
3.7
6.8
4.7
2.3
1.8
1.0
4.2
3.7
6.7
4.2
1.1
1.6
1.7
2.8
0.6
3.7
6.8
5.5
5.4
1.5
6.0
3.0
0.9
5.2
4.4
1.1
5.2
3.7
1.0
4.8
3.7
1.2
5.2
5.2
4.6
1.3
5.2
5.0
6.1
4.6
3.9
1.3
5.2
1.3
4.9

0.09
0.25
0.20
0.42
0.42
0.41
1.49
0.44
0.12
1.21
0.46
0.18
0.21
0.24
0.56
0.19
0.07
0.12
0.14
0.11
0.13
0.16
0.43
0.36
0.39
1.19
0.30
0.29
0.13
0.21
0.42
0.53
0.92
0.36
0.18
0.30
0.21
0.25
0.39
0.29
0.43
0.35
0.85
0.11
0.13
0.13
0.13
0.13
0.17
0.21
0.20
0.31
0.39
0.12
0.17
0.14
0.18
0.29
0.21
0.18
0.19
0.26
0.36
0.58

0.36
0.39
0.35
0.39
0.28
0.20
0.23
0.34
0.35
0.37
0.43
0.29
0.09
0.36
0.44
0.37
0.37
0.12
0.11
0.27
0.52
0.37
0.18
0.14
0.07
0.34
0.28
0.52
0.31
0.08
0.12
0.11
0.22
0.04
0.26
0.52
0.42
0.41
0.11
0.46
0.22
0.06
0.40
0.34
0.08
0.40
0.28
0.08
0.36
0.28
0.09
0.40
0.40
0.35
0.09
0.39
0.38
0.47
0.36
0.30
0.11
0.40
0.10
0.40

0.01
0.02
0.02
0.03
0.03
0.03
0.11
0.03
0.01
0.09
0.04
0.01
0.02
0.02
0.05
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.03
0.03
0.02
0.09
0.02
0.02
0.01
0.02
0.03
0.03
0.07
0.02
0.01
0.02
0.02
0.02
0.03
0.02
0.03
0.02
0.07
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.02
0.03
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.02
0.02
0.03
0.05

520

Female
ASR(W)
CUM 0-74
*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

578

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Testis (C62) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

204
1019
1292
41
1220
515
28
478
640
17
618
137
29216
887
27275
1183
47
1101
237
16
89
131
2360
108
2190
1507
43
1413
385
612
1739
52
1663
148
3800
121
3465
9956
315
298
1489
7701
385
29
351
2520
77
2373
333
110
983
685
202
914

5.7
5.8
4.8
1.1
5.5
4.7
1.1
6.0
4.4
1.1
4.9
6.0
4.8
1.2
5.4
5.2
1.4
6.3
5.2
3.6
4.7
6.5
4.5
1.4
5.4
5.0
1.3
5.4
4.2
6.5
5.5
1.7
6.0
5.2
5.1
1.4
6.0
4.8
1.7
1.3
3.6
6.3
3.6
0.9
4.7
4.3
1.2
4.9
5.4
6.8
5.9
5.8
4.4
6.2

0.42
0.19
0.14
0.18
0.16
0.21
0.22
0.29
0.18
0.26
0.20
0.53
0.03
0.04
0.03
0.16
0.20
0.20
0.35
0.93
0.50
0.60
0.10
0.14
0.12
0.13
0.20
0.15
0.22
0.27
0.13
0.24
0.15
0.44
0.08
0.13
0.10
0.05
0.10
0.08
0.10
0.07
0.19
0.18
0.26
0.09
0.13
0.10
0.30
0.68
0.19
0.23
0.32
0.21

0.45
0.45
0.37
0.09
0.42
0.36
0.09
0.46
0.33
0.08
0.37
0.45
0.37
0.10
0.42
0.40
0.11
0.47
0.39
0.26
0.34
0.50
0.35
0.12
0.42
0.39
0.10
0.42
0.32
0.50
0.42
0.14
0.46
0.40
0.39
0.11
0.46
0.37
0.13
0.10
0.26
0.48
0.28
0.07
0.36
0.33
0.09
0.37
0.41
0.52
0.45
0.45
0.34
0.48

0.03
0.01
0.01
0.01
0.01
0.02
0.02
0.02
0.01
0.02
0.02
0.04
0.00
0.00
0.00
0.01
0.02
0.01
0.03
0.07
0.04
0.04
0.01
0.01
0.01
0.01
0.02
0.01
0.02
0.02
0.01
0.02
0.01
0.03
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.02
0.05
0.01
0.02
0.02
0.02

11
43
292
8
5
142
24
72
75
242
2
256
50
66
13
587
520
41
55
41
81
152
53
264
42

1.0
0.8
1.6
0.7
0.2
0.7
0.7
4.0
0.6
0.7
0.2
0.7
1.0
0.8
0.4
3.8
4.1
1.3
1.8
1.8
2.7
2.5
1.6
1.1
1.5

0.33
0.13
0.10
0.25
0.09
0.08
0.15
0.48
0.08
0.05
0.11
0.05
0.14
0.10
0.11
0.16
0.18
0.22
0.24
0.31
0.31
0.21
0.24
0.07
0.24

0.06
0.06
0.11
0.07
0.02
0.06
0.05
0.30
0.06
0.06
0.01
0.06
0.10
0.08
0.03
0.29
0.32
0.10
0.13
0.14
0.21
0.19
0.12
0.08
0.11

0.02
0.01
0.01
0.03
0.01
0.01
0.01
0.04
0.01
0.01
0.01
0.00
0.02
0.01
0.01
0.01
0.01
0.02
0.02
0.02
0.02
0.02
0.02
0.01
0.02

Cases

Female
ASR(W)
CUM 0-74

*
*
*
*
*
*
*
*
*

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

521

579

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Testis (C62) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

554
47
38
13
20
31
2
181
15
24
37
21
42
12
53
147
85
64
6
15
32
14
11
87
228

0.6
0.6
0.7
0.4
0.5
0.5
0.4
0.6
0.7
1.2
1.3
0.9
0.8
0.4
1.2
1.1
1.0
0.9
1.0
1.3
0.7
0.5
0.3
2.2
2.3

0.03
0.09
0.11
0.13
0.13
0.09
0.27
0.05
0.19
0.25
0.54
0.20
0.13
0.14
0.18
0.10
0.11
0.12
0.44
0.34
0.13
0.15
0.11
0.25
0.16

0.04
0.04
0.04
0.03
0.04
0.03
0.02
0.05
0.06
0.09
0.07
0.09
0.05
0.04
0.10
0.10
0.07
0.07
0.06
0.08
0.07
0.05
0.03
0.18
0.18

0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.02
0.02
0.02
0.03
0.01
0.01
0.02
0.01
0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.02
0.01

1717
146
80
445
158
461
816
610
1859
1361
85
469
198
81
76
145
104
151
178
51
69
46
81
589
1042
308
482
613
587
247
40
583
32
94
43
118
58
25
139
90
55
292
47
27
64
139
108
58
35
40
132
120
95
227

7.5
7.4
7.9
1.7
3.6
3.7
3.7
5.4
6.5
9.2
2.5
3.7
6.6
4.7
5.5
7.4
4.6
5.0
5.8
4.1
4.7
5.7
5.7
7.7
8.1
5.9
8.9
8.8
8.0
8.1
5.1
5.6
6.1
5.6
4.6
4.1
4.2
5.2
4.7
5.4
3.7
5.0
4.5
3.6
4.8
5.0
4.7
4.6
4.2
8.5
5.4
5.7
7.3
5.2

0.19
0.63
0.91
0.08
0.30
0.18
0.13
0.22
0.15
0.26
0.28
0.18
0.48
0.53
0.64
0.63
0.46
0.42
0.44
0.58
0.58
0.88
0.66
0.34
0.27
0.35
0.42
0.38
0.35
0.54
0.81
0.24
1.11
0.61
0.83
0.41
0.61
1.11
0.44
0.62
0.50
0.31
0.73
0.69
0.63
0.45
0.46
0.63
0.74
1.42
0.51
0.55
0.80
0.37

0.58
0.58
0.59
0.14
0.27
0.28
0.29
0.40
0.50
0.71
0.18
0.27
0.52
0.36
0.42
0.57
0.34
0.39
0.46
0.32
0.34
0.42
0.44
0.60
0.65
0.47
0.71
0.68
0.62
0.64
0.41
0.42
0.48
0.41
0.35
0.31
0.31
0.42
0.36
0.42
0.26
0.37
0.35
0.25
0.38
0.37
0.35
0.32
0.31
0.61
0.42
0.43
0.54
0.38

0.01
0.05
0.07
0.01
0.02
0.01
0.01
0.02
0.01
0.02
0.02
0.01
0.04
0.04
0.05
0.05
0.03
0.03
0.04
0.05
0.04
0.06
0.05
0.03
0.02
0.03
0.03
0.03
0.03
0.04
0.07
0.02
0.08
0.04
0.06
0.03
0.04
0.08
0.03
0.05
0.04
0.02
0.05
0.05
0.05
0.03
0.03
0.04
0.05
0.10
0.04
0.04
0.06
0.03

522

Female
ASR(W)
CUM 0-74

*
*
*

*
*
*
*

*
*
*

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp

*Important. See note on population page.

580

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Testis (C62) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

128
185
41
1171
85
102
179
155
137
215
563
980
411
28
66
151
99
15
59
54
92
41
48
57
1214
82
65
26
147
75
62
151
2611
158
126
446
401
702
1104
565
1316
2156
699
809
277
1038

2.1
1.9
4.0
9.6
4.1
2.9
4.2
1.8
1.9
1.7
5.1
6.6
7.5
3.5
2.2
3.1
2.3
3.4
3.9
2.4
2.8
2.6
3.7
2.5
5.3
6.9
10.3
6.0
10.6
8.6
7.8
9.1
6.0
5.6
5.7
6.1
6.5
6.3
6.5
7.4
7.6
5.6
5.6
5.7
6.2
7.6

0.19
0.14
0.63
0.29
0.45
0.29
0.33
0.15
0.17
0.12
0.22
0.21
0.38
0.66
0.29
0.26
0.24
0.89
0.52
0.33
0.31
0.41
0.56
0.35
0.16
0.79
1.34
1.25
0.91
1.03
1.02
0.77
0.12
0.47
0.54
0.30
0.34
0.25
0.20
0.32
0.22
0.12
0.22
0.20
0.38
0.24

0.17
0.17
0.31
0.74
0.31
0.22
0.32
0.13
0.14
0.14
0.38
0.48
0.56
0.23
0.16
0.23
0.16
0.23
0.30
0.17
0.20
0.18
0.27
0.18
0.41
0.54
0.78
0.44
0.81
0.67
0.61
0.71
0.45
0.43
0.42
0.48
0.52
0.50
0.50
0.57
0.59
0.44
0.43
0.45
0.49
0.60

0.02
0.01
0.05
0.02
0.04
0.02
0.02
0.01
0.01
0.01
0.02
0.02
0.03
0.05
0.02
0.02
0.02
0.06
0.04
0.02
0.02
0.03
0.04
0.02
0.01
0.06
0.10
0.09
0.07
0.08
0.08
0.06
0.01
0.04
0.04
0.02
0.03
0.02
0.02
0.02
0.02
0.01
0.02
0.02
0.03
0.02

1044
18
537
220
84
734
288
61
18
696
133
7
11
28
24
53

5.8
2.9
5.5
5.3
6.3
5.5
5.3
6.4
2.7
6.8
3.9
3.5
2.2
4.7
4.4
5.3

0.18
0.70
0.24
0.37
0.71
0.21
0.32
0.83
0.65
0.26
0.34
1.37
0.70
0.90
0.97
0.74

0.45
0.21
0.42
0.42
0.51
0.43
0.42
0.52
0.20
0.53
0.30
0.24
0.16
0.37
0.34
0.42

0.01
0.05
0.02
0.03
0.06
0.02
0.03
0.07
0.05
0.02
0.03
0.09
0.05
0.07
0.07
0.06

Cases

Female
ASR(W)
CUM 0-74

*
*

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

523

581

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other male genital organs (C63)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

0
2
0
1
0

0.1
0.0
-

0.04
0.02
-

2
6
1
2
32
1
5
3
1
1
0

0.3
0.3
0.2
0.1
0.1
0.2
0.2
0.0
0.0
0.1
-

0.20
0.14
0.16
0.10
0.03
0.15
0.09
0.02
0.03
0.10
-

0.02
0.05
0.02
0.02
0.01
0.02
0.00
0.00
0.01
-

0.02
0.02
0.02
0.00
0.01
0.01
0.00
0.00
0.01
-

174
14
17
7
4
1
0
4
116
2
9
14
3
11
4
36
194
22
8
31
127
45
3
5
2
0
2
28
61
4
1
3
1
2
15
32
21
17
0
16
3
3
0
98
12
86
34
6
26
13
6
5
4
50
6
43
32
23
14
21
7
14
2
2

0.2
0.2
0.1
0.2
0.2
0.1
0.1
0.3
0.3
0.3
0.1
0.1
0.1
0.2
0.2
0.2
0.2
0.1
0.2
0.2
0.2
0.2
0.2
0.3
0.1
0.2
0.2
0.2
0.0
0.3
0.1
0.3
0.2
0.2
0.2
0.1
0.2
0.2
0.3
0.2
0.2
0.1
0.2
0.1
0.2
0.2
0.3
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.1
0.2
0.2
0.1
0.2
0.1

0.02
0.05
0.03
0.07
0.09
0.05
0.06
0.03
0.26
0.09
0.03
0.05
0.03
0.11
0.03
0.01
0.04
0.05
0.03
0.02
0.04
0.14
0.11
0.22
0.05
0.05
0.03
0.08
0.04
0.18
0.08
0.24
0.06
0.05
0.04
0.04
0.04
0.09
0.15
0.02
0.06
0.02
0.03
0.05
0.03
0.05
0.12
0.05
0.05
0.02
0.05
0.02
0.03
0.05
0.03
0.03
0.07
0.04
0.12
0.05

0.02
0.02
0.01
0.02
0.03
0.00
0.01
0.03
0.04
0.03
0.01
0.00
0.01
0.03
0.02
0.02
0.03
0.02
0.02
0.02
0.03
0.03
0.04
0.05
0.00
0.02
0.03
0.02
0.03
0.04
0.02
0.03
0.02
0.01
0.01
0.01
0.02
0.02
0.02
0.02
0.01
0.01
0.01
0.02
0.04
0.01
0.01
0.01
0.01
0.01
0.01
0.03
0.01
0.02
0.02
0.01
0.01
0.01

0.00
0.01
0.00
0.01
0.01
0.00
0.01
0.00
0.04
0.01
0.00
0.00
0.00
0.02
0.00
0.00
0.01
0.01
0.00
0.00
0.01
0.02
0.02
0.04
0.00
0.01
0.00
0.01
0.03
0.03
0.01
0.01
0.00
0.00
0.01
0.01
0.02
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.02
0.01
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.01

524

Female
ASR(W)
CUM 0-74
*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

582

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other male genital organs (C63) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

7
22
59
3
55
35
3
32
23
3
18
6
1109
98
951
44
3
40
7
1
4
2
89
11
74
46
5
41
10
17
82
10
69
6
183
13
136
425
42
30
41
300
22
2
20
84
8
74
11
3
36
28
8
19

0.1
0.1
0.2
0.1
0.2
0.3
0.1
0.4
0.1
0.2
0.1
0.2
0.2
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.2
0.0
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.2
0.1
0.1
0.1
0.2
0.1
0.2
0.2
0.1
0.1

0.05
0.02
0.03
0.06
0.03
0.05
0.08
0.07
0.03
0.12
0.03
0.08
0.00
0.02
0.01
0.02
0.06
0.03
0.04
0.23
0.09
0.03
0.02
0.05
0.02
0.02
0.07
0.02
0.03
0.04
0.02
0.09
0.02
0.07
0.02
0.05
0.02
0.01
0.04
0.03
0.03
0.01
0.04
0.05
0.04
0.02
0.05
0.02
0.06
0.07
0.03
0.04
0.04
0.02

0.02
0.01
0.02
0.01
0.03
0.04
0.01
0.04
0.02
0.02
0.01
0.03
0.02
0.01
0.02
0.02
0.01
0.02
0.01
0.02
0.00
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.03
0.02
0.02
0.03
0.02
0.02
0.02
0.03
0.02
0.02
0.02
0.02
0.01
0.02
0.01
0.01
0.01
0.03
0.01
0.02
0.02
0.01
0.01

0.01
0.00
0.00
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.01
0.00
0.00
0.01
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.00
0.01
0.01
0.00
0.01
0.01
0.00

1
8

0.1
0.1

0.11
0.05

0.01
0.02

0.01
0.01

4
3
70
6
2
14
8
0
15
0
5
1
17
17
0
10
6
15
15
28
65
13

0.3
0.1
0.3
0.2
0.1
0.2
0.0
0.1
0.1
0.0
0.1
0.1
0.3
0.1
0.4
0.1
0.3
0.2
0.2

0.15
0.06
0.04
0.07
0.05
0.04
0.02
0.02
0.03
0.04
0.03
0.03
0.09
0.05
0.11
0.04
0.07
0.02
0.07

0.02
0.01
0.03
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.03
0.01
0.04
0.02
0.03
0.02
0.03

0.01
0.01
0.00
0.01
0.01
0.01
0.00
0.00
0.01
0.01
0.00
0.00
0.01
0.01
0.01
0.01
0.01
0.00
0.01

Cases

Female
ASR(W)
CUM 0-74

*
*
*
*
*
*
*
*
*

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

525

583

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other male genital organs (C63) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

115
9
15
3
0
11
2
48
1
0
0
1
3
0
1
5
20
17
1
2
6
1
0
1
3

0.1
0.1
0.3
0.1
0.2
0.3
0.2
0.0
0.0
0.1
0.1
0.1
0.3
0.3
0.1
0.2
0.2
0.0
0.0
0.0

0.01
0.04
0.08
0.06
0.08
0.23
0.04
0.05
0.03
0.05
0.07
0.05
0.06
0.07
0.08
0.17
0.06
0.05
0.03
0.02

0.02
0.01
0.04
0.01
0.04
0.06
0.03
0.00
0.00
0.01
0.01
0.01
0.03
0.03
0.01
0.02
0.01
0.00
0.01

0.00
0.01
0.01
0.01
0.01
0.05
0.00
0.00
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.00

25
3
2
16
6
20
41
25
66
20
5
12
2
4
8
3
5
5
9
1
5
0
3
14
34
12
7
3
4
6
1
19
1
7
3
4
5
0
5
13
1
21
1
4
4
3
6
2
3
1
6
6
19
5

0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.2
0.2
0.1
0.2
0.1
0.1
0.2
0.4
0.2
0.1
0.1
0.2
0.0
0.3
0.2
0.1
0.2
0.1
0.1
0.0
0.1
0.1
0.1
0.2
0.1
0.3
0.2
0.1
0.2
0.1
0.5
0.1
0.2
0.0
0.4
0.1
0.0
0.2
0.1
0.2
0.1
0.2
0.1
1.3
0.1

0.02
0.08
0.12
0.01
0.04
0.03
0.02
0.03
0.02
0.02
0.09
0.02
0.04
0.09
0.16
0.11
0.05
0.07
0.08
0.04
0.13
0.11
0.04
0.03
0.04
0.05
0.02
0.03
0.05
0.13
0.04
0.09
0.10
0.13
0.08
0.08
0.04
0.15
0.08
0.05
0.03
0.23
0.08
0.02
0.07
0.09
0.10
0.14
0.11
0.07
0.35
0.03

0.01
0.02
0.04
0.01
0.00
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.00
0.02
0.05
0.02
0.01
0.01
0.03
0.01
0.02
0.02
0.02
0.02
0.01
0.01
0.00
0.00
0.01
0.01
0.02
0.02
0.03
0.02
0.01
0.02
0.01
0.06
0.00
0.03
0.03
0.02
0.00
0.02
0.01
0.03
0.02
0.01
0.02
0.12
0.01

0.00
0.01
0.03
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.00
0.01
0.00
0.00
0.00
0.01
0.01
0.00
0.02
0.01
0.01
0.01
0.01
0.01
0.02
0.00
0.01
0.02
0.01
0.00
0.01
0.01
0.02
0.02
0.01
0.01
0.03
0.00

526

Female
ASR(W)
CUM 0-74

*
*
*

*
*
*
*

*
*
*

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp

*Important. See note on population page.

584

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other male genital organs (C63) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

5
12
2
30
9
18
5
29
6
9
18
21
11
0
10
16
8
0
2
2
6
4
2
3
36
3
1
3
2
2
4
6
67
5
5
19
12
21
37
10
69
37
30
48
10
38

0.1
0.1
0.2
0.2
0.3
0.4
0.1
0.3
0.1
0.1
0.1
0.1
0.2
0.2
0.2
0.2
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.2
0.1
0.5
0.1
0.2
0.4
0.2
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.2
0.2
0.2

0.06
0.04
0.16
0.03
0.12
0.10
0.04
0.05
0.02
0.02
0.03
0.03
0.06
0.08
0.07
0.07
0.08
0.08
0.07
0.08
0.09
0.04
0.02
0.12
0.14
0.31
0.07
0.11
0.20
0.10
0.02
0.06
0.07
0.04
0.04
0.03
0.02
0.03
0.03
0.01
0.03
0.03
0.06
0.04

0.01
0.01
0.01
0.02
0.03
0.04
0.01
0.03
0.00
0.01
0.01
0.02
0.02
0.02
0.02
0.03
0.01
0.01
0.02
0.01
0.01
0.00
0.01
0.02
0.01
0.05
0.02
0.03
0.05
0.02
0.01
0.01
0.02
0.02
0.02
0.01
0.02
0.01
0.03
0.01
0.01
0.03
0.01
0.02

0.00
0.00
0.01
0.00
0.01
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.00
0.01
0.01
0.04
0.01
0.02
0.03
0.01
0.00
0.01
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00

40
2
13
12
3
21
5
3
3
20
16
0
2
1
10
2

0.2
0.5
0.1
0.2
0.2
0.1
0.1
0.3
0.9
0.2
0.3
0.4
0.2
0.4
0.2

0.03
0.40
0.03
0.06
0.11
0.03
0.04
0.20
0.58
0.04
0.09
0.30
0.17
0.16
0.15

0.02
0.10
0.01
0.02
0.02
0.01
0.01
0.07
0.09
0.02
0.03
0.03
0.05
0.03

0.00
0.09
0.00
0.01
0.01
0.00
0.00
0.04
0.08
0.00
0.01
0.02
0.03
0.02

Cases

Female
ASR(W)
CUM 0-74

*
*

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

527

585

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Kidney (C64)
Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

528

Female
ASR(W)
CUM 0-74

18
121
25
21
45

0.7
2.5
2.6
0.5
1.8

0.18
0.24
0.53
0.13
0.31

34
84
16
15
37

1.2
1.5
1.6
0.3
1.7

0.23
0.17
0.41
0.08
0.35

76
114
20
66
1368
58
131
291
79
26
29

9.3
5.0
2.8
4.7
6.7
6.8
3.9
3.9
3.0
2.3
3.3

1.11
0.52
0.67
0.59
0.19
0.90
0.35
0.23
0.35
0.46
0.63

1.05
0.53
0.30
0.55
0.82
0.85
0.51
0.45
0.35
0.32
0.40

0.14
0.07
0.08
0.09
0.03
0.13
0.05
0.03
0.05
0.07
0.09

37
79
13
45
863
39
113
186
60
25
17

3.9
2.9
1.9
2.5
3.2
4.1
2.7
2.4
2.0
1.9
1.5

0.68
0.35
0.54
0.39
0.12
0.67
0.26
0.18
0.26
0.39
0.38

0.47
0.32
0.22
0.25
0.35
0.45
0.30
0.27
0.23
0.19
0.21

0.08
0.05
0.08
0.05
0.01
0.09
0.04
0.02
0.03
0.04
0.07 *

7444
892
1066
460
309
169
7
433
3675
55
378
1438
284
1140
190
1833
9195
517
645
1673
6274
1725
125
63
47
17
222
1171
2355
298
40
49
32
23
606
1275
1185
1358
88
1249
188
126
52
6808
483
6239
2372
586
1771
729
225
494
393
4479
568
3797
2277
1186
1623
1806
453
1349
117
281

9.6
9.9
7.4
11.4
11.6
9.5
8.5
13.1
9.5
11.0
10.7
10.1
10.9
9.9
12.4
10.7
9.4
4.6
11.2
10.4
9.9
8.7
9.9
4.1
5.5
5.5
10.4
9.5
9.3
12.0
3.4
6.6
6.1
4.5
9.8
10.1
9.5
11.8
12.2
11.8
11.3
12.1
9.4
10.6
9.2
10.8
10.7
12.8
10.3
10.9
13.0
10.6
9.8
11.8
13.4
11.6
12.0
11.7
12.6
13.7
14.3
13.8
12.6
14.4

0.12
0.34
0.24
0.56
0.68
0.78
3.37
0.66
0.16
1.52
0.59
0.27
0.66
0.30
0.94
0.26
0.10
0.21
0.45
0.26
0.13
0.22
0.91
0.55
0.81
1.42
0.73
0.30
0.20
0.70
0.57
0.96
1.19
1.00
0.41
0.30
0.29
0.34
1.33
0.35
0.85
1.12
1.41
0.14
0.43
0.15
0.22
0.55
0.25
0.42
0.92
0.50
0.51
0.18
0.57
0.20
0.26
0.36
0.32
0.33
0.69
0.39
1.19
0.91

1.13
1.16
0.89
1.34
1.38
1.15
1.08
1.55
1.12
1.35
1.25
1.25
1.38
1.21
1.55
1.27
1.13
0.57
1.31
1.26
1.18
1.05
1.20
0.48
0.62
0.78
1.30
1.13
1.11
1.41
0.32
0.74
0.86
0.43
1.19
1.21
1.15
1.46
1.52
1.46
1.42
1.45
1.35
1.28
1.16
1.30
1.27
1.55
1.22
1.33
1.58
1.29
1.21
1.42
1.57
1.40
1.46
1.42
1.49
1.68
1.72
1.70
1.54
1.73

0.02
0.05
0.03
0.08
0.09
0.10
0.54
0.09
0.02
0.23
0.08
0.04
0.10
0.04
0.15
0.04
0.01
0.03
0.06
0.04
0.02
0.03
0.13
0.07
0.11
0.22
0.11
0.04
0.03
0.10
0.07
0.12
0.17
0.12
0.06
0.04
0.04
0.05
0.20
0.05
0.12
0.15
0.22
0.02
0.06
0.02
0.03
0.08
0.03
0.06
0.14
0.07
0.07
0.03
0.08
0.03
0.04
0.05
0.04
0.05
0.10
0.05
0.17
0.12

4780
569
642
290
221
114
2
284
2381
29
248
931
233
686
81
1096
5346
312
409
1120
3448
1001
99
41
35
14
158
625
1443
186
23
32
17
13
409
738
748
868
55
797
121
95
21
4005
359
3607
1490
382
1091
394
133
253
290
3025
420
2545
1548
766
1033
1202
314
885
95
183

5.4
5.8
3.8
6.0
7.2
6.0
2.6
6.9
5.4
5.5
5.9
5.3
6.5
4.9
5.2
5.7
4.6
2.3
5.8
5.8
4.6
4.3
6.3
2.0
3.0
2.6
6.1
4.3
4.7
5.6
1.8
3.1
3.4
2.4
5.1
4.9
5.2
6.2
5.7
6.2
5.6
6.7
2.8
5.3
5.4
5.3
5.5
5.9
5.4
4.7
5.5
4.5
6.8
6.4
7.0
6.4
6.8
6.2
6.6
7.4
7.2
7.5
7.0
7.3

0.09
0.26
0.17
0.40
0.53
0.62
2.07
0.46
0.12
1.17
0.43
0.19
0.45
0.21
0.60
0.19
0.07
0.14
0.30
0.18
0.09
0.15
0.68
0.34
0.52
0.79
0.50
0.20
0.13
0.44
0.42
0.57
1.11
0.75
0.26
0.21
0.20
0.24
0.80
0.25
0.58
0.77
0.84
0.10
0.29
0.11
0.15
0.32
0.18
0.25
0.50
0.31
0.43
0.13
0.35
0.14
0.19
0.26
0.22
0.23
0.42
0.28
0.75
0.61

0.62
0.65
0.44
0.71
0.81
0.76
0.38
0.84
0.62
0.71
0.71
0.61
0.77
0.56
0.61
0.68
0.54
0.27
0.65
0.70
0.54
0.49
0.67
0.20
0.37
0.31
0.75
0.51
0.54
0.61
0.19
0.36
0.38
0.35
0.61
0.57
0.61
0.73
0.61
0.74
0.65
0.80
0.25
0.61
0.65
0.61
0.63
0.71
0.62
0.56
0.65
0.52
0.82
0.74
0.81
0.74
0.80
0.72
0.77
0.86
0.82
0.89
0.79
0.89

0.01
0.03
0.02
0.05
0.07
0.08
0.33
0.06
0.02
0.16
0.06
0.02
0.06
0.03
0.09
0.02
0.01
0.02
0.04
0.03
0.01
0.02
0.08
0.04
0.07
0.10
0.07
0.03
0.02
0.06
0.05
0.07
0.10
0.10
0.04
0.03
0.03
0.03
0.10
0.03
0.07
0.10
0.09
0.01
0.04
0.01
0.02
0.05
0.02
0.04
0.07
0.04
0.06
0.02
0.05
0.02
0.02
0.03
0.03
0.03
0.06
0.04
0.10
0.08

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

586

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Kidney (C64) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

559
2329
3460
480
2924
1568
353
1188
2192
209
1971
318
78891
7436
69100
3419
346
2968
621
45
224
345
7053
653
6214
4018
384
3555
1268
1121
5201
474
4632
465
8810
864
7372
23773
897
2320
2290
17980
1519
334
1165
7196
675
6378
447
215
2009
1374
762
2008

12.5
11.3
11.0
14.4
10.5
12.5
14.3
12.1
12.1
15.3
11.9
10.0
11.2
12.1
11.2
12.6
12.5
12.8
10.7
14.0
12.5
9.9
11.8
9.8
12.3
10.8
12.1
10.6
11.2
9.7
11.9
15.6
11.4
13.1
10.8
12.9
11.0
10.7
5.2
12.8
10.6
11.1
12.0
12.1
11.9
12.5
13.1
12.6
8.3
10.3
10.7
10.8
11.3
11.4

0.55
0.25
0.19
0.67
0.20
0.33
0.78
0.37
0.27
1.08
0.28
0.59
0.04
0.14
0.04
0.23
0.68
0.25
0.44
2.13
0.85
0.58
0.15
0.39
0.17
0.18
0.63
0.19
0.32
0.31
0.18
0.74
0.18
0.64
0.12
0.45
0.13
0.07
0.18
0.27
0.23
0.09
0.32
0.68
0.36
0.15
0.52
0.16
0.41
0.73
0.25
0.30
0.43
0.27

1.55
1.37
1.33
1.75
1.28
1.51
1.73
1.46
1.45
1.82
1.43
1.18
1.35
1.47
1.35
1.54
1.57
1.56
1.33
2.18
1.54
1.19
1.43
1.20
1.50
1.31
1.47
1.27
1.33
1.15
1.41
1.81
1.36
1.59
1.30
1.57
1.32
1.30
0.63
1.55
1.29
1.33
1.46
1.48
1.45
1.51
1.61
1.52
1.00
1.24
1.26
1.26
1.37
1.37

0.08
0.03
0.03
0.10
0.03
0.05
0.11
0.05
0.04
0.15
0.04
0.08
0.01
0.02
0.01
0.03
0.10
0.03
0.06
0.37
0.12
0.08
0.02
0.06
0.02
0.02
0.09
0.03
0.04
0.04
0.02
0.10
0.02
0.09
0.02
0.07
0.02
0.01
0.03
0.04
0.03
0.01
0.04
0.10
0.05
0.02
0.08
0.02
0.06
0.10
0.04
0.04
0.06
0.04

325
1600
2339
349
1950
1049
278
762
1452
138
1297
193
50061
5308
43312
2126
236
1838
353
31
144
170
4542
505
3931
2828
297
2473
796
652
3416
310
3044
307
5337
616
4386
14423
530
1567
1519
10643
871
248
613
4617
549
3987
295
137
1141
760
494
1313

5.9
6.2
6.2
7.9
5.9
6.9
8.4
6.5
6.5
6.7
6.5
5.1
5.9
6.4
5.9
6.1
6.3
6.2
5.5
7.5
6.9
4.6
5.9
5.1
6.2
6.2
6.9
6.1
5.9
5.1
6.2
7.1
6.1
6.8
5.5
7.0
5.6
5.4
2.6
6.6
5.8
5.5
5.7
6.6
5.3
6.8
8.0
6.7
4.8
5.8
5.4
5.3
5.9
6.2

0.37
0.17
0.14
0.44
0.15
0.24
0.53
0.27
0.19
0.60
0.20
0.42
0.03
0.09
0.03
0.15
0.42
0.16
0.31
1.36
0.59
0.39
0.10
0.24
0.11
0.13
0.42
0.14
0.23
0.22
0.12
0.43
0.13
0.45
0.08
0.29
0.09
0.05
0.12
0.17
0.16
0.06
0.21
0.44
0.24
0.11
0.36
0.11
0.30
0.54
0.18
0.21
0.30
0.19

0.70
0.74
0.72
0.95
0.69
0.79
1.00
0.74
0.75
0.78
0.75
0.57
0.68
0.75
0.69
0.72
0.73
0.74
0.67
1.01
0.83
0.55
0.69
0.58
0.72
0.73
0.80
0.71
0.70
0.59
0.72
0.88
0.71
0.80
0.64
0.81
0.65
0.63
0.30
0.76
0.70
0.64
0.66
0.74
0.62
0.80
0.94
0.80
0.56
0.68
0.62
0.61
0.71
0.72

0.05
0.02
0.02
0.06
0.02
0.03
0.07
0.03
0.02
0.08
0.03
0.05
0.00
0.01
0.00
0.02
0.06
0.02
0.04
0.21
0.08
0.05
0.01
0.03
0.01
0.02
0.06
0.02
0.03
0.03
0.02
0.06
0.02
0.06
0.01
0.04
0.01
0.01
0.02
0.02
0.02
0.01
0.03
0.06
0.03
0.01
0.05
0.02
0.04
0.07
0.02
0.03
0.04
0.03

27
123

4.7
2.3

0.93
0.22

0.60
0.26

0.14
0.03

25
65

3.5
1.2

0.75
0.16

0.35
0.10

0.09
0.02 *

21
75
1090
56
110
115
558
6
435
43
105
40
1747
1628
69
167
201
252
641
356
1360
216

1.6
3.2
4.8
1.8
5.1
1.3
2.6
0.7
2.0
1.0
1.7
1.5
11.0
11.4
4.4
4.5
5.6
6.3
6.6
5.3
3.9
3.4

0.38
0.37
0.16
0.25
0.51
0.12
0.12
0.30
0.10
0.16
0.17
0.24
0.27
0.29
0.56
0.36
0.44
0.41
0.27
0.30
0.11
0.25

0.15
0.44
0.56
0.16
0.59
0.15
0.30
0.08
0.24
0.13
0.19
0.17
1.37
1.42
0.57
0.51
0.63
0.73
0.80
0.61
0.44
0.38

0.04
0.06
0.02
0.03
0.07
0.02
0.02
0.04
0.01
0.02
0.02
0.03
0.04
0.04
0.09
0.05
0.05
0.05
0.04
0.04
0.01
0.03

9
46
574
18
57
70
222
3
193
21
59
9
1057
992
33
61
97
92
291
184
631
148

0.6
1.9
2.4
0.6
2.8
0.8
1.2
0.4
0.9
0.5
0.9
0.3
5.6
5.8
1.6
1.5
1.9
1.9
2.5
2.1
1.5
1.9

0.21
0.28
0.12
0.14
0.40
0.10
0.08
0.23
0.07
0.12
0.12
0.11
0.18
0.20
0.31
0.21
0.22
0.21
0.17
0.19
0.07
0.18

0.10
0.23
0.27
0.07
0.29
0.08
0.12
0.03
0.10
0.05
0.09
0.02
0.69
0.72
0.14
0.18
0.24
0.21
0.28
0.24
0.15
0.22

0.04 *
0.04
0.01 *
0.02 *
0.04 *
0.01
0.01 *
0.02
0.01
0.01 *
0.01 *
0.01 *
0.03
0.03
0.03
0.03
0.03
0.03
0.02
0.02
0.01
0.02

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

529

587

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Kidney (C64) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

530

Female
ASR(W)
CUM 0-74

4253
439
282
130
108
227
35
1229
89
58
42
70
75
32
51
314
385
344
12
29
63
18
19
87
264

4.7
4.9
5.2
4.6
3.9
4.3
4.7
5.6
5.9
5.8
3.4
3.6
2.0
1.7
1.7
4.6
4.6
5.3
1.7
3.0
1.7
0.8
0.7
2.9
3.3

0.07
0.25
0.32
0.43
0.39
0.31
0.82
0.17
0.70
0.80
0.86
0.44
0.25
0.31
0.26
0.28
0.24
0.29
0.52
0.58
0.22
0.18
0.17
0.31
0.21

0.56
0.60
0.63
0.58
0.49
0.51
0.51
0.65
0.78
0.75
0.33
0.46
0.25
0.17
0.21
0.59
0.54
0.63
0.16
0.32
0.20
0.08
0.08
0.35
0.41

0.01
0.04
0.05
0.07
0.06
0.04
0.11
0.02
0.12
0.12
0.08
0.07
0.04
0.04
0.04
0.05
0.03
0.04
0.06
0.08
0.03
0.02
0.02
0.04
0.03

1967
214
154
63
48
120
20
546
31
27
17
38
26
34
21
224
226
194
7
25
34
9
16
47
138

1.9
2.1
2.3
2.0
1.4
2.1
1.9
2.2
1.6
2.0
4.0
1.7
0.7
1.6
0.8
2.5
2.4
2.5
1.4
2.3
0.9
0.4
0.6
1.6
1.6

0.04
0.15
0.19
0.25
0.21
0.19
0.46
0.10
0.30
0.42
1.13
0.28
0.14
0.30
0.19
0.18
0.17
0.19
0.56
0.48
0.16
0.14
0.15
0.24
0.14

0.21
0.24
0.25
0.22
0.17
0.24
0.19
0.26
0.17
0.25
0.22
0.17
0.09
0.16
0.07
0.28
0.28
0.29
0.12
0.27
0.09
0.05
0.05
0.17
0.18

0.01
0.02
0.02
0.03
0.03
0.03
0.05
0.01
0.04
0.07
0.09
0.03
0.02
0.04 *
0.02 *
0.03 *
0.02
0.03
0.05
0.07
0.02 *
0.02 *
0.01
0.03 *
0.02 *

3569
246
119
3743
511
1622
1559
1557
7193
1550
670
1993
501
209
172
298
344
318
445
155
215
137
181
1651
2971
571
1140
1091
976
516
132
1021
91
358
207
734
297
92
579
399
112
1105
206
51
239
640
203
146
45
98
369
478
261
954

12.2
11.0
10.6
13.0
7.3
8.6
5.4
9.8
20.2
7.4
15.6
10.2
15.0
9.1
9.8
11.6
9.5
8.4
11.4
7.2
10.8
8.3
8.4
16.3
16.0
8.4
17.1
11.9
9.5
11.3
15.0
8.7
10.2
15.2
12.2
13.1
10.5
10.9
12.6
13.6
7.3
12.3
10.6
4.6
11.5
13.3
6.5
8.1
3.7
14.1
8.5
11.6
13.0
14.2

0.21
0.72
0.99
0.22
0.34
0.23
0.15
0.26
0.24
0.20
0.62
0.24
0.69
0.67
0.78
0.69
0.55
0.49
0.56
0.62
0.77
0.78
0.67
0.42
0.31
0.37
0.52
0.37
0.31
0.51
1.36
0.28
1.12
0.84
1.02
0.53
0.66
1.22
0.57
0.72
0.70
0.40
0.83
0.68
0.83
0.59
0.48
0.71
0.56
1.46
0.49
0.57
0.85
0.49

1.48
1.23
1.33
1.55
0.93
1.06
0.63
1.18
2.50
0.88
1.94
1.22
1.79
1.05
1.24
1.42
1.10
1.00
1.36
0.78
1.38
0.97
0.99
2.05
1.98
0.98
2.16
1.42
1.16
1.41
1.73
0.99
1.27
1.84
1.38
1.57
1.29
1.33
1.55
1.77
0.89
1.49
1.29
0.56
1.37
1.64
0.79
1.00
0.46
1.68
1.00
1.46
1.60
1.71

0.03
0.09
0.14
0.03
0.05
0.03
0.02
0.03
0.03
0.03
0.08
0.03
0.09
0.09
0.11
0.10
0.07
0.07
0.08
0.08
0.11
0.10
0.08
0.06
0.04
0.05
0.07
0.05
0.04
0.07
0.18
0.04
0.15
0.11
0.11
0.07
0.09
0.16
0.07
0.10
0.10
0.05
0.11
0.09
0.11
0.08
0.06
0.09
0.08
0.19
0.06
0.08
0.12
0.06

2720
182
74
2533
307
1084
804
988
4572
1059
469
1577
293
102
76
205
151
196
238
95
108
73
108
1120
2010
375
757
681
672
349
77
537
48
201
122
384
162
51
336
212
86
635
124
38
129
372
118
76
35
50
243
232
135
568

6.8
6.5
5.2
6.1
3.8
5.0
2.4
4.8
9.5
4.2
6.6
5.8
6.5
3.9
3.5
6.4
3.8
4.2
5.1
3.8
4.7
3.2
4.2
8.7
7.9
4.1
8.8
5.5
4.9
6.1
7.6
4.2
3.6
6.6
4.9
5.4
4.4
4.5
5.0
6.3
4.9
5.5
6.0
3.3
5.2
6.6
3.3
3.7
2.6
6.7
4.3
5.4
5.5
6.4

0.15
0.54
0.65
0.13
0.25
0.18
0.10
0.17
0.15
0.15
0.34
0.17
0.44
0.44
0.43
0.49
0.36
0.34
0.37
0.44
0.50
0.45
0.49
0.30
0.21
0.26
0.39
0.24
0.22
0.40
0.94
0.20
0.59
0.55
0.53
0.34
0.41
0.74
0.36
0.54
0.57
0.26
0.78
0.65
0.53
0.45
0.35
0.52
0.56
1.15
0.37
0.51
0.55
0.32

0.81
0.73
0.58
0.72
0.48
0.57
0.27
0.56
1.18
0.51
0.83
0.68
0.73
0.43
0.42
0.77
0.43
0.46
0.60
0.49
0.58
0.38
0.47
1.09
0.99
0.48
1.06
0.66
0.54
0.70
0.90
0.48
0.50
0.79
0.55
0.61
0.52
0.57
0.57
0.77
0.58
0.67
0.59
0.31
0.60
0.71
0.36
0.38
0.28
0.72
0.49
0.55
0.67
0.77

0.02
0.07
0.08
0.02 *
0.03 *
0.02
0.01 *
0.02
0.02
0.02
0.04
0.02
0.05
0.05
0.06
0.07
0.04
0.04
0.05
0.06
0.06
0.06
0.05
0.04
0.03
0.03
0.05
0.03
0.03
0.05
0.13
0.03
0.09
0.07
0.07
0.04
0.05
0.10
0.04
0.06
0.07
0.03
0.07
0.06
0.07
0.05
0.04
0.05
0.06
0.12
0.04
0.05
0.07
0.04

*Important. See note on population page.

588

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Kidney (C64) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

1033
1619
82
1503
239
492
589
484
546
1665
934
1831
645
57
436
769
202
48
165
127
196
212
126
200
2563
127
71
69
149
131
77
170
4518
284
276
721
690
1126
2067
663
2233
3514
1527
1484
425
1667

13.7
15.6
6.5
8.7
9.7
12.1
9.8
4.9
5.4
12.1
5.4
12.0
9.8
4.8
9.6
11.3
4.5
5.4
7.6
4.6
5.2
9.4
6.2
5.9
6.8
8.3
8.3
11.0
7.7
11.3
7.6
7.3
7.9
7.8
8.0
6.5
7.4
7.1
8.1
6.8
7.8
6.9
7.8
7.4
7.6
8.7

0.43
0.40
0.76
0.24
0.64
0.57
0.42
0.23
0.25
0.31
0.19
0.29
0.40
0.69
0.54
0.43
0.33
1.02
0.65
0.44
0.39
0.69
0.61
0.49
0.15
0.76
1.06
1.42
0.65
1.08
0.89
0.60
0.12
0.47
0.50
0.26
0.30
0.22
0.19
0.28
0.18
0.12
0.21
0.20
0.39
0.23

1.68
1.95
0.73
1.02
1.20
1.49
1.23
0.59
0.64
1.46
0.63
1.48
1.14
0.54
1.11
1.35
0.54
0.55
0.91
0.55
0.64
1.16
0.71
0.66
0.84
0.99
1.03
1.28
0.97
1.35
0.90
0.87
0.97
0.94
0.99
0.75
0.87
0.83
0.97
0.80
0.91
0.81
0.94
0.87
0.91
1.03

0.06
0.05
0.10
0.03
0.09
0.08
0.06
0.03
0.03
0.04
0.02
0.04
0.05
0.09
0.06
0.06
0.04
0.10
0.08
0.05
0.05
0.09
0.08
0.05
0.02
0.11
0.15
0.18
0.10
0.13
0.12
0.08
0.02
0.07
0.07
0.03
0.04
0.03
0.03
0.04
0.02
0.02
0.03
0.03
0.05
0.03

845
1218
55
946
166
326
376
273
291
1602
590
1213
354
32
200
320
116
28
84
90
109
93
65
106
1843
56
42
27
87
62
38
116
2929
187
170
446
421
724
1374
384
1326
2052
939
854
292
1156

7.1
7.9
3.6
4.3
4.7
6.2
4.6
2.4
2.4
6.5
3.0
6.0
4.2
2.6
3.5
4.1
2.3
3.3
3.2
2.8
2.6
3.2
2.7
2.9
4.2
2.9
4.1
3.3
3.7
3.6
3.7
4.0
4.4
4.5
4.6
3.4
3.7
3.7
4.4
3.4
3.9
3.3
4.1
3.6
4.3
4.5

0.28
0.25
0.51
0.17
0.38
0.39
0.28
0.17
0.17
0.19
0.14
0.19
0.27
0.51
0.35
0.30
0.25
0.90
0.39
0.33
0.28
0.43
0.42
0.38
0.12
0.46
0.76
0.69
0.44
0.54
0.70
0.42
0.09
0.37
0.43
0.19
0.21
0.16
0.14
0.19
0.13
0.09
0.16
0.14
0.28
0.15

0.88
0.95
0.42
0.49
0.57
0.73
0.56
0.26
0.26
0.78
0.34
0.72
0.47
0.34
0.38
0.44
0.23
0.33
0.36
0.32
0.30
0.33
0.31
0.31
0.51
0.30
0.48
0.40
0.47
0.41
0.46
0.49
0.53
0.51
0.53
0.39
0.42
0.42
0.50
0.39
0.45
0.37
0.48
0.41
0.49
0.52

0.03
0.03
0.07
0.02
0.05 *
0.05
0.03
0.02 *
0.02
0.02
0.02
0.02
0.03
0.07
0.03
0.03
0.03
0.08
0.05
0.04
0.03
0.05
0.05
0.04
0.02
0.05
0.09
0.10
0.06
0.07
0.08
0.06
0.01
0.05
0.05
0.02
0.03
0.02
0.02
0.03
0.02
0.01
0.02
0.02
0.04
0.02

2165
29
1142
616
185
1610
561
85
26
1044
358
23
42
51
100
125

9.7
6.9
9.5
10.9
10.6
9.7
9.2
9.3
5.7
8.3
8.8
6.2
6.7
10.7
8.4
11.8

0.22
1.36
0.29
0.46
0.81
0.25
0.40
1.03
1.15
0.27
0.49
1.47
1.09
1.53
1.00
1.11

1.15
1.02
1.12
1.30
1.27
1.13
1.07
1.02
0.78
0.98
1.06
0.59
0.76
1.41
0.96
1.49

0.03
0.25
0.04
0.06
0.11
0.03
0.06
0.14
0.18
0.04
0.07
0.18
0.14
0.23
0.12
0.15

1247
12
669
300
124
996
309
66
9
614
180
13
27
21
54
49

4.9
3.0
5.0
4.7
6.5
5.5
4.9
6.4
2.1
4.5
3.8
2.3
3.6
3.9
3.5
4.4

0.15
0.90
0.21
0.30
0.64
0.19
0.30
0.85
0.72
0.20
0.30
0.77
0.72
0.87
0.56
0.71

0.56
0.30
0.55
0.54
0.78
0.60
0.55
0.72
0.29
0.51
0.46
0.21
0.51
0.47
0.44
0.51

0.02
0.13
0.03
0.04
0.08
0.02
0.04
0.12
0.12
0.03
0.04
0.10
0.11
0.12
0.07
0.09

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

531

589

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Renal pelvis (C65)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

532

Female
ASR(W)
CUM 0-74

0
17
4
0
0

0.5
0.4
-

0.12
0.20
-

0
5
1
2
0

0.1
0.1
0.1
-

0.05
0.09
0.04
-

1
1
0
3
30
1
4
10
4
2
6

0.1
0.0
0.2
0.2
0.1
0.1
0.1
0.2
0.2
0.7

0.13
0.03
0.14
0.03
0.08
0.06
0.04
0.08
0.13
0.30

0.02
0.00
0.04
0.02
0.02
0.02
0.02
0.03
0.07

0.02
0.00
0.02
0.00
0.01
0.01
0.01
0.02
0.04

0
2
0
1
24
0
1
2
1
1
2

0.0
0.1
0.1
0.0
0.0
0.0
0.1
0.2

0.03
0.05
0.02
0.02
0.02
0.04
0.08
0.12

0.00
0.01
0.00
0.00
0.01
0.01
0.02

0.00
0.00
0.00
0.00
0.01
0.01
0.01 *

392
54
79
47
28
2
0
16
146
3
17
86
10
75
8
74
605
30
23
91
458
92
7
4
0
1
9
65
174
13
3
1
3
1
35
115
90
70
2
66
4
2
2
526
18
503
115
15
98
34
6
28
16
260
11
246
181
63
84
100
17
83
3
17

0.5
0.6
0.5
1.1
1.0
0.1
0.4
0.3
0.7
0.4
0.5
0.4
0.6
0.5
0.4
0.6
0.3
0.4
0.6
0.6
0.4
0.6
0.2
0.4
0.4
0.5
0.6
0.5
0.2
0.1
0.6
0.2
0.6
0.8
0.7
0.5
0.3
0.5
0.2
0.2
0.3
0.7
0.3
0.7
0.5
0.4
0.5
0.5
0.4
0.6
0.3
0.6
0.3
0.7
0.9
0.5
0.6
0.7
0.5
0.8
0.3
0.9

0.02
0.08
0.06
0.17
0.20
0.06
0.12
0.03
0.41
0.11
0.06
0.12
0.07
0.17
0.05
0.02
0.05
0.09
0.06
0.03
0.05
0.23
0.12
0.40
0.14
0.06
0.05
0.15
0.12
0.13
0.37
0.19
0.11
0.08
0.08
0.07
0.22
0.07
0.10
0.12
0.23
0.03
0.08
0.04
0.05
0.09
0.06
0.09
0.18
0.11
0.09
0.04
0.09
0.05
0.07
0.07
0.07
0.07
0.12
0.09
0.16
0.22

0.05
0.06
0.05
0.15
0.12
0.00
0.05
0.04
0.11
0.06
0.06
0.04
0.06
0.07
0.04
0.07
0.03
0.06
0.06
0.08
0.05
0.11
0.02
0.05
0.04
0.05
0.08
0.06
0.01
0.03
0.08
0.02
0.08
0.10
0.09
0.07
0.04
0.07
0.03
0.02
0.05
0.08
0.04
0.09
0.06
0.03
0.07
0.07
0.05
0.08
0.04
0.08
0.03
0.09
0.12
0.06
0.07
0.08
0.04
0.09
0.02
0.11

0.00
0.01
0.01
0.03
0.03
0.00
0.02
0.00
0.06
0.02
0.01
0.02
0.01
0.03
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.05
0.02
0.05
0.02
0.01
0.01
0.02
0.01
0.03
0.05
0.02
0.02
0.01
0.01
0.01
0.03
0.01
0.02
0.02
0.05
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.03

285
43
55
18
12
3
0
17
122
0
15
68
6
61
4
76
461
28
18
58
355
86
5
7
2
0
10
60
155
10
7
2
2
2
33
98
42
57
2
55
10
7
3
359
13
343
95
12
82
26
3
22
19
212
8
198
177
60
76
61
9
52
3
11

0.2
0.3
0.2
0.3
0.3
0.1
0.4
0.2
0.3
0.3
0.1
0.3
0.3
0.3
0.3
0.2
0.2
0.3
0.4
0.3
0.2
0.3
0.1
0.3
0.3
0.4
0.3
0.6
0.2
0.3
0.7
0.4
0.4
0.3
0.4
0.2
0.4
0.3
0.3
0.2
0.3
0.2
0.4
0.3
0.2
0.3
0.3
0.1
0.4
0.4
0.4
0.1
0.4
0.6
0.3
0.4
0.3
0.2
0.3
0.2
0.3

0.02
0.06
0.04
0.08
0.09
0.07
0.11
0.02
0.09
0.04
0.05
0.04
0.17
0.04
0.02
0.04
0.05
0.04
0.02
0.03
0.09
0.12
0.09
0.11
0.05
0.03
0.09
0.23
0.11
0.26
0.53
0.07
0.05
0.05
0.05
0.14
0.06
0.10
0.14
0.11
0.02
0.05
0.02
0.03
0.05
0.04
0.06
0.08
0.08
0.10
0.03
0.05
0.03
0.05
0.05
0.05
0.04
0.07
0.04
0.13
0.11

0.03
0.04
0.02
0.03
0.04
0.02
0.05
0.03
0.04
0.02
0.01
0.03
0.05
0.04
0.04
0.02
0.02
0.03
0.04
0.03
0.01
0.03
0.02
0.03
0.04
0.04
0.03
0.08
0.01
0.03
0.06
0.04
0.05
0.04
0.05
0.03
0.05
0.04
0.05
0.04
0.02
0.04
0.04
0.02
0.04
0.04
0.01
0.05
0.06
0.04
0.01
0.05
0.08
0.05
0.04
0.02
0.03
0.02
0.03
0.05

0.00
0.01
0.00
0.01
0.02
0.01
0.02
0.00
0.01
0.00
0.00
0.01
0.03
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.01
0.02
0.02
0.02
0.01
0.01
0.01
0.04
0.01
0.03
0.04
0.01
0.01
0.01
0.01
0.03
0.01
0.02
0.02
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.02

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

590

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Renal pelvis (C65) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

43
136
223
15
205
81
9
71
109
5
103
31
4799
203
4487
172
7
163
24
0
8
15
395
19
362
177
9
162
57
81
383
11
367
29
478
27
407
1372
65
69
114
1119
69
7
60
296
15
279
24
11
157
85
51
116

0.9
0.6
0.7
0.4
0.7
0.6
0.3
0.6
0.6
0.4
0.6
0.8
0.6
0.3
0.6
0.6
0.2
0.6
0.4
0.4
0.4
0.6
0.3
0.6
0.4
0.3
0.4
0.5
0.6
0.8
0.4
0.8
0.7
0.5
0.4
0.5
0.6
0.4
0.4
0.5
0.6
0.5
0.3
0.6
0.5
0.3
0.5
0.4
0.5
0.8
0.6
0.7
0.6

0.14
0.05
0.05
0.11
0.05
0.07
0.12
0.08
0.06
0.18
0.06
0.15
0.01
0.02
0.01
0.05
0.09
0.05
0.08
0.14
0.10
0.03
0.07
0.03
0.03
0.09
0.04
0.06
0.07
0.04
0.11
0.04
0.13
0.03
0.09
0.03
0.02
0.05
0.05
0.05
0.02
0.06
0.10
0.07
0.03
0.08
0.03
0.09
0.15
0.06
0.07
0.10
0.06

0.12
0.07
0.08
0.04
0.08
0.07
0.04
0.07
0.07
0.06
0.07
0.10
0.07
0.04
0.08
0.07
0.04
0.07
0.05
0.05
0.05
0.07
0.04
0.08
0.05
0.03
0.06
0.06
0.07
0.09
0.05
0.09
0.09
0.06
0.06
0.06
0.07
0.05
0.05
0.06
0.07
0.06
0.03
0.07
0.06
0.04
0.06
0.05
0.05
0.09
0.08
0.08
0.07

0.02
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.03
0.01
0.02
0.00
0.00
0.00
0.01
0.02
0.01
0.01
0.03
0.02
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.02
0.00
0.01
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.02
0.01
0.00
0.01
0.00
0.01
0.02
0.01
0.01
0.01
0.01

29
150
166
14
149
84
13
70
83
2
81
11
3724
173
3463
171
9
161
9
0
4
4
307
23
278
171
7
161
45
67
280
9
267
25
383
25
336
1101
43
60
70
925
58
7
51
226
11
207
11
9
111
73
42
90

0.5
0.5
0.4
0.3
0.4
0.4
0.4
0.5
0.3
0.1
0.3
0.2
0.3
0.2
0.4
0.4
0.2
0.4
0.1
0.2
0.1
0.3
0.2
0.4
0.3
0.1
0.3
0.3
0.4
0.4
0.2
0.4
0.6
0.3
0.3
0.3
0.3
0.2
0.2
0.3
0.4
0.3
0.2
0.4
0.3
0.1
0.3
0.2
0.2
0.4
0.4
0.4
0.3

0.09
0.04
0.03
0.09
0.03
0.05
0.10
0.06
0.03
0.05
0.04
0.07
0.01
0.01
0.01
0.03
0.07
0.04
0.05
0.11
0.05
0.02
0.04
0.02
0.03
0.06
0.03
0.04
0.06
0.03
0.06
0.03
0.13
0.02
0.05
0.02
0.01
0.03
0.03
0.03
0.01
0.04
0.06
0.06
0.02
0.04
0.02
0.06
0.09
0.04
0.05
0.07
0.04

0.06
0.06
0.04
0.04
0.04
0.05
0.04
0.06
0.03
0.01
0.03
0.02
0.04
0.02
0.04
0.04
0.02
0.05
0.01
0.02
0.01
0.04
0.02
0.04
0.04
0.02
0.04
0.04
0.05
0.05
0.01
0.05
0.07
0.04
0.03
0.04
0.04
0.02
0.03
0.03
0.04
0.04
0.02
0.04
0.03
0.02
0.03
0.03
0.02
0.05
0.03
0.06
0.04

0.01
0.01
0.00
0.01
0.01
0.01
0.02
0.01
0.00
0.01
0.01
0.01
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.01
0.00
0.01
0.00
0.02
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01

0
24

0.5

0.10

0.06

0.01

0
12

0.2

0.05

0.01

0.01 *

3
0
103
6
6
2
8
0
0
0
1
1
110
94
13
46
32
66
124
99
323
50

0.2
0.4
0.2
0.3
0.0
0.0
0.0
0.0
0.7
0.6
0.9
1.1
0.8
1.5
1.1
1.2
0.8
0.8

0.12
0.04
0.08
0.12
0.01
0.01
0.01
0.04
0.07
0.07
0.26
0.17
0.16
0.18
0.10
0.13
0.05
0.12

0.02
0.05
0.02
0.04
0.00
0.01
0.00
0.01
0.08
0.07
0.10
0.13
0.09
0.16
0.14
0.15
0.10
0.09

0.02
0.01
0.01
0.02
0.00
0.00
0.00
0.01
0.01
0.01
0.03
0.02
0.02
0.03
0.02
0.02
0.01
0.02

1
0
67
3
1
1
3
0
2
0
1
1
52
50
1
19
18
30
49
43
125
25

0.1
0.2
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.2
0.2
0.1
0.4
0.2
0.5
0.3
0.3
0.2
0.3

0.10
0.03
0.05
0.03
0.01
0.01
0.01
0.01
0.04
0.03
0.04
0.07
0.10
0.06
0.10
0.05
0.05
0.02
0.07

0.01
0.03
0.01
0.01
0.00
0.00
0.00
0.00
0.03
0.03
0.02
0.05
0.02
0.06
0.04
0.03
0.03
0.03

0.01 *
0.00 *
0.01 *
0.01 *
0.00 *
0.00
- *
0.00 *
0.00 *
0.00
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.00
0.01

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

533

591

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Renal pelvis (C65) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

534

Female
ASR(W)
CUM 0-74

522
49
13
19
29
25
6
164
6
4
1
8
0
1
1
1
34
31
2
1
6
17
4
7
26

0.6
0.6
0.3
0.8
1.2
0.5
0.8
0.8
0.4
0.4
0.0
0.4
0.1
0.0
0.0
0.4
0.5
0.3
0.1
0.2
0.8
0.2
0.3
0.3

0.03
0.10
0.07
0.19
0.24
0.11
0.34
0.07
0.18
0.21
0.01
0.16
0.06
0.05
0.01
0.08
0.09
0.22
0.10
0.06
0.19
0.08
0.10
0.06

0.08
0.08
0.03
0.11
0.17
0.08
0.09
0.11
0.03
0.04
0.00
0.07
0.01
0.01
0.00
0.05
0.06
0.03
0.03
0.02
0.09
0.02
0.04
0.04

0.00
0.01
0.01
0.03
0.04
0.02
0.04
0.01
0.02
0.03
0.00
0.03
0.01
0.01
0.00
0.01
0.01
0.03
0.03
0.01
0.02
0.01
0.01
0.01

156
14
4
3
8
7
2
51
4
0
0
4
2
0
0
1
20
19
1
0
1
5
1
5
10

0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.2
0.2
0.2
0.1
0.0
0.2
0.2
0.2
0.0
0.2
0.0
0.2
0.1

0.01
0.04
0.03
0.06
0.09
0.04
0.11
0.03
0.12
0.11
0.04
0.01
0.04
0.05
0.21
0.03
0.09
0.03
0.08
0.04

0.02
0.02
0.01
0.01
0.03
0.01
0.02
0.03
0.04
0.04
0.01
0.00
0.01
0.02
0.00
0.02
0.01
0.02
0.02

0.00
0.01
0.00
0.01
0.01
0.00
0.02
0.00
0.02
0.02
0.01
- *
- *
0.00 *
0.01
0.01
0.00 *
0.01 *
0.01
0.01 *
0.01 *

172
14
5
44
73
202
84
31
312
254
22
126
23
17
10
20
37
29
6
14
24
10
5
74
130
65
54
79
102
41
11
25
7
16
29
27
31
2
59
19
0
51
31
7
8
53
7
15
12
7
47
31
19
53

0.5
0.5
0.4
0.1
1.0
0.9
0.3
0.2
0.9
1.2
0.5
0.6
0.7
0.7
0.5
0.7
0.9
0.7
0.1
0.7
1.2
0.6
0.1
0.7
0.6
0.9
0.8
0.8
1.0
0.8
0.9
0.2
0.6
0.7
1.5
0.4
1.0
0.2
1.1
0.6
0.5
1.5
0.6
0.3
1.0
0.2
0.8
1.0
0.8
1.0
0.6
0.8
0.7

0.04
0.15
0.19
0.02
0.13
0.07
0.03
0.04
0.05
0.08
0.11
0.06
0.14
0.19
0.16
0.17
0.16
0.13
0.06
0.20
0.25
0.19
0.06
0.08
0.06
0.11
0.11
0.09
0.10
0.13
0.29
0.04
0.23
0.17
0.29
0.09
0.18
0.16
0.15
0.15
0.07
0.28
0.25
0.12
0.14
0.08
0.21
0.31
0.29
0.14
0.11
0.19
0.10

0.07
0.06
0.06
0.02
0.11
0.12
0.03
0.03
0.11
0.15
0.06
0.08
0.08
0.10
0.05
0.10
0.12
0.08
0.02
0.08
0.15
0.08
0.01
0.08
0.08
0.12
0.08
0.09
0.12
0.11
0.04
0.03
0.08
0.10
0.20
0.05
0.13
0.04
0.15
0.08
0.06
0.21
0.07
0.04
0.13
0.02
0.12
0.12
0.08
0.12
0.07
0.09
0.10

0.01
0.02
0.03
0.00
0.02
0.01
0.00
0.00
0.01
0.01
0.01
0.01
0.02
0.03
0.02
0.03
0.02
0.02
0.01
0.03
0.04
0.03
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.02
0.03
0.01
0.04
0.03
0.04
0.01
0.03
0.03
0.02
0.02
0.01
0.04
0.03
0.02
0.02
0.01
0.03
0.04
0.05
0.02
0.02
0.03
0.02

134
9
4
16
36
96
40
28
286
215
9
84
19
5
6
10
18
9
7
4
9
8
0
74
104
59
63
60
72
26
10
10
7
8
16
19
22
0
26
5
0
25
7
3
8
26
5
6
3
3
30
14
5
33

0.3
0.2
0.2
0.0
0.3
0.3
0.1
0.1
0.6
0.8
0.1
0.3
0.4
0.1
0.2
0.3
0.2
0.1
0.1
0.2
0.2
0.5
0.5
0.3
0.5
0.7
0.5
0.5
0.4
0.7
0.1
0.2
0.2
0.6
0.2
0.3
0.3
0.1
0.2
0.2
0.2
0.3
0.3
0.1
0.2
0.1
0.4
0.4
0.4
0.2
0.4

0.03
0.08
0.10
0.01
0.06
0.04
0.02
0.03
0.04
0.06
0.04
0.04
0.09
0.07
0.08
0.10
0.06
0.05
0.05
0.10
0.08
0.19
0.06
0.04
0.08
0.09
0.07
0.06
0.09
0.25
0.02
0.10
0.09
0.16
0.06
0.09
0.07
0.07
0.04
0.11
0.12
0.11
0.07
0.06
0.10
0.07
0.24
0.08
0.12
0.09
0.07

0.03
0.02
0.01
0.00
0.05
0.05
0.01
0.02
0.07
0.10
0.02
0.03
0.04
0.02
0.01
0.04
0.03
0.02
0.01
0.02
0.01
0.07
0.06
0.05
0.07
0.09
0.06
0.05
0.04
0.12
0.01
0.02
0.04
0.07
0.03
0.03
0.04
0.02
0.02
0.03
0.03
0.04
0.04
0.01
0.03
0.01
0.04
0.06
0.04
0.03
0.05

0.00
0.01
0.01
0.00 *
0.01 *
0.01
0.00 *
0.00
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.03
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.05
0.00
0.02
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.02
0.01
0.01
0.02
0.01
0.03
0.01
0.01
0.01
0.01

*Important. See note on population page.

592

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Renal pelvis (C65) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

19
31
3
84
33
20
25
23
35
42
80
100
35
5
39
73
45
3
23
41
40
33
22
18
275
14
12
2
14
8
10
18
492
31
30
74
37
100
216
61
116
124
89
128
26
82

0.2
0.3
0.2
0.4
1.4
0.5
0.4
0.2
0.3
0.3
0.4
0.6
0.5
0.4
0.7
1.0
0.9
0.3
1.1
1.3
1.0
1.2
1.0
0.5
0.7
0.7
1.4
0.4
0.7
0.5
0.9
0.7
0.8
0.8
0.8
0.6
0.4
0.6
0.8
0.6
0.4
0.2
0.5
0.6
0.5
0.4

0.06
0.05
0.12
0.05
0.25
0.11
0.08
0.04
0.05
0.05
0.05
0.06
0.09
0.22
0.12
0.12
0.14
0.17
0.24
0.22
0.16
0.22
0.24
0.12
0.04
0.20
0.43
0.28
0.19
0.20
0.29
0.17
0.04
0.15
0.15
0.07
0.06
0.06
0.06
0.08
0.04
0.02
0.05
0.05
0.09
0.05

0.03
0.04
0.03
0.05
0.18
0.06
0.06
0.03
0.04
0.04
0.05
0.08
0.06
0.06
0.08
0.13
0.13
0.03
0.13
0.17
0.13
0.18
0.12
0.07
0.09
0.07
0.20
0.06
0.08
0.05
0.09
0.07
0.10
0.12
0.09
0.07
0.04
0.07
0.10
0.08
0.05
0.03
0.06
0.08
0.05
0.05

0.01
0.01
0.02
0.01
0.03
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.03
0.02
0.02
0.02
0.02
0.03
0.03
0.02
0.04
0.03
0.02
0.01
0.03
0.07
0.04
0.03
0.03
0.04
0.02
0.01
0.03
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01

6
25
1
67
28
8
24
8
20
22
73
113
35
3
19
24
15
5
9
12
13
7
6
8
214
2
5
5
13
2
3
16
322
20
27
41
31
81
135
46
84
95
61
74
7
68

0.1
0.1
0.1
0.3
0.8
0.2
0.3
0.1
0.1
0.1
0.3
0.5
0.3
0.2
0.3
0.2
0.2
0.3
0.3
0.2
0.2
0.2
0.2
0.1
0.4
0.1
0.3
0.6
0.5
0.1
0.1
0.4
0.4
0.5
0.5
0.2
0.2
0.4
0.4
0.3
0.2
0.1
0.2
0.3
0.1
0.2

0.02
0.03
0.05
0.04
0.16
0.06
0.06
0.02
0.03
0.02
0.05
0.05
0.06
0.12
0.07
0.06
0.06
0.15
0.12
0.07
0.07
0.08
0.10
0.05
0.03
0.05
0.15
0.30
0.15
0.07
0.08
0.13
0.03
0.11
0.11
0.04
0.05
0.05
0.04
0.06
0.03
0.02
0.03
0.03
0.04
0.03

0.01
0.02
0.01
0.03
0.10
0.02
0.03
0.01
0.01
0.01
0.03
0.06
0.04
0.01
0.03
0.03
0.04
0.03
0.03
0.03
0.03
0.02
0.03
0.01
0.05
0.01
0.02
0.10
0.06
0.01
0.02
0.06
0.05
0.06
0.05
0.03
0.03
0.04
0.05
0.04
0.03
0.02
0.03
0.03
0.01
0.03

0.00
0.00
0.01
0.01
0.02 *
0.01
0.01
0.00 *
0.00
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.02
0.01
0.00
0.01
0.02
0.05
0.02
0.01
0.02
0.02
0.00
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.00
0.00
0.00
0.00
0.01
0.00

214
3
100
40
16
110
28
5
1
57
29
2
1
2
16
7

0.9
0.8
0.8
0.6
0.9
0.6
0.4
0.5
0.2
0.4
0.6
0.5
0.1
0.5
1.2
0.4

0.06
0.50
0.08
0.10
0.23
0.06
0.09
0.25
0.20
0.06
0.12
0.38
0.14
0.36
0.35
0.18

0.10
0.05
0.11
0.07
0.11
0.08
0.05
0.07
0.02
0.05
0.08
0.06
0.03
0.06
0.18
0.04

0.01
0.04
0.01
0.01
0.03
0.01
0.01
0.04
0.02
0.01
0.02
0.06
0.03
0.06
0.05
0.03

296
4
144
36
6
89
39
6
1
41
12
0
1
0
7
3

0.9
1.2
0.9
0.5
0.2
0.4
0.6
0.6
0.3
0.2
0.2
0.1
0.3
0.2

0.06
0.64
0.08
0.08
0.09
0.05
0.10
0.24
0.27
0.04
0.06
0.08
0.12
0.14

0.12
0.11
0.12
0.06
0.01
0.05
0.08
0.07
0.03
0.02
0.04
0.02

0.01
0.08
0.01
0.01
0.01
0.01
0.02
0.04
0.01
0.01
0.02
0.02

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

535

593

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Ureter (C66)
Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

536

Female
ASR(W)
CUM 0-74

0
11
3
2
0

0.3
0.3
0.3
-

0.08
0.19
0.24
-

0
3
1
0
0

0.1
0.1
-

0.04
0.12
-

1
2
0
1
30
2
1
1
0
4
0

0.1
0.1
0.1
0.1
0.2
0.0
0.0
0.3
-

0.10
0.09
0.09
0.03
0.15
0.04
0.01
0.15
-

0.03
0.03
0.02
0.02
0.03
0.00
0.00
0.02
-

0.03
0.02
0.02
0.00
0.03
0.00
0.00
0.02
-

0
5
0
1
10
0
1
3
0
0
1

0.2
0.1
0.0
0.0
0.0
0.1

0.10
0.07
0.01
0.02
0.02
0.10

0.03
0.01
0.00
0.01
0.01

0.02
0.01
0.00
0.00
0.01 *

331
27
80
26
7
10
0
30
134
1
16
74
4
69
4
92
327
32
6
29
257
65
2
4
0
0
2
51
70
2
5
1
2
0
11
49
69
48
2
46
4
4
0
382
5
375
92
9
82
15
4
11
19
198
9
186
87
38
65
84
8
76
3
14

0.4
0.3
0.5
0.6
0.2
0.5
0.8
0.3
0.2
0.4
0.5
0.1
0.6
0.3
0.5
0.3
0.3
0.1
0.2
0.3
0.3
0.2
0.2
0.1
0.4
0.2
0.1
0.3
0.1
0.2
0.2
0.3
0.5
0.4
0.4
0.4
0.2
0.4
0.5
0.1
0.5
0.4
0.2
0.4
0.2
0.3
0.2
0.4
0.5
0.2
0.5
0.4
0.3
0.4
0.6
0.3
0.7
0.3
0.5

0.02
0.05
0.06
0.13
0.08
0.18
0.16
0.03
0.24
0.12
0.06
0.07
0.07
0.17
0.05
0.02
0.05
0.05
0.04
0.02
0.04
0.12
0.12
0.08
0.05
0.03
0.07
0.15
0.10
0.16
0.06
0.05
0.06
0.06
0.25
0.06
0.13
0.20
0.03
0.04
0.03
0.04
0.07
0.05
0.06
0.14
0.07
0.10
0.03
0.07
0.04
0.05
0.06
0.06
0.07
0.10
0.08
0.21
0.14

0.04
0.02
0.05
0.08
0.01
0.06
0.11
0.04
0.04
0.04
0.06
0.02
0.07
0.08
0.06
0.03
0.03
0.01
0.02
0.04
0.03
0.01
0.02
0.02
0.04
0.03
0.01
0.04
0.04
0.01
0.04
0.06
0.05
0.05
0.05
0.03
0.04
0.05
0.01
0.06
0.04
0.02
0.05
0.02
0.03
0.02
0.06
0.06
0.02
0.06
0.05
0.05
0.05
0.08
0.04
0.09
0.04
0.05

0.00
0.01
0.01
0.02
0.01
0.03
0.03
0.00
0.04
0.01
0.01
0.01
0.01
0.04
0.01
0.00
0.01
0.01
0.00
0.00
0.01
0.01
0.02
0.01
0.01
0.00
0.01
0.03
0.04
0.01
0.01
0.01
0.01
0.04
0.01
0.02
0.03
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.02
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.03
0.02

199
22
39
8
8
3
0
15
91
2
11
39
2
36
2
62
240
20
12
21
185
44
3
3
0
3
2
32
52
4
4
1
2
2
7
32
40
46
2
43
2
1
1
237
7
229
68
7
60
19
3
16
8
134
5
127
69
30
60
41
5
36
0
9

0.2
0.2
0.2
0.2
0.2
0.1
0.3
0.2
0.2
0.2
0.2
0.1
0.2
0.1
0.2
0.2
0.1
0.1
0.1
0.2
0.1
0.2
0.1
0.7
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.3
0.1
0.1
0.3
0.3
0.2
0.3
0.0
0.0
0.0
0.2
0.1
0.2
0.2
0.1
0.2
0.2
0.1
0.2
0.1
0.2
0.1
0.2
0.2
0.2
0.3
0.2
0.1
0.2
0.3

0.01
0.04
0.03
0.07
0.09
0.06
0.09
0.02
0.11
0.07
0.03
0.05
0.04
0.10
0.03
0.01
0.03
0.05
0.02
0.01
0.02
0.11
0.07
0.43
0.04
0.03
0.02
0.05
0.12
0.09
0.17
0.20
0.03
0.03
0.04
0.04
0.15
0.05
0.03
0.03
0.04
0.02
0.03
0.02
0.02
0.04
0.03
0.05
0.08
0.06
0.04
0.02
0.04
0.02
0.03
0.04
0.04
0.03
0.05
0.04
0.11

0.02
0.02
0.02
0.02
0.03
0.01
0.06
0.02
0.03
0.03
0.01
0.03
0.03
0.03
0.02
0.01
0.02
0.01
0.02
0.01
0.03
0.01
0.05
0.01
0.01
0.01
0.04
0.02
0.03
0.03
0.01
0.02
0.03
0.03
0.02
0.03
0.03
0.01
0.03
0.02
0.02
0.02
0.02
0.02
0.02
0.00
0.02
0.01
0.03
0.03
0.02
0.04
0.02
0.02
0.03
0.03

0.00
0.01
0.01
0.01
0.01
0.01
0.02
0.00
0.01
0.01
0.01
0.01
0.02
0.01
0.00
0.00
0.01
0.00
0.00
0.00
0.02
0.01
0.05
0.00
0.00
0.01
0.03
0.02
0.03
0.03
0.00
0.00
0.01
0.01
0.02
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.02
0.01
0.00
0.00
0.01
0.00
0.00
0.01
0.01
0.01
0.01
0.01
0.02

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

594

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Ureter (C66) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

23
94
174
8
164
44
7
37
95
0
92
18
3617
98
3425
142
3
136
19
1
4
12
306
6
292
180
3
176
61
54
290
7
279
18
285
17
246
856
49
33
39
730
61
4
55
268
12
250
14
6
96
41
47
91

0.4
0.4
0.5
0.2
0.5
0.3
0.3
0.4
0.5
0.5
0.5
0.5
0.2
0.5
0.5
0.1
0.5
0.3
0.3
0.2
0.3
0.4
0.1
0.5
0.4
0.1
0.5
0.5
0.4
0.6
0.2
0.6
0.5
0.3
0.3
0.3
0.3
0.3
0.2
0.2
0.4
0.4
0.1
0.5
0.4
0.2
0.4
0.2
0.3
0.5
0.3
0.7
0.4

0.10
0.04
0.04
0.08
0.04
0.05
0.11
0.06
0.05
0.05
0.12
0.01
0.02
0.01
0.04
0.07
0.05
0.07
0.26
0.11
0.09
0.03
0.04
0.03
0.04
0.06
0.04
0.07
0.05
0.04
0.09
0.04
0.12
0.02
0.07
0.02
0.01
0.04
0.03
0.03
0.02
0.06
0.06
0.07
0.03
0.07
0.03
0.05
0.11
0.05
0.06
0.10
0.05

0.06
0.05
0.06
0.02
0.06
0.04
0.02
0.05
0.05
0.06
0.06
0.05
0.02
0.06
0.06
0.02
0.06
0.04
0.03
0.05
0.04
0.05
0.01
0.06
0.05
0.01
0.06
0.06
0.04
0.07
0.03
0.07
0.06
0.04
0.03
0.04
0.04
0.03
0.02
0.02
0.05
0.05
0.01
0.06
0.05
0.03
0.06
0.02
0.02
0.06
0.05
0.08
0.05

0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.00
0.00
0.00
0.01
0.01
0.01
0.01
0.03
0.03
0.01
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.02
0.01

18
91
111
4
106
36
2
34
73
2
71
12
2410
83
2267
89
2
84
19
0
4
15
201
7
188
127
5
122
38
43
213
6
205
15
228
10
193
630
41
27
33
525
34
3
31
157
5
146
6
3
48
28
25
55

0.3
0.2
0.2
0.1
0.2
0.2
0.1
0.2
0.3
0.1
0.3
0.2
0.2
0.1
0.2
0.2
0.0
0.2
0.2
0.1
0.3
0.2
0.1
0.2
0.2
0.1
0.2
0.2
0.3
0.3
0.1
0.3
0.2
0.2
0.1
0.2
0.2
0.2
0.1
0.1
0.2
0.2
0.1
0.2
0.2
0.1
0.2
0.1
0.1
0.2
0.1
0.2
0.2

0.07
0.03
0.02
0.05
0.03
0.03
0.05
0.04
0.03
0.08
0.04
0.06
0.00
0.01
0.01
0.03
0.04
0.03
0.06
0.07
0.10
0.02
0.02
0.02
0.02
0.05
0.02
0.04
0.05
0.02
0.05
0.02
0.06
0.01
0.04
0.01
0.01
0.03
0.02
0.02
0.01
0.03
0.03
0.04
0.02
0.03
0.02
0.04
0.06
0.03
0.03
0.05
0.03

0.05
0.03
0.03
0.01
0.03
0.03
0.01
0.03
0.04
0.02
0.04
0.01
0.03
0.01
0.03
0.02
0.00
0.03
0.03
0.01
0.05
0.03
0.01
0.03
0.03
0.01
0.03
0.03
0.03
0.03
0.02
0.03
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.01
0.02
0.03
0.00
0.04
0.02
0.01
0.02
0.01
0.01
0.02
0.02
0.03
0.02

0.01
0.00
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.02
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.01
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.01
0.01
0.01
0.01
0.00

0
6

0.1

0.04

0.01

0.01

0
11

0.2

0.05

0.02

0.01 *

0
1
63
3
1
2
5
0
8
1
1
1
72
67
3
26
45
55
102
75
281
55

0.0
0.3
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.4
0.4
0.3
0.7
1.0
1.3
0.9
0.8
0.7
0.8

0.04
0.04
0.07
0.05
0.02
0.01
0.01
0.03
0.01
0.04
0.05
0.06
0.15
0.13
0.15
0.17
0.09
0.10
0.04
0.11

0.01
0.04
0.02
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.06
0.06
0.04
0.09
0.12
0.17
0.12
0.09
0.08
0.09

0.01
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.03
0.02
0.02
0.03
0.01
0.02
0.01
0.02

1
0
76
0
1
4
3
0
4
0
1
0
33
33
0
15
21
34
58
51
161
42

0.1
0.3
0.0
0.0
0.0
0.0
0.0
0.2
0.2
0.3
0.3
0.5
0.4
0.4
0.3
0.4

0.07
0.03
0.03
0.02
0.01
0.01
0.02
0.03
0.03
0.08
0.07
0.10
0.05
0.06
0.02
0.07

0.01
0.03
0.01
0.00
0.00
0.00
0.00
0.02
0.02
0.03
0.04
0.05
0.04
0.04
0.03
0.04

0.01 *
0.00 *
- *
0.01 *
0.00
0.00 *
0.00
- *
0.00 *
- *
0.00
0.00
0.01
0.01
0.01
0.01
0.01
0.00
0.01

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

537

595

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Ureter (C66) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

538

Female
ASR(W)
CUM 0-74

438
44
30
24
13
24
1
112
6
0
0
2
4
1
1
3
24
23
0
1
3
0
2
0
9

0.5
0.5
0.6
1.0
0.6
0.5
0.1
0.6
0.4
0.1
0.1
0.1
0.0
0.1
0.3
0.4
0.1
0.1
0.1
0.1

0.03
0.09
0.11
0.20
0.16
0.11
0.14
0.06
0.19
0.07
0.06
0.07
0.04
0.03
0.06
0.08
0.06
0.04
0.06
0.05

0.07
0.07
0.10
0.12
0.07
0.07
0.02
0.08
0.06
0.00
0.01
0.01
0.01
0.01
0.03
0.04
0.00
0.01
0.01
0.02

0.00
0.01
0.02
0.03
0.03
0.02
0.02
0.01
0.03
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01

235
26
9
3
5
10
3
58
4
0
0
0
4
1
0
4
20
17
0
3
0
0
1
3
5

0.2
0.2
0.1
0.1
0.1
0.2
0.3
0.2
0.3
0.1
0.0
0.0
0.2
0.2
0.4
0.0
0.1
0.1

0.01
0.05
0.04
0.06
0.07
0.05
0.16
0.03
0.14
0.06
0.05
0.02
0.05
0.05
0.22
0.03
0.07
0.03

0.03
0.03
0.01
0.01
0.02
0.03
0.03
0.03
0.06
0.02
0.00
0.00
0.01
0.01
0.02
0.02
0.01

0.00
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.03
0.01
0.00 *
- *
0.00 *
0.00
0.01
0.02
- *
- *
0.01 *
0.00 *

128
5
3
27
47
121
26
36
89
130
12
44
16
10
6
7
34
15
12
9
11
13
8
43
71
33
35
43
53
24
2
35
15
26
20
44
22
3
45
17
6
63
8
3
9
34
15
11
9
3
31
30
16
51

0.4
0.2
0.3
0.1
0.6
0.6
0.1
0.2
0.2
0.6
0.3
0.2
0.4
0.4
0.3
0.3
0.8
0.4
0.3
0.3
0.5
0.6
0.4
0.4
0.3
0.4
0.5
0.4
0.5
0.4
0.2
0.3
1.3
1.0
0.9
0.6
0.7
0.3
0.8
0.6
0.4
0.7
0.3
0.2
0.4
0.6
0.4
0.6
0.6
0.3
0.6
0.8
0.8
0.7

0.04
0.09
0.16
0.02
0.10
0.05
0.02
0.03
0.03
0.05
0.08
0.03
0.11
0.14
0.13
0.10
0.14
0.10
0.09
0.10
0.14
0.17
0.14
0.07
0.04
0.07
0.09
0.07
0.07
0.09
0.14
0.05
0.36
0.20
0.21
0.10
0.15
0.18
0.12
0.14
0.15
0.09
0.13
0.09
0.14
0.12
0.12
0.17
0.21
0.20
0.11
0.15
0.20
0.10

0.05
0.02
0.02
0.01
0.06
0.07
0.01
0.03
0.03
0.08
0.04
0.03
0.05
0.06
0.04
0.02
0.09
0.05
0.04
0.03
0.06
0.09
0.05
0.05
0.04
0.05
0.06
0.05
0.05
0.04
0.02
0.04
0.17
0.13
0.13
0.08
0.08
0.02
0.08
0.08
0.02
0.09
0.04
0.02
0.04
0.07
0.04
0.07
0.08
0.02
0.08
0.10
0.08
0.09

0.01
0.01
0.01
0.00
0.01
0.01
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.02
0.01
0.01
0.01
0.02
0.03
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.06
0.03
0.04
0.02
0.02
0.02
0.02
0.02
0.01
0.01
0.02
0.02
0.02
0.02
0.01
0.03
0.03
0.02
0.02
0.02
0.03
0.02

90
6
5
24
27
65
17
47
89
67
10
42
14
11
2
2
14
7
7
2
7
6
4
23
52
19
22
33
27
17
5
15
1
15
6
15
10
0
16
2
2
22
2
0
4
20
8
3
0
3
14
7
4
18

0.2
0.2
0.2
0.0
0.3
0.2
0.0
0.2
0.2
0.2
0.1
0.1
0.2
0.3
0.1
0.1
0.3
0.1
0.1
0.0
0.2
0.2
0.1
0.1
0.1
0.1
0.2
0.2
0.2
0.2
0.6
0.1
0.2
0.4
0.3
0.1
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.1
0.2
0.2
0.1
0.1
0.2

0.02
0.09
0.10
0.01
0.06
0.03
0.01
0.03
0.02
0.03
0.04
0.02
0.07
0.09
0.07
0.05
0.08
0.05
0.06
0.03
0.09
0.12
0.06
0.03
0.02
0.04
0.04
0.04
0.03
0.06
0.28
0.03
0.15
0.12
0.13
0.04
0.08
0.05
0.05
0.09
0.03
0.10
0.07
0.06
0.07
0.07
0.12
0.05
0.06
0.07
0.04

0.02
0.03
0.03
0.01
0.04
0.03
0.01
0.02
0.02
0.03
0.02
0.01
0.02
0.03
0.01
0.00
0.03
0.02
0.02
0.01
0.02
0.02
0.01
0.02
0.02
0.02
0.02
0.04
0.02
0.02
0.10
0.01
0.01
0.04
0.03
0.02
0.03
0.01
0.00
0.01
0.02
0.01
0.02
0.03
0.02
0.01
0.02
0.02
0.01
0.01
0.02

0.00
0.01
0.02
0.00 *
0.01 *
0.00
0.00 *
0.00
0.00
0.01
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.00
0.01
0.01
0.01
0.01
0.01
0.04
0.00
0.02
0.01
0.02
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01

*Important. See note on population page.

596

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Ureter (C66) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

16
21
1
38
0
3
10
14
21
8
64
35
14
8
34
25
8
6
11
23
25
17
11
15
102
6
7
3
8
6
4
4
313
13
17
46
37
67
140
28
100
127
78
77
30
80

0.2
0.2
0.1
0.2
0.1
0.2
0.1
0.2
0.1
0.3
0.2
0.2
0.5
0.6
0.3
0.2
0.6
0.4
0.6
0.6
0.7
0.5
0.4
0.2
0.3
0.8
0.4
0.4
0.4
0.3
0.2
0.5
0.3
0.4
0.3
0.3
0.4
0.5
0.3
0.3
0.2
0.4
0.3
0.5
0.4

0.05
0.04
0.09
0.03
0.04
0.05
0.04
0.04
0.02
0.04
0.04
0.05
0.19
0.11
0.07
0.06
0.26
0.13
0.14
0.12
0.18
0.16
0.11
0.03
0.13
0.31
0.26
0.16
0.16
0.17
0.09
0.03
0.10
0.11
0.05
0.06
0.05
0.04
0.06
0.03
0.02
0.04
0.04
0.10
0.04

0.02
0.03
0.01
0.02
0.01
0.02
0.02
0.03
0.01
0.05
0.03
0.02
0.06
0.09
0.04
0.02
0.08
0.06
0.09
0.07
0.10
0.07
0.05
0.03
0.02
0.12
0.06
0.09
0.04
0.04
0.03
0.06
0.05
0.06
0.04
0.04
0.05
0.06
0.04
0.04
0.03
0.05
0.04
0.08
0.05

0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.03
0.02
0.01
0.01
0.04
0.02
0.02
0.02
0.03
0.03
0.01
0.00
0.02
0.05
0.04
0.03
0.03
0.03
0.02
0.00
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.02
0.01

6
11
0
47
1
1
8
4
16
13
49
28
12
0
7
8
4
1
9
1
6
10
2
3
99
3
3
0
5
6
2
8
160
8
11
25
27
37
79
11
74
80
42
32
20
49

0.0
0.1
0.2
0.0
0.0
0.1
0.0
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.0
0.0
0.2
0.0
0.1
0.2
0.0
0.1
0.2
0.1
0.2
0.2
0.3
0.1
0.2
0.2
0.2
0.3
0.1
0.2
0.1
0.2
0.1
0.2
0.1
0.2
0.1
0.2
0.2

0.02
0.02
0.03
0.03
0.02
0.03
0.02
0.02
0.02
0.03
0.02
0.03
0.05
0.03
0.02
0.03
0.09
0.02
0.05
0.09
0.02
0.04
0.02
0.07
0.16
0.09
0.16
0.06
0.07
0.02
0.06
0.09
0.03
0.04
0.02
0.03
0.03
0.02
0.01
0.03
0.02
0.06
0.03

0.01
0.01
0.02
0.00
0.00
0.01
0.00
0.01
0.01
0.03
0.02
0.01
0.01
0.01
0.00
0.04
0.01
0.01
0.02
0.00
0.02
0.02
0.02
0.03
0.03
0.02
0.02
0.02
0.03
0.01
0.02
0.02
0.03
0.01
0.03
0.01
0.02
0.01
0.03
0.02

0.00
0.00
0.00
0.00 *
0.00
0.00
0.00 *
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.02
0.01
0.01
0.01
0.00
0.00
0.02
0.02
0.02
0.02
0.01
0.00
0.01
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00

106
0
75
25
7
66
20
1
0
40
19
2
0
0
11
6

0.4
0.6
0.4
0.4
0.3
0.3
0.2
0.3
0.4
0.3
1.0
0.4

0.04
0.07
0.07
0.15
0.04
0.07
0.15
0.05
0.10
0.25
0.35
0.19

0.05
0.08
0.04
0.05
0.04
0.04
0.03
0.04
0.05
0.06
0.12
0.06

0.01
0.01
0.01
0.02
0.01
0.01
0.02
0.01
0.02
0.06
0.05
0.04

100
0
59
15
4
27
12
3
0
28
14
2
3
1
7
0

0.3
0.4
0.2
0.1
0.1
0.2
0.2
0.2
0.2
0.3
0.3
0.2
0.3
-

0.04
0.05
0.06
0.07
0.02
0.05
0.10
0.04
0.06
0.21
0.19
0.17
0.11
-

0.04
0.05
0.02
0.02
0.01
0.03
0.02
0.04
0.05
0.06
0.04
0.04
-

0.01
0.01
0.01
0.02
0.00
0.01
0.01
0.01
0.05
0.04
0.04
0.02
-

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

539

597

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Bladder (C67)
Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

Female
ASR(W)
CUM 0-74

81
1080
175
29
95

4.5
27.9
19.0
3.0
6.6

0.51
0.89
1.45
0.66
0.78

11
262
22
17
63

0.5
5.4
2.2
1.8
4.1

0.16
0.34
0.48
0.48
0.61

136
238
41
168
3309
35
293
423
141
88
33

15.1
12.8
7.0
12.8
16.8
3.8
8.8
5.8
5.2
7.1
3.8

1.37
0.87
1.13
1.01
0.30
0.66
0.54
0.29
0.46
0.79
0.68

1.89
1.48
0.91
1.44
1.97
0.44
1.04
0.68
0.63
0.79
0.51

0.20
0.13
0.19
0.15
0.05
0.10
0.08
0.04
0.07
0.11
0.12

31
104
16
59
1299
17
109
138
53
33
16

2.6
4.2
2.5
3.3
4.5
1.7
2.4
1.7
1.7
1.6
1.3

0.53
0.44
0.63
0.44
0.13
0.41
0.24
0.15
0.24
0.31
0.35

0.27
0.49
0.25
0.35
0.49
0.24
0.26
0.20
0.22
0.12
0.12

0.06
0.07
0.09
0.06
0.02
0.07
0.04
0.02
0.04
0.04
0.05 *

15145
1812
3282
734
647
378
9
911
6445
96
831
2720
221
2462
307
4103
20643
969
659
1534
17188
3784
145
129
68
37
227
3022
4768
301
122
57
88
44
538
3524
2662
3457
73
3329
273
147
110
18528
495
17800
4275
466
3773
1147
153
971
1008
9640
477
8908
4492
2611
3158
2849
365
2463
131
536

17.5
19.4
20.2
16.5
22.8
18.7
10.3
25.2
14.8
17.8
19.6
17.2
7.5
19.2
21.6
20.7
19.0
8.0
11.4
10.1
23.3
17.4
10.8
6.8
6.9
9.3
10.8
21.9
17.1
11.5
9.3
6.3
11.3
8.4
9.3
23.9
20.7
26.4
10.3
27.3
14.6
12.4
17.4
23.6
9.3
24.9
18.8
10.9
20.9
17.6
10.2
20.3
22.3
22.8
10.9
24.3
21.5
22.0
22.7
19.6
10.9
22.3
13.8
23.7

0.15
0.47
0.37
0.65
0.93
1.00
3.60
0.87
0.19
1.91
0.74
0.34
0.52
0.40
1.28
0.35
0.14
0.27
0.45
0.26
0.19
0.30
0.92
0.63
0.88
1.74
0.74
0.43
0.26
0.67
0.89
0.87
1.35
1.28
0.41
0.44
0.42
0.48
1.24
0.51
0.92
1.07
1.75
0.19
0.42
0.21
0.29
0.52
0.35
0.53
0.85
0.67
0.74
0.24
0.51
0.27
0.33
0.46
0.42
0.38
0.59
0.47
1.23
1.09

2.04
2.31
2.35
1.97
2.75
2.20
1.09
2.94
1.73
1.95
2.24
2.07
0.83
2.31
2.43
2.40
2.20
0.87
1.33
1.12
2.75
2.02
1.24
0.75
0.65
1.15
1.16
2.61
1.98
1.33
0.92
0.59
1.25
0.98
1.04
2.85
2.44
3.10
1.09
3.22
1.72
1.48
1.97
2.80
1.04
2.96
2.24
1.31
2.48
2.06
1.19
2.37
2.60
2.70
1.24
2.89
2.56
2.64
2.74
2.26
1.24
2.59
1.68
2.78

0.02
0.07
0.06
0.10
0.14
0.15
0.53
0.13
0.03
0.27
0.11
0.05
0.08
0.06
0.19
0.05
0.02
0.04
0.07
0.04
0.03
0.05
0.14
0.09
0.12
0.28
0.11
0.07
0.04
0.10
0.13
0.13
0.21
0.19
0.06
0.07
0.06
0.07
0.17
0.08
0.14
0.16
0.27
0.03
0.06
0.03
0.04
0.08
0.05
0.08
0.13
0.10
0.11
0.04
0.07
0.04
0.05
0.07
0.06
0.06
0.09
0.07
0.19
0.16

5241
599
1169
238
209
114
2
300
2279
30
301
933
134
789
72
1269
6751
292
312
562
5496
1390
72
48
17
17
100
1099
1601
154
30
10
29
20
206
1119
874
1293
38
1240
162
111
47
6100
258
5773
1515
267
1241
457
113
340
266
3514
325
3100
1584
880
1080
975
219
749
66
188

4.9
5.5
6.1
4.1
5.8
5.4
2.0
6.5
4.2
4.0
6.5
4.3
3.0
4.7
4.7
5.4
4.8
1.8
3.9
2.8
5.9
4.9
3.9
1.9
1.4
3.2
3.5
6.2
4.2
4.2
1.9
0.9
3.6
2.7
2.5
5.6
5.5
7.5
3.4
7.9
5.7
5.6
6.0
6.2
3.3
6.6
4.6
3.6
4.9
4.8
4.5
5.2
4.9
6.1
4.6
6.3
5.5
5.6
5.7
4.9
4.3
5.2
4.3
6.5

0.08
0.24
0.20
0.31
0.46
0.54
1.50
0.42
0.10
0.82
0.43
0.16
0.28
0.19
0.58
0.17
0.07
0.11
0.23
0.12
0.09
0.15
0.49
0.29
0.34
0.91
0.36
0.22
0.12
0.36
0.37
0.30
0.77
0.63
0.18
0.20
0.20
0.24
0.58
0.26
0.51
0.60
1.01
0.09
0.22
0.10
0.13
0.24
0.15
0.25
0.45
0.31
0.33
0.12
0.27
0.13
0.16
0.23
0.19
0.17
0.31
0.21
0.56
0.54

0.57
0.63
0.70
0.48
0.64
0.66
0.22
0.78
0.47
0.44
0.79
0.52
0.36
0.55
0.53
0.64
0.57
0.21
0.47
0.33
0.72
0.58
0.44
0.29
0.15
0.33
0.38
0.75
0.49
0.54
0.19
0.16
0.42
0.34
0.30
0.66
0.68
0.93
0.38
0.97
0.69
0.67
0.77
0.73
0.37
0.77
0.53
0.41
0.58
0.57
0.52
0.62
0.58
0.71
0.50
0.75
0.67
0.64
0.68
0.57
0.48
0.61
0.46
0.81

0.01
0.03
0.03
0.05
0.06
0.08
0.17
0.06
0.01
0.13
0.06
0.02
0.04
0.03
0.09
0.02
0.01
0.02
0.04
0.02
0.01
0.02
0.07
0.06
0.05
0.12
0.06
0.03
0.02
0.06
0.05
0.06
0.10
0.10
0.03
0.03
0.03
0.04
0.09
0.04
0.08
0.09
0.16
0.01
0.03
0.01
0.02
0.04
0.02
0.04
0.07
0.05
0.05
0.02
0.04
0.02
0.02
0.03
0.03
0.03
0.05
0.03
0.08
0.08

*Important. See note on population page.

Care should be taken when comparing populations. See Chapter 5 Comparability and quality of data
598
540

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp
Care

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Bladder (C67) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

1393
6244
8537
417
8007
3423
308
3093
4338
166
4145
827
175440
6605
164400
8084
325
7603
1064
12
208
832
16299
697
15312
9715
387
8991
2404
3190
13141
418
12544
1254
19184
734
17511
51459
1585
2080
2241
45005
2691
257
2407
10569
504
9864
1001
522
4877
3292
1817
4435

27.7
27.0
24.5
11.9
26.0
25.1
11.7
28.8
20.8
11.4
21.6
22.3
22.1
10.5
23.5
26.2
11.7
28.5
16.5
3.7
10.9
20.8
24.1
10.2
26.6
23.5
11.5
23.9
18.7
24.5
26.1
13.0
27.0
31.2
21.1
11.0
23.3
20.9
8.5
11.4
10.9
24.2
19.7
8.8
22.5
17.2
9.7
18.0
16.7
23.0
23.8
23.9
24.0
22.2

0.78
0.36
0.28
0.60
0.31
0.45
0.70
0.55
0.33
0.91
0.36
0.82
0.06
0.13
0.06
0.31
0.66
0.35
0.53
1.10
0.78
0.76
0.20
0.39
0.23
0.25
0.60
0.27
0.40
0.46
0.24
0.66
0.26
0.95
0.16
0.42
0.19
0.10
0.22
0.26
0.24
0.12
0.39
0.57
0.47
0.17
0.44
0.19
0.55
1.05
0.36
0.44
0.59
0.35

3.34
3.26
2.92
1.32
3.10
2.99
1.33
3.46
2.46
1.40
2.55
2.61
2.62
1.22
2.79
3.16
1.36
3.45
1.98
0.57
1.27
2.51
2.84
1.13
3.16
2.79
1.31
2.85
2.16
2.94
3.15
1.58
3.26
3.79
2.50
1.27
2.76
2.46
0.95
1.32
1.24
2.88
2.35
0.97
2.70
2.05
1.15
2.15
1.96
2.65
2.79
2.80
2.91
2.67

0.12
0.06
0.04
0.09
0.05
0.07
0.10
0.08
0.05
0.14
0.05
0.12
0.01
0.02
0.01
0.05
0.10
0.05
0.08
0.20
0.12
0.11
0.03
0.06
0.03
0.04
0.09
0.04
0.06
0.07
0.04
0.10
0.04
0.14
0.02
0.06
0.03
0.01
0.03
0.04
0.04
0.02
0.06
0.08
0.07
0.03
0.07
0.03
0.09
0.16
0.06
0.07
0.09
0.05

541
2466
2899
242
2617
1214
191
1013
1470
96
1361
281
61379
3832
56118
3036
204
2777
348
3
61
280
6382
448
5848
3526
220
3194
805
1022
4820
236
4527
482
6653
445
5923
17555
478
1156
824
14924
854
175
674
3460
277
3111
306
225
1512
1013
766
1611

8.2
7.9
6.4
4.6
6.6
6.4
4.6
7.1
5.3
4.0
5.4
6.5
5.8
3.9
6.2
7.2
4.6
7.8
4.5
0.8
2.4
5.9
6.8
3.8
7.5
6.2
4.3
6.2
4.7
6.3
7.0
4.5
7.2
9.2
5.6
4.4
6.1
5.4
1.9
4.2
3.1
6.3
4.6
3.8
5.0
4.2
3.5
4.3
4.4
7.7
5.9
5.9
7.9
6.3

0.40
0.18
0.13
0.32
0.15
0.21
0.36
0.25
0.16
0.45
0.17
0.43
0.03
0.07
0.03
0.15
0.34
0.17
0.26
0.45
0.33
0.39
0.10
0.19
0.11
0.12
0.31
0.13
0.19
0.23
0.12
0.32
0.13
0.49
0.08
0.22
0.09
0.05
0.09
0.13
0.11
0.06
0.17
0.31
0.21
0.08
0.23
0.09
0.27
0.58
0.17
0.21
0.32
0.18

0.96
0.97
0.77
0.49
0.80
0.77
0.46
0.86
0.65
0.45
0.67
0.84
0.70
0.45
0.74
0.86
0.55
0.93
0.52
0.11
0.25
0.72
0.81
0.45
0.90
0.73
0.47
0.74
0.53
0.76
0.83
0.54
0.86
1.15
0.67
0.48
0.74
0.64
0.21
0.48
0.35
0.75
0.57
0.45
0.61
0.50
0.41
0.52
0.52
0.95
0.70
0.71
0.95
0.76

0.06
0.03
0.02
0.05
0.02
0.03
0.05
0.04
0.02
0.07
0.03
0.07
0.00
0.01
0.00
0.02
0.05
0.02
0.04
0.07
0.05
0.06
0.01
0.03
0.02
0.02
0.04
0.02
0.03
0.03
0.02
0.05
0.02
0.07
0.01
0.03
0.01
0.01
0.01
0.02
0.02
0.01
0.03
0.05
0.03
0.01
0.04
0.01
0.04
0.09
0.03
0.03
0.05
0.03

81
351
2499
73
138
1996
169
500
238
1128
35
767
109
167
51
4767
4422
255
415
473
718
1174
951
3011
549

14.7
6.7
10.9
5.9
6.2
8.1
5.0
20.7
2.8
6.2
4.2
3.8
2.8
2.8
1.9
27.7
28.1
18.1
10.6
10.8
16.6
10.6
11.8
7.9
7.4

1.66
0.37
0.22
0.73
0.56
0.19
0.40
0.97
0.18
0.19
0.71
0.14
0.28
0.22
0.27
0.42
0.45
1.16
0.53
0.53
0.63
0.32
0.41
0.15
0.34

1.77
0.75
1.23
0.62
0.60
0.87
0.59
2.50
0.34
0.79
0.58
0.46
0.33
0.34
0.24
3.41
3.45
2.09
1.24
1.26
1.95
1.17
1.38
0.83
0.81

0.25
0.05
0.03
0.09
0.07
0.03
0.06
0.15
0.03
0.03
0.11
0.02
0.04
0.03
0.04
0.06
0.07
0.18
0.08
0.07
0.09
0.04
0.06
0.02
0.05

21
95
803
15
45
609
37
100
86
225
2
182
37
61
13
1153
1101
26
112
143
207
423
291
937
216

3.8
1.4
2.8
1.0
1.8
2.0
0.9
3.5
1.0
1.4
0.2
1.0
1.0
1.0
0.4
5.1
5.3
1.7
2.1
2.2
3.5
2.6
2.2
1.7
2.0

0.83
0.15
0.11
0.27
0.27
0.09
0.16
0.38
0.11
0.10
0.15
0.07
0.17
0.13
0.12
0.16
0.17
0.33
0.22
0.22
0.27
0.14
0.16
0.06
0.16

0.29
0.17
0.29
0.13
0.21
0.22
0.10
0.41
0.14
0.18
0.01
0.10
0.15
0.12
0.05
0.59
0.62
0.19
0.21
0.25
0.40
0.27
0.23
0.17
0.22

0.09
0.02 *
0.02
0.04 *
0.04
0.01 *
0.02 *
0.05 *
0.02
0.01 *
0.01
0.01
0.03 *
0.02 *
0.02 *
0.02
0.03
0.05
0.03
0.03
0.04
0.02
0.02
0.01
0.02

*Important. See note on population page.


Care should be taken when comparing populations. See Chapter 5 Comparability and quality of data
Cancer Incidence in Five Continents Vol. IX, IARC 2007

541

599

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Bladder (C67) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

Female
ASR(W)
CUM 0-74

7405
766
447
236
242
395
47
2022
95
57
103
128
107
85
219
279
600
493
35
72
199
121
119
445
1353

9.1
10.2
9.2
10.1
10.2
8.9
6.8
11.0
8.5
6.3
7.0
7.3
3.1
5.1
9.3
4.7
7.6
8.0
4.6
7.9
5.1
5.6
4.4
15.8
17.6

0.11
0.40
0.46
0.69
0.69
0.47
1.01
0.27
0.96
0.85
1.18
0.66
0.31
0.56
0.66
0.30
0.31
0.36
0.80
0.96
0.36
0.51
0.40
0.76
0.49

1.08
1.25
1.10
1.17
1.21
1.09
0.86
1.25
1.06
0.75
0.63
0.94
0.35
0.53
1.20
0.56
0.79
0.84
0.51
0.79
0.65
0.68
0.49
2.05
2.23

0.02
0.06
0.07
0.10
0.10
0.07
0.16
0.04
0.15
0.13
0.12
0.11
0.04
0.07
0.10
0.05
0.04
0.05
0.10
0.13
0.05
0.08
0.06
0.11
0.07

1935
176
139
67
77
104
16
548
24
27
14
39
30
36
47
102
181
159
3
19
96
39
23
72
175

1.6
1.7
2.1
2.0
2.1
1.6
1.1
2.1
1.4
2.9
2.7
1.8
0.8
2.2
2.6
1.3
1.8
1.9
0.8
2.0
2.3
1.6
0.7
2.5
2.1

0.04
0.13
0.18
0.25
0.25
0.16
0.31
0.09
0.30
0.57
0.83
0.29
0.15
0.38
0.41
0.13
0.14
0.15
0.46
0.48
0.24
0.25
0.15
0.30
0.16

0.19
0.18
0.25
0.26
0.27
0.19
0.08
0.24
0.15
0.40
0.36
0.20
0.07
0.28
0.37
0.17
0.18
0.18
0.06
0.20
0.28
0.18
0.06
0.33
0.25

0.01
0.02
0.03
0.04
0.04
0.02
0.04
0.01
0.04
0.09
0.12
0.04
0.02
0.06 *
0.06 *
0.02 *
0.02
0.02
0.04
0.06
0.03 *
0.04 *
0.02
0.05 *
0.02 *

6654
630
284
4323
1691
5587
4313
3079
7424
6154
743
2856
588
378
311
504
695
652
538
279
363
310
295
2329
4370
1603
1734
1968
2526
645
196
1844
330
836
737
2310
1276
356
1674
1024
739
2273
699
436
755
1960
1356
583
479
295
1820
1602
675
2331

20.9
25.9
24.3
14.4
21.5
25.8
12.9
18.0
20.1
26.6
16.3
13.6
16.0
15.0
15.8
18.8
15.7
15.1
12.5
11.5
15.8
15.3
11.2
22.4
21.5
21.2
25.5
19.8
22.7
12.8
20.3
14.5
33.0
32.9
35.2
37.2
40.4
34.1
30.6
31.7
47.2
21.8
30.9
33.1
31.3
35.8
37.8
28.7
34.0
38.8
38.5
34.4
31.6
31.3

0.26
1.05
1.46
0.22
0.54
0.36
0.20
0.33
0.24
0.35
0.60
0.26
0.68
0.81
0.93
0.85
0.64
0.61
0.56
0.74
0.88
0.96
0.70
0.47
0.33
0.54
0.62
0.46
0.46
0.52
1.53
0.35
1.92
1.17
1.40
0.83
1.24
1.95
0.79
1.06
1.75
0.48
1.27
1.70
1.22
0.87
1.07
1.23
1.62
2.30
0.94
0.93
1.24
0.68

2.46
3.12
3.06
1.79
2.49
3.09
1.62
2.12
2.48
3.18
1.98
1.49
1.77
1.82
1.93
2.29
1.81
1.77
1.52
1.30
1.85
1.85
1.33
2.74
2.57
2.43
3.07
2.21
2.59
1.43
2.25
1.66
4.06
4.09
4.32
4.62
4.89
4.36
3.58
3.80
6.01
2.62
3.81
3.93
4.05
4.41
4.75
3.52
4.25
4.95
4.81
4.26
3.78
3.82

0.04
0.16
0.22
0.03
0.08
0.05
0.03
0.05
0.04
0.05
0.09
0.04
0.09
0.12
0.14
0.13
0.09
0.09
0.08
0.11
0.13
0.14
0.10
0.07
0.05
0.08
0.09
0.07
0.07
0.07
0.22
0.05
0.27
0.17
0.20
0.12
0.17
0.29
0.11
0.15
0.26
0.07
0.18
0.24
0.19
0.13
0.15
0.18
0.24
0.35
0.14
0.13
0.18
0.10

2560
249
81
865
393
1467
992
983
2731
2156
268
951
135
67
64
108
148
127
147
70
76
78
56
881
1565
646
607
769
909
262
72
721
93
212
195
551
339
75
536
253
122
687
196
85
188
455
223
115
65
97
469
364
155
672

5.4
7.5
5.0
1.7
3.8
5.1
2.3
3.9
5.2
7.7
2.9
3.0
2.2
1.6
2.1
2.6
2.5
1.9
2.1
1.9
2.6
2.3
1.6
5.3
4.6
5.4
5.6
5.1
5.5
3.4
6.5
4.7
6.4
5.6
6.8
7.0
7.0
5.8
6.1
6.0
6.4
4.3
6.4
5.4
6.1
6.5
5.0
4.3
3.9
10.1
6.7
6.2
5.0
6.5

0.12
0.53
0.61
0.06
0.22
0.15
0.08
0.13
0.11
0.18
0.20
0.11
0.21
0.24
0.30
0.29
0.24
0.20
0.20
0.28
0.34
0.32
0.25
0.20
0.14
0.25
0.25
0.21
0.21
0.24
0.84
0.19
0.80
0.44
0.61
0.37
0.48
0.80
0.32
0.44
0.60
0.20
0.57
0.69
0.53
0.37
0.37
0.44
0.53
1.16
0.37
0.39
0.45
0.29

0.63
0.87
0.63
0.20
0.41
0.58
0.27
0.45
0.63
0.96
0.32
0.32
0.24
0.17
0.22
0.30
0.30
0.19
0.22
0.19
0.31
0.22
0.20
0.61
0.55
0.66
0.67
0.57
0.59
0.37
0.78
0.55
0.77
0.62
0.76
0.79
0.77
0.68
0.67
0.70
0.71
0.49
0.78
0.59
0.75
0.77
0.54
0.46
0.45
1.26
0.77
0.73
0.58
0.78

0.02
0.07
0.09
0.01 *
0.03 *
0.02
0.01 *
0.02
0.02
0.03
0.03
0.02
0.03
0.03
0.04
0.04
0.04
0.03
0.03
0.04
0.05
0.05
0.04
0.03
0.02
0.04
0.04
0.03
0.03
0.03
0.12
0.03
0.11
0.06
0.08
0.05
0.06
0.11
0.04
0.06
0.08
0.03
0.08
0.09
0.07
0.05
0.05
0.06
0.07
0.16
0.05
0.05
0.06
0.04

*Important. See note on population page.

Care should be taken when comparing populations. See Chapter 5 Comparability and quality of data
600
542

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Care

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Bladder (C67) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

1153
1844
368
3889
444
1005
1016
1985
1931
1597
2931
2303
1061
370
1553
2329
1044
286
898
1002
1592
905
853
1214
7588
468
140
98
247
266
250
433
9000
975
908
2858
2432
4480
7475
1875
8350
11249
5203
4994
721
5012

14.8
16.6
26.8
19.6
17.9
22.9
16.0
18.1
15.9
11.3
15.5
14.4
15.1
27.1
29.3
31.9
21.5
22.2
35.8
30.2
37.6
37.0
37.5
30.7
17.4
29.6
14.6
13.4
11.7
18.3
22.7
16.9
14.5
25.9
24.4
21.9
23.1
25.4
25.5
17.0
25.2
19.3
23.5
21.5
11.8
23.4

0.44
0.39
1.43
0.34
0.86
0.74
0.52
0.43
0.38
0.29
0.30
0.31
0.47
1.54
0.80
0.69
0.68
1.53
1.29
1.01
0.98
1.31
1.39
0.94
0.22
1.41
1.29
1.44
0.79
1.17
1.49
0.86
0.16
0.84
0.83
0.44
0.49
0.40
0.31
0.41
0.30
0.19
0.34
0.32
0.46
0.34

1.75
2.00
3.36
2.27
2.10
2.89
1.93
2.20
1.88
1.39
1.91
1.74
1.78
3.04
3.38
3.78
2.49
2.67
4.43
3.68
4.43
4.54
4.45
3.76
2.09
3.74
1.80
1.59
1.38
2.19
2.77
2.07
1.70
3.06
2.88
2.51
2.68
3.01
2.99
1.96
2.92
2.19
2.74
2.54
1.37
2.79

0.06
0.06
0.22
0.05
0.12
0.11
0.07
0.06
0.05
0.04
0.04
0.04
0.07
0.21
0.11
0.10
0.10
0.21
0.18
0.14
0.14
0.18
0.20
0.13
0.03
0.22
0.20
0.21
0.12
0.18
0.22
0.13
0.02
0.12
0.12
0.06
0.07
0.06
0.05
0.06
0.04
0.03
0.05
0.05
0.07
0.05

381
545
85
1341
146
196
384
583
556
666
947
765
350
58
289
451
173
54
165
133
246
158
161
202
2691
140
38
33
99
74
71
132
2682
272
263
1039
962
1883
3041
624
3062
4242
2015
1881
293
2203

2.6
2.7
4.6
5.4
3.8
3.3
4.1
3.7
3.2
2.2
4.1
3.3
3.2
3.1
3.8
4.7
2.6
3.4
4.6
3.0
4.2
5.2
5.5
3.8
5.0
6.2
2.8
2.9
3.4
3.4
5.2
3.6
3.2
5.9
5.8
6.3
6.4
7.9
7.7
4.4
7.0
5.2
7.1
6.0
3.2
7.5

0.14
0.13
0.54
0.18
0.33
0.26
0.24
0.17
0.15
0.09
0.14
0.13
0.19
0.47
0.26
0.25
0.21
0.59
0.43
0.30
0.30
0.49
0.51
0.32
0.11
0.58
0.54
0.58
0.39
0.46
0.68
0.37
0.07
0.38
0.39
0.23
0.24
0.21
0.16
0.20
0.15
0.09
0.18
0.16
0.21
0.18

0.32
0.30
0.54
0.64
0.44
0.38
0.49
0.42
0.34
0.24
0.48
0.40
0.39
0.28
0.40
0.49
0.29
0.38
0.47
0.31
0.47
0.59
0.57
0.41
0.59
0.77
0.33
0.34
0.44
0.39
0.61
0.43
0.38
0.69
0.70
0.75
0.73
0.96
0.93
0.48
0.80
0.60
0.83
0.71
0.38
0.93

0.02
0.02
0.08
0.03
0.05 *
0.03
0.03
0.02 *
0.02
0.01
0.02
0.02
0.03
0.06
0.03
0.03
0.03
0.08
0.06
0.04
0.04
0.06
0.07
0.04
0.02
0.09
0.08
0.09
0.06
0.07
0.10
0.05
0.01
0.05
0.05
0.03
0.03
0.03
0.02
0.03
0.02
0.01
0.03
0.02
0.03
0.03

2964
25
2516
1443
397
1413
592
111
45
2115
637
33
49
55
211
261

11.5
7.7
19.1
22.4
20.9
7.5
8.9
12.0
11.3
15.4
12.9
7.5
6.5
12.2
13.0
20.5

0.22
1.61
0.40
0.62
1.10
0.21
0.38
1.18
1.70
0.35
0.55
1.54
1.01
1.67
1.09
1.33

1.30
0.90
2.18
2.66
2.22
0.81
0.95
1.27
1.48
1.76
1.54
0.63
0.84
1.24
1.55
2.51

0.03
0.24
0.06
0.09
0.15
0.03
0.06
0.18
0.27
0.05
0.08
0.19
0.16
0.22
0.16
0.21

1089
2
791
474
141
547
213
34
13
778
182
12
14
22
54
62

3.3
0.7
5.0
6.0
6.0
2.2
2.4
3.3
3.3
4.4
3.0
1.7
1.7
3.7
2.3
4.6

0.11
0.52
0.20
0.31
0.57
0.11
0.18
0.60
0.97
0.18
0.25
0.58
0.48
0.80
0.41
0.65

0.39
0.10
0.58
0.72
0.62
0.25
0.24
0.40
0.52
0.49
0.32
0.12
0.19
0.40
0.21
0.53

0.02
0.08
0.03
0.05
0.08
0.02
0.03
0.09
0.18
0.03
0.03
0.07
0.07
0.11
0.05
0.10

*Important. See note on population page.


Care should be taken when comparing populations. See Chapter 5 Comparability and quality of data
Cancer Incidence in Five Continents Vol. IX, IARC 2007

543

601

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other urinary organs (C68)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

544

Female
ASR(W)
CUM 0-74

0
8
2
0
1

0.2
0.2
0.0

0.08
0.17
0.02

1
0
0
0
1

0.1
0.1

0.06
0.05

3
6
1
2
41
1
3
7
1
0
0

0.3
0.3
0.2
0.1
0.2
0.1
0.1
0.1
0.1
-

0.21
0.14
0.16
0.09
0.03
0.12
0.05
0.04
0.05
-

0.03
0.04
0.00
0.02
0.03
0.01
0.01
0.01
-

0.02
0.02
0.00
0.00
0.03
0.01
0.01
0.01
-

2
8
0
3
28
0
2
7
2
0
0

0.2
0.3
0.2
0.1
0.0
0.1
0.0
-

0.13
0.13
0.11
0.02
0.04
0.03
0.02
-

0.03
0.04
0.02
0.01
0.01
-

0.02
0.02
0.01
0.00
0.01
- *

946
15
21
20
4
3
0
5
872
1
5
29
6
22
2
43
228
12
13
29
156
26
5
1
0
0
3
16
68
2
3
2
0
2
9
47
23
21
2
18
2
1
1
106
8
97
59
18
40
16
6
9
4
79
8
71
38
15
36
24
8
16
2
4

1.1
0.2
0.1
0.4
0.2
0.1
0.1
2.1
0.1
0.1
0.2
0.2
0.2
0.1
0.2
0.2
0.1
0.2
0.2
0.2
0.1
0.3
0.1
0.2
0.1
0.2
0.1
0.2
0.3
0.4
0.1
0.3
0.2
0.2
0.2
0.2
0.1
0.1
0.2
0.1
0.1
0.1
0.3
0.4
0.2
0.3
0.4
0.2
0.1
0.2
0.2
0.2
0.2
0.1
0.2
0.2
0.2
0.1
0.2
0.2

0.04
0.04
0.03
0.09
0.08
0.07
0.06
0.07
0.14
0.03
0.03
0.10
0.04
0.09
0.03
0.01
0.03
0.06
0.04
0.02
0.03
0.16
0.05
0.09
0.03
0.03
0.05
0.14
0.23
0.28
0.05
0.05
0.04
0.04
0.18
0.04
0.08
0.10
0.19
0.01
0.05
0.01
0.03
0.10
0.03
0.07
0.18
0.07
0.03
0.02
0.06
0.02
0.03
0.04
0.04
0.03
0.08
0.04
0.12
0.10

0.13
0.02
0.01
0.04
0.02
0.01
0.01
0.24
0.02
0.04
0.02
0.02
0.02
0.01
0.02
0.02
0.02
0.01
0.02
0.03
0.01
0.03
0.01
0.04
0.05
0.07
0.01
0.04
0.02
0.02
0.01
0.02
0.02
0.01
0.05
0.01
0.01
0.01
0.02
0.05
0.02
0.02
0.08
0.01
0.00
0.02
0.01
0.03
0.02
0.02
0.02
0.02
0.02
0.01
0.01
0.02

0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.00
0.00
0.00
0.01
0.01
0.00
0.00
0.02
0.02
0.00
0.00
0.01
0.03
0.03
0.06
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.05
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.04
0.01
0.00
0.00
0.01
0.00
0.00
0.01
0.01
0.00
0.01
0.00
0.01
0.01

317
8
11
7
5
3
0
2
279
1
1
18
3
15
2
13
134
12
22
14
80
20
8
0
1
0
1
9
41
11
1
2
0
1
5
18
14
16
2
14
3
3
0
71
14
56
34
15
19
11
5
6
2
50
16
32
26
11
16
14
8
6
0
1

0.3
0.1
0.0
0.1
0.1
0.2
0.0
0.6
0.3
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.3
0.1
0.1
0.1
0.5
0.1
0.1
0.0
0.1
0.3
0.0
0.2
0.2
0.0
0.1
0.1
0.1
0.2
0.1
0.1
0.2
0.1
0.2
0.1
0.1
0.2
0.1
0.1
0.2
0.1
0.0
0.1
0.3
0.1
0.1
0.1
0.1
0.1
0.2
0.0
0.0

0.02
0.02
0.02
0.03
0.07
0.09
0.02
0.04
0.27
0.01
0.02
0.04
0.02
0.07
0.02
0.01
0.02
0.06
0.02
0.01
0.02
0.18
0.05
0.05
0.01
0.02
0.09
0.04
0.15
0.18
0.02
0.03
0.03
0.02
0.12
0.03
0.07
0.10
0.01
0.06
0.01
0.02
0.06
0.02
0.04
0.09
0.05
0.01
0.01
0.07
0.01
0.02
0.02
0.03
0.02
0.06
0.01
0.02

0.04
0.01
0.00
0.01
0.02
0.03
0.06
0.03
0.01
0.01
0.01
0.01
0.01
0.01
0.04
0.01
0.01
0.01
0.06
0.01
0.00
0.01
0.04
0.03
0.03
0.00
0.01
0.01
0.01
0.01
0.01
0.02
0.03
0.01
0.03
0.01
0.01
0.03
0.01
0.01
0.02
0.01
0.01
0.03
0.01
0.01
0.01
0.01
0.01
0.01
0.00
-

0.00
0.00
0.00
0.01
0.01
0.02
0.00
0.03
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.03
0.01
0.00
0.00
0.02
0.02
0.03
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.02
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.01
0.00
-

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

602

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other urinary organs (C68) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

10
71
164
23
128
76
17
54
33
4
29
8
1715
154
1486
83
9
70
15
1
4
10
190
18
171
57
4
50
18
26
97
6
89
14
206
31
162
561
21
61
39
414
21
5
15
86
7
78
8
2
72
32
18
33

0.2
0.3
0.5
0.6
0.4
0.6
0.6
0.5
0.2
0.3
0.1
0.2
0.2
0.2
0.2
0.2
0.3
0.2
0.2
0.3
0.2
0.2
0.3
0.3
0.3
0.1
0.1
0.1
0.2
0.2
0.2
0.2
0.2
0.3
0.2
0.4
0.2
0.2
0.1
0.3
0.2
0.2
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.3
0.2
0.2
0.2

0.06
0.04
0.04
0.14
0.04
0.07
0.16
0.07
0.03
0.14
0.03
0.09
0.01
0.02
0.01
0.03
0.09
0.03
0.06
0.25
0.11
0.08
0.02
0.07
0.02
0.02
0.06
0.02
0.04
0.04
0.02
0.09
0.02
0.09
0.02
0.08
0.02
0.01
0.03
0.04
0.03
0.01
0.03
0.07
0.04
0.02
0.06
0.02
0.05
0.04
0.04
0.04
0.06
0.03

0.02
0.03
0.06
0.06
0.05
0.07
0.06
0.07
0.02
0.05
0.02
0.03
0.02
0.03
0.02
0.03
0.02
0.03
0.02
0.04
0.01
0.03
0.03
0.03
0.02
0.02
0.02
0.02
0.02
0.02
0.03
0.02
0.04
0.03
0.05
0.03
0.02
0.01
0.03
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.04
0.02
0.02
0.02

0.01
0.01
0.01
0.02
0.01
0.01
0.02
0.01
0.00
0.03
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.02
0.01
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.01
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.01
0.01
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.00

5
24
65
13
49
28
8
19
27
8
18
2
938
204
690
38
15
22
1
0
0
1
92
18
71
39
11
28
14
14
58
17
39
4
94
23
64
286
16
66
15
181
21
9
11
76
17
57
2
2
21
13
8
28

0.1
0.1
0.2
0.3
0.1
0.2
0.2
0.2
0.1
0.4
0.1
0.0
0.1
0.2
0.1
0.1
0.4
0.0
0.0
0.0
0.1
0.2
0.1
0.1
0.3
0.1
0.1
0.1
0.1
0.4
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.3
0.1
0.1
0.1
0.3
0.1
0.1
0.3
0.1
0.0
0.0
0.1
0.1
0.1
0.1

0.05
0.02
0.02
0.08
0.02
0.03
0.08
0.04
0.02
0.15
0.02
0.03
0.00
0.02
0.00
0.02
0.10
0.01
0.01
0.01
0.01
0.04
0.01
0.02
0.09
0.01
0.03
0.02
0.01
0.10
0.01
0.03
0.01
0.05
0.01
0.01
0.02
0.03
0.02
0.01
0.03
0.09
0.03
0.01
0.07
0.01
0.02
0.03
0.02
0.03
0.03
0.02

0.01
0.01
0.02
0.04
0.02
0.02
0.02
0.02
0.01
0.06
0.01
0.00
0.01
0.03
0.01
0.01
0.05
0.00
0.01
0.02
0.01
0.01
0.04
0.01
0.01
0.00
0.01
0.04
0.01
0.01
0.01
0.03
0.01
0.01
0.01
0.03
0.01
0.01
0.02
0.03
0.01
0.01
0.03
0.01
0.00
0.01
0.01
0.01
0.01

0.01
0.00
0.00
0.01
0.00
0.00
0.01
0.01
0.00
0.02
0.00
0.00
0.00
0.00
0.00
0.00
0.02
0.00
0.00
0.01
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00

0
9

0.2

0.05

0.02

0.01

0
8

0.1

0.04

0.01

0.01 *

0
8
15
0
2
3
7
0
3
1
5
0
41
39
1
17
7
12
18
13
25
3

0.3
0.1
0.1
0.0
0.0
0.0
0.0
0.1
0.2
0.2
0.1
0.4
0.3
0.3
0.2
0.2
0.1
0.0

0.12
0.02
0.06
0.02
0.01
0.01
0.02
0.04
0.04
0.04
0.06
0.11
0.13
0.08
0.04
0.05
0.01
0.02

0.06
0.01
0.01
0.00
0.00
0.00
0.00
0.02
0.03
0.03
0.00
0.06
0.01
0.03
0.02
0.02
0.01
0.01

0.02
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.00
0.02
0.01
0.01
0.01
0.01
0.00
0.00

0
2
16
0
1
2
3
0
4
2
1
0
24
23
1
9
3
4
12
13
22
10

0.1
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.1
0.1
0.2
0.0
0.1
0.1
0.1
0.0
0.1

0.06
0.02
0.05
0.02
0.01
0.01
0.04
0.02
0.02
0.02
0.08
0.06
0.02
0.04
0.03
0.05
0.01
0.03

0.02
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.01
0.01
0.02
0.00
0.01
0.01
0.01
0.01
0.01

- *
0.01
0.00 *
- *
0.00 *
0.00
0.00 *
0.00
0.01 *
0.00 *
- *
0.00
0.00
0.01
0.01
0.00
0.01
0.00
0.01
0.00
0.00

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

545

603

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other urinary organs (C68) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

546

Female
ASR(W)
CUM 0-74

67
6
1
2
3
4
2
19
3
1
1
5
0
3
3
1
13
13
0
0
6
1
0
3
8

0.1
0.1
0.0
0.1
0.1
0.1
0.3
0.1
0.2
0.1
0.0
0.3
0.2
0.1
0.0
0.2
0.2
0.2
0.0
0.1
0.1

0.01
0.03
0.02
0.10
0.07
0.05
0.19
0.03
0.14
0.07
0.02
0.13
0.10
0.06
0.01
0.05
0.06
0.07
0.05
0.06
0.04

0.01
0.01
0.00
0.00
0.02
0.02
0.02
0.01
0.03
0.01
0.00
0.03
0.02
0.02
0.00
0.02
0.02
0.03
0.01
0.01
0.02

0.00
0.01
0.00
0.00
0.01
0.01
0.01
0.00
0.02
0.01
0.00
0.02
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01

78
10
2
3
2
4
0
19
4
0
0
1
0
0
0
2
8
8
0
0
5
1
0
0
1

0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.2
0.0
0.0
0.1
0.1
0.1
0.1
0.0

0.01
0.03
0.02
0.05
0.04
0.03
0.02
0.12
0.05
0.02
0.03
0.04
0.05
0.05
0.01

0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.03
0.01
0.00
0.01
0.01
0.01
0.01
0.00

0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.02
0.01
- *
- *
0.00 *
0.00
0.00
0.01 *
0.01 *
- *
0.00 *

117
5
3
11
21
50
71
12
37
26
5
26
6
1
1
4
2
8
12
3
9
9
8
36
66
47
16
9
81
24
2
12
3
36
14
21
11
2
22
2
2
244
3
2
1
18
6
4
3
2
17
46
18
165

0.4
0.2
0.3
0.0
0.3
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.2
0.0
0.0
0.1
0.0
0.2
0.3
0.1
0.3
0.5
0.3
0.3
0.3
0.6
0.2
0.1
0.7
0.5
0.2
0.1
0.3
1.4
0.7
0.3
0.3
0.2
0.4
0.0
0.2
2.4
0.1
0.2
0.0
0.3
0.2
0.2
0.2
0.3
0.3
1.0
0.8
2.1

0.03
0.08
0.17
0.01
0.06
0.03
0.03
0.02
0.02
0.03
0.05
0.03
0.07
0.02
0.04
0.07
0.02
0.09
0.08
0.06
0.12
0.18
0.12
0.06
0.04
0.09
0.06
0.03
0.08
0.10
0.15
0.03
0.18
0.23
0.20
0.07
0.11
0.18
0.08
0.03
0.11
0.16
0.07
0.13
0.04
0.07
0.08
0.10
0.13
0.22
0.08
0.16
0.19
0.17

0.04
0.03
0.02
0.00
0.03
0.03
0.03
0.01
0.01
0.02
0.01
0.01
0.02
0.02
0.01
0.05
0.02
0.03
0.06
0.04
0.05
0.03
0.07
0.02
0.01
0.07
0.04
0.03
0.01
0.03
0.16
0.05
0.02
0.03
0.04
0.02
0.01
0.01
0.24
0.01
0.03
0.01
0.03
0.02
0.03
0.04
0.04
0.04
0.11
0.10
0.20

0.00
0.01
0.02
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.01
0.01
0.02
0.01
0.02
0.03
0.02
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.03
0.00
0.02
0.03
0.02
0.01
0.01
0.03
0.01
0.01
0.01
0.02
0.01
0.02
0.01
0.01
0.01
0.02
0.03
0.03
0.01
0.02
0.03
0.02

77
2
2
16
6
16
45
15
33
25
5
28
2
1
3
2
2
1
4
2
0
3
2
24
62
25
7
17
49
13
1
9
4
15
8
7
6
0
9
2
1
130
1
0
7
8
5
2
0
0
5
15
6
63

0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.2
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.2
0.2
0.0
0.1
0.3
0.1
0.2
0.1
0.3
0.4
0.2
0.1
0.3
0.1
0.0
0.0
0.8
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.5

0.02
0.05
0.09
0.01
0.03
0.02
0.02
0.02
0.02
0.02
0.04
0.02
0.03
0.02
0.10
0.02
0.04
0.03
0.09
0.03
0.03
0.06
0.03
0.04
0.05
0.02
0.03
0.04
0.05
0.16
0.02
0.15
0.13
0.08
0.05
0.27
0.05
0.01
0.04
0.09
0.07
0.03
0.06
0.06
0.06
0.04
0.07
0.10
0.07

0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.02
0.01
0.00
0.01
0.01
0.01
0.02
0.02
0.03
0.00
0.01
0.03
0.02
0.02
0.01
0.05
0.04
0.02
0.01
0.02
0.01
0.01
0.08
0.01
0.02
0.02
0.01
0.01
0.03
0.03
0.05

0.00
0.01
0.01
0.00 *
0.00 *
0.00
0.00 *
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.00
0.00
0.01
0.01
0.00
0.00
0.01
0.00
0.00
0.01
0.01
0.02
0.00
0.03
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01

*Important. See note on population page.

604

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other urinary organs (C68) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

10
6
0
27
1
5
3
61
106
3
41
15
5
6
182
15
17
5
3
4
19
10
8
0
97
3
1
4
6
3
5
6
121
8
10
21
19
33
19
9
112
82
49
23
26
29

0.1
0.1
0.2
0.0
0.1
0.1
0.6
0.8
0.0
0.2
0.1
0.1
0.4
3.2
0.2
0.3
0.6
0.1
0.1
0.4
0.3
0.3
0.2
0.2
0.1
0.5
0.3
0.2
0.4
0.2
0.2
0.2
0.3
0.1
0.2
0.2
0.1
0.1
0.3
0.2
0.2
0.1
0.4
0.1

0.04
0.02
0.03
0.03
0.06
0.03
0.08
0.08
0.01
0.04
0.03
0.03
0.18
0.27
0.06
0.08
0.31
0.04
0.06
0.09
0.12
0.10
0.02
0.10
0.14
0.29
0.11
0.13
0.19
0.11
0.02
0.07
0.10
0.03
0.04
0.03
0.01
0.03
0.03
0.02
0.03
0.02
0.09
0.02

0.01
0.01
0.02
0.01
0.01
0.01
0.07
0.09
0.00
0.03
0.01
0.01
0.06
0.38
0.03
0.04
0.07
0.01
0.03
0.05
0.03
0.03
0.03
0.02
0.05
0.03
0.03
0.05
0.03
0.02
0.01
0.03
0.01
0.01
0.02
0.01
0.01
0.04
0.02
0.02
0.01
0.05
0.01

0.01
0.00
0.00
0.01
0.01
0.00
0.01
0.01
0.00
0.00
0.00
0.00
0.03
0.04
0.01
0.01
0.04
0.01
0.01
0.02
0.02
0.00
0.02
0.02
0.03
0.02
0.02
0.03
0.02
0.00
0.01
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00

7
14
0
18
1
4
6
23
78
11
24
9
3
3
43
1
4
1
3
1
5
2
3
0
70
0
1
0
2
4
0
2
44
1
7
4
11
11
14
5
46
40
13
18
10
22

0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.4
0.0
0.1
0.0
0.0
0.2
0.5
0.0
0.1
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.0
0.1
0.0
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.2
0.1

0.02
0.03
0.02
0.02
0.04
0.03
0.04
0.05
0.02
0.02
0.01
0.02
0.14
0.10
0.02
0.03
0.03
0.03
0.04
0.04
0.07
0.08
0.02
0.05
0.09
0.05
0.02
0.01
0.01
0.04
0.02
0.02
0.02
0.01
0.02
0.02
0.01
0.02
0.01
0.05
0.02

0.01
0.01
0.01
0.01
0.01
0.01
0.03
0.01
0.01
0.00
0.01
0.03
0.06
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.02
0.01

0.00
0.00
0.00
- *
0.00
0.00
0.00 *
0.01
0.00
0.00
0.00
0.00
0.02
0.01
0.00
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00

59
0
34
1
0
36
18
2
1
31
5
0
1
0
2
2

0.2
0.3
0.0
0.2
0.2
0.2
0.3
0.2
0.1
0.1
0.1
0.1

0.03
0.04
0.01
0.03
0.06
0.12
0.26
0.04
0.04
0.08
0.07
0.10

0.02
0.03
0.00
0.02
0.01
0.03
0.03
0.01
0.01
0.01

0.00
0.01
0.00
0.01
0.01
0.03
0.01
0.01
0.01
0.01

16
0
12
6
1
4
5
0
0
10
0
0
0
0
0
0

0.0
0.1
0.1
0.1
0.0
0.1
0.1
-

0.01
0.03
0.04
0.07
0.01
0.04
0.02
-

0.01
0.01
0.01
0.01
0.00
0.01
0.01
-

0.00
0.00
0.01
0.01
0.00
0.01
0.00
-

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

547

605

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Eye (C69)
Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

548

Female
ASR(W)
CUM 0-74

4
24
3
56
141

0.2
0.4
0.3
2.2
3.8

0.09
0.09
0.18
0.40
0.37

0
14
2
60
117

0.2
0.2
2.0
3.8

0.06
0.14
0.32
0.47

3
38
8
19
310
3
33
60
21
1
7

0.4
1.5
1.2
1.2
1.5
0.4
0.9
0.7
0.7
0.1
0.6

0.23
0.26
0.44
0.29
0.09
0.21
0.18
0.10
0.16
0.06
0.22

0.04
0.16
0.12
0.15
0.14
0.04
0.08
0.07
0.07
0.04

0.03
0.04
0.07
0.05
0.01
0.03
0.02
0.01
0.02
0.02

4
32
3
18
300
3
32
35
21
0
6

0.4
1.0
0.3
0.9
1.1
0.3
0.8
0.4
0.6
0.5

0.26
0.19
0.20
0.22
0.07
0.16
0.14
0.07
0.14
0.20

0.02
0.09
0.03
0.07
0.10
0.02
0.07
0.04
0.03
0.04

0.02
0.03
0.02
0.02
0.01
0.02
0.02
0.01
0.01
0.02 *

555
61
91
23
10
9
0
18
312
3
28
64
4
59
9
100
718
20
13
117
544
143
2
1
2
0
15
114
165
3
2
0
1
0
49
104
82
62
2
60
3
2
1
482
23
441
121
16
103
32
2
27
17
235
12
208
126
85
109
88
9
78
2
17

0.8
0.8
0.7
0.6
0.4
0.6
0.6
0.9
0.7
0.9
0.5
0.2
0.6
0.8
0.6
0.8
0.3
0.2
0.6
1.0
0.8
0.1
0.2
0.3
0.5
1.0
0.7
0.2
0.3
0.9
0.6
1.0
0.7
0.6
0.2
0.7
0.4
0.4
0.5
0.9
0.4
1.0
0.6
0.3
0.7
0.5
0.1
0.6
0.3
0.7
0.3
0.7
0.7
0.9
0.9
0.7
0.3
0.9
0.1
0.9

0.04
0.11
0.09
0.14
0.13
0.24
0.17
0.06
0.38
0.18
0.07
0.08
0.09
0.27
0.07
0.03
0.06
0.07
0.06
0.05
0.07
0.08
0.17
0.25
0.13
0.11
0.06
0.11
0.26
0.86
0.09
0.12
0.08
0.09
0.13
0.10
0.25
0.29
0.55
0.05
0.09
0.06
0.06
0.09
0.08
0.09
0.06
0.13
0.08
0.05
0.09
0.05
0.07
0.11
0.09
0.08
0.10
0.11
0.10
0.23

0.08
0.07
0.08
0.08
0.05
0.07
0.05
0.09
0.10
0.10
0.05
0.01
0.06
0.07
0.07
0.08
0.02
0.01
0.05
0.10
0.08
0.00
0.01
0.04
0.04
0.11
0.06
0.01
0.03
0.04
0.06
0.09
0.08
0.06
0.01
0.06
0.02
0.02
0.02
0.09
0.03
0.09
0.06
0.02
0.07
0.05
0.00
0.06
0.02
0.07
0.02
0.07
0.08
0.09
0.09
0.07
0.02
0.09
0.12

0.00
0.01
0.01
0.02
0.02
0.03
0.02
0.01
0.06
0.02
0.01
0.01
0.01
0.03
0.01
0.00
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.03
0.01
0.01
0.01
0.00
0.02
0.04
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.00
0.01
0.01
0.01
0.00
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.03

454
46
73
17
14
7
1
14
259
2
21
45
5
40
3
80
547
13
6
86
420
112
1
0
2
0
12
92
120
3
1
1
0
0
29
83
107
81
3
77
4
2
1
412
11
387
91
10
79
28
5
22
20
185
11
164
97
73
90
75
7
68
3
15

0.6
0.5
0.5
0.4
0.6
0.3
1.5
0.3
0.7
0.2
0.6
0.3
0.2
0.3
0.2
0.5
0.5
0.1
0.1
0.4
0.7
0.6
0.1
0.1
0.5
0.8
0.4
0.1
0.1
0.1
0.4
0.7
0.9
0.7
0.5
0.7
0.3
0.3
0.1
0.7
0.2
0.7
0.4
0.2
0.5
0.4
0.3
0.5
0.6
0.5
0.3
0.5
0.5
0.8
0.7
0.6
0.2
0.7
0.3
0.8

0.03
0.08
0.07
0.11
0.20
0.12
1.45
0.10
0.05
0.11
0.15
0.06
0.08
0.07
0.09
0.06
0.03
0.03
0.04
0.05
0.04
0.06
0.07
0.11
0.14
0.11
0.04
0.07
0.07
0.09
0.07
0.09
0.09
0.09
0.26
0.10
0.16
0.22
0.05
0.04
0.06
0.05
0.05
0.07
0.06
0.09
0.12
0.11
0.14
0.04
0.08
0.05
0.06
0.11
0.08
0.07
0.09
0.10
0.18
0.24

0.06
0.05
0.05
0.05
0.04
0.04
0.06
0.04
0.06
0.05
0.03
0.01
0.03
0.02
0.04
0.05
0.01
0.01
0.04
0.07
0.06
0.01
0.01
0.05
0.08
0.04
0.01
0.01
0.01
0.04
0.07
0.09
0.06
0.03
0.06
0.02
0.02
0.06
0.02
0.07
0.04
0.01
0.05
0.04
0.01
0.05
0.05
0.05
0.02
0.05
0.05
0.07
0.06
0.05
0.02
0.07
0.03
0.08

0.00
0.01
0.01
0.01
0.02
0.02
0.06
0.01
0.00
0.01
0.00
0.00
0.01
0.01
0.01
0.00
0.00
0.00
0.01
0.00
0.01
0.01
0.01
0.02
0.01
0.00
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.00
0.01
0.00
0.00
0.00
0.01
0.01
0.00
0.01
0.01
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.02

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

606

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Eye (C69) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

33
159
188
9
170
66
7
57
138
4
130
25
4871
180
4491
190
9
174
34
3
8
23
438
25
403
221
8
206
85
94
324
10
304
20
530
14
486
1546
37
46
151
1271
66
8
57
387
13
366
51
9
143
95
53
157

0.9
0.9
0.7
0.3
0.7
0.7
0.3
0.8
0.8
0.3
0.8
0.9
0.8
0.3
0.8
0.8
0.4
0.8
0.7
0.8
0.5
0.7
0.9
0.4
1.0
0.7
0.3
0.7
0.8
0.9
0.9
0.3
0.9
0.6
0.7
0.2
0.8
0.8
0.3
0.3
0.6
0.9
0.6
0.3
0.6
0.7
0.3
0.8
1.0
0.6
0.8
0.8
0.9
1.0

0.17
0.07
0.06
0.10
0.06
0.09
0.13
0.11
0.07
0.15
0.08
0.21
0.01
0.02
0.01
0.06
0.12
0.07
0.12
0.45
0.17
0.17
0.05
0.09
0.05
0.05
0.10
0.05
0.09
0.10
0.06
0.11
0.06
0.13
0.03
0.05
0.04
0.02
0.05
0.04
0.05
0.03
0.08
0.11
0.10
0.04
0.07
0.04
0.14
0.21
0.07
0.09
0.14
0.09

0.09
0.09
0.06
0.02
0.07
0.06
0.03
0.07
0.09
0.02
0.09
0.10
0.08
0.02
0.08
0.08
0.03
0.09
0.06
0.02
0.05
0.07
0.08
0.03
0.09
0.07
0.02
0.07
0.10
0.11
0.08
0.04
0.09
0.08
0.07
0.01
0.08
0.07
0.02
0.02
0.04
0.09
0.05
0.01
0.06
0.07
0.01
0.08
0.12
0.05
0.08
0.08
0.10
0.08

0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.00
0.00
0.00
0.01
0.01
0.01
0.01
0.02
0.02
0.02
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.02
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.01
0.01
0.00
0.00
0.01
0.02
0.02
0.01
0.01
0.01
0.01

40
145
153
5
141
58
5
51
99
1
98
23
4121
128
3816
172
3
162
35
1
10
24
416
17
389
213
7
201
67
84
274
13
258
22
483
14
448
1291
27
32
113
1087
45
1
39
301
14
274
38
12
131
82
37
128

0.9
0.6
0.5
0.1
0.5
0.4
0.2
0.5
0.6
0.1
0.7
0.9
0.6
0.2
0.6
0.6
0.1
0.6
0.5
0.1
0.5
0.6
0.7
0.3
0.8
0.6
0.3
0.6
0.6
0.7
0.6
0.5
0.6
0.6
0.6
0.2
0.7
0.6
0.2
0.2
0.4
0.7
0.3
0.0
0.4
0.5
0.3
0.5
0.6
0.6
0.8
0.7
0.6
0.8

0.16
0.06
0.05
0.07
0.05
0.06
0.10
0.08
0.07
0.09
0.08
0.23
0.01
0.02
0.01
0.05
0.08
0.06
0.11
0.14
0.16
0.15
0.04
0.07
0.05
0.05
0.10
0.05
0.09
0.08
0.05
0.13
0.05
0.15
0.03
0.06
0.04
0.02
0.04
0.03
0.04
0.03
0.06
0.04
0.08
0.03
0.07
0.04
0.11
0.22
0.08
0.09
0.12
0.08

0.10
0.07
0.04
0.01
0.05
0.04
0.02
0.04
0.05
0.00
0.06
0.07
0.06
0.01
0.06
0.05
0.01
0.06
0.05
0.02
0.07
0.06
0.02
0.07
0.05
0.02
0.05
0.06
0.08
0.06
0.04
0.06
0.07
0.05
0.01
0.06
0.05
0.01
0.01
0.04
0.07
0.03
0.00
0.04
0.05
0.02
0.05
0.07
0.06
0.08
0.07
0.06
0.08

0.02
0.01
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.00
0.01
0.02
0.00
0.00
0.00
0.01
0.00
0.01
0.01
0.01
0.02
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.01
0.00
0.01
0.00
0.02
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.01
0.02
0.01
0.01
0.01
0.01

0
13
32
1
2
28
5
6
23
95
1
37
13
7
4
76
59
7
3
0
4
21
6
21
4

0.3
0.3
0.1
0.1
0.3
0.2
0.3
0.3
0.3
0.1
0.2
0.3
0.1
0.2
0.5
0.5
0.3
0.2
0.2
0.3
0.3
0.2
0.1

0.09
0.06
0.06
0.06
0.07
0.08
0.11
0.06
0.03
0.13
0.03
0.09
0.04
0.09
0.06
0.06
0.12
0.11
0.12
0.10
0.15
0.04
0.09

0.02
0.02
0.00
0.01
0.02
0.01
0.04
0.02
0.02
0.01
0.01
0.02
0.01
0.02
0.05
0.05
0.04
0.01
0.01
0.02
0.02
0.01
0.01

0.01
0.00
0.00
0.01
0.00
0.01
0.02
0.00
0.00
0.01
0.00
0.01
0.00
0.01
0.01
0.01
0.02
0.01
0.00
0.01
0.01
0.00
0.01

1
11
26
1
2
18
6
5
19
39
1
33
14
3
4
65
57
4
3
2
3
6
8
24
1

0.1
0.3
0.2
0.1
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.2
0.3
0.0
0.2
0.4
0.4
0.2
0.1
0.0
0.3
0.1
0.3
0.2
0.0

0.09
0.09
0.05
0.08
0.20
0.07
0.10
0.09
0.06
0.03
0.12
0.03
0.09
0.03
0.10
0.05
0.05
0.09
0.03
0.02
0.15
0.07
0.14
0.05
0.02

0.00
0.02
0.01
0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.02
0.00
0.01
0.03
0.03
0.02
0.00
0.00
0.01
0.01
0.02
0.01
0.00

0.00
0.01 *
0.00
- *
0.01
0.00 *
0.01 *
0.01 *
0.00
0.00 *
0.01
0.00
0.00 *
0.00 *
0.01 *
0.01
0.01
0.01
0.00
0.00
0.01
0.00
0.01
0.00
0.00

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

549

607

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Eye (C69) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

550

Female
ASR(W)
CUM 0-74

206
13
14
14
9
14
3
53
9
4
7
4
15
12
23
40
15
12
2
1
17
4
13
10
20

0.3
0.2
0.3
0.5
0.3
0.3
0.3
0.3
0.5
0.2
0.4
0.2
0.3
0.5
0.6
0.3
0.2
0.2
0.5
0.1
0.5
0.3
0.5
0.4
0.3

0.02
0.06
0.08
0.13
0.12
0.08
0.19
0.05
0.18
0.13
0.25
0.09
0.09
0.16
0.13
0.05
0.07
0.08
0.33
0.14
0.15
0.15
0.14
0.13
0.07

0.02
0.03
0.03
0.03
0.02
0.02
0.03
0.03
0.02
0.00
0.07
0.01
0.03
0.05
0.05
0.02
0.01
0.01
0.02
0.04
0.02
0.02
0.03
0.03

0.00
0.01
0.01
0.01
0.01
0.01
0.02
0.00
0.01
0.00
0.06
0.01
0.01
0.02
0.02
0.00
0.00
0.00
0.01
0.01
0.01
0.01
0.01
0.01

177
13
9
5
8
10
0
51
2
0
4
4
12
12
10
36
7
5
0
2
4
4
7
8
37

0.2
0.2
0.2
0.2
0.3
0.2
0.3
0.1
1.0
0.2
0.2
0.5
0.3
0.3
0.1
0.1
0.2
0.1
0.2
0.3
0.3
0.5

0.02
0.06
0.06
0.09
0.11
0.07
0.05
0.10
0.56
0.10
0.07
0.16
0.11
0.05
0.05
0.06
0.15
0.08
0.10
0.10
0.10
0.09

0.02
0.01
0.02
0.02
0.01
0.02
0.02
0.00
0.09
0.01
0.02
0.04
0.03
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.04

0.00
0.00
0.01
0.01
0.01
0.01
0.00
0.00
0.08
0.00
0.01
0.02 *
0.02 *
0.00 *
0.00
0.00
0.01
0.00 *
0.01 *
0.01
0.01 *
0.01 *

104
12
7
201
20
102
115
101
236
217
41
168
27
10
15
19
19
26
32
12
16
10
14
54
100
29
34
41
49
27
5
96
2
15
3
28
10
2
18
10
5
58
7
5
15
29
16
5
8
3
18
22
13
40

0.4
0.6
0.6
0.8
0.4
0.6
0.4
0.7
0.7
1.3
1.0
1.0
0.8
0.6
1.0
0.7
0.6
0.8
1.0
0.8
1.0
0.6
0.5
0.6
0.6
0.4
0.6
0.5
0.6
0.6
0.6
0.9
0.3
0.8
0.2
0.6
0.4
0.3
0.5
0.5
0.4
0.8
0.4
0.4
0.9
0.7
0.5
0.3
0.7
0.5
0.7
1.1
0.7
0.7

0.04
0.18
0.21
0.06
0.12
0.07
0.05
0.08
0.05
0.10
0.18
0.08
0.16
0.22
0.28
0.17
0.17
0.16
0.20
0.26
0.28
0.21
0.13
0.11
0.08
0.08
0.14
0.08
0.10
0.12
0.30
0.09
0.24
0.23
0.14
0.15
0.12
0.19
0.15
0.20
0.18
0.13
0.17
0.20
0.29
0.17
0.12
0.13
0.24
0.31
0.22
0.34
0.20
0.14

0.04
0.05
0.06
0.08
0.04
0.06
0.04
0.08
0.08
0.13
0.11
0.10
0.10
0.05
0.08
0.08
0.07
0.07
0.08
0.06
0.08
0.09
0.06
0.06
0.06
0.05
0.06
0.06
0.06
0.07
0.04
0.09
0.03
0.08
0.03
0.07
0.04
0.04
0.05
0.04
0.04
0.08
0.04
0.05
0.11
0.07
0.04
0.03
0.09
0.05
0.04
0.07
0.07
0.07

0.00
0.02
0.03
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.02
0.01
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.03
0.03
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.02
0.02
0.01
0.01
0.02
0.03
0.01
0.02
0.02
0.01
0.02
0.03
0.03
0.02
0.01
0.02
0.03
0.03
0.01
0.02
0.02
0.01

111
13
5
259
12
118
118
146
222
180
42
135
23
8
17
19
13
45
18
7
16
3
10
53
115
28
44
41
39
21
3
109
4
10
18
23
6
4
23
18
4
52
5
4
7
20
11
2
6
1
14
21
6
42

0.3
0.5
0.6
0.7
0.2
0.6
0.4
0.8
0.6
0.9
0.9
0.7
0.7
0.5
1.0
0.7
0.3
1.1
0.4
0.4
0.7
0.1
0.2
0.5
0.5
0.4
0.5
0.4
0.5
0.4
0.3
0.9
0.3
0.5
1.2
0.5
0.2
0.6
0.4
0.9
0.3
0.7
0.1
0.4
0.5
0.4
0.4
0.1
0.6
0.1
0.3
0.6
0.2
0.5

0.04
0.14
0.28
0.05
0.06
0.06
0.05
0.08
0.05
0.07
0.18
0.07
0.14
0.22
0.27
0.20
0.13
0.19
0.12
0.17
0.19
0.09
0.10
0.10
0.07
0.09
0.09
0.07
0.11
0.10
0.19
0.10
0.21
0.21
0.52
0.17
0.10
0.31
0.14
0.28
0.17
0.15
0.08
0.19
0.27
0.10
0.14
0.06
0.35
0.09
0.09
0.19
0.11
0.11

0.03
0.05
0.05
0.07
0.02
0.06
0.04
0.08
0.06
0.10
0.09
0.07
0.08
0.04
0.10
0.07
0.03
0.13
0.05
0.05
0.09
0.02
0.02
0.05
0.06
0.04
0.05
0.04
0.04
0.04
0.03
0.09
0.03
0.05
0.11
0.04
0.02
0.05
0.04
0.07
0.02
0.06
0.01
0.05
0.04
0.05
0.04
0.01
0.06
0.02
0.03
0.06
0.02
0.06

0.00
0.02
0.02
0.00 *
0.01 *
0.01
0.00 *
0.01
0.00
0.01
0.01
0.01
0.02
0.02
0.03
0.02
0.01
0.02
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.02
0.02
0.03
0.01
0.01
0.03
0.01
0.02
0.01
0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.03
0.02
0.01
0.02
0.01
0.01

*Important. See note on population page.

608

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Eye (C69) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

54
64
3
141
16
15
16
50
45
56
86
115
35
9
16
30
23
2
9
15
12
10
7
15
291
7
9
5
6
4
6
11
357
35
11
51
47
107
147
63
204
265
110
82
32
129

0.8
0.7
0.5
0.9
0.7
0.5
0.4
0.6
0.6
0.5
0.6
0.8
0.6
0.9
0.5
0.6
0.5
0.3
0.5
0.6
0.3
0.7
0.4
0.5
0.9
0.7
1.2
1.0
0.3
0.8
0.5
0.4
0.8
1.0
0.3
0.5
0.6
0.8
0.7
0.8
0.9
0.6
0.7
0.5
0.6
0.8

0.11
0.09
0.30
0.09
0.17
0.14
0.11
0.10
0.10
0.09
0.07
0.08
0.11
0.32
0.18
0.15
0.10
0.20
0.16
0.19
0.09
0.28
0.15
0.17
0.06
0.32
0.42
0.44
0.13
0.45
0.23
0.14
0.04
0.18
0.10
0.08
0.11
0.08
0.07
0.11
0.08
0.04
0.08
0.07
0.12
0.08

0.09
0.07
0.02
0.09
0.09
0.04
0.04
0.05
0.06
0.05
0.06
0.09
0.06
0.11
0.04
0.06
0.05
0.04
0.05
0.07
0.02
0.05
0.05
0.04
0.09
0.04
0.15
0.13
0.04
0.04
0.05
0.06
0.08
0.11
0.05
0.05
0.06
0.08
0.07
0.08
0.09
0.06
0.07
0.05
0.06
0.08

0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.04
0.01
0.01
0.01
0.03
0.02
0.02
0.01
0.02
0.02
0.01
0.01
0.02
0.06
0.06
0.02
0.02
0.03
0.02
0.00
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01

57
91
9
147
10
21
27
41
48
101
87
118
33
4
15
25
8
1
6
4
12
8
10
10
254
5
5
6
12
2
1
8
309
10
17
53
40
59
138
46
198
276
80
59
17
152

0.7
0.6
1.0
0.8
0.4
0.5
0.4
0.4
0.7
0.7
0.6
0.7
0.4
0.4
0.4
0.5
0.2
0.6
0.4
0.1
0.3
0.3
0.6
0.4
0.7
0.3
0.8
1.3
0.7
0.1
0.1
0.5
0.6
0.3
0.6
0.5
0.5
0.4
0.6
0.5
0.8
0.5
0.5
0.3
0.3
0.8

0.14
0.08
0.39
0.08
0.12
0.13
0.10
0.08
0.14
0.10
0.08
0.07
0.08
0.28
0.18
0.13
0.06
0.62
0.20
0.07
0.10
0.13
0.27
0.17
0.06
0.13
0.46
0.64
0.24
0.10
0.12
0.21
0.04
0.11
0.18
0.09
0.09
0.06
0.06
0.09
0.07
0.04
0.07
0.05
0.08
0.08

0.06
0.07
0.05
0.08
0.04
0.04
0.04
0.03
0.05
0.06
0.05
0.06
0.03
0.04
0.04
0.04
0.02
0.03
0.03
0.02
0.02
0.03
0.04
0.03
0.07
0.03
0.05
0.10
0.08
0.02
0.01
0.05
0.06
0.03
0.05
0.05
0.04
0.04
0.06
0.05
0.08
0.05
0.05
0.03
0.03
0.08

0.01
0.01
0.02
0.01
0.01 *
0.01
0.01
0.01 *
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.03
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.02
0.03
0.05
0.03
0.02
0.01
0.02
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.00
0.01
0.01

225
2
170
76
17
149
65
9
6
137
12
0
1
4
3
4

1.1
0.3
1.5
1.6
1.0
1.0
1.2
1.2
1.0
1.2
0.3
0.1
0.8
0.6
0.3

0.08
0.25
0.12
0.20
0.25
0.09
0.15
0.41
0.41
0.11
0.11
0.08
0.42
0.43
0.18

0.11
0.04
0.17
0.16
0.11
0.10
0.11
0.13
0.06
0.13
0.02
0.02
0.04
0.05

0.01
0.03
0.02
0.02
0.03
0.01
0.02
0.05
0.03
0.01
0.01
0.01
0.03
0.03

161
0
98
64
9
86
35
11
1
124
11
0
2
0
1
7

0.7
1.0
1.1
0.5
0.5
0.6
1.2
0.3
1.0
0.3
0.5
0.0
0.9

0.07
0.11
0.16
0.22
0.06
0.11
0.39
0.27
0.10
0.11
0.39
0.02
0.41

0.07
0.09
0.12
0.03
0.05
0.06
0.11
0.10
0.02
0.04
0.06

0.01
0.01
0.02
0.02
0.01
0.01
0.04
0.01
0.01
0.03
0.03

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

551

609

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Brain, nervous system (C70-72)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

Female
ASR(W)
CUM 0-74

26
231
36
10
57

0.7
4.0
3.7
0.6
1.6

0.15
0.28
0.63
0.28
0.28

35
200
20
14
63

1.6
3.1
1.8
0.7
2.8

0.29
0.23
0.42
0.23
0.47

30
221
51
94
1796
35
217
312
126
30
48

4.2
7.8
7.0
5.4
8.0
3.8
5.5
3.7
4.3
2.8
4.3

0.79
0.58
1.05
0.59
0.20
0.65
0.38
0.22
0.40
0.53
0.66

0.36
0.77
0.79
0.56
0.83
0.36
0.54
0.37
0.44
0.33
0.44

0.07
0.08
0.16
0.07
0.02
0.08
0.05
0.03
0.05
0.07
0.09

36
190
46
95
1716
26
188
295
105
23
38

4.3
5.9
5.9
4.8
6.3
2.8
4.1
3.4
3.0
1.8
2.7

0.77
0.47
0.90
0.51
0.16
0.56
0.31
0.21
0.31
0.39
0.46

0.47
0.60
0.64
0.50
0.63
0.22
0.42
0.32
0.29
0.19
0.21

0.08
0.06
0.13
0.07
0.02
0.05
0.04
0.02
0.04
0.04
0.05 *

4603
506
769
226
172
111
2
201
2401
21
194
778
95
673
97
896
5486
334
219
998
3884
1080
55
50
19
8
125
766
1314
77
30
19
12
9
379
756
777
703
28
665
91
49
31
3326
238
3044
1275
197
1053
420
89
318
305
2041
168
1812
1054
591
707
695
125
562
40
93

6.6
6.0
6.0
6.4
7.6
6.8
2.6
7.0
6.9
5.3
5.9
6.0
3.6
6.7
5.9
5.9
5.9
3.1
3.6
4.7
7.4
5.8
4.3
3.4
2.1
3.9
4.6
7.3
5.3
3.2
3.4
3.1
3.6
1.8
4.5
7.4
6.4
7.0
3.8
7.3
5.9
5.5
5.9
6.4
4.2
6.7
6.1
3.8
6.8
6.1
4.0
7.3
8.6
5.9
3.8
6.2
6.1
6.6
6.2
5.7
3.7
6.4
4.0
5.6

0.10
0.28
0.23
0.45
0.63
0.68
1.94
0.53
0.15
1.24
0.45
0.23
0.37
0.28
0.63
0.21
0.08
0.18
0.25
0.16
0.13
0.19
0.60
0.52
0.52
1.58
0.45
0.30
0.15
0.38
0.70
0.73
1.36
0.61
0.25
0.31
0.24
0.28
0.73
0.31
0.66
0.81
1.26
0.12
0.28
0.14
0.17
0.28
0.22
0.31
0.45
0.43
0.51
0.14
0.30
0.15
0.20
0.29
0.25
0.22
0.34
0.29
0.64
0.65

0.66
0.59
0.61
0.64
0.75
0.72
0.51
0.71
0.69
0.52
0.57
0.60
0.35
0.66
0.66
0.58
0.58
0.28
0.35
0.45
0.72
0.58
0.45
0.33
0.16
0.30
0.50
0.73
0.51
0.31
0.29
0.28
0.22
0.18
0.42
0.71
0.64
0.69
0.30
0.73
0.59
0.53
0.64
0.61
0.39
0.64
0.60
0.37
0.67
0.58
0.35
0.68
0.87
0.59
0.35
0.63
0.60
0.66
0.60
0.56
0.35
0.63
0.36
0.55

0.01
0.03
0.03
0.05
0.07
0.08
0.45
0.06
0.02
0.12
0.05
0.02
0.04
0.03
0.09
0.02
0.01
0.02
0.03
0.02
0.01
0.02
0.08
0.06
0.05
0.13
0.06
0.03
0.02
0.04
0.06
0.07
0.09
0.07
0.03
0.03
0.03
0.03
0.07
0.03
0.07
0.08
0.14
0.01
0.03
0.01
0.02
0.03
0.02
0.04
0.05
0.05
0.06
0.02
0.03
0.02
0.02
0.03
0.03
0.03
0.04
0.03
0.07
0.07

3700
364
587
163
112
62
1
170
2064
22
155
683
85
591
71
725
4423
270
207
934
2976
834
35
38
22
4
132
552
1135
104
24
14
5
12
362
596
584
564
31
524
71
40
26
2740
203
2488
1042
165
870
323
67
254
197
1767
135
1579
936
509
636
588
137
446
41
76

4.8
4.2
4.3
4.0
4.8
3.9
1.8
5.5
5.2
5.1
4.8
4.4
2.3
5.1
4.8
4.3
4.3
2.3
3.1
4.2
5.1
4.3
2.5
2.4
2.2
1.0
4.6
5.2
4.0
3.4
2.5
1.7
0.9
2.5
4.0
4.9
4.6
5.0
3.5
5.2
4.6
3.7
5.1
4.7
3.1
5.0
4.3
2.6
4.9
4.1
2.6
5.1
5.2
4.5
2.4
4.9
4.9
5.3
5.2
4.2
3.3
4.8
3.4
4.2

0.09
0.24
0.20
0.36
0.53
0.55
1.77
0.50
0.13
1.19
0.43
0.18
0.26
0.24
0.60
0.18
0.07
0.15
0.22
0.14
0.11
0.16
0.44
0.42
0.51
0.50
0.41
0.27
0.13
0.36
0.56
0.49
0.49
0.82
0.22
0.25
0.21
0.24
0.64
0.27
0.62
0.67
1.23
0.11
0.23
0.12
0.14
0.22
0.18
0.24
0.34
0.35
0.40
0.12
0.21
0.14
0.18
0.28
0.23
0.19
0.29
0.26
0.55
0.59

0.47
0.40
0.42
0.40
0.44
0.43
0.22
0.51
0.52
0.51
0.47
0.44
0.24
0.50
0.53
0.41
0.41
0.20
0.27
0.41
0.48
0.40
0.25
0.20
0.21
0.10
0.48
0.47
0.39
0.30
0.21
0.15
0.07
0.26
0.39
0.49
0.44
0.48
0.32
0.49
0.39
0.35
0.40
0.45
0.29
0.47
0.41
0.23
0.48
0.39
0.27
0.48
0.46
0.43
0.22
0.47
0.47
0.47
0.48
0.40
0.34
0.44
0.39
0.35

0.01
0.03
0.02
0.04
0.05
0.06
0.22
0.05
0.01
0.12
0.04
0.02
0.03
0.02
0.08
0.02
0.01
0.01
0.02
0.02
0.01
0.02
0.05
0.04
0.05
0.05
0.05
0.02
0.01
0.04
0.05
0.04
0.04
0.08
0.03
0.02
0.02
0.02
0.07
0.03
0.05
0.06
0.10
0.01
0.03
0.01
0.02
0.02
0.02
0.03
0.04
0.04
0.04
0.01
0.02
0.01
0.02
0.03
0.02
0.02
0.04
0.02
0.07
0.05

*Important. See note on population page.

Care should be taken when comparing populations. See Chapter 5 Comparability and quality of data
610
552

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp
Care

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Brain, nervous system (C70-72) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

301
1264
1915
143
1741
744
106
621
1081
62
1015
181
40649
2489
36753
1625
119
1419
282
10
92
175
3656
278
3237
2118
137
1918
657
723
2388
103
2211
208
4792
300
4221
12623
551
738
1347
9855
663
103
552
3510
246
3169
372
125
1233
819
354
1082

7.6
6.9
6.7
4.1
7.1
6.6
4.2
7.3
6.8
4.2
7.1
6.8
6.4
3.9
6.8
6.7
4.1
7.0
5.3
2.5
5.0
6.3
6.8
4.2
7.4
6.5
4.5
6.7
6.5
7.2
6.4
3.4
6.6
6.6
6.4
4.1
7.1
6.1
3.3
3.8
4.9
7.1
5.8
3.8
6.4
6.4
4.4
6.6
6.8
7.1
7.4
7.3
6.4
6.7

0.48
0.21
0.16
0.35
0.18
0.25
0.42
0.31
0.22
0.55
0.24
0.54
0.03
0.08
0.04
0.18
0.38
0.20
0.33
0.81
0.53
0.55
0.12
0.26
0.14
0.15
0.39
0.16
0.27
0.28
0.14
0.34
0.16
0.49
0.10
0.24
0.12
0.06
0.15
0.14
0.14
0.08
0.24
0.38
0.29
0.11
0.29
0.12
0.36
0.67
0.22
0.27
0.37
0.22

0.76
0.69
0.67
0.38
0.71
0.65
0.42
0.72
0.66
0.42
0.69
0.65
0.63
0.37
0.67
0.68
0.40
0.71
0.53
0.21
0.54
0.60
0.67
0.39
0.72
0.64
0.45
0.65
0.63
0.71
0.62
0.32
0.64
0.62
0.63
0.40
0.70
0.61
0.31
0.36
0.48
0.70
0.61
0.41
0.67
0.62
0.41
0.65
0.69
0.70
0.74
0.72
0.65
0.69

0.05
0.02
0.02
0.04
0.02
0.03
0.05
0.03
0.02
0.07
0.02
0.06
0.00
0.01
0.00
0.02
0.05
0.02
0.04
0.09
0.07
0.05
0.01
0.03
0.01
0.02
0.04
0.02
0.03
0.03
0.01
0.04
0.02
0.05
0.01
0.03
0.01
0.01
0.02
0.02
0.02
0.01
0.03
0.05
0.03
0.01
0.03
0.01
0.04
0.07
0.03
0.03
0.04
0.02

238
1114
1509
120
1372
618
89
517
920
50
858
159
33939
2282
30558
1407
111
1236
219
12
75
127
3258
320
2826
1799
122
1646
563
514
2097
107
1948
194
3832
241
3355
10362
430
702
1228
7893
560
99
454
2915
208
2634
287
85
967
646
302
889

5.4
5.1
4.6
2.8
4.9
4.6
2.8
5.2
4.8
2.5
5.2
5.1
4.7
2.9
5.0
4.9
2.9
5.3
4.1
2.7
3.9
4.4
5.1
3.6
5.5
4.7
3.1
4.9
5.0
4.6
4.9
2.7
5.1
5.5
4.6
2.8
5.2
4.5
2.4
3.0
4.2
5.2
4.2
2.6
4.9
4.7
3.1
5.0
5.0
4.0
5.4
5.3
4.9
4.9

0.41
0.18
0.13
0.27
0.15
0.21
0.32
0.27
0.18
0.38
0.20
0.45
0.03
0.06
0.03
0.15
0.29
0.18
0.30
0.77
0.46
0.48
0.10
0.22
0.12
0.12
0.29
0.14
0.23
0.23
0.13
0.28
0.14
0.46
0.08
0.19
0.10
0.05
0.12
0.12
0.12
0.07
0.20
0.28
0.27
0.09
0.22
0.10
0.31
0.50
0.19
0.23
0.33
0.19

0.49
0.48
0.44
0.24
0.47
0.42
0.23
0.49
0.47
0.28
0.49
0.54
0.45
0.27
0.48
0.47
0.27
0.51
0.36
0.21
0.35
0.39
0.48
0.33
0.52
0.45
0.28
0.47
0.48
0.42
0.47
0.25
0.49
0.54
0.43
0.25
0.48
0.43
0.21
0.28
0.41
0.49
0.40
0.24
0.45
0.45
0.30
0.47
0.49
0.39
0.51
0.49
0.46
0.47

0.04
0.02
0.01
0.03
0.02
0.02
0.03
0.03
0.02
0.05
0.02
0.05
0.00
0.01
0.00
0.02
0.03
0.02
0.03
0.09
0.05
0.04
0.01
0.02
0.01
0.01
0.03
0.01
0.02
0.02
0.01
0.03
0.01
0.05
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.01
0.02
0.03
0.02
0.01
0.03
0.01
0.03
0.05
0.02
0.02
0.03
0.02

24
179
618
46
130
1212
64
98
314
1093
36
1006
142
274
85
945
802
107
95
86
72
187
104
675
99

3.0
3.4
3.4
4.0
5.6
5.7
1.9
5.2
3.0
4.1
3.7
3.7
3.0
3.6
2.9
6.1
6.1
4.9
2.8
2.6
2.3
2.7
2.1
2.5
2.4

0.67
0.27
0.15
0.69
0.52
0.19
0.24
0.55
0.18
0.14
0.64
0.12
0.26
0.23
0.32
0.20
0.22
0.53
0.30
0.32
0.30
0.22
0.24
0.11
0.31

0.36
0.29
0.32
0.41
0.59
0.60
0.17
0.52
0.31
0.43
0.38
0.38
0.28
0.36
0.29
0.64
0.63
0.53
0.24
0.26
0.22
0.23
0.20
0.23
0.21

0.10
0.03
0.01
0.07
0.06
0.02
0.03
0.06
0.02
0.02
0.08
0.02
0.03
0.03
0.04
0.02
0.03
0.08
0.03
0.03
0.03
0.02
0.02
0.01
0.02

8
141
397
45
116
1404
51
91
200
542
19
649
123
129
64
740
632
69
64
90
58
132
94
623
112

0.9
2.7
2.2
3.6
4.7
6.2
1.5
4.7
2.1
2.3
1.9
2.8
2.6
1.9
2.2
4.3
4.3
3.3
1.9
2.4
1.6
1.8
1.9
2.0
1.8

0.35
0.25
0.12
0.57
0.47
0.20
0.22
0.54
0.15
0.11
0.45
0.11
0.24
0.17
0.28
0.16
0.18
0.43
0.27
0.33
0.25
0.18
0.26
0.10
0.22

0.11
0.24
0.19
0.44
0.48
0.67
0.13
0.43
0.20
0.23
0.20
0.29
0.24
0.21
0.18
0.44
0.43
0.33
0.16
0.23
0.15
0.16
0.17
0.17
0.18

0.05
0.02 *
0.01
0.07 *
0.05
0.02 *
0.02 *
0.05 *
0.02
0.01 *
0.06
0.01
0.03 *
0.02 *
0.03 *
0.02
0.02
0.06
0.02
0.03
0.02
0.01
0.02
0.01
0.02

*Important. See note on population page.


Care should be taken when comparing populations. See Chapter 5 Comparability and quality of data
Cancer Incidence in Five Continents Vol. IX, IARC 2007

553

611

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Brain, nervous system (C70-72) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

Female
ASR(W)
CUM 0-74

2797
264
152
110
103
177
23
774
50
67
61
80
76
87
124
282
170
137
17
16
56
23
43
195
431

3.0
3.0
2.5
3.5
3.2
3.0
2.7
3.5
2.7
5.1
3.1
3.5
1.6
3.5
3.3
2.8
2.1
2.3
2.7
1.4
1.6
1.1
1.5
6.0
5.3

0.06
0.19
0.22
0.35
0.35
0.24
0.57
0.14
0.41
0.69
0.84
0.40
0.19
0.41
0.32
0.19
0.17
0.21
0.66
0.36
0.21
0.22
0.23
0.44
0.26

0.29
0.30
0.23
0.35
0.29
0.27
0.32
0.33
0.25
0.51
0.24
0.34
0.15
0.36
0.33
0.29
0.18
0.20
0.24
0.10
0.14
0.10
0.13
0.63
0.52

0.01
0.03
0.02
0.05
0.04
0.03
0.08
0.02
0.05
0.08
0.07
0.05
0.02
0.06
0.04
0.03
0.02
0.02
0.06
0.03
0.02
0.02
0.02
0.05
0.03

2469
218
125
75
92
171
24
731
44
44
33
72
71
67
86
252
140
108
13
19
53
44
38
143
264

2.4
2.1
2.0
2.3
2.7
2.8
2.6
3.0
2.3
3.1
3.0
2.9
1.5
2.6
2.7
2.4
1.7
1.6
2.1
1.7
1.4
2.2
1.2
4.4
3.1

0.05
0.15
0.19
0.27
0.29
0.22
0.55
0.12
0.37
0.51
0.80
0.35
0.18
0.37
0.33
0.16
0.15
0.16
0.63
0.40
0.19
0.36
0.20
0.38
0.20

0.23
0.20
0.16
0.20
0.27
0.28
0.24
0.30
0.23
0.29
0.27
0.28
0.14
0.25
0.25
0.23
0.15
0.14
0.18
0.16
0.11
0.17
0.09
0.42
0.31

0.01
0.02
0.02
0.03
0.03
0.03
0.05
0.01
0.05
0.07
0.10
0.04
0.02
0.04 *
0.04 *
0.02 *
0.02
0.02
0.06
0.04
0.02 *
0.03 *
0.02
0.04 *
0.02 *

1618
100
64
1165
273
916
1606
1386
1923
1135
225
1056
180
96
87
129
167
228
188
68
89
75
80
541
931
340
363
488
478
223
50
810
28
142
107
303
144
48
263
152
116
472
147
68
113
277
184
126
79
31
231
221
136
385

6.5
4.6
6.6
4.5
4.8
5.9
6.1
10.2
6.1
6.3
5.9
6.5
5.8
5.4
5.4
5.9
5.8
6.4
5.8
4.3
5.4
5.4
4.2
6.3
6.0
6.1
6.1
5.9
5.6
6.3
5.7
7.5
3.8
7.6
7.5
6.5
7.2
7.6
6.7
6.2
8.0
6.8
9.4
7.2
7.2
7.3
6.4
7.5
7.5
4.9
6.8
7.0
8.3
6.9

0.18
0.47
0.86
0.14
0.31
0.21
0.17
0.30
0.15
0.20
0.41
0.22
0.45
0.58
0.61
0.55
0.50
0.44
0.44
0.55
0.63
0.68
0.52
0.32
0.23
0.38
0.36
0.29
0.28
0.49
0.85
0.27
0.91
0.74
0.95
0.47
0.83
1.29
0.52
0.60
0.76
0.38
0.97
0.96
0.80
0.54
0.51
0.72
0.90
0.92
0.56
0.58
0.80
0.41

0.66
0.52
0.62
0.43
0.51
0.58
0.64
1.02
0.65
0.64
0.60
0.64
0.64
0.53
0.56
0.67
0.57
0.63
0.61
0.48
0.54
0.62
0.47
0.68
0.63
0.64
0.64
0.62
0.57
0.65
0.64
0.78
0.43
0.75
0.78
0.68
0.70
0.72
0.67
0.66
0.78
0.66
0.96
0.75
0.73
0.76
0.65
0.80
0.84
0.54
0.70
0.70
0.86
0.71

0.02
0.06
0.09
0.01
0.03
0.02
0.02
0.03
0.02
0.02
0.04
0.02
0.05
0.06
0.07
0.06
0.05
0.05
0.05
0.06
0.06
0.08
0.06
0.03
0.02
0.04
0.04
0.03
0.03
0.05
0.11
0.03
0.09
0.07
0.09
0.05
0.07
0.11
0.05
0.06
0.08
0.03
0.09
0.10
0.08
0.05
0.05
0.08
0.10
0.11
0.05
0.05
0.08
0.04

1460
86
55
1012
210
760
1253
1322
1734
975
205
927
145
83
77
97
151
169
141
56
72
50
68
473
839
308
317
460
453
175
52
622
31
120
111
288
119
50
206
141
94
401
109
56
93
227
188
109
52
24
201
210
90
363

4.8
3.4
5.0
3.3
3.2
4.7
4.3
7.9
4.6
4.9
4.1
5.2
4.2
3.7
4.4
3.9
4.5
4.3
3.8
3.0
3.9
2.9
3.6
4.7
4.4
4.5
4.6
4.7
4.5
4.0
6.0
5.0
4.1
5.7
6.2
5.6
4.5
6.0
3.8
5.2
6.0
4.0
5.8
5.3
5.1
4.5
6.0
5.5
4.4
3.7
4.5
5.5
3.8
5.5

0.15
0.41
0.76
0.11
0.24
0.20
0.13
0.25
0.13
0.18
0.32
0.20
0.39
0.45
0.55
0.45
0.41
0.36
0.35
0.46
0.52
0.47
0.50
0.27
0.21
0.33
0.34
0.27
0.25
0.36
0.89
0.22
1.04
0.68
0.91
0.45
0.60
0.96
0.37
0.61
0.66
0.27
0.81
0.79
0.69
0.40
0.51
0.64
0.73
0.94
0.45
0.53
0.45
0.38

0.48
0.35
0.50
0.31
0.36
0.45
0.44
0.81
0.49
0.51
0.42
0.47
0.40
0.38
0.44
0.42
0.49
0.47
0.40
0.34
0.37
0.34
0.38
0.47
0.45
0.47
0.47
0.48
0.46
0.42
0.63
0.52
0.38
0.52
0.63
0.59
0.46
0.74
0.38
0.49
0.61
0.40
0.56
0.56
0.46
0.48
0.64
0.51
0.45
0.37
0.48
0.57
0.44
0.55

0.01
0.04
0.08
0.01 *
0.03 *
0.02
0.01 *
0.02
0.01
0.02
0.03
0.02
0.04
0.05
0.06
0.05
0.04
0.04
0.04
0.05
0.05
0.06
0.05
0.02
0.02
0.03
0.03
0.03
0.02
0.04
0.11
0.03
0.08
0.06
0.08
0.04
0.05
0.11
0.03
0.05
0.07
0.03
0.07
0.08
0.06
0.04
0.05
0.06
0.07
0.09
0.04
0.05
0.05
0.03

*Important. See note on population page.

Care should be taken when comparing populations. See Chapter 5 Comparability and quality of data
612
554

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Care

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Brain, nervous system (C70-72) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

439
630
65
955
146
355
347
445
735
573
1345
876
332
64
221
402
240
50
128
128
187
142
109
146
1586
94
56
33
95
72
45
116
2871
172
182
570
599
727
1464
562
1676
2833
1064
1019
338
1071

7.0
6.5
5.7
6.7
7.0
9.7
6.6
5.1
7.8
4.7
9.4
6.1
5.6
6.1
5.6
6.6
5.5
5.8
6.9
4.8
5.7
7.6
6.1
5.0
5.7
7.2
8.1
6.5
5.8
7.4
5.2
5.7
5.8
5.5
6.2
5.9
7.5
5.4
6.8
6.5
7.3
6.5
6.6
5.9
6.9
6.5

0.37
0.27
0.74
0.23
0.65
0.54
0.39
0.26
0.32
0.22
0.28
0.22
0.33
0.86
0.45
0.36
0.37
0.96
0.74
0.45
0.45
0.78
0.65
0.46
0.16
0.78
1.21
1.27
0.64
1.00
0.82
0.57
0.11
0.44
0.50
0.27
0.33
0.22
0.19
0.29
0.20
0.13
0.22
0.20
0.39
0.21

0.67
0.69
0.60
0.70
0.72
1.00
0.73
0.53
0.81
0.49
0.98
0.65
0.58
0.65
0.58
0.72
0.61
0.61
0.66
0.53
0.54
0.75
0.66
0.52
0.59
0.84
0.77
0.63
0.64
0.78
0.52
0.59
0.61
0.57
0.64
0.64
0.78
0.56
0.71
0.70
0.75
0.70
0.66
0.62
0.69
0.69

0.03
0.03
0.08
0.03
0.07
0.06
0.04
0.03
0.03
0.02
0.03
0.02
0.03
0.09
0.04
0.04
0.04
0.10
0.07
0.05
0.04
0.07
0.07
0.05
0.02
0.10
0.12
0.12
0.07
0.10
0.09
0.06
0.01
0.05
0.05
0.03
0.04
0.02
0.02
0.03
0.02
0.02
0.02
0.02
0.04
0.02

383
590
45
736
126
369
316
362
605
571
1121
699
261
39
211
362
202
37
108
110
148
123
111
132
1164
64
49
24
77
60
39
89
2131
138
127
418
487
615
1056
375
1208
2171
866
740
254
823

4.3
4.8
3.2
4.8
4.5
8.3
4.5
3.6
5.7
3.4
7.5
4.0
3.7
2.8
4.9
5.2
4.3
4.6
5.4
3.5
3.7
5.5
6.2
3.8
4.0
3.8
6.4
5.3
4.0
4.5
3.7
4.2
4.1
4.3
4.3
4.0
5.1
4.3
4.4
4.1
4.8
4.3
4.9
3.9
4.6
4.1

0.25
0.22
0.51
0.20
0.48
0.48
0.30
0.21
0.29
0.18
0.26
0.16
0.27
0.55
0.46
0.35
0.33
0.97
0.64
0.38
0.35
0.63
0.69
0.43
0.13
0.58
1.08
1.26
0.50
0.72
0.68
0.50
0.10
0.41
0.44
0.23
0.26
0.20
0.15
0.23
0.16
0.11
0.20
0.16
0.32
0.17

0.45
0.48
0.36
0.48
0.45
0.88
0.47
0.37
0.55
0.33
0.74
0.41
0.38
0.28
0.50
0.51
0.43
0.42
0.55
0.38
0.38
0.57
0.64
0.39
0.41
0.38
0.61
0.48
0.41
0.40
0.41
0.40
0.42
0.45
0.45
0.43
0.55
0.44
0.45
0.42
0.48
0.45
0.48
0.40
0.45
0.43

0.02
0.02
0.06
0.02
0.05 *
0.05
0.03
0.02 *
0.03
0.01
0.02
0.02
0.03
0.06
0.04
0.03
0.04
0.09
0.06
0.04
0.04
0.06
0.07
0.04
0.01
0.06
0.10
0.10
0.06
0.07
0.08
0.05
0.01
0.04
0.04
0.02
0.03
0.02
0.02
0.03
0.02
0.01
0.02
0.02
0.03
0.02

1328
24
686
334
106
1070
349
55
25
783
158
6
19
29
27
68

6.6
4.7
6.3
6.8
7.1
7.2
6.3
6.5
4.8
7.0
4.4
1.7
2.7
5.1
3.2
8.2

0.19
1.02
0.25
0.40
0.73
0.23
0.35
0.91
1.00
0.26
0.38
0.81
0.67
0.97
0.80
1.19

0.69
0.45
0.66
0.72
0.70
0.71
0.64
0.55
0.50
0.72
0.40
0.12
0.28
0.48
0.26
0.74

0.02
0.12
0.03
0.05
0.08
0.03
0.04
0.09
0.13
0.03
0.04
0.07
0.09
0.12
0.06
0.11

983
14
528
234
70
815
247
43
20
508
124
4
10
25
23
49

4.6
4.3
4.7
4.2
4.5
5.0
3.9
4.5
4.0
4.0
3.4
1.9
1.5
4.5
3.2
5.1

0.16
1.23
0.22
0.31
0.60
0.20
0.27
0.72
0.93
0.19
0.34
0.96
0.51
0.92
0.97
0.88

0.47
0.52
0.46
0.43
0.45
0.50
0.40
0.41
0.43
0.41
0.31
0.17
0.14
0.43
0.26
0.46

0.02
0.22
0.02
0.03
0.06
0.02
0.03
0.08
0.12
0.02
0.03
0.08
0.06
0.10
0.06
0.08

*Important. See note on population page.


Care should be taken when comparing populations. See Chapter 5 Comparability and quality of data
Cancer Incidence in Five Continents Vol. IX, IARC 2007

555

613

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Thyroid (C73)
Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

556

Female
ASR(W)
CUM 0-74

32
53
14
11
14

1.4
1.1
1.3
0.5
1.0

0.26
0.17
0.37
0.23
0.30

88
151
34
26
45

3.6
2.6
3.1
1.5
3.1

0.41
0.22
0.54
0.38
0.54

6
88
8
39
861
16
85
141
57
11
17

0.7
3.5
1.1
2.1
3.6
1.7
2.2
1.7
2.0
1.0
1.7

0.31
0.41
0.42
0.36
0.13
0.44
0.25
0.15
0.28
0.30
0.42

0.04
0.42
0.14
0.22
0.38
0.22
0.24
0.18
0.21
0.09
0.20

0.03
0.06
0.07
0.05
0.02
0.07
0.03
0.02
0.04
0.03
0.07

17
338
43
208
4399
42
450
739
356
80
68

1.9
9.8
4.8
9.3
14.9
4.4
9.4
8.2
10.2
6.5
5.7

0.47
0.60
0.79
0.67
0.24
0.69
0.46
0.31
0.56
0.75
0.72

0.22
1.04
0.53
0.90
1.46
0.49
0.96
0.78
1.03
0.65
0.68

0.06
0.08
0.10
0.08
0.03
0.09
0.06
0.03
0.07
0.08
0.10 *

2095
295
271
68
54
26
2
54
1243
3
79
300
38
257
63
475
2720
329
103
470
1789
545
22
37
33
5
66
339
779
47
26
37
17
18
169
438
432
386
7
368
82
36
40
1434
69
1334
568
66
484
213
26
173
117
1100
62
972
476
290
332
318
47
266
15
54

2.9
3.2
2.1
2.0
2.2
1.5
1.5
1.7
3.4
0.6
2.6
2.2
1.4
2.4
3.6
3.0
2.8
2.9
1.6
2.3
3.2
2.8
1.5
2.5
3.7
2.2
2.3
3.0
3.0
1.8
2.3
4.8
4.0
3.2
2.2
3.9
3.4
3.8
0.9
4.1
5.1
3.8
6.3
2.6
1.3
2.8
2.5
1.3
2.8
2.8
1.1
3.5
3.1
3.0
1.4
3.2
2.6
3.2
2.7
2.5
1.5
2.9
1.7
3.1

0.06
0.19
0.13
0.25
0.31
0.30
1.07
0.24
0.10
0.38
0.30
0.13
0.23
0.15
0.48
0.14
0.06
0.16
0.17
0.11
0.08
0.12
0.34
0.42
0.66
1.01
0.31
0.17
0.11
0.27
0.47
0.81
1.00
0.77
0.18
0.20
0.17
0.20
0.34
0.22
0.57
0.64
1.02
0.07
0.15
0.08
0.11
0.16
0.13
0.20
0.24
0.27
0.29
0.09
0.18
0.10
0.12
0.19
0.15
0.14
0.23
0.18
0.43
0.43

0.30
0.34
0.22
0.23
0.19
0.14
0.10
0.22
0.35
0.09
0.28
0.23
0.16
0.25
0.40
0.31
0.30
0.30
0.19
0.25
0.34
0.29
0.18
0.24
0.37
0.23
0.28
0.32
0.32
0.20
0.23
0.51
0.47
0.35
0.24
0.40
0.36
0.38
0.08
0.40
0.53
0.42
0.63
0.28
0.16
0.30
0.28
0.14
0.32
0.31
0.13
0.37
0.34
0.32
0.17
0.33
0.29
0.35
0.28
0.27
0.19
0.31
0.23
0.33

0.01
0.02
0.01
0.03
0.03
0.03
0.07
0.03
0.01
0.06
0.03
0.02
0.03
0.02
0.06
0.02
0.01
0.02
0.02
0.02
0.01
0.01
0.05
0.04
0.07
0.11
0.05
0.02
0.01
0.03
0.05
0.10
0.12
0.10
0.02
0.02
0.02
0.02
0.03
0.02
0.07
0.08
0.12
0.01
0.02
0.01
0.01
0.02
0.02
0.03
0.03
0.03
0.04
0.01
0.02
0.01
0.01
0.02
0.02
0.02
0.03
0.02
0.07
0.05

6839
802
733
265
178
102
7
180
4349
19
204
898
171
704
173
1368
8487
1264
308
2002
4783
1572
57
135
94
22
236
826
2516
129
81
155
33
59
802
1160
1256
1113
51
1007
191
107
62
4052
345
3582
1774
334
1377
720
157
525
367
3380
277
2908
1451
861
1057
1052
209
831
59
163

9.3
8.8
5.6
7.5
7.3
5.9
6.0
5.8
11.8
4.1
6.7
6.4
4.8
6.9
10.0
9.0
8.4
9.5
4.3
8.3
9.0
7.8
3.7
8.5
8.8
5.8
7.4
7.9
8.9
4.0
6.8
15.7
6.9
9.3
8.3
11.1
9.6
10.2
4.9
10.6
10.3
8.9
10.1
7.8
4.9
8.3
7.1
4.8
8.0
8.1
5.1
9.9
10.0
8.8
4.8
9.5
7.8
9.8
8.4
7.7
4.9
9.2
4.6
9.0

0.12
0.32
0.22
0.49
0.57
0.60
2.33
0.46
0.18
0.99
0.49
0.22
0.38
0.27
0.79
0.25
0.09
0.27
0.25
0.20
0.14
0.20
0.50
0.77
0.92
1.45
0.50
0.30
0.18
0.36
0.79
1.29
1.27
1.25
0.31
0.35
0.28
0.32
0.70
0.36
0.76
0.89
1.32
0.13
0.27
0.15
0.17
0.27
0.22
0.31
0.43
0.45
0.54
0.16
0.29
0.18
0.21
0.35
0.27
0.24
0.35
0.33
0.61
0.75

0.87
0.83
0.53
0.68
0.67
0.54
0.57
0.53
1.10
0.39
0.62
0.59
0.48
0.63
0.92
0.85
0.80
0.94
0.43
0.82
0.83
0.73
0.37
0.78
0.89
0.58
0.69
0.72
0.86
0.40
0.57
1.54
0.69
0.97
0.82
1.05
0.90
0.95
0.51
0.98
1.03
0.92
0.99
0.73
0.47
0.77
0.68
0.49
0.76
0.78
0.51
0.93
0.90
0.83
0.47
0.88
0.72
0.89
0.77
0.73
0.50
0.85
0.48
0.89

0.01
0.03
0.02
0.05
0.05
0.06
0.24
0.04
0.02
0.10
0.05
0.02
0.04
0.03
0.08
0.02
0.01
0.03
0.03
0.02
0.01
0.02
0.06
0.07
0.10
0.14
0.06
0.03
0.02
0.04
0.07
0.14
0.13
0.14
0.04
0.03
0.03
0.03
0.08
0.03
0.08
0.10
0.14
0.01
0.03
0.01
0.02
0.03
0.02
0.03
0.05
0.05
0.05
0.02
0.03
0.02
0.02
0.03
0.03
0.02
0.04
0.03
0.07
0.07

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

614

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Thyroid (C73) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

99
644
842
65
756
384
53
323
480
22
452
108
19839
1052
17616
969
64
845
222
7
81
131
2019
112
1790
856
42
766
230
305
1513
76
1381
116
2588
121
2216
6586
518
330
680
4971
265
37
223
1699
96
1518
202
52
580
411
179
463

2.4
3.4
2.8
2.0
2.9
3.2
2.2
3.5
2.8
1.5
3.0
3.6
3.0
1.6
3.1
3.8
2.2
4.0
4.1
1.7
4.3
4.5
3.6
1.6
3.9
2.5
1.3
2.5
2.2
2.9
3.9
2.4
3.9
3.6
3.3
1.6
3.5
3.0
2.9
1.7
2.5
3.4
2.2
1.2
2.5
2.9
1.7
3.0
3.7
2.8
3.3
3.4
3.1
2.8

0.25
0.14
0.10
0.26
0.11
0.17
0.31
0.20
0.13
0.33
0.15
0.36
0.02
0.05
0.02
0.13
0.28
0.14
0.28
0.66
0.48
0.41
0.08
0.15
0.10
0.09
0.21
0.09
0.15
0.17
0.10
0.29
0.11
0.35
0.07
0.15
0.08
0.04
0.13
0.10
0.10
0.05
0.14
0.20
0.17
0.07
0.18
0.08
0.26
0.41
0.14
0.17
0.24
0.14

0.26
0.36
0.29
0.25
0.30
0.35
0.26
0.37
0.30
0.20
0.32
0.37
0.31
0.18
0.33
0.41
0.24
0.43
0.41
0.22
0.42
0.45
0.39
0.17
0.42
0.26
0.15
0.26
0.23
0.29
0.41
0.27
0.42
0.36
0.34
0.19
0.36
0.32
0.31
0.20
0.27
0.36
0.23
0.12
0.26
0.31
0.17
0.32
0.40
0.29
0.33
0.34
0.30
0.28

0.03
0.02
0.01
0.04
0.01
0.02
0.04
0.02
0.02
0.05
0.02
0.04
0.00
0.01
0.00
0.01
0.03
0.02
0.03
0.10
0.05
0.04
0.01
0.02
0.01
0.01
0.03
0.01
0.02
0.02
0.01
0.04
0.01
0.04
0.01
0.02
0.01
0.00
0.02
0.01
0.01
0.01
0.02
0.03
0.02
0.01
0.02
0.01
0.03
0.04
0.02
0.02
0.02
0.01

338
2132
2696
242
2348
1171
180
946
1496
93
1370
321
60456
4256
51843
2966
213
2522
636
40
214
371
6201
564
5205
2605
170
2314
596
848
4903
365
4355
377
7819
494
6306
20454
2014
1224
2779
14047
839
162
659
4887
332
4285
691
170
1760
1215
542
1288

8.4
10.4
8.7
5.6
9.2
9.0
5.5
10.3
8.5
4.9
9.0
11.9
8.7
5.2
9.1
11.0
5.6
11.9
11.6
8.4
10.9
13.6
10.1
5.9
11.0
7.3
4.2
7.4
5.7
8.1
12.5
9.6
12.6
11.4
9.5
5.2
10.0
9.1
9.8
5.0
8.8
9.8
6.6
4.5
7.6
8.0
4.8
8.3
11.8
8.5
9.9
9.7
9.1
7.9

0.49
0.23
0.17
0.37
0.20
0.28
0.43
0.36
0.23
0.52
0.26
0.70
0.04
0.08
0.04
0.21
0.39
0.25
0.47
1.35
0.76
0.76
0.13
0.25
0.16
0.15
0.33
0.16
0.24
0.29
0.19
0.51
0.20
0.61
0.11
0.24
0.13
0.07
0.22
0.15
0.17
0.09
0.24
0.36
0.31
0.12
0.27
0.13
0.46
0.69
0.24
0.29
0.41
0.23

0.75
0.96
0.80
0.58
0.83
0.84
0.57
0.93
0.80
0.47
0.84
1.08
0.82
0.52
0.85
1.03
0.56
1.10
1.12
0.81
1.08
1.26
0.96
0.59
1.02
0.68
0.41
0.69
0.53
0.74
1.18
0.96
1.18
1.03
0.89
0.53
0.92
0.86
0.97
0.51
0.86
0.91
0.62
0.45
0.69
0.76
0.47
0.78
1.09
0.77
0.91
0.90
0.86
0.71

0.04
0.02
0.02
0.04
0.02
0.03
0.05
0.03
0.02
0.06
0.02
0.06
0.00
0.01
0.00
0.02
0.04
0.02
0.05
0.15
0.08
0.07
0.01
0.03
0.02
0.01
0.04
0.02
0.02
0.03
0.02
0.05
0.02
0.06
0.01
0.03
0.01
0.01
0.02
0.02
0.02
0.01
0.02
0.04
0.03
0.01
0.03
0.01
0.05
0.07
0.02
0.03
0.04
0.02

8
84
447
11
18
314
35
54
82
262
17
184
17
53
58
526
474
43
50
81
93
175
122
432
77

1.1
1.4
2.2
1.0
0.7
1.4
0.9
2.7
0.8
1.0
1.7
0.7
0.4
0.7
2.0
3.4
3.5
2.0
1.3
2.7
2.3
2.0
2.0
1.3
1.5

0.42
0.15
0.11
0.33
0.17
0.08
0.16
0.38
0.09
0.07
0.45
0.06
0.10
0.11
0.27
0.15
0.17
0.34
0.19
0.32
0.25
0.16
0.20
0.06
0.19

0.14
0.14
0.23
0.08
0.09
0.15
0.10
0.29
0.09
0.12
0.22
0.08
0.05
0.09
0.23
0.35
0.37
0.19
0.14
0.28
0.29
0.21
0.22
0.14
0.17

0.06
0.02
0.01
0.03
0.02
0.01
0.02
0.04
0.01
0.01
0.08
0.01
0.01
0.02
0.04
0.02
0.02
0.04
0.02
0.03
0.03
0.02
0.02
0.01
0.02

57
295
1557
20
33
1044
105
190
202
579
44
355
42
93
196
1948
1747
161
196
221
472
819
473
1194
393

7.7
4.7
7.2
1.5
1.2
4.7
3.0
9.3
1.9
2.6
3.9
1.5
1.0
1.4
5.8
11.7
12.1
7.0
5.6
6.2
11.6
9.2
7.4
3.2
8.0

1.09
0.28
0.19
0.34
0.21
0.15
0.30
0.69
0.14
0.12
0.60
0.08
0.15
0.15
0.42
0.27
0.30
0.58
0.41
0.47
0.55
0.34
0.38
0.10
0.46

0.80
0.45
0.69
0.15
0.14
0.46
0.28
0.83
0.21
0.28
0.32
0.14
0.12
0.15
0.49
1.17
1.21
0.68
0.57
0.68
1.23
0.99
0.76
0.33
0.82

0.13
0.03 *
0.02
0.04 *
0.03
0.02 *
0.03 *
0.06 *
0.02
0.02 *
0.06
0.01
0.02 *
0.02 *
0.04 *
0.03
0.03
0.07
0.04
0.05
0.06
0.04
0.04
0.01
0.04

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

557

615

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Thyroid (C73) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

558

Female
ASR(W)
CUM 0-74

2314
215
118
73
121
109
25
644
49
46
62
25
46
32
25
260
180
147
11
22
43
18
52
38
90

2.3
2.2
1.7
2.2
3.6
1.9
3.1
2.5
2.4
3.5
1.0
1.1
1.1
1.7
0.7
2.9
2.0
2.0
1.3
2.3
1.1
0.8
1.7
1.1
1.1

0.05
0.18
0.17
0.27
0.35
0.20
0.64
0.10
0.40
0.56
0.20
0.23
0.17
0.32
0.15
0.21
0.15
0.17
0.43
0.51
0.17
0.20
0.24
0.19
0.12

0.24
0.22
0.16
0.21
0.42
0.16
0.37
0.27
0.25
0.37
0.10
0.10
0.12
0.20
0.07
0.32
0.21
0.21
0.16
0.29
0.13
0.13
0.18
0.12
0.12

0.01
0.02
0.02
0.03
0.05
0.02
0.10
0.01
0.06
0.07
0.03
0.02
0.02
0.04
0.02
0.03
0.02
0.02
0.05
0.07
0.02
0.03
0.03
0.02
0.01

13725
989
753
339
809
715
128
4122
265
120
86
103
138
137
71
1206
636
512
46
78
191
87
209
157
329

12.2
8.5
10.1
8.8
21.4
10.3
13.1
14.1
12.3
7.3
5.0
4.0
3.2
5.9
2.9
11.1
6.6
6.5
7.0
6.8
4.5
3.7
6.2
4.5
3.6

0.11
0.28
0.38
0.49
0.77
0.40
1.18
0.22
0.81
0.72
0.91
0.40
0.28
0.54
0.38
0.35
0.27
0.30
1.08
0.81
0.33
0.41
0.43
0.37
0.20

1.19
0.87
0.98
0.83
2.14
1.02
1.34
1.42
1.23
0.75
0.55
0.44
0.33
0.53
0.31
1.22
0.64
0.64
0.69
0.70
0.44
0.38
0.60
0.47
0.36

0.01
0.03
0.04
0.05
0.09
0.04
0.13
0.03
0.09
0.09
0.13
0.05
0.03
0.06 *
0.05 *
0.05 *
0.03
0.03
0.12
0.10
0.04 *
0.05 *
0.05
0.04 *
0.02 *

737
73
25
892
64
206
244
306
571
210
52
384
75
59
60
58
62
143
106
32
36
46
96
205
337
75
136
209
122
71
41
94
23
105
87
143
71
17
119
127
53
210
71
31
84
151
93
50
35
15
80
104
45
156

2.8
3.4
2.3
3.3
1.1
1.2
0.9
2.1
1.7
1.2
1.2
2.2
2.3
3.1
3.8
2.4
2.2
4.3
3.0
2.0
2.2
3.8
5.1
2.2
2.1
1.2
2.1
2.5
1.4
1.9
4.6
0.8
3.2
4.9
6.3
3.3
3.5
2.4
3.2
5.9
3.6
2.8
4.9
3.3
5.2
4.2
3.5
3.1
3.6
2.5
2.5
3.7
2.9
2.8

0.11
0.40
0.46
0.11
0.15
0.09
0.06
0.13
0.07
0.08
0.17
0.11
0.27
0.42
0.50
0.32
0.29
0.36
0.30
0.36
0.37
0.59
0.54
0.16
0.12
0.15
0.19
0.18
0.13
0.24
0.74
0.09
0.69
0.50
0.74
0.30
0.48
0.64
0.32
0.55
0.49
0.20
0.63
0.61
0.59
0.37
0.37
0.45
0.63
0.65
0.32
0.41
0.46
0.24

0.30
0.38
0.25
0.29
0.12
0.13
0.09
0.22
0.18
0.11
0.16
0.23
0.23
0.27
0.38
0.27
0.23
0.44
0.31
0.20
0.22
0.40
0.53
0.24
0.22
0.12
0.23
0.26
0.15
0.20
0.52
0.10
0.38
0.51
0.69
0.36
0.36
0.23
0.33
0.54
0.36
0.27
0.52
0.35
0.55
0.42
0.33
0.35
0.34
0.22
0.26
0.36
0.30
0.29

0.01
0.05
0.06
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.03
0.04
0.05
0.04
0.03
0.04
0.03
0.04
0.04
0.06
0.06
0.02
0.01
0.02
0.02
0.02
0.01
0.03
0.10
0.01
0.08
0.05
0.08
0.03
0.05
0.06
0.03
0.05
0.05
0.02
0.07
0.07
0.06
0.04
0.04
0.05
0.06
0.06
0.03
0.04
0.05
0.03

1880
198
70
3860
128
512
785
1254
2012
524
293
1281
198
203
182
119
220
461
405
122
165
214
306
526
930
152
405
637
308
216
91
263
51
334
266
451
203
49
341
349
150
700
198
97
259
520
341
200
146
58
306
295
123
482

6.5
8.7
5.5
12.2
2.0
3.0
2.8
8.2
5.4
2.9
5.5
7.0
5.8
9.9
11.2
5.2
7.3
13.2
10.9
8.0
9.3
18.1
17.0
5.4
5.1
2.2
6.3
7.5
3.2
5.3
10.9
2.3
8.2
17.0
20.4
10.7
10.0
7.6
8.3
15.4
9.5
8.9
14.1
10.0
16.5
14.8
12.4
12.0
14.2
8.7
8.7
10.3
7.1
8.0

0.16
0.65
0.70
0.20
0.19
0.14
0.11
0.24
0.13
0.14
0.34
0.21
0.43
0.73
0.86
0.49
0.51
0.63
0.56
0.77
0.75
1.31
1.04
0.26
0.19
0.21
0.34
0.32
0.20
0.39
1.19
0.14
1.30
1.03
1.39
0.55
0.81
1.19
0.51
0.88
0.79
0.37
1.09
1.06
1.11
0.71
0.70
0.88
1.21
1.21
0.55
0.67
0.69
0.39

0.65
0.81
0.60
1.12
0.21
0.30
0.27
0.80
0.55
0.27
0.57
0.67
0.57
0.93
1.09
0.50
0.71
1.30
1.07
0.76
0.95
1.80
1.67
0.55
0.52
0.21
0.61
0.76
0.31
0.54
1.06
0.22
0.75
1.61
2.03
1.03
0.94
0.79
0.81
1.51
0.85
0.89
1.33
0.93
1.64
1.41
1.11
1.24
1.32
0.93
0.86
0.96
0.65
0.79

0.02
0.06
0.08
0.02 *
0.02 *
0.01
0.01 *
0.02
0.01
0.01
0.04
0.02
0.04
0.07
0.09
0.05
0.05
0.06
0.06
0.07
0.08
0.13
0.10
0.03
0.02
0.02
0.03
0.03
0.02
0.04
0.12
0.02
0.11
0.09
0.13
0.05
0.07
0.12
0.05
0.08
0.07
0.04
0.10
0.10
0.11
0.07
0.06
0.09
0.11
0.13
0.05
0.06
0.06
0.04

*Important. See note on population page.

616

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Thyroid (C73) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

70
167
19
247
43
59
66
194
151
152
125
219
116
10
55
94
81
9
40
27
68
51
23
37
407
27
7
15
38
25
17
41
524
34
24
95
78
105
230
84
232
433
153
189
72
177

1.0
1.7
1.7
1.6
1.8
1.5
1.2
2.1
1.7
1.1
0.8
1.4
1.8
1.3
1.5
1.6
1.8
1.0
2.4
1.0
2.2
2.4
1.7
1.4
1.3
2.0
1.0
2.3
2.0
2.5
1.8
2.0
1.0
0.9
0.8
0.9
1.0
0.8
1.0
0.9
1.0
0.9
0.9
1.1
1.4
1.1

0.12
0.13
0.39
0.11
0.28
0.20
0.15
0.16
0.14
0.09
0.08
0.10
0.17
0.44
0.21
0.18
0.20
0.39
0.39
0.21
0.28
0.35
0.42
0.24
0.07
0.40
0.39
0.65
0.34
0.52
0.44
0.34
0.04
0.16
0.16
0.10
0.12
0.08
0.07
0.10
0.07
0.05
0.08
0.08
0.17
0.08

0.11
0.18
0.17
0.18
0.19
0.17
0.14
0.21
0.17
0.13
0.09
0.16
0.18
0.09
0.15
0.16
0.20
0.14
0.22
0.10
0.20
0.25
0.14
0.13
0.13
0.23
0.10
0.17
0.18
0.23
0.22
0.22
0.10
0.11
0.07
0.09
0.09
0.08
0.11
0.09
0.10
0.10
0.09
0.11
0.15
0.11

0.01
0.02
0.04
0.01
0.03
0.02
0.02
0.02
0.02
0.01
0.01
0.01
0.02
0.03
0.02
0.02
0.03
0.05
0.04
0.02
0.03
0.04
0.03
0.02
0.01
0.05
0.04
0.06
0.04
0.05
0.06
0.04
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01

412
838
112
649
214
340
320
1233
564
714
405
802
342
42
197
239
294
20
112
185
254
185
72
123
1031
98
21
26
90
55
66
106
1293
85
76
209
213
322
588
252
640
1133
363
475
160
485

4.2
6.7
9.4
4.2
7.7
8.1
5.2
12.4
6.0
3.5
2.5
4.5
4.9
4.7
4.7
4.1
6.3
3.4
6.5
7.4
7.4
10.1
4.4
4.0
3.3
6.5
2.4
4.6
4.8
4.9
6.6
4.9
2.4
2.6
2.3
2.3
2.6
2.3
2.6
3.0
2.8
2.3
2.2
2.7
3.0
2.7

0.22
0.24
0.91
0.18
0.55
0.46
0.31
0.37
0.27
0.14
0.13
0.16
0.28
0.76
0.37
0.28
0.38
0.83
0.65
0.56
0.48
0.80
0.56
0.39
0.11
0.69
0.57
0.95
0.55
0.75
0.87
0.51
0.07
0.30
0.29
0.17
0.19
0.14
0.12
0.20
0.12
0.07
0.12
0.13
0.25
0.13

0.44
0.69
0.85
0.41
0.78
0.81
0.51
1.18
0.57
0.37
0.26
0.45
0.48
0.44
0.46
0.38
0.60
0.31
0.61
0.72
0.67
0.94
0.41
0.40
0.31
0.64
0.26
0.45
0.46
0.48
0.65
0.47
0.22
0.25
0.22
0.21
0.25
0.22
0.24
0.28
0.26
0.22
0.20
0.24
0.29
0.25

0.02
0.03
0.08
0.02
0.06 *
0.05
0.03
0.04 *
0.03
0.02
0.01
0.02
0.03
0.07
0.04
0.03
0.04
0.07
0.06
0.05
0.05
0.07
0.05
0.04
0.01
0.07
0.07
0.09
0.06
0.07
0.09
0.05
0.01
0.03
0.03
0.02
0.02
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.01

506
14
304
112
35
257
130
20
26
181
132
5
37
23
18
40

2.5
2.7
2.7
2.3
2.3
1.7
2.2
2.2
5.4
1.6
3.4
1.6
5.7
4.3
1.8
3.8

0.11
0.76
0.16
0.22
0.41
0.11
0.20
0.51
1.13
0.12
0.31
0.75
0.98
0.91
0.47
0.62

0.26
0.31
0.27
0.24
0.25
0.17
0.22
0.23
0.66
0.17
0.33
0.17
0.56
0.45
0.17
0.34

0.01
0.12
0.02
0.02
0.05
0.01
0.02
0.06
0.17
0.01
0.03
0.09
0.11
0.11
0.05
0.06

1639
21
857
310
107
750
334
52
180
598
430
38
138
61
60
81

8.1
3.9
7.8
6.5
6.9
5.0
5.9
5.3
37.4
5.1
11.5
11.7
22.5
10.4
6.8
8.5

0.21
0.94
0.27
0.39
0.69
0.19
0.33
0.75
2.87
0.22
0.57
2.01
1.94
1.35
1.02
0.99

0.77
0.41
0.74
0.59
0.65
0.46
0.53
0.45
4.18
0.48
1.11
1.20
2.18
1.02
0.68
0.81

0.02
0.14
0.03
0.04
0.07
0.02
0.03
0.07
0.37
0.02
0.06
0.22
0.20
0.15
0.10
0.10

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

559

617

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Adrenal gland (C74)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

560

Female
ASR(W)
CUM 0-74

2
30
2
0
8

0.1
0.6
0.2
0.2

0.04
0.11
0.12
0.09

1
16
0
0
4

0.0
0.2
0.3

0.03
0.06
0.17

3
15
4
5
118
0
3
17
2
0
1

0.4
0.5
0.4
0.3
0.6
0.1
0.2
0.1
0.1

0.24
0.14
0.23
0.15
0.06
0.05
0.06
0.04
0.15

0.05
0.04
0.01
0.03
0.04
0.01
0.02
0.00
0.02

0.03
0.02
0.01
0.02
0.00
0.01
0.01
0.00
0.02

1
12
2
8
149
1
11
13
3
2
4

0.1
0.4
0.2
0.4
0.7
0.1
0.3
0.2
0.1
0.2
0.3

0.13
0.11
0.16
0.15
0.06
0.11
0.08
0.04
0.05
0.12
0.16

0.02
0.02
0.01
0.02
0.04
0.01
0.02
0.02
0.01
0.02
0.03

0.02
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.02 *

199
19
19
3
3
0
0
4
144
2
5
30
5
25
4
53
249
17
12
62
153
53
2
1
1
0
12
33
63
6
2
0
2
1
20
32
32
25
2
23
5
1
4
148
15
132
53
9
42
28
6
20
5
89
11
76
49
25
23
16
3
13
0
2

0.4
0.3
0.2
0.1
0.3
0.2
0.5
0.8
0.1
0.4
0.2
0.4
0.3
0.4
0.3
0.2
0.2
0.3
0.4
0.4
0.2
0.1
0.2
0.5
0.5
0.3
0.3
0.2
1.0
0.5
0.2
0.5
0.3
0.4
0.3
0.4
0.5
0.2
1.3
0.4
0.3
0.4
0.3
0.2
0.4
0.5
0.3
0.6
0.2
0.3
0.3
0.3
0.4
0.4
0.2
0.2
0.1
0.2
0.3

0.03
0.08
0.06
0.07
0.17
0.12
0.05
0.64
0.07
0.07
0.10
0.09
0.16
0.06
0.02
0.05
0.07
0.04
0.04
0.06
0.15
0.05
0.23
0.14
0.10
0.04
0.12
0.16
0.87
0.48
0.05
0.10
0.06
0.08
0.18
0.09
0.26
0.20
0.79
0.04
0.08
0.05
0.05
0.07
0.06
0.10
0.14
0.14
0.09
0.04
0.09
0.04
0.06
0.09
0.05
0.05
0.06
0.07
0.21

0.03
0.02
0.02
0.01
0.01
0.02
0.04
0.06
0.02
0.02
0.01
0.03
0.01
0.03
0.03
0.01
0.02
0.02
0.03
0.03
0.03
0.00
0.01
0.03
0.04
0.02
0.02
0.03
0.07
0.02
0.01
0.03
0.02
0.03
0.02
0.03
0.03
0.01
0.06
0.03
0.02
0.03
0.02
0.02
0.02
0.03
0.03
0.03
0.01
0.02
0.03
0.02
0.03
0.02
0.02
0.01
0.01
0.02
0.01

0.00
0.01
0.00
0.01
0.01
0.01
0.00
0.05
0.01
0.00
0.00
0.01
0.01
0.01
0.00
0.00
0.01
0.00
0.00
0.00
0.02
0.00
0.01
0.01
0.01
0.00
0.01
0.02
0.05
0.02
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.03
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.02
0.01
0.00
0.00
0.01
0.00
0.00
0.01
0.00
0.00
0.01
0.00
0.01

222
26
30
9
8
7
0
4
132
1
5
31
7
24
7
47
207
14
10
53
126
36
0
2
1
0
8
23
50
7
3
2
0
0
19
19
29
24
1
23
4
2
2
143
13
124
38
5
33
14
2
12
9
85
12
67
53
22
22
46
13
32
6
6

0.4
0.4
0.3
0.3
0.5
0.7
0.2
0.4
0.2
0.2
0.3
0.2
0.3
0.4
0.4
0.3
0.2
0.2
0.2
0.3
0.3
0.2
0.2
0.3
0.3
0.2
0.3
0.4
0.2
0.2
0.3
0.3
0.3
0.1
0.3
0.4
0.3
0.7
0.4
0.3
0.4
0.2
0.1
0.3
0.2
0.1
0.4
0.2
0.3
0.2
0.3
0.4
0.3
0.2
0.4
0.3
0.5
0.5
0.4

0.03
0.09
0.07
0.12
0.20
0.31
0.13
0.04
0.23
0.12
0.06
0.10
0.07
0.16
0.06
0.02
0.05
0.05
0.03
0.03
0.05
0.18
0.19
0.11
0.08
0.03
0.11
0.28
0.18
0.05
0.07
0.06
0.06
0.08
0.08
0.22
0.22
0.60
0.04
0.07
0.05
0.04
0.03
0.06
0.07
0.04
0.12
0.07
0.03
0.07
0.04
0.06
0.07
0.05
0.07
0.10
0.10
0.22
0.22

0.03
0.03
0.02
0.02
0.04
0.04
0.01
0.03
0.02
0.02
0.02
0.02
0.02
0.04
0.03
0.02
0.01
0.01
0.02
0.02
0.02
0.02
0.01
0.02
0.02
0.02
0.02
0.03
0.02
0.02
0.02
0.02
0.02
0.01
0.02
0.03
0.02
0.04
0.03
0.02
0.03
0.01
0.00
0.02
0.01
0.00
0.02
0.03
0.02
0.02
0.02
0.03
0.02
0.02
0.04
0.04
0.04
0.06
0.03

0.00
0.01
0.00
0.01
0.01
0.02
0.01
0.00
0.02
0.01
0.00
0.01
0.01
0.02
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.00
0.00
0.01
0.02
0.01
0.01
0.00
0.00
0.00
0.01
0.00
0.01
0.02
0.03
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.01
0.01
0.03
0.01

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

618

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Adrenal gland (C74) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

9
55
86
9
75
36
5
31
38
8
29
4
1680
163
1448
72
7
65
11
0
5
6
180
33
142
66
6
57
23
18
83
9
71
3
205
15
173
532
31
35
76
384
29
6
23
157
13
134
16
4
33
21
19
36

0.3
0.5
0.4
0.3
0.4
0.4
0.2
0.4
0.3
0.6
0.3
0.2
0.3
0.3
0.4
0.4
0.2
0.4
0.3
0.3
0.2
0.5
0.6
0.5
0.3
0.2
0.3
0.3
0.2
0.3
0.3
0.3
0.2
0.4
0.2
0.4
0.3
0.2
0.2
0.3
0.4
0.3
0.2
0.4
0.3
0.2
0.3
0.3
0.2
0.3
0.2
0.4
0.3

0.12
0.07
0.04
0.10
0.05
0.07
0.11
0.09
0.06
0.21
0.06
0.10
0.01
0.02
0.01
0.05
0.09
0.06
0.09
0.15
0.08
0.04
0.10
0.04
0.04
0.09
0.04
0.07
0.06
0.04
0.12
0.04
0.12
0.03
0.06
0.03
0.02
0.04
0.03
0.03
0.02
0.06
0.10
0.08
0.03
0.06
0.03
0.08
0.11
0.05
0.06
0.10
0.05

0.02
0.03
0.03
0.02
0.03
0.03
0.02
0.03
0.02
0.04
0.02
0.01
0.02
0.02
0.03
0.03
0.02
0.03
0.02
0.01
0.03
0.03
0.05
0.03
0.02
0.01
0.02
0.02
0.02
0.02
0.02
0.02
0.01
0.02
0.02
0.03
0.02
0.02
0.02
0.02
0.03
0.03
0.01
0.03
0.03
0.02
0.03
0.03
0.02
0.02
0.01
0.03
0.02

0.01
0.00
0.00
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.01
0.01
0.00
0.00
0.01
0.00

7
58
76
13
61
42
15
25
45
4
41
10
1758
154
1519
70
4
63
8
0
2
6
200
19
172
82
5
75
25
24
101
13
83
11
196
18
161
515
28
46
72
362
29
5
24
178
12
162
12
4
50
35
12
50

0.3
0.4
0.3
0.4
0.3
0.5
0.6
0.4
0.4
0.2
0.4
0.6
0.3
0.2
0.3
0.4
0.1
0.4
0.2
0.1
0.3
0.4
0.3
0.5
0.3
0.2
0.3
0.3
0.2
0.4
0.4
0.3
0.4
0.3
0.2
0.3
0.3
0.2
0.2
0.2
0.3
0.3
0.2
0.3
0.3
0.2
0.4
0.2
0.3
0.4
0.4
0.2
0.3

0.13
0.06
0.04
0.11
0.04
0.08
0.17
0.09
0.06
0.12
0.07
0.22
0.01
0.02
0.01
0.05
0.06
0.06
0.07
0.09
0.18
0.03
0.06
0.04
0.04
0.08
0.04
0.07
0.05
0.04
0.12
0.04
0.15
0.03
0.06
0.03
0.01
0.04
0.03
0.03
0.02
0.06
0.08
0.08
0.03
0.06
0.03
0.07
0.18
0.06
0.07
0.07
0.05

0.02
0.03
0.02
0.03
0.02
0.04
0.06
0.03
0.03
0.02
0.03
0.04
0.02
0.02
0.03
0.03
0.01
0.03
0.01
0.01
0.02
0.03
0.02
0.03
0.02
0.01
0.02
0.02
0.02
0.03
0.03
0.02
0.03
0.02
0.02
0.02
0.02
0.01
0.02
0.02
0.02
0.03
0.01
0.03
0.03
0.02
0.03
0.01
0.02
0.03
0.03
0.02
0.03

0.01
0.00
0.00
0.01
0.00
0.01
0.02
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.00
0.01
0.00
0.00
0.01
0.00

4
27

0.4
0.6

0.21
0.12

0.02
0.05

0.01
0.01

0
12

0.3

0.10

0.02

0.01 *

4
1
71
10
7
14
64
1
41
8
1
4
73
59
12
12
9
9
25
13
70
8

0.3
0.2
0.3
0.3
0.6
0.2
0.2
0.1
0.2
0.2
0.0
0.2
0.5
0.5
0.5
0.6
0.6
0.5
0.6
0.6
0.5
0.2

0.13
0.19
0.05
0.11
0.22
0.05
0.03
0.11
0.03
0.07
0.01
0.09
0.06
0.06
0.16
0.19
0.23
0.19
0.15
0.18
0.07
0.10

0.02
0.01
0.04
0.02
0.03
0.01
0.01
0.01
0.01
0.02
0.00
0.01
0.04
0.04
0.04
0.04
0.04
0.03
0.04
0.03
0.03
0.02

0.01
0.01
0.01
0.01
0.01
0.00
0.00
0.01
0.00
0.01
0.00
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.00
0.01

2
0
48
2
3
17
34
2
28
1
2
4
50
38
9
6
7
6
15
9
50
7

0.1
0.2
0.0
0.2
0.2
0.1
0.2
0.1
0.0
0.0
0.1
0.3
0.3
0.3
0.4
0.6
0.4
0.3
0.3
0.4
0.1

0.10
0.04
0.03
0.12
0.05
0.02
0.16
0.02
0.02
0.03
0.08
0.05
0.05
0.11
0.18
0.24
0.19
0.10
0.14
0.06
0.09

0.03
0.02
0.00
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.02
0.02
0.02
0.02
0.03
0.02
0.02
0.02
0.02
0.01

0.02 *
0.00 *
0.00 *
0.01 *
0.00
0.00 *
0.01
0.00
0.00 *
0.01 *
0.01 *
0.00
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

561

619

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Adrenal gland (C74) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

562

Female
ASR(W)
CUM 0-74

267
24
17
9
11
16
1
83
5
5
3
2
5
3
5
20
20
15
0
5
4
1
5
8
19

0.4
0.3
0.3
0.4
0.4
0.3
0.1
0.5
0.3
0.2
0.4
0.1
0.1
0.1
0.1
0.2
0.3
0.3
0.5
0.1
0.1
0.2
0.3
0.3

0.02
0.07
0.09
0.13
0.14
0.09
0.08
0.05
0.12
0.09
0.38
0.06
0.05
0.08
0.06
0.06
0.07
0.08
0.23
0.05
0.07
0.09
0.10
0.06

0.03
0.03
0.02
0.03
0.04
0.02
0.01
0.03
0.02
0.01
0.02
0.01
0.01
0.02
0.01
0.02
0.02
0.02
0.02
0.01
0.00
0.01
0.02
0.03

0.00
0.01
0.01
0.01
0.02
0.01
0.01
0.00
0.01
0.01
0.02
0.00
0.00
0.02
0.01
0.01
0.01
0.01
0.01
0.00
0.00
0.00
0.01
0.01

233
9
16
12
7
16
3
51
3
2
7
12
3
9
2
8
19
15
1
3
4
2
9
8
14

0.3
0.1
0.3
0.4
0.3
0.3
0.4
0.3
0.2
0.1
1.4
0.6
0.1
0.3
0.0
0.1
0.3
0.3
0.2
0.3
0.1
0.1
0.4
0.3
0.2

0.02
0.05
0.09
0.14
0.10
0.08
0.26
0.04
0.13
0.05
0.68
0.18
0.04
0.12
0.03
0.03
0.08
0.08
0.25
0.20
0.06
0.06
0.12
0.09
0.05

0.02
0.01
0.02
0.02
0.02
0.02
0.03
0.02
0.02
0.00
0.06
0.03
0.01
0.03
0.00
0.01
0.02
0.02
0.01
0.03
0.01
0.01
0.02
0.03
0.02

0.00
0.00
0.00
0.01
0.01
0.01
0.02
0.00
0.01
0.00
0.03
0.01
0.01
0.01 *
0.00 *
0.00 *
0.00
0.01
0.01
0.02
0.00 *
0.00 *
0.01
0.01 *
0.00 *

72
1
4
127
9
51
50
71
95
43
13
39
8
7
9
10
10
8
8
3
10
0
1
16
31
11
4
14
22
9
6
32
2
14
3
12
3
1
11
4
11
18
2
0
5
17
10
3
1
0
10
11
4
16

0.5
0.0
0.7
0.5
0.3
0.5
0.2
0.6
0.3
0.4
0.3
0.2
0.4
0.4
0.8
0.6
0.4
0.5
0.4
0.5
0.8
0.1
0.3
0.4
0.3
0.1
0.3
0.4
0.7
0.9
0.4
0.2
0.8
0.6
0.5
0.1
0.6
0.5
0.5
1.1
0.4
0.1
0.2
0.8
0.3
0.2
0.1
0.9
0.4
0.5
0.4

0.06
0.04
0.36
0.05
0.10
0.08
0.03
0.08
0.04
0.06
0.09
0.04
0.16
0.15
0.28
0.22
0.15
0.17
0.14
0.28
0.26
0.15
0.10
0.09
0.12
0.08
0.10
0.09
0.27
0.40
0.07
0.16
0.26
0.45
0.20
0.08
0.64
0.20
0.28
0.35
0.12
0.04
0.09
0.27
0.11
0.10
0.08
0.33
0.17
0.32
0.11

0.03
0.00
0.03
0.05
0.02
0.04
0.02
0.05
0.03
0.03
0.04
0.02
0.03
0.04
0.06
0.04
0.04
0.02
0.02
0.02
0.06
0.01
0.02
0.02
0.03
0.01
0.02
0.03
0.03
0.07
0.02
0.04
0.06
0.04
0.04
0.02
0.03
0.03
0.03
0.06
0.03
0.04
0.06
0.04
0.02
0.01
0.05
0.03
0.04
0.03

0.00
0.00
0.02
0.00
0.01
0.01
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.02
0.02
0.02
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.00
0.01
0.00
0.01
0.01
0.01
0.03
0.00
0.03
0.02
0.02
0.01
0.01
0.03
0.01
0.01
0.02
0.01
0.02
0.02
0.01
0.01
0.01
0.02
0.01
0.02
0.01

72
4
3
116
9
60
48
66
99
44
19
68
8
6
3
3
8
12
6
3
7
0
6
31
32
13
15
22
27
4
3
35
1
6
2
8
8
0
13
3
5
19
2
5
5
10
13
5
3
4
17
8
6
18

0.4
0.3
0.6
0.4
0.2
0.5
0.2
0.5
0.3
0.3
0.3
0.4
0.3
0.3
0.3
0.2
0.4
0.6
0.2
0.3
0.3
0.4
0.7
0.3
0.2
0.4
0.4
0.4
0.2
0.4
0.4
0.0
0.3
0.6
0.4
0.5
0.5
0.2
0.4
0.4
0.4
0.7
0.3
0.4
0.8
0.2
0.3
0.4
0.5
0.3
0.8
0.4

0.05
0.15
0.35
0.04
0.07
0.08
0.03
0.08
0.03
0.06
0.08
0.05
0.11
0.15
0.17
0.12
0.17
0.18
0.11
0.20
0.14
0.19
0.17
0.08
0.07
0.16
0.10
0.10
0.11
0.25
0.07
0.04
0.13
0.49
0.19
0.29
0.20
0.11
0.19
0.13
0.33
0.38
0.18
0.19
0.26
0.08
0.18
0.24
0.22
0.17
0.39
0.12

0.03
0.02
0.03
0.03
0.02
0.04
0.02
0.04
0.03
0.02
0.04
0.04
0.03
0.03
0.02
0.01
0.03
0.04
0.02
0.02
0.04
0.04
0.04
0.02
0.02
0.03
0.03
0.03
0.01
0.04
0.03
0.03
0.03
0.02
0.03
0.03
0.02
0.03
0.03
0.02
0.04
0.03
0.03
0.05
0.02
0.03
0.04
0.05
0.02
0.03
0.03

0.00
0.01
0.02
0.00 *
0.01 *
0.01
0.00 *
0.01
0.00
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.02
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.02
0.03
0.01
0.01
0.02
0.01

*Important. See note on population page.

620

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Adrenal gland (C74) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

35
46
1
27
14
22
27
16
25
51
44
36
15
1
13
17
15
2
5
9
16
5
4
4
55
0
2
0
3
3
2
8
98
9
1
14
15
27
52
22
80
117
32
44
16
42

0.5
0.5
0.1
0.2
0.6
0.5
0.6
0.3
0.5
0.4
0.4
0.3
0.3
0.0
0.7
0.4
0.5
0.3
0.5
0.5
0.7
0.3
0.2
0.1
0.2
0.3
0.2
0.5
0.2
0.7
0.3
0.4
0.0
0.2
0.3
0.3
0.4
0.3
0.5
0.4
0.3
0.3
0.4
0.4

0.09
0.07
0.08
0.05
0.15
0.11
0.16
0.08
0.11
0.06
0.06
0.05
0.08
0.04
0.28
0.12
0.15
0.23
0.26
0.19
0.20
0.20
0.11
0.06
0.04
0.18
0.10
0.35
0.16
0.28
0.03
0.14
0.03
0.06
0.09
0.07
0.06
0.08
0.06
0.04
0.06
0.06
0.10
0.07

0.06
0.05
0.01
0.02
0.08
0.06
0.06
0.02
0.03
0.05
0.03
0.03
0.03
0.05
0.03
0.04
0.03
0.03
0.04
0.05
0.02
0.02
0.01
0.02
0.04
0.02
0.04
0.03
0.04
0.02
0.03
0.00
0.01
0.02
0.02
0.02
0.02
0.03
0.03
0.02
0.03
0.03
0.03

0.01
0.01
0.01
0.00
0.02
0.01
0.01
0.00
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.00
0.03
0.01
0.02
0.02
0.01
0.00
0.01
0.00
0.00
0.01
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00

44
44
5
40
16
18
22
18
9
50
37
24
8
3
13
18
10
1
1
5
7
7
7
6
60
4
0
4
2
2
0
4
112
2
2
12
29
31
61
23
67
125
41
33
14
43

0.5
0.4
0.5
0.3
0.5
0.5
0.4
0.3
0.1
0.4
0.3
0.1
0.2
0.6
0.5
0.5
0.5
0.1
0.0
0.3
0.2
0.8
0.5
0.5
0.3
0.3
1.1
0.1
0.3
0.5
0.3
0.1
0.1
0.2
0.4
0.3
0.4
0.3
0.4
0.4
0.3
0.3
0.4
0.4

0.10
0.06
0.25
0.06
0.12
0.14
0.13
0.07
0.05
0.08
0.05
0.03
0.07
0.38
0.24
0.16
0.16
0.13
0.01
0.19
0.10
0.37
0.26
0.27
0.04
0.23
0.62
0.08
0.27
0.24
0.03
0.08
0.11
0.07
0.10
0.06
0.06
0.07
0.06
0.04
0.06
0.05
0.12
0.07

0.04
0.03
0.04
0.03
0.06
0.04
0.04
0.02
0.01
0.03
0.02
0.01
0.01
0.04
0.04
0.03
0.03
0.02
0.02
0.02
0.04
0.04
0.03
0.02
0.03
0.08
0.01
0.03
0.02
0.02
0.01
0.01
0.01
0.03
0.02
0.03
0.03
0.03
0.03
0.02
0.02
0.03
0.03

0.01
0.01
0.02
0.00
0.02 *
0.01
0.01
0.00 *
0.00
0.00
0.00
0.00
0.01
0.02
0.01
0.01
0.01
0.02
0.01
0.01
0.02
0.02
0.01
0.00
0.02
0.04
0.01
0.02
0.01
0.00
0.00
0.01
0.00
0.01
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00

67
1
25
7
1
31
20
3
5
34
9
4
0
1
2
2

0.4
0.3
0.3
0.2
0.0
0.3
0.5
0.5
0.9
0.4
0.4
2.6
0.2
0.7
0.2

0.06
0.29
0.07
0.07
0.03
0.05
0.12
0.31
0.43
0.07
0.13
1.34
0.19
0.63
0.14

0.03
0.04
0.02
0.02
0.02
0.03
0.05
0.13
0.03
0.02
0.15
0.01
0.04
0.03

0.00
0.04
0.01
0.01
0.00
0.01
0.03
0.08
0.01
0.01
0.08
0.01
0.03
0.02

56
0
29
11
4
36
14
2
1
31
12
0
2
3
2
5

0.3
0.4
0.3
0.5
0.3
0.4
0.4
0.2
0.4
0.5
0.4
0.6
0.1
1.3

0.05
0.08
0.11
0.28
0.05
0.12
0.26
0.21
0.08
0.16
0.32
0.33
0.11
0.65

0.02
0.02
0.02
0.03
0.02
0.02
0.02
0.01
0.03
0.03
0.03
0.06
0.01
0.06

0.00
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.03
0.04
0.01
0.03

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

563

621

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other endocrine (C75)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

564

Female
ASR(W)
CUM 0-74

0
3
1
0
3

0.0
0.1
0.3

0.03
0.10
0.18

0
0
0
1
8

0.0
0.3

0.02
0.14

3
16
2
4
75
5
2
5
0
2
1

0.4
0.5
0.2
0.2
0.3
0.6
0.0
0.1
0.1
0.1

0.21
0.14
0.14
0.13
0.04
0.27
0.03
0.03
0.11
0.05

0.07
0.04
0.01
0.02
0.04
0.07
0.00
0.01
0.02
0.00

0.04
0.01
0.01
0.02
0.01
0.04
0.00
0.00
0.02
0.00

1
17
2
4
76
1
0
3
2
2
0

0.1
0.6
0.3
0.2
0.3
0.1
0.0
0.0
0.2
-

0.13
0.16
0.25
0.09
0.03
0.12
0.02
0.03
0.13
-

0.02
0.08
0.03
0.01
0.03
0.01
0.00
0.00
0.02
-

0.02
0.02
0.03
0.01
0.00
0.01
0.00
0.00
0.01
- *

86
5
11
2
3
2
0
3
57
0
3
19
5
14
3
23
147
20
6
36
81
37
2
4
1
1
5
21
36
3
0
2
0
1
13
15
19
12
2
10
5
1
2
69
13
56
20
6
13
6
3
3
4
39
5
29
23
9
13
27
8
18
3
1

0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.1
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.2
0.2
0.2
0.3
0.2
0.9
0.2
0.3
0.2
0.2
0.3
0.3
0.2
0.2
0.2
0.1
0.3
0.1
0.4
0.1
0.3
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.1
0.2
0.2
0.2
0.3
0.1

0.02
0.03
0.04
0.06
0.09
0.08
0.09
0.02
0.06
0.04
0.08
0.05
0.10
0.04
0.02
0.05
0.05
0.03
0.03
0.04
0.14
0.18
0.15
0.91
0.07
0.07
0.03
0.09
0.23
0.26
0.05
0.06
0.04
0.04
0.18
0.05
0.17
0.10
0.20
0.02
0.06
0.03
0.02
0.05
0.03
0.04
0.06
0.05
0.06
0.02
0.04
0.02
0.04
0.05
0.03
0.05
0.08
0.06
0.18
0.11

0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.02
0.02
0.02
0.01
0.05
0.01
0.02
0.02
0.01
0.02
0.01
0.02
0.02
0.02
0.01
0.05
0.01
0.03
0.01
0.03
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.02
0.02
0.02
0.02
0.01

0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.05
0.01
0.00
0.00
0.01
0.01
0.01
0.01
0.00
0.00
0.00
0.04
0.00
0.01
0.01
0.02
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.01

104
6
7
0
1
0
0
4
84
0
2
17
7
9
0
12
81
12
7
22
39
16
1
1
1
0
4
8
24
5
1
1
1
1
6
6
12
10
0
9
1
1
0
47
11
36
14
4
8
5
2
2
3
35
7
25
18
7
10
12
6
6
2
2

0.1
0.1
0.1
0.0
0.1
0.2
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.3
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.1

0.02
0.03
0.03
0.01
0.08
0.03
0.07
0.03
0.08
0.04
0.02
0.01
0.03
0.04
0.02
0.02
0.02
0.05
0.13
0.11
0.07
0.03
0.02
0.08
0.05
0.10
0.25
0.07
0.03
0.04
0.03
0.04
0.05
0.05
0.08
0.02
0.05
0.02
0.02
0.03
0.02
0.03
0.06
0.03
0.05
0.02
0.05
0.02
0.03
0.03
0.03
0.03
0.07
0.04
0.11
0.07

0.01
0.01
0.00
0.01
0.02
0.01
0.01
0.02
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.00
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01

0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.00
0.00
0.00
0.01
0.02
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.01

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

622

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other endocrine (C75) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

10
21
34
8
24
22
7
15
26
1
24
2
895
103
725
39
5
34
5
0
2
3
95
17
74
30
2
25
9
13
51
4
46
6
113
15
83
317
30
34
52
196
10
3
7
85
6
77
12
3
18
15
8
19

0.3
0.2
0.1
0.2
0.1
0.2
0.3
0.2
0.2
0.1
0.2
0.1
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.2
0.2
0.3
0.2
0.1
0.1
0.1
0.1
0.2
0.2
0.1
0.2
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.2
0.1
0.2
0.2
0.2
0.1
0.2
0.2
0.1

0.10
0.03
0.02
0.08
0.02
0.05
0.11
0.05
0.04
0.07
0.04
0.05
0.01
0.02
0.01
0.03
0.08
0.04
0.05
0.07
0.12
0.02
0.06
0.02
0.02
0.04
0.02
0.03
0.05
0.03
0.07
0.03
0.13
0.02
0.05
0.02
0.01
0.04
0.03
0.02
0.01
0.03
0.08
0.05
0.02
0.05
0.02
0.07
0.10
0.03
0.04
0.07
0.03

0.02
0.01
0.01
0.02
0.01
0.02
0.02
0.02
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.02
0.01
0.01
0.01
0.02
0.02
0.02
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.02
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.01

0.01
0.00
0.00
0.01
0.00
0.00
0.01
0.01
0.00
0.02
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.01
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.01
0.00
0.00
0.01
0.00

4
16
27
6
19
10
3
6
13
1
12
5
613
96
481
32
4
26
10
1
3
6
63
10
52
24
4
20
9
4
31
4
26
4
71
6
53
193
19
22
35
112
8
4
4
90
11
74
6
1
8
6
2
17

0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.2
0.2
0.2
0.1
0.0
0.1
0.0
0.1
0.1

0.07
0.03
0.02
0.05
0.02
0.03
0.04
0.04
0.02
0.05
0.03
0.09
0.00
0.01
0.00
0.02
0.06
0.03
0.06
0.18
0.09
0.11
0.02
0.04
0.02
0.02
0.06
0.02
0.02
0.03
0.02
0.06
0.02
0.05
0.01
0.03
0.01
0.01
0.03
0.02
0.02
0.01
0.03
0.06
0.02
0.02
0.06
0.02
0.04
0.01
0.02
0.02
0.04
0.03

0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.03
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.00
0.00
0.01

0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.02
0.01
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

0
2

0.0

0.02

0.00

0.00

2
2

0.2
0.0

0.13
0.03

0.01
0.00

0.01
0.00 *

5
4
239
2
1
13
13
0
19
4
11
1
21
19
2
5
7
10
13
8
44
4

0.5
0.2
1.2
0.0
0.1
0.1
0.1
0.1
0.1
0.2
0.0
0.1
0.2
0.1
0.2
0.2
0.4
0.3
0.3
0.2
0.1

0.26
0.13
0.08
0.03
0.07
0.03
0.02
0.02
0.05
0.05
0.03
0.03
0.04
0.04
0.09
0.10
0.14
0.08
0.10
0.04
0.08

0.04
0.02
0.12
0.01
0.00
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.01
0.00
0.01
0.03
0.03
0.02
0.02
0.02
0.01

0.02
0.01
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.01

4
0
304
0
2
7
13
0
21
1
13
0
14
11
1
3
10
5
3
8
16
4

0.4
1.4
0.2
0.1
0.1
0.1
0.0
0.2
0.1
0.1
0.1
0.1
0.4
0.2
0.1
0.2
0.1
0.1

0.20
0.09
0.12
0.02
0.02
0.02
0.01
0.05
0.02
0.02
0.06
0.07
0.15
0.08
0.04
0.08
0.03
0.06

0.03
0.14
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.04
0.01
0.00
0.01
0.01
0.01

0.02 *
0.01 *
- *
0.01 *
0.00
0.00 *
0.00
0.00 *
0.00 *
- *
0.00
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.00

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

565

623

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other endocrine (C75) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

566

Female
ASR(W)
CUM 0-74

201
17
9
7
7
16
0
61
3
2
1
5
10
2
3
6
20
17
0
3
4
1
0
3
9

0.2
0.2
0.2
0.2
0.2
0.3
0.3
0.2
0.1
0.0
0.2
0.2
0.1
0.0
0.0
0.3
0.3
0.3
0.1
0.0
0.1
0.1

0.02
0.05
0.05
0.08
0.08
0.07
0.04
0.09
0.05
0.02
0.11
0.07
0.07
0.03
0.02
0.07
0.08
0.15
0.06
0.03
0.06
0.04

0.02
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.00
0.00
0.02
0.02
0.02
0.00
0.00
0.02
0.02
0.01
0.01
0.00
0.01
0.01

0.00
0.00
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.01
0.01
0.02
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.01

94
12
3
3
3
9
2
31
5
0
1
10
3
1
10
3
6
2
2
2
2
1
1
2
8

0.1
0.1
0.0
0.1
0.1
0.1
0.3
0.1
0.3
0.1
0.4
0.1
0.0
0.3
0.0
0.1
0.0
0.3
0.2
0.0
0.0
0.0
0.1
0.1

0.01
0.04
0.03
0.05
0.04
0.05
0.21
0.02
0.13
0.05
0.12
0.03
0.02
0.11
0.02
0.04
0.03
0.23
0.14
0.03
0.03
0.04
0.05
0.03

0.01
0.01
0.01
0.01
0.00
0.01
0.02
0.01
0.03
0.00
0.03
0.00
0.00
0.03
0.00
0.01
0.00
0.04
0.01
0.00
0.00
0.00
0.01
0.01

0.00
0.00
0.00
0.00
0.00
0.00
0.02
0.00
0.02
0.00
0.01
0.00
0.00 *
0.01 *
0.00 *
0.00
0.00
0.04
0.01
0.00 *
0.00 *
0.00
0.01 *
0.00 *

39
2
2
17
1
22
31
26
39
15
3
20
4
2
0
2
5
3
1
0
2
2
1
5
15
7
8
6
4
4
1
32
2
5
1
3
6
0
0
1
1
11
5
1
2
2
2
10
3
0
3
7
2
6

0.2
0.1
0.2
0.1
0.0
0.2
0.1
0.2
0.1
0.1
0.1
0.2
0.1
0.2
0.1
0.2
0.1
0.0
0.2
0.2
0.1
0.1
0.1
0.2
0.2
0.1
0.0
0.2
0.2
0.3
0.3
0.2
0.1
0.1
0.3
0.0
0.1
0.1
0.6
0.1
0.0
0.1
0.0
0.6
0.4
0.2
0.3
0.1
0.1

0.03
0.08
0.15
0.01
0.01
0.04
0.03
0.04
0.02
0.03
0.06
0.04
0.07
0.11
0.07
0.10
0.07
0.05
0.12
0.18
0.09
0.02
0.02
0.07
0.06
0.04
0.02
0.09
0.22
0.05
0.23
0.11
0.07
0.10
0.13
0.02
0.09
0.03
0.33
0.07
0.03
0.04
0.03
0.20
0.23
0.12
0.15
0.08
0.06

0.01
0.01
0.02
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.00
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.03
0.03
0.03
0.01
0.01
0.04
0.00
0.01
0.04
0.02
0.01
0.06
0.03
0.01
0.02
0.01
0.01

0.00
0.01
0.02
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.00
0.00
0.01
0.01
0.00
0.00
0.01
0.01
0.01
0.02
0.01
0.01
0.00
0.01
0.01
0.00
0.02
0.02
0.00
0.02
0.02
0.01
0.01
0.01
0.00

35
1
1
15
0
14
20
39
24
16
0
24
2
5
3
0
4
5
3
2
0
1
3
13
27
4
4
7
5
1
1
18
3
4
1
7
1
0
1
4
2
13
3
1
1
2
3
13
0
1
0
6
2
7

0.2
0.1
0.1
0.0
0.1
0.1
0.2
0.1
0.1
0.2
0.0
0.3
0.2
0.1
0.2
0.1
0.2
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.2
0.1
0.1
0.0
0.1
0.0
0.0
0.2
0.1
0.2
0.4
0.1
0.1
0.1
0.1
0.8
0.0
0.2
0.1
0.2

0.03
0.05
0.08
0.01
0.03
0.02
0.04
0.02
0.03
0.04
0.04
0.12
0.15
0.08
0.08
0.04
0.13
0.02
0.07
0.03
0.03
0.05
0.09
0.05
0.04
0.07
0.05
0.04
0.08
0.06
0.03
0.04
0.02
0.01
0.18
0.08
0.08
0.30
0.11
0.06
0.06
0.07
0.23
0.05
0.11
0.09
0.07

0.01
0.00
0.01
0.00
0.01
0.01
0.02
0.01
0.01
0.01
0.00
0.03
0.02
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.02
0.02
0.01
0.01
0.00
0.00
0.01
0.02
0.02
0.03
0.01
0.01
0.01
0.01
0.07
0.02
0.01
0.01

0.00
0.01
0.01
0.00 *
- *
0.00
0.00 *
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.02
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.02
0.01
0.01
0.00
0.01
0.02
0.01
0.01
0.01

*Important. See note on population page.

624

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other endocrine (C75) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

5
7
1
17
3
9
11
21
21
13
39
15
3
3
6
3
1
0
2
5
7
1
3
2
28
3
0
1
1
0
0
3
36
1
3
16
16
18
33
13
51
49
10
22
5
14

0.1
0.1
0.1
0.1
0.1
0.3
0.2
0.3
0.3
0.1
0.3
0.1
0.1
0.6
0.3
0.1
0.0
0.2
0.4
0.3
0.0
0.2
0.1
0.1
0.2
0.2
0.1
0.3
0.1
0.0
0.1
0.2
0.3
0.2
0.2
0.2
0.3
0.1
0.1
0.2
0.1
0.1

0.04
0.03
0.15
0.04
0.07
0.10
0.07
0.06
0.07
0.03
0.05
0.03
0.03
0.33
0.12
0.03
0.02
0.13
0.18
0.10
0.05
0.10
0.12
0.03
0.12
0.20
0.10
0.15
0.02
0.03
0.05
0.06
0.07
0.04
0.04
0.06
0.04
0.02
0.03
0.04
0.05
0.03

0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.02
0.02
0.01
0.03
0.01
0.00
0.03
0.02
0.00
0.01
0.02
0.02
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.00
0.01
0.02
0.02
0.01
0.01
0.02
0.03
0.01
0.01
0.01
0.01
0.01

0.00
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.00
0.00
0.00
0.00
0.02
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.02
0.01
0.01
0.00
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00

4
9
1
11
2
12
10
10
15
12
37
7
0
1
5
4
2
0
0
2
2
1
2
3
34
4
0
0
0
0
0
4
19
2
1
8
4
6
23
8
51
42
11
15
6
8

0.1
0.1
0.1
0.1
0.1
0.4
0.2
0.1
0.1
0.1
0.2
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.0

0.04
0.02
0.09
0.02
0.05
0.13
0.06
0.04
0.04
0.02
0.04
0.02
0.14
0.04
0.04
0.04
0.08
0.05
0.07
0.08
0.10
0.02
0.12
0.11
0.01
0.06
0.03
0.03
0.03
0.02
0.03
0.03
0.04
0.02
0.03
0.03
0.05
0.02

0.01
0.01
0.01
0.01
0.01
0.03
0.01
0.01
0.01
0.01
0.02
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.01
0.02
0.01
0.01
0.02
0.03
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.00

0.00
0.00
0.01
0.00
0.00 *
0.01
0.01
0.00 *
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00

25
0
12
3
1
21
6
1
4
17
9
0
3
3
1
2

0.2
0.1
0.1
0.1
0.2
0.1
0.1
0.6
0.2
0.3
0.6
0.5
0.1
0.5

0.03
0.04
0.04
0.10
0.04
0.05
0.10
0.35
0.04
0.11
0.37
0.27
0.11
0.35

0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.08
0.01
0.02
0.04
0.03
0.01
0.03

0.00
0.00
0.00
0.01
0.00
0.01
0.01
0.05
0.00
0.01
0.03
0.02
0.01
0.02

6
0
6
2
1
15
2
1
2
8
4
0
0
0
1
0

0.0
0.1
0.1
0.1
0.1
0.0
0.2
0.3
0.1
0.2
0.3
-

0.01
0.02
0.05
0.06
0.03
0.02
0.15
0.24
0.03
0.08
0.29
-

0.00
0.00
0.00
0.01
0.01
0.00
0.01
0.02
0.00
0.01
0.02
-

0.00
0.00
0.00
0.01
0.00
0.00
0.01
0.01
0.00
0.00
0.02
-

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

567

625

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Hodgkin lymphoma (C81)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

568

Female
ASR(W)
CUM 0-74

50
180
31
37
27

1.5
2.5
2.8
1.4
0.9

0.23
0.20
0.53
0.32
0.21

46
83
18
24
16

1.2
1.2
1.4
1.6
0.4

0.19
0.14
0.33
0.42
0.13

16
75
24
41
627
19
79
183
43
9
10

2.1
2.3
2.7
2.0
2.5
2.2
1.9
1.9
1.4
0.8
0.8

0.53
0.30
0.61
0.33
0.11
0.50
0.22
0.15
0.23
0.29
0.26

0.19
0.21
0.26
0.17
0.20
0.24
0.15
0.16
0.13
0.07
0.06

0.05
0.04
0.09
0.03
0.01
0.07
0.02
0.02
0.03
0.03
0.02

20
58
14
37
544
8
69
154
29
8
8

2.2
1.5
1.5
1.6
1.8
0.8
1.4
1.6
0.8
0.8
0.6

0.52
0.22
0.44
0.28
0.08
0.30
0.19
0.13
0.16
0.28
0.22

0.21
0.13
0.17
0.16
0.15
0.10
0.16
0.13
0.08
0.06
0.04

0.05
0.02
0.07
0.04
0.01
0.04
0.03
0.01
0.02
0.02
0.02 *

1751
233
285
76
50
27
1
68
932
8
71
273
61
209
33
305
2281
112
146
524
1453
491
26
21
12
1
82
317
627
70
8
6
2
3
213
308
318
300
27
265
50
26
22
1216
118
1066
562
148
402
223
71
143
93
973
114
815
477
216
342
290
65
223
21
48

2.7
2.8
2.5
2.4
2.5
1.8
0.9
2.7
2.9
2.3
2.6
2.3
2.2
2.2
2.0
2.1
2.4
1.0
2.2
2.2
3.1
2.7
1.9
1.6
1.2
0.7
2.5
3.6
2.5
2.7
0.8
0.8
1.1
0.6
2.4
3.4
2.7
3.3
3.0
3.4
3.1
2.8
3.2
2.7
1.9
2.8
2.5
2.5
2.5
2.8
2.6
2.9
2.7
2.9
2.5
2.9
2.9
2.6
3.2
2.4
1.9
2.8
2.0
3.3

0.07
0.19
0.15
0.28
0.38
0.37
0.89
0.35
0.10
0.84
0.31
0.14
0.28
0.16
0.36
0.13
0.05
0.10
0.19
0.10
0.09
0.13
0.38
0.37
0.36
0.72
0.30
0.22
0.10
0.33
0.30
0.33
0.77
0.35
0.18
0.21
0.15
0.20
0.59
0.23
0.45
0.56
0.75
0.08
0.18
0.09
0.11
0.22
0.13
0.19
0.32
0.26
0.29
0.09
0.23
0.11
0.14
0.19
0.18
0.15
0.23
0.19
0.43
0.51

0.23
0.23
0.21
0.21
0.22
0.14
0.06
0.22
0.24
0.18
0.22
0.19
0.17
0.20
0.18
0.18
0.21
0.09
0.20
0.21
0.26
0.24
0.19
0.15
0.10
0.05
0.25
0.30
0.22
0.23
0.07
0.08
0.06
0.03
0.23
0.29
0.23
0.27
0.20
0.28
0.29
0.30
0.24
0.23
0.16
0.24
0.22
0.23
0.22
0.22
0.21
0.23
0.21
0.25
0.20
0.25
0.24
0.23
0.26
0.21
0.16
0.24
0.19
0.31

0.01
0.02
0.01
0.03
0.03
0.03
0.06
0.03
0.01
0.07
0.03
0.01
0.02
0.02
0.04
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.05
0.04
0.03
0.05
0.04
0.02
0.01
0.03
0.03
0.04
0.04
0.02
0.02
0.02
0.01
0.02
0.04
0.02
0.05
0.06
0.06
0.01
0.02
0.01
0.01
0.02
0.01
0.02
0.03
0.02
0.02
0.01
0.02
0.01
0.01
0.02
0.02
0.01
0.02
0.02
0.05
0.05

1410
181
194
54
46
18
0
59
780
10
68
223
46
173
27
235
1789
110
102
389
1164
361
19
13
15
2
55
233
505
51
2
17
2
2
153
273
240
285
26
252
35
19
13
985
103
864
454
121
329
184
57
123
89
766
94
640
402
203
274
284
66
216
23
41

2.2
2.3
1.8
1.8
2.3
1.3
2.4
2.4
2.7
2.5
1.8
1.4
1.9
1.8
1.6
1.9
0.9
1.5
1.6
2.6
2.0
1.4
0.7
1.7
0.9
1.8
2.7
1.9
1.7
0.1
1.9
0.6
0.3
1.6
3.2
2.1
3.1
2.4
3.3
2.0
1.8
1.8
2.1
1.5
2.3
2.0
1.8
2.1
2.2
1.8
2.6
2.5
2.2
1.7
2.3
2.4
2.6
2.4
2.2
1.6
2.6
1.8
2.9

0.06
0.18
0.14
0.25
0.36
0.33
0.33
0.09
0.89
0.31
0.12
0.21
0.16
0.35
0.11
0.05
0.09
0.15
0.08
0.08
0.11
0.34
0.22
0.45
0.68
0.25
0.19
0.09
0.24
0.08
0.48
0.41
0.20
0.13
0.22
0.14
0.20
0.48
0.22
0.35
0.44
0.52
0.07
0.15
0.09
0.10
0.17
0.12
0.17
0.24
0.25
0.27
0.08
0.18
0.10
0.13
0.19
0.15
0.14
0.20
0.19
0.39
0.49

0.17
0.18
0.14
0.15
0.18
0.09
0.18
0.19
0.21
0.19
0.14
0.11
0.15
0.13
0.13
0.16
0.07
0.14
0.14
0.21
0.17
0.09
0.07
0.12
0.06
0.17
0.22
0.16
0.15
0.01
0.13
0.04
0.02
0.14
0.25
0.18
0.25
0.20
0.26
0.16
0.16
0.15
0.17
0.13
0.18
0.16
0.14
0.17
0.18
0.14
0.20
0.21
0.18
0.15
0.19
0.19
0.20
0.19
0.17
0.13
0.20
0.14
0.22

0.01
0.01
0.01
0.02
0.03
0.02
0.03
0.01
0.07
0.03
0.01
0.02
0.01
0.03
0.01
0.00
0.01
0.02
0.01
0.01
0.01
0.02
0.02
0.03
0.05
0.03
0.02
0.01
0.02
0.01
0.03
0.03
0.02
0.01
0.02
0.01
0.02
0.04
0.02
0.03
0.04
0.05
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.02
0.02
0.01
0.02
0.01
0.01
0.02
0.01
0.01
0.02
0.02
0.03
0.04

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

626

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Hodgkin lymphoma (C81) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

135
576
797
99
682
349
68
276
419
39
376
65
17078
1677
14764
729
85
612
118
1
41
73
1737
226
1468
893
80
784
267
255
1136
100
1007
89
2023
210
1686
5363
196
515
741
3832
233
59
169
1370
139
1192
127
54
477
315
138
454

3.9
3.4
3.0
2.8
3.1
3.3
2.7
3.7
2.8
2.5
2.9
2.5
2.8
2.4
2.9
3.3
2.7
3.5
2.3
0.2
2.2
3.0
3.4
3.1
3.7
3.0
2.5
3.0
2.8
2.7
3.4
3.1
3.5
3.1
2.8
2.5
3.0
2.6
1.2
2.4
2.4
3.1
2.1
2.0
2.1
2.4
2.2
2.5
2.1
3.2
2.9
2.8
2.9
3.1

0.35
0.15
0.11
0.29
0.12
0.18
0.34
0.23
0.14
0.41
0.16
0.33
0.02
0.06
0.02
0.13
0.30
0.15
0.22
0.20
0.34
0.38
0.08
0.21
0.10
0.10
0.28
0.11
0.17
0.18
0.11
0.31
0.11
0.34
0.06
0.18
0.07
0.04
0.08
0.11
0.09
0.05
0.14
0.27
0.17
0.07
0.19
0.07
0.19
0.45
0.14
0.16
0.26
0.15

0.32
0.29
0.25
0.25
0.25
0.28
0.24
0.30
0.24
0.22
0.24
0.22
0.24
0.21
0.25
0.28
0.22
0.29
0.21
0.21
0.26
0.28
0.25
0.30
0.24
0.20
0.24
0.23
0.23
0.29
0.27
0.29
0.28
0.24
0.22
0.25
0.23
0.10
0.21
0.22
0.26
0.19
0.18
0.19
0.21
0.19
0.22
0.18
0.26
0.25
0.24
0.22
0.26

0.03
0.01
0.01
0.03
0.01
0.02
0.03
0.02
0.01
0.04
0.01
0.03
0.00
0.01
0.00
0.01
0.03
0.01
0.02
0.04
0.03
0.01
0.02
0.01
0.01
0.02
0.01
0.02
0.02
0.01
0.03
0.01
0.03
0.01
0.02
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.03
0.02
0.01
0.02
0.01
0.02
0.04
0.01
0.02
0.02
0.01

80
505
672
84
575
310
67
239
324
26
296
66
14009
1349
12155
689
77
600
76
2
23
51
1490
155
1297
748
68
658
192
200
952
72
865
78
1696
181
1420
4515
160
424
533
3346
219
56
159
1032
126
879
112
55
388
268
116
379

2.3
2.7
2.5
2.1
2.5
2.8
2.2
3.1
2.1
1.4
2.2
2.7
2.2
1.7
2.4
3.0
2.2
3.3
1.5
0.3
1.2
2.4
2.8
1.8
3.1
2.3
1.9
2.4
2.0
2.2
2.7
2.1
2.8
2.6
2.3
1.9
2.6
2.2
0.9
1.8
1.7
2.7
2.0
1.7
2.1
1.8
1.9
1.8
1.8
3.4
2.5
2.5
2.1
2.6

0.27
0.13
0.10
0.23
0.11
0.17
0.28
0.22
0.12
0.28
0.14
0.35
0.02
0.05
0.02
0.12
0.25
0.15
0.18
0.24
0.25
0.37
0.08
0.15
0.09
0.09
0.23
0.10
0.15
0.16
0.10
0.25
0.11
0.32
0.06
0.15
0.07
0.03
0.07
0.09
0.07
0.05
0.14
0.23
0.18
0.06
0.17
0.06
0.18
0.49
0.13
0.16
0.21
0.14

0.18
0.22
0.19
0.16
0.20
0.22
0.16
0.24
0.16
0.11
0.17
0.21
0.18
0.14
0.19
0.24
0.19
0.26
0.13
0.03
0.11
0.19
0.22
0.15
0.25
0.19
0.15
0.19
0.16
0.16
0.22
0.16
0.23
0.20
0.18
0.14
0.20
0.18
0.07
0.15
0.14
0.22
0.16
0.14
0.17
0.14
0.16
0.15
0.16
0.28
0.19
0.19
0.18
0.21

0.02
0.01
0.01
0.02
0.01
0.01
0.02
0.02
0.01
0.02
0.01
0.03
0.00
0.00
0.00
0.01
0.02
0.01
0.02
0.02
0.03
0.03
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.01
0.03
0.00
0.01
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.02
0.01
0.01
0.02
0.01
0.02
0.04
0.01
0.01
0.02
0.01

18
34
157
3
2
90
14
50
129
474
3
261
42
67
19
565
470
86
13
13
16
41
19
109
12

1.8
0.6
0.9
0.2
0.1
0.5
0.4
2.8
1.2
1.5
0.3
0.9
0.9
0.8
0.7
3.7
3.7
3.2
0.4
0.5
0.5
0.5
0.4
0.4
0.2

0.43
0.10
0.08
0.14
0.05
0.05
0.12
0.40
0.11
0.08
0.19
0.06
0.14
0.10
0.16
0.15
0.17
0.38
0.13
0.17
0.13
0.09
0.09
0.04
0.07

0.11
0.05
0.07
0.04
0.01
0.04
0.03
0.21
0.10
0.13
0.03
0.08
0.09
0.08
0.05
0.31
0.31
0.28
0.03
0.05
0.05
0.04
0.03
0.04
0.02

0.03
0.01
0.01
0.02
0.01
0.01
0.01
0.03
0.01
0.01
0.02
0.01
0.02
0.01
0.01
0.01
0.02
0.04
0.01
0.01
0.01
0.01
0.01
0.00
0.01

15
23
101
4
2
44
8
63
59
176
1
118
15
37
15
540
461
69
8
6
10
27
12
54
7

1.8
0.4
0.5
0.8
0.1
0.2
0.2
3.5
0.5
0.8
0.1
0.5
0.3
0.5
0.5
3.4
3.5
2.8
0.3
0.2
0.3
0.4
0.2
0.2
0.1

0.51
0.08
0.06
0.44
0.06
0.04
0.07
0.46
0.07
0.06
0.08
0.05
0.08
0.08
0.12
0.15
0.17
0.36
0.12
0.09
0.09
0.08
0.08
0.03
0.06

0.18
0.04
0.04
0.05
0.01
0.02
0.02
0.26
0.04
0.07
0.00
0.05
0.02
0.04
0.04
0.27
0.27
0.26
0.03
0.02
0.03
0.03
0.02
0.02
0.01

0.06
0.01 *
0.00
0.02 *
0.00
0.00 *
0.01 *
0.03 *
0.01
0.01 *
0.00
0.01
0.01 *
0.01 *
0.01 *
0.01
0.01
0.05
0.01
0.01
0.01
0.01
0.01
0.00
0.00

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

569

627

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Hodgkin lymphoma (C81) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

570

Female
ASR(W)
CUM 0-74

346
31
20
15
13
22
2
111
5
54
58
13
29
78
81
62
69
51
5
13
35
3
16
54
130

0.4
0.3
0.3
0.4
0.4
0.4
0.3
0.4
0.3
3.2
2.2
0.5
0.6
2.8
2.0
0.6
0.9
0.9
0.9
1.2
0.9
0.1
0.5
1.5
1.5

0.02
0.06
0.08
0.11
0.12
0.09
0.19
0.05
0.15
0.49
0.59
0.15
0.12
0.36
0.24
0.09
0.11
0.13
0.43
0.36
0.16
0.08
0.12
0.21
0.14

0.03
0.03
0.04
0.04
0.04
0.03
0.02
0.04
0.03
0.29
0.13
0.05
0.05
0.25
0.16
0.07
0.07
0.07
0.07
0.10
0.09
0.02
0.04
0.13
0.14

0.00
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.02
0.06
0.03
0.02
0.01
0.04
0.02
0.01
0.01
0.01
0.03
0.03
0.02
0.01
0.01
0.02
0.01

191
22
13
6
7
8
3
56
6
33
25
10
23
33
32
63
48
27
7
14
18
0
11
35
77

0.2
0.2
0.2
0.2
0.2
0.1
0.3
0.2
0.3
1.8
1.2
0.4
0.5
1.3
1.0
0.5
0.6
0.4
0.9
1.2
0.4
0.3
1.0
0.9

0.01
0.05
0.06
0.08
0.07
0.05
0.18
0.03
0.14
0.36
0.35
0.13
0.11
0.26
0.20
0.07
0.09
0.08
0.38
0.35
0.10
0.09
0.18
0.10

0.02
0.02
0.01
0.02
0.02
0.01
0.01
0.02
0.04
0.17
0.11
0.03
0.05
0.14
0.09
0.04
0.05
0.03
0.09
0.14
0.05
0.02
0.09
0.07

0.00
0.01
0.00
0.01
0.01
0.00
0.01
0.00
0.02
0.05
0.05
0.01
0.01
0.04 *
0.03 *
0.01 *
0.01
0.01
0.04
0.05
0.01 *
- *
0.01
0.02 *
0.01 *

440
29
19
665
100
323
564
308
682
355
66
370
63
43
34
38
60
84
90
36
33
26
34
184
293
102
110
153
168
68
26
239
34
56
27
106
40
14
115
54
48
181
29
24
46
77
74
49
27
9
78
81
46
175

2.1
1.7
2.1
2.6
2.2
2.5
2.5
2.5
2.4
2.4
2.0
2.7
2.2
2.4
2.4
2.0
2.4
2.6
2.8
2.6
2.2
2.8
2.3
2.4
2.4
2.1
2.2
2.3
2.3
2.0
3.2
2.3
6.9
3.3
2.7
3.5
3.0
2.7
4.2
3.6
3.3
3.1
2.5
3.1
3.7
2.9
3.1
4.2
3.0
1.6
3.5
3.6
3.1
4.4

0.10
0.33
0.49
0.10
0.24
0.15
0.11
0.15
0.10
0.14
0.25
0.15
0.29
0.38
0.44
0.34
0.32
0.30
0.30
0.47
0.39
0.62
0.42
0.19
0.15
0.23
0.22
0.21
0.19
0.27
0.66
0.15
1.37
0.49
0.58
0.39
0.59
0.90
0.46
0.57
0.48
0.26
0.54
0.69
0.61
0.39
0.37
0.64
0.61
0.55
0.47
0.46
0.49
0.37

0.17
0.14
0.16
0.21
0.18
0.20
0.22
0.22
0.20
0.20
0.15
0.21
0.19
0.18
0.19
0.16
0.20
0.22
0.22
0.23
0.16
0.21
0.19
0.21
0.19
0.17
0.18
0.19
0.20
0.19
0.28
0.19
0.59
0.28
0.22
0.27
0.22
0.21
0.34
0.28
0.29
0.25
0.20
0.22
0.29
0.23
0.27
0.31
0.26
0.17
0.26
0.28
0.28
0.33

0.01
0.03
0.04
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.03
0.03
0.04
0.03
0.03
0.03
0.03
0.04
0.03
0.04
0.03
0.02
0.01
0.02
0.02
0.02
0.02
0.02
0.07
0.01
0.10
0.04
0.05
0.03
0.04
0.06
0.03
0.04
0.05
0.02
0.04
0.05
0.05
0.03
0.03
0.05
0.05
0.06
0.03
0.03
0.04
0.03

334
21
18
712
72
280
369
312
646
260
93
304
52
30
31
44
73
60
68
15
27
18
36
161
248
107
101
138
110
45
14
213
15
54
34
102
40
14
77
47
35
154
42
17
37
73
61
40
21
13
68
59
40
112

1.5
1.1
1.9
2.6
1.6
2.2
1.6
2.5
2.1
1.7
2.5
2.3
1.6
1.7
2.4
2.3
2.7
2.1
2.3
1.3
1.8
1.6
2.7
2.1
1.9
2.2
1.9
2.2
1.5
1.5
1.8
2.0
2.8
3.1
3.4
3.7
3.6
2.7
2.7
2.9
2.5
2.5
4.2
2.1
2.4
3.0
2.6
3.3
2.8
2.9
2.4
2.6
3.2
2.6

0.09
0.25
0.47
0.10
0.21
0.14
0.09
0.15
0.09
0.12
0.27
0.14
0.24
0.34
0.45
0.37
0.34
0.28
0.29
0.38
0.35
0.44
0.48
0.19
0.14
0.24
0.21
0.21
0.16
0.27
0.50
0.14
0.86
0.49
0.68
0.43
0.68
0.87
0.39
0.50
0.43
0.23
0.79
0.55
0.52
0.42
0.36
0.58
0.65
0.84
0.34
0.41
0.58
0.29

0.11
0.09
0.15
0.19
0.12
0.17
0.13
0.20
0.17
0.14
0.19
0.17
0.15
0.11
0.19
0.18
0.21
0.15
0.16
0.09
0.14
0.13
0.20
0.16
0.15
0.17
0.15
0.17
0.11
0.12
0.13
0.17
0.23
0.26
0.27
0.27
0.25
0.18
0.20
0.22
0.20
0.19
0.32
0.17
0.20
0.22
0.19
0.24
0.19
0.21
0.20
0.20
0.25
0.20

0.01
0.02
0.04
0.01 *
0.02 *
0.01
0.01 *
0.01
0.01
0.01
0.02
0.01
0.02
0.02
0.03
0.03
0.03
0.02
0.02
0.02
0.03
0.03
0.03
0.01
0.01
0.02
0.02
0.02
0.01
0.02
0.04
0.01
0.06
0.04
0.05
0.03
0.04
0.06
0.03
0.03
0.04
0.02
0.05
0.04
0.04
0.03
0.03
0.04
0.04
0.06
0.03
0.03
0.04
0.02

*Important. See note on population page.

628

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Hodgkin lymphoma (C81) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

122
194
35
285
49
92
100
179
205
276
403
285
96
17
76
177
79
9
45
46
84
40
39
64
471
33
19
14
38
34
21
44
1076
74
55
235
135
319
505
207
472
1049
318
351
97
333

2.0
2.3
3.4
2.4
2.3
2.7
2.4
2.1
2.8
2.4
3.3
2.0
1.8
1.9
2.4
3.9
1.9
1.4
2.8
2.1
2.6
2.7
2.7
2.6
2.0
3.1
3.3
3.6
2.3
3.9
2.5
2.5
2.5
2.6
2.2
3.3
2.1
2.9
2.9
2.8
2.6
2.8
2.4
2.5
2.1
2.4

0.19
0.17
0.60
0.15
0.34
0.28
0.26
0.16
0.21
0.15
0.18
0.12
0.19
0.50
0.30
0.31
0.22
0.53
0.44
0.31
0.29
0.46
0.47
0.35
0.10
0.58
0.80
1.01
0.41
0.75
0.59
0.41
0.08
0.32
0.32
0.23
0.19
0.17
0.14
0.20
0.13
0.09
0.14
0.14
0.22
0.14

0.16
0.18
0.28
0.20
0.20
0.22
0.19
0.16
0.23
0.18
0.28
0.17
0.14
0.17
0.20
0.30
0.15
0.12
0.23
0.17
0.22
0.21
0.22
0.22
0.16
0.24
0.29
0.26
0.21
0.32
0.20
0.21
0.20
0.21
0.20
0.27
0.17
0.25
0.24
0.24
0.21
0.23
0.21
0.21
0.18
0.20

0.02
0.01
0.05
0.01
0.03
0.02
0.02
0.01
0.02
0.01
0.01
0.01
0.02
0.04
0.03
0.02
0.02
0.04
0.04
0.03
0.03
0.03
0.04
0.03
0.01
0.04
0.07
0.07
0.04
0.06
0.05
0.04
0.01
0.03
0.03
0.02
0.02
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.01

126
255
15
222
42
84
93
164
165
327
285
320
113
13
69
108
72
8
25
31
55
39
25
42
400
35
6
11
36
37
18
41
773
54
51
167
133
191
327
130
381
742
221
246
81
301

2.0
2.6
1.3
1.8
1.8
2.3
2.1
1.9
2.3
2.5
2.3
2.1
2.1
1.4
2.3
2.4
1.7
1.4
1.8
1.5
1.8
2.5
2.2
1.6
1.7
3.1
1.1
2.4
2.8
4.5
2.1
2.1
1.9
2.0
2.3
2.2
2.1
1.7
1.8
1.9
2.0
1.8
1.6
1.8
1.7
2.1

0.19
0.17
0.34
0.13
0.32
0.26
0.23
0.16
0.20
0.15
0.15
0.12
0.21
0.41
0.31
0.25
0.21
0.60
0.40
0.28
0.25
0.43
0.46
0.28
0.09
0.60
0.48
0.84
0.49
0.84
0.55
0.38
0.07
0.29
0.35
0.19
0.20
0.13
0.11
0.17
0.11
0.07
0.12
0.12
0.19
0.13

0.14
0.19
0.11
0.13
0.16
0.19
0.15
0.14
0.17
0.18
0.19
0.16
0.15
0.10
0.17
0.18
0.13
0.10
0.12
0.11
0.13
0.19
0.15
0.13
0.13
0.23
0.10
0.18
0.19
0.34
0.18
0.18
0.14
0.17
0.16
0.18
0.16
0.14
0.14
0.15
0.16
0.15
0.14
0.14
0.15
0.16

0.01
0.01
0.03
0.01
0.03 *
0.02
0.02
0.01 *
0.01
0.01
0.01
0.01
0.02
0.03
0.02
0.02
0.02
0.04
0.03
0.02
0.02
0.03
0.03
0.02
0.01
0.04
0.04
0.06
0.03
0.06
0.05
0.03
0.01
0.02
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01

422
14
183
94
29
321
102
15
8
203
63
3
10
10
9
21

2.3
2.6
1.9
2.4
2.3
2.5
2.0
1.7
1.4
2.0
1.8
1.3
1.6
1.7
1.7
1.9

0.12
0.74
0.14
0.26
0.44
0.14
0.21
0.44
0.53
0.14
0.23
0.80
0.54
0.54
0.71
0.44

0.20
0.25
0.17
0.20
0.19
0.20
0.16
0.12
0.18
0.17
0.15
0.10
0.17
0.14
0.14
0.16

0.01
0.08
0.01
0.02
0.04
0.01
0.02
0.03
0.09
0.01
0.02
0.06
0.06
0.05
0.05
0.04

351
6
151
62
21
269
74
13
6
185
36
1
6
9
5
12

2.0
1.2
1.6
1.6
1.4
2.0
1.4
1.6
0.9
1.7
1.0
0.1
1.0
1.6
0.5
1.6

0.11
0.50
0.13
0.21
0.33
0.13
0.17
0.44
0.37
0.13
0.19
0.09
0.42
0.53
0.32
0.51

0.15
0.07
0.12
0.12
0.13
0.16
0.11
0.16
0.06
0.15
0.08
0.08
0.18
0.03
0.12

0.01
0.03
0.01
0.02
0.03
0.01
0.01
0.05
0.03
0.01
0.02
0.04
0.07
0.02
0.04

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

571

629

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Non-Hodgkin lymphoma (C82-85,C96)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

572

Female
ASR(W)
CUM 0-74

130
869
71
150
248

5.3
16.9
6.7
6.0
7.7

0.50
0.62
0.83
0.71
0.60

96
548
38
128
190

3.8
9.9
3.7
4.4
6.0

0.41
0.44
0.61
0.53
0.54

52
293
34
125
2472
47
363
469
270
100
93

6.4
11.9
4.3
8.0
11.4
5.3
9.8
5.9
9.2
8.8
10.1

0.93
0.77
0.80
0.75
0.24
0.78
0.53
0.28
0.58
0.91
1.09

0.60
1.34
0.48
0.75
1.24
0.52
1.11
0.63
0.96
1.02
1.21

0.10
0.11
0.12
0.09
0.03
0.10
0.08
0.04
0.08
0.12
0.16

74
185
23
121
2313
42
372
392
255
100
88

6.8
6.8
2.9
6.3
8.2
4.3
8.2
4.8
7.8
7.2
7.3

0.87
0.54
0.62
0.59
0.18
0.68
0.44
0.25
0.51
0.77
0.81

0.69
0.82
0.29
0.71
0.90
0.53
0.88
0.52
0.88
0.72
0.83

0.10
0.08
0.08
0.09
0.02
0.10
0.06
0.03
0.07
0.09
0.12 *

11312
1179
2054
622
390
186
9
514
5791
63
504
1852
247
1580
256
2238
15345
1210
785
2413
10622
3423
197
144
109
36
349
2363
4037
331
90
116
76
42
954
2271
1803
1969
90
1852
264
172
80
9688
738
8799
2930
562
2323
1054
266
764
585
6054
526
5346
2853
1595
2015
1996
369
1609
124
343

14.4
13.0
14.0
15.1
14.8
10.7
12.7
16.0
14.9
13.9
13.7
12.9
9.0
13.7
16.6
12.7
15.0
10.5
12.8
13.2
16.4
16.6
14.3
9.5
11.8
10.8
13.9
18.9
15.0
12.8
8.0
14.7
13.5
7.5
13.5
17.5
14.1
16.7
11.6
17.1
15.7
16.9
13.7
15.0
12.6
15.1
12.9
10.9
13.3
14.4
11.9
15.5
14.3
15.5
11.8
15.9
14.7
15.0
15.5
14.7
11.0
16.0
12.2
17.7

0.14
0.39
0.32
0.64
0.78
0.81
4.45
0.73
0.20
1.82
0.65
0.31
0.59
0.36
1.09
0.28
0.13
0.31
0.47
0.29
0.17
0.30
1.05
0.85
1.16
1.97
0.79
0.42
0.25
0.71
0.88
1.40
1.82
1.17
0.47
0.40
0.34
0.40
1.26
0.43
1.01
1.32
1.70
0.17
0.47
0.18
0.24
0.48
0.29
0.46
0.80
0.58
0.62
0.21
0.52
0.23
0.29
0.40
0.36
0.34
0.59
0.42
1.12
1.02

1.61
1.46
1.54
1.65
1.61
1.26
1.51
1.83
1.67
1.44
1.55
1.48
1.00
1.57
1.81
1.40
1.65
1.10
1.42
1.48
1.81
1.81
1.63
1.03
1.20
1.22
1.54
2.06
1.64
1.37
0.80
1.59
1.49
0.63
1.51
1.91
1.55
1.88
1.23
1.94
1.64
1.70
1.59
1.60
1.31
1.62
1.41
1.17
1.46
1.53
1.27
1.65
1.59
1.72
1.28
1.78
1.69
1.71
1.77
1.61
1.20
1.74
1.31
1.92

0.02
0.05
0.04
0.09
0.10
0.11
0.61
0.10
0.03
0.21
0.09
0.04
0.08
0.05
0.15
0.04
0.02
0.04
0.06
0.04
0.02
0.04
0.15
0.10
0.15
0.27
0.12
0.05
0.03
0.09
0.11
0.19
0.23
0.14
0.07
0.05
0.05
0.05
0.16
0.06
0.12
0.15
0.23
0.02
0.06
0.02
0.03
0.06
0.04
0.06
0.11
0.08
0.08
0.03
0.07
0.03
0.04
0.05
0.05
0.04
0.08
0.05
0.15
0.13

9680
992
1622
549
360
152
3
400
5113
39
450
1724
240
1458
180
1914
12707
1009
613
1991
8842
2740
145
132
91
38
319
1838
3274
291
85
94
66
27
747
1853
1663
1779
89
1664
196
108
78
8470
609
7752
2629
489
2089
872
217
626
552
5491
447
4892
2649
1574
1915
1867
345
1509
108
307

10.4
9.5
9.5
11.2
11.3
7.7
3.9
10.2
11.1
6.7
10.6
8.8
6.3
9.4
11.5
9.4
10.2
7.0
8.2
9.7
11.2
10.9
8.5
6.9
7.1
8.0
11.5
12.0
9.8
8.4
6.1
8.6
8.5
3.8
8.8
11.5
11.1
11.5
9.3
11.7
8.3
7.1
10.6
10.5
8.7
10.6
9.0
7.2
9.4
9.7
7.9
10.3
11.5
10.7
7.5
11.2
10.6
11.1
11.1
10.6
7.7
11.6
8.1
11.4

0.12
0.32
0.26
0.54
0.66
0.66
2.38
0.56
0.17
1.19
0.57
0.23
0.43
0.28
0.90
0.24
0.10
0.23
0.34
0.23
0.14
0.23
0.74
0.67
0.78
1.58
0.67
0.33
0.18
0.51
0.72
0.93
1.21
0.75
0.34
0.32
0.29
0.31
1.01
0.33
0.65
0.77
1.33
0.13
0.36
0.15
0.19
0.34
0.22
0.35
0.57
0.45
0.53
0.16
0.36
0.18
0.23
0.33
0.28
0.27
0.44
0.33
0.81
0.76

1.18
1.10
1.07
1.31
1.28
0.95
0.49
1.18
1.24
0.69
1.24
1.02
0.72
1.09
1.27
1.06
1.16
0.77
0.92
1.09
1.27
1.21
0.99
0.73
0.73
0.85
1.29
1.34
1.09
0.93
0.54
1.03
1.05
0.50
0.98
1.30
1.27
1.30
1.02
1.32
0.92
0.76
1.33
1.17
0.91
1.19
1.01
0.75
1.07
1.04
0.83
1.12
1.39
1.22
0.84
1.28
1.21
1.30
1.24
1.20
0.84
1.34
0.93
1.29

0.02
0.05
0.03
0.07
0.09
0.09
0.35
0.07
0.02
0.15
0.08
0.03
0.06
0.04
0.12
0.03
0.01
0.03
0.05
0.03
0.02
0.03
0.10
0.08
0.10
0.18
0.10
0.04
0.03
0.07
0.08
0.13
0.17
0.12
0.05
0.04
0.04
0.04
0.13
0.04
0.08
0.09
0.21
0.02
0.05
0.02
0.03
0.04
0.03
0.05
0.07
0.06
0.08
0.02
0.05
0.02
0.03
0.04
0.04
0.04
0.06
0.04
0.11
0.10

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

630

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Non-Hodgkin lymphoma (C82-85,C96) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

715
3238
4891
419
4369
2039
315
1689
2859
167
2671
488
109372
8060
96987
4916
481
4230
711
34
186
478
9967
1084
8574
5837
384
5291
1642
1834
7425
447
6761
563
13409
933
11473
35380
1885
2516
3246
27178
1701
269
1407
8169
654
7307
878
304
3215
2244
979
2745

15.0
15.3
15.1
12.1
15.3
16.0
12.6
17.0
15.0
11.2
15.4
14.5
15.0
12.2
15.3
17.5
16.0
17.6
12.0
9.7
10.0
13.5
16.3
15.2
16.7
15.3
11.8
15.4
14.1
15.3
16.4
13.9
16.2
15.5
15.8
12.6
16.5
15.4
10.6
12.8
13.3
16.3
13.3
9.3
14.4
13.8
11.4
14.0
15.5
14.5
16.7
17.1
14.6
14.9

0.59
0.28
0.23
0.61
0.24
0.37
0.73
0.44
0.29
0.89
0.31
0.69
0.05
0.14
0.05
0.26
0.74
0.29
0.47
1.71
0.75
0.67
0.17
0.47
0.19
0.21
0.62
0.22
0.36
0.38
0.20
0.67
0.21
0.70
0.14
0.43
0.16
0.09
0.25
0.26
0.25
0.11
0.33
0.58
0.40
0.16
0.46
0.17
0.54
0.87
0.31
0.38
0.49
0.30

1.68
1.69
1.69
1.33
1.72
1.79
1.40
1.90
1.68
1.21
1.72
1.56
1.67
1.31
1.70
1.91
1.67
1.93
1.38
1.13
1.21
1.52
1.78
1.61
1.83
1.76
1.32
1.77
1.58
1.66
1.82
1.40
1.81
1.69
1.77
1.38
1.85
1.70
1.12
1.39
1.51
1.81
1.49
0.98
1.61
1.53
1.22
1.56
1.80
1.63
1.88
1.94
1.66
1.67

0.08
0.04
0.03
0.08
0.03
0.05
0.10
0.06
0.04
0.12
0.04
0.09
0.01
0.02
0.01
0.03
0.09
0.04
0.06
0.25
0.11
0.09
0.02
0.06
0.02
0.03
0.08
0.03
0.05
0.05
0.03
0.08
0.03
0.09
0.02
0.06
0.02
0.01
0.03
0.03
0.04
0.01
0.04
0.07
0.05
0.02
0.06
0.02
0.08
0.12
0.04
0.05
0.06
0.04

679
3122
4586
390
4097
1881
283
1571
2632
170
2437
416
98397
6768
87949
4547
380
4019
636
31
148
446
9221
901
8073
5333
336
4833
1455
1637
6863
348
6338
571
11471
776
9845
30766
1562
2062
2615
24065
1557
257
1280
7336
570
6580
654
305
2684
1833
978
2491

11.5
11.1
11.2
8.6
11.4
11.3
8.2
12.3
10.6
8.1
10.8
10.9
10.6
7.9
10.9
12.3
9.6
12.7
8.9
6.7
6.9
10.4
11.4
9.1
11.9
10.6
7.5
10.6
9.4
11.3
11.4
8.0
11.4
11.4
10.8
8.3
11.3
10.7
7.0
8.3
9.6
11.4
9.4
6.7
10.2
10.1
8.1
10.3
9.9
11.8
11.7
11.8
11.3
10.8

0.50
0.23
0.18
0.45
0.20
0.29
0.51
0.35
0.23
0.65
0.25
0.60
0.04
0.10
0.04
0.21
0.51
0.23
0.38
1.24
0.59
0.56
0.13
0.31
0.15
0.16
0.43
0.17
0.28
0.31
0.16
0.45
0.17
0.56
0.11
0.31
0.13
0.07
0.19
0.19
0.20
0.08
0.26
0.44
0.31
0.13
0.35
0.14
0.41
0.76
0.25
0.30
0.41
0.25

1.33
1.26
1.27
0.92
1.30
1.32
0.88
1.45
1.21
0.88
1.25
1.23
1.21
0.86
1.25
1.38
1.00
1.44
1.02
0.71
0.82
1.18
1.27
0.99
1.35
1.22
0.83
1.23
1.07
1.28
1.30
0.85
1.32
1.28
1.22
0.90
1.30
1.21
0.77
0.90
1.08
1.31
1.06
0.71
1.16
1.16
0.94
1.18
1.12
1.32
1.32
1.35
1.32
1.21

0.07
0.03
0.02
0.06
0.03
0.04
0.07
0.05
0.03
0.09
0.03
0.08
0.01
0.01
0.01
0.03
0.06
0.03
0.05
0.17
0.08
0.07
0.02
0.04
0.02
0.02
0.06
0.02
0.04
0.04
0.02
0.06
0.02
0.07
0.02
0.04
0.02
0.01
0.03
0.02
0.03
0.01
0.03
0.05
0.04
0.02
0.05
0.02
0.06
0.10
0.03
0.04
0.05
0.03

47
376
1685
37
71
1199
137
207
431
1241
30
1072
175
250
95
2778
2526
188
183
279
331
727
495
2128
343

7.1
6.7
8.1
3.4
3.1
5.5
4.3
9.7
4.4
5.3
3.3
4.4
4.0
3.7
3.5
17.1
17.5
10.0
4.8
7.3
8.8
7.4
7.5
6.2
5.7

1.08
0.36
0.21
0.60
0.41
0.18
0.37
0.70
0.22
0.16
0.60
0.14
0.31
0.25
0.37
0.34
0.36
0.79
0.37
0.47
0.51
0.29
0.39
0.14
0.35

0.78
0.72
0.86
0.38
0.33
0.61
0.44
1.11
0.46
0.61
0.32
0.47
0.41
0.40
0.44
1.90
1.96
1.03
0.56
0.82
0.94
0.79
0.81
0.67
0.60

0.15
0.05
0.03
0.07
0.05
0.02
0.04
0.09
0.03
0.02
0.07
0.02
0.04
0.03
0.05
0.04
0.05
0.11
0.05
0.06
0.06
0.04
0.04
0.02
0.04

35
247
1246
19
47
841
82
159
220
639
20
604
84
155
71
2651
2433
172
149
226
290
605
406
1614
305

5.6
4.2
5.3
1.6
1.9
3.5
2.5
6.5
2.3
3.4
2.1
2.9
1.9
2.4
2.3
13.7
14.0
9.1
3.6
4.4
6.1
5.2
4.9
3.8
3.7

0.98
0.28
0.16
0.40
0.28
0.14
0.28
0.54
0.16
0.14
0.47
0.12
0.22
0.20
0.28
0.28
0.30
0.73
0.31
0.35
0.40
0.24
0.31
0.11
0.27

0.66
0.44
0.58
0.19
0.21
0.38
0.24
0.74
0.22
0.37
0.22
0.31
0.18
0.27
0.24
1.56
1.59
0.99
0.41
0.48
0.63
0.57
0.50
0.40
0.41

0.14
0.03 *
0.02
0.05 *
0.04
0.02 *
0.03 *
0.07 *
0.02
0.02 *
0.06
0.02
0.02 *
0.03 *
0.03 *
0.04
0.04
0.10
0.04
0.04
0.05
0.03
0.03
0.01
0.03

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

573

631

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Non-Hodgkin lymphoma (C82-85,C96) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

574

Female
ASR(W)
CUM 0-74

5102
417
320
164
197
331
37
1506
82
135
182
142
255
161
247
550
684
539
25
120
283
131
159
164
410

5.6
4.5
5.7
5.6
6.9
6.1
4.7
6.8
4.9
10.4
5.1
7.0
6.6
8.2
7.6
6.8
8.1
8.1
3.3
11.9
7.1
6.0
5.5
5.3
5.0

0.08
0.23
0.34
0.46
0.53
0.35
0.79
0.19
0.61
0.99
0.71
0.61
0.43
0.68
0.53
0.33
0.32
0.36
0.71
1.13
0.43
0.53
0.44
0.42
0.25

0.62
0.51
0.64
0.59
0.81
0.66
0.51
0.75
0.58
1.16
0.50
0.79
0.71
0.99
0.78
0.73
0.88
0.89
0.35
1.34
0.74
0.65
0.62
0.60
0.54

0.01
0.03
0.05
0.06
0.08
0.05
0.10
0.03
0.09
0.14
0.07
0.08
0.06
0.10
0.07
0.05
0.04
0.05
0.08
0.16
0.05
0.06
0.06
0.06
0.03

3537
334
224
133
134
211
33
1085
48
91
64
97
165
93
121
460
464
377
21
66
188
105
127
124
351

3.3
3.2
3.3
3.8
3.9
3.2
3.2
4.2
2.5
6.5
6.5
4.2
4.2
4.4
5.1
5.1
5.0
5.0
4.0
6.6
4.6
4.6
4.0
3.9
4.1

0.06
0.18
0.22
0.34
0.34
0.23
0.59
0.13
0.38
0.74
1.15
0.44
0.34
0.51
0.51
0.25
0.24
0.27
0.91
0.84
0.35
0.46
0.36
0.36
0.22

0.36
0.36
0.36
0.44
0.43
0.34
0.37
0.46
0.31
0.72
0.80
0.46
0.48
0.48
0.52
0.61
0.55
0.53
0.46
0.76
0.49
0.50
0.44
0.45
0.47

0.01
0.02
0.03
0.05
0.05
0.03
0.08
0.02
0.06
0.10
0.18
0.06
0.05
0.07 *
0.06 *
0.04 *
0.03
0.03
0.12
0.11
0.04 *
0.06 *
0.05
0.05 *
0.03 *

2469
244
111
1136
577
1983
1106
1041
2723
1961
305
2257
348
219
207
273
355
397
519
189
206
138
303
894
1422
679
600
757
908
468
98
1289
94
366
242
701
314
110
648
432
173
1194
265
84
300
661
333
209
109
88
570
409
323
882

8.7
11.1
10.1
4.2
9.0
11.0
4.0
7.0
8.0
9.6
7.4
11.9
10.1
9.3
11.8
11.4
10.7
10.7
13.0
9.3
10.9
8.1
12.3
9.5
8.0
10.7
9.3
8.6
9.3
10.7
10.8
11.2
11.0
15.7
14.7
14.2
12.9
12.3
14.6
15.9
11.7
14.1
14.3
7.9
15.8
14.4
11.1
12.1
8.9
12.0
14.2
11.1
18.1
14.0

0.18
0.75
0.98
0.13
0.40
0.27
0.13
0.23
0.16
0.23
0.44
0.26
0.56
0.67
0.85
0.72
0.61
0.56
0.60
0.74
0.81
0.81
0.77
0.34
0.23
0.44
0.39
0.33
0.33
0.53
1.14
0.32
1.26
0.86
1.09
0.62
0.88
1.28
0.66
0.87
0.90
0.45
1.03
0.95
1.03
0.63
0.65
0.89
0.91
1.32
0.66
0.64
1.10
0.52

0.92
1.23
1.16
0.45
0.93
1.18
0.43
0.75
0.88
1.07
0.80
1.28
1.10
0.97
1.32
1.22
1.15
1.14
1.41
1.01
1.20
0.87
1.41
1.06
0.89
1.09
1.05
0.92
0.98
1.15
1.11
1.24
1.15
1.67
1.66
1.51
1.38
1.44
1.56
1.72
1.26
1.51
1.61
0.79
1.80
1.65
1.16
1.31
1.08
1.40
1.53
1.18
1.81
1.55

0.02
0.09
0.13
0.01
0.05
0.03
0.01
0.03
0.02
0.03
0.05
0.03
0.07
0.08
0.11
0.09
0.07
0.07
0.08
0.09
0.10
0.10
0.10
0.04
0.03
0.05
0.05
0.04
0.04
0.06
0.14
0.04
0.14
0.10
0.12
0.07
0.09
0.17
0.07
0.10
0.11
0.05
0.12
0.10
0.12
0.08
0.07
0.11
0.12
0.18
0.08
0.07
0.12
0.06

2439
200
110
1130
495
1734
876
964
2579
1818
335
2296
331
187
161
241
325
347
454
150
173
112
220
840
1507
727
626
720
836
466
64
1068
107
329
203
578
333
76
608
347
174
1190
285
92
277
537
314
165
86
92
487
408
293
854

6.1
6.9
7.9
2.7
6.0
7.8
2.7
5.1
5.5
7.4
5.1
8.9
7.1
6.3
6.8
7.6
7.8
7.5
8.7
5.5
6.8
6.3
7.6
6.6
5.8
8.0
7.0
5.8
6.5
7.9
6.5
8.1
8.7
10.6
8.9
9.0
9.5
7.4
9.2
10.6
10.0
10.8
12.9
7.0
11.5
9.2
8.9
8.0
7.2
10.3
9.5
8.7
11.8
9.7

0.14
0.54
0.82
0.09
0.31
0.22
0.10
0.18
0.12
0.19
0.33
0.21
0.44
0.52
0.60
0.55
0.50
0.45
0.46
0.54
0.59
0.73
0.60
0.27
0.18
0.35
0.31
0.25
0.26
0.43
0.87
0.26
0.98
0.68
0.76
0.47
0.69
1.06
0.44
0.71
0.79
0.38
0.99
0.81
0.86
0.49
0.57
0.68
0.90
1.20
0.55
0.55
0.85
0.40

0.66
0.77
0.97
0.31
0.66
0.87
0.29
0.54
0.62
0.85
0.53
0.98
0.78
0.75
0.78
0.87
0.81
0.86
0.99
0.62
0.80
0.68
0.92
0.73
0.65
0.87
0.81
0.61
0.75
0.88
0.73
0.95
1.06
1.21
1.02
0.98
1.05
0.78
1.07
1.14
1.11
1.19
1.40
0.79
1.30
1.05
0.95
0.92
0.77
1.26
1.06
0.94
1.27
1.08

0.02
0.07
0.11
0.01 *
0.04 *
0.03
0.01 *
0.02
0.01
0.03
0.03
0.03
0.06
0.07
0.08
0.07
0.06
0.06
0.06
0.07
0.08
0.08
0.08
0.03
0.02
0.04
0.04
0.03
0.03
0.05
0.11
0.04
0.13
0.08
0.09
0.05
0.07
0.12
0.05
0.08
0.10
0.04
0.10
0.10
0.10
0.06
0.06
0.08
0.09
0.16
0.06
0.06
0.09
0.05

*Important. See note on population page.

632

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Non-Hodgkin lymphoma (C82-85,C96) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

380
570
133
1777
154
266
353
848
1031
624
769
989
539
62
467
661
583
53
259
243
363
230
220
295
3659
195
74
82
192
176
112
287
5935
356
287
1168
1005
1633
2551
1053
3625
5683
1946
2087
617
2056

5.4
5.6
10.5
10.8
6.6
6.6
6.2
8.7
10.8
4.8
5.0
6.4
8.3
6.4
10.2
10.7
13.1
5.7
12.1
8.9
9.8
10.8
12.5
9.3
9.7
13.6
8.4
12.8
10.2
14.6
11.1
12.6
10.6
10.0
8.7
10.5
11.2
10.7
10.2
10.9
13.3
11.6
10.3
10.5
11.4
11.0

0.28
0.24
0.95
0.27
0.57
0.42
0.36
0.32
0.37
0.20
0.20
0.21
0.38
0.87
0.54
0.46
0.56
0.97
0.82
0.61
0.55
0.80
0.95
0.62
0.18
1.03
1.04
1.54
0.79
1.22
1.12
0.80
0.14
0.55
0.55
0.33
0.38
0.28
0.22
0.35
0.24
0.16
0.25
0.24
0.48
0.26

0.57
0.58
1.00
1.19
0.77
0.77
0.67
0.93
1.13
0.51
0.54
0.71
0.86
0.69
1.05
1.11
1.41
0.60
1.34
0.98
1.03
1.13
1.33
0.93
1.10
1.48
0.89
1.48
1.09
1.60
1.20
1.43
1.16
1.12
0.90
1.17
1.21
1.20
1.15
1.23
1.49
1.26
1.15
1.17
1.31
1.22

0.03
0.03
0.11
0.04
0.07
0.05
0.04
0.04
0.04
0.02
0.02
0.03
0.04
0.10
0.06
0.05
0.07
0.10
0.10
0.07
0.06
0.09
0.10
0.06
0.02
0.13
0.13
0.20
0.10
0.15
0.14
0.10
0.02
0.07
0.06
0.04
0.05
0.04
0.03
0.05
0.03
0.02
0.03
0.03
0.06
0.03

386
571
111
1645
150
202
337
701
970
646
669
951
555
75
457
597
527
31
216
202
317
203
180
262
3183
148
83
54
156
176
83
272
5014
289
264
1055
877
1438
2389
901
3190
4990
1799
1818
681
2127

3.6
3.8
7.6
8.0
4.5
3.7
4.1
5.7
7.8
2.9
3.8
4.7
6.0
6.2
7.8
7.3
10.1
4.1
9.3
6.0
7.3
7.5
8.4
6.4
6.8
7.8
7.8
6.4
7.0
11.1
6.8
8.9
7.3
7.2
6.6
7.9
7.7
7.4
7.6
7.8
9.4
7.9
7.8
7.6
9.9
8.6

0.21
0.18
0.78
0.23
0.40
0.29
0.25
0.24
0.29
0.13
0.17
0.17
0.28
0.81
0.43
0.34
0.47
1.03
0.71
0.48
0.45
0.60
0.73
0.49
0.14
0.72
0.98
1.01
0.62
1.02
0.81
0.62
0.11
0.46
0.45
0.28
0.30
0.22
0.18
0.29
0.19
0.13
0.21
0.20
0.42
0.21

0.41
0.44
0.84
0.92
0.57
0.41
0.50
0.63
0.86
0.33
0.40
0.53
0.66
0.77
0.89
0.78
1.13
0.41
1.09
0.66
0.79
0.88
0.91
0.66
0.79
0.88
0.88
0.77
0.80
1.26
0.87
0.92
0.83
0.79
0.77
0.90
0.87
0.83
0.85
0.87
1.07
0.89
0.88
0.85
1.13
0.98

0.02
0.02
0.09
0.03
0.05 *
0.03
0.03
0.03 *
0.03
0.01
0.02
0.02
0.03
0.10
0.05
0.04
0.06
0.08
0.09
0.05
0.05
0.08
0.08
0.05
0.02
0.09
0.13
0.13
0.08
0.12
0.11
0.07
0.01
0.06
0.06
0.04
0.04
0.03
0.02
0.04
0.02
0.02
0.03
0.02
0.05
0.03

3166
42
1598
912
252
2533
832
131
42
1550
545
56
79
69
135
159

14.0
8.6
13.1
16.6
14.7
15.3
13.6
14.9
8.6
12.3
12.4
13.9
10.9
13.4
11.1
13.6

0.26
1.39
0.34
0.58
0.98
0.32
0.49
1.34
1.37
0.32
0.57
2.12
1.32
1.65
1.29
1.18

1.55
0.89
1.39
1.84
1.61
1.69
1.45
1.66
0.94
1.37
1.32
1.51
1.26
1.55
1.17
1.36

0.03
0.16
0.04
0.07
0.12
0.04
0.06
0.19
0.18
0.04
0.07
0.28
0.18
0.24
0.14
0.14

2640
28
1305
798
208
2206
627
118
31
1434
441
32
59
47
140
127

9.8
6.9
9.8
12.1
10.2
11.0
9.0
11.7
6.4
9.6
8.7
7.5
7.4
8.0
7.6
11.2

0.21
1.40
0.29
0.48
0.78
0.26
0.39
1.14
1.20
0.28
0.46
1.46
1.01
1.19
0.81
1.10

1.11
0.69
1.08
1.36
1.16
1.21
1.06
1.34
0.71
1.13
0.95
0.96
0.80
0.82
0.83
1.24

0.03
0.18
0.04
0.06
0.10
0.03
0.05
0.16
0.17
0.04
0.06
0.21
0.14
0.15
0.10
0.14

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

575

633

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Immunoproliferative diseases (C88)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

576

Female
ASR(W)
CUM 0-74

0
1
1
0
0

0.0
0.1
-

0.01
0.13
-

0
3
0
0
0

0.0
-

0.02
-

0
0
0
0
10
0
0
2
0
2
0

0.0
0.0
0.2
-

0.02
0.02
0.12
-

0.00
0.00
0.04
-

0.00
0.00
0.03
-

0
1
0
0
14
0
0
0
0
0
0

0.0
0.0
-

0.02
0.01
-

0.00
0.01
-

0.00
0.00
- *

207
31
11
29
10
7
0
19
76
2
22
12
1
11
4
27
374
17
9
29
305
93
4
1
3
0
5
75
82
3
2
1
1
0
9
65
36
40
0
40
7
3
4
178
8
168
25
1
24
10
1
9
16
110
4
103
38
42
23
26
1
25
0
5

0.2
0.3
0.1
0.6
0.3
0.4
0.5
0.2
0.4
0.5
0.1
0.0
0.1
0.3
0.1
0.3
0.1
0.1
0.2
0.4
0.4
0.2
0.1
0.3
0.3
0.5
0.3
0.1
0.2
0.1
0.1
0.2
0.5
0.3
0.3
0.3
0.4
0.3
0.7
0.2
0.1
0.2
0.1
0.0
0.1
0.2
0.0
0.2
0.3
0.3
0.1
0.3
0.2
0.3
0.2
0.2
0.0
0.2
0.2

0.02
0.06
0.02
0.12
0.10
0.14
0.12
0.02
0.29
0.12
0.02
0.04
0.03
0.16
0.03
0.02
0.03
0.05
0.04
0.03
0.05
0.12
0.06
0.18
0.13
0.06
0.04
0.07
0.15
0.08
0.14
0.06
0.06
0.05
0.05
0.06
0.16
0.15
0.37
0.02
0.05
0.02
0.02
0.02
0.03
0.05
0.04
0.07
0.09
0.03
0.05
0.03
0.03
0.05
0.03
0.04
0.02
0.05
0.07

0.03
0.05
0.01
0.08
0.02
0.04
0.07
0.02
0.07
0.05
0.01
0.01
0.01
0.06
0.02
0.04
0.01
0.01
0.02
0.05
0.05
0.01
0.01
0.02
0.05
0.06
0.04
0.01
0.02
0.02
0.06
0.03
0.03
0.03
0.07
0.04
0.12
0.03
0.02
0.03
0.01
0.00
0.01
0.01
0.00
0.01
0.04
0.03
0.01
0.03
0.02
0.03
0.02
0.02
0.03
0.01

0.00
0.01
0.00
0.02
0.01
0.02
0.02
0.00
0.05
0.02
0.00
0.01
0.00
0.03
0.00
0.00
0.00
0.01
0.01
0.00
0.01
0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.03
0.03
0.07
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.01
0.00
0.01
0.00
0.00
0.01
0.01
0.01
0.01
0.01

132
19
2
21
9
2
0
8
58
2
11
15
3
12
1
16
206
7
8
13
174
55
2
2
1
0
3
45
47
3
1
0
1
0
4
37
24
22
0
21
2
2
0
131
2
128
20
2
18
6
2
4
11
76
3
71
26
19
15
12
3
9
0
5

0.1
0.2
0.0
0.3
0.2
0.1
0.2
0.1
0.4
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.2
0.2
0.1
0.1
0.1
0.1
0.2
0.1
0.0
0.0
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.2
0.1
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1

0.01
0.04
0.00
0.08
0.06
0.05
0.07
0.02
0.32
0.05
0.02
0.06
0.02
0.10
0.02
0.01
0.02
0.03
0.02
0.02
0.03
0.07
0.09
0.10
0.07
0.04
0.02
0.02
0.04
0.05
0.03
0.04
0.03
0.03
0.03
0.07
0.12
0.01
0.02
0.01
0.02
0.02
0.02
0.03
0.05
0.04
0.08
0.02
0.03
0.02
0.02
0.03
0.02
0.02
0.02
0.02
0.08

0.01
0.02
0.03
0.01
0.01
0.01
0.01
0.08
0.01
0.01
0.01
0.01
0.02
0.01
0.02
0.00
0.01
0.01
0.02
0.02
0.01
0.02
0.02
0.02
0.02
0.02
0.01
0.03
0.02
0.02
0.02
0.01
0.02
0.01
0.00
0.02
0.01
0.00
0.01
0.01
0.00
0.01
0.04
0.01
0.00
0.02
0.01
0.01
0.01
0.01
0.01
0.02

0.00
0.01
0.01
0.01
0.01
0.01
0.00
0.05
0.01
0.00
0.01
0.00
0.02
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.02
0.01
0.01
0.00
0.00
0.01
0.00
0.00
0.00
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

634

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Immunoproliferative diseases (C88) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

33
86
89
7
76
40
4
35
36
0
36
10
1952
73
1798
110
5
102
18
0
1
17
174
7
162
76
2
71
16
33
141
6
132
6
280
8
258
759
27
22
37
658
18
3
15
119
6
107
13
8
75
50
13
64

0.7
0.4
0.2
0.2
0.2
0.3
0.2
0.3
0.2
0.2
0.3
0.2
0.1
0.3
0.4
0.2
0.4
0.3
0.1
0.5
0.3
0.1
0.3
0.2
0.1
0.2
0.1
0.2
0.3
0.2
0.3
0.1
0.3
0.1
0.3
0.3
0.1
0.1
0.2
0.4
0.1
0.1
0.2
0.2
0.1
0.2
0.2
0.4
0.4
0.4
0.2
0.3

0.13
0.04
0.03
0.08
0.03
0.05
0.09
0.05
0.03
0.03
0.09
0.01
0.01
0.01
0.04
0.08
0.04
0.07
0.05
0.12
0.02
0.04
0.02
0.02
0.04
0.02
0.03
0.04
0.03
0.07
0.03
0.07
0.02
0.04
0.02
0.01
0.03
0.03
0.03
0.01
0.03
0.06
0.04
0.02
0.05
0.02
0.07
0.13
0.04
0.06
0.05
0.04

0.09
0.04
0.02
0.03
0.02
0.03
0.02
0.04
0.01
0.01
0.03
0.03
0.01
0.03
0.05
0.02
0.05
0.03
0.00
0.05
0.03
0.01
0.03
0.02
0.01
0.02
0.01
0.02
0.04
0.01
0.04
0.02
0.03
0.01
0.04
0.04
0.02
0.01
0.02
0.04
0.02
0.01
0.02
0.02
0.01
0.02
0.02
0.04
0.05
0.05
0.02
0.03

0.02
0.01
0.00
0.01
0.00
0.01
0.01
0.01
0.00
0.00
0.01
0.00
0.00
0.00
0.01
0.01
0.01
0.01
0.00
0.02
0.00
0.01
0.00
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.01
0.02
0.01
0.01
0.01
0.01

0
0

0
0
1
0
0
0
0
0
0
0
0
0
20
19
1
0
3
4
5
2
19
4

0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.1

0.00
0.03
0.03
0.08
0.03
0.05
0.02
0.01
0.01
0.03

0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.00
0.00
0.01

Cases

Female
ASR(W)
CUM 0-74

19
68
82
9
66
36
3
32
32
5
27
7
1331
66
1216
58
3
54
11
0
2
9
150
7
142
46
0
45
9
17
106
4
94
6
180
7
164
433
13
20
19
375
19
4
13
77
8
68
13
6
46
29
9
41

0.3
0.2
0.2
0.2
0.2
0.2
0.1
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.1
0.2
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.2
0.2
0.1
0.2

0.07
0.02
0.02
0.06
0.03
0.04
0.05
0.05
0.02
0.10
0.02
0.04
0.00
0.01
0.00
0.02
0.04
0.02
0.05
0.07
0.07
0.02
0.03
0.02
0.01
0.01
0.02
0.03
0.02
0.05
0.02
0.03
0.01
0.03
0.01
0.01
0.02
0.02
0.02
0.01
0.02
0.05
0.02
0.01
0.05
0.01
0.05
0.10
0.03
0.04
0.04
0.03

0.03
0.02
0.03
0.02
0.03
0.03
0.02
0.03
0.01
0.01
0.01
0.00
0.01
0.01
0.02
0.02
0.01
0.02
0.02
0.01
0.02
0.02
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.01
0.02
0.01
0.02
0.01
0.02
0.02
0.00
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.01
0.02
0.03
0.03
0.02
0.02
0.02

0
0

0.00
0.00
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.00

0
0
0
0
0
0
0
0
0
0
0
0
10
10
0
2
1
1
2
2
12
1

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.01
0.01
0.03
0.02
0.01
0.01
0.01
0.01
0.02

0.00
0.00
0.01
0.00
0.00
0.00
0.00

0.01
0.00
0.00
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.02
0.00
0.01
0.01
0.00
- *
- *
- *
- *
- *
- *
- *
- *
- *
0.00
0.00
0.01
0.00
0.00
0.00
0.00

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

577

635

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Immunoproliferative diseases (C88) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

578

Female
ASR(W)
CUM 0-74

24
1
1
0
0
2
0
9
0
0
0
0
0
1
0
0
0
0
0
0
0
2
0
0
0

0.0
0.0
0.0
0.1
0.0
0.1
0.1
-

0.01
0.01
0.03
0.04
0.02
0.05
0.07
-

0.00
0.00
0.01
0.01
0.01
0.01
0.01
-

0.00
0.00
0.01
0.01
0.00
0.01
0.00
-

6
0
1
1
0
0
0
0
0
1
0
1
0
0
0
0
1
1
0
0
0
1
0
0
0

0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
-

0.00
0.01
0.03
0.08
0.04
0.01
0.01
0.04
-

0.00
0.00
0.00
0.01
0.00
0.01
-

0.00
0.00
0.00
0.01
0.00
- *
- *
- *
- *
0.01 *
- *
- *

8
1
0
7
18
41
1
22
75
145
7
37
25
22
12
32
44
29
92
31
4
11
41
6
24
11
7
4
3
4
7
32
14
1
6
19
6
1
8
32
3
8
0
0
0
11
0
4
2
1
2
14
1
5

0.0
0.0
0.0
0.3
0.2
0.0
0.1
0.2
0.6
0.2
0.2
0.7
0.9
0.6
1.2
0.9
0.7
2.0
1.2
0.2
0.6
1.6
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.8
0.2
1.4
0.0
0.3
0.3
0.1
0.1
0.2
0.9
0.2
0.1
0.2
0.2
0.1
0.1
0.0
0.3
0.0
0.1

0.01
0.03
0.01
0.06
0.03
0.00
0.03
0.02
0.05
0.06
0.03
0.14
0.20
0.18
0.22
0.15
0.13
0.22
0.23
0.11
0.19
0.26
0.02
0.02
0.04
0.04
0.02
0.02
0.04
0.32
0.04
0.40
0.04
0.13
0.06
0.06
0.06
0.06
0.17
0.10
0.03
0.06
0.10
0.10
0.14
0.03
0.09
0.04
0.03

0.00
0.00
0.03
0.02
0.00
0.02
0.02
0.07
0.02
0.02
0.07
0.09
0.05
0.16
0.08
0.08
0.25
0.18
0.03
0.09
0.20
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.09
0.02
0.16
0.01
0.05
0.04
0.01
0.02
0.09
0.02
0.01
0.02
0.03
0.01
0.02
0.00
0.04
0.00

0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.01
0.00
0.02
0.03
0.02
0.03
0.02
0.02
0.03
0.04
0.01
0.03
0.04
0.00
0.00
0.01
0.01
0.00
0.00
0.01
0.04
0.01
0.05
0.01
0.02
0.01
0.01
0.01
0.02
0.02
0.00
0.01
0.02
0.01
0.02
0.00
0.01
0.00

12
4
0
7
10
28
0
12
57
73
12
35
13
11
7
22
15
21
44
19
4
7
22
13
28
3
6
0
4
1
6
24
7
1
5
16
4
1
4
16
0
3
0
1
0
4
1
6
0
1
1
4
2
4

0.0
0.1
0.0
0.1
0.1
0.0
0.1
0.2
0.1
0.1
0.2
0.3
0.2
0.5
0.2
0.4
0.7
0.6
0.2
0.4
0.8
0.1
0.1
0.0
0.0
0.0
0.0
0.7
0.1
0.3
0.0
0.2
0.2
0.1
0.1
0.1
0.4
0.0
0.0
0.0
0.0
0.3
0.2
0.0
0.1
0.0
0.0

0.01
0.06
0.01
0.03
0.02
0.01
0.02
0.03
0.04
0.02
0.07
0.10
0.08
0.12
0.06
0.09
0.12
0.17
0.10
0.15
0.19
0.02
0.01
0.02
0.02
0.01
0.02
0.30
0.03
0.13
0.01
0.13
0.07
0.04
0.10
0.04
0.11
0.01
0.03
0.01
0.03
0.13
0.19
0.02
0.05
0.03
0.02

0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.02
0.04
0.01
0.05
0.02
0.04
0.08
0.08
0.02
0.06
0.12
0.01
0.01
0.01
0.01
0.00
0.00
0.08
0.01
0.03
0.02
0.02
0.01
0.02
0.01
0.06
0.00
0.00
0.05
0.02
0.00
0.01
0.01
0.00

0.00
0.01
0.00 *
0.01 *
0.00
- *
0.00
0.00
0.00
0.01
0.00
0.01
0.02
0.01
0.02
0.01
0.01
0.02
0.03
0.01
0.02
0.03
0.00
0.00
0.00
0.00
0.00
0.00
0.04
0.00
0.02
0.01
0.01
0.01
0.02
0.00
0.02
0.00
0.00
0.02
0.02
0.00
0.01
0.01
0.00

*Important. See note on population page.

636

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Immunoproliferative diseases (C88) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

10
20
5
92
1
31
3
3
17
5
8
10
4
3
28
11
19
2
5
3
5
3
1
9
118
1
1
0
7
4
3
0
291
10
12
31
22
50
87
59
136
206
66
81
8
63

0.1
0.2
0.4
0.5
0.0
0.8
0.0
0.0
0.2
0.0
0.0
0.1
0.1
0.2
0.5
0.1
0.4
0.1
0.1
0.1
0.1
0.1
0.0
0.2
0.3
0.0
0.1
0.4
0.3
0.2
0.5
0.3
0.3
0.2
0.2
0.3
0.3
0.5
0.4
0.3
0.3
0.3
0.1
0.3

0.04
0.04
0.18
0.05
0.04
0.14
0.03
0.02
0.04
0.02
0.01
0.02
0.03
0.10
0.10
0.04
0.09
0.10
0.06
0.05
0.05
0.05
0.03
0.09
0.03
0.04
0.14
0.14
0.16
0.09
0.03
0.09
0.09
0.04
0.04
0.04
0.03
0.07
0.04
0.02
0.04
0.04
0.04
0.04

0.02
0.02
0.04
0.05
0.01
0.11
0.01
0.00
0.02
0.00
0.01
0.01
0.01
0.01
0.05
0.02
0.06
0.01
0.02
0.01
0.01
0.01
0.02
0.03
0.02
0.07
0.04
0.06
0.04
0.04
0.03
0.02
0.03
0.03
0.05
0.04
0.04
0.03
0.04
0.00
0.03

0.01
0.01
0.02
0.01
0.01
0.02
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.02
0.03
0.02
0.00
0.01
0.02
0.01
0.01
0.01
0.00
0.01
0.01
0.00
0.01
0.01
0.00
0.01

8
17
3
55
1
46
2
1
11
2
14
16
2
2
13
3
4
1
0
4
4
0
3
4
63
0
4
0
6
3
7
0
193
10
5
27
5
29
53
26
89
146
44
57
9
62

0.1
0.1
0.1
0.2
0.0
0.7
0.0
0.0
0.1
0.0
0.1
0.1
0.0
0.1
0.1
0.0
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.3
0.1
0.4
0.3
0.2
0.1
0.2
0.0
0.1
0.1
0.2
0.2
0.2
0.1
0.2
0.1
0.2

0.02
0.03
0.08
0.03
0.02
0.11
0.02
0.01
0.02
0.00
0.02
0.02
0.01
0.11
0.05
0.01
0.02
0.08
0.06
0.03
0.05
0.05
0.02
0.07
0.12
0.03
0.17
0.02
0.07
0.06
0.04
0.01
0.03
0.02
0.04
0.02
0.02
0.02
0.03
0.03
0.03

0.01
0.01
0.01
0.02
0.08
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.02
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.03
0.07
0.03
0.03
0.02
0.02
0.00
0.01
0.01
0.02
0.02
0.02
0.01
0.03
0.01
0.02

0.00
0.00
0.01
0.00
- *
0.02
0.00
0.00 *
0.00
0.00
0.00
0.00
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.00
0.02
0.03
0.00
0.01
0.01
0.01
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00

80
0
40
23
3
73
26
7
1
94
13
1
1
2
3
6

0.3
0.3
0.4
0.2
0.4
0.4
0.9
0.5
0.7
0.3
0.1
0.1
0.4
0.2
0.5

0.04
0.05
0.09
0.11
0.05
0.09
0.35
0.46
0.07
0.08
0.13
0.06
0.28
0.14
0.23

0.03
0.04
0.06
0.03
0.04
0.05
0.05
0.08
0.04
0.06
0.04
0.06

0.01
0.01
0.01
0.02
0.01
0.01
0.03
0.01
0.01
0.06
0.03
0.03

58
0
25
18
3
47
21
2
1
60
6
1
2
0
1
2

0.2
0.1
0.2
0.2
0.2
0.3
0.2
0.3
0.3
0.1
0.1
0.3
0.0
0.1

0.03
0.03
0.07
0.10
0.03
0.07
0.15
0.28
0.04
0.04
0.09
0.19
0.02
0.09

0.02
0.01
0.02
0.02
0.02
0.04
0.05
0.05
0.03
0.01
0.02
0.02

0.00
0.00
0.01
0.01
0.00
0.01
0.04
0.05
0.01
0.00
0.02
0.02

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

579

637

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Multiple myeloma (C90)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

580

Female
ASR(W)
CUM 0-74

7
68
16
11
43

0.4
1.5
1.7
1.0
3.0

0.15
0.20
0.43
0.35
0.52

7
33
15
4
44

0.3
0.6
1.5
0.4
4.0

0.11
0.12
0.40
0.23
0.66

20
38
12
42
778
28
105
94
56
87
28

2.3
2.0
1.8
3.1
3.9
3.1
3.1
1.3
2.2
6.9
3.6

0.54
0.35
0.55
0.49
0.14
0.61
0.31
0.14
0.31
0.77
0.69

0.30
0.27
0.23
0.42
0.49
0.39
0.37
0.16
0.30
0.81
0.50

0.08
0.06
0.08
0.08
0.02
0.09
0.04
0.02
0.05
0.11
0.10

22
40
13
39
785
22
84
80
41
78
14

1.8
1.7
1.9
2.3
2.9
2.4
2.0
1.0
1.3
4.6
1.2

0.46
0.27
0.56
0.37
0.11
0.51
0.22
0.12
0.21
0.58
0.34

0.18
0.23
0.22
0.30
0.36
0.32
0.25
0.12
0.15
0.48
0.10

0.06
0.04
0.08
0.06
0.02
0.07
0.03
0.02
0.03
0.08
0.04 *

3480
350
558
178
120
52
1
137
1915
18
151
650
195
450
63
570
4060
265
465
615
2642
801
111
31
32
8
94
482
1094
212
15
25
16
5
210
572
549
545
46
491
112
94
16
2798
381
2394
1056
353
691
349
136
206
190
1823
360
1412
807
498
631
745
315
427
83
68

4.1
3.8
3.6
4.1
4.1
2.7
0.7
3.7
4.5
3.4
3.7
4.3
7.0
3.7
4.2
3.0
3.9
2.4
8.3
3.9
3.8
4.0
8.6
1.9
3.6
2.2
4.4
3.7
4.1
8.6
1.2
3.1
2.6
1.0
3.4
4.0
4.3
4.3
6.6
4.1
6.0
7.8
2.7
3.9
7.2
3.6
4.6
8.1
3.8
5.3
8.5
4.3
4.3
4.5
8.3
4.0
4.0
4.3
4.6
5.2
9.4
4.0
8.6
3.1

0.07
0.21
0.16
0.32
0.40
0.39
0.66
0.33
0.11
0.85
0.33
0.18
0.52
0.18
0.55
0.13
0.06
0.15
0.39
0.16
0.08
0.15
0.84
0.36
0.66
0.86
0.47
0.18
0.13
0.60
0.32
0.64
0.76
0.45
0.24
0.18
0.19
0.20
0.99
0.20
0.59
0.85
0.69
0.08
0.38
0.08
0.15
0.44
0.15
0.29
0.77
0.31
0.32
0.11
0.45
0.11
0.15
0.21
0.19
0.20
0.55
0.20
0.97
0.40

0.48
0.47
0.41
0.48
0.47
0.38
0.06
0.41
0.52
0.40
0.42
0.54
0.86
0.47
0.58
0.35
0.48
0.31
1.03
0.47
0.45
0.49
1.05
0.28
0.42
0.32
0.52
0.46
0.50
1.07
0.17
0.39
0.32
0.10
0.41
0.49
0.51
0.51
0.83
0.49
0.72
0.94
0.29
0.46
0.86
0.42
0.56
1.04
0.45
0.69
1.20
0.55
0.49
0.55
0.98
0.48
0.51
0.54
0.55
0.64
1.07
0.51
0.97
0.37

0.01
0.03
0.02
0.05
0.06
0.06
0.06
0.05
0.02
0.12
0.05
0.03
0.08
0.03
0.09
0.02
0.01
0.02
0.06
0.02
0.01
0.02
0.12
0.06
0.10
0.15
0.07
0.03
0.02
0.09
0.06
0.10
0.11
0.05
0.04
0.03
0.03
0.03
0.15
0.03
0.09
0.13
0.09
0.01
0.05
0.01
0.02
0.07
0.02
0.05
0.13
0.05
0.05
0.02
0.06
0.02
0.02
0.03
0.03
0.03
0.08
0.03
0.14
0.06

3034
269
463
164
94
28
0
122
1749
23
122
562
199
361
42
417
3542
268
453
586
2159
723
106
34
25
10
93
425
987
219
20
26
10
10
225
440
423
467
57
406
122
101
18
2326
388
1908
911
362
536
293
136
151
137
1760
464
1254
714
422
540
604
255
346
62
64

2.9
2.4
2.5
2.8
2.7
1.2
2.5
3.3
3.3
2.4
2.8
4.9
2.2
2.8
1.9
2.7
1.8
6.0
3.1
2.4
2.7
5.9
1.4
1.9
2.1
3.5
2.5
2.8
6.0
1.2
2.3
1.5
1.2
2.8
2.4
2.7
2.8
5.9
2.6
4.9
5.9
2.9
2.6
5.4
2.3
3.1
5.7
2.3
3.4
5.7
2.5
2.6
3.2
7.5
2.5
2.7
2.6
2.9
3.2
5.4
2.4
4.2
2.1

0.06
0.16
0.13
0.26
0.30
0.24
0.26
0.09
0.78
0.25
0.13
0.37
0.13
0.46
0.10
0.05
0.11
0.29
0.13
0.06
0.11
0.61
0.26
0.39
0.78
0.38
0.14
0.10
0.42
0.28
0.46
0.51
0.38
0.20
0.13
0.14
0.15
0.80
0.15
0.49
0.64
0.73
0.06
0.28
0.06
0.11
0.31
0.11
0.21
0.51
0.22
0.25
0.09
0.36
0.08
0.11
0.15
0.14
0.14
0.36
0.14
0.57
0.31

0.34
0.29
0.30
0.35
0.35
0.17
0.29
0.38
0.37
0.31
0.34
0.62
0.27
0.33
0.22
0.33
0.21
0.70
0.38
0.30
0.32
0.66
0.14
0.20
0.29
0.43
0.30
0.34
0.71
0.14
0.30
0.16
0.13
0.34
0.29
0.33
0.34
0.68
0.31
0.60
0.69
0.42
0.32
0.65
0.28
0.38
0.72
0.28
0.42
0.67
0.32
0.31
0.40
0.92
0.31
0.33
0.30
0.36
0.39
0.66
0.29
0.49
0.24

0.01
0.02
0.02
0.04
0.05
0.04
0.04
0.01
0.11
0.04
0.02
0.06
0.02
0.07
0.01
0.01
0.02
0.04
0.02
0.01
0.02
0.09
0.04
0.06
0.11
0.06
0.02
0.01
0.06
0.05
0.07
0.06
0.06
0.03
0.02
0.02
0.02
0.11
0.02
0.07
0.09
0.12
0.01
0.04
0.01
0.02
0.05
0.02
0.03
0.08
0.03
0.04
0.01
0.05
0.01
0.02
0.02
0.02
0.02
0.05
0.02
0.08
0.04

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

638

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Multiple myeloma (C90) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

212
885
1516
303
1198
711
230
477
741
118
615
140
31760
4949
25840
1387
252
1096
236
15
73
144
3068
535
2461
1580
263
1287
441
524
2003
250
1712
155
3921
559
3119
10233
424
1566
860
7262
587
214
358
2509
416
2045
261
80
935
633
276
784

4.1
4.0
4.5
8.9
4.0
5.4
9.1
4.5
3.7
8.2
3.3
3.7
4.2
8.0
3.8
4.7
9.1
4.2
4.0
4.2
4.0
4.0
4.7
7.9
4.3
4.0
8.0
3.5
3.5
4.2
4.0
8.1
3.7
3.8
4.5
8.4
4.3
4.3
2.5
8.7
4.1
4.0
4.4
7.7
3.5
4.2
8.1
3.8
4.5
3.7
4.7
4.7
3.7
4.1

0.30
0.14
0.12
0.53
0.12
0.21
0.62
0.22
0.14
0.78
0.14
0.34
0.02
0.12
0.03
0.13
0.58
0.14
0.27
1.11
0.47
0.35
0.09
0.35
0.09
0.10
0.51
0.10
0.18
0.20
0.10
0.53
0.10
0.33
0.08
0.37
0.08
0.04
0.12
0.22
0.14
0.05
0.19
0.54
0.19
0.09
0.41
0.09
0.29
0.43
0.16
0.20
0.23
0.15

0.48
0.47
0.53
1.04
0.48
0.65
1.04
0.56
0.45
1.03
0.40
0.41
0.50
0.97
0.46
0.57
1.13
0.51
0.48
0.43
0.48
0.49
0.55
0.94
0.51
0.49
0.97
0.44
0.41
0.51
0.48
0.98
0.43
0.39
0.55
1.05
0.52
0.53
0.31
1.06
0.49
0.49
0.53
0.96
0.41
0.50
0.97
0.46
0.57
0.47
0.55
0.56
0.46
0.51

0.04
0.02
0.02
0.08
0.02
0.03
0.09
0.03
0.02
0.12
0.02
0.05
0.00
0.02
0.00
0.02
0.09
0.02
0.04
0.15
0.07
0.05
0.01
0.05
0.01
0.02
0.07
0.02
0.03
0.03
0.01
0.08
0.01
0.05
0.01
0.06
0.01
0.01
0.02
0.03
0.02
0.01
0.03
0.08
0.03
0.01
0.06
0.01
0.05
0.07
0.02
0.03
0.04
0.02

183
786
1374
328
1021
704
258
438
687
114
567
115
28286
5324
22012
1348
298
1018
190
18
69
100
3016
733
2223
1490
262
1207
382
388
1957
299
1621
166
3318
592
2499
8886
413
1559
779
5998
587
260
318
2266
450
1760
174
57
676
462
257
628

2.8
2.5
3.1
6.9
2.5
3.8
7.2
2.9
2.5
5.3
2.2
2.6
2.8
6.0
2.5
3.3
7.3
2.8
2.6
4.5
3.2
2.2
3.3
6.7
2.9
2.7
5.6
2.4
2.4
2.5
2.9
6.1
2.5
3.0
2.9
6.4
2.6
2.9
1.8
6.2
3.1
2.5
3.3
6.2
2.4
3.0
6.3
2.6
2.5
1.8
2.8
2.8
2.6
2.6

0.23
0.10
0.09
0.40
0.09
0.16
0.48
0.16
0.11
0.53
0.11
0.27
0.02
0.09
0.02
0.10
0.44
0.10
0.20
1.07
0.40
0.24
0.07
0.26
0.07
0.08
0.37
0.08
0.13
0.14
0.07
0.38
0.07
0.27
0.06
0.28
0.06
0.03
0.09
0.16
0.11
0.04
0.15
0.41
0.15
0.07
0.31
0.07
0.20
0.26
0.12
0.15
0.18
0.12

0.33
0.32
0.38
0.82
0.32
0.47
0.88
0.35
0.30
0.68
0.27
0.31
0.35
0.72
0.30
0.39
0.90
0.33
0.31
0.71
0.39
0.25
0.40
0.80
0.34
0.33
0.68
0.29
0.29
0.31
0.35
0.74
0.31
0.35
0.35
0.76
0.32
0.35
0.22
0.74
0.38
0.31
0.41
0.77
0.29
0.36
0.74
0.32
0.30
0.22
0.34
0.34
0.32
0.31

0.03
0.02
0.01
0.06
0.01
0.02
0.07
0.02
0.02
0.08
0.02
0.04
0.00
0.01
0.00
0.01
0.07
0.01
0.03
0.19
0.06
0.03
0.01
0.04
0.01
0.01
0.05
0.01
0.02
0.02
0.01
0.06
0.01
0.04
0.01
0.04
0.01
0.01
0.01
0.02
0.02
0.01
0.02
0.06
0.02
0.01
0.05
0.01
0.03
0.04
0.02
0.02
0.03
0.02

12
78

2.2
1.5

0.65
0.17

0.33
0.16

0.11
0.02

8
50

1.5
0.8

0.54
0.12

0.18
0.10

0.08
0.02 *

8
20
291
21
46
71
445
11
280
38
57
46
708
620
45
49
65
60
187
134
531
123

0.6
1.1
1.2
0.6
2.1
0.8
2.4
1.3
1.4
1.0
0.9
1.7
4.2
4.0
3.2
1.2
1.4
1.4
1.6
1.6
1.4
1.7

0.22
0.28
0.08
0.14
0.33
0.10
0.12
0.41
0.09
0.17
0.13
0.26
0.17
0.17
0.49
0.18
0.19
0.18
0.12
0.15
0.06
0.16

0.08
0.10
0.15
0.07
0.24
0.09
0.30
0.21
0.18
0.15
0.11
0.23
0.50
0.48
0.41
0.15
0.16
0.16
0.19
0.19
0.15
0.17

0.03
0.02
0.01
0.02
0.04
0.01
0.02
0.07
0.01
0.03
0.02
0.04
0.02
0.02
0.08
0.03
0.03
0.03
0.02
0.02
0.01
0.02

0
17
212
18
41
53
289
15
167
16
43
36
660
581
43
36
66
83
192
149
515
123

0.7
0.8
0.5
1.6
0.6
1.8
1.6
0.9
0.4
0.7
1.2
3.2
3.0
2.8
0.8
1.0
1.4
1.2
1.3
1.0
1.1

0.16
0.06
0.12
0.26
0.08
0.11
0.42
0.07
0.11
0.11
0.20
0.13
0.14
0.44
0.14
0.14
0.16
0.10
0.13
0.05
0.12

0.06
0.10
0.08
0.22
0.08
0.22
0.12
0.11
0.05
0.09
0.16
0.40
0.38
0.39
0.11
0.12
0.18
0.14
0.16
0.11
0.14

- *
0.02
0.01 *
0.02 *
0.04 *
0.01
0.02 *
0.04
0.01
0.01 *
0.02 *
0.03 *
0.02
0.02
0.07
0.02
0.02
0.03
0.01
0.02
0.01
0.02

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

581

639

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Multiple myeloma (C90) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

582

Female
ASR(W)
CUM 0-74

1137
96
70
45
30
70
11
346
14
11
26
13
47
34
44
46
111
80
10
21
26
12
22
52
141

1.3
1.1
1.3
1.8
1.2
1.4
1.6
1.7
1.0
1.3
1.8
0.8
1.4
2.0
1.8
0.7
1.4
1.3
1.3
2.6
0.7
0.6
0.8
1.8
1.7

0.04
0.12
0.16
0.27
0.22
0.17
0.48
0.10
0.30
0.38
0.63
0.21
0.21
0.35
0.28
0.11
0.13
0.14
0.46
0.57
0.13
0.18
0.17
0.25
0.15

0.17
0.15
0.14
0.24
0.16
0.17
0.23
0.20
0.13
0.16
0.16
0.13
0.19
0.25
0.22
0.09
0.17
0.14
0.16
0.36
0.08
0.07
0.11
0.20
0.22

0.01
0.02
0.02
0.05
0.04
0.02
0.08
0.01
0.05
0.06
0.07
0.04
0.03
0.05
0.04
0.02
0.02
0.02
0.06
0.09
0.02
0.03
0.03
0.03
0.02

900
68
59
39
22
43
10
280
10
14
5
25
22
28
24
81
95
73
7
15
23
13
30
42
102

0.8
0.6
0.9
1.2
0.6
0.7
0.7
1.1
0.7
1.3
0.7
1.1
0.6
1.9
1.3
1.1
1.0
0.9
1.5
1.6
0.5
0.5
1.0
1.5
1.2

0.03
0.08
0.12
0.20
0.13
0.11
0.23
0.07
0.22
0.36
0.42
0.22
0.12
0.36
0.29
0.12
0.11
0.11
0.59
0.41
0.11
0.14
0.19
0.23
0.12

0.11
0.09
0.12
0.16
0.08
0.11
0.10
0.15
0.10
0.17
0.13
0.13
0.06
0.26
0.17
0.15
0.12
0.11
0.14
0.20
0.07
0.07
0.16
0.20
0.16

0.00
0.01
0.02
0.03
0.02
0.02
0.04
0.01
0.03
0.05
0.09
0.03
0.01
0.06 *
0.04 *
0.02 *
0.02
0.02
0.06
0.06
0.02 *
0.02 *
0.03
0.03 *
0.02 *

802
73
33
380
202
792
365
480
1084
740
106
663
137
96
75
110
118
146
120
98
65
50
53
363
652
270
254
217
411
152
31
583
31
91
108
237
159
39
194
137
64
422
114
52
87
332
111
66
61
33
222
155
90
312

2.6
3.1
2.8
1.3
2.6
3.8
1.1
2.9
3.0
3.3
2.4
3.2
3.7
3.8
3.8
4.2
3.2
3.5
2.9
4.0
2.9
2.5
2.0
3.6
3.3
3.7
3.7
2.3
3.8
3.0
3.4
4.6
2.8
3.7
4.9
3.8
4.9
4.3
3.8
4.4
4.1
4.1
5.1
3.6
3.7
6.0
3.2
3.5
4.4
4.1
4.8
3.3
4.4
4.2

0.09
0.36
0.50
0.07
0.19
0.14
0.06
0.13
0.09
0.13
0.23
0.13
0.32
0.41
0.45
0.41
0.31
0.30
0.27
0.43
0.38
0.40
0.29
0.19
0.13
0.23
0.23
0.16
0.19
0.25
0.63
0.20
0.53
0.40
0.51
0.27
0.42
0.74
0.29
0.40
0.51
0.21
0.52
0.53
0.43
0.36
0.32
0.44
0.59
0.73
0.33
0.29
0.48
0.25

0.32
0.39
0.32
0.17
0.27
0.44
0.15
0.34
0.37
0.41
0.33
0.35
0.42
0.48
0.38
0.52
0.38
0.37
0.33
0.47
0.38
0.26
0.28
0.45
0.39
0.47
0.47
0.26
0.47
0.36
0.44
0.53
0.36
0.44
0.58
0.44
0.55
0.56
0.45
0.50
0.55
0.50
0.59
0.40
0.43
0.70
0.37
0.43
0.49
0.49
0.63
0.40
0.49
0.52

0.01
0.06
0.07
0.01
0.03
0.02
0.01
0.02
0.01
0.02
0.03
0.02
0.05
0.06
0.06
0.06
0.04
0.04
0.04
0.06
0.06
0.05
0.04
0.03
0.02
0.03
0.03
0.02
0.03
0.04
0.09
0.03
0.08
0.06
0.07
0.04
0.06
0.10
0.04
0.05
0.08
0.03
0.07
0.08
0.06
0.05
0.04
0.06
0.08
0.11
0.05
0.04
0.06
0.04

943
60
35
517
180
734
368
498
1092
629
134
741
139
82
72
103
128
144
140
87
61
55
56
365
733
239
237
168
440
137
29
411
46
127
84
242
133
30
204
137
45
424
120
48
93
291
112
77
43
34
197
147
81
339

2.0
1.9
2.2
1.1
1.8
2.8
1.0
2.2
2.1
2.3
1.8
2.4
2.5
2.3
2.7
2.8
2.5
2.5
2.6
2.8
2.0
2.3
1.8
2.5
2.3
2.1
2.4
1.2
2.8
1.9
2.3
2.6
3.3
3.6
3.0
2.8
2.4
1.8
2.6
3.5
2.4
2.9
4.1
3.0
3.1
3.9
2.5
2.9
2.6
3.1
3.0
2.3
3.1
3.2

0.07
0.27
0.40
0.05
0.16
0.12
0.05
0.11
0.07
0.10
0.17
0.10
0.24
0.29
0.36
0.31
0.25
0.24
0.24
0.35
0.29
0.37
0.28
0.14
0.10
0.16
0.17
0.10
0.15
0.19
0.47
0.14
0.61
0.36
0.39
0.21
0.25
0.39
0.21
0.35
0.37
0.16
0.46
0.48
0.38
0.27
0.27
0.36
0.43
0.62
0.25
0.22
0.38
0.20

0.24
0.23
0.23
0.15
0.21
0.34
0.13
0.27
0.26
0.28
0.23
0.27
0.29
0.28
0.31
0.34
0.30
0.28
0.34
0.35
0.25
0.27
0.22
0.30
0.28
0.26
0.31
0.15
0.33
0.23
0.26
0.30
0.36
0.44
0.36
0.34
0.26
0.20
0.31
0.45
0.32
0.35
0.48
0.37
0.36
0.44
0.29
0.36
0.38
0.31
0.36
0.28
0.34
0.39

0.01
0.04
0.05
0.01 *
0.02 *
0.02
0.01 *
0.01
0.01
0.01
0.02
0.01
0.03
0.04
0.05
0.04
0.04
0.03
0.03
0.05
0.04
0.05
0.04
0.02
0.01
0.02
0.02
0.02
0.02
0.03
0.07
0.02
0.07
0.05
0.05
0.03
0.04
0.06
0.03
0.05
0.06
0.02
0.06
0.07
0.05
0.04
0.04
0.05
0.07
0.08
0.03
0.03
0.05
0.03

*Important. See note on population page.

640

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Multiple myeloma (C90) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

128
239
28
810
61
101
166
209
293
248
238
493
173
44
171
225
164
53
82
94
144
54
74
117
1492
50
28
18
59
44
37
64
2205
110
106
461
341
627
1065
408
1427
2175
850
831
276
814

1.6
2.2
2.0
4.2
2.4
2.3
2.7
2.0
2.6
1.8
1.3
3.1
2.5
3.2
3.1
3.0
3.5
4.3
3.2
2.8
3.5
1.9
3.0
2.9
3.6
3.2
3.0
2.9
2.8
3.1
3.3
2.5
3.7
3.0
2.9
3.6
3.3
3.6
3.8
3.9
4.4
3.9
3.9
3.6
4.5
3.8

0.15
0.14
0.38
0.16
0.31
0.24
0.22
0.14
0.16
0.11
0.09
0.14
0.19
0.52
0.25
0.21
0.28
0.69
0.38
0.30
0.30
0.29
0.38
0.29
0.10
0.46
0.59
0.70
0.38
0.49
0.57
0.33
0.08
0.29
0.29
0.18
0.19
0.15
0.12
0.20
0.12
0.09
0.14
0.13
0.28
0.14

0.21
0.28
0.25
0.49
0.34
0.28
0.32
0.26
0.32
0.24
0.17
0.38
0.31
0.38
0.34
0.35
0.42
0.49
0.39
0.37
0.41
0.20
0.34
0.34
0.43
0.37
0.36
0.40
0.39
0.33
0.40
0.28
0.44
0.39
0.34
0.43
0.39
0.42
0.44
0.47
0.50
0.45
0.45
0.45
0.54
0.45

0.02
0.02
0.06
0.02
0.05
0.03
0.03
0.02
0.02
0.02
0.01
0.02
0.03
0.07
0.03
0.03
0.04
0.09
0.06
0.05
0.04
0.04
0.05
0.04
0.01
0.07
0.09
0.10
0.07
0.07
0.08
0.05
0.01
0.04
0.04
0.03
0.03
0.02
0.02
0.03
0.02
0.01
0.02
0.02
0.04
0.02

168
335
32
748
66
110
192
151
295
378
232
569
222
41
192
206
147
27
79
116
144
52
65
114
1280
44
36
23
70
63
36
68
1809
117
102
404
272
606
971
354
1257
1957
806
766
220
790

1.3
1.9
1.8
3.0
1.7
2.0
2.0
1.2
2.0
1.5
1.1
2.5
2.2
2.6
2.5
2.0
2.5
1.9
2.7
2.9
2.7
1.7
2.0
2.2
2.5
1.8
3.1
1.7
2.7
2.8
2.6
1.9
2.3
2.5
2.2
2.5
1.9
2.6
2.6
2.7
2.8
2.6
2.9
2.5
2.6
2.5

0.10
0.11
0.34
0.13
0.22
0.20
0.16
0.10
0.12
0.08
0.08
0.11
0.16
0.49
0.21
0.16
0.22
0.44
0.34
0.29
0.25
0.26
0.28
0.23
0.08
0.31
0.59
0.40
0.37
0.39
0.48
0.27
0.06
0.25
0.24
0.14
0.13
0.12
0.10
0.16
0.10
0.07
0.12
0.11
0.20
0.10

0.17
0.24
0.21
0.36
0.19
0.25
0.28
0.15
0.26
0.19
0.14
0.32
0.27
0.29
0.27
0.24
0.28
0.25
0.36
0.39
0.33
0.22
0.21
0.27
0.30
0.25
0.32
0.19
0.30
0.38
0.32
0.24
0.28
0.31
0.30
0.31
0.22
0.32
0.32
0.32
0.32
0.31
0.35
0.28
0.29
0.29

0.01
0.02
0.05
0.02
0.03 *
0.03
0.02
0.01 *
0.02
0.01
0.01
0.02
0.02
0.06
0.03
0.02
0.03
0.06
0.05
0.04
0.03
0.04
0.04
0.03
0.01
0.05
0.07
0.07
0.05
0.07
0.07
0.04
0.01
0.04
0.04
0.02
0.02
0.02
0.01
0.02
0.01
0.01
0.02
0.01
0.03
0.01

1099
13
583
307
78
785
260
37
11
706
146
4
30
26
18
56

4.5
3.8
4.5
5.0
4.2
4.4
4.1
4.3
2.8
5.2
3.1
1.5
3.3
5.3
1.2
4.4

0.14
1.12
0.19
0.30
0.49
0.16
0.26
0.72
0.85
0.20
0.28
0.78
0.66
1.06
0.32
0.61

0.51
0.37
0.53
0.59
0.48
0.49
0.47
0.52
0.40
0.58
0.33
0.15
0.28
0.63
0.14
0.46

0.02
0.14
0.03
0.04
0.07
0.02
0.04
0.11
0.15
0.03
0.04
0.09
0.09
0.16
0.05
0.08

858
1
442
228
64
629
200
20
16
506
111
5
20
24
24
27

2.9
0.5
3.0
2.9
2.5
2.7
2.6
1.8
4.1
3.0
2.0
0.7
2.6
4.5
1.5
1.7

0.11
0.48
0.16
0.22
0.35
0.12
0.20
0.44
1.04
0.15
0.21
0.32
0.61
0.94
0.36
0.36

0.33
0.08
0.36
0.36
0.23
0.30
0.31
0.19
0.58
0.35
0.26
0.10
0.27
0.59
0.19
0.19

0.02
0.08
0.02
0.03
0.05
0.02
0.03
0.06
0.16
0.02
0.03
0.07
0.08
0.15
0.05
0.06

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

583

641

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Leukaemia (C91-95)
Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

584

Female
ASR(W)
CUM 0-74

85
375
53
33
84

3.2
6.5
5.1
1.3
2.6

0.38
0.37
0.71
0.35
0.38

75
300
39
29
51

2.7
4.8
3.6
1.4
2.0

0.34
0.29
0.58
0.40
0.37

104
174
65
117
2029
58
304
551
253
68
69

13.7
5.9
7.4
7.0
9.1
6.9
7.8
6.2
8.2
6.2
6.2

1.60
0.50
0.98
0.68
0.21
0.93
0.46
0.27
0.53
0.80
0.79

1.29
0.51
0.56
0.62
0.84
0.54
0.65
0.50
0.71
0.58
0.60

0.17
0.07
0.11
0.09
0.03
0.09
0.05
0.03
0.06
0.09
0.10

79
114
49
117
1739
42
290
434
226
63
72

8.3
3.4
5.7
5.7
6.4
4.3
6.2
4.8
6.5
5.1
5.8

1.20
0.33
0.86
0.54
0.16
0.68
0.38
0.23
0.45
0.70
0.71

0.68
0.27
0.54
0.52
0.58
0.38
0.51
0.39
0.57
0.45
0.57

0.11
0.04
0.12
0.07
0.02
0.08
0.04
0.03
0.05
0.07
0.09 *

8363
1101
1315
444
248
95
1
307
4318
58
476
1138
177
940
146
1469
10422
722
528
1926
7022
1912
105
98
60
16
244
1262
2755
219
58
53
34
21
721
1541
1373
1253
52
1163
119
69
39
6990
424
6479
1960
371
1556
667
157
491
467
4269
399
3720
1933
1420
1435
1465
301
1154
84
211

11.3
12.7
9.7
11.7
10.6
6.4
1.8
9.9
11.7
13.6
13.3
8.1
6.3
8.5
10.0
8.9
10.8
6.8
9.0
9.1
11.5
10.0
7.8
7.2
7.3
5.1
8.7
10.8
10.8
9.0
6.1
7.4
8.5
4.7
9.0
12.6
11.2
11.1
7.2
11.4
7.8
7.3
7.3
10.9
7.6
11.4
9.1
7.8
9.6
10.2
8.8
11.3
11.4
11.2
9.1
11.5
10.3
13.5
11.3
11.0
9.0
12.0
8.4
11.7

0.13
0.40
0.30
0.60
0.75
0.73
1.81
0.63
0.19
1.90
0.67
0.26
0.49
0.31
0.87
0.25
0.11
0.27
0.40
0.22
0.16
0.25
0.79
0.81
1.00
1.72
0.59
0.36
0.22
0.62
0.89
1.07
1.89
1.07
0.36
0.39
0.32
0.35
1.03
0.38
0.78
0.95
1.36
0.15
0.38
0.17
0.21
0.42
0.26
0.41
0.76
0.54
0.56
0.18
0.46
0.21
0.25
0.40
0.32
0.30
0.53
0.38
0.94
0.92

1.13
1.36
0.95
1.25
1.03
0.61
0.30
0.91
1.15
1.31
1.50
0.80
0.62
0.83
1.06
0.84
1.06
0.63
0.96
0.81
1.16
0.98
0.81
0.62
0.66
0.36
0.71
1.11
1.07
1.02
0.51
0.67
0.74
0.56
0.84
1.26
1.06
1.13
0.73
1.15
0.76
0.70
0.76
1.08
0.78
1.12
0.92
0.82
0.95
1.04
0.90
1.13
1.11
1.12
1.00
1.13
1.03
1.43
1.14
1.11
0.92
1.19
0.72
1.16

0.02
0.05
0.03
0.07
0.08
0.07
0.30
0.07
0.02
0.20
0.09
0.03
0.06
0.03
0.12
0.03
0.01
0.03
0.05
0.03
0.02
0.03
0.11
0.08
0.11
0.14
0.07
0.04
0.03
0.08
0.09
0.12
0.15
0.15
0.05
0.04
0.04
0.04
0.13
0.04
0.09
0.10
0.16
0.02
0.05
0.02
0.03
0.06
0.03
0.05
0.11
0.07
0.07
0.02
0.06
0.02
0.03
0.05
0.04
0.04
0.07
0.05
0.11
0.10

5993
757
920
355
155
56
2
249
3150
34
315
973
183
773
113
1059
7617
562
405
1510
4990
1438
89
64
36
13
198
965
2049
187
48
46
25
22
610
1025
987
979
53
914
94
61
27
5232
447
4707
1533
320
1192
479
109
358
333
3443
356
2989
1570
1001
1103
1140
281
844
79
171

6.9
8.0
6.1
7.8
6.1
4.0
3.3
6.9
7.1
6.5
7.5
5.4
4.5
5.7
7.5
5.8
6.8
4.7
5.5
6.6
7.0
6.4
5.1
4.0
3.5
2.6
6.7
7.0
6.9
5.5
4.3
5.2
3.3
4.4
6.7
7.4
7.0
7.3
5.4
7.5
4.3
3.8
4.8
7.1
6.3
7.2
5.7
4.7
6.1
5.7
4.1
6.7
7.3
7.2
5.9
7.4
6.9
7.7
7.0
6.9
6.3
7.1
6.1
6.9

0.11
0.32
0.25
0.49
0.59
0.64
2.36
0.54
0.15
1.41
0.50
0.20
0.37
0.25
0.74
0.20
0.09
0.22
0.29
0.18
0.13
0.20
0.59
0.57
0.65
0.82
0.49
0.30
0.17
0.43
0.73
0.85
0.75
1.05
0.28
0.32
0.25
0.28
0.78
0.31
0.55
0.60
1.25
0.13
0.31
0.14
0.16
0.28
0.21
0.28
0.41
0.41
0.46
0.15
0.33
0.17
0.20
0.31
0.25
0.23
0.40
0.29
0.72
0.67

0.66
0.80
0.55
0.78
0.61
0.31
0.49
0.59
0.67
0.53
0.81
0.52
0.44
0.54
0.63
0.51
0.61
0.41
0.54
0.55
0.65
0.54
0.44
0.32
0.26
0.24
0.53
0.62
0.62
0.57
0.36
0.47
0.39
0.30
0.57
0.69
0.67
0.68
0.50
0.71
0.38
0.36
0.39
0.66
0.58
0.67
0.53
0.45
0.56
0.53
0.37
0.63
0.68
0.70
0.59
0.71
0.66
0.73
0.66
0.71
0.63
0.74
0.64
0.73

0.01
0.04
0.02
0.06
0.06
0.05
0.37
0.05
0.02
0.13
0.06
0.02
0.04
0.03
0.08
0.02
0.01
0.02
0.04
0.02
0.01
0.02
0.07
0.05
0.05
0.09
0.05
0.03
0.02
0.05
0.07
0.08
0.10
0.07
0.03
0.03
0.03
0.03
0.09
0.03
0.05
0.06
0.11
0.01
0.04
0.01
0.02
0.03
0.02
0.03
0.05
0.05
0.05
0.02
0.04
0.02
0.02
0.03
0.03
0.03
0.05
0.03
0.09
0.07

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

642

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Leukaemia (C91-95) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

553
1978
3415
292
3044
1477
217
1226
1903
150
1738
363
74692
5241
66537
3090
250
2689
643
26
157
441
6804
526
6069
3491
259
3137
1130
1144
4892
249
4511
411
9246
597
7939
24462
1175
1669
2517
18641
1168
233
913
6207
510
5502
612
224
2223
1543
683
2154

12.2
9.8
11.2
8.5
11.6
12.1
8.8
13.2
10.4
10.2
10.5
11.2
10.7
8.2
11.0
11.5
8.8
11.7
11.8
6.6
8.7
13.9
11.4
7.8
12.1
9.7
8.0
9.7
10.3
10.5
11.4
7.8
11.5
12.0
11.4
8.5
12.0
11.1
7.1
8.9
9.2
11.8
9.5
8.0
9.9
11.0
9.6
11.1
10.7
11.7
11.9
12.1
10.4
12.1

0.58
0.24
0.21
0.51
0.23
0.34
0.62
0.41
0.26
0.85
0.28
0.65
0.04
0.12
0.05
0.23
0.57
0.25
0.49
1.33
0.71
0.77
0.15
0.35
0.17
0.18
0.51
0.19
0.33
0.34
0.18
0.50
0.20
0.66
0.13
0.36
0.15
0.08
0.22
0.22
0.20
0.10
0.29
0.54
0.36
0.14
0.44
0.16
0.45
0.86
0.27
0.33
0.44
0.29

1.21
1.00
1.14
0.95
1.17
1.27
0.98
1.35
1.04
1.01
1.05
1.10
1.07
0.85
1.10
1.15
0.91
1.17
1.22
0.70
0.87
1.45
1.15
0.77
1.23
0.97
0.83
0.96
1.03
1.08
1.16
0.79
1.17
1.15
1.16
0.91
1.22
1.11
0.64
0.93
0.84
1.19
0.95
0.81
0.98
1.08
1.02
1.08
1.08
1.21
1.21
1.19
1.07
1.28

0.07
0.03
0.03
0.07
0.03
0.04
0.08
0.05
0.03
0.11
0.03
0.08
0.01
0.02
0.01
0.03
0.07
0.03
0.06
0.18
0.09
0.09
0.02
0.04
0.02
0.02
0.07
0.02
0.04
0.04
0.02
0.07
0.02
0.08
0.02
0.05
0.02
0.01
0.02
0.03
0.03
0.01
0.04
0.07
0.04
0.02
0.06
0.02
0.06
0.10
0.03
0.04
0.05
0.04

378
1746
2760
296
2389
1329
226
1075
1440
123
1300
251
57712
4675
50808
2407
218
2092
428
19
116
288
5553
543
4847
2775
216
2490
856
888
3850
249
3489
308
6957
509
5983
18307
891
1393
1963
13749
921
208
688
4597
410
4059
437
162
1605
1080
563
1711

7.2
7.1
7.3
6.4
7.4
8.3
6.6
8.8
6.4
6.1
6.4
6.7
6.8
5.4
7.0
7.2
5.6
7.4
6.7
4.2
5.5
8.3
7.1
5.5
7.4
6.1
4.8
6.2
6.4
7.1
7.2
5.7
7.2
7.1
7.1
5.5
7.5
7.0
4.8
5.6
6.6
7.2
5.9
5.3
6.0
6.7
5.7
6.9
6.7
7.0
7.6
7.4
7.0
8.0

0.46
0.21
0.16
0.40
0.18
0.27
0.47
0.33
0.20
0.58
0.22
0.52
0.03
0.08
0.04
0.18
0.40
0.20
0.37
0.99
0.53
0.66
0.11
0.25
0.13
0.14
0.35
0.15
0.26
0.29
0.15
0.39
0.16
0.51
0.10
0.26
0.12
0.06
0.18
0.16
0.15
0.08
0.23
0.40
0.28
0.11
0.30
0.12
0.34
0.67
0.22
0.26
0.37
0.23

0.71
0.67
0.72
0.69
0.71
0.81
0.72
0.84
0.61
0.58
0.61
0.67
0.64
0.53
0.66
0.68
0.51
0.70
0.59
0.35
0.44
0.73
0.66
0.52
0.70
0.57
0.45
0.58
0.59
0.67
0.70
0.54
0.71
0.68
0.66
0.55
0.70
0.65
0.42
0.56
0.55
0.68
0.57
0.53
0.58
0.63
0.53
0.64
0.63
0.65
0.74
0.72
0.65
0.80

0.05
0.02
0.02
0.05
0.02
0.03
0.06
0.04
0.02
0.07
0.02
0.06
0.00
0.01
0.00
0.02
0.05
0.02
0.04
0.10
0.05
0.06
0.01
0.03
0.01
0.01
0.04
0.02
0.03
0.03
0.02
0.04
0.02
0.05
0.01
0.03
0.01
0.01
0.02
0.02
0.02
0.01
0.03
0.05
0.03
0.01
0.04
0.01
0.04
0.07
0.03
0.03
0.04
0.03

62
353
1032
52
100
939
163
167
432
1715
30
1169
265
245
119
1800
1531
160
129
157
211
433
546
1712
200

8.5
6.8
5.8
5.8
4.6
4.9
5.2
8.4
4.3
5.8
2.9
4.4
5.3
3.0
4.5
10.8
10.5
7.5
4.2
4.8
6.5
5.4
9.0
6.0
4.2

1.15
0.38
0.20
0.93
0.55
0.21
0.42
0.69
0.21
0.15
0.53
0.14
0.34
0.21
0.42
0.26
0.28
0.67
0.41
0.46
0.50
0.31
0.45
0.17
0.37

0.79
0.55
0.52
0.45
0.45
0.45
0.47
0.80
0.37
0.52
0.20
0.40
0.45
0.28
0.39
1.10
1.06
0.76
0.40
0.50
0.57
0.50
0.93
0.56
0.41

0.15
0.04
0.02
0.07
0.05
0.02
0.04
0.07
0.02
0.02
0.04
0.02
0.04
0.03
0.04
0.03
0.03
0.10
0.04
0.05
0.05
0.03
0.05
0.02
0.03

37
242
828
41
63
748
113
116
256
942
30
738
139
175
78
1393
1182
102
89
96
156
341
438
1158
159

4.2
5.1
4.4
4.5
3.3
3.7
3.6
5.7
2.7
3.8
3.0
3.2
3.0
2.4
2.8
7.0
6.7
4.5
2.9
2.7
3.8
3.7
5.9
3.7
3.1

0.73
0.36
0.18
0.82
0.53
0.18
0.35
0.59
0.18
0.13
0.56
0.12
0.27
0.19
0.32
0.20
0.21
0.48
0.34
0.37
0.36
0.25
0.38
0.14
0.35

0.43
0.37
0.36
0.39
0.28
0.34
0.29
0.54
0.22
0.35
0.30
0.27
0.24
0.22
0.25
0.69
0.67
0.42
0.27
0.25
0.36
0.34
0.59
0.33
0.26

0.11
0.03 *
0.02
0.07 *
0.04
0.01 *
0.03 *
0.06 *
0.02
0.02 *
0.07
0.01
0.03 *
0.02 *
0.03 *
0.02
0.03
0.06
0.03
0.03
0.04
0.02
0.03
0.01
0.03

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

585

643

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Leukaemia (C91-95) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

586

Female
ASR(W)
CUM 0-74

4462
409
289
140
157
263
36
1218
75
89
149
157
233
151
204
670
458
359
31
68
160
93
108
182
413

5.0
4.9
4.9
4.8
5.2
4.4
5.4
5.7
3.9
5.3
7.6
6.9
4.8
5.6
4.8
6.6
6.1
6.2
5.1
6.6
4.6
4.9
3.9
5.9
5.3

0.08
0.27
0.30
0.42
0.43
0.29
0.92
0.18
0.50
0.65
1.28
0.57
0.33
0.52
0.36
0.29
0.30
0.35
0.96
0.83
0.38
0.54
0.38
0.45
0.27

0.45
0.43
0.44
0.47
0.46
0.36
0.44
0.49
0.36
0.47
0.51
0.60
0.39
0.55
0.39
0.60
0.49
0.49
0.39
0.62
0.38
0.38
0.39
0.53
0.49

0.01
0.03
0.03
0.06
0.05
0.03
0.10
0.02
0.06
0.09
0.08
0.06
0.04
0.07
0.04
0.04
0.03
0.03
0.08
0.10
0.03
0.05
0.05
0.05
0.03

3477
290
242
113
125
218
32
973
64
71
61
120
181
109
126
624
348
276
20
52
146
85
118
128
321

3.7
3.1
3.8
3.5
3.9
3.7
4.0
4.1
3.5
3.8
7.4
5.2
3.9
4.1
4.1
5.5
4.3
4.1
3.8
5.0
4.0
4.3
4.0
4.1
4.1

0.07
0.20
0.26
0.35
0.36
0.26
0.76
0.14
0.46
0.51
1.45
0.48
0.30
0.45
0.42
0.24
0.24
0.27
0.87
0.72
0.36
0.49
0.38
0.37
0.23

0.31
0.26
0.34
0.30
0.33
0.30
0.33
0.37
0.29
0.33
0.40
0.42
0.34
0.40
0.36
0.50
0.36
0.35
0.29
0.49
0.34
0.39
0.32
0.29
0.37

0.01
0.02
0.03
0.03
0.03
0.02
0.06
0.01
0.05
0.06
0.08
0.05
0.04
0.06 *
0.05 *
0.03 *
0.02
0.03
0.07
0.08
0.03 *
0.05 *
0.04
0.03 *
0.02 *

2195
201
94
2275
421
1682
1640
1449
3150
2091
346
1360
326
212
185
294
293
410
509
190
130
128
135
930
1532
524
675
688
841
333
77
1207
107
237
162
411
248
67
425
275
139
736
221
107
203
563
303
216
106
79
364
381
187
598

8.2
9.8
9.7
8.4
6.4
9.5
6.0
10.3
9.8
10.8
8.6
8.3
10.1
9.6
10.6
11.5
9.1
11.1
13.4
11.4
6.8
9.1
6.8
10.8
9.1
8.7
11.6
8.4
9.5
9.0
9.0
10.6
15.2
11.7
9.2
9.1
9.8
9.2
11.3
11.6
10.0
9.2
11.7
9.5
11.8
12.8
10.3
11.2
10.6
14.1
9.5
10.8
10.5
9.9

0.20
0.74
1.07
0.19
0.35
0.26
0.17
0.30
0.19
0.26
0.50
0.25
0.59
0.71
0.81
0.70
0.61
0.59
0.64
0.95
0.65
0.98
0.67
0.42
0.28
0.44
0.52
0.37
0.37
0.59
1.08
0.32
1.97
0.89
0.97
0.61
0.87
1.56
0.71
0.86
0.88
0.42
1.04
1.08
1.06
0.73
0.66
0.83
1.21
1.88
0.63
0.76
0.89
0.50

0.78
0.94
0.97
0.92
0.70
0.99
0.62
1.01
1.00
1.11
0.88
0.74
1.02
1.00
1.18
1.27
0.94
1.11
1.40
1.10
0.72
0.86
0.67
1.02
0.95
0.84
1.12
0.79
0.91
0.80
1.01
1.08
1.42
1.13
1.00
0.80
0.94
0.87
1.02
1.21
0.96
0.88
1.16
0.93
1.10
1.16
0.96
1.26
0.91
1.18
0.88
1.02
1.02
0.95

0.02
0.08
0.12
0.02
0.04
0.03
0.02
0.03
0.02
0.03
0.06
0.02
0.07
0.08
0.10
0.09
0.07
0.07
0.08
0.09
0.08
0.09
0.07
0.04
0.03
0.05
0.05
0.04
0.04
0.05
0.14
0.04
0.16
0.09
0.10
0.05
0.08
0.13
0.06
0.08
0.09
0.04
0.10
0.11
0.09
0.07
0.07
0.11
0.10
0.16
0.06
0.07
0.09
0.05

1947
177
68
2158
285
1206
1297
1289
2488
1625
371
1218
260
178
136
231
219
316
347
147
117
106
74
776
1456
462
549
563
770
270
62
848
72
184
124
399
212
48
368
215
122
685
161
91
140
424
243
118
60
49
318
263
162
522

5.3
6.4
6.1
5.6
3.6
6.2
4.4
7.2
5.7
7.2
5.9
5.7
6.9
6.3
6.7
8.0
6.0
6.8
7.3
7.2
5.4
5.5
3.6
6.5
6.0
5.3
6.7
5.2
6.6
4.8
6.6
6.7
5.2
6.6
6.0
6.2
7.8
5.6
6.9
6.7
7.8
6.5
8.8
7.4
5.7
7.5
6.8
6.4
4.9
6.3
7.3
6.6
9.3
6.5

0.16
0.60
0.90
0.14
0.25
0.22
0.15
0.25
0.14
0.22
0.38
0.21
0.50
0.60
0.69
0.63
0.52
0.44
0.48
0.77
0.59
0.78
0.49
0.33
0.24
0.33
0.38
0.29
0.33
0.38
0.96
0.26
0.85
0.64
0.98
0.49
0.90
1.24
0.55
0.65
0.76
0.37
1.12
1.01
0.66
0.57
0.54
0.74
0.77
1.17
0.65
0.59
1.04
0.42

0.50
0.60
0.50
0.60
0.38
0.60
0.42
0.67
0.57
0.69
0.63
0.50
0.72
0.63
0.66
0.80
0.55
0.68
0.71
0.69
0.52
0.48
0.35
0.59
0.57
0.52
0.67
0.50
0.55
0.49
0.54
0.62
0.58
0.64
0.53
0.58
0.67
0.53
0.66
0.65
0.71
0.56
0.74
0.70
0.57
0.69
0.62
0.65
0.46
0.61
0.61
0.60
0.82
0.62

0.02
0.06
0.08
0.01 *
0.03 *
0.02
0.01 *
0.02
0.01
0.02
0.04
0.02
0.05
0.06
0.07
0.07
0.05
0.05
0.05
0.07
0.06
0.07
0.05
0.03
0.02
0.03
0.04
0.03
0.03
0.04
0.09
0.03
0.10
0.06
0.07
0.04
0.06
0.10
0.04
0.06
0.08
0.03
0.08
0.09
0.07
0.05
0.05
0.07
0.07
0.11
0.05
0.05
0.08
0.04

*Important. See note on population page.

644

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Leukaemia (C91-95) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

629
1020
115
1440
133
300
304
417
663
984
982
1334
509
80
366
483
365
62
162
211
338
145
171
229
3035
155
68
44
178
98
85
175
4314
246
250
895
654
1231
2349
900
2547
4448
1596
1776
473
1746

9.3
10.2
10.3
9.1
6.1
7.4
6.3
4.8
7.3
8.3
7.0
9.1
8.4
8.1
8.1
7.8
8.8
5.1
7.7
8.4
9.0
7.2
9.1
7.7
9.0
10.7
8.8
8.0
10.3
9.5
8.4
8.4
8.6
7.8
8.0
8.6
7.7
8.4
9.8
9.9
9.6
9.4
8.8
9.1
9.0
9.9

0.40
0.34
1.03
0.27
0.59
0.46
0.42
0.25
0.33
0.30
0.26
0.26
0.41
1.07
0.52
0.43
0.51
0.78
0.73
0.71
0.53
0.75
0.82
0.67
0.19
0.95
1.24
1.37
0.86
1.17
1.00
0.72
0.14
0.54
0.57
0.33
0.34
0.27
0.23
0.36
0.22
0.16
0.25
0.24
0.45
0.27

0.95
1.08
0.99
0.89
0.58
0.85
0.62
0.43
0.70
0.83
0.68
0.95
0.83
0.74
0.82
0.74
0.81
0.54
0.74
0.80
0.92
0.72
0.87
0.69
0.90
1.08
0.92
0.82
0.98
0.81
0.76
0.80
0.85
0.74
0.81
0.85
0.69
0.81
0.96
1.00
0.90
0.91
0.84
0.92
0.88
0.99

0.04
0.04
0.11
0.03
0.06
0.06
0.04
0.02
0.03
0.03
0.02
0.03
0.04
0.10
0.05
0.04
0.05
0.10
0.07
0.06
0.06
0.07
0.08
0.06
0.02
0.12
0.14
0.15
0.09
0.10
0.11
0.08
0.02
0.06
0.06
0.04
0.03
0.03
0.02
0.04
0.02
0.02
0.03
0.03
0.05
0.03

616
942
76
1098
153
355
279
333
495
1250
712
1047
422
71
277
355
257
49
113
163
274
96
108
183
2274
130
48
43
126
73
65
137
3163
198
141
643
515
964
1954
656
2076
3417
1140
1357
325
1331

5.9
6.5
5.8
5.9
6.4
6.9
4.3
3.6
5.0
5.9
4.4
5.7
5.8
5.9
5.7
5.0
5.7
5.8
5.4
5.4
7.1
4.6
5.2
5.6
6.4
6.3
4.8
6.0
6.3
4.7
5.8
5.1
5.4
5.4
4.2
5.4
5.1
5.5
6.7
6.1
6.2
5.8
5.3
6.0
4.9
6.1

0.32
0.26
0.76
0.22
0.68
0.44
0.37
0.23
0.28
0.23
0.20
0.20
0.37
0.89
0.54
0.35
0.41
1.24
0.70
0.52
0.53
0.66
0.70
0.62
0.17
0.71
0.88
1.27
0.68
0.73
0.89
0.58
0.11
0.44
0.44
0.27
0.30
0.22
0.19
0.29
0.18
0.13
0.20
0.20
0.32
0.22

0.60
0.64
0.57
0.53
0.55
0.68
0.39
0.30
0.45
0.59
0.42
0.55
0.52
0.48
0.51
0.46
0.57
0.51
0.46
0.52
0.67
0.37
0.50
0.46
0.60
0.63
0.44
0.51
0.65
0.46
0.60
0.44
0.52
0.54
0.40
0.51
0.42
0.49
0.62
0.58
0.57
0.54
0.47
0.58
0.46
0.56

0.03
0.02
0.08
0.02
0.05 *
0.05
0.03
0.02 *
0.02
0.02
0.02
0.02
0.03
0.08
0.04
0.03
0.04
0.09
0.06
0.05
0.05
0.05
0.06
0.04
0.02
0.08
0.09
0.11
0.07
0.07
0.09
0.05
0.01
0.05
0.04
0.03
0.03
0.02
0.02
0.03
0.02
0.01
0.02
0.02
0.03
0.02

2640
26
1483
770
162
1615
588
94
45
1776
384
20
46
57
91
124

12.3
6.7
12.9
14.2
10.0
10.3
10.1
11.8
9.7
14.8
9.5
5.9
7.2
10.8
9.2
11.2

0.26
1.38
0.36
0.56
0.85
0.28
0.44
1.26
1.50
0.37
0.53
1.59
1.18
1.46
1.41
1.16

1.23
0.60
1.28
1.48
1.03
0.96
1.00
1.02
1.00
1.51
0.95
0.66
0.62
1.10
0.79
1.21

0.03
0.18
0.04
0.07
0.10
0.03
0.05
0.14
0.20
0.05
0.06
0.19
0.12
0.20
0.12
0.14

1827
20
1048
577
118
1212
389
66
38
1253
269
15
27
45
69
77

7.5
4.6
8.3
9.1
6.4
6.6
6.3
6.8
8.4
8.7
6.6
4.1
4.2
8.1
6.5
7.5

0.21
1.07
0.29
0.46
0.72
0.23
0.36
0.92
1.40
0.28
0.47
1.37
0.89
1.23
1.19
1.10

0.71
0.26
0.82
0.92
0.52
0.58
0.58
0.64
0.93
0.89
0.57
0.29
0.40
0.82
0.56
0.58

0.02
0.07
0.03
0.05
0.07
0.02
0.04
0.11
0.19
0.03
0.04
0.11
0.09
0.15
0.09
0.09

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

587

645

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Lymphoid leukaemia (C91)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

588

Female
ASR(W)
CUM 0-74

37
174
23
16
30

1.2
3.1
2.2
0.6
1.1

0.22
0.26
0.46
0.20
0.25

27
114
22
14
12

0.9
1.9
2.0
0.5
0.5

0.18
0.19
0.43
0.23
0.20

45
84
26
44
788
28
138
293
113
28
29

6.1
2.7
3.1
2.8
3.6
3.6
3.5
3.1
3.7
2.6
2.2

1.13
0.33
0.65
0.43
0.14
0.68
0.30
0.19
0.36
0.53
0.43

0.53
0.21
0.27
0.26
0.30
0.22
0.25
0.22
0.28
0.18
0.15

0.11
0.04
0.09
0.06
0.01
0.05
0.03
0.02
0.04
0.05
0.04

35
53
23
37
592
24
141
233
107
19
25

4.5
1.6
2.5
1.9
2.3
2.6
3.2
2.5
3.2
1.8
2.0

1.00
0.23
0.54
0.32
0.10
0.54
0.27
0.17
0.32
0.46
0.42

0.29
0.12
0.18
0.18
0.18
0.21
0.21
0.17
0.24
0.14
0.18

0.07
0.03
0.06
0.04
0.01
0.06
0.02
0.02
0.03
0.04
0.05 *

4577
669
685
297
119
40
1
156
2267
29
314
524
75
436
70
695
5009
247
232
1079
3298
869
48
34
19
2
136
568
1367
100
23
14
10
6
403
746
704
601
18
560
41
27
10
3265
186
3040
895
168
705
308
67
228
236
1927
188
1665
905
760
748
688
140
546
36
97

6.5
8.0
5.5
7.9
5.5
3.1
1.8
5.5
6.4
6.8
8.9
3.9
2.8
4.2
4.9
4.7
5.5
2.7
4.1
4.8
5.9
5.0
3.8
3.3
2.8
0.3
4.9
5.3
5.7
4.2
2.8
2.6
3.6
1.7
4.8
6.7
6.0
5.7
2.4
5.9
3.1
3.4
1.8
5.5
3.5
5.9
4.4
3.6
4.8
4.9
3.8
5.7
5.9
5.4
4.3
5.5
5.0
7.6
6.2
5.5
4.3
6.1
3.6
6.2

0.10
0.32
0.24
0.50
0.58
0.55
1.81
0.49
0.15
1.38
0.56
0.18
0.33
0.23
0.61
0.19
0.08
0.18
0.27
0.16
0.12
0.18
0.56
0.62
0.68
0.21
0.44
0.27
0.16
0.43
0.62
0.74
1.47
0.74
0.26
0.30
0.24
0.26
0.59
0.29
0.53
0.69
0.69
0.11
0.26
0.13
0.15
0.28
0.19
0.29
0.50
0.40
0.41
0.13
0.32
0.15
0.18
0.31
0.24
0.22
0.37
0.29
0.61
0.74

0.63
0.85
0.53
0.84
0.53
0.25
0.30
0.50
0.61
0.64
0.99
0.39
0.28
0.41
0.47
0.40
0.52
0.22
0.42
0.39
0.57
0.46
0.42
0.25
0.20
0.40
0.52
0.52
0.47
0.21
0.22
0.26
0.13
0.42
0.63
0.56
0.56
0.29
0.58
0.28
0.34
0.12
0.53
0.37
0.55
0.41
0.37
0.42
0.47
0.41
0.51
0.54
0.52
0.48
0.52
0.47
0.78
0.62
0.53
0.44
0.57
0.27
0.57

0.01
0.04
0.03
0.06
0.06
0.04
0.30
0.05
0.02
0.14
0.07
0.02
0.04
0.02
0.08
0.02
0.01
0.02
0.04
0.02
0.01
0.02
0.08
0.05
0.05
0.05
0.03
0.02
0.06
0.05
0.06
0.09
0.06
0.03
0.03
0.03
0.03
0.09
0.03
0.05
0.07
0.06
0.01
0.04
0.01
0.02
0.04
0.02
0.03
0.07
0.04
0.05
0.02
0.04
0.02
0.02
0.04
0.03
0.03
0.05
0.03
0.07
0.07

2979
439
444
198
80
22
2
103
1481
14
196
413
75
327
51
443
3308
188
150
736
2123
602
25
18
9
3
95
419
923
78
20
11
6
8
306
451
449
422
15
399
36
23
9
2338
157
2149
609
124
474
202
40
157
151
1408
135
1221
685
465
536
464
105
355
24
60

3.6
4.8
3.2
4.4
3.3
2.2
3.3
3.1
3.5
3.3
4.5
2.5
2.0
2.6
3.8
2.7
3.3
1.9
2.1
3.2
3.4
3.0
1.4
1.3
1.1
0.6
3.2
3.5
3.4
2.5
2.3
1.8
0.9
1.8
3.3
3.6
3.4
3.5
1.6
3.7
1.8
1.3
2.4
3.3
2.4
3.5
2.5
1.9
2.8
2.7
1.6
3.4
3.5
3.1
2.3
3.3
3.2
3.9
3.6
2.9
2.4
3.1
2.1
2.5

0.08
0.26
0.19
0.38
0.44
0.53
2.36
0.39
0.11
1.14
0.39
0.14
0.25
0.18
0.55
0.15
0.06
0.15
0.18
0.12
0.10
0.15
0.32
0.36
0.42
0.39
0.34
0.24
0.12
0.30
0.60
0.60
0.42
0.75
0.19
0.24
0.18
0.21
0.43
0.24
0.36
0.35
1.00
0.09
0.20
0.11
0.11
0.18
0.15
0.21
0.26
0.31
0.33
0.10
0.21
0.12
0.15
0.24
0.19
0.16
0.25
0.20
0.45
0.44

0.34
0.48
0.27
0.43
0.32
0.13
0.49
0.25
0.33
0.25
0.49
0.23
0.17
0.24
0.35
0.22
0.27
0.13
0.20
0.23
0.29
0.23
0.08
0.10
0.08
0.07
0.22
0.28
0.29
0.27
0.16
0.15
0.08
0.10
0.25
0.32
0.30
0.31
0.13
0.33
0.17
0.13
0.21
0.30
0.21
0.31
0.22
0.19
0.24
0.23
0.15
0.28
0.30
0.29
0.23
0.29
0.28
0.35
0.32
0.28
0.22
0.31
0.20
0.27

0.01
0.03
0.02
0.04
0.04
0.03
0.37
0.03
0.01
0.09
0.05
0.01
0.03
0.02
0.07
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.02
0.03
0.03
0.05
0.03
0.02
0.01
0.04
0.04
0.05
0.05
0.04
0.02
0.02
0.02
0.02
0.04
0.02
0.04
0.04
0.08
0.01
0.02
0.01
0.01
0.02
0.01
0.02
0.03
0.03
0.03
0.01
0.03
0.01
0.01
0.02
0.02
0.02
0.03
0.02
0.05
0.04

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

646

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Lymphoid leukaemia (C91) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

309
932
1657
114
1495
699
86
593
831
68
752
168
35444
2308
31706
1515
111
1334
376
15
83
268
3319
238
3009
1584
106
1428
475
615
2292
107
2119
200
4552
249
4022
11971
390
727
1360
9184
565
106
448
2969
227
2625
308
121
1150
800
338
1029

7.2
5.0
5.7
3.4
6.1
6.0
3.5
6.7
5.0
4.9
5.0
5.2
5.4
3.7
5.7
5.9
4.1
6.2
7.2
3.7
4.7
8.8
5.8
3.6
6.3
4.7
3.3
4.8
4.8
5.9
5.8
3.3
5.9
6.5
5.9
3.7
6.5
5.8
2.7
4.0
4.8
6.2
4.9
3.8
5.3
5.5
4.4
5.6
5.7
6.8
6.4
6.6
5.4
6.2

0.46
0.18
0.15
0.33
0.17
0.24
0.39
0.31
0.19
0.60
0.20
0.45
0.03
0.08
0.04
0.17
0.39
0.19
0.40
0.98
0.53
0.63
0.11
0.24
0.13
0.13
0.32
0.14
0.24
0.26
0.14
0.33
0.15
0.51
0.09
0.24
0.11
0.06
0.14
0.15
0.14
0.07
0.22
0.38
0.28
0.11
0.30
0.12
0.33
0.69
0.21
0.25
0.33
0.21

0.68
0.48
0.56
0.37
0.58
0.60
0.38
0.66
0.48
0.52
0.48
0.48
0.52
0.38
0.54
0.58
0.41
0.60
0.72
0.30
0.43
0.90
0.57
0.37
0.61
0.45
0.30
0.45
0.43
0.60
0.55
0.30
0.56
0.60
0.59
0.40
0.63
0.56
0.22
0.41
0.39
0.61
0.47
0.39
0.50
0.53
0.47
0.53
0.57
0.64
0.65
0.63
0.56
0.63

0.05
0.02
0.02
0.04
0.02
0.03
0.05
0.03
0.02
0.08
0.02
0.05
0.00
0.01
0.00
0.02
0.05
0.02
0.05
0.10
0.06
0.07
0.01
0.03
0.01
0.01
0.04
0.02
0.02
0.03
0.01
0.04
0.02
0.05
0.01
0.03
0.01
0.01
0.01
0.02
0.02
0.01
0.02
0.05
0.03
0.01
0.04
0.01
0.04
0.07
0.03
0.03
0.04
0.02

179
772
1174
130
1005
556
105
444
534
43
487
109
25064
1827
22147
1112
93
967
216
9
58
146
2577
242
2272
1080
81
963
322
415
1653
102
1490
128
3028
199
2664
8086
292
559
949
6078
395
76
309
2123
147
1895
195
72
748
483
230
773

3.6
3.5
3.4
2.8
3.4
3.7
3.1
4.0
2.7
2.4
2.7
3.4
3.2
2.2
3.4
3.6
2.5
3.7
3.7
2.0
2.8
4.8
3.5
2.5
3.8
2.6
1.8
2.7
2.6
3.7
3.4
2.3
3.4
3.4
3.4
2.2
3.7
3.4
1.9
2.4
3.2
3.5
2.8
2.0
3.0
3.4
2.0
3.5
3.1
3.5
3.8
3.5
3.1
4.0

0.34
0.16
0.12
0.27
0.13
0.19
0.33
0.24
0.14
0.39
0.15
0.40
0.02
0.05
0.03
0.13
0.28
0.15
0.29
0.69
0.39
0.54
0.09
0.18
0.10
0.10
0.22
0.11
0.18
0.22
0.11
0.25
0.12
0.38
0.07
0.17
0.09
0.04
0.12
0.11
0.11
0.06
0.17
0.26
0.22
0.08
0.18
0.09
0.24
0.51
0.17
0.19
0.27
0.18

0.33
0.31
0.32
0.31
0.31
0.36
0.35
0.37
0.24
0.20
0.25
0.31
0.28
0.21
0.29
0.32
0.24
0.33
0.31
0.13
0.21
0.40
0.31
0.23
0.34
0.22
0.17
0.22
0.22
0.30
0.30
0.21
0.31
0.31
0.30
0.22
0.32
0.29
0.13
0.23
0.23
0.31
0.25
0.20
0.26
0.29
0.17
0.30
0.27
0.30
0.35
0.33
0.27
0.38

0.03
0.01
0.01
0.04
0.01
0.02
0.04
0.02
0.01
0.04
0.01
0.04
0.00
0.01
0.00
0.01
0.03
0.01
0.03
0.05
0.04
0.04
0.01
0.02
0.01
0.01
0.03
0.01
0.02
0.02
0.01
0.03
0.01
0.04
0.01
0.02
0.01
0.00
0.01
0.01
0.01
0.01
0.02
0.03
0.02
0.01
0.02
0.01
0.03
0.05
0.02
0.02
0.02
0.02

26
139
304
6
29
252
40
99
174
761
14
480
98
104
55
1028
879
81
34
31
55
113
295
525
44

3.3
3.0
2.2
0.9
1.5
1.6
1.4
5.2
1.9
2.6
1.4
1.8
2.0
1.2
2.2
6.2
6.1
3.7
1.5
1.4
2.3
1.8
4.7
2.2
1.3

0.71
0.27
0.14
0.41
0.32
0.14
0.22
0.55
0.15
0.10
0.37
0.09
0.21
0.13
0.30
0.20
0.22
0.46
0.29
0.30
0.35
0.20
0.32
0.11
0.24

0.27
0.23
0.15
0.05
0.16
0.12
0.12
0.52
0.13
0.21
0.09
0.15
0.14
0.09
0.17
0.64
0.63
0.34
0.11
0.12
0.17
0.14
0.52
0.18
0.11

0.09
0.02
0.01
0.02
0.03
0.01
0.02
0.06
0.01
0.01
0.02
0.01
0.02
0.01
0.03
0.03
0.03
0.06
0.02
0.02
0.02
0.01
0.04
0.01
0.02

13
98
223
5
20
151
37
61
90
336
15
271
41
64
25
731
628
38
27
20
42
110
279
401
35

1.1
2.5
1.6
0.9
1.1
1.0
1.4
3.1
1.0
1.3
1.5
1.2
0.9
0.9
1.0
3.5
3.5
1.5
1.1
1.0
1.3
1.4
3.4
1.5
0.8

0.32
0.27
0.13
0.40
0.34
0.11
0.24
0.46
0.11
0.08
0.41
0.07
0.15
0.11
0.20
0.14
0.15
0.27
0.25
0.27
0.25
0.18
0.28
0.10
0.20

0.06
0.16
0.11
0.05
0.09
0.08
0.09
0.27
0.06
0.11
0.14
0.09
0.07
0.07
0.07
0.34
0.34
0.15
0.08
0.07
0.10
0.12
0.37
0.12
0.06

0.02
0.02 *
0.01
0.02 *
0.02
0.01 *
0.02 *
0.04 *
0.01
0.01 *
0.05
0.01
0.01 *
0.01 *
0.02 *
0.02
0.02
0.04
0.02
0.02
0.02
0.01
0.03
0.01
0.01

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

589

647

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Lymphoid leukaemia (C91) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

590

Female
ASR(W)
CUM 0-74

1234
128
72
44
38
76
10
365
19
50
71
48
101
77
95
230
166
120
18
28
51
32
31
86
202

1.6
1.7
1.4
1.5
1.4
1.4
1.4
1.9
1.0
2.3
5.2
2.2
1.9
2.4
2.0
1.9
2.6
2.5
3.1
2.5
1.7
2.0
1.1
3.0
2.7

0.05
0.16
0.17
0.24
0.23
0.17
0.48
0.11
0.24
0.39
1.12
0.32
0.20
0.33
0.22
0.14
0.21
0.24
0.77
0.48
0.25
0.38
0.21
0.32
0.20

0.11
0.11
0.10
0.14
0.09
0.09
0.07
0.13
0.06
0.17
0.32
0.12
0.12
0.24
0.13
0.13
0.17
0.17
0.21
0.15
0.10
0.10
0.09
0.22
0.21

0.00
0.01
0.01
0.03
0.02
0.01
0.02
0.01
0.02
0.05
0.06
0.02
0.02
0.05
0.02
0.01
0.02
0.02
0.05
0.04
0.02
0.02
0.02
0.03
0.02

885
66
64
29
44
64
4
263
18
33
26
39
67
47
44
185
92
69
6
17
45
25
36
57
145

1.1
1.0
1.2
1.1
1.5
1.2
0.6
1.3
1.1
1.5
4.8
1.9
1.3
1.5
1.3
1.5
1.4
1.4
1.4
1.6
1.6
1.5
1.3
1.9
2.0

0.04
0.13
0.16
0.21
0.23
0.16
0.31
0.09
0.26
0.30
1.24
0.31
0.16
0.26
0.23
0.12
0.16
0.18
0.57
0.40
0.25
0.32
0.23
0.26
0.17

0.07
0.06
0.08
0.07
0.11
0.08
0.04
0.09
0.08
0.10
0.23
0.11
0.08
0.15
0.10
0.11
0.09
0.09
0.06
0.12
0.10
0.11
0.09
0.11
0.16

0.00
0.01
0.01
0.01
0.02
0.01
0.02
0.01
0.02
0.03
0.06
0.02
0.01
0.04 *
0.03 *
0.01 *
0.01
0.01
0.03
0.04
0.02 *
0.02 *
0.02
0.02 *
0.02 *

1103
135
54
1319
223
908
778
784
1906
1194
198
749
171
129
103
154
169
210
321
115
71
69
74
473
791
261
357
346
375
151
47
670
56
130
85
186
130
35
241
160
45
351
107
52
88
286
156
102
44
45
164
167
103
273

4.4
7.0
5.9
5.0
3.5
5.3
3.0
5.9
6.0
6.5
4.9
4.9
5.6
5.7
6.0
6.1
5.3
6.2
8.6
7.1
3.9
5.4
3.6
6.0
5.0
4.6
6.4
4.6
4.8
4.6
5.7
6.1
8.2
7.1
4.9
4.9
5.7
5.6
6.8
7.3
3.4
4.9
6.1
5.3
6.0
7.0
5.5
5.7
5.3
8.9
4.6
5.8
6.0
4.9

0.15
0.65
0.86
0.15
0.26
0.20
0.13
0.24
0.16
0.21
0.37
0.20
0.46
0.54
0.61
0.52
0.47
0.46
0.52
0.77
0.52
0.80
0.47
0.34
0.22
0.34
0.41
0.29
0.29
0.45
0.88
0.25
1.55
0.75
0.68
0.51
0.74
1.33
0.58
0.72
0.53
0.34
0.84
0.88
0.85
0.58
0.51
0.63
0.94
1.60
0.47
0.62
0.71
0.38

0.39
0.66
0.59
0.55
0.38
0.55
0.29
0.55
0.62
0.65
0.52
0.41
0.56
0.62
0.68
0.71
0.54
0.58
0.91
0.64
0.39
0.52
0.37
0.55
0.53
0.43
0.61
0.43
0.44
0.36
0.59
0.61
0.75
0.64
0.58
0.40
0.52
0.54
0.61
0.76
0.27
0.43
0.57
0.49
0.52
0.66
0.51
0.62
0.38
0.77
0.42
0.50
0.58
0.47

0.01
0.07
0.10
0.02
0.03
0.02
0.01
0.02
0.02
0.02
0.04
0.02
0.05
0.07
0.08
0.07
0.05
0.05
0.06
0.07
0.06
0.07
0.05
0.03
0.02
0.03
0.04
0.03
0.03
0.04
0.11
0.03
0.12
0.07
0.08
0.04
0.06
0.11
0.05
0.07
0.05
0.03
0.07
0.08
0.07
0.05
0.05
0.07
0.07
0.13
0.04
0.05
0.07
0.03

862
101
30
1151
137
563
545
662
1275
875
211
579
121
103
80
118
118
139
212
74
64
57
34
338
615
191
261
251
308
105
36
447
41
78
48
179
90
16
194
107
35
295
92
41
51
213
120
63
20
24
143
115
75
209

2.6
3.8
2.9
3.1
1.8
3.1
2.0
3.9
2.9
3.9
3.4
3.1
3.3
3.5
4.2
3.9
3.4
3.1
4.4
3.9
3.1
3.3
1.7
3.1
2.9
2.3
3.3
2.7
3.2
2.1
4.0
3.7
2.8
3.1
3.0
3.1
3.8
2.6
4.0
3.7
2.8
3.0
5.7
3.6
2.3
4.2
3.3
3.6
1.6
3.5
3.8
3.4
5.2
3.1

0.12
0.49
0.64
0.11
0.19
0.17
0.12
0.20
0.10
0.17
0.30
0.17
0.36
0.45
0.56
0.44
0.42
0.30
0.37
0.58
0.46
0.66
0.35
0.25
0.18
0.24
0.30
0.23
0.25
0.27
0.78
0.20
0.65
0.49
0.83
0.39
0.73
1.04
0.46
0.51
0.51
0.28
0.95
0.74
0.47
0.48
0.41
0.57
0.47
0.97
0.55
0.49
0.83
0.34

0.22
0.31
0.25
0.32
0.18
0.29
0.18
0.34
0.28
0.37
0.35
0.24
0.34
0.33
0.42
0.39
0.30
0.33
0.45
0.40
0.30
0.25
0.16
0.27
0.27
0.22
0.32
0.24
0.26
0.20
0.31
0.35
0.27
0.28
0.26
0.27
0.31
0.21
0.37
0.36
0.22
0.24
0.45
0.33
0.22
0.35
0.27
0.36
0.14
0.32
0.28
0.29
0.41
0.26

0.01
0.04
0.05
0.01 *
0.02 *
0.01
0.01 *
0.02
0.01
0.02
0.03
0.01
0.04
0.05
0.06
0.05
0.04
0.04
0.04
0.05
0.05
0.05
0.03
0.02
0.01
0.02
0.03
0.02
0.02
0.03
0.07
0.02
0.07
0.04
0.05
0.03
0.05
0.07
0.03
0.04
0.04
0.02
0.07
0.06
0.04
0.04
0.03
0.05
0.04
0.08
0.03
0.04
0.06
0.02

*Important. See note on population page.

648

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Lymphoid leukaemia (C91) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

334
597
52
739
58
189
161
179
308
523
587
827
311
46
187
223
173
27
61
99
152
62
63
119
1832
86
43
25
103
44
45
79
2236
129
118
484
286
588
1427
492
1397
2321
878
1004
223
990

5.2
6.1
5.3
5.0
3.0
4.8
3.6
2.2
3.7
4.7
4.4
5.8
5.3
5.3
4.0
4.1
4.5
2.6
3.4
4.4
4.2
3.8
3.5
4.9
5.6
6.4
6.0
4.9
6.1
4.9
4.6
4.3
4.8
4.4
4.2
5.0
3.7
4.2
6.2
5.8
5.5
5.2
5.1
5.3
4.5
5.8

0.32
0.27
0.79
0.21
0.47
0.38
0.34
0.18
0.25
0.24
0.22
0.22
0.34
0.94
0.36
0.35
0.39
0.59
0.55
0.56
0.38
0.63
0.54
0.61
0.16
0.77
1.06
1.16
0.67
0.92
0.76
0.56
0.11
0.43
0.45
0.26
0.26
0.20
0.19
0.29
0.18
0.12
0.20
0.19
0.33
0.21

0.52
0.61
0.45
0.47
0.27
0.56
0.33
0.19
0.33
0.45
0.41
0.62
0.53
0.42
0.42
0.36
0.39
0.30
0.29
0.41
0.45
0.32
0.34
0.38
0.55
0.70
0.67
0.40
0.56
0.45
0.42
0.40
0.46
0.42
0.40
0.48
0.29
0.38
0.61
0.57
0.50
0.50
0.47
0.52
0.40
0.59

0.03
0.03
0.07
0.02
0.04
0.05
0.03
0.02
0.02
0.02
0.02
0.03
0.04
0.08
0.04
0.03
0.04
0.07
0.05
0.05
0.04
0.05
0.05
0.04
0.02
0.09
0.12
0.10
0.07
0.08
0.08
0.05
0.01
0.04
0.04
0.03
0.02
0.02
0.02
0.03
0.02
0.01
0.02
0.02
0.03
0.02

290
455
32
518
64
211
126
134
223
611
385
555
245
41
135
149
125
22
50
62
125
35
48
95
1181
63
24
15
69
32
31
53
1457
86
65
320
200
401
1015
328
987
1667
527
697
135
703

2.9
3.4
2.8
3.1
3.6
4.2
2.4
1.7
2.3
3.1
2.6
3.1
3.7
3.6
3.1
2.1
3.1
2.8
2.8
2.2
3.7
2.2
2.9
3.4
3.5
3.6
2.2
2.8
3.5
2.3
2.6
2.4
2.7
2.5
1.9
2.8
2.3
2.5
3.6
3.3
2.9
3.1
2.7
3.3
2.1
3.4

0.24
0.20
0.57
0.17
0.60
0.37
0.32
0.18
0.21
0.19
0.17
0.16
0.32
0.75
0.47
0.24
0.33
1.03
0.55
0.37
0.40
0.52
0.60
0.54
0.13
0.58
0.57
1.00
0.51
0.55
0.62
0.46
0.09
0.32
0.29
0.21
0.22
0.17
0.15
0.23
0.13
0.10
0.16
0.16
0.22
0.17

0.28
0.30
0.27
0.27
0.27
0.40
0.19
0.13
0.19
0.29
0.23
0.29
0.31
0.29
0.26
0.20
0.30
0.22
0.20
0.21
0.35
0.15
0.24
0.25
0.32
0.35
0.20
0.22
0.36
0.20
0.23
0.15
0.25
0.25
0.18
0.25
0.15
0.19
0.33
0.28
0.26
0.27
0.22
0.30
0.19
0.30

0.02
0.02
0.05
0.02
0.04 *
0.03
0.02
0.01 *
0.02
0.01
0.01
0.01
0.02
0.06
0.03
0.02
0.03
0.06
0.04
0.03
0.04
0.03
0.04
0.03
0.01
0.06
0.06
0.07
0.05
0.05
0.06
0.03
0.01
0.03
0.03
0.02
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.01

1238
11
801
397
78
710
298
45
18
1107
140
7
9
22
17
58

6.2
3.2
7.3
7.8
4.9
5.0
5.5
6.0
4.1
9.5
3.9
2.0
1.6
4.2
3.2
5.5

0.19
0.98
0.28
0.44
0.61
0.21
0.34
0.94
0.99
0.30
0.36
1.04
0.55
0.93
1.03
0.84

0.61
0.34
0.74
0.80
0.49
0.45
0.51
0.50
0.49
0.97
0.40
0.21
0.14
0.48
0.22
0.58

0.02
0.15
0.03
0.05
0.07
0.02
0.04
0.09
0.15
0.04
0.04
0.11
0.06
0.13
0.07
0.10

818
4
577
284
43
501
193
28
6
696
107
5
7
18
19
42

3.6
0.8
4.8
5.0
2.9
3.1
3.5
3.1
1.2
4.9
3.3
1.7
1.5
3.5
3.3
5.1

0.15
0.45
0.23
0.36
0.54
0.17
0.29
0.65
0.52
0.21
0.37
1.02
0.66
0.83
1.04
1.00

0.34
0.04
0.47
0.49
0.21
0.23
0.31
0.28
0.11
0.51
0.26
0.10
0.12
0.32
0.25
0.39

0.02
0.02
0.03
0.04
0.04
0.01
0.03
0.07
0.07
0.03
0.03
0.06
0.05
0.09
0.07
0.08

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

591

649

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Myeloid leukaemia (C92-94)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

592

Female
ASR(W)
CUM 0-74

39
139
30
3
44

1.6
2.3
2.9
0.3
1.2

0.29
0.22
0.54
0.22
0.25

38
142
17
6
34

1.5
2.2
1.6
0.5
1.3

0.26
0.19
0.40
0.26
0.29

39
72
23
64
1007
24
124
226
127
25
36

5.1
2.5
2.8
3.8
4.5
2.7
3.1
2.7
4.1
2.3
3.6

0.97
0.33
0.62
0.50
0.15
0.55
0.29
0.18
0.38
0.47
0.62

0.50
0.24
0.21
0.33
0.45
0.26
0.27
0.25
0.41
0.27
0.40

0.11
0.05
0.07
0.06
0.02
0.07
0.03
0.02
0.05
0.06
0.09

27
47
20
66
961
17
108
173
93
29
36

2.6
1.3
2.5
3.1
3.4
1.6
2.2
1.9
2.6
2.1
2.9

0.63
0.21
0.60
0.40
0.11
0.41
0.22
0.15
0.29
0.41
0.50

0.27
0.10
0.29
0.27
0.34
0.17
0.21
0.19
0.25
0.20
0.28

0.07
0.02
0.09
0.05
0.01
0.05
0.03
0.02
0.04
0.04
0.07 *

3137
373
525
134
112
47
0
100
1670
29
147
516
89
419
71
680
4919
444
275
801
3334
957
53
58
37
14
106
626
1295
116
32
37
22
13
302
735
597
557
31
513
62
33
22
3155
205
2911
967
186
770
338
83
249
213
2007
177
1761
947
591
594
665
140
518
41
100

4.0
4.2
3.6
3.5
4.4
2.9
3.0
4.3
6.8
4.1
3.7
3.1
3.7
4.8
3.8
4.8
3.9
4.6
4.0
5.2
4.7
3.8
3.6
4.1
4.9
3.7
5.1
4.8
4.7
3.2
4.5
4.7
2.6
3.9
5.6
4.7
4.8
4.3
4.7
3.7
2.9
4.6
4.7
3.6
4.8
4.3
3.8
4.4
4.9
4.5
5.2
5.1
5.0
4.0
5.1
4.9
5.4
4.5
4.8
4.1
5.0
4.1
4.9

0.08
0.22
0.17
0.32
0.46
0.45
0.33
0.11
1.31
0.36
0.17
0.34
0.19
0.59
0.16
0.07
0.19
0.28
0.15
0.10
0.16
0.53
0.51
0.70
1.71
0.38
0.23
0.14
0.44
0.63
0.77
1.18
0.73
0.25
0.24
0.20
0.22
0.79
0.23
0.50
0.54
1.10
0.10
0.26
0.10
0.14
0.29
0.17
0.28
0.53
0.35
0.36
0.12
0.30
0.13
0.17
0.24
0.19
0.19
0.36
0.23
0.65
0.53

0.43
0.44
0.37
0.40
0.44
0.31
0.28
0.46
0.66
0.47
0.36
0.30
0.37
0.52
0.40
0.50
0.40
0.51
0.39
0.54
0.48
0.37
0.35
0.41
0.36
0.30
0.54
0.52
0.54
0.29
0.45
0.49
0.37
0.40
0.60
0.45
0.52
0.37
0.52
0.40
0.28
0.55
0.49
0.37
0.50
0.47
0.40
0.49
0.55
0.44
0.60
0.53
0.53
0.44
0.54
0.52
0.59
0.46
0.52
0.43
0.55
0.39
0.54

0.01
0.03
0.02
0.04
0.05
0.05
0.04
0.01
0.14
0.05
0.02
0.04
0.02
0.09
0.02
0.01
0.02
0.04
0.02
0.01
0.02
0.07
0.06
0.08
0.14
0.04
0.03
0.02
0.06
0.07
0.10
0.12
0.12
0.03
0.03
0.02
0.03
0.09
0.03
0.06
0.07
0.14
0.01
0.03
0.01
0.02
0.04
0.02
0.04
0.08
0.05
0.05
0.02
0.04
0.02
0.02
0.03
0.02
0.03
0.05
0.03
0.08
0.07

2445
291
389
142
65
27
0
95
1311
18
107
470
88
377
53
520
3834
351
230
711
2508
756
63
44
20
8
96
486
1018
100
26
33
19
13
282
504
480
463
33
426
46
30
14
2435
250
2143
798
163
625
249
60
182
162
1711
185
1484
798
476
495
569
145
414
45
103

2.8
2.9
2.6
3.2
2.5
1.5
2.6
2.9
3.0
2.8
2.5
2.2
2.7
3.1
2.6
3.2
2.7
3.0
3.2
3.3
3.2
3.6
2.6
1.9
1.5
3.2
3.3
3.2
2.8
1.9
3.3
2.4
2.2
3.1
3.6
3.3
3.3
3.4
3.3
2.3
2.2
2.1
3.3
3.4
3.2
2.8
2.3
3.0
2.8
2.2
3.1
3.5
3.5
3.1
3.6
3.4
3.5
3.1
3.5
3.3
3.5
3.4
4.2

0.06
0.19
0.15
0.30
0.36
0.33
0.32
0.09
0.82
0.31
0.13
0.25
0.16
0.44
0.13
0.06
0.15
0.21
0.12
0.08
0.13
0.49
0.44
0.44
0.63
0.35
0.18
0.11
0.30
0.40
0.60
0.63
0.68
0.19
0.21
0.17
0.18
0.62
0.19
0.40
0.46
0.75
0.08
0.22
0.09
0.11
0.20
0.13
0.19
0.31
0.25
0.30
0.10
0.24
0.11
0.14
0.19
0.16
0.16
0.29
0.19
0.53
0.49

0.28
0.29
0.24
0.34
0.27
0.15
0.24
0.29
0.28
0.30
0.26
0.23
0.27
0.25
0.26
0.32
0.27
0.31
0.30
0.34
0.31
0.35
0.23
0.13
0.14
0.30
0.33
0.32
0.28
0.20
0.31
0.31
0.18
0.30
0.36
0.34
0.34
0.34
0.34
0.20
0.21
0.18
0.32
0.33
0.32
0.28
0.23
0.30
0.29
0.21
0.33
0.36
0.37
0.32
0.38
0.36
0.36
0.30
0.37
0.34
0.38
0.38
0.44

0.01
0.02
0.02
0.04
0.04
0.03
0.03
0.01
0.09
0.04
0.02
0.03
0.02
0.05
0.01
0.01
0.02
0.03
0.02
0.01
0.01
0.06
0.04
0.04
0.07
0.04
0.02
0.01
0.04
0.05
0.06
0.09
0.06
0.02
0.02
0.02
0.02
0.08
0.02
0.04
0.05
0.07
0.01
0.03
0.01
0.01
0.02
0.02
0.03
0.04
0.03
0.04
0.01
0.03
0.01
0.02
0.02
0.02
0.02
0.04
0.02
0.07
0.06

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

650

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Myeloid leukaemia (C92-94) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

227
937
1547
147
1373
670
110
547
887
68
815
169
34462
2587
30520
1385
127
1186
235
11
64
151
3099
256
2715
1608
130
1436
531
483
2326
128
2137
185
4177
311
3478
11146
723
851
1079
8360
548
114
424
2805
250
2487
279
96
961
670
311
963

4.7
4.5
4.9
4.3
4.9
5.4
4.4
5.7
4.6
4.4
4.7
5.2
4.7
4.0
4.8
5.0
4.4
4.9
4.1
2.9
3.5
4.5
5.0
3.7
5.2
4.3
4.1
4.2
4.6
4.3
5.2
4.0
5.1
5.1
4.9
4.3
5.0
4.8
4.1
4.4
4.1
5.0
4.3
3.8
4.3
4.8
4.7
4.8
4.6
4.7
4.9
5.1
4.6
5.2

0.35
0.16
0.13
0.36
0.14
0.22
0.44
0.26
0.17
0.55
0.18
0.44
0.03
0.08
0.03
0.14
0.39
0.16
0.28
0.90
0.45
0.42
0.10
0.23
0.11
0.11
0.37
0.12
0.21
0.21
0.12
0.36
0.12
0.41
0.08
0.25
0.09
0.05
0.16
0.16
0.13
0.06
0.19
0.36
0.22
0.09
0.30
0.10
0.29
0.50
0.17
0.21
0.29
0.18

0.51
0.48
0.52
0.47
0.53
0.59
0.50
0.62
0.48
0.43
0.49
0.54
0.50
0.42
0.51
0.52
0.45
0.52
0.45
0.40
0.40
0.48
0.53
0.35
0.56
0.45
0.47
0.45
0.52
0.45
0.55
0.44
0.55
0.53
0.52
0.44
0.54
0.51
0.40
0.47
0.42
0.53
0.45
0.39
0.46
0.49
0.50
0.50
0.46
0.54
0.52
0.52
0.48
0.58

0.04
0.02
0.02
0.05
0.02
0.03
0.06
0.03
0.02
0.07
0.02
0.05
0.00
0.01
0.00
0.02
0.05
0.02
0.04
0.15
0.06
0.05
0.01
0.03
0.01
0.01
0.05
0.02
0.03
0.03
0.01
0.05
0.02
0.05
0.01
0.03
0.01
0.01
0.02
0.02
0.02
0.01
0.02
0.05
0.03
0.01
0.04
0.01
0.04
0.07
0.02
0.03
0.03
0.02

175
828
1383
149
1204
673
110
543
786
66
710
124
28270
2463
24773
1123
108
975
183
10
50
121
2601
265
2244
1381
117
1233
441
422
1953
131
1778
156
3468
284
2917
8992
557
732
925
6690
460
116
335
2124
224
1861
214
82
789
551
286
798

3.3
3.2
3.5
3.2
3.6
4.0
3.2
4.2
3.4
3.1
3.4
3.1
3.2
2.8
3.3
3.2
2.7
3.3
2.7
2.2
2.3
3.1
3.2
2.7
3.3
3.0
2.7
3.0
3.2
3.2
3.6
3.1
3.6
3.3
3.4
3.0
3.5
3.3
2.7
2.9
3.1
3.4
2.8
2.9
2.7
3.0
3.2
3.0
3.3
3.3
3.6
3.6
3.5
3.6

0.30
0.13
0.11
0.28
0.12
0.18
0.32
0.22
0.14
0.40
0.15
0.32
0.02
0.06
0.02
0.11
0.27
0.13
0.22
0.70
0.34
0.33
0.07
0.17
0.08
0.09
0.26
0.10
0.18
0.18
0.10
0.29
0.10
0.32
0.06
0.19
0.07
0.04
0.12
0.11
0.11
0.05
0.15
0.29
0.17
0.07
0.23
0.08
0.24
0.42
0.14
0.18
0.24
0.15

0.35
0.34
0.37
0.35
0.37
0.41
0.34
0.42
0.34
0.34
0.34
0.34
0.33
0.29
0.34
0.33
0.26
0.34
0.26
0.22
0.21
0.30
0.32
0.28
0.33
0.30
0.25
0.31
0.31
0.34
0.37
0.28
0.38
0.34
0.34
0.31
0.35
0.33
0.27
0.29
0.30
0.34
0.30
0.30
0.29
0.31
0.32
0.31
0.33
0.32
0.36
0.37
0.34
0.38

0.03
0.02
0.01
0.04
0.01
0.02
0.04
0.03
0.02
0.05
0.02
0.04
0.00
0.01
0.00
0.01
0.03
0.01
0.03
0.09
0.04
0.04
0.01
0.02
0.01
0.01
0.03
0.01
0.02
0.02
0.01
0.03
0.01
0.04
0.01
0.02
0.01
0.00
0.01
0.01
0.01
0.01
0.02
0.04
0.02
0.01
0.03
0.01
0.03
0.05
0.02
0.02
0.03
0.02

30
155
658
20
23
418
109
65
195
749
14
539
126
107
57
669
571
71
78
116
152
276
232
1014
141

4.4
2.7
3.3
2.2
1.2
2.0
3.4
3.0
1.8
2.5
1.3
2.0
2.5
1.4
2.0
4.0
3.9
3.6
2.3
3.2
4.1
3.1
4.0
3.3
2.7

0.85
0.23
0.14
0.54
0.30
0.12
0.33
0.40
0.13
0.10
0.36
0.09
0.23
0.14
0.27
0.16
0.17
0.47
0.27
0.34
0.36
0.21
0.31
0.12
0.26

0.42
0.22
0.33
0.19
0.09
0.21
0.31
0.27
0.17
0.24
0.10
0.20
0.25
0.15
0.20
0.41
0.39
0.38
0.25
0.35
0.40
0.33
0.39
0.33
0.29

0.11
0.02
0.01
0.04
0.02
0.01
0.03
0.04
0.02
0.01
0.03
0.01
0.03
0.02
0.03
0.02
0.02
0.07
0.03
0.04
0.04
0.02
0.03
0.01
0.03

19
112
533
16
11
333
66
52
128
505
11
344
78
81
47
567
480
52
50
68
103
198
150
638
114

2.2
1.9
2.5
1.5
0.4
1.5
1.9
2.4
1.3
2.1
1.1
1.5
1.7
1.1
1.6
3.0
2.9
2.4
1.4
1.6
2.3
2.0
2.4
1.8
2.1

0.55
0.19
0.12
0.41
0.13
0.10
0.24
0.36
0.12
0.10
0.33
0.08
0.19
0.13
0.24
0.13
0.14
0.36
0.21
0.25
0.25
0.17
0.26
0.09
0.28

0.23
0.16
0.24
0.13
0.05
0.15
0.17
0.26
0.12
0.20
0.11
0.14
0.14
0.12
0.16
0.31
0.30
0.22
0.14
0.16
0.23
0.21
0.21
0.18
0.19

0.08
0.02 *
0.01
0.04 *
0.02
0.01 *
0.03 *
0.04 *
0.01
0.01 *
0.04
0.01
0.02 *
0.02 *
0.03 *
0.02
0.02
0.04
0.02
0.02
0.03
0.02
0.02
0.01
0.02

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

593

651

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Myeloid leukaemia (C92-94) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

594

Female
ASR(W)
CUM 0-74

2782
239
182
69
105
164
24
769
46
35
74
88
117
54
91
287
261
215
10
36
95
45
60
87
197

2.9
2.6
2.9
2.2
3.3
2.5
3.5
3.3
2.4
2.6
2.2
3.8
2.5
2.4
2.3
3.0
3.2
3.3
1.4
3.7
2.5
2.1
2.1
2.7
2.4

0.06
0.18
0.22
0.28
0.34
0.21
0.74
0.13
0.41
0.48
0.60
0.42
0.24
0.36
0.26
0.21
0.21
0.24
0.46
0.64
0.27
0.33
0.28
0.29
0.17

0.29
0.26
0.29
0.22
0.32
0.23
0.32
0.32
0.25
0.30
0.16
0.37
0.23
0.25
0.21
0.31
0.30
0.30
0.15
0.42
0.22
0.21
0.26
0.28
0.26

0.01
0.02
0.03
0.04
0.04
0.02
0.08
0.02
0.06
0.07
0.04
0.05
0.03
0.05
0.03
0.03
0.02
0.02
0.05
0.09
0.03
0.04
0.04
0.04
0.02

2210
193
153
77
69
140
24
633
39
38
33
66
99
42
67
269
225
182
12
31
87
43
57
62
171

2.1
1.8
2.2
2.2
2.0
2.2
3.0
2.5
2.0
2.3
2.1
2.6
2.3
1.8
2.4
2.4
2.5
2.4
1.9
2.9
2.1
2.0
1.8
1.9
2.0

0.05
0.14
0.18
0.26
0.25
0.20
0.64
0.10
0.35
0.41
0.64
0.33
0.24
0.31
0.33
0.16
0.17
0.19
0.59
0.54
0.23
0.32
0.24
0.24
0.16

0.20
0.17
0.22
0.21
0.19
0.19
0.25
0.25
0.19
0.23
0.15
0.24
0.24
0.17
0.23
0.24
0.24
0.23
0.19
0.30
0.21
0.19
0.18
0.15
0.20

0.00
0.01
0.02
0.03
0.03
0.02
0.05
0.01
0.04
0.05
0.04
0.04
0.03
0.04 *
0.04 *
0.02 *
0.02
0.02
0.06
0.07
0.03 *
0.03 *
0.03
0.02 *
0.02 *

988
64
35
846
187
706
632
610
1109
868
139
566
146
77
79
129
122
189
188
68
55
58
45
403
658
245
292
257
400
171
30
427
50
102
71
175
107
19
184
114
53
351
99
49
104
252
120
109
57
33
179
204
77
280

3.5
2.7
3.3
3.1
2.8
3.8
2.2
4.1
3.3
4.2
3.5
3.2
4.2
3.5
4.5
5.0
3.7
4.7
4.8
3.8
2.7
3.7
2.4
4.2
3.7
3.8
4.6
3.0
4.1
4.2
3.3
3.7
6.9
4.3
3.7
3.3
3.8
2.5
4.5
4.2
3.8
4.0
4.7
3.8
5.1
5.3
3.9
5.3
5.1
5.0
4.4
4.9
4.0
4.3

0.12
0.36
0.57
0.11
0.22
0.16
0.10
0.18
0.11
0.16
0.32
0.14
0.37
0.43
0.53
0.45
0.38
0.36
0.37
0.50
0.38
0.58
0.40
0.23
0.16
0.27
0.28
0.21
0.22
0.37
0.62
0.18
1.21
0.46
0.53
0.30
0.44
0.75
0.41
0.46
0.53
0.25
0.51
0.60
0.57
0.43
0.39
0.53
0.75
0.98
0.40
0.43
0.49
0.29

0.36
0.28
0.35
0.33
0.30
0.41
0.24
0.42
0.35
0.44
0.33
0.31
0.44
0.34
0.49
0.53
0.41
0.51
0.49
0.41
0.32
0.34
0.21
0.44
0.39
0.39
0.47
0.30
0.42
0.42
0.42
0.39
0.65
0.47
0.38
0.33
0.38
0.19
0.41
0.44
0.41
0.41
0.53
0.40
0.51
0.47
0.38
0.62
0.51
0.39
0.41
0.51
0.41
0.42

0.01
0.05
0.07
0.01
0.03
0.02
0.01
0.02
0.01
0.02
0.03
0.02
0.05
0.05
0.07
0.06
0.04
0.05
0.04
0.06
0.05
0.06
0.04
0.03
0.02
0.03
0.03
0.02
0.03
0.04
0.09
0.02
0.11
0.06
0.06
0.03
0.05
0.06
0.04
0.05
0.06
0.03
0.07
0.08
0.06
0.04
0.04
0.08
0.08
0.09
0.04
0.05
0.06
0.03

979
71
36
892
134
578
554
580
1102
714
152
583
133
72
53
100
101
161
132
64
47
44
38
374
734
239
265
219
394
146
26
293
30
97
69
185
109
24
171
106
49
366
55
42
84
184
105
52
32
25
160
131
81
266

2.5
2.5
2.9
2.3
1.7
2.8
1.7
3.1
2.6
3.1
2.4
2.4
3.5
2.7
2.4
3.6
2.6
3.6
2.9
2.9
2.1
2.2
1.9
3.0
2.9
2.8
3.1
2.1
3.1
2.5
2.6
2.4
2.4
3.4
2.8
2.8
3.7
2.3
2.9
3.0
2.9
3.3
2.4
3.2
3.3
3.0
2.9
2.7
2.9
2.8
3.2
3.0
3.9
3.1

0.10
0.34
0.59
0.09
0.17
0.14
0.08
0.15
0.09
0.14
0.23
0.12
0.34
0.38
0.39
0.42
0.31
0.32
0.30
0.48
0.36
0.41
0.35
0.20
0.15
0.23
0.24
0.17
0.20
0.26
0.57
0.15
0.54
0.41
0.51
0.28
0.52
0.63
0.30
0.41
0.44
0.23
0.46
0.64
0.46
0.29
0.31
0.47
0.60
0.65
0.34
0.33
0.61
0.25

0.26
0.28
0.24
0.25
0.18
0.29
0.18
0.32
0.26
0.32
0.26
0.24
0.37
0.28
0.23
0.37
0.25
0.35
0.26
0.26
0.20
0.23
0.19
0.29
0.28
0.29
0.33
0.22
0.27
0.28
0.22
0.23
0.31
0.35
0.25
0.27
0.35
0.23
0.29
0.29
0.31
0.30
0.22
0.31
0.34
0.30
0.30
0.28
0.28
0.28
0.31
0.30
0.39
0.33

0.01
0.04
0.05
0.01 *
0.02 *
0.01
0.01 *
0.02
0.01
0.02
0.02
0.01
0.04
0.04
0.04
0.04
0.03
0.04
0.03
0.04
0.04
0.05
0.03
0.02
0.01
0.02
0.03
0.02
0.02
0.03
0.06
0.02
0.07
0.04
0.05
0.03
0.04
0.06
0.03
0.04
0.05
0.02
0.04
0.06
0.05
0.03
0.03
0.05
0.06
0.07
0.03
0.03
0.05
0.03

*Important. See note on population page.

652

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Myeloid leukaemia (C92-94) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

264
375
63
605
53
99
136
205
339
377
327
461
179
33
145
166
176
19
82
102
172
69
77
84
1105
64
25
14
69
49
39
85
1994
110
127
382
321
593
874
390
1034
2004
687
713
228
728

3.6
3.6
5.0
3.6
2.2
2.4
2.6
2.3
3.5
3.0
2.1
3.0
2.8
2.7
3.3
2.4
3.9
1.5
3.6
3.6
4.4
3.0
4.2
2.2
3.2
4.0
2.7
2.3
3.9
4.2
3.8
3.7
3.6
3.2
3.6
3.5
3.4
3.9
3.5
4.0
3.7
4.0
3.6
3.5
4.2
4.0

0.23
0.19
0.66
0.16
0.31
0.25
0.24
0.17
0.21
0.16
0.13
0.14
0.22
0.52
0.33
0.21
0.31
0.40
0.44
0.40
0.36
0.38
0.54
0.26
0.11
0.53
0.64
0.65
0.52
0.69
0.64
0.44
0.09
0.31
0.33
0.20
0.20
0.17
0.13
0.21
0.13
0.10
0.15
0.14
0.29
0.16

0.39
0.42
0.54
0.37
0.23
0.26
0.27
0.21
0.36
0.31
0.22
0.31
0.28
0.32
0.33
0.26
0.39
0.16
0.38
0.35
0.44
0.35
0.42
0.24
0.32
0.36
0.25
0.30
0.41
0.32
0.33
0.38
0.38
0.30
0.40
0.35
0.36
0.40
0.33
0.41
0.37
0.39
0.36
0.37
0.45
0.39

0.03
0.03
0.08
0.02
0.04
0.03
0.03
0.02
0.02
0.02
0.01
0.02
0.02
0.07
0.03
0.02
0.04
0.05
0.05
0.04
0.04
0.05
0.06
0.03
0.01
0.06
0.07
0.09
0.06
0.06
0.07
0.05
0.01
0.04
0.04
0.02
0.03
0.02
0.01
0.03
0.01
0.01
0.02
0.02
0.04
0.02

280
408
42
501
71
125
146
169
261
518
263
452
164
28
106
137
124
21
56
95
124
50
42
70
999
60
23
26
54
33
31
71
1643
108
76
299
284
498
900
306
984
1627
565
600
168
602

2.6
2.7
2.8
2.5
2.3
2.4
1.8
1.7
2.6
2.3
1.5
2.4
2.0
2.2
2.1
2.0
2.5
2.2
2.5
3.0
2.9
1.9
1.9
1.9
2.6
2.5
2.4
3.0
2.7
2.0
3.1
2.5
2.6
2.8
2.4
2.5
2.6
2.7
3.0
2.7
3.0
2.6
2.4
2.5
2.5
2.6

0.18
0.15
0.49
0.13
0.31
0.23
0.19
0.14
0.19
0.12
0.10
0.12
0.18
0.48
0.25
0.21
0.25
0.60
0.43
0.36
0.30
0.35
0.33
0.28
0.10
0.39
0.66
0.78
0.44
0.40
0.62
0.34
0.07
0.30
0.32
0.17
0.18
0.14
0.12
0.18
0.12
0.08
0.13
0.12
0.22
0.13

0.27
0.29
0.30
0.24
0.24
0.25
0.20
0.15
0.25
0.25
0.16
0.25
0.21
0.18
0.20
0.18
0.26
0.22
0.23
0.29
0.28
0.19
0.22
0.19
0.26
0.24
0.22
0.27
0.27
0.23
0.33
0.26
0.26
0.29
0.22
0.25
0.26
0.27
0.29
0.29
0.30
0.26
0.24
0.26
0.25
0.25

0.02
0.02
0.06
0.01
0.03 *
0.03
0.02
0.01 *
0.02
0.01
0.01
0.01
0.02
0.05
0.02
0.02
0.03
0.06
0.04
0.04
0.03
0.04
0.04
0.03
0.01
0.05
0.06
0.08
0.05
0.05
0.07
0.04
0.01
0.03
0.03
0.02
0.02
0.02
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.01

1283
15
658
365
77
834
261
49
23
628
214
13
32
32
62
58

5.6
3.5
5.4
6.3
4.7
4.9
4.2
5.7
4.7
5.0
5.0
3.9
5.1
5.9
5.5
5.1

0.17
0.97
0.22
0.35
0.58
0.18
0.27
0.84
1.03
0.21
0.38
1.20
1.00
1.07
0.94
0.75

0.57
0.26
0.52
0.67
0.51
0.48
0.44
0.52
0.45
0.53
0.49
0.45
0.41
0.56
0.54
0.52

0.02
0.11
0.03
0.04
0.07
0.02
0.04
0.11
0.13
0.03
0.04
0.15
0.10
0.14
0.09
0.09

916
16
451
282
66
652
186
36
27
529
144
10
17
25
45
33

3.6
3.7
3.4
4.0
3.2
3.3
2.7
3.5
6.0
3.7
3.0
2.3
2.2
4.2
3.0
2.3

0.13
0.97
0.18
0.28
0.47
0.15
0.22
0.63
1.19
0.18
0.28
0.92
0.56
0.86
0.56
0.45

0.34
0.23
0.34
0.42
0.30
0.32
0.26
0.35
0.69
0.37
0.27
0.19
0.23
0.45
0.28
0.19

0.01
0.07
0.02
0.03
0.05
0.02
0.03
0.08
0.17
0.02
0.03
0.09
0.07
0.11
0.06
0.05

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

595

653

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Leukaemia unspecified (C95)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

596

Female
ASR(W)
CUM 0-74

9
62
0
14
10

0.3
1.0
0.5
0.4

0.13
0.15
0.18
0.15

10
44
0
9
5

0.4
0.7
0.3
0.2

0.12
0.11
0.19
0.10

20
18
16
9
234
6
42
32
13
15
4

2.5
0.7
1.5
0.5
1.0
0.7
1.2
0.4
0.4
1.4
0.4

0.62
0.18
0.38
0.17
0.07
0.30
0.19
0.07
0.11
0.38
0.23

0.25
0.06
0.08
0.03
0.09
0.06
0.13
0.03
0.03
0.13
0.06

0.07
0.02
0.02
0.01
0.01
0.03
0.03
0.01
0.01
0.04
0.04

17
14
6
14
186
1
41
28
26
15
11

1.4
0.4
0.7
0.7
0.7
0.1
0.9
0.3
0.7
1.2
0.9

0.39
0.13
0.30
0.19
0.05
0.06
0.14
0.06
0.15
0.32
0.29

0.12
0.04
0.06
0.07
0.06
0.09
0.03
0.08
0.11
0.11

0.04
0.02
0.03
0.02
0.01
0.02
0.01
0.02
0.03
0.04 *

649
59
105
13
17
8
0
51
381
0
15
98
13
85
5
94
494
31
21
46
390
86
4
6
4
0
2
68
93
3
3
2
2
2
16
60
72
95
3
90
16
9
7
570
33
528
98
17
81
21
7
14
18
335
34
294
81
69
93
112
21
90
7
14

0.8
0.6
0.6
0.3
0.6
0.5
1.5
0.9
0.3
0.6
0.4
0.6
0.4
0.5
0.4
0.2
0.3
0.3
0.5
0.4
0.3
0.3
0.4
0.1
0.4
0.3
0.1
0.2
0.2
0.2
0.4
0.2
0.3
0.5
0.7
0.5
0.7
1.0
1.0
0.9
0.7
0.6
0.8
0.4
0.4
0.4
0.3
0.5
0.3
0.4
0.9
0.8
0.9
0.4
0.5
0.7
0.8
0.6
0.9
0.7
0.6

0.03
0.08
0.06
0.08
0.15
0.18
0.22
0.05
0.09
0.06
0.12
0.07
0.17
0.05
0.02
0.04
0.08
0.04
0.03
0.04
0.16
0.14
0.22
0.08
0.06
0.03
0.07
0.11
0.13
0.11
0.26
0.06
0.05
0.07
0.08
0.29
0.08
0.28
0.38
0.40
0.04
0.10
0.04
0.04
0.09
0.05
0.07
0.18
0.07
0.11
0.05
0.14
0.06
0.05
0.07
0.08
0.08
0.14
0.10
0.28
0.18

0.07
0.06
0.05
0.01
0.06
0.05
0.14
0.08
0.04
0.05
0.04
0.05
0.06
0.04
0.04
0.02
0.03
0.02
0.04
0.04
0.03
0.02
0.05
0.01
0.05
0.03
0.00
0.01
0.05
0.02
0.03
0.04
0.05
0.08
0.05
0.08
0.09
0.09
0.07
0.05
0.07
0.04
0.05
0.04
0.02
0.04
0.01
0.04
0.07
0.08
0.07
0.04
0.06
0.06
0.07
0.05
0.08
0.06
0.05

0.00
0.01
0.01
0.01
0.02
0.02
0.03
0.01
0.01
0.01
0.02
0.01
0.03
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.02
0.02
0.04
0.01
0.01
0.00
0.00
0.01
0.05
0.01
0.01
0.01
0.01
0.05
0.01
0.03
0.04
0.06
0.00
0.01
0.00
0.01
0.02
0.01
0.01
0.02
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.03
0.02

569
27
87
15
10
7
0
51
358
2
12
90
20
69
9
96
475
23
25
63
359
80
1
2
7
2
7
60
108
9
2
2
0
1
22
70
58
94
5
89
12
8
4
459
40
415
126
33
93
28
9
19
20
324
36
284
87
60
72
107
31
75
10
8

0.5
0.2
0.4
0.2
0.3
0.3
1.2
0.6
0.1
0.2
0.4
0.4
0.4
0.7
0.4
0.3
0.1
0.3
0.3
0.3
0.2
0.1
0.1
0.5
0.5
0.2
0.2
0.2
0.2
0.1
0.1
0.3
0.2
0.2
0.3
0.5
0.4
0.5
0.3
0.3
0.2
0.5
0.5
0.5
0.3
0.4
0.3
0.3
0.3
0.3
0.3
0.6
0.5
0.6
0.2
0.3
0.3
0.5
0.6
0.5
0.6
0.2

0.03
0.04
0.05
0.06
0.14
0.13
0.20
0.04
0.08
0.08
0.05
0.10
0.06
0.23
0.05
0.01
0.03
0.06
0.03
0.02
0.03
0.06
0.04
0.21
0.35
0.07
0.03
0.02
0.07
0.07
0.11
0.30
0.05
0.03
0.04
0.07
0.20
0.07
0.09
0.14
0.10
0.03
0.08
0.03
0.04
0.08
0.04
0.05
0.09
0.07
0.09
0.04
0.09
0.05
0.03
0.05
0.05
0.06
0.12
0.08
0.20
0.08

0.04
0.02
0.03
0.01
0.01
0.04
0.10
0.05
0.01
0.03
0.03
0.03
0.03
0.03
0.02
0.01
0.03
0.02
0.02
0.01
0.01
0.05
0.04
0.01
0.01
0.01
0.02
0.01
0.02
0.02
0.01
0.03
0.04
0.04
0.04
0.01
0.02
0.04
0.03
0.04
0.03
0.04
0.03
0.02
0.01
0.02
0.02
0.04
0.04
0.04
0.02
0.03
0.04
0.05
0.07
0.05
0.06
0.03

0.00
0.01
0.01
0.01
0.01
0.02
0.02
0.00
0.01
0.01
0.01
0.01
0.01
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.01
0.02
0.04
0.01
0.00
0.00
0.01
0.01
0.02
0.01
0.00
0.01
0.01
0.03
0.01
0.01
0.01
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.00
0.01
0.00
0.00
0.01
0.01
0.01
0.02
0.01
0.03
0.01

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

654

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Leukaemia unspecified (C95) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

17
109
211
31
176
108
21
86
185
14
171
26
4786
346
4311
190
12
169
32
0
10
22
386
32
345
299
23
273
124
46
274
14
255
26
517
37
439
1345
62
91
78
1097
55
13
41
433
33
390
25
7
112
73
34
162

0.3
0.4
0.6
0.9
0.5
0.8
0.8
0.8
0.8
0.9
0.8
0.7
0.6
0.5
0.6
0.6
0.4
0.6
0.5
0.5
0.6
0.5
0.4
0.6
0.7
0.7
0.7
0.9
0.3
0.5
0.5
0.5
0.5
0.5
0.6
0.5
0.5
0.3
0.5
0.3
0.5
0.4
0.4
0.4
0.7
0.6
0.7
0.4
0.3
0.5
0.4
0.4
0.7

0.07
0.04
0.04
0.16
0.04
0.08
0.19
0.09
0.06
0.25
0.06
0.14
0.01
0.03
0.01
0.05
0.12
0.05
0.09
0.16
0.14
0.03
0.08
0.03
0.04
0.15
0.04
0.09
0.05
0.03
0.13
0.03
0.11
0.02
0.10
0.03
0.01
0.04
0.05
0.04
0.02
0.05
0.12
0.06
0.03
0.10
0.04
0.08
0.10
0.05
0.06
0.08
0.06

0.03
0.03
0.06
0.11
0.05
0.07
0.10
0.07
0.08
0.05
0.08
0.08
0.05
0.05
0.05
0.05
0.04
0.05
0.06
0.04
0.07
0.05
0.05
0.05
0.06
0.06
0.06
0.09
0.03
0.05
0.05
0.05
0.02
0.05
0.07
0.05
0.05
0.03
0.05
0.03
0.05
0.03
0.04
0.03
0.06
0.05
0.06
0.04
0.02
0.04
0.03
0.03
0.08

0.01
0.01
0.01
0.03
0.01
0.01
0.03
0.01
0.01
0.02
0.01
0.02
0.00
0.00
0.00
0.01
0.02
0.01
0.01
0.02
0.02
0.00
0.01
0.00
0.01
0.02
0.01
0.01
0.01
0.00
0.02
0.00
0.01
0.00
0.01
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.02
0.01
0.00
0.02
0.00
0.01
0.02
0.01
0.01
0.01
0.01

24
146
203
17
180
100
11
88
120
14
103
18
4378
385
3888
172
17
150
29
0
8
21
375
36
331
314
18
294
93
51
244
16
221
24
461
26
402
1229
42
102
89
981
66
16
44
350
39
303
28
8
68
46
47
140

0.3
0.3
0.4
0.4
0.4
0.5
0.3
0.6
0.3
0.6
0.3
0.3
0.4
0.4
0.4
0.4
0.3
0.4
0.3
0.3
0.5
0.3
0.3
0.4
0.5
0.3
0.5
0.6
0.2
0.3
0.3
0.3
0.4
0.3
0.2
0.3
0.3
0.2
0.3
0.3
0.3
0.3
0.3
0.3
0.4
0.4
0.4
0.3
0.2
0.2
0.2
0.4
0.4

0.07
0.04
0.03
0.09
0.04
0.06
0.10
0.08
0.04
0.16
0.03
0.09
0.01
0.02
0.01
0.03
0.08
0.04
0.08
0.12
0.18
0.02
0.05
0.03
0.03
0.08
0.03
0.07
0.04
0.02
0.08
0.03
0.09
0.02
0.05
0.02
0.01
0.03
0.04
0.03
0.01
0.04
0.09
0.04
0.02
0.08
0.02
0.06
0.08
0.03
0.04
0.08
0.05

0.03
0.02
0.04
0.03
0.03
0.05
0.03
0.05
0.02
0.05
0.02
0.02
0.03
0.03
0.03
0.03
0.02
0.03
0.02
0.02
0.03
0.03
0.02
0.03
0.04
0.02
0.05
0.06
0.02
0.02
0.04
0.02
0.03
0.03
0.02
0.03
0.03
0.02
0.03
0.02
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.02
0.02
0.02
0.04
0.04

0.01
0.00
0.00
0.01
0.00
0.01
0.01
0.01
0.00
0.02
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.01
0.00
0.01
0.00
0.01
0.00
0.01
0.00
0.00
0.00
0.01
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.00
0.01
0.01
0.00
0.01
0.01
0.01

6
59
70
26
48
269
14
3
63
205
2
150
41
34
7
103
81
8
17
10
4
44
19
173
15

0.8
1.1
0.3
2.8
2.0
1.3
0.4
0.2
0.6
0.7
0.2
0.6
0.8
0.5
0.3
0.6
0.5
0.3
0.4
0.2
0.1
0.5
0.3
0.6
0.3

0.33
0.15
0.04
0.63
0.33
0.10
0.12
0.09
0.08
0.05
0.13
0.05
0.13
0.08
0.10
0.06
0.06
0.13
0.11
0.08
0.04
0.09
0.07
0.05
0.08

0.10
0.10
0.04
0.22
0.20
0.12
0.04
0.02
0.06
0.06
0.00
0.06
0.06
0.03
0.02
0.06
0.05
0.04
0.04
0.04
0.01
0.04
0.02
0.05
0.02

0.05
0.02
0.01
0.05
0.03
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.00
0.01

5
32
72
20
32
264
10
3
38
101
4
123
20
30
6
95
74
12
12
8
11
33
9
119
10

0.8
0.7
0.3
2.1
1.7
1.2
0.3
0.2
0.4
0.4
0.4
0.5
0.4
0.4
0.2
0.4
0.4
0.5
0.3
0.1
0.2
0.3
0.1
0.3
0.2

0.37
0.14
0.04
0.59
0.39
0.10
0.10
0.10
0.07
0.04
0.20
0.05
0.10
0.08
0.08
0.05
0.05
0.17
0.09
0.06
0.07
0.07
0.03
0.04
0.09

0.13
0.05
0.02
0.21
0.13
0.11
0.03
0.01
0.04
0.04
0.04
0.04
0.03
0.03
0.02
0.04
0.03
0.05
0.05
0.02
0.03
0.01
0.01
0.03
0.01

0.07
0.01 *
0.00
0.05 *
0.03
0.01 *
0.01 *
0.01 *
0.01
0.01 *
0.02
0.01
0.01 *
0.01 *
0.01 *
0.01
0.01
0.02
0.02
0.01
0.01
0.00
0.00
0.00
0.01

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

597

655

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Leukaemia unspecified (C95) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

598

Female
ASR(W)
CUM 0-74

446
42
35
27
14
23
2
84
10
4
4
21
15
20
18
153
31
24
3
4
14
16
17
9
14

0.5
0.6
0.7
1.0
0.5
0.5
0.4
0.5
0.5
0.4
0.2
0.9
0.4
0.7
0.5
1.6
0.4
0.4
0.5
0.5
0.4
0.8
0.6
0.3
0.2

0.03
0.10
0.12
0.21
0.14
0.11
0.27
0.06
0.16
0.21
0.13
0.21
0.10
0.19
0.13
0.15
0.07
0.08
0.34
0.23
0.10
0.21
0.15
0.10
0.05

0.05
0.07
0.05
0.12
0.05
0.04
0.06
0.04
0.04
0.00
0.03
0.10
0.04
0.06
0.05
0.16
0.02
0.02
0.03
0.06
0.05
0.07
0.05
0.03
0.02

0.00
0.01
0.01
0.03
0.02
0.01
0.05
0.01
0.02
0.00
0.02
0.03
0.01
0.02
0.02
0.02
0.01
0.01
0.02
0.03
0.01
0.02
0.02
0.01
0.01

382
31
25
7
12
14
4
77
7
0
2
15
15
20
15
170
31
25
2
4
14
17
25
9
5

0.4
0.3
0.4
0.2
0.4
0.2
0.5
0.3
0.3
0.4
0.6
0.3
0.7
0.5
1.5
0.3
0.3
0.4
0.5
0.4
0.8
0.8
0.3
0.1

0.02
0.05
0.09
0.09
0.12
0.06
0.26
0.04
0.13
0.39
0.16
0.08
0.19
0.13
0.13
0.06
0.07
0.30
0.25
0.10
0.19
0.17
0.10
0.03

0.03
0.03
0.03
0.02
0.03
0.03
0.04
0.03
0.02
0.02
0.06
0.02
0.08
0.03
0.15
0.03
0.03
0.04
0.07
0.03
0.08
0.06
0.02
0.00

0.00
0.01
0.01
0.01
0.01
0.01
0.02
0.00
0.01
0.02
0.02
0.01
0.03 *
0.01 *
0.02 *
0.01
0.01
0.03
0.04
0.01 *
0.02 *
0.02
0.01 *
0.00 *

104
2
5
110
11
68
230
55
135
29
9
45
9
6
3
11
2
11
0
7
4
1
16
54
83
18
26
85
66
11
0
110
1
5
6
50
11
13
0
1
41
34
15
6
11
25
27
5
5
1
21
10
7
45

0.3
0.1
0.6
0.4
0.2
0.4
0.8
0.3
0.4
0.1
0.2
0.3
0.2
0.4
0.1
0.4
0.0
0.3
0.5
0.1
0.0
0.8
0.6
0.4
0.3
0.5
0.8
0.6
0.2
0.9
0.1
0.3
0.6
0.8
0.3
1.1
0.0
2.8
0.4
0.9
0.3
0.7
0.4
0.8
0.2
0.3
0.2
0.5
0.1
0.4
0.7

0.03
0.05
0.28
0.04
0.05
0.05
0.06
0.05
0.03
0.03
0.06
0.05
0.08
0.16
0.09
0.12
0.02
0.08
0.25
0.08
0.03
0.24
0.09
0.05
0.08
0.14
0.09
0.07
0.07
0.09
0.13
0.15
0.45
0.14
0.11
0.33
0.03
0.46
0.06
0.35
0.15
0.27
0.09
0.18
0.09
0.14
0.17
0.14
0.04
0.19
0.13

0.03
0.04
0.04
0.02
0.04
0.09
0.03
0.03
0.01
0.04
0.02
0.03
0.04
0.01
0.03
0.03
0.05
0.02
0.09
0.03
0.03
0.02
0.05
0.06
0.05
0.02
0.08
0.02
0.02
0.04
0.07
0.04
0.14
0.01
0.28
0.04
0.07
0.03
0.06
0.03
0.07
0.02
0.03
0.02
0.04
0.00
0.03
0.06

0.00
0.02
0.00
0.01
0.01
0.01
0.01
0.00
0.00
0.01
0.00
0.01
0.02
0.01
0.01
0.01
0.02
0.01
0.03
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.02
0.01
0.02
0.05
0.01
0.05
0.01
0.03
0.02
0.02
0.01
0.02
0.02
0.02
0.02
0.01
0.00
0.01
0.01

106
5
2
115
14
65
198
47
111
36
8
56
6
3
3
13
0
16
3
9
6
5
2
64
107
32
23
93
68
19
0
108
1
9
7
35
13
8
3
2
38
24
14
8
5
27
18
3
8
0
15
17
6
47

0.2
0.2
0.3
0.3
0.1
0.3
0.6
0.2
0.2
0.1
0.1
0.2
0.1
0.1
0.1
0.5
0.2
0.0
0.4
0.2
0.1
0.0
0.4
0.3
0.2
0.2
0.5
0.3
0.2
0.6
0.0
0.1
0.2
0.4
0.2
0.7
0.0
0.0
2.1
0.1
0.7
0.6
0.1
0.4
0.6
0.1
0.3
0.3
0.2
0.2
0.3

0.03
0.08
0.23
0.03
0.05
0.04
0.06
0.04
0.02
0.03
0.05
0.03
0.06
0.09
0.07
0.18
0.04
0.02
0.17
0.09
0.04
0.02
0.08
0.03
0.04
0.05
0.06
0.04
0.05
0.06
0.02
0.05
0.09
0.08
0.07
0.29
0.01
0.01
0.37
0.03
0.35
0.25
0.07
0.08
0.16
0.05
0.13
0.08
0.06
0.10
0.05

0.02
0.02
0.01
0.03
0.01
0.02
0.06
0.02
0.02
0.01
0.01
0.02
0.01
0.01
0.01
0.04
0.00
0.00
0.04
0.02
0.02
0.02
0.01
0.02
0.05
0.03
0.01
0.04
0.01
0.02
0.03
0.01
0.09
0.18
0.01
0.06
0.06
0.01
0.03
0.05
0.01
0.04
0.02
0.01
0.02
0.02

0.00
0.01
0.01
0.00 *
0.01 *
0.00
0.01 *
0.00
0.00
0.00
0.01
0.00
0.01
0.01
0.01
0.01
0.00
0.00
0.02
0.01
0.01
0.00
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.04
0.04
0.00
0.02
0.03
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01

*Important. See note on population page.

656

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Leukaemia unspecified (C95) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

31
48
0
96
22
12
7
33
16
84
68
46
19
1
34
94
16
16
19
10
14
14
31
26
98
5
0
5
6
5
1
11
84
7
5
29
47
50
48
18
116
123
31
59
22
28

0.4
0.4
0.5
0.9
0.3
0.1
0.3
0.2
0.6
0.4
0.3
0.3
0.0
0.8
1.3
0.4
1.1
0.7
0.4
0.3
0.4
1.4
0.6
0.3
0.3
0.7
0.3
0.4
0.1
0.3
0.2
0.2
0.2
0.2
0.5
0.3
0.2
0.2
0.4
0.2
0.1
0.3
0.3
0.1

0.08
0.06
0.06
0.19
0.08
0.05
0.06
0.05
0.07
0.06
0.04
0.06
0.04
0.19
0.14
0.11
0.32
0.18
0.13
0.08
0.12
0.31
0.13
0.03
0.16
0.33
0.14
0.17
0.05
0.10
0.02
0.07
0.12
0.04
0.09
0.06
0.03
0.04
0.04
0.02
0.03
0.04
0.07
0.03

0.04
0.05
0.05
0.08
0.03
0.02
0.03
0.01
0.07
0.05
0.03
0.03
0.07
0.12
0.02
0.08
0.07
0.04
0.02
0.06
0.11
0.08
0.02
0.02
0.11
0.01
0.04
0.02
0.01
0.02
0.01
0.02
0.05
0.02
0.02
0.01
0.04
0.02
0.01
0.03
0.03
0.01

0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.04
0.02
0.01
0.01
0.02
0.03
0.02
0.00
0.01
0.06
0.01
0.02
0.01
0.00
0.01
0.01
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00

46
79
2
79
18
19
7
30
11
121
64
40
13
2
36
69
8
6
7
6
25
11
18
18
94
7
1
2
3
8
3
13
63
4
0
24
31
65
39
22
105
123
48
60
22
26

0.5
0.4
0.1
0.3
0.4
0.3
0.1
0.2
0.1
0.5
0.3
0.2
0.1
0.1
0.6
0.9
0.1
0.7
0.2
0.2
0.5
0.4
0.4
0.4
0.3
0.2
0.1
0.2
0.1
0.5
0.2
0.2
0.1
0.0
0.1
0.2
0.3
0.1
0.1
0.3
0.1
0.2
0.2
0.3
0.1

0.10
0.06
0.10
0.04
0.11
0.08
0.03
0.04
0.02
0.06
0.05
0.03
0.03
0.04
0.13
0.15
0.04
0.34
0.07
0.10
0.15
0.22
0.12
0.12
0.04
0.11
0.12
0.15
0.05
0.27
0.14
0.08
0.01
0.02
0.02
0.05
0.05
0.02
0.02
0.04
0.02
0.03
0.03
0.07
0.02

0.04
0.04
0.01
0.03
0.04
0.03
0.01
0.03
0.01
0.05
0.04
0.01
0.01
0.06
0.08
0.01
0.07
0.02
0.01
0.03
0.03
0.04
0.03
0.02
0.03
0.02
0.02
0.01
0.02
0.03
0.03
0.01
0.00
0.01
0.02
0.01
0.01
0.02
0.01
0.01
0.02
0.03
0.01

0.01
0.01
0.01
0.01
0.01 *
0.01
0.00
0.01 *
0.00
0.01
0.01
0.00
0.00
0.01
0.01
0.01
0.04
0.01
0.01
0.01
0.01
0.02
0.01
0.00
0.02
0.02
0.02
0.01
0.02
0.02
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00

119
0
24
8
7
71
29
0
4
41
30
0
5
3
12
8

0.5
0.2
0.1
0.4
0.4
0.5
0.9
0.3
0.6
0.5
0.6
0.5
0.7

0.05
0.04
0.04
0.15
0.05
0.09
0.47
0.05
0.12
0.26
0.36
0.19
0.24

0.05
0.02
0.01
0.03
0.04
0.05
0.06
0.02
0.06
0.07
0.06
0.03
0.11

0.01
0.01
0.01
0.02
0.01
0.01
0.05
0.01
0.02
0.05
0.04
0.02
0.05

93
0
20
11
9
59
10
2
5
28
18
0
3
2
5
2

0.3
0.1
0.1
0.2
0.3
0.1
0.2
1.2
0.1
0.3
0.4
0.4
0.2
0.1

0.04
0.02
0.04
0.07
0.04
0.04
0.14
0.53
0.03
0.09
0.23
0.30
0.14
0.06

0.03
0.01
0.01
0.01
0.02
0.01
0.01
0.12
0.01
0.04
0.04
0.05
0.03
-

0.00
0.00
0.00
0.01
0.00
0.01
0.01
0.07
0.00
0.01
0.03
0.04
0.02
-

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

599

657

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Myeloproliferative disorders (MPD)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

Female
ASR(W)
CUM 0-74

0
3
0
0
0

0.0
-

0.03
-

0
1
0
0
0

0.0
-

0.02
-

3
0
0
0
0
0
1
0
0
4
0

0.3
0.0
0.3
-

0.18
0.03
0.16
-

0.05
0.01
0.04
-

0.03
0.01
0.02
-

4
0
0
0
0
0
1
1
0
2
0

0.4
0.0
0.0
0.2
-

0.22
0.03
0.01
0.11
-

0.04
0.00
0.00
0.01
-

0.03
0.00
0.00
0.01
- *

865
109
332
93
43
3
0
37
182
2
64
4
0
4
0
3
551
41
28
74
379
82
4
5
4
0
5
54
149
17
7
2
1
1
33
81
2
47
1
45
1
1
0
2
1
1
3
1
2
31
9
22
1
4
0
3
3
95
98
101
22
78
7
21

1.0
1.2
2.0
2.3
1.6
0.2
1.1
0.5
0.4
1.6
0.0
0.0
0.0
0.5
0.3
0.5
0.4
0.5
0.4
0.2
0.3
0.4
0.2
0.4
0.5
0.7
0.6
0.2
0.1
0.2
0.5
0.6
0.0
0.4
0.2
0.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.4
0.6
0.4
0.0
0.0
0.0
0.0
0.8
0.7
0.8
0.6
0.8
0.7
1.0

0.04
0.11
0.12
0.25
0.25
0.10
0.18
0.04
0.30
0.22
0.02
0.02
0.01
0.02
0.06
0.09
0.05
0.03
0.05
0.12
0.14
0.22
0.10
0.06
0.05
0.18
0.24
0.17
0.08
0.22
0.09
0.07
0.01
0.06
0.18
0.07
0.03
0.05
0.00
0.01
0.00
0.01
0.02
0.01
0.08
0.20
0.09
0.03
0.01
0.01
0.01
0.09
0.08
0.08
0.14
0.09
0.25
0.24

0.12
0.14
0.21
0.28
0.21
0.02
0.11
0.05
0.03
0.17
0.00
0.00
0.00
0.06
0.03
0.05
0.04
0.06
0.04
0.01
0.03
0.03
0.02
0.05
0.06
0.08
0.06
0.03
0.05
0.04
0.06
0.00
0.05
0.02
0.05
0.00
0.00
0.00
0.00
0.00
0.05
0.06
0.05
0.00
0.00
0.00
0.00
0.09
0.09
0.09
0.06
0.09
0.08
0.11

0.01
0.02
0.02
0.04
0.04
0.01
0.02
0.00
0.03
0.03
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.01
0.02
0.02
0.01
0.01
0.01
0.02
0.03
0.02
0.05
0.01
0.01
0.00
0.01
0.02
0.01
0.00
0.00
0.00
0.00
0.00
0.01
0.03
0.01
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.02
0.01
0.04
0.03

929
137
365
112
29
3
0
35
155
4
89
7
1
6
0
5
476
41
38
72
303
58
6
5
4
0
8
29
165
19
2
5
2
0
42
90
2
46
2
43
0
0
0
1
0
1
3
0
3
33
7
25
0
3
0
3
1
84
87
98
21
77
7
27

0.9
1.3
1.9
2.4
0.7
0.1
0.9
0.3
0.6
1.7
0.0
0.0
0.0
0.0
0.4
0.3
0.5
0.4
0.3
0.2
0.4
0.3
0.4
0.3
0.1
0.5
0.6
0.1
0.5
0.1
0.5
0.5
0.0
0.3
0.3
0.3
0.0
0.0
0.0
0.0
0.3
0.2
0.4
0.0
0.0
0.0
0.6
0.5
0.6
0.5
0.7
0.6
1.2

0.03
0.12
0.11
0.25
0.15
0.08
0.18
0.03
0.34
0.21
0.01
0.01
0.02
0.01
0.02
0.05
0.09
0.04
0.02
0.03
0.18
0.14
0.19
0.10
0.03
0.04
0.13
0.09
0.22
0.08
0.08
0.07
0.00
0.05
0.18
0.05
0.00
0.00
0.01
0.01
0.06
0.08
0.09
0.00
0.00
0.01
0.08
0.06
0.07
0.11
0.08
0.21
0.26

0.10
0.17
0.20
0.27
0.05
0.01
0.10
0.04
0.07
0.23
0.00
0.00
0.00
0.04
0.03
0.06
0.04
0.04
0.02
0.06
0.03
0.06
0.03
0.01
0.05
0.06
0.01
0.05
0.06
0.06
0.03
0.02
0.03
0.00
0.00
0.03
0.01
0.04
0.00
0.00
0.00
0.06
0.06
0.07
0.05
0.08
0.09
0.17

0.00
0.02
0.02
0.03
0.02
0.01
0.02
0.00
0.05
0.03
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.00
0.00
0.03
0.02
0.03
0.02
0.00
0.01
0.02
0.01
0.03
0.01
0.01
0.01
0.02
0.01
0.00
0.00
0.01
0.01
0.01
0.00
0.00
0.00
0.01
0.01
0.01
0.02
0.01
0.04
0.04

*Important. See note on population page.

Care should be taken when comparing populations. See Chapter 5 Comparability and quality of data
658
600

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp
Care

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Myeloproliferative disorders (MPD) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

1
5
7
0
7
136
23
109
2
0
2
0
116
18
89
209
27
169
58
3
18
35
588
45
528
3
1
2
3
3
10
0
8
2
602
42
503
1502
74
121
116
1140
0
0
0
15
2
11
29
1
6
109
0
1

0.0
0.0
0.0
0.0
1.0
0.8
1.0
0.0
0.0
0.0
0.0
0.0
0.8
0.9
0.7
1.0
0.7
1.0
1.0
0.9
0.7
1.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.7
0.6
0.7
0.6
0.4
0.6
0.5
0.7
0.0
0.0
0.0
0.5
0.0
0.0
0.8
0.0

0.02
0.01
0.01
0.01
0.09
0.18
0.11
0.01
0.01
0.00
0.01
0.00
0.05
0.18
0.06
0.14
0.40
0.24
0.20
0.04
0.10
0.04
0.01
0.04
0.01
0.02
0.01
0.01
0.01
0.03
0.03
0.09
0.03
0.02
0.05
0.06
0.05
0.02
0.01
0.02
0.01
0.10
0.05
0.01
0.08
0.01

0.00
0.00
0.00
0.00
0.12
0.10
0.12
0.00
0.00
0.00
0.00
0.00
0.09
0.13
0.08
0.12
0.03
0.12
0.12
0.10
0.08
0.11
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.08
0.07
0.08
0.07
0.04
0.08
0.06
0.08
0.00
0.00
0.00
0.06
0.00
0.00
0.10
0.00

0.00
0.00
0.00
0.00
0.01
0.03
0.01
0.00
0.00
0.00
0.00
0.00
0.01
0.03
0.01
0.02
0.02
0.03
0.02
0.01
0.01
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.01
0.01
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.01
0.00

0
2
13
1
12
145
33
104
1
0
1
0
101
8
88
210
25
170
54
0
18
36
572
58
503
4
0
4
0
1
3
0
3
0
550
52
448
1383
73
137
109
1019
3
0
3
18
0
17
25
2
10
97
1
0

0.0
0.0
0.0
0.0
0.7
0.9
0.7
0.0
0.0
0.0
0.0
0.0
0.5
0.6
0.5
0.8
0.9
0.9
0.6
0.6
0.7
0.0
0.0
0.0
0.0
0.0
0.5
0.5
0.5
0.5
0.3
0.5
0.4
0.5
0.0
0.0
0.0
0.0
0.4
0.1
0.0
0.6
0.0
-

0.01
0.01
0.01
0.01
0.07
0.16
0.08
0.00
0.00
0.00
0.00
0.00
0.04
0.13
0.05
0.11
0.21
0.16
0.03
0.08
0.04
0.01
0.01
0.00
0.01
0.01
0.02
0.08
0.03
0.01
0.04
0.05
0.04
0.02
0.00
0.01
0.01
0.01
0.08
0.08
0.01
0.06
0.00
-

0.00
0.00
0.00
0.08
0.11
0.07
0.00
0.00
0.00
0.06
0.07
0.06
0.10
0.12
0.11
0.07
0.06
0.07
0.00
0.00
0.00
0.00
0.05
0.06
0.05
0.05
0.03
0.06
0.05
0.05
0.00
0.00
0.03
0.02
0.00
0.06
-

0.00
0.00
0.00
0.01
0.02
0.01
0.00
0.00
0.00
0.01
0.02
0.01
0.02
0.03
0.02
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.01
0.01
0.01
0.00
0.00
0.00
0.01
0.01
0.00
0.01
-

6
37
0
0
0
2
0
0
1
0
0
0
0
0
1
282
250
11
0
0
5
5
4
0
0

1.0
0.8
0.0
0.0
0.0
1.7
1.7
0.5
0.1
0.0
0.1
-

0.43
0.14
0.01
0.01
0.04
0.11
0.11
0.16
0.05
0.02
0.03
-

0.18
0.09
0.00
0.00
0.00
0.21
0.20
0.05
0.01
0.00
0.01
-

0.09
0.02
0.00
0.00
0.00
0.02
0.02
0.02
0.01
0.00
0.01
-

4
26
0
0
0
2
0
0
0
0
0
0
0
0
0
250
217
18
0
0
2
2
1
0
0

0.6
0.4
0.0
1.2
1.2
0.9
0.0
0.0
0.0
-

0.29
0.08
0.00
0.08
0.09
0.24
0.02
0.01
0.02
-

0.04
0.05
0.00
0.13
0.13
0.10
0.00
0.00
0.00
-

0.03
0.01 *
- *
0.00 *
- *
- *
- *
- *
- *
- *
0.01
0.01
0.03
0.00
0.00
0.00
-

*Important. See note on population page.


Care should be taken when comparing populations. See Chapter 5 Comparability and quality of data
Cancer Incidence in Five Continents Vol. IX, IARC 2007

601

659

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Myeloproliferative disorders (MPD) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

Female
ASR(W)
CUM 0-74

31
4
0
2
0
2
1
0
0
1
4
0
0
0
0
0
58
36
6
16
0
0
0
2
6

0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.7
0.6
0.8
1.8
0.1
0.1

0.01
0.03
0.05
0.03
0.11
0.13
0.09
0.09
0.10
0.35
0.46
0.04
0.03

0.00
0.01
0.01
0.00
0.01
0.03
0.01
0.08
0.06
0.07
0.21
0.00
0.01

0.00
0.00
0.01
0.00
0.01
0.03
0.01
0.01
0.01
0.03
0.06
0.00
0.00

34
13
0
0
0
0
1
0
0
1
2
2
0
1
1
0
43
33
4
6
0
0
0
2
7

0.0
0.1
0.1
0.0
0.2
0.1
0.1
0.0
0.5
0.4
0.7
0.6
0.1
0.1

0.01
0.04
0.06
0.05
0.13
0.05
0.06
0.03
0.07
0.08
0.37
0.27
0.05
0.03

0.00
0.02
0.00
0.02
0.01
0.00
0.00
0.05
0.05
0.09
0.07
0.00
0.01

0.00
0.00
0.00
0.02
0.00
0.01 *
0.00 *
- *
0.01
0.01
0.05
0.03
- *
- *
0.00 *
0.00 *

0
41
0
62
14
157
59
3
342
0
0
0
92
51
52
0
63
85
38
57
37
41
19
67
146
0
34
76
63
7
0
231
35
0
32
265
138
6
10
2
43
8
56
55
0
0
0
0
13
0
35
2
0
0

1.9
0.2
0.2
0.8
0.2
0.0
1.0
2.7
2.0
2.7
1.5
2.1
0.9
2.8
1.9
2.1
0.8
0.7
0.8
0.6
0.9
0.6
0.1
2.0
4.2
1.9
5.5
5.2
0.7
0.2
0.1
2.8
0.1
2.4
4.3
1.2
0.9
0.1
-

0.29
0.03
0.05
0.07
0.03
0.01
0.05
0.28
0.30
0.39
0.21
0.23
0.16
0.40
0.33
0.38
0.19
0.09
0.06
0.12
0.10
0.08
0.05
0.13
0.82
0.36
0.38
0.48
0.29
0.05
0.05
0.43
0.03
0.36
0.62
0.34
0.18
0.05
-

0.24
0.03
0.03
0.09
0.02
0.00
0.11
0.31
0.24
0.31
0.21
0.23
0.10
0.29
0.23
0.22
0.09
0.07
0.10
0.06
0.09
0.07
0.02
0.24
0.45
0.23
0.60
0.60
0.07
0.02
0.00
0.36
0.01
0.23
0.58
0.12
0.11
0.01
-

0.04
0.00
0.01
0.01
0.00
0.00
0.01
0.04
0.04
0.05
0.03
0.03
0.02
0.05
0.04
0.05
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.09
0.05
0.04
0.06
0.03
0.01
0.00
0.06
0.00
0.05
0.09
0.04
0.02
0.01
-

0
52
0
77
16
128
60
2
349
0
1
0
70
79
50
0
63
79
39
55
35
35
20
66
215
0
65
80
85
7
0
220
39
0
15
197
68
4
4
0
17
5
50
36
0
0
0
0
14
0
28
0
0
0

1.9
0.2
0.2
0.5
0.1
0.0
0.8
0.0
1.6
2.5
2.4
1.5
1.7
0.8
2.0
1.5
1.7
0.7
0.5
0.7
0.6
0.6
0.6
0.1
1.4
3.4
0.6
3.0
1.7
0.2
0.0
1.1
0.0
1.6
2.7
1.2
0.5
-

0.29
0.02
0.05
0.05
0.02
0.00
0.05
0.01
0.21
0.31
0.36
0.21
0.20
0.13
0.33
0.27
0.34
0.17
0.07
0.06
0.08
0.08
0.08
0.04
0.10
0.78
0.18
0.25
0.25
0.12
0.02
0.26
0.02
0.28
0.51
0.34
0.11
-

0.20
0.02
0.03
0.06
0.02
0.09
0.00
0.17
0.31
0.30
0.17
0.19
0.09
0.20
0.19
0.21
0.08
0.06
0.09
0.08
0.06
0.07
0.01
0.14
0.35
0.07
0.33
0.22
0.05
0.01
0.13
0.00
0.18
0.29
0.12
0.07
-

0.03
0.00 *
0.01 *
0.01
0.00 *
0.01
0.00
0.03
0.04
0.05
0.03
0.03
0.02
0.04
0.04
0.04
0.02
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.08
0.02
0.03
0.03
0.03
0.00
0.03
0.00
0.04
0.06
0.03
0.01
-

*Important. See note on population page.

Care should be taken when comparing populations. See Chapter 5 Comparability and quality of data
660
602

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Care

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Myeloproliferative disorders (MPD) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

72
43
11
179
2
1
24
120
63
3
3
236
75
14
0
0
0
0
36
0
0
0
20
0
796
35
1
0
20
2
0
1
247
13
8
237
103
253
554
24
1148
983
435
383
0
743

0.9
0.4
0.8
1.0
0.1
0.0
0.4
1.2
0.6
0.0
0.0
1.4
1.1
1.0
1.5
0.8
2.0
2.0
0.1
1.1
0.1
0.1
0.4
0.3
0.2
1.9
1.0
1.5
1.9
0.2
4.1
1.8
2.1
1.7
3.8

0.11
0.06
0.25
0.08
0.04
0.03
0.08
0.11
0.08
0.01
0.01
0.10
0.13
0.29
0.26
0.19
0.08
0.35
0.05
0.25
0.09
0.05
0.03
0.10
0.09
0.13
0.10
0.10
0.08
0.04
0.13
0.06
0.11
0.09
0.15

0.12
0.05
0.09
0.11
0.01
0.00
0.04
0.13
0.07
0.00
0.00
0.18
0.14
0.12
0.17
0.09
0.24
0.17
0.14
0.01
0.00
0.05
0.05
0.03
0.22
0.10
0.16
0.20
0.02
0.45
0.20
0.23
0.19
0.45

0.02
0.01
0.03
0.01
0.01
0.00
0.01
0.01
0.01
0.00
0.00
0.01
0.02
0.04
0.04
0.03
0.01
0.05
0.04
0.01
0.00
0.00
0.02
0.01
0.02
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.02

90
43
15
143
9
1
29
93
62
9
4
207
92
9
0
0
0
0
38
0
0
0
11
0
860
33
0
0
11
0
0
0
216
14
4
266
101
270
647
10
962
1209
411
419
0
822

0.8
0.3
0.9
0.7
0.2
0.0
0.3
0.7
0.5
0.0
0.0
1.0
1.0
0.5
1.4
0.4
1.8
0.8
0.5
0.3
0.4
0.1
1.8
0.7
1.2
1.7
0.1
2.5
1.7
1.5
1.4
3.1

0.09
0.04
0.25
0.06
0.07
0.01
0.07
0.08
0.07
0.01
0.01
0.07
0.11
0.19
0.26
0.12
0.07
0.16
0.17
0.02
0.11
0.04
0.13
0.08
0.09
0.08
0.03
0.10
0.06
0.09
0.08
0.12

0.10
0.03
0.11
0.07
0.02
0.04
0.08
0.06
0.01
0.00
0.11
0.12
0.08
0.15
0.03
0.21
0.05
0.06
0.03
0.04
0.01
0.21
0.07
0.13
0.19
0.01
0.27
0.18
0.17
0.16
0.35

0.01
0.01
0.03
0.01
0.01 *
0.01
0.01 *
0.01
0.00
0.00
0.01
0.01
0.03
0.03
0.02
0.01
0.02
0.02
0.00
0.01
0.01
0.02
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.02

272
0
398
0
7
365
95
10
0
0
34
2
3
5
9
13

1.1
3.2
0.3
2.0
1.4
1.1
0.8
0.5
0.5
1.0
0.6
1.1

0.07
0.17
0.12
0.11
0.15
0.37
0.14
0.36
0.31
0.46
0.23
0.33

0.12
0.35
0.01
0.20
0.16
0.14
0.10
0.03
0.09
0.11
0.07
0.14

0.01
0.02
0.01
0.01
0.02
0.05
0.02
0.03
0.05
0.06
0.03
0.05

232
0
299
0
6
353
98
8
0
0
26
0
4
3
6
7

0.8
2.2
0.3
1.5
1.3
0.8
0.6
0.6
0.5
0.4
0.8

0.06
0.14
0.14
0.09
0.14
0.28
0.12
0.28
0.30
0.18
0.30

0.08
0.23
0.03
0.13
0.13
0.14
0.08
0.07
0.10
0.05
0.10

0.01
0.02
0.02
0.01
0.02
0.06
0.02
0.04
0.06
0.02
0.04

*Important. See note on population page.


Care should be taken when comparing populations. See Chapter 5 Comparability and quality of data
Cancer Incidence in Five Continents Vol. IX, IARC 2007

603

661

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Myelodysplastic syndromes (MDS)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

Female
ASR(W)
CUM 0-74

0
5
0
0
0

0.1
-

0.04
-

0
6
0
0
0

0.1
-

0.04
-

5
0
0
3
0
0
0
3
0
35
2

0.6
0.3
0.0
3.3
0.2

0.27
0.15
0.02
0.58
0.13

0.09
0.03
0.00
0.44
-

0.05
0.02
0.00
0.08
-

7
0
0
9
0
0
0
1
0
34
1

0.5
0.5
0.0
2.5
0.1

0.19
0.17
0.01
0.46
0.11

0.07
0.04
0.32
0.03

0.04
0.02
0.06
0.03 *

856
130
305
145
65
36
0
39
92
8
36
5
0
5
0
0
1034
83
52
111
765
148
12
10
6
0
13
103
286
22
5
8
9
0
45
183
0
85
0
85
0
0
0
0
0
0
1
0
1
55
6
47
0
0
0
0
0
138
136
140
18
121
7
29

0.9
1.3
1.8
2.9
2.1
1.9
1.1
0.2
1.4
0.9
0.0
0.0
0.9
0.7
0.9
0.7
0.9
0.6
0.9
0.5
0.8
0.6
0.7
0.9
0.8
0.3
0.8
0.8
0.8
1.0
0.6
0.6
0.0
0.0
0.8
0.3
1.0
1.0
0.9
1.0
0.5
1.1
0.8
1.2

0.03
0.12
0.11
0.26
0.27
0.33
0.20
0.03
0.51
0.16
0.02
0.02
0.03
0.07
0.13
0.07
0.04
0.06
0.26
0.16
0.34
0.16
0.07
0.06
0.18
0.15
0.30
0.26
0.12
0.08
0.07
0.08
0.00
0.01
0.12
0.14
0.15
0.09
0.08
0.08
0.13
0.10
0.30
0.24

0.09
0.11
0.16
0.28
0.22
0.20
0.13
0.03
0.15
0.09
0.00
0.01
0.08
0.05
0.09
0.08
0.09
0.06
0.08
0.06
0.05
0.06
0.07
0.09
0.09
0.03
0.05
0.09
0.10
0.06
0.07
0.00
0.00
0.08
0.01
0.11
0.09
0.11
0.10
0.03
0.11
0.05
0.13

0.00
0.02
0.01
0.04
0.04
0.05
0.03
0.00
0.08
0.02
0.00
0.00
0.00
0.01
0.02
0.01
0.01
0.01
0.03
0.03
0.03
0.02
0.01
0.01
0.03
0.02
0.04
0.02
0.01
0.01
0.01
0.00
0.00
0.02
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.02
0.04

559
72
206
85
55
20
0
27
75
4
15
2
1
1
0
0
798
67
41
124
541
121
8
6
7
2
14
75
218
22
8
7
6
0
41
126
0
75
2
71
1
1
0
0
0
0
0
0
0
43
13
29
0
0
0
0
0
136
153
123
25
97
7
22

0.5
0.6
0.9
1.2
1.6
0.9
0.6
0.2
0.3
0.2
0.0
0.0
0.0
0.5
0.4
0.5
0.6
0.5
0.4
0.5
0.2
0.8
0.5
0.5
0.4
0.5
0.5
0.5
0.5
0.5
0.5
0.6
0.4
0.1
0.4
0.1
0.1
0.4
0.5
0.4
0.7
0.8
0.6
0.5
0.6
0.5
0.7

0.02
0.07
0.07
0.16
0.25
0.22
0.12
0.02
0.20
0.08
0.01
0.04
0.00
0.02
0.05
0.08
0.06
0.03
0.04
0.19
0.10
0.32
0.40
0.14
0.05
0.04
0.11
0.18
0.20
0.20
0.08
0.06
0.05
0.10
0.05
0.05
0.08
0.07
0.16
0.09
0.07
0.07
0.06
0.11
0.08
0.20
0.22

0.05
0.06
0.08
0.12
0.19
0.11
0.06
0.02
0.04
0.03
0.00
0.00
0.05
0.04
0.04
0.06
0.05
0.04
0.06
0.03
0.10
0.05
0.05
0.04
0.05
0.04
0.04
0.04
0.05
0.05
0.07
0.04
0.04
0.01
0.01
0.05
0.06
0.04
0.07
0.09
0.06
0.05
0.06
0.06
0.05

0.00
0.01
0.01
0.02
0.04
0.03
0.02
0.00
0.04
0.01
0.00
0.00
0.00
0.01
0.01
0.01
0.00
0.01
0.03
0.02
0.04
0.05
0.02
0.01
0.01
0.01
0.03
0.03
0.04
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.03
0.02

*Important. See note on population page.

Care should be taken when comparing populations. See Chapter 5 Comparability and quality of data
662
604

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp
Care

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Myelodysplastic syndromes (MDS) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

0
0
9
0
9
214
38
170
0
0
0
0
22
0
22
318
25
281
54
1
21
32
900
34
846
2
0
2
2
0
0
0
0
0
928
56
806
2476
133
147
154
2005
0
0
0
0
0
0
55
0
0
206
0
0

0.0
0.0
1.5
1.4
1.4
0.0
0.0
1.0
0.9
0.9
0.8
0.3
1.1
0.7
1.2
0.5
1.3
0.0
0.0
0.0
0.9
0.8
1.0
0.9
0.7
0.8
0.7
1.0
0.8
1.4
-

0.01
0.01
0.11
0.24
0.12
0.00
0.00
0.06
0.18
0.06
0.12
0.34
0.24
0.14
0.04
0.08
0.05
0.01
0.01
0.01
0.03
0.11
0.04
0.02
0.06
0.07
0.06
0.02
0.11
0.10
-

0.00
0.00
0.15
0.12
0.14
0.00
0.00
0.11
0.12
0.11
0.10
0.08
0.15
0.08
0.11
0.04
0.12
0.00
0.00
0.09
0.06
0.10
0.10
0.06
0.08
0.09
0.10
0.08
0.14
-

0.00
0.00
0.02
0.03
0.02
0.00
0.00
0.01
0.03
0.01
0.02
0.08
0.04
0.02
0.01
0.01
0.01
0.00
0.00
0.00
0.01
0.01
0.00
0.01
0.01
0.01
0.00
0.02
0.02
-

0
0
6
0
6
219
38
179
1
0
1
0
14
3
11
263
38
214
34
0
11
22
795
53
724
0
0
0
2
0
0
0
0
1
829
67
714
2105
103
174
162
1630
0
0
0
0
0
0
42
1
0
186
0
0

0.0
0.0
1.1
1.0
1.1
0.0
0.0
0.0
0.0
0.0
0.5
0.8
0.5
0.4
0.5
0.4
0.7
0.4
0.7
0.0
0.0
0.6
0.7
0.7
0.6
0.4
0.6
0.6
0.6
0.6
0.0
1.0
-

0.01
0.01
0.09
0.17
0.10
0.01
0.01
0.00
0.00
0.00
0.04
0.14
0.04
0.08
0.16
0.09
0.03
0.06
0.03
0.01
0.03
0.03
0.09
0.03
0.01
0.04
0.05
0.05
0.02
0.10
0.02
0.09
-

0.00
0.00
0.11
0.13
0.11
0.00
0.00
0.00
0.00
0.00
0.06
0.09
0.05
0.04
0.07
0.03
0.06
0.04
0.07
0.00
0.00
0.07
0.08
0.07
0.06
0.04
0.07
0.06
0.06
0.08
0.11
-

0.00
0.00
0.01
0.03
0.01
0.00
0.00
0.00
0.00
0.00
0.01
0.02
0.01
0.01
0.02
0.01
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.01
0.01
0.01
0.00
0.02
0.01
-

4
0
0
0
0
0
0
8
0
0
0
0
0
0
1
281
248
10
9
0
32
51
103
0
4

0.7
0.4
0.0
1.4
1.4
0.7
0.2
0.8
0.4
1.3
0.1

0.35
0.14
0.04
0.09
0.09
0.23
0.08
0.14
0.06
0.15
0.03

0.11
0.05
0.00
0.14
0.13
0.09
0.04
0.10
0.04
0.11
0.01

0.07
0.02
0.00
0.01
0.01
0.04
0.01
0.02
0.01
0.02
0.00

3
0
0
0
0
0
0
2
0
0
0
0
0
0
1
224
189
9
4
0
16
35
75
0
1

0.5
0.1
0.0
0.9
0.8
0.4
0.1
0.3
0.2
0.6
0.0

0.28
0.04
0.03
0.06
0.06
0.15
0.05
0.08
0.03
0.09
0.00

0.05
0.01
0.08
0.08
0.02
0.01
0.03
0.01
0.06
-

0.05
- *
- *
- *
- *
0.01 *
- *
- *
- *
- *
0.01
0.01
0.01
0.01
0.01
0.00
0.01
-

*Important. See note on population page.


Care should be taken when comparing populations. See Chapter 5 Comparability and quality of data
Cancer Incidence in Five Continents Vol. IX, IARC 2007

605

663

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Myelodysplastic syndromes (MDS) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

Female
ASR(W)
CUM 0-74

59
9
0
0
0
0
1
1
0
2
1
1
4
0
0
2
38
35
0
3
0
0
0
5
25

0.1
0.1
0.1
0.0
0.2
0.0
0.1
0.1
0.0
0.5
0.5
0.3
0.2
0.3

0.01
0.03
0.14
0.01
0.16
0.01
0.07
0.05
0.02
0.08
0.09
0.15
0.08
0.06

0.01
0.01
0.02
0.00
0.03
0.00
0.01
0.02
0.01
0.04
0.05
0.01
0.03
0.04

0.00
0.00
0.02
0.00
0.02
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01

43
13
0
0
0
1
1
0
0
3
1
1
0
0
0
1
30
27
1
2
0
0
0
8
29

0.0
0.1
0.0
0.1
0.3
0.1
0.1
0.0
0.3
0.3
0.2
0.2
0.3
0.4

0.01
0.03
0.01
0.09
0.16
0.13
0.05
0.01
0.06
0.06
0.21
0.16
0.10
0.07

0.00
0.01
0.00
0.02
0.04
0.02
0.01
0.03
0.03
0.02
0.02
0.03

0.00
0.00
0.00
0.02
0.03
0.02
0.01
- *
- *
- *
0.01
0.01
0.02
- *
- *
0.01 *
0.01 *

0
22
0
0
23
183
1
0
308
0
0
0
50
35
57
0
69
101
19
42
32
69
0
80
149
0
89
117
138
0
0
250
25
0
15
174
53
0
66
1
13
0
1
44
0
0
0
0
16
0
71
0
0
0

0.8
0.3
0.8
0.0
0.8
1.2
1.2
2.6
1.4
2.4
0.4
1.6
1.2
2.9
0.8
0.7
1.3
1.2
1.3
1.9
2.1
0.9
2.6
1.4
1.2
0.0
0.8
0.1
3.0
1.0
1.5
-

0.18
0.06
0.06
0.00
0.05
0.18
0.22
0.36
0.18
0.25
0.10
0.26
0.23
0.38
0.10
0.07
0.14
0.12
0.11
0.12
0.44
0.39
0.22
0.21
0.18
0.04
0.22
0.06
0.49
0.28
0.19
-

0.08
0.02
0.08
0.00
0.09
0.10
0.13
0.27
0.13
0.23
0.03
0.17
0.14
0.26
0.09
0.07
0.15
0.10
0.12
0.17
0.19
0.07
0.27
0.14
0.11
0.01
0.08
0.01
0.37
0.10
0.19
-

0.02
0.01
0.01
0.00
0.01
0.02
0.03
0.05
0.02
0.03
0.01
0.04
0.04
0.05
0.01
0.01
0.02
0.01
0.01
0.02
0.06
0.03
0.03
0.03
0.02
0.01
0.03
0.01
0.07
0.04
0.03
-

0
23
0
0
26
149
0
0
344
0
0
0
38
22
47
0
38
62
9
38
19
45
0
69
163
0
67
129
128
0
0
184
16
0
13
144
40
4
42
0
10
0
2
36
0
0
0
0
10
0
57
0
0
0

0.6
0.2
0.4
0.6
0.6
0.5
1.3
0.5
0.9
0.2
0.7
0.6
1.4
0.5
0.5
0.6
0.6
0.7
1.0
0.9
0.2
1.8
0.6
0.2
0.4
0.4
0.0
2.1
0.6
0.8
-

0.14
0.04
0.03
0.04
0.12
0.14
0.21
0.10
0.12
0.06
0.14
0.15
0.26
0.09
0.05
0.09
0.06
0.08
0.09
0.26
0.06
0.23
0.12
0.11
0.08
0.14
0.02
0.39
0.22
0.12
-

0.06
0.02
0.03
0.07
0.06
0.05
0.12
0.05
0.09
0.02
0.06
0.07
0.13
0.05
0.05
0.06
0.06
0.07
0.11
0.10
0.17
0.04
0.03
0.04
0.05
0.23
0.07
0.09
-

0.02
- *
0.01 *
0.01
- *
0.01
0.02
0.02
0.03
0.01
0.02
0.01
0.02
0.02
0.04
0.01
0.01
0.01
0.01
0.01
0.01
0.04
0.02
0.01
0.02
0.01
0.02
0.05
0.03
0.02
-

*Important. See note on population page.

Care should be taken when comparing populations. See Chapter 5 Comparability and quality of data
664
606

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Care

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Myelodysplastic syndromes (MDS) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

0
20
20
198
12
0
34
47
149
0
0
95
43
27
0
1
0
0
69
0
0
0
13
0
433
29
0
0
43
0
0
0
387
21
21
288
183
357
540
24
1272
1298
716
479
0
627

0.2
1.2
0.9
0.5
0.5
0.4
1.3
0.6
0.6
1.8
0.0
2.2
0.5
0.9
1.6
2.0
0.6
0.5
0.6
1.9
1.5
1.8
1.7
0.2
3.2
2.0
2.9
1.8
2.6

0.04
0.28
0.07
0.15
0.09
0.07
0.11
0.06
0.09
0.37
0.01
0.29
0.15
0.05
0.31
0.33
0.03
0.12
0.13
0.12
0.11
0.10
0.08
0.05
0.10
0.06
0.11
0.09
0.11

0.03
0.09
0.08
0.05
0.06
0.04
0.16
0.06
0.07
0.24
0.25
0.05
0.09
0.13
0.25
0.06
0.05
0.08
0.18
0.10
0.14
0.16
0.02
0.26
0.19
0.25
0.15
0.23

0.01
0.03
0.01
0.02
0.01
0.01
0.02
0.01
0.01
0.06
0.05
0.02
0.01
0.04
0.05
0.00
0.02
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.01

0
12
15
37
10
0
30
29
131
0
0
119
46
22
0
0
0
0
52
0
0
0
10
0
379
16
0
0
43
0
0
0
299
19
14
214
161
336
402
15
1131
987
676
360
0
606

0.1
0.8
0.2
0.2
0.2
0.2
0.8
0.5
0.4
1.3
1.3
0.2
0.6
0.7
1.4
0.4
0.4
0.4
1.0
0.8
1.1
0.8
0.1
1.9
1.0
2.0
1.0
1.6

0.02
0.24
0.03
0.07
0.05
0.04
0.09
0.05
0.06
0.35
0.21
0.09
0.04
0.26
0.25
0.03
0.10
0.11
0.08
0.07
0.07
0.05
0.03
0.08
0.04
0.09
0.06
0.08

0.01
0.08
0.01
0.03
0.03
0.03
0.09
0.05
0.04
0.10
0.13
0.01
0.06
0.05
0.18
0.05
0.04
0.04
0.10
0.06
0.10
0.08
0.01
0.17
0.10
0.18
0.09
0.15

0.00
0.03
0.00
0.01 *
0.01
0.01 *
0.01
0.01
0.01
0.03
0.03
0.01
0.01
0.02
0.04
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.01

464
0
454
0
15
623
211
10
0
0
38
4
11
4
15
3

1.7
3.2
0.8
3.0
3.0
1.3
0.7
0.6
1.3
1.0
1.0
0.2

0.08
0.16
0.21
0.12
0.21
0.43
0.13
0.33
0.45
0.51
0.31
0.13

0.16
0.28
0.08
0.24
0.28
0.04
0.08
0.06
0.09
0.13
0.12
0.03

0.01
0.02
0.03
0.02
0.03
0.03
0.02
0.06
0.05
0.08
0.04
0.02

347
0
327
0
8
432
118
5
0
0
26
3
0
3
7
11

0.9
1.8
0.2
1.4
1.2
0.5
0.4
0.4
0.6
0.3
0.6

0.05
0.11
0.08
0.08
0.13
0.25
0.08
0.23
0.35
0.14
0.21

0.07
0.17
0.02
0.12
0.08
0.06
0.05
0.05
0.07
0.03
0.10

0.01
0.02
0.02
0.01
0.02
0.03
0.01
0.05
0.04
0.02
0.05

*Important. See note on population page.


Care should be taken when comparing populations. See Chapter 5 Comparability and quality of data
Cancer Incidence in Five Continents Vol. IX, IARC 2007

607

665

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other and unspecified (O&U)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

608

Female
ASR(W)
CUM 0-74

59
440
53
91
102

2.7
10.3
5.7
7.0
6.3

0.37
0.52
0.80
0.97
0.75

49
369
43
94
92

2.1
7.3
4.3
8.0
6.3

0.31
0.39
0.66
0.98
0.78

111
359
97
143
3823
128
472
781
142
61
38

12.6
16.7
15.3
10.4
18.7
13.9
13.9
10.1
5.0
5.2
4.2

1.27
0.97
1.63
0.90
0.32
1.26
0.66
0.37
0.43
0.68
0.70

1.35
1.84
1.74
1.20
2.18
1.56
1.72
1.05
0.53
0.62
0.54

0.17
0.14
0.25
0.13
0.05
0.18
0.10
0.05
0.06
0.10
0.11

81
451
116
143
4007
133
608
684
211
74
60

6.2
16.5
14.8
8.0
13.9
12.3
13.4
8.2
6.3
4.4
5.4

0.82
0.83
1.45
0.68
0.23
1.10
0.56
0.32
0.45
0.55
0.73

0.63
1.74
1.47
0.87
1.48
1.34
1.53
0.85
0.68
0.46
0.65

0.10
0.12
0.19
0.10
0.03
0.16
0.08
0.05
0.06
0.08
0.11 *

9061
825
1385
421
181
181
3
473
5167
42
383
1428
295
1121
95
1783
8785
641
602
1155
6299
1688
157
93
47
15
143
1149
2216
282
48
57
52
24
442
1265
1054
953
70
874
191
134
47
6799
604
6118
2026
484
1526
531
154
367
397
3642
562
2995
1672
751
1479
1298
401
890
133
205

10.4
8.8
8.6
9.4
6.0
10.2
3.9
13.0
11.9
7.6
8.3
9.2
10.6
8.8
6.2
9.4
8.2
5.4
10.6
7.3
8.6
7.8
12.0
5.3
5.1
3.3
7.0
8.3
8.0
11.1
3.8
6.8
8.8
4.6
7.1
8.7
7.9
7.4
10.0
7.2
10.8
12.1
7.4
9.4
11.4
9.2
8.9
10.9
8.5
8.0
9.3
7.6
8.6
8.8
13.2
8.3
8.0
6.4
10.7
9.3
12.1
8.4
13.8
9.7

0.11
0.31
0.24
0.49
0.48
0.77
2.35
0.63
0.17
1.22
0.47
0.25
0.64
0.28
0.66
0.24
0.09
0.22
0.44
0.22
0.12
0.20
0.98
0.58
0.77
0.94
0.60
0.27
0.18
0.67
0.57
0.94
1.35
0.96
0.35
0.27
0.25
0.26
1.22
0.27
0.82
1.10
1.13
0.13
0.47
0.13
0.20
0.51
0.22
0.36
0.80
0.41
0.46
0.15
0.57
0.16
0.20
0.25
0.29
0.27
0.62
0.30
1.23
0.73

1.14
0.95
0.94
1.05
0.61
1.38
0.42
1.45
1.29
0.94
0.82
1.04
1.22
1.00
0.67
1.05
0.92
0.59
1.26
0.82
0.97
0.86
1.46
0.54
0.55
0.39
0.80
0.90
0.91
1.27
0.44
0.76
0.95
0.62
0.76
0.99
0.86
0.80
1.03
0.79
1.31
1.47
0.86
1.05
1.33
1.02
1.03
1.23
1.00
0.91
1.04
0.88
0.91
1.01
1.63
0.93
0.94
0.69
1.21
1.04
1.35
0.96
1.52
1.07

0.02
0.04
0.03
0.07
0.07
0.12
0.33
0.09
0.02
0.20
0.07
0.04
0.09
0.04
0.10
0.03
0.01
0.03
0.07
0.03
0.02
0.03
0.15
0.08
0.10
0.16
0.09
0.04
0.03
0.10
0.09
0.14
0.18
0.16
0.05
0.04
0.04
0.04
0.16
0.04
0.12
0.16
0.17
0.02
0.07
0.02
0.03
0.07
0.03
0.05
0.12
0.06
0.07
0.02
0.08
0.02
0.03
0.04
0.04
0.04
0.09
0.04
0.17
0.10

9366
1071
1669
509
194
172
0
487
4719
48
497
1438
328
1086
85
1830
10405
728
689
1409
7459
2135
183
115
63
23
195
1464
2556
287
59
59
36
28
527
1504
1213
1237
70
1156
239
173
62
6816
603
6125
2253
573
1654
613
208
390
408
4446
634
3723
1967
993
1512
1321
400
908
134
216

8.1
9.0
8.1
8.0
4.6
8.2
9.8
8.0
6.6
9.1
6.6
7.4
6.3
5.7
7.6
7.3
4.9
8.9
7.0
7.7
7.3
10.0
5.2
5.0
3.8
6.9
7.6
6.8
7.8
4.0
4.8
4.6
4.1
6.3
7.5
7.0
6.6
6.7
6.6
8.3
8.7
7.5
7.0
8.0
6.8
6.9
7.9
6.6
6.5
8.0
5.9
7.3
7.4
9.5
7.1
6.9
6.1
7.7
6.6
8.0
6.1
9.3
6.7

0.10
0.30
0.23
0.42
0.38
0.66
0.52
0.13
1.08
0.49
0.20
0.45
0.22
0.64
0.20
0.08
0.19
0.36
0.19
0.11
0.18
0.80
0.52
0.66
0.86
0.52
0.24
0.15
0.49
0.58
0.65
0.87
0.79
0.29
0.24
0.22
0.22
0.82
0.23
0.61
0.75
1.11
0.10
0.34
0.11
0.16
0.36
0.18
0.28
0.59
0.33
0.41
0.13
0.40
0.14
0.17
0.23
0.22
0.20
0.43
0.23
0.85
0.53

0.86
0.96
0.86
0.86
0.52
1.07
1.09
0.82
0.83
1.02
0.75
0.82
0.72
0.66
0.85
0.83
0.56
1.02
0.79
0.87
0.81
1.10
0.61
0.64
0.50
0.80
0.83
0.75
0.92
0.34
0.53
0.47
0.53
0.69
0.84
0.77
0.73
0.72
0.72
0.92
0.96
0.80
0.76
0.88
0.75
0.75
0.91
0.70
0.73
0.93
0.66
0.83
0.81
1.06
0.78
0.79
0.68
0.87
0.72
0.87
0.67
1.04
0.77

0.01
0.04
0.03
0.06
0.06
0.10
0.07
0.02
0.18
0.07
0.03
0.06
0.03
0.10
0.03
0.01
0.03
0.05
0.03
0.02
0.03
0.11
0.08
0.10
0.13
0.08
0.03
0.02
0.07
0.07
0.10
0.11
0.12
0.04
0.03
0.03
0.03
0.12
0.03
0.09
0.11
0.16
0.01
0.05
0.01
0.02
0.05
0.03
0.04
0.09
0.05
0.06
0.02
0.06
0.02
0.03
0.03
0.03
0.03
0.06
0.03
0.12
0.08

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

666

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other and unspecified (O&U) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

490
2039
2938
390
2495
992
251
718
1866
199
1655
285
67689
6912
58753
2483
310
2113
519
21
157
331
4701
576
3984
3928
378
3462
972
1049
4342
394
3864
349
6253
668
5102
19199
957
1930
1550
14585
1276
328
935
5675
640
4918
310
184
1260
762
656
2376

9.4
8.7
8.7
11.6
8.3
7.5
10.1
6.8
9.0
13.6
8.6
7.6
8.7
11.2
8.5
8.3
11.0
8.1
8.3
5.6
8.1
8.8
7.1
8.6
7.0
9.6
11.5
9.3
8.0
8.0
8.7
12.8
8.3
8.8
7.0
10.1
6.8
7.9
5.3
10.6
7.2
8.0
9.6
11.8
8.9
9.4
12.5
9.1
5.3
8.2
6.1
5.5
8.9
11.3

0.45
0.21
0.17
0.61
0.18
0.25
0.66
0.27
0.22
0.99
0.23
0.48
0.04
0.14
0.04
0.18
0.63
0.19
0.38
1.26
0.66
0.51
0.11
0.36
0.12
0.16
0.61
0.17
0.27
0.27
0.14
0.66
0.15
0.52
0.09
0.40
0.10
0.06
0.18
0.25
0.19
0.07
0.28
0.67
0.30
0.13
0.51
0.13
0.32
0.65
0.18
0.21
0.37
0.25

1.07
0.93
0.98
1.39
0.92
0.84
1.18
0.75
0.98
1.62
0.93
0.85
0.98
1.32
0.95
0.93
1.28
0.90
0.95
0.45
0.88
1.03
0.79
1.01
0.77
1.08
1.31
1.04
0.93
0.90
0.98
1.62
0.92
0.91
0.79
1.16
0.76
0.89
0.59
1.23
0.81
0.90
1.08
1.39
0.98
1.06
1.53
1.02
0.60
0.82
0.69
0.60
1.00
1.18

0.07
0.03
0.02
0.09
0.02
0.04
0.09
0.04
0.03
0.15
0.03
0.07
0.01
0.02
0.01
0.02
0.09
0.03
0.05
0.16
0.10
0.07
0.02
0.05
0.02
0.02
0.08
0.02
0.04
0.04
0.02
0.10
0.02
0.07
0.01
0.06
0.01
0.01
0.03
0.04
0.03
0.01
0.04
0.10
0.04
0.02
0.08
0.02
0.05
0.08
0.03
0.03
0.05
0.04

541
2615
3425
421
2952
1204
283
901
2197
226
1954
320
76745
7787
66703
3062
380
2620
550
38
160
342
6121
770
5209
4545
460
4002
1017
1284
5550
496
4958
421
7716
790
6376
22584
1056
2209
1881
17206
1228
315
902
5785
677
4981
392
212
1510
995
725
2076

7.4
7.5
7.4
8.7
7.2
6.3
7.6
5.9
7.3
9.9
7.0
6.4
7.1
8.2
7.0
6.8
8.9
6.7
6.8
7.8
6.4
7.2
6.2
6.8
6.2
7.9
9.4
7.6
6.1
7.4
7.6
10.1
7.3
6.8
6.3
8.0
6.2
6.8
4.6
8.3
6.9
6.8
6.4
6.8
6.2
7.0
8.7
6.8
5.2
6.8
5.8
5.6
6.7
7.5

0.37
0.18
0.14
0.45
0.15
0.21
0.49
0.23
0.18
0.71
0.19
0.42
0.03
0.10
0.03
0.14
0.48
0.16
0.32
1.32
0.54
0.50
0.09
0.26
0.10
0.13
0.47
0.14
0.22
0.24
0.12
0.49
0.13
0.41
0.08
0.30
0.09
0.05
0.15
0.19
0.17
0.06
0.20
0.42
0.23
0.10
0.36
0.11
0.29
0.53
0.17
0.20
0.29
0.19

0.79
0.82
0.86
1.02
0.83
0.71
0.92
0.65
0.79
1.13
0.76
0.69
0.79
0.92
0.77
0.74
0.99
0.71
0.71
0.76
0.67
0.74
0.67
0.76
0.67
0.89
1.05
0.86
0.67
0.82
0.84
1.10
0.81
0.75
0.70
0.93
0.69
0.76
0.52
0.95
0.78
0.76
0.69
0.71
0.68
0.76
0.95
0.73
0.55
0.72
0.66
0.65
0.71
0.85

0.05
0.02
0.02
0.07
0.02
0.03
0.07
0.03
0.03
0.10
0.03
0.06
0.00
0.01
0.00
0.02
0.07
0.02
0.04
0.19
0.08
0.06
0.01
0.04
0.01
0.02
0.07
0.02
0.03
0.04
0.02
0.07
0.02
0.06
0.01
0.05
0.01
0.01
0.02
0.03
0.02
0.01
0.03
0.06
0.03
0.01
0.05
0.02
0.04
0.07
0.03
0.03
0.04
0.03

45
459
2433
21
58
1436
38
100
622
1808
115
1207
456
334
251
1672
1516
109
221
86
127
361
236
1205
175

7.4
8.4
10.9
1.6
2.5
6.0
1.2
4.2
6.8
8.7
13.8
5.7
11.6
5.4
9.4
9.6
9.5
7.1
5.8
2.0
3.1
3.4
3.2
3.2
2.7

1.15
0.40
0.23
0.36
0.34
0.17
0.20
0.44
0.28
0.22
1.30
0.17
0.57
0.30
0.60
0.25
0.26
0.71
0.40
0.25
0.29
0.19
0.24
0.10
0.24

0.94
0.94
1.20
0.19
0.29
0.63
0.17
0.50
0.84
1.03
1.74
0.69
1.36
0.62
1.23
1.10
1.10
0.87
0.63
0.20
0.32
0.33
0.32
0.32
0.25

0.18
0.05
0.03
0.05
0.04
0.02
0.03
0.06
0.04
0.03
0.19
0.03
0.08
0.04
0.09
0.04
0.04
0.12
0.05
0.03
0.04
0.02
0.03
0.01
0.03

24
372
1989
17
35
1476
37
86
330
1100
73
802
280
268
171
1982
1814
101
210
101
114
345
216
1242
184

4.2
6.0
7.3
1.3
1.4
5.1
1.1
2.9
3.6
6.1
8.0
3.9
7.1
4.3
5.7
8.4
8.4
6.1
4.3
1.7
2.3
2.3
1.9
2.3
2.1

0.87
0.32
0.18
0.32
0.24
0.15
0.19
0.34
0.20
0.19
0.95
0.14
0.44
0.27
0.44
0.21
0.22
0.63
0.33
0.23
0.26
0.16
0.18
0.07
0.23

0.41
0.70
0.76
0.13
0.17
0.54
0.13
0.32
0.43
0.71
0.96
0.46
0.75
0.50
0.70
0.88
0.88
0.72
0.42
0.15
0.24
0.21
0.17
0.22
0.19

0.11
0.04 *
0.02
0.04 *
0.03
0.02 *
0.03 *
0.05 *
0.03
0.03 *
0.14
0.02
0.05 *
0.04 *
0.06 *
0.03
0.03
0.09
0.04
0.02
0.03
0.02
0.02
0.01
0.02

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

609

667

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other and unspecified (O&U) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

610

Female
ASR(W)
CUM 0-74

5170
456
357
147
180
234
41
1298
60
67
76
300
284
106
480
741
431
360
28
43
856
301
152
156
588

6.2
6.2
7.3
5.8
7.5
4.9
5.8
6.7
5.4
5.8
6.9
15.4
8.0
6.1
18.5
10.7
5.5
5.9
4.0
4.6
21.4
13.8
5.6
5.3
7.5

0.09
0.32
0.40
0.50
0.59
0.34
0.95
0.20
0.82
0.79
1.33
0.92
0.49
0.61
0.90
0.43
0.27
0.31
0.79
0.73
0.75
0.81
0.46
0.43
0.32

0.72
0.74
0.84
0.67
0.85
0.56
0.69
0.74
0.56
0.54
0.49
1.80
0.96
0.78
2.35
1.22
0.60
0.66
0.42
0.50
2.47
1.62
0.68
0.66
0.96

0.01
0.05
0.06
0.07
0.08
0.05
0.14
0.03
0.10
0.11
0.12
0.13
0.07
0.09
0.14
0.06
0.04
0.05
0.10
0.10
0.10
0.11
0.07
0.06
0.05

4260
440
302
132
149
222
35
1211
55
54
45
242
238
97
268
751
402
345
17
40
716
214
105
83
413

3.7
4.1
4.6
3.8
4.1
3.5
2.9
4.7
3.0
4.7
8.4
10.6
6.1
5.8
13.2
8.9
4.2
4.2
3.6
4.4
17.3
9.0
3.3
2.8
4.9

0.06
0.20
0.27
0.34
0.35
0.24
0.51
0.14
0.42
0.68
1.56
0.69
0.41
0.61
0.87
0.34
0.21
0.23
0.90
0.70
0.66
0.63
0.33
0.32
0.24

0.40
0.46
0.51
0.42
0.49
0.37
0.27
0.51
0.35
0.44
0.82
1.11
0.65
0.77
1.50
1.07
0.42
0.40
0.42
0.56
2.08
1.05
0.37
0.34
0.57

0.01
0.03
0.04
0.05
0.05
0.03
0.06
0.02
0.07
0.09
0.20
0.09
0.05
0.10 *
0.12 *
0.05 *
0.03
0.03
0.13
0.10
0.09 *
0.08 *
0.04
0.04 *
0.03 *

1342
104
56
2094
448
2478
3567
1786
3481
2843
372
1259
390
208
124
161
327
354
641
182
264
171
283
800
1601
451
608
1037
835
453
53
1824
88
53
142
417
274
70
386
247
165
1075
143
100
123
348
229
167
75
61
315
181
156
630

4.4
4.1
4.8
7.2
6.3
12.2
11.2
10.9
9.6
12.2
8.5
6.0
10.9
8.9
6.7
6.1
8.4
8.4
15.8
8.7
13.1
9.1
12.0
8.0
8.3
6.3
9.2
10.7
7.9
9.4
5.2
14.2
8.3
2.3
7.0
5.9
8.3
6.9
7.1
6.8
10.6
10.3
5.7
7.6
4.6
5.8
6.6
8.2
5.3
8.7
5.9
4.0
7.1
8.3

0.13
0.41
0.65
0.16
0.31
0.26
0.20
0.26
0.17
0.24
0.45
0.17
0.57
0.64
0.61
0.49
0.50
0.46
0.65
0.69
0.84
0.77
0.77
0.29
0.22
0.31
0.38
0.34
0.28
0.46
0.75
0.34
0.94
0.34
0.77
0.32
0.63
0.92
0.39
0.46
0.83
0.33
0.55
0.81
0.44
0.35
0.46
0.69
0.65
1.19
0.35
0.34
0.58
0.36

0.46
0.40
0.55
0.91
0.76
1.43
1.36
1.23
1.08
1.36
0.95
0.60
1.19
1.00
0.81
0.71
0.94
0.90
1.95
1.01
1.48
1.06
1.47
0.89
0.89
0.70
1.03
1.18
0.85
1.02
0.67
1.58
0.87
0.28
0.65
0.59
0.82
0.73
0.68
0.70
1.22
1.13
0.57
0.94
0.54
0.63
0.74
0.85
0.62
0.89
0.54
0.39
0.81
0.86

0.02
0.06
0.09
0.02
0.04
0.04
0.03
0.03
0.02
0.04
0.06
0.02
0.08
0.08
0.09
0.07
0.07
0.06
0.09
0.09
0.11
0.11
0.10
0.04
0.03
0.04
0.05
0.05
0.04
0.06
0.12
0.05
0.13
0.04
0.08
0.04
0.07
0.12
0.05
0.06
0.12
0.05
0.07
0.12
0.07
0.05
0.06
0.09
0.09
0.14
0.05
0.04
0.08
0.05

1754
164
63
1396
424
2369
2480
1578
3820
3164
322
1915
324
119
105
127
208
282
424
147
194
181
187
850
1988
544
692
1092
1070
476
84
1990
92
76
191
463
307
75
505
264
141
1047
161
83
133
375
230
165
50
68
367
157
167
656

3.2
3.7
3.9
3.0
4.5
10.0
6.0
6.3
6.8
10.1
4.3
5.5
5.8
3.5
3.8
3.5
4.0
4.6
7.6
4.9
6.7
6.5
6.6
4.9
5.6
4.3
6.3
7.3
5.9
6.0
7.3
11.6
4.4
2.1
6.3
4.3
5.8
5.2
4.5
4.8
6.8
6.2
3.7
4.8
3.0
4.1
5.0
5.6
3.0
4.6
4.5
2.0
4.8
4.7

0.10
0.35
0.58
0.09
0.25
0.24
0.13
0.18
0.12
0.21
0.29
0.15
0.38
0.37
0.43
0.36
0.33
0.32
0.41
0.48
0.57
0.61
0.56
0.20
0.15
0.23
0.28
0.27
0.22
0.32
0.89
0.29
0.56
0.31
0.65
0.28
0.43
0.76
0.24
0.40
0.60
0.24
0.39
0.60
0.34
0.29
0.38
0.50
0.54
0.68
0.29
0.20
0.50
0.23

0.28
0.27
0.35
0.36
0.53
1.06
0.71
0.62
0.71
1.14
0.49
0.56
0.58
0.38
0.43
0.38
0.39
0.46
0.91
0.55
0.76
0.66
0.76
0.49
0.56
0.44
0.63
0.73
0.55
0.62
0.82
1.24
0.44
0.17
0.65
0.39
0.55
0.53
0.37
0.43
0.65
0.61
0.32
0.48
0.26
0.40
0.54
0.56
0.28
0.36
0.43
0.19
0.50
0.42

0.01
0.04
0.07
0.01 *
0.03 *
0.03
0.02 *
0.02
0.02
0.03
0.03
0.02
0.05
0.05
0.06
0.05
0.04
0.04
0.06
0.06
0.07
0.08
0.07
0.03
0.02
0.03
0.03
0.03
0.03
0.04
0.13
0.04
0.08
0.03
0.07
0.03
0.05
0.09
0.03
0.05
0.08
0.03
0.05
0.08
0.04
0.04
0.05
0.07
0.06
0.08
0.04
0.03
0.06
0.03

*Important. See note on population page.

668

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

Other and unspecified (O&U) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

566
893
169
1568
450
586
513
452
1200
664
1178
1313
294
118
898
952
598
72
305
349
410
233
226
188
4238
110
58
60
160
128
83
188
7606
462
609
1603
1087
3183
4349
1354
4029
7991
3014
3213
811
3125

7.5
8.3
12.3
7.7
18.2
13.5
8.2
4.5
10.3
4.9
6.9
8.4
4.4
8.5
17.0
13.1
12.5
5.0
11.7
10.5
9.4
8.6
10.2
4.8
10.0
7.0
5.8
7.5
7.6
9.1
7.7
7.2
12.5
12.5
16.7
11.9
10.1
17.8
14.6
12.1
11.9
13.5
13.4
13.5
13.3
14.1

0.32
0.28
0.97
0.21
0.88
0.58
0.37
0.22
0.32
0.20
0.22
0.24
0.27
0.86
0.62
0.44
0.53
0.69
0.73
0.60
0.49
0.61
0.73
0.39
0.17
0.70
0.81
1.05
0.64
0.84
0.88
0.57
0.15
0.59
0.70
0.32
0.32
0.33
0.23
0.34
0.21
0.16
0.26
0.25
0.49
0.26

0.91
0.99
1.59
0.81
2.06
1.61
0.90
0.52
1.15
0.59
0.77
1.00
0.47
0.92
1.87
1.47
1.38
0.48
1.24
1.21
1.02
0.92
1.12
0.57
1.19
0.74
0.69
0.69
0.80
1.01
0.93
0.70
1.46
1.49
1.93
1.25
1.06
1.99
1.58
1.27
1.26
1.44
1.43
1.46
1.47
1.52

0.04
0.04
0.15
0.03
0.12
0.08
0.05
0.03
0.04
0.03
0.03
0.03
0.03
0.11
0.08
0.06
0.07
0.09
0.10
0.08
0.07
0.08
0.10
0.05
0.02
0.09
0.13
0.14
0.09
0.12
0.13
0.07
0.02
0.09
0.10
0.04
0.05
0.05
0.03
0.05
0.03
0.02
0.04
0.04
0.07
0.04

462
767
169
2025
495
506
544
363
1031
852
1137
1266
350
106
648
716
430
74
247
275
347
214
186
141
5339
135
69
68
142
149
78
215
7267
420
534
1795
1048
3650
5017
1555
4836
9407
3469
3511
975
3777

3.6
4.3
9.5
6.9
12.2
8.1
5.6
2.7
6.5
3.4
5.7
5.2
3.2
5.8
7.6
6.5
6.4
4.2
6.9
5.8
5.6
5.4
6.2
2.2
9.9
4.9
4.6
6.1
4.5
5.9
4.6
5.7
9.1
8.7
11.0
9.9
6.9
14.6
11.8
10.1
10.2
11.0
11.2
10.7
11.1
11.2

0.20
0.18
0.81
0.19
0.59
0.40
0.27
0.16
0.23
0.15
0.19
0.16
0.20
0.72
0.37
0.28
0.33
0.68
0.56
0.43
0.34
0.49
0.64
0.23
0.16
0.49
0.66
0.89
0.47
0.61
0.60
0.47
0.12
0.45
0.53
0.28
0.25
0.28
0.20
0.30
0.18
0.14
0.22
0.21
0.41
0.21

0.40
0.49
0.97
0.72
1.31
0.90
0.62
0.32
0.66
0.37
0.62
0.53
0.31
0.51
0.78
0.61
0.61
0.38
0.63
0.57
0.58
0.51
0.49
0.20
1.17
0.45
0.49
0.62
0.46
0.51
0.43
0.60
1.04
0.95
1.23
1.01
0.72
1.67
1.29
1.05
1.07
1.19
1.21
1.18
1.22
1.19

0.02
0.02
0.10
0.03
0.08 *
0.05
0.03
0.02 *
0.03
0.02
0.02
0.02
0.02
0.08
0.05
0.04
0.05
0.08
0.07
0.05
0.05
0.06
0.06
0.03
0.02
0.07
0.09
0.12
0.06
0.08
0.08
0.06
0.02
0.06
0.07
0.04
0.03
0.04
0.03
0.04
0.02
0.02
0.03
0.03
0.06
0.03

3230
72
1430
674
215
1774
610
122
53
1579
273
9
42
66
60
77

12.9
20.2
11.0
10.4
10.8
9.5
9.3
14.0
13.3
11.7
5.9
1.9
6.3
13.1
3.8
6.0

0.24
2.52
0.30
0.43
0.77
0.24
0.39
1.31
1.94
0.31
0.38
0.72
1.03
1.65
0.62
0.72

1.45
2.49
1.22
1.14
1.01
1.01
0.98
1.49
1.37
1.28
0.72
0.18
0.86
1.47
0.42
0.76

0.03
0.38
0.04
0.06
0.10
0.03
0.06
0.19
0.25
0.04
0.06
0.10
0.16
0.23
0.08
0.11

3121
52
1375
766
233
1904
549
108
47
1724
251
25
23
39
65
75

9.7
17.9
8.5
9.0
9.4
7.8
6.4
9.4
10.7
10.0
4.2
3.3
3.1
6.7
2.5
5.3

0.20
2.63
0.25
0.38
0.70
0.20
0.30
0.97
1.60
0.27
0.30
0.74
0.66
1.11
0.39
0.69

1.04
2.54
0.87
0.93
0.96
0.81
0.62
0.96
1.17
1.09
0.49
0.30
0.40
0.83
0.29
0.63

0.03
0.46
0.04
0.05
0.10
0.03
0.04
0.14
0.23
0.04
0.04
0.12
0.10
0.17
0.06
0.11

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

611

669

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

All sites (C00-96)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

1998
7170
1512
2223
4435

94.0
162.9
159.6
157.5
205.5

2.22
2.06
4.17
4.39
3.94

2365
9206
2036
6295
89421
2185
7792
16831
4990
3802
1452

275.1
450.8
329.1
458.4
441.4
242.4
224.7
222.3
178.0
314.3
159.8

5.95
5.15
7.65
5.94
1.58
5.28
2.66
1.77
2.63
5.29
4.33

338.3 0.67
335.1 1.98
311.5 1.50
456.1 3.48
355.6 3.79
313.8 4.27
259.5 19.52
380.2 3.47
334.4 0.95
363.7 8.93
321.5 3.09
344.1 1.58
376.1 3.87
332.9 1.73
353.7 5.13
308.0 1.39
341.6 0.61
222.2 1.44
423.1 2.80
267.2 1.35
367.8 0.80
338.6 1.36
411.4 5.82
224.3 3.86
232.4 5.31
225.8 9.08
280.1 3.75
366.3 1.83
338.5 1.19
448.5 4.32
205.7 4.44
265.2 6.05
268.9 7.88
230.9 6.72
266.3 2.18
375.0 1.83
335.2 1.70
391.7 1.93
431.8 8.09
388.0 2.01
442.0 5.29
497.4 7.09
320.3 7.83
370.7 0.81
404.5 2.83
368.1 0.86
369.7 1.32
440.1 3.29
355.2 1.47
378.6 2.48
445.8 5.54
365.4 2.89
340.7 2.97
373.5 1.02
442.1 3.28
362.6 1.09
354.1 1.40
361.3 1.96
407.4 1.81
403.6 1.78
453.9 3.87
391.2 2.03
457.8 7.16
388.4 4.63

275145
30369
47439
19207
9638
5784
196
13118
134782
1811
12801
50875
10053
39857
5148
55282
344567
25289
23702
42913
243207
68192
5266
3778
2051
776
6067
46120
88323
11073
2412
2073
1584
1223
16380
49689
41622
46838
2948
43013
7527
5313
1882
252570
20979
228235
81730
19084
61662
24914
7226
17092
14337
146682
18815
123103
69755
39254
54223
55109
14466
40191
4284
7967

612

Female
ASR(W)
CUM 0-74

1912
6765
1093
2810
3866

84.7
121.8
106.0
173.5
199.4

2.03
1.53
3.27
4.14
4.09

32.18
51.93
40.00
52.69
51.71
27.64
26.19
24.67
20.15
39.20
18.81

0.82
0.76
1.18
0.88
0.23
0.77
0.40
0.26
0.39
0.78
0.67

2493
10535
2017
7282
98563
2072
9636
16531
6069
2691
2173

240.3
376.8
263.3
389.3
347.1
203.7
211.8
199.1
183.0
189.9
190.3

5.29
4.00
6.20
4.69
1.19
4.60
2.25
1.60
2.47
3.89
4.22

26.41
42.64
29.76
42.25
38.34
22.20
23.76
21.37
20.32
20.61
21.60

0.63
0.58
0.89
0.66
0.16
0.61
0.31
0.22
0.34
0.48
0.60 *

40.76
40.59
37.13
54.53
43.45
39.33
33.42
45.34
40.49
43.99
38.39
42.50
46.94
41.02
43.64
37.35
41.57
26.55
53.02
32.35
44.68
41.28
51.49
26.62
28.48
27.78
33.68
44.77
41.21
56.31
23.65
32.62
32.01
28.07
32.37
45.40
40.95
48.08
54.07
47.53
54.46
60.98
39.79
45.38
50.53
44.95
45.69
54.79
43.85
46.76
55.00
45.18
41.46
45.93
54.82
44.49
43.57
44.09
49.71
49.24
55.78
47.60
56.48
47.64

0.10
0.29
0.22
0.51
0.56
0.63
3.09
0.50
0.14
1.29
0.45
0.23
0.57
0.25
0.78
0.20
0.09
0.21
0.42
0.21
0.11
0.20
0.88
0.55
0.79
1.34
0.57
0.27
0.18
0.65
0.64
0.92
1.06
1.02
0.34
0.26
0.25
0.28
1.21
0.29
0.77
1.00
1.18
0.11
0.42
0.12
0.20
0.50
0.22
0.38
0.86
0.44
0.44
0.15
0.48
0.16
0.20
0.28
0.26
0.26
0.58
0.29
1.06
0.66

249053
26901
41466
17636
8318
4577
185
11591
125992
1588
10799
46382
9096
36501
4628
50440
327502
26805
19127
44719
232115
65969
4386
3546
2108
963
6232
45112
84936
9106
2333
2429
1550
1249
17571
48254
40098
45106
2577
41807
6885
4593
1987
218022
17456
197537
75178
16505
57610
24091
6600
16887
12601
142725
17765
120853
68746
37312
49728
47324
12401
34579
3823
7451

271.2 0.59
267.3 1.73
247.0 1.33
362.2 3.06
269.1 3.24
231.3 3.63
232.4 18.26
287.0 2.95
273.4 0.83
275.9 7.64
255.8 2.80
254.1 1.28
232.6 2.60
257.5 1.48
296.6 4.56
253.4 1.23
273.5 0.52
192.6 1.22
260.3 1.96
217.6 1.07
305.8 0.72
272.1 1.15
261.4 4.18
184.4 3.31
180.3 4.04
206.6 7.46
228.1 3.00
305.6 1.63
264.6 0.97
265.0 2.90
176.0 3.87
230.3 4.81
236.2 6.85
180.7 5.35
208.3 1.64
319.6 1.68
274.5 1.46
306.3 1.62
263.5 5.34
310.5 1.73
294.5 3.90
289.2 4.71
285.8 7.22
282.4 0.69
247.2 1.94
287.7 0.76
267.3 1.03
247.5 2.03
275.5 1.23
276.0 1.88
256.3 3.35
291.2 2.40
271.6 2.62
292.3 0.85
289.6 2.25
292.9 0.94
287.5 1.20
290.9 1.72
308.8 1.50
277.8 1.38
273.9 2.58
281.9 1.67
277.1 4.66
290.6 3.83

30.83
30.37
27.89
41.43
31.11
27.02
28.91
32.87
31.03
31.63
29.44
29.32
26.88
29.70
34.41
29.08
31.36
21.39
30.16
24.44
35.32
30.99
29.86
20.10
20.07
24.05
25.87
35.20
30.16
30.86
18.58
25.60
26.67
19.76
23.29
36.80
31.48
35.32
30.45
35.79
33.29
32.70
32.72
32.21
28.20
32.77
30.89
28.50
31.82
31.99
29.64
33.70
31.30
33.65
33.25
33.76
33.35
33.19
35.60
31.89
31.14
32.43
31.45
33.54

0.08
0.23
0.18
0.41
0.43
0.48
2.87
0.39
0.11
1.02
0.36
0.17
0.35
0.19
0.66
0.16
0.07
0.16
0.27
0.15
0.09
0.15
0.57
0.42
0.52
0.94
0.42
0.22
0.13
0.40
0.50
0.61
0.83
0.69
0.23
0.21
0.20
0.21
0.74
0.23
0.51
0.60
0.99
0.09
0.27
0.09
0.14
0.28
0.16
0.27
0.49
0.33
0.35
0.11
0.31
0.12
0.16
0.22
0.20
0.18
0.35
0.22
0.64
0.49

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

670

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

All sites (C00-96) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

18958
83650
128563
16315
109126
56025
12644
42507
68150
6183
61375
12123
2686175
260784
2324530
117613
13191
100666
18988
640
5110
12840
236554
28983
200510
139168
13229
120447
41564
43120
181129
14757
162003
15177
312187
30233
258954
839579
40402
80696
59469
643810
49964
12350
36947
200621
21177
174615
17690
7759
71096
48290
26569
67434

393.9
393.5
394.9
494.6
379.8
438.8
519.9
422.4
357.6
443.3
351.5
358.7
366.7
430.1
360.5
411.8
478.2
408.7
318.0
184.5
277.3
355.9
378.8
437.8
378.5
360.5
413.1
343.8
348.7
360.4
392.0
484.9
379.4
409.2
370.4
465.4
372.1
366.2
229.2
454.4
276.8
379.4
387.4
452.8
367.7
343.9
419.3
337.2
316.8
368.0
374.0
375.9
376.4
365.8

3.02
1.44
1.15
4.00
1.21
1.95
4.80
2.17
1.43
5.76
1.49
3.44
0.23
0.86
0.25
1.27
4.22
1.38
2.40
7.50
3.97
3.37
0.82
2.61
0.90
1.01
3.68
1.04
1.79
1.84
0.99
4.10
1.02
3.57
0.70
2.76
0.77
0.42
1.18
1.63
1.18
0.50
1.78
4.18
1.98
0.79
2.96
0.83
2.48
4.36
1.47
1.79
2.43
1.49

48.34
48.79
48.61
61.81
46.69
54.13
65.50
51.73
44.04
55.05
43.24
43.81
44.96
53.69
44.12
50.63
60.32
50.09
38.92
21.59
33.59
43.56
46.15
54.43
46.03
44.23
51.96
42.03
42.41
44.39
48.32
61.14
46.69
50.07
45.33
58.27
45.49
44.75
27.31
56.76
33.59
46.29
47.74
56.90
45.09
42.10
52.22
41.21
38.89
44.90
45.77
45.79
45.85
45.01

0.44
0.21
0.17
0.60
0.18
0.29
0.72
0.32
0.21
0.85
0.21
0.50
0.03
0.13
0.04
0.18
0.63
0.20
0.35
1.11
0.59
0.47
0.12
0.39
0.13
0.15
0.54
0.15
0.26
0.27
0.14
0.60
0.14
0.52
0.10
0.42
0.11
0.06
0.18
0.25
0.18
0.07
0.26
0.63
0.28
0.12
0.45
0.12
0.37
0.63
0.22
0.27
0.35
0.22

17375
83775
115047
13343
99568
49400
10216
38551
65573
5798
59111
10517
2519943
227098
2201064
109504
11131
94985
16661
708
4437
11200
235446
27323
201213
135728
11881
120100
38428
41351
170312
13041
153676
14412
290580
25281
243156
782044
42010
67270
60468
602779
42401
9751
32096
183968
18766
160260
15155
7435
67409
45844
24719
62680

306.6
311.6
295.0
292.7
294.8
307.5
295.2
315.3
280.8
281.9
281.6
283.3
285.0
262.3
288.7
307.0
278.2
316.0
247.3
155.8
208.7
286.2
296.5
266.3
307.4
286.1
265.6
282.7
271.7
301.4
300.7
293.1
298.3
309.2
286.7
274.0
296.7
283.2
196.4
270.9
221.5
303.3
267.9
244.8
274.7
260.8
265.2
260.5
241.1
299.9
308.7
308.1
296.3
289.0

2.59
1.21
0.95
2.66
1.03
1.52
3.09
1.80
1.21
3.90
1.29
3.05
0.20
0.57
0.22
1.03
2.72
1.16
2.04
6.01
3.25
3.04
0.67
1.67
0.77
0.86
2.56
0.91
1.52
1.63
0.83
2.72
0.88
2.95
0.58
1.81
0.67
0.35
0.99
1.09
0.93
0.44
1.39
2.62
1.67
0.65
2.03
0.70
2.08
3.80
1.29
1.56
2.10
1.29

35.37
35.88
34.02
33.90
33.96
35.42
34.29
36.22
32.48
32.56
32.56
32.85
32.77
30.26
33.22
35.09
32.06
36.11
28.16
17.29
23.28
32.60
33.96
30.61
35.24
33.20
31.08
32.79
31.50
35.02
34.50
33.93
34.21
35.41
32.89
31.73
34.09
32.50
21.90
31.29
24.86
34.91
30.73
27.93
31.51
29.92
30.66
29.89
27.22
34.24
35.75
35.64
34.21
33.32

0.34
0.16
0.13
0.37
0.14
0.20
0.42
0.23
0.16
0.53
0.17
0.41
0.03
0.08
0.03
0.13
0.38
0.15
0.27
0.83
0.43
0.38
0.09
0.23
0.10
0.11
0.35
0.12
0.20
0.22
0.11
0.36
0.11
0.38
0.08
0.25
0.09
0.05
0.13
0.15
0.13
0.06
0.18
0.35
0.21
0.09
0.28
0.09
0.28
0.50
0.18
0.21
0.27
0.17

952
14409
58043
2611
4487
53948
5958
4854
9868
24525
995
22464
4079
5655
2593
49005
44374
2853
9474
10694
14450
32173
22523
95427
19083

160.1
262.2
265.3
204.6
193.8
225.6
181.2
210.1
106.6
116.5
115.9
102.2
100.6
88.2
96.6
291.4
291.8
183.4
243.3
255.4
346.8
301.5
300.1
256.1
281.4

5.35
2.25
1.14
4.16
3.00
1.04
2.40
3.18
1.09
0.79
3.72
0.71
1.63
1.22
1.91
1.37
1.46
3.63
2.55
2.66
2.96
1.77
2.17
0.86
2.23

18.58
29.35
30.29
25.20
22.63
25.90
21.39
24.72
12.60
13.79
14.53
11.96
11.65
10.17
11.70
34.72
34.74
22.34
28.62
29.91
41.83
35.21
35.58
29.73
33.28

0.79
0.30
0.15
0.58
0.40
0.14
0.32
0.45
0.15
0.11
0.55
0.10
0.22
0.17
0.27
0.20
0.21
0.57
0.36
0.36
0.43
0.24
0.29
0.12
0.30

957
10312
46991
1520
3548
45867
3810
4583
10633
23406
749
22062
4196
6520
2604
52806
49053
2439
7024
8033
10507
22714
17037
66574
13873

143.7
165.8
196.1
111.7
141.1
175.4
108.2
188.7
115.7
124.3
80.0
104.5
102.3
101.2
85.2
273.7
282.2
134.5
166.2
166.2
214.1
189.4
189.9
152.1
179.0

4.86
1.68
0.97
3.02
2.43
0.90
1.82
2.96
1.14
0.86
2.97
0.72
1.62
1.29
1.69
1.26
1.37
2.85
2.12
2.21
2.26
1.42
1.75
0.66
1.87

16.15
18.05
21.04
13.37
16.39
19.62
12.02
20.93
13.18
14.22
9.12
11.83
11.16
11.58
9.57
30.84
31.87
15.03
18.37
18.25
23.69
20.57
20.51
16.51
19.54

0.67
0.21 *
0.12
0.40 *
0.33
0.11 *
0.23 *
0.37 *
0.15
0.12 *
0.39
0.10
0.20 *
0.17 *
0.22 *
0.16
0.17
0.39
0.27
0.26
0.28
0.17
0.20
0.08
0.21

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

613

671

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

All sites (C00-96) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

614

Female
ASR(W)
CUM 0-74

243346
22186
15093
7143
7639
12877
1894
59887
3832
1309
1674
3511
4799
1928
4570
14343
18524
16174
792
1558
5764
3617
2979
5325
16862

284.5
273.7
293.2
277.3
301.3
267.6
256.8
298.3
288.2
121.4
103.3
184.6
129.3
105.1
166.6
213.3
230.3
257.0
108.4
166.6
148.1
165.9
109.2
182.0
213.6

0.59
2.00
2.51
3.45
3.62
2.49
6.09
1.32
5.21
3.59
4.70
3.21
1.93
2.50
2.65
1.94
1.72
2.06
4.06
4.37
1.99
2.80
2.02
2.54
1.67

34.60
33.09
35.29
33.84
36.96
32.45
31.22
34.68
35.03
13.44
9.85
21.86
15.24
12.58
20.03
25.14
25.91
29.35
11.16
18.54
17.10
19.73
12.79
21.99
26.50

0.09
0.29
0.37
0.52
0.54
0.37
0.90
0.19
0.79
0.51
0.54
0.47
0.28
0.37
0.39
0.29
0.24
0.30
0.47
0.60
0.26
0.39
0.29
0.36
0.24

185902
17437
12268
5967
6357
10959
1548
51125
3143
1662
1382
3988
4924
1697
4169
18872
18939
16474
795
1670
6699
3656
3104
3883
10715

164.7
158.2
175.9
168.4
175.6
167.6
144.9
190.7
165.4
128.6
135.4
171.8
124.3
90.7
192.0
207.9
197.3
206.0
141.7
157.9
159.1
154.3
97.7
125.8
124.5

0.39
1.22
1.61
2.24
2.25
1.65
3.84
0.87
3.11
3.38
5.28
2.77
1.82
2.35
3.23
1.60
1.47
1.66
5.28
4.02
2.00
2.61
1.78
2.05
1.22

18.20
17.75
19.56
18.71
19.62
18.60
15.11
21.29
18.70
14.12
14.69
19.12
13.72
10.43
21.51
23.69
21.06
22.10
15.38
16.70
17.94
17.33
10.62
14.18
14.12

0.05
0.16
0.22
0.30
0.30
0.22
0.46
0.12
0.43
0.47
0.74
0.37
0.24
0.34 *
0.42 *
0.23 *
0.19
0.22
0.68
0.50
0.25 *
0.33 *
0.23
0.27 *
0.16 *

100923
8845
4102
83984
20910
74128
76508
52071
142735
75917
14278
56395
13603
8068
6181
9136
12391
13093
15210
6560
7230
5332
7567
33357
58801
24147
23444
30859
37498
18015
2837
50202
4067
11675
8645
24241
12704
3727
20126
12505
5323
41765
8486
4271
8629
22131
10166
6796
4242
3400
17841
15898
8957
31928

335.6
382.5
361.2
287.4
287.4
365.2
238.5
320.5
394.4
347.3
322.1
280.8
385.3
342.5
334.8
352.5
323.4
328.7
375.3
312.2
352.4
297.7
309.7
330.5
308.4
341.0
353.3
327.3
359.7
385.1
298.6
407.5
422.4
472.0
433.8
399.4
416.5
383.9
392.8
401.8
345.6
431.0
391.1
329.3
380.2
419.4
295.3
349.4
315.8
461.1
388.4
351.4
433.9
445.4

1.10
4.17
5.73
1.01
2.09
1.41
0.91
1.45
1.07
1.33
2.74
1.23
3.38
4.00
4.42
3.78
3.14
2.98
3.17
4.17
4.37
4.59
3.84
1.87
1.33
2.29
2.37
1.93
1.92
3.00
5.89
1.87
7.22
4.55
5.25
2.87
4.18
7.08
3.03
3.93
4.79
2.25
4.77
5.44
4.52
3.15
3.09
4.44
5.16
8.19
3.17
3.16
4.79
2.65

39.85
46.19
44.01
35.25
34.12
43.53
28.54
37.70
46.86
40.08
39.42
32.04
47.10
41.50
40.30
42.39
38.75
38.97
45.81
36.73
42.37
35.38
37.87
39.12
36.29
39.81
41.87
38.22
41.69
45.38
35.22
47.50
50.58
56.56
51.44
46.66
48.68
45.76
45.54
48.62
41.65
51.25
46.31
38.74
45.46
49.29
34.96
41.76
37.92
56.38
45.98
41.58
50.77
53.04

0.15
0.59
0.82
0.14
0.29
0.19
0.12
0.19
0.15
0.19
0.38
0.17
0.48
0.56
0.62
0.53
0.43
0.42
0.44
0.55
0.60
0.61
0.52
0.25
0.18
0.32
0.32
0.27
0.26
0.40
0.85
0.27
0.97
0.63
0.70
0.38
0.54
0.94
0.40
0.54
0.67
0.31
0.64
0.74
0.61
0.42
0.42
0.62
0.71
1.16
0.42
0.42
0.66
0.37

93710
7450
3413
80489
16623
60301
69055
45175
135496
81492
15337
56933
10427
6207
4596
7329
9563
10454
11068
4781
5241
3881
5218
29805
57464
24225
20759
29529
34948
16391
2750
45548
3429
9797
7300
20320
10553
2831
19278
10409
4142
35731
7427
3220
7452
17706
8214
5392
3198
2780
15262
12700
7356
26927

235.1
253.4
238.8
188.0
216.3
278.7
190.4
220.4
285.9
331.9
226.8
226.6
246.3
222.0
218.9
243.0
236.7
234.0
232.9
204.4
222.3
208.1
213.0
227.2
220.2
262.3
233.9
250.3
264.9
274.9
284.5
324.8
287.4
325.8
329.9
303.1
292.1
263.6
289.8
308.4
232.6
301.2
314.2
235.2
305.8
314.1
218.4
251.9
227.5
308.5
281.7
263.8
288.6
305.8

0.88
3.27
4.48
0.72
1.87
1.27
0.79
1.15
0.85
1.29
2.03
1.07
2.64
3.14
3.55
3.12
2.72
2.50
2.44
3.45
3.42
3.97
3.34
1.50
1.10
1.96
1.83
1.65
1.63
2.48
5.83
1.64
6.02
3.79
4.81
2.58
3.67
6.03
2.53
3.57
3.76
1.90
4.58
4.68
4.24
2.84
2.69
3.79
4.46
6.72
2.76
2.87
3.90
2.19

26.02
27.58
26.37
21.24
24.56
30.78
21.48
24.31
32.37
38.26
25.88
24.81
27.80
24.93
24.16
27.34
26.27
25.84
26.09
22.50
25.14
22.62
23.97
25.27
24.54
29.82
25.85
27.87
29.20
30.71
31.81
36.68
32.07
35.92
36.54
32.78
32.05
28.84
32.30
34.18
25.93
33.28
34.54
26.00
33.84
34.66
23.66
28.11
25.42
34.32
31.18
29.00
31.87
33.98

0.11
0.41
0.56
0.08 *
0.23 *
0.15
0.09 *
0.13
0.11
0.17
0.24
0.13
0.33
0.38
0.43
0.38
0.32
0.31
0.30
0.40
0.42
0.46
0.39
0.18
0.13
0.24
0.22
0.21
0.20
0.30
0.75
0.22
0.70
0.45
0.54
0.29
0.41
0.70
0.30
0.42
0.47
0.23
0.52
0.56
0.50
0.33
0.31
0.46
0.54
0.82
0.31
0.33
0.46
0.26

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp

*Important. See note on population page.

672

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

All sites (C00-96) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

21561
35364
4247
56101
7077
13212
14604
27124
32573
36569
45672
56329
23176
3206
16262
24800
13875
2611
9769
10643
14450
10197
8399
11808
112960
7495
2934
2928
7382
4110
4380
11173
180671
11857
11233
42553
30029
51419
105676
27818
125296
153763
72892
63447
21535
82051

282.6
327.9
314.6
306.2
286.8
310.4
239.0
259.2
286.0
263.8
258.0
358.2
339.6
249.9
320.7
351.6
299.4
221.7
400.4
334.7
350.3
413.2
389.9
310.8
274.2
487.3
318.5
430.6
372.3
315.3
417.1
462.4
306.8
323.2
314.1
339.6
299.0
303.6
378.1
267.3
396.6
279.2
344.7
282.0
365.0
399.1

1.96
1.77
4.99
1.40
3.49
2.78
2.07
1.67
1.69
1.41
1.27
1.54
2.27
4.87
2.77
2.36
2.60
5.24
4.42
3.48
3.06
4.44
4.69
3.13
0.90
5.83
6.29
8.51
4.56
5.25
6.55
4.64
0.75
3.04
3.08
1.77
1.83
1.41
1.23
1.68
1.22
0.76
1.37
1.19
2.59
1.46

34.63
39.58
36.78
35.47
34.12
37.89
29.38
31.17
33.29
32.25
30.74
42.87
40.24
28.57
37.22
41.14
35.26
25.37
47.07
40.40
40.51
49.26
45.01
36.82
32.59
57.88
36.57
51.32
44.01
37.18
49.80
55.22
36.58
38.45
37.54
38.64
34.06
35.23
43.62
30.65
44.93
31.78
39.04
32.72
42.36
46.35

0.27
0.25
0.71
0.20
0.48
0.39
0.28
0.23
0.22
0.19
0.16
0.22
0.31
0.64
0.36
0.31
0.36
0.65
0.60
0.47
0.41
0.61
0.63
0.41
0.13
0.83
0.88
1.19
0.66
0.72
0.92
0.66
0.11
0.43
0.43
0.25
0.25
0.20
0.17
0.24
0.17
0.11
0.19
0.17
0.37
0.20

22927
35963
3914
51515
8211
11163
16331
22281
26510
49126
43071
50203
21964
2043
10480
15630
10019
1592
6597
7896
10085
7151
5973
7976
103557
7323
2419
2679
6151
3767
3739
10547
170281
10593
9924
39434
29546
49763
100693
26649
118708
151471
69355
59509
21981
82865

195.9
230.3
249.9
253.4
241.0
209.0
200.1
182.9
202.8
201.6
226.7
239.0
243.4
157.1
181.2
196.8
190.5
151.6
252.4
227.5
218.9
272.3
264.6
188.3
242.1
378.8
226.1
324.8
264.8
233.7
311.7
365.8
254.5
259.8
251.0
289.2
251.1
254.7
308.0
232.9
330.3
235.2
291.6
239.9
307.7
323.5

1.45
1.32
4.24
1.28
2.86
2.16
1.71
1.34
1.41
1.02
1.18
1.13
1.79
4.05
2.16
1.79
2.02
4.95
3.61
2.88
2.41
3.77
4.04
2.50
0.87
4.89
5.28
7.24
3.80
4.43
5.58
4.01
0.67
2.69
2.76
1.67
1.66
1.30
1.11
1.57
1.13
0.69
1.27
1.11
2.30
1.27

22.47
25.85
28.14
28.60
27.05
23.27
23.08
20.02
21.71
22.65
25.25
26.99
27.27
16.57
19.80
21.03
20.88
16.03
27.59
25.24
23.93
29.31
28.59
20.43
27.78
42.57
24.69
36.53
29.96
25.90
35.37
41.40
28.86
29.51
28.41
32.49
28.11
28.76
34.52
26.00
36.58
26.31
32.70
26.89
34.53
36.41

0.17
0.16
0.54
0.16
0.35 *
0.26
0.21
0.16 *
0.16
0.12
0.13
0.14
0.22
0.46
0.24
0.21
0.25
0.52
0.43
0.34
0.29
0.44
0.48
0.28
0.11
0.62
0.65
0.89
0.49
0.53
0.71
0.50
0.09
0.34
0.34
0.21
0.21
0.16
0.14
0.20
0.14
0.09
0.16
0.14
0.30
0.16

80987
1258
46659
21326
6318
56537
22211
2950
1168
46370
13882
928
1932
1654
4071
4386

343.8
323.5
377.9
359.6
349.7
326.8
359.7
338.7
284.3
359.5
308.8
238.8
270.8
341.9
285.9
371.1

1.26
9.75
1.81
2.61
4.61
1.44
2.48
6.41
8.67
1.73
2.81
8.87
6.65
8.57
5.55
5.95

40.51
38.62
43.74
42.13
40.84
37.49
41.47
38.66
33.19
42.52
36.97
27.05
32.61
41.34
34.07
44.47

0.18
1.45
0.26
0.36
0.65
0.20
0.35
0.92
1.23
0.25
0.41
1.20
0.97
1.28
0.73
0.86

67703
921
38316
17722
5438
50028
18092
2701
1165
40625
12411
798
1467
1901
3708
3558

267.1
245.6
295.9
276.3
280.8
262.6
270.1
271.2
260.6
286.1
262.3
181.8
210.2
335.2
255.6
308.2

1.12
8.79
1.62
2.30
4.17
1.28
2.14
5.46
7.85
1.53
2.55
7.30
5.65
7.86
5.25
5.66

30.05
28.01
33.09
30.65
31.23
29.23
29.78
30.66
30.38
32.25
29.59
20.31
23.10
38.68
28.79
34.99

0.14
1.32
0.21
0.29
0.53
0.17
0.28
0.75
1.10
0.20
0.32
0.94
0.70
1.06
0.60
0.74

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

615

673

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

All sites but non-melanoma skin (C00-96/C44)


Cases
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Male
ASR(W)
CUM 0-74

1844
6908
1379
2173
4371

86.3
156.1
146.1
153.6
202.6

2.12
2.01
4.00
4.33
3.91

2201
6732
1605
3592
70229
2040
7766
13656
4194
3610
1256

256.2
330.6
259.2
260.3
346.6
226.8
224.0
179.8
148.9
297.5
137.8

5.75
4.37
6.77
4.47
1.37
5.11
2.65
1.59
2.40
5.14
4.02

331.8 0.67
334.1 1.98
310.9 1.50
336.9 3.01
354.6 3.79
312.3 4.26
259.5 19.52
378.9 3.47
334.2 0.95
362.8 8.92
320.4 3.08
343.2 1.57
375.5 3.87
331.9 1.73
352.8 5.12
307.2 1.38
340.2 0.61
221.6 1.44
421.9 2.79
266.6 1.35
366.2 0.80
337.4 1.35
410.8 5.81
223.7 3.85
231.4 5.30
225.4 9.07
279.5 3.75
364.8 1.82
337.0 1.18
447.0 4.32
205.4 4.44
264.5 6.04
267.6 7.86
230.9 6.72
265.7 2.18
372.9 1.83
333.8 1.69
390.7 1.92
431.2 8.09
387.0 2.01
440.8 5.28
496.1 7.08
319.4 7.82
369.8 0.81
404.0 2.83
367.2 0.86
368.7 1.32
439.0 3.28
354.3 1.47
377.4 2.48
444.6 5.54
364.2 2.88
340.0 2.97
372.6 1.02
441.3 3.27
361.7 1.09
353.2 1.39
360.1 1.95
406.4 1.80
402.5 1.77
453.2 3.87
390.0 2.03
457.1 7.15
387.5 4.63

269555
30271
47343
14039
9614
5755
196
13074
134700
1806
12757
50729
10033
39737
5133
55142
343106
25220
23624
42779
242117
67931
5258
3768
2042
775
6051
45921
87885
11034
2408
2068
1577
1223
16330
49395
41445
46713
2944
42896
7507
5298
1877
251927
20951
227632
81495
19018
61499
24822
7196
17034
14306
146334
18779
122812
69583
39125
54081
54954
14443
40062
4277
7945

616

Female
ASR(W)
CUM 0-74

1815
6637
986
2777
3780

80.3
119.3
95.5
171.4
194.9

1.97
1.51
3.10
4.11
4.03

29.88
38.20
31.27
30.45
40.88
25.98
26.12
19.94
16.83
37.42
16.40

0.79
0.65
1.05
0.67
0.20
0.75
0.40
0.23
0.36
0.77
0.62

2352
8004
1645
4105
77358
1903
9609
13452
5135
2438
1947

227.9
280.2
211.7
212.1
273.8
187.9
211.2
161.6
155.4
171.5
171.0

5.16
3.39
5.51
3.42
1.03
4.42
2.24
1.44
2.27
3.70
4.01

25.04
31.61
23.72
22.84
30.22
20.56
23.69
17.32
17.13
18.59
19.55

0.62
0.48
0.78
0.46
0.14
0.59
0.31
0.20
0.31
0.46
0.56 *

40.05
40.50
37.07
40.88
43.35
39.21
33.42
45.22
40.47
43.91
38.26
42.41
46.88
40.92
43.52
37.28
41.43
26.48
52.89
32.29
44.52
41.14
51.44
26.54
28.36
27.71
33.61
44.60
41.06
56.14
23.59
32.56
31.90
28.07
32.31
45.19
40.80
47.99
54.03
47.44
54.34
60.84
39.70
45.29
50.49
44.86
45.59
54.70
43.75
46.66
54.89
45.08
41.39
45.84
54.75
44.41
43.47
43.97
49.60
49.12
55.72
47.47
56.43
47.54

0.10
0.29
0.22
0.44
0.56
0.63
3.09
0.50
0.14
1.29
0.44
0.23
0.57
0.25
0.78
0.20
0.09
0.21
0.42
0.21
0.11
0.20
0.88
0.55
0.79
1.34
0.57
0.27
0.18
0.65
0.64
0.92
1.06
1.02
0.33
0.26
0.25
0.28
1.21
0.29
0.77
1.00
1.18
0.11
0.42
0.12
0.20
0.50
0.22
0.38
0.86
0.44
0.44
0.15
0.48
0.16
0.20
0.28
0.26
0.26
0.58
0.29
1.06
0.66

244027
26796
41349
13042
8283
4553
185
11557
125919
1585
10758
46278
9069
36425
4616
50316
326290
26738
19059
44576
231266
65732
4372
3533
2106
961
6212
44947
84578
9074
2324
2426
1546
1248
17514
48033
39979
44997
2569
41709
6868
4583
1983
217537
17397
197120
74996
16452
57483
24025
6572
16850
12570
142366
17722
120551
68591
37198
49626
47197
12376
34479
3817
7433

266.3 0.59
266.3 1.73
246.3 1.33
273.5 2.68
268.2 3.23
230.2 3.62
232.4 18.26
286.2 2.94
273.3 0.83
275.2 7.63
255.0 2.79
253.5 1.28
231.8 2.59
256.9 1.48
295.8 4.55
252.8 1.22
272.5 0.52
192.1 1.22
259.4 1.96
217.0 1.07
304.6 0.72
271.2 1.15
260.4 4.17
183.9 3.30
180.1 4.04
206.1 7.45
227.5 3.00
304.5 1.63
263.5 0.97
264.0 2.90
175.3 3.86
230.0 4.81
235.8 6.84
180.5 5.35
207.6 1.63
318.2 1.67
273.7 1.46
305.6 1.62
262.6 5.33
309.8 1.73
293.7 3.90
288.4 4.71
285.1 7.21
281.7 0.69
246.4 1.93
287.1 0.76
266.7 1.03
246.7 2.03
274.9 1.23
275.3 1.88
255.4 3.35
290.6 2.39
271.0 2.62
291.5 0.85
288.9 2.25
292.2 0.94
286.8 1.20
289.9 1.72
308.2 1.50
277.1 1.38
273.3 2.58
281.1 1.66
276.6 4.66
290.0 3.82

30.30
30.28
27.83
31.48
31.04
26.91
28.91
32.79
31.02
31.53
29.35
29.26
26.81
29.64
34.34
29.02
31.26
21.35
30.07
24.38
35.21
30.90
29.77
20.06
20.06
24.01
25.82
35.09
30.05
30.75
18.52
25.57
26.65
19.74
23.21
36.66
31.39
35.25
30.37
35.73
33.21
32.64
32.62
32.15
28.13
32.72
30.84
28.43
31.77
31.91
29.55
33.63
31.24
33.58
33.19
33.69
33.28
33.10
35.54
31.81
31.08
32.34
31.41
33.47

0.08
0.23
0.18
0.35
0.43
0.48
2.87
0.39
0.11
1.01
0.36
0.17
0.35
0.19
0.66
0.16
0.07
0.16
0.27
0.15
0.09
0.15
0.57
0.42
0.52
0.94
0.42
0.22
0.13
0.40
0.49
0.61
0.83
0.69
0.23
0.21
0.20
0.21
0.74
0.23
0.51
0.60
0.99
0.09
0.27
0.09
0.14
0.28
0.16
0.27
0.49
0.33
0.35
0.11
0.31
0.12
0.16
0.22
0.20
0.18
0.35
0.22
0.64
0.49

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp

*Important. See note on population page.

674

Cases

Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

All sites but non-melanoma skin (C00-96/C44) (contd)


Cases
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

18925
83398
128214
16270
108837
55857
12614
42375
67971
6166
61217
12098
2678584
260184
2317952
117270
13154
100374
18921
640
5093
12791
235878
28918
199913
138865
13201
120193
41469
43007
180632
14733
161549
15120
311115
30149
258045
836565
40281
80476
59291
641428
49841
12332
36846
200115
21129
174180
17597
7744
70877
48122
26512
67288

393.2
392.4
393.8
493.3
378.8
437.5
518.6
421.2
356.8
442.1
350.7
358.0
365.7
429.3
359.5
410.6
477.0
407.5
316.9
184.5
276.4
354.6
377.7
436.9
377.4
359.7
412.3
343.0
347.9
359.5
390.9
484.1
378.3
407.6
369.2
464.3
370.8
364.9
228.5
453.3
276.2
378.1
386.5
452.3
366.7
343.1
418.5
336.4
315.2
367.2
372.9
374.6
375.6
365.0

3.01
1.44
1.15
4.00
1.21
1.95
4.79
2.17
1.43
5.76
1.49
3.44
0.23
0.86
0.25
1.26
4.21
1.37
2.39
7.50
3.96
3.36
0.81
2.60
0.89
1.01
3.68
1.04
1.78
1.84
0.98
4.10
1.02
3.56
0.69
2.75
0.77
0.42
1.18
1.63
1.18
0.50
1.78
4.17
1.98
0.79
2.95
0.83
2.47
4.36
1.47
1.79
2.43
1.48

48.26
48.68
48.51
61.67
46.59
53.99
65.35
51.60
43.95
54.91
43.16
43.75
44.86
53.61
44.02
50.50
60.21
49.96
38.82
21.59
33.49
43.45
46.05
54.34
45.91
44.15
51.88
41.96
42.34
44.30
48.21
61.06
46.58
49.90
45.21
58.15
45.36
44.62
27.25
56.65
33.53
46.15
47.66
56.85
44.99
42.02
52.14
41.13
38.71
44.79
45.65
45.66
45.77
44.92

0.44
0.21
0.17
0.59
0.18
0.29
0.72
0.32
0.21
0.85
0.21
0.50
0.03
0.13
0.04
0.18
0.63
0.20
0.35
1.11
0.59
0.47
0.12
0.39
0.13
0.15
0.54
0.15
0.26
0.27
0.14
0.60
0.14
0.52
0.10
0.42
0.11
0.06
0.18
0.25
0.18
0.07
0.26
0.63
0.28
0.12
0.45
0.12
0.37
0.63
0.22
0.27
0.35
0.22

17339
83526
114702
13301
99284
49232
10184
38425
65431
5787
58983
10495
2513430
226451
2195599
109232
11107
94747
16600
704
4424
11156
234747
27238
200613
135447
11846
119866
38361
41249
169910
13001
153328
14357
289612
25188
242365
779507
41900
67066
60289
600853
42294
9725
32016
183617
18720
159969
15080
7409
67174
45658
24668
62538

306.0
310.6
294.1
291.8
294.0
306.4
294.3
314.3
280.1
281.4
281.0
282.7
284.3
261.6
288.0
306.2
277.6
315.2
246.3
154.9
208.1
285.0
295.6
265.4
306.5
285.4
264.8
282.1
271.1
300.7
299.9
292.1
297.6
307.8
285.8
273.0
295.7
282.3
195.9
270.1
220.9
302.3
267.2
244.1
274.0
260.3
264.5
260.1
239.9
298.8
307.7
306.9
295.6
288.3

2.59
1.20
0.95
2.66
1.03
1.52
3.08
1.79
1.21
3.89
1.29
3.05
0.20
0.57
0.22
1.03
2.72
1.16
2.04
5.99
3.24
3.04
0.67
1.67
0.77
0.86
2.56
0.91
1.52
1.63
0.83
2.72
0.88
2.94
0.58
1.80
0.66
0.35
0.99
1.09
0.93
0.44
1.39
2.61
1.66
0.65
2.03
0.70
2.07
3.80
1.29
1.56
2.09
1.28

35.30
35.78
33.93
33.82
33.88
35.32
34.20
36.12
32.41
32.51
32.50
32.79
32.70
30.19
33.15
35.01
32.01
36.03
28.06
17.19
23.22
32.47
33.87
30.53
35.15
33.14
31.01
32.73
31.46
34.94
34.42
33.84
34.14
35.28
32.80
31.63
33.99
32.41
21.86
31.21
24.80
34.81
30.67
27.88
31.45
29.87
30.60
29.85
27.10
34.14
35.65
35.53
34.14
33.27

0.34
0.16
0.13
0.37
0.13
0.20
0.42
0.23
0.16
0.53
0.17
0.41
0.03
0.08
0.03
0.13
0.38
0.15
0.27
0.82
0.43
0.38
0.09
0.23
0.10
0.11
0.35
0.12
0.20
0.22
0.11
0.36
0.11
0.38
0.08
0.25
0.09
0.05
0.13
0.15
0.13
0.06
0.18
0.35
0.21
0.09
0.28
0.09
0.28
0.50
0.18
0.21
0.27
0.17

929
14287
56776
2586
4472
53528
5884
4311
9751
24258
975
22147
4034
5555
2548
48406
43823
2818
9375
10601
14186
31858
22050
95011
18940

156.0
260.0
259.6
202.7
193.1
223.9
178.9
188.0
105.3
115.2
113.6
100.9
99.5
86.7
95.0
288.0
288.4
181.3
240.7
253.2
340.6
298.5
294.2
255.0
279.3

5.28
2.24
1.13
4.15
2.99
1.04
2.39
3.00
1.09
0.79
3.68
0.71
1.62
1.21
1.90
1.37
1.45
3.61
2.53
2.65
2.93
1.76
2.15
0.85
2.22

18.03
29.14
29.68
24.92
22.56
25.71
21.15
22.28
12.43
13.65
14.21
11.80
11.52
10.01
11.52
34.37
34.38
22.08
28.37
29.68
41.14
34.92
34.98
29.62
33.07

0.78
0.30
0.15
0.57
0.39
0.14
0.32
0.43
0.15
0.11
0.55
0.10
0.22
0.17
0.27
0.20
0.21
0.56
0.36
0.36
0.42
0.24
0.29
0.12
0.30

944
10208
45492
1507
3540
45495
3748
4081
10537
23244
742
21890
4165
6453
2576
52172
48449
2414
6901
7972
10260
22387
16464
66166
13733

141.4
164.2
190.7
110.9
140.8
174.1
106.5
171.4
114.6
123.4
79.2
103.7
101.5
100.1
84.3
270.7
279.0
133.2
164.0
165.1
210.1
187.2
185.6
151.3
177.7

4.82
1.67
0.96
3.01
2.43
0.90
1.80
2.83
1.14
0.85
2.95
0.72
1.62
1.28
1.68
1.26
1.36
2.83
2.11
2.20
2.24
1.41
1.74
0.66
1.87

15.83
17.89
20.51
13.26
16.35
19.49
11.82
19.03
13.06
14.12
9.02
11.73
11.08
11.46
9.46
30.52
31.54
14.90
18.19
18.12
23.32
20.38
20.14
16.43
19.41

0.66
0.21 *
0.12
0.40 *
0.33
0.11 *
0.23 *
0.35 *
0.15
0.12 *
0.39
0.10
0.20 *
0.17 *
0.22 *
0.16
0.17
0.39
0.27
0.26
0.28
0.17
0.20
0.08
0.21

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

617

675

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

All sites but non-melanoma skin (C00-96/C44) (contd)


Cases
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
ASR(W)
CUM 0-74

618

Female
ASR(W)
CUM 0-74

241155
21999
14900
7084
7563
12740
1878
59431
3804
1294
1625
3409
4638
1859
4454
14119
17810
15516
776
1518
5618
3538
2846
4762
15907

281.9
271.3
289.4
275.0
298.2
264.9
254.7
295.8
286.1
119.9
100.5
179.1
124.7
100.9
162.3
209.8
221.5
246.7
106.5
162.2
144.4
162.2
104.3
162.2
200.9

0.59
1.99
2.49
3.44
3.60
2.48
6.06
1.31
5.19
3.56
4.66
3.16
1.90
2.45
2.62
1.93
1.69
2.02
4.03
4.31
1.96
2.77
1.97
2.39
1.62

34.30
32.82
34.85
33.54
36.62
32.19
30.96
34.44
34.75
13.28
9.46
21.30
14.68
12.02
19.53
24.79
24.99
28.26
11.01
18.00
16.71
19.32
12.21
19.59
25.06

0.09
0.29
0.36
0.52
0.54
0.37
0.90
0.19
0.79
0.51
0.53
0.47
0.27
0.36
0.38
0.29
0.24
0.29
0.47
0.59
0.26
0.39
0.28
0.33
0.23

183620
17248
12038
5899
6245
10804
1531
50666
3096
1648
1368
3896
4787
1627
4085
18638
18185
15768
781
1636
6554
3572
2990
3433
9884

162.7
156.4
172.5
166.5
172.6
165.1
143.4
188.9
162.8
127.2
133.8
167.7
120.5
86.5
187.9
205.0
189.7
197.7
139.0
154.2
155.7
150.8
94.2
110.4
114.7

0.39
1.21
1.60
2.23
2.24
1.64
3.82
0.86
3.09
3.36
5.25
2.73
1.79
2.29
3.19
1.59
1.45
1.62
5.22
3.97
1.98
2.58
1.75
1.92
1.17

17.99
17.56
19.23
18.50
19.26
18.33
14.93
21.09
18.39
13.99
14.51
18.69
13.28
9.91
21.02
23.36
20.33
21.29
15.20
16.23
17.57
16.95
10.26
12.35
12.96

0.05
0.16
0.21
0.30
0.30
0.22
0.46
0.12
0.43
0.47
0.73
0.36
0.24
0.33 *
0.42 *
0.23 *
0.19
0.21
0.67
0.49
0.25 *
0.33 *
0.22
0.25 *
0.15 *

93110
8425
3941
77140
20055
67116
69185
52071
119560
61586
12979
54512
13603
8068
6181
9136
12391
13093
15210
6560
7230
5332
7567
32591
56994
20426
22953
30171
32802
15479
2736
36298
3436
9837
6920
20359
10796
3041
17602
10509
4979
35578
7500
3347
7079
18632
8952
5541
3327
2931
15768
13663
7717
26664

311.4
365.4
347.8
264.1
276.9
332.2
217.5
320.5
332.0
283.0
293.1
272.2
385.3
342.5
334.8
352.5
323.4
328.7
375.3
312.2
352.4
297.7
309.7
323.0
299.8
291.2
345.8
320.6
315.9
332.9
289.2
295.6
358.9
399.5
351.1
337.8
356.0
314.8
345.4
339.8
323.6
368.3
348.0
259.5
313.5
354.4
261.1
286.6
251.0
399.8
343.7
306.5
375.2
373.6

1.06
4.08
5.63
0.97
2.05
1.35
0.87
1.45
0.99
1.21
2.62
1.21
3.38
4.00
4.42
3.78
3.14
2.98
3.17
4.17
4.37
4.59
3.84
1.85
1.31
2.13
2.34
1.91
1.81
2.81
5.81
1.60
6.70
4.20
4.79
2.66
3.89
6.44
2.86
3.64
4.64
2.09
4.53
4.86
4.13
2.91
2.91
4.04
4.64
7.66
3.00
2.98
4.47
2.44

37.23
44.29
42.70
32.63
33.10
39.90
26.07
37.70
39.70
32.94
36.17
31.25
47.10
41.50
40.30
42.39
38.75
38.97
45.81
36.73
42.37
35.38
37.87
38.38
35.49
34.23
41.16
37.58
36.82
39.49
34.37
34.51
43.13
48.23
41.98
39.60
41.86
38.05
40.05
41.48
39.28
44.13
41.56
30.58
37.71
41.91
30.92
34.28
30.08
49.12
40.85
36.47
44.12
44.86

0.15
0.58
0.81
0.13
0.29
0.19
0.11
0.19
0.14
0.17
0.36
0.17
0.48
0.56
0.62
0.53
0.43
0.42
0.44
0.55
0.60
0.61
0.52
0.25
0.18
0.29
0.32
0.27
0.24
0.37
0.84
0.23
0.89
0.58
0.63
0.35
0.51
0.86
0.37
0.50
0.65
0.29
0.61
0.66
0.56
0.39
0.39
0.56
0.63
1.08
0.40
0.39
0.61
0.34

85705
7025
3248
69885
16085
53701
62577
45175
111613
66532
13263
54789
10427
6207
4596
7329
9563
10454
11068
4781
5241
3881
5218
29100
56099
20651
20322
29067
30746
14081
2646
33352
2831
8259
6051
17330
9029
2264
17061
8869
3890
29752
6730
2755
6310
15147
7319
4523
2790
2281
13360
11151
6365
22403

218.8
241.7
231.0
167.3
211.7
252.7
175.9
220.4
239.7
274.3
199.7
221.3
246.3
222.0
218.9
243.0
236.7
234.0
232.9
204.4
222.3
208.1
213.0
223.6
217.1
227.3
230.6
247.3
235.8
240.7
275.4
243.9
242.3
280.6
284.7
262.4
253.1
219.4
258.2
269.0
219.9
255.9
288.0
204.5
264.8
273.0
198.9
214.1
201.2
262.6
249.6
239.1
253.6
259.4

0.86
3.20
4.42
0.69
1.85
1.22
0.77
1.15
0.78
1.18
1.92
1.06
2.64
3.14
3.55
3.12
2.72
2.50
2.44
3.45
3.42
3.97
3.34
1.49
1.09
1.84
1.82
1.64
1.55
2.34
5.74
1.44
5.56
3.55
4.55
2.42
3.45
5.58
2.41
3.37
3.66
1.77
4.40
4.39
3.97
2.67
2.59
3.52
4.23
6.27
2.62
2.76
3.69
2.03

24.28
26.37
25.64
18.81
24.11
28.00
19.78
24.31
27.18
31.90
22.65
24.36
27.80
24.93
24.16
27.34
26.27
25.84
26.09
22.50
25.14
22.62
23.97
24.97
24.26
25.84
25.57
27.58
25.93
26.97
30.74
27.46
27.11
31.08
31.51
28.35
27.70
24.12
28.68
29.78
24.55
28.29
31.71
22.47
29.37
30.07
21.51
24.00
22.37
29.28
27.56
26.40
27.96
28.85

0.11
0.40
0.55
0.08 *
0.23 *
0.14
0.09 *
0.13
0.10
0.15
0.23
0.13
0.33
0.38
0.43
0.38
0.32
0.31
0.30
0.40
0.42
0.46
0.39
0.18
0.13
0.23
0.22
0.21
0.19
0.28
0.73
0.19
0.64
0.42
0.50
0.27
0.38
0.64
0.28
0.39
0.46
0.21
0.49
0.52
0.46
0.31
0.30
0.43
0.50
0.75
0.30
0.31
0.43
0.24

*Important. See note on population page.

676

Cases

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Age-standardized (world) incidence (per 100,000) and


cumulative (0-74) incidence (percent)
rates and standard errors

All sites but non-melanoma skin (C00-96/C44) (contd)


Cases
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
ASR(W)
CUM 0-74

Cases

Female
ASR(W)
CUM 0-74

20144
32138
3238
53499
6542
12434
13764
27082
31316
34854
41152
48834
20324
3185
16262
24741
13842
2608
8082
8049
12291
7944
6609
9811
106443
5372
2670
2190
5771
4110
3410
7993
170303
11212
10702
32929
30029
51419
84893
27816
91379
147351
58248
63438
15649
65898

264.5
298.5
242.4
293.8
265.6
292.7
226.0
258.8
276.1
251.7
233.8
311.9
298.6
248.0
320.7
350.6
298.7
221.1
335.9
255.0
299.3
325.2
310.2
262.2
261.4
354.0
294.4
328.4
294.0
315.3
326.2
336.1
290.6
306.1
300.1
263.7
299.0
303.6
304.8
267.3
291.4
269.1
276.4
281.9
267.8
322.1

1.90
1.69
4.41
1.37
3.36
2.71
2.01
1.67
1.66
1.38
1.22
1.44
2.13
4.85
2.77
2.35
2.60
5.22
4.08
3.06
2.84
3.96
4.18
2.91
0.88
5.01
6.09
7.52
4.08
5.25
5.81
3.99
0.73
2.96
3.02
1.57
1.83
1.41
1.11
1.68
1.06
0.75
1.23
1.19
2.23
1.32

32.53
36.20
28.66
34.22
31.75
35.82
27.93
31.13
32.25
30.83
27.85
37.47
35.48
28.40
37.22
41.06
35.19
25.34
39.83
30.84
34.72
39.31
36.15
31.38
31.40
42.71
34.16
39.34
35.14
37.18
38.92
40.64
34.92
36.83
36.11
30.15
34.06
35.23
35.40
30.65
33.06
30.80
31.39
32.71
31.35
37.70

0.26
0.24
0.63
0.20
0.46
0.38
0.27
0.23
0.22
0.19
0.15
0.20
0.29
0.63
0.36
0.31
0.36
0.65
0.55
0.41
0.38
0.54
0.56
0.38
0.13
0.72
0.85
1.04
0.59
0.72
0.81
0.56
0.10
0.42
0.42
0.22
0.25
0.20
0.15
0.24
0.14
0.11
0.17
0.17
0.32
0.18

20734
30469
3261
49387
7558
10326
15413
22207
25333
45729
39120
42120
18820
2029
10480
15568
9974
1585
5221
5888
8380
5221
4444
6535
98687
5031
2159
1912
4680
3767
2761
7218
163202
10199
9567
31523
29546
49763
81004
26648
90040
147148
57044
59504
16684
67318

180.4
199.0
210.5
246.4
224.2
196.3
190.6
182.4
196.7
189.5
209.1
203.8
213.6
155.5
181.2
195.9
189.7
150.9
207.2
175.4
187.4
204.8
202.2
158.1
235.2
265.9
211.5
244.5
208.6
233.7
237.9
260.6
246.7
252.1
243.9
237.2
251.1
254.7
254.4
232.9
257.5
230.8
245.1
239.9
242.9
269.4

1.40
1.24
3.91
1.27
2.78
2.10
1.68
1.34
1.40
0.99
1.15
1.05
1.70
4.03
2.16
1.79
2.02
4.93
3.31
2.56
2.26
3.31
3.55
2.32
0.86
4.15
5.16
6.39
3.41
4.43
4.93
3.43
0.66
2.66
2.73
1.53
1.66
1.30
1.02
1.57
1.01
0.68
1.17
1.11
2.07
1.17

20.61
22.18
23.63
27.91
25.13
21.90
21.98
19.97
21.18
21.22
23.22
22.92
23.97
16.40
19.80
20.94
20.79
15.98
22.71
19.40
20.46
21.97
21.49
17.18
27.10
29.68
23.45
27.73
23.58
25.90
27.06
29.70
28.07
28.76
27.66
26.69
28.11
28.76
28.58
26.00
28.50
25.89
27.54
26.89
27.37
30.50

0.16
0.15
0.49
0.16
0.34 *
0.25
0.20
0.16 *
0.16
0.12
0.13
0.13
0.20
0.46
0.24
0.21
0.25
0.52
0.39
0.30
0.27
0.38
0.41
0.26
0.11
0.52
0.64
0.78
0.43
0.53
0.62
0.43
0.08
0.34
0.34
0.19
0.21
0.16
0.13
0.20
0.12
0.09
0.15
0.14
0.26
0.15

80965
1258
46460
21017
6277
56503
20948
2879
1168
46203
13815
924
1924
1647
4061
4354

343.7
323.5
376.5
354.0
347.6
326.6
339.9
331.3
284.3
358.2
307.4
237.8
269.5
340.7
285.3
368.6

1.26
9.75
1.81
2.59
4.60
1.44
2.42
6.35
8.67
1.73
2.81
8.86
6.63
8.56
5.54
5.93

40.50
38.62
43.61
41.55
40.59
37.47
39.38
37.92
33.19
42.39
36.83
26.97
32.45
41.23
34.01
44.20

0.18
1.45
0.26
0.36
0.65
0.20
0.34
0.91
1.23
0.25
0.41
1.20
0.97
1.28
0.73
0.86

67690
921
38176
17515
5393
50009
17420
2663
1164
40477
12368
794
1464
1897
3699
3543

267.1
245.6
294.9
273.5
278.9
262.5
261.2
267.4
260.4
285.2
261.3
180.9
209.7
334.5
255.2
306.8

1.12
8.79
1.61
2.29
4.16
1.28
2.11
5.42
7.85
1.52
2.55
7.28
5.65
7.85
5.25
5.65

30.04
28.01
32.99
30.36
31.04
29.22
28.87
30.19
30.38
32.17
29.50
20.20
23.04
38.62
28.75
34.85

0.14
1.32
0.21
0.29
0.53
0.17
0.27
0.74
1.10
0.20
0.32
0.93
0.70
1.06
0.60
0.74

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

619

677

Age-standardized incidence rates by


histological type

621

Age-standardized (world) incidence rates (per 100,000)


by histological type

Oesophagus (C15) - Male

Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Non-Hispanic White
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Georgia: Black
USA, Georgia: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
USA, Louisiana: Black
USA, Louisiana: White
USA, Maine
USA, Massachusetts

Sarcoma

Other

Unspec.

0.1
0.1
0.5
9.5

0.1
0.0
0.1
0.1
0.2
-

2.3
0.4
0.7
0.4
0.7
1.0
0.1
0.1
0.1
0.4
0.4

0.1
0.1
0.0
-

0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.2
0.2
0.1
0.1
0.0
0.2
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.3
0.1
0.1
0.1
0.1
0.2
0.0
0.2
0.0
0.1
0.1
0.1
0.3
0.1
0.1
0.1
0.1
0.1
0.4
0.2
0.1
0.1
0.2

0.2
0.2
0.2
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.3
0.7
0.3
0.2
0.3
0.3
0.4
0.4
0.1
0.3
0.4
0.3
0.4
0.2
0.2
0.2
0.3
0.2
0.2
0.4
0.2
0.1
0.3
0.2
0.3
0.1
0.2
0.2
0.2
0.2
0.4
0.4
0.4
0.4
0.2
0.2
0.4
0.2
0.4
0.2
0.4
0.3
0.7
0.3
0.3
0.2
0.3
0.4
0.4
0.1
0.4
0.4
0.4
0.3

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
-

Carcinoma

Squamous

Adeno

Other

Unspec.

0.0
0.9
0.5
5.9
4.5

0.4
0.7
0.4

0.1
0.1

3.2
7.7
7.0
6.1
7.8
5.7
1.4
1.1
1.1
5.8
1.9

1.2
1.9
0.9
0.8
1.0
1.3
0.8
0.3
0.6
0.7
0.6

1.5
1.4
1.5
1.5
1.7
1.5
1.9
1.6
1.5
2.6
1.3
2.6
7.8
1.5
1.8
1.1
1.5
1.6
4.9
2.8
1.0
1.3
2.7
1.2
1.6
3.9
1.9
0.7
1.4
3.7
2.6
1.2
1.8
4.4
1.3
1.2
0.9
2.0
6.4
1.8
7.7
11.2
1.7
1.8
6.6
1.4
2.9
2.6
7.2
1.1
9.3
1.3
1.1
2.3
7.8
1.5
1.5
1.2
1.7
2.8
3.7
1.6
6.3
1.6
1.4
1.8

2.3
2.1
2.5
2.1
2.3
1.5
4.6
2.8
2.4
2.7
2.4
2.4
0.6
2.8
4.2
2.8
2.6
2.4
0.5
0.4
0.4
1.6
0.5
3.3
1.9
0.9
0.3
0.5
1.5
0.5
2.7
0.5
0.8
1.6
3.3
3.5
3.6
1.1
3.8
1.9
1.5
2.3
2.9
0.5
3.2
2.4
2.3
0.4
3.0
0.8
2.8
3.5
3.7
1.0
4.2
4.0
3.9
3.4
2.7
0.9
3.3
1.0
3.2
4.4
4.6

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

680

622

Cancer Incidence in Five Continents Vol. IX, IARC 2008

Number of cases
MV

Total

0.0
0.2
7.0
0.7

3
64
5
70
92

4
70
5
125
219

0.0
-

3.0
3.1
0.6
2.5
1.1
0.8
0.7
0.3
0.1
0.2

48
227
56
103
1878
72
89
113
48
81
24

58
262
72
115
2406
81
112
159
55
82
26 *

0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0

0.2
0.1
0.1
0.1
0.1
0.3
0.3
0.6
0.1
0.2
0.3
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.0
0.1
0.1
0.1
0.3
0.0
0.0
0.7
1.1
0.4
0.8
0.4
0.2
0.1
0.2
0.1
0.5
0.2
0.1
0.1
0.4
0.1
0.1
0.2
0.2
0.2
0.4
0.2
0.3
0.1
0.2
0.2

3307
332
640
160
110
62
5
162
1663
27
146
766
227
535
90
752
4397
872
68
55
13
67
12
634
1011
129
27
13
186
22
17
589
275
311
477
3301
582
705
53
646
166
136
26
3452
391
3038
1226
349
128
213
440
773
199
2463
397
2023
1129
577
716
794
52
102
251
536
303
1437

3568
349
673
171
112
62
5
174
1836
30
156
816
243
569
91
799
4569
912
73
55
14
72
13
661
1036
133
28
13
189
23
17
605
282
325
492
3436
625
714
53
655
179
149
26
3734
433
3276
1292
359
132
219
470
809
210
2562
421
2098
1179
600
763
823
57
105
259
557
312
1495

*
*
*
*

Americ
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
Asia
Bahra
China
China
China
China
China
China
Cypru
India,
India,
India,
India,
India,
India,
India,
Israel
Israel
Israel
Japan
Japan
Japan
Japan
Japan
Japan
Japan
Korea
Korea
Korea
Korea
Korea
Korea

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Oesophagus (C15) - Male (Contd)

es

al

4
0
5
5
9

*
*
*
*

8
2
2
5
6
1
2
9
5
2
6*

8
9
3
1
2
2
5
4
6
0
6
6
3
9
1
9
9
2
3
5
4
2
3
1
6
3
8
3
9
3
7
5
2
5
2
6
5
4
3
5
9
9
6
4
3
6
2
9
2
9
0
9
0
2
1
8
9
0
3
3
7
5
9
7
2
5

America, North (Contd)


USA, Michigan
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Michigan: Black
USA, Michigan: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York state
USA, New York state: Black
USA, New York state: White
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 registries)
USA, SEER (9 registries): Black
USA, SEER (9 registries): White
USA, SEER (14 registries)
USA, SEER (14 registries): Asian and Pacific Islander
USA, SEER (14 registries): Black
USA, SEER (14 registries): Hispanic White
USA, SEER (14 registries): Non-hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, New Delhi
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon

Carcinoma

Sarcoma

Other

Unspec.

0.4
0.5
1.0
0.4
0.8
0.4
0.2
0.6
0.2
0.3
0.3
0.5
0.3
0.4
0.3
0.2
0.5
0.3
0.4
0.3
0.3
0.5
0.3
0.4
0.8
0.4
0.2
0.3
0.2
0.4
0.2
0.4
0.3
0.7
0.3
0.3
0.1
0.5
0.2
0.3
0.3
0.8
0.2
0.3
0.3
0.2
0.1
0.4
0.3
0.4
0.3
0.3

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.3
3.0
0.3
4.8
0.0
4.3
0.3
0.7
0.1
0.1
1.6
0.1
0.1
0.2
0.0
0.1
0.5
0.1
1.1
0.1
0.1
0.1
0.0
0.1
0.0
0.3
0.1

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
-

0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.1

Squamous

Adeno

Other

Unspec.

1.9
2.7
7.3
1.5
6.7
1.4
1.5
6.8
1.0
1.1
2.2
7.5
1.6
1.1
2.6
1.5
0.8
2.3
6.9
1.7
1.8
6.9
1.3
1.6
5.8
1.1
1.3
1.3
1.8
7.7
1.4
1.6
1.9
6.4
1.3
1.8
2.2
6.1
1.6
1.3
3.7
12.2
1.4
1.7
5.4
1.3
0.4
0.9
1.4
1.6
1.3
1.8

3.8
3.1
0.7
3.8
0.7
4.2
3.6
1.5
3.8
3.5
3.0
1.1
3.3
2.9
1.5
3.9
2.7
0.7
3.1
3.2
0.9
3.5
3.9
1.0
4.0
3.1
3.9
4.0
1.2
4.2
4.5
3.0
0.6
3.5
2.8
0.5
0.9
1.6
3.5
2.8
0.7
3.4
2.6
0.8
2.8
3.1
4.4
3.8
3.6
3.9
4.3

0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1

2.1
5.7
8.1
14.6
1.1
11.6
0.6
6.0
5.0
3.7
7.8
2.1
2.1
0.8
0.8
0.6
4.6
5.0
11.1
12.5
9.1
7.3
10.4
6.5
6.1
6.6
4.7
8.3
4.7

1.4
0.2
0.4
0.9
0.1
0.4
0.5
0.4
1.1
0.4
0.1
0.5
0.6
1.0
1.0
0.3
0.4
0.1
0.2
0.4
0.2
0.3
0.6
0.3
0.2
0.4
0.2
0.3
0.3

0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.3
0.3
0.2
0.1
0.1
0.1
0.2
0.0
0.0
0.2

Number of cases
MV

Total

0.2
0.1
0.3
0.1
0.5
0.2
0.3
0.5
0.3
0.0
0.2
0.3
0.2
0.2
0.6
0.1
0.1
0.2
0.4
0.2
0.2
0.4
0.2
0.2
0.5
0.2
0.5
0.2
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.0
0.2
0.1
0.1
0.2
0.4
0.1
0.3
0.6
0.3
0.3
0.1
0.1
0.1
0.4

2002
792
206
580
265
1722
1019
119
897
162
1574
249
1295
257
8
57
188
3281
518
2668
39349
4922
33481
2266
227
1970
550
670
2809
278
2481
228
4367
482
3599
11316
483
1328
697
8724
855
355
495
2582
317
2236
198
114
1069
722
398
1173

2086
814
217
591
280
1791
1088
130
955
173
1646
259
1355
278
11
61
201
3517
556
2861
41538
5264
35284
2412
252
2089
611
703
2875
287
2534
239
4513
503
3715
11756
496
1380
721
9070
898
377
516
2800
352
2410
202
124
1114
748
415
1278

0.4
0.4
0.4
10.3
8.0
0.0
2.4
1.5
2.4
0.8
1.4
6.1
0.6
0.1
0.1
0.1
1.3
0.8
2.0
2.8
1.8
1.3
1.6
0.8
1.1
1.6
1.1

19
365
1937
196
181
1453
508
24
605
56
901
312
804
290
76
319
304
14
207
220
480
1411
698
3118
777
5843
511
361
124
216
236

23
514
2030
254
230
2291
532
25
808
69
1369
333
1070
380
91
358
332
15
252
246
503
1656
773
4084
892
6856
620
397
142
253
280

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

623

*
*
*
*
*

*
*
*
*

681

Age-standardized (world) incidence rates (per 100,000)


by histological type

Oesophagus (C15) - Male (Contd)

Asia (Contd)
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland (data not available)
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg (data not available)
Germany, Free State of Saxony (data not available)
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania (data not available)
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio
Italy, Syracuse Province
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce (data not available)
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg

Carcinoma

Sarcoma

Other

Unspec.

0.1
0.1
0.2
0.3
0.2
0.1
0.3
0.3
0.2
0.2
0.1
0.4
0.1
0.1

0.1
0.0
0.0
0.1
-

0.0
0.0
0.0
0.1
-

0.5
0.2
0.7
0.1
0.2
0.5
0.0
0.5
0.3
0.3
0.2
0.4
0.4
0.2
0.6
0.2
0.3
0.2
0.2
0.7
0.3
0.3
1.9
0.1
1.7
0.2
0.4
0.2
0.2
0.0
0.3
0.4
0.1
0.2
0.6
0.3
0.1
0.1
0.1
0.1
0.1
0.3
0.3
0.2
0.2
0.3
0.2
0.4
0.1
0.1
0.2
0.3
0.4
0.2
1.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.1
0.0
0.0
0.2
0.0
0.0
0.0
-

Squamous

Adeno

Other

Unspec.

5.0
5.5
5.8
0.6
0.5
1.2
1.3
1.6
5.3
1.4
3.9
4.6
2.5
0.2
1.8
0.9
6.6
1.0
1.5

0.1
0.2
0.4
0.5
0.0
0.7
0.4
0.7
1.0
0.6
0.6
0.5
0.6
0.9
0.1
0.1
0.1
0.3
0.4

0.3
0.1
0.1
0.1
0.0
0.1
0.2
0.0
0.0
0.1

2.3
2.9
2.5
3.9
2.1
3.1
0.5
3.1
2.7
2.5
4.0
8.8
11.8
7.1
7.9
4.0
4.9
9.3
11.3
10.3
3.6
7.1
3.3
3.7
3.7
4.5
2.0
2.4
3.4
4.9
2.1
1.2
1.4
0.8
2.2
1.4
0.9
5.5
2.9
0.5
1.3
1.1
0.7
2.5
3.7
0.6
1.6
1.2
3.7
4.6
3.5
4.2
0.8
1.6
2.7
2.4
5.7
3.7
4.0

1.1
0.7
1.5
0.5
2.7
2.8
0.3
0.3
1.2
2.9
0.2
1.5
1.4
1.7
1.5
1.6
1.4
2.9
1.3
2.8
1.2
2.6
1.3
1.6
1.3
1.6
3.0
4.0
1.0
0.9
1.4
0.5
0.9
0.3
0.7
0.5
0.9
1.3
0.9
0.1
0.7
0.4
0.6
1.1
1.4
0.6
0.6
0.2
0.7
0.9
0.5
0.6
1.2
1.4
0.6
0.3
1.1
0.7
0.6

0.1
0.2
0.1
0.0
0.2
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.2
0.1
0.0
0.2
0.1
0.2
0.1
0.1
0.1
0.0
0.1
0.2
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.1
0.0
0.1
0.0
0.1

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

682

624

Cancer Incidence in Five Continents Vol. IX, IARC 2008

Number of cases
MV

Total

1.7
1.2
1.6
0.8
0.6
0.2
0.4
0.1
0.0
0.7
0.2
0.2
0.1
0.3
0.4
1.1
0.3
0.2

40
1133
68
13
10
42
62
38
166
135
377
340
24
13
76
25
181
40
166

51
1334
83
20
14
45
72
41
174
195
390
352
25
13
84
34
204
47
182

0.5
0.1
0.3
1.5
0.1
0.2
1.4
1.8
0.8
0.3
0.5
0.1
0.8
0.0
0.0
0.0
0.1
0.1
0.2
0.1
0.2
0.2
0.1
0.5
0.0
0.2
0.6
0.1
1.0
0.5
0.4
0.4
0.2
0.4
0.1
0.4
0.6
0.1
0.2
0.4
0.2
0.5
0.6
1.0
0.1
0.4
0.4
0.1
0.7
1.6
1.6
0.7
0.1
1.1
0.6
0.2
0.9
2.0

1149
92
50
1476
355
1212
244
639
1494
1223
203
365
307
160
252
210
255
501
267
261
93
234
316
500
561
293
49
856
40
147
62
103
76
11
158
58
30
711
83
9
47
83
45
66
42
16
114
76
97
407
340
575
31
578
65
177
717
479
807

1297
97
58
1742
362
1274
702
943
1780
1329
224
370
327
161
253
211
261
503
268
271
97
237
456
553
680
302
49
941
42
170
71
134
92
12
181
62
36
748
87
13
53
94
63
79
49
19
133
95
100
452
435
707
39
600
115
210
740
578
1077

*
*
*

*
*
*
*

*
*
*

Europe
Serbia
Slova
Slove
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Switz
Switz
Switz
Switz
Switz
Switz
Switz
The N
The N
The N
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, N
UK, S
Oceani
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Frenc
New Z
USA,
USA,
USA,
USA,
USA,
USA,

*
*

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Oesophagus (C15) - Male (Contd)

es

al

1
4
3
0
4
5
2
1
4
5
0
2
5
3
4
4
4
7
2

7
7
8
2
2
4
2
3
0
9
4
0
7
1
3
1
1
3
8
1
7
7
6
3
0
2
9
1
2
0
1
4
2
2
1
2
6
8
7
3
3
4
3
9
9
9
3
5
0
2
5
7
9
0
5
0
0
8
7

*
*
*

*
*
*
*

*
*
*

Europe (Contd)
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, England, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern And Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory (data not available)
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Carcinoma

Sarcoma

Other

Unspec.

0.2
0.3
0.3
0.5
0.3
0.2
0.5
0.0
0.0
0.1
0.2
0.1
0.3
0.2
0.2
0.2
0.4
0.1
0.2
0.5
0.3
0.3
0.5
0.8
1.9
1.5
0.7
0.8
0.6
1.3
1.4
0.9
0.9
0.5

0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.4
0.3
0.2
0.2
0.2
0.3
0.4
0.6
0.3
0.1
0.2
0.2
0.1
0.1

0.0
0.0
0.1
0.0
0.0
-

0.0
0.0
0.0
0.0
0.0
0.0
0.2
-

Squamous

Adeno

Other

Unspec.

1.7
5.6
3.9
1.9
5.3
6.8
5.4
1.8
4.7
1.9
2.6
4.0
4.2
3.2
1.5
5.1
3.3
4.9
2.9
3.1
5.1
5.6
2.5
2.4
2.4
1.8
2.4
2.7
2.4
1.8
1.7
2.0
2.1
2.2
1.8
3.9

0.5
0.8
0.6
0.5
1.0
1.1
1.5
1.2
1.6
1.2
1.0
0.6
0.8
0.8
1.6
2.6
2.8
1.9
2.1
2.7
1.8
2.7
4.2
3.6
2.5
5.0
5.8
5.6
5.0
5.5
5.2
4.8
6.0
5.1
4.2
6.6

0.0
0.0
0.1
0.3
0.0
0.2
0.1
0.1
0.1
0.1
0.0
0.2
0.1
0.1
0.3
0.1
0.1
0.1
0.2
0.2
0.1
0.2
0.0
0.1
0.1
0.1
0.1
0.1
0.2

1.8
2.2
0.9
3.0
1.6
1.6
1.1
7.5
1.6
3.2
5.4
1.2
5.5
5.1
1.0

2.3
2.8
3.2
3.8
2.6
2.9
3.2
1.0
2.8
1.1
0.3
1.0
0.5
2.7

0.1
0.1
0.8
0.2
0.1
0.1
0.3
0.1
0.0
0.2
-

Number of cases
MV

Total

0.6
1.5
0.5
0.5
0.4
0.4
0.5
0.4
0.3
0.3
0.2
0.0
0.4
0.4
0.0
0.3
0.1
0.1
0.2
0.3
0.2
0.2
0.1
0.1
0.1
0.0
0.0
0.2
0.0
1.2
0.3
0.1
0.1
0.8
0.4

419
1023
355
36
286
543
332
30
137
93
140
98
101
141
1336
120
56
43
93
85
74
215
4235
233
199
902
877
1519
2148
807
2322
3861
1803
1767
408
2240

549
1253
371
43
311
576
355
36
143
103
148
101
109
156
1345
125
57
44
96
87
76
221
4306
237
204
995
1046
1708
2367
861
2824
4622
2032
1918
455
2391

0.1
0.0
0.1
0.3
0.4
0.1
0.2
0.2
0.4
0.1
0.3
0.1
0.1

1051
639
297
127
782
312
35
38
634
187
18
12
32
67
44

1123
682
308
135
856
326
45
39
694
190
18
12
33
68
45

*
*
*Important. See note on population page.
Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

625

683

Age-standardized (world) incidence rates (per 100,000)


by histological type

Oesophagus (C15) - Female

Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Non-Hispanic White
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Georgia: Black
USA, Georgia: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
USA, Louisiana: Black
USA, Louisiana: White
USA, Maine
USA, Massachusetts

Sarcoma

Other

Unspec.

0.0
0.0
0.2
3.2

0.0
0.1
0.0
0.1
0.0
0.0
-

1.2
0.2
0.3
0.2
0.9
0.1
0.0
0.0
0.1
-

0.0
-

0.0
0.1
0.0
0.0
0.0
0.0
0.2
0.1
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0

0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.3
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.0
0.1
0.0
0.0
0.1
0.1
0.0
0.1
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

Carcinoma

Squamous

Adeno

Other

Unspec.

0.0
0.6
0.1
3.4
1.8

0.0
0.1
0.1
0.3
0.0

0.1

1.2
2.4
1.6
1.7
1.4
3.6
1.1
0.3
0.2
0.7
0.2

0.6
0.5
0.5
0.2
0.2
0.2
0.1
0.0
0.2
0.2
0.2

0.8
0.7
1.0
0.7
0.5
0.2
0.7
0.8
0.1
0.8
0.8
1.5
0.6
0.8
0.5
0.7
0.8
1.7
0.5
0.2
0.4
1.3
0.9
0.7
1.6
0.9
0.3
0.2
0.8
0.1
0.7
0.6
1.6
0.4
0.8
0.7
1.0
3.3
0.8
2.3
3.0
0.6
0.8
1.9
0.6
1.0
1.1
2.3
0.6
2.7
0.5
0.7
0.9
2.3
0.6
0.7
0.6
0.5
1.0
1.4
0.8
1.7
0.7
0.7
0.8

0.3
0.2
0.3
0.3
0.5
0.1
0.3
0.3
0.5
0.2
0.3
0.2
0.3
0.7
0.4
0.4
0.3
0.2
0.2
0.2
0.5
0.3
0.3
0.3
0.0
0.2
0.3
0.4
0.1
0.2
0.3
0.4
0.4
0.6
0.2
0.6
0.1
0.1
0.1
0.4
0.3
0.4
0.2
0.2
0.1
0.2
0.2
0.2
0.5
0.5
0.2
0.5
0.5
0.4
0.4
0.3
0.0
0.3
0.1
0.4
0.4
0.6

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

684

626

Cancer Incidence in Five Continents Vol. IX, IARC 2008

Number of cases
MV

Total

0.0
0.1
4.5
0.1

3
36
2
37
30

4
41
2
78
67

0.1
0.8
0.6
0.4
0.5
0.1
0.3
0.2
0.3
0.1
-

29
86
15
34
466
49
62
33
15
16
5

36
95
19
43
621
51
78
55
24
17
5*

0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.1
0.0
0.0
0.0
0.0
0.1
0.2
0.1
0.1
0.2
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.1

1256
115
275
60
39
12
0
50
643
6
56
215
65
149
24
223
1582
325
33
10
9
19
10
227
391
68
14
7
50
6
1
241
107
136
132
1196
183
279
34
243
61
54
7
1182
163
1009
399
124
59
61
186
208
59
765
163
586
335
162
192
241
18
32
81
159
85
470

1424
123
293
68
43
12
0
58
759
6
62
238
72
164
24
243
1677
345
34
10
10
19
10
245
418
72
15
8
54
6
1
258
112
141
140
1273
198
288
36
250
65
58
7
1288
171
1105
419
129
62
62
198
215
62
800
168
616
350
180
205
254
19
38
82
171
93
501

*
*
*
*

Americ
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
Asia
Bahra
China
China
China
China
China
China
Cypru
India,
India,
India,
India,
India,
India,
India,
Israel
Israel
Israel
Japan
Japan
Japan
Japan
Japan
Japan
Japan
Korea
Korea
Korea
Korea
Korea
Korea

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Oesophagus (C15) - Female (Contd)

es

al

4
1
2
8
7

*
*
*
*

6
5
9
3
1
1
8
5
4
7
5*

4
3
3
8
3
2
0
8
9
6
2
8
2
4
4
3
7
5
4
0
0
9
0
5
8
2
5
8
4
6
1
8
2
1
0
3
8
8
6
0
5
8
7
8
1
5
9
9
2
2
8
5
2
0
8
6
0
0
5
4
9
8
2
1
3
1

America, North (Contd)


USA, Michigan
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Michigan: Black
USA, Michigan: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York state
USA, New York state: Black
USA, New York state: White
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 registries)
USA, SEER (9 registries): Black
USA, SEER (9 registries): White
USA, SEER (14 registries)
USA, SEER (14 registries): Asian and Pacific Islander
USA, SEER (14 registries): Black
USA, SEER (14 registries): Hispanic White
USA, SEER (14 registries): Non-hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, New Delhi
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon

Carcinoma

Sarcoma

Other

Unspec.

0.1
0.2
0.3
0.1
0.3
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.2
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.4
0.6
0.1
0.6
0.0
0.4
0.1
0.1
0.1
1.1
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.1
-

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
-

Squamous

Adeno

Other

Unspec.

0.7
0.9
2.1
0.6
1.9
0.5
0.6
2.2
0.4
0.4
0.9
2.1
0.7
0.3
0.2
0.4
0.9
2.5
0.7
0.7
2.0
0.6
0.6
1.8
0.5
0.4
0.6
0.7
2.6
0.5
0.7
0.8
2.1
0.6
0.8
0.6
1.9
0.4
0.7
1.0
2.0
0.6
0.6
1.6
0.5
0.3
0.4
0.7
0.7
0.5
0.7

0.5
0.3
0.2
0.4
0.2
0.5
0.4
0.3
0.5
0.5
0.5
0.3
0.5
0.2
0.1
0.0
0.3
0.4
0.2
0.5
0.4
0.2
0.5
0.6
0.2
0.6
0.4
0.6
0.5
0.3
0.5
0.6
0.4
0.2
0.4
0.4
0.1
0.2
0.3
0.4
0.3
0.1
0.4
0.3
0.2
0.3
0.3
0.9
0.5
0.5
0.5
0.5

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0

1.4
1.1
1.3
4.0
0.3
1.3
0.2
4.0
1.6
2.8
5.0
1.6
0.6
0.5
0.6
0.2
0.5
0.8
1.8
1.8
1.0
1.1
1.2
0.3
0.3
0.5
0.3
0.4
0.4

0.0
0.1
0.3
0.0
0.1
0.1
0.2
0.1
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.1
0.0
0.1
-

0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
-

Number of cases
MV

Total

0.1
0.0
0.0
0.0
0.1
0.1
0.1
0.2
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.1
0.2
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.1

551
248
87
161
106
442
279
49
228
41
591
96
482
46
1
9
34
1267
291
947
12480
1989
10162
709
99
580
127
205
827
131
686
79
1376
221
1075
3774
161
526
192
2873
228
87
139
747
122
610
43
41
306
207
111
322

600
264
90
174
110
487
312
54
255
46
613
100
499
51
1
9
39
1382
309
1043
13450
2101
10997
771
110
631
150
224
870
134
723
82
1470
229
1158
3998
169
544
202
3061
244
97
145
854
133
704
45
46
338
230
117
352

0.1
0.1
1.7
2.6
1.1
0.2
1.5
0.6
0.8
5.0
0.1
0.1
0.1
0.1
0.2
0.2
0.3
0.5
0.3
0.2
0.3
0.2
0.1
0.2
0.2

10
85
428
59
31
538
57
7
378
17
620
199
461
211
26
195
189
6
24
50
98
260
105
585
114
437
48
39
12
23
27

10
120
455
70
43
965
60
7
479
19
905
214
598
295
28
228
221
7
37
61
106
327
123
823
150
662
75
49
16
29
41

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

627

*
*
*
*
*

*
*
*
*

685

Age-standardized (world) incidence rates (per 100,000)


by histological type

Oesophagus (C15) - Female (Contd)

Asia (Contd)
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland (data not available)
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg (data not available)
Germany, Free State of Saxony (data not available)
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania (data not available)
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio
Italy, Syracuse Province
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce (data not available)
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg

Carcinoma

Sarcoma

Other

Unspec.

0.0
0.1
0.0
0.0
0.2
0.5
0.1
0.1
0.1
0.0

0.0
0.0
0.0
-

0.0
0.1
0.0
-

0.1
0.1
0.0
0.0
0.1
0.0
0.1
0.0
0.1
0.0
0.0
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.5
0.3
0.0
0.1
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.3
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.2

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0

Squamous

Adeno

Other

Unspec.

0.2
0.4
0.3
1.3
0.1
1.2
1.1
1.6
7.5
0.3
0.8
0.8
2.3
0.3
0.4
0.3
1.2
0.3
0.9

0.1
0.0
0.2
0.3
0.5
0.3
0.1
0.2
0.1
0.2
0.2
0.0
0.1
0.2
0.1

0.0
0.1
0.0
0.0
0.0
0.0
0.0

0.4
0.6
0.5
0.2
0.7
0.8
0.1
0.4
0.3
1.1
0.4
0.7
1.3
0.7
1.2
1.0
0.9
1.3
1.5
1.1
0.4
0.7
1.0
0.9
1.0
1.0
0.3
2.1
0.9
0.9
0.4
0.3
0.4
0.1
0.5
0.3
0.1
1.0
1.0
0.1
0.3
0.3
0.1
0.2
0.7
0.3
0.5
0.3
0.5
0.9
0.2
0.3
0.2
0.6
0.4
0.4
0.9
0.3
0.6

0.2
0.1
0.1
0.1
0.4
0.4
0.1
0.1
0.1
0.5
0.0
0.1
0.3
0.1
0.1
0.1
0.1
0.3
0.1
0.2
0.3
0.2
0.2
0.2
0.2
0.3
0.6
0.8
0.2
0.1
0.2
0.0
0.1
0.0
0.1
0.1
0.3
0.1
0.1
0.1
0.1
0.0
0.1
0.3
0.1
0.1
0.0
0.0
0.2
0.1
0.1
0.2
0.3
0.1
0.1
0.2
0.1
0.1

0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.2
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

686

628

Cancer Incidence in Five Continents Vol. IX, IARC 2008

Number of cases
MV

Total

0.2
0.2
0.2
0.2
0.3
0.3
0.3
0.3
0.3
0.2
0.1
0.1
0.3
0.3
0.2
0.1
0.1

4
111
8
14
1
36
49
35
141
36
103
87
11
5
20
7
42
17
89

7
154
12
16
3
39
55
41
166
61
110
94
11
5
31
16
49
18
95

0.1
0.1
0.1
0.0
0.3
0.3
0.1
0.1
0.1
0.0
0.2
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.1
0.4
0.0
0.2
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.2
0.0
0.1
0.0
0.2
0.0
0.1
0.0
0.0
0.1
0.1
0.2
0.2
0.2
0.1
0.0
0.3
0.1
0.0
0.2
0.5

276
22
11
155
108
343
55
126
241
468
41
36
71
18
52
56
48
93
43
39
18
32
113
124
172
81
16
507
17
29
17
38
25
3
67
22
10
178
30
3
16
30
7
11
11
5
49
20
20
117
41
73
9
241
13
46
197
74
272

340
27
11
209
108
373
205
213
319
518
48
38
78
18
53
58
51
93
43
42
20
33
172
147
206
85
16
597
19
40
20
54
37
5
81
27
13
198
37
4
19
35
16
12
14
6
54
29
27
144
76
103
11
252
30
63
203
106
446

*
*
*

*
*
*
*

*
*
*

Europe
Serbia
Slova
Slove
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Switz
Switz
Switz
Switz
Switz
Switz
Switz
The N
The N
The N
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, N
UK, S
Oceani
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Frenc
New Z
USA,
USA,
USA,
USA,
USA,
USA,

*
*

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Oesophagus (C15) - Female (Contd)

es

al

7
4
2
6
3
9
5
1
6
1
0
4
1
5
1
6
9
8
5

0
7
1
9
8
3
5
3
9
8
8
8
8
8
3
8
1
3
3
2
0
3
2
7
6
5
6
7
9
0
0
4
7
5
1
7
3
8
7
4
9
5
6
2
4
6
4
9
7
4
6
3
1
2
0
3
3
6
6

*
*
*

*
*
*
*

*
*
*

Europe (Contd)
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, England, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern And Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory (data not available)
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Carcinoma

Sarcoma

Other

Unspec.

0.1
0.0
0.1
0.0
0.1
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.1
0.2
0.1
0.1
0.1
0.4
0.8
0.7
0.3
0.4
0.3
0.6
0.6
0.5
0.3
0.3

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.2
0.1
0.1
0.1
0.1
0.2
0.2
0.1
0.0
0.1

0.0
0.0
0.0
-

0.0
0.0
0.0
-

Squamous

Adeno

Other

Unspec.

0.4
0.3
0.5
0.1
0.3
0.6
0.5
0.1
0.5
0.2
0.2
0.4
0.3
0.2
0.8
1.9
0.8
1.5
0.4
0.9
1.1
1.5
1.3
1.0
0.8
1.8
2.3
2.0
2.0
1.8
1.7
1.6
2.0
2.4
1.6
2.6

0.1
0.1
0.2
0.0
0.2
0.1
0.2
0.2
0.2
0.1
0.1
0.0
0.1
0.1
0.3
0.3
0.2
0.1
0.2
0.5
0.1
0.3
0.8
0.8
0.5
1.0
1.3
1.0
1.1
1.0
1.0
1.0
1.0
1.0
1.2
1.6

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2

1.4
1.4
1.0
1.6
1.2
1.3
0.9
0.8
1.1
0.6
0.7
1.8
0.5
0.6

0.4
0.3
0.5
0.3
0.4
0.5
1.2
0.3
0.4
0.2
0.2
0.2
0.3

0.0
0.0
0.5
0.0
0.1
0.0
0.1
-

Number of cases
MV

Total

0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.2
0.1
0.0
0.2
0.1
0.1
0.0
0.1
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.5
0.2
0.0
0.1
0.3
0.1

135
95
85
5
32
66
43
3
21
14
22
14
7
15
591
53
12
15
17
21
18
68
1761
84
60
524
568
829
1338
421
1373
2238
1005
1190
266
1392

165
128
93
5
40
75
55
4
25
20
24
20
12
20
596
55
13
15
17
27
20
69
1796
85
61
602
692
992
1525
483
1791
2878
1176
1347
304
1524

0.0
0.0
0.1
0.2
0.2
0.0
0.1
0.2
0.0
0.1

604
266
152
53
419
148
20
4
321
40
0
7
9
8
15

664
293
161
59
484
158
25
4
370
43
0
7
9
9
17

*
*

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

629

687

Age-standardized (world) incidence rates (per 100,000)


by histological type

Anus (C21) - Male

Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Non-Hispanic White
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Georgia: Black
USA, Georgia: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
USA, Louisiana: Black
USA, Louisiana: White
USA, Maine
USA, Massachusetts

Sarcoma

Other

Unspec.

0.0
0.1
-

0.0
0.0
0.1

0.2
0.1
0.0
0.0
-

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.3
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0

Carcinoma

Squamous

Adeno

Other

Unspec.

0.0
0.1
0.3
0.1

0.3
0.1

0.1
-

0.2
0.5
0.1
0.3
0.3
0.1
0.1
0.2
0.4

0.4
0.0
0.2
0.5
0.2
0.2
0.1
0.2
-

0.4
0.3
0.5
0.4
0.6
0.2
0.4
0.4
0.1
0.2
0.4
0.6
0.4
0.3
0.5
0.8
1.0
1.8
0.3
0.6
1.2
0.7
1.1
0.1
0.3
1.1
0.1
1.0
0.4
1.0
0.5
0.5
1.2
0.5
2.0
2.1
2.0
0.8
0.9
0.8
0.7
1.1
1.1
1.1
0.6
0.7
0.4
0.6
0.9
0.5
0.6
0.4
0.5
0.7
0.5
1.6
0.4
0.7
0.8
0.7

0.5
0.1
0.2
0.3
0.5
0.1
0.3
0.8
0.2
0.1
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.2
0.2
0.3
0.3
0.2
0.2
0.3
0.2
0.1
0.2
0.2
0.2
0.1
0.3
0.2
0.2
0.1
0.1
0.1
0.1
0.5
0.6
0.4
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.3
0.1
0.2
0.2
0.2
0.2
0.2
0.1
0.2
0.2
0.5
0.3
0.2
0.2
0.2
0.2

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

688

630

Cancer Incidence in Five Continents Vol. IX, IARC 2008

Number of cases
MV

Total

0.0
0.2
-

2
22
3
0
4

2
23
3
2
4

0.0
-

0.3
0.1
0.2
0.1
0.0
-

2
17
4
2
124
4
17
23
7
5
4

2
19
4
2
169
4
19
24
7
5
4*

0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

736
46
102
24
28
5
0
27
487
2
15
90
22
65
6
127
1001
245
29
5
5
24
1
170
260
39
3
2
41
1
1
169
29
80
116
753
94
78
11
65
43
29
13
609
73
526
208
98
30
68
48
159
24
301
54
240
153
51
92
118
10
38
21
95
49
191

778
47
103
25
28
5
0
27
526
2
15
91
22
66
6
127
1008
247
29
5
5
24
1
172
261
39
3
2
42
1
1
169
29
80
117
759
95
79
11
66
43
29
13
617
73
534
210
98
30
68
49
160
24
303
55
241
153
51
94
118
10
38
21
95
50
193

*
*
*
*

Americ
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
Asia
Bahra
China
China
China
China
China
China
Cypru
India,
India,
India,
India,
India,
India,
India,
Israel
Israel
Israel
Japan
Japan
Japan
Japan
Japan
Japan
Japan
Korea
Korea
Korea
Korea
Korea
Korea

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Anus (C21) - Male (Contd)

es

al

2
3
3
2
4

*
*
*
*

2
9
4
2
9
4
9
4
7
5
4*

8
7
3
5
8
5
0
7
6
2
5
1
2
6
6
7
8
7
9
5
5
4
1
2
1
9
3
2
2
1
1
9
9
0
7
9
5
9
1
6
3
9
3
7
3
4
0
8
0
8
9
0
4
3
5
1
3
1
4
8
0
8
1
5
0
3

America, North (Contd)


USA, Michigan
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Michigan: Black
USA, Michigan: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York state
USA, New York state: Black
USA, New York state: White
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 registries)
USA, SEER (9 registries): Black
USA, SEER (9 registries): White
USA, SEER (14 registries)
USA, SEER (14 registries): Asian and Pacific Islander
USA, SEER (14 registries): Black
USA, SEER (14 registries): Hispanic White
USA, SEER (14 registries): Non-hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, New Delhi
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon

Carcinoma

Sarcoma

Other

Unspec.

0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.2
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.1
0.1
0.0
0.0
0.0
0.3
0.0
0.0
0.0
0.0
-

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
0.0
0.0
0.0
-

Squamous

Adeno

Other

Unspec.

0.4
0.5
0.6
0.5
0.5
0.4
0.6
0.7
0.6
0.4
0.6
1.0
0.5
0.7
0.3
0.4
0.9
0.7
1.0
0.7
0.6
0.7
0.6
0.5
0.5
0.5
0.5
0.7
0.5
0.8
0.5
0.7
0.7
1.1
0.7
0.7
0.1
0.8
0.4
0.7
0.6
0.4
0.7
0.6
0.6
0.6
0.3
0.4
0.6
0.6
0.5
0.4

0.2
0.3
0.2
0.3
0.2
0.2
0.1
0.2
0.1
0.2
0.1
0.2
0.1
0.2
0.4
0.2
0.1
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.2
0.1
0.1
0.2
0.2
0.2
0.2
0.1
0.2
0.2
0.2
0.1
0.2
0.1
0.1
0.3
0.1
0.1
0.3
0.2
0.1
0.2
0.2

0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.0

1.0
0.0
0.1
0.0
0.2
0.2
0.2
0.2
0.3
0.1
0.2
0.2
0.2
0.1
0.0
0.0
0.0
0.0
0.0
0.2
0.2
0.1
0.3
0.2
0.2

0.1
7.6
0.4
0.0
0.2
0.0
0.2
0.1
0.3
0.1
0.0
0.3
0.3
0.1
0.4
0.2
0.2
0.2
0.1
0.2
0.2
0.1
0.1
0.1
0.1
0.2

0.1
0.1
0.0
0.0
0.0
0.0
-

Number of cases
MV

Total

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

215
101
26
74
31
181
127
15
111
21
197
42
154
52
3
12
37
569
92
470
5932
701
5055
252
29
217
77
113
296
31
258
29
735
103
595
1942
45
226
152
1487
107
17
90
458
57
392
27
14
160
109
58
104

217
101
26
74
32
182
130
15
114
22
198
43
154
53
3
12
38
579
92
479
5995
706
5112
256
30
220
78
117
300
31
262
29
738
103
598
1954
45
227
153
1497
108
17
91
466
58
398
27
14
162
109
58
104

0.0
0.5
0.3
0.2
0.1
0.0
0.1
0.1
0.5
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.1
0.1
0.0
0.0
0.1

6
9
1739
5
7
49
8
5
44
0
71
23
136
27
4
85
80
5
21
8
16
26
10
91
14
264
29
10
9
7
18

6
13
1851
5
7
57
8
5
51
0
81
27
160
31
4
88
83
5
24
10
17
27
10
112
15
309
33
11
9
7
20

*
*
*
*
*

*
*
*
*

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

631

689

Age-standardized (world) incidence rates (per 100,000)


by histological type

Anus (C21) - Male (Contd)

Asia (Contd)
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland (data not available)
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg (data not available)
Germany, Free State of Saxony (data not available)
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania (data not available)
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio
Italy, Syracuse Province
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce (data not available)
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg

Carcinoma

Sarcoma

Other

Unspec.

0.0
0.0
0.1
0.0

0.0
0.0
0.1
0.0

0.0
0.0
0.1
0.0
-

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.2
0.1
0.0
0.1
0.1
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
-

Squamous

Adeno

Other

Unspec.

0.2
0.1
0.1
0.1
0.0
0.4
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1

0.2
0.2
0.3
0.1
0.1
0.4
0.2
0.2
0.3
0.2
0.2
0.1
0.1
0.1
0.1

0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
-

0.3
0.5
0.1
0.2
0.2
0.1
0.0
0.1
0.5
0.1
0.4
0.6
0.4
0.3
0.4
0.3
0.5
0.1
0.0
0.4
0.5
0.7
0.2
0.4
0.5
0.1
0.3
0.2
0.1
0.3
0.4
0.2
0.4
0.2
0.2
0.4
0.3
0.4
0.2
0.1
0.1
0.1
0.4
0.5
0.2
0.3
0.3
0.1
0.1
0.4
0.3
0.1
0.2
0.1
0.2
0.1

0.2
0.3
0.2
0.1
0.4
0.1
0.2
0.1
0.2
0.2
0.1
0.1
0.0
0.2
0.0
0.1
0.1
0.0
0.1
0.1
0.2
0.0
0.1
0.2
0.4
0.3
0.6
0.2
0.3
0.0
0.2
0.2
0.4
0.2
0.2
0.2
0.4
0.2
0.1
0.1
0.4
0.4
0.1
0.3
0.2
0.2
0.1
0.1
0.3
0.6
0.2
0.0

0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

690

632

Cancer Incidence in Five Continents Vol. IX, IARC 2008

Number of cases
MV

Total

0.1
0.0
0.1
0.1
0.0
0.1
0.0

0
84
2
1
4
11
6
9
18
18
33
26
4
3
10
4
2
5
23

0
95
2
1
4
11
6
11
19
20
33
26
4
3
10
6
3
6
24

0.0
0.1
0.1
0.0
0.1
0.1
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.1
0.1
0.2
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.0

151
12
0
124
24
79
178
22
125
131
16
22
17
7
11
20
21
26
4
4
7
15
61
43
44
28
3
64
6
12
18
32
19
1
20
15
5
62
14
3
15
26
23
6
2
7
39
26
8
44
25
32
8
77
6
16
89
57
26

153
12
1
142
24
83
213
35
142
137
16
22
17
7
11
20
21
26
4
4
7
16
65
43
52
28
3
68
6
14
19
33
22
1
20
15
6
83
15
3
15
27
25
7
2
8
41
27
9
47
29
35
9
77
10
21
92
58
30

*
*
*

*
*
*
*

*
*
*

Europe
Serbia
Slova
Slove
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Switz
Switz
Switz
Switz
Switz
Switz
Switz
The N
The N
The N
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, N
UK, S
Oceani
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Frenc
New Z
USA,
USA,
USA,
USA,
USA,
USA,

*
*

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Anus (C21) - Male (Contd)

es

al

0
5
2
1
4
1
6
1
9
0
3
6
4
3
0
6
3
6
4

3
2
1
2
4
3
3
5
2
7
6
2
7
7
1
0
1
6
4
4
7
6
5
3
2
8
3
8
6
4
9
3
2
1
0
5
6
3
5
3
5
7
5
7
2
8
1
7
9
7
9
5
9
7
0
1
2
8
0

*
*
*

*
*
*
*

*
*
*

Europe (Contd)
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, England, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern And Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory (data not available)
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Carcinoma

Sarcoma

Other

Unspec.

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.1
0.0
0.0
0.0
0.0
-

0.0
0.0
0.0
0.0
0.1
-

0.0
0.1
0.0
0.0
-

0.0
0.0
0.0
-

Squamous

Adeno

Other

Unspec.

0.1
0.1
0.1
0.2
0.2
0.2
0.1
0.4
0.6
0.2
0.2
0.2
0.1
0.4
0.4
0.7
0.6
0.5
0.2
0.2
0.5
0.4
0.3
0.3
0.1
0.4
0.4
0.5
0.5
0.4
0.5
0.5
0.3
0.3
0.4
0.4

0.2
0.4
0.2
0.8
0.2
0.1
0.3
0.2
0.3
0.1
0.2
0.3
0.0
0.0
0.8
0.2
0.0
0.2
0.2
0.1
0.1
0.0
0.1
0.3
0.1
0.2
0.2
0.1
0.1
0.2
0.1
0.2
0.1

0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.7
0.5
0.1
0.7
0.3
0.4
0.1
0.3
0.2
0.1
0.7
0.4

0.3
0.3
0.2
0.4
0.3
0.3
0.7
0.2
0.2
0.1
0.2
0.2
0.2

0.0
0.1
0.1
0.0
0.0
0.3
0.0
-

Number of cases
MV

Total

0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.2
0.0
0.0
0.0
0.1
0.0
0.0
0.0

51
82
22
2
47
33
13
7
16
19
14
14
8
19
179
11
6
7
10
3
8
19
216
11
6
59
67
96
196
64
163
320
109
94
34
116

58
93
22
3
49
34
15
7
16
19
14
14
9
20
180
11
6
8
11
3
8
19
221
11
6
63
77
98
205
68
212
357
120
97
34
118

0.0
0.0
0.0
-

225
92
20
21
96
41
6
3
69
16
1
2
3
2
8

232
99
20
21
100
41
6
3
73
16
1
2
3
2
8

*
*

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

633

691

Age-standardized (world) incidence rates (per 100,000)


by histological type

Anus (C21) - Female

Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Non-Hispanic White
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Georgia: Black
USA, Georgia: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
USA, Louisiana: Black
USA, Louisiana: White
USA, Maine
USA, Massachusetts

Sarcoma

Other

Unspec.

0.1
-

0.1
-

0.1
-

0.0
0.0
-

0.1
0.0
0.0
0.1
0.0
0.1
-

0.0
0.0
0.1

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.3
0.1
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

Carcinoma

Squamous

Adeno

Other

Unspec.

0.0
0.0

0.1
0.4
0.0
0.0

0.0
-

0.5
0.8
0.8
0.5
0.7
1.0
0.4
0.4
0.5
1.1

0.1
0.4
0.2
0.1
0.1
0.1
0.2
0.1
0.3
-

0.7
0.6
0.9
0.6
1.1
0.3
1.1
0.7
0.6
0.4
0.8
0.5
0.9
1.2
0.9
1.0
0.8
0.6
0.1
0.3
0.6
1.2
0.8
0.7
0.1
0.2
0.6
0.7
1.2
0.2
0.7
0.6
1.3
1.0
0.7
0.9
0.7
1.2
1.3
1.2
1.1
0.7
1.2
1.0
1.0
0.8
1.2
0.7
1.1
1.0
0.9
0.9
0.9
1.0
0.9
1.1
0.9
0.7
1.4
0.6
1.1
1.1
0.9

0.3
0.1
0.1
0.1
0.3
0.2
2.0
0.1
0.4
0.2
0.1
0.1
0.2
0.1
0.0
0.1
0.1
0.1
0.3
0.0
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.2
0.4
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.3
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

692

634

Cancer Incidence in Five Continents Vol. IX, IARC 2008

Number of cases
MV

Total

1
22
2
3
2

1
22
2
3
2

0.2
0.2
0.1
0.0
0.0
-

10
36
5
13
256
1
57
41
20
15
13

10
37
5
13
319
1
59
44
21
15
13 *

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.2
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

973
77
168
38
44
12
1
52
550
5
26
170
28
141
21
189
1359
240
14
5
5
22
0
186
332
30
5
3
71
0
8
209
58
67
150
1073
153
126
12
113
30
19
11
991
68
913
314
110
30
79
59
253
51
466
67
392
275
122
193
178
15
35
36
142
62
248

1011
77
169
39
44
12
1
52
586
5
26
175
28
146
21
191
1369
243
14
5
5
22
0
189
332
30
5
3
71
0
8
209
59
67
150
1082
153
127
12
114
31
19
12
999
70
919
318
110
30
79
61
255
51
469
67
395
276
124
194
181
15
35
36
145
62
251

*
*
*
*

Americ
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
Asia
Bahra
China
China
China
China
China
China
Cypru
India,
India,
India,
India,
India,
India,
India,
Israel
Israel
Israel
Japan
Japan
Japan
Japan
Japan
Japan
Japan
Korea
Korea
Korea
Korea
Korea
Korea

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Anus (C21) - Female (Contd)

es

al

1
2
2
3
2

*
*
*
*

0
7
5
3
9
1
9
4
1
5
3*

1
7
9
9
4
2
1
2
6
5
6
5
8
6
1
1
9
3
4
5
5
2
0
9
2
0
5
3
1
0
8
9
9
7
0
2
3
7
2
4
1
9
2
9
0
9
8
0
0
9
1
5
1
9
7
5
6
4
4
1
5
5
6
5
2
1

America, North (Contd)


USA, Michigan
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Michigan: Black
USA, Michigan: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York state
USA, New York state: Black
USA, New York state: White
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 registries)
USA, SEER (9 registries): Black
USA, SEER (9 registries): White
USA, SEER (14 registries)
USA, SEER (14 registries): Asian and Pacific Islander
USA, SEER (14 registries): Black
USA, SEER (14 registries): Hispanic White
USA, SEER (14 registries): Non-hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, New Delhi
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon

Carcinoma

Sarcoma

Other

Unspec.

0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0

0.0
0.0
0.0
0.0
0.0

Squamous

Adeno

Other

Unspec.

0.7
0.8
1.0
0.7
0.9
0.7
0.8
0.5
0.8
0.9
0.8
0.7
0.8
0.8
0.3
1.3
0.9
0.9
0.9
0.9
0.7
1.0
0.9
0.9
0.8
1.0
1.2
0.8
0.7
0.8
1.0
0.9
0.8
0.9
0.9
0.2
0.7
0.6
1.1
0.8
0.3
1.0
0.9
0.7
0.9
0.9
0.5
1.0
1.1
1.4
0.6

0.1
0.2
0.2
0.2
0.2
0.1
0.1
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.0
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1

0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0

0.0
0.2
0.1
0.1
0.3
0.1
0.2
0.1
0.1
0.3
0.3
0.1
0.0
0.1
0.0
0.1
0.1
0.0
0.1
0.2
0.1
0.2
0.1
0.1

0.1
4.7
0.1
0.0
0.1
0.1
0.1
0.3
0.1
0.1
0.1
0.1
0.1
0.3
0.1
0.2
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.1

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

Number of cases
MV

Total

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

342
156
41
115
48
290
224
13
209
35
342
27
302
65
0
9
56
779
113
654
9174
772
8176
449
43
395
139
201
504
37
455
50
1021
97
893
2939
82
226
213
2391
146
16
128
693
63
621
68
17
260
185
121
152

345
157
42
115
50
291
226
13
211
36
348
27
308
67
0
9
58
789
115
662
9272
784
8260
450
43
396
142
201
510
37
461
50
1031
98
902
2968
83
227
213
2418
147
16
129
708
65
634
69
18
264
187
122
155

0.0
0.3
0.2
0.2
0.1
0.1
0.1
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0

0
8
1208
1
4
49
8
5
35
2
55
14
56
12
2
97
93
4
16
11
12
22
18
87
11
267
25
25
5
5
12

0
8
1304
1
6
65
8
5
41
2
67
14
71
14
2
100
96
4
17
11
12
25
18
107
13
323
31
27
7
6
13

*
*
*
*
*

*
*
*
*

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

635

693

Age-standardized (world) incidence rates (per 100,000)


by histological type

Anus (C21) - Female (Contd)

Asia (Contd)
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland (data not available)
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg (data not available)
Germany, Free State of Saxony (data not available)
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania (data not available)
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio
Italy, Syracuse Province
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce (data not available)
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg

Carcinoma

Sarcoma

Other

Unspec.

0.0
0.0
0.0
0.0
0.0
0.0
-

0.1
0.0
0.0
0.0
0.1

0.0
0.0
-

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
-

Squamous

Adeno

Other

Unspec.

0.3
0.0
0.2
0.1
0.0
0.0
0.2
0.0
0.2
0.2
0.4
0.1
0.2
0.1
0.1

0.2
0.1
0.0
0.3
0.3
0.0
0.1
0.2
0.1
0.2
0.2
0.4
0.2
0.1
0.0
0.1

0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.7
0.8
1.1
0.1
0.4
0.3
0.1
0.1
0.4
1.1
0.5
0.9
1.1
1.1
0.7
1.6
1.1
0.6
0.9
0.8
0.7
0.8
1.1
0.6
0.5
0.9
1.2
0.3
0.7
0.7
0.6
0.7
1.0
0.6
0.3
0.2
0.5
0.8
0.2
0.5
0.6
0.2
0.2
0.3
0.9
0.3
0.5
0.4
0.2
0.1
0.1
0.8
0.1
0.5
0.3
0.6
0.2

0.1
0.2
0.2
0.2
0.1
0.1
0.2
0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.2
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.0
0.2
0.4
0.1
0.1
0.1
0.2
0.1
0.0
0.2
0.2
0.2
0.1
0.3
0.2
0.1
0.3
0.3
0.0
0.3
0.1
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.2
0.4
0.1
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
-

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

694

636

Cancer Incidence in Five Continents Vol. IX, IARC 2008

Number of cases
MV

Total

0.0
0.1
0.1
0.3
0.0
0.0
0.0
0.0
0.0
0.0

3
91
3
5
2
8
4
1
8
12
43
37
2
4
17
3
4
1
26

3
96
4
7
3
9
4
1
8
14
45
39
2
4
18
3
4
1
27

0.0
0.1
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.1
0.1
0.2
0.0
0.0
0.0
0.0
0.2
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.0
0.0
0.0

354
33
19
147
37
90
121
40
216
294
42
46
39
27
28
81
57
39
26
26
17
28
118
86
76
69
11
74
14
25
19
68
48
2
58
20
10
117
27
9
23
43
17
6
4
8
70
28
19
55
51
45
7
170
9
52
101
109
72

368
33
19
167
37
94
153
60
238
305
45
46
39
27
29
81
59
39
26
26
17
29
129
87
84
69
11
76
14
26
22
72
48
2
64
20
10
150
28
9
25
46
25
6
5
8
70
40
19
66
61
48
7
172
17
58
103
111
78

*
*
*

*
*
*
*

*
*
*

Europe
Serbia
Slova
Slove
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Switz
Switz
Switz
Switz
Switz
Switz
Switz
The N
The N
The N
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, N
UK, S
Oceani
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Frenc
New Z
USA,
USA,
USA,
USA,
USA,
USA,

*
*

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Anus (C21) - Female (Contd)

es

al

3
6
4
7
3
9
4
1
8
4
5
9
2
4
8
3
4
1
7

8
3
9
7
7
4
3
0
8
5
5
6
9
7
9
1
9
9
6
6
7
9
9
7
4
9
1
6
4
6
2
2
8
2
4
0
0
0
8
9
5
6
5
6
5
8
0
0
9
6
1
8
7
2
7
8
3
1
8

*
*
*

*
*
*
*

*
*
*

Europe (Contd)
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, England, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern And Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory (data not available)
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Carcinoma

Sarcoma

Other

Unspec.

0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.2
0.0
0.2
0.0
0.0
-

0.0
0.0
0.0
0.0
0.0
0.1

0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.3
-

0.0
0.0
0.0
-

Squamous

Adeno

Other

Unspec.

0.1
0.1
0.2
0.1
0.2
0.2
0.3
0.0
0.2
0.3
0.3
0.3
0.9
2.0
0.3
1.2
1.2
0.7
1.0
1.7
0.3
0.3
0.3
0.5
0.6
0.7
0.7
0.6
0.7
0.7
0.5
0.6
0.5
0.7

0.1
0.2
0.2
0.1
0.2
0.2
0.0
0.4
0.1
0.2
0.1
0.1
0.1
0.0
0.0
0.2
0.7
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1

0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.8
0.6
0.5
0.7
0.3
0.5
0.5
0.7
0.5
0.4
0.1
1.4

0.2
0.1
0.2
0.0
0.2
0.2
0.2
0.5
0.1
0.0
0.1
-

0.0
0.0
0.2
0.1
0.0
0.1
0.0
-

Number of cases
MV

Total

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0

44
79
43
2
23
37
17
8
10
13
14
15
13
20
412
45
2
19
29
14
13
61
303
16
20
95
84
173
266
86
310
489
155
176
41
183

55
86
44
2
23
39
18
9
10
13
15
15
13
20
412
46
2
19
29
15
15
62
306
16
20
97
93
177
271
89
358
528
163
182
42
188

0.0
0.0
0.0
0.0
0.0
-

272
104
54
18
110
53
9
2
125
26
2
0
2
3
19

279
116
56
19
114
55
9
2
127
26
2
0
2
3
19

*
*

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

637

695

Age-standardized (world) incidence rates (per 100,000)


by histological type

Liver (C22) - Male


Carcinoma

Hepato-

Sarcoma

Hepato Cholangio Other Unspec. blastoma Haemangio


Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Non-Hispanic White
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Georgia: Black
USA, Georgia: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
USA, Louisiana: Black
USA, Louisiana: White
USA, Maine
USA, Massachusetts

638

Other Unspec.

Number of cases
MV

Total

0.2
19.8
1.1
1.8
13.9

0.2
0.5
0.4
0.5
0.4

0.1
0.1
0.1
-

0.5
0.2
0.2
-

0.0
0.0
0.1

0.5
1.0
0.4
6.2
0.1

13
377
17
40
38

22
912
20
100
265

1.9
1.7
0.8
2.0
2.4
0.7
1.3
1.1
1.3
2.0
2.1

0.7
1.2
1.9
0.5
0.3
0.1
0.6
0.3
0.7
0.3
0.2

0.4
0.1
0.1
0.3
0.1
0.0
0.1
0.6
0.1

1.5
0.3
0.5
0.0
0.2
0.0
0.1
0.1
-

0.1
0.0
0.2
-

0.0
0.0
-

0.1
0.2
0.1
-

0.4
2.6
3.0
0.8
0.1
4.1
1.1
4.3
1.1
0.8
-

22
113
24
38
554
11
70
123
37
36
22

41
135
41
49
585
46
105
444
94
44
22 *

2.7
3.3
3.6
2.7
1.4
1.2
1.8
1.6
2.7
1.6
1.2
2.6
3.0
2.5
4.5
3.3
5.8
7.0
9.5
16.5
8.8
9.1
6.4
3.8
6.6
7.5
14.1
10.2
8.4
5.3
22.7
3.6
14.4
7.7
8.3
3.4
3.0
3.6
6.1
3.3
5.7
6.5
4.3
3.4
4.2
3.1
2.8
3.7
4.7
2.6
3.5
2.4
1.9
3.7
5.7
3.2
2.9
2.4
2.7
4.3
6.3
6.0
4.8
3.9
2.6
4.0

0.4
0.6
0.5
0.6
0.6
0.2
0.4
0.3
0.4
0.2
0.7
0.5
0.7
0.8
0.6
0.6
0.8
0.6
1.1
0.4
1.0
0.4
0.7
0.6
0.5
0.9
0.8
0.6
0.6
1.3
0.6
1.0
0.5
0.8
0.6
0.4
0.8
1.2
0.8
0.7
0.8
0.3
0.5
0.6
0.5
0.5
0.7
0.5
0.8
0.5
0.5
0.8
0.7
0.8
0.7
0.4
0.6
0.5
0.7
1.0
0.6
0.9
0.7
0.7
0.6

0.1
0.2
0.1
0.3
0.0
0.1
0.0
0.1
0.2
0.1
0.2
0.1
0.1
0.2
0.3
0.2
0.2
0.2
0.1
0.3
0.3
0.1
0.5
0.3
0.8
0.8
0.5
0.7
1.5
0.4
0.5
0.4
0.4
0.2
0.1
0.2
0.1
0.2
0.4
0.4
0.3
0.2
0.1
0.2
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.1
0.2
0.2
0.1
0.1
0.1
0.0
0.1
0.1
0.1

0.1
0.1
0.3
0.1
0.1
0.0
0.1
0.1
0.0
0.3
0.3
0.3
0.3
0.3
0.2
0.2
0.3
0.5
0.5
0.3
0.1
0.2
0.2
0.4
0.5
0.3
0.1
0.7
0.1
0.4
0.3
0.4
0.1
0.1
0.3
0.4
0.2
0.2
0.1
0.3
0.2
0.3
0.2
0.1
0.1
0.1
0.0
0.2
0.1
0.1
0.3
0.6
0.3
0.2
0.1
0.2
0.4
0.2
0.1
0.6
0.3
0.2
0.1

0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.6
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.5
0.1
0.9
0.5
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.0
0.2
0.1
0.1

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
0.0
0.0
0.0
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.2
0.0
0.0
0.1
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.0
-

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
0.3
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
-

0.7
0.2
0.3
0.5
0.3
1.1
0.6
0.6
0.4
0.3
0.4
0.4
0.2
0.2
0.2
0.3
0.5
0.1
0.2
0.1
0.2
0.2
0.5
0.1
0.3
0.3
0.8
0.1
0.4
0.2
0.4
0.2
0.4
0.1
0.1
1.1
1.6
0.2
0.8
1.1
0.8
0.2
0.1
0.1
0.1
0.2
0.2
0.2
0.3
0.6
0.2
0.2
0.2
0.1
0.5
1.5
0.6
0.7
0.5
0.3
0.6

1882
265
383
78
42
29
1
46
972
12
54
409
79
324
77
576
4915
1091
90
190
63
157
14
426
1479
161
142
80
392
21
95
472
1304
374
1045
2134
383
499
50
434
101
69
26
2457
263
2111
691
263
83
143
170
480
86
1547
241
1189
572
288
395
640
62
127
169
441
121
867

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

696

Other

Cancer Incidence in Five Continents Vol. IX, IARC 2008

3301
417
736
168
59
32
1
87
1696
16
89
638
123
506
100
798
7052
1651
139
294
93
240
21
616
2083
224
190
99
591
36
144
642
1858
525
1594
2987
537
602
57
527
135
98
30
3370
358
2914
872
326
108
170
216
603
130
2031
343
1553
766
379
516
853
86
162
228
591
196
1162

*
*
*
*

Americ
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
Asia
Bahra
China
China
China
China
China
China
Cypru
India,
India,
India,
India,
India,
India,
India,
Israel
Israel
Israel
Japan
Japan
Japan
Japan
Japan
Japan
Japan
Korea
Korea
Korea
Korea
Korea
Korea

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Liver (C22) - Male (Contd)

es

Carcinoma

al

2
2
0
0
5

*
*
*
*

1
5
1
9
5
6
5
4
4
4
2*

1
7
6
8
9
2
1
7
6
6
9
8
3
6
0
8
2
1
9
4
3
0
1
6
3
4
0
9
1
6
4
2
8
5
4
7
7
2
7
7
5
8
0
0
8
4
2
6
8
0
6
3
0
1
3
3
6
9
6
3
6
2
8
1
6
2

Hepato-

Sarcoma

Hepato Cholangio Other Unspec. blastoma Haemangio


America, North (Contd)
USA, Michigan
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Michigan: Black
USA, Michigan: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York state
USA, New York state: Black
USA, New York state: White
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 registries)
USA, SEER (9 registries): Black
USA, SEER (9 registries): White
USA, SEER (14 registries)
USA, SEER (14 registries): Asian and Pacific Islander
USA, SEER (14 registries): Black
USA, SEER (14 registries): Hispanic White
USA, SEER (14 registries): Non-hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, New Delhi
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon

Other

Other Unspec.

Number of cases
MV

Total

3.3
4.6
7.9
3.6
7.1
2.7
2.9
7.4
2.4
2.1
4.1
5.9
3.5
4.5
7.0
7.7
2.5
5.1
6.7
4.2
3.9
5.8
3.3
2.5
5.8
2.0
2.2
2.9
3.9
9.8
3.2
4.1
4.5
7.2
3.3
4.7
12.7
6.4
7.9
3.1
2.9
3.1
2.7
5.1
6.5
4.7
2.3
2.2
3.8
4.4
2.2
2.8

0.8
0.8
0.9
0.7
0.7
0.8
0.6
0.8
0.5
0.4
0.7
0.9
0.7
0.7
1.8
0.7
0.6
0.8
0.9
0.8
0.7
0.7
0.6
0.6
0.8
0.6
0.4
0.5
0.7
0.6
0.6
0.6
0.7
0.8
0.7
0.7
1.0
0.7
0.7
0.6
0.6
0.6
0.6
0.7
0.8
0.6
0.5
0.6
0.8
0.8
0.8
0.9

0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.2
0.2
0.2
0.2
0.3
0.4
0.1
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.2
0.1
0.3
0.3
0.2
0.3
0.2
0.2
0.1
0.2
0.4
0.2
0.4
0.2
0.1
0.0
0.1
0.2
0.2
0.2
0.1
0.3
0.2
0.2
0.2
0.1

0.2
0.4
0.5
0.4
0.4
0.2
0.2
0.2
0.2
0.3
0.2
0.4
0.1
0.3
0.7
0.3
0.3
0.3
0.6
0.2
0.2
0.4
0.2
0.4
0.9
0.3
0.2
0.1
0.2
0.4
0.1
0.1
0.2
0.3
0.2
0.2
0.3
0.4
0.3
0.2
0.3
0.3
0.2
0.2
0.1
0.2
0.0
0.1
0.2
0.2
0.2
0.2

0.1
0.0
0.0
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.3
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.1

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
-

0.4
0.2
0.2
0.2
0.5
0.4
0.5
1.7
0.4
0.5
0.8
0.5
0.4
0.5
0.5
0.3
0.4
0.8
0.3
0.4
0.7
0.4
0.3
0.6
0.3
1.1
0.2
0.2
0.4
0.1
0.2
0.2
0.2
0.1
0.3
0.5
0.4
0.4
0.2
0.4
0.6
0.3
0.6
1.0
0.6
0.0
0.1
0.2
0.2
0.2
0.6

1230
618
189
404
224
956
621
111
491
62
1242
170
965
249
23
120
97
3028
449
2226
28846
3534
22272
1226
196
974
313
285
1868
275
1473
159
3585
446
2365
10058
1858
1115
1397
5553
434
97
325
2854
313
2355
127
64
681
505
210
688

1613
791
233
529
295
1257
813
146
646
99
1621
229
1247
368
37
175
145
4206
616
3072
39416
4843
30392
1576
265
1247
495
462
2366
354
1865
201
4885
584
3210
13843
2592
1483
2082
7485
583
141
427
4014
463
3301
163
73
991
748
259
893

3.4
21.0
19.1
5.1
0.8
5.0
1.5
1.7
0.9
2.6
1.2
0.9
3.3
1.3
2.4
2.3
1.8
11.8
19.1
35.6
11.4
22.3
30.4
5.7
34.6
37.8
33.8
26.9
38.1
28.7

1.4
0.3
1.6
1.3
0.2
0.3
0.9
0.3
0.6
0.6
0.3
0.5
0.1
0.1
0.2
0.2
0.1
1.0
1.0
1.7
1.2
0.9
1.6
0.6
2.9
2.5
2.7
2.6
2.4
2.7

0.1
0.1
0.1
0.0
0.1
0.2
0.1
0.2
0.1
0.0
0.2
0.1
0.2
0.2
0.1
0.3
0.2
0.1
0.9
0.9
1.2
1.1
0.8
1.2

0.4
20.7
0.3
0.1
0.0
20.3
0.3
0.0
0.3
0.1
0.4
0.2
0.0
0.0
0.1
2.1
0.1
2.2
0.0
0.0
0.2
0.2
0.1
0.2
0.1
0.2

0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.2
0.1
0.2
0.2
0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.1

0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0

0.0
0.0
0.0
0.0
0.0
0.0
-

0.3
8.2
27.3
30.3
24.8
0.2
0.8
1.8
1.1
0.1
0.5
1.2
0.4
0.3
0.4
9.2
0.1
0.1
3.4
0.8
3.3
7.8
6.2
8.3
8.2
4.5
8.7
3.9

20
706
3669
88
487
1070
353
67
185
18
685
60
389
165
50
310
273
32
509
144
583
536
640
12227
262
9822
881
796
277
235
467

30
2425
6289
440
713
6001
857
74
269
34
895
65
491
209
78
556
463
42
862
815
1632
1709
1923
13494
969
40709
4438
2582
990
1349
1961

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

639

*
*
*
*
*

*
*
*
*

697

Age-standardized (world) incidence rates (per 100,000)


by histological type

Liver (C22) - Male (Contd)


Carcinoma

Hepato-

Sarcoma

Hepato Cholangio Other Unspec. blastoma Haemangio


Asia (Contd)
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland (data not available)
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg (data not available)
Germany, Free State of Saxony (data not available)
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania (data not available)
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio
Italy, Syracuse Province
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce (data not available)
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg

640

Other Unspec.

Number of cases
MV

Total

37.6
34.2
28.1
3.4
1.8
6.4
6.6
5.3
4.2
12.7
5.0
5.8
1.3
2.3
4.7
3.7
2.3
2.6
2.3

2.2
2.6
3.8
0.2
1.0
0.2
1.1
0.7
0.6
0.3
0.4
0.1
0.1
3.8
3.3
0.5
0.5
0.2

0.9
0.8
1.6
0.0
0.3
0.2
0.2
0.1
0.1
0.1
0.1
0.0
0.0
0.2
0.2

0.2
0.2
1.0
0.2
0.5
0.3
0.2
2.5
0.1
0.1
0.3
0.1
0.0
0.1
0.0
0.0
0.0

0.2
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1

0.0
0.1
0.0
0.0
-

0.0
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.1
-

3.5
6.2
8.9
3.3
3.9
2.2
2.1
0.4
0.2
5.6
13.2
14.8
6.4
9.6
9.8
25.1
5.7
0.4
0.3

82
2277
220
26
33
115
175
107
78
403
458
419
13
26
338
164
82
96
143

352
9909
659
74
77
209
325
124
138
1570
1522
1352
59
111
730
723
233
109
253

5.4
5.8
3.2
0.5
0.9
1.4
0.7
1.9
3.7
2.0
1.6
5.9
10.9
6.6
7.7
7.7
8.8
10.9
4.5
6.6
3.4
5.9
3.7
3.7
4.5
3.9
1.5
1.1
4.7
15.7
5.3
2.8
6.9
2.2
8.5
4.6
25.0
7.5
14.3
3.8
7.5
3.9
4.3
7.9
10.1
6.2
3.8
7.9
14.2
9.4
1.1
1.1
1.1
1.4
1.0
1.3
2.1
2.4
0.6

1.0
0.5
0.3
0.4
0.1
0.5
0.1
0.5
0.8
0.9
0.6
1.2
0.5
1.1
1.3
1.1
0.7
0.9
0.5
0.7
0.5
0.9
0.8
0.3
0.4
0.8
0.3
0.3
0.3
1.2
0.6
0.5
0.6
0.1
0.5
0.4
0.6
1.2
0.7
0.3
1.2
0.3
1.1
0.8
1.1
0.1
0.4
0.3
0.6
0.8
0.0
0.5
0.4
0.3
0.3
0.2
0.5
0.4
0.3

0.4
0.4
0.8
0.1
0.1
0.1
0.0
0.1
0.1
0.2
0.2
0.1
0.0
0.2
0.1
0.1
0.2
0.1
0.1
0.2
0.4
0.1
0.5
0.3
0.0
0.8
0.1
0.2
0.2
0.2
1.6
0.2
0.7
0.3
0.0
0.1
0.1
0.1
0.4
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.2
0.0

0.3
0.1
0.2
0.3
0.1
0.0
0.5
0.1
0.2
0.3
0.2
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.4
0.0
0.0
0.2
0.1
0.0
0.1
0.4
0.6
0.2
0.2
0.3
0.2
0.9
0.9
0.4
0.2
0.1
0.7
0.3
0.5
0.1
0.1
0.0
0.3
0.1
0.2
0.1
0.4
0.1
0.1
0.1
0.2

0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.3
0.1
0.1
0.0
0.2
0.1
0.0
0.0
0.1
0.1
0.2
0.1
0.2
0.0
0.0
0.1
0.1
0.1

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
-

0.0
-

1.3
0.5
2.5
2.1
0.0
0.2
4.9
3.7
2.2
0.6
1.1
6.0
3.8
0.1
2.1
0.1
2.0
2.7
1.0
0.3
0.9
0.5
0.1
0.1
1.6
1.0
9.3
11.2
4.9
5.2
3.6
4.5
6.0
5.1
6.6
7.6
3.8
10.2
1.2
2.4
8.5
6.8
14.2
4.6
8.5
1.0
7.6
2.9
2.1
0.7
0.2
1.8
1.3
0.3
2.2
3.5

1897
101
49
428
71
369
299
517
1591
735
140
268
109
83
201
296
273
424
65
121
62
154
166
395
477
226
19
156
45
423
113
252
138
29
388
151
173
943
206
47
109
208
210
176
94
40
213
289
212
687
53
245
21
324
49
121
294
340
312

2604
174
79
998
88
496
1949
1162
2569
878
182
485
372
150
301
339
475
588
128
162
93
197
355
407
615
323
20
291
149
732
243
558
351
75
794
333
535
1709
450
188
224
354
510
316
192
145
608
456
308
1325
313
420
35
388
92
182
330
623
651

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

698

Other

Cancer Incidence in Five Continents Vol. IX, IARC 2008

*
*
*

*
*
*
*

*
*
*

Europe
Serbia
Slova
Slove
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Switz
Switz
Switz
Switz
Switz
Switz
Switz
The N
The N
The N
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, N
UK, S
Oceani
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Frenc
New Z
USA,
USA,
USA,
USA,
USA,
USA,

*
*

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Liver (C22) - Male (Contd)

es

Carcinoma

al

2
9
9
4
7
9
5
4
8
0
2
2
9
1
0
3
3
9
3

4
4
9
8
8
6
9
2
9
8
2
5
2
0
1
9
5
8
8
2
3
7
5
7
5
3
0
1
9
2
3
8
1
5
4
3
5
9
0
8
4
4
0
6
2
5
8
6
8
5
3
0
5
8
2
2
0
3
1

Hepato-

Sarcoma

Hepato Cholangio Other Unspec. blastoma Haemangio

*
*
*

*
*
*
*

*
*
*

Europe (Contd)
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, England, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern And Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory (data not available)
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Other

Other Unspec.

Number of cases
MV

Total

1.3
2.2
3.1
3.1
7.4
5.8
5.6
2.3
3.8
2.2
4.0
5.5
5.1
3.5
2.2
5.5
2.7
4.1
3.1
11.9
5.3
5.3
1.1
0.6
1.2
1.0
1.7
1.9
1.8
1.4
1.5
1.9
1.4
1.7
0.7
2.2

1.1
0.7
0.6
0.5
0.8
0.6
0.7
0.4
0.6
0.1
0.4
1.0
0.2
0.5
0.6
0.5
0.5
0.6
0.2
1.3
0.5
0.8
0.2
0.1
0.1
0.7
2.3
1.4
1.0
0.8
0.8
0.7
1.1
0.5
0.3
1.0

0.3
0.3
0.1
0.2
0.3
0.3
0.1
0.2
0.1
0.3
0.5
0.5
0.1
0.1
0.1
0.2
0.4
0.2
0.1
0.2
0.1
0.0
0.1
0.0
0.0
0.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1

0.4
0.3
0.1
0.1
0.1
0.1
0.1
0.1
0.4
0.3
0.2
0.2
0.2
0.0
0.6
0.2
0.1
0.0
0.5
0.3
0.0
0.0
0.3
0.2
0.0
0.1
0.2

0.0
0.1
0.1
0.3
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.1

0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
-

2.2
3.0
1.9
1.0
1.0
3.9
1.9
1.6
4.3
5.0
1.9
0.7
2.7
0.9
0.0
5.5
2.7
3.5
0.9
2.3
5.6
2.7
0.4
0.3
0.2
0.1
0.0
0.1
0.0
0.6
0.4
0.1
0.4
1.0
0.3

599
530
381
28
280
313
218
25
113
86
190
120
105
158
1241
95
26
34
67
110
61
150
810
30
50
112
269
278
364
136
377
805
289
296
65
408

1070
1041
415
66
491
778
395
61
219
264
285
202
177
194
1250
176
57
58
88
216
125
214
1029
40
58
223
506
634
825
239
907
1736
595
616
136
794

3.4
2.5
2.7
1.6
2.4
2.8
2.8
9.5
3.1
6.7
10.4
8.0
7.6
5.8
4.1

0.6
0.8
0.4
0.5
0.3
0.5
1.0
0.3
0.6
1.0
2.3
1.0
1.3
1.2
0.3

0.1
0.1
0.1
0.0
0.1
0.2
0.0
0.0
0.0
0.1

0.0
0.1
0.0
0.1
0.0
0.2
0.5
0.0
0.1
0.2
0.2
0.1

0.1
0.1
0.3
0.1
0.1
0.2
0.0
0.2
0.4
0.6
-

0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.1
-

0.0
0.0
0.0
0.1
-

0.0
-

0.1
0.0
0.1
1.0
2.0
0.1
2.9
0.4
1.1
1.2
1.0
1.5
0.7
0.9

658
227
77
40
465
150
24
43
335
296
35
54
44
84
43

997
439
196
55
836
229
34
59
506
395
46
68
54
107
69

*
*

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

641

699

Age-standardized (world) incidence rates (per 100,000)


by histological type

Liver (C22) - Female


Carcinoma

Hepato-

Sarcoma

Hepato Cholangio Other Unspec. blastoma Haemangio


Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Non-Hispanic White
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Georgia: Black
USA, Georgia: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
USA, Louisiana: Black
USA, Louisiana: White
USA, Maine
USA, Massachusetts

642

Other Unspec.

Number of cases
MV

Total
16
227
7
73
159

4.1
0.3
1.3
12.0

0.3
0.1
0.1
0.3
0.3

0.1
0.1
0.1

0.0
0.0
0.1
0.1

0.0
0.0

0.0
-

0.0
-

0.4
0.0
0.2
4.2
0.1

10
88
5
21
23

0.6
0.6
0.2
0.3
0.6
0.6
0.6
0.5
1.2
0.8
0.8

0.1
2.4
1.3
0.3
0.3
0.4
1.0
0.2
0.8
0.1
0.2

0.2
0.1
0.1
0.4
0.1
0.1
0.1
0.2
-

0.4
0.5
0.6
0.1
0.0
0.1
0.1
0.1
0.1
-

0.0
0.0
0.2
0.0
0.1
0.1

0.1
-

0.0
0.0
0.0
-

0.0
-

0.2
2.0
1.8
0.5
0.1
2.1
0.9
2.9
1.6
0.2
-

9
122
16
11
274
15
85
66
35
21
13

0.7
0.8
0.8
0.8
0.1
0.6
0.3
0.7
0.2
0.4
0.8
0.9
0.7
2.3
1.0
1.7
2.0
2.2
3.8
2.5
3.2
2.9
1.0
2.1
1.8
4.8
1.6
2.8
4.6
9.1
1.2
4.5
1.9
2.7
1.0
1.0
1.0
1.6
0.9
1.7
2.2
0.6
0.8
1.1
0.8
0.7
1.0
1.5
0.6
0.8
0.6
0.7
1.0
1.8
0.9
0.9
0.6
0.7
1.0
1.4
1.3
1.0
1.0
0.6
0.7

0.3
0.4
0.4
0.3
0.4
0.1
0.2
0.3
0.2
0.1
0.5
0.5
0.5
0.5
0.3
0.5
0.5
0.6
0.4
0.9
0.9
0.2
0.3
0.6
0.4
0.5
0.7
0.8
0.9
0.7
0.4
0.6
0.4
0.7
0.4
0.4
0.4
0.1
0.4
0.3
0.2
0.5
0.4
0.5
0.4
0.4
0.3
0.4
0.3
0.4
0.4
0.5
0.5
0.5
0.5
0.3
0.4
0.5
0.4
0.3
0.4
0.4
0.4
0.4
0.5

0.1
0.1
0.1
0.1
0.0
0.2
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.3
0.1
0.2
0.4
0.1
0.2
0.3
0.2
0.1
0.3
0.4
0.3
0.2
0.2
0.2
0.2
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.1
0.0
0.1

0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.2
0.0
0.2
0.0
0.1
0.1
0.1
0.1
0.4
0.2
0.3
0.1
0.0
0.2
0.1
0.1
0.1
0.0
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.2
0.1
0.1
0.0
0.0
0.1
0.2
0.1
0.1
0.1
0.1
0.0

0.1
0.1
0.0
0.1
0.0
0.2
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.0
0.9
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.2
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.1
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0

0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.2
0.1
0.1
0.2
0.0
0.1
0.4
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.0
0.1
0.1
0.2
0.1
0.2
0.2
0.1
0.1
0.2
0.1
0.2
0.1
0.1
0.0
0.1
0.0
0.1
0.1
0.2
0.3
0.2
0.2
0.0
0.1
0.0
0.1
0.2
0.0
0.1
0.2
0.1
0.0
0.1
0.1
0.2
0.3
0.2
0.2
0.1
0.1
0.2

726
91
157
27
17
15
0
22
375
3
19
228
54
170
33
238
2246
433
37
57
32
78
12
165
752
64
60
27
238
32
48
242
535
141
536
1003
187
222
14
199
44
37
7
1093
110
948
329
109
38
55
78
228
54
751
125
589
302
141
226
261
27
51
63
196
50
311

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

700

Other

Cancer Incidence in Five Continents Vol. IX, IARC 2008

*
*
*
*

16
148
26
22
300
41
124
321
129
25
13 *
1393
164
309
79
25
18
0
45
708
5
40
359
81
271
47
345
3296
713
56
92
47
114
22
276
1072
92
84
33
340
46
73
348
804
207
768
1475
257
276
18
249
56
49
7
1550
153
1356
457
143
53
73
108
323
74
1074
185
834
392
203
291
349
36
67
89
255
72
488

Americ
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
Asia
Bahra
China
China
China
China
China
China
Cypru
India,
India,
India,
India,
India,
India,
India,
Israel
Israel
Israel
Japan
Japan
Japan
Japan
Japan
Japan
Japan
Korea
Korea
Korea
Korea
Korea
Korea

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Liver (C22) - Female (Contd)

es

Carcinoma

al

6
7
7
3
9

*
*
*
*

6
8
6
2
0
1
4
1
9
5
3*

3
4
9
9
5
8
0
5
8
5
0
9
1
1
7
5
6
3
6
2
7
4
2
6
2
2
4
3
0
6
3
8
4
7
8
5
7
6
8
9
6
9
7
0
3
6
7
3
3
3
8
3
4
4
5
4
2
3
1
9
6
7
9
5
2
8

Hepato-

Sarcoma

Hepato Cholangio Other Unspec. blastoma Haemangio


America, North (Contd)
USA, Michigan
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Michigan: Black
USA, Michigan: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York state
USA, New York state: Black
USA, New York state: White
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 registries)
USA, SEER (9 registries): Black
USA, SEER (9 registries): White
USA, SEER (14 registries)
USA, SEER (14 registries): Asian and Pacific Islander
USA, SEER (14 registries): Black
USA, SEER (14 registries): Hispanic White
USA, SEER (14 registries): Non-hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, New Delhi
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon

Other

Other Unspec.

Number of cases
MV

Total

0.9
1.2
1.9
1.0
1.7
0.7
0.7
1.6
0.6
0.6
0.9
1.2
0.7
1.3
1.2
1.6
1.0
1.2
1.7
1.0
1.0
1.4
0.9
0.7
1.1
0.6
0.6
0.9
0.9
2.0
0.7
1.0
1.2
1.8
0.9
1.3
4.0
1.5
2.4
0.8
0.7
0.7
0.6
1.4
1.6
1.3
0.7
0.3
1.1
1.3
0.5
0.7

0.5
0.5
0.3
0.5
0.3
0.5
0.4
0.6
0.4
0.5
0.5
0.3
0.5
0.6
1.1
0.5
0.6
0.5
0.4
0.5
0.5
0.4
0.5
0.5
0.5
0.4
0.5
0.4
0.4
0.5
0.4
0.6
0.5
0.4
0.4
0.5
0.6
0.4
0.7
0.4
0.4
0.4
0.3
0.5
0.4
0.5
0.4
0.4
0.6
0.6
0.6
0.5

0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.1
0.2
0.3
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1

0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.2
0.0
0.1
0.1
0.1
0.1
0.3
0.5
0.3
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.2
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1

0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.2
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.0
0.0
0.0
0.1
0.1
0.1
0.2
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.2
0.1
0.1
0.0
0.2
0.2
0.1
0.2
0.1
0.0
0.2
0.2
0.2
0.2
0.3
0.2
0.1
0.1
0.2
0.1
0.1
0.2
0.1
0.1
0.2
0.1
0.3
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.3
0.2
0.2
0.1
0.1
0.2
0.1
0.3
0.3
0.2
0.1
0.0
0.1
0.1
0.1
0.3

565
281
72
197
86
461
282
45
231
38
522
63
419
122
11
44
61
1348
202
1037
13170
1472
10518
639
75
544
201
149
788
105
653
77
1611
172
1102
4591
781
420
679
2643
180
54
112
1217
111
1053
70
21
340
252
106
311

799
373
90
271
113
664
375
59
309
66
752
83
619
178
15
68
88
1981
291
1520
18834
2074
15047
854
102
729
291
238
1074
140
895
97
2297
232
1574
6525
1129
582
970
3746
250
71
164
1854
179
1588
96
27
506
382
143
430

1.0
3.8
3.8
2.0
0.2
0.8
0.5
0.3
0.1
1.0
0.6
0.3
1.3
0.4
0.9
0.9
0.3
4.1
7.0
10.0
3.5
6.0
9.1
1.9
8.0
9.6
8.1
7.0
7.3
7.8

0.8
0.1
1.1
0.2
0.1
0.2
0.4
0.2
0.1
0.4
0.2
0.4
0.1
0.1
0.2
0.2
0.1
0.7
0.4
0.8
0.6
0.6
0.8
0.3
1.3
1.4
1.0
1.1
0.6
1.4

0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.4
0.4
0.6
0.5
0.3
0.4

0.6
7.3
0.1
0.0
3.9
0.1
0.0
0.1
0.0
0.3
0.1
0.0
0.0
0.0
0.9
0.0
0.9
0.0
0.1
0.1
0.0
0.0
0.1
0.0

0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.2
0.1
0.1
0.3
0.1
0.0
0.1
0.1
0.0
0.1

0.0
0.0
0.0
0.0
0.1
0.0
0.0

0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.1
0.0
0.0
0.0
0.0
0.0

0.8
0.1
2.1
10.4
10.3
8.0
0.1
0.3
0.5
0.6
0.0
0.4
0.4
0.2
0.1
0.1
3.2
0.0
1.4
0.4
1.0
3.3
2.1
3.4
3.0
1.4
2.4
1.9

11
146
968
29
180
343
67
24
53
3
319
34
167
53
20
184
168
14
225
49
182
201
263
5036
128
3177
312
234
89
71
185

17
729
1771
174
252
2300
177
29
83
8
433
35
232
88
30
333
293
15
388
446
659
880
906
5654
607
13339
1582
869
339
374
712

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

643

*
*
*
*
*

*
*
*
*

701

Age-standardized (world) incidence rates (per 100,000)


by histological type

Liver (C22) - Female (Contd)


Carcinoma

Hepato-

Sarcoma

Hepato Cholangio Other Unspec. blastoma Haemangio


Asia (Contd)
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland (data not available)
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg (data not available)
Germany, Free State of Saxony (data not available)
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania (data not available)
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio
Italy, Syracuse Province
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce (data not available)
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg

644

Other Unspec.

Number of cases
MV

Total

6.8
9.0
7.0
0.9
1.0
1.7
1.8
2.0
2.2
3.7
1.1
1.2
0.4
0.5
1.3
0.8
0.4
0.9
0.7

1.3
1.3
1.1
0.1
1.1
0.8
0.4
0.8
0.8
0.5
0.3
0.3
0.1
1.8
2.3
0.2
0.2
0.1

1.0
0.3
0.4
0.3
0.1
0.2
0.1
0.0
0.0
0.0
0.1
0.3

0.1
0.1
0.3
0.9
0.1
0.3
0.9
0.1
0.1
0.2
0.0
0.1
0.0
0.0

0.1
0.1
0.8
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
-

0.0
0.0
0.0
-

0.0
0.1
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.1
-

2.7
2.2
2.3
2.3
2.4
0.9
0.6
0.4
0.3
1.8
3.3
3.4
2.5
2.9
3.6
11.7
1.3
0.0
0.1

31
791
52
9
11
40
71
45
39
157
133
121
4
8
128
73
19
35
55

131
3269
185
37
27
82
114
53
70
568
459
409
14
36
278
347
60
36
111

1.1
1.4
0.5
0.2
0.3
0.5
0.3
0.6
1.0
0.5
0.6
0.5
1.3
0.8
1.0
1.6
1.3
0.8
0.6
1.0
0.5
0.5
1.3
0.7
1.2
1.0
0.1
0.3
0.6
3.4
1.4
0.5
1.6
0.3
1.9
1.3
6.9
1.1
6.6
1.1
2.0
1.3
1.3
2.1
0.7
2.6
0.7
2.6
3.1
1.6
0.6
0.2
0.4
0.5
0.1
0.5
0.6
0.4
0.2

0.7
0.3
0.3
0.2
0.2
0.4
0.1
0.3
0.4
0.6
0.4
0.6
0.3
0.7
0.9
0.6
0.4
0.2
0.3
0.6
0.2
0.4
0.7
0.2
0.3
0.5
0.3
0.2
0.5
0.4
0.8
0.3
0.4
0.2
0.1
0.4
0.6
0.4
0.2
0.4
0.6
0.2
0.6
0.4
0.3
0.3
0.3
0.2
0.2
0.4
0.1
0.5
0.2
0.3
0.3
0.2
0.3
0.2
0.2

0.3
0.3
0.3
0.1
0.0
0.1
0.0
0.1
0.1
0.2
0.1
0.0
0.1
0.0
0.1
0.0
0.0
0.1
0.0
0.2
0.2
0.0
0.4
0.2
0.2
0.0
0.1
0.3
0.0
0.0
0.1
0.1
0.0
0.4
0.0
0.5
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.1
0.0

0.1
0.1
0.0
0.1
0.0
0.1
0.0
0.3
0.0
0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.2
0.1
0.1
0.2
0.0
0.0
0.2
0.0
0.2
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.1

0.0
0.0
0.1
0.1
0.0
0.1
0.0
0.1
0.1
0.2
0.1
0.2
0.0
0.0
0.1
0.2
0.3
0.1
0.0
0.0
0.1
0.0
0.1

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.2
0.0
0.0
0.0
0.0
0.2
0.0
0.0
0.0
0.0
-

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
-

0.5
0.2
0.7
0.7
0.0
0.1
2.1
1.8
1.0
0.3
0.5
0.9
0.5
0.0
0.3
0.0
0.3
0.3
0.0
0.1
0.2
0.2
0.0
0.0
0.5
0.5
2.4
3.2
1.5
2.1
1.4
1.5
1.9
2.0
2.2
2.1
1.4
3.5
0.5
0.8
3.9
3.8
3.0
1.9
2.2
0.7
0.0
2.0
1.2
0.8
0.4
0.1
0.9
0.9
0.1
0.8
1.4

891
36
19
316
44
240
153
299
793
403
115
56
29
23
60
98
61
54
14
33
19
32
85
125
225
90
7
76
13
144
43
80
55
9
136
71
67
274
110
13
51
104
99
70
13
18
68
131
76
197
51
171
10
193
20
89
142
110
261

1319
78
31
705
50
366
1100
784
1449
540
150
104
77
48
96
110
123
75
21
52
31
39
280
129
324
156
7
164
59
284
129
294
185
29
383
192
199
635
296
86
104
193
295
184
52
90
249
277
122
525
251
299
17
250
61
152
159
269
565

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

702

Other

Cancer Incidence in Five Continents Vol. IX, IARC 2008

*
*
*

*
*
*
*

*
*
*

Europe
Serbia
Slova
Slove
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Switz
Switz
Switz
Switz
Switz
Switz
Switz
The N
The N
The N
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, N
UK, S
Oceani
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Frenc
New Z
USA,
USA,
USA,
USA,
USA,
USA,

*
*

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Liver (C22) - Female (Contd)

es

Carcinoma

al

1
9
5
7
7
2
4
3
0
8
9
9
4
6
8
7
0
6
1

9
8
1
5
0
6
0
4
9
0
0
4
7
8
6
0
3
5
1
2
1
9
0
9
4
6
7
4
9
4
9
4
5
9
3
2
9
5
6
6
4
3
5
4
2
0
9
7
2
5
1
9
7
0
1
2
9
9
5

Hepato-

Sarcoma

Hepato Cholangio Other Unspec. blastoma Haemangio

*
*
*

*
*
*
*

*
*
*

Europe (Contd)
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, England, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern And Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory (data not available)
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Other

Other Unspec.

Number of cases
MV

Total

0.7
0.6
0.6
0.6
1.1
1.3
1.7
0.6
1.2
0.4
0.8
1.0
1.5
0.7
0.7
0.6
0.6
0.9
0.8
1.8
0.9
0.8
0.3
0.2
0.2
0.3
0.4
0.5
0.4
0.3
0.5
0.4
0.4
0.4
0.4
0.5

0.7
0.6
0.4
0.2
0.3
0.4
0.5
0.2
0.3
0.2
0.4
0.5
0.1
0.5
0.5
0.3
0.5
0.3
0.3
0.3
0.5
0.7
0.1
0.2
0.2
0.6
1.8
1.0
0.8
0.8
0.6
0.5
0.8
0.5
0.6
0.9

0.2
0.2
0.1
0.3
0.1
0.1
0.3
0.3
0.1
0.0
0.1
0.2
0.0
0.0
0.1
0.1
0.2
0.1
0.1
0.3
0.0
0.0
0.0
0.0
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1

0.2
0.1
0.1
0.1
0.0
0.0
0.1
0.0
0.0
0.1
0.1
0.0
0.2
0.1
0.0
0.2
0.1
0.0
0.0
1.8
0.1
0.0
0.0
0.1
0.1
0.0
0.1
0.1

0.0
0.0
0.1
0.0
0.1
0.3
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.0
0.0
0.0
-

0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
-

1.5
1.2
0.5
0.6
0.2
1.1
0.7
1.0
1.2
1.7
0.7
0.3
0.9
0.4
0.0
1.1
0.5
0.6
0.2
0.5
0.5
0.5
0.2
0.2
0.1
0.0
0.0
0.1
0.0
0.3
0.1
0.0
0.2
0.3
0.1

429
323
143
9
65
116
98
6
49
29
70
33
35
64
687
19
13
16
30
30
22
50
361
18
17
61
232
146
193
77
234
352
152
137
54
230

793
667
168
37
146
332
187
31
99
112
135
76
78
98
705
50
22
20
37
64
31
72
484
28
23
163
673
425
540
155
607
912
401
366
114
512

0.8
0.6
0.5
0.4
0.4
0.7
1.0
2.6
0.8
2.1
2.3
1.6
2.3
2.7
0.8

0.4
0.5
0.3
0.2
0.2
0.4
0.7
0.5
0.5
0.6
1.2
0.6
1.1
0.4
0.4

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1

0.0
0.1
0.0
0.5
0.0
0.2
-

0.0
0.1
0.2
0.0
0.1
-

0.0
0.0
0.0
0.0
0.1
0.1
0.1

0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
-

0.0
0.0
0.0
0.3
0.6
0.0
0.8
0.3
0.4
0.4
0.5
0.7
0.2
0.2

230
80
31
11
145
49
16
14
148
127
11
15
20
53
12

378
189
72
19
292
85
18
18
247
171
17
21
27
65
18

*
*

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

645

703

Age-standardized (world) incidence rates (per 100,000)


by histological type

Lung (C34) - Male


Carcinoma

Squamous Adeno Small cell Large cell


Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Non-Hispanic White
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Georgia: Black
USA, Georgia: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
USA, Louisiana: Black
USA, Louisiana: White
USA, Maine
USA, Massachusetts

646

Sarcoma Other Unspec.

Number of cases
MV

Total

12.0
2.6
16.9
1.0
1.6

1.1
2.6
6.7
0.5
1.2

0.1
1.6
5.4
0.2
0.4

4.6
4.3
5.7
0.8
5.5

0.2
0.1

0.0
0.1
0.0

1.9
2.6
2.4
2.3
0.6

357
447
324
29
65

373
541
335
45
146

8.0
7.8
6.9
6.5
7.6
2.3
3.9
2.2
1.1
3.4
0.7

7.1
4.6
3.6
5.6
6.9
0.9
2.8
1.7
2.9
3.9
2.8

2.3
1.7
0.4
1.4
2.5
1.1
1.5
0.7
0.4
2.0
0.2

25.5
3.7
3.5
3.3
5.3
1.2
3.0
1.3
0.9
2.8
0.7

0.3
0.0
0.2
0.3
0.3
0.2
0.2
0.1
0.1
-

0.1
0.1
0.0
0.0
-

0.0
0.0
-

2.1
8.7
11.5
3.8
10.6
5.4
10.1
5.0
2.4
1.4
1.4

261
437
91
211
4331
49
393
443
149
143
39

377
496
153
265
6486
98
711
808
214
155
52 *

11.5
10.8
9.9
11.5
18.1
12.9
21.4
15.5
11.3
17.7
12.0
19.6
19.5
19.7
12.7
9.9
9.3
8.0
15.5
4.7
8.7
5.4
5.4
8.4
8.8
18.1
5.2
10.1
4.6
4.8
9.2
9.5
6.2
16.0
5.1
10.2
9.3
12.0
16.4
11.7
17.9
23.2
8.4
13.0
14.9
12.9
18.1
13.9
18.6
12.9
21.6
17.5
10.1
15.2
23.0
14.5
18.4
14.0
25.7
20.4
28.1
16.0
27.5
18.4
16.0
12.3

12.5
12.0
9.6
15.0
19.5
8.8
11.2
15.0
13.0
15.5
11.6
17.9
19.8
17.4
15.1
13.1
14.2
13.2
20.7
11.6
15.9
8.7
8.3
13.4
13.3
20.4
10.9
13.8
8.0
10.9
10.4
14.9
11.9
20.2
8.5
15.4
11.9
18.1
21.0
18.0
21.3
26.2
13.4
17.1
16.9
17.1
17.2
15.1
17.5
14.3
18.9
16.7
11.6
17.7
23.5
17.0
16.5
16.6
20.7
20.7
22.5
23.7
22.3
20.2
15.5
16.9

6.1
6.5
5.2
5.8
8.6
6.8
10.4
8.2
5.9
9.8
6.0
10.1
7.3
10.7
9.1
6.3
5.8
5.0
6.6
3.2
4.8
3.4
2.5
5.6
5.3
6.7
2.7
5.5
2.8
3.4
7.4
6.5
3.6
6.6
3.3
6.8
6.4
7.3
6.6
7.4
6.2
8.4
2.1
8.2
6.4
8.4
9.9
7.5
7.4
7.8
7.6
10.5
6.7
9.0
8.5
9.3
11.3
9.4
15.2
10.4
11.6
10.2
10.3
10.5
9.3
7.7

8.7
8.1
11.6
11.8
14.5
12.6
5.3
12.5
6.7
7.2
7.0
13.8
16.5
13.2
6.4
9.2
9.1
9.1
14.3
8.1
9.2
6.0
5.8
9.4
8.4
12.9
7.1
10.2
4.5
6.1
6.4
9.5
7.2
12.9
5.1
10.1
5.2
10.2
13.8
10.1
8.1
10.0
4.3
12.1
14.2
11.9
15.3
13.4
17.6
12.3
17.8
14.8
8.4
10.8
17.7
10.0
13.7
8.5
15.7
14.4
19.2
11.0
19.5
12.9
13.4
9.0

2.3
2.9
2.7
3.0
2.4
2.6
0.8
4.1
1.8
2.4
2.4
5.5
5.1
5.6
5.1
4.0
4.3
4.3
8.5
2.9
5.1
3.6
3.6
4.2
3.9
7.2
2.7
3.8
2.0
2.6
1.8
4.4
3.1
7.8
2.3
4.7
3.3
4.7
6.4
4.7
6.0
6.6
4.0
4.4
4.3
4.4
4.9
4.8
6.4
4.3
5.9
4.6
4.3
4.9
6.5
4.7
5.6
5.0
7.1
4.8
6.3
2.9
6.1
4.5
5.7
4.6

0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.0
0.1
0.3
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.1
0.2
0.2
0.2
0.1
0.1
0.1
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1

0.1
0.0
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.1
0.3
0.0
0.4
0.1
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0

6.7
2.4
2.3
3.9
3.4
1.8
.
10.4
9.7
7.3
5.5
4.9
5.0
4.9
4.7
2.9
1.9
1.5
3.6
0.7
1.0
0.6
0.6
1.5
1.3
2.4
0.7
1.6
1.1
1.0
0.4
1.3
1.0
2.8
1.2
2.0
4.5
1.3
2.0
1.3
6.5
8.0
3.8
6.2
8.0
6.1
4.7
2.5
3.1
2.4
5.7
4.5
2.6
3.3
4.5
3.1
2.9
3.1
5.4
4.2
8.7
5.7
6.0
3.7
4.0
3.7

31475
3302
5387
1742
1518
766
33
1790
15244
264
1429
9394
1678
7659
673
7658
41702
7670
802
521
369
524
91
5026
10034
1563
336
335
1228
168
187
5953
3569
3412
3531
30936
4375
6141
408
5683
1000
783
193
37576
2876
34387
13622
3355
1002
2297
2880
10649
1620
21907
3176
18363
12457
5620
10585
9159
782
1323
2500
6614
2740
10743

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

704

O&U

Cancer Incidence in Five Continents Vol. IX, IARC 2008

39973
3942
6567
2193
1850
837
34
2327
20062
306
1855
10858
1963
8834
744
8603
46149
8526
888
565
394
564
97
5648
10869
1696
357
367
1326
184
193
6469
3834
3720
3842
34471
5096
6667
443
6173
1141
886
221
43100
3355
39393
15499
3679
1104
2517
3310
12088
1910
24456
3559
20503
13797
6358
12132
10313
894
1477
2880
7384
3151
12045

*
*
*
*

Americ
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
Asia
Bahra
China
China
China
China
China
China
Cypru
India,
India,
India,
India,
India,
India,
India,
Israel
Israel
Israel
Japan
Japan
Japan
Japan
Japan
Japan
Japan
Korea
Korea
Korea
Korea
Korea
Korea

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Lung (C34) - Male (Contd)

es

Carcinoma

al

73
41
35
45
46

Squamous Adeno Small cell Large cell


*
*
*
*

77
96
53
65
86
98
11
08
14
55
52 *

73
42
67
93
50
37
34
27
62
06
55
58
63
34
44
03
49
26
88
65
94
64
97
48
69
96
57
67
26
84
93
69
34
20
42
71
96
67
43
73
41
86
21
00
55
93
99
79
04
17
10
88
10
56
59
03
97
58
32
13
94
77
80
84
51
45

America, North (Contd)


USA, Michigan
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Michigan: Black
USA, Michigan: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York state
USA, New York state: Black
USA, New York state: White
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 registries)
USA, SEER (9 registries): Black
USA, SEER (9 registries): White
USA, SEER (14 registries)
USA, SEER (14 registries): Asian and Pacific Islander
USA, SEER (14 registries): Black
USA, SEER (14 registries): Hispanic White
USA, SEER (14 registries): Non-hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, New Delhi
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon

O&U

Sarcoma Other Unspec.

Number of cases
MV

Total

15.3
16.9
22.7
15.7
22.2
14.5
17.2
23.5
16.7
12.4
12.3
19.9
11.8
8.5
2.4
5.8
10.2
12.0
15.3
11.8
13.9
19.9
13.6
16.6
21.8
16.0
16.8
11.8
14.9
23.5
14.2
16.3
11.7
19.4
11.4
12.2
6.7
20.6
5.7
12.7
19.0
21.1
18.4
14.1
21.8
13.6
6.0
11.0
11.2
10.8
21.2
12.3

16.7
19.8
24.0
19.0
23.0
16.0
17.8
23.4
17.3
14.4
17.7
20.4
17.7
10.5
3.6
7.6
12.4
17.1
18.6
17.2
16.4
20.4
16.1
17.1
21.9
16.5
16.2
15.2
17.4
25.1
16.8
21.4
15.5
21.2
15.2
15.8
12.0
21.0
8.8
16.5
16.9
17.5
16.6
14.9
22.2
14.2
7.8
15.8
15.7
15.6
18.4
15.5

8.5
9.3
9.6
9.5
8.8
8.6
10.3
9.1
10.4
8.7
7.5
7.3
7.7
5.6
2.4
4.0
6.8
6.6
5.5
7.0
8.2
7.5
8.5
9.4
7.8
9.6
9.8
7.5
9.3
8.6
9.4
9.6
7.1
8.1
7.4
7.4
3.6
8.1
3.6
8.2
10.1
7.5
10.8
8.0
8.6
8.0
3.8
8.2
7.3
7.3
12.4
7.5

11.4
13.9
18.7
12.8
18.1
10.6
11.3
16.6
10.8
10.0
8.6
13.3
8.3
6.5
2.3
6.0
7.2
8.7
11.1
8.6
10.9
15.5
10.5
13.4
18.9
12.8
13.9
9.6
10.2
16.4
9.7
8.8
10.2
17.3
9.8
10.1
6.8
15.7
5.5
10.4
14.6
18.9
13.3
10.0
16.2
9.6
4.1
11.4
11.4
11.9
14.0
7.5

4.2
4.8
6.9
4.3
6.4
3.9
4.8
7.1
4.6
4.2
5.0
6.5
4.9
3.5
0.6
2.5
4.1
4.8
4.9
4.8
4.6
6.0
4.5
4.1
5.2
4.0
4.5
4.1
5.3
8.3
5.1
5.2
4.6
7.4
4.4
4.7
3.1
7.1
2.5
4.8
5.4
6.2
5.2
5.0
7.0
4.9
2.4
4.5
5.1
5.6
4.8
4.0

0.1
0.1
0.2
0.1
0.2
0.1
0.1
0.2
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.1

0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1

3.8
1.6
2.7
1.3
4.8
3.7
6.5
8.4
6.4
1.3
3.4
4.7
3.3
3.0
0.9
2.8
3.2
3.9
5.2
3.8
4.1
5.5
4.0
4.0
5.4
3.8
10.2
4.0
2.4
3.6
2.3
3.2
2.0
2.9
2.0
2.5
1.3
3.8
1.5
2.6
3.8
4.3
3.6
5.9
9.4
5.7
1.9
3.5
2.5
1.8
6.9
5.9

17713
7877
1871
5935
2467
15075
11412
1078
10247
1568
14601
1789
12523
2003
34
442
1469
29281
3476
24994
384973
39822
335775
22804
2277
20150
7101
5595
25861
2389
23134
2241
39650
4445
32365
110720
5554
12119
5066
87367
8131
1807
6278
29383
3612
25360
1298
1048
9060
6141
4718
8404

19900
8606
2060
6466
2758
16940
13325
1230
12001
1817
16143
1981
13838
2371
43
545
1718
34233
4032
29285
437311
45289
381699
25553
2622
22525
8702
6544
28666
2643
25655
2441
44116
4895
36135
123305
5991
13454
5592
97580
9164
2070
7047
34338
4244
29624
1482
1190
10388
6962
5598
10010

9.5
15.1
11.9
7.9
1.8
4.8
6.0
2.5
3.2
1.9
2.9
2.6
1.1
8.0
7.6
10.4
7.1
9.3
11.9
10.7
10.9
10.0
10.7
17.2
14.2
20.3
16.3
18.4
17.1

6.2
17.7
17.1
6.1
2.0
4.4
11.0
1.6
3.0
2.5
1.8
1.0
2.0
8.1
7.8
10.1
13.2
12.2
18.2
13.2
16.9
13.0
11.5
9.5
8.3
10.3
9.2
8.9
10.1

4.5
2.2
5.2
0.7
0.3
1.3
3.1
0.5
2.9
0.9
0.4
2.5
0.4
4.1
3.9
6.1
3.9
3.4
4.9
4.5
5.2
4.6
4.6
6.4
5.1
7.7
6.4
5.9
6.3

10.3
33.0
4.1
31.7
0.2
23.1
1.2
1.6
2.2
0.7
0.5
4.8
0.9
3.2
3.1
3.6
0.8
1.4
5.8
3.4
11.6
1.7
1.3
2.7
1.8
2.5
2.5
3.2
2.4

0.2
0.4
7.6
0.2
0.2
0.2
1.0
0.0
1.8
0.1
0.0
0.0
0.3
5.4
5.2
7.1
0.3
0.4
1.0
0.3
1.4
0.3
0.3
0.8
0.6
0.3
0.7
0.2
1.0

0.1
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.1
0.1

0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1

3.5
3.0
11.8
.
55.4
47.0
.
2.5
4.4
8.1
3.5
1.8
2.6
6.1
5.2
3.2
2.7
2.9
12.0
8.1
0.1
8.5
0.1
13.6
9.8
14.3
16.1
11.6
10.9
14.8
13.2

148
2238
10409
195
976
5831
590
511
496
114
1268
235
2037
269
190
4368
3841
504
1074
1226
1476
3558
2991
12242
2110
30712
2375
2015
863
889
1656

186
3831
12932
600
1280
12764
1086
569
956
175
1923
284
2515
362
264
5190
4498
551
1510
1625
1805
4633
3803
16745
2876
41126
3365
2476
1082
1199
2168

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

647

*
*
*
*
*

*
*
*
*

705

Age-standardized (world) incidence rates (per 100,000)


by histological type

Lung (C34) - Male (Contd)


Carcinoma

Squamous Adeno Small cell Large cell


Asia (Contd)
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland (data not available)
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg (data not available)
Germany, Free State of Saxony (data not available)
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania (data not available)
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio
Italy, Syracuse Province
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce (data not available)
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg

648

Sarcoma Other Unspec.

Number of cases
MV

Total

14.1
16.1
16.5
2.2
3.9
10.0
5.6
2.2
9.5
7.0
10.6
12.8
2.2
4.4
8.3
9.4
4.8
13.8
19.8

8.2
11.0
9.3
2.5
1.6
7.5
3.1
2.0
2.0
8.0
14.7
16.7
3.8
11.5
9.8
9.6
4.8
5.0
10.2

4.9
6.6
8.1
2.0
1.2
3.4
1.0
0.5
4.0
3.4
5.0
5.6
1.0
5.0
2.4
5.6
1.3
7.0
10.9

2.5
3.0
2.8
2.2
3.0
6.4
3.4
2.3
6.7
10.2
7.9
8.7
3.1
7.6
2.6
9.4
0.8
2.0
4.2

0.8
0.5
1.3
3.9
2.6
0.7
0.1
0.2
1.0
5.3
0.6
0.7
0.3
0.3
0.1
0.5
3.7
19.8

0.2
0.1
0.4
0.1
0.2
0.1
0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.1
0.1

0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.1

14.2
12.4
18.9
2.8
3.0
10.8
7.8
2.5
1.9
17.9
6.4
7.1
1.5
5.9
9.2
17.7
3.1
5.8
9.1

233
7134
459
111
134
561
509
123
445
1763
3092
2751
77
264
897
730
314
932
5075

309
9048
625
143
156
697
711
160
595
3164
3541
3140
88
313
1229
1117
408
1089
5860

10.1
12.1
12.2
22.4
18.5
19.2
15.7
25.9
24.3
12.7
25.3
26.2
20.7
21.0
22.3
16.1
15.9
14.4
17.7
25.8
15.8
12.2
10.7
9.5
15.6
18.2
7.7
12.4
13.7
15.1
18.3
15.6
14.9
11.7
10.0
13.4
17.4
12.1
12.1
7.1
11.0
17.3
14.2
12.2
25.0
13.4
11.7
13.8
15.8
18.3
16.6
24.4
12.3
8.8
23.4
13.3
10.1
8.8
16.2

11.6
14.8
11.2
4.6
13.6
12.2
2.1
9.6
7.9
12.2
5.4
14.0
12.3
13.7
13.3
14.3
13.7
11.8
12.5
14.9
9.5
9.3
11.3
8.2
10.5
14.5
10.6
6.4
18.7
16.4
20.3
8.3
16.5
9.1
15.9
13.6
10.6
11.5
12.1
7.3
10.0
15.4
7.1
14.3
15.6
8.2
12.6
10.5
12.1
14.3
4.7
5.7
6.5
9.2
5.9
5.7
9.5
7.1
4.1

6.9
7.3
6.2
3.6
9.5
8.9
4.1
7.7
8.1
8.1
10.9
7.6
8.4
8.8
7.3
8.2
7.3
6.4
8.3
8.7
7.7
5.2
9.8
5.5
10.5
11.0
5.3
5.5
7.4
5.2
7.5
5.2
5.0
4.7
5.2
6.1
5.2
5.2
7.6
2.7
6.6
7.6
4.8
5.6
6.5
3.4
6.2
4.9
6.9
5.0
4.9
6.5
5.1
6.6
7.0
6.5
4.7
3.7
4.2

7.1
4.4
8.6
3.0
8.7
11.9
1.4
9.2
4.9
4.0
4.2
6.1
7.6
6.6
6.0
6.3
7.3
5.3
6.4
5.5
3.5
5.5
18.9
2.7
16.4
6.1
6.5
6.1
5.2
5.0
10.9
6.2
6.2
4.3
5.1
5.1
8.7
9.2
11.5
4.6
6.8
7.0
4.7
4.0
6.0
2.4
13.7
6.4
9.9
7.1
1.6
4.3
5.3
4.4
3.5
1.8
3.5
4.6
8.8

0.7
3.8
1.7
0.8
1.4
1.0
0.6
0.2
0.8
3.2
0.6
2.2
3.5
0.8
0.6
1.4
2.1
1.4
1.4
3.1
2.7
0.6
2.3
3.3
2.6
1.0
0.8
0.4
3.7
1.5
1.0
2.5
0.9
2.8
4.7
1.3
6.0
0.9
0.5
2.2
0.4
0.9
0.3
0.6
0.7
2.4
0.6
0.5
0.6
1.5
0.3
0.3
0.0
2.9
1.4
0.4
1.1
1.0
0.4

0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.1
0.2
0.1
0.0
0.1
0.0
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.0
0.1
0.2
0.0
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.0
0.0

0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.1
0.0
0.1
0.2
0.1
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.0

5.9
2.9
7.2
29.7
2.8
4.5
25.5
19.0
18.2
5.8
19.0
2.5
2.6
1.4
1.9
0.8
2.8
1.0
1.6
2.7
1.7
1.0
0.8
7.2
0.8
8.5
1.3
10.4
14.1
18.7
6.1
14.9
19.6
11.3
16.8
16.1
17.9
9.9
9.8
21.1
14.9
10.1
18.7
12.3
12.9
15.0
12.9
8.1
15.7
17.6
33.6
23.0
9.3
3.3
18.8
20.3
1.3
7.1
21.1

11013
964
438
12938
3757
10367
7437
8837
17998
8554
2265
1984
1210
923
1252
1689
1797
1532
913
1116
690
756
2673
2776
4661
2428
283
3805
472
1157
1056
2296
1334
337
2129
1242
709
3993
945
382
944
2544
1132
724
418
398
2168
1587
964
3613
2835
5052
405
5682
931
2471
2968
2915
4832

12825
1069
545
18962
3987
11974
15483
12028
23221
10221
2965
2082
1251
961
1312
1727
1950
1564
931
1203
723
766
3830
3503
6011
2870
296
5178
628
1588
1340
3297
1989
432
3124
1811
1031
4909
1208
564
1213
3170
1791
955
501
607
2788
2078
1305
4789
4781
6927
532
6505
1501
2947
3115
3710
7722

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

706

O&U

Cancer Incidence in Five Continents Vol. IX, IARC 2008

*
*
*

*
*
*
*

*
*
*

Europe
Serbia
Slova
Slove
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Switz
Switz
Switz
Switz
Switz
Switz
Switz
The N
The N
The N
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, N
UK, S
Oceani
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Frenc
New Z
USA,
USA,
USA,
USA,
USA,
USA,

*
*

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Lung (C34) - Male (Contd)

es

Carcinoma

al

09
48
25
43
56
97
11
60
95
64
41
40
88
13
29
17
08
89
60

25
69
45
62
87
74
83
28
21
21
65
82
51
61
12
27
50
64
31
03
23
66
30
03
11
70
96
78
28
88
40
97
89
32
24
11
31
09
08
64
13
70
91
55
01
07
88
78
05
89
81
27
32
05
01
47
15
10
22

Squamous Adeno Small cell Large cell

*
*
*

*
*
*
*

*
*
*

Europe (Contd)
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, England, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern And Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory (data not available)
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

O&U

Sarcoma Other Unspec.

Number of cases
MV

Total

23.4
25.3
22.1
16.0
24.2
18.4
16.4
13.5
17.4
16.2
16.6
19.6
17.7
19.7
5.8
13.4
13.3
15.6
13.1
11.4
15.8
13.0
17.8
21.7
17.2
12.3
15.4
15.8
17.1
10.2
9.1
10.9
12.3
13.0
11.1
18.3

9.6
6.2
12.8
5.0
11.2
12.6
10.8
3.7
10.9
5.8
9.2
8.7
7.9
10.2
6.4
13.0
16.4
11.6
10.2
13.3
16.0
11.8
11.7
10.5
9.5
5.6
9.4
5.5
7.6
5.9
4.9
6.1
5.7
5.7
4.0
9.7

7.0
7.5
10.5
7.0
10.3
8.2
5.8
7.8
8.4
6.3
9.5
7.5
8.0
7.3
3.1
6.7
7.1
8.2
6.4
7.4
9.1
6.6
8.9
9.8
9.2
4.7
7.8
6.7
8.0
4.9
4.4
4.9
6.5
6.1
4.6
9.7

2.3
5.1
5.3
4.1
4.9
7.9
7.8
5.4
10.3
5.1
7.0
10.5
7.8
5.8
4.3
8.1
4.1
7.8
6.1
11.6
3.6
10.7
10.3
12.4
15.5
12.0
22.2
22.8
14.6
11.5
9.5
16.0
17.4
15.7
4.0
12.7

2.1
1.2
2.3
0.3
0.5
0.7
0.7
0.2
1.2
0.9
0.3
1.0
0.4
0.5
0.4
1.1
0.4
1.3
0.6
0.6
0.4
0.9
1.9
1.1
2.8
0.4
0.5
0.5
0.5
0.3
0.4
0.3
2.8
0.5
2.1
3.6

0.0
0.0
0.0
0.1
0.0
0.1
0.1
0.0
0.0
0.0
0.1
0.1
0.0
0.1
0.0
0.1
0.2
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.1
0.0
0.0
0.0
0.1

0.1
0.0
0.0
0.0
0.0
0.0
0.2
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.1

13.3
15.5
4.5
5.6
4.9
6.3
7.6
7.3
6.0
8.5
7.8
4.2
7.4
5.6
0.8
3.1
3.2
4.5
3.2
4.3
3.6
3.5
3.8
4.6
2.9
0.3
0.5
0.3
5.5
0.1
7.4
2.7
1.2
3.2
18.6
6.7

8298
7012
3920
408
2510
3314
1947
324
1113
1060
1727
1120
854
1584
8225
651
356
306
702
577
467
1025
30297
2084
2010
3439
3770
5988
8950
2607
7604
15734
6703
7476
1795
9697

10626
9443
4013
489
2825
3851
2280
441
1292
1399
2072
1253
1034
1836
8419
704
402
342
779
647
513
1121
32734
2267
2134
4680
5866
9062
15621
3625
11985
23674
10178
10415
2686
12957

9.2
10.8
5.0
14.1
8.7
8.1
5.5
17.1
9.8
10.6
5.5
11.5
18.9
7.5
11.0

8.7
12.3
10.2
8.9
9.1
11.3
8.9
8.8
8.1
14.8
13.8
18.1
17.7
10.0
17.0

4.8
5.1
4.8
5.2
4.6
5.5
2.8
8.0
4.4
5.2
1.5
7.5
7.2
3.8
5.7

12.1
10.2
8.2
5.6
7.2
10.8
7.0
17.6
5.4
6.9
4.5
6.7
11.4
5.4
7.5

1.2
2.4
3.7
1.2
0.6
1.7
1.1
1.2
0.5
3.5
2.0
3.1
7.2
2.8
3.1

0.1
0.0
0.1
0.1
0.0
0.1
0.0
0.1
0.2
0.3
0.1

0.0
0.0
0.1
0.1
0.0
0.0
0.2
0.1

1.5
0.3
4.2
7.9
6.1
2.1
0.3
9.6
7.0
2.6
1.3
1.8
5.5
1.2
3.4

7871
4200
1926
657
5304
2156
194
215
3689
1829
115
310
299
466
515

9268
5264
2321
816
6609
2523
222
250
4728
1981
121
332
324
504
564

*
*

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

649

707

Age-standardized (world) incidence rates (per 100,000)


by histological type

Lung (C34) - Female


Carcinoma

Squamous Adeno Small cell Large cell


Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Non-Hispanic White
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Georgia: Black
USA, Georgia: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
USA, Louisiana: Black
USA, Louisiana: White
USA, Maine
USA, Massachusetts

650

Sarcoma Other Unspec.

Number of cases
MV

Total

0.7
0.2
0.4
0.2
0.9

0.5
1.4
0.5
1.0
0.9

0.2
0.2
0.0
0.2

0.3
0.9
0.6
0.7
2.3

0.0
0.0
0.0
0.1

0.3
0.8
.
1.8
0.2

32
132
17
28
33

37
174
17
40
56

0.5
1.9
1.1
1.8
1.6
0.6
1.3
0.6
0.5
0.6
0.3

2.5
3.6
1.8
3.8
3.3
0.5
2.1
1.0
1.8
2.2
2.1

0.6
0.6
0.3
0.7
1.0
0.3
0.5
0.2
0.2
0.2
0.2

6.6
1.4
1.9
1.4
1.8
0.5
1.1
0.4
0.3
1.2
0.9

0.1
0.2
0.2
0.1
0.1
0.0
0.1
-

0.1
0.0
0.2
0.0
0.0
0.0
-

0.0
0.0
0.0
-

0.6
4.5
5.0
2.0
3.6
2.6
4.2
2.1
1.3
0.7
1.2

74
259
39
134
2151
21
231
186
90
66
41

105
300
71
173
3229
51
408
359
136
74
52 *

4.5
4.7
4.2
4.6
6.8
4.0
7.5
5.2
4.3
5.7
5.7
6.1
4.7
6.5
6.9
4.9
4.3
3.7
5.8
0.9
1.1
2.8
1.9
4.4
3.6
5.9
1.1
0.7
1.6
1.3
2.0
4.7
1.5
6.1
2.1
5.2
4.4
5.2
5.8
5.2
5.8
6.7
3.9
5.5
5.0
5.6
5.9
5.2
5.9
5.0
5.1
6.1
4.5
6.1
7.9
5.9
7.1
5.2
9.9
6.9
6.6
6.4
7.0
6.8
6.3
5.9

11.2
11.3
10.3
15.3
13.5
5.2
9.2
12.5
11.2
12.4
11.0
10.2
9.1
10.5
13.9
10.7
11.9
11.7
15.1
9.2
7.8
7.0
6.6
13.1
10.4
11.0
10.4
10.8
5.2
6.6
8.5
13.6
8.8
12.3
6.0
14.1
10.3
15.8
13.1
16.1
13.7
14.1
12.8
14.0
8.9
14.6
10.7
10.5
9.1
11.2
8.8
11.4
9.7
13.0
13.5
13.0
11.9
11.6
14.3
11.9
11.5
15.3
9.9
12.8
12.6
15.6

4.7
4.8
4.7
5.3
6.4
4.6
13.5
5.8
4.4
7.7
4.5
6.9
3.3
7.8
7.5
5.4
4.8
3.9
5.5
0.5
0.5
2.6
1.5
5.0
4.0
5.1
0.6
0.7
1.7
0.8
1.5
6.0
1.0
5.1
2.1
6.2
5.3
5.9
4.0
6.1
4.0
4.6
2.6
6.4
3.0
6.9
6.3
5.5
3.9
6.4
3.4
7.2
5.0
7.0
5.4
7.4
8.2
6.9
11.1
7.1
4.9
8.2
5.0
8.0
8.5
6.3

5.4
5.7
7.7
7.0
6.4
5.9
6.0
7.0
4.3
6.0
4.1
5.9
4.7
6.1
5.9
6.2
5.9
6.0
9.0
2.9
2.2
3.7
2.9
7.1
5.1
7.4
4.3
1.9
2.2
3.9
1.9
6.8
2.7
7.6
2.8
7.0
3.5
6.1
5.7
6.2
5.0
5.5
4.5
7.0
5.4
7.2
7.1
7.7
6.6
8.3
5.8
7.5
4.6
5.9
8.2
5.7
7.6
4.6
8.2
6.9
6.3
6.2
6.9
7.0
8.1
6.2

1.9
2.3
2.6
2.7
1.5
1.5
0.7
2.7
1.4
2.9
2.1
2.7
2.4
2.8
2.8
3.0
3.1
3.4
4.7
2.7
1.5
1.9
1.8
3.8
2.6
3.5
1.7
1.5
1.1
1.0
1.0
3.6
1.8
3.6
1.6
3.7
2.3
3.6
3.6
3.7
2.7
2.6
3.1
3.1
2.3
3.2
2.7
3.1
3.7
3.0
2.6
2.8
3.4
3.3
3.7
3.3
3.6
3.3
4.2
2.8
2.3
2.6
2.6
2.9
3.5
3.9

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.0
0.0
0.1
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.2
0.0
0.0
0.1
0.2
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.2
0.3
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.2
0.0

3.8
1.6
1.3
1.6
1.6
0.2
.
5.0
5.7
3.8
2.9
2.2
1.4
2.3
3.8
1.9
1.3
1.1
1.5
0.7
0.6
0.3
0.5
1.4
0.8
0.9
0.6
0.6
0.5
0.5
0.3
1.0
0.6
1.1
0.7
1.5
2.5
0.8
1.1
0.8
2.6
2.9
1.5
3.0
2.2
3.1
2.2
1.5
1.6
1.5
1.7
2.3
1.7
1.7
2.3
1.7
1.6
1.7
2.5
2.1
3.2
3.0
2.1
2.1
2.2
2.4

23632
2571
4479
1442
936
380
22
1234
11342
184
1042
5559
856
4660
514
6221
35421
6780
603
345
158
432
80
4918
8276
1076
247
174
900
102
110
5521
2233
2343
2659
27963
3647
5291
298
4965
718
528
178
29402
1634
27513
8547
2570
655
1882
1493
6994
1174
16664
2197
14257
8789
3885
7178
5844
426
1026
1294
4517
2079
9969

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

708

O&U

Cancer Incidence in Five Continents Vol. IX, IARC 2008

30148
3093
5440
1773
1133
402
23
1594
15166
219
1305
6470
997
5425
586
6967
40104
7753
684
377
170
479
88
5683
9129
1171
263
185
980
112
116
6150
2414
2579
2937
31924
4288
5840
324
5485
831
611
203
33616
1835
31497
9866
2842
721
2086
1720
8080
1406
18830
2508
16097
9892
4513
8299
6716
487
1178
1501
5179
2454
11373

*
*
*
*

Americ
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
Asia
Bahra
China
China
China
China
China
China
Cypru
India,
India,
India,
India,
India,
India,
India,
Israel
Israel
Israel
Japan
Japan
Japan
Japan
Japan
Japan
Japan
Korea
Korea
Korea
Korea
Korea
Korea

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Lung (C34) - Female (Contd)


Carcinoma

es

al

37
74
17
40
56

Squamous Adeno Small cell Large cell


*
*
*
*

05
00
71
73
29
51
08
59
36
74
52 *

48
93
40
73
33
02
23
94
66
19
05
70
97
25
86
67
04
53
84
77
70
79
88
83
29
71
63
85
80
12
16
50
14
79
37
24
88
40
24
85
31
11
03
16
35
97
66
42
21
86
20
80
06
30
08
97
92
13
99
16
87
78
01
79
54
73

America, North (Contd)


USA, Michigan
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Michigan: Black
USA, Michigan: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York state
USA, New York state: Black
USA, New York state: White
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 registries)
USA, SEER (9 registries): Black
USA, SEER (9 registries): White
USA, SEER (14 registries)
USA, SEER (14 registries): Asian and Pacific Islander
USA, SEER (14 registries): Black
USA, SEER (14 registries): Hispanic White
USA, SEER (14 registries): Non-hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, New Delhi
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon

O&U

Sarcoma Other Unspec.

Number of cases
MV

Total

6.6
7.1
8.7
6.8
8.4
6.3
6.8
7.6
6.7
5.9
5.2
6.8
5.2
3.5
0.4
2.0
4.5
5.1
4.9
5.3
5.7
6.4
5.7
6.4
7.8
6.3
6.3
6.2
5.7
9.6
5.3
6.0
5.0
7.1
5.1
5.2
1.8
7.0
2.3
5.7
6.4
5.0
6.8
5.3
6.5
5.3
2.0
3.8
5.7
5.9
8.2
5.3

13.1
15.3
15.3
15.4
15.1
12.8
13.0
12.9
13.0
14.7
14.1
12.3
14.8
8.3
1.5
5.1
10.8
14.2
12.1
14.9
12.6
11.6
12.8
12.4
14.0
12.1
11.7
13.9
12.8
17.0
12.4
16.9
12.4
13.1
12.8
12.5
8.6
12.1
6.1
13.9
10.3
8.1
11.0
10.2
10.1
10.2
5.1
11.3
14.1
14.2
12.7
11.9

7.4
8.1
6.0
8.8
5.9
7.7
7.6
7.3
7.6
7.0
5.8
4.7
6.2
4.1
0.6
2.5
5.5
5.3
3.5
5.8
6.4
4.6
6.8
7.7
5.9
7.8
7.7
7.3
6.5
6.1
6.6
8.1
5.7
5.1
6.3
5.8
1.4
5.1
2.3
6.9
6.3
2.4
7.6
5.9
5.4
6.1
2.4
6.9
7.0
7.0
10.5
6.1

6.8
8.3
9.0
8.2
8.6
6.6
6.3
8.1
6.1
6.8
5.2
5.3
5.4
3.5
0.8
2.1
4.5
5.3
5.0
5.5
6.2
6.5
6.3
7.3
7.9
7.1
7.3
6.7
5.7
8.0
5.4
5.2
6.2
7.9
6.3
6.0
2.7
7.1
2.8
6.7
5.7
4.6
6.1
5.2
6.1
5.2
2.4
5.8
7.6
7.6
8.1
4.5

3.0
3.4
4.0
3.3
3.7
2.9
3.3
4.0
3.2
3.1
3.6
3.7
3.7
2.3
0.4
1.3
3.1
3.4
2.6
3.7
3.1
3.0
3.2
2.8
3.0
2.8
2.7
3.3
3.6
4.3
3.5
3.3
3.2
4.0
3.3
3.2
1.6
3.5
1.5
3.6
2.6
2.2
2.8
3.1
3.7
3.0
1.4
3.2
3.6
4.1
3.0
3.2

0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.0
0.1

0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.1

2.2
1.0
1.4
0.9
2.4
2.1
3.0
2.6
3.0
0.7
2.3
2.1
2.4
1.9
0.3
1.5
2.2
2.1
1.5
2.2
2.2
2.0
2.3
2.2
2.5
2.1
5.2
2.9
1.4
1.7
1.4
2.3
1.2
1.4
1.2
1.5
0.7
1.6
0.8
1.7
1.9
1.5
2.1
3.0
3.6
3.0
0.9
2.3
1.6
1.0
3.7
3.6

13779
6414
1376
4996
1769
11864
8154
748
7340
1251
12223
1265
10796
1407
15
262
1112
25381
2728
22156
294649
25734
262301
17097
1642
15197
4995
4937
19180
1865
17095
1787
31654
3103
26803
87820
3465
7929
3695
72275
4793
826
3929
20246
2010
17936
807
719
7798
5393
3426
6375

15696
7159
1527
5584
1980
13555
9549
857
8617
1485
13898
1386
12323
1744
18
325
1377
29864
3044
26268
338828
29095
302420
19352
1847
17223
6072
5843
21859
2073
19534
2007
35887
3443
30528
99738
3758
8816
4120
82510
5536
963
4529
24106
2397
21367
919
853
9027
6164
4146
7691

2.6
2.4
1.7
1.0
0.3
1.1
0.6
0.4
0.4
0.3
0.8
0.4
0.2
1.4
1.5
0.3
0.7
0.5
1.1
0.8
0.9
1.3
0.7
1.3
1.3
1.9
1.5
1.4
1.3

3.1
10.1
11.5
3.3
1.4
4.0
3.5
0.6
0.8
1.2
0.9
0.6
0.5
5.0
5.3
2.2
7.8
6.6
9.3
7.8
9.3
6.8
7.2
4.8
4.1
5.5
4.8
4.8
5.4

1.7
0.4
0.9
0.1
0.0
0.2
0.3
0.1
0.1
0.3
0.2
0.6
0.1
1.0
1.1
0.9
0.4
0.4
0.8
0.7
0.7
1.1
0.6
1.0
0.8
1.2
0.8
1.5
1.0

2.8
12.2
1.3
8.5
0.1
9.3
0.0
0.4
0.1
0.2
0.1
1.0
0.2
1.1
1.1
0.4
0.1
0.2
1.5
0.5
3.0
0.3
0.2
0.6
0.5
0.6
0.5
0.7
0.5

0.2
0.3
2.7
0.1
0.1
0.2
0.4
0.1
0.1
0.1
0.0
0.2
2.3
2.4
0.5
0.2
0.3
0.2
0.1
0.4
0.1
0.2
0.3
0.2
0.1
0.4
0.0
0.2

0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
-

1.4
1.2
5.2
.
34.4
18.0
.
0.2
1.0
0.7
1.0
0.4
0.7
3.0
0.6
1.2
1.0
0.6
2.8
2.3
0.0
2.6
0.0
4.2
2.6
4.5
5.2
4.3
3.5
4.7
4.6

52
987
4620
59
629
2455
285
119
115
15
404
83
427
122
42
2035
1951
68
427
426
577
1258
1216
4842
721
9096
770
640
278
294
532

64
1759
6134
182
840
5718
521
128
226
20
599
96
537
182
51
2493
2331
82
588
617
720
1798
1605
7141
1041
14666
1302
930
399
479
822

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

651

*
*
*
*
*

*
*
*
*

709

Age-standardized (world) incidence rates (per 100,000)


by histological type

Lung (C34) - Female (Contd)


Carcinoma
Squamous Adeno Small cell Large cell

Asia (Contd)
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland (data not available)
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg (data not available)
Germany, Free State of Saxony (data not available)
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania (data not available)
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio
Italy, Syracuse Province
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce (data not available)
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg

652

Sarcoma Other Unspec.

Number of cases
MV

Total

1.4
1.5
2.1
0.7
0.3
1.5
1.6
0.5
1.0
1.1
1.7
1.9
0.6
0.8
4.4
4.7
0.9
0.8
0.7

4.7
6.1
4.6
1.0
1.1
3.6
3.1
0.7
0.6
4.1
8.1
8.8
3.1
5.6
8.6
7.4
2.6
1.7
1.7

0.7
1.1
1.2
0.5
0.4
0.1
0.6
0.3
0.4
0.4
1.4
1.6
0.6
2.2
2.0
0.2
0.5
0.8

0.7
0.8
0.8
0.3
0.3
1.3
1.8
0.5
1.0
2.5
2.2
2.2
0.9
2.8
2.0
4.2
0.2
0.2
0.3

0.4
0.2
0.3
0.6
0.5
0.4
0.0
0.2
1.5
0.2
0.2
0.4
0.3
0.1
0.1
0.2
0.7
1.3

0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0

0.0
0.1
0.0
0.0
0.0
0.0
-

2.8
4.5
4.7
1.5
0.6
3.0
4.0
0.3
0.2
5.1
2.7
2.8
1.8
1.7
6.2
8.6
1.3
0.8
1.0

83
2520
146
32
19
169
292
32
47
652
1306
1176
28
102
692
429
123
116
416

120
3659
227
45
22
220
395
36
61
1138
1582
1434
33
115
933
633
167
141
500

1.5
2.1
1.5
0.7
2.5
1.6
1.4
2.2
3.2
5.0
1.8
2.0
1.1
1.1
2.9
1.8
1.4
1.2
1.0
1.7
1.0
0.9
2.6
1.5
2.2
3.3
5.3
4.0
1.1
1.2
2.0
2.0
1.4
0.7
1.4
1.4
0.9
1.6
1.3
0.2
1.2
2.2
1.0
1.2
1.0
0.5
1.2
1.3
1.7
1.9
0.9
1.2
1.3
2.7
3.8
2.7
0.6
0.6
1.0

5.4
6.9
3.6
0.9
5.4
4.1
0.9
3.3
2.8
11.9
1.6
4.7
3.0
4.4
4.0
4.4
3.7
3.8
1.9
3.3
2.9
3.9
5.1
4.6
3.7
5.7
12.6
4.3
3.8
4.4
4.5
3.2
4.2
3.0
6.2
4.0
2.9
4.3
4.5
1.7
4.2
5.6
1.9
3.3
5.1
2.4
3.6
3.2
3.6
5.0
1.4
1.4
2.0
6.2
2.7
2.8
3.0
2.6
1.2

2.4
2.8
2.2
0.1
2.5
1.7
0.5
1.4
2.1
6.3
1.7
1.9
1.5
1.9
1.2
1.9
1.4
1.0
1.3
1.9
1.2
0.6
4.7
2.3
3.9
3.9
4.5
3.4
1.6
1.0
1.3
1.1
0.7
1.0
1.6
2.0
0.9
1.4
1.4
0.1
2.0
1.6
0.4
0.5
1.2
0.4
1.7
1.1
1.2
1.1
0.5
0.5
0.6
4.2
2.9
3.6
0.5
0.4
0.3

2.1
1.0
3.2
0.2
2.0
2.0
0.2
1.6
1.2
2.6
0.6
1.3
1.1
1.8
1.3
1.7
1.1
0.8
0.7
0.6
0.3
1.0
7.0
1.2
3.4
1.9
5.1
2.9
1.3
1.1
2.9
1.7
1.1
1.0
1.8
1.3
0.7
2.1
3.0
0.3
1.8
1.7
0.5
1.0
1.7
0.5
2.8
1.9
0.7
1.7
0.2
0.5
0.6
2.8
1.6
0.8
0.6
0.7
1.2

0.5
1.9
0.6
0.2
0.5
0.5
0.2
0.1
0.3
2.3
0.3
0.7
0.6
0.2
0.0
0.5
0.7
0.5
0.8
0.5
0.8
0.2
1.1
1.6
0.7
0.4
2.4
0.5
0.5
0.6
0.6
0.6
0.4
0.4
1.1
0.9
1.4
0.4
0.4
0.2
0.3
0.7
0.3
0.5
1.0
0.4
0.5
0.4
0.7
0.1
0.1
0.2
1.8
0.4
0.1
0.3
0.5
0.1

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.1
0.1
0.0
0.0
0.1
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.2
0.1
0.1
0.0
0.1
0.2
0.1
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

1.9
0.6
2.1
2.4
0.5
0.7
3.8
3.8
4.3
3.3
2.7
0.4
0.4
0.2
0.3
0.1
0.3
0.3
0.1
0.3
0.4
0.1
0.2
2.4
0.3
2.0
1.4
5.1
2.4
2.8
1.3
3.3
3.7
2.9
4.5
3.3
3.3
2.2
2.7
2.8
3.4
2.1
2.3
1.7
1.7
1.5
2.8
1.7
3.2
3.7
3.9
2.8
1.2
1.4
5.5
7.3
0.2
1.3
2.7

4564
396
137
1282
966
2029
1137
1864
4966
6507
454
446
207
192
280
398
367
342
123
183
125
161
1250
1253
1404
807
286
2111
104
274
234
576
293
73
811
315
119
1250
272
59
273
670
145
142
90
60
582
376
200
986
470
731
76
3264
365
1223
641
652
1047

5519
446
185
2330
1021
2324
2782
2804
6825
7790
677
478
217
200
304
402
399
357
127
195
137
165
1897
1638
1873
987
302
3052
165
386
321
897
495
101
1294
470
189
1620
394
91
336
853
259
186
112
88
813
509
309
1454
922
1224
98
3751
609
1519
681
863
1891

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

710

O&U

Cancer Incidence in Five Continents Vol. IX, IARC 2008

*
*
*

*
*
*
*

*
*
*

Europe
Serbia
Slova
Slove
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Switz
Switz
Switz
Switz
Switz
Switz
Switz
The N
The N
The N
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, N
UK, S
Oceani
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Frenc
New Z
USA,
USA,
USA,
USA,
USA,
USA,

*
*

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Lung (C34) - Female (Contd)

es

Carcinoma

al

20
59
27
45
22
20
95
36
61
38
82
34
33
15
33
33
67
41
00

19
46
85
30
21
24
82
04
25
90
77
78
17
00
04
02
99
57
27
95
37
65
97
38
73
87
02
52
65
86
21
97
95
01
94
70
89
20
94
91
36
53
59
86
12
88
13
09
09
54
22
24
98
51
09
19
81
63
91

Squamous Adeno Small cell Large cell

*
*
*

*
*
*
*

*
*
*

Europe (Contd)
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, England, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern And Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory (data not available)
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

O&U

Sarcoma Other Unspec.

Number of cases
MV

Total

4.8
2.0
2.0
0.5
0.6
0.9
0.9
0.4
0.5
0.6
0.4
1.0
0.5
0.8
2.3
3.4
1.4
2.8
2.0
1.3
2.2
1.7
3.3
3.4
3.2
4.1
5.8
5.5
6.6
3.4
3.2
3.9
4.2
3.8
3.9
7.1

3.4
1.8
5.3
0.9
2.6
3.3
3.2
1.2
2.5
1.4
2.5
3.2
1.4
1.7
5.8
7.2
6.2
5.6
5.3
6.0
8.3
7.4
6.1
4.8
4.8
3.7
7.0
4.1
5.3
4.1
3.1
4.4
3.9
3.5
2.7
7.0

2.0
1.0
2.8
0.2
0.8
0.7
0.6
0.2
0.6
0.1
0.3
0.4
0.5
0.2
2.5
3.7
1.7
3.4
2.6
1.7
3.3
3.4
4.3
4.1
4.4
2.9
5.9
5.1
5.9
3.0
2.6
3.1
4.3
3.6
3.6
7.5

0.6
0.9
1.1
1.0
0.9
1.0
1.1
0.4
0.9
0.3
0.7
1.4
0.5
0.6
2.8
2.8
0.8
2.9
1.9
4.7
1.3
4.8
3.8
5.0
4.6
5.9
12.4
12.9
8.5
5.7
5.0
8.1
8.3
7.0
2.2
7.4

0.6
0.4
0.7
0.3
0.3
0.3
0.4
0.3
0.1
0.2
0.1
0.4
0.2
0.2
0.6
0.6
0.8
0.4
0.8
0.3
0.6
0.9
0.5
1.1
0.5
0.4
0.4
0.4
0.2
0.3
0.3
1.6
0.5
1.2
2.1

0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

3.4
2.0
0.9
0.3
0.6
0.6
1.2
0.9
0.7
0.6
0.7
0.5
0.7
0.5
0.5
1.2
0.7
1.8
0.7
0.8
1.3
1.1
1.1
1.0
0.9
0.2
0.3
0.2
3.2
0.0
3.5
1.2
0.7
1.3
9.3
3.7

2346
1266
1149
42
288
464
320
22
111
85
184
143
74
138
5881
347
87
123
252
223
172
480
11486
692
682
1792
2620
3795
5722
1434
4311
9568
3762
3859
1084
6883

3064
1765
1180
49
351
557
396
39
134
121
229
166
96
172
6054
391
106
140
274
247
196
525
12354
739
726
2602
4310
6150
10848
2130
7229
15134
6089
5635
1728
9746

2.3
3.0
1.3
4.3
2.4
2.6
1.4
4.7
3.8
3.5
2.8
1.7
7.9
1.7
5.4

5.4
6.7
6.0
5.9
5.9
6.3
5.5
4.5
5.8
10.4
9.5
10.6
14.5
7.2
13.1

2.7
2.8
2.2
4.0
2.6
2.9
1.6
4.4
3.3
3.6
1.0
2.0
9.1
1.0
5.5

5.1
3.9
3.6
3.6
3.4
4.9
4.3
4.7
3.4
3.7
1.8
3.0
8.0
2.6
3.9

0.9
1.4
1.7
0.7
0.5
0.9
0.5
1.0
0.6
1.8
1.1
1.2
3.8
0.6
2.7

0.0
0.0
0.0
0.0
0.3
0.0
0.1
0.1
0.2

0.0
0.0
0.0
0.0
0.1
-

0.6
0.1
1.8
2.8
2.6
1.0
0.3
4.0
4.4
1.2
0.5
0.4
2.4
0.5
2.4

3877
1978
974
371
2878
1111
117
78
2331
1165
79
136
238
250
378

4677
2480
1202
446
3676
1339
138
95
3151
1273
85
142
256
278
423

*
*

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

653

711

Age-standardized (world) incidence rates (per 100,000)


by histological type

Bone (C40-41) - Male


Sarcoma

Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Non-Hispanic White
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Georgia: Black
USA, Georgia: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
USA, Louisiana: Black
USA, Louisiana: White
USA, Maine
USA, Massachusetts

Other

Unspec.

0.3
0.0
-

0.3
0.1
0.0
0.2

0.2
0.1
0.0
0.1
0.1
0.1
0.0
0.3
0.1

0.1
0.0
0.1
0.0
0.0
0.1

0.1
0.0
0.1
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.1

0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0

Osteo

Chondro

Ewing

Other

Unspec.

0.2
0.4
0.3
0.4
0.5

0.2
0.3
0.2
0.0

0.2
0.2
0.1
0.0

0.1
0.2
0.1

0.8
0.3
0.2
0.2
0.8
0.5
0.7
0.3
0.6
0.2
0.3

0.3
0.1
0.3
0.2
0.3
0.3
0.2
0.2
0.5
0.1

0.1
0.1
0.1
0.4
0.3
0.1
0.2
0.1
0.1
0.2
0.2

0.3
0.2
0.4
0.4
0.3
0.4
0.5
0.4
0.3
0.4
0.4
0.3
0.3
0.3
0.4
0.4
0.4
0.2
0.4
0.4
0.4
0.4
0.6
0.4
0.5
0.3
1.3
0.5
0.4
0.3
0.5
0.4
0.4
0.5
0.3
0.6
0.3
0.3
0.5
0.4
0.5
0.4
0.4
0.3
0.4
0.3
0.5
0.3
0.3
0.3
0.3
0.3
0.4
0.4
0.4
0.4
0.7
1.0
0.4
0.3
0.3
0.4

0.3
0.3
0.3
0.2
0.4
0.1
0.1
0.3
0.1
0.3
0.3
0.1
0.3
0.4
0.2
0.3
0.2
0.1
0.1
0.1
0.2
0.3
0.2
0.3
0.2
0.2
0.2
0.3
0.1
0.2
0.3
0.3
0.3
0.4
0.2
0.4
0.2
0.2
0.3
0.3
0.1
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.2
0.1
0.2
0.3
0.3
0.2
0.3
0.3
0.2
0.4
0.2
0.2
0.2

0.2
0.2
0.3
0.2
0.1
0.8
0.3
0.2
0.1
0.2
0.0
0.2
0.2
0.2
0.2
0.1
0.1
0.4
0.2
0.1
0.2
0.0
0.2
0.1
0.4
0.1
0.0
0.2
0.2
0.2
0.2
0.3
0.2
0.2
0.1
0.3
0.2
0.2
0.0
0.3
0.0
0.3
0.2
0.2
0.2
0.2
0.3
0.3
0.2
0.2
0.1
0.4
0.1
0.3
0.3
0.3

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

712

654

Cancer Incidence in Five Continents Vol. IX, IARC 2008

Number of cases
MV

Total

0.2
0.4
0.6
0.5

43
91
5
14
32

45
106
5
29
44

0.9
1.1
0.0
0.0
0.0
0.1
0.1
-

0.1
1.8
1.6
0.2
0.8
0.2
0.3
0.2
0.0
0.5
0.1

11
69
18
21
384
11
58
63
47
9
10

12
97
25
24
558
13
67
78
48
13
11 *

0.1
0.1
0.1
0.0
0.1
0.1
0.3
0.2
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.3
0.3
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1

0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0

587
66
106
24
22
18
0
25
300
1
25
123
20
99
18
130
914
153
7
7
6
35
0
90
246
27
8
5
83
3
2
110
66
50
258
529
137
91
7
79
12
7
3
485
48
432
189
66
15
48
39
146
29
295
37
246
175
83
108
108
14
24
40
67
36
170

688
72
116
24
22
18
0
28
381
1
26
137
21
112
19
138
942
157
7
7
6
36
0
92
250
27
8
5
84
3
2
113
67
51
264
547
142
93
7
81
12
7
3
513
49
459
195
67
16
48
41
148
31
303
37
253
182
86
115
114
14
24
41
72
38
173

*
*
*
*

Americ
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
Asia
Bahra
China
China
China
China
China
China
Cypru
India,
India,
India,
India,
India,
India,
India,
Israel
Israel
Israel
Japan
Japan
Japan
Japan
Japan
Japan
Japan
Korea
Korea
Korea
Korea
Korea
Korea

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Bone (C40-41) - Male (Contd)

es

Sarcoma

al

45
06
5
29
44

*
*
*
*

12
97
25
24
58
13
67
78
48
13
11 *

88
72
16
24
22
18
0
28
81
1
26
37
21
12
19
38
42
57
7
7
6
36
0
92
50
27
8
5
84
3
2
13
67
51
64
47
42
93
7
81
12
7
3
13
49
59
95
67
16
48
41
48
31
03
37
53
82
86
15
14
14
24
41
72
38
73

America, North (Contd)


USA, Michigan
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Michigan: Black
USA, Michigan: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York state
USA, New York state: Black
USA, New York state: White
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 registries)
USA, SEER (9 registries): Black
USA, SEER (9 registries): White
USA, SEER (14 registries)
USA, SEER (14 registries): Asian and Pacific Islander
USA, SEER (14 registries): Black
USA, SEER (14 registries): Hispanic White
USA, SEER (14 registries): Non-hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, New Delhi
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon

Other

Unspec.

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0

0.1
0.1
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.3
0.1
0.0
0.0
0.1
0.1

0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0

0.2
0.0
0.1
0.9
0.0
0.1
0.2
0.0
0.1
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.0
0.1

Osteo

Chondro

Ewing

Other

Unspec.

0.4
0.3
0.3
0.3
0.3
0.4
0.3
0.3
0.4
0.4
0.4
0.3
0.4
0.4
0.4
0.3
0.5
0.4
0.6
0.3
0.4
0.4
0.4
0.3
0.3
0.3
0.4
0.4
0.4
0.5
0.3
0.3
0.4
0.4
0.3
0.4
0.3
0.4
0.4
0.4
0.3
0.3
0.3
0.4
0.2
0.4
0.5
0.4
0.3
0.3
0.3
0.3

0.3
0.3
0.1
0.4
0.2
0.3
0.3
0.2
0.3
0.4
0.3
0.1
0.3
0.2
0.3
0.1
0.3
0.2
0.3
0.3
0.2
0.3
0.3
0.2
0.3
0.2
0.3
0.3
0.1
0.3
0.2
0.3
0.2
0.3
0.3
0.1
0.2
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.3
0.4
0.4
0.3
0.3
0.2
0.2

0.2
0.2
0.3
0.3
0.2
0.2
0.3
0.3
0.1
0.3
0.2
0.2
0.1
0.4
0.2
0.1
0.3
0.2
0.1
0.2
0.2
0.1
0.2
0.2
0.3
0.2
0.1
0.3
0.0
0.2
0.0
0.2
0.2
0.1
0.0
0.2
0.3
0.2
0.1
0.2
0.2
0.1
0.2
0.2
0.2
0.1
0.2
0.3

0.1
0.0
0.1
0.0
0.1
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.1
0.1

0.2
0.4
0.4
0.7
0.1
0.3
0.7
0.3
0.3
0.3
0.4
0.8
0.3
0.4
0.4
0.3
0.2
0.1
0.1
0.3
0.4
0.2
0.4
0.4
0.4
0.5
0.3
0.7
0.4

0.1
0.1
0.0
0.0
0.2
0.1
0.3
0.2
0.2
0.1
0.0
0.3
0.4
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.2

0.5
0.0
0.1
0.0
0.1
0.4
0.1
0.1
0.1
0.2
0.2
0.0
0.4
0.4
0.2
0.1
0.1
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1

0.4
0.0
0.0
0.0
0.1
0.2
0.1
0.1
0.2
0.1
0.0
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.0
0.2
0.1

Number of cases
MV

Total

0.1
0.0
0.1
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.1
0.3
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.1

269
105
20
84
27
236
137
9
126
28
261
21
219
45
4
13
26
529
70
424
5985
554
5140
281
27
248
86
100
353
28
310
23
694
58
576
1988
112
173
328
1340
89
18
69
519
42
458
81
19
138
88
45
131

294
108
22
85
31
257
146
10
134
29
268
22
225
45
4
13
26
567
76
454
6323
581
5433
289
27
256
95
101
365
28
321
23
707
61
586
2047
113
179
336
1382
95
21
72
583
48
512
82
20
144
89
46
155

0.2
0.5
0.1
3.1
1.1
0.4
0.4
0.2
0.2
0.1
0.3
0.9
0.1
0.1
0.1
0.1
0.1
0.3
0.0
0.0
0.1
0.1
0.2
0.3
0.1
0.3
0.3
0.1

11
47
126
10
58
141
35
27
92
8
259
61
421
68
14
208
182
22
9
7
12
50
26
98
29
725
71
50
23
41
56

12
63
146
21
73
283
36
29
118
9
295
67
502
75
17
225
194
24
12
15
13
56
27
118
33
900
92
57
29
49
60

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

655

*
*
*
*
*

*
*
*
*

713

Age-standardized (world) incidence rates (per 100,000)


by histological type

Bone (C40-41) - Male (Contd)


Sarcoma

Asia (Contd)
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland (data not available)
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg (data not available)
Germany, Free State of Saxony (data not available)
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania (data not available)
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio
Italy, Syracuse Province
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce (data not available)
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg

656

Unspec.

0.0
0.0
0.0
0.0
0.1
0.0
0.0

0.0
0.2
0.0
0.1
0.0
0.1
0.2
0.0
0.0
0.0
0.1
0.1

0.0
0.1
0.0
0.0
0.0
1.8
0.0
0.2
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.1
0.0
0.1
0.0
0.2
0.1
0.0
0.1
0.6
0.1
0.1
0.2
0.0
0.1
0.1
0.0
0.0
0.0
0.1
0.1
0.0

0.1
0.1
0.0
0.1
0.0
0.0
0.1
0.1
0.1
0.0
0.2
0.2
0.0
0.2
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.2
0.0
0.2
0.1
0.2
0.1
0.2
0.1
0.1
0.1
0.0
0.2
0.1
0.1
0.2
0.4
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1

Chondro

Ewing

Other

Unspec.

0.4
0.5
0.4
0.2
0.2
0.2
0.5
0.1
0.3
0.9
0.3
0.3
0.3
0.2
0.5
0.2
0.4
0.5
0.3

0.2
0.2
0.0
0.1
0.1
0.2
0.2
0.1
0.2
0.2
0.2
0.1
0.0
0.0
0.1
0.3

0.3
0.1
0.0
0.2
1.5
0.1
0.0
0.1
0.3
0.0
0.1
0.1
0.1
0.2
0.1
0.1

0.1
0.1
0.1
0.1
0.3
0.0
0.0
0.0
0.0
0.2
0.2

0.3
0.3
0.3
0.3
0.3
0.4
0.3
0.3
0.2
0.3
0.5
0.5
0.2
0.2
0.4
0.4
0.3
0.2
0.6
0.5
0.5
0.7
0.2
0.3
0.2
0.4
0.6
0.2
0.8
0.1
0.1
0.5
0.3
0.2
0.4
0.3
0.4
0.1
0.7
0.4
0.3
0.3
0.1
0.3
0.1
0.1
0.4
0.3
0.2
0.3
0.4
0.3
0.2
0.4
0.3
0.2
0.4
0.3
0.2

0.2
0.3
0.3
0.2
0.2
0.4
0.2
0.1
0.2
0.1
0.3
0.2
0.2
0.2
0.2
0.3
0.3
0.1
0.1
0.3
0.4
0.1
0.2
0.2
0.2
0.3
0.6
0.2
0.3
0.4
0.4
0.4
0.2
0.1
0.2
0.3
0.2
0.2
0.1
0.1
0.4
0.1
0.1
0.1
0.3
0.2
0.3
0.0
0.3
0.2
0.1
0.2
0.3
0.2
0.2
0.2
0.3
0.2
0.1

0.3
0.2
0.1
0.1
0.2
0.2
0.2
0.2
0.2
0.2
0.4
0.1
0.3
0.6
0.1
0.4
0.3
0.1
0.2
0.2
0.0
0.2
0.3
0.5
0.4
0.3
0.4
0.4
0.4
0.3
0.1
0.4
0.3
0.1
0.1
0.2
0.2
0.1
0.4
0.2
0.3
0.2
0.1
0.2
0.0
0.1
0.5
0.2
0.1
0.1
0.2
0.3
0.3

0.1
0.1
0.1
0.1
0.1
0.1
0.3
0.1
0.2
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.0
0.1
0.1
0.0
0.1
0.0
0.1
0.2
0.0
0.1
0.1
0.0
0.1
0.5
0.0
0.1
0.1
0.2
0.1
0.1
0.0
0.1
0.0
0.1
0.0

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

714

Other

Osteo

Cancer Incidence in Five Continents Vol. IX, IARC 2008

Number of cases
MV

Total

0.4
0.3
0.2
0.2
0.0
0.5
0.2
0.2
0.1
1.4
0.0
0.0
0.1
0.3
0.1
0.0

6
204
16
12
23
15
43
17
58
116
45
38
3
4
27
5
18
32
93

8
250
18
15
25
23
47
18
61
244
46
39
3
4
30
12
20
34
95

0.1
0.1
0.2
0.4
0.0
0.3
0.4
0.3
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.3
0.4
0.1
0.2
0.1
0.1
0.7
0.3
0.2
0.2
0.4
0.1
0.4
0.1
0.1
0.0
0.0
0.6
0.0
0.1
0.4
0.5
0.0
0.1
0.2
0.1
0.3
0.3

184
15
8
277
37
173
170
325
260
119
44
18
16
15
14
25
35
16
16
16
13
15
25
45
44
29
13
97
5
18
12
37
14
5
29
18
18
44
11
5
14
20
21
7
9
7
34
14
14
36
57
97
8
122
18
28
88
72
79

199
17
9
345
37
178
270
388
309
132
48
18
17
15
16
25
38
18
16
16
14
15
32
45
53
29
13
107
6
21
15
41
14
6
30
20
26
52
17
7
17
23
35
7
10
8
36
28
15
39
85
126
9
127
21
39
92
108
106

*
*
*

*
*
*
*

*
*
*

Europe
Serbia
Slova
Slove
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Switz
Switz
Switz
Switz
Switz
Switz
Switz
The N
The N
The N
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, N
UK, S
Oceani
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Frenc
New Z
USA,
USA,
USA,
USA,
USA,
USA,

*
*

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Bone (C40-41) - Male (Contd)

es

Sarcoma

al

8
50
18
15
25
23
47
18
61
44
46
39
3
4
30
12
20
34
95

99
17
9
45
37
78
70
88
09
32
48
18
17
15
16
25
38
18
16
16
14
15
32
45
53
29
13
07
6
21
15
41
14
6
30
20
26
52
17
7
17
23
35
7
10
8
36
28
15
39
85
26
9
27
21
39
92
08
06

*
*
*

*
*
*
*

*
*
*

Europe (Contd)
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, England, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern And Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory (data not available)
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Other

Unspec.

0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0

0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.1
0.1
0.0
0.1
0.2
0.4
0.1
0.1
0.1
0.1
0.0
0.0
0.7
0.0
0.1
0.0
0.1
0.1
0.0
0.0
0.0
0.1

0.0
0.0
0.1
0.0
0.4
0.0
-

0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.9
0.2
0.1
0.2
0.1

Osteo

Chondro

Ewing

Other

Unspec.

0.9
0.3
0.3
0.6
0.3
0.2
0.8
0.4
0.4
0.6
0.4
0.4
0.4
0.2
0.4
0.5
0.4
0.3
0.2
0.2
0.2
0.3
0.4
0.3
0.2
0.2
0.3
0.3
0.3
0.2
0.3

0.1
0.3
0.4
0.3
0.2
0.3
0.2
0.1
0.4
0.2
0.1
0.3
0.2
0.4
0.3
0.5
0.5
0.5
0.2
0.3
0.1
0.3
0.5
0.2
0.2
0.2
0.2
0.2
0.3
0.2
0.2
0.2
0.3
0.2
0.2

0.3
0.3
0.1
0.5
0.3
0.4
0.3
0.3
0.4
0.0
0.3
0.1
0.1
0.3
0.2
0.1
0.4
0.1
0.6
0.5
0.5
0.2
0.2
0.1
0.3
0.3
0.2
0.2
0.1
0.2
0.3
0.3
0.2
0.1
0.3

0.3
0.0
0.2
0.0
0.1
0.0
0.1
0.1
0.0
0.1
0.1
0.2
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.1

0.3
0.3
0.5
0.3
0.2
0.2
0.3
0.5
0.5
0.2
0.4
1.1
0.5

0.2
0.3
0.2
0.1
0.4
0.3
0.1
0.6
0.2
0.3
0.6
0.2
0.3

0.3
0.3
0.3
0.4
0.1
0.1
0.4
0.7
0.3
0.1
0.2
0.1

0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.0
0.2
-

Number of cases
MV

Total

0.9
0.3
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.3
0.0
0.0
0.0
0.0

269
156
50
6
36
54
32
2
23
21
29
16
9
29
234
9
6
2
18
10
7
13
420
34
19
61
79
78
131
51
151
304
97
129
23
121

370
207
50
8
41
59
36
3
25
22
30
16
10
31
234
10
6
2
18
10
7
14
423
34
19
65
128
91
138
58
226
366
107
132
26
129

0.0
0.0
0.2
0.0
-

167
97
46
8
123
40
8
15
127
33
0
5
6
6
11

178
100
49
8
128
43
8
17
133
33
0
5
6
6
11

*
*

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

657

715

Age-standardized (world) incidence rates (per 100,000)


by histological type

Bone (C40-41) - Female


Sarcoma

Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Non-Hispanic White
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Georgia: Black
USA, Georgia: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
USA, Louisiana: Black
USA, Louisiana: White
USA, Maine
USA, Massachusetts

Other

Unspec.

0.1
-

0.0
0.0
0.1
0.0
0.3

0.3
0.0
0.4
0.1
0.0
0.1
0.0
0.1
0.1
-

0.0
0.0
0.0
0.0
0.1

0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0

Osteo

Chondro

Ewing

Other

Unspec.

0.2
0.4
0.2
0.3
0.4

0.2
0.1
0.2
0.0
0.2

0.2
0.1
-

0.2
0.1
0.1

0.5
0.2
0.8
0.3
0.5
0.3
0.4
0.2
0.6
0.2
0.3

0.1
0.0
0.1
0.3
0.3
0.1
0.2
0.0
-

0.2
0.1
0.1
0.2
0.2
0.1
0.1
0.1
0.1
0.0
-

0.3
0.3
0.3
0.2
0.4
0.1
0.2
0.3
0.2
0.3
0.2
0.3
0.2
0.3
0.3
0.3
0.3
0.4
0.4
0.3
0.2
0.3
0.4
0.4
0.2
0.1
0.3
0.4
0.4
0.4
0.3
0.4
0.3
0.3
0.3
0.2
0.1
0.3
0.3
0.3
0.3
0.3
0.3
0.2
0.2
0.3
0.1
0.4
0.2
0.2
0.3
0.3
0.3
0.3
0.2
0.3
0.3
0.5
0.1
0.3
0.3
0.4
0.2

0.2
0.1
0.1
0.0
0.3
0.1
1.8
0.1
0.2
0.2
0.1
0.1
0.2
0.1
0.2
0.2
0.2
0.1
0.2
0.1
0.1
0.2
0.2
0.1
0.1
0.2
0.3
0.1
0.2
0.1
0.1
0.2
0.2
0.3
0.2
0.2
0.2
0.2
0.5
0.2
0.2
0.2
0.2
0.1
0.1
0.2
0.1
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.3
0.3
0.2
0.3
0.2
0.3
0.1
0.1

0.2
0.2
0.2
0.2
0.0
0.2
0.1
0.2
0.1
0.1
0.1
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.2
0.0
0.0
0.1
0.2
0.2
0.1
0.2
0.1
0.1
0.2
0.1
0.2
0.2
0.1
0.2
0.0
0.2
0.2
0.1
0.1
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.2
0.2

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

716

658

Cancer Incidence in Five Continents Vol. IX, IARC 2008

Number of cases
MV

Total

0.3
0.2
0.3
0.5

33
57
6
17
33

35
71
6
29
49

0.4
0.6
0.0
0.1
0.0
0.0
0.1
0.0

0.3
1.2
1.0
0.0
0.7
0.4
0.1
0.2
0.2
0.0
-

7
51
20
21
298
5
37
52
34
4
7

11
67
27
21
482
9
41
63
37
5
7*

0.1
0.0
0.0
0.1
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.7
0.5
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.2
0.0
0.0
0.1
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1

0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.3
0.1
0.1
0.0

418
51
71
16
16
7
1
11
225
1
19
80
15
64
10
117
650
110
10
6
6
17
1
61
193
20
5
7
72
3
3
79
54
48
190
347
105
70
4
66
13
6
5
361
45
313
140
42
15
25
35
102
25
270
33
227
128
70
95
99
9
12
21
75
28
130

516
52
76
18
16
7
1
11
314
1
20
98
21
76
12
129
680
114
10
7
7
18
2
61
194
20
5
7
72
3
3
80
57
49
197
366
106
74
5
69
13
6
5
386
50
333
145
43
15
26
36
106
27
278
33
235
133
73
100
116
10
16
25
88
28
136

*
*
*
*

Americ
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
Asia
Bahra
China
China
China
China
China
China
Cypru
India,
India,
India,
India,
India,
India,
India,
Israel
Israel
Israel
Japan
Japan
Japan
Japan
Japan
Japan
Japan
Korea
Korea
Korea
Korea
Korea
Korea

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Bone (C40-41) - Female (Contd)

es

Sarcoma

al

35
71
6
29
49

*
*
*
*

11
67
27
21
82
9
41
63
37
5
7*

16
52
76
18
16
7
1
11
14
1
20
98
21
76
12
29
80
14
10
7
7
18
2
61
94
20
5
7
72
3
3
80
57
49
97
66
06
74
5
69
13
6
5
86
50
33
45
43
15
26
36
06
27
78
33
35
33
73
00
16
10
16
25
88
28
36

America, North (Contd)


USA, Michigan
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Michigan: Black
USA, Michigan: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York state
USA, New York state: Black
USA, New York state: White
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 registries)
USA, SEER (9 registries): Black
USA, SEER (9 registries): White
USA, SEER (14 registries)
USA, SEER (14 registries): Asian and Pacific Islander
USA, SEER (14 registries): Black
USA, SEER (14 registries): Hispanic White
USA, SEER (14 registries): Non-hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, New Delhi
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon

Other

Unspec.

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.1
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.0
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.0

0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
-

0.4
0.0
0.0
0.5
0.0
0.1
0.1
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.1
0.0
0.0
0.0

Osteo

Chondro

Ewing

Other

Unspec.

0.3
0.4
0.4
0.4
0.5
0.3
0.2
0.2
0.2
0.5
0.3
0.1
0.3
0.3
0.4
0.2
0.4
0.6
0.4
0.3
0.3
0.3
0.3
0.2
0.2
0.3
0.2
0.2
0.1
0.2
0.1
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.4
0.4
0.3
0.3
0.4
0.3
0.3
0.2
0.2
0.2
0.2
0.2

0.2
0.2
0.0
0.2
0.0
0.2
0.3
0.2
0.3
0.1
0.3
0.2
0.3
0.2
0.2
0.1
0.3
0.3
0.3
0.3
0.2
0.1
0.2
0.2
0.0
0.2
0.2
0.3
0.2
0.1
0.2
0.2
0.2
0.1
0.3
0.2
0.1
0.1
0.2
0.2
0.2
0.1
0.2
0.2
0.1
0.2
0.5
0.1
0.3
0.4
0.2
0.2

0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.2
0.2
0.1
0.2
0.3
0.4
0.3
0.2
0.2
0.2
0.2
0.0
0.2
0.2
0.1
0.2
0.2
0.2
0.2
0.2
0.3
0.1
0.0
0.2
0.1
0.1
0.0
0.1
0.2
0.2
0.3
0.2
0.0
0.2
0.1
0.2
0.2
0.1
0.2
0.2

0.1
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.0
0.1
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.1

0.2
0.3
0.1
0.1
0.3
0.1
0.2
0.2
0.2
0.2
0.5
0.2
0.4
0.4
0.2
0.1
0.2
0.2
0.1
0.2
0.2
0.3
0.2
0.5
0.3
0.3
0.4

0.1
0.1
0.0
0.3
0.1
0.1
0.1
0.1
0.1
0.3
0.3
0.2
0.2
0.1
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.2
0.2
0.0
0.2

0.2
0.0
0.1
0.3
0.1
0.1
0.1
0.2
0.1
0.3
0.3
0.2
0.0
0.2
0.1
0.0
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.0

0.0
0.0
0.0
0.0
0.2
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0

Number of cases
MV

Total

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.0
0.0
0.1

225
83
16
65
24
194
132
9
114
20
218
17
181
41
3
17
21
553
86
446
4909
483
4171
234
25
199
83
75
263
16
234
18
564
50
466
1550
88
135
257
1040
78
20
58
459
43
398
59
12
135
99
37
96

241
86
19
65
27
207
141
11
121
22
232
18
193
45
3
19
23
594
90
479
5246
519
4457
247
26
211
95
77
274
16
244
19
587
54
484
1638
91
145
269
1099
87
21
66
509
50
438
61
13
145
104
39
118

0.2
0.1
1.9
1.0
0.2
0.1
0.3
0.2
0.1
0.2
0.7
0.1
0.0
0.0
0.2
0.1
0.0
0.0
0.0
0.2
0.1
0.3
0.1
0.2
0.2
0.2

5
27
90
2
41
110
20
21
70
2
144
26
235
47
13
164
148
16
10
6
10
25
15
76
13
585
54
48
25
17
45

5
34
107
9
48
251
23
22
92
2
178
27
283
54
13
183
158
18
13
13
10
30
17
93
21
722
81
52
30
22
57

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

659

*
*
*
*
*

*
*
*
*

717

Age-standardized (world) incidence rates (per 100,000)


by histological type

Bone (C40-41) - Female (Contd)


Sarcoma

Asia (Contd)
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland (data not available)
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg (data not available)
Germany, Free State of Saxony (data not available)
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania (data not available)
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio
Italy, Syracuse Province
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce (data not available)
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg

660

Unspec.

0.0
0.0
0.0
0.0
0.0

0.0
0.1
0.3
0.0
0.0
0.2
0.1
0.0
0.0
0.1
0.0
0.0

0.0
0.0
0.0
0.0
0.0
1.4
0.0
0.2
0.2
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.2
0.0
0.2
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.0

0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.2
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.0
0.0
0.1
0.1
0.0
0.0

Chondro

Ewing

Other

Unspec.

0.4
0.3
0.8
0.1
0.4
0.2
0.3
0.1
0.3
0.8
0.3
0.4
0.6
0.1
0.3
0.1
0.1
0.2
0.2

0.2
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.3
0.2

0.1
0.1
0.1
0.2
0.2
0.0
0.1
0.2
0.4
0.1
0.1
0.0
0.2
0.1
0.1
0.2
0.1
0.2

0.0
0.1
0.0
0.0
0.1
0.0
0.3
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.1

0.3
0.3
0.2
0.1
0.2
0.3
0.3
0.1
0.2
0.3
0.2
0.5
0.3
0.3
0.2
0.5
0.1
0.1
0.2
0.2
0.3
0.2
0.5
0.4
0.4
0.2
0.2
0.0
0.4
0.3
0.1
0.2
0.1
0.1
0.2
0.2
0.2
0.2
0.1
0.3
0.3
0.2
1.4
0.2
0.3
0.2
0.1
0.3
0.2
0.3
0.3
0.2
0.1
0.3
0.3
0.2

0.1
0.2
0.1
0.3
0.4
0.2
0.1
0.1
0.1
0.1
0.1
0.3
0.3
0.2
0.2
0.5
0.1
0.3
0.1
0.0
0.1
0.2
0.2
0.2
0.1
0.2
0.2
0.2
0.3
0.2
0.1
0.2
0.1
0.3
0.1
0.6
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.3
0.1
0.1
0.2
0.2
0.1
0.2
0.2
0.1
0.1
0.1
0.1

0.2
0.4
0.2
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.3
0.1
0.1
0.3
0.1
0.4
0.1
0.3
0.1
0.3
0.2
0.2
0.2
0.8
0.2
0.5
0.1
0.3
0.2
0.2
0.3
0.8
0.5
0.1
0.2
0.2
0.3
0.1
0.2
0.0
0.1
0.4
0.2
0.1
0.0
0.2
0.2
0.1

0.1
0.1
0.2
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.0
0.0
0.1
0.3
0.0
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.0
0.1
0.2
0.0
0.2
0.0
0.0
0.1
0.1
0.0
0.1
0.1
0.0

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

718

Other

Osteo

Cancer Incidence in Five Continents Vol. IX, IARC 2008

Number of cases
MV

Total

0.1
0.1
0.2
0.3
0.4
0.1
0.0
0.2
0.9
0.0
0.0
0.4
0.1
0.5
0.1
0.1
-

6
157
20
11
11
15
32
15
54
106
44
37
3
4
17
5
12
23
56

7
187
21
15
11
20
36
16
57
203
49
41
4
4
19
17
14
24
57

0.0
0.0
0.2
0.0
0.2
0.2
0.1
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.2
0.1
0.1
0.0
0.0
0.4
0.1
0.1
0.4
0.2
0.1
0.4
0.0
0.1
0.4
0.1
0.0
0.2
0.2
0.0
0.2
0.1
0.1
0.2
0.1

145
16
1
236
28
133
141
266
179
87
30
14
22
14
19
17
36
23
9
13
8
14
25
58
55
21
1
73
2
11
5
30
11
4
27
12
12
41
16
6
12
25
15
4
6
3
21
22
6
28
48
81
7
108
10
20
75
58
59

159
18
1
282
28
135
205
311
234
102
33
14
22
15
19
17
38
24
9
13
8
16
34
60
62
21
1
78
5
13
5
37
14
4
29
13
19
50
18
9
13
28
28
5
6
3
23
34
9
32
64
104
7
111
15
28
85
88
85

*
*
*

*
*
*
*

*
*
*

Europe
Serbia
Slova
Slove
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Switz
Switz
Switz
Switz
Switz
Switz
Switz
The N
The N
The N
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, N
UK, S
Oceani
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Frenc
New Z
USA,
USA,
USA,
USA,
USA,
USA,

*
*

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Bone (C40-41) - Female (Contd)


Sarcoma

es

al

7
87
21
15
11
20
36
16
57
03
49
41
4
4
19
17
14
24
57

59
18
1
82
28
35
05
11
34
02
33
14
22
15
19
17
38
24
9
13
8
16
34
60
62
21
1
78
5
13
5
37
14
4
29
13
19
50
18
9
13
28
28
5
6
3
23
34
9
32
64
04
7
11
15
28
85
88
85

*
*
*

*
*
*
*

*
*
*

Europe (Contd)
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, England, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern And Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory (data not available)
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Other

Unspec.

0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.1
0.1
0.1
0.0
0.0
0.1
0.0
0.0
0.2
0.0
0.1
0.3
0.1
0.1
0.1
0.1
0.1
0.0
0.6
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
-

0.0
0.1
0.0
0.0
0.1
0.1
0.1
0.3
0.1
0.0
0.4
-

Osteo

Chondro

Ewing

Other

Unspec.

0.6
0.3
0.3
0.1
0.3
0.2
0.2
0.2
0.2
0.0
0.2
0.2
0.3
0.4
0.2
0.1
0.1
0.4
0.6
0.9
0.2
0.4
0.3
0.3
0.2
0.2
0.3
0.2
0.2
0.3
0.3
0.2
0.2
0.4
0.1
0.2

0.1
0.1
0.2
0.2
0.2
0.2
0.1
0.5
0.1
0.1
0.1
0.2
0.2
0.2
0.5
0.5
0.2
0.0
0.2
0.2
0.3
0.4
0.3
0.1
0.1
0.1
0.1
0.3
0.2
0.2
0.1
0.2
0.2
0.1

0.1
0.2
0.0
0.1
0.1
0.1
0.2
0.1
0.5
0.1
0.8
0.4
0.1
0.3
0.1
0.4
0.2
0.2
0.1
0.3
0.1
0.1
0.2
0.1
0.2
0.2
0.1
0.1
0.2

0.2
0.0
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.2
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0

0.3
0.4
0.2
0.3
0.2
0.3
0.3
0.3
0.3
0.3
0.4
0.2
0.2
0.4
0.3

0.2
0.2
0.3
0.1
0.2
0.2
0.2
0.2
0.1
0.1
0.3
0.1
0.1
0.0

0.1
0.2
0.1
0.1
0.2
0.1
0.8
0.2
0.1
0.3
0.3

0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.2

Number of cases
MV

Total

0.6
0.2
0.0
0.2
0.0
0.0
0.0
0.3
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.3
0.0
0.0
0.1
0.0

168
105
47
6
25
28
20
2
16
11
26
7
15
29
162
13
1
3
16
9
5
14
385
27
14
40
88
47
102
52
128
240
82
108
18
84

260
146
47
7
26
33
22
4
17
11
29
8
15
32
164
13
1
3
17
10
5
14
389
27
14
45
138
59
114
56
225
286
98
114
23
93

0.0
0.0
0.0
0.2
0.0
-

136
81
32
7
94
43
5
9
84
19
2
2
3
4
5

144
87
34
7
99
47
5
12
87
19
2
2
3
4
5

*
*

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

661

719

Age-standardized (world) incidence rates (per 100,000)


by histological type

Skin (C43-44) - Male


Carcinoma

Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Non-Hispanic White
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Georgia: Black
USA, Georgia: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
USA, Louisiana: Black
USA, Louisiana: White
USA, Maine
USA, Massachusetts

Melanoma

Other

Unspec.

0.2
0.0
0.2
0.0

0.2
0.3
0.6
0.9
0.9

0.1
0.1
0.8
0.3

0.5
0.3
0.2
0.8
0.8
0.3
0.1
0.4
0.0
0.5
0.3

1.7
0.9
1.5
1.3
1.2
0.1
0.1
0.2
0.4
-

3.3
4.2
2.7
4.4
6.5
1.8
3.5
2.4
2.5
1.4
1.8

0.3
0.7
0.3
0.7
0.7
0.7
0.6
0.1
0.8
0.7
0.6
0.1
0.6
0.6
0.5
0.9
0.9
0.1
0.4
0.7
0.4
0.4
1.1
1.1
0.6
0.2
0.5
0.3
1.3
1.5
0.4
0.4
0.4
1.1
0.8
0.6
0.2
0.6
0.5
0.5
0.5
0.6
0.1
0.6
0.5
0.7
0.4
0.7
0.3
0.6
0.4
0.5
0.2
0.5
0.5
0.7
0.7
0.7
0.8
0.2
0.9
0.4
0.7

0.0
0.0
0.1
0.2
0.1
-

10.9
10.3
10.8
9.1
11.3
6.4
5.9
14.0
11.4
12.6
8.0
10.8
0.6
12.4
8.8
15.4
15.2
12.9
0.6
0.9
0.4
2.6
0.1
19.3
11.9
1.0
1.2
0.8
2.8
1.1
0.3
21.7
0.9
1.0
2.9
22.0
16.9
18.0
0.9
19.0
7.1
0.8
17.3
13.7
0.8
15.1
14.1
17.3
0.9
23.8
1.0
17.7
16.8
10.6
0.6
11.7
12.2
13.7
16.7
8.6
1.0
9.0
0.9
11.3
15.7
15.0

Squamous

Basal cell

Other

Unspec.

2.5
2.8
3.0
1.7
1.8

4.4
3.5
9.5
0.8
0.4

0.2
0.3
0.1
0.1
0.3

3.4
14.2
11.5
46.8
21.2
4.4
0.1
10.4
5.2
3.7
6.5

12.9
101.0
55.5
149.0
71.3
10.8
29.6
23.4
11.7
14.9

1.2
23.8
-

4.8
0.0
94.2
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

720

662

Cancer Incidence in Five Continents Vol. IX, IARC 2008

Number of cases
MV

Total

0.3
0.1
1.0
0.1

158
263
138
44
71

159
277
138
59
79

0.3
0.3
0.2
0.2
0.4
0.1
0.1
0.5
0.3

0.5
3.2
1.0
0.4
0.1
0.2
0.0
1.8
0.1
0.1
-

182
2547
438
2734
20558
160
146
3228
863
210
212

191
2576
447
2772
20584
161
150
3363
869
210
212 *

0.2
0.3
0.2
0.3
0.3
0.4
0.3
0.0
0.1
0.3
0.3
0.5
0.2
0.3
0.3
0.4
0.3
0.4
0.2
0.2
0.2
0.3
0.5
0.9
0.1
0.2
0.3
0.6
0.2
0.8
0.3
0.4
0.5
0.4
0.3
0.4
0.5
0.6
0.4
0.3
0.3
0.2
0.4
0.6
0.8
0.4
0.8
0.3
0.2
0.4
0.6
0.3
0.3
0.4
0.3
0.4
0.7
0.1
0.5
0.3
0.3
0.4

0.0
0.0
0.1
0.1
0.2
-

13837
1043
1633
5498
307
141
6
501
4312
67
329
1673
35
1512
160
2743
16790
2907
17
25
13
82
2
2580
3625
63
16
11
234
13
2
3022
168
134
667
14717
2338
2163
11
2073
139
22
110
9319
67
9062
3396
1316
45
1234
112
3199
689
4394
64
4087
2491
1479
2274
1319
16
200
53
1243
693
3357

14086
1043
1646
5520
307
145
6
502
4520
67
330
1703
37
1540
164
2776
16861
2918
17
25
13
83
2
2590
3635
63
16
11
235
13
2
3031
169
135
670
14778
2353
2178
11
2088
143
23
113
9454
69
9193
3440
1321
45
1239
112
3243
702
4432
64
4123
2508
1486
2287
1334
16
205
53
1258
739
3392

*
*
*
*

Americ
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
Asia
Bahra
China
China
China
China
China
China
Cypru
India,
India,
India,
India,
India,
India,
India,
Israel
Israel
Israel
Japan
Japan
Japan
Japan
Japan
Japan
Japan
Korea
Korea
Korea
Korea
Korea
Korea

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Skin (C43-44) - Male (Contd)

es

Carcinoma

al

9
7
8
9
9

*
*
*
*

1
6
7
2
4
1
0
3
9
0
2*

6
3
6
0
7
5
6
2
0
7
0
3
7
0
4
6
1
8
7
5
3
3
2
0
5
3
6
1
5
3
2
1
9
5
0
8
3
8
1
8
3
3
3
4
9
3
0
1
5
9
2
3
2
2
4
3
8
6
7
4
6
5
3
8
9
2

America, North (Contd)


USA, Michigan
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Michigan: Black
USA, Michigan: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York state
USA, New York state: Black
USA, New York state: White
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 registries)
USA, SEER (9 registries): Black
USA, SEER (9 registries): White
USA, SEER (14 registries)
USA, SEER (14 registries): Asian and Pacific Islander
USA, SEER (14 registries): Black
USA, SEER (14 registries): Hispanic White
USA, SEER (14 registries): Non-hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, New Delhi
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon

Melanoma

Other

Unspec.

0.0
0.0
0.0
-

14.5
13.7
0.8
17.4
1.0
15.8
9.8
0.5
10.6
12.7
14.2
0.5
16.6
14.2
2.1
2.4
23.7
9.3
0.8
10.9
13.1
0.7
14.4
12.4
0.8
12.6
10.3
18.5
12.7
0.6
13.1
18.2
15.1
0.8
17.9
14.8
1.0
0.9
3.0
19.4
14.4
0.6
18.4
10.2
0.5
10.9
16.7
20.6
17.2
16.9
13.2
11.3

0.5
0.6
0.9
0.5
0.9
0.4
0.4
0.8
0.3
0.2
0.5
0.9
0.4
0.4
0.5
0.4
0.4
0.6
0.4
0.4
0.6
0.3
0.4
0.7
0.3
0.2
0.3
0.4
0.6
0.4
0.4
0.5
0.7
0.4
0.4
0.3
0.7
0.3
0.4
0.3
0.5
0.3
0.3
0.4
0.2
0.6
0.3
0.4
0.4
0.4
0.3

0.2
0.0
0.0
0.1
0.1
0.0
0.0
0.1
0.1
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
-

0.4
0.8
0.7
0.1
0.1
0.4
0.2
2.9
0.3
0.5
0.3
0.4
0.3
0.2
11.2
12.2
1.4
0.5
0.4
0.5
0.5
0.7
0.4
0.4
0.5
0.5
0.7
0.3
0.7
0.5

0.2
0.2
0.4
0.1
0.0
0.3
0.0
0.1
0.1
0.0
0.1
0.1
0.5
0.5
0.4
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.2

Squamous

Basal cell

Other

Unspec.

0.0
0.0
-

0.0
0.0
0.0
0.0
0.0
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
-

0.6
0.7
0.4
0.7
0.4
0.6
0.5
0.2
0.5
0.4
0.7
0.3
0.8
0.7
0.5
0.9
0.5
0.2
0.6
0.6
0.2
0.7
0.4
0.1
0.4
0.5
0.5
0.7
0.2
0.7
1.1
0.7
0.4
0.8
0.8
0.4
0.3
0.4
0.9
0.6
0.1
0.7
0.6
0.3
0.6
0.9
0.4
0.7
0.8
0.5
0.5

1.5
0.7
1.3
0.9
0.1
0.8
5.2
0.8
1.8
0.8
0.7
0.5
0.8
1.0
1.0
0.5
1.0
0.6
2.3
1.1
1.8
0.4
0.9
0.9
0.8
1.4
0.8
0.8
0.9

2.5
0.7
3.6
0.7
0.2
1.0
16.6
0.2
0.3
0.3
0.2
0.3
0.6
1.3
1.3
0.8
1.0
1.0
3.2
1.5
3.5
0.5
0.8
1.2
1.2
2.0
1.0
2.0
1.4

0.2
0.2
0.2
0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.5
0.5
0.2
0.2
0.3
0.4
0.1
0.5
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1

Number of cases
MV

Total

0.1
0.1
0.1
-

4857
1883
50
1806
76
4566
1897
22
1849
413
4239
53
4111
875
8
59
806
6128
112
5941
99891
1040
94280
4803
52
4345
1218
2204
5980
44
5586
696
13579
141
12958
36383
294
380
906
33280
1915
34
1836
6315
70
5878
1056
438
3431
2326
901
2100

4928
1889
51
1811
81
4632
1960
25
1909
420
4284
53
4155
891
8
61
820
6382
118
6186
101309
1062
95631
4869
53
4407
1287
2221
6030
44
5629
697
13651
142
13029
36593
295
382
912
33475
1946
35
1864
6542
73
6099
1061
443
3454
2336
912
2148

0.1
0.1
0.7
1.4
0.1
0.1
0.0
0.1
0.2
1.6
0.2
0.2
0.1
0.3
0.2
0.0
0.1
0.1
0.1
0.2
0.1
0.1
0.2
0.1
0.2

25
151
1403
27
14
490
81
532
131
24
371
53
288
93
50
2199
2110
57
111
100
274
342
505
515
158
2510
218
224
66
92
152

25
167
1417
27
17
527
81
602
141
24
378
58
325
100
50
2373
2252
58
117
110
281
363
509
545
166
2656
229
230
68
94
160

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

663

*
*
*
*
*

*
*
*
*

721

Age-standardized (world) incidence rates (per 100,000)


by histological type

Skin (C43-44) - Male (Contd)


Carcinoma

Asia (Contd)
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland (data not available)
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg (data not available)
Germany, Free State of Saxony (data not available)
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania (data not available)
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio
Italy, Syracuse Province
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce (data not available)
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg

Melanoma

Other

Unspec.

0.0
0.0
0.2
0.1
0.0
0.1
0.2
0.1
0.1
0.1
0.2
0.0

0.4
0.6
0.5
0.2
0.6
0.5
1.2
0.4
0.5
0.8
0.4
0.4
0.4
0.7
0.6
0.8
0.5
1.0
1.3

0.1
0.1
0.1
0.2
0.1
0.0
0.1
0.3
0.1
0.2
0.2
0.2
0.1
0.0
0.3
0.1

0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.2
0.4
0.1
0.1
0.1
0.1
0.3
0.8
0.1
0.5
0.5
2.3
0.2
0.3
1.8
0.5
0.9
0.2
0.4
0.4
0.1
0.3
0.3
0.2
0.1
0.1
0.3
0.2
0.0

8.6
13.0
12.4
2.7
4.6
5.5
2.7
6.9
9.9
11.9
5.3
11.3
4.7
7.4
10.7
7.1
7.2
9.8
6.7
6.2
6.2
7.3
9.7
12.7
8.0
8.1
9.3
7.4
9.8
8.4
6.4
9.8
7.9
9.6
10.4
7.0
3.9
9.5
7.8
3.8
6.1
10.0
5.0
3.4
5.4
4.6
10.7
5.6
7.8
9.4
3.2
3.7
5.5
14.2
5.7
4.4
2.6
3.7
3.8

0.1
0.3
0.1
0.2
0.3
0.1
0.2
0.2
0.1
0.1
0.0
0.2
0.2
0.7
0.3
0.6
0.5
0.1
0.4
0.3
0.4
0.5
0.5
0.3
0.5
0.4
0.2
0.1
0.6
0.3
0.4
1.3
0.4
0.4
0.4
0.2
0.5
0.2
0.4
0.3
0.3
0.2
0.2
0.3
0.0

Squamous

Basal cell

Other

Unspec.

1.0
1.0
0.8
0.4
0.7
2.4
1.9
1.4
2.1
1.3
2.5
2.8
0.8
2.1
1.5
1.8
2.7
5.5
3.4

0.9
0.9
0.8
0.8
1.5
2.4
2.4
2.6
1.5
1.6
5.4
6.6
0.3
1.9
2.0
1.7
2.0
13.7
8.9

0.2
0.2
0.1
0.4
0.3
0.1
0.3
0.3
0.5
0.5
0.4
0.3
0.1
0.1
0.1
0.2

7.5
6.0
12.2
4.1
8.8
9.3
5.7
10.0
8.9
3.0
9.9
4.5
7.1
9.4
7.9
37.8
10.4
12.5
19.7
7.1
7.0
11.3
5.7
10.4
4.7
11.8
9.0
14.0
13.0
12.3
8.3
13.8
14.1
11.3
4.5
10.5
9.0
14.8
1.7
5.3
16.1
10.8
2.0
1.9
9.0
1.5

16.1
10.6
0.6
17.6
1.0
22.3
14.6
50.9
53.9
24.9
39.4
1.2
35.5
42.2
0.5
72.4
52.0
57.7
61.6
48.8
50.0
56.8
39.7
50.7
13.6
45.8
33.3
51.9
52.2
51.2
22.6
47.2
44.3
52.4
39.1
32.4
48.3
55.3
12.1
21.6
53.4
0.9
18.5
9.8
0.1
0.0
9.5

0.3
0.5
0.2
0.2
0.3
0.8
0.2
0.4
0.3
0.1
0.3
0.3
0.8
0.4
0.2
0.7
0.3
0.5
0.9
0.4
0.6
0.6
0.4
0.2
1.3
0.6
0.5
1.2
0.5
0.5
0.2
0.8
0.4
0.3
0.3
0.2
0.5
0.6
0.2
0.2
0.4
0.3
0.1
0.2
0.1
0.2
0.2

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

722

664

Cancer Incidence in Five Continents Vol. IX, IARC 2008

Number of cases
MV

Total

0.2
0.5
0.1
0.0
0.0
0.1
0.0
0.0
0.1
0.2
0.1
0.1
0.0

19
554
35
17
58
108
199
75
129
271
748
684
18
46
171
92
144
591
1036

19
579
39
17
59
111
200
75
132
279
748
684
18
46
173
97
146
595
1062

0.1
0.1
0.1
1.2
0.1
0.2
0.4
0.8
0.7
0.8
0.2
0.7
0.1
0.1
0.3
0.1
1.3
0.3
4.8
2.3
0.1
0.3
0.0
1.6
3.5
0.2
0.7
0.2
1.1
0.1
0.3
0.1
0.1
1.0
0.5
0.2
4.1
1.7
1.6
0.1
0.2
0.6
0.3
0.9

10083
695
294
7544
1140
7946
8015
1013
26236
16162
1476
375
104
120
258
236
258
373
124
110
89
159
4096
1738
5144
2865
179
13952
706
1976
1816
3999
1996
746
2954
2172
373
6955
1122
959
1651
3884
1317
1309
503
969
2467
2294
1367
5821
1638
3551
1058
4895
666
1057
301
1598
2143

10220
698
296
7626
1144
7970
8145
1044
26632
16634
1521
375
104
120
258
236
261
373
124
110
89
159
4350
1801
5422
2872
179
14764
707
2024
1824
4323
2085
749
2973
2174
403
6959
1122
963
1654
3894
1362
1311
505
971
2472
2431
1381
5832
1655
3611
1081
4907
672
1099
301
1624
2238

*
*
*

*
*
*
*

*
*
*

Europe
Serbia
Slova
Slove
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Switz
Switz
Switz
Switz
Switz
Switz
Switz
The N
The N
The N
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, N
UK, S
Oceani
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Frenc
New Z
USA,
USA,
USA,
USA,
USA,
USA,

*
*

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Skin (C43-44) - Male (Contd)

es

Carcinoma

al

9
9
9
7
9
1
0
5
2
9
8
4
8
6
3
7
6
5
2

0
8
6
6
4
0
5
4
2
4
1
5
4
0
8
6
1
3
4
0
9
9
0
1
2
2
9
4
7
4
4
3
5
9
3
4
3
9
2
3
4
4
2
1
5
1
2
1
1
2
5
1
1
7
2
9
1
4
8

*
*
*

*
*
*
*

*
*
*

Europe (Contd)
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, England, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern And Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory (data not available)
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Melanoma

Other

Unspec.

1.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.2
0.4
0.3
0.1
0.1
0.0
0.1
0.1
0.1
0.2
0.2
0.1
0.3
0.1
0.1
0.3
0.1

3.8
6.4
9.0
5.0
3.4
4.9
3.9
3.3
5.2
4.3
6.5
6.6
6.4
4.0
11.9
18.5
11.5
18.6
12.8
12.4
11.8
16.6
10.0
9.4
8.9
8.8
6.9
6.8
6.9
9.8
10.7
6.2
6.1
6.9
7.5
8.4

0.1
0.2
0.2
0.6
0.6
0.4
0.6
0.5
0.3
0.3
0.8
0.6
0.2
0.3
0.2
0.1
0.4
0.3
0.6
0.4
0.4
0.6
0.2
0.1
0.2
0.1
0.2
0.2
0.0
0.3
0.2

0.0
0.0
0.0
0.5
0.1
-

38.5
55.8
31.0
30.8
27.3
44.5
32.4
3.1
34.8
13.6
0.3
1.0
2.4
2.2
41.1

0.3
0.5
0.1
0.0
0.2
0.1
0.2
0.5
0.4
0.5
0.8
0.1
0.5

Squamous

Basal cell

Other

Unspec.

4.9
6.5
7.4
0.4
0.0
14.6
17.4
13.2
17.9
15.7
11.3
11.0
31.1
22.7
21.4
18.0
20.4
33.3
15.3
15.8
13.2
15.7
14.0
19.6
9.2
12.9
27.7
17.1

15.0
38.9
32.6
0.3
0.0
0.1
48.8
61.1
36.3
68.1
62.5
36.7
0.8
100.0
1.0
79.3
59.4
68.8
91.2
0.0
0.0
0.0
59.5
58.7
0.0
79.7
0.3
54.6
0.0
65.8
59.1

0.5
0.2
0.3
0.3
0.3
0.2
0.4
0.7
0.8
0.9
0.1
0.1
0.5
1.6
0.3
0.8
0.3
0.8
1.0
0.5
0.4
0.4
0.4
0.4
0.0
0.5
0.3
0.4
0.0
0.4
0.4

4.1
0.9
11.7
5.2
0.0
-

0.0
0.0
0.1
0.3
0.0
4.8
0.2
0.0
-

0.1
1.1
0.8
0.6
2.4
2.0
0.8
0.9
0.6
0.7
0.4
0.5
2.0

Number of cases
MV

Total

0.8
0.4
0.4
0.0
0.0
0.0
0.2
0.0
0.2
0.1
0.3
0.0
0.2
0.3
0.3
0.2
0.0
0.1
0.0
0.0
5.1
0.1
0.1
2.8
0.1

4875
8368
3440
70
145
365
213
32
1798
2705
2387
2391
1896
2125
10744
2390
361
842
1833
146
1079
3548
15706
970
816
10348
564
967
22022
891
34824
8958
15432
1300
6143
17514

5162
8501
3447
76
152
367
214
34
1801
2706
2398
2396
1903
2126
10749
2392
361
842
1841
148
1080
3551
15716
972
816
10506
580
988
22353
894
36689
9389
15708
1312
6281
17624

0.1
0.2
0.1
0.1
-

8554
6638
1954
537
4434
3897
362
14
4437
630
5
15
20
32
514

8646
6703
1967
539
4468
3921
365
15
4451
631
5
15
20
32
515

*
*

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

665

723

Age-standardized (world) incidence rates (per 100,000)


by histological type

Skin (C43-44) - Female


Carcinoma

Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Non-Hispanic White
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Georgia: Black
USA, Georgia: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
USA, Louisiana: Black
USA, Louisiana: White
USA, Maine
USA, Massachusetts

Melanoma

Other

Unspec.

0.1
0.0
0.2
0.0

0.4
0.3
0.5
1.4
2.3

0.3
0.1
0.4
0.0
0.4

0.3
0.8
0.2
0.9
0.6
0.3
0.2
0.3
0.1
1.6
0.2

1.1
0.8
0.1
1.6
1.1
0.4
0.1
0.2
0.0
0.2

2.9
4.2
2.0
4.5
5.7
3.5
2.9
2.1
2.8
1.1
2.1

0.2
0.5
0.3
0.6
0.5
0.4
0.3
0.1
0.5
0.2
0.1
0.3
0.3
0.3
0.5
0.5
0.1
0.4
0.3
0.6
0.6
0.2
0.1
0.1
0.4
0.2
0.2
0.9
0.2
0.2
0.3
0.6
0.5
0.3
0.1
0.3
0.3
0.1
0.4
0.3
0.2
0.3
0.2
0.3
0.2
0.3
0.1
0.2
0.3
0.3
0.1
0.3
0.3
0.4
0.3
0.4
0.3
0.2
0.5
0.4
0.5

0.0
0.0
0.0
0.0
0.3
0.1
-

9.3
10.0
8.9
7.0
11.1
6.7
5.3
12.5
9.2
15.7
8.5
7.4
0.5
8.8
6.7
9.7
10.3
8.9
0.3
0.6
0.3
4.0
0.7
13.8
7.9
0.6
0.4
0.7
2.6
0.9
1.2
16.2
0.8
0.6
3.1
15.7
12.6
13.3
0.5
14.3
4.3
0.1
11.6
8.9
0.9
10.2
9.3
10.7
0.6
16.6
0.6
12.6
11.6
7.3
0.5
8.4
9.0
12.6
13.0
5.7
0.6
6.6
0.7
7.9
11.8
11.5

Squamous

Basal cell

Other

Unspec.

1.2
0.7
1.3
0.9
2.6

2.6
1.5
8.6
0.0
1.1

0.1
0.1
0.2
0.2
0.4

1.1
9.3
6.7
36.7
13.5
2.5
6.6
4.5
2.0
5.3

9.5
83.1
43.6
137.0
57.4
11.7
28.5
22.7
14.4
13.5

0.6
12.2
-

3.8
0.0
0.0
75.4
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

724

666

Cancer Incidence in Five Continents Vol. IX, IARC 2008

Number of cases
MV

Total

0.1
0.0
0.1
0.8
0.0

107
134
111
33
109

108
142
112
49
114

0.2
0.4
0.2
0.4
0.3
0.2
0.3
0.2
0.0
0.1
0.0

0.1
2.5
0.8
0.2
0.1
0.8
0.0
1.8
0.3
0.2
-

166
2625
382
3233
22859
194
161
3101
1012
271
249

170
2653
387
3270
22892
201
162
3252
1030
272
249 *

0.2
0.4
0.3
0.5
0.3
0.3
0.3
0.1
0.8
0.3
0.4
0.7
0.3
0.4
0.3
0.4
0.4
0.9
0.2
0.2
0.3
0.5
0.5
0.4
0.8
0.6
0.2
0.2
0.3
0.6
0.3
0.7
0.3
0.5
0.4
0.4
0.8
0.3
0.5
0.7
0.4
0.4
0.7
0.3
0.4
0.5
0.8
0.3
0.6
0.3
0.3
0.4
0.6
0.4
0.3
0.5
0.3
0.3
0.5
0.2
0.4
0.3
0.2
0.4

0.0
0.0
0.0
0.0
0.0
-

12460
1052
1432
4861
333
153
4
472
3719
81
353
1262
44
1099
124
1803
12486
2220
20
26
6
133
6
1865
2746
52
16
10
293
9
7
2167
178
112
829
10407
1828
1770
13
1689
109
14
83
6346
126
6082
2627
1009
45
941
93
2449
518
3457
73
3187
2004
1368
1886
1009
16
151
60
926
582
2934

12684
1053
1446
4879
333
153
4
475
3907
81
353
1284
44
1121
127
1821
12542
2232
20
26
6
134
6
1876
2747
52
16
10
293
9
7
2168
178
112
832
10454
1846
1774
13
1693
109
14
83
6408
127
6143
2660
1012
45
944
97
2478
519
3492
77
3218
2017
1376
1898
1017
16
153
60
934
612
2965

*
*
*
*

Americ
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
Asia
Bahra
China
China
China
China
China
China
Cypru
India,
India,
India,
India,
India,
India,
India,
Israel
Israel
Israel
Japan
Japan
Japan
Japan
Japan
Japan
Japan
Korea
Korea
Korea
Korea
Korea
Korea

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Skin (C43-44) - Female (Contd)

es

Carcinoma

al

8
2
2
9
4

*
*
*
*

0
3
7
0
2
1
2
2
0
2
9*

4
3
6
9
3
3
4
5
7
1
3
4
4
1
7
1
2
2
0
6
6
4
6
6
7
2
6
0
3
9
7
8
8
2
2
4
6
4
3
3
9
4
3
8
7
3
0
2
5
4
7
8
9
2
7
8
7
6
8
7
6
3
0
4
2
5

America, North (Contd)


USA, Michigan
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Michigan: Black
USA, Michigan: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York state
USA, New York state: Black
USA, New York state: White
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 registries)
USA, SEER (9 registries): Black
USA, SEER (9 registries): White
USA, SEER (14 registries)
USA, SEER (14 registries): Asian and Pacific Islander
USA, SEER (14 registries): Black
USA, SEER (14 registries): Hispanic White
USA, SEER (14 registries): Non-hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, New Delhi
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon

Melanoma

Other

Unspec.

0.0
0.0
0.0
-

11.4
10.5
0.6
14.2
0.7
12.9
6.2
0.4
6.8
9.7
9.7
0.6
11.8
9.7
0.8
3.5
16.5
6.4
0.7
7.8
9.2
0.6
10.3
9.6
0.5
9.9
6.5
15.5
9.4
0.4
9.9
11.1
11.4
0.6
14.1
10.5
0.9
0.6
3.2
14.4
10.0
0.8
13.4
6.4
0.6
6.8
13.0
17.4
14.5
14.3
9.9
8.7

0.5
0.6
0.7
0.5
0.7
0.4
0.3
0.4
0.3
0.3
0.4
0.5
0.4
0.4
0.2
0.2
0.7
0.4
0.7
0.3
0.4
0.6
0.3
0.3
0.7
0.3
0.3
0.3
0.4
0.8
0.3
0.7
0.5
0.8
0.5
0.4
0.3
0.6
0.3
0.4
0.4
0.5
0.3
0.2
0.5
0.2
0.7
0.7
0.5
0.6
0.4
0.4

0.1
0.1
0.0
0.1
0.0
0.2
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0

0.2
0.5
0.6
0.3
0.2
0.3
0.2
3.3
0.3
0.1
0.2
0.1
0.2
0.3
9.5
10.5
0.8
0.6
0.3
0.7
0.5
0.5
0.2
0.5
0.4
0.3
0.3
0.8
0.5
0.4

0.3
0.1
0.5
0.0
0.1
0.2
0.0
0.0
0.1
0.0
0.4
0.4
0.4
0.0
0.1
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.2

Squamous

Basal cell

Other

Unspec.

0.0
0.0
0.0
-

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.4
0.5
0.2
0.5
0.2
0.4
0.3
0.1
0.3
0.2
0.4
0.1
0.4
0.5
0.8
0.4
0.5
0.4
0.2
0.4
0.4
0.2
0.4
0.3
0.2
0.3
0.2
0.4
0.4
0.2
0.4
0.6
0.4
0.2
0.5
0.5
0.2
0.2
0.3
0.5
0.3
0.1
0.3
0.2
0.2
0.2
0.5
0.4
0.5
0.6
0.3
0.3

0.4
0.3
1.1
0.4
0.0
0.5
3.1
0.5
0.1
0.4
0.6
0.2
0.4
0.4
0.4
0.3
1.1
0.3
1.2
0.6
1.2
0.2
0.5
0.6
0.3
1.1
0.4
0.9
0.8

1.5
0.8
3.5
0.3
0.1
0.7
13.4
0.3
0.7
0.3
0.1
0.4
0.2
1.8
2.0
0.5
0.9
0.3
2.2
1.1
2.4
0.4
0.5
1.0
1.0
1.9
1.0
1.8
1.2

0.1
0.2
0.1
0.2
0.3
0.1
0.1
0.1
0.1
0.3
0.3
0.1
0.1
0.3
0.3
0.1
0.4
0.1
0.1
0.1
0.2
0.2
0.1
0.1
0.1

Number of cases
MV

Total

0.0
0.0
0.0
-

4099
1588
48
1512
68
3829
1378
21
1325
324
3313
44
3209
637
7
84
542
5058
155
4844
77044
1168
71774
3999
56
3601
859
1858
4666
57
4318
506
11122
146
10533
28441
298
356
1116
25311
1470
59
1362
4498
94
4087
855
381
3025
2096
709
1704

4149
1596
50
1518
71
3874
1413
21
1360
329
3371
48
3261
644
7
85
548
5253
158
5034
78038
1192
72701
4060
58
3660
898
1866
4699
57
4345
508
11175
148
10582
28622
300
364
1121
25469
1499
61
1386
4628
95
4212
856
387
3045
2108
719
1733

0.1
0.1
0.3
1.0
0.2
0.1
0.0
0.0
0.1
1.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.3
0.1
0.1

14
121
1609
16
13
420
69
520
118
8
215
33
184
63
37
2213
2155
40
143
67
269
346
606
457
162
2606
214
250
87
127
175

14
132
1628
17
13
463
69
584
124
8
220
34
206
67
37
2360
2285
41
145
75
275
372
614
495
172
2772
227
252
94
131
182

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

667

*
*
*
*
*

*
*
*
*

725

Age-standardized (world) incidence rates (per 100,000)


by histological type

Skin (C43-44) - Female (Contd)


Carcinoma

Asia (Contd)
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland (data not available)
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg (data not available)
Germany, Free State of Saxony (data not available)
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania (data not available)
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio
Italy, Syracuse Province
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce (data not available)
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg

Melanoma

Other

Unspec.

0.0
0.0
0.0
0.2
0.1
0.2
0.1
0.1
0.1
0.0
0.1
0.1
0.1

0.2
0.5
0.5
0.3
0.3
0.4
0.5
0.3
0.3
0.6
0.4
0.4
0.2
0.4
0.3
0.4
1.5
1.0

0.1
0.1
0.2
0.1
0.0
0.0
0.1
0.2
0.1
0.3
0.3
0.3
0.1
0.1
0.1
0.2
0.1
0.1

0.1
0.0
0.1
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.2
0.3
0.0
0.1
0.1
0.1
0.1
0.1
0.6
0.1
0.4
0.6
0.9
0.3
0.3
0.9
0.4
0.2
0.1
0.3
0.4
0.1
0.4
0.4
0.1
0.3
0.1
0.1
0.0

7.8
11.4
12.9
3.5
5.9
8.8
2.4
5.8
8.8
14.1
6.6
12.1
6.3
9.5
11.5
7.3
8.4
11.8
9.8
5.7
7.5
10.4
10.5
11.5
10.1
7.8
19.0
11.0
10.1
8.2
7.9
10.6
7.4
11.4
9.7
6.3
3.4
10.6
7.1
4.4
6.7
9.3
5.1
3.3
9.5
4.7
11.4
6.2
7.6
10.0
4.2
5.2
5.1
14.6
5.6
4.6
3.5
4.8
4.8

0.1
0.3
0.1
0.2
0.2
0.3
0.1
0.2
0.3
0.1
0.1
0.2
0.2
0.3
0.3
0.2
0.8
0.5
0.2
0.3
0.5
0.3
0.5
0.4
0.1
0.2
0.3
0.4
0.9
0.4
0.1
0.3
0.2
0.2
0.5
0.4
0.4
0.6
0.0
0.2
0.3
0.3
0.3
0.2
0.2
0.1
0.1

Squamous

Basal cell

Other

Unspec.

0.4
0.6
1.2
0.1
0.0
1.1
1.1
0.9
1.4
1.0
1.6
1.6
1.4
0.8
1.2
1.1
1.2
3.2
1.9

0.8
0.8
1.2
0.8
1.5
2.6
2.6
3.0
2.1
1.5
5.3
5.8
1.0
2.5
2.0
2.1
2.1
11.9
7.4

0.2
0.2
0.1
0.2
0.1
0.1
0.1
0.2
0.2
0.4
0.4
0.4
0.0
0.0
0.1
0.2

3.9
2.9
6.9
2.6
3.5
3.9
3.2
5.0
3.8
1.9
4.2
1.4
2.8
3.9
7.6
17.3
3.2
5.0
7.9
2.5
1.9
4.2
2.3
3.3
1.9
5.6
2.7
2.9
4.8
3.7
3.5
4.4
6.7
2.3
1.9
4.4
2.9
6.1
0.8
4.1
5.3
6.0
0.9
1.0
5.3
0.9

11.9
8.2
0.6
16.6
0.6
20.7
10.7
40.1
52.5
24.2
30.4
0.8
25.6
29.7
0.6
62.4
40.7
38.1
36.6
33.6
34.6
38.9
27.5
35.3
8.3
35.7
22.9
26.1
34.2
36.1
13.7
32.2
38.4
23.4
29.2
18.6
30.9
38.6
10.6
24.4
32.8
0.4
15.0
7.5
0.3
0.0
10.1

0.2
0.3
0.0
0.2
0.2
0.6
0.1
0.3
0.3
0.1
0.2
0.2
0.4
0.3
0.5
0.4
0.2
0.7
0.3
0.4
0.3
0.5
0.2
0.2
0.5
0.6
0.3
0.4
0.3
0.3
0.2
0.4
0.0
0.3
0.2
0.2
0.4
0.5
0.1
0.3
0.3
0.3
0.0
0.3
0.1
0.3
0.2

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

726

668

Cancer Incidence in Five Continents Vol. IX, IARC 2008

Number of cases
MV

Total

0.1
0.1
0.0
0.1
0.0
0.0
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.0

19
547
58
18
17
99
151
75
89
263
784
733
14
37
161
88
126
493
903

20
583
60
18
17
101
153
76
90
281
789
738
14
37
161
91
127
497
917

0.1
0.1
0.1
1.1
0.0
0.2
0.3
0.6
0.6
0.7
0.1
0.5
0.0
0.0
0.2
0.2
0.9
0.0
3.7
1.6
0.1
0.3
1.4
2.6
0.0
0.2
0.6
0.1
1.2
0.1
0.4
0.1
0.0
0.7
0.4
0.1
4.0
1.9
0.7
0.0
0.3
0.4
0.2
0.7

10413
702
318
11872
905
8102
7108
991
26983
17279
2397
431
165
180
302
252
319
505
204
120
114
226
4090
1482
4850
2637
257
12876
677
1683
1375
3200
1622
644
2634
1706
274
6916
822
513
1261
2892
998
922
564
458
2323
1627
1131
5147
2612
6122
705
4584
806
1217
486
1704
4230

10575
709
324
12026
909
8143
7268
1034
27469
17771
2474
432
165
180
304
252
323
505
205
124
114
227
4313
1540
5132
2644
257
13593
681
1721
1378
3490
1713
646
2658
1706
309
6926
823
518
1269
2912
1049
925
571
464
2327
1758
1149
5162
2657
6222
723
4600
819
1259
486
1727
4452

*
*
*

*
*
*
*

*
*
*

Europe
Serbia
Slova
Slove
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Switz
Switz
Switz
Switz
Switz
Switz
Switz
The N
The N
The N
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, N
UK, S
Oceani
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Frenc
New Z
USA,
USA,
USA,
USA,
USA,
USA,

*
*

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Skin (C43-44) - Female (Contd)

es

Carcinoma

al

0
3
0
8
7
1
3
6
0
1
9
8
4
7
1
1
7
7
7

5
9
4
6
9
3
8
4
9
1
4
2
5
0
4
2
3
5
5
4
4
7
3
0
2
4
7
3
1
1
8
0
3
6
8
6
9
6
3
8
9
2
9
5
1
4
7
8
9
2
7
2
3
0
9
9
6
7
2

*
*
*

*
*
*
*

*
*
*

Europe (Contd)
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, England, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern And Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory (data not available)
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Melanoma

Other

Unspec.

1.0
0.1
0.2
0.2
0.0
0.1
0.0
0.4
0.1
0.0
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.6
0.1

3.6
6.3
8.7
4.8
5.8
6.6
4.8
2.0
6.6
4.8
7.0
7.5
8.7
4.2
12.1
19.0
13.2
15.4
12.7
14.3
16.5
19.6
12.9
12.9
12.6
9.8
9.4
9.1
8.9
12.6
11.9
7.1
7.5
8.2
10.2
10.1

0.1
0.1
0.1
1.0
0.7
0.4
0.7
0.2
0.4
0.4
0.7
0.6
0.2
0.3
0.2
0.3
0.2
0.2
0.2
0.8
0.3
0.5
0.2
0.1
0.2
0.0
0.2
0.1
0.3
0.0
0.2
0.2

0.0
0.0
0.0
0.2
0.1
0.0
-

26.5
41.1
25.7
32.4
23.4
31.5
26.0
4.7
31.4
8.3
0.9
1.0
1.6
1.4
26.3

0.4
0.5
0.4
0.0
0.3
0.2
0.2
0.6
0.6
0.2
0.3
0.1
1.0

Squamous

Basal cell

Other

Unspec.

2.8
3.4
3.9
0.1
6.2
8.0
5.4
6.4
7.2
4.1
5.8
18.6
13.1
15.5
9.4
11.3
19.9
7.0
6.7
6.4
6.3
6.2
8.8
3.7
5.1
12.9
7.7

11.7
31.0
24.9
0.1
0.0
0.0
38.2
43.1
24.9
59.7
53.0
25.8
0.5
93.0
0.5
64.3
46.0
61.5
83.8
0.0
45.3
47.0
59.8
0.3
40.8
0.0
48.1
45.8

0.3
0.2
0.3
0.4
0.2
0.4
0.1
0.3
0.6
0.5
0.7
0.4
0.0
0.4
0.9
0.5
0.2
0.4
0.7
0.6
0.4
0.4
0.4
0.3
0.2
0.4
0.2
0.3
0.3
0.3

1.9
0.3
3.7
2.0
0.0
-

0.0
0.0
0.0
0.6
0.0
3.2
0.3
0.0
-

0.0
0.5
0.5
0.4
1.4
1.2
0.2
0.6
0.4
0.3
0.3
0.3
0.3
0.5

Number of cases
MV

Total

0.6
0.5
0.4
0.1
0.0
0.2
0.0
0.2
0.0
0.2
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
3.6
0.0
0.0
2.6
0.0

4344
9089
3819
71
269
507
282
34
1510
2153
1965
2074
1667
1585
9137
2572
368
863
1713
175
1132
3774
14233
821
743
8751
811
1344
21488
1202
30173
7660
13407
1598
5712
17393

4614
9274
3830
71
272
509
287
35
1518
2155
1981
2079
1675
1589
9137
2585
369
864
1718
176
1135
3777
14243
824
743
8931
831
1364
21842
1213
31935
8125
13656
1613
5904
17501

0.2
0.0
0.0
0.0
-

6019
4905
1629
560
3979
2586
286
21
4272
398
8
9
14
28
292

6081
4961
1634
563
3996
2599
292
21
4288
399
8
9
14
28
293

*
*

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

669

727

Age-standardized (world) incidence rates (per 100,000)


by histological type

Cervix uteri (C53)


Carcinoma

Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Non-Hispanic White
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Georgia: Black
USA, Georgia: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
USA, Louisiana: Black
USA, Louisiana: White
USA, Maine
USA, Massachusetts

Sarcoma

Other

Unspec.

0.7
0.1
1.3
13.2

0.0
0.1
-

0.0
0.1
0.1

0.6
0.6
0.2
0.3
0.7
0.4
0.2
0.1
0.6

3.1
1.7
1.2
4.3
1.6
1.3
2.2
0.4
0.6
1.8
0.9

0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.0
0.1
-

0.4
0.7
0.2
0.4
0.4
0.5
0.2
0.4
0.4
0.2
0.3
0.2
0.4
0.2
0.3
0.5
0.4
0.4
0.6
0.7
0.3
0.4
0.7
0.4
0.1
1.0
1.1
0.7
0.4
0.6
0.5
0.4
0.8
0.4
0.3
0.4
0.7
0.4
0.2
0.3
0.4
0.5
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.2
0.3
0.4
0.3
0.4
0.4
0.4
0.3
0.3
0.4
0.3
0.4
0.3
0.4

0.2
0.2
0.1
0.3
0.2
0.1
0.2
0.1
0.3
0.3
0.4
0.3
0.3
0.3
0.2
0.2
0.1
0.3
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.3
0.3
0.3
0.2
0.2
0.2
0.3
0.2
0.2
0.2
0.5
0.2
0.8
0.9
0.6
0.5
0.6
0.4
0.3
0.4
0.7
0.2
0.4
0.3
0.2
0.3
0.6
0.3
0.3
0.3
0.3
0.4
0.6
0.2
0.5
0.3
0.1
0.1

0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.1

Squamous

Adeno

Other

Unspec.

10.0
1.5
6.6
24.1
29.8

0.2
0.3
0.2
1.3
2.3

0.1
0.8

11.4
24.4
27.2
24.1
13.7
16.7
19.8
13.7
16.1
9.9
37.3

1.3
4.5
3.8
4.2
2.5
1.8
2.5
2.2
1.8
3.1
3.2

4.7
6.0
4.1
5.0
5.0
5.7
6.1
6.7
4.4
5.0
5.4
5.7
8.1
4.9
4.6
4.3
5.3
3.9
4.9
1.7
3.1
7.3
2.6
3.1
6.8
6.3
4.0
5.5
11.2
2.9
7.3
4.3
4.4
5.5
9.6
4.0
4.1
3.9
6.2
3.7
7.3
9.3
1.7
6.0
9.2
5.7
5.7
4.9
6.3
4.0
7.2
5.2
3.9
6.1
10.5
5.3
5.2
4.5
6.9
6.8
9.3
4.3
9.9
5.5
4.7
3.6

1.4
1.6
1.4
1.3
1.6
1.4
0.9
1.8
1.3
0.9
1.1
1.0
1.1
1.0
1.2
1.0
1.5
1.3
1.1
1.0
1.2
1.8
0.7
1.3
1.6
0.8
0.7
2.2
2.3
0.7
1.7
1.4
1.4
0.9
2.2
1.4
1.2
1.1
0.9
1.1
1.3
1.3
1.4
1.5
1.3
1.6
1.3
1.3
1.2
1.5
1.2
1.4
1.0
1.5
1.2
1.5
1.3
1.6
1.4
1.2
0.8
1.7
1.1
1.3
1.0
1.2

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

728

670

Cancer Incidence in Five Continents Vol. IX, IARC 2008

Number of cases
MV

Total

0.6
0.1
0.2
19.1
1.2

218
107
72
384
593

229
109
72
649
818

0.2
0.0
0.0
0.0
0.1
-

0.1
6.4
5.2
0.5
3.0
1.9
2.7
2.2
1.4
1.4
1.9

132
1053
269
700
5161
200
1233
1477
595
203
479

139
1154
302
711
6028
216
1314
1655
637
220
498 *

0.1
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.1
0.0
0.0
0.1
0.0
0.0
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.1
0.1

0.2
0.0
0.0
0.0
0.1
0.3
0.0
0.1
0.3
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.2
0.1
0.1
0.2
0.4
0.2
0.1
0.0
0.1
0.0
0.2
0.1
0.1
0.1
0.2
0.1
0.0
0.1
0.2
0.1
0.4
0.1
0.2
0.1
0.0
0.0

5187
789
816
265
190
136
6
292
2451
30
212
1112
371
703
116
934
8009
1254
112
58
60
294
13
576
2749
259
64
91
1397
22
68
734
900
529
2967
3462
778
690
80
592
183
149
21
4672
831
3719
2046
639
244
350
648
1335
209
3308
753
2422
1379
641
1199
1226
147
125
506
700
273
1207

5389
797
828
267
191
138
6
295
2623
30
214
1157
391
723
119
965
8109
1263
112
59
61
295
13
581
2769
262
64
91
1404
23
69
740
909
532
2990
3524
799
700
82
600
194
151
23
4771
854
3794
2098
647
247
353
662
1371
216
3401
775
2492
1410
651
1245
1244
151
126
513
711
278
1224

*
*
*
*

Americ
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
Asia
Bahra
China
China
China
China
China
China
Cypru
India,
India,
India,
India,
India,
India,
India,
Israel
Israel
Israel
Japan
Japan
Japan
Japan
Japan
Japan
Japan
Korea
Korea
Korea
Korea
Korea
Korea

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Cervix uteri (C53) (Contd)

es

Carcinoma

al

29
09
72
49
18

*
*
*
*

39
54
02
11
28
16
14
55
37
20
98 *

89
97
28
67
91
38
6
95
23
30
14
57
91
23
19
65
09
63
12
59
61
95
13
81
69
62
64
91
04
23
69
40
09
32
90
24
99
00
82
00
94
51
23
71
54
94
98
47
47
53
62
71
16
01
75
92
10
51
45
44
51
26
13
11
78
24

America, North (Contd)


USA, Michigan
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Michigan: Black
USA, Michigan: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York state
USA, New York state: Black
USA, New York state: White
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 registries)
USA, SEER (9 registries): Black
USA, SEER (9 registries): White
USA, SEER (14 registries)
USA, SEER (14 registries): Asian and Pacific Islander
USA, SEER (14 registries): Black
USA, SEER (14 registries): Hispanic White
USA, SEER (14 registries): Non-hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, New Delhi
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon

Sarcoma

Other

Unspec.

0.3
0.4
0.7
0.3
0.5
0.3
0.2
0.3
0.2
0.4
0.5
0.7
0.4
0.3
0.3
0.3
0.3
0.5
1.0
0.4
0.3
0.5
0.3
0.3
0.2
0.3
0.3
0.1
0.3
0.5
0.3
0.2
0.3
0.6
0.2
0.3
0.2
0.5
0.4
0.3
0.3
0.3
0.2
0.3
0.3
0.3
0.3
0.0
0.2
0.3
0.6
0.7

0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.3
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.2
0.0
0.0
0.2
0.0
0.0
0.0
0.0

0.6
0.6
0.2
0.1
0.0
0.4
0.1
0.7
0.1
0.2
0.1
4.6
0.2
0.2
0.2
0.1
0.0
0.2
0.1
0.1
0.4
0.0
0.2
0.1
0.2
0.1
0.9
0.1

0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0

0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

Squamous

Adeno

Other

Unspec.

4.6
5.1
7.6
4.4
7.3
4.1
5.4
8.6
5.0
4.7
5.4
8.8
5.0
4.9
3.5
5.9
4.4
5.1
8.8
4.5
5.3
7.9
5.0
4.9
5.3
4.8
5.8
4.7
4.9
8.0
4.5
4.3
4.3
6.4
4.0
5.2
4.4
7.3
9.0
4.3
6.2
8.7
5.3
5.9
7.5
5.8
3.6
5.3
4.0
3.8
6.6
5.1

1.3
1.3
0.9
1.4
0.9
1.4
1.3
0.8
1.4
1.2
1.4
1.4
1.4
1.3
1.6
0.9
1.7
1.3
1.3
1.3
1.3
1.1
1.4
1.1
0.8
1.2
1.4
1.1
1.3
0.9
1.3
1.1
1.3
0.9
1.3
1.4
1.4
1.0
2.0
1.3
1.4
1.0
1.6
1.3
1.1
1.3
1.1
1.1
1.2
1.1
1.5
1.4

0.3
0.4
0.6
0.4
0.5
0.3
0.3
0.7
0.3
0.4
0.4
0.6
0.4
0.3
0.2
0.3
0.4
0.5
0.4
0.4
0.4
0.4
0.3
0.4
0.3
0.4
0.4
0.4
0.4
0.4
0.5
0.4
0.4
0.3
0.4
0.5
0.4
0.7
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.3
0.6
0.3
0.3
0.3
0.2

4.8
3.1
7.2
2.1
0.5
2.2
3.5
22.9
8.3
11.1
16.8
10.4
7.6
3.9
4.2
1.9
4.2
4.2
9.8
4.1
8.2
3.8
5.0
12.3
12.1
13.4
14.9
10.9
16.1

0.6
0.5
1.6
0.2
0.2
0.8
0.6
0.7
0.6
1.1
0.8
0.9
0.5
0.8
0.9
0.3
1.0
0.9
1.5
1.0
1.5
0.8
1.2
1.4
1.3
1.7
1.2
2.2
1.7

0.1
0.1
0.4
0.0
0.1
0.1
0.3
0.1
0.1
0.2
0.2
0.2
0.1
0.2
0.6
0.7
0.2
0.7
0.2
0.3
0.4
0.5
0.4
0.6
0.2
0.6

Number of cases
MV

Total

0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.2
0.3
0.2
0.1
0.1
0.1
0.1
0.1
0.3
0.1
0.1
0.2
0.1
0.1
0.3
0.1
0.4
0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.3
0.3
0.3
0.0
0.1
0.1
0.1
0.1
0.2

2133
992
330
631
415
1640
1359
211
1120
196
2278
451
1715
374
24
143
191
4807
1157
3414
54030
8445
42321
2488
284
2128
860
709
2964
402
2448
214
5461
813
4004
17422
1383
2317
3685
9723
1088
390
673
5083
680
4232
308
149
1083
722
578
1211

2193
1013
337
645
425
1690
1390
216
1146
206
2339
466
1759
394
27
150
201
4976
1199
3533
55469
8693
43436
2569
302
2191
919
719
3020
415
2487
215
5553
826
4075
17731
1395
2360
3732
9923
1113
399
688
5333
712
4439
311
153
1102
734
591
1247

0.1
0.2
3.0
2.1
0.0
3.4
1.5
1.9
0.8
3.6
17.3
0.8
0.1
0.1
0.7
0.5
0.0
0.5
0.7
0.3
1.0
1.2
0.3
1.8
0.2
1.2

38
265
2193
33
77
629
133
98
2253
80
2731
722
2965
1010
261
855
809
41
208
191
489
449
627
1713
298
16649
1693
1149
678
532
1305

38
298
2251
33
86
722
133
101
2550
93
3121
741
3653
1138
284
911
853
44
229
204
500
512
651
1963
313
17576
1812
1169
696
540
1375

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

671

*
*
*
*
*

*
*
*
*

729

Age-standardized (world) incidence rates (per 100,000)


by histological type

Cervix uteri (C53) (Contd)


Carcinoma

Asia (Contd)
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland (data not available)
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg (data not available)
Germany, Free State of Saxony (data not available)
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania (data not available)
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio
Italy, Syracuse Province
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce (data not available)
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg

Sarcoma

Other

Unspec.

0.2
0.0
0.1
0.7
0.7
0.3
0.3
4.5
0.4
0.4
0.2
0.3
0.2
0.1
0.1
0.1

0.0
0.1
0.3
0.0
0.0
0.0
0.2
0.1
0.1
0.0

0.0
0.2
0.1
0.0
0.0
0.0
0.0

0.9
0.3
0.5
0.1
0.2
1.2
0.2
1.8
0.3
0.2
0.3
0.2
0.1
0.2
0.2
0.3
0.0
0.1
0.3
0.1
0.2
1.1
0.1
0.8
0.6
0.1
0.5
0.1
0.2
0.5
0.3
0.3
0.2
0.3
0.3
0.0
0.2
0.1
0.7
0.2
0.2
0.2
0.6
0.5
0.3
0.2
0.3
0.9
0.2
0.2
1.1
0.4
0.5
0.5
0.6

0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.2
0.0
0.1
0.2
0.0
0.1
0.0
0.1
0.0
0.1
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0

Squamous

Adeno

Other

Unspec.

11.0
13.9
11.2
3.5
4.2
13.1
10.3
5.2
6.3
10.9
7.5
8.1
5.1
4.9
23.7
16.4
14.0
2.8
4.1

1.3
1.6
1.2
0.5
0.4
2.2
2.9
0.5
0.8
2.2
2.0
2.3
0.6
0.8
3.7
3.9
2.4
0.7
0.6

0.6
0.5
0.5
0.3
0.2
0.5
0.1
0.1
0.7
0.6
0.6
0.2
1.1
0.5
0.5
0.4
0.5
0.2

6.3
9.9
4.6
9.3
5.2
5.5
15.1
7.2
12.6
8.1
13.1
6.4
5.4
6.4
6.8
8.3
4.5
4.1
5.9
6.9
6.0
4.8
5.3
5.6
5.0
7.7
7.3
6.4
6.2
4.3
5.5
3.9
5.3
3.1
4.0
5.0
3.4
5.1
5.4
3.7
4.8
5.8
3.9
3.8
4.9
3.7
3.7
3.4
3.7
4.0
8.5
14.3
3.0
7.8
14.7
10.6
9.0
7.7
7.6

0.9
1.3
1.3
0.9
0.9
1.1
1.3
0.9
1.3
1.7
0.8
1.2
0.9
1.1
0.8
1.0
1.2
1.3
0.6
0.7
1.2
0.5
0.9
1.3
0.9
1.1
1.6
1.1
1.4
1.3
1.1
1.1
1.5
1.0
1.1
1.1
0.8
1.1
1.0
1.5
1.1
1.1
0.3
0.4
0.9
1.0
0.9
0.7
0.9
0.9
0.8
1.4
0.4
1.6
1.1
0.9
1.7
1.0
0.8

0.2
0.3
0.2
0.1
0.2
0.3
0.5
0.2
0.2
0.4
0.3
0.3
0.2
0.1
0.1
0.2
0.1
0.1
0.8
0.1
0.2
0.1
0.2
0.2
0.3
0.4
0.4
0.2
0.3
0.3
0.1
0.2
0.0
0.1
0.1
0.1
0.2
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.0
0.2
0.1
0.1
0.1
0.4
0.0
0.3
0.2
0.4
0.1

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

730

672

Cancer Incidence in Five Continents Vol. IX, IARC 2008

Number of cases
MV

Total

0.9
1.6
1.3
0.2
1.6
1.4
0.4
0.1
1.5
0.1
0.2
0.1
0.8
1.5
1.0
0.2
0.2

137
4644
260
56
89
398
632
104
157
1770
1011
899
35
77
1265
511
543
126
451

141
5033
283
58
90
416
671
108
159
1966
1023
910
35
78
1297
546
573
136
467

0.3
0.1
0.2
0.4
0.0
0.7
0.8
1.4
0.4
0.1
0.3
0.1
0.0
0.1
0.0
0.0
0.0
0.1
0.2
0.0
0.6
0.0
0.0
0.2
0.6
0.3
0.2
0.2
0.0
0.3
0.0
0.4
0.1
0.0
0.0
0.2
0.0
0.7
0.1
0.4
0.2
0.1
0.3
0.3
0.1
0.7
2.2
0.1
0.0
0.6
0.3
1.0
0.4
0.2

2555
279
77
3974
415
1404
4851
1682
5272
1962
757
309
165
135
200
327
236
240
149
158
100
110
475
653
672
421
74
909
64
154
102
266
182
32
272
172
76
576
105
64
111
306
163
76
45
59
240
162
110
349
944
2235
53
1518
481
860
1260
998
1829

2644
285
82
4015
419
1503
5148
1920
5414
2019
771
312
165
135
200
328
237
240
149
161
100
110
539
714
747
426
74
930
64
171
105
276
195
33
283
172
83
585
106
65
113
312
183
79
46
63
247
179
112
355
980
2400
54
1524
502
871
1356
1033
1874

*
*
*

*
*
*
*

*
*
*

Europe
Serbia
Slova
Slove
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Switz
Switz
Switz
Switz
Switz
Switz
Switz
The N
The N
The N
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, N
UK, S
Oceani
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Frenc
New Z
USA,
USA,
USA,
USA,
USA,
USA,

*
*

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Cervix uteri (C53) (Contd)

es

Carcinoma

al

41
33
83
58
90
16
71
08
59
66
23
10
35
78
97
46
73
36
67

44
85
82
15
19
03
48
20
14
19
71
12
65
35
00
28
37
40
49
61
00
10
39
14
47
26
74
30
64
71
05
76
95
33
83
72
83
85
06
65
13
12
83
79
46
63
47
79
12
55
80
00
54
24
02
71
56
33
74

*
*
*

*
*
*
*

*
*
*

Europe (Contd)
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, England, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern And Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory (data not available)
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Sarcoma

Other

Unspec.

0.7
0.2
0.1
0.2
0.2
0.1
0.5
0.4
0.2
0.3
0.7
0.3
0.3
0.1
0.1
0.2
0.1
0.2
0.2
0.2
0.3
0.1
0.6
0.5
0.5
0.1
0.2
0.5
0.7
0.3
0.2
0.2

0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.2
0.4
0.1
0.1
0.1
0.2
0.1
1.4
0.1
0.1
0.1
0.2
0.2
0.1
0.0

0.0
0.0
0.1
0.0
0.0
0.2
0.0
0.0
-

0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.1
0.3
0.1

Squamous

Adeno

Other

Unspec.

20.6
12.6
11.3
3.4
5.6
3.6
6.7
3.2
4.3
4.1
4.6
2.7
6.3
3.2
5.1
2.6
4.9
2.8
5.5
5.0
3.0
3.7
4.3
3.6
3.8
3.7
5.7
6.3
6.7
2.8
5.1
3.6
4.9
5.6
5.3
6.7

1.7
1.4
1.7
1.4
1.0
1.0
1.4
1.6
1.7
1.1
0.9
1.2
0.7
0.5
1.6
1.2
1.4
0.7
0.9
1.1
1.0
0.5
1.1
0.7
1.5
1.3
1.5
1.4
1.4
1.0
1.5
1.2
1.4
1.6
1.3
1.4

0.3
0.4
1.2
0.1
0.2
0.2
0.1
0.2
0.4
0.1
0.1
0.0
0.2
0.2
0.2
0.2
0.2
0.3
0.1
0.3
0.3
0.1
0.2
0.5
0.5
0.6
0.2
0.3
0.3
0.5
0.6
0.5
0.4

4.3
4.9
2.8
5.5
3.4
4.8
3.7
12.1
6.1
5.3
2.8
6.1
6.8
3.7
5.3

1.1
1.3
1.1
1.0
1.2
1.3
1.0
1.2
1.2
1.5
1.5
2.1
1.6
1.2
1.7

0.3
0.4
1.1
0.4
0.3
0.3
0.2
0.3
0.5
0.4
0.2
0.7
0.2
0.5

Number of cases
MV

Total

2.1
0.4
0.1
0.2
0.1
0.1
0.1
0.1
0.0
0.3
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.4
0.1
0.0
0.0
0.3
0.1

3782
2575
1004
50
316
322
407
36
127
165
234
86
128
137
2231
66
58
22
117
86
45
108
3368
175
191
522
678
1224
2018
398
1655
2603
1173
1403
389
1561

4149
2664
1007
52
323
324
415
36
132
167
244
86
129
141
2235
66
58
22
119
86
46
109
3380
177
191
536
728
1289
2081
407
1809
2842
1257
1448
405
1591

0.1
0.0
0.0
0.0
0.1
0.1
0.4
0.1
-

1304
744
259
107
815
401
49
72
979
298
16
56
56
47
75

1338
805
261
108
837
412
49
73
993
298
16
56
56
47
75

*
*

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

673

731

Age-standardized (world) incidence rates (per 100,000)


by histological type

Corpus uteri (C54)


Carcinoma

Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Non-Hispanic White
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Georgia: Black
USA, Georgia: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
USA, Louisiana: Black
USA, Louisiana: White
USA, Maine
USA, Massachusetts

Sarcoma

Other

Unspec.

0.1
0.1
0.1
0.4
1.9

0.1
0.2
0.5
0.3
0.1

0.5
0.4
0.5

0.2
0.3
0.1
0.1
0.1
0.6
0.2
0.2
0.3
-

2.1
0.1
0.1
0.2
0.1
0.2
0.2
0.2
0.4
-

0.3
0.1
0.1
0.0
0.2
0.6
0.2
0.1
0.3
0.5
0.2

0.1
0.1
0.0
0.2
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.4
0.2
0.4
0.2
0.1
0.3
0.2
0.7
0.6
0.5
0.5
0.5
0.9
0.3
0.5
0.3
0.4
0.2
0.5
0.7
0.5
0.2
0.2
0.2
0.5
0.2
0.2
0.3
0.3
0.3
0.3
0.2
0.1
0.2
0.4
0.2
0.1
0.2
0.3
0.2
0.1
0.1
0.3
0.1
0.3
0.3

0.1
0.1
0.1
0.2
0.0
0.1
0.2
0.1
0.2
0.2
0.2
0.3
0.1
0.0
0.3
0.2
0.2
0.1
0.0
0.2
0.2
0.4
0.2
0.1
0.3
0.1
0.1
0.2
0.1
0.1
0.2
0.2
0.2
0.3
0.2
0.4
0.2
0.2
0.2
0.2
0.4
0.4
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.3
0.3
0.3
0.2
0.3
0.1
0.2
0.1
0.1
0.2
0.3
0.1
0.2
0.1

0.3
0.3
0.3
0.2
0.1
0.3
0.2
0.4
0.3
0.2
0.2
0.2
0.2
0.1
0.1
0.4
0.4
0.4
0.3
0.5
0.2
0.3
0.5
0.5
0.8
0.3
0.6
0.5
1.0
0.6
0.5
0.4
0.5
0.5
0.4
0.3
0.3
0.5
0.3
0.6
0.5
0.7
0.3
0.8
0.3
0.3
0.4
0.6
0.3
0.5
0.3
0.3
0.3
0.6
0.3
0.4
0.3
0.2
0.3
0.5
0.3
0.5
0.3
0.3
0.3

Adeno

Other

Unspec.

0.5
1.9
2.3
1.6
1.3

0.5
0.0
0.3
0.1

5.3
5.5
1.8
5.5
5.4
2.5
4.4
5.6
2.9
4.8
4.2
13.6
15.4
12.4
17.1
13.0
12.1
2.0
13.2
13.4
12.8
13.8
9.9
8.8
10.2
13.7
11.5
13.8
14.9
11.0
8.3
10.7
11.1
12.4
17.2
13.5
9.7
7.8
13.9
10.1
13.0
6.0
17.3
9.7
9.5
10.3
15.8
12.7
18.3
10.1
19.1
11.9
10.1
13.7
12.7
10.2
13.2
11.2
11.9
8.8
13.6
9.4
12.0
14.1
15.9
9.5
16.9
16.8
18.4
14.4
10.7
8.9
10.9
9.1
11.5
19.8
18.7

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

732

674

Cancer Incidence in Five Continents Vol. IX, IARC 2008

Number of cases
MV

Total

0.0
0.1
1.1
0.2

22
127
32
26
31

22
127
32
38
53

0.1
0.4
0.3
0.4
0.8
0.6
0.3
0.2
0.3

0.1
1.1
0.1
1.1
0.3
0.3
0.8
0.4
0.2
-

76
172
14
106
1703
44
231
486
111
87
47

0.9
0.8
0.7
1.1
0.7
0.6
1.1
0.9
1.5
0.6
1.0
1.9
0.7
1.2
0.7
1.0
0.9
1.7
0.5
0.8
0.8
0.1
1.0
1.2
2.2
0.3
0.9
1.1
0.6
0.5
1.1
0.7
1.9
0.9
0.9
0.8
1.0
1.9
1.0
2.1
2.1
2.2
0.9
2.0
0.8
1.0
1.2
1.8
0.9
1.6
0.8
0.7
1.0
1.7
0.9
0.9
1.1
0.9
1.0
1.2
0.9
1.7
0.7
1.2
1.0

0.4
0.0
0.0
0.1
0.0
0.1
0.8
0.0
0.1
0.0
0.1
0.1
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.1
0.1
0.0
0.0
0.1
0.0
0.0
0.2
0.1
0.1
0.1
0.2
0.3
0.1
0.2
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.2
0.0
0.0
0.1
0.0
0.0
0.1
0.1
0.0
0.1
0.1

12749
1560
2113
802
409
259
2
553
6409
84
558
2021
421
1557
235
2416
17842
3843
215
171
140
329
60
2707
4798
439
106
164
993
83
50
2816
1492
877
2394
12844
1955
2780
123
2616
335
208
108
10591
939
9503
3466
1147
271
848
729
2691
675
7966
745
6956
4120
2302
2420
1990
144
284
512
1458
1096
4897

*
*
*
*

87
185
14
110
2025
48
247
548
125
91
47 *
13240
1569
2129
808
410
260
2
561
6857
84
560
2047
429
1574
235
2436
17933
3857
215
171
141
330
60
2719
4814
440
106
165
995
84
50
2827
1495
879
2403
12921
1992
2793
124
2628
345
215
110
10691
951
9590
3500
1159
276
855
739
2715
686
8021
756
6999
4140
2326
2441
2012
145
286
521
1471
1115
4929

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bah
Chi
Chi
Chi
Chi
Chi
Chi
Cyp
Indi
Indi
Indi
Indi
Indi
Indi
Indi
Isra
Isra
Isra
Japa
Japa
Japa
Japa
Japa
Japa
Japa
Kor
Kor
Kor
Kor
Kor
Kor

*Impo
Note:

Age-standardized (world) incidence rates (per 100,000)


by histological type

Corpus uteri (C54) (Contd)

es

Carcinoma

2
7
2
8
3

*
*
*
*

7
5
4
0
5
8
7
8
5
1
7 *

0
9
9
8
0
0
2
1
7
4
0
7
9
4
5
6
3
7
5
1
1
0
0
9
4
0
6
5
5
4
0
7
5
9
3
1
2
3
4
8
5
5
0
1
1
0
0
9
6
5
9
5
6
1
6
9
0
6
1
2
5
6
1
1
5
9

America, North (Contd)


USA, Michigan
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Michigan: Black
USA, Michigan: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York state
USA, New York state: Black
USA, New York state: White
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 registries)
USA, SEER (9 registries): Black
USA, SEER (9 registries): White
USA, SEER (14 registries)
USA, SEER (14 registries): Asian and Pacific Islander
USA, SEER (14 registries): Black
USA, SEER (14 registries): Hispanic White
USA, SEER (14 registries): Non-hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, New Delhi
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon

Sarcoma

Other

Unspec.

0.3
0.3
0.3
0.3
0.3
0.3
0.2
0.3
0.2
0.5
0.2
0.3
0.2
0.3
0.2
0.4
0.4
0.6
0.3
0.3
0.3
0.2
0.3
0.4
0.3
0.3
0.1
0.3
0.3
0.2
0.2
0.3
0.3
0.2
0.2
0.2
0.3
0.2
0.2
0.1
0.2
0.1
0.2
0.3
0.2
0.1
0.1
0.3
0.4
0.3
0.2

0.3
0.4
0.5
0.3
0.4
0.3
0.3
0.2
0.3
0.6
0.4
0.7
0.4
0.3
0.5
0.4
0.3
0.4
0.6
0.4
0.3
0.5
0.3
0.3
0.7
0.3
0.2
0.3
0.5
0.7
0.4
0.4
0.4
0.5
0.4
0.4
0.4
0.6
0.4
0.3
0.3
0.5
0.2
0.2
0.4
0.2
0.5
0.2
0.4
0.5
0.5
0.2

1.0
1.2
2.0
1.1
1.8
0.9
1.1
2.3
1.0
0.9
1.2
1.7
1.1
0.7
0.9
0.5
0.8
1.2
2.2
1.1
1.0
1.8
0.9
0.8
1.2
0.8
0.6
0.8
1.2
2.0
1.1
0.7
1.1
1.9
1.0
1.0
0.7
1.8
0.9
1.0
1.0
2.1
0.6
0.8
1.6
0.7
0.9
1.0
0.9
0.9
0.8
0.9

0.6
0.8
0.2
0.1
0.0
1.2
0.1
0.2
0.1
0.1
1.2
0.1
0.4
0.4
0.2
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.0

0.2
0.2
0.2
0.1
0.0
0.1
0.4
0.0
0.1
0.0
0.0
0.0
0.4
0.4
0.3
0.2
0.0
0.3
0.0
0.2
0.1
0.2
0.1
0.2
0.1
0.1
0.1
0.1

0.5
0.2
0.6
0.1
0.4
0.5
0.0
0.5
0.2
0.0
0.1
0.3
0.9
0.9
0.4
0.2
0.3
0.2
0.2
0.4
0.1
0.3
0.3
0.2
0.4
0.5
0.1
0.2

Adeno

Other

Unspec.

16.9
16.6
11.5
18.3
11.3
17.6
15.7
10.8
16.3
13.7
18.4
11.5
19.9
11.7
9.2
9.2
13.4
16.8
11.7
18.1
14.9
9.8
15.6
17.4
9.7
17.9
10.9
15.6
20.0
10.0
20.9
17.7
15.9
10.3
16.9
14.8
10.2
9.8
10.5
16.5
11.5
10.5
11.9
11.0
8.6
11.3
14.9
19.8
16.2
16.4
18.0
17.2

0.3
0.4
0.5
0.4
0.5
0.3
0.2
0.2
0.2
0.1
0.3
0.3
0.3
0.3
0.3
0.3
0.5
0.6
0.5
0.3
0.4
0.3
0.2
0.2
0.2
0.2
0.1
0.3
0.5
0.3
0.4
0.3
0.4
0.3
0.3
0.3
0.4
0.3
0.3
0.3
0.4
0.2
0.4
0.6
0.4
0.1
0.2
0.2
0.2
0.2
0.2

4.0
4.7
7.5
0.8
1.0
9.0
10.1
1.4
0.5
2.3
1.7
1.7
2.3
11.0
11.2
8.1
4.3
3.3
6.5
5.0
6.1
2.6
4.8
2.2
1.9
2.0
2.4
1.7
2.5

0.1
0.0
0.0
0.1
0.6
0.1
0.1
0.3
0.2
0.2
0.2
0.1
0.0
0.0
0.1
0.2
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.0

Number of cases
MV

Total

0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.3
0.1
0.1
0.1
0.0
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.3
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.2
0.1
0.0
0.1
0.0
0.0
0.0
0.1

6854
2831
481
2319
606
6125
3800
264
3497
545
6738
561
6001
848
50
210
572
14037
1524
12130
138265
10512
122663
8299
510
7537
1662
2219
11282
569
10496
820
16946
1145
14401
43352
2410
3009
3178
34247
2024
513
1470
8380
756
7424
986
505
3753
2592
1504
3723

6898
2846
485
2330
611
6164
3828
268
3521
560
6790
575
6039
864
50
215
582
14221
1549
12287
139510
10674
123708
8369
523
7592
1706
2233
11360
578
10565
823
17062
1156
14502
43641
2417
3047
3196
34472
2045
519
1484
8506
775
7526
990
511
3778
2608
1516
3771

0.3
0.2
2.8
4.9
0.0
0.3
0.1
0.2
0.5
1.9
0.0
0.2
0.1
0.5
0.2
0.0
0.4
0.4
0.2
0.1
0.1
0.0
0.3
0.1
0.1

33
324
1816
12
62
1271
358
281
147
10
526
84
545
107
81
2292
2141
138
192
144
305
531
451
1121
302
3069
270
190
111
73
183

33
370
1848
14
70
1358
359
282
171
10
547
90
623
117
82
2363
2187
139
202
145
312
588
463
1263
316
3157
274
190
116
77
188

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

675

*
*
*
*
*

*
*
*
*

733

Age-standardized (world) incidence rates (per 100,000)


by histological type

Corpus uteri (C54) (Contd)


Carcinoma

Asia (Contd)
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland (data not available)
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg (data not available)
Germany, Free State of Saxony (data not available)
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania (data not available)
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio
Italy, Syracuse Province
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce (data not available)
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg

Sarcoma

Other

Unspec.

0.1
0.1
0.1
0.2
0.1
0.1
0.8
0.1
0.1
0.1
0.0
0.1
0.1

0.1
0.1
0.1
0.1
0.1
0.1
0.4
0.1
0.4
0.4
0.6
0.5
0.3
0.0
0.1
0.3
0.2

0.1
0.3
0.1
0.5
0.6
0.1
0.1
0.2
0.4
0.5
0.8
0.8
0.5
1.1
0.2
0.2
0.3
0.5
0.5

0.6
0.1
0.5
0.1
0.1
0.9
0.3
0.9
0.2
0.1
0.3
0.1
0.1
0.1
0.2
0.2
0.0
0.1
0.1
0.3
0.1
0.7
0.1
0.6
0.5
0.1
0.3
0.2
0.1
0.2
0.0
0.4
0.0
0.1
0.5
0.2
0.1
0.1
0.1
0.1
0.1
0.2
0.3
0.2
0.2
0.1
0.3
0.4
0.1
0.2
0.5
0.0
0.1
0.1
0.2

0.4
0.9
0.9
0.7
0.2
0.2
0.3
0.4
0.4
0.6
0.9
0.2
0.1
0.5
0.3
0.6
0.4
0.2
0.4
0.2
0.2
0.4
0.1
0.2
0.1
0.3
0.3
0.1
0.6
0.3
0.4
0.4
0.4
0.5
0.8
0.0
0.2
0.4
0.1
0.5
0.4
0.4
0.9
0.7
0.6
0.4
0.6
0.5
0.3
1.0
0.4
0.2
0.5
0.5
0.4
0.4
0.4
0.6

0.5
1.0
1.3
0.4
0.8
0.6
0.5
0.3
0.6
0.4
0.7
0.6
0.6
0.3
0.4
0.5
0.5
0.4
0.5
0.8
0.3
0.7
0.2
0.4
0.4
0.4
0.8
0.5
0.2
1.3
0.4
1.4
0.7
0.3
0.5
0.7
0.3
0.5
0.4
0.8
0.7
0.6
0.2
0.7
0.4
1.2
0.7
0.1
0.8
0.8
0.3
0.3
0.7
0.8
0.4
0.4
0.4
0.6
0.4

Adeno

Other

Unspec.

2.3
2.7
1.7
2.8
3.4
5.0
2.3
0.4
5.6
7.7
7.8
8.0
6.5
6.8
3.0
2.1
2.4
5.7
5.5

0.1
0.1
0.2
0.3
0.2
0.1
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.3
0.1

10.6
10.6
11.4
11.0
10.4
11.0
13.5
9.2
16.2
11.2
12.3
12.2
8.1
9.3
12.1
8.6
9.0
7.2
7.6
9.9
9.8
7.1
5.5
11.5
9.8
11.9
11.3
8.1
11.9
9.1
12.4
11.3
8.5
9.5
9.8
14.2
6.5
9.5
13.6
10.9
11.6
10.5
7.9
10.5
12.9
11.4
9.8
11.1
10.7
10.0
14.0
13.5
15.3
12.6
12.8
11.2
5.9
7.9
12.0

0.2
0.0
0.1
1.6
0.2
0.1
0.2
0.1
0.3
0.1
0.1
0.0
0.2
0.4
0.1
0.2
0.0
0.1
0.1
0.1
0.1
0.0
0.2
0.1
0.1
0.3
0.1
0.2
0.1
0.1
0.6
0.1
0.0
0.9
0.2
0.4
0.1
0.1
0.2
0.4
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.3
0.6
0.1
0.0
0.2
0.1
0.1
0.1

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

734

676

Cancer Incidence in Five Continents Vol. IX, IARC 2008

Number of cases
MV

Total

0.1
0.1
0.2
0.3
0.2
0.7
0.1
0.1
0.2
0.1
0.1
0.7
0.1
0.3
0.0

23
950
45
42
29
127
115
13
129
794
859
728
45
86
138
54
89
206
546

24
972
49
42
29
129
118
14
130
876
867
734
46
87
140
73
90
215
548

0.2
0.0
0.4
0.4
0.0
0.2
0.5
1.2
0.3
0.1
0.3
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.3
0.0
0.3
0.1
0.1
0.2
0.0
0.9
0.1
0.3
0.3
0.4
0.2
0.2
0.6
0.3
0.3
0.3
0.4
0.5
0.8
0.1
0.0
0.3
0.2
0.9
0.2
0.2
0.5
1.2
0.1
0.1
0.5
0.4
0.1
0.2
0.6

4698
369
196
5649
915
2762
5198
2329
8058
2975
923
559
274
228
390
436
438
401
205
289
197
230
559
1489
1347
804
120
1177
143
344
273
790
334
98
683
486
142
1154
335
159
296
622
323
253
114
184
600
521
304
899
1806
2322
250
2731
462
996
859
1218
2998

4778
371
202
5719
917
2892
5420
2582
8224
3079
939
563
276
232
393
442
446
401
205
295
200
235
620
1544
1407
809
122
1219
144
361
276
820
349
105
701
492
155
1182
350
164
307
650
353
256
115
187
614
571
315
919
1856
2424
252
2760
485
1012
874
1246
3184

*
*
*

*
*
*
*

*
*
*

Euro
Serb
Slov
Slov
Spa
Spa
Spa
Spa
Spa
Spa
Spa
Spa
Spa
Spa
Spa
Swe
Swi
Swi
Swi
Swi
Swi
Swi
Swi
The
The
The
UK
UK
UK
UK
UK
UK
UK
UK
UK
UK
UK
Ocea
Aus
Aus
Aus
Aus
Aus
Aus
Aus
Aus
Fren
New
USA
USA
USA
USA
USA
USA

*Impo
Note:

Age-standardized (world) incidence rates (per 100,000)


by histological type

Corpus uteri (C54) (Contd)


Carcinoma

es

4
2
9
2
9
9
8
4
0
6
7
4
6
7
0
3
0
5
8

8
1
2
9
7
2
0
2
4
9
9
3
6
2
3
2
6
1
5
5
0
5
0
4
7
9
2
9
4
1
6
0
9
5
1
2
5
2
0
4
7
0
3
6
5
7
4
1
5
9
6
4
2
0
5
2
4
6
4

*
*
*

*
*
*
*

*
*
*

Europe (Contd)
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, England, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern And Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory (data not available)
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Sarcoma

Other

Unspec.

0.2
0.2
0.1
0.1
0.1
0.0
0.0
0.5
0.1
0.1
0.3
0.1
0.1
0.1
0.1
0.3
0.1
0.2
0.0
0.0
0.0
0.0
0.3
0.4
0.4
0.2
0.3
0.3
0.6
0.6
0.4
0.3
0.2

0.6
0.4
0.1
0.1
0.3
0.2
0.2
0.2
0.6
0.9
0.5
0.4
0.5
0.0
0.4
0.0
0.5
0.3
0.1
0.5
0.3
0.3
0.5
0.2
0.2
0.2
0.0
0.1
0.2
0.3
0.1
0.2
0.4
0.1

0.3
0.7
0.5
0.9
0.5
0.7
0.7
0.2
0.6
0.4
0.4
1.2
0.8
0.3
0.1
0.4
0.5
0.7
0.7
0.5
0.7
0.7
0.6
0.7
0.5
0.6
0.6
0.6
0.4
0.6
0.6
0.6
0.6
0.6
0.7
0.6

0.2
0.1
0.1
0.1
0.2
0.2
0.5
0.3
0.1
0.5
0.4
0.4
1.3
0.2
0.5

0.2
0.4
0.4
0.5
0.3
0.2
0.2
0.6
0.4
0.4
0.9
0.5
0.5
0.5
0.2

0.6
0.8
0.5
0.6
0.6
0.6
0.9
1.0
0.8
1.1
1.0
1.5
1.6
1.1
1.0

Adeno

Other

Unspec.

9.5
15.3
15.4
8.9
9.3
10.2
10.2
10.6
11.8
12.3
10.6
12.5
10.9
9.7
14.4
10.2
9.9
15.4
10.8
8.9
11.9
11.2
10.2
10.8
11.5
11.0
8.7
8.8
8.6
9.2
9.1
8.1
9.4
10.0
8.2
8.8

0.9
0.1
0.1
0.1
0.1
0.1
0.4
0.0
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.0
0.1
0.0
0.2
0.1
0.1
0.0
0.2
0.1
0.1
0.0
0.0
0.1

8.2
9.9
11.2
7.4
9.9
7.9
7.2
10.5
9.4
16.7
10.5
14.2
24.1
17.4
17.6

0.0
0.0
0.1
0.4
0.1
0.3
0.1
0.3
0.3
0.2
0.5
0.4
0.1

Number of cases
MV

Total

0.6
0.3
0.1
0.5
0.1
0.1
0.3
0.2
0.2
0.1
0.1
0.1
0.4
0.0
0.0
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.8
0.1
0.0
0.0
0.1
0.1

2184
3310
1399
127
566
876
574
111
307
440
511
340
257
436
6402
228
108
140
258
160
148
344
7576
487
504
1469
1021
1768
2705
1082
3307
5406
2279
2569
604
2212

2349
3409
1402
141
575
901
597
115
314
448
522
347
269
442
6404
228
108
142
262
160
150
346
7601
487
507
1522
1087
1843
2785
1114
3646
5776
2381
2635
618
2291

0.0
0.0
0.1
0.1
0.1
0.1
0.3
0.1
0.0
0.1
0.0
0.0

2210
1394
731
160
2017
574
80
57
1446
803
46
111
158
214
207

2237
1418
751
164
2052
593
81
58
1473
806
46
111
158
216
208

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

677

735

Age-standardized (world) incidence rates (per 100,000)


by histological type

Ovary (C56)

Carcinoma

sex cord Germ Other Unsp.

Serous Mucin. Endom. Clear Adeno. Oth. Unsp. stromal


Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Non-Hispanic White
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Georgia: Black
USA, Georgia: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
USA, Louisiana: Black
USA, Louisiana: White
USA, Maine
USA, Massachusetts

678

Number of cases
MV

Total

0.6
1.2
1.5
0.6

0.5
0.7
0.3
0.6

0.3
0.3
0.2

0.0
0.1
-

0.6
0.6
0.6
2.6
0.6

0.3
0.1
0.1
0.6
0.1

0.5
0.4
1.8

0.1
0.3
0.3
0.6

0.3
0.1
0.3
0.4

0.2
0.1
0.2

0.1
0.8
4.0
1.7

49
256
33
56
66

53
290
34
114
122

2.2
1.6
1.0
0.8
1.8
1.7
2.4
1.4
1.1
0.7
1.3

0.5
0.9
0.2
0.6
0.8
0.4
0.9
0.7
0.4
0.5
0.6

0.3
1.2
0.1
0.3
2.1
2.2
0.8
0.4
0.4
0.3
0.4

0.3
0.1
0.5
0.2
0.2
0.1
0.3
0.4

1.0
2.1
1.9
3.0
1.9
0.6
0.8
0.6
1.6
1.4
1.5

0.8
0.6
0.8
0.4
0.6
0.4
0.3
0.1
0.6
0.3
1.1

3.0
0.7
0.4
0.3
0.7
0.5
0.6
0.3
0.3
0.7
0.2

0.0
0.1
0.1
0.1
0.6
0.2
0.1
0.3
0.1
-

0.3
0.4
0.2
0.1
0.4
0.5
0.4
0.5
0.3
0.2
0.4

0.2
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
-

0.9
3.3
1.6
0.6
2.9
1.2
2.8
1.7
1.2
0.7
0.1

73
282
40
120
2379
69
310
357
171
65
67

97
331
52
126
3197
81
426
483
207
70
68 *

3.5
3.5
3.8
3.1
4.3
3.3
1.4
2.9
3.5
3.2
3.1
3.3
2.1
3.7
2.8
3.2
3.8
4.0
2.2
1.6
1.9
3.5
2.0
4.9
3.6
1.9
2.3
3.2
2.9
3.3
2.4
4.7
2.2
2.0
3.0
4.5
4.2
4.0
0.9
4.3
3.0
3.0
3.1
3.7
1.9
4.0
3.5
3.9
2.5
4.5
1.9
4.0
3.4
3.7
1.8
4.1
3.6
4.2
3.2
2.7
1.6
2.9
1.9
3.1
4.4
4.4

0.7
0.5
0.4
1.0
0.6
1.0
1.1
0.7
0.5
0.6
0.6
0.3
0.6
0.6
0.7
0.8
0.8
0.9
0.5
1.0
0.6
1.1
0.8
0.8
0.6
1.1
1.2
0.7
0.2
1.1
0.8
0.8
0.7
0.7
0.8
0.8
0.6
0.1
0.7
0.6
0.3
1.0
0.8
0.5
0.8
0.6
0.6
0.5
0.6
0.5
0.6
0.6
0.8
0.4
0.9
0.8
0.9
0.8
0.7
0.3
0.7
0.6
0.8
0.5
0.8

1.0
1.3
0.9
1.2
1.1
0.8
1.3
1.2
1.0
1.4
0.9
1.6
0.7
1.9
1.3
1.1
1.2
1.1
0.2
1.5
1.0
1.0
1.4
1.2
1.3
0.5
1.1
1.6
1.1
2.2
0.6
1.6
1.1
0.4
1.1
1.4
1.3
1.4
0.4
1.5
1.0
0.4
1.4
0.9
0.4
0.9
1.0
1.2
0.7
1.4
0.5
1.1
1.2
1.2
0.6
1.3
1.2
1.3
1.2
0.8
0.8
1.1
0.5
1.0
1.1
1.5

0.6
0.6
0.7
0.7
0.3
0.4
0.5
0.6
0.5
0.6
0.2
0.0
0.3
0.2
0.4
0.5
0.6
0.2
0.9
0.9
0.4
0.6
0.6
0.5
0.2
0.9
0.7
0.5
2.0
0.6
0.7
0.2
0.3
0.5
0.5
0.6
0.1
0.7
0.5
0.3
0.7
0.3
0.1
0.4
0.3
0.4
0.1
0.5
0.1
0.4
0.5
0.5
0.1
0.5
0.5
0.4
0.4
0.2
0.1
0.2
0.1
0.2
0.5
0.7

1.4
1.0
1.1
1.4
1.2
0.6
1.2
1.5
1.7
0.5
1.3
1.8
1.4
1.9
1.5
1.6
1.5
1.4
1.4
1.1
0.7
0.9
1.1
1.6
1.3
1.1
0.8
0.5
1.5
1.0
0.9
1.4
0.9
1.3
1.5
1.6
1.4
1.4
1.5
1.4
1.3
1.8
0.3
2.0
1.6
2.0
1.9
2.1
2.3
2.0
1.8
1.9
1.5
1.7
2.0
1.6
1.8
1.3
1.8
2.1
2.5
3.0
1.9
2.2
1.3
1.2

0.2
0.1
0.2
0.3
0.2
0.0
0.2
0.2
0.2
0.1
0.2
0.2
0.2
0.1
0.3
0.4
0.3
0.0
0.5
0.2
0.3
0.7
0.4
0.6
0.4
0.7
0.5
0.4
0.6
0.3
0.8
0.4
0.2
0.4
0.5
0.3
0.3
0.2
0.3
0.7
0.5
1.4
0.3
0.4
0.3
0.3
0.3
0.2
0.3
0.2
0.3
0.5
0.3
0.2
0.3
0.2
0.3
0.4
0.5
0.3
0.5
0.4
0.5
0.1
0.4

0.3
0.3
0.5
0.6
0.4
0.2
0.2
0.3
0.1
0.3
0.5
0.5
0.5
0.7
0.5
0.6
0.6
0.5
0.2
0.6
0.6
0.1
0.7
0.5
0.7
0.5
0.4
0.5
0.2
0.5
0.4
0.6
0.5
0.6
0.5
0.6
0.5
0.6
0.4
0.3
0.3
0.8
0.7
0.9
0.7
0.7
0.7
0.7
0.8
0.7
0.7
0.5
0.5
0.5
0.5
0.5
0.6
0.6
0.7
0.4
0.7
0.5
0.4
0.3

0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.2
0.4
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.2
0.3
0.1
0.2
0.1
0.2
0.1
0.2
0.1
0.1
0.1
0.2
0.3
0.2
0.2
0.3
0.1
0.2
0.1
0.2
0.1
0.2
0.0
0.3
0.1
0.1
0.2
0.3
0.2
0.2
0.1
0.2
0.2
0.4
0.4
0.2
0.2
0.1
0.1

0.4
0.4
0.3
0.5
0.6
0.3
0.4
0.3
1.1
0.3
0.3
0.4
0.3
0.3
0.2
0.4
0.6
0.7
1.0
0.4
0.8
0.4
0.5
0.4
0.6
0.1
0.5
0.2
0.4
0.5
0.5
0.4
0.5
0.4
0.3
0.3
0.5
0.2
0.2
0.3
0.1
0.4
0.4
0.4
0.2
0.2
0.3
0.1
0.3
0.2
0.3
0.4
0.5
0.4
0.3
0.5
0.3
0.4
0.3
0.2
0.4
0.4
0.5
0.3

0.3
0.2
0.2
0.3
0.3
0.2
0.3
0.3
0.4
0.3
0.2
0.2
0.2
0.1
0.2
0.3
0.3
0.5
0.5
0.2
0.3
0.8
0.3
0.3
0.1
0.1
0.1
0.3
0.2
0.4
0.2
0.2
0.3
0.3
0.3
0.3
0.3
0.3
0.5
0.6
0.2
0.3
0.3
0.3
0.2
0.3
0.3
0.2
0.2
0.2
0.2
0.3
0.2
0.3
0.2
0.3
0.3
0.2
0.5
0.3
0.2
0.2
0.3
0.4

0.9
0.2
0.2
0.3
0.3
0.3
0.5
1.5
0.2
0.3
0.5
0.6
0.5
0.6
0.4
0.2
0.1
0.2
0.0
0.1
0.0
0.1
0.2
0.3
0.1
0.2
0.2
0.2
0.1
0.3
0.2
0.2
0.5
0.2
0.2
0.7
0.7
0.8
0.5
0.7
0.5
0.5
0.3
0.5
0.2
0.6
0.5
0.4
0.3
0.4
0.3
0.2
0.4
0.5
0.4
0.4
0.3
0.5
0.3
0.3
0.4

7084
754
1258
382
255
128
4
308
3654
43
298
1528
227
1283
122
1566
10617
2158
111
128
80
218
31
1472
2812
194
99
81
710
52
40
1550
960
433
1693
7450
1349
1312
42
1245
170
104
55
6765
441
6245
2313
797
185
587
407
1871
401
4195
362
3688
2063
1158
1354
1311
95
221
285
1021
489
2445

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

736

cell

Cancer Incidence in Five Continents Vol. IX, IARC 2008

8326
815
1365
428
283
137
4
342
4580
46
326
1721
270
1431
129
1702
11298
2275
121
130
83
226
31
1562
2961
216
104
86
739
52
40
1633
996
478
1758
7981
1467
1412
45
1340
193
123
59
7411
510
6817
2573
843
206
612
477
2061
440
4556
417
3987
2204
1275
1516
1438
106
234
322
1111
538
2656

*
*
*
*

Americ
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
Asia
Bahra
China
China
China
China
China
China
Cypru
India,
India,
India,
India,
India,
India,
India,
Israel
Israel
Israel
Japan
Japan
Japan
Japan
Japan
Japan
Japan
Korea
Korea
Korea
Korea
Korea
Korea

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Ovary (C56) (Contd)

es

Carcinoma

al

53
90
34
14
22

*
*
*
*

97
31
52
26
97
81
26
83
07
70
68 *

26
15
65
28
83
37
4
42
80
46
26
21
70
31
29
02
98
75
21
30
83
26
31
62
61
16
04
86
39
52
40
33
96
78
58
81
67
12
45
40
93
23
59
11
10
17
73
43
06
12
77
61
40
56
17
87
04
75
16
38
06
34
22
11
38
56

sex cord Germ Other Unsp.

Serous Mucin. Endom. Clear Adeno. Oth. Unsp. stromal


America, North (Contd)
USA, Michigan
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Michigan: Black
USA, Michigan: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York state
USA, New York state: Black
USA, New York state: White
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 registries)
USA, SEER (9 registries): Black
USA, SEER (9 registries): White
USA, SEER (14 registries)
USA, SEER (14 registries): Asian and Pacific Islander
USA, SEER (14 registries): Black
USA, SEER (14 registries): Hispanic White
USA, SEER (14 registries): Non-hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, New Delhi
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon

cell

Number of cases
MV

Total

4.0
3.8
2.1
4.3
2.2
4.3
3.5
2.5
3.6
5.4
4.1
2.1
4.5
3.6
2.9
2.9
4.2
4.3
2.5
4.7
3.8
2.1
4.1
3.5
2.1
3.6
3.5
4.3
4.1
2.1
4.3
4.6
4.1
2.2
4.5
3.8
2.3
2.0
3.0
4.3
3.6
2.3
4.0
3.2
2.1
3.4
3.9
3.6
5.0
5.2
3.7
4.2

0.7
0.7
0.6
0.8
0.5
0.8
0.7
0.5
0.7
0.8
1.0
0.8
1.0
0.7
1.0
0.7
0.6
0.8
0.6
0.8
0.7
0.5
0.8
0.7
0.5
0.7
0.6
0.5
0.9
0.6
0.9
0.6
0.7
0.6
0.7
0.8
0.7
0.6
0.7
0.8
0.7
0.5
0.7
0.6
0.5
0.6
0.7
0.7
0.6
0.7
0.7
0.8

1.2
1.3
0.5
1.6
0.6
1.3
1.4
0.4
1.5
1.2
1.4
0.6
1.6
0.9
0.7
1.1
0.8
1.2
0.7
1.3
1.2
0.5
1.3
1.1
0.4
1.2
1.1
1.3
1.4
0.5
1.5
1.3
1.2
0.5
1.3
1.2
1.1
0.5
1.0
1.4
0.9
0.4
1.1
0.9
0.6
0.9
1.5
1.4
1.3
1.3
1.4
1.4

0.5
0.4
0.1
0.6
0.2
0.5
0.4
0.2
0.5
0.4
0.5
0.2
0.5
0.4
0.3
0.3
0.4
0.5
0.2
0.6
0.4
0.1
0.5
0.4
0.0
0.5
0.3
0.5
0.6
0.2
0.6
0.6
0.5
0.1
0.6
0.5
0.6
0.2
0.3
0.5
0.3
0.1
0.4
0.3
0.1
0.3
0.6
0.8
0.5
0.5
0.3
0.6

1.4
1.4
1.4
1.5
1.4
1.4
1.5
1.0
1.5
1.4
2.1
1.6
2.2
1.4
2.9
1.1
1.4
1.6
1.3
1.6
1.6
1.4
1.6
1.6
1.2
1.7
1.6
1.4
1.5
0.8
1.6
1.1
1.4
1.6
1.5
1.6
0.9
1.6
1.5
1.7
1.3
1.2
1.3
1.4
1.2
1.4
1.0
1.3
1.6
1.5
1.6
1.5

0.3
0.4
0.2
0.5
0.3
0.4
0.3
0.1
0.3
0.3
0.4
0.4
0.4
0.4
0.5
0.5
0.4
0.4
0.3
0.4
0.3
0.3
0.4
0.2
0.1
0.2
0.3
0.2
0.4
0.3
0.4
0.2
0.3
0.2
0.4
0.4
0.4
0.3
0.4
0.4
0.2
0.1
0.3
0.4
0.4
0.4
0.3
0.1
0.3
0.3
0.6
0.3

0.5
0.8
0.8
0.8
0.7
0.5
0.3
0.2
0.3
0.8
0.6
0.6
0.6
0.6
1.1
0.5
0.7
0.8
0.9
0.8
0.6
0.6
0.6
0.6
0.3
0.6
0.5
0.6
0.6
0.7
0.6
0.5
0.7
0.7
0.7
0.6
0.4
0.7
0.5
0.6
0.4
0.6
0.4
0.5
0.3
0.5
0.5
0.2
0.8
0.8
0.8
0.5

0.3
0.3
0.6
0.3
0.5
0.2
0.2
0.3
0.2
0.1
0.2
0.5
0.2
0.1
0.3
0.1
0.0
0.2
0.4
0.2
0.2
0.3
0.1
0.2
0.2
0.2
0.2
0.1
0.2
0.3
0.2
0.1
0.2
0.4
0.1
0.2
0.1
0.3
0.2
0.1
0.2
0.5
0.1
0.2
0.3
0.2
0.1
0.2
0.1
0.1
0.2
0.2

0.3
0.3
0.4
0.2
0.4
0.3
0.3
0.3
0.3
0.3
0.5
0.3
0.5
0.3
0.2
0.6
0.5
0.5
0.4
0.4
0.4
0.4
0.3
0.4
0.3
0.2
0.3
0.4
0.5
0.4
0.4
0.4
0.4
0.4
0.4
0.5
0.4
0.5
0.4
0.3
0.4
0.2
0.4
0.4
0.4
0.3
0.3
0.4
0.5
0.3
0.3

0.3
0.4
0.3
0.4
0.3
0.3
0.3
0.4
0.3
0.1
0.4
0.3
0.4
0.4
0.3
0.3
0.5
0.3
0.3
0.3
0.3
0.3
0.3
0.2
0.2
0.2
0.3
0.4
0.3
0.5
0.3
0.3
0.3
0.3
0.3
0.3
0.2
0.2
0.3
0.3
0.3
0.1
0.3
0.3
0.3
0.3
0.4
0.4
0.4
0.4
0.2
0.2

0.4
0.2
0.3
0.2
0.4
0.4
0.4
0.4
0.4
0.1
0.5
0.9
0.5
0.4
0.9
0.2
0.5
0.4
0.3
0.4
0.4
0.5
0.4
0.4
0.5
0.4
1.0
0.3
0.3
0.3
0.3
0.2
0.2
0.3
0.2
0.3
0.2
0.4
0.2
0.3
0.4
0.6
0.3
0.5
0.6
0.5
0.3
0.3
0.2
0.2
0.5
0.7

3441
1454
231
1210
302
3094
1914
116
1778
353
3643
282
3221
554
40
153
354
7413
740
6402
77255
5209
69131
3856
228
3543
1133
1222
5211
270
4812
405
9194
597
7866
24727
1451
1574
2237
19235
1232
222
993
5409
414
4860
562
210
2244
1554
731
1939

3771
1586
258
1313
336
3385
2101
131
1950
394
3942
320
3473
602
47
166
382
8177
818
7068
84293
5946
75272
4229
255
3886
1302
1325
5647
301
5213
426
9907
657
8477
26634
1518
1762
2344
20761
1361
273
1069
5991
478
5358
601
223
2414
1670
831
2179

1.1
1.2
0.7
0.6
0.2
0.6
3.0
0.5
1.1
1.0
0.2
0.6
1.5
4.0
4.3
1.2
1.8
2.6
2.2
1.2
1.6
1.2
1.5
1.4
1.5
1.4
1.6
1.4
1.5

0.5
0.4
1.0
0.1
0.8
0.7
0.2
0.9
0.5
0.2
0.4
0.8
0.5
0.5
0.1
0.9
0.9
1.5
0.8
0.9
0.6
0.6
0.7
0.8
0.8
0.3
0.9
0.9

0.9
0.3
0.4
0.1
0.2
0.1
0.8
0.1
0.1
0.3
0.0
0.1
0.7
1.2
1.3
0.3
0.7
0.8
0.7
0.7
0.9
0.4
0.6
0.4
0.4
0.4
0.4
0.4
0.5

0.1
0.0
0.3
0.1
0.1
0.3
0.1
0.0
0.0
0.0
0.2
0.2
0.2
0.0
0.7
0.4
1.2
1.2
0.8
0.5
0.7
0.2
0.2
0.3
0.2
0.1
0.3

2.8
1.1
0.2
1.5
0.4
0.6
1.6
1.8
1.6
2.3
4.2
2.0
0.8
1.4
1.4
0.8
0.7
0.3
0.8
0.9
0.7
0.6
0.9
0.4
0.5
0.4
0.7
0.6
0.4

0.1
0.1
0.1
0.1
0.1
0.2
0.5
0.2
0.1
0.6
0.4
0.4
0.1
0.2
0.2
0.1
0.1
0.1
0.0
0.1
0.2
0.1
0.1
0.2
0.1
0.2
0.1
0.1
0.1

0.9
1.4
0.0
0.0
0.2
0.8
0.1
0.2
0.1
3.7
0.1
0.7
0.7
0.1
0.4
0.2
0.8
0.0
0.1
0.1
0.2
0.2
0.1
0.4
0.1

0.6
0.0
0.1
0.1
0.0
0.1
0.5
0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.1
0.1
0.1
0.2
0.1
0.1

0.5
0.3
0.3
0.2
0.1
0.2
0.3
0.2
0.4
0.3
0.1
0.2
0.2
0.4
0.4
0.3
0.5
0.3
0.7
0.4
0.7
0.3
0.2
0.5
0.5
0.6
0.4
0.4
0.4

0.1
0.1
0.1
0.0
0.1
0.2
0.0
0.1
0.0
0.2
0.2
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.0
0.1
0.1

0.3
0.4
0.2
5.2
5.8
1.3
0.1
2.0
0.5
1.8
1.1
1.9
6.8
0.4
0.8
0.6
0.6
0.8
1.2
1.2
0.0
1.4
1.2
0.7
0.7
0.5
0.7
0.8
1.1

42
240
569
47
110
1338
125
185
351
41
1177
259
1467
323
144
1498
1434
53
199
192
293
506
370
1435
263
4596
495
313
148
163
283

49
322
616
47
133
1634
139
190
559
45
1541
282
1802
443
148
1741
1617
64
232
239
313
668
448
1994
352
5334
565
340
167
186
354

*
*
*
*
*

*
*
*
*

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

679

737

Age-standardized (world) incidence rates (per 100,000)


by histological type

Ovary (C56) (Contd)


Carcinoma

sex cord Germ Other Unsp.

Serous Mucin. Endom. Clear Adeno. Oth. Unsp. stromal


Asia (Contd)
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland (data not available)
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg (data not available)
Germany, Free State of Saxony (data not available)
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania (data not available)
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio
Italy, Syracuse Province
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce (data not available)
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg

680

Number of cases
MV

Total

1.0
1.7
1.6
1.2
1.8
1.7
0.9
1.0
2.0
1.7
2.4
2.4
3.1
2.2
1.0
0.9
1.7
2.0
2.0

0.6
0.7
0.7
0.4
0.4
1.2
1.6
0.9
1.3
1.6
0.8
0.8
0.4
0.7
1.3
0.9
1.7
0.6
0.4

0.3
0.6
0.3
0.6
0.9
1.0
0.2
0.5
0.5
1.8
1.4
1.4
1.6
2.0
1.0
0.5
0.3
1.3
0.6

0.1
0.3
0.1
0.1
0.1
0.9
0.2
0.1
0.5
1.3
1.4
0.3
1.3
0.8
0.4
0.4
0.2
0.3

0.5
0.5
0.5
1.1
1.2
1.8
1.7
1.4
2.7
1.0
0.7
0.7
0.4
1.4
0.4
0.5
0.5
0.6
0.3

0.1
0.2
0.2
0.3
0.2
0.4
0.4
0.3
0.5
0.2
0.1
0.1
0.2
0.2
0.0
0.1
0.1
0.1
0.1

0.2
0.1
0.2
0.7
0.4
0.2
0.2
0.6
0.5
1.3
0.1
0.1
0.0
0.1
0.2
0.2

0.1
0.2
0.3
0.0
0.1
0.2
0.1
0.3
0.0
0.0
0.0
0.2
0.1
0.1
0.2
0.1

0.8
0.5
0.8
0.2
0.1
0.7
0.5
0.4
0.4
0.6
0.7
0.6
0.4
1.0
0.5
0.4
0.3
0.4
0.3

0.1
0.1
0.3
0.1
0.1
0.1
0.2
0.2
0.2
0.2
0.1
0.7
0.1
0.1
0.0
0.1
0.2

0.7
0.9
0.7
0.7
0.3
1.4
0.9
0.7
0.1
2.9
0.3
0.3
0.6
0.7
0.4
1.4
0.4
0.4
0.4

37
1398
104
51
58
208
262
98
195
826
736
594
41
101
223
90
167
180
406

43
1618
116
64
60
230
289
111
201
1133
771
619
44
108
235
124
178
195
425

3.2
6.4
3.4
1.7
3.5
3.4
1.3
2.2
4.4
5.6
5.6
5.7
3.4
3.7
3.5
3.6
3.9
2.6
5.6
3.6
2.9
1.7
2.6
5.3
3.0
3.8
6.1
3.7
2.7
2.8
2.5
3.9
3.3
1.9
3.3
3.0
1.5
2.4
3.5
3.1
3.2
2.9
1.7
2.0
3.8
3.1
3.1
3.0
4.4
2.7
1.8
0.8
2.7
6.0
0.3
3.3
1.4
1.8
4.4

0.8
1.5
0.9
0.5
1.0
0.9
1.1
1.0
1.5
1.5
1.3
1.1
1.0
1.0
1.4
0.9
0.9
0.6
0.9
0.9
0.6
0.6
0.6
0.8
1.0
1.1
0.7
1.3
0.6
0.6
0.4
0.9
1.0
0.4
0.5
0.6
0.7
0.9
0.7
1.0
0.8
0.8
0.9
1.5
1.3
0.5
0.8
0.6
0.7
0.7
0.7
0.5
1.7
1.1
0.1
1.1
0.6
0.7
0.7

0.9
1.5
1.2
0.2
0.9
0.8
0.4
1.1
1.6
1.4
0.4
0.3
1.4
0.6
0.7
0.4
0.8
0.5
1.4
1.1
0.5
0.6
0.6
1.1
0.7
0.8
0.4
0.9
0.5
1.6
0.8
1.1
1.9
0.9
1.1
1.1
0.6
0.7
0.6
0.8
0.2
1.4
0.5
0.6
0.9
0.6
1.0
0.5
0.7
0.7
0.2
0.3
1.1
1.5
0.4
1.4
0.2
0.5
0.8

0.1
0.2
0.2
0.1
0.5
0.4
0.3
0.0
0.3
0.7
0.3
0.2
0.4
0.3
0.1
0.2
0.4
0.2
0.2
0.0
0.4
0.3
0.1
0.3
0.1
0.2
0.7
0.4
0.2
0.4
0.2
0.4
0.2
0.3
0.3
0.1
0.4
0.5
0.2
0.2
0.4
0.0
0.1
0.2
0.2
0.3
0.2
0.3
0.2
0.1
0.1
0.9
0.6
0.3
0.2
0.2
0.2

2.8
1.1
1.1
3.6
1.4
2.1
2.8
2.9
2.0
2.2
1.1
1.1
1.5
2.1
4.1
2.7
1.4
2.1
1.2
1.7
1.4
1.6
2.1
0.8
2.6
1.8
0.8
2.7
3.4
0.4
1.8
0.9
1.7
2.2
1.5
1.5
1.5
2.5
3.3
0.5
2.3
1.6
1.6
1.5
2.4
1.5
1.7
2.2
2.1
1.7
5.8
7.3
2.2
1.8
8.6
1.6
0.8
1.3
1.2

0.4
0.2
0.1
1.1
0.2
0.3
2.0
0.3
0.9
0.2
0.4
0.2
0.2
0.5
0.6
0.4
0.1
0.2
0.6
0.5
0.5
0.2
0.5
0.3
0.4
0.1
0.4
0.4
0.3
0.7
0.7
0.1
0.1
0.5
0.2
0.8
0.6
0.4
0.7
0.7
0.0
0.3
0.2
0.5
0.8
0.2
0.3
0.1
0.2
1.6
1.4
0.2
0.2
0.5
0.3
0.1
0.3
0.1

1.4
0.3
1.5
0.2
0.3
1.3
0.4
2.3
0.7
0.3
0.7
0.4
0.2
0.4
0.6
0.3
0.3
0.1
0.1
0.1
0.1
0.5
2.7
0.3
2.7
0.7
0.9
0.6
0.2
0.8
0.3
0.8
0.4
0.6
0.5
0.8
0.5
0.5
1.0
0.5
0.5
0.5
0.3
0.4
0.5
0.9
0.8
0.6
0.6
0.4
0.6
0.4
0.3
2.1
0.7
0.3
0.5
0.9

0.2
0.1
0.6
0.2
0.2
0.5
0.1
0.4
0.3
0.6
0.2
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.2
0.1
0.2
0.2
0.1
0.1
0.1
0.0
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.2
0.1
0.2
0.1
0.0
0.1
0.0
0.4
0.4
0.1
0.2
0.0
0.3
0.0
0.1
0.5

0.4
0.2
0.5
0.0
0.3
0.3
0.3
0.3
0.3
0.4
0.3
0.2
0.2
0.2
0.2
0.4
0.2
0.1
0.3
0.4
0.1
0.4
0.3
0.5
0.2
0.2
0.3
0.7
0.1
0.2
0.5
0.3
0.1
0.5
0.2
0.7
0.1
0.4
0.3
0.1
0.3
0.3
0.5
0.2
0.2
0.3
0.3
0.4
0.5
0.3
0.2
0.4
0.3
0.3

0.2
0.2
0.1
0.1
0.2
0.2
0.1
0.1
0.2
0.4
0.1
0.1
0.3
0.2
0.1
0.2
0.1
0.3
0.1
0.2
0.0
0.1
0.1
0.3
0.1
0.1
0.2
0.3
0.3
0.2
0.2
0.1
0.2
0.1
0.1
0.1
0.2
0.2
0.3
0.1
0.2
0.2
0.1
0.3
0.3
0.3
0.1
0.1
0.2
0.1
0.1
0.3
0.3
0.1
0.2
0.1
0.2
0.1

0.9
0.5
0.9
1.8
0.1
0.5
2.1
2.9
1.3
0.3
1.4
0.3
0.3
0.2
0.5
0.2
0.3
0.1
0.0
0.6
0.2
0.6
0.2
1.3
0.1
0.7
0.3
1.2
0.7
1.0
0.8
1.6
0.7
1.8
1.1
0.9
1.3
0.4
1.2
2.5
1.5
1.2
2.1
1.2
1.0
0.7
1.0
1.5
1.2
0.8
1.8
2.7
0.8
0.3
2.5
1.0
0.2
1.3
2.5

3710
310
112
3816
610
1918
2900
1929
5182
2835
735
379
237
178
311
360
359
304
230
180
120
155
638
1046
1145
503
102
1319
88
214
134
481
269
66
468
264
106
830
227
90
172
394
221
130
80
97
413
330
217
582
1241
1825
144
2202
390
707
452
736
1938

4153
338
128
4081
622
2208
3729
2529
5834
2984
784
398
246
191
336
371
378
311
232
199
129
165
861
1267
1402
560
105
1531
96
243
163
593
308
82
574
310
127
881
268
107
209
482
297
161
95
110
483
420
252
680
1405
2120
159
2343
473
797
477
902
2547

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

738

cell

Cancer Incidence in Five Continents Vol. IX, IARC 2008

*
*
*

*
*
*
*

*
*
*

Europe
Serbia
Slova
Slove
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Switz
Switz
Switz
Switz
Switz
Switz
Switz
The N
The N
The N
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, N
UK, S
Oceani
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Frenc
New Z
USA,
USA,
USA,
USA,
USA,
USA,

*
*

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Ovary (C56) (Contd)

es

Carcinoma

al

43
18
16
64
60
30
89
11
01
33
71
19
44
08
35
24
78
95
25

53
38
28
81
22
08
29
29
34
84
84
98
46
91
36
71
78
11
32
99
29
65
61
67
02
60
05
31
96
43
63
93
08
82
74
10
27
81
68
07
09
82
97
61
95
10
83
20
52
80
05
20
59
43
73
97
77
02
47

sex cord Germ Other Unsp.

Serous Mucin. Endom. Clear Adeno. Oth. Unsp. stromal

*
*
*

*
*
*
*

*
*
*

Europe (Contd)
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, England, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern And Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory (data not available)
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

cell

Number of cases
MV

Total

1.6
3.8
4.9
1.9
3.6
2.4
2.4
2.2
2.8
2.0
2.5
4.0
3.3
2.0
4.3
4.7
6.7
3.4
4.4
3.6
5.0
5.0
3.2
3.4
3.3
4.5
2.6
2.9
3.5
4.1
3.7
3.0
3.5
3.3
4.0
3.5

0.9
1.3
0.6
1.2
0.8
1.0
1.3
0.5
0.3
1.0
1.1
0.9
0.7
0.9
1.1
1.0
1.5
0.9
0.8
0.6
0.7
0.4
1.1
1.3
1.4
1.1
1.3
1.0
1.3
0.8
1.2
1.0
1.0
1.1
2.5
1.1

0.6
1.1
1.4
0.3
3.0
1.3
0.6
1.5
1.0
1.5
0.9
1.3
0.8
1.3
1.4
0.5
0.8
1.0
0.3
1.7
0.8
0.7
1.0
1.1
1.0
1.0
1.1
1.8
1.5
1.7
1.0
0.8
1.3
1.2
1.5
1.4

0.0
0.4
0.3
0.4
0.7
0.3
0.3
0.4
1.0
0.3
0.3
0.5
0.8
0.5
0.6
0.2
0.1
0.5
0.1
1.0
0.1
0.7
0.4
0.2
0.4
0.6
0.4
0.7
0.7
0.7
0.5
0.4
0.6
0.7
0.8
0.6

3.3
1.4
1.1
0.9
1.4
1.4
1.0
0.9
1.2
1.3
1.5
1.1
1.1
0.9
1.6
1.3
1.2
2.1
2.9
0.8
2.2
1.0
2.2
2.5
1.8
2.5
3.2
2.1
2.2
2.3
2.7
2.8
2.1
2.8
1.7
2.0

0.7
0.8
0.1
0.0
0.3
0.4
0.2
0.3
0.4
0.3
0.2
0.2
0.3
0.2
0.1
0.1
0.2
0.4
0.3
0.8
0.1
0.2
0.2
0.2
0.2
0.4
0.2
0.2
0.1
0.2
0.3
0.2
0.2
1.1
0.3

0.2
0.5
0.3
0.5
0.5
0.3
0.6
0.6
0.4
0.3
0.5
0.1
0.2
0.5
0.4
0.4
0.2
1.0
0.0
0.5
0.3
0.5
0.1
0.1
0.1
1.5
2.1
1.6
0.8
1.2
1.4
2.1
1.9
1.2
0.7
0.8

0.4
0.3
0.1
0.0
0.1
0.1
0.4
0.1
0.1
0.2
0.4
0.2
0.3
0.2
0.3
0.1
0.2
0.3
0.4
0.2
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.3
0.1

0.4
0.3
0.4
0.4
0.5
0.2
0.6
0.8
0.3
0.4
0.2
0.5
0.2
0.2
0.4
0.2
0.9
0.1
0.3
0.4
0.3
0.3
0.5
0.4
0.2
0.4
0.4
0.3
0.4
0.3
0.3
0.3
0.3
0.4
0.3

0.1
0.2
0.2
0.2
0.1
0.2
0.1
0.0
0.1
0.2
0.2
0.2
0.2
0.1
0.2
0.1
0.3
0.3
0.1
0.1
0.3
0.2
0.3
0.3
0.3
0.3
0.4
0.3
0.3
0.3
0.3
0.4
0.2
0.4

1.2
1.0
0.3
0.5
0.5
0.5
0.7
0.8
0.8
0.6
0.7
0.3
0.7
0.5
0.0
0.4
0.5
0.5
0.2
0.1
0.3
0.3
0.2
0.2
0.1
0.0
0.1
0.1
0.5
0.1
1.3
0.6
0.3
0.5
1.5
0.6

1458
1896
804
68
553
516
343
64
165
224
298
197
145
236
3984
171
100
73
212
122
119
238
5760
382
342
1317
1027
1602
2707
1104
3227
5335
1960
2370
787
2308

1720
2140
818
77
600
581
388
81
195
256
338
214
167
264
3989
185
111
82
224
128
128
256
5946
392
345
1543
1294
1963
3399
1246
4131
6896
2494
2789
905
2656

3.6
3.6
3.2
4.2
3.2
3.8
3.7
2.4
3.4
3.2
1.5
3.3
3.0
2.8
4.7

0.7
1.0
0.6
0.4
0.6
0.3
0.7
0.9
0.9
0.6
0.2
0.5
1.0
0.7
0.5

0.7
0.9
0.8
0.8
0.8
0.5
0.6
1.2
0.9
1.0
1.8
0.5
1.9
0.8

0.5
0.5
0.3
0.4
0.5
0.4
0.2
0.2
0.5
0.6
1.6
0.5
1.1
0.1

1.0
0.9
1.4
0.7
1.2
1.0
1.1
2.1
1.3
1.1
1.1
0.8
0.8
1.0
1.5

0.1
0.1
0.2
0.1
0.3
0.2
0.2
0.2
0.2
0.1
0.4
0.2
0.3

0.4
0.5
0.3
0.2
0.2
0.4
1.0
0.5
0.4
0.4
0.5
0.4
0.4
0.4
0.4

0.0
0.1
0.2
0.1
0.1
0.2
0.2
0.1
0.2
0.4
0.2
-

0.4
0.4
0.4
0.3
0.4
0.4
0.5
0.2
0.6
0.7
0.7
1.0
1.3
0.2

0.3
0.3
0.3
0.3
0.3
0.2
0.4
0.2
0.3
0.3
0.3
0.2
1.0
0.1
0.3

0.2
0.1
0.3
0.5
0.5
0.2
0.2
0.6
0.6
0.4
0.2
0.2
0.3
0.5
0.6

1794
925
436
135
1343
459
74
36
1146
353
21
56
48
104
100

1967
1035
494
148
1515
500
84
36
1262
381
24
59
50
111
110

*
*

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

681

739

Age-standardized (world) incidence rates (per 100,000)


by histological type

Testis (C62)

Germ cell
Seminoma Spermatocytic seminoma
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Non-Hispanic White
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Georgia: Black
USA, Georgia: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
USA, Louisiana: Black
USA, Louisiana: White
USA, Maine
USA, Massachusetts

Non-seminomatous

682

Unspec.

Number of cases
MV

Total

0.1
0.2
0.3
0.3
0.0

0.0
0.1
0.0

0.1
0.1
0.0

0.1
0.0
0.2
0.3

0.0
0.1
0.1

6
32
5
5
8

6
33
5
7
16

2.2
0.2
0.5
0.7
1.1
3.8
1.3
1.0
1.8
0.6
1.6

0.0
0.0
0.1
0.1
0.1
0.1
-

1.7
0.2
0.3
0.5
0.8
4.2
0.8
1.2
1.5
0.2
1.1

1.0
0.2
0.3
0.1
0.1
0.2
0.1
0.1
0.1
0.2
-

0.6
1.0
0.0
0.6
0.4
0.2
0.3
0.4
0.2
-

38
40
10
33
566
84
107
248
136
11
38

40
49
10
34
740
86
115
276
147
13
38 *

2.4
2.7
2.4
2.6
1.8
1.6
1.5
2.7
2.4
2.7
2.7
2.2
0.8
2.7
2.4
2.6
2.5
2.6
1.1
1.3
0.5
2.1
3.4
3.6
2.1
0.7
1.0
0.7
1.7
1.5
0.2
3.4
0.9
0.8
1.9
3.6
3.2
3.1
1.0
3.4
1.7
0.4
3.1
2.4
0.5
2.8
2.0
2.1
0.7
2.9
0.6
2.6
3.2
2.6
0.7
2.9
2.8
3.4
2.6
2.3
0.7
2.8
0.7
3.1
3.2
3.1

0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.2
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1

2.0
2.4
2.0
2.3
1.6
0.9
1.5
1.9
1.9
1.9
2.7
1.4
0.2
1.8
2.6
2.0
2.1
2.0
1.1
0.3
0.5
1.5
0.8
2.9
1.9
0.2
0.5
1.0
1.8
1.3
0.5
3.2
0.6
0.5
1.7
3.0
2.1
2.2
0.4
2.5
1.1
0.3
2.0
1.8
0.3
2.1
1.5
1.5
0.3
2.2
0.2
2.0
1.8
1.9
0.5
2.1
2.1
2.6
1.9
1.4
0.6
2.0
0.5
1.9
2.3
2.5

0.1
0.1
0.1
0.0
0.2
0.1
0.4
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.2
0.1
0.2
0.1
0.1
0.2
0.1
0.1
0.2
0.2
0.1
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.2
0.1

0.1
0.0
0.0
0.2
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0

2948
448
515
152
76
39
4
115
1432
18
149
439
33
398
98
660
4562
922
31
24
8
164
13
637
1122
27
14
11
443
10
3
596
179
94
1166
3048
691
491
14
465
48
7
39
1826
68
1723
853
337
36
292
65
775
183
1543
59
1416
812
466
505
450
14
75
44
402
202
1014

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

740

Other

Cancer Incidence in Five Continents Vol. IX, IARC 2008

3034
451
520
153
76
39
4
115
1508
19
149
443
34
401
98
665
4585
926
31
25
8
164
13
640
1126
29
14
11
444
10
3
597
180
96
1171
3063
698
493
14
467
50
7
40
1840
70
1735
858
340
37
294
66
779
185
1554
60
1426
817
467
511
454
14
75
45
405
204
1019

*
*
*
*

Americ
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
Asia
Bahra
China
China
China
China
China
China
Cypru
India,
India,
India,
India,
India,
India,
India,
Israel
Israel
Israel:
Japan
Japan
Japan
Japan
Japan
Japan
Japan
Korea
Korea
Korea
Korea
Korea
Korea

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Testis (C62) (Contd)

es

Germ cell

al

6
33
5
7
16

Seminoma Spermatocytic seminoma


*
*
*
*

40
49
10
34
40
86
15
76
47
13
38 *

34
51
20
53
76
39
4
15
08
19
49
43
34
01
98
65
85
26
31
25
8
64
13
40
26
29
14
11
44
10
3
97
80
96
71
63
98
93
14
67
50
7
40
40
70
35
58
40
37
94
66
79
85
54
60
26
17
67
11
54
14
75
45
05
04
19

America, North (Contd)


USA, Michigan
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Michigan: Black
USA, Michigan: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York state
USA, New York state: Black
USA, New York state: White
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 registries)
USA, SEER (9 registries): Black
USA, SEER (9 registries): White
USA, SEER (14 registries)
USA, SEER (14 registries): Asian and Pacific Islander
USA, SEER (14 registries): Black
USA, SEER (14 registries): Hispanic White
USA, SEER (14 registries): Non-hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, New Delhi
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon

Non-seminomatous

Other

Unspec.

Number of cases
MV

Total

2.8
2.7
0.5
3.5
0.6
3.2
2.4
0.8
2.7
3.1
2.8
0.9
3.3
2.7
1.8
2.4
3.2
2.6
0.8
3.1
2.6
0.7
3.0
2.7
0.6
2.9
2.3
3.5
3.0
0.6
3.4
2.7
2.8
0.8
3.3
2.6
1.0
0.8
1.8
3.5
1.8
0.6
2.3
2.2
0.6
2.5
2.7
4.6
3.4
3.4
2.4
3.6

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0

1.9
1.8
0.5
2.2
0.4
2.2
1.8
0.3
2.1
2.7
2.2
0.4
2.7
2.3
1.7
1.9
3.0
1.7
0.3
2.1
2.0
0.4
2.3
2.1
0.4
2.3
1.6
2.9
2.2
0.8
2.4
2.4
2.1
0.5
2.5
2.0
0.7
0.4
1.7
2.7
1.6
0.3
2.2
1.9
0.4
2.1
2.6
2.1
2.3
2.3
1.8
2.3

0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.2
0.2
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.1
0.1
0.3
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.2
0.2

0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.1

1280
513
28
476
40
1209
637
16
616
136
1178
47
1096
233
16
86
130
2330
106
2162
28977
871
27062
1495
42
1402
383
607
1732
52
1656
147
3787
120
3453
9905
314
294
1481
7663
381
29
347
2475
75
2333
333
109
976
684
201
899

1292
515
28
478
41
1220
640
17
618
137
1183
47
1101
237
16
89
131
2360
108
2190
29216
887
27275
1507
43
1413
385
612
1739
52
1663
148
3800
121
3465
9956
315
298
1489
7701
385
29
351
2520
77
2373
333
110
983
685
202
914

0.4
0.5
0.8
0.7
0.1
0.2
2.0
0.3
0.2
0.4
0.5
0.3
0.1
2.0
2.2
0.6
0.8
1.1
1.6
1.4
0.8
0.6
1.0
0.2
0.1
0.2
0.1
0.2
0.1

0.0
0.0
0.2
0.0
0.0
0.0
0.1
0.0
0.0
0.0
-

0.4
0.2
0.5
0.0
0.2
1.6
0.1
0.2
0.1
0.2
0.2
1.5
1.7
0.6
0.9
0.3
1.0
0.9
0.8
0.3
0.2
0.3
0.4
0.4
0.3
0.3
0.3

0.1
0.0
0.2
0.0
0.3
0.2
0.1
0.1
0.1
0.2
0.1
0.1
0.2
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.1
-

0.2
0.1
0.2
0.2
0.6
0.1
0.1
0.2
0.1
0.8
0.0
0.1
0.1
0.0
0.1
0.3
0.0
0.1
0.0
0.1
0.2
0.0
0.0
0.0
0.0
0.0

9
37
282
8
5
126
22
71
62
2
225
42
215
61
13
535
487
38
54
38
79
145
52
238
37
525
44
36
12
20
29

11
43
292
8
5
142
24
72
75
2
256
50
242
66
13
587
520
41
55
41
81
152
53
264
42
554
47
38
13
20
31

*
*
*
*
*

*
*
*
*

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

683

741

Age-standardized (world) incidence rates (per 100,000)


by histological type

Testis (C62) (Contd)


Germ cell
Seminoma Spermatocytic seminoma

Asia (Contd)
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland (data not available)
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg (data not available)
Germany, Free State of Saxony (data not available)
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania (data not available)
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio
Italy, Syracuse Province
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce (data not available)
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg

Non-seminomatous

684

Unspec.

Number of cases
MV

Total

0.2
0.4
0.7
0.2
0.4
0.3
0.3
0.6
0.5
0.6
0.5
0.4
0.6
0.4
0.4
0.2
1.2
1.0

0.1
0.0
0.0
0.0
0.0
0.0

0.3
0.1
0.5
1.0
0.2
0.4
0.1
0.4
0.2
0.4
0.3
0.6
0.6
0.2
0.1
0.1
0.9
1.1

0.2
0.1
0.1
0.1
0.1
0.0
0.2
0.1
0.0
0.1
0.1

0.2
0.0
0.0
0.3
0.1
0.0
0.2
0.0
0.0
0.1
0.1
0.0
0.1

1
171
15
24
37
21
38
11
52
118
83
62
6
15
28
12
11
84
220

2
181
15
24
37
21
42
12
53
147
85
64
6
15
32
14
11
87
228

4.5
3.9
4.2
0.8
1.9
1.6
1.7
1.6
3.3
5.0
1.0
3.3
2.0
3.1
4.6
2.4
2.3
3.2
1.7
2.1
2.3
2.8
4.1
5.8
4.6
4.5
3.2
3.1
3.3
3.0
2.3
2.2
2.6
1.6
2.7
3.0
2.2
2.6
1.6
1.6
2.9
2.7
2.1
2.0
4.5
1.4
3.0
2.7
3.9
2.8
0.9
0.8
2.8
4.9
2.0
1.9
0.6
0.8
0.7

0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.2
0.0
0.1
0.2
0.0
0.1
0.1
0.3
0.1
0.1
0.1
0.1
0.4
0.1
0.1
0.0
0.1
0.2
0.0
0.1
0.0
0.0
0.0
0.0

2.1
2.8
3.4
0.6
1.6
1.6
1.6
1.6
2.9
3.9
1.3
3.2
2.5
2.5
2.6
2.1
2.5
2.4
2.3
2.4
3.1
2.6
1.5
2.6
3.0
3.3
1.9
2.3
2.5
2.1
2.3
1.5
1.4
2.6
1.7
1.9
1.4
1.9
2.5
1.6
1.5
1.7
1.6
2.6
2.6
2.6
2.2
1.9
3.0
2.2
0.7
0.8
1.1
4.6
1.1
2.1
1.0
0.9
0.6

0.5
0.3
0.2
0.1
0.1
0.3
0.1
0.3
0.1
0.1
0.1
0.1
0.0
0.2
0.1
0.1
0.1
0.1
0.3
0.1
0.2
0.1
0.2
0.2
0.1
0.2
0.0
0.1
0.1
0.1
0.2
0.2
0.1
0.3
0.2
0.2
0.2
0.4
0.1
0.3
0.1
0.1
0.1
0.1
0.1
0.5
0.1
0.2
0.1
0.2

0.2
0.4
0.1
0.1
0.0
0.1
0.2
1.8
0.1
0.1
0.0
0.0
0.1
0.0
0.0
0.3
0.1
0.1
0.2
0.1
0.1
0.5
0.3
0.1
0.7
0.2
0.1
0.1
0.3
0.4
0.3
0.6
0.1
0.7
0.1
0.9
0.3
0.1
0.2
0.1
0.1
0.5
0.2
0.0
0.1
0.1

1707
146
79
433
157
447
764
402
1818
1341
84
197
80
76
145
104
149
178
51
69
46
79
290
601
557
246
40
568
32
86
43
113
55
23
134
89
55
289
47
27
59
129
94
57
38
34
132
97
94
224
120
175
41
1166
82
170
154
131
202

1717
146
80
445
158
461
816
610
1859
1361
85
198
81
76
145
104
151
178
51
69
46
81
308
613
587
247
40
583
32
94
43
118
58
25
139
90
55
292
47
27
64
139
108
58
40
35
132
120
95
227
128
185
41
1171
85
179
155
137
215

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

742

Other

Cancer Incidence in Five Continents Vol. IX, IARC 2008

*
*
*

*
*
*
*

*
*
*

Europe
Serbia
Slova
Slove
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Switz
Switz
Switz
Switz
Switz
Switz
Switz
The N
The N
The N
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, N
UK, S
Oceania
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Frenc
New Z
USA,
USA,
USA,
USA,
USA,
USA,

*
*

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Testis (C62) (Contd)

es

Germ cell

al

2
81
15
24
37
21
42
12
53
47
85
64
6
15
32
14
11
87
28

17
46
80
45
58
61
16
10
59
61
85
98
81
76
45
04
51
78
51
69
46
81
08
13
87
47
40
83
32
94
43
18
58
25
39
90
55
92
47
27
64
39
08
58
40
35
32
20
95
27
28
85
41
71
85
79
55
37
15

Seminoma Spermatocytic seminoma

*
*
*

*
*
*
*

*
*
*

Europe (Contd)
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, England, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern And Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory (data not available)
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Non-seminomatous

Other

Unspec.

Number of cases
MV

Total

2.4
2.7
3.2
1.4
1.1
1.5
0.9
0.8
1.7
0.8
1.0
1.3
1.9
0.9
2.8
3.9
5.6
3.5
5.9
5.7
4.8
5.6
2.8
2.6
2.5
3.4
3.8
3.5
3.6
4.0
3.8
3.3
3.2
3.1
3.3
4.3

0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

1.2
3.5
4.2
2.0
0.8
1.5
1.2
2.2
1.8
1.6
1.4
1.3
1.5
1.2
2.5
2.8
4.7
2.6
4.4
2.8
2.9
3.3
3.1
2.9
3.2
2.6
2.4
2.7
2.6
3.0
2.8
2.0
2.2
2.4
2.6
3.1

0.6
0.2
0.1
0.2
0.0
0.1
0.3
0.4
0.1
0.3
0.2
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.2
0.1
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1

0.8
0.2
0.1
0.0
0.0
0.3
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.7
0.0
0.0
0.0
0.2
0.0

484
960
411
28
63
149
97
14
59
54
89
41
48
54
1213
81
65
26
145
75
62
151
2604
157
126
439
368
693
1096
546
1171
2032
684
784
270
1016

563
980
411
28
66
151
99
15
59
54
92
41
48
57
1214
82
65
26
147
75
62
151
2611
158
126
446
401
702
1104
565
1316
2156
699
809
277
1038

3.1
2.8
3.1
4.7
3.1
3.3
4.4
1.4
4.3
2.4
2.3
1.2
3.2
2.9
3.3

0.0
0.0
0.0
0.0
0.2
-

2.5
2.5
2.1
1.5
2.2
2.0
1.9
0.7
2.3
1.5
1.2
1.1
1.4
1.5
2.0

0.1
0.1
0.2
0.2
0.1
0.1
0.2
0.4
0.1
0.0
0.1
-

0.0
0.0
0.1
0.1
0.1
-

1021
524
214
84
714
288
59
18
685
133
7
11
28
24
53

1044
537
220
84
734
288
61
18
696
133
7
11
28
24
53

*
*

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

685

743

Age-standardized (world) incidence rates (per 100,000)


by histological type

Kidney and renal pelvis (C64-65) - Male


Carcinoma

Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Non-Hispanic White
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Georgia: Black
USA, Georgia: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
USA, Louisiana: Black
USA, Louisiana: White
USA, Maine
USA, Massachusetts

Other

Unspec.

0.0
0.1
0.0
-

0.3
0.1
0.3
0.3
0.4

0.0
0.1
0.4
0.1
0.2
0.0
-

2.1
0.8
0.3
0.2
0.5
0.4
0.1
0.0
0.1
0.2
0.1

0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.2
0.0
0.2
0.2
0.5
0.1
0.2
0.1
0.2
0.3
0.6
0.2
0.3
0.3
0.1
0.5
0.2
0.2
0.1
0.2
0.2
0.2
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.0
0.0
0.1
0.1
0.1
0.2
0.1
0.2
0.1
0.0
0.0

0.2
0.2
0.3
0.3
0.8
0.2
0.2
0.1
0.2
0.2
0.3
0.2
0.2
0.2
0.1
0.1
0.0
0.2
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.3
0.1
0.3
0.3
0.4
0.3
0.2
0.3
0.2
0.1
0.2
0.1
0.3
0.2
0.1
0.3
0.4
0.3
0.2
0.1
0.2
0.3
0.1
0.1
0.5
0.3
0.2
0.1

Squamous

Adeno

Other

Unspec.

0.1
0.5
0.7
0.1

0.2
1.8
2.0
0.1
1.1

0.0
-

0.5
0.1
0.2
0.1
0.1
0.4
0.2
0.2
0.3
0.7

6.8
2.3
1.0
2.5
4.2
4.8
2.4
2.5
2.0
1.5
2.9

0.6
0.6
0.6
1.2
1.1
0.4
0.5
0.5
0.7
0.8
0.8
0.4
0.9
0.6
0.7
0.7
0.6
0.6
0.5
0.7
0.4
0.6
0.6
0.4
0.2
0.3
0.6
0.6
0.2
0.8
0.4
0.4
0.7
0.7
0.9
0.8
0.4
0.8
0.5
0.4
0.7
0.9
0.4
1.0
0.9
0.9
0.7
1.0
0.6
1.0
0.6
0.8
0.4
0.9
0.9
0.8
0.8
0.9
0.3
1.0
0.6
1.0
1.0
0.8

8.0
9.1
6.5
10.3
10.3
8.3
8.5
11.6
7.4
9.2
8.9
9.2
10.1
9.0
11.1
9.6
8.5
7.9
8.6
3.2
5.3
9.8
5.5
8.5
8.6
11.0
3.1
6.1
9.1
5.6
4.0
9.3
4.2
10.1
9.6
8.9
8.4
10.7
11.5
10.7
9.8
10.4
8.1
9.3
8.0
9.5
9.3
9.7
11.8
9.2
11.3
8.9
9.1
10.7
12.1
10.5
11.2
10.6
11.5
12.3
11.4
12.7
12.6
12.4
11.5
10.3

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

744

686

Cancer Incidence in Five Continents Vol. IX, IARC 2008

Number of cases
MV

Total

0.1
0.4
0.2
0.2

17
118
29
17
31

18
138
29
21
45

0.5
0.5
0.7
0.2
0.4
0.2
0.2
0.3
0.2

1.3
0.9
0.9
1.6
0.9
0.9
1.1
0.5
0.5
0.1

69
105
12
58
1053
51
108
220
68
26
35

77
115
20
69
1398
59
135
301
83
28
35 *

0.3
0.3
0.3
0.2
0.6
0.4
0.3
0.4
0.2
0.2
0.3
0.2
0.2
0.3
0.3
0.4
0.3
0.2
0.5
0.3
0.2
0.2
0.1
0.3
0.5
0.3
0.1
0.4
0.2
0.4
0.2
0.3
0.1
0.3
0.3
0.3
0.6
0.3
0.2
0.4
0.4
0.4
0.3
0.6
0.4
0.4
0.2
0.3
0.4
0.3
0.4
0.4
0.4
0.4
0.1
0.7
0.2
0.5
0.3
0.3

0.9
0.2
0.2
0.6
0.5
0.2
0.8
1.4
1.7
0.7
0.2
0.3
0.1
0.5
0.2
0.1
0.1
0.3
0.1
0.1
0.1
0.2
0.0
0.3
0.1
0.0
0.2
0.1
0.1
0.5
0.0
0.1
0.0
0.6
0.7
0.4
0.5
0.7
0.4
0.3
0.1
0.3
0.1
0.4
0.3
0.1
0.3
0.2
0.3
0.1
0.2
0.2
0.3
0.8
0.5
0.7
0.2
0.2
0.4

6366
789
973
377
287
162
7
367
3018
48
338
1399
251
1135
183
1702
8946
1659
111
61
42
214
15
1133
2327
287
41
48
581
31
23
1283
497
601
1618
6142
1100
1348
88
1237
155
97
51
6642
444
6115
2278
731
219
502
542
1719
358
4334
521
3699
2244
1116
1539
1742
101
277
402
1338
540
2283

7836
946
1145
507
337
171
7
449
3821
58
395
1524
294
1215
198
1907
9800
1817
132
67
47
231
18
1236
2529
311
43
50
641
35
24
1390
547
668
1764
6732
1275
1428
90
1315
192
128
54
7334
501
6742
2487
763
231
522
601
1869
409
4739
579
4043
2458
1249
1707
1906
120
298
470
1432
602
2465

*
*
*
*

Americ
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
Asia
Bahra
China
China
China
China
China
China
Cypru
India,
India,
India,
India,
India,
India,
India,
Israel
Israel
Israel
Japan
Japan
Japan
Japan
Japan
Japan
Japan
Korea
Korea
Korea
Korea
Korea
Korea

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Kidney and renal pelvis (C64-65) - Male (Contd)

es

Carcinoma

8
8
9
1
5

*
*
*
*

7
5
0
9
8
9
5
1
3
8
5*

6
6
5
7
7
1
7
9
1
8
5
4
4
5
8
7
0
7
2
7
7
1
8
6
9
1
3
0
1
5
4
0
7
8
4
2
5
8
0
5
2
8
4
4
1
2
7
3
1
2
1
9
9
9
9
3
8
9
7
6
0
8
0
2
2
5

America, North (Contd)


USA, Michigan
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Michigan: Black
USA, Michigan: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York state
USA, New York state: Black
USA, New York state: White
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 registries)
USA, SEER (9 registries): Black
USA, SEER (9 registries): White
USA, SEER (14 registries)
USA, SEER (14 registries): Asian and Pacific Islander
USA, SEER (14 registries): Black
USA, SEER (14 registries): Hispanic White
USA, SEER (14 registries): Non-hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, New Delhi
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon

Other

Unspec.

0.2
0.4
0.7
0.3
0.5
0.2
0.2
0.2
0.2
0.3
0.3
0.3
0.1
0.4
0.0
0.2
0.3
0.2
0.3
0.2
0.3
0.2
0.3
0.5
0.3
0.2
0.2
0.2
0.2
0.2
0.1
0.2
0.4
0.2
0.2
0.1
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.3
0.2
0.1
0.1
0.2
0.2
0.3
0.1

0.4
0.3
0.4
0.3
0.5
0.4
0.4
0.8
0.4
0.5
0.4
0.3
0.5
0.3
0.2
0.5
0.4
0.5
0.4
0.3
0.3
0.3
0.3
0.1
0.3
0.2
0.3
0.4
0.6
0.3
0.2
0.3
0.4
0.4
0.3
0.2
0.3
0.3
0.4
0.3
0.2
0.4
0.3
0.3
0.3
0.3
0.2
0.3
0.3
0.3
0.4

0.8
0.0
0.8
0.0
0.9
0.0
0.0
0.0
0.2
0.2
0.2
0.1
0.0
0.5
0.0
0.5
0.0
0.1
0.0
0.1
0.0
0.0
0.1
0.0

0.3
0.2
0.1
0.1
0.0
0.3
0.4
0.2
0.1
0.1
0.1
0.2
0.2
0.3
0.3
0.2
0.2
0.2
0.1
0.1
0.0
0.2
0.0
0.2
0.2
0.2
0.1
0.2
0.2

Squamous

Adeno

Other

Unspec.

0.8
0.7
0.5
0.7
0.6
0.9
0.8
0.7
0.8
1.0
0.9
0.5
1.0
0.6
0.8
0.5
0.9
0.5
0.9
0.8
0.5
0.9
0.8
0.4
0.8
0.9
0.7
1.0
0.5
1.0
0.8
0.7
0.6
0.7
0.7
0.5
0.5
0.6
0.8
0.9
0.5
1.0
0.8
0.5
0.8
0.5
0.9
0.8
0.6
0.9
0.8

9.8
11.4
12.6
11.2
12.5
9.5
10.7
13.5
10.5
9.0
11.1
11.1
11.3
10.0
13.3
11.8
8.9
10.3
8.4
10.9
10.0
10.8
10.0
9.6
11.0
9.4
9.5
8.9
10.8
14.1
10.4
12.4
9.8
11.6
10.0
9.7
4.7
11.5
9.7
10.0
10.7
11.2
10.5
11.1
11.5
11.2
7.7
9.3
9.9
9.9
10.1
10.0

0.1
0.2
0.2
0.1
0.3
0.1
0.0
0.0
0.1
0.1
0.2
0.2
0.2
0.1
0.2
0.1
0.1
0.3
0.0
0.0
0.1
0.1
0.3
0.1
0.0
0.1
0.2
0.1
0.2
0.1
0.3
0.2
0.2
0.0
0.1
0.0
0.0
0.1
0.0
0.1
0.0
0.2
0.2
0.2
0.1

0.4
0.6
0.3
0.4
0.1
0.2
0.6
0.1
0.1
0.0
0.1
0.1
0.8
0.8
1.3
0.8
0.7
1.3
1.0
1.0
0.6
0.6
0.7
0.6
0.6
0.8
1.1
0.7

3.5
0.9
2.9
0.6
0.7
0.6
4.1
0.8
0.5
1.6
0.9
2.0
0.8
9.7
10.2
3.4
3.0
4.0
5.8
5.6
4.5
2.7
2.1
3.4
3.4
3.5
3.4
2.6
2.8

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

Number of cases
MV

Total

0.3
0.1
0.2
0.1
0.4
0.3
0.5
0.7
0.5
0.1
0.4
0.6
0.4
0.1
0.3
0.1
0.1
0.3
0.4
0.3
0.3
0.4
0.3
0.2
0.1
0.2
0.8
0.1
0.2
0.4
0.2
0.3
0.1
0.2
0.1
0.2
0.1
0.3
0.1
0.2
0.3
0.2
0.4
0.6
0.8
0.5
0.0
0.1
0.1
0.1
0.2
0.6

3367
1528
329
1172
446
2866
2086
189
1884
319
3318
317
2896
566
38
204
318
6768
606
5976
76034
6776
66991
3869
359
3429
1158
1077
5034
413
4525
455
8516
813
7128
23015
886
2145
2211
17502
1432
303
1110
6711
605
5968
426
212
1932
1309
737
1955

3683
1649
362
1259
495
3129
2301
214
2074
349
3591
353
3131
645
45
232
360
7448
672
6576
83690
7639
73587
4195
393
3717
1325
1202
5584
485
4999
494
9288
891
7779
25145
962
2389
2404
19099
1588
341
1225
7492
690
6657
471
226
2166
1459
813
2124

0.6
0.2
0.1
3.2
4.3
0.2
0.1
0.1
0.2
0.3
1.7
0.4
0.6
0.5
0.5
1.6
1.4
0.2
0.9
0.4
1.2
1.3
1.0
1.2
1.1
1.0
1.1
1.1

20
110
706
15
69
826
42
111
104
5
404
43
512
101
34
1616
1527
72
161
177
279
640
380
1282
178
3977
392
247
126
110
207

27
147
730
24
75
1193
62
116
117
6
435
43
566
106
41
1857
1722
82
213
233
318
765
455
1683
266
4775
488
295
149
137
252

*
*
*
*
*

*
*
*
*

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

687

745

Age-standardized (world) incidence rates (per 100,000)


by histological type

Kidney and renal pelvis (C64-65) - Male (Contd)


Carcinoma
Asia (Contd)
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland (data not available)
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg (data not available)
Germany, Free State of Saxony (data not available)
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania (data not available)
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio
Italy, Syracuse Province
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce (data not available)
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg

688

Unspec.

0.0
0.3
0.1
0.0
0.1
0.0
0.6
0.1
0.1
0.0
0.0
0.0
0.0

0.3
0.1
0.1
0.2
1.1
0.2
0.2
0.1
0.2
0.1
0.2
0.2
0.2
0.0
0.0
0.0
0.3
0.3

0.5
0.3
0.6
0.1
0.2
0.4
0.1
2.4
0.3
0.2
0.6
0.1
0.0
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.5
0.1
0.3
0.4
0.2
0.2
1.5
0.3
0.4
0.4
1.0
0.1
0.5
0.2
1.8
0.5
0.4
0.3
0.2
0.5
0.2
0.2
1.4
0.5
0.5
0.1
0.4
0.1
0.3
0.7
0.4
0.2
0.3
1.3

0.3
0.4
0.2
0.3
0.1
0.4
0.3
0.3
0.2
0.2
0.5
0.9
0.4
0.4
0.4
0.3
0.2
0.4
0.2
0.2
0.0
0.6
0.3
0.4
0.2
0.0
0.6
0.3
0.3
0.8
0.4
0.1
0.3
0.1
0.4
0.7
0.4
0.4
0.2
0.5
0.3
0.3
0.2
0.3
0.3
0.5
0.9
0.3
0.0
0.2
0.5
0.4

Adeno

Other

Unspec.

1.0
0.9
0.6
0.5
0.1
0.5
0.1
0.2
0.1
0.1
0.4
0.5
0.3
0.1
0.8
0.8
0.3
0.3
0.6

3.3
4.2
4.2
4.8
1.6
2.8
1.3
1.2
1.5
2.9
3.3
3.8
1.1
2.0
0.7
0.2
0.3
2.3
2.5

0.0
0.0
0.0
0.1
0.0
0.0

0.9
0.4
0.4
0.5
1.1
0.9
0.3
0.3
1.0
1.2
0.5
0.6
0.7
0.5
0.7
1.0
0.7
0.8
0.7
1.1
0.6
0.4
0.8
0.7
0.9
0.8
0.9
0.5
0.5
1.1
1.3
0.4
0.8
0.5
1.1
1.3
0.5
0.7
1.7
0.5
0.2
0.9
0.8
0.5
0.8
0.7
0.8
0.7
0.9
0.9
0.2
0.4
0.3
0.4
0.2
0.4
0.6
0.3
0.4

10.2
9.8
8.6
7.2
6.5
7.4
3.1
3.9
15.3
5.9
11.6
13.4
7.9
9.0
10.7
8.4
7.2
9.6
6.6
9.5
6.5
6.6
7.7
9.7
8.8
10.1
13.6
5.8
7.7
10.1
9.4
10.6
8.0
7.9
10.5
11.3
4.9
9.0
8.0
3.0
8.3
11.0
3.6
6.2
11.1
3.0
7.2
7.9
10.5
11.4
8.0
9.1
3.8
7.3
6.7
6.3
3.9
4.1
5.7

0.1
0.1
0.1
0.0
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.3
0.1
0.3
0.3
0.2
0.1
0.1
0.7
0.3
0.4
0.1
0.2
0.0
0.5
0.1
0.1
0.4
0.0
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.0
0.0
0.0
-

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

746

Other

Squamous

Cancer Incidence in Five Continents Vol. IX, IARC 2008

Number of cases
MV

Total

0.9
1.1
1.1
0.7
0.4
0.6
0.5
0.1
0.9
1.0
1.1
0.4
1.0
0.2
0.5
0.2
0.2
0.2

35
1201
83
53
38
69
58
29
50
206
340
309
11
20
60
24
18
84
266

41
1393
95
62
43
78
75
33
52
315
419
375
14
30
69
35
23
94
290

0.9
0.6
1.2
4.9
0.5
0.5
1.8
3.1
4.2
0.9
2.8
0.5
0.5
0.3
0.3
0.3
0.6
0.3
0.3
1.0
0.9
0.4
0.1
1.4
0.1
0.6
0.6
2.1
2.5
2.3
1.8
1.7
2.0
1.3
1.7
1.1
1.6
0.8
1.1
1.7
2.4
1.7
1.9
1.1
2.7
0.8
1.0
2.1
1.6
1.8
5.4
5.3
1.6
0.9
3.6
3.1
0.2
0.4
4.7

3504
241
112
2499
539
1697
1062
1099
5910
1521
578
503
217
168
303
365
320
437
162
213
126
178
508
1023
947
524
136
777
70
319
196
641
257
82
552
376
87
1073
206
44
193
583
152
137
86
48
366
401
244
856
650
1190
63
1361
184
424
484
541
1061

3741
260
124
3787
584
1824
1643
1588
7505
1804
692
524
226
182
318
381
347
451
169
239
147
186
636
1170
1078
557
143
1046
98
374
236
761
328
94
638
418
112
1156
237
58
247
693
210
161
105
57
416
509
280
1007
1052
1650
85
1587
272
614
507
581
1707

*
*
*

*
*
*
*

*
*
*

Europe
Serbia
Slova
Slove
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Switz
Switz
Switz
Switz
Switz
Switz
Switz
The N
The N
The N
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, N
UK, S
Oceani
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Frenc
New Z
USA,
USA,
USA,
USA,
USA,
USA,

*
*

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Kidney and renal pelvis (C64-65) - Male (Contd)


Carcinoma

es

1
3
5
2
3
8
5
3
2
5
9
5
4
0
9
5
3
4
0

1
0
4
7
4
4
3
8
5
4
2
4
6
2
8
1
7
1
9
9
7
6
6
0
8
7
3
6
8
4
6
1
8
4
8
8
2
6
7
8
7
3
0
1
5
7
6
9
0
7
2
0
5
7
2
4
7
1
7

*
*
*

*
*
*
*

*
*
*

Europe (Contd)
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, England, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern And Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory (data not available)
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Other

Unspec.

0.2
0.1
0.1
0.8
0.2
0.3
0.2
0.5
0.1
0.0
0.3
0.4
0.1
0.0
0.1
0.2
0.2
0.4
0.1
0.3
0.3
0.4
0.1
0.1
0.1
1.0
1.1
1.3
0.6
0.8
0.5
1.0
1.4
0.8
0.3
1.0

0.3
0.2
0.6
0.5
0.2
0.3
0.8
0.3
0.2
0.3
0.2
0.2
0.5
0.3
0.2
0.4
0.5
0.1
1.2
0.1
0.5
0.3
0.3
0.2
0.3
0.4
0.3
0.3
0.3
0.3
0.3
0.2
0.4
0.2
0.3

0.3
0.3
0.1
0.1
0.2
0.1
0.2
0.2
0.2
0.2
0.4
0.1
0.3

0.3
0.2
0.3
0.5
0.2
0.3
0.2
0.3
0.4
0.2
0.4
0.6
0.4

Squamous

Adeno

Other

Unspec.

0.8
0.7
0.5
0.9
1.0
1.1
1.1
0.3
1.0
1.3
1.3
1.1
1.0
0.7
0.7
0.8
1.4
0.4
0.6
0.6
0.9
1.0
0.8
0.7
0.8
0.6
0.6
0.6
0.8
0.6
0.6
0.5
0.7
0.6
0.5
0.7

2.9
9.1
7.9
3.1
8.1
9.2
3.2
3.3
6.3
3.7
3.8
8.4
5.0
4.7
6.0
7.4
7.7
9.2
6.6
9.2
6.8
5.6
6.5
6.0
7.0
5.1
5.7
5.5
6.6
5.7
5.6
5.0
5.8
5.9
5.1
6.3

0.1
0.0
0.0
0.1
0.0
0.0
0.1
0.2
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0

0.8
1.0
0.6
1.1
0.6
0.9
0.5
0.5
0.5
0.8
0.5
0.3
0.7
1.4
0.8

9.0
8.7
10.3
8.9
8.2
7.9
8.9
4.4
6.5
7.9
6.0
5.6
9.6
7.4
10.3

0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.2
-

Number of cases
MV

Total

1.4
2.4
1.3
0.5
0.6
1.5
0.7
0.7
0.8
0.5
0.6
0.6
0.8
0.3
0.4
0.5
0.1
0.8
0.9
0.5
0.4
0.5
1.1
1.5
0.8
0.0
0.0
0.1
0.5
1.2
0.4
0.2
0.3
2.0
0.8

779
1527
663
52
405
717
206
39
166
153
210
216
122
205
2680
132
79
64
140
130
82
174
4322
261
274
566
491
832
1643
572
1714
2437
1071
1210
323
1309

1014
1931
680
62
475
842
247
51
188
168
236
245
148
218
2838
141
83
71
163
139
87
188
5010
315
306
795
727
1226
2283
724
2349
3638
1616
1612
451
1749

0.1
0.0
0.2
0.9
1.1
0.2
0.6
1.1
0.3
0.3
0.3
0.3
0.2
0.4

2163
1066
543
180
1477
523
85
25
909
363
22
40
51
111
122

2379
1242
656
201
1720
589
90
27
1101
387
25
43
53
116
132

*
*
*Important. See note on population page.
Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

689

747

Age-standardized (world) incidence rates (per 100,000)


by histological type

Kidney and renal pelvis (C64-65) - Female


Carcinoma

Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Non-Hispanic White
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Georgia: Black
USA, Georgia: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
USA, Louisiana: Black
USA, Louisiana: White
USA, Maine
USA, Massachusetts

Other

Unspec.

0.1
0.1
0.0
0.0

0.6
0.2
0.6
0.2
0.3

0.1
0.2
0.0
0.0
0.1
0.0
0.0
0.2
-

1.0
0.3
0.3
0.1
0.2
0.3
0.1
0.0
0.0
0.3
-

0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.2
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0

0.1
0.1
0.1
0.1
0.2
0.0
0.2
0.0
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.3
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.3
0.1
0.1
0.0
0.1
0.2
0.0
0.2
0.2
0.1
0.1

Squamous

Adeno

Other

Unspec.

0.0
0.2
0.2

0.5
1.0
0.9
0.8

0.1

0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2

2.6
1.4
1.3
1.6
1.9
2.5
1.4
1.4
1.1
1.0
1.4

0.3
0.4
0.3
0.3
0.3
0.3
0.5
0.3
0.5
0.4
0.2
0.5
0.4
0.5
0.4
0.4
0.2
0.3
0.1
0.5
0.5
0.4
0.3
0.6
0.2
0.4
0.3
0.1
0.4
0.2
0.2
0.3
0.4
0.4
0.5
0.2
0.6
0.4
0.4
0.3
0.5
0.3
0.5
0.5
0.5
0.3
0.6
0.2
0.5
0.6
0.5
0.3
0.5
0.6
0.4
0.6
0.4
0.2
0.4
0.3
0.4
0.6
0.6

4.3
5.1
3.2
5.6
6.5
5.0
2.6
6.0
4.0
4.3
4.7
4.5
5.6
4.1
4.9
5.1
4.1
3.7
5.3
1.8
2.9
5.4
2.4
3.7
4.2
5.0
1.4
3.0
4.6
2.5
1.9
4.5
2.0
5.1
5.2
4.1
4.4
5.2
4.8
5.2
4.4
5.3
2.0
4.4
4.5
4.4
4.6
3.9
4.8
3.6
5.4
4.4
5.9
5.5
6.0
5.5
6.2
5.6
5.8
6.4
6.2
6.7
6.1
6.6
5.3
5.4

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

748

690

Cancer Incidence in Five Continents Vol. IX, IARC 2008

Number of cases
MV

Total

0.0
0.3
0.1
0.1

33
75
15
12
30

34
89
17
17
37

0.2
0.5
0.3
0.4
0.4
0.5
0.2
0.3
0.1

0.6
0.1
0.4
0.7
0.8
0.6
0.7
0.5
0.3
-

31
74
12
41
674
32
90
136
44
21
19

37
81
13
46
887
39
114
188
61
26
19 *

0.4
0.5
0.3
0.2
0.3
0.5
0.3
0.4
0.6
0.4
0.5
0.6
0.4
0.2
0.3
0.3
0.3
0.6
0.1
0.4
0.3
0.3
0.4
0.3
0.3
0.9
1.0
0.2
0.2
0.4
0.3
0.3
0.3
0.5
0.6
0.5
0.7
0.8
0.6
0.4
0.5
0.3
0.4
0.4
0.3
0.4
0.2
0.4
0.6
0.4
0.2
0.4
0.4
0.4
0.3
0.4
0.4
0.2
0.5
0.3
0.2
0.3

0.5
0.0
0.1
0.2
0.1
0.3
0.4
0.8
0.5
0.4
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.2
0.1
0.1
0.1
0.2
0.3
0.1
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.2
0.1
0.1
0.1
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.2

3947
507
554
215
198
108
2
250
1877
25
211
897
214
670
77
1044
5193
971
89
45
36
153
13
606
1422
172
27
32
409
19
15
727
316
371
1085
3367
672
844
53
775
117
89
23
3869
330
3500
1393
376
122
245
345
1031
275
2878
368
2446
1560
725
961
1099
84
169
280
817
312
1568

5065
612
697
308
233
117
2
301
2503
29
263
999
239
747
85
1172
5807
1087
104
48
37
168
14
685
1598
196
30
34
442
19
15
836
340
427
1178
3803
790
925
57
852
131
102
24
4364
372
3950
1585
420
136
275
394
1173
309
3237
428
2743
1725
826
1109
1263
98
194
323
937
354
1750

*
*
*
*

Americ
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
Asia
Bahra
China
China
China
China
China
China
Cypru
India,
India,
India,
India,
India,
India,
India,
Israel
Israel
Israel
Japan
Japan
Japan
Japan
Japan
Japan
Japan
Korea
Korea
Korea
Korea
Korea
Korea

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Kidney and renal pelvis (C64-65) - Female (Contd)

es

Carcinoma

4
9
7
7
7

*
*
*
*

7
1
3
6
7
9
4
8
1
6
9*

5
2
7
8
3
7
2
1
3
9
3
9
9
7
5
2
7
7
4
8
7
8
4
5
8
6
0
4
2
9
5
6
0
7
8
3
0
5
7
2
1
2
4
4
2
0
5
0
6
5
4
3
9
7
8
3
5
6
9
3
8
4
3
7
4
0

America, North (Contd)


USA, Michigan
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Michigan: Black
USA, Michigan: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York state
USA, New York state: Black
USA, New York state: White
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 registries)
USA, SEER (9 registries): Black
USA, SEER (9 registries): White
USA, SEER (14 registries)
USA, SEER (14 registries): Asian and Pacific Islander
USA, SEER (14 registries): Black
USA, SEER (14 registries): Hispanic White
USA, SEER (14 registries): Non-hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, New Delhi
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon

Other

Unspec.

0.1
0.2
0.3
0.2
0.3
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.1
0.2
0.2
0.2
0.1
0.1
0.1
0.2
0.2
0.2
0.1
0.1
0.1
0.2
0.1
0.0
0.1
0.2
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1

0.4
0.6
0.7
0.6
0.6
0.4
0.4
0.1
0.4
0.5
0.4
0.5
0.4
0.3
0.2
0.4
0.3
0.4
0.5
0.5
0.4
0.4
0.4
0.4
0.3
0.4
0.5
0.3
0.4
0.3
0.3
0.4
0.4
0.5
0.4
0.3
0.2
0.4
0.3
0.3
0.4
0.6
0.3
0.3
0.4
0.3
0.3
0.3
0.3
0.3
0.2
0.4

0.4
0.0
0.2
0.0
0.2
0.0
0.1
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.1

0.3
0.2
0.0
0.0
0.0
0.7
0.3
0.1
0.1
0.2
0.1
0.1
0.3
0.3
0.4
0.1
0.2
0.1
0.1
0.2
0.2
0.2
0.2
0.1
0.3

Squamous

Adeno

Other

Unspec.

0.4
0.4
0.3
0.5
0.3
0.5
0.5
0.3
0.5
0.3
0.5
0.2
0.5
0.2
0.3
0.2
0.5
0.3
0.5
0.5
0.3
0.5
0.5
0.1
0.5
0.4
0.5
0.5
0.3
0.5
0.8
0.4
0.3
0.4
0.4
0.2
0.3
0.3
0.4
0.4
0.2
0.5
0.5
0.3
0.5
0.3
0.4
0.4
0.3
0.5
0.5

5.4
5.9
7.3
5.6
6.8
5.1
5.5
6.0
5.5
4.3
5.3
5.3
5.4
4.8
7.1
6.0
4.0
4.9
4.2
5.2
5.1
5.5
5.1
5.4
6.2
5.2
4.8
4.5
5.5
6.3
5.4
6.0
4.8
6.1
4.8
4.7
2.2
5.7
5.2
4.8
5.0
5.8
4.7
5.9
6.9
5.8
4.4
5.2
4.8
4.8
5.3
5.3

0.1
0.1
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0

0.4
0.2
0.1
0.1
0.0
0.1
0.3
0.0
0.1
0.1
0.0
0.0
0.4
0.4
0.2
0.3
0.1
0.5
0.3
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.2

2.6
0.4
1.5
0.4
0.3
0.3
1.7
0.4
0.6
0.3
0.9
0.1
4.8
5.1
0.9
1.1
1.3
1.7
2.0
1.7
0.9
1.4
1.2
1.3
1.5
1.2
1.0
1.2

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

Number of cases
MV

Total

0.2
0.0
0.0
0.0
0.2
0.2
0.2
0.3
0.2
0.1
0.2
0.3
0.2
0.1
0.1
0.1
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.4
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.0
0.1
0.3
0.4
0.3
0.0
0.0
0.1
0.1
0.1
0.2

2227
1006
264
733
325
1864
1367
123
1229
172
2058
222
1787
305
28
125
144
4239
467
3670
47752
4824
41531
2712
274
2385
736
645
3268
267
2944
290
5077
575
4176
13785
525
1438
1453
10218
837
230
597
4280
480
3720
283
135
1083
723
479
1261

2505
1133
291
832
363
2099
1535
140
1378
204
2297
245
1999
362
31
148
174
4849
528
4209
53785
5481
46775
2999
304
2634
841
719
3696
319
3311
332
5720
641
4722
15524
573
1627
1589
11568
929
255
664
4843
560
4194
306
146
1252
833
536
1403

0.3
0.1
0.1
1.9
2.2
0.1
0.1
0.1
0.1
0.1
0.9
0.1
0.3
0.2
0.2
0.5
0.7
0.0
0.3
0.2
0.4
0.5
0.4
0.5
0.5
0.5
0.4
0.5

21
49
387
7
40
450
19
55
59
2
177
21
201
55
7
958
921
28
63
74
102
265
186
537
117
1674
172
125
51
44
100

25
77
404
10
46
641
21
58
71
3
195
21
225
60
10
1109
1042
34
80
115
122
340
227
756
173
2123
228
158
66
56
127

*
*
*
*
*

*
*
*
*

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

691

749

Age-standardized (world) incidence rates (per 100,000)


by histological type

Kidney and renal pelvis (C64-65) - Female (Contd)


Carcinoma
Asia (Contd)
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland (data not available)
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg (data not available)
Germany, Free State of Saxony (data not available)
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania (data not available)
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio
Italy, Syracuse Province
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce (data not available)
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg

692

Unspec.

0.0
0.1
0.3
0.1
0.4
0.0
0.0
0.0
0.0

0.2
0.2
0.1
0.3
2.4
0.3
0.1
0.2
0.1
0.2
0.1
0.1
0.4
0.0
0.1
0.3
0.1

0.2
0.2
0.1
0.0
0.0
0.1
0.1
1.1
0.1
0.1
0.2
0.1
0.0
0.1
0.0
0.0
0.1
0.1
0.0
0.3
0.2
0.1
0.1
0.3
0.2
0.1
0.4
0.1
0.1
0.2
0.3
0.1
0.1
0.1
0.8
0.3
0.4
0.1
0.0
0.3
0.2
0.5
0.1
0.3
0.0
0.2
0.1
0.4
0.2
0.0
0.1
0.6

0.3
0.2
0.4
0.2
0.4
0.2
0.2
0.2
0.3
0.2
0.6
0.2
0.1
0.2
0.5
0.4
0.4
0.1
0.5
0.3
0.3
0.3
0.4
0.2
0.4
0.4
0.0
0.2
0.0
0.1
0.3
0.6
0.7
0.2
1.0
0.6
0.3
0.3
0.6
1.0
0.6
0.4
0.8
0.4
0.3
0.3
0.5
0.4
0.0
0.3
0.3
0.3
0.3

Adeno

Other

Unspec.

0.1
0.2
0.2
0.2
0.1
0.1
0.2
0.2
0.2
0.2
0.5
0.2
0.2
0.2
0.2

1.4
1.5
1.3
1.1
0.9
0.9
0.6
1.1
0.7
1.4
1.7
1.8
0.9
1.4
0.2
0.1
0.2
1.2
1.4

0.0
0.0
-

0.4
0.2
0.1
0.1
0.3
0.3
0.1
0.2
0.6
0.8
0.1
0.4
0.2
0.3
0.3
0.2
0.2
0.4
0.2
0.2
0.5
0.3
0.5
0.5
0.4
0.4
0.7
0.2
0.2
0.3
0.5
0.2
0.3
0.0
0.3
0.4
0.2
0.3
0.3
0.2
0.3
0.3
0.2
0.2
0.3
0.1
0.4
0.4
0.3
0.5
0.1
0.2
0.1
0.2
0.2
0.3
0.2
0.1
0.2

5.5
5.6
4.8
3.9
3.4
4.1
1.3
1.7
7.2
3.2
5.2
5.6
3.4
3.2
5.8
3.1
3.4
4.1
3.5
4.0
2.6
2.9
3.6
4.4
4.3
5.0
6.2
2.9
3.1
4.2
4.3
4.4
3.2
3.5
3.9
4.8
2.8
3.9
4.0
1.3
4.2
5.2
1.6
2.2
4.9
1.5
3.2
2.8
4.4
5.0
4.6
4.9
3.1
3.4
2.8
2.7
1.8
1.8
3.6

0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.3
0.0
0.1
0.0
0.0
0.1
0.0
0.5
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

750

Other

Squamous

Cancer Incidence in Five Continents Vol. IX, IARC 2008

Number of cases
MV

Total

0.4
0.5
0.3
0.5
0.4
0.4
0.2
0.0
0.4
0.6
0.6
0.4
0.5
0.3
0.3
0.2
0.0
0.1

17
480
29
20
14
33
28
31
20
138
185
159
6
20
26
8
13
48
139

22
597
35
27
17
42
28
34
21
225
246
213
8
25
35
14
17
52
148

0.5
0.4
0.4
1.6
0.2
0.3
0.7
1.8
1.9
0.6
0.9
0.3
0.2
0.1
0.3
0.1
0.3
0.1
0.2
0.4
0.3
0.2
0.0
0.6
0.1
0.4
0.9
0.7
0.6
1.1
0.4
0.6
0.9
0.6
0.8
0.5
1.1
0.5
0.6
1.3
0.6
1.2
1.2
0.6
0.9
0.5
0.5
1.2
0.5
0.8
2.2
2.2
0.3
0.5
2.0
1.5
0.1
0.2
1.8

2572
171
70
1786
316
1069
549
640
3686
1038
390
287
100
75
194
162
179
237
91
103
68
102
335
614
627
343
74
422
40
170
113
328
129
41
280
183
64
595
104
27
107
310
75
61
42
27
214
179
117
484
537
910
49
795
117
270
272
291
1073

2854
191
78
2549
343
1180
844
1016
4858
1274
478
312
107
82
215
169
205
245
99
117
81
108
434
741
744
375
87
547
55
209
138
403
184
51
362
217
86
660
131
41
137
398
123
82
53
38
273
246
140
601
851
1243
56
1013
194
400
281
311
1624

*
*
*

*
*
*
*

*
*
*

Europe
Serbia
Slova
Slove
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Switz
Switz
Switz
Switz
Switz
Switz
Switz
The N
The N
The N
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, N
UK, S
Oceani
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Frenc
New Z
USA,
USA,
USA,
USA,
USA,
USA,

*
*

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Kidney and renal pelvis (C64-65) - Female (Contd)

es

Carcinoma

2
7
5
7
7
2
8
4
1
5
6
3
8
5
5
4
7
2
8

4
1
8
9
3
0
4
6
8
4
8
2
7
2
5
9
5
5
9
7
1
8
4
1
4
5
7
7
5
9
8
3
4
1
2
7
6
0
1
1
7
8
3
2
3
8
3
6
0
1
1
3
6
3
4
0
1
1
4

*
*
*

*
*
*
*

*
*
*

Europe (Contd)
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, England, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern And Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory (data not available)
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Other

Unspec.

0.1
0.1
0.0
0.3
0.0
0.1
0.1
0.2
0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.0
0.3
0.0
0.1
0.0
0.4
0.4
0.6
0.3
0.4
0.3
0.4
0.6
0.4
0.2
0.5

0.3
0.4
0.6
0.3
0.5
0.4
0.6
0.1
0.2
0.3
0.3
0.3
0.5
0.4
0.2
0.4
0.1
0.2
0.6
0.2
0.3
0.5
0.8
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.4
0.2
0.3

0.2
0.2
0.1
0.0
0.0
0.1
0.2
0.3
0.1
0.1
0.1
0.1
0.1

0.4
0.3
0.3
0.2
0.5
0.4
0.5
0.4
0.4
0.1
0.3

Squamous

Adeno

Other

Unspec.

0.6
0.5
0.3
0.2
0.2
0.3
0.3
0.5
0.3
0.2
0.3
0.2
0.2
0.1
0.4
0.1
0.3
0.6
0.5
0.1
0.1
0.5
0.4
0.4
0.5
0.2
0.4
0.4
0.4
0.3
0.3
0.3
0.4
0.3
0.2
0.4

1.5
4.4
3.1
2.0
2.9
2.9
1.4
1.6
2.7
2.1
1.9
2.5
1.9
2.3
3.6
2.4
3.4
3.0
3.3
2.9
2.9
3.0
3.4
3.3
3.4
2.6
2.8
2.8
3.4
2.8
2.7
2.2
2.8
2.7
2.7
3.1

0.0
0.0
0.0
0.1
0.2
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.9
1.2
0.5
0.2
0.4
0.7
0.6
0.5
0.3
0.2
0.2
0.3
0.1

4.3
4.2
4.2
5.7
4.4
4.1
5.6
0.6
3.4
3.3
2.0
3.2
3.9
2.8
3.8

0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.2
0.1
-

Number of cases
MV

Total

0.7
1.1
0.5
0.2
0.3
0.5
0.3
0.7
0.3
0.4
0.2
0.2
0.4
0.1
0.2
0.2
0.3
0.2
0.1
0.3
0.1
0.4
0.6
0.6
0.3
0.0
0.0
0.0
0.3
0.0
0.5
0.2
0.1
0.1
0.9
0.5

517
1024
377
31
164
271
99
23
76
82
107
78
55
108
1926
48
40
29
92
55
38
113
2726
171
177
339
285
515
1035
319
967
1337
610
658
208
840

663
1326
389
35
219
344
131
33
93
102
122
100
71
114
2057
58
47
32
100
64
41
132
3251
207
197
487
452
805
1509
430
1410
2147
1000
928
299
1224

0.0
0.0
0.1
0.5
0.5
0.1
0.6
0.6
0.3
0.3
0.1
0.5
0.2

1355
663
273
113
931
297
67
6
522
170
10
28
20
51
49

1543
813
336
130
1085
348
72
10
655
192
13
28
21
61
52

*
*
*Important. See note on population page.
Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

693

751

Age-standardized (world) incidence rates (per 100,000)


by histological type

Bladder (C67) - Male


Carcinoma

Squamous Transitional Adeno Other Unspec.


Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Non-Hispanic White
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Georgia: Black
USA, Georgia: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
USA, Louisiana: Black
USA, Louisiana: White
USA, Maine
USA, Massachusetts

694

Number of cases
MV

Total

81
1080
175
29
95

0.5
4.7
0.2
0.1
1.0

2.2
17.8
17.9
0.9
1.3

0.5
1.2
0.3
0.0
0.1

0.1
0.0
0.1
-

0.5
1.2
0.4
0.3
2.9

0.0
0.1
0.1

0.8
2.9
1.5
1.1

70
991
174
15
45

0.4
0.5
0.2
0.1
0.2
0.0
0.2
0.2
0.1

11.0
9.3
5.0
11.1
12.9
3.2
6.8
4.4
4.0
5.0
2.7

0.8
0.5
0.9
0.4
0.5
0.3
0.2
0.1
0.5
0.4

0.0
-

3.1
0.2
0.2
0.4
0.9
0.1
0.4
0.1
0.2
0.4
0.5

0.0
0.0
0.0
-

0.1
0.0
-

0.2
2.2
0.4
0.6
2.4
0.5
1.0
1.0
0.8
1.0
0.1

121
226
40
156
2839
32
260
343
120
77
33

0.1
0.2
0.2
0.1
0.1
0.1
0.3
0.1
0.2
0.1
0.1
0.3
0.1
0.1
0.2
0.2
0.2
0.2
0.2
0.3
0.2
0.2
0.5
0.1
0.1
0.2
0.0
0.3
0.1
0.2
0.2
0.2
0.4
0.2
0.3
0.4
0.2
0.2
0.3
0.2
0.2
0.2
0.3
0.2
0.3
0.2
0.2
0.1
0.2
0.1
0.2
0.2
0.3
0.2
0.3
0.3
0.3
0.2
0.1
0.2

15.5
18.5
19.2
14.5
21.6
18.3
10.3
23.6
12.1
17.1
18.6
16.2
6.7
18.2
20.5
19.7
18.0
16.5
9.7
6.2
6.5
10.1
8.9
20.9
16.3
10.1
8.8
6.1
8.7
11.0
7.8
22.9
7.5
10.2
9.3
22.2
19.5
25.3
9.3
26.2
13.3
11.0
16.3
22.1
8.0
23.4
17.6
16.4
8.7
19.1
9.6
19.8
21.6
21.7
10.0
23.1
20.4
21.1
21.6
18.4
12.0
22.5
9.4
21.4
26.4
26.0

0.2
0.2
0.1
0.3
0.1
0.2
0.3
0.3
0.4
0.1
0.2
0.1
0.3
0.3
0.2
0.2
0.4
0.0
0.2
0.2
0.2
0.2
0.2
0.1
0.2
0.2
0.1
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.3
0.2
0.1
0.3
0.4
0.3
0.2
0.3
0.3
0.3
0.4
0.2
0.1
0.2
0.1
0.3
0.3
0.2
0.2
0.3
0.2
0.3
0.5
0.3
0.3
0.2

0.1
0.1
0.1
0.2
0.2
0.0
0.1
0.1
0.1
0.0
0.1
0.3
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.2
0.1
0.0
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1

0.2
0.3
0.2
0.4
0.4
0.1
0.2
0.1
0.1
0.4
0.3
0.2
0.3
0.4
0.3
0.3
0.3
0.2
0.4
0.2
0.2
0.3
0.3
0.4
0.3
0.1
0.2
0.3
0.3
0.2
0.2
0.2
0.3
0.3
0.4
0.2
0.5
0.4
0.4
0.4
0.5
0.3
0.5
0.3
0.3
0.5
0.3
0.4
0.3
0.2
0.4
0.3
0.4
0.3
0.2
0.3
0.3
0.7
0.1
0.4
0.3
0.4
0.2

0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.2
0.1
0.0
0.1
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0

1.2
0.1
0.3
0.9
0.2
0.7
2.1
0.3
0.1
0.1
0.2
0.5
0.2
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.3
0.1
0.2
0.1
0.2
0.2
0.3
0.4
0.2
0.4
0.3
0.1
0.1
0.2
0.2
0.3
0.1
0.2
0.2
0.2
0.2
0.2
0.3
0.2
0.2
0.3
0.1
0.2
0.3
0.2

13852
1776
3230
668
635
378
9
879
5371
96
810
2670
214
2419
302
4051
20410
3742
143
125
65
225
37
2992
4735
294
121
57
534
88
43
3504
954
647
1512
17006
2617
3419
71
3293
267
145
107
18260
480
17550
4199
1132
150
959
456
3708
996
9502
468
8779
4432
2570
3102
2814
130
530
358
2436
1363
6161

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

752

Sarcoma Other Unspec.

Cancer Incidence in Five Continents Vol. IX, IARC 2008

*
*
*
*

136
238
41
168
3309
35
293
423
141
88
33 *
15145
1812
3282
734
647
378
9
911
6445
96
831
2720
221
2462
307
4103
20643
3784
145
129
68
227
37
3022
4768
301
122
57
538
88
44
3524
969
659
1534
17188
2662
3457
73
3329
273
147
110
18528
495
17800
4275
1147
153
971
466
3773
1008
9640
477
8908
4492
2611
3158
2849
131
536
365
2463
1393
6244

Americ
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
Asia
Bahra
China
China
China
China
China
China
Cypru
India,
India,
India,
India,
India,
India,
India,
Israel
Israel
Israel
Japan
Japan
Japan
Japan
Japan
Japan
Japan
Korea
Korea
Korea
Korea
Korea
Korea

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Bladder (C67) - Male (Contd)


Carcinoma

1
0
5
9
5

*
*
*
*

6
8
1
8
9
5
3
3
1
8
3*

5
2
2
4
7
8
9
1
5
6
1
0
1
2
7
3
3
4
5
9
8
7
7
2
8
1
2
7
8
8
4
4
9
9
4
8
2
7
3
9
3
7
0
8
5
0
5
7
3
1
6
3
8
0
7
8
2
1
8
9
1
6
5
3
3
4

Squamous Transitional Adeno Other Unspec.


America, North (Contd)
USA, Michigan
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Michigan: Black
USA, Michigan: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York state
USA, New York state: Black
USA, New York state: White
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 registries)
USA, SEER (9 registries): Black
USA, SEER (9 registries): White
USA, SEER (14 registries)
USA, SEER (14 registries): Asian and Pacific Islander
USA, SEER (14 registries): Black
USA, SEER (14 registries): Hispanic White
USA, SEER (14 registries): Non-hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, New Delhi
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon

Sarcoma Other Unspec.

Number of cases
MV

Total

0.2
0.2
0.3
0.2
0.3
0.2
0.2
0.6
0.2
0.1
0.2
0.2
0.2
0.1
0.2
0.1
0.2
0.2
0.2
0.2
0.3
0.2
0.1
0.2
0.1
0.1
0.2
0.2
0.4
0.2
0.1
0.2
0.3
0.2
0.2
0.1
0.3
0.1
0.2
0.2
0.3
0.2
0.1
0.2
0.1
0.2
0.2
0.2
0.2
0.1
0.1

23.3
23.9
10.7
27.5
10.7
24.8
19.7
10.0
20.5
21.3
24.9
10.7
27.1
15.7
3.7
10.2
19.9
22.7
9.0
25.1
20.9
9.4
22.3
22.0
10.5
22.4
17.3
23.5
25.0
11.8
26.0
29.9
20.2
9.8
22.3
19.8
8.1
10.2
10.2
23.1
18.7
7.9
21.5
16.2
8.6
17.0
16.0
21.2
22.8
22.9
23.0
20.9

0.2
0.3
0.4
0.3
0.4
0.2
0.2
0.5
0.2
0.2
0.3
0.3
0.3
0.2
0.2
0.2
0.3
0.3
0.3
0.2
0.3
0.2
0.3
0.5
0.3
0.3
0.2
0.2
0.3
0.2
0.3
0.2
0.4
0.2
0.2
0.1
0.3
0.2
0.2
0.2
0.2
0.3
0.2
0.3
0.2
0.1
0.2
0.2
0.2
0.2
0.3

0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.3
0.1
0.2
0.0
0.1

0.3
0.4
0.3
0.5
0.2
0.3
0.2
0.1
0.2
0.5
0.4
0.2
0.4
0.2
0.1
0.3
0.5
0.3
0.6
0.4
0.3
0.4
0.6
0.2
0.6
0.3
0.2
0.3
0.3
0.3
0.2
0.3
0.3
0.3
0.3
0.2
0.3
0.2
0.3
0.2
0.1
0.3
0.3
0.3
0.3
0.2
0.8
0.2
0.3
0.3
0.4

0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1

0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0

0.3
0.1
0.1
0.1
0.2
0.3
0.3
0.2
0.3
0.0
0.3
0.2
0.3
0.2
0.1
0.2
0.3
0.2
0.3
0.2
0.2
0.3
0.3
0.1
0.3
0.5
0.2
0.2
0.1
0.2
0.5
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.2
0.2
0.2
0.2
0.3
0.3
0.3
0.1
0.2
0.1
0.1
0.3
0.3

8399
3395
306
3067
410
7878
4258
163
4069
810
8003
322
7525
1043
12
202
817
15887
675
14926
172592
6453
161763
9512
373
8810
2324
3137
13004
416
12411
1234
18962
724
17311
50862
1566
2048
2206
44497
2641
249
2366
10289
482
9610
996
509
4809
3254
1795
4347

8537
3423
308
3093
417
8007
4338
166
4145
827
8084
325
7603
1064
12
208
832
16299
697
15312
175440
6605
164400
9715
387
8991
2404
3190
13141
418
12544
1254
19184
734
17511
51459
1585
2080
2241
45005
2691
257
2407
10569
504
9864
1001
522
4877
3292
1817
4435

0.6
0.1
0.1
0.2
0.0
0.1
0.1
0.1
0.5
0.1
0.2
0.1
0.0
0.1
0.1
0.2
0.1
0.1
0.2
0.1
0.1
0.3
0.1
0.0
0.0
0.0
0.0
0.0

10.7
4.3
9.9
5.3
1.1
3.6
19.8
1.6
2.9
2.7
2.5
3.0
1.8
25.8
26.2
17.2
9.3
9.7
15.8
9.2
10.9
5.8
5.9
7.6
8.4
8.0
8.5
8.4
7.6

1.3
0.2
0.2
0.2
0.1
0.0
0.3
0.1
0.2
0.1
0.1
0.1
0.0
0.3
0.3
0.2
0.2
0.2
0.3
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.4
0.3
0.1

0.0
0.1
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

1.4
1.8
0.1
0.1
0.0
1.3
0.3
0.1
0.0
1.4
0.0
0.5
0.6
0.0
0.3
0.1
0.7
0.1
0.1
0.1
0.0
0.1
0.2
0.1

0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
-

0.7
0.1
0.6
6.2
6.8
0.0
0.8
0.6
0.9
0.1
1.6
2.8
0.1
0.9
0.8
0.6
0.8
0.8
0.1
1.0
0.0
1.7
1.0
1.1
1.5
0.8
1.2
1.3
1.1

73
274
2376
71
116
1595
149
495
170
30
596
105
845
138
49
4558
4245
250
388
445
707
1026
896
2428
477
6688
676
421
217
220
355

81
351
2499
73
138
1996
169
500
238
35
767
109
1128
167
51
4767
4422
255
415
473
718
1174
951
3011
549
7405
766
447
236
242
395

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

695

*
*
*
*
*

*
*
*
*

753

Age-standardized (world) incidence rates (per 100,000)


by histological type

Bladder (C67) - Male (Contd)


Carcinoma

Squamous Transitional Adeno Other Unspec.


Asia (Contd)
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland (data not available)
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg (data not available)
Germany, Free State of Saxony (data not available)
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania (data not available)
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio
Italy, Syracuse Province
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce (data not available)
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg

696

Number of cases
MV

Total

0.1
0.0
0.2
0.3
0.1
0.1
0.6
0.2
0.1
0.1
0.0
0.2
0.2
0.2
0.1
0.2
0.4

5.3
9.7
6.5
4.6
5.9
5.3
2.3
4.0
8.5
3.4
6.9
7.3
4.3
7.1
4.3
4.5
3.7
13.7
15.3

0.1
0.2
0.5
0.1
0.5
0.3
0.1
0.2
0.2
0.2
0.2
0.1
0.2
0.2
0.1
0.3
0.4

0.0
0.1
0.1
0.0
0.1
0.1

0.1
0.1
0.2
0.5
0.2
0.1
0.1
0.3
0.2
0.1
0.1
0.1
0.0
0.2
0.4

0.0
0.0
0.0
0.0
0.1
0.0
0.0

0.0
0.0
0.0
0.0

1.2
1.0
1.4
1.1
0.3
1.2
0.3
0.2
0.7
0.2
0.2
0.1
0.3
0.4
0.9
0.5
1.4
1.0

43
1892
83
46
101
122
99
83
218
237
586
482
34
70
188
101
106
416
1294

47
2022
95
57
103
128
107
85
219
279
600
493
35
72
199
121
119
445
1353

0.1
0.1
0.4
0.4
0.2
0.2
0.3
0.2
0.2
0.2
0.2
0.3
0.1
0.2
0.4
0.2
0.2
0.1
0.2
0.3
0.5
0.1
0.2
0.1
0.2
0.2
0.1
0.1
0.1
0.2
0.0
0.1
0.1
0.4
0.0
0.2
0.3
0.2
0.2
0.5
0.0
0.1
0.2
0.2
0.2
0.1
0.1
0.2
0.2
0.1
0.6
1.1
0.1
0.1
0.1
0.0
0.2
0.1
0.5

18.4
24.5
22.5
10.9
20.1
22.6
9.7
11.5
18.1
24.8
14.5
14.9
13.2
14.8
17.9
14.9
14.4
11.7
10.4
14.2
14.1
10.3
18.9
18.1
19.4
11.5
19.5
12.8
31.0
27.8
33.1
34.0
35.3
30.1
25.6
30.8
37.7
19.6
28.6
28.4
29.6
32.6
30.5
23.6
35.5
31.6
36.1
29.7
29.5
28.9
8.2
9.8
25.1
18.6
13.0
12.2
16.9
13.0
6.1

0.2
0.1
0.1
0.5
0.3
0.4
0.2
0.3
0.3
0.3
0.3
0.3
0.2
0.5
0.2
0.1
0.2
0.5
0.3
0.3
0.3
0.2
0.2
0.2
0.3
0.1
0.2
0.4
0.5
0.6
0.1
0.1
0.5
0.4
0.2
1.0
0.3
0.2
0.4
0.2
0.1
0.4
0.8
0.2
0.4
0.4
0.4
0.1
0.3
0.9
0.8
0.6
0.2
0.4
0.1
0.3
0.4
0.3

0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.0
0.2
0.1
0.1
0.0
0.1
0.2
0.2
0.2
0.0
0.1
0.0
0.2
0.1
0.1
0.0
0.1
0.0
0.1
0.0
0.3
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0

1.3
0.5
0.9
0.2
0.7
1.7
0.2
1.5
0.3
0.2
0.6
0.3
0.2
0.1
0.1
0.2
0.1
0.1
0.1
0.4
0.1
0.1
1.6
0.1
2.5
0.4
0.3
0.3
0.4
0.3
0.2
0.3
0.2
0.9
2.2
0.3
0.3
0.7
0.6
0.2
0.2
0.3
0.5
0.4
0.3
0.9
1.5
0.4
0.4
0.3
1.1
0.3
0.2
0.8
0.3
0.3
0.6
1.2

0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.1
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.1
0.1
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0

0.7
0.6
0.5
2.3
0.1
0.7
2.5
4.6
1.0
0.8
0.6
0.2
1.0
0.1
0.1
0.1
0.1
0.1
0.5
0.3
0.3
0.2
0.3
1.3
0.3
0.4
0.3
0.9
1.2
3.7
1.3
2.6
4.6
2.1
2.2
0.1
7.9
1.0
1.2
3.6
1.2
2.5
6.2
3.3
2.9
1.6
0.8
2.5
1.4
1.5
4.4
3.8
0.7
0.3
3.4
3.4
0.3
1.6
3.2

6476
622
275
3945
1686
5354
3418
2322
6995
5793
719
582
376
308
498
691
645
535
275
356
303
293
1418
1837
2313
625
192
1715
317
758
672
2132
1132
332
1558
1019
596
2172
661
401
721
1832
1142
507
276
453
1778
1456
649
2242
996
1566
359
3809
247
803
1947
1740
1149

6654
630
284
4323
1691
5587
4313
3079
7424
6154
743
588
378
311
504
695
652
538
279
363
310
295
1603
1968
2526
645
196
1844
330
836
737
2310
1276
356
1674
1024
739
2273
699
436
755
1960
1356
583
295
479
1820
1602
675
2331
1153
1844
368
3889
444
1016
1985
1931
1597

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

754

Sarcoma Other Unspec.

Cancer Incidence in Five Continents Vol. IX, IARC 2008

*
*
*

*
*
*
*

*
*
*

Europe
Serbia
Slova
Slove
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Switz
Switz
Switz
Switz
Switz
Switz
Switz
The N
The N
The N
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, N
UK, S
Oceani
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Frenc
New Z
USA,
USA,
USA,
USA,
USA,
USA,

*
*

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Bladder (C67) - Male (Contd)


Carcinoma

7
2
5
7
3
8
7
5
9
9
0
3
5
2
9
1
9
5
3

4
0
4
3
1
7
3
9
4
4
3
8
8
1
4
5
2
8
9
3
0
5
3
8
6
5
6
4
0
6
7
0
6
6
4
4
9
3
9
6
5
0
6
3
5
9
0
2
5
1
3
4
8
9
4
6
5
1
7

*
*
*

*
*
*
*

*
*
*

Squamous Transitional Adeno Other Unspec.


Europe (Contd)
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, England, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern And Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory (data not available)
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Sarcoma Other Unspec.

Number of cases
MV

Total

0.2
0.3
0.2
0.3
0.1
0.2
0.4
0.3
0.2
0.2
0.3
0.2
0.1
0.2
0.1
0.3
0.8
0.2
0.2
0.2
0.2
0.2
0.3
0.2
0.2
0.2
0.3
0.3
0.2
0.4
0.2
0.2
0.2
0.1
0.4

11.8
12.4
13.7
24.0
27.4
29.8
19.4
18.6
34.3
27.9
34.5
34.6
34.6
28.4
16.8
27.9
12.0
12.3
10.8
16.6
21.5
15.4
13.6
25.2
23.5
20.6
21.3
23.0
23.9
15.6
20.7
17.0
21.1
19.9
9.4
21.2

0.7
0.2
0.2
0.4
0.3
0.2
0.2
0.4
0.1
0.2
0.1
0.5
0.1
0.3
0.2
0.5
0.3
0.1
0.2
0.2
0.5
0.2
0.2
0.2
0.2
0.2
0.3
0.2
0.1
0.4
0.2
0.3
0.3
0.1
0.2

0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.1
0.0
0.3
0.1
0.0
0.1
0.1
0.1
0.4
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.0
0.0
0.1

0.2
0.2
0.3
0.3
0.4
0.3
0.5
0.5
0.2
0.7
0.5
0.6
0.6
0.9
0.1
0.2
0.9
0.6
0.2
0.6
0.3
0.1
0.1
0.2
0.6
1.1
1.4
0.6
0.9
0.8
1.3
1.4
0.8
0.2
0.7

0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.2
0.2
0.1
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.1

0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

1.6
1.2
0.6
1.9
1.1
1.3
1.0
2.4
1.0
1.1
2.1
0.6
2.0
0.8
0.1
0.4
0.5
0.3
0.3
0.7
0.4
0.3
0.2
0.0
0.2
0.0
0.1
0.4
0.3
0.0
2.8
0.4
0.3
0.2
1.8
0.5

2622
2085
1043
350
1488
2213
996
247
872
959
1505
884
796
1169
7571
461
133
95
238
254
245
425
8895
973
901
2759
2312
4249
7207
1795
7233
10247
4757
4800
618
4775

2931
2303
1061
370
1553
2329
1044
286
898
1002
1592
905
853
1214
7588
468
140
98
247
266
250
433
9000
975
908
2858
2432
4480
7475
1875
8350
11249
5203
4994
721
5012

0.1
0.1
0.2
0.3
0.1
0.2
0.3
0.1
0.0
0.2
0.1
-

10.7
18.2
21.6
20.1
6.4
8.1
11.3
10.2
14.4
12.4
7.5
6.1
11.5
12.5
19.8

0.2
0.2
0.1
0.1
0.1
0.2
0.1
0.2
0.2
0.1
0.2

0.1
0.1
0.1
0.1
0.1
0.1
0.3
0.1
0.1

0.3
0.4
0.1
0.2
0.1
0.2
0.2
0.3
0.1
0.2
0.2
0.2
0.1

0.0
0.0
0.1
0.0
0.0
0.0
-

0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.1
-

0.1
0.0
0.2
0.3
0.6
0.1
0.2
0.6
0.5
0.1
0.0
0.2

2779
2329
1384
393
1286
572
102
43
2039
631
33
49
55
210
257

2964
2516
1443
397
1413
592
111
45
2115
637
33
49
55
211
261

*
*

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

697

755

Age-standardized (world) incidence rates (per 100,000)


by histological type

Bladder (C67) - Female


Carcinoma

Squamous Transitional Adeno Other Unspec.


Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Non-Hispanic White
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Georgia: Black
USA, Georgia: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
USA, Louisiana: Black
USA, Louisiana: White
USA, Maine
USA, Massachusetts

698

Number of cases
MV

Total

1.9
0.1
0.7

0.3
2.3
2.0
0.9
1.0

0.1
0.4
0.1

0.0
-

0.1
0.1
0.5
1.7

0.0
0.0
0.1

0.0
-

0.1
0.8
0.5
0.4

10
232
22
11
31

11
262
22
17
63

0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.3
0.2
0.1

1.8
3.0
1.2
2.5
3.0
1.2
1.4
1.0
0.8
1.2
1.2

0.2
0.2
0.2
0.1
0.1
0.2
0.1
-

0.0
0.0
-

0.6
0.1
0.1
0.2
0.3
0.1
0.3
0.1
0.1
0.0
-

0.0
0.1
0.0
0.0
0.0
-

0.0
-

0.2
0.6
0.7
0.3
0.9
0.3
0.4
0.5
0.3
0.1
-

26
96
11
51
1028
14
91
95
40
29
16

31
104
16
59
1299
17
109
138
53
33
16 *

0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.2
0.2
0.1
0.1
0.1
0.1
0.2
0.0
0.2
0.1
0.2
0.1
0.1
0.3
0.1
0.2
0.3
0.1
0.3
0.1
0.2
0.2
0.3
0.2
0.3
0.1
0.1
0.2
0.3
0.2
0.1
0.1
0.1
0.1
0.0
0.1
0.2
0.1
0.0
0.1

4.2
5.1
5.6
3.6
5.5
5.4
2.0
6.0
3.2
3.5
5.9
4.0
2.5
4.4
4.1
5.0
4.4
4.6
3.4
1.9
1.3
3.2
3.0
5.9
3.8
3.7
1.8
0.8
2.2
3.1
2.7
5.2
1.7
3.4
2.4
5.5
5.1
7.2
3.0
7.5
4.9
4.8
5.3
5.7
2.7
6.0
4.1
4.3
3.7
4.7
2.9
4.5
4.6
5.6
3.8
5.9
5.1
5.2
5.2
4.5
3.5
6.2
3.6
4.9
7.7
7.4

0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.3
0.3
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.2
0.1
0.1
0.1

0.0
0.1
0.0
0.0
0.3
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.2
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
0.1
0.0
0.1
0.0

0.1
0.1
0.1
0.2
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.1
0.2
0.1
0.1
0.2
0.1
0.2
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.2
0.1
0.3
0.1
0.2
0.1
0.1
0.1

0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.4
0.1
0.1
0.2
0.0
0.3
0.6
0.2
0.2
0.0
0.1
0.0
0.3
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.0
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.2
0.1

4663
568
1129
208
205
114
2
279
1843
27
288
903
125
768
67
1242
6592
1360
71
48
17
98
17
1073
1580
151
30
10
202
28
20
1106
286
307
549
5362
840
1269
38
1216
159
110
46
5990
249
5675
1472
451
109
338
254
1211
258
3427
308
3030
1545
846
1038
953
63
186
209
737
516
2403

5241
599
1169
238
209
114
2
300
2279
30
301
933
134
789
72
1269
6751
1390
72
48
17
100
17
1099
1601
154
30
10
206
29
20
1119
292
312
562
5496
874
1293
38
1240
162
111
47
6100
258
5773
1515
457
113
340
267
1241
266
3514
325
3100
1584
880
1080
975
66
188
219
749
541
2466

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

756

Sarcoma Other Unspec.

Cancer Incidence in Five Continents Vol. IX, IARC 2008

*
*
*
*

Americ
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
Asia
Bahra
China
China
China
China
China
China
Cypru
India,
India,
India,
India,
India,
India,
India,
Israel
Israel
Israel
Japan
Japan
Japan
Japan
Japan
Japan
Japan
Korea
Korea
Korea
Korea
Korea
Korea

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Bladder (C67) - Female (Contd)

Carcinoma

1
2
2
7
3

*
*
*
*

1
4
6
9
9
7
9
8
3
3
6*

1
9
9
8
9
4
2
0
9
0
1
3
4
9
2
9
1
0
2
8
7
0
7
9
1
4
0
0
6
9
0
9
2
2
2
6
4
3
8
0
2
1
7
0
8
3
5
7
3
0
7
1
6
4
5
0
4
0
0
5
6
8
9
9
1
6

Squamous Transitional Adeno Other Unspec.


America, North (Contd)
USA, Michigan
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Michigan: Black
USA, Michigan: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York state
USA, New York state: Black
USA, New York state: White
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 registries)
USA, SEER (9 registries): Black
USA, SEER (9 registries): White
USA, SEER (14 registries)
USA, SEER (14 registries): Asian and Pacific Islander
USA, SEER (14 registries): Black
USA, SEER (14 registries): Hispanic White
USA, SEER (14 registries): Non-hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, New Delhi
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon

Sarcoma Other Unspec.

Number of cases
MV

Total

0.1
0.1
0.2
0.1
0.2
0.1
0.1
0.2
0.1
0.1
0.1
0.2
0.1
0.1
0.3
0.1
0.1
0.1
0.2
0.1
0.1
0.2
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.3
0.1
0.1
0.0
0.2
0.1
0.1
0.2
0.3
0.1
0.2
0.2
0.1
0.2
0.2
0.1
0.1
0.2
0.1

5.9
6.0
3.7
6.8
3.7
6.2
4.8
3.4
4.9
6.2
6.6
3.8
7.2
4.1
0.5
2.1
5.5
6.2
3.0
6.9
5.4
3.2
5.7
5.7
3.6
5.7
4.1
6.0
6.6
4.0
6.8
8.8
5.2
3.6
5.8
5.0
1.8
3.5
2.7
5.8
4.2
3.1
4.5
3.7
2.8
3.9
4.0
7.1
5.6
5.5
7.2
5.8

0.1
0.1
0.3
0.1
0.3
0.1
0.1
0.3
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.2
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.2
0.1
0.1
0.0
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
0.0
0.0
0.0
0.0

0.1
0.1
0.2
0.1
0.2
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.2
0.2
0.2
0.1
0.1
0.1
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1

0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.0

0.1
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.2
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.2
0.1
0.1
0.2
0.1
0.1
0.0
0.0
0.0
0.1
0.1

2853
1206
186
1010
235
2578
1424
94
1317
271
2971
196
2720
337
3
60
270
6148
430
5636
59765
3671
54695
3431
212
3109
766
1001
4735
227
4453
474
6508
433
5794
17144
469
1121
809
14573
823
162
656
3301
258
2974
300
222
1474
982
748
1563

2899
1214
191
1013
242
2617
1470
96
1361
281
3036
204
2777
348
3
61
280
6382
448
5848
61379
3832
56118
3526
220
3194
805
1022
4820
236
4527
482
6653
445
5923
17555
478
1156
824
14924
854
175
674
3460
277
3111
306
225
1512
1013
766
1611

0.4
0.0
0.0
0.1
0.0
0.1
0.1
0.0
0.0
0.1
0.1
0.0
0.1
0.2
0.1
0.1
0.1
0.0
0.0
0.0

2.7
1.0
2.4
0.8
0.3
0.5
3.5
0.5
0.1
0.6
0.9
0.6
0.3
4.6
4.8
1.6
1.6
1.7
3.0
2.0
1.9
1.1
1.6
1.3
1.2
1.6
1.6
1.7
1.2

0.4
0.0
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.1
0.0
0.1

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.3
0.1
0.2
0.0
0.4
0.0
0.0
0.3
0.1
0.1
0.1
0.0
0.1
0.0
0.2
0.0
0.0
0.0
0.0
0.0
0.1
0.0

0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
0.0
0.0
-

0.2
0.0
0.1
1.8
1.7
0.3
0.2
0.0
0.4
1.0
0.0
0.2
0.1
0.5
0.4
0.5
0.0
0.5
0.3
0.3
0.4
0.4
0.2
0.3
0.3

20
74
768
13
41
465
29
100
64
2
140
36
156
48
12
1091
1051
26
89
120
193
327
256
676
175
1620
131
115
59
67
85

21
95
803
15
45
609
37
100
86
2
182
37
225
61
13
1153
1101
26
112
143
207
423
291
937
216
1935
176
139
67
77
104

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

699

*
*
*
*
*

*
*
*
*

757

Age-standardized (world) incidence rates (per 100,000)


by histological type

Bladder (C67) - Female (Contd)


Carcinoma

Squamous Transitional Adeno Other Unspec.


Asia (Contd)
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland (data not available)
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg (data not available)
Germany, Free State of Saxony (data not available)
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania (data not available)
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio
Italy, Syracuse Province
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce (data not available)
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg

700

Number of cases
MV

Total

0.0
0.1
0.1
0.3
0.0
0.2
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.1

0.8
1.7
1.2
2.0
2.2
1.0
0.4
1.5
2.3
0.7
1.6
1.6
0.8
1.8
1.8
1.0
0.6
2.0
1.8

0.1
0.1
0.2
0.2
0.1
0.2
0.1
0.1
0.1
0.2
0.2
0.0
0.1
0.1
0.0

0.0
0.0
0.0
0.0
-

0.0
0.4
0.1
0.0
0.2
0.1
0.1
0.0
0.0
0.1
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
0.0
0.0
0.0

0.3
0.3
0.2
0.4
0.3
0.2
0.1
0.2
0.0
0.3
0.1
0.1
0.1
0.3
0.4
0.1
0.3
0.1

11
472
20
21
12
37
26
35
46
81
172
151
3
18
82
28
21
63
165

16
548
24
27
14
39
30
36
47
102
181
159
3
19
96
39
23
72
175

0.1
0.0
0.1
0.0
0.1
0.1
0.0
0.0
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.1
0.1
0.2
0.1
0.1
0.3
0.4
0.1
0.0
0.2
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.2
0.2
0.1
0.0
0.1
0.1
0.0
0.1

4.5
6.6
4.2
1.3
3.5
4.2
1.7
2.3
4.6
6.6
2.4
1.8
1.3
1.8
2.3
2.2
1.6
1.7
1.8
2.1
2.1
1.4
4.6
4.5
4.3
2.7
5.7
4.1
6.1
4.6
6.2
6.5
5.6
5.3
4.8
5.5
4.9
3.7
6.0
4.2
5.8
5.8
3.9
3.4
8.9
3.5
6.2
5.3
4.3
5.8
1.4
1.4
4.4
4.9
2.6
2.8
3.3
2.5
1.1

0.1
0.1
0.3
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.1
0.1
0.0
0.1
0.0
0.1
0.0
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.0
0.2
0.1
0.1
0.1
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.0
0.1

0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0

0.3
0.2
0.2
0.0
0.1
0.4
0.0
0.4
0.1
0.1
0.2
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.5
0.0
0.8
0.2
0.3
0.1
0.1
0.0
0.1
0.2
0.5
0.2
0.2
0.1
0.0
0.1
0.1
0.0
0.1
0.0
0.0
0.3
0.1
0.1
0.1
0.2
0.1
0.1
0.2
0.1
0.1
0.1
0.3

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.3
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0

0.3
0.6
0.2
0.3
0.0
0.2
0.5
1.0
0.3
0.4
0.2
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.0
0.0
0.1
0.3
0.1
0.1
0.0
0.3
0.2
0.8
0.4
0.5
1.2
0.3
0.6
0.2
1.4
0.2
0.2
0.8
0.3
0.6
0.9
0.5
0.8
0.2
0.3
0.4
0.3
0.3
0.7
0.7
0.0
0.1
0.9
1.0
0.1
0.4
0.7

2415
245
75
779
392
1342
757
719
2502
1960
243
129
63
63
103
148
120
144
70
70
76
56
518
693
760
245
71
667
88
178
170
493
261
69
467
246
86
630
181
72
179
410
184
98
88
60
439
339
143
634
313
430
84
1282
73
289
572
480
430

2560
249
81
865
393
1467
992
983
2731
2156
268
135
67
64
108
148
127
147
70
76
78
56
646
769
909
262
72
721
93
212
195
551
339
75
536
253
122
687
196
85
188
455
223
115
97
65
469
364
155
672
381
545
85
1341
146
384
583
556
666

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

758

Sarcoma Other Unspec.

Cancer Incidence in Five Continents Vol. IX, IARC 2008

*
*
*

*
*
*
*

*
*
*

Europe
Serbia
Slova
Slove
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Switz
Switz
Switz
Switz
Switz
Switz
Switz
The N
The N
The N
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, N
UK, S
Oceani
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Frenc
New Z
USA,
USA,
USA,
USA,
USA,
USA,

*
*

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Bladder (C67) - Female (Contd)

Carcinoma

6
8
4
7
4
9
0
6
7
2
1
9
3
9
6
9
3
2
5

0
9
1
5
3
7
2
3
1
6
8
5
7
4
8
8
7
7
0
6
8
6
6
9
9
2
2
1
3
2
5
1
9
5
6
3
2
7
6
5
8
5
3
5
7
5
9
4
5
2
1
5
5
1
6
4
3
6
6

*
*
*

*
*
*
*

*
*
*

Squamous Transitional Adeno Other Unspec.


Europe (Contd)
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, England, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern And Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory (data not available)
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Sarcoma Other Unspec.

Number of cases
MV

Total

0.1
0.1
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.3
0.0
0.4
0.0
0.2
0.1
0.2
0.2
0.2
0.2
0.3
0.2
0.2
0.2
0.2
0.3
0.2
0.3

2.9
2.9
2.8
2.5
3.3
4.2
2.3
2.9
4.3
2.8
3.7
4.7
4.9
3.5
4.7
5.8
2.1
2.4
2.6
3.1
4.4
3.0
2.8
5.5
5.4
5.5
5.6
6.8
6.9
3.8
5.3
4.3
6.1
5.3
2.2
6.5

0.2
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.2
0.0
0.0
0.2
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.0
0.1

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0

0.0
0.0
0.0
0.2
0.1
0.1
0.0
0.1
0.1
0.0
0.2
0.2
0.1
0.1
0.1
0.4
0.1
0.2
0.1
0.0
0.0
0.1
0.1
0.1
0.3
0.4
0.6
0.3
0.3
0.2
0.4
0.5
0.3
0.1
0.2

0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1

0.0
0.0
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.6
0.3
0.1
0.2
0.2
0.3
0.2
0.3
0.2
0.0
0.3
0.2
0.3
0.1
0.0
0.1
0.1
0.1
0.3
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.2
0.1
0.0
1.0
0.1
0.1
0.1
0.5
0.3

803
677
339
53
262
402
156
46
152
129
231
142
146
191
2683
135
34
31
91
72
69
123
2620
269
262
957
872
1685
2814
569
2514
3671
1750
1731
244
2036

947
765
350
58
289
451
173
54
165
133
246
158
161
202
2691
140
38
33
99
74
71
132
2682
272
263
1039
962
1883
3041
624
3062
4242
2015
1881
293
2203

0.1
0.1
0.2
0.2
0.2
0.1
0.2
0.1
0.1
0.4
0.2

3.0
4.7
5.6
5.6
1.7
2.1
3.1
2.8
3.9
2.8
1.1
1.7
3.4
2.2
4.3

0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.2
0.2
-

0.0
0.0
0.0
0.0
0.0
-

0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.0
0.0
-

0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
0.1
0.2
0.2
0.0
0.5
0.2
0.0
0.1
0.0

1014
726
456
135
492
194
31
11
732
179
12
14
21
54
61

1089
791
474
141
547
213
34
13
778
182
12
14
22
54
62

*
*

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

701

759

Age-standardized (world) incidence rates (per 100,000)


by histological type

Eye (C69) - Male


Retinoblastoma Melanoma

Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Non-Hispanic White
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Georgia: Black
USA, Georgia: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
USA, Louisiana: Black
USA, Louisiana: White
USA, Maine
USA, Massachusetts

Carcinoma

Squamous Other Unspec.

702

Number of cases
MV

Total

0.1
0.1
0.1
0.2

0.0
-

0.1
0.3
0.2
1.6
3.4

0.0
0.0
0.1

0.0
0.0

0.0
0.0

0.0
-

0.0
0.0
0.4
-

4
21
3
48
140

4
24
3
56
141

0.0
0.2
0.4
0.3
0.1
0.2
0.2

0.2
0.0
0.3
0.3
0.2
0.1
0.1
-

0.8
0.7
0.4
0.4
0.2
0.3
0.4
0.4
0.1
0.4

0.2
0.2
0.1
0.1
0.0
-

0.2
0.1
0.0
0.0
0.0
-

0.2
0.1
0.0
0.0
0.0
-

0.0
-

0.6
0.1
0.0
0.2
0.1
0.1
-

3
34
8
19
257
3
32
54
20
1
7

3
38
8
19
310
3
33
60
21
1
7*

0.1
0.2
0.1
0.2
0.1
0.2
0.1
0.1
0.0
0.1
0.4
0.1
0.2
0.2
0.2
0.2
0.2
0.1
0.2
0.2
0.2
0.3
0.9
0.2
0.2
0.1
0.2
0.2
0.1
0.1
0.1
0.4
0.4
0.5
0.2
0.2
0.2
0.2
0.1
0.1
0.2
0.2
0.2
0.1
0.2
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.2
0.1

0.5
0.5
0.5
0.5
0.4
0.4
0.3
0.5
0.2
0.6
0.3
0.0
0.3
0.2
0.4
0.4
0.5
0.1
0.2
0.7
0.3
0.1
0.1
0.5
0.1
0.0
0.1
0.6
0.5
0.4
0.4
0.5
0.0
0.6
0.3
0.3
0.4
0.4
0.3
0.4
0.0
0.5
0.5
0.6
0.6
0.5
0.6
0.1
0.6
0.5
0.7

0.1
0.1
0.0
0.1
0.0
0.1
0.0
0.1
0.2
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.2
0.2
0.2
0.0
0.2
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.2
0.0
0.1
0.1
0.0

0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.2
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0

360
47
39
14
9
9
0
15
205
3
19
43
2
40
6
79
542
108
2
1
2
0
10
86
136
3
1
0
44
0
82
17
12
100
394
55
46
2
44
3
2
1
269
16
241
92
25
2
20
14
76
13
172
11
148
73
63
83
65
2
12
5
59
18
53

555
61
91
23
10
9
0
18
312
3
28
64
4
59
9
100
718
143
2
1
2
0
15
114
165
3
2
0
49
1
0
104
20
13
117
544
82
62
2
60
3
2
1
482
23
441
121
32
2
27
16
103
17
235
12
208
126
85
109
88
2
17
9
78
33
159

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

760

Sarcoma Other Unspec.

Cancer Incidence in Five Continents Vol. IX, IARC 2008

*
*
*
*

Americ
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
Asia
Bahra
China
China
China
China
China
China
Cypru
India,
India,
India,
India,
India,
India,
India,
Israel
Israel
Israel
Japan
Japan
Japan
Japan
Japan
Japan
Japan
Korea
Korea
Korea
Korea
Korea
Korea

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Eye (C69) - Male (Contd)


Retinoblastoma Melanoma

es

al

4
24
3
56
41

*
*
*
*

3
38
8
19
10
3
33
60
21
1
7*

55
61
91
23
10
9
0
18
12
3
28
64
4
59
9
00
18
43
2
1
2
0
15
14
65
3
2
0
49
1
0
04
20
13
17
44
82
62
2
60
3
2
1
82
23
41
21
32
2
27
16
03
17
35
12
08
26
85
09
88
2
17
9
78
33
59

America, North (Contd)


USA, Michigan
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Michigan: Black
USA, Michigan: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York state
USA, New York state: Black
USA, New York state: White
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 registries)
USA, SEER (9 registries): Black
USA, SEER (9 registries): White
USA, SEER (14 registries)
USA, SEER (14 registries): Asian and Pacific Islander
USA, SEER (14 registries): Black
USA, SEER (14 registries): Hispanic White
USA, SEER (14 registries): Non-hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, New Delhi
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon

Carcinoma

Squamous Other Unspec.

Sarcoma Other Unspec.

Number of cases
MV

Total

0.2
0.3
0.2
0.3
0.2
0.2
0.1
0.2
0.1
0.2
0.1
0.2
0.1
0.1
0.5
0.1
0.1
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.2
0.1
0.2
0.2
0.2
0.1
0.2
0.1
0.2
0.2
0.1
0.1
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.2

0.4
0.3
0.1
0.4
0.1
0.4
0.6
0.6
0.6
0.5
0.1
0.6
0.3
0.1
0.4
0.5
0.0
0.6
0.5
0.0
0.5
0.4
0.0
0.5
0.5
0.7
0.6
0.1
0.6
0.5
0.5
0.0
0.5
0.5
0.1
0.1
0.1
0.6
0.3
0.4
0.4
0.0
0.5
0.7
0.3
0.6
0.6
0.6
0.7

0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.2
0.2
0.1
0.2
0.1
0.0
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.0
0.1
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

150
60
7
51
8
136
88
3
82
16
124
7
110
25
3
7
15
283
22
254
3312
143
3002
168
8
153
54
56
210
7
194
9
394
14
352
1141
34
38
125
909
46
7
38
302
10
284
30
3
89
62
42
125

188
66
7
57
9
170
138
4
130
25
190
9
174
34
3
8
23
438
25
403
4871
180
4491
221
8
206
85
94
324
10
304
20
530
14
486
1546
37
46
151
1271
66
8
57
387
13
366
51
9
143
95
53
157

0.1
0.2
0.1
0.2
0.1
0.3
0.2
0.0
0.1
0.1
0.0
0.2
0.2
0.2
0.3
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.1

0.0
0.0
0.1
0.0
0.1
0.0
0.2
0.2
0.1
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.1

0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0

0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.1
0.2
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.0

0
12
31
1
1
22
5
4
21
1
31
12
82
6
4
60
50
6
3
0
4
21
6
16
3
153
10
14
10
6
11

0
13
32
1
2
28
5
6
23
1
37
13
95
7
4
76
59
7
3
0
4
21
6
21
4
206
13
14
14
9
14

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

703

*
*
*
*
*

*
*
*
*

761

Age-standardized (world) incidence rates (per 100,000)


by histological type

Eye (C69) - Male (Contd)


Retinoblastoma Melanoma

Asia (Contd)
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland (data not available)
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg (data not available)
Germany, Free State of Saxony (data not available)
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania (data not available)
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio
Italy, Syracuse Province
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce (data not available)
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg

Carcinoma

Squamous Other Unspec.

704

Number of cases
MV

Total

0.1
0.3
0.1
0.1
0.1
0.1
0.1
0.1
0.3
0.1
0.1
0.2
0.1
0.2
0.3
0.0
0.1

0.1
0.1
0.0
0.3
0.0
0.1
0.1
0.1
0.0
0.0
0.1
0.0
0.1
0.2
0.1

0.1
0.0
0.1
0.1
0.3
0.2
0.0
0.0
0.0
0.2
0.1
0.2
0.2
0.0

0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0

0.0
0.0
-

0.0
0.0
0.0
0.1
0.0
0.0

0.1
0.1
0.1
0.0
0.0
0.1
0.0
0.2
0.2
0.0
-

2
46
7
2
6
4
11
12
22
33
13
11
1
1
14
3
13
10
19

3
53
9
4
7
4
15
12
23
40
15
12
2
1
17
4
13
10
20

0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.2
0.1
0.1
0.2
0.1
0.2
0.1
0.3
0.2
0.3
0.0
0.2
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.6
0.1
0.1
0.1
0.4
0.1
0.1
0.2
0.2
0.1

0.3
0.5
0.5
0.5
0.3
0.4
0.2
0.3
0.5
0.8
0.8
0.6
0.2
0.6
0.5
0.3
0.5
0.6
0.4
0.7
0.5
0.2
0.4
0.1
0.4
0.5
0.3
0.6
0.3
0.3
0.1
0.4
0.3
0.3
0.3
0.3
0.2
0.3
0.3
0.2
0.5
0.4
0.3
0.2
0.4
0.7
0.3
0.3
0.5
0.5
0.4
0.4
0.1
0.7
0.5
0.2
0.2
0.3
0.3

0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.2
0.0
0.1
0.1
0.1
0.1
0.0
0.0
0.2
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.2
0.1
0.1
0.0
0.2
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.1
-

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0

0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.1
0.1
0.0
0.2
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
-

0.0
0.0
0.1
0.1
0.0
0.1
0.0
-

0.0
0.1
0.1
0.0
0.0
0.3
0.1
0.2
0.0
0.1
0.2
0.0
0.1
0.0
0.0
0.1
0.2
0.0
0.0
0.1
0.3
0.1
0.1
0.1
0.0
0.1
0.3
0.0
0.3
0.1
0.1
0.2
0.2
0.1
0.0
0.2
0.1
0.0
0.1
0.0
0.0
0.0
0.1

83
12
6
192
19
80
107
56
194
161
34
12
8
9
5
19
13
14
9
8
7
12
19
18
39
27
5
64
1
10
1
13
5
1
10
6
5
41
6
4
13
24
11
5
3
4
10
16
10
24
47
58
3
95
14
15
48
41
51

104
12
7
201
20
102
115
101
236
217
41
27
10
15
19
19
26
32
12
16
10
14
29
41
49
27
5
96
2
15
3
28
10
2
18
10
5
58
7
5
15
29
16
5
3
8
18
22
13
40
54
64
3
141
16
16
50
45
56

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

762

Sarcoma Other Unspec.

Cancer Incidence in Five Continents Vol. IX, IARC 2008

*
*
*

*
*
*
*

*
*
*

Europe
Serbia
Slova
Slove
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Switz
Switz
Switz
Switz
Switz
Switz
Switz
The N
The N
The N
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, N
UK, S
Oceani
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Frenc
New Z
USA,
USA,
USA,
USA,
USA,
USA,

*
*

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Eye (C69) - Male (Contd)


Retinoblastoma Melanoma

es

al

3
53
9
4
7
4
15
12
23
40
15
12
2
1
17
4
13
10
20

04
12
7
01
20
02
15
01
36
17
41
27
10
15
19
19
26
32
12
16
10
14
29
41
49
27
5
96
2
15
3
28
10
2
18
10
5
58
7
5
15
29
16
5
3
8
18
22
13
40
54
64
3
41
16
16
50
45
56

*
*
*

*
*
*
*

*
*
*

Europe (Contd)
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, England, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern And Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory (data not available)
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Carcinoma

Squamous Other Unspec.

Sarcoma Other Unspec.

Number of cases
MV

Total

0.0
0.1
0.1
0.2
0.1
0.1
0.4
0.1
0.1
0.4
0.6
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.1
0.1
0.1
0.2
0.1
0.1

0.1
0.6
0.5
0.6
0.3
0.3
0.2
0.1
0.2
0.4
0.2
0.2
0.2
0.3
0.5
0.2
0.9
0.6
0.3
0.1
0.4
0.3
0.5
0.9
0.3
0.4
0.4
0.6
0.5
0.5
0.4
0.5
0.5
0.3
0.3
0.5

0.1
0.1
0.0
0.2
0.0
0.1
0.3
0.1
0.2
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1

0.0
0.0
0.0
0.0
0.0
0.1
0.2
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
0.1
0.0
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0

0.0
0.0
0.0
-

0.3
0.0
0.1
0.1
0.0
0.0
0.0
0.3
0.0
0.0
0.0
0.0
0.0
0.3
0.0
0.0
0.1
0.0

42
105
35
8
14
26
23
2
7
13
10
8
7
14
192
5
9
5
5
3
4
10
303
32
11
37
37
88
98
43
119
158
74
69
24
108

86
115
35
9
16
30
23
2
9
15
12
10
7
15
291
7
9
5
6
4
6
11
357
35
11
51
47
107
147
63
204
265
110
82
32
129

0.2
0.2
0.3
0.2
0.1
0.2
0.6
0.2
0.1
0.4
-

0.6
0.8
1.1
0.4
0.6
0.6
1.0
0.2
0.7
0.0
0.1

0.3
0.5
0.1
0.5
0.2
0.3
0.1
0.2
0.1
0.1
0.5
0.0
0.3

0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.1
-

0.0
0.0
0.0
0.0
0.1
0.0
-

0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.4
-

0.0
0.0
-

0.1
0.0
0.1
-

166
132
53
15
136
62
5
6
130
12
0
1
4
3
4

225
170
76
17
149
65
9
6
137
12
0
1
4
3
4

*
*
*Important. See note on population page.
Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

705

763

Age-standardized (world) incidence rates (per 100,000)


by histological type

Eye (C69) - Female


Retinoblastoma Melanoma

Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Non-Hispanic White
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Georgia: Black
USA, Georgia: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
USA, Louisiana: Black
USA, Louisiana: White
USA, Maine
USA, Massachusetts

Carcinoma

Squamous Other Unspec.

706

Number of cases
MV

Total

0.1
0.1
0.2

0.1
0.1

0.0
0.1
1.6
3.0

0.1

0.1
-

0.0
0.0

0.1
-

0.2
0.3

0
13
2
51
111

0
14
2
60
117

0.1
0.3
0.3
0.3
0.2
0.3
0.1

0.1
0.0
0.2
0.1
0.3
0.2
0.1
0.1
0.0
0.1

0.0
0.2
0.1
0.5
0.2
0.3
0.1
0.1
0.2

0.0
0.1
0.0
0.0
-

0.0
0.0
0.0
0.1

0.1
0.0
0.0
0.1
0.0
-

0.2
-

0.6
0.0
0.3
0.0
0.1
0.1
-

3
16
3
17
229
3
31
30
19
0
6

4
32
3
18
300
3
32
35
21
0
6*

0.1
0.1
0.1
0.0
0.2
1.5
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.2
0.1
0.0
0.0
0.2
0.1
0.2
0.2
0.2
0.2
0.1
0.2
0.1
0.1
0.1
0.2
0.2
0.3
0.1
0.1
0.2
0.2
0.1
0.2
0.1
0.1
0.2
0.2
0.2
0.1
0.2
0.2
0.2
0.1
0.0

0.4
0.4
0.4
0.3
0.3
0.3
0.3
0.4
0.2
0.3
0.2
0.0
0.2
0.1
0.3
0.4
0.4
0.1
0.1
0.4
0.5
0.3
0.0
0.1
0.5
0.0
0.0
0.2
0.5
0.7
0.4
0.1
0.4
0.1
0.1
0.4
0.1
0.5
0.2
0.2
0.3
0.0
0.3
0.4
0.3
0.0
0.3
0.4
0.5
0.5
0.3
0.2
0.5
0.1
0.5
0.7
0.5

0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

270
38
27
12
12
7
1
11
149
2
11
28
5
23
2
54
375
85
1
0
1
0
10
71
81
2
1
1
23
0
52
9
5
66
281
45
51
3
48
4
2
1
214
6
200
67
20
5
14
10
55
13
132
11
113
52
55
69
45
3
8
6
39
8
45

454
46
73
17
14
7
1
14
259
2
21
45
5
40
3
80
547
112
1
0
2
0
12
92
120
3
1
1
29
0
0
83
13
6
86
420
107
81
3
77
4
2
1
412
11
387
91
28
5
22
10
79
20
185
11
164
97
73
90
75
3
15
7
68
40
145

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

764

Sarcoma Other Unspec.

Cancer Incidence in Five Continents Vol. IX, IARC 2008

*
*
*
*

Americ
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
Asia
Bahra
China
China
China
China
China
China
Cypru
India,
India,
India,
India,
India,
India,
India,
Israel
Israel
Israel
Japan
Japan
Japan
Japan
Japan
Japan
Japan
Korea
Korea
Korea
Korea
Korea
Korea

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Eye (C69) - Female (Contd)


Retinoblastoma Melanoma

es

al

0
14
2
60
17

*
*
*
*

4
32
3
18
00
3
32
35
21
0
6*

54
46
73
17
14
7
1
14
59
2
21
45
5
40
3
80
47
12
1
0
2
0
12
92
20
3
1
1
29
0
0
83
13
6
86
20
07
81
3
77
4
2
1
12
11
87
91
28
5
22
10
79
20
85
11
64
97
73
90
75
3
15
7
68
40
45

America, North (Contd)


USA, Michigan
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Michigan: Black
USA, Michigan: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York state
USA, New York state: Black
USA, New York state: White
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 registries)
USA, SEER (9 registries): Black
USA, SEER (9 registries): White
USA, SEER (14 registries)
USA, SEER (14 registries): Asian and Pacific Islander
USA, SEER (14 registries): Black
USA, SEER (14 registries): Hispanic White
USA, SEER (14 registries): Non-hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, New Delhi
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon

Carcinoma

Squamous Other Unspec.

Sarcoma Other Unspec.

Number of cases
MV

Total

0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.4
0.1
0.1
0.1
0.1
0.3
0.2
0.2
0.2
0.1
0.1
0.1
0.2
0.2
0.2
0.2
0.0
0.1
0.2
0.1
0.1
0.2
0.1
0.2
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.2
0.2
0.2
0.1
0.1
0.3
0.2
0.0
0.2

0.3
0.3
0.0
0.4
0.0
0.4
0.3
0.4
0.5
0.4
0.4
0.3
0.1
0.5
0.4
0.0
0.5
0.4
0.0
0.4
0.4
0.0
0.4
0.4
0.6
0.5
0.1
0.5
0.5
0.4
0.0
0.4
0.4
0.0
0.0
0.2
0.5
0.2
0.0
0.2
0.3
0.0
0.3
0.5
0.3
0.5
0.4
0.4
0.5

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0

116
47
4
42
4
107
70
1
69
17
98
3
90
24
1
8
15
246
15
221
2552
114
2319
146
7
136
40
34
153
12
138
9
343
13
314
872
22
29
89
711
21
1
19
222
14
199
19
5
92
59
23
106

153
58
5
51
5
141
99
1
98
23
172
3
162
35
1
10
24
416
17
389
4121
128
3816
213
7
201
67
84
274
13
258
22
483
14
448
1291
27
32
113
1087
45
1
39
301
14
274
38
12
131
82
37
128

0.1
0.2
0.2
0.0
0.1
0.2
0.1
0.3
0.1
0.2
0.1
0.1
0.0
0.3
0.1
0.3
0.2
0.1
0.1
0.1
0.1
0.1
0.1

0.0
0.0
0.0
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.2
0.2
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.0

0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0

0.0
0.0
0.2
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.0

1
9
24
1
2
14
6
5
19
1
32
14
31
3
4
49
45
4
1
2
2
6
6
23
1
133
11
8
3
8
9

1
11
26
1
2
18
6
5
19
1
33
14
39
3
4
65
57
4
3
2
3
6
8
24
1
177
13
9
5
8
10

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

707

*
*
*
*
*

*
*
*
*

765

Age-standardized (world) incidence rates (per 100,000)


by histological type

Eye (C69) - Female (Contd)


Retinoblastoma Melanoma

Asia (Contd)
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland (data not available)
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg (data not available)
Germany, Free State of Saxony (data not available)
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania (data not available)
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio
Italy, Syracuse Province
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce (data not available)
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg

Carcinoma

Squamous Other Unspec.

708

Number of cases
MV

Total

0.2
0.1
0.2
0.1
0.2
0.1
0.2
0.1
0.1
0.2
0.1
0.1
0.1
0.2

0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.2

0.0
0.3
0.2
0.2
0.0
0.1
0.1
0.1

0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.1
0.0

0.0
0.0

0.0
0.1
0.7
0.0
0.0
0.1
0.1
0.0

0
44
1
0
2
3
10
12
10
27
7
5
0
2
3
4
7
6
31

0
51
2
0
4
4
12
12
10
36
7
5
0
2
4
4
7
8
37

0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.4
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.5
0.2
0.1
0.2
0.1
0.1
0.3
0.2
0.1
0.2
0.1
0.6
0.1
0.1
0.1
0.4
0.1

0.2
0.5
0.3
0.5
0.1
0.4
0.2
0.2
0.4
0.6
0.6
0.6
0.1
0.7
0.5
0.2
1.0
0.3
0.4
0.6
0.1
0.2
0.2
0.1
0.2
0.3
0.3
0.7
0.3
0.2
0.5
0.3
0.2
0.6
0.2
0.4
0.2
0.2
0.1
0.4
0.2
0.2
0.1
0.1
0.3
0.2
0.4
0.1
0.4
0.4
0.4
0.1
0.6
0.3
0.2
0.2
0.2
0.3

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
-

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
0.1
0.0
0.1
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.1
-

0.0
0.0
0.1
0.0
0.0
-

0.0
0.3
0.1
0.0
0.0
0.4
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.2
0.1
0.1
0.2
0.1
0.0
0.0
0.1
0.5
0.0
0.3
0.2
0.3
0.0
0.0
0.1
0.0
0.0
0.2
0.1
0.0
0.0
0.1
0.1
0.0
0.0
0.2

86
8
3
237
12
95
107
54
179
133
35
13
7
8
8
13
13
12
7
8
0
7
20
20
26
20
3
67
1
4
14
10
4
3
10
14
3
29
3
1
4
9
2
2
0
5
6
9
5
18
52
75
8
108
8
20
40
42
86

111
13
5
259
12
118
118
146
222
180
42
23
8
17
19
13
45
18
7
16
3
10
28
41
39
21
3
109
4
10
18
23
6
4
23
18
4
52
5
4
7
20
11
2
1
6
14
21
6
42
57
91
9
147
10
27
41
48
101

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

766

Sarcoma Other Unspec.

Cancer Incidence in Five Continents Vol. IX, IARC 2008

*
*
*

*
*
*
*

*
*
*

Europe
Serbia
Slova
Slove
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Switz
Switz
Switz
Switz
Switz
Switz
Switz
The N
The N
The N
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, N
UK, S
Oceani
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Frenc
New Z
USA,
USA,
USA,
USA,
USA,
USA,

*
*

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Eye (C69) - Female (Contd)


Retinoblastoma Melanoma

es

al

0
51
2
0
4
4
12
12
10
36
7
5
0
2
4
4
7
8
37

11
13
5
59
12
18
18
46
22
80
42
23
8
17
19
13
45
18
7
16
3
10
28
41
39
21
3
09
4
10
18
23
6
4
23
18
4
52
5
4
7
20
11
2
1
6
14
21
6
42
57
91
9
47
10
27
41
48
01

*
*
*

*
*
*
*

*
*
*

Europe (Contd)
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, England, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern And Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory (data not available)
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Carcinoma

Squamous Other Unspec.

Sarcoma Other Unspec.

Number of cases
MV

Total

0.1
0.1
0.1
0.2
0.1
0.6
0.2
0.1
0.2
0.1
0.1
0.4
0.5
0.2
0.3
0.2
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.1
0.1
0.1
0.0
0.1

0.1
0.5
0.3
0.2
0.2
0.2
0.1
0.2
0.1
0.1
0.2
0.3
0.2
0.4
0.2
0.3
0.4
0.4
0.1
0.1
0.2
0.4
0.2
0.3
0.4
0.3
0.2
0.5
0.3
0.3
0.4
0.3
0.2
0.1
0.6

0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.2
0.1
0.0
0.0
0.0
0.1
0.2
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1

0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.2
0.1
0.0
0.0
0.1
0.1
0.2
0.1
0.0
0.2
0.0
0.3
0.0
0.0
0.0
0.0

57
99
33
1
13
21
7
1
4
2
6
7
8
10
165
2
4
6
8
2
1
8
259
7
16
41
36
41
100
26
98
150
62
47
14
130

87
118
33
4
15
25
8
1
6
4
12
8
10
10
254
5
5
6
12
2
1
8
309
10
17
53
40
59
138
46
198
276
80
59
17
152

0.2
0.2
0.2
0.2
0.0
0.0
0.2
0.2
0.1
0.4
0.3

0.5
0.7
0.9
0.3
0.4
0.5
0.9
0.7
0.1
0.0
0.2

0.1
0.1
0.0
0.0
0.0
0.0
0.3
0.1
0.1
0.3

0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
0.1
-

0.0
0.0
0.0
-

0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.1
-

124
63
37
7
75
29
9
1
118
10
0
2
0
1
6

161
98
64
9
86
35
11
1
124
11
0
2
0
1
7

*
*
*Important. See note on population page.
Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

709

767

Age-standardized (world) incidence rates (per 100,000)


by histological type

Brain and central nervous system (C71-72) - Male


Gliomas

Embryonal

Astro. Oligo. Epend. Other Medullobl.


Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Non-Hispanic White
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Georgia: Black
USA, Georgia: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
USA, Louisiana: Black
USA, Louisiana: White
USA, Maine
USA, Massachusetts

710

Other neuro Other Unspec.

Number of cases
MV

Total

0.5
1.9
2.3
0.2
0.5

0.1
0.1
-

0.1
0.1
0.0

0.1
0.2
0.1
0.2

0.0
0.2
0.3
-

0.0
0.3
0.0
0.1

0.0
-

0.1
1.3
0.4
0.2
0.4

22
149
31
4
21

26
227
35
9
45

2.2
2.7
1.8
2.9
3.3
0.9
3.0
1.8
2.4
1.7
3.0

0.3
0.1
0.1
0.5
0.2
0.3
0.2
0.4
0.3
-

0.4
0.1
0.1
0.2
0.2
0.4
0.2
0.1
0.1
0.1
0.1

0.0
0.1
0.1
0.1
0.4
0.1
0.2
0.1

0.2
0.4
0.1
0.1
0.3
0.2
0.2
0.3
0.3
0.1

0.1
0.1
0.2
0.2
0.1
0.0
0.0
0.1
-

0.0
0.0
-

0.4
0.7
0.8
0.0
0.0
0.1
0.0
0.0
-

0.4
3.7
3.3
1.4
3.3
2.4
1.3
1.3
0.7
0.2
0.9

22
176
26
65
1031
15
168
207
103
24
35

28
220
49
92
1747
34
213
309
123
27
47 *

3.8
3.9
3.9
3.9
4.7
5.1
2.6
5.2
3.4
3.1
3.8
4.0
2.2
4.5
3.7
3.9
4.0
3.8
2.6
1.7
1.5
3.0
2.5
4.8
3.6
1.9
2.4
1.0
2.9
2.7
0.6
5.2
1.8
2.2
3.1
5.1
4.1
4.7
2.1
4.9
4.0
3.8
3.5
4.1
2.7
4.4
4.3
4.3
2.4
5.2
2.6
4.8
5.7
3.9
2.3
4.2
4.3
4.5
4.4
3.7
2.3
3.7
2.4
4.1
5.4
4.7

0.8
0.9
0.7
1.2
0.7
0.5
0.7
0.8
0.5
0.8
0.3
0.1
0.4
1.3
0.6
0.6
0.7
0.4
0.6
0.3
0.4
0.6
0.9
0.5
0.3
0.9
0.4
0.2
0.9
0.8
0.4
0.3
0.4
0.8
0.8
0.7
0.4
0.7
0.4
0.5
0.2
0.6
0.2
0.6
0.4
0.5
0.4
0.5
0.3
0.5
0.9
0.6
0.2
0.7
0.5
0.7
0.3
0.5
0.5
0.8
0.2
0.6
0.5
0.8

0.2
0.2
0.2
0.1
0.2
0.1
0.1
0.2
1.0
0.2
0.2
0.2
0.0
0.3
0.2
0.2
0.1
0.1
0.2
0.3
0.2
0.1
0.4
0.3
0.2
0.2
0.2
0.1
0.2
0.2
0.3
0.3
0.4
0.3
0.4
0.1
0.1
0.2
0.1
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.4
0.2
0.1
0.2
0.2
0.2
0.2
0.2
0.3
0.2
0.2
0.4
0.3

0.4
0.5
0.3
0.6
0.7
0.4
0.3
0.4
0.1
0.3
0.5
0.4
0.6
0.2
0.4
0.3
0.3
0.4
0.2
0.1
0.4
0.2
0.1
0.3
0.2
0.1
0.2
0.2
0.2
0.3
0.4
0.3
0.6
0.5
0.6
0.3
0.3
0.2
0.4
0.4
0.4
0.4
0.5
0.5
0.6
0.3
0.4
0.4
0.3
0.2
0.3
0.4
0.4
0.5
0.5
0.4
0.4
0.4
0.6
0.4
0.4

0.2
0.2
0.1
0.0
0.1
0.2
0.3
0.2
0.3
0.2
0.2
0.1
0.3
0.1
0.3
0.2
0.2
0.1
0.1
0.2
0.3
0.2
0.0
0.2
0.2
0.3
0.1
0.1
0.2
0.3
0.3
0.3
0.4
0.3
0.1
0.1
0.3
0.2
0.3
0.3
0.3
0.2
0.5
0.1
0.4
0.5
0.2
0.2
0.2
0.3
0.3
0.1
0.2
0.1
0.1
0.1
0.3
0.1
0.3

0.2
0.1
0.3
0.1
0.7
0.1
0.2
0.1
0.2
0.1
0.2
0.1
0.1
0.2
0.2
0.2
0.3
0.2
0.8
0.2
0.2
0.3
0.3
0.2
0.4
0.1
0.2
0.2
0.2
0.1
0.1
0.1
0.5
0.4
1.2
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.2
0.1
0.2
0.1
0.1
0.2
0.2
0.1
0.1
0.4
0.1
0.2
0.1
0.1

0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0

0.2
0.1
0.1
0.1
0.1
0.1
0.0
0.3
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.2
0.2
0.3
0.2
0.1
0.1
0.3
0.1
0.6
0.2
0.1
0.2
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.3
0.1

0.6
0.1
0.2
0.1
0.3
0.2
0.3
1.1
0.2
0.2
0.3
0.2
0.3
0.3
0.2
0.2
0.1
0.2
0.1
0.2
0.1
0.2
0.3
0.1
0.2
0.2
0.1
0.1
0.2
0.2
0.2
0.4
0.1
0.1
0.2
0.2
0.2
0.5
0.4
0.5
0.2
0.1
0.1
0.1
0.1
0.2
0.2
0.2
0.3
0.2
0.1
0.2
0.2
0.3
0.1
0.2
0.2
0.3
0.2
0.2

3574
427
670
171
137
98
2
164
1721
20
164
643
79
556
86
760
4802
956
44
45
15
115
8
677
1158
64
27
16
338
11
9
667
285
182
888
3404
658
633
26
598
72
39
26
2726
189
2502
1112
377
74
293
166
928
262
1754
133
1565
917
514
599
574
32
81
98
470
261
1129

4488
503
760
222
168
110
2
200
2316
21
186
758
94
654
96
883
5396
1058
52
48
18
122
8
753
1291
74
30
17
374
12
9
743
326
210
985
3824
768
691
28
653
87
48
29
3275
235
2999
1253
417
88
316
193
1037
300
1997
158
1779
1039
582
697
684
39
92
121
555
298
1248

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

768

Other

Cancer Incidence in Five Continents Vol. IX, IARC 2008

*
*
*
*

Americ
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
Asia
Bahra
China
China
China
China
China
China
Cypru
India,
India,
India,
India,
India,
India,
India,
Israel
Israel
Israel
Japan
Japan
Japan
Japan
Japan
Japan
Japan
Korea
Korea
Korea
Korea
Korea
Korea

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Brain and central nervous system (C71-72) - Male (Contd)

es

Gliomas

al

26
27
35
9
45

*
*
*
*

28
20
49
92
47
34
13
09
23
27
47 *

88
03
60
22
68
10
2
00
16
21
86
58
94
54
96
83
96
58
52
48
18
22
8
53
91
74
30
17
74
12
9
43
26
10
85
24
68
91
28
53
87
48
29
75
35
99
53
17
88
16
93
37
00
97
58
79
39
82
97
84
39
92
21
55
98
48

Embryonal

Astro. Oligo. Epend. Other Medullobl.


America, North (Contd)
USA, Michigan
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Michigan: Black
USA, Michigan: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York state
USA, New York state: Black
USA, New York state: White
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 registries)
USA, SEER (9 registries): Black
USA, SEER (9 registries): White
USA, SEER (14 registries)
USA, SEER (14 registries): Asian and Pacific Islander
USA, SEER (14 registries): Black
USA, SEER (14 registries): Hispanic White
USA, SEER (14 registries): Non-hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, New Delhi
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon

Other

Other neuro Other Unspec.

Number of cases
MV

Total

4.2
4.1
2.1
4.7
2.2
4.5
4.3
2.5
4.5
4.3
4.3
2.6
4.5
3.5
0.6
3.5
4.1
4.2
2.5
4.6
4.2
2.4
4.5
4.4
2.8
4.5
4.1
4.4
4.6
2.3
4.7
4.7
4.2
2.4
4.7
4.1
2.0
2.3
3.2
4.8
4.2
2.4
4.8
3.9
2.6
4.0
4.6
4.6
4.7
4.5
4.4
4.3

0.9
1.0
0.6
1.1
0.5
1.0
0.7
0.6
0.7
0.9
0.6
0.1
0.6
0.7
0.9
0.4
0.9
0.7
0.3
0.8
0.6
0.3
0.7
0.6
0.1
0.6
0.5
1.1
0.5
0.2
0.5
0.8
0.8
0.4
0.8
0.6
0.4
0.3
0.4
0.8
0.5
0.2
0.5
0.6
0.3
0.6
0.9
0.9
0.9
0.9
0.8
0.8

0.3
0.2
0.1
0.3
0.1
0.3
0.2
0.1
0.2
0.3
0.3
0.3
0.3
0.3
0.2
0.1
0.3
0.3
0.2
0.3
0.2
0.1
0.3
0.3
0.2
0.3
0.2
0.3
0.2
0.2
0.2
0.3
0.2
0.2
0.3
0.2
0.1
0.2
0.2
0.3
0.2
0.1
0.2
0.3
0.1
0.3
0.2
0.2
0.2
0.2
0.2
0.3

0.4
0.4
0.4
0.4
0.3
0.5
0.3
0.1
0.3
0.5
0.4
0.3
0.5
0.2
0.2
0.3
0.5
0.4
0.5
0.4
0.3
0.4
0.4
0.4
0.4
0.3
0.5
0.4
0.1
0.4
0.1
0.5
0.4
0.5
0.4
0.2
0.3
0.3
0.5
0.3
0.4
0.3
0.4
0.4
0.4
0.4
0.5
0.6
0.8
0.5
0.2

0.2
0.3
0.2
0.3
0.3
0.3
0.4
0.2
0.4
0.5
0.2
0.1
0.2
0.2
0.2
0.4
0.3
0.2
0.3
0.3
0.2
0.3
0.3
0.2
0.3
0.3
0.2
0.2
0.1
0.2
0.2
0.3
0.2
0.3
0.2
0.2
0.1
0.2
0.3
0.3
0.1
0.3
0.3
0.2
0.3
0.3
0.3
0.3
0.4
0.2
0.2

0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.2
0.1
0.2
0.2
0.2
0.1
0.1
0.1
0.2
0.1
0.2
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.3
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.2
0.2
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
-

0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1

0.4
0.2
0.3
0.2
0.3
0.4
0.5
0.5
0.5
0.1
0.3
0.4
0.3
0.2
0.2
0.2
0.2
0.3
0.2
0.3
0.3
0.3
0.3
0.2
0.5
0.2
0.8
0.2
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.1
0.2
0.2
0.2
0.3
0.2
0.2
0.5
0.3
0.5
0.1
0.2
0.2
0.1
0.1
0.6

1666
668
88
563
118
1520
911
51
856
156
1378
96
1209
233
7
73
148
3066
222
2727
34783
2019
31584
1820
100
1661
545
617
2115
90
1956
192
4204
251
3719
10961
470
608
1187
8589
571
81
484
2882
191
2625
337
112
1048
692
303
937

1875
727
101
609
136
1709
1059
60
995
178
1580
116
1383
274
8
89
172
3499
260
3105
39855
2396
36100
2072
129
1882
651
715
2347
97
2177
208
4714
290
4161
12403
535
715
1330
9696
658
101
550
3426
236
3101
369
124
1222
813
352
1066

1.4
1.1
1.7
0.2
0.2
0.6
3.7
1.9
1.4
2.4
2.0
2.1
1.3
4.1
4.0
3.5
1.2
0.7
1.5
1.4
1.4
0.9
0.9
1.0
0.8
1.0
1.1
1.3
0.8

0.0
0.3
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.2
0.1
0.6
0.7
0.5
0.2
0.1
0.2
0.2
0.0
0.2
0.1
0.2
0.3
0.5
0.2

0.1
0.0
0.2
0.1
0.0
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.2
0.2
0.2
0.1
0.3
0.2
0.1
0.2
0.1
0.1
0.2
0.2
0.1
0.1

0.7
0.6
0.3
1.2
0.3
0.5
0.1
0.2
0.4
0.5
0.8
0.4
0.3
0.3
0.0
0.0
0.3
0.4
0.1
0.2
0.2
0.2
0.1
0.2
0.1
0.1
0.0
0.1

0.2
0.1
0.3
0.0
0.1
0.2
0.1
0.2
0.2
0.1
0.2
0.1
0.3
0.3
0.3
0.1
0.1
0.1
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.2
0.3

0.1
0.1
0.1
0.2
0.0
0.2
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.1

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0

0.2
0.0
0.2
2.3
0.1
0.0
0.2
0.0
0.3
0.1
0.0
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.3
0.0
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1

0.2
1.3
0.4
5.6
4.2
0.5
0.3
0.5
1.3
0.4
0.2
0.6
3.5
1.0
0.3
0.2
0.1
1.0
1.3
0.2
0.0
0.8
0.5
1.1
1.3
0.6
1.2
0.7
1.2

18
126
534
23
102
530
47
71
262
23
917
128
929
246
56
777
672
97
59
48
57
146
96
415
65
1787
143
113
73
78
106

23
168
613
44
130
1011
59
93
309
34
998
140
1069
271
85
927
786
107
88
80
69
184
104
649
95
2698
248
144
105
98
168

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

711

*
*
*
*
*

*
*
*
*

769

Age-standardized (world) incidence rates (per 100,000)


by histological type

Brain and central nervous system (C71-72) - Male (Contd)


Gliomas

Embryonal

Astro. Oligo. Epend. Other Medullobl.


Asia (Contd)
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland (data not available)
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg (data not available)
Germany, Free State of Saxony (data not available)
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania (data not available)
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio
Italy, Syracuse Province
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce (data not available)
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg

712

Other neuro Other Unspec.

Number of cases
MV

Total

1.6
1.1
0.9
2.4
1.6
1.2
0.7
1.5
1.7
1.0
0.9
0.9
1.5
0.8
0.6
0.4
0.6
3.1
2.8

0.4
0.3
0.3
0.1
0.1
0.1
0.3
0.1
0.2
0.3
0.1
0.2
0.1
0.3
0.6

0.1
0.1
0.2
0.1
0.0
0.0
0.4
0.2
0.0
0.2
0.3
0.1
0.1
0.1
0.0
0.2
0.4

0.1
0.1
0.3
0.1
0.4
0.0
0.3
0.3
0.5
0.0
0.0
0.0
0.5
0.4

0.2
0.3
0.3
0.1
0.1
0.1
0.2
0.2
0.1
0.2
0.2
0.2
0.1
0.1
0.1
0.4
0.3

0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.0
0.2
0.1
0.5
0.1
0.1
0.1
0.3
0.2

0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.0

0.1
0.2
0.1
0.4
0.0
0.1
0.1
0.0
0.0
0.0
0.1
0.1

0.3
1.4
0.8
1.7
0.8
1.3
0.4
0.5
0.1
0.8
0.3
0.3
0.1
0.1
0.6
0.5
0.6
0.9
0.3

20
491
37
41
47
45
48
72
109
139
145
114
16
15
35
10
25
160
365

22
759
48
66
58
74
67
82
114
280
164
131
17
16
56
21
43
191
415

3.7
3.4
3.9
2.2
3.4
3.9
2.3
2.7
3.3
3.8
3.9
2.1
2.6
2.1
2.5
2.3
3.4
3.0
1.6
3.1
2.5
2.5
3.9
3.5
4.2
3.8
4.3
4.6
1.3
3.1
3.5
3.0
3.1
2.8
2.6
2.1
2.9
2.6
4.1
2.7
2.1
3.4
2.5
2.4
2.0
2.9
2.5
3.3
3.5
3.5
2.7
3.9
3.5
4.2
3.1
2.4
3.1
2.8
2.0

0.2
0.1
0.7
0.3
0.4
0.6
0.2
0.3
0.4
0.5
0.3
1.4
1.5
2.2
1.0
1.5
1.4
1.1
1.2
0.8
1.0
0.4
0.5
0.3
0.2
0.5
0.3
0.4
0.1
0.4
0.7
0.1
0.3
0.4
0.3
0.3
0.3
0.4
0.5
0.4
0.2
0.5
0.1
0.1
0.3
0.6
0.2
0.2
0.3
0.6
0.2
0.3
0.1
0.9
0.4
0.4
0.6
1.1
0.1

0.3
0.1
0.2
0.1
0.2
0.3
0.1
0.1
0.2
0.3
0.3
0.0
0.2
0.1
0.4
0.3
0.3
0.3
0.1
0.0
0.2
0.3
0.2
0.1
0.3
0.8
0.1
0.2
0.1
0.6
0.5
0.4
0.1
0.2
0.3
0.7
0.1
0.1
0.0
0.1
0.2
0.1
0.6
0.3
0.3
0.1
0.2
0.1
0.2
0.1
0.2
0.4
0.1

0.3
0.2
0.3
0.1
0.1
0.3
0.1
0.5
0.2
0.2
0.0
0.5
0.5
0.2
1.3
0.5
0.6
0.7
0.6
0.6
0.3
0.2
0.2
0.1
0.1
0.7
0.4
0.4
0.4
0.2
0.4
1.1
0.3
1.1
0.3
0.5
0.3
1.1
0.3
0.7
0.8
0.4
0.1
0.7
0.5
0.3
0.4
0.4
0.5
0.2
0.6
0.4
0.2
0.7
0.3
0.2
0.1

0.3
0.2
0.2
0.3
0.2
0.3
0.2
0.2
0.2
0.3
0.3
0.4
0.3
0.3
0.2
0.6
0.1
0.3
0.3
0.2
0.8
0.4
0.2
0.3
0.5
0.1
0.3
0.1
0.1
0.8
0.2
0.4
0.2
0.2
0.4
0.4
0.8
0.3
0.3
0.1
0.4
0.2
0.4
0.2
1.0
0.5
0.0
0.3
0.1
0.3
0.2
0.2
0.3
0.2
0.2

0.2
0.0
0.0
0.1
0.0
0.2
0.1
0.2
0.1
0.1
0.0
0.3
0.1
0.2
0.0
0.2
0.0
0.2
0.2
0.4
0.0
0.0
0.3
0.2
0.1
0.0
0.1
0.1
0.2
0.2
0.0
0.2
0.0
0.1
0.6
0.0
0.2
0.1
0.0

0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.1
0.0

0.2
0.1
0.2
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.0
0.3
0.1
0.2
0.1
0.1
0.2
0.1
0.0
0.1
0.2
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.1

1.0
0.4
1.2
1.0
0.1
0.2
2.8
5.6
1.5
0.9
0.8
0.9
0.3
0.2
0.1
0.4
0.4
0.2
0.4
0.4
1.1
0.2
0.4
1.3
0.2
0.4
0.7
1.3
1.2
2.9
2.3
2.6
1.0
3.1
1.5
2.8
3.1
2.6
2.4
2.7
3.5
1.9
3.2
3.4
2.1
2.7
2.9
2.0
2.4
1.3
2.9
1.4
0.9
0.4
2.4
2.4
0.3
2.6
2.0

1270
86
51
856
254
832
731
607
1404
876
188
124
84
80
120
141
184
176
58
58
52
69
238
362
396
202
40
583
12
84
70
157
86
24
149
71
61
251
94
38
55
170
95
44
18
41
118
123
84
271
229
517
43
799
89
198
408
436
372

1524
100
62
1103
265
898
1529
1303
1853
1120
221
172
94
86
127
160
224
187
67
89
72
76
330
481
472
221
48
798
28
137
104
297
141
44
257
152
111
465
146
67
112
272
183
104
29
78
228
218
130
378
415
610
61
938
142
330
437
718
562

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

770

Other

Cancer Incidence in Five Continents Vol. IX, IARC 2008

*
*
*

*
*
*
*

*
*
*

Europe
Serbia
Slova
Slove
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Switz
Switz
Switz
Switz
Switz
Switz
Switz
The N
The N
The N
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, N
UK, S
Oceani
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Frenc
New Z
USA,
USA,
USA,
USA,
USA,
USA,

*
*

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Brain and central nervous system (C71-72) - Male (Contd)


Gliomas

es

al

22
59
48
66
58
74
67
82
14
80
64
31
17
16
56
21
43
91
15

24
00
62
03
65
98
29
03
53
20
21
72
94
86
27
60
24
87
67
89
72
76
30
81
72
21
48
98
28
37
04
97
41
44
57
52
11
65
46
67
12
72
83
04
29
78
28
18
30
78
15
10
61
38
42
30
37
18
62

*
*
*

*
*
*
*

*
*
*

Embryonal

Astro. Oligo. Epend. Other Medullobl.


Europe (Contd)
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, England, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern And Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory (data not available)
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Other

Other neuro Other Unspec.

Number of cases
MV

Total

5.0
2.9
3.3
3.6
3.7
3.8
3.8
4.0
3.2
3.1
2.6
3.5
2.6
3.1
3.5
4.7
5.7
3.1
3.6
4.9
3.5
4.0
3.5
3.2
4.1
3.6
3.9
3.8
4.3
4.1
3.4
3.9
3.9
4.1
3.4
4.1

0.2
0.3
0.4
0.1
0.2
0.4
0.6
0.4
0.1
0.3
0.2
0.3
0.3
0.3
0.5
0.9
0.3
0.3
0.6
0.2
0.4
0.6
0.6
0.7
0.4
0.5
0.6
0.3
0.4
0.3
0.5
0.4
0.3
0.4
0.4
0.6

0.1
0.3
0.2
0.1
0.3
0.1
0.0
0.2
0.2
0.2
0.6
0.1
0.4
0.5
0.5
0.1
0.2
0.2
0.3
0.4
0.6
0.3
0.2
0.2
0.3
0.1
0.2
0.3
0.2
0.2
0.4
0.1

0.6
0.1
0.2
1.7
0.6
0.3
0.5
0.6
0.5
0.3
0.9
1.0
1.1
0.4
0.3
0.1
0.3
0.3
0.1
0.3
0.2
0.2
0.4
0.7
0.9
0.6
0.9
1.1
0.9
1.1
1.0
0.6
0.3
0.6

0.3
0.3
0.5
0.2
0.2
0.1
0.4
0.1
0.5
0.6
0.1
0.3
0.3
0.3
0.4
0.6
0.5
0.5
0.2
0.2
0.2
0.1
0.3
0.4
0.1
0.3
0.2
0.2
0.2
0.3
0.2
0.2
0.3

0.3
0.1
0.1
0.1
0.0
0.5
0.2
0.1
0.4
0.2
0.9
0.1
0.5
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.1
0.0
0.1

0.0
0.0
0.1
0.0
0.2
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.2
0.4
0.1
0.1
0.0
0.0
0.1
0.0
0.3
0.2
0.1
0.2
0.1
0.3
0.1
0.1
0.0
0.0
1.1
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.0
0.1

2.2
1.6
0.6
0.5
0.4
1.3
0.4
0.8
1.7
0.6
1.2
0.8
1.7
0.7
0.2
0.9
1.2
1.2
0.7
0.5
0.7
0.4
0.7
0.5
0.5
0.4
0.2
0.2
0.3
0.4
1.8
0.4
0.4
0.2
2.0
0.6

976
593
319
24
151
281
192
18
79
99
116
74
65
118
1477
83
42
25
82
60
37
106
2394
148
160
425
370
521
1082
425
1041
1950
672
794
207
766

1279
856
326
62
218
392
237
50
127
121
186
139
106
144
1558
93
56
33
95
69
44
116
2836
171
182
564
585
723
1453
555
1648
2775
1050
1012
334
1063

4.5
4.4
5.1
4.9
4.8
4.4
4.4
1.2
4.4
2.7
0.6
1.3
3.5
2.1
4.7

0.5
0.5
0.2
0.5
0.5
0.5
0.1
0.2
0.7
0.3
0.5
0.3
0.3
0.4

0.2
0.3
0.2
0.5
0.4
0.2
0.6
0.2
0.2
0.1
0.2
0.1
0.5

0.6
0.5
0.6
0.2
0.2
0.3
0.7
0.5
0.4
0.3
0.4
0.1
0.3
0.1
0.4

0.3
0.2
0.4
0.1
0.2
0.2
0.6
0.8
0.4
0.5
0.6
0.4
1.6

0.0
0.1
0.1
0.1
0.1
0.3
0.1
0.1
0.3
-

0.0
0.0
0.0
0.0
0.1
0.3

0.1
0.1
0.1
0.1
0.1
0.9
0.1
0.1
0.6
0.5
0.1

0.1
0.1
0.1
0.7
0.9
0.2
1.1
0.6
0.1
0.1
0.0
0.1

1132
565
256
88
903
302
42
13
631
137
4
14
27
24
61

1299
673
329
105
1061
344
54
25
775
153
5
18
29
25
67

*
*

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

713

771

Age-standardized (world) incidence rates (per 100,000)


by histological type

Brain and central nervous system (C71-72) - Female


Gliomas

Embryonal

Astro. Oligo. Epend. Other Medullobl.


Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Non-Hispanic White
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Georgia: Black
USA, Georgia: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
USA, Louisiana: Black
USA, Louisiana: White
USA, Maine
USA, Massachusetts

714

Other neuro Other Unspec.

Number of cases
MV

Total

0.5
1.3
0.5
0.3
0.3

0.0
0.1
0.1
0.1
-

0.2
0.2
0.0

0.0
0.2
0.0

0.0
0.2
0.3
0.0

0.0
0.1
0.1
-

0.2
0.0
0.0
0.0

0.6
1.0
0.6
0.3
1.0

22
121
14
5
13

31
195
20
14
38

1.6
2.1
1.9
2.5
2.4
0.9
2.3
1.2
2.0
1.3
1.2

0.2
0.2
0.2
0.3
0.3
0.3
0.2
0.1
0.1

0.2
0.1
0.1
0.2
0.1
0.1
0.1
0.1
-

0.0
0.2
0.1
0.2
0.1
0.1
0.1
-

0.6
0.1
0.3
0.2
0.2
0.3
0.1
0.1
0.3
0.4

0.3
0.0
0.1
0.1
0.1
0.1

0.1
0.0
-

0.1
0.2
0.4
0.0
0.1
0.1
0.0
0.1

0.9
3.3
2.7
1.6
2.7
0.8
0.9
1.4
0.2
0.2
0.7

26
136
22
62
866
17
140
180
93
18
27

31
186
43
94
1617
23
183
289
104
21
37 *

2.5
2.5
2.6
2.2
3.0
2.8
1.8
3.1
2.3
3.1
2.8
2.9
1.4
3.4
2.7
2.7
2.7
2.7
1.1
1.3
1.4
2.6
1.0
3.4
2.4
2.0
1.5
1.0
2.3
0.5
0.8
3.3
1.2
1.6
2.4
3.4
2.9
3.1
1.8
3.3
2.4
2.0
2.5
2.9
1.6
3.1
2.8
2.6
1.5
3.3
1.6
3.3
3.5
2.8
1.3
3.1
3.2
3.4
3.2
2.6
1.9
2.8
1.8
3.0
3.4
3.1

0.6
0.5
0.6
0.5
0.5
0.2
0.7
0.6
1.2
0.5
0.4
0.1
0.5
0.8
0.6
0.4
0.5
0.1
0.5
0.2
0.5
0.6
0.3
0.3
0.4
0.3
0.4
0.4
0.5
0.3
0.2
0.3
0.5
0.6
0.7
0.1
0.7
0.4
0.1
0.5
0.4
0.1
0.5
0.3
0.4
0.1
0.5
0.1
0.5
0.6
0.5
0.2
0.6
0.4
0.6
0.4
0.3
0.3
0.4
0.2
0.4
0.6
0.7

0.2
0.2
0.2
0.2
0.3
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.3
0.3
0.2
0.2
0.3
0.1
0.1
0.4
0.2
0.2
0.1
0.1
0.2
0.3
0.3
0.1
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.2
0.2
0.2
0.2
0.3
0.2
0.4
0.1
0.3
0.2
0.2
0.1
0.2
0.3
0.2
0.3
0.1
0.1
0.1
0.1
0.2
0.2
0.2

0.3
0.4
0.3
0.6
0.2
0.3
0.4
0.3
0.4
0.3
0.3
0.2
0.4
0.5
0.2
0.3
0.3
0.3
0.3
0.4
0.3
0.3
0.3
0.3
0.1
0.2
0.3
0.2
0.3
0.3
0.3
0.4
0.3
0.3
0.5
0.3
0.5
0.4
0.4
0.4
0.3
0.4
0.2
0.3
0.2
0.4
0.2
0.3
0.4
0.3
0.2
0.3
0.4
0.5
0.6
0.3
0.3
0.4
0.4
0.3
0.5
0.3

0.1
0.3
0.1
0.1
0.1
0.3
0.3
0.1
0.4
0.1
0.1
0.1
0.2
0.1
0.2
0.1
0.1
0.2
0.2
0.2
0.1
0.1
0.2
0.5
0.1
0.1
0.1
0.2
0.2
0.1
0.2
0.4
0.1
0.6
0.5
1.3
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.2
0.1
0.0
0.1
0.1
0.2
0.1
0.2
0.1
0.2
0.1
0.3
0.1
0.3
0.1
0.2

0.1
0.1
0.2
0.1
0.6
0.1
0.3
0.1
0.1
0.0
0.1
0.0
0.2
0.1
0.1
0.1
0.2
0.1
0.1
0.2
0.1
0.2
0.2
0.3
0.2
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.3
0.4
0.1
0.1
0.1
0.1
0.1
0.0
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.2
0.2
0.1

0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0

0.1
0.0
0.1
0.1
0.0
0.0
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.2
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1

0.6
0.1
0.1
0.2
0.1
0.0
0.2
1.0
0.4
0.1
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.2
0.1
0.2
0.1
0.2
0.1
0.2
0.2
0.2
0.1
0.2
0.1
0.1
0.2
0.1
0.3
0.1
0.1
0.1
0.2
0.3
0.4
0.3
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.3
0.2
0.1
0.1
0.2
0.3
0.3
0.1
0.4
0.2
0.2
0.2

2541
286
456
107
90
54
1
111
1286
20
130
538
64
471
62
591
3592
695
24
29
16
110
4
472
898
74
20
6
294
4
10
474
209
149
776
2427
459
475
22
445
56
33
20
2174
150
1982
858
274
52
220
124
729
159
1456
104
1306
766
413
484
453
31
62
96
354
175
930

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

772

Other

Cancer Incidence in Five Continents Vol. IX, IARC 2008

3511
357
569
159
111
62
1
161
1924
22
145
653
80
566
70
704
4284
808
32
36
21
126
4
540
1086
93
24
12
348
5
12
575
259
188
908
2894
578
543
28
507
67
38
24
2692
194
2449
998
314
64
248
154
838
193
1720
123
1545
917
498
615
574
39
76
132
437
229
1072

*
*
*
*

Americ
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
Asia
Bahra
China
China
China
China
China
China
Cypru
India,
India,
India,
India,
India,
India,
India,
Israel
Israel
Israel
Japan
Japan
Japan
Japan
Japan
Japan
Japan
Korea
Korea
Korea
Korea
Korea
Korea

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Brain and central nervous system (C71-72) - Female (Contd)

es

Gliomas

al

31
95
20
14
38

*
*
*
*

31
86
43
94
17
23
83
89
04
21
37 *

11
57
69
59
11
62
1
61
24
22
45
53
80
66
70
04
84
08
32
36
21
26
4
40
86
93
24
12
48
5
12
75
59
88
08
94
78
43
28
07
67
38
24
92
94
49
98
14
64
48
54
38
93
20
23
45
17
98
15
74
39
76
32
37
29
72

Embryonal

Astro. Oligo. Epend. Other Medullobl.


America, North (Contd)
USA, Michigan
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Michigan: Black
USA, Michigan: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York state
USA, New York state: Black
USA, New York state: White
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 registries)
USA, SEER (9 registries): Black
USA, SEER (9 registries): White
USA, SEER (14 registries)
USA, SEER (14 registries): Asian and Pacific Islander
USA, SEER (14 registries): Black
USA, SEER (14 registries): Hispanic White
USA, SEER (14 registries): Non-hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, New Delhi
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon

Other

Other neuro Other Unspec.

Number of cases
MV

Total

2.8
2.7
1.5
3.2
1.5
3.0
3.2
1.5
3.4
3.6
3.0
1.5
3.2
2.0
0.6
2.1
2.2
3.0
2.0
3.2
2.9
1.6
3.1
3.0
1.5
3.1
3.3
3.0
3.2
1.9
3.3
3.4
2.8
1.5
3.1
2.8
1.3
1.6
2.5
3.2
2.9
1.5
3.5
2.6
1.6
2.8
3.0
2.8
3.2
2.9
3.2
3.0

0.6
0.7
0.3
0.9
0.3
0.7
0.6
0.2
0.7
0.9
0.4
0.2
0.4
0.7
0.9
0.6
0.8
0.5
0.3
0.5
0.5
0.2
0.5
0.5
0.3
0.5
0.3
0.5
0.5
0.2
0.5
0.5
0.6
0.2
0.7
0.5
0.3
0.2
0.4
0.6
0.3
0.1
0.3
0.5
0.2
0.5
0.6
0.3
0.8
0.9
0.5
0.6

0.2
0.2
0.1
0.2
0.1
0.2
0.1
0.1
0.2
0.1
0.3
0.2
0.3
0.3
0.2
0.4
0.3
0.2
0.1
0.2
0.2
0.1
0.2
0.2
0.1
0.2
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.2
0.2
0.2
0.2
0.1
0.2
0.2
0.1
0.3
0.2
0.3
0.2
0.2
0.2
0.2

0.3
0.3
0.3
0.3
0.3
0.3
0.2
0.1
0.2
0.2
0.5
0.2
0.5
0.4
0.5
0.2
0.4
0.4
0.3
0.4
0.4
0.3
0.4
0.4
0.4
0.4
0.3
0.5
0.4
0.3
0.5
0.4
0.4
0.3
0.4
0.4
0.3
0.3
0.3
0.4
0.2
0.1
0.3
0.4
0.3
0.4
0.6
0.0
0.6
0.6
0.2
0.3

0.1
0.2
0.0
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.0
0.2
0.1
0.2
0.1
0.2
0.2
0.0
0.2
0.2
0.1
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.0
0.1
0.2
0.2
0.1
0.2
0.2
0.1
0.1
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.3
0.1
0.2
0.3
0.3
0.1

0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.2
0.1
0.1
0.1
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.1
0.2
0.4
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.0
0.1

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.1
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1

0.2
0.2
0.1
0.2
0.1
0.3
0.4
0.3
0.4
0.1
0.3
0.4
0.3
0.1
0.0
0.2
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.3
0.2
0.6
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.2
0.2
0.2
0.2
0.1
0.3
0.2
0.4
0.0
0.3
0.1
0.1
0.2
0.4

1220
523
70
443
95
1112
721
35
675
130
1091
79
965
159
10
56
89
2446
221
2149
27120
1679
24573
1479
84
1367
447
406
1703
87
1580
157
3170
185
2795
8361
338
512
1017
6403
466
66
394
2188
150
1985
247
70
794
531
236
734

1469
599
84
505
111
1344
903
47
844
159
1338
104
1178
203
11
67
120
3009
292
2623
32720
2119
29562
1748
114
1603
552
509
2031
103
1888
187
3717
228
3268
10022
410
656
1183
7672
549
90
452
2724
185
2472
285
81
945
633
293
857

0.5
0.6
1.0
0.3
0.2
0.3
2.8
1.0
0.6
1.6
1.6
1.1
0.7
2.8
2.8
2.2
0.5
0.6
1.1
1.1
0.9
0.8
0.8
0.8
0.6
0.7
0.6
0.8
0.8

0.1
0.0
0.2
0.0
0.1
0.1
0.1
0.1
0.0
0.2
0.2
0.4
0.4
0.3
0.1
0.0
0.1
0.2
0.0
0.0
0.2
0.1
0.1
0.1
0.2
0.2

0.1
0.2
0.1
0.0
0.1
0.3
0.0
0.1
0.1
0.0
0.1
0.1
0.3
0.1
0.3
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1

0.1
0.5
0.2
0.9
0.1
0.5
0.4
0.2
0.2
0.4
0.5
0.5
0.2
0.3
0.3
0.1
0.2
0.2
0.1
0.2
0.3
0.1
0.3
0.1
0.1
0.1
0.0
0.1
0.1

0.1
0.2
0.1
0.2
0.1
0.5
0.1
0.1
0.1
0.3
0.1
0.1
0.1
0.1
0.0
0.1
0.2
0.1
0.1
0.2
0.2
0.1
0.0

0.1
0.1
0.0
0.0
0.3
0.0
0.1
0.1
0.0
0.0
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.1

0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0

0.1
0.1
0.1
1.5
0.1
0.1
0.2
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.2

1.0
0.2
0.1
4.7
3.9
0.2
0.4
0.5
0.5
0.3
0.2
0.4
1.8
0.7
0.3
0.2
0.2
0.7
0.9
0.2
0.1
0.7
0.5
0.9
1.0
0.5
1.0
1.1
1.0

5
88
331
16
90
556
46
75
158
14
581
110
444
110
41
569
503
59
35
41
50
91
79
358
58
1405
109
98
40
49
96

8
126
380
37
116
934
48
89
195
19
639
121
527
127
64
722
617
69
56
74
58
126
89
580
106
2332
211
123
73
86
159

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

715

*
*
*
*
*

*
*
*
*

773

Age-standardized (world) incidence rates (per 100,000)


by histological type

Brain and central nervous system (C71-72) - Female (Contd)


Gliomas

Embryonal

Astro. Oligo. Epend. Other Medullobl.


Asia (Contd)
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland (data not available)
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg (data not available)
Germany, Free State of Saxony (data not available)
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania (data not available)
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio
Italy, Syracuse Province
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce (data not available)
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg

716

Other neuro Other Unspec.

Number of cases
MV

Total

0.6
0.9
0.6
0.8
1.0
0.7
0.4
0.9
1.2
0.8
0.7
0.7
0.8
0.8
0.6
0.6
0.6
2.2
1.6

0.8
0.2
0.1
0.0
0.0
0.0
0.3
0.1
0.1
0.1
0.3
0.1
0.1
0.1
0.2
0.3

0.2
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.2
0.1
0.0
0.2
0.2

0.1
0.2
0.6
0.1
0.2
0.2
0.2
0.2
0.1
0.1
0.2
0.1
0.3
0.4

0.2
0.1
0.1
0.1
1.0
0.1
0.1
0.1
0.1
0.2
0.2
0.2
0.4
0.2
0.0
0.1
0.1
0.3
0.1

0.1
0.1
0.2
0.0
0.1
0.1
0.1
0.0
0.3
0.2
0.2
-

0.1
0.0
0.0
0.0
0.0
0.0
0.0

0.1
0.3
0.1
0.0
0.2
0.0
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.1

0.8
1.1
1.0
1.8
0.3
0.9
0.2
0.6
0.2
1.0
0.3
0.3
0.3
0.1
0.7
1.0
0.3
0.8
0.2

15
426
24
17
24
36
40
51
73
115
109
80
11
18
25
21
27
108
208

24
684
42
41
33
58
49
60
78
250
135
103
13
19
52
40
38
135
247

2.5
2.6
2.7
1.6
2.5
2.8
1.5
2.0
2.4
2.8
3.0
1.4
1.5
1.2
1.8
2.2
2.1
1.7
1.5
2.3
1.7
2.0
2.7
2.5
3.2
2.2
3.6
2.8
2.5
2.6
2.2
2.3
1.8
3.5
1.8
2.1
2.1
1.4
3.1
1.8
1.2
2.2
2.1
1.6
2.0
1.1
1.6
1.8
1.5
2.5
1.6
2.7
1.9
2.7
1.6
1.5
2.1
2.0
1.3

0.1
0.2
0.3
0.3
0.2
0.5
0.2
0.2
0.3
0.5
0.2
1.1
1.2
2.2
0.8
1.1
0.8
1.0
0.5
0.3
0.8
0.9
0.3
0.3
0.2
0.5
0.3
0.4
0.2
0.5
0.3
0.0
0.7
0.1
0.1
0.4
0.3
0.5
0.4
0.7
0.4
0.1
0.1
0.2
0.3
0.3
0.3
0.4
0.1
0.3
0.1
0.7
0.1
0.2
0.4
0.7
0.1

0.2
0.3
0.0
0.1
0.2
0.3
0.1
0.1
0.2
0.2
0.3
0.1
0.1
0.5
0.2
0.3
0.3
0.2
0.1
0.4
0.1
0.3
0.1
0.3
0.3
0.1
0.8
0.3
0.0
0.3
0.1
0.1
0.2
0.2
0.1
0.2
0.2
0.2
0.1
0.7
0.6
0.2
0.6
0.1
0.4
0.0
0.1
0.1
0.2
0.0
0.2
0.3
0.2
0.1

0.2
0.0
0.2
0.1
0.1
0.3
0.1
0.4
0.1
0.2
0.0
0.3
0.3
0.2
0.6
0.2
0.4
0.4
0.3
0.4
0.2
0.4
0.1
0.2
0.3
0.2
0.2
0.1
0.3
0.2
1.1
0.1
0.4
0.4
0.4
0.3
0.4
0.8
0.2
0.3
0.2
0.2
0.2
0.2
0.7
0.3
0.3
0.3
0.2
0.4
0.4
0.1
0.3
0.2
0.3
0.1

0.2
0.1
0.4
0.2
0.2
0.1
0.1
0.2
0.1
0.0
0.5
0.2
0.1
0.2
0.2
0.1
0.2
0.1
0.1
0.2
0.1
0.3
0.2
0.0
0.0
0.7
0.3
0.4
0.2
0.3
0.5
0.2
0.1
0.1
0.2
0.2
0.4
0.7
0.0
0.1
0.2
0.3
0.0
0.2
0.1
0.3
0.2
0.2
0.4
0.1

0.1
0.2
0.1
0.2
0.0
0.1
0.0
0.1
0.1
0.0
0.2
0.0
0.0
0.1
0.1
0.2
0.1
0.4
0.0
0.3
0.2
0.1
0.5
0.2
0.2
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.0
0.2
0.4
0.1
0.2
0.1

0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0

0.2
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.2
0.0
0.0
0.1
0.3
0.2
0.1
0.0
0.1
0.1
0.2
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.1

0.8
0.2
1.1
0.7
0.1
0.2
1.9
4.0
1.1
0.7
0.4
0.7
0.2
0.1
0.4
0.4
0.1
0.2
0.2
0.3
0.1
0.4
1.0
0.3
0.3
1.0
1.1
0.4
1.6
2.1
1.9
0.9
1.2
0.9
1.8
2.0
1.4
1.2
1.5
2.6
1.3
2.7
1.9
0.2
1.7
2.0
1.7
1.2
1.3
1.7
1.1
0.7
0.3
1.8
1.8
0.2
1.8
1.4

997
72
38
707
185
648
545
522
1117
703
176
96
70
71
88
124
132
126
47
44
35
57
172
301
334
151
35
378
18
66
56
139
63
29
107
62
43
167
63
28
36
116
84
28
18
23
82
104
48
217
173
476
29
556
64
155
320
332
333

1279
86
54
925
203
732
1179
1150
1602
942
200
140
81
77
95
146
168
137
53
70
50
62
293
433
437
171
47
596
29
113
102
268
117
48
202
140
84
391
107
49
89
224
177
64
21
51
200
204
87
359
337
574
45
718
121
294
346
593
545

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

774

Other

Cancer Incidence in Five Continents Vol. IX, IARC 2008

*
*
*

*
*
*
*

*
*
*

Europe
Serbia
Slova
Slove
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Switz
Switz
Switz
Switz
Switz
Switz
Switz
The N
The N
The N
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, N
UK, S
Oceani
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Frenc
New Z
USA,
USA,
USA,
USA,
USA,
USA,

*
*

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Brain and central nervous system (C71-72) - Female (Contd)

es

Gliomas

al

24
84
42
41
33
58
49
60
78
50
35
03
13
19
52
40
38
35
47

79
86
54
25
03
32
79
50
02
42
00
40
81
77
95
46
68
37
53
70
50
62
93
33
37
71
47
96
29
13
02
68
17
48
02
40
84
91
07
49
89
24
77
64
21
51
00
04
87
59
37
74
45
18
21
94
46
93
45

*
*
*

*
*
*
*

*
*
*

Embryonal

Astro. Oligo. Epend. Other Medullobl.


Europe (Contd)
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, England, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern And Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory (data not available)
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Other

Other neuro Other Unspec.

Number of cases
MV

Total

3.7
2.0
2.0
1.7
2.7
2.9
2.7
1.7
2.8
2.0
1.5
3.6
2.7
2.2
2.3
2.3
4.4
2.2
2.6
2.8
2.2
2.8
2.4
2.5
2.5
2.1
2.4
2.4
2.8
2.3
2.0
2.4
2.7
2.6
2.3
2.5

0.3
0.3
0.4
0.4
0.3
0.4
0.5
0.2
0.3
0.0
0.2
0.3
0.3
0.4
0.1
0.6
0.5
0.1
0.2
0.5
0.3
0.6
0.4
0.6
0.3
0.3
0.3
0.4
0.3
0.3
0.3
0.3
0.3

0.1
0.1
0.2
0.1
0.2
0.1
0.0
0.1
0.2
0.2
0.1
0.4
0.2
0.3
0.1
0.4
0.5
0.5
0.3
0.2
0.4
0.1
0.2
0.1
0.3
0.2
0.2
0.1
0.2
0.1
0.1
0.3
0.1

0.6
0.0
0.2
0.5
0.6
0.2
0.4
1.5
0.3
0.2
0.8
0.7
1.1
0.3
0.2
0.4
0.1
0.8
0.1
0.5
0.0
0.2
0.2
0.3
0.6
0.7
0.8
0.5
0.6
0.7
0.7
0.9
0.4
0.3
0.4

0.1
0.1
0.1
0.2
0.2
0.3
0.0
0.3
0.1
0.2
0.1
0.3
0.2
0.4
1.3
0.2
0.2
0.1
0.2
0.1
0.4
0.2
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.1
0.1
0.1

0.4
0.1
0.0
0.0
0.1
0.2
0.0
0.1
0.2
0.4
0.2
0.1
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.0

0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.1
0.1
0.0
0.0
0.0
0.1
0.1
0.0
0.3
0.0
0.1
0.2
0.1
0.1
0.0
0.1
0.9
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.1

1.6
1.0
0.5
0.1
0.7
1.0
0.5
1.0
1.3
0.6
0.9
0.5
1.1
0.4
0.3
0.8
0.3
0.6
0.5
0.6
0.6
0.5
0.4
0.5
0.2
0.4
0.1
0.2
0.3
0.4
1.2
0.3
0.3
0.1
1.3
0.4

786
464
238
12
125
224
139
10
69
80
75
55
69
101
1027
46
42
19
57
37
29
74
1684
103
112
270
258
389
693
248
654
1355
475
523
142
515

1017
676
248
37
201
353
201
37
106
105
145
117
105
126
1125
63
48
24
74
59
38
89
2077
134
126
411
474
608
1045
362
1169
2073
849
732
250
810

2.8
3.0
3.0
2.9
3.0
2.8
2.7
1.1
2.3
2.3
1.2
1.2
2.9
2.1
3.7

0.5
0.5
0.3
0.5
0.4
0.4
0.1
0.4
0.3
0.6
0.0
0.6

0.2
0.2
0.1
0.5
0.2
0.1
0.1
0.2
0.2
0.2
0.7
-

0.5
0.4
0.3
0.2
0.2
0.2
0.7
0.5
0.4
0.2
0.6
0.1
0.3
-

0.1
0.1
0.2
0.2
0.1
0.2
0.5
0.1
0.1
0.3

0.1
0.1
0.0
0.1
0.0
0.1
0.1
0.2
0.2
0.5

0.0
0.0
0.0
0.0
-

0.1
0.1
0.0
0.0
0.2
0.9
0.0
-

0.1
0.1
0.1
0.2
0.8
0.1
0.6
0.4
0.1
0.2
0.1

771
400
164
61
633
202
35
12
359
103
3
7
20
19
43

932
517
226
70
802
242
39
18
493
118
4
8
23
22
49

*
*

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

717

775

Age-standardized (world) incidence rates (per 100,000)


by histological type

Thyroid (C73) - Male


Carcinoma

Follicular Papillary Medular Anaplastic Other Unspec.


Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Non-Hispanic White
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Georgia: Black
USA, Georgia: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
USA, Louisiana: Black
USA, Louisiana: White
USA, Maine
USA, Massachusetts

718

Number of cases
MV

Total

0.5
0.2
0.1
0.1
0.3

0.6
0.5
0.9
0.3

0.1
0.1
0.2
-

0.1
0.2
0.1
0.1

0.1
0.0
0.0
0.1

0.0
0.0
0.2
0.1

0.1
0.2
0.0

32
48
14
6
10

32
53
14
11
14

0.0
0.5
0.3
0.3
0.5
0.3
0.1
0.2
0.1

0.4
1.9
0.6
1.2
1.9
1.3
1.4
1.3
1.1
0.7
1.2

0.1
0.2
0.2
0.1
0.1
0.0
0.1
0.1
0.1
0.1

0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.1

0.1
0.2
0.1
0.1
0.1
0.0
0.1
-

0.1
0.2
0.1
0.4
0.1
0.0
0.0
0.1
0.1

0.4
0.1
0.5
0.2
0.2
0.1
0.3
-

5
81
8
37
740
15
76
134
50
11
17

6
88
8
39
861
16
85
141
57
11
17 *

0.3
0.2
0.2
0.4
0.1
0.4
0.1
0.3
0.3
0.3
0.4
0.3
0.5
0.4
0.3
0.3
0.2
0.3
0.3
0.1
1.1
0.4
0.3
0.4
0.4
0.2
0.2
0.3
0.4
0.3
0.4
0.2
0.3
0.4
0.3
0.4
0.3
0.9
0.8
0.7
0.4
0.2
0.4
0.3
0.3
0.2
0.4
0.2
0.4
0.4
0.4
0.2
0.4
0.3
0.3
0.4
0.6
1.0
0.6
0.5
0.6
0.3
0.4

2.3
2.7
1.7
1.5
1.6
1.0
1.5
1.4
2.6
0.4
2.0
1.6
0.7
1.8
2.8
2.4
2.2
2.2
1.1
2.1
3.2
1.9
1.1
2.4
2.4
1.1
1.7
4.6
1.7
3.7
3.0
3.2
2.4
1.1
1.8
2.6
2.7
3.1
0.5
3.4
4.0
2.8
5.3
1.9
0.7
2.1
1.8
2.2
0.7
2.8
0.8
2.1
2.5
2.3
1.0
2.5
2.0
2.6
2.1
1.7
0.4
2.2
0.8
2.1
1.8
2.7

0.1
0.1
0.1
0.1
0.4
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.0
0.1
0.1
0.2
0.1
0.2
0.2
0.1
0.2
0.1
0.0
0.1
0.2
0.2
0.1
0.2
0.0
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.3
0.2

0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.1
0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.1
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.2
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0

0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.2
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.1
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
0.0
0.0
0.0
0.0
-

0.1
0.0
0.0
0.2
0.0
0.0
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

1961
293
269
68
54
26
2
52
1115
3
79
297
37
255
62
471
2706
542
22
36
33
66
5
337
776
47
26
37
168
17
18
436
328
102
469
1779
424
386
7
368
79
36
39
1408
65
1312
561
212
26
172
64
479
117
1088
60
962
475
288
328
316
15
54
45
266
99
638

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

776

Sarcoma Other Unspec.

Cancer Incidence in Five Continents Vol. IX, IARC 2008

2095
295
271
68
54
26
2
54
1243
3
79
300
38
257
63
475
2720
545
22
37
33
66
5
339
779
47
26
37
169
17
18
438
329
103
470
1789
432
386
7
368
82
36
40
1434
69
1334
568
213
26
173
66
484
117
1100
62
972
476
290
332
318
15
54
47
266
99
644

*
*
*
*

Americ
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
Asia
Bahra
China
China
China
China
China
China
Cypru
India,
India,
India,
India,
India,
India,
India,
Israel
Israel
Israel
Japan
Japan
Japan
Japan
Japan
Japan
Japan
Korea
Korea
Korea
Korea
Korea
Korea

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Thyroid (C73) - Male (Contd)

es

Carcinoma

al

2
3
4
1
4

*
*
*
*

6
8
8
9
1
6
5
1
7
1
7*

5
5
1
8
4
6
2
4
3
3
9
0
8
7
3
5
0
5
2
7
3
6
5
9
9
7
6
7
9
7
8
8
9
3
0
9
2
6
7
8
2
6
0
4
9
4
8
3
6
3
6
4
7
0
2
2
6
0
2
8
5
4
7
6
9
4

Follicular Papillary Medular Anaplastic Other Unspec.


America, North (Contd)
USA, Michigan
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Michigan: Black
USA, Michigan: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York state
USA, New York state: Black
USA, New York state: White
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 registries)
USA, SEER (9 registries): Black
USA, SEER (9 registries): White
USA, SEER (14 registries)
USA, SEER (14 registries): Asian and Pacific Islander
USA, SEER (14 registries): Black
USA, SEER (14 registries): Hispanic White
USA, SEER (14 registries): Non-hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, New Delhi
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon

Sarcoma Other Unspec.

Number of cases
MV

Total

0.3
0.3
0.2
0.4
0.2
0.3
0.4
0.4
0.4
0.4
0.6
0.4
0.7
0.5
0.3
0.7
0.4
0.3
0.5
0.4
0.3
0.4
0.4
0.2
0.3
0.3
0.3
0.5
0.5
0.5
0.5
0.4
0.3
0.4
0.4
0.3
0.4
0.3
0.4
0.3
0.2
0.3
0.4
0.5
0.4
0.3
0.3
0.4
0.4
0.4
0.4

2.2
2.6
1.6
2.9
1.5
2.4
2.1
0.7
2.2
2.9
2.8
1.5
3.0
3.3
1.7
3.6
3.6
2.8
1.0
3.1
2.3
1.0
2.4
1.9
0.9
1.9
1.5
2.3
3.1
1.7
3.2
2.8
2.6
1.1
2.9
2.4
2.4
1.1
2.0
2.7
1.6
0.8
1.9
2.2
1.0
2.3
3.1
2.2
2.6
2.7
2.3
2.2

0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.1
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.2
0.1

0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.1

0.0
0.1
0.2
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
0.0
0.1
0.1
0.1
0.0
0.1
0.2
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.1
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.1

832
381
52
321
63
748
473
21
446
105
958
62
836
219
7
79
130
1997
111
1769
19625
1025
17441
840
39
753
225
304
1507
76
1375
116
2574
120
2206
6542
516
324
676
4942
263
37
221
1669
94
1494
201
50
577
409
178
452

842
384
53
323
65
756
480
22
452
108
969
64
845
222
7
81
131
2019
112
1790
19839
1052
17616
856
42
766
230
305
1513
76
1381
116
2588
121
2216
6586
518
330
680
4971
265
37
223
1699
96
1518
202
52
580
411
179
463

0.2
0.3
0.3
0.1
0.0
0.2
0.2
0.1
0.1
0.1
0.2
0.1
0.2
0.3
0.3
0.1
0.1
0.2
0.1
0.1
0.2
0.1
0.1
0.2
0.2
0.1
0.2
0.2
0.3

0.9
0.6
1.6
0.2
0.2
0.4
2.3
0.3
1.3
0.3
0.0
0.3
1.4
2.6
2.8
1.7
0.9
2.1
1.9
1.6
1.5
0.9
1.0
1.7
1.6
1.3
1.5
3.1
1.1

0.0
0.1
0.0
0.1
0.2
0.0
0.1
0.1
0.0
0.1
0.0
0.2
0.2
0.2
0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.1
0.2

0.0
0.1
0.2
0.0
0.1
0.0
0.0
0.1
0.2
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.1

0.0
0.0
0.1
0.0
0.1
0.1
0.2
0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0

0.2
0.0
0.3
0.1
0.0
0.2
0.0
0.0
0.0
0.1
0.2
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0

0.0
0.1
0.0
0.0
0.0
-

0.0
0.0
0.0
0.0
-

0.1
0.0
0.7
1.2
0.2
0.0
0.2
0.1
0.1
0.2
0.7
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.1
0.3
0.1
0.2
0.1
0.2

8
74
437
8
13
277
35
52
54
17
163
16
197
43
58
505
460
41
47
77
88
168
113
373
71
2212
200
114
69
118
99

8
84
447
11
18
314
35
54
82
17
184
17
262
53
58
526
474
43
50
81
93
175
122
432
77
2314
215
118
73
121
109

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

719

*
*
*
*
*

*
*
*
*

777

Age-standardized (world) incidence rates (per 100,000)


by histological type

Thyroid (C73) - Male (Contd)


Carcinoma

Follicular Papillary Medular Anaplastic Other Unspec.


Asia (Contd)
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland (data not available)
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg (data not available)
Germany, Free State of Saxony (data not available)
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania (data not available)
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio
Italy, Syracuse Province
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce (data not available)
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg

720

Number of cases
MV

Total

0.1
0.2
0.1
0.2
0.1
0.1
0.2
0.1
0.4
0.4
0.4
0.1
0.5
0.3
0.3
0.3
0.3
0.2

2.0
2.0
1.8
2.8
0.7
0.5
0.6
1.2
0.5
1.9
1.4
1.5
1.1
1.7
0.5
0.2
1.2
0.5
0.6

0.2
0.0
0.0
0.1
0.1
0.0
0.1
0.1
0.0
0.0
0.1
0.0
0.1
0.1

0.1
0.0
0.2
0.2
0.2
0.1
0.1
0.1
0.2
0.2
0.1
0.1
0.1

0.0
0.2
0.2
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.2
0.0
0.0
0.0
0.1
0.0
0.0

0.0
0.0
0.0
0.0
-

0.0
-

0.7
0.1
0.2
0.1
0.2
0.1
0.2
0.3
0.0
0.0
0.1
0.2
0.1
0.0
0.1

22
623
47
45
62
23
45
30
24
235
179
146
11
22
41
14
50
35
86

25
644
49
46
62
25
46
32
25
260
180
147
11
22
43
18
52
38
90

0.5
0.8
1.0
0.2
0.3
0.3
0.1
0.3
0.4
0.3
0.2
0.3
0.3
0.6
0.4
0.3
0.4
0.4
0.5
0.5
0.5
0.4
0.2
0.5
0.3
0.5
0.6
0.2
0.4
0.3
0.5
0.2
0.7
0.3
0.2
0.4
0.6
0.4
0.5
0.1
0.6
0.8
0.4
0.5
0.2
0.5
0.4
0.5
0.4
0.3
0.3
0.3
0.2
0.2
0.3
0.1
0.3
0.1
0.2

1.6
2.1
0.5
2.8
0.7
0.6
0.5
1.4
1.0
0.6
0.6
1.6
2.2
2.4
1.2
1.7
3.5
2.2
1.2
1.5
2.6
4.0
0.8
1.7
0.7
1.0
3.6
0.4
2.5
3.5
5.0
1.8
2.3
1.3
2.3
4.9
2.2
1.7
3.7
2.0
4.0
2.6
1.9
2.3
1.8
2.7
1.7
2.4
1.9
2.1
0.3
0.8
1.3
1.1
1.1
0.8
1.6
1.1
0.4

0.3
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.3
0.3
0.4
0.3
0.1
0.3
0.4
0.1
0.1
0.5
0.4
0.1
0.2
0.1
0.1
0.2
0.1
0.4
0.4
0.2
0.2
0.3
0.2
0.5
0.3
0.1
0.2
0.1
0.2
0.3
0.1
0.1
0.2
0.2
0.2
0.4
0.1
0.2
0.1
0.1
0.0
0.2
0.2
0.2
0.1

0.1
0.2
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.2
0.2
0.3
0.1
0.0
0.0
0.2
0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.2
0.2
0.2
0.1
0.2
0.1
0.1
0.1
0.1
0.3
0.1
0.1
0.2
0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.1
0.1
0.0
0.0
0.0

0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.2
0.3
0.1
0.0
0.1
0.1
0.1
0.0
0.0
0.1
0.2
0.1
0.0
0.2
0.1
0.0
0.1
0.0
0.0
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.1
0.0

0.1
0.2
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.1
0.0
0.1
0.5
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.0
0.0
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.1

0.0
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
-

0.1
0.1
0.3
0.1
0.0
0.1
0.2
0.1
0.0
0.2
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.3
0.2
0.7
0.2
0.3
0.1
0.2
0.3
0.1
1.1
0.2
0.3
0.7
0.0
0.2
0.0
0.3
0.4
0.1
0.2
0.1
0.1
0.0
0.3
0.2
0.0
0.1
0.2

718
71
20
881
64
195
199
282
547
205
51
74
59
60
58
61
143
106
32
36
45
95
64
207
110
69
41
87
23
100
85
118
65
17
114
127
50
204
69
28
82
141
75
49
14
35
79
92
39
153
58
159
18
243
35
65
193
139
121

737
73
25
892
64
206
244
306
571
210
52
75
59
60
58
62
143
106
32
36
46
96
75
209
122
71
41
94
23
105
87
143
71
17
119
127
53
210
71
31
84
151
93
50
15
35
80
104
45
156
70
167
19
247
43
66
194
151
152

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

778

Sarcoma Other Unspec.

Cancer Incidence in Five Continents Vol. IX, IARC 2008

*
*
*

*
*
*
*

*
*
*

Europe
Serbia
Slova
Slove
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Switz
Switz
Switz
Switz
Switz
Switz
Switz
The N
The N
The N
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, N
UK, S
Oceani
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Frenc
New Z
USA,
USA,
USA,
USA,
USA,
USA,

*
*

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Thyroid (C73) - Male (Contd)


Carcinoma

es

al

5
4
9
6
2
5
6
2
5
0
0
7
1
2
3
8
2
8
0

7
3
5
2
4
6
4
6
1
0
2
5
9
0
8
2
3
6
2
6
6
6
5
9
2
1
1
4
3
5
7
3
1
7
9
7
3
0
1
1
4
1
3
0
5
5
0
4
5
6
0
7
9
7
3
6
4
1
2

*
*
*

*
*
*
*

*
*
*

Follicular Papillary Medular Anaplastic Other Unspec.


Europe (Contd)
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, England, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern And Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory (data not available)
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Sarcoma Other Unspec.

Number of cases
MV

Total

0.1
0.2
0.4
0.1
0.2
0.3
0.4
0.2
0.3
0.2
0.8
0.2
0.3
0.2
0.4
0.4
0.4
0.7
0.5
0.3
0.1
0.2
0.3
0.2
0.3
0.3
0.1
0.3
0.3
0.2
0.2
0.2
0.3
0.4
0.3

0.3
0.9
1.0
0.8
1.1
1.0
1.2
0.6
1.6
0.5
1.0
1.1
1.2
0.5
0.8
1.5
0.1
1.7
1.0
1.7
1.1
1.3
0.6
0.4
0.5
0.4
0.5
0.4
0.6
0.4
0.5
0.5
0.5
0.6
0.6
0.6

0.1
0.1
0.2
0.4
0.1
0.2
0.1
0.2
0.3
0.1
0.8
0.0
0.1
0.2
0.1
0.4
0.2
0.1
0.2
0.3
0.4
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1

0.0
0.1
0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.3
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1

0.1
0.0
0.0
0.0
0.1
0.2
0.1
0.0
0.1
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.1
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
0.0

0.2
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.2
-

93
204
115
9
55
91
81
9
40
26
68
49
22
36
406
27
7
15
37
25
16
41
521
33
24
87
71
94
212
78
207
387
145
181
66
177

125
219
116
10
55
94
81
9
40
27
68
51
23
37
407
27
7
15
38
25
17
41
524
34
24
95
78
105
230
84
232
433
153
189
72
177

0.4
0.6
0.3
0.5
0.3
0.3
0.6
0.9
0.3
0.5
0.5
0.7
0.4
0.9

1.8
1.8
1.8
1.4
1.1
1.8
1.6
3.7
1.1
2.6
1.6
5.1
3.2
1.2
2.5

0.1
0.2
0.1
0.1
0.1
0.1
0.2
0.5
0.1
0.2

0.0
0.1
0.1
0.3
0.1
0.0
0.0
0.0
0.0
0.1

0.0
0.0
0.0
0.0
0.2
0.0
0.0
0.1

0.1
0.1
0.1
0.0
0.0
0.7
0.0
0.0
0.0

0.0
-

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
-

493
291
112
34
251
129
20
26
177
131
5
36
23
18
40

506
304
112
35
257
130
20
26
181
132
5
37
23
18
40

*
*

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

721

779

Age-standardized (world) incidence rates (per 100,000)


by histological type

Thyroid (C73) - Female


Carcinoma

Follicular Papillary Medular Anaplastic Other Unspec.


Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Non-Hispanic White
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Georgia: Black
USA, Georgia: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
USA, Louisiana: Black
USA, Louisiana: White
USA, Maine
USA, Massachusetts

722

Number of cases
MV

Total

1.3
0.4
0.6
0.5
0.7

1.8
1.5
2.2
0.1
0.6

0.1
0.0
0.3
0.0

0.1
0.4
0.0
0.4

0.1
0.0
-

0.1
0.5
1.1

0.0

0.0

0.1
0.3
0.3
0.3

87
145
34
24
31

88
151
34
26
45

0.3
0.9
0.7
1.6
1.9
0.2
0.5
0.5
1.0
0.8
0.9

1.0
7.1
1.8
6.2
8.5
3.6
8.0
6.9
7.2
3.7
4.2

0.1
0.2
0.1
0.1
0.1
0.1
0.2
0.3
0.1

0.1
0.3
0.2
0.3
0.1
0.3
0.1

0.2
0.1
0.2
0.2
0.2
0.1
0.0
0.0
0.5
-

0.2
0.3
0.1
0.3
1.9
0.1
0.2
0.1
0.3
0.1
0.4

0.0
0.0
0.1
-

0.1
1.1
2.0
0.5
2.0
0.3
0.3
0.4
1.1
1.2
-

16
329
31
197
3798
39
440
706
320
65
68

17
338
43
208
4399
42
450
739
356
80
68 *

0.7
0.8
0.4
0.6
0.4
0.6
0.4
0.8
0.5
0.7
0.7
0.9
0.6
0.7
0.9
0.8
0.7
0.4
0.5
0.9
0.7
1.3
0.6
0.7
0.6
0.4
1.0
0.6
0.3
0.9
0.8
0.7
0.7
0.8
0.9
1.0
0.9
1.0
1.3
1.3
0.9
0.9
0.8
0.9
0.9
1.0
0.7
1.2
0.7
1.0
1.1
0.8
0.8
0.8
0.9
1.0
0.9
1.2
1.6
1.5
1.2
1.2
0.8
0.9

7.8
7.7
4.8
6.5
6.6
5.0
5.2
5.1
9.7
3.6
5.8
5.3
3.5
5.9
8.7
7.8
7.3
6.7
3.1
7.6
7.4
6.4
4.4
6.9
7.9
3.1
6.1
14.0
7.3
6.3
8.8
9.8
8.2
3.4
7.2
7.9
8.4
8.7
3.7
9.2
8.6
7.0
9.0
6.4
3.6
6.9
5.9
6.7
3.7
8.4
3.7
6.7
8.7
7.7
3.6
8.3
6.5
8.4
7.0
6.0
2.6
6.7
3.4
7.4
7.0
9.1

0.2
0.2
0.1
0.1
0.2
0.1
0.1
0.2
0.0
0.2
0.3
0.1
0.1
0.1
0.2
0.2
0.1
0.2
0.1
0.1
0.2
0.1
0.1
0.2
0.2
0.1
0.2
0.1
0.1
0.2
0.2
0.1
0.2
0.2
0.1
0.0
0.2
0.2
0.2
0.2
0.1
0.2
0.1
0.3
0.1
0.2
0.1
0.1
0.0
0.1
0.2
0.1
0.2
0.2
0.1
0.3
0.1
0.2
0.6
0.2

0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.4
0.0
0.3
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.1
0.0
0.1
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.0

0.1
0.0
0.0
0.1
0.1
0.7
0.1
0.0
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.2
0.2
0.1
0.0
0.1
0.2
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.1
0.1
0.2
0.0
0.1
0.0
0.0

0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.2
0.1
0.1
0.0
0.1
0.1
0.0
0.0
0.1
0.2
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.1
0.1
0.1
0.3
0.0
0.1
0.0
0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.3
0.1
0.1
0.0
0.1

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
-

0.5
0.0
0.0
0.0
0.0
0.0
0.9
0.0
0.1
0.1
0.0
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.2
0.0
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.2
0.1
0.0

6278
801
729
264
177
101
7
179
3798
19
203
891
169
699
172
1362
8447
1568
57
134
94
236
22
823
2507
127
81
155
801
33
58
1156
1256
304
1999
4761
1248
1107
50
1002
189
106
62
4028
342
3562
1765
720
157
525
331
1371
366
3362
273
2894
1446
858
1047
1036
59
158
206
818
335
2123

6839
802
733
265
178
102
7
180
4349
19
204
898
171
704
173
1368
8487
1572
57
135
94
236
22
826
2516
129
81
155
802
33
59
1160
1264
308
2002
4783
1256
1113
51
1007
191
107
62
4052
345
3582
1774
720
157
525
334
1377
367
3380
277
2908
1451
861
1057
1052
59
163
209
831
338
2132

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

780

Sarcoma Other Unspec.

Cancer Incidence in Five Continents Vol. IX, IARC 2008

*
*
*
*

Americ
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
Asia
Bahra
China
China
China
China
China
China
Cypru
India,
India,
India,
India,
India,
India,
India,
Israel
Israel
Israel
Japan
Japan
Japan
Japan
Japan
Japan
Japan
Korea
Korea
Korea
Korea
Korea
Korea

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Thyroid (C73) - Female (Contd)

es

Carcinoma

al

8
1
4
6
5

*
*
*
*

7
8
3
8
9
2
0
9
6
0
8*

9
2
3
5
8
2
7
0
9
9
4
8
1
4
3
8
7
2
7
5
4
6
2
6
6
9
1
5
2
3
9
0
4
8
2
3
6
3
1
7
1
7
2
2
5
2
4
0
7
5
4
7
7
0
7
8
1
1
7
2
9
3
9
1
8
2

Follicular Papillary Medular Anaplastic Other Unspec.


America, North (Contd)
USA, Michigan
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Michigan: Black
USA, Michigan: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York state
USA, New York state: Black
USA, New York state: White
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 registries)
USA, SEER (9 registries): Black
USA, SEER (9 registries): White
USA, SEER (14 registries)
USA, SEER (14 registries): Asian and Pacific Islander
USA, SEER (14 registries): Black
USA, SEER (14 registries): Hispanic White
USA, SEER (14 registries): Non-hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, New Delhi
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon

Sarcoma Other Unspec.

Number of cases
MV

Total

0.8
0.9
1.0
0.9
0.9
0.8
0.8
0.9
0.8
0.9
1.3
0.9
1.4
0.9
1.2
0.8
0.9
1.1
0.9
1.1
0.9
0.9
0.9
0.8
0.9
0.8
0.4
0.6
1.4
1.6
1.3
0.8
0.9
0.8
0.9
0.9
0.8
0.9
0.8
1.0
0.9
0.9
0.9
0.9
1.1
0.9
0.9
0.7
0.8
0.9
1.1
0.9

7.5
7.7
4.2
9.0
4.2
8.0
7.4
3.5
7.9
10.7
9.1
4.3
9.9
10.3
7.0
9.5
12.5
8.6
4.5
9.4
7.4
3.9
7.8
6.1
2.9
6.3
5.0
7.1
10.7
7.5
10.9
10.3
8.2
4.0
8.7
7.7
8.5
3.8
7.6
8.5
5.4
3.4
6.2
6.7
3.4
7.0
10.6
7.5
8.7
8.5
7.6
6.7

0.1
0.1
0.1
0.2
0.1
0.1
0.2
0.1
0.2
0.2
0.2
0.1
0.2
0.1
0.1
0.1
0.2
0.1
0.2
0.2
0.1
0.2
0.2
0.2
0.2
0.1
0.1
0.2
0.2
0.1
0.1
0.2
0.1
0.2
0.2
0.1
0.1
0.2
0.2
0.1
0.2
0.1
0.1
0.2
0.1
0.1
0.1
0.2
0.1
0.1

0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.2
0.0
0.1
0.1
0.0
0.1
0.1
0.3
0.0
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.0
0.0
0.1
0.1
0.0

0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0

0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.1
0.2
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.2
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.1
0.0
0.1
0.0
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.0

2665
1164
177
942
237
2322
1492
93
1366
318
2941
211
2500
630
40
211
368
6142
556
5157
60008
4202
51480
2590
168
2301
584
845
4873
363
4328
376
7789
490
6281
20337
2004
1211
2768
13969
830
161
651
4805
324
4216
690
170
1754
1212
536
1270

2696
1171
180
946
242
2348
1496
93
1370
321
2966
213
2522
636
40
214
371
6201
564
5205
60456
4256
51843
2605
170
2314
596
848
4903
365
4355
377
7819
494
6306
20454
2014
1224
2779
14047
839
162
659
4887
332
4285
691
170
1760
1215
542
1288

0.9
0.5
0.9
0.0
0.6
0.5
0.3
0.4
0.4
0.6
0.4
0.7
0.8
0.8
1.0
0.2
0.3
0.4
0.2
1.0
0.3
0.4
0.8
0.4
0.7
0.3
0.6
1.0

5.9
3.3
5.9
1.3
0.8
1.8
8.3
1.1
2.9
0.6
0.2
0.8
4.7
10.2
10.6
5.5
4.8
5.5
10.9
8.6
6.1
2.2
6.9
10.6
7.3
8.8
7.6
19.7
8.1

0.1
0.0
0.1
0.2
0.1
0.2
0.1
0.0
0.2
0.1
0.3
0.3
0.2
0.0
0.1
0.1
0.0
0.2
0.1
0.1
0.1
0.2
0.2
0.2

0.4
0.0
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.0

0.2
0.2
0.0
0.1
0.2
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.1

0.3
0.6
0.1
0.0
0.1
0.2
0.0
0.5
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.3
0.1

0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
-

0.0
-

0.2
0.1
1.2
3.8
0.4
0.1
0.4
0.2
0.2
0.1
0.7
1.4
0.1
0.2
0.2
0.1
0.4
0.2
0.0
0.2
0.4
0.4
0.4
0.5
0.2
0.5
0.5
0.8

57
265
1525
19
29
950
104
189
159
42
310
40
439
71
195
1831
1659
154
189
211
456
802
457
1029
373
13311
940
743
328
794
668

57
295
1557
20
33
1044
105
190
202
44
355
42
579
93
196
1948
1747
161
196
221
472
819
473
1194
393
13725
989
753
339
809
715

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

723

*
*
*
*
*

*
*
*
*

781

Age-standardized (world) incidence rates (per 100,000)


by histological type

Thyroid (C73) - Female (Contd)


Carcinoma

Follicular Papillary Medular Anaplastic Other Unspec.


Asia (Contd)
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland (data not available)
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg (data not available)
Germany, Free State of Saxony (data not available)
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania (data not available)
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio
Italy, Syracuse Province
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce (data not available)
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg

724

Number of cases
MV

Total

1.1
1.0
0.8
0.3
0.2
0.9
0.8
0.9
0.8
1.8
1.2
1.1
2.6
0.9
1.4
0.8
1.5
1.3
0.7

10.1
12.1
10.4
6.9
3.9
1.9
1.4
4.6
2.0
7.5
5.0
5.0
3.5
5.5
2.2
1.8
4.2
2.3
2.5

0.1
0.1
0.3
0.1
0.1
0.0
0.1
0.2
0.1
0.1
0.1
0.3
0.1
0.1
0.0
0.2
0.2

0.2
0.2
0.2
0.4
0.1
0.5
0.1
0.1
0.1
0.3
0.3
0.2
0.1
0.1

0.2
0.1
0.2
0.1
0.0
0.1
0.1
0.0
0.2
0.1
0.0
0.1
0.1

0.1
0.1
0.5
0.1
0.1
0.0
0.1
0.5
0.1
0.1
0.2
0.2
0.0
0.1
0.0
0.0
0.0

0.1
-

1.3
0.5
0.6
0.1
0.3
0.8
0.3
0.1
0.7
0.1
0.1
0.1
0.1
0.3
0.6
0.2
0.5
0.1

120
4024
256
119
84
98
129
135
70
1125
628
506
45
77
183
71
203
149
324

128
4122
265
120
86
103
138
137
71
1206
636
512
46
78
191
87
209
157
329

1.1
2.1
2.2
0.8
0.6
0.7
0.4
0.8
0.9
0.5
1.3
0.9
0.7
0.7
0.7
1.0
1.3
0.8
0.9
1.3
1.1
0.9
0.3
0.9
0.6
0.8
1.2
0.5
0.5
1.5
0.8
1.1
1.1
1.7
0.4
0.9
1.2
0.9
1.2
0.6
1.2
3.2
1.4
1.5
1.3
0.8
1.2
1.1
0.7
0.7
1.9
0.9
0.7
0.5
1.9
0.5
0.9
0.7
0.8

4.5
6.3
2.6
10.7
1.1
1.5
1.9
6.4
3.8
2.0
3.6
4.3
8.8
9.8
3.9
5.7
11.2
9.2
6.6
7.1
16.4
15.2
1.6
6.1
2.1
4.0
9.2
1.4
6.9
13.3
18.5
6.4
7.6
5.0
6.0
13.6
6.9
6.6
11.8
6.0
13.9
9.9
8.4
10.1
6.9
12.6
6.5
7.2
5.3
6.5
1.5
4.8
8.0
3.3
4.4
3.8
10.9
4.7
1.9

0.4
0.1
0.3
0.2
0.1
0.1
0.1
0.3
0.2
0.2
0.2
0.4
0.2
0.3
0.1
0.3
0.3
0.5
0.4
0.5
0.5
0.6
0.1
0.4
0.1
0.2
0.2
0.1
0.1
0.4
0.5
0.3
0.3
0.4
0.3
0.6
0.4
0.1
0.8
0.2
1.0
0.4
0.2
0.1
0.4
0.4
0.3
0.2
0.2
0.2
0.1
0.2
0.2
0.0
0.2
0.2
0.1

0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.0
0.2
0.2
0.1
0.1
0.1
0.0
0.2
0.0
0.0
0.1
0.1
0.1
0.1
0.4
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.2
0.1
0.2
0.0
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.1
0.0
0.1
0.1
0.1
0.1

0.1
0.0
0.1
0.2
0.0
0.2
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.2
0.2
0.2
0.2
0.1
0.1
0.0
0.0
0.1
0.1
0.0
0.3
0.1
0.2
0.0
0.1
0.0
0.1
0.1
0.2
0.3
0.0
0.1
0.0
0.0
0.2
0.1
0.0
0.0
0.1
0.1
0.2

0.2
0.0
0.0
0.1
0.1
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.2
0.1
0.1
0.6
0.2
0.2
1.0
0.1
0.5
0.0
0.3
0.4
0.2
0.1
0.2
0.1
0.2
0.1
0.1
0.2
0.3
0.1
0.1
0.1
0.1
0.0
0.0
0.6
0.1
0.1
0.1
0.2

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0

0.0
0.1
0.0
0.0
-

0.1
0.0
0.3
0.3
0.2
0.2
0.5
0.2
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.1
0.0
0.0
1.2
0.3
1.7
0.9
0.5
0.8
0.1
0.5
0.6
0.1
3.1
0.2
1.0
2.0
0.1
0.1
0.5
0.0
1.2
0.4
0.3
0.5
0.3
0.0
0.0
0.6
0.7
0.1
0.2
0.3

1824
196
66
3822
128
474
683
1167
1937
512
291
197
203
182
118
219
456
404
122
162
214
305
132
636
261
211
91
253
50
311
263
385
183
44
309
347
140
680
194
94
256
495
281
197
56
139
304
247
116
464
366
806
111
639
196
308
1223
542
647

1880
198
70
3860
128
512
785
1254
2012
524
293
198
203
182
119
220
461
405
122
165
214
306
152
637
308
216
91
263
51
334
266
451
203
49
341
349
150
700
198
97
259
520
341
200
58
146
306
295
123
482
412
838
112
649
214
320
1233
564
714

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

782

Sarcoma Other Unspec.

Cancer Incidence in Five Continents Vol. IX, IARC 2008

*
*
*

*
*
*
*

*
*
*

Europe
Serbia
Slova
Slove
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Switz
Switz
Switz
Switz
Switz
Switz
Switz
The N
The N
The N
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, N
UK, S
Oceani
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Frenc
New Z
USA,
USA,
USA,
USA,
USA,
USA,

*
*

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Thyroid (C73) - Female (Contd)

es

Carcinoma

al

8
2
5
0
6
3
8
7
1
6
6
2
6
8
1
7
9
7
9

0
8
0
0
8
2
5
4
2
4
3
8
3
2
9
0
1
5
2
5
4
6
2
7
8
6
1
3
1
4
6
1
3
9
1
9
0
0
8
7
9
0
1
0
8
6
6
5
3
2
2
8
2
9
4
0
3
4
4

*
*
*

*
*
*
*

*
*
*

Follicular Papillary Medular Anaplastic Other Unspec.


Europe (Contd)
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, England, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern And Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory (data not available)
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Sarcoma Other Unspec.

Number of cases
MV

Total

0.3
0.6
0.6
0.5
1.0
0.7
0.8
1.1
1.0
1.1
1.7
0.9
0.3
0.5
0.9
0.2
0.4
1.6
0.6
1.1
0.7
0.5
0.7
0.5
0.4
0.5
0.5
0.6
0.9
0.6
0.4
0.5
0.8
0.7
0.7

0.9
3.4
3.8
3.7
3.2
3.1
4.8
3.4
5.0
6.1
4.9
7.9
3.2
3.1
2.4
4.9
1.7
4.2
2.9
4.0
5.2
3.7
1.6
1.9
1.3
1.5
1.8
1.5
1.7
1.8
1.6
1.5
1.3
1.5
1.7
1.7

0.1
0.2
0.2
0.3
0.1
0.1
0.3
0.2
0.1
1.2
0.3
0.2
0.3
0.2
0.1
0.3
0.1
0.1
0.3
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1

0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.2
0.2
0.0
0.0
0.1
0.2
0.1
0.1
0.0
0.2
0.1
0.1
0.0
0.1
0.0
0.1
0.0
0.1
0.0
0.1

0.5
0.0
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.0
0.3
0.0
0.1
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0

0.1
0.0
0.1
0.1
0.1
0.0
0.2
0.0
0.1
0.0
0.0
0.0
0.2
0.1
0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.1
0.1

0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.1
0.0
0.0
0.0
-

0.5
0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
0.0
0.0
0.0
0.4
0.0

321
768
341
42
193
235
284
20
110
185
247
184
72
118
1029
98
20
26
90
54
65
105
1285
85
76
202
204
302
545
243
582
1036
339
456
139
472

405
802
342
42
197
239
294
20
112
185
254
185
72
123
1031
98
21
26
90
55
66
106
1293
85
76
209
213
322
588
252
640
1133
363
475
160
485

1.1
1.5
1.1
0.8
1.0
0.5
0.8
3.9
1.1
1.2
0.8
1.5
1.6
1.2
1.3

6.4
6.0
5.2
5.6
3.5
5.1
4.4
31.5
3.6
10.1
10.9
20.5
8.6
5.5
7.1

0.2
0.1
0.1
0.2
0.2
0.1
0.2
0.2
0.1
0.1
0.1
0.2

0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.3
0.1
0.1
0.3
0.2
0.0
-

0.0
0.1
0.0
0.0
0.0
0.0
0.6
0.0
0.0
0.2
-

0.1
0.1
0.1
0.1
0.1
0.6
0.0
0.0
-

0.0
0.0
-

0.0
-

0.0
0.0
0.0
0.1
0.1
0.0
0.2
0.1
-

1590
832
308
105
730
332
50
179
592
430
38
138
61
60
81

1639
857
310
107
750
334
52
180
598
430
38
138
61
60
81

*
*

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

725

783

Age-standardized (world) incidence rates (per 100,000)


by histological type

Hodgkin lymphoma - Male


Nodular

Classical

Nodular

Mixed

Lymphocytic

Unspec.

0.0
0.2
-

0.3
-

0.6
1.7
0.1
0.2

0.0
1.3
0.7
0.0
0.4

0.0
0.1
0.4
0.1

0.0
0.0
0.0
0.0
0.1
-

0.1
0.0
0.0
0.3
0.1
0.1
0.1
0.1

0.5
0.4
0.3
0.5
0.3
0.6
1.1
0.2
0.2
0.1

0.4
0.1
0.3
0.2
0.2
0.6
0.6
0.2
0.3
0.1

0.1
0.2
0.2
0.1
0.1
0.1
0.9
0.2
0.7
0.2
0.0
0.1
0.0
0.2
0.0
0.1
0.1
0.3
0.1
0.2
0.1
0.4
0.1
0.1
0.1
0.0
0.3
0.1
0.1
0.1
0.1
0.3
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.2
0.1
0.0
0.2
0.2

0.1
0.1
0.1
0.1
0.1
0.3
0.2
0.1
0.6
0.1
0.1
0.2
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.4
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.0
0.1

1.7
1.8
1.5
1.9
1.7
0.8
1.4
1.8
1.5
1.3
1.1
1.4
1.1
1.2
1.4
1.6
0.7
0.8
0.9
1.2
2.3
1.3
1.2
0.3
0.4
1.0
0.7
0.4
2.1
0.6
0.9
1.0
2.0
1.7
2.1
2.1
2.2
1.7
1.1
2.4
1.4
0.8
1.5
1.3
1.5
1.3
1.6
1.2
1.4
1.5
1.6
1.0
1.7
1.6
1.6
1.9
1.2
0.2
1.8
0.5
1.6
2.5
2.0

0.4
0.4
0.2
0.3
0.2
0.6
0.7
0.3
0.7
0.7
0.4
0.4
0.4
0.4
0.3
0.4
0.3
0.4
0.4
0.2
0.5
0.3
0.6
0.6
0.1
0.7
0.2
0.6
0.2
0.5
0.6
0.5
0.4
0.4
0.1
0.4
0.3
0.3
0.4
0.5
0.5
0.5
0.4
0.4
0.4
0.5
0.4
0.4
0.6
0.5
0.4
0.5
0.5
0.6
0.6
0.6
0.4
0.9
0.6
0.6
0.7
0.5

lymphocytic lymphocyte-rich sclerosis cellularity


Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Non-Hispanic White
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Georgia: Black
USA, Georgia: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
USA, Louisiana: Black
USA, Louisiana: White
USA, Maine
USA, Massachusetts
*Important. See note on population page.
Note: The rates are based on the histological groups described in Chapter 4.

784

726

Cancer Incidence in Five Continents Vol. IX, IARC 2008

depletion

Number of cases
MV

Total

1.4
0.2
0.5
0.6
0.2

50
180
31
37
27

50
180
31
37
27

0.1
0.0
0.1
0.1
0.1

1.2
1.6
2.3
1.4
1.6
1
0.4
0.3
0.7
0.6
0.4

11
71
22
39
626
19
77
182
43
9
10

16
75
24
41
627
19
79
183
43
9
10 *

0.0
0.0
0.1
0.0
0.0
0.0
0.3
0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0

0.5
0.3
0.4
0.1
0.4
0.1
.
0.2
0.6
.
0.1
0.3
0.3
0.4
0.3
0.5
0.4
0.6
0.4
0.5
0.1
0.7
0.7
0.7
0.4
0.5
0.4
0.1
0.3
.
.
0.5
0.2
0.4
0.4
0.5
0.4
0.6
0.2
0.6
0.8
1.1
0.3
0.6
0.5
0.6
0.6
0.6
0.6
0.6
0.7
0.5
0.4
0.5
0.7
0.5
0.5
0.3
0.5
0.4
1.1
0.4
0.5
0.4
0.5
0.6

1694
233
284
76
50
27
1
67
877
8
71
272
61
208
33
300
2259
488
26
21
12
82
1
314
622
69
8
6
211
2
3
306
112
145
519
1438
310
298
27
263
46
25
21
1209
117
1060
554
219
71
140
146
397
91
956
113
799
473
215
333
288
20
47
64
222
133
564

1751
233
285
76
50
27
1
68
932
8
71
273
61
209
33
305
2281
491
26
21
12
82
1
317
627
70
8
6
213
2
3
308
112
146
524
1453
318
300
27
265
50
26
22
1216
118
1066
562
223
71
143
148
402
93
973
114
815
477
216
342
290
21
48
65
223
135
576

*
*
*
*

Americ
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
Asia
Bahra
China
China
China
China
China
China
Cypru
India,
India,
India,
India,
India,
India,
India,
Israel
Israel
Israel
Japan
Japan
Japan
Japan
Japan
Japan
Japan
Korea
Korea
Korea
Korea
Korea
Korea

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Hodgkin lymphoma - Male (Contd)

es

al

0
0
1
7
7

*
*
*
*

6
5
4
1
7
9
9
3
3
9
0*

1
3
5
6
0
7
1
8
2
8
1
3
1
9
3
5
1
1
6
1
2
2
1
7
7
0
8
6
3
2
3
8
2
6
4
3
8
0
7
5
0
6
2
6
8
6
2
3
1
3
8
2
3
3
4
5
7
6
2
0
1
8
5
3
5
6

Nodular

Classical

Nodular

Mixed

Lymphocytic

Unspec.

0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.4
0.1
0.3
0.1
0.2
0.1
0.0
0.0
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.2
0.1
0.1
0.0
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.1
0.1

0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.2
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.2
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.2
0.2
0.1
0.1
0.3
0.2

1.9
2.2
1.5
2.5
1.4
2.0
1.6
1.2
1.7
1.3
1.9
1.4
2.1
1.3
1.0
1.9
2.0
1.4
2.2
1.6
1.1
1.7
1.7
1.2
1.8
1.3
1.7
2.1
1.5
2.2
1.6
1.7
1.4
1.8
1.5
0.7
1.1
1.1
1.9
1.0
0.8
1.1
1.3
1.1
1.4
1.4
2.0
1.6
1.6
1.5
1.8

0.4
0.5
0.5
0.4
0.6
0.4
0.4
0.2
0.5
0.6
0.5
0.5
0.5
0.3
0.6
0.3
0.6
0.6
0.6
0.5
0.5
0.5
0.5
0.6
0.5
0.6
0.2
0.6
0.7
0.6
0.7
0.4
0.4
0.4
0.5
0.3
0.5
0.6
0.5
0.5
0.5
0.5
0.4
0.2
0.5
0.2
0.2
0.6
0.5
0.5
0.5

0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.1
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.1
0.1
0.2
0.1
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
-

0.4
0.0
0.4
0.0
0.0
1.5
0.0
0.1
0.0
0.2
1.9
2.0
1.4
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.1
0.0
0.1

0.3
0.2
0.2
0.0
0.0
0.8
0.2
0.1
0.2
0.0
0.1
0.3
0.7
0.7
0.8
0.1
0.0
0.3
0.1
0.0
0.1
0.1
0.1
0.1
0.2
0.1
0.2

0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0

lymphocytic lymphocyte-rich sclerosis cellularity


America, North (Contd)
USA, Michigan
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Michigan: Black
USA, Michigan: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York state
USA, New York state: Black
USA, New York state: White
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 registries)
USA, SEER (9 registries): Black
USA, SEER (9 registries): White
USA, SEER (14 registries)
USA, SEER (14 registries): Asian and Pacific Islander
USA, SEER (14 registries): Black
USA, SEER (14 registries): Hispanic White
USA, SEER (14 registries): Non-hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, New Delhi
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon

depletion

Number of cases
MV

Total

0.5
0.4
0.6
0.4
0.7
0.5
0.5
0.5
0.5
0.3
0.5
0.4
0.6
0.4
0.2
0.5
0.5
0.6
0.8
0.5
0.5
0.6
0.5
0.5
0.4
0.5
0.6
0.5
0.5
0.5
0.5
0.5
0.4
0.5
0.4
0.4
0.2
0.5
0.4
0.4
0.4
0.4
0.4
0.6
0.7
0.6
0.2
0.7
0.4
0.4
0.5
0.5

778
344
68
271
99
663
413
38
371
64
716
84
602
115
1
40
71
1687
217
1428
16774
1646
14505
874
80
766
261
254
1128
100
1000
88
2006
210
1670
5302
196
512
734
3786
224
57
162
1312
130
1145
127
53
473
315
135
451

797
349
68
276
99
682
419
39
376
65
729
85
612
118
1
41
73
1737
226
1468
17078
1677
14764
893
80
784
267
255
1136
100
1007
89
2023
210
1686
5363
196
515
741
3832
233
59
169
1370
139
1192
127
54
477
315
138
454

0.9
0.3
0.3
0.2
0.1
0.3
0.4
0.3
0.9
0.1
0.7
0.9
1.5
0.8
0.1
0.9
0.8
0.8
0.1
0.5
0.1
0.2
0.3
0.2
0.2
0.1
0.1
0.2
0.1
0.3
0.1

16
34
155
3
2
89
14
47
128
3
261
42
474
66
19
547
457
85
13
13
14
37
19
109
12
346
31
20
15
13
22

18
34
157
3
2
90
14
50
129
3
261
42
474
67
19
565
470
86
13
13
16
41
19
109
12
346
31
20
15
13
22

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

727

*
*
*
*
*

*
*
*
*

785

Age-standardized (world) incidence rates (per 100,000)


by histological type

Hodgkin lymphoma - Male (Contd)


Nodular

Classical

Nodular

Mixed

Lymphocytic

Unspec.

0.2
0.0
0.1
0.0
0.0
0.0
0.1
0.1
0.0
0.0

0.0
0.0
0.3
0.2
0.0
0.0
0.0
0.1
0.0
0.0
0.2
0.1

0.1
1.3
0.7
0.1
0.0
1.1
0.5
0.3
0.6
0.5
0.9
0.9
0.2
0.2
0.4
0.6

0.1
0.1
0.2
1.0
0.4
0.0
0.0
0.5
0.4
0.0
0.1
0.1
0.3
0.0
0.4
0.5

0.0
0.1
0.0
0.2
0.0
0.0
0.0
0.0
0.0
0.1

0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.2
0.1
0.1
0.1
0.1
0.3
0.3
0.2
0.1
0.5
0.1
0.1
0.0
0.1
0.1
0.4
0.1
0.1
0.2
0.1
0.2
0.0
0.1
0.3
0.1
0.4
0.2
0.2
0.1
0.0
0.0
0.3
0.1
0.0
0.0

0.1
0.0
0.3
0.3
0.1
0.0
0.2
0.2
0.2
0.2
0.1
0.1
0.2
0.4
0.1
0.0
0.1
0.3
0.1
0.1
0.2
0.2
0.3
0.1
0.1
0.8
0.2
0.1
0.1
0.1
0.1
0.3
0.1
0.2
0.1
0.4
0.1
0.2
0.4
0.2
0.1
0.5
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.2
0.1
0.1
0.1

0.7
1.0
0.6
1.0
1.6
1.3
0.7
0.1
0.9
1.4
1.2
1.3
1.5
1.4
0.9
1.2
1.6
1.4
1.6
1.4
1.7
0.8
0.4
1.2
0.8
0.5
2.4
1.1
4.2
1.3
1.7
2.0
1.9
1.9
1.9
2.0
1.1
1.1
1.4
2.0
1.3
1.7
1.1
1.9
1.6
1.5
1.0
1.1
1.8
0.8
0.7
2.0
1.3
0.3
1.5
1.0
1.4
1.1

0.3
0.4
0.7
0.7
0.2
0.4
0.8
0.1
0.7
0.4
0.4
0.6
0.3
0.1
0.4
0.5
0.3
0.3
0.3
0.5
0.3
0.6
0.6
0.6
0.9
0.3
0.4
0.9
0.5
0.5
0.3
0.4
0.1
1.4
1.0
1.2
0.5
0.3
0.3
0.5
0.4
0.7
1.3
0.9
0.6
0.8
1.3
0.8
0.4
0.3
0.4
0.9
0.3
0.1
0.3
0.2
0.4
0.5

0.0
0.1
0.2
0.0
0.0
0.1
0.0
0.0
0.1
0.2
0.1
0.1
0.0
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.2
0.0
0.1
0.1
0.2
0.2
0.3
0.1
0.0
0.2
0.0
0.0
0.0
0.2
0.0
0.0
0.0
0.0
0.0
0.0

lymphocytic lymphocyte-rich sclerosis cellularity


Asia (Contd)
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland (data not available)
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg (data not available)
Germany, Free State of Saxony (data not available)
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania (data not available)
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio
Italy, Syracuse Province
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce (data not available)
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
*Important. See note on population page.
Note: The rates are based on the histological groups described in Chapter 4.

786

728

Cancer Incidence in Five Continents Vol. IX, IARC 2008

depletion

Number of cases
MV

Total

0.1
0.2
0.1
0.3
0.8
0.3
0.6
1
1
0.3
0.1
0.1
.
0.3
0.3
0.1
0.1
0.4
0.2

2
111
5
53
57
13
29
78
81
60
69
51
5
13
35
3
16
51
124

2
111
5
54
58
13
29
78
81
62
69
51
5
13
35
3
16
54
130

0.9
0.3
0.5
0.3
0.2
0.6
0.7
2.1
0.5
0.4
0.1
0.2
0.1
0.5
0.6
0.4
0.6
0.8
0.3
0.5
0.1
0.5
0.9
0.3
0.6
0.1
0.4
0.5
1
1.1
0.2
1.1
0.4
0.6
0.5
0.2
0.6
1.3
0.5
0.3
1.8
0.4
0.9
0.1
0.6
0.1
0.8
0.8
0.8
1.7
0.7
0.9
0.2
0.3
1.8
0.3
0.8
0.9
0.7

428
29
19
655
100
323
564
306
662
344
66
63
43
34
37
60
81
90
36
33
26
34
86
147
164
67
26
237
34
55
27
100
39
14
115
54
48
180
29
24
46
76
73
49
9
27
78
71
45
172
118
194
35
285
46
100
179
205
270

440
29
19
665
100
323
564
308
682
355
66
63
43
34
38
60
84
90
36
33
26
34
102
153
168
68
26
239
34
56
27
106
40
14
115
54
48
181
29
24
46
77
74
49
9
27
78
81
46
175
122
194
35
285
49
100
179
205
276

*
*
*

*
*
*
*

*
*
*

Europe
Serbia
Slova
Slove
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Switz
Switz
Switz
Switz
Switz
Switz
Switz
The N
The N
The N
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, N
UK, S
Oceani
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Frenc
New Z
USA,
USA,
USA,
USA,
USA,
USA,

*
*

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Hodgkin lymphoma - Male (Contd)

es

al

2
1
5
4
8
3
9
8
1
2
9
1
5
3
5
3
6
4
0

0
9
9
5
0
3
4
8
2
5
6
3
3
4
8
0
4
0
6
3
6
4
2
3
8
8
6
9
4
6
7
6
0
4
5
4
8
1
9
4
6
7
4
9
9
7
8
1
6
5
2
4
5
5
9
0
9
5
6

*
*
*

*
*
*
*

*
*
*

Nodular

Classical

Nodular

Mixed

Lymphocytic

Unspec.

0.0
0.1
0.1
0.1
0.2
0.3
0.3
0.1
0.2
0.5
0.1
0.1
0.4
0.0
0.1
0.1
0.1
0.1
0.0
0.2
0.2
0.2
0.1
0.0
0.0
0.1
0.1

0.1
0.1
0.0
0.2
0.1
0.3
0.2
0.2
0.2
0.1
0.1
0.2
0.2
0.2
0.6
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.2
0.1
0.1
0.2
0.2
0.2

0.7
0.9
0.8
1.0
0.9
1.8
0.9
0.7
1.6
1.2
0.9
0.8
0.8
1.3
1.0
1.6
1.2
2.9
1.5
1.4
1.7
1.6
1.7
1.7
1.5
2.0
0.9
1.7
1.8
1.6
1.3
1.3
1.3
1.4
0.8
1.3

0.3
0.5
0.7
0.3
0.2
1.1
0.4
0.1
0.5
0.4
0.8
1.2
0.1
0.5
0.4
1.0
0.8
0.2
0.2
1.0
0.6
0.4
0.3
0.3
0.2
0.6
0.2
0.4
0.5
0.5
0.5
0.4
0.5
0.5
0.3
0.5

0.1
0.1
0.1
0.0
0.1
0.1
0.2
0.0
0.1
0.1
0.0
0.0
0.2
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.1
0.2
0.2
0.2
0.1
0.2
0.0
0.1

0.1
0.1
0.2
0.1
0.1
0.1
0.2
0.1
0.2

1.2
1.1
1.2
1.2
1.5
0.9
1.2
0.2
0.9
0.9
0.4
0.7
0.8
1.3
1.0

0.4
0.2
0.7
0.8
0.4
0.5
0.4
0.4
0.6
0.6
0.8
0.7
0.1
0.6

0.1
0.0
0.0
0.0
0.0
0.0
-

lymphocytic lymphocyte-rich sclerosis cellularity


Europe (Contd)
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, England, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern And Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory (data not available)
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

depletion

Number of cases
MV

Total

1.9
0.3
0.2
0.4
1
0.3
0.3
.
0.2
0.3
0.5
0.1
1.6
0.5
0.4
0.5
0.2
0.4
0.5
1.3
0.2
0.3
0.3
0.3
0.4
0.4
0.8
0.4
0.2
0.3
0.6
0.9
0.5
0.3
1
0.4

383
272
96
17
76
177
79
9
44
46
84
40
39
64
471
33
19
14
38
34
21
44
1076
74
55
235
127
312
497
207
396
959
310
344
83
330

403
285
96
17
76
177
79
9
45
46
84
40
39
64
471
33
19
14
38
34
21
44
1076
74
55
235
135
319
505
207
472
1049
318
351
97
333

0.5
0.3
0.2
0.1
0.3
0.3
0.4
0.8
0.4
0.2
0.4
0.1
0.2
0.4
0.1

412
175
92
29
319
101
14
8
201
63
3
10
10
9
21

422
183
94
29
321
102
15
8
203
63
3
10
10
9
21

*
*
*Important. See note on population page.
Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

729

787

Age-standardized (world) incidence rates (per 100,000)


by histological type

Hodgkin lymphoma - Female


Nodular

Classical

Nodular

Mixed

Lymphocytic

Unspec.

0.0
0.1
-

0.0
0.1
0.2
-

0.4
0.9
0.1
0.2

0.5
0.3
0.1
0.1

0.0
0.3
0.1

0.1
0.0
0.0
-

0.1
0.0
0.0
0.1
0.0
0.1
0.1

0.1
0.3
0.2
0.2
0.4
0.2
0.6
1.1
0.2
0.3
-

0.4
0.2
0.2
0.1
0.2
0.3
0.2
0.2
0.2

0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.1
0.2
0.1
0.0
0.1
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.1
0.0
0.0
0.1
0.0
0.1
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.0
0.0
0.1
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.1
0.1

1.6
1.8
1.3
1.4
1.8
1.0
1.8
1.7
2.4
2.0
1.2
0.9
1.4
1.5
1.1
1.4
1.5
1.0
0.5
1.4
1.3
0.9
2.1
1.3
1.1
1.5
1.0
0.6
0.3
2.4
0.7
0.9
1.1
2.0
1.6
2.3
1.6
2.4
1.0
0.7
1.5
1.5
0.9
1.6
1.3
1.5
1.3
1.8
1.1
1.5
2.0
1.7
1.2
1.8
1.7
2.0
1.5
1.5
0.9
2.0
0.9
1.8
1.9
2.1

0.2
0.2
0.1
0.2
0.1
0.1
0.3
0.2
0.3
0.3
0.2
0.2
0.2
0.2
0.1
0.2
0.2
0.1
0.1
0.2
0.2
0.3
0.2
0.0
0.1
0.3
0.4
0.1
0.2
0.2
0.2
0.1
0.2
0.3
0.2
0.2
0.3
0.2
0.2
0.2
0.2
0.2
0.1
0.2
0.2
0.2
0.2
0.2
0.1
0.2
0.2
0.3
0.4
0.4
0.5
0.4
0.3
0.4
0.1
0.2

lymphocytic lymphocyte-rich sclerosis cellularity


Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Non-Hispanic White
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Georgia: Black
USA, Georgia: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
USA, Louisiana: Black
USA, Louisiana: White
USA, Maine
USA, Massachusetts
*Important. See note on population page.
Note: The rates are based on the histological groups described in Chapter 4.

788

730

Cancer Incidence in Five Continents Vol. IX, IARC 2008

depletion

Number of cases
MV

Total

1.2
0.1
0.1
0.8
0

45
83
18
23
15

46
83
18
24
16

0.0
0.1
0.1
0.0
-

1.5
1
1.3
1.1
1.2
0.3
0.3
0.2
0.4
0.5
0.2

15
55
13
35
544
8
66
153
29
8
8

20
58
14
37
544
8
69
154
29
8
8*

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0

0.3
0.2
0.2
0.1
0.2
0.1
.
0.2
0.4
.
0
0.3
0.2
0.3
0.1
0.3
0.2
0.2
0.2
0
0.2
0.2
.
0.3
0.2
0.1
0.1
0.3
0.2
.
.
0.3
0.1
0.2
0.2
0.3
0.3
0.5
0.3
0.5
0.8
0.8
0.3
0.4
0.3
0.4
0.3
0.4
0.2
0.5
0.3
0.4
0.2
0.3
0.4
0.3
0.4
0.1
0.4
0.2
0.3
0.4
0.2
0.3
0.2
0.3

1352
180
193
54
46
18
0
59
724
10
68
216
46
166
27
228
1773
358
19
13
15
54
2
231
505
51
2
17
153
2
2
273
110
102
387
1150
235
285
26
252
34
18
13
977
103
856
450
183
57
122
121
325
88
757
92
633
395
202
271
282
23
41
66
214
76
500

1410
181
194
54
46
18
0
59
780
10
68
223
46
173
27
235
1789
361
19
13
15
55
2
233
505
51
2
17
153
2
2
273
110
102
389
1164
240
285
26
252
35
19
13
985
103
864
454
184
57
123
121
329
89
766
94
640
402
203
274
284
23
41
66
216
80
505

*
*
*
*

Americ
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
Asia
Bahra
China
China
China
China
China
China
Cypru
India,
India,
India,
India,
India,
India,
India,
Israel
Israel
Israel
Japan
Japan
Japan
Japan
Japan
Japan
Japan
Korea
Korea
Korea
Korea
Korea
Korea

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Hodgkin lymphoma - Female (Contd)

es

al

6
3
8
4
6

*
*
*
*

0
8
4
7
4
8
9
4
9
8
8*

0
1
4
4
6
8
0
9
0
0
8
3
6
3
7
5
9
1
9
3
5
5
2
3
5
1
2
7
3
2
2
3
0
2
9
4
0
5
6
2
5
9
3
5
3
4
4
4
7
3
1
9
9
6
4
0
2
3
4
4
3
1
6
6
0
5

Nodular

Classical

Nodular

Mixed

Lymphocytic

Unspec.

0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.1
0.0
0.1
0.1
0.2
0.0
0.1
0.1
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.2
0.1
0.0
0.1
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.1
0.0
0.0

0.0
0.1
0.1
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.1
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.2
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.1
0.1

1.8
2.2
1.6
2.4
1.4
1.9
1.7
0.8
1.8
2.0
2.1
1.2
2.5
1.2
0.3
0.9
1.9
1.9
1.1
2.2
1.6
1.0
1.7
1.7
1.1
1.8
1.2
1.6
2.0
1.5
2.1
1.6
1.7
1.4
2.0
1.6
0.6
1.1
1.1
2.1
1.2
0.7
1.4
1.2
1.0
1.2
1.5
2.8
1.9
1.9
1.3
2.0

0.2
0.2
0.1
0.2
0.1
0.2
0.2
0.2
0.2
0.3
0.3
0.3
0.3
0.1
0.1
0.2
0.3
0.2
0.3
0.2
0.2
0.2
0.2
0.4
0.2
0.3
0.2
0.3
0.2
0.3
0.5
0.2
0.1
0.2
0.2
0.1
0.2
0.2
0.3
0.2
0.3
0.2
0.1
0.1
0.1
0.1
0.0
0.2
0.2
0.2
0.2

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
-

0.8
0.1
0.3
0.0
2.5
0.1
0.1
0.0
0.2
2.1
2.2
1.7
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.0
0.0
0.0

0.4
0.0
0.1
0.0
0.5
0.1
0.1
0.0
0.1
0.5
0.4
0.6
0.1
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

lymphocytic lymphocyte-rich sclerosis cellularity


America, North (Contd)
USA, Michigan
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Michigan: Black
USA, Michigan: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York state
USA, New York state: Black
USA, New York state: White
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 registries)
USA, SEER (9 registries): Black
USA, SEER (9 registries): White
USA, SEER (14 registries)
USA, SEER (14 registries): Asian and Pacific Islander
USA, SEER (14 registries): Black
USA, SEER (14 registries): Hispanic White
USA, SEER (14 registries): Non-hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, New Delhi
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon

depletion

Number of cases
MV

Total

0.4
0.3
0.2
0.3
0.3
0.4
0.2
0.3
0.2
0.3
0.3
0.3
0.4
0.2
.
0.2
0.3
0.4
0.3
0.4
0.3
0.3
0.3
0.3
0.2
0.3
0.4
0.2
0.3
0.1
0.3
0.4
0.3
0.2
0.3
0.3
0.1
0.2
0.2
0.3
0.4
0.4
0.4
0.4
0.5
0.3
0.2
0.5
0.2
0.3
0.4
0.3

656
306
67
235
82
561
322
26
294
63
685
77
596
75
2
22
51
1451
151
1263
13794
1338
11955
741
68
651
188
197
949
72
862
78
1685
181
1409
4481
160
424
529
3316
213
56
153
987
123
838
112
55
385
266
116
374

672
310
67
239
84
575
324
26
296
66
689
77
600
76
2
23
51
1490
155
1297
14009
1349
12155
748
68
658
192
200
952
72
865
78
1696
181
1420
4515
160
424
533
3346
219
56
159
1032
126
879
112
55
388
268
116
379

0.6
0.2
0.1
0.8
0.1
0.2
0.2
0.5
0.4
.
0.4
0.3
0.8
0.5
0.1
0.8
0.8
0.4
0.2
0.2
0
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1

15
21
98
4
2
44
8
62
58
1
118
15
176
37
15
511
439
68
8
6
10
24
12
54
7
187
21
13
6
7
7

15
23
101
4
2
44
8
63
59
1
118
15
176
37
15
540
461
69
8
6
10
27
12
54
7
191
22
13
6
7
8

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

731

*
*
*
*
*

*
*
*
*

789

Age-standardized (world) incidence rates (per 100,000)


by histological type

Hodgkin lymphoma - Female (Contd)


Nodular

Classical

Nodular

Mixed

Lymphocytic

Unspec.

0.0
0.1
0.1
0.0
0.0
-

0.0
0.3
0.1
0.0
0.1
0.0
0.1

0.1
0.1
0.1
1.0
0.7
0.0
0.0
0.6
0.4
0.2
0.4
0.3
0.5
0.7
0.0
0.0
0.3
0.4

0.1
0.0
0.1
0.2
0.1
0.1
0.1
0.3
0.1
0.0
0.0
0.2
0.1
0.2
0.0
0.4
0.3

0.0
0.1
0.1
0.0
0.1
0.0

0.0
0.1
0.0
0.1
0.1
0.0
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.1
0.1
0.0
0.1
0.1
0.0
0.0
0.0
-

0.0
0.1
0.2
0.0
0.0
0.1
0.1
0.2
0.0
0.2
0.1
0.3
0.2
0.0
0.1
0.0
0.2
0.0
0.3
0.2
0.1
0.2
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.2
0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0

0.7
0.6
1.1
1.4
1.2
1.5
0.7
0.2
1.0
1.3
1.6
1.2
1.5
1.7
1.3
2.1
1.5
1.4
1.2
1.4
0.5
1.7
0.9
1.6
0.6
0.8
1.4
1.3
2.7
1.7
2.8
2.6
2.7
1.4
1.7
1.9
1.5
1.2
3.5
1.8
0.9
2.2
1.3
2.7
0.4
1.9
1.3
1.2
2.2
1.3
1.0
1.1
0.9
1.3
0.1
1.6
1.2
1.3
1.4

0.1
0.0
0.5
0.6
0.2
0.2
0.4
0.0
0.4
0.2
0.5
0.1
0.1
0.4
0.3
0.1
0.1
0.1
0.6
0.3
0.2
0.3
0.3
0.4
0.2
0.3
0.3
0.2
0.1
0.6
0.3
0.5
0.4
0.3
0.2
0.3
0.1
0.1
0.1
0.3
0.3
0.6
0.4
0.4
0.8
0.4
0.2
0.1
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.4

0.0
0.0
0.1
0.1
0.0
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.1
0.0
0.0
0.2
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.0

lymphocytic lymphocyte-rich sclerosis cellularity


Asia (Contd)
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland (data not available)
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg (data not available)
Germany, Free State of Saxony (data not available)
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania (data not available)
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio
Italy, Syracuse Province
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce (data not available)
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
*Important. See note on population page.
Note: The rates are based on the histological groups described in Chapter 4.

790

732

Cancer Incidence in Five Continents Vol. IX, IARC 2008

depletion

Number of cases
MV

Total

0.1
0.1
0.1
0.2
0.3
0.2
0.5
0.4
0.3
0.2
0.2
0.1
0.2
0.5
0.2
.
0.1
0.3
0.1

3
55
6
33
24
10
23
32
31
60
48
27
7
14
18
0
10
32
76

3
56
6
33
25
10
23
33
32
63
48
27
7
14
18
0
11
35
77

0.6
0.4
0.1
0.3
0.2
0.4
0.4
2.1
0.4
0.2
0.2
0.1
0.1
0.3
0.3
0.2
0.3
0.7
.
0.4
0.4
0.6
1
0.1
0.5
0
.
0.3
0.1
1
0.1
1
0.2
1
0.3
0.2
0.5
0.9
0.2
0.2
1.3
0.6
0.9
0.2
1.9
0.3
0.4
0.4
0.4
1
0.6
1
0
0.1
1.6
0.2
0.6
0.8
0.6

319
21
18
703
72
280
369
306
620
250
91
52
30
31
42
73
58
68
15
27
18
36
99
128
108
45
14
211
15
53
34
95
37
14
77
47
35
152
42
17
37
73
61
40
13
21
68
50
40
107
120
255
15
219
40
93
164
165
324

334
21
18
712
72
280
369
312
646
260
93
52
30
31
44
73
60
68
15
27
18
36
107
138
110
45
14
213
15
54
34
102
40
14
77
47
35
154
42
17
37
73
61
40
13
21
68
59
40
112
126
255
15
222
42
93
164
165
327

*
*
*

*
*
*
*

*
*
*

Europe
Serbia
Slova
Slove
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Switz
Switz
Switz
Switz
Switz
Switz
Switz
The N
The N
The N
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, N
UK, S
Oceani
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Frenc
New Z
USA,
USA,
USA,
USA,
USA,
USA,

*
*

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Hodgkin lymphoma - Female (Contd)

es

al

3
6
6
3
5
0
3
3
2
3
8
7
7
4
8
0
1
5
7

4
1
8
2
2
0
9
2
6
0
3
2
0
1
4
3
0
8
5
7
8
6
7
8
0
5
4
3
5
4
4
2
0
4
7
7
5
4
2
7
7
3
1
0
3
1
8
9
0
2
6
5
5
2
2
3
4
5
7

*
*
*

*
*
*
*

*
*
*

Nodular

Classical

Nodular

Mixed

Lymphocytic

Unspec.

0.0
0.0
0.0
0.0
0.2
0.0
0.2
0.1
0.0
0.0
0.1
0.1
0.4
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0

0.1
0.0
0.0
0.2
0.0
0.0
0.1
0.1
0.1
0.1
0.0
0.4
0.4
0.1
0.1
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.1

0.4
1.4
1.4
1.0
1.3
1.8
1.1
0.7
1.1
1.0
1.3
1.9
1.1
0.7
1.2
2.2
1.1
1.8
2.2
2.2
1.5
1.6
1.5
1.6
1.7
1.5
1.4
1.4
1.3
1.3
1.4
1.0
1.1
1.2
0.8
1.5

0.2
0.3
0.4
0.1
0.2
0.4
0.3
0.6
0.3
0.3
0.2
0.4
0.2
0.2
0.3
0.1
0.3
0.5
0.1
0.1
0.1
0.2
0.2
0.3
0.2
0.1
0.2
0.2
0.1
0.2
0.2
0.2
0.1
0.2

0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.2

0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.2
-

1.3
1.2
1.2
0.6
1.5
1.1
0.6
0.5
1.1
0.8
0.7
1.0
0.4
1.3

0.2
0.1
0.2
0.6
0.2
0.1
0.5
0.2
0.0
0.1
0.1

0.0
0.0
0.0
0.0
0.0
0.2
-

lymphocytic lymphocyte-rich sclerosis cellularity


Europe (Contd)
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, England, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern And Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory (data not available)
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

depletion

Number of cases
MV

Total

1.4
0.3
0.2
0.1
0.7
0.2
0.1
0
0.2
0.1
0.2
0
0.9
0.6
0.3
0.3
.
0.2
0.2
1.7
.
0.2
0.2
0.1
0.3
0.3
0.5
0.2
0.2
0.2
0.4
0.6
0.3
0.2
0.7
0.2

272
305
113
12
68
107
71
8
25
31
55
38
25
41
400
35
6
11
36
37
18
41
773
54
51
163
122
188
321
127
309
680
219
244
76
297

285
320
113
13
69
108
72
8
25
31
55
39
25
42
400
35
6
11
36
37
18
41
773
54
51
167
133
191
327
130
381
742
221
246
81
301

0.4
0.2
0
0.1
0.2
0.2
0.3
0.4
0.3
0.1
.
0.1
0.3
.
0.1

342
148
61
21
268
74
13
6
185
36
1
6
9
5
12

351
151
62
21
269
74
13
6
185
36
1
6
9
5
12

*
*
*Important. See note on population page.
Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

733

791

Age-standardized (world) incidence rates (per 100,000)


by histological type

Haematopoietic and lymphoid tissues - Male


NK-cell

Myeloid

lymphoma, NOS

Non-Hodgkin

Other

Unspec.

0.7
16.7
8.8
2.8
6.9

0.5
0.6
0.1

1.6
2.5
2.9
0.3
1.2

5.0
1.2
0.8
3.9

0.0
-

8.2
5.8
2.7
6.7
7.8
5.7
9.5
6.1
6.9
9.7
10.8

0.1
0.3
0.2
0.7
0.5
0.4
0.6
0.4
0.8
1.1

6.0
2.5
2.8
4.0
4.5
2.7
3.1
2.7
4.1
5.9
3.7

2.9
7.6
4.2
2.9
6.1
1.2
1.1
0.6
2.6
6.6
2.5

17.0
21.2
17.7
22.8
19.7
12.3
14.2
20.8
14.4
20.0
22.9
15.9
14.7
16.0
20.9
14.3
19.1
19.8
20.9
10.1
14.0
17.5
10.1
22.0
19.7
21.3
9.6
15.6
16.0
14.2
6.7
22.9
11.7
20.3
16.2
20.6
19.6
20.5
15.7
20.9
17.9
19.8
14.1
17.2
16.8
17.2
16.4
18.7
18.6
19.5
17.5
16.3
20.1
19.7
19.2
19.7
18.8
22.6
20.6
19.6
18.6
19.2
19.1
20.0
21.6
19.1

1.2
1.3
1.2
1.3
1.8
0.9
1.1
1.2
0.8
1.1
1.1
1.3
1.0
1.2
0.9
1.5
2.1
1.9
1.0
1.2
1.7
0.4
2.2
1.5
1.7
0.6
1.6
1.4
1.1
1.0
1.6
1.3
1.9
1.3
1.5
1.3
1.6
1.8
1.6
1.4
1.2
1.4
1.2
1.6
1.2
1.1
1.5
1.6
1.5
1.4
1.0
1.1
1.1
1.2
1.0
1.1
1.1
1.3
1.5
2.6
1.9
1.6
1.4
0.9
1.4

5.9
6.6
7.4
8.7
8.1
4.9
5.1
4.8
8.5
6.6
3.7
3.1
3.7
4.8
3.8
6.2
5.7
4.9
4.4
5.3
4.5
4.9
6.2
6.3
6.2
4.1
5.6
5.2
5.6
2.8
7.2
4.9
6.0
5.1
6.6
4.7
5.7
4.5
5.8
3.7
2.9
4.6
4.7
3.6
4.8
4.3
6.2
5.4
6.7
3.9
4.5
5.1
5.0
4.0
5.1
4.9
7.2
6.1
6.5
5.5
7.2
5.3
6.8
4.7
4.5

2.7
0.4
1.0
0.7
0.5
1.4
0.7
4.7
1.2
0.6
1.2
0.6
1.3
1.1
1.3
0.9
0.9
0.9
0.5
0.5
0.8
0.8
1.0
0.7
0.7
0.3
0.5
0.6
0.5
0.3
0.9
0.6
0.8
0.8
1.0
1.0
1.2
0.6
1.2
2.1
2.7
1.1
1.8
1.4
1.8
1.3
1.0
0.7
1.1
0.8
1.4
0.6
1.3
1.1
1.3
1.0
0.6
1.2
1.2
1.2
1.3
1.0
1.2
1.4
1.2

B-cell
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Non-Hispanic White
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Georgia: Black
USA, Georgia: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
USA, Louisiana: Black
USA, Louisiana: White
USA, Maine
USA, Massachusetts

T-cell and

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

792

734

Cancer Incidence in Five Continents Vol. IX, IARC 2008

Number of cases
MV

Total

1.6
4.1
1.4
4.5
1.2

222
1217
138
158
322

222
1321
141
194
375

0.0
0.1
0.1
0.3
0.0
0.0
-

6.0
3.5
3.8
4.5
5.2
5.1
6.5
3.4
5.5
2.7
2.0

129
459
72
240
5249
133
696
976
564
295
192

184
505
111
287
5289
133
773
1119
579
296
192 *

0.2
0.1
0.1
0.0
0.2
0.3
0.1
0.1
0.0
0.1
0.2
0.1
0.1
0.1
0.1
0.3
0.2
0.1
0.1
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.0
0.1
0.0
0.1

4.9
2.8
3.7
3.2
3.4
2.8
1.0
4.4
6.5
2.5
2.4
3.6
2.6
3.9
2.9
4.4
3.7
3.5
3.4
3.2
3.0
3.4
1.9
3.5
3.5
2.1
1.7
3.0
4.0
4.2
2.5
3.5
2.4
2.6
4.0
3.7
3.2
4.3
3.1
4.4
4.9
5.8
3.3
5.1
4.1
5.2
3.5
3.8
3.9
3.9
3.2
3.7
3.4
4.3
3.9
4.5
3.4
3.4
3.9
4.0
2.8
5.1
3.5
4.4
3.4
3.2

20569
2829
3855
1408
850
375
11
936
9117
149
1039
3297
550
2700
442
3817
30140
6195
409
281
202
684
57
4157
8169
778
172
199
1921
133
67
4575
2259
1768
4984
20474
3260
3711
180
3461
452
305
124
18821
1481
17087
5426
2010
516
1448
1142
4201
1172
11106
1163
9578
5213
3526
3765
4121
282
647
922
3167
1327
5614

25083
2900
4575
1511
876
379
11
1053
12374
151
1253
3661
620
2990
469
4307
31786
6459
433
289
214
710
60
4339
8403
804
177
205
1972
137
69
4713
2338
1867
5168
21735
3763
3939
189
3676
503
339
139
19656
1552
17841
5975
2166
575
1539
1288
4597
1259
12260
1289
10584
5634
3788
4338
4473
305
677
1026
3414
1514
6192

*
*
*
*

Americ
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
Asia
Bahra
China
China
China
China
China
China
Cypru
India,
India,
India,
India,
India,
India,
India,
Israel
Israel
Israel
Japan
Japan
Japan
Japan
Japan
Japan
Japan
Korea
Korea
Korea
Korea
Korea
Korea

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Haematopoietic and lymphoid tissues - Male (Contd)

es

al

22
21
41
94
75

*
*
*
*

84
05
11
87
89
33
73
19
79
96
92 *

83
00
75
11
76
79
11
53
74
51
53
61
20
90
69
07
86
59
33
89
14
10
60
39
03
04
77
05
72
37
69
13
38
67
68
35
63
39
89
76
03
39
39
56
52
41
75
66
75
39
88
97
59
60
89
84
34
88
38
73
05
77
26
14
14
92

NK-cell

Myeloid

lymphoma, NOS

Non-Hodgkin

Other

Unspec.

19.6
21.4
19.7
22.0
19.0
19.6
18.3
18.8
18.3
19.5
21.5
22.6
21.5
17.6
10.1
13.8
20.8
20.4
20.3
20.9
18.7
18.4
18.8
17.6
17.3
17.4
15.6
19.8
20.7
19.4
20.5
19.5
20.7
19.1
21.6
19.9
11.4
20.0
16.4
21.0
16.9
16.4
17.0
17.1
18.4
17.0
21.1
18.4
22.4
23.1
18.1
19.5

1.4
1.7
2.1
1.7
2.0
1.3
1.3
1.5
1.3
1.2
1.7
1.7
1.6
1.4
2.4
1.0
1.5
1.4
1.7
1.4
1.3
1.6
1.3
1.4
1.6
1.3
1.1
1.9
1.5
1.8
1.3
2.3
1.6
1.9
1.6
1.5
1.2
1.8
1.3
1.5
1.2
1.5
1.2
1.2
1.3
1.2
1.4
1.4
1.6
1.6
1.1
1.2

4.9
7.8
6.7
8.2
4.3
5.0
4.6
4.4
4.7
5.2
6.7
6.2
6.6
5.9
3.9
5.5
6.3
7.1
4.9
7.5
4.7
4.0
4.8
4.3
4.1
4.3
4.7
4.3
5.2
4.0
5.1
5.1
6.5
5.7
6.7
6.4
5.2
5.8
5.3
6.6
4.3
3.8
4.3
4.8
4.7
4.8
5.9
4.7
4.9
7.3
4.6
5.2

1.4
1.1
0.9
1.2
1.0
1.4
1.2
1.0
1.2
0.9
1.3
1.3
1.2
1.1
0.9
0.7
1.4
1.3
1.3
1.3
1.3
1.1
1.3
1.7
1.5
1.7
1.5
0.7
1.1
1.6
1.1
0.6
1.0
0.9
1.1
1.0
0.7
0.9
0.8
1.1
1.3
0.8
1.4
1.2
0.8
1.2
0.8
2.0
1.3
1.3
1.5
1.0

0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.1
0.1

4.6
2.2
6.7
0.7
1.5
1.9
0.8
9.9
1.9
3.6
2.2
1.4
3.2
1.2
3.8
20.4
20.6
12.0
3.8
2.8
6.1
5.4
3.5
3.6
3.3
4.5
3.6
4.5
4.5
5.0
4.8

0.1
0.7
0.3
0.0
0.1
0.4
0.1
0.8
0.1
0.0
0.7
2.9
3.1
1.2
0.5
0.1
0.8
0.6
4.2
1.0
0.7
0.7
0.5
0.5
0.9
0.5
1.0

6.2
3.5
3.3
2.2
1.2
2.0
3.4
3.4
1.8
1.3
2.0
2.5
2.5
1.4
2.1
7.1
6.9
4.8
2.5
3.2
5.0
3.6
5.3
3.3
2.7
3.0
2.7
2.9
2.3
3.3
2.5

4.1
5.5
0.7
0.4
2.9
4.4
3.0
3.0
2.6
0.3
2.7
2.0
4.7
0.0
0.5
0.9
0.9
0.5
0.6
3.6
2.2
0.5
2.3
0.9
0.8
0.3
0.2
0.5
0.4
1.3
0.1

0.2
0.0
0.0
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.4
0.1
0.2
0.1
0.2
0.2
0.0
0.2
0.1

B-cell
America, North (Contd)
USA, Michigan
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Michigan: Black
USA, Michigan: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York state
USA, New York state: Black
USA, New York state: White
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 registries)
USA, SEER (9 registries): Black
USA, SEER (9 registries): White
USA, SEER (14 registries)
USA, SEER (14 registries): Asian and Pacific Islander
USA, SEER (14 registries): Black
USA, SEER (14 registries): Hispanic White
USA, SEER (14 registries): Non-hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, New Delhi
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon

T-cell and

Number of cases
MV

Total

3.8
4.1
3.5
4.4
3.5
3.9
3.8
3.9
3.8
2.8
4.6
4.1
4.5
3.9
4.2
3.8
3.7
4.3
4.0
4.5
4.1
3.4
4.2
4.1
3.4
4.1
5.1
3.5
3.6
3.0
3.7
3.8
3.7
3.5
3.8
3.8
2.7
3.3
4.1
3.8
3.7
2.7
4.0
4.8
3.9
4.9
3.0
3.8
3.3
3.3
3.6
4.4

9242
4408
774
3552
935
8112
4985
391
4553
862
9310
945
7968
1552
75
417
1023
18227
1959
15704
199998
16596
175615
10382
845
9252
2999
3288
12912
835
11717
1077
26924
2047
22862
70234
3588
5572
6632
53257
3032
608
2386
14880
1353
13146
1797
557
6111
4619
1822
5517

9927
4617
827
3706
1021
8703
5541
435
5062
1001
10030
1040
8567
1720
79
456
1147
21501
2231
18640
217914
18341
191273
10989
909
9790
3234
3538
14471
952
13124
1137
28386
2195
24098
74812
3718
6041
6930
56884
3474
719
2693
17019
1588
14972
1848
617
6454
4785
1951
5748

4.7
4.3
4.3
6.3
3.2
3.2
2.6
3.8
3.1
1.4
3.2
4.4
3.0
5.0
2.6
3.8
3.7
3.3
3.1
3.8
3.2
4.8
3.9
4.8
4.1
3.3
3.4
3.6
3.9
3.2
3.5

123
802
2900
97
151
2200
319
420
912
69
2521
476
3401
547
257
5263
4704
383
370
441
481
1065
1154
4390
574
10140
870
658
324
374
634

131
844
3127
97
191
2432
321
428
935
71
2521
478
3401
552
262
5869
5194
415
370
504
643
1408
1284
4390
674
10815
936
680
351
384
668

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

735

*
*
*
*
*

*
*
*
*

793

Age-standardized (world) incidence rates (per 100,000)


by histological type

Haematopoietic and lymphoid tissues - Male (Contd)


NK-cell

Myeloid

lymphoma, NOS

Non-Hodgkin

Other

Unspec.

4.1
6.0
3.7
8.5
6.1
1.6
2.5
5.3
8.0
3.6
6.8
6.6
3.6
11.5
5.1
3.7
3.1
5.5
5.8

0.5
0.9
0.5
2.5
1.4
0.2
0.1
0.2
0.4
0.4
1.5
1.6
1.0
1.0
0.2
0.1
1.0
0.4
0.6

3.8
3.3
2.4
2.9
2.4
3.9
2.6
2.4
2.3
3.1
4.4
4.4
2.2
5.7
2.5
2.1
2.1
2.9
2.8

0.2
0.5
1.1
0.6
5.3
5.0
4.4
1.1
1.6
0.5
0.5
0.1
0.3
1.8
1.4
1.3
1.0
1.0

0.1
0.0
0.2
0.4
0.1
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.1

7.2
15.0
9.2
5.1
12.0
13.1
3.6
7.1
11.3
15.0
10.7
16.6
16.7
19.2
19.2
16.9
17.5
20.7
19.3
14.2
13.3
13.3
11.2
10.3
11.1
13.3
17.2
13.9
17.3
14.9
19.2
13.6
18.0
13.6
18.0
20.5
12.5
12.1
16.3
12.4
6.8
20.4
11.2
18.0
16.8
13.0
16.5
7.7
16.4
11.6
5.7
7.9
8.7
14.3
5.0
7.6
4.9
8.3
6.0

0.8
3.5
0.2
0.1
0.6
0.9
0.1
0.1
0.8
1.1
0.8
0.9
1.2
1.1
0.3
0.7
0.6
0.7
1.3
0.9
0.9
0.4
0.9
0.7
0.7
1.0
1.5
0.8
1.9
2.2
2.8
1.0
0.8
1.8
2.0
3.9
1.4
1.2
1.1
1.1
1.1
1.8
1.5
1.1
1.3
0.7
1.0
0.3
1.1
1.2
0.6
0.7
2.1
1.3
0.2
0.4
0.6
0.5
0.3

3.5
5.4
3.3
3.3
3.2
5.4
2.4
4.1
5.1
4.2
3.5
8.1
6.8
9.8
5.0
6.7
9.2
6.2
8.1
5.8
8.7
3.2
3.8
5.1
6.0
4.4
3.3
7.5
13.0
4.3
6.5
11.3
10.4
3.2
5.8
4.3
7.4
4.1
7.1
11.1
5.1
5.3
3.9
5.3
5.0
7.3
6.7
5.0
4.0
4.3
4.6
4.2
7.0
5.5
2.7
3.4
3.8
5.3
3.0

2.3
0.6
2.3
3.0
1.4
3.5
2.1
5.4
1.4
1.0
0.3
0.7
0.4
0.4
1.8
0.4
1.0
1.7
0.7
0.7
0.3
2.9
4.6
2.6
3.4
1.4
2.8
1.0
5.0
1.1
3.3
1.4
3.1
2.8
0.8
2.0
4.4
3.9
1.2
14.5
2.5
3.6
1.0
1.9
1.3
3.8
3.2
7.9
4.2
1.5
1.9
3.2
3.5
0.7
1.3
4.8
5.3
0.7

0.1
0.3
0.1
0.1
0.1
0.4
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.3
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.2
0.3
0.2
0.1
0.1
0.2
0.2
0.1
0.3
0.0
0.1
0.0
0.1
0.1
0.3
0.2
0.1
0.2
0.1
0.0
0.0
0.2
0.2
0.0

B-cell
Asia (Contd)
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland (data not available)
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg (data not available)
Germany, Free State of Saxony (data not available)
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania (data not available)
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio
Italy, Syracuse Province
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce (data not available)
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg

T-cell and

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

794

736

Cancer Incidence in Five Continents Vol. IX, IARC 2008

Number of cases
MV

Total

3.3
3.8
2.4
2.3
3.9
3.7
2.6
3.5
2.4
5.3
3.6
3.5
3.7
4.5
2.8
4.3
2.5
3.2
2.1

85
2907
159
231
356
295
524
318
485
1040
1349
1049
72
228
469
238
259
267
892

86
3080
171
238
362
313
539
347
495
1268
1349
1049
72
228
469
238
289
405
995

5.6
1.9
7.6
2.6
1.5
2.9
2.9
3.6
3.9
3.1
3.1
2.1
1.8
1.6
2.0
2.1
2.2
3.2
0.9
2.1
2.1
3.7
2.6
2.8
3.3
2.9
2.0
5.4
3.5
4.7
2.4
5.9
3.8
4.8
2.3
3.1
6.3
5.7
4.9
2.4
3.7
3.2
4.3
1.5
5.4
3.9
2.8
9.3
3.6
6.5
4.6
3.9
3.8
1.8
6.9
3.3
2.9
3.2
4.8

4934
572
219
3754
1255
4774
3172
2557
6554
4710
743
887
625
588
688
940
1129
1278
603
454
434
540
1159
1498
2017
887
212
3421
294
666
547
1353
745
209
1350
877
318
2347
655
326
578
1535
708
485
189
276
1228
722
567
1650
1156
1912
304
4301
302
840
1642
2200
1848

5474
582
238
3860
1255
4838
3172
2995
7682
4937
764
978
635
588
709
942
1168
1297
607
474
437
551
1484
1859
2364
964
213
3592
306
695
565
1807
918
223
1351
879
435
2368
657
342
590
1567
747
495
201
307
1264
961
601
1797
1219
1912
312
4496
363
884
1644
2216
1864

*
*
*

*
*
*
*

*
*
*

Europe
Serbia
Slova
Slove
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Switz
Switz
Switz
Switz
Switz
Switz
Switz
The N
The N
The N
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, N
UK, S
Oceani
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Frenc
New Z
USA,
USA,
USA,
USA,
USA,
USA,

*
*

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Haematopoietic and lymphoid tissues - Male (Contd)

es

al

86
80
71
38
62
13
39
47
95
68
49
49
72
28
69
38
89
05
95

74
82
38
60
55
38
72
95
82
37
64
78
35
88
09
42
68
97
07
74
37
51
84
59
64
64
13
92
06
95
65
07
18
23
51
79
35
68
57
42
90
67
47
95
01
07
64
61
01
97
19
12
12
96
63
84
44
16
64

*
*
*

*
*
*
*

*
*
*

NK-cell

Myeloid

lymphoma, NOS

Non-Hodgkin

Other

Unspec.

5.2
11.2
11.8
9.1
11.5
12.7
14.7
10.3
15.1
11.7
11.5
10.0
10.4
9.4
11.6
14.2
11.8
10.8
15.5
15.5
14.9
13.4
15.2
13.2
12.2
12.0
8.7
11.4
14.2
14.9
14.4
11.4
12.4
12.6
10.1
14.5

0.3
0.4
1.1
0.5
0.9
1.3
1.0
0.0
2.2
1.8
1.5
1.8
1.2
0.4
0.7
1.6
1.4
0.2
1.2
1.6
1.5
0.0
1.1
0.8
0.7
1.2
0.9
0.9
0.6
0.6
0.7
0.6
1.0
1.3
1.0
1.3

2.1
5.0
4.5
5.5
3.3
2.4
3.9
1.5
7.3
3.6
4.4
3.0
5.4
2.2
6.1
7.6
2.8
2.3
7.1
4.4
3.8
3.8
4.7
4.0
4.4
7.3
5.9
7.1
7.0
4.4
10.9
7.8
8.5
7.0
4.2
10.4

1.8
1.0
1.6
2.7
1.9
1.3
2.6
1.3
0.4
0.1
1.7
0.4
4.7
1.6
1.6
4.6
6.8
0.7
1.0
1.4
3.7
1.3
1.8
1.8
1.5
5.0
3.4
2.6
1.7
2.2
4.7
1.5
2.9
1.9
1.2

0.1
0.1
0.0
0.1
0.0
0.1
0.1
0.2
0.2
0.1
0.1
0.3
0.6
0.0
0.5
0.1
0.1
0.0
0.1
0.0
0.0
0.1
0.2
0.1
0.2
0.2
0.1
0.1
0.1

18.0
19.1
21.9
18.7
18.9
16.1
18.0
8.7
21.0
14.1
11.3
11.8
16.8
10.7
17.3

0.9
1.4
0.7
0.9
1.0
1.6
1.3
0.8
1.8
1.4
1.5
3.1
0.7
2.5

8.5
11.8
6.3
5.8
9.9
8.7
8.2
4.7
5.0
6.5
5.0
6.9
8.0
7.1
6.5

2.6
1.4
1.2
1.8
1.4
3.1
2.9
3.1
1.7
1.1
1.1
1.1
0.2
1.3
1.2

0.1
0.1
0.2
0.1
0.1
0.1
0.2
0.0
0.1
0.2
0.6
-

B-cell
Europe (Contd)
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, England, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern And Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory (data not available)
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

T-cell and

Number of cases
MV

Total

3.6
3.0
1.9
2.7
4.2
3.9
3.7
2.1
1.6
2.8
3.1
4.7
3.9
6.0
5.5
3.0
4.3
3.6
2.3
4.6
1.4
2.4
2.1
2.1
1.5
4.7
4.3
3.5
3.1
4.1
6.5
4.3
4.7
3.0
7.8
4.1

1826
2909
1343
224
966
1303
1058
144
582
526
768
409
471
612
9521
457
165
143
499
303
230
505
13212
746
671
2707
1694
3304
4934
2393
6089
11382
4815
4660
1095
5765

2000
3157
1343
230
1032
1381
1131
170
613
551
850
432
499
650
9533
465
172
144
499
324
237
527
13379
756
684
3080
2308
4151
7146
2468
10155
14793
5609
5637
1374
6049

3.9
3.6
6.1
2.7
4.1
3.3
3.8
5.0
4.5
3.2
3.7
1.9
3.7
3.0
3.6

6650
3751
1897
485
5662
1793
237
96
4024
1130
83
164
160
264
352

7721
4556
2012
517
5994
2012
289
99
4126
1160
87
170
163
271
361

*
*
*Important. See note on population page.
Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

737

795

Age-standardized (world) incidence rates (per 100,000)


by histological type

Haematopoietic and lymphoid tissues - Female


NK-cell

Myeloid

lymphoma, NOS

Non-Hodgkin

Other

Unspec.

0.4
9.5
5.3
1.8
6.7

0.3
0.2
0.2

1.5
2.3
1.6
0.5
1.3

3.7
0.7
0.6
3.3

0.1
0.0

5.6
4.0
2.9
5.1
5.5
4.8
7.2
5.0
5.5
6.1
6.9

0.8
0.3
0.2
0.3
0.4
0.2
0.6
0.2
0.4
1.4
0.6

3.4
1.3
2.5
3.6
3.4
1.6
2.3
2.0
2.6
4.8
3.0

2.7
4.2
1.6
2.0
4.5
1.2
0.7
0.5
2.3
4.7
1.5

11.0
14.0
11.5
15.3
13.6
7.5
3.3
12.3
9.4
11.0
14.6
10.8
10.3
10.9
14.3
10.2
12.6
12.7
12.6
6.9
7.4
13.5
8.0
13.9
12.7
13.7
7.1
10.1
11.4
8.4
4.7
14.5
8.1
13.2
12.0
13.4
13.7
13.1
12.7
13.2
11.3
10.8
11.9
11.6
11.7
11.6
11.1
12.0
11.8
12.2
11.5
10.9
14.1
13.0
13.4
13.0
12.6
14.6
14.1
12.9
10.4
12.0
12.0
13.2
14.0
13.3

0.9
0.8
0.9
0.9
0.8
0.5
1.9
1.1
0.9
0.3
1.0
0.6
0.9
0.5
1.3
0.5
0.9
1.3
1.2
1.0
1.3
1.1
1.2
1.3
0.9
1.4
0.6
0.6
0.5
0.9
0.5
0.9
0.8
1.3
0.7
0.9
0.8
1.0
1.3
1.0
0.7
0.7
0.8
0.8
1.3
0.7
0.8
1.2
1.4
1.0
1.0
0.7
0.7
0.7
1.1
0.6
0.6
0.6
0.8
0.9
0.9
0.7
1.1
0.8
0.6
0.9

4.1
4.8
5.3
6.9
4.8
2.6
4.1
3.3
4.0
4.8
2.6
2.2
2.7
3.1
2.7
4.1
3.8
4.5
3.1
3.0
4.0
2.0
3.8
4.2
3.8
2.5
4.3
4.1
3.0
2.2
4.7
3.4
4.0
4.1
4.2
3.3
4.0
3.8
4.0
2.4
2.3
2.1
3.3
3.4
3.2
2.8
3.5
3.0
3.9
2.3
3.0
3.5
3.5
3.1
3.6
3.5
4.8
4.3
4.7
4.5
6.1
4.3
4.8
3.3
3.2

2.0
0.3
0.6
0.6
0.2
0.7
0.6
3.5
0.3
0.4
0.7
0.5
0.7
0.5
0.9
0.6
0.4
0.4
0.3
0.1
0.6
0.3
0.5
0.4
0.3
0.1
0.4
0.3
0.1
0.5
0.2
0.3
0.5
0.6
0.7
0.9
0.6
0.9
0.8
0.7
1.1
1.2
0.8
1.2
0.7
0.5
0.2
0.6
0.6
0.8
0.7
0.9
0.9
0.9
0.9
0.4
0.7
0.9
0.6
1.5
0.5
1.1
1.2
0.8

B-cell
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Non-Hispanic White
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Georgia: Black
USA, Georgia: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
USA, Louisiana: Black
USA, Louisiana: White
USA, Maine
USA, Massachusetts

T-cell and

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

796

738

Cancer Incidence in Five Continents Vol. IX, IARC 2008

Number of cases
MV

Total

1.3
2.7
1.7
3.3
0.6

178
811
91
129
236

178
891
92
161
285

0.0
0.1
0.2
0.0
0.1
-

5.1
2.0
3.2
3.7
3.6
2.8
5.6
2.9
4.7
2.5
2.4

134
287
51
239
4825
106
684
759
513
276
175

186
340
85
286
4851
106
747
908
522
277
175 *

0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.0
0.2
0.0
0.1
0.0
0.0

3.6
2.0
2.5
2.1
3.0
2.8
2.0
3.3
4.8
2.3
1.7
2.4
2.0
2.5
2.6
2.9
2.5
2.6
1.7
1.7
2.0
3.2
1.7
2.7
2.4
1.6
2.0
1.7
2.9
1.6
1.7
2.1
1.8
1.8
3.0
2.4
2.3
3.3
2.5
3.5
2.6
2.6
2.4
3.4
3.2
3.5
2.4
2.4
2.1
2.6
2.2
2.5
2.6
3.0
2.5
3.2
2.7
2.4
2.4
2.5
3.1
2.1
2.4
2.6
2.5
2.6

16141
2183
2895
1170
665
260
5
732
7334
103
794
2922
553
2330
317
2994
23719
4849
339
233
158
601
61
3166
6483
694
157
175
1624
108
58
3427
1885
1453
4112
15764
2673
3155
196
2913
367
242
108
15454
1378
13863
4507
1549
432
1069
1019
3408
944
9557
1108
8169
4550
2969
3269
3497
237
566
819
2647
1103
5051

20327
2246
3578
1286
702
261
5
841
10300
106
1002
3283
627
2611
336
3411
25346
5135
356
243
164
635
63
3377
6740
741
164
178
1669
110
59
3571
1954
1558
4296
17009
3099
3368
203
3119
415
273
123
16160
1446
14496
5096
1726
484
1193
1173
3838
1033
10773
1270
9209
4960
3236
3813
3844
263
596
930
2882
1259
5724

*
*
*
*

Americ
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
USA,
Asia
Bahra
China
China
China
China
China
China
Cypru
India,
India,
India,
India,
India,
India,
India,
Israel
Israel
Israel
Japan
Japan
Japan
Japan
Japan
Japan
Japan
Korea
Korea
Korea
Korea
Korea
Korea

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Haematopoietic and lymphoid tissues - Female (Contd)

es

al

78
91
92
61
85

*
*
*
*

86
40
85
86
51
06
47
08
22
77
75 *

27
46
78
86
02
61
5
41
00
06
02
83
27
11
36
11
46
35
56
43
64
35
63
77
40
41
64
78
69
10
59
71
54
58
96
09
99
68
03
19
15
73
23
60
46
96
96
26
84
93
73
38
33
73
70
09
60
36
13
44
63
96
30
82
59
24

NK-cell

Myeloid

lymphoma, NOS

Non-Hodgkin

Other

Unspec.

13.6
14.7
14.0
15.1
14.1
13.4
12.1
11.5
12.2
13.7
14.4
15.1
14.5
11.4
10.3
9.4
13.0
13.8
14.0
14.1
12.6
12.4
12.7
11.6
11.6
11.4
10.2
13.6
13.9
13.1
13.8
14.3
13.2
13.1
13.7
13.1
8.0
13.2
11.7
13.7
11.4
11.8
11.1
11.8
12.9
11.7
12.1
12.4
14.5
14.6
12.7
13.2

1.0
1.1
1.7
0.9
1.7
0.8
0.7
1.1
0.6
0.5
1.0
1.5
0.9
0.7
0.5
0.3
0.9
0.9
1.4
0.8
0.8
1.1
0.7
0.8
1.0
0.7
0.5
0.9
0.9
1.0
0.8
1.2
1.0
1.5
0.9
0.9
0.7
1.3
0.7
0.9
0.8
0.8
0.7
0.8
1.0
0.8
0.6
0.4
1.0
0.9
0.6
0.8

3.6
5.8
5.0
6.0
3.2
3.6
3.4
3.1
3.4
3.1
4.3
4.2
4.3
3.9
2.2
3.7
4.3
4.5
3.7
4.7
3.2
2.9
3.3
3.0
2.7
3.0
3.2
3.2
3.6
3.1
3.6
3.4
4.5
4.2
4.6
4.3
3.4
4.1
4.1
4.4
2.9
2.9
2.8
3.0
3.2
3.0
4.2
3.4
3.6
5.2
3.5
3.6

0.8
0.8
0.7
0.8
0.6
0.8
1.0
1.4
0.9
0.5
0.9
0.5
0.9
0.4
0.5
0.5
0.9
0.7
0.9
0.8
0.6
0.9
1.1
0.7
1.1
1.1
0.5
0.8
0.7
0.8
0.4
0.6
0.5
0.7
0.7
0.4
0.4
0.6
0.7
1.0
0.5
1.1
0.9
0.5
0.9
0.7
2.1
0.8
0.9
1.2
0.6

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.1
0.1
0.3
0.2
0.1
0.1
0.1
0.1
0.0
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0

2.2
1.2
4.5
0.1
0.8
1.0
0.7
6.0
1.1
2.8
1.3
0.6
2.2
1.0
2.8
15.5
15.6
9.9
2.9
1.7
4.4
4.2
2.8
2.5
2.3
2.7
2.5
2.6
3.3
2.5
2.9

0.0
0.4
0.0
0.1
0.1
0.0
0.4
0.0
0.2
1.5
1.5
1.3
0.3
0.1
0.4
0.4
2.8
0.6
0.3
0.4
0.4
0.3
0.5
0.3
0.3

3.3
2.3
2.5
1.5
0.4
1.5
1.9
2.5
1.3
1.1
1.5
1.7
2.1
1.1
1.6
5.1
4.8
3.8
1.5
1.6
2.6
2.2
3.0
1.8
2.1
2.2
2.1
2.2
2.2
2.0
2.2

3.9
3.3
0.4
0.1
1.7
2.8
1.7
2.2
1.2
0.3
1.9
0.9
3.0
0.1
0.3
1.0
0.9
0.6
0.4
1.9
2.1
0.4
1.7
0.6
0.9
0.2
0.2
0.3
0.4
0.8
0.1

0.2
0.0
0.1
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.4
0.0
0.1
0.1
0.0
0.1
0.1
0.0
0.1
0.2
0.1

B-cell
America, North (Contd)
USA, Michigan
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Michigan: Black
USA, Michigan: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York state
USA, New York state: Black
USA, New York state: White
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 registries)
USA, SEER (9 registries): Black
USA, SEER (9 registries): White
USA, SEER (14 registries)
USA, SEER (14 registries): Asian and Pacific Islander
USA, SEER (14 registries): Black
USA, SEER (14 registries): Hispanic White
USA, SEER (14 registries): Non-hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, New Delhi
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon

T-cell and

Number of cases
MV

Total

2.8
3.0
2.4
3.2
2.4
2.8
2.3
2.5
2.3
2.4
3.3
2.7
3.4
3.0
2.1
2.9
3.6
3.1
2.6
3.2
2.9
2.3
2.9
2.9
1.9
3.0
3.1
2.8
2.4
2.0
2.4
2.3
2.7
2.2
2.8
2.7
2.0
2.2
3.1
2.6
2.7
2.1
2.9
3.3
2.5
3.5
2.4
2.6
2.3
2.0
3.1
3.4

8119
4038
788
3179
941
6982
4302
379
3876
673
8067
866
6925
1176
61
321
778
16013
1978
13591
168138
15006
146647
8981
754
7981
2483
2699
11259
783
10171
986
21750
1865
18297
57226
2934
4875
5359
43115
2683
612
2037
12180
1195
10671
1286
472
4712
3538
1656
4609

8821
4314
841
3399
1024
7591
4793
412
4333
789
8833
962
7567
1353
68
364
901
19307
2295
16512
185841
16844
162084
9648
814
8579
2704
2931
12779
900
11545
1052
23305
2003
19653
61880
3055
5345
5647
46836
3087
729
2302
14294
1438
12484
1345
533
5021
3687
1808
4871

3.0
3.5
3.1
4.4
2.8
2.5
2.1
3.0
2.0
2.0
2.3
2.2
1.7
3.4
1.5
2.9
2.9
2.2
2.2
2.7
1.8
3.1
2.3
2.9
2.4
2.2
2.0
2.6
2.2
2.7
2.1

79
540
2178
60
106
1631
210
314
515
62
1509
238
1870
370
184
4626
4173
312
280
328
410
899
935
3299
469
7497
679
507
271
273
458

87
565
2408
60
127
1803
213
318
529
65
1509
239
1870
373
186
5188
4612
344
280
389
548
1177
1071
3299
589
7997
718
526
286
281
473

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

739

*
*
*
*
*

*
*
*
*

797

Age-standardized (world) incidence rates (per 100,000)


by histological type

Haematopoietic and lymphoid tissues - Female (Contd)


NK-cell

Myeloid

lymphoma, NOS

Non-Hodgkin

Other

Unspec.

2.5
3.6
2.3
6.4
7.4
1.6
1.2
3.1
6.0
3.5
4.5
4.3
4.2
7.0
3.3
3.0
3.0
4.1
4.5

0.5
0.4
0.3
1.1
0.6
0.0
0.0
0.1
0.2
0.7
0.7
0.9
0.3
0.1
0.1
0.8
0.2
0.4

3.1
2.5
2.0
2.6
2.4
2.7
2.3
1.8
2.4
2.4
3.3
3.2
2.9
3.8
2.1
2.0
1.8
2.2
2.5

0.1
0.2
0.3
0.8
0.6
3.3
3.4
2.9
0.5
1.1
0.4
0.4
0.1
1.1
1.2
0.7
0.8
0.6

0.0
0.1
0.1
0.0
0.0
0.0
0.1

4.6
10.2
6.3
3.1
7.3
8.4
2.4
4.7
6.9
9.9
7.2
10.8
10.4
11.8
11.9
11.6
11.5
12.4
11.5
9.4
9.9
8.4
7.1
6.6
7.6
9.3
10.9
8.1
13.5
10.3
11.2
9.1
11.7
6.9
11.8
14.3
9.1
8.0
13.7
9.9
4.6
13.0
7.9
11.7
11.3
8.0
10.4
4.9
9.6
7.7
3.5
5.0
6.5
9.7
3.4
4.8
3.0
5.5
4.2

0.4
0.9
0.1
0.1
0.4
0.6
0.1
0.0
0.4
0.7
0.4
0.4
0.5
0.2
0.3
0.3
0.1
0.4
0.9
0.5
0.1
0.3
0.5
0.2
0.3
0.4
0.5
0.6
0.2
0.7
1.5
0.6
0.8
0.1
0.6
1.7
0.6
0.6
0.4
0.6
0.4
0.4
1.1
0.4
0.6
1.1
0.7
0.3
0.8
0.9
0.4
0.5
1.5
0.6
0.1
0.2
0.1
0.4
0.1

2.5
5.0
2.9
2.5
2.1
3.7
1.9
3.1
4.0
3.1
2.4
5.7
5.7
6.1
3.6
4.5
6.1
3.8
5.6
4.1
5.3
2.6
2.8
3.3
4.5
2.6
2.6
4.8
6.7
3.4
3.6
7.6
6.0
2.8
3.3
3.0
4.4
3.4
4.0
8.1
3.3
3.0
2.9
2.7
2.8
4.8
4.5
3.0
3.9
3.1
3.3
3.0
4.6
3.3
2.6
2.3
2.6
3.9
2.4

1.8
0.3
1.3
2.1
1.2
2.7
1.4
3.9
1.2
0.8
0.2
0.5
0.2
0.2
0.9
0.5
0.9
1.4
0.3
0.6
0.2
1.4
3.3
1.4
2.4
1.0
2.3
0.6
3.9
0.7
2.5
0.5
2.4
1.6
0.4
1.5
3.8
4.3
1.0
10.8
1.8
2.7
0.7
2.4
0.9
2.6
2.0
5.7
3.2
0.9
1.1
2.3
2.6
0.4
1.0
3.2
4.0
0.3

0.1
0.1
0.0
0.0
0.3
0.0
0.1
0.1
0.0
0.3
0.1
0.1
0.0
0.1
0.2
0.2
0.0
0.0
0.0
0.0
0.1
0.1
0.2
0.2
0.0
0.2
0.1
0.2
0.4
0.3
0.1
0.0
0.0
0.4
0.1
0.1
0.2
0.0
0.2
0.0
0.1
0.1
0.1
0.1
0.0

B-cell
Asia (Contd)
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland (data not available)
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg (data not available)
Germany, Free State of Saxony (data not available)
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania (data not available)
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Sondrio
Italy, Syracuse Province
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce (data not available)
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg

T-cell and

*Important. See note on population page.


Note: The rates are based on the histological groups described in Chapter 4.

798

740

Cancer Incidence in Five Continents Vol. IX, IARC 2008

Number of cases
MV

Total

1.9
2.8
1.7
1.1
3.7
2.9
1.7
2.4
1.7
4.4
2.3
2.2
2.2
2.8
2.6
3.1
2.7
2.5
1.7

72
2205
118
180
128
225
354
219
269
925
981
787
53
141
357
204
226
211
717

77
2338
122
181
133
246
368
231
272
1166
981
787
53
141
357
204
275
304
810

4.0
1.3
5.6
1.9
0.9
2.1
2.3
2.6
2.3
2.5
2.6
1.5
1.4
1.7
2.3
1.5
0.9
2.1
0.6
1.8
2.2
1.8
1.6
1.9
2.6
1.4
2.1
4.0
0.7
2.5
1.8
3.1
2.7
3.3
1.8
1.8
6.0
4.2
4.5
2.7
0.9
2.3
3.6
2.1
2.8
1.8
2.8
7.0
4.2
4.4
3.2
3.1
2.0
1.5
6.4
2.7
2.5
2.2
3.4

4692
507
191
3804
1007
3913
2601
2365
5794
3937
833
774
552
473
575
787
935
1013
490
389
355
381
1056
1295
1877
803
161
2588
273
602
426
1108
662
145
1230
711
289
2278
618
282
505
1221
619
349
165
190
1044
630
497
1561
1198
1920
244
3568
314
819
1306
1948
2257

5341
516
213
3889
1012
3979
2601
2765
6909
4145
853
851
559
473
597
788
969
1033
496
409
360
392
1431
1660
2263
881
161
2755
287
641
444
1576
790
163
1230
715
368
2307
618
304
510
1256
670
366
176
213
1088
822
538
1719
1268
1920
252
3726
389
869
1308
1964
2285

*
*
*

*
*
*
*

*
*
*

Europe
Serbia
Slova
Slove
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Switz
Switz
Switz
Switz
Switz
Switz
Switz
The N
The N
The N
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, E
UK, N
UK, S
Oceani
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Austr
Frenc
New Z
USA,
USA,
USA,
USA,
USA,
USA,

*
*

*Import
Note: T

Age-standardized (world) incidence rates (per 100,000)


by histological type

Haematopoietic and lymphoid tissues - Female (Contd)

es

al

77
38
22
81
33
46
68
31
72
66
81
87
53
41
57
04
75
04
10

41
16
13
89
12
79
01
65
09
45
53
51
59
73
97
88
69
33
96
09
60
92
31
60
63
81
61
55
87
41
44
76
90
63
30
15
68
07
18
04
10
56
70
66
76
13
88
22
38
19
68
20
52
26
89
69
08
64
85

*
*
*

*
*
*
*

*
*
*

NK-cell

Myeloid

lymphoma, NOS

Non-Hodgkin

Other

Unspec.

3.8
7.5
7.9
7.3
8.1
8.0
10.7
4.7
12.8
8.7
8.8
7.2
7.7
6.7
7.4
8.1
8.5
6.4
10.8
11.9
9.4
8.3
9.9
9.1
8.6
8.2
5.2
7.7
9.2
9.5
9.2
7.3
8.3
8.4
6.6
10.1

0.2
0.2
0.7
0.8
0.6
0.6
0.7
0.1
1.2
1.0
1.1
1.1
0.6
0.3
0.5
0.6
1.1
0.0
0.5
1.2
0.7
0.1
0.7
0.7
0.5
0.5
0.5
0.5
0.4
0.4
0.5
0.3
0.7
0.7
0.6
0.7

1.5
3.8
3.4
4.0
2.1
2.0
2.5
2.2
5.2
3.0
2.9
1.9
2.5
1.9
5.0
4.0
2.4
3.0
4.7
2.0
3.1
2.5
3.3
3.6
2.8
5.3
4.1
5.0
5.6
2.9
7.3
5.3
5.9
4.9
2.5
7.3

1.4
0.6
1.2
1.8
1.6
1.0
2.1
0.4
0.2
0.1
0.9
0.4
2.3
1.2
1.1
2.8
2.4
0.8
1.0
0.9
2.9
0.8
1.1
1.0
1.1
3.7
2.0
1.8
1.6
1.6
3.4
1.0
2.3
1.6
0.9

0.0
0.1
0.0
0.1
0.2
0.0
1.0
0.0
0.1
0.1
0.1
0.5
0.2
0.0
0.3
0.1
0.3
0.1
0.0
0.1
0.1
0.0
0.0
0.1
0.1
0.1
0.1
0.0
0.0

11.5
13.3
14.6
11.4
12.6
10.9
12.2
6.8
13.1
9.6
7.4
7.8
12.0
7.8
12.8

0.6
0.6
0.6
0.3
0.6
0.6
0.8
0.7
1.0
0.3
0.9
0.8
0.8
1.2

5.2
7.4
4.0
3.7
6.2
5.3
4.8
6.0
3.7
3.9
2.7
2.8
5.3
3.6
3.7

1.7
1.1
0.4
1.5
1.0
1.6
1.7
2.6
1.4
0.7
1.2
0.7
0.8
0.4
0.7

0.1
0.1
0.1
0.0
0.0
0.0
-

B-cell
Europe (Contd)
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, England, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern And Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory (data not available)
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

T-cell and

Number of cases
MV

Total

2.3
2.1
2.2
2.8
3.6
2.4
2.3
3.4
0.7
1.6
3.4
3.1
2.7
4.0
4.2
2.0
3.4
2.3
1.4
2.3
1.5
2.0
1.4
1.4
0.6
3.7
2.8
2.7
2.5
2.6
4.4
2.9
3.7
2.3
6.3
3.2

1476
2673
1339
210
862
1082
867
95
478
462
656
326
359
531
8026
362
159
120
412
291
179
439
10522
622
516
2241
1359
2768
4282
1882
4912
9474
4129
3912
975
5427

1631
2909
1339
220
939
1161
935
108
498
485
739
351
377
563
8039
371
171
120
412
315
191
477
10694
647
530
2609
1931
3643
6416
1962
8705
12706
4876
4777
1235
5738

2.9
2.7
4.7
2.8
2.9
2.4
2.3
3.8
2.9
3.2
1.2
2.9
2.8
3.7
3.4

5077
2803
1518
392
4580
1299
181
82
3146
845
55
109
117
234
243

5962
3446
1621
407
4879
1453
219
86
3253
879
56
112
122
247
251

*
*
*Important. See note on population page.
Note: The rates are based on the histological groups described in Chapter 4.
Cancer Incidence in Five Continents Vol. IX, IARC 2008

741

799

Indices of data quality

743

Indices of data quality

Oral cavity pharynx (C00-14)


Male
Cases MV(%) DCO(%) UB(%) MI(%)
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

263 94.3
285 97.5
83 100.0
93 65.6
66 71.2
83 92.8
398 91.7
139 87.1
286 99.0
5006 85.5
21 81.0
180 86.7
355 93.5
49 89.8
188 96.3
34 100.0
7960
853
1239
512
277
276
7
386
4015
46
349
1811
321
1475
180
1545
10472
896
664
1016
7733
2102
142
197
64
12
154
1433
2551
323
100
48
25
33
386
1531
1124
1207
97
1089
288
223
58
8128
686
7344
2737
641
2069
741
229
494
453
4333
705
3485
2156
1164
1701
1842
468
1356
119
265

96.2
98.9
98.1
98.6
97.1
99.6
100.0
98.2
94.1
100.0
97.4
98.1
96.9
98.4
97.8
97.2
98.6
99.1
98.9
98.6
98.5
99.0
98.6
99.0
100.0
100.0
99.4
98.8
99.1
99.7
98.0
100.0
100.0
100.0
99.2
99.0
97.5
99.4
99.0
99.5
95.5
96.0
98.3
96.0
94.2
96.2
97.7
96.7
98.0
98.4
98.3
98.4
97.8
98.1
97.7
98.1
98.7
98.6
96.4
97.6
97.2
97.9
98.3
98.1

2.1
4.5
2.4
2.3
7.2
0.7
4.9
9.5
3.9
3.9
8.2
0.0
0.6
0.0
0.5
0.6
0.0
0.0
0.5
0.7
0.0
0.9
0.9
1.2
0.7
0.6
0.5
0.4
0.1
0.3
0.2
0.4
0.3
0.7
0.0
0.0
0.0
0.6
0.3
0.3
0.0
0.0
0.0
0.0
0.0
0.0
0.4
0.8
0.2
1.0
0.2
1.7
2.2
0.0
2.7
3.2
2.6
0.8
1.4
0.6
0.1
0.4
0.0
2.2
1.2
1.4
1.1
0.6
0.5
0.8
0.7
1.1
0.6
0.0
0.4

0.0
0.0
0.0
0.0
0.0

15.4

744

66 100.0
209 97.1
35 100.0
61 68.9
45 73.3

3.6
5.8
2.2
0.0
0.0
0.0
0.0
0.0
0.0
1.1
0.0

49.4
31.7
36.0
48.6
35.3
47.6
50.6
51.5
49.0
47.9

36 97.2
153 88.2
41 75.6
71 97.2
1682 79.5
10 80.0
163 92.0
181 92.3
43 90.7
47 95.7
29 100.0

2.5
0.0
0.1
0.0
0.0
0.0
0.0
0.0
4.9
0.0
0.0
0.6
0.6
0.6
0.6
1.5
0.5
0.4
0.3
0.4
0.5
0.1
0.0
0.5
0.0
0.0
0.0
0.1
0.4
0.3
1.0
0.0
0.0
0.0
0.5
0.3
0.5
0.1
0.0
0.1
0.7
0.0
0.0
0.5
0.4
0.5
0.5
0.3
0.5
0.5
0.0
0.8
0.0
0.4
0.6
0.3
0.2
0.2
1.9
0.2
0.0
0.2
0.0
0.0

31.4
27.4
33.7
23.2
30.7
22.8
42.9
36.5
33.1
41.3
24.6
25.6
41.7
22.3
26.1
26.8
25.4
34.7
34.5
26.0
23.9
26.1
38.7

3803
398
685
234
89
67
4
158
1965
31
172
795
130
651
67
678
5171
536
318
485
3711
1103
75
110
33
7
72
720
1280
154
58
39
23
10
196
745
549
619
43
560
100
69
28
3871
314
3494
1315
289
1007
379
117
250
214
2029
256
1686
941
557
674
718
168
545
53
123

18.8
23.0
25.4
32.8
46.0
37.5
40.0
24.2
26.9
22.4
20.7
24.7
38.1
23.7
35.4
41.3
17.2
26.5
34.0
25.9
24.9
36.3
21.5
19.8
27.1
16.8
21.4
25.2
33.2
24.0
21.4
21.1
26.3
28.9
39.5
25.4
42.9
36.2

*Important. See note on population page.

802

Female
Cases MV(%) DCO(%) UB(%) MI(%)

94.8
98.5
98.2
98.3
98.9
100.0
100.0
96.2
91.5
100.0
99.4
97.7
98.5
97.5
97.0
97.2
98.1
98.9
98.4
98.1
98.0
97.6
100.0
97.3
97.0
100.0
100.0
97.2
98.4
98.1
100.0
97.4
100.0
100.0
98.0
98.4
98.2
98.4
100.0
98.4
99.0
98.6
100.0
97.0
98.4
96.9
96.0
95.5
96.3
97.1
98.3
97.2
96.7
98.2
96.5
98.4
97.6
98.4
97.0
97.1
96.4
97.2
100.0
97.6

0.0
4.4
2.8
0.7
17.1
1.4
5.5
0.0
0.6
3.9
4.7
0.0
0.5
0.0
0.4
0.4
0.0
0.0
0.0
0.8
0.0
0.6
0.3
0.0
0.3
1.5
0.4
0.7
0.6
0.9
0.0
0.8
1.2
0.0
0.9
3.0
0.0
0.0
1.5
0.5
1.3
0.0
2.6
0.0
0.0
0.0
0.5
0.2
0.5
0.0
0.4
1.0
1.4
0.0
2.1
1.0
2.2
2.3
2.1
2.4
1.3
0.9
1.6
2.3
1.2
2.3
1.1
1.0
0.7
0.9
1.0
0.6
1.1
0.0
0.0

0.0
0.0
0.0
0.0
0.0

15.8

0.0
11.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2.1
0.0

38.9
17.0
26.8
36.6
22.1
80.0
34.4
42.5
46.5
34.6

4.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
7.6
0.0
0.0
1.9
0.8
2.2
0.0
1.5
0.5
0.2
0.0
1.0
0.6
0.6
0.0
0.0
0.0
0.0
0.0
0.7
0.2
0.0
0.0
0.0
0.0
0.0
0.5
0.3
0.9
0.3
0.0
0.4
0.0
0.0
0.0
0.2
0.3
0.2
0.7
1.4
0.3
0.8
0.9
0.0
0.0
0.1
0.4
0.1
1.0
0.2
1.3
0.7
1.2
0.6
0.0
0.8

31.5
32.4
30.9
27.8
36.0
17.9
50.0
25.3
32.9
12.9
33.1
27.4
26.9
28.1
26.9
26.5
29.8
27.8
36.5
21.0
31.5
31.0
38.7
15.3
35.1
29.4
35.1
41.4
23.1
21.7
50.0
20.9
30.9
21.1
23.7
20.9
24.5
31.0
33.3
28.6
26.4
30.3
26.3
28.2
31.8
27.1
23.5
27.4
21.6
28.5
24.2
33.2
23.4
25.9
23.5
28.6
32.7
36.3
31.9
39.6
38.2

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Oral cavity pharynx (C00-14) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Female
Cases MV(%) DCO(%) UB(%) MI(%)

593 97.0
2343 97.7
3651 98.0
557 98.2
3005 98.0
1624 98.8
459 99.3
1142 98.5
2036 97.9
193 97.9
1817 97.9
348 97.4
79486 97.5
8566 96.9
67751 97.5
2875 98.4
426 97.9
2317 98.4
559 97.9
18 100.0
115 98.3
418 97.6
6234 96.5
871 96.2
5026 96.5
3555 97.1
396 94.9
3045 97.4
1394 96.4
1292 97.8
4604 98.7
501 98.4
3957 98.7
364 99.5
9008 98.8
966 99.0
7304 98.7
24558 98.4
1428 99.1
2534 98.3
1456 98.5
18821 98.4
1759 97.2
528 97.7
1216 96.9
6431 95.8
625 93.9
5661 96.1
450 98.9
210 97.6
1991 98.4
1366 98.8
745 97.6
1939 96.3

0.3
0.9
0.4
0.0
0.5
0.5
0.0
0.7
1.0
1.0
1.0
2.3
1.1
1.5
1.1
0.4
0.7
0.3
0.7
0.0
0.9
0.7
1.2
1.5
1.1
1.5
3.0
1.3
1.4
1.1
0.2
0.2
0.2
0.5
0.4
0.3
0.4
0.4
0.1
0.5
0.3
0.4
0.8
0.8
0.8
2.3
4.0
2.1
0.2
1.9
0.5
0.2
0.5
1.4

1.7
0.7
0.9
0.9
1.0
0.2
0.2
0.3
0.8
1.0
0.8
0.0
0.7
0.7
0.7
0.7
0.7
0.8
0.2
0.0
0.0
0.2
1.1
1.4
1.0
0.9
1.3
0.9
0.5
0.3
0.4
0.2
0.5
0.0
0.2
0.1
0.2
0.5
0.4
0.3
0.4
0.5
1.5
0.8
1.8
1.5
1.8
1.4
0.0
0.0
0.4
0.1
0.5
1.8

23.6
25.9
22.5
26.8
21.9
21.9
24.8
20.7
23.1
32.6
22.0
19.5
25.6
36.0
24.5
25.9
39.0
24.0
21.6
22.2
32.2
17.7
25.9
35.1
24.2
30.0
40.4
29.6
21.5
23.8
25.1
29.9
25.2
24.5
23.8
28.5
22.3
25.3
32.4
33.8
24.8
23.8
30.0
44.7
23.8
27.7
44.8
25.9
21.8
25.2
25.4
26.3
26.6
25.0

268 95.9
1253 97.4
1772 97.9
183 98.9
1533 97.7
768 98.7
141 100.0
613 98.4
905 97.0
47 97.9
846 96.9
140 92.1
37828 97.1
3526 97.1
32483 97.1
1511 97.3
176 96.0
1251 97.3
243 96.7
8 100.0
46 97.8
183 96.7
3295 95.1
434 96.5
2713 94.8
1790 97.7
162 97.5
1559 97.6
548 94.2
655 99.1
2224 98.2
226 98.2
1943 98.2
188 98.9
4493 98.2
396 99.5
3667 98.2
11833 97.9
821 98.5
1047 98.0
685 98.1
9072 97.8
719 96.8
173 96.5
538 96.8
2787 94.8
281 93.6
2426 95.1
231 98.7
93 94.6
1030 98.5
698 98.4
337 97.9
1002 93.9

1.5
1.0
0.8
0.0
0.9
0.3
0.0
0.3
1.5
0.0
1.7
4.3
1.3
1.2
1.4
1.3
0.6
1.4
0.4
0.0
0.0
0.5
1.6
1.2
1.8
1.3
1.9
1.3
3.1
0.5
0.7
0.4
0.8
1.1
0.6
0.3
0.6
0.7
0.6
0.6
0.1
0.8
1.0
1.7
0.7
2.8
2.8
2.9
0.0
3.2
0.2
0.3
1.2
2.0

1.9
1.0
0.5
0.5
0.5
0.1
0.0
0.2
1.0
2.1
0.9
2.9
0.8
0.8
0.8
0.8
3.4
0.5
0.8
0.0
0.0
0.5
1.4
1.2
1.5
0.8
0.0
0.9
0.5
0.0
0.5
0.4
0.6
0.0
0.4
0.3
0.2
0.6
0.6
1.0
0.7
0.5
1.3
1.2
1.3
1.5
1.8
1.2
0.0
0.0
0.5
0.3
0.0
3.3

26.1
27.1
25.5
30.1
25.4
24.1
31.2
22.0
30.1
51.1
29.1
33.6
27.2
31.8
27.3
25.7
32.4
25.7
23.5
25.0
21.7
24.6
25.6
31.6
24.9
27.5
32.1
28.3
27.6
31.1
25.9
26.1
26.2
32.4
25.5
30.1
25.4
27.8
25.5
33.2
20.3
28.4
28.5
37.6
26.0
28.4
29.2
28.9
20.3
31.2
26.7
27.4
25.5
27.6

39 89.7
1671 86.2
5254 95.9
83 96.4
74 90.5
1512 87.2
1133 98.3
79 100.0
1915 83.3
3490 87.6
176 92.0
4297 85.5
754 96.0
1014 86.9
584 93.8
962 93.2
854 95.0
83 95.2
213 93.0
137 87.6
331 93.4
650 90.0
548 92.7
2299 81.3
341 88.3

10.3
0.0
0.2
0.0
5.4
0.5
0.0

0.0
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.3
0.0
0.0
0.0
0.0
0.0
0.2
2.5
1.4
2.4
0.0
0.0
0.0
0.0
0.7
0.0
1.2

38.5
42.4
41.1

17 94.1
771 88.8
2093 94.8
33 93.9
37 83.8
853 88.4
418 98.6
53 96.2
886 80.9
1013 86.2
82 80.5
1628 84.9
296 95.9
607 90.3
241 90.5
576 92.5
525 93.3
34 100.0
98 87.8
75 81.3
121 92.6
281 86.8
226 94.7
884 83.4
156 87.2

5.9
0.1
0.3
0.0
0.0
0.7
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.9
0.2
0.0
0.0
0.0
0.0
0.0
0.0
2.8
1.9
0.0
2.0
2.7
0.0
0.0
0.0
0.0
0.6

47.1
33.3 *
29.3
*
40.5
35.4 *
*
4.7 *
30.4
*

1.0
1.0
0.0
5.5
0.0
4.2
2.2
0.8
0.9
0.0
7.0
5.1
1.8
3.2
2.9
8.5
7.0

55.4
47.4
28.5
39.4
1.7
29.9
27.5
46.0
62.0
36.6
47.2
45.8
56.1
63.0

1.1
0.5
0.0
5.3
0.0
2.6
3.3
1.6
1.7
0.0
10.2
6.7
0.8
7.1
0.9
8.9
8.3

28.0
29.9
35.7
69.3
38.8
50.2
38.9
56.0
64.1

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

*
*
*

745

803

Indices of data quality

Oral cavity pharynx (C00-14) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

5641
490
349
146
187
291
59
1417
77
45
92
350
775
77
862
973
1575
1409
68
98
466
155
462
194
461

87.1
90.4
96.6
91.1
89.8
85.6
91.5
88.1
80.5
95.6
95.7
96.9
92.9
97.4
99.2
77.7
99.2
99.3
97.1
99.0
96.8
86.5
97.0
95.9
97.0

5.7
2.4
1.1
6.2
4.3
3.8
1.7
5.4
9.1
4.4
2.2
1.1
4.3
0.0
0.0
8.7
0.0
0.0
0.0
0.0
0.0
0.6
2.4
2.6
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.3
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
0.0
0.9

41.5
41.2
34.1
43.8
35.3
44.0
53.4
31.5
41.6

3352 95.5
284 99.6
130 94.6
5048 98.3
592 99.5
2208 98.1
3438 89.8
3175 82.9
4184 95.5
2261 97.9
566 95.6
1393 99.4
975 99.5
697 98.9
420 99.5
578 99.3
715 99.9
742 99.2
1190 99.7
608 99.5
684 98.4
247 100.0
493 97.8
1356 88.9
2080 96.2
909 88.0
1176 93.7
1249 94.6
1084 88.2
767 99.0
56 100.0
915 97.5
116 96.6
309 92.2
219 94.1
422 92.2
270 95.2
31 96.8
423 98.1
175 96.6
117 84.6
1621 97.5
181 98.3
80 93.8
137 94.2
307 96.4
197 83.8
233 97.4
67 88.1
90 96.7
461 98.5
312 90.4
259 96.1
1067 97.8

4.0
0.4
2.3

0.1
0.0
0.8
0.0
0.0
1.3
0.0
13.6
1.1
1.5
0.0
0.3
0.0
0.0
0.0
0.5
0.0
0.5
0.0
0.0
0.7
0.0
1.2
2.1
0.0
0.0
0.0
0.0
0.8
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
4.5
0.0
0.0
8.7
0.0
0.0

53.2
46.5
36.2
51.3

5.0
3.5
2.2
0.2
0.4
0.1

0.1
8.4
3.3
2.6
6.1
2.3
5.7
0.4
0.0
1.2
0.9
1.0
0.5
0.2
0.7
0.0
0.2
0.6
0.9
0.3
0.6
2.5
0.0
0.7
2.0
1.3
6.0
0.0
0.4
0.0
0.0
0.8

17.1
18.1

50.8
1.9
79.4
58.0
14.9
15.0

37.3
41.0
51.0
57.2
41.4
71.6
31.1
35.2
33.1
35.0
36.5
30.1
37.7
37.9
35.4
40.1
34.0
51.5
107.4
36.9
46.0
30.9
43.8
48.4
45.1
30.4
49.7
65.5
53.4
38.8
37.2
49.6
51.6
52.2
50.9
37.0
48.3
43.1
47.5
47.4
41.4
47.2
46.8
40.3
55.6
46.6
49.4
41.3
41.0

*Important. See note on population page.

804

746

Female
Cases MV(%) DCO(%) UB(%) MI(%)
2085 77.8
197 84.8
111 89.2
60 80.0
79 78.5
107 85.0
13 76.9
565 82.7
32 71.9
37 97.3
34 100.0
162 95.1
412 92.2
37 81.1
478 96.9
600 80.2
591 99.3
519 99.2
30 100.0
42 100.0
243 95.9
131 86.3
145 95.2
82 91.5
213 97.7
1105
83
62
926
201
650
848
688
1165
1080
194
854
187
135
85
136
192
156
206
80
106
66
70
318
586
388
241
423
390
212
45
361
33
108
69
200
128
12
216
86
36
485
62
30
72
131
65
67
23
37
180
133
78
335

93.4
98.8
96.8
97.0
100.0
97.7
87.0
71.5
93.5
97.4
93.8
97.5
98.9
100.0
100.0
97.8
100.0
99.4
99.5
100.0
97.2
100.0
98.6
87.4
93.0
80.2
88.4
92.4
86.9
95.8
100.0
93.1
97.0
90.7
91.3
89.5
85.9
83.3
97.2
97.7
83.3
95.5
98.4
76.7
80.6
91.6
73.8
92.5
95.7
91.9
96.1
88.0
97.4
95.2

15.1
6.6
5.4
10.0
17.7
3.7
23.1
12.0
18.8
2.7
0.0
1.2
4.6
2.7
0.4
7.7
0.2
0.2
0.0
0.0
0.4
0.8
4.1
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2.7
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.9

1.6 *
67.9 *
151.0
7.3 *
18.3 *

5.7
0.0
1.6

0.2
0.0
1.6
0.0
0.0
2.3
0.0
24.0
2.1
1.7
0.0
1.2
0.5
0.0
0.0
2.2
0.0
0.0
0.0
0.0
0.9
0.0
0.0
3.1
0.0
0.0
0.4
0.0
0.8
0.0
0.0
0.8
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
3.3
0.0
0.0
0.0
0.0
0.0
0.0
0.0
9.0
0.0
0.0

49.2
48.2
43.5
42.1 *
*
38.0
35.7 *
32.0
48.8
43.2
55.2
32.4
27.3
23.7
32.9
30.9
22.9
37.2
31.6
21.3
30.2
31.8
32.9
97.8
30.5
40.7
27.4
39.2
46.4
38.2
33.3
51.0
51.5
45.4
34.8
42.5
46.1
50.0
41.2
44.2
41.7
41.0
46.8
43.3
40.3
52.7
53.8
49.3
47.8
43.9
37.2
45.1
29.5
40.6

7.5
4.2
2.7
0.2
0.0
0.4

0.0
9.4
6.3
4.1
10.8
3.3
7.4
0.9
0.0
1.7
0.0
2.8
4.3
1.0
0.8
8.3
0.5
0.0
0.0
0.6
0.0
10.0
0.0
3.1
1.5
3.0
4.3
0.0
1.7
1.5
0.0
1.5

40.5
36.5
35.1
36.7
48.1
33.6
80.8
30.8
34.4
12.3
19.4

40.9

*
*
*

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Oral cavity pharynx (C00-14) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

908 88.8
1609 96.5
125 95.2
1252 99.1
226 88.5
484 92.8
545 96.3
1269 98.1
1484 95.4
2022 89.7
1831 88.9
3795 94.5
1286 99.2
209 98.6
816 97.9
1465 98.4
1095 98.2
163 97.5
351 97.7
604 98.8
756 97.4
364 98.4
323 97.2
389 97.7
2439 99.9
274 98.2
101 96.0
93 100.0
206 97.6
144 99.3
148 100.0
422 98.6
5023 99.6
317 100.0
329 99.7
688 97.8
721 93.5
1322 96.8
2023 96.4
613 97.9
1790 85.4
3212 90.0
1195 93.3
1255 96.3
423 94.6
2119 98.3

3.1
0.4
0.8
0.0
3.5
2.7
0.0

0.0
0.8
0.2
0.6
0.3
0.4
4.2
2.9
1.0
0.0
0.3

0.2
0.0
0.0
0.0
0.0
1.9
0.2
0.0
0.0
3.7
0.1
0.3
0.4
0.5
0.2
0.5
0.1
0.6
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.4
0.1
0.5
0.0
1.5
2.6
3.0
0.5
0.0
0.0
0.2

3001 96.2
141 99.3
2107 97.2
897 99.2
307 99.3
2249 97.4
884 98.8
86 98.8
66 95.5
921 98.2
465 99.1
50 100.0
56 96.4
61 100.0
106 99.1
161 99.4

0.3
0.0
0.2
0.0
0.0
0.4
0.2
0.0
3.0
0.9
0.4
0.0
0.0
0.0
0.9
0.6

0.0
0.0
0.1
0.1
0.3
0.8
0.1
0.0
0.0
0.0
0.2
0.0
1.8
0.0
0.0
0.0

3.9
4.5
4.6
0.4
0.5
1.2
0.2
0.6
0.6
1.7
0.0
1.1
0.3
2.2
2.1
0.0
1.0
0.0
0.0
0.7
0.0
0.9

63.2
66.6
40.8
40.7
55.3
36.4
54.3
45.0
49.7
82.7
46.8
68.9
51.9
23.0
48.4
33.6
42.4
17.2
32.5
17.5
31.2
30.2
35.6
40.9
36.3
40.9
41.6
36.6
35.4
45.8
43.2
41.0
33.6
43.2
33.3
35.9
44.3
39.1
34.6
38.0
41.3
38.1
41.3
39.0
38.2
26.6
32.6
21.5
21.0
12.2
24.4
26.9
34.9
50.0
41.9
28.6

25.5

Female
Cases MV(%) DCO(%) UB(%) MI(%)
237
361
62
655
81
121
243
348
349
498
719
512
272
32
162
281
166
35
70
119
159
79
58
86
1482
116
40
46
63
50
42
154
2796
148
127
399
390
679
1024
382
1097
1833
663
761
219
1105

89.9
90.3
96.8
98.9
79.0
83.5
91.4
98.3
92.6
88.6
85.8
91.0
99.6
96.9
97.5
98.6
95.8
97.1
97.1
98.3
96.9
96.2
91.4
96.5
99.8
98.3
95.0
100.0
96.8
100.0
100.0
98.7
99.5
99.3
100.0
96.5
92.8
94.7
96.6
97.6
81.8
88.1
92.5
95.9
93.2
97.2

3.4
0.8
0.0
0.0
7.4
5.8
0.4

46.4
52.1
27.4
41.1
67.9 *
42.4
48.1
28.4 *
38.7
77.9
30.7
56.8
32.4
25.0
26.7
34.2
31.6
40.0
21.4
21.8
28.3
30.4
34.5
36.0
30.8
29.3
45.0
30.4
30.2
62.0
47.6
23.4
32.1

0.0
0.3
0.9
0.6
0.3
0.9
5.7
2.7
1.4
0.5
0.4

0.0
0.0
0.0
0.0
0.0
8.3
0.4
0.0
0.0
3.4
0.3
0.6
0.0
3.1
0.0
0.4
0.0
0.0
0.0
0.0
0.6
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.0
0.3
1.0
0.0
1.8
3.7
2.5
0.8
0.0
0.0
0.3

1342
32
836
377
130
1068
328
41
20
484
217
14
32
24
53
78

95.8
100.0
95.1
96.8
99.2
96.3
99.1
97.6
95.0
95.7
99.1
100.0
100.0
100.0
96.2
100.0

0.7
0.0
0.7
0.0
0.0
1.0
0.6
0.0
5.0
1.4
0.5
0.0
0.0
0.0
1.9
0.0

0.0
0.0
0.2
0.0
0.0
0.9
0.0
0.0
0.0
0.0
0.5
0.0
0.0
0.0
1.9
0.0

24.8
37.5
23.1
21.5
16.7
21.3
26.2
17.1
55.0
38.4
28.1

6.9
3.5
6.1
0.4
0.0
0.6
0.7
3.0
2.9
2.9
0.0
0.6
1.3
6.9
3.5
1.7
0.0
0.0
0.0
0.0
0.0
1.3

29.1
36.6
45.4
43.3
37.4
34.6
38.8
40.9
37.3
39.6
50.2
35.0

32.1

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

747

805

Indices of data quality

Oesophagus (C15)
Male
Cases MV(%) DCO(%) UB(%) MI(%)
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

4 75.0
70 91.4
5 100.0
125 56.0
219 42.0

7.1
14.2

58
262
72
115
2406
81
112
159
55
82
26

82.8
86.6
77.8
89.6
78.1
88.9
79.5
71.1
87.3
98.8
92.3

17.2
8.0
18.1
9.6
9.3
6.2
9.8
13.2
7.3

3568
349
673
171
112
62
5
174
1836
30
156
816
243
569
91
799
4569
282
325
492
3436
912
73
55
14
13
72
661
1036
133
28
13
23
17
189
605
625
714
53
655
179
149
26
3734
433
3276
1292
470
809
359
132
219
210
2562
421
2098
1179
600
763
823
259
557
57
105

92.7
95.1
95.1
93.6
98.2
100.0
100.0
93.1
90.6
90.0
93.6
93.9
93.4
94.0
98.9
94.1
96.2
97.5
95.7
97.0
96.1
95.6
93.2
100.0
92.9
92.3
93.1
95.9
97.6
97.0
96.4
100.0
95.7
100.0
98.4
97.4
93.1
98.7
100.0
98.6
92.7
91.3
100.0
92.4
90.3
92.7
94.9
93.6
95.6
97.2
97.0
97.3
94.8
96.1
94.3
96.4
95.8
96.2
93.8
96.5
96.9
96.2
91.2
97.1

1.3
0.3
1.0
2.3
0.0

0.0

0.0
2.9
1.5
0.0
1.3
2.8
2.5
3.0
0.0
0.8
1.0
1.8
0.6
0.8
1.0
1.5
1.4
0.0
7.1
7.7
2.8
1.2
0.6
0.8
0.0
0.0
4.3
0.0
0.5
0.5
1.4
0.3
0.0
0.3
3.4
4.0
0.0
5.2
7.6
4.9
2.5
3.2
2.1
1.4
0.8
1.8
5.2
2.0
3.6
1.8
1.5
1.7
1.3
0.9
1.2
0.7
3.5
0.0

0.0
0.0
0.0
0.0
0.0

25.7

0.0
5.0
2.8
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

103.4
55.3
59.7
86.1
65.1
91.4
83.9
106.9
74.5
88.4

3.7
0.0
0.0
0.0
0.0
0.0
0.0
0.0
7.2
0.0
0.0
1.3
1.2
1.4
0.0
2.5
1.2
0.4
1.2
0.8
1.3
0.9
2.7
0.0
0.0
0.0
0.0
0.9
1.0
0.8
3.6
0.0
0.0
0.0
1.1
1.0
1.1
0.0
0.0
0.0
2.2
2.7
0.0
0.8
0.5
0.9
0.7
0.9
0.6
0.6
0.8
0.5
0.0
0.6
1.0
0.6
0.8
1.0
2.2
0.2
0.0
0.4
0.0
1.0

112.9
110.0
111.9
136.3
106.3
127.4
80.0
119.5
111.2
100.0
112.8
84.8
87.7
84.0
80.2
99.2
94.4
83.0
86.8
82.7
98.1
87.2
83.6
73.6
90.8
93.9
92.5
89.3
76.9
121.7
94.1
77.8
100.5
86.4
87.5
101.9
86.6
89.9
96.0
69.2
86.8
90.1
86.8
91.6
91.9
92.0
91.1
95.5
88.6
93.8
84.2
86.5
84.8
93.8
91.3
92.9
86.6
89.6
85.6
87.7
98.1

*Important. See note on population page.

806

748

Female
Cases MV(%) DCO(%) UB(%) MI(%)
4 75.0
41 87.8
2 100.0
78 47.4
67 44.8
36 80.6
95 90.5
19 78.9
43 79.1
621 75.0
51 96.1
78 79.5
55 60.0
24 62.5
17 94.1
5 100.0
1424
123
293
68
43
12
0
58
759
6
62
238
72
164
24
243
1677
112
141
140
1273
345
34
10
10
10
19
245
418
72
15
8
6
1
54
258
198
288
36
250
65
58
7
1288
171
1105
419
198
215
129
62
62
62
800
168
616
350
180
205
254
82
171
19
38

88.2
93.5
93.9
88.2
90.7
100.0
0.0
86.2
84.7
100.0
90.3
90.3
90.3
90.9
100.0
91.8
94.3
95.5
96.5
94.3
94.0
94.2
97.1
100.0
90.0
100.0
100.0
92.7
93.5
94.4
93.3
87.5
100.0
100.0
92.6
93.4
92.4
96.9
94.4
97.2
93.8
93.1
100.0
91.8
95.3
91.3
95.2
93.9
96.7
96.1
95.2
98.4
95.2
95.6
97.0
95.1
95.7
90.0
93.7
94.9
98.8
93.0
94.7
84.2

9.8
13.4
16.7
6.3
15.8
16.3
10.6
3.9
10.3
16.4
16.7
0.0
2.6
0.0
2.0
2.9
0.0
0.0
1.7
3.4
0.0
3.2
5.0
6.9
4.3
0.0
0.4
1.7
1.8
1.4
0.7
1.9
2.9
2.9
0.0
10.0
0.0
0.0
3.3
1.7
1.4
6.7
0.0
0.0
0.0
0.0
1.9
2.0
1.0
2.8
0.8
3.1
3.4
0.0
5.6
1.8
6.2
2.6
2.5
2.3
2.3
3.2
0.0
0.0
2.5
3.0
2.4
2.0
5.0
1.5
0.4
0.0
0.6
0.0
0.0

0.0
0.0
0.0
0.0
0.0

39.0

0.0
3.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
5.9
0.0

100.0
48.4
52.6
69.8
54.8
74.5
76.9
100.0
62.5
80.9

5.8
0.0
0.0
0.0
0.0
0.0
0.0
1.7
10.7
0.0
0.0
3.8
1.4
4.3
0.0
4.5
1.3
0.9
0.7
0.7
1.4
0.9
0.0
0.0
0.0
0.0
0.0
1.2
1.4
1.4
0.0
0.0
0.0
0.0
1.9
1.6
1.0
0.3
2.8
0.0
1.5
1.7
0.0
0.8
0.6
0.8
0.7
1.5
0.0
0.8
1.6
0.0
1.6
0.3
0.0
0.3
1.1
0.6
1.0
0.4
0.0
0.6
0.0
2.6

101.3
118.7
94.2
105.9
116.3
150.0
1.0
96.6
99.9
133.3
91.9
90.8
101.4
87.2
95.8
92.6
89.0
73.2
97.2
70.0
92.1
91.6
117.6
73.7
92.7
88.8
88.9
100.0
75.0
33.3
100.0
59.3
96.9
85.9
74.0
75.0
73.6
96.9
94.8
100.0
80.6
72.5
82.2
92.6
92.4
94.4
92.2
88.7
100.0
90.3
85.0
88.1
85.4
90.0
91.1
85.9
95.3
103.7
91.2
105.3
92.1

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Oesophagus (C15) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Female
Cases MV(%) DCO(%) UB(%) MI(%)

312
1495
2086
280
1791
814
217
591
1088
130
955
173
41538
5264
35284
1646
259
1355
278
11
61
201
3517
556
2861
2412
252
2089
611
703
2875
287
2534
239
4513
503
3715
11756
496
1380
721
9070
898
377
516
2800
352
2410
202
124
1114
748
415
1278

97.1
96.1
96.0
94.6
96.1
97.3
94.9
98.1
93.7
91.5
93.9
93.6
94.7
93.5
94.9
95.6
96.1
95.6
92.4
72.7
93.4
93.5
93.3
93.2
93.3
93.9
90.1
94.3
90.0
95.3
97.7
96.9
97.9
95.4
96.8
95.8
96.9
96.3
97.4
96.2
96.7
96.2
95.2
94.2
95.9
92.2
90.1
92.8
98.0
91.9
96.0
96.5
95.9
91.8

1.3
1.5
1.1
0.4
1.2
1.2
2.3
0.8
1.8
2.3
1.8
4.6
2.3
3.1
2.2
1.4
0.8
1.5
2.9
9.1
1.6
3.0
2.8
3.4
2.8
3.3
6.0
3.1
2.5
2.4
0.6
0.7
0.6
0.8
1.0
1.4
1.0
1.1
1.4
1.1
1.0
1.0
1.2
1.1
1.4
4.3
6.0
4.0
0.0
3.2
0.9
0.3
1.2
3.4

0.6
1.1
1.5
3.2
1.3
0.4
0.5
0.3
4.0
3.8
4.0
0.6
1.4
1.3
1.4
1.0
0.8
1.0
1.1
9.1
1.6
0.5
1.5
0.9
1.6
2.0
1.2
2.1
1.3
0.6
0.6
1.0
0.4
0.8
0.7
0.8
0.7
1.0
0.4
0.7
0.7
1.1
1.9
2.4
1.6
2.3
2.6
2.0
0.0
0.0
1.4
1.6
1.7
3.6

95.5
89.8
89.5
78.9
91.5
90.9
72.8
98.1
84.5
76.9
85.5
107.5
89.8
87.3
91.1
89.2
79.9
91.7
87.4
109.1
95.1
84.6
87.7
84.2
89.4
93.3
88.5
96.8
92.8
96.0
92.5
93.0
93.9
82.0
90.6
85.7
91.7
92.3
83.7
84.6
78.9
95.2
87.4
90.5
85.7
90.5
90.6
91.1
92.6
87.1
91.9
94.3
85.8
84.8

93 91.4
501 93.8
600 91.8
110 96.4
487 90.8
264 93.9
90 96.7
174 92.5
312 89.4
54 90.7
255 89.4
46 89.1
13450 92.8
2101 94.7
10997 92.4
613 96.4
100 96.0
499 96.6
51 90.2
1 100.0
9 100.0
39 87.2
1382 91.7
309 94.2
1043 90.8
771 92.0
110 90.0
631 91.9
150 84.7
224 91.5
870 95.1
134 97.8
723 94.9
82 96.3
1470 93.6
229 96.5
1158 92.8
3998 94.4
169 95.3
544 96.7
202 95.0
3061 93.9
244 93.4
97 89.7
145 95.9
854 87.5
133 91.7
704 86.6
45 95.6
46 89.1
338 90.5
230 90.0
117 94.9
352 91.5

2.2
2.6
1.3
0.0
1.6
2.7
1.1
3.4
4.2
3.7
4.3
8.7
2.9
2.2
3.1
1.5
2.0
1.4
0.0
0.0
0.0
0.0
2.2
1.6
2.4
4.0
4.5
4.1
4.0
4.5
1.0
0.0
1.2
2.4
2.3
1.7
2.3
1.7
2.4
1.5
0.5
1.8
2.5
3.1
2.1
7.3
3.8
8.1
4.4
8.7
1.5
0.9
1.7
3.1

1.1
1.8
2.7
2.7
2.7
1.1
1.1
1.1
3.5
5.6
3.1
0.0
1.7
1.5
1.7
0.7
1.0
0.6
3.9
0.0
0.0
5.1
2.4
1.0
2.9
3.0
4.5
2.9
2.0
1.3
1.4
0.7
1.1
0.0
0.8
1.3
0.8
1.0
0.6
0.9
1.0
1.0
2.0
3.1
1.4
2.8
1.5
2.8
0.0
0.0
1.5
1.3
0.0
2.3

100.0
81.4
83.8
79.1
85.0
83.0
67.8
89.7
83.7
75.9
86.3
102.2
87.0
86.2
88.2
81.4
83.0
81.2
107.8
200.0
144.4
97.4
82.9
75.4
86.0
88.7
94.5
91.8
90.0
92.0
94.8
85.8
97.8
96.3
85.9
82.1
87.0
87.2
74.0
87.9
67.3
89.1
88.1
91.8
84.8
90.3
100.0
88.8
62.2
93.5
92.6
91.3
80.3
84.7

23
514
2030
254
230
2291
532
25
808
1070
69
1369
333
380
91
358
332
15
252
246
503
1656
773
4084
892

82.6
71.0
95.4
77.2
78.7
63.4
95.5
96.0
74.9
75.1
81.2
65.8
93.7
76.3
83.5
89.1
91.6
93.3
82.1
89.4
95.4
85.2
90.3
76.3
87.1

8.7
0.2
0.8
1.2
3.0
0.6
0.0

0.0
0.0
0.0
0.0
1.7
0.0
0.0
4.0
1.6
0.0
0.0
0.2
0.0
0.0
0.0
1.7
1.2
0.0
2.4
1.2
0.0
0.0
0.1
0.0
0.6

73.9
86.0
74.6

10 100.0
120 70.8
455 94.1
70 84.3
43 72.1
965 55.8
60 95.0
7 100.0
479 78.9
598 77.1
19 89.5
905 68.5
214 93.0
295 71.5
28 92.9
228 85.5
221 85.5
7 85.7
37 64.9
61 82.0
106 92.5
327 79.5
123 85.4
823 71.1
150 76.0

0.0
0.0
1.1
2.9
4.7
0.8
0.0

0.0
0.0
0.0
0.0
2.3
0.0
0.0
0.0
1.0
0.0
0.0
0.0
0.0
0.0
0.0
2.6
2.7
0.0
8.1
0.0
0.0
0.0
1.6
0.0
2.7

100.0
75.8 *
71.4
*
65.1
72.0 *
*
71.4 *
42.0
*
15.8
48.4
*
*
*
85.0

2.1
2.4
2.9
13.3
0.0
7.1
2.2
2.8
1.8
0.0
15.5
3.7
1.4
8.4
4.8
12.0
8.4

76.1
70.4
30.0
46.7
14.5
51.7
76.8
69.0
56.9
56.9
57.7
66.0
76.7
68.5

2.1
1.2
0.0
15.4
0.0
13.6
0.0
4.8
5.0
0.0
27.0
9.8
1.9
12.8
7.3
16.8
14.0

70.3
55.7
53.8
56.6
68.3
72.9
62.7

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

749

807

Indices of data quality

Oesophagus (C15) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

6856 85.2
620 82.4
397 90.9
142 87.3
253 85.4
280 84.3
51 78.4
1334 84.9
83 81.9
20 65.0
14 71.4
45 93.3
72 86.1
41 92.7
174 95.4
195 69.2
390 96.7
352 96.6
25 96.0
13 100.0
84 90.5
34 73.5
204 88.7
47 85.1
182 91.2

5.7
4.8
4.0
4.9
3.6
3.9
2.0
6.7
2.4
35.0
21.4
4.4
8.3
0.0
0.0
6.7
0.0
0.0
0.0
0.0
0.0
5.9
2.0
2.1
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2.1
1.1

78.0
82.4
66.8
85.2
60.1
77.5
73.5
61.5
88.0

1297 88.6
97 94.8
58 86.2
1742 84.7
362 98.1
1274 95.1
702 34.8
943 67.8
1780 83.9
1329 92.0
224 90.6
700 94.6
370 98.6
327 93.9
161 99.4
253 99.6
211 99.5
261 97.7
503 99.6
268 99.6
271 96.3
97 95.9
237 98.7
679 75.8
1036 82.2
456 69.3
513 84.4
553 90.4
680 82.5
302 97.0
49 100.0
941 91.0
42 95.2
170 86.5
71 87.3
134 76.9
92 82.6
12 91.7
181 87.3
62 93.5
36 83.3
748 95.1
87 95.4
13 69.2
53 88.7
94 88.3
63 71.4
79 83.5
19 84.2
49 85.7
133 85.7
95 80.0
100 97.0
452 90.0

10.2
3.1
6.9

0.1
0.0
1.7
0.0
0.0
3.8
0.0
22.6
0.7
3.5
0.0
1.3
0.0
0.3
0.0
0.0
0.0
0.4
0.2
0.0
1.1
1.0
0.4
1.9
0.3
0.0
0.8
0.0
1.9
0.0
0.0
0.6
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
6.3
0.0
0.0

90.6
83.5
63.8
92.4

29.9
9.7
5.4
0.5
0.0
1.4

0.0
21.8
15.5
10.1
14.2
4.5
12.1
2.3
0.0
2.3
0.0
0.6
0.0
3.0
0.0
0.0
2.2
0.0
11.1
0.4
0.0
0.0
0.0
3.2
4.8
2.5
0.0
0.0
0.8
3.2
0.0
0.9

88.9
62.5

90.8
1.2
94.1
62.3
61.7
48.9

77.5
107.1
93.0
93.9
109.6
92.4
84.3
79.7
78.0
82.0
84.6
97.6
79.7
78.9
77.6
85.6
86.6
95.8
170.4
61.1
75.4
55.8
75.8
84.9
78.8
85.7
102.3
92.9
84.7
83.1
106.0
90.2
108.3
97.2
80.6
67.1
89.0
93.1
107.7
98.1
108.5
71.4
69.6
100.0
79.1
88.7
118.9
88.0
93.6

*Important. See note on population page.

808

750

Female
Cases MV(%) DCO(%) UB(%) MI(%)
662 66.0
75 64.0
49 79.6
16 75.0
29 79.3
41 65.9
7 57.1
154 72.1
12 66.7
16 87.5
3 33.3
39 92.3
55 89.1
41 85.4
166 84.9
61 59.0
110 93.6
94 92.6
11 100.0
5 100.0
31 64.5
16 43.8
49 85.7
18 94.4
95 93.7

16.2
16.0
8.2
12.5
6.9
14.6
0.0
14.9
16.7
12.5
66.7
2.6
5.5
4.9
0.0
13.1
0.0
0.0
0.0
0.0
0.0
18.8
4.1
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

340
27
11
209
108
373
205
213
319
518
48
399
38
78
18
53
58
51
93
43
42
20
33
144
271
172
117
147
206
85
16
597
19
40
20
54
37
5
81
27
13
198
37
4
19
35
16
12
6
14
54
29
27
144

16.5
14.8
0.0

0.0
0.0
0.0
0.0
0.0
7.0
1.5
30.0
0.9
2.9
0.0
1.5
0.0
0.0
0.0
0.0
0.0
2.0
0.0
0.0
2.4
0.0
0.0
2.8
0.0
0.0
0.9
0.0
0.0
0.0
0.0
1.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
17.2
0.0
0.0

81.2
81.5
100.0
74.2
100.0
92.0
26.8
59.2
75.5
90.3
85.4
92.5
94.7
91.0
100.0
98.1
96.6
94.1
100.0
100.0
92.9
90.0
97.0
69.4
67.2
65.7
76.1
84.4
83.5
95.3
100.0
84.9
89.5
72.5
85.0
70.4
67.6
60.0
82.7
81.5
76.9
89.9
81.1
75.0
84.2
85.7
43.8
91.7
83.3
78.6
90.7
69.0
74.1
81.3

36.1
10.8
8.2
1.7
0.0
1.3

0.0
27.1
28.8
9.9
22.2
8.8
12.1
4.7
0.0
2.2
0.0
10.0
5.0
1.9
8.1
20.0
3.7
0.0
15.4
2.0
0.0
0.0
0.0
8.6
18.8
0.0
0.0
0.0
0.0
3.4
3.7
2.8

85.6
81.3
65.3
100.0
65.5
92.7
42.9
61.7
83.3
64.1
18.2

90.9

*
*
*

*
81.3 *
224.5
38.9 *
46.3 *
91.2
92.6
81.8
100.5 *
*
76.1
115.1 *
85.0
101.3
106.0
70.8
90.0
84.2
75.6
72.2
81.1
105.2
74.5
88.2
72.1
85.7
80.0
103.0
204.9
73.1
82.0
61.5
87.8
86.9
94.1
106.3
95.1
100.0
100.0
65.0
118.5
116.2
120.0
92.6
88.9
57.7
88.4
51.4
100.0
94.7
91.4
137.5
108.3
66.7
80.4
88.9
110.3
77.8
78.5

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Oesophagus (C15) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

435
707
39
600
115
166
210
740
578
1077
549
1253
371
43
311
576
355
36
143
103
148
101
109
156
1345
125
57
44
96
87
76
221
4306
237
204
995
1046
1708
2367
861
2824
4622
2032
1918
455
2391

78.2
81.3
79.5
96.3
56.5
77.1
84.3
96.9
82.9
74.9
76.3
81.6
95.7
83.7
92.0
94.3
93.5
83.3
95.8
90.3
94.6
97.0
92.7
90.4
99.3
96.0
98.2
97.7
96.9
97.7
97.4
97.3
98.4
98.3
97.5
90.7
83.8
88.9
90.7
93.7
82.2
83.5
88.7
92.1
89.7
93.7

5.1
2.0
7.7
0.7
10.4
5.4
1.0

94.3
92.5
107.7
88.7
100.0
100.2
110.5
90.9
90.8
106.0
89.6
98.9
100.5
104.7
99.1
87.5
93.0
72.2
81.8
100.0
90.5
93.1
71.6
96.8
91.7
63.2
80.7
75.0
72.9
82.8
85.5
79.6
94.4

0.4
4.0
1.7
1.5
0.9
1.1
6.4
3.9
1.7
0.9
0.5

0.2
0.0
0.0
0.0
0.0
3.0
0.0
0.1
0.0
7.2
0.0
0.8
2.7
0.0
0.6
0.2
0.3
0.0
0.0
1.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.4
0.1
1.2
0.0
3.3
2.9
3.6
0.9
0.0
0.0
1.0

1123 93.6
29 93.1
682 93.7
308 96.4
135 94.1
856 91.4
326 95.7
45 77.8
39 97.4
694 91.4
190 98.4
18 100.0
12 100.0
33 97.0
68 98.5
45 97.8

1.2
3.4
0.4
0.0
0.7
1.6
1.5
0.0
2.6
3.3
0.5
0.0
0.0
3.0
0.0
0.0

0.0
0.0
0.0
0.6
0.0
0.8
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

95.7
75.9
98.5
91.2
90.7
104.1
74.8
108.9
66.7
86.2
88.9

12.1
10.0
12.5
1.6
2.3
3.9
1.9
2.3
8.3
2.8
1.9
0.7
1.0
1.8
6.4
0.0
0.0
2.3
1.0
1.1
0.0
2.3

94.1
106.1
101.1
105.3
102.0
99.4
107.0
91.0
88.1
105.5
106.6
95.1

91.1

Female
Cases MV(%) DCO(%) UB(%) MI(%)
76 53.9
103 70.9
11 81.8
252 95.6
30 43.3
42 73.8
63 73.0
203 97.0
106 69.8
446 61.0
165 81.8
128 74.2
93 91.4
5 100.0
40 80.0
75 88.0
55 78.2
4 75.0
25 84.0
20 70.0
24 91.7
20 70.0
12 58.3
20 75.0
596 99.2
55 96.4
13 92.3
15 100.0
17 100.0
27 77.8
20 90.0
69 98.6
1796 98.1
85 98.8
61 98.4
602 87.0
692 82.1
992 83.6
1525 87.7
483 87.2
1791 76.7
2878 77.8
1176 85.5
1347 88.3
304 87.5
1524 91.3
664
10
293
161
59
484
158
25
4
370
43
0
7
9
9
17

91.0
100.0
90.8
94.4
89.8
86.6
93.7
80.0
100.0
86.8
93.0
0.0
100.0
100.0
88.9
88.2

7.9
2.9
0.0
0.4
6.7
2.4
0.0

103.9
93.2
100.0
84.1
116.7 *
77.4
123.8
114.8 *
95.3
114.3
86.7
110.9
97.8
120.0
66.7
84.0
88.6
75.0
88.0
135.0
116.7
90.0
100.0
80.0
93.5
85.5
92.3
93.3
105.9
66.7
110.0
73.9
95.8

0.3
3.9
2.1
1.4
1.0
2.5
9.5
4.1
3.6
1.3
0.4

0.0
0.0
0.0
0.0
0.0
7.1
0.0
0.0
0.0
9.0
0.0
1.6
4.3
0.0
2.5
0.0
0.0
0.0
0.0
0.0
4.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.7
0.4
1.5
0.1
8.5
5.1
4.1
1.0
0.0
0.0
0.8

0.6
0.0
2.0
0.0
0.0
2.3
2.5
0.0
0.0
5.4
2.3
0.0
0.0
0.0
11.1
0.0

0.0
0.0
0.0
0.6
0.0
2.5
0.0
0.0
0.0
0.3
0.0
0.0
0.0
0.0
0.0
0.0

81.6
60.0
81.6
82.6
66.4
96.7
81.0
60.0
50.0
86.5
72.1

21.7
10.3
17.2
4.3
0.0
10.0
8.0
14.5
0.0
8.0
20.0
0.0
25.0
33.3
5.0
1.8
0.0
0.0
0.0
3.7
0.0
1.4

80.3
95.0
101.3
96.2
95.2
101.0
98.2
86.3
91.6
90.3
98.0
95.4

76.5

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

751

809

Indices of data quality

Stomach (C16)
Male
Cases MV(%) DCO(%) UB(%) MI(%)
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

147
147
51
59
129

87.1
85.0
98.0
42.4
58.9

120
575
119
259
5895
381
935
2444
599
236
222

75.0
90.6
75.6
93.1
79.5
77.2
76.7
74.2
76.1
99.2
91.9

23.3
4.0
19.3
5.0
8.4
16.0
10.1
11.7
17.0

6653 92.3
702 97.0
1144 94.4
363 92.8
247 96.4
257 99.2
8 100.0
296 92.9
3300 89.3
30 93.3
306 94.4
896 94.3
320 94.7
563 94.1
116 95.7
955 95.5
7725 97.9
1312 97.7
595 96.6
1638 98.2
4112 98.0
1610 98.0
153 96.1
204 97.1
38 100.0
57 96.5
222 99.1
785 98.5
2393 98.2
261 96.6
121 95.9
45 100.0
107 99.1
177 97.2
672 98.1
940 98.8
634 95.6
1033 97.5
96 97.9
916 97.4
154 91.6
116 93.1
30 86.7
4540 94.8
624 93.8
3851 94.9
1314 95.8
477 94.5
792 96.5
377 96.8
163 96.3
179 97.2
199 94.5
2842 97.1
498 94.4
2194 97.8
1052 97.3
573 97.6
792 96.7
1016 96.7
410 95.4
592 97.5
117 99.1
136 99.3

1.3
0.4
1.4
2.5
0.0

13.6
10.1

4.1

0.0
1.4
1.3
0.0
3.6
2.1
1.6
2.3
0.9
1.8
0.5
0.6
1.0
0.4
0.4
0.7
2.0
0.0
0.0
0.0
0.5
0.8
0.5
0.8
0.8
0.0
0.9
1.7
0.6
0.1
1.3
1.1
1.0
1.1
5.2
5.2
6.7
3.7
4.2
3.6
2.8
3.4
2.7
1.3
1.8
1.1
4.0
1.5
3.6
1.0
1.5
0.7
1.1
1.0
1.7
0.5
0.0
0.0

0.0
0.0
0.0
0.0
0.0

39.5

752

71 95.8
111 75.7
25 100.0
64 45.3
102 58.8

21.6
12.7

0.0
4.5
1.7
0.0
0.0
0.0
0.0
0.0
0.0
0.8
0.0

112.5
41.6
63.9
61.8
55.1
92.1
75.8
75.4
65.9
75.7

83
343
70
167
3600
182
736
1438
484
157
187

73.5
91.5
68.6
94.6
77.9
63.7
71.5
69.7
70.9
99.4
88.2

22.9
4.1
24.3
3.0
9.6
28.0
15.4
15.9
21.1

4.7
0.0
0.5
0.0
0.0
0.0
0.0
0.3
9.2
0.0
0.0
2.5
1.6
3.0
0.9
1.6
0.5
0.2
0.7
0.6
0.5
0.2
0.7
0.0
0.0
0.0
0.0
0.0
0.3
0.4
0.0
0.0
0.0
0.0
0.7
0.2
1.9
0.7
0.0
0.8
2.6
0.9
6.7
0.4
0.5
0.3
0.3
0.8
0.0
0.3
0.6
0.0
0.0
0.4
0.8
0.3
0.5
0.7
1.4
0.7
0.5
0.8
0.0
0.0

63.1
59.5
63.0
59.8
63.6
84.4
62.5
59.1
62.6
66.7
65.4
61.2
63.1
60.9
62.1
62.8
59.8
60.0
70.9
61.7
58.0
57.2
74.5

3736
431
650
200
131
110
5
172
1832
18
187
640
197
435
64
525
5064
970
439
1241
2379
1071
105
142
39
61
165
467
1748
217
105
27
70
137
557
591
427
647
49
592
149
117
23
2685
429
2205
954
386
541
297
136
144
131
1904
377
1430
631
329
460
719
331
378
84
92

87.1
95.1
88.5
90.5
93.1
100.0
100.0
87.8
82.6
83.3
91.4
90.9
88.8
91.7
98.4
93.7
96.1
98.7
95.4
97.3
94.5
95.5
95.2
97.9
100.0
96.7
95.8
93.6
97.3
95.9
100.0
100.0
97.1
98.5
97.8
96.3
93.4
94.4
95.9
94.3
91.3
93.2
87.0
93.3
93.9
93.1
92.9
93.5
92.1
94.9
95.6
93.8
91.6
94.1
92.0
94.4
96.4
92.4
94.3
94.4
93.1
95.5
95.2
96.7

2.5
0.5
3.8
4.0
0.0

58.1
55.9
63.0
74.3
79.3
60.0
61.7
66.7
61.5
60.1
57.6
56.1
61.5
56.3
78.6
85.3
70.0
58.4
70.4
56.8
63.4
70.9
59.6
63.1
67.5
61.5
49.2
59.7
68.9
59.2
55.9
55.7
57.8
66.2
77.3
57.6
76.1
49.3

*Important. See note on population page.

810

Female
Cases MV(%) DCO(%) UB(%) MI(%)

5.3

0.0
4.7
2.4
5.6
3.2
4.5
4.6
4.6
0.0
2.7
0.9
0.3
0.2
0.5
1.6
1.5
1.0
0.0
0.0
0.0
1.8
2.4
0.6
0.0
0.0
0.0
0.0
0.7
0.4
1.4
2.1
2.6
2.0
2.7
6.0
5.1
8.7
5.0
4.7
5.1
4.1
4.1
4.3
3.4
2.2
4.9
3.1
3.7
6.6
3.1
1.4
1.8
1.7
0.7
0.9
0.5
2.4
0.0

0.0
0.0
0.0
0.0
0.0

45.9

2.4
3.8
2.9
0.0
0.0
0.0
0.1
0.0
0.0
0.6
0.0

97.6
38.8
54.3
48.5
50.3
90.1
73.6
75.9
78.1
66.9

7.2
0.0
0.0
0.0
0.0
0.0
0.0
1.7
14.5
0.0
0.0
3.0
4.1
2.5
0.0
2.5
0.8
0.4
1.6
0.7
0.9
0.7
1.9
0.7
0.0
0.0
1.2
0.4
0.7
1.4
0.0
0.0
1.4
0.7
0.5
0.8
0.9
0.8
0.0
0.8
0.7
0.0
0.0
0.3
0.2
0.3
0.4
0.5
0.4
0.7
0.7
0.7
0.0
0.4
0.5
0.3
0.8
1.2
1.3
0.6
0.9
0.3
0.0
0.0

71.0
70.5
66.8
66.5
75.6
112.7
80.0
73.3
69.7
50.0
75.9
70.2
87.8
63.0
64.1
68.8
63.4
61.8
65.1
60.0
66.1
64.1
70.5
64.8
64.0
61.0
66.8
56.2
37.0
70.0
49.6
59.6
64.5
63.2
65.2
71.4
64.4
71.8
78.6
60.9
62.7
67.6
62.3
64.5
67.1
63.0
61.6
66.2
57.6
55.0
65.3
70.6
64.8
68.9
62.6
68.9
63.7
72.5
56.1
86.9
56.5

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Stomach (C16) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Female
Cases MV(%) DCO(%) UB(%) MI(%)

334
1654
2091
373
1681
1072
283
768
1056
148
881
203
50995
6864
40907
2581
343
2090
397
41
180
168
5747
796
4514
2267
326
1866
603
686
3454
365
2987
320
6215
738
4457
17304
2093
2025
2196
10779
895
365
517
3861
556
3189
265
119
1194
855
379
1213

96.7
97.1
96.7
97.1
96.6
97.9
97.9
97.9
94.7
94.6
94.6
94.1
96.1
94.8
96.3
97.3
98.3
97.2
94.5
90.2
96.7
92.9
95.0
92.7
95.5
94.9
93.3
95.2
93.2
96.1
97.9
97.0
98.0
95.9
97.4
97.2
97.5
97.5
97.7
96.9
98.0
97.5
95.2
95.1
95.4
93.0
90.8
93.5
97.7
95.8
97.2
97.8
96.8
94.4

0.3
1.0
0.8
0.3
0.9
1.3
1.1
1.3
2.6
3.4
2.5
3.0
1.8
2.5
1.7
1.0
0.3
1.1
3.5
7.3
1.7
4.8
1.9
3.0
1.7
1.8
2.5
1.7
1.8
1.2
0.5
0.0
0.6
2.5
1.0
1.4
1.1
0.8
0.5
1.0
0.5
0.8
1.2
1.1
1.2
4.2
5.9
3.9
0.0
3.4
0.8
0.4
1.3
2.1

0.9
1.0
1.3
1.9
1.2
0.1
0.0
0.1
2.1
0.0
2.5
0.0
1.0
1.1
0.9
0.9
0.6
0.9
0.8
0.0
1.1
0.6
1.6
1.6
1.5
2.4
3.1
2.3
0.5
0.4
0.4
1.1
0.4
0.6
0.3
0.3
0.4
0.6
0.2
0.5
0.8
0.6
2.6
2.5
2.7
1.2
0.9
1.3
0.0
0.0
0.4
0.4
0.8
2.3

57.8
61.0
56.0
57.9
55.8
51.0
54.4
50.0
61.0
75.0
59.6
52.2
58.2
68.9
57.1
54.9
64.7
54.7
62.2
70.7
66.7
56.0
52.2
64.3
50.7
62.5
69.9
62.8
60.4
55.8
55.2
64.7
55.0
61.9
55.6
63.6
54.7
58.3
57.5
67.9
59.1
56.7
64.6
72.6
60.3
62.5
75.2
60.8
56.6
49.6
53.3
51.7
64.4
50.9

181
1087
1359
313
1017
751
254
490
615
102
493
115
32695
5303
25097
1653
254
1295
248
36
130
74
4025
763
2988
1469
253
1164
364
353
2193
297
1845
242
4040
580
2718
11269
1532
1564
1623
6413
544
230
307
2519
423
2009
175
65
688
489
227
650

90.1
92.7
94.3
92.7
94.7
95.1
93.3
95.9
94.1
93.1
94.1
88.7
93.8
93.2
93.7
95.7
95.7
95.8
90.7
94.4
90.0
90.5
92.7
92.7
92.5
92.5
90.9
92.6
87.6
94.9
96.0
94.6
96.3
92.6
94.7
94.5
93.9
95.4
98.3
94.5
96.5
94.6
93.4
93.5
93.2
90.7
88.9
91.0
93.1
95.4
95.2
94.5
93.0
88.3

3.9
2.6
1.0
1.3
1.0
1.9
2.8
1.4
1.6
2.9
1.4
7.8
2.7
3.0
2.8
1.8
0.4
2.2
4.0
2.8
4.6
2.7
2.5
1.4
2.8
3.9
5.5
3.8
1.9
1.7
0.8
0.7
0.9
2.1
1.8
2.2
2.1
1.4
0.3
1.2
1.2
1.7
2.6
2.6
2.6
6.2
7.6
6.1
1.1
1.5
1.2
0.6
1.8
4.5

2.8
2.4
2.6
3.2
2.6
0.7
0.4
0.8
3.3
2.9
3.4
0.9
1.3
1.7
1.3
0.7
1.6
0.5
1.6
2.8
1.5
1.4
1.7
2.4
1.5
2.3
2.0
2.5
1.1
0.8
1.0
2.4
0.7
0.0
0.9
0.7
1.1
0.8
0.4
1.0
0.7
0.9
2.4
2.6
2.3
1.5
2.1
1.3
0.6
0.0
1.2
1.6
0.9
4.8

47
917
3291
431
585
8367
302
164
1119
704
51
961
158
265
122
2025
1907
101
1967
2673
3377
7073
4446
19306
5290

91.5
82.0
95.7
90.7
81.7
72.6
92.1
98.8
64.5
77.0
52.9
69.9
91.8
80.0
73.8
93.2
93.7
97.0
84.6
93.5
98.1
84.8
94.4
77.4
90.0

2.1
0.0
0.6
0.5
1.5
0.4
0.0

0.0
0.0
0.0
0.0
0.9
0.0
0.0
0.6
9.5
0.0
0.0
0.1
0.0
0.0
0.0
0.9
0.8
0.0
2.1
0.6
0.0
0.0
0.2
0.0
0.6

78.7
71.4
62.2

31
487
1926
156
295
4839
149
110
544
327
24
477
76
149
31
1371
1279
60
945
1492
1637
3249
2317
9372
2799

87.1
80.3
94.1
81.4
83.1
68.8
89.3
99.1
61.8
70.6
62.5
68.6
84.2
65.8
64.5
90.7
92.3
91.7
78.0
90.3
96.2
81.1
89.8
73.1
86.1

3.2
0.0
1.0
0.6
0.3
0.5
0.0

0.0
0.2
0.0
0.0
1.4
0.0
0.0
0.9
10.7
0.0
0.0
0.4
0.0
0.0
0.0
0.9
0.9
1.7
3.0
0.9
0.0
0.0
0.3
0.0
0.7

3.9
3.4
5.9
9.8
0.6
6.8
7.4
1.9
1.6
1.0
13.3
3.1
0.7
11.0
2.6
10.5
6.3

72.3
62.0
24.4
53.6
13.7
42.9
69.0
51.4
39.7
34.0
40.7
41.9
58.7
44.1

5.5
2.1
8.3
12.8
0.0
14.1
12.9
3.4
2.5
3.3
19.0
3.7
2.3
14.7
5.4
14.0
9.4

69.6
70.1
63.2
60.7
64.4
61.8
57.5
63.5
64.2
77.5
62.1
60.0
64.4
67.8
64.8
63.0
60.6
64.9
70.2
72.2
72.3
68.9
58.4
56.1
60.2
66.2
69.6
67.8
65.4
68.8
62.1
64.0
62.8
67.4
63.8
62.1
64.7
63.6
60.9
64.5
58.9
65.6
71.3
79.1
66.4
70.5
77.5
69.8
70.9
70.8
64.4
60.3
70.5
64.2
48.4
89.1 *
65.6
*
58.6
62.4 *
*
22.7 *
53.1
*
25.0
44.9
*
*
*
69.4
57.6
47.4
39.0
46.7
49.2
62.0
49.6

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

753

811

Indices of data quality

Stomach (C16) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

57198
5009
3645
1924
1701
3039
413
13090
944
31
44
225
420
219
156
497
1439
1316
60
63
227
120
73
310
881

88.8
88.8
92.6
90.0
90.2
90.8
91.0
89.1
90.1
74.2
84.1
90.7
86.4
91.8
96.2
64.4
96.5
96.8
96.7
88.9
89.4
68.3
97.3
88.7
90.8

5.0
3.3
3.5
3.0
2.4
2.4
2.4
5.7
2.5
25.8
13.6
5.3
7.1
0.5
0.0
9.3
0.0
0.0
0.0
0.0
0.0
15.0
1.4
0.6
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2.3
0.0
0.2
0.5
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.9
1.5

4213 88.9
420 97.4
145 91.7
10596 87.1
574 98.8
1940 93.8
5898 46.7
3697 74.1
5209 86.1
1574 92.6
1233 92.8
2106 96.5
380 98.7
245 96.7
183 98.9
312 99.7
293 99.3
405 97.5
370 99.5
316 100.0
187 97.3
151 97.4
270 99.3
1662 70.1
3261 79.1
844 68.8
1339 74.6
1282 86.3
1600 84.8
657 93.9
116 99.1
1426 91.4
151 94.0
667 92.4
330 90.0
1488 87.4
457 88.2
311 90.4
750 85.7
654 94.5
218 87.6
2052 95.3
571 89.1
153 90.2
538 93.7
1550 93.9
383 81.2
180 92.2
141 83.7
196 94.9
624 94.7
1135 89.7
489 96.5
1176 93.9

10.6
1.7
4.1

0.0
0.0
0.7
0.0
0.0
5.5
0.2
16.1
0.4
2.9
0.0
0.4
0.0
0.4
0.0
0.3
0.0
0.2
0.0
0.0
0.5
0.7
0.4
1.6
0.1
0.0
0.6
0.0
0.2
0.0
0.0
0.3
0.0
0.0
0.0
0.0
0.0
0.3
0.0
0.0
0.0
0.0
0.0
0.7
0.0
0.0
0.0
0.0
2.1
0.0
0.0
6.2
0.0
0.0

26.0
9.8
5.1
0.4
0.6
1.0

0.0
27.7
19.3
12.8
24.3
8.3
10.6
4.3
0.0
2.7
2.6
1.9
0.6
0.9
1.5
1.9
2.0
0.6
1.4
0.8
1.4
2.0
0.6
1.8
3.9
3.9
4.3
0.0
1.3
0.4
0.0
0.4

52.2
53.5
44.0
47.6
45.3
52.0
43.6
43.7
44.2
42.2
40.5

68.9
1.3
93.3
75.3
42.9
64.0
76.3
61.7
68.3
83.7
76.1
85.7
81.3
83.0
72.9
83.5
73.2
66.1
81.2
72.7
67.3
77.1
71.9
73.2
72.2
76.5
61.6
78.1
160.8
59.8
75.4
58.1
61.8
66.3
63.6
73.3
71.5
73.5
64.8
77.9
74.7
70.2
71.1
70.7
66.7
73.0
67.0
72.3
83.0
67.5
69.4
74.2
79.4
68.1
54.8
63.6
67.3
65.2
61.1

*Important. See note on population page.

812

754

Female
Cases MV(%) DCO(%) UB(%) MI(%)
29856
2617
2009
1019
989
1474
228
7165
490
30
42
181
220
99
83
427
958
884
33
41
195
81
36
162
443

84.4
85.5
89.1
88.5
84.9
86.7
82.9
87.1
87.3
63.3
61.9
82.9
87.3
88.9
97.6
63.7
93.4
93.7
90.9
90.2
90.8
75.3
94.4
85.8
90.3

8.0
5.5
6.0
4.8
5.7
3.4
1.3
7.4
4.1
26.7
33.3
10.5
7.7
1.0
0.0
13.3
0.0
0.0
0.0
0.0
0.0
12.3
0.0
1.2
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.9
2.0

1.0 *
93.8 *
125.0
42.6 *
72.0 *

3733 87.1
366 92.6
124 81.5
7638 84.3
369 99.2
1323 90.8
3682 41.3
2395 69.7
3873 82.4
933 90.6
999 90.2
1741 95.0
210 98.1
160 92.5
97 100.0
172 94.8
172 99.4
259 97.7
215 98.6
205 99.5
108 98.1
68 98.5
107 98.1
1346 63.0
2842 73.0
697 62.6
1011 69.0
1175 83.5
1241 81.5
521 91.6
70 100.0
910 85.6
112 90.2
497 90.1
223 87.9
1099 80.6
356 82.6
196 84.2
698 77.8
430 89.5
145 82.1
1529 92.3
400 85.3
86 81.4
338 85.5
1202 88.0
273 79.9
121 90.9
76 77.6
120 85.8
431 91.4
823 83.7
368 88.6
873 89.1

12.1
3.3
13.7

0.1
0.0
0.8
0.0
0.0
7.4
0.3
18.9
0.5
3.3
0.0
0.6
0.0
0.0
0.0
2.9
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.8
0.0
0.0
0.3
0.0
1.0
0.0
0.0
1.2
0.0
0.0
0.0
0.0
0.0
0.5
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
9.4
0.0
0.0

79.7
72.1
65.3
76.9 *
*
81.3
89.1 *
77.9
86.1
85.9
83.6
75.1
70.5
85.6
79.4
85.5
71.5
62.9
70.7
77.1
74.1
73.5
106.5
171.8
62.9
81.9
58.2
68.3
79.5
72.4
61.4
78.2
67.0
60.8
74.9
76.9
73.0
71.9
74.1
75.1
67.8
68.1
73.5
93.0
74.0
65.5
72.5
71.9
73.7
67.7
73.8
70.5
65.2
65.1

31.6
11.4
6.6
0.8
0.7
1.3

0.0
35.9
25.1
17.9
29.7
10.4
11.1
6.1
0.0
6.3
5.4
3.0
1.8
2.2
2.5
5.6
4.6
0.7
3.4
1.3
2.0
8.1
0.9
4.5
2.2
3.3
9.2
1.7
2.6
1.7
1.4
2.7

55.3
58.7
49.2
48.4
47.8
55.3
61.2
45.0
50.4
22.1
18.2

73.4

*
*
*

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Stomach (C16) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

1842 77.4
3018 81.7
148 95.9
1825 96.5
447 42.1
793 79.2
646 85.1
3584 97.4
2352 83.8
4592 79.2
2581 77.8
3088 82.7
1460 95.1
159 91.2
850 92.0
1401 93.1
489 93.5
168 83.3
314 92.4
360 92.2
506 91.7
407 94.1
275 90.5
509 91.9
3182 99.5
118 98.3
115 97.4
58 100.0
186 97.3
193 93.8
140 96.4
188 97.3
6687 98.0
436 98.4
383 99.0
1341 91.7
1434 85.6
2412 89.8
4017 92.2
955 91.5
3386 83.0
5543 81.6
2833 87.0
3084 91.0
780 92.3
2740 92.6

5.8
1.7
2.0
0.3
13.9
5.7
0.8

89.5
80.1
83.1
81.4
88.6
85.3
108.5
76.1
81.2
97.2
87.9
84.0
82.1
77.4
77.3
70.4
68.0
84.5
68.8
85.3
78.7
68.8
63.6
86.4
82.3
64.4
60.9
63.8
67.7
67.4
67.1
56.4
75.3

0.1
3.5
1.5
1.3
0.7
1.7
9.1
3.9
2.5
1.3
0.4

0.3
0.0
0.0
0.0
0.0
3.2
0.2
0.0
0.0
6.3
0.0
0.7
1.8
0.6
0.6
0.5
0.8
0.0
0.0
0.3
0.8
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.3
0.1
0.9
0.0
5.9
4.7
3.2
0.5
0.0
0.0
1.2

2083 95.3
22 100.0
1078 93.8
567 95.4
155 96.8
1751 94.6
512 96.5
71 98.6
29 96.6
1212 93.9
546 97.4
21 100.0
63 98.4
59 96.6
285 97.2
77 96.1

0.8
0.0
1.9
0.0
0.0
1.2
1.4
0.0
3.4
2.1
0.5
0.0
0.0
1.7
0.0
2.6

0.0
0.0
0.1
0.2
0.6
0.7
0.2
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0

58.1
63.6
57.2
66.5
68.8
59.2
76.0
64.8
82.8
79.1
54.9

12.7
10.6
11.9
3.2
5.0
3.1
2.7
3.3
11.3
2.2
1.7
2.8
2.0
5.8
3.5
0.0
0.0
0.0
0.5
3.6
1.4
2.1

74.4
64.9
67.1
64.8
66.0
69.2
70.6
71.9
71.8
66.5
68.1
68.3

57.1

Female
Cases MV(%) DCO(%) UB(%) MI(%)
1567
2245
85
1192
241
435
394
2428
1563
4582
1346
1913
936
88
524
722
298
79
214
225
338
244
161
333
2084
89
59
33
120
140
68
105
3935
272
270
658
829
1402
2405
505
1745
3168
1534
1554
507
1860

75.5
78.6
88.2
94.1
36.9
74.3
76.1
97.2
79.4
72.9
73.7
80.9
94.1
79.5
87.6
87.4
87.6
86.1
83.2
86.7
91.4
89.8
85.1
86.8
98.8
98.9
88.1
93.9
87.5
92.1
94.1
93.3
97.3
97.8
97.0
84.0
81.3
83.2
86.4
81.4
73.7
72.7
81.8
82.9
84.0
89.3

1171 93.3
13 100.0
530 89.6
305 93.4
87 95.4
1014 91.1
276 92.4
46 93.5
20 100.0
743 89.6
381 97.9
24 95.8
34 94.1
51 98.0
191 99.5
45 95.6

5.7
2.2
3.5
0.7
11.2
6.4
1.5

88.4
77.5
92.9
85.2
89.7 *
84.5
111.9
79.9 *
75.9
99.5
90.2
78.4
83.2
83.0
79.8
74.4
79.7
87.3
68.7
89.3
82.0
71.7
68.3
97.6
86.9
61.8
78.0
87.9
72.5
69.3
60.3
73.3
82.6

0.6
5.9
2.4
2.6
2.2
1.9
13.7
5.5
6.1
3.2
0.8

0.4
0.0
0.0
0.0
0.0
6.4
0.3
0.0
0.0
7.9
0.1
0.5
1.7
1.1
1.3
0.8
1.3
0.0
0.9
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.4
0.1
1.6
0.0
9.9
8.5
4.3
0.8
0.0
0.0
0.5

1.3
0.0
2.1
0.0
0.0
2.8
3.3
0.0
0.0
4.8
0.5
0.0
0.0
2.0
0.0
2.2

0.0
0.0
0.0
0.0
0.0
1.3
0.0
0.0
0.0
0.1
0.3
0.0
0.0
0.0
0.5
0.0

60.9
53.8
62.6
71.8
81.4
63.0
73.6
82.6
55.0
79.5
59.1

16.9
13.5
13.3
4.2
10.2
5.7
5.3
7.4
6.3
8.9
1.3
3.3
3.7
6.8
5.7
0.0
0.0
3.0
1.7
5.0
0.0
6.7

74.8
71.9
74.3
76.1
71.7
80.4
79.2
77.9
74.5
79.3
76.7
75.6

71.1

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

755

813

Indices of data quality

Large bowel (C18-21)


Male
Cases MV(%) DCO(%) UB(%) MI(%)
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

152
339
113
75
125

94.1
90.0
98.2
58.7
71.2

260
494
103
246
6570
119
472
975
234
189
84

76.2
92.3
86.4
90.2
81.8
83.2
84.1
79.1
85.5
97.9
97.6

22.7
2.2
7.8
6.9
6.2
9.2
6.6
7.7
7.7

35704
3709
5920
1999
1211
1017
54
1839
18074
241
1640
5782
1090
4634
554
6296
36828
3456
2344
4536
26000
7417
522
556
254
130
686
4889
9612
1109
390
259
293
192
1616
5523
4308
5373
280
5004
767
570
173
28655
2171
26101
8695
1991
6609
2479
760
1660
1402
17898
2146
15271
8658
5039
6168
6449
1620
4777
492
953

93.4
96.0
96.2
94.6
96.9
99.2
98.1
93.6
91.0
96.3
95.5
97.0
96.0
97.2
97.5
97.3
97.7
98.5
97.4
97.8
97.7
97.9
97.1
98.4
98.4
96.9
97.5
97.9
98.2
97.4
99.0
98.5
99.3
99.0
98.2
98.3
96.4
98.4
97.5
98.4
96.5
96.1
97.1
96.6
95.3
96.7
96.5
95.1
96.9
97.7
96.8
98.1
96.6
97.0
95.3
97.1
97.3
97.4
96.9
97.4
95.6
98.1
95.3
98.2

0.7
0.1
0.6
1.2
0.1

4.1
9.6

0.0

0.0
0.8
0.8
0.0
2.3
0.7
0.5
0.7
0.2
1.0
0.6
0.3
0.6
0.5
0.6
0.7
1.3
0.7
0.4
0.8
0.4
0.7
0.4
0.5
0.3
0.8
0.0
0.0
0.6
0.3
1.3
0.8
1.8
0.7
2.1
2.3
1.7
2.3
3.2
2.2
1.7
2.1
1.5
0.8
0.9
0.7
2.2
1.5
3.0
1.4
0.9
0.9
0.8
0.8
1.9
0.5
2.6
0.6

0.0
0.3
0.0
0.0
0.0

21.2

756

154 94.2
271 91.1
95 100.0
89 64.0
94 70.2

6.6
19.1

0.0
5.1
2.9
0.0
0.0
0.0
0.0
0.0
0.0
0.5
0.0

87.7
29.8
30.1
45.9
37.9
57.1
57.0
56.6
49.1
54.9

210
590
106
330
7518
144
648
1020
290
275
106

76.2
91.2
84.9
93.0
81.0
72.9
83.0
74.6
83.4
96.4
93.4

21.4
4.2
7.5
4.5
7.0
11.8
7.1
11.9
9.7

4.1
0.1
0.1
0.1
0.0
0.1
0.0
0.3
7.9
0.0
0.0
1.3
1.7
1.2
1.3
0.7
0.4
0.3
0.6
0.6
0.4
0.2
0.8
0.0
0.0
0.0
0.4
0.1
0.4
0.6
0.5
0.0
0.0
0.5
0.2
0.3
0.6
0.1
0.0
0.2
0.8
0.7
1.2
0.2
0.3
0.2
0.3
0.4
0.3
0.3
0.5
0.2
0.1
0.3
0.6
0.2
0.4
0.1
1.1
0.3
0.5
0.2
0.8
0.2

34.4
32.0
31.9
39.5
31.8
36.6
29.6
27.5
35.7
34.9
37.7
38.3
52.3
35.4
31.9
37.2
35.3
32.3
45.1
30.4
36.2
34.7
50.2

31165
2914
5048
1746
1137
774
33
1690
16167
253
1403
5630
1330
4231
506
5592
35620
3312
2506
3981
25444
7219
524
529
251
145
552
4878
9675
1268
333
217
276
180
1562
5592
4216
5659
382
5210
930
690
211
27711
2363
24982
8668
2299
6285
2623
861
1714
1342
18153
2456
15259
8780
5302
6335
6035
1737
4262
521
912

91.0
94.5
93.9
93.1
95.7
99.5
97.0
92.7
88.0
92.9
94.1
96.7
96.5
96.8
96.8
96.1
96.6
98.3
96.4
97.2
96.2
96.3
94.5
98.5
96.4
97.9
97.1
95.9
97.5
97.4
98.5
98.6
98.9
98.9
97.5
97.2
96.2
97.5
98.2
97.5
95.8
95.8
95.7
96.5
96.4
96.4
95.6
95.0
95.8
97.2
96.9
97.4
95.5
95.7
94.2
95.9
97.0
95.4
96.4
96.5
95.7
96.8
95.6
95.8

1.3
0.3
1.8
1.6
0.2

31.5
35.1
35.4
44.3
35.9
28.6
33.4
27.6
32.5
35.7
36.5
33.9
38.9
34.1
44.3
44.4
49.1
35.1
41.6
34.9
35.5
42.5
33.6
32.9
40.3
29.5
37.4
37.6
45.7
37.0
38.2
35.5
37.2
39.6
49.1
36.6
53.7
39.8

*Important. See note on population page.

814

Female
Cases MV(%) DCO(%) UB(%) MI(%)

4.7

0.0
1.1
1.3
0.0
2.7
0.8
0.5
0.9
0.0
1.2
0.9
0.4
0.8
0.6
1.0
1.4
1.0
0.0
1.2
1.4
0.9
1.8
0.5
0.4
0.9
0.5
0.0
0.6
0.4
0.6
1.4
0.8
0.8
0.8
2.0
2.3
0.9
2.2
2.0
2.2
2.1
2.2
2.1
1.2
1.0
1.3
1.8
2.0
3.9
1.7
1.0
1.5
0.6
0.9
1.1
0.8
1.0
0.8

0.0
0.0
0.0
0.0
0.0

21.4

0.0
4.4
0.0
0.3
0.0
0.0
0.0
0.0
0.0
2.5
0.0

93.3
28.6
32.1
42.1
36.8
62.5
58.3
60.7
52.8
40.0

5.5
0.1
0.1
0.1
0.0
0.1
0.0
0.8
10.4
0.0
0.0
1.4
1.3
1.4
1.0
0.9
0.5
0.2
0.4
0.4
0.6
0.2
0.2
0.0
0.0
0.0
0.2
0.3
0.4
0.4
0.3
0.0
0.4
0.0
0.2
0.5
0.9
0.3
0.0
0.3
0.9
0.6
1.9
0.1
0.2
0.1
0.3
0.4
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.3
0.3
1.0
0.5
0.5
0.6
1.3
1.2

34.4
33.2
33.2
39.6
30.3
35.3
21.2
29.9
35.0
28.1
37.4
39.1
46.6
37.3
29.2
37.1
36.4
29.0
44.2
29.2
38.1
35.6
46.9
29.0
37.5
35.0
42.6
30.3
27.6
27.2
32.2
31.9
35.9
36.2
35.2
33.8
35.5
43.3
46.2
37.4
34.4
41.0
34.1
37.4
44.6
34.9
36.0
41.7
33.4
35.4
38.5
43.5
38.3
39.3
35.9
36.5
38.3
43.8
36.1
45.1
38.3

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Large bowel (C18-21) (contd)

)
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
Cases MV(%) DCO(%) UB(%) MI(%)

Female
Cases MV(%) DCO(%) UB(%) MI(%)

2171
9712
13112
1629
11279
5555
1254
4224
8625
715
7832
1340
307163
27683
268954
13569
1396
11779
2009
73
633
1260
28258
2766
24605
16548
1421
14702
4945
4489
22290
1524
20421
1789
33857
3020
27826
92106
5622
8328
6364
70792
5557
1321
4180
22324
2474
19326
1688
865
7301
4765
3249
7687

96.0
97.2
97.0
97.4
96.9
98.3
97.8
98.5
96.1
95.5
96.2
95.8
96.8
95.8
96.9
97.7
97.3
97.7
95.7
94.5
95.9
95.9
95.9
95.0
96.0
96.7
95.4
96.7
92.8
96.3
97.9
96.9
97.9
98.0
97.8
97.3
97.9
97.7
98.4
96.9
97.7
97.7
96.5
95.2
97.0
95.9
94.8
96.0
98.6
96.6
97.2
97.5
97.3
95.5

1.4
1.1
0.8
0.4
0.9
0.5
0.3
0.5
1.7
2.0
1.7
2.3
1.3
1.8
1.3
0.7
0.8
0.7
1.9
2.7
1.7
1.7
1.4
2.2
1.3
1.6
2.1
1.6
2.1
1.4
0.5
0.7
0.5
1.2
0.7
0.8
0.7
0.7
0.4
0.9
0.6
0.7
1.3
1.2
1.3
2.3
3.2
2.2
0.2
1.6
0.7
0.5
0.8
1.7

1.1
0.8
0.9
0.9
0.9
0.3
0.6
0.2
1.3
1.7
1.3
0.6
0.6
0.9
0.6
0.6
0.7
0.6
0.5
0.0
0.6
0.5
1.0
1.2
1.0
1.1
1.5
1.0
0.7
0.5
0.4
0.5
0.4
0.1
0.2
0.6
0.2
0.4
0.3
0.7
0.5
0.4
1.4
2.0
1.1
0.9
0.9
0.9
0.0
0.1
0.5
0.4
0.6
1.3

35.7
37.6
37.4
40.0
37.4
36.0
38.4
35.7
36.5
45.0
35.9
37.4
36.6
44.7
36.3
35.4
39.4
35.6
38.7
41.1
39.3
37.5
35.8
43.2
35.3
39.5
49.6
39.5
37.9
38.4
36.6
42.9
36.6
33.5
35.0
41.0
35.0
35.8
31.2
43.2
31.0
36.0
37.2
45.1
35.1
37.6
47.9
36.9
36.9
37.9
34.4
34.7
37.5
37.1

2240 93.9
10291 94.9
13331 95.9
1813 95.1
11320 96.0
5814 97.0
1412 96.6
4348 97.1
8496 95.4
840 95.7
7594 95.3
1186 94.3
305145 95.8
31173 95.5
263920 95.8
13925 96.7
1499 96.7
12088 96.7
1710 94.3
58 100.0
477 93.7
1138 94.6
29994 94.9
3664 95.9
25520 94.6
17131 95.7
1611 94.4
15061 95.8
4719 92.3
4518 95.0
22679 96.6
1724 96.1
20624 96.7
1864 96.1
33868 96.6
3361 96.5
27853 96.4
91132 96.6
5089 98.0
9161 96.2
5649 97.0
70342 96.5
5153 95.5
1389 95.8
3715 95.5
20818 94.3
2653 93.9
17644 94.4
1657 97.3
888 94.9
6881 95.9
4644 96.2
3310 96.7
7392 93.9

80
1374
8775
272
427
6533
575
510
543
1155
36
1334
249
335
151
7337
6966
272
1630
1812
2304
6166
3464
14062
3652

86.3
78.2
94.3
96.7
85.2
79.9
95.8
99.4
77.0
79.0
91.7
79.5
89.6
85.4
92.1
92.7
93.7
94.1
89.1
92.4
97.1
87.6
92.4
79.0
90.2

7.5
0.0
0.9
0.4
0.9
0.4
0.0

0.0
0.1
0.0
0.0
0.5
0.0
0.0
0.0
7.2
0.0
0.0
0.3
0.0
0.0
0.7
1.0
0.7
2.2
2.7
0.4
0.0
0.0
0.1
0.0
0.5

56.3
52.4
43.5

1.7
1.6
0.0
5.4
0.0
7.5
0.7
1.6
1.3
0.0
8.2
2.3
1.2
7.4
2.1
5.6
5.1

51.1
45.7
24.0
31.9
8.3
32.5
41.9
35.5
35.6
29.9
30.7
37.8
47.2
33.7

47
1135
7234
242
366
6339
448
457
395
675
34
914
160
302
115
7371
6982
257
1220
1454
1749
4331
2842
10353
2807

91.5
80.8
93.4
97.1
84.7
79.2
94.4
98.2
78.5
72.0
85.3
76.0
98.8
82.5
93.0
91.7
92.9
94.2
84.7
89.3
94.5
83.9
89.1
74.7
86.6

2.3
1.6
1.0
0.8
1.1
1.2
1.1
1.3
1.7
1.8
1.7
3.8
1.6
1.9
1.6
1.1
1.0
1.1
3.2
0.0
2.7
3.4
1.5
1.0
1.6
2.5
3.9
2.4
2.1
1.8
0.8
1.4
0.8
1.6
1.2
1.1
1.3
1.0
0.4
1.0
0.8
1.1
1.7
1.4
1.9
3.4
3.7
3.4
0.5
1.9
1.1
0.8
1.1
2.4

0.8
1.6
1.4
1.9
1.4
0.2
0.3
0.2
1.6
0.8
1.8
0.6
0.8
0.8
0.8
0.6
0.7
0.6
0.4
0.0
0.6
0.4
1.1
1.0
1.1
1.1
0.9
1.1
0.7
0.8
0.6
0.6
0.5
0.5
0.3
0.3
0.3
0.5
0.3
0.5
0.5
0.5
1.7
1.7
1.6
1.0
1.2
1.0
0.1
0.1
0.8
0.8
0.4
1.6

36.3
38.3
36.8
40.7
36.5
36.2
40.6
34.9
39.1
42.5
38.8
35.2
37.3
43.4
37.2
37.2
38.0
37.8
41.1
41.4
47.8
38.3
36.4
41.3
36.1
40.0
47.7
40.3
39.2
35.7
38.4
45.2
38.2
38.3
35.9
40.9
36.1
36.6
28.6
41.8
29.8
37.3
38.4
40.6
37.9
38.8
45.7
38.4
37.3
40.1
35.5
35.3
37.9
38.1

4.3
0.0
1.1
0.0
1.4
0.6
0.2

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.9
5.3
0.0
0.0
0.2
0.0
0.0
0.0
1.0
0.8
1.9
3.0
0.5
0.0
0.0
0.1
0.0
0.7

53.2
52.6 *
43.3
*
34.2
43.4 *
*
20.2 *
38.0
*
8.8
34.0
*
*
*
42.8

2.8
1.6
0.0
7.8
0.0
8.6
1.7
2.3
1.9
0.8
12.3
3.8
2.2
11.5
4.2
8.7
6.3

42.6
40.2
32.3
35.7
40.6
51.8
40.7

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

757

815

Indices of data quality

Large bowel (C18-21) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

25365
2101
1490
899
695
1497
165
7332
369
131
152
443
490
94
210
1560
3228
2907
117
204
389
265
265
385
1139

90.0
88.0
93.4
92.5
90.9
90.2
90.3
91.0
90.0
84.7
94.1
93.5
90.2
88.3
97.1
79.2
97.0
97.2
95.7
94.6
88.7
63.0
90.2
91.7
92.0

3.2
2.7
2.3
2.1
1.4
2.4
0.6
3.8
3.5
14.5
4.6
2.0
5.1
0.0
0.0
5.0
0.0
0.0
0.0
0.0
0.0
16.6
6.4
2.1
0.1

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2.6
1.7

37.9
37.4
37.2
33.5
40.0
39.3
37.3
30.1
36.6

12767
908
452
7875
2819
8578
10419
7224
21727
8994
1454
5234
1780
858
744
1224
1570
1675
1671
754
813
709
1076
4491
8616
2277
2975
4465
4778
2473
308
5362
401
1013
1036
3008
1364
416
2257
1433
452
4781
944
425
1019
2470
1009
638
398
286
2052
2175
920
3307

94.2
97.6
94.0
88.3
98.9
93.3
68.4
82.4
90.0
93.9
93.3
97.2
99.4
96.3
98.3
98.8
99.4
98.1
99.6
99.6
96.6
97.3
99.1
85.2
89.9
78.0
86.6
94.2
85.3
96.6
99.0
91.9
95.5
90.9
94.8
92.1
91.1
91.6
92.3
97.6
87.2
96.3
93.6
90.1
94.1
95.1
83.6
94.4
89.4
94.1
95.0
90.5
95.5
94.8

5.3
1.3
2.9

0.1
0.0
1.1
0.0
0.0
5.7
0.1
12.8
0.5
2.1
0.0
0.3
0.0
0.0
0.1
0.3
0.0
0.3
0.0
0.0
0.4
0.0
0.4
1.0
0.1
0.0
0.1
0.0
0.9
0.1
0.0
0.5
1.0
0.0
0.0
0.0
0.0
0.2
0.0
0.0
0.0
0.0
0.1
0.9
0.0
0.0
0.0
0.2
0.0
0.0
0.1
5.8
0.0
0.0

49.7
36.7
39.2
69.9

14.0
4.7
2.9
0.3
0.3
0.6

0.1
12.7
8.5
8.5
12.1
2.9
7.5
2.5
0.0
1.8
1.2
1.0
0.4
0.5
0.8
1.0
1.0
0.1
1.8
0.4
0.2
1.2
0.1
0.5
1.1
1.6
3.0
0.7
1.0
0.4
0.1
0.7

28.2
28.6

47.0
0.3
72.8
59.6
34.3
41.4

45.1
57.9
56.1
57.5
55.8
57.7
45.2
42.6
45.1
41.9
40.2
41.2
39.8
48.2
53.2
49.3
46.4
52.1
106.1
36.9
54.9
35.7
39.3
47.6
41.4
47.1
49.2
45.9
44.7
43.8
38.6
43.9
48.1
45.6
41.7
42.4
42.7
38.3
44.2
36.5
40.1
39.4
45.3
41.2
34.1
41.6
41.3
38.6
39.2

*Important. See note on population page.

816

758

Female
Cases MV(%) DCO(%) UB(%) MI(%)
19979
1665
1245
642
623
1167
156
5539
327
152
83
373
438
62
112
1483
2782
2537
72
173
384
235
217
272
842

87.3
84.4
89.2
87.7
87.0
88.5
87.8
88.8
86.9
90.1
90.4
92.0
89.5
98.4
99.1
81.1
96.0
96.0
98.6
94.2
92.4
59.6
87.1
95.2
93.9

4.1
3.9
2.7
2.8
3.2
2.3
0.6
5.0
4.6
8.6
8.4
1.6
4.8
0.0
0.0
3.3
0.0
0.0
0.0
0.0
0.0
20.4
4.1
0.7
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.7
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.8
0.4
0.8

0.5 *
71.1 *
64.1
27.2 *
37.3 *

11780
858
435
8868
2287
7301
8271
5693
16111
8821
1803
5780
1367
747
576
1012
1348
1362
1372
641
703
571
718
4166
8443
2851
2773
4239
4923
2438
269
4075
367
983
861
2490
1344
371
2302
1104
431
3974
814
365
779
2112
840
469
396
265
1839
1798
811
2751

91.6
94.3
88.5
86.2
98.5
90.9
65.7
80.1
87.5
92.0
90.4
95.4
97.7
92.8
96.9
98.7
99.4
97.1
99.1
99.4
93.0
94.2
97.6
78.4
83.7
72.3
79.4
89.5
82.2
95.3
99.6
87.5
92.6
89.1
90.2
88.0
85.0
88.9
87.9
95.1
86.3
94.0
90.2
87.7
90.9
91.7
80.7
93.4
88.9
90.6
92.6
87.2
92.4
91.9

7.5
1.6
8.7

0.1
0.0
0.2
0.0
0.0
7.2
0.2
13.7
0.7
2.6
0.0
0.7
0.0
0.0
0.0
0.3
0.0
0.2
0.0
0.0
1.0
0.0
1.4
0.8
0.1
0.0
0.2
0.0
0.9
0.0
0.0
0.8
0.8
0.0
0.0
0.0
0.0
0.5
0.0
0.0
0.0
0.0
0.0
0.8
0.0
0.0
0.0
0.2
0.0
0.0
0.0
7.5
0.0
0.0

53.5
45.7
43.9
63.5 *
*
46.9
58.2 *
56.6
58.7
59.5
57.4
45.3
44.5
51.9
46.2
49.9
39.1
43.5
49.5
57.6
50.1
47.1
60.4
124.3
44.0
61.0
39.8
42.8
52.4
44.7
47.6
47.5
52.0
40.1
44.3
42.0
44.8
41.0
44.7
41.6
36.0
46.8
45.1
45.2
37.5
38.8
45.0
48.0
41.4
46.2
45.8
43.9
39.5
40.9

16.2
6.2
3.9
0.3
0.5
0.9

0.3
18.5
13.4
11.2
18.0
5.8
9.8
3.2
0.0
3.4
1.1
2.2
0.9
0.6
1.6
1.6
2.3
0.1
1.2
0.7
0.7
2.5
0.3
1.1
0.8
2.3
4.0
1.1
1.5
0.9
0.1
1.2

40.5
43.1
39.0
37.4
36.9
40.5
34.6
32.6
41.3
34.9
17.1

49.7

*
*
*

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Large bowel (C18-21) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

2116
3384
375
7808
801
1245
1860
4368
4871
5299
5616
8311
3093
358
2043
3328
1453
343
1126
995
1681
1022
934
1236
13048
527
335
272
648
503
372
935
23987
1627
1541
4507
4206
6644
11592
3604
11560
18022
7801
8807
2382
9035

80.9
84.6
93.1
96.1
55.8
84.9
87.5
98.0
89.1
84.8
81.4
88.2
98.0
93.3
93.2
94.5
96.6
89.5
94.9
95.2
93.9
95.8
92.2
93.3
99.1
97.9
94.3
96.3
97.2
98.4
97.0
97.5
98.1
98.8
98.6
91.1
87.5
90.7
92.3
93.1
86.2
85.0
87.2
91.0
90.4
93.1

3.6
1.3
0.8
0.4
6.5
2.5
0.3

66.6
61.1
59.7
50.1
65.2
58.9
63.0
45.8
52.9
78.7
58.0
62.3
54.8
53.9
58.6
45.9
46.5
43.7
43.2
48.3
43.7
42.5
45.7
61.0
48.3
35.5
43.3
41.9
40.3
37.6
44.9
40.6
45.2

0.2
3.1
1.0
1.1
0.5
1.3
6.2
3.5
2.5
1.0
0.4

0.4
0.0
0.0
0.0
0.0
2.0
0.2
0.1
0.0
5.3
0.1
0.5
0.8
0.3
0.6
0.5
0.3
0.0
0.1
0.0
0.4
0.1
0.0
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.2
0.2
1.0
0.0
4.6
4.0
2.7
0.8
0.0
0.0
0.6

11289
144
6249
2928
885
8543
2894
438
69
6436
1890
134
270
200
739
458

96.2
95.8
93.7
93.9
95.8
94.4
96.7
95.4
97.1
95.1
98.4
97.0
97.8
99.0
99.1
97.8

0.4
1.4
0.8
0.0
0.1
0.8
1.2
0.0
2.9
1.4
0.4
0.7
0.4
0.0
0.5
0.2

0.0
0.0
0.1
0.5
0.0
1.1
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.4

36.8
27.8
36.0
38.4
39.9
38.4
40.6
33.3
37.7
45.3
31.2

8.8
7.1
6.9
1.2
2.2
2.3
1.9
1.9
5.2
2.4
0.5
2.1
1.5
4.6
3.3
0.0
0.0
0.4
0.2
0.4
0.8
1.8

42.1
42.8
46.4
45.8
44.6
46.7
48.8
47.6
45.6
46.4
44.9
47.4

31.2

Female
Cases MV(%) DCO(%) UB(%) MI(%)
2598
3472
390
8066
779
1093
1752
3528
3749
7610
3859
6086
2450
268
1381
2129
1224
252
789
774
1299
717
687
962
12548
569
262
209
561
454
257
856
22425
1493
1382
3983
3309
5751
9400
3204
10896
17201
6420
7116
2181
8111

77.9
82.9
92.1
94.5
56.6
81.3
86.3
97.0
85.9
82.2
80.5
86.1
96.4
89.2
90.8
89.9
92.8
84.1
88.6
93.9
93.5
90.9
88.1
91.4
98.7
94.2
92.7
96.2
94.7
95.6
96.9
95.1
97.4
98.1
97.3
87.2
83.0
85.4
87.2
87.8
81.0
79.7
82.5
86.2
88.9
89.5

9461
82
5143
2605
830
7252
2282
340
40
6296
1470
116
143
162
613
334

94.4
96.3
91.9
92.1
92.0
92.5
93.6
92.4
92.5
93.0
97.1
95.7
96.5
98.8
97.4
96.7

4.6
1.7
1.5
0.5
8.3
3.3
0.6

66.9
61.7
50.0
49.7
65.1 *
61.5
66.0
43.9 *
54.1
81.1
60.4
59.9
56.9
50.4
55.8
46.5
49.6
49.6
45.2
54.3
46.0
51.6
44.7
61.6
49.5
37.3
45.4
49.3
45.3
39.4
44.0
40.0
49.1

0.4
3.8
2.0
1.8
1.5
2.0
8.9
5.3
4.3
1.5
0.7

0.5
0.0
0.0
0.0
0.0
2.9
0.1
0.1
0.0
6.1
0.1
0.4
1.3
0.4
0.6
0.1
0.5
1.2
0.4
0.0
0.2
0.0
0.0
0.3
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.4
0.3
1.3
0.0
7.4
6.2
3.1
0.7
0.0
0.0
0.6

1.0
1.2
1.5
0.0
0.6
1.5
1.8
0.6
5.0
2.6
0.7
0.9
0.0
0.0
0.3
1.5

0.0
0.0
0.1
0.2
0.0
0.8
0.1
0.0
0.0
0.0
0.3
1.7
0.7
0.0
0.0
0.0

36.7
35.4
36.0
37.6
43.9
40.2
41.5
43.5
45.0
44.3
29.3

11.8
9.1
8.4
2.2
6.0
4.3
4.1
3.6
7.9
5.8
0.9
2.1
2.2
6.8
4.6
1.1
0.4
1.4
0.0
1.5
0.4
3.6

47.5
46.1
47.0
48.7
46.2
47.8
51.0
50.0
48.5
47.8
45.0
48.2

33.2

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

759

817

Indices of data quality

Liver (C22)
Male
Cases MV(%) DCO(%) UB(%) MI(%)
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

22
912
20
100
265

59.1
41.3
85.0
40.0
14.3

15.9
34.3

41 53.7
135 83.7
41 58.5
49 77.6
585 94.7
46 23.9
105 66.7
444 27.7
94 39.4
44 81.8
22 100.0

41.5
10.4
26.8
18.4
1.2
41.3
8.6
41.2
33.0

3301 57.0
417 63.5
736 52.0
168 46.4
59 71.2
32 90.6
1 100.0
87 52.9
1696 57.3
16 75.0
89 60.7
638 64.1
123 64.2
506 64.0
100 77.0
798 72.2
7052 69.7
1858 70.2
525 71.2
1594 65.6
2987 71.4
1651 66.1
139 64.7
294 64.6
93 67.7
21 66.7
240 65.4
616 69.2
2083 71.0
224 71.9
190 74.7
99 80.8
36 58.3
144 66.0
591 66.3
642 73.5
537 71.3
602 82.9
57 87.7
527 82.4
135 74.8
98 70.4
30 86.7
3370 72.9
358 73.5
2914 72.4
872 79.2
216 78.7
603 79.6
326 80.7
108 76.9
170 84.1
130 66.2
2031 76.2
343 70.3
1553 76.6
766 74.7
379 76.0
516 76.6
853 75.0
228 74.1
591 74.6
86 72.1
162 78.4

3.5
0.5
4.5
8.9
0.0

0.0

0.0
1.1
2.6
0.0
22.5
10.5
8.9
11.1
1.0
5.0
2.5
1.7
4.0
2.8
2.5
3.8
2.2
3.7
0.0
9.5
6.3
4.4
2.3
5.4
1.6
0.0
5.6
0.7
2.4
2.2
4.3
3.3
1.8
3.6
8.1
11.2
0.0
12.9
11.7
13.2
3.7
1.9
4.6
2.8
0.9
4.7
10.8
7.0
12.8
6.1
6.1
2.6
2.5
5.2
7.0
4.7
10.5
5.6

0.0
0.0
0.0
0.0
0.0

41.8

760

16
227
7
73
159

62.5
38.8
71.4
28.8
14.5

29.1
37.1

4.9
5.2
7.3
0.0
0.0
0.0
0.0
0.0
0.0
4.5
0.0

158.5
80.0
61.0
171.4
209.9
102.2
196.2
104.5
151.1
110.8

16 56.3
148 82.4
26 61.5
22 50.0
300 91.3
41 36.6
124 68.5
321 20.6
129 27.1
25 84.0
13 100.0

31.3
11.5
34.6
45.5
4.0
51.2
8.9
42.1
47.3

17.0
1.0
0.1
0.0
0.0
3.1
0.0
3.4
32.6
0.0
0.0
6.9
5.7
7.3
6.0
7.8
3.4
2.7
3.2
4.0
3.4
1.8
2.2
1.7
2.2
4.8
2.1
1.3
3.8
4.9
4.2
2.0
2.8
5.6
4.9
2.6
3.7
1.7
1.8
1.7
4.4
5.1
3.3
2.2
2.0
2.2
1.3
1.4
1.3
0.6
0.9
0.6
1.5
1.9
2.6
1.7
2.3
1.8
5.8
1.3
1.8
1.2
0.0
0.0

93.3
76.7
82.1
100.6
125.4
181.3
300.0
111.5
96.3
56.3
125.8
115.0
130.9
112.6
71.0
90.7
77.2
70.2
81.0
66.1
88.1
74.0
79.1

1393 52.1
164 55.5
309 50.8
79 34.2
25 68.0
18 83.3
0
0.0
45 48.9
708 53.0
5 60.0
40 47.5
359 63.5
81 66.7
271 62.7
47 70.2
345 69.0
3296 68.1
804 66.5
207 68.1
768 69.8
1475 68.0
713 60.7
56 66.1
92 62.0
47 68.1
22 54.5
114 68.4
276 59.8
1072 70.1
92 69.6
84 71.4
33 81.8
46 69.6
73 65.8
340 70.0
348 69.5
257 72.8
276 80.4
18 77.8
249 79.9
56 78.6
49 75.5
7 100.0
1550 70.5
153 71.9
1356 69.9
457 72.0
108 72.2
323 70.6
143 76.2
53 71.7
73 75.3
74 73.0
1074 69.9
185 67.6
834 70.6
392 77.0
203 69.5
291 77.7
349 74.8
89 70.8
255 76.9
36 75.0
67 76.1

5.0
1.2
7.8
10.1
4.0

61.7
86.4
77.1
85.3
80.0
70.7
83.3
81.3
71.6
84.7
78.0
79.7
75.4
81.4
91.9
98.0
80.0
87.9
83.0
89.7
97.7
93.1
101.3
87.1
80.6
97.1
97.7
84.9
91.0
86.0
103.1
87.1
105.8
95.1
105.3
92.9
105.8
83.3

*Important. See note on population page.

818

Female
Cases MV(%) DCO(%) UB(%) MI(%)

0.0

0.0
6.7
2.8
0.0
30.0
13.1
11.1
14.0
0.0
7.0
3.2
2.2
3.4
3.5
3.6
5.6
3.6
1.1
4.3
9.1
4.4
8.0
3.1
4.3
0.0
0.0
2.2
4.1
3.5
3.7
4.7
4.7
5.6
4.8
3.6
4.1
0.0
13.4
11.8
13.9
8.5
0.9
11.5
2.8
0.0
5.5
10.8
11.2
17.8
10.0
5.4
7.4
3.1
6.9
7.9
6.3
5.6
9.0

6.3
0.0
0.0
0.0
0.0

56.4

12.5
4.1
3.8
0.0
0.0
0.0
0.0
0.0
0.0
8.0
0.0

231.3
63.5
76.9
200.0
280.0
117.1
183.9
110.6
139.5
155.0

18.6
0.0
0.0
0.0
0.0
0.0
0.0
0.0
36.6
0.0
0.0
8.9
11.1
8.1
8.5
9.0
4.2
3.4
3.9
4.0
4.7
1.8
1.8
3.3
0.0
4.5
0.0
1.8
4.9
4.3
7.1
3.0
2.2
9.6
5.3
4.0
3.9
2.5
0.0
2.8
1.8
2.0
0.0
2.0
2.6
2.0
2.2
2.8
2.2
0.7
1.9
0.0
2.7
2.2
2.2
2.3
0.8
3.4
4.5
0.3
0.0
0.4
0.0
1.5

126.0
112.8
104.2
132.9
168.0
194.4
2.0
144.4
128.8
180.0
195.0
125.9
135.8
125.1
78.7
112.5
92.1
79.0
96.6
83.1
104.7
91.3
87.5
73.7
110.1
88.3
108.7
92.9
78.8
78.3
69.9
80.9
101.1
103.1
97.8
100.0
97.2
108.9
95.9
185.7
103.8
113.1
104.5
118.6
120.4
121.7
109.1
96.2
127.4
108.1
107.3
114.1
108.3
122.7
104.9
125.4
137.0
127.0
138.8
119.4
111.9

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Liver (C22) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Female
Cases MV(%) DCO(%) UB(%) MI(%)

196
1162
1613
295
1257
791
233
529
813
146
646
99
39416
4843
30392
1621
229
1247
368
37
175
145
4206
616
3072
1576
265
1247
495
462
2366
354
1865
201
4885
584
3210
13843
2592
1483
2082
7485
583
141
427
4014
463
3301
163
73
991
748
259
893

61.7
74.6
76.3
75.9
76.1
78.1
81.1
76.4
76.4
76.0
76.0
62.6
73.2
73.0
73.3
76.6
74.2
77.4
67.7
62.2
68.6
66.9
72.0
72.9
72.5
77.8
74.0
78.1
63.2
61.7
79.0
77.7
79.0
79.1
73.4
76.4
73.7
72.7
71.7
75.2
67.1
74.2
74.4
68.8
76.1
71.1
67.6
71.3
77.9
87.7
68.7
67.5
81.1
77.0

6.1
6.0
3.5
2.0
3.7
3.9
2.6
4.5
5.5
8.9
5.0
20.2
6.3
7.4
6.6
4.4
5.2
4.6
7.3
8.1
6.3
9.0
4.8
4.7
5.1
9.1
10.6
9.2
8.7
5.6
3.0
2.5
3.2
4.0
3.3
2.1
3.9
3.0
1.6
3.9
3.5
3.2
6.9
7.8
6.6
12.4
16.8
12.1
1.8
0.0
2.0
1.3
6.6
9.2

5.6
5.2
5.3
4.7
5.4
1.9
1.7
1.9
5.8
2.7
6.7
3.0
3.6
3.1
3.7
2.2
1.3
2.2
3.0
8.1
2.3
2.8
3.7
2.6
3.6
5.5
5.7
5.6
2.8
3.9
1.8
1.7
1.8
1.5
2.1
1.9
2.2
2.9
2.5
2.2
3.7
2.9
7.9
10.6
7.0
3.3
3.0
3.1
0.0
1.4
5.3
4.9
2.7
7.4

87.8
86.7
87.7
82.7
90.1
86.6
78.5
91.3
95.8
87.7
98.3
120.2
84.8
86.6
87.5
80.0
81.7
82.4
83.4
83.8
78.9
89.7
70.1
70.8
72.4
97.6
85.3
103.1
88.5
85.9
80.1
76.6
84.0
79.6
81.0
77.4
85.8
81.6
70.7
84.4
67.7
89.6
97.6
103.5
97.7
84.9
92.4
85.9
96.3
97.3
85.5
77.4
100.0
86.0

72
488
799
113
664
373
90
271
375
59
309
66
18834
2074
15047
752
83
619
178
15
68
88
1981
291
1520
854
102
729
291
238
1074
140
895
97
2297
232
1574
6525
1129
582
970
3746
250
71
164
1854
179
1588
96
27
506
382
143
430

69.4
63.7
70.7
76.1
69.4
75.3
80.0
72.7
75.2
76.3
74.8
57.6
69.9
71.0
69.9
69.4
75.9
67.7
68.5
73.3
64.7
69.3
68.0
69.4
68.2
74.8
73.5
74.6
69.1
62.6
73.4
75.0
73.0
79.4
70.1
74.1
70.0
70.4
69.2
72.2
70.0
70.6
72.0
76.1
68.3
65.6
62.0
66.3
72.9
77.8
67.2
66.0
74.1
72.3

1.4
10.5
4.1
1.8
4.4
5.4
3.3
6.3
4.0
3.4
4.2
24.2
8.0
8.1
8.4
7.6
4.8
8.4
14.6
20.0
17.6
12.5
7.1
8.2
7.4
11.5
13.7
11.5
5.5
6.7
3.5
3.6
3.6
5.2
5.1
2.6
6.2
4.4
2.2
4.0
5.3
4.9
7.6
5.6
9.1
15.7
15.6
15.8
4.2
7.4
3.6
1.3
1.4
12.8

8.3
9.2
6.9
6.2
7.1
2.1
1.1
2.6
8.0
5.1
8.7
0.0
4.2
3.9
4.3
2.9
1.2
3.2
0.6
0.0
0.0
1.1
4.0
3.1
4.1
4.8
5.9
4.8
2.7
6.3
2.8
1.4
3.1
1.0
2.1
1.3
2.3
3.3
2.8
2.2
3.7
3.4
7.6
9.9
6.7
3.7
3.9
3.3
2.1
3.7
3.4
2.6
6.3
10.2

145.8
102.0
105.5
99.1
106.5
100.0
100.0
100.4
127.7
111.9
131.4
101.5
102.8
106.3
105.7
99.1
101.2
101.5
91.6
93.3
104.4
83.0
85.3
89.7
87.1
102.2
108.8
103.2
94.5
104.2
105.8
97.9
109.7
105.2
97.3
95.7
102.1
98.9
80.5
104.0
82.5
108.7
121.6
118.3
128.7
102.9
110.6
103.2
109.4
118.5
97.8
91.1
128.0
104.2

30
2425
6289
440
713
6001
857
74
269
491
34
895
65
209
78
556
463
42
862
815
1632
1709
1923
13494
969

66.7
29.1
58.3
20.0
68.3
17.8
41.2
90.5
68.8
79.2
52.9
76.5
92.3
78.9
64.1
55.8
59.0
76.2
59.0
17.7
35.7
31.4
33.3
90.6
27.0

0.0
0.0
3.0
0.5
2.1
0.5
0.4

0.0
0.1
0.0
0.0
1.7
0.0
0.0
2.7
23.0
0.0
0.0
0.6
0.0
0.0
0.0
7.2
7.8
2.4
10.3
1.5
0.0
0.0
2.0
0.0
1.1

96.7
96.9
84.9

17
729
1771
174
252
2300
177
29
83
232
8
433
35
88
30
333
293
15
388
446
659
880
906
5654
607

64.7
20.0
54.7
16.7
71.4
14.9
37.9
82.8
63.9
72.0
37.5
73.7
97.1
60.2
66.7
55.3
57.3
93.3
58.0
11.0
27.6
22.8
29.0
89.1
21.1

17.6
0.0
5.0
0.6
2.4
1.1
0.0

0.0
0.0
0.0
0.0
1.6
0.0
0.0
0.0
24.1
0.0
0.0
0.0
0.0
0.0
3.3
9.9
9.9
6.7
11.3
0.9
0.0
0.0
2.1
0.0
1.2

105.9
96.3 *
92.9
*
71.4
76.3 *
*
137.9 *
61.4
*
25.0
56.6
*
*
*
151.3

4.5
2.2
5.9
10.6
0.0
13.4
10.3
19.1
15.3
9.5
30.6
5.4
8.3
22.7
21.9
8.8
18.6

89.6
73.0
84.5
60.2
20.6
53.0
108.1
80.6
86.1
80.9
85.3
93.6
89.2
90.5

10.8
1.7
25.0
15.7
0.0
21.6
13.3
16.2
13.0
0.0
30.7
7.8
14.1
28.8
29.1
10.3
20.6

79.4
87.0
88.0
84.9
93.5
86.9
87.5

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

761

819

Indices of data quality

Liver (C22) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

40709
4438
2582
990
1349
1961
352
9909
659
74
77
209
325
124
138
1570
1522
1352
59
111
730
723
233
109
253

24.1
19.9
30.8
28.0
17.4
23.8
23.3
23.0
33.4
35.1
42.9
55.0
53.8
86.3
56.5
25.7
30.1
31.0
22.0
23.4
46.3
22.7
35.2
88.1
56.5

8.6
5.5
6.7
6.5
5.2
3.1
2.6
8.5
5.8
44.6
36.4
13.9
16.9
5.6
0.7
28.2
0.0
0.0
0.0
0.0
0.4
22.1
4.7
1.8
0.0

0.0
0.0
0.1
0.0
0.0
0.0
0.9
0.0
0.0
2.7
0.0
0.5
0.3
1.6
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.4
1.8
2.4

77.6
78.8
76.6
79.0
70.8
77.3
82.7
63.6
79.5

2604
174
79
998
88
496
1949
1162
2569
878
182
972
485
372
150
301
339
475
588
128
162
93
197
619
1255
355
459
407
615
323
20
291
149
732
243
558
351
75
794
333
535
1709
450
188
224
354
510
316
145
192
608
456
308
1325

72.8
58.0
62.0
42.9
80.7
74.4
15.3
44.5
61.9
83.7
76.9
82.4
55.3
29.3
55.3
66.8
87.3
57.5
72.1
50.8
74.7
66.7
78.2
45.4
52.4
46.8
47.9
97.1
77.6
70.0
95.0
53.6
30.2
57.8
46.5
45.2
39.3
38.7
48.9
45.3
32.3
55.2
45.8
25.0
48.7
58.8
41.2
55.7
27.6
49.0
35.0
63.4
68.8
51.8

18.1
2.9
17.7

0.2
0.0
5.1
0.0
0.0
10.5
0.3
35.5
1.1
5.0
0.0
1.9
0.0
0.5
0.7
8.3
0.0
2.3
0.5
0.0
0.6
1.1
9.6
7.1
1.7
0.0
2.8
0.0
1.0
0.3
0.0
3.4
2.0
0.0
0.0
0.0
0.0
1.3
0.0
0.0
0.0
0.0
0.0
7.4
0.0
0.0
0.0
2.2
10.3
0.0
0.5
20.6
0.0
0.0

86.2
73.0
78.5
106.7

45.6
20.0
11.3
1.0
1.1
4.0

0.6
45.2
36.7
16.3
45.1
0.0
14.6
15.5
0.0
3.4
0.7
1.1
0.8
1.4
2.6
5.3
1.6
0.9
1.7
1.0
0.9
6.4
0.4
3.7
7.6
6.3
6.9
1.6
2.1
0.9
0.0
3.0

76.6
50.8

95.7
0.4
84.6
54.5
66.1

143.3
129.3
102.5
109.8
87.4
123.6
96.4
101.4
89.8
102.0
118.6
112.1
105.1
146.8
191.4
117.9
143.0
235.5
209.5
68.4
69.6
71.9
145.2
73.3
84.5
125.0
146.7
83.9
78.0
87.2
95.0
78.9
90.7
89.8
85.0
62.8
78.1
67.3
81.9
80.4
83.3
94.3
93.0
91.0
83.3
76.3
76.8
83.4
78.4

*Important. See note on population page.

820

762

Female
Cases MV(%) DCO(%) UB(%) MI(%)
13339
1582
869
339
374
712
131
3269
185
37
27
82
114
53
70
568
459
409
14
36
278
347
60
36
111

23.8
19.7
26.9
26.3
19.0
26.0
23.7
24.2
28.1
24.3
40.7
48.8
62.3
84.9
55.7
27.6
29.0
29.6
28.6
22.2
46.0
21.0
31.7
97.2
49.5

10.1
7.6
9.9
7.4
9.6
4.8
1.5
11.3
10.3
67.6
48.1
13.4
18.4
1.9
1.4
26.4
0.0
0.0
0.0
0.0
0.4
25.1
3.3
0.0
0.0

0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
3.7
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.8

1.1 *
90.8 *
233.3
108.3 *
*

1319 67.6
78 46.2
31 61.3
705 44.8
50 88.0
366 65.6
1100 13.9
784 38.1
1449 54.7
540 74.6
150 76.7
744 72.4
104 53.8
77 37.7
48 47.9
96 62.5
110 89.1
123 49.6
75 72.0
21 66.7
52 63.5
31 61.3
39 82.1
386 29.8
666 43.7
280 30.4
231 33.8
129 96.9
324 69.4
156 57.7
7 100.0
164 46.3
59 22.0
284 50.7
129 33.3
294 27.2
185 29.7
29 31.0
383 35.5
192 37.0
199 33.7
635 43.1
296 37.2
86 15.1
104 49.0
193 53.9
295 33.6
184 38.0
90 20.0
52 25.0
249 27.3
277 47.3
122 62.3
525 37.5

23.4
6.4
29.0

0.2
0.0
3.2
0.0
0.0
11.5
0.7
39.7
2.1
5.4
0.0
3.6
0.0
1.3
0.0
5.2
0.0
3.3
1.3
0.0
7.7
0.0
12.8
7.3
1.2
0.0
1.3
0.0
0.9
0.0
0.0
2.4
0.0
0.0
0.0
0.0
0.0
3.4
0.0
0.0
0.0
0.0
0.0
3.5
0.0
0.0
0.0
3.8
3.3
0.0
0.4
23.5
0.0
0.0

87.5
96.2
87.1
105.7 *
*
156.0
143.7 *
99.0
129.3
96.3
121.3
113.7
140.4
123.4
106.3
137.5
129.1
109.8
217.3
261.9
146.2
177.4
220.5
206.5
80.5
62.9
80.5
214.7
81.2
92.9
257.1
187.2
98.3
92.3
114.0
101.0
89.7
144.8
113.8
83.3
98.4
92.4
66.9
105.8
94.2
94.8
99.7
97.3
97.8
103.4
96.8
86.6
100.8
83.8

48.0
22.2
14.1
0.7
0.0
5.5

0.0
59.3
46.5
18.9
57.6
0.0
18.5
24.4
0.0
6.1
10.2
3.5
5.4
2.4
7.0
10.3
7.6
1.6
4.0
3.0
2.7
11.6
0.0
8.3
11.9
8.2
13.3
0.0
4.0
5.8
0.0
6.3

73.9
74.2
73.6
71.1
77.0
73.7
64.1
58.1
83.2
85.4
61.4

105.2

*
*
*

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Liver (C22) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

313
420
35
388
92
122
182
330
623
651
1070
1041
415
66
491
778
395
61
219
264
285
202
177
194
1250
176
57
58
88
216
125
214
1029
40
58
223
506
634
825
239
907
1736
595
616
136
794

16.9
58.3
60.0
83.5
53.3
48.4
66.5
89.1
54.6
47.9
56.0
50.9
91.8
42.4
57.0
40.2
55.2
41.0
51.6
32.6
66.7
59.4
59.3
81.4
99.3
54.0
45.6
58.6
76.1
50.9
48.8
70.1
78.7
75.0
86.2
50.2
53.2
43.8
44.1
56.9
41.6
46.4
48.6
48.1
47.8
51.4

18.2
5.5
5.7
2.1
19.6
9.8
0.0

0.4
9.1
5.7
4.6
1.7
4.2
19.5
8.9
15.1
3.7
0.9

1.9
0.0
0.0
0.0
0.0
13.1
0.0
0.0
0.0
17.1
0.3
15.7
2.9
1.5
4.1
2.4
2.0
0.0
1.8
0.0
2.1
0.5
2.8
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.8
0.0
0.0
0.0
0.0
3.6
0.4
5.5
0.2
25.1
11.8
7.8
2.0
0.0
0.0
2.4

997
28
439
196
55
836
229
34
59
506
395
46
68
54
107
69

66.0
64.3
51.7
39.3
72.7
55.6
65.5
70.6
72.9
66.2
74.9
76.1
79.4
81.5
78.5
62.3

2.0
3.6
3.2
0.0
1.8
4.5
14.0
2.9
20.3
10.7
2.3
6.5
1.5
1.9
0.0
4.3

0.0
0.0
0.5
1.0
0.0
3.3
0.4
0.0
1.7
0.2
0.5
2.2
0.0
0.0
0.0
1.4

35.2
20.5
12.4
5.3
12.1
9.8
6.4
10.6
13.1
10.0
2.3
6.7
7.9
14.7
11.9
1.1
0.0
6.9
0.0
8.3
0.0
11.7

111.5
96.7
108.6
78.1
107.3
138.3
139.6
109.7
93.1
109.7
121.9
104.0
103.1
113.6
93.7
73.9
87.3
98.4
84.9
117.4
93.3
94.1
76.8
123.2
132.2
75.0
66.7
91.4
93.2
75.0
88.0
93.5
142.2
136.2
115.2
57.1
80.0
95.0
91.6
88.6
94.8
80.3
93.3
158.8
90.8
89.3
92.9
89.1
90.3
109.1
85.0
81.2
76.5
101.7
88.3
72.7

78.3

Female
Cases MV(%) DCO(%) UB(%) MI(%)
251
299
17
250
61
117
152
159
269
565
793
667
168
37
146
332
187
31
99
112
135
76
78
98
705
50
22
20
37
64
31
72
484
28
23
163
673
425
540
155
607
912
401
366
114
512

20.3
57.2
58.8
77.2
32.8
29.1
58.6
89.3
40.9
46.2
54.1
48.4
85.1
24.3
44.5
34.9
52.4
19.4
49.5
25.9
51.9
43.4
44.9
65.3
97.4
38.0
59.1
80.0
81.1
46.9
71.0
69.4
74.6
64.3
73.9
37.4
34.5
34.4
35.7
49.7
38.6
38.6
37.9
37.4
47.4
44.9

17.5
3.3
5.9
2.4
21.3
17.1
1.3

0.6
8.5
5.2
4.3
4.5
3.8
23.0
8.2
21.9
7.0
0.6

0.0
0.0
0.0
0.0
0.0
12.8
0.7
0.6
0.0
16.3
0.1
13.3
4.2
0.0
2.7
1.8
2.1
0.0
3.0
0.9
0.0
0.0
3.8
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
4.9
0.4
4.9
0.0
23.2
14.5
7.3
2.2
0.0
0.0
1.6

378
6
189
72
19
292
85
18
18
247
171
17
21
27
65
18

60.8
83.3
42.3
43.1
57.9
49.7
57.6
88.9
77.8
59.9
74.3
64.7
71.4
74.1
81.5
66.7

4.0
0.0
3.7
0.0
5.3
6.5
21.2
0.0
22.2
13.4
2.9
5.9
0.0
3.7
1.5
11.1

0.0
0.0
0.0
0.0
0.0
3.4
1.2
0.0
0.0
0.4
2.3
0.0
4.8
3.7
0.0
5.6

48.3
21.9
14.8
10.7
16.2
8.9
15.1
10.7
25.8
16.2
8.9
16.3
9.2
28.2
25.5
2.0
0.0
5.0
0.0
17.2
0.0
13.9

104.8
100.7
135.3
89.2
131.1 *
167.7
181.6
108.2 *
96.3
110.1
115.1
109.0
145.8
100.0
132.4
93.7
106.3
116.1
81.8
173.2
106.7
128.9
91.0
162.2
182.7
80.0
72.7
85.0
113.5
92.2
96.8
101.4
206.4
187.0
125.8
32.7
93.2
110.2
104.5
96.2
116.8
92.3
120.2
152.6
106.3
114.6
183.3
102.6
141.7
179.8
117.8
92.9
144.4
83.3
89.1
90.6

116.7

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

763

821

Indices of data quality

Pancreas (C25)
Male
Cases MV(%) DCO(%) UB(%) MI(%)
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

9
164
22
12
66

44.4
33.5
59.1
16.7
19.7

90
112
28
47
1315
39
141
341
81
56
18

43.3
73.2
32.1
66.0
36.0
17.9
36.9
24.9
39.5
91.1
88.9

51.1
13.4
50.0
27.7
27.0
20.5
14.9
27.9
22.2

5651
667
1058
302
223
50
5
285
2750
38
273
1178
283
892
115
1237
7730
627
552
1015
5484
1470
119
94
45
21
129
1006
1966
252
55
30
36
38
341
1182
940
1079
76
995
188
139
40
5626
464
5100
1741
467
1256
520
164
343
294
3509
482
2955
1549
893
1023
1360
402
949
116
196

55.4
60.3
56.1
53.3
52.5
70.0
80.0
56.1
52.9
57.9
66.3
74.0
67.5
76.0
81.7
75.1
78.0
79.3
76.3
80.8
77.6
79.0
78.2
83.0
80.0
71.4
81.4
78.7
79.2
75.0
80.0
80.0
80.6
89.5
79.8
79.4
78.1
84.4
96.1
83.5
75.5
74.1
85.0
75.4
75.0
75.4
76.4
76.9
76.3
85.4
86.0
85.4
73.1
80.3
79.0
80.5
80.1
79.1
71.8
74.4
70.4
76.1
65.5
77.6

4.6
0.7
5.6
5.6
0.0

5.5
13.6

0.0

0.0
4.9
5.2
0.0
7.0
8.1
8.5
8.1
0.9
4.5
1.5
1.1
1.1
1.3
1.6
2.9
2.5
1.1
0.0
4.8
1.6
3.5
1.2
0.4
0.0
0.0
0.0
0.0
1.8
1.4
3.9
3.1
0.0
3.2
8.5
10.1
2.5
9.3
11.2
9.1
5.3
4.9
5.3
3.3
3.7
2.6
7.5
4.7
7.1
4.2
3.5
3.8
3.3
1.8
3.2
1.2
2.6
1.5

0.0
0.0
0.0
0.0
0.0

24.4

764

8
109
18
6
56

62.5
29.4
66.7
16.7
19.6

15.6
23.2

3.3
9.8
7.1
0.0
0.0
0.0
0.7
0.0
0.0
1.8
0.0

118.9
92.9
75.0
157.4
92.7
110.3
112.1
102.3
90.1
125.0

89
113
14
65
1449
41
182
337
102
49
28

32.6
77.9
35.7
56.9
38.2
43.9
35.7
26.1
31.4
67.3
75.0

56.2
8.0
57.1
33.8
28.9
19.5
21.4
29.4
36.3

17.7
0.4
0.1
0.0
0.0
2.0
0.0
1.4
36.1
0.0
0.0
3.5
3.5
3.5
4.3
4.5
3.4
2.7
4.5
2.6
3.5
1.8
2.5
2.1
0.0
4.8
1.6
1.5
3.4
6.3
1.8
3.3
2.8
2.6
3.8
2.7
3.0
0.7
0.0
0.8
2.7
1.4
2.5
1.3
1.7
1.2
1.6
1.7
1.5
1.2
0.6
1.5
0.7
1.5
1.5
1.6
2.3
1.5
6.6
2.1
1.2
2.4
3.4
3.6

99.0
91.5
97.6
98.0
93.3
270.0
60.0
95.4
99.6
89.5
96.7
103.7
103.9
103.9
86.1
98.4
92.0
85.3
90.6
80.0
95.7
90.5
100.0

5909
657
1156
332
230
38
5
287
2897
40
267
1265
325
930
105
1190
8080
650
646
1139
5594
1647
156
84
51
33
150
1100
2102
295
56
53
56
25
449
1132
908
1128
78
1033
210
159
42
5598
524
5010
1710
495
1198
504
183
314
320
3752
571
3103
1593
906
1062
1317
420
891
119
188

48.7
54.6
52.9
39.5
51.7
71.1
80.0
49.5
45.5
47.5
55.1
65.1
65.2
65.2
81.9
68.9
71.4
78.5
70.4
77.3
69.4
68.9
72.4
67.9
74.5
84.8
72.0
66.6
73.5
70.2
78.6
75.5
80.4
68.0
80.2
70.9
66.3
77.6
79.5
77.4
75.7
76.7
78.6
70.5
72.3
70.2
68.4
70.1
67.6
78.2
78.7
78.3
67.2
72.9
73.7
72.6
76.8
71.7
65.9
65.8
69.0
64.3
68.1
72.3

5.9
0.8
5.9
7.5
0.0

73.6
93.3
92.4
87.7
90.9
70.0
111.1
94.7
88.9
94.8
93.3
91.6
94.7
91.8
84.6
82.0
110.0
91.6
91.6
92.3
98.4
93.8
100.3
93.5
99.4
91.5
93.5
91.5
89.0
92.8
100.3
94.0
98.2
92.6
90.8
93.6
86.2
91.8

*Important. See note on population page.

822

Female
Cases MV(%) DCO(%) UB(%) MI(%)

0.0

0.0
5.6
7.2
0.0
9.4
9.0
6.5
9.9
1.0
5.7
3.1
2.2
3.6
2.5
3.3
7.8
6.4
3.6
5.9
3.0
6.0
9.2
2.3
3.7
0.0
1.9
5.4
4.0
2.7
1.8
5.3
3.5
2.6
3.5
4.8
5.0
4.8
10.2
10.5
10.3
7.2
5.3
8.0
4.2
3.8
4.1
7.8
6.0
10.2
5.3
3.0
3.6
3.6
3.2
2.6
3.5
1.7
3.2

0.0
0.0
0.0
0.0
0.0

35.8

1.1
13.3
7.1
0.0
0.0
0.0
0.0
0.0
0.0
4.1
0.0

110.1
104.4
107.1
116.9
92.7
95.1
106.6
104.2
84.3
119.9

20.8
0.5
0.0
0.0
0.0
0.0
0.0
3.8
42.0
0.0
0.0
6.5
4.9
7.0
2.9
7.3
3.8
2.8
3.3
2.7
4.1
1.6
1.9
3.6
0.0
0.0
0.0
1.7
3.9
4.4
5.4
5.7
1.8
4.0
2.4
4.2
3.6
1.1
0.0
1.2
2.4
1.3
4.8
1.3
1.5
1.3
1.6
2.2
1.4
1.6
1.1
1.9
2.8
1.4
2.1
1.3
1.9
2.1
6.7
1.7
1.4
1.8
0.8
2.1

98.5
88.3
95.7
99.7
90.9
289.5
140.0
103.1
98.0
107.5
111.6
99.9
100.9
100.3
87.6
98.3
92.9
87.7
93.7
80.9
96.3
93.3
98.1
87.3
97.1
93.3
94.9
107.1
75.5
94.6
96.0
88.0
95.9
94.5
95.2
96.2
96.0
89.0
91.2
97.6
92.5
84.9
93.9
102.6
100.0
103.8
92.7
87.4
94.9
92.5
94.8
96.3
95.5
103.8
100.1
97.0
96.4
95.2
96.7
91.6
96.8

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Pancreas (C25) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Female
Cases MV(%) DCO(%) UB(%) MI(%)

419
1813
2760
395
2334
1241
305
921
1614
150
1455
244
60120
6260
52183
2532
273
2188
458
20
149
278
5743
634
4925
2992
322
2633
952
906
3988
346
3587
304
7026
717
5767
18724
1048
1937
1390
14219
1047
277
765
4459
539
3845
381
182
1607
1080
517
1543

74.2
78.5
79.0
79.5
78.8
84.4
84.3
84.6
75.3
74.0
75.6
68.4
77.4
75.9
77.5
81.0
78.4
81.4
68.8
60.0
71.1
68.3
75.5
73.2
75.6
78.3
78.9
78.1
72.5
70.9
80.9
79.5
81.0
78.6
80.0
83.5
80.1
78.5
76.5
77.7
80.1
78.6
77.8
72.9
79.7
76.5
72.9
76.6
78.7
83.0
77.4
77.0
70.6
73.4

1.2
5.2
2.6
1.5
2.8
2.9
2.3
3.1
5.6
8.0
5.4
10.7
4.9
5.9
4.8
3.3
4.4
3.2
8.1
20.0
6.7
8.3
5.4
4.9
5.5
5.9
7.8
5.8
5.5
3.5
1.6
2.0
1.5
6.6
3.0
2.5
2.9
2.4
2.2
2.5
2.0
2.4
5.6
5.4
5.6
9.4
12.8
9.1
0.5
3.8
2.2
1.3
5.0
7.0

4.8
4.1
3.7
3.8
3.7
1.1
0.7
1.3
7.7
6.7
7.9
1.2
3.2
2.9
3.2
1.7
1.5
1.7
2.8
0.0
0.7
4.0
3.1
2.1
3.2
6.3
6.5
6.3
2.2
3.6
2.0
0.9
2.1
0.7
1.7
1.0
1.8
2.7
2.3
2.4
2.2
2.8
5.8
6.1
5.8
3.2
2.6
3.3
0.0
0.5
4.5
3.8
3.3
5.8

95.0
96.6
92.9
83.8
94.8
87.3
81.6
89.7
95.2
109.3
93.7
100.4
94.1
94.1
94.9
90.6
96.3
90.4
91.0
110.0
90.6
91.0
87.1
87.9
88.0
96.5
100.0
97.2
95.2
100.3
94.9
96.2
95.7
103.0
91.1
91.1
91.7
92.4
85.2
91.1
80.8
94.5
105.2
102.5
106.0
97.8
99.1
98.4
99.0
96.7
92.0
91.7
97.5
94.3

417
2124
2860
467
2358
1360
357
993
1620
210
1399
233
63114
7539
53793
2885
363
2456
422
22
150
240
6762
972
5643
3192
404
2748
923
980
4149
434
3646
386
7256
832
5787
19530
1119
2209
1542
14516
1138
378
757
4479
564
3832
325
156
1617
1111
463
1660

66.9
68.9
72.0
76.4
71.0
79.7
81.2
79.1
66.7
73.8
65.8
58.4
70.7
71.7
70.3
74.5
73.6
74.3
62.1
68.2
64.0
60.4
68.6
69.5
68.3
73.2
69.1
73.6
65.9
61.0
73.7
72.1
73.8
69.7
73.5
77.2
72.7
72.0
77.9
72.8
75.7
71.0
72.3
70.9
73.1
70.1
69.3
70.1
72.0
83.3
67.7
68.9
63.3
66.0

4.1
9.1
3.1
1.5
3.4
3.0
2.2
3.3
6.5
5.7
6.7
12.4
6.1
5.9
6.2
5.0
4.7
5.1
14.9
13.6
8.7
18.8
6.1
4.2
6.5
9.0
10.6
8.7
4.7
5.7
2.5
2.3
2.6
6.0
4.4
3.7
4.6
3.6
2.3
3.5
3.2
3.8
5.4
3.4
6.3
12.0
12.6
12.1
1.8
1.3
3.0
1.8
4.3
8.1

5.3
5.9
4.6
3.2
5.0
1.1
0.6
1.3
9.6
5.7
10.3
2.1
3.8
3.4
3.8
2.9
3.6
2.8
3.8
0.0
4.7
3.8
3.7
4.1
3.6
6.5
7.7
6.4
2.1
4.7
2.6
2.5
2.5
1.3
2.2
1.3
2.4
3.2
2.1
2.4
2.7
3.5
6.9
7.9
6.5
2.9
2.8
2.9
1.5
0.6
6.1
5.9
3.0
8.3

95.4
98.7
94.7
88.4
96.4
87.4
84.3
88.5
98.6
96.2
99.3
97.0
94.8
92.9
96.0
92.5
85.7
94.7
97.9
81.8
93.3
103.3
85.9
83.0
86.7
99.3
96.3
100.7
94.0
99.5
97.5
92.2
99.4
97.7
93.0
87.7
95.2
93.7
84.7
90.5
78.3
96.9
100.3
95.2
102.4
94.4
100.2
94.3
91.1
99.4
93.5
93.2
104.8
94.2

28
180
1006
91
172
1812
84
94
134
412
21
436
50
116
47
1446
1300
71
349
381
369
1119
733
3524
718

60.7
40.0
40.5
30.8
73.3
22.2
47.6
74.5
42.5
72.6
23.8
52.8
82.0
71.6
27.7
52.3
54.2
67.6
35.0
30.2
48.8
42.4
34.7
42.4
25.9

14.3
0.0
5.7
0.0
1.7
1.0
0.0

3.6
0.0
0.0
0.0
1.7
0.0
0.0
2.1
47.8
0.0
0.0
0.5
0.0
0.0
0.0
3.7
3.7
2.8
37.8
0.5
0.0
0.0
1.9
0.0
2.6

92.9
93.3
87.7

17
134
797
82
122
1587
48
58
60
234
11
299
21
72
31
1373
1260
37
242
353
285
987
661
2874
546

76.5
50.0
35.8
25.6
82.8
21.6
41.7
63.8
38.3
53.4
18.2
48.5
90.5
73.6
38.7
47.0
49.0
67.6
27.3
26.9
44.9
35.5
29.7
36.1
25.8

11.8
0.0
5.9
0.0
1.6
1.3
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
5.2
45.0
0.0
0.0
0.7
0.0
0.0
0.0
3.7
3.7
5.4
37.2
2.0
0.0
0.0
1.1
0.0
2.2

117.6
107.5 *
92.1
*
68.0
76.6 *
*
43.1 *
46.7
*

2.2
3.2
0.0
17.4
0.0
10.3
4.3
11.8
10.8
7.0
27.2
6.3
10.6
26.2
20.5
22.8
20.2

97.1
75.2
77.1
53.7
4.8
52.8
98.5
98.9
99.5
97.3
93.5
92.8
91.8
96.4

8.3
4.7
0.0
23.7
0.0
12.5
3.2
13.3
11.6
2.7
35.5
9.9
14.4
30.1
25.1
27.0
22.7

52.2
94.1
97.5
101.7
100.4
91.5
92.4
91.9
94.7

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

*
*
*

765

823

Indices of data quality

Pancreas (C25) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

6464
592
359
194
193
361
36
1664
113
34
32
61
82
34
25
261
399
342
21
36
54
45
48
122
320

38.5
34.1
32.9
40.7
32.1
41.8
44.4
47.6
44.2
52.9
59.4
77.0
58.5
55.9
80.0
32.2
54.9
56.4
61.9
36.1
51.9
33.3
50.0
66.4
60.0

8.5
9.1
8.1
8.2
5.2
4.4
2.8
11.0
5.3
44.1
25.0
1.6
14.6
0.0
0.0
11.1
0.0
0.0
0.0
0.0
0.0
6.7
4.2
0.8
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2.9
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
4.1
1.9

98.7
101.9
94.4
96.9
86.0
97.2
116.7
76.2
97.3

2732
214
99
2229
280
1026
2816
1555
4030
1746
466
1811
267
192
109
194
244
248
170
92
110
112
94
985
1686
638
655
818
1051
386
78
939
84
300
184
501
253
71
468
262
92
985
213
125
153
527
181
195
99
90
345
335
185
747

74.4
65.9
50.5
49.1
81.1
64.3
18.2
59.0
49.1
69.1
59.4
69.4
71.2
49.5
65.1
71.1
71.7
70.6
85.3
79.3
70.9
58.9
73.4
44.4
54.4
43.7
42.9
55.5
58.4
67.1
79.5
43.0
48.8
47.0
45.1
41.1
41.9
39.4
54.5
35.9
44.6
50.6
47.4
28.0
43.8
42.3
40.9
48.7
36.4
44.4
47.2
42.7
52.4
48.9

20.1
4.2
12.1

0.4
0.0
2.0
0.0
0.0
18.6
0.2
30.7
0.9
3.1
0.0
2.7
0.0
0.5
0.0
4.6
0.0
3.2
0.0
0.0
0.0
0.9
9.6
8.2
0.9
0.0
2.1
0.0
1.4
0.3
0.0
1.8
1.2
0.0
0.0
0.0
0.0
1.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2.6
2.0
0.0
0.3
19.1
0.0
0.0

101.3
92.5
70.7
96.5

25.8
10.2
9.2
0.8
0.9
3.9

0.0
41.6
30.0
17.1
38.9
21.9
16.1
19.2
0.0
5.9
0.0
3.3
2.2
0.6
2.4
5.6
2.8
1.5
2.2
1.2
0.9
4.0
0.7
3.6
3.9
4.1
5.1
1.1
2.6
0.6
0.0
2.1

8.2
54.9

103.3
9.3
86.7
72.9
63.9

140.1
83.7
89.8
96.7
102.4
100.2
94.8
116.5
104.7
118.3
112.9
123.8
115.3
170.0
170.7
151.8
104.5
224.5
211.3
73.9
93.3
73.0
99.5
88.6
97.9
97.4
101.7
91.7
92.0
91.8
101.4
88.1
88.7
91.7
103.1
87.9
91.3
89.7
89.6
109.2
92.6
101.7
87.7
102.0
87.5
96.8
93.4
90.8
90.4

*Important. See note on population page.

824

766

Female
Cases MV(%) DCO(%) UB(%) MI(%)
4709
411
294
149
154
244
43
1253
80
31
16
53
64
25
9
305
336
294
11
31
51
44
21
78
225

34.0
29.4
24.8
38.9
33.1
37.3
30.2
39.8
31.3
45.2
62.5
67.9
75.0
36.0
55.6
37.4
51.8
51.7
45.5
54.8
56.9
40.9
57.1
66.7
62.7

10.2
7.8
9.5
9.4
8.4
7.0
2.3
13.4
11.3
38.7
25.0
0.0
14.1
4.0
0.0
15.7
0.3
0.0
0.0
3.2
0.0
0.0
0.0
1.3
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
5.1
1.8

3397
232
90
1872
272
1050
1895
1368
3958
1958
438
2098
263
196
100
172
219
279
118
62
116
103
69
1028
1957
751
687
893
1021
476
66
916
103
275
171
510
303
86
609
255
77
1115
274
103
204
485
165
175
94
96
408
291
173
857

69.7
50.9
47.8
45.8
75.7
54.9
19.7
52.8
44.6
60.0
52.3
59.5
69.6
44.9
56.0
64.5
68.0
67.7
70.3
59.7
62.9
36.9
82.6
40.8
44.5
38.2
35.7
45.0
47.7
53.8
66.7
38.3
41.7
41.8
40.4
33.3
39.9
44.2
40.6
34.1
36.4
42.9
38.0
32.0
33.3
30.9
30.9
40.6
29.8
35.4
37.3
33.0
38.2
43.6

23.6
8.6
20.0

0.4
0.0
5.6
0.0
0.0
21.6
0.3
32.7
1.2
4.0
0.0
3.8
0.0
1.5
0.0
1.7
0.0
1.1
0.0
0.0
0.0
1.9
10.1
4.5
1.2
0.0
1.7
0.0
2.2
0.4
0.0
2.0
1.0
0.0
0.0
0.0
0.0
1.2
0.0
0.0
0.0
0.0
0.0
1.0
0.0
0.0
0.0
3.4
1.1
0.0
0.0
17.2
0.0
0.0

26.6
14.5
11.6
1.0
0.9
5.7

0.0
44.7
37.9
22.8
48.2
28.6
19.3
22.3
0.0
6.9
3.9
6.5
0.6
2.2
3.3
2.3
4.8
1.2
5.2
1.9
1.8
5.8
1.0
6.0
10.9
3.4
5.3
4.2
4.4
2.4
0.6
2.9

99.0
98.1
87.8
102.0
86.4
101.2
80.2
78.8
100.0
37.7
23.4

101.2

*
*
*

3.9 *
106.8 *
128.6
44.9 *
*
99.6
102.6
103.3
96.7 *
*
144.8
84.5 *
90.8
97.7
102.7
95.0
93.2
116.0
98.5
142.0
111.6
139.3
110.0
210.2
219.4
138.8
116.5
276.8
219.1
79.2
96.9
78.7
98.7
93.5
100.4
125.8
98.5
100.0
93.5
84.2
95.3
94.4
105.8
92.8
99.6
99.6
97.0
84.3
87.4
94.6
92.2
101.8
96.0
93.6
91.1
95.8
92.1
85.0
89.0

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Pancreas (C25) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

853
1175
97
1403
243
383
386
265
702
1338
1143
1650
561
66
281
530
378
64
160
149
244
208
129
170
2162
148
79
59
183
134
92
175
3716
240
193
799
737
1114
1886
702
2200
4002
1537
1525
380
1418

21.2
50.3
30.9
60.9
39.5
54.3
59.6
78.5
46.7
52.1
59.6
49.2
91.8
39.4
43.4
53.0
51.9
50.0
40.0
51.7
55.3
68.8
55.0
44.1
87.5
64.9
64.6
74.6
78.7
60.4
72.8
76.6
64.8
50.4
74.6
42.3
37.6
31.1
38.0
43.7
33.0
40.4
38.3
43.1
38.4
48.2

1586
28
862
403
118
1253
397
43
17
815
365
35
45
48
123
92

63.0
57.1
49.3
59.6
62.7
54.8
65.0
72.1
70.6
49.6
73.2
71.4
77.8
70.8
71.5
76.1

9.1
2.8
7.2
1.7
16.0
6.5
0.3

102.7
89.9
121.6
96.3
91.0
94.6
115.5
204.5
106.4
95.7
114.2
95.5
101.2
92.4
131.1
90.6
89.0
89.1
94.4
106.0
101.6
93.3
81.4
147.1
149.2
77.7
87.3
98.3
90.7
96.3
100.0
106.3
115.3

0.8
9.8
5.1
4.0
5.3
4.7
16.5
8.7
15.3
3.7
0.8

1.1
0.0
0.0
0.1
0.0
6.8
0.0
0.4
0.0
12.9
0.3
1.0
5.0
3.0
1.1
1.1
1.9
1.6
1.9
0.0
0.4
0.0
0.8
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
3.4
0.3
5.3
0.0
34.0
13.2
6.8
2.1
0.0
0.0
1.6

2.6
3.6
3.2
0.0
0.8
3.3
13.9
0.0
23.5
10.1
2.7
2.9
6.7
0.0
3.3
0.0

0.0
0.0
0.5
0.2
0.0
5.4
1.0
0.0
0.0
0.5
0.8
0.0
0.0
0.0
0.8
1.1

96.9
92.9
91.9
90.6
99.6
93.5
94.7
125.6
147.1
94.4
87.1

30.8
18.0
21.2
3.2
13.6
6.4
7.0
8.2
9.4
12.5
0.7
6.6
2.9
7.8
20.0
2.7
0.0
1.7
1.6
9.7
2.2
6.3

125.9
95.5
92.1
96.8
94.4
98.7
105.5
91.2
89.8
94.5
113.4
98.8

93.5

Female
Cases MV(%) DCO(%) UB(%) MI(%)
807
1033
125
1633
247
363
365
213
620
1668
840
1317
594
52
269
484
281
50
136
141
176
166
138
165
2336
144
84
50
163
141
81
191
3781
202
186
803
761
1188
2093
718
2258
4283
1587
1572
369
1630

20.0
48.4
30.4
50.0
40.1
44.1
54.5
73.7
42.3
45.6
59.8
47.6
87.4
36.5
32.3
45.9
52.0
32.0
30.9
40.4
52.8
57.2
37.7
41.2
86.2
63.9
52.4
62.0
71.2
52.5
49.4
62.3
55.7
48.5
65.6
34.0
28.3
25.5
31.3
33.3
26.9
34.3
30.6
34.3
33.1
41.7

1594
17
788
389
138
1200
417
45
19
780
384
27
37
68
159
73

58.2
52.9
42.1
51.4
50.0
46.0
51.3
62.2
63.2
40.3
76.0
85.2
78.4
75.0
78.0
68.5

8.9
3.4
9.6
2.7
14.6
5.8
1.1

0.7
13.7
6.0
3.9
3.6
4.9
18.2
12.4
18.1
3.3
1.0

1.0
0.0
0.0
0.0
0.0
8.8
0.0
0.0
0.0
13.6
0.1
0.8
7.7
1.9
1.9
1.7
1.1
0.0
0.0
0.0
1.7
0.6
0.7
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
4.6
0.0
5.9
0.1
38.9
17.2
6.4
1.9
0.0
0.0
1.4

4.0
0.0
4.7
0.0
2.9
4.9
19.7
8.9
31.6
13.2
2.3
0.0
2.7
4.4
0.6
5.5

0.0
0.0
0.5
0.5
0.0
6.8
1.9
0.0
0.0
0.4
0.3
0.0
0.0
0.0
0.6
0.0

30.2
17.3
24.4
4.9
7.7
10.8
12.0
10.3
18.0
9.6
1.4
11.4
5.4
14.5
20.0
4.9
2.4
2.0
3.1
14.9
0.0
20.4

98.3
87.6
93.6
97.6
99.2 *
96.1
136.4
235.7 *
96.5
99.5
119.5
94.8
99.3
105.8
133.8
92.1
102.3
88.0
95.6
117.7
99.4
103.0
84.1
145.5
162.8
82.6
86.9
106.0
96.3
112.1
86.4
103.1
124.1
130.6
94.1
94.2
98.0
93.6
99.3
109.0
93.9
91.9
96.1
106.8
96.3
93.3
94.1
89.6
94.1
90.6
95.2
88.2
115.6
89.5
99.0
85.7

87.7

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

767

825

Indices of data quality

Larynx (C32)
Male
Cases MV(%) DCO(%) UB(%) MI(%)
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

53 98.1
162 95.1
51 100.0
14 57.1
55 69.1

3.1
14.5

70 95.7
184 88.6
57 87.7
108 96.3
2542 81.5
10 90.0
181 85.1
233 90.1
40 90.0
59 98.3
17 100.0

4.3
5.4
5.3
0.0
6.8
0.0
3.3
3.4
5.0

3092
291
497
140
134
106
4
164
1577
38
141
947
240
696
51
719
3868
192
392
513
2724
722
88
36
11
5
75
476
1041
196
19
15
6
13
200
575
470
631
70
550
151
128
20
4264
417
3786
1483
396
1076
336
120
212
172
2323
421
1861
1107
530
995
1022
339
680
113
147

0.4
0.0
0.6
0.0
0.0

96.6
97.6
97.4
96.4
97.8
99.1
100.0
98.8
95.4
97.4
99.3
97.4
97.5
97.3
100.0
97.2
98.2
99.0
97.7
98.6
98.2
97.8
98.9
100.0
100.0
100.0
97.3
97.9
98.8
98.0
94.7
100.0
100.0
100.0
98.0
99.5
96.6
98.7
97.1
98.9
96.7
98.4
85.0
95.9
94.7
96.1
98.2
98.0
98.3
99.7
100.0
99.5
95.9
97.4
97.6
97.3
98.4
98.3
97.0
98.0
97.6
98.2
97.3
98.6

0.0

0.0
0.6
0.5
0.0
0.0
0.7
0.0
1.0
0.0
0.7
0.7
0.0
0.5
1.0
0.7
1.0
0.0
0.0
0.0
0.0
2.7
1.1
0.5
1.0
0.0
0.0
0.0
0.0
1.0
0.2
1.9
0.2
0.0
0.2
0.7
0.8
0.0
3.0
4.3
2.8
1.0
1.3
0.9
0.0
0.0
0.0
2.3
1.9
2.4
1.8
0.8
1.1
0.5
0.6
0.6
0.6
0.0
0.0

0.0
0.0
0.0
0.0
0.0

9.9

768

3 100.0
14 85.7
2 100.0
6 66.7
8 75.0

7.1
12.5

0.0
5.4
5.3
0.9
0.0
0.0
0.0
0.0
0.0
0.0
0.0

72.9
40.8
36.8
39.8
47.3
80.0
48.6
61.4
45.0
53.0

5
56
9
16
486
1
47
14
7
11
6

100.0
78.6
88.9
100.0
74.5
100.0
68.1
92.9
85.7
100.0
100.0

0.0
1.8
11.1
0.0
4.9
0.0
8.5
7.1
0.0

2.1
0.0
0.2
0.0
0.0
0.0
0.0
0.6
3.9
0.0
0.0
1.4
2.5
1.0
0.0
1.0
0.4
0.5
0.5
0.0
0.4
0.3
0.0
0.0
0.0
0.0
0.0
0.2
0.2
0.0
5.3
0.0
0.0
0.0
0.0
0.2
0.4
0.0
0.0
0.0
2.0
0.8
10.0
0.2
0.2
0.2
0.2
0.3
0.2
0.0
0.0
0.0
0.6
0.3
0.0
0.4
0.0
0.2
0.8
0.4
0.6
0.3
0.9
0.7

42.7
35.4
39.4
40.7
41.8
44.3
25.0
44.5
45.7
13.2
43.3
28.6
33.3
27.3
25.5
29.6
31.7
30.2
38.3
28.5
31.7
30.6
40.9

615
76
88
27
36
17
1
31
300
6
33
225
46
176
18
170
967
27
101
78
750
167
23
7
4
0
14
118
245
44
1
1
2
1
29
164
136
180
16
162
32
23
9
1052
96
943
346
91
253
86
37
49
37
538
118
406
328
137
288
267
74
191
25
41

95.0
94.7
97.7
100.0
97.2
100.0
100.0
93.5
93.0
100.0
97.0
97.3
93.5
98.9
100.0
96.5
96.9
100.0
100.0
100.0
96.0
98.8
100.0
100.0
100.0
0.0
100.0
98.3
96.7
100.0
100.0
100.0
100.0
100.0
100.0
95.1
95.6
97.8
100.0
98.1
93.8
95.7
88.9
97.0
96.9
96.9
97.1
97.8
96.8
98.8
100.0
98.0
97.3
96.7
96.6
96.6
97.6
99.3
96.9
97.4
95.9
97.9
92.0
97.6

0.5
0.0
0.0
0.0
0.0

30.7
29.6
36.6
36.7
42.1
6.7
16.7
46.2
34.5
38.1
24.9
30.7
37.1
30.5
53.0
57.0
35.0
28.8
43.2
27.5
29.0
43.4
24.0
36.0
52.5
27.4
29.1
30.0
40.1
28.2
27.0
30.9
29.4
32.5
38.6
29.3
27.4
31.3

*Important. See note on population page.

826

Female
Cases MV(%) DCO(%) UB(%) MI(%)

0.0

0.0
0.0
1.0
0.0
0.0
0.4
2.2
0.0
0.0
0.6
0.9
0.0
0.0
0.0
1.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.6
0.0
0.0
0.0
0.0
0.0
0.0
2.4
2.2
0.6
0.0
0.6
6.3
4.3
11.1
2.0
1.0
2.1
1.7
1.1
2.0
1.2
0.0
2.0
2.7
2.4
2.5
2.5
1.5
0.0
1.0
1.1
1.4
1.0
4.0
2.4

0.0
0.0
0.0
0.0
0.0
0.0
19.6
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2.9
0.0
0.0
0.0
0.0
0.0
0.0
0.0
6.0
0.0
0.0
1.8
2.2
1.1
0.0
1.8
0.6
0.0
0.0
0.0
0.8
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.5
0.6
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.3
0.0
0.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.3
0.0
1.0
0.7
1.4
0.5
0.0
0.0

28.6

*
*
*
*

220.0
12.5
43.8
28.6
300.0
63.8
114.3
28.6
34.1
42.4
35.5
39.8
37.0
30.6
23.5
48.4
48.0
16.7
42.4
27.6
32.6
26.7
16.7
30.6
35.9
25.9
47.5
23.1
36.3
35.9
60.9
7.1
36.4
36.7
45.5
50.0
100.0
37.9
34.1
30.1
32.8
50.0
30.9
56.3
65.2
33.3
29.4
30.2
29.5
25.7
25.3
26.1
27.9
27.0
28.6
32.4
34.4
42.4
32.8
26.8
29.2
25.0
26.2
32.4
23.6
48.0
24.4

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Larynx (C32) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Female
Cases MV(%) DCO(%) UB(%) MI(%)

244 96.7
1122 97.1
1744 96.5
312 97.1
1411 96.3
787 98.7
243 98.8
535 98.7
1163 96.2
130 94.6
1027 96.4
145 97.2
39169 97.2
5208 96.7
33037 97.2
1522 98.1
242 98.8
1246 98.0
228 96.1
4 100.0
70 95.7
148 95.9
3308 96.7
459 94.8
2778 97.0
2089 96.8
260 95.8
1778 96.9
664 94.6
451 98.0
2577 98.1
283 97.9
2254 98.1
202 97.0
3811 98.6
544 98.9
3062 98.5
10735 98.2
328 99.1
1512 98.1
742 98.0
8052 98.2
911 97.6
281 96.8
624 98.1
3200 96.0
486 95.7
2669 96.1
126 100.0
103 99.0
729 97.8
472 98.3
488 98.2
874 97.0

1.2
1.1
1.4
1.6
1.3
0.6
0.4
0.7
2.3
3.1
2.2
1.4
1.4
1.8
1.4
0.6
0.4
0.6
1.8
0.0
1.4
2.0
1.3
3.3
1.0
2.2
3.5
2.1
1.5
1.1
0.8
0.4
0.8
3.0
0.6
0.2
0.7
0.6
0.0
0.4
0.9
0.7
0.8
0.7
0.6
2.0
3.1
1.9
0.0
1.0
1.1
0.6
1.0
1.0

0.4
1.0
1.4
1.0
1.5
0.1
0.4
0.0
0.9
1.5
0.8
1.4
0.7
0.8
0.6
0.5
0.4
0.5
0.0
0.0
0.0
0.0
1.0
0.9
1.0
0.8
0.8
0.8
0.8
0.2
0.3
0.0
0.3
0.0
0.1
0.2
0.1
0.4
0.3
0.5
0.3
0.3
1.3
2.1
1.0
1.3
1.0
1.2
0.0
0.0
0.1
0.0
0.2
1.5

28.3
35.4
31.1
42.0
28.8
31.0
40.3
26.5
29.1
36.2
28.3
24.8
30.6
41.5
29.3
30.6
40.5
28.7
30.7
125.0
31.4
29.1
34.6
53.2
31.9
31.2
40.4
30.7
28.5
31.9
31.2
41.0
30.3
38.1
31.1
43.0
29.1
31.3
31.7
40.3
29.2
29.9
27.2
36.3
23.4
30.8
38.5
29.7
28.6
28.2
32.1
32.2
28.9
27.9

76
315
508
95
408
247
75
171
272
41
228
37
10149
1407
8548
414
65
345
68
1
9
56
996
172
817
559
85
462
184
117
665
107
549
57
1013
165
813
2848
53
403
129
2243
204
50
152
739
107
623
37
36
191
121
129
235

98.7
96.8
97.4
98.9
97.1
98.8
100.0
98.2
97.1
92.7
97.8
100.0
96.8
96.8
96.8
97.1
100.0
96.5
97.1
100.0
88.9
98.2
96.6
94.2
97.1
95.9
95.3
95.9
91.8
98.3
98.2
99.1
98.0
98.2
98.4
100.0
98.3
97.4
98.1
99.3
99.2
97.0
98.0
98.0
98.7
94.6
95.3
94.4
100.0
97.2
96.3
97.5
98.4
97.9

0.0
1.0
0.6
0.0
0.7
0.8
0.0
1.2
1.1
2.4
0.9
0.0
1.4
1.6
1.4
1.9
0.0
2.3
1.5
0.0
11.1
0.0
0.9
2.9
0.5
1.4
1.2
1.5
3.3
0.0
0.9
0.9
0.9
1.8
0.6
0.0
0.7
1.0
0.0
0.2
0.8
1.2
1.0
2.0
0.0
3.0
3.7
2.9
0.0
0.0
2.1
0.8
0.8
1.3

1.3
1.6
1.0
1.1
1.0
0.0
0.0
0.0
1.1
4.9
0.4
0.0
0.8
0.9
0.8
0.2
0.0
0.3
1.5
0.0
0.0
1.8
1.4
2.3
1.2
1.6
2.4
1.5
1.1
0.0
0.5
0.0
0.5
0.0
0.2
0.0
0.1
0.5
0.0
0.2
0.0
0.5
0.5
0.0
0.7
1.9
0.0
2.2
0.0
0.0
0.0
0.0
0.8
0.0

25 92.0
273 86.8
958 94.7
14 100.0
90 80.0
679 86.7
156 96.8
71 97.2
419 86.2
1546 79.1
44 84.1
1341 73.0
313 95.2
370 84.1
133 96.2
766 92.2
656 93.8
89 95.5
113 92.0
96 84.4
194 94.3
354 94.1
258 96.5
926 83.7
191 94.8

4.0
0.0
0.3
0.0
3.3
0.7
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.4
1.4
0.0
0.0
0.0
0.0
0.0
0.8
3.1
2.6
1.1
2.7
5.2
0.0
0.0
0.4
0.0
0.5

76.0
63.0
40.1

4
22
78
2
17
80
9
8
47
185
1
170
54
65
7
127
115
9
14
10
14
25
14
75
10

100.0
86.4
92.3
100.0
94.1
77.5
100.0
87.5
80.9
74.6
100.0
71.8
94.4
69.2
85.7
89.0
90.4
88.9
85.7
70.0
85.7
88.0
71.4
78.7
70.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
3.1
1.7
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

1.4
1.2
0.0
10.4
0.0
4.3
1.5
1.2
0.8
1.1
5.3
3.1
1.5
1.1
0.8
6.8
3.1

38.9
39.6
10.6
41.3
4.5
38.9
34.1
24.8
38.5
16.0
22.0
25.6
36.3
27.2

6.4
0.5
0.0
15.3
0.0
9.2
0.0
3.1
2.6
11.1
14.3
0.0
7.1
4.0
7.1
13.3
20.0

36.8
33.7
31.5
25.3
32.6
30.8
24.0
33.3
28.3
36.6
27.2
24.3
32.0
37.0
31.5
35.7
33.8
36.5
38.2
100.0
30.4
31.1
40.7
29.3
37.9
43.5
37.9
28.3
33.3
34.0
44.9
32.1
45.6
34.0
30.9
34.9
32.9
26.4
33.5
27.1
33.5
28.9
46.0
23.0
31.1
36.4
30.7
32.4
27.8
41.4
47.9
38.8
31.1
150.0
104.5 *
35.9
*
58.8
62.5 *
*
*
31.9
*
46.5
33.5
21.4
21.4
28.0
100.0
42.7
50.0

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

*
*
*

769

827

Indices of data quality

Larynx (C32) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

3999 84.6
382 83.8
256 89.1
111 88.3
122 97.5
203 87.2
48 70.8
916 85.0
67 85.1
24 91.7
45 93.3
84 97.6
70 94.3
22 100.0
267 97.4
334 83.8
340 98.8
294 99.0
19 94.7
27 100.0
116 88.8
41 82.9
100 94.0
211 93.4
875 95.5

6.3
4.7
3.1
2.7
0.0
2.0
2.1
8.1
4.5
8.3
2.2
1.2
1.4
0.0
0.0
5.4
0.0
0.0
0.0
0.0
0.0
7.3
5.0
0.9
0.0

0.0
0.0
0.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.9
1.5

64.1
67.5
57.4
50.5
55.7
62.1
65.6
38.2
65.7

1376
128
65
2908
369
1322
2647
2001
2289
975
359
515
220
202
124
183
285
276
434
169
169
85
182
523
745
351
381
402
474
262
29
502
92
325
168
473
317
71
448
241
178
924
179
55
206
404
271
151
74
94
343
312
166
761

4.4
2.3
4.6

0.0
0.0
1.5
0.0
0.0
1.5
0.2
8.5
0.5
0.9
0.0
0.4
0.0
0.0
0.0
0.0
0.0
0.4
0.0
0.0
1.2
0.0
0.0
1.9
0.0
0.0
0.3
0.0
0.8
0.0
0.0
0.8
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.3
0.0
0.0
0.0
11.5
0.0
0.0

56.7
41.4
33.8
87.5

95.2
96.9
92.3
96.4
99.5
98.3
82.8
85.9
96.5
98.8
93.9
98.8
99.1
99.5
100.0
99.5
100.0
98.9
100.0
100.0
95.9
98.8
100.0
91.0
95.4
82.1
94.0
91.0
83.3
98.1
100.0
95.4
97.8
89.8
95.2
92.0
94.3
90.1
96.9
99.2
87.1
97.4
96.1
94.5
94.2
94.3
67.2
95.4
89.2
93.6
96.8
86.5
95.8
98.2

11.0
5.5
1.9
0.0
0.0
0.2

0.0
6.5
4.2
3.7
5.5
3.0
10.5
1.1
0.0
1.2
0.0
2.2
2.4
0.2
0.3
1.4
0.7
0.0
3.9
0.3
0.0
1.8
1.0
1.2
2.6
2.0
4.1
0.0
2.0
0.0
0.0
0.5

17.9
7.1

56.8

78.0
56.0
23.7
26.7

40.4
59.4
61.5
55.7
48.3
61.3
32.2

73.8
30.7
29.1
15.7
46.0
53.2
46.9
34.5
47.8
45.7
31.1
36.9
38.5
43.2
19.7
29.2
32.0
33.7
42.9
42.5
49.1
27.7
32.7
48.7
47.7
39.2
35.9
35.9
41.7
37.3
34.6

*Important. See note on population page.

828

770

Female
Cases MV(%) DCO(%) UB(%) MI(%)
408
58
27
12
12
31
7
85
5
4
3
11
16
6
38
65
27
23
2
2
23
20
10
18
41

64.0
72.4
85.2
100.0
66.7
71.0
100.0
62.4
80.0
25.0
100.0
72.7
87.5
83.3
100.0
76.9
96.3
95.7
100.0
100.0
87.0
80.0
80.0
88.9
92.7

21.8
17.2
0.0
0.0
25.0
19.4
0.0
28.2
20.0
75.0
0.0
0.0
12.5
0.0
0.0
15.4
0.0
0.0
0.0
0.0
0.0
5.0
10.0
5.6
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
16.7
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2.4

167
12
3
80
47
133
151
166
259
228
27
67
24
18
15
16
44
32
32
11
10
11
13
48
53
81
36
66
78
31
10
103
8
20
20
49
28
3
59
29
18
114
12
3
12
48
21
13
4
11
37
23
7
88

94.0
100.0
100.0
98.8
100.0
97.7
65.6
77.7
93.4
98.2
92.6
100.0
100.0
94.4
100.0
100.0
100.0
96.9
100.0
100.0
100.0
100.0
92.3
83.3
92.5
84.0
77.8
92.4
83.3
100.0
100.0
92.2
100.0
90.0
90.0
79.6
96.4
100.0
91.5
100.0
94.4
93.9
100.0
66.7
91.7
93.8
71.4
84.6
100.0
90.9
100.0
82.6
85.7
96.6

4.8
0.0
0.0

0.6
0.0
0.0
0.0
0.0
2.3
0.7
15.7
1.2
0.9
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
4.2
0.0
0.0
0.0
0.0
2.6
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
13.0
0.0
0.0

26.5
6.6
3.9
0.0
0.0
0.0

0.0
12.5
7.5
3.7
22.2
3.0
9.0
0.0
0.0
1.0
0.0
5.0
5.0
0.0
0.0
0.0
1.7
0.0
0.0
1.8
0.0
0.0
0.0
2.1
0.0
7.7
0.0
0.0
0.0
4.3
0.0
1.1

101.0
86.2
74.1
58.3
116.7
61.3
21.4
82.4
80.0

31.3

63.0

*
*
*

*
65.0 *
320.0
22.2 *
68.3 *
58.7
50.0
33.3
93.8 *
*
41.4
74.8 *
53.6
46.3
55.7
37.0
46.3

77.1
34.0
32.1
25.0
40.9
44.9
45.2
10.0
46.6
37.5
40.0
50.0
34.7
35.7
66.7
35.6
13.8
9.3
34.2
66.7
66.7
75.0
27.1
23.8
30.8
50.0
34.1
43.2
39.1
57.1
31.8

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Larynx (C32) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

589 88.5
940 93.4
70 98.6
534 99.4
223 79.4
544 90.4
450 97.3
702 97.3
813 88.6
818 83.7
2122 87.2
1391 93.7
516 99.0
107 93.5
648 97.2
1042 97.7
475 95.4
92 92.4
208 95.7
323 98.1
535 96.1
282 98.9
228 93.9
508 97.0
775 99.9
78 100.0
33 90.9
48 97.9
74 98.6
94 97.9
71 100.0
108 100.0
2868 99.4
204 98.5
180 98.3
328 96.3
429 93.7
783 95.3
1271 96.6
295 95.3
970 87.2
1745 90.1
720 95.0
864 96.9
270 95.2
1237 97.4
931
34
492
172
69
596
226
23
19
330
183
10
15
22
39
88

97.0
97.1
94.1
94.2
98.6
95.6
98.7
91.3
84.2
95.5
99.5
100.0
100.0
100.0
100.0
98.9

2.9
0.4
0.0
0.0
5.4
2.6
0.4

67.6
63.9
42.9
32.4
60.5
47.8
57.6
68.5
66.1
96.5
55.6
70.5
53.3
38.3
54.5
41.7
52.1
38.0
58.7
62.5
44.5
52.5
37.3
43.5
29.5
26.9
33.3
33.3
44.6
35.1
26.8
29.6
34.2

0.3
0.7
0.4
0.6
1.0
1.0
4.8
2.4
1.4
0.4
0.4

0.2
0.0
0.0
0.0
0.0
3.1
0.0
0.1
0.0
5.4
0.1
0.4
0.4
0.9
0.6
0.5
0.8
0.0
0.5
0.0
0.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.9
0.2
1.0
0.0
1.4
3.3
2.5
0.1
0.0
0.0
0.2

0.0
0.0
0.2
0.0
0.0
1.2
0.0
8.7
10.5
0.9
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.2
0.0
0.0
1.2
0.0
0.0
5.3
0.0
0.0
0.0
0.0
0.0
0.0
0.0

43.4
44.1
36.0
50.6
31.4
39.1
36.3
34.8
78.9
37.3
21.3

9.8
5.9
5.5
0.6
1.9
1.4
0.4
2.1
2.2
1.9
0.3
1.7
1.1
3.9
2.4
0.0
3.0
2.1
0.0
0.0
0.0
0.0

34.4
36.6
39.6
37.5
37.0
33.6
35.8
38.6
35.6
38.5
35.9
38.2

18.2

Female
Cases MV(%) DCO(%) UB(%) MI(%)
40
54
9
96
43
57
88
31
44
64
212
87
56
4
21
57
22
0
3
5
20
8
5
15
162
13
5
7
16
13
8
23
526
31
29
72
107
184
315
59
188
357
153
158
66
301

80.0
92.6
100.0
95.8
83.7
93.0
96.6
100.0
72.7
76.6
87.7
94.3
98.2
75.0
95.2
96.5
100.0
0.0
100.0
100.0
90.0
100.0
100.0
93.3
100.0
84.6
100.0
100.0
100.0
100.0
100.0
95.7
99.6
100.0
100.0
97.2
92.5
94.0
96.2
98.3
81.4
84.9
91.5
94.3
92.4
97.3

114
5
42
27
12
89
35
3
1
48
27
1
0
8
7
10

91.2
100.0
97.6
96.3
100.0
91.0
97.1
100.0
100.0
95.8
96.3
100.0
0.0
100.0
85.7
100.0

10.0
1.9
0.0
0.0
0.0
0.0
0.0

0.0
0.9
0.0
0.6
1.7
0.0
7.3
4.6
1.9
0.0
0.0

0.0
0.0
0.0
0.0
0.0
3.5
0.0
0.0
0.0
10.9
0.5
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.4
0.0
1.1
0.0
0.0
7.4
3.9
0.0
0.0
0.0
0.3

1.8
0.0
2.4
0.0
0.0
1.1
0.0
0.0
0.0
2.1
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

22.7
5.7
5.7
1.8
25.0
4.8
1.8
0.0
0.0
0.0
0.0
5.0
0.0
0.0
6.7
0.0
0.0
0.0
0.0
0.0
0.0
4.3

62.5
68.5
22.2
41.7
26.2 *
41.7
64.8
100.0 *
75.0
95.3
53.8
56.3
51.8
50.0
63.5
29.8
22.7
33.3
200.0
15.0
50.0
40.0
53.3
27.8
61.5
40.0
28.6
43.8
23.1
25.0
21.7
39.2
37.9
48.6
36.4
41.3
32.4
44.1
46.8
49.0
49.7
50.6
42.4
38.5
46.5
60.0
64.3
14.8
34.7
44.9
31.4
66.7
43.8
11.1

10.0

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

771

829

Indices of data quality

Lung (C33-34)
Male
Cases MV(%) DCO(%) UB(%) MI(%)
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

374
541
335
46
146

95.7
82.6
96.7
65.2
44.5

379
500
154
266
6525
100
711
810
214
156
52

69.4
88.0
59.1
79.7
66.9
51.0
55.3
54.9
69.6
92.3
75.0

19.8
5.2
34.4
13.2
13.8
16.0
12.7
21.9
23.8

40042
3948
6580
2196
1850
837
34
2329
20105
307
1856
10879
1969
8849
744
8606
46192
3838
3728
3847
34497
8531
890
565
394
97
565
5650
10878
1697
357
367
184
195
1327
6474
5102
6670
443
6176
1141
886
221
43150
3357
39440
15518
3314
12103
3682
1105
2519
1913
24478
3560
20524
13811
6363
12143
10320
2882
7389
895
1478

78.8
83.8
82.1
79.5
82.1
91.5
97.1
76.9
76.0
86.3
77.0
86.5
85.5
86.7
90.5
89.0
90.4
93.1
91.7
91.9
89.7
90.0
90.3
92.2
93.7
93.8
92.9
89.0
92.3
92.2
94.1
91.3
91.3
96.9
92.6
92.0
85.9
92.1
92.1
92.1
87.6
88.4
87.3
87.2
85.7
87.3
87.9
87.0
88.1
91.2
90.8
91.3
84.8
89.6
89.2
89.6
90.3
88.4
87.3
88.8
86.8
89.6
87.5
89.6

2.6
0.4
2.6
4.0
0.1

8.7
16.4

0.0

0.0
3.2
2.8
0.3
7.3
4.9
4.6
5.1
0.7
2.4
1.2
0.8
1.0
1.1
1.3
1.9
1.7
1.1
1.0
2.1
1.2
2.1
0.9
0.8
0.6
0.8
0.5
0.0
1.3
0.9
3.8
1.9
1.8
1.9
5.9
5.3
8.6
6.5
7.4
6.5
4.3
4.1
4.3
2.9
2.4
3.1
5.0
3.1
5.3
2.7
2.4
2.3
1.9
2.2
2.8
2.0
4.2
2.4

0.0
0.0
0.0
0.0
0.0

32.5

772

37 86.5
174 75.9
17 100.0
40 70.0
59 61.0

12.1
11.9

3.7
5.8
1.3
0.0
0.0
0.0
0.0
0.0
0.0
2.6
0.0

123.0
73.6
66.2
90.6
72.8
110.0
88.2
99.3
91.6
82.5

106
307
71
173
3247
51
412
364
136
74
52

70.8
85.7
54.9
77.5
66.6
41.2
56.8
52.2
66.2
89.2
78.8

17.9
7.8
35.2
13.9
14.2
27.5
13.6
23.9
25.0

9.8
0.1
0.1
0.0
0.0
0.2
0.0
0.9
19.3
0.0
0.1
3.6
4.0
3.5
2.7
3.1
1.7
1.1
1.1
1.8
1.7
0.8
1.3
1.2
1.0
0.0
0.9
0.6
1.4
0.8
1.7
0.8
2.2
1.0
2.0
1.5
2.1
0.6
0.7
0.6
2.5
1.9
2.3
0.8
0.9
0.8
0.6
0.4
0.7
0.5
0.0
0.6
0.4
0.8
1.0
0.8
0.7
0.8
3.2
0.6
0.5
0.6
0.6
0.4

84.7
82.3
84.8
83.3
84.1
116.7
94.1
83.2
83.8
92.5
88.0
86.5
95.5
84.9
74.6
81.9
81.4
74.5
83.6
72.4
83.1
80.5
88.0

30202
3097
5444
1777
1133
404
23
1597
15202
219
1306
6475
997
5430
586
6977
40142
2420
2582
2941
31947
7758
684
377
170
89
479
5687
9142
1174
263
187
112
116
982
6156
4288
5844
324
5489
831
611
203
33649
1840
31524
9874
1722
8086
2847
723
2089
1408
18851
2509
16117
9897
4518
8305
6723
1501
5186
487
1180

78.4
83.1
82.3
81.4
82.6
94.6
95.7
77.5
74.8
84.0
79.9
85.9
85.9
85.9
87.7
89.3
88.3
92.5
90.9
90.5
87.6
87.5
88.2
91.5
92.9
91.0
90.2
86.5
90.7
91.9
93.9
94.1
91.1
94.8
91.9
89.8
85.1
90.6
92.0
90.5
86.4
86.4
87.7
87.5
89.1
87.4
86.6
86.8
86.6
90.4
90.9
90.2
83.5
88.5
87.6
88.6
88.9
86.1
86.5
87.0
86.2
87.2
87.5
87.1

2.9
0.5
2.5
3.0
0.1

62.7
83.5
81.0
82.3
89.6
68.4
74.5
86.7
80.1
82.4
78.1
74.5
76.3
74.6
80.0
83.4
76.0
78.6
83.7
78.6
82.6
83.6
82.6
80.4
78.3
81.9
81.8
80.5
85.6
80.1
84.4
81.5
80.7
84.3
89.6
82.2
95.6
80.7

*Important. See note on population page.

830

Female
Cases MV(%) DCO(%) UB(%) MI(%)

0.0

0.0
2.8
3.5
0.0
6.7
5.1
4.1
5.3
1.0
2.6
1.6
1.0
1.2
1.7
1.7
3.0
2.0
1.3
1.2
4.5
1.9
3.4
1.2
0.8
0.8
0.5
0.0
1.7
1.8
1.3
3.5
2.3
0.9
2.4
5.9
5.1
8.4
5.5
4.2
5.6
4.3
3.5
4.4
3.1
2.8
3.3
5.0
3.3
5.5
3.0
2.7
2.3
1.9
2.2
2.5
2.1
3.5
2.0

0.0
0.0
0.0
0.0
0.0

37.9

3.8
5.9
2.8
0.0
0.0
0.0
0.0
0.0
0.0
1.4
0.0

153.8
63.2
62.0
93.1
65.5
115.7
88.1
102.7
97.1
77.7

10.1
0.2
0.1
0.0
0.0
0.0
0.0
1.1
19.9
0.0
0.1
3.8
4.4
3.7
3.2
2.8
1.9
1.5
1.0
1.8
2.0
0.6
0.4
1.1
1.8
1.1
0.8
0.5
1.7
1.2
3.0
1.1
2.7
0.0
1.6
1.9
1.9
0.5
0.3
0.5
2.0
1.8
1.5
0.7
0.7
0.7
0.8
0.8
0.8
0.6
0.7
0.6
1.1
0.6
0.9
0.6
0.9
1.0
3.0
0.8
1.2
0.6
2.1
0.3

78.7
77.4
81.1
73.7
74.1
102.7
65.2
79.5
78.1
77.2
81.9
80.6
86.8
79.9
71.7
77.7
77.8
71.9
81.4
57.1
80.1
77.6
78.4
54.1
80.7
77.4
83.7
81.4
50.3
83.9
81.0
65.7
79.5
76.0
72.6
67.9
73.0
82.3
84.3
80.8
72.6
71.9
73.1
77.5
76.7
77.8
75.3
72.6
76.8
76.6
75.7
81.6
75.2
80.7
74.8
74.6
79.8
84.9
78.5
87.3
77.5

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Lung (C33-34) (contd)

)
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
Cases MV(%) DCO(%) UB(%) MI(%)

Female
Cases MV(%) DCO(%) UB(%) MI(%)

3155
12065
19922
2761
16959
8615
2062
6473
13338
1232
12012
1818
437751
45345
382072
16153
1982
13847
2377
43
545
1723
34267
4036
29314
25578
2624
22547
8706
6547
28694
2648
25678
2444
44153
4900
36166
123409
5996
13468
5597
97660
9181
2074
7059
34371
4249
29652
1483
1190
10394
6966
5602
10021

87.0
89.2
89.0
89.5
89.0
91.5
90.8
91.8
85.6
87.6
85.4
86.3
88.0
87.9
88.0
90.4
90.3
90.5
84.5
79.1
81.1
85.5
85.5
86.2
85.4
89.2
86.9
89.5
81.6
85.5
90.2
90.4
90.2
91.8
89.9
90.8
89.6
89.8
92.7
90.1
90.6
89.5
88.7
87.3
89.1
85.6
85.1
85.6
87.6
88.1
87.2
88.2
84.3
83.9

2.9
3.1
1.9
1.4
2.0
1.9
1.6
2.0
4.7
5.7
4.6
7.2
3.6
4.2
3.6
2.2
1.8
2.2
5.8
9.3
5.5
6.0
4.0
4.7
4.0
4.7
6.4
4.6
4.6
2.8
1.3
1.4
1.3
2.1
2.1
1.8
2.2
1.8
1.1
1.8
1.7
1.8
3.0
3.1
3.0
7.0
7.5
7.0
0.7
3.3
1.6
1.3
2.7
4.8

2.3
2.0
2.4
2.3
2.4
0.7
0.8
0.6
4.5
2.8
4.7
0.9
1.9
1.7
1.9
1.2
1.5
1.1
1.6
0.0
2.9
1.3
2.3
2.2
2.3
2.8
3.5
2.7
1.7
2.2
1.1
1.3
1.1
0.9
0.9
0.7
1.0
1.4
1.0
0.9
1.8
1.5
3.4
3.4
3.4
2.2
2.3
2.1
0.4
0.5
2.3
2.1
1.6
4.5

78.1
82.8
80.1
77.7
80.6
75.1
74.9
75.3
83.4
87.5
83.2
82.8
81.1
84.7
81.3
80.3
82.4
80.7
80.6
69.8
79.6
81.1
76.9
79.3
76.9
83.5
87.8
84.3
80.5
82.2
81.2
81.8
82.0
78.9
78.4
78.2
79.1
80.7
73.5
82.7
70.1
81.7
83.2
88.4
81.9
82.8
87.1
82.7
83.1
82.7
80.2
79.4
82.2
78.9

2458
11381
15710
1980
13569
7167
1527
5592
9559
858
8626
1485
339134
29126
302680
13910
1389
12332
1747
18
327
1378
29887
3048
26285
19374
1850
17242
6075
5846
21873
2074
19547
2008
35923
3445
30559
99833
3766
8824
4128
82579
5538
963
4531
24136
2400
21393
920
853
9039
6168
4148
7694

84.7
87.7
87.8
89.3
87.5
89.6
90.1
89.5
85.4
87.3
85.2
84.2
87.0
88.5
86.7
88.0
91.3
87.6
80.7
83.3
80.7
80.8
85.0
89.6
84.4
88.4
88.9
88.2
82.2
84.5
87.8
90.0
87.5
89.0
88.2
90.1
87.8
88.1
92.2
89.9
89.7
87.6
86.6
85.8
86.8
84.0
83.8
84.0
87.8
84.3
86.4
87.5
82.6
82.9

2.6
3.3
1.8
0.7
1.9
2.5
1.6
2.7
3.9
4.0
4.0
7.9
3.6
3.4
3.6
3.1
1.6
3.3
8.0
5.6
9.2
7.8
3.6
2.5
3.8
4.5
5.1
4.5
3.9
2.9
1.6
1.9
1.6
3.2
2.5
1.9
2.7
2.1
1.2
1.8
2.3
2.2
3.5
3.2
3.6
7.7
7.9
7.7
0.8
3.5
1.9
1.3
3.2
5.2

2.9
2.4
2.5
2.5
2.5
0.7
0.8
0.7
4.5
2.1
4.8
0.7
1.9
1.6
2.0
1.3
0.9
1.3
1.4
0.0
0.3
1.7
2.3
1.4
2.4
2.9
2.4
3.0
1.2
2.4
1.4
1.3
1.4
0.9
1.0
0.7
1.0
1.6
1.3
1.0
1.7
1.6
3.9
4.4
3.8
2.2
2.3
2.1
0.2
0.7
2.4
2.4
1.5
4.6

186
3847
12941
600
1282
12766
1088
569
962
2525
175
1933
284
363
264
5201
4506
553
1511
1627
1806
4635
3806
16759
2877

79.6
58.5
80.5
32.5
76.3
45.7
54.4
89.8
52.1
81.0
65.1
66.0
82.7
74.1
72.0
84.2
85.4
91.5
71.1
75.5
81.8
76.8
78.7
73.1
73.4

9.7
0.0
1.9
0.5
1.6
0.7
0.1

0.5
0.1
0.0
0.0
0.6
0.0
0.0
1.1
12.1
0.0
0.0
0.0
0.0
0.0
0.0
3.1
2.8
2.4
3.1
1.5
0.0
0.0
0.6
0.0
1.0

94.6
88.1
85.0

64
1765
6136
182
845
5720
521
128
228
540
20
600
96
182
51
2496
2334
82
589
618
720
1801
1608
7144
1042

81.3
56.1
75.3
32.4
74.8
43.0
54.7
93.0
50.9
79.3
75.0
67.5
86.5
67.0
82.4
81.7
83.7
82.9
72.7
69.1
80.1
70.0
75.8
67.8
69.3

10.9
0.0
2.6
0.5
3.2
0.9
0.0

0.0
0.2
0.0
0.0
0.8
0.0
0.0
1.6
14.9
0.0
0.0
0.0
0.0
0.0
2.0
2.8
2.7
2.4
2.4
1.3
0.0
0.0
0.7
0.0
1.4

3.0
1.7
1.1
12.8
0.0
8.3
4.5
5.2
4.3
2.5
25.7
7.1
6.4
14.0
13.2
19.3
15.7

92.1
73.2
43.9
55.6
16.0
49.5
85.0
81.2
88.9
76.2
79.9
78.1
83.7
83.9

4.4
2.4
0.0
13.7
0.0
20.9
5.9
6.2
5.0
3.7
25.0
10.0
10.0
18.1
14.1
22.2
16.4

78.2
75.0
76.0
73.2
76.3
73.1
73.9
72.7
80.0
81.1
80.1
75.8
76.4
79.3
76.7
74.8
77.2
74.9
78.3
88.9
74.9
79.0
72.1
76.4
71.8
78.3
81.6
78.9
75.9
79.1
78.1
79.6
78.7
74.1
75.0
74.3
75.5
76.6
69.8
78.7
55.5
77.9
79.5
79.8
79.8
78.5
81.8
78.6
80.5
80.8
77.3
76.3
77.0
74.9
76.6
86.6 *
85.3
*
77.4
70.5 *
*
46.9 *
53.1
*
20.0
52.7
*
*
*
75.2
74.2
85.6
68.8
69.5
69.6
81.5
78.3

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

773

831

Indices of data quality

Lung (C33-34) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

41176
3368
2480
1083
1201
2170
309
9057
628
143
156
698
711
160
596
3165
3547
3145
89
313
1236
1117
409
1090
5886

74.7
70.6
81.4
79.7
74.2
76.4
75.4
78.9
73.6
77.6
85.9
80.5
71.6
76.9
74.8
55.7
87.3
87.6
87.6
84.3
73.1
65.4
77.0
85.6
86.6

7.9
6.1
5.0
5.5
4.3
3.8
2.3
9.3
5.6
18.9
10.9
4.7
14.3
5.0
0.2
15.5
0.0
0.0
0.0
0.0
0.0
12.8
5.4
1.9
0.0

0.0
0.0
0.1
0.0
0.0
0.0
0.3
0.0
0.0
0.0
0.0
0.0
1.0
0.6
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
3.4
2.0

84.2
87.4
75.1
81.7
77.4
81.0
85.0
69.5
85.0

12849
1071
547
19017
3997
11993
15536
12086
23276
10243
2971
7809
2091
1257
978
1316
1740
1958
1579
941
1212
727
776
5810
9140
3833
4175
3525
6019
2873
296
5184
632
1607
1346
3306
1994
432
3125
1812
1035
4931
1212
565
1236
3179
1795
961
609
501
2790
2091
1308
4797

85.9
90.2
80.4
68.3
94.2
86.6
48.1
73.5
77.5
83.7
76.4
87.0
95.3
96.7
96.1
95.4
97.8
92.2
98.0
98.1
92.8
95.5
98.7
73.0
76.7
69.8
77.6
79.3
77.6
84.6
95.6
73.5
75.3
73.0
78.8
69.6
67.1
78.0
68.2
68.6
68.7
81.4
78.3
67.8
77.5
80.3
63.2
76.0
65.7
83.4
77.8
76.5
73.9
75.5

11.3
1.9
7.7

0.2
0.0
1.8
0.0
0.0
9.0
0.1
19.3
0.4
2.9
0.0
1.8
0.1
0.2
0.0
1.7
0.0
2.2
0.1
0.0
0.8
0.0
0.4
1.0
0.2
0.0
0.3
0.0
1.1
0.0
0.0
1.3
0.3
0.0
0.0
0.0
0.0
0.2
0.0
0.0
0.0
0.0
0.0
1.1
0.0
0.0
0.0
0.8
2.8
0.0
0.3
10.9
0.0
0.0

90.8
86.0
81.7
86.2

17.0
7.2
5.6
0.6
0.7
2.4

0.2
21.3
15.6
12.0
18.6
12.3
11.6
9.3
0.0
3.6
1.7
3.4
0.5
0.7
2.2
2.3
2.4
0.6
4.2
1.1
1.2
3.2
0.2
2.3
4.8
4.2
4.1
0.4
2.2
0.6
0.4
1.8

59.5
48.5

91.8
0.3
87.9
68.2
64.6
72.4

102.5
78.8
86.3
93.5
94.4
94.3
90.2
84.7
97.2
91.4
99.1
108.4
87.4
112.3
100.4
100.0
97.7
130.7
184.1
69.9
84.7
70.9
81.4
85.7
89.0
93.2
91.1
86.4
86.7
86.1
88.0
85.2
91.2
90.0
90.2
86.1
94.5
82.0
85.1
93.0
85.0
90.4
88.0
85.6
93.1
86.6
87.0
87.7
85.9

*Important. See note on population page.

832

774

Female
Cases MV(%) DCO(%) UB(%) MI(%)
14691
1303
933
399
479
822
120
3667
227
46
22
220
395
36
62
1139
1584
1436
33
115
934
634
168
142
505

62.1
59.2
68.9
69.7
61.4
64.7
69.2
68.9
64.3
71.7
86.4
76.8
73.9
88.9
77.4
57.3
82.6
82.0
84.8
88.7
74.1
67.8
73.2
82.4
83.2

12.6
9.0
9.5
9.3
5.6
5.4
4.2
15.5
10.6
28.3
13.6
7.3
13.4
0.0
0.0
14.5
0.0
0.0
0.0
0.0
0.0
11.7
6.0
2.1
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.8
2.8
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
3.5
2.2

0.1 *
84.5 *
141.1
56.3 *
128.1 *

5532
447
186
2337
1021
2330
2789
2830
6851
7803
678
2745
479
218
202
306
403
400
362
128
196
139
167
1597
2188
1901
1104
1648
1875
990
303
3066
166
391
327
900
496
101
1295
470
189
1625
398
92
343
856
260
187
88
112
815
510
309
1459

82.7
88.8
73.7
55.1
94.6
87.3
40.9
66.5
72.8
83.6
67.1
84.6
93.3
95.4
96.0
92.2
99.0
92.0
95.6
96.9
93.9
91.4
97.6
68.8
68.6
65.9
71.1
76.6
75.0
81.8
94.7
69.3
63.3
71.1
73.1
64.0
59.3
72.3
62.7
67.0
63.0
77.2
69.1
65.2
81.3
78.6
56.2
76.5
68.2
80.4
71.7
73.9
64.7
67.9

13.9
2.0
10.2

0.3
0.0
1.1
0.0
0.0
8.5
0.2
24.6
0.6
3.1
0.0
2.3
0.0
0.0
0.0
2.6
0.0
2.8
0.3
0.0
0.5
0.0
1.2
1.1
0.3
0.0
0.4
0.0
1.8
0.0
0.0
1.3
0.6
0.0
0.0
0.0
0.0
1.0
0.0
0.0
0.0
0.0
0.0
2.2
0.0
0.0
0.0
0.0
3.4
0.0
0.0
13.7
0.0
0.0

87.4
80.3
71.0
82.6 *
*
92.7
93.5 *
82.3
90.9
91.5
89.1
83.4
88.9
88.1
78.7
99.0
99.5
80.3
101.7
107.0
93.9
96.4
106.6
196.7
66.6
84.6
68.8
83.8
90.6
82.0
83.2
89.8
86.1
81.6
90.2
80.1
81.0
75.2
86.1
88.7
72.3
89.7
81.4
82.6
82.8
77.9
92.3
79.7
83.0
82.6
82.5
78.6
78.6
78.8

25.6
8.8
8.3
0.5
1.3
2.8

0.0
24.7
22.1
13.2
23.9
13.2
11.8
9.4
0.0
4.5
3.6
4.6
1.2
0.9
3.2
3.0
5.2
0.9
7.9
1.8
2.0
1.1
0.6
0.9
5.8
7.0
2.3
0.0
3.1
1.6
1.3
3.5

82.6
88.1
79.4
76.9
76.2
84.1
93.8
65.4
80.6
61.4
40.5

90.4

*
*
*

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Lung (C33-34) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

4793
6950
533
6516
1506
3229
2955
3133
3718
7745
10672
9481
4033
491
2833
3857
2287
443
1300
1402
2074
1254
1037
1839
8437
705
403
343
779
648
514
1126
32797
2272
2138
4688
5873
9094
15639
3630
11995
23713
10193
10435
2693
12969

59.3
73.0
76.2
87.4
62.1
85.1
83.8
95.2
78.6
62.6
78.1
74.2
97.7
83.5
88.9
86.1
85.4
73.6
86.2
75.8
83.4
89.4
82.6
86.3
97.7
92.5
88.6
89.5
90.1
89.2
91.1
91.5
92.6
91.9
94.2
73.5
64.3
66.2
57.3
72.0
63.5
66.5
65.9
71.8
66.9
74.9

9278
175
5270
2323
816
6619
2524
223
250
4733
1983
121
332
324
504
566

84.9
92.6
79.8
83.0
80.5
80.3
85.5
87.4
86.0
78.0
92.3
95.0
93.4
92.3
92.5
91.3

6.7
2.0
3.0
1.0
8.4
2.0
0.4

94.8
88.8
97.0
88.6
90.0
89.8
108.1
114.9
88.8
104.3
79.4
95.7
91.3
90.0
99.2
83.0
86.4
84.2
83.2
101.4
90.7
82.5
82.9
103.6
106.2
69.9
77.2
83.1
79.5
79.8
82.3
77.5
98.6

0.3
7.1
3.1
2.5
1.7
3.6
10.8
7.8
8.2
2.1
0.9

0.1
0.0
0.0
0.0
0.0
2.8
0.1
0.0
0.0
7.7
0.1
1.3
0.8
0.8
1.0
0.9
1.0
0.7
0.9
0.2
1.2
0.1
0.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2.2
0.3
2.0
0.0
16.3
10.1
4.8
1.2
0.0
0.0
1.5

1.8
1.7
2.7
0.0
0.2
3.0
4.8
1.8
8.8
5.0
1.3
0.0
0.6
1.2
1.8
1.4

0.0
0.0
0.3
0.3
0.2
3.1
0.0
0.0
1.6
0.0
0.3
0.0
0.3
0.3
0.2
0.4

85.3
86.9
84.0
86.9
84.5
86.2
85.4
101.8
87.2
90.8
74.9

16.2
11.3
13.1
1.5
4.1
3.9
3.3
4.4
10.4
4.2
1.5
5.3
2.0
8.2
6.0
0.1
0.2
0.9
0.9
2.5
0.4
4.8

94.4
89.5
85.6
90.3
89.8
95.0
98.8
88.3
86.2
90.1
89.7
88.3

74.7

Female
Cases MV(%) DCO(%) UB(%) MI(%)
929
1230
98
3761
613
611
1520
685
867
1894
3076
1777
1188
49
354
558
398
39
134
122
231
166
99
172
6073
391
106
140
274
250
197
528
12386
740
729
2606
4320
6169
10864
2130
7253
15168
6107
5650
1735
9764

51.3
59.8
77.6
87.1
60.0
75.1
80.5
94.2
75.7
55.4
76.6
71.8
97.4
85.7
82.2
83.3
80.9
56.4
82.8
70.5
80.1
86.1
77.8
80.2
97.2
88.7
82.1
87.9
92.0
90.4
87.8
91.5
93.0
93.6
94.0
68.9
60.8
61.8
52.8
67.3
59.7
63.3
61.8
68.5
62.9
70.7

4685
70
2487
1202
447
3685
1339
138
95
3159
1275
85
143
257
278
423

82.9
85.7
79.8
81.0
83.2
78.3
83.0
84.8
82.1
74.0
91.5
92.9
95.8
93.0
89.9
89.4

9.6
2.5
3.1
0.9
11.1
3.8
0.5

0.5
8.2
3.2
2.6
2.2
3.9
11.5
8.2
9.0
2.4
0.7

0.1
0.0
0.0
0.0
0.0
4.4
0.1
0.1
0.0
10.1
0.1
1.9
0.8
0.0
1.1
0.4
1.8
2.6
0.0
0.0
0.9
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2.8
0.3
2.6
0.0
20.4
12.0
4.8
1.5
0.0
0.0
1.5

2.2
2.9
3.0
0.0
0.2
3.1
5.7
1.4
10.5
5.4
0.9
0.0
0.0
1.6
0.7
1.2

0.0
0.0
0.2
0.7
0.0
3.7
0.1
0.0
3.2
0.1
0.2
0.0
0.0
0.0
0.4
0.2

20.5
13.2
15.6
1.9
8.2
6.5
6.3
7.3
23.1
7.5
3.3
7.4
2.4
10.1
9.3
1.3
0.0
1.4
0.7
3.2
2.0
4.7

92.8
80.1
94.9
83.0
89.3 *
82.2
109.2
116.1 *
80.2
109.1
76.8
95.7
86.4
87.8
89.9
83.9
84.5
84.6
91.0
123.8
91.3
83.1
87.9
108.7
102.3
69.6
68.9
78.6
78.8
76.0
73.6
75.6
90.9
90.4
86.1
83.1
88.6
87.4
98.5
93.9
86.3
84.1
89.4
87.4
85.9
83.2
80.0
77.8
78.3
84.8
80.6
78.5
108.7
88.4
89.9
67.5

65.2

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

775

833

Indices of data quality

Melanoma of skin (C43)


Male
Cases MV(%) DCO(%) UB(%) MI(%)
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

5
15
5
9
15

100.0
100.0
100.0
100.0
66.7

27
102
16
69
1392
16
124
188
73
18
16

74.1
96.1
100.0
98.6
99.6
100.0
96.8
98.4
97.3
100.0
100.0

25.9
2.9
0.0
1.4
0.0
0.0
0.0
0.0
0.0

8496
945
1550
352
283
116
6
458
4438
62
286
1557
17
1420
149
2636
15400
100
57
536
13688
2657
9
15
4
1
67
2391
3197
24
12
6
6
2
185
2737
2176
2053
7
1971
123
8
108
8811
41
8590
3205
46
3080
1229
15
1181
671
4084
28
3832
2336
1357
2145
1179
30
1129
9
183

97.7
100.0
99.7
99.1
100.0
98.3
100.0
100.0
95.8
100.0
99.7
98.1
88.2
98.1
97.3
98.8
99.6
99.0
98.2
99.4
99.6
99.7
100.0
100.0
100.0
100.0
98.5
99.7
99.7
100.0
100.0
100.0
100.0
100.0
99.5
99.7
99.4
99.3
100.0
99.2
96.7
87.5
97.2
98.5
95.1
98.5
98.6
100.0
98.6
99.6
100.0
99.6
98.2
99.1
100.0
99.1
99.3
99.6
99.4
98.9
100.0
98.8
100.0
97.8

0.1
0.0
0.1
0.0
0.0

0.0
0.0

0.0

0.0
0.0
0.1
0.0
0.3
0.3
5.9
0.3
0.0
0.5
0.2
0.0
0.0
0.4
0.2
0.2
0.0
0.0
0.0
0.0
0.0
0.2
0.2
0.0
0.0
0.0
0.0
0.0
0.5
0.1
0.5
0.4
0.0
0.5
1.6
12.5
0.9
1.3
4.9
1.3
1.2
0.0
1.3
0.4
0.0
0.4
1.2
0.5
0.0
0.5
0.5
0.2
0.2
0.4
0.0
0.4
0.0
0.5

0.0
0.0
0.0
0.0
0.0

11 100.0
14 100.0
5 100.0
16 93.8
28 89.3

776

0.0
3.6

0.0
1.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

70.4
20.6
37.5
10.1
20.0
37.5
31.5
39.4
57.5
34.7

29
122
15
93
1687
32
135
173
96
19
23

89.7
95.1
100.0
98.9
100.0
100.0
99.3
100.0
92.7
100.0
100.0

6.9
0.8
0.0
0.0
0.0
0.0
0.0
0.0
2.1

2.1
0.0
0.1
0.0
0.0
1.7
0.0
0.0
4.0
0.0
0.0
1.4
5.9
1.5
2.7
0.5
0.2
0.0
0.0
0.0
0.2
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.2
0.0
0.2
1.6
0.0
1.9
0.1
0.0
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.3
0.0
0.3
0.1
0.1
0.4
0.2
0.0
0.2
0.0
0.0

20.8
17.2
20.1
22.4
13.4
18.1
16.7
16.8
22.6
16.1
22.4
22.6
29.4
24.4
17.4
18.6
16.0
31.0
21.1
22.4
16.8
16.4
11.1

7658
948
1329
285
298
129
4
441
3834
78
312
1180
17
1045
115
1697
11330
111
44
689
9605
1995
6
13
4
4
114
1711
2389
20
7
7
5
6
236
1947
1727
1665
5
1595
92
4
79
5923
68
5726
2478
44
2351
946
17
907
488
3133
34
2916
1862
1262
1796
890
35
834
10
135

97.5
99.9
99.4
99.6
100.0
100.0
100.0
99.8
95.3
100.0
100.0
98.1
100.0
97.9
97.4
98.9
99.5
100.0
100.0
99.6
99.6
99.5
100.0
100.0
100.0
100.0
99.1
99.5
100.0
100.0
100.0
100.0
100.0
100.0
100.0
99.9
99.0
99.8
100.0
99.7
100.0
100.0
100.0
99.0
98.5
98.9
98.7
90.9
98.9
99.8
100.0
99.8
99.8
99.0
91.2
99.0
99.4
99.4
99.3
99.2
100.0
99.2
100.0
98.5

0.2
0.1
0.2
0.4
0.0

11.9
17.3
14.9
29.2
58.3
16.7
50.0
20.0
15.5
16.3
13.8
14.4
22.0
62.5
20.4
21.3
29.3
21.7
18.3
19.6
18.7
13.8
20.0
14.1
19.4
21.3
39.3
22.3
23.0
18.3
19.1
24.1
70.0
23.2
55.6
27.3

*Important. See note on population page.

834

Female
Cases MV(%) DCO(%) UB(%) MI(%)

0.0

0.0
0.0
0.3
0.0
0.0
0.4
0.0
0.5
0.0
0.5
0.2
0.0
0.0
0.0
0.2
0.3
0.0
0.0
0.0
0.0
0.0
0.3
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.6
0.1
0.0
0.1
0.0
0.0
0.0
0.8
0.0
0.9
1.0
9.1
0.9
0.2
0.0
0.2
0.2
0.7
5.9
0.7
0.5
0.2
0.2
0.6
0.0
0.6
0.0
1.5

0.0
0.0
0.0
0.0
0.0

7.1

0.0
4.1
0.0
1.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0

44.8
18.9
20.0

2.2
0.0
0.2
0.0
0.0
0.0
0.0
0.0
4.3
0.0
0.0
1.4
0.0
1.6
2.6
0.4
0.2
0.0
0.0
0.0
0.2
0.2
0.0
0.0
0.0
0.0
0.0
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
0.1
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.2
0.0
0.2
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.1
0.3
0.4
0.2
0.0
0.2
0.0
0.0

14.7
11.9
13.8
21.4
10.4
15.5

17.2
25.0
24.4
26.6
45.8
13.2

10.7
16.1
9.0
13.8
18.6
100.0
19.3
13.9
13.7
12.4
22.5
29.5
12.6
13.3
13.7
66.7
12.3
14.6
11.7
25.0
28.6
33.3
15.3
12.0
11.8
11.4
60.0
11.7
15.2
125.0
10.1
15.1
22.1
15.3
14.9
50.0
14.8
9.6
35.3
9.3
11.3
17.5
38.2
18.2
18.1
11.5
12.8
20.9
37.1
20.7
50.0
20.7

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Melanoma of skin (C43) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

706 93.5
3140 98.9
4579 98.4
36 86.1
4343 98.5
1721 99.7
21 95.2
1679 99.7
1781 96.5
8 62.5
1751 96.6
395 98.2
93718 98.6
462 95.2
89053 98.5
3941 98.9
16 100.0
3863 98.9
824 98.2
8 100.0
44 95.5
771 98.3
5706 96.8
53 96.2
5589 96.8
4566 98.6
25 96.0
4153 98.5
1192 94.2
2108 99.3
5533 99.2
20 100.0
5175 99.2
640 99.8
12579 99.5
58 98.3
12120 99.5
33579 99.4
174 99.4
162 98.8
734 99.2
31093 99.4
1823 98.4
17 94.1
1763 98.5
6036 96.8
25 88.0
5664 96.7
968 99.5
428 98.8
3235 99.3
2168 99.6
855 98.7
2002 97.6
2
45
150
2
2
107
7
59
24
58
4
61
13
0
5
1774
1701
23
18
17
17
48
36
129
23

100.0
86.7
95.3
100.0
100.0
90.7
100.0
100.0
95.8
100.0
100.0
100.0
100.0
0.0
100.0
94.0
95.2
100.0
100.0
64.7
100.0
89.6
88.9
100.0
100.0

0.4
0.7
0.6
11.1
0.6
0.1
0.0
0.1
1.6
12.5
1.5
1.5
0.6
2.6
0.7
0.6
0.0
0.6
0.4
0.0
0.0
0.4
0.6
0.0
0.6
0.7
0.0
0.7
1.6
0.3
0.2
0.0
0.3
0.2
0.2
0.0
0.2
0.3
0.0
0.0
0.4
0.3
0.4
0.0
0.5
1.5
8.0
1.5
0.1
0.5
0.2
0.1
0.7
0.9

5.7
0.4
0.8
0.0
0.9
0.1
0.0
0.1
1.9
12.5
1.9
0.3
0.6
1.1
0.6
0.4
0.0
0.4
0.8
0.0
0.0
0.9
1.5
0.0
1.5
0.6
4.0
0.6
0.7
0.3
0.4
0.0
0.3
0.0
0.2
0.0
0.2
0.2
0.0
0.0
0.0
0.2
1.2
5.9
1.0
1.4
0.0
1.4
0.0
0.7
0.4
0.3
0.2
1.2

17.8
19.5
15.9
30.6
16.5
13.7
33.3
13.6
30.5
62.5
30.8
24.6
19.8
40.7
20.5
19.4
43.8
19.6
15.9
37.5
29.5
14.8
22.7
41.5
22.7
21.1
28.0
23.0
34.1
17.5
21.0
45.0
22.3
13.9
15.4
20.7
15.5
16.7
32.2
32.7
20.4
17.1
17.3
41.2
17.5
24.0
76.0
25.2
17.0
16.8
15.5
16.0
21.1
22.9

0.0
0.0
1.3
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
3.4
2.4
0.0
0.0
17.6
0.0
0.0
0.0
0.0
0.0

50.0
8.9
48.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.5
0.5
0.0
0.0
5.9
0.0
10.4
2.8
0.0
0.0

50.0
42.1
29.7
25.0
11.5
21.7
44.4
58.8
23.5
54.2
25.0
69.0
60.9

Female
Cases MV(%) DCO(%) UB(%) MI(%)
576 94.8
2716 98.9
3804 98.8
29 89.7
3590 98.8
1428 99.4
18 88.9
1392 99.6
1271 97.2
10 100.0
1232 97.2
307 98.4
71525 98.7
545 96.0
67236 98.7
3099 98.1
24 83.3
3023 98.3
583 98.8
3 100.0
72 98.6
504 98.8
4554 96.9
73 97.3
4434 96.9
3779 98.5
23 95.7
3426 98.4
831 95.3
1764 99.6
4297 99.3
17 100.0
3997 99.3
453 99.6
10207 99.5
55 96.4
9791 99.5
26085 99.3
190 98.9
160 95.0
942 99.5
23543 99.4
1392 98.1
35 94.3
1306 98.4
4277 97.4
49 98.0
3921 97.3
781 99.9
361 98.3
2810 99.3
1922 99.4
668 98.5
1591 98.2
1
28
129
4
5
91
7
82
28
44
1
48
3
0
9
1726
1681
16
22
14
28
45
41
87
32

100.0
96.4
96.1
100.0
100.0
85.7
100.0
96.3
96.4
100.0
100.0
100.0
100.0
0.0
100.0
95.0
95.5
100.0
100.0
71.4
92.9
93.3
87.8
100.0
100.0

0.5
0.6
0.7
6.9
0.7
0.1
0.0
0.1
1.2
0.0
1.2
1.0
0.6
2.4
0.6
0.9
8.3
0.9
0.5
0.0
1.4
0.4
0.5
0.0
0.5
0.7
0.0
0.8
1.3
0.2
0.1
0.0
0.1
0.4
0.2
0.0
0.2
0.3
0.5
2.5
0.1
0.3
0.6
2.9
0.5
1.4
2.0
1.5
0.0
0.3
0.3
0.2
0.7
0.6

4.5
0.5
0.3
0.0
0.3
0.1
0.0
0.1
1.5
0.0
1.5
0.7
0.5
0.7
0.5
0.8
8.3
0.7
0.2
0.0
0.0
0.2
1.5
0.0
1.5
0.6
0.0
0.7
0.4
0.2
0.5
0.0
0.4
0.0
0.2
0.0
0.2
0.3
0.0
1.3
0.0
0.3
1.2
2.9
1.1
1.0
0.0
1.0
0.0
0.8
0.4
0.4
0.4
0.9

0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
2.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
3.1
2.7
0.0
0.0
7.1
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
0.2
0.0
0.0
0.0
0.0
6.7
7.3
0.0
0.0

14.2
14.2
10.9
41.4
11.2
9.9
38.9
9.7
25.2
60.0
25.5
16.3
15.2
43.9
15.7
14.3
41.7
14.2
13.2
66.7
12.5
12.9
19.4
32.9
19.3
15.8
52.2
17.0
27.4
11.2
17.7
64.7
18.8
17.9
11.4
45.5
11.4
12.5
22.1
41.9
12.1
12.9
12.9
51.4
12.3
19.0
44.9
20.1
12.4
8.3
10.9
10.7
16.9
15.7
7.1 *
43.4
*
60.0
56.0 *
*
9.1 *
25.0
*
6.3
18.1
9.1
64.3
35.7
44.4
39.0
67.8
50.0

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

*
*
*

777

835

Indices of data quality

Melanoma of skin (C43) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

465
42
37
9
18
23
3
123
11
2
10
9
39
6
16
55
34
26
2
6
27
18
13
32
107

97.2
97.6
94.6
100.0
100.0
100.0
100.0
96.7
90.9
100.0
100.0
88.9
100.0
100.0
93.8
89.1
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
97.2

1.7
2.4
2.7
0.0
0.0
0.0
0.0
3.3
9.1
0.0
0.0
0.0
0.0
0.0
6.3
5.5
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.9

42.6
59.5
21.6
44.4
50.0
30.4

2407
278
135
782
289
958
822
1044
3457
2303
222
1664
375
104
120
258
236
261
373
124
110
89
159
721
1497
629
406
1113
726
336
78
860
76
186
99
441
177
63
449
178
59
772
136
39
104
395
148
56
56
36
399
196
141
568

95.3
100.0
99.3
99.2
100.0
99.9
100.0
97.0
97.6
98.0
98.2
99.7
100.0
100.0
100.0
100.0
100.0
98.9
100.0
100.0
100.0
100.0
100.0
91.3
97.0
90.1
95.1
100.0
97.2
98.2
100.0
99.8
100.0
90.3
100.0
92.5
96.0
98.4
99.6
100.0
100.0
100.0
100.0
97.4
99.0
100.0
95.9
100.0
100.0
100.0
99.0
83.7
97.2
98.4

3.7
0.0
0.7

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
1.0
1.9
0.0
0.2
0.0
0.0
0.0
0.0
0.0
0.4
0.0
0.0
0.0
0.0
0.0
4.6
0.1
0.0
1.2
0.0
0.1
0.0
0.0
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
15.8
0.0
0.0

29.4
18.7
23.0
60.1

0.0
2.8
0.8
0.1
0.9
0.0

0.0
3.3
2.8
2.4
3.7
0.0
1.9
0.9
0.0
0.0
0.0
0.0
0.0
0.2
0.0
1.6
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2

60.0
54.5

12.8

52.9

92.3
25.0
39.3

31.8
41.2
42.0
26.5
24.7
39.6
24.9
16.8
40.4
20.0
13.6
29.2
21.5
18.8
31.5
11.8
25.8
27.7
52.8
18.9
18.1
17.5
18.8
14.6
22.0
20.5
19.7
21.1
23.1
19.2
24.3
26.0
17.5
27.5
35.3
25.5
27.2
38.5
25.0
21.0
27.7
37.5
28.6
27.8
19.8
36.2
29.8
20.8

*Important. See note on population page.

836

778

Female
Cases MV(%) DCO(%) UB(%) MI(%)
490
38
22
26
19
27
3
124
13
4
3
9
16
6
6
47
35
32
0
3
16
7
13
47
86

96.3
100.0
100.0
92.3
94.7
100.0
100.0
95.2
92.3
100.0
100.0
88.9
93.8
100.0
100.0
93.6
100.0
100.0
0.0
100.0
100.0
100.0
100.0
100.0
97.7

2.9
0.0
0.0
3.8
0.0
0.0
0.0
4.8
7.7
0.0
0.0
0.0
0.0
0.0
0.0
4.3
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

2570
284
159
1422
371
1543
790
1034
3586
2811
400
1626
432
165
180
304
252
323
505
205
124
114
227
759
1564
739
506
1078
930
334
153
1397
83
183
129
500
189
79
441
166
57
947
126
53
127
353
154
56
56
72
425
209
158
638

95.1
98.9
96.9
99.5
100.0
99.9
99.9
95.8
97.6
98.0
99.0
99.8
99.8
100.0
100.0
99.3
100.0
98.8
100.0
99.5
96.8
100.0
99.6
91.2
97.0
93.5
97.2
100.0
94.8
98.8
100.0
99.8
100.0
91.3
100.0
94.2
93.7
100.0
100.0
100.0
96.5
99.6
100.0
98.1
100.0
98.6
98.7
100.0
96.4
97.2
100.0
85.2
95.6
98.4

3.9
0.7
3.1

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.3
0.8
1.9
0.0
0.1
0.2
0.0
0.0
0.7
0.0
1.2
0.0
0.5
1.6
0.0
0.0
4.9
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
14.4
0.0
0.0

0.1
3.9
0.9
0.1
0.3
0.2

0.0
3.8
2.7
2.2
2.8
0.0
2.2
1.2
0.0
0.0
0.0
0.0
0.0
0.0
1.6
0.0
0.0
0.0
1.8
0.0
0.0
1.9
0.0
0.8
0.6
0.0
0.0
0.0
0.0
0.0
0.0
0.3

36.1
42.1
22.7
26.9
26.3
29.6
100.0
34.3
23.1

62.9

*
*
*

*
*

30.8
17.0 *
40.7 *

26.0
15.8
10.7
31.6 *
*
20.2
35.9 *
32.2
20.7
17.5
30.0
19.4
11.6
25.5
16.1
15.1
19.8
16.1
14.1
17.1
19.4
22.8
13.2
48.0
13.6
17.1
14.6
16.0
10.1
18.9
11.1
14.4
13.3
15.3
16.3
16.8
23.8
8.9

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

22.9
21.9
18.8
26.2
35.8
23.6
15.6
19.5
30.4
16.1
12.2
17.6
24.4
29.1
16.5

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Melanoma of skin (C43) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

238
385
72
2305
137
151
259
259
367
523
642
1006
595
55
152
308
181
31
114
112
239
143
113
129
4232
269
97
104
230
148
110
371
5348
327
285
882
580
988
1570
892
2772
2977
1064
1303
395
1471

95.4
100.0
100.0
99.7
97.1
96.7
95.4
100.0
98.9
95.4
91.3
96.9
100.0
90.9
95.4
99.7
99.4
93.5
100.0
100.0
99.2
97.9
98.2
99.2
100.0
100.0
100.0
100.0
100.0
98.6
100.0
99.5
100.0
100.0
100.0
99.3
97.2
97.9
99.2
99.7
93.7
94.6
95.8
99.1
98.7
99.3

8624
127
6504
1658
498
4434
2658
294
15
4284
564
1
7
13
22
483

99.0
99.2
99.2
99.2
100.0
99.9
99.5
100.0
93.3
99.7
99.8
100.0
100.0
100.0
100.0
99.8

2.1
0.0
0.0
0.0
2.2
2.6
0.4

59.2
39.5
20.8
28.1
35.6
38.9
37.8
36.7
36.2
49.9
46.1
40.3
32.8
18.2
45.0
22.4
25.6
48.4
22.8
28.6
24.7
28.0
25.7
36.4
25.9
15.6
20.6
14.4
19.1
23.6
12.7
15.9
26.5

0.0
0.5
0.5
0.1
0.0
0.2
3.1
2.4
0.2
0.3
0.1

0.0
0.0
0.0
0.0
0.0
0.0
0.8
0.0
0.0
1.1
0.0
1.3
0.0
5.5
2.0
0.3
0.6
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.3
0.7
0.4
0.1
0.2
1.5
1.2
0.8
0.0
0.0
0.0

0.1
0.0
0.1
0.0
0.0
0.0
0.4
0.0
6.7
0.2
0.2
0.0
0.0
0.0
0.0
0.2

0.0
0.0
0.0
0.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

14.7
12.6
11.0
13.9
15.9
14.6
10.7
12.9
33.3
17.4
10.1

0.0
6.4
1.7
0.0
3.6
2.0
0.0
0.0
3.2
0.0
0.0
0.0
0.7
0.9
0.8
0.0
0.0
0.0
0.0
1.4
0.0
0.5

22.5
25.5
25.2
25.5
25.9
21.5
26.5
34.5
27.5
27.9
20.3
23.6

8.5

Female
Cases MV(%) DCO(%) UB(%) MI(%)
464
728
70
2472
166
190
341
412
550
1055
663
1191
686
57
272
447
242
28
142
147
276
149
146
148
4267
293
109
97
247
176
157
448
7164
430
386
1020
831
1364
2153
1212
3267
3802
1345
1608
607
1954

97.0
100.0
98.6
99.8
99.4
98.9
97.7
100.0
99.3
95.5
91.6
97.8
100.0
100.0
98.9
99.8
97.9
96.4
99.3
99.3
99.3
98.7
97.9
97.3
100.0
100.0
100.0
100.0
100.0
99.4
99.4
99.6
100.0
99.8
100.0
98.4
97.6
98.5
99.5
99.1
91.8
94.8
97.8
99.1
98.7
99.6

6068
100
4821
1427
518
3977
1927
254
20
4140
356
4
6
10
19
278

99.0
100.0
99.0
99.8
100.0
99.9
99.8
98.8
100.0
99.6
99.7
100.0
100.0
100.0
100.0
99.6

1.3
0.0
0.0
0.0
0.6
0.5
0.6

44.2
34.5
20.0
16.3
42.9 *
40.1
34.3
20.9 *
19.5
34.2
36.3
32.5
24.1
14.0
23.3
18.1
14.5
32.1
21.8
17.0
13.4
20.1
16.4
23.6
17.6
6.8
17.4
9.3
11.7
10.8
14.0
9.8
15.2

0.0
0.4
0.1
0.2
0.2
0.4
2.8
1.2
0.5
0.0
0.1

0.2
0.0
0.0
0.0
0.0
0.5
0.6
0.0
0.0
1.1
0.0
1.3
0.0
0.0
0.0
0.0
0.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.1
0.2
0.1
0.0
0.5
1.2
1.2
0.1
0.0
0.0
0.1

0.2
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.2
0.3
0.0
0.0
0.0
0.0
0.4

0.0
0.0
0.0
0.2
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

10.6
7.0
7.6
8.8
7.7
10.6
8.7
6.7

0.0
6.6
0.8
0.0
0.0
0.4
0.2
1.2
3.6
0.7
0.0
0.7
1.3
2.1
2.7
0.0
0.0
0.0
0.0
0.6
0.0
0.4

13.2
20.6
17.7
18.7
18.3
15.1
19.9
26.2
21.1
21.1
14.3
16.4

11.1
8.7

7.2

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

779

837

Indices of data quality

Breast (C50)
Male
Cases MV(%) DCO(%) UB(%) MI(%)
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

12 100.0
31 93.5
8 100.0
15 53.3
9 100.0

6.5
0.0

16
13
1
10
211
1
11
28
9
10
1

93.8
84.6
100.0
100.0
83.4
100.0
90.9
89.3
100.0
90.0
100.0

0.0
0.0
0.0
0.0
3.8
0.0
9.1
3.6
0.0

541
50
93
31
16
15
0
27
279
5
25
206
41
161
9
237
710
42
67
64
526
150
16
4
5
2
8
107
196
31
2
4
0
3
21
132
75
134
8
124
41
18
22
598
56
534
166
50
115
60
27
32
49
367
58
298
157
65
92
158
56
100
23
23

97.0
96.0
100.0
100.0
100.0
100.0
0.0
100.0
95.0
100.0
100.0
96.1
97.6
95.7
100.0
96.6
99.0
100.0
98.5
98.4
99.0
98.7
100.0
100.0
100.0
100.0
87.5
99.1
100.0
100.0
100.0
100.0
0.0
100.0
100.0
100.0
97.3
100.0
100.0
100.0
100.0
100.0
100.0
98.0
96.4
98.1
98.2
100.0
97.4
100.0
100.0
100.0
95.9
98.1
98.3
98.0
96.2
98.5
95.7
97.5
98.2
97.0
95.7
91.3

0.6
0.0
0.0
0.0
0.0

0.0

0.0
0.0
1.1
0.0
0.0
1.5
0.0
1.9
0.0
1.3
0.4
0.0
1.5
0.0
0.4
0.7
0.0
0.0
0.0
0.0
0.0
0.9
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.3
0.0
0.0
0.0
0.0
0.0
0.0
1.5
3.6
1.3
0.6
0.0
0.9
0.0
0.0
0.0
4.1
1.6
1.7
1.7
1.3
1.5
1.1
1.3
0.0
2.0
0.0
8.7

0.0
0.0
0.0
0.0
0.0

19.4

0.0
15.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
10.0
0.0

162.5
7.7

1.8
0.0
0.0
0.0
0.0
0.0
0.0
0.0
3.6
0.0
0.0
1.5
2.4
1.2
0.0
0.8
0.3
0.0
0.0
1.6
0.2
0.7
0.0
0.0
0.0
0.0
12.5
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.3
0.0
0.4
0.6
0.0
0.9
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.6
0.0
1.1
0.6
1.8
0.0
4.3
0.0

27.2
40.0
20.4
19.4
50.0
13.3

20.0
12.3
100.0
54.5
64.3
22.2
12.5

25.9
28.3
24.0
17.0
24.4
15.5
11.1
17.3
24.1
21.4
23.9
28.1
24.3
16.7
31.3
50.0
11.2
28.1
22.6
75.0
33.3
28.8
16.0
20.9
37.5
20.2
4.9
11.1
20.7
28.6
20.2
24.1
16.0
27.8
11.7
11.1
12.5
10.2
28.6
50.0
25.2
43.9
21.5
32.6
24.1
28.6
22.0
26.1
8.7

*Important. See note on population page.

838

780

Female
Cases MV(%) DCO(%) UB(%) MI(%)
414
2426
308
332
330

92.5
94.7
98.4
68.4
73.6

844
2023
423
1046
22598
300
2139
2971
966
730
332

91.0
88.7
87.5
97.2
82.2
95.3
92.9
93.0
91.4
98.9
99.1

5.0
3.1
6.6
2.0
4.6
2.7
2.2
2.5
3.9

69765 96.6
7942 98.6
12036 98.3
3532 98.0
2309 98.4
1418 99.6
69 100.0
3165 97.3
35883 95.0
438 97.9
2973 97.7
14411 97.6
2772 97.2
11396 97.7
1578 98.4
15932 98.2
103024 98.7
8465 99.4
5850 98.9
12858 99.3
74632 98.5
21604 98.8
1265 98.7
1061 99.5
727 99.6
317 99.4
1869 99.2
15257 98.6
26058 99.0
2796 98.9
654 99.4
958 99.6
509 99.0
289 99.7
4837 99.4
15293 98.8
13519 98.2
13411 98.6
791 99.0
12386 98.6
2156 97.0
1299 96.7
754 97.9
62279 98.2
4975 97.5
56396 98.3
24156 97.6
5235 96.9
18594 97.8
8107 98.8
2159 98.3
5757 99.0
4044 98.0
42991 97.7
5240 96.9
36402 97.7
20631 98.1
10645 98.1
13794 97.6
14040 98.0
3757 97.3
10202 98.3
1199 97.0
2240 97.9

0.6
0.1
0.6
1.2
0.0

4.5
12.1

0.6

0.0
0.8
0.7
0.0
1.0
0.6
0.6
0.6
0.0
0.7
0.6
0.2
0.4
0.4
0.7
0.7
0.6
0.2
0.3
0.3
0.5
0.9
0.4
0.3
0.2
0.1
0.4
0.0
0.3
0.6
0.7
0.7
0.6
0.7
1.2
1.3
1.1
1.2
1.6
1.2
1.7
2.0
1.6
0.7
0.8
0.7
1.2
1.4
2.1
1.3
1.0
0.7
0.7
0.7
0.9
0.6
1.3
0.9

0.0
0.0
0.0
0.3
0.0

13.6

3.1
8.2
1.4
0.2
0.0
0.0
0.0
0.0
0.0
0.7
0.0

41.7
20.0
19.4
22.3
22.8
32.0
33.7
31.8
32.3
25.3

2.1
0.1
0.0
0.0
0.0
0.1
0.0
0.3
4.1
0.0
0.0
1.3
1.6
1.2
1.1
0.5
0.2
0.2
0.2
0.1
0.3
0.2
0.2
0.2
0.1
0.3
0.2
0.1
0.2
0.3
0.2
0.1
0.0
0.0
0.0
0.2
0.4
0.1
0.0
0.1
1.1
0.9
0.9
0.1
0.2
0.1
0.2
0.3
0.2
0.2
0.4
0.1
0.1
0.2
0.3
0.2
0.3
0.1
0.7
0.3
0.3
0.4
0.4
0.3

25.7
23.9
24.3
27.5
27.2
31.7
17.4
28.3
25.8
29.0
26.1
23.8
32.6
22.1
15.5
21.2
20.1
16.1
29.4
17.6
20.6
19.1
31.1
15.1
19.7
20.8
29.1
19.4
16.0
16.7
15.9
19.4
20.7
17.6
21.1
26.9
21.0
27.2
33.8
18.4
21.0
30.5
20.4
21.1
28.7
19.2
20.2
27.0
18.1
20.3
22.7
31.1
22.1
22.4
22.6
22.5
25.1
32.3
22.4
33.4
23.1

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Breast (C50) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

63
184
310
42
262
120
29
90
134
21
111
20
6798
760
5823
266
30
228
33
0
5
28
728
79
622
317
35
269
76
82
477
45
421
26
653
83
539
1787
67
229
85
1390
147
42
103
692
65
617
34
25
125
88
46
197

95.2
98.9
97.1
100.0
96.9
100.0
100.0
100.0
98.5
100.0
98.2
90.0
97.4
97.4
97.3
98.1
100.0
97.8
90.9
0.0
100.0
89.3
96.2
94.9
96.5
98.7
97.1
98.9
93.4
95.1
97.9
93.3
98.3
92.3
99.4
100.0
99.3
98.7
100.0
99.1
98.8
98.5
97.3
95.2
98.1
96.5
93.8
96.9
100.0
100.0
99.2
100.0
95.7
93.9

0.0
0.5
1.3
0.0
1.5
0.0
0.0
0.0
0.0
0.0
0.0
10.0
1.2
1.3
1.2
0.8
0.0
0.9
9.1
0.0
0.0
10.7
1.0
1.3
1.0
0.9
2.9
0.7
0.0
3.7
0.6
2.2
0.5
3.8
0.6
0.0
0.7
0.7
0.0
0.4
0.0
0.8
0.7
0.0
1.0
1.7
4.6
1.5
0.0
0.0
0.8
0.0
4.3
3.0

1
9
69
1
3
106
13
16
43
133
2
93
64
62
8
191
181
6
13
8
5
22
18
72
15

100.0
77.8
100.0
100.0
100.0
87.7
100.0
100.0
79.1
75.2
100.0
89.2
93.8
80.6
100.0
85.9
87.8
83.3
100.0
87.5
100.0
95.5
88.9
88.9
80.0

0.0
0.0
0.0
0.0
0.0
1.9
0.0
7.0
4.5
0.0
2.2
0.0
1.6
0.0
4.7
4.4
16.7
0.0
12.5
0.0
4.5
5.6
2.8
13.3

4.8
0.5
1.6
0.0
1.5
0.0
0.0
0.0
0.7
0.0
0.9
0.0
0.9
0.7
0.9
0.8
0.0
0.9
0.0
0.0
0.0
0.0
1.8
0.0
1.9
0.3
0.0
0.4
1.3
1.2
1.3
2.2
1.2
0.0
0.0
0.0
0.0
0.3
0.0
0.4
1.2
0.3
0.7
0.0
1.0
1.0
1.5
0.8
0.0
0.0
0.0
0.0
0.0
1.5

Female
Cases MV(%) DCO(%) UB(%) MI(%)

14.3
18.5
23.5
33.3
22.5
32.5
48.3
27.8
25.4
28.6
23.4
45.0
22.9
29.6
22.6
30.1
33.3
30.3
30.3
1.0
40.0
21.4
25.8
31.6
26.2
28.4
37.1
28.6
27.6
24.4
22.2
26.7
22.3
19.2
21.4
31.3
20.4
25.2
17.9
29.3
31.8
24.7
19.7
28.6
16.5
13.3
27.7
12.0
23.5
24.0
29.6
21.6
28.3
19.8

5015
25386
34337
3770
29961
13845
2801
10870
19564
1685
17697
3222
764169
66900
668489
31011
3104
26794
5242
160
1327
3650
67708
7618
58020
40806
3548
36041
12184
13397
49083
3566
44441
4034
89413
7442
75089
237378
13427
19968
17512
184010
13371
2974
10251
56843
5499
49755
4884
2325
22098
14728
6593
19401

97.4
97.8
97.6
97.7
97.6
98.5
98.3
98.5
97.8
97.7
97.8
96.9
97.9
97.3
97.9
98.1
97.4
98.1
97.9
98.1
98.6
97.7
97.3
97.3
97.2
97.2
96.3
97.3
93.4
98.4
98.4
98.0
98.5
97.7
98.7
98.3
98.6
98.5
99.4
98.1
99.1
98.4
97.8
97.7
97.8
96.9
95.8
97.1
99.1
98.2
98.8
99.0
97.8
96.7

1.5
1.0
0.9
0.7
0.9
0.7
0.5
0.7
1.1
1.4
1.0
2.1
1.0
1.3
1.0
0.8
0.9
0.8
1.1
0.6
0.8
1.2
0.8
0.8
0.8
1.9
2.7
1.9
1.5
0.8
0.6
0.7
0.6
1.5
0.6
0.7
0.6
0.6
0.2
0.7
0.4
0.7
0.9
0.9
1.0
1.5
2.2
1.5
0.1
0.9
0.5
0.3
0.8
1.4

0.5
0.7
0.8
0.8
0.8
0.2
0.3
0.2
0.7
0.5
0.7
0.2
0.5
0.6
0.5
0.4
0.5
0.4
0.3
1.3
0.2
0.3
0.8
0.9
0.9
0.5
0.7
0.5
0.4
0.3
0.3
0.4
0.3
0.1
0.2
0.3
0.2
0.3
0.1
0.3
0.2
0.3
0.9
0.9
0.9
1.0
1.2
0.9
0.0
0.2
0.2
0.2
0.3
1.0

19.9
20.9
21.8
30.1
20.9
23.9
31.2
22.1
22.9
30.6
22.3
20.0
21.6
30.9
21.2
24.1
30.1
23.9
20.6
23.1
22.7
19.4
22.9
31.3
22.2
23.7
32.6
23.6
21.5
18.9
23.5
33.0
23.2
22.2
20.5
29.5
20.2
21.3
15.6
30.0
17.3
21.4
22.8
33.0
20.0
21.7
32.3
21.0
20.9
20.4
17.0
17.4
23.5
21.0

0.0 100.0
0.0
11.1
0.0
13.0
0.0
0.0 1033.3
0.0
13.2
0.0
0.0
31.3
0.0
32.6
0.0
0.0
50.0
0.0
31.2
0.0
0.0
0.0
3.7
41.9
2.8
0.0
0.0
23.1
0.0
37.5
0.0
20.0
0.0
18.2
0.0
22.2
0.0
25.0
0.0
40.0

340
1903
9411
199
703
8508
561
1444
2487
5839
149
5792
1133
1598
746
16409
15456
686
1309
1102
1774
3966
2481
11103
1882

95.9
85.4
97.3
99.5
89.2
91.4
99.5
98.7
80.1
83.7
95.3
85.9
98.1
87.4
98.5
92.9
94.0
95.2
93.1
94.6
97.1
93.0
96.6
90.1
94.6

2.9
0.0
0.2
0.0
0.7
0.2
0.0

0.9
0.1
0.0
0.0
1.0
0.0
0.0
0.6
0.4
0.0
0.0
0.0
0.0
0.0
0.3
1.7
1.3
1.2
1.6
0.6
0.0
0.0
0.2
0.0
0.3

32.9
26.1 *
21.1
*
21.5
21.5 *
*
11.3 *
26.8
*
5.4
24.1
*
*
*
27.9

1.6
1.1
0.0
4.8
0.0
4.3
0.4
0.9
0.8
0.4
5.3
1.6
1.0
2.7
1.2
2.5
2.1

22.4
23.4
19.6
21.4
22.7
30.5
23.5

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

781

839

Indices of data quality

Breast (C50) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

201
15
11
4
4
13
0
76
4
6
12
8
6
15
24
83
22
18
2
2
13
3
6
16
68

84.6
80.0
90.9
100.0
75.0
100.0
0.0
48.7
75.0
100.0
100.0
100.0
100.0
93.3
100.0
65.1
95.5
94.4
100.0
100.0
100.0
100.0
100.0
93.8
97.1

12.4
13.3
9.1
0.0
25.0
0.0
0.0
48.7
25.0
0.0
0.0
0.0
0.0
0.0
0.0
12.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

218
16
9
108
63
207
163
163
213
131
23
73
20
25
12
13
30
35
31
13
20
9
27
48
120
59
33
54
77
29
7
63
8
26
13
49
28
7
65
25
4
71
15
6
18
36
23
10
8
5
37
25
28
48

95.0
100.0
100.0
95.4
100.0
89.9
78.5
63.8
88.7
97.7
87.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
96.8
100.0
100.0
100.0
100.0
89.6
93.3
72.9
84.8
88.9
84.4
96.6
100.0
92.1
100.0
92.3
100.0
98.0
92.9
100.0
90.8
100.0
100.0
97.2
100.0
100.0
100.0
94.4
73.9
100.0
100.0
100.0
97.3
92.0
100.0
95.8

4.6
0.0
0.0

4.9
5.5
5.6
0.0
0.0
0.0

0.0
10.4
5.8
10.2
15.2
7.4
9.1
3.4
0.0
3.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
30.8
0.0
20.0
0.0
18.2
0.0
25.0
0.0
50.0
0.0
30.8
0.0
1.5
0.0
29.6
0.0
25.0
0.0
0.0
0.0
62.5
0.0
0.0
0.0
0.0
0.0
50.0
0.0
0.0
0.0
0.0
15.4
0.0 233.3
0.0 2333.3
0.0
1.5
35.3
0.0
0.0
0.0
0.0
0.0
9.2
0.0
30.7
2.8
2.3
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.8
0.0
0.0
0.0
0.0
0.0
0.0
1.6
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
8.0
0.0
0.0

34.9
18.8
64.8
27.1
35.6
50.9
44.6
36.6
47.8
21.9
55.0
28.0
41.7
69.2
53.3
34.3
41.9
76.9
40.0
55.6
40.7
70.8
19.2
52.5
21.2
57.4
77.9
37.9
57.1
33.3
25.0
15.4
7.7
10.2
17.9
20.0
28.0
36.6
6.7
50.0
22.2
16.7
26.1
30.0
50.0
25.0
18.9
44.0
14.3
39.6

*Important. See note on population page.

840

782

Female
Cases MV(%) DCO(%) UB(%) MI(%)
26441
2540
1857
968
803
1756
163
8501
491
551
519
1055
845
265
1497
5148
5335
4553
270
512
959
538
593
940
3071

95.8
95.6
97.5
97.1
93.8
96.1
92.6
95.4
97.6
97.1
97.3
94.3
93.3
97.0
97.3
86.4
99.1
99.1
99.6
99.0
96.5
89.6
94.6
92.0
96.8

1.3
1.3
0.8
1.0
1.0
1.1
1.2
1.8
0.4
2.2
2.5
1.1
3.4
0.0
0.0
5.5
0.0
0.0
0.0
0.0
0.1
1.9
3.0
1.1
0.0

0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.4
0.0
0.0
0.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
3.3
1.2

4.5 *
34.2 *
17.0
14.8 *
17.3 *

23551
1905
998
14046
6288
19351
16212
10984
24587
18687
2828
17864
3610
2268
1513
2547
3514
3675
4278
1599
1825
1212
1929
7317
13711
6113
5075
8997
8671
3965
756
9637
800
2622
1833
4932
2598
575
5368
2808
1058
8570
1840
748
1995
4313
1971
1415
831
667
4074
3155
2088
6894

95.3
97.5
93.8
95.3
99.0
94.6
84.4
78.1
90.6
96.6
95.0
99.1
98.9
98.7
99.3
98.7
98.9
98.9
99.7
98.7
98.0
98.6
98.7
91.5
94.2
87.6
92.7
93.0
90.6
97.0
99.7
96.2
93.8
92.1
96.9
95.2
91.8
95.8
95.0
99.3
91.9
97.0
98.4
94.4
96.7
96.4
82.3
96.7
95.3
96.9
96.4
93.0
95.0
96.7

3.9
1.3
4.7

0.1
0.0
0.6
0.0
0.0
4.6
0.1
17.8
2.6
1.6
0.0
0.1
0.0
0.0
0.1
0.4
0.0
0.2
0.0
0.0
0.3
0.0
0.9
1.3
0.1
0.0
0.0
0.0
0.5
0.0
0.0
0.4
1.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.7
0.0
0.0
0.0
0.3
1.2
0.0
0.1
5.3
0.0
0.0

34.2
30.1
26.9
42.7 *
*
28.9
34.1 *
37.6
39.1
36.1
45.0
22.9
21.7
27.2
28.7
23.4
24.3
22.5
25.6
31.7
30.9
27.3
29.5
72.4
24.8
34.9
22.9
29.3
33.5
35.3
23.0
33.1
30.9
22.0
26.7
25.7
29.2
33.4
29.6
24.0
27.8
30.0
26.8
32.5
26.2
24.6
30.1
29.3
26.0
24.6
29.0
28.1
23.3
26.0

4.2
4.1
2.6
0.2
0.2
0.2

0.1
5.8
4.3
5.0
6.3
4.2
4.0
1.8
0.1
1.5
1.4
1.6
0.5
0.6
1.3
1.0
1.2
0.0
1.0
0.3
0.3
2.1
0.1
0.6
0.7
1.1
0.8
0.1
0.8
0.3
0.3
0.8

18.4
21.0
15.5
16.1
19.9
18.9
23.0
16.2
14.9
20.4
13.6

25.5

*
*
*

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Breast (C50) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

32
60
11
79
16
17
24
78
67
72
230
88
42
4
29
49
27
4
9
16
24
15
11
18
163
11
5
6
10
9
6
19
358
19
21
58
61
81
156
60
245
320
107
154
37
77

87.5
96.7
100.0
100.0
75.0
76.5
91.7
97.4
100.0
86.1
88.7
89.8
97.6
75.0
100.0
98.0
96.3
100.0
100.0
100.0
100.0
100.0
90.9
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
90.2
90.1
94.9
95.0
75.1
90.9
84.1
95.5
89.2
98.7

3.1
0.0
0.0
0.0
12.5
0.0
0.0

0.0
3.3
1.2
0.6
0.0
0.8
3.8
9.3
1.9
0.0
0.0

0.0
0.0
0.0
0.0
0.0
5.9
0.0
0.0
0.0
2.8
0.0
0.0
0.0
0.0
0.0
0.0
3.7
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.2
0.0
5.0
5.3
1.9
0.9
0.0
0.0
0.0

160
3
75
37
6
15
33
7
3
74
25
3
0
5
4
12

97.5
100.0
94.7
100.0
100.0
100.0
100.0
100.0
66.7
95.9
100.0
100.0
0.0
100.0
100.0
100.0

0.0
0.0
1.3
0.0
0.0
0.0
0.0
0.0
33.3
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
3.9
8.0
2.4
25.0
0.0
2.0
0.0
0.0
0.0
0.0
0.0
0.0
9.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

50.0
46.7
27.3
25.3
39.1
44.1
66.7
55.2
59.7
31.3
64.8
52.4
75.0
17.2
32.7
50.9
33.3
37.5
29.2
26.7
72.7
38.9
34.4
27.3
16.7
22.2
66.7
42.1
38.8
28.6
31.0
27.9
34.6
28.2
30.0
20.0
29.1
45.8
33.8
13.5
39.0
23.8
16.0
24.3
55.6
226.7
15.2
28.6
66.7
20.3
16.0

16.7

Female
Cases MV(%) DCO(%) UB(%) MI(%)
4645
6192
1027
12521
1840
2083
4068
5924
7428
10556
10774
9223
4910
517
2675
4454
2998
389
1460
1651
2282
1447
1232
1998
29643
1759
675
653
1395
1130
975
2547
56440
3486
3193
9817
8126
13745
21597
8802
27384
44467
16611
17740
4688
17137

91.4
92.3
96.1
98.4
92.7
90.1
95.4
98.7
90.6
82.0
88.5
92.0
98.0
97.9
95.7
97.0
97.2
92.8
97.0
98.4
95.4
98.5
95.8
96.3
99.8
97.8
97.3
98.3
97.9
98.3
99.3
98.8
99.4
99.6
99.1
95.8
92.8
93.1
89.8
95.1
87.2
89.2
91.6
96.1
96.4
96.4

2.6
0.7
1.0
0.3
1.8
2.0
0.2

44.8
43.6
38.8
29.4
34.0 *
38.0
33.7
29.9 *
33.0
53.5
37.1
42.4
39.5
35.2
35.0
29.3
30.6
28.3
29.7
25.5
31.7
24.7
29.2
34.8
25.4
19.2
33.2
28.6
32.3
30.0
23.0
18.8
31.1

0.1
2.0
0.9
0.8
0.6
0.9
4.4
4.0
1.0
0.7
0.3

0.1
0.0
0.0
0.0
0.0
2.4
0.3
0.1
0.0
2.1
0.2
0.2
0.6
0.2
0.9
0.4
0.5
0.5
0.3
0.0
0.4
0.0
0.1
0.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.5
0.3
0.9
0.0
3.0
4.0
2.5
0.8
0.0
0.0
0.3

19216 97.9
277 98.9
10449 97.9
4952 98.3
1405 98.9
14383 96.9
5228 98.6
906 97.9
339 92.6
11339 97.3
4078 99.5
241 100.0
433 100.0
667 99.3
1311 99.9
1184 98.9

0.5
0.4
0.6
0.0
0.1
1.2
0.7
0.1
4.1
1.0
0.1
0.0
0.0
0.3
0.0
0.3

0.0
0.0
0.1
0.2
0.0
0.8
0.0
0.0
0.6
0.1
0.1
0.0
0.0
0.1
0.0
0.3

22.1
23.8
20.7
24.2
25.1
24.0
21.2
22.3
28.3
27.7
15.7

8.0
4.7
5.1
1.4
1.0
1.9
1.7
1.5
4.4
1.9
0.4
2.1
0.8
2.6
1.5
0.2
0.0
0.3
0.9
1.0
0.0
0.8

28.8
31.7
32.9
32.8
31.6
31.7
33.0
33.5
31.9
32.8
31.2
32.9

17.5

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

783

841

Indices of data quality

Cervix uteri (C53)


Male
Cases MV(%) DCO(%) UB(%) MI(%)
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
*Important. See note on population page.

842

784

Female
Cases MV(%) DCO(%) UB(%) MI(%)
229 95.2
109 98.2
72 100.0
649 59.2
818 72.5

0.9
7.0

139
1154
302
711
6028
216
1314
1655
637
220
498

95.0
91.2
89.1
98.5
85.6
92.6
93.8
89.2
93.4
92.3
96.2

2.9
2.2
5.6
1.1
4.1
2.3
2.1
3.3
3.9

5389
797
828
267
191
138
6
295
2623
30
214
1157
391
723
119
965
8109
909
532
2990
3524
1263
112
59
61
13
295
581
2769
262
64
91
23
69
1404
740
799
700
82
600
194
151
23
4771
854
3794
2098
662
1371
647
247
353
216
3401
775
2492
1410
651
1245
1244
513
711
151
126

96.3
99.0
98.6
99.3
99.5
98.6
100.0
99.0
93.4
100.0
99.1
96.1
94.9
97.2
97.5
96.8
98.8
99.0
99.4
99.2
98.2
99.3
100.0
98.3
98.4
100.0
99.7
99.1
99.3
98.9
100.0
100.0
95.7
98.6
99.5
99.2
97.4
98.6
97.6
98.7
94.3
98.7
91.3
97.9
97.3
98.0
97.5
97.9
97.4
98.8
98.8
99.2
96.8
97.3
97.2
97.2
97.8
98.5
96.3
98.6
98.6
98.5
97.4
99.2

0.3
0.0
0.4
0.4
0.0

2.6

0.0
0.7
0.4
0.0
0.5
0.7
1.3
0.4
0.0
0.7
0.3
0.3
0.2
0.2
0.5
0.2
0.0
0.0
0.0
0.0
0.3
0.2
0.3
0.4
0.0
0.0
4.3
1.4
0.1
0.5
1.1
0.7
1.2
0.7
1.5
1.3
4.3
1.6
2.1
1.5
1.7
1.5
1.8
0.6
0.8
0.3
3.2
1.5
1.5
1.6
1.0
1.1
1.2
0.4
0.4
0.4
0.7
0.8

0.0
0.0
0.0
0.0
0.0

22.9

2.2
6.3
2.6
0.1
0.0
0.0
0.0
0.0
0.0
1.8
0.0

26.6
15.5
17.5
20.1
24.9
44.0
34.1
39.5
31.2
26.7

2.8
0.0
0.0
0.0
0.0
0.0
0.0
0.0
5.7
0.0
0.0
2.1
2.6
1.2
1.7
1.9
0.5
0.4
0.0
0.2
0.7
0.3
0.0
1.7
1.6
0.0
0.0
0.2
0.2
0.0
0.0
0.0
0.0
0.0
0.3
0.0
0.6
0.6
1.2
0.5
4.1
0.0
4.3
0.2
0.5
0.2
0.4
0.3
0.5
0.3
0.4
0.3
0.0
0.7
0.9
0.6
0.8
0.2
1.3
0.5
0.2
0.7
0.7
0.0

29.4
24.1
27.1
31.5
28.3
44.2
34.9
29.7
30.0
35.5
34.7
43.0
32.0
21.0
33.6
28.0
29.4
44.0
20.5
32.5
24.6
40.2
14.6
26.5
28.5
51.1
43.8
27.5
34.8
15.9
21.4
35.5
25.2
26.7
30.5
26.7
33.5
35.8
39.1
30.4
39.5
29.0
28.7
33.8
27.0
24.3
26.3
23.8
33.8
30.6
35.7
29.8
31.4
30.4
28.2
29.7
35.7
25.7
37.1
18.3

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Cervix uteri (C53) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Female
Cases MV(%) DCO(%) UB(%) MI(%)
278
1224
2193
425
1690
1013
337
645
1390
216
1146
206
55469
8693
43436
2339
466
1759
394
27
150
201
4976
1199
3533
2569
302
2191
919
719
3020
415
2487
215
5553
826
4075
17731
1395
2360
3732
9923
1113
399
688
5333
712
4439
311
153
1102
734
591
1247

98.2
98.6
97.3
97.6
97.0
97.9
97.9
97.8
97.8
97.7
97.7
95.1
97.4
97.1
97.4
97.4
96.8
97.5
94.9
88.9
95.3
95.0
96.6
96.5
96.6
96.8
94.0
97.1
93.6
98.6
98.1
96.9
98.4
99.5
98.3
98.4
98.3
98.3
99.1
98.2
98.7
98.0
97.8
97.7
97.8
95.3
95.5
95.3
99.0
97.4
98.3
98.4
97.8
97.1

0.0
0.6
0.5
0.5
0.5
0.5
0.6
0.5
1.1
0.9
1.1
3.4
1.1
1.2
1.1
0.7
0.2
0.9
1.5
0.0
1.3
2.0
0.7
1.1
0.6
2.0
4.6
1.7
1.3
0.3
0.5
0.2
0.6
0.0
0.6
0.7
0.7
0.5
0.3
0.6
0.3
0.7
1.2
1.0
1.2
2.2
2.1
2.2
0.3
2.6
0.7
0.7
1.4
1.8

1.1
0.7
1.6
1.2
1.7
0.8
0.6
0.9
0.7
0.9
0.7
1.0
0.9
1.0
0.9
1.5
3.0
1.1
1.3
11.1
0.7
0.5
1.3
1.3
1.4
0.8
0.7
0.8
1.3
0.3
0.6
1.4
0.4
0.0
0.5
0.5
0.4
0.7
0.4
0.9
0.5
0.7
0.8
0.5
1.0
2.3
2.2
2.2
0.0
0.0
0.5
0.4
0.2
0.8

38 100.0
298 88.9
2251 97.4
33 100.0
86 89.5
722 87.1
133 100.0
101 97.0
2550 88.4
3653 81.2
93 86.0
3121 87.5
741 97.4
1138 88.8
284 91.9
911 93.9
853 94.8
44 93.2
229 90.8
204 93.6
500 97.8
512 87.7
651 96.3
1963 87.3
313 95.2

0.0
0.0
0.1
0.0
0.0
0.4
0.0

0.0
0.0
0.0
0.0
1.2
0.0
0.0
0.0
0.4
0.0
0.0
0.1
0.0
0.0
0.4
1.8
1.3
4.5
2.6
1.0
0.0
0.0
0.8
0.0
0.3

1.1
0.8
5.4
4.1
0.0
3.3
0.0
1.3
1.3
0.0
6.6
2.0
0.6
4.5
2.0
6.4
3.8

29.1
28.2
29.3
30.1
29.6
28.3
28.8
28.5
30.8
42.6
29.1
27.2
30.0
37.7
29.4
29.2
33.9
28.5
28.2
51.9
28.0
25.9
30.2
33.2
29.5
34.0
50.0
32.7
31.7
28.1
32.7
40.0
32.4
31.6
27.0
29.9
26.7
28.2
28.6
34.7
20.1
30.3
32.6
41.9
27.6
31.3
44.5
29.9
22.5
28.1
27.0
28.6
34.5
22.9
36.8
28.9 *
30.3
*
36.0
41.7 *
*
19.8 *
27.9
*
4.3
23.1
*
*
*
29.8
33.2
42.2
19.6
31.4
26.9
42.3
26.8

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

785

843

Indices of data quality

Cervix uteri (C53) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

17576 94.7
1812 93.4
1169 98.3
696 97.4
540 98.5
1375 94.9
141 97.2
5033 92.3
283 91.9
58 96.6
90 98.9
416 95.7
671 94.2
108 96.3
159 98.7
1966 90.0
1023 98.8
910 98.8
35 100.0
78 98.7
1297 97.5
546 93.6
573 94.8
136 92.6
467 96.6
2644
285
82
4015
419
1503
5148
1920
5414
2019
771
788
312
165
135
200
328
237
240
149
161
100
110
1102
1937
539
761
714
747
426
74
930
64
171
105
276
195
33
283
172
83
585
106
65
113
312
183
79
63
46
247
179
112
355

*Important. See note on population page.

844

786

Female
Cases MV(%) DCO(%) UB(%) MI(%)

96.6
97.9
93.9
99.0
99.0
93.4
94.2
87.6
97.4
97.2
98.2
99.0
99.0
100.0
100.0
100.0
99.7
99.6
100.0
100.0
98.1
100.0
100.0
88.9
94.8
88.1
94.0
91.5
90.0
98.8
100.0
97.7
100.0
90.1
97.1
96.4
93.3
97.0
96.1
100.0
91.6
98.5
99.1
98.5
98.2
98.1
89.1
96.2
93.7
97.8
97.2
90.5
98.2
98.3

0.9
1.3
0.4
0.3
0.2
0.7
0.0
2.0
0.0
3.4
1.1
0.5
2.8
0.0
0.0
3.3
0.0
0.0
0.0
0.0
0.0
0.7
1.9
0.7
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2.9
1.1

3.0
1.4
3.7

0.1
0.0
1.2
0.0
0.0
6.1
0.0
10.9
0.8
1.9
0.0
0.3
1.0
0.0
0.0
0.0
0.0
0.4
0.0
0.0
0.6
0.0
0.0
2.9
0.2
0.0
0.1
0.0
0.5
0.0
0.0
0.6
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.6
0.0
0.0
8.4
0.0
0.0

3.0
1.4
1.1
0.2
0.0
0.3

0.0
7.8
4.4
3.5
5.8
3.6
5.4
0.5
0.0
0.4
0.0
1.8
0.0
0.4
0.5
0.0
0.4
0.0
0.0
0.3
0.0
0.0
0.0
0.3
0.5
0.0
0.0
0.0
1.6
0.0
0.0
0.0

18.5
22.5
16.2
13.2
12.6
16.9
12.8
15.3
19.4
18.0
20.1

41.4

*
*
*

*
52.7 *
23.2
11.0 *
12.6 *
29.7
26.3
22.0
50.6 *
*
30.2
35.0 *
25.8
36.0
38.1
42.4
39.6
24.0
26.1
24.4
25.0
17.4
20.7
19.2
21.5
21.1
15.0
20.9
83.3
31.9
36.9
31.4
30.0
36.9
33.6
29.7
39.4
15.6
17.5
10.5
14.9
15.9
12.1
20.1
14.5

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

20.0
6.6
10.8
15.0
12.8
12.6
11.4
6.3
21.7
24.7
29.1
16.1
12.4

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Cervix uteri (C53) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Female
Cases MV(%) DCO(%) UB(%) MI(%)
980
2400
54
1524
502
702
871
1356
1033
1874
4149
2664
1007
52
323
324
415
36
132
167
244
86
129
141
2235
66
58
22
119
86
46
109
3380
177
191
536
728
1289
2081
407
1809
2842
1257
1448
405
1591

96.3
93.1
98.1
99.6
95.8
92.7
98.7
92.9
96.6
97.6
91.2
96.7
99.7
96.2
97.8
99.4
98.1
100.0
96.2
98.8
95.9
100.0
99.2
97.2
99.8
100.0
100.0
100.0
98.3
100.0
97.8
99.1
99.6
98.9
100.0
97.4
93.1
95.0
97.0
97.8
91.5
91.6
93.3
96.9
96.0
98.1

1.4
0.5
0.0
0.0
2.0
0.7
0.0

53.6
50.3
50.0
35.6
44.1 *
42.4
50.7
21.5 *
33.5
60.2
33.4
39.3
26.2
32.7
37.2
28.4
33.7
25.0
27.3
34.1
28.7
25.6
21.7
31.9
35.6
28.8
31.0
31.8
42.0
19.8
23.9
31.2
36.0

0.0
2.2
0.6
0.5
0.0
1.1
4.2
2.9
0.8
0.2
0.1

0.3
0.0
0.0
0.0
0.0
3.7
0.2
0.0
0.0
0.0
0.3
0.2
0.0
0.0
0.0
0.0
0.7
0.0
0.0
0.0
0.8
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.7
0.1
0.4
0.0
1.5
2.2
2.5
0.6
0.0
0.0
0.4

1338
48
805
261
108
837
412
49
73
993
298
16
56
56
47
75

97.5
100.0
92.4
99.2
99.1
97.4
97.3
100.0
98.6
98.6
100.0
100.0
100.0
100.0
100.0
100.0

0.3
0.0
0.5
0.0
0.9
0.7
1.2
0.0
0.0
0.3
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.1
0.0
0.0
0.4
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

31.1
35.4
31.2
34.5
40.1
31.4
35.0
34.7
45.2
34.4
26.2

3.0
1.9
2.8
0.3
0.0
1.2
0.3
1.0
0.0
1.5
0.0
0.8
0.0
0.8
0.7
0.0
0.0
0.0
0.8
0.0
0.0
0.9

38.7
41.4
47.3
39.5
39.5
45.2
42.0
43.4
37.4
36.9
36.5
37.5

26.7

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

787

845

Indices of data quality

Other uterus (C54-55)


Male
Cases MV(%) DCO(%) UB(%) MI(%)
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
*Important. See note on population page.

846

788

Female
Cases MV(%) DCO(%) UB(%) MI(%)
28 100.0
144 91.0
37 100.0
57 71.9
77 63.6
95 85.3
361 78.7
68 72.1
129 93.8
2940 76.2
54 92.6
288 87.8
605 85.6
175 68.6
107 96.3
47 100.0
13530
1593
2162
822
415
265
2
577
7031
86
577
2112
454
1613
240
2534
18308
1523
920
2470
13153
3918
225
173
141
60
335
2755
4894
457
109
170
85
50
1020
2853
2007
2867
129
2696
375
235
120
11126
1019
9955
3627
785
2795
1191
285
877
720
8364
836
7253
4219
2375
2507
2083
550
1513
151
297

95.2
98.9
98.2
98.4
99.0
99.6
100.0
97.1
92.1
100.0
98.6
98.2
96.9
98.6
100.0
98.5
98.9
99.6
98.5
99.0
98.9
99.3
99.1
99.4
99.3
100.0
99.1
99.3
99.2
98.5
100.0
98.2
98.8
100.0
99.1
99.3
97.9
99.1
97.7
99.1
96.0
94.9
98.3
98.1
97.1
98.2
98.2
96.9
98.6
98.7
98.2
98.9
97.8
98.4
96.2
98.6
99.0
98.7
98.4
97.9
96.0
98.6
97.4
99.0

8.3
9.1
10.5
4.7
20.6
3.9
8.3
3.7
6.3
5.3
21.7
0.0
0.7
0.1
0.8
0.9
0.0
0.0
1.7
0.8
0.0
0.9
0.5
0.7
0.5
0.0
0.6
0.4
0.1
0.4
0.4
0.4
0.4
0.4
0.0
0.0
0.0
0.9
0.3
0.3
0.7
0.0
0.6
0.0
0.0
0.4
0.2
0.8
0.3
0.8
0.3
1.3
2.1
0.0
1.2
1.8
1.1
1.0
1.5
0.8
0.4
0.0
0.6
1.0
0.9
2.4
0.7
0.4
0.5
0.4
0.6
0.9
0.5
0.7
0.7

0.0
0.0
0.0
0.0
0.0

20.8

0.0
16.1
2.9
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

68.4
37.1
52.9
39.5
40.1
44.4
50.7
42.1
90.9
73.6

3.6
0.1
0.1
0.0
0.0
0.4
0.0
0.3
6.9
0.0
0.2
0.8
1.5
0.5
0.0
0.5
0.3
0.1
0.4
0.3
0.3
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.2
0.2
0.0
1.2
0.0
0.0
0.2
0.1
0.5
0.1
0.0
0.1
1.3
0.9
1.7
0.1
0.0
0.1
0.3
1.0
0.1
0.3
1.4
0.0
0.1
0.2
0.5
0.2
0.2
0.3
0.6
0.3
1.1
0.1
2.0
0.0

17.5
15.8
16.2
16.8
21.7
17.0
20.8
17.9
15.1
16.8
23.6
44.1
18.4
11.7
15.7
17.7
13.1
33.3
16.4
17.6
17.3
31.6
17.0
17.4
19.0
34.1
13.8
11.8
9.4
16.0
17.5
18.6
16.4
15.1
26.4
14.8
37.1
48.1
20.8
18.7
32.7
17.4
20.0
33.5
16.5
17.8
28.1
14.7
18.2
19.3
34.2
18.0
19.0
17.2
16.9
21.0
38.0
15.0
35.8
17.8

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Other uterus (C54-55) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Female
Cases MV(%) DCO(%) UB(%) MI(%)
1141
5076
7131
651
6355
2916
509
2375
3975
281
3654
560
144439
11540
127614
7057
634
6245
900
55
224
602
14800
1696
12701
8654
568
7830
1896
2260
11503
595
10688
838
17413
1209
14767
44733
2460
3224
3296
35225
2132
553
1537
9148
905
8014
999
519
3852
2634
1552
3983

97.6
98.6
98.4
97.1
98.5
98.5
97.6
98.6
98.1
97.2
98.1
97.3
98.3
96.8
98.4
98.7
96.1
99.0
96.4
96.4
96.0
96.8
97.9
96.9
98.0
98.6
96.5
98.7
95.6
99.1
98.8
97.1
98.8
99.0
98.8
98.1
98.8
98.8
99.5
97.4
98.7
98.8
98.2
97.6
98.4
97.0
95.0
97.3
99.4
98.3
98.7
98.9
98.6
97.6

0.9
0.5
0.5
0.8
0.5
0.7
0.8
0.6
0.8
1.1
0.8
1.8
0.7
1.4
0.7
0.3
0.6
0.3
1.8
0.0
1.3
1.8
0.7
1.1
0.6
0.8
2.1
0.7
1.0
0.4
0.4
1.3
0.3
0.5
0.4
0.6
0.4
0.4
0.2
0.6
0.4
0.4
0.6
0.5
0.7
1.6
2.7
1.4
0.0
0.4
0.3
0.3
0.4
1.2

0.7
0.7
0.7
1.2
0.6
0.3
0.6
0.3
0.7
1.1
0.6
0.4
0.4
0.7
0.4
0.4
0.8
0.3
0.7
1.8
0.9
0.5
0.6
0.6
0.6
0.3
0.5
0.3
0.3
0.1
0.3
0.5
0.3
0.2
0.2
0.6
0.2
0.3
0.1
0.7
0.4
0.3
0.7
0.5
0.7
0.9
1.4
0.7
0.0
0.4
0.4
0.3
0.0
0.8

16.2
16.6
17.2
32.1
15.9
18.4
32.4
15.6
18.5
33.8
17.4
22.3
18.3
34.8
17.3
18.8
29.3
18.0
20.3
20.0
21.9
19.4
18.1
33.8
16.2
17.8
33.1
17.3
20.4
18.4
17.5
32.8
17.0
13.8
17.0
30.3
16.3
17.8
14.3
32.7
15.6
17.1
21.0
38.0
15.4
20.5
37.9
19.0
17.1
17.5
16.4
15.9
17.0
18.0

42
383
1878
17
70
1548
386
293
218
748
11
736
104
148
96
2655
2449
157
228
183
322
687
538
1795
358

97.6
87.2
97.7
88.2
88.6
89.6
99.0
99.3
81.2
86.0
90.9
85.5
93.3
81.8
96.9
94.7
95.9
96.2
88.6
84.2
96.0
82.5
91.3
75.5
89.1

2.4
0.0
0.2
0.0
0.0
0.3
0.5

0.0
0.0
0.0
0.0
1.4
0.0
0.0
0.0
6.9
0.0
0.0
0.1
0.0
0.0
0.0
1.6
1.1
1.9
0.9
2.7
0.0
0.0
0.7
0.0
0.6

28.6
36.0 *
15.7
*
34.3
22.2 *
*
3.4 *
34.4
*

3.2
1.1
0.0
10.1
0.0
12.8
2.1
0.8
0.8
0.6
10.5
4.4
1.9
10.3
4.5
12.9
7.0

31.3
20.0
32.9
46.4
36.0
33.0
37.5
56.4
38.5

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

*
*
*

789

847

Indices of data quality

Other uterus (C54-55) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

3783
335
225
132
97
227
26
1129
68
51
44
149
149
36
135
1072
867
734
46
87
142
73
93
237
569

*Important. See note on population page.

848

790

Female
Cases MV(%) DCO(%) UB(%) MI(%)
86.0
85.4
92.4
87.9
83.5
85.9
88.5
87.8
92.6
98.0
97.7
96.0
96.0
91.7
99.3
81.6
99.1
99.2
97.8
98.9
98.6
74.0
98.9
94.9
98.8

10.3
11.6
6.2
7.6
11.3
7.0
7.7
9.3
1.5
2.0
2.3
0.0
1.3
0.0
0.0
10.4
0.0
0.0
0.0
0.0
0.0
15.1
1.1
0.4
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2.1
0.4

57.2
65.7
59.1
47.7
78.4
60.4
69.2
48.7
48.5

5023 95.0
372 99.2
208 94.7
5913 98.6
922 99.8
3073 94.6
5658 93.7
2711 86.1
8489 96.9
3215 96.4
948 97.7
3609 98.8
599 98.8
282 98.6
237 97.5
395 99.2
445 98.7
460 97.8
448 100.0
211 100.0
328 96.6
209 95.2
254 97.2
1694 92.6
3902 94.7
803 82.9
1224 92.2
1616 94.4
1561 91.0
847 97.5
122 98.4
1308 95.7
144 99.3
369 94.9
286 97.6
867 92.0
369 92.7
116 89.7
719 95.4
493 98.8
197 84.3
1356 96.3
355 94.6
178 92.1
323 92.9
680 92.6
411 87.1
270 94.8
209 95.2
121 97.5
632 95.1
593 89.5
321 96.3
1061 95.6

4.5
0.5
2.9

0.1
0.0
1.0
0.0
0.0
4.9
0.0
9.0
0.3
2.9
0.0
0.2
0.0
0.7
0.4
0.5
0.0
0.2
0.0
0.0
1.2
0.0
2.0
0.4
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.6
0.0
0.0
0.0
1.5
1.0
0.0
0.0
7.8
0.0
0.0

35.1
25.0
26.9
33.0 *
*
24.9
32.1 *
39.0
31.6
29.2
32.3
20.5
31.9
41.5
36.3
35.7
37.5
36.7
35.5
46.0
43.9
27.3
46.1
51.0
18.6
32.8
14.6
22.5
26.8
23.3
25.4
23.2
26.4
23.8
28.3
33.9
38.5
40.5
32.1
23.9
54.1
31.1
35.5
45.5
27.6
37.2
44.3
33.3
39.2
19.6
37.8
25.5
22.4
29.4

4.2
4.9
1.5
0.2
0.3
0.4

0.0
6.8
4.6
7.0
7.8
2.6
5.0
1.5
0.0
1.9
0.0
1.1
0.0
0.7
0.5
2.6
1.7
0.0
4.6
0.8
0.6
2.2
0.0
1.5
1.7
1.5
1.0
0.8
1.1
0.0
0.3
0.7

16.8
3.4

19.5

*
*
*

8.5 *
43.8 *
24.7
9.7 *
26.2 *

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Other uterus (C54-55) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Female
Cases MV(%) DCO(%) UB(%) MI(%)
1878 96.4
2555 95.2
258 98.8
2813 98.5
501 94.2
711 94.2
1034 97.5
1006 97.7
1373 90.5
3245 92.9
2662 90.2
3492 95.4
1455 99.0
152 88.2
623 96.5
953 96.3
616 95.0
124 93.5
328 96.6
452 97.3
530 97.0
357 96.9
286 93.4
455 95.8
7068 99.9
234 99.1
111 99.1
143 97.9
266 97.7
186 98.9
156 96.8
349 99.1
7637 99.6
487 100.0
507 99.4
1566 95.8
1179 92.2
1965 94.5
3031 95.7
1186 96.1
3870 88.5
6111 91.2
2568 94.0
2842 95.9
643 95.8
2505 95.8

1.5
0.7
0.4
0.2
0.6
1.0
0.1

37.4
29.4
20.2
23.1
24.7 *
29.9
26.2
13.4 *
41.4
46.3
35.4
32.4
28.9
28.3
32.6
29.7
30.8
28.2
28.4
30.8
27.7
23.2
28.3
33.6
22.7
18.8
25.2
21.7
24.1
24.2
23.7
24.4
26.3

0.0
1.3
0.8
1.0
0.7
1.3
4.9
3.0
1.9
0.6
0.7

0.2
0.0
0.0
0.0
0.0
1.5
0.0
0.0
0.0
4.2
0.3
0.1
0.3
0.7
0.3
0.4
0.8
1.6
0.0
0.0
0.2
0.0
0.0
0.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.5
0.3
0.3
0.0
1.9
3.0
1.9
0.4
0.0
0.0
0.2

2375 98.0
36 94.4
1461 97.1
751 97.3
168 97.0
2161 97.4
603 96.4
88 95.5
73 93.2
1503 97.2
821 99.3
46 100.0
114 99.1
161 100.0
221 98.6
211 99.1

0.6
0.0
0.6
0.0
0.0
1.2
1.5
1.1
4.1
1.6
0.1
0.0
0.9
0.0
0.0
0.0

0.0
0.0
0.1
0.4
0.0
0.4
0.7
0.0
1.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0

18.7
19.4
17.3
19.0
20.8
17.8
21.4
27.3
49.3
28.4
15.1

8.2
4.7
3.8
0.8
5.3
2.1
1.6
2.3
4.8
1.8
0.9
1.7
1.1
3.5
2.9
0.4
0.0
0.0
0.4
0.0
0.6
0.9

25.2
22.9
24.7
25.1
24.2
25.5
28.5
26.9
25.3
24.5
27.2
27.1

10.9

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

791

849

Indices of data quality

Ovary (C56)
Male
Cases MV(%) DCO(%) UB(%) MI(%)
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White
*Important. See note on population page.

850

792

Female
Cases MV(%) DCO(%) UB(%) MI(%)
53
290
34
114
122

92.5
88.3
97.1
49.1
54.1

97
331
52
126
3197
81
426
483
207
70
68

75.3
85.2
76.9
95.2
74.4
85.2
72.8
73.9
82.6
92.9
98.5

13.4
3.3
9.6
4.0
9.1
3.7
7.7
7.2
5.8

8326
815
1365
428
283
137
4
342
4580
46
326
1721
270
1431
129
1702
11298
996
478
1758
7981
2275
121
130
83
31
226
1562
2961
216
104
86
52
40
739
1633
1467
1412
45
1340
193
123
59
7411
510
6817
2573
477
2061
843
206
612
440
4556
417
3987
2204
1275
1516
1438
322
1111
106
234

85.1
92.5
92.2
89.3
90.1
93.4
100.0
90.1
79.8
93.5
91.4
88.8
84.1
89.7
94.6
92.0
94.0
96.4
90.6
96.3
93.3
94.9
91.7
98.5
96.4
100.0
96.5
94.2
95.0
89.8
95.2
94.2
100.0
100.0
96.1
94.9
92.0
92.9
93.3
92.9
88.1
84.6
93.2
91.3
86.5
91.6
89.9
85.3
90.8
94.5
89.8
95.9
91.1
92.1
86.8
92.5
93.6
90.8
89.3
91.2
88.5
91.9
89.6
94.4

1.4
0.6
1.2
2.6
0.0

3.1
14.8

0.0

0.0
1.2
1.5
0.0
3.7
4.5
5.9
4.3
3.1
1.6
0.9
0.3
1.7
0.5
1.1
1.2
0.8
0.0
0.0
0.0
0.0
1.6
0.8
1.9
0.0
0.0
0.0
0.0
0.9
0.7
2.9
2.1
2.2
1.9
4.1
4.1
5.1
3.5
4.3
3.5
3.9
4.8
3.7
2.5
3.4
2.3
4.1
2.8
5.3
2.5
1.6
2.6
1.5
1.4
2.5
1.1
2.8
0.4

1.9
0.0
0.0
0.0
0.0

20.3

7.2
10.6
1.9
0.8
0.0
0.0
0.0
0.0
0.0
0.0
0.0

59.8
31.7
38.5
43.7
38.3
46.9
59.9
53.0
50.7
28.6

9.8
0.0
0.2
0.0
0.0
0.0
0.0
0.9
17.7
0.0
0.0
2.8
3.3
2.6
2.3
2.1
1.1
0.8
1.7
0.5
1.2
0.4
0.8
0.8
0.0
0.0
0.0
0.4
0.8
2.3
1.0
1.2
0.0
0.0
0.5
0.8
1.4
0.6
2.2
0.6
2.1
3.3
0.0
0.4
0.4
0.4
0.7
0.8
0.6
0.5
1.5
0.2
0.2
0.3
0.7
0.3
0.8
0.5
3.1
1.1
1.2
1.1
0.9
1.3

67.4
67.0
75.7
66.4
68.6
92.0
75.0
73.7
62.8
63.0
82.8
72.3
83.0
71.1
56.6
68.8
65.5
49.5
73.0
49.8
70.9
62.2
64.5
50.0
68.6
65.3
79.2
53.8
55.8
53.8
60.0
49.3
74.3
63.1
66.4
62.2
67.7
78.2
92.7
62.7
65.7
65.1
66.2
67.4
66.0
68.0
59.5
64.1
58.7
76.4
67.9
77.5
68.6
75.2
72.2
66.1
67.0
72.0
65.6
67.9
73.1

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Ovary (C56) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Female
Cases MV(%) DCO(%) UB(%) MI(%)
538
2656
3771
336
3385
1586
258
1313
2101
131
1950
394
84293
5946
75272
3942
320
3473
602
47
166
382
8177
818
7068
4229
255
3886
1302
1325
5647
301
5213
426
9907
657
8477
26634
1518
1762
2344
20761
1361
273
1069
5991
478
5358
601
223
2414
1670
831
2179

90.9
92.1
91.2
89.9
91.4
91.7
89.5
92.2
91.1
88.5
91.2
89.6
91.7
87.6
91.8
92.4
88.1
92.7
92.0
85.1
92.2
92.7
90.7
90.5
90.6
91.2
89.4
91.2
87.0
92.2
92.3
89.7
92.3
95.1
92.8
90.9
92.8
92.8
95.6
89.3
95.4
92.6
90.5
81.3
92.9
90.3
86.6
90.7
93.5
94.2
93.0
93.1
88.0
89.0

2.0
2.4
1.5
0.6
1.5
2.0
1.9
2.0
2.4
1.5
2.5
5.8
2.4
3.1
2.4
2.1
1.6
2.2
3.3
6.4
3.0
3.1
1.9
1.0
2.1
4.1
3.9
4.2
1.5
1.8
1.1
1.0
1.1
0.5
1.7
2.1
1.7
1.4
0.4
2.0
0.9
1.5
2.4
4.0
2.1
4.1
5.2
4.1
0.2
1.8
0.9
0.8
2.4
3.8

2.0
2.2
2.0
2.4
1.9
0.9
0.8
1.0
2.9
3.8
2.8
0.5
1.4
2.0
1.4
1.3
3.1
1.0
0.7
0.0
0.6
0.8
1.7
1.7
1.7
2.1
3.1
2.0
1.1
1.5
0.7
1.0
0.7
0.9
0.8
1.1
0.8
1.2
1.1
1.8
0.5
1.2
3.3
5.1
2.7
2.2
2.5
2.0
0.0
1.3
1.8
1.7
1.6
2.6

80.7
65.8
69.1
65.2
69.7
65.4
64.7
65.6
71.7
79.4
71.6
65.2
67.0
71.5
68.0
62.6
66.6
63.7
61.6
42.6
56.0
66.0
60.9
63.9
61.4
71.4
77.6
72.4
63.0
76.2
70.2
75.1
71.5
68.5
64.4
65.4
66.2
65.2
48.0
68.8
47.6
68.6
67.2
68.5
67.5
65.8
73.4
66.4
61.2
70.4
65.6
65.1
74.1
65.2

49 85.7
322 74.5
616 92.4
47 100.0
133 82.7
1634 81.9
139 89.9
190 97.4
559 62.8
1802 81.4
45 91.1
1541 76.4
282 91.8
443 72.9
148 97.3
1741 86.0
1617 88.7
64 82.8
232 85.8
239 80.3
313 93.6
668 75.7
448 82.6
1994 72.0
352 74.7

4.1
0.0
0.8
0.0
0.8
0.5
0.0

0.0
0.0
0.0
0.0
2.3
0.0
0.0
0.0
18.4
0.0
0.0
0.4
0.0
0.0
0.0
2.4
1.9
4.7
3.0
1.7
0.0
0.0
0.9
0.0
0.6

67.3
51.2 *
101.8
*
52.6
41.9 *
*
25.0 *
35.1
*

2.9
1.2
0.0
5.6
0.0
9.3
0.0
3.2
2.6
3.1
11.2
5.0
2.2
12.0
8.5
9.6
14.2

33.0
63.3
47.4
52.3
38.0
55.8
56.9
69.7
53.1

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

*
*
*

793

851

Indices of data quality

Ovary (C56) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region
*Important. See note on population page.

852

794

Female
Cases MV(%) DCO(%) UB(%) MI(%)
5334
565
340
167
186
354
43
1618
116
64
60
230
289
111
201
1133
771
619
44
108
235
124
178
195
425

86.2
87.6
92.1
88.6
87.6
79.9
86.0
86.4
89.7
79.7
96.7
90.4
90.7
88.3
97.0
72.9
95.5
96.0
93.2
93.5
94.9
72.6
93.8
92.3
95.5

2.8
1.6
2.1
1.2
1.1
2.3
2.3
4.6
1.7
10.9
1.7
3.5
4.8
0.0
0.5
8.5
0.0
0.0
0.0
0.0
0.0
0.0
2.2
1.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.6
0.0
0.0
0.0
0.9
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.5
1.2

42.6
46.0
32.9
31.1
37.6
44.6
55.8
36.4
36.2

4153
338
128
4081
622
2208
3729
2529
5834
2984
784
2217
398
246
191
336
371
378
311
232
199
129
165
1175
2561
861
842
1267
1402
560
105
1531
96
243
163
593
308
82
574
310
127
881
268
107
209
482
297
161
110
95
483
420
252
680

89.3
91.7
87.5
93.5
98.1
86.9
77.8
76.3
88.8
95.0
93.8
95.2
95.2
96.3
93.2
92.6
97.0
95.0
97.7
99.1
90.5
93.0
93.9
72.5
83.3
74.1
75.9
82.6
81.7
89.8
97.1
86.2
91.7
88.1
82.2
81.1
87.3
80.5
81.5
85.2
83.5
94.2
84.7
84.1
82.3
81.7
74.4
80.7
88.2
84.2
85.5
78.6
86.1
85.6

8.9
2.7
4.7

0.2
0.0
0.0
0.0
0.0
10.6
0.0
19.8
0.8
2.2
0.0
0.8
0.0
0.0
0.5
1.5
0.0
0.5
0.0
0.0
1.5
0.0
6.1
1.8
0.4
0.0
0.7
0.0
0.8
0.0
0.0
0.7
0.0
0.0
0.0
0.0
0.0
1.2
0.0
0.0
0.0
0.0
0.0
0.9
0.0
0.0
0.0
1.9
1.8
0.0
0.2
10.7
0.0
0.0

65.4
58.9
64.1
67.1 *
*
74.0
45.2 *
55.4
63.7
73.8
69.3
65.4
76.1
74.4
73.8
62.2
72.5
68.5
83.0
88.4
91.5
89.9
115.2
168.4
56.6
71.9
53.6
63.0
64.1
68.2
80.0
75.5
60.4
57.6
61.3
65.4
56.5
76.8
58.9
59.4
47.9
79.0
52.2
57.0
51.7
64.9
57.2
57.8
51.8
50.0
72.7
59.0
53.2
61.5

6.1
3.8
3.1
0.4
0.6
0.8

1.0
23.9
13.2
9.3
21.6
9.4
9.6
5.2
0.0
2.7
2.1
1.6
1.8
0.7
1.6
1.2
2.3
0.6
0.8
0.3
1.1
0.9
0.5
1.7
1.7
4.3
1.8
0.0
1.7
1.0
0.0
1.3

28.3
10.4

49.8

*
*
*

*
50.8 *
25.8
30.8 *
*

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Ovary (C56) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Female
Cases MV(%) DCO(%) UB(%) MI(%)
1405
2120
159
2343
473
563
797
477
902
2547
1720
2140
818
77
600
581
388
81
195
256
338
214
167
264
3989
185
111
82
224
128
128
256
5946
392
345
1543
1294
1963
3399
1246
4131
6896
2494
2789
905
2656

88.3
86.1
90.6
94.0
82.5
87.2
88.7
94.8
81.6
76.1
84.8
88.6
98.3
88.3
92.2
88.8
88.4
79.0
84.6
87.5
88.2
92.1
86.8
89.4
99.9
92.4
90.1
89.0
94.6
95.3
93.0
93.0
96.9
97.4
99.1
85.4
79.4
81.6
79.6
88.6
78.1
77.4
78.6
85.0
87.0
86.9

1967 91.2
24 83.3
1035 89.4
494 88.3
148 91.2
1515 88.6
500 91.8
84 88.1
36 100.0
1262 90.8
381 92.7
24 87.5
59 94.9
50 96.0
111 93.7
110 90.9

2.2
0.7
0.6
0.7
3.8
1.6
0.0

66.5
64.7
69.8
67.8
56.8 *
56.0
64.7
75.9 *
64.0
76.1
53.9
62.3
71.5
63.6
49.2
57.5
59.9
61.7
69.2
47.3
59.8
53.3
56.3
81.8
77.5
58.4
60.4
54.9
64.7
71.9
75.0
70.7
79.2

0.1
4.3
1.5
2.8
1.3
2.4
9.3
6.3
5.3
0.8
0.6

0.2
0.0
0.0
0.0
0.0
2.0
0.5
0.2
0.0
8.8
0.1
0.6
0.6
3.9
1.2
0.3
1.0
1.2
0.5
0.0
0.3
0.0
0.0
0.4
0.0
0.0
0.0
0.0
0.0
0.0
0.8
0.0
0.0
0.0
0.0
1.4
0.4
1.8
0.1
6.3
9.2
3.9
1.2
0.0
0.0
1.4

1.3
4.2
1.7
0.0
0.0
1.5
3.2
2.4
0.0
2.4
0.8
0.0
1.7
0.0
1.8
0.0

0.0
0.0
0.0
0.2
0.0
2.4
0.0
0.0
0.0
0.0
0.8
4.2
1.7
2.0
0.0
0.0

68.8
62.5
59.5
70.4
67.6
73.9
63.4
71.4
61.1
69.3
55.4

13.0
5.9
7.4
1.1
2.6
2.2
2.6
3.9
8.6
4.6
0.4
1.8
0.5
6.0
4.9
0.5
0.9
3.7
0.0
0.8
0.0
4.7

82.0
74.3
73.8
74.0
73.2
75.4
76.0
72.8
72.1
73.1
59.4
75.7

73.6

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

795

853

Indices of data quality

Prostate (C61)
Male
Cases MV(%) DCO(%) UB(%) MI(%)
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

142
273
134
262
418

90.8
71.4
96.3
57.6
63.4

341
1727
415
1029
16155
529
2070
3406
1075
1932
229

88.9
95.0
81.2
93.8
83.8
92.4
85.1
78.0
82.9
99.8
94.3

8.5
2.5
12.3
4.8
5.3
3.4
5.1
10.2
11.0

76342
9362
14085
3649
2562
1515
29
3315
37402
542
3881
13398
3460
9447
1496
14987
103927
6246
9190
12278
70762
21432
1903
920
605
229
1740
14539
27673
4491
587
670
466
160
4991
14329
12995
14162
1156
12665
2665
1934
603
72917
7976
63829
23930
7023
16649
7971
2714
5119
4628
41322
6238
33285
17485
11050
13571
15914
4777
11003
1343
2008

94.3
91.8
96.1
96.1
97.3
99.7
96.6
96.9
93.4
95.6
93.1
94.5
92.4
95.2
96.3
96.2
97.0
97.9
96.6
97.4
96.7
97.1
95.6
98.3
96.7
96.1
97.5
97.0
97.9
97.5
99.7
98.4
98.1
97.5
98.0
97.6
95.8
97.9
97.9
97.8
96.5
96.5
98.0
97.2
95.1
97.4
95.8
93.9
96.6
98.0
97.3
98.3
96.1
96.3
94.8
96.4
96.5
96.1
95.9
96.1
94.0
96.9
94.9
96.0

0.7
0.2
0.9
1.5
0.2

7.3
15.1

3.1

0.0
1.1
0.5
0.4
1.7
1.1
1.4
1.0
0.3
1.2
1.0
0.5
0.9
0.8
1.1
1.0
0.8
0.4
1.0
0.9
0.8
1.1
0.7
0.8
0.0
0.4
0.6
0.0
0.7
0.8
1.3
0.6
0.3
0.6
0.8
0.9
0.3
1.7
3.0
1.5
2.2
2.9
1.9
0.8
1.0
0.6
2.0
2.0
3.5
1.9
1.4
1.0
0.7
0.9
1.4
0.7
2.2
1.0

0.0
0.0
0.0
0.0
0.0

19.4

0.3
2.3
1.7
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0

58.1
17.4
23.1
22.7
20.4
31.0
31.9
40.1
38.5
25.8

2.9
0.1
0.1
0.0
0.0
0.2
0.0
0.4
5.7
0.0
0.0
2.5
3.1
2.3
2.0
1.3
0.6
0.4
0.6
0.5
0.7
0.4
0.6
0.4
1.0
0.4
0.5
0.3
0.4
0.4
0.2
0.3
0.2
0.0
0.3
0.5
0.8
0.3
0.3
0.3
1.7
1.3
1.3
0.3
0.3
0.3
0.7
0.7
0.7
0.7
0.7
0.7
0.2
0.5
0.4
0.5
0.5
0.4
1.6
0.3
0.2
0.3
0.4
0.7

19.0
17.5
17.4
22.2
21.9
23.8
37.9
20.8
18.1
18.5
28.6
22.6
34.9
19.2
10.0
17.8
14.5
9.8
18.0
11.9
15.9
13.3
20.9
11.8
14.2
13.3
16.7
9.0
10.0
10.1
9.4
11.1
15.0
13.8
14.3
14.6
14.6
18.7
21.5
12.8
15.6
20.7
15.2
16.3
22.1
14.0
12.7
15.8
11.3
16.3
17.1
23.1
16.8
19.6
18.4
15.8
16.5
22.7
13.9
21.1
17.1

*Important. See note on population page.

854

796

Female
Cases MV(%) DCO(%) UB(%) MI(%)
*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Prostate (C61) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

5417
25644
42512
6463
34438
19137
5154
13626
17661
1980
15519
3980
784436
95223
653240
38030
5225
31523
5891
143
1533
4074
70437
12099
56746
38748
4595
31442
11245
13098
53915
5325
46933
4342
97659
11739
79315
255181
10110
30470
17271
189664
15161
4735
10135
55354
6685
47288
6477
2302
21790
14760
7073
20032

95.4
97.1
97.7
97.0
97.7
98.4
98.0
98.6
96.6
95.5
96.7
94.2
96.4
95.2
96.4
97.7
97.4
97.7
94.4
84.6
93.3
95.1
94.4
95.3
94.2
96.9
95.9
96.9
93.2
96.8
97.2
96.3
97.3
96.6
97.2
97.3
97.2
97.0
97.7
96.5
97.1
97.0
95.3
93.9
96.0
93.1
90.9
93.4
98.3
97.2
96.2
96.3
97.3
96.3

1.3
1.1
0.7
0.7
0.8
0.6
0.6
0.6
1.4
2.3
1.3
2.7
1.3
1.8
1.2
0.4
0.3
0.4
1.4
2.8
1.8
1.3
0.9
1.2
0.9
1.7
2.4
1.8
2.0
1.5
0.7
1.0
0.7
1.7
0.7
0.7
0.7
0.8
0.5
0.8
0.8
0.8
1.5
1.6
1.4
1.9
3.3
1.8
0.2
1.4
0.8
0.5
1.1
0.9

1.8
1.0
0.8
1.2
0.8
0.3
0.4
0.2
1.1
0.8
1.2
1.3
1.1
1.2
1.0
1.1
1.1
1.0
0.9
0.7
1.2
0.8
2.6
2.0
2.7
0.7
0.6
0.7
0.6
0.4
0.7
0.7
0.6
0.3
0.4
0.5
0.4
0.7
0.5
0.6
0.6
0.7
1.9
2.2
1.7
3.7
4.1
3.7
0.1
0.2
0.7
0.7
0.5
0.9

14.4
14.9
13.0
15.8
13.0
12.2
15.0
11.4
17.3
22.8
16.7
15.0
15.6
20.9
15.5
12.7
16.5
12.5
16.0
22.4
17.5
15.0
14.7
17.1
14.3
17.2
24.2
17.6
16.5
16.7
15.7
20.2
15.7
15.4
14.2
16.3
14.3
14.4
10.8
17.8
11.7
14.8
16.5
23.2
13.8
16.0
23.3
15.3
14.3
14.1
13.6
13.3
16.2
16.9

78
335
3553
16
47
1838
73
1030
326
1346
36
1219
108
346
143
8689
7779
253
573
690
981
2688
1787
4452
1106

85.9
65.1
91.3
56.3
70.2
68.6
80.8
96.0
68.7
83.5
91.7
75.6
94.4
74.6
87.4
73.0
77.4
75.5
89.7
88.8
94.2
82.5
90.7
72.1
80.0

2.6
0.0
0.5
0.0
4.3
0.4
0.0

0.0
0.0
0.0
0.0
4.3
0.0
0.0
1.0
22.4
0.0
0.0
0.2
0.0
0.0
0.7
10.3
8.1
8.3
1.4
2.5
0.0
0.0
1.3
0.0
1.5

51.3
43.9
27.2

2.1
1.3
0.0
9.1
0.0
10.7
0.7
3.0
2.6
2.8
8.9
3.0
1.1
8.0
5.2
17.5
11.8

Female
Cases MV(%) DCO(%) UB(%) MI(%)

*
*

68.1
32.3

*
*
*

17.0
47.9

8.3
36.3

*
*
*

25.0
36.3
37.7
29.2
27.1
30.7
42.8
41.2

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

797

855

Indices of data quality

Prostate (C61) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

6354 87.2
455 79.6
309 85.8
123 80.5
187 92.0
308 89.6
74 82.4
1947 91.6
75 90.7
88 86.4
58 91.4
186 94.6
187 92.0
166 84.3
206 100.0
1239 69.9
1314 96.6
1093 96.5
84 97.6
137 96.4
211 93.4
106 82.1
127 89.8
508 89.2
1014 91.5
24603
2691
1204
6114
5407
18254
6551
4879
15172
9906
1857
17314
3267
1789
1535
2185
3574
3157
4325
1512
1710
1576
2244
5902
9864
4245
3814
7814
6291
3313
823
8490
626
1752
957
3268
1827
611
3207
2004
298
7321
1225
446
1100
3480
948
776
448
534
2935
2251
1423
4572

95.4
98.6
96.6
92.3
99.4
91.9
62.5
76.9
91.2
87.1
86.8
98.2
98.8
98.4
99.4
98.2
98.9
97.3
99.4
98.6
96.0
96.6
99.2
87.0
85.6
78.1
84.9
88.8
84.8
97.1
98.9
85.9
96.3
88.8
83.1
83.1
85.9
89.5
84.0
98.1
71.5
95.5
92.4
81.4
92.9
89.2
81.3
82.2
82.8
95.3
93.0
86.9
93.5
89.7

3.2
2.4
3.2
1.6
2.1
1.9
0.0
3.1
2.7
13.6
3.4
0.0
4.3
1.2
0.0
10.3
0.0
0.0
0.0
0.0
0.0
4.7
3.9
2.2
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.7
0.0
0.0
2.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2.8
3.5

37.3
42.4
40.5
56.1
38.0
36.0
26.4
25.4
36.0

4.1
0.7
2.1

0.1
0.0
0.6
0.0
0.0
7.4
0.1
12.9
0.9
4.2
0.0
0.5
0.0
0.2
0.1
0.6
0.0
0.6
0.0
0.0
0.7
0.2
0.3
1.7
0.2
0.0
0.6
0.0
1.0
0.1
0.0
1.0
0.3
0.0
0.0
0.0
0.0
0.3
0.0
0.0
0.0
0.0
0.0
3.6
0.0
0.0
0.0
1.9
2.9
0.0
0.1
9.0
0.0
0.0

24.1
14.2
17.9
57.7

13.0
10.2
3.4
0.4
0.5
0.4

0.1
10.3
12.3
9.6
13.3
6.3
8.4
1.9
0.0
2.3
1.3
1.7
0.8
0.8
2.1
2.6
0.9
0.0
1.7
0.4
0.6
5.6
0.1
1.6
1.6
4.5
2.5
0.2
1.5
0.4
0.1
0.9

5.4
2.7

34.2

45.3
43.3
18.1
52.8

20.3
53.4
48.6
43.9
54.4
44.9
22.5
19.3
29.5
20.2
20.9
22.4
22.7
19.3
33.0
27.9
24.5
27.2
59.6
21.5
30.1
18.5
18.6
29.9
22.3
29.2
31.1
22.5
16.2
26.3
28.4
27.1
25.5
22.1
18.5
45.0
22.8
26.0
38.1
27.3
22.5
46.0
39.7
37.5
19.9
21.1
34.6
17.5
19.8

*Important. See note on population page.

856

798

Female
Cases MV(%) DCO(%) UB(%) MI(%)

*
*
*

*
*
*
*

*
*
*

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Prostate (C61) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

2548
5009
509
14669
633
1468
2002
5755
7139
2654
3385
4821
2875
622
2768
4282
2692
457
1578
1062
1822
1558
1111
1787
37300
1327
686
558
1640
724
826
2234
34831
2108
2029
7547
5424
9897
15705
7073
20113
31674
10334
13588
2759
10668

81.9
88.6
91.0
92.1
67.1
74.9
90.5
98.3
84.0
75.1
84.0
86.2
94.4
85.9
90.0
89.5
86.4
70.2
90.7
89.2
86.5
89.5
88.2
97.3
99.3
93.9
89.7
93.5
96.0
90.5
89.7
95.3
97.9
98.3
97.9
86.1
86.7
88.5
90.1
89.0
82.2
80.9
79.9
89.4
78.3
84.3

19271
199
9436
5171
1439
13958
4668
753
233
13827
3762
283
604
328
1184
1140

94.3
97.0
88.5
95.5
88.0
91.9
94.9
94.7
97.0
89.6
97.1
98.6
96.9
96.6
97.3
96.7

2.9
1.3
1.0
1.0
9.8
4.1
0.6

46.9
40.4
37.1
36.8
48.8
46.0
40.8
32.4
34.0
60.7
54.2
53.1
43.8
26.8
36.8
26.3
29.8
44.2
29.2
47.5
36.6
29.3
30.5
43.4
32.9
21.0
33.1
28.0
25.8
30.7
24.1
24.0
33.8

0.3
2.9
1.5
5.2
0.9
1.7
5.9
5.4
2.7
0.5
0.3

0.7
0.0
0.0
0.0
0.0
5.4
0.0
0.0
0.0
5.3
0.1
0.7
3.0
1.8
1.8
1.1
2.4
2.6
1.6
0.3
0.9
0.1
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
2.3
0.5
1.4
0.0
6.7
7.3
3.4
1.5
0.0
0.0
0.9

0.8
0.5
1.1
0.0
0.7
1.9
2.2
0.5
2.6
1.9
0.6
0.4
0.5
0.9
0.5
0.6

0.0
0.0
0.3
0.2
0.4
1.3
0.1
0.0
0.4
0.0
0.5
0.0
0.3
0.3
0.6
0.6

23.2
13.6
25.9
23.2
30.0
25.6
20.4
19.0
29.6
20.6
14.7

12.2
8.5
9.3
2.6
4.8
4.7
3.7
6.6
5.7
3.8
0.7
5.3
2.1
4.3
0.6
0.4
0.3
1.4
0.4
2.3
0.6
2.5

Female
Cases MV(%) DCO(%) UB(%) MI(%)

*
*

31.3
33.4
34.4
32.6
32.3
28.6
36.9
34.4
38.0
32.8
37.5
35.3

17.6

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

799

857

Indices of data quality

Testis (C62)
Male
Cases MV(%) DCO(%) UB(%) MI(%)
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

6 100.0
33 97.0
5 100.0
7 71.4
16 50.0
40 95.0
49 81.6
10 100.0
34 97.1
740 76.5
86 97.7
115 93.0
276 89.9
147 92.5
13 84.6
38 100.0
3034
451
520
153
76
39
4
115
1508
19
149
443
34
401
98
665
4585
180
96
1171
3063
926
31
25
8
13
164
640
1126
29
14
11
10
3
444
597
698
493
14
467
50
7
40
1840
70
1735
858
66
779
340
37
294
185
1554
60
1426
817
467
511
454
45
405
14
75

97.2
99.3
99.0
99.3
100.0
100.0
100.0
100.0
95.0
94.7
100.0
99.1
97.1
99.3
100.0
99.2
99.5
99.4
97.9
99.6
99.5
99.6
100.0
96.0
100.0
100.0
100.0
99.5
99.6
93.1
100.0
100.0
100.0
100.0
99.8
99.8
99.0
99.6
100.0
99.6
96.0
100.0
97.5
99.2
97.1
99.3
99.4
98.5
99.5
99.1
97.3
99.3
98.9
99.3
98.3
99.3
99.4
99.8
98.8
99.1
97.8
99.3
100.0
100.0

3.0
18.8
0.0
2.0
0.0
0.0
2.0
1.2
0.9
1.1
1.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.2
0.0
0.2
0.0
0.0
0.1
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.2
0.0
0.2
0.0
0.0
0.0
0.3
1.4
0.3
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.3
0.0
0.4
0.0
0.0
0.2
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0

12.1

5.0
16.3
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

2.5
16.3
10.0
20.6
13.4
16.3
20.0
13.4
15.0
9.6

2.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
4.8
0.0
0.0
0.2
2.9
0.0
0.0
0.5
0.1
0.0
1.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
3.4
0.0
0.0
0.0
0.0
0.0
0.2
0.3
0.0
0.0
0.0
4.0
0.0
2.5
0.0
0.0
0.0
0.3
0.0
0.4
0.3
0.0
0.3
0.0
0.1
0.0
0.1
0.0
0.0
0.6
0.0
0.0
0.0
0.0
0.0

4.4
4.2
4.6
5.9
7.9
10.3
25.0
2.6
4.0
10.5
2.7
3.6
2.9
3.7
3.1
6.0
5.7
4.4
12.5
6.5
5.3
4.5
6.5
4.9
4.2
6.6
27.6
9.1
7.0
5.7
3.3
3.0
3.2
6.0
42.9
6.7
17.1
6.3
3.6
10.6
3.1
3.8
10.8
3.1
5.4
4.4
13.3
4.3
3.4
5.8
3.3
5.7
15.6
4.7
14.3
4.0

*Important. See note on population page.

858

800

Female
Cases MV(%) DCO(%) UB(%) MI(%)
*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Testis (C62) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

204
1019
1292
41
1220
515
28
478
640
17
618
137
29216
887
27275
1183
47
1101
237
16
89
131
2360
108
2190
1507
43
1413
385
612
1739
52
1663
148
3800
121
3465
9956
315
298
1489
7701
385
29
351
2520
77
2373
333
110
983
685
202
914

99.0
99.5
99.1
97.6
99.1
99.6
100.0
99.6
99.5
94.1
99.7
99.3
99.2
98.2
99.2
99.6
100.0
99.5
98.3
100.0
96.6
99.2
98.7
98.1
98.7
99.2
97.7
99.2
99.5
99.2
99.6
100.0
99.6
99.3
99.7
99.2
99.7
99.5
99.7
98.7
99.5
99.5
99.0
100.0
98.9
98.2
97.4
98.3
100.0
99.1
99.3
99.9
99.5
98.4

0.0
0.2
0.1
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.7
0.2
0.2
0.2
0.0
0.0
0.0
0.4
0.0
0.0
0.8
0.1
0.0
0.1
0.3
2.3
0.2
0.0
0.2
0.2
0.0
0.2
0.0
0.1
0.0
0.1
0.1
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.3
0.0
0.3
0.0
0.9
0.2
0.0
0.0
0.4

0.5
0.0
0.5
0.0
0.5
0.2
0.0
0.2
0.2
5.9
0.0
0.0
0.3
0.7
0.3
0.1
0.0
0.1
0.4
0.0
1.1
0.0
0.5
1.9
0.4
0.3
0.0
0.3
0.0
0.0
0.1
0.0
0.1
0.0
0.1
0.0
0.1
0.1
0.0
0.3
0.1
0.1
0.8
0.0
0.9
1.0
1.3
0.8
0.0
0.0
0.2
0.0
0.0
0.9

3.4
4.3
4.5
17.1
4.1
3.5
14.3
2.7
3.6
5.9
3.6
6.6
5.0
10.8
4.9
3.6
6.4
3.5
6.3
6.3
9.0
4.6
4.8
7.4
4.7
6.4
11.6
6.4
6.2
5.6
4.2
5.8
4.2
4.1
4.3
8.3
4.0
4.9
5.4
10.1
6.0
4.4
7.5
17.2
6.8
5.9
11.7
5.9
3.6
2.7
4.8
3.9
4.0
4.3

11
43
292
8
5
142
24
72
75
242
2
256
50
66
13
587
520
41
55
41
81
152
53
264
42

81.8
86.0
96.6
100.0
100.0
88.7
91.7
98.6
82.7
88.8
100.0
87.9
84.0
92.4
100.0
91.1
93.7
92.7
98.2
92.7
97.5
95.4
98.1
90.2
88.1

0.0
0.0
0.3
0.0
0.0
0.7
0.0

9.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
8.0
0.0
0.0
0.4
0.0
0.0
0.0
5.3
3.1
7.3
0.0
0.0
0.0
0.0
0.0
0.0
0.0

9.1
9.3
7.2

1.3
0.4
0.0
2.0
0.0
1.5
0.0
0.3
0.4
0.0
1.8
4.9
0.0
0.0
1.9
1.5
4.8

Female
Cases MV(%) DCO(%) UB(%) MI(%)

*
*

40.0
20.4

*
*
*

25.3

14.8

*
*
*

3.4
5.5
7.3
8.6
6.6
15.1
17.8
9.5

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

801

859

Indices of data quality

Testis (C62) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

554
47
38
13
20
31
2
181
15
24
37
21
42
12
53
147
85
64
6
15
32
14
11
87
228

94.8
93.6
94.7
92.3
100.0
93.5
50.0
94.5
100.0
100.0
100.0
100.0
90.5
91.7
98.1
80.3
97.6
96.9
100.0
100.0
87.5
85.7
100.0
96.6
96.5

0.9
0.0
2.6
0.0
0.0
0.0
0.0
1.7
0.0
0.0
0.0
0.0
7.1
0.0
0.0
4.8
1.2
1.6
0.0
0.0
0.0
0.0
0.0
2.3
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.4

13.9
21.3
15.8
15.4
5.0
9.7

1717
146
80
445
158
461
816
610
1859
1361
85
469
198
81
76
145
104
151
178
51
69
46
81
589
1042
308
482
613
587
247
40
583
32
94
43
118
58
25
139
90
55
292
47
27
64
139
108
58
35
40
132
120
95
227

99.4
100.0
98.8
97.3
99.4
97.0
93.6
65.9
97.8
98.5
98.8
99.4
99.5
98.8
100.0
100.0
100.0
98.7
100.0
100.0
100.0
100.0
97.5
95.2
95.8
94.2
96.9
98.0
94.9
99.6
100.0
97.4
100.0
91.5
100.0
95.8
94.8
92.0
96.4
98.9
100.0
99.0
100.0
100.0
92.2
92.8
87.0
98.3
97.1
95.0
100.0
80.8
98.9
98.7

0.5
0.0
0.0

0.1
0.0
1.3
0.0
0.0
3.0
0.0
32.8
0.7
0.9
0.0
0.4
0.0
0.0
0.0
0.0
0.0
0.7
0.0
0.0
0.0
0.0
1.2
2.9
1.0
0.0
0.4
0.0
0.2
0.0
0.0
0.3
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
15.0
0.0
0.0

4.6
3.4
3.8

2.6
1.3
0.4
0.2
0.0
0.0

0.0
1.5
2.1
0.3
2.3
0.5
1.5
0.4
0.0
0.3
0.0
0.0
0.0
0.0
0.0
0.0
0.7
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.4

9.0
6.7

11.9

9.4

21.4
18.2
9.2

4.6
22.1
12.0
12.0
5.8
20.0
6.2

16.3
6.5
9.7
4.8
3.8
4.3
2.0
5.0
6.5
6.3
5.3
7.0
11.9
1.7
4.0
7.2
3.3

802

*
*
*

*
*
*
*

*
*
*

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

4.1
10.6
3.7
9.4
6.5
11.1
1.7
11.4
3.8
7.5
5.3
4.4

*Important. See note on population page.

860

Female
Cases MV(%) DCO(%) UB(%) MI(%)

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Testis (C62) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

128
185
41
1171
85
102
179
155
137
215
563
980
411
28
66
151
99
15
59
54
92
41
48
57
1214
82
65
26
147
75
62
151
2611
158
126
446
401
702
1104
565
1316
2156
699
809
277
1038

93.8
94.6
100.0
99.6
96.5
94.1
95.0
99.4
95.6
94.0
86.0
98.0
100.0
100.0
95.5
98.7
98.0
93.3
100.0
100.0
96.7
100.0
100.0
94.7
99.9
98.8
100.0
100.0
98.6
100.0
100.0
100.0
99.7
99.4
100.0
98.4
91.8
98.7
99.3
96.6
89.0
94.2
97.9
96.9
97.5
97.9

0.8
0.0
0.0
0.0
0.0
0.0
0.0

33.6
30.8
7.3
4.3
13.2
22.1
14.5
13.5
22.6

0.0
0.5
0.1
0.3
0.0
0.3
0.6
0.3
0.6
0.0
0.1

0.8
0.0
0.0
0.0
0.0
1.0
0.0
0.0
0.0
1.9
0.2
0.0
0.0
0.0
1.5
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.4
0.5
0.0
0.0
2.5
1.0
2.7
0.6
0.0
0.0
0.3

1044
18
537
220
84
734
288
61
18
696
133
7
11
28
24
53

97.8
100.0
97.6
97.3
100.0
97.3
100.0
96.7
100.0
98.4
100.0
100.0
100.0
100.0
100.0
100.0

0.1
0.0
0.0
0.0
0.0
0.4
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.5
0.0
0.7
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

4.5
5.6
2.8
3.6
1.0
3.5
2.8
3.3
11.1
6.0
8.3

3.6
1.2
0.9
0.0
0.0
0.0
1.3
1.0
6.7
0.0
0.0
0.0
0.0
0.0
3.5
0.0
0.0
0.0
0.0
0.0
0.0
0.0

Female
Cases MV(%) DCO(%) UB(%) MI(%)

*
*

13.3
9.4
5.1
3.6
5.1
4.6
5.1
13.3
7.4
6.5
9.8
6.3
15.8
3.7
3.7
1.5
11.5
8.2
4.0
4.8
4.0
5.0
8.7
3.8
4.7
5.1
3.6
2.7
4.0
3.0
4.7
5.3
4.0
4.5

7.5

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

803

861

Indices of data quality

Kidney etc. (C64-66, C68)


Male
Cases MV(%) DCO(%) UB(%) MI(%)
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

18 94.4
157 86.6
34 100.0
23 78.3
46 69.6

5.7
13.0

81 90.1
123 88.6
21 61.9
72 83.3
1469 74.1
62 87.1
139 80.6
309 73.5
84 82.1
32 90.6
35 100.0

9.9
2.4
14.3
12.5
9.1
0.0
2.2
7.4
8.3

9113 81.9
988 83.8
1246 85.5
553 75.4
348 85.6
184 95.1
7 100.0
484 82.4
4827 80.1
60 83.3
416 86.3
1627 92.2
304 85.2
1306 93.9
204 92.6
2042 89.9
10355 91.6
591 91.4
687 90.0
1822 92.0
7145 91.6
1908 91.5
139 84.2
72 91.7
47 89.4
18 83.3
236 92.8
1303 91.9
2667 92.4
315 92.4
51 96.1
53 96.2
37 89.2
26 96.2
661 90.9
1486 92.7
1367 87.0
1497 94.7
94 97.9
1379 94.3
198 81.3
133 76.7
55 94.5
7822 91.0
514 88.9
7214 91.2
2638 91.9
628 90.4
1991 92.3
794 96.0
241 95.0
542 96.3
432 88.0
5016 91.8
596 89.9
4300 91.9
2583 91.6
1302 89.7
1808 90.7
2014 91.7
486 86.0
1524 93.6
125 84.8
316 93.0

1.1
0.4
1.4
3.8
0.0

0.0

0.0
1.9
0.8
0.0
2.4
0.9
1.3
0.8
0.0
1.9
0.7
0.5
0.7
0.5
0.7
0.8
2.2
1.4
0.0
0.0
0.4
0.8
0.5
0.6
0.0
0.0
0.0
0.0
0.8
0.4
2.0
0.6
0.0
0.7
4.0
3.8
5.5
2.3
4.1
2.2
2.2
1.4
2.5
0.9
0.8
0.9
1.2
1.7
2.3
1.7
1.2
1.4
0.8
0.8
1.4
0.7
0.8
0.3

0.0
0.0
0.0
0.0
0.0

20.4

804

35
92
18
17
38

97.1
84.8
88.9
70.6
81.6

7.6
7.9

0.0
8.9
14.3
0.0
0.0
0.0
0.0
0.0
0.0
3.1
0.0

70.4
33.3
28.6
50.0
33.7
51.6
46.0
43.0
38.1
46.9

39 84.6
94 90.4
13 92.3
50 90.0
925 74.3
39 82.1
117 79.5
198 73.2
63 73.0
26 80.8
20 100.0

10.3
3.2
7.7
6.0
8.6
2.6
6.0
10.6
19.0

8.9
0.1
0.0
0.0
0.0
0.0
0.0
0.6
16.7
0.0
0.0
1.5
2.6
1.2
2.0
1.5
0.8
0.7
1.2
0.8
0.8
0.5
2.2
0.0
2.1
0.0
0.8
0.2
0.4
0.0
0.0
0.0
0.0
0.0
0.5
0.6
1.2
0.3
0.0
0.4
3.0
3.0
0.0
0.4
0.2
0.4
0.4
0.5
0.4
0.0
0.0
0.0
0.2
0.4
0.8
0.3
0.6
0.2
1.8
0.3
0.0
0.4
0.0
0.9

33.3
35.1
41.5
38.9
34.2
46.2
42.9
35.7
28.9
45.0
36.3
32.0
32.2
32.3
28.9
31.8
35.1
34.9
33.9
31.7
36.4
33.3
35.3

5581 79.0
642 83.2
747 80.6
323 71.2
246 85.4
123 91.9
2 100.0
318 83.6
2873 76.5
32 87.5
275 81.1
1056 90.2
244 89.8
798 90.2
89 89.9
1247 89.3
6181 89.7
372 92.7
461 87.9
1213 92.3
4068 88.8
1151 89.2
115 87.0
51 92.2
38 97.4
17 88.2
171 91.2
726 88.3
1691 89.5
211 88.6
35 91.4
37 94.6
21 100.0
18 100.0
454 92.7
886 87.5
844 85.7
987 91.8
61 93.4
909 91.5
136 89.0
106 86.8
25 96.0
4672 89.2
393 89.3
4235 89.2
1687 88.3
416 88.2
1252 88.3
450 90.0
144 90.3
297 89.6
319 89.3
3421 89.3
449 86.6
2902 89.5
1820 90.7
867 88.1
1185 87.4
1318 87.5
336 87.2
979 87.6
98 85.7
204 87.3

1.5
0.5
3.7
3.1
0.0

30.9
34.1
33.9
34.3
45.1
35.8
37.8
15.4
32.5
34.6
31.7
31.1
22.3
32.2
30.8
39.1
16.4
30.3
31.1
30.5
31.0
27.9
32.1
29.5
23.7
32.1
35.4
32.7
33.1
33.2
36.3
42.4
34.5
31.8
29.2
32.5
29.6
32.0

*Important. See note on population page.

862

Female
Cases MV(%) DCO(%) UB(%) MI(%)

0.0

0.0
1.3
1.0
0.0
2.9
0.8
0.4
0.9
0.0
1.5
0.9
0.0
1.5
0.4
1.1
1.0
1.7
0.0
0.0
0.0
0.6
1.2
1.2
1.9
0.0
0.0
0.0
0.0
0.7
1.6
2.4
0.9
0.0
1.0
2.9
2.8
4.0
3.0
1.5
3.2
2.8
1.4
3.3
1.8
1.4
2.0
2.5
2.1
3.8
1.9
1.0
1.6
1.0
0.7
0.0
0.9
0.0
1.5

0.0
0.0
0.0
0.0
0.0

17.4

2.6
6.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

94.9
20.2
15.4
40.0
33.0
61.5
39.3
39.9
47.6
38.5

10.5
0.2
0.0
0.0
0.0
0.0
0.0
0.6
20.4
0.0
0.0
1.8
1.2
2.0
0.0
1.4
1.0
0.5
1.1
0.6
1.1
0.6
0.9
0.0
0.0
0.0
0.6
0.6
1.1
0.9
0.0
0.0
0.0
0.0
0.2
1.5
1.7
0.8
0.0
0.9
1.5
1.9
0.0
0.4
0.5
0.4
0.4
0.5
0.3
0.2
0.0
0.3
0.9
0.4
0.4
0.4
0.6
0.2
2.2
0.5
0.6
0.4
0.0
0.0

32.5
34.0
41.8
39.3
35.0
48.0
150.0
31.1
27.7
34.4
37.5
31.4
32.8
31.3
16.9
30.2
34.6
30.6
31.0
27.0
37.8
34.1
35.7
22.8
38.6
34.5
30.8
54.3
29.7
28.6
27.8
28.9
38.4
28.9
29.0
23.0
29.9
24.3
20.8
40.0
27.9
24.4
28.5
28.9
26.0
29.9
32.4
27.1
35.4
31.0
31.7
28.7
32.4
34.1
38.1
34.7
33.2
30.4
34.1
32.7
32.4

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Kidney etc. (C64-66, C68) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

635
2630
4021
526
3421
1769
386
1350
2429
218
2195
375
89022
7891
78498
3816
365
3337
679
47
240
382
7944
696
7039
4432
400
3943
1404
1282
5971
498
5367
526
9779
939
8187
26562
1032
2483
2482
20243
1670
350
1295
7846
709
6985
493
234
2334
1532
878
2248

90.1
93.0
91.9
90.7
92.0
93.2
91.5
93.6
90.9
88.5
91.1
92.0
91.2
88.9
91.4
92.6
90.1
92.7
88.4
85.1
88.3
89.0
91.3
90.4
91.3
92.5
91.5
92.5
88.0
90.2
90.6
85.5
90.9
92.4
92.0
91.6
92.0
91.9
92.5
90.1
92.2
92.0
90.4
88.9
90.9
89.8
87.9
89.9
90.7
93.6
89.8
90.1
91.1
92.3

1.1
1.7
1.0
1.0
1.0
0.8
0.5
1.0
2.3
1.8
2.4
2.7
1.6
2.2
1.6
1.1
2.2
1.0
2.5
4.3
1.7
2.9
1.2
1.6
1.2
2.7
2.8
2.7
2.1
1.0
0.9
2.0
0.8
1.0
0.9
0.7
1.0
0.8
0.4
1.0
0.6
0.8
2.9
2.9
2.9
3.3
4.1
3.2
0.4
1.3
1.0
0.7
1.8
2.1

1.6
1.3
1.4
1.5
1.4
0.5
1.0
0.4
2.1
1.4
2.2
0.3
0.9
1.1
0.9
0.7
0.0
0.8
0.1
0.0
0.0
0.3
1.0
0.9
1.0
1.2
1.5
1.1
0.4
0.9
0.6
0.4
0.7
0.4
0.3
0.7
0.3
0.7
0.7
0.6
0.7
0.7
2.0
2.0
1.8
1.5
2.3
1.3
0.2
0.9
0.8
0.5
0.6
1.4

34.8
30.6
33.2
25.9
34.6
31.2
25.4
33.2
34.0
27.1
34.7
37.6
32.1
30.1
32.7
30.4
31.2
30.8
38.3
40.4
30.8
42.9
27.1
23.9
27.7
36.9
36.0
37.8
40.7
37.5
30.4
25.1
31.4
30.0
34.6
26.7
35.9
34.2
33.7
29.6
29.2
35.6
32.6
32.0
33.4
33.4
33.9
33.9
34.3
37.2
33.6
36.6
31.4
35.2

27 74.1
162 75.9
1033 89.3
24 62.5
84 91.7
1271 69.9
65 69.2
119 95.8
122 89.3
578 90.3
6 83.3
446 92.8
45 100.0
112 93.8
42 83.3
1970 87.6
1828 89.2
86 88.4
256 77.0
285 75.8
385 89.1
885 84.4
543 85.5
1989 76.1
324 68.5

11.1
0.0
1.5
0.0
0.0
0.4
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.8
8.2
0.0
0.0
0.4
0.0
0.0
0.0
2.7
2.4
2.3
6.6
2.1
0.0
0.0
0.0
0.0
2.2

59.3
39.5
38.3

1.6
0.3
0.0
2.2
0.0
2.7
0.0
2.2
1.9
2.3
16.4
3.9
2.3
5.3
6.3
7.8
13.0

60.7
29.4
27.0
16.7
26.2
27.9
46.5
43.2
29.9
32.5
37.2
52.6
58.6

Female
Cases MV(%) DCO(%) UB(%) MI(%)
377
1865
2681
380
2254
1197
301
885
1635
150
1467
218
57133
5768
49732
2424
262
2105
382
31
152
190
5142
553
4468
3165
320
2784
893
776
3967
342
3555
351
6042
674
4979
16440
630
1720
1637
12274
984
267
706
5076
582
4397
314
151
1321
874
569
1486

88.6
89.8
89.5
90.0
89.4
89.2
91.0
88.6
89.2
88.0
89.3
85.3
89.2
88.5
89.2
90.0
91.2
89.8
85.1
90.3
84.9
84.2
88.0
88.8
87.8
90.8
90.3
90.9
87.8
90.1
89.1
84.5
89.5
87.5
89.1
90.2
88.8
89.2
91.7
89.0
91.6
88.8
90.4
90.6
90.2
88.7
85.9
89.0
92.4
92.7
87.0
87.3
89.8
90.2

1.3
2.2
1.1
0.5
1.2
1.8
0.7
2.1
2.3
3.3
2.2
5.0
1.9
1.9
2.0
1.3
0.4
1.4
3.1
0.0
3.3
3.7
1.8
1.1
1.9
2.9
2.8
2.9
2.9
0.9
0.7
1.2
0.6
3.7
1.4
1.0
1.5
1.1
0.0
1.0
0.6
1.3
2.0
1.1
2.4
3.7
4.6
3.6
0.0
0.0
1.1
1.0
1.1
2.6

1.3
1.9
1.8
1.3
1.8
0.8
0.7
0.7
2.5
2.0
2.5
0.5
1.2
1.1
1.2
1.0
1.5
1.0
2.1
0.0
2.0
2.6
1.7
1.8
1.7
1.3
1.6
1.3
0.3
0.9
0.8
0.6
0.8
0.9
0.9
0.6
0.9
1.0
0.8
0.9
0.7
1.1
1.5
0.0
2.1
1.8
1.7
1.7
0.3
0.0
2.0
2.1
1.2
2.2

25 84.0
96 66.7
601 86.7
11 72.7
48 87.5
733 72.2
21 90.5
60 95.0
77 83.1
231 89.2
3 66.7
203 90.6
23 100.0
62 90.3
10 70.0
1166 86.8
1098 88.7
35 82.9
104 76.0
139 67.6
160 85.6
410 77.3
291 81.1
939 70.8
225 67.6

4.0
0.0
1.8
0.0
0.0
0.7
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
9.1
0.0
0.0
0.5
0.0
0.0
0.0
3.2
3.0
5.7
10.6
1.4
0.0
0.0
0.3
0.0
4.0

5.2
0.0
0.0
3.9
0.0
4.8
10.0
2.8
1.9
2.9
13.5
3.6
5.0
11.0
7.9
11.9
12.0

36.1
28.0
32.2
25.8
33.6
32.2
27.6
34.1
33.5
24.7
34.4
34.4
30.9
27.5
31.7
30.9
27.1
31.9
34.3
32.3
30.9
37.9
27.5
23.7
28.4
34.5
28.4
35.9
40.1
33.8
31.2
30.7
31.8
35.6
33.1
28.0
34.2
33.5
29.7
28.8
25.3
35.6
30.1
25.8
32.0
30.3
33.0
30.4
26.4
25.2
33.1
35.4
33.7
30.1
44.0
50.0 *
43.4
*
50.0
31.2 *
*
*
35.1
*
33.3
29.6
*
*
*
25.9
43.3
51.1
35.6
40.5
40.2
56.3
45.8

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

805

863

Indices of data quality

Kidney etc. (C64-66, C68) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

5280
538
326
175
153
280
44
1524
104
63
44
85
79
37
56
319
456
411
14
31
78
36
25
97
307

83.9
81.2
85.3
85.1
81.0
82.9
86.4
86.7
86.5
85.7
88.6
88.2
78.5
89.2
96.4
65.8
82.5
83.7
78.6
67.7
87.2
66.7
80.0
89.7
91.9

2.9
1.3
1.8
2.9
0.7
2.1
0.0
3.1
4.8
7.9
2.3
1.2
8.9
0.0
0.0
17.9
0.0
0.0
0.0
0.0
0.0
13.9
4.0
5.2
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.0
1.0

32.3
35.5
31.0
25.1
28.8
35.7
27.3
27.1
26.9

3986
270
130
3825
652
1995
1740
1636
7631
1960
709
2189
546
237
189
329
417
370
475
181
259
169
202
1804
3238
716
1245
1222
1212
605
147
1093
116
436
270
826
361
99
705
437
120
1463
248
63
257
745
231
176
69
110
464
585
314
1223

93.4
93.0
90.8
66.2
92.6
93.2
63.5
69.1
78.9
85.3
83.6
90.3
96.0
96.2
92.6
95.4
95.9
92.2
97.1
96.1
90.0
86.4
96.0
82.4
84.1
80.2
84.9
87.4
87.3
93.7
95.2
75.1
75.9
84.6
83.0
84.0
79.2
87.9
87.2
90.2
78.3
87.6
87.5
77.8
78.2
83.9
71.0
84.7
84.1
82.7
88.4
79.7
87.9
86.5

4.9
1.1
6.2

0.1
0.0
0.8
0.0
0.0
2.5
0.1
26.5
0.3
4.5
0.0
1.1
0.0
0.0
0.5
1.2
0.0
0.5
0.4
0.0
0.8
0.6
2.5
0.9
0.0
0.0
0.2
0.0
0.6
0.0
0.0
0.7
2.6
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.6
4.3
0.0
0.2
10.8
0.0
0.0

39.5
33.7
36.9
51.2

9.5
4.3
3.7
0.5
0.6
1.3

0.0
12.7
10.7
5.9
10.6
5.9
7.5
3.5
0.0
2.0
0.9
0.9
2.2
0.1
0.0
3.0
1.0
0.0
0.8
0.2
0.0
1.6
0.0
1.2
2.6
1.7
2.9
0.0
0.6
0.5
0.3
0.4

19.0

44.3

77.8
72.0
24.7

45.6
48.5
46.6
50.1
52.6
51.2
44.7
35.2
36.7
34.4
31.0
40.3
40.3
41.9
44.2
45.9
38.5
52.5
86.4
29.8
58.0
26.9
41.9
48.8
42.3
46.3
46.3
40.5
36.0
42.6
35.5
36.3
47.5
32.9
36.8
35.4
32.3
35.9
54.0
36.2
38.1
48.9
43.2
46.4
30.7
30.4
34.7
29.0
28.7

*Important. See note on population page.

864

806

Female
Cases MV(%) DCO(%) UB(%) MI(%)
2436 79.7
264 75.4
169 79.3
72 79.2
63 81.0
141 79.4
25 76.0
674 81.5
43 83.7
27 74.1
17 82.4
43 79.1
32 100.0
35 91.4
21 95.2
231 62.3
274 77.7
238 77.3
8 75.0
28 82.1
40 75.0
15 53.3
18 77.8
55 89.1
154 94.2
3021
199
85
2589
376
1261
906
1078
4980
1366
493
1731
328
119
87
219
185
213
256
103
124
90
114
1241
2228
478
849
791
820
405
93
571
60
239
152
425
200
51
387
221
89
812
134
41
148
426
136
87
38
56
292
268
150
682

89.9
89.9
88.2
70.3
92.8
90.6
63.2
62.9
76.3
82.1
82.2
87.3
92.4
94.1
92.0
90.0
96.2
87.8
96.9
92.2
88.7
84.4
93.9
78.8
79.5
77.4
80.8
82.7
83.4
91.4
86.0
76.9
75.0
79.9
82.2
81.6
70.5
80.4
78.3
83.7
74.2
83.3
79.9
65.9
76.4
78.4
61.8
74.7
71.1
80.4
79.8
73.1
84.7
80.2

3.4
2.7
2.4
2.8
0.0
1.4
4.0
4.0
2.3
14.8
17.6
4.7
0.0
0.0
0.0
20.3
0.0
0.0
0.0
0.0
0.0
6.7
11.1
5.5
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.6

2.5 *
73.3 *
55.6
9.1 *
*

7.7
2.5
4.7

0.1
0.0
1.2
0.0
0.0
3.4
0.0
30.1
0.4
4.0
0.0
1.2
0.3
0.0
0.0
1.4
0.0
0.9
0.0
0.0
0.0
0.0
2.6
0.9
0.1
0.0
0.2
0.0
0.4
0.0
0.0
1.1
1.7
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2.3
5.3
0.0
0.0
15.7
0.0
0.0

41.1
38.2
37.6
42.5 *
*
53.1
46.2 *
40.4
49.6
60.5
47.1
45.8
36.3
52.1
35.6
41.6
47.0
32.9
39.1
53.4
52.4
32.2
71.9
89.9
34.1
65.7
29.0
39.7
46.8
41.5
47.3
46.2
41.7
31.8
32.2
42.1
36.5
47.1
37.5
26.7
27.2
38.5
35.8
22.0
31.8
36.6
25.0
40.2
36.8
33.5
30.1
39.6
39.3
25.8

12.0
6.6
4.8
0.7
0.0
1.8

0.0
16.0
13.0
10.0
14.7
8.5
11.2
4.9
0.0
4.0
1.7
2.1
2.0
0.7
0.5
0.0
2.6
0.0
0.0
0.5
0.0
0.0
1.4
1.9
1.5
2.3
10.5
0.0
0.3
0.7
0.0
1.5

33.5
39.4
32.0
25.0
31.7
35.5
42.0
28.4
41.9

47.8

*
*
*

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Kidney etc. (C64-66, C68) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

1078
1677
86
1652
273
520
627
582
708
1718
1119
1981
699
76
691
882
272
62
202
195
280
272
167
233
3037
150
91
78
177
148
96
198
5444
336
333
862
783
1326
2442
761
2561
3847
1743
1712
507
1858

62.5
72.4
74.4
86.1
67.4
75.0
69.2
95.0
82.1
62.3
77.1
79.2
97.6
85.5
89.0
85.4
83.5
80.6
88.6
91.8
88.9
89.3
81.4
94.4
94.8
94.0
95.6
91.0
87.0
93.2
94.8
92.9
87.2
83.3
90.1
73.0
69.3
70.0
73.1
79.6
73.1
68.3
67.9
76.0
74.0
75.9

2544
32
1351
682
208
1822
627
93
28
1172
411
27
44
53
129
140

91.2
90.6
86.2
83.4
89.9
86.4
89.2
94.6
92.9
83.4
94.2
88.9
93.2
96.2
96.1
92.9

5.6
1.6
3.5
1.0
7.0
2.3
0.6

55.3
50.0
55.8
51.3
67.3
48.3
53.3
37.3
43.5
51.3
50.4
53.6
49.5
43.4
34.2
34.4
46.0
30.6
43.1
47.7
42.1
34.2
36.5
54.1
69.0
30.0
53.8
42.3
52.0
34.5
44.8
51.5
57.3

0.2
6.0
2.7
2.7
1.4
3.1
9.7
6.0
5.5
0.8
0.5

0.1
0.0
0.0
0.0
0.0
3.8
0.5
0.0
0.0
6.2
0.0
1.1
1.7
1.3
1.0
0.6
0.4
0.0
0.0
0.0
1.1
0.0
0.6
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.0
0.0
0.0
0.0
0.0
1.9
0.5
2.4
0.1
11.0
10.6
4.0
1.1
0.0
0.0
0.9

0.9
0.0
1.2
0.0
0.5
1.6
4.0
0.0
3.6
3.6
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.1
0.4
0.5
1.5
0.0
0.0
0.0
0.2
0.5
0.0
0.0
0.0
0.8
0.7

34.7
21.9
33.8
33.4
36.1
38.1
35.7
40.9
21.4
43.0
34.1

12.1
10.9
7.7
0.7
2.6
2.3
2.3
4.0
4.8
2.5
1.0
3.9
0.7
4.8
3.9
0.0
0.0
1.3
0.6
2.7
1.0
1.0

66.1
58.1
49.6
52.9
47.4
48.5
51.9
51.3
48.9
51.8
44.8
52.1

31.4

Female
Cases MV(%) DCO(%) UB(%) MI(%)
864
1268
56
1078
196
339
414
308
405
1648
736
1363
404
38
269
353
139
35
105
104
133
112
76
117
2226
61
51
32
107
74
43
142
3455
216
215
516
490
853
1602
446
1530
2267
1055
978
329
1295

63.7
73.6
87.5
79.0
60.2
72.9
67.9
95.1
78.0
66.3
78.4
77.2
97.0
86.8
78.4
79.0
77.0
65.7
81.9
80.8
88.0
79.5
77.6
94.9
94.0
83.6
84.3
90.6
92.5
87.8
93.0
85.2
84.6
83.3
90.7
70.5
65.1
65.3
69.8
74.9
69.5
63.5
62.4
71.6
70.5
69.9

1659 88.1
16 100.0
884 82.4
357 81.8
135 86.7
1116 86.0
365 86.0
75 92.0
10 60.0
693 80.4
206 89.3
15 80.0
31 100.0
22 95.5
68 85.3
52 94.2

5.1
1.1
7.1
1.2
5.1
2.4
0.7

0.2
5.1
3.3
2.7
0.9
3.6
12.1
7.5
8.0
2.1
0.5

0.1
0.0
0.0
0.2
0.0
3.2
0.0
0.0
0.0
4.9
0.1
1.5
1.5
0.0
1.5
1.4
5.8
0.0
1.0
0.0
0.8
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.4
0.2
2.6
0.1
17.3
11.4
4.5
1.4
0.0
0.0
1.8

1.0
0.0
1.2
0.0
1.5
1.4
4.1
0.0
20.0
3.9
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.1
0.3
0.7
1.5
0.3
0.0
0.0
0.1
1.5
0.0
0.0
0.0
2.9
1.9

17.0
9.5
9.0
1.5
5.3
4.1
1.7
5.8
11.4
1.9
0.0
5.3
2.7
6.6
2.6
4.9
0.0
0.0
0.9
4.1
0.0
8.5

47.1
45.0
44.6
56.4
48.5 *
41.7
54.8
36.4 *
37.8
46.1
52.9
51.1
51.5
39.5
37.8
41.1
51.3
40.0
34.3
52.9
39.1
40.2
42.1
54.7
70.3
31.1
49.0
75.0
54.2
37.8
65.1
40.8
59.3
60.9
49.4
50.4
55.8
49.1
55.2
52.9
53.6
51.4
50.7
47.7
50.5
41.1
25.0
38.8
37.8
30.2
35.8
36.2
40.0
40.0
45.5
33.5

26.9

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

807

865

Indices of data quality

Bladder (C67)
Male
Cases MV(%) DCO(%) UB(%) MI(%)
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

81
1080
175
29
95

86.4
91.8
99.4
51.7
47.4

136 89.0
238 95.0
41 97.6
168 92.9
3309 85.8
35 91.4
293 88.7
423 81.1
141 85.1
88 87.5
33 100.0
15145
1812
3282
734
647
378
9
911
6445
96
831
2720
221
2462
307
4103
20643
969
659
1534
17188
3784
145
129
68
37
227
3022
4768
301
122
57
88
44
538
3524
2662
3457
73
3329
273
147
110
18528
495
17800
4275
466
3773
1147
153
971
1008
9640
477
8908
4492
2611
3158
2849
365
2463
131
536

91.5
98.0
98.4
91.0
98.1
100.0
100.0
96.5
83.3
100.0
97.5
98.2
96.8
98.3
98.4
98.7
98.9
98.5
98.2
98.6
98.9
98.9
98.6
96.9
95.6
100.0
99.1
99.0
99.3
97.7
99.2
100.0
100.0
97.7
99.3
99.4
98.3
98.9
97.3
98.9
97.8
98.6
97.3
98.6
97.0
98.6
98.2
97.9
98.3
98.7
98.0
98.8
98.8
98.6
98.1
98.6
98.7
98.4
98.2
98.8
98.1
98.9
99.2
98.9

4.2
15.8
9.6
1.7
2.4
3.0
4.7
0.0
2.0
3.8
2.8
0.0
0.5
0.1
0.7
1.1
0.2
0.0
0.2
0.6
0.0
0.4
0.4
0.0
0.4
0.0
0.4
0.4
0.4
0.5
0.3
0.4
0.4
0.7
0.8
1.5
0.0
0.0
0.4
0.3
0.3
0.8
0.0
0.0
0.0
0.2
0.3
0.5
0.4
1.4
0.4
1.5
0.7
2.7
1.0
2.2
1.0
1.1
1.3
1.1
0.8
0.7
0.8
0.7
0.7
1.0
0.7
0.4
0.5
0.3
0.1
0.3
0.1
0.0
0.0

0.0
0.0
0.0
0.0
0.0

17.2

808

11 90.9
262 88.5
22 100.0
17 64.7
63 49.2

1.5
3.4
0.0
0.0
0.0
0.0
0.3
0.0
0.0
1.1
0.0

48.5
22.7
22.0
35.1
26.6
42.9
33.1
35.0
32.6
39.8

31 83.9
104 92.3
16 68.8
59 86.4
1299 79.1
17 82.4
109 83.5
138 68.8
53 75.5
33 87.9
16 100.0

6.8
0.1
0.0
0.1
0.0
0.0
0.0
0.1
16.0
0.0
0.0
0.8
1.4
0.8
1.3
0.4
0.2
0.0
0.5
0.3
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
0.7
0.0
0.0
0.0
0.0
0.2
0.1
0.2
0.1
0.0
0.1
0.7
0.7
0.0
0.1
0.4
0.1
0.3
0.0
0.3
0.3
0.0
0.3
0.0
0.2
0.4
0.2
0.4
0.1
0.9
0.1
0.0
0.1
0.0
0.0

26.4
21.2
19.8
30.2
20.7
31.7
33.3
21.7
32.0
18.8
24.3
19.7
32.1
18.8
14.7
18.5
19.6
19.0
25.6
17.7
19.8
18.9
29.7

5241
599
1169
238
209
114
2
300
2279
30
301
933
134
789
72
1269
6751
292
312
562
5496
1390
72
48
17
17
100
1099
1601
154
30
10
29
20
206
1119
874
1293
38
1240
162
111
47
6100
258
5773
1515
267
1241
457
113
340
266
3514
325
3100
1584
880
1080
975
219
749
66
188

17.2
18.6
19.8
24.9
17.2
14.0
17.0
18.2
20.6
19.9
15.6
17.4
28.8
17.5
24.9
31.3
19.1
17.9
29.9
17.8
19.1
31.8
17.6
19.9
31.4
18.4
19.4
18.0
24.5
18.1
20.3
17.6
19.8
17.1
26.0
15.8
26.0
18.5

*Important. See note on population page.

866

Female
Cases MV(%) DCO(%) UB(%) MI(%)

89.0
94.8
96.6
87.4
98.1
100.0
100.0
93.0
80.9
90.0
95.7
96.8
93.3
97.3
93.1
97.9
97.6
97.9
98.4
97.7
97.6
97.8
98.6
100.0
100.0
100.0
98.0
97.6
98.7
98.1
100.0
100.0
96.6
100.0
98.1
98.8
96.1
98.1
100.0
98.1
98.1
99.1
97.9
98.2
96.5
98.3
97.2
95.1
97.6
98.7
96.5
99.4
97.0
97.5
94.8
97.7
97.5
96.1
96.1
97.7
95.4
98.4
95.5
98.9

6.5
6.3
12.9
4.8
31.3
10.2
6.2
5.9
3.7
6.5
11.3
0.0
1.4
0.5
1.5
0.8
0.5
0.0
0.7
1.9
0.0
2.3
0.3
0.7
0.3
0.0
0.6
0.6
0.3
1.3
0.4
0.6
0.6
1.4
0.0
0.0
0.0
0.0
0.7
0.4
1.3
0.0
0.0
0.0
0.0
1.0
0.2
1.6
1.0
0.0
1.0
1.2
0.9
0.0
1.2
2.3
1.1
1.8
2.2
1.7
0.4
1.8
0.0
0.4
1.5
4.0
1.3
1.0
1.8
0.8
0.3
0.9
0.1
1.5
0.0

0.0
0.0
0.0
0.0
0.0

23.7

0.0
2.9
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

96.8
26.0
50.0
44.1
27.3
41.2
34.9
47.1
49.1
64.4

7.4
0.2
0.1
0.0
0.0
0.0
0.0
0.3
16.9
0.0
0.0
1.7
3.0
1.5
4.2
0.8
0.5
1.0
0.3
0.9
0.4
0.3
0.0
0.0
0.0
0.0
2.0
0.2
0.2
0.6
0.0
0.0
3.4
0.0
0.0
0.1
0.9
0.1
0.0
0.1
0.6
0.0
2.1
0.2
0.4
0.2
0.3
0.4
0.3
0.2
0.0
0.3
0.0
0.2
0.3
0.2
0.3
0.2
1.5
0.3
0.5
0.3
0.0
0.5

29.8
25.0
23.3
30.7
27.8
33.3
50.0
21.3
36.8
20.0
21.3
26.3
38.1
24.5
26.4
24.1
27.4
27.1
41.3
24.7
27.3
26.3
51.4
20.0
26.1
28.5
40.3
33.3
20.0
34.5
15.0
25.7
28.1
24.8
21.6
21.1
21.8
40.1
44.1
29.8
22.8
53.1
21.7
30.8
46.1
27.6
31.5
43.4
27.6
30.1
26.1
43.4
24.9
28.0
26.0
28.4
28.0
40.2
24.3
33.3
27.7

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Bladder (C67) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

1393 97.8
6244 98.7
8537 98.4
417 98.3
8007 98.4
3423 99.2
308 99.4
3093 99.2
4338 98.2
166 98.2
4145 98.2
827 97.9
175440 98.4
6605 97.7
164400 98.4
8084 99.0
325 99.1
7603 99.0
1064 98.0
12 100.0
208 97.1
832 98.2
16299 97.5
697 96.8
15312 97.5
9715 97.9
387 96.4
8991 98.0
2404 96.7
3190 98.3
13141 99.0
418 99.5
12544 98.9
1254 98.4
19184 98.8
734 98.6
17511 98.9
51459 98.8
1585 98.8
2080 98.5
2241 98.4
45005 98.9
2691 98.1
257 96.9
2407 98.3
10569 97.4
504 95.6
9864 97.4
1001 99.5
522 97.5
4877 98.6
3292 98.8
1817 98.8
4435 98.0
81
351
2499
73
138
1996
169
500
238
1128
35
767
109
167
51
4767
4422
255
415
473
718
1174
951
3011
549

90.1
78.1
95.1
97.3
84.1
79.9
88.2
99.0
71.4
74.9
85.7
77.7
96.3
82.6
96.1
95.6
96.0
98.0
93.5
94.1
98.5
87.4
94.2
80.6
86.9

Female
Cases MV(%) DCO(%) UB(%) MI(%)

0.6
0.6
0.6
1.2
0.5
0.4
0.0
0.4
0.7
1.8
0.7
1.5
0.6
1.0
0.6
0.3
0.0
0.3
0.7
0.0
1.4
0.5
0.5
1.3
0.5
1.1
1.6
1.1
0.7
0.7
0.3
0.0
0.3
0.8
0.4
0.4
0.4
0.3
0.3
0.3
0.4
0.3
0.6
1.6
0.5
1.0
1.4
1.0
0.0
0.8
0.4
0.1
0.7
0.8

0.8
0.5
0.6
0.0
0.6
0.2
0.0
0.2
0.6
0.0
0.7
0.1
0.4
0.6
0.4
0.4
0.6
0.4
0.4
0.0
0.0
0.5
0.7
0.6
0.7
0.6
1.3
0.5
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.0
0.1
0.3
0.1
0.3
0.2
0.3
0.9
1.2
0.8
1.1
1.4
1.1
0.0
0.4
0.2
0.2
0.2
0.8

20.7
18.2
18.7
23.0
18.6
16.9
25.3
16.0
18.6
28.3
18.3
20.6
18.8
27.0
18.8
18.3
26.5
18.2
20.3
41.7
21.2
19.6
19.0
25.3
18.7
20.1
28.4
20.5
21.5
19.0
18.3
25.6
18.3
17.1
18.0
27.1
17.7
18.8
18.5
25.8
17.0
18.7
19.1
26.1
18.4
19.8
28.4
19.6
18.9
21.5
17.7
17.2
17.8
19.7

541 95.4
2466 97.4
2899 98.4
242 97.1
2617 98.5
1214 99.3
191 97.4
1013 99.7
1470 96.9
96 97.9
1361 96.8
281 96.4
61379 97.4
3832 95.8
56118 97.5
3036 97.9
204 96.1
2777 97.9
348 96.8
3 100.0
61 98.4
280 96.4
6382 96.3
448 96.0
5848 96.4
3526 97.3
220 96.4
3194 97.3
805 95.2
1022 97.9
4820 98.2
236 96.2
4527 98.4
482 98.3
6653 97.8
445 97.3
5923 97.8
17555 97.7
478 98.1
1156 97.0
824 98.2
14924 97.6
854 96.4
175 92.6
674 97.3
3460 95.4
277 93.1
3111 95.6
306 98.0
225 98.7
1512 97.5
1013 96.9
766 97.7
1611 97.0

1.5
1.1
0.5
0.8
0.5
0.2
0.5
0.1
1.6
2.1
1.5
1.4
1.0
2.1
1.0
0.8
1.5
0.8
2.3
0.0
1.6
2.5
1.0
1.3
1.0
1.5
2.7
1.4
0.4
1.0
0.4
1.7
0.4
1.2
0.8
1.1
0.8
0.7
0.4
1.1
0.5
0.7
1.5
2.3
1.3
2.3
4.3
2.1
0.0
0.4
0.5
0.3
0.5
0.9

1.8
0.9
0.5
0.8
0.5
0.1
0.5
0.0
0.9
0.0
1.0
0.4
0.6
0.8
0.6
0.5
0.5
0.5
0.6
0.0
0.0
0.7
0.9
0.7
0.9
0.9
0.5
0.9
0.4
0.2
0.4
0.4
0.4
0.0
0.3
0.2
0.3
0.5
0.8
0.4
0.6
0.4
1.4
4.0
0.7
1.4
1.8
1.4
0.0
0.0
0.5
0.6
0.7
1.4

1.2
0.0
0.3
0.0
2.9
0.5
0.0

2.5
0.3
0.0
0.0
2.2
0.0
0.0
0.8
22.7
0.0
0.0
0.1
0.0
0.0
0.0
1.2
1.2
0.0
0.5
0.6
0.0
0.0
0.3
0.0
1.6

43.2
43.9
28.6

21 95.2
95 77.9
803 95.6
15 86.7
45 91.1
609 76.4
37 78.4
100 100.0
86 74.4
225 69.3
2 100.0
182 76.9
37 97.3
61 78.7
13 92.3
1153 94.6
1101 95.5
26 100.0
112 79.5
143 83.9
207 93.2
423 77.3
291 88.0
937 72.1
216 81.0

4.8
0.0
0.4
0.0
0.0
0.7
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
20.9
0.0
0.0
0.0
0.0
0.0
0.0
1.3
1.3
0.0
3.6
2.1
0.0
0.0
0.3
0.0
0.9

0.8
1.2
0.0
6.3
0.0
3.6
2.0
0.9
0.8
0.0
6.0
0.8
0.6
5.8
3.0
9.4
5.8

46.4
35.9
4.5
42.4
8.6
27.9
20.0
17.8
27.9
16.4
24.2
27.7
36.5
35.9

3.5
0.4
0.0
8.8
0.0
11.5
0.0
1.3
1.1
0.0
17.0
4.2
3.4
14.4
5.2
14.5
13.0

23.1
24.4
23.2
39.3
22.0
21.3
35.6
18.6
24.8
27.1
24.6
24.9
25.4
42.4
24.6
24.4
37.3
23.7
28.7
66.7
39.3
26.1
23.9
44.6
22.3
26.6
39.1
26.7
26.6
25.2
24.1
43.2
23.3
23.9
24.6
39.1
23.5
25.9
26.6
39.1
24.0
25.2
29.5
42.9
26.1
28.4
45.8
27.4
23.2
26.2
21.8
21.6
28.1
25.6
42.9
70.5 *
33.5
*
33.3
40.7 *
*
15.0 *
27.9
*
41.8
25.4
34.8
36.4
31.4
42.6
35.1
47.7
47.2

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

*
*
*

809

867

Indices of data quality

Bladder (C67) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

7405
766
447
236
242
395
47
2022
95
57
103
128
107
85
219
279
600
493
35
72
199
121
119
445
1353

90.3
88.3
94.2
91.9
90.9
89.9
91.5
93.6
87.4
80.7
98.1
95.3
92.5
97.6
99.5
84.9
97.7
97.8
97.1
97.2
94.5
83.5
89.1
93.5
95.6

2.6
3.0
1.1
2.1
1.2
2.3
0.0
2.7
2.1
17.5
1.9
1.6
3.7
0.0
0.0
1.4
0.0
0.0
0.0
0.0
0.0
0.0
1.7
1.1
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.3
1.1

31.8
31.6
28.6
31.4
28.1
35.4
44.7
22.9
25.3

6654
630
284
4323
1691
5587
4313
3079
7424
6154
743
2856
588
378
311
504
695
652
538
279
363
310
295
2329
4370
1603
1734
1968
2526
645
196
1844
330
836
737
2310
1276
356
1674
1024
739
2273
699
436
755
1960
1356
583
479
295
1820
1602
675
2331

97.3
98.7
96.8
91.3
99.7
95.8
79.2
75.4
94.2
94.1
96.8
98.4
99.0
99.5
99.0
98.8
99.4
98.9
99.4
98.6
98.1
97.7
99.3
88.1
87.3
88.5
91.8
93.3
91.6
96.9
98.0
93.0
96.1
90.7
91.2
92.3
88.7
93.3
93.1
99.5
80.6
95.6
94.6
92.0
95.5
93.5
84.2
87.0
94.6
93.6
97.7
90.9
96.1
96.2

2.3
0.6
1.1

0.1
0.0
1.1
0.0
0.0
3.9
0.1
20.9
0.2
3.1
0.0
0.3
0.0
0.3
0.3
0.4
0.0
0.8
0.4
0.0
0.3
0.0
0.7
0.8
0.1
0.0
0.1
0.0
0.6
0.0
0.0
0.5
0.6
0.0
0.0
0.0
0.0
0.3
0.0
0.0
0.0
0.0
0.0
0.9
0.0
0.0
0.0
0.7
0.8
0.0
0.0
6.6
0.0
0.0

25.9
23.2
16.2
51.8

7.1
3.7
1.8
0.2
0.1
0.2

0.0
10.0
10.4
5.1
7.8
2.5
4.6
2.2
0.0
1.8
0.6
0.2
0.1
0.3
0.2
1.1
0.5
0.0
0.7
0.2
0.1
0.9
0.0
0.3
0.6
1.4
2.1
0.0
0.1
0.2
0.0
0.3

23.4
23.4

35.3

53.7
52.9
11.7

23.9
38.0
35.2
35.0
32.7
37.1
25.9
38.9
43.4
41.5
31.7
48.1
42.8
35.3
49.8
48.8
36.5
54.2
64.2
24.3
26.5
19.4
18.4
24.3
35.3
26.0
29.1
20.0
17.8
22.5
25.3
20.8
21.1
25.0
20.5
19.7
32.3
22.6
25.7
19.3
25.8
25.7
30.0
25.3
18.6
21.3
26.1
20.7
19.3

*Important. See note on population page.

868

810

Female
Cases MV(%) DCO(%) UB(%) MI(%)
1935 83.7
176 74.4
139 82.7
67 88.1
77 87.0
104 81.7
16 68.8
548 86.1
24 83.3
27 77.8
14 85.7
39 94.9
30 86.7
36 97.2
47 97.9
102 79.4
181 95.0
159 95.0
3 100.0
19 94.7
96 85.4
39 71.8
23 91.3
72 87.5
175 94.3

5.9
6.3
5.0
3.0
3.9
4.8
0.0
8.6
8.3
14.8
14.3
5.1
0.0
0.0
0.0
2.9
0.0
0.0
0.0
0.0
0.0
5.1
0.0
5.6
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.6

*
61.5 *
208.7
11.1 *
*

2560 94.3
249 98.4
81 92.6
865 90.1
393 99.7
1467 91.5
992 76.3
983 73.1
2731 91.6
2156 90.9
268 90.7
951 95.7
135 95.6
67 94.0
64 98.4
108 95.4
148 100.0
127 94.5
147 98.0
70 100.0
76 92.1
78 97.4
56 100.0
881 81.6
1565 82.8
646 80.2
607 85.2
769 90.1
909 83.6
262 93.5
72 98.6
721 92.5
93 94.6
212 84.0
195 87.2
551 89.5
339 77.0
75 92.0
536 87.1
253 97.2
122 70.5
687 91.7
196 92.3
85 84.7
188 95.2
455 90.1
223 82.5
115 85.2
65 92.3
97 90.7
469 93.6
364 93.1
155 92.3
672 94.3

5.1
1.2
6.2

0.0
0.0
0.0
0.0
0.0
7.0
0.1
22.2
0.3
3.6
0.0
0.4
0.0
0.0
0.0
0.9
0.0
1.6
0.7
0.0
1.3
0.0
0.0
0.8
0.1
0.0
0.0
0.0
0.4
0.0
0.0
0.3
2.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
4.4
0.0
0.0

33.9
24.9
32.1
52.0 *
*
33.3
47.6 *
39.6
37.3
41.4
41.0
35.8
64.4
73.1
64.1
53.7
60.8
70.9
49.7
67.1
48.7
42.3
85.7
92.2
35.2
43.7
28.0
27.7
43.3
49.2
27.8
33.6
22.6
29.2
22.1
27.6
24.8
25.3
31.0
23.7
21.9
45.1
28.1
23.5
26.1
22.2
25.6
21.7
36.9
12.9
27.9
29.7
24.5
24.6

11.0
4.6
2.8
0.4
1.1
0.8

0.0
16.2
14.9
10.8
13.3
4.9
10.1
4.2
0.0
1.8
1.1
2.4
0.5
0.5
1.8
1.3
0.7
0.0
0.0
0.6
1.0
2.4
0.0
1.1
0.9
2.6
1.5
0.0
1.7
1.1
0.6
0.6

39.7
44.9
36.0
34.3
40.3
46.2
28.1
34.2
75.0
12.8
16.7

41.4

*
*
*

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Bladder (C67) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

1153
1844
368
3889
444
1005
1016
1985
1931
1597
2931
2303
1061
370
1553
2329
1044
286
898
1002
1592
905
853
1214
7588
468
140
98
247
266
250
433
9000
975
908
2858
2432
4480
7475
1875
8350
11249
5203
4994
721
5012

86.4
84.9
97.6
97.9
55.6
85.8
79.0
98.1
90.1
71.9
89.5
90.5
98.3
94.6
95.8
95.0
95.4
86.4
97.1
95.7
94.5
97.7
93.3
96.3
99.8
98.5
95.0
96.9
96.4
95.5
98.0
98.2
98.8
99.8
99.2
96.5
95.1
94.8
96.4
95.7
86.6
91.1
91.4
96.1
85.7
95.3

2964
25
2516
1443
397
1413
592
111
45
2115
637
33
49
55
211
261

93.8
100.0
92.6
95.9
99.0
91.0
96.6
91.9
95.6
96.4
99.1
100.0
100.0
100.0
99.5
98.5

2.4
0.6
0.8
0.2
6.3
0.7
0.2

55.0
45.1
32.1
32.0
50.1
39.3
42.5
29.4
36.5
52.7
38.0
43.9
39.7
32.4
32.0
28.0
38.6
35.7
23.8
28.0
28.4
27.7
23.7
35.0
28.2
19.2
39.3
38.8
36.0
34.6
14.8
30.3
44.1

0.0
1.5
0.7
0.3
0.6
0.4
4.0
1.8
1.6
0.3
0.2

0.3
0.0
0.0
0.0
0.0
3.7
0.0
0.1
0.0
4.9
0.2
0.5
0.7
0.8
1.2
0.5
0.6
1.0
0.1
0.1
0.4
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.9
0.2
0.5
0.0
2.7
1.6
1.9
0.5
0.0
0.0
0.3

0.8
0.0
0.5
0.0
0.0
1.6
2.2
1.8
4.4
1.7
0.3
0.0
0.0
0.0
0.5
0.4

0.0
0.0
0.2
0.3
0.3
1.6
0.2
0.0
0.0
0.0
0.2
0.0
0.0
0.0
0.0
0.4

34.5
52.0
22.3
20.6
20.2
51.4
40.2
46.8
15.6
27.1
18.4

6.5
4.2
6.4
1.0
2.2
2.1
1.0
1.7
7.7
1.1
0.0
1.8
0.3
2.1
2.1
0.0
0.0
0.0
0.4
0.8
0.0
1.6

23.3
28.6
26.9
26.5
26.0
37.8
26.0
32.6
27.4
27.6
36.5
27.6

18.0

Female
Cases MV(%) DCO(%) UB(%) MI(%)
381
545
85
1341
146
196
384
583
556
666
947
765
350
58
289
451
173
54
165
133
246
158
161
202
2691
140
38
33
99
74
71
132
2682
272
263
1039
962
1883
3041
624
3062
4242
2015
1881
293
2203

82.2
78.9
98.8
95.6
50.0
83.2
75.3
98.1
86.3
64.6
84.8
88.5
96.9
91.4
90.7
89.1
90.2
85.2
92.1
97.0
93.9
89.9
90.7
94.6
99.7
96.4
89.5
93.9
91.9
97.3
97.2
93.2
97.7
98.9
99.6
92.1
90.6
89.5
92.5
91.2
82.1
86.5
86.8
92.0
83.3
92.4

5.0
2.4
1.2
0.6
9.6
2.6
0.3

0.2
2.6
1.3
0.7
1.3
0.9
5.7
3.3
3.1
0.7
0.3

0.0
0.0
0.0
0.0
0.0
3.6
0.3
0.0
0.0
7.8
0.1
0.1
0.6
0.0
1.7
0.4
0.6
3.7
0.0
0.0
0.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.1
0.3
1.4
0.0
4.8
3.0
2.8
0.4
0.0
0.0
0.4

1089
2
791
474
141
547
213
34
13
778
182
12
14
22
54
62

93.1
100.0
91.8
96.2
95.7
89.9
91.1
91.2
84.6
94.1
98.4
100.0
100.0
95.5
100.0
98.4

1.0
0.0
1.3
0.0
0.0
2.7
4.7
0.0
7.7
2.8
1.1
0.0
0.0
0.0
0.0
1.6

0.0
0.0
0.0
0.2
0.0
1.8
0.0
0.0
7.7
0.1
0.5
0.0
0.0
4.5
0.0
0.0

9.4
8.4
7.6
2.6
3.4
3.1
4.7
4.6
3.7
1.8
0.0
1.6
1.9
3.1
1.5
0.7
0.0
0.0
0.0
2.7
0.0
4.5

56.2
49.4
15.3
41.7
47.1 *
37.6
45.3
37.7 *
43.9
53.0
38.8
42.6
42.0
27.6
47.3
31.5
51.3
53.7
30.3
37.6
38.6
35.4
29.8
41.1
36.6
37.9
65.8
51.5
55.6
43.2
32.4
47.0
60.8
33.5
38.3
39.9
37.4
36.2
45.8
33.8
41.8
35.9
38.1
57.0
38.1
41.6
150.0
27.3
24.5
22.5
64.5
49.3
64.7
38.5
36.4
31.3

35.5

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

811

869

Indices of data quality

Brain and central nervous sytem (C70-72)


Male
Cases MV(%) DCO(%) UB(%) MI(%)
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

26
231
36
10
57

84.6
65.8
88.9
50.0
52.6

30
221
51
94
1796
35
217
312
126
30
48

76.7
80.1
51.0
70.2
58.4
45.7
78.8
67.3
84.1
80.0
75.0

3.3
7.7
41.2
21.3
14.9
14.3
2.8
13.1
7.1

4603 79.0
506 84.8
769 88.0
226 77.0
172 82.0
111 88.3
2 100.0
201 82.1
2401 73.3
21 95.2
194 88.1
778 85.0
95 84.2
673 85.1
97 89.7
896 85.9
5486 88.9
334 87.7
219 85.8
998 90.2
3884 89.0
1080 90.1
55 81.8
50 94.0
19 84.2
8 100.0
125 93.6
766 89.8
1314 89.8
77 87.0
30 90.0
19 94.7
12 91.7
9 100.0
379 90.5
756 89.8
777 85.6
703 91.3
28 92.9
665 91.3
91 81.3
49 79.6
31 87.1
3326 83.4
238 80.3
3044 83.6
1275 88.7
197 85.8
1053 89.5
420 90.2
89 84.3
318 92.5
305 86.9
2041 87.9
168 85.1
1812 88.0
1054 88.1
591 88.3
707 86.1
695 83.7
125 80.0
562 84.7
40 80.0
93 88.2

1.2
0.2
0.8
0.4
0.0

24.2
14.0

0.0

0.0
1.0
1.5
0.0
4.1
4.4
5.3
4.2
0.0
1.2
0.9
1.2
2.3
0.4
1.0
1.7
3.6
0.0
5.3
0.0
0.0
2.0
1.1
2.6
0.0
5.3
0.0
0.0
0.8
0.9
2.4
1.0
0.0
1.1
3.3
2.0
6.5
5.5
3.8
5.7
2.0
2.0
1.9
1.7
2.2
1.3
3.9
2.7
3.6
2.8
1.1
2.2
1.1
1.3
2.4
1.1
2.5
0.0

0.0
0.0
0.0
0.0
0.0

36.4

6.7
12.2
3.9
0.0
0.0
0.0
0.0
0.0
0.0
10.0
0.0

93.3
51.6
60.8
93.6
61.5
37.1
67.3
76.0
75.4
54.2

11.6
0.0
0.0
0.0
0.0
0.9
0.0
2.0
22.1
0.0
0.0
3.1
3.2
3.0
5.2
1.6
1.0
0.9
0.9
0.8
1.1
0.4
0.0
0.0
0.0
0.0
0.8
0.4
0.9
1.3
3.3
0.0
0.0
0.0
1.1
0.8
0.4
0.9
0.0
0.9
3.3
2.0
0.0
0.5
0.0
0.5
0.8
0.5
0.9
0.5
0.0
0.6
0.0
0.8
1.8
0.8
0.9
0.7
2.5
1.2
0.8
1.1
0.0
0.0

66.9
68.0
68.8
69.9
54.1
82.9
100.0
74.6
64.9
38.1
75.8
73.1
64.2
75.5
52.6
67.1
71.6
65.3
68.5
51.0
78.2
69.7
70.9
44.8
74.8
70.4
79.2
63.3
63.2
100.0
88.9
52.2
79.1
58.7
61.3
42.9
62.9
63.7
75.5
61.3
73.2
59.7
74.9
63.8
57.4
65.3
58.3
49.4
59.7
65.2
68.1
57.1
70.5
74.0
76.8
77.1
74.2
73.6
75.4
80.0
67.7

*Important. See note on population page.

870

812

Female
Cases MV(%) DCO(%) UB(%) MI(%)
35
200
20
14
63

74.3
63.0
70.0
35.7
42.9

36
190
46
95
1716
26
188
295
105
23
38

75.0
72.6
50.0
66.3
53.6
73.1
76.1
63.1
89.5
78.3
73.7

2.8
8.9
34.8
28.4
16.1
7.7
4.8
19.3
3.8

3700 71.6
364 79.9
587 80.4
163 68.1
112 80.4
62 87.1
1 100.0
170 67.6
2064 65.6
22 90.9
155 89.7
683 81.3
85 80.0
591 81.9
71 88.7
725 83.4
4423 83.9
270 81.5
207 81.2
934 85.5
2976 83.7
834 86.0
35 77.1
38 81.6
22 77.3
4 100.0
132 87.1
552 87.1
1135 82.7
104 81.7
24 83.3
14 57.1
5 80.0
12 83.3
362 84.8
596 81.9
584 79.5
564 86.7
31 77.4
524 87.0
71 84.5
40 87.5
26 84.6
2740 80.7
203 77.3
2488 80.9
1042 85.7
165 80.6
870 86.7
323 87.0
67 80.6
254 88.6
197 82.2
1767 84.4
135 83.0
1579 84.4
936 83.3
509 83.1
636 78.9
588 79.1
137 73.0
446 81.2
41 78.0
76 81.6

1.6
0.5
1.9
2.5
0.0

26.0
15.9

0.0

0.0
1.2
1.9
0.0
1.3
5.6
7.1
5.4
1.4
1.9
2.1
4.1
2.4
1.7
2.1
3.5
8.6
5.3
0.0
0.0
3.0
3.3
2.7
1.0
8.3
14.3
0.0
8.3
1.7
3.2
2.4
2.5
6.5
2.3
1.4
2.5
0.0
6.1
7.4
6.1
2.7
2.4
2.8
1.5
1.5
1.6
3.0
3.2
7.4
2.8
1.3
3.7
2.5
2.9
4.4
2.5
0.0
1.3

0.0
0.0
0.0
0.0
0.0

36.5

8.3
14.2
8.7
0.0
0.0
0.0
0.5
0.0
0.0
0.0
0.0

58.3
67.9
67.4
80.0
59.3
26.9
73.9
74.6
76.2
81.5

16.2
0.0
0.0
0.0
0.0
0.0
0.0
2.4
28.8
0.0
0.0
4.1
0.0
4.2
1.4
3.9
1.8
0.4
1.9
1.4
2.0
0.6
0.0
0.0
0.0
0.0
0.0
0.9
2.2
3.8
0.0
0.0
0.0
0.0
1.7
2.5
2.4
0.5
0.0
0.6
7.0
5.0
7.7
0.4
0.0
0.5
1.0
0.6
1.0
0.6
0.0
0.8
0.0
0.7
0.7
0.8
1.1
0.4
3.9
1.5
2.9
1.1
7.3
0.0

63.1
69.2
67.0
72.4
72.3
87.1
200.0
64.7
58.2
68.2
70.3
73.8
77.6
74.1
56.3
66.3
69.9
53.7
69.6
49.5
78.4
64.1
51.4
40.2
75.0
70.7
76.9
75.0
78.6
60.0
41.7
52.5
82.2
64.7
59.8
58.1
60.3
56.3
55.0
61.5
68.7
63.1
70.2
60.0
49.7
62.0
56.7
50.7
57.1
66.5
64.2
67.4
65.2
71.5
72.3
68.7
73.3
66.4
75.6
53.7
76.3

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Brain and central nervous sytem (C70-72) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Female
Cases MV(%) DCO(%) UB(%) MI(%)

301
1264
1915
143
1741
744
106
621
1081
62
1015
181
40649
2489
36753
1625
119
1419
282
10
92
175
3656
278
3237
2118
137
1918
657
723
2388
103
2211
208
4792
300
4221
12623
551
738
1347
9855
663
103
552
3510
246
3169
372
125
1233
819
354
1082

87.7
90.4
88.6
86.0
88.8
91.5
86.8
92.1
85.8
83.9
85.8
87.3
87.2
84.0
87.4
87.0
82.4
87.3
85.5
90.0
82.6
86.3
87.1
84.9
87.4
87.8
77.4
88.2
83.3
86.4
89.8
92.2
89.5
92.3
89.0
86.0
89.3
88.3
87.8
84.6
89.3
88.5
86.9
80.6
88.0
84.2
80.9
84.7
91.4
90.4
85.8
85.1
85.9
87.6

1.3
1.5
1.7
0.0
1.8
1.9
1.9
1.9
4.7
8.1
4.5
3.9
2.6
3.2
2.6
1.8
4.2
1.7
5.0
10.0
5.4
4.6
1.6
1.1
1.6
3.6
10.2
3.2
4.3
2.9
0.8
1.0
0.9
1.0
1.7
2.3
1.7
1.3
1.3
2.4
0.7
1.3
3.3
3.9
3.3
5.3
3.3
5.3
0.3
1.6
1.3
1.6
1.4
3.5

2.3
1.3
1.9
3.5
1.8
0.4
1.9
0.2
3.1
1.6
3.3
0.0
1.5
1.7
1.4
1.0
2.5
1.0
0.7
0.0
1.1
0.6
1.9
1.8
1.9
2.3
4.4
2.2
1.7
0.7
0.7
0.0
0.8
0.0
0.5
0.7
0.5
1.0
0.7
1.2
0.8
1.0
4.1
4.9
3.8
1.6
2.0
1.5
0.3
0.8
0.8
0.6
1.4
4.8

66.1
65.6
68.8
60.8
69.8
66.3
61.3
68.0
68.1
50.0
69.2
66.3
67.8
60.7
69.5
56.2
45.4
59.1
63.8
10.0
62.0
68.0
54.2
46.8
55.9
70.8
70.1
72.8
71.2
73.9
66.5
61.2
68.6
76.4
68.4
58.7
69.3
69.2
61.9
61.2
48.3
73.7
79.3
75.7
81.0
67.7
61.0
69.5
63.4
65.6
74.8
77.7
68.1
68.1

238
1114
1509
120
1372
618
89
517
920
50
858
159
33939
2282
30558
1407
111
1236
219
12
75
127
3258
320
2826
1799
122
1646
563
514
2097
107
1948
194
3832
241
3355
10362
430
702
1228
7893
560
99
454
2915
208
2634
287
85
967
646
302
889

76.9
86.4
82.8
84.2
82.7
87.4
83.1
87.8
79.8
74.0
80.0
81.8
82.5
78.8
82.8
81.0
73.0
81.6
79.0
91.7
85.3
74.0
80.3
75.9
80.9
84.4
73.0
85.1
81.0
79.8
83.7
84.1
83.6
83.0
85.2
80.9
85.5
83.4
83.0
78.1
85.9
83.4
84.6
73.7
87.0
79.0
77.4
79.3
86.8
84.7
84.2
84.2
80.1
85.3

2.9
2.6
2.9
0.0
3.2
2.6
2.2
2.7
5.9
8.0
5.8
6.3
3.5
4.1
3.5
3.6
5.4
3.6
4.1
0.0
1.3
6.3
3.0
2.8
3.0
5.0
11.5
4.6
3.6
4.1
1.1
0.0
1.2
5.2
2.5
3.3
2.4
2.4
3.0
3.3
1.5
2.5
3.6
5.1
3.3
5.7
2.9
6.0
0.0
5.9
2.4
1.2
5.6
4.2

3.4
2.2
3.2
3.3
3.2
1.1
3.4
0.8
6.2
10.0
6.1
1.3
2.1
2.8
2.1
2.0
7.2
1.5
2.7
0.0
0.0
4.7
1.8
2.8
1.7
3.1
3.3
3.0
1.2
1.4
1.5
1.9
1.4
0.0
1.1
1.2
1.1
1.7
0.5
3.0
1.3
1.7
4.1
9.1
2.9
2.5
2.4
2.3
0.7
0.0
1.6
2.2
1.3
5.3

72.3
58.6
67.7
56.7
69.0
68.3
59.6
70.6
71.0
68.0
71.8
71.7
65.9
59.4
67.6
55.2
40.5
58.2
63.5
41.7
50.7
74.0
52.7
40.9
54.8
66.1
55.7
68.0
66.6
79.4
66.5
64.5
67.9
72.2
64.9
56.0
66.8
66.8
52.3
60.5
45.5
72.1
78.9
79.8
79.7
65.2
59.6
67.2
58.2
65.9
72.3
70.4
67.5
67.6

24
179
618
46
130
1212
64
98
314
1093
36
1006
142
274
85
945
802
107
95
86
72
187
104
675
99

79.2
75.4
87.2
54.3
78.5
54.9
79.7
76.5
85.0
86.6
66.7
91.8
91.5
90.9
65.9
83.9
85.8
90.7
68.4
62.8
83.3
78.6
92.3
63.1
68.7

4.2
0.0
2.4
0.0
2.3
0.9
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
6.1
12.4
0.0
0.0
0.0
0.0
0.0
2.4
3.7
2.9
0.0
8.4
1.2
0.0
0.0
0.0
0.0
2.0

66.7
108.4
57.6

8
141
397
45
116
1404
51
91
200
542
19
649
123
129
64
740
632
69
64
90
58
132
94
623
112

62.5
70.9
87.4
51.1
77.6
62.5
94.1
83.5
81.5
84.3
73.7
90.9
91.1
86.8
64.1
78.8
81.8
85.5
67.2
61.1
86.2
72.7
89.4
59.4
54.5

0.0
0.0
3.5
2.2
7.8
0.8
0.0

0.0
0.7
0.0
0.0
0.9
0.0
0.0
0.0
15.0
0.0
0.0
0.0
0.0
0.0
1.6
4.7
3.2
2.9
6.3
3.3
0.0
0.0
0.0
0.0
1.8

62.5
122.0 *
51.9
*
49.1
40.2 *
*
87.9 *
31.5
*
63.2
32.8
*
*
*
75.2

1.9
1.2
5.6
2.6
0.7
3.3
16.5
4.1
3.4
3.7
23.2
20.9
1.4
4.3
1.0
6.8
20.2

69.2
51.7
74.0
35.7
55.6
30.1
75.9
66.3
41.9
41.7
41.7
49.0
44.6
41.4

3.0
1.8
10.5
3.9
0.0
3.9
18.8
6.8
5.7
7.2
26.6
15.6
0.0
6.1
1.1
10.8
31.3

76.6
22.2
34.5
31.8
45.7
40.0
38.4

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

813

871

Indices of data quality

Brain and central nervous sytem (C70-72) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

2797
264
152
110
103
177
23
774
50
67
61
80
76
87
124
282
170
137
17
16
56
23
43
195
431

66.6
59.8
78.3
69.1
80.6
65.0
91.3
65.1
78.0
62.7
82.0
61.3
73.7
88.5
96.0
50.0
88.2
86.9
94.1
93.8
62.5
47.8
58.1
84.1
88.2

11.1
12.9
7.2
10.0
5.8
4.5
0.0
15.8
12.0
28.4
14.8
18.8
13.2
1.1
0.0
16.3
0.0
0.0
0.0
0.0
1.8
34.8
7.0
3.1
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.3
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2

76.8
88.3
74.3
73.6
71.8
61.0
65.2
58.9
70.0

1618
100
64
1165
273
916
1606
1386
1923
1135
225
1056
180
96
87
129
167
228
188
68
89
75
80
541
931
340
363
488
478
223
50
810
28
142
107
303
144
48
263
152
116
472
147
68
113
277
184
126
79
31
231
221
136
385

83.7
86.0
82.8
78.8
96.0
92.6
49.8
48.8
75.7
78.3
85.3
86.0
73.3
89.6
93.1
94.6
88.6
82.0
94.1
86.8
65.2
73.3
87.5
68.4
74.4
70.9
71.9
75.6
83.7
91.0
80.0
72.6
42.9
60.6
68.2
53.5
61.8
54.2
58.6
46.7
54.3
54.4
64.6
57.4
48.7
62.1
51.6
36.5
53.2
61.3
51.9
56.1
64.0
72.2

12.7
3.0
3.1

0.2
0.0
4.7
0.0
0.0
0.9
0.2
45.1
0.6
2.7
0.0
1.4
0.6
0.0
0.0
3.1
0.0
1.8
0.0
0.0
2.2
0.0
2.5
4.6
0.3
0.0
0.0
0.0
2.1
0.0
0.0
0.5
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.8
5.1
0.0
0.4
18.6
0.0
0.0

76.1
101.0
62.5
90.6

32.6
6.0
8.4
0.2
1.8
1.5

0.0
23.5
20.4
13.2
24.5
15.2
9.8
4.0
2.0
3.0
0.0
3.5
1.9
0.7
0.0
4.2
1.1
1.3
2.6
0.8
0.0
0.0
0.0
3.2
4.3
4.8
8.9
0.0
1.7
0.9
0.7
2.1

50.0
46.1

74.7
10.7
95.7
88.4
46.2

93.7
86.0
72.5
100.6
85.6
108.9
74.8

147.1
70.2
92.9
32.5
70.1
97.9
72.2
112.0
75.1
78.6
52.8
63.6
71.6
54.2
77.1
60.5
52.0
55.3
91.3
48.3
61.8
61.9
72.9
53.3
43.7
86.1
72.6
68.8
89.1
61.0
52.2

*Important. See note on population page.

872

814

Female
Cases MV(%) DCO(%) UB(%) MI(%)
2469
218
125
75
92
171
24
731
44
44
33
72
71
67
86
252
140
108
13
19
53
44
38
143
264

60.8
52.3
79.2
54.7
58.7
61.4
62.5
62.5
56.8
45.5
72.7
59.7
85.9
86.6
94.2
46.4
81.4
78.7
84.6
94.7
49.1
56.8
71.1
81.1
85.2

14.8
15.1
4.0
6.7
14.1
6.4
0.0
20.1
29.5
45.5
18.2
11.1
2.8
0.0
0.0
20.6
0.0
0.0
0.0
0.0
0.0
13.6
2.6
2.8
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.7
1.1

75.1
83.0
94.4
68.0
70.7
66.1
37.5
56.8
88.6

1460
86
55
1012
210
760
1253
1322
1734
975
205
927
145
83
77
97
151
169
141
56
72
50
68
473
839
308
317
460
453
175
52
622
31
120
111
288
119
50
206
141
94
401
109
56
93
227
188
109
52
24
201
210
90
363

79.1
83.7
70.9
78.5
91.0
88.7
49.0
50.6
70.1
74.1
88.3
79.5
69.7
85.5
92.2
92.8
85.4
78.7
90.1
89.3
62.5
70.0
89.7
60.7
71.0
56.8
62.1
70.4
76.2
88.6
69.2
61.9
64.5
55.8
53.2
52.8
53.8
58.0
53.4
44.7
50.0
43.4
57.8
57.1
39.8
51.5
48.4
26.6
46.2
79.2
41.3
50.0
54.4
60.6

14.0
5.8
14.5

0.7
0.0
1.8
0.0
0.0
0.7
0.3
42.9
1.0
2.9
0.0
2.6
0.0
0.0
0.0
2.1
0.0
0.6
0.0
0.0
4.2
0.0
1.5
3.6
1.2
0.0
1.3
0.0
0.7
0.0
0.0
1.6
3.2
0.0
0.0
0.0
0.0
2.0
0.0
0.0
0.0
0.0
0.0
3.6
0.0
0.0
0.0
0.9
5.8
0.0
0.0
20.5
0.0
0.0

69.7
100.0
63.6
97.3 *
*
93.3
82.6 *
63.5
101.6
82.4
107.3
71.1

34.6
6.4
10.1
0.2
1.5
2.2

0.0
31.5
23.4
19.8
33.8
19.1
14.6
5.7
0.0
4.3
0.0
5.0
1.8
2.1
1.7
2.0
4.9
2.1
6.4
1.7
0.0
3.6
0.0
3.5
6.9
4.6
9.6
4.2
1.0
1.9
0.0
1.9

48.6
35.2

86.4

*
*
*

15.1 *
47.7 *
81.6
34.3 *
*

154.3
73.3
89.3
23.7
63.3
100.9
77.7
80.8
71.1
54.8
54.2
47.7
70.5
52.9
56.0
70.9
60.3
51.4
97.5
40.4
55.4
62.4
74.0
56.4
41.3
98.1
78.1
63.2
93.8
62.2
52.3

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Brain and central nervous sytem (C70-72) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

439
630
65
955
146
355
347
445
735
573
1345
876
332
64
221
402
240
50
128
128
187
142
109
146
1586
94
56
33
95
72
45
116
2871
172
182
570
599
727
1464
562
1676
2833
1064
1019
338
1071

57.6
84.9
72.3
85.0
62.3
59.2
61.4
93.5
61.5
66.7
76.6
69.5
97.9
39.1
69.2
72.1
81.3
36.0
62.5
78.9
62.6
53.5
61.5
81.5
94.8
88.3
75.0
75.8
86.3
87.5
84.4
91.4
84.5
86.6
87.9
75.3
62.8
72.1
74.5
76.9
63.1
70.1
63.7
78.4
61.5
72.2

1328
24
686
334
106
1070
349
55
25
783
158
6
19
29
27
68

86.8
83.3
84.0
78.1
84.0
85.1
88.0
78.2
52.0
81.4
89.2
83.3
73.7
93.1
96.3
91.2

19.4
1.6
3.1
0.4
9.6
2.3
0.9

89.3
79.5
106.2
77.7
84.8
61.3
81.3
103.1
62.3
89.4
74.3
99.4
102.7
62.5
79.9
67.7
84.4
80.0
77.3
78.1
82.9
81.7
65.1
101.4
97.5
77.7
58.9
66.7
75.8
79.2
71.1
83.6
79.7

0.0
4.7
1.0
0.6
0.9
1.5
6.5
5.8
4.6
0.9
0.2

0.2
0.0
0.0
0.0
0.0
7.0
0.0
0.0
0.0
13.3
0.4
3.2
1.2
4.7
1.4
0.5
0.0
0.0
2.3
0.0
1.1
0.0
1.8
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
3.0
0.3
1.5
0.0
13.7
5.1
4.5
1.9
0.0
0.0
0.9

0.6
4.2
0.7
0.0
0.0
1.8
2.3
0.0
16.0
4.0
1.3
0.0
0.0
0.0
3.7
1.5

0.0
0.0
0.1
0.3
0.9
2.1
0.3
0.0
8.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

77.7
54.2
80.3
82.3
73.9
75.3
87.7
83.6
68.0
82.8
63.3

34.3
10.6
10.4
0.9
12.5
3.6
2.7
5.4
10.0
7.0
0.0
6.4
3.5
11.0
14.4
0.0
1.8
6.1
0.0
4.2
0.0
2.6

76.9
78.9
60.9
83.2
74.0
79.9
80.3
74.7
74.0
78.0
67.8
84.5

64.7

Female
Cases MV(%) DCO(%) UB(%) MI(%)
383
590
45
736
126
369
316
362
605
571
1121
699
261
39
211
362
202
37
108
110
148
123
111
132
1164
64
49
24
77
60
39
89
2131
138
127
418
487
615
1056
375
1208
2171
866
740
254
823

55.4
82.0
64.4
77.3
52.4
48.0
53.8
92.8
56.7
62.2
76.8
69.4
96.2
33.3
61.6
63.8
69.3
27.0
65.7
74.5
50.7
48.8
65.8
78.8
91.3
73.4
87.8
79.2
77.9
63.3
76.9
83.1
81.4
77.5
89.0
65.3
54.4
63.9
66.2
68.8
55.5
64.5
55.8
71.5
55.9
64.0

983
14
528
234
70
815
247
43
20
508
124
4
10
25
23
49

82.4
64.3
76.9
72.6
87.1
79.1
83.4
88.4
70.0
72.8
87.1
75.0
90.0
84.0
87.0
87.8

20.6
2.7
6.7
1.0
14.3
2.7
1.3

90.1
76.9
75.6
76.1
82.3 *
44.4
92.1
103.0 *
53.6
105.3
72.1
102.4
103.1
110.3
78.2
69.3
79.2
62.2
68.5
81.8
70.3
79.7
64.0
93.2
101.5
89.1
67.3
79.2
79.2
75.0
102.6
74.2
80.6

0.5
6.0
3.1
1.6
1.6
1.8
8.4
7.3
6.1
1.2
0.5

0.3
0.0
0.0
0.0
0.0
6.0
0.3
0.0
0.0
14.4
0.1
1.6
1.1
2.6
2.8
1.9
1.0
0.0
0.0
0.0
0.0
0.0
1.8
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
3.1
0.0
2.4
0.0
18.7
6.7
4.0
2.3
0.0
0.0
1.2

1.3
0.0
1.7
0.0
0.0
3.2
4.5
0.0
10.0
4.9
2.4
0.0
0.0
4.0
4.3
2.0

0.0
0.0
0.0
0.4
0.0
3.2
0.0
0.0
5.0
0.0
0.8
0.0
0.0
0.0
0.0
2.0

73.1
78.6
80.7
80.8
81.0
76.6
88.3
79.1
55.0
88.8
56.5

37.7
10.9
9.7
2.7
12.8
2.8
5.5
4.5
10.8
1.9
0.9
8.8
3.3
9.0
12.9
1.6
0.0
0.0
1.3
13.3
0.0
5.6

78.0
80.1
56.1
74.8
75.2
80.5
76.7
74.5
66.6
79.3
67.7
87.2

59.2

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

815

873

Indices of data quality

Thyroid (C73)
Male
Cases MV(%) DCO(%) UB(%) MI(%)
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

32 100.0
53 90.6
14 100.0
11 54.5
14 71.4
6 83.3
88 92.0
8 100.0
39 94.9
861 85.9
16 93.8
85 89.4
141 95.0
57 87.7
11 100.0
17 100.0
2095
295
271
68
54
26
2
54
1243
3
79
300
38
257
63
475
2720
329
103
470
1789
545
22
37
33
5
66
339
779
47
26
37
17
18
169
438
432
386
7
368
82
36
40
1434
69
1334
568
66
484
213
26
173
117
1100
62
972
476
290
332
318
47
266
15
54

93.6
99.3
99.3
100.0
100.0
100.0
100.0
96.3
89.7
100.0
100.0
99.0
97.4
99.2
98.4
99.2
99.5
99.7
99.0
99.8
99.4
99.4
100.0
97.3
100.0
100.0
100.0
99.4
99.6
100.0
100.0
100.0
100.0
100.0
99.4
99.5
98.1
100.0
100.0
100.0
96.3
100.0
97.5
98.2
94.2
98.4
98.8
97.0
99.0
99.5
100.0
99.4
100.0
98.9
96.8
99.0
99.8
99.3
98.8
99.4
95.7
100.0
100.0
100.0

5.7
0.0
16.7
3.4
0.0
2.6
1.2
0.0
2.4
0.7
3.5
0.0
0.0
0.0
0.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
0.1
0.0
0.0
0.0
0.2
0.2
0.0
0.0
0.0
0.0
0.0
0.3
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.9
0.0
0.0
0.0
0.0
0.0
0.0
1.4
4.3
1.3
0.4
0.0
0.4
0.0
0.0
0.0
0.0
0.5
0.0
0.6
0.2
0.3
0.3
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0

11.3

816

88 98.9
151 96.0
34 100.0
26 92.3
45 68.9

2.0
4.4

0.0
4.5
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

50.0
12.5
12.5
10.3
7.8
25.0
27.1
9.9
24.6
34.1

17 94.1
338 97.3
43 72.1
208 94.7
4399 86.3
42 92.9
450 97.8
739 95.5
356 89.9
80 81.3
68 100.0

5.9
0.6
4.7
2.9
0.7
0.0
0.0
0.8
2.8

6.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
10.3
0.0
0.0
0.7
0.0
0.8
1.6
0.4
0.1
0.0
1.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.2
0.5
0.0
0.0
0.0
3.7
0.0
2.5
0.1
0.0
0.1
0.2
1.5
0.0
0.0
0.0
0.0
0.0
0.4
3.2
0.2
0.0
0.0
0.9
0.0
0.0
0.0
0.0
0.0

10.2
8.8
16.6
10.3
11.1
26.9

6839
802
733
265
178
102
7
180
4349
19
204
898
171
704
173
1368
8487
1264
308
2002
4783
1572
57
135
94
22
236
826
2516
129
81
155
33
59
802
1160
1256
1113
51
1007
191
107
62
4052
345
3582
1774
334
1377
720
157
525
367
3380
277
2908
1451
861
1057
1052
209
831
59
163

0.1
0.0
0.0
0.4
0.0

14.8
8.4
12.7
16.0
28.9
14.0
6.3
11.6
11.2
9.7
14.6
11.9
11.2
11.4
18.2
6.1
13.0
11.0
12.8
15.4
10.8
17.6
5.6
16.0
9.4
8.8
11.4
14.3
11.4
7.3
13.9
2.5
12.3
15.9
12.4
9.3
12.1
9.3
4.7
7.7
4.6
6.8
9.7
4.8
10.6
13.2
10.3
12.0
13.5
25.5
11.7
33.3
13.0

*Important. See note on population page.

874

Female
Cases MV(%) DCO(%) UB(%) MI(%)

91.8
99.9
99.5
99.6
99.4
99.0
100.0
99.4
87.3
100.0
99.5
99.2
98.8
99.3
99.4
99.6
99.5
99.4
98.7
99.9
99.5
99.7
100.0
99.3
100.0
100.0
100.0
99.6
99.6
98.4
100.0
100.0
100.0
98.3
99.9
99.7
99.4
99.5
98.0
99.5
99.0
99.1
100.0
99.4
99.1
99.4
99.5
99.1
99.6
100.0
100.0
100.0
99.7
99.5
98.6
99.5
99.7
99.7
99.1
98.5
98.6
98.4
100.0
96.9

0.0

0.0
0.0
0.1
0.0
0.5
0.1
0.0
0.1
0.0
0.1
0.1
0.2
0.3
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.2
0.8
0.0
0.0
0.0
1.7
0.0
0.1
0.1
0.2
0.0
0.2
0.5
0.9
0.0
0.2
0.6
0.2
0.3
0.9
0.2
0.0
0.0
0.0
0.0
0.3
0.7
0.2
0.1
0.1
0.2
0.4
0.0
0.5
0.0
0.6

0.0
0.0
0.0
0.0
0.0

4.6

0.0
2.1
2.3
0.5
0.0
0.0
0.0
0.0
0.0
2.5
0.0

47.1
7.7
4.7
10.6
3.3
14.3
8.9
7.3
13.5
4.7

7.9
0.0
0.0
0.0
0.0
1.0
0.0
0.0
12.5
0.0
0.0
0.4
0.6
0.4
0.6
0.1
0.1
0.1
0.0
0.0
0.2
0.1
0.0
0.0
0.0
0.0
0.0
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
0.1
2.0
0.0
0.5
0.0
0.0
0.1
0.0
0.1
0.1
0.0
0.1
0.0
0.0
0.0
0.3
0.0
0.0
0.0
0.0
0.0
0.4
0.2
0.0
0.2
0.0
0.6

4.4
4.0
9.0
7.5
6.2
7.8
4.4
3.2
15.8
6.9
5.7
9.9
4.8
1.2
3.5
5.2
6.3
7.8
4.9
5.0
5.0
7.0
5.9
3.9
6.2
11.6
6.2
8.4
9.1
8.5
4.7
6.3
4.2
4.1
2.0
4.2
4.7
7.5
1.6
6.8
7.8
6.8
4.2
5.1
3.8
3.3
3.2
3.0
4.1
4.7
8.3
4.5
6.5
5.2
6.5
7.1
12.0
6.0
15.3
6.7

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Thyroid (C73) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Female
Cases MV(%) DCO(%) UB(%) MI(%)

99
644
842
65
756
384
53
323
480
22
452
108
19839
1052
17616
969
64
845
222
7
81
131
2019
112
1790
856
42
766
230
305
1513
76
1381
116
2588
121
2216
6586
518
330
680
4971
265
37
223
1699
96
1518
202
52
580
411
179
463

100.0
99.1
98.8
96.9
98.9
99.2
98.1
99.4
98.5
95.5
98.7
97.2
98.9
97.4
99.0
98.9
96.9
98.9
98.6
100.0
97.5
99.2
98.9
99.1
98.8
98.1
92.9
98.3
97.8
99.7
99.6
100.0
99.6
100.0
99.5
99.2
99.5
99.3
99.6
98.2
99.4
99.4
99.2
100.0
99.1
98.2
97.9
98.4
99.5
96.2
99.5
99.5
99.4
97.6

0.0
0.8
0.5
0.0
0.5
0.5
1.9
0.3
0.8
0.0
0.9
1.9
0.5
0.9
0.5
0.1
0.0
0.1
0.5
0.0
0.0
0.8
0.2
0.0
0.3
1.2
7.1
0.9
0.4
0.3
0.1
0.0
0.1
0.0
0.2
0.8
0.1
0.2
0.0
0.3
0.0
0.2
0.4
0.0
0.4
0.6
1.0
0.6
0.0
1.9
0.3
0.2
0.6
0.9

0.0
0.2
0.6
3.1
0.4
0.0
0.0
0.0
0.4
0.0
0.4
0.9
0.4
0.9
0.3
0.6
1.6
0.6
0.5
0.0
1.2
0.0
0.2
0.0
0.3
0.5
0.0
0.5
0.4
0.0
0.2
0.0
0.2
0.0
0.1
0.0
0.1
0.2
0.0
0.6
0.3
0.2
0.4
0.0
0.4
0.9
1.0
0.7
0.5
0.0
0.2
0.2
0.0
1.1

18.2
9.3
11.8
15.4
11.8
11.2
15.1
10.8
12.7
9.1
13.1
9.3
10.6
14.4
10.8
9.8
14.1
9.9
9.9
28.6
8.6
9.2
7.9
10.7
8.0
14.7
19.0
15.4
15.7
8.9
7.5
9.2
7.7
13.8
9.6
14.0
9.3
10.6
9.5
16.1
10.4
10.5
14.7
21.6
13.9
10.1
11.5
10.5
8.4
13.5
7.4
7.1
13.4
12.5

338 99.1
2132 99.6
2696 98.9
242 97.9
2348 98.9
1171 99.4
180 98.3
946 99.6
1496 99.7
93 100.0
1370 99.7
321 99.1
60456 99.3
4256 98.7
51843 99.3
2966 99.2
213 99.1
2522 99.1
636 99.1
40 100.0
214 98.6
371 99.2
6201 99.0
564 98.6
5205 99.1
2605 99.4
170 98.8
2314 99.4
596 98.0
848 99.6
4903 99.4
365 99.5
4355 99.4
377 99.7
7819 99.6
494 99.2
6306 99.6
20454 99.4
2014 99.5
1224 98.9
2779 99.6
14047 99.4
839 98.9
162 99.4
659 98.8
4887 98.3
332 97.6
4285 98.4
691 99.9
170 100.0
1760 99.7
1215 99.8
542 98.9
1288 98.6

0.0
0.3
0.4
0.4
0.4
0.1
0.0
0.1
0.1
0.0
0.1
0.3
0.2
0.4
0.2
0.1
0.5
0.0
0.3
0.0
0.9
0.0
0.1
0.0
0.1
0.3
0.0
0.3
0.0
0.1
0.2
0.0
0.3
0.0
0.1
0.0
0.1
0.1
0.1
0.2
0.1
0.1
0.2
0.0
0.3
0.4
0.9
0.4
0.0
0.0
0.1
0.0
0.4
0.9

0.9
0.1
0.5
0.8
0.5
0.3
0.6
0.2
0.2
0.0
0.2
0.3
0.3
0.3
0.3
0.4
0.5
0.4
0.0
0.0
0.0
0.0
0.4
0.4
0.3
0.1
0.0
0.1
0.5
0.1
0.2
0.3
0.2
0.0
0.1
0.4
0.1
0.2
0.1
0.2
0.1
0.1
0.7
0.6
0.8
1.0
1.5
1.0
0.0
0.0
0.1
0.1
0.4
0.4

8
84
447
11
18
314
35
54
82
262
17
184
17
53
58
526
474
43
50
81
93
175
122
432
77

100.0
88.1
97.8
72.7
72.2
88.2
100.0
96.3
65.9
75.2
100.0
88.6
94.1
81.1
100.0
96.0
97.0
95.3
94.0
95.1
94.6
96.0
92.6
86.3
92.2

0.0
0.0
0.2
0.0
0.0
0.3
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
3.7
18.3
0.0
0.0
0.0
0.0
0.0
0.0
1.0
0.4
2.3
0.0
1.2
0.0
0.0
0.0
0.0
0.0

12.5
19.0
15.0

57 100.0
295 89.8
1557 97.9
20 95.0
33 87.9
1044 91.0
105 99.0
190 99.5
202 78.7
579 75.8
44 95.5
355 87.3
42 95.2
93 76.3
196 99.5
1948 94.0
1747 95.0
161 95.7
196 96.4
221 95.5
472 96.6
819 97.9
473 96.6
1194 86.2
393 94.9

0.0
0.0
0.2
0.0
0.0
0.2
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.5
11.9
0.0
0.0
0.3
0.0
0.0
0.0
3.1
2.5
3.1
0.5
0.5
0.0
0.0
0.2
0.0
0.5

1.2
0.0
0.0
3.8
0.0
0.0
0.0
1.0
0.6
0.0
6.0
1.2
2.2
1.1
4.1
5.3
6.5

44.4
16.2
32.9
22.3
16.4
42.0
14.8
15.1
22.9
18.9
31.9
40.3

1.5
0.5
0.0
3.1
0.0
3.2
0.0
0.5
0.4
0.0
3.1
0.5
0.4
1.0
1.5
5.9
1.0

5.0
4.2
6.0
6.2
6.2
5.0
3.9
5.3
5.3
10.8
5.0
4.0
5.1
7.3
5.1
4.3
4.2
4.6
4.6
2.5
7.0
3.2
5.0
8.9
4.9
5.1
5.3
5.3
6.0
6.6
4.5
5.5
4.6
2.4
4.4
3.6
4.4
5.0
5.6
6.3
4.6
4.9
5.6
8.0
5.2
4.8
6.3
4.9
3.5
4.1
4.1
4.0
6.5
6.6
1.8
5.8 *
7.6
*
33.3
8.9 *
*
*
18.3
*
14.4
7.3
11.7
13.6
6.6
8.2
15.9
26.2
14.0

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

*
*
*

817

875

Indices of data quality

Thyroid (C73) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

2314 95.6
215 93.0
118 96.6
73 94.5
121 97.5
109 90.8
25 88.0
644 96.7
49 95.9
46 97.8
62 100.0
25 92.0
46 97.8
32 93.8
25 96.0
260 90.4
180 99.4
147 99.3
11 100.0
22 100.0
43 95.3
18 77.8
52 96.2
38 92.1
90 95.6
737
73
25
892
64
206
244
306
571
210
52
384
75
59
60
58
62
143
106
32
36
46
96
205
337
75
136
209
122
71
41
94
23
105
87
143
71
17
119
127
53
210
71
31
84
151
93
50
35
15
80
104
45
156

97.4
97.3
80.0
98.8
100.0
94.7
81.6
92.2
95.8
97.6
98.1
98.7
98.7
100.0
100.0
100.0
98.4
100.0
100.0
100.0
100.0
97.8
99.0
92.7
94.7
85.3
96.3
99.0
90.2
97.2
100.0
92.6
100.0
95.2
97.7
82.5
91.5
100.0
95.8
100.0
94.3
97.1
97.2
90.3
97.6
93.4
80.6
98.0
100.0
93.3
98.8
88.5
86.7
98.1

1.0
0.5
2.5
1.4
0.0
2.8
0.0
1.7
2.0
2.2
0.0
0.0
2.2
0.0
0.0
1.9
0.0
0.0
0.0
0.0
0.0
5.6
3.8
5.3
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.1

12.9
16.7
11.0
15.1
4.1
13.8
12.0
9.3
6.1

2.4
2.7
8.0

0.0
0.0
4.0
0.0
0.0
4.9
0.0
7.2
0.7
1.4
0.0
0.5
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
3.4
0.0
0.0
0.0
0.0
0.8
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
11.5
0.0
0.0

22.7
28.8
36.0
12.3

10.2
0.7
1.8
0.0
0.0
0.0

0.0
2.9
5.0
6.7
3.7
0.0
4.1
2.8
0.0
3.2
0.0
0.0
1.1
0.0
0.0
0.0
0.0
0.0
1.9
0.0
0.0
0.0
0.0
0.0
0.0
2.0
0.0
0.0
1.3
0.0
2.2
0.0

15.6

55.6
78.8
10.5

31.6
47.5
19.6
27.7
33.8
36.5
21.6

32.7
22.0
30.7
8.1
26.8
24.6
21.1
17.1
38.3
17.4
15.2
8.0
15.4
12.7
35.3
19.3
7.1
14.2
20.0
18.3
9.7
19.0
11.3
19.4
22.0
11.4
8.3
11.3
17.3
17.8
15.4

*Important. See note on population page.

876

818

Female
Cases MV(%) DCO(%) UB(%) MI(%)
13725
989
753
339
809
715
128
4122
265
120
86
103
138
137
71
1206
636
512
46
78
191
87
209
157
329

97.0
95.0
98.7
96.8
98.1
93.4
93.8
97.6
96.6
99.2
97.7
95.1
93.5
98.5
98.6
93.3
98.7
98.8
97.8
98.7
95.8
81.6
97.1
94.9
98.5

0.6
0.8
0.1
0.3
0.0
0.8
0.0
0.5
0.8
0.8
2.3
1.0
2.9
0.0
0.0
1.3
0.0
0.0
0.0
0.0
0.0
4.6
1.4
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.3
0.3

1880
198
70
3860
128
512
785
1254
2012
524
293
1281
198
203
182
119
220
461
405
122
165
214
306
526
930
152
405
637
308
216
91
263
51
334
266
451
203
49
341
349
150
700
198
97
259
520
341
200
146
58
306
295
123
482

97.0
99.0
94.3
99.0
100.0
92.6
87.0
93.1
96.3
97.7
99.3
99.1
99.5
100.0
100.0
99.2
99.5
98.9
99.8
100.0
98.2
100.0
99.7
91.4
94.8
86.8
95.8
99.8
84.7
97.7
100.0
96.2
98.0
93.1
98.9
85.4
90.1
89.8
90.6
99.4
93.3
97.1
98.0
96.9
98.8
95.2
82.4
98.5
95.2
96.6
99.3
83.7
94.3
96.3

2.7
0.5
1.4

0.0
0.0
1.4
0.0
0.0
6.4
0.0
6.1
0.2
0.8
0.0
0.1
0.0
0.0
0.0
0.8
0.0
0.9
0.0
0.0
0.0
0.0
0.0
3.2
0.1
0.0
0.0
0.0
0.3
0.0
0.0
1.5
0.0
0.0
0.0
0.0
0.0
2.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
14.2
0.0
0.0

6.4
0.8
1.7
0.2
0.0
0.2

0.0
4.2
4.3
2.6
4.0
0.0
5.5
1.9
0.0
0.8
0.0
0.3
0.0
0.0
0.0
0.0
0.3
0.0
0.0
0.0
0.0
1.0
0.0
0.2
0.3
0.5
0.0
0.0
0.3
0.3
0.0
0.2

5.5
7.4
5.4
6.5
3.5
6.7
8.2
3.6
2.6

3.6

11.0

*
*
*

*
33.3 *
15.3
3.8 *
*
18.0
20.2
14.3
5.4 *
*
26.6
24.5 *
9.2
17.8
22.3
18.1
11.9

23.6
17.2
26.3
5.2
13.3
25.0
19.0
11.0
24.3
9.8
4.2
5.3
11.1
9.9
10.2
11.1
6.6
7.2
12.6
5.6
8.2
5.0
6.7
8.5
6.0
6.8
8.6
10.5
11.5
12.2
11.0

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Thyroid (C73) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

70
167
19
247
43
59
66
194
151
152
125
219
116
10
55
94
81
9
40
27
68
51
23
37
407
27
7
15
38
25
17
41
524
34
24
95
78
105
230
84
232
433
153
189
72
177

82.9
95.2
94.7
98.4
81.4
91.5
98.5
99.5
92.1
79.6
74.4
93.2
99.1
90.0
100.0
96.8
100.0
100.0
100.0
96.3
100.0
96.1
95.7
97.3
99.8
100.0
100.0
100.0
97.4
100.0
94.1
100.0
99.4
97.1
100.0
91.6
91.0
89.5
92.2
92.9
89.2
89.4
94.8
95.8
91.7
100.0

506
14
304
112
35
257
130
20
26
181
132
5
37
23
18
40

97.4
100.0
95.7
100.0
97.1
97.7
99.2
100.0
100.0
97.8
99.2
100.0
97.3
100.0
100.0
100.0

5.7
0.0
0.0
0.4
2.3
1.7
0.0

45.7
35.3
26.3
26.3
32.0
31.8
30.3
16.5
23.2

0.0
0.0
1.0
0.9
0.0
1.7
4.4
2.6
1.1
0.0
0.0

0.0
0.0
0.0
0.0
0.0
1.7
0.0
0.0
0.0
7.9
0.0
0.5
0.0
10.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2.1
0.0
1.0
0.0
4.8
3.4
2.3
1.3
0.0
0.0
0.0

0.0
0.0
0.3
0.0
0.0
0.0
0.8
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.8
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

11.7
21.4
11.2
17.0
23.8
17.9
12.3

7.3
10.4
5.5
0.9
0.0
0.0
3.2
0.0
0.0
0.0
0.0
0.0
3.9
4.3
0.0
0.0
0.0
0.0
2.6
0.0
0.0
0.0

52.8
28.3
28.4
40.0
33.3
23.4
18.5
22.2
22.5
25.9
16.2
25.5
26.1
43.2
32.2
11.1
28.6
6.7
28.9
32.0
23.5
39.0
33.0
33.3
31.6
21.8
54.3
28.3
15.5
29.3
28.4
29.4
23.3
19.4
24.3

7.7
18.2
11.4

7.5

Female
Cases MV(%) DCO(%) UB(%) MI(%)
412
838
112
649
214
340
320
1233
564
714
405
802
342
42
197
239
294
20
112
185
254
185
72
123
1031
98
21
26
90
55
66
106
1293
85
76
209
213
322
588
252
640
1133
363
475
160
485

88.8
96.2
99.1
98.5
91.6
96.8
96.3
99.2
96.1
90.6
79.3
95.8
99.7
100.0
98.0
98.3
96.6
100.0
98.2
100.0
97.2
99.5
100.0
95.9
99.8
100.0
95.2
100.0
100.0
98.2
98.5
99.1
99.4
100.0
100.0
96.7
95.8
93.8
92.7
96.4
90.9
91.4
93.4
96.0
86.9
97.3

2.9
0.6
0.9
0.2
1.4
0.6
0.6

31.6
15.3
12.5
19.3
11.7 *
13.6
14.1
4.1 *
13.1

0.0
0.9
0.9
0.9
0.0
0.8
3.1
3.0
1.3
0.0
0.0

0.2
0.0
0.0
0.0
0.0
0.3
0.3
0.0
0.0
3.4
0.0
0.5
0.0
0.0
0.0
0.4
1.4
0.0
0.9
0.0
0.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.0
0.5
0.9
0.0
2.8
3.0
1.9
0.3
0.0
0.0
0.2

1639
21
857
310
107
750
334
52
180
598
430
38
138
61
60
81

97.0
100.0
97.1
99.4
98.1
97.3
99.4
96.2
99.4
99.0
100.0
100.0
100.0
100.0
100.0
100.0

0.3
0.0
0.0
0.0
0.0
0.5
0.3
0.0
0.6
0.2
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.9
0.5
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

5.4
4.8
3.4
6.5
12.5
7.9
9.6
3.8
7.2
9.5
4.9

3.2
6.4
3.0
0.3
0.0
0.0
0.8
1.7
0.0
0.9
0.0
0.8
0.0
0.0
3.3
0.0
0.0
0.0
0.0
1.8
0.0
0.0

33.6
16.5
16.1
2.4
23.7
15.9
13.2
15.0
11.6
7.0
8.3
5.4
12.5
18.7
23.8
11.2
47.6
15.4
15.6
20.0
22.7
16.0
24.3
26.3
18.7
21.1
26.1
17.5
12.7
20.8
21.4
25.1
19.8
16.3
23.1

4.9

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

819

877

Indices of data quality

Lymphoma (C81-90,C96)
Male
Cases MV(%) DCO(%) UB(%) MI(%)
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

187 100.0
1118 94.6
119 97.5
198 81.8
318 87.1

1.3
7.2

88 76.1
406 93.3
70 80.0
208 89.9
3887 99.4
94 100.0
547 90.5
748 96.3
369 95.9
198 99.5
131 100.0

9.1
5.2
11.4
8.7
0.0
0.0
0.4
0.7
0.8

16750 88.9
1793 96.9
2908 95.4
905 94.7
570 99.1
272 99.3
11 100.0
738 93.2
8714 82.5
91 97.8
748 94.7
2787 94.3
504 91.5
2250 94.8
356 95.5
3140 93.4
22060 96.3
1604 97.9
1405 95.2
3581 96.7
15022 96.1
4808 96.8
338 94.1
197 99.0
156 96.2
45 95.6
530 96.4
3237 96.9
5840 97.8
616 96.6
115 98.3
148 98.6
95 98.9
50 98.0
1386 97.3
3216 97.9
2706 91.7
2854 97.5
163 95.7
2648 97.6
433 92.1
295 92.9
122 92.6
13880 96.7
1245 95.9
12427 96.8
4573 93.5
1064 90.6
3440 94.5
1636 94.7
474 90.9
1122 96.6
884 95.1
8960 94.8
1004 92.6
7676 95.1
4175 95.3
2351 96.4
3011 93.2
3057 95.0
750 92.0
2284 96.0
228 93.4
464 96.8

0.6
0.1
0.9
1.0
0.0

0.0

0.0
1.4
0.6
0.0
0.9
0.7
1.0
0.7
0.3
1.6
0.7
0.5
0.6
0.5
0.7
0.8
0.3
0.0
1.3
2.2
0.6
1.0
0.5
1.0
0.0
0.7
0.0
0.0
0.4
0.5
1.6
0.4
0.6
0.3
1.8
2.0
1.6
2.5
2.6
2.5
2.6
2.7
2.6
0.8
0.6
0.8
1.7
1.8
2.3
1.8
1.5
0.9
1.0
0.7
0.9
0.6
1.8
0.2

0.0
0.0
0.0
0.0
0.0

16.4

820

149
667
71
156
250

99.3
92.8
98.6
78.8
82.8

3.3
10.0

11.4
1.0
1.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

94.3
39.2
37.1
13.0
35.8
60.6
41.0
60.4
45.3
34.7

116 74.1
284 87.3
50 78.0
197 91.9
3656 99.6
72 100.0
525 93.0
626 94.4
325 97.2
186 99.5
110 100.0

15.5
8.1
10.0
7.1
0.0
0.0
0.6
1.4
0.6

8.3
0.0
0.2
0.1
0.0
0.0
0.0
0.9
15.8
0.0
0.1
2.7
2.4
2.8
2.0
2.4
1.0
0.6
0.9
0.9
1.1
0.7
0.9
0.5
1.3
0.0
1.1
0.6
0.5
0.5
0.0
0.0
0.0
0.0
0.6
0.6
2.1
0.4
0.0
0.4
3.5
3.1
2.5
0.1
0.1
0.1
1.2
1.6
1.0
1.7
2.3
1.2
0.5
0.8
1.2
0.8
0.8
0.9
2.7
0.7
0.5
0.7
0.0
0.9

45.7
42.4
46.5
52.0
49.3
48.9
27.3
48.1
44.8
50.5
47.9
52.5
56.9
52.2
36.5
51.5
42.0
38.0
41.4
35.0
45.2
38.0
41.4

14256 87.1
1461 96.5
2281 93.7
788 93.9
509 95.5
200 99.5
3 100.0
589 91.0
7700 80.9
74 97.3
651 92.6
2524 93.3
488 90.2
2004 94.1
250 96.8
2582 93.1
18244 95.4
1394 97.2
1176 93.9
2979 96.2
12339 95.1
3879 96.1
272 94.9
181 96.1
132 97.7
50 100.0
470 95.5
2541 96.0
4813 97.0
564 94.3
108 97.2
137 99.3
79 98.7
39 97.4
1129 97.2
2603 97.3
2350 91.5
2553 97.7
172 97.7
2343 97.7
355 92.7
230 91.7
109 94.5
11912 96.5
1102 95.6
10652 96.6
4014 91.9
974 90.2
2972 92.4
1355 92.9
412 92.2
904 93.0
789 95.1
8093 93.9
1008 90.5
6857 94.2
3791 94.7
2218 95.0
2744 91.3
2767 94.1
669 90.3
2080 95.2
193 92.2
417 97.4

0.9
0.1
0.9
0.6
0.0

31.1
40.4
39.8
40.1
45.2
45.3
37.9
30.0
34.6
43.5
40.5
39.6
40.5
39.9
42.5
43.7
43.4
46.3
40.2
47.6
44.5
45.0
44.8
38.1
36.9
38.9
42.1
45.3
46.2
46.1
51.4
46.7
46.1
47.0
47.5
47.1
52.6
43.8

*Important. See note on population page.

878

Female
Cases MV(%) DCO(%) UB(%) MI(%)

0.0

0.0
1.2
1.1
0.0
0.9
0.8
0.6
0.8
0.8
1.4
0.9
0.5
1.0
0.4
1.0
1.1
1.1
0.0
0.8
0.0
1.1
1.4
0.4
0.9
0.9
0.0
1.3
0.0
0.2
0.3
1.9
0.4
0.6
0.4
3.1
2.2
4.6
2.7
2.4
2.7
3.0
2.7
3.2
1.6
1.0
2.0
2.0
2.5
5.0
2.2
1.8
1.4
1.5
1.1
1.0
1.1
1.0
0.7

0.0
0.0
0.0
0.0
0.0

16.6

7.8
4.2
2.0
0.0
0.0
0.0
0.2
0.0
0.0
0.0
0.0

69.8
50.0
38.0
5.6
36.6
66.7
42.9
50.0
51.1
32.9

9.3
0.2
0.1
0.0
0.0
0.0
0.0
2.0
17.0
0.0
0.0
3.0
2.7
3.0
1.2
2.6
1.3
0.6
1.6
1.1
1.3
0.8
0.7
0.0
0.0
0.0
1.1
0.7
0.7
1.6
0.9
0.0
0.0
0.0
0.8
0.6
1.2
0.4
0.0
0.4
2.3
3.0
0.9
0.1
0.2
0.1
1.4
1.3
1.4
1.3
1.0
1.4
0.5
0.8
1.2
0.8
1.1
0.8
2.8
0.9
0.6
1.1
0.5
1.0

45.4
42.5
45.7
51.0
47.2
61.0
66.7
48.7
44.0
43.2
51.3
55.1
55.9
55.6
35.6
51.8
43.2
37.7
49.3
34.6
46.3
41.5
55.5
32.1
44.4
42.0
50.9
48.1
32.8
39.2
43.6
35.2
44.6
43.1
46.1
45.3
46.6
55.2
60.0
49.5
45.1
45.2
45.6
49.4
48.5
50.4
43.8
45.4
44.1
43.0
46.6
49.0
47.4
52.3
50.9
46.4
49.3
48.1
49.7
49.2
50.8

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Lymphoma (C81-90,C96) (contd)

)
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Male
Cases MV(%) DCO(%) UB(%) MI(%)

Female
Cases MV(%) DCO(%) UB(%) MI(%)

1095
4785
7293
828
6325
3139
617
2477
4055
324
3698
703
160162
14759
139389
7142
823
6040
1083
50
301
712
14946
1852
12665
8386
729
7433
2366
2646
10705
803
9612
813
19633
1710
16536
51735
2532
4619
4884
38930
2539
545
1949
12167
1215
10651
1279
446
4702
3242
1406
4047

93.3
94.9
95.6
93.8
95.8
96.7
95.0
97.1
93.9
91.0
94.1
92.7
94.7
92.3
94.9
95.4
92.6
95.8
93.0
94.0
95.0
91.9
91.5
90.6
91.6
95.5
94.2
95.6
94.6
95.3
95.0
91.9
95.3
95.9
96.4
94.2
96.6
95.9
97.7
93.6
96.4
96.1
91.3
88.4
92.6
91.5
87.7
92.0
97.4
94.8
95.3
96.5
95.7
96.8

2.0
1.8
0.7
0.2
0.7
0.9
1.0
0.8
2.4
4.3
2.2
3.7
1.5
1.9
1.5
0.8
1.2
0.8
2.3
0.0
1.3
2.9
1.4
1.8
1.4
2.3
4.0
2.2
0.6
1.6
0.6
0.7
0.6
2.5
0.7
0.7
0.7
0.7
0.7
0.9
0.6
0.8
1.8
1.1
1.6
2.4
4.1
2.3
0.1
1.8
0.8
0.5
1.4
3.2

2.6
1.3
1.8
2.1
1.8
0.7
0.8
0.7
2.2
2.5
2.2
1.1
1.6
1.8
1.6
1.6
2.4
1.5
1.5
2.0
1.0
1.7
3.2
2.8
3.3
1.1
0.5
1.1
2.1
0.5
1.4
1.7
1.3
0.2
0.8
1.1
0.8
1.1
0.6
1.2
0.9
1.1
4.2
5.7
3.6
4.1
4.0
3.9
0.4
0.9
1.3
0.8
0.8
0.0

45.8
43.9
48.5
46.1
49.5
44.7
45.7
44.7
48.3
46.0
48.7
45.5
45.1
44.3
46.2
41.2
39.5
42.5
44.7
56.0
43.9
44.4
38.7
36.3
39.6
49.6
53.4
50.5
48.3
47.9
45.6
43.5
46.9
46.6
42.2
42.0
42.8
42.9
39.0
42.5
33.4
45.1
47.8
51.0
47.9
44.9
48.0
45.3
44.8
44.4
43.7
42.5
48.2
47.8

961
4481
6714
811
5759
2931
611
2280
3675
315
3327
604
142023
13507
123332
6642
758
5691
913
51
242
606
13877
1796
11735
7617
666
6743
2038
2242
9878
723
8918
821
16665
1556
13928
44600
2148
4065
3946
33784
2382
577
1770
10711
1154
9287
953
423
3794
2592
1360
3539

91.8
93.5
95.1
94.0
95.2
95.8
95.3
96.0
93.7
94.0
93.6
89.6
93.8
91.3
94.0
94.9
92.3
95.3
90.8
88.2
90.9
91.3
90.4
89.1
90.5
94.6
93.5
94.6
93.8
95.0
93.9
91.3
94.1
95.7
95.5
94.5
95.5
95.0
97.0
93.1
95.9
95.0
90.8
87.7
92.1
89.3
86.7
89.7
94.9
93.9
95.0
96.1
94.8
96.4

2.7
1.7
0.8
0.5
0.9
1.3
1.3
1.4
2.1
0.6
2.3
5.6
1.8
2.0
1.9
1.3
1.2
1.3
3.0
3.9
2.9
2.8
1.5
1.3
1.5
2.9
3.6
3.0
0.9
2.0
1.0
1.5
1.0
2.1
1.1
1.1
1.1
1.1
0.6
1.1
0.6
1.2
1.8
1.7
1.5
3.4
3.5
3.4
0.4
1.9
0.8
0.6
1.5
3.5

2.4
2.3
1.9
2.1
1.8
0.5
0.5
0.5
2.4
2.9
2.3
1.8
1.8
2.4
1.8
1.5
2.2
1.4
1.5
2.0
1.2
1.5
3.8
4.0
3.8
1.2
1.4
1.1
2.4
0.5
1.5
1.7
1.5
0.4
0.7
0.7
0.8
1.2
0.6
1.3
1.1
1.2
4.2
4.7
3.9
5.1
6.8
4.8
0.2
1.2
1.6
1.0
1.0
0.1

46.9
49.2
48.1
47.1
49.0
43.9
46.0
43.5
53.4
59.7
53.0
45.9
47.0
48.6
47.9
43.4
40.0
44.6
47.6
43.1
52.9
45.5
40.7
40.9
41.1
51.9
54.7
53.0
53.4
51.1
49.0
46.1
50.2
47.0
45.2
47.1
45.7
44.8
39.2
46.3
34.1
46.8
51.7
54.1
51.7
47.8
51.3
48.2
43.8
50.4
44.9
43.8
49.3
47.7

77
488
2252
48
93
1581
172
303
631
2160
44
1613
255
374
160
4071
3635
320
245
360
411
960
650
2787
482

94.8
96.9
94.8
100.0
81.7
88.7
98.8
97.7
98.7
100.0
97.7
100.0
100.0
98.4
100.0
93.0
94.0
94.7
100.0
86.4
84.9
79.1
83.5
100.0
79.9

1.3
0.0
1.0
0.0
2.2
0.6
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.7
0.0
0.0
0.0
0.0
0.0
0.0
0.0
3.3
2.8
3.4
0.0
1.7
0.0
0.0
2.0
0.0
1.5

58.4
39.5
50.5

58
320
1681
23
66
1097
108
263
332
1104
36
889
115
235
122
3861
3485
284
195
299
384
826
569
2195
436

94.8
96.9
93.6
100.0
86.4
89.6
98.1
98.5
98.2
100.0
91.7
100.0
100.0
99.1
99.2
92.7
93.7
95.1
100.0
83.9
84.4
80.1
83.0
100.0
72.7

3.4
0.0
1.7
0.0
4.5
0.4
0.0

1.7
0.0
0.0
0.0
0.0
0.0
0.0
0.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
3.2
2.7
2.1
0.0
1.3
0.0
0.0
2.3
0.0
1.4

55.2
40.6 *
49.6
*
69.7
48.5 *
*
18.1 *
35.5
*
2.8
37.3
*
*
*
39.1

1.1
0.0
0.0
0.0
0.0
1.3
0.0
2.1
1.8
0.6
0.0
5.6
1.9
11.0
7.4
0.0
12.9

84.9
48.6
10.7
34.2
2.3
35.1
38.0
73.1
69.7
55.5
60.9
67.7
71.9
78.4

1.5
0.0
0.0
0.0
0.0
0.9
0.8
2.1
1.9
0.7
0.0
8.0
3.6
11.1
10.0
0.0
17.4

82.1
65.9
48.2
51.8
59.2
69.2
72.7

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

821

879

Indices of data quality

Lymphoma (C81-90,C96) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

6609
545
411
224
240
425
50
1972
101
200
266
168
331
274
372
658
864
670
40
154
344
148
197
270
681

94.8
93.6
97.8
96.0
98.8
95.8
98.0
95.6
96.0
98.5
98.5
97.0
98.5
98.5
97.6
80.2
100.0
100.0
100.0
100.0
100.0
100.0
98.5
87.4
91.5

3.8
3.5
1.2
2.7
0.0
2.1
0.0
3.5
3.0
0.0
0.4
1.2
0.9
0.0
0.3
4.6
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.7
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.4
1.8

3719
347
163
2188
897
3139
2036
1851
4564
3201
484
3327
573
380
328
453
577
656
821
354
308
225
431
1447
2391
1062
971
1131
1490
692
162
2143
173
514
383
1063
519
164
965
655
288
1805
408
160
433
1081
518
328
199
131
872
659
460
1374

92.6
97.7
96.3
96.2
100.0
98.0
100.0
97.0
90.7
96.3
96.9
95.0
97.2
97.4
100.0
98.2
99.7
97.0
97.7
98.9
95.8
98.7
98.6
78.9
86.1
79.8
88.1
88.5
89.1
95.1
100.0
95.2
94.2
95.5
97.1
84.9
88.1
95.7
99.9
99.7
83.7
98.8
99.8
91.9
98.4
98.3
96.1
97.0
86.9
90.8
96.7
79.8
95.9
94.3

6.6
1.4
3.7

0.0
0.0
0.0
0.0
0.0
1.7
0.0
0.4
0.4
3.4
0.0
0.5
0.5
0.0
0.0
0.7
0.0
2.4
0.0
0.0
1.0
0.0
1.2
2.4
0.2
0.0
0.4
0.0
1.1
0.1
0.0
0.7
0.6
0.0
0.0
0.0
0.0
0.6
0.0
0.0
0.0
0.0
0.2
1.3
0.0
0.0
0.0
0.3
3.5
0.0
0.1
18.4
0.0
0.0

0.0
2.5
3.5
0.3
0.0
1.5

0.3
18.6
13.4
4.6
11.5
11.5
8.5
2.9
0.0
2.0
0.0
1.0
0.8
0.3
0.6
1.2
0.0
0.0
0.7
0.1
0.0
0.6
0.0
1.4
0.8
0.3
2.0
0.0
0.6
0.2
0.0
0.8

50.6
54.5
41.8
49.1
42.1
52.2
57.0
41.8
55.4
26.8
18.1

48.8
1.2
103.4
70.6
22.6
88.8
54.7
39.5
45.4
55.1
44.2
44.4
50.2
54.6
53.6
58.3
50.8

90.7
40.9
49.8
19.7
52.3
48.8
44.8
43.8
52.3
42.2
38.7
44.1
39.3
45.3
43.9
45.4
36.5
34.4
43.0
44.9
62.5
35.8
41.5
51.4
40.2
49.2
50.6
40.1
46.9
33.0
40.9

*Important. See note on population page.

880

822

Female
Cases MV(%) DCO(%) UB(%) MI(%)
4634
424
297
179
163
262
46
1421
64
139
94
133
210
154
177
604
608
478
35
95
229
119
168
201
530

94.3
94.3
96.3
95.0
98.2
95.0
93.5
94.9
96.9
100.0
96.8
94.0
97.1
98.1
97.7
77.5
100.0
100.0
100.0
100.0
100.0
100.0
97.6
86.6
91.3

4.2
3.3
3.4
2.8
1.2
3.8
0.0
4.2
1.6
0.0
0.0
0.8
0.5
0.6
0.0
3.3
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.5
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
3.5
1.1

3728
285
163
2366
757
2776
1613
1786
4374
2780
574
3376
535
310
271
410
541
572
706
271
265
192
334
1379
2516
1076
970
1026
1390
649
113
1716
175
511
326
938
510
121
893
547
254
1771
447
158
407
905
488
288
150
140
753
618
416
1309

90.3
97.9
91.4
97.4
99.6
97.7
100.0
97.1
89.1
96.2
97.2
92.5
96.6
97.7
100.0
97.1
99.8
97.7
97.2
98.2
95.8
97.4
97.9
79.1
81.3
77.9
87.0
87.9
87.6
94.3
100.0
94.9
92.6
93.3
95.7
81.3
89.6
93.4
100.0
99.5
85.4
98.2
100.0
89.9
99.3
98.5
93.4
94.4
88.0
92.1
95.1
80.4
93.5
93.0

8.7
1.4
8.0

0.0
0.0
0.0
0.0
0.0
1.8
0.0
0.2
0.5
3.4
0.0
0.8
0.9
0.0
0.0
2.0
0.0
1.7
0.1
0.0
1.5
0.5
1.2
1.7
0.3
0.0
0.4
0.0
1.6
0.0
0.0
0.6
0.0
0.0
0.0
0.0
0.0
2.5
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.0
2.7
0.0
0.5
16.3
0.0
0.0

0.0
2.7
5.2
0.4
0.0
2.1

0.0
18.8
18.1
5.4
12.4
12.1
9.9
4.3
0.0
2.1
1.1
1.0
2.1
1.1
0.2
3.3
0.0
0.5
0.4
0.2
0.0
0.6
0.0
1.0
2.0
0.3
2.7
0.0
0.5
0.8
0.0
1.0

47.9
46.5
42.4
46.4
42.3
48.5
55.4
35.9
28.1
33.8
40.5

43.3

*
*
*

0.4 *
108.4 *
64.9
20.9 *
66.6 *
58.5
46.0
46.0
45.6 *
*
43.6
41.4 *
47.7
56.3
54.3
53.1
56.7

95.1
42.1
55.9
17.8
61.3
54.4
45.5
54.9
56.5
43.4
40.1
51.5
48.3
48.2
54.5
56.1
42.8
41.3
45.8
41.6
39.9
41.5
43.4
43.4
49.0
38.7
53.6
48.2
50.5
42.1
47.1

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Lymphoma (C81-90,C96) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

640
1023
201
2964
265
490
622
1239
1546
1153
1418
1777
812
126
742
1074
845
117
391
386
596
327
334
485
5740
279
122
114
296
258
173
395
9507
550
460
1895
1503
2629
4208
1727
5660
9113
3180
3350
998
3266

94.4
100.0
96.0
97.5
88.7
92.0
92.9
100.0
99.0
98.1
93.3
92.2
100.0
96.8
95.4
96.4
93.6
88.0
95.1
95.1
93.1
96.9
94.6
97.1
100.0
97.5
96.7
100.0
100.0
94.2
96.5
97.7
98.2
98.2
97.2
91.5
81.8
89.4
86.0
97.3
73.7
81.9
90.1
87.9
82.7
95.9

5.6
0.0
0.5
0.5
4.9
0.6
0.2

0.2
4.5
1.6
1.4
0.6
1.2
5.9
5.3
4.8
1.2
0.4

0.0
0.0
0.0
0.1
0.0
1.6
0.8
0.0
0.0
0.0
0.1
4.2
0.0
0.0
0.5
0.4
0.9
1.7
0.8
0.3
1.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
4.5
1.0
2.0
0.1
1.4
2.7
9.9
1.9
0.0
0.0
0.7

4767 91.9
69 100.0
2404 88.6
1336 95.5
362 97.2
3712 97.7
1220 94.8
190 91.1
62 96.8
2553 98.1
767 98.0
64 95.3
120 96.7
107 100.0
165 98.8
242 97.5

0.6
0.0
0.8
0.0
0.6
1.5
3.4
0.5
3.2
1.8
0.7
3.1
1.7
0.0
0.0
0.4

0.0
0.0
0.2
0.3
0.8
0.4
0.2
0.0
0.0
0.0
0.4
0.0
0.8
0.0
1.2
0.0

0.0
5.2
3.3
0.0
1.6
2.0
0.8
2.1
6.8
3.3
0.0
0.7
0.6
3.9
2.9
0.0
0.0
0.0
0.0
0.8
1.2
2.3

66.1
59.0
52.2
54.9
58.5
49.0
61.3
50.1
48.3
59.1
47.8
60.6
53.1
52.4
50.5
41.2
50.4
53.0
43.5
53.4
46.8
40.7
36.8
51.3
58.8
40.1
50.8
49.1
52.0
48.4
44.5
43.3
53.4
58.5
52.2
48.5
48.1
50.3
46.8
48.3
49.1
49.8
52.1
49.8
48.4
42.9
13.0
43.4
42.9
50.6
43.9
40.2
46.8
46.8
48.8
44.6

44.2

Female
Cases MV(%) DCO(%) UB(%) MI(%)
688
1178
161
2670
259
442
624
1017
1441
1353
1200
1856
892
131
731
914
750
67
320
353
520
294
273
422
4926
227
129
88
268
279
144
381
7789
470
422
1653
1287
2264
3740
1411
4917
7835
2870
2887
991
3280

95.1
100.0
95.0
96.1
86.9
88.7
92.0
99.9
99.0
97.7
93.6
92.2
100.0
94.7
94.5
93.9
93.7
86.6
96.9
94.1
91.7
96.3
94.9
96.9
100.0
96.5
96.1
100.0
100.0
93.9
91.7
96.3
97.8
95.1
96.7
88.6
80.4
86.7
83.6
95.8
71.1
79.7
89.7
87.5
82.7
95.8

3907
35
1923
1106
296
3151
922
153
54
2185
594
39
87
80
170
168

91.4
97.1
89.0
94.7
97.0
97.7
94.7
90.2
96.3
97.6
96.8
97.4
98.9
95.0
96.5
97.0

4.8
0.0
0.6
0.7
6.2
0.9
0.2

0.2
5.5
1.9
1.6
1.3
1.9
6.8
4.9
4.8
1.0
0.2

0.0
0.0
0.0
0.1
0.0
3.4
1.1
0.0
0.0
0.0
0.1
3.8
0.0
0.8
1.0
0.2
1.2
0.0
0.0
0.0
0.8
0.0
0.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
4.7
0.5
2.4
0.0
2.0
4.0
10.7
1.6
0.0
0.0
0.8

0.6
2.9
1.0
0.0
0.0
1.6
2.8
1.3
0.0
2.2
0.7
0.0
0.0
0.0
1.2
0.6

0.0
0.0
0.3
0.1
0.0
0.2
0.2
0.0
1.9
0.0
0.3
0.0
0.0
0.0
0.6
0.6

0.0
4.8
3.9
0.0
3.8
2.6
2.7
2.0
10.4
2.2
0.0
1.7
1.7
4.0
3.1
0.0
0.8
0.0
0.0
2.2
0.0
3.7

59.4
52.8
49.1
54.7
72.9 *
50.3
62.0
51.1 *
52.4
56.8
42.2
53.1
52.9
61.1
50.2
46.6
55.3
61.2
41.6
56.9
46.9
45.9
43.2
53.8
63.1
41.9
51.2
55.7
46.3
40.5
46.5
47.0
58.2
53.3
51.7
53.8
51.8
51.7
50.8
51.9
51.9
50.2
54.0
49.2
53.0
47.3
45.7
42.3
48.3
52.4
45.1
47.3
58.2
31.5
48.3
44.3

42.9

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

823

881

Indices of data quality

Leukaemia (C91-95)
Male
Cases MV(%) DCO(%) UB(%) MI(%)
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

85 100.0
375 88.3
53 100.0
33 100.0
84 85.7
104
174
65
117
2029
58
304
551
253
68
69

11.5
13.1

64.4
86.8
58.5
76.1
99.1
100.0
91.1
79.1
100.0
100.0
100.0

18.3
11.5
16.9
23.1
0.0
0.0
0.3
3.3
0.0

8363 72.0
1101 99.5
1315 73.1
444 94.8
248 93.1
95 98.9
1 100.0
307 82.7
4318 59.4
58 100.0
476 71.6
1138 82.2
177 84.7
940 81.7
146 92.5
1469 80.6
10422 93.8
722 95.8
528 96.0
1926 97.3
7022 92.3
1912 95.2
105 98.1
98 95.9
60 91.7
16 93.8
244 98.0
1262 94.3
2755 97.0
219 98.6
58 96.6
53 94.3
34 94.1
21 100.0
721 98.3
1541 96.1
1373 79.2
1253 88.7
52 96.2
1163 88.2
119 83.2
69 81.2
39 82.1
6990 94.4
424 95.0
6479 94.5
1960 86.8
371 87.3
1556 86.5
667 91.9
157 91.7
491 91.9
467 90.1
4269 83.4
399 86.7
3720 82.7
1933 88.3
1420 90.0
1435 79.8
1465 88.3
301 87.7
1154 88.4
84 90.5
211 94.3

2.1
0.4
3.6
2.0
0.0

0.0

0.0
5.9
2.0
0.0
2.9
2.3
1.7
2.4
2.1
2.2
1.7
1.5
0.8
0.6
2.1
2.6
1.0
4.1
6.7
0.0
1.2
3.0
0.9
0.9
0.0
0.0
2.9
0.0
0.7
1.0
3.8
3.3
0.0
3.4
10.1
8.7
15.4
5.5
5.0
5.5
4.9
4.0
5.2
2.5
1.9
2.9
5.1
5.4
6.8
5.4
3.4
2.7
3.7
2.1
2.0
2.2
4.8
3.8

0.0
0.3
0.0
0.0
0.0

41.3

824

75 100.0
300 89.3
39 100.0
29 100.0
51 86.3

10.7
13.7

6.7
1.7
9.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

71.2
62.6
46.2
16.2
51.0
79.3
71.7
77.1
66.8
77.2

79
114
49
117
1739
42
290
434
226
63
72

68.4
82.5
51.0
75.2
99.4
100.0
90.0
73.5
100.0
100.0
100.0

13.9
14.0
30.6
23.9
0.0
0.0
1.7
6.0
0.0

17.1
0.0
0.8
0.0
0.0
1.1
0.0
2.6
32.8
0.0
0.0
5.4
5.6
5.3
3.4
5.2
1.8
1.0
0.8
0.7
2.3
0.6
0.0
0.0
0.0
0.0
0.0
0.8
0.7
0.0
0.0
3.8
0.0
0.0
0.3
1.0
4.2
0.6
1.9
0.6
4.2
5.8
2.6
0.0
0.0
0.0
1.4
1.3
1.4
1.2
0.6
1.4
0.2
1.8
1.3
1.8
1.5
2.5
7.0
1.3
1.7
1.2
0.0
0.5

55.0
46.7
58.3
54.5
56.9
88.4
300.0
65.1
55.1
41.4
51.3
82.5
102.3
80.5
45.9
69.6
57.5
56.5
61.9
45.4
62.0
58.8
70.5

5993
757
920
355
155
56
2
249
3150
34
315
973
183
773
113
1059
7617
562
405
1510
4990
1438
89
64
36
13
198
965
2049
187
48
46
25
22
610
1025
987
979
53
914
94
61
27
5232
447
4707
1533
320
1192
479
109
358
333
3443
356
2989
1570
1001
1103
1140
281
844
79
171

66.8
99.3
69.8
88.5
94.8
100.0
100.0
81.5
52.1
100.0
67.3
80.1
85.8
78.7
90.3
77.1
92.0
96.4
93.3
96.7
89.9
91.8
96.6
96.9
97.2
84.6
94.4
89.8
95.5
93.6
91.7
95.7
100.0
100.0
98.2
94.0
76.7
86.0
96.2
85.2
75.5
78.7
66.7
94.2
95.7
94.1
82.5
81.6
82.6
86.2
85.3
86.0
84.7
78.8
80.9
78.3
86.3
88.4
79.2
86.8
85.8
87.1
88.6
91.8

3.2
0.3
3.7
5.1
0.0

45.1
62.3
55.1
63.0
65.5
45.3
61.8
76.2
47.6
58.8
54.6
57.5
65.4
58.5
78.2
71.0
110.3
62.2
65.6
62.6
67.6
70.1
68.1
57.6
61.8
57.8
57.0
60.9
59.1
62.3
67.7
56.8
60.5
62.8
70.4
61.0
88.1
65.9

*Important. See note on population page.

882

Female
Cases MV(%) DCO(%) UB(%) MI(%)

0.0

0.0
5.6
3.5
0.0
5.1
2.2
2.7
2.1
1.8
3.4
2.9
1.1
2.7
1.0
3.8
4.7
2.2
3.1
0.0
0.0
3.0
5.9
2.0
2.7
6.3
0.0
0.0
0.0
0.2
3.0
3.2
4.2
1.9
4.4
13.8
9.8
22.2
5.8
4.3
5.9
6.7
5.9
7.0
5.2
4.6
5.6
7.2
7.3
7.6
7.4
4.7
2.6
2.8
2.7
4.6
2.1
5.1
4.1

0.0
0.0
0.0
0.0
0.0

47.3

5.1
2.6
6.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

68.4
73.7
49.0
12.8
52.9
76.2
69.7
78.6
71.2
73.4

20.4
0.1
0.2
0.0
0.0
0.0
0.0
4.0
38.4
0.0
0.0
6.8
4.4
7.2
6.2
7.3
2.3
0.5
1.5
0.9
3.0
0.8
0.0
0.0
0.0
0.0
0.0
1.0
0.9
1.1
2.1
2.2
0.0
0.0
0.5
1.2
4.3
1.0
1.9
1.0
2.1
1.6
3.7
0.0
0.0
0.0
2.3
1.9
2.4
1.9
0.9
2.2
0.9
2.1
2.2
2.1
1.3
2.1
8.0
0.6
1.1
0.5
0.0
0.6

54.8
46.4
58.8
53.2
58.7
89.3
50.0
55.8
54.8
70.6
53.7
83.6
86.9
84.0
42.5
72.6
59.9
54.4
65.9
44.3
66.3
60.5
66.3
46.0
64.5
59.6
73.8
62.5
54.3
68.0
68.2
47.9
66.9
58.5
62.0
56.6
62.7
85.1
85.2
96.3
60.5
56.4
61.5
70.2
70.6
70.6
67.6
80.7
64.2
60.7
66.5
71.1
67.5
72.9
61.5
58.6
64.9
66.5
64.9
74.7
67.8

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Leukaemia (C91-95) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

553 79.0
1978 82.8
3415 89.0
292 88.0
3044 89.0
1477 95.0
217 92.2
1226 95.4
1903 83.4
150 89.3
1738 82.9
363 75.5
74692 87.1
5241 87.8
66537 86.8
3090 89.6
250 90.4
2689 89.4
643 89.1
26 100.0
157 87.3
441 88.7
6804 78.2
526 85.4
6069 77.2
3491 93.0
259 91.5
3137 92.9
1130 90.0
1144 89.0
4892 79.1
249 79.1
4511 78.9
411 93.4
9246 93.6
597 94.0
7939 93.3
24462 91.9
1175 96.0
1669 92.0
2517 95.9
18641 91.0
1168 80.3
233 78.5
913 81.4
6207 81.4
510 81.4
5502 81.5
612 97.9
224 83.0
2223 94.2
1543 98.0
683 89.6
2154 95.1
62
353
1032
52
100
939
163
167
432
1715
30
1169
265
245
119
1800
1531
160
129
157
211
433
546
1712
200

93.5
92.6
89.1
100.0
77.0
94.2
100.0
98.2
96.3
100.0
96.7
100.0
99.2
100.0
95.8
85.2
85.6
90.6
100.0
91.1
60.7
79.2
95.8
100.0
98.5

Female
Cases MV(%) DCO(%) UB(%) MI(%)

2.9
3.8
1.4
0.7
1.5
1.3
0.9
1.4
7.7
4.7
8.1
10.5
3.5
3.5
3.6
1.8
2.0
1.8
4.2
0.0
5.7
4.1
2.9
2.5
3.0
3.0
4.2
3.0
0.0
3.1
2.1
3.2
2.1
3.6
2.2
1.2
2.3
2.0
1.6
1.4
1.0
2.2
3.4
3.9
2.8
5.7
5.9
5.8
0.8
3.6
2.2
1.4
3.4
4.9

5.4
4.2
2.6
4.1
2.6
0.9
1.4
0.9
4.6
3.3
4.8
3.0
3.0
2.5
3.1
2.3
1.2
2.5
2.0
0.0
1.9
2.3
7.5
4.2
7.9
0.7
0.8
0.7
1.1
0.8
4.0
3.2
4.1
1.0
1.0
0.8
1.0
1.9
0.7
1.4
1.1
2.1
6.0
5.6
5.9
7.1
5.3
7.2
0.2
1.8
1.4
0.1
0.6
0.0

52.3
64.8
62.5
66.1
63.1
58.2
66.4
57.6
70.2
77.3
70.0
63.9
61.7
67.5
62.6
58.7
66.0
59.9
50.7
42.3
52.9
50.1
54.3
56.1
54.5
72.0
81.1
73.3
70.6
64.8
61.9
71.9
62.8
56.4
56.7
65.0
56.9
57.9
55.1
65.2
45.0
60.2
66.2
72.1
66.2
58.7
63.1
59.6
57.0
61.6
54.4
53.1
66.2
57.4

378
1746
2760
296
2389
1329
226
1075
1440
123
1300
251
57712
4675
50808
2407
218
2092
428
19
116
288
5553
543
4847
2775
216
2490
856
888
3850
249
3489
308
6957
509
5983
18307
891
1393
1963
13749
921
208
688
4597
410
4059
437
162
1605
1080
563
1711

78.6
78.0
86.2
88.2
85.7
90.6
92.9
90.0
81.9
88.6
81.0
77.7
84.4
85.6
84.0
85.5
86.2
85.3
83.4
94.7
89.7
80.2
74.4
83.6
73.0
90.7
92.1
90.4
88.6
86.0
76.1
78.3
75.7
89.9
90.8
92.3
90.2
89.6
95.7
89.2
95.5
88.3
79.3
77.9
80.8
78.2
77.6
78.2
98.9
79.0
92.4
97.4
85.8
91.8

4.0
6.1
1.7
2.0
1.7
2.6
0.9
3.0
6.3
3.3
6.7
11.6
4.5
3.9
4.6
3.0
1.4
3.3
6.3
0.0
4.3
7.6
3.5
1.1
3.9
4.5
4.6
4.6
0.0
3.0
2.4
2.0
2.5
6.5
3.2
2.0
3.5
2.9
1.0
2.7
1.2
3.4
4.7
1.9
4.5
7.4
8.5
7.4
0.0
5.6
3.1
1.9
3.9
8.2

6.1
4.4
4.2
3.4
4.4
1.1
0.4
1.2
6.2
3.3
6.5
1.6
3.7
3.2
3.8
3.2
3.2
3.2
2.8
0.0
0.9
3.8
9.4
5.9
9.9
0.5
0.0
0.5
2.0
1.1
4.5
2.8
4.5
1.3
1.1
0.8
1.2
2.3
0.9
2.1
1.0
2.6
8.3
8.2
8.0
8.0
7.1
8.1
0.2
1.9
1.9
0.0
1.6
0.0

57.1
65.1
64.5
67.6
65.5
57.6
65.5
56.4
75.7
67.5
77.3
67.3
64.7
68.1
65.9
63.6
58.7
66.1
52.6
31.6
50.9
54.2
57.3
61.1
57.4
76.7
81.0
78.4
72.4
65.2
66.1
61.8
68.0
58.1
60.3
67.8
60.3
60.9
54.7
65.5
44.1
64.3
72.4
77.4
72.8
62.2
72.4
62.2
60.2
64.8
59.0
59.2
70.2
63.9

6.5
0.0
1.9
0.0
11.0
0.1
0.0

0.0
0.0
0.0
0.0
2.0
0.0
0.0
1.8
0.0
0.0
0.0
0.0
0.0
0.0
0.0
5.6
6.0
1.3
0.0
0.6
0.0
0.0
1.1
0.0
0.5

74.2
74.5
65.2

37
242
828
41
63
748
113
116
256
942
30
738
139
175
78
1393
1182
102
89
96
156
341
438
1158
159

91.9
93.4
84.8
100.0
81.0
92.2
99.1
99.1
96.5
100.0
100.0
100.0
99.3
99.4
98.7
80.8
82.5
84.3
100.0
86.5
55.1
76.5
91.1
100.0
99.4

8.1
0.0
3.5
0.0
0.0
0.4
0.9

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.9
0.0
0.0
0.0
0.0
0.0
0.0
0.0
5.9
6.1
3.9
0.0
1.0
0.0
0.0
1.8
0.0
0.0

64.9
71.5 *
67.6
*
54.0
65.0 *
*
58.2 *
54.3
*
30.0
46.9
*
*
*
68.6

3.0
0.0
0.0
0.0
0.4
0.0
4.2
6.2
5.2
5.0
0.0
6.4
3.3
19.6
2.7
0.0
1.0

103.0
67.5
46.4
47.9
16.7
49.9
64.0
80.6
82.2
67.8
82.2
90.7
81.5
92.5

3.1
0.0
0.0
0.0
0.7
0.0
1.3
10.1
7.8
10.8
0.0
8.3
4.5
23.2
4.8
0.0
0.6

80.9
86.5
80.1
69.8
91.1
78.7
81.8

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

825

883

Indices of data quality

Leukaemia (C91-95) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

4462
409
289
140
157
263
36
1218
75
89
149
157
233
151
204
670
458
359
31
68
160
93
108
182
413

92.6
92.4
95.5
87.1
95.5
93.9
100.0
92.9
89.3
94.4
98.0
91.7
95.7
83.4
99.5
85.1
100.0
100.0
100.0
100.0
100.0
100.0
75.0
42.3
89.8

6.8
6.6
3.5
10.0
4.5
5.3
0.0
6.8
8.0
1.1
1.3
6.4
3.9
0.7
0.5
14.0
0.0
0.0
0.0
0.0
0.0
0.0
0.9
1.1
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.5

72.8
73.1
63.0
77.9
61.8
76.4
75.0
63.9
70.7

2195
201
94
2275
421
1682
1640
1449
3150
2091
346
1360
326
212
185
294
293
410
509
190
130
128
135
930
1532
524
675
688
841
333
77
1207
107
237
162
411
248
67
425
275
139
736
221
107
203
563
303
216
106
79
364
381
187
598

87.5
99.0
86.2
98.6
100.0
99.9
100.0
73.6
80.3
94.4
98.3
92.5
84.7
100.0
100.0
95.2
100.0
96.3
100.0
100.0
96.9
100.0
96.3
64.1
71.7
76.0
73.8
74.0
82.5
86.8
98.7
95.2
99.1
97.0
95.7
66.9
81.5
89.6
100.0
100.0
71.9
100.0
99.5
97.2
97.5
97.3
93.4
100.0
95.3
100.0
98.1
70.1
91.4
88.0

12.3
1.0
13.8

0.0
0.0
0.0
0.0
0.0
0.0
0.0
21.0
0.8
4.5
0.0
1.0
3.1
0.0
0.0
2.0
0.0
1.7
0.0
0.0
2.3
0.0
0.0
2.4
0.1
0.0
0.1
0.0
1.5
0.9
0.0
0.1
0.0
0.0
0.0
0.0
0.0
3.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
27.6
0.0
0.0

76.4
53.2
55.3
74.1

0.0
5.4
8.9
1.1
1.4
4.3

0.8
33.3
28.2
6.7
25.9
26.0
15.2
11.4
1.3
3.4
0.0
1.7
1.2
0.7
1.6
1.5
0.0
0.0
1.4
0.0
0.0
2.8
1.0
2.7
3.3
0.0
1.9
0.0
1.9
1.3
0.0
4.3

60.5
21.5

61.8

93.5
44.0
65.9

56.2
63.8
58.7
76.3
60.2
66.2
61.9

167.7
50.1
70.8
66.5
74.3
54.8
80.2
58.4
60.0
51.4
54.0
75.3
83.5
68.5
79.1
72.2
55.6
51.0
66.8
59.7
63.6
66.5
54.4
58.1
68.5
77.4
49.1
62.4
80.8
56.1
60.9

*Important. See note on population page.

884

826

Female
Cases MV(%) DCO(%) UB(%) MI(%)
3477
290
242
113
125
218
32
973
64
71
61
120
181
109
126
624
348
276
20
52
146
85
118
128
321

93.1
94.5
96.7
94.7
96.0
98.6
93.8
93.6
96.9
98.6
95.1
89.2
95.6
90.8
100.0
82.7
100.0
100.0
100.0
100.0
100.0
100.0
61.0
47.7
87.5

6.3
4.1
2.9
4.4
4.0
1.4
0.0
6.2
3.1
0.0
1.6
9.2
4.4
0.9
0.0
17.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.6
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.6
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.8
0.0
0.9

1947
177
68
2158
285
1206
1297
1289
2488
1625
371
1218
260
178
136
231
219
316
347
147
117
106
74
776
1456
462
549
563
770
270
62
848
72
184
124
399
212
48
368
215
122
685
161
91
140
424
243
118
60
49
318
263
162
522

84.4
98.3
88.2
98.6
99.3
99.8
100.0
72.6
78.1
93.2
98.4
91.4
86.2
100.0
100.0
94.8
100.0
93.7
100.0
99.3
94.0
100.0
95.9
55.3
64.4
68.6
67.6
69.3
77.5
84.8
100.0
91.9
98.6
96.7
96.8
56.9
75.0
79.2
100.0
99.5
71.3
100.0
100.0
94.5
98.6
95.0
92.2
99.2
91.7
100.0
97.8
69.6
91.4
86.4

15.4
1.7
11.8

0.0
0.0
0.0
0.0
0.0
0.1
0.0
22.1
0.8
5.4
0.0
0.8
1.5
0.0
0.0
2.2
0.0
2.8
0.0
0.0
1.7
0.0
0.0
1.5
0.1
0.0
0.4
0.0
1.0
0.0
0.0
1.9
0.0
0.0
0.0
0.0
0.0
2.1
0.0
0.0
0.0
0.0
0.0
1.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
27.8
0.0
0.0

0.0
5.3
10.5
1.5
1.6
5.7

1.7
43.0
35.4
10.2
32.1
30.7
20.6
10.7
0.0
4.4
1.4
1.6
1.6
2.0
3.3
2.1
0.0
0.0
5.7
0.0
0.0
4.4
0.0
5.0
5.3
0.8
3.3
0.0
2.2
1.9
1.2
5.6

69.8
70.3
63.6
69.0
65.6
56.9
51.6
59.4
53.1
58.3
58.0

62.4

*
*
*

0.7 *
*
57.6
48.4 *
62.6 *
78.2
55.4
66.2
71.8 *
*
71.4
67.9 *
58.5
79.9
66.0
74.1
67.7

197.9
48.6
79.7
81.2
82.4
63.6
81.9
62.9
64.2
68.1
58.2
65.3
73.7
53.3
89.6
77.2
67.9
68.3
61.8
58.4
64.8
64.3
61.8
62.6
72.9
70.0
76.5
67.9
92.0
51.2
66.5

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

Leukaemia (C91-95) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

629
1020
115
1440
133
300
304
417
663
984
982
1334
509
80
366
483
365
62
162
211
338
145
171
229
3035
155
68
44
178
98
85
175
4314
246
250
895
654
1231
2349
900
2547
4448
1596
1776
473
1746

95.1
100.0
100.0
95.6
77.4
87.7
100.0
99.5
100.0
100.0
89.9
94.0
100.0
97.5
91.3
91.9
94.8
80.6
92.6
97.2
87.9
91.0
94.2
89.5
99.7
99.4
95.6
97.7
100.0
93.9
98.8
92.6
100.0
100.0
100.0
84.2
64.7
71.0
49.4
97.0
48.3
73.8
87.6
79.6
74.6
96.5

2640 83.6
26 92.3
1483 83.5
770 92.6
162 90.1
1615 93.1
588 90.6
94 72.3
45 97.8
1776 96.8
384 97.4
20 100.0
46 95.7
57 98.2
91 96.7
124 97.6

4.9
0.0
0.0
2.6
19.5
1.0
0.0

66.9
68.4
60.0
54.3
88.3
72.9
109.9
102.6
77.8
65.2
72.2
70.7
63.7
68.8
73.8
67.7
60.6
66.1
75.3
74.9
58.3
74.5
63.7
73.4
61.7
49.7
61.8
70.5
44.4
56.1
54.1
57.7
67.6

0.4
11.5
3.5
1.7
1.0
1.9
8.3
8.2
7.8
0.6
0.3

0.0
0.0
0.0
0.0
0.0
3.7
0.0
0.0
0.0
0.0
0.4
0.2
0.0
0.0
1.4
0.0
1.4
3.2
0.0
0.0
2.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
12.8
1.4
6.3
0.1
1.7
7.2
15.6
4.1
0.0
0.0
0.9

1.7
0.0
1.5
0.0
0.6
6.0
9.2
0.0
2.2
3.2
1.3
0.0
4.3
1.8
1.1
0.8

0.0
0.0
0.2
0.4
4.9
0.4
0.2
0.0
0.0
0.0
0.3
0.0
0.0
0.0
1.1
0.0

51.7
61.5
45.8
47.7
60.2
61.9
59.0
59.6
51.1
40.5
56.0

0.0
8.5
5.8
0.0
2.5
5.2
4.3
3.6
14.5
5.6
0.0
2.1
1.4
5.8
10.5
0.6
0.0
2.3
0.0
6.1
1.2
7.4

71.2
57.5
74.9
62.4
52.5
54.3
61.6
56.5
58.0
57.6
60.0
51.8

58.1

Female
Cases MV(%) DCO(%) UB(%) MI(%)
616
942
76
1098
153
355
279
333
495
1250
712
1047
422
71
277
355
257
49
113
163
274
96
108
183
2274
130
48
43
126
73
65
137
3163
198
141
643
515
964
1954
656
2076
3417
1140
1357
325
1331

93.2
100.0
100.0
96.5
76.5
81.7
100.0
99.7
99.8
100.0
87.2
94.1
100.0
97.2
86.3
93.2
91.4
91.8
92.0
98.8
85.4
84.4
96.3
89.1
99.6
99.2
85.4
100.0
100.0
90.4
100.0
82.5
100.0
99.5
100.0
81.5
58.1
67.3
45.2
96.3
44.5
71.8
85.4
76.0
71.1
95.2

1827 82.3
20 100.0
1048 82.2
577 92.2
118 96.6
1212 92.6
389 90.2
66 77.3
38 94.7
1253 95.7
269 96.7
15 100.0
27 92.6
45 97.8
69 97.1
77 97.4

6.7
0.0
0.0
1.4
15.7
1.7
0.0

71.4
70.9
57.9
60.5
79.2 *
55.6
105.0
120.1 *
87.9
58.5
81.9
73.3
70.9
54.9
68.0
69.3
66.6
49.0
69.0
76.1
48.9
92.7
67.6
80.3
71.2
46.9
66.7
100.0
57.1
67.1
50.8
70.1
78.2

0.3
16.9
4.3
2.4
1.4
2.1
10.6
10.8
10.0
0.9
0.5

0.2
0.0
0.0
0.1
0.0
5.4
0.0
0.0
0.0
0.0
0.3
0.3
0.0
0.0
3.2
0.6
1.2
2.0
3.5
0.0
1.1
1.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
15.1
1.4
6.5
0.1
1.5
10.5
16.0
3.3
0.0
0.0
1.7

1.9
0.0
2.3
0.0
0.0
6.4
9.5
3.0
5.3
4.3
1.1
0.0
0.0
0.0
1.4
1.3

0.0
0.0
0.8
0.7
1.7
0.3
0.3
0.0
0.0
0.0
0.4
0.0
3.7
0.0
0.0
0.0

53.6
45.0
44.8
51.0
69.2
61.3
57.6
69.7
57.9
43.9
59.9

0.0
11.2
5.5
0.0
2.8
7.6
3.7
6.6
4.1
3.5
0.0
2.9
1.0
3.7
10.9
0.8
0.0
0.0
0.0
8.2
0.0
17.5

80.9
64.7
78.8
65.4
57.1
61.0
64.6
62.2
67.2
62.2
56.6
55.8

71.4

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

827

885

Indices of data quality

All sites but skin (C00-96/C44)


Male
Cases MV(%) DCO(%) UB(%) MI(%)
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

1844
6908
1379
2173
4371

93.5
79.5
96.3
67.1
59.7

2201
6732
1605
3592
70229
2040
7766
13656
4194
3610
1256

76.8
89.8
75.3
89.4
79.0
77.8
79.2
73.3
81.8
97.8
94.7

17.5
4.2
16.9
7.9
7.6
9.5
6.3
11.5
10.2

269555
30271
47343
14039
9614
5755
196
13074
134700
1806
12757
50729
10033
39737
5133
55142
343106
25220
23624
42779
242117
67931
5258
3768
2042
775
6051
45921
87885
11034
2408
2068
1577
1223
16330
49395
41445
46713
2944
42896
7507
5298
1877
251927
20951
227632
81495
19018
61499
24822
7196
17034
14306
146334
18779
122812
69583
39125
54081
54954
14443
40062
4277
7945

87.1
91.1
90.3
88.9
91.6
97.4
98.0
89.0
83.8
92.3
88.7
91.6
89.6
92.0
94.3
93.1
94.5
93.8
94.0
94.4
94.5
94.4
92.4
93.3
93.8
94.1
94.4
94.7
95.6
95.0
95.1
95.6
95.4
93.5
95.1
95.8
92.3
96.0
96.5
95.9
92.4
92.3
94.1
93.3
91.6
93.4
93.0
91.4
93.4
95.4
94.3
95.9
92.8
93.7
92.1
93.8
94.0
93.8
92.0
93.2
90.9
94.0
91.2
94.0

1.4
0.2
1.5
2.4
0.1

7.8
12.9

1.3

0.0
1.7
1.4
0.2
3.4
2.3
2.4
2.4
0.4
1.5
0.9
0.6
0.9
0.8
1.0
1.2
1.2
0.9
1.0
1.3
1.1
1.3
0.7
0.8
0.3
0.5
0.6
0.4
0.7
0.7
2.0
1.1
0.8
1.1
2.8
2.9
2.8
3.5
4.5
3.4
2.7
3.1
2.6
1.3
1.3
1.3
2.8
2.3
4.0
2.1
1.6
1.3
1.2
1.2
1.9
1.0
2.7
1.2

0.1
0.0
0.0
0.0
0.0

25.3

828

1815
6637
986
2777
3780

93.7
86.1
97.1
65.9
63.1

8.2
12.0

2.2
5.3
2.9
0.1
0.0
0.0
0.0
0.0
0.0
0.6
0.0

88.6
36.9
44.4
50.9
41.6
62.3
55.0
60.7
53.9
45.8

2352
8004
1645
4105
77358
1903
9609
13452
5135
2438
1947

80.5
86.9
77.0
91.6
78.5
75.9
82.9
78.1
82.2
95.0
95.5

12.5
4.3
14.4
6.4
7.1
11.7
6.0
9.5
10.0

6.9
0.1
0.2
0.0
0.0
0.3
0.0
0.7
13.7
0.0
0.0
2.6
3.1
2.5
2.1
1.9
0.9
0.8
0.9
0.9
1.0
0.5
0.9
0.6
0.8
0.5
0.6
0.4
0.7
0.8
1.0
0.6
0.6
1.1
0.8
0.7
1.2
0.4
0.3
0.4
2.1
1.7
1.8
0.4
0.4
0.4
0.7
0.7
0.6
0.6
0.7
0.6
0.2
0.6
0.8
0.6
0.6
0.6
2.3
0.5
0.5
0.5
0.6
0.6

44.9
40.8
42.7
47.5
48.0
57.6
54.6
46.7
45.0
44.5
48.5
51.7
61.5
50.3
35.7
43.2
39.2
41.7
43.5
34.7
40.6
37.7
48.0

244027
26796
41349
13042
8283
4553
185
11557
125919
1585
10758
46278
9069
36425
4616
50316
326290
26738
19059
44576
231266
65732
4372
3533
2106
961
6212
44947
84578
9074
2324
2426
1546
1248
17514
48033
39979
44997
2569
41709
6868
4583
1983
217537
17397
197120
74996
16452
57483
24025
6572
16850
12570
142366
17722
120551
68591
37198
49626
47197
12376
34479
3817
7433

86.8
92.6
89.8
88.9
91.8
97.9
98.4
88.5
83.1
92.0
89.4
92.2
91.6
92.4
94.9
93.4
94.4
95.8
94.1
95.7
94.0
94.2
92.9
95.0
95.9
95.3
95.3
93.9
95.5
94.7
95.9
97.1
96.2
95.7
96.2
95.1
92.7
95.2
95.9
95.1
92.6
92.1
94.4
93.4
93.4
93.4
93.0
92.1
93.1
95.2
94.4
95.5
92.9
93.3
91.7
93.4
94.3
93.3
92.3
92.9
92.1
93.1
92.6
93.2

1.7
0.3
1.9
2.5
0.1

32.3
38.0
38.0
41.9
47.3
35.4
38.7
52.8
34.9
39.2
36.7
37.6
39.9
38.0
44.7
49.7
37.1
41.1
45.2
41.2
44.0
48.1
43.1
37.4
40.9
36.1
38.9
43.2
50.3
43.1
47.6
42.3
45.3
46.0
53.0
43.6
55.6
45.6

*Important. See note on population page.

886

Female
Cases MV(%) DCO(%) UB(%) MI(%)

1.5

0.0
1.8
1.9
0.1
3.6
2.2
2.0
2.3
0.5
1.5
1.0
0.6
1.0
0.7
1.1
1.6
1.5
0.5
0.9
1.1
1.1
1.9
0.7
0.8
0.7
0.4
0.5
1.0
0.6
0.8
1.8
1.3
1.1
1.3
2.9
2.9
3.0
3.1
2.9
3.1
2.7
2.7
2.7
1.5
1.5
1.5
2.5
2.4
4.1
2.1
1.5
1.5
1.2
1.3
1.4
1.2
1.8
1.4

0.2
0.0
0.0
0.0
0.0

22.7

2.9
8.2
2.4
0.2
0.0
0.0
0.0
0.0
0.0
1.1
0.0

69.6
30.6
35.0
38.1
34.5
62.5
50.8
52.1
52.8
45.4

7.3
0.1
0.1
0.0
0.0
0.1
0.0
0.9
14.0
0.0
0.0
2.5
2.5
2.4
1.8
1.7
0.9
0.6
0.8
0.7
1.0
0.4
0.5
0.5
0.3
0.4
0.4
0.4
0.7
0.9
1.0
0.5
0.6
0.7
0.6
0.8
1.1
0.4
0.3
0.4
1.5
1.2
1.3
0.3
0.3
0.3
0.6
0.7
0.5
0.5
0.7
0.4
0.4
0.5
0.7
0.5
0.6
0.5
1.9
0.6
0.7
0.6
0.9
0.6

44.0
41.3
43.9
45.8
45.4
54.8
46.5
46.6
43.4
44.4
46.6
47.7
55.8
46.6
33.6
41.8
39.9
34.7
49.9
31.8
41.8
39.1
52.4
30.4
40.8
39.4
50.5
41.5
27.1
37.0
38.5
33.8
41.0
37.0
39.5
42.5
39.7
47.7
54.2
37.9
41.1
45.9
41.1
42.3
48.0
41.0
38.4
44.5
36.5
39.6
42.8
51.2
42.5
44.7
41.4
42.5
46.0
51.9
44.0
52.8
45.0

*
*
*
*

Amer
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
USA
Asia
Bahr
Chin
Chin
Chin
Chin
Chin
Chin
Cypr
India
India
India
India
India
India
India
Israe
Israe
Israe
Japan
Japan
Japan
Japan
Japan
Japan
Japan

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

All sites but skin (C00-96/C44) (contd)


Male
Cases MV(%) DCO(%) UB(%) MI(%)

)
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Female
Cases MV(%) DCO(%) UB(%) MI(%)

18925
83398
128214
16270
108837
55857
12614
42375
67971
6166
61217
12098
2678584
260184
2317952
117270
13154
100374
18921
640
5093
12791
235878
28918
199913
138865
13201
120193
41469
43007
180632
14733
161549
15120
311115
30149
258045
836565
40281
80476
59291
641428
49841
12332
36846
200115
21129
174180
17597
7744
70877
48122
26512
67288

91.8
94.1
94.4
93.6
94.4
95.9
95.1
96.2
91.6
90.9
91.7
91.5
93.2
91.9
93.3
94.9
94.2
95.0
91.2
85.2
90.0
91.9
91.2
91.5
91.1
93.9
92.0
93.9
89.2
93.0
94.3
93.2
94.4
94.9
94.8
94.5
94.9
94.4
94.1
93.6
94.2
94.5
92.7
91.1
93.2
90.4
88.1
90.7
96.0
93.9
93.7
94.2
92.6
91.2

1.7
1.8
1.1
0.9
1.2
1.0
0.9
1.0
3.2
4.3
3.1
4.1
2.0
2.7
2.0
1.1
1.0
1.1
2.8
4.5
2.8
2.8
1.9
2.3
1.9
2.7
4.0
2.7
2.7
1.8
0.9
1.2
0.8
1.8
1.1
1.0
1.1
1.0
0.7
1.1
1.0
1.1
2.0
2.0
1.9
3.8
5.3
3.7
0.3
2.0
1.0
0.7
1.7
2.6

2.2
1.4
1.5
1.8
1.4
0.5
0.6
0.4
2.5
2.0
2.6
1.0
1.3
1.4
1.3
1.0
1.2
1.0
1.1
1.1
1.3
1.0
2.3
2.0
2.3
1.6
1.9
1.5
1.1
0.9
0.9
0.9
0.8
0.4
0.6
0.7
0.6
0.9
0.7
0.9
0.9
0.9
2.5
2.8
2.3
2.7
2.8
2.6
0.1
0.4
1.1
0.9
0.9
3.2

41.5
41.2
39.6
41.4
40.0
37.3
39.6
36.9
46.5
51.8
46.1
41.3
42.0
47.6
42.2
37.8
41.9
38.0
40.3
49.5
42.6
38.7
38.0
39.5
38.0
46.1
53.4
47.2
46.8
41.8
41.9
46.5
42.4
40.1
38.5
41.6
38.3
39.8
41.2
44.3
34.0
40.4
44.2
50.4
42.7
43.7
52.5
43.3
35.6
40.9
38.6
38.0
46.1
41.5

17339
83526
114702
13301
99284
49232
10184
38425
65431
5787
58983
10495
2513430
226451
2195599
109232
11107
94747
16600
704
4424
11156
234747
27238
200613
135447
11846
119866
38361
41249
169910
13001
153328
14357
289612
25188
242365
779507
41900
67066
60289
600853
42294
9725
32016
183617
18720
159969
15080
7409
67174
45658
24668
62538

91.3
92.9
93.4
93.2
93.4
94.7
94.3
94.7
92.0
92.2
92.0
90.7
93.1
92.4
93.1
93.7
93.1
93.7
91.3
90.8
91.3
91.5
91.3
92.1
91.1
93.5
92.0
93.6
89.3
92.9
93.7
92.8
93.7
93.9
94.4
94.2
94.3
94.1
95.8
93.5
95.3
93.9
92.9
91.8
93.2
91.0
89.6
91.1
95.7
93.7
94.0
94.4
92.0
91.1

2.1
2.1
1.2
0.8
1.3
1.4
1.1
1.5
2.7
2.8
2.7
4.8
2.1
2.3
2.1
1.6
1.4
1.7
3.5
3.6
3.2
3.5
1.9
1.6
2.0
3.0
4.3
2.9
2.3
1.7
1.0
1.3
1.0
2.1
1.4
1.3
1.4
1.2
0.6
1.3
0.9
1.3
2.0
1.9
2.0
4.0
4.7
4.0
0.3
1.9
1.1
0.7
1.8
3.2

1.8
1.7
1.7
1.9
1.7
0.5
0.5
0.5
2.4
1.8
2.5
0.7
1.2
1.3
1.2
1.0
1.3
0.9
1.0
1.3
0.8
1.0
1.8
1.6
1.9
1.5
1.6
1.5
1.0
1.0
0.9
1.0
0.9
0.4
0.6
0.6
0.6
0.9
0.6
0.9
0.7
0.9
2.3
2.6
2.2
2.0
2.2
1.9
0.2
0.5
1.1
1.0
0.9
2.7

42.5
41.5
41.5
46.8
41.2
41.4
46.7
40.3
45.1
51.7
44.7
41.8
41.9
49.6
41.9
41.7
46.1
42.0
40.8
44.0
42.6
39.8
39.3
45.3
38.9
44.8
53.9
45.1
44.6
41.3
43.4
51.7
43.5
42.2
39.5
46.6
39.5
40.7
34.1
48.3
31.1
41.7
43.6
50.8
41.9
42.3
51.1
42.1
36.3
40.4
38.2
38.0
45.7
41.2

929
14287
56776
2586
4472
53528
5884
4311
9751
24258
975
22147
4034
5555
2548
48406
43823
2818
9375
10601
14186
31858
22050
95011
18940

84.4
65.5
84.4
61.3
77.9
58.4
78.0
95.3
73.3
82.9
76.4
80.5
88.0
82.5
83.0
85.4
87.3
90.1
77.9
78.6
84.5
78.6
81.5
77.6
78.5

6.5
0.0
1.5
0.5
2.2
0.6
0.1

0.5
0.1
0.0
0.0
1.0
0.0
0.0
1.2
9.3
0.0
0.0
0.1
0.0
0.0
0.4
4.0
3.2
2.6
5.1
1.1
0.0
0.0
0.7
0.0
1.0

67.8
71.7
60.7

944
10208
45492
1507
3540
45495
3748
4081
10537
23244
742
21890
4165
6453
2576
52172
48449
2414
6901
7972
10260
22387
16464
66166
13733

91.4
73.7
87.7
71.1
81.8
67.9
86.4
96.8
78.7
80.6
82.3
82.6
92.3
82.8
91.0
88.7
90.2
91.7
78.1
76.3
86.0
77.1
80.9
75.8
76.9

4.9
0.0
1.4
0.5
1.9
0.6
0.1

0.4
0.1
0.0
0.0
0.8
0.0
0.0
0.7
5.2
0.0
0.0
0.1
0.0
0.0
0.3
2.3
1.8
2.3
5.7
1.1
0.0
0.0
0.6
0.0
0.9

47.8
56.0 *
47.1
*
52.6
43.5 *
*
18.9 *
33.5
*
46.0
32.1
*
*
*
42.0

2.7
2.4
4.3
6.9
3.4
6.1
5.8
3.3
2.8
2.1
17.0
4.3
3.1
11.3
7.7
11.6
9.9

80.3
56.7
24.9
44.1
54.9
37.8
46.0
57.1
55.8
47.6
50.4
56.5
67.9
57.2

2.7
2.1
5.0
6.5
2.0
6.5
3.6
3.0
2.5
2.0
16.2
5.4
4.1
13.0
8.6
11.8
10.3

50.2
53.4
42.1
46.1
51.6
61.6
52.2

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

829

887

Indices of data quality

All sites but skin (C00-96/C44) (contd)

Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Male
Cases MV(%) DCO(%) UB(%) MI(%)

Female
Cases MV(%) DCO(%) UB(%) MI(%)

241155
21999
14900
7084
7563
12740
1878
59431
3804
1294
1625
3409
4638
1859
4454
14119
17810
15516
776
1518
5618
3538
2846
4762
15907

72.2
67.5
76.5
76.8
71.6
74.6
72.0
74.2
73.9
79.5
88.2
84.6
84.3
89.3
89.5
63.9
87.5
87.6
87.8
86.0
71.1
59.9
82.8
86.7
88.2

6.1
4.6
4.2
4.3
3.2
2.9
2.0
6.8
4.4
16.5
8.7
6.2
7.7
1.1
1.1
12.7
0.0
0.0
0.0
0.0
10.9
12.7
4.4
1.8
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.3
0.0
0.0
0.5
0.2
0.0
0.3
0.7
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
2.0
1.7

62.2
64.8
57.2
58.5
55.7
61.1
61.7
49.6
60.0

183620
17248
12038
5899
6245
10804
1531
50666
3096
1648
1368
3896
4787
1627
4085
18638
18185
15768
781
1636
6554
3572
2990
3433
9884

78.8
75.7
82.2
83.0
80.1
80.9
75.8
81.4
81.5
86.9
90.7
87.8
88.8
92.3
93.2
77.6
92.4
92.2
94.4
93.0
81.6
71.3
88.9
88.7
92.0

5.8
4.7
4.1
3.8
4.0
2.9
1.7
6.5
4.6
10.8
7.8
4.1
5.8
0.5
0.5
8.1
0.0
0.0
0.0
0.1
7.5
8.8
2.7
1.2
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
0.2
0.0
0.2
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
2.1
1.1

46.1
49.9
42.8
40.0
40.3
44.0
48.3
35.9
43.1

93110
8425
3941
77140
20055
67116
69185
52071
119560
61586
12979
54512
13603
8068
6181
9136
12391
13093
15210
6560
7230
5332
7567
32591
56994
20426
22953
30171
32802
15479
2736
36298
3436
9837
6920
20359
10796
3041
17602
10509
4979
35578
7500
3347
7079
18632
8952
5541
3327
2931
15768
13663
7717
26664

91.2
94.7
90.2
81.1
97.5
91.4
59.4
74.1
83.5
88.8
86.2
93.3
94.7
92.6
96.4
95.8
97.6
93.6
97.6
97.2
94.1
94.3
97.5
78.4
81.9
75.1
81.1
86.0
83.0
92.0
97.1
83.7
85.4
83.0
84.1
80.1
79.5
85.6
82.4
87.0
71.0
88.9
85.3
76.9
86.5
87.0
73.9
81.7
78.3
86.4
86.5
82.1
87.5
85.3

7.2
1.4
4.4

0.1
0.0
1.3
0.0
0.0
6.4
0.1
18.9
0.7
3.2
0.0
0.9
0.2
0.1
0.1
1.2
0.0
1.3
0.1
0.0
0.8
0.2
1.1
2.0
0.2
0.0
0.5
0.0
1.0
0.1
0.0
0.9
0.5
0.0
0.0
0.0
0.0
0.4
0.0
0.0
0.0
0.0
0.0
1.7
0.0
0.0
0.0
0.9
2.3
0.0
0.1
10.8
0.0
0.0

51.7
39.9
40.2
73.6

85705
7025
3248
69885
16085
53701
62577
45175
111613
66532
13263
54789
10427
6207
4596
7329
9563
10454
11068
4781
5241
3881
5218
29100
56099
20651
20322
29067
30746
14081
2646
33352
2831
8259
6051
17330
9029
2264
17061
8869
3890
29752
6730
2755
6310
15147
7319
4523
2790
2281
13360
11151
6365
22403

89.5
92.3
87.6
88.0
97.7
91.4
72.0
74.1
83.8
90.3
90.1
92.4
94.9
93.8
96.1
95.4
97.6
94.5
98.3
97.6
93.5
93.2
97.4
77.1
81.4
75.1
79.6
85.5
82.4
90.8
96.4
85.2
85.4
85.4
86.8
81.5
80.6
84.8
83.7
88.9
77.8
88.5
85.3
82.0
87.9
87.2
75.6
84.4
84.2
86.8
87.0
82.2
87.3
86.2

8.6
2.5
7.5

0.2
0.0
1.0
0.0
0.0
6.3
0.1
19.2
1.2
2.7
0.0
0.9
0.2
0.1
0.1
1.0
0.0
0.9
0.0
0.0
0.9
0.1
1.4
1.8
0.2
0.0
0.4
0.0
0.9
0.0
0.0
1.0
0.7
0.0
0.0
0.0
0.0
0.6
0.0
0.0
0.0
0.0
0.0
1.1
0.0
0.0
0.0
0.9
1.2
0.0
0.1
10.6
0.0
0.0

52.8
45.5
41.6
55.3 *
*
47.2
51.9 *
52.8
56.3
57.0
57.4
44.8
43.8
50.5
45.4
47.5
47.1
42.8
46.5
54.2
51.4
47.3
56.3
117.0
41.1
59.0
38.5
46.2
51.8
51.1
45.1
49.5
49.2
42.2
41.5
42.4
41.9
52.2
50.8
41.6
44.0
49.0
44.2
44.8
43.0
44.8
46.6
40.3
43.4
48.4
47.8
48.4
38.2
43.9

15.5
7.0
4.5
0.5
0.6
1.2

0.1
17.5
14.1
9.2
16.0
8.2
9.3
4.9
0.1
2.6
1.1
1.7
0.8
0.7
1.4
2.0
1.4
0.3
2.4
0.6
0.7
2.7
0.2
1.6
2.8
3.1
3.2
0.3
1.4
0.5
0.2
1.3

50.0
29.3

64.9
10.5
79.8
79.4
36.5
54.8

52.6
65.5
66.0
65.3
62.2
69.7
48.6
50.6
59.6
52.1
53.0
55.5
51.9
54.5
62.9
61.3
53.4
66.3
117.9
42.5
57.7
41.2
45.2
53.9
53.3
48.2
52.9
52.6
50.5
51.8
49.2
47.5
52.1
53.2
48.0
52.6
52.5
49.6
53.1
50.7
50.2
56.9
52.5
56.3
52.8
48.6
55.0
45.3
49.2

*Important. See note on population page.

888

830

11.7
6.6
4.8
0.4
0.5
1.4

0.2
18.9
14.8
9.7
17.5
8.6
9.2
5.2
0.1
3.0
2.0
2.5
1.2
1.0
2.0
2.3
2.6
0.5
2.8
0.9
1.0
3.2
0.3
2.0
2.6
3.0
2.9
0.6
1.7
1.0
0.5
1.8

39.9
22.6

47.7

*
*
*

8.8 *
65.8 *
59.2
22.7 *
38.1 *

Europ
Latv
Lithu
Malt
Norw
Polan
Polan
Polan
Portu
Portu
Russ
Serb
Slov
Slov
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Swed
Swit
Swit
Swit
Swit
Swit
Swit
Swit
The
The
The
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
UK,
Ocea
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Aust
Fren
New
USA
USA
USA
USA
USA
USA

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Indices of data quality

All sites but skin (C00-96/C44) (contd)

)
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Male
Cases MV(%) DCO(%) UB(%) MI(%)

Female
Cases MV(%) DCO(%) UB(%) MI(%)

20144
32138
3238
53499
6542
12434
13764
27082
31316
34854
41152
48834
20324
3185
16262
24741
13842
2608
8082
8049
12291
7944
6609
9811
106443
5372
2670
2190
5771
4110
3410
7993
170303
11212
10702
32929
30029
51419
84893
27816
91379
147351
58248
63438
15649
65898

71.2
81.0
86.4
91.7
61.6
80.0
83.0
96.9
83.0
74.6
79.5
82.0
97.0
85.7
89.2
88.2
87.9
77.8
88.5
86.0
87.8
90.1
86.9
91.4
98.4
93.0
89.7
92.6
94.1
89.7
91.3
94.2
94.8
94.7
95.9
83.9
77.4
80.1
78.8
85.8
74.3
76.4
77.8
83.2
78.1
84.4

20734
30469
3261
49387
7558
10326
15413
22207
25333
45729
39120
42120
18820
2029
10480
15568
9974
1585
5221
5888
8380
5221
4444
6535
98687
5031
2159
1912
4680
3767
2761
7218
163202
10199
9567
31523
29546
49763
81004
26648
90040
147148
57044
59504
16684
67318

80.1
84.6
89.3
92.0
73.7
80.2
85.5
96.7
83.9
78.8
82.5
84.9
97.0
86.1
88.0
87.5
89.2
79.4
87.7
88.0
89.0
89.1
86.2
90.0
98.2
93.2
90.9
94.4
93.8
91.3
93.4
94.0
95.6
95.8
96.1
85.0
77.8
79.5
77.1
86.0
74.5
77.2
79.5
83.9
82.8
85.1

80965
1258
46460
21017
6277
56503
20948
2879
1168
46203
13815
924
1924
1647
4061
4354

91.3
93.7
88.3
91.4
90.1
89.8
92.5
91.6
89.4
89.5
95.3
95.0
94.8
94.5
95.8
95.5

67690
921
38176
17515
5393
50009
17420
2663
1164
40477
12368
794
1464
1897
3699
3543

91.6
93.8
90.0
91.6
92.0
90.6
92.4
92.4
91.2
90.7
96.0
95.3
97.2
96.1
95.9
95.7

5.6
1.5
2.0
0.9
8.9
2.8
0.5

75.9
67.3
61.0
52.3
72.3
67.5
81.5
59.4
57.2
83.6
69.6
71.8
66.3
53.1
62.8
52.3
56.4
57.1
50.8
62.1
52.5
51.8
49.2
69.2
52.1
40.0
51.2
50.6
47.3
53.2
48.9
46.3
60.7

0.3
5.0
2.0
2.4
1.1
1.9
7.8
5.6
5.1
1.2
0.5

0.3
0.0
0.0
0.0
0.0
3.7
0.2
0.0
0.0
6.3
0.1
1.3
1.3
1.1
1.2
0.7
1.1
1.0
0.7
0.1
0.8
0.1
0.3
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
2.4
0.4
1.8
0.0
8.5
6.6
4.8
1.3
0.0
0.0
0.9

0.9
1.0
1.3
0.0
0.5
2.0
3.3
0.6
7.0
2.7
0.7
1.0
0.8
0.7
0.7
0.6

0.0
0.0
0.2
0.3
0.5
1.5
0.1
0.0
1.5
0.0
0.3
0.1
0.3
0.2
0.3
0.4

41.9
40.5
39.5
42.1
46.0
45.0
41.9
42.0
58.3
43.5
39.7

13.0
9.5
9.7
1.6
4.2
3.6
2.7
4.0
7.9
3.7
0.7
3.4
1.8
5.7
4.3
0.3
0.2
1.2
0.5
2.7
0.7
3.1

58.0
54.8
58.5
57.1
56.6
54.4
56.6
56.7
56.9
56.6
59.3
57.3

36.4

4.6
1.3
2.0
0.8
6.6
2.8
0.6

62.0
55.5
47.9
49.1
58.2 *
55.2
70.6
46.9 *
49.8
69.8
55.5
56.9
55.7
50.7
53.9
48.0
49.6
51.0
45.1
52.2
43.9
47.1
44.7
62.2
51.3
35.8
47.6
46.9
47.0
46.9
43.5
40.2
52.2

0.3
5.3
2.2
1.8
1.4
2.0
8.3
6.0
5.4
1.6
0.6

0.2
0.0
0.0
0.0
0.0
4.1
0.3
0.1
0.0
5.4
0.2
1.0
1.0
0.8
1.1
0.5
0.9
0.9
0.5
0.0
0.5
0.0
0.2
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.9
0.3
2.0
0.0
8.2
7.1
4.5
1.1
0.0
0.0
0.8

1.1
0.8
1.4
0.0
0.5
2.2
2.9
0.9
4.8
2.9
0.6
0.6
0.3
0.8
0.5
0.8

0.0
0.0
0.2
0.3
0.1
1.3
0.2
0.0
1.5
0.1
0.3
0.4
0.3
0.2
0.3
0.3

38.7
37.4
34.5
40.1
43.0
41.1
38.4
41.9
43.4
44.3
34.6

12.8
7.9
8.5
1.9
4.7
3.8
3.9
3.9
8.1
4.4
1.0
3.3
2.2
6.4
5.0
0.9
0.4
0.8
0.8
3.3
0.5
3.8

49.7
51.3
56.4
54.6
54.1
53.2
53.2
54.2
52.7
53.5
52.4
54.5

34.4

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

831

889

Percentage of other and unspecified site (O&U)


and unknown age (Unk), all sites
Male
Africa
Algeria, Setif
Egypt, Gharbiah
Tunisia, Centre, Sousse
Uganda, Kyadondo County
Zimbabwe, Harare: African
America, Central and South
Argentina, Bahia Blanca
Brazil, Brasilia
Brazil, Cuiaba
Brazil, Goiania
Brazil, Sao Paulo
Chile, Valdivia
Colombia, Cali
Costa Rica
Ecuador, Quito
France, La Martinique
Peru, Trujillo
America, North
Canada (Excluding Quebec, Yukon and Nunavut)
Canada, Alberta
Canada, British Columbia
Canada, Manitoba
Canada, New Brunswick
Canada, Newfoundland and Labrador
Canada, Northwest Territories
Canada, Nova Scotia
Canada, Ontario
Canada, Prince Edward Island
Canada, Saskatchewan
USA, Alabama
USA, Alabama: Black
USA, Alabama: White
USA, Alaska
USA, Arizona
USA, California
USA, California: Asian and Pacific Islander
USA, California: Black
USA, California: Hispanic White
USA, California: Non-Hispanic White
USA, California, Greater San Francisco Bay Area
USA, California, Greater San Francisco Bay Area: Black
USA, California, Greater San Francisco Bay Area: Chinese
USA, California, Greater San Francisco Bay Area: Filipino
USA, California, Greater San Francisco Bay Area: Japanese
USA, California, Greater San Francisco Bay Area: Hispanic White
USA, California, Greater San Francisco Bay Area: Non-Hispanic White
USA, California, Los Angeles County
USA, California, Los Angeles County: Black
USA, California, Los Angeles County: Chinese
USA, California, Los Angeles County: Filipino
USA, California, Los Angeles County: Japanese
USA, California, Los Angeles County: Korean
USA, California, Los Angeles County: Hispanic White
USA, California, Los Angeles County: Non-Hispanic White
USA, Colorado
USA, Connecticut
USA, Connecticut: Black
USA, Connecticut: White
USA, District of Columbia
USA, District of Columbia: Black
USA, District of Columbia: White
USA, Florida
USA, Florida: Black
USA, Florida: White
USA, Georgia
USA, Georgia: Black
USA, Georgia: White
USA, Georgia, Atlanta
USA, Georgia, Atlanta: Black
USA, Georgia, Atlanta: White
USA, Idaho
USA, Illinois
USA, Illinois: Black
USA, Illinois: White
USA, Indiana
USA, Iowa
USA, Kentucky
USA, Louisiana
USA, Louisiana: Black
USA, Louisiana: White
USA, Louisiana, New Orleans: Black
USA, Louisiana, New Orleans: White

Unk

3.0
6.1
3.5
4.1
2.3

2.8
2.5

2.6
5.5
3.9
3.3
2.4

2.3
1.9

*
*
*

4.7
3.9
4.8
2.3
4.3
5.9
6.1
4.6
2.8
1.6
2.6

2.7
6.1
1.1
0.3
10.5
0.0
4.6
0.9
0.7
-

3.2
4.3
5.8
2.0
4.1
6.4
6.3
4.1
3.5
2.7
2.8

2.4
5.3
1.3
0.3
10.7
0.1
3.7
0.4
0.5
0.0
-

3.3
2.7
2.9
2.2
1.9
3.1
1.5
3.6
3.8
2.3
3.0
2.8
2.9
2.8
1.8
3.2
2.5
2.5
2.5
2.7
2.6
2.5
3.0
2.5
2.3
1.9
2.4
2.5
2.5
2.5
2.0
2.7
3.3
2.0
2.7
2.5
2.5
2.0
2.4
2.0
2.5
2.5
2.5
2.7
2.9
2.7
2.5
2.5
2.5
2.1
2.1
2.1
2.8
2.5
3.0
2.4
2.4
1.9
2.7
2.4
2.8
2.2
3.1
2.6

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
-

3.8
4.0
4.0
2.9
2.3
3.8
4.2
3.7
3.0
4.6
3.1
3.6
3.0
1.8
3.6
3.2
2.7
3.6
3.2
3.2
3.2
4.2
3.2
3.0
2.4
3.1
3.2
3.0
3.2
2.5
2.4
2.3
2.2
3.0
3.1
3.0
2.7
2.7
2.8
3.5
3.8
3.1
3.1
3.5
3.1
3.0
3.5
2.9
2.5
3.2
2.3
3.2
3.1
3.6
3.1
2.9
2.7
3.0
2.8
3.2
2.6
3.5
2.9

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

*Important. See note on population page.

890

832

Female
O&U
Unk

O&U

Ame
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Asia
Bah
Ch
Ch
Ch
Ch
Ch
Ch
Cy
Ind
Ind
Ind
Ind
Ind
Ind
Ind
Isra
Isra
Isra
Jap
Jap
Jap
Jap
Jap
Jap
Jap

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Percentage of other and unspecified site (O&U)


and unknown age (Unk), all sites (Contd)
Male
America, North (contd)
USA, Maine
USA, Massachusetts
USA, Michigan
USA, Michigan: Black
USA, Michigan: White
USA, Michigan, Detroit
USA, Michigan, Detroit: Black
USA, Michigan, Detroit: White
USA, Missouri
USA, Missouri: Black
USA, Missouri: White
USA, Montana
USA, NPCR
USA, NPCR: Black
USA, NPCR: White
USA, New Jersey
USA, New Jersey: Black
USA, New Jersey: White
USA, New Mexico
USA, New Mexico: American Indian
USA, New Mexico: Hispanic White
USA, New Mexico: Non-Hispanic White
USA, New York State
USA, New York State: Black
USA, New York State: White
USA, Ohio
USA, Ohio: Black
USA, Ohio: White
USA, Oklahoma
USA, Oregon
USA, Pennsylvania
USA, Pennsylvania: Black
USA, Pennsylvania: White
USA, Rhode Island
USA, SEER (9 Registries)
USA, SEER (9 Registries): Black
USA, SEER (9 Registries): White
USA, SEER (14 Registries)
USA, SEER (14 Registries): Asian and Pacific Islander
USA, SEER (14 Registries): Black
USA, SEER (14 Registries): Hispanic White
USA, SEER (14 Registries): Non-Hispanic White
USA, South Carolina
USA, South Carolina: Black
USA, South Carolina: White
USA, Texas
USA, Texas: Black
USA, Texas: White
USA, Utah
USA, Vermont
USA, Washington State
USA, Washington, Seattle
USA, West Virginia
USA, Wisconsin
Asia
Bahrain: Bahraini
China, Guangzhou City
China, Hong Kong
China, Jiashan
China, Nangang District, Harbin City
China, Shanghai
China, Zhongshan
Cyprus
India, Chennai (Madras)
India, New Delhi
India, Karunagappally
India, Mumbai (Bombay)
India, Nagpur
India, Poona
India, Trivandrum
Israel
Israel: Jews
Israel: Non-Jews
Japan, Aichi Prefecture
Japan, Fukui Prefecture
Japan, Hiroshima
Japan, Miyagi Prefecture
Japan, Nagasaki Prefecture
Japan, Osaka Prefecture
Japan, Yamagata Prefecture

Female
O&U
Unk

O&U

Unk

2.6
2.4
2.3
2.4
2.3
1.8
2.0
1.7
2.7
3.2
2.7
2.4
2.5
2.7
2.5
2.1
2.4
2.1
2.7
3.3
3.1
2.6
2.0
2.0
2.0
2.8
2.9
2.9
2.3
2.4
2.4
2.7
2.4
2.3
2.0
2.2
2.0
2.3
2.4
2.4
2.6
2.3
2.6
2.7
2.5
2.8
3.0
2.8
1.8
2.4
1.8
1.6
2.5
3.5

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

3.1
3.1
3.0
3.2
3.0
2.4
2.8
2.3
3.4
3.9
3.3
3.0
3.0
3.4
3.0
2.8
3.4
2.8
3.3
5.4
3.6
3.1
2.6
2.8
2.6
3.3
3.9
3.3
2.6
3.1
3.3
3.8
3.2
2.9
2.7
3.1
2.6
2.9
2.5
3.3
3.1
2.9
2.9
3.2
2.8
3.1
3.6
3.1
2.6
2.9
2.2
2.2
2.9
3.3

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-

4.7
3.2
4.2
0.8
1.3
2.7
0.6
2.1
6.3
7.4
11.6
5.4
11.2
5.9
9.7
3.4
3.4
3.8
2.3
0.8
0.9
1.1
1.0
1.3
0.9

0.1
2.9
0.8
0.6
0.2
1.2
0.9
0.1
0.0
0.0
0.0
-

2.5
3.6
4.2
1.1
1.0
3.2
1.0
1.9
3.1
4.7
9.7
3.6
6.7
4.1
6.6
3.8
3.7
4.1
3.0
1.3
1.1
1.5
1.3
1.9
1.3

0.1
0.1
1.9
0.8
0.1
0.2
1.3
0.8
0.1
0.0
-

*
*
*
*
*
*
*
*
*

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

833

891

Percentage of other and unspecified site (O&U)


and unknown age (Unk), all sites (Contd)
Male
Asia (contd)
Korea
Korea, Busan
Korea, Daegu
Korea, Daejeon
Korea, Gwangju
Korea, Incheon
Korea, Jejudo
Korea, Seoul
Korea, Ulsan
Kuwait: Kuwaitis
Kuwait: Non-Kuwaitis
Malaysia, Penang
Malaysia, Sarawak
Oman: Omani
Pakistan, South Karachi
Philippines, Manila
Singapore
Singapore: Chinese
Singapore: Indian
Singapore: Malay
Thailand, Chiang Mai
Thailand, Lampang
Thailand, Songkhla
Turkey, Antalya
Turkey, Izmir
Europe
Austria
Austria, Tyrol
Austria, Vorarlberg
Belarus
Belgium, Antwerp
Belgium, Flanders
Bulgaria
Croatia
Czech Republic
Denmark
Estonia
Finland
France, Bas-Rhin
France, Calvados
France, Doubs
France, Haut-Rhin
France, Herault
France, Isere
France, Loire-Atlantique
France, Manche
France, Somme
France, Tarn
France, Vendee
Germany, Brandenburg
Germany, Free State of Saxony
Germany, Hamburg
Germany, Mecklenburg-Western Pomerania
Germany, Munich
Germany, Northrhine-Westphalia: Munster
Germany, Saarland
Iceland
Ireland
Italy, Biella Province
Italy, Brescia Province
Italy, Ferrara Province
Italy, Florence and Prato
Italy, Genoa Province
Italy, Macerata Province
Italy, Milan
Italy, Modena Province
Italy, Naples
Italy, North East Cancer Surveillance Network
Italy, Parma Province
Italy, Ragusa Province
Italy, Reggio Emilia Province
Italy, Romagna Region
Italy, Salerno Province
Italy, Sassari Province
Italy, Syracuse Province
Italy, Sondrio
Italy, Torino
Italy, Umbria Region
Italy, Varese Province
Italy, Veneto Region

Unk

2.1
2.1
2.4
2.1
2.4
1.8
2.2
2.2
1.6
5.1
4.5
8.5
5.9
5.5
10.5
5.2
2.3
2.2
3.5
2.8
14.9
8.3
5.1
2.9
3.5

0.0
0.5
0.1
0.1
0.1
1.3
0.0
0.0
0.1
0.2
0.1

2.3
2.5
2.5
2.2
2.3
2.0
2.3
2.4
1.7
3.2
3.3
6.1
4.8
5.7
6.4
4.0
2.1
2.1
2.1
2.4
10.7
5.9
3.4
2.1
3.9

0.0
0.2
0.4
0.1
0.1
1.3
0.1
0.1
0.4
0.1

1.3
1.2
1.4
2.5
2.1
3.3
4.7
3.4
2.4
3.7
2.6
2.2
2.9
2.6
2.0
1.8
2.6
2.7
4.2
2.8
3.7
3.2
3.7
2.4
2.7
1.9
2.6
3.4
2.2
2.5
1.9
3.6
2.2
0.5
1.6
1.7
2.2
1.9
1.9
2.0
3.1
2.6
1.7
2.3
1.4
1.6
2.3
2.5
1.8
1.8
1.8
1.1
1.7
2.0

0.1
-

1.9
2.2
1.8
1.7
2.6
3.9
3.6
3.5
2.8
3.9
2.1
3.4
3.1
1.9
2.3
1.7
2.2
2.7
3.8
3.1
3.7
4.7
3.6
2.9
3.5
2.2
3.3
3.7
3.1
2.9
3.1
4.4
2.7
0.8
2.6
2.3
2.9
2.6
2.6
2.5
3.4
2.9
2.2
2.6
1.8
2.1
2.8
3.1
1.6
2.4
2.4
1.2
2.3
2.4

0.2
0.0
-

*Important. See note on population page.

892

834

Female
O&U
Unk

O&U

*
*
*

*
*
*
*

*
*
*

Euro
Lat
Lit
Ma
No
Pol
Pol
Pol
Por
Por
Ru
Ser
Slo
Slo
Spa
Spa
Spa
Spa
Spa
Spa
Spa
Spa
Spa
Spa
Spa
Sw
Sw
Sw
Sw
Sw
Sw
Sw
Sw
The
The
The
UK
UK
UK
UK
UK
UK
UK
UK
UK
UK
UK
Oce
Au
Au
Au
Au
Au
Au
Au
Au
Fre
Ne
US
US
US
US
US
US

*Imp
Cancer Incidence in Five Continents Vol. IX, IARC 2007

Percentage of other and unspecified site (O&U)


and unknown age (Unk), all sites (Contd)
Male
Europe (contd)
Latvia
Lithuania
Malta
Norway
Poland, Cracow
Poland, Kielce
Poland, Warsaw City
Portugal, Porto
Portugal, South Regional
Russia, St Petersburg
Serbia
Slovak Republic
Slovenia
Spain, Albacete
Spain, Asturias
Spain, Basque Country
Spain, Canary Islands
Spain, Cuenca
Spain, Girona
Spain, Granada
Spain, Murcia
Spain, Navarra
Spain, Tarragona
Spain, Zaragoza
Sweden
Switzerland, Geneva
Switzerland, Graubunden and Glarus
Switzerland, Neuchatel
Switzerland, St Gall-Appenzell
Switzerland, Ticino
Switzerland, Valais
Switzerland, Vaud
The Netherlands
The Netherlands, Eindhoven
The Netherlands, Maastricht
UK, East of England Region
UK, England, Merseyside and Cheshire
UK, England, North Western
UK, England, Northern and Yorkshire
UK, England, Oxford Region
UK, England, South and Western Regions
UK, England, Thames
UK, England, Trent
UK, England, West Midlands
UK, Northern Ireland
UK, Scotland
Oceania
Australia, New South Wales
Australia, Northern Territory
Australia, Queensland
Australia, South
Australia, Tasmania
Australia, Victoria
Australia, Western
Australian Capital Territory
French Polynesia
New Zealand
USA, Hawaii
USA, Hawaii: Chinese
USA, Hawaii: Filipino
USA, Hawaii: Hawaiian
USA, Hawaii: Japanese
USA, Hawaii: White

Female
O&U
Unk

O&U

Unk

2.6
2.5
4.0
2.8
6.4
4.4
3.5
1.7
3.7
1.8
2.6
2.3
1.3
3.7
5.5
3.8
4.3
2.8
3.1
3.3
2.8
2.3
2.7
1.6
3.8
1.5
2.0
2.0
2.2
3.1
1.9
1.7
4.2
3.9
5.4
3.8
3.6
6.2
4.1
4.9
3.2
5.2
4.1
5.1
3.8
3.8

6.1
0.0
0.1
0.4
0.1
0.1
0.2
2.7
0.1
0.1
-

2.0
2.1
4.3
3.9
6.0
4.5
3.3
1.6
3.9
1.7
2.6
2.5
1.6
5.2
6.2
4.6
4.3
4.6
3.7
3.5
3.4
3.0
3.1
1.8
5.2
1.8
2.9
2.5
2.3
4.0
2.1
2.0
4.3
4.0
5.4
4.6
3.5
7.3
5.0
5.8
4.1
6.2
5.0
5.9
4.4
4.6

4.8
0.0
0.1
0.9
0.1
0.0
0.2
3.3
0.1
0.1
-

4.0
5.7
3.1
3.2
3.4
3.1
2.7
4.1
4.5
3.4
2.0
1.0
2.2
4.0
1.5
1.8

0.0
-

4.6
5.6
3.6
4.3
4.3
3.8
3.0
4.0
4.0
4.2
2.0
3.1
1.6
2.1
1.8
2.1

0.2
-

*
*

*Important. See note on population page.


Cancer Incidence in Five Continents Vol. IX, IARC 2007

835

893

Cancer Incidence in Five Continents Volume VIII: Errata


1. The data for Spain, Girona, are for the period 19951997
(three years) and not 19941997 (four years). As a consequence,
the annual population numbers indicated in the population
pyramid on page 430 are wrong. The correct numbers are:
Age
0-
5-
10-
15-
20-
25-
30-
35-
40-
45-
50-
55-
60-
65-
70-
75-
80-
85+
Total

Male
13281
13169
14864
19445
20131
19848
21060
20289
18636
16971
14746
11664
13909
13095
11250
7026
4300
2840
256524

Female
12225
12739
14496
18675
19905
19596
20496
19896
17653
16193
13876
11725
14664
14427
12963
9716
6827
5322
261394

The corrected population pyramid can be downloaded at:


http://www.iacr.com.fr/girona_pop_1995-1997.pdf.
Please note that this does not affect the incidence rates
published in the volume.
2. There were two typing errors at the top of page 88 in the
formula giving the crude rate per 100 000:
The sum of the person-years yi and the sum of cases
di should be reversed.
5 x 1755/12925220 should be replaced by 105 x
1755/12925220.
3. Page 38, table 3.1:
The O&U (Other and Unspecified) category does not include
C75. C80 was omitted from this table and should be included
in the O&U category.
4. There is a typographical error in Table 4.5 on page 47:
The ICD-O codes for the melanoma category should be
8720-8790, not 8270-8790.
5. There were typographical errors in the Miettinen formula
page 72:

(R1/R2)

1 Z/X

x = (R1 R2) / (S12 + S22)


There are typographical errors on page 72, in the right
column:

Line 23: in the population and / is the should be


replaced by in the population and is the.
Line 26: The estimate of f is given by should be
replaced by The estimate of is given by.

6. There is a typographical error on page 73, in the left


column, line 8, in the formulae:
Var (yI) = (1-p)di
The should be replaced by a p, thus:
Var (yI) = p (1-p)di
7. There is a typographical error in Table 8.1 on page 87:
In the last column, under row 85+, the figure should be
0.50, not 0.30.
8. It has come to our attention that there is a mistake in the
population data for Switzerland, Geneva (19931997). The
correct numbers are:
Age
0-
5-
10-
15-
20-
25-
30-
35-
40-
45-
50-
55-
60-
65-
70-
75-
80-
85+
Total

Male
11757
10721
10110
10766
12735
15542
17241
15888
14127
14535
13750
11340
9323
7109
5578
3587
2551
1949
188609

Female
11170
10340
9588
10650
13594
16533
17901
16023
15067
15875
14870
11748
10153
8975
7921
5978
5301
5745
207432

As a consequence, the crude, age-standardized and cumulative


rates presented in the book for Switzerland, Geneva (1993
1997) are wrong.

895

Please download the http://www.iacr.com.fr/geneva.zip file


which contains:
1. The corrected pages 448 and 449 as PDF files.
2. The age-specific tables (male and female) as a PDF file.
3. The corrected CI5VIII.POP file to be used with the CI5VIII
Windows-based software included on the CD-ROM. Please replace
the current file installed on your hard disk with this new one.

896

4. The corrected person-years at risk as text files (in CSV and


PRN formats) to be incorporated into statistical packages.
We apologize for any inconvenience this may have caused.
The Editors

899ACHEVE

4/08/09

15:16

Page 899

Achev dimprimer sur rotative


par lImprimerie Darantiere Dijon-Quetigny
en aot 2009

Dpt lgal : aot 2009


N dimpression : 29-0557
Imprim en France

You might also like